PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Dinculescu, A; Stupay, RM; Deng, WT; Dyka, FM; Min, SH; Boye, SL; Chiodo, VA; Abrahan, CE; Zhu, P; Li, QH; Strettoi, E; Novelli, E; Nagel-Wolfrum, K; Wolfrum, U; Smith, WC; Hauswirth, WW				Dinculescu, Astra; Stupay, Rachel M.; Deng, Wen-Tao; Dyka, Frank M.; Min, Seok-Hong; Boye, Sanford L.; Chiodo, Vince A.; Abrahan, Carolina E.; Zhu, Ping; Li, Qiuhong; Strettoi, Enrica; Novelli, Elena; Nagel-Wolfrum, Kerstin; Wolfrum, Uwe; Smith, W. Clay; Hauswirth, William W.			AAV-Mediated Clarin-1 Expression in the Mouse Retina: Implications for USH3A Gene Therapy	PLOS ONE			English	Article							SYNDROME TYPE-III; USHER PROTEIN NETWORK; LEBER CONGENITAL AMAUROSIS; PHOTORECEPTOR CELLS; CAUSATIVE GENE; TRANSDUCIN TRANSLOCATION; MONOCLONAL-ANTIBODIES; INDUCED DEGENERATION; ROD PHOTORECEPTORS; MOLECULAR LINKS	Usher syndrome type III (USH3A) is an autosomal recessive disorder caused by mutations in clarin-1 (CLRN1) gene, leading to progressive retinal degeneration and sensorineural deafness. Efforts to develop therapies for preventing photoreceptor cell loss are hampered by the lack of a retinal phenotype in the existing USH3 mouse models and by conflicting reports regarding the endogenous retinal localization of clarin-1, a transmembrane protein of unknown function. In this study, we used an AAV-based approach to express CLRN1 in the mouse retina in order to determine the pattern of its subcellular localization in different cell types. We found that all major classes of retinal cells express AAV-delivered CLRN1 driven by the ubiquitous, constitutive small chicken beta-actin promoter, which has important implications for the design of future USH3 gene therapy studies. Within photoreceptor cells, AAV-expressed CLRN1 is mainly localized at the inner segment region and outer plexiform layer, similar to the endogenous expression of other usher proteins. Subretinal delivery using a full strength viral titer led to significant loss of retinal function as evidenced by ERG analysis, suggesting that there is a critical limit for CLRN1 expression in photoreceptor cells. Taken together, these results suggest that CLRN1 expression is potentially supported by a variety of retinal cells, and the right combination of AAV vector dose, promoter, and delivery method needs to be selected to develop safe therapies for USH3 disorder.	[Dinculescu, Astra; Stupay, Rachel M.; Deng, Wen-Tao; Dyka, Frank M.; Min, Seok-Hong; Boye, Sanford L.; Chiodo, Vince A.; Abrahan, Carolina E.; Zhu, Ping; Li, Qiuhong; Smith, W. Clay; Hauswirth, William W.] Univ Florida, Ophthalmol, Gainesville, FL USA; [Nagel-Wolfrum, Kerstin; Wolfrum, Uwe] Johannes Gutenberg Univ Mainz, Inst Zool, Cell & Matrix Biol, Saarstr 21, Mainz, Germany; [Strettoi, Enrica; Novelli, Elena] CNR, Inst Neurosci, I-56100 Pisa, Italy	State University System of Florida; University of Florida; Johannes Gutenberg University of Mainz; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR)	Dinculescu, A (corresponding author), Univ Florida, Ophthalmol, Gainesville, FL USA.	astra@ufl.edu	Smith, W. Clay/AAQ-1589-2021; Nagel-Wolfrum, Kerstin/AAX-6477-2020; Deng, Wen-Tao/AAC-4754-2021	Deng, Wen-Tao/0000-0002-9357-0656; Novelli, Elena/0000-0002-6588-4930; hauswirth, william/0000-0002-3244-4947; Strettoi, Enrica/0000-0002-6101-599X	Usher III Initiative, Inc.,; Foundation Fighting Blindness; Research to Prevent Blindness, Inc.; Macula Vision Research Foundation; NEI grant [P30EY021721]; Deutsche Forschungsgemeinschaft (DFG) [GRK 1044]; ProRetina Stiftung; FAUN-Stiftung, Nuremberg; European Community [FP7/2009/241955, FP7/2009/242013]; BMBF [0314106]; Macula Vision Research Foundation (MVRF), USA; Foundation Fighting Blindness (FFB) [TA-NMT-0611-0538-JGU]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001427] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [T32EY007132, P30EY021721] Funding Source: NIH RePORTER	Usher III Initiative, Inc.,; Foundation Fighting Blindness(European Commission); Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); Macula Vision Research Foundation; NEI grant; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); ProRetina Stiftung; FAUN-Stiftung, Nuremberg; European Community(European Commission); BMBF(Federal Ministry of Education & Research (BMBF)); Macula Vision Research Foundation (MVRF), USA; Foundation Fighting Blindness (FFB); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Support was provided by Usher III Initiative, Inc., Foundation Fighting Blindness, Research to Prevent Blindness, Inc., and Macula Vision Research Foundation; NEI grant P30EY021721; the Deutsche Forschungsgemeinschaft (DFG, GRK 1044 to UW); the ProRetina Stiftung (UW); the FAUN-Stiftung, Nuremberg (to UW and KNW); European Community FP7/2009/241955 (SYSCILIA) (to UW) and FP7/2009/242013 (TREATRUSH) (to UW); BMBF, grant 0314106 (HOPE2) (to UW), and under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases (EUR-USH) (to KNW), and Foundation Fighting Blindness (FFB; TA-NMT-0611-0538-JGU to UW and KNW). ES is the recipient of a grant from Macula Vision Research Foundation (MVRF), USA.	ADAMUS G, 1991, VISION RES, V31, P17, DOI 10.1016/0042-6989(91)90069-H; Adato A, 2002, EUR J HUM GENET, V10, P339, DOI 10.1038/sj.ejhg.5200831; Ahmed ZM, 2013, PHYSIOL GENOMICS, V45, P987, DOI 10.1152/physiolgenomics.00135.2013; Alagramam KN, 2001, HUM MOL GENET, V10, P1709, DOI 10.1093/hmg/10.16.1709; Arshavsky VY, 2012, J BIOL CHEM, V287, P1620, DOI 10.1074/jbc.R111.305243; Baker SA, 2008, J CELL BIOL, V183, P485, DOI 10.1083/jcb.200806009; Bonnet C, 2012, CURR OPIN NEUROL, V25, P42, DOI 10.1097/WCO.0b013e32834ef8b2; Boye SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011306; Cohen M, 2007, INT J AUDIOL, V46, P82, DOI 10.1080/14992020600975279; Coleman JE, 2005, INVEST OPHTH VIS SCI, V46, P12, DOI 10.1167/iovs.04-0691; Fields RR, 2002, AM J HUM GENET, V71, P607, DOI 10.1086/342098; Geller SF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000607; Geng RS, 2012, J NEUROSCI, V32, P9485, DOI 10.1523/JNEUROSCI.0311-12.2012; Geng RS, 2009, HUM MOL GENET, V18, P2748, DOI 10.1093/hmg/ddp210; Gopal SR, 2015, J NEUROSCI, V35, P10188, DOI 10.1523/JNEUROSCI.1096-15.2015; Gurevich VV, 2011, PROG RETIN EYE RES, V30, P405, DOI 10.1016/j.preteyeres.2011.07.002; Hanson SM, 2007, J MOL BIOL, V368, P375, DOI 10.1016/j.jmb.2007.02.053; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Herrera W, 2008, INVEST OPHTH VIS SCI, V49, P2651, DOI 10.1167/iovs.07-1505; Isosomppi J, 2009, MOL VIS, V15, P1806; Jacobson SG, 2006, MOL THER, V13, P1074, DOI 10.1016/j.ymthe.2006.03.005; Joensuu T, 2001, AM J HUM GENET, V69, P673, DOI 10.1086/323610; Kassai H, 2005, NEURON, V47, P529, DOI 10.1016/j.neuron.2005.07.025; Kimberling WJ, 2010, GENET MED, V12, P512, DOI 10.1097/GIM.0b013e3181e5afb8; KNOSPE V, 1988, CURR EYE RES, V7, P1137, DOI 10.3109/02713688809001885; Kong L, 2006, NEUROBIOL DIS, V21, P468, DOI 10.1016/j.nbd.2005.08.017; Kremer H, 2006, HUM MOL GENET, V15, pR262, DOI 10.1093/hmg/ddl205; KUHN H, 1984, FEBS LETT, V176, P473, DOI 10.1016/0014-5793(84)81221-1; Maerker T, 2008, HUM MOL GENET, V17, P71, DOI 10.1093/hmg/ddm285; Malm E, 2011, EUR J OPHTHALMOL, V21, P30, DOI 10.5301/EJO.2010.5433; Mercer AJ, 2011, VISUAL NEUROSCI, V28, P453, DOI 10.1017/S0952523811000356; Millan JM, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/417217; Nagel-Wolfrum K, 2014, ADV EXP MED BIOL, V801, P741, DOI 10.1007/978-1-4614-3209-8_93; Nair KS, 2005, NEURON, V46, P555, DOI 10.1016/j.neuron.2005.03.023; Ness SL, 2003, J MED GENET, V40, P767, DOI 10.1136/jmg.40.10.767; Nevin LM, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-36; Ogun O, 2014, J CELL BIOL, V207, P375, DOI 10.1083/jcb.201404016; Overlack N, 2008, VISION RES, V48, P400, DOI 10.1016/j.visres.2007.08.021; Overlack N, 2011, BBA-MOL CELL RES, V1813, P1883, DOI 10.1016/j.bbamcr.2011.05.015; Pakarinen L, 1996, INT OPHTHALMOL, V19, P307; Pang JJ, 2008, INVEST OPHTH VIS SCI, V49, P4278, DOI 10.1167/iovs.07-1622; Pang JJ, 2006, MOL THER, V13, P565, DOI 10.1016/j.ymthe.2005.09.001; Pearring JN, 2013, PROG RETIN EYE RES, V36, P24, DOI 10.1016/j.preteyeres.2013.03.002; Peng YW, 2011, INVEST OPHTH VIS SCI, V52, P6421, DOI 10.1167/iovs.10-6557; Petrs-Silva H, 2009, MOL THER, V17, P463, DOI 10.1038/mt.2008.269; Phillips JB, 2013, GENE EXPR PATTERNS, V13, P473, DOI 10.1016/j.gep.2013.09.001; Plantinga RF, 2006, ACTA OPHTHALMOL SCAN, V84, P36, DOI 10.1111/j.1600-0420.2005.00507.x; Plantinga RF, 2005, AUDIOL NEURO-OTOL, V10, P79, DOI 10.1159/000083363; Rachel Rivka A, 2012, Cilia, V1, P22, DOI 10.1186/2046-2530-1-22; Ratnam K, 2013, JAMA OPHTHALMOL, V131, P67, DOI 10.1001/2013.jamaophthalmol.2; Reiners J, 2006, ADV EXP MED BIOL, V572, P349; Reiners J, 2005, HUM MOL GENET, V14, P3933, DOI 10.1093/hmg/ddi417; Reiners J, 2003, INVEST OPHTH VIS SCI, V44, P5006, DOI 10.1167/iovs.03-0483; Reiners J, 2006, EXP EYE RES, V83, P97, DOI 10.1016/j.exer.2005.11.010; Roepman Ronald, 2007, V43, P209, DOI 10.1007/978-1-4020-5943-8_10; Sahly I, 2012, J CELL BIOL, V199, P381, DOI 10.1083/jcb.201202012; Saihan Z, 2009, CURR OPIN NEUROL, V22, P19, DOI 10.1097/WCO.0b013e3283218807; Siegert S, 2012, NAT NEUROSCI, V15, P487, DOI 10.1038/nn.3032; SMITH RJH, 1994, AM J MED GENET, V50, P32, DOI 10.1002/ajmg.1320500107; Smith WC, 2013, PROG MOL BIOL TRANSL, V118, P243, DOI 10.1016/B978-0-12-394440-5.00010-3; Smith WC, 1996, EXP EYE RES, V62, P585; Tian G, 2009, J BIOL CHEM, V284, P18980, DOI 10.1074/jbc.M109.003160; Tian M, 2014, EXP EYE RES, V118, P145, DOI 10.1016/j.exer.2013.10.021; van Wijk E, 2006, HUM MOL GENET, V15, P751, DOI 10.1093/hmg/ddi490; van Wijk E, 2009, HUM MOL GENET, V18, P51, DOI 10.1093/hmg/ddn312; Vastinsalo H, 2011, EUR J HUM GENET, V19, P30, DOI 10.1038/ejhg.2010.140; Williams DS, 2008, VISION RES, V48, P433, DOI 10.1016/j.visres.2007.08.015; Wright RN, 2012, INVEST OPHTH VIS SCI, V53, P1519, DOI 10.1167/iovs.11-8845; Yan D, 2010, J HUM GENET, V55, P327, DOI 10.1038/jhg.2010.29; Zallocchi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030573; Zallocchi M, 2009, HEARING RES, V255, P109, DOI 10.1016/j.heares.2009.06.006; Ziccardi L, 2012, J NEUROSCI, V32, P13010, DOI 10.1523/JNEUROSCI.1913-12.2012	73	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148874	10.1371/journal.pone.0148874	http://dx.doi.org/10.1371/journal.pone.0148874			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881841	Green Published, Green Submitted, gold			2022-12-27	WOS:000371219000028
J	Johnson, RC; Vance-Borland, K				Johnson, R. C.; Vance-Borland, Ken			Linking Genetic Variation in Adaptive Plant Traits to Climate in Tetraploid and Octoploid Basin Wildrye [Leymus cinereus (Scribn. & Merr.) A. Love] in the Western US	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; POPULATION DIFFERENTIATION; CHAMERION-ANGUSTIFOLIUM; SEED TRANSFER; TRADE-OFFS; ADAPTATION; GENECOLOGY; ZONES; POLYPLOIDY; ROSACEAE	Few studies have assessed how ploidy type within a species affects genetic variation among populations in relation to source climates. Basin wildrye (Leymus cinereus (Scribn. & Merr.) A. Love) is a large bunchgrass common in the intermountain Western U.S. found in both octoploid and tetraploid types. In common gardens at two sites over two years differences in both ploidy type and genetic variation within ploidy were observed in phenology, morphology, and production traits on 57 octoploid and 52 tetraploid basin wildrye from the intermountain Western U.S. (P<0.01). Octoploids had larger leaves, longer culms, and greater crown circumference than tetraploids but the numerical ranges of plant traits and their source climates overlapped between ploidy types. Still, among populations octoploids often had greater genetic variation for traits and occupied more diverse climates than tetraploids. Genetic variation for both ploidy types was linked to source climates in canonical correlation analysis, with the first two variates explaining 70% of the variation. Regression of those canonical variates with seed source climate variables produced models that explained 64% and 38% of the variation, respectively, and were used to map 15 seed zones covering 673258 km(2). Utilization of these seed zones will help ensure restoration with adaptive seed sources for both ploidy types. The link between genetic traits and seed source climates suggests climate driven natural selection and adaptive evolution in basin wildrye. The more diverse climates occupied by octoploids and higher trait variation suggests a higher capacity for ecological differentiation than tetraploids in the intermountain Western U.S.	[Johnson, R. C.] ARS, Plant Germplasm Res & Testing, USDA, Pullman, WA USA; [Vance-Borland, Ken] Conservat Planning Inst, Corvallis, OR USA	United States Department of Agriculture (USDA)	Johnson, RC (corresponding author), ARS, Plant Germplasm Res & Testing, USDA, Pullman, WA USA.	rcjohnson@wsu.edu		Vance-Borland, Ken/0000-0003-2179-8106	United States Department of Agriculture-Agriculture Research Service; Bureau of Land Management; Great Basin Native Plant Project	United States Department of Agriculture-Agriculture Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Bureau of Land Management; Great Basin Native Plant Project	This work was funded by United States Department of Agriculture-Agriculture Research Service, Bureau of Land Management, and Great Basin Native Plant Project.	AKAIKE H, 1969, ANN I STAT MATH, V21, P243, DOI 10.1007/BF02532251; Anamthawat-Jonsson K, 2014, J SYST EVOL, V52, P716, DOI 10.1111/jse.12106; Anderson JT, 2015, AM NAT, V186, pS60, DOI 10.1086/682404; [Anonymous], 1986, MULTIVARIATE STAT ME; Bischoff A, 2010, OIKOS, V119, P445, DOI 10.1111/j.1600-0706.2009.17776.x; Bretagnolle F, 2001, INT J PLANT SCI, V162, P309, DOI 10.1086/319572; Buggs RJA, 2007, EVOLUTION, V61, P125, DOI 10.1111/j.1558-5646.2007.00010.x; CAMPBELL RK, 1986, SILVAE GENET, V35, P85; Cash SD, 1998, CROP SCI, V38, P278, DOI 10.2135/cropsci1998.0011183X003800010052x; Cochran W.G., 1967, STAT METHODS; Culumber CM, 2013, CROP SCI, V53, P996, DOI 10.2135/cropsci2012.06.0396; Davies GM, 2012, ECOL APPL, V22, P1562, DOI 10.1890/10-2089.1; Draper N.R., 1981, APPL REGRESSION ANAL, Vsecond, DOI DOI 10.1002/9781118625590; Endler J. A., 1986, NATURAL SELECTION WI; Erickson V. J., 2008, Native Plants Journal, V9, P255, DOI 10.2979/NPJ.2008.9.3.255; Espeland, 2013, NATIVE PLANTS J, V14, P231, DOI [10.3368/npj.14.3.231, DOI 10.3368/NPJ.14.3.231]; Fan X, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-247; Galloway LF, 2000, EVOLUTION, V54, P1173, DOI 10.1111/j.0014-3820.2000.tb00552.x; GATES DM, 1968, ANN REV PLANT PHYSIO, V19, P211, DOI 10.1146/annurev.pp.19.060168.001235; HANCOCK J F JR, 1979, American Journal of Botany, V66, P366; HANCOCK JF, 1981, AM J BOT, V68, P1, DOI 10.2307/2442984; Hancock N, 2013, RESTOR ECOL, V21, P569, DOI 10.1111/j.1526-100X.2012.00931.x; Hao GY, 2013, NEW PHYTOL, V197, P970, DOI 10.1111/nph.12051; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; Horning ME, 2010, RESTOR ECOL, V18, P235, DOI 10.1111/j.1526-100X.2008.00441.x; Hufford KM, 2003, TRENDS ECOL EVOL, V18, P147, DOI 10.1016/S0169-5347(03)00002-8; Husband BC, 2004, NEW PHYTOL, V161, P703, DOI 10.1046/j.1469-8137.2004.00998.x; Johnson RC, 2013, BOTANY, V91, P686, DOI 10.1139/cjb-2013-0046; Johnson RC, 2012, RANGELAND ECOL MANAG, V65, P523, DOI 10.2111/REM-D-11-00165.1; Johnson RC, 2015, EVOL APPL, V8, P172, DOI 10.1111/eva.12240; Jones TA, 2005, USDA FOREST SERVICE, P49; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; Levitt J., 1972, Responses of plants to environmental stresses.; Li WL, 1996, AM J BOT, V83, P15, DOI 10.2307/2445949; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; MACDONALD SE, 1989, AM J BOT, V76, P1627, DOI 10.2307/2444400; Manzaneda AJ, 2015, EVOLUTION, V69, P2689, DOI 10.1111/evo.12776; Maricle BR, 2007, ENVIRON EXP BOT, V60, P458, DOI 10.1016/j.envexpbot.2007.01.001; Martin SL, 2013, EVOLUTION, V67, P1780, DOI 10.1111/evo.12065; Nicotra AB, 2010, TRENDS PLANT SCI, V15, P684, DOI 10.1016/j.tplants.2010.09.008; Ogle D, 2012, PLANT GUIDE COMMON S; OMERNIK JM, 1987, ANN ASSOC AM GEOGR, V77, P118, DOI 10.1111/j.1467-8306.1987.tb00149.x; Petit C, 1997, J ECOL, V85, P657, DOI 10.2307/2960536; Ramsey J, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0352; Ramsey J, 2011, P NATL ACAD SCI USA, V108, P7096, DOI 10.1073/pnas.1016631108; Rice KJ, 2003, FRONT ECOL ENVIRON, V1, P469, DOI 10.1890/1540-9295(2003)001[0469:MMRITF]2.0.CO;2; SCHEINER SM, 1984, EVOLUTION, V38, P845, DOI 10.1111/j.1558-5646.1984.tb00356.x; St Clair JB, 2005, ANN BOT, V96, P1199, DOI [10.1093/aob/mci278, DOI 10.1093/AOB/MCI278, DOI 10.1093/A0B/MCI278]; St Clair JB, 2013, EVOL APPL, V6, P933, DOI 10.1111/eva.12077; Wang TL, 2012, J APPL METEOROL CLIM, V51, P16, DOI 10.1175/JAMC-D-11-043.1; Wang TL, 2010, ECOL APPL, V20, P153, DOI 10.1890/08-2257.1; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834	54	8	8	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148982	10.1371/journal.pone.0148982	http://dx.doi.org/10.1371/journal.pone.0148982			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881894	gold, Green Submitted, Green Published			2022-12-27	WOS:000371219000039
J	Fan, XQ; Zhang, X; Shen, J; Zhao, HB; Yu, XT; Chen, YA; Zhuang, ZN; Deng, XL; Feng, H; Wang, YF; Peng, L				Fan, Xiaoqiang; Zhang, Xiu; Shen, Jie; Zhao, Haibin; Yu, Xuetao; Chen, Yong'an; Zhuang, Zhuonan; Deng, Xiaolong; Feng, Hua; Wang, Yunfei; Peng, Long			Decreased TUSC3 Promotes Pancreatic Cancer Proliferation, Invasion and Metastasis	PLOS ONE			English	Article							NF-KAPPA-B; OVARIAN-CANCER; ADJUVANT CHEMOTHERAPY; PLUS GEMCITABINE; SURVIVAL; TRIAL; ADENOCARCINOMA; RESECTION; IMPACT; CARCINOGENESIS	Pancreatic cancer is an aggressive disease with dismal prognosis. It is of paramount importance to understand the underlying etiological mechanisms and identify novel, consistent, and easy-to-apply prognostic factors for precision therapy. TUSC3 (tumor suppressor candidate 3) was identified as a potential tumor suppressor gene and previous study showed TUSC3 is decreased in pancreatic cancer at mRNA level, but its putative tumor suppressor function remains to be verified. In this study, TUSC3 expression was found to be suppressed both at mRNA and protein levels in cell line models as well as in clinical samples; decreased TUSC3 expression was associated with higher pathological TNM staging and poorer outcome. In three pairs of cell lines with different NF-kappa B activity, TUSC3 expression was found to be reversely correlated with NF-kappa B activity. TUSC3-silenced pancreatic cancer cell line exhibited enhanced potential of proliferation, migration and invasion. In an orthotopic implanted mice model, TUSC3 silenced cells exhibited more aggressive phenotype with more liver metastasis. In conclusion, the current study shows that decreased immunological TUSC3 staining is a factor prognostic of poor survival in pancreatic cancer patients and decreased TUSC3 promotes pancreatic cancer cell proliferation, invasion and metastasis. The reverse correlation between NF-kappa B activity and TUSC3 expression may suggest a novel regulation pattern for this molecule.	[Fan, Xiaoqiang; Zhang, Xiu; Shen, Jie; Yu, Xuetao; Chen, Yong'an; Deng, Xiaolong; Feng, Hua; Wang, Yunfei; Peng, Long] Jimin Hosp, Dept Oncol, Shanghai, Peoples R China; [Zhao, Haibin] Taihu Hosp, Dept Pathol, Wuxi, Jiangsu, Peoples R China; [Zhuang, Zhuonan] Shandong Univ, Affiliated Qilu Hosp, Dept Gen Surg, Jinan 250100, Shandong, Peoples R China	Shandong University	Shen, J (corresponding author), Jimin Hosp, Dept Oncol, Shanghai, Peoples R China.	Jieshendoc@163.com			Shanghai Municipal 415 Commission of Health and Family Planning [201440345]; Shanghai Municipal Commission of Health and Family Planning [201440345]	Shanghai Municipal 415 Commission of Health and Family Planning; Shanghai Municipal Commission of Health and Family Planning	This study was supported by Shanghai Municipal 415 Commission of Health and Family Planning (Grant No. 201440345 to Xiaoqiang Fan) [http://www.wsjsw.gov.cn/wsj/]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank for Dr Paul J. Chiao from MD Anderson Cancer Center, Texas University, USA for providing cell lines as gifts and advice. This study was supported by Shanghai Municipal Commission of Health and Family Planning (Grant No. 201440345).	Ali S, 2010, J CELL BIOCHEM, V110, P171, DOI 10.1002/jcb.22523; Arbieva ZH, 2000, GENOME RES, V10, P244, DOI 10.1101/gr.10.2.244; Bashyam MD, 2005, NEOPLASIA, V7, P556, DOI 10.1593/neo.04586; Birnbaum DJ, 2011, GENE CHROMOSOME CANC, V50, P456, DOI 10.1002/gcc.20870; Chang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101452; Chen H, 2010, EJSO-EUR J SURG ONC, V36, P657, DOI 10.1016/j.ejso.2010.05.014; Combs SE, 2014, ANN SURG ONCOL, V21, P2801, DOI 10.1245/s10434-014-3607-8; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Cooke SL, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-288; Dobrovolskaia MA, 2005, CURR CANCER DRUG TAR, V5, P325, DOI 10.2174/1568009054629645; Fujioka S, 2003, ONCOGENE, V22, P1365, DOI 10.1038/sj.onc.1206323; Fujioka S, 2003, CLIN CANCER RES, V9, P346; Garcea G, 2011, WORLD J SURG, V35, P868, DOI 10.1007/s00268-011-0984-z; Harder J, 2012, BRIT J CANCER, V106, P1033, DOI 10.1038/bjc.2012.18; Horak P, 2014, SCI REP-UK, V4, DOI 10.1038/srep03739; Ishibashi H, 2003, J CLIN ENDOCR METAB, V88, P2309, DOI 10.1210/jc.2002-021353; Jamieson NB, 2005, BRIT J CANCER, V92, P21, DOI 10.1038/sj.bjc.6602305; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kratochvilova K, 2015, INT J CANCER, V137, P1330, DOI 10.1002/ijc.29502; Mohorko E, 2011, J INHERIT METAB DIS, V34, P869, DOI 10.1007/s10545-011-9337-1; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Oettle H, 2013, JAMA-J AM MED ASSOC, V310, P1473, DOI 10.1001/jama.2013.279201; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Pils D, 2005, CANCER-AM CANCER SOC, V104, P2417, DOI 10.1002/cncr.21538; Pils D, 2013, CANCER-AM CANCER SOC, V119, P946, DOI 10.1002/cncr.27850; Raimondi S, 2009, NAT REV GASTRO HEPAT, V6, P699, DOI 10.1038/nrgastro.2009.177; Raut CP, 2007, ANN SURG, V246, P52, DOI 10.1097/01.sla.0000259391.84304.2b; Sclabas Guido M, 2003, Int J Gastrointest Cancer, V33, P15, DOI 10.1385/IJGC:33:1:15; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Szkandera J, 2014, BRIT J CANCER, V110, P183, DOI 10.1038/bjc.2013.701; Vanhara P, 2013, INT J ONCOL, V42, P1383, DOI 10.3892/ijo.2013.1824; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Xu XL, 2004, WORLD J GASTROENTERO, V10, P3441; Zhou H, 2009, P NATL ACAD SCI USA, V106, P15750, DOI 10.1073/pnas.0908332106	35	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149028	10.1371/journal.pone.0149028	http://dx.doi.org/10.1371/journal.pone.0149028			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871953	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100090
J	Hennerici, T; Pollmann, R; Schmidt, T; Seipelt, M; Tackenberg, B; Mobs, C; Ghoreschi, K; Hertl, M; Eming, R				Hennerici, Tina; Pollmann, Robert; Schmidt, Thomas; Seipelt, Maria; Tackenberg, Bjoern; Moebs, Christian; Ghoreschi, Kamran; Hertl, Michael; Eming, Ruediger			Increased Frequency of T Follicular Helper Cells and Elevated Interleukin-27 Plasma Levels in Patients with Pemphigus	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; MYASTHENIA-GRAVIS; B-CELLS; DESMOGLEIN 3; SJOGRENS-SYNDROME; IMMUNE-RESPONSE; PATHOGENIC IGG; P-28 SUBUNIT; VULGARIS	Pemphigus is an autoimmune disease in which IgG auto-antibodies (auto-ab) against the desmosomal cadherins desmoglein (Dsg) 3 and Dsg1 cause loss of epidermal keratinocyte adhesion. Aim of this study was to investigate cytokines derived from antigen-presenting cells (APC) and their relation to CD4+ T cell subpopulations and to the auto-ab response in pemphigus. In this regard, patients with pemphigus were compared to patients with myasthenia gravis (MG), an unrelated auto-ab-mediated autoimmune disease, and healthy controls. In pemphigus and MG, the plasma concentrations of the APC-derived immunomodulatory cytokine IL-27 were highly increased. Strikingly, IL-27 strongly correlated with Dsg-specific IgG auto-ab titers. T helper (Th) 17 cells were augmented in both pemphigus and MG patients while T follicular helper (Tfh) cells, which are essential in providing B cell help, were increased only in pemphigus along with increasing plasma concentrations of IL-21, a cytokine produced by Th17 and Tfh cells. Moreover, we could detect Dsg3-specific autoreactive T cells producing IL-21 upon ex vivo stimulation with Dsg3. These findings suggest that IL-27 and IL-21-producing T cells, are involved in the pathogenesis of pemphigus. The further characterization of IL-21-producing T cells and of the role of IL-27 will lead to a more defined understanding of the auto-ab response in pemphigus.	[Hennerici, Tina; Pollmann, Robert; Schmidt, Thomas; Moebs, Christian; Hertl, Michael; Eming, Ruediger] Univ Marburg, Dept Dermatol & Allergol, Marburg, Germany; [Seipelt, Maria; Tackenberg, Bjoern] Univ Marburg, Dept Neurol, Marburg, Germany; [Ghoreschi, Kamran] Univ Tubingen, Dept Dermatol, Tubingen, Germany	Philipps University Marburg; Philipps University Marburg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Eming, R (corresponding author), Univ Marburg, Dept Dermatol & Allergol, Marburg, Germany.	eming@med.uni-marburg.de		Pollmann, Robert/0000-0002-4596-516X; Mobs, Christian/0000-0002-5197-7669; Ghoreschi, Kamran/0000-0002-5526-7517	German Research Foundation (Deutsche Forschungsgemeinschaft) [HE 1602/7-3]; University Hospital Giessen and Marburg GmbH, Marburg, Germany (UKGM)	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); University Hospital Giessen and Marburg GmbH, Marburg, Germany (UKGM)	This work was supported by Grant HE 1602/7-3 (to M.H. and R.E.) from the German Research Foundation (Deutsche Forschungsgemeinschaft). MH received a grant from the University Hospital Giessen and Marburg GmbH, Marburg, Germany (UKGM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amber KT, 2013, EXP DERMATOL, V22, P699, DOI 10.1111/exd.12229; Asothai R, 2015, IMMUNOBIOLOGY, V220, P1129, DOI 10.1016/j.imbio.2015.06.008; Batten M, 2010, J EXP MED, V207, P2895, DOI 10.1084/jem.20100064; Berrih-Aknin S, 2014, J AUTOIMMUN, V52, P90, DOI 10.1016/j.jaut.2013.12.011; Bovenschen HJ, 2011, J INVEST DERMATOL, V131, P1853, DOI 10.1038/jid.2011.139; Cao YX, 2008, J IMMUNOL, V180, P922, DOI 10.4049/jimmunol.180.2.922; Coquet JM, 2007, J IMMUNOL, V178, P2827, DOI 10.4049/jimmunol.178.5.2827; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Dolff S, 2011, ARTHRITIS RES THER, V13, pR157, DOI DOI 10.1186/AR3474; Eming R, 2008, J INVEST DERMATOL, V128, P2850, DOI 10.1038/jid.2008.172; Eming R, 2014, J IMMUNOL, V193, P4391, DOI 10.4049/jimmunol.1401081; Franchimont D, 2004, ANN NY ACAD SCI, V1024, P124, DOI 10.1196/annals.1321.009; Frew JW, 2011, DERMATOL CLIN, V29, P599, DOI 10.1016/j.det.2011.07.001; Ganguly D, 2013, NAT REV IMMUNOL, V13, P566, DOI 10.1038/nri3477; Gertel-Lapter S, 2013, AUTOIMMUN REV, V12, P894, DOI 10.1016/j.autrev.2013.03.009; Giordano CN, 2012, AUTOIMMUNITY, V45, P427, DOI 10.3109/08916934.2012.697593; Goldberg R, 2004, J IMMUNOL, V173, P6465, DOI 10.4049/jimmunol.173.10.6465; Goldberg R, 2004, J IMMUNOL, V173, P1171, DOI 10.4049/jimmunol.173.2.1171; Gringhuis SI, 2014, FUCOSE BASED PAMPS P, P5; Hall RP, 2015, BRIT J DERMATOL, V172, P760, DOI 10.1111/bjd.13350; Hertl M, 2006, J CLIN INVEST, V116, P1159, DOI 10.1172/JCI28547; Hertl M, 1998, J INVEST DERMATOL, V110, P62, DOI 10.1046/j.1523-1747.1998.00086.x; Honda K, 2005, INFLAMM BOWEL DIS, V11, P1044, DOI 10.1097/01.MIB.0000191611.05466.1f; Jin L, 2014, INT J CLIN EXP PATHO, V7, P1988; Kneisel A, 2011, J DTSCH DERMATOL GES, V9, P844, DOI 10.1111/j.1610-0387.2011.07793.x; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Larousserie F, 2004, J PATHOL, V202, P164, DOI 10.1002/path.1508; Li JF, 2005, J NEUROL SCI, V232, P3, DOI 10.1016/j.jns.2004.12.013; Li QT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079746; Li Y, 2014, NEUROL SCI, V35, P29, DOI 10.1007/s10072-013-1460-3; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Liu R, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4100; Liu Y, 2014, INT IMMUNOPHARMACOL, V22, P98, DOI 10.1016/j.intimp.2014.06.024; Luo CM, 2013, J NEUROIMMUNOL, V256, P55, DOI 10.1016/j.jneuroim.2012.12.001; Mobs C, 2010, J IMMUNOL, V184, P2194, DOI 10.4049/jimmunol.0901379; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Muller R, 2008, EXP DERMATOL, V17, P35, DOI 10.1111/j.1600-0625.2007.00615.x; Murrell DE, 2008, J AM ACAD DERMATOL, V58, P1043, DOI 10.1016/j.jaad.2008.01.012; Nishifuji K, 2000, J INVEST DERMATOL, V114, P88, DOI 10.1046/j.1523-1747.2000.00840.x; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Saito R, 2005, J NEUROIMMUNOL, V170, P172, DOI 10.1016/j.jneuroim.2005.09.001; Shen H, 2011, ARTHRITIS RHEUM-US, V63, P860, DOI 10.1002/art.30180; Shibata S, 2013, J INVEST DERMATOL, V133, P479, DOI 10.1038/jid.2012.313; Shibata S, 2010, J INVEST DERMATOL, V130, P1034, DOI 10.1038/jid.2009.349; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Spolski R, 2014, NAT REV DRUG DISCOV, V13, P381, DOI 10.1038/nrd4296; Stanley JR, 2008, J INVEST DERMATOL, V128, pE16, DOI [10.1038/skinbio.2008.2, DOI 10.1038/SKINBIO.2008.2]; Sugiyama H, 2007, DERMATOLOGY, V214, P210, DOI 10.1159/000099585; Tackenberg B, 2007, EUR J IMMUNOL, V37, P849, DOI 10.1002/eji.200636449; Takahashi H, 2008, J IMMUNOL, V181, P1526, DOI 10.4049/jimmunol.181.2.1526; Takahashi H, 2009, J IMMUNOL, V182, P1740, DOI 10.4049/jimmunol.182.3.1740; Tangye SG, 2013, NAT REV IMMUNOL, V13, P412, DOI 10.1038/nri3447; Veldman C, 2004, J IMMUNOL, V172, P6468, DOI 10.4049/jimmunol.172.10.6468; Wang J, 2013, CLIN EXP IMMUNOL, V174, P212, DOI 10.1111/cei.12162; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Xia L, 2012, SCAND J RHEUMATOL, V41, P73, DOI 10.3109/03009742.2011.620574; Xu RC, 2013, EUR J DERMATOL, V23, P795, DOI 10.1684/ejd.2013.2177; Yilmaz V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123546	58	38	38	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148919	10.1371/journal.pone.0148919	http://dx.doi.org/10.1371/journal.pone.0148919			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872212	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100074
J	Hu, Y; Lv, GH; Ren, SY; Johansen, D				Hu, Yan; Lv, Guohua; Ren, Siying; Johansen, Daniel			Mid- to Long-Term Outcomes of Cervical Disc Arthroplasty versus Anterior Cervical Discectomy and Fusion for Treatment of Symptomatic Cervical Disc Disease: A Systematic Review and Meta-Analysis of Eight Prospective Randomized Controlled Trials	PLOS ONE			English	Review							ADJACENT-LEVEL DEGENERATION; 7-YEAR FOLLOW-UP; SINGLE-LEVEL; ARTIFICIAL DISC; HETEROTOPIC OSSIFICATION; CONTROLLED MULTICENTER; CLINICAL-OUTCOMES; INTERBODY FUSION; RADIOGRAPHIC ANALYSIS; SEGMENTAL KINEMATICS	Purpose This study aimed to investigate the mid-to long-term outcomes of cervical disc arthroplasty (CDA) versus anterior cervical discectomy and fusion (ACDF) for the treatment of 1-level or 2-level symptomatic cervical disc disease. Methods Medline, Embase, and the Cochrane Central Register of Controlled Trials databases were searched to identify relevant randomized controlled trials that reported mid-to long-term outcomes (at least 48 months) of CDA versus ACDF. All data were analyzed by Review Manager 5.3 software. The relative risk (RR) and 95% confidence intervals (CIs) were calculated for dichotomous variables. The weighted mean difference (WMD) and 95% CIs were calculated for continuous variables. A random effect model was used for heterogeneous data; otherwise, a fixed effect model was used. Results Eight prospective randomized controlled trials (RCTs) were retrieved in this meta-analysis, including 1317 and 1051 patients in CDA and ACDF groups, respectively. Patients after an ACDF had a significantly lower rate of follow-up than that after CDA. Pooled analysis showed patients in CDA group achieved significantly higher rates of overall success, Neck Disability Index (NDI) success, neurological success and significantly lower rates of implant/surgery-related serious adverse events and secondary procedure compared with that in ACDF group. The long-term functional outcomes (NDI, Visual Analog Scale (VAS) neck and arm pain scores, the Short Form 36 Health Survey physical component score (SF-36 PCS)), patient satisfaction and recommendation, and the incidence of superior adjacent segment degeneration also favored patients in CDA group with statistical difference. Regarding inferior adjacent segment degeneration, patients in CDA group had a lower rate without statistical significance. Conclusions This meta-analysis showed that cervical disc arthroplasty was superior over anterior discectomy and fusion for the treatment of symptomatic cervical disc disease in terms of over-all success, NDI success, neurological success, implant/surgery-related serious adverse events, secondary procedure, functional outcomes, patient satisfaction and recommendation, and superior adjacent segment degeneration.	[Hu, Yan; Lv, Guohua] Cent South Univ, Xiangya Hosp 2, Dept Spine Surg, Changsha, Hunan, Peoples R China; [Ren, Siying] Cent South Univ, Xiangya Hosp 2, Dept Resp Med, Changsha, Hunan, Peoples R China; [Johansen, Daniel] Univ Calif Los Angeles, David Geffen Sch Med, Dept Orthopaed Surg, Res Ctr,Orthopaed Hosp, Los Angeles, CA 90095 USA	Central South University; Central South University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lv, GH (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Spine Surg, Changsha, Hunan, Peoples R China.	spinelv@163.com		Hu, Yan/0000-0003-0451-4642; Ren, Siying/0000-0001-6618-690X	China Scholarship Council [201306370115]	China Scholarship Council(China Scholarship Council)	Funded by China Scholarship Council No. 201306370115 (YH) http://www.csc.edu.cn.	Ament JD, 2015, SPINE, V40, P1072, DOI 10.1097/BRS.0000000000000898; Anakwenze OA, 2009, SPINE, V34, P2001, DOI 10.1097/BRS.0b013e3181b03fe6; Arts MP, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-122; Bae HW, 2015, SPINE, V40, P759, DOI 10.1097/BRS.0000000000000887; Bartels RHMA, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-85; BOHLMAN HH, 1993, J BONE JOINT SURG AM, V75A, P1298, DOI 10.2106/00004623-199309000-00005; Buchowski JM, 2009, J BONE JOINT SURG AM, V91A, P223, DOI 10.2106/JBJS.I.00564; Burkus JK, 2014, J NEUROSURG-SPINE, V21, P516, DOI 10.3171/2014.6.SPINE13996; Burkus JK, 2010, J NEUROSURG-SPINE, V13, P308, DOI 10.3171/2010.3.SPINE09513; Chen J, 2012, EUR SPINE J, V21, P674, DOI 10.1007/s00586-011-2094-x; Cheng L, 2011, CLIN ORTHOP RELAT R, V469, P3408, DOI 10.1007/s11999-011-2039-z; Coric D, 2013, J NEUROSURG-SPINE, V18, P36, DOI 10.3171/2012.9.SPINE12555; Coric D, 2011, J NEUROSURG-SPINE, V15, P348, DOI 10.3171/2011.5.SPINE10769; Davis RJ, 2015, J NEUROSURG-SPINE, V22, P15, DOI 10.3171/2014.7.SPINE13953; Davis RJ, 2013, J NEUROSURG-SPINE, V19, P532, DOI 10.3171/2013.6.SPINE12527; Delamarter RB, 2013, SPINE, V38, P711, DOI 10.1097/BRS.0b013e3182797592; DiAngelo DJ, 2003, J SPINAL DISORD TECH, V16, P314, DOI 10.1097/00024720-200308000-00002; Dmitriev AE, 2005, SPINE, V30, P1165, DOI 10.1097/01.brs.0000162441.23824.95; Ganbat D, 2014, P I MECH ENG H, V228, P200, DOI 10.1177/0954411914522024; Gandhi AA, 2015, SPINE, V40, P1578, DOI 10.1097/BRS.0000000000001044; Gao Y, 2013, J BONE JOINT SURG AM, V95A, P555, DOI 10.2106/JBJS.K.00599; Garrido BJ, 2010, J SPINAL DISORD TECH, V23, P367, DOI 10.1097/BSD.0b013e3181bb8568; Goffin J, 2004, J SPINAL DISORD TECH, V17, P79, DOI 10.1097/00024720-200404000-00001; Hacker FM, 2013, SPINE, V38, P2223, DOI 10.1097/BRS.0000000000000060; Hilibrand Alan S, 2004, Spine J, V4, p190S, DOI 10.1016/j.spinee.2004.07.007; Hilibrand AS, 1999, J BONE JOINT SURG AM, V81A, P519, DOI 10.2106/00004623-199904000-00009; Hisey MS, 2014, INT J SPINE SURG, V8, DOI 10.14444/1007; Hisey MS, 2015, J SPINAL DISORD TECH, V28, pE237, DOI 10.1097/BSD.0000000000000185; Janssen ME, 2015, J BONE JOINT SURG AM, V97A, P1738, DOI 10.2106/JBJS.N.01186; Jawahar A, 2010, SPINE J, V10, P1043, DOI 10.1016/j.spinee.2010.08.014; Karabag H, 2014, J PAK MED ASSOC, V64, P1348; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Lee JH, 2014, SPINE J, V14, P1199, DOI 10.1016/j.spinee.2013.08.010; Leung C, 2005, NEUROSURGERY, V57, P759, DOI 10.1227/01.NEU.0000175856.31210.58; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Luo JQ, 2015, ARCH ORTHOP TRAUM SU, V135, P155, DOI 10.1007/s00402-014-2125-2; Majd ME, 1999, SPINE, V24, P1604, DOI 10.1097/00007632-199908010-00016; Mummaneni PV, 2007, J NEUROSURG-SPINE, V6, P198, DOI 10.3171/spi.2007.6.3.198; Nabhan A, 2011, EUR SPINE J, V20, P934, DOI 10.1007/s00586-010-1588-2; Nabhan A, 2007, J Long Term Eff Med Implants, V17, P229; Nunley PD, 2013, SPINE J, V13, P5, DOI 10.1016/j.spinee.2012.11.032; Park DK, 2011, SPINE, V36, P721, DOI 10.1097/BRS.0b013e3181df10fc; Peng-Fei S, 2008, INT ORTHOP, V32, P103, DOI 10.1007/s00264-006-0287-4; Phillips FM, 2015, SPINE, V40, P674, DOI 10.1097/BRS.0000000000000869; Phillips FM, 2013, SPINE, V38, pE907, DOI 10.1097/BRS.0b013e318296232f; Pickett GE, 2006, J NEUROSURG-SPINE, V4, P98, DOI 10.3171/spi.2006.4.2.98; Rao RD, 2007, J BONE JOINT SURG AM, V89A, P1360; Ren CP, 2014, EUR SPINE J, V23, P1115, DOI 10.1007/s00586-014-3220-3; Sasso RC, 2011, J BONE JOINT SURG AM, V93A, P1684, DOI [10.2106/JBJS.J.00476, 10.2106/JBJSJ.00476]; Shriver MF, 2016, SPINE J, V16, P168, DOI 10.1016/j.spinee.2015.10.032; Shriver MF, 2015, SPINE J, V15, P2016, DOI 10.1016/j.spinee.2015.05.010; Tian W, 2014, J SPINAL DISORD TECH, DOI [10.1097/BSD.0000000000000206, DOI 10.1097/BSD.0000000000000206]; Tsermoulas G, 2013, BRIT J NEUROSURG, V27, P132, DOI 10.3109/02688697.2012.703354; Maldonado CV, 2011, EUR SPINE J, V20, P403, DOI 10.1007/s00586-011-1916-1; Verma K, 2013, SPINE, V38, P2253, DOI 10.1097/BRS.0000000000000052; Wagner SC, 2014, SPINE J, V14, P2513, DOI 10.1016/j.spinee.2014.05.005; Walraevens J, 2010, NEUROSURGERY, V67, P679, DOI 10.1227/01.NEU.0000377039.89725.F3; Wigfield C, 2002, J NEUROSURG, V96, P17, DOI 10.3171/spi.2002.96.1.0017; Wu AM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000665; Yang BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035032; Yue WM, 2005, SPINE, V30, P2138, DOI 10.1097/01.brs.0000180479.63092.17; Zechmeister I, 2011, EUR SPINE J, V20, P177, DOI 10.1007/s00586-010-1583-7; Zhang HX, 2014, INT ORTHOP, V38, P2533, DOI 10.1007/s00264-014-2497-5; Zigler JE, 2013, SPINE, V38, P203, DOI 10.1097/BRS.0b013e318278eb38	64	69	72	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149312	10.1371/journal.pone.0149312	http://dx.doi.org/10.1371/journal.pone.0149312			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872258	Green Submitted, Green Published, gold			2022-12-27	WOS:000370054100147
J	Huang, SQ; Cao, XJ; Tian, XC; Wang, WM				Huang, Songqian; Cao, Xiaojuan; Tian, Xianchang; Wang, Weimin			High-Throughput Sequencing Identifies MicroRNAs from Posterior Intestine of Loach (Misgurnus anguillicaudatus) and Their Response to Intestinal Air-Breathing Inhibition	PLOS ONE			English	Article							HUMAN ENDOTHELIAL-CELLS; CANCER-CELLS; VASCULAR INTEGRITY; GENE-EXPRESSION; MIR-200 FAMILY; C-ELEGANS; RT-PCR; ANGIOGENESIS; GROWTH; ZEBRAFISH	MicroRNAs (miRNAs) exert important roles in animal growth, immunity, and development, and regulate gene expression at the post-transcriptional level. Knowledges about the diversities of miRNAs and their roles in accessory air-breathing organs (ABOs) of fish remain unknown. In this work, we used high-throughput sequencing to identify known and novel miRNAs from the posterior intestine, an important ABO, in loach (Misgurnus anguillicaudatus) under normal and intestinal air-breathing inhibited conditions. A total of 204 known and 84 novel miRNAs were identified, while 47 miRNAs were differentially expressed between the two small RNA libraries (i.e. between the normal and intestinal air-breathing inhibited group). Potential miRNA target genes were predicted by combining our transcriptome data of the posterior intestine of the loach under the same conditions, and then annotated using COG, GO, KEGG, Swissprot and Nr databases. The regulatory networks of miRNAs and their target genes were analyzed. The abundances of nine known miRNAs were validated by qRT-PCR. The relative expression profiles of six known miRNAs and their eight corresponding target genes, and two novel potential miRNAs were also detected. Histological characteristics of the posterior intestines in both normal and air-breathing inhibited group were further analyzed. This study contributes to our understanding on the functions and molecular regulatory mechanisms of miRNAs in accessory air-breathing organs of fish.	[Huang, Songqian; Cao, Xiaojuan; Tian, Xianchang; Wang, Weimin] Huazhong Agr Univ, Minist Agr, Minist Educ,Key Lab Freshwater Anim Breeding, Coll Fisheries,Key Lab Agr Anim Genet Breeding &, Wuhan 437000, Hubei, Peoples R China; [Cao, Xiaojuan; Wang, Weimin] Freshwater Aquaculture Collaborat Innovat Ctr Hub, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs	Cao, XJ; Wang, WM (corresponding author), Huazhong Agr Univ, Minist Agr, Minist Educ,Key Lab Freshwater Anim Breeding, Coll Fisheries,Key Lab Agr Anim Genet Breeding &, Wuhan 437000, Hubei, Peoples R China.; Cao, XJ; Wang, WM (corresponding author), Freshwater Aquaculture Collaborat Innovat Ctr Hub, Wuhan, Hubei, Peoples R China.	caoxiaojuan@mail.hzau.edu.cn; wangwm@mail.hzau.edu.cn	黄, 松钱/ABB-8634-2021		National Natural Science Foundation of China [31201719]; Fundamental Research Funds for the Central Universities of China [2662015PY033]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This study was financially supported by National Natural Science Foundation of China (Project Number: 31201719) and the Fundamental Research Funds for the Central Universities of China (Project Number: 2662015PY033).	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cao XJ, 2009, ANAT HISTOL EMBRYOL, V38, P254, DOI 10.1111/j.1439-0264.2009.00932.x; Chan LS, 2009, EUR J PHARM SCI, V38, P370, DOI 10.1016/j.ejps.2009.08.008; Chan SY, 2010, CELL CYCLE, V9, P1072, DOI 10.4161/cc.9.6.11006; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Cheng WW, 2011, INT J MOL MED, V27, P393, DOI 10.3892/ijmm.2011.598; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Choi YC, 2011, MOL CELLS, V32, P77, DOI 10.1007/s10059-011-1042-2; Davis-Dusenbery BN, 2011, J BIOL CHEM, V286, P28097, DOI 10.1074/jbc.M111.236950; Doebele C, 2010, BLOOD, V115, P4944, DOI 10.1182/blood-2010-01-264812; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Fu YS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022957; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Grundmann S, 2011, CIRCULATION, V123, P999, DOI 10.1161/CIRCULATIONAHA.110.000323; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; Hassel D, 2012, CIRC RES, V111, P1421, DOI 10.1161/CIRCRESAHA.112.279711; Jalali S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046808; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Kikkawa N, 2010, BRIT J CANCER, V103, P877, DOI 10.1038/sj.bjc.6605811; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kloosterman WP, 2006, NUCLEIC ACIDS RES, V34, P2558, DOI 10.1093/nar/gkl278; Kuhnert F, 2008, DEVELOPMENT, V135, P3989, DOI 10.1242/dev.029736; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li SC, 2010, GENOMICS, V96, P1, DOI 10.1016/j.ygeno.2010.03.009; Ma YH, 2010, CANCER LETT, V298, P150, DOI 10.1016/j.canlet.2010.06.012; MCMAHON BR, 1987, J EXP BIOL, V133, P371; Menghini R, 2009, CIRCULATION, V120, P1524, DOI 10.1161/CIRCULATIONAHA.109.864629; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Nikolic Iva, 2010, J Angiogenes Res, V2, P9, DOI 10.1186/2040-2384-2-9; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pulkkinen K, 2008, FEBS LETT, V582, P2397, DOI 10.1016/j.febslet.2008.05.048; Randall D. J., 1981, EVOLUTION AIR BREATH; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Saito Y, 2009, BIOCHEM BIOPH RES CO, V379, P726, DOI 10.1016/j.bbrc.2008.12.098; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Stahlhut C, 2012, DEVELOPMENT, V139, P4356, DOI 10.1242/dev.083774; Suarez Y, 2007, CIRC RES, V100, P1164, DOI 10.1161/01.RES.0000265065.26744.17; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wu HJ, 2014, ANTI-CANCER DRUG, V25, P799, DOI 10.1097/CAD.0000000000000107; Xu ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054174; Yi SK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-754; Yue JQ, 2013, LAB INVEST, V93, P748, DOI 10.1038/labinvest.2013.63; Zhou QB, 2012, MIRNAS HUMAN DIS, P25; Zhou QB, 2011, P NATL ACAD SCI USA, V108, P8287, DOI 10.1073/pnas.1105254108; Zhu N, 2011, ATHEROSCLEROSIS, V215, P286, DOI 10.1016/j.atherosclerosis.2010.12.024	55	16	17	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149123	10.1371/journal.pone.0149123	http://dx.doi.org/10.1371/journal.pone.0149123			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872032	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100109
J	Marcelin, JR; Berg, ML; Tan, EM; Amer, H; Cummins, NW; Rizza, SA				Marcelin, Jasmine R.; Berg, Melody L.; Tan, Eugene M.; Amer, Hatem; Cummins, Nathan W.; Rizza, Stacey A.			Is Abnormal Urine Protein/Osmolality Ratio Associated with Abnormal Renal Function in Patients Receiving Tenofovir Disoproxil Fumarate?	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; HIV-INFECTED PATIENTS; HIV-1-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; TUBULAR DYSFUNCTION; DOUBLE-BLIND; EMTRICITABINE; ALAFENAMIDE; PROTEINURIA	Background Risk factors for and optimal surveillance of renal dysfunction in patients on tenofovir disoproxil fumarate (TDF) remain unclear. We investigated whether a urine protein-osmolality (P/O) ratio would be associated with renal dysfunction in HIV-infected persons on TDF. Methods This retrospective, single-center study investigated the relationship between parameters of renal function (estimated glomerular filtration rate (eGFR) and P/O-ratio) and risk factors for development of kidney dysfunction. Subjects were HIV-infected adults receiving TDF with at least one urinalysis and serum creatinine performed between 2010 and 2013. Regression analyses were used to analyze risk factors associated with abnormal P/O-ratio and abnormal eGFR during TDF therapy. Results Patients were predominately male (81%); (65%) were Caucasian. Mean age was 45.1 (+/- 11.8) years; median [IQR] TDF duration was 3.3 years. [1.5-7.6]. Median CD4(+) T cell count and HIV viral load were 451 cells/mu L [267.5-721.5] and 62 copies/mL [0-40,150], respectively. Abnormal P/O-ratio was not associated with low eGFR. 68% of subjects had an abnormal P/O-ratio and 9% had low eGFR. Duration of TDF use, age, diabetes and hypertension were associated with renal dysfunction in this study. After adjustment for age, subjects on TDF > 5 years had almost a four-fold increased likelihood of having an abnormal P/O-ratio than subjects on TDF for < 1yr (OR 3.9; 95% CI 1.2-14.0; p = 0.024). Conclusion Abnormal P/O-ratio is common in HIV-infected patients on TDF but was not significantly associated with low eGFR, suggesting that abnormal P/O-ratio may be a very early biomarker of decreased renal function in HIV infected patients.	[Marcelin, Jasmine R.; Berg, Melody L.; Cummins, Nathan W.; Rizza, Stacey A.] Mayo Clin, Div Infect Dis, Dept Med, Rochester, MN USA; [Tan, Eugene M.] Mayo Clin, Dept Internal Med, Rochester, MN USA; [Amer, Hatem] Mayo Clin, Div Nephrol & Hypertens, Dept Med, Rochester, MN USA; [Berg, Melody L.] Indiana Univ, Hlth Methodist Hosp, Dept Pharm, Indianapolis, IN 46204 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Indiana University System; Indiana University-Purdue University Indianapolis	Marcelin, JR; Rizza, SA (corresponding author), Mayo Clin, Div Infect Dis, Dept Med, Rochester, MN USA.	marcelin.jasmine@mayo.edu; rizza.stacey@mayo.edu	Amer, Hatem/AAN-2676-2020	Amer, Hatem/0000-0002-9570-0506; Marcelin, Jasmine/0000-0003-0504-753X; Tan, Eugene/0000-0003-4141-7155	National Center for Advancing Translational Sciences (NCATS) [UL1 TR000135]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This publication was supported by Grant Number UL1 TR000135 from the National Center for Advancing Translational Sciences (NCATS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.	Abraham P, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-61; Baxi SM, 2015, AIDS; Canale D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103055; Cooper RD, 2010, CLIN INFECT DIS, V51, P496, DOI 10.1086/655681; Fernandez-Fernandez B, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/354908; Fernando SK, 2008, AM J MED SCI, V335, P89, DOI 10.1097/MAJ.0b013e31812e6b34; Gara N, 2012, ALIMENT PHARM THER, V35, P1317, DOI 10.1111/j.1365-2036.2012.05093.x; Gervasoni C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080242; Guaraldi G, 2009, J ANTIMICROB CHEMOTH, V63, P374, DOI 10.1093/jac/dkn499; Gunthard HF, 2014, JAMA-J AM MED ASSOC, V312, P410, DOI 10.1001/jama.2014.8722; Izzedine H, 2005, NEPHROL DIAL TRANSPL, V20, P743, DOI 10.1093/ndt/gfh658; Kearney BP, 2004, CLIN PHARMACOKINET, V43, P595, DOI 10.2165/00003088-200443090-00003; Kiertiburanakul Sasisopin, 2011, J Int Assoc Physicians AIDS Care (Chic), V10, P297, DOI 10.1177/1545109711406735; Kinai E, 2009, AIDS RES HUM RETROV, V25, P387, DOI 10.1089/aid.2008.0202; Kohler JJ, 2011, LAB INVEST, V91, P852, DOI 10.1038/labinvest.2011.48; Labarga P, 2009, AIDS, V23, P689, DOI 10.1097/QAD.0b013e3283262a64; Lamb EJ, 2013, CLIN CHEM, V59, P462, DOI 10.1373/clinchem.2012.184259; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Lucas GM, 2014, CLIN PRACTICE GUIDEL; Mills A., 2015, LANCET INFECT DIS; Mills A, 2015, JAIDS-J ACQ IMM DEF, V69, P439, DOI 10.1097/QAI.0000000000000618; Mugwanya KK, 2015, JAMA INTERN MED, V175, P246, DOI 10.1001/jamainternmed.2014.6786; Nishijima T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029977; Nishijima T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022661; O'Donnell EP, 2011, J ANTIMICROB CHEMOTH, V66, P1120, DOI 10.1093/jac/dkr039; Overton ET, 2009, HIV MED, V10, P343, DOI 10.1111/j.1468-1293.2009.00693.x; Panel on Antiretroviral Guidelines for Adults and Adolescents, GUID US ANT AG HIV 1; Peyriere H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142491; Rollot F, 2003, CLIN INFECT DIS, V37, pE174, DOI 10.1086/379829; Ryom L, 2013, J INFECT DIS, V207, P1359, DOI 10.1093/infdis/jit043; Sax Paul E, 2014, J Acquir Immune Defic Syndr, V67, P52, DOI 10.1097/QAI.0000000000000225; Sax PE, 2015, LANCET, V385, P2606, DOI 10.1016/S0140-6736(15)60616-X; Sise ME, 2015, AIDS, V29, P941, DOI 10.1097/QAD.0000000000000628; Tordato F, 2011, HIV MED, V12, P4, DOI 10.1111/j.1468-1293.2010.00855.x; Tourret J, 2013, J AM SOC NEPHROL, V24, P1519, DOI 10.1681/ASN.2012080857; Wever K, 2010, JAIDS-J ACQ IMM DEF, V55, P78, DOI 10.1097/QAI.0b013e3181d05579; WHO, 2010, ANT THER HIV INF AD; WILSON DM, 1993, AM J CLIN PATHOL, V100, P419, DOI 10.1093/ajcp/100.4.419; Young B, 2009, AIDS PATIENT CARE ST, V23, P589, DOI 10.1089/apc.2008.0232; Zimmermann AE, 2006, CLIN INFECT DIS, V42, P283, DOI 10.1086/499048	41	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149562	10.1371/journal.pone.0149562	http://dx.doi.org/10.1371/journal.pone.0149562			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872144	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100164
J	Notenbomer, A; Roelen, CAM; van Rhenen, W; Groothoff, JW				Notenbomer, Annette; Roelen, Corne A. M.; van Rhenen, Willem; Groothoff, Johan W.			Focus Group Study Exploring Factors Related to Frequent Sickness Absence	PLOS ONE			English	Article							2 PREDICTION MODELS; WORK ENGAGEMENT; JOB DEMANDS; EMPLOYEES; HEALTH; RISK; VALIDATION; BURNOUT; COHORT; LEAVE	Introduction Research investigating frequent sickness absence (3 or more episodes per year) is scarce and qualitative research from the perspective of frequent absentees themselves is lacking. The aim of the current study is to explore awareness, determinants of and solutions to frequent sickness absence from the perspective of frequent absentees themselves. Methods We performed a qualitative study of 3 focus group discussions involving a total of 15 frequent absentees. Focus group discussions were audiotaped and transcribed verbatim. Results were analyzed with the Graneheim method using the Job Demands Resources (JD-R) model as theoretical framework. Results Many participants were not aware of their frequent sickness absence and the risk of future long-term sickness absence. As determinants, participants mentioned job demands, job resources, home demands, poor health, chronic illness, unhealthy lifestyles, and diminished feeling of responsibility to attend work in cases of low job resources. Managing these factors and improving communication (skills) were regarded as solutions to reduce frequent sickness absence. Conclusions The JD-R model provided a framework for determinants of and solutions to frequent sickness absence. Additional determinants were poor health, chronic illness, unhealthy lifestyles, and diminished feeling of responsibility to attend work in cases of low job resources. Frequent sickness absence should be regarded as a signal that something is wrong. Managers, supervisors, and occupational health care providers should advise and support frequent absentees to accommodate job demands, increase both job and personal resources, and improve health rather than express disapproval of frequent sickness absence and apply pressure regarding work attendance.	[Notenbomer, Annette; Roelen, Corne A. M.; van Rhenen, Willem] ArboNed Occupat Hlth Serv, Utrecht, Netherlands; [Notenbomer, Annette; Roelen, Corne A. M.; Groothoff, Johan W.] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Div Community & Occupat Med, Groningen, Netherlands; [Roelen, Corne A. M.] Vrije Univ Amsterdam, VU Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [van Rhenen, Willem] Business Univ Nyenrode, Ctr Human Resource Org & Management Effectiveness, Breukelen, Netherlands	University of Groningen; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Notenbomer, A (corresponding author), ArboNed Occupat Hlth Serv, Utrecht, Netherlands.; Notenbomer, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Div Community & Occupat Med, Groningen, Netherlands.	annette.notenbomer@arboned.nl	van Rhenen, Willem/AAS-9406-2021					Bakker A.B., 2007, J MANAGE PSYCHOL, V22 (3), P309, DOI [10.1108/02683940710733115, DOI 10.1108/02683940710733115]; Eakin JM, 1998, SOCIOL HEALTH ILL, V20, P896, DOI 10.1111/1467-9566.00134; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Hakanen JJ, 2008, WORK STRESS, V22, P224, DOI 10.1080/02678370802379432; Henderson M, 2005, BMJ-BRIT MED J, V330, P802, DOI 10.1136/bmj.330.7495.802; HORNQUIST JO, 1990, SCAND J SOC MED, V18, P91, DOI 10.1177/140349489001800202; Johansson G, 2004, SOC SCI MED, V58, P1857, DOI 10.1016/S0277-9536(03)00407-6; Kohler S, 1993, J ORGAN BEHAV, V4, P515; Koopmans PC, 2008, OCCUP ENVIRON MED, V65, P494, DOI 10.1136/oem.2007.034322; Koopmans PC, 2008, OCCUP MED-OXFORD, V58, P268, DOI 10.1093/occmed/kqn040; Krueger R., 2008, FOCUS GROUPS PRACTIC; Makikangas A, 2003, PERS INDIV DIFFER, V35, P537, DOI 10.1016/S0191-8869(02)00217-9; Niedhammer I, 1998, OCCUP ENVIRON MED, V55, P735, DOI 10.1136/oem.55.11.735; Notenbomer A, 2015, OCCUP MED-OXFORD, V65, P373, DOI 10.1093/occmed/kqv052; Petrie KJ, 1997, PERCEPTIONS HLTH ILL; Roelen CA, 2013, EUR J PUBLIC HEALTH, V23, P128, DOI 10.1093/eurpub/cks036; Roelen CAM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-105; Roelen CAM, 2009, OCCUP MED-OXFORD, V59, P502, DOI 10.1093/occmed/kqp089; Roskes K, 2005, INT ARCH OCC ENV HEA, V78, P270, DOI 10.1007/s00420-004-0596-0; Ryan RM, 2000, PSYCHOL INQ, V11, P319, DOI 10.1207/S15327965PLI1104_03; Ryan RM, 1997, J PERS, V65, P529, DOI 10.1111/j.1467-6494.1997.tb00326.x; Schaufeli WB, 2009, J ORGAN BEHAV, V30, P893, DOI 10.1002/job.595; Steel R.P., 2003, HUM RESOUR MANAGE R, V13, P243, DOI [10.1016/S1053-4822(03)00015-9, DOI 10.1016/S1053-4822(03)00015-9]; ten Brummelhuis LL, 2013, J ORGAN BEHAV, V34, P273, DOI 10.1002/job.1789; Xanthopoulou D, 2009, J VOCAT BEHAV, V74, P235, DOI 10.1016/j.jvb.2008.11.003; Xanthopoulou Despoina, 2007, INT J STRESS MANAG, V14, P121, DOI [DOI 10.1037/1072-5245.14.2.121, 10.1037/1072-5245.14.2.121]	26	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148647	10.1371/journal.pone.0148647	http://dx.doi.org/10.1371/journal.pone.0148647			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6SI	26872050	Green Submitted, Green Published, gold			2022-12-27	WOS:000370054100046
J	Perez-Fontan, M; Lopes, DM; Enriquez, AG; Lopez-Calvino, B; Lopez-Muniz, A; Falcon, TG; Rodriguez-Carmona, A				Perez-Fontan, Miguel; Lopes, Daniela Machado; Garcia Enriquez, Alba; Lopez-Calvino, Beatriz; Lopez-Muniz, Andres; Garcia Falcon, Teresa; Rodriguez-Carmona, Ana			Inhibition of Gastric Acid Secretion by H2 Receptor Antagonists Associates a Definite Risk of Enteric Peritonitis and Infectious Mortality in Patients Treated with Peritoneal Dialysis	PLOS ONE			English	Article							PROTON PUMP INHIBITORS; SUPPRESSION; DISEASE; ORIGIN	Background Evidences linking treatment with inhibitors of gastric acid secretion (IGAS) and an increased risk of serious infections are inconclusive, both in the population at large and in the particular case of patients with chronic kidney disease. We have undertaken an investigation to disclose associations between treatment with IGAS and infectious outcomes, in patients undergoing chronic Peritoneal Dialysis (PD). Method Observational, historic cohort, single center design. Six hundred and ninety-one patients incident on PD were scrutinized for an association among treatment with IGAS (H2 antagonists H2A or proton pump inhibitors PPI) (main study variable), on one side, and the risks of enteric peritoneal infection (main outcome), overall peritoneal infection, and general and infectious mortality (secondary outcomes). We applied a three-step multivariate approach, based on classic Cox models (baseline variables), time-dependent analyses and, when appropriate, competing risk analyses. Main results The clinical characteristics of patients treated with H2A, PPI or none of these were significantly different. Multivariate analyses disclosed a consistently increased risk of enteric peritonitis in patients treated with IGAS (RR 1.65, 95% CI 1.08-2.55, p = 0.018, Cox). Stratified analysis indicated that patients treated with H2A, rather than those on PPI, supported the burden of this risk. Similar findings applied for the risk of infectious mortality. On the contrary, we were not able to detect any association among the study variables, on one side, and the general risks of peritonitis or mortality, on the other. Conclusions Treatment with IGAS associates increased incidences of enteric peritonitis and infectious mortality, among patients on chronic PD. The association is clear in the case of H2A but less consistent in the case of PPI. Our results support the convenience of preferring PPI to H2A, for gastric acid inhibition in PD patients.	[Perez-Fontan, Miguel; Garcia Enriquez, Alba; Lopez-Muniz, Andres; Garcia Falcon, Teresa; Rodriguez-Carmona, Ana] Univ Hosp A Coruna, Div Nephrol, La Coruna, Spain; [Lopes, Daniela Machado] Hosp de Gaia, Div Nephrol, Vilanova De Gaia, Portugal; [Lopez-Calvino, Beatriz] Univ Hosp A Coruna, Div Epidemiol 2, La Coruna, Spain	Complejo Hospitalario Universitario A Coruna; Complejo Hospitalario Universitario A Coruna	Perez-Fontan, M (corresponding author), Univ Hosp A Coruna, Div Nephrol, La Coruna, Spain.	Miguel.Perez.Fontan@sergas.es	Perez-Fontán, Miguel/ABG-4064-2020	Perez-Fontán, Miguel/0000-0001-7027-2296; Lopez-Calvino, Beatriz/0000-0002-2869-1929				Abraham NS, 2012, CURR OPIN GASTROEN, V28, P615, DOI 10.1097/MOG.0b013e328358d5b9; Bavishi C, 2011, ALIMENT PHARM THER, V34, P1269, DOI 10.1111/j.1365-2036.2011.04874.x; Caravaca F, 1998, PERITON DIALYSIS INT, V18, P41; del Peso G, 2001, PERITON DIALYSIS INT, V21, P360; Eom CS, 2011, CAN MED ASSOC J, V183, P310, DOI 10.1503/cmaj.092129; Fisher LD, 1999, ANNU REV PUBL HEALTH, V20, P145, DOI 10.1146/annurev.publhealth.20.1.145; Kalman RS, 2015, SEMIN DIALYSIS, V28, P68, DOI 10.1111/sdi.12301; Kanno T, 2009, BIOCHEM BIOPH RES CO, V381, P666, DOI 10.1016/j.bbrc.2009.02.109; Kwon JE, 2014, WORLD J GASTROENTERO, V20, P8187, DOI 10.3748/wjg.v20.i25.8187; Leonard J, 2007, AM J GASTROENTEROL, V102, P2047, DOI 10.1111/j.1572-0241.2007.01275.x; Manlucu J, 2005, NEPHROL DIAL TRANSPL, V20, P2376, DOI 10.1093/ndt/gfi025; MURPHY SA, 1991, STOCH PROC APPL, V39, P153, DOI 10.1016/0304-4149(91)90039-F; Nessim SJ, 2008, PERITON DIALYSIS INT, V28, P246; Sabatino A, 2015, NEPHROL DIAL TRANSPL, V30, P924, DOI 10.1093/ndt/gfu287; Shirazian S, 2010, NAT REV NEPHROL, V6, P480, DOI 10.1038/nrneph.2010.84; Siple JF, 2012, ANN PHARMACOTHER, V46, P1413, DOI 10.1345/aph.1R174; Stiefel U, 2006, ANTIMICROB AGENTS CH, V50, P3905, DOI 10.1128/AAC.00522-06; Theisen J, 2000, J GASTROINTEST SURG, V4, P50, DOI 10.1016/S1091-255X(00)80032-3; Tleyjeh IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056498; Trikudanathan G, 2011, INT J CLIN PRACT, V65, P674, DOI 10.1111/j.1742-1241.2011.02650.x; Vakil N, 2009, AM J GASTROENTEROL, V104, pS17, DOI 10.1038/ajg.2009.47; Wallace JL, 2011, GOODMAN GILMANS PHAR; Zedtwitz-Liebenstein K, 2002, CRIT CARE MED, V30, P1118, DOI 10.1097/00003246-200205000-00026	23	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148806	10.1371/journal.pone.0148806	http://dx.doi.org/10.1371/journal.pone.0148806			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872254	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100057
J	Pfeifer, R; Teuben, M; Andruszkow, H; Barkatali, BM; Pape, HC				Pfeifer, Roman; Teuben, Michel; Andruszkow, Hagen; Barkatali, Bilal M.; Pape, Hans-Christoph			Mortality Patterns in Patients with Multiple Trauma: A Systematic Review of Autopsy Studies	PLOS ONE			English	Review							BLUNT TRAUMA; PREVENTABLE DEATHS; HOSPITAL DEATHS; EPIDEMIOLOGY; INJURY; CARE; FATALITIES; LOCATION; TIME	Purpose A high percentage (50%-60%) of trauma patients die due to their injuries prior to arrival at the hospital. Studies on preclinical mortality including post-mortem examinations are rare. In this review, we summarized the literature focusing on clinical and preclinical mortality and studies included post-mortem examinations. Methods A literature search was conducted using PubMed/Medline database for relevant medical literature in English or German language published within the last four decades (1980-2015). The following MeSH search terms were used in different combinations: "multiple trauma", "epidemiology", "mortality ", "cause of death", and "autopsy". References from available studies were searched as well. Results Marked differences in demographic parameters and injury severity between studies were identified. Moreover, the incidence of penetrating injuries has shown a wide range (between 4% and 38%). Both unimodal and bimodal concepts of trauma mortality have been favored. Studies have shown a wide variation in time intervals used to analyze the distribution of death. Thus, it is difficult to say which distribution is correct. Conclusions We have identified variable results indicating bimodal or unimodal death distribution. Further more stundardized studies in this field are needed. We would like to encourage investigators to choose the inclusion criteria more critically and to consider factors affecting the pattern of mortality.	[Pfeifer, Roman; Teuben, Michel; Andruszkow, Hagen; Pape, Hans-Christoph] Univ Aachen, Med Ctr, Dept Orthoped & Trauma Surg, Aachen, Germany; [Barkatali, Bilal M.] Salford Royal NHS Fdn Trust, Dept Trauma & Orthopaed Surg, Salford, Lancs, England	RWTH Aachen University; Salford Royal NHS Foundation Trust	Pfeifer, R (corresponding author), Univ Aachen, Med Ctr, Dept Orthoped & Trauma Surg, Aachen, Germany.	rpfeifer@ukaachen.de		Pape, Hans-Christoph/0000-0002-2059-4980				BAKER CC, 1980, AM J SURG, V140, P144, DOI 10.1016/0002-9610(80)90431-6; Bamvita JM, 2007, J TRAUMA, V63, P135, DOI 10.1097/TA.0b013e318068651d; Chiara O, 2002, INJURY, V33, P553, DOI 10.1016/S0020-1383(02)00123-7; Demetriades D, 2004, J AM COLL SURGEONS, V198, P20, DOI 10.1016/j.jamcollsurg.2003.09.003; Evans JA, 2010, WORLD J SURG, V34, P158, DOI 10.1007/s00268-009-0266-1; GORIS RJA, 1982, J TRAUMA, V22, P141, DOI 10.1097/00005373-198202000-00011; Hodgson NF, 2000, CAN J SURG, V43, P130; Kleber C, 2012, WORLD J SURG, V36, P2125, DOI 10.1007/s00268-012-1650-9; Lefering R, 2012, EUR J TRAUMA EMERG S, V38, P3, DOI 10.1007/s00068-011-0168-4; Lim, 1974, J AM COLL EMERG PHYS, V69, P368, DOI 10.1016/S0361-1124(74)80005-5; MacLeod JBA, 2007, AM J SURG, V193, P195, DOI 10.1016/j.amjsurg.2006.09.010; Marson AC, 2001, J TRAUMA, V50, P917; Meislin H, 1997, J TRAUMA, V43, P433, DOI 10.1097/00005373-199709000-00008; Ong AW, 2002, J AM COLL SURGEONS, V194, P401, DOI 10.1016/S1072-7515(02)01123-7; Pang JM, 2008, INJURY, V39, P102, DOI 10.1016/j.injury.2007.05.022; Pfeifer R, 2009, INJURY, V40, P907, DOI 10.1016/j.injury.2009.05.006; PORIES SE, 1989, J TRAUMA, V29, P1607, DOI 10.1097/00005373-198912000-00001; SAHDEV P, 1994, ACCIDENT ANAL PREV, V26, P377, DOI 10.1016/0001-4575(94)90011-6; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; SHACKFORD SR, 1989, J TRAUMA, V29, P1392, DOI 10.1097/00005373-198910000-00018; Sharma BR, 2005, INJURY, V36, P976, DOI 10.1016/j.injury.2004.09.025; Soreide K, 2007, WORLD J SURG, V31, P2092, DOI 10.1007/s00268-007-9226-9; Stewart RM, 2003, J TRAUMA, V54, P66, DOI 10.1097/00005373-200301000-00009; Tien HC, 2007, J TRAUMA, V62, P142, DOI 10.1097/01.ta.0000251558.38388.47; TRUNKEY DD, 1983, SCI AM, V249, P28, DOI 10.1038/scientificamerican0883-28; World Health Organization, 2008, GLOBAL BURDEN DIS; World Health Organization, 2013, GLOB STAT REP ROAD S	27	60	63	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148844	10.1371/journal.pone.0148844	http://dx.doi.org/10.1371/journal.pone.0148844			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871937	Green Submitted, Green Published, gold			2022-12-27	WOS:000370054100063
J	Welc, SS; Morse, DA; Mattingly, AJ; Laitano, O; King, MA; Clanton, TL				Welc, Steven S.; Morse, Deborah A.; Mattingly, Alex J.; Laitano, Orlando; King, Michelle A.; Clanton, Thomas L.			The Impact of Hyperthermia on Receptor-Mediated Interleukin-6 Regulation in Mouse Skeletal Muscle	PLOS ONE			English	Article							NF-KAPPA-B; LPS-BINDING-PROTEIN; INCREASES INTERLEUKIN-6; LIPOPOLYSACCHARIDE LPS; ADRENERGIC-RECEPTORS; CYTOKINE EXPRESSION; C2C12 MYOBLASTS; TOLL-LIKE; STRESS; IL-6	In inflammatory cells, hyperthermia inhibits lipopolysaccharide (LPS)-induced interleukin-6 (IL-6) gene expression and protein secretion. Since hyperthermia alone stimulates IL-6 in skeletal muscle, we hypothesized that it would amplify responses to other receptor-mediated stimuli. IL-6 regulation was tested in C2C12 myotubes and in soleus during treatment with epinephrine (EPI) or LPS. In EPI-treated myotubes (100 ng/ml), 1 h exposure at 40.5 degrees C-42 degrees C transiently increased IL-6 mRNA compared to EPI treatment alone at 37 degrees C. In LPS-treated myotubes (1 mu g/ml), exposure to 41 degrees C-42 degrees C also increased IL-6 mRNA. In isolated mouse soleus, similar amplifications of IL-6 gene expression were observed in 41 degrees C, during both low (1 ng/ml) and high dose (100 ng/ml) EPI, but only in high dose LPS (1 mu g/ml). In myotubes, heat increased IL-6 secretion during EPI exposure but had no effect or inhibited secretion with LPS. In soleus there were no effects of heat on IL-6 secretion during either EPI or LPS treatment. Mechanisms for the effects of heat on IL-6 mRNA were explored using a luciferase-reporter in C2C12 myotubes. Overexpression of heat shock factor-1 (HSF-1) had no impact on IL-6 promoter activity during EPI stimulation, but elevated IL-6 promoter activity during LPS stimulation. In contrast, when the activator protein-1 (AP-1) element was mutated, responses to both LPS and EPI were suppressed in heat. Using siRNA against activating transcription factor-3 (ATF-3), a heat-stress-induced inhibitor of IL-6, no ATF-3-dependent effects were observed. The results demonstrate that, unlike inflammatory cells, hyperthermia in muscle fibers amplifies IL-6 gene expression to EPI and LPS. The effect appears to reflect differential engagement of HSF-1 and AP-1 sensitive elements on the IL-6 gene, with no evidence for involvement of ATF-3. The functional significance of increased IL-6 mRNA expression during heat may serve to overcome the well-known suppression of protein synthetic pathways occurring during heat shock.	[Welc, Steven S.; Morse, Deborah A.; Mattingly, Alex J.; Laitano, Orlando; King, Michelle A.; Clanton, Thomas L.] Univ Florida, Coll Hlth & Human Performance, Dept Appl Physiol & Kinesiol, Gainesville, FL USA; [Laitano, Orlando] Fed Univ Vale do Sao Francisco, Phys Educ Sch, Petrolina, Brazil	State University System of Florida; University of Florida	Clanton, TL (corresponding author), Univ Florida, Coll Hlth & Human Performance, Dept Appl Physiol & Kinesiol, Gainesville, FL USA.	tclanton@hhp.ufl.edu	Laitano, Orlando/C-3965-2013; Laitano, Orlando/AAM-8085-2021; Clanton, Thomas/AAS-9422-2020	Laitano, Orlando/0000-0003-2768-1427; Laitano, Orlando/0000-0003-2768-1427; Clanton, Thomas/0000-0003-0600-7150; Welc, Steven/0000-0002-2353-0325	American Heart Association [11GRNT7990119]; University of Florida BK; Betty Stevens Endowment; Brazilian Council for the Development of Science and Technology (CNPq) [249094/2013-4]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001427] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); University of Florida BK; Betty Stevens Endowment; Brazilian Council for the Development of Science and Technology (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The work was supported by American Heart Association #11GRNT7990119 (TLC), University of Florida BK, and Betty Stevens Endowment (TLC). OL was supported by a post-doctoral fellowship from the Brazilian Council for the Development of Science and Technology (CNPq-#249094/2013-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccam M, 2003, J IMMUNOL, V170, P3099, DOI 10.4049/jimmunol.170.6.3099; Blix IJS, 1999, J PERIODONTAL RES, V34, P34, DOI 10.1111/j.1600-0765.1999.tb02219.x; BOSENBERG AT, 1988, J APPL PHYSIOL, V65, P106, DOI 10.1152/jappl.1988.65.1.106; BROOKS GA, 1971, AM J PHYSIOL, V221, P427, DOI 10.1152/ajplegacy.1971.221.2.427; Chen HQ, 2006, FEBS LETT, V580, P3145, DOI 10.1016/j.febslet.2006.04.066; Chen Q, 2006, NAT IMMUNOL, V7, P1299, DOI 10.1038/ni1406; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Dodge IL, 2003, J IMMUNOL, V170, P4457, DOI 10.4049/jimmunol.170.9.4457; FEBBRAIO MA, 1994, J APPL PHYSIOL, V77, P2827, DOI 10.1152/jappl.1994.77.6.2827; Fernandez-Verdejo R, 2014, INT J SPORTS MED, V35, P273, DOI 10.1055/s-0033-1353147; Fisher DT, 2010, IMMUNOL RES, V46, P177, DOI 10.1007/s12026-009-8122-9; FLEGEL WA, 1989, INFECT IMMUN, V57, P2237, DOI 10.1128/IAI.57.7.2237-2245.1989; Frost RA, 2006, AM J PHYSIOL-REG I, V290, pR773, DOI 10.1152/ajpregu.00490.2005; Frost RA, 2004, AM J PHYSIOL-ENDOC M, V286, pE809, DOI 10.1152/ajpendo.00560.2003; Frost RA, 2003, AM J PHYSIOL-REG I, V285, pR1153, DOI 10.1152/ajpregu.00164.2003; Frost RA, 2002, AM J PHYSIOL-REG I, V283, pR698, DOI 10.1152/ajpregu.00039.2002; FURCHGOTT RF, 1953, J PHARMACOL EXP THER, V108, P129; Gelinas JN, 2007, J BIOL CHEM, V282, P27527, DOI 10.1074/jbc.M701077200; Gentile LF, 2013, SHOCK, V39, P113, DOI 10.1097/SHK.0b013e318277109c; Greiwe JS, 1999, J APPL PHYSIOL, V86, P531, DOI 10.1152/jappl.1999.86.2.531; Hagiwara S, 2007, INFLAMM RES, V56, P297, DOI 10.1007/s00011-007-6161-z; HAHN PY, 1995, SHOCK, V4, P269, DOI 10.1097/00024382-199510000-00007; Inouye S, 2007, J BIOL CHEM, V282, P33210, DOI 10.1074/jbc.M704471200; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Koj A, 1996, BBA-MOL BASIS DIS, V1317, P84, DOI 10.1016/S0925-4439(96)00048-8; Koyama S, 2000, AM J PHYSIOL-LUNG C, V278, pL658, DOI 10.1152/ajplung.2000.278.4.L658; KREGEL KC, 1991, J APPL PHYSIOL, V71, P192, DOI 10.1152/jappl.1991.71.1.192; Kropfl JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106120; Milne KJ, 2002, J APPL PHYSIOL, V93, P561, DOI 10.1152/japplphysiol.00528.2001; Opal SM, 1999, J INFECT DIS, V180, P1584, DOI 10.1086/315093; Ostberg JR, 2000, J LEUKOCYTE BIOL, V68, P815; PANNIERS R, 1994, BIOCHIMIE, V76, P737, DOI 10.1016/0300-9084(94)90078-7; Parikh AA, 1998, J SURG RES, V77, P40, DOI 10.1006/jsre.1998.5332; Patel H, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/121237; RHEE JG, 1984, INT J RADIAT ONCOL, V10, P393, DOI 10.1016/0360-3016(84)90060-9; Rhind SG, 2004, INT J HYPERTHER, V20, P503, DOI 10.1080/02656730410001670651; RYAN TP, 1993, J BIOCHEM TOXICOL, V8, P33, DOI 10.1002/jbt.2570080106; Santos NC, 2003, CHEMBIOCHEM, V4, P96, DOI 10.1002/cbic.200390020; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Sigala I, 2011, AM J PHYSIOL-REG I, V300, pR1152, DOI 10.1152/ajpregu.00376.2010; Steensberg A, 2001, J PHYSIOL-LONDON, V537, P633, DOI 10.1111/j.1469-7793.2001.00633.x; Steensberg A, 2000, J PHYSIOL-LONDON, V529, P237, DOI 10.1111/j.1469-7793.2000.00237.x; Takii R, 2010, J IMMUNOL, V184, P1041, DOI 10.4049/jimmunol.0902579; van Wijck K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022366; VANALPHEN GWHM, 1963, INT J NEUROPHARMACOL, V2, P259, DOI 10.1016/0028-3908(63)90001-7; Wagstaff MJD, 1998, EUR J NEUROSCI, V10, P3343, DOI 10.1046/j.1460-9568.1998.00339.x; Wang Q, 2000, CLIN SCI, V99, P489, DOI 10.1042/CS20000059; Warren GL, 2011, MUSCLE NERVE, V44, P85, DOI 10.1002/mus.22001; WEBB P, 1992, EUR J APPL PHYSIOL O, V64, P471, DOI 10.1007/BF00625070; Welc SS, 2013, J APPL PHYSIOL, V115, P1126, DOI 10.1152/japplphysiol.00636.2013; Welc SS, 2013, AM J PHYSIOL-CELL PH, V305, pC406, DOI 10.1152/ajpcell.00084.2013; Welc SS, 2013, EXP PHYSIOL, V98, P359, DOI 10.1113/expphysiol.2012.068189; Welc SS, 2012, AM J PHYSIOL-CELL PH, V303, pC455, DOI 10.1152/ajpcell.00028.2012; Yamaki T, 2012, AM J PHYSIOL-CELL PH, V303, pC135, DOI 10.1152/ajpcell.00111.2012; Yu B, 1996, J BIOL CHEM, V271, P4100; Zakharova E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009900; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; ZUO JR, 1994, MOL CELL BIOL, V14, P7557, DOI 10.1128/MCB.14.11.7557; ZUO JR, 1995, MOL CELL BIOL, V15, P4319	60	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148927	10.1371/journal.pone.0148927	http://dx.doi.org/10.1371/journal.pone.0148927			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872389	gold, Green Published, Green Submitted			2022-12-27	WOS:000370054100076
J	Ganchimeg, T; Nagata, C; Vogel, JP; Morisaki, N; Pileggi-Castro, C; Ortiz-Panozo, E; Jayaratne, K; Mittal, S; Ota, E; Souza, JP; Mori, R				Ganchimeg, Togoobaatar; Nagata, Chie; Vogel, Joshua P.; Morisaki, Naho; Pileggi-Castro, Cynthia; Ortiz-Panozo, Eduardo; Jayaratne, Kapila; Mittal, Suneeta; Ota, Erika; Souza, Joao Paulo; Mori, Rintaro		WHO Multicountry Survey Maternal	Optimal Timing of Delivery among Low-Risk Women with Prior Caesarean Section: A Secondary Analysis of the WHO Multicountry Survey on Maternal and Newborn Health	PLOS ONE			English	Article							TERM; MORBIDITY; MORTALITY; OUTCOMES; LABOR	Objective To investigate optimal timing of elective repeat caesarean section among low-risk pregnant women with prior caesarean section in a multicountry sample from largely low-and middle-income countries. Design Secondary analysis of a cross-sectional study. Setting Twenty-nine countries from the World Health Organization Multicountry Survey on Maternal and Newborn Health. Population 29,647 women with prior caesarean section and no pregnancy complications in their current pregnancy who delivered a term singleton (live birth and stillbirth) at gestational age 37-41 weeks by pre-labour caesarean section, intra-partum caesarean section, or vaginal birth following spontaneous onset of labour. Methods We compared the rate of short-term adverse maternal and newborn outcomes following pre-labour caesarean section at a given gestational age, to those following ongoing pregnancies beyond that gestational age. Main Outcome Measures Severe maternal outcomes, neonatal morbidity, and intra-hospital early neonatal mortality. Results Odds of neonatal morbidity and intra-hospital early neonatal mortality were 0.48 (95% confidence interval [CI] 0.39-0.60) and 0.31 (95% CI 0.16-0.58) times lower for ongoing pregnancies compared to pre-labour caesarean section at 37 weeks. We did not find any significant change in the risk of severe maternal outcomes between pre-labour caesarean section at a given gestational age and ongoing pregnancies beyond that gestational age. Conclusions Elective repeat caesarean section at 37 weeks had higher risk of neonatal morbidity and mortality compared to ongoing pregnancy, however risks at later gestational ages did not differ between groups.	[Ganchimeg, Togoobaatar] Univ Tsukuba, Fac Med, Ibaraki, Japan; [Ganchimeg, Togoobaatar; Ota, Erika; Mori, Rintaro] Natl Ctr Child Hlth & Dev, Dept Hlth Policy, Tokyo, Japan; [Nagata, Chie] Natl Ctr Child Hlth & Dev, Dept Educ Clin Res, Tokyo, Japan; [Vogel, Joshua P.] WHO, UNDP UNFPA UNICEF WHO World Bank, Special Programme Res Dev & Res Training Human Re, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland; [Morisaki, Naho] Natl Ctr Child Hlth & Dev, Dept Social Med, Tokyo, Japan; [Pileggi-Castro, Cynthia] Univ Sao Paulo, Dept Pediat, Ribeirao Preto Med Sch, Sao Paulo, Brazil; [Ortiz-Panozo, Eduardo] Natl Inst Publ Hlth, Ctr Populat Hlth Res, Cuernavaca, Morelos, Mexico; [Jayaratne, Kapila] Minist Hlth, Family Hlth Bur, Colombo, Sri Lanka; [Mittal, Suneeta] Fortis Mem Res Inst, Dept Obstet & Gynecol, Gurgaon, India; [Souza, Joao Paulo] Univ Sao Paulo, Dept Social Med, Ribeirao Preto Med Sch, Sao Paulo, Brazil	University of Tsukuba; National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; United Nations Population Fund; World Health Organization; National Center for Child Health & Development - Japan; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Instituto Nacional de Salud Publica; Universidade de Sao Paulo	Nagata, C (corresponding author), Natl Ctr Child Hlth & Dev, Dept Educ Clin Res, Tokyo, Japan.	nagata-chi@ncchd.go.jp	Jayaratne, Kapila/ABC-9841-2020; Souza, João Paulo/G-1982-2010; Vogel, Joshua/K-7649-2019; Ortiz-Panozo, Eduardo/AAY-7743-2020	Jayaratne, Kapila/0000-0001-9795-4342; Souza, João Paulo/0000-0002-2288-4244; Vogel, Joshua/0000-0002-3214-7096; Yunis, Khalid/0000-0002-6384-2745; Ortiz-Panozo, Eduardo/0000-0002-3141-210X; Zavaleta, Nelly/0000-0002-6929-5834; Morisaki, Naho/0000-0001-6151-4513; Togoobaatar, Ganchimeg/0000-0002-5116-5601; Ota, Erika/0000-0002-3945-7441; Perez-Cuevas, Ricardo/0000-0002-5564-5821; Shrestha, Naveen/0000-0002-9325-598X; Mori, Rintaro/0000-0001-7656-6156	UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP); World Health Organization (WHO); United States Agency for International Development (USAID); Ministry of Health, Labour and Welfare of Japan; Gynuity Health Projects; Japan Agency for Medical Research and Development [26260101]; National Center for Child Health and Development of Japan [26-5]	UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP); World Health Organization (WHO)(World Health Organization); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Gynuity Health Projects; Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); National Center for Child Health and Development of Japan	WHO Multicountry Survey was financially supported by the UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP); the World Health Organization (WHO); the United States Agency for International Development (USAID); the Ministry of Health, Labour and Welfare of Japan; and Gynuity Health Projects. This study was financially supported by the Ministry of Health, Labour and Welfare of Japan, the Japan Agency for Medical Research and Development (No. 26260101, RM, http://www.mhlw.go.jp/seisakunitsuite/bunya/hokabunya/kenkyujigyou/hojokin-koubo-h26/gaiyo2/01-01.html), and the National Center for Child Health and Development of Japan (No. 26-5, RM, http://www.ncchd.go.jp/center/information/entrust/26-ichiran.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zirqi I, 2010, BJOG-INT J OBSTET GY, V117, P809, DOI 10.1111/j.1471-0528.2010.02533.x; Betran AP, 2007, PAEDIATR PERINAT EP, V21, P98, DOI 10.1111/j.1365-3016.2007.00786.x; Caughey Aaron B, 2007, BMC Pregnancy Childbirth, V7, P18, DOI 10.1186/1471-2393-7-18; Cavallaro FL, 2013, B WORLD HEALTH ORGAN, P914; Clark EAS, 2011, AM J OBSTET GYNECOL, V205, pS2, DOI 10.1016/j.ajog.2011.09.028; Declercq E, 2011, BIRTH-ISS PERINAT C, V38, P99, DOI 10.1111/j.1523-536X.2010.00459.x; Eshkoli T, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.12.037; Ganchimeg T, 2014, BJOG-INT J OBSTET GY, V121, P89, DOI 10.1111/1471-0528.12635; Hansen AK, 2008, BMJ-BRIT MED J, V336, P85, DOI 10.1136/bmj.39405.539282.BE; Liu SL, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.05.033; Main E, 2010, 0885012 CAL DEP PUBL; Mandujano A, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.12.005; Pileggi-Castro C, 2014, BJOG-INT J OBSTET GY, V121, P110, DOI 10.1111/1471-0528.12637; Roberts CL, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-125; Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG), 2006, COLL STAT C OBS 23 T; Salim R, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-68; Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007; Silver RM, 2010, SEMIN PERINATOL, V34, P258, DOI 10.1053/j.semperi.2010.03.006; Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8; Souza JP, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-286; Stock SJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2838; Tita ATN, 2011, OBSTET GYNECOL, V117, P280, DOI 10.1097/AOG.0b013e3182078115; Tita ATN, 2009, NEW ENGL J MED, V360, P111, DOI 10.1056/NEJMoa0803267; Vogel JP, 2014, BJOG-INT J OBSTET GY, V121, P76, DOI 10.1111/1471-0528.12633; Vogel JP, 2014, LANCET; Wanyonyi SZ, 2014, BJOG-INT J OBSTET GY, V121, P141, DOI 10.1111/1471-0528.12477; Wilmink FA, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.052; Zanardo Vincenzo, 2004, Pediatr Crit Care Med, V5, P566, DOI 10.1097/01.PCC.0000144702.16107.24	28	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149091	10.1371/journal.pone.0149091	http://dx.doi.org/10.1371/journal.pone.0149091			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866368	Green Published, gold			2022-12-27	WOS:000370050700065
J	Tcheng, DK; Nayak, AK; Fowlkes, CC; Punyasena, SW				Tcheng, David K.; Nayak, Ashwin K.; Fowlkes, Charless C.; Punyasena, Surangi W.			Visual Recognition Software for Binary Classification and Its Application to Spruce Pollen Identification	PLOS ONE			English	Article							EASTERN NORTH-AMERICA; FEATURES; PLANT	Discriminating between black and white spruce (Picea mariana and Picea glauca) is a difficult palynological classification problem that, if solved, would provide valuable data for paleoclimate reconstructions. We developed an open-source visual recognition software (ARLO, Automated Recognition with Layered Optimization) capable of differentiating between these two species at an accuracy on par with human experts. The system applies pattern recognition and machine learning to the analysis of pollen images and discovers general-purpose image features, defined by simple features of lines and grids of pixels taken at different dimensions, size, spacing, and resolution. It adapts to a given problem by searching for the most effective combination of both feature representation and learning strategy. This results in a powerful and flexible framework for image classification. We worked with images acquired using an automated slide scanner. We first applied a hash-based "pollen spotting" model to segment pollen grains from the slide background. We next tested ARLO's ability to reconstruct black to white spruce pollen ratios using artificially constructed slides of known ratios. We then developed a more scalable hash-based method of image analysis that was able to distinguish between the pollen of black and white spruce with an estimated accuracy of 83.61%, comparable to human expert performance. Our results demonstrate the capability of machine learning systems to automate challenging taxonomic classifications in pollen analysis, and our success with simple image representations suggests that our approach is generalizable to many other object recognition problems.	[Tcheng, David K.] Univ Illinois, Illinois Informat Inst, Urbana, IL 61801 USA; [Nayak, Ashwin K.] Univ Illinois, Sch Integrat Biol, Urbana, IL 61801 USA; [Fowlkes, Charless C.] Univ Calif Irvine, Dept Comp Sci, Irvine, CA USA; [Punyasena, Surangi W.] Univ Illinois, Sch Integrat Biol, Dept Plant Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Irvine; University of Illinois System; University of Illinois Urbana-Champaign	Punyasena, SW (corresponding author), Univ Illinois, Sch Integrat Biol, Dept Plant Biol, Urbana, IL 61801 USA.	punyasena@life.illinois.edu		Punyasena, Surangi/0000-0003-2110-5840; Fowlkes, Charless/0000-0002-2990-1780	National Science Foundation [NSF EF-1137396, NSF-DBI 1053036, NSF-DBI 1262547]; National Center for Supercomputing Applications Institute for Advanced Computing Applications and Technologies (NCSA IACAT) Fellowship; Research Experiences for Undergraduates (REU) from NSF Macrosystems Biology; Div Of Biological Infrastructure [1262547] Funding Source: National Science Foundation; Emerging Frontiers [1137396] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Center for Supercomputing Applications Institute for Advanced Computing Applications and Technologies (NCSA IACAT) Fellowship; Research Experiences for Undergraduates (REU) from NSF Macrosystems Biology(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by the National Science Foundation (NSF EF-1137396 to SWP and DKT; NSF-DBI 1053036 to CCF; NSF-DBI 1262547 to CCF) and a National Center for Supercomputing Applications Institute for Advanced Computing Applications and Technologies (NCSA IACAT) Fellowship awarded to SWP. AN was supported by Research Experiences for Undergraduates (REU) from NSF Macrosystems Biology awarded to SWP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlein PJ, 1998, QUATERNARY SCI REV, V17, P549, DOI 10.1016/S0277-3791(98)00012-2; Birks HH, 2000, J BIOGEOGR, V27, P31, DOI 10.1046/j.1365-2699.2000.00375.x; BIRKS HJB, 1980, CAN J BOT, V58, P2043, DOI 10.1139/b80-237; BRUBAKER LB, 1987, CAN J BOT, V65, P899, DOI 10.1139/b87-124; CAIN SA, 1948, SCIENCE, V108, P115, DOI 10.1126/science.108.2796.115; Dean T, 2013, PROC CVPR IEEE, P1814, DOI 10.1109/CVPR.2013.237; Erdtman G, 1931, SCIENCE, V73, P399, DOI 10.1126/science.73.1893.399; Faegri K, 1989, TXB POLLEN ANAL; HANSEN BCS, 1985, CAN J BOT, V63, P2159, DOI 10.1139/b85-305; Holt K, 2011, REV PALAEOBOT PALYNO, V167, P175, DOI 10.1016/j.revpalbo.2011.08.006; Holt KA, 2014, NEW PHYTOL, V203, P735, DOI 10.1111/nph.12848; Indyk P., 1998, Proceedings of the Thirtieth Annual ACM Symposium on Theory of Computing, P604, DOI 10.1145/276698.276876; Iversen J, 1989, J BIOGEOGR; Jackson ST, 2000, QUATERNARY SCI REV, V19, P489, DOI 10.1016/S0277-3791(99)00093-1; Jackson ST, 2007, ENCY QUATERNARY SCI, P2413; Kaya Y, 2013, GRANA, V52, P71, DOI 10.1080/00173134.2012.754050; Lighthill James, 1973, ARTIFICIAL INTELLIGE; Lindbladh M, 2009, MORPHOMETRIC ANAL PO, V89, P1459; Mander L, 2014, INT J PLANT SCI, V175, P931, DOI 10.1086/677680; Mander L, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1905; Norvig P., 2015, ARTIFICIAL INTELLIGE; PRAGLOWS.J, 1970, REV PALAEOBOT PALYNO, V10, P203, DOI 10.1016/0034-6667(70)90003-5; Punt W, 2007, REV PALAEOBOT PALYNO, V143, P1, DOI 10.1016/j.revpalbo.2006.06.008; Punyasena SW, 2012, NEW PHYTOL, V196, P937, DOI 10.1111/j.1469-8137.2012.04291.x; REITSMA T, 1969, REV PALAEOBOT PALYNO, V9, P175, DOI 10.1016/0034-6667(69)90003-7; Richtarik P., 2012, MATH PROGRAM, P1; Stillman EC, 1996, QUATERNARY SCI REV, V15, P1, DOI 10.1016/0277-3791(95)00076-3	29	10	10	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148879	10.1371/journal.pone.0148879	http://dx.doi.org/10.1371/journal.pone.0148879			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867017	Green Published, gold			2022-12-27	WOS:000370050700044
J	Cox, JA; Zhang, B; Pope, HM; Voigt, MM				Cox, Jane A.; Zhang, Bo; Pope, Holly M.; Voigt, Mark M.			Transcriptome Analysis of Chemically-Induced Sensory Neuron Ablation in Zebrafish	PLOS ONE			English	Article							PERIPHERAL-NERVE INJURY; SCHWANN-CELL PHENOTYPE; C-JUN; NEGATIVE REGULATOR; SIGNALING PATHWAY; UP-REGULATION; TNF-ALPHA; EXPRESSION; FIBERS; QUANTIFICATION	Peripheral glia are known to have a critical role in the initial response to axon damage and degeneration. However, little is known about the cellular responses of non-myelinating glia to nerve injury. In this study, we analyzed the transcriptomes of wild-type and mutant (lacking peripheral glia) zebrafish larvae that were treated with metronidazole. This treatment allowed us to conditionally and selectively ablate cranial sensory neurons whose axons are ensheathed only by non-myelinating glia. While transcripts representing over 27,000 genes were detected by RNAseq, only a small fraction (similar to 1% of genes) were found to be differentially expressed in response to neuronal degeneration in either line at either 2 hrs or 5 hrs of metronidazole treatment. Analysis revealed that most expression changes (332 out of the total of 458 differentially expressed genes) occurred over a continuous period (from 2 to 5 hrs of metronidazole exposure), with a small number of genes showing changes limited to only the 2 hr (55 genes) or 5 hr (71 genes) time points. For genes with continuous alterations in expression, some of the most meaningful sets of enriched categories in the wild-type line were those involving the inflammatory TNF-alpha and IL6 signaling pathways, oxidoreductase activities and response to stress. Intriguingly, these changes were not observed in the mutant line. Indeed, cluster analysis indicated that the effects of metronidazole treatment on gene expression was heavily influenced by the presence or absence of glia, indicating that the peripheral non-myelinating glia play a significant role in the transcriptional response to sensory neuron degeneration. This is the first transcriptome study of metronidazole-induced neuronal death in zebrafish and the response of non-myelinating glia to sensory neuron degeneration. We believe this study provides important insight into the mechanisms by which non-myelinating glia react to neuronal death and degeneration in sensory circuits.	[Cox, Jane A.; Pope, Holly M.; Voigt, Mark M.] St Louis Univ, Sch Med, Dept Physiol & Pharmacol, St Louis, MO USA; [Cox, Jane A.; Voigt, Mark M.] St Louis Univ, Sch Med, Ctr Neurosci, St Louis, MO USA; [Zhang, Bo] Washington Univ, Sch Med, Ctr Regenerat Med, Dept Dev Biol, St Louis, MO USA	Saint Louis University; Saint Louis University; Washington University (WUSTL)	Voigt, MM (corresponding author), St Louis Univ, Sch Med, Dept Physiol & Pharmacol, St Louis, MO USA.; Voigt, MM (corresponding author), St Louis Univ, Sch Med, Ctr Neurosci, St Louis, MO USA.	voigtm@slu.edu	zb, aber/A-6874-2011	zb, aber/0000-0003-2962-5314	National Institute for Neurological Disorders and Stroke [NS087574]; National Institute of General Medical Sciences [GM008306]; National Institute on Drug Abuse [DA027995]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS087574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R25DA027995] Funding Source: NIH RePORTER	National Institute for Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NS087574, National Institute for Neurological Disorders and Stroke (http://www.ninds.nih.gov/) to MMV; GM008306, National Institute of General Medical Sciences (http://www.nigms.nih.gov/Pages/default.aspx) to HP; and DA027995, National Institute on Drug Abuse, (http://www.drugabuse.gov/) to BZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021; Bennett GJ, 2014, NAT REV NEUROL, V10, P326, DOI 10.1038/nrneurol.2014.77; Brazda V, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-42; Brosamle C, 2002, GLIA, V39, P47, DOI 10.1002/glia.10088; Brushart TM, 2013, EXP NEUROL, V247, P272, DOI 10.1016/j.expneurol.2013.05.007; Burnett Mark G, 2004, Neurosurg Focus, V16, pE1, DOI 10.3171/foc.2004.16.5.2; Caron SJC, 2008, DEVELOPMENT, V135, P3259, DOI 10.1242/dev.023200; Cheepudomwit T, 2008, NEUROSCI LETT, V430, P230, DOI 10.1016/j.neulet.2007.11.003; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Cox JA, 2011, DEV BIOL, V357, P305, DOI 10.1016/j.ydbio.2011.06.044; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; de Oliveira I, 2010, NITROREDUCTASE ENZYM; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dubin AE, 2010, J CLIN INVEST, V120, P3760, DOI 10.1172/JCI42843; Dubovy P, 2011, ANN ANAT, V193, P267, DOI 10.1016/j.aanat.2011.02.011; Geuna S, 2015, J NEUROSCI METH, V243, P39, DOI 10.1016/j.jneumeth.2015.01.021; Gibbons Christopher H, 2014, Continuum (Minneap Minn), V20, P1398, DOI 10.1212/01.CON.0000455874.68556.02; Gomez-Sanchez JA, 2015, J CELL BIOL, V210, P153, DOI 10.1083/jcb.201503019; Griffin JW, 2008, GLIA, V56, P1518, DOI 10.1002/glia.20778; Hansen A, 2002, DEV DYNAM, V223, P483, DOI 10.1002/dvdy.10074; Hantke J, 2014, BRAIN, V137, P2922, DOI 10.1093/brain/awu257; Harrisingh MC, 2004, EMBO J, V23, P3061, DOI 10.1038/sj.emboj.7600309; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Hoke A, 2006, J NEUROSCI, V26, P9646, DOI 10.1523/JNEUROSCI.1620-06.2006; Jessen KR, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020487; Jonz MG, 2008, J EXP BIOL, V211, P2371, DOI 10.1242/jeb.010587; Jortner BS, 2000, TOXICOL PATHOL, V28, P54, DOI 10.1177/019262330002800108; Kaku M, 2014, CURR OPIN HIV AIDS, V9, P521, DOI 10.1097/COH.0000000000000103; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kotrschal K, 1997, CHEM SENSES, V22, P111, DOI 10.1093/chemse/22.2.111; Kucenas S, 2006, NEUROSCIENCE, V138, P641, DOI 10.1016/j.neuroscience.2005.11.058; Lamora A, 2009, NEUROSCIENCE, V159, P1175, DOI 10.1016/j.neuroscience.2009.01.049; Lara-Ramirez R, 2008, NEUROSCIENCE, V152, P601, DOI 10.1016/j.neuroscience.2008.01.014; Lee JW, 2009, CELL SIGNAL, V21, P69, DOI 10.1016/j.cellsig.2008.09.015; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lister JA, 2006, DEV BIOL, V290, P92, DOI 10.1016/j.ydbio.2005.11.014; Martini R, 2008, GLIA, V56, P1566, DOI 10.1002/glia.20766; Mathis S, 2015, J MED GENET, V52, P681, DOI 10.1136/jmedgenet-2015-103272; McGlone F, 2014, NEURON, V82, P737, DOI 10.1016/j.neuron.2014.05.001; Miltenburg NC, 2014, CANCER TREAT REV, V40, P872, DOI 10.1016/j.ctrv.2014.04.004; Mirsky R, 2008, J PERIPHER NERV SYST, V13, P122, DOI 10.1111/j.1529-8027.2008.00168.x; Murinson BB, 2005, J NEUROSCI, V25, P1179, DOI 10.1523/JNEUROSCI.1372-04.2005; Namer B, 2008, J NEUROPHYSIOL, V100, P2062, DOI 10.1152/jn.90482.2008; Napoli I, 2012, NEURON, V73, P729, DOI 10.1016/j.neuron.2011.11.031; Ohtori S, 2004, SPINE, V29, P1082, DOI 10.1097/00007632-200405150-00006; Parkinson DB, 2008, J CELL BIOL, V181, P625, DOI 10.1083/jcb.200803013; Patro R, 2014, NAT BIOTECHNOL, V32, P462, DOI 10.1038/nbt.2862; Pereira V, 2014, PAIN, V155, P2534, DOI 10.1016/j.pain.2014.09.013; Perry TA, 2004, EXP NEUROL, V190, P133, DOI 10.1016/j.expneurol.2004.07.013; Pope HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103283; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sagasti A, 2005, CURR BIOL, V15, P804, DOI 10.1016/j.cub.2005.03.048; Sagnelli A, 2013, J NEUROL, V260, P2684, DOI 10.1007/s00415-013-7113-x; Said G, 2013, HAND CLINIC, V115, P579, DOI 10.1016/B978-0-444-52902-2.00033-3; Shubayev VI, 2000, BRAIN RES, V855, P83, DOI 10.1016/S0006-8993(99)02321-5; Smith ES, 2012, J COMP NEUROL, V520, P2785, DOI 10.1002/cne.23133; Steiner I, 2013, HAND CLINIC, V115, P543, DOI 10.1016/B978-0-444-52902-2.00031-X; Stewart RA, 2006, DEV BIOL, V292, P174, DOI 10.1016/j.ydbio.2005.12.035; Sundin L, 2002, J EXP ZOOL, V293, P232, DOI 10.1002/jez.10130; Uceyler N, 2013, AKTUEL NEUROL, V40, P96, DOI 10.1055/s-0033-1333767; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; Wooten M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5122; Xiao Y, 2015, DIS MODEL MECH, V8, P553, DOI 10.1242/dmm.018184; Yang DP, 2012, J NEUROSCI, V32, P7158, DOI 10.1523/JNEUROSCI.5812-11.2012; Ydens E, 2013, NEUROBIOL DIS, V55, P95, DOI 10.1016/j.nbd.2013.03.005; Zrouri H, 2004, EUR J NEUROSCI, V20, P1811, DOI 10.1111/j.1460-9568.2004.03641.x	68	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148726	10.1371/journal.pone.0148726	http://dx.doi.org/10.1371/journal.pone.0148726			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863206	Green Published, Green Submitted, gold			2022-12-27	WOS:000370046600101
J	Geibel, S; Habtamu, K; Mekonnen, G; Jani, N; Kay, L; Shibru, J; Bedilu, L; Kalibala, S				Geibel, Scott; Habtamu, Kassahun; Mekonnen, Gebeyehu; Jani, Nrupa; Kay, Lynnette; Shibru, Julyata; Bedilu, Lake; Kalibala, Samuel			Reliability and Validity of an Interviewer-Administered Adaptation of the Youth Self-Report for Mental Health Screening of Vulnerable Young People in Ethiopia	PLOS ONE			English	Article							CHILD SEXUAL-ABUSE; ADDIS-ABABA; ANXIETY PROBLEMS; STREET CHILDREN; REPORT YSR; DEPRESSION; DISORDERS; QUESTIONNAIRE; SCALES; ADOLESCENTS	Objective Evaluate the reliability and validity of the Youth Self-Report (YSR) as a screening tool for mental health problems among young people vulnerable to HIV in Ethiopia. Design A cross-sectional assessment of young people currently receiving social services. Methods Young people age 15-18 participated in a study where a translated and adapted version of the YSR was administered by trained nurses, followed by an assessment by Ethiopian psychiatrists. Internal reliability of YSR syndrome scales were assessed using Chronbach's alpha. Test-retest reliability was assessed through repeating the YSR one month later. To assess validity, analysis of the sensitivity and specificity of the YSR compared to the psychiatrist assessment was conducted. Results Across the eight syndrome scales, the YSR best measured the diagnosis of anxiety/depression and social problems among young women, and attention problems among young men. Among individual YSR syndrome scales, internal reliability ranged from unacceptable (Chronback's alpha = 0.11, rule-breaking behavior among young women) to good (alpha >= 0.71, anxiety/depression among young women). Anxiety/depression scores of >= 8.5 among young women also had good sensitivity (0.833) and specificity (0.754) to predict a true diagnosis. The YSR syndrome scales for social problems among young women and attention problems among young men also had fair consistency and validity measurements. Most YSR scores had significant positive correlations between baseline and post-one month administration. Measures of reliability and validity for most other YSR syndrome scales were fair to poor. Conclusions The adapted, personally administered, Amharic version of the YSR has sufficient reliability and validity in identifying young vulnerable women with anxiety/depression and/or social problems, and young men with attention problems; which were the most common mental health disorders observed by psychiatrists among the migrant populations in this study. Further assessment of the applicability of the YSR among vulnerable young people for less common disorders in Ethiopia is needed.	[Geibel, Scott; Jani, Nrupa; Kalibala, Samuel] Populat Council, Washington, DC USA; [Habtamu, Kassahun] Univ Addis Ababa, Sch Psychol, Addis Ababa, Ethiopia; [Mekonnen, Gebeyehu] Populat Council, Addis Ababa, Ethiopia; [Kay, Lynnette; Shibru, Julyata] Retrak, Addis Ababa, Ethiopia; [Bedilu, Lake] Bahir Dar Univ, Dept Psychol, Bahir Dar, Ethiopia	Population Council; Addis Ababa University; Bahir Dar University	Kalibala, S (corresponding author), Populat Council, Washington, DC USA.	skalibala@popcouncil.org		Geibel, Scott/0000-0001-9969-8776; Jani, Nrupa/0000-0001-6768-9963; Yeworiew, Lake/0000-0002-7434-9809	President's Emergency Plan for AIDS Relief; U.S. Agency for International Development (USAID) through HIVCore - USAID under Project SEARCH [AID-OAA-TO-11-00060]	President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); U.S. Agency for International Development (USAID) through HIVCore - USAID under Project SEARCH(United States Agency for International Development (USAID))	This report was made possible through support provided by the President's Emergency Plan for AIDS Relief and the U.S. Agency for International Development (USAID) through HIVCore, a Task Order funded by USAID under the Project SEARCH indefinite quantity contract (contract no. AID-OAA-TO-11-00060). The funders reviewed and approved the study design, data analysis, and submission for publication. The funders had no role in data collection or preparation of the manuscript.	Achenbach T. M, 2001, MANUAL ASEBA SCH AGE; Achenbach TM, 2003, J CLIN CHILD ADOLESC, V32, P328, DOI 10.1207/S15374424JCCP3203_02; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Ashenafi Y, 2000, E AFR MED J, V77, P565; Bares C, 2012, INT J SOC PSYCHIATR, V58, P386, DOI 10.1177/0020764011400999; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Bordin IA, 2013, CAD SAUDE PUBLICA, V29, P13, DOI 10.1590/S0102-311X2013000100004; Byck GR, 2013, SOC PSYCH PSYCH EPID, V48, P1555, DOI 10.1007/s00127-013-0657-3; Central Statistical Agency,, 2012, ETH DEM HLTH SURV 20; Chorpita BF, 2010, J CONSULT CLIN PSYCH, V78, P526, DOI 10.1037/a0019602; Chung YC, 2013, EARLY INTERV PSYCHIA, V7, P71, DOI 10.1111/j.1751-7893.2012.00363.x; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98; Davison ML, 1997, ASSESSMENT, V4, P259, DOI 10.1177/107319119700400306; Deribew A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-408; Deribew A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-201; Derogatis LR., 2010, CORSINI ENCY PSYCHOL, DOI [10.1002/9780470479216.corpsy0970, DOI 10.1002/9780470479216.CORPSY0970]; Dingle K, 2010, J AFFECT DISORDERS, V121, P45, DOI 10.1016/j.jad.2009.05.013; Ebesutani C, 2011, J CLIN CHILD ADOLESC, V40, P338, DOI 10.1080/15374416.2011.546041; Erulkar A.S., 2006, J YOUTH STUD, V9, P361, DOI DOI 10.1080/13676260600805697; Erulkar A, 2009, INT PERSPECT SEX R H, V35, P186, DOI 10.1363/ipsrh.35.186.09; Erulkar A, 2007, VULNERABLE CHILD YOU, V2, P246, DOI 10.1080/17450120701487857; FELDT LS, 1987, APPL PSYCH MEAS, V11, P93, DOI 10.1177/014662168701100107; Ferdinand RF, 2008, J ANXIETY DISORD, V22, P126, DOI 10.1016/j.janxdis.2007.01.008; Fricchione GL, 2012, HARVARD REV PSYCHIAT, V20, P47, DOI 10.3109/10673229.2012.655211; Gebreyesus SH, 2009, J PUBLIC HEALTH POL, V30, P269, DOI 10.1057/jphp.2009.22; Gelaye B, 2013, PSYCHIAT RES, V210, P653, DOI 10.1016/j.psychres.2013.07.015; Georgsdottir I, 2013, EARLY HUM DEV, V89, P999, DOI 10.1016/j.earlhumdev.2013.08.018; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Hailemariam S, 2012, INT J MENT HEALTH SY, V6, DOI 10.1186/1752-4458-6-23; Hanlon C, 2010, BRIT J PSYCHIAT, V197, P468, DOI 10.1192/bjp.bp.109.076497; Henriksen J, 2012, DAN MED J, V59; Ivarsson T, 2002, EUR CHILD ADOLES PSY, V11, P31, DOI 10.1007/s007870200005; Izutsu T, RELIABILITY VALIDITY; Janssens A, 2009, EUR CHILD ADOLES PSY, V18, P691, DOI 10.1007/s00787-009-0030-y; Jemal J, 2012, ETHIOP J HEALTH SCI, V22, P59; Lalor KJ, 1999, CHILD ABUSE NEGLECT, V23, P759, DOI 10.1016/S0145-2134(99)00047-2; Laukkanen E, 2013, EUR CHILD ADOLES PSY, V22, P501, DOI 10.1007/s00787-013-0390-1; Lautenschlager GJ, 2008, APPL PSYCH MEAS, V32, P502, DOI 10.1177/0146621607312307; Louthrenoo O, 2013, J INT ASS PROVI 0530; Maruish ME, 1998, ASSESSMENT, V5, P407, DOI 10.1177/107319119800500410; Mayston Rosie, 2012, AIDS, V26 Suppl 2, pS117, DOI 10.1097/QAD.0b013e32835bde0f; Miettunen J, 2014, PSYCHOL MED, V44, P1727, DOI 10.1017/S0033291713002328; Mills R, 2013, CHILD ABUSE NEGLECT, V37, P292, DOI 10.1016/j.chiabu.2012.11.008; Muthupalaniappen L, 2012, SE ASIAN J TROP MED, V43, P1273; Nakimuli-Mpungu E, 2012, AIDS BEHAV, V16, P2101, DOI 10.1007/s10461-011-0087-8; Nguyen PH, 2013, PUBLIC HEALTH NUTR, V3, P1; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Okello J, WAR RELATED TRAUMA E; Petot D, 2011, J ADOLESCENCE, V34, P977, DOI 10.1016/j.adolescence.2010.11.011; Reda AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016049; Rescorla LA, 2013, J CLIN CHILD ADOLESC, V42, P262, DOI 10.1080/15374416.2012.717870; Ridge NW, 2009, J CLIN PSYCHOL, V65, P1115, DOI 10.1002/jclp.20620; Roberts RM, 2011, CLEFT PALATE-CRAN J, V48, P727, DOI 10.1597/09-050; Schwalbe CS, 2013, INT J LAW PSYCHIAT, V36, P107, DOI 10.1016/j.ijlp.2013.01.003; Steinhausen HC, 2009, J ANXIETY DISORD, V23, P218, DOI 10.1016/j.janxdis.2008.07.003; Tadele G, 2009, ETHIOP J HEALTH DEV, V23, P174; Tadesse AW, 2012, AIDS CARE, V24, P1359, DOI 10.1080/09540121.2011.650677; Tavakol M, 2011, INT J MED EDUC, V2, P1, DOI 10.5116/ijme.4d27.32ff; Thrane LE, 2004, AM INDIAN ALASKA NAT, V11, P20; van Lang NDJ, 2005, BEHAV RES THER, V43, P1485, DOI 10.1016/j.brat.2004.11.005; Weitkamp K, 2011, PRAX KINDERPSYCHOL K, V60, P820; Wondie Y, 2011, J CHILD SEX ABUS, V20, P305, DOI 10.1080/10538712.2011.573458; World Health Organization, 2016, MHGAP INT GUID MENT; Zhou ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037199	64	7	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0147267	10.1371/journal.pone.0147267	http://dx.doi.org/10.1371/journal.pone.0147267			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6PR	26863626	Green Published, gold, Green Submitted			2022-12-27	WOS:000370046600024
J	Huang, XY; Zhang, X; Wang, F; Wei, HY; Ma, H; Sui, ML; Lu, J; Wang, HL; Dumler, JS; Sheng, GY; Xu, BL				Huang, Xueyong; Zhang, Xi; Wang, Fang; Wei, Haiyan; Ma, Hong; Sui, Meili; Lu, Jie; Wang, Huaili; Dumler, J. Stephen; Sheng, Guangyao; Xu, Bianli			Clinical Efficacy of Therapy with Recombinant Human Interferon a1b in Hand, Foot, and Mouth Disease with Enterovirus 71 Infection	PLOS ONE			English	Article							ETIOLOGIC CHARACTERISTICS; ALPHA; CHINA; CELLS; GENE	A rapid expansion of HFMD with enterovirus 71 infection outbreaks has occurred and caused deaths in recent years in China, but no vaccine or antiviral drug is currently available for EV71 infection. This study aims to provide treatment programs for HFMD patients. We conducted a randomized, double-blind, controlled trial and evaluated clinical efficacy of therapy with rHuIFN-a1b in HFMD patients with EV71 infection. There were statistical differences in outcomes including the fever clearance time, healing time of typical skin or oral mucosa lesions, and EV71 viral load of the HFMD patients among ultrasonic aerosol inhalation group, intramuscular injection group and control group. rHuIFN-a1b therapy reduced the fever clearance time, healing time of typical skin or oral mucosa lesions, and EV71 viral load in children with HFMD.	[Huang, Xueyong; Wei, Haiyan; Ma, Hong; Xu, Bianli] Henan Ctr Dis Control & Prevent, Zhengzhou, Peoples R China; [Zhang, Xi] Childrens Hosp Kaifeng City, Zhengzhou, Peoples R China; [Wang, Fang] Childrens Hosp Zhengzhou City, Zhengzhou, Peoples R China; [Sui, Meili; Lu, Jie] Zhengzhou Univ, Coll Publ Hlth, Zhengzhou 450052, Peoples R China; [Wang, Huaili; Sheng, Guangyao] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou 450052, Peoples R China; [Dumler, J. Stephen] Univ Maryland, Sch Med, Dept Pathol & Microbiol, Baltimore, MD 21201 USA; [Dumler, J. Stephen] Univ Maryland, Sch Med, Dept Immunol, Baltimore, MD 21201 USA	Zhengzhou University; Zhengzhou University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Xu, BL (corresponding author), Henan Ctr Dis Control & Prevent, Zhengzhou, Peoples R China.; Sheng, GY (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou 450052, Peoples R China.	shenggyfh@163.com; bianlixu@163.com	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257	Henan Province Health Department; National Health and Family Planning Commission of the People's Republic of China [201001015]; Science and Technology Bureau of Henan Province [122102310268]	Henan Province Health Department; National Health and Family Planning Commission of the People's Republic of China; Science and Technology Bureau of Henan Province	This study was supported by grants from Henan Province Health Department and National Health and Family Planning Commission of the People's Republic of China Co-build Project (201001015), and Science and Technology Bureau of Henan Province (122102310268).	Bible JM, 2007, REV MED VIROL, V17, P371, DOI 10.1002/rmv.538; Cao HJ, 2012, EUR J INTEGR MED, V4, pE85, DOI 10.1016/j.eujim.2011.11.004; Ding X, 2014, J CLIN MICROBIOL, V52, P1862, DOI 10.1128/JCM.03298-13; Huang Xue-yong, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P883; Huang XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08904; Ioannidis I, 2013, J VIROL, V87, P3261, DOI 10.1128/JVI.01956-12; Kadurugamuwa JL, 2011, AM J INFECT CONTROL, V39, P788, DOI 10.1016/j.ajic.2011.01.015; Liu X, 2012, CURR CANCER DRUG TAR, V12, P561, DOI 10.2174/156800912800673293; Masci P, 2007, CLIN PHARMACOL THER, V81, P354, DOI 10.1038/sj.clpt.6100081; Ryu WS, 2010, J CLIN MICROBIOL, V48, P2490, DOI 10.1128/JCM.02369-09; Stegmann KA, 2012, J INFECT DIS, V205, P1351, DOI 10.1093/infdis/jis210; [孙薇 Sun Wei], 2011, [中国药房, China Pharmacy], V22, P1277; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Tee KK, 2010, J VIROL, V84, P3339, DOI 10.1128/JVI.01019-09; Urin V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130797; Xu LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065948; Xu MH, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-489; Yu HeJuan, 2010, Modern Preventive Medicine, V37, P1517; Zhang Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059086, 10.1371/journal.pone.0056341]; Zheng YL, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-99	20	12	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148907	10.1371/journal.pone.0148907	http://dx.doi.org/10.1371/journal.pone.0148907			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882102	Green Submitted, gold, Green Published			2022-12-27	WOS:000371219000031
J	Lobbens, ES; Fodera, V; Nyberg, NT; Andersen, K; Jager, AK; Jorgensen, L; van de Weert, M				Lobbens, Eva S.; Fodera, Vito; Nyberg, Nils T.; Andersen, Kirsten; Jager, Anna K.; Jorgensen, Lene; van de Weert, Marco			The Inhibitory Effect of Natural Products on Protein Fibrillation May Be Caused by Degradation Products - A Study Using Aloin and Insulin	PLOS ONE			English	Article							THIOFLAVIN-T; AMYLOID FIBRILS; ALPHA-SYNUCLEIN; IN-VITRO; DISEASE; BINDING; TEMPERATURE; MECHANISM; RICH	Protein fibrillation is the pathological hallmark of several neurodegenerative diseases and also complicates the manufacturing and use of protein drugs. As a case study, the inhibitory activity of the natural compound aloin against insulin fibrillation was investigated. Based on Thioflavin T assays, high-performance liquid chromatography and transmission electron microscopy it was found that a degradation product of aloin, formed over weeks of storage, was able to significantly inhibit insulin fibrillation. The activity of the stored aloin was significantly reduced in the presence of small amounts of sodium azide or ascorbic acid, suggesting the active compound to be an oxidation product. A high-performance liquid chromatography method and a liquid chromatography-mass spectrometry method were developed to investigate the degradation products in the aged aloin solution. We found that the major compounds in the solution were aloin A and aloin B. In addition, 10-hydroxy aloin and elgonica dimers were detected in smaller amounts. The identified compounds were isolated and tested for activity by means of Thioflavin T assays, but no activity was observed. Thus, the actual fibrillation inhibitor is an as yet unidentified and potentially metastable degradation product of aloin. These results suggest that degradation products, and in particular oxidation products, are to be considered thoroughly when natural products are investigated for activity against protein fibrillation.	[Lobbens, Eva S.; Fodera, Vito; Andersen, Kirsten; Jorgensen, Lene; van de Weert, Marco] Univ Copenhagen, Fac Hlth & Med Sci, Dept Pharm, Copenhagen, Denmark; [Nyberg, Nils T.; Jager, Anna K.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	van de Weert, M (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Pharm, Copenhagen, Denmark.	marco.vandeweert@sund.ku.dk	Lobbens, Eva/Q-4433-2016; Jorgensen, L/C-4290-2008; Foderà, Vito/AAZ-9925-2020; Foderà, Vito/F-9029-2010; van de Weert, Marco/AGR-7726-2022	Lobbens, Eva/0000-0001-8319-6798; Jorgensen, L/0000-0002-9110-6470; Foderà, Vito/0000-0003-2855-0568; Foderà, Vito/0000-0003-2855-0568; 	Alfred Benzon Fonden; DRA; FluoStar platereader, The Danish National Technology Foundation; Danish Research Council for Technology and Production Sciences; Danish Advanced Technology Foundation; FP7 Marie-404 Curie Actions Intra European Fellowship (IEF) for Career Development [299385]; Danish Research Council for Independent Research Nature and Universe [10-08564]	Alfred Benzon Fonden; DRA; FluoStar platereader, The Danish National Technology Foundation; Danish Research Council for Technology and Production Sciences; Danish Advanced Technology Foundation; FP7 Marie-404 Curie Actions Intra European Fellowship (IEF) for Career Development; Danish Research Council for Independent Research Nature and Universe	The authors received no specific funding for this work. However, the following funding is acknowledged: Alfred Benzon Fonden and DRA for co-funding the FluoStar platereader, The Danish National Technology Foundation for funding the HPLC, The Danish Research Council for Technology and Production Sciences for funding the centrifuge and The Danish Advanced Technology Foundation for funding the water bath. VF acknowledges support from the FP7 Marie-404 Curie Actions Intra European Fellowship (IEF) for Career Development 2012-2014, project nr. 299385 "FibCat" (University of Copenhagen). NMR equipment used in this work was purchased via grant #10-08564 from the Danish Research Council for Independent Research Nature and Universe.; The authors would like to thank Minna Gronning for helping setting up the ThT assay, Thomas Sylvest Christiansen, Henrik Thyge Corfitsen and Javohirhon Turaev for coming up with initial ideas for the project, Hamzeh Diab for performing the ThT assay investigating the activity of D-(+)-Glucose. Karina Juul Vissing for performing the studies on the shelf life of ThT. The Core Facility for Integrated Microscopy, Faculty of Health and Medical Sciences, University of Copenhagen for the TEM experiments. Alfred Benzon Fonden and DRA for co-funding the FluoStar platereader, The Danish National Technology Foundation for funding the HPLC, The Danish Research Council for Technology and Production Sciences for funding the centrifuge and The Danish Advanced Technology Foundation for funding the water bath. VF acknowledges support from the FP7 Marie-Curie Actions Intra European Fellowship (IEF) for Career Development 2012-2014, project nr. 299385 "FibCat" (University of Copenhagen). NMR equipment used in this work was purchased via grant #10-08564 from the Danish Research Council for Independent Research Nature and Universe.	Amini R, 2013, INT J BIOL MACROMOL, V60, P334, DOI 10.1016/j.ijbiomac.2013.06.013; Calcul L, 2012, FUTURE MED CHEM, V4, P1751, DOI [10.4155/FMC.12.124, 10.4155/fmc.12.124]; Dewick Pau M., 2009, MEDICINAL NATURAL PR; Ding WJ, 2014, INT J FOOD SCI TECH, V49, P1773, DOI [10.1111/ijfs.12500, 10.1111/ijfs.125]; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Esmaeili A., 2014, PHARM BIOL, P1; Fodera V, 2008, J PHYS CHEM B, V112, P3853, DOI 10.1021/jp710131u; Fodera V, 2012, J PHYS CHEM LETT, V3, P2803, DOI 10.1021/jz301375d; Gibson TJ, 2006, PROTEIN SCI, V15, P1133, DOI 10.1110/ps.051879606; Groenning M, 2009, CURR PROTEIN PEPT SC, V10, P509, DOI 10.2174/138920309789352038; Groenning M, 2007, J STRUCT BIOL, V159, P483, DOI 10.1016/j.jsb.2007.06.004; Groenning M, 2007, J STRUCT BIOL, V158, P358, DOI 10.1016/j.jsb.2006.12.010; Hong DP, 2006, BIOCHEMISTRY-US, V45, P9342, DOI 10.1021/bi0604936; Hudson SA, 2009, FEBS J, V276, P5960, DOI 10.1111/j.1742-4658.2009.07307.x; Ivanova MI, 2009, P NATL ACAD SCI USA, V106, P18990, DOI 10.1073/pnas.0910080106; Krebs MRH, 2005, J STRUCT BIOL, V149, P30, DOI 10.1016/j.jsb.2004.08.002; Li J, 2004, CHEM BIOL, V11, P1513, DOI 10.1016/j.chembiol.2004.08.025; Li XZ, 2013, FITOTERAPIA, V84, P273, DOI 10.1016/j.fitote.2012.12.009; Liu KN, 2012, BBA-GEN SUBJECTS, V1820, P1774, DOI 10.1016/j.bbagen.2012.07.012; MANITTO P, 1990, J CHEM SOC PERK T 1, P1297, DOI 10.1039/p19900001297; Nielsen L, BIOCHEMISTRY, V40, P6036; Palhano FL, 2013, J AM CHEM SOC, V135, P7503, DOI 10.1021/ja3115696; Rasmussen T, 2010, PHARM RES-DORDR, V27, P1337, DOI 10.1007/s11095-010-0116-8; Shikama Y, 2010, INTERNAL MED, V49, P397, DOI 10.2169/internalmedicine.49.2633; Smith MI, 2012, COLLOID SURFACE B, V89, P216, DOI 10.1016/j.colsurfb.2011.09.018; Stefani M, 2013, INT J MOL SCI, V14, P12411, DOI 10.3390/ijms140612411; VASSAR PS, 1959, ARCH PATHOL, V68, P487; Wamer WG, 2003, FREE RADICAL BIO MED, V34, P233, DOI 10.1016/S0891-5849(02)01242-X; Zhu JJ, 2010, J CHROMATOGR A, V1217, P5384, DOI 10.1016/j.chroma.2010.05.039; Zhu M, 2004, J BIOL CHEM, V279, P26846, DOI 10.1074/jbc.M403129200	30	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149148	10.1371/journal.pone.0149148	http://dx.doi.org/10.1371/journal.pone.0149148			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882071	Green Published, Green Submitted, gold			2022-12-27	WOS:000371219000051
J	Maimela, E; Alberts, M; Modjadji, SEP; Choma, SSR; Dikotope, SA; Ntuli, TS; Van Geertruyden, JP				Maimela, Eric; Alberts, Marianne; Modjadji, Sewela E. P.; Choma, Solomon S. R.; Dikotope, Sekgothe A.; Ntuli, Thembelihle S.; Van Geertruyden, Jeane-Pierre			The Prevalence and Determinants of Chronic Non-Communicable Disease Risk Factors amongst Adults in the Dikgale Health Demographic and Surveillance System (HDSS) Site, Limpopo Province of South Africa	PLOS ONE			English	Article							PHYSICAL INACTIVITY; TOBACCO USE; POPULATION; HYPERTENSION; VARIABILITY; CONSUMPTION; OVERWEIGHT; PATTERNS; PRIORITY; SMOKING	Background The aim of the study was to determine the prevalence and determinants of chronic non-communicable disease (NCD) risk factors in a rural community in the Limpopo Province of South Africa. Methods This survey was conducted using the WHO "STEPwise approach to the surveillance of non-communicable diseases" (STEPS) methodology. Participants were residents of the Dikgale HDSS site and standardised international protocols were used to measure behavioural risk factors (smoking, alcohol consumption, fruit and vegetable intake and, physical activity) and physical characteristics (weight, height, waist and hip circumferences and blood pressure-BP). Fasting blood glucose, triglyceride, cholesterol and HDL-C were determined in 732 participants. Data were analysed using STATA 12 for Windows. Results The prevalence of current smokers amongst the participants was 13.7%, of which 81.3% were daily smokers. Alcohol was consumed by 16.3% of the participants. The majority of participants (88.6%) had low daily intake of fruit and vegetables and low physical activity (66.5%). The prevalence of hypertension amongst the participants was 38.2%. Overweight, obesity and high waist circumference were prevalent in females. The cardio-metabolic risk profile was not significantly different between men and women. People who were older than 40 years, overweight or obese and those who consumed alcohol were more likely to be hypertensive. Smoking was associated significantly with older age, males, never married and divorced people. Alcohol consumption was associated with older age, males, low educational status and low income. Conclusion High levels of risk factors for NCDs among adults in the Dikgale HDSS suggest an urgent need for health interventions to control these risk factors at the population level in order to reduce the prevalence of NCDs.	[Maimela, Eric; Alberts, Marianne; Modjadji, Sewela E. P.; Choma, Solomon S. R.; Dikotope, Sekgothe A.; Ntuli, Thembelihle S.] Univ Limpopo, Dept Med Sci Publ Hlth & Hlth Promot, Turfloop Campus, Polokwane, South Africa; [Maimela, Eric; Van Geertruyden, Jeane-Pierre] Univ Antwerp, Int Hlth Unit, B-2020 Antwerp, Belgium	University of Limpopo; University of Antwerp	Maimela, E (corresponding author), Univ Limpopo, Dept Med Sci Publ Hlth & Hlth Promot, Turfloop Campus, Polokwane, South Africa.; Maimela, E (corresponding author), Univ Antwerp, Int Hlth Unit, B-2020 Antwerp, Belgium.	ericmaimela@webmail.co.za	Van geertruyden, Jean-Pierre/K-6425-2014; Modjadji, Perpetua/GRS-2210-2022; Van geertruyden, Jean-Pierre/S-3254-2019	Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Modjadji, Perpetua/0000-0002-8339-9875; Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Maimela, Eric/0000-0003-2843-4663; Choma, Solomon/0000-0003-1338-6523	University of Limpopo; International Health Unit; Antwerp University in Belgium; Vlaamse Interuniversitaire Raad (VLIR); Medical Science Department, University of Limpopo, in South Africa; International Health Unit, Antwerp University in Belgium; VLIR-UOS programme in Belgium	University of Limpopo; International Health Unit; Antwerp University in Belgium; Vlaamse Interuniversitaire Raad (VLIR); Medical Science Department, University of Limpopo, in South Africa; International Health Unit, Antwerp University in Belgium; VLIR-UOS programme in Belgium	The financial support for the conduct of the research and preparation of the article was provided by University of Limpopo, the International Health Unit, Antwerp University in Belgium, and the Vlaamse Interuniversitaire Raad (VLIR) (http://www.vliruos.be). VLIR contributed in the study design, data collection and analysis, and decision to publish the manuscript. The sponsors contributed in the payment to attend courses on Epidemiology, Biostatistics and Qualitative data analysis including writing of the article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Medical Science Department, University of Limpopo, in South Africa and the International Health Unit, Antwerp University in Belgium for their human and financial support during the execution of the study, not forgetting the immeasurable financial support received from the VLIR-UOS programme in Belgium.	Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Al-Nsour M, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110077; Alberts M, 1999, S AFR MED J, V89, P851; Alberts M, 2005, EUROPEAN J CARDIOVAS; Alikhani S, 2009, PUBLIC HEALTH, V123, P358, DOI 10.1016/j.puhe.2009.02.011; AlNuaim AR, 1996, INT J CARDIOL, V54, P41, DOI 10.1016/0167-5273(96)02555-7; Anand K, 2007, NATL MED J INDIA, V20, P3; [Anonymous], 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3823; Ashraf A, 2009, GLOBAL HEALTH ACTION, V2, P19, DOI 10.3402/gha.v2i0.1997; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bhasin SK, 2013, INDIAN MED GAZET AUG; Bradshaw D, 2001, DETERMINANTS HLTH TH; Bradshaw D, NONCOMMUNICABLE DIS; Cook I, 2012, THESIS U CAPE TOWN S; Cook I, 2012, J PHYS ACT HEALTH, V9, P300, DOI 10.1123/jpah.9.2.300; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; Dalton M, 2003, J INTERN MED, V254, P555, DOI 10.1111/j.1365-2796.2003.01229.x; Geneau R, 2010, LANCET, V376, P1689, DOI 10.1016/S0140-6736(10)61414-6; Goedecke JH, CHRONIC DISEASES OF; Guthold R, 2008, AM J PREV MED, V34, P486, DOI 10.1016/j.amepre.2008.02.013; Hall JN, 2009, AM J PREV MED, V36, P402, DOI 10.1016/j.amepre.2009.01.029; Hamrah MS, 2013, ASIAN PAC J CANCER P, V14, P1919, DOI 10.7314/APJCP.2013.14.3.1919; Hansen BH, 2012, MED SCI SPORT EXER, V44, P266, DOI 10.1249/MSS.0b013e31822cb354; Hoy D, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120067; Hunter DJ, 2013, NEW ENGL J MED, V369, P14; Kakde S, 2012, PUBLIC HEALTH, V126, P635, DOI 10.1016/j.puhe.2012.05.002; Kanjala C, 2010, GLOBAL HEALTH ACTION, V3, P59, DOI 10.3402/gha.v3i0.5236; Kanungsukkasem U, 2009, GLOBAL HEALTH ACTION, V2, P35, DOI 10.3402/gha.v2i0.1988; Kaur P, 2011, J POSTGRAD MED, V57, P9, DOI 10.4103/0022-3859.74284; Lazzeri G, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-123; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; Manuc D, 2006, J PREVENTIVE MED, V14, P3; Mehan BM, 2006, INT J DIABDEVCTRIES, V26, P4; Minh HV, 2005, PREV CHRONIC DIS; Motala AA, 2011, DIABETES CARE, V34, P1032, DOI 10.2337/dc10-1921; Msyamboza KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020316; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Ng N, 2006, B WHO, V84; Ng N, 2009, GLOBAL HEALTH ACTION, V2, P44, DOI 10.3402/gha.v2i0.1985; Ng N, 2009, GLOBAL HEALTH ACTION, V2, P7, DOI 10.3402/gha.v2i0.1984; Peltzer K, 2012, GLOBAL HEALTH ACTION, V5, DOI [10.3402/gha.v5i0.18545, 10.3402/gha.v5i0.18668]; Pham LH, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-291; Pickering Thomas G, 2005, J Clin Hypertens (Greenwich), V7, P102, DOI 10.1111/j.1524-6175.2005.04377.x; Puoane TR, 2012, S AFRICAN HLTH REV; Reddy P, 1996, S AFR MED J, V86, P1389; Singh RB, 2000, J HUM HYPERTENS, V14, P749, DOI 10.1038/sj.jhh.1001057; Sugathan TN, 2008, INDIAN J MED RES, V127, P555; Thankappan KR, 2010, INDIAN J MED RES, V131, P53; Thorogood M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-326; Traissac P, 1999, REV EPIDEMIOL SANTE, V47, P593; Bich TH, 2009, GLOBAL HEALTH ACTION, V2, P28, DOI 10.3402/gha.v2i0.2017; Venkitachalam L, 2012, CIRCULATION, V125, P1858, DOI 10.1161/CIRCULATIONAHA.111.064378; WHO, 2011, STEPS MAN STEPS INST; World Health Organization, 2007, REG OFF S E AS REG F; World Health Organization, 2007, NAUR NCD RISK FACT S; World Health Organization, GLOB STAT REP NONC D; Zhou JC, 2012, HEALTH PLACE, V18, P1300, DOI 10.1016/j.healthplace.2012.09.001	57	61	61	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0147926	10.1371/journal.pone.0147926	http://dx.doi.org/10.1371/journal.pone.0147926			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3BP	26882033	gold, Green Published, Green Submitted			2022-12-27	WOS:000371219000010
J	Cao, ZY; Ding, Y; Ke, ZP; Cao, L; Li, N; Ding, G; Wang, ZZ; Xiao, W				Cao, Zeyu; Ding, Yue; Ke, Zhipeng; Cao, Liang; Li, Na; Ding, Gang; Wang, Zhenzhong; Xiao, Wei			Luteoloside Acts as 3C Protease Inhibitor of Enterovirus 71 In Vitro	PLOS ONE			English	Article							LONICERA-JAPONICA; SUBSTITUTED FLAVANOIDS; ANTIVIRAL ACTIVITY; INFECTION; IDENTIFICATION; CELL; PHARMACOKINETICS; RHABDOMYOSARCOMA; REPLICATION; SEQUENCE	Luteoloside is a member of the flavonoids family that exhibits several bioactivities including anti-microbial and anti-cancer activities. However, the antiviral activity of luteoloside against enterovirus 71 (EV71) and the potential mechanism(s) responsible for this effect remain unknown. In this study, the antiviral potency of luteoloside against EV71 and its inhibitory effects on 3C protease activity were evaluated. First, we investigated the cytotoxicity of luteoloside against rhabdomyosarcoma (RD) cells, which was the cell line selected for an in vitro infection model. In a subsequent antiviral assay, the cytopathic effect of EV71 was significantly and dose-dependently relieved by the administration of luteoloside (EC50 = 0.43 mM, selection index = 5.3). Using a plaque reduction assay, we administered luteoloside at various time points and found that the compound reduced EV71 viability in RD cells rather than increasing defensive mobilization or viral absorption. Moreover, biochemical studies focused on VP1 (a key structural protein of EV71) mRNA transcript and protein levels also revealed the inhibitory effects of luteoloside on the EV71 viral yield. Finally, we performed inhibition assays using luteoloside to evaluate its effect on recombinant 3C protease activity. Our results demonstrated that luteoloside blocked 3C protease enzymatic activity in a dose-dependent manner (IC50 = 0.36 mM) that was similar to the effect of rutin, which is a well-known C3 protease inhibitor. Collectively, the results from this study indicate that luteoloside can block 3C protease activity and subsequently inhibit EV71 production in vitro.	[Cao, Zeyu; Ding, Yue; Ke, Zhipeng; Cao, Liang; Li, Na; Ding, Gang; Wang, Zhenzhong; Xiao, Wei] Jiangsu Kan Pharmaceut Co Ltd, State Key Lab New Tech Chinese Med Pharmaceut Pro, Lianyungang, Jiangsu, Peoples R China		Xiao, W (corresponding author), Jiangsu Kan Pharmaceut Co Ltd, State Key Lab New Tech Chinese Med Pharmaceut Pro, Lianyungang, Jiangsu, Peoples R China.	kanionlunwen@163.com			National Major New Drugs Innovation and Development Project by Ministry of Science and Technology [2013ZX09402203]; Jiangsu Kanion Pharmaceutical Co., Ltd.	National Major New Drugs Innovation and Development Project by Ministry of Science and Technology; Jiangsu Kanion Pharmaceutical Co., Ltd.	This work was supported by National Major New Drugs Innovation and Development Project by Ministry of Science and Technology (2013ZX09402203). Jiangsu Kanion Pharmaceutical Co., Ltd. provided support in the form of salaries for all authors and the research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Binford SL, 2007, ANTIMICROB AGENTS CH, V51, P4366, DOI 10.1128/AAC.00905-07; Brown BA, 1995, VIRUS RES, V39, P195, DOI 10.1016/0168-1702(95)00087-9; Chen TC, 2008, J ANTIMICROB CHEMOTH, V62, P1169, DOI 10.1093/jac/dkn424; Chen XQ, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/504563; CONTI C, 1992, ANTIMICROB AGENTS CH, V36, P95, DOI 10.1128/AAC.36.1.95; CONTI C, 1990, ANTIMICROB AGENTS CH, V34, P460, DOI 10.1128/AAC.34.3.460; Dragovich PS, 1998, J MED CHEM, V41, P2819, DOI 10.1021/jm9800696; ESANU V, 1981, Revue Roumaine de Medecine Virologie, V32, P213; Fan SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089961; GENOVESE D, 1995, ANTIVIR RES, V27, P123, DOI 10.1016/0166-3542(95)00088-4; He L, 2013, PLOS ONE, V25; Hung HC, 2011, J INFECT DIS, V203, P1784, DOI 10.1093/infdis/jir174; Hung HC, 2010, J ANTIMICROB CHEMOTH, V65, P676, DOI 10.1093/jac/dkp502; KJELLEN L, 1985, J GEN VIROL, V66, P2279, DOI 10.1099/0022-1317-66-10-2279; Kok TW, 1998, J CLIN VIROL, V11, P61, DOI 10.1016/S0928-0197(98)00026-9; Kuyumcu-Martinez NM, 2002, J VIROL, V76, P2062, DOI 10.1128/JVI.76.5.2062-2074.2002; Lei XB, 2011, J VIROL, V85, P8811, DOI 10.1128/JVI.00447-11; Lei XB, 2010, J VIROL, V84, P8051, DOI 10.1128/JVI.02491-09; Li ML, 2002, VIROLOGY, V293, P386, DOI 10.1006/viro.2001.1310; Li X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076007; Li XJ, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-250; Lin YJ, J VIROL METHODS, V182, P93, DOI [10.1016/j.jviromet.2012.03.020, DOI 10.1016/J.JVIR0MET.2012.03.020]; Liu AL, 2008, PLANTA MED, V74, P847, DOI 10.1055/s-2008-1074558; Liu JN, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-483; Lu J, 2011, WORLD J GASTROENTERO, V17, P4135, DOI 10.3748/wjg.v17.i36.4135; Massignan T, 2010, J BIOL CHEM, V285, P7752, DOI 10.1074/jbc.M109.064949; MINOR PD, 1990, CURR TOP MICROBIOL, V161, P121; Mizuta K, 2009, VACCINE, V27, P3153, DOI 10.1016/j.vaccine.2009.03.060; Nakashima S, 2015, BIOORG MED CHEM LETT, V25, P2702, DOI 10.1016/j.bmcl.2015.04.052; Oberste MS, 2003, J CLIN VIROL, V26, P375, DOI 10.1016/S1386-6532(03)00004-0; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; Patick AK, 1999, ANTIMICROB AGENTS CH, V43, P2444, DOI 10.1128/AAC.43.10.2444; Qiu F, 2013, BIOMED CHROMATOGR, V27, P311, DOI 10.1002/bmc.2793; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sandoval IV, 1997, J VIROL, V71, P4679, DOI 10.1128/JVI.71.6.4679-4693.1997; Shang XF, 2011, J ETHNOPHARMACOL, V138, P1, DOI 10.1016/j.jep.2011.08.016; Shi WF, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-327; Shih SR, 2004, MED RES REV, V24, P449, DOI 10.1002/med.10067; SPOUGE JL, 1992, P NATL ACAD SCI USA, V89, P7581, DOI 10.1073/pnas.89.16.7581; Sun YS, 2014, J SEP SCI, V37, P1703, DOI 10.1002/jssc.201400153; VRIJSEN R, 1987, ANTIVIR RES, V7, P35, DOI 10.1016/0166-3542(87)90037-4; Wang JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052954; Wang Y, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0308-2; Weng KF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000593; Xi XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056966; Xiong JH, 2013, FOOD CHEM, V138, P327, DOI 10.1016/j.foodchem.2012.10.127; Xu L, 2014, VIRUSES-BASEL, V6, P2778, DOI 10.3390/v6072778; Yin YX, 2014, VIRUS GENES, V48, P538, DOI 10.1007/s11262-014-1046-z; Zandi K, 2011, J MED PLANTS RES, V5, P5534; Zhang JH, 2014, VIRUS RES, V189, P248, DOI 10.1016/j.virusres.2014.06.003; Zhou W, 2015, J CHROMATOGR A, V1376, P84, DOI 10.1016/j.chroma.2014.12.018	51	30	33	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148693	10.1371/journal.pone.0148693	http://dx.doi.org/10.1371/journal.pone.0148693			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26870944	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100050
J	le Feber, J; Pavlidou, ST; Erkamp, N; van Putten, MJAM; Hofmeijer, J				le Feber, Joost; Pavlidou, Stelina Tzafi; Erkamp, Niels; van Putten, Michel J. A. M.; Hofmeijer, Jeannette			Progression of Neuronal Damage in an In Vitro Model of the Ischemic Penumbra	PLOS ONE			English	Article							CEREBRAL-CORTEX; SPREADING DEPOLARIZATION; NETWORKS; CULTURES; HYPOXIA; PHOSPHORYLATION; INTERNEURONS; SYNAPSES; SURVIVAL; GROWTH	Improvement of neuronal recovery in the ischemic penumbra around a brain infarct has a large potential to advance clinical recovery of patients with acute ischemic stroke. However, pathophysiological mechanisms leading to either recovery or secondary damage in the penumbra are not completely understood. We studied neuronal dynamics in a model system of the penumbra consisting of networks of cultured cortical neurons exposed to controlled levels and durations of hypoxia. Short periods of hypoxia (pO(2) approximate to 20mmHg) reduced spontaneous activity, due to impeded synaptic function. After approximate to 6 hours, activity and connectivity partially recovered, even during continuing hypoxia. If the oxygen supply was restored within 12 hours, changes in network connectivity were completely reversible. For longer periods of hypoxia (12-30 h), activity levels initially increased, but eventually decreased and connectivity changes became partially irreversible. After approximate to 30 hours, all functional connections disappeared and no activity remained. Since this complete silence seemed unrelated to hypoxic depths, but always followed an extended period of low activity, we speculate that irreversible damage (at least partly) results from insufficient neuronal activation. This opens avenues for therapies to improve recovery by neuronal activation.	[le Feber, Joost; Pavlidou, Stelina Tzafi; Erkamp, Niels; van Putten, Michel J. A. M.; Hofmeijer, Jeannette] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Clin Neurophysiol, POB 217, NL-7500 AE Enschede, Netherlands; [van Putten, Michel J. A. M.] Med Spectrum Twente, Dept Clin Neurophysiol, Enschede, Netherlands; [Hofmeijer, Jeannette] Rijnstate Hosp, Dept Neurol, Arnhem, Netherlands	University of Twente; Medical Spectrum Twente; Rijnstate Hospital	le Feber, J (corresponding author), Univ Twente, MIRA Inst Biomed Technol & Tech Med, Clin Neurophysiol, POB 217, NL-7500 AE Enschede, Netherlands.	j.lefeber@utwente.nl	van Putten, Michel J.A.M./D-6519-2018	van Putten, Michel J.A.M./0000-0001-8319-3626				Akanda N, 2009, J BIOMOL SCREEN, V14, P1228, DOI 10.1177/1087057109348378; Becchetti A, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00063; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Bolay H, 2002, STROKE, V33, P1369, DOI 10.1161/01.STR.0000013708.54623.DE; Butz M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003259; del Zoppo GJ, 2011, J CEREBR BLOOD F MET, V31, P1836, DOI 10.1038/jcbfm.2011.93; Doubal FN, 2011, J NEUROL NEUROSUR PS, V82, P540, DOI 10.1136/jnnp.2009.190298; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Florence SL, 1998, SCIENCE, V282, P1117, DOI 10.1126/science.282.5391.1117; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Grote J, 1996, J AUTONOM NERV SYST, V57, P168, DOI 10.1016/0165-1838(95)00096-8; Gualtieri F, 2013, NEUROMOL MED, V15, P133, DOI 10.1007/s12017-012-8203-0; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hofmeijer J, 2014, BRAIN RES, V1557, P180, DOI 10.1016/j.brainres.2014.02.027; Hofmeijer J, 2012, STROKE, V43, P607, DOI 10.1161/STROKEAHA.111.632943; ICHIKAWA M, 1993, NEUROSCI RES, V16, P95, DOI 10.1016/0168-0102(93)90076-3; KHAZIPOV R, 1995, J NEUROPHYSIOL, V74, P2138, DOI 10.1152/jn.1995.74.5.2138; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Law JKY, 2009, PHYSIOL MEAS, V30, P155, DOI 10.1088/0967-3334/30/2/004; Le Bon-Jegoa M, 2007, FRONT NEUROSCI-SWITZ, V1, P123, DOI 10.3389/neuro.01.1.1.009.2007; le Feber J, 2007, J NEURAL ENG, V4, P54, DOI 10.1088/1741-2560/4/2/006; le Feber J, 2014, PHYS BIOL, V11, DOI 10.1088/1478-3975/11/3/036005; Lee HK, 2006, PHARMACOL THERAPEUT, V112, P810, DOI 10.1016/j.pharmthera.2006.06.003; LIPTON P, 1982, J PHYSIOL-LONDON, V325, P51, DOI 10.1113/jphysiol.1982.sp014135; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Marom S, 2002, Q REV BIOPHYS, V35, P63, DOI 10.1017/S0033583501003742; NAIR PK, 1987, STROKE, V18, P616, DOI 10.1161/01.STR.18.3.616; Petito CK, 1998, J NEUROPATH EXP NEUR, V57, P231, DOI 10.1097/00005072-199803000-00004; PURVES D, 1980, SCIENCE, V210, P153, DOI 10.1126/science.7414326; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; ROMIJN HJ, 1984, NEUROSCI BIOBEHAV R, V8, P301, DOI 10.1016/0149-7634(84)90055-1; Schmitz Y, 2009, J NEUROSCI, V29, P11973, DOI 10.1523/JNEUROSCI.2927-09.2009; Stegenga J, 2008, IEEE T BIO-MED ENG, V55, P1382, DOI 10.1109/TBME.2007.913987; Stoyanova II, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-49; Stoyanova II, 2013, REGUL PEPTIDES, V186, P43, DOI 10.1016/j.regpep.2013.07.004; Symon L, 1977, J Clin Pathol Suppl (R Coll Pathol), V11, P149; Tjepkema-Cloostermans MC, 2014, CLIN NEUROPHYSIOL, V125, P255, DOI 10.1016/j.clinph.2013.08.005; Toledo-Rodriguez M, 2003, NEOCORTEX BASIC NEUR, P719; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Van Pelt J, 2004, NEUROSCI LETT, V361, P86, DOI 10.1016/j.neulet.2003.12.062; Wagenaar D A, 2005, MEABENCH TOOLSET MUL; Wagenaar DA, 2004, J NEUROSCI METH, V138, P27, DOI 10.1016/j.jneumeth.2004.03.005; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Wu K, 2004, MOL BRAIN RES, V130, P178, DOI 10.1016/j.molbrainres.2004.07.019; Zandt BJ, 2013, J NEUROSCI, V33, P5915, DOI 10.1523/JNEUROSCI.5115-12.2013; Zandt BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022127	46	24	25	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0147231	10.1371/journal.pone.0147231	http://dx.doi.org/10.1371/journal.pone.0147231			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871437	gold, Green Published			2022-12-27	WOS:000370054100006
J	Ma, ZC; Han, Q; Wang, XL; Ai, ZS; Zheng, YJ				Ma, Zhicong; Han, Qi; Wang, Xiaolei; Ai, Zisheng; Zheng, Yongjun			Galectin-3 Inhibition Is Associated with Neuropathic Pain Attenuation after Peripheral Nerve Injury	PLOS ONE			English	Article							MICROGLIAL ACTIVATION; IL-1-BETA PRODUCTION; MULTIPLE-SCLEROSIS; SIGNALING PATHWAY; INNATE IMMUNITY; AUTOPHAGY; CONTRIBUTES; MECHANISMS; EXPRESSION; SENSOR	Neuropathic pain remains a prevalent and persistent clinical problem because it is often poorly responsive to the currently used analgesics. It is very urgent to develop novel drugs to alleviate neuropathic pain. Galectin-3 (gal3) is a multifunctional protein belonging to the carbohydrate-ligand lectin family, which is expressed by different cells. Emerging studies showed that gal3 elicits a pro-inflammatory response by recruiting and activating lymphocytes, macrophages and microglia. In the study we investigated whether gal3 inhibition could suppress neuroinflammation and alleviate neuropathic pain following peripheral nerve injury. We found that L5 spinal nerve ligation (SNL) increases the expression of gal3 in dorsal root ganglions at the mRNA and protein level. Intrathecal administration of modified citrus pectin (MCP), a gal3 inhibitor, reduces gal3 expression in dorsal root ganglions. MCP treatment also inhibits SNL-induced gal3 expression in primary ratmicroglia. SNL results in an increased activation of autophagy that contributes to microglial activation and subsequent inflammatory response. Intrathecal administration of MCP significantly suppresses SNL-induced autophagy activation. MCP also inhibits lipopolysaccharide (LPS)-induced autophagy in cultured microglia in vitro. MCP further decreases LPS-induced expression of proinflammatory mediators including IL-1 beta, TNF-alpha and IL-6 by regulating autophagy. Intrathecal administration of MCP results in adecreased mechanical and cold hypersensitivity following SNL. These results demonstrated that gal3 inhibition is associated with the suppression of SNL-induced inflammatory process andneurophathic pain attenuation.	[Ma, Zhicong] Shanxi Med Univ, Hosp 2, Dept Anesthesiol, Taiyuan 030001, Peoples R China; [Ma, Zhicong] Cent S Univ, Xiangya Hosp, Dept Anesthesiol, Changsha 410008, Hunan, Peoples R China; [Han, Qi; Wang, Xiaolei; Zheng, Yongjun] Fudan Univ, Huadong Hosp, Dept Pain Management, 221 West Yanan Rd, Shanghai 200040, Peoples R China; [Han, Qi; Wang, Xiaolei; Zheng, Yongjun] Fudan Univ, Huadong Hosp, Shanghai Key Lab Clin Geriatr Med, 221 West Yanan Rd, Shanghai 200040, Peoples R China; [Ai, Zisheng] Tongji Univ, Coll Med, Dept Prevent Med, Shanghai 200092, Peoples R China	Shanxi Medical University; Central South University; Fudan University; Fudan University; Tongji University	Zheng, YJ (corresponding author), Fudan Univ, Huadong Hosp, Dept Pain Management, 221 West Yanan Rd, Shanghai 200040, Peoples R China.; Zheng, YJ (corresponding author), Fudan Univ, Huadong Hosp, Shanghai Key Lab Clin Geriatr Med, 221 West Yanan Rd, Shanghai 200040, Peoples R China.	zhengyongjun1971@126.com	wang, xiao/HGB-7081-2022	wang, xiao/0000-0002-4088-3341; Ai, Zi-Sheng/0000-0001-8417-4160	Shanghai Key Laboratory of Clinical Geriatric Medicine [13dz2260700]	Shanghai Key Laboratory of Clinical Geriatric Medicine	This work was supported by the Shanghai Key Laboratory of Clinical Geriatric Medicine (13dz2260700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arad U, 2015, CYTOKINE, V73, P30, DOI 10.1016/j.cyto.2015.01.016; Boza-Serrano A, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0156-0; Burguillos MA, 2015, CELL REP, V10, P1626, DOI 10.1016/j.celrep.2015.02.012; Calvier L, 2015, JACC-HEART FAIL, V3, P59, DOI 10.1016/j.jchf.2014.08.002; Calvo M, 2011, GLIA, V59, P554, DOI 10.1002/glia.21124; Carson MJ, 2002, GLIA, V40, P218, DOI 10.1002/glia.10145; Choy YJ, 2015, J CHEM NEUROANAT, V66-67, P10, DOI 10.1016/j.jchemneu.2015.03.003; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Dominguez E, 2008, J NEUROCHEM, V107, P50, DOI 10.1111/j.1471-4159.2008.05566.x; Dominguez E, 2010, J NEUROSCI, V30, P5754, DOI 10.1523/JNEUROSCI.5007-09.2010; Ge YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097436; Guo ML, 2015, AUTOPHAGY, V11, P995, DOI 10.1080/15548627.2015.1052205; Hughes RAC, 2002, BRIT MED J, V324, P466, DOI 10.1136/bmj.324.7335.466; Jeon SB, 2010, J IMMUNOL, V185, P7037, DOI 10.4049/jimmunol.1000154; Jia WZ, 2013, AM J PATHOL, V182, P1821, DOI 10.1016/j.ajpath.2013.01.017; Kapinas K, 2010, J BIOL CHEM, V285, P25221, DOI 10.1074/jbc.M110.116137; Kim CF, 2011, J PAIN, V12, P370, DOI 10.1016/j.jpain.2010.08.003; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kolatsi-Joannou M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018683; Lalancette-Hebert M, 2012, J NEUROSCI, V32, P10383, DOI 10.1523/JNEUROSCI.1498-12.2012; Leal MF, 2015, CLIN EXP MED, V15, P415, DOI 10.1007/s10238-014-0299-0; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liang PZ, 2015, NEUROSCI BULL, V31, P435, DOI 10.1007/s12264-015-1545-5; Meng N, 2010, J CELL PHYSIOL, V225, P174, DOI 10.1002/jcp.22210; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Moalem G, 2006, BRAIN RES REV, V51, P240, DOI 10.1016/j.brainresrev.2005.11.004; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Satoh K, 2011, BRAIN RES, V1382, P266, DOI 10.1016/j.brainres.2011.01.049; Seetharaman J, 1998, J BIOL CHEM, V273, P13047, DOI 10.1074/jbc.273.21.13047; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Shi GD, 2013, GLIA, V61, P504, DOI 10.1002/glia.22451; Uceyler N, 2007, BRAIN BEHAV IMMUN, V21, P553, DOI 10.1016/j.bbi.2006.10.003; Uceyler N, 2007, PAIN, V132, P195, DOI 10.1016/j.pain.2007.07.031; Xu Y, 2008, AUTOPHAGY, V4, P110, DOI 10.4161/auto.5225; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yang Z, 2015, NEUROPATH APPL NEURO, V41, pe95, DOI 10.1111/nan.12177; Zhou XL, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-51	38	31	32	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148792	10.1371/journal.pone.0148792	http://dx.doi.org/10.1371/journal.pone.0148792			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872020	gold, Green Published, Green Submitted			2022-12-27	WOS:000370054100055
J	Monterroso, B; Reija, B; Jimenez, M; Zorrilla, S; Rivas, G				Monterroso, Begona; Reija, Belen; Jimenez, Mercedes; Zorrilla, Silvia; Rivas, German			Charged Molecules Modulate the Volume Exclusion Effects Exerted by Crowders on FtsZ Polymerization	PLOS ONE			English	Article							MACROMOLECULAR CROWDING AGENTS; STATIC LIGHT-SCATTERING; LINEAR SELF-ASSOCIATION; DIVISION PROTEIN FTSZ; QUANTITATIVE CHARACTERIZATION; SEDIMENTATION EQUILIBRIUM; ESCHERICHIA-COLI; STERIC EXCLUSION; DNA-REPLICATION; EGG-WHITE	We have studied the influence of protein crowders, either combined or individually, on the GTP-induced FtsZ cooperative assembly, crucial for the formation of the dynamic septal ring and, hence, for bacterial division. It was earlier demonstrated that high concentrations of inert polymers like Ficoll 70, used to mimic the crowded cellular interior, favor the assembly of FtsZ into bundles with slow depolymerization. We have found, by fluorescence anisotropy together with light scattering measurements, that the presence of protein crowders increases the tendency of FtsZ to polymerize at micromolar magnesium concentration, being the effect larger with ovomucoid, a negatively charged protein. Neutral polymers and a positively charged protein also diminished the critical concentration of assembly, the extent of the effect being compatible with that expected according to pure volume exclusion models. FtsZ polymerization was also observed to be strongly promoted by a negatively charged polymer, DNA, and by some unrelated polymers like PEGs at concentrations below the crowding regime. The influence of mixed crowders mimicking the heterogeneity of the intracellular environment on the tendency of FtsZ to assemble was also studied and nonadditive effects were found to prevail. Far from exactly reproducing the bacterial cytoplasm environment, this approach serves as a simplified model illustrating how its intrinsically crowded and heterogeneous nature may modulate FtsZ assembly into a functional Z-ring.	[Monterroso, Begona; Jimenez, Mercedes; Zorrilla, Silvia; Rivas, German] CSIC, Ctr Invest Biol, Madrid, Spain; [Reija, Belen; Zorrilla, Silvia] CSIC, Inst Quim Fis Rocasolano, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR)	Monterroso, B; Zorrilla, S; Rivas, G (corresponding author), CSIC, Ctr Invest Biol, Madrid, Spain.; Zorrilla, S (corresponding author), CSIC, Inst Quim Fis Rocasolano, Madrid, Spain.	monterroso@cib.csic.es; silvia@cib.csic.es; grivas@cib.csic.es	Rivas, German/AAG-7458-2022; Monterroso, Begoña/J-9748-2014; Rivas, German/AFL-7528-2022; Jimenez Sarmiento, Mercedes/K-2691-2014; Zorrilla, Silvia/J-9771-2014	Rivas, German/0000-0003-3450-7478; Monterroso, Begoña/0000-0003-2538-084X; Rivas, German/0000-0003-3450-7478; Jimenez Sarmiento, Mercedes/0000-0003-2006-1903; Zorrilla, Silvia/0000-0002-6309-9058	Spanish government [BIO2011-28941-C03, BFU 2014-52070-C2-2-P]; European Commission [HEALTH-F3-2009-223432]; Human Frontiers Science Program [RGP0050/2010-C102]	Spanish government(Spanish GovernmentEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Human Frontiers Science Program(Human Frontier Science Program)	This work was supported by Spanish government BIO2011-28941-C03 (GR and SZ) and BFU 2014-52070-C2-2-P (GR) (www.mineco.gob.es), European Commission HEALTH-F3-2009-223432 (GR) (http://ec.europa.eu/), and Human Frontiers Science Program RGP0050/2010-C102 (GR) (www.hfsp.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahijado-Guzman R, 2013, J BIOL CHEM, V288, P27358, DOI 10.1074/jbc.M113.482943; Batra J, 2009, PROTEINS, V77, P133, DOI 10.1002/prot.22425; BHAT R, 1992, PROTEIN SCI, V1, P1133, DOI 10.1002/pro.5560010907; Chen YD, 2009, BIOCHEMISTRY-US, V48, P6664, DOI 10.1021/bi8022653; DAVIS JG, 1971, BIOCHEMISTRY-US, V10, P39, DOI 10.1021/bi00777a006; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Fan YQ, 2012, INT J BIOL MACROMOL, V51, P113, DOI 10.1016/j.ijbiomac.2012.04.014; Fernandez C, 2011, J PHYS CHEM B, V115, P1289, DOI 10.1021/jp110285b; Fernandez C, 2009, BIOPHYS J, V96, P1992, DOI 10.1016/j.bpj.2008.11.054; Fodeke AA, 2010, J PHYS CHEM B, V114, P10876, DOI 10.1021/jp104342f; Frederick KB, 2008, J MOL BIOL, V378, P540, DOI 10.1016/j.jmb.2008.02.022; FREDERICQ E, 1949, J BIOL CHEM, V181, P499; Gonzalez JM, 2003, J BIOL CHEM, V278, P37664, DOI 10.1074/jbc.M305230200; Granath KA., 1958, J COLLOID SCI, V13, P308; Hall D, 2003, BBA-PROTEINS PROTEOM, V1649, P127, DOI 10.1016/S1570-9639(03)00167-5; Hong JA, 2010, J AM CHEM SOC, V132, P10445, DOI 10.1021/ja103166y; Jiao M, 2010, BIOPHYS J, V99, P914, DOI 10.1016/j.bpj.2010.05.013; KNOLL D, 1983, J BIOL CHEM, V258, P5710; Kornberg A, 2000, J BACTERIOL, V182, P3613, DOI 10.1128/JB.182.13.3613-3618.2000; LEE JC, 1981, J BIOL CHEM, V256, P7193; Liu YG, 2012, LANGMUIR, V28, P3831, DOI 10.1021/la204757z; Longsworth LG, 1940, J AM CHEM SOC, V62, P2580, DOI 10.1021/ja01867a002; Mingorance J, 2010, TRENDS MICROBIOL, V18, P348, DOI 10.1016/j.tim.2010.06.001; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Monterroso B, 2012, BIOCHEMISTRY-US, V51, P6108, DOI 10.1021/bi300891q; Monterroso B, 2012, BIOCHEMISTRY-US, V51, P4541, DOI 10.1021/bi300401b; Phillip Y, 2013, FEBS LETT, V587, P1046, DOI 10.1016/j.febslet.2013.01.007; Popp D, 2009, BIOPOLYMERS, V91, P340, DOI 10.1002/bip.21136; Reddy MK, 1995, METHOD ENZYMOL, V262, P466; Reija B, 2011, ANAL BIOCHEM, V418, P89, DOI 10.1016/j.ab.2011.07.001; Richards FM, 1971, ENZYMES; Rivas G, 2001, P NATL ACAD SCI USA, V98, P3150, DOI 10.1073/pnas.051634398; Rivas G, 2000, J BIOL CHEM, V275, P11740, DOI 10.1074/jbc.275.16.11740; Rivas German, 2013, Biophys Rev, V5, P63, DOI 10.1007/s12551-013-0115-1; ROSS PD, 1979, BIOCHEM BIOPH RES CO, V88, P1308, DOI 10.1016/0006-291X(79)91123-9; SUZUKI A, 1989, BIOCHEMISTRY-US, V28, P6513, DOI 10.1021/bi00441a052; Tang JX, 1997, BIOCHEMISTRY-US, V36, P12600, DOI 10.1021/bi9711386; TELLAM RL, 1983, BIOCHEM J, V213, P651, DOI 10.1042/bj2130651; UI N, 1971, BIOCHIM BIOPHYS ACTA, V229, P567; Weast R. C., 1984, HDB CHEM PHYS; Winzor DJ, 2006, BIOPHYS CHEM, V119, P186, DOI 10.1016/j.bpc.2005.08.001; Wu D, 2013, J PHYS CHEM B, V117, P111, DOI 10.1021/jp308880v; YI QM, 1985, GENE, V36, P241; Zhou BR, 2008, BBA-PROTEINS PROTEOM, V1784, P472, DOI 10.1016/j.bbapap.2008.01.004; Zhou HX, 2008, PROTEINS, V72, P1109, DOI 10.1002/prot.22111; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817; Zorrilla S, 2004, BIOPHYS CHEM, V108, P89, DOI 10.1016/j.bpc.2003.10.012	47	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149060	10.1371/journal.pone.0149060	http://dx.doi.org/10.1371/journal.pone.0149060			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26870947	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100095
J	Patnaik, BB; Wang, TH; Kang, SW; Hwang, HJ; Park, SY; Park, EB; Chung, JM; Song, DK; Kim, C; Kim, S; Lee, JS; Han, YS; Park, HS; Lee, YS				Patnaik, Bharat Bhusan; Wang, Tae Hun; Kang, Se Won; Hwang, Hee-Ju; Park, So Young; Park, Eun Bi; Chung, Jong Min; Song, Dae Kwon; Kim, Changmu; Kim, Soonok; Lee, Jun Sang; Han, Yeon Soo; Park, Hong Seog; Lee, Yong Seok			Sequencing, De Novo Assembly, and Annotation of the Transcriptome of the Endangered Freshwater Pearl Bivalve, Cristaria plicata, Provides Novel Insights into Functional Genes and Marker Discovery	PLOS ONE			English	Article							TANDEM-REPEAT GALECTIN; MOLECULAR-CLONING; RUDITAPES-PHILIPPINARUM; MANTLE TRANSCRIPTOME; EXPRESSION ANALYSIS; PROTOZOAN PARASITE; INNATE IMMUNITY; THERMAL-STRESS; PACIFIC OYSTER; MANILA CLAM	Background The freshwater mussel Cristaria plicata (Bivalvia: Eulamellibranchia: Unionidae), is an economically important species in molluscan aquaculture due to its use in pearl farming. The species have been listed as endangered in South Korea due to the loss of natural habitats caused by anthropogenic activities. The decreasing population and a lack of genomic information on the species is concerning for environmentalists and conservationists. In this study, we conducted a de novo transcriptome sequencing and annotation analysis of C. plicata using Illumina HiSeq 2500 next-generation sequencing (NGS) technology, the Trinity assembler, and bioinformatics databases to prepare a sustainable resource for the identification of candidate genes involved in immunity, defense, and reproduction. Results The C. plicata transcriptome analysis included a total of 286,152,584 raw reads and 281,322,837 clean reads. The de novo assembly identified a total of 453,931 contigs and 374,794 non-redundant unigenes with average lengths of 731.2 and 737.1 bp, respectively. Furthermore, 100% coverage of C. plicata mitochondrial genes within two unigenes supported the quality of the assembler. In total, 84,274 unigenes showed homology to entries in at least one database, and 23,246 unigenes were allocated to one or more Gene Ontology (GO) terms. The most prominent GO biological process, cellular component, and molecular function categories (level 2) were cellular process, membrane, and binding, respectively. A total of 4,776 unigenes were mapped to 123 biological pathways in the KEGG database. Based on the GO terms and KEGG annotation, the unigenes were suggested to be involved in immunity, stress responses, sex-determination, and reproduction. A total of 17,251 cDNA simple sequence repeats (cSSRs) were identified from 61,141 unigenes (size of > 1 kb) with the most abundant being dinucleotide repeats. Conclusions This dataset represents the first transcriptome analysis of the endangered mollusc, C. plicata. The transcriptome provides a comprehensive sequence resource for the conservation of genetic information in this species and enrichment of the genetic database. The development of molecular markers will assist in the genetic improvement of C. plicata.	[Patnaik, Bharat Bhusan; Wang, Tae Hun; Kang, Se Won; Hwang, Hee-Ju; Park, So Young; Park, Eun Bi; Chung, Jong Min; Song, Dae Kwon; Lee, Yong Seok] Soonchunhyang Univ, Coll Nat Sci, Dept Life Sci & Biotechnol, 22 Soonchunhyangro, Asan 336745, Chungchungnam D, South Korea; [Kim, Changmu; Kim, Soonok] Natl Inst Biol Resources, Inchon 404170, South Korea; [Lee, Jun Sang] Kangwon Natl Univ, Inst Environm Res, 1 Kangwondaehak Gil, Chuncheon Si 200701, Gangwon Do, South Korea; [Han, Yeon Soo] Chonnam Natl Univ, Coll Agr & Life Sci, 300 Yongbong Dong, Gwangju 500757, South Korea; [Park, Hong Seog] GnC BIO Co LTD, Res Inst, 621-6 Banseok Dong, Daejeon 305150, South Korea; [Patnaik, Bharat Bhusan] TACT, Trident Sch Biotech Sci, Bhubaneswar 751024, Odisha, India	Soonchunhyang University; National Institute of Biological Resources; Kangwon National University; Chonnam National University	Lee, YS (corresponding author), Soonchunhyang Univ, Coll Nat Sci, Dept Life Sci & Biotechnol, 22 Soonchunhyangro, Asan 336745, Chungchungnam D, South Korea.	yslee@sch.ac.kr	LEE, YONGSEOK/AAF-3965-2020; Patnaik, Bharat Bhusan/H-2973-2019	Patnaik, Bharat Bhusan/0000-0003-1383-6758; Lee, Yongseok/0000-0002-8687-589X	grant entitled "The Genetic and Genomic Evaluation of Indigenous Biological Resources" - National Institute of Biological Resources [NIBR201503202]; grant entitled "The Genetic and Genomic Evaluation of Indigenous Biological Resources" - National Institute of Biological Resources, Incheon, Korea [NIBR201503202]	grant entitled "The Genetic and Genomic Evaluation of Indigenous Biological Resources" - National Institute of Biological Resources; grant entitled "The Genetic and Genomic Evaluation of Indigenous Biological Resources" - National Institute of Biological Resources, Incheon, Korea	This work was supported by the grant entitled "The Genetic and Genomic Evaluation of Indigenous Biological Resources" funded by the National Institute of Biological Resources (NIBR201503202).; This work was supported by the grant entitled "The Genetic and Genomic Evaluation of Indigenous Biological Resources (NIBR201503202)" funded by the National Institute of Biological Resources, Incheon, Korea.	Abdul-Muneer PM, 2014, GENET RES INT, V2014, DOI 10.1155/2014/691759; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arancibia SA, 2007, BIOL RES, V40, P97, DOI 10.4067/S0716-97602007000200001; Diaz GA, 2010, ISJ-INVERT SURVIV J, V7, P157; Artigaud S, 2014, MAR GENOM, V15, P3, DOI 10.1016/j.margen.2014.03.006; Bai Z, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022886, DOI 10.1371/J0URNAL.P0NE.0022886]; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Birol I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130720; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Bogan AE, 2015, IUCN RED LIST THREAT; Bouhouche N, 2000, TRENDS MICROBIOL, V8, P77, DOI 10.1016/S0966-842X(99)01679-0; Boutet I, 2008, GENE, V407, P130, DOI 10.1016/j.gene.2007.10.005; Castellanos-Martinez S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107873; Chatterjee B.P., 2013, MARINE PROTEINS PEPT, V1st ed., P41, DOI [10.1002/9781118375082.ch3, DOI 10.1002/9781118375082.CH3]; Chavez-Villalba J, 2011, J SHELLFISH RES, V30, P231, DOI 10.2983/035.030.0206; Che RB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087940; Chen HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079516; Cheng CF, 2012, SCI WORLD J, DOI 10.1100/2012/906737; Clark MS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-362; Collins AJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00091; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Deng YW, 2014, BIOSCI BIOTECH BIOCH, V78, P1685, DOI 10.1080/09168451.2014.936351; Dong Y, 2014, INT J MOL SCI, V15, P19472, DOI 10.3390/ijms151119472; Dong Zhi-Guo, 2004, Acta Hydrobiologica Sinica, V28, P440; Estari M., 2011, Biology and Medicine, V3, P191; Evans TG, 2012, PHILOS T R SOC B, V367, P1733, DOI 10.1098/rstb.2012.0019; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Feldmeyer B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-317; Franchini Paolo, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-59; Galloway TS, 2001, ECOTOXICOLOGY, V10, P5, DOI 10.1023/A:1008939520263; Gerdol Marco, 2014, BMC Research Notes, V7, P722, DOI 10.1186/1756-0500-7-722; Gorbushin AM, 2015, DEV COMP IMMUNOL, V48, P210, DOI 10.1016/j.dci.2014.10.007; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo XM, 2015, FISH SHELLFISH IMMUN, V46, P107, DOI 10.1016/j.fsi.2015.05.018; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; He J, FRESHWATER BIVALVES; Hook SE, 2014, AQUAT TOXICOL, V146, P247, DOI 10.1016/j.aquatox.2013.11.001; Hoshino AA, GENET DIVERS MICROOR, V6, P149; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Hu XJ, 2014, FISH SHELLFISH IMMUN, V40, P446, DOI 10.1016/j.fsi.2014.07.005; Huang ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051279; Jia ZY, 2008, MOL ECOL RESOUR, V8, P1520, DOI 10.1111/j.1755-0998.2008.02310.x; Joshi NA, SICKLE SLIDING WINDO; Jung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027938; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kang Se Won, 2015, Korean Journal of Malacology, V31, P243, DOI 10.9710/kjm.2015.31.3.243; Kashimada K, 2010, DEVELOPMENT, V137, P3921, DOI 10.1242/dev.048983; Kim JY, 2008, DEV COMP IMMUNOL, V32, P1131, DOI 10.1016/j.dci.2008.03.002; Kondo T, SPECIAL PUBLICATION, V3, pv; Kong PF, 2011, FISH SHELLFISH IMMUN, V30, P836, DOI 10.1016/j.fsi.2011.01.005; Kopp A, 2012, TRENDS GENET, V28, P175, DOI 10.1016/j.tig.2012.02.002; Kuchel RP, 2010, J INVERTEBR PATHOL, V104, P97, DOI 10.1016/j.jip.2010.02.001; Lee JH, 2012, MITOCHONDR DNA, V23, P39, DOI 10.3109/19401736.2011.643882; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Leung PTY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-804; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Llera-Herrera R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073176; Lopez-Uribe MM, 2013, APIDOLOGIE, V44, P163, DOI 10.1007/s13592-012-0168-3; Ma JJ, 2010, FISH SHELLFISH IMMUN, V29, P501, DOI 10.1016/j.fsi.2010.05.006; Ma KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039727; Martin J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-663; Matsumoto T, 2003, ZOOL SCI, V20, P37, DOI 10.2108/zsj.20.37; Matsumoto T, 2013, ZOOL SCI, V30, P826, DOI 10.2108/zsj.30.826; Mehr S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1565-6; Meng XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064485; Micallef G, 2012, MAR BIOTECHNOL, V14, P559, DOI 10.1007/s10126-012-9447-2; Milan M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-234; Naimi A, 2009, COMP BIOCHEM PHYS B, V154, P134, DOI 10.1016/j.cbpb.2009.05.011; Ning X, 2015, FISH SHELLFISH IMMUN; Niu D, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067456, DOI 10.1371/J0URNAL.P0NE.0067456]; Noh JY, 2014, GENE, V534, P204, DOI 10.1016/j.gene.2013.10.058; Osada M, 2004, COMP BIOCHEM PHYS B, V139, P123, DOI 10.1016/j.cbpc.2004.07.002; Oshima Y, 2008, GEN COMP ENDOCR, V159, P170, DOI 10.1016/j.ygcen.2008.08.013; Pairett AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069852; Pauletto M, 2014, FISH SHELLFISH IMMUN, V37, P154, DOI 10.1016/j.fsi.2014.01.017; Penarrubia L, 2015, CONSERV GENET RESOUR, V7, P393, DOI 10.1007/s12686-014-0378-2; Peng K, 2012, AQUACULTURE, V334, P45, DOI 10.1016/j.aquaculture.2011.12.039; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Philipp EER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033091; Prentis PJ, 2014, MAR GENOM, V18, P113, DOI 10.1016/j.margen.2014.08.004; Qiao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075211; Ren Q, 2011, FISH SHELLFISH IMMUN, V31, P1232, DOI 10.1016/j.fsi.2011.07.020; Rhee SY, 2008, NAT REV GENET, V9, P509, DOI 10.1038/nrg2363; Roberts S, 2009, MAR BIOTECHNOL, V11, P24, DOI 10.1007/s10126-008-9117-6; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Romero A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017003; Sanz N, 2013, BIOL INVASIONS, V15, P2333, DOI 10.1007/s10530-013-0456-5; Schmitt P, 2010, J BIOL CHEM, V285, P29208, DOI 10.1074/jbc.M110.143388; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Senatore A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118321; Shi MJ, 2013, MAR BIOTECHNOL, V15, P706, DOI 10.1007/s10126-013-9517-0; Smith SA, 2011, NATURE, V480, P364, DOI 10.1038/nature10526; Tanaka SS, 2014, CELL MOL LIFE SCI, V71, P4781, DOI 10.1007/s00018-014-1703-3; Tanguy Marion, 2013, Results Immunol, V3, P40, DOI 10.1016/j.rinim.2013.04.001; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Teaniniuraitemoana V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122819; Teaniniuraitemoana V, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-491; The Gene Ontology Consortium, 2008, NUCL ACIDS RES, V36; Tindwa H, 2013, INT J MOL SCI, V14, P22462, DOI 10.3390/ijms141122462; Tong Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134280; Toubiana M, 2014, DEV COMP IMMUNOL, V45, P300, DOI 10.1016/j.dci.2014.03.021; Uliano-Silva M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102973; Vasta GR, 2012, ANN NY ACAD SCI, V1253, pE14, DOI 10.1111/j.1749-6632.2012.06698.x; Venier P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-69; Venier P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-72; Vidotto M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-407; Vogel H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-308; Wang H, 2016, MITOCHONDRIAL DNA A, V27, P1478, DOI 10.3109/19401736.2014.953100; Wang L, 2011, ISJ-INVERT SURVIV J, V8, P241; Wang W, 2014, MAR BIOTECHNOL, V16, P547, DOI 10.1007/s10126-014-9573-0; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wei GY, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0786-0; Whitten MMA, 2004, J IMMUNOL, V172, P2177, DOI 10.4049/jimmunol.172.4.2177; Woo S, 2013, ZOOL STUD, V52, DOI 10.1186/1810-522X-52-15; Wu D, 2013, FISH SHELLFISH IMMUN, V34, P1033, DOI 10.1016/j.fsi.2012.12.009; Xie YL, 2014, BIOINFORMATICS, V30, P1660, DOI 10.1093/bioinformatics/btu077; Yan YB, 2011, AM J BOT, V98, pE1, DOI 10.3732/ajb.1000387; Yang XL, 2011, FISH SHELLFISH IMMUN, V31, P389, DOI 10.1016/j.fsi.2011.06.003; Yu FF, 2011, J SHELLFISH RES, V30, P247, DOI 10.2983/035.030.0208; Yue HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127332; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zeng DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057515; Zhang DC, 2011, GENET MOL RES, V10, P1963, DOI 10.4238/vol10-3gmr1149; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang LL, 2014, MAR BIOTECHNOL, V16, P17, DOI 10.1007/s10126-013-9526-z; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056732; Zhang ZH, 2012, GENE, V497, P172, DOI 10.1016/j.gene.2012.01.058	127	41	42	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148622	10.1371/journal.pone.0148622	http://dx.doi.org/10.1371/journal.pone.0148622			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872384	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100040
J	Tse, G; Tse, V; Yeo, JM; Sun, B				Tse, Gary; Tse, Vivian; Yeo, Jie Ming; Sun, Bing			Atrial Anti-Arrhythmic Effects of Heptanol in Langendorff-Perfused Mouse Hearts	PLOS ONE			English	Article							GAP-JUNCTION PROTEIN; VENTRICULAR-TACHYCARDIA; INCREASED VULNERABILITY; CONDUCTION SYSTEM; IONIC MECHANISMS; SODIUM CURRENT; WILD-TYPE; REPOLARIZATION; ARRHYTHMIAS; MICE	Acute effects of heptanol (0.1 to 2 mM) on atrial electrophysiology were explored in Langendorff- perfused mouse hearts. Left atrial bipolar electrogram or monophasic action potential recordings were obtained during right atrial stimulation. Regular pacing at 8 Hz elicited atrial activity in 11 out of 11 hearts without inducing atrial arrhythmias. Programmed electrical stimulation using a S1S2 protocol provoked atrial tachy-arrhythmias in 9 of 17 hearts. In the initially arrhythmic group, 2 mM heptanol exerted anti-arrhythmic effects (Fisher's exact test, P < 0.05) and increased atrial effective refractory period (ERP) from 26.0 +/- 1.9 to 57.1 +/- 2.5 ms (ANOVA, P < 0.001) despite increasing activation latency from 18.7 +/- 1.1 to 28.9 +/- 2.1 ms (P < 0.001) and leaving action potential duration at 90% repolarization (APD(90)) unaltered (25.6 +/- 1.2 vs. 27.2 +/- 1.2 ms; P > 0.05), which led to increases in ERP/latency ratio from 1.4 +/- 0.1 to 2.1 +/- 0.2 and ERP/APD(90) ratio from 1.0 +/- 0.1 to 2.1 +/- 0.2 (P < 0.001). In contrast, in the initially non-arrhythmic group, heptanol did not alter arrhythmogenicity, increased AERP from 47.3 +/- 5.3 to 54.5 +/- 3.1 ms (P < 0.05) and activation latency from 23.7 +/- 2.2 to 31.3 +/- 2.5 ms and did not alter APD(90) (24.1 +/- 1.2 vs. 25.0 +/- 2.3 ms; P > 0.05), leaving both AERP/latency ratio (2.1 +/- 0.3 vs. 1.9 +/- 0.2; P > 0.05) and ERP/APD(90) ratio (2.0 +/- 0.2 vs. 2.1 +/- 0.1; P > 0.05) unaltered. Lower heptanol concentrations (0.1, 0.5 and 1 mM) did not alter arrhythmogenicity or the above parameters. The present findings contrast with known ventricular pro-arrhythmic effects of heptanol associated with decreased ERP/ latency ratio, despite increased ERP/APD ratio observed in both the atria and ventricles.	[Tse, Gary] Univ Hong Kong, Li Ka Shing Fac Med, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Tse, Vivian] McGill Univ, Dept Physiol, Montreal, PQ, Canada; [Yeo, Jie Ming] Univ London Imperial Coll Sci Technol & Med, Fac Med, London, England; [Sun, Bing] Tongji Univ, Affiliated Tongji Hosp, Dept Cardiol, Shanghai 200092, Peoples R China	University of Hong Kong; McGill University; Imperial College London; Tongji University	Sun, B (corresponding author), Tongji Univ, Affiliated Tongji Hosp, Dept Cardiol, Shanghai 200092, Peoples R China.	woowoocncn@163.com	Tse, Gary/P-1171-2015	Tse, Gary/0000-0001-5510-1253; Yeo, Jie Ming/0000-0001-9541-8941	Wellcome Trust Vacation Scholarship; Trinity Hall, Cambridge; Biotechnology and Biological Sciences Research Council (BBSRC) Doctoral CASE Studentship at the Department of Biochemistry, University of Cambridge; British Heart Foundation; Medical Research Council; Xention Discovery	Wellcome Trust Vacation Scholarship(Wellcome Trust); Trinity Hall, Cambridge; Biotechnology and Biological Sciences Research Council (BBSRC) Doctoral CASE Studentship at the Department of Biochemistry, University of Cambridge(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Xention Discovery	Support was provided by: Wellcome Trust Vacation Scholarship; Trinity Hall, Cambridge; a Biotechnology and Biological Sciences Research Council (BBSRC) Doctoral CASE Studentship at the Department of Biochemistry, University of Cambridge, in conjunction with Xention Discovery; British Heart Foundation; Medical Research Council.	Abriel H, 2010, J MOL CELL CARDIOL, V48, P2, DOI 10.1016/j.yjmcc.2009.08.025; Alcolea S, 2004, CIRC RES, V94, P100, DOI 10.1161/01.RES.0000108261.67979.2A; Antzelevitch C, 2005, HEART RHYTHM, V2, P804, DOI 10.1016/j.hrthm.2005.05.013; Antzelevitch C, 1999, CURR OPIN CARDIOL, V14, P274, DOI 10.1097/00001573-199905000-00013; Antzelevitch Charles, 2011, Card Electrophysiol Clin, V3, P23, DOI 10.1016/j.ccep.2010.10.012; Arora Rishi, 2003, Indian Pacing Electrophysiol J, V3, P187; Aschar-Sobbi R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7018; Balasubramaniam R, 2003, J PHYSIOL-LONDON, V552, P535, DOI 10.1113/jphysiol.2003.048249; BASTIAANSE EML, 1993, J MEMBRANE BIOL, V136, P135, DOI 10.1007/BF02505758; Berul CI, 2003, PHYSIOL GENOMICS, V13, P207, DOI 10.1152/physiolgenomics.00183.2002; BEYER EC, 1987, J CELL BIOL, V105, P2621, DOI 10.1083/jcb.105.6.2621; BOERSMA L, 1994, CIRCULATION, V90, P1012, DOI 10.1161/01.CIR.90.2.1012; Boyett MR, 2009, EXP PHYSIOL, V94, P1035, DOI 10.1113/expphysiol.2009.046920; BRUGADA P, 1985, PACE, V8, P889, DOI 10.1111/j.1540-8159.1985.tb05908.x; Chen BP, 2005, CLIN EXP PHARMACOL P, V32, P655, DOI 10.1111/j.0305-1870.2005.04246.x; Dautova Y, 2010, EXP PHYSIOL, V95, P994, DOI 10.1113/expphysiol.2010.053868; Dautova Y, 2009, PFLUG ARCH EUR J PHY, V458, P443, DOI 10.1007/s00424-008-0633-z; DAVIS LM, 1994, J AM COLL CARDIOL, V24, P1124, DOI 10.1016/0735-1097(94)90879-6; Fabritz L, 2003, BASIC RES CARDIOL, V98, P25, DOI 10.1007/s00395-003-0386-y; Fahmi AI, 2001, J PHYSIOL-LONDON, V537, P693; GELLENS ME, 1992, P NATL ACAD SCI USA, V89, P554, DOI 10.1073/pnas.89.2.554; GROS D, 1994, CIRC RES, V74, P839, DOI 10.1161/01.RES.74.5.839; Gussak I, 2000, J ELECTROCARDIOL, V33, P159, DOI 10.1016/S0022-0736(00)80072-2; Head CE, 2005, J CARDIOVASC ELECTR, V16, P1329, DOI 10.1111/j.1540-8167.2005.00200.x; Jansen JA, 2010, J MOL CELL CARDIOL, V48, P76, DOI 10.1016/j.yjmcc.2009.08.018; Keevil VL, 2000, PFLUG ARCH EUR J PHY, V440, P275, DOI 10.1007/s004240051049; Killeen MJ, 2008, ACTA PHYSIOL, V192, P455, DOI 10.1111/j.1748-1716.2007.01822.x; Knollmann BC, 2001, J CARDIOVASC ELECTR, V12, P1286, DOI 10.1046/j.1540-8167.2001.01286.x; KOLLER BS, 1995, CIRCULATION, V91, P2378, DOI 10.1161/01.CIR.91.9.2378; Li GH, 2002, CARDIOVASC PATHOL, V11, P158, DOI 10.1016/S1054-8807(02)00102-3; Li GR, 2002, J MOL CELL CARDIOL, V34, P1185, DOI 10.1006/jmcc.2002.2053; Lin XM, 2010, J MOL CELL CARDIOL, V48, P238, DOI 10.1016/j.yjmcc.2009.05.014; NELSON WL, 1991, CIRC RES, V68, P977, DOI 10.1161/01.RES.68.4.977; Ohara T, 2002, AM J PHYSIOL-HEART C, V283, pH1116, DOI 10.1152/ajpheart.00927.2001; Remme CA, 2009, BASIC RES CARDIOL, V104, P511, DOI 10.1007/s00395-009-0012-8; ROZANSKI GJ, 1984, CIRC RES, V55, P486, DOI 10.1161/01.RES.55.4.486; Sabir IN, 2007, PFLUG ARCH EUR J PHY, V454, P209, DOI 10.1007/s00424-007-0217-3; Sabir IN, 2008, PROG BIOPHYS MOL BIO, V98, P208, DOI 10.1016/j.pbiomolbio.2008.10.011; Schroeter A, 2010, J MOL CELL CARDIOL, V49, P16, DOI 10.1016/j.yjmcc.2010.04.004; Sepp R, 1996, HEART, V76, P412, DOI 10.1136/hrt.76.5.412; Shaw RM, 1997, CIRC RES, V81, P727; Sheikh SM, 2001, J PHYSIOL-LONDON, V535, P579, DOI 10.1111/j.1469-7793.2001.t01-1-00579.x; SMEETS JLRM, 1986, CIRC RES, V58, P96, DOI 10.1161/01.RES.58.1.96; SPACH MS, 1994, J CARDIOVASC ELECTR, V5, P182, DOI 10.1111/j.1540-8167.1994.tb01157.x; Sun DQ, 2001, P NATL ACAD SCI USA, V98, P9983, DOI 10.1073/pnas.171317998; Temple IP, 2013, HEART RHYTHM, V10, P297, DOI 10.1016/j.hrthm.2012.10.020; THOMAS GP, 1995, J PHARMACOL EXP THER, V274, P1379; Tse G, 2016, J ARRYTHM, V32, P75, DOI 10.1016/j.joa.2015.11.003; Tse G, 2015, IJC HEART VASC, V9, P75, DOI 10.1016/j.ijcha.2015.10.003; Tse G, 2016, BIOMED REP, V4, P313, DOI 10.3892/br.2016.577; Tse G, 2012, J PHYSIOL SCI, V62, P79, DOI 10.1007/s12576-011-0187-2; Verheule S, 2004, CIRC RES, V94, P1458, DOI 10.1161/01.RES.0000129579.59664.9d; WIENER N, 1946, Arch Inst Cardiol Mex, V16, P205	53	33	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148858	10.1371/journal.pone.0148858	http://dx.doi.org/10.1371/journal.pone.0148858			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872148	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000370054100065
J	Asati, A; Kachurina, O; Karol, A; Dhir, V; Nguyen, M; Parkhill, R; Kouiavskaia, D; Chumakov, K; Warren, W; Kachurin, A				Asati, Atul; Kachurina, Olga; Karol, Alex; Dhir, Vipra; Nguyen, Michael; Parkhill, Robert; Kouiavskaia, Diana; Chumakov, Konstantin; Warren, William; Kachurin, Anatoly			Fluorescence Adherence Inhibition Assay: A Novel Functional Assessment of Blocking Virus Attachment by Vaccine-Induced Antibodies	PLOS ONE			English	Article							YELLOW-FEVER VIRUS; LINKED-IMMUNOSORBENT-ASSAY; FLOW-CYTOMETRY; IMMUNOFLUORESCENCE ASSAY; NEUTRALIZATION TEST; INFLUENZA-VIRUS; IGG ANTIBODIES; PROTEIN; ELISA; 17D	Neutralizing antibodies induced by vaccination or natural infection play a critically important role in protection against the viral diseases. In general, neutralization of the viral infection occurs via two major pathways: pre- and post-attachment modes, the first being the most important for such infections as influenza and polio, the latter being significant for filoviruses. Neutralizing capacity of antibodies is typically evaluated by virus neutralization assays that assess reduction of viral infectivity to the target cells in the presence of functional antibodies. Plaque reduction neutralization test, microneutralization and immunofluorescent assays are often used as gold standard virus neutralization assays. However, these methods are associated with several important prerequisites such as use of live virus requiring safety precautions, tedious evaluation procedure and long assessment time. Hence, there is a need for a robust, inexpensive high throughput functional assay that can be performed rapidly using inactivated virus, without extensive safety precautions. Herein, we report a novel high throughput Fluorescence Adherence Inhibition assay (fADI) using inactivated virus labeled with fluorescent secondary antibodies virus and Vero cells or erythrocytes as targets. It requires only few hours to assess pre-attachment neutralizing capacity of donor sera. fADI assay was tested successfully on donors immunized with polio, yellow fever and influenza vaccines. To further simplify and improve the throughput of the assay, we have developed a mathematical approach for calculating the 50% titers from a single sample dilution, without the need to analyze multi-point titration curves. Assessment of pre- and post-vaccination human sera from subjects immunized with IPOL (R), YF-VAX (R) and 2013-2014 Fluzone (R) vaccines demonstrated high efficiency of the assay. The results correlated very well with microneutralization assay performed independently by the FDA Center of Biologics Evaluation and Research, with plaque reduction neutralization test performed by Focus Diagnostics, and with hemaglutination inhibition assay performed in-house at Sanofi Pasteur. Taken together, fADI assay appears to be a useful high throughput functional immunoassay for assessment of antibody-related neutralization of the viral infections for which pre-attachment neutralization pathway is predominant, such as polio, influenza, yellow fever and dengue.	[Asati, Atul; Kachurina, Olga; Karol, Alex; Dhir, Vipra; Nguyen, Michael; Parkhill, Robert; Warren, William; Kachurin, Anatoly] Sanofi Pasteur VaxDesign Campus, 2501 Discovery Dr Suite 3000, Orlando, FL 32826 USA; [Kouiavskaia, Diana; Chumakov, Konstantin] US FDA, Ctr Biol Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Kachurin, A (corresponding author), Sanofi Pasteur VaxDesign Campus, 2501 Discovery Dr Suite 3000, Orlando, FL 32826 USA.	anatoly.kachurin@sanofipasteur.com			Defense Threat Reduction Agency (DTRA) [HDTRA1-13-C-00011]; Biomedical Advanced Research and Development Authority (BARDA), Department of Health and Human Services [HHSO100201000035C]; Sanofi Pasteur; CBER FDA	Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); Biomedical Advanced Research and Development Authority (BARDA), Department of Health and Human Services; Sanofi Pasteur; CBER FDA	This project has been funded in whole or in part with Federal funds from Defense Threat Reduction Agency (DTRA) and Biomedical Advanced Research and Development Authority (BARDA), Department of Health and Human Services, under Contract No. HDTRA1-13-C-00011 and HHSO100201000035C, respectively. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. The authors Atul Asati, Olga Kachurina, Alex Karol, Vipra Dhir, Michael Nguyen, Robert Parkhill, William Warren and Anatoly Kachurin are employed by Sanofi Pasteur. The authors Diana Kouiavskaia and Konstantin Chumakov are employed by Center for Biologics Evaluation and Research within FDA (CBER FDA). Both Sanofi Pasteur and CBER FDA provided support in the form of salaries for authors AA, OK, A. Kachurin, VD, MN, RP, WW, A. Karol, DK, and KC respectively, but did not have any additional role in the study design, data collection and analysis or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	[Anonymous], 1999, WHO M; BARRY M, 1991, AM J TROP MED HYG, V44, P79, DOI 10.4269/ajtmh.1991.44.79; Biacchesi S, 2005, J VIROL METHODS, V128, P192, DOI 10.1016/j.jviromet.2005.05.005; de la Vega M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-99; DEUBEL V, 1983, AM J TROP MED HYG, V32, P565, DOI 10.4269/ajtmh.1983.32.565; Devon J, 2010, VIROLOGY, V401, P228, DOI [10.1016/j.virol.2010.02.029, DOI 10.1016/J.VIROL.2010.02.029]; Earl PL, 2003, J VIROL, V77, P10684, DOI 10.1128/JVI.77.19.10684-10688.2003; GROOT H, 1962, B WORLD HEALTH ORGAN, V27, P699; Julander JG, 2011, VACCINE, V29, P6008, DOI 10.1016/j.vaccine.2011.06.034; Kachurin A, 2014, Patent No. [US8778347 B2, 8778347B2]; Klingen Y, 2008, J VIROL, V82, P237, DOI 10.1128/JVI.01342-07; Kraus AA, 2007, J CLIN MICROBIOL, V45, P3777, DOI 10.1128/JCM.00827-07; Kremser L, 2004, ANAL CHEM, V76, P7360, DOI 10.1021/ac048999m; Lonsdale R, 2003, J VIROL METHODS, V110, P67, DOI 10.1016/S0166-0934(03)00102-2; MATLIN KS, 1981, J CELL BIOL, V91, P601, DOI 10.1083/jcb.91.3.601; NICHOLS JE, 1993, ARCH VIROL, V130, P441, DOI 10.1007/BF01309672; Niedrig M, 1999, TROP MED INT HEALTH, V4, P867, DOI 10.1046/j.1365-3156.1999.00496.x; Niedrig M, 2008, CLIN VACCINE IMMUNOL, V15, P177, DOI 10.1128/CVI.00078-07; Plotkin S, 2008, VACCINES, P959; Roberson S, 1993, IMMUNOLOGICAL BASIS; Roukens AH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001993; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Sliva K, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-14; Vazquez S, 2003, J VIROL METHODS, V110, P179, DOI 10.1016/S0166-0934(03)00128-9; Wang Z, 2004, J VIROL METHODS, V120, P207, DOI 10.1016/j.jviromet.2004.05.010; World Health Organization, 2007, GUID PLAQ RED NEUTR; World Health Organization, 2011, MAN LAB DIAGN VIR SU; World Health Organization (WHO), 1997, MAN VIR INV POL; You JO, 2006, INT J NANOMED, V1, P59, DOI 10.2147/nano.2006.1.1.59	29	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0144261	10.1371/journal.pone.0144261	http://dx.doi.org/10.1371/journal.pone.0144261			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863313	Green Published, gold, Green Submitted			2022-12-27	WOS:000370046600003
J	Chomczynski, P; Wilfinger, WW; Eghbalnia, HR; Kennedy, A; Rymaszewski, M; Mackey, K				Chomczynski, Piotr; Wilfinger, William W.; Eghbalnia, Hamid R.; Kennedy, Amy; Rymaszewski, Michal; Mackey, Karol			Inter-Individual Differences in RNA Levels in Human Peripheral Blood	PLOS ONE			English	Article							GENE-EXPRESSION ANALYSIS; RIBOSOMAL-RNA; WHOLE-BLOOD; HOUSEKEEPING GENES; CELLS; STABILIZATION; VALIDATION	Relatively little is known about the range of RNA levels in human blood. This report provides assessment of peripheral blood RNA level and its inter-individual differences in a group of 35 healthy humans consisting of 25 females and 10 males ranging in age from 50 to 89 years. In this group, the average total RNA level was 14.59 mu g/ml of blood, with no statistically significant difference between females and males. The individual RNA level ranged from 6.7 to 22.7 mu g/ml of blood. In healthy subjects, the repeated sampling of an individual's blood showed that RNA level, whether high or low, was stable. The inter-individual differences in RNA level in blood can be attributed to both, differences in cell number and the amount of RNA per cell. The 3.4-fold range of inter-individual differences in total RNA levels, documented herein, should be taken into account when evaluating the results of quantitative RT-PCR and/or RNA sequencing studies of human blood. Based on the presented results, a comprehensive assessment of gene expression in blood should involve determination of both the amount of mRNA per unit of total RNA (U /ng RNA) and the amount of mRNA per unit of blood (U / ml blood) to assure a thorough interpretation of physiological or pathological relevance of study results.	[Chomczynski, Piotr; Wilfinger, William W.; Kennedy, Amy; Rymaszewski, Michal; Mackey, Karol] Mol Res Ctr Inc, Cincinnati, OH USA; [Eghbalnia, Hamid R.] Univ Cincinnati, Coll Med, Cincinnati, OH USA	University System of Ohio; University of Cincinnati	Chomczynski, P (corresponding author), Mol Res Ctr Inc, Cincinnati, OH USA.	piotr@mrcgene.com		Wilfinger, William/0000-0002-7891-2232	Molecular research Center, Inc.	Molecular research Center, Inc.	This study was funded by Molecular research Center, Inc. All authors, except HE, are employees of Molecular Research center, Inc. and performed the following roles in the study: PCh, WWW, KM, study design, data collection and analysis, decision to publish, preparation of the manuscript. AK, MR, data collection and analysis. HE, statistical analysis and manuscript preparation.	Anderson R, 2008, QUANTITATIVE APPL SO, V152, P1; [Anonymous], 2014, TECHNICAL NOTE ANAL, P3; Baechler EC, 2004, GENES IMMUN, V5, P347, DOI 10.1038/sj.gene.6364098; Bowyer JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133315; Chomczynski P, 2013, NAT METHODS, V10, pan1; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; Hantzsch M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113298; Hart T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-778; Hiebeler D, 2014, MATLAB R REFERENCE; Kabanova S, 2009, INT J MED SCI, V6, P156; Mesko B, 2011, TRENDS MOL MED, V17, P223, DOI 10.1016/j.molmed.2010.12.004; Mohr S, 2007, TRENDS MOL MED, V13, P422, DOI 10.1016/j.molmed.2007.08.003; Mostafavi S, 2014, MOL PSYCHIATR, V19, P1267, DOI 10.1038/mp.2013.161; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; O'Neil Dominic, 2013, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0419s103; Pahl A, 2002, CLIN CHEM, V48, P2251; Rainen L, 2002, CLIN CHEM, V48, P1883; Raval A, 2012, BLOOD, V120, P4812, DOI 10.1182/blood-2012-04-423111; Rouchka EC, 2013, OA BIOINFORMATICS, V1, P3; Shen-Orr SS, 2010, NAT METHODS, V7, P287, DOI [10.1038/NMETH.1439, 10.1038/nmeth.1439]; Shin H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091041; Stamova BS, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-49; Stults DM, 2008, GENOME RES, V18, P13, DOI 10.1101/gr.6858507; Stults DM, 2009, CANCER RES, V69, P9096, DOI 10.1158/0008-5472.CAN-09-2680; TRUDNOWSKI RJ, 1974, CLIN CHEM, V20, P615; Uemura M, 2012, ONCOGENE, V31, P1254, DOI 10.1038/onc.2011.319; Wang J, 2004, CLIN BIOCHEM, V37, P741, DOI 10.1016/j.clinbiochem.2004.03.013; Wehrens R, 1997, J CHEMOMETR, V11, P157, DOI 10.1002/(SICI)1099-128X(199703)11:2<157::AID-CEM471>3.0.CO;2-J; WU CFJ, 1986, ANN STAT, V14, P1261, DOI 10.1214/aos/1176350142; Yun JJ, 2006, NUCLEIC ACIDS RES, V34, P6718, DOI 10.1093/nar/gkl1020	33	21	22	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148260	10.1371/journal.pone.0148260	http://dx.doi.org/10.1371/journal.pone.0148260			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863434	Green Submitted, gold, Green Published			2022-12-27	WOS:000370046600049
J	Fried, S; Tosun, S; Troost, G; Keil, S; Zaenker, KS; Dittmar, T				Fried, Sabrina; Tosun, Songuel; Troost, Gabriele; Keil, Silvia; Zaenker, Kurt S.; Dittmar, Thomas			Lipopolysaccharide (LPS) Promotes Apoptosis in Human Breast Epithelial x Breast Cancer Hybrids, but Not in Parental Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; MESENCHYMAL STEM-CELLS; NF-KAPPA-B; SPONTANEOUS FUSION; TUMOR-GROWTH; PROGRESSION; CHEMORESISTANCE; PROLIFERATION; GLIOBLASTOMA; NECROPTOSIS	Toll-like receptors (TLRs) belong to the group of pathogen recognition receptors known to play a crucial role in the innate immune system. In cancer, TLR expression is still debated controversially due to contradictory results reporting that both induction of apoptosis as well as tumor progression could depend on TLR signaling, whereby recent data rather indicate a pro-tumorigenic effect. The biological phenomenon of cell fusion has been associated with cancer progression due to findings revealing that fusion-derived hybrid cells could exhibit properties like an increased metastatogenic capacity and an increased drug resistance. Thus, M13MDA435 hybrid cell lines, which derived from spontaneous fusion events between human M13SV1-EGFP-Neo breast epithelial cells and human MDA-MB-435-Hyg breast cancer cells, were investigated. Cultivation of cells in the presence of the TLR4 ligand LPS potently induced apoptosis in all hybrid clones, but not in parental cells, which was most likely attributed to differential kinetics of the TLR4 signal transduction cascade. Activation of this pathway concomitant with NF-kappa B nuclear translocation and TNF-alpha expression was solely observed in hybrid cells. However, induction of LPS mediated apoptosis was not TNF-alpha dependent since TNF-alpha neutralization was not correlated to a decreased amount of dead cells. In addition to TNF-alpha, LPS also caused IFN-beta expression in hybrid clones 1 and 3. Interestingly, hybrid clones differ in the mode of LPS induced apoptosis. While neutralization of IFN-beta was sufficient to impair the LPS induced apoptosis in M13MDA435-1 and -3 hybrids, the amount of apoptotic M13MDA435-2 and -4 hybrid cells remained unchanged in the presence of neutralizing IFN-beta antibodies. In summary, the fusion of non-LPS susceptible parental human breast epithelial cells and human breast cancer cells gave rise to LPS susceptible hybrid cells, which is in view with the cell fusion hypothesis that hybrid cells could exhibit novel properties.	[Fried, Sabrina; Tosun, Songuel; Troost, Gabriele; Keil, Silvia; Zaenker, Kurt S.; Dittmar, Thomas] Univ Witten Herdecke, Inst Immunol & Expt Oncol, Ctr Biomed Educ & Res, Stockumer Str 10, Witten, Germany	Witten Herdecke University	Dittmar, T (corresponding author), Univ Witten Herdecke, Inst Immunol & Expt Oncol, Ctr Biomed Educ & Res, Stockumer Str 10, Witten, Germany.	thomas.dittmar@uni-wh.de	Dittmar, Thomas/X-3691-2019; Dittmar, Thomas/T-6679-2019		Fritz-Bender Foundation, Munich, Germany; Witten/Herdecke University	Fritz-Bender Foundation, Munich, Germany; Witten/Herdecke University	SF, ST, SK, GT and TD were supported by the Fritz-Bender Foundation, Munich, Germany. ST was supported by an Internal Grant of Witten/Herdecke University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22945; Berndt B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063711; Berndt Benjamin, 2013, Critical Reviews in Oncogenesis, V18, P97; Bjerkvig R, 2005, NAT REV CANCER, V5, P899, DOI 10.1038/nrc1740; Carloni V, 2013, ONCOGENE, V32, P2649, DOI 10.1038/onc.2012.268; Carpentier A, 2010, NEURO-ONCOLOGY, V12, P401, DOI 10.1093/neuonc/nop047; Chang CC, 2001, RADIAT RES, V155, P201, DOI 10.1667/0033-7587(2001)155[0201:AHBECT]2.0.CO;2; Chawla-Sarkar M, 2001, CLIN CANCER RES, V7, P1821; Chen Q, 2001, BLOOD, V98, P2183, DOI 10.1182/blood.V98.7.2183; Chicoine MR, 2007, NEUROSURGERY, V60, P372, DOI 10.1227/01.NEU.0000249280.61761.2E; Dittmar T, 2000, ANTISENSE NUCLEIC A, V10, P401, DOI 10.1089/oli.1.2000.10.401; Dittmar T, 2013, CURR MOL MED, V13, P735, DOI 10.2174/1566524011313050005; Dittmar T, 2011, CELL FUSION HLTH DIS, P950; Dittmar T, 2015, INT J MOL SCI, V16, P30362, DOI 10.3390/ijms161226240; Dittmar T, 2011, CLIN EXP METASTAS, V28, P75, DOI 10.1007/s10585-010-9359-3; Dittmar T, 2009, MED HYPOTHESES, V73, P542, DOI 10.1016/j.mehy.2009.05.044; Duelli D, 2003, CANCER CELL, V3, P445, DOI 10.1016/S1535-6108(03)00114-4; Harmey JH, 2002, INT J CANCER, V101, P415, DOI 10.1002/ijc.10632; He XH, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1027-1; Hsu RYC, 2011, CANCER RES, V71, P1989, DOI 10.1158/0008-5472.CAN-10-2833; Islam MQ, 2006, STEM CELLS DEV, V15, P905, DOI 10.1089/scd.2006.15.905; Jung DY, 2005, J IMMUNOL, V174, P6467, DOI 10.4049/jimmunol.174.10.6467; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kelly MG, 2006, CANCER RES, V66, P3859, DOI 10.1158/0008-5472.CAN-05-3948; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liao SJ, 2012, BREAST CANCER RES TR, V133, P853, DOI 10.1007/s10549-011-1844-0; Lu X, 2009, CANCER RES, V69, P8536, DOI 10.1158/0008-5472.CAN-09-2159; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Martin-Padura I, 2012, NEOPLASIA, V14, P1057, DOI 10.1593/neo.12736; Matijevic T, 2010, CURR PHARM DESIGN, V16, P1081, DOI 10.2174/138161210790963779; McComb S, 2014, P NATL ACAD SCI USA, V111, pE3206, DOI 10.1073/pnas.1407068111; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; MILLER FR, 1989, CANCER RES, V49, P4316; MILLER FR, 1988, J CELL BIOCHEM, V36, P129, DOI 10.1002/jcb.240360204; Mohr M, 2015, METHODS MOL BIOL, P21, DOI 10.1007/978-1-4939-2703-6_2; Munshi N, 2002, J IMMUNOL, V168, P5860, DOI 10.4049/jimmunol.168.11.5860; Nagler C, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-21; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Neff SB, 2006, AM J PHYSIOL-LUNG C, V290, pL86, DOI 10.1152/ajplung.00391.2004; Ozel C, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-10; Otto F, 1996, EUR J CANCER, V32A, P1712, DOI 10.1016/0959-8049(96)00186-4; Pawelek JM, 2008, NAT REV CANCER, V8, P377, DOI 10.1038/nrc2371; Pidgeon GP, 1999, BRIT J CANCER, V81, P1311, DOI 10.1038/sj.bjc.6694369; Rachkovsky M, 1998, CLIN EXP METASTAS, V16, P299; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Ramakrishnan M, 2013, CANC RES; Razack AHA, 2007, ASIAN J SURG, V30, P302, DOI 10.1016/S1015-9584(08)60045-7; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Volk-Draper L, 2014, CANCER RES, V74, P5421, DOI 10.1158/0008-5472.CAN-14-0067; Wang HL, 2007, J IMMUNOL, V179, P1834, DOI 10.4049/jimmunol.179.3.1834; Wang RF, 2008, ONCOGENE, V27, P181, DOI 10.1038/sj.onc.1210906; Xaus J, 2000, BLOOD, V95, P3823; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109980; Yang HA, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-92; Zhou XF, 2015, AM J PATHOL, V185, P2049, DOI 10.1016/j.ajpath.2015.03.014	57	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148438	10.1371/journal.pone.0148438	http://dx.doi.org/10.1371/journal.pone.0148438			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863029	gold, Green Published			2022-12-27	WOS:000370046600072
J	Fujimoto, Y; Urashima, T; Shimura, D; Ito, R; Kawachi, S; Kajimura, I; Akaike, T; Kusakari, Y; Fujiwara, M; Ogawa, K; Goda, N; Ida, H; Minamisawa, S				Fujimoto, Yoshitaka; Urashima, Takashi; Shimura, Daisuke; Ito, Reiji; Kawachi, Sadataka; Kajimura, Ichige; Akaike, Toru; Kusakari, Yoichiro; Fujiwara, Masako; Ogawa, Kiyoshi; Goda, Nobuhito; Ida, Hiroyuki; Minamisawa, Susumu			Low Cardiac Output Leads Hepatic Fibrosis in Right Heart Failure Model Rats	PLOS ONE			English	Article							LIVER; INDUCTION; HYPOXIA; DISEASE	Background Hepatic fibrosis progresses with right heart failure, and becomes cardiac cirrhosis in a severe case. Although its causal factor still remains unclear. Here we evaluated the progression of hepatic fibrosis using a pulmonary artery banding (PAB)-induced right heart failure model and investigated whether cardiac output (CO) is responsible for the progression of hepatic fibrosis. Methods and Results Five-week-old Sprague-Dawley rats divided into the PAB and sham-operated control groups. After 4 weeks from operation, we measured CO by echocardiography, and hepatic fibrosis ratio by pathological examination using a color analyzer. In the PAB group, CO was significantly lower by 48% than that in the control group (78.2 +/- 27.6 and 150.1 +/- 31.2 ml/min, P<0.01). Hepatic fibrosis ratio and serum hyaluronic acid, an index of hepatic fibrosis, were significantly increased in the PAB group than those in the control group (7.8 +/- 1.7 and 1.0 +/- 0.2%, P<0.01, 76.2 +/- 27.5 and 32.7 +/- 7.5 ng/ml, P<0.01). Notably, the degree of hepatic fibrosis significantly correlated a decrease in CO. Immunohistological analysis revealed that hepatic stellate cells were markedly activated in hypoxic areas, and HIF-1 alpha positive hepatic cells were increased in the PAB group. Furthermore, by real-time PCR analyses, transcripts of profibrotic and fibrotic factors (TGF-beta 1, CTGF, procollargen I, procollargen III, MMP 2, MMP 9, TIMP 1, TIMP 2) were significantly increased in the PAB group. In addition, western blot analyses revealed that the protein level of HIF-1 alpha was significantly increased in the PAB group than that in the control group (2.31 +/- 0.84 and 1.0 +/- 0.18 arbitrary units, P<0.05). Conclusions Our study demonstrated that low CO and tissue hypoxia were responsible for hepatic fibrosis in right failure heart model rats.	[Fujimoto, Yoshitaka; Shimura, Daisuke; Kajimura, Ichige; Akaike, Toru; Kusakari, Yoichiro; Minamisawa, Susumu] Jikei Univ, Sch Med, Dept Cell Physiol, Tokyo, Japan; [Fujimoto, Yoshitaka; Urashima, Takashi; Ito, Reiji; Fujiwara, Masako; Ida, Hiroyuki] Jikei Univ, Sch Med, Dept Pediat, Tokyo, Japan; [Kawachi, Sadataka; Ogawa, Kiyoshi] Saitama Childrens Med Ctr, Div Cardiol, Saitama, Japan; [Goda, Nobuhito] Waseda Univ, Dept Life Sci & Med Biosci, Tokyo, Japan	Jikei University; Jikei University; Saitama Children's Medical Center; Waseda University	Urashima, T (corresponding author), Jikei Univ, Sch Med, Dept Pediat, Tokyo, Japan.	urashima-t@jikei.ac.jp	Shimura, Daisuke/ABB-8456-2021; Goda, Nobuhito/W-2468-2019; Shimura, Daisuke/ABA-3516-2021	Shimura, Daisuke/0000-0002-9954-2162; Minamisawa, Susumu/0000-0003-4728-2116; Goda, Nobuhito/0000-0003-0295-4257; Ito, Reiji/0000-0003-3016-8106	Grants-in-Aid for Scientific Research [13J05481] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Abdellatif M.S, 2015, OPEN MICROBIOL J, V9, P136; Allen LA, 2009, EUR J HEART FAIL, V11, P170, DOI 10.1093/eurjhf/hfn031; Arteel GE, 1997, HEPATOLOGY, V25, P920, DOI 10.1002/hep.510250422; Asrani SK, 2012, HEPATOLOGY, V56, P1160, DOI 10.1002/hep.25692; Calvani M, 2006, BLOOD, V107, P2705, DOI 10.1182/blood-2005-09-3541; Camposilvan S, 2008, ANN THORAC SURG, V86, P177, DOI 10.1016/j.athoracsur.2008.03.077; Dai DF, 2014, MODERN PATHOL, V27, P1552, DOI 10.1038/modpathol.2014.79; Giallourakis Cosmas C, 2002, Clin Liver Dis, V6, P947, DOI 10.1016/S1089-3261(02)00056-9; Hao CQ, 2014, CLIN EXP MED, V14, P141, DOI 10.1007/s10238-013-0229-6; Khan JA, 2007, JCPSP-J COLL PHYSICI, V17, P323; Kietzmann T, 1999, BLOOD, V94, P4177, DOI 10.1182/blood.V94.12.4177.424k14_4177_4185; Lambrecht J, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00209; Leach RM, 2002, THORAX, V57, P170, DOI 10.1136/thorax.57.2.170; Lindsay I, 2015, AM J CARDIOL, V115, P249, DOI 10.1016/j.amjcard.2014.10.032; McCabe N, 2013, CONGENIT HEART DIS, V8, pE139, DOI 10.1111/j.1747-0803.2012.00700.x; Megalla S, 2011, MED SCI MONITOR, V17, pCR537, DOI 10.12659/MSM.881977; MILLER MJ, 1986, CIRCULATION, V73, P799, DOI 10.1161/01.CIR.73.4.799; Moon JO, 2009, AM J PHYSIOL-GASTR L, V296, pG582, DOI 10.1152/ajpgi.90368.2008; Myers RP, 2003, HEPATOLOGY, V37, P393, DOI 10.1053/jhep.2003.50062; Poelzl Gerhard, 2015, Curr Heart Fail Rep, V12, P68, DOI 10.1007/s11897-014-0238-0; Richter S, 2000, AM J PHYSIOL-GASTR L, V279, pG454, DOI 10.1152/ajpgi.2000.279.2.G454; Seki E, 2015, J HEPATO-BIL-PAN SCI, V22, P512, DOI 10.1002/jhbp.245; Seki E, 2015, HEPATOLOGY, V61, P1066, DOI 10.1002/hep.27332; SHERLOCK S, 1951, BRIT HEART J, V13, P273; Shimura D, 2013, AM J PHYSIOL-HEART C, V305, pH494, DOI 10.1152/ajpheart.00867.2012; Simonetto DA, 2015, HEPATOLOGY, V61, P648, DOI 10.1002/hep.27387; Takeda Y, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-22; Wang YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074051; Yoshida D, 2006, J NEURO-ONCOL, V76, P13, DOI 10.1007/s11060-005-3279-0; Zhan L, 2015, BIOCHIMIE, V108, P1, DOI 10.1016/j.biochi.2014.10.013	30	16	17	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148666	10.1371/journal.pone.0148666	http://dx.doi.org/10.1371/journal.pone.0148666			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863419	Green Published, Green Submitted, gold			2022-12-27	WOS:000370046600094
J	Jiang, T; Qiao, H; Zheng, ZJ; Chu, QL; Li, X; Yong, Q; Ouyang, J				Jiang, Ting; Qiao, Hui; Zheng, Zhaojuan; Chu, Qiulu; Li, Xin; Yong, Qiang; Ouyang, Jia			Lactic Acid Production from Pretreated Hydrolysates of Corn Stover by a Newly Developed Bacillus coagulans Strain	PLOS ONE			English	Article							FUEL ETHANOL-PRODUCTION; BIOMASS-DERIVED XYLOSE; SACCHAROMYCES-CEREVISIAE; PICHIA-STIPITIS; LIGNOCELLULOSIC BIOMASS; ZYMOMONAS-MOBILIS; ESCHERICHIA-COLI; WHEAT-STRAW; INHIBITORS; FERMENTATION	An inhibitor-tolerance strain, Bacillus coagulans GKN316, was developed through atmospheric and room temperature plasma (ARTP) mutation and evolution experiment in condensed dilute-acid hydrolysate (CDH) of corn stover. The fermentabilities of other hydrolysates with B. coagulans GKN316 and the parental strain B. coagulans NL01 were assessed. When using condensed acid-catalyzed steam-exploded hydrolysate (CASEH), condensed acid-catalyzed liquid hot water hydrolysate (CALH) and condensed acid-catalyzed sulfite hydrolysate (CASH) as substrates, the concentration of lactic acid reached 45.39, 16.83, and 18.71 g/L by B. coagulans GKN316, respectively. But for B. coagulans NL01, only CASEH could be directly fermented to produce 15.47 g/L lactic acid. The individual inhibitory effect of furfural, 5-hydroxymethylfurfural (HMF), vanillin, syringaldehyde and p-hydroxybenzaldehyde (pHBal) on xylose utilization by B. coagulans GKN316 was also studied. The strain B. coagulans GKN316 could effectively convert these toxic inhibitors to the less toxic corresponding alcohols in situ. These results suggested that B. coagulans GKN316 was well suited to production of lactic acid from undetoxified lignocellulosic hydrolysates.	[Jiang, Ting; Qiao, Hui; Zheng, Zhaojuan; Chu, Qiulu; Li, Xin; Ouyang, Jia] Nanjing Forestry Univ, Coll Chem Engn, Nanjing 210037, Jiangsu, Peoples R China; [Yong, Qiang; Ouyang, Jia] Nanjing Forestry Univ, Minist Educ, Key Lab Forest Genet & Biotechnol, Nanjing 210037, Jiangsu, Peoples R China	Nanjing Forestry University; Nanjing Forestry University	Ouyang, J (corresponding author), Nanjing Forestry Univ, Coll Chem Engn, Nanjing 210037, Jiangsu, Peoples R China.; Ouyang, J (corresponding author), Nanjing Forestry Univ, Minist Educ, Key Lab Forest Genet & Biotechnol, Nanjing 210037, Jiangsu, Peoples R China.	hgouyj@njfu.edu.cn		Chu, Qiulu/0000-0003-4782-8668	National Natural Science Foundation of China [51561145015, 31200443]; Excellent Youth Foundation of Jiangsu Province of China [BK2012038]; Doctorate Fellowship Foundation of Nanjing Forestry University; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Youth Foundation of Jiangsu Province of China; Doctorate Fellowship Foundation of Nanjing Forestry University; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported by the National Natural Science Foundation of China (51561145015, 31200443), Excellent Youth Foundation of Jiangsu Province of China (BK2012038), and the Doctorate Fellowship Foundation of Nanjing Forestry University. The authors are also grateful to the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) for partial funding of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida JRM, 2007, J CHEM TECHNOL BIOT, V82, P340, DOI 10.1002/jctb.1676; Baral NR, 2014, APPL MICROBIOL BIOT, V98, P9151, DOI 10.1007/s00253-014-6106-8; Bellido C, 2011, BIORESOURCE TECHNOL, V102, P10868, DOI 10.1016/j.biortech.2011.08.128; Bischoff KM, 2010, BIOTECHNOL LETT, V32, P823, DOI 10.1007/s10529-010-0222-z; Cardona CA, 2007, BIORESOURCE TECHNOL, V98, P2415, DOI 10.1016/j.biortech.2007.01.002; Chandel AK, 2013, BIOENERG RES, V6, P388, DOI 10.1007/s12155-012-9241-z; Chang Q, 2007, BBA-MOL CELL RES, V1773, P321, DOI 10.1016/j.bbamcr.2006.10.009; Delgenes JP, 1996, ENZYME MICROB TECH, V19, P220, DOI 10.1016/0141-0229(95)00237-5; Franden MA, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-99; Girio FM, 2010, BIORESOURCE TECHNOL, V101, P4775, DOI 10.1016/j.biortech.2010.01.088; Guo T, 2013, BIORESOURCE TECHNOL, V135, P379, DOI 10.1016/j.biortech.2012.08.029; Heer D, 2008, MICROB BIOTECHNOL, V1, P497, DOI 10.1111/j.1751-7915.2008.00050.x; Jiang M, 2014, J IND MICROBIOL BIOT, V41, P115, DOI 10.1007/s10295-013-1346-7; Jiang T, 2014, PROTEIN EXPRES PURIF, V95, P219, DOI 10.1016/j.pep.2013.12.014; Jonsson LJ, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-16; Klinke HB, 2003, BIOTECHNOL BIOENG, V81, P738, DOI 10.1002/bit.10523; Koppram R, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-32; Larsson S, 2000, 21 S BIOT FUELS CHEM; Li XZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095455; Limayem A, 2012, PROG ENERG COMBUST, V38, P449, DOI 10.1016/j.pecs.2012.03.002; Liu ZL, 2005, 26 S BIOT FUELS CHEM; Mussatto SI, 2004, BIORESOURCE TECHNOL, V93, P1, DOI 10.1016/j.biortech.2003.10.005; Oh H, 2005, BIORESOURCE TECHNOL, V96, P1492, DOI 10.1016/j.biortech.2004.11.020; Ou MS, 2011, J IND MICROBIOL BIOT, V38, P599, DOI 10.1007/s10295-010-0796-4; Ouyang J, 2013, BIORESOURCE TECHNOL, V135, P475, DOI 10.1016/j.biortech.2012.09.096; Ouyang J, 2012, APPL BIOCHEM BIOTECH, V168, P2387, DOI 10.1007/s12010-012-9944-9; Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P25, DOI 10.1016/S0960-8524(99)00161-3; Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P17, DOI 10.1016/S0960-8524(99)00160-1; Parawira W, 2011, CRIT REV BIOTECHNOL, V31, P20, DOI 10.3109/07388551003757816; Parreiras LS, 2014, ENG 2 STAGE EVOLUTIO; Persson P, 2002, BIOTECHNOL BIOENG, V79, P694, DOI 10.1002/bit.10324; Petersson A, 2006, YEAST, V23, P455, DOI 10.1002/yea.1370; Taherzadeh MJ, 2011, BIOMASS BIOF BIOCHEM, P287; Ye LD, 2013, BIORESOURCE TECHNOL, V132, P38, DOI 10.1016/j.biortech.2013.01.011; Zaldivar J, 2001, APPL MICROBIOL BIOT, V56, P17, DOI 10.1007/s002530100624; Zhang Y, 2012, NEW BIOTECHNOL, V29, P345, DOI 10.1016/j.nbt.2011.09.001; Zheng ZJ, 2014, APPL BIOCHEM BIOTECH, V173, P1896, DOI 10.1007/s12010-014-0975-2; Zhu JJ, 2014, BIOPROC BIOSYST ENG, V37, P2215, DOI 10.1007/s00449-014-1199-0	38	34	36	8	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149101	10.1371/journal.pone.0149101	http://dx.doi.org/10.1371/journal.pone.0149101			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863012	Green Submitted, gold, Green Published			2022-12-27	WOS:000370046600153
J	Santos, CD; Przybyzin, S; Wikelski, M; Dechmann, DKN				Santos, Carlos D.; Przybyzin, Sebastian; Wikelski, Martin; Dechmann, Dina K. N.			Collective Decision-Making in Homing Pigeons: Larger Flocks Take Longer to Decide but Do Not Make Better Decisions	PLOS ONE			English	Article							ORIENTATION; LEADERSHIP; INFORMATION; SPEED; BIRDS; HOME	Social animals routinely are challenged to make consensus decisions about movement directions and routes. However, the underlying mechanisms facilitating such decision-making processes are still poorly known. A prominent question is how group members participate in group decisions. We addressed this question by examining how flocks of homing pigeons (Columba livia) decide their homing direction. We released newly formed flocks varying in size and determined the time taken to choose a homing direction (decision-making period) and the accuracy of that choice. We found that the decision-making period increases exponentially with flock size, which is consistent with a participatory decision-making process. We additionally found that there is no effect of flock size on the accuracy of the decisions made, which does not match with current theory for democratic choices of flight directions. Our combined results are better explained by a participatory choice of leaders that subsequently undertake the flock directional decisions. However, this decision-making model would only entirely fit with our results if leaders were chosen based on traits other than their navigational experience. Our study provides rare empirical evidence elucidating decision-making processes in freely moving groups of animals.	[Santos, Carlos D.; Przybyzin, Sebastian; Wikelski, Martin; Dechmann, Dina K. N.] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany; [Santos, Carlos D.] Univ Fed Maranhao, Ctr Ciencias Biol & Saude, Dept Biol, Campus Bacanga, Sao Luis, MA, Brazil; [Przybyzin, Sebastian; Wikelski, Martin; Dechmann, Dina K. N.] Univ Konstanz, Dept Biol, Constance, Germany	Max Planck Society; Universidade Federal do Maranhao; University of Konstanz	Santos, CD (corresponding author), Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany.; Santos, CD (corresponding author), Univ Fed Maranhao, Ctr Ciencias Biol & Saude, Dept Biol, Campus Bacanga, Sao Luis, MA, Brazil.	cdsantos@orn.mpg.de	Santos, Carlos/E-5881-2013	Santos, Carlos/0000-0001-5693-9795; Dechmann, Dina/0000-0003-0043-8267	Portuguese Foundation for Science and Technology [SFRH/BPD/64786/2009]; Max Planck Institute for Ornithology	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Max Planck Institute for Ornithology(Max Planck Society)	This research was funded by the Portuguese Foundation for Science and Technology (www.fct.pt) through a Postdoctoral grant to CDS (SFRH/BPD/64786/2009), and by the Max Planck Institute for Ornithology (www.orn.mpg.de/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinelli C., 2013, R PACKAGE CIRCULAR C; [Anonymous], 2010, R LANG ENV STAT COMP; BENVENUTI S, 1985, ORNIS SCAND, V16, P45, DOI 10.2307/3676574; Biro D, 2002, J EXP BIOL, V205, P3833; Biro D, 2006, CURR BIOL, V16, P2123, DOI 10.1016/j.cub.2006.08.087; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Conradt L, 2009, PHILOS T R SOC B, V364, P719, DOI 10.1098/rstb.2008.0276; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Dell'Ariccia G, 2008, ANIM BEHAV, V76, P1165, DOI 10.1016/j.anbehav.2008.05.022; Dell'Ariccia G, 2009, J EXP BIOL, V212, P3361, DOI 10.1242/jeb.032995; Dyer JRG, 2008, ANIM BEHAV, V75, P461, DOI 10.1016/j.anbehav.2007.05.010; Dyer JRG, 2009, PHILOS T R SOC B, V364, P781, DOI 10.1098/rstb.2008.0233; Faria JJ, 2009, ANIM BEHAV, V78, P587, DOI 10.1016/j.anbehav.2009.05.019; Flack A, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0213; Flack A, 2013, ANIM BEHAV, V86, P723, DOI 10.1016/j.anbehav.2013.07.005; Flack A, 2012, ANIM BEHAV, V83, P703, DOI 10.1016/j.anbehav.2011.12.018; Franks NR, 2003, P ROY SOC B-BIOL SCI, V270, P2457, DOI 10.1098/rspb.2003.2527; Hilton GM, 1999, BEHAV ECOL, V10, P391, DOI 10.1093/beheco/10.4.391; KEETON WT, 1970, AUK, V87, P797, DOI 10.2307/4083715; Nagy M, 2013, P NATL ACAD SCI USA, V110, P13049, DOI 10.1073/pnas.1305552110; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Noji EK, 2005, EPIDEMIOL REV, V27, P3, DOI 10.1093/epirev/mxi007; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; Santos CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102771; Schiffner I, 2009, NATURWISSENSCHAFTEN, V96, P251, DOI 10.1007/s00114-008-0476-7; Simons AM, 2004, TRENDS ECOL EVOL, V19, P453, DOI 10.1016/j.tree.2004.07.001; TAMM S, 1980, BEHAV ECOL SOCIOBIOL, V7, P319, DOI 10.1007/BF00300672; WALLRAFF HG, 1978, OIKOS, V30, P401, DOI 10.2307/3543490; Ward AJW, 2008, P NATL ACAD SCI USA, V105, P6948, DOI 10.1073/pnas.0710344105; Ward AJW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032411; Zar JH, 1999, BIOSTATISTICAL ANAL	32	4	4	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0147497	10.1371/journal.pone.0147497	http://dx.doi.org/10.1371/journal.pone.0147497			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863416	Green Published, gold, Green Submitted			2022-12-27	WOS:000370046600031
J	Majekova, M; Paal, T; Plowman, NS; Bryndova, M; Kasari, L; Norberg, A; Weiss, M; Bishop, TR; Luke, SH; Sam, K; Le Bagousse-Pinguet, Y; Leps, J; Gotzenberger, L; de Bello, F				Majekova, Maria; Paal, Taavi; Plowman, Nichola S.; Bryndova, Michala; Kasari, Liis; Norberg, Anna; Weiss, Matthias; Bishop, Tom R.; Luke, Sarah H.; Sam, Katerina; Le Bagousse-Pinguet, Yoann; Leps, Jan; Goetzenberger, Lars; de Bello, Francesco			Evaluating Functional Diversity: Missing Trait Data and the Importance of Species Abundance Structure and Data Transformation	PLOS ONE			English	Article							PLANT-COMMUNITIES; DISTRIBUTIONS; ASSEMBLAGES; COMPETITION; ECOSYSTEMS; ECOLOGY; FOREST; SCALE; ANT	Functional diversity (FD) is an important component of biodiversity that quantifies the difference in functional traits between organisms. However, FD studies are often limited by the availability of trait data and FD indices are sensitive to data gaps. The distribution of species abundance and trait data, and its transformation, may further affect the accuracy of indices when data is incomplete. Using an existing approach, we simulated the effects of missing trait data by gradually removing data from a plant, an ant and a bird community dataset (12, 59, and 8 plots containing 62, 297 and 238 species respectively). We ranked plots by FD values calculated from full datasets and then from our increasingly incomplete datasets and compared the ranking between the original and virtually reduced datasets to assess the accuracy of FD indices when used on datasets with increasingly missing data. Finally, we tested the accuracy of FD indices with and without data transformation, and the effect of missing trait data per plot or per the whole pool of species. FD indices became less accurate as the amount of missing data increased, with the loss of accuracy depending on the index. But, where transformation improved the normality of the trait data, FD values from incomplete datasets were more accurate than before transformation. The distribution of data and its transformation are therefore as important as data completeness and can even mitigate the effect of missing data. Since the effect of missing trait values pool-wise or plot-wise depends on the data distribution, the method should be decided case by case. Data distribution and data transformation should be given more careful consideration when designing, analysing and interpreting FD studies, especially where trait data are missing. To this end, we provide the R package "traitor" to facilitate assessments of missing trait data.	[Majekova, Maria] Comenius Univ, Dept Soil Sci, Fac Nat Sci, Bratislava, Slovakia; [Majekova, Maria; Le Bagousse-Pinguet, Yoann; Leps, Jan; de Bello, Francesco] Univ South Bohemia, Fac Sci, Dept Bot, Ceske Budejovice, Czech Republic; [Paal, Taavi; Kasari, Liis] Univ Tartu, Inst Ecol & Earth Sci, Ulikooli 18, EE-50090 Tartu, Estonia; [Plowman, Nichola S.; Weiss, Matthias; Sam, Katerina; Leps, Jan] Biol Ctr CAS, Inst Entomol, Ceske Budejovice, Czech Republic; [Plowman, Nichola S.; Sam, Katerina] Univ South Bohemia, Fac Sci, Dept Zool, Ceske Budejovice, Czech Republic; [Bryndova, Michala] Biol Ctr CAS, Inst Soil Biol, Ceske Budejovice, Czech Republic; [Bryndova, Michala] Univ South Bohemia, Fac Sci, Dept Ecosyst Biol, Ceske Budejovice, Czech Republic; [Norberg, Anna] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Bishop, Tom R.] Univ Liverpool, Dept Earth Ocean & Ecol Sci, Liverpool L69 3BX, Merseyside, England; [Bishop, Tom R.] Univ Pretoria, Dept Zool & Entomol, Ctr Invas Biol, ZA-0002 Pretoria, South Africa; [Luke, Sarah H.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Luke, Sarah H.] Univ Cambridge, Dept Zool, Cambridge, England; [Le Bagousse-Pinguet, Yoann] Univ Rey Juan Carlos, Area Biodiversidad & Conservac, Dept Ciencias, Escuela Super Ciencias Expt & Tecnol, C Tulipan S-N, Mostoles, Spain; [Goetzenberger, Lars; de Bello, Francesco] Biol Ctr CAS, Inst Bot, Trebon, Czech Republic	Comenius University Bratislava; University of South Bohemia Ceske Budejovice; University of Tartu; Tartu University Institute of Ecology & Earth Sciences; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of Helsinki; University of Liverpool; University of Pretoria; University of East Anglia; University of Cambridge; Universidad Rey Juan Carlos; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences	Plowman, NS (corresponding author), Biol Ctr CAS, Inst Entomol, Ceske Budejovice, Czech Republic.; Plowman, NS (corresponding author), Univ South Bohemia, Fac Sci, Dept Zool, Ceske Budejovice, Czech Republic.	nichola.plowman@gmail.com	Leps, Jan/B-6913-2013; Le Bagousse-Pinguet, Yoann/I-2413-2016; de Bello, Francesco/AFQ-8650-2022; Sam, Katerina/I-2209-2014; Plowman, Nichola S/H-5616-2019; de Bello, Francesco/H-1582-2014; de Bello, Francesco/HCI-1196-2022; Götzenberger, Lars/H-1587-2014; Bishop, Tom Rhys/G-3213-2014; Weiss, Matthias/R-6659-2018; Tůmová, Michala/GWR-0053-2022	Leps, Jan/0000-0002-4822-7429; Le Bagousse-Pinguet, Yoann/0000-0002-5615-5541; Sam, Katerina/0000-0002-3436-0579; de Bello, Francesco/0000-0001-9202-8198; de Bello, Francesco/0000-0001-9202-8198; Götzenberger, Lars/0000-0003-3040-2900; Bishop, Tom Rhys/0000-0001-7061-556X; Tůmová, Michala/0000-0002-5417-3340; Luke, Sarah H./0000-0002-8335-5960; Weiss, Matthias/0000-0001-9095-0779; Norberg, Anna/0000-0002-3520-1043	VEGA [2/0016/15]; European Social Fund's Doctoral Studies and Internationalisation Programme DoRa (T6); Estonian Research Council [IUT 20-31]; Grant Agency of University of South Bohemia [156/2013/P]; Czech Science Foundation [14-36098G]; SAFE Project from the Sime Darby Foundation; UK Natural Environment Research Council (NERC); GACR [14-32024P, P505/12/1296]; project Postdoc USB through EU Education for Competitiveness Operational Programme [CZ.1.07/2.3.00/30.0006]; European Social Fund; Czech State Budget; Marie Sklodowska-Curie Actions Individual Fellowship (MSCA-IF) within the European Program Horizon (DRYFUN Project) [656035]; European Union's Seventh Framework Programme for research, technological development and demonstration [GA-2010-267243];  [APVV-0866-12]; Natural Environment Research Council [1230944, 1122589] Funding Source: researchfish	VEGA(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)European Commission); European Social Fund's Doctoral Studies and Internationalisation Programme DoRa (T6); Estonian Research Council(Estonian Research Council); Grant Agency of University of South Bohemia; Czech Science Foundation(Grant Agency of the Czech Republic); SAFE Project from the Sime Darby Foundation; UK Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); GACR(Grant Agency of the Czech Republic); project Postdoc USB through EU Education for Competitiveness Operational Programme; European Social Fund(European Social Fund (ESF)); Czech State Budget; Marie Sklodowska-Curie Actions Individual Fellowship (MSCA-IF) within the European Program Horizon (DRYFUN Project); European Union's Seventh Framework Programme for research, technological development and demonstration; ; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	MM was supported by VEGA 2/0016/15 and the project No. APVV-0866-12, TP was supported by European Social Fund's Doctoral Studies and Internationalisation Programme DoRa (T6) and Estonian Research Council (grant no IUT 20-31), NSP was supported by the Grant Agency of University of South Bohemia (156/2013/P) and the Czech Science Foundation (14-36098G), SHL was supported by the SAFE Project (including funding from the Sime Darby Foundation) and the UK Natural Environment Research Council (NERC), and KS was supported by GACR No. 14-32024P. YLBP was supported by the project Postdoc USB (reg. no. CZ.1.07/2.3.00/30.0006) realized through EU Education for Competitiveness Operational Programme. This project is funded by European Social Fund and Czech State Budget. YLBP is also supported by a Marie Sklodowska-Curie Actions Individual Fellowship (MSCA-IF) within the European Program Horizon 2020(DRYFUN Project 656035). LG received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no. GA-2010-267243 - PLANT FELLOWS; FdB and JL were supported by GACR P505/12/1296.	Anderson BJ, 2012, METHODS ECOL EVOL, V3, P783, DOI 10.1111/j.2041-210X.2012.00229.x; Botta-Dukat Z, 2005, J VEG SCI, V16, P533, DOI 10.1111/j.1654-1103.2005.tb02393.x; Carmona CP, 2015, FUNCT ECOL, V29, P579, DOI 10.1111/1365-2435.12366; Chiarucci A, 1999, J VEG SCI, V10, P35, DOI 10.2307/3237158; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; de Bello F, 2013, J VEG SCI, V24, P807, DOI 10.1111/jvs.12008; Ewers RM, 2011, PHILOS T R SOC B, V366, P3292, DOI 10.1098/rstb.2011.0049; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; Gibb H, 2015, OECOLOGIA, V177, P519, DOI 10.1007/s00442-014-3101-9; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Laliberte E., 2014, FD MEASURING FUNCTIO; Laughlin DC, 2014, J ECOL, V102, P186, DOI 10.1111/1365-2745.12187; Leps J, 1999, J VEG SCI, V10, P219, DOI 10.2307/3237143; Leps J, 2006, PRESLIA, V78, P481; Leps J, 2014, J APPL ECOL, V51, P978, DOI 10.1111/1365-2664.12255; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Luke SH, 2014, BIODIVERS CONSERV, V23, P2817, DOI 10.1007/s10531-014-0750-2; MACARTHUR R, 1960, AM NAT, V94, P25, DOI 10.1086/282106; Mason NWH, 2013, J VEG SCI, V24, P777, DOI 10.1111/jvs.12097; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Pakeman RJ, 2007, APPL VEG SCI, V10, P91, DOI 10.1111/j.1654-109X.2007.tb00507.x; Pakeman RJ, 2014, METHODS ECOL EVOL, V5, P9, DOI 10.1111/2041-210X.12136; Penone C, 2014, METHODS ECOL EVOL, V5, P961, DOI 10.1111/2041-210X.12232; Pinheiro J., 2014, R PACKAGE VERSION, V3, P1; Pinheiro J, 2001, MIXED EFFECTS MODELS; Sam Katerina, 2014, BULLETIN OF THE BRITISH ORNITHOLOGISTS CLUB, V134, P116; Sandel B, 2015, J VEG SCI, V26, P828, DOI 10.1111/jvs.12292; Sasaki T, 2014, J APPL ECOL, V51, P299, DOI 10.1111/1365-2664.12192; Schleuter D, 2010, ECOL MONOGR, V80, P469, DOI 10.1890/08-2225.1; Swenson NG, 2011, P ROY SOC B-BIOL SCI, V278, P877, DOI 10.1098/rspb.2010.1369; Taugourdeau S, 2014, ECOL EVOL, V4, P944, DOI 10.1002/ece3.989; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tvardikova K., 2013, TROPHIC RELATIONSHIP; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729; WHITTAKER RH, 1965, SCIENCE, V147, P250, DOI 10.1126/science.147.3655.250	36	64	64	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149270	10.1371/journal.pone.0149270	http://dx.doi.org/10.1371/journal.pone.0149270			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881747	Green Submitted, Green Published, gold			2022-12-27	WOS:000371219000066
J	Nieboer, D; van der Ploeg, T; Steyerberg, EW				Nieboer, Daan; van der Ploeg, Tjeerd; Steyerberg, Ewout W.			Assessing Discriminative Performance at External Validation of Clinical Prediction Models	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; ADMISSION CHARACTERISTICS; IMPACT; REGRESSION; FRAMEWORK	Introduction External validation studies are essential to study the generalizability of prediction models. Recently a permutation test, focusing on discrimination as quantified by the c-statistic, was proposed to judge whether a prediction model is transportable to a new setting. We aimed to evaluate this test and compare it to previously proposed procedures to judge any changes in c-statistic from development to external validation setting. Methods We compared the use of the permutation test to the use of benchmark values of the c-statistic following from a previously proposed framework to judge transportability of a prediction model. In a simulation study we developed a prediction model with logistic regression on a development set and validated them in the validation set. We concentrated on two scenarios: 1) the case-mix was more heterogeneous and predictor effects were weaker in the validation set compared to the development set, and 2) the case-mix was less heterogeneous in the validation set and predictor effects were identical in the validation and development set. Furthermore we illustrated the methods in a case study using 15 datasets of patients suffering from traumatic brain injury. Results The permutation test indicated that the validation and development set were homogenous in scenario 1 (in almost all simulated samples) and heterogeneous in scenario 2 (in 17%-39% of simulated samples). Previously proposed benchmark values of the c-statistic and the standard deviation of the linear predictors correctly pointed at the more heterogeneous case-mix in scenario 1 and the less heterogeneous case-mix in scenario 2. Conclusion The recently proposed permutation test may provide misleading results when externally validating prediction models in the presence of case-mix differences between the development and validation population. To correctly interpret the c-statistic found at external validation it is crucial to disentangle case-mix differences from incorrect regression coefficients.	[Nieboer, Daan; Steyerberg, Ewout W.] Erasmus MC Univ Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [van der Ploeg, Tjeerd] Inholland Univ, Med Ctr Alkmaar, Dept Sci, Alkmaar, Netherlands	Erasmus University Rotterdam; Erasmus MC; Medical Center Of Alkmaar	Nieboer, D (corresponding author), Erasmus MC Univ Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands.	d.nieboer@erasmusmc.nl		van der Ploeg, Tjeerd/0000-0003-0429-6753	Netherlands Organization for Scientific Research (ZonMw) [ZonMw 9120.8004 (TOP)]	Netherlands Organization for Scientific Research (ZonMw)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development)	This work was funded by The Netherlands Organization for Scientific Research (ZonMw 9120.8004 (TOP)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2014, STAT MED, V33, P517, DOI 10.1002/sim.5941; Austin PC, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-82; Bleeker SE, 2003, J CLIN EPIDEMIOL, V56, P826, DOI 10.1016/S0895-4356(03)00207-5; COX DR, 1958, BIOMETRIKA, V45, P562, DOI 10.1093/biomet/45.3-4.562; Debray TPA, 2015, J CLIN EPIDEMIOL, V68, P280, DOI 10.1016/j.jclinepi.2014.06.018; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Moons KGM, 2012, HEART, V98, P691, DOI 10.1136/heartjnl-2011-301247; R Core Team, 2018, R LANG ENV STAT COMP; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Siontis GCM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3318; Steyerberg EW, CLIN PREDICTION MODE; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Vergouwe Y, 2010, AM J EPIDEMIOL, V172, P971, DOI 10.1093/aje/kwq223; Wang LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116957; Wessler BS, 2015, CIRC-CARDIOVASC QUAL, V8, P368, DOI 10.1161/CIRCOUTCOMES.115.001693	20	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148820	10.1371/journal.pone.0148820	http://dx.doi.org/10.1371/journal.pone.0148820			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881753	Green Published, gold, Green Submitted			2022-12-27	WOS:000371219000026
J	Ying, SZ; Cao, H; Hu, H; Wang, X; Tang, YH; Huang, CX				Ying, Shaozhen; Cao, Hong; Hu, He; Wang, Xin; Tang, Yanhong; Huang, Congxin			Alk7 Depleted Mice Exhibit Prolonged Cardiac Repolarization and Are Predisposed to Ventricular Arrhythmia	PLOS ONE			English	Article							MYOCARDIAL ISCHEMIA/REPERFUSION INJURY; LONG QT SYNDROME; K+ CHANNEL; ADIPOSE-TISSUE; X-RECEPTOR; I-TO; APOPTOSIS; PROTECTS; CELLS; PATHOGENESIS	We aimed to investigate the role of activin receptor-like kinase (ALK7) in regulating cardiac electrophysiology. Here, we showed that Alk7(-/-) mice exhibited prolonged QT intervals in telemetry ECG recordings. Furthermore, Langendorff-perfused Alk7(-/-) hearts had significantly longer action potential duration (APD) and greater incidence of ventricular arrhythmia (AV) induced by burst pacing. Using whole-cell patch clamp, we found that the densities of repolarizing K+ currents I-to and I-K1 were profoundly reduced in Alk7(-/-) ventricular cardiomyocytes. Mechanistically, the expression of Kv4.2 (a major subunit of I-to carrying channel) and KCHIP2 (a key accessory subunit of I-to carrying channel), was markedly decreased in Alk7(-/-) hearts. These findings suggest that endogenous expression of ALK7 is necessary to maintain repolarizing K+ currents in ventricular cardiomyocytes, and finally prevent action potential prolongation and ventricular arrhythmia.	[Ying, Shaozhen; Cao, Hong; Hu, He; Wang, Xin; Tang, Yanhong; Huang, Congxin] Wuhan Univ, Renmin Hosp, Dept Cardiol, 238 Jiefang Rd, Wuhan 430060, Hubei Province, Peoples R China	Wuhan University	Huang, CX (corresponding author), Wuhan Univ, Renmin Hosp, Dept Cardiol, 238 Jiefang Rd, Wuhan 430060, Hubei Province, Peoples R China.	CongxinHuang@hotmail.com			National Science Technology Support Plan [2011BAI11B12]; National Natural Science Foundation of China [81370282]	National Science Technology Support Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by funding from The National Science Technology Support Plan (Grant No. 2011BAI11B12) and the National Natural Science Foundation of China (Grant No. 81370282). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is supported by funding from The National Science Technology Support Plan (Grant No. 2011BAI11B12) and the National Natural Science Foundation of China (Grant No. 81370282).	Andersson O, 2008, P NATL ACAD SCI USA, V105, P7252, DOI 10.1073/pnas.0800272105; Bertolino P, 2008, P NATL ACAD SCI USA, V105, P7246, DOI 10.1073/pnas.0801285105; Bingen BO, 2015, SCI REP-UK, V5, DOI 10.1038/srep15187; Brunet S, 2004, J PHYSIOL-LONDON, V559, P103, DOI 10.1113/jphysiol.2004.063347; Camm AJ, 2000, EUR HEART J, V21, P1232, DOI 10.1053/euhj.2000.2222; Carlsson LMS, 2009, BIOCHEM BIOPH RES CO, V382, P309, DOI 10.1016/j.bbrc.2009.03.014; Chang H, 2002, ENDOCR REV, V23, P787, DOI 10.1210/er.2002-0003; Cheng JH, 2004, ACTA PHARMACOL SIN, V25, P137; Clancy CE, 2005, PHYSIOL REV, V85, P33, DOI 10.1152/physrev.00005.2004; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; He Q, 2014, CIRC-HEART FAIL, V7, P1032, DOI 10.1161/CIRCHEARTFAILURE.114.001260; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Huang H, 2015, CARDIOVASC RES, V108, P50, DOI 10.1093/cvr/cvv206; Isbrandt D, 2002, J MOL MED-JMM, V80, P524, DOI 10.1007/s00109-002-0364-0; Jia Y, 2003, CARDIOVASC RES, V60, P278, DOI 10.1016/S0008-6363(03)00528-5; Kaese S, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00345; Kogame M, 2006, J MED INVESTIG, V53, P238, DOI 10.2152/jmi.53.238; KOUMI S, 1995, CIRCULATION, V92, P164, DOI 10.1161/01.CIR.92.2.164; Kwon JJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11450; Li G-R., 2010, OPEN CIRC VASC J, V3, P95, DOI [10.2174/1877382601003010095, DOI 10.2174/1877382601003010095]; Li HL, 2010, P NATL ACAD SCI USA, V107, P13818, DOI 10.1073/pnas.1008397107; Lu Y, 2003, J PHYSIOL-LONDON, V551, P253, DOI 10.1113/jphysiol.2003.046045; Menegola M, 2006, J NEUROSCI, V26, P12137, DOI 10.1523/JNEUROSCI.2783-06.2006; Mukherjee D, 2015, J PINEAL RES, V58, P275, DOI 10.1111/jpi.12213; Nadeem L, 2011, AM J PATHOL, V178, P1177, DOI 10.1016/j.ajpath.2010.11.066; Nagaya T, 2010, EUR J EPIDEMIOL, V25, P195, DOI 10.1007/s10654-009-9423-y; Patel SP, 2005, J PHYSIOL-LONDON, V569, P7, DOI 10.1113/jphysiol.2005.086223; Patel SP, 2004, J PHYSIOL-LONDON, V557, P19, DOI 10.1113/jphysiol.2003.058172; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Pu J, 2014, J AM COLL CARDIOL, V63, P2220, DOI 10.1016/j.jacc.2014.02.576; Pu J, 2013, EUR HEART J, V34, P1834, DOI 10.1093/eurheartj/ehs011; Qin M, 2012, J MOL CELL CARDIOL, V53, P880, DOI 10.1016/j.yjmcc.2012.10.003; Rossow CF, 2009, J MOL CELL CARDIOL, V46, P249, DOI 10.1016/j.yjmcc.2008.10.016; Shan PR, 2008, BIOCHEM BIOPH RES CO, V375, P628, DOI 10.1016/j.bbrc.2008.08.074; Tracy CC, 2003, AM J PHYSIOL-HEART C, V284, pH168, DOI 10.1152/ajpheart.00661.2002; Tsuchida K, 2004, MOL CELL ENDOCRINOL, V220, P59, DOI 10.1016/j.mce.2004.03.009; van Noord C, 2010, EUR J ENDOCRINOL, V162, P241, DOI 10.1530/EJE-09-0878; Wang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep07681; Wickenden AD, 1998, CARDIOVASC RES, V37, P312, DOI 10.1016/S0008-6363(97)00256-3; Yao JJ, 2012, J BIOL CHEM, V287, P41534, DOI 10.1074/jbc.M112.390260; Yao TB, 2015, ANTIOXID REDOX SIGN, V22, P633, DOI 10.1089/ars.2014.5887; Yeung HM, 2015, J PINEAL RES, V58, P12, DOI 10.1111/jpi.12190; Yu LM, 2014, J PINEAL RES, V57, P228, DOI 10.1111/jpi.12161; Zhang N, 2006, DIABETOLOGIA, V49, P506, DOI 10.1007/s00125-005-0095-1; Zhang WC, 2013, ARQ BRAS CARDIOL, V101, P134, DOI [10.5935/abc.20130148, 10.5935/abc.20130129]	45	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149205	10.1371/journal.pone.0149205	http://dx.doi.org/10.1371/journal.pone.0149205			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882027	Green Published, Green Submitted, gold			2022-12-27	WOS:000371219000059
J	Zurcher, K; Ballif, M; Zwahlen, M; Rieder, HL; Egger, M; Fenner, L				Zuercher, Kathrin; Ballif, Marie; Zwahlen, Marcel; Rieder, Hans L.; Egger, Matthias; Fenner, Lukas			Tuberculosis Mortality and Living Conditions in Bern, Switzerland, 1856-1950	PLOS ONE			English	Article							BRIEF EPIDEMIOLOGIC HISTORY; ENGLAND; AMERICA; DISEASE; ARCANA; EUROPE; WALES	Background Tuberculosis (TB) is a poverty-related disease that is associated with poor living conditions. We studied TB mortality and living conditions in Bern between 1856 and 1950. Methods We analysed cause-specific mortality based on mortality registers certified by autopsies, and public health reports 1856 to 1950 from the city council of Bern. Results TB mortality was higher in the Black Quarter (550 per 100,000) and in the city centre (327 per 100,000), compared to the outskirts (209 per 100,000 in 1911-1915). TB mortality correlated positively with the number of persons per room (r = 0.69, p = 0.026), the percentage of rooms without sunlight (r = 0.72, p = 0.020), and negatively with the number of windows per apartment (r = -0.79, p = 0.007). TB mortality decreased 10-fold from 330 per 100,000 in 1856 to 33 per 100,000 in 1950, as housing conditions improved, indoor crowding decreased, and open-air schools, sanatoria, systematic tuberculin skin testing of school children and chest radiography screening were introduced. Conclusions Improved living conditions and public health measures may have contributed to the massive decline of the TB epidemic in the city of Bern even before effective antibiotic treatment became finally available in the 1950s.	[Zuercher, Kathrin; Ballif, Marie; Zwahlen, Marcel; Egger, Matthias; Fenner, Lukas] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Ballif, Marie; Fenner, Lukas] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Ballif, Marie; Fenner, Lukas] Univ Basel, Basel, Switzerland; [Rieder, Hans L.] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland	University of Bern; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Zurich	Fenner, L (corresponding author), Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.; Fenner, L (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.; Fenner, L (corresponding author), Univ Basel, Basel, Switzerland.	lukas.fenner@ispm.unibe.ch	Zwahlen, Marcel/AFF-8559-2022	Zwahlen, Marcel/0000-0002-6772-6346; Zurcher, Kathrin/0000-0002-7915-3194; Egger, Matthias/0000-0001-7462-5132; Fenner, Lukas/0000-0003-3309-4835				[Anonymous], 1908, Proc R Soc Med, V1, P1; [Anonymous], 1870, BERICHT SANITATS COM; [Anonymous], 2008, HIST STAT SCHWEIZ ON; [Anonymous], 1882, BERLINER KLIN WOCHEN, V19, P221; [Anonymous], 1927, TODESFALLE TODESURSA; Baumann H, 1937, TUBERKULOSEFURSORGE; BHATTI N, 1995, BRIT MED J, V310, P967, DOI 10.1136/bmj.310.6985.967; BLOWER SM, 1995, NAT MED, V1, P815, DOI 10.1038/nm0895-815; D'Arcy Hart P, 1939, TUBERCLE, V21, P30; Daniel TM, 2006, RESP MED, V100, P1862, DOI 10.1016/j.rmed.2006.08.006; DANIELS M, 1949, BMJ-BRIT MED J, V2, P1135, DOI 10.1136/bmj.2.4637.1135; Davies RPO, 1999, INT J TUBERC LUNG D, V3, P1051; Drolet GJ, 1952, NEW YORK TUBERCULOSI, V1952, P1; Drolet GJ, 1924, TUBERCLE, V5, P232; Egger M, 2014, PHILOSOPHIE AACH KANT: NEUE WEGE ZUM VERSTANDNIS VON KANTS TRANSZENDENTAL- UND MORALPHILOSOPHIE, P1; Freudiger H, 1930, STAT AMT STADT BERN; GRIGG ERN, 1958, AM REV TUBERC PULM, V78, P151; GRIGG ERN, 1958, AM REV TUBERC PULM, V78, P426; Holloway KL, 2014, J BIOSOC SCI, V46, P600, DOI 10.1017/S0021932013000527; Landolt C., 1899, WOHNUNGS ENQUETE STA; Marie-Davy F., 1911, REV HYG POLICE SANIT, V33, P714; Mosse M., 1913, EINFLUSS SOZIALEN LA, P551; Murphy S, 2002, INT J EPIDEMIOL, V31, P742, DOI 10.1093/ije/31.4.742; Nepfer M., 1996, WOHNUNGSFRAGE STADT; Oei W, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/124861; Pernet P., 2014, PRIERE NE PAS CRACHE; QGIS Development Team, 2015, QGIS GEOGR INF SYST; Redeker F, 1958, HBD TUBERCULOSE, P407; Regli J., 1995, BERNISCHE HOHENKLINI; Rieder HL, 1998, SOZ PRAVENTIV MED, V43, P162, DOI 10.1007/BF01359724; SPENCE DPS, 1993, BRIT MED J, V307, P759, DOI 10.1136/bmj.307.6907.759; Stead WW, 2001, INT J TUBERC LUNG D, V5, P807; Walser E, 1976, BERNER Z GESCH HEIMA, V38, P99; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WILSON LG, 1990, J HIST MED ALL SCI, V45, P366, DOI 10.1093/jhmas/45.3.366	36	11	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149195	10.1371/journal.pone.0149195	http://dx.doi.org/10.1371/journal.pone.0149195			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881850	Green Published, Green Accepted, gold			2022-12-27	WOS:000371219000057
J	Cao, JW; Huang, WL				Cao, Jingwen; Huang, Wenlong			Compensatory Increase of Transglutaminase 2 Is Responsible for Resistance to mTOR Inhibitor Treatment (Publication with Expression of Concern. See vol. 15, 2020)	PLOS ONE			English	Article; Publication with Expression of Concern							FACTOR-KAPPA-B; TISSUE TRANSGLUTAMINASE; CANCER-CELLS; MAMMALIAN TARGET; UP-REGULATION; ACTIVATION; COMPLEX; DRUG; APOPTOSIS; SURVIVAL	The mechanistic target of rapamycin complex 1 (mTORC1) plays a crucial role in controlling cell growth and homeostasis. Deregulation of mTOR signaling is frequently observed in some cancers, making it an attractive drug target for cancer therapy. Although mTORC1 inhibitor rapalog-based therapy has shown positive results in various pre-clinical animal cancer studies, tumors rebound upon treatment discontinuation. Moreover, several recent clinical trials showed that the mTORC1 inhibitors rapamycin and rapalog only reduce the capacity for cell proliferation without promoting cell death, consistent with the concept that rapamycin is cytostatic and reduces disease progression but is not cytotoxic. It is imperative that rapamycin-regulated events and additional targets for more effective drug combinations be identified. Here, we report that rapamycin treatment promotes a compensatory increase in transglutaminase 2 (TGM2) levels in mTORC1-driven tumors. TGM2 inhibition potently sensitizes mTORC1-hyperactive cancer cells to rapamycin treatment, and a rapamycininduced autophagy blockade inhibits the compensatory TGM2 upregulation. More importantly, tumor regression was observed in MCF-7-xenograft tumor-bearing mice treated with both mTORC1 and TGM2 inhibitors compared with those treated with either a single inhibitor or the vehicle control. These results demonstrate a critical role for the compensatory increase in transglutaminase 2 levels in promoting mTORC1 inhibitor resistance and suggest that rational combination therapy may potentially suppress cancer therapy resistance.	[Cao, Jingwen; Huang, Wenlong] China Pharmaceut Univ, Nanjing, Jiangsu, Peoples R China; [Cao, Jingwen] Chinese Acad Med Sci, Beijing 100730, Peoples R China	China Pharmaceutical University; Chinese Academy of Medical Sciences - Peking Union Medical College	Huang, WL (corresponding author), China Pharmaceut Univ, Nanjing, Jiangsu, Peoples R China.	wenlonghuangcpu@gmail.com			National Soft Science Research Program of China [2013GXS4B083]	National Soft Science Research Program of China	The National Soft Science Research Program of China (Grant No. 2013GXS4B083). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai LB, 2012, J BIOL CHEM, V287, P18330, DOI 10.1074/jbc.M112.339317; Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Baldo P, 2008, CURR CANCER DRUG TAR, V8, P647, DOI 10.2174/156800908786733513; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Boehm JE, 2002, J BIOL CHEM, V277, P20127, DOI 10.1074/jbc.C200147200; Boroughs LK, 2014, J BIOL CHEM, V289, P10115, DOI 10.1074/jbc.M113.464693; Britschgi A, 2012, CANCER CELL, V22, P796, DOI 10.1016/j.ccr.2012.10.023; Budillon A, 2013, AMINO ACIDS, V44, P63, DOI 10.1007/s00726-011-1167-9; Cao LY, 2008, CARCINOGENESIS, V29, P1893, DOI 10.1093/carcin/bgn158; Carew JS, 2011, TARGET ONCOL, V6, P17, DOI 10.1007/s11523-011-0167-8; Choi K, 2005, CHEM BIOL, V12, P469, DOI 10.1016/j.chembiol.2005.02.007; Delhase M, 2012, P NATL ACAD SCI USA, V109, pE177, DOI 10.1073/pnas.1119296109; Dibble CC, 2012, MOL CELL, V47, P535, DOI 10.1016/j.molcel.2012.06.009; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Frese-Schaper M, 2010, FEBS LETT, V584, P2867, DOI 10.1016/j.febslet.2010.04.072; Ghosh S, 2006, CANCER CELL, V10, P215, DOI 10.1016/j.ccr.2006.08.007; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; He WX, 2015, EXP THER MED, V10, P1413, DOI 10.3892/etm.2015.2679; Herman JF, 2006, ONCOGENE, V25, P3049, DOI 10.1038/sj.onc.1209324; Hoang B, 2012, J BIOL CHEM, V287, P21796, DOI 10.1074/jbc.M111.304626; Huang L, 2015, AM J CANCER RES, V5, P2756; Iwanami A, 2013, P NATL ACAD SCI USA, V110, P4339, DOI 10.1073/pnas.1217602110; Jang GY, 2010, ONCOGENE, V29, P356, DOI 10.1038/onc.2009.342; Katt WP, 2015, MOL PHARMACEUT, V12, P46, DOI 10.1021/mp500405h; Khanna M, 2011, MOL CANCER THER, V10, P626, DOI 10.1158/1535-7163.MCT-10-0912; Kim DS, 2006, CANCER RES, V66, P10936, DOI 10.1158/0008-5472.CAN-06-1521; Kumar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013390; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li J, 2014, CELL METAB, V19, P373, DOI 10.1016/j.cmet.2014.01.001; Lim HJ, 2015, J CANCER RES CLIN, V141, P671, DOI 10.1007/s00432-014-1803-3; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mangala LS, 2007, ONCOGENE, V26, P2459, DOI 10.1038/sj.onc.1210035; Mann AP, 2006, CANCER RES, V66, P8788, DOI 10.1158/0008-5472.CAN-06-1457; Marsh DJ, 2008, NAT CLIN PRACT ONCOL, V5, P357, DOI 10.1038/ncponc1112; Martz CA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.aaa1877; Mehta K, 2010, BIOCHEM PHARMACOL, V80, P1921, DOI 10.1016/j.bcp.2010.06.029; Menon S, 2008, Oncogene, V27 Suppl 2, pS43, DOI 10.1038/onc.2009.352; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Mikaelian I, 2013, CANCER RES, V73, P6621, DOI 10.1158/0008-5472.CAN-13-0560; Ng S, 2011, AUTOPHAGY, V7, P1173, DOI 10.4161/auto.7.10.16681; Park D, 2010, AMINO ACIDS, V39, P619, DOI 10.1007/s00726-010-0500-z; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sato N, 2010, GENE CHROMOSOME CANC, V49, P353, DOI 10.1002/gcc.20747; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Verma A, 2007, CURR CANCER DRUG TAR, V7, P559, DOI 10.2174/156800907781662275; Wang Y, 2012, BIOCHEM BIOPH RES CO, V417, P251, DOI 10.1016/j.bbrc.2011.11.094; Yamaguchi H, 2006, MOL CELL BIOL, V26, P569, DOI 10.1128/MCB.26.2.569-579.2006; Zha XJ, 2015, CANCER LETT, V359, P97, DOI 10.1016/j.canlet.2015.01.001	50	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149388	10.1371/journal.pone.0149388	http://dx.doi.org/10.1371/journal.pone.0149388			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872016	gold, Green Published, Green Submitted			2022-12-27	WOS:000370054100154
J	Jovic, D; Vukovic, D; Marinkovic, J				Jovic, Dragana; Vukovic, Dejana; Marinkovic, Jelena			Prevalence and Patterns of Multi-Morbidity in Serbian Adults: A Cross-Sectional Study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; HEALTH SURVEY; MULTIMORBIDITY; IMPACT; RISK; OSTEOARTHRITIS; DEPRESSION; ASTHMA; INDEX	Introduction Like many developing countries, Serbia is facing a growing burden of chronic diseases. Within such public health issue, multi-morbidity requires a special attention. Aims This study investigated the prevalence of multi-morbidity in the Serbia population and assessed the co-occurrence of chronic diseases by age and gender. Methods We analyzed data from the 2013 National Health Survey, which included 13,103 individuals >= 20 years old. Multi-morbidity patterns were identified by exploratory factor analysis of data on self-reported chronic diseases, as well as data on measured body weight and height. The analysis was stratified by age and gender. Results Multi-morbidity was present in nearly one-third of respondents (26.9%) and existed in all age groups, with the highest prevalence among individuals aged 65 years and older (47.2% of men and 65.0% of women). Six patterns of multi-morbidity were identified: non-communicable, cardio-metabolic, respiratory, cardiovascular, aggregate, and mechanical/mental/metabolic. The non-communicable pattern was observed in both genders but only in the 20-44 years age group, while the aggregate pattern occurred only in middle-aged men. Cardio-metabolic and respiratory patterns were present in all age groups. Cardiovascular and mechanical/mental/metabolic patterns showed similar presentation in both men and women. Conclusions Multi-morbidity is a common occurrence among adults in Serbia, especially in the elderly. While several patterns may be explained by underlying pathophysiologies, some require further investigation and follow-up. Recognizing the complexity of multi-morbidity in Serbia is of great importance from both clinical and preventive perspectives given that it affects one-third of the population and may require adjustment of the healthcare system to address the needs of affected individuals.	[Jovic, Dragana] Inst Publ Hlth Serbia, Ctr Hyg & Human Ecol, Belgrade, Serbia; [Vukovic, Dejana] Univ Belgrade, Fac Med, Inst Social Med, Belgrade, Serbia; [Marinkovic, Jelena] Univ Belgrade, Fac Med, Inst Med Stat & Informat, Belgrade, Serbia	University of Belgrade; University of Belgrade	Jovic, D (corresponding author), Inst Publ Hlth Serbia, Ctr Hyg & Human Ecol, Belgrade, Serbia.	drdraganajovic@gmail.com		Vukovic, Dejana/0000-0002-3323-3711; Marinkovic, Jelena/0000-0001-8852-384X				Agborsangaya CB, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-201; [Anonymous], 2012, EUROPEAN HLTH INTERV; [Anonymous], 2011, TG EHIS 2012 M; Arthritis foundation, 2014, OST KIDN; Bay-Jensen AC, 2012, MENOPAUSE, V20; Booth HP, 2014, FAM PRACT, V31, P38, DOI 10.1093/fampra/cmt061; Breedveld FC, 2004, RHEUMATOLOGY, V43, pI4, DOI 10.1093/rheumatology/keh102; Diederichs C, 2011, J GERONTOL A-BIOL, V66, P301, DOI 10.1093/gerona/glq208; European Health Interview Survey Task Force II, 2009, EUR HLTH INT SURV WA; Eurostat, 2008, SURV SAMPL REF GUID; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Ferketich AK, 2000, ARCH INTERN MED, V160, P1261, DOI 10.1001/archinte.160.9.1261; Foguet-Boreu Q, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-55; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Fortin M, 2012, ANN FAM MED, V10, P142, DOI 10.1370/afm.1337; Fortin M, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-111; Garin N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084794; Hare DL, 2014, EUR HEART J, V35, P1365, DOI 10.1093/eurheartj/eht462; Hartmann J, 2011, HLTH INT, P11; Holden L, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-15; Huang HL, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-80; Huertas Alice, 2011, Ther Adv Respir Dis, V5, P217, DOI 10.1177/1753465811400490; Institute of Public Health of Serbia "Dr Milan Jovanovic Batut", 2014, HLTH STAT YB REP SER; Jankovic J, 2011, SCAND J PUBLIC HEALT, V39, P230, DOI 10.1177/1403494811401477; Jankovic S, 2007, EUR J PUBLIC HEALTH, V17, P80, DOI 10.1093/eurpub/ckl072; Khatib O, 2004, East Mediterr Health J, V10, P778; Laniado-Laborin R, 2009, INT J ENV RES PUB HE, V6, P209, DOI 10.3390/ijerph6010209; Liu DW, 2013, CHINESE MED J-PEKING, V126, P4093, DOI 10.3760/cma.j.issn.0366-6999.20131431; Abad-Diez JM, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-75; Mayoclinic.org, 1998, DIS COND; Mehta LS, 2011, HEART FAIL CLIN, V7, P39, DOI 10.1016/j.hfc.2010.08.005; Mercer SW, 2009, FAM PRACT, V26, P79, DOI 10.1093/fampra/cmp020; Ministry of Health of the Republic of Serbia. National Health Survey Serbia, 2006, NAT HLTH SURV SERB 2; Nagorni-Obradovic LM, 2014, NPJ PRIM CARE RESP M, V24, DOI 10.1038/npjpcrm.2014.8; Nichols GA, 2011, DIABETOLOGIA, V54, P523, DOI 10.1007/s00125-010-1965-8; Organization WH, 2009, GLOB HLTH RISKS MORT; Osborne J., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [10.7275/jyj1-4868, DOI 10.7275/JYJ1-4868, 10.4135/9781412995627.d8, DOI 10.4135/9781412995627.D8]; Palange P, 1998, THORAX, V53, P989, DOI 10.1136/thx.53.11.989; Poblador-Plou B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100375; Prados-Torres A, 2014, J CLIN EPIDEMIOL, V67, P254, DOI 10.1016/j.jclinepi.2013.09.021; Prados-Torres A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032190; Schafer I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015941; Srbija Republika, 2014, REZ ISTR ZDRAVLJ STA; van den Akker M, 2001, J CLIN EPIDEMIOL, V54, P675, DOI 10.1016/S0895-4356(00)00358-9; van den Akker M, 1996, EUR J GEN PRACT, V2, P65, DOI [DOI 10.3109/13814789609162146, 10.3109/13814789609162146]; Vukovic D, 2008, CROAT MED J, V49, P832, DOI 10.3325/cmj.2008.49.832; Wang HHX, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0188-0; Ward BW, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130389; WHO Regional Office for Europe, 2010, EV ORG PROV PRIM CAR; Wilson Ian, 2006, Int J Chron Obstruct Pulmon Dis, V1, P61, DOI 10.2147/copd.2006.1.1.61	50	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148646	10.1371/journal.pone.0148646	http://dx.doi.org/10.1371/journal.pone.0148646			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871936	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100045
J	Kol, A; Walker, NJ; Nordstrom, M; Borjesson, DL				Kol, A.; Walker, N. J.; Nordstrom, M.; Borjesson, D. L.			Th17 Pathway As a Target for Multipotent Stromal Cell Therapy in Dogs: Implications for Translational Research	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; INFLAMMATORY-BOWEL-DISEASE; T-CELLS; HEALTHY DOGS; IN-VITRO; DIFFERENTIATION; EXPRESSION; CYTOKINE; BLOOD; TISSUES	Detrimental Th17 driven inflammatory and autoimmune disease such as Crohn's disease, graft versus host disease and multiple sclerosis remain a significant cause of morbidity and mortality worldwide. Multipotent stromal/stem cell (MSC) inhibit Th17 polarization and activation in vitro and in rodent models. As such, MSC based therapeutic approaches are being investigated as novel therapeutic approaches to treat Th17 driven diseases in humans. The significance of naturally occurring diseases in dogs is increasingly recognized as a realistic platform to conduct pre-clinical testing of novel therapeutics. Full characterization of Th17 cells in dogs has not been completed. We have developed and validated a flow-cytometric method to detect Th17 cells in canine blood. We further demonstrate that Th17 and other IL17 producing cells are present in tissues of dogs with naturally occurring chronic inflammatory diseases. Finally, we have determined the kinetics of a canine specific Th17 polarization in vitro and demonstrate that canine MSC inhibit Th17 polarization in vitro, in a PGE2 independent mechanism. Our findings provide fundamental research tools and suggest that naturally occurring diseases in dogs, such as inflammatory bowel disease, may be harnessed to translate novel MSC based therapeutic strategies that target the Th17 pathway.	[Kol, A.; Walker, N. J.; Nordstrom, M.; Borjesson, D. L.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA	University of California System; University of California Davis	Borjesson, DL (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.	dlborjesson@ucdavis.edu		Kol, Amir/0000-0003-2324-6962	Center of Companion Animal Health, UC Davis School of Veterinary Medicine [2015-06-F]; California Institute for Regenerative Medicine's Stem Cell Training Program; ARCS foundation	Center of Companion Animal Health, UC Davis School of Veterinary Medicine; California Institute for Regenerative Medicine's Stem Cell Training Program; ARCS foundation	This work was supported by the Center of Companion Animal Health, UC Davis School of Veterinary Medicine (Grant # 2015-06-F) and a generous gift from Mr. Dick and Carolyn Randall. AK was supported by the California Institute for Regenerative Medicine's Stem Cell Training Program and a scholarship from the ARCS foundation.	Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chao K, 2014, J GASTROEN HEPATOL, V29, P1808, DOI 10.1111/jgh.12592; Chatterjee D, 2014, BLOOD, V123, P594, DOI 10.1182/blood-2013-09-524827; Chizzolini C, 2008, BLOOD, V112, P3696, DOI 10.1182/blood-2008-05-155408; Clark KC, 2015, STEM CELL REV; Collins FS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002747; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Eysteinsdottir JH, 2013, SCAND J IMMUNOL, V78, P529, DOI 10.1111/sji.12114; Fellman CL, 2011, VET IMMUNOL IMMUNOP, V140, P175, DOI 10.1016/j.vetimm.2010.11.005; Firth FA, 2015, ARCH DERMATOL RES, V307, P333, DOI 10.1007/s00403-015-1540-8; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Ghannam S, 2010, J IMMUNOL, V185, P302, DOI 10.4049/jimmunol.0902007; Gullick NJ, 2013, CLIN EXP IMMUNOL, V174, P292, DOI 10.1111/cei.12167; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Honkanen J, 2010, J IMMUNOL, V185, P1959, DOI 10.4049/jimmunol.1000788; Igarashi H, 2015, VET IMMUNOL IMMUNOP, V164, P160, DOI 10.1016/j.vetimm.2015.02.005; Jain P, 2012, HAEMATOL-HEMATOL J, V97, P599, DOI 10.3324/haematol.2011.047316; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kenealy SJ, 2003, J NEUROIMMUNOL, V143, P7, DOI [10.1016/j.jneuroim.2003.08.005, 10.1016/j.jneuroim.2003.08.009]; Knights D, 2013, GUT, V62, P1505, DOI 10.1136/gutjnl-2012-303954; Kol A, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9116; Kol A, 2014, STEM CELLS DEV, V23, P1831, DOI 10.1089/scd.2014.0128; Kondo T, 2009, J IMMUNOL, V182, P1794, DOI 10.4049/jimmunol.0801347; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lin S, 2014, P NATL ACAD SCI USA, V111, P17224, DOI 10.1073/pnas.1413624111; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Liu XX, 2015, IMMUNOL RES, V61, P219, DOI 10.1007/s12026-014-8612-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubberts E, 2015, NAT REV RHEUMATOL, V11, P415, DOI 10.1038/nrrheum.2015.53; Luz-Crawford P, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt216; Marinoni B, 2014, AUTOIMMUN HIGHLIGHTS, V5, P9, DOI 10.1007/s13317-013-0057-4; McGeachy MJ, 2013, J LEUKOCYTE BIOL, V94, P921, DOI 10.1189/jlb.0313113; Nagasawa M, 2015, SCIENCE, V348, P333, DOI 10.1126/science.1261022; Obermajer N, 2014, J IMMUNOL, V193, P4988, DOI 10.4049/jimmunol.1401776; Ohta H, 2013, VET IMMUNOL IMMUNOP, V155, P259, DOI 10.1016/j.vetimm.2013.07.006; Olsson M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001332; Park ES, 2013, VET PATHOL, V50, P1127, DOI 10.1177/0300985813488957; Paulissen SMJ, 2013, J IMMUNOL, V191, P1364, DOI 10.4049/jimmunol.1300274; Pelletier M, 2010, BLOOD, V115, P335, DOI 10.1182/blood-2009-04-216085; Pianta S, 2014, STEM CELL REV; Raychaudhuri SK, 2015, CLIN RHEUMATOL; Rei M, 2015, CANCER RES, V75, P798, DOI 10.1158/0008-5472.CAN-14-3228; Schmitz S, 2014, SCAND J IMMUNOL, V80, P85, DOI 10.1111/sji.12186; Schmitz S, 2012, VET IMMUNOL IMMUNOP, V146, P87, DOI 10.1016/j.vetimm.2012.01.013; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Singer NG, 2011, ANNU REV PATHOL-MECH, V6, P457, DOI 10.1146/annurev-pathol-011110-130230; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039333; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Valli JL, 2010, VET IMMUNOL IMMUNOP, V134, P218, DOI 10.1016/j.vetimm.2009.09.023; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wang GD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2814; Wilbe M, 2010, NAT GENET, V42, P250, DOI 10.1038/ng.525; Xu H, 2012, MUCOSAL IMMUNOL, V5, P658, DOI 10.1038/mi.2012.39; Yamamoto K, 2015, NAT REV RHEUMATOL, V11, P375, DOI 10.1038/nrrheum.2015.7; Yen HR, 2009, J IMMUNOL, V183, P7161, DOI 10.4049/jimmunol.0900368; YOO ZB, 1995, J IMMUNOL, V155, P5483; Zerhouni EA, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000341	63	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148568	10.1371/journal.pone.0148568	http://dx.doi.org/10.1371/journal.pone.0148568			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872054	Green Published, gold			2022-12-27	WOS:000370054100037
J	Schmidt, P; Mackay, A				Schmidt, Patrick; Mackay, Alex			Why Was Silcrete Heat-Treated in the Middle Stone Age? An Early Transformative Technology in the Context of Raw Material Use at Mertenhof Rock Shelter, South Africa	PLOS ONE			English	Article							LATE PLEISTOCENE ARCHAEOLOGY; HOWIESONS POORT; WESTERN CAPE; BLOMBOS CAVE; LAYERS; SITE; TOOL	People heat treated silcrete during the Middle Stone Age (MSA) in southern Africa but the spatial and temporal variability of this practice remains poorly documented. This paucity of data in turn makes it difficult to interrogate the motive factors underlying the application of this technique. In this paper we present data on heat treatment of silcrete through the Howiesons Poort and post-Howiesons Poort of the rock shelter site Mertenhof, located in the Western Cape of South Africa. In contrast to other sites where heat treatment has been documented, distance to rock source at Mertenhof can be reasonably well estimated, and the site is known to contain high proportions of a diversity of fine grained rocks including silcrete, hornfels and chert at various points through the sequence. Our results suggest the prevalence of heat treatment is variable through the sequence but that it is largely unaffected by the relative abundance of silcrete prevalence. Instead there is a strong inverse correlation between frequency of heat treatment in silcrete and prevalence of chert in the assemblage, and a generally positive correlation with the proportion of locally available rock. While it is difficult to separate individual factors we suggest that, at Mertenhof at least, heat treatment may have been used to improve the fracture properties of silcrete at times when other finer grained rocks were less readily available. As such, heat treatment appears to have been a component of the MSA behavioural repertoire that was flexibly deployed in ways sensitive to other elements of technological organisation.	[Schmidt, Patrick] Univ Tubingen, Dept Prehist & Quaternary Ecol, Tubingen, Germany; [Mackay, Alex] Univ Wollongong, Ctr Archaeol Sci, Sch Earth & Environm Sci, Wollongong, NSW, Australia; [Mackay, Alex] Univ Cape Town, Dept Archaeol, ZA-7700 Rondebosch, South Africa	Eberhard Karls University of Tubingen; University of Wollongong; University of Cape Town	Schmidt, P (corresponding author), Univ Tubingen, Dept Prehist & Quaternary Ecol, Tubingen, Germany.	patrick.schmidt@uni-tuebingen.de	Schmidt, Patrick/D-3925-2016; Mackay, Alex/F-1811-2014	Schmidt, Patrick/0000-0002-8727-6127; Mackay, Alex/0000-0002-6396-0821	Australian Research Council [130100068]; Deutsche Forschungsgemeinschaft (DFG) [CO 226/25-1, MI 1748/2-1, NI 299/25-1]; Deutsche Forschungsgemeinschaft; Tuebingen University	Australian Research Council(Australian Research Council); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tuebingen University	Excavations at MRS were funded by Australian Research Council grant DE#130100068. The Deutsche Forschungsgemeinschaft (DFG) funded of the research project Heat Treatment in the South African MSA (Grant Nr: CO 226/25-1, MI 1748/2-1, NI 299/25-1) that made this study possible. The authors acknowledge support by the Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University.	Ambrose SH, 2006, J HUM EVOL, V50, P365, DOI 10.1016/j.jhevol.2005.12.006; Brown K, 2010, PALEOANTHROPOLOGY, V2010; Brown KS, 2009, SCIENCE, V325, P859, DOI 10.1126/science.1175028; Domanski M., 1994, ARCHAEOMETRY, V36, P177, DOI DOI 10.1111/J.1475-4754.1994.TB00963.X; Hallinan E., 2015, ANTIQUITY PROJECT GA, V89; Henshilwood CS, 2014, J ARCHAEOL SCI, V45, P284, DOI 10.1016/j.jas.2014.01.033; Jacobs Z, 2013, J ARCHAEOL SCI, V40, P579, DOI 10.1016/j.jas.2012.06.037; Jarvis A., 2008, CGIAR CSI SRTM 90 M, DOI DOI 10.1111/ecog.00774; Kuhn SL., 1995, MOUSTERIAN LITHIC TE, DOI [10.1515/9781400864034, DOI 10.1515/9781400864034]; Mackay A, 2015, J AFRICAN ARCHAEOLOG, V13; Mackay A, 2014, J HUM EVOL, V72, P26, DOI 10.1016/j.jhevol.2014.03.003; Mackay A, 2010, S AFR ARCHAEOL BULL, V65, P132; Mackay A, 2011, J ARCHAEOL SCI, V38, P1430, DOI 10.1016/j.jas.2011.02.006; Mourre V, 2010, SCIENCE, V330, P659, DOI 10.1126/science.1195550; Porraz G, 2013, J ARCHAEOL SCI, V40, P3376, DOI 10.1016/j.jas.2013.02.012; Roberts D. L, 2003, MEMOIR, V95; SCHINDLER DL, 1982, AM ANTIQUITY, V47, P526, DOI 10.2307/280233; Schmidt P, 2015, J HUM EVOL, V85, P22, DOI 10.1016/j.jhevol.2015.05.001; Schmidt P, 2013, J ARCHAEOL SCI, V40, P3519, DOI 10.1016/j.jas.2012.10.016; Schmidt P, 2012, J ARCHAEOL SCI, V39, P135, DOI 10.1016/j.jas.2011.09.012; Singer R., 1982, MIDDLE STONE AGE KLA; Soriano S, 2007, J ARCHAEOL SCI, V34, P681, DOI 10.1016/j.jas.2006.06.017; Steele TE, 2012, S AFR ARCHAEOL BULL, V67, P108; SUMMERFIELD MA, 1983, J SEDIMENT PETROL, V53, P895; Texier PJ, 2013, J ARCHAEOL SCI, V40, P3412, DOI 10.1016/j.jas.2013.02.021; Villa P, 2010, J ARCHAEOL SCI, V37, P630, DOI 10.1016/j.jas.2009.10.028; Visser HN, 1973, CARTOGRAPHERS; Volman T.P., 1981, MIDDLE STONE AGE SO; Will M, 2015, PLOS ONE; Will M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131824; Will M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098359; [No title captured]	32	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149243	10.1371/journal.pone.0149243	http://dx.doi.org/10.1371/journal.pone.0149243			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DD6RE	26867145	Green Published, gold, Green Submitted			2022-12-27	WOS:000370050700081
J	Seyffert, M; Lagisetty, P; Landgraf, J; Chopra, V; Pfeiffer, PN; Conte, ML; Rogers, MAM				Seyffert, Michael; Lagisetty, Pooja; Landgraf, Jessica; Chopra, Vineet; Pfeiffer, Paul N.; Conte, Marisa L.; Rogers, Mary A. M.			Internet-Delivered Cognitive Behavioral Therapy to Treat Insomnia: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; SLEEP RESTRICTION THERAPY; SEVERITY INDEX; DISORDER; WEB; VALIDATION; MANAGEMENT; EFFICACY; SUPPORT; WORKERS	Background Insomnia is of major public health importance. While cognitive behavioral therapy is beneficial, in-person treatment is often unavailable. We assessed the effectiveness of internet-delivered cognitive behavioral therapy for insomnia. Objectives The primary objectives were to determine whether online cognitive behavioral therapy for insomnia could improve sleep efficiency and reduce the severity of insomnia in adults. Secondary outcomes included sleep quality, total sleep time, time in bed, sleep onset latency, wake time after sleep onset, and number of nocturnal awakenings. Data Sources We searched PubMed/MEDLINE, the Cumulative Index to Nursing and Allied Health Literature, PsycInfo, Cochrane Library, Embase, and the Web of Science for randomized trials. Methods Studies were eligible if they were randomized controlled trials in adults that reported application of cognitive behavioral therapy for insomnia via internet delivery. Mean differences in improvement in sleep measures were calculated using the Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis. Results We found 15 trials, all utilizing a pretest-posttest randomized control group design. Sleep efficiency was 72% at baseline and improved by 7.2% (95% CI: 5.1%, 9.3%; p<0.001) with internet-delivered cognitive behavioral therapy versus control. Internet-delivered cognitive behavioral therapy resulted in a decrease in the insomnia severity index by 4.3 points (95% CI: -7.1, -1.5; p = 0.017) compared to control. Total sleep time averaged 5.7 hours at baseline and increased by 20 minutes with internet-delivered therapy versus control (95% CI: 9, 31; p = 0.004). The severity of depression decreased by 2.3 points (95% CI: -2.9, -1.7; p = 0.013) in individuals who received internet-delivered cognitive behavioral therapy compared to control. Improvements in sleep efficiency, the insomnia severity index and depression scores with internet-delivered cognitive behavioral therapy were maintained from 4 to 48 weeks after post-treatment assessment. There were no statistically significant differences between sleep efficiency, total sleep time, and insomnia severity index for internet-delivered versus in-person therapy with a trained therapist. Conclusion In conclusion, internet-delivered cognitive behavioral therapy is effective in improving sleep in adults with insomnia. Efforts should be made to educate the public and expand access to this therapy. Registration Number, Prospero: CRD42015017622	[Seyffert, Michael; Pfeiffer, Paul N.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Seyffert, Michael; Lagisetty, Pooja; Chopra, Vineet; Rogers, Mary A. M.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Seyffert, Michael; Lagisetty, Pooja; Landgraf, Jessica] Univ Michigan, Robert Wood Johnson Clin Scholars Program, Ann Arbor, MI 48109 USA; [Chopra, Vineet; Pfeiffer, Paul N.] Vet Adm Ann Arbor Healthcare Syst, Vet Adm Ctr Clin Management Res, Ann Arbor, MI USA; [Conte, Marisa L.] Univ Michigan, Hlth Sci Lib, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Rogers, MAM (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.	maryroge@umich.edu		Seyffert, Michael/0000-0002-8717-1667; Chopra, Vineet/0000-0001-8670-9376; Conte, Marisa/0000-0001-7377-163X; Rogers, Mary/0000-0001-5519-3223	Robert Wood Johnson Foundation Clinical Scholars Program	Robert Wood Johnson Foundation Clinical Scholars Program(Robert Wood Johnson Foundation (RWJF))	This study was supported by the Robert Wood Johnson Foundation Clinical Scholars Program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alterman T, 2013, AM J IND MED, V56, P647, DOI 10.1002/ajim.22108; American Academy of Sleep Medicine, 2014, INT CLASS SLEEP DIS, V3rd; Andersson G, 2014, WORLD PSYCHIATRY, V13, P288, DOI 10.1002/wps.20151; Baker S, 2014, CLIN GUIDELINE TREAT; Balk E.M, 2012, AHRQ PUBLICATION; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Bernert RA, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0554-4; Blom K, 2015, BEHAV RES THER, V70, P47, DOI 10.1016/j.brat.2015.05.002; Blom K, 2015, SLEEP, V38, P267, DOI 10.5665/sleep.4412; Bramoweth AD, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0401-4; Buckley J, 2003, PRACTICAL ASSESS RES, V8; Cheng SK, 2012, PSYCHOTHER PSYCHOSOM, V81, P206, DOI 10.1159/000335379; Cochrane Collaboration, TOOL ASS RISK BIAS; Cornell JE, 2014, ANN INTERN MED, V160, P267, DOI 10.7326/M13-2886; Cunningham JA, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0521-5; Espie CA, 2012, SLEEP, V35, P769, DOI 10.5665/sleep.1872; FU R, 2013, AHRQ PUBLICATION; Grandner MA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00112; Ho FYY, 2015, SLEEP MED REV, V19, P17, DOI 10.1016/j.smrv.2014.06.010; Ho FYY, 2014, BEHAV RES THER, V63, P147, DOI 10.1016/j.brat.2014.10.002; Holmqvist M, 2014, SLEEP MED, V15, P187, DOI 10.1016/j.sleep.2013.10.013; IntHout J, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-25; Kaldo V, 2015, BEHAV RES THER, V71, P90, DOI 10.1016/j.brat.2015.06.001; Kessler RC, 2011, SLEEP, V34, P1161, DOI 10.5665/SLEEP.1230; Kyle SD, 2014, SLEEP, V37, P229, DOI 10.5665/sleep.3386; Kyle SD, 2011, SLEEP MED, V12, P735, DOI 10.1016/j.sleep.2011.03.016; Lancee J, 2015, COGN BEHAV THER, P1; Lancee J, 2013, BEHAV RES THER, V51, P797, DOI 10.1016/j.brat.2013.09.004; Lancee J, 2012, BEHAV RES THER, V50, P22, DOI 10.1016/j.brat.2011.09.012; Markwald RR, 2013, P NATL ACAD SCI USA, V110, P5695, DOI 10.1073/pnas.1216951110; Mitchell MD, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-40; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Morin CM, 2009, ARCH INTERN MED, V169, P447, DOI 10.1001/archinternmed.2008.610; Morris J, 2015, ANXIETY STRESS COPIN, P1; Naidu VV, 2015, OCCUP MED LOND; National Institute for Health and Care Excellence, 2011, NICE GUID CG123 COMM; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Pereira K, 2015, DIABETES TECHNOL THE, V17, P55, DOI 10.1089/dia.2014.0155; Real Time Statistics Project, INT LIV STATS; Ritterband LM, 2009, ARCH GEN PSYCHIAT, V66, P692, DOI 10.1001/archgenpsychiatry.2009.66; Schutte-Rodin S, 2008, J CLIN SLEEP MED, V4, P487; Sivertsen B, 2012, PSYCHOSOM MED, V74, P758, DOI 10.1097/PSY.0b013e3182648619; Strom L, 2004, J CONSULT CLIN PSYCH, V72, P113, DOI 10.1037/0022-006X.72.1.113; Thiart H, 2015, SCAND J WORK ENV HEA, V41, P164, DOI 10.5271/sjweh.3478; Thorndike FP, 2011, BEHAV SLEEP MED, V9, P216, DOI 10.1080/15402002.2011.606766; Trauer JM, 2015, ANN INTERN MED, V163, P191, DOI 10.7326/M14-2841; van Straten A, 2014, PSYCHOL MED, V44, P1521, DOI 10.1017/S0033291713002249; Vincent N, 2009, SLEEP, V32, P807, DOI 10.1093/sleep/32.6.807; Winkelman JW, 2015, NEW ENGL J MED, V373, P1437, DOI 10.1056/NEJMcp1412740; Zachariae R, 2016, SLEEP MED REV, V30, P1, DOI 10.1016/j.smrv.2015.10.004	50	150	159	14	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149139	10.1371/journal.pone.0149139	http://dx.doi.org/10.1371/journal.pone.0149139			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6RE	26867139	Green Published, Green Submitted, gold			2022-12-27	WOS:000370050700072
J	Bloch, C; Schneider, JW; Sinkjaer, T				Bloch, Carter; Schneider, Jesper W.; Sinkjaer, Thomas			Size, Accumulation and Performance for Research Grants: Examining the Role of Size for Centres of Excellence	PLOS ONE			English	Article							CUMULATIVE ADVANTAGE; SCIENCE; INEQUALITY	The present paper examines the relation between size, accumulation and performance for research grants, where we examine the relation between grant size for Centres of Excellence (CoE) funded by the Danish National Research Foundation (DNRF) and various ex post research performance measures, including impact and shares of highly cited articles. We examine both the relation between size and performance and also how performance for CoEs evolves over the course of grant periods. In terms of dynamics, it appears that performance over the grant period (i.e. 10 years) is falling for the largest CoEs, while it is increasing for those among the smallest half. Overall, multivariate econometric analysis finds evidence that performance is increasing in grant size and over time. In both cases, the relation appears to be non/linear, suggesting that there is a point at which performance peaks. The CoEs have also been very successful in securing additional funding, which can be viewed as a 'cumulative effect' of center grants. In terms of new personnel, the far majority of additional funding is spent on early career researchers, hence, this accumulation would appear to have a 'generational' dimension, allowing for scientific expertise to be passed on to an increasing number of younger researchers.	[Bloch, Carter; Schneider, Jesper W.] Aarhus Univ, Dept Polit Sci, Danish Ctr Studies Res & Res Policy, Bartholins Alle 7, DK-8000 Aarhus C, Denmark; [Sinkjaer, Thomas] Danish Natl Res Fdn, Holbergsgade 14, DK-1057 Copenhagen K, Denmark; [Sinkjaer, Thomas] Aalborg Univ, Dept Hlth Sci & Technol, Fredrik Bajers Vej 7, DK-9220 Aalborg, Denmark	Aarhus University; Danmarks Grundforskningsfond; Aalborg University	Bloch, C (corresponding author), Aarhus Univ, Dept Polit Sci, Danish Ctr Studies Res & Res Policy, Bartholins Alle 7, DK-8000 Aarhus C, Denmark.	carter.bloch@ps.au.dk	Schneider, Jesper Wiborg/J-9068-2012	Schneider, Jesper Wiborg/0000-0001-5556-0919				Aksnes DW, 2012, J INFORMETR, V6, P36, DOI 10.1016/j.joi.2011.08.002; ALLISON PD, 1982, AM SOCIOL REV, V47, P615, DOI 10.2307/2095162; ARELLANO M, 1991, REV ECON STUD, V58, P277, DOI 10.2307/2297968; ARELLANO M, 1995, J ECONOMETRICS, V68, P29, DOI 10.1016/0304-4076(94)01642-D; Bloch C, 2015, SCI PUBL POLICY, V42, P30, DOI 10.1093/scipol/scu019; COLE JR, 1972, SCIENCE, V178, P368, DOI 10.1126/science.178.4059.368; Costas R., 2013, BIBLIO ANAL PUBLICAT; DiPrete TA, 2006, ANNU REV SOCIOL, V32, P271, DOI 10.1146/annurev.soc.32.061604.123127; Fortin JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065263; HANSEN LP, 1982, ECONOMETRICA, V50, P1029, DOI 10.2307/1912775; Hermanowicz JC, 2013, MINERVA, V51, P363, DOI 10.1007/s11024-013-9231-0; Hicks D, 2011, MINERVA, V49, P137, DOI 10.1007/s11024-011-9170-6; Ida T, 2013, SCIENTOMETRICS, V94, P1253, DOI 10.1007/s11192-012-0841-3; Jamtveit B, 2009, P NATL ACAD SCI USA, V106, P13160, DOI 10.1073/pnas.0903190106; JOHNSTON R, 1994, HIGH EDUC, V28, P25, DOI 10.1007/BF01383570; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; PRICE DJD, 1976, J AM SOC INFORM SCI, V27, P292, DOI 10.1002/asi.4630270505; Rogers JD, 2012, RES EVALUAT, V21, P368, DOI 10.1093/reseval/rvs028; Roodman D, 2009, STATA J, V9, P86, DOI 10.1177/1536867X0900900106; SARGAN JD, 1958, ECONOMETRICA, V26, P393, DOI 10.2307/1907619; Seglen PO, 2000, SCIENTOMETRICS, V49, P125, DOI 10.1023/A:1005665309719; Stephan PE, 1996, J ECON LIT, V34, P1199; University Alliance, 2011, FUND RES EXC RES GRO; Von Tunzelmann N., 2003, EFFECTS SIZE RES PER; Walsh JP, 2015, RES POLICY, V44, P1584, DOI 10.1016/j.respol.2015.04.010; Waltman L, 2015, J INFORMETR, V9, P872, DOI 10.1016/j.joi.2015.08.001; Youtie J, 2013, RES EVALUAT, V22, P145, DOI 10.1093/reseval/rvt002	27	8	8	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0147726	10.1371/journal.pone.0147726	http://dx.doi.org/10.1371/journal.pone.0147726			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6PR	26862907	Green Published, gold, Green Submitted			2022-12-27	WOS:000370046600035
J	Chen, BY; Gao, ET; Chen, HY; Yang, JL; Shi, F; Zheng, C; Zhu, WF; Xiang, DH; Chen, XJ; Zhang, MZ				Chen, Binyao; Gao, Enting; Chen, Haoyu; Yang, Jianling; Shi, Fei; Zheng, Ce; Zhu, Weifang; Xiang, Dehui; Chen, Xinjian; Zhang, Mingzhi			Profile and Determinants of Retinal Optical Intensity in Normal Eyes with Spectral Domain Optical Coherence Tomography	PLOS ONE			English	Article							NERVE-FIBER LAYER; QUANTITATIVE-ANALYSIS; PIGMENT EPITHELIUM; 3-DIMENSIONAL PROFILE; MACULAR DISEASE; GANGLION-CELLS; AGE; THICKNESS; GLAUCOMA; DENSITY	Purpose To investigate the profile and determinants of retinal optical intensity in normal subjects using 3D spectral domain optical coherence tomography (SD OCT). Methods A total of 231 eyes from 231 healthy subjects ranging in age from 18 to 80 years were included and underwent a 3D OCT scan. Forty-four eyes were randomly chosen to be scanned by two operators for reproducibility analysis. Distribution of optical intensity of each layer and regions specified by the Early Treatment of Diabetic Retinopathy Study (ETDRS) were investigated by analyzing the OCT raw data with our automatic graph-based algorithm. Univariate and multivariate analyses were performed between retinal optical intensity and sex, age, height, weight, spherical equivalent (SE), axial length, image quality, disc area and rim/disc area ratio (R/D area ratio). Results For optical intensity measurements, the intraclass correlation coefficient of each layer ranged from 0.815 to 0.941, indicating good reproducibility. Optical intensity was lowest in the central area of retinal nerve fiber layer, ganglion cell layer, inner plexiform layer, inner nuclear layer, outer plexiform layer and photoreceptor layer, except for the retinal pigment epithelium (RPE). Optical intensity was positively correlated with image quality in all retinal layers (0.553<beta<0.851, p<0.01), and negatively correlated with age in most retinal layers (-0.362<beta<-0.179, p<0.01), except for the RPE (beta = 0.456, p<0.01), outer nuclear layer and photoreceptor layer (p>0.05). There was no relationship between retinal optical intensity and sex, height, weight, SE, axial length, disc area and R/D area ratio. Conclusions There was a specific pattern of distribution of retinal optical intensity in different regions. The optical intensity was affected by image quality and age. Image quality can be used as a reference for normalization. The effect of age needs to be taken into consideration when using OCT for diagnosis.	[Chen, Binyao; Chen, Haoyu; Yang, Jianling; Zheng, Ce; Zhang, Mingzhi] Shantou Univ, Joint Shantou Int Eye Ctr, Shantou, Peoples R China; [Chen, Binyao; Chen, Haoyu; Yang, Jianling; Zheng, Ce; Zhang, Mingzhi] Chinese Univ Hong Kong, Shantou, Peoples R China; [Gao, Enting; Shi, Fei; Zhu, Weifang; Xiang, Dehui; Chen, Xinjian] Soochow Univ, Sch Elect & Informat Engn, Suzhou, Peoples R China	Shantou University; Soochow University - China	Zhang, MZ (corresponding author), Shantou Univ, Joint Shantou Int Eye Ctr, Shantou, Peoples R China.; Zhang, MZ (corresponding author), Chinese Univ Hong Kong, Shantou, Peoples R China.; Chen, XJ (corresponding author), Soochow Univ, Sch Elect & Informat Engn, Suzhou, Peoples R China.	xjchen@suda.edu.cn; zmz@jsiec.org	Xiang, Dehui/B-1938-2016; Chen, Haoyu/A-7432-2013	Xiang, Dehui/0000-0001-7873-9778; Chen, Haoyu/0000-0003-0676-4610; Chen, Xinjian/0000-0002-0871-293X	National Nature Science Foundation of China [30901646, 81170853]; Innovation Training Program for the University Students of Guangdong Province [1056013105]; Joint Shantou International Eye Center [2012-18]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Training Program for the University Students of Guangdong Province; Joint Shantou International Eye Center	This work was funded by the National Nature Science Foundation of China (HC, 30901646 and 81170853, http://www.nsfc.gov.cn/), the Innovation Training Program for the University Students of Guangdong Province (BC, 1056013105, http://gjxx.edugd.cn/gdhe/), and the Research Grant of Joint Shantou International Eye Center (MZ, 2012-18, http://www.jsiec.org/). The funders played a role in data collection and analysis, and decision to publish.	Abignano G, 2013, ANN RHEUM DIS, V72, P1845, DOI 10.1136/annrheumdis-2012-202682; Aggarwal P, 2007, J BIOSCIENCES, V32, P293, DOI 10.1007/s12038-007-0029-9; Ahlers C, 2009, INVEST OPHTH VIS SCI, V50, P3417, DOI 10.1167/iovs.08-2759; Alasil T, 2013, J GLAUCOMA, V22, P532, DOI 10.1097/IJG.0b013e318255bb4a; BALAZSI AG, 1984, AM J OPHTHALMOL, V97, P760, DOI 10.1016/0002-9394(84)90509-9; Barbas Carlos F 3rd, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.ip47; Barthelmes D, 2006, INVEST OPHTH VIS SCI, V47, P1161, DOI 10.1167/iovs.05-0783; Barthelmes D, 2008, INVEST OPHTH VIS SCI, V49, P3529, DOI 10.1167/iovs.07-1320; Barthelmes D, 2008, INVEST OPHTH VIS SCI, V49, P2156, DOI 10.1167/iovs.07-0478; Baumann B, 2012, BIOMED OPT EXPRESS, V3, P1670, DOI 10.1364/BOE.3.001670; BOULTON M, 1990, VISION RES, V30, P1291, DOI 10.1016/0042-6989(90)90003-4; Bruno L, 2011, GUIDE INTERPRETING S, P8; Chen XJ, 2013, INVEST OPHTH VIS SCI, V54, P6846, DOI 10.1167/iovs.13-12062; Cheung CY, 2011, INVEST OPHTH VIS SCI, V52, P9629, DOI 10.1167/iovs.11-7481; COLEMAN DJ, 1973, ARCH OPHTHALMOL-CHIC, V90, P29; Coscas G, 2013, OPHTHALMOLOGICA, V229, P32, DOI 10.1159/000342159; CURCIO CA, 1993, INVEST OPHTH VIS SCI, V34, P3278; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; Demirkaya N, 2013, INVEST OPHTH VIS SCI, V54, P4934, DOI 10.1167/iovs.13-11913; FEENEYBURNS L, 1984, INVEST OPHTH VIS SCI, V25, P195; Fukuchi T, 2001, GRAEF ARCH CLIN EXP, V239, P424, DOI 10.1007/s004170100296; Gao ET, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128925; GAO H, 1992, INVEST OPHTH VIS SCI, V33, P1; Geitzenauer W, 2011, BRIT J OPHTHALMOL, V95, P171, DOI 10.1136/bjo.2010.182170; Giani A, 2011, RETINA-J RET VIT DIS, V31, P942, DOI 10.1097/IAE.0b013e31820a68cc; Hoang QV, 2002, VISUAL NEUROSCI, V19, P395, DOI 10.1017/S0952523802194028; Horu T, 2012, OPHTHALMOLOGY, V119, P1047, DOI 10.1016/j.ophtha.2011.10.030; Hoye VJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P1287; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; JONAS JB, 1990, INVEST OPHTH VIS SCI, V31, P736; JONAS JB, 1992, INVEST OPHTH VIS SCI, V33, P2012; Kanamori A, 2003, AM J OPHTHALMOL, V135, P513, DOI 10.1016/S0002-9394(02)02003-2; Kennedy CJ, 1995, EYE, V9, P763, DOI 10.1038/eye.1995.192; Kerrigan-Baumrind LA, 2000, INVEST OPHTH VIS SCI, V41, P741; Kozak I, 2007, OPHTHALMOLOGY, V114, P537, DOI 10.1016/j.ophtha.2006.06.054; Le PV, 2013, INVEST OPHTH VIS SCI, V54, P4287, DOI 10.1167/iovs.12-11388; Litts K, 2011, ARVO C MAY 2 FORT LA; Lujan BJ, 2011, INVEST OPHTH VIS SCI, V52, P1486, DOI 10.1167/iovs.10-5946; MATSUMOTO C, 1994, CALCIFIED TISSUE INT, V55, P324, DOI 10.1007/BF00299308; Neudorfer M, 2012, INVEST OPHTH VIS SCI, V53, P3104, DOI 10.1167/iovs.11-8700; Nouri-Mahdavi K, 2013, AM J OPHTHALMOL, V156, P1297, DOI 10.1016/j.ajo.2013.08.001; Ooto S, 2011, INVEST OPHTH VIS SCI, V52, P8769, DOI 10.1167/iovs.11-8388; Ooto S, 2010, INVEST OPHTH VIS SCI, V51, P465, DOI 10.1167/iovs.09-4047; Otani T, 2011, RETINA-J RET VIT DIS, V31, P497, DOI 10.1097/IAE.0b013e3181ed8dae; PandaJonas S, 1995, OPHTHALMOLOGY, V102, P1853, DOI 10.1016/S0161-6420(95)30784-1; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; Polito A, 2002, AM J OPHTHALMOL, V134, P240, DOI 10.1016/S0002-9394(02)01528-3; Pons ME, 2000, ARCH OPHTHALMOL-CHIC, V118, P1044, DOI 10.1001/archopht.118.8.1044; REPKA MX, 1989, OPHTHALMOLOGY, V96, P26; Schmitt O, 2004, BRAIN RES PROTOC, V12, P157, DOI 10.1016/j.brainresprot.2003.10.003; SCHUMAN JS, 2004, OPTICAL COHERENCE TO, P21; Shi F, 2015, IEEE T MED IMAGING, V34, P441, DOI 10.1109/TMI.2014.2359980; Spaide RF, 2011, RETINA-J RET VIT DIS, V31, P1609, DOI 10.1097/IAE.0b013e3182247535; Staurenghi G, 2014, OPHTHALMOLOGY, V121, P1572, DOI 10.1016/j.ophtha.2014.02.023; Sung KR, 2011, INVEST OPHTH VIS SCI, V52, P2634, DOI 10.1167/iovs.10-6246; Tappeiner C, 2008, INVEST OPHTH VIS SCI, V49, P1609, DOI 10.1167/iovs.07-1264; van der Schoot J, 2012, INVEST OPHTH VIS SCI, V53, P2424, DOI 10.1167/iovs.11-8436; Zhang QX, 2013, SCI REP-UK, V3, DOI 10.1038/srep02644	58	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148183	10.1371/journal.pone.0148183	http://dx.doi.org/10.1371/journal.pone.0148183			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863010	gold, Green Submitted, Green Published			2022-12-27	WOS:000370046600045
J	Choi, A; Fusch, G; Rochow, N; Fusch, C				Choi, Arum; Fusch, Gerhard; Rochow, Niels; Fusch, Christoph			Target Fortification of Breast Milk: Predicting the Final Osmolality of the Feeds	PLOS ONE			English	Article							PRETERM INFANTS; PROTEIN; OSMOLARITY; NUTRITION	For preterm infants, it is common practice to add human milk fortifiers to native breast milk to enhance protein and calorie supply because the growth rates and nutritional requirements of preterm infants are considerably higher than those of term infants. However, macronutrient intake may still be inadequate because the composition of native breast milk has individual inter-and intra-sample variation. Target fortification (TFO) of breast milk is a new nutritional regime aiming to reduce such variations by individually measuring and adding deficient macronutrients. Added TFO components contribute to the final osmolality of milk feeds. It is important to predict the final osmolality of TFO breast milk to ensure current osmolality recommendations are followed to minimize feeding intolerance and necrotizing enterocolitis. This study aims to develop and validate equations to predict the osmolality of TFO milk batches. To establish prediction models, the osmolalities of either native or supplemented breast milk with known amounts of fat, protein, and carbohydrates were analyzed. To validate prediction models, the osmolalities of each macronutrient and combinations of macronutrients were measured in an independent sample set. Additionally, osmolality was measured in TFO milk samples obtained from a previous clinical study and compared with predicted osmolality using the prediction equations. Following the addition of 1 g of carbohydrates (glucose polymer), 1 g of hydrolyzed protein, or 1 g of whey protein per 100 mL breast milk, the average increase in osmolality was 20, 38, and 4 mOsm/kg respectively. Adding fat decreased osmolality only marginally due to dilution effect. Measured and predicted osmolality of combinations of macronutrients as well as single macronutrient (R-2 = 0.93) were highly correlated. Using clinical data (n = 696), the average difference between the measured and predicted osmolality was 3 +/- 11 mOsm/kg and was not statistically significant. In conclusion, the prediction model can be utilized to estimate osmolality values after fortification.	[Choi, Arum; Fusch, Gerhard; Rochow, Niels; Fusch, Christoph] McMaster Univ, Dept Pediat, Div Neonatol, Hamilton, ON, Canada	McMaster University	Fusch, C (corresponding author), McMaster Univ, Dept Pediat, Div Neonatol, Hamilton, ON, Canada.	fusch@mcmaster.ca	Choi, Arum/R-7185-2019; Fusch, Gerhard/ABG-1096-2021; Rochow, Niels/A-9785-2011	Fusch, Gerhard/0000-0003-4026-3211; Rochow, Niels/0000-0001-7990-3904	Canadian Institute of Health Research (CIHR) [MOP-125883]	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Christoph Fusch holds the Hamilton Health Sciences Foundation - Jack Sinclair Chair in Neonatology, Faculty of Health Sciences at McMaster University, Hamilton, Ontario, Canada. The study was funded by Canadian Institute of Health Research (CIHR) #MOP-125883.	Agostoni C, 2010, J PEDIATR GASTR NUTR, V50, P85, DOI 10.1097/MPG.0b013e3181adaee0; [Anonymous], 1976, PEDIATRICS, V57, P278; Arslanoglu S, 2006, J PERINATOL, V26, P614, DOI 10.1038/sj.jp.7211571; BOOK LS, 1975, J PEDIATR-US, V87, P602, DOI 10.1016/S0022-3476(75)80835-3; Chang WK, 2011, JPEN-PARENTER ENTER, V35, P412, DOI 10.1177/0148607110383864; Chauhan M, 2008, ARCH DIS CHILD-FETAL, V93, pF162, DOI 10.1136/adc.2007.115824; CHICA-Canada Paediatrics Interest Group, CHICA CAN POS STAT H; De Castro-Morel M, 2002, MILCHWISSENSCHAFT, V57, P367; De Curtis M, 1999, ARCH DIS CHILD-FETAL, V81, pF141, DOI 10.1136/fn.81.2.F141; Fenton TR, 2002, J PEDIATR GASTR NUTR, V35, P298, DOI 10.1097/00005176-200209000-00011; Fusch G, 2015, CLIN NUTR, V34, P465, DOI 10.1016/j.clnu.2014.05.005; Jocson MAL, 1997, PEDIATRICS, V100, P240, DOI 10.1542/peds.100.2.240; KOO WWK, 1991, JPEN-PARENTER ENTER, V15, P144, DOI 10.1177/0148607191015002144; Kreissl A, 2013, J PEDIATR GASTR NUTR, V57, P432, DOI 10.1097/MPG.0b013e3182a208c7; MAUER AM, 1985, PEDIATRICS, V75, P976; Pearson F, 2013, ARCH DIS CHILD-FETAL, V98, pF166, DOI 10.1136/adc.2011.300492; Polberger S, 2009, NESTLE NUTR WORKS SE, V63, P195, DOI 10.1159/000209982; Radmacher PG, 2012, J PERINATOL, V32, P227, DOI 10.1038/jp.2011.83; Rochow N, 2015, NUTRIENTS, V7, P2297, DOI 10.3390/nu7042297; Rochow N, 2013, J PEDIATR-US, V163, P1001, DOI 10.1016/j.jpeds.2013.04.052; Silkand V, 2011, J DAIRY SCI, V94, P6194, DOI [10.3168/jds.2011-4477, DOI 10.3168/JDS.2011-4477]; Slutzah M, 2010, J PEDIATR-US, V156, P26, DOI 10.1016/j.jpeds.2009.07.023; Srinivasan L, 2004, ARCH DIS CHILD-FETAL, V89, pF514, DOI 10.1136/adc.2003.037192	23	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148941	10.1371/journal.pone.0148941	http://dx.doi.org/10.1371/journal.pone.0148941			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863130	Green Published, Green Submitted, gold			2022-12-27	WOS:000370046600127
J	Manzanilla, OV; de Miranda, GS; Giupponi, APD				Manzanilla, Osvaldo Villarreal; de Miranda, Gustavo Silva; de Leao Giupponi, Alessandro Ponce			New Proposal of Setal Homology in Schizomida and Revision of Surazomus (Hubbardiidae) from Ecuador	PLOS ONE			English	Article							ARACHNIDA; PHYLOGENY; CHELICERAE; MORPHOLOGY; TAXONOMY; WORLD	The homology of three somatic systems in Schizomida is studied yielding the following results: (1) proposal of homology and chaetotaxy of abdominal setae in Surazomus; (2) revision of the cheliceral chaetotaxy in Schizomida, with suggestion of new homology scheme between Hubbardiidae and Protoschizomidae, description of a new group of setae in Hubbardiinae (G7), and division of setae group 5 in two subgroups, G5A and G5B; (3) proposal of segmental homology between trimerous and tetramerous female flagellum in Hubbardiinae with association of segment III of tri-segmented species to segments III + IV of tetra-egmented species. Considerations about the dorsal microsetae on the male flagellum are made. The genus Surazomus in Ecuador is revised. The sympatric species Surazomus palenque sp. nov. and S. kitu sp. nov. (Ecuador, Pichincha) are described and illustrated. The female of S. cuenca (Rowland and Reddell, 1979) is described, with two new distributional records for the species. Surazomus cumbalensis (Kraus, 1957) is recorded for the first time from Ecuador (Pichincha).	[Manzanilla, Osvaldo Villarreal; de Miranda, Gustavo Silva; de Leao Giupponi, Alessandro Ponce] Univ Fed Rio de Janeiro, Museu Nacl, Dept Invertebrados, Posgrad Zool, Rio De Janeiro, RJ, Brazil; [de Miranda, Gustavo Silva] Univ Copenhagen, Zool Museum, Ctr Macroecol Evolut & Climate, Nat Hist Museum Denmark, DK-2100 Copenhagen, Denmark; [de Leao Giupponi, Alessandro Ponce] Fiocruz MS, LIRN, Lab Referencia Nacl Vetores Riquetsioses, BR-21045900 Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; University of Copenhagen; Fundacao Oswaldo Cruz	Giupponi, APD (corresponding author), Univ Fed Rio de Janeiro, Museu Nacl, Dept Invertebrados, Posgrad Zool, Rio De Janeiro, RJ, Brazil.; Giupponi, APD (corresponding author), Fiocruz MS, LIRN, Lab Referencia Nacl Vetores Riquetsioses, BR-21045900 Rio De Janeiro, RJ, Brazil.	agiupponi@gmail.com	de Miranda, Gustavo Silva/C-1252-2013; VIllarreal, Osvaldo/AAY-9555-2020; Giupponi, Alessandro PL/M-5692-2013	de Miranda, Gustavo Silva/0000-0002-2895-9331; VIllarreal, Osvaldo/0000-0001-5355-3723; 	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [5900115, 8922-13-6]; PETROBRAS	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PETROBRAS(Fundacao de Amparo a Pesquisa do Amapa (FAPEAP)Petrobras)	This study was financially supported by grants from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (www.capes.gov.br/) to OVM (process number 5900115 CAPES/PECPG) and to GSM (process number 8922-13-6 CAPES/Science Without Borders). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Work of MNRJ Ecuador Expeditions has been facilitated by the steady support of Alvaro Barragan, Mauricio Vega and Emilia Moreno (QCAZ). We are indebted to Adriano B. Kury and Amazonas Chagas Jr. for their help during fieldwork. We also thank Adriano B. Kury for the discussion on homology, and suggestions in the text. Depositing the primary types in Ecuador was part of our agreement with Ecuadorian authorities. We are also thankful to Jairo Moreno-Gonzalez by the relevant information exchanged to the development of the work, Ricardo Pinto da Rocha for sending a specimen of Wuayuuzomus for analysis, and Lorenzo Prendini for access to the collection of the AMNH, and to the anonymous referees for many important improvements to the text. The SEM micrographs were taken in the SEM Lab of Marine Diversity of the MNRJ (financed by PETROBRAS), with the kind assistance of Amanda Veiga. Personnel at the SEM Platform Rudolf Barth (IOC-FIOCRUZ)-Roger Magno Macedo Silva, Wendell Girard Dias, Romulo Custodio dos Santos and Taissa Oliveira-also provided SEM facilities.	ARMAS L. F. DE, 2009, B SOC ENTOMOLOGICA A, V45, P447; Bonaldo A, 2007, REV BRAS ZOOL, V24, P323, DOI 10.1590/S0101-81752007000200009; Borner C., 1904, Zoologica, VHeft 42I and 42II, P1; CAMILO G R, 1988, Caribbean Journal of Science, V24, P52; COKENDOLPHER J C, 1988, Insecta Mundi, V2, P90; Cokendolpher James C., 1992, Texas Memorial Museum Speleological Monograph, V3, P31; Cokendolpher JC, 2000, AMAZONIANA, V16, P187; de Armas L.F., 2010, B SOC ENTOMOLOGICA A, V46, P9; de Armas L.F., 2010, B SOC ENTOMOL ARAGON, V46, P203; Armas Luis F. de, 2010, Pap. Avulsos Zool., V50, P579; Armas Luis F. de, 2009, Pap. Avulsos Zool., V49, P361; Delgado-Santa L, 2012, B SEA, V50, P183; FIRSTMAN B, 1973, Journal of Arachnology, V1, P1; Francke OF, 2009, TEXAS MEMORIAL MUSEU, V5, P33; Garcia LF, 2012, TURK ZOOL DERG, V35, P1; Grasshoff M., 1978, Symposia of the Zoological Society of London, P273; Hammen LVD, 1985, ZOOL VERH, V220, P1; Hansen HJ, 1905, ARK ZOOL, V2, P1; HARVEY M S, 1992, Invertebrate Taxonomy, V6, P77, DOI 10.1071/IT9920077; Harvey MS, 2008, INVERTEBR SYST, V22, P167, DOI 10.1071/IS07026; Harvey Mark S., 2001, Records of the Western Australian Museum Supplement, V64, P171; Haupt Joachim, 2009, Arthropoda Selecta, V18, P17; Inkscape, 2015, DRAW FREEL; Kraus O., 1957, Senckenbergiana Biologica, V38, P245; LAWRENCE RF, 1969, T ROY SOC S AFR, V38, P123, DOI 10.1080/00359196909519080; Monjaraz-Ruedas R, 2015, ZOOTAXA, V3915, P451, DOI 10.11646/zootaxa.3915.4.1; Monjaraz-Ruedas R, 2013, J ARACHNOL, V41, P420, DOI 10.1636/Ha13-17.1; Moreno-Gonzalez JA, 2014, ZOOTAXA, V3852, P227, DOI 10.11646/zootaxa.3852.2.4; Moreno-Gonzalez Jairo A., 2012, Zootaxa, V3560, P61; Morphbank, 2014, BIOL IM; PintodaRocha R, 1996, J ARACHNOL, V24, P265; Reddell J.R., 1984, Bulletin of the British Arachnological Society, V6, P172; Reddell James R., 1995, Texas Memorial Museum Speleological Monograph, V4, P1; Remy P., 1961, B MUSEUM NATL HIS 2E, V33, P500; Remy P. A., 1961, B MUS NATL HIST NAT, V33, P406; Rowland J.M., 1971, Bulletin Ass mex Cave Stud, VNo. 4,1971, P13; ROWLAND JM, 1978, J ARACHNOL, V6, P161; ROWLAND JM, 1980, J ARACHNOL, V8, P1; ROWLAND JM, 1972, J NEW YORK ENTOMOL S, V80, P195; ROWLAND JM, 1979, J ARACHNOL, V7, P89; Rowland JM, 1975, OCCASIONAL PAPERS MU, V31, P1; Santoro AL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065813, 10.1371/journal.pone.0066932]; Santos AJ, 2009, J ARACHNOL, V37, P39, DOI 10.1636/H07-80.1; SAVORY TH, 1971, EVOLUTION ARACHNIDA; Shultz JW, 2007, ZOOL J LINN SOC-LOND, V150, P221, DOI 10.1111/j.1096-3642.2007.00284.x; SHULTZ JW, 1990, CLADISTICS, V6, P1, DOI 10.1111/j.1096-0031.1990.tb00523.x; SNODGRASS R. E., 1938, SMITHSONIAN MISC COLL, V97, P1; Teruel Rolando, 2007, Boletin de la SEA, V40, P39; van der Hammen L., 1986, Zoologische Mededelingen (Leiden), V60, P217; Villarreal O, 2014, ZOOTAXA, V3765, P371, DOI 10.11646/zootaxa.3765.4.5; Villarreal OM, 2008, ZOOTAXA, V1860, P60; Viquez C, 2011, B SEA, V48, P77; WEYGOLDT P, 1979, Z ZOOL SYST EVOL, V17, P85; Wheeler WC, 1998, CLADISTICS, V14, P173, DOI 10.1111/j.1096-0031.1998.tb00331.x; Yoshikura M.;., 1975, Kumamoto J Sci (Biol), V12, P71	55	19	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0147012	10.1371/journal.pone.0147012	http://dx.doi.org/10.1371/journal.pone.0147012			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863017	Green Submitted, Green Published, gold			2022-12-27	WOS:000370046600018
J	Momeni, N; Rabbat, M				Momeni, Naghmeh; Rabbat, Michael			Qualities and Inequalities in Online Social Networks through the Lens of the Generalized Friendship Paradox	PLOS ONE			English	Article								The friendship paradox is the phenomenon that in social networks, people on average have fewer friends than their friends do. The generalized friendship paradox is an extension to attributes other than the number of friends. The friendship paradox and its generalized version have gathered recent attention due to the information they provide about network structure and local inequalities. In this paper, we propose several measures of nodal qualities which capture different aspects of their activities and influence in online social networks. Using these measures we analyse the prevalence of the generalized friendship paradox over Twitter and we report high levels of prevalence (up to over 90% of nodes). We contend that this prevalence of the friendship paradox and its generalized version arise because of the hierarchical nature of the connections in the network. This hierarchy is nested as opposed to being star-like. We conclude that these paradoxes are collective phenomena not created merely by a minority of well-connected or high-attribute nodes. Moreover, our results show that a large fraction of individuals can experience the generalized friendship paradox even in the absence of a significant correlation between degrees and attributes.	[Momeni, Naghmeh; Rabbat, Michael] McGill Univ, Dept Elect & Comp Engn, 3480 Univ St, Montreal, PQ H3A 0E9, Canada	McGill University	Momeni, N (corresponding author), McGill Univ, Dept Elect & Comp Engn, 3480 Univ St, Montreal, PQ H3A 0E9, Canada.	naghmeh.momenitaramsari@mail.mcgill.ca	Momeni, Naghmeh/F-9858-2015	Momeni, Naghmeh/0000-0003-2911-1911	Natural Sciences and Engineering Research Council of Canada [RGPAS 429296-2012]; McGill Engineering Doctoral Award	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); McGill Engineering Doctoral Award	This work was supported by the Natural Sciences and Engineering Research Council of Canada grant RGPAS 429296-2012 (http://www.nserc-crsng.gc.ca/index_eng.asp) and the McGill Engineering Doctoral Award (https://www.mcgill.ca/engineering/current-students/graduate-students/funding/meda). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Budak C., 2011, PROC 20 INT C WORLD, P665, DOI 10.1145/1963405.1963499; Chou HTG, 2012, CYBERPSYCH BEH SOC N, V15, P117, DOI 10.1089/cyber.2011.0324; Christakis NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012948; Droz M, 2009, EUR PHYS J B, V71, P579, DOI 10.1140/epjb/e2009-00160-1; Eom YH, 2014, SCI REP-UK, V4, DOI 10.1038/srep04603; FELD SL, 1991, AM J SOCIOL, V96, P1464, DOI 10.1086/229693; Fotouhi B, 2014, COMPLEX NETWORKS DYN; Fotouhi B., 2014, P INT C SOC INF, P339; Garcia-Herranz M, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0092413, 10.1371/journal.pone.0086067]; Han B., 2012, P 13 ACM INT S MOB A, P5, DOI DOI 10.1145/2248371.2248376; Hill S, 2006, STAT SCI, V21, P256, DOI 10.1214/088342306000000222; Hodas N., 2012, SOCIALCOM; Hodas NO., 2013, P 7 INT AAAI C WEBL, V13, P8; Jo HH, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.022809; Kempe D., 2003, P 9 ACM SIGKDD INT C, V11, P105, DOI DOI 10.1145/956750.956769; Kimura M, 2010, DATA MIN KNOWL DISC, V20, P70, DOI 10.1007/s10618-009-0150-5; Kooti F, 2014, P 8 INT AAAI C WEBL, P266; Kwak H., 2010, PROC 19 INT C WORLD, P591, DOI 10.1145/1772690.1772751; Lattanzi S, 2015, POWER RANDOM NEIGHBO; Momeni N, 2015, STUD COMPUT INTELL, V597, P45, DOI 10.1007/978-3-319-16112-9_5; Nakano R., 2007, P 22 AAAI C ART INT, P1371, DOI DOI 10.1073/PNAS.012582999; Nguyen NP, 2012, PROCEEDINGS OF THE 3RD ANNUAL ACM WEB SCIENCE CONFERENCE, 2012, P213; Perisic A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000280; Song X., 2007, P 16 ACM C C INF KNO, P971, DOI DOI 10.1145/1321440.1321588; Szolnoki A, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/30007; Ugander J., 2011, ARXIV11114503; Yang J., 2011, P 4 ACM INT C WEB SE, P177	28	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0143633	10.1371/journal.pone.0143633	http://dx.doi.org/10.1371/journal.pone.0143633			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863225	Green Published, gold, Green Submitted			2022-12-27	WOS:000370046600002
J	Muller, CA; Riemer, S; Viranyi, Z; Huber, L; Range, F				Mueller, Corsin A.; Riemer, Stefanie; Viranyi, Zsofia; Huber, Ludwig; Range, Friederike			Inhibitory Control, but Not Prolonged Object-Related Experience Appears to Affect Physical Problem-Solving Performance of Pet Dogs	PLOS ONE			English	Article							CANIS-LUPUS-FAMILIARIS; CORVIDS CORVUS-CORAX; SELF-CONTROL; TOOL-USE; PAN-TROGLODYTES; GORILLA-GORILLA; BEHAVIORAL FLEXIBILITY; PONGO-PYGMAEUS; COGNITION; APES	Human infants develop an understanding of their physical environment through playful interactions with objects. Similar processes may influence also the performance of non-human animals in physical problem-solving tasks, but to date there is little empirical data to evaluate this hypothesis. In addition or alternatively to prior experiences, inhibitory control has been suggested as a factor underlying the considerable individual differences in performance reported for many species. Here we report a study in which we manipulated the extent of object-related experience for a cohort of dogs (Canis familiaris) of the breed Border Collie over a period of 18 months, and assessed their level of inhibitory control, prior to testing them in a series of four physical problem-solving tasks. We found no evidence that differences in object-related experience explain variability in performance in these tasks. It thus appears that dogs do not transfer knowledge about physical rules from one physical problem-solving task to another, but rather approach each task as a novel problem. Our results, however, suggest that individual performance in these tasks is influenced in a complex way by the subject's level of inhibitory control. Depending on the task, inhibitory control had a positive or a negative effect on performance and different aspects of inhibitory control turned out to be the best predictors of individual performance in the different tasks. Therefore, studying the interplay between inhibitory control and problem-solving performance will make an important contribution to our understanding of individual and species differences in physical problem-solving performance.	[Mueller, Corsin A.; Riemer, Stefanie; Viranyi, Zsofia; Huber, Ludwig; Range, Friederike] Med Univ Vienna, Univ Vet Med Vienna, Messerli Res Inst, Vienna, Austria; [Mueller, Corsin A.; Riemer, Stefanie; Viranyi, Zsofia; Huber, Ludwig; Range, Friederike] Univ Vienna, Vienna, Austria; [Mueller, Corsin A.; Riemer, Stefanie] Univ Vienna, Dept Cognit Biol, Vienna, Austria; [Riemer, Stefanie] Lincoln Univ, Sch Life Sci, Anim Behav Cognit & Welf Res Grp, Lincoln, England	Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna; University of Vienna; University of Lincoln	Muller, CA (corresponding author), Med Univ Vienna, Univ Vet Med Vienna, Messerli Res Inst, Vienna, Austria.; Muller, CA (corresponding author), Univ Vienna, Vienna, Austria.; Muller, CA (corresponding author), Univ Vienna, Dept Cognit Biol, Vienna, Austria.	corsin.mueller@vetmeduni.ac.at		Huber, Ludwig/0000-0002-0217-136X; Riemer, Stefanie/0000-0001-8008-5291; Range, Friederike/0000-0003-3127-5536	Austrian Science Fund [P21418]; DK CogCom Program (FWF) [W1234]; Vienna Science and Technology Fund [CS11-005, CS11-026]; Clever Dog Lab from Royal Canin	Austrian Science Fund(Austrian Science Fund (FWF)); DK CogCom Program (FWF); Vienna Science and Technology Fund; Clever Dog Lab from Royal Canin	This work was funded by the Austrian Science Fund (http://www.fwf.ac.at/) grant P21418 to LH and FR. In addition, SR received support from the DK CogCom Program (FWF Doctoral Programs W1234), LH and ZV from the Vienna Science and Technology Fund (http://www.wwtf.at/) grants CS11-005 and CS11-026, and the Clever Dog Lab from Royal Canin and a private sponsor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiach-Serrano A, 2012, J COMP PSYCHOL, V126, P355, DOI 10.1037/a0028050; Albiach-Serrano A, 2012, APPL ANIM BEHAV SCI, V141, P25, DOI 10.1016/j.applanim.2012.07.005; Amici F, 2008, CURR BIOL, V18, P1415, DOI 10.1016/j.cub.2008.08.020; [Anonymous], 2014, R LANG ENV STAT COMP; Auersperg AMI, 2015, J COMP PSYCHOL, V129, P62, DOI 10.1037/a0038314; Auersperg AMI, 2011, BIOL LETTERS, V7, P825, DOI 10.1098/rsbl.2011.0388; Auersperg AMI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020231; Auersperg AMI, 2009, BIOL LETTERS, V5, P455, DOI 10.1098/rsbl.2009.0114; Baillargeon R., 2002, BLACKWELL HDB CHILDH, P47, DOI DOI 10.1002/9780470996652.CH3; Bania AE, 2009, ANIM COGN, V12, P85, DOI 10.1007/s10071-008-0173-0; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Baumeister RF, 1998, J PERS SOC PSYCHOL, V74, P1252, DOI 10.1037/0022-3514.74.5.1252; Bensky MK, 2013, ADV STUD BEHAV, V45, P209, DOI 10.1016/B978-0-12-407186-5.00005-7; Bezdjian S, 2011, CLIN PSYCHOL REV, V31, P1209, DOI 10.1016/j.cpr.2011.07.005; Boesch C, 2012, WILD CULTURES: A COMPARISON BETWEEN CHIMPANZEE AND HUMAN CULTURES, P1, DOI 10.1017/CBO9781139178532; Bonawitz EB, 2012, COGNITIVE PSYCHOL, V64, P215, DOI 10.1016/j.cogpsych.2011.12.002; Brauer J, 2006, J COMP PSYCHOL, V120, P38, DOI 10.1037/0735-7036.120.1.38; Bray EE, 2014, ANIM COGN, V17, P15, DOI 10.1007/s10071-013-0633-z; BRENT L, 1995, PRIMATES, V36, P265, DOI 10.1007/BF02381352; BROWN AL, 1990, COGNITIVE SCI, V14, P107, DOI 10.1016/0364-0213(90)90028-U; Byrne R. W., 1997, MACHIAVELLIAN INTELL, P289, DOI DOI 10.1017/CBO9780511525636.012; Cacchione T, 2009, J COMP PSYCHOL, V123, P168, DOI 10.1037/a0013580; Carlson SM, 2001, CHILD DEV, V72, P1032, DOI 10.1111/1467-8624.00333; Cunningham C, 2011, ANIM COGN, V14, P599, DOI 10.1007/s10071-011-0380-y; DIAMOND A, 1990, ANN NY ACAD SCI, V608, P637, DOI 10.1111/j.1749-6632.1990.tb48913.x; Dowsett SM, 2000, DEV PSYCHOBIOL, V36, P161, DOI 10.1002/(SICI)1098-2302(200003)36:2<161::AID-DEV7>3.0.CO;2-0; Duckworth AL, 2005, PSYCHOL SCI, V16, P939, DOI 10.1111/j.1467-9280.2005.01641.x; Duckworth AL, 2010, APPETITE, V54, P304, DOI 10.1016/j.appet.2009.11.016; Fiset S, 2013, J COMP PSYCHOL, V127, P115, DOI 10.1037/a0030595; FRANK H, 1982, ANIM BEHAV, V30, P95, DOI 10.1016/S0003-3472(82)80241-8; FRANK H, 1980, Z TIERPSYCHOL, V53, P389; Fratkin JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054907; Gagne JR, 2010, BEHAV GENET, V40, P327, DOI 10.1007/s10519-009-9316-6; Gajdon G. K., 2014, Open Journal of Animal Sciences, V4, P51, DOI 10.4236/ojas.2014.42008; GIBSON EJ, 1988, ANNU REV PSYCHOL, V39, P1, DOI 10.1146/annurev.ps.39.020188.000245; Graham KL, 2010, Q REV BIOL, V85, P393, DOI 10.1086/656903; Hanus D, 2011, ANIM COGN, V14, P871, DOI 10.1007/s10071-011-0421-6; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; Hauser MD, 2002, ANIM BEHAV, V64, P387, DOI 10.1006/anbe.2002.3066; Herrmann E, 2008, J COMP PSYCHOL, V122, P220, DOI 10.1037/0735-7036.122.2.220; Herrmann E, 2012, PHILOS T R SOC B, V367, P2753, DOI 10.1098/rstb.2012.0191; Huber L, 2006, ANIM COGN, V9, P295, DOI 10.1007/s10071-006-0033-8; Irie-Sugimoto N, 2008, ANIM COGN, V11, P359, DOI 10.1007/s10071-007-0126-z; Johnson SP, 2010, COGNITIVE SCI, V34, P1158, DOI 10.1111/j.1551-6709.2010.01127.x; Jones AC, 2005, APPL ANIM BEHAV SCI, V95, P1, DOI 10.1016/j.applanim.2005.04.008; Kundey SMA, 2010, ANIM COGN, V13, P497, DOI 10.1007/s10071-009-0300-6; Legare CH, 2012, CHILD DEV, V83, P173, DOI 10.1111/j.1467-8624.2011.01691.x; Liedtke J, 2011, ANIM COGN, V14, P143, DOI 10.1007/s10071-010-0347-4; LIMONGELLI L, 1995, J COMP PSYCHOL, V109, P18, DOI 10.1037/0735-7036.109.1.18; Lockman JJ, 2000, CHILD DEV, V71, P137, DOI 10.1111/1467-8624.00127; MacLean EL, 2014, P NATL ACAD SCI USA, V111, pE2140, DOI 10.1073/pnas.1323533111; MacLean EL, 2012, ANIM COGN, V15, P223, DOI 10.1007/s10071-011-0448-8; Manrique HM, 2011, ANIM COGN, V14, P213, DOI 10.1007/s10071-010-0355-4; Marshall-Pescini S, 2011, ANIM COGN, V14, P137, DOI 10.1007/s10071-010-0340-y; Marshall-Pescini S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118469; Marshall-Pescini S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035437; Martin-Ordas G, 2012, ANIM COGN, V15, P1007, DOI 10.1007/s10071-012-0504-z; Miklosi A., 2007, DOG BEHAV EVOLUTION; Miller HC, 2010, PSYCHOL SCI, V21, P534, DOI 10.1177/0956797610364968; MISCHEL W, 1988, J PERS SOC PSYCHOL, V54, P687, DOI 10.1037/0022-3514.54.4.687; MISCHEL W, 1989, SCIENCE, V244, P933, DOI 10.1126/science.2658056; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Montgomery SH, 2014, ANIM BEHAV, V90, P281, DOI 10.1016/j.anbehav.2014.02.004; Muller CA, 2014, ANIM COGN, V17, P1071, DOI 10.1007/s10071-014-0739-y; Muller CA, 2014, ANIM COGN, V17, P821, DOI 10.1007/s10071-013-0709-9; Muller CA, 2011, BIOL LETTERS, V7, P689, DOI 10.1098/rsbl.2011.0287; Mulcahy NJ, 2006, ANIM COGN, V9, P193, DOI 10.1007/s10071-006-0019-6; Muraven M, 2000, PSYCHOL BULL, V126, P247, DOI 10.1037/0033-2909.126.2.247; Oaten M, 2006, BRIT J HEALTH PSYCH, V11, P717, DOI 10.1348/135910706X96481; Osthaus B, 2005, ANIM COGN, V8, P37, DOI 10.1007/s10071-004-0230-2; PARKER ST, 1977, J HUM EVOL, V6, P623, DOI 10.1016/S0047-2484(77)80135-8; Range F, 2012, ANIM COGN, V15, P597, DOI 10.1007/s10071-012-0488-8; Range F, 2011, ANIM COGN, V14, P575, DOI 10.1007/s10071-011-0394-5; Reaux JE, 2000, FOLK PHYS APES CHIMP, P108; Riemer S, 2014, ANIM COGN, V17, P815, DOI 10.1007/s10071-013-0701-4; Riemer S, 2014, J COMP PSYCHOL, V128, P31, DOI 10.1037/a0033202; Santos LR, 2006, INFANCY, V9, P147, DOI 10.1207/s15327078in0902_4; Santos LR, 2004, DEVELOPMENTAL SCI, V7, P167, DOI 10.1111/j.1467-7687.2004.00335.x; Seed AM, 2006, CURR BIOL, V16, P697, DOI 10.1016/j.cub.2006.02.066; Seed A, 2009, ETHOLOGY, V115, P401, DOI 10.1111/j.1439-0310.2009.01644.x; Seed AM, 2009, J EXP PSYCHOL ANIM B, V35, P23, DOI 10.1037/a0012925; Silva FJ, 2005, LEARN BEHAV, V33, P47; Spelke ES, 2000, AM PSYCHOL, V55, P1233, DOI 10.1037/0003-066X.55.11.1233; Stahl AE, 2015, SCIENCE, V348, P91, DOI 10.1126/science.aaa3799; Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x; Taylor AH, 2009, P R SOC B, V276, P247, DOI 10.1098/rspb.2008.1107; Tebbich S, 2007, ANIM COGN, V10, P225, DOI 10.1007/s10071-006-0061-4; Teschke I, 2011, ANIM COGN, V14, P555, DOI 10.1007/s10071-011-0390-9; Thompson WR, 1954, CAN J PSYCHOLOGY, V8, P17, DOI 10.1037/h0083595; Tsukayama E, 2013, DEVELOPMENTAL SCI, V16, P879, DOI 10.1111/desc.12067; Tsukayama E, 2012, EUR J PERSONALITY, V26, P318, DOI 10.1002/per.841; Tsukayama E, 2010, JUDGM DECIS MAK, V5, P72; Udell MAR, 2010, BIOL REV, V85, P327, DOI 10.1111/j.1469-185X.2009.00104.x; VISALBERGHI E, 1994, J COMP PSYCHOL, V108, P15, DOI 10.1037/0735-7036.108.1.15; von Bayern AMP, 2009, CURR BIOL, V19, P1965, DOI 10.1016/j.cub.2009.10.037; Wallis LJ, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00071; Yamazaki Y, 2011, ANIM COGN, V14, P175, DOI 10.1007/s10071-010-0351-8; [No title captured]	98	29	29	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0147753	10.1371/journal.pone.0147753	http://dx.doi.org/10.1371/journal.pone.0147753			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863141	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000370046600037
J	Owocki, K; Kremer, B; Wrzosek, B; Krolikowska, A; Kazmierczak, J				Owocki, Krzysztof; Kremer, Barbara; Wrzosek, Beata; Krolikowska, Agata; Kazmierczak, Jozef			Fungal Ferromanganese Mineralisation in Cretaceous Dinosaur Bones from the Gobi Desert, Mongolia	PLOS ONE			English	Article							BIOGENIC MANGANESE OXIDES; RAMAN-SPECTROSCOPY; STRAIN KR21-2; IRON-OXIDES; MN OXIDES; MINERALS; TODOROKITE; MECHANISMS; AMBER; IDENTIFICATION	Well-preserved mycelia of fungal- or saprolegnia-like biota mineralised by ferromanganese oxides were found for the first time in long bones of Late Cretaceous dinosaurs from the Gobi Desert (Nemegt Valley, Mongolia). The mycelia formed a biofilm on the wall of the bone marrow cavity and penetrated the osteon channels of the nearby bone tissue. Optical microscopy, Raman, SEM/EDS, SEM/BSE, electron microprobe and cathodoluminescence analyses revealed that the mineralisation of the mycelia proceeded in two stages. The first stage was early post-mortem mineralisation of the hyphae by Fe/Mn-oxide coatings and microconcretions. Probably this proceeded in a mildly acidic to circumneutral environment, predominantly due to heterotrophic bacteria degrading the mycelial necromass and liberating Fe and Mn sorbed by the mycelia during its lifetime. The second stage of mineralisation, which proceeded much later following the final burial of the bones in an alkaline environment, resulted from the massive precipitation of calcite and occasionally barite on the iron/manganeseoxide-coated mycelia. The ineral phases produced by fungal biofilms colonising the interiors of decaying dinosaur bones not only enhance the preservation (fossilisation) of fungal remains but can also be used as indicators of the geochemistry of the dinosaur burial sites.	[Owocki, Krzysztof; Kremer, Barbara; Kazmierczak, Jozef] Polish Acad Sci, Inst Paleobiol, Warsaw, Poland; [Wrzosek, Beata; Krolikowska, Agata] Warsaw Univ, Fac Chem, Warsaw, Poland	Polish Academy of Sciences; Institute of Paleobiology of the Polish Academy of Sciences; University of Warsaw	Owocki, K (corresponding author), Polish Acad Sci, Inst Paleobiol, Warsaw, Poland.	kowoc@twarda.pan.pl	Królikowska, Agata/D-9594-2014; Królikowska, Agata/AAH-3944-2019; Wrzosek, Beata/I-9473-2016; Owocki, Krzysztof/ABA-4558-2020; Kremer, Barbara/ABB-1201-2020	Królikowska, Agata/0000-0001-7245-2709; Królikowska, Agata/0000-0001-7245-2709; Owocki, Krzysztof/0000-0002-1270-3622; Kremer, Barbara/0000-0002-0464-1265	Polish Ministry of Science and Higher Education [N N307 24293]; European Regional Development Fund within Innovation Economy Operational Programme [POIG.02.02.00-00-025/09]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); European Regional Development Fund within Innovation Economy Operational Programme	The study was supported by the grant N N307 24293 of the Polish Ministry of Science and Higher Education for KO. Cathodoluminescence analyses were performed at the NanoFun laboratories co-financed by the European Regional Development Fund within the Innovation Economy Operational Programme POIG.02.02.00-00-025/09.	[Anonymous], 1974, OCCASIONAL PAPERS FA; [Anonymous], 1970, PALAENTOL POL; Ascaso C, 2005, MICROPALEONTOLOGY, V51, P59, DOI 10.2113/51.1.59; Bargar JR, 2009, GEOCHIM COSMOCHIM AC, V73, P889, DOI 10.1016/j.gca.2008.10.036; Beckner GJ, 2009, CARBONATE CEMENTATIO, P27; BEHRENSMEYER AK, 1982, PALEOBIOLOGY, V8, P211, DOI 10.1017/S0094837300006941; BERNARD MC, 1993, J ELECTROCHEM SOC, V140, P3065, DOI 10.1149/1.2220986; BISCHOFF WD, 1985, AM MINERAL, V70, P581; BRIGGS DEG, 1993, SCIENCE, V259, P1439, DOI 10.1126/science.259.5100.1439; BRIGGS DEG, 1994, PALAIOS, V9, P431, DOI 10.2307/3515135; Brock-Hon AL, 2012, GEODERMA, V179, P1, DOI 10.1016/j.geoderma.2012.02.012; Buciuman F, 1999, PHYS CHEM CHEM PHYS, V1, P185, DOI 10.1039/a807821a; Carpenter K, 2005, NEUES JAHRB GEOL P-M, P83; Carpenter K., 1999, J VERTEBR PALEONTOL, V19, P36; Daniel JC, 2010, PALAIOS, V25, P507, DOI 10.2110/palo.2009.p09-120r; Davis PG, 1997, INT J OSTEOARCHAEOL, V7, P388, DOI 10.1002/(SICI)1099-1212(199707/08)7:4<388::AID-OA357>3.0.CO;2-H; De Luca NG, 2000, ADV MICROB PHYSIOL, V43, P39, DOI 10.1016/S0065-2911(00)43002-X; deFaria DLA, 1997, J RAMAN SPECTROSC, V28, P873, DOI 10.1002/(SICI)1097-4555(199711)28:11<873::AID-JRS177>3.0.CO;2-B; Ehrlich HL., 2015, GEOMICROBIOL J; Feng XH, 2010, GEOCHIM COSMOCHIM AC, V74, P3232, DOI 10.1016/j.gca.2010.03.005; Froment F, 2008, J RAMAN SPECTROSC, V39, P560, DOI 10.1002/jrs.1858; Gadd GM, 2010, MICROBIOL-SGM, V156, P609, DOI 10.1099/mic.0.037143-0; GRADZINSKI R, 1977, Acta Geologica Polonica, V27, P281; Grangeon S, 2010, AM MINERAL, V95, P1608, DOI 10.2138/am.2010.3516; HACKETT CJ, 1981, MED SCI LAW, V21, P243, DOI 10.1177/002580248102100403; Hedges REM, 2002, ARCHAEOMETRY, V44, P319, DOI 10.1111/1475-4754.00064; Hof CHJ, 1997, PALAIOS, V12, P420, DOI 10.2307/3515381; Isaac S, 1997, MYCOLOGIST 2, V4, P182; Jackson FD, 2009, PALAIOS, V24, P840, DOI 10.2110/palo.2009.p09-053r; Jans MME, 2008, CURRENT DEVELOPMENTS IN BIOEROSION, P397, DOI 10.1007/978-3-540-77598-0_20; Jans MME, 2004, J ARCHAEOL SCI, V31, P87, DOI 10.1016/j.jas.2003.07.007; Jerzykiewicz T, 1998, GEOSCI CAN, V25, P15; Jerzykiewicz Tom, 2000, P279; Julien C, 2002, J RAMAN SPECTROSC, V33, P223, DOI 10.1002/jrs.838; Julien CM, 2004, SPECTROCHIM ACTA A, V60, P689, DOI 10.1016/S1386-1425(03)00279-8; Kalgutkar RM, 2000, AASP FDN CONTRIBUTIO, V39, P1; Kaye TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002808; Kim HS, 2004, J PHYS CHEM B, V108, P17019, DOI 10.1021/jp048810a; Kim HS, 2003, J AM CHEM SOC, V125, P14284, DOI 10.1021/ja0375784; Kosman DJ, 2003, MOL MICROBIOL, V47, P1185, DOI 10.1046/j.1365-2958.2003.03368.x; Kremer B, 2012, PALAEOGEOGR PALAEOCL, V358, P51, DOI 10.1016/j.palaeo.2012.07.020; Kretzschmar M., 1982, FACIES, V7, P237, DOI [10.1007/BF02537228, DOI 10.1007/BF02537228]; Krings M, 2013, PERSOONIA, V30, P1, DOI 10.3767/003158513X664819; Marshall CP, 2013, ASTROBIOLOGY, V13, P920, DOI 10.1089/ast.2013.1034; Miller AZ, 2012, CHEM GEOL, V322, P181, DOI 10.1016/j.chemgeo.2012.07.005; Mironova-Ulmane N, 2009, J ALLOY COMPD, V480, P97, DOI 10.1016/j.jallcom.2008.10.056; Miyata N, 2004, FEMS MICROBIOL ECOL, V47, P101, DOI 10.1016/S0168-6496(03)00251-4; Miyata N, 2006, GEOMICROBIOL J, V23, P63, DOI 10.1080/01490450500533809; Miyata N, 2007, J BIOSCI BIOENG, V104, P1, DOI 10.1263/jbb.104.1; Miyata N, 2006, APPL ENVIRON MICROB, V72, P6467, DOI 10.1128/AEM.00417-06; Oh SJ, 1998, HYPERFINE INTERACT, V112, P59, DOI 10.1023/A:1011076308501; Pasteris J.D., 1991, CAN MINERAL, V29, P143; Pearson K, 1920, BIOMETRIKA, V13, P25, DOI 10.1093/biomet/13.1.25; Pearson Karl, 1895, P ROY SOC LONDON, V58, P240, DOI [DOI 10.1098/RSPL.1895.0041, 10.1098/rspl.1895.0041]; Pfretzschner HU, 2006, PALAEONTOGR ABT A, V278, P135, DOI 10.1127/pala/278/2006/135; Pfretzschner HU, 2011, PALAEOGEOGR PALAEOCL, V310, P117, DOI 10.1016/j.palaeo.2011.01.026; Poinar G, 2006, J INVERTEBR PATHOL, V93, P36, DOI 10.1016/j.jip.2006.04.006; Puceat E, 2004, CHEM GEOL, V205, P83, DOI 10.1016/j.chemgeo.2003.12.014; REMY W, 1994, AM J BOT, V81, P690, DOI 10.2307/2445647; Reynard B, 1999, CHEM GEOL, V155, P233, DOI 10.1016/S0009-2541(98)00169-7; Sagemann J, 1999, GEOCHIM COSMOCHIM AC, V63, P1083, DOI 10.1016/S0016-7037(99)00087-3; Santelli CM, 2011, GEOCHIM COSMOCHIM AC, V75, P2762, DOI 10.1016/j.gca.2011.02.022; Sawlowicz Z, 2000, PRACE MINERALOGICZNE; Sharma N, 2005, MICROPALEONTOLOGY, V51, P73, DOI 10.2113/51.1.73; SHERMAN DM, 1985, AM MINERAL, V70, P1262; Shuvalov Vladimir F., 2000, P256; SIEGEL SM, 1990, WATER AIR SOIL POLL, V53, P335; Speranza M, 2010, MICROSCOPY SCI TECHN, P1135; STOOPS GJ, 1978, GEODERMA, V20, P63, DOI 10.1016/0016-7061(78)90050-2; Talyor T.N., 2015, FOSSIL FUNGI; Taylor TN, 1997, REV PALAEOBOT PALYNO, V95, P83, DOI 10.1016/S0034-6667(96)00029-2; Taylor TN, 1999, NATURE, V399, P648, DOI 10.1038/21349; Taylor TN, 2015, SYSTEMATICS EVOLUTIO, P259, DOI [10.1007/978-3-662-46011-5_10, DOI 10.1007/978-3-662-46011-5_10]; Taylor TN, 1993, FOSS REC, P9; Tebo BM, 2004, ANNU REV EARTH PL SC, V32, P287, DOI 10.1146/annurev.earth.32.101802.120213; Thomas DB, 2011, PALAEOGEOGR PALAEOCL, V310, P62, DOI 10.1016/j.palaeo.2011.06.016; THOMAS GM, 1988, J PALEONTOL, V62, P141; Trueman CN, 2002, ARCHAEOMETRY, V44, P371, DOI 10.1111/1475-4754.t01-1-00070; Trueman CNG, 2004, J ARCHAEOL SCI, V31, P721, DOI 10.1016/j.jas.2003.11.003; Turner-Walker G, 2008, PALAEOGEOGR PALAEOCL, V266, P227, DOI 10.1016/j.palaeo.2008.03.024; Verrecchia EP, 2000, MICROBIAL SEDIMENTS, P68; Villalobos M, 2006, AM MINERAL, V91, P489, DOI 10.2138/am.2006.1925; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Webb SM, 2005, AM MINERAL, V90, P1342, DOI 10.2138/am.2005.1669; Wedl, 1864, AKAD WISSENSCHAFTEN, V50, P171; Weigelt Johannes, 1989, RECENT VERTEBRATE CA, DOI DOI 10.7208/CHICAGO/9780226881683.001.0001; White SN, 2009, CHEM GEOL, V259, P240, DOI 10.1016/j.chemgeo.2008.11.008; Wilby PR, 1996, J GEOLOGICAL SCI, V153, P665, DOI [10.1144/gsjgs.153.5.0665, DOI 10.1144/GSJGS.153.5.0665]; Winkelmann G, 1994, METAL IONS IN FUNGI; Wopenka B, 2005, MAT SCI ENG C-BIO S, V25, P131, DOI 10.1016/j.msec.2005.01.008; Xiao F, 2012, INT J ELECTROCHEM SC, V7, P7440	91	14	15	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0146293	10.1371/journal.pone.0146293	http://dx.doi.org/10.1371/journal.pone.0146293			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863014	gold, Green Published, Green Submitted			2022-12-27	WOS:000370046600009
J	Pfortmueller, CA; Schwetlick, M; Mueller, T; Lehmann, B; Exadaktylos, AK				Pfortmueller, Carmen Andrea; Schwetlick, Miriam; Mueller, Thomas; Lehmann, Beat; Exadaktylos, Aristomenis Konstantinos			Adult Asylum Seekers from the Middle East Including Syria in Central Europe: What Are Their Health Care Problems?	PLOS ONE			English	Article							BODILY DISTRESS; MULTIMORBIDITY; PREVALENCE; MORBIDITY; DISEASES	Background Forced displacement related to persecution and violent conflict has reached a new peak in recent years. The primary aim of this study is to provide an initial overview of the acute and chronic health care problems of asylum seekers from the Middle East, with special emphasis on asylum seekers from Syria. Methods Our retrospective data analysis comprised adult patients presenting to our emergency department between 01.11.2011 and 30.06.2014 with the official resident status of an "asylum seeker" or "refugee" from the Middle East. Results In total, 880 patients were included in the study. Of these, 625 (71.0%) were male and 255 (29.0%) female. The median age was 34 (range 16-84). 222 (25.2%) of our patients were from Syria. The most common reason for presentation was surgical (381, 43.3%), followed by medical (321, 36.5%) and psychiatric (137, 15.6%). In patients with surgical presentations, trauma-related problems were most common (n = 196, 50.6%). Within the group of patients with medical presentation, acute infectious diseases were most common (n = 141, 43.9%), followed by neurological problems (n = 70, 21.8%) and gastrointestinal problems (n = 47, 14.6%). There were no differences between Syrian and non-Syrian refugees concerning surgical or medical admissions. The most common chronic disorder of unclear significance was chronic gastrointestinal problems (n = 132, 15%), followed by chronic musculoskeletal problems (n = 108, 12.3%) and chronic headaches (n = 78, 8.9%). Patients from Syria were significantly younger and more often suffered from a post-traumatic stress disorder than patients of other nationalities (p<0.0001, and p = 0.05, respectively). Conclusion Overall a remarkable number of our very young group of patients suffered from psychiatric disorders and unspecified somatic symptoms. Asylum seekers should be carefully evaluated when presenting to a medical facility and physicians should be aware of the high incidence of unspecified somatic symptoms in this patient population. In general, there is no major difference between asylum seekers from Syria when compared to other nationalities of asylum seekers from the Middle East.	[Pfortmueller, Carmen Andrea] Med Univ Vienna, Dept Gen Anaesthesiol Intens Care & Pain Manageme, Vienna, Austria; [Schwetlick, Miriam; Lehmann, Beat; Exadaktylos, Aristomenis Konstantinos] Univ Hosp Bern, Univ Dept Emergency Med, CH-3010 Bern, Switzerland; [Schwetlick, Miriam; Mueller, Thomas; Lehmann, Beat; Exadaktylos, Aristomenis Konstantinos] Univ Bern, Bern, Switzerland; [Mueller, Thomas] Univ Hosp Psychiat, Bern, Switzerland	Medical University of Vienna; University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern	Pfortmueller, CA (corresponding author), Med Univ Vienna, Dept Gen Anaesthesiol Intens Care & Pain Manageme, Vienna, Austria.	cpfortmueller@gmail.com	Müller, Thomas/D-1212-2010	Müller, Thomas/0000-0001-9315-8138; Pfortmueller, Carmen/0000-0003-0326-2770				Aarts S, 2012, J PSYCHOSOM RES, V73, P211, DOI 10.1016/j.jpsychores.2012.05.014; Bischoff A, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13252; Bryant RA, 2013, JAMA PSYCHIAT, V70, P839, DOI 10.1001/jamapsychiatry.2013.1137; Buhmann Cacilie, 2015, Torture, V25, P1; Buhmann CB, 2014, DAN MED J, V61; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cloitre M, 2009, J TRAUMA STRESS, V22, P399, DOI 10.1002/jts.20444; Cookson ST, 2015, CONFL HEALTH, V9, DOI 10.1186/s13031-015-0044-7; Doocy Shannon, 2015, PLoS Curr, V7, DOI 10.1371/currents.dis.6b7587562e58cf965bf2d7be36f96de6; Fink P, 2007, PSYCHOSOM MED, V69, P30, DOI 10.1097/PSY.0b013e31802e46eb; Fink P, 2010, J PSYCHOSOM RES, V68, P415, DOI 10.1016/j.jpsychores.2010.02.004; Fortin M, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-111; Harris MF, 2001, MED J AUSTRALIA, V175, P589, DOI 10.5694/j.1326-5377.2001.tb143739.x; Higashi T, 2007, NEW ENGL J MED, V356, P2496, DOI 10.1056/NEJMsa066253; Laban CJ, 2008, SOC PSYCH PSYCH EPID, V43, P507, DOI 10.1007/s00127-008-0333-1; Maier T, 2010, SWISS MED WKLY, V140, DOI 10.4414/smw.2010.13110; McKenzie ED, 2015, CONFL HEALTH, V9, DOI 10.1186/s13031-015-0038-5; Migration Bf, 2012, AS 2011 2011; Mohammad Y, 2012, J THORAC DIS, V4, P203, DOI 10.3978/j.issn.2072-1439.2011.11.07; Nickerson A, 2011, PSYCHIAT RES, V187, P267, DOI 10.1016/j.psychres.2010.12.015; Pfortmueller CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082671; Pfortmueller CA, 2012, WIEN KLIN WOCHENSCHR, V124, P647, DOI 10.1007/s00508-012-0227-9; Piette John D, 2008, J Diabetes Sci Technol, V2, P15; Starfield B, 2011, HEALTH POLICY, V103, P3, DOI 10.1016/j.healthpol.2011.09.004; Stone-Brown K, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7375; van den Bussche H, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-54	26	50	50	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148196	10.1371/journal.pone.0148196	http://dx.doi.org/10.1371/journal.pone.0148196			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6PR	26863216	Green Published, gold, Green Submitted			2022-12-27	WOS:000370046600047
J	Scannell, JW; Bosley, J				Scannell, Jack W.; Bosley, Jim			When Quality Beats Quantity: Decision Theory, Drug Discovery, and the Reproducibility Crisis	PLOS ONE			English	Article							COST EFFICIENCY; BIOMEDICAL-RESEARCH; SUCCESS RATES; PRODUCTIVITY; VALIDATION; IMPROVE; MODELS; CHALLENGES; QUESTIONS; OPTIMIZE	A striking contrast runs through the last 60 years of biopharmaceutical discovery, research, and development. Huge scientific and technological gains should have increased the quality of academic science and raised industrial R&D efficiency. However, academia faces a "reproducibility crisis"; inflation-adjusted industrial R&D costs per novel drug increased nearly 100 fold between 1950 and 2010; and drugs are more likely to fail in clinical development today than in the 1970s. The contrast is explicable only if powerful headwinds reversed the gains and/or if many "gains" have proved illusory. However, discussions of reproducibility and R&D productivity rarely address this point explicitly. The main objectives of the primary research in this paper are: (a) to provide quantitatively and historically plausible explanations of the contrast; and (b) identify factors to which R&D efficiency is sensitive. We present a quantitative decision-theoretic model of the R&D process. The model represents therapeutic candidates (e.g., putative drug targets, molecules in a screening library, etc.) within a "measurement space", with candidates' positions determined by their performance on a variety of assays (e.g., binding affinity, toxicity, in vivo efficacy, etc.) whose results correlate to a greater or lesser degree. We apply decision rules to segment the space, and assess the probability of correct R&D decisions. We find that when searching for rare positives (e.g., candidates that will successfully complete clinical development), changes in the predictive validity of screening and disease models that many people working in drug discovery would regard as small and/or unknowable (i.e., an 0.1 absolute change in correlation coefficient between model output and clinical outcomes in man) can offset large (e.g., 10 fold, even 100 fold) changes in models' brute-force efficiency. We also show how validity and reproducibility correlate across a population of simulated screening and disease models. We hypothesize that screening and disease models with high predictive validity are more likely to yield good answers and good treatments, so tend to render themselves and their diseases academically and commercially redundant. Perhaps there has also been too much enthusiasm for reductionist molecular models which have insufficient predictive validity. Thus we hypothesize that the average predictive validity of the stock of academically and industrially "interesting" screening and disease models has declined over time, with even small falls able to offset large gains in scientific knowledge and brute-force efficiency. The rate of creation of valid screening and disease models may be the major constraint on R&D productivity.	[Scannell, Jack W.] Univ Oxford, Ctr Adv Sustainable Med Innovat, Oxford, England; [Scannell, Jack W.] Univ Edinburgh, Innogen Inst, Sci Technol & Innovat Studies, Edinburgh, Midlothian, Scotland; [Scannell, Jack W.] JW Scannell Analyt Ltd, 32 Queens Crescent, Edinburgh, Midlothian, Scotland; [Bosley, Jim] Clerbos LLC, Kennett Sq, PA USA	University of Oxford; University of Edinburgh	Scannell, JW (corresponding author), Univ Oxford, Ctr Adv Sustainable Med Innovat, Oxford, England.; Scannell, JW (corresponding author), Univ Edinburgh, Innogen Inst, Sci Technol & Innovat Studies, Edinburgh, Midlothian, Scotland.; Scannell, JW (corresponding author), JW Scannell Analyt Ltd, 32 Queens Crescent, Edinburgh, Midlothian, Scotland.	jack.scannell@ed.ac.uk			JW Scannell Analytics Ltd; Clerbos LLC	JW Scannell Analytics Ltd; Clerbos LLC	The authors received funding from JW Scannell Analytics Ltd (JWS) and from Clerbos LLC (JB). JW Scannell Analytics Ltd provided research materials for JWS and paid the PLOS ONE Publication Fee for the paper. Clerbos LLC provided support in the form of salary for JB. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ajay, 1998, J MED CHEM, V41, P3314, DOI 10.1021/jm970666c; Alberts B, 2014, P NATL ACAD SCI USA, V111, P5773, DOI 10.1073/pnas.1404402111; [Anonymous], 2000, Nat Biotechnol, V18 Suppl, pIT50; Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3439; Bacchetti P, 2008, BIOMETRICS, V64, P577, DOI [10.1111/j.1541-0420.2008.01004.x, 10.1111/j.1541-0420.2008.01004_1.x]; Bacchetti P, 2008, BIOMETRICS, V64, P592, DOI 10.1111/j.1541-0420.2008.01004_5.x; Bacchetti P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001628; Bacchetti P, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-17; Baker S, 1989, COMMUNICATIONS STAT, V20, P2739; Beck B, 2002, ENCY ENV, P1275; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Belzung C, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-9; Bender A, 2008, CURR OPIN DRUG DISC, V11, P327; Benner SA, 2013, ASTROBIOLOGY, V13, P510, DOI 10.1089/ast.2012.0954; Berndt ER, 2015, HEALTH AFFAIR, V34, P245, DOI 10.1377/hlthaff.2014.1029; Berry DA, 2006, NAT REV DRUG DISCOV, V5, P27, DOI 10.1038/nrd1927; Bickerton GR, 2012, NAT CHEM, V4, P90, DOI [10.1038/nchem.1243, 10.1038/NCHEM.1243]; Booth B, 2004, NAT REV DRUG DISCOV, V3, P451, DOI 10.1038/nrd1384; Brand D., 2004, YEARS HOURS CALCULAT; Brown CD, 2006, CHEMOMETR INTELL LAB, V80, P24, DOI 10.1016/j.chemolab.2005.05.004; Brunke S, 2015, DIS MODEL MECH, V8, P473, DOI 10.1242/dmm.019901; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Casadevall A, 2015, P NATL ACAD SCI US; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; Colquhoun D, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140216; Coma I, 2009, J BIOMOL SCREEN, V14, P66, DOI 10.1177/1087057108326664; Cook D, 2014, NAT REV DRUG DISCOV; CRONBACH LJ, 1955, PSYCHOL BULL, V52, P281, DOI 10.1037/h0040957; Cumming JG, 2013, NAT REV DRUG DISCOV, V12, P948, DOI 10.1038/nrd4128; DeMonaco HJ, 2006, PHARMACOTHERAPY, V26, P323, DOI 10.1592/phco.26.3.323; DETSKY AS, 1990, STAT MED, V9, P173, DOI 10.1002/sim.4780090124; Dillon S, 2006, TARGET VALIDATION DR; DIMASI JA, 1995, CLIN PHARMACOL THER, V58, P1, DOI 10.1016/0009-9236(95)90066-7; Do CB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002973; Dolle RE, 2011, METHODS MOL BIOL, V685, P3, DOI 10.1007/978-1-60761-931-4_1; Dranchak P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057888; Eder J, 2014, NAT REV DRUG DISCOV; Edwards W, 2007, ADVANCES IN DECISION ANALYSIS: FROM FOUNDATIONS TO APPLICATIONS, P1, DOI 10.1017/CBO9780511611308; Fanelli D, 2012, SCIENTOMETRICS, V90, P891, DOI 10.1007/s11192-011-0494-7; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Funtowicz S. O., 1990, UNCERTAINTY QUALITY; GART JJ, 1966, AM J EPIDEMIOL, V83, P593, DOI 10.1093/oxfordjournals.aje.a120610; Gasparini M, 2013, EPIDEMIOL BIOSTAT PU, V10, DOI 10.2427/8760; Geysen HM, 2003, NAT REV DRUG DISCOV, V2, P222, DOI 10.1038/nrd10335; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Haibe-Kains B, 2013, NATURE, V504, P389, DOI 10.1038/nature12831; Hanley JA, 2008, BIOMETRICS, V64, P586, DOI 10.1111/j.1541-0420.2008.01004_2.x; Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786; Healy D., 1997, ANTIDEPRESSANT ERA; Healy David, 2002, CREATION PSYCHOPHARM; Henderson VC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001489; Hogan JC, 1997, NAT BIOTECHNOL, V15, P328, DOI 10.1038/nbt0497-328; Holbeck SL, 2010, MOL CANCER THER, V9, P1451, DOI 10.1158/1535-7163.MCT-10-0106; Hopkins AL, 2014, NAT REV DRUG DISCOV, V13, P105, DOI 10.1038/nrd4163; Horrobin D, 2011, NAT BIOTECHNOL, V19, P1099; Horrobin DF, 2003, NAT REV DRUG DISCOV, V2, P151, DOI 10.1038/nrd1012; Horrobin DF, 2000, J ROY SOC MED, V93, P341, DOI 10.1177/014107680009300702; Howard RA, 2007, ADVANCES IN DECISION ANALYSIS: FROM FOUNDATIONS TO APPLICATIONS, P32, DOI 10.1017/CBO9780511611308.004; Huang RL, 2006, J MED CHEM, V49, P1964, DOI 10.1021/jm051029m; Ioannidis JPA, 2011, SCIENCE, V334, P1230, DOI 10.1126/science.1211811; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Joyner MJ, 2014, J PHYSIOL-LONDON, V592, P2381, DOI 10.1113/jphysiol.2014.272336; LaMattina J, 2012, FORBES; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Langer T, 2009, CURR OPIN PHARMACOL, V9, P589, DOI 10.1016/j.coph.2009.06.001; Le Fanu J., 1999, RISE FALL MODERN MED; Leach A. R., 2005, INTRO CHEMOINFORMATI; Lendrem DW, 2015, NAT REV DRUG DISCOV, V14, P220, DOI 10.1038/nrd4320-c1; Lewis K, 2013, NAT REV DRUG DISCOV, V12, P371, DOI 10.1038/nrd3975; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Macleod MR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002273; Mayr LM, 2008, J BIOMOL SCREEN, V13, P443, DOI 10.1177/1087057108319644; McArthur R A, 2008, ANIMAL TRANSLATIONAL, V1; Muller P, 2008, BIOMETRICS, V64, P587, DOI 10.1111/j.1541-0420.2008.01004_3.x; Munos B, 2009, NAT REV DRUG DISCOV, V8, P959, DOI 10.1038/nrd2961; O'Hagan A, 2005, PHARM STAT, V4, P187, DOI 10.1002/pst.175; Pammolli F, 2011, NAT REV DRUG DISCOV, V10, P428, DOI 10.1038/nrd3405; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Pedro-Rosa L, 2015, J BIOMOL SCREEN, V20, P122, DOI 10.1177/1087057114548832; Perrin S, 2014, NATURE, V507, P423, DOI 10.1038/507423a; Peterson M., 2009, INTRO DECISION THEOR; Petrone FM, 2012, ACS CHEM BIOL, V7, P1399, DOI 10.1021/cb3001028; Pickett SD, 2000, J CHEM INF COMP SCI, V40, P263, DOI 10.1021/ci990261w; Powledge TM, 2003, GENOME BIOL; Rask-Andersen M, 2011, NAT REV DRUG DISCOV, V10, P579, DOI 10.1038/nrd3478; Sadowski J, 1998, J MED CHEM, V41, P3325, DOI 10.1021/jm9706776; Sams-Dodd F, 2006, DRUG DISCOV TODAY, V11, P355, DOI 10.1016/j.drudis.2006.02.005; Sams-Dodd F, 2005, DRUG DISCOV TODAY, V10, P139, DOI 10.1016/S1359-6446(04)03316-1; Sams-Dodd F, 2013, DRUG DISCOV TODAY, V18, P211, DOI 10.1016/j.drudis.2012.10.010; SANGER F, 1988, ANNU REV BIOCHEM, V57, P1, DOI 10.1146/annurev.bi.57.070188.000245; Scannell JW, 2015, REV RECENT CLIN TRIA, V10, P28, DOI 10.2174/1574887110666150430151751; Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681; Senn S., 2007, STAT ISSUES DRUG DEV; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; Simon R, 2008, BIOMETRICS, V64, P589, DOI 10.1111/j.1541-0420.2008.01004_4.x; Spiegelhalter DJ, 2004, BAYESIAN APPROACHES, DOI DOI 10.1002/0470092602; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; VANBRUNT J, 1986, BIO-TECHNOL, V4, P277; Walters WP, 2003, NAT REV DRUG DISCOV, V2, P259, DOI 10.1038/nrd1063; Willan AR, 2005, STAT MED, V24, P1791, DOI 10.1002/sim.2069; WILLNER P, 1984, PSYCHOPHARMACOLOGY, V83, P1, DOI 10.1007/BF00427414; Wong CC, 2012, J PHARMACOL EXP THER, V341, P572, DOI 10.1124/jpet.112.191957; Young NS, 2008, PLOS MED, V5, P1418, DOI 10.1371/journal.pmed.0050201; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	105	141	145	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0147215	10.1371/journal.pone.0147215	http://dx.doi.org/10.1371/journal.pone.0147215			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6PR	26863229	Green Published, Green Submitted, gold			2022-12-27	WOS:000370046600020
J	Schlick, B; Massoner, P; Lueking, A; Charoentong, P; Blattner, M; Schaefer, G; Marquart, K; Theek, C; Amersdorfer, P; Zielinski, D; Kirchner, M; Trajanoski, Z; Rubin, MA; Mullner, S; Schulz-Knappe, P; Klocker, H				Schlick, Bettina; Massoner, Petra; Lueking, Angelika; Charoentong, Pornpimol; Blattner, Mirjam; Schaefer, Georg; Marquart, Klaus; Theek, Carmen; Amersdorfer, Peter; Zielinski, Dirk; Kirchner, Matthias; Trajanoski, Zlatko; Rubin, Mark A.; Muellner, Stefan; Schulz-Knappe, Peter; Klocker, Helmut			Serum Autoantibodies in Chronic Prostate Inflammation in Prostate Cancer Patients	PLOS ONE			English	Article							INCREASED EXPRESSION; BIOMARKER DISCOVERY; ANTIGEN LEVELS; BENIGN; SPOP; IDENTIFICATION; HYPERPLASIA; ANTIBODIES; SIGNATURES; MUTATIONS	Background Chronic inflammation is frequently observed on histological analysis of malignant and nonmalignant prostate specimens. It is a suspected supporting factor for prostate diseases and their progression and a main cause of false positive PSA tests in cancer screening. We hypothesized that inflammation induces autoantibodies, which may be useful biomarkers. We aimed to identify and validate prostate inflammation associated serum autoantibodies in prostate cancer patients and evaluate the expression of corresponding autoantigens. Methods Radical prostatectomy specimens of prostate cancer patients (N = 70) were classified into high and low inflammation groups according to the amount of tissue infiltrating lymphocytes. The corresponding pre-surgery blood serum samples were scrutinized for autoantibodies using a low-density protein array. Selected autoantigens were identified in prostate tissue and their expression pattern analyzed by immunohistochemistry and qPCR. The identified autoantibody profile was cross-checked in an independent sample set (N = 63) using the Luminex-bead protein array technology. Results Protein array screening identified 165 autoantibodies differentially abundant in the serum of high compared to low inflammation patients. The expression pattern of three corresponding antigens were established in benign and cancer tissue by immunohistochemistry and qPCR: SPAST (Spastin), STX18 (Syntaxin 18) and SPOP (speckle-type POZ protein). Of these, SPAST was significantly increased in prostate tissue with high inflammation. All three autoantigens were differentially expressed in primary and/or castration resistant prostate tumors when analyzed in an inflammation-independent tissue microarray. Cross-validation of the inflammation autoantibody profile on an independent sample set using a Luminex-bead protein array, retrieved 51 of the significantly discriminating autoantibodies. Three autoantibodies were significantly upregulated in both screens, MUT, RAB11B and CSRP2 (p>0.05), two, SPOP and ZNF671, close to statistical significance (p = 0.051 and 0.076). Conclusions We provide evidence of an inflammation-specific autoantibody profile and confirm the expression of corresponding autoantigens in prostate tissue. This supports evaluation of autoantibodies as non-invasive markers for prostate inflammation.	[Schlick, Bettina; Massoner, Petra; Klocker, Helmut] Med Univ Innsbruck, Div Expt Urol, Dept Urol, A-6020 Innsbruck, Austria; [Schlick, Bettina; Massoner, Petra; Schaefer, Georg] Ctr Personalized Canc Med, ONCOTYROL, Innsbruck, Austria; [Lueking, Angelika; Marquart, Klaus; Theek, Carmen; Amersdorfer, Peter; Muellner, Stefan; Schulz-Knappe, Peter] Protagen AG, Dortmund, Germany; [Schaefer, Georg] Med Univ Innsbruck, Dept Pathol, A-6020 Innsbruck, Austria; [Charoentong, Pornpimol; Trajanoski, Zlatko] Med Univ Innsbruck, Div Bioinformat, A-6020 Innsbruck, Austria; [Blattner, Mirjam; Rubin, Mark A.] Cornell Univ, Dept Pathol & Lab Med, Inst Precis Med, Weill Med Coll, New York, NY 10021 USA; [Zielinski, Dirk; Kirchner, Matthias] TARGOS Mol Pathol GmbH, Kassel, Germany	Medical University of Innsbruck; Protagen Protein Services (PPS); Medical University of Innsbruck; Medical University of Innsbruck; Cornell University; Targos Molecular Pathology GmbH	Klocker, H (corresponding author), Med Univ Innsbruck, Div Expt Urol, Dept Urol, A-6020 Innsbruck, Austria.	helmut.klocker@i-med.ac.at	Klocker, Helmut/AAI-7130-2020; Trajanoski, Zlatko/AAT-6703-2021	Rubin, Mark/0000-0002-8321-9950; Amersdorfer, Peter/0000-0002-0983-5755	COMET K1 Center Oncotyrol-Center for Personalized Medicine - Austrian Research Promotion Agency (FFG); Future Foundation of the Country of Tyrol; Protagen AG; ONCOTYROL GmbH; TARGOS Molecular Pathology GmbH	COMET K1 Center Oncotyrol-Center for Personalized Medicine - Austrian Research Promotion Agency (FFG); Future Foundation of the Country of Tyrol; Protagen AG; ONCOTYROL GmbH; TARGOS Molecular Pathology GmbH	The study was supported by COMET K1 Center Oncotyrol-Center for Personalized Medicine, financed by the Austrian Research Promotion Agency (FFG) and the Future Foundation of the Country of Tyrol, and Protagen AG. ONCOTYROL GmbH, Protagen AG and TARGOS Molecular Pathology GmbH provided support in the form of salaries for authors [BS, PM, GS], [AL, KM, CT, PA, SM, PSK], [DZ, MK] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. All other authors declare no competing interest. The specific roles of these authors are articulated in the 'author contributions' section.	Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Bartsch G, 2008, BJU INT, V101, P809, DOI 10.1111/j.1464-410X.2008.07502.x; Bassett T, 2008, CANCER LETT, V272, P167, DOI 10.1016/j.canlet.2008.07.014; Battikhi MNG, 2006, INT UROL NEPHROL, V38, P21, DOI 10.1007/s11255-005-1662-6; Bei R, 2009, CANCER LETT, V281, P8, DOI 10.1016/j.canlet.2008.11.009; Beyer NH, 2012, J NEUROIMMUNOL, V242, P26, DOI 10.1016/j.jneuroim.2011.08.013; Blattner M, 2014, NEOPLASIA, V16, P14, DOI 10.1593/neo.131704; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bostanci Y, 2013, CURR OPIN UROL, V23, P5, DOI 10.1097/MOU.0b013e32835abd4a; Bradford TJ, 2006, UROL ONCOL-SEMIN ORI, V24, P237, DOI 10.1016/j.urolonc.2005.11.033; Bul M, 2011, ACTA ONCOL, V50, P4, DOI 10.3109/0284186X.2010.522197; Caruso C, 2009, CANCER IMMUNOL IMMUN, V58, P1919, DOI 10.1007/s00262-009-0658-y; Carver BS, 2003, J UROLOGY, V169, P589, DOI 10.1016/S0022-5347(05)63959-6; Casiano CA, 2006, MOL CELL PROTEOMICS, V5, P1745, DOI 10.1074/mcp.R600010-MCP200; Croswell JM, 2011, ONCOLOGY-NY, V25, P452; Dancau AM, 2010, METHODS MOL BIOL, V576, P49, DOI 10.1007/978-1-59745-545-9_4; De Marzo AM, 2007, UROL ONCOL-SEMIN ORI, V25, P398, DOI 10.1016/j.urolonc.2007.05.007; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; De Nunzio C, 2011, EUR UROL, V60, P106, DOI 10.1016/j.eururo.2011.03.055; DETRE S, 1995, J CLIN PATHOL, V48, P876, DOI 10.1136/jcp.48.9.876; Draberova E, 2011, J NEUROPATH EXP NEUR, V70, P811, DOI 10.1097/NEN.0b013e31822c256d; Duffy MJ, 2015, ADV CLIN CHEM, V71, P1, DOI [10.1016/bs.acc.2015.05.001, 10.1016/B978-0-12-801401-1.00001-3]; Dunphy EJ, 2004, J CLIN IMMUNOL, V24, P492, DOI 10.1023/B:JOCI.0000040920.96065.5a; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Fujita K, 2011, J UROLOGY, V185, P1722, DOI 10.1016/j.juro.2010.12.058; Gallon S, 2013, MATH BIOSCI, V242, P129, DOI 10.1016/j.mbs.2012.12.007; Geng C, 2013, P NATL ACAD SCI USA, V110, P6997, DOI 10.1073/pnas.1304502110; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gronberg H, 2003, LANCET, V361, P859, DOI 10.1016/S0140-6736(03)12713-4; Groves HK, 2013, PROSTATE CANCER P D, V16, P260, DOI 10.1038/pcan.2013.11; HASUI Y, 1994, PROSTATE, V25, P91, DOI 10.1002/pros.2990250206; Hayes JH, 2014, JAMA-J AM MED ASSOC, V311, P1143, DOI 10.1001/jama.2014.2085; Horn S, 2006, PROTEOMICS, V6, P605, DOI 10.1002/pmic.200401293; Horta ES, 2014, CLIN CANCER RES, V20, P3862, DOI 10.1158/1078-0432.CCR-14-0652; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jia D, 2014, HEPATOLOGY; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Jun BH, 2012, MOLECULES, V17, P2474, DOI 10.3390/molecules17032474; Karaman H, 2013, INT J MED SCI, V10, P1387, DOI 10.7150/ijms.6126; Kramer G, 2002, PROSTATE, V52, P43, DOI 10.1002/pros.10084; Lacombe J, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/574981; Lepor H, 2004, REV UROL S9, V6, P3; Li GQ, 2014, CANCER CELL, V25, P455, DOI 10.1016/j.ccr.2014.02.007; Lin HS, 2007, CANCER EPIDEM BIOMAR, V16, P2396, DOI 10.1158/1055-9965.EPI-07-0318; Liu YA, 2012, J IMMUNOTHER, V35, P299, DOI 10.1097/CJI.0b013e3182518e83; Lueking A, 2005, MOL CELL PROTEOMICS, V4, P1382, DOI 10.1074/mcp.T500004-MCP200; Mani RS, 2014, DRUG DISCOVERY TODAY; Maricque BB, 2011, PROSTATE, V71, P134, DOI 10.1002/pros.21229; Massoner P, 2012, PROSTATE, V72, P427, DOI 10.1002/pros.21444; MCCLINTON S, 1990, BRIT J CANCER, V61, P400, DOI 10.1038/bjc.1990.87; McDowell KL, 2010, PROSTATE, V70, P377, DOI 10.1002/pros.21071; Miah S, 2014, INDIAN J UROL, V30, P214, DOI 10.4103/0970-1591.126909; Narayanan NK, 2009, PROSTATE, V69, P133, DOI 10.1002/pros.20862; Nickel JC, 2001, BJU INT, V87, P797, DOI 10.1046/j.1464-410x.2001.02193.x; Nickel JC, 1999, BJU INT, V84, P976; O'Rourke DJ, 2012, CLIN CHIM ACTA, V413, P561, DOI 10.1016/j.cca.2011.11.027; Ozden C, 2007, INT UROL NEPHROL, V39, P859, DOI 10.1007/s11255-006-9125-2; Palapattu GS, 2005, CARCINOGENESIS, V26, P1170, DOI 10.1093/carcin/bgh317; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ran YL, 2008, CLIN CANCER RES, V14, P2696, DOI 10.1158/1078-0432.CCR-07-2021; Robert G, 2011, PROSTATE, V71, P1701, DOI 10.1002/pros.21387; Robert G, 2009, PROSTATE, V69, P1774, DOI 10.1002/pros.21027; Roehrborn CG, 2011, BJU INT, V108, P806, DOI 10.1111/j.1464-410X.2011.10365.x; Russo N, 2013, ONCOGENE, V32, P5026, DOI 10.1038/onc.2012.532; Salinas S, 2007, J NEUROSCI RES, V85, P2778, DOI 10.1002/jnr.21238; Scanlan MJ, 1998, INT J CANCER, V76, P652, DOI 10.1002/(SICI)1097-0215(19980529)76:5<652::AID-IJC7>3.3.CO;2-9; Schaefer G, 2013, PROSTATE CANC PROSTA; Sfanos KS, 2012, HISTOPATHOLOGY, V60, P199, DOI 10.1111/j.1365-2559.2011.04033.x; Sherer Y, 2004, SEMIN ARTHRITIS RHEU, V34, P501, DOI 10.1016/j.semarthrit.2004.07.002; Soussi T, 2000, CANCER RES, V60, P1777; Storr SJ, 2006, EXPERT REV ANTICANC, V6, P1215, DOI 10.1586/14737140.6.8.1215; Taylor BS, 2008, MOL CELL PROTEOMICS, V7, P600, DOI 10.1074/mcp.M700263-MCP200; Wang XJ, 2005, NEW ENGL J MED, V353, P1224, DOI 10.1056/NEJMoa051931; Wei QQ, 2014, PARKINSONISM RELAT D; Wu LL, 2010, CLIN CANCER RES, V16, P3760, DOI 10.1158/1078-0432.CCR-10-0193; Xu YW, 2014, AM J GASTROENTEROL, V109, P36, DOI 10.1038/ajg.2013.384; Zheng SL, 2006, PROSTATE, V66, P1556, DOI 10.1002/pros.20496	79	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0147739	10.1371/journal.pone.0147739	http://dx.doi.org/10.1371/journal.pone.0147739			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863016	Green Submitted, gold, Green Published			2022-12-27	WOS:000370046600036
J	Bullard, RL; Williams, J; Karim, S				Bullard, Rebekah L.; Williams, Jaclyn; Karim, Shahid			Temporal Gene Expression Analysis and RNA Silencing of Single and Multiple Members of Gene Family in the Lone Star Tick Amblyomma americanum	PLOS ONE			English	Article							SERINE-PROTEASE INHIBITOR; SALIVARY-GLAND; IXODES-SCAPULARIS; MOLECULAR CHARACTERIZATION; METALLOPROTEASES; CLONING; ACARI; IDENTIFICATION; VECTOR; PROTEINS	Saliva is an integral factor in the feeding success of veterinary and medically important ticks. Therefore, the characterization of the proteins present in tick saliva is an important area of tick research. Here, we confirmed previously generated sialotranscriptome data using quantitative real-time PCR. The information obtained in this in-depth study of gene expression was used to measure the effects of metalloprotease gene silencing on tick feeding. We analyzed the temporal expression of seven housekeeping genes and 44 differentially expressed salivary molecules selected from a previously published Amblyomma americanum sialotranscriptome. Separate reference genes were selected for the salivary glands and midgut from among the seven housekeeping genes, to normalize the transcriptional expression of differentially expressed genes. The salivary gland reference gene, ubiquitin, was used to normalize the expression of 44 salivary genes. Unsurprisingly, each gene family was expressed throughout the blood meal, but the expression of specific genes differed at each time point. To further clarify the complex nature of the many proteins found in the saliva, we disrupted the translation of several members of the metalloprotease family. Intriguingly, the nucleotide sequence similarity of the reprolysin metalloprotease gene family is so homologous that a single synthesized dsRNA sequence knocked down multiple members of the family. The use of multigene knockdown yielded a more significant picture of the role of metalloproteases in tick feeding success, and changes were observed in the female engorgement weight and larval hatching success. Interestingly, the depletion of metalloprotease transcripts also reduced the total number of bacteria present in the salivary glands. These data provide insight into the expression and functions of tick salivary proteins expressed while feeding on its host.	[Bullard, Rebekah L.; Williams, Jaclyn; Karim, Shahid] Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA	University of Southern Mississippi	Karim, S (corresponding author), Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA.	Shahid.karim@usm.edu		Karim, Shahid/0000-0001-5596-3304	National Institute of Allergy and Infectious Diseases [AI099919]; National Science Foundation [EPS 0903787, EPS 1006883]; United States Department of State [PGA-P21049]; National Institutes of General Medical Sciences award [P20RR016476]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103476] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Science Foundation(National Science Foundation (NSF)); United States Department of State; National Institutes of General Medical Sciences award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institute of Allergy and Infectious Diseases award #AI099919, the National Science Foundation (EPS 0903787 and EPS 1006883 to MS-EPSCoR), United States Department of State award#PGA-P21049 (Pakistan-United States Science and Technology Cooperation Program) to SK and the National Institutes of General Medical Sciences award #P20RR016476 to the MS-INBRE core facility. The funders had no role in study design, data collection, analysis, decision to publish, or manuscript preparation.	Alarcon-Chaidez FJ, 2007, INSECT BIOCHEM MOLEC, V37, P48, DOI 10.1016/j.ibmb.2006.10.002; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anderson JF, 2008, INFECT DIS CLIN N AM, V22, P195, DOI 10.1016/j.idc.2007.12.006; Barnard AC, 2012, VET PARASITOL, V186, P403, DOI 10.1016/j.vetpar.2011.11.026; Barrett A. J., 2004, HDB PROTEOLYTIC ENZY, V1; Beaufays J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003987; Beaufays J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003941; Bergman DK, 2000, J PARASITOL, V86, P516, DOI 10.1645/0022-3395(2000)086[0516:IAMCOA]2.0.CO;2; Bishop R, 2002, INT J PARASITOL, V32, P833, DOI 10.1016/S0020-7519(02)00027-9; Browning R, 2013, INSECT MOL BIOL, V22, P245, DOI 10.1111/imb.12017; Browning R, 2012, J MED ENTOMOL, V49, P1339, DOI 10.1603/ME12123; Budachetri K, 2015, INSECT MOL BIOL, V24, P570, DOI 10.1111/imb.12184; Ceraul SM, 2008, INFECT IMMUN, V76, P5429, DOI 10.1128/IAI.00866-08; Ceraul SM, 2011, INFECT IMMUN, V79, P321, DOI 10.1128/IAI.00362-10; Childs JE, 2003, ANNU REV ENTOMOL, V48, P307, DOI 10.1146/annurev.ento.48.091801.112728; Chmelar J, 2012, J PROTEOMICS, V75, P3842, DOI 10.1016/j.jprot.2012.04.026; Commins SP, 2011, J ALLERGY CLIN IMMUN, V127, P1286, DOI 10.1016/j.jaci.2011.02.019; Cortinas R, 2014, J MED ENTOMOL, V51, P352, DOI 10.1603/ME13122; Decrem Y, 2008, INT J PARASITOL, V38, P549, DOI 10.1016/j.ijpara.2007.09.003; Decrem Y, 2008, FEBS J, V275, P1485, DOI 10.1111/j.1742-4658.2008.06308.x; Diaz-Martin V, 2013, J PROTEOMICS, V80, P216, DOI 10.1016/j.jprot.2013.01.015; Duell JR, 2013, J MED ENTOMOL, V50, P1330, DOI 10.1603/ME13117; Fitak RR, 2014, TICKS TICK-BORNE DIS, V5, P797, DOI 10.1016/j.ttbdis.2014.06.005; Flower DR, 1996, BIOCHEM J, V318, P1; Francischetti IMB, 2002, BLOOD, V99, P3602, DOI 10.1182/blood-2001-12-0237; Francischetti IMB, 2003, BIOCHEM BIOPH RES CO, V305, P869, DOI 10.1016/S0006-291X(03)00857-X; Francischetti IMB, 2009, FRONT BIOSCI-LANDMRK, V14, P2051, DOI 10.2741/3363; Frauenschuh A, 2007, J BIOL CHEM, V282, P27250, DOI 10.1074/jbc.M704706200; Gargano AFG, 2014, J CHROMATOGR A, V1351, P70, DOI 10.1016/j.chroma.2014.05.031; Gebbia JA, 2001, INFECT IMMUN, V69, P456, DOI 10.1128/IAI.69.1.456-462.2001; Goddard J, 2009, VET PARASITOL, V160, P1, DOI 10.1016/j.vetpar.2008.10.089; Gong HY, 2007, J INSECT PHYSIOL, V53, P1079, DOI 10.1016/j.jinsphys.2007.06.008; Grubhoffer L, 2004, PARASITOLOGY, V129, pS113, DOI 10.1017/S0031182004004858; Harnnoi T, 2007, COMP BIOCHEM PHYS B, V147, P93, DOI 10.1016/j.cbpb.2006.12.008; Havlikova S, 2009, INT J PARASITOL, V39, P1485, DOI 10.1016/j.ijpara.2009.05.005; Karim S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131292; Karim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028525; Kato N, 2005, J BIOCHEM, V138, P225, DOI 10.1093/jb/mvi123; Keirans JE, 1998, J PARASITOL, V84, P629, DOI 10.2307/3284739; Koci J, 2013, J MED ENTOMOL, V50, P79, DOI 10.1603/ME12034; Lalzar I, 2014, ENVIRON MICROBIOL, V16, P3657, DOI 10.1111/1462-2920.12455; Li WF, 2006, PEPTIDES, V27, P2350, DOI 10.1016/j.peptides.2006.03.016; Liu XY, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002993; Mangeon A, 2010, PLANT SIGNAL BEHAV, V5, P99, DOI 10.4161/psb.5.2.10336; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P841, DOI 10.1016/j.ibmb.2008.06.007; Matsushita M, 2010, J INNATE IMMUN, V2, P24, DOI 10.1159/000228160; Narasimhan S, 2014, CELL HOST MICROBE, V15, P58, DOI 10.1016/j.chom.2013.12.001; Nijhof AM, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-112; Paddock CD, 2007, CURR TOP MICROBIOL, V315, P289; Paesen GC, 1999, MOL CELL, V3, P661, DOI 10.1016/S1097-2765(00)80359-7; PATRICK CD, 1975, J MED ENTOMOL, V12, P389, DOI 10.1093/jmedent/12.3.389; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Platts-Mills TAE, 2015, IMMUNOL ALLERGY CLIN, V35, P247, DOI 10.1016/j.iac.2015.01.009; Rachinsky A, 2007, INSECT BIOCHEM MOLEC, V37, P1291, DOI 10.1016/j.ibmb.2007.08.001; Ramos OHP, 2003, PROTEIN EXPRES PURIF, V28, P34, DOI 10.1016/S1046-5928(02)00644-7; Ribeiro JMC, 1998, EXP PARASITOL, V89, P213, DOI 10.1006/expr.1998.4296; Rice GI, 2004, BIOCHEM J, V383, P45, DOI 10.1042/BJ20040634; Sachetto-Martins G, 2000, BBA-GENE STRUCT EXPR, V1492, P1, DOI 10.1016/S0167-4781(00)00064-6; Sangamnatdej S, 2002, INSECT MOL BIOL, V11, P79, DOI 10.1046/j.0962-1075.2001.00311.x; Sasaki SD, 2008, EXP PARASITOL, V118, P214, DOI 10.1016/j.exppara.2007.08.003; Savage HM, 2013, AM J TROP MED HYG, V89, P445, DOI 10.4269/ajtmh.13-0209; Sayler KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115769; Schwarz A, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-4; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sitnik JL, 2014, GENETICS, V196, P781, DOI 10.1534/genetics.113.160945; Springer YP, 2014, J MED ENTOMOL, V51, P342, DOI 10.1603/ME13115; Steen NA, 2006, TOXICON, V47, P1, DOI 10.1016/j.toxicon.2005.09.010; Tonk M, 2014, GENE, V540, P146, DOI 10.1016/j.gene.2014.03.002; Turner AJ, 2001, BIOESSAYS, V23, P261, DOI 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K; Valdes JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062562; Valenzuela JG, 2002, J EXP BIOL, V205, P2843; Viljakainen L, 2005, INSECT MOL BIOL, V14, P335, DOI 10.1111/j.1365-2583.2005.00564.x; Wikel SK, 1999, INT J PARASITOL, V29, P851, DOI 10.1016/S0020-7519(99)00042-9; Yi HY, 2014, APPL MICROBIOL BIOT, V98, P5807, DOI 10.1007/s00253-014-5792-6	74	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0147966	10.1371/journal.pone.0147966	http://dx.doi.org/10.1371/journal.pone.0147966			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872360	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100013
J	Papalia, I; Magaudda, L; Righi, M; Ronchi, G; Viano, N; Geuna, S; Colonna, MR				Papalia, Igor; Magaudda, Ludovico; Righi, Maria; Ronchi, Giulia; Viano, Nicoletta; Geuna, Stefano; Colonna, Michele Rosario			Epineurial Window Is More Efficient in Attracting Axons than Simple Coaptation in a Sutureless (Cyanoacrylate-Bound) Model of End-to-Side Nerve Repair in the Rat Upper Limb: Functional and Morphometric Evidences and Review of the Literature	PLOS ONE			English	Article							CILIARY NEUROTROPHIC FACTOR; LONG-TERM EVALUATION; PERIPHERAL-NERVE; QUANTITATIVE ASSESSMENT; FIBRIN GLUE; MUSCLE REINNERVATION; PERINEURIAL WINDOW; REGENERATING AXONS; UPPER-EXTREMITY; SCHWANN-CELLS	End-to-side nerve coaptation brings regenerating axons from the donor to the recipient nerve. Several techniques have been used to perform coaptation: microsurgical sutures with and without opening a window into the epi(peri)neurial connective tissue; among these, window techniques have been proven more effective in inducing axonal regeneration. The authors developed a sutureless model of end-to-side coaptation in the rat upper limb. In 19 adult Wistar rats, the median and the ulnar nerves of the left arm were approached from the axillary region, the median nerve transected and the proximal stump sutured to the pectoral muscle to prevent regeneration. Animals were then randomly divided in two experimental groups (7 animals each, 5 animals acting as control): Group 1: the distal stump of the transected median nerve was fixed to the ulnar nerve by applying cyanoacrylate solution; Group 2: a small epineurial window was opened into the epineurium of the ulnar nerve, caring to avoid damage to the nerve fibres; the distal stump of the transected median nerve was then fixed to the ulnar nerve by applying cyanoacrylate solution. The grasping test for functional evaluation was repeated every 10-11 weeks starting from week-15, up to the sacrifice (week 36). At week 36, the animals were sacrificed and the regenerated nerves harvested and processed for morphological investigations (high-resolution light microscopy as well as stereological and morphometrical analysis). This study shows that a) cyanoacrylate in end-to-side coaptation produces scarless axon regeneration without toxic effects; b) axonal regeneration and myelination occur even without opening an epineurial window, but c) the window is related to a larger number of regenerating fibres, especially myelinated and mature, and better functional outcomes.	[Papalia, Igor; Magaudda, Ludovico; Righi, Maria] Univ Messina, Dept Biomed Sci & Morphol & Funct Images, Messina, Italy; [Ronchi, Giulia; Viano, Nicoletta; Geuna, Stefano] Univ Turin, Dept Clin & Biol Sci, Turin, Italy; [Ronchi, Giulia; Geuna, Stefano] Univ Turin, Cavalieri Ottolenghi Fdn NICO, Neurosci Inst, Turin, Italy; [Colonna, Michele Rosario] Univ Messina, Dept Expt & Clin Surg & Med Specialties, Messina, Italy	University of Messina; University of Turin; University of Turin; University of Messina	Geuna, S (corresponding author), Univ Turin, Dept Clin & Biol Sci, Turin, Italy.; Geuna, S (corresponding author), Univ Turin, Cavalieri Ottolenghi Fdn NICO, Neurosci Inst, Turin, Italy.	stefano.geuna@unito.it	Ronchi, Giulia/J-4785-2018; Colonna, Michele/ABI-6680-2020	Ronchi, Giulia/0000-0002-4795-7024; Colonna, Michele/0000-0001-5586-4066; Geuna, Stefano/0000-0002-6962-831X				Akeda K, 2006, PLAST RECONSTR SURG, V117, P1194, DOI 10.1097/01.prs.0000201460.54187.d7; Al-Qattan MM, 1998, BRIT J PLAST SURG, V51, P238, DOI 10.1054/bjps.1997.0188; Al-Qattan MM, 2002, J HAND SURG-AM, V27A, P739, DOI 10.1053/jhsu.2002.34313; Al-Qattan MM, 2001, J RECONSTR MICROSURG, V17, P99, DOI 10.1055/s-2001-12698; Amr SM, 2005, MICROSURG, V25, P126, DOI 10.1002/micr.20036; Bajrovic F, 2002, NEUROSCIENCE, V111, P587, DOI 10.1016/S0306-4522(01)00588-7; Battiston B, 1999, J HAND SURG-AM, V24A, P1185; Beck-Broichsitter BE, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/724197; Bertelli JA, 2003, J RECONSTR MICROSURG, V19, P313; Bertelli JA, 1996, J RECONSTR MICROSURG, V12, P559, DOI 10.1055/s-2007-1006630; BERTELLI JA, 1995, J NEUROSCI METH, V58, P151, DOI 10.1016/0165-0270(94)00169-H; Bontioti E, 2005, J PERIPHER NERV SYST, V10, P58, DOI 10.1111/j.1085-9489.2005.10109.x; Bontioti E, 2009, INT REV NEUROBIOL, V87, P251, DOI 10.1016/S0074-7742(09)87012-8; Bontioti EN, 2003, J PERIPHER NERV SYST, V8, P159, DOI 10.1046/j.1529-8027.2003.03023.x; BRUSHART TME, 1988, J NEUROSCI, V8, P1026; BRUSHART TME, 1993, J NEUROSCI, V13, P2730, DOI 10.1523/JNEUROSCI.13-06-02730.1993; Cederna PS, 2001, PLAST RECONSTR SURG, V107, P789, DOI 10.1097/00006534-200103000-00021; Cederna PS, 2000, PLAST RECONSTR SURG, V105, P2003, DOI 10.1097/00006534-200005000-00014; Chen YG, 1998, J HAND SURG-AM, V23A, P1025, DOI 10.1016/S0363-5023(98)80010-5; Choi BH, 2004, INT J ORAL MAX SURG, V33, P777, DOI 10.1016/j.ijom.2004.03.006; Choi EH, 2005, MICROSURG, V25, P495, DOI 10.1002/micr.20154; Chung K, 2001, BRAIN RES, V895, P204, DOI 10.1016/S0006-8993(01)02092-3; Colonna M, 2016, PLAST AESTH IN PRESS; Dvali LT, 2008, HAND CLIN, V24, P455, DOI 10.1016/j.hcl.2008.04.006; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fox IK, 2012, MICROSURG, V32, P552, DOI 10.1002/micr.22036; Frey M, 2003, EUR J PLAST SURG, V26, P89; Frey M, 2003, EUR J PLAST SURG, V26, P85, DOI [10.1007/s00238-003-0475-z., DOI 10.1007/s00238-003-0475-z]; Gencer ZK, 2014, J CRANIOFAC SURG, V25, P652, DOI 10.1097/SCS.0000000000000605; Geuna S, 2000, ANN ANAT, V182, P23, DOI 10.1016/S0940-9602(00)80117-X; Geuna S, 2006, BRAIN RES REV, V52, P381, DOI 10.1016/j.brainresrev.2006.05.002; Giovanoli P, 2000, PLAST RECONSTR SURG, V106, P383, DOI 10.1097/00006534-200008000-00021; GORDON T, 1993, BRAIN RES BULL, V30, P477, DOI 10.1016/0361-9230(93)90281-F; GURNEY ME, 1992, J NEUROSCI, V12, P3241, DOI 10.1523/JNEUROSCI.12-08-03241.1992; Hayashi A, 2004, PLAST RECONSTR SURG, V114, P129, DOI 10.1097/01.PRS.0000129075.96217.92; Hilliard MA, 2009, J NEUROCHEM, V108, P23, DOI 10.1111/j.1471-4159.2008.05754.x; Kanje M, 2000, NEUROREPORT, V11, P2455, DOI 10.1097/00001756-200008030-00023; Kayikcioglu A, 2000, ANN PLAS SURG, V45, P641; Kelly EJ, 2007, J PLAST RECONSTR AES, V60, P1, DOI 10.1016/j.bjps.2005.12.059; Kim JK, 2011, J PLAST RECONSTR AES, V64, P255, DOI 10.1016/j.bjps.2010.04.033; Kolter M, 2015, J CONTROL RELEASE, V197, P165, DOI 10.1016/j.jconrel.2014.11.005; Kostakoglu N, 1999, BRIT J PLAST SURG, V52, P404, DOI 10.1054/bjps.1999.3123; Kovacic U, 2007, EXP NEUROL, V203, P358, DOI 10.1016/j.expneurol.2006.08.018; Landegren T, 2006, SCAND J PLAST RECONS, V40, P65, DOI 10.1080/02844310500513030; Landegren T, 2010, INT J ORAL MAX SURG, V39, P705, DOI 10.1016/j.ijom.2010.03.008; Landegren T, 2007, SCAND J PLAST RECONS, V41, P217, DOI 10.1080/02844310701552001; Larsen JO, 1998, J NEUROSCI METH, V85, P107, DOI 10.1016/S0165-0270(98)00129-0; Liang XD, 2014, NEURAL REGEN RES, V9, P594, DOI 10.4103/1673-5374.130099; Liu K, 1999, J ORTHOP RES, V17, P293, DOI 10.1002/jor.1100170220; LUNDBORG G, 1994, J HAND SURG-BRIT EUR, V19B, P277, DOI 10.1016/0266-7681(94)90069-8; Lutz BS, 2000, BRIT J PLAST SURG, V53, P149, DOI 10.1054/bjps.1999.3252; MACKINNON SE, 1991, MUSCLE NERVE, V14, P1116, DOI 10.1002/mus.880141113; Matsumoto M, 1999, J RECONSTR MICROSURG, V15, P281, DOI 10.1055/s-2007-1000102; McCallister WV, 2001, J HAND SURG-AM, V26A, P478, DOI 10.1053/jhsu.2001.24148; McCallister WV, 1999, J RECONSTR MICROSURG, V15, P597, DOI 10.1055/s-2007-1000144; Mennen U, 2004, J HAND SURG-BRIT EUR, V29B, P514, DOI 10.1016/j.jhsh.2004.03.009; Mennen U, 1999, S AFR MED J, V89, P1188; Mennen U, 1998, HAND SURG, V3, P1; Mennen Ulrich, 2003, Hand Surg, V8, P25, DOI 10.1142/S0218810403001340; Millesi H, 2008, HAND CLIN, V24, P461, DOI 10.1016/j.hcl.2008.04.007; Myckatyn TM, 2004, J RECONSTR MICROSURG, V20, P533, DOI 10.1055/s-2004-836125; Noah EM, 1997, J RECONSTR MICROSURG, V13, P99, DOI 10.1055/s-2007-1000224; Silva DNE, 2012, ACTA CIR BRAS, V27, P325, DOI 10.1590/S0102-86502012000400008; Silva DNE, 2010, ACTA CIR BRAS, V25, P158, DOI 10.1590/S0102-86502010000200007; Okajima S, 2000, J RECONSTR MICROSURG, V16, P313, DOI 10.1055/s-2000-7339; Ornelas L, 2006, J RECONSTR MICROSURG, V22, P123, DOI 10.1055/s-2006-932507; PALAZZI S, 1995, J RECONSTR MICROSURG, V11, P135, DOI 10.1055/s-2007-1006521; Pannucci C, 2007, RESTOR NEUROL NEUROS, V25, P45; Papalia I, 2007, MICROSURG, V27, P56, DOI 10.1002/micr.20303; Papalia I, 2003, J NEUROSCI METH, V127, P43, DOI 10.1016/S0165-0270(03)00098-0; Papalia I, 2007, J NEUROSURG, V107, P378, DOI 10.3171/JNS-07/08/0378; Piskin A, 2009, MICROSURG, V29, P144, DOI 10.1002/micr.20599; Rovak JM, 2000, MICROSURG, V20, P6, DOI 10.1002/(SICI)1098-2752(2000)20:1<6::AID-MICR2>3.0.CO;2-5; Samal F, 2006, ANN ANAT, V188, P337, DOI 10.1016/j.aanat.2006.01.017; Sananpanich K, 2002, J HAND SURG-AM, V27A, P133, DOI 10.1053/jhsu.2002.30370; Sananpanich K, 2007, J NEUROTRAUM, V24, P864, DOI 10.1089/neu.2006.0226; Schmitz C, 2005, NEUROSCIENCE, V130, P813, DOI 10.1016/j.neuroscience.2004.08.050; Sherif MM, 2010, J HAND SURG-AM, V35A, P446, DOI 10.1016/j.jhsa.2009.10.033; SPENCER PS, 1975, BRAIN RES, V96, P323, DOI 10.1016/0006-8993(75)90742-8; Tam SL, 2003, J NEUROBIOL, V57, P221, DOI 10.1002/neu.10276; Tanigawa N, 2005, J NEUROTRAUM, V22, P605, DOI 10.1089/neu.2005.22.605; Tarasidis G, 1998, OTOLARYNG HEAD NECK, V119, P337, DOI 10.1016/S0194-5998(98)70074-9; Tarasidis G, 1997, ANN OTO RHINOL LARYN, V106, P506, DOI 10.1177/000348949710600612; Terzis JK, 2009, PLAST RECONSTR SURG, V124, P1142, DOI 10.1097/PRS.0b013e3181b2b8bc; Tham SKY, 1998, J HAND SURG-AM, V23A, P844, DOI 10.1016/S0363-5023(98)80161-5; Tos P, 2011, ACTA NEUROCHIR SUPPL, V108, P241, DOI 10.1007/978-3-211-99370-5_37; Tung TH, 2003, J NEUROSURG, V98, P313, DOI 10.3171/jns.2003.98.2.0313; Tung THH, 2001, J HAND SURG-AM, V26A, P1065, DOI 10.1053/jhsu.2001.28427; VITERBO F, 1994, PLAST RECONSTR SURG, V94, P1038, DOI 10.1097/00006534-199412000-00019; Viterbo F, 1992, Rev Paul Med, V110, P267; Viterbo Fausto, 2009, Plast Reconstr Surg, V124, pe351, DOI 10.1097/PRS.0b013e3181bf8471; Walker JC, 2004, J NEUROTRAUM, V21, P217, DOI 10.1089/089771504322778677; Wieken K, 2003, J RECONSTR MICROSURG, V19, P17, DOI 10.1055/s-2003-37186; Witzel C, 2005, J COMP NEUROL, V485, P183, DOI 10.1002/cne.20436; Wood MD, 2015, EXP NEUROL, V265, P171, DOI 10.1016/j.expneurol.2015.02.001; Yamauchi Toru, 2000, Medical Electron Microscopy, V33, P151, DOI 10.1007/s007950000015; Yan JG, 2002, J HAND SURG-AM, V27A, P484, DOI 10.1053/jhsu.2002.32953; Yan YH, 2011, MICROSURG, V31, P122, DOI 10.1002/micr.20840; Yuksel F, 2004, MICROSURG, V24, P363, DOI 10.1002/micr.20058; Zhang F, 2002, MICROSURG, V22, P122, DOI 10.1002/micr.21736; Zhang Z, 2001, Am J Orthop (Belle Mead NJ), V30, P400; Zhang ZJ, 2006, MICROSURG, V26, P262, DOI 10.1002/micr.20237; Zhang ZJ, 2000, J RECONSTR MICROSURG, V16, P303, DOI 10.1055/s-2000-7338; Zhao JZ, 1997, J RECONSTR MICROSURG, V13, P31, DOI 10.1055/s-2008-1063938; Zhu QT, 2008, MUSCLE NERVE, V38, P1506, DOI 10.1002/mus.21116	105	15	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148443	10.1371/journal.pone.0148443	http://dx.doi.org/10.1371/journal.pone.0148443			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872263	Green Published, gold			2022-12-27	WOS:000370054100030
J	Qi, YJ; Fang, H; Liu, WQ				Qi, Yujun; Fang, Hai; Liu, Weiqing			Experimental Study of the Bending Properties and Deformation Analysis of Web-Reinforced Composite Sandwich Floor Slabs with Four Simply Supported Edges	PLOS ONE			English	Article							GFRP BRIDGE DECK; STATIC BEHAVIOR; COLLAPSE MODES; PANELS	Web-reinforced composite sandwich panels exhibit good mechanical properties in one-way bending, but few studies have investigated their flexural behavior and deformation calculation methods under conditions of four simply supported edges. This paper studies the bending performance of and deformation calculation methods for two-way web-reinforced composite sandwich panels with different web spacing and heights. Polyurethane foam, two-way orthogonal glass-fiber woven cloth and unsaturated resin were used as raw materials in this study. Vacuum infusion molding was used to prepare an ordinary composite sandwich panel and 5 web-reinforced composite sandwich panels with different spacing and web heights. The panels were subjected to two-way panel bending tests with simple support for all four edges. The mechanical properties of these sandwich panels during the elastic stage were determined by applying uniformly distributed loads. The non-linear mechanical characteristics and failure modes were obtained under centrally concentrated loading. Finally, simulations of the sandwich panels, which used the mechanical model established herein, were used to deduce the formulae for the deflection deformation for this type of sandwich panel. The experimental results show that webs can significantly improve the limit bearing capacity and flexural rigidity of sandwich panels, with smaller web spacing producing a stronger effect. When the web spacing is 75 mm, the limit bearing capacity is 4.63 times that of an ordinary sandwich panel. The deduced deflection calculation formulae provide values that agree well with the measurements (maximum error <15%). The results that are obtained herein can provide a foundation for the structural design of this type of panel.	[Qi, Yujun; Fang, Hai; Liu, Weiqing] Nanjing Tech Univ, Coll Civil Engn, Nanjing 211816, Jiangsu, Peoples R China	Nanjing Tech University	Liu, WQ (corresponding author), Nanjing Tech Univ, Coll Civil Engn, Nanjing 211816, Jiangsu, Peoples R China.	wqliu@njtech.edu.cn			Key Program of the National Natural Science Foundation of China [51238003]; National Natural Science Foundation of China [51308287]; Natural Science Foundation of Jiangsu Province [BK20130936]	Key Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This study was supported by the Key Program of the National Natural Science Foundation of China (No. 51238003), the National Natural Science Foundation of China (No. 51308287) and the Natural Science Foundation of Jiangsu Province (No. BK20130936).	Awad ZK, 2013, MATER DESIGN, V45, P125, DOI 10.1016/j.matdes.2012.08.072; Crupi V, 2012, INT J IMPACT ENG, V43, P6, DOI 10.1016/j.ijimpeng.2011.12.002; Daniel IM, 2002, INT J DAMAGE MECH, V11, P309, DOI 10.1106/105678902027247; Dawood M, 2010, COMPOS STRUCT, V92, P950, DOI 10.1016/j.compstruct.2009.09.040; DRANSFIELD K, 1994, COMPOS SCI TECHNOL, V50, P305, DOI 10.1016/0266-3538(94)90019-1; Hudson CW, 2010, COMPOS STRUCT, V92, P2077, DOI 10.1016/j.compstruct.2009.10.018; Islam MM, 2010, COMPOS STRUCT, V93, P206, DOI 10.1016/j.compstruct.2010.05.019; Karlsson KF, 1997, COMPOS PART A-APPL S, V28, P97, DOI 10.1016/S1359-835X(96)00098-X; Keller T, 2014, J COMPOS CONSTR, V18, DOI 10.1061/(ASCE)CC.1943-5614.0000423; Koh TM, 2013, COMPOS PART B-ENG, V44, P620, DOI 10.1016/j.compositesb.2012.02.017; Lascoup B, 2006, COMPOS SCI TECHNOL, V66, P1385, DOI 10.1016/j.compscitech.2005.09.005; Mamalis AG, 2008, INT J CRASHWORTHINES, V13, P349, DOI 10.1080/13588260801933691; Manalo AC, 2010, CONSTR BUILD MATER, V24, P1952, DOI 10.1016/j.conbuildmat.2010.04.005; Manalo AC, 2010, COMPOS STRUCT, V92, P2703, DOI 10.1016/j.compstruct.2010.03.006; Manalo AC, 2010, COMPOS STRUCT, V92, P984, DOI 10.1016/j.compstruct.2009.09.046; Marasco AI, 2006, COMPOS PART A-APPL S, V37, P295, DOI 10.1016/j.compositesa.2005.03.029; Potluri P, 2003, COMPOS STRUCT, V59, P251, DOI 10.1016/S0263-8223(02)00087-9; Reis EM, 2008, CONSTR BUILD MATER, V22, P1009, DOI 10.1016/j.conbuildmat.2007.03.023; Roberts JC, 2002, COMPOS PART B-ENG, V33, P315, DOI 10.1016/S1359-8368(02)00017-3; Russo A, 2007, COMPOS STRUCT, V81, P575, DOI 10.1016/j.compstruct.2006.10.007; Sokolinsky VS, 2003, COMPOS STRUCT, V60, P219, DOI 10.1016/S0263-8223(02)00293-3; Tagarielli VL, 2004, COMPOS PART B-ENG, V35, P523, DOI 10.1016/j.compositesb.2003.07.001; Viana GM, 2003, J SANDW STRUCT MATER, V5, P103, DOI 10.1177/1099636203005002020; Wang L, 2014, COMPOS PART B-ENG, V67, P270, DOI 10.1016/j.compositesb.2014.07.003; Wu ZM, 2014, COMPOS PART B-ENG, V60, P329, DOI 10.1016/j.compositesb.2013.12.078; Zi G, 2008, COMPOS STRUCT, V85, P155, DOI 10.1016/j.compstruct.2007.10.015; Zi G, 2008, COMPOS STRUCT, V82, P257, DOI 10.1016/j.compstruct.2007.01.010	27	2	2	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149103	10.1371/journal.pone.0149103	http://dx.doi.org/10.1371/journal.pone.0149103			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871435	gold, Green Submitted, Green Published			2022-12-27	WOS:000370054100105
J	Singh, A; Kamal, R; Mudiam, MKR; Gupta, MK; Satyanarayana, GNV; Bihari, V; Shukla, N; Khan, AH; Kesavachandran, CN				Singh, Amarnath; Kamal, Ritul; Mudiam, Mohana Krishna Reddy; Gupta, Manoj Kumar; Satyanarayana, Gubbala Naga Venkata; Bihari, Vipin; Shukla, Nishi; Khan, Altaf Hussain; Kesavachandran, Chandrasekharan Nair			Heat and PAHs Emissions in Indoor Kitchen Air and Its Impact on Kidney Dysfunctions among Kitchen Workers in Lucknow, North India	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; MUTAGENIC ALDEHYDES; PARTICULATE MATTER; CANCER-MORTALITY; COOKING FUMES; RENAL-DISEASE; EXPOSURE; ALBUMINURIA; ULTRAFINE; WORKING	Indoor air quality and heat exposure have become an important occupational health and safety concern in several workplaces including kitchens of hotels. This study investigated the heat, particulate matter (PM), total volatile organic compounds (TVOCs) and polycyclic aromatic hydrocarbons (PAHs) emissions in indoor air of commercial kitchen and its association with kidney dysfunctions among kitchen workers. A cross sectional study was conducted on 94 kitchen workers employed at commercial kitchen in Lucknow city, North India. A questionnaire-based survey was conducted to collect the personal and occupational history of the kitchen workers. The urine analysis for specific gravity and microalbuminuria was conducted among the study subjects. Indoor air temperature, humidity, wet/dry bulb temperature and humidex heat stress was monitored during cooking activities at the kitchen. Particulate matter (PM) for 1 and 2.5 microns were monitored in kitchen during working hours using Hazdust. PAHS in indoor air was analysed using UHPLC. Urinary hydroxy-PAHs in kitchen workers were measured using GC/MS-MS. Higher indoor air temperature, relative humidity, PM1 and PM2.5 (p<0.001) was observed in the kitchen due to cooking process. Indoor air PAHs identified are Napthalene, fluorine, acenaphthene, phenanthrene, pyrene, chrysene and indeno [1,2,3-cd) pyrene. Concentrations of all PAHs identified in kitchen were above the permissible OSHA norms for indoor air. Specific gravity of urine was significantly higher among the kitchen workers (p<0.001) as compared to the control group. Also, the prevalence of microalbuminuria was higher (p<0.001) among kitchen workers. Urinary PAH metabolites detected among kitchen workers were 1-NAP, 9-HF, 3-HF, 9-PHN and 1-OHP. Continuous heat exposure in kitchens due to cooking can alter kidney functions viz., high specific gravity of urine in kitchen workers. Exposure to PM, VOCs and PAHs in indoor air and presence of urinary PAHs metabolites may lead to inflammation, which can cause microalbuminuria in kitchen workers, as observed in the present study.	[Singh, Amarnath; Kamal, Ritul; Bihari, Vipin; Kesavachandran, Chandrasekharan Nair] CSIR Indian Inst Toxicol Res, Div Epidemiol, PB 80,MG Marg, Lucknow 226001, Uttar Pradesh, India; [Shukla, Nishi; Khan, Altaf Hussain] CSIR Indian Inst Toxicol Res, Environm Monitoring Div, PB 80,MG Marg, Lucknow 226001, Uttar Pradesh, India; [Mudiam, Mohana Krishna Reddy; Gupta, Manoj Kumar; Satyanarayana, Gubbala Naga Venkata] CSIR Indian Inst Toxicol Res, Div Analyt Chem, PB 80,MG Marg, Lucknow 226001, Uttar Pradesh, India; [Singh, Amarnath] Babu Banarasi Univ, Dept Biochem, BBD City, Faizabad Rd, Lucknow 226028, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Babu Banarasi Das University	Kesavachandran, CN (corresponding author), CSIR Indian Inst Toxicol Res, Div Epidemiol, PB 80,MG Marg, Lucknow 226001, Uttar Pradesh, India.	ckesavachandran@gmail.com	Mudiam, Mohana Krishna Reddy/O-6824-2014	Mudiam, Mohana Krishna Reddy/0000-0002-0771-8053; Kamal, Ritul/0000-0001-9741-1698	Council of Scientific and Industrial Research, New Delhi-Network program, Government of India [INDEPTH-BSC-0111]	Council of Scientific and Industrial Research, New Delhi-Network program, Government of India	This study was funded by the Council of Scientific and Industrial Research, New Delhi-Network program (Code: INDEPTH-BSC-0111), Government of India.	Afshari A, 2005, INDOOR AIR, V15, P141, DOI 10.1111/j.1600-0668.2005.00332.x; Al-Tawheed AR, 2003, ANN SAUDI MED, V23, P283, DOI 10.5144/0256-4947.2003.283; Alshaarawy O, 2013, ENVIRON RES, V126, P98, DOI 10.1016/j.envres.2013.07.006; Armstrong LE, 1998, INT J SPORT NUTR, V8, P345, DOI 10.1123/ijsn.8.4.345; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Beldean-Galea MS, 2014, ACTA CHIM SLOV, V61, P202; Biswas Rajib, 2011, Indian J Occup Environ Med, V15, P120, DOI 10.4103/0019-5278.93202; Brake DJ, 2003, OCCUP ENVIRON MED, V60, P90, DOI 10.1136/oem.60.2.90; BUCKLEY TJ, 1992, BRIT J IND MED, V49, P113; Buonanno G, 2011, AEROSOL SCI TECH, V45, P1069, DOI 10.1080/02786826.2011.580797; BURGAZ S, 1992, INT ARCH OCC ENV HEA, V63, P397, DOI 10.1007/BF00386935; Canadian Centre for Occupational Health and Safety, 2015, HUM RAT WORK; Center for Disease Control and Prevention, 2012, FREQ ASK QUEST EXTR; CORTEZ OD, 2009, GLOB HLTH ACTION, V2, P2069, DOI DOI 10.3402/GHA.V2I0.2069; Crowe J, 2014, OCCUP ENV MED S1, V71, pA51, DOI [DOI 10.1136/OEMED-2014-102362.157, DOI 10.1136/0EMED-2014-102362.157]; Festa A, 2000, KIDNEY INT, V58, P1703, DOI 10.1046/j.1523-1755.2000.00331.x; Gallagner KP, 1964, MONOGRAPHS NATL CANC, V53, P89; Glassock RJ, 2010, CURR HYPERTENS REP, V12, P364, DOI 10.1007/s11906-010-0133-3; GRIMMER G, 1991, INT J ENVIRON AN CH, V43, P177, DOI 10.1080/03067319108026974; Gupta MK, 2015, J ANAL TOXICOL, V39, P365, DOI 10.1093/jat/bkv023; Hallan SI, 2009, J AM SOC NEPHROL, V20, P1069, DOI 10.1681/ASN.2008070730; Hansen AL, 2008, INT J EPIDEMIOL, V37, P1359, DOI 10.1093/ije/dyn165; Haruyama Y, 2010, IND HEALTH, V48, P135, DOI 10.2486/indhealth.48.135; HERIKSTAD BV, 1993, CARCINOGENESIS, V14, P307, DOI 10.1093/carcin/14.2.307; Hoy WE, 2001, KIDNEY INT, V60, P249, DOI 10.1046/j.1523-1755.2001.00793.x; Jakubowski Marek, 2005, International Journal of Occupational Medicine and Environmental Health, V18, P5; Johnson DW, 2012, MED J AUSTRALIA, V197, P224, DOI 10.5694/mja11.11468; JONGENEELEN FJ, 1992, INT ARCH OCC ENV HEA, V63, P511, DOI 10.1007/BF00386338; Kamijo YI, 2006, IND HEALTH, V44, P345, DOI 10.2486/indhealth.44.345; KING H, 1973, J CHRON DIS, V26, P623, DOI 10.1016/0021-9681(73)90053-2; Lamers RJAN, 2005, OSTEOARTHR CARTILAGE, V13, P762, DOI 10.1016/j.joca.2005.04.005; Levin A, 2008, CLIN J AM SOC NEPHRO, V3, P862, DOI 10.2215/CJN.04841107; McLaughlin M., 2013, 9 11 RESPONDERS SUFF; Moret S, 2000, J CHROMATOGR A, V882, P245, DOI 10.1016/S0021-9673(00)00079-0; Mumford JL, 1995, CARCINOGENESIS, V16, P3031, DOI 10.1093/carcin/16.12.3031; NY ET, 1993, AM IND HYG ASSOC J, V54, P277, DOI 10.1202/0002-8894(1993)054<0277:TRBPAH>2.0.CO;2; Occupational Health and Safety, ACC IND AIR QUAL LEV; Occupational Safety and Health Administration, OSHA FACT SHEET PROT; Occupational Safety and Health Administration, OSHA TECHN MAN OSHA; Raju DSSK., 2014, ASIAN J PHARM CLIN R, V7, P53; Robinson AL, 2006, ENVIRON SCI TECHNOL, V40, P7820, DOI 10.1021/es060781p; SANTELLA RM, 1993, CANCER EPIDEM BIOMAR, V2, P59; SCHOENBERG JB, 1984, J NATL CANCER I, V72, P973; Sjaastad AK, 2010, OCCUP ENVIRON MED, V67, P228, DOI 10.1136/oem.2009.046144; Sjaastad AK, 2009, ANN OCCUP HYG, V53, P723, DOI 10.1093/annhyg/mep059; Sjaastad AK, 2008, ANN OCCUP HYG, V52, P739, DOI 10.1093/annhyg/men060; Srivastava A, 2000, ANN OCCUP HYG, V44, P449, DOI 10.1016/S0003-4878(00)00003-X; Svendsen K, 2002, ANN OCCUP HYG, V46, P395, DOI 10.1093/annhyg/mef045; To WM, 2000, INDOOR BUILT ENVIRON, V9, P228, DOI 10.1177/1420326X0000900312; Vaidya C, 2010, CLEV CLIN J MED, V77, P715, DOI 10.3949/ccjm.77a.08051; VAINIOTALO S, 1993, AM IND HYG ASSOC J, V54, P376, DOI 10.1202/0002-8894(1993)054<0376:CFAAHP>2.0.CO;2; Venkatachalam MA, 2010, AM J PHYSIOL-RENAL, V298, pF1078, DOI 10.1152/ajprenal.00017.2010; Wallace LA, 2004, ENVIRON SCI TECHNOL, V38, P2304, DOI 10.1021/es0306260; Wallace L, 2008, ENVIRON SCI TECHNOL, V42, P8641, DOI 10.1021/es801402v; World Healh Organisation, 1991, PRINC METH ASS NEPHR; World Health Organization, 1996, GUIDELINES; Zhu LZ, 2003, CHEMOSPHERE, V50, P611, DOI 10.1016/S0045-6535(02)00668-9	57	38	42	7	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148641	10.1371/journal.pone.0148641	http://dx.doi.org/10.1371/journal.pone.0148641			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871707	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100044
J	Tu, YH; Wang, YL; Ding, LN; Zhang, J; Wu, WC				Tu, Yunhai; Wang, Yilong; Ding, Luna; Zhang, Jiao; Wu, Wencan			Development of a Novel Thyroid Function Fluctuated Animal Model for Thyroid-Associated Ophthalmopathy	PLOS ONE			English	Article							GRAVES-OPHTHALMOPATHY; THYROTROPIN RECEPTOR; CURRENT INSIGHTS; DISEASE; ORBITOPATHY; HYPERTHYROIDISM; EXPRESSION; AUTOANTIBODIES; PATHOGENESIS; ANTIBODIES	Background The establishment of a suitable and stable animal model is critical for research on thyroid-associated ophthalmopathy (TAO). In clinical practice, we found that patients treated with I-131 often exhibit TAO; therefore, we aimed to establish a novel thyroid function fluctuated animal model of TAO by simulating the clinical treatment process. Methods We treated SD rats with I-131 to damage the thyroid and then used sodium levothyroxine (L-T4) to supplement the thyroid hormone (TH) levels every seven days, leading to a fluctuating level of thyroid hormones that simulated the status of clinical TAO patients. Rats administered normal saline were considered as a control. The weight, intraocular pressure, and serum T3, T4, TSH and TRAb levels of the rats were measured, and the pathological changes were analyzed by H& E staining and transmission electron microscopy (TEM). Results The experimental rats (TAO group) exhibited significantly reduced weight and elevated intraocular pressure compared with the control rats. Meanwhile, the serum levels of T3 and T4 were up-regulated in the TAO group, but the TSH level decreased during the 10-week study. Moreover, increased numbers of blood vessels and inflammatory cell infiltrations were observed in the orbital tissues of the TAOrats, while no abnormal changes occurred in the control rats. The orbital myofibrils in the TAO rats appeared fractured and dissolved, with twisted structures. Mitochondrial swelling and vacuoles within the endoplasmic reticulum, swelling nerve fibers, shedding nerve myelin, and macrophages were found in the TAO group. Conclusion Rats treated with I-131 and sodium levothyroxine exhibited characteristics similar to those of TAO patients in the clinic, providing an effective and simple method for the establishment of a stable animal model for research on the pathogenesis and treatment of TAO.	[Tu, Yunhai; Ding, Luna; Zhang, Jiao; Wu, Wencan] Wenzhou Med Univ, Hosp Eye, Wenzhou 325000, Peoples R China; [Wang, Yilong] Wenzhou Med Univ, Dept Lab Anim Ctr, Wenzhou 325000, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Wu, WC (corresponding author), Wenzhou Med Univ, Hosp Eye, Wenzhou 325000, Peoples R China.	wuwencan118@163.com			Zhejiang Provincial Natural Science Foundation of China [LQ12H12004, LY12H12006]; Eye Hospital of Wenzhou Medical University [YNCX201315]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Eye Hospital of Wenzhou Medical University	This study was financially supported by the Zhejiang Provincial Natural Science Foundation of China under Grant Nos. LQ12H12004 and LY12H12006, and The Eye Hospital of Wenzhou Medical University (YNCX201315).	Arnold K, 1996, ORBIT, V15, P159, DOI 10.3109/01676839609150233; BAHN RS, 1993, NEW ENGL J MED, V329, P1468; Banga JP, 2015, HORM METAB RES, V47, P797, DOI 10.1055/s-0035-1555956; Bartalena L, 2000, ENDOCR REV, V21, P168, DOI 10.1210/er.21.2.168; Bartalena L, 1998, NEW ENGL J MED, V338, P73, DOI 10.1056/NEJM199801083380201; BARTLEY GB, 1995, AM J OPHTHALMOL, V119, P792, DOI 10.1016/S0002-9394(14)72787-4; Clement SC, 2015, CANC TREAT REV, V10; Cockerham KP, 1997, OPHTHALMOLOGY, V104, P914, DOI 10.1016/S0161-6420(97)30207-3; Costagliola S, 1998, J IMMUNOL, V160, P1458; Czarnywojtek Agata, 2013, Neuro Endocrinol Lett, V34, P241; Eckstein AK, 2009, HORM METAB RES, V41, P456, DOI 10.1055/s-0029-1220935; Eckstein AK, 2004, BRIT J OPHTHALMOL, V88, P803, DOI 10.1136/bjo.2003.035915; Eckstein AK, 2006, J CLIN ENDOCR METAB, V91, P3464, DOI 10.1210/jc.2005-2813; Gerding MN, 2000, CLIN ENDOCRINOL, V52, P267, DOI 10.1046/j.1365-2265.2000.00959.x; HEUFELDER AE, 1992, EUR J CLIN INVEST, V22, P529, DOI 10.1111/j.1365-2362.1992.tb01501.x; HEUFELDER AE, 1993, EUR J CLIN INVEST, V23, P10, DOI 10.1111/j.1365-2362.1993.tb00712.x; Jang SY, 2013, EYE, V27, P964, DOI 10.1038/eye.2013.120; Kim SE, 2012, GRAEF ARCH CLIN EXP, V250, P1521, DOI 10.1007/s00417-012-2092-7; Klee GG, 1997, ENDOCRIN METAB CLIN, V26, P763, DOI 10.1016/S0889-8529(05)70281-4; Konuk EBY, 2006, EUR J ENDOCRINOL, V155, P681, DOI 10.1530/eje.1.02280; KROLL AJ, 1966, ARCH OPHTHALMOL-CHIC, V76, P244, DOI 10.1001/archopht.1966.03850010246017; Maheshwari R, 2012, INDIAN J OPHTHALMOL, V60, P87, DOI 10.4103/0301-4738.94048; Molnar I, 1997, AUTOIMMUNITY, V25, P91, DOI 10.3109/08916939708996275; Moshkelgosha S, 2015, CURR PHARM DESIGN, V21, P2414, DOI 10.2174/1381612821666150316121945; Noh JY, 2000, THYROID, V10, P809, DOI 10.1089/thy.2000.10.809; Salvi M, 2015, HORM METAB RES, V47, P779, DOI 10.1055/s-0035-1554721; Sen E, 2012, J GLAUCOMA, V21, P586, DOI 10.1097/IJG.0b013e31822e8c4f; SMITH BR, 1988, ENDOCR REV, V9, P106, DOI 10.1210/edrv-9-1-106; SURKS MI, 1990, JAMA-J AM MED ASSOC, V263, P1529, DOI 10.1001/jama.263.11.1529; TALLSTEDT L, 1992, NEW ENGL J MED, V326, P1733, DOI 10.1056/NEJM199206253262603; Traisk F, 2009, J CLIN ENDOCR METAB, V94, P3700, DOI 10.1210/jc.2009-0747; TSALOUMAS MD, 1994, EYE, V8, P638, DOI 10.1038/eye.1994.159; Vondrichova T, 2007, THYROID, V17, P511, DOI 10.1089/thy.2007.0028; Weetman AP, 1997, MOL CELL ENDOCRINOL, V126, P113, DOI 10.1016/S0303-7207(96)03986-X; Wiesweg B, 2013, HORM METAB RES, V45, P549, DOI 10.1055/s-0033-1343451	35	2	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148595	10.1371/journal.pone.0148595	http://dx.doi.org/10.1371/journal.pone.0148595			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872324	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100039
J	Wasitthankasem, R; Posuwan, N; Vichaiwattana, P; Theamboonlers, A; Klinfueng, S; Vuthitanachot, V; Thanetkongtong, N; Saelao, S; Foonoi, M; Fakthongyoo, A; Makaroon, J; Srisingh, K; Asawarachun, D; Owatanapanich, S; Wutthiratkowit, N; Tohtubtiang, K; Yoocharoen, P; Vongpunsawad, S; Poovorawan, Y				Wasitthankasem, Rujipat; Posuwan, Nawarat; Vichaiwattana, Preeyaporn; Theamboonlers, Apiradee; Klinfueng, Sirapa; Vuthitanachot, Viboonsak; Thanetkongtong, Napha; Saelao, Siriporn; Foonoi, Monthana; Fakthongyoo, Apinya; Makaroon, Jamorn; Srisingh, Klaita; Asawarachun, Duangporn; Owatanapanich, Somchai; Wutthiratkowit, Norra; Tohtubtiang, Kraisorn; Yoocharoen, Pornsak; Vongpunsawad, Sompong; Poovorawan, Yong			Decreasing Hepatitis C Virus Infection in Thailand in the Past Decade: Evidence from the 2014 National Survey	PLOS ONE			English	Article							BLOOD-DONORS; RISK-FACTORS; GENOTYPE DISTRIBUTION; PEGYLATED INTERFERON; COST-EFFECTIVENESS; PREVALENCE; EPIDEMIOLOGY; SOFOSBUVIR; RIBAVIRIN; SEROEPIDEMIOLOGY	Hepatitis C virus (HCV) infection affects >= 180 million individuals worldwide especially those living in developing countries. Recent advances in direct-acting therapeutics promise effective treatments for chronic HCV carriers, but only if the affected individuals are identified. Good treatment coverage therefore requires accurate epidemiological data on HCV infection. In 2014, we determined the current prevalence of HCV in Thailand to assess whether over the past decade the significant number of chronic carriers had changed. In total, 5964 serum samples from Thai residents between 6 months and 71 years of age were obtained from 7 provinces representing all 4 geographical regions of Thailand and screened for the anti-HCV antibody. Positive samples were further analyzed using RT-PCR, sequencing, and phylogenetic analysis to identify the prevailing HCV genotypes. We found that 56 (0.94%) samples tested positive for anti-HCV antibody (mean age = 36.6 +/- 17.6 years), while HCV RNA of the core and NS5B subgenomic regions was detected in 23 (41%) and 19 (34%) of the samples, respectively. The seropositive rates appeared to increase with age and peaked in individuals 41-50 years old. These results suggested that approximately 759,000 individuals are currently anti-HCV-positive and that 357,000 individuals have viremic HCV infection. These numbers represent a significant decline in the prevalence of HCV infection. Interestingly, the frequency of genotype 6 variants increased from 8.9% to 34.8%, while the prevalence of genotype 1b declined from 27% to 13%. These most recent comprehensive estimates of HCV burden in Thailand are valuable towards evidence-based treatment coverage for specific population groups, appropriate allocation of resources, and improvement in the national public health policy.	[Wasitthankasem, Rujipat; Posuwan, Nawarat; Vichaiwattana, Preeyaporn; Theamboonlers, Apiradee; Klinfueng, Sirapa; Vongpunsawad, Sompong; Poovorawan, Yong] Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Bangkok 10330, Thailand; [Vuthitanachot, Viboonsak; Thanetkongtong, Napha] Chumpare Hosp, Khon Kaen, Thailand; [Saelao, Siriporn; Foonoi, Monthana; Fakthongyoo, Apinya] Uttaradit Hosp, Mueang, Uttaradit, Thailand; [Makaroon, Jamorn] Lablae Hosp, Lablae, Uttaradit, Thailand; [Srisingh, Klaita] Naresuan Univ Hosp, Mueang, Phitsanulok, Thailand; [Asawarachun, Duangporn] Phra Nakhon Si Ayutthaya Hosp, Phra Nakhon Si Ayutthaya, Thailand; [Owatanapanich, Somchai] King Narai Hosp, Khao Sam Yot, Lop Buri, Thailand; [Wutthiratkowit, Norra] Narathiwat Ratchanakarin Hosp, Mueang, Narathiwat, Thailand; [Tohtubtiang, Kraisorn] Trang Hosp, Mueang, Trang, Thailand; [Yoocharoen, Pornsak] Minist Publ Hlth, Dept Dis Control, Bur Gen Communicable Dis, Nonthaburi, Thailand	Chulalongkorn University; Ministry of Public Health - Thailand	Poovorawan, Y (corresponding author), Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Bangkok 10330, Thailand.	yong.p@chula.ac.th	ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	vongpunsawad, sompong/0000-0001-7520-8728; Poovorawan, Yong/0000-0002-2337-6807	National Research University Project, Office of Higher Education Commission [WCU-58-006-HR]; National Research Council of Thailand (NRCT); Chulalongkorn University Centenary Academic Development Project [CU56-HR01]; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University [RES560530093]; Outstanding Professor of Thailand Research Fund [DPG5480002]; Center of Excellence in Clinical Virology of Chulalongkorn University [GCE 58-014-30-004]; King Chulalongkorn Memorial Hospital; Rachadapisek Sompote Fund of Chulalongkorn University; National Science and Technology Development Agency	National Research University Project, Office of Higher Education Commission; National Research Council of Thailand (NRCT)(National Research Council of Thailand (NRCT)); Chulalongkorn University Centenary Academic Development Project; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University(Chulalongkorn University); Outstanding Professor of Thailand Research Fund; Center of Excellence in Clinical Virology of Chulalongkorn University; King Chulalongkorn Memorial Hospital(Chulalongkorn University); Rachadapisek Sompote Fund of Chulalongkorn University; National Science and Technology Development Agency	This work was supported by The National Research University Project, Office of Higher Education Commission (WCU-58-006-HR), The National Research Council of Thailand (NRCT), The Research Chair Grant from the National Science and Technology Development Agency, Chulalongkorn University Centenary Academic Development Project (CU56-HR01), Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University (RES560530093), The Outstanding Professor of Thailand Research Fund (DPG5480002), and The Center of Excellence in Clinical Virology of Chulalongkorn University (GCE 58-014-30-004), King Chulalongkorn Memorial Hospital, and the Rachadapisek Sompote Fund of Chulalongkorn University for postdoctoral fellowship to Rujipat Wasitthankasem. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkarathamrongsin S, 2013, INTERVIROLOGY, V56, P284, DOI 10.1159/000351621; Akkarathamrongsin S, 2011, INTERVIROLOGY, V54, P10, DOI 10.1159/000318884; ARGUILLAS MO, 1991, GASTROENTEROL JPN, V26, P170; Baid-Agrawal S, 2014, J HEPATOL, V60, P928, DOI 10.1016/j.jhep.2014.01.012; Caruana SR, 2005, AUST NZ J PUBL HEAL, V29, P64, DOI 10.1111/j.1467-842X.2005.tb00751.x; Chhatwal J, 2015, ANN INTERN MED, V162, P397, DOI 10.7326/M14-1336; Chimparlee N, 2011, SE ASIAN J TROP MED, V42, P609; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Cure S, 2015, J MED ECON, V18, P678, DOI 10.3111/13696998.2015.1040024; Fellay J, 2010, NATURE, V464, P405, DOI 10.1038/nature08825; Fu YSH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047324, 10.1371/journal.pone.0028006]; Gane EJ, 2015, GASTROENTEROLOGY, V149, P1454, DOI 10.1053/j.gastro.2015.07.063; Comas LG, 2015, J MED VIROL, V87, P1697, DOI 10.1002/jmv.24219; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hart-Malloy R, 2013, AM J PUBLIC HEALTH, V103, P1402, DOI 10.2105/AJPH.2013.301231; Haslina MNN, 2012, SE ASIAN J TROP MED, V43, P668; Houghton M, 2009, LIVER INT, V29, P82, DOI 10.1111/j.1478-3231.2008.01925.x; Inoue Y, 2000, AM J TROP MED HYG, V62, P92, DOI 10.4269/ajtmh.2000.62.92; Ishida T, 2002, J CLIN VIROL, V24, P31, DOI 10.1016/S1386-6532(01)00222-0; Jittiwutikarn J, 2006, AM J TROP MED HYG, V74, P1111, DOI 10.4269/ajtmh.2006.74.1111; Kanistanon D, 1997, J CLIN MICROBIOL, V35, P1772, DOI 10.1128/JCM.35.7.1772-1776.1997; Kao HH, 2015, NEPHRON, V130, P127, DOI 10.1159/000430988; Kohli A, 2014, JAMA-J AM MED ASSOC, V312, P631, DOI 10.1001/jama.2014.7085; Luksamijarulkul Pipat, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P272; Lwin AA, 2007, HEPATOL RES, V37, P337, DOI 10.1111/j.1872-034X.2007.00053.x; Ng KT, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00168-12; Nguyen VTT, 2007, HEPATOL INT, V1, P387, DOI 10.1007/s12072-007-9008-3; Pfeil AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126984; PHANUPHAK P, 1985, ASIAN PAC J ALLERGY, V3, P195; Ratanasuwan Winai, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P416; Sawanpanyalert P, 1996, J EPIDEMIOL COMMUN H, V50, P174, DOI 10.1136/jech.50.2.174; Sistayanarain A, 2011, MOL BIOL REP, V38, P4287, DOI 10.1007/s11033-010-0552-x; Do SH, 2015, HEPATOL RES, V45, P259, DOI 10.1111/hepr.12350; Songsivilai S, 1997, AM J TROP MED HYG, V57, P66, DOI 10.4269/ajtmh.1997.57.66; Sunanchaikarn S, 2007, ASIAN PAC J ALLERGY, V25, P175; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Suwanagool Surapol, 1995, Journal of the Medical Association of Thailand, V78, P611; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thaikruea L, 2004, TRANSFUSION, V44, P1433, DOI 10.1111/j.1537-2995.2004.04073.x; Verachai Viroj, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P849; Vidimliski PD, 2014, J MED VIROL, V86, P1491, DOI 10.1002/jmv.23979; Wang JEH, 1995, J PUBLIC HEALTH MED, V17, P387; World Health Organization, 2014, HEP C; Yamada H, 2015, HEPATOL RES, V45, P480, DOI 10.1111/hepr.12367; Zhang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082598	48	32	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149362	10.1371/journal.pone.0149362	http://dx.doi.org/10.1371/journal.pone.0149362			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6SI	26871561	Green Submitted, gold, Green Published			2022-12-27	WOS:000370054100151
J	Dierickx, S; Gryseels, C; Mwesigwa, J; O'Neill, S; Bannister-Tyrell, M; Ronse, M; Jaiteh, F; Gerrets, R; D'Alessandro, U; Grietens, KP				Dierickx, Susan; Gryseels, Charlotte; Mwesigwa, Julia; O'Neill, Sarah; Bannister-Tyrell, Melanie; Ronse, Maya; Jaiteh, Fatou; Gerrets, Rene; D'Alessandro, Umberto; Grietens, Koen Peeters			Factors Associated with Non-Participation and Non-Adherence in Directly Observed Mass Drug Administration for Malaria in The Gambia	PLOS ONE			English	Article							HEALTH-CARE; ELIMINATION; TRANSMISSION; COMBINATION; UGANDA; TRIAL	Introduction The potential benefits of Mass Drug Administration (MDA) for malaria elimination are being considered in several malaria endemic countries where a decline in malaria transmission has been reported. For this strategy to work, it is important that a large proportion of the target population participates, requiring an in-depth understanding of factors that may affect participation and adherence to MDA programs. Methodology This social science study was ancillary to a one-round directly observed MDA campaign with dihydroartemisinin-piperaquine, carried out in 12 villages in rural Gambia between June and August 2014. The social science study employed a mixed-methods approach combining qualitative methods (participant observation and in-depth interviewing) and quantitative methods (structured follow-up interviews among non-participating and non-adhering community members). Results Of 3942 people registered in the study villages, 67.9% adhered to the three consecutive daily doses. For the remaining villagers, 12.6% did not attend the screening, 3.5% was not eligible and 16% did not adhere to the treatment schedule. The main barriers for non-participation and adherence were long and short-term mobility of individuals and specific subgroups, perceived adverse drug reactions and rumors, inconveniences related to the logistics of MDA (e.g. waiting times) and the perceived lack of information about MDA. Conclusion While, there was no fundamental resistance from the target communities, adherence was 67.9%. This shows the necessity of understanding local perceptions and barriers to increase its effectiveness. Moreover, certain of the constraining factors were socio-spatially clustered which might prove problematic since focal areas of residual malaria transmission may remain allowing malaria to spread to adjacent areas where transmission had been temporarily interrupted.	[Dierickx, Susan; Gryseels, Charlotte; O'Neill, Sarah; Bannister-Tyrell, Melanie; Ronse, Maya; Jaiteh, Fatou; D'Alessandro, Umberto; Grietens, Koen Peeters] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Dierickx, Susan; Gryseels, Charlotte; Gerrets, Rene] Amsterdam Inst Social Sci Res, Amsterdam, Netherlands; [Dierickx, Susan] Vrije Univ Brussel, Ctr Expertise Gender Divers & Intersect, Rhea, Brussels, Belgium; [Mwesigwa, Julia; Jaiteh, Fatou; D'Alessandro, Umberto] MRC Unit, Fajara, Gambia; [D'Alessandro, Umberto] Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England; [Grietens, Koen Peeters] PASS Int, Tessenderlo, Belgium; [Grietens, Koen Peeters] Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki 852, Japan	Institute of Tropical Medicine (ITM); University of Amsterdam; Vrije Universiteit Brussel; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Nagasaki University	Dierickx, S (corresponding author), Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium.; Dierickx, S (corresponding author), Amsterdam Inst Social Sci Res, Amsterdam, Netherlands.; Dierickx, S (corresponding author), Vrije Univ Brussel, Ctr Expertise Gender Divers & Intersect, Rhea, Brussels, Belgium.	susan.dierickx@vub.ac.be	Peeters Grietens, Koen/G-7028-2019	Peeters Grietens, Koen/0000-0001-6570-9887; O'Neill, Sarah/0000-0001-8807-0991; Gryseels, Charlotte/0000-0002-8963-4469; Dierickx, Susan/0000-0003-3140-0771; Ronse, Maya/0000-0001-7182-6940; Mwesigwa, Julia/0000-0003-2452-3677	UK Medical Research Council (MRC); UK Department for International Development (DFID) under the MRC/DFID; European Union; MRC [MC_EX_MR/J002364/1] Funding Source: UKRI; Medical Research Council [MC_EX_MR/J002364/1] Funding Source: researchfish	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID) under the MRC/DFID(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This award is jointly funded by the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement and is also part of the EDCTP2 programme supported by the European Union.	Amazigo UV, 2002, ANN TROP MED PARASIT, V96, P41, DOI 10.1179/000349802125000646; Bhullar N, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-70; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Cassell JA, 2006, HEALTH POLICY PLANN, V21, P373, DOI 10.1093/heapol/czl020; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; Crowell V, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-4; De Martin S, 2001, TROP MED INT HEALTH, V6, P442, DOI 10.1046/j.1365-3156.2001.00723.x; Dial NJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-47; GARFIELD RM, 1986, SOC SCI MED, V22, P869, DOI 10.1016/0277-9536(86)90241-8; Gikonyo C, 2008, SOC SCI MED, V67, P708, DOI 10.1016/j.socscimed.2008.02.003; Gilson L, 2003, SOC SCI MED, V56, P1453, DOI 10.1016/S0277-9536(02)00142-9; Greenwood B, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-S3-S2; Gryseels C, 2015, AM J TROP MED HYG, V93, P810, DOI 10.4269/ajtmh.15-0259; Katabarwa MN, 2001, ANN TROP MED PARASIT, V95, P275, DOI 10.1080/00034983.2001.11813639; Kingori P, 2013, SOC SCI MED, V98, P361, DOI 10.1016/j.socscimed.2013.10.013; Krentel A, 2012, HEALTH POLICY PLANN, V27, P384, DOI 10.1093/heapol/czr048; Marshall Martin N, 1996, FAMILY PRACTICE, P4; Mwesigwa J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0829-6; Nichter M, 2008, INTRODUCING ZINC DIA; Okell LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020179; Parker M, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-3; Pindolia DK, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-205; Poirot E, 2013, MASS DRUG A IN PRESS; Sheik-Mohamed A, 1999, TROP MED INT HEALTH, V4, P695, DOI 10.1046/j.1365-3156.1999.00473.x; Shekalaghe SA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-247; Takem EN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067108; Toe LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080800	28	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148627	10.1371/journal.pone.0148627	http://dx.doi.org/10.1371/journal.pone.0148627			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6RE	26866685	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000370050700023
J	Guo, HL; Liao, XH; Liu, Q; Zhang, L				Guo, Hui-Lin; Liao, Xiao-Hui; Liu, Qi; Zhang, Ling			Angiotensin II Type 2 Receptor Decreases Transforming Growth Factor-beta Type II Receptor Expression and Function in Human Renal Proximal Tubule Cells	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; AT(2) RECEPTORS; BLOOD-PRESSURE; TGF-BETA-1; NATRIURESIS; MECHANISM; OBESE; STIMULATION; INHIBITION; INCREASES	Transforming growth factor-beta (TGF-beta), via its receptors, induces epithelial-mesenchymal transition (EMT) and plays an important role in the development of renal tubulointersitial fibrosis. Angiotensin II type 2 receptor (AT(2)R), which mediates beneficial renal physiological functions, has received attention as a prospective therapeutic target for renoprotection. In this study, we investigated the effect and underlying mechanism of AT(2)R on the TGF-beta receptor II (TGF-beta RII) expression and function in human proximal tubular cells (HK-2). Here, we show that the AT(2)R agonist CGP42112A decreased TGF-beta RII protein expression in a concentration- and time-dependent manner in HK-2 cells. The inhibitory effect of the AT(2)R on TGF-beta RII expression was blocked by the AT(2)R antagonists PD123319 or PD123177. Stimulation with TGF-beta 1 enhanced EMT in HK-2 cells, which was prevented by pre-treatment with CGP42112A. One of mechanisms in this regulation is associated with the increased TGF-beta RII degradation after activation of AT(2)R. Furthermore, laser confocal immunofluorescence microscopy showed that AT(2)R and TGF-beta RII colocalized in HK-2 cells. AT(2)R and TGF-beta RII coimmunoprecipitated and this interaction was increased after AT(2)R agonist stimulation for 30 min. The inhibitory effect of the AT(2)R on TGF-beta RII expression was also blocked by the nitric oxide synthase inhibitor L-NAME, indicating that nitric oxide is involved in the signaling pathway. Taken together, our study indicates that the renal AT(2)R regulates TGF-beta RII expression and function via the nitric oxide pathway, which may be important in the control of renal tubulointerstitial fibrosis.	[Guo, Hui-Lin; Liao, Xiao-Hui; Zhang, Ling] Chongqing Med Univ, Affiliated Hosp 2, Dept Nephrol, Chongqing 400010, Peoples R China; [Liu, Qi] Chongqing Med Univ, Affiliated Hosp 2, Key Lab Mol Biol Infect Dis, Inst Viral Hepatitis, Chongqing 400010, Peoples R China	Chongqing Medical University; Chongqing Medical University	Zhang, L (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Dept Nephrol, Chongqing 400010, Peoples R China.; Liu, Q (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Key Lab Mol Biol Infect Dis, Inst Viral Hepatitis, Chongqing 400010, Peoples R China.	txzzliuqi@163.com; lindazhang8508@sina.com			Chongqing Municipal Health and Family Planning Commission [20142031]; Chongqing Medical University [201404]	Chongqing Municipal Health and Family Planning Commission; Chongqing Medical University	These studies were supported in part by grants from medical scientific research projects of Chongqing Municipal Health and Family Planning Commission (No. 20142031), and the funding for fostering talents of Chongqing Medical University (No. 201404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadir PM, 2011, J INTERF CYTOK RES, V31, P471, DOI 10.1089/jir.2010.0043; Ali Q, 2013, KIDNEY INT, V84, P931, DOI 10.1038/ki.2013.193; Aurelie NDC, 2011, CURR HYPERTENS REP, V13, P122, DOI 10.1007/s11906-011-0187-x; Barnes JL, 2011, CONTRIB NEPHROL, V169, P73, DOI 10.1159/000313946; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Burns WC, 2007, CELLS TISSUES ORGANS, V185, P222, DOI 10.1159/000101323; Carey RM, 2013, CLIN EXP PHARMACOL P, V40, P527, DOI 10.1111/1440-1681.12059; Castoldi G, 2014, AM J PHYSIOL-RENAL, V307, pF1123, DOI 10.1152/ajprenal.00247.2014; Dhande I, 2013, HYPERTENSION, V61, P1218, DOI 10.1161/HYPERTENSIONAHA.111.00422; Fan JM, 2001, AM J KIDNEY DIS, V37, P820, DOI 10.1016/S0272-6386(01)80132-3; Fukuda N, 2000, AM J HYPERTENS, V13, P191, DOI 10.1016/S0895-7061(99)00152-1; Giani JF, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0477-1; Hakam AC, 2006, AM J PHYSIOL-RENAL, V290, pF1430, DOI 10.1152/ajprenal.00218.2005; Hakam AC, 2006, HYPERTENSION, V47, P1117, DOI 10.1161/01.HYP.0000220112.91724.fc; Hills CE, 2010, AM J NEPHROL, V31, P68, DOI 10.1159/000256659; Ichiki T, 1998, HYPERTENSION, V31, P342, DOI 10.1161/01.HYP.31.1.342; Jin XQ, 2002, HYPERTENSION, V39, P1021, DOI 10.1161/01.HYP.0000016179.52601.B4; Kamitani S, 2011, INT ARCH ALLERGY IMM, V155, P119, DOI 10.1159/000318854; Kato M, 2006, J AM SOC NEPHROL, V17, P3325, DOI 10.1681/ASN.2006070754; Kemp BA, 2014, CIRC RES, V115, P388, DOI 10.1161/CIRCRESAHA.115.304110; Li YK, 2010, MOL CELL BIOCHEM, V339, P263, DOI 10.1007/s11010-010-0389-6; Liu J., 2015, MOL NEUROBIOL; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Padia SH, 2013, PFLUG ARCH EUR J PHY, V465, P99, DOI 10.1007/s00424-012-1146-3; Padia SH, 2012, HYPERTENSION, V59, P437, DOI 10.1161/HYPERTENSIONAHA.111.184788; Painemal P, 2013, BIOFACTORS, V39, P467, DOI 10.1002/biof.1087; Petersen M, 2008, KIDNEY INT, V73, P705, DOI 10.1038/sj.ki.5002717; Roulston CL, 2004, NEUROSCIENCE, V127, P753, DOI 10.1016/j.neuroscience.2004.04.062; Ruster C, 2011, J AM SOC NEPHROL, V22, P1189, DOI 10.1681/ASN.2010040384; Salomone LJ, 2007, HYPERTENSION, V49, P155, DOI 10.1161/01.HYP.0000251881.89610.ee; Siragy HM, 2007, AM J PHYSIOL-REG I, V293, pR1461, DOI 10.1152/ajpregu.00014.2007; Su JZ, 2002, HYPERTENSION, V40, P853, DOI 10.1161/01.HYP.0000042096.17141.B1; Sumners C, 2015, CURR OPIN PHARMACOL, V21, P115, DOI 10.1016/j.coph.2015.01.004; Ulmasov B, 2009, AM J PHYSIOL-GASTR L, V296, pG284, DOI 10.1152/ajpgi.90409.2008; Wolf G, 1999, J MOL MED-JMM, V77, P556, DOI 10.1007/s001099900028; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Xu YF, 2012, INT J MOL MED, V29, P781, DOI 10.3892/ijmm.2012.911; Yang J, 2012, J HYPERTENS, V30, P1176, DOI 10.1097/HJH.0b013e3283532099; Yin RY, 2015, FREE RADICAL BIO MED, V89, P895, DOI 10.1016/j.freeradbiomed.2015.10.406; Yoshikawa M, 2007, J AM SOC NEPHROL, V18, P58, DOI 10.1681/ASN.2005111187; Zeisberg M, 2004, J MOL MED, V82, P175, DOI 10.1007/s00109-003-0517-9; Zhang XH, 2012, ARTERIOSCL THROM VAS, V32, P1015, DOI 10.1161/ATVBAHA.111.244962	42	10	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148696	10.1371/journal.pone.0148696	http://dx.doi.org/10.1371/journal.pone.0148696			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867007	Green Submitted, gold, Green Published			2022-12-27	WOS:000370050700026
J	Liu, G; Gao, Y; Huang, FF; Yuan, MY; Peng, SL				Liu, Gang; Gao, Yang; Huang, Fang-Fang; Yuan, Ming-Yue; Peng, Shao-Lin			The Invasion of Coastal Areas in South China by Ipomoea cairica May Be Accelerated by the Ecotype Being More Locally Adapted to Salt Stress	PLOS ONE			English	Article							PLANT PHENOTYPIC PLASTICITY; LEAF CONSTRUCTION COST; COMPETITIVE ABILITY; GENETIC DIVERSITY; CO2 ASSIMILATION; NITROGEN-CONTENT; ADAPTATION; EVOLUTION; SALINITY; ENVIRONMENTS	Local adaptation and phenotypic plasticity are two alternative mechanisms used by invasive plants for range expansion. We conducted a series of experiments to investigate the role of these mechanisms in the recent expansion of the invasive Ipomoea cairica from non-saline to salt-stressed coastal habitats. A comparison of the plant's photosynthetic traits and construction costs across habitats was conducted through a field survey. Meanwhile, a full factorial greenhouse experiment was conducted with two ecotypes (non-saline and coastal) of I. cairica and two salinity gradients (water and 4 g L-1 NaCl solution) to evaluate the roles of the two strategies by comparing their main traits. The results revealed that the construction cost and A(max) of I. cairica did not change with the habitat type. The ecotype and saline treatments, however, significantly influenced the plant growth. The non-saline ecotype (NE) generally showed higher or equal plasticity of biomass-allocation and functional traits compared to the coastal ecotype (CE). However, the fitness and biomass of the NE significantly decreased with salinity, whereas those aspects of the CE did not change. Our results indicate that the recent expansion of I. cairica into coastal areas may be accelerated by the local adaptation of the CE to salt stress. Additionally, in South China, the CE will most likely evolve adaptations to both saline and non-saline environments, which will further broaden the invasion range of I. cairica in the future.	[Liu, Gang] Shaanxi Normal Univ, Coll Life Sci, Xian 710119, Peoples R China; [Liu, Gang; Gao, Yang; Huang, Fang-Fang; Yuan, Ming-Yue; Peng, Shao-Lin] Sun Yat Sen Univ, Sch Life Sci, Guangdong Higher Educ Inst, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Gang; Gao, Yang; Huang, Fang-Fang; Yuan, Ming-Yue; Peng, Shao-Lin] Sun Yat Sen Univ, Sch Life Sci, Guangdong Higher Educ Inst, Guangdong Key Lab Plant Resources,Key Lab Biodive, Guangzhou 510275, Guangdong, Peoples R China	Shaanxi Normal University; Sun Yat Sen University; Sun Yat Sen University	Peng, SL (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Guangdong Higher Educ Inst, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.; Peng, SL (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Guangdong Higher Educ Inst, Guangdong Key Lab Plant Resources,Key Lab Biodive, Guangzhou 510275, Guangdong, Peoples R China.	lsspsl@mail.sysu.edu.cn		Liu, Gang/0000-0002-5633-4216	National Natural Science Foundation of China [31300401, 31030015]; international fund of 985 project, Sun Yat-Sen University; Scientific Research Fund of Hongda Zhang, Sun Yat-Sen University; fund of State Key Laboratory of Biocontrol, Sun Yat-sen University [SKLBC14KF04]; Fundamental Research Funds for the Central Universities [GK201503044]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); international fund of 985 project, Sun Yat-Sen University; Scientific Research Fund of Hongda Zhang, Sun Yat-Sen University; fund of State Key Laboratory of Biocontrol, Sun Yat-sen University; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by the National Natural Science Foundation of China (31300401 and 31030015), the international fund of 985 project, Sun Yat-Sen University and the Scientific Research Fund of Hongda Zhang, Sun Yat-Sen University, the fund of State Key Laboratory of Biocontrol, Sun Yat-sen University(SKLBC14KF04), and the Fundamental Research Funds for the Central Universities (GK201503044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaka M, 2005, J VEG SCI, V16, P647, DOI 10.1111/j.1654-1103.2005.tb02407.x; Albacete A, 2008, J EXP BOT, V59, P4119, DOI 10.1093/jxb/ern251; Amsellem L, 2000, MOL ECOL, V9, P443, DOI 10.1046/j.1365-294x.2000.00876.x; Ashraf M, 2013, PHOTOSYNTHETICA, V51, P163, DOI 10.1007/s11099-013-0021-6; Avolio ML, 2013, ECOLOGY, V94, P953, DOI 10.1890/12-1119.1; Baker H. G., 1965, The genetics of colonizing species., P147; Barthod S, 2005, ANN FOREST SCI, V62, P545, DOI 10.1051/forest:2005047; Baruch Z, 1999, OECOLOGIA, V121, P183, DOI 10.1007/s004420050920; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; Burns JH, 2006, BIOL INVASIONS, V8, P797, DOI 10.1007/s10530-005-3838-5; Chen LY, 2013, PLOS ONE, V8; Cheng LL, 2001, J EXP BOT, V52, P1865, DOI 10.1093/jexbot/52.362.1865; Colautti RI, 2013, SCIENCE, V342, P364, DOI 10.1126/science.1242121; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; Davidson AM, 2011, ECOL LETT, V14, P419, DOI 10.1111/j.1461-0248.2011.01596.x; Dawson W, 2011, GLOBAL ECOL BIOGEOGR, V20, P299, DOI 10.1111/j.1466-8238.2010.00599.x; DEVRIES FWT, 1974, J THEOR BIOL, V45, P339, DOI DOI 10.1016/0022-5193(74)90119-2; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Drenovsky RE, 2008, AM J BOT, V95, P681, DOI 10.3732/ajb.2007408; Dybdahl MF, 2005, ECOLOGY, V86, P1592, DOI 10.1890/04-0898; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; File AL, 2012, P ROY SOC B-BIOL SCI, V279, P209, DOI 10.1098/rspb.2011.1995; Funk JL, 2008, J ECOL, V96, P1162, DOI 10.1111/j.1365-2745.2008.01435.x; Funk JL, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot026; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Gianoli E, 2005, EVOL ECOL, V19, P603, DOI 10.1007/s10682-005-2220-5; Huang QQ, 2011, WEED RES, V51, P534, DOI 10.1111/j.1365-3180.2011.00868.x; Huang QQ, 2009, BIODIVERS CONSERV, V18, P305, DOI 10.1007/s10531-008-9485-2; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Leishman MR, 2007, NEW PHYTOL, V176, P635, DOI 10.1111/j.1469-8137.2007.02189.x; Liu G, 2015, BIOL INVASIONS, V17, P3479, DOI 10.1007/s10530-015-0972-6; Liu G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048829; Mal TK, 2005, AM J BOT, V92, P819, DOI 10.3732/ajb.92.5.819; Matesanz S, 2013, ECOLOGY, V94, P2464, DOI 10.1890/12-1359.1; McDowell SCL, 2002, AM J BOT, V89, P1431, DOI 10.3732/ajb.89.9.1431; Meloni Diego Ariel, 2004, Brazilian Journal of Plant Physiology, V16, P39, DOI 10.1590/S1677-04202004000100006; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; MORAN NA, 1992, AM NAT, V139, P971, DOI 10.1086/285369; Nichols PGH, 2009, PLANT SOIL, V315, P241, DOI 10.1007/s11104-008-9747-5; Parker IM, 2003, CONSERV BIOL, V17, P59, DOI 10.1046/j.1523-1739.2003.02019.x; Phillips AJ, 2015, AM J BOT, V102, P73, DOI 10.3732/ajb.1400234; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; PUTZ FE, 1984, BIOTROPICA, V16, P19, DOI 10.2307/2387889; Putz FE., 2012, VINE ECOLOGY ECOLOGY; Rewald B, 2012, J EXP BOT, V63, P2717, DOI 10.1093/jxb/err457; Richards CL, 2008, AM J BOT, V95, P931, DOI 10.3732/ajb.2007364; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; Richards CL, 2010, ESTUAR COAST, V33, P840, DOI 10.1007/s12237-009-9186-4; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Ross C.A., 2009, INVASION SUCCESS PLA; Rozema J, 1988, PLANT POPULATION ECO, P137; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; SCHEINER SM, 1993, ANNU REV ECOL SYST, V24, P35, DOI 10.1146/annurev.es.24.110193.000343; Schnitzer SA, 2002, TRENDS ECOL EVOL, V17, P223, DOI 10.1016/S0169-5347(02)02491-6; Sexton JP, 2002, ECOL APPL, V12, P1652, DOI 10.1890/1051-0761(2002)012[1652:PAGDMA]2.0.CO;2; Shen XY, 2011, BIOL INVASIONS, V13, P869, DOI 10.1007/s10530-010-9875-8; Suarez N, 2005, BIOL PLANTARUM, V49, P111, DOI 10.1007/s10535-005-1116-0; Sultan SE, 2002, AM NAT, V160, P271, DOI 10.1086/341015; Sultan SE, 2004, PERSPECT PLANT ECOL, V6, P227, DOI 10.1078/1433-8319-00082; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Valladares F, 2007, NEW PHYTOL, V176, P749, DOI 10.1111/j.1469-8137.2007.02275.x; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Walls RL, 2010, ESTUAR COAST, V33, P902, DOI 10.1007/s12237-009-9190-8; WILLIAMS DG, 1993, FUNCT ECOL, V7, P623, DOI 10.2307/2390140; WILLIAMS K, 1987, PLANT CELL ENVIRON, V10, P725	65	12	14	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149262	10.1371/journal.pone.0149262	http://dx.doi.org/10.1371/journal.pone.0149262			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867222	Green Published, gold, Green Submitted			2022-12-27	WOS:000370050700082
J	Szkaradkiewicz, A; Karpinski, TM; Linke, K; Majewski, P; Rozkiewicz, D; Goslinska-Kuzniarek, O				Szkaradkiewicz, Andrzej; Karpinski, Tomasz M.; Linke, Krzysztof; Majewski, Przemyslaw; Rozkiewicz, Dorota; Goslinska-Kuzniarek, Olga			Expression of cagA, virB/D Complex and/or vacA Genes in Helicobacter pylori Strains Originating from Patients with Gastric Diseases	PLOS ONE			English	Article							IV SECRETION SYSTEM; PATHOGENICITY ISLAND; VACUOLATING CYTOTOXIN; VIRULENCE FACTORS; EPITHELIAL-CELLS; CANCER; PATHOGENESIS; INFECTION; CARCINOGENESIS; DISRUPTION	In order to better understand pathogenicity of Helicobacter pylori, particularly in the context of its carcinogenic activity, we analysed expression of virulence genes: cagA, virB/D complex (virB4, virB7, virB8, virB9, virB10, virB11, virD4) and vacA in strains of the pathogen originating from persons with gastric diseases. The studies were conducted on 42 strains of H. pylori isolated from patients with histological diagnosis of non-atrophic gastritis-NAG (group 1, including subgroup 1 containing cagA(+) isolates and subgroup 2 containing cagA(-) strains), multifocal atrophic gastritis-MAG (group 2) and gastric adenocarcinoma-GC (group 3). Expression of H. pylori genes was studied using microarray technology. In group 1, in all strains of H. pylori cagA(+) (subgroup 1) high expression of the gene as well as of virB/D was disclosed, accompanied by moderate expression of vacA. In strains of subgroup 2 a moderate expression of vacA was detected. All strains in groups 2 and 3 carried cagA gene but they differed in its expression: a high expression was detected in isolates of group 2 and its hyperexpression in strains of group 3 (hypervirulent strains). In both groups high expression of virB/D and vacA was disclosed. Our results indicate that chronic active gastritis may be induced by both cagA(+) strains of H. pylori, manifesting high expression of virB/D complex but moderate activity of vacA, and cagA(-) strains with moderate expression of vacA gene. On the other hand, in progression of gastric pathology and carcinogenesis linked to H. pylori a significant role was played by hypervirulent strains, manifesting a very high expression of cagA and high activity of virB/D and vacA genes.	[Szkaradkiewicz, Andrzej; Karpinski, Tomasz M.; Goslinska-Kuzniarek, Olga] Poznan Univ Med Sci, Dept Med Microbiol, Wieniawskiego Str 3, PL-61712 Poznan, Poland; [Linke, Krzysztof] Poznan Univ Med Sci, Dept Gastroenterol Human Nutr & Internal Dis, Przybyszewskiego Str 49, PL-60355 Poznan, Poland; [Majewski, Przemyslaw] Poznan Univ Med Sci, Dept Clin Pathomorphol, Przybyszewskiego Str 49, PL-60355 Poznan, Poland; [Rozkiewicz, Dorota] Med Univ Bialystok, Dept Paediat Infect Dis, Univ Childrens Hosp, Waszyngtona Str 17, PL-15274 Bialystok, Poland	Poznan University of Medical Sciences; Poznan University of Medical Sciences; Poznan University of Medical Sciences; Medical University of Bialystok	Szkaradkiewicz, A (corresponding author), Poznan Univ Med Sci, Dept Med Microbiol, Wieniawskiego Str 3, PL-61712 Poznan, Poland.	szkaradkiewicza@poczta.onet.pl	Rozkiewicz, Dorota/S-1101-2018; Majewski, Przemysław Wojciech/GLR-2179-2022; Karpiński, Tomasz M./G-5645-2011	Rozkiewicz, Dorota/0000-0002-8368-8706; Karpiński, Tomasz M./0000-0001-6599-9204; Goslinska-Pawlowska, Olga/0000-0002-2288-2812	Poznan University of Medical Sciences, Poland [502-01-02206316-02658]	Poznan University of Medical Sciences, Poland	The research was supported by a grant from Poznan University of Medical Sciences, Poland (502-01-02206316-02658). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research was supported by a grant from Poznan University of Medical Sciences, Poland (502-01-02206316-02658).	Akopyants NS, 1998, MOL MICROBIOL, V28, P37, DOI 10.1046/j.1365-2958.1998.00770.x; Al-Ghoul L, 2004, BIOCHEM BIOPH RES CO, V322, P860, DOI 10.1016/j.bbrc.2004.07.199; Ali A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/139580; Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; Argent RH, 2008, J MED MICROBIOL, V57, P145, DOI 10.1099/jmm.0.47465-0; Aviles-Jimenez F, 2012, INFECT IMMUN, V80, P594, DOI 10.1128/IAI.05845-11; Backert S, 2008, CELL MICROBIOL, V10, P1573, DOI 10.1111/j.1462-5822.2008.01156.x; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Christie PJ, 2000, TRENDS MICROBIOL, V8, P354, DOI 10.1016/S0966-842X(00)01792-3; CORREA P, 1992, CANCER RES, V52, P6735; Cover TL, 2005, NAT REV MICROBIOL, V3, P320, DOI 10.1038/nrmicro1095; COVER TL, 1992, J BIOL CHEM, V267, P10570; CRABTREE JE, 1991, LANCET, V338, P332, DOI 10.1016/0140-6736(91)90477-7; de Bernard M, 2014, HELICOBACTER, V19, P11, DOI 10.1111/hel.12160; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Graham JE, 2002, GASTROENTEROLOGY, V123, P1637, DOI 10.1053/gast.2002.36589; Hatakeyama M, 2005, CANCER SCI, V96, P835, DOI 10.1111/j.1349-7006.2005.00130.x; Hocker M, 2003, LANCET, V362, P1231, DOI 10.1016/S0140-6736(03)14547-3; Ishikawa S, 2009, FEBS LETT, V583, P2414, DOI 10.1016/j.febslet.2009.06.043; Jang BG, 2011, PATHOBIOLOGY, V78, P302, DOI 10.1159/000321703; Kane MD, 2009, DRUG DISCOV SER, V11, P1; Karita M, 1998, J INFECT DIS, V178, P213, DOI 10.1086/515606; Ki MR, 2014, MOL CELL BIOCHEM, V396, P23, DOI 10.1007/s11010-014-2138-8; Kodama Masaaki, 2004, Journal of Infection and Chemotherapy, V10, P316, DOI 10.1007/s10156-004-0353-z; Konturek Peter C, 2003, Med Sci Monit, V9, pSR53; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Megraud F, 2015, CLIN MICROBIOL INFEC, V21, P984, DOI 10.1016/j.cmi.2015.06.004; Megraud F, 2007, CLIN MICROBIOL REV, V20, P280, DOI 10.1128/CMR.00033-06; Memon AA, 2014, J CLIN MICROBIOL, V52, P2984, DOI 10.1128/JCM.00551-14; Noto Jennifer M, 2012, Methods Mol Biol, V921, P41; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Selbach M, 2002, INFECT IMMUN, V70, P665, DOI 10.1128/IAI.70.2.665-671.2002; Tamer E, 2013, ISRN GASTROENTEROLOG, V2013; Tegtmeyer N, 2011, FEBS J, V278, P1190, DOI 10.1111/j.1742-4658.2011.08035.x; Tsang YH, 2010, ONCOGENE, V29, P5643, DOI 10.1038/onc.2010.304; Vannini A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098416; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Warburton VJ, 1998, J CLIN PATHOL, V51, P55, DOI 10.1136/jcp.51.1.55; Watanabe T, 1998, GASTROENTEROLOGY, V115, P642, DOI 10.1016/S0016-5085(98)70143-X; Wessler S, 2008, TRENDS MICROBIOL, V16, P397, DOI 10.1016/j.tim.2008.05.005; Winter JA, 2014, J INFECT DIS, V210, P954, DOI 10.1093/infdis/jiu154; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10	42	3	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148936	10.1371/journal.pone.0148936	http://dx.doi.org/10.1371/journal.pone.0148936			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866365	Green Published, Green Submitted, gold			2022-12-27	WOS:000370050700047
J	Bhattacharya, J; Lindsen, JP				Bhattacharya, Joydeep; Lindsen, Job P.			Music for a Brighter World: Brightness Judgment Bias by Musical Emotion	PLOS ONE			English	Article							NEURAL BASIS; PERCEPTION; LIGHT; PITCH; POTENTIALS; RESPONSES; MAPPINGS; METAPHOR	A prevalent conceptual metaphor is the association of the concepts of good and evil with brightness and darkness, respectively. Music cognition, like metaphor, is possibly embodied, yet no study has addressed the question whether musical emotion can modulate brightness judgment in a metaphor consistent fashion. In three separate experiments, participants judged the brightness of a grey square that was presented after a short excerpt of emotional music. The results of Experiment 1 showed that short musical excerpts are effective emotional primes that cross-modally influence brightness judgment of visual stimuli. Grey squares were consistently judged as brighter after listening to music with a positive valence, as compared to music with a negative valence. The results of Experiment 2 revealed that the bias in brightness judgment does not require an active evaluation of the emotional content of the music. By applying a different experimental procedure in Experiment 3, we showed that this brightness judgment bias is indeed a robust effect. Altogether, our findings demonstrate a powerful role of musical emotion in biasing brightness judgment and that this bias is aligned with the metaphor viewpoint.	[Bhattacharya, Joydeep; Lindsen, Job P.] Univ London, Dept Psychol, London, England	University of London	Bhattacharya, J (corresponding author), Univ London, Dept Psychol, London, England.	j.bhattacharya@gold.ac.uk			EPSRC, UK [EP/H01294X]; European Commission [612022]	EPSRC, UK(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Commission(European CommissionEuropean Commission Joint Research Centre)	The research was supported by the EPSRC, UK (Research Grant EP/H01294X) and by the European Commission (Grant Agreement No. 612022). This publication reflects the views only of the authors, and the funders cannot be held responsible for any use that may be made of the information contained therein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbib MAeoc, LANGUAGE MUSIC BRAIN; Arikan MK, 1999, NEUROSCI LETT, V268, P21; Banerjee P, 2012, PSYCHOL SCI, V23, P407, DOI 10.1177/0956797611432497; Baraldi FB, 2009, MUSIC PERCEPT, V26, P257, DOI 10.1525/MP.2009.26.3.257; Bernardi L, 2009, CIRCULATION, V119, P3171, DOI 10.1161/CIRCULATIONAHA.108.806174; BERNSTEIN L., 1976, UNANSWERED QUESTION; Bigand E, 2005, ANN NY ACAD SCI, V1060, P429, DOI 10.1196/annals.1360.036; Brandt MJ, 2014, SOC PSYCHOL-GERMANY, V45, P246, DOI 10.1027/1864-9335/a000191; Chong HJ, 2013, MUSIC MED, V5, P39, DOI DOI 10.1177/1943862112470144; Cohen J.E., 1988, STAT POWER ANAL BEHA; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; Daltrozzo J, 2009, BRAIN RES, V1270, P88, DOI 10.1016/j.brainres.2009.03.019; DeNora T., 2000, MUSIC EVERYDAY LIFE; Eitan Z, 2010, COGNITION, V114, P405, DOI 10.1016/j.cognition.2009.10.013; Fritz T, 2009, CURR BIOL, V19, P573, DOI 10.1016/j.cub.2009.02.058; Gibbs RW, 2004, J PRAGMATICS, V36, P1189, DOI 10.1016/j.pragma.2003.10.009; Goerlich KS, 2012, J COGNITIVE NEUROSCI, V24, P1725, DOI 10.1162/jocn_a_00213; Goerlich KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019501; Johnson M, 1980, METAPHORS WE LIVE BY, Vxiii; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; Kivy P., 1990, MUSIC ALONE PHILOS R, Vxii; Koelsch S, 2005, TRENDS COGN SCI, V9, P578, DOI 10.1016/j.tics.2005.10.001; Koelsch S, 2011, PHYS LIFE REV, V8, P89, DOI 10.1016/j.plrev.2011.04.004; Kreutz G, 2008, PSYCHOL MUSIC, V36, P101, DOI 10.1177/0305735607082623; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Landau MJ, 2010, PSYCHOL BULL, V136, P1045, DOI 10.1037/a0020970; Lartillot O., 2007, INT C DIG AUD EFF, P237; Logeswaran N, 2009, NEUROSCI LETT, V455, P129, DOI 10.1016/j.neulet.2009.03.044; Ludwig VU, 2011, P NATL ACAD SCI USA, V108, P20661, DOI 10.1073/pnas.1112605108; Marin MM, 2012, EMOTION, V12, P618, DOI 10.1037/a0025020; Marin MM, 2010, EDUC COMPET GLOB WOR, P1; MARKS LE, 1974, AM J PSYCHOL, V87, P173, DOI 10.2307/1422011; Meier BP, 2007, EMOTION, V7, P366, DOI 10.1037/1528-3542.7.2.366; Meyer L., 1956, EMOTION MEANING MUSI; Moore KS, 2013, J MUSIC THER, V50, P198, DOI 10.1093/jmt/50.3.198; North AC, 1997, SOCIAL PSYCHOL MUSIC, Vxv; North AC, 2012, BRIT J PSYCHOL, V103, P293, DOI 10.1111/j.2044-8295.2011.02072.x; Orr MG, 2005, MUSIC PERCEPT, V22, P583, DOI 10.1525/mp.2005.22.4.583; Proffitt DR, 2006, PERSPECT PSYCHOL SCI, V1, P110, DOI 10.1111/j.1745-6916.2006.00008.x; Rentfrow PJ, 2003, J PERS SOC PSYCHOL, V84, P1236, DOI 10.1037/0022-3514.84.6.1236; Riener C, 2003, 44 ANN M PSYCH SOC V; Rosenthal R, 1991, METAANALYTIC PROCEDU; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Sloboda J, 2009, OXFORD HDB MUSIC PSY, P431, DOI [DOI 10.1093/OXFORDHB/9780199298457.013.0040, 10.1093/oxfordhb/9780199298457.013.0040]; Sloboda JA, 2011, HDB MUSIC EMOTION TH, Vxiv; Sollberger B, 2003, MUSIC PERCEPT, V20, P263, DOI 10.1525/mp.2003.20.3.263; Song HJ, 2012, J EXP SOC PSYCHOL, V48, P450, DOI 10.1016/j.jesp.2011.10.003; Spruyt A, 2002, SOC COGNITION, V20, P227, DOI 10.1521/soco.20.3.227.21106; Steinbeis N, 2011, J COGNITIVE NEUROSCI, V23, P604, DOI 10.1162/jocn.2009.21383; Stravinsky I., 1975, AUTOBIOGRAPHY; VieIllard S, 2008, COGNITION EMOTION, V22, P720, DOI 10.1080/02699930701503567	51	15	15	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148959	10.1371/journal.pone.0148959	http://dx.doi.org/10.1371/journal.pone.0148959			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DD6PR	26863420	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000370046600130
J	Pettis, JS; Rice, N; Joselow, K; vanEngelsdorp, D; Chaimanee, V				Pettis, Jeffery S.; Rice, Nathan; Joselow, Katie; vanEngelsdorp, Dennis; Chaimanee, Veeranan			Colony Failure Linked to Low Sperm Viability in Honey Bee (Apis mellifera) Queens and an Exploration of Potential Causative Factors	PLOS ONE			English	Article							HYMENOPTERA; APIDAE; FLUVALINATE; COUMAPHOS; MORTALITY; HISTORY; LOSSES; HEALTH; RACES	Queen health is closely linked to colony performance in honey bees as a single queen is normally responsible for all egg laying and brood production within the colony. In the U.S. in recent years, queens have been failing at a high rate; with 50% or greater of queens replaced in colonies within 6 months when historically a queen might live one to two years. This high rate of queen failure coincides with the high mortality rates of colonies in the US, some years with >50% of colonies dying. In the current study, surveys of sperm viability in US queens were made to determine if sperm viability plays a role in queen or colony failure. Wide variation was observed in sperm viability from four sets of queens removed from colonies that beekeepers rated as in good health (n = 12; average viability = 92%), were replacing as part of normal management (n = 28; 57%), or where rated as failing (n = 18 and 19; 54% and 55%). Two additional paired set of queens showed a statistically significant difference in viability between colonies rated by the beekeeper as failing or in good health from the same apiaries. Queens removed from colonies rated in good health averaged high viability (ca. 85%) while those rated as failing or in poor health had significantly lower viability (ca. 50%). Thus low sperm viability was indicative of, or linked to, colony performance. To explore the source of low sperm viability, six commercial queen breeders were surveyed and wide variation in viability (range 60-90%) was documented between breeders. This variability could originate from the drones the queens mate with or temperature extremes that queens are exposed to during shipment. The role of shipping temperature as a possible explanation for low sperm viability was explored. We documented that during shipment queens are exposed to temperature spikes (<8 and > 40 degrees C) and these spikes can kill 50% or more of the sperm stored in queen spermathecae in live queens. Clearly low sperm viability is linked to colony performance and laboratory and field data provide evidence that temperature extremes are a potential causative factor.	[Pettis, Jeffery S.; Rice, Nathan; Joselow, Katie] USDA ARS, Bee Res Lab, Beltsville, MD USA; [vanEngelsdorp, Dennis] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Chaimanee, Veeranan] Maejo Univ, Dept Biotechnol, Phrae Campus, Rong Kwang, Phrae, Thailand	United States Department of Agriculture (USDA); University System of Maryland; University of Maryland College Park; Maejo University	Chaimanee, V (corresponding author), Maejo Univ, Dept Biotechnol, Phrae Campus, Rong Kwang, Phrae, Thailand.	chveeranan@gmail.com			USDA-ARS Areawide Program funds; ARS [ARS-0425645] Funding Source: Federal RePORTER	USDA-ARS Areawide Program funds; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	USDA-ARS Areawide Program funds supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2011, J INVERTEBR PATHOL, V106, P380, DOI 10.1016/j.jip.2010.12.005; Anderson KE, 2011, INSECT SOC, V58, P431, DOI 10.1007/s00040-011-0194-6; Buchler R, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.07; Burley LM, 2008, J ECON ENTOMOL, V101, P1081, DOI 10.1603/0022-0493(2008)101[1081:SOHBHA]2.0.CO;2; Chaimanee V, 2014, APIDOLOGIE, V45, P451, DOI 10.1007/s13592-013-0258-x; Collins AM, 2004, J APICULT RES, V43, P128, DOI 10.1080/00218839.2004.11101123; Collins AM, 1999, THERIOGENOLOGY, V51, P1513, DOI 10.1016/S0093-691X(99)00094-1; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; DeGrandi-Hoffman Gloria, 2013, Insects, V4, P71, DOI 10.3390/insects4010071; Delaney DA, 2011, APIDOLOGIE, V42, P1, DOI 10.1051/apido/2010027; Franck P, 1998, EVOLUTION, V52, P1119, DOI [10.2307/2411242, 10.1111/j.1558-5646.1998.tb01839.x]; FURGALA B, 1962, J INSECT PATHOL, V4, P429; Gauthier L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016217; Guzman L. I. de, 1999, American Bee Journal, V139, P304; Haarmann T, 2002, J ECON ENTOMOL, V95, P28, DOI 10.1603/0022-0493-95.1.28; HARBO JR, 1984, J APICULT RES, V23, P31, DOI 10.1080/00218839.1984.11100606; Hawthorne DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026796; Higes M, 2009, ENV MICROBIOL REP, V1, P495, DOI 10.1111/j.1758-2229.2009.00052.x; Lodesani Marco, 2004, Italian Journal of Animal Science, V3, P385; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Pettis JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070182; Pettis JS, 2004, APIDOLOGIE, V35, P605, DOI 10.1051/apido:2004056; PETTIS JS, 1991, APIDOLOGIE, V22, P1, DOI 10.1051/apido:19910101; Ramirez-Romero R, 2008, ECOTOX ENVIRON SAFE, V70, P327, DOI 10.1016/j.ecoenv.2007.12.002; Rinderer TE, 1999, AM BEE J, V139, P134; Sandrock C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103592; SCHIFF NM, 1995, J ECON ENTOMOL, V88, P1216, DOI 10.1093/jee/88.5.1216; SCHIFF NM, 1994, ANN ENTOMOL SOC AM, V87, P842, DOI 10.1093/aesa/87.6.842; Schiff NM, 1996, APIDOLOGIE, V27, P77, DOI 10.1051/apido:19960202; SHEPPARD WS, 1989, AM BEE J, V129, P664; SHEPPARD WS, 1989, AM BEE J, V129, P617; Tarpy DR, 2012, J ECON ENTOMOL, V105, P20, DOI 10.1603/EC11276; vanEngelsdorp D, 2013, PREV VET MED, V108, P225, DOI 10.1016/j.prevetmed.2012.08.004; Vanengelsdorp D, 2012, J APICULT RES, V51, P115, DOI 10.3896/IBRA.1.51.1.14; vanEngelsdorp D, 2010, J APICULT RES, V49, P7, DOI 10.3896/IBRA.1.49.1.03; Winston M., 1987, The biology of the honey bee.; Woodward D., 2007, QUEEN BEE BIOL READI; Woyke J., 1971, J Apic Res, V10, P45; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014720; Yue C, 2006, J INVERTEBR PATHOL, V92, P105, DOI 10.1016/j.jip.2006.03.001	41	56	58	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0147220	10.1371/journal.pone.0147220	http://dx.doi.org/10.1371/journal.pone.0147220			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863438	Green Published, gold, Green Submitted			2022-12-27	WOS:000370046600022
J	Hu, XG; Liu, H; Jin, YQ; Sun, YQ; Li, Y; Zhao, W; El-Kassaby, YA; Wang, XR; Mao, JF				Hu, Xian-Ge; Liu, Hui; Jin, YuQing; Sun, Yan-Qiang; Li, Yue; Zhao, Wei; El-Kassaby, Yousry A.; Wang, Xiao-Ru; Mao, Jian-Feng			De Novo Transcriptome Assembly and Characterization for the Widespread and Stress-Tolerant Conifer Platycladus orientalis	PLOS ONE			English	Article							PICEA-GLAUCA GENOME; TERPENE SYNTHASES; RNA-SEQ; INTERIOR SPRUCE; SSR MARKERS; GENE FAMILY; TOOL; EVOLUTION; SELECTION; KEGG	Platycladus orientalis, of the family Cupressaceae, is a widespread conifer throughout China and is extensively used for ecological reforestation, horticulture, and in medicine. Transcriptome assemblies are required for this ecologically important conifer for understanding genes underpinning adaptation and complex traits for breeding programs. To enrich the species' genomic resources, a de novo transcriptome sequencing was performed using Illumina paired-end sequencing. In total, 104,073,506 high quality sequence reads (approximately 10.3 Gbp) were obtained, which were assembled into 228,948 transcripts and 148,867 unigenes that were longer than 200 nt. Quality assessment using CEGMA showed that the transcriptomes obtained were mostly complete for highly conserved core eukaryotic genes. Based on similarity searches with known proteins, 62,938 (42.28% of all unigenes), 42,158 (28.32%), and 23,179 (15.57%) had homologs in the Nr, GO, and KOG databases, 25,625 (17.21%) unigenes were mapped to 322 pathways by BLASTX comparison against the KEGG database and 1,941 unigenes involved in environmental signaling and stress response were identified. We also identified 43 putative terpene synthase (TPS) functional genes loci and compared them with TPSs from other species. Additionally, 5,296 simple sequence repeats (SSRs) were identified in 4,715 unigenes, which were assigned to 142 motif types. This is the first report of a complete transcriptome analysis of P. orientalis. These resources provide a foundation for further studies of adaptation mechanisms and molecular-based breeding programs.	[Hu, Xian-Ge; Liu, Hui; Jin, YuQing; Sun, Yan-Qiang; Li, Yue; Zhao, Wei; Wang, Xiao-Ru; Mao, Jian-Feng] Beijing Forestry Univ, Natl Engn Lab Tree Breeding, Key Lab Genet & Breeding Forest Trees & Ornamenta, Minist Educ,Coll Biol Sci & Technol, Beijing, Peoples R China; [Zhao, Wei; Wang, Xiao-Ru] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden; [El-Kassaby, Yousry A.] Univ British Columbia, Fac Forestry, Dept Forest & Conservat Sci, Vancouver, BC V6T 1W5, Canada	Beijing Forestry University; Umea University; University of British Columbia	Mao, JF (corresponding author), Beijing Forestry Univ, Natl Engn Lab Tree Breeding, Key Lab Genet & Breeding Forest Trees & Ornamenta, Minist Educ,Coll Biol Sci & Technol, Beijing, Peoples R China.	jianfeng.mao@bjfu.edu.cn	El-Kassaby, Yousry A/K-9856-2016; Mao, Jian-Feng/V-9251-2019; LIU, HUI/AAN-5354-2021; Wang, Xiao-Ru/AAC-4444-2020; Wang, Xiao-Ru/H-6811-2012	El-Kassaby, Yousry A/0000-0002-4887-8977; Mao, Jian-Feng/0000-0001-9735-8516; Wang, Xiao-Ru/0000-0002-6150-7046; Wang, Xiao-Ru/0000-0002-6150-7046; Liu, Hui/0000-0003-1980-5952	Fundamental Research Funds for the Central Universities [YX2013-41]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Funding provided by Fundamental Research Funds for the Central Universities (NO. YX2013-41). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews S., 2010, FASTQC QUALITY CONTR; Aubourg S, 2002, MOL GENET GENOMICS, V267, P730, DOI 10.1007/s00438-002-0709-y; Birol I, 2013, BIOINFORMATICS, V29, P1492, DOI 10.1093/bioinformatics/btt178; Bohlmann J, 1998, P NATL ACAD SCI USA, V95, P4126, DOI 10.1073/pnas.95.8.4126; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Chen X. W., 2010, Journal of Sustainable Forestry, V29, P1, DOI 10.1080/10549810903463346; Cheng J-Q, 1992, CHINESE WOODY PLANTS; CHU JM, 2012, J METEOROLOGY ENV, V28, P15; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dong T. M., 1990, PLATYCLADUS ORIENTAL; Dudareva N, 2003, PLANT CELL, V15, P1227, DOI 10.1105/tpc.011015; El-Dien OG, GENES GENOM IN PRESS; El-Dien OG, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1597-y; El-Kassaby YA, 2012, NEW FOREST, V43, P631, DOI 10.1007/s11056-012-9338-4; El-Kassaby YA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025737; El-Kassaby YA, 2009, GENET RES, V91, P111, DOI 10.1017/S001667230900007X; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Irmisch S, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0270-y; Jiang P, 2009, J SHIHEZI U NATURAL, V27, P30; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kulheim C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1598-x; Kuwahara K, 2014, PLANT GENET RESOUR-C, V12, P185, DOI 10.1017/S1479262113000464; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Xin-ping, 2011, Forest Research, V24, P91; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Luo W-X, 1988, SHAANXI FOREST SCI T, V16, P1; Martin DM, 2004, PLANT PHYSIOL, V135, P1908, DOI 10.1104/pp.104.042028; Meglecz E, 2014, MOL ECOL RESOUR, V14, P1302, DOI 10.1111/1755-0998.12271; Neale DB, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r59; Noormohammadi Z, 2014, SCI HORTIC-AMSTERDAM, V178, P175, DOI 10.1016/j.scienta.2014.08.002; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; [潘宪伟 Pan Xianwei], 2012, [中草药, Chinese Traditional and Herbal Drugs], V43, P1641; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Proost S, 2009, PLANT CELL, V21, P3718, DOI 10.1105/tpc.109.071506; Qiao F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106900; Rambaut A, 2009, FIGTREE V1 3 1; Ratcliffe B, 2015, HEREDITY, V115, P547, DOI 10.1038/hdy.2015.57; Shi X-B, 1987, FOREST SCI TECHNOLOG, V7, P15; Silva RA, 2014, AUSTRALAS PLANT PATH, V43, P89, DOI 10.1007/s13313-013-0249-4; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Van Bel M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r134; W-Y Shi, 1986, J BEIJING FORESTRY U, V8, P74; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Warren RL, 2015, PLANT J, V83, P189, DOI 10.1111/tpj.12886; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; [张俊飞 Zhang Junfei], 2013, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V24, P2231; Zhang YJ, 2014, G3-GENES GENOM GENET, V4, P851, DOI 10.1534/g3.113.009779	54	38	38	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148985	10.1371/journal.pone.0148985	http://dx.doi.org/10.1371/journal.pone.0148985			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881995	Green Published, Green Submitted, gold			2022-12-27	WOS:000371219000040
J	Stelmach, P; Wedemeyer, C; Fuest, L; Kurscheid, G; Gehrke, T; Klenke, S; Jager, M; Kauther, MD; Bachmann, HS				Stelmach, Patrick; Wedemeyer, Christian; Fuest, Lena; Kurscheid, Gina; Gehrke, Thorsten; Klenke, Stefanie; Jaeger, Marcus; Kauther, Max D.; Bachmann, Hagen S.			The BCL2-938C > A Promoter Polymorphism Is Associated with Risk for and Time to Aseptic Loosening of Total Hip Arthroplasty	PLOS ONE			English	Article							GENETIC SUSCEPTIBILITY; CC GENOTYPE; BCL2; -938C-GREATER-THAN-A; APOPTOSIS; REPLACEMENT; MEMBRANE; PATHWAYS; SURVIVAL; OUTCOMES	Aseptic loosening is a major cause of revision surgery of total hip arthroplasty (THA). Only few host factors affecting aseptic loosening have been identified until now, although they are urgently needed to identify and possibly treat those patients at higher risk for aseptic loosening. To determine whether the functional single nucleotide polymorphism (SNP) c.-938C>A (rs2279115), located in the promoter region of the BCL2 gene has an impact on aseptic loosening of THA we genotyped and analyzed 234 patients suffering from aseptic loosening and 231 patients after primary THA. The polymorphism is associated with risk for aseptic loosening with the CC genotype at highest risk for aseptic loosening, Odds Ratio CC vs. AA 1.93, 95%CI 1.15-3.25, p = 0.013. In contrast, low risk AA genotype carriers that still developed aseptic loosening showed a significantly shorter time to aseptic loosening than patients carrying the C allele (p = 0.004). These results indicate that the BCL2 -938C>A polymorphism influences the occurrence and course of aseptic loosening and suggests this polymorphism as an interesting candidate for prospective studies and analyses in THA registers.	[Stelmach, Patrick; Fuest, Lena; Kurscheid, Gina; Klenke, Stefanie; Bachmann, Hagen S.] Univ Hosp Essen, Inst Pharmacogenet, Essen, Germany; [Wedemeyer, Christian; Fuest, Lena; Kurscheid, Gina; Jaeger, Marcus; Kauther, Max D.] Univ Hosp Essen, Dept Orthopaed & Trauma Surg, Essen, Germany; [Gehrke, Thorsten] Helios ENDO Klin, Dept Joint Surg, Hamburg, Germany; [Klenke, Stefanie] Univ Hosp Essen, Dept Anaesthesiol & Intens Care, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Bachmann, HS (corresponding author), Univ Hosp Essen, Inst Pharmacogenet, Essen, Germany.	hagen.bachmann@uk-essen.de		Jager, Marcus/0000-0001-9516-1058	German Research Foundation (DFG), Bonn, Germany [WE 3634/1-2]	German Research Foundation (DFG), Bonn, Germany(German Research Foundation (DFG))	The study was supported by the German Research Foundation (DFG), Bonn, Germany (WE 3634/1-2) www.dfg.de. The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelani MA, 2014, CLIN ORTHOP RELAT R, V472, P1518, DOI 10.1007/s11999-013-3377-9; Bachmann HS, 2007, CLIN CANCER RES, V13, P5790, DOI 10.1158/1078-0432.CCR-06-2673; Bachmann HS, 2011, INT J CANCER, V129, P2390, DOI 10.1002/ijc.25904; Bachmann HS, 2003, PHARMACOGENETICS, V13, P759, DOI 10.1097/00008571-200312000-00006; Cherian J. J., 2015, CLIN ORTHOP RELAT RE; Del Buono A, 2012, BRIT MED BULL, V101, P39, DOI 10.1093/bmb/ldr011; Dorjgochoo T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060915; El Hindy N, 2011, J NEUROSURG, V114, P1631, DOI 10.3171/2010.12.JNS10478; Gallo J, 2014, ACTA BIOMATER, V10, P2354, DOI 10.1016/j.actbio.2014.02.003; Gorenoi Vitali, 2009, GMS Health Technol Assess, V5, pDoc13, DOI 10.3205/hta000075; Greenfield EM, 2014, CLIN ORTHOP RELAT R, V472, P3709, DOI 10.1007/s11999-014-3786-4; Huk OL, 2001, J MATER SCI-MATER M, V12, P653, DOI 10.1023/A:1011254029864; Javid J, 2015, CLIN TRANSL ONCOL, V17, P289, DOI 10.1007/s12094-014-1226-2; Karrholm J, 2010, ACTA ORTHOP, V81, P3, DOI 10.3109/17453671003635918; Kunkele A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-452; Landgraeber S, 2006, BIOMATERIALS, V27, P3010, DOI 10.1016/j.biomaterials.2006.01.006; Landgraeber S, 2008, BIOMATERIALS, V29, P3444, DOI 10.1016/j.biomaterials.2008.04.044; Lehnerdt GF, 2009, ANN ONCOL, V20, P1094, DOI 10.1093/annonc/mdn763; Lucht U, 2000, ACTA ORTHOP SCAND, V71, P433, DOI 10.1080/000164700317381081; Maclnnes SJ, 2014, ORS 2014 ANN M; Mahomed NN, 2003, J BONE JOINT SURG AM, V85A, P27, DOI 10.2106/00004623-200301000-00005; Makela KT, 2008, J BONE JOINT SURG AM, V90A, P2160, DOI 10.2106/JBJS.G.00870; Makela KT, 2014, ACTA ORTHOP, V85, P107, DOI 10.3109/17453674.2014.893498; Nich C, 2013, J BIOMED MATER RES A, V101, P3033, DOI 10.1002/jbm.a.34599; Pan FY, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/s13018-014-0108-1; Park BL, 2004, J HUM GENET, V49, P449, DOI 10.1007/s10038-004-0173-0; Park YH, 2009, CLIN CANCER RES, V15, P2107, DOI 10.1158/1078-0432.CCR-08-1588; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; Sadoghi P, 2013, J ARTHROPLASTY, V28, P1329, DOI 10.1016/j.arth.2013.01.012; Sundfeldt M, 2006, ACTA ORTHOP, V77, P177, DOI 10.1080/17453670610045902; Teng SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125294; Volkmann N, 2014, CELL DEATH DIFFER, V21, P206, DOI 10.1038/cdd.2013.153; Wedemeyer C, 2009, EUR J MED RES, V14, P250, DOI 10.1186/2047-783X-14-6-250; YAN YZ, 2014, BIOL RES, V47, DOI DOI 10.1186/S13000-014-0177-9; Yang F, 2011, BIOMATERIALS, V32, P9159, DOI 10.1016/j.biomaterials.2011.08.039; Zhang C, 2014, J AFFECT DISORDERS, V155, P288, DOI 10.1016/j.jad.2013.11.010; Zhang N, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-48	37	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149528	10.1371/journal.pone.0149528	http://dx.doi.org/10.1371/journal.pone.0149528			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881923	Green Submitted, Green Published, gold			2022-12-27	WOS:000371219000079
J	Baek, SH; Seok, HY; Koo, YS; Kim, BJ				Baek, Seol-Hee; Seok, Hung Youl; Koo, Yong Seo; Kim, Byung-Jo			Lengthened Cutaneous Silent Period in Fibromyalgia Suggesting Central Sensitization as a Pathogenesis	PLOS ONE			English	Article							SMALL FIBER NEUROPATHY; CARPAL-TUNNEL-SYNDROME; DIABETES-MELLITUS; PAIN; DISEASE; POLYNEUROPATHY; ABNORMALITIES; DISORDERS; DENSITY; REFLEX	The pathogenesis of fibromyalgia (FM) has not been clearly elucidated, but central sensitization, which plays an important role in the development of neuropathic pain, is considered to be the main mechanism. The cutaneous silent period (CSP), which is a spinal reflex mediated by A-delta cutaneous afferents, is useful for the evaluation of sensorimotor integration at the spinal and supraspinal levels. To understand the pathophysiology of FM, we compared CSP patterns between patients with FM and normal healthy subjects. Twenty-four patients with FM diagnosed in accordance with the 1990 American College of Rheumatology classification system and 24 age-and sex-matched healthy volunteers were recruited. The CSP was measured from the abductor pollicis brevis muscle. Demographic data, number of tender points, and visual analog scale and FM impact questionnaire scores were collected. The measured CSP and clinical parameters of the patient and control groups were compared. In addition, possible correlations between the CSP parameters and the other clinical characteristics were analyzed. Mean CSP latencies did not differ between patients (55.50 +/- 10.97 ms) and healthy controls (60.23 +/- 11.87 ms; p = 0.158), although the mean CSP duration was significantly longer in patients (73.75 +/- 15.67 ms) than in controls (63.50 +/- 14.05 ms; p = 0.021). CSP variables did not correlate with any clinical variables. The significantly longer CSP duration in FM patients suggests central dysregulation at the spinal and supraspinal levels, rather than peripheral small fiber dysfunction.	[Baek, Seol-Hee; Seok, Hung Youl; Koo, Yong Seo; Kim, Byung-Jo] Korea Univ, Coll Med, Med Ctr, Dept Neurol, Seoul 136705, South Korea	Korea University; Korea University Medicine (KU Medicine)	Kim, BJ (corresponding author), Korea Univ, Coll Med, Med Ctr, Dept Neurol, Seoul 136705, South Korea.	nukbj@korea.ac.kr	Kim, Byung-Jo/A-5943-2012	Kim, Byung-Jo/0000-0002-0445-7185	National Research Foundation of Korea (NRF) - Korean Government (MSIP) [NRF-2015R1A5A7037674]; Technology Innovation Program - Ministry of Trade, Industry and Energy (MI, Korea) [10049743]	National Research Foundation of Korea (NRF) - Korean Government (MSIP); Technology Innovation Program - Ministry of Trade, Industry and Energy (MI, Korea)	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean Government (MSIP; no. NRF-2015R1A5A7037674) and the Technology Innovation Program (or the Industrial Strategic Technology Development Program) (10049743, "Establishing a medical device development open platform, as a hub for accelerating close firm-hospital communication") funded by the Ministry of Trade, Industry and Energy (MI, Korea). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean Government (MSIP; no. NRF-2015R1A5A7037674) and the Technology Innovation Program (or the Industrial Strategic Technology Development Program) (10049743, "Establishing a medical device development open platform, as a hub for accelerating close firm-hospital communication") funded by the Ministry of Trade, Industry and Energy (MI, Korea).	Banic B, 2004, PAIN, V107, P7, DOI 10.1016/j.pain.2003.05.001; Caro XJ, 2014, ARTHRITIS RHEUMATOL, V66, P1945, DOI 10.1002/art.38662; Desmeules JA, 2003, ARTHRITIS RHEUM-US, V48, P1420, DOI 10.1002/art.10893; Floeter MK, 2003, MUSCLE NERVE, V28, P391, DOI 10.1002/mus.10447; Giannoccaro MP, 2014, MUSCLE NERVE, V49, P757, DOI 10.1002/mus.24156; Gracely RH, 2002, ARTHRITIS RHEUM-US, V46, P1333, DOI 10.1002/art.10225; Han JK, 2007, CLIN NEUROPHYSIOL, V118, P1705, DOI 10.1016/j.clinph.2007.04.024; Inghilleri M, 2002, MUSCLE NERVE, V25, P695, DOI 10.1002/mus.10101; Jensen KB, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-32; Kim BJ, 2010, J NEUROL SCI, V293, P1, DOI 10.1016/j.jns.2010.03.032; Kim YA, 2002, J KOREAN MED SCI, V17, P220, DOI 10.3346/jkms.2002.17.2.220; Koo YS, 2012, J CLIN NEUROL, V8, P1, DOI 10.3988/jcn.2012.8.1.1; Koo YS, 2010, CLIN NEUROPHYSIOL, V121, P1584, DOI 10.1016/j.clinph.2010.03.012; Kosmidis ML, 2014, J NEUROL SCI, V347, P143, DOI 10.1016/j.jns.2014.09.035; Kuchinad A, 2007, J NEUROSCI, V27, P4004, DOI 10.1523/JNEUROSCI.0098-07.2007; Leis AA, 1998, MUSCLE NERVE, V21, P1243, DOI 10.1002/(SICI)1097-4598(199810)21:10<1243::AID-MUS1>3.0.CO;2-B; Low PA, 2013, J CLIN NEUROL, V9, P1, DOI 10.3988/jcn.2013.9.1.1; Lutz J, 2008, ARTHRITIS RHEUM-US, V58, P3960, DOI 10.1002/art.24070; Mhalla A, 2010, PAIN, V149, P495, DOI 10.1016/j.pain.2010.03.009; MOUNTZ JM, 1995, ARTHRITIS RHEUM, V38, P926, DOI 10.1002/art.1780380708; Oaklander AL, 2006, PAIN, V120, P235, DOI 10.1016/j.pain.2005.09.036; Oaklander AL, 2013, PAIN, V154, P2310, DOI 10.1016/j.pain.2013.06.001; Oaklander AL, 2013, PEDIATRICS, V131, pE1091, DOI 10.1542/peds.2012-2597; Onal MR, 2010, CLIN NEUROPHYSIOL, V121, P714, DOI 10.1016/j.clinph.2009.12.024; Osio M, 2004, J PERIPHER NERV SYST, V9, P224, DOI 10.1111/j.1085-9489.2004.09400.x; Park SY, 2014, J CLIN NEUROL, V10, P334, DOI 10.3988/jcn.2014.10.4.334; Polydefkis M, 2000, NEUROLOGY, V55, P1115, DOI 10.1212/WNL.55.8.1115; Pullman SL, 1996, NEUROLOGY, V46, P503, DOI 10.1212/WNL.46.2.503; Ramirez M, 2015, SEMIN ARTHRITIS RHEU, V45, P214, DOI 10.1016/j.semarthrit.2015.03.003; Robinson ME, 2011, J PAIN, V12, P436, DOI 10.1016/j.jpain.2010.10.003; RUSSELL IJ, 1992, ARTHRITIS RHEUM, V35, P550, DOI 10.1002/art.1780350509; RUSSELL IJ, 1994, ARTHRITIS RHEUM-US, V37, P1593, DOI 10.1002/art.1780371106; Sahin O, 2011, NEUROL RES, V33, P339, DOI 10.1179/016164110X12767786356516; Samuelsson K, 2014, J CLIN NEUROL, V10, P108, DOI 10.3988/jcn.2014.10.2.108; Sarchielli P, 2007, J PAIN, V8, P737, DOI 10.1016/j.jpain.2007.05.002; Schmidt-Wilcke T, 2011, NAT REV RHEUMATOL, V7, P518, DOI 10.1038/nrrheum.2011.98; Schwenkreis P, 2011, MUSCLE NERVE, V43, P479, DOI 10.1002/mus.21920; Serrao M, 2002, ACTA NEUROL SCAND, V105, P196, DOI 10.1034/j.1600-0404.2002.1o085.x; Smith HS, 2011, PAIN PHYSICIAN, V14, pE217; Stetkarova I, 2015, BIOMED PAP, V159, P327, DOI 10.5507/bp.2013.081; Svilpauskaite J, 2006, MUSCLE NERVE, V33, P487, DOI 10.1002/mus.20496; Svilpauskaite Jovita, 2006, Medicina (Kaunas), V42, P300; Thaisetthawatkul P, 2013, MUSCLE NERVE, V48, P883, DOI 10.1002/mus.23891; Tilki HE, 2014, J CLIN NEUROL, V10, P10, DOI 10.3988/jcn.2014.10.1.10; Uceyler N, 2013, BRAIN, V136, P1857, DOI 10.1093/brain/awt053; Umay E, 2013, REV BRAS REUMATOL, V53, P288, DOI 10.1590/S0482-50042013000300007; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Yaman M, 2007, NEUROSCI LETT, V419, P258, DOI 10.1016/j.neulet.2007.04.018; Yunus MB, 2007, SEMIN ARTHRITIS RHEU, V36, P339, DOI 10.1016/j.semarthrit.2006.12.009	49	20	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149248	10.1371/journal.pone.0149248	http://dx.doi.org/10.1371/journal.pone.0149248			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871583	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100133
J	de Bruijn, HS; Brooks, S; van der Ploeg-van den Heuvel, A; ten Hagen, TLM; de Haas, ERM; Robinson, DJ				de Bruijn, Henriette S.; Brooks, Sander; van der Ploeg-van den Heuvel, Angelique; ten Hagen, Timo L. M.; de Haas, Ellen R. M.; Robinson, Dominic J.			Light Fractionation Significantly Increases the Efficacy of Photodynamic Therapy Using BF-200 ALA in Normal Mouse Skin	PLOS ONE			English	Article							TOPICAL 5-AMINOLEVULINIC ACID; BASAL-CELL CARCINOMA; 2-FOLD ILLUMINATION SCHEMES; PROTOPORPHYRIN-IX; AMINOLEVULINIC-ACID; METHYL AMINOLEVULINATE; FOLLOW-UP; LIPOSOMES; DERIVATIVES; GUIDELINES	Background Light fractionation significantly increases the efficacy of 5-aminolevulinic acid (ALA) based photodynamic therapy (PDT) using the nano-emulsion based gel formulation BF-200. PDT using BF-200 ALA has recently been clinically approved and is under investigation in several phase III trials for the treatment of actinic keratosis. This study is the first to compare BF-200 ALA with ALA in preclinical models. Results In hairless mouse skin there is no difference in the temporal and spatial distribution of protoporphyrin IX determined by superficial imaging and fluorescence microscopy in frozen sections. In the skin-fold chamber model, BF-200 ALA leads to more PpIX fluorescence at depth in the skin compared to ALA suggesting an enhanced penetration of BF-200 ALA. Light fractionated PDT after BF-200 ALA application results in significantly more visual skin damage following PDT compared to a single illumination. Both ALA formulations show the same visual skin damage, rate of photobleaching and change in vascular volume immediately after PDT. Fluorescence immunohistochemical imaging shows loss of VE-cadherin in the vasculature at day 1 post PDT which is greater after BF-200 ALA compared to ALA and more profound after light fractionation compared to a single illumination. Discussion The present study illustrates the clinical potential of light fractionated PDT using BF-200 ALA for enhancing PDT efficacy in (pre-) malignant skin conditions such as basal cell carcinoma and vulval intraepithelial neoplasia and its application in other lesion such as cervical intraepithelial neoplasia and oral squamous cell carcinoma where current approaches have limited efficacy.	[de Bruijn, Henriette S.; van der Ploeg-van den Heuvel, Angelique; Robinson, Dominic J.] Erasmus MC, Dept Otolaryngol & Head & Neck Surg, Ctr Opt Diagnost & Therapy, Rotterdam, Netherlands; [Brooks, Sander; de Haas, Ellen R. M.] Erasmus MC, Dept Dermatol, Rotterdam, Netherlands; [ten Hagen, Timo L. M.] Erasmus MC, Dept Surg Oncol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	de Bruijn, HS (corresponding author), Erasmus MC, Dept Otolaryngol & Head & Neck Surg, Ctr Opt Diagnost & Therapy, Rotterdam, Netherlands.	h.debruijn@erasmusmc.nl			Biofrontera Pharmaceuticals AG	Biofrontera Pharmaceuticals AG	This study was supported by Biofrontera Pharmaceuticals AG (http://biofrontera.com/en/) to DJR in a grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2011, CANCER RES, V71, P6040, DOI 10.1158/0008-5472.CAN-11-0805; Blake E, 2013, PHOTODIAGN PHOTODYN, V10, P575, DOI 10.1016/j.pdpdt.2013.06.006; Braathen LR, 2007, J AM ACAD DERMATOL, V56, P125, DOI 10.1016/j.jaad.2006.06.006; Choi MC, 2015, LASER SURG MED, V47, P566, DOI 10.1002/lsm.22384; de Bruijn HS, 2006, J PHOTOCH PHOTOBIO B, V85, P184, DOI 10.1016/j.jphotobiol.2006.07.004; de Bruijn HS, 2007, PHOTOCH PHOTOBIO SCI, V6, P1325, DOI 10.1039/b708340h; de Bruijn HS, 2006, PHOTODERMATOL PHOTO, V22, P238, DOI 10.1111/j.1600-0781.2006.00240.x; de Bruijn HS, 2013, PHOTOCH PHOTOBIO SCI, V12, P241, DOI 10.1039/c2pp25287b; de Bruijn HS, 2008, J PHOTOCH PHOTOBIO B, V92, P91, DOI 10.1016/j.jphotobiol.2008.05.005; de Bruijn HS, 1999, CANCER RES, V59, P901; de Haas ERM, 2006, J INVEST DERMATOL, V126, P2679, DOI 10.1038/sj.jid.5700460; de Vijlder HC, 2012, ACTA DERM-VENEREOL, V92, P641, DOI 10.2340/00015555-1448; Dirschka T, 2013, BRIT J DERMATOL, V168, P825, DOI 10.1111/bjd.12158; Dreher F, 1997, J CONTROL RELEASE, V45, P131, DOI 10.1016/S0168-3659(96)01559-3; Foldvari M, 2010, MOL PHARMACEUT, V7, P751, DOI 10.1021/mp900283x; Fotinos N, 2006, PHOTOCHEM PHOTOBIOL, V82, P994, DOI 10.1562/2006-02-03-IR-794; Gerritsen MJP, 2009, DERMATOLOGY, V218, P193, DOI 10.1159/000183753; Helgesen ALO, 2015, BRIT J DERMATOL, V173, P1156, DOI 10.1111/bjd.14033; Hillemanns P, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.10.1107; Jerjes W, 2011, LASER SURG MED, V43, P192, DOI 10.1002/lsm.21036; Juzeniene A, 2002, PHOTOCHEM PHOTOBIOL, V76, P329, DOI 10.1562/0031-8655(2002)076<0329:TAOAAA>2.0.CO;2; Kawczyk-Krupka A, 2012, PHOTODIAGN PHOTODYN, V9, P148, DOI 10.1016/j.pdpdt.2011.12.007; Kriska T, 2005, ARCH BIOCHEM BIOPHYS, V433, P435, DOI 10.1016/j.abb.2004.09.025; Lesar A, 2007, PHOTODIAGN PHOTODYN, V4, P224, DOI 10.1016/j.pdpdt.2007.09.002; Maisch T, 2007, PHOTOCH PHOTOBIO SCI, V6, P545, DOI 10.1039/b614770d; Maisch T, 2010, EXP DERMATOL, V19, pE302, DOI 10.1111/j.1600-0625.2009.01001.x; Middelburg TA, 2013, PHOTODIAGN PHOTODYN, V10, P703, DOI 10.1016/j.pdpdt.2013.09.002; Middelburg TA, 2014, PHOTOCHEM PHOTOBIOL, V90, P896, DOI 10.1111/php.12271; Moan J, 2003, INT J CANCER, V103, P132, DOI 10.1002/ijc.10802; MOAN J, 1990, J PHOTOCH PHOTOBIO B, V6, P343, DOI 10.1016/1011-1344(90)85104-5; Morton C, 2015, EUR J DERMATOL; Morton CA, 2008, BRIT J DERMATOL, V159, P1245, DOI 10.1111/j.1365-2133.2008.08882.x; Neittaanmaki-Perttu N, 2014, BRIT J DERMATOL, V171, P1172, DOI 10.1111/bjd.13326; Oh EK, 2011, EUR J PHARM SCI, V44, P149, DOI 10.1016/j.ejps.2011.07.003; RATCLIFFE SL, 1995, BRIT J CANCER, V71, P300, DOI 10.1038/bjc.1995.60; Robinson DJ, 2000, PHOTOCHEM PHOTOBIOL, V72, P794, DOI 10.1562/0031-8655(2000)072<0794:TAAPTO>2.0.CO;2; Robinson DJ, 1999, PHOTOCHEM PHOTOBIOL, V69, P61, DOI 10.1111/j.1751-1097.1999.tb05307.x; Robinson DJ, 2003, PHOTOCHEM PHOTOBIOL, V77, P319, DOI 10.1562/0031-8655(2003)077<0319:DATOTF>2.0.CO;2; Robinson DJ, 1998, PHOTOCHEM PHOTOBIOL, V67, P140, DOI 10.1562/0031-8655(1998)067<0140:FPOAIP>2.3.CO;2; Seynhaeve ALB, 2007, CANCER RES, V67, P9455, DOI 10.1158/0008-5472.CAN-07-1599; Star WM, 2006, ACTA DERM-VENEREOL, V86, P412, DOI 10.2340/00015555-0129; van der Veen N, 1999, PHOTOCHEM PHOTOBIOL, V70, P921, DOI 10.1562/0031-8655(1999)070<0921:PEAVIH>2.3.CO;2; ZELLMER S, 1995, BBA-BIOMEMBRANES, V1237, P176, DOI 10.1016/0005-2736(95)00100-H	43	20	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148850	10.1371/journal.pone.0148850	http://dx.doi.org/10.1371/journal.pone.0148850			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872051	Green Submitted, Green Published, gold			2022-12-27	WOS:000370054100064
J	Ge, X; Tao, FB; Huang, K; Mao, LJ; Huang, SH; Niu, Y; Hao, JH; Sun, YL; Rutayisire, E				Ge, Xing; Tao, Fangbiao; Huang, Kun; Mao, Leijing; Huang, Sanhuan; Niu, Ying; Hao, Jiahu; Sun, Yanli; Rutayisire, Erigene			Maternal Snoring May Predict Adverse Pregnancy Outcomes: A Cohort Study in China	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; RISK-FACTORS; GLUCOSE-METABOLISM; BIRTH-WEIGHT; WOMEN; DISTURBANCES; PREVALENCE; HYPERTENSION; ASSOCIATION; POPULATION	Objective To examine the prevalence of snoring during pregnancy and its effects on key pregnancy outcomes. Methods Pregnant women were consecutively recruited in their first trimester. Habitual snoring was screened by using a questionnaire in the 1st and 3rd trimester, respectively. According to the time of snoring, participants were divided into pregnancy onset snorers, chronic snorers and non-snorers. Logistic regressions were performed to examine the associations between snoring and pregnancy outcomes. Results Of 3 079 pregnant women, 16.6% were habitual snorers, with 11.7% were pregnancy onset snorers and 4.9% were chronic snorers. After adjusting for potential confounders, chronic snorers were independently associated with gestational diabetes mellitus (GDM) (RR 1.66, 95% CI 1.09-2.53). Both pregnancy onset and chronic snorers were independently associated with placental adhesion (RR 1.96, 95% CI 1.17-3.27, and RR 2.33, 95% CI 1.22-4.46, respectively). Pregnancy onset snorers were at higher risk of caesarean delivery (RR 1.37, 95% CI 1.09-1.73) and having macrosomia (RR 1.54, 95% CI 1.05-2.27) and large for gestational age (LGA) (RR 1.71, 95% CI 1.31-2.24) infants. In addition, being overweight or obese before pregnancy plays an important role in mediating snoring and adverse pregnancy outcomes. Conclusions Maternal snoring may increase the risk of adverse pregnancy outcomes, and being overweight or obese before pregnancy with snoring is remarkable for researchers. Further studies are still needed to confirm our results.	[Ge, Xing; Tao, Fangbiao; Huang, Kun; Mao, Leijing; Huang, Sanhuan; Niu, Ying; Hao, Jiahu; Sun, Yanli; Rutayisire, Erigene] Anhui Med Univ, Sch Publ Hlth, Dept Maternal & Child Hlth, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China; [Ge, Xing; Tao, Fangbiao; Huang, Kun; Mao, Leijing; Huang, Sanhuan; Niu, Ying; Hao, Jiahu; Sun, Yanli; Rutayisire, Erigene] Anhui Prov Key Lab Populat Hlth & Aristogen, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China	Anhui Medical University	Tao, FB (corresponding author), Anhui Med Univ, Sch Publ Hlth, Dept Maternal & Child Hlth, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China.; Tao, FB (corresponding author), Anhui Prov Key Lab Populat Hlth & Aristogen, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China.	taofangbiao@126.com			National Natural Science Foundation of China, National Natural Science Funds Commission [81330068, 81373012]; Anhui Medical University [XJ201205]	National Natural Science Foundation of China, National Natural Science Funds Commission; Anhui Medical University	This work was supported by 1) the National Natural Science Foundation of China (No. 81330068, http://fund.sciencenet.cn/), which is supported by National Natural Science Funds Commission. This funding was received by FT; 2) the National Natural Science Foundation of China (No. 81373012, http://fund.sciencenet.cn/), which is supported by National Natural Science Funds Commission. This funding was received by KH; and 3) the Research Fund for the Doctor Program of Anhui Medical University (No: XJ201205), a fund to encourage doctor's scientific achievements of Anhui Medical University, which is supported by Anhui Medical University. There is no URL for this funding.	Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; BLIWISE DL, 1991, CHEST, V99, P600, DOI 10.1378/chest.99.3.600; Bourjeily G, 2010, EUR RESPIR J, V36, P849, DOI 10.1183/09031936.00021810; Bourjeily G, 2015, SLEEP BREATH, V19, P835, DOI 10.1007/s11325-014-1099-1; Bourjeily G, 2014, SLEEP MED, V15, P550, DOI 10.1016/j.sleep.2014.01.004; Cai XH, 2013, SLEEP BREATH, V17, P951, DOI 10.1007/s11325-012-0783-2; Carey JC, 2000, NEW ENGL J MED, V342, P534, DOI 10.1056/NEJM200002243420802; Chen Chunming, 2004, Biomed Environ Sci, V17 Suppl, P1; Chen YH, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.023; del Campo F, 2013, SLEEP BREATH, V17, P463, DOI 10.1007/s11325-012-0754-7; Domingo C, 2006, INT J GYNECOL OBSTET, V93, P57, DOI 10.1016/j.ijgo.2006.01.004; Facco FL, 2014, AM J PERINAT, V31, P899, DOI 10.1055/s-0033-1363768; Facco FL, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.12.035; Facco FL, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.03.041; Facco FL, 2010, OBSTET GYNECOL, V115, P77, DOI 10.1097/AOG.0b013e3181c4f8ec; Franklin KA, 2000, CHEST, V117, P137, DOI 10.1378/chest.117.1.137; Frederick IO, 2013, SLEEP BREATH, V17, P541, DOI 10.1007/s11325-012-0717-z; Hu FB, 1999, AM J EPIDEMIOL, V150, P806; Hung TH, 1999, OBSTET GYNECOL, V93, P545, DOI 10.1016/S0029-7844(98)00460-8; Hutchison BL, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-144; Izci B, 2006, EUR RESPIR J, V27, P321, DOI 10.1183/09031936.06.00148204; Ko HS, 2013, ARCH GYNECOL OBSTET, V287, P429, DOI 10.1007/s00404-012-2602-1; Lash GE, 2007, PLACENTA, V28, P390, DOI 10.1016/j.placenta.2006.06.001; Leung PL, 2005, BJOG-INT J OBSTET GY, V112, P1568, DOI 10.1111/j.1471-0528.2005.00737.x; Louis JM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.867; Luque-Fernandez MA, 2013, DIABETES CARE, V36, P3353, DOI 10.2337/dc13-0778; Macones GA, 2012, AM J OBSTET GYNECOL, V206, pE1, DOI 10.1016/j.ajog.2012.02.017; Micheli K, 2011, EPIDEMIOLOGY, V22, P738, DOI 10.1097/EDE.0b013e31822546fd; Mikolajczyk RT, 2011, LANCET, V377, P1855, DOI 10.1016/S0140-6736(11)60364-4; Mindell JA, 2015, SLEEP MED, V16, P483, DOI 10.1016/j.sleep.2014.12.006; O'Brien LM, 2013, SLEEP, V36, P1625, DOI 10.5665/sleep.3112; O'Brien LM, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.034; O'Keeffe M, 2013, INT J OBESITY, V37, P765, DOI 10.1038/ijo.2012.142; Pamidi S, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.07.033; Peker Y, 2002, AM J RESP CRIT CARE, V166, P159, DOI 10.1164/rccm.2105124; Pien GW, 2014, THORAX, V69, P371, DOI 10.1136/thoraxjnl-2012-202718; Pijnenborg Robert, 2002, Reprod Biomed Online, V4 Suppl 3, P14; Qiu CF, 2010, BMC WOMENS HEALTH, V10, DOI 10.1186/1472-6874-10-17; Redhead K, 2014, THORAX, V69, P1048, DOI 10.1136/thoraxjnl-2014-205485; Sarberg M, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-15; Schanz A, 2014, PLACENTA, V35, P1089, DOI 10.1016/j.placenta.2014.09.012; Stamatakis KA, 2010, CHEST, V137, P95, DOI 10.1378/chest.09-0791; Svensson M, 2006, CHEST, V129, P933, DOI 10.1378/chest.129.4.933; Tauman R, 2012, J MATERN-FETAL NEO M, V25, P1283, DOI 10.3109/14767058.2011.629255; Tishler PV, 2003, JAMA-J AM MED ASSOC, V289, P2230, DOI 10.1001/jama.289.17.2230; Ugur MG, 2012, CLIN EXP OBSTET GYN, V39, P214; Xiong X, 2000, AM J OBSTET GYNECOL, V183, P148, DOI 10.1067/mob.2000.105735; Yang Z, 2014, SCI REP-UK, V4, DOI 10.1038/srep05549; Young T, 1996, SLEEP, V19, pS202, DOI 10.1093/sleep/19.suppl_10.S202; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	50	32	34	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148732	10.1371/journal.pone.0148732	http://dx.doi.org/10.1371/journal.pone.0148732			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871434	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100051
J	Passlack, N; Schmiedchen, B; Raila, J; Schweigert, FJ; Stumpff, F; Kohn, B; Neumann, K; Zentek, J				Passlack, Nadine; Schmiedchen, Bettina; Raila, Jens; Schweigert, Florian J.; Stumpff, Friederike; Kohn, Barbara; Neumann, Konrad; Zentek, Juergen			Impact of Increasing Dietary Calcium Levels on Calcium Excretion and Vitamin D Metabolites in the Blood of Healthy Adult Cats	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GROWTH-FACTOR 23; PARATHYROID-HORMONE; URINARY PH; PHOSPHORUS; FGF23; DEFICIENCY; DOGS; HYPERCALCIURIA; SECRETION	Background Dietary calcium (Ca) concentrations might affect regulatory pathways within the Ca and vitamin D metabolism and consequently excretory mechanisms. Considering large variations in Ca concentrations of feline diets, the physiological impact on Ca homeostasis has not been evaluated to date. In the present study, diets with increasing concentrations of dicalcium phosphate were offered to ten healthy adult cats (Ca/phosphorus (P): 6.23/6.02, 7.77/7.56, 15.0/12.7, 19.0/17.3, 22.2/19.9, 24.3/21.6 g/kg dry matter). Each feeding period was divided into a 10-day adaptation and an 8-day sampling period in order to collect urine and faeces. On the last day of each feeding period, blood samples were taken. Results Urinary Ca concentrations remained unaffected, but faecal Ca concentrations increased (P < 0.001) with increasing dietary Ca levels. No effect on whole and intact parathyroid hormone levels, fibroblast growth factor 23 and calcitriol concentrations in the blood of the cats were observed. However, the calcitriol precursors 25(OH)D-2 and 25(OH)D-3, which are considered the most useful indicators for the vitamin D status, decreased with higher dietary Ca levels (P = 0.013 and P = 0.033). Increasing dietary levels of dicalcium phosphate revealed an acidifying effect on urinary fasting pH (6.02) and postprandial pH (6.01) (P < 0.001), possibly mediated by an increase of urinary phosphorus (P) concentrations (P < 0.001). Conclusions In conclusion, calcitriol precursors were linearly affected by increasing dietary Ca concentrations. The increase in faecal Ca excretion indicates that Ca homeostasis of cats is mainly regulated in the intestine and not by the kidneys. Long-term studies should investigate the physiological relevance of the acidifying effect observed when feeding diets high in Ca and P.	[Passlack, Nadine; Zentek, Juergen] Free Univ Berlin, Inst Anim Nutr, Dept Vet Med, Konigin Luise Str 49, D-14195 Berlin, Germany; [Schmiedchen, Bettina; Raila, Jens; Schweigert, Florian J.] Univ Potsdam, Inst Nutr Sci, Arthur Scheunert Allee 114-116, D-14558 Bergholz Rehbrucke, Germany; [Stumpff, Friederike] Free Univ Berlin, Inst Vet Physiol, Dept Vet Med, Oertzenweg 19b, D-14163 Berlin, Germany; [Kohn, Barbara] Free Univ Berlin, Dept Vet Med, Clin Small Anim, Oertzenweg 19b, D-14163 Berlin, Germany; [Neumann, Konrad] Charite, Inst Biometry & Clin Epidemiol, Hindenburgdamm 30, D-12203 Berlin, Germany	Free University of Berlin; University of Potsdam; Free University of Berlin; Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Passlack, N (corresponding author), Free Univ Berlin, Inst Anim Nutr, Dept Vet Med, Konigin Luise Str 49, D-14195 Berlin, Germany.	nadine.passlack@fu-berlin.de		Zentek, Jurgen/0000-0003-2864-9250; Schweigert, Florian/0000-0001-7103-2438				AAFCO, 2014, AAFCO METHODS SUBSTA; Anderson PH, 2010, J STEROID BIOCHEM, V121, P288, DOI 10.1016/j.jsbmb.2010.03.022; Aronov PA, 2008, ANAL BIOANAL CHEM, V391, P1917, DOI 10.1007/s00216-008-2095-8; Bergwitz C, 2010, ANNU REV MED, V61, P91, DOI 10.1146/annurev.med.051308.111339; Bihuniak JD, 2013, J ACAD NUTR DIET, V113, P447, DOI 10.1016/j.jand.2012.11.002; Burkholder WJ, 2000, J AM VET MED ASSOC, V216, P1730, DOI 10.2460/javma.2000.216.1730; Ceglia L, 2009, J CLIN ENDOCR METAB, V94, P645, DOI 10.1210/jc.2008-1796; CLEMENTS MR, 1987, NATURE, V325, P62, DOI 10.1038/325062a0; Cline J, 2012, TOP COMPANION ANIM M, V27, P159, DOI 10.1053/j.tcam.2012.09.004; de Morais HA, 2008, VET CLIN N AM-SMALL, V38, P559, DOI 10.1016/j.cvsm.2008.02.003; Dijcker JC, 2011, NUTR RES REV, V24, P96, DOI 10.1017/S0954422410000351; Dillitzer N, 2010, C P 14 C EUR SOC VET, P67; Dittmer KE, 2011, VET PATHOL, V48, P389, DOI 10.1177/0300985810375240; Federation europeenne de l'industrie des aliments pour animaux familiers The European Pet Food Federation (FEDIAF), 2014, NUTR GUID COMPL COMP; Felsenfeld AJ, 2007, CLIN J AM SOC NEPHRO, V2, P1283, DOI 10.2215/CJN.01520407; Finch NC, 2013, J VET INTERN MED, V27, P227, DOI 10.1111/jvim.12036; Galvao JFD, 2013, J VET EMERG CRIT CAR, V23, P134, DOI 10.1111/vec.12036; Geddes RF, 2013, J VET INTERN MED, V27, P234, DOI 10.1111/jvim.12044; Geddes RF, 2013, J VET EMERG CRIT CAR, V23, P122, DOI 10.1111/vec.12032; Hardcastle MR, 2015, VET PATHOL, V52, P770, DOI 10.1177/0300985815586222; IZQUIERDO JV, 1991, J NUTR, V121, pS89, DOI 10.1093/jn/121.suppl_11.S89; KIENZLE E, 1991, J NUTR, V121, pS87, DOI 10.1093/jn/121.suppl_11.S87; KIENZLE E, 1993, DEUT TIERARZTL WOCH, V100, P198; KIENZLE E, 1994, J NUTR PHILADELPHIA, V124, P2652, DOI DOI 10.1093/JN/124.SUPPL_12.2652S; KIRK CA, 1995, J AM VET MED ASSOC, V207, P1429; Lips P, 2012, SCAND J CLIN LAB INV, V72, P60, DOI 10.3109/00365513.2012.681960; Maalouf NM, 2011, J CLIN ENDOCR METAB, V96, P3733, DOI 10.1210/jc.2011-1531; Mack JK, 2015, J ANIM PHYSIOL AN N, V99, P801, DOI 10.1111/jpn.12294; Morris JG, 1999, J NUTR, V129, P909, DOI 10.1093/jn/129.4.909; National Research Council, 2006, NUTR REQ DOGS CATS; Osborne CA, 1995, P 13 ACVIM FOR, P487; Passlack N, 2014, BRIT J NUTR, V111, P785, DOI 10.1017/S0007114513003279; Passlack N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070530; Pastoor F., 1993, THESIS U UTRECHT; PASTOOR FJH, 1995, J NUTR, V125, P1334; PASTOOR FJH, 1994, J NUTR, V124, P2212, DOI 10.1093/jn/124.11.2212; Penniston KL, 2009, UROLOGY, V73, P484, DOI 10.1016/j.urology.2008.10.035; Pineda C, 2012, DOMEST ANIM ENDOCRIN, V42, P256, DOI 10.1016/j.domaniend.2012.01.003; Rodriguez-Ortiz ME, 2012, J AM SOC NEPHROL, V23, P1190, DOI 10.1681/ASN.2011101006; Schlesinger DP, 2011, CAN VET J, V52, P50; SCOTT P. PATRICIA, 1967, P163; Shimada T, 2005, AM J PHYSIOL-RENAL, V289, pF1088, DOI 10.1152/ajprenal.00474.2004; SKOCH ER, 1991, J SMALL ANIM PRACT, V32, P413, DOI 10.1111/j.1748-5827.1991.tb00968.x; Stevenson AE, 2004, VET THER, V5, P218; Torres PU, 2006, KIDNEY INT, V70, P240, DOI 10.1038/sj.ki.5001658; Verbeke G, 2000, LINEAR MIXED MODELS, P20; Wesseling-Perry K, 2014, J CLIN ENDOCR METAB, V99, pE1951, DOI 10.1210/jc.2014-2125; ZEMEL MB, 1981, J NUTR, V111, P545, DOI 10.1093/jn/111.3.545	48	7	7	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149190	10.1371/journal.pone.0149190	http://dx.doi.org/10.1371/journal.pone.0149190			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26870965	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100122
J	Reitan, T; Nielsen, A				Reitan, Trond; Nielsen, Anders			Do Not Divide Count Data with Count Data; A Story from Pollination Ecology with Implications Beyond	PLOS ONE			English	Article							SPECIES RICHNESS; PLANTS; DIVERSITY; DECLINES; MODELS; TRENDS	Studies in ecology are often describing observed variations in a certain ecological phenomenon by use of environmental explanatory variables. A common problem is that the numerical nature of the ecological phenomenon does not always fit the assumptions underlying traditional statistical tests. A text book example comes from pollination ecology where flower visits are normally reported as frequencies; number of visits per flower per unit time. Using visitation frequencies in statistical analyses comes with two major caveats: the lack of knowledge on its error distribution and that it does not include all information found in the data; 10 flower visits in 20 flowers is treated the same as recording 100 visits in 200 flowers. We simulated datasets with various "flower visitation distributions" over various numbers of flowers observed (exposure) and with different types of effects inducing variation in the data. The different datasets were then analyzed first with the traditional approach using number of visits per flower and then by using count data models. The analysis of count data gave a much better chance of detecting effects than the traditionally used frequency approach. We conclude that if the data structure, statistical analyses and interpretations of results are mixed up, valuable information can be lost.	[Reitan, Trond; Nielsen, Anders] Univ Oslo, Dept Biosci, CEES, POB 1066 Blindern, NO-0316 Oslo, Norway	University of Oslo	Reitan, T (corresponding author), Univ Oslo, Dept Biosci, CEES, POB 1066 Blindern, NO-0316 Oslo, Norway.	trond.reitan@ibv.uio.no	Reitan, Trond/P-4554-2019		Norwegian Research Council [230279/E50]; Research Council of Norway [230279/E50-PolliClim]	Norwegian Research Council(Research Council of NorwayEuropean Commission); Research Council of Norway(Research Council of Norway)	This work was supported by the Norwegian Research Council, 230279/E50. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Research Council of Norway (project 230279/E50-PolliClim) financially supported this study. We thank Dr. Lars Qviller for useful comments on an earlier draft of the manuscript.	ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; Bates D, 2014, J STAT SOFTWAR UNPUB; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Chamorro S, 2012, ANN BOT; Chao A, 2003, ENVIRON ECOL STAT, V10, P429, DOI 10.1023/A:1026096204727; Dauber J, 2010, J ECOL, V98, P188, DOI 10.1111/j.1365-2745.2009.01590.x; Denison DGT, 2002, BAYESIAN METHODS NON, P18; Dunstan PK, 2013, J AGR BIOL ENVIR ST, V18, P357, DOI 10.1007/s13253-013-0146-x; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Frimpong E. A., 2009, International Journal of Tropical Insect Science, V29, P62, DOI 10.1017/S1742758409990117; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Handeland K, 2013, VET PARASITOL, V195, P142, DOI 10.1016/j.vetpar.2013.02.012; Herrera CM, 2005, AM J BOT, V92, P13, DOI 10.3732/ajb.92.1.13; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Lazaro A, 2010, OIKOS, V119, P825, DOI 10.1111/j.1600-0706.2009.18017.x; Lewis F, 2011, METHODS ECOL EVOL, V2, P155, DOI 10.1111/j.2041-210X.2010.00063.x; Mao CX, 2005, ECOLOGY, V86, P1143, DOI 10.1890/04-1078; McCulloch C. E., 2008, GEN LINEAR MIXED MOD; Nielsen A, 2012, BASIC APPL ECOL, V13, P489, DOI 10.1016/j.baae.2012.08.008; Nielsen A, 2011, ECOL RES, V26, P969, DOI 10.1007/s11284-011-0852-1; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; Popic TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066665; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Qviller L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071299; Reitan T, 2009, STOCH ENV RES RISK A, V23, P627, DOI 10.1007/s00477-008-0248-0; Rhodes JR, 2011, ECOGRAPHY, V34, P1040, DOI 10.1111/j.1600-0587.2011.06370.x; Rodven R, 2009, J ANIM ECOL, V78, P600, DOI 10.1111/j.1365-2656.2008.01515.x; Skaug H. J., 2014, GEN LINEAR MIXED MOD; Totland O, 2006, AM J BOT, V93, P868, DOI 10.3732/ajb.93.6.868; Tylianakis JM, 2010, BIOL CONSERV, V143, P2270, DOI 10.1016/j.biocon.2009.12.004; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Westphal C, 2008, ECOL MONOGR, V78, P653, DOI 10.1890/07-1292.1	33	28	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149129	10.1371/journal.pone.0149129	http://dx.doi.org/10.1371/journal.pone.0149129			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872136	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100110
J	Seliger, C; Meier, CR; Becker, C; Jick, SS; Bogdahn, U; Hau, P; Leitzmann, MF				Seliger, Corinna; Meier, Christoph R.; Becker, Claudia; Jick, Susan S.; Bogdahn, Ulrich; Hau, Peter; Leitzmann, Michael F.			Use of Selective Cyclooxygenase-2 Inhibitors, Other Analgesics, and Risk of Glioma	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; LOW-DOSE CHEMOTHERAPY; PHASE-II TRIAL; COX-2 INHIBITION; GLIOBLASTOMA CELLS; MEDICATION USE; BRAIN-TUMORS; CELECOXIB; COMBINATION; TEMOZOLOMIDE	Background Selective cyclooxygenase-2 (COX-2) inhibitors are analgesic, antipyretic, and anti-inflammatory drugs. They have been found to inhibit the development of glioma in laboratory investigations. Whether these drugs reduce the risk of glioma incidence in humans is unknown. Methods We conducted a matched case-control analysis using the U.K.-based Clinical Practice Research Datalink (CPRD). We identified 2,469 cases matched to 24,690 controls on age, sex, calendar time, general practice, and number of years of active history in the CPRD prior to the index date. We conducted conditional logistic regression analyses to determine relative risks, estimated as odds ratios (ORs) with 95% confidence intervals (CIs) of glioma in relation to use of selective COX-2 inhibitors, adjusted for several confounding variables. Results Use of selective COX-2 inhibitors was unrelated to risk of glioma (adjusted OR for 1-9 versus 0 prescriptions = 1.02; 95% CI = 0.92-1.13, 10-29 versus 0 prescriptions = 1.01; 95% CI = 0.80-1.28, >= 30 versus 0 prescriptions = 1.16; 95% CI = 0.86-1.55). Trends for increasing numbers of prescriptions for other non-steroidal anti-inflammatory drugs (NSAIDs), and non-NSAID analgesics were also not associated with glioma risk. Conclusion Further epidemiologic studies are needed to confirm the null relation of use of selective COX-2 inhibitors to glioma risk and to explain the discrepancy between laboratory investigations and our observational study. Impact: Use of selective COX-2 inhibitors is unrelated to glioma risk.	[Seliger, Corinna; Bogdahn, Ulrich; Hau, Peter] Regensburg Univ Hosp, Dept Neurol, Regensburg, Germany; [Seliger, Corinna; Bogdahn, Ulrich; Hau, Peter] Regensburg Univ Hosp, Wilhelm Sander NeuroOncol Unit, Regensburg, Germany; [Meier, Christoph R.; Becker, Claudia] Univ Basel, Dept Pharmaceut Sci, Div CIin Pharm & Epidemiol, Basel Pharmacoepidemiol Unit, Basel, Switzerland; [Meier, Christoph R.; Jick, Susan S.] Boston Univ, Sch Publ Hlth, Boston Collaborat Drug Surveillance Program, Boston, MA USA; [Meier, Christoph R.] Univ Basel Hosp, Hosp Pharm, CH-4031 Basel, Switzerland; [Leitzmann, Michael F.] Univ Regensburg, Dept Epidemiol & Prevent Med, D-93053 Regensburg, Germany	University of Regensburg; University of Regensburg; University of Basel; Boston University; University of Basel; University of Regensburg	Seliger, C (corresponding author), Regensburg Univ Hosp, Dept Neurol, Regensburg, Germany.; Seliger, C (corresponding author), Regensburg Univ Hosp, Wilhelm Sander NeuroOncol Unit, Regensburg, Germany.	Corinna.Seliger@ukr.de	Seliger, Corinna/GSE-3989-2022	Hau, Peter/0000-0003-3894-5053; Jick, Susan/0000-0002-2215-1067	German Research Foundation [KFO 262/P10]	German Research Foundation(German Research Foundation (DFG))	This study was sponsored by the German Research Foundation [KFO 262/P10 to C.S and M. L.]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	2011 UKC, 2011, UK POP ETHN GROUP; Andre N, 2011, ONCOTARGET, V2, P960; Bannon FJ, 2013, CANCER CAUSE CONTROL, V24, P2027, DOI 10.1007/s10552-013-0279-9; Benson VS, 2008, BRIT J CANCER, V99, P185, DOI 10.1038/sj.bjc.6604445; Bijnsdorp IV, 2007, J NEURO-ONCOL, V85, P25, DOI 10.1007/s11060-007-9385-4; Chen JC, 2007, ANTICANCER RES, V27, P2547; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; Daugherty SE, 2011, CANCER PREV RES, V4, P2027, DOI 10.1158/1940-6207.CAPR-11-0274; Eberstal S, 2014, J NEUROIMMUNOL, V274, P161, DOI 10.1016/j.jneuroim.2014.06.019; Eberstal S, 2014, INT J CANCER, V134, P2748, DOI 10.1002/ijc.28607; Eberstal S, 2012, CANCER IMMUNOL IMMUN, V61, P1191, DOI 10.1007/s00262-011-1196-y; Ferris JS, 2012, INT J CANCER, V131, pE1031, DOI 10.1002/ijc.27536; Friis S, 2003, BRIT J CANCER, V88, P684, DOI 10.1038/sj.bjc.6600760; Fujita M, 2011, CANCER RES, V71, P2664, DOI 10.1158/0008-5472.CAN-10-3055; Gaiser T, 2008, NEUROSCI LETT, V442, P109, DOI 10.1016/j.neulet.2008.07.014; Gaist D, 2013, BRIT J CANCER, V108, P1189, DOI 10.1038/bjc.2013.87; Gierse JK, 2005, J PHARMACOL EXP THER, V312, P1206, DOI 10.1124/jpet.104.076877; Gilbert MR, 2010, NEURO-ONCOLOGY, V12, P1167, DOI 10.1093/neuonc/noq100; Gutstein HB, 1997, ANESTHESIOLOGY, V87, P1118, DOI 10.1097/00000542-199711000-00016; Hau P, 2007, ONCOLOGY-BASEL, V73, P21, DOI 10.1159/000120028; Heiss A, 2009, EXP CELL RES, V315, P2115, DOI 10.1016/j.yexcr.2009.04.002; Inskip PD, 1995, EPIDEMIOL REV, V17, P382; Jick SS, 2003, PHARMACOTHERAPY, V23, P686, DOI 10.1592/phco.23.5.686.32205; Kang KB, 2007, INT J RADIAT ONCOL, V67, P888, DOI 10.1016/j.ijrobp.2006.09.055; Kang SG, 2006, ONCOL REP, V15, P7; Kardosh A, 2004, CANCER BIOL THER, V3, P55, DOI 10.4161/cbt.3.1.571; Kesari S, 2008, NEURO-ONCOLOGY, V10, P300, DOI 10.1215/15228517-2008-005; Kesari S, 2007, NEURO-ONCOLOGY, V9, P354, DOI 10.1215/15228517-2007-006; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Kosaka A, 2014, CANCER IMMUNOL IMMUN, V63, P847, DOI 10.1007/s00262-014-1561-8; Kuipers GK, 2007, INT J RADIAT BIOL, V83, P677, DOI 10.1080/09553000701558985; Levin VA, 2006, J NEURO-ONCOL, V78, P85, DOI 10.1007/s11060-005-9062-4; Liu YQ, 2014, BRIT J CLIN PHARMACO, V78, P58, DOI 10.1111/bcp.12311; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Ma HI, 2011, J NEUROSURG, V114, P651, DOI 10.3171/2009.11.JNS091396; Moore SC, 2009, CANCER RES, V69, P8349, DOI 10.1158/0008-5472.CAN-09-1669; Nam DH, 2004, ONCOL REP, V11, P263; Petersen C, 2000, CLIN CANCER RES, V6, P2513; Reardon DA, 2005, CANCER-AM CANCER SOC, V103, P329, DOI 10.1002/cncr.20776; Robison NJ, 2014, PEDIATR BLOOD CANCER, V61, P636, DOI 10.1002/pbc.24794; Sareddy GR, 2012, J NEURO-ONCOL, V106, P99, DOI 10.1007/s11060-011-0662-x; Scheurer ME, 2008, CANCER EPIDEM BIOMAR, V17, P1277, DOI 10.1158/1055-9965.EPI-07-2621; Scheurer ME, 2011, INT J CANCER, V129, P2290, DOI 10.1002/ijc.25883; Seliger C, 2015, NEUROONCOLOGY; Sharma V, 2011, NEUROCHEM INT, V59, P567, DOI 10.1016/j.neuint.2011.06.018; Sivak-Sears NR, 2004, AM J EPIDEMIOL, V159, P1131, DOI 10.1093/aje/kwh153; Sorensen HT, 2003, BRIT J CANCER, V88, P1687, DOI 10.1038/sj.bjc.6600945; Stockhammer F, 2010, J NEURO-ONCOL, V100, P407, DOI 10.1007/s11060-010-0192-y; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Suzuki K, 2013, NEURO-ONCOLOGY, V15, P1186, DOI 10.1093/neuonc/not062; Tuettenberg J, 2005, J CANCER RES CLIN, V131, P31, DOI 10.1007/s00432-004-0620-5; Vera M, 2014, INT J PHARMACEUT, V473, P518, DOI 10.1016/j.ijpharm.2014.07.028; Wagemakers M, 2009, TRANSL ONCOL, V2, P1, DOI 10.1593/tlo.08160; Walbert T, 2011, J NEURO-ONCOL, V102, P273, DOI 10.1007/s11060-010-0313-7; Walley T, 1997, LANCET, P350; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563; Yood MU, 2007, PHARMACOEPIDEM DR S, V16, P961, DOI 10.1002/pds.1454; Zhang HT, 2012, ONCOL RES, V20, P447, DOI 10.3727/096504013X13685487925176	58	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149293	10.1371/journal.pone.0149293	http://dx.doi.org/10.1371/journal.pone.0149293			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871579	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100142
J	Skipp, PJS; Hughes, C; McKenna, T; Edwards, R; Langridge, J; Thomson, NR; Clarke, IN				Skipp, Paul J. S.; Hughes, Chris; McKenna, Therese; Edwards, Richard; Langridge, James; Thomson, Nicholas R.; Clarke, Ian N.			Quantitative Proteomics of the Infectious and Replicative Forms of Chlamydia trachomatis	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; PELVIC-INFLAMMATORY-DISEASE; III SECRETION SYSTEM; LYMPHOGRANULOMA-VENEREUM; DEVELOPMENTAL CYCLE; RISK-FACTORS; PROTEIN; PNEUMONIAE; QUANTIFICATION; PREVALENCE	The obligate intracellular developmental cycle of Chlamydia trachomatis presents significant challenges in defining its proteome. In this study we have applied quantitative proteomics to both the intracellular reticulate body (RB) and the extracellular elementary body (EB) from C. trachomatis. We used C. trachomatis L2 as a model chlamydial isolate for our study since it has a high infectivity: particle ratio and there is an excellent quality genome sequence. EBs and RBs (>99% pure) were quantified by chromosomal and plasmid copy number using PCR, from which the concentrations of chlamydial proteins per bacterial cell/genome were determined. RBs harvested at 15h post infection (PI) were purified by three successive rounds of gradient centrifugation. This is the earliest possible time to obtain purified RBs, free from host cell components in quantity, within the constraints of the technology. EBs were purified at 48h PI. We then used two-dimensional reverse phase UPLC to fractionate RB or EB peptides before mass spectroscopic analysis, providing absolute amount estimates of chlamydial proteins. The ability to express the data as molecules per cell gave ranking in both abundance and energy requirements for synthesis, allowing meaningful identification of rate-limiting components. The study assigned 562 proteins with high confidence and provided absolute estimates of protein concentration for 489 proteins. Interestingly, the data showed an increase in TTS capacity at 15h PI. Most of the enzymes involved in peptidoglycan biosynthesis were detected along with high levels of muramidase (in EBs) suggesting breakdown of peptidoglycan occurs in the non-dividing form of the microorganism. All the genome-encoded enzymes for glycolysis, pentose phosphate pathway and tricarboxylic acid cycle were identified and quantified; these data supported the observation that the EB is metabolically active. The availability of detailed, accurate quantitative proteomic data will be invaluable for investigations into gene regulation and function.	[Skipp, Paul J. S.] Univ Southampton, Ctr Biol Sci, Ctr Prote Res, Southampton, Hants, England; [Hughes, Chris; McKenna, Therese; Langridge, James] Waters Corp, Stamford Ave, Wilmslow, Cheshire, England; [Thomson, Nicholas R.] Wellcome Trust Sanger Inst, Pathogen Genom, Hinxton, England; [Clarke, Ian N.] Univ Southampton, Sch Med, Mol Microbiol Grp, Southampton, Hants, England; [Edwards, Richard] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Edwards, Richard] Univ Southampton, Sch Biol Sci, Southampton, Hants, England	University of Southampton; Waters UK; Wellcome Trust Sanger Institute; University of Southampton; University of New South Wales Sydney; University of Southampton	Skipp, PJS (corresponding author), Univ Southampton, Ctr Biol Sci, Ctr Prote Res, Southampton, Hants, England.	pjss@soton.ac.uk	Edwards, Richard/C-8755-2011; Thomson, Nicholas R/P-5988-2014	Edwards, Richard/0000-0002-3645-5539; Thomson, Nicholas R/0000-0002-4432-8505; Clarke, Ian/0000-0002-4938-1620	Wellcome Trust [057347]; Waters Corporation	Wellcome Trust(Wellcome TrustEuropean Commission); Waters Corporation	This study was supported by a grant from the Wellcome Trust (#057347). This funder had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript. Waters Corporation provided support in the form of salaries for authors C.H.,T.M. and J.L. These authors had roles in data collection and analysis, preparation of the manuscript and contribution of analysis tools.	Albrecht M, 2010, NUCLEIC ACIDS RES, V38, P868, DOI 10.1093/nar/gkp1032; [Anonymous], 2008, REPROD HLTH MATTERS, V20, P207; Beeckman DSA, 2010, CURR ISSUES MOL BIOL, V12, P17; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; Belland RJ, 2001, P NATL ACAD SCI USA, V98, P13984, DOI 10.1073/pnas.241377698; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; Cecil JA, 2001, J INFECT DIS, V184, P1216, DOI 10.1086/323662; de Vrieze NHN, 2013, SEX TRANSM INFECT, V89, P548, DOI 10.1136/sextrans-2012-050915; Falk L, 2005, SEX TRANSM INFECT, V81, P73, DOI 10.1136/sti.2004.010439; Fehlner-Gardiner C, 2002, J BIOL CHEM, V277, P26893, DOI 10.1074/jbc.M203937200; Fenton KA, 2005, J INFECT DIS, V191, pS127, DOI 10.1086/425286; Fields KA, 2003, MOL MICROBIOL, V48, P671, DOI 10.1046/j.1365-2958.2003.03462.x; Hefty PS, 2007, J BACTERIOL, V189, P198, DOI 10.1128/JB.01034-06; Herod MR, 2014, BIOCHEM J, V464, P461, DOI 10.1042/BJ20140959; Iliffe-Lee ER, 1999, MOL MICROBIOL, V33, P177, DOI 10.1046/j.1365-2958.1999.01464.x; Kong FYS, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1030-9; Lambden PR, 2006, MICROBIOL-SGM, V152, P2573, DOI 10.1099/mic.0.29032-0; Lerat E, 2005, NUCLEIC ACIDS RES, V33, P3125, DOI 10.1093/nar/gki631; Liechti GW, 2014, NATURE, V506, P507, DOI 10.1038/nature12892; Liu XY, 2010, J BACTERIOL, V192, P2852, DOI 10.1128/JB.01628-09; Montigiani S, 2002, INFECT IMMUN, V70, P368, DOI 10.1128/IAI.70.1.368-379.2002; Moorhead AM, 2010, INFECT IMMUN, V78, P1990, DOI 10.1128/IAI.01340-09; Oakeshott P., 2010, BRIT MED J, V340, pc1642, DOI [10.1136/bmj.c1642, DOI 10.1136/BMJ.C1642]; Omsland A, 2012, P NATL ACAD SCI USA, V109, P19781, DOI 10.1073/pnas.1212831109; Persson K, 2012, SEX TRANSM INFECT, V88, P451, DOI 10.1136/sextrans-2011-050409; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; Pickett MA, 2005, MICROBIOL-SGM, V151, P893, DOI 10.1099/mic.0.27625-0; Price MJ, 2013, AM J EPIDEMIOL, V178, P484, DOI 10.1093/aje/kws583; Saka HA, 2011, MOL MICROBIOL, V82, P1185, DOI 10.1111/j.1365-2958.2011.07877.x; Salim O, 2008, VIROLOGY, V377, P440, DOI 10.1016/j.virol.2008.05.001; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Skilton RJ, 2007, J BACTERIOL, V189, P4957, DOI 10.1128/JB.00235-07; Skilton RJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007723; Skipp P, 2005, PROTEOMICS, V5, P1558, DOI 10.1002/pmic.200401044; Sonnenberg P, 2013, LANCET, V382, P1795, DOI 10.1016/S0140-6736(13)61947-9; Stenner-Liewen F, 2002, J BIOL CHEM, V277, P9633, DOI 10.1074/jbc.C100693200; Sun L, 2010, NATURE, V467, P163, DOI 10.1038/467163a; Szaflarski W, 2007, ORIGINS LIFE EVOL B, V37, P423, DOI 10.1007/s11084-007-9091-4; Thomson NR, 2008, GENOME RES, V18, P161, DOI 10.1101/gr.7020108; Vandahl BB, 2001, ELECTROPHORESIS, V22, P1204, DOI 10.1002/1522-2683()22:6<1204::AID-ELPS1204>3.0.CO;2-M; Vissers JPC, 2007, MOL CELL PROTEOMICS, V6, P755, DOI 10.1074/mcp.M600303-MCP200; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; WARD ME, 1983, BRIT MED BULL, V39, P109, DOI 10.1093/oxfordjournals.bmb.a071800	43	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149011	10.1371/journal.pone.0149011	http://dx.doi.org/10.1371/journal.pone.0149011			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871455	Green Published, gold, Green Accepted			2022-12-27	WOS:000370054100087
J	Thanakun, S; Pornprasertsuk-Damrongsri, S; Gokyu, M; Kobayashi, H; Izumi, Y				Thanakun, Supanee; Pornprasertsuk-Damrongsri, Suchaya; Gokyu, Misa; Kobayashi, Hiroaki; Izumi, Yuichi			Inverse Association of Plasma IgG Antibody to Aggregatibacter actinomycetemcomitans and High C-Reactive Protein Levels in Patients with Metabolic Syndrome and Periodontitis	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; REAL-TIME PCR; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; PORPHYROMONAS-GINGIVALIS; THAI POPULATION; PERIODONTOPATHIC BACTERIA; SYSTEMIC ANTIBODIES; SERUM ANTIBODIES; IMMUNE-RESPONSE; METAANALYSIS	The association between clinically diagnosed periodontitis, a common chronic oral infection, and metabolic syndrome has been previously reported. The aim of this study was to investigate the association of plasma IgG levels against Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, and Prevotella intermedia, C-reactive protein, and periodontal status with metabolic syndrome. Plasma IgG levels and C-reactive protein were measured by enzyme-linked immunosorbent assay, and salivary levels of A. actinomycetemcomitans and P. gingivalis were determined by quantitative real-time polymerase chain reaction. Among 127 individuals aged 35-76 years, 57 participants had metabolic syndrome and severe periodontitis, 25 had metabolic syndrome and an absence of severe periodontitis, 17 healthy individuals had severe periodontitis, and 28 healthy individuals were without severe periodontitis. Patients with metabolic syndrome had reduced humoral immune response to A. actinomycetemcomitans (p = 0.008), regardless of their salivary levels or periodontitis status compared with healthy participants. The IgG antibody response to P. gingivalis, regardless of their salivary levels or participants' health condition, was significantly higher in severe periodontitis patients (p < 0.001). Plasma IgG titers for P. intermedia were inconsistent among metabolic syndrome or periodontal participants. Our results indicate that the presence of lower levels of IgG antibodies to A. actinomycetemcomitans (OR = 0.1; 95% CI 0.0-0.7), but not P. gingivalis, a severe periodontitis status (OR = 7.8; 95% CI 1.1-57.0), high C-reactive protein levels (OR = 9.4; 95% CI 1.0-88.2) and body mass index (OR = 3.0; 95% CI 1.7-5.2), are associated with the presence of metabolic syndrome. The role of the decreased IgG antibody response to A. actinomycetemcomitans, increased C-reactive protein levels on the association between periodontal disease and metabolic syndrome in a group of Thai patients is suggested.	[Thanakun, Supanee] Mahidol Univ, Fac Dent, Dept Oral Med & Periodontol, Bangkok 10700, Thailand; [Pornprasertsuk-Damrongsri, Suchaya] Mahidol Univ, Fac Dent, Dept Oral & Maxillofacial Radiol, Bangkok 10700, Thailand; [Gokyu, Misa; Kobayashi, Hiroaki; Izumi, Yuichi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Periodontol, Tokyo, Japan; [Izumi, Yuichi] Tokyo Med & Dent Univ, Global Ctr Excellence Program Tooth & Bone Res, Tokyo, Japan	Mahidol University; Mahidol University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Thanakun, S (corresponding author), Mahidol Univ, Fac Dent, Dept Oral Med & Periodontol, Bangkok 10700, Thailand.	supanee.tha@mahidol.ac.th	Kobayashi, Hiroaki/AAG-6812-2019	Thanakun, Supanee/0000-0002-2570-0658; Gokyu, Misa/0000-0003-1482-9218	Faculty of Dentistry, Mahidol University [2011]; Tokyo Medical and Dental University [25293424]; Ronpaku (JSPS) [NRCT-11123]	Faculty of Dentistry, Mahidol University; Tokyo Medical and Dental University; Ronpaku (JSPS)	This work was supported by the Faculty of Dentistry, Mahidol University (www.dt.mahidol.ac.th; grant number 2011; ST); Tokyo Medical and Dental University (www.tmd.ac.jp; grant number 25293424; YI); and Ronpaku (www.tmd.ac.jp; grant number NRCT-11123; ST JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alfakry H, 2011, SCAND J IMMUNOL, V74, P383, DOI 10.1111/j.1365-3083.2011.02584.x; Armitage GC, 2004, PERIODONTOL 2000, V34, P9, DOI 10.1046/j.0906-6713.2002.003421.x; Atieh MA, 2008, J PERIODONTOL, V79, P1620, DOI [10.1902/jop.2008.070668, 10.1902/jop.2008.070668 ]; Beckstrom BW, 2007, ORAL SURG ORAL MED O, V103, P359, DOI 10.1016/j.tripleo.2006.08.016; Devaraj S, 2008, AM J CLIN PATHOL, V129, P815, DOI 10.1309/RN84K51B2JJY1Y0B; Dye BA, 2009, J PERIODONTOL, V80, P634, DOI 10.1902/jop.2009.080474; Furuichi Y, 2003, J PERIODONTOL, V74, P1491, DOI 10.1902/jop.2003.74.10.1491; Gemmell E, 2002, CRIT REV ORAL BIOL M, V13, P17, DOI 10.1177/154411130201300104; Graswinckel JEM, 2004, J CLIN PERIODONTOL, V31, P562, DOI 10.1111/j.1600-051X.2004.00522.x; GUNSOLLEY JC, 1990, J PERIODONTOL, V61, P412, DOI 10.1902/jop.1990.61.7.412; Hayman L, 2011, CLIN EXP IMMUNOL, V164, P118, DOI 10.1111/j.1365-2249.2010.04314.x; He JY, 2012, CLIN ORAL INVEST, V16, P1579, DOI 10.1007/s00784-011-0654-4; Hyvarinen K, 2015, ACTA DIABETOL, V52, P179, DOI 10.1007/s00592-014-0586-y; Ishikawa I, 1988, Adv Dent Res, V2, P334; Iwasaki M, 2016, GERODONTOLOGY, V33, P193, DOI 10.1111/ger.12135; Johansson A, 2005, CEREBROVASC DIS, V20, P226, DOI 10.1159/000087703; Johansson A, 2005, EUR J ORAL SCI, V113, P197, DOI 10.1111/j.1600-0722.2005.00218.x; Karels AJ, 2007, INTERNET J ALLIED HE, V5; KAWANO Y, 1994, J IMMUNOL, V153, P4948; Kinane DF, 2007, PERIODONTOL 2000, V43, P278, DOI 10.1111/j.1600-0757.2006.00169.x; Kinane DF, 1999, PERIODONTOL 2000, V20, P289, DOI 10.1111/j.1600-0757.1999.tb00164.x; Lakio L, 2009, J ORAL MICROBIOL, V1, DOI [10.3402/jom.v3401i3400.1979, DOI 10.3402/J0M.V3401I3400.1979]; Maeda H, 2003, FEMS IMMUNOL MED MIC, V39, P81, DOI 10.1016/S0928-8244(03)00224-4; Miyashita H, 2012, ARCH ORAL BIOL, V57, P820, DOI 10.1016/j.archoralbio.2011.11.008; Moreno S, 2013, COLOMB MEDICA, V44, P51; Mustapha IZ, 2007, J PERIODONTOL, V78, P2289, DOI 10.1902/jop.2007.070140; Nibali L, 2013, J CLIN ENDOCR METAB, V98, P913, DOI 10.1210/jc.2012-3552; OFFENBACHER S, 1993, J PERIODONTAL RES, V28, P523, DOI 10.1111/j.1600-0765.1993.tb02118.x; Offenbacher S, 2008, J PERIODONTOL, V79, P1577, DOI 10.1902/jop.2008.080220; Paju S, 2009, J CLIN MICROBIOL, V47, P235, DOI 10.1128/JCM.01824-08; Papapanou PN, 2004, J CLIN PERIODONTOL, V31, P985, DOI 10.1111/j.1600-051X.2004.00599.x; Papapanou PN, 2002, EUR J ORAL SCI, V110, P345, DOI 10.1034/j.1600-0722.2002.21361.x; Paraskevas S, 2008, J CLIN PERIODONTOL, V35, P277, DOI 10.1111/j.1600-051X.2007.01173.x; Pischon N, 2007, J DENT RES, V86, P400, DOI 10.1177/154405910708600503; Pitiphat W, 2008, J CLIN PERIODONTOL, V35, P120, DOI 10.1111/j.1600-051X.2007.01179.x; Pussinen PJ, 2011, J CLIN PERIODONTOL, V38, P405, DOI 10.1111/j.1600-051X.2011.01703.x; Pussinen PJ, 2003, ARTERIOSCL THROM VAS, V23, P1250, DOI 10.1161/01.ATV.0000072969.71452.87; Rajakaruna GA, 2012, J MICROBIOL, V50, P827, DOI 10.1007/s12275-012-2030-8; Rams TE, 2006, J PERIODONTAL RES, V41, P228, DOI 10.1111/j.1600-0765.2005.00860.x; Sakamoto M, 2001, MICROBIOL IMMUNOL, V45, P39, DOI 10.1111/j.1348-0421.2001.tb01272.x; Saygun I, 2011, J PERIODONTAL RES, V46, P235, DOI 10.1111/j.1600-0765.2010.01335.x; Seymour GJ, 2001, ACTA ODONTOL SCAND, V59, P167, DOI 10.1080/000163501750266765; Tabara Y, 2008, J CLIN ENDOCR METAB, V93, P715, DOI 10.1210/jc.2007-0397; Tanaka S, 2006, J PERIODONTAL RES, V41, P1, DOI 10.1111/j.1600-0765.2005.00829.x; Thanakun S, 2014, J PERIODONTOL, V85, P1502, DOI 10.1902/jop.2014.140105; Torrungruang K, 2009, J PERIODONTOL, V80, P122, DOI [10.1902/jop.2009.080248, 10.1902/jop.2009.080248 ]; Ueno M, 2012, INT HEART J, V53, P209, DOI 10.1536/ihj.53.209; Wara-aswapati N, 2009, ORAL DIS, V15, P354, DOI 10.1111/j.1601-0825.2009.01562.x; WHISLER RL, 1986, CELL IMMUNOL, V102, P287, DOI 10.1016/0008-8749(86)90422-3; Zhang RX, 2006, EUR J IMMUNOL, V36, P2993, DOI 10.1002/eji.200635207	51	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148638	10.1371/journal.pone.0148638	http://dx.doi.org/10.1371/journal.pone.0148638			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871443	gold, Green Published, Green Submitted			2022-12-27	WOS:000370054100042
J	Zhong, C; Batty, M; Manley, E; Wang, JQ; Wang, ZJ; Chen, F; Schmitt, G				Zhong, Chen; Batty, Michael; Manley, Ed; Wang, Jiaqiu; Wang, Zijia; Chen, Feng; Schmitt, Gerhard			Variability in Regularity: Mining Temporal Mobility Patterns in London, Singapore and Beijing Using Smart-Card Data	PLOS ONE			English	Article								To discover regularities in human mobility is of fundamental importance to our understanding of urban dynamics, and essential to city and transport planning, urban management and policymaking. Previous research has revealed universal regularities at mainly aggregated spatio-temporal scales but when we zoom into finer scales, considerable heterogeneity and diversity is observed instead. The fundamental question we address in this paper is at what scales are the regularities we detect stable, explicable, and sustainable. This paper thus proposes a basic measure of variability to assess the stability of such regularities focusing mainly on changes over a range of temporal scales. We demonstrate this by comparing regularities in the urban mobility patterns in three world cities, namely London, Singapore and Beijing using one-week of smart-card data. The results show that variations in regularity scale as non-linear functions of the temporal resolution, which we measure over a scale from 1 minute to 24 hours thus reflecting the diurnal cycle of human mobility. A particularly dramatic increase in variability occurs up to the temporal scale of about 15 minutes in all three cities and this implies that limits exist when we look forward or backward with respect to making short-term predictions. The degree of regularity varies in fact from city to city with Beijing and Singapore showing higher regularity in comparison to London across all temporal scales. A detailed discussion is provided, which relates the analysis to various characteristics of the three cities. In summary, this work contributes to a deeper understanding of regularities in patterns of transit use from variations in volumes of travellers entering subway stations, it establishes a generic analytical framework for comparative studies using urban mobility data, and it provides key points for the management of variability by policy-makers intent on for making the travel experience more amenable.	[Zhong, Chen; Batty, Michael; Manley, Ed; Wang, Jiaqiu] UCL, Ctr Adv Spatial Anal, London, England; [Wang, Zijia; Chen, Feng] Beijing Jiaotong Univ, Sch Civil & Architectural Engn, 3 Shangyuancun, Beijing, Peoples R China; [Wang, Zijia; Chen, Feng] Beijing Engn & Technol Res Ctr Rail Transit Line, 3 Shangyuancun, Beijing, Peoples R China; [Schmitt, Gerhard] Swiss Fed Inst Technol, Dept Architecture, Future Cities Lab, Zurich, Switzerland	University of London; University College London; Beijing Jiaotong University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Zhong, C (corresponding author), UCL, Ctr Adv Spatial Anal, London, England.	c.zhong@ucl.ac.uk	Batty, Michael/D-4422-2011; zhong, chen/AAB-5097-2019	Batty, Michael/0000-0002-9931-1305; zhong, chen/0000-0003-3582-1266; Manley, Ed/0000-0002-8904-0513	European Research Council [249393-ERC-2009-AdG]; National Natural Science Foundation of China [51408029]; Transport for London; Singapore Land Transport Authority; Beijing Transport Committee; EPSRC [EP/I018433/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I018433/1] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Transport for London; Singapore Land Transport Authority; Beijing Transport Committee; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was co-funded by the European Research Council (https://erc.europa.eu/) under 249393-ERC-2009-AdG (PI: Michael Batty) and the National Natural Science Foundation of China(http://www.nsfc.gov.cn/) under grant number: 51408029 (PI: Feng Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the valuable comments from the anonymous reviewers. This research cooperation was established at the Centre for Advanced Spatial Analysis (CASA), the Singapore-ETH Centre (SEC) and the Beijing Jiaotong University. It is co-funded by the European Research Council under the Mechanicity Programme (Grant 249393-ERC-2009-AdG) and the National Natural Science Foundation of China (Grant Number: 51408029). The authors thank Transport for London, the Singapore Land Transport Authority, and Beijing Transport Committee for supporting this research and providing the requisite data.	Agard Bruno, 2006, 12 IFAC S INF CONTR; Bagchi M, 2004, P I CIVIL ENG-MUNIC, V157, P39, DOI 10.1680/muen.2004.157.1.39; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Batty M, 2001, URBAN STUD, V38, P635, DOI 10.1080/00420980120035268; Batty M., 2004, BUILT ENV, V30, P324, DOI [10.2148/benv.30.4.324.57156, DOI 10.2148/BENV.30.4.324.57156]; Belik V, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.011001; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Cheong CC, 2010, HOUSEHOLD INTERVIEW, P52; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Gordon JB, 2013, TRANSPORT RES REC, P17, DOI 10.3141/2343-03; Hasan S, 2013, J STAT PHYS, V151, P304, DOI 10.1007/s10955-012-0645-0; Kang CG, 2012, PHYSICA A, V391, P1702, DOI 10.1016/j.physa.2011.11.005; Kuhnert C, 2006, PHYSICA A, V363, P96, DOI 10.1016/j.physa.2006.01.058; Liang L., 2009, INT TRANSP SYST 2009; Liang X, 2013, SCI REP-UK, V3, DOI 10.1038/srep02983; Manual H.C., 2000, SPECIAL REPORT; Munizaga MA, 2012, TRANSPORT RES C-EMER, V24, P9, DOI 10.1016/j.trc.2012.01.007; Noulas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037027; Pelletier MP, 2011, TRANSPORT RES C-EMER, V19, P557, DOI 10.1016/j.trc.2010.12.003; Rodrigue JP., 2013, GEOGRAPHY TRANSPORT, DOI DOI 10.4324/9781315618159-2; Roth C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015923; Schneider CM, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0246; Silva R, 2015, P NATL ACAD SCI USA, V112, P5643, DOI 10.1073/pnas.1412908112; Sun LJ, 2013, P NATL ACAD SCI USA, V110, P13774, DOI 10.1073/pnas.1306440110; Sung H, 2011, CITIES, V28, P70, DOI 10.1016/j.cities.2010.09.004; Thiemann C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015422; Transport for London, 2011, TRAV LOND SUPPL REP; Yan XY, 2013, SCI REP-UK, V3, DOI 10.1038/srep02678; Zhong C, 2015, J COMPUT SCI-NETH, V9, P125, DOI 10.1016/j.jocs.2015.04.021; Zhong C, 2014, INT J GEOGR INF SCI, V28, P2178, DOI 10.1080/13658816.2014.914521; Zhong C, 2014, COMPUT ENVIRON URBAN, V48, P124, DOI 10.1016/j.compenvurbsys.2014.07.004	33	66	74	8	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149222	10.1371/journal.pone.0149222	http://dx.doi.org/10.1371/journal.pone.0149222			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872333	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100129
J	Latorre, R; Huynh, J; Mazzoni, M; Gupta, A; Bonora, E; Clavenzani, P; Chang, L; Mayer, EA; De Giorgio, R; Sternini, C				Latorre, Rocco; Huynh, Jennifer; Mazzoni, Maurizio; Gupta, Arpana; Bonora, Elena; Clavenzani, Paolo; Chang, Lin; Mayer, Emeran A.; De Giorgio, Roberto; Sternini, Catia			Expression of the Bitter Taste Receptor, T2R38, in Enteroendocrine Cells of the Colonic Mucosa of Overweight/Obese vs. Lean Subjects	PLOS ONE			English	Article							DIET-INDUCED OBESITY; GASTROINTESTINAL-TRACT; ALPHA-TRANSDUCIN; GENE-EXPRESSION; SWEET TASTE; GUT; GUSTDUCIN; ENDOCRINE; FAMILY; MOUSE	Bitter taste receptors (T2Rs) are expressed in the mammalian gastrointestinal mucosa. In the mouse colon, T2R138 is localized to enteroendocrine cells and is upregulated by long-term high fat diet that induces obesity. The aims of this study were to test whether T2R38 expression is altered in overweight/obese (OW/OB) compared to normal weight (NW) subjects and characterize the cell types expressing T2R38, the human counterpart of mouse T2R138, in human colon. Colonic mucosal biopsies were obtained during colonoscopy from 35 healthy subjects (20 OW/OB and 15 NW) and processed for quantitative RT-PCR and immunohistochemistry using antibodies to T2R38, chromogranin A (CgA), glucagon like peptide-1 (GLP-1), cholecystokinin (CCK), or peptide YY (PYY). T2R38 mRNA levels in the colonic mucosa of OW/OB were increased (> 2 fold) compared to NW subjects but did not reach statistical significance (P = 0.06). However, the number of T2R38 immunoreactive (IR) cells was significantly increased in OW/OB vs. NW subjects (P = 0.01) and was significantly correlated with BMI values (r = 0.7557; P = 0.001). In both OW/OB and NW individuals, all T2R38-IR cells contained CgA-IR supporting they are enteroendocrine. In both groups, T2R38-IR colocalized with CCK-, GLP1- or PYY-IR. The overall CgA-IR cell population was comparable in OW/OB and NW individuals. This study shows that T2R38 is expressed in distinct populations of enteroendocrine cells in the human colonic mucosa and supports T2R38 upregulation in OW/OB subjects. T2R38 might mediate host functional responses to increased energy balance and intraluminal changes occurring in obesity, which could involve peptide release from enteroendocrine cells.	[Latorre, Rocco; Huynh, Jennifer; Chang, Lin; Mayer, Emeran A.; Sternini, Catia] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, CURE DDRC,Div Digest Dis, Los Angeles, CA 90095 USA; [Huynh, Jennifer; Sternini, Catia] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Mazzoni, Maurizio; Clavenzani, Paolo] Univ Bologna, Dept Vet Med Sci, Bologna, Italy; [Gupta, Arpana; Chang, Lin; Mayer, Emeran A.] Univ Calif Los Angeles, David Geffen Sch Med, Oppenheimer Family Ctr Neurobiol Stress, Los Angeles, CA 90095 USA; [Bonora, Elena; De Giorgio, Roberto] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Bologna; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Bologna	Sternini, C (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, CURE DDRC,Div Digest Dis, Los Angeles, CA 90095 USA.; Sternini, C (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA.	csternin@ucla.edu	Mazzoni, Maurizio/J-1918-2016; Chang, Lin/AAI-4333-2021	Mazzoni, Maurizio/0000-0002-7384-5990; Chang, Lin/0000-0001-6800-2967; Bonora, Elena/0000-0001-6132-7734	NIH [P30 DK 41301, P50 DK064539]; Spitzer Award [R01 DK 098447]; Fondazione del Monte di Bologna e Ravenna of Italy; Ricerca Finalizzata RER (Ita-MNGIE); Ministry of Health of Italy; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK106528, P30DK041301, P50DK064539, R01DK098447] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spitzer Award; Fondazione del Monte di Bologna e Ravenna of Italy; Ricerca Finalizzata RER (Ita-MNGIE); Ministry of Health of Italy(Ministry of Health, Italy); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a NIH P30 DK 41301 (Cell Imaging Core to CS), Spitzer Award (CS), R01 DK 098447 (CS), NIH P50 DK064539 (EAM), Fondazione del Monte di Bologna e Ravenna of Italy (RDeG) and Ricerca Finalizzata RER2009 (Ita-MNGIE), and Ministry of Health of Italy (RDeG).	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Batterham RL, 2003, ANN NY ACAD SCI, V994, P162, DOI 10.1111/j.1749-6632.2003.tb03176.x; Behrens M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040304; Behrens M, 2011, PHYSIOL BEHAV, V105, P4, DOI 10.1016/j.physbeh.2011.02.010; Cani PD, 2008, PATHOL BIOL, V56, P305, DOI 10.1016/j.patbio.2007.09.008; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chen MC, 2006, AM J PHYSL CELL PHYS; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Depoortere I, 2014, GUT, V63, P179, DOI 10.1136/gutjnl-2013-305112; Dockray G, 2004, CURR OPIN PHARMACOL, V4, P557, DOI 10.1016/j.coph.2004.05.005; Dockray G J, 2003, J Physiol Pharmacol, V54 Suppl 4, P9; Dockray GJ, 1996, PHYSIOL REV, V76, P767, DOI 10.1152/physrev.1996.76.3.767; Dotson CD, 2010, APPETITE, V54, P93, DOI 10.1016/j.appet.2009.09.011; FURNESS JB, 1999, AM J PHYSIOL-GASTR L, V277, pG922, DOI DOI 10.1002/9780470910016.CH1; Furness JB, 2013, NAT REV GASTRO HEPAT, V10, P729, DOI 10.1038/nrgastro.2013.180; Gautier JF, 2005, DIABETES METAB, V31, P233, DOI 10.1016/S1262-3636(07)70190-8; Glendinning JI, 2008, PHYSIOL BEHAV, V93, P757, DOI 10.1016/j.physbeh.2007.11.029; Halatchev IG, 2005, CELL METAB, V1, P159, DOI 10.1016/j.cmet.2005.02.003; Hao SZ, 2008, AM J PHYSIOL-REG I, V294, pR33, DOI 10.1152/ajpregu.00675.2007; Hao S, 2009, AM J PHYSIOL-REG I, V296, pR528, DOI 10.1152/ajpregu.90423.2008; Havel PJ, 2001, EXP BIOL MED, V226, P963, DOI 10.1177/153537020122601102; He W, 2004, J NEUROSCI, V24, P7674, DOI 10.1523/JNEUROSCI.2441-04.2004; Hofer D, 1999, NEWS PHYSIOL SCI, V14, P18; Hofer D, 1996, P NATL ACAD SCI USA, V93, P6631, DOI 10.1073/pnas.93.13.6631; Hofer D, 1998, HISTOCHEM CELL BIOL, V110, P303, DOI 10.1007/s004180050292; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Janssen S, 2011, P NATL ACAD SCI USA, V108, P2094, DOI 10.1073/pnas.1011508108; Janssen S, 2013, TRENDS ENDOCRIN MET, V24, P92, DOI 10.1016/j.tem.2012.11.006; Jeon TI, 2008, J CLIN INVEST, V118, P3693, DOI 10.1172/JCI36461; Jeon TI, 2011, BIOCHEM J, V438, P33, DOI 10.1042/BJ20110009; Kaji I, 2009, AM J PHYSIOL-GASTR L, V296, pG971, DOI 10.1152/ajpgi.90514.2008; Latorre R, NEUROGASTRO MOTIL IN; Latorre R, 2013, FISH PHYSIOL BIOCHEM, V39, P1555, DOI 10.1007/s10695-013-9808-4; Lee RJ, 2014, INNATE IMMUN-LONDON, V20, P606, DOI 10.1177/1753425913503386; Lee RJ, 2014, J CLIN INVEST, V124, P1393, DOI 10.1172/JCI72094; Lee RJ, 2012, J CLIN INVEST, V122, P4145, DOI 10.1172/JCI64240; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Mazzoni M, 2013, J CELL MOL MED, V17, P466, DOI 10.1111/jcmm.12026; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Prandi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082820; Raybould HE, 1998, NEWS PHYSIOL SCI, V13, P275; Rehfeld JF, 2004, HORM METAB RES, V36, P735, DOI 10.1055/s-2004-826154; Rozengurt E, 2006, AM J PHYSIOL-GASTR L, V291, pG171, DOI 10.1152/ajpgi.00073.2006; Rozengurt N, 2006, AM J PHYSIOL-GASTR L, V291, pG792, DOI 10.1152/ajpgi.00074.2006; Schirra J, 2005, REGUL PEPTIDES, V128, P109, DOI 10.1016/j.regpep.2004.06.018; Sternini C, 2008, CURR OPIN ENDOCRINOL, V15, P73, DOI 10.1097/MED.0b013e3282f43a73; Sternini C, 2007, AM J PHYSIOL-GASTR L, V292, pG457, DOI 10.1152/ajpgi.00411.2006; Sutherland K, 2007, AM J PHYSIOL-GASTR L, V292, pG1420, DOI 10.1152/ajpgi.00504.2006; Takechi R, 2008, HISTOCHEM CELL BIOL, V129, P779, DOI 10.1007/s00418-008-0404-0; Tepper BJ, 2008, ANNU REV NUTR, V28, P367, DOI 10.1146/annurev.nutr.28.061807.155458; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Vegezzi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107732; Widmayer P, 2012, INT J OBESITY, V36, P1353, DOI 10.1038/ijo.2011.216; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Wu SV, 2005, PHYSIOL GENOMICS, V22, P139, DOI 10.1152/physiolgenomics.00030.2005; Wu SV, 2002, P NATL ACAD SCI USA, V99, P2392, DOI 10.1073/pnas.042617699; Young RL, 2009, GUT, V58, P337, DOI 10.1136/gut.2008.148932	64	42	42	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0147468	10.1371/journal.pone.0147468	http://dx.doi.org/10.1371/journal.pone.0147468			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866366	Green Published, gold, Green Submitted			2022-12-27	WOS:000370050700002
J	NikNadia, NMN; Sam, IC; Khaidir, N; Ngui, R; Lim, YAL; Goh, XT; Choy, SH; Chan, YF				NikNadia, N. M. N.; Sam, I-Ching; Khaidir, Nasibah; Ngui, Romano; Lim, Yvonne A. L.; Goh, Xiang Ting; Choy, Seow Huey; Chan, Yoke Fun			Risk Factors for Enterovirus A71 Seropositivity in Rural Indigenous Populations in West Malaysia	PLOS ONE			English	Article							TRANSMITTED HELMINTH INFECTIONS; EFFECTIVE CONTROL PROGRAM; MOUTH-DISEASE; ORANG ASLI; 71 VACCINE; HAND; FOOT; CHILDREN; CHINA; SEROEPIDEMIOLOGY	Enterovirus A71 (EV-A71), which is transmitted by the fecal-oral route, causes hand, foot and mouth disease and, rarely, severe neurological complications. In Malaysia, the indigenous rural community (Orang Asli) has a high prevalence of parasitic diseases due to poor sanitation, water supply and hygiene practices. This cross-sectional study compared the seroepidemiology of EV-A71 among rural Orang Asli and urban Kuala Lumpur populations in West Malaysia, and determined the risk factors associated with EV-A71 seropositivity in rural Orang Asli. Seropositive rates were determined by neutralization assay. EV-A71 seropositivity was strongly associated with increasing age in both populations. Rural Orang Asli children <= 12 years had significantly higher EV-A71 seropositivity rates than urban Kuala Lumpur children (95.5% vs 57.6%, P < 0.001), and also higher rates in the age groups of 1-3, 4-6 and 7-12 years. Multivariate analysis confirmed that age <= 12 years (adjusted OR 8.1, 95% CI 3.2-20.7, P < 0.001) and using untreated water (adjusted OR 6.2, 95% CI 2.3-16.6, P < 0.001) were independently associated with EV-A71 seropositivity in the Orang Asli population. Supply of clean drinking water may reduce the risk of EV-A71 infection. With significantly higher EV-A71 seropositive rates, younger rural children should be a priority target for future vaccination programs in Malaysia.	[NikNadia, N. M. N.; Sam, I-Ching; Khaidir, Nasibah; Chan, Yoke Fun] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Ngui, Romano; Lim, Yvonne A. L.; Goh, Xiang Ting; Choy, Seow Huey] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Chan, YF (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	chanyf@um.edu.my	LIM, YVONNE AL/B-5276-2010; Sam, Jamal I-Ching/B-8688-2010; Ngui, Romano/H-9645-2015; Goh, Xiang Ting/AAD-7175-2020; Chan, Yoke Fun/B-5351-2010; Choy, Seow Huey/AAD-8828-2020	LIM, YVONNE AL/0000-0003-4050-6332; Sam, Jamal I-Ching/0000-0002-1296-7898; Ngui, Romano/0000-0002-3520-579X; Chan, Yoke Fun/0000-0001-7089-0510; Choy, Seow Huey/0000-0003-0020-871X; goh, xiang ting/0000-0002-2186-5447	University Malaya Research Grant Scheme [RG522-13HTM]; Postgraduate Research Fund from University Malaya [PG033-2014B]; Ministry of Higher Education, Malaysia [E000013-20001, FP022-2014A]	University Malaya Research Grant Scheme; Postgraduate Research Fund from University Malaya; Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia)	This study was supported by University Malaya Research Grant Scheme (RG522-13HTM) and Postgraduate Research Fund (PG033-2014B) from University Malaya, High Impact Research grant (E000013-20001) and Fundamental Research Grant Scheme (FP022-2014A) from the Ministry of Higher Education, Malaysia.	Ahmed A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-119; Ahmed A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-242; Al-Delaimy AK, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003074; Al-Mekhlafi HM, 2011, ANN TROP MED PARASIT, V105, P135, DOI 10.1179/136485911X12899838683368; Al-Mekhlafi HM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002516; Al-Mekhlafi MH, 2008, ACTA TROP, V107, P200, DOI 10.1016/j.actatropica.2008.05.022; Ang LW, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-270; Ang LW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127999; Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Bedford J, 2013, WHEN CULTURE IMPACTS HEALTH: GLOBAL LESSONS FOR EFFECTIVE HEALTH RESEARCH, P193, DOI 10.1016/B978-0-12-415921-1.00017-8; Chan YF, 2012, TROP BIOMED, V29, P451; Chan YF, 2011, NEUROL ASIA, V16, P1; Chang JL, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0474-9; Chang LY, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e88; Chua Kaw Bing, 2011, Virologica Sinica, V26, P221, DOI 10.1007/s12250-011-3195-8; Economic Planning Unit Prime Minister's Department Malaysia, 2013, PERCENTAGE DISTRIBUT; Fang QY, 2013, ARCH VIROL, V158, P895, DOI 10.1007/s00705-012-1566-6; Huang HI, 2012, FUTURE MICROBIOL, V7, P467, DOI [10.2217/FMB.12.22, 10.2217/fmb.12.22]; Huang KYA, 2015, J INFECT DIS, V212, P808, DOI 10.1093/infdis/jiv094; Huang WC, 2017, J MICROBIOL IMMUNOL, V50, P10, DOI 10.1016/j.jmii.2014.11.013; Jaafar J., 2004, J DEP STAT MALAYSIA, V1, P43; Ji H, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-248; Leuridan E, 2011, CLIN INFECT DIS, V53, P68, DOI 10.1093/cid/cir270; Li L, 2015, VACCINE, V33, P1107, DOI 10.1016/j.vaccine.2014.10.081; Li W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087603; Li W, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-322; Lim PY, 2015, VACCINE, V33, P6017, DOI 10.1016/j.vaccine.2015.05.108; Lim YAL, 2009, TROP BIOMED, V26, P110; Linsuwanon P, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-16; Liu LD, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0448-7; Mao LX, 2010, J CLIN VIROL, V49, P100, DOI 10.1016/j.jcv.2010.07.009; Masron T., 2012, GEOGR MALAYS J SOC S, V8, P20; Nasr NA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-28; Nasr NA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-27; Ngui R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000974; Noor MAM, 2012, J INT COMP EDUC, V1, P90; Ooi EE, 2002, EMERG INFECT DIS, V8, P995, DOI 10.3201/eid0809.010397; Peng LH, 1997, MALAYS J CHILD HLTH, V9, P104; Rabenau HF, 2010, MED MICROBIOL IMMUN, V199, P45, DOI 10.1007/s00430-009-0133-6; The Government of Malaysia's Official Portal, IMM SCHED; Tran Chau Bich Nguyen, 2011, PLoS One, V6, pe21116, DOI 10.1371/journal.pone.0021116; Wang SM, 2012, EUR J CLIN MICROBIOL, V31, P1219, DOI 10.1007/s10096-011-1432-6; Xie YH, 2015, EPIDEMIOL INFECT, V143, P1432, DOI 10.1017/S0950268814002301; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Yang CF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-306; Yu HY, 2011, JPN J INFECT DIS, V64, P528; Zeng M, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.72; Zhu FC, 2013, LANCET, V381, P2024, DOI 10.1016/S0140-6736(13)61049-1	48	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148767	10.1371/journal.pone.0148767	http://dx.doi.org/10.1371/journal.pone.0148767			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866912	gold, Green Published, Green Submitted			2022-12-27	WOS:000370050700034
J	Vivien, R; Lejzerowicz, F; Pawlowski, J				Vivien, Regis; Lejzerowicz, Franck; Pawlowski, Jan			Next-Generation Sequencing of Aquatic Oligochaetes: Comparison of Experimental Communities	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; ENVIRONMENTAL DNA; WORMS ANNELIDA; BIODIVERSITY; CLITELLATA; AMPLIFICATION; ARTHROPODS; SEDIMENTS; ALIGNMENT; RECOVERY	Aquatic oligochaetes are a common group of freshwater benthic invertebrates known to be very sensitive to environmental changes and currently used as bioindicators in some countries. However, more extensive application of oligochaetes for assessing the ecological quality of sediments in watercourses and lakes would require overcoming the difficulties related to morphology-based identification of oligochaetes species. This study tested the Next-Generation Sequencing (NGS) of a standard cytochrome c oxydase I (COI) barcode as a tool for the rapid assessment of oligochaete diversity in environmental samples, based on mixed specimen samples. To know the composition of each sample we Sanger sequenced every specimen present in these samples. Our study showed that a large majority of OTUs (Operational Taxonomic Unit) could be detected by NGS analyses. We also observed congruence between the NGS and specimen abundance data for several but not all OTUs. Because the differences in sequence abundance data were consistent across samples, we exploited these variations to empirically design correction factors. We showed that such factors increased the congruence between the values of oligochaetes-based indices inferred from the NGS and the Sanger-sequenced specimen data. The validation of these correction factors by further experimental studies will be needed for the adaptation and use of NGS technology in biomonitoring studies based on oligochaete communities.	[Vivien, Regis] Eawag EPFL, Ecotox Ctr, Swiss Ctr Appl Ecotoxicol, CH-1015 Lausanne, Switzerland; [Lejzerowicz, Franck; Pawlowski, Jan] Univ Geneva, Dept Genet & Evolut, Geneva, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of Geneva	Vivien, R (corresponding author), Eawag EPFL, Ecotox Ctr, Swiss Ctr Appl Ecotoxicol, CH-1015 Lausanne, Switzerland.	regis.vivien@centreecotox.ch	Pawlowski, Jan/AAO-3306-2021; Lejzerowicz, Franck/AAG-7812-2021; Vivien, Régis/AAN-2549-2020	Pawlowski, Jan/0000-0003-2421-388X; Lejzerowicz, Franck/0000-0002-3195-032X	SWISSBOL; UNITEC; Fondation Schmidheiny; Swiss National Science Foundation [316030_150817]	SWISSBOL; UNITEC; Fondation Schmidheiny; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by SWISSBOL (www.swissbol.ch), UNITEC (www.unige.ch/unitec/presentation.html), Fondation Schmidheiny (www.fondation-schmidheiny.ch/informations.html), and Swiss National Science Foundation grant 316030_150817. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armendariz L, 2012, LIMNOLOGICA, V42, P118, DOI 10.1016/j.limno.2011.09.005; Association Francaise de Normalisation (AFNOR), 2002, T90390 AFNOR NF; Baird DJ, 2012, MOL ECOL, V21, P2039, DOI 10.1111/j.1365-294X.2012.05519.x; Beauchamp KA, 2001, MOL PHYLOGENET EVOL, V19, P216, DOI 10.1006/mpev.2001.0923; Bely AE, 2004, MOL PHYLOGENET EVOL, V30, P50, DOI 10.1016/S1055-7903(03)00180-5; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Brinkhurst RO, 1966, WATER SEWAGE WORKS, V113, P434; Brodin Y, 2013, MOL ECOL RESOUR, V13, P996, DOI 10.1111/1755-0998.12053; Carew ME, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-45; Deagle BE, 2013, MOL ECOL RESOUR, V13, P620, DOI 10.1111/1755-0998.12103; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Egge E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074371; Envall I, 2012, ZOOL J LINN SOC-LOND, V165, P495, DOI 10.1111/j.1096-3642.2012.00828.x; Erseus C, 2009, ANNELIDS IN MODERN BIOLOGY, P31; Esling P, 2015, NUCLEIC ACIDS RES, V43, P2513, DOI 10.1093/nar/gkv107; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gibson J, 2014, P NATL ACAD SCI USA, V111, P8007, DOI 10.1073/pnas.1406468111; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gustafsson DR, 2009, MOL PHYLOGENET EVOL, V51, P182, DOI 10.1016/j.ympev.2008.12.016; Hajibabaei M, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-28; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Ji YQ, 2013, ECOL LETT, V16, P1245, DOI 10.1111/ele.12162; Kermarrec L, 2013, MOL ECOL RESOUR, V13, P607, DOI 10.1111/1755-0998.12105; Kvist S, 2010, MOL PHYLOGENET EVOL, V57, P687, DOI 10.1016/j.ympev.2010.08.018; Lafont M, 2006, HYDROBIOLOGIA, V564, P171, DOI 10.1007/s10750-005-1717-9; Lafont M., 1989, THESIS U CLAUDE BERN; Lang C, 1997, AQUAT SCI, V59, P26, DOI 10.1007/PL00001303; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; Martinsson S, 2013, ZOOL SCR, V42, P612, DOI 10.1111/zsc.12032; Morgan MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071974; Prygiel J, 1999, HYDROBIOLOGIA, V410, P25, DOI 10.1023/A:1003799224961; Richly E, 2004, MOL BIOL EVOL, V21, P1081, DOI 10.1093/molbev/msh110; Rodriguez P., 2011, POLLUTION BIOL AQUAT; Rougerie R, 2009, PESQUI AGROPECU BRAS, V44, P789, DOI 10.1590/S0100-204X2009000800002; Sarka J, 1994, HYDROBIOLOGIA, V322, P29, DOI DOI 10.1007/978-94-011-0842-3_26; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Stein ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051273; Sturmbauer C, 1999, MOL BIOL EVOL, V16, P967, DOI 10.1093/oxfordjournals.molbev.a026186; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Tkach V, 1999, ACTA PARASITOL, V44, P147; Vivien R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125485; Vivien Regis, 2014, Ecohydrology & Hydrobiology, V14, P142, DOI 10.1016/j.ecohyd.2014.03.003; Wessa P, 2014, OFFIC RES DEV ED, V1, P23; Yu DW, 2012, METHODS ECOL EVOL, V3, P613, DOI 10.1111/j.2041-210X.2012.00198.x; Zhan AB, 2013, METHODS ECOL EVOL, V4, P558, DOI 10.1111/2041-210X.12037; Zhou H, 2010, ZOOL SCR, V39, P378, DOI 10.1111/j.1463-6409.2010.00429.x; Zhou X, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-4; Zimmermann J, 2015, MOL ECOL RESOUR, V15, P526, DOI 10.1111/1755-0998.12336	52	19	24	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148644	10.1371/journal.pone.0148644	http://dx.doi.org/10.1371/journal.pone.0148644			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866802	Green Published, Green Submitted, gold			2022-12-27	WOS:000370050700024
J	Amon, M; Jager, F				Amon, Miha; Jager, Franc			Electrocardiogram ST-Segment Morphology Delineation Method Using Orthogonal Transformations	PLOS ONE			English	Article							ADAPTIVE ESTIMATION; EPISODES; COMPLEX; DATABASE	Differentiation between ischaemic and non-ischaemic transient ST segment events of long term ambulatory electrocardiograms is a persisting weakness in present ischaemia detection systems. Traditional ST segment level measuring is not a sufficiently precise technique due to the single point of measurement and severe noise which is often present. We developed a robust noise resistant orthogonal-transformation based delineation method, which allows tracing the shape of transient ST segment morphology changes from the entire ST segment in terms of diagnostic and morphologic feature-vector time series, and also allows further analysis. For these purposes, we developed a new Legendre Polynomials based Transformation (LPT) of ST segment. Its basis functions have similar shapes to typical transient changes of ST segment morphology categories during myocardial ischaemia (level, slope and scooping), thus providing direct insight into the types of time domain morphology changes through the LPT feature-vector space. We also generated new Karhunen and Loeve Transformation (KLT) ST segment basis functions using a robust covariance matrix constructed from the ST segment pattern vectors derived from the Long Term ST Database (LTST DB). As for the delineation of significant transient ischaemic and non-ischaemic ST segment episodes, we present a study on the representation of transient ST segment morphology categories, and an evaluation study on the classification power of the KLT- and LPT-based feature vectors to classify between ischaemic and non-ischaemic ST segment episodes of the LTST DB. Classification accuracy using the KLT and LPT feature vectors was 90% and 82%, respectively, when using the k-Nearest Neighbors (k = 3) classifier and 10-fold cross-validation. New sets of feature-vector time series for both transformations were derived for the records of the LTST DB which is freely available on the PhysioNet website and were contributed to the LTST DB. The KLT and LPT present new possibilities for human-expert diagnostics, and for automated ischaemia detection.	[Amon, Miha; Jager, Franc] Univ Ljubljana, Fac Comp & Informat Sci, Vecna Pot 113, Ljubljana 1000, Slovenia	University of Ljubljana	Jager, F (corresponding author), Univ Ljubljana, Fac Comp & Informat Sci, Vecna Pot 113, Ljubljana 1000, Slovenia.	franc.jager@fri.uni-lj.si			Innovation Scheme grant; European Union; Republic of Slovenia; Slovenian Research Agency (ARRS) [P3-0124]	Innovation Scheme grant; European Union(European Commission); Republic of Slovenia; Slovenian Research Agency (ARRS)(Slovenian Research Agency - Slovenia)	This work was financed by the Innovation Scheme grant for PhD study (http://www.uni-lj.si) to Miha Amon, financed by the European Union and by the Republic of Slovenia (MA). This work was financed in part by the Slovenian Research Agency (ARRS) (https://www.arrs.gov.si/) under the research project P3-0124 Metabolic and inborn factors of reproductive health, birth II (FJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buemi M., 1991, Proceedings. Computers in Cardiology (Cat. No.91CH3116-1), P385, DOI 10.1109/CIC.1991.169125; Clifford G, 2006, ADV METHODS TOOLS EC; Clifford GD, 2009, PHILOS T R SOC A, V367, P411, DOI 10.1098/rsta.2008.0157; DEVLIN SJ, 1981, J AM STAT ASSOC, V76, P354, DOI 10.2307/2287836; Faganeli J, 2010, PHYSIOL MEAS, V31, P323, DOI 10.1088/0967-3334/31/3/004; GALLINO A, 1984, J AM COLL CARDIOL, V4, P245, DOI 10.1016/S0735-1097(84)80209-0; Garcia J, 1998, COMPUT BIOMED RES, V31, P271, DOI 10.1006/cbmr.1998.1481; Garcia J, 1996, COMPUT CARDIOL, P249, DOI 10.1109/CIC.1996.542520; Georgiev G, 2012, PROCEDIA COMPUT SCI, V12, P426, DOI 10.1016/j.procs.2012.09.099; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Jager F, 2003, MED BIOL ENG COMPUT, V41, P172, DOI 10.1007/BF02344885; Jager F, 1998, COMPUT BIOMED RES, V31, P305, DOI 10.1006/cbmr.1998.1483; KITTLER J, 1973, PATTERN RECOGN, V5, P335, DOI 10.1016/0031-3203(73)90025-3; Lagerholm M, 2000, IEEE T BIO-MED ENG, V47, P838, DOI 10.1109/10.846677; Laguna P, 1996, MED BIOL ENG COMPUT, V34, P58, DOI 10.1007/BF02637023; Laguna P, 1999, MED BIOL ENG COMPUT, V37, P175, DOI 10.1007/BF02513285; Laguna P, 1994, COMPUT CARDIOL, P233; Minchole A, 2010, BIOMED SIGNAL PROCES, V5, P21, DOI 10.1016/j.bspc.2009.09.001; Moody G B, 1989, COMPUT CARDIOL, V16, P269; Moody GB., 1982, COMPUT CARDIOL, V9, P39; Oefinger MB, 2006, THESIS MIT; Radhakrishnan S, 2010, INT J COMPUT SCI ENG, V2, P1532; Smrdel A, 2004, MED BIOL ENG COMPUT, V42, P303, DOI 10.1007/BF02344704; TADDEI A, 1992, EUR HEART J, V13, P1164, DOI 10.1093/oxfordjournals.eurheartj.a060332; Taddei A, 1992, J AMB MONIT, V5, P167; Tou J. T., 1974, PATTERN RECOGN; Trefethen L. N., 1997, NUMERICAL LINEAR ALG, V50; Vilakazi CB, 2011, COMPUT CARDIOL CONF, V38, P633; Weisstein E. W., 2015, LEGENDRE POLYNOMIAL; Weisstein EW, 2015, GRAM SCHMIDT ORTHONO	30	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148814	10.1371/journal.pone.0148814	http://dx.doi.org/10.1371/journal.pone.0148814			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863140	gold, Green Submitted, Green Published			2022-12-27	WOS:000370046600109
J	Silva, GAE; de Moura, L; Curado, MP; Gomes, FD; Otero, U; de Rezende, LFM; Daumas, RP; Guimaraes, RM; Meira, KC; Leite, ID; Valente, JG; Moreira, RI; Koifman, R; Malta, DC; Mello, MSD; Guedes, TWG; Boffetta, P				Azevedo e Silva, Gulnar; de Moura, Lenildo; Curado, Maria Paula; Gomes, Fabio da Silva; Otero, Ubirani; Machado de Rezende, Leandro Fornias; Daumas, Regina Paiva; Guimaraes, Raphael Mendonca; Meira, Karina Cardoso; Leite, Iuri da Costa; Valente, Joaquim Goncalves; Moreira, Ronaldo Ismerio; Koifman, Rosalina; Malta, Deborah Carvalho; de Campos Mello, Marcia Sarpa; Guimaraes Guedes, Thiago Wagnos; Boffetta, Paolo			The Fraction of Cancer Attributable to Ways of Life, Infections, Occupation, and Environmental Agents in Brazil in 2020	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; LUNG-CANCER; RISK; BURDEN; HEALTH; PREVALENCE; BEHAVIORS; EXPOSURE; SMOKING; STATE	Many human cancers develop as a result of exposure to risk factors related to the environment and ways of life. The aim of this study was to estimate attributable fractions of 25 types of cancers resulting from exposure to modifiable risk factors in Brazil. The prevalence of exposure to selected risk factors among adults was obtained from population-based surveys conducted from 2000 to 2008. Risk estimates were based on data drawn from meta-analyses or large, high quality studies. Population-attributable fractions (PAF) for a combination of risk factors, as well as the number of preventable deaths and cancer cases, were calculated for 2020. The known preventable risk factors studied will account for 34% of cancer cases among men and 35% among women in 2020, and for 46% and 39% deaths, respectively. The highest attributable fractions were estimated for tobacco smoking, infections, low consumption of fruits and vegetables, excess weight, reproductive factors, and physical inactivity. This is the first study to systematically estimate the fraction of cancer attributable to potentially modifiable risk factors in Brazil. Strategies for primary prevention of tobacco smoking and control of infection and the promotion of a healthy diet and physical activity should be the main priorities in policies for cancer prevention in the country.	[Azevedo e Silva, Gulnar; Guimaraes Guedes, Thiago Wagnos] Univ Estado Rio De Janeiro, Inst Social Med, Rio De Janeiro, Rio De Janeiro, Brazil; [de Moura, Lenildo] Pan Amer Hlth Org, Brasilia, DF, Brazil; [Curado, Maria Paula] Hosp AC Camargo Fund Antonio Prudente, AC Camargo Canc Ctr, Sao Paulo, SP, Brazil; [Curado, Maria Paula] Int Prevent Res Inst, Lyon, France; [Gomes, Fabio da Silva; Otero, Ubirani; de Campos Mello, Marcia Sarpa] Minist Hlth, Natl Canc Inst, Rio De Janeiro, Rio De Janeiro, Brazil; [Machado de Rezende, Leandro Fornias; Koifman, Rosalina] Univ Sao Paulo, Sch Med, Dept Prevent Med, Sao Paulo, SP, Brazil; [Daumas, Regina Paiva; Leite, Iuri da Costa; Valente, Joaquim Goncalves] Minist Hlth, Natl Sch Publ Hlth, Oswaldo Cruz Fdn, Rio De Janeiro, Rio De Janeiro, Brazil; [Guimaraes, Raphael Mendonca] Minist Hlth, Joaquim Venancio Polytech Sch Hlth, Oswaldo Cruz Fdn, Rio De Janeiro, Rio De Janeiro, Brazil; [Meira, Karina Cardoso] Univ Fed Rio Grande do Norte, Sch Nursing, BR-59072970 Natal, RN, Brazil; [Moreira, Ronaldo Ismerio] Minist Hlth, Oswaldo Cruz Fdn, Natl Inst Infectolgy, Rio De Janeiro, Rio De Janeiro, Brazil; [Malta, Deborah Carvalho] Minist Hlth, Hlth Surveillance Secretariat, Brasilia, DF, Brazil; [Boffetta, Paolo] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA	Universidade do Estado do Rio de Janeiro; Pan American Health Organization; A.C.Camargo Cancer Center; National Cancer Institute (Inca); Universidade de Sao Paulo; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal do Rio Grande do Norte; Fundacao Oswaldo Cruz; Icahn School of Medicine at Mount Sinai	Silva, GAE (corresponding author), Univ Estado Rio De Janeiro, Inst Social Med, Rio De Janeiro, Rio De Janeiro, Brazil.	gulnar@ims.uerj.br	Boffetta, Paolo/AAI-7767-2021; Malta, Deborah C/H-7880-2012; Rezende, Leandro F. M./C-1724-2012; Malta, Deborah Carvalho/GNM-8218-2022; GUIMARAES, RAPHAEL/ABH-8745-2020; Malta, Deborah Carvalho/L-2491-2019; DAUMAS, REGINA P/M-9387-2013; Curado, Maria Paula/M-6200-2013; MEIRA, KARINA KCM KARINA/C-8555-2018	Boffetta, Paolo/0000-0002-3811-2791; Malta, Deborah C/0000-0002-8214-5734; Rezende, Leandro F. M./0000-0002-7469-1399; Malta, Deborah Carvalho/0000-0002-8214-5734; Malta, Deborah Carvalho/0000-0002-8214-5734; DAUMAS, REGINA P/0000-0002-8923-7711; Curado, Maria Paula/0000-0001-8172-2483; Cardoso Meira, Karina/0000-0002-1722-5703; Sarpa de Campos Mello, Marcia/0000-0001-8976-4653				Silva Gulnar Azevedo e, 2011, Rev. Saúde Pública, V45, P1009, DOI 10.1590/S0034-89102011005000076; Bakos L, 2013, AN BRAS DERMATOL, V88, P226, DOI 10.1590/S0365-05962013000200007; Behrens G, 2013, BRIT J CANCER, V108, P798, DOI 10.1038/bjc.2013.37; Boffetta P, 2009, ANN ONCOL, V20, P550, DOI 10.1093/annonc/mdn597; Brasil. Instituto Brasileiro de Geografia e Estagistica (IBGE, 2009, PESQ ESP TAB PETAB; Brasil. Instituto Brasileiro de Geografia e Estatistica (IBGE), 2004, PESQ NAC AM DOM PNAD; Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2009, VIG BRAS 2008 VIG FA; Brasil. Universidade de Pernambuco, 2010, EST PREV BAS POP INF; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Brenner DR, 2014, PREV MED, V66, P131, DOI 10.1016/j.ypmed.2014.06.018; [Censo Demografico Brasil. Instituto Brasileiro de Geografia e Estatistica (IBGE)], 2000, CENS DEM 2000 PESS O; Correa PCRP, 2009, BMC PUBLIC HEALTH, V9, P1; Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2; de Freitas CU, 2013, EPIDEMIOL SERV SAUDE, V22, P445, DOI 10.5123/S1679-49742013000300009; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Ezzati M, 2003, LANCET, V362, P271, DOI 10.1016/S0140-6736(03)13968-2; Figueira-Silva Cecília M., 2004, Rev. Soc. Bras. Med. Trop., V37, P409; Girianelli VR, 2011, REV BRAS GINECOL OBS, V32, P39; Giuliano AR, 2008, CANCER EPIDEM BIOMAR, V17, P2036, DOI 10.1158/1055-9965.EPI-08-0151; Gomes F. S., 2011, SCN News, P57; Hamra GB, 2014, ENVIRON HEALTH PERSP, V122, P906, DOI [10.1289/ehp.1408092, 10.1289/ehp/1408092]; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; *IARC, 1997, HDB CANC PREV, V1; IBGE, 2008, PESQ NAC AM DOM; Inoue M, 2012, ANN ONCOL, V23, P1362, DOI 10.1093/annonc/mdr437; Instituto Brasileiro de Geografia e Estatistica-IBGE, 2010, PESQ ORC FAM 2008 20; [Instituto Nacional de Cancer Brasil. Ministerio da Saude], 2014, EST CANC REG CANC BA; International Agency for Research on Cancer, 1971, IARC MONOGRAPHS EVAL, V1-110, P1971; LEVIN M L, 1953, Acta Unio Int Contra Cancrum, V9, P531; Liu YP, 2011, EUR UROL, V60, P1029, DOI 10.1016/j.eururo.2011.07.007; Malta DC, 2011, EPIDEMIOL SERV SAUDE, V20, P425, DOI [10.5123/S1679-49742011000400002, DOI 10.5123/S1679-49742011000400002]; Menezes AMB, 2002, REV SAUDE PUBL, V36, P129, DOI 10.1590/S0034-89102002000200002; Milton K, 2014, GLOB PUBLIC HEALTH, V9, P369, DOI 10.1080/17441692.2014.894548; Ministerio da Saude (BR), 2014, SIST INF MORT; Ministerio da Saude (Brasil), 2009, PESQ NAC DEM SAUD CR; Moore SC, 2010, BRIT J CANCER, V103, P933, DOI 10.1038/sj.bjc.6605902; O'Rorke MA, 2010, INT J CANCER, V126, P2957, DOI 10.1002/ijc.24997; Oliveira AF, 2008, CLINICS, V63, P215, DOI 10.1590/S1807-59322008000200010; Olsen JH, 1997, APMIS, V105, P141; Park S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090871; Parkin DM, 2011, BRIT J CANCER, V105, pS77, DOI 10.1038/bjc.2011.489; Peto J, 2001, NATURE, V411, P390, DOI 10.1038/35077256; Pinto M, 2010, CAD SAUDE PUBLICA, V26, P1234, DOI 10.1590/S0102-311X2010000600016; Purdue MP, 2015, ANN EPIDEMIOL, V25, P188, DOI 10.1016/j.annepidem.2014.11.009; Rodrigues MN, 2005, REV SAUDE PUBL, V39, P847, DOI 10.1590/S0034-89102005000500022; Santana VS, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-S1-S10; Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9; Schottenfeld D, 2013, ANNU REV PUBL HEALTH, V34, P97, DOI 10.1146/annurev-publhealth-031912-114350; Shin A, 2011, ANN ONCOL, V22, P1435, DOI 10.1093/annonc/mdq592; Stahel RA, 2010, ANN ONCOL, V21, pv126, DOI 10.1093/annonc/mdq173; Szklo AS, 2007, CAD SAUDE PUBLICA, V23, P823, DOI 10.1590/S0102-311X2007000400010; Szwarcwald CL, 2014, CIENC SAUDE COLETIVA, V19, P333, DOI 10.1590/1413-81232014192.14072012; Valente VB, 2005, REV SOC BRAS MED TRO, V38, P488, DOI 10.1590/S0037-86822005000600008; Victora CG, 2011, LANCET, V377, P2042, DOI 10.1016/S0140-6736(11)60055-X; Wang JB, 2012, ANN ONCOL, V23, P2983, DOI 10.1093/annonc/mds139; Whiteman DC, 2015, AUST NZ J PUBL HEAL, V39, P477, DOI 10.1111/1753-6405.12471; World Cancer Research Fund/American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; World Health Organization & Food and Agriculture Organization, 2003, DIET NUTR PREV CHRON, V916; World Health Organization (WHO), GLOB HLTH OBS OV OB; World Health Organization (WHO), 2012, REC AMB AIR QUAL POL	61	47	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148761	10.1371/journal.pone.0148761	http://dx.doi.org/10.1371/journal.pone.0148761			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6PR	26863517	gold, Green Published, Green Submitted			2022-12-27	WOS:000370046600104
J	Cohen, A; Weindling, E; Rabinovich, E; Nachman, I; Fuchs, S; Chuartzman, S; Gal, L; Schuldiner, M; Bar-Nun, S				Cohen, Aviv; Weindling, Esther; Rabinovich, Efrat; Nachman, Iftach; Fuchs, Shai; Chuartzman, Silvia; Gal, Lihi; Schuldiner, Maya; Bar-Nun, Shoshana			Water-Transfer Slows Aging in Saccharomyces cerevisiae	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; CHRONOLOGICAL LIFE-SPAN; CALORIE RESTRICTION; YEAST; DEGRADATION; ER; TRANSCRIPTION; POPULATIONS; LONGEVITY; ELEMENT	Transferring Saccharomyces cerevisiae cells to water is known to extend their lifespan. However, it is unclear whether this lifespan extension is due to slowing the aging process or merely keeping old yeast alive. Here we show that in water-transferred yeast, the toxicity of polyQ proteins is decreased and the aging biomarker 47Q aggregates at a reduced rate and to a lesser extent. These beneficial effects of water-transfer could not be reproduced by diluting the growth medium and depended on de novo protein synthesis and proteasomes levels. Interestingly, we found that upon water-transfer 27 proteins are downregulated, 4 proteins are upregulated and 81 proteins change their intracellular localization, hinting at an active genetic program enabling the lifespan extension. Furthermore, the aging-related deterioration of the heat shock response (HSR), the unfolded protein response (UPR) and the endoplasmic reticulum-associated protein degradation (ERAD), was largely prevented in water-transferred yeast, as the activities of these proteostatic network pathways remained nearly as robust as in young yeast. The characteristics of young yeast that are actively maintained upon water-transfer indicate that the extended lifespan is the outcome of slowing the rate of the aging process.	[Cohen, Aviv; Weindling, Esther; Rabinovich, Efrat; Nachman, Iftach; Bar-Nun, Shoshana] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel; [Fuchs, Shai; Chuartzman, Silvia; Gal, Lihi; Schuldiner, Maya] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Tel Aviv University; Weizmann Institute of Science	Bar-Nun, S (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel.	shoshbn@tauex.tau.ac.il	Schuldiner, Maya/C-9488-2009; Nachman, Iftach/AAK-2051-2020; Nachman, Iftach/E-6750-2010	Schuldiner, Maya/0000-0001-9947-115X; Nachman, Iftach/0000-0002-4667-0398	Chief Scientist Office of the Ministry of Health, Israel [3-3211]; Israel Science Foundation [394/11]	Chief Scientist Office of the Ministry of Health, Israel; Israel Science Foundation(Israel Science Foundation)	Initial stages of this study were supported by a grant from the Chief Scientist Office of the Ministry of Health, Israel (grant no. 3-3211 to SB) and later by a grant from The Israel Science Foundation (grant no. 394/11 to SB).	Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Aris JP, 2013, EXP GERONTOL, V48, P1107, DOI 10.1016/j.exger.2013.01.006; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Bosis E, 2010, GENETICS, V184, P695, DOI 10.1534/genetics.109.111419; Brandes N, 2013, ELIFE, V2, DOI 10.7554/eLife.00306; Brehme M, 2014, CELL REP, V9, P1135, DOI 10.1016/j.celrep.2014.09.042; Breker M, 2013, J CELL BIOL, V200, P839, DOI 10.1083/jcb.201301120; Burtner CR, 2009, CELL CYCLE, V8, P1256, DOI 10.4161/cc.8.8.8287; Casagrande R, 2000, MOL CELL, V5, P729, DOI 10.1016/S1097-2765(00)80251-8; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Cohen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044785; Cohen Y, 2011, METHODS MOL BIOL, V781, P127, DOI 10.1007/978-1-61779-276-2_8; Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042; Fabrizio P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001024; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Gerstbrein B, 2005, AGING CELL, V4, P127, DOI 10.1111/j.1474-9726.2005.00153.x; GRANOT D, 1993, YEAST, V9, P465, DOI 10.1002/yea.320090503; Hekimi S, 2011, TRENDS CELL BIOL, V21, P569, DOI 10.1016/j.tcb.2011.06.008; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jung PP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119807; Kaeberlein M, 2007, PLOS GENET, V3, P655, DOI 10.1371/journal.pgen.0030084; Kamei Y, 2014, J BIOL CHEM, V289, P32081, DOI 10.1074/jbc.M114.600528; Kennedy BK, 2014, CELL, V159, P708, DOI 10.1016/j.cell.2014.10.039; Lim PJ, 2009, J CELL BIOL, V187, P201, DOI 10.1083/jcb.200903024; Ljubuncic P, 2009, GERONTOLOGY, V55, P205, DOI 10.1159/000200772; Longo VD, 2014, CELL METAB, V19, P181, DOI 10.1016/j.cmet.2013.12.008; Longo VD, 2012, CELL METAB, V16, P18, DOI 10.1016/j.cmet.2012.06.002; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Mei SC, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002048; Miller J. J., 1989, YEASTS, P489; MORI K, 1992, EMBO J, V11, P2583, DOI 10.1002/j.1460-2075.1992.tb05323.x; Nachman I, 2007, CELL, V131, P544, DOI 10.1016/j.cell.2007.09.044; Nussbaum I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111505; Ocampo A, 2011, MECH AGEING DEV, V132, P315, DOI 10.1016/j.mad.2011.06.007; Parrella E, 2008, METHODS, V46, P256, DOI 10.1016/j.ymeth.2008.10.004; Rabek JP, 2003, BIOCHEM BIOPH RES CO, V305, P566, DOI 10.1016/S0006-291X(03)00826-X; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Richardson A, 1981, RELATIONSHIP AGING P; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sinclair D, 1998, ANNU REV MICROBIOL, V52, P533, DOI 10.1146/annurev.micro.52.1.533; Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019; SORGER PK, 1987, EMBO J, V6, P3035, DOI 10.1002/j.1460-2075.1987.tb02609.x; Tollefsbol Trygve O, 2007, Methods Mol Biol, V371, P1; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wei M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040013; Weindling E, 2015, BIOCHEM BIOPH RES CO, V457, P473, DOI 10.1016/j.bbrc.2015.01.021; WING SS, 1995, BIOCHEM J, V307, P639, DOI 10.1042/bj3070639	48	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148650	10.1371/journal.pone.0148650	http://dx.doi.org/10.1371/journal.pone.0148650			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862897	gold, Green Published, Green Submitted			2022-12-27	WOS:000370046600089
J	Henriquez, RA; Chica, AB; Billeke, P; Bartolomeo, P				Henriquez, Rodrigo A.; Chica, Ana B.; Billeke, Pablo; Bartolomeo, Paolo			Fluctuating Minds: Spontaneous Psychophysical Variability during Mind-Wandering	PLOS ONE			English	Article							TASK-UNRELATED THOUGHT; DEFAULT NETWORK; ATTENTION; BRAIN; EXPERIENCE	Mind-wandering is the occasional distraction we experience while performing a cognitive task. It arises without any external precedent, varies over time, and interferes with the processing of sensory information. Here, we asked whether the transition from the on-task state to mind-wandering is a gradual process or an abrupt event. We developed a new experimental approach, based on the continuous, online assessment of individual psychophysical performance. Probe questions were asked whenever response times (RTs) exceeded 2 standard deviations from the participant's average RT. Results showed that mind-wandering reports were generally preceded by slower RTs, as compared to trials preceding on-task reports. Mind-wandering episodes could be reliably predicted from the response time difference between the last and the second-to-last trials. Thus, mind-wandering reports follow an abrupt increase in behavioral variability, lasting between 2.5 and 10 seconds.	[Henriquez, Rodrigo A.; Bartolomeo, Paolo] Univ Paris 06, INSERM, U1127, F-75013 Paris, France; [Henriquez, Rodrigo A.; Bartolomeo, Paolo] Univ Paris 06, Sorbonne Univ, UMR S 1127, F-75013 Paris, France; [Henriquez, Rodrigo A.; Bartolomeo, Paolo] CNRS, UMR 7225, F-75013 Paris, France; [Henriquez, Rodrigo A.; Bartolomeo, Paolo] Inst Cerveau & Moelle Epiniere, ICM, F-75013 Paris, France; [Chica, Ana B.] Univ Granada, Dept Expt Psychol, Granada, Spain; [Chica, Ana B.] Univ Granada, Brain Mind & Behav Res Ctr, Granada, Spain; [Billeke, Pablo] Univ Desarrollo, Fac Govt, Res Ctr Social Complex, Santiago, Chile; [Bartolomeo, Paolo] Catholic Univ Milan, Dept Psychol, Milan, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; University of Granada; University of Granada; Universidad del Desarrollo; Catholic University of the Sacred Heart	Henriquez, RA (corresponding author), Univ Paris 06, INSERM, U1127, F-75013 Paris, France.; Henriquez, RA (corresponding author), Univ Paris 06, Sorbonne Univ, UMR S 1127, F-75013 Paris, France.; Henriquez, RA (corresponding author), CNRS, UMR 7225, F-75013 Paris, France.; Henriquez, RA (corresponding author), Inst Cerveau & Moelle Epiniere, ICM, F-75013 Paris, France.	rhenriquezch@gmail.com	Henríquez, Rodrigo A./AAM-9515-2021; Bartolomeo, Paolo/B-3046-2009; Chica, Ana B./AAC-1677-2021; Billeke, Pablo/D-5311-2011	Henríquez, Rodrigo A./0000-0002-4970-8013; Bartolomeo, Paolo/0000-0002-2640-6426; Chica, Ana B./0000-0001-5804-1591; Billeke, Pablo/0000-0003-4261-0678	National Commission for Scientific and Technological Research - CONICYT, Chile [72120217]; Ramon y Cajal fellowship from Spanish Ministry of Education and Science [RYC-2011-09320]; program "Investissements d'Avenir" [ANR-10-IAIHU-06];  [PSI2011-22416];  [PSI2014-58681-P]	National Commission for Scientific and Technological Research - CONICYT, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Ramon y Cajal fellowship from Spanish Ministry of Education and Science(German Research Foundation (DFG)); program "Investissements d'Avenir"(French National Research Agency (ANR)); ; 	This work was supported by a doctoral fellowship from the National Commission for Scientific and Technological Research - CONICYT 72120217, Chile to R.A.H, and A.B.C was supported by a Ramon y Cajal fellowship from the Spanish Ministry of Education and Science, RYC-2011-09320. This research was funded by research projects PSI2011-22416 and PSI2014-58681-P to A.B.C. This research also has received funding from the program "Investissements d'Avenir" ANR-10-IAIHU-06.	Axelrod V, 2015, P NATL ACAD SCI USA; Bastian M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00573; Braboszcz C, 2011, NEUROIMAGE, V54, P3040, DOI 10.1016/j.neuroimage.2010.10.008; Castellanos FX, 2005, BIOL PSYCHIAT, V57, P1416, DOI 10.1016/j.biopsych.2004.12.005; Cheyne JA, 2009, COGNITION, V111, P98, DOI 10.1016/j.cognition.2008.12.009; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Feldman H, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00215; Friston KJ, 2010, BIOL CYBERN, V102, P227, DOI 10.1007/s00422-010-0364-z; GIAMBRA LM, 1989, PSYCHOL AGING, V4, P136, DOI 10.1037/0882-7974.4.2.136; Gilbert SJ, 2005, EUR J NEUROSCI, V21, P1423, DOI 10.1111/j.1460-9568.2005.03981.x; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Le Van Quyen M, 2011, NEW IDEAS PSYCHOL, V29, P57, DOI 10.1016/j.newideapsych.2010.11.001; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Morin A., 2009, ENCY CONSCIOUSNESS, P389; Rastelli F, 2013, CORTEX, V49, P1989, DOI 10.1016/j.cortex.2013.04.001; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Sadaghiani S, 2010, J NEUROSCI, V30, P10243, DOI 10.1523/JNEUROSCI.1004-10.2010; Schooler JW, 2011, TRENDS COGN SCI, V15, P319, DOI 10.1016/j.tics.2011.05.006; Seli P, 2013, FRONT PSYCHOL, V4, P1, DOI DOI 10.3389/FPSYG.2013; Seli P, 2013, J EXP PSYCHOL HUMAN, V39, P1, DOI 10.1037/a0030954; Smallwood J, 2004, CONSCIOUS COGN, V13, P657, DOI 10.1016/j.concog.2004.06.003; Smallwood JM, 2003, CONSCIOUS COGN, V12, P452, DOI 10.1016/S1053-8100(03)00018-7; Smallwood J, 2008, J COGNITIVE NEUROSCI, V20, P458, DOI 10.1162/jocn.2008.20037; Smallwood J, 2008, BRAIN COGNITION, V66, P50, DOI 10.1016/j.bandc.2007.05.004; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; TEASDALE JD, 1995, MEM COGNITION, V23, P551, DOI 10.3758/BF03197257; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727	28	10	10	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0147174	10.1371/journal.pone.0147174	http://dx.doi.org/10.1371/journal.pone.0147174			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863144	Green Published, Green Submitted, gold			2022-12-27	WOS:000370046600019
J	McMillan, R; McIsaac, M; Janssen, I				McMillan, Rachel; McIsaac, Michael; Janssen, Ian			Family Structure as a Correlate of Organized Sport Participation among Youth	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SEDENTARY BEHAVIOR; ADOLESCENTS; CHILDREN; HEALTH; BENEFITS; CUSTODY; SCHOOL	Organized sport is one way that youth participate in physical activity. There are disparities in organized sport participation by family-related factors. The purpose of this study was to determine whether non-traditional family structure and physical custody arrangements are associated with organized sport participation in youth, and if so whether this relationship is mediated by socioeconomic status. Data were from the 2009-10 Health Behaviour in School-aged Children survey, a nationally representative cross-section of Canadian youth in grades 6-10 (N = 21,201). Information on family structure was derived from three survey items that asked participants the number of adults they lived with, their relationship to these adults, and if applicable, how often they visited another parent outside their home. Participants were asked whether or not they were currently involved in an organized sport. Logistic regression was used to compare the odds of organized sport participation according to family structure. Bootstrap-based mediation analysis was used to assess mediation by perceived family wealth. The results indicated that by comparison to traditional families, boys and girls from reconstituted families with irregular visitation of a second parent, reconstituted families with regular visitation of a second parent, single-parent families with irregular visitation of a second parent, and single-parent families with regular visitation of a second parent were less likely to participate in organized sport than those from traditional families, with odds ratios ranging from 0.48 (95% confidence interval: 0.38-0.61) to 0.78 (95% confidence interval: 0.56-1.08). The relationship between family structure and organized sport was significantly mediated by perceived family wealth, although the magnitude of the mediation was modest (ie, <20% change in effect estimate). In conclusion, youth living in both single-parent and reconstituted families experienced significant disparities in organized sport participation that was partially mediated by perceived family wealth.	[McMillan, Rachel; McIsaac, Michael; Janssen, Ian] Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada; [Janssen, Ian] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada	Queens University - Canada; Queens University - Canada	Janssen, I (corresponding author), Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada.; Janssen, I (corresponding author), Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada.	ian.janssen@queensu.ca	Janssen, Ian/B-7700-2009; McIsaac, Michael/O-1503-2013	Janssen, Ian/0000-0003-2159-3012; McIsaac, Michael/0000-0002-5273-5450	Ontario Graduate Scholarship award; Canada Research Chair award; Public Health Agency of Canada; Health Canada [4500267124]	Ontario Graduate Scholarship award(Ontario Graduate Scholarship); Canada Research Chair award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Public Health Agency of Canada; Health Canada	The first author was supported by an Ontario Graduate Scholarship award and the last author was supported by a Canada Research Chair award. The Health Behaviour in School-aged Children Survey (HBSC), a World Health Organization / European Region collaborative study, was funded in Canada by the Public Health Agency of Canada and Health Canada (Contract: 4500267124). The funders had not role in the design of this study, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauserman R, 2002, J FAM PSYCHOL, V16, P91, DOI 10.1037/0893-3200.16.1.91; Bramlett MD, 2007, HEALTH AFFAIR, V26, P549, DOI 10.1377/hlthaff.26.2.549; BRENER ND, 1995, AM J EPIDEMIOL, V141, P575, DOI 10.1093/oxfordjournals.aje.a117473; Canadian Fitness and Lifestyle Research Institute, 2004, 2004 PHYS ACT SPORT; Canadian Heritage, 2013, SPORTS PART 2010; Carson V, 2011, HEALTH PLACE, V17, P920, DOI 10.1016/j.healthplace.2011.04.007; Colley R, 2010, HEALTH REP, V21; Currie C, 2009, INT J PUBLIC HEALTH, V54, P131, DOI 10.1007/s00038-009-5404-x; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-98; Eime RM, 2010, MED SCI SPORT EXER, V42, P1022, DOI 10.1249/MSS.0b013e3181c3adaa; Freeman JG, 2012, HLTH CANADAS YOUNG P; Gorely T, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-33; Jablonska B, 2007, SOC PSYCH PSYCH EPID, V42, P656, DOI 10.1007/s00127-007-0210-3; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Lisha NE, 2010, ADDICT BEHAV, V35, P399, DOI 10.1016/j.addbeh.2009.12.032; MacKinnon DP, 2012, J CONSUM PSYCHOL, V22, P600, DOI 10.1016/j.jcps.2012.03.009; O'Loughlin J, 1999, ANN EPIDEMIOL, V9, P397, DOI 10.1016/S1047-2797(99)00030-7; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Quarmby T, 2010, LEISURE STUD, V29, P53, DOI 10.1080/02614360903242560; Rothman K., 1998, MODERN EPIDEMIOLOGY; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Seltzer JA, 1998, DEMOGRAPHY, V35, P135, DOI 10.2307/3004047; Tammelin T, 2003, AM J PREV MED, V24, P22, DOI 10.1016/S0749-3797(02)00575-5; Tigerstrom B. von, 2011, American Journal of Public Health, V101, pe10, DOI 10.2105/AJPH.2011.300201; Tillman KH, 2007, SOCIOL INQ, V77, P383, DOI 10.1111/j.1475-682X.2007.00198.x; Toftegaard-Stockel J, 2011, SCAND J MED SCI SPOR, V21, P606, DOI 10.1111/j.1600-0838.2010.01093.x; Vella SA, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-113	28	30	30	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0147403	10.1371/journal.pone.0147403	http://dx.doi.org/10.1371/journal.pone.0147403			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6PR	26863108	Green Published, gold, Green Submitted			2022-12-27	WOS:000370046600028
J	Reiter, T; Jagoda, E; Capellini, TD				Reiter, Taylor; Jagoda, Evelyn; Capellini, Terence D.			Dietary Variation and Evolution of Gene Copy Number among Dog Breeds	PLOS ONE			English	Article							HIGH-ALTITUDE ADAPTATION; HUNTER-GATHERERS; REFSUM-DISEASE; PHYTANIC ACID; AMYLASE GENE; DOMESTICATION; DNA; SELECTION; ORIGINS; SITE	Prolonged human interactions and artificial selection have influenced the genotypic and phenotypic diversity among dog breeds. Because humans and dogs occupy diverse habitats, ecological contexts have likely contributed to breed-specific positive selection. Prior to the advent of modern dog-feeding practices, there was likely substantial variation in dietary landscapes among disparate dog breeds. As such, we investigated one type of genetic variant, copy number variation, in three metabolic genes: glucokinase regulatory protein (GCKR), phytanol-CoA 2-hydroxylase (PHYH), and pancreatic alpha-amylase 2B (AMY2B). These genes code for proteins that are responsible for metabolizing dietary products that originate from distinctly different food types: sugar, meat, and starch, respectively. After surveying copy number variation among dogs with diverse dietary histories, we found no correlation between diet and positive selection in either GCKR or PHYH. Although it has been previously demonstrated that dogs experienced a copy number increase in AMY2B relative to wolves during or after the dog domestication process, we demonstrate that positive selection continued to act on amylase copy number in dog breeds that consumed starch-rich diets in time periods after domestication. Furthermore, we found that introgression with wolves is not responsible for deterioration of positive selection on AMY2B among diverse dog breeds. Together, this supports the hypothesis that the amylase copy number expansion is found universally in dogs.	[Reiter, Taylor; Jagoda, Evelyn; Capellini, Terence D.] Harvard Univ, Human Evolutionary Biol, 11 Divin Ave, Cambridge, MA 02138 USA	Harvard University	Capellini, TD (corresponding author), Harvard Univ, Human Evolutionary Biol, 11 Divin Ave, Cambridge, MA 02138 USA.	tcapellini@fas.harvard.edu		Reiter, Taylor/0000-0002-7388-421X	Global Health and Health Policy Secondary Field, Harvard University; Cordiero Fellowship; Museum of Comparative Zoology, Harvard University; Grants-in-Aid for Scientific Research [26450433] Funding Source: KAKEN	Global Health and Health Policy Secondary Field, Harvard University; Cordiero Fellowship; Museum of Comparative Zoology, Harvard University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Global Health and Health Policy Secondary Field, Harvard University (TR), fellowship name: Cordiero Fellowship, http://ghhp.fas.harvard.edu/cordeiro-summer-research-fellowship; and Museum of Comparative Zoology, Harvard University (TR), grant name: Grants-in-aid of undergraduate research, http://www.mcz.harvard.edu/grants_and_funding/gur.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2010, P NATL ACAD SCI USA, V107, P1160, DOI 10.1073/pnas.0909918107; Arendt M, 2014, ANIM GENET, V45, P716, DOI 10.1111/age.12179; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bogoras W, 1901, AM ANTHROPOL, V3, P80, DOI 10.1525/aa.1901.3.1.02a00060; Boyko AR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000451; Choy K, 2010, ARCHAEOL ANTHROP SCI, V2, P1, DOI 10.1007/s12520-010-0022-3; Clutton-Brock Juliet, 1995, P7; Coppinger L, 2001, DOGS A NEW UNDERSTAN; Croes K, 1996, EUR J BIOCHEM, V240, P674, DOI 10.1111/j.1432-1033.1996.0674h.x; DAYAN T, 1994, J ARCHAEOL SCI, V21, P633, DOI 10.1006/jasc.1994.1062; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Ding ZL, 2012, HEREDITY, V108, P507, DOI 10.1038/hdy.2011.114; Esaka T, 1970, ARCHAEOL J, V40, P6; Feltovich N., 2003, Experimental Economics, V6, P273, DOI 10.1023/A:1026273319211; FLIGNER MA, 1976, J AM STAT ASSOC, V71, P210, DOI 10.2307/2285771; Freedman AH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004016; HABU J., 2004, ANCIENT JOMON JAPAN; Harrison JA, 1960, AINU NO JAPAN STUDY; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; HORII A, 1987, GENE, V60, P57; Jansen GA, 1997, NAT GENET, V17, P190, DOI 10.1038/ng1097-190; Kil DY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012882; Larson G, 2012, P NATL ACAD SCI USA, V109, P8878, DOI 10.1073/pnas.1203005109; Li Y, 2014, MOL BIOL EVOL, V31, P1200, DOI 10.1093/molbev/msu070; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Losey RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063740; Mandel AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013352; Marlowe FW, 2005, EVOL ANTHROPOL, V14, P54, DOI 10.1002/evan.20046; Mihalik SJ, 1997, NAT GENET, V17, P185, DOI 10.1038/ng1097-185; Murdock GP, 2008, ONLINE CULTURAL MAT; Nicholas TJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-414; Nicholas TJ, 2009, GENOME RES, V19, P491, DOI 10.1101/gr.084715.108; Okumura N, 1999, ANTHROPOL SCI, V107, P213, DOI 10.1537/ase.107.213; Pang JF, 2009, MOL BIOL EVOL, V26, P2849, DOI 10.1093/molbev/msp195; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Pechenkina EA, 2005, J ARCHAEOL SCI, V32, P1176, DOI 10.1016/j.jas.2005.02.015; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; Porsild AE, 1953, EDIBLE PLANTS ARCTIC, V1953, P6; Schluter A, 2002, BIOCHEM J, V362, P61, DOI 10.1042/0264-6021:3620061; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Skoglund P, 2011, MOL BIOL EVOL, V28, P1505, DOI 10.1093/molbev/msq342; Strohle A, 2011, NUTR RES, V31, P429, DOI 10.1016/j.nutres.2011.05.003; Tsutaya T, 2014, ANTHROPOL SCI, V122, P89, DOI 10.1537/ase.140604; Usher CL, 2015, NAT GENET, V47, P921, DOI 10.1038/ng.3340; van den Brink DM, 2006, CELL MOL LIFE SCI, V63, P1752, DOI 10.1007/s00018-005-5463-y; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Wang GD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2814; Weng Q., 2000, GeoJournal, V51, P191, DOI 10.1023/A:1012021520392; Wong AK, 2010, GENETICS, V184, P595, DOI 10.1534/genetics.109.106831; Yang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063148; Yang XY, 2009, SCI CHINA SER D, V52, P1164, DOI 10.1007/s11430-009-0089-9	54	21	21	3	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148899	10.1371/journal.pone.0148899	http://dx.doi.org/10.1371/journal.pone.0148899			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863414	Green Submitted, Green Published, gold			2022-12-27	WOS:000370046600121
J	Saracco, JF; Radley, P; Pyle, P; Rowan, E; Taylor, R; Helton, L				Saracco, James F.; Radley, Paul; Pyle, Peter; Rowan, Erin; Taylor, Ron; Helton, Lauren			Linking Vital Rates of Landbirds on a Tropical Island to Rainfall and Vegetation Greenness	PLOS ONE			English	Article							NIGHTINGALE REED-WARBLER; BIODIVERSITY HOTSPOTS; MARK-RECAPTURE; CLIMATE-CHANGE; RECOVERY DATA; BIRD; SAIPAN; SURVIVAL; CONSERVATION; PHENOLOGY	Remote tropical oceanic islands are of high conservation priority, and they are exemplified by range-restricted species with small global populations. Spatial and temporal patterns in rainfall and plant productivity may be important in driving dynamics of these species. Yet, little is known about environmental influences on population dynamics for most islands and species. Here we leveraged avian capture-recapture, rainfall, and remote-sensed habitat data (enhanced vegetation index [EVI]) to assess relationships between rainfall, vegetation greenness, and demographic rates (productivity, adult apparent survival) of three native bird species on Saipan, Northern Mariana Islands: rufous fantail (Rhipidura rufifrons), bridled white-eye (Zosterops conspicillatus), and golden white-eye (Cleptornis marchei). Rainfall was positively related to vegetation greenness at all but the highest rainfall levels. Temporal variation in greenness affected the productivity of each bird species in unique ways. Predicted productivity of rufous fantail was highest when dry and wet season greenness values were high relative to site-specific 5-year seasonal mean values (i.e., relative greenness); while the white-eye species had highest predicted productivity when relative greenness contrasted between wet and dry seasons. Survival of rufous fantail and bridled white eye was positively related to relative dry-season greenness and negatively related to relative wet-season greenness. Bridled white-eye survival also showed evidence of a positive response to overall greenness. Our results highlight the potentially important role of rainfall regimes in affecting population dynamics of species on oceanic tropical islands. Understanding linkages between rainfall, vegetation, and animal population dynamics will be critical for developing effective conservation strategies in this and other regions where the seasonal timing, extent, and variability of rainfall is expected to change in the coming decades.	[Saracco, James F.; Pyle, Peter; Rowan, Erin; Taylor, Ron; Helton, Lauren] Inst Bird Populat, POB 1346, Point Reyes Stn, CA 94956 USA; [Radley, Paul] Dept Lands & Nat Resources, Commonwealth Northern Mariana Isl, Div Fish & Wildlife, POB 10007, Saipan, CM 96950 USA; [Radley, Paul] Edith Cowan Univ, Sch Nat Sci, 270 Joondalup Dr, Joondalup, WA 6027, Australia	Edith Cowan University	Saracco, JF (corresponding author), Inst Bird Populat, POB 1346, Point Reyes Stn, CA 94956 USA.	jsaracco@birdpop.org	Saracco, James F./H-6520-2019	Saracco, James F./0000-0001-5084-1834; Radley, Paul/0000-0003-0315-2790	Commonwealth of the Northern Mariana Islands Division of Fish and Wildlife through State Wildlife and Pittman-Robertson Wildlife Restoration Grants from the U.S. Fish and Wildlife Service	Commonwealth of the Northern Mariana Islands Division of Fish and Wildlife through State Wildlife and Pittman-Robertson Wildlife Restoration Grants from the U.S. Fish and Wildlife Service	This study was supported by the Commonwealth of the Northern Mariana Islands Division of Fish and Wildlife through State Wildlife and Pittman-Robertson Wildlife Restoration Grants from the U.S. Fish and Wildlife Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker RJ, 2004, STAT SINICA, V14, P1037; Barker RJ, 1997, BIOMETRICS, V53, P666, DOI 10.2307/2533966; Barker RJ, 1999, BIRD STUDY, V46, P82; Barton K., 2013, MUMIN MULTI MODEL IN; Bellard C, 2014, GLOBAL ECOL BIOGEOGR, V23, P1376, DOI 10.1111/geb.12228; Benning TL, 2002, P NATL ACAD SCI USA, V99, P14246, DOI 10.1073/pnas.162372399; Birdlife International, 2014, END BIRD AR FACTSH M; Boyce MS, 2006, TRENDS ECOL EVOL, V21, P141, DOI 10.1016/j.tree.2005.11.018; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Camp RJ, 2009, BIRD CONSERV INT, V19, P323, DOI 10.1017/S0959270909008417; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; Collins M, 2010, NAT GEOSCI, V3, P391, DOI 10.1038/NGEO868; Courchamp F, 2014, TRENDS ECOL EVOL, V29, P127, DOI 10.1016/j.tree.2014.01.001; Craig RJ, 2002, J FIELD ORNITHOL, V73, P70, DOI 10.1648/0273-8570-73.1.70; CRAIG RJ, 1990, AUK, V107, P500; Craig RJ, 2001, WILSON BULL, V113, P317, DOI 10.1676/0043-5643(2001)113[0317:MPASPI]2.0.CO;2; Craig RJ, 1996, WILSON BULL, V108, P246; de Lima RF, 2011, BIOL CONSERV, V144, P627, DOI 10.1016/j.biocon.2010.10.021; DeSante D. F., 2009, BIRD POPULATIONS, V9, P86; DeSante David F., 2005, U S Forest Service General Technical Report PSW, V191, P926; Desante DF, 2015, MAPS MANUAL 2015 PRO; Ducatez S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089955; Glenn EP, 2008, SENSORS-BASEL, V8, P2136, DOI 10.3390/s8042136; Hijmans RJ, 2012, RASTER GEOGRAPHIC AN; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Keener V., 2013, CLIMATE CHANGE PACIF; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; Kishimoto-Yamada K, 2015, ENTOMOL SCI, V18, P407, DOI 10.1111/ens.12134; Laake JL, 2013, RMARK R INTERFACE AN; Lander MA, 2004, TECHNICAL REPORT NO; MARSHALL JOE T., 1949, CONDOR, V51, P200, DOI 10.2307/1364563; Miura T, 1998, J GEOPHYS RES-ATMOS, V103, P32001, DOI 10.1029/98JD00051; Mosher SM, 2002, WILSON BULL, V114, P1, DOI 10.1676/0043-5643(2002)114[0001:DONEAN]2.0.CO;2; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Park S, 2009, PHOTOGRAMM ENG REM S, V75, P1231, DOI 10.14358/PERS.75.10.1231; Pimm SL, 1991, BALANCE NATURE ECOLO; Polis GA, 1997, ECOLOGY, V78, P1884; Potithep S, 2010, INT ARCH PHOTOGRAMM, V38, P609; Pratt H.D., 2010, AVIAN SUBSPECIES, V67, P78, DOI DOI 10.1525/0M.2010.67.1.79; R Core Team, 2021, R LANGUAGE ENV STAT; Radley P, 2011, WILSON J ORNITHOL, V123, P588, DOI 10.1676/10-154.1; REICH PB, 1995, CAN J BOT, V73, P164, DOI 10.1139/b95-020; Robinson RA, 2007, BIRD STUDY, V54, P230, DOI 10.1080/00063650709461479; Roche EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058092; Rodda GH, 1998, AVIAN CONSERVATION: RESEARCH AND MANAGEMENT, P367; Ruiz-Gutierrez V, 2012, AUK, V129, P500, DOI 10.1525/auk.2012.11171; Sachtleben T, 2006, WILSON J ORNITHOL, V118, P309, DOI 10.1676/05-049.1; Saleska SR, 2007, SCIENCE, V318, P612, DOI 10.1126/science.1146663; Schodde R, 1999, DIRECTORY AUSTR BIRD; Schuur EAG, 2003, ECOLOGY, V84, P1165, DOI 10.1890/0012-9658(2003)084[1165:PAGCRT]2.0.CO;2; Sillett TS, 2000, SCIENCE, V288, P2040, DOI 10.1126/science.288.5473.2040; Skagen SK, 2012, ECOL APPL, V22, P1131, DOI 10.1890/11-0291.1; Slattery SM, 2002, J APPL STAT, V29, P497, DOI 10.1080/02664760120108548; Slikas B, 2000, AUK, V117, P355, DOI 10.1642/0004-8038(2000)117[0355:PROMWE]2.0.CO;2; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V7; Steadman DW, 2006, EXTINCTION BIOGEOGRA; van Oldenborgh GJ, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1311; VANSCHAIK CP, 1993, ANNU REV ECOL SYST, V24, P353, DOI 10.1146/annurev.es.24.110193.002033; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Widlansky MJ, 2013, NAT CLIM CHANGE, V3, P417, DOI [10.1038/NCLIMATE1726, 10.1038/nclimate1726]; Williams SE, 2008, DIVERS DISTRIB, V14, P69, DOI 10.1111/j.1472-4642.2007.00418.x; WOLDA H, 1988, ANNU REV ECOL SYST, V19, P1, DOI 10.1146/annurev.es.19.110188.000245; Wolfe JD, 2015, OECOLOGIA, V178, P715, DOI 10.1007/s00442-015-3256-z; Xiao XM, 2004, REMOTE SENS ENVIRON, V89, P519, DOI 10.1016/j.rse.2003.11.008; Xiao XM, 2003, REMOTE SENS ENVIRON, V84, P385, DOI 10.1016/S0034-4257(02)00129-3; Zarones L, 2013, BIRD CONSERV INT, V23, P454, DOI 10.1017/S0959270912000470	68	10	11	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148570	10.1371/journal.pone.0148570	http://dx.doi.org/10.1371/journal.pone.0148570			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863013	gold, Green Published, Green Submitted			2022-12-27	WOS:000370046600081
J	Barnes, JC; Boutwell, BB; Miller, JM; DeShay, RA; Beaver, KM; White, N				Barnes, J. C.; Boutwell, Brian B.; Miller, J. Mitchell; DeShay, Rashaan A.; Beaver, Kevin M.; White, Norman			Exposure to Pre- and Perinatal Risk Factors Partially Explains Mean Differences in Self-Regulation between Races	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; DISPARITIES; CARE; HEALTH; OUTCOMES; SMOKING; DELINQUENCY; GOTTFREDSON; BEHAVIORS; PREGNANCY	Objectives To examine whether differential exposure to pre- and perinatal risk factors explained differences in levels of self-regulation between children of different races (White, Black, Hispanic, Asian, and Other). Methods Multiple regression models based on data from the Early Childhood Longitudinal Study, Birth Cohort (n approximate to 9,850) were used to analyze the impact of pre- and perinatal risk factors on the development of self-regulation at age 2 years. Results Racial differences in levels of self-regulation were observed. Racial differences were also observed for 9 of the 12 pre-/perinatal risk factors. Multiple regression analyses revealed that a portion of the racial differences in self-regulation was explained by differential exposure to several of the pre-/perinatal risk factors. Specifically, maternal age at childbirth, gestational timing, and the family's socioeconomic status were significantly related to the child's level of self-regulation. These factors accounted for a statistically significant portion of the racial differences observed in self-regulation. Conclusions The findings indicate racial differences in self-regulation may be, at least partially, explained by racial differences in exposure to pre- and perinatal risk factors.	[Barnes, J. C.] Univ Cincinnati, Sch Criminal Justice, Cincinnati, OH USA; [Boutwell, Brian B.; White, Norman] St Louis Univ, Coll Publ Hlth & Social Justice, Sch Social Work, Criminol & Criminal Justice, St Louis, MO 63103 USA; [Boutwell, Brian B.] St Louis Univ, Coll Publ Hlth & Social Justice, Dept Epidemiol Secondary Appointment, St Louis, MO 63103 USA; [Miller, J. Mitchell] Univ N Florida, Dept Criminol & Criminal Justice, Jacksonville, FL USA; [DeShay, Rashaan A.] Calif State Univ Stanislaus, Dept Criminal Justice, Turlock, CA 95382 USA; [Beaver, Kevin M.] Florida State Univ, Coll Criminol & Criminal Justice, Tallahassee, FL 32306 USA	University System of Ohio; University of Cincinnati; Saint Louis University; Saint Louis University; State University System of Florida; University of North Florida; California State University System; California State University Stanislaus; State University System of Florida; Florida State University	Barnes, JC (corresponding author), Univ Cincinnati, Sch Criminal Justice, Cincinnati, OH USA.	jc.barnes@uc.edu	Beaver, Kevin M./B-4631-2013	DeShay, Rashaan/0000-0003-2360-9858; Barnes, J.C./0000-0001-6932-5397				AHADI SA, 1993, EUR J PERSONALITY, V7, P359, DOI 10.1002/per.2410070506; Alexander GR, 2005, OBSTET GYN CLIN N AM, V32, P1, DOI 10.1016/j.ogc.2004.10.005; Alexander GR, 2002, MENT RETARD DEV D R, V8, P215, DOI 10.1002/mrdd.10047; Alexander GR, 2002, AM J PUBLIC HEALTH, V92, P1970, DOI 10.2105/AJPH.92.12.1970; Alexander GR, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.006; Allison PD, 2002, MISSING DATA; Baler RD, 2008, J PSYCHIATR NEUROSCI, V33, P187; Barkley R. A., 1997, ADHD NATURE SELF CON; Barnes JC, 2013, DEV PSYCHOL, V49, P2272, DOI 10.1037/a0032061; Beaver KM, 2014, MERRILL PALMER QUART, V60, P142, DOI 10.13110/merrpalmquar1982.60.2.0142; Beaver KM, 2013, PERS INDIV DIFFER, V55, P29, DOI 10.1016/j.paid.2013.01.020; Beaver KM, 2005, INT J OFFENDER THER, V49, P450, DOI 10.1177/0306624X05274687; Bengiamin MI, 2010, MATERN CHILD HLTH J, V14, P618, DOI 10.1007/s10995-009-0485-y; Berger A, 2007, PROG NEUROBIOL, V82, P256, DOI 10.1016/j.pneurobio.2007.06.004; Bethel J., 2005, ECLS B METHODOLOGY R, V2; Boutwell BB, 2010, J RES CRIME DELINQ, V47, P174, DOI 10.1177/0022427809357715; Bronson MB, 2000, SELF-REGULATION IN EARLY CHILDHOOD, P1; Burke W, 2007, JAMA-J AM MED ASSOC, V298, P1682, DOI 10.1001/jama.298.14.1682; Caspi A, 2001, PSYCHOL INQ, V12, P49, DOI 10.1207/S15327965PLI1202_01; D'Onofrio BM, 2008, DEV PSYCHOPATHOL, V20, P139, DOI 10.1017/S0954579408000072; D'Onofrio BM, 2009, J CHILD PSYCHOL PSYC, V50, P1018, DOI 10.1111/j.1469-7610.2009.02068.x; DeGangi GA., 1995, INFANT TODDLER SYMPT; Executive Office of the President Office of Management and Budget, 2000, STAND OCC CLASS MAN; FISCELLA K, 1995, OBSTET GYNECOL, V85, P468, DOI 10.1016/0029-7844(94)00408-6; Gibson CL, 2010, J RES CRIME DELINQ, V47, P31, DOI 10.1177/0022427809348903; Gottfredson M.R., 1990, GEN THEORY CRIME; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Hay C, 2006, CRIMINOLOGY, V44, P739, DOI 10.1111/j.1745-9125.2006.00062.x; Heaman M.I., 2008, BMC PREGNANCY CHILDB, V8; Herrnstein Richard J., 1994, THE BELL CURVE INTEL; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Leblanc N, 2008, J ABNORM CHILD PSYCH, V36, P977, DOI 10.1007/s10802-008-9227-7; LYNAM D, 1993, J ABNORM PSYCHOL, V102, P187, DOI 10.1037/0021-843X.102.2.187; Lynch JL, 2011, SOCIOL INQ, V81, P499, DOI 10.1111/j.1475-682X.2011.00390.x; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Martin JW, 2010, NATIVE AMERICANS, CHRISTIANITY, AND THE RESHAPING OF THE AMERICAN RELIGIOUS LANDSCAPE, P1; Martin Joyce A, 2002, Natl Vital Stat Rep, V51, P1; McLafferty Sara, 2004, J Med Syst, V28, P321, DOI 10.1023/B:JOMS.0000032848.76032.28; Mega JL, 2014, JAMA-J AM MED ASSOC, V312, P1969, DOI 10.1001/jama.2014.15224; Meldrum RC, 2008, J CRIM JUST, V36, P244, DOI 10.1016/j.jcrimjus.2008.04.005; Mick E, 2002, J DEV BEHAV PEDIATR, V23, P16, DOI 10.1097/00004703-200202000-00004; Miller HV, 2011, AM J HEALTH BEHAV, V35, P15; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Morris RG, 2011, CRIM JUSTICE BEHAV, V38, P584, DOI 10.1177/0093854811402453; Muraven M, 2000, PSYCHOL BULL, V126, P247, DOI 10.1037/0033-2909.126.2.247; Nord C., 2004, EARLY CHILDHOOD LONG; Olds D, 1998, JAMA-J AM MED ASSOC, V280, P1238, DOI 10.1001/jama.280.14.1238; Paul IM, 2008, MATERN CHILD HLTH J, V12, P452, DOI 10.1007/s10995-007-0280-6; Poehlmann J, 2011, DEV PSYCHOPATHOL, V23, P177, DOI 10.1017/S0954579410000726; Pogarsky G, 2003, CRIMINOLOGY, V41, P1249, DOI 10.1111/j.1745-9125.2003.tb01019.x; Pratt TC, 2000, CRIMINOLOGY, V38, P931, DOI 10.1111/j.1745-9125.2000.tb00911.x; Pratt TC, 2006, INT J OFFENDER THER, V50, P672, DOI 10.1177/0306624X06286623; Raine A., 2013, ANATOMY VIOLENCE BIO; Rushton JP, 2005, PSYCHOL PUBLIC POL L, V11, P235, DOI 10.1037/1076-8971.11.2.235; Schilling CM, 2011, J CRIM JUST, V39, P3, DOI 10.1016/j.jcrimjus.2010.11.001; Shi LY, 2004, HEALTH SERV RES, V39, P1881, DOI 10.1111/j.1475-6773.2004.00323.x; Unnever J.D., 2011, THEORY AFRICAN AM OF; van Ierland Y, 2009, EARLY HUM DEV, V85, P617, DOI 10.1016/j.earlhumdev.2009.09.009; Wilson J.Q., 1985, CRIME HUMAN NATURE; Wright JP, 2005, CRIMINOLOGY, V43, P1169, DOI 10.1111/j.1745-9125.2005.00036.x	60	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0141954	10.1371/journal.pone.0141954	http://dx.doi.org/10.1371/journal.pone.0141954			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3BP	26882110	Green Published, gold, Green Submitted			2022-12-27	WOS:000371219000001
J	Liu, B; Yang, L; Yang, YZ; Lu, YH				Liu, Bing; Yang, Long; Yang, Yizhong; Lu, Yanhui			Influence of Landscape Diversity and Composition on the Parasitism of Cotton Bollworm Eggs in Maize	PLOS ONE			English	Article							CONSERVATION BIOLOGICAL-CONTROL; NATURAL ENEMIES; AGRICULTURAL LANDSCAPES; BIOCONTROL SERVICES; CEREAL APHIDS; CROP PEST; HETEROGENEITY; CONFIGURATION; BIODIVERSITY; HABITAT	We deployed >50,000 Helicoverpa armigera eggs in maize fields to assess the rate of parasitism by Trichogramma chilonis across 33 sites during a three-year span (2012-2014) in northern China. Subsequently, we used a partial least squares (PLS) regression approach to assess the relationship of landscape diversity with composition and parasitism potential. The parasitism rate of H. armigera eggs by T. chilonis ranged from 0-25.8%, with a mean value of 5.6%. Landscape diversity greatly enhanced parasitism at all four different spatial scales (0.5, 1.0, 1.5 and 2.0 km radius). Both the proportion of arable area and the total planting area of two major crops (cotton and maize) had a negative correlation to the parasitism rate at each scale, whereas parasitism was positively correlated to the proportion of host crops of H. armigera other than cotton and maize at the 0.5 to 2.0 km radius scales as well as to that of non-crop habitat at the 0.5 and 1.0 km radius scales. The study indicated that maintaining landscape diversity provided an important biocontrol service by limiting H. armigera through the egg parasitoid T. chilonis, whereas rapid agricultural intensification would greatly reduce the presence and parasitism of T. chilonis in China.	[Liu, Bing; Yang, Yizhong] Yangzhou Univ, Coll Hort & Plant Protect, Yangzhou 225009, Jiangsu, Peoples R China; [Liu, Bing; Yang, Long; Lu, Yanhui] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Yangzhou University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Yang, YZ (corresponding author), Yangzhou Univ, Coll Hort & Plant Protect, Yangzhou 225009, Jiangsu, Peoples R China.; Lu, YH (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	yzyang@yzu.edu.cn; yhlu@ippcaas.cn		Liu, Bing/0000-0001-7303-4496; Lu, Yanhui/0000-0002-6552-0248	National Natural Science Funds [31222046, 31321004]; Jiangsu Province graduate student research and creative projects [CXZZ13_0907]	National Natural Science Funds(National Natural Science Foundation of China (NSFC)); Jiangsu Province graduate student research and creative projects	This research was supported by the National Natural Science Funds (No. 31222046, 31321004), and the Jiangsu Province graduate student research and creative projects (No. CXZZ13_0907).	Alignier A, 2014, BIOL CONTROL, V77, P76, DOI 10.1016/j.biocontrol.2014.06.006; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; Bianchi FJJA, 2005, AGR ECOSYST ENVIRON, V107, P145, DOI 10.1016/j.agee.2004.11.007; Briggs CJ, 2004, THEOR POPUL BIOL, V65, P299, DOI 10.1016/j.tpb.2003.11.001; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Chaplin-Kramer R, 2011, ECOL LETT, V14, P922, DOI 10.1111/j.1461-0248.2011.01642.x; ESRI, 2010, ARCGIS 10 ARCMAP VER; Gardiner MM, 2010, BIOL CONTROL, V55, P11, DOI 10.1016/j.biocontrol.2010.06.008; Gardiner MM, 2009, DIVERS DISTRIB, V15, P554, DOI 10.1111/j.1472-4642.2009.00563.x; Gardiner MM, 2009, ECOL APPL, V19, P143, DOI 10.1890/07-1265.1; Grez AA, 2014, BIOL CONTROL, V76, P1, DOI 10.1016/j.biocontrol.2014.04.005; Guo YY, 1998, RESEARCH OF COTTON B; Jonsson M, 2012, J APPL ECOL, V49, P706, DOI 10.1111/j.1365-2664.2012.02130.x; Landis DA, 2000, ANNU REV ENTOMOL, V45, P175, DOI 10.1146/annurev.ento.45.1.175; Landis DA, 2008, P NATL ACAD SCI USA, V105, P20552, DOI 10.1073/pnas.0804951106; Liang GeMei, 1999, Plant Protection, V25, P15; Liu B, 2016, BIOL CONTROL, V93, P15, DOI 10.1016/j.biocontrol.2015.11.004; McGarigal K, 2012, FRAGSTATS V4 SPAT PA; Naranjo SE, 2015, ANNU REV ENTOMOL, V60, P621, DOI 10.1146/annurev-ento-010814-021005; Ostman O, 2001, BASIC APPL ECOL, V2, P365, DOI 10.1078/1439-1791-00072; Plecas M, 2014, AGR ECOSYST ENVIRON, V183, P1, DOI 10.1016/j.agee.2013.10.016; Power AG, 2010, PHILOS T R SOC B, V365, P2959, DOI 10.1098/rstb.2010.0143; Ramsden MW, 2015, AGR ECOSYST ENVIRON, V199, P94, DOI 10.1016/j.agee.2014.08.024; Rand TA, 2006, ECOL LETT, V9, P603, DOI 10.1111/j.1461-0248.2006.00911.x; Roschewitz I, 2005, AGR ECOSYST ENVIRON, V108, P218, DOI 10.1016/j.agee.2005.02.005; Roubos CR, 2014, BIOL CONTROL, V75, P28, DOI 10.1016/j.biocontrol.2014.01.006; SAS Institute, 2011, SAS STAT 9 3 US GUID; Sivakoff FS, 2012, BIOL CONTROL, V63, P296, DOI 10.1016/j.biocontrol.2012.09.008; Steckel J, 2014, BIOL CONSERV, V172, P56, DOI 10.1016/j.biocon.2014.02.015; Tenenhaus M, 2005, FOOD QUAL PREFER, V16, P315, DOI 10.1016/j.foodqual.2004.05.013; Thies C, 2003, OIKOS, V101, P18, DOI 10.1034/j.1600-0706.2003.12567.x; Thies C, 1999, SCIENCE, V285, P893, DOI 10.1126/science.285.5429.893; Thies C, 2011, ECOL APPL, V21, P2187, DOI 10.1890/10-0929.1; Tscharntke T, 2007, BIOL CONTROL, V43, P294, DOI 10.1016/j.biocontrol.2007.08.006; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Vasseur C, 2013, AGR ECOSYST ENVIRON, V166, P3, DOI 10.1016/j.agee.2012.08.013; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Wold S., 1995, QSAR CHEMOMETRIC MET, V2, P195; Woltz JM, 2014, AGR FOREST ENTOMOL, V16, P341, DOI 10.1111/afe.12064; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Wyckhuys KAG, 2013, BIOL CONTROL, V65, P152, DOI 10.1016/j.biocontrol.2012.11.010; Zhang Y. J., 1981, Natural Enemies of Insects, V3, P14; Zhao ZH, 2014, J ECON ENTOMOL, V107, P630, DOI 10.1603/EC13054; Zhou K, 2014, AGR ECOSYST ENVIRON, V183, P176, DOI 10.1016/j.agee.2013.11.008	45	12	14	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149476	10.1371/journal.pone.0149476	http://dx.doi.org/10.1371/journal.pone.0149476			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881784	Green Published, Green Submitted, gold			2022-12-27	WOS:000371219000077
J	Borghese, MFA; Ortiz, MC; Balonga, S; Szokalo, RM; Majowicz, MP				Albertoni Borghese, Maria F.; Ortiz, Maria C.; Balonga, Sabrina; Moreira Szokalo, Rocio; Majowicz, Monica P.			The Role of Endothelin System in Renal Structure and Function during the Postnatal Development of the Rat Kidney	PLOS ONE			English	Article							BLOOD-PRESSURE; SEX-DIFFERENCES; NEPHRON NUMBER; SIGNALING PATHWAYS; GLOMERULAR VOLUME; MICE DEFICIENT; RECEPTORS; PROLIFERATION; EXPRESSION; REDUCTION	Renal development in rodents, unlike in humans, continues during early postnatal period. We aimed to evaluate whether the pharmacological inhibition of Endothelin system during this period affects renal development, both at structural and functional level in male and female rats. Newborn rats were treated orally from postnatal day 1 to 20 with vehicle or bosentan (Actelion, 20 mg/kg/day), a dual endothelin receptor antagonist (ERA). The animals were divided in 4 groups: control males, control females, ERA males and ERA females. At day 21, we evaluated renal function, determined the glomerular number by a maceration method and by morphometric analysis and evaluated possible structural renal alterations by three methods: < alpha >-Smooth muscle actin (alpha-SMA) immunohistochemistry, Masson's trichrome and Sirius red staining. The pharmacological inhibition of Endothelin system with a dual ERA during the early postnatal period of the rat did not leads to renal damage in the kidneys of male and female rats. However, ERA administration decreased the number of glomeruli, the juxtamedullary filtration surface area and the glomerular filtration rate and increased the proteinuria. These effects could predispose to hypertension or renal diseases in the adulthood. On the other hand, these effects were more pronounced in male rats, suggesting that there are sex differences that could be greater later in life. These results provide evidence that Endothelin has an important role in rat renal postnatal development. However these results do not imply that the same could happen in humans, since human renal development is complete at birth.	[Albertoni Borghese, Maria F.; Ortiz, Maria C.; Balonga, Sabrina; Moreira Szokalo, Rocio; Majowicz, Monica P.] Univ Buenos Aires, Fac Farm & Bioquim, Dept Ciencias Biol, Catedra Biol Celular & Mol, RA-1113 Buenos Aires, DF, Argentina	University of Buenos Aires	Majowicz, MP (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Dept Ciencias Biol, Catedra Biol Celular & Mol, RA-1113 Buenos Aires, DF, Argentina.	mmajow@ffyb.uba.ar			University of Buenos Aires [UBACYT 20020090200685, UBACYT 20020130200184BA]	University of Buenos Aires(University of Buenos Aires)	This work was supported by grants from the University of Buenos Aires (http://www.uba.ar/secyt/), grants UBACYT 20020090200685 and UBACYT 20020130200184BA (to MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie L, 1996, PEDIATR NEPHROL, V10, P185; Adur J, 2003, BIOCHEM BIOPH RES CO, V305, P700, DOI 10.1016/S0006-291X(03)00769-1; Barton M, 2012, CLIN KIDNEY J, V5, P17, DOI 10.1093/ckj/sfs001; Boesen EI, 2015, CURR OPIN PHARMACOL, V21, P25, DOI 10.1016/j.coph.2014.12.007; Bouallegue A, 2007, CURR VASC PHARMACOL, V5, P45, DOI 10.2174/157016107779317161; Chen QW, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-52; Clouthier DE, 2000, DEV BIOL, V217, P10, DOI 10.1006/dbio.1999.9527; Cowley AW, 2013, HYPERTENSION, V62, P85, DOI 10.1161/HYPERTENSIONAHA.113.01194; DAMADIAN RV, 1965, J LAB CLIN MED, V65, P26; De Miguel C, 2016, CURR OPIN NEPHROL HY, V25, P35, DOI 10.1097/MNH.0000000000000185; Foschi M, 1997, EMBO J, V16, P6439, DOI 10.1093/emboj/16.21.6439; Garg P, 2011, ADV CHRONIC KIDNEY D, V18, P233, DOI 10.1053/j.ackd.2011.06.001; Guron G, 1999, J AM SOC NEPHROL, V10, P1550; Ho J, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00128; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; Hoy WE, 2008, CURR OPIN NEPHROL HY, V17, P258, DOI 10.1097/MNH.0b013e3282f9b1a5; Hua H, 2003, AM J PHYSIOL-RENAL, V284, pF303, DOI 10.1152/ajprenal.00127.2002; Jin CH, 2013, AM J PHYSIOL-RENAL, V305, pF1099, DOI 10.1152/ajprenal.00400.2013; Kim SI, 2014, J AM SOC NEPHROL, V25, P1966, DOI 10.1681/ASN.2013030252; Kittikulsuth W, 2013, BRIT J PHARMACOL, V168, P318, DOI 10.1111/j.1476-5381.2012.01922.x; Kittikulsuth W, 2013, CLIN EXP PHARMACOL P, V40, P362, DOI 10.1111/1440-1681.12084; Kohan DE, 2011, PHYSIOL REV, V91, P1, DOI 10.1152/physrev.00060.2009; Kuo Hung-Tien, 2006, KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, V22, P371, DOI 10.1016/S1607-551X(09)70325-0; KURIHARA Y, 1994, NATURE, V368, P703, DOI 10.1038/368703a0; KURIHARA Y, 1995, J CLIN INVEST, V96, P293, DOI 10.1172/JCI118033; Lee JJ, 2007, KAOHSIUNG J MED SCI, V23, P170, DOI 10.1016/S1607-551X(09)70393-6; Little MH, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008300; Tomat AL, 2008, AM J PHYSIOL-REG I, V295, pR543, DOI 10.1152/ajpregu.00050.2008; Tomat AL, 2013, NUTRITION, V29, P568, DOI 10.1016/j.nut.2012.09.008; Loria A, 2007, AM J PHYSIOL-REG I, V293, pR695, DOI 10.1152/ajpregu.00191.2007; Loria A, 2007, AM J PHYSIOL-RENAL, V293, pF506, DOI 10.1152/ajprenal.00066.2007; Maguire JJ, 2014, BRIT J PHARMACOL, V171, P5555, DOI 10.1111/bph.12874; MALKUSCH W, 1995, EXP LUNG RES, V21, P67, DOI 10.3109/01902149509031745; Marquez MG, 2002, ANAT EMBRYOL, V205, P431, DOI 10.1007/s00429-002-0262-9; Moritz KM, 2009, AM J PHYSIOL-RENAL, V296, pF1, DOI 10.1152/ajprenal.00049.2008; Murawski IJ, 2010, ORGANOGENESIS, V6, P189, DOI 10.4161/org.6.3.12125; Nigam S., 1996, KIDNEY, P72; POLDERMAN KH, 1993, ANN INTERN MED, V118, P429, DOI 10.7326/0003-4819-118-6-199303150-00006; Puddu M, 2009, AM J NEPHROL, V30, P162, DOI 10.1159/000211324; RUBANYI GM, 1994, PHARMACOL REV, V46, P325; Saez F, 2007, HYPERTENSION, V49, P1429, DOI 10.1161/HYPERTENSIONAHA.107.087957; Samuel T, 2005, J AM SOC NEPHROL, V16, P3102, DOI 10.1681/ASN.2005010123; Sorokin A, 2002, CLIN SCI, V103, p132S, DOI 10.1042/CS103S132S; SOUSTER LP, 1980, J ANAT, V130, P595; Suganami T, 2003, HYPERTENSION, V42, P1183, DOI 10.1161/01.HYP.0000101689.64849.97; Tostes RC, 2008, CLIN SCI, V114, P85, DOI 10.1042/CS20070169; Uchide T, 2002, CLIN SCI, V103, p167S, DOI 10.1042/CS103S167S; Vignon-Zellweger N, 2012, LIFE SCI, V91, P490, DOI 10.1016/j.lfs.2012.03.026; Welch AK, 2013, BRIT J PHARMACOL, V168, P327, DOI 10.1111/j.1476-5381.2012.01826.x; Yanagisawa H, 1998, DEVELOPMENT, V125, P825; Yoo KH, 2009, J KOREAN MED SCI, V24, P138, DOI 10.3346/jkms.2009.24.1.138	51	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148866	10.1371/journal.pone.0148866	http://dx.doi.org/10.1371/journal.pone.0148866			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872270	gold, Green Published, Green Submitted			2022-12-27	WOS:000370054100066
J	Matsumoto, Y; Sakakihara, S; Grushnikov, A; Kikuchi, K; Noji, H; Yamaguchi, A; Iino, R; Yagi, Y; Nishino, K				Matsumoto, Yoshimi; Sakakihara, Shouichi; Grushnikov, Andrey; Kikuchi, Kazuma; Noji, Hiroyuki; Yamaguchi, Akihito; Iino, Ryota; Yagi, Yasushi; Nishino, Kunihiko			A Microfluidic Channel Method for Rapid Drug-Susceptibility Testing of Pseudomonas aeruginosa	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; AUTOMATED MICROSCOPY; EFFLUX PUMPS; STAPHYLOCOCCUS-AUREUS; CARBAPENEM RESISTANCE; MEXAB-OPRM; FLUOROQUINOLONE RESISTANCE; MULTIDRUG-RESISTANCE; CLINICAL STRAINS; CULTURE DEVICE	The recent global increase in the prevalence of antibiotic-resistant bacteria and lack of development of new therapeutic agents emphasize the importance of selecting appropriate antimicrobials for the treatment of infections. However, to date, the development of completely accelerated drug susceptibility testing methods has not been achieved despite the availability of a rapid identification method. We proposed an innovative rapid method for drug susceptibility testing for Pseudomonas aeruginosa that provides results within 3 h. The drug susceptibility testing microfluidic (DSTM) device was prepared using soft lithography. It consisted of five sets of four microfluidic channels sharing one inlet slot, and the four channels are gathered in a small area, permitting simultaneous microscopic observation. Antimicrobials were pre-introduced into each channel and dried before use. Bacterial suspensions in cation-adjusted Mueller-Hinton broth were introduced from the inlet slot and incubated for 3 h. Susceptibilities were microscopically evaluated on the basis of differences in cell numbers and shapes between drug-treated and control cells, using dedicated software. The results of 101 clinically isolated strains of P. aeruginosa obtained using the DSTM method strongly correlated with results obtained using the ordinary microbroth dilution method. Ciprofloxacin, meropenem, ceftazidime, and piperacillin caused elongation in susceptible cells, while meropenem also induced spheroplast and bulge formation. Morphological observation could alternatively be used to determine the susceptibility of P. aeruginosa to these drugs, although amikacin had little effect on cell shape. The rapid determination of bacterial drug susceptibility using the DSTM method could also be applicable to other pathogenic species, and it could easily be introduced into clinical laboratories without the need for expensive instrumentation.	[Matsumoto, Yoshimi; Sakakihara, Shouichi; Grushnikov, Andrey; Kikuchi, Kazuma; Yamaguchi, Akihito; Yagi, Yasushi; Nishino, Kunihiko] Osaka Univ, Inst Sci & Ind Res, Osaka, Japan; [Noji, Hiroyuki] Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Tokyo, Japan; [Iino, Ryota] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, 5-1 Higashiyama, Okazaki, Aichi 4448787, Japan; [Iino, Ryota] Natl Inst Nat Sci, Inst Mol Sci, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan; [Iino, Ryota] Grad Univ Adv Studies SOKENDAI, Miura Dist, Kanagawa, Japan	Osaka University; University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Graduate University for Advanced Studies - Japan	Matsumoto, Y (corresponding author), Osaka Univ, Inst Sci & Ind Res, Osaka, Japan.	yoshimi@sanken.osaka-u.ac.jp	Iino, Ryota/B-7746-2011	Iino, Ryota/0000-0003-0110-5704	Japanese Society for the Promotion of Science; Center of Innovation Program from Japan Science and Technology Agency; Adaptable and Seamless Technology Transfer Program through target-driven RD (JST) [AS242Z01738P, AS2531229P]; (NEXT Program) from the Cabinet Office, Government of Japan [LS080]; Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation from the Japan Society for the Promotion of Science [07-03]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [26000011, 26713004, 26102507] Funding Source: KAKEN	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Center of Innovation Program from Japan Science and Technology Agency; Adaptable and Seamless Technology Transfer Program through target-driven RD (JST); (NEXT Program) from the Cabinet Office, Government of Japan; Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation from the Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid from the Japanese Society for the Promotion of Science, the Center of Innovation Program from Japan Science and Technology Agency, the Grant AS242Z01738P (YM) and AS2531229P (YM) from Adaptable and Seamless Technology Transfer Program through target-driven R&D (JST), the Grant LS080 (KN) (NEXT Program) from the Cabinet Office, Government of Japan, and the Grant Project ID 07-03 (AY) Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation from the Japan Society for the Promotion of Science, and the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaka T, 2001, ANTIMICROB AGENTS CH, V45, P2263, DOI 10.1128/AAC.45.8.2263-2268.2001; Alva A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082809; Angeletti S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120502; Aoki N, 2009, J ANTIMICROB CHEMOTH, V63, P534, DOI 10.1093/jac/dkn530; Ballestero S, 1996, J ANTIMICROB CHEMOTH, V38, P39, DOI 10.1093/jac/38.1.39; Banerjee R, 2015, CLIN INFECT DIS, V61, P1071, DOI 10.1093/cid/civ447; Barnini S, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0459-8; Burnham CAD, 2014, J CLIN MICROBIOL, V52, P982, DOI 10.1128/JCM.03255-13; Calderaro A, 2014, CLIN MICROBIOL INFEC, V20, pO468, DOI 10.1111/1469-0691.12490; Chen CH, 2010, ANAL CHEM, V82, P1012, DOI 10.1021/ac9022764; Choi J, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009650; Choi J, 2013, LAB CHIP, V13, P280, DOI 10.1039/c2lc41055a; den Hertog AL, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-380; Douglas IS, 2015, AM J RESP CRIT CARE, V191, P566, DOI 10.1164/rccm.201408-1468OC; El Amin N, 2005, APMIS, V113, P187, DOI 10.1111/j.1600-0463.2005.apm1130306.x; Fredborg M, 2013, J CLIN MICROBIOL, V51, P2047, DOI 10.1128/JCM.00440-13; Giske CG, 2008, MICROB DRUG RESIST, V14, P23, DOI 10.1089/mdr.2008.0778; Hakki M, 2007, BONE MARROW TRANSPL, V39, P687, DOI 10.1038/sj.bmt.1705653; Henrichfreise B, 2007, ANTIMICROB AGENTS CH, V51, P4062, DOI 10.1128/AAC.00148-07; Hou ZN, 2014, LAB CHIP, V14, P3409, DOI 10.1039/c4lc00451e; HUANG HJ, 1993, J BACTERIOL, V175, P7793, DOI 10.1128/JB.175.24.7793-7800.1993; Huang ZK, 2015, J ANTIMICROB CHEMOTH, V70, P456, DOI 10.1093/jac/dku384; Iino R, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00300; Iino R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00040; Institute CaLS, 2006, M7A7 I CALS CLSI; Kalashnikov M, 2012, LAB CHIP, V12, P4523, DOI 10.1039/c2lc40531h; Kimura S, 2005, DIAGN MICR INFEC DIS, V53, P241, DOI 10.1016/j.diagmicrobio.2005.05.017; Kinnunen P, 2012, SMALL, V8, P2477, DOI 10.1002/smll.201200110; Kirikae T, 2008, J ANTIMICROB CHEMOTH, V61, P612, DOI 10.1093/jac/dkm537; Koh TH, 2008, INT J ANTIMICROB AG, V32, P446, DOI 10.1016/j.ijantimicag.2008.05.017; Kohler T, 1999, ANTIMICROB AGENTS CH, V43, P424, DOI 10.1128/AAC.43.2.424; Lay JO, 2000, METH MOL B, V146, P461, DOI 10.1385/1-59259-045-4:461; Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09; Livermore DM, 2002, CLIN INFECT DIS, V34, P634, DOI 10.1086/338782; Llanes C, 2004, ANTIMICROB AGENTS CH, V48, P1797, DOI 10.1128/AAC.48.5.1797-1802.2004; Lu Y, 2013, ANAL CHEM, V85, P3971, DOI 10.1021/ac4004248; Makristathis A, 2014, CLIN MICROBIOL INFEC, V20, pO760, DOI 10.1111/1469-0691.12561; Maniati M, 2007, J ANTIMICROB CHEMOTH, V60, P132, DOI 10.1093/jac/dkm126; Masuda N, 2000, ANTIMICROB AGENTS CH, V44, P3322, DOI 10.1128/AAC.44.12.3322-3327.2000; Matsumoto Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018547; Mesaros N, 2007, CLIN MICROBIOL INFEC, V13, P560, DOI 10.1111/j.1469-0691.2007.01681.x; Metzger S, 2014, DIAGN MICR INFEC DIS, V79, P160, DOI 10.1016/j.diagmicrobio.2013.11.029; Michael JS, 2010, INT J TUBERC LUNG D, V14, P482; Mohan R, 2013, BIOSENS BIOELECTRON, V49, P118, DOI 10.1016/j.bios.2013.04.046; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; Morita Y, 2001, J GEN APPL MICROBIOL, V47, P27, DOI 10.2323/jgam.47.27; Nakajima A, 2002, MICROBIOL IMMUNOL, V46, P391, DOI 10.1111/j.1348-0421.2002.tb02711.x; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; Nordmann P, 2002, CLIN MICROBIOL INFEC, V8, P321, DOI 10.1046/j.1469-0691.2002.00401.x; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Peitz I, 2010, LAB CHIP, V10, P2944, DOI 10.1039/c004691d; Poole K, 2005, ANTIMICROB AGENTS CH, V49, P479, DOI 10.1128/AAC.49.2.479-487.2005; Price CS, 2014, J MICROBIOL METH, V98, P50, DOI 10.1016/j.mimet.2013.12.021; Quale J, 2006, ANTIMICROB AGENTS CH, V50, P1633, DOI 10.1128/AAC.50.5.1633-1641.2006; Ryan BM, 2001, EXPERT OPIN INV DRUG, V10, P1409, DOI 10.1517/13543784.10.8.1409; Satoh Ritsuko, 2008, Journal of Infection and Chemotherapy, V14, P325, DOI 10.1007/s10156-008-0620-5; Schweizer Herbert P, 2003, Genet Mol Res, V2, P48; Sekiguchi JI, 2005, ANTIMICROB AGENTS CH, V49, P3734, DOI 10.1128/AAC.49.9.3734-3742.2005; Sekiguchi Jun-ichiro, 2007, Journal of Infection and Chemotherapy, V13, P418, DOI 10.1007/s10156-007-0560-5; Sekiguchi JI, 2007, J CLIN MICROBIOL, V45, P979, DOI 10.1128/JCM.01772-06; Senda K, 1996, ANTIMICROB AGENTS CH, V40, P349, DOI 10.1128/AAC.40.2.349; Shiferaw G, 2007, J CLIN MICROBIOL, V45, P1093, DOI 10.1128/JCM.01949-06; Strateva T, 2009, J MED MICROBIOL, V58, P1133, DOI 10.1099/jmm.0.009142-0; Takagi R, 2013, ANALYST, V138, P1000, DOI 10.1039/c2an36323b; Wagner VE, 2008, CLIN REV ALLERG IMMU, V35, P124, DOI 10.1007/s12016-008-8079-9; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335	66	39	41	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148797	10.1371/journal.pone.0148797	http://dx.doi.org/10.1371/journal.pone.0148797			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872134	gold, Green Published, Green Submitted			2022-12-27	WOS:000370054100056
J	Morris, GP; Wright, AL; Tan, RP; Gladbach, A; Ittner, LM; Vissel, B				Morris, Gary P.; Wright, Amanda L.; Tan, Richard P.; Gladbach, Amadeus; Ittner, Lars M.; Vissel, Bryce			A Comparative Study of Variables Influencing Ischemic Injury in the Longa and Koizumi Methods of Intraluminal Filament Middle Cerebral Artery Occlusion in Mice	PLOS ONE			English	Article							LASER-DOPPLER FLOWMETRY; INFARCT VOLUME; BLOOD-FLOW; TRIPHENYLTETRAZOLIUM CHLORIDE; RODENT MODELS; CEREBROVASCULAR ANATOMY; BRAIN-INJURY; SUTURE; STROKE; REPERFUSION	The intraluminal filament model of middle cerebral artery occlusion (MCAO) in mice and rats has been plagued by inconsistency, owing in part to the multitude of variables requiring control. In this study we investigated the impact of several major variables on survival rate, lesion volume, neurological scores, cerebral blood flow (CBF) and body weight including filament width, time after reperfusion, occlusion time and the choice of surgical method. Using the Koizumi method, we found ischemic injury can be detected as early as 30 min after reperfusion, to a degree that is not statistically different from 24 h post-perfusion, using 2,3,5-Triphenyltetrazolium chloride (TTC) staining. We also found a distinct increase in total lesion volume with increasing occlusion time, with 30-45 min a critical time for the development of large, reproducible lesions. Furthermore, although we found no significant difference in total lesion volume generated by the Koizumi and Longa methods of MCAO, nor were survival rates appreciably different between the two at 4 h after reperfusion, the Longa method produces significantly greater reperfusion. Finally, we found no statistical evidence to support the exclusion of data from animals experiencing a CBF reduction of < 70% in the MCA territory following MCAO, using laser-Doppler flowmetry. Instead we suggest the main usefulness of laser-Doppler flowmetry is for guiding filament placement and the identification of subarachnoid haemorrhages and premature reperfusion. In summary, this study provides detailed evaluation of the Koizumi method of intraluminal filament MCAO in mice and a direct comparison to the Longa method.	[Morris, Gary P.; Wright, Amanda L.; Tan, Richard P.; Vissel, Bryce] Garvan Inst Med Res, Neurodegenerat Disorders, Sydney, NSW, Australia; [Morris, Gary P.; Vissel, Bryce] Univ New S Wales, Fac Med, Sydney, NSW, Australia; [Tan, Richard P.] Heart Res Inst, Sydney, NSW 2042, Australia; [Gladbach, Amadeus; Ittner, Lars M.] Univ New S Wales, Dementia Res Unit, Dept Anat, Sch Med Sci,Fac Med, Sydney, NSW, Australia; [Ittner, Lars M.] Neurosci Res Australia, Sydney, NSW, Australia; [Vissel, Bryce] Univ Technol Sydney, Fac Sci, Sydney, NSW 2007, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney; University of Sydney; Heart Research Institute; University of New South Wales Sydney; Neuroscience Research Australia; University of Technology Sydney	Vissel, B (corresponding author), Garvan Inst Med Res, Neurodegenerat Disorders, Sydney, NSW, Australia.; Vissel, B (corresponding author), Univ New S Wales, Fac Med, Sydney, NSW, Australia.; Vissel, B (corresponding author), Univ Technol Sydney, Fac Sci, Sydney, NSW 2007, Australia.	brycevissel@gmail.com		Wright, Amanda/0000-0001-7141-6212; Vissel, Bryce/0000-0001-8860-8050; Morris, Gary/0000-0002-8729-3920; Ittner, Lars/0000-0001-6738-3825	National Health and Medical Research Council (NHMRC) of Australia [1083569]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council (NHMRC) of Australia via research project grant #1083569, Stanley and John Roth, The Boyarsy family, David King, Doug Battersby, Iain S. Gray in memory of Kylie, Joshua Burger in honor of Marko Burger, Tony and Vivian Howland-Rose, Edith Sheldon in memory of Walter Sheldon, Bill Gruy and SpinalCure Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No research costs or authors' salaries were funded by a tobacco company.	Abraham H, 2002, EXP BRAIN RES, V142, P131, DOI 10.1007/s00221-001-0909-4; Alkayed NJ, 1998, STROKE, V29, P159, DOI 10.1161/01.STR.29.1.159; Amki ME, J NEUROSCIENCE METHO; Ansari S, 2011, JOVE-J VIS EXP, DOI 10.3791/2879; Barber PA, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-76; Baron JC, 2001, CEREBROVASC DIS, V11, P2, DOI 10.1159/000049119; BEDNAR MM, 1994, NEUROL RES, V16, P129; Belayev L, 1996, STROKE, V27, P1616, DOI 10.1161/01.STR.27.9.1616; Belayev L, 1999, BRAIN RES, V833, P181, DOI 10.1016/S0006-8993(99)01528-0; Benedek A, 2006, BRAIN RES, V1116, P159, DOI 10.1016/j.brainres.2006.07.123; Beretta S, 2013, JOVE-J VIS EXP, DOI 10.3791/50214; Carmichael S Thomas, 2005, NeuroRx, V2, P396; Chen Y, 2008, J NEUROSCI METH, V174, P18, DOI 10.1016/j.jneumeth.2008.06.021; Chiang T, 2011, JOVE-J VIS EXP, DOI 10.3791/2761; COLE DJ, 1990, ACTA NEUROPATHOL, V80, P152, DOI 10.1007/BF00308918; Connolly ES, 1996, NEUROSURGERY, V38, P523, DOI 10.1097/00006123-199603000-00021; DETTMERS C, 1994, NEUROL RES, V16, P205; DIRNAGL U, 1989, J CEREBR BLOOD F MET, V9, P589, DOI 10.1038/jcbfm.1989.84; Dirnagl U, 2010, RODENT MODELS STROKE, Vxii; Dirnagl U, 2006, J CEREBR BLOOD F MET, V26, P1465, DOI 10.1038/sj.jcbfm.9600298; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; Furuya K, 2004, J NEUROSURG, V100, P97, DOI 10.3171/jns.2004.100.1.0097; Gibson CL, 2005, EXP NEUROL, V193, P522, DOI 10.1016/j.expneurol.2005.01.009; Guan YJ, 2012, STROKE, V43, P888, DOI 10.1161/STROKEAHA.111.636456; Guzel Aslan, 2014, Exp Transl Stroke Med, V6, P6, DOI 10.1186/2040-7378-6-6; Hall AA, 2009, J NEUROSCI RES, V87, P333, DOI 10.1002/jnr.21857; Harada H, 2005, BRAIN RES PROTOC, V14, P165, DOI 10.1016/j.brainresprot.2004.12.007; Hata R, 1998, J CEREBR BLOOD F MET, V18, P367, DOI 10.1097/00004647-199804000-00004; HATFIELD RH, 1991, NEUROPATH APPL NEURO, V17, P61, DOI 10.1111/j.1365-2990.1991.tb00694.x; He Z, 1999, STROKE, V30, P2743, DOI 10.1161/01.STR.30.12.2743; Hedna Vishnumurthy Shushrutha, 2015, J Vasc Interv Neurol, V8, P74; Hof PR., 2000, COMP CYTOARCHITECTON; Howells DW, 2010, J CEREBR BLOOD F MET, V30, P1412, DOI 10.1038/jcbfm.2010.66; Huang J, 1998, J Stroke Cerebrovasc Dis, V7, P296, DOI 10.1016/S1052-3057(98)80046-3; Huang ZH, 1996, J CEREBR BLOOD F MET, V16, P981, DOI 10.1097/00004647-199609000-00023; Jiang SX, 2005, J BIOL CHEM, V280, P33811, DOI 10.1074/jbc.M503113200; Jin R, 2014, EMBOLIC MIDDLE CEREB; KAPLAN B, 1991, STROKE, V22, P1032, DOI 10.1161/01.STR.22.8.1032; Kitagawa K, 1998, J CEREBR BLOOD F MET, V18, P570, DOI 10.1097/00004647-199805000-00012; Kleinschnitz C, 2006, J EXP MED, V203, P513, DOI 10.1084/jem.20052458; Koizumi JYY, 1986, JPN J STROKE, V8, P1, DOI [DOI 10.3995/JSTROKE.8.1, DOI 10.3995/jstroke.8.1]; LAING RJ, 1993, STROKE, V24, P294, DOI 10.1161/01.STR.24.2.294; Lee S, 2014, J VET MED SCI, V76, P1555, DOI 10.1292/jvms.14-0258; Li FH, 1997, J CEREBR BLOOD F MET, V17, P1132, DOI 10.1097/00004647-199710000-00016; LISZCZAK TM, 1984, ACTA NEUROPATHOL, V65, P150, DOI 10.1007/BF00690469; Liu F, 2011, J BIOMED BIOTECHNOL, V2011, P9, DOI DOI 10.1155/2011/464701; Liu F, 2009, J NEUROSCI METH, V179, P1, DOI 10.1016/j.jneumeth.2008.12.028; Liu Shimin, 2009, J Exp Stroke Transl Med, V2, P2; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Macrae IM, 2011, BRIT J PHARMACOL, V164, P1062, DOI 10.1111/j.1476-5381.2011.01398.x; Maeda K, 1999, NEUROBIOL DIS, V6, P101, DOI 10.1006/nbdi.1998.0235; Maeda K, 1998, NEUROREPORT, V9, P1317, DOI 10.1097/00001756-199805110-00012; Manwani B, 2014, STROKE, V45, P571, DOI 10.1161/STROKEAHA.113.002944; Mao Y, 1999, MOL BRAIN RES, V63, P366, DOI 10.1016/S0169-328X(98)00271-X; MATSUO Y, 1994, BRAIN RES, V656, P344, DOI 10.1016/0006-8993(94)91478-8; Maysami S, 2008, J CEREBR BLOOD F MET, V28, P1104, DOI 10.1038/jcbfm.2008.4; McColl BW, 2004, BRAIN RES, V997, P15, DOI 10.1016/j.brainres.2003.10.028; MEMEZAWA H, 1992, STROKE, V23, P552, DOI 10.1161/01.STR.23.4.552; MICHENFELDER JD, 1976, ARCH NEUROL-CHICAGO, V33, P345, DOI 10.1001/archneur.1976.00500050031006; Molinaro P, 2008, J NEUROSCI, V28, P1179, DOI 10.1523/JNEUROSCI.4671-07.2008; Murakami K, 1998, J NEUROSCI, V18, P205; Park Sin-Young, 2014, Exp Neurobiol, V23, P104, DOI 10.5607/en.2014.23.1.104; Pham Mirko, 2010, Exp Transl Stroke Med, V2, P6, DOI 10.1186/2040-7378-2-6; Pignataro G, 2004, NEUROPHARMACOLOGY, V46, P439, DOI 10.1016/j.neuropharm.2003.09.015; Pignataro G, 2007, BRAIN, V130, P151, DOI 10.1093/brain/awl325; REITH W, 1994, ACTA NEUROCHIR, V131, P151, DOI 10.1007/BF01401466; Riva M, 2012, EXP NEUROL, V233, P815, DOI 10.1016/j.expneurol.2011.12.006; Rowe DD, 2012, J BIOL CHEM, V287, P4177, DOI 10.1074/jbc.M111.296434; Rupadevi M, 2011, J PHARMACOL PHARMACO, V2, P36, DOI 10.4103/0976-500X.77113; Schaller B, 2004, J CEREBR BLOOD F MET, V24, P351, DOI 10.1097/00004647-200404000-00001; Scherbakov N, 2011, STROKE, V42, P3646, DOI 10.1161/STROKEAHA.111.619163; Schmid-Elsaesser R, 1998, STROKE, V29, P2162, DOI 10.1161/01.STR.29.10.2162; Shen Q, 2005, J CEREBR BLOOD F MET, V25, P1336, DOI 10.1038/sj.jcbfm.9600126; Shimamura N, 2006, J NEUROSCI METH, V156, P161, DOI 10.1016/j.jneumeth.2006.02.017; Smith HK, 2015, J NEUROSCI METH, V249, P99, DOI 10.1016/j.jneumeth.2015.04.008; Sutherland GR, 1996, STROKE, V27, P1663, DOI 10.1161/01.STR.27.9.1663; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Taguchi Akihiko, 2010, J Exp Stroke Transl Med, V3, P28; Taninishi H, 2015, J NEUROSCI METH, V241, P111, DOI 10.1016/j.jneumeth.2014.12.006; Tsuchiya D, 2003, BRAIN RES, V970, P131, DOI 10.1016/S0006-8993(03)02300-X; Tureyen K, 2005, NEUROSURGERY, V56, P382, DOI 10.1227/01.NEU.0000148004.61621.D2; Tureyen K, 2004, J NEUROSCI METH, V139, P203, DOI 10.1016/j.jneumeth.2004.04.029; Wardlaw JM, 2012, LANCET, V379, P2364, DOI 10.1016/S0140-6736(12)60738-7; Woitzik J, 2002, J NEUROSCI METH, V122, P75, DOI 10.1016/S0165-0270(02)00277-7; Yang D, 2014, EUR NEUROL, V71, P4, DOI 10.1159/000356048; Yang J, 2015, STROKE, V46; Yuan FL, 2012, J NEUROTRAUM, V29, P1499, DOI 10.1089/neu.2011.2105; Zhang F, 2012, AM J NEURORADIOL, V33, P935, DOI 10.3174/ajnr.A2887; Zhang J, 2012, J APPL PHYSIOL, V113, P1709, DOI 10.1152/japplphysiol.01079.2012; Zhao WZ, 1997, J CEREBR BLOOD F MET, V17, P1281, DOI 10.1097/00004647-199712000-00003	90	67	68	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148503	10.1371/journal.pone.0148503	http://dx.doi.org/10.1371/journal.pone.0148503			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26870954	Green Published, gold			2022-12-27	WOS:000370054100032
J	Gao, Z; Han, Y; Hu, YH; Wu, XY; Wang, YB; Zhang, XQ; Fu, JJ; Zou, X; Zhang, J; Chen, XW; Jose, PA; Lu, X; Zeng, CY				Gao, Zhao; Han, Yu; Hu, Yunhui; Wu, Xiaoyan; Wang, Yongbin; Zhang, Xiaoqun; Fu, Jinjuan; Zou, Xue; Zhang, Jun; Chen, Xiongwen; Jose, Pedro A.; Lu, Xi; Zeng, Chunyu			Targeting HO-1 by Epigallocatechin-3-Gallate Reduces Contrast-Induced Renal Injury via Anti-Oxidative Stress and Anti-Inflammation Pathways	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; INDUCED NEPHROPATHY; NLRP3 INFLAMMASOME; HEME OXYGENASE-1; UP-REGULATION; RISK-FACTORS; RAT MODEL; ACTIVATION; EGCG; APOPTOSIS	Both oxidative stress and inflammation are involved in the pathogenesis of contrast-induced nephropathy (CIN). Epigallocatechin-3-gallate (EGCG), a purified catechin from green tea, has antioxidant and anti-inflammatory effects. However, it is unknown whether or not EGCG is effective in treating CIN. Our present study found that intravenous administration of EGCG, either before or just after the establishment of CIN, had a protective effect, determined by normalization of serum creatinine and blood urea nitrogen levels, improvement in renal histopathological scoring and alleviation of apoptosis, accompanied by decreased oxidative stress and inflammation. Because EGCG is a potent inducer of the antioxidant heme oxygenase-1 (HO-1), we studied HO-1 signaling in CIN. HO-1 levels were increased in CIN; treatment with EGCG further increased HO-1 levels, accompanied by an increase in Nrf2, a regulator of antioxidant proteins. Interestingly, blockade of HO-1 with protoporphyrin IX zinc (II) (ZnPP) prevented the protective effect of EGCG on CIN. ZnPP also blocked the ability of EGCG to increase the activity of an antioxidant (superoxide dismutase), and decrease markers of oxidative stress (myeloperoxidase and malondialdehyde) and inflammation (myeloperoxidase and IL-1 beta), indicating that HO-1 is the upstream molecule that regulates the EGCG-mediated protection. To determine further the role of HO-1 on the EGCG-mediated inhibition of inflammation, we studied the effect of EGCG on the NLRP3 inflammasome, an upstream signaling of IL-1 beta. EGCG down-regulated NLRP3 expression, which was blocked by ZnPP, indicating that HO-1 links EGCG with NLRP3. Therefore, EGCG, via up-regulation of HO-1, protects against CIN by amelioration of oxidative stress and inflammation.	[Gao, Zhao; Han, Yu; Hu, Yunhui; Wu, Xiaoyan; Wang, Yongbin; Zhang, Xiaoqun; Fu, Jinjuan; Zou, Xue; Zhang, Jun; Chen, Xiongwen; Lu, Xi; Zeng, Chunyu] Third Mil Med Univ, Daping Hosp, Dept Cardiol, Chongqing, Peoples R China; [Gao, Zhao; Han, Yu; Hu, Yunhui; Wu, Xiaoyan; Wang, Yongbin; Zhang, Xiaoqun; Fu, Jinjuan; Zou, Xue; Zhang, Jun; Chen, Xiongwen; Lu, Xi; Zeng, Chunyu] Chongqing Inst Cardiol, Chongqing Key Lab Hypertens Res, Chongqing, Peoples R China; [Jose, Pedro A.] George Washington Univ, Sch Med & Hlth Sci, Dept Med, Div Renal Dis & Hypertens, Washington, DC 20052 USA; [Jose, Pedro A.] George Washington Univ, Sch Med & Hlth Sci, Dept Physiol, Washington, DC 20052 USA	Army Medical University; Chinese Academy of Sciences; George Washington University; George Washington University	Lu, X; Zeng, CY (corresponding author), Third Mil Med Univ, Daping Hosp, Dept Cardiol, Chongqing, Peoples R China.	xixi0332@126.com; chunyuzeng01@163.com	Chen, Xiongwen/D-5988-2012	Chen, Xiongwen/0000-0002-3829-5815	National Natural Science Foundation of China [31430043, 31471089]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088243] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by funds from the National Natural Science Foundation of China (http://www.nsfc.gov.cn) (31430043, 31471089). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGMON Y, 1994, J CLIN INVEST, V94, P1069, DOI 10.1172/JCI117421; Alpert MA, 2014, J AM COLL CARDIOL, V63, P80, DOI 10.1016/j.jacc.2013.07.097; Bakker PJ, 2014, AM J PATHOL, V184, P2013, DOI 10.1016/j.ajpath.2014.04.005; Belcher JD, 2014, BLOOD, V123, P377, DOI 10.1182/blood-2013-04-495887; Berry M, 2012, IMMUNOTHERAPY-UK, V4, P323, DOI [10.2217/IMT.11.175, 10.2217/imt.11.175]; Bird JE, 1996, J AM SOC NEPHROL, V7, P1153; Caiazza A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/578974; Chok Mohammed Koussai, 2009, Inflammation & Allergy Drug Targets, V8, P252; Dolinay T, 2012, AM J RESP CRIT CARE, V185, P1225, DOI 10.1164/rccm.201201-0003OC; Doria A, 2012, AUTOIMMUN REV, V12, P22, DOI 10.1016/j.autrev.2012.07.018; Dostert C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006510; Dutra FF, 2014, P NATL ACAD SCI USA, V111, pE4110, DOI 10.1073/pnas.1405023111; Guan WW, 2015, EUR J PHARMACOL, V761, P144, DOI 10.1016/j.ejphar.2015.05.009; Hosseinian N, 2015, THER ADV RESPIR DIS, V9, P188, DOI 10.1177/1753465815586335; Inoue H, 2013, BIOSCI BIOTECH BIOCH, V77, P1223, DOI 10.1271/bbb.121003; Jorgensen AL, 2013, CRIT CARE NURSE, V33, P37, DOI 10.4037/ccn2013680; Kaizu T, 2003, KIDNEY INT, V63, P1393, DOI 10.1046/j.1523-1755.2003.00882.x; Kakuta Y, 2011, TRANSPL INT, V24, P514, DOI 10.1111/j.1432-2277.2011.01224.x; Kanwar YS, 2013, AM J PHYSIOL-RENAL, V304, pF1167, DOI 10.1152/ajprenal.00032.2013; Khurana S, 2013, NUTRIENTS, V5, P3779, DOI 10.3390/nu5103779; Kim SJ, 2013, FREE RADICAL BIO MED, V65, P997, DOI 10.1016/j.freeradbiomed.2013.08.178; Kochi T, 2014, CANCER LETT, V342, P60, DOI 10.1016/j.canlet.2013.08.031; Kodama A, 2013, KIDNEY INT, V83, P446, DOI 10.1038/ki.2012.429; Kwon MS, 2015, INT J MOL SCI, V16, P5028, DOI 10.3390/ijms16035028; Leemans JC, 2014, NAT REV NEPHROL, V10, P398, DOI 10.1038/nrneph.2014.91; Li QW, 2014, CELL BIOCHEM BIOPHYS, V69, P495, DOI 10.1007/s12013-014-9823-9; Liu TQ, 2015, FREE RADICAL BIO MED, V81, P170, DOI 10.1016/j.freeradbiomed.2014.10.509; Luo YP, 2014, INT IMMUNOPHARMACOL, V20, P24, DOI 10.1016/j.intimp.2014.02.017; Maioli M, 2012, CIRCULATION, V125, P3099, DOI 10.1161/CIRCULATIONAHA.111.085290; McCullough PA, 2011, CIRCULATION, V124, P1210, DOI 10.1161/CIRCULATIONAHA.111.054502; Navaneethan SD, 2009, AM J KIDNEY DIS, V53, P617, DOI 10.1053/j.ajkd.2008.08.033; Niu YC, 2013, AGING CELL, V12, P1041, DOI 10.1111/acel.12133; Pan H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124775; Peng A, 2011, KIDNEY INT, V80, P601, DOI 10.1038/ki.2011.121; Piazza M, 2011, INNATE IMMUN-LONDON, V17, P293, DOI 10.1177/1753425910369020; Quintavalle C, 2012, CIRCULATION, V126, P3008, DOI 10.1161/CIRCULATIONAHA.112.103317; Reinecke H, 2007, CLIN RES CARDIOL, V96, P130, DOI 10.1007/s00392-007-0473-4; Ribaldo PDB, 2009, J NUTR, V139, P96, DOI 10.3945/jn.108.095018; Sahin K, 2010, LIFE SCI, V87, P240, DOI 10.1016/j.lfs.2010.06.014; Scapagnini G, 2011, MOL NEUROBIOL, V44, P192, DOI 10.1007/s12035-011-8181-5; Seeliger E, 2012, EUR HEART J, V33, P2007, DOI 10.1093/eurheartj/ehr494; Stone GW, 2003, JAMA-J AM MED ASSOC, V290, P2284, DOI 10.1001/jama.290.17.2284; Takahashi T, 2009, J CLIN BIOCHEM NUTR, V44, P28, DOI 10.3164/jcbn.08-210-HO; Tang XJ, 2014, CURR OPIN NEPHROL HY, V23, P385, DOI 10.1097/01.mnh.0000447017.28852.52; Toldo S, 2015, ANTIOXID REDOX SIGN, V22, P1146, DOI 10.1089/ars.2014.5989; Toprak O, 2008, NEPHROL DIAL TRANSPL, V23, P853, DOI 10.1093/ndt/gfm691; Tsai PY, 2011, FREE RADICAL BIO MED, V51, P744, DOI 10.1016/j.freeradbiomed.2011.05.016; Turner CM, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-21; Twal M, 2013, PHARMACOL RES, V67, P68, DOI 10.1016/j.phrs.2012.10.011; van Kempen TS, 2015, NAT REV RHEUMATOL, V11, P483, DOI 10.1038/nrrheum.2015.60; Wagner M, 2003, KIDNEY INT, V63, P1564, DOI 10.1046/j.1523-1755.2003.00897.x; Wang YC, 2014, ANN NEUROL, V75, P876, DOI 10.1002/ana.24159; Wang YQ, 2015, BASIC CLIN PHARMACOL, V117, P164, DOI 10.1111/bcpt.12383; Wu CC, 2006, LIFE SCI, V78, P2889, DOI 10.1016/j.lfs.2005.11.013; Wu JJ, 2014, EUR J PHARMACOL, V745, P59, DOI 10.1016/j.ejphar.2014.09.046; Xu JG, 2014, FREE RADICAL BIO MED, V71, P186, DOI 10.1016/j.freeradbiomed.2014.03.009; Yang YD, 2015, INT J CLIN EXP PATHO, V8, P2484; Ye T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119543; Yokozawa T, 1999, J PHARM PHARMACOL, V51, P1325, DOI 10.1211/0022357991776912; Yoon SN, 2014, ACTA HISTOCHEM, V116, P1210, DOI 10.1016/j.acthis.2014.07.003; Zeng CY, 2006, CIRC RES, V99, P494, DOI 10.1161/01.RES.0000240500.96746.ec; Zhao BH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116583; Zhou P, 2013, MOL MED REP, V7, P1096, DOI 10.3892/mmr.2013.1296	63	76	81	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149032	10.1371/journal.pone.0149032	http://dx.doi.org/10.1371/journal.pone.0149032			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866373	Green Submitted, Green Published, gold			2022-12-27	WOS:000370050700056
J	Lee, J; Oh, KJ; Lee, D; Kim, BY; Choi, JS; Ku, B; Kim, SJ				Lee, Juhyeon; Oh, Kyoung-Jin; Lee, Dasom; Kim, Bo Yeon; Choi, Joon Sig; Ku, Bonsu; Kim, Seung Jun			Structural Study of the HD-PTP Bro1 Domain in a Complex with the Core Region of STAM2, a Subunit of ESCRT-0	PLOS ONE			English	Article							PROTEIN; ALIX; RECEPTOR; BINDING; MEMBRANE; EGFR; TRAFFICKING; MACHINERY; INTERACT; SHARE	EGFR is a key player in cell proliferation and survival signaling, and its sorting into MVBs for eventual lysosomal degradation is controlled by the coordination of multiple ESCRT complexes on the endosomal membrane. HD-PTP is a cytosolic protein tyrosine phosphatase, and is associated with EGFR trafficking by interacting with the ESCRT-0 protein STAM2 and the ESCRT-III protein CHMP4B via its N-terminal Bro1 domain. Intriguingly, the homologous domain of two other human Bro1 domain-containing proteins, Alix and Brox, binds CHMP4B but not STAM2, despite their high structural similarity. To elucidate this binding specificity, we determined the complex structure of the HD-PTP Bro1 domain bound to the STAM2 core region. STAM2 binds to the hydrophobic concave pocket of the HD-PTP Bro1 domain, as CHMP4B does to the pocket of Alix, Brox, or HD-PTP but in the opposite direction. Critically, Thr145 of HD-PTP, corresponding to Lys151 of Alix and Arg145 of Brox, is revealed to be a determinant residue enabling this protein to bind STAM2, as the Alix-or Brox-mimicking mutations of this residue blocks the intermolecular interaction. This work therefore provides the structural basis for how HD-PTP recognizes the ESCRT-0 component to control EGFR sorting.	[Lee, Juhyeon; Ku, Bonsu; Kim, Seung Jun] Korea Res Inst Biosci & Biotechnol, Dis Target Struct Res Ctr, Daejeon, South Korea; [Lee, Juhyeon; Choi, Joon Sig] Chungnam Natl Univ, Dept Biochem, Daejeon, South Korea; [Oh, Kyoung-Jin; Lee, Dasom] Korea Res Inst Biosci & Biotechnol, Res Ctr Metab Regulat, Daejeon, South Korea; [Kim, Bo Yeon] Korea Res Inst Biosci & Biotechnol, World Class Inst, Incurable Dis Therapeut Res Ctr, Ochang, Cheongwon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungnam National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Ku, B; Kim, SJ (corresponding author), Korea Res Inst Biosci & Biotechnol, Dis Target Struct Res Ctr, Daejeon, South Korea.	bku@kribb.re.kr; ksj@kribb.re.kr	Kim, Seung Jun/N-5248-2019; Oh, Kyoung-Jin/AAV-1483-2021	Kim, Seung Jun/0000-0002-6913-6358; Oh, Kyoung-Jin/0000-0002-2224-7202; Choi, Joon Sig/0000-0002-8463-841X; Ku, Bonsu/0000-0003-1784-8975	National Research Foundation of Korea [2011-0030027, 2015M3A9B5030308]; World Class Institute program - Ministry of Science, ICT and Future Planning [WCI 2009-002]; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program for Creative Research	National Research Foundation of Korea(National Research Foundation of Korea); World Class Institute program - Ministry of Science, ICT and Future Planning; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program for Creative Research	This work was supported by grants from the National Research Foundation of Korea (2011-0030027 and 2015M3A9B5030308; to SJK) and the World Class Institute program (WCI 2009-002; to BYK) funded by the Ministry of Science, ICT and Future Planning. This work was also supported by the Korea Research Institute of Bioscience and Biotechnology Research Initiative Program for Creative Research (to BK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adell MAY, 2014, J CELL BIOL, V205, P33, DOI 10.1083/jcb.201310114; Ali N, 2013, CURR BIOL, V23, P453, DOI 10.1016/j.cub.2013.02.033; Bazley LA, 2005, ENDOCR-RELAT CANCER, V12, pS17, DOI 10.1677/erc.1.01032; Cao LG, 1998, J BIOL CHEM, V273, P21077, DOI 10.1074/jbc.273.33.21077; Castiglioni S, 2007, BIOCHEM BIOPH RES CO, V364, P534, DOI 10.1016/j.bbrc.2007.10.022; Chen DY, 2012, J CELL SCI, V125, P4841, DOI 10.1242/jcs.108597; Dores MR, 2012, J CELL BIOL, V197, P407, DOI 10.1083/jcb.201110031; Dowlatshahi DP, 2012, DEV CELL, V23, P1247, DOI 10.1016/j.devcel.2012.10.023; Doyotte A, 2008, P NATL ACAD SCI USA, V105, P6308, DOI 10.1073/pnas.0707601105; Dussupt V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000339; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fisher RD, 2007, CELL, V128, P841, DOI 10.1016/j.cell.2007.01.035; Goh LK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017459; Herbst RS, 2004, INT J RADIAT ONCOL, V59, P21, DOI 10.1016/j.ijrobp.2003.11.041; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Ichioka F, 2007, ARCH BIOCHEM BIOPHYS, V457, P142, DOI 10.1016/j.abb.2006.11.008; Keren-Kaplan T, 2013, EMBO J, V32, P538, DOI 10.1038/emboj.2013.4; Kimura Y, 2015, EUKARYOT CELL, V14, P976, DOI 10.1128/EC.00091-15; Kolch W, 2010, NAT REV CANCER, V10, P618, DOI 10.1038/nrc2900; Kostaras E, 2013, ONCOGENE, V32, P5220, DOI 10.1038/onc.2012.554; Lee S, 2007, NAT STRUCT MOL BIOL, V14, P194, DOI 10.1038/nsmb1203; Mariotti M, 2009, INT J BIOCHEM CELL B, V41, P687, DOI 10.1016/j.biocel.2008.08.005; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCullough J, 2008, P NATL ACAD SCI USA, V105, P7687, DOI 10.1073/pnas.0801567105; Mu RL, 2012, STRUCTURE, V20, P887, DOI 10.1016/j.str.2012.03.001; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pashkova N, 2013, DEV CELL, V25, P520, DOI 10.1016/j.devcel.2013.04.007; Popov S, 2009, J VIROL, V83, P7185, DOI 10.1128/JVI.00198-09; Pradhan-Sundd T, 2014, DEV BIOL, V392, P93, DOI 10.1016/j.ydbio.2014.04.019; Schmidt O, 2012, CURR BIOL, V22, pR116, DOI 10.1016/j.cub.2012.01.028; Schuh AL, 2014, CRIT REV BIOCHEM MOL, V49, P242, DOI 10.3109/10409238.2014.881777; Sette P, 2011, STRUCTURE, V19, P1485, DOI 10.1016/j.str.2011.07.016; Sirisaengtaksin N, 2014, J BIOL CHEM, V289, P3026, DOI 10.1074/jbc.M113.495671; Stefani F, 2011, CURR BIOL, V21, P1245, DOI 10.1016/j.cub.2011.06.028; Sun S, 2015, BIOCHEM J, V466, P475, DOI 10.1042/BJ20141156; Tanaka K, 2013, J BIOL CHEM, V288, P23990, DOI 10.1074/jbc.M113.478891; Tomas A, 2014, TRENDS CELL BIOL, V24, P26, DOI 10.1016/j.tcb.2013.11.002; Zhai QT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027466	39	10	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149113	10.1371/journal.pone.0149113	http://dx.doi.org/10.1371/journal.pone.0149113			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866605	Green Published, gold, Green Submitted			2022-12-27	WOS:000370050700067
J	Nigatu, YT; Reijneveld, SA; de Jonge, P; van Rossum, E; Bultmann, U				Nigatu, Yeshambel T.; Reijneveld, Sijmen A.; de Jonge, Peter; van Rossum, Elisabeth; Bultmann, Ute			The Combined Effects of Obesity, Abdominal Obesity and Major Depression/Anxiety on Health-Related Quality of Life: the LifeLines Cohort Study	PLOS ONE			English	Article							MEDICAL DISORDERS; ECONOMIC BURDEN; BODY-WEIGHT; ASSOCIATION; POPULATION; DETERMINANTS; VALIDATION; OVERWEIGHT; COUNTRIES; TRENDS	Background Obesity and major depressive disorder (MDD)/anxiety disorders often co-occur and aggravate each other resulting in adverse health-related outcomes. As little is known about the potential effects of interaction between obesity and MDD and/or anxiety disorders on health-related quality of life (HR-QoL), this study was aimed at examining these combined effects. Methods We collected data among N = 89,332 participants from the LifeLines cohort study. We categorized body weight using body mass index (kg/m(2)) as normal weight (18.5-24.99), overweight (25-29.9), mild obesity (30-34.9) and moderate/severe obesity (>= 35); we measured abdominal obesity using a waist circumference of >= 102 and >= 88 cm for males and females, respectively. MDD and anxiety disorders were diagnosed with the Mini-International Neuropsychiatric Interview. HR-QoL was assessed using the RAND-36 questionnaire to compute physical and mental quality of life scores. We used binary logistic and linear regression analyses. Results The combined effect of obesity and MDD and/or anxiety disorders on physical QoL was larger than the sum of their separate effects; regression coefficients, B (95%-confidence interval, 95%-CI) were: - 1.32 (-1.75; -0.90). However, the combined effect of obesity and major depression alone on mental QoL was less than the additive effect. With increasing body weight participants report poorer physical QoL; when they also have MDD and/or anxiety disorders participants report even poorer physical QoL. In persons without MDD and/or anxiety disorders, obesity was associated with a better mental QoL. Conclusions Obesity and MDD and/or anxiety disorders act synergistically on physical and mental QoL. The management of MDD and/or anxiety disorders and weight loss may be important routes to improve HR-QoL.	[Nigatu, Yeshambel T.; Reijneveld, Sijmen A.; Bultmann, Ute] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Groningen, Netherlands; [de Jonge, Peter] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands; [van Rossum, Elisabeth] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands	University of Groningen; University of Groningen; Erasmus University Rotterdam; Erasmus MC	Nigatu, YT (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Groningen, Netherlands.	y.t.nigatu@umcg.nl	van Rossum, Elisabeth/AAP-9388-2020; Nigatu, Yeshambel/N-9628-2019; de Jonge, Peter/L-6395-2013	Nigatu, Yeshambel Tesfa/0000-0002-5192-4188; de Jonge, Peter/0000-0002-0866-6929; Bultmann, Ute/0000-0001-9589-9220; Reijneveld, Sijmen/0000-0002-1206-7523				Afari N, 2010, DEPRESS ANXIETY, V27, P799, DOI 10.1002/da.20704; Alley DE, 2007, JAMA-J AM MED ASSOC, V298, P2020, DOI 10.1001/jama.298.17.2020; Atlantis E, 2012, QUAL LIFE RES, V21, P1695, DOI 10.1007/s11136-011-0101-7; Badia X, 2014, PITUITARY, V17, P187, DOI 10.1007/s11102-013-0484-2; Barajas Gutierrez M A, 1998, Rev Esp Salud Publica, V72, P221, DOI 10.1590/S1135-57271998000300007; Barnes RD, 2014, OBESITY, V22, P2508, DOI 10.1002/oby.20889; Baune BT, 2007, J PSYCHOSOM RES, V62, P109, DOI 10.1016/j.jpsychores.2006.09.014; Blumenthal SR, 2014, JAMA PSYCHIAT, V71, P889, DOI 10.1001/jamapsychiatry.2014.414; Cameron AJ, 2012, INT J OBESITY, V36, P295, DOI 10.1038/ijo.2011.103; de Wit LM, 2010, DEPRESS ANXIETY, V27, P1057, DOI 10.1002/da.20738; Egede LE, 2007, GEN HOSP PSYCHIAT, V29, P409, DOI 10.1016/j.genhosppsych.2007.06.002; Fontaine KR, 2000, INT J EAT DISORDER, V27, P101, DOI 10.1002/(SICI)1098-108X(200001)27:1&lt;101::AID-EAT12&gt;3.0.CO;2-D; Friedman KE, 2002, OBES RES, V10, P33, DOI 10.1038/oby.2002.5; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Gariepy G, 2010, OBESITY, V18, P1033, DOI 10.1038/oby.2009.333; Ghoorah K, 2016, EUR HEART J-ACUTE CA, V5, P77, DOI 10.1177/2048872614523349; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; Hays RD, 2001, ANN MED, V33, P350, DOI 10.3109/07853890109002089; Hilbert A, 2014, OBESITY, V22, P79, DOI 10.1002/oby.20561; Kabadi SM, 2012, DIABETES CARE, V35, P2048, DOI 10.2337/dc12-0235; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Knol MJ, 2007, INT J EPIDEMIOL, V36, P1111, DOI 10.1093/ije/dym157; Knol MJ, 2012, INT J EPIDEMIOL, V41, P514, DOI 10.1093/ije/dyr218; Krueger RF, 2015, WORLD PSYCHIATRY, V14, P27, DOI 10.1002/wps.20175; Laaksonen M, 2005, OBES RES, V13, P2169, DOI 10.1038/oby.2005.269; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Muller-Riemenschneider F, 2008, EUR J EPIDEMIOL, V23, P499, DOI 10.1007/s10654-008-9239-1; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Nigatu Y, 2013, EUROPEAN J PUBLIC S1, V23; Nigatu YT, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1682-9; Pan A, 2012, INT J OBESITY, V36, P595, DOI 10.1038/ijo.2011.111; Pan A, 2014, AM J EPIDEMIOL, V180, P254, DOI 10.1093/aje/kwu136; Penninx BWJH, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-129; Pi-Sunyer FX, 2002, OBES SURG, V12, p6S, DOI 10.3810/pgm.2009.11.2074; Rait G, 2009, BRIT J PSYCHIAT, V195, P520, DOI 10.1192/bjp.bp.108.058636; Renzaho A, 2010, QUAL LIFE RES, V19, P515, DOI 10.1007/s11136-010-9610-z; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Slagter SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096406; Sobocki P, 2007, EUR PSYCHIAT, V22, P146, DOI 10.1016/j.eurpsy.2006.10.006; Sobocki P, 2007, VALUE HEALTH, V10, P153, DOI 10.1111/j.1524-4733.2006.00162.x; Soto M, 2005, QUAL LIFE RES, V14, P759; Stolk RP, 2008, EUR J EPIDEMIOL, V23, P67, DOI 10.1007/s10654-007-9204-4; Thormann J, 2013, FORTSCHR NEUROL PSYC, V81, P145, DOI 10.1055/s-0032-1330351; van Zutven K, 2015, INT J OBESITY, V39, P346, DOI 10.1038/ijo.2014.100; Vetter ML, 2011, INT J OBESITY, V35, P1087, DOI 10.1038/ijo.2010.230; Vogelzangs N, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.27; Ware J, 1994, SF 36 PHYS MENTAL SU; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P1167, DOI 10.1016/S0895-4356(98)00108-5; Whisman MA, 2005, J FAM PSYCHOL, V19, P111, DOI 10.1037/0893-3200.19.1.111; WHO, 2008, WAIST CIRCUMFERENCE	51	45	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148871	10.1371/journal.pone.0148871	http://dx.doi.org/10.1371/journal.pone.0148871			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6RE	26866920	Green Submitted, gold, Green Published			2022-12-27	WOS:000370050700043
J	van Geemen, D; Soares, ALF; Oomen, PJA; Driessen-Mol, A; den Broek, MWJTJV; van den Bogaerdt, AJ; Bogers, AJJC; Goumans, MJTH; Baaijens, FPT; Bouten, CVC				van Geemen, Daphne; Soares, Ana L. F.; Oomen, Pim J. A.; Driessen-Mol, Anita; Janssen-van den Broek, Marloes W. J. T.; van den Bogaerdt, Antoon J.; Bogers, Ad J. J. C.; Goumans, Marie-Jose T. H.; Baaijens, Frank P. T.; Bouten, Carlijn V. C.			Age-Dependent Changes in Geometry, Tissue Composition and Mechanical Properties of Fetal to Adult Cryopreserved Human Heart Valves	PLOS ONE			English	Article							CELL PHENOTYPE; AORTIC VALVES; COLLAGEN; CALCIFICATION; RELEVANCE; PRESSURE; LEAFLETS; BEHAVIOR; ELASTIN; MATRIX	There is limited information about age-specific structural and functional properties of human heart valves, while this information is key to the development and evaluation of living valve replacements for pediatric and adolescent patients. Here, we present an extended data set of structure-function properties of cryopreserved human pulmonary and aortic heart valves, providing age-specific information for living valve replacements. Tissue composition, morphology, mechanical properties, and maturation of leaflets from 16 pairs of structurally unaffected aortic and pulmonary valves of human donors (fetal-53 years) were analyzed. Interestingly, no major differences were observed between the aortic and pulmonary valves. Valve annulus and leaflet dimensions increase throughout life. The typical three-layered leaflet structure is present before birth, but becomes more distinct with age. After birth, cell numbers decrease rapidly, while remaining cells obtain a quiescent phenotype and reside in the ventricularis and spongiosa. With age and maturation-but more pronounced in aortic valves-the matrix shows an increasing amount of collagen and collagen cross-links and a reduction in glycosaminoglycans. These matrix changes correlate with increasing leaflet stiffness with age. Our data provide a new and comprehensive overview of the changes of structure-function properties of fetal to adult human semilunar heart valves that can be used to evaluate and optimize future therapies, such as tissue engineering of heart valves. Changing hemodynamic conditions with age can explain initial changes in matrix composition and consequent mechanical properties, but cannot explain the ongoing changes in valve dimensions and matrix composition at older age.	[van Geemen, Daphne; Soares, Ana L. F.; Oomen, Pim J. A.; Driessen-Mol, Anita; Janssen-van den Broek, Marloes W. J. T.; Baaijens, Frank P. T.; Bouten, Carlijn V. C.] Eindhoven Univ Technol, Dept Biomed Engn, Soft Tissue Biomech & Engn, POB 513, NL-5600 MB Eindhoven, Netherlands; [Oomen, Pim J. A.; Driessen-Mol, Anita; Baaijens, Frank P. T.; Bouten, Carlijn V. C.] Eindhoven Univ Technol, Inst Complex Mol Syst, POB 513, NL-5600 MB Eindhoven, Netherlands; [van den Bogaerdt, Antoon J.; Bogers, Ad J. J. C.] Erasmus Univ, Med Ctr, Heart Valve Bank Rotterdam, Dept Cardiothorac Surg, Rotterdam, Netherlands; [Bogers, Ad J. J. C.] Erasmus Univ, Med Ctr, Dept Cardiothorac Surg, Rotterdam, Netherlands; [Goumans, Marie-Jose T. H.] Leiden Univ, Dept Mol Cell Biol, Med Ctr, Leiden, Netherlands	Eindhoven University of Technology; Eindhoven University of Technology; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Bouten, CVC (corresponding author), Eindhoven Univ Technol, Dept Biomed Engn, Soft Tissue Biomech & Engn, POB 513, NL-5600 MB Eindhoven, Netherlands.; Bouten, CVC (corresponding author), Eindhoven Univ Technol, Inst Complex Mol Syst, POB 513, NL-5600 MB Eindhoven, Netherlands.	C.V.C.Bouten@tue.nl	Goumans, Marie-José/AAG-4994-2021; Goumans, Marie Jose/U-1455-2019; Bouten, Carlijn/AAT-5187-2020	Goumans, Marie Jose/0000-0001-9344-6746; Bouten, Carlijn/0000-0003-1035-5094; Baaijens, Frank/0000-0002-0975-5376; Bogers, Ad/0000-0001-6200-1998; Oomen, Pim/0000-0002-0069-4538	Dutch Technology Foundation (STW); applied science division of The Netherlands Organisation for Scientific Research (NWO); Technology Program of the Dutch Ministry of Economic Affairs [06233]	Dutch Technology Foundation (STW)(Technologiestichting STW); applied science division of The Netherlands Organisation for Scientific Research (NWO); Technology Program of the Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	This research is supported by the Dutch Technology Foundation (STW, http://www.stw.nl/en), applied science division of The Netherlands Organisation for Scientific Research (NWO, http://www.nwo.nl/en/), and the Technology Program of the Dutch Ministry of Economic Affairs under grant agreement under grant number 06233. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa E, 2006, CIRCULATION, V113, P1344, DOI 10.1161/CIRCULATIONAHA.105.591768; Balguid A, 2007, TISSUE ENG, V13, P1501, DOI 10.1089/ten.2006.0279; BASHEY RI, 1967, J GERONTOL, V22, P203, DOI 10.1093/geronj/22.2.203; CHRISTIE GW, 1995, ANN THORAC SURG, V60, pS156, DOI 10.1016/0003-4975(95)00219-B; Cox MAJ, 2008, J BIOMECH, V41, P422, DOI 10.1016/j.jbiomech.2007.08.006; Dainese L, 2006, ARTIF ORGANS, V30, P259, DOI 10.1111/j.1525-1594.2006.00213.x; Delgadillo Jorge O. Virues, 2010, Journal of Biomedical Science & Engineering, V3, P645, DOI 10.4236/jbise.2010.37088; Driessen NJB, 2005, J BIOMECH ENG-T ASME, V127, P329, DOI 10.1115/1.1865187; Gao YS, 2010, PHYSIOL REV, V90, P1291, DOI 10.1152/physrev.00032.2009; Gerson CJ, 2009, CRYOBIOLOGY, V59, P171, DOI 10.1016/j.cryobiol.2009.06.012; Gross L, 1931, AM J PATHOL, V7, P0445; Hasan A, 2014, J BIOMECH, V47, P1949, DOI 10.1016/j.jbiomech.2013.09.023; Hinton RB, 2011, ANNU REV PHYSIOL, V73, P29, DOI 10.1146/annurev-physiol-012110-142145; Hjortnaes J, 2015, ATHEROSCLEROSIS, V242, P251, DOI 10.1016/j.atherosclerosis.2015.07.008; Kasyanov V, 2013, CONNECT TISSUE RES, V8207, P1; Kortsmit J, 2009, TISSUE ENG PART C-ME, V15, P707, DOI [10.1089/ten.tec.2008.0658, 10.1089/ten.TEC.2008.0658]; Kortsmit J, 2009, TISSUE ENG PT A, V15, P797, DOI 10.1089/ten.tea.2008.0197; Kriemler S, 2008, EUR RESPIR J, V32, P664, DOI 10.1183/09031936.00166407; Leeson-Dietrich J, 1995, J Heart Valve Dis, V4, P88; Lindeman JHN, 2010, P NATL ACAD SCI USA, V107, P862, DOI 10.1073/pnas.0910312107; MARON BJ, 1974, AM J PATHOL, V74, P331; McDonald PC, 2002, CARDIOVASC PATHOL, V11, P193, DOI 10.1016/S1054-8807(01)00102-8; Merryman WD, 2010, J BIOMECH, V43, P87, DOI 10.1016/j.jbiomech.2009.09.013; Merryman WD, 2006, AM J PHYSIOL-HEART C, V290, pH224, DOI 10.1152/ajpheart.00521.2005; Mol A, 2006, CIRCULATION, V114, pI152, DOI 10.1161/CIRCULATIONAHA.105.001123; MORETTI A, 1963, BIOCHEM J, V87, P396, DOI 10.1042/bj0870396; Oomen PJA, 2016, ACTA BIOMATER, V29, P161, DOI 10.1016/j.actbio.2015.10.044; Rabkin E, 2002, J HEART VALVE DIS, V11, P308; Rabkin-Aikawa E, 2004, J HEART VALVE DIS, V13, P841; ROSS D, 1992, EUR J CARDIO-THORAC, V6, P113, DOI 10.1016/1010-7940(92)90115-E; Sacks MS, 2009, J BIOMECH, V42, P1804, DOI 10.1016/j.jbiomech.2009.05.015; Sacks MS, 2002, J BIOMED MATER RES, V62, P359, DOI 10.1002/jbm.10293; SAUREN AAHJ, 1983, J BIOMECH, V16, P327, DOI 10.1016/0021-9290(83)90016-7; Schoen FJ, 2012, ANNU REV PATHOL-MECH, V7, P161, DOI 10.1146/annurev-pathol-011110-130257; Schoen FJ, 2011, CURR OPIN BIOTECH, V22, P698, DOI 10.1016/j.copbio.2011.01.004; Simmons CA, 2005, CIRC RES, V96, P792, DOI 10.1161/01.RES.0000161998.92009.64; Soares ALF, 2014, J MECH BEHAV BIOMED, V29, P557, DOI 10.1016/j.jmbbm.2013.07.009; Stephens EH, 2008, ACTA BIOMATER, V4, P1148, DOI 10.1016/j.actbio.2008.03.014; Stephens EH, 2007, J HEART VALVE DIS, V16, P672; Stephens EH, 2010, TISSUE ENG PT A, V16, P867, DOI [10.1089/ten.tea.2009.0288, 10.1089/ten.TEA.2009.0288]; Stradins P, 2004, EUR J CARDIO-THORAC, V26, P634, DOI 10.1016/j.ejcts.2004.05.043; Sucosky P, 2009, ARTERIOSCL THROM VAS, V29, P254, DOI 10.1161/ATVBAHA.108.176347; Vesely I, 2000, J HEART VALVE DIS, V9, P27; Votteler M, 2013, DEVELOPMENT, V140, P2345, DOI 10.1242/dev.093500	44	33	34	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149020	10.1371/journal.pone.0149020	http://dx.doi.org/10.1371/journal.pone.0149020			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867221	Green Published, Green Submitted, gold			2022-12-27	WOS:000370050700055
J	Xue, C; Peng, RJ; Cao, Y; Wang, SS; Shi, YX; An, X; Xu, F; Yuan, ZY				Xue, Cong; Peng, Roujun; Cao, Ye; Wang, Shusen; Shi, Yanxia; An, Xin; Xu, Fei; Yuan, Zhongyu			Ovarian Function, Not Age, Predicts the Benefit from Ovarian Suppression or Ablation for Premenopausal Women with Breast Cancer	PLOS ONE			English	Article							ADJUVANT CHEMOTHERAPY; PROGNOSTIC IMPACT; YOUNG-WOMEN; AMENORRHEA; THERAPY; METAANALYSIS; SURVIVAL; MARKERS; RISK	The role of adjuvant ovarian suppression or ablation (OS/OA) in premenopausal women with hormone receptor-positive breast cancer remains controversial. The purpose of our study was to examine which patients might benefit from the addition of OS/OA to tamoxifen. We analyzed the data of 2065 premenopausal patients with hormone receptor-positive invasive ductal carcinomas who were treated at Sun Yat-Sen University Cancer Center from 2000 to 2008. The five-year disease-free survival rate (DFSR) and overall survival rate (OSR) were compared by menstrual status and treatment. Compared with patients older than forty years of age, patients younger than forty years old had significant lower DFSRs and OSRs. The addition of OS/OA to tamoxifen increased the DFSR and OSR of patients with normal menstrual cycles after chemotherapy, regardless of their age at diagnosis. Patients with normal menstrual cycles after chemotherapy are the main beneficiaries of an adjuvant OS/OA.	[Xue, Cong; Peng, Roujun; Wang, Shusen; Shi, Yanxia; An, Xin; Xu, Fei; Yuan, Zhongyu] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Dept Med Oncol,Canc Ctr, 651 Dongfeng East Rd, Guangzhou 510275, Guangdong, Peoples R China; [Cao, Ye] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Dept GCP,Canc Ctr, 651 Dongfeng East Rd, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Yuan, ZY (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Dept Med Oncol,Canc Ctr, 651 Dongfeng East Rd, Guangzhou 510275, Guangdong, Peoples R China.	yuanzhy@sysucc.org.cn			National Natural Science Foundation of China [81372820]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	ZY Yuan was supported by National Natural Science Foundation of China (Grant No. 81372820). http://www.nsfc.gov.cn/publish/portal0/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Aebi S, 2000, LANCET, V355, P1869, DOI 10.1016/S0140-6736(00)02292-3; Ahn SH, 2007, J CLIN ONCOL, V25, P2360, DOI 10.1200/JCO.2006.10.3754; Anders C, 2008, CANCER INVEST, V26, P286, DOI 10.1080/07357900701829777; Anderson RA, 2013, EUR J CANCER, V49, P3404, DOI 10.1016/j.ejca.2013.07.014; [Anonymous], 1996, Lancet, V348, P1189; Bines J, 1996, J CLIN ONCOL, V14, P1718, DOI 10.1200/JCO.1996.14.5.1718; Bliss JM, 2007, JNCI-J NATL CANCER I, V99, P516, DOI 10.1093/jnci/djk109; BONADONNA G, 1995, NEW ENGL J MED, V332, P901, DOI 10.1056/NEJM199504063321401; Burstein HJ, 2000, NEW ENGL J MED, V343, P1086, DOI 10.1056/NEJM200010123431506; Cuzick J, 2007, LANCET, V369, P1711; Davidson NE, 2005, J CLIN ONCOL, V23, P5973, DOI 10.1200/JCO.2005.05.551; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; GOLDHIRSCH A, 1990, ANN ONCOL, V1, P183, DOI 10.1093/oxfordjournals.annonc.a057718; Goodwin PJ, 1999, J CLIN ONCOL, V17, P2365, DOI 10.1200/JCO.1999.17.8.2365; Henry NL, 2013, ANN ONCOL, V24, P2011, DOI 10.1093/annonc/mdt149; Pagani O, 1998, EUR J CANCER, V34, P632, DOI 10.1016/S0959-8049(97)10036-3; Park IH, 2012, ANN ONCOL, V23, P2283, DOI 10.1093/annonc/mds006; Parulekar WR, 2005, J CLIN ONCOL, V23, P6002, DOI 10.1200/JCO.2005.07.096; Puhalla S, 2009, BREAST, V18, pS122, DOI 10.1016/S0960-9776(09)70286-3; Yu B, 2010, CANCER-AM CANCER SOC, V116, P2099, DOI 10.1002/cncr.25037	21	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148849	10.1371/journal.pone.0148849	http://dx.doi.org/10.1371/journal.pone.0148849			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866810	Green Published, Green Submitted, gold			2022-12-27	WOS:000370050700042
J	Alvarado-Facundo, E; Vassell, R; Schmeisser, F; Weir, JP; Weiss, CD; Wang, W				Alvarado-Facundo, Esmeralda; Vassell, Russell; Schmeisser, Falko; Weir, Jerry P.; Weiss, Carol D.; Wang, Wei			Glycosylation of Residue 141 of Subtype H7 Influenza A Hemagglutinin (HA) Affects HA-Pseudovirus Infectivity and Sensitivity to Site A Neutralizing Antibodies	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; RECEPTOR-BINDING; LENTIVIRAL VECTOR; IMMUNE-RESPONSE; GENE DELIVERY; CELL-CULTURE; IN-VIVO; VIRUS; VACCINE; PSEUDOTYPES	Human infections with H7 subtype influenza virus have been reported, including an H7N7 outbreak in Netherlands in 2003 and H7N9 infections in China in 2013. Previously, we reported murine monoclonal antibodies (mAbs) that recognize the antigenic site A of H7 hemagglutinin (HA). To better understand protective immunity of H7 vaccines and vaccine candidate selection, we used these mAbs to assess the antigenic relatedness among two H7 HA isolated from past human infections and determine residues that affect susceptibility to neutralization. We found that these mAbs neutralize pseudoviruses bearing HA of A/Shanghai/02/2013(H7N9), but not A/Netherlands/219/2003(H7N7). Glycosylation of the asparagine residue at position 141 (N141) (N133, H3 HA numbering) in the HA of A/Netherlands/219/2003 HA is responsible for this resistance, and it affects the infectivity of HA-pseudoviruses. The presence of threonine at position 143 (T135, H3 HA numbering) in the HA of A/Netherlands/219/2003, rather than an alanine found in the HA of A/Shanghai/02/2013(H7N9), accounts for these differences. These results demonstrate a key role for glycosylation of residue N141 in affecting H7 influenza HA-mediated entry and sensitivity to neutralizing antibodies, which have implications for candidate vaccine design.	[Alvarado-Facundo, Esmeralda; Vassell, Russell; Weiss, Carol D.; Wang, Wei] US FDA, Immunoregulat Lab, Div Viral Prod, Ctr Biol Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA; [Schmeisser, Falko; Weir, Jerry P.] US FDA, Lab DNA Viruses, Div Viral Prod, Ctr Biol Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Weiss, CD; Wang, W (corresponding author), US FDA, Immunoregulat Lab, Div Viral Prod, Ctr Biol Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA.	carol.weiss@fda.hhs.gov; wei.wang@fda.hhs.gov	Weiss, Carol D./F-6438-2011	Weiss, Carol D./0000-0002-9965-1289	US Food and Drug Administration; Biomedical Advanced Research and Development Authority, Department of Health and Human Services	US Food and Drug Administration; Biomedical Advanced Research and Development Authority, Department of Health and Human Services	This work was supported by the US Food and Drug Administration and the Biomedical Advanced Research and Development Authority, Department of Health and Human Services. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, SUMM STAT DEV AV A H; Bart SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008761; Belser JA, 2009, EMERG INFECT DIS, V15, P859, DOI 10.3201/eid1506.090072; CDC, AV INFL A H7N9 VIR; Couch RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049704; Cox RJ, 2009, VACCINE, V27, P1889, DOI 10.1016/j.vaccine.2009.01.116; Daniels PS, 1987, EMBO J, V6, P1459; DASSR, 2011, P NATL ACAD SCI USA, V108, pE1417, DOI DOI 10.1073/PNAS.1108754108; de Wit E, 2010, J VIROL, V84, P1597, DOI 10.1128/JVI.01783-09; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Fries LF, 2013, NEW ENGL J MED, V369, P2564, DOI 10.1056/NEJMc1313186; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; GERBER P, 1955, J EXP MED, V101, P627, DOI 10.1084/jem.101.6.627; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Hutter J, 2013, J IMMUNOL, V190, P220, DOI 10.4049/jimmunol.1201060; Jackson LA, 2015, JAMA-J AM MED ASSOC, V314, P237, DOI 10.1001/jama.2015.7916; Jadhao SJ, 2008, VACCINE, V26, P1742, DOI 10.1016/j.vaccine.2008.01.036; Jernigan DB, 2015, ANNU REV MED, V66, P361, DOI 10.1146/annurev-med-010714-112311; Job ER, 2013, J IMMUNOL, V190, P2169, DOI 10.4049/jimmunol.1202433; Kumar SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128940; Lin YP, 2012, P NATL ACAD SCI USA, V109, P21474, DOI 10.1073/pnas.1218841110; Lopez-Martinez I, 2013, EMERG INFECT DIS, V19, P1531, DOI 10.3201/eid1909.130087; Mulligan MJ, 2014, JAMA-J AM MED ASSOC, V312, P1409, DOI 10.1001/jama.2014.12854; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Pappas C, 2007, CLIN VACCINE IMMUNOL, V14, P1425, DOI 10.1128/CVI.00174-07; Schmeisser F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117108; Wang CC, 2009, P NATL ACAD SCI USA, V106, P18137, DOI 10.1073/pnas.0909696106; Wang W., 2011, MOL PAIN, V23, P7, DOI DOI 10.1371/J0URNAL.PPAT.1002081; Wang W, 2008, J VIROL METHODS, V153, P111, DOI 10.1016/j.jviromet.2008.07.015; Wang W, 2010, VIROLOGY, V407, P374, DOI 10.1016/j.virol.2010.08.027; Watanabe T, 2013, NATURE, V501, P551, DOI 10.1038/nature12392; Wei CJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000799; Whiteley A, 2007, INFLUENZA OTHER RESP, V1, P157, DOI 10.1111/j.1750-2659.2007.00022.x; World Health Organization, SUMM STAT DEV AV AV; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yang H, 2013, J VIROL, V87, P12433, DOI 10.1128/JVI.01854-13; Yang H, 2012, J VIROL, V86, P8645, DOI 10.1128/JVI.00281-12; YEWDELL JW, 1986, J VIROL, V57, P623, DOI 10.1128/JVI.57.2.623-628.1986; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	39	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149149	10.1371/journal.pone.0149149	http://dx.doi.org/10.1371/journal.pone.0149149			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862918	Green Submitted, Green Published, gold			2022-12-27	WOS:000370046600161
J	Meiring, S; Cohen, C; Quan, V; de Gouveia, L; Feldman, C; Karstaedt, A; Klugman, KP; Madhi, SA; Rabie, H; Sriruttan, C; von Gottberg, A				Meiring, Susan; Cohen, Cheryl; Quan, Vanessa; de Gouveia, Linda; Feldman, Charles; Karstaedt, Alan; Klugman, Keith P.; Madhi, Shabir A.; Rabie, Helene; Sriruttan, Charlotte; von Gottberg, Anne		GERMS-SA	HIV Infection and the Epidemiology of Invasive Pneumococcal Disease (IPD) in South African Adults and Older Children Prior to the Introduction of a Pneumococcal Conjugate Vaccine (PCV)	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; ANTIBIOTIC-RESISTANCE; BACTEREMIA; IMPACT; ERA; PREVALENCE; INDIVIDUALS; MORTALITY; COHORT; PNEUMONIA	Introduction Streptococcus pneumoniae is the commonest cause of bacteremic pneumonia among HIVinfected persons. As more countries with high HIV prevalence are implementing infant pneumococcal conjugate vaccine (PCV) programs, we aimed to describe the baseline clinical characteristics of adult invasive pneumococcal disease (IPD) in the pre-PCV era in South Africa in order to interpret potential indirect effects following vaccine use. Methods National, active, laboratory-based surveillance for IPD was conducted in South Africa from 1 January 2003 through 31 December 2008. At 25 enhanced surveillance (ES) hospital sites, clinical data, including HIV serostatus, were collected from IPD patients >= 5 years of age. We compared the clinical characteristics of individuals with IPD in those HIV-infected and -uninfected using multivariable analysis. PCV was introduced into the routine South African Expanded Program on Immunization (EPI) in 2009. Results In South Africa, from 2003-2008, 17 604 cases of IPD occurred amongst persons >= 5 years of age, with an average incidence of 7 cases per 100 000 person-years. Against a national HIV-prevalence of 18%, 89% (4190/4734) of IPD patients from ES sites were HIV-infected. IPD incidence in HIV-infected individuals is 43 times higher than in HIV-uninfected persons (52 per 100 000 vs. 1.2 per 100 000), with a peak in the HIV-infected elderly population of 237 per 100 000 persons. Most HIV-infected individuals presented with bacteremia (74%, 3 091/4 190). HIV-uninfected individuals were older; and had more chronic conditions (excluding HIV) than HIV-infected persons (39% (210/544) vs. 19% (790/4190), p< 0.001). During the pre-PCV immunization era in South Africa, 71% of serotypes amongst HIVinfected persons were covered by PCV13 vs. 73% amongst HIV-uninfected persons, p = 0.4, OR 0.9 (CI 0.7-1.1). Conclusion Seventy to eighty-five percent of adult IPD in the pre-PCV era were vaccine serotypes and 93% of cases had recognized risk factors (including HIV-infection) for pneumococcal vaccination. These data describe the epidemiology of IPD amongst HIV-infected and -uninfected adults during the pre-PCV era and provide a robust baseline to calculate the indirect effect of PCV in future studies.	[Meiring, Susan; Quan, Vanessa; de Gouveia, Linda] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Div Publ Hlth Surveillance & Response, Johannesburg, South Africa; [Cohen, Cheryl; Klugman, Keith P.; Madhi, Shabir A.; von Gottberg, Anne] Natl Inst Communicable Dis, Ctr Resp Dis & Meningitis, Johannesburg, South Africa; [Cohen, Cheryl] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Feldman, Charles] Charlotte Maxeke Johannesburg Acad Hosp, Dept Internal Med, Div Pulmonol, Johannesburg, South Africa; [Karstaedt, Alan] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; [Klugman, Keith P.] Chris Hani Baragwanath Acad Hosp, Dept Internal Med, Johannesburg, South Africa; [Klugman, Keith P.] Emory Univ, Hubert Sch Publ Hlth, Dept Global Hlth, Atlanta, GA 30322 USA; [Madhi, Shabir A.] Univ Witwatersrand, Sch Pathol, MRC, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa; [Madhi, Shabir A.; von Gottberg, Anne] Univ Witwatersrand, Dept Sci & Technol, Natl Res Fdn Vaccine Preventable Dis, Johannesburg, South Africa; [Rabie, Helene] Tygerberg Hosp, Dept Pediat Med, Cape Town, South Africa; [Sriruttan, Charlotte] Natl Inst Communicable Dis, Ctr Opportunist Trop & Hosp Associated Infect, Johannesburg, South Africa	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; Emory University; University of Witwatersrand; National Research Foundation - South Africa; University of Witwatersrand; Tygerberg Hospital; National Institute for Communicable Diseases (NICD)	Meiring, S (corresponding author), Natl Hlth Lab Serv, Natl Inst Communicable Dis, Div Publ Hlth Surveillance & Response, Johannesburg, South Africa.	susan.meiring@nhls.ac.za	Meiring, Susan/M-1463-2019; Rabie, Helena/ABH-1437-2020; Feldman, Charles/ABF-3315-2020; Lekalakala, Ruth/D-4944-2017	Meiring, Susan/0000-0003-4508-5469; Rabie, Helena/0000-0001-6336-2963; Feldman, Charles/0000-0002-6881-8314; Keddy, Karen Helena/0000-0001-8640-2235; McCarthy, Kerrigan/0000-0001-8958-9795; Govender, Nelesh/0000-0001-7869-9462; Whitelaw, Andrew/0000-0001-9070-5247; Cohen, Cheryl/0000-0003-0376-2302; Heney, Claire/0000-0002-4201-9530; von Gottberg, Anne/0000-0002-0243-7455; ahmed, khatija/0000-0003-0309-1641; Davidsson, Leigh/0000-0002-8822-7554; Lekalakala, Ruth/0000-0001-8560-8581	National Health Laboratory Service/National Institute for Communicable Disease; HHS Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Global AIDS Program (GAP) [U62/PSO022901]	National Health Laboratory Service/National Institute for Communicable Disease; HHS Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Global AIDS Program (GAP)	Development of this publication was partially funded by the National Health Laboratory Service/National Institute for Communicable Disease and by the HHS Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Global AIDS Program (GAP) Cooperative Agreement U62/PSO022901. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of CDC.	Adam MA, 2009, SAMJ S AFR MED J, V99, P661; [Anonymous], 2005, ASSA2003 AIDS DEMOGR; [Anonymous], 2006, INITIAL OBSERVATIONS; [Anonymous], 2008, MIDYEAR POPULATION E; [Anonymous], 2009, GERMS SA ANN REPORT; Atashili J, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-138; Bar-Zeev N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128738; Bennett Nancy M., 2012, Morbidity and Mortality Weekly Report, V61, P816; Bhorat AE, 2015, AIDS, V29, P1345, DOI 10.1097/QAD.0000000000000689; Buie KA, 2004, J INFECT DIS, V189, P1996, DOI 10.1086/386548; Burgos J, 2015, EUR J CLIN MICROBIOL, V34, P177, DOI 10.1007/s10096-014-2221-9; Burgos J, 2012, JAIDS-J ACQ IMM DEF, V59, P31, DOI 10.1097/QAI.0b013e31823d0f5f; Cheyip M, 2007, GERMS SA COLLECTION; Cohen AL, 2010, AIDS, V24, P2253, DOI 10.1097/QAD.0b013e32833d46fd; CreweBrown HH, 1997, CLIN INFECT DIS, V25, P1165, DOI 10.1086/516104; Crowther-Gibson P, 2012, ANTIMICROB AGENTS CH, V56, P5088, DOI 10.1128/AAC.06463-11; Dworkin MS, 2001, CLIN INFECT DIS, V32, P794, DOI 10.1086/319218; Everett DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017765; Feikin DR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-186; Feikin DR, 2000, AM J PUBLIC HEALTH, V90, P223, DOI 10.2105/AJPH.90.2.223; Feikin DR, 2005, CLIN INFECT DIS, V41, P481, DOI 10.1086/432015; Feldman C, 1999, S AFR MED J, V89, P1222; Ferrand RA, 2012, CLIN INFECT DIS, V55, P145, DOI 10.1093/cid/cis271; French N, 2000, LANCET, V355, P2106, DOI 10.1016/S0140-6736(00)02377-1; French N, 2016, MALAWI MED J, V28, P115, DOI 10.1056/NEJMoa0903029; Gilks CF, 1996, LANCET, V347, P718, DOI 10.1016/S0140-6736(96)90076-8; Glennie SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025610; Heffernan RT, 2005, J INFECT DIS, V191, P2038, DOI 10.1086/430356; Hibbs JR, 1997, CLIN INFECT DIS, V25, P195, DOI 10.1086/514538; JANOFF EN, 1992, ANN INTERN MED, V117, P314, DOI 10.7326/0003-4819-117-4-314; Johnson L., 2011, S AFR J HIV MED, V13, P22; Johnson LF, 2015, AIDS, V29, P1401, DOI 10.1097/QAD.0000000000000721; Jones N, 1998, AIDS, V12, P2177, DOI 10.1097/00002030-199816000-00013; Jordano Q, 2004, CLIN INFECT DIS, V38, P1623, DOI 10.1086/420933; Karstaedt AS, 2001, CLIN INFECT DIS, V33, P610, DOI 10.1086/322589; Mayanja BN, 2010, TROP MED INT HEALTH, V15, P697, DOI 10.1111/j.1365-3156.2010.02528.x; Moroney JF, 2001, CLIN INFECT DIS, V33, P797, DOI 10.1086/322623; Nunes MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027929; Nuorti JP, 2000, ANN INTERN MED, V132, P182, DOI 10.7326/0003-4819-132-3-200002010-00003; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Paterson DL, 2003, ANTIMICROB AGENTS CH, V47, P3554, DOI 10.1128/AAC.47.11.3554-3560.2003; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Ranieri R, 2005, AIDS RES HUM RETROV, V21, P407, DOI 10.1089/aid.2005.21.407; Sepako E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100640; Siemieniuk RAC, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-314; Soeters HM, 2012, ANTIMICROB AGENTS CH, V56, P1602, DOI 10.1128/AAC.05813-11; Souter J, 2014, SA PHARM J, V81, P15; von Gottberg A, 2014, NEW ENGL J MED, V371, P1889, DOI 10.1056/NEJMoa1401914; von Mollendorf C, 2016, EMERG INFECT DIS, V22, P261, DOI 10.3201/eid2202.150967; Wayne PA, 2008, PERF STAND ANT SUS S; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Wong KK, 2015, BMC INFECT IN PRESS; Yin Z, 2012, AIDS, V26, P87, DOI 10.1097/QAD.0b013e32834dcf27; Yu VL, 2003, CLIN INFECT DIS, V37, P230, DOI 10.1086/377534	54	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149104	10.1371/journal.pone.0149104	http://dx.doi.org/10.1371/journal.pone.0149104			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863135	Green Published, gold, Green Submitted			2022-12-27	WOS:000370046600154
J	Ounnas, F; Prive, F; Salen, P; Gaci, N; Tottey, W; Calani, L; Bresciani, L; Lopez-Gutierrez, N; Hazane-Puch, F; Laporte, F; Brugere, JF; Del Rio, D; Demeilliers, C; de Lorgeril, M				Ounnas, Faycal; Prive, Florence; Salen, Patricia; Gaci, Nadia; Tottey, William; Calani, Luca; Bresciani, Letizia; Lopez-Gutierrez, Noelia; Hazane-Puch, Florence; Laporte, Francois; Brugere, Jean-Francois; Del Rio, Daniele; Demeilliers, Christine; de Lorgeril, Michel			Whole Rye Consumption Improves Blood and Liver n-3 Fatty Acid Profile and Gut Microbiota Composition in Rats	PLOS ONE			English	Article							ALPHA-LINOLENIC ACID; COLONIC FERMENTATION; WHEAT BREAD; METABOLISM; GRAIN; LIGNANS; OBESITY; DIET; ENTEROLACTONE; HEALTH	Background Whole rye (WR) consumption seems to be associated with beneficial health effects. Although rye fiber and polyphenols are thought to be bioactive, the mechanisms behind the health effects of WR have yet to be fully identified. This study in rats was designed to investigate whether WR can influence the metabolism of n-3 and n-6 long-chain fatty acids (LCFA) and gut microbiota composition. Methods For 12 weeks, rats were fed a diet containing either 50% WR or 50% refined rye (RR). The WR diet provided more fiber (+21%) and polyphenols (+29%) than the RR diet. Fat intake was the same in both diets and particularly involved similar amounts of essential (18-carbon) n-3 and n-6 LCFAs. Results The WR diet significantly increased the 24-hour urinary excretion of polyphenol metabolites-including enterolactone-compared with the RR diet. The WR rats had significantly more n-3 LCFA-in particular, eicosapentanoic (EPA) and docosahexanoic (DHA) acids-in their plasma and liver. Compared with the RR diet, the WR diet brought significant changes in gut microbiota composition, with increased diversity in the feces (Shannon and Simpson indices), decreased Firmicutes/ Bacteroidetes ratio and decreased proportions of uncultured Clostridiales cluster IA and Clostridium cluster IV in the feces. In contrast, no difference was found between groups with regards to cecum microbiota. The WR rats had lower concentrations of total short-chain fatty acids (SCFA) in cecum and feces (p<0.05). Finally, acetate was lower (p<0.001) in the cecum of WR rats while butyrate was lower (p<0.05) in the feces of WR rats. Interpretation This study shows for the first time that WR consumption results in major biological modifications- increased plasma and liver n-3 EPA and DHA levels and improved gut microbiota profile, notably with increased diversity-known to provide health benefits. Unexpectedly, WR decreased SCFA levels in both cecum and feces. More studies are needed to understand the interactions between whole rye (fiber and polyphenols) and gut microbiota and also the mechanisms of action responsible for stimulating n-3 fatty acid metabolism.	[Ounnas, Faycal; Prive, Florence; Salen, Patricia; de Lorgeril, Michel] Univ Grenoble 1, Lab TIMC IMAG CNRS UMR 5525, Equipe PRETA, Coeur & Nutr, Grenoble 1, France; [Ounnas, Faycal; Prive, Florence; Demeilliers, Christine] Univ Grenoble Alpes, Lab Fundamental & Appl Bioenerget LBFA, Grenoble, France; [Ounnas, Faycal; Prive, Florence; Demeilliers, Christine] INSERM, U1055, Grenoble, France; [Gaci, Nadia; Tottey, William; Brugere, Jean-Francois] Univ Auvergne, Clermont Univ, EA CIDAM 4678, Clermont Ferrand, France; [Calani, Luca; Bresciani, Letizia; Del Rio, Daniele] Univ Parma, Lab Phytochem Physiol, Interlab Grp LS9, Dept Food Sci,Med Sch, Bldg C,Via Volturno 39, I-43125 Parma, Italy; [Hazane-Puch, Florence; Laporte, Francois] CHU Grenoble, Dept Biochim Pharmacol & Toxicol, Unite Biochim Hormonale & Nutr, F-38043 Grenoble, France; [Lopez-Gutierrez, Noelia] Univ Almeria, Res Ctr Agr & Food Biotechnol BITAL, Dept Chem & Phys, Analyt Chem Area,CeiA3, Agrifood Campus Int Excellence, E-04120 Almeria, Spain	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); University of Parma; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Universidad de Almeria	Ounnas, F (corresponding author), Univ Grenoble 1, Lab TIMC IMAG CNRS UMR 5525, Equipe PRETA, Coeur & Nutr, Grenoble 1, France.; Ounnas, F (corresponding author), Univ Grenoble Alpes, Lab Fundamental & Appl Bioenerget LBFA, Grenoble, France.; Ounnas, F (corresponding author), INSERM, U1055, Grenoble, France.	ounnasf@ujf-grenoble.fr	Demeilliers, Christine/GWZ-9743-2022; Brugère, Jean-François/AAB-4001-2019; Del Rio, Daniele/E-8696-2010	Brugère, Jean-François/0000-0002-1559-2331; Del Rio, Daniele/0000-0001-5394-1259; PUCH, Florence/0000-0003-2770-289X; Demeilliers, Christine/0000-0002-8648-4805; Bresciani, Letizia/0000-0002-7768-4987	Barilla G. R. Fratelli Spa; European Community [245121]	Barilla G. R. Fratelli Spa; European Community(European Commission)	This project has been funded by Barilla G. R. Fratelli Spa and supported in part by the 7th Framework Program ATHENA [Grant agreement no.: 245121] from the European Community. The funding is managed by the Grenoble University (School of Medicine) without involvement of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen MF, 2001, J AGR FOOD CHEM, V49, P5679, DOI 10.1021/jf010668c; Andreasen MF, 2000, J AGR FOOD CHEM, V48, P2837, DOI 10.1021/jf991266w; Belobrajdic DP, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-62; Bervoets L, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-10; Boto-Ordonez M, 2014, FOOD FUNCT, V5, P1932, DOI [10.1039/c4fo00029c, 10.1039/C4FO00029C]; Burdge GC, 2005, REPROD NUTR DEV, V45, P581, DOI 10.1051/rnd:2005047; Burdge GC, 2002, BRIT J NUTR, V88, P355, DOI 10.1079/BJN2002662; Burdge GC, 2002, BRIT J NUTR, V88, P411, DOI 10.1079/BJN2002689; Calani L, 2014, FOOD FUNCT, V5, P1738, DOI [10.1039/C4FO00328D, 10.1039/c4fo00328d]; Carbonero F, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00448; Caricilli AM, 2013, NUTRIENTS, V5, P829, DOI 10.3390/nu5030829; Childs CE, 2008, P NUTR SOC, V67, P19, DOI 10.1017/S0029665108005983; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Czank C, 2013, AM J CLIN NUTR, V97, P995, DOI 10.3945/ajcn.112.049247; Damdimopoulou P, 2011, J NUTR, V141, P1583, DOI 10.3945/jn.111.140277; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; de Lorgeril M, 2008, AM HEART J, V155, P175, DOI 10.1016/j.ahj.2007.08.009; di Giuseppe R, 2009, AM J CLIN NUTR, V89, P354, DOI 10.3945/ajcn.2008.26661; Emken EA, 2001, LIPIDS, V36, P965, DOI 10.1007/s11745-001-0807-4; Everard A, 2013, BEST PRACT RES CL GA, V27, P73, DOI 10.1016/j.bpg.2013.03.007; Feria-Gervasio D, 2011, APPL MICROBIOL BIOT, V91, P1425, DOI 10.1007/s00253-011-3462-5; Freeland KR, 2010, BRIT J NUTR, V103, P82, DOI 10.1017/S0007114509991462; Frolich W, 2013, FOOD NUTR RES, V57, DOI 10.3402/fnr.v57i0.18503; Giltay EJ, 2004, AM J CLIN NUTR, V80, P1167, DOI 10.1093/ajcn/80.5.1167; Glitso LV, 1998, BRIT J NUTR, V80, P457, DOI 10.1017/S0007114598001536; Glitso LV, 2000, BRIT J NUTR, V84, P429; Gobert M, 2009, J DAIRY SCI, V92, P6095, DOI 10.3168/jds.2009-2087; Hallmans G, 2003, P NUTR SOC, V62, P193, DOI 10.1079/PNS2002229; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Juntunen KS, 2000, BRIT J NUTR, V84, P839; Kyro C, 2012, SCAND J PUBLIC HEALT, V40, P76, DOI 10.1177/1403494811421057; Landete JM, 2012, FOOD RES INT, V46, P410, DOI 10.1016/j.foodres.2011.12.023; Lankinen M, 2010, NUTR METAB CARDIOVAS, V20, P249, DOI 10.1016/j.numecd.2009.04.009; Lappi J, 2013, J NUTR, V143, P648, DOI 10.3945/jn.112.172668; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Le Gall M, 2009, BRIT J NUTR, V102, P1590, DOI 10.1017/S0007114509990924; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Martinez-Ramirez HR, 2013, J ANIM SCI, V91, P2729, DOI 10.2527/jas.2012-5783; Matijasic BB, 2014, EUR J NUTR, V53, P1051, DOI 10.1007/s00394-013-0607-6; Nilsson M, 1997, J SCI FOOD AGR, V73, P143, DOI 10.1002/(SICI)1097-0010(199702)73:2&lt;143::AID-JSFA698&gt;3.0.CO;2-H; Nordlund E, 2012, J AGR FOOD CHEM, V60, P8134, DOI 10.1021/jf3008037; Ounnas F, 2014, FOOD NUTR RES, V58, DOI 10.3402/fnr.v58.24604; Parkar SG, 2013, ANAEROBE, V23, P12, DOI 10.1016/j.anaerobe.2013.07.009; Pawlosky R, 2003, BRIT J NUTR, V90, P993, DOI 10.1079/BJN2003985; Penttinen P, 2007, ENDOCRINOLOGY, V148, P4875, DOI 10.1210/en.2007-0289; Reeves PG, 1993, J NUTR, V123; Rey FE, 2013, P NATL ACAD SCI USA, V110, P13582, DOI 10.1073/pnas.1312524110; Sibbons CM, 2014, PROSTAG LEUKOTR ESS, V90, P47, DOI 10.1016/j.plefa.2013.12.006; Siurek B, 2012, FOOD SCI TECHNOL INT, V18, P559, DOI 10.1177/1082013211433079; Superko HR, 2013, CIRCULATION, V128, P2154, DOI 10.1161/CIRCULATIONAHA.113.002731; Theil PK, 2011, BRIT J NUTR, V105, P373, DOI 10.1017/S0007114510003715; Tottey W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062544; Toufektsian MC, 2011, J NUTR, V141, P37, DOI 10.3945/jn.110.127225; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Unno T, 2014, J NUTR SCI VITAMINOL, V60, P213, DOI 10.3177/jnsv.60.213; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Wu HY, 2015, JAMA INTERN MED, V175, P373, DOI 10.1001/jamainternmed.2014.6283; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhao LP, 2013, NAT REV MICROBIOL, V11, P639, DOI 10.1038/nrmicro3089	61	17	18	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148118	10.1371/journal.pone.0148118	http://dx.doi.org/10.1371/journal.pone.0148118			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862900	Green Published, Green Submitted, gold			2022-12-27	WOS:000370046600044
J	Costa-Cabral, S; Brough, R; Konde, A; Aarts, M; Campbell, J; Marinari, E; Riffell, J; Bardelli, A; Torrance, C; Lord, CJ; Ashworth, A				Costa-Cabral, Sara; Brough, Rachel; Konde, Asha; Aarts, Marieke; Campbell, James; Marinari, Eliana; Riffell, Jenna; Bardelli, Alberto; Torrance, Christopher; Lord, Christopher J.; Ashworth, Alan			CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASES; SMALL-MOLECULE INHIBITOR; K-RAS ONCOGENES; COLORECTAL-CANCER; LUNG-CARCINOMA; BREAST-CANCER; CELL-CYCLE; THERAPY; REVEALS; PATIENT	Activating KRAS mutations are found in approximately 20% of human cancers but no RAS-directed therapies are currently available. Here we describe a novel, robust, KRAS synthetic lethal interaction with the cyclin dependent kinase, CDK1. This was discovered using parallel siRNA screens in KRAS mutant and wild type colorectal isogenic tumour cells and subsequently validated in a genetically diverse panel of 26 colorectal and pancreatic tumour cell models. This established that the KRAS/CDK1 synthetic lethality applies in tumour cells with either amino acid position 12 ( p.G12V, pG12D, p.G12S) or amino acid position 13 (p.G13D) KRAS mutations and can also be replicated in vivo in a xenograft model using a small molecule CDK1 inhibitor. Mechanistically, CDK1 inhibition caused a reduction in the S-phase fraction of KRAS mutant cells, an effect also characterised by modulation of Rb, a master control of the G1/S checkpoint. Taken together, these observations suggest that the KRAS/CDK1 interaction is a robust synthetic lethal effect worthy of further investigation.	[Costa-Cabral, Sara; Brough, Rachel; Konde, Asha; Aarts, Marieke; Campbell, James; Marinari, Eliana; Riffell, Jenna; Lord, Christopher J.; Ashworth, Alan] Inst Canc Res, CRUK Gene Funct Lab, London SW3 6JB, England; [Costa-Cabral, Sara; Brough, Rachel; Konde, Asha; Aarts, Marieke; Campbell, James; Marinari, Eliana; Riffell, Jenna; Lord, Christopher J.; Ashworth, Alan] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Bardelli, Alberto] IFOM FIRC Inst Mol Oncol, Via Adamello 16, I-20139 Milan, Italy; [Torrance, Christopher] Horizon Discovery, 7100 Cambridge Res Pk, Cambridge CB25 9TL, England; [Torrance, Christopher] PhoreMost, 23 Cambridge Sci Pk,Milton Rd, Cambridge CB4 0EY, England; [Ashworth, Alan] Univ Calif San Francisco, UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; IFOM - FIRC Institute of Molecular Oncology; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Lord, CJ (corresponding author), Inst Canc Res, CRUK Gene Funct Lab, London SW3 6JB, England.; Lord, CJ (corresponding author), Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England.	Chris.Lord@icr.ac.uk	Lord, Christopher J/B-3295-2012; Lord, Christopher/AAX-7130-2021	Lord, Christopher J/0000-0002-3226-0515; Campbell, James/0000-0001-6756-8766	Cancer Research UK [C347/A8363]; Fundacao para a Ciencia e a Tecnologia [SFRH/BD/65004/2009]; Cancer Research UK [14276] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Cancer Research UK(Cancer Research UK)	This worked was funded by Cancer Research UK, C347/A8363, CJL AA, and Fundacao para a Ciencia e a Tecnologia, SFRH/BD/65004/2009, SCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Horizon Discovery did not provide financial support in either the form of authors' salaries and/or research materials; they provided the KRAS isogenic cell lines.	Aleem E, 2005, NAT CELL BIOL, V7, P831, DOI 10.1038/ncb1284; Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Ashworth A, 2011, CELL, V145, P30, DOI 10.1016/j.cell.2011.03.020; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; BOS JL, 1989, CANCER RES, V49, P4682; Brough R, 2011, CANCER DISCOV, V1, P260, DOI 10.1158/2159-8290.CD-11-0107; Byth KF, 2009, MOL CANCER THER, V8, P1856, DOI 10.1158/1535-7163.MCT-08-0836; Cheng CK, 2012, P NATL ACAD SCI USA, V109, P12722, DOI 10.1073/pnas.1202492109; Corcoran RB, 2013, CANCER CELL, V23, P121, DOI 10.1016/j.ccr.2012.11.007; Di Nicolantonio F, 2008, P NATL ACAD SCI USA, V105, P20864, DOI 10.1073/pnas.0808757105; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Enserink JM, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-11; Fry DW, 2004, MOL CANCER THER, V3, P1427; Goga A, 2007, NAT MED, V13, P820, DOI 10.1038/nm1606; Horiuchi D, 2012, J EXP MED, V209, P679, DOI 10.1084/jem.20111512; Hu X, 2011, CELL PROLIFERAT, V44, P205, DOI 10.1111/j.1365-2184.2011.00753.x; Jancik S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/150960; Jimeno A, 2009, J CLIN ONCOL, V27, P1130, DOI 10.1200/JCO.2008.19.8168; Johnson N, 2011, NAT MED, V17, P875, DOI 10.1038/nm.2377; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Knudsen ES, 1996, J BIOL CHEM, V271, P8313, DOI 10.1074/jbc.271.14.8313; Kumar MS, 2012, CELL, V149, P642, DOI 10.1016/j.cell.2012.02.059; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Lord CJ, 2009, J CLIN PATHOL, V62, P195, DOI 10.1136/jcp.2008.058735; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Malumbres M, 2007, CURR OPIN GENET DEV, V17, P60, DOI 10.1016/j.gde.2006.12.008; NAKANO H, 1984, P NATL ACAD SCI-BIOL, V81, P71, DOI 10.1073/pnas.81.1.71; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Parry D, 2010, MOL CANCER THER, V9, P2344, DOI 10.1158/1535-7163.MCT-10-0324; Puyol M, 2010, CANCER CELL, V18, P63, DOI 10.1016/j.ccr.2010.05.025; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; SANTOS E, 1984, SCIENCE, V223, P661, DOI 10.1126/science.6695174; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Singh A, 2012, CELL, V148, P639, DOI 10.1016/j.cell.2011.12.033; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Squires MS, 2009, MOL CANCER THER, V8, P324, DOI 10.1158/1535-7163.MCT-08-0890; Steckel M, 2012, CELL RES, V22, P1227, DOI 10.1038/cr.2012.82; Timofeev O, 2010, J BIOL CHEM, V285, P16978, DOI 10.1074/jbc.M109.096552; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Wang Y, 2010, ONCOGENE, V29, P4658, DOI 10.1038/onc.2010.218; WHITEHEAD RH, 1985, JNCI-J NATL CANCER I, V74, P759	47	48	54	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149099	10.1371/journal.pone.0149099	http://dx.doi.org/10.1371/journal.pone.0149099			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881434	Green Submitted, Green Published, gold			2022-12-27	WOS:000371219000045
J	Li, GL; Zhao, H; Wang, HF; Guo, XL; Guo, XQ; Sun, QH; Xu, BH				Li, Guilin; Zhao, Hang; Wang, Hongfang; Guo, Xulei; Guo, Xingqi; Sun, Qinghua; Xu, Baohua			Characterization of a Decapentapletic Gene (AccDpp) from Apis cerana cerana and Its Possible Involvement in Development and Response to Oxidative Stress	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; GLUTATHIONE-S-TRANSFERASE; ASIAN HONEY-BEE; MOLECULAR CHARACTERIZATION; EXPRESSION; MECHANISMS; ROS; ACTIVATION; GENERATION; PATTERN	To tolerate many acute and chronic oxidative stress-producing agents that exist in the environment, organisms have evolved many classes of signal transduction pathways, including the transforming growth factor beta (TGF beta) signal pathway. Decapentapletic gene (Dpp) belongs to the TGF beta superfamily, and studies on Dpp have mainly focused on its role in the regulation of development. No study has investigated the response of Dpp to oxidative pressure in any organism, including Apis cerana cerana (A. cerana cerana). In this study, we identified a Dpp gene from A. cerana cerana named AccDpp. The 5' flanking region of AccDpp had many transcription factor binding sites that relevant to development and stress response. AccDpp was expressed at all stages of A. cerana cerana, with its highest expression in 15-day worker bees. The mRNA level of AccDpp was higher in the poison gland and midgut than other tissues. Furthermore, the transcription of AccDpp could be repressed by 4 degrees C and UV, but induced by other treatments, according to our qRT-PCR analysis. It is worth noting that the expression level of AccDpp protein was increased after a certain time when A. cerana cerana was subjected to all simulative oxidative stresses, a finding that was not completely consistent with the result from qRT-PCR. It is interesting that recombinant AccDpp restrained the growth of Escherichia coli, a function that might account for the role of the antimicrobial peptides of AccDpp. In conclusion, these results provide evidence that AccDpp might be implicated in the regulation of development and the response of oxidative pressure. The findings may lay a theoretical foundation for further genetic studies of Dpp.	[Li, Guilin; Zhao, Hang; Guo, Xulei; Guo, Xingqi; Sun, Qinghua] Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An 271018, Shandong, Peoples R China; [Wang, Hongfang; Xu, Baohua] Shandong Agr Univ, Coll Anim Sci & Technol, Tai An 271018, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University	Sun, QH (corresponding author), Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An 271018, Shandong, Peoples R China.; Xu, BH (corresponding author), Shandong Agr Univ, Coll Anim Sci & Technol, Tai An 271018, Shandong, Peoples R China.	qhsun@sdau.edu.cn; bhxu@sdau.edu.cn			Chian Agriculture Research System [CARS-45]; National Natural Science Foundation of China [31172275]; Shandong Province Fine Varieties Breeding Projects	Chian Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province Fine Varieties Breeding Projects	This work was financially supported by the earmarked fund for the Chian Agriculture Research System (No. CARS-45), the National Natural Science Foundation of China (No.31172275) and Shandong Province Fine Varieties Breeding Projects (2014-2016).	Abrashev RI, 2008, CAN J MICROBIOL, V54, P977, DOI 10.1139/W08-091; Affolter M, 2001, EMBO J, V20, P3298, DOI 10.1093/emboj/20.13.3298; Agarwal A, 2008, ANTIOXID REDOX SIGN, V10, P1375, DOI 10.1089/ars.2007.1964; Alaux C., 2010, BIOL LETT, DOI 101098/rsbl 2009.0986.; Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019; ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155; Banerjee B D, 2001, Rev Environ Health, V16, P1; Black D, 2004, J HEPATOL, V40, P942, DOI 10.1016/j.jhep.2004.02.031; BLACKMAN RK, 1991, DEVELOPMENT, V111, P657; Boileau TWM, 2003, J BIOCHEM MOL TOXIC, V17, P108, DOI 10.1002/jbt.10067; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brown SE, 2009, INSECT BIOCHEM MOLEC, V39, P792, DOI 10.1016/j.ibmb.2009.09.004; Chen JC, 2012, J AM SOC NEPHROL, V23, P215, DOI 10.1681/ASN.2011070645; Chen X, 2015, NEPHROLOGY, V20, P20; Chen Y., 2014, MEDIATORS INFLAMM, P2014; Cheng S. L., 2001, APICULTURAL SCI CHIN; Chiu C, 2001, INT J MOL MED, V8, P251; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Ericsson A, 2006, J IMMUNOL, V176, P3642, DOI 10.4049/jimmunol.176.6.3642; FERGUSON EL, 1992, CELL, V71, P451, DOI 10.1016/0092-8674(92)90514-D; Filipic M, 2006, HUM EXP TOXICOL, V25, P67, DOI 10.1191/0960327106ht590oa; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; FU YH, 1987, MOL CELL BIOL, V7, P1691, DOI 10.1128/MCB.7.5.1691; GOGOS JA, 1992, SCIENCE, V257, P1951, DOI 10.1126/science.1290524; Hanafusa H, 1999, J BIOL CHEM, V274, P27161, DOI 10.1074/jbc.274.38.27161; Hubackova S, 2012, AGING-US, V4, P932, DOI 10.18632/aging.100520; Imjongjirak C, 2005, J BIOCHEM MOL BIOL, V38, P49; IRISH VF, 1987, GENE DEV, V1, P868, DOI 10.1101/gad.1.8.868; Jiang Q, 2006, INT J MOL MED, V18, P381; Kerr JT, 2015, SCIENCE, V349, P177, DOI 10.1126/science.aaa7031; Lal MA, 2002, KIDNEY INT, V61, P2006, DOI 10.1046/j.1523-1755.2002.00367.x; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Lee SH, 2001, SCIENCE, V292, P2083, DOI 10.1126/science.1059501; Lee YW, 2001, NEUROCHEM RES, V26, P1187, DOI 10.1023/A:1013955020515; Li JH, 2005, ARCH INSECT BIOCHEM, V60, P1, DOI 10.1002/arch.20075; Li YZ, 2012, ARCH INSECT BIOCHEM, V79, P121, DOI 10.1002/arch.21011; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Marionnet C, 2003, J INVEST DERMATOL, V121, P1447, DOI 10.1111/j.1523-1747.2003.12629.x; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Mates JM, 2010, FREE RADICAL BIO MED, V49, P1328, DOI 10.1016/j.freeradbiomed.2010.07.028; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Meng F., 2014, J CHEM, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0093100; Michaeloudes C, 2011, AM J PHYSIOL-LUNG C, V300, pL295, DOI 10.1152/ajplung.00134.2010; MICHELETTE ERD, 1993, APIDOLOGIE, V24, P431, DOI 10.1051/apido:19930410; Mitobe J, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-110; Moustakas A, 2002, IMMUNOL LETT, V82, P85, DOI 10.1016/S0165-2478(02)00023-8; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Ninov N, 2010, CURR BIOL, V20, P513, DOI 10.1016/j.cub.2010.01.063; Niwa N, 2000, DEVELOPMENT, V127, P4373; Owsiak A, 2015, J MICROB BIOTEC FOOD, V4, P48, DOI 10.15414/jmbfs.2015.4.special1.48-51; PADGETT RW, 1993, P NATL ACAD SCI USA, V90, P2905, DOI 10.1073/pnas.90.7.2905; Park D, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-1; PENG YS, 1987, J INVERTEBR PATHOL, V49, P54, DOI 10.1016/0022-2011(87)90125-X; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; ROBERTS AB, 1981, P NATL ACAD SCI-BIOL, V78, P5339, DOI 10.1073/pnas.78.9.5339; Samarakoon R, 2013, CELL SIGNAL, V25, P264, DOI 10.1016/j.cellsig.2012.10.003; Sanchez A, 1996, J BIOL CHEM, V271, P7416, DOI 10.1074/jbc.271.13.7416; Santoro MG, 2000, BIOCHEM PHARMACOL, V59, P55, DOI 10.1016/S0006-2952(99)00299-3; Scharlaken B, 2008, DEV COMP IMMUNOL, V32, P883, DOI 10.1016/j.dci.2008.01.010; Sharma K, 2005, AM J PHYSIOL-RENAL, V288, pF1069, DOI 10.1152/ajprenal.00345.2004; Shi JH, 2008, BIOMATERIALS, V29, P2820, DOI 10.1016/j.biomaterials.2008.03.020; Shin DM, 2008, FASEB J, V22, P2498, DOI 10.1096/fj.07-095455; Soltaninejad K, 2009, MED SCI MONITOR, V15, pRA75; Spokony RF, 2007, DEV GENES EVOL, V217, P499, DOI 10.1007/s00427-007-0159-y; Srisuparbh D, 2003, J BIOCHEM MOL BIOL, V36, P572; STJOHNSTON RD, 1990, GENE DEV, V4, P1114, DOI 10.1101/gad.4.7.1114; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Umasuthan N, 2012, COMP BIOCHEM PHYS C, V155, P539, DOI 10.1016/j.cbpc.2012.01.001; WHARTON KA, 1993, DEVELOPMENT, V117, P807; Wiggers GA, 2008, AM J PHYSIOL-HEART C, V295, pH1033, DOI 10.1152/ajpheart.00430.2008; Wongsiri, 2009, ASIAN HONEY BEES BIO; Yin KF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-998; Yuksel S, 2008, ACTA BIOL HUNG, V59, P57, DOI 10.1556/ABiol.59.2008.1.5; Zhang YY, 2013, CELL STRESS CHAPERON, V18, P503, DOI 10.1007/s12192-013-0406-2; Zhao HT, 2014, J GENET, V93, P53, DOI 10.1007/s12041-014-0332-9	77	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149117	10.1371/journal.pone.0149117	http://dx.doi.org/10.1371/journal.pone.0149117			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881804	gold, Green Submitted, Green Published			2022-12-27	WOS:000371219000048
J	Peternel, L; Noda, T; Petric, T; Ude, A; Morimoto, J; Babic, J				Peternel, Luka; Noda, Tomoyuki; Petric, Tadej; Ude, Ales; Morimoto, Jun; Babic, Jan			Adaptive Control of Exoskeleton Robots for Periodic Assistive Behaviours Based on EMG Feedback Minimisation	PLOS ONE			English	Article							MOVEMENT; DESIGN; TORQUE; NORMALIZATION; ADAPTATION; MODEL	In this paper we propose an exoskeleton control method for adaptive learning of assistive joint torque profiles in periodic tasks. We use human muscle activity as feedback to adapt the assistive joint torque behaviour in a way that the muscle activity is minimised. The user can then relax while the exoskeleton takes over the task execution. If the task is altered and the existing assistive behaviour becomes inadequate, the exoskeleton gradually adapts to the new task execution so that the increased muscle activity caused by the new desired task can be reduced. The advantage of the proposed method is that it does not require biomechanical or dynamical models. Our proposed learning system uses Dynamical Movement Primitives (DMPs) as a trajectory generator and parameters of DMPs are modulated using Locally Weighted Regression. Then, the learning system is combined with adaptive oscillators that determine the phase and frequency of motion according to measured Electromyography (EMG) signals. We tested the method with real robot experiments where subjects wearing an elbow exoskeleton had to move an object of an unknown mass according to a predefined reference motion. We further evaluated the proposed approach on a wholearm exoskeleton to show that it is able to adaptively derive assistive torques even for multiple-joint motion.	[Peternel, Luka; Petric, Tadej; Ude, Ales; Babic, Jan] Jozef Stefan Inst, Dept Automat Biocybernet & Robot, Ljubljana, Slovenia; [Peternel, Luka; Noda, Tomoyuki; Morimoto, Jun] ATR Computat Neurosci Labs, Dept Brain Robot Interface, Kyoto, Japan	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Peternel, L (corresponding author), Jozef Stefan Inst, Dept Automat Biocybernet & Robot, Ljubljana, Slovenia.; Peternel, L (corresponding author), ATR Computat Neurosci Labs, Dept Brain Robot Interface, Kyoto, Japan.	luka.peternel@ijs.si	Ude, Aleš/ABB-7839-2020; Peternel, Luka/AAX-9766-2021; Petric, Tadej/AAS-2471-2021	Ude, Aleš/0000-0003-3677-3972; Peternel, Luka/0000-0002-8696-3689; Petric, Tadej/0000-0002-3407-4206; Babic, Jan/0000-0002-1870-8264; Noda, Tomoyuki/0000-0002-1055-5080	Japanese Ministry of Education, Culture, Sports, Science and Technology SRPBS; European Commission FP-7 through the CoDyCo project [600716]; European Commission Horizon through the SPEXOR project [687662]; Japanese Ministry of Internal Affairs and Communications under contract entitled " Novel and innovative R&D making use of brain structures"; Cabinet Office Government of Japan ImPACT; New Energy andIndustrial Technology Development Organization; Slovene Human Resources Development and Scholarship Fund [146, 163]; Japanese Ministry of Internal Affairs and Communications SCOPE; Japanese Ministry of Education, Culture, Sports, Science and Technology KAKENHI [23120004]; Japan Science and Technology Agency SICP; Japan Society for the Promotion of Science and Slovenian Ministry of Education, Science and Sport: Japan-Slovenia research Cooperative Program; Japan Society for the Promotion of Science KAKENHI [24700203]	Japanese Ministry of Education, Culture, Sports, Science and Technology SRPBS; European Commission FP-7 through the CoDyCo project; European Commission Horizon through the SPEXOR project; Japanese Ministry of Internal Affairs and Communications under contract entitled " Novel and innovative R&D making use of brain structures"; Cabinet Office Government of Japan ImPACT; New Energy andIndustrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Slovene Human Resources Development and Scholarship Fund; Japanese Ministry of Internal Affairs and Communications SCOPE; Japanese Ministry of Education, Culture, Sports, Science and Technology KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency SICP; Japan Society for the Promotion of Science and Slovenian Ministry of Education, Science and Sport: Japan-Slovenia research Cooperative Program; Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japanese Ministry of Education, Culture, Sports, Science and Technology SRPBS; by European Commission FP-7 through the CoDyCo project (#600716); by European Commission Horizon 2020 through the SPEXOR project (#687662)"; by Japanese Ministry of Internal Affairs and Communications under contract entitled " Novel and innovative R&D making use of brain structures"; by Cabinet Office Government of Japan ImPACT; and by a project commissioned by New Energy andIndustrial Technology Development Organization. LP was supported by Slovene Human Resources Development and Scholarship Fund (146. and 163. JR)<SUP>2</SUP>. JM was supported by Japanese Ministry of Internal Affairs and Communications SCOPE; by Japanese Ministry of Education, Culture, Sports, Science and Technology KAKENHI (#23120004); by Japan Science and Technology Agency SICP; and by Japan Society for the Promotion of Science and Slovenian Ministry of Education, Science and Sport: Japan-Slovenia research Cooperative Program. TN was supported by Japan Society for the Promotion of Science KAKENHI (#24700203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Ollinger G, 2013, IEEE INT C INT ROBOT, P1182, DOI 10.1109/IROS.2013.6696500; Babic J, 2011, ADAPT BEHAV, V19, P250, DOI 10.1177/1059712311411112; Beyl P, 2014, IEEE-ASME T MECH, V19, P1046, DOI 10.1109/TMECH.2013.2268942; Cavallaro EE, 2006, IEEE T BIO-MED ENG, V53, P2387, DOI 10.1109/TBME.2006.880883; Chou CP, 1996, IEEE T ROBOTIC AUTOM, V12, P90, DOI 10.1109/70.481753; De Luca CJ, 2010, J BIOMECH, V43, P1573, DOI 10.1016/j.jbiomech.2010.01.027; De Luca CJ, 1997, J APPL BIOMECH, V13, P135, DOI 10.1123/jab.13.2.135; Dollar AM, 2008, IEEE T ROBOT, V24, P144, DOI 10.1109/TRO.2008.915453; Earp JE, 2013, J ELECTROMYOGR KINES, V23, P238, DOI 10.1016/j.jelekin.2012.08.015; Ferris DP, 2006, GAIT POSTURE, V23, P425, DOI 10.1016/j.gaitpost.2005.05.004; Fleischer C, 2008, IEEE T ROBOT, V24, P872, DOI 10.1109/TRO.2008.926860; Gams A, 2013, IEEE T BIO-MED ENG, V60, P1636, DOI 10.1109/TBME.2013.2240682; Gams A, 2009, AUTON ROBOT, V27, P3, DOI 10.1007/s10514-009-9118-y; Hermens H.J.M.R.F.B., 1999, SENIAM EUROPEAN RECO; Hesse S, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-30; Hildebrandt A, 2005, P AMER CONTR CONF, P680, DOI 10.1109/ACC.2005.1470036; Ijspeert AJ, 2002, 2002 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-3, PROCEEDINGS, P958, DOI 10.1109/IRDS.2002.1041514; Ijspeert AJ, 2013, NEURAL COMPUT, V25, P328, DOI 10.1162/NECO_a_00393; Kandel E., 2000, PRINCIPLES NEURAL SC; Kawamoto H., 2002, 2002 IEEE International Conference on Systems, Man and Cybernetics. Conference Proceedings (Cat. No.02CH37349), DOI 10.1109/ICSMC.2002.1173328; Kazerooni H, 2006, INT J ROBOT RES, V25, P561, DOI 10.1177/0278364906065505; Kiguchi K, 2001, IEEE T SYST MAN CY B, V31, P353, DOI 10.1109/3477.931520; Kong KC, 2006, IEEE-ASME T MECH, V11, P428, DOI 10.1109/TMECH.2006.878550; Lenzi T, 2012, IEEE T BIO-MED ENG, V59, P2180, DOI 10.1109/TBME.2012.2198821; Noda T, 2014, IEEE INT C INT ROBOT, P3573, DOI 10.1109/IROS.2014.6943062; Noda T, 2012, IEEE-RAS INT C HUMAN, P21, DOI 10.1109/HUMANOIDS.2012.6651494; Noda T, 2013, IEEE INT CONF ROBOT, P2657, DOI 10.1109/ICRA.2013.6630942; Peternel L, 2015, PROCEEDINGS OF THE 17TH INTERNATIONAL CONFERENCE ON ADVANCED ROBOTICS (ICAR), P34, DOI 10.1109/ICAR.2015.7251430; Peternel L, 2015, IEEE INT CONF ROBOT, P1497, DOI 10.1109/ICRA.2015.7139387; Peternel L, 2014, AUTON ROBOT, V36, P123, DOI 10.1007/s10514-013-9361-0; Petric T, 2014, IEEE INT CONF ROBOT, P4770, DOI 10.1109/ICRA.2014.6907557; Petric T, 2011, INT J ROBOT RES, V30, P1775, DOI 10.1177/0278364911421511; Pratt JE, 2004, IEEE INT CONF ROBOT, P2430, DOI 10.1109/ROBOT.2004.1307425; Riener R, 2005, IEEE T NEUR SYS REH, V13, P380, DOI 10.1109/TNSRE.2005.848628; Righetti L, 2006, PHYSICA D, V216, P269, DOI 10.1016/j.physd.2006.02.009; Ronsse R, 2011, MED BIOL ENG COMPUT, V49, P1173, DOI 10.1007/s11517-011-0816-1; Ronsse R, 2011, IEEE T BIO-MED ENG, V58, P1001, DOI 10.1109/TBME.2010.2089629; Rosen J, 2001, IEEE T SYST MAN CY A, V31, P210, DOI 10.1109/3468.925661; Sardellitti I, 2007, 2007 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-9, P1828; Schaal S, 1998, NEURAL COMPUT, V10, P2047, DOI 10.1162/089976698300016963; Song R, 2005, MED BIOL ENG COMPUT, V43, P473, DOI 10.1007/BF02344728; Sugar TG, 2007, IEEE T NEUR SYS REH, V15, P336, DOI 10.1109/TNSRE.2007.903903; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Tsagarakis NG, 2003, AUTON ROBOT, V15, P21, DOI 10.1023/A:1024484615192; Ugurlu B, 2014, HUMAN MACHINE SYSTEM, VPP, P1; Ugurlu B, 2015, IEEE INT C INT ROBOT, P1633, DOI 10.1109/IROS.2015.7353586; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593; Veneman JF, 2007, IEEE T NEUR SYS REH, V15, P379, DOI 10.1109/TNSRE.2007.903919; Wang DH, 2014, IEEE-ASME T MECH, V19, P1268, DOI 10.1109/TMECH.2013.2278207; Yang DP, 2009, J BIONIC ENG, V6, P255, DOI 10.1016/S1672-6529(08)60119-5; Yang DP, 2012, INT J HUM ROBOT, V9, DOI 10.1142/S0219843612500077; YANG JF, 1984, ARCH PHYS MED REHAB, V65, P517; Zoss AB, 2006, IEEE-ASME T MECH, V11, P128, DOI 10.1109/TMECH.2006.871087	53	90	95	6	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148942	10.1371/journal.pone.0148942	http://dx.doi.org/10.1371/journal.pone.0148942			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881743	gold, Green Published, Green Submitted			2022-12-27	WOS:000371219000036
J	Fischer, KD; Hall, SC; Agrawal, DK				Fischer, Kimberly D.; Hall, Sannette C.; Agrawal, Devendra K.			Vitamin D Supplementation Reduces Induction of Epithelial-Mesenchymal Transition in Allergen Sensitized and Challenged Mice	PLOS ONE			English	Article							AIRWAY INFLAMMATION; D DEFICIENCY; MOUSE MODEL; N-CADHERIN; TGF-BETA; ASTHMA; MYOFIBROBLAST	Asthma is a chronic disease of the lung associated with airway hyperresponsiveness (AHR), airway obstruction and airway remodeling. Airway remodeling involves differentiation of airway epithelial cells into myofibroblasts via epithelial-mesenchymal transition (EMT) to intensify the degree of subepithelial fibrosis. EMT involves loss in E-cadherin with an increase in mesenchymal markers, including vimentin and N-cadherin. There is growing evidence that vitamin D has immunomodulatory and anti-inflammatory properties. However, the underlying molecular mechanisms of these effects are still unclear. In this study, we examined the contribution of vitamin D on the AHR, airway inflammation and expression of EMT markers in the airways of mice sensitized and challenged with a combination of clinically relevant allergens, house dust mite, ragweed, and Alternaria (HRA). Female Balb/c mice were fed with vitamin D-sufficient (2000 IU/kg) or vitamin D-supplemented (10,000 IU/kg) diet followed by sensitization with HRA. The density of inflammatory cells in the bronchoalveolar lavage fluid (BALF), lung histology, and expression of EMT markers by immunofluorescence were examined. Vitamin D-supplementation decreased AHR, airway inflammation in the BALF and the features of airway remodeling compared to vitamin D-sufficiency in HRA-sensitized and -challenged mice. This was accompanied with increased expression of E-cadherin and decreased vimentin and N-cadherin expression in the airways. These results indicate that vitamin D may be a beneficial adjunct in the treatment regime in allergic asthma.	[Fischer, Kimberly D.; Agrawal, Devendra K.] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE USA; [Hall, Sannette C.; Agrawal, Devendra K.] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA; [Agrawal, Devendra K.] Creighton Univ, Sch Med, Dept Clin & Translat Sci, Omaha, NE USA	Creighton University; Creighton University; Creighton University	Agrawal, DK (corresponding author), Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE USA.; Agrawal, DK (corresponding author), Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA.; Agrawal, DK (corresponding author), Creighton Univ, Sch Med, Dept Clin & Translat Sci, Omaha, NE USA.	DKAGR@creighton.edu	Agrawal, Devendra/GLR-3925-2022	Agrawal, Devendra/0000-0001-5445-0013	National Institutes of Health, USA [R01HL086680, R01AI075315]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116042, R01HL086680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075315] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by research grant R01HL086680 and R01AI075315 from the National Institutes of Health, USA to DK Agrawal. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Agrawal T, 2013, CLIN EXP ALLERGY, V43, P672, DOI 10.1111/cea.12102; Agrawal T, 2012, J CLIN IMMUNOL, V32, P1093, DOI 10.1007/s10875-012-9696-x; Arshi S, 2014, ANN ALLERG ASTHMA IM, V113, P404, DOI 10.1016/j.anai.2014.07.005; Bener A, 2012, INT ARCH ALLERGY IMM, V157, P168, DOI 10.1159/000323941; Berair R, 2014, ASTHMA THERAPY ITS E; Bergeron C, 2010, CAN RESPIR J, V17, pE85, DOI 10.1155/2010/318029; Bergeron Celine, 2009, Proc Am Thorac Soc, V6, P301, DOI 10.1513/pats.200808-089RM; Berraies A, 2014, J ASTHMA ALLERGY, V7, P23, DOI 10.2147/JAA.S46944; Castro M, 2014, JAMA-J AM MED ASSOC, V311, P2083, DOI 10.1001/jama.2014.5052; Cupisti A, 2015, INT J NEPHROL RENOV, V8, P151, DOI 10.2147/IJNRD.S90968; De Wever O, 2004, J CELL SCI, V117, P4691, DOI 10.1242/jcs.01322; Doerner AM, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-100; Fan M, 2006, INT IMMUNOPHARMACOL, V6, P36, DOI 10.1016/j.intimp.2005.07.008; Fischer KD, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0146-6; Foong RE, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.276; Freishtat RJ, 2010, J PEDIATR-US, V156, P948, DOI 10.1016/j.jpeds.2009.12.033; Ge XN, 2010, J IMMUNOL, V185, P1205, DOI 10.4049/jimmunol.1000039; Gorman S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067823; Gorman S, 2012, PEDIAT ALLERG IMM-UK, V23, P83, DOI 10.1111/j.1399-3038.2011.01146.x; Hackett TL, 2013, AM J RESP CELL MOL, V49, P662, DOI 10.1165/rcmb.2013-0124OC; Hansdottir S, 2010, J IMMUNOL, V184, P965, DOI 10.4049/jimmunol.0902840; Hatami G, 2014, IRAN J PEDIATR, V24, P710; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641; Johnson JR, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-118; Johnson JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016175; Kelly MM, 2010, J ALLERGY CLIN IMMUN, V125, P349, DOI 10.1016/j.jaci.2009.09.011; Kim MH, 2014, J ENDOCRINOL, V220, P117, DOI 10.1530/JOE-13-0381; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Lemanske Robert F. Jr., 2003, Journal of Allergy and Clinical Immunology, V111, pS502; Locke NR, 2007, AM J RESP CELL MOL, V36, P625, DOI 10.1165/rcmb.2006-0083OC; Majak P, 2011, J ALLERGY CLIN IMMUN, V127, P1294, DOI 10.1016/j.jaci.2010.12.016; Micallef L, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S5; Muehleisen B, 2013, J ALLERGY CLIN IMMUN, V131, P324, DOI 10.1016/j.jaci.2012.12.1562; Nanzer AM, 2014, J ALLERGY CLIN IMMUN, V133, P1755, DOI 10.1016/j.jaci.2014.03.015; Nials AT, 2008, DIS MODEL MECH, V1, P213, DOI 10.1242/dmm.000323; Ramirez AM, 2010, J STEROID BIOCHEM, V118, P142, DOI 10.1016/j.jsbmb.2009.11.004; Rosen CJ, 2012, J CLIN ENDOCR METAB, V97, P1146, DOI 10.1210/jc.2011-2218; Shao ZF, 2009, J ALLERGY CLIN IMMUN, V123, P917, DOI 10.1016/j.jaci.2009.01.052; Sorkness RL, 2007, AM J PHYSIOL-LUNG C, V292, pL85, DOI 10.1152/ajplung.00234.2006; Sun Z, 2014, MICROCIRCULATION, V21, P208, DOI 10.1111/micc.12123; Taher YA, 2008, J IMMUNOL, V180, P5211, DOI 10.4049/jimmunol.180.8.5211; Yawn J, 2015, J STEROID BIOCHEM, V148, P326, DOI 10.1016/j.jsbmb.2015.01.017; Yin K, 2014, J INFLAMM RES, V7, P69, DOI 10.2147/JIR.S63898; Zhang M, 2009, LUNG, V187, P187, DOI 10.1007/s00408-009-9139-5	45	28	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149180	10.1371/journal.pone.0149180	http://dx.doi.org/10.1371/journal.pone.0149180			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872336	gold, Green Published, Green Submitted			2022-12-27	WOS:000370054100120
J	Hu, JZ; Ni, SF; Cao, Y; Zhang, T; Wu, TD; Yin, XZ; Lang, Y; Lu, HB				Hu, Jianzhong; Ni, Shuangfei; Cao, Yong; Zhang, Tao; Wu, Tianding; Yin, Xianzhen; Lang, Ye; Lu, Hongbin			The Angiogenic Effect of microRNA-21 Targeting TIMP3 through the Regulation of MMP2 and MMP9	PLOS ONE			English	Article							SPINAL-CORD-INJURY; TISSUE INHIBITOR; MATRIX METALLOPROTEINASES; IN-VITRO; CONTUSION INJURY; DOWN-REGULATION; TUMOR-GROWTH; MIR-21; APOPTOSIS; EXPRESSION	microRNAs are a novel set of small, non-protein-coding nucleotide RNAs that negatively regulate the expression of target mRNAs. miRNA-21 is a microRNA that is highly enriched in endothelial cells. miRNA-21 has been shown to be a potential pro-angiogenic factor in some biological systems. Our previous study showed that the expression of miRNA-21 was up-regulated after spinal cord injury. However, the effect of miRNA-21 on angiogenesis in the spinal cord was unclear. In this study, to understand the role of miRNA-21 on injured endothelial cells exclusively, an oxygen and glucose deprivation model of endothelial cells was constructed, and the up-regulation of miRNA-21 was discovered in this model. An increased level of miRNA-21 by mimics promoted the survival, migration and tube formation of endothelial cells, which simultaneously inhibited tissue inhibitor of metalloproteinase-3 (TIMP3) expression and promoted matrix metalloproteinase-2 (MMP2) and matrix metalloproteinase-9 (MMP9) expression and secretion. A decreased level of miRNA-21 by antagomir exerted an opposite effect. As is well known, survival, migration and tube formation of endothelial cells are necessary prerequisites for angiogenesis after injury. TIMP3 was validated as a direct target of miRNA-21 by dual-luciferase reporter assay. Silencing with small interfering RNA against TIMP3 promoted tube formation and increased MMP2 and MMP9 expression at the protein level. In vivo, we found that decreased levels of miRNA-21 inhibited angiogenesis after spinal cord injury in rats using synchrotron radiation micro-computed tomography. In summary, these findings suggest that miRNA-21 has a protective effect on angiogenesis by reducing cell death and promoting cell survival, migration and tube formation via partially targeting the TIMP3 by potentially regulating MMP2 and MMP9. TIMP3 is a functional target gene. Identifying the role of miRNA-21 in the protection of angiogenesis might offer a novel therapeutic target for secondary spinal cord injury, in which angiogenesis is indispensable.	[Hu, Jianzhong; Ni, Shuangfei; Cao, Yong; Zhang, Tao; Wu, Tianding; Lang, Ye] Cent S Univ, Xiangya Hosp, Dept Spine Surg, Changsha 410008, Hunan, Peoples R China; [Yin, Xianzhen] Chinese Acad Sci, Shanghai Inst Mat Med, Ctr Drug Delivery Syst, Shanghai 201203, Peoples R China; [Lu, Hongbin] Cent S Univ, Xiangya Hosp, Res Ctr Sports Med, Dept Sports Med, Changsha 410008, Hunan, Peoples R China	Central South University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Central South University	Lu, HB (corresponding author), Cent S Univ, Xiangya Hosp, Res Ctr Sports Med, Dept Sports Med, Changsha 410008, Hunan, Peoples R China.	hongbinlu@hotmail.com		Yin, Xianzhen/0000-0002-7870-1718	National Natural Science Foundation of China [81371956, 81171698]; Specialized Research Fund for the Doctoral Program of Higher Education [20130162110078]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Foundation of China (No. 81371956 and No. 81171698) and Specialized Research Fund for the Doctoral Program of Higher Education (No. 20130162110078). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, J Spinal Cord Med, V36, P715, DOI 10.1179/1079026813Z.000000000230; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Benton RL, 2009, ASN NEURO, V1, DOI 10.1042/AN20090008; Bhalala OG, 2012, J NEUROSCI, V32, P17935, DOI 10.1523/JNEUROSCI.3860-12.2012; Bond M, 2000, J BIOL CHEM, V275, P41358, DOI 10.1074/jbc.M007929200; Brown RC, 2005, BIOCHEM BIOPH RES CO, V327, P1114, DOI 10.1016/j.bbrc.2004.12.123; Cao Y, 2015, SCI REP-UK, V5, DOI [10.1038/srep12643, 10.1038/srep18326]; Casella GTB, 2006, EXP NEUROL, V202, P8, DOI 10.1016/j.expneurol.2006.05.028; Casella GTB, 2002, EXP NEUROL, V173, P63, DOI 10.1006/exnr.2001.7827; Chang L, 2015, MOL MED REP, V12, P1197, DOI 10.3892/mmr.2015.3477; Clark IA, 2008, INT J BIOCHEM CELL B, V40, P1362, DOI 10.1016/j.biocel.2007.12.006; Das AM, 2014, ANGIOGENESIS, V17, P163, DOI 10.1007/s10456-013-9385-2; Deryugina EI, 2015, MATRIX BIOL, V44-46, P94, DOI 10.1016/j.matbio.2015.04.004; Di Giovanni S, 2003, ANN NEUROL, V53, P454, DOI 10.1002/ana.10472; Dray C, 2009, P NATL ACAD SCI USA, V106, P9459, DOI 10.1073/pnas.0900222106; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002; Handsley MM, 2005, INT J CANCER, V115, P849, DOI 10.1002/ijc.20945; Hu JZ, 2013, J NEUROTRAUM, V30, P1349, DOI 10.1089/neu.2012.2748; Hu JZ, 2014, MED PHYS, V41, DOI 10.1118/1.4894704; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Jiang FS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/501581; Kang KH, 2008, CARDIOVASC RES, V79, P150, DOI 10.1093/cvr/cvn072; Lambert V, 2003, FASEB J, V17, P2290, DOI 10.1096/fj.03-0113fje; Lan FM, 2015, J NEUROCHEM, V134, P811, DOI 10.1111/jnc.13174; Li ZB, 2015, EUR REV MED PHARMACO, V19, P3208; Liu NK, 2009, EXP NEUROL, V219, P424, DOI 10.1016/j.expneurol.2009.06.015; Ma XD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8151; Ma XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082604; Naglich JG, 2001, CANCER RES, V61, P8480; Nieto-Diaz M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00053; Ning B, 2014, INT J BIOL SCI, V10, P997, DOI 10.7150/ijbs.9058; Ouyang YB, 2014, NEUROSCI LETT, V565, P53, DOI 10.1016/j.neulet.2013.11.015; Qi JH, 2003, NAT MED, V9, P407, DOI 10.1038/nm846; Qi JH, 2015, APOPTOSIS, V20, P523, DOI 10.1007/s10495-014-1076-y; Rundhaug JE, 2005, J CELL MOL MED, V9, P267, DOI 10.1111/j.1582-4934.2005.tb00355.x; Schrimpf C, 2012, J AM SOC NEPHROL, V23, P868, DOI 10.1681/ASN.2011080851; Senger DR, 2011, CSH PERSPECT BIOL, V3, DOI DOI 10.1101/cshperspect.a005090; Surey S, 2014, NEUROSCIENCE, V275, P62, DOI 10.1016/j.neuroscience.2014.06.003; Voellenkle C, 2012, RNA, V18, P472, DOI 10.1261/rna.027615.111; Wang CB, 2014, COGN NEUROSCI-UK, V5, P3, DOI 10.1080/17588928.2013.797388; Wang LJ, 2015, ONCOTARGET, V6, P5932, DOI 10.18632/oncotarget.3465; Wang N, 2013, DIGEST DIS SCI, V58, P1863, DOI 10.1007/s10620-013-2612-2; Wang SS, 2009, CURR OPIN GENET DEV, V19, P205, DOI 10.1016/j.gde.2009.04.002; Yang XL, 2013, NUCLEIC ACIDS RES, V41, P9688, DOI 10.1093/nar/gkt680; Yang Y, 2015, BRAIN RES, V1623, P30, DOI 10.1016/j.brainres.2015.04.024; Yoon YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068600; Yu YM, 2011, EUR J NEUROSCI, V33, P1587, DOI 10.1111/j.1460-9568.2011.07643.x; Zen K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001826; Zhang AM, 2011, UROLOGY, V78, DOI 10.1016/j.urology.2011.03.030; Zhang L, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-30; Zhang MQ, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130670; Zhang W, 2014, ONCOL REP, V32, P1913, DOI 10.3892/or.2014.3418; Zhang WF, 2013, CELL BIOL INT, V37, P47, DOI 10.1002/cbin.10011; Zhao Y, 2013, TOXICOL LETT, V223, P35, DOI 10.1016/j.toxlet.2013.08.020	54	43	46	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149537	10.1371/journal.pone.0149537	http://dx.doi.org/10.1371/journal.pone.0149537			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872030	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100163
J	Jiang, S; Zheng, XY; Yu, PY; Yue, XY; Ahmed, M; Cai, DY; Teng, YW				Jiang, Shuang; Zheng, Xiaoyan; Yu, Peiyuan; Yue, Xiaoyan; Ahmed, Maqsood; Cai, Danying; Teng, Yuanwen			Primitive Genepools of Asian Pears and Their Complex Hybrid Origins Inferred from Fluorescent Sequence-Specific Amplification Polymorphism (SSAP) Markers Based on LTR Retrotransposons	PLOS ONE			English	Article							GENETIC-RELATIONSHIPS; PHYLOGENETIC UTILITY; HYPERVARIABLE REGIONS; PYRUS SPP.; GENOME; DIVERSITY; DNA; CULTIVARS; AFLP; CLASSIFICATION	Recent evidence indicated that interspecific hybridization was the major mode of evolution in Pyrus. The genetic relationships and origins of the Asian pear are still unclear because of frequent hybrid events, fast radial evolution, and lack of informative data. Here, we developed fluorescent sequence-specific amplification polymorphism (SSAP) markers with lots of informative sites and high polymorphism to analyze the population structure among 93 pear accessions, including nearly all species native to Asia. Results of a population structure analysis indicated that nearly all Asian pear species experienced hybridization, and originated from five primitive genepools. Four genepools corresponded to four primary Asian species: P. betulaefolia, P. pashia, P. pyrifolia, and P. ussuriensis. However, cultivars of P. ussuriensis were not monophyletic and introgression occurred from P. pyrifolia. The specific genepool detected in putative hybrids between occidental and oriental pears might be from occidental pears. The remaining species, including P. calleryana, P. xerophila, P. sinkiangensis, P. phaeocarpa, P. hondoensis, and P. hopeiensis in Asia, were inferred to be of hybrid origins and their possible genepools were identified. This study will be of great help for understanding the origin and evolution of Asian pears.	[Jiang, Shuang; Yu, Peiyuan; Yue, Xiaoyan; Teng, Yuanwen] Zhejiang Univ, Dept Hort, State Agr Minist Key Lab Hort Plant Growth Dev &, Hangzhou 310058, Zhejiang, Peoples R China; [Jiang, Shuang] Shanghai Acad Agr Sci, Forest & Fruit Tree Inst, Shanghai 201403, Peoples R China; [Zheng, Xiaoyan] Lishui Univ, Inst Hort & Landscape, Coll Ecol, Lishui 323000, Zhejiang, Peoples R China; [Ahmed, Maqsood] MUST, Dept Biotechnol, Main Allama Iqbal Rd, Mirpur 10250, Azad Kashmir, Pakistan; [Cai, Danying] Zhejiang Acad Agr Sci, Inst Hort, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Shanghai Academy of Agricultural Sciences; Lishui University; Zhejiang Academy of Agricultural Sciences	Teng, YW (corresponding author), Zhejiang Univ, Dept Hort, State Agr Minist Key Lab Hort Plant Growth Dev &, Hangzhou 310058, Zhejiang, Peoples R China.; Cai, DY (corresponding author), Zhejiang Acad Agr Sci, Inst Hort, Hangzhou, Zhejiang, Peoples R China.	dycai@zju.edu.cn; ywteng@zju.edu.cn	Teng, Yuanwen/A-3515-2015	Teng, Yuanwen/0000-0001-8656-9035	National Natural Science Foundation of China [31201592]; Specialized Research Fund for the Doctoral Program of Higher Education [20110101110091]; Grant for Innovative Research Team of Zhejiang Province of China [2013TD05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Grant for Innovative Research Team of Zhejiang Province of China	This research was funded by a Grant from the National Natural Science Foundation of China (No. 31201592, http://www.nsfc.gov.cn/) awarded to DC, and a Specialized Research Fund for the Doctoral Program of Higher Education (20110101110091, http://www.cutech.edu.cn/cn/index.htm) and a Grant for Innovative Research Team of Zhejiang Province of China (2013TD05, http://www.zjnsf.gov.cn/) awarded to YT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2010, AFR J BIOTECHNOL, V9, P8323; Bailey L, 1917, STANDARD CYCLOPEDIA, P2865; Bao L, 2008, SCI HORTIC-AMSTERDAM, V116, P374, DOI 10.1016/j.scienta.2008.02.008; Bao L, 2007, GENET RESOUR CROP EV, V54, P959, DOI 10.1007/s10722-006-9152-y; Bassil N, 2010, GENET RESOUR CROP EV, V57, P357, DOI 10.1007/s10722-009-9474-7; CHALLICE JS, 1973, BOT J LINN SOC, V67, P121, DOI 10.1111/j.1095-8339.1973.tb01734.x; Doyle J. J., 1987, PHYTOCHEM B, P11; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Havecker ER, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-225; Iketani H, 1998, GENET RESOUR CROP EV, V45, P533, DOI 10.1023/A:1008646016181; Iketani H, 2012, PLANT SYST EVOL, V298, P1689, DOI 10.1007/s00606-012-0670-0; Iketani H, 2010, CONSERV GENET, V11, P115, DOI 10.1007/s10592-009-0009-8; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jiang S, 2015, MOL GENET GENOMICS, V290, P225, DOI 10.1007/s00438-014-0914-5; Kalendar R, 2011, HEREDITY, V106, P520, DOI 10.1038/hdy.2010.93; Katayama H, 2012, TREE GENET GENOMES, V8, P313, DOI 10.1007/s11295-011-0442-y; KIKUCHI A, 1948, HORTICULTURE FRUIT T; Kim H, 2012, BREEDING SCI, V62, P53, DOI 10.1270/jsbbs.62.53; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Liu J, 2013, TREE GENET GENOMES, V9, P433, DOI 10.1007/s11295-012-0564-x; Lo EYY, 2012, MOL PHYLOGENET EVOL, V63, P230, DOI 10.1016/j.ympev.2011.10.005; Monte-Corvo L, 2000, GENET RESOUR CROP EV, V47, P257, DOI 10.1023/A:1008794809807; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Peterson DG, 2002, GENOME RES, V12, P795, DOI 10.1101/gr.226102; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rubtsov GA, 1944, AM NAT, V78, P358, DOI 10.1086/281206; Sabot F, 2006, HEREDITY, V97, P381, DOI 10.1038/sj.hdy.6800903; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Syed NH, 2006, THEOR APPL GENET, V112, P517, DOI 10.1007/s00122-005-0155-4; Syed NH, 2007, NATURE PROTOCOLS, V1, P2746; Tam SM, 2005, THEOR APPL GENET, V110, P819, DOI 10.1007/s00122-004-1837-z; Teng Y, 2004, ACTA HORTIC, P175, DOI 10.17660/ActaHortic.2004.634.21; Teng YW, 2002, J AM SOC HORTIC SCI, V127, P262, DOI 10.21273/JASHS.127.2.262; Teng YW, 2001, J HORTIC SCI BIOTECH, V76, P771; VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Waugh R, 1997, MOL GEN GENET, V253, P687, DOI 10.1007/s004380050372; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wu J, 2013, GENOME RES, V23, P396, DOI 10.1101/gr.144311.112; Wuyun T, 2013, TREE GENET GENOMES, V9, P167, DOI 10.1007/s11295-012-0544-1; Yu D. J., 1979, TAXONOMY FRUIT TREE; Zheng XY, 2008, MOL PHYLOGENET EVOL, V48, P892, DOI 10.1016/j.ympev.2008.05.039; Zheng XY, 2014, MOL PHYLOGENET EVOL, V80, P54, DOI 10.1016/j.ympev.2014.07.009; Zheng XY, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-255	49	19	24	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149192	10.1371/journal.pone.0149192	http://dx.doi.org/10.1371/journal.pone.0149192			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871452	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100123
J	Li, XQ; Ma, N; Li, XG; Wang, B; Sun, SS; Gao, F; Mo, DP; Song, LG; Sun, X; Liu, L; Zhao, XQ; Wang, YL; Wang, YJ; Zhao, ZG; Miao, ZR				Li, Xiao-Qing; Ma, Ning; Li, Xin-Gang; Wang, Bo; Sun, Shu-Sen; Gao, Feng; Mo, Da-Peng; Song, Li-Gang; Sun, Xuan; Liu, Lian; Zhao, Xing-Quan; Wang, Yi-Long; Wang, Yong-Jun; Zhao, Zhi-Gang; Miao, Zhong-Rong			Association of PON1, P2Y12 and COX1 with Recurrent Ischemic Events in Patients with Extracranial or Intracranial Stenting	PLOS ONE			English	Article							CLOPIDOGREL PLATELET REACTIVITY; PERCUTANEOUS CORONARY INTERVENTION; GENE SEQUENCE VARIATIONS; PROTON PUMP INHIBITORS; CHINESE PATIENTS; ANTIPLATELET THERAPY; RESPONSE VARIABILITY; ASPIRIN RESISTANCE; CYTOCHROME-P450 3A; P2Y(12) RECEPTOR	Background and Purpose Short-term combined use of clopidogrel and aspirin improves cerebrovascular outcomes in patients with symptomatic extracranial or intracranial stenosis. Antiplatelet non-responsiveness is related to recurrent ischemic events, but the culprit genetic variants responsible for the non-responsiveness have not been well studied. We aimed to identify the genetic variants associated with poor clinical outcomes. Methods Patients with symptomatic extracranial or intracranial stenosis scheduled for stenting and receiving dual antiplatelets (clopidogrel 75 mg and aspirin 100 mg daily) for at least 5 days before intervention were enrolled. Ischemic events including recurrent transient ischemic attack, stroke, myocardial infarction, and vascular-related mortality within 12 months follow-up were recorded. We examined the influence of genetic polymorphisms on treatment outcome in our patients. Results A total of 268 patients were enrolled into our study and ischemic events were observed in 39 patients. For rs662 of paraoxonase 1 (PON1), allele C was associated with an increased risk of ischemic events (OR = 1.64, 95% CI = 1.03-2.62, P = 0.029). The A-allele carriers of rs2046934 of P2Y12 had a significant association with adverse events (OR = 2.01, 95% CI = 1.10-3.67, P = 0.041). The variant T-allele of cyclooxygenase-1 (COX1) rs1330344 significantly increased the risk of recurrent clinical events (OR = 1.85, 95% CI = 1.12-3.03, P = 0.017). The other single nucleotide polymorphism (SNP) had no association with ischemic events. Conclusions PON1, P2Y12 and COX1 polymorphisms were associated with poorer vascular outcomes. Testing for these polymorphisms may be valuable in the identification of patients at risk for recurrent ischemic events.	[Li, Xiao-Qing; Ma, Ning; Wang, Bo; Gao, Feng; Mo, Da-Peng; Song, Li-Gang; Sun, Xuan; Liu, Lian; Miao, Zhong-Rong] Capital Med Univ, Beijing Tiantan Hosp, Dept Intervent Neuroradiol, Natl Clin Res Ctr Neurol Dis,Ctr Stroke,Beijing I, Beijing, Peoples R China; [Li, Xiao-Qing] Shaanxi Prov Peoples Hosp, Dept Neurol, Xian, Peoples R China; [Li, Xin-Gang; Zhao, Zhi-Gang] Capital Med Univ, Beijing Tiantan Hosp, Dept Pharm, Beijing, Peoples R China; [Sun, Shu-Sen] Western New England Univ, Coll Pharm, Springfield, MA USA; [Zhao, Xing-Quan; Wang, Yi-Long; Wang, Yong-Jun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China	Capital Medical University; Xi'an Medical University; Capital Medical University; Western New England University; Capital Medical University	Miao, ZR (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Intervent Neuroradiol, Natl Clin Res Ctr Neurol Dis,Ctr Stroke,Beijing I, Beijing, Peoples R China.; Zhao, ZG (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Pharm, Beijing, Peoples R China.	1022zzg@sina.com; zhongrongm@163.com		Li, Xingang/0000-0001-6726-9571	National Natural Science Foundation of China [81371290, 81503157]; Beijing High-level Personnel Funds [2013-2-19]; Beijing Key Laboratory of Translational Medicine for Cerebrovascular Diseases [2014NXGZ01]; National Science and Technology Support Program of 'The 12th Five-Year Plan' of the Ministry of Science and Technology; Organization Department of Beijing Municipal Committee [2014000021469G258]; Social Development Key Projects of Shannxi Province [12015SF023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing High-level Personnel Funds; Beijing Key Laboratory of Translational Medicine for Cerebrovascular Diseases; National Science and Technology Support Program of 'The 12th Five-Year Plan' of the Ministry of Science and Technology; Organization Department of Beijing Municipal Committee; Social Development Key Projects of Shannxi Province	This study was funded by the National Natural Science Foundation of China (81371290, 81503157), Beijing High-level Personnel Funds (2013-2-19), National Science and Technology Support Program of 'The 12th Five-Year Plan' of the Ministry of Science and Technology, Beijing Key Laboratory of Translational Medicine for Cerebrovascular Diseases (2014NXGZ01), Organization Department of Beijing Municipal Committee (2014000021469G258) and Social Development Key Projects of Shannxi Province (12015SF023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angiolillo DJ, 2007, J AM COLL CARDIOL, V49, P1505, DOI 10.1016/j.jacc.2006.11.044; Angiolillo DJ, 2009, AM J CARDIOL, V103, p27A, DOI 10.1016/j.amjcard.2008.11.020; Anselmi CV, 2013, JACC-CARDIOVASC INTE, V6, P1166, DOI 10.1016/j.jcin.2013.06.010; Bliden KP, 2007, J AM COLL CARDIOL, V49, P657, DOI 10.1016/j.jacc.2006.10.050; Bouman HJ, 2011, NAT MED, V17, P110, DOI 10.1038/nm.2281; Brown DG, 2015, J AM ACAD DERMATOL, V72, P524, DOI 10.1016/j.jaad.2014.10.027; Campo G, 2011, J THROMB HAEMOST, V9, P2106, DOI 10.1111/j.1538-7836.2011.04457.x; Cao LP, 2014, GENE, V546, P172, DOI 10.1016/j.gene.2014.06.023; Cavallari U, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-59; Chai Y, 2013, INT J NEUROSCI, V123, P752, DOI 10.3109/00207454.2013.798733; Clarke TA, 2003, DRUG METAB DISPOS, V31, P53, DOI 10.1124/dmd.31.1.53; Cuisset T, 2007, THROMB RES, V120, P893, DOI 10.1016/j.thromres.2007.01.012; Delaney JT, 2012, CLIN PHARMACOL THER, V91, P257, DOI 10.1038/clpt.2011.221; DEMORAIS SMF, 1994, MOL PHARMACOL, V46, P594; DEMORAIS SMF, 1994, J BIOL CHEM, V269, P15419; Fan L, 2013, GERONTOLOGY, V59, P122, DOI 10.1159/000342489; Farid NA, 2007, CLIN PHARMACOL THER, V81, P735, DOI 10.1038/sj.clpt.6100139; Fontana P, 2003, CIRCULATION, V108, P2971, DOI 10.1161/01.CIR.0000106904.80795.35; Fontana P, 2003, CIRCULATION, V108, P989, DOI 10.1161/01.CIR.0000085073.69189.88; Frelinger AL, 2013, J AM COLL CARDIOL, V61, P872, DOI 10.1016/j.jacc.2012.11.040; Geeganage CM, 2012, STROKE, V43, P1058, DOI 10.1161/STROKEAHA.111.637686; Gurbel PA, 2005, J AM COLL CARDIOL, V46, P1820, DOI 10.1016/j.jacc.2005.07.041; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; Ingelman-Sundberg M, 2007, PHARMACOL THERAPEUT, V116, P496, DOI 10.1016/j.pharmthera.2007.09.004; Li XL, 2013, CLIN APPL THROMB-HEM, V19, P513, DOI 10.1177/1076029612444002; Lins R, 1999, SEMIN THROMB HEMOST, V25, P29; Mackness B, 1998, GEN PHARMACOL-VASC S, V31, P329, DOI 10.1016/S0306-3623(98)00028-7; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Mooij MG, 2016, CLIN PHARMACOKINET, V55, P507, DOI 10.1007/s40262-015-0328-5; Oh IY, 2012, HEART, V98, P139, DOI 10.1136/hrt.2011.227272; Park KW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052779; Rudberg I, 2008, CLIN PHARMACOL THER, V83, P322, DOI 10.1038/sj.clpt.6100291; Savi P, 2000, THROMB HAEMOSTASIS, V84, P891, DOI 10.1055/s-0037-1614133; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Sibbing D, 2010, CIRCULATION, V121, P512, DOI 10.1161/CIRCULATIONAHA.109.885194; Sim SC, 2006, CLIN PHARMACOL THER, V79, P103, DOI 10.1016/j.clpt.2005.10.002; Storey RF, 2006, CURR PHARM DESIGN, V12, P1255, DOI 10.2174/138161206776361318; Tresukosol D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110188; Wang X, 2013, INT J STROKE, V8, P663, DOI 10.1111/j.1747-4949.2012.00828.x; Wu HY, 2013, INT J CARDIOL, V165, P204, DOI 10.1016/j.ijcard.2012.08.017; Wu HY, 2012, PHARMACOGENET GENOM, V22, P887, DOI 10.1097/FPC.0b013e328359253a; Xie C, 2014, PHARMACOGENET GENOM, V24, P204, DOI 10.1097/FPC.0000000000000035; Zhang LN, 2013, THROMB RES, V132, P81, DOI 10.1016/j.thromres.2013.05.006; Zhu P, 2013, J APPL MATH, DOI 10.1155/2013/105752	45	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148891	10.1371/journal.pone.0148891	http://dx.doi.org/10.1371/journal.pone.0148891			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26870959	gold, Green Published, Green Submitted			2022-12-27	WOS:000370054100068
J	Sango, HA; Testa, J; Meda, N; Contrand, B; Traore, MS; Staccini, P; Lagarde, E				Sango, Hammadoum A.; Testa, Jean; Meda, Nicolas; Contrand, Benjamin; Traore, Mamadou S.; Staccini, Pascal; Lagarde, Emmanuel			Mortality and Morbidity of Urban Road Traffic Crashes in Africa: Capture-Recapture Estimates in Bamako, Mali, 2012	PLOS ONE			English	Article							INJURIES; CASUALTIES; PAKISTAN; KARACHI; POLICE; FRANCE	Background Low- and middle-income countries are currently facing the massive public health challenge of road traffic injuries. The lack of effective surveillance systems hinders proper assessment of epidemiologic status and intervention priorities. The objective of our study was to estimate the mortality and morbidity attributable to road crashes in Bamako, Mali using the capture-recapture method. Methods During the 1 January, 2012-31 April, 2012 period, we collected data on road traffic crashes from the road accident registers of the police forces of Bamako, Mali on the one hand, and from a register kept by health facilities in the same area. An automatic, then manual matching procedure was performed to find pairs of records related to the same crash victims. The number of victims and the number of fatalities were estimated by the capture-recapture method using the Chapman estimator. Results The health facility and the police registries included 3587 and 1432 records, respectively. The matching procedure identified 603 common records, 31 of which were fatalities. The annual incidence estimate for road victims was 1038 in 100 000 and the annual incidence estimate for road fatalities was 12 in 100 000. Victims from both sources were more likely to be male, in the 15-34 age group, and almost half of all injured road users and two in three fatalities were using motorized two-wheelers. One victim out of five was a pedestrian. Conclusion Our estimates are in line with available literature data from low-income countries. While more cases were reported by health facilities than by police forces, we believe that an effective surveillance system should not be based solely on medical reports as much would be missing as regards the crash circumstances and characteristics.	[Sango, Hammadoum A.; Traore, Mamadou S.] Univ Sci Tech & Technol Bamako, Fac Med & Odontostomatol, Dept Enseignement & Rech Sante Publ & Specialites, Bamako, Mali; [Testa, Jean; Meda, Nicolas] Minist Sante, Ctr MURAZ, Dept Sante Publ, Bobo Dioulasso, Burkina Faso; [Contrand, Benjamin; Lagarde, Emmanuel] Univ Bordeaux 2, INSERM, U897, Equipe Prevent & Prise Charge Traumatismes,ISPED, F-33076 Bordeaux, France; [Staccini, Pascal] Univ Nice Sophia Antipolis, INSERM, UMR 912, Dept Ingn Risque & Informat Sante,SESSTIM, F-06189 Nice, France; [Meda, Nicolas] Univ Ouagadougou, UFR Sci Sante, Ctr Rech Int Sante, Ouagadougou, Burkina Faso; [Traore, Mamadou S.] Minist Sante & Hyg Publ, INRSP, Bamako, Mali	University of Science & Technology of Bamako; Centre Muraz; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Testa, J (corresponding author), Minist Sante, Ctr MURAZ, Dept Sante Publ, Bobo Dioulasso, Burkina Faso.	jean.testa@centre-muraz.bf	contrand, benjamin/T-1994-2019; Lagarde, Emmanuel/F-7132-2013	Lagarde, Emmanuel/0000-0001-8031-7400				Abegaz T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103001; Amoros E, 2008, EUR J PUBLIC HEALTH, V18, P360, DOI 10.1093/eurpub/ckn018; Amoros E, 2006, ACCIDENT ANAL PREV, V38, P627, DOI 10.1016/j.aap.2005.11.006; Chapman DG, 1951, SOME PROPERTIES HYPE; Constant A, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000228; Dhillon PK, 2001, ACCIDENT ANAL PREV, V33, P529, DOI 10.1016/S0001-4575(00)00066-X; Kudryavtsev AV, 2013, INT J INJ CONTROL SA, V20, P349, DOI 10.1080/17457300.2012.745576; Lagarde E, 2007, PLOS MED, V4, P967, DOI 10.1371/journal.pmed.0040170; Lateef MU, 2010, ASIA-PAC J PUBLIC HE, V22, P332, DOI 10.1177/1010539509356808; Razzak JA, 1998, INT J EPIDEMIOL, V27, P866, DOI 10.1093/ije/27.5.866; Republic of Mali, 2001, INT ORD 3073 MICT MS, P6; Samuel JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031091; Tercero F, 2004, ACCIDENT ANAL PREV, V36, P13, DOI 10.1016/S0001-4575(02)00109-4; Tercero F, 1998, INT J CONSUMER PRODU, V5, P99; Van Hung Trinh, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P405; WHO, 2013, GLOB STAT REP ROAD S, P318; WHO, 2009, ROAD SAF WORLD REP S; Zavareh DK, 2008, INT J INJ CONTROL SA, V15, P9, DOI 10.1080/17457300701794105	18	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149070	10.1371/journal.pone.0149070	http://dx.doi.org/10.1371/journal.pone.0149070			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6SI	26871569	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100097
J	Yun, BH; Chon, SJ; Choi, YS; Cho, S; Lee, BS; Seo, SK				Yun, Bo Hyon; Chon, Seung Joo; Choi, Young Sik; Cho, SiHyun; Lee, Byung Seok; Seo, Seok Kyo			Pathophysiology of Endometriosis: Role of High Mobility Group Box-1 and Toll-Like Receptor 4 Developing Inflammation in Endometrium	PLOS ONE			English	Article							NF-KAPPA-B; HMGB1; PATHOGENESIS; EXPRESSION; CYTOKINE; PROTEIN; DISEASE; TLR4	Oxidative stress has been proposed as a potential factor associated with the establishment and progression of endometriosis. Although a few studies have shown possible mechanisms which may play roles in development, progression of endometriosis, few are known in regards of initiation of the disease, especially in the relationship with endometrium. The aim of our study was to investigate whether normal endometrium may be changed by Damage-associated molecular patterns (DAMPs), which may contribute developing pathologic endometrium to induce endometriosis. Endometrial tissues were obtained from 10 patients with fibroids undergoing hysterectomy at a university hospital. High mobility group box-1 (HMGB-1), which is a representative DAMP, has been chosen that may induce alteration in endometrium. In preceding immunohistochemistry experiments using paraffin-block sections from endometriosis (N = 33) and control (N = 27) group, retrospectively, HMGB-1 expression was shown in both epithelial and stromal cell. HMGB-1 expression was significantly increased in secretory phase of endometriosis group, comparing to the controls. To examine the alteration of endometrial stromal cell (HESC) by oxidative stress in terms of HMGB-1, cell proliferation and expression of its receptor, TLR4 was measured according to recombinant HMGB-1 use. Cell proliferation was assessed by CCK-8 assay; real-time PCR and western blotting were used to quantify Toll like receptor 4 (TLR4) mRNA and protein expression respectively. A TLR4 antagonist (LPS-RS) and an inhibitor of the NF-kappa B pathway (TPCA-1, an IKK-2 inhibitor) were used to confirm the relationships between HMGB-1, TLR4, and the NF-kappa B pathway. Passive release of HMGB-1 was significantly proportional to the increase in cell death (P < 0.05). HESCs showed significant proliferation following treatment with rHMGB-1 (P < 0.05), and increased TLR4 expression was observed following rHMGB-1 treatment (P < 0.05) in a concentration-dependent manner. Treatment with a TLR4 antagonist and an NF-kappa B inhibitor resulted in suppression of rHMGB-1-induced HESC proliferation (P < 0.05). Levels of IL-6 were significantly decreased following treatment with an NF-kappa B inhibitor (P < 0.05). Our results support the development of altered, pathological endometrium resulted from oxidative stress in normal endometrium. These findings may provide important insights into the changes in endometrium linking the development and progression of endometriosis.	[Yun, Bo Hyon; Chon, Seung Joo; Choi, Young Sik; Lee, Byung Seok; Seo, Seok Kyo] Yonsei Univ, Coll Med, Severance Hosp, Dept Obstet & Gynecol, Seoul, South Korea; [Yun, Bo Hyon; Choi, Young Sik; Cho, SiHyun; Lee, Byung Seok; Seo, Seok Kyo] Yonsei Univ, Coll Med, Inst Womens Life Med Sci, Seoul, South Korea; [Chon, Seung Joo] Gachon Univ Med & Sci, Grad Sch Med, Gil Hosp, Dept Obstet & Gynecol, Inchon, South Korea; [Cho, SiHyun] Yonsei Univ, Coll Med, Dept Obstet & Gynecol, Gangnam Severance Hosp, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Gachon University; Yonsei University; Yonsei University Health System	Seo, SK (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Dept Obstet & Gynecol, Seoul, South Korea.; Seo, SK (corresponding author), Yonsei Univ, Coll Med, Inst Womens Life Med Sci, Seoul, South Korea.	tudeolseo@yuhs.ac		Yun, Bo Hyon/0000-0001-5703-797X; Cho, SiHyun/0000-0003-2718-6645; Choi, Young Sik/0000-0002-1157-4822; Seo, Seok Kyo/0000-0003-3404-0484; LEE, Byung Seok/0000-0001-6001-2079	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [NRF-2012R1A1A1013167]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (NRF-2012R1A1A1013167). The Design of study and the experiments were modified and supported by NRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson GD, 2010, J ENDOMETR PELVIC PA, V2, P3, DOI 10.1177/228402651000200102; Allhorn S, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-40; Andersson U, 2010, BBA-GENE REGUL MECH, V1799, P141, DOI 10.1016/j.bbagrm.2009.11.003; Barkauskaite V, 2007, LUPUS, V16, P794, DOI 10.1177/0961203307081895; Bhutada S, 2014, HUM REPROD, V29, P763, DOI 10.1093/humrep/det461; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Chapron C, 2006, HUM REPROD, V21, P1839, DOI 10.1093/humrep/del079; Dhupar R, 2011, SHOCK, V35, P293, DOI 10.1097/SHK.0b013e3181f6aab0; Gonzalez-Ramos R, 2012, FERTIL STERIL, V98, P520, DOI 10.1016/j.fertnstert.2012.06.021; Guo SW, 2007, GYNECOL OBSTET INVES, V63, P71, DOI 10.1159/000096047; Huang WC, 2010, CYTOKINE, V51, P119, DOI 10.1016/j.cyto.2010.02.021; Kang R, 2014, ONCOGENE, V33, P567, DOI 10.1038/onc.2012.631; Kobayashi H, 2014, MOL MED REP, V9, P9, DOI 10.3892/mmr.2013.1755; Lebovic DI, 2001, FERTIL STERIL, V75, P1, DOI 10.1016/S0015-0282(00)01630-7; Lee SA, 2014, YONSEI MED J, V55, P1165, DOI 10.3349/ymj.2014.55.5.1165; Lucidi RS, 2005, FERTIL STERIL, V84, P16, DOI 10.1016/j.fertnstert.2004.10.058; Maiorov EG, 2013, SEMIN CANCER BIOL, V23, P243, DOI 10.1016/j.semcancer.2013.05.003; Murphy AA, 1998, SEMIN REPROD ENDOCR, V16, P263, DOI 10.1055/s-2007-1016286; Ngo C, 2009, AM J PATHOL, V175, P225, DOI 10.2353/ajpath.2009.080804; Noyes R W, 1975, Am J Obstet Gynecol, V122, P262; Reis FM, 2013, HUM REPROD UPDATE, V19, P406, DOI 10.1093/humupd/dmt010; Sahu D, 2008, FEBS LETT, V582, P3973, DOI 10.1016/j.febslet.2008.09.061; Seo SK, 2010, HUM REPROD, V25, P1251, DOI 10.1093/humrep/deq027; Treutiger CJ, 2003, J INTERN MED, V254, P375, DOI 10.1046/j.1365-2796.2003.01204.x; van Beijnum JR, 2013, ONCOGENE, V32, P363, DOI 10.1038/onc.2012.49; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Weng H, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-311	29	27	30	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148165	10.1371/journal.pone.0148165	http://dx.doi.org/10.1371/journal.pone.0148165			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872033	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100019
J	Choudhury, D; Ghosh, A; Chanda, DD; Das Talukdar, A; Choudhury, MD; Paul, D; Maurya, AP; Chakravorty, A; Bhattacharjee, A				Choudhury, Debarati; Ghosh, Anamika; Chanda, Debadatta Dhar; Das Talukdar, Anupam; Choudhury, Manabendra Dutta; Paul, Deepjyoti; Maurya, Anand Prakash; Chakravorty, Atanu; Bhattacharjee, Amitabha			Premature Termination of MexR Leads to Overexpression of MexAB-OprM Efflux Pump in Pseudomonas aeruginosa in a Tertiary Referral Hospital in India	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; BETA-LACTAMASE; EXPRESSION; OPERON; PREVALENCE; EMERGENCE; REPRESSOR; SYSTEM; IMPACT	Objectives The present study was undertaken to investigate the mutations that are present in mexR gene of multidrug resistant (MDR) isolates of Pseudomonas aeruginosa collected from a tertiary referral hospital of north east India. Methods 76 MDR clinical isolates of P. aeruginosa were obtained from the patients who were admitted to or attended the clinics of Silchar medical college and hospital. They were screened phenotypically for the presence of efflux pump activity by an inhibitor based method. Acquired resistance mechanisms were detected by multiplex PCR. Real time PCR was performed to study the expression of mexA gene of MexAB-OprM efflux pump in isolates with increase efflux pump activity. mexR gene of the isolates with overexpressed MexAB-OprM efflux pump was amplified, sequenced and analysed. Results Out of 76 MDR isolates, 24 were found to exhibit efflux pump activity phenotypically against ciprofloxacin and meropenem. Acquired resistance mechanisms were absent in 11 of them and among those isolates, 8 of them overexpressed MexAB-OprM. All the 8 isolates possessed mutation in mexR gene. 11 transversions, 4 transitions, 2 deletion mutations and 2 insertion mutations were found in all the isolates. However, the most significant observation was the formation of a termination codon at 35th position which resulted in the termination of the polypeptide and leads to overexpression of the MexAB-OprM efflux pump. Conclusions This study highlighted emergence of a novel mutation which is probably associated with multi drug resistance. Therefore, further investigations and actions are needed to prevent or at least hold back the expansion and emergence of newer mutations in nosocomial pathogens which may compromise future treatment options.	[Choudhury, Debarati; Das Talukdar, Anupam; Choudhury, Manabendra Dutta] Assam Univ, Dept Life Sci & Bioinformat, Silchar, Assam, India; [Ghosh, Anamika; Paul, Deepjyoti; Maurya, Anand Prakash; Bhattacharjee, Amitabha] Assam Univ, Dept Microbiol, Silchar, Assam, India; [Chanda, Debadatta Dhar; Chakravorty, Atanu] Silchar Med Coll & Hosp, Dept Microbiol, Silchar, Assam, India	Assam University; Assam University	Bhattacharjee, A (corresponding author), Assam Univ, Dept Microbiol, Silchar, Assam, India.	ab0404@gmail.com	Choudhury, Manabendra/AAP-1817-2021	Paul, Deepjyoti/0000-0002-6078-9408; Ghose, Anamika/0000-0002-3616-3085; Dutta Choudhury, Manabendra/0000-0002-9472-0572; Talukdar, Anupam Das/0000-0001-8916-2791; Maurya, Anand Prakash/0000-0001-5231-8174	Department of Biotechnology (DBT) government of India [Assam University Institutional Biotech Hub] [BT/04/NE/2009]; University grants commission-basic scientific research fellowship [F.7-13/2007(BSR)]; DBT, Govt. of India; Department of Biotechnology (DBT) government of India [DBT-NER twining] [BCIL/NER-BPMC/2014-203]	Department of Biotechnology (DBT) government of India [Assam University Institutional Biotech Hub]; University grants commission-basic scientific research fellowship; DBT, Govt. of India(Department of Biotechnology (DBT) India); Department of Biotechnology (DBT) government of India [DBT-NER twining]	This work was supported by the Department of Biotechnology (DBT) government of India [Assam University Institutional Biotech Hub (BT/04/NE/2009), DBT-NER twining (BCIL/NER-BPMC/2014-203)] (www.dbtindia.nic.in); University grants commission-basic scientific research fellowship(F.7-13/2007(BSR))(www.ugc.ac.in). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the help from Assam University Biotech Hub for providing laboratory facility to complete this work. They also acknowledge the help of HOD, Microbiology, Assam University for providing infrastructure. e-journal access facility provided by Bioinformatics Centre, Assam University, Assam funded by DBT, Govt. of India is acknowledged. The authors are indebted to Prof. K. Poole, Queens University, Canada, for providing strains (P. aeruginosa PAO1 and P. aeruginosa knockout mutant of MexAB-OprM).	Clinical and Laboratory Standards Institute Performance standards for Antimicrobial Susceptibility Testing Twenty-First Informational Supplement, M100S21 CLSI; Evans K, 2001, J BACTERIOL, V183, P807, DOI 10.1128/JB.183.3.807-812.2001; Hirsch EB, 2010, EXPERT REV PHARM OUT, V10, P441, DOI [10.1586/erp.10.49, 10.1586/ERP.10.49]; Jh Y., 2002, J ANTIMICROB CHEMOTH, V49, P837; Kriengkauykiat J, 2005, ANTIMICROB AGENTS CH, V49, P565, DOI 10.1128/AAC.49.2.565-570.2005; Lim D, 2002, J BIOL CHEM, V277, P29253, DOI 10.1074/jbc.M111381200; Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09; Livermore DM, 2001, J ANTIMICROB CHEMOTH, V47, P247, DOI 10.1093/jac/47.3.247; Llanes C, 2004, ANTIMICROB AGENTS CH, V48, P1797, DOI 10.1128/AAC.48.5.1797-1802.2004; Maurya AP, 2014, ANTIMICROB AGENTS CH, V58, P6966, DOI 10.1128/AAC.02365-14; Mendes RE, 2009, J ANTIMICROB CHEMOTH, V63, P55, DOI 10.1093/jac/dkn434; Mesaros N, 2007, J ANTIMICROB CHEMOTH, V59, P378, DOI 10.1093/jac/dkl504; Poole K, 1996, ANTIMICROB AGENTS CH, V40, P2021, DOI 10.1128/AAC.40.9.2021; Poole K, 2001, J MOL MICROB BIOTECH, V3, P255; Pournaras S, 2005, J ANTIMICROB CHEMOTH, V56, P761, DOI 10.1093/jac/dki296; Quale J, 2006, ANTIMICROB AGENTS CH, V50, P1633, DOI 10.1128/AAC.50.5.1633-1641.2006; Rodriguez-Martinez JM, 2009, ANTIMICROB AGENTS CH, V53, P4783, DOI 10.1128/AAC.00574-09; Saito K, 2001, FEMS MICROBIOL LETT, V195, P23, DOI 10.1016/S0378-1097(00)00539-5; Shibl A, 2013, INT J INFECT DIS, V17, pE1130, DOI 10.1016/j.ijid.2013.06.016; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Wu JJ, 2007, ANTIMICROB AGENTS CH, V51, P1223, DOI 10.1128/AAC.01195-06; Xavier DE, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-217; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Ziha-Zarifi I, 1999, ANTIMICROB AGENTS CH, V43, P287, DOI 10.1128/AAC.43.2.287	25	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149156	10.1371/journal.pone.0149156	http://dx.doi.org/10.1371/journal.pone.0149156			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866484	gold, Green Submitted, Green Published			2022-12-27	WOS:000370050700075
J	Mahoney, JM; Titiz, AS; Hernan, AE; Scott, RC				Mahoney, J. Matthew; Titiz, Ali S.; Hernan, Amanda E.; Scott, Rod C.			Short-Range Temporal Interactions in Sleep; Hippocampal Spike Avalanches Support a Large Milieu of Sequential Activity Including Replay	PLOS ONE			English	Article							PLACE-CELL SEQUENCES; FIRING PATTERNS; MEMORY; ORGANIZATION; ASSEMBLIES	Hippocampal neural systems consolidate multiple complex behaviors into memory. However, the temporal structure of neural firing supporting complex memory consolidation is unknown. Replay of hippocampal place cells during sleep supports the view that a simple repetitive behavior modifies sleep firing dynamics, but does not explain how multiple episodes could be integrated into associative networks for recollection during future cognition. Here we decode sequential firing structure within spike avalanches of all pyramidal cells recorded in sleeping rats after running in a circular track. We find that short sequences that combine into multiple long sequences capture the majority of the sequential structure during sleep, including replay of hippocampal place cells. The ensemble, however, is not optimized for maximally producing the behavior-enriched episode. Thus behavioral programming of sequential correlations occurs at the level of short-range interactions, not whole behavioral sequences and these short sequences are assembled into a large and complex milieu that could support complex memory consolidation.	[Mahoney, J. Matthew; Hernan, Amanda E.; Scott, Rod C.] Univ Vermont, Coll Med, Dept Neurol Sci, Burlington, VT 05405 USA; [Titiz, Ali S.] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA 90095 USA; [Scott, Rod C.] UCL, Inst Child Hlth, Neurosci Unit, London, England	University of Vermont; University of California System; University of California Los Angeles; University of London; University College London	Mahoney, JM (corresponding author), Univ Vermont, Coll Med, Dept Neurol Sci, Burlington, VT 05405 USA.	John.M.Mahoney@uvm.edu		Hernan, Amanda/0000-0003-4931-3481; Scott, Rod/0000-0002-8944-928X	National Institutes of Health [NS074450, NS073083, R01-NS075249]; Great Ormond Street Hospital Children's Charity; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075249, R01NS074450, R01NS073083] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Great Ormond Street Hospital Children's Charity; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by the following: National Institutes of Health grants (RCS): NS074450, NS073083, and R01-NS075249; and Great Ormond Street Hospital Children's Charity (RCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MI, 2003, J NEUROSCI, V23, P8827; Battaglia FP, 2011, TRENDS COGN SCI, V15, P310, DOI 10.1016/j.tics.2011.05.008; Beggs JM, 2003, J NEUROSCIENCE; Beggs JM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00163; Begleiter R, 2004, J ARTIF INTELL RES, V22, P385, DOI 10.1613/jair.1491; Bendor D, 2012, NAT NEUROSCI, V15, P1439, DOI 10.1038/nn.3203; Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; Brown EN, 1998, J NEUROSCI, V18, P7411; Buhry L, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/203462; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Dupret D, 2010, NAT NEUROSCI, V13, P995, DOI 10.1038/nn.2599; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Gupta AS, 2010, NEURON, V65, P695, DOI 10.1016/j.neuron.2010.01.034; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Harris KD, 2005, NAT REV NEUROSCI; Jeffery KJ, 2003, HIPPOCAMPUS, V13, P175, DOI 10.1002/hipo.10047; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Lenck-Santini PP, 2002, J NEUROSCI, V22, P9035; Mehta MR, 2007, NAT NEUROSCI, V10, P13, DOI 10.1038/nn0107-13; MULLER RU, 1987, J NEUROSCI, V7, P1935; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Pfeiffer BE, 2013, NATURE, V497, P74, DOI 10.1038/nature12112; Ribeiro TL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014129; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Wamsley EJ, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-013-0433-5; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017; Zhou JL, 2007, EPILEPSIA, V48, P720, DOI 10.1111/j.1528-1167.2006.00972.x	30	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0147708	10.1371/journal.pone.0147708	http://dx.doi.org/10.1371/journal.pone.0147708			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866597	gold, Green Published, Green Submitted			2022-12-27	WOS:000370050700004
J	Zupancic, J; Babic, MN; Zalar, P; Gunde-Cimerman, N				Zupancic, Jerneja; Babic, Monika Novak; Zalar, Polona; Gunde-Cimerman, Nina			The Black Yeast Exophiala dermatitidis and Other Selected Opportunistic Human Fungal Pathogens Spread from Dishwashers to Kitchens	PLOS ONE			English	Article							BLASTOSCHIZOMYCES-CAPITATUS; AUREOBASIDIUM-PULLULANS; CRYPTOCOCCUS-NEOFORMANS; WANGIELLA-DERMATITIDIS; RHODOTORULA INFECTION; CANDIDA-PARAPSILOSIS; WATER; DIVERSITY; GEOTRICHUM; FUSARIUM	We investigated the diversity and distribution of fungi in nine different sites inside 30 residential dishwashers. In total, 503 fungal strains were isolated, which belong to 10 genera and 84 species. Irrespective of the sampled site, 83% of the dishwashers were positive for fungi. The most frequent opportunistic pathogenic species were Exophiala dermatitidis, Candida parapsilosis sensu stricto, Exophiala phaeomuriformis, Fusarium dimerum, and the Saprochaete/Magnusiomyces clade. The black yeast E. dermatitidis was detected in 47% of the dishwashers, primarily at the dishwasher rubber seals, at up to 10(6) CFU/cm(2); the other fungi detected were in the range of 10(2) to 10(5) CFU/cm(2). The other most heavily contaminated dishwasher sites were side nozzles, doors and drains. Only F. dimerum was isolated from washed dishes, while dishwasher waste water contained E. dermatitidis, Exophiala oligosperma and Sarocladium killiense. Plumbing systems supplying water to household appliances represent the most probable route for contamination of dishwashers, as the fungi that represented the core dishwasher mycobiota were also detected in the tap water. Hot aerosols from dishwashers contained the human opportunistic yeast C. parapsilosis, Rhodotorula mucilaginosa and E. dermatitidis (as well as common air-borne genera such as Aspergillus, Penicillium, Trichoderma and Cladosporium). Comparison of fungal contamination of kitchens without and with dishwashers revealed that virtually all were contaminated with fungi. In both cases, the most contaminated sites were the kitchen drain and the dish drying rack. The most important difference was higher prevalence of black yeasts (E. dermatitidis in particular) in kitchens with dishwashers. In kitchens without dishwashers, C. parapsilosis strongly prevailed with negligible occurrence of E. dermatitidis. F. dimerum was isolated only from kitchens with dishwashers, while Saprochaete/Magnusiomyces isolates were only found within dishwashers. We conclude that dishwashers represent a reservoir of enriched opportunistic pathogenic species that can spread from the dishwasher into the indoor biome.	[Zupancic, Jerneja; Babic, Monika Novak; Zalar, Polona; Gunde-Cimerman, Nina] Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana, Slovenia; [Gunde-Cimerman, Nina] Ctr Excellence Integrated Approaches Chem & Biol, Ljubljana, Slovenia	University of Ljubljana	Gunde-Cimerman, N (corresponding author), Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana, Slovenia.; Gunde-Cimerman, N (corresponding author), Ctr Excellence Integrated Approaches Chem & Biol, Ljubljana, Slovenia.	nina.gunde-cimerman@bf.uni-lj.si	Babič, Monika Novak/AAF-6089-2020	Babič, Monika Novak/0000-0003-3028-6057; Gunde-Cimerman, Nina/0000-0002-9464-3263	Ministry of Higher Education, Science and Technology of the Republic of Slovenia; Ministry of Higher Education, Science and Technology; University of Ljubljana [1244]; Slovenian Research Agency through the Infrastructural Centre Mycosmo, MRIC UL; Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins (CIPKeBiP); European Commission [ICT-2013-612944 MAESTRA, ICT-2013-604102 HBP]; Slovenia Research Agency [382228-1/2013]; Slovenian Research Agency (Infrastructural Centre Mycosmo, MRIC UL);  [P2-0103]	Ministry of Higher Education, Science and Technology of the Republic of Slovenia; Ministry of Higher Education, Science and Technology; University of Ljubljana; Slovenian Research Agency through the Infrastructural Centre Mycosmo, MRIC UL; Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins (CIPKeBiP); European Commission(European CommissionEuropean Commission Joint Research Centre); Slovenia Research Agency(Slovenian Research Agency - Slovenia); Slovenian Research Agency (Infrastructural Centre Mycosmo, MRIC UL)(Slovenian Research Agency - Slovenia); 	The authors acknowledge the financial support received from: Ministry of Higher Education, Science and Technology of the Republic of Slovenia in corporation with Slovenia Research Agency, as a Young Researcher grant (JZ) (no. 382228-1/2013); Ministry of Higher Education, Science and Technology and the University of Ljubljana via the "Innovative scheme for co-financing of doctoral studies", Contract No. 1244 (MNB); Slovenian Research Agency through the Infrastructural Centre Mycosmo, MRIC UL and the grant P2-0103 (PZ); Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins (CIPKeBiP); European Commission, via the grants ICT-2013-612944 MAESTRA and ICT-2013-604102 HBP (NGC).r Our acknowledgments go to all of the people who kindly provided samples from their dishwashers and kitchens surfaces. This study was supported by the Ministry of Higher Education, Science and Technology of the Republic of Slovenia, as a Young Researcher grant to JZ. We also thank the Slovenian Research Agency (Infrastructural Centre Mycosmo, MRIC UL) and the Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins (CIPKeBiP), for providing financial support. Last but not least we wish to thank prof. Borge Diderichsen for careful and critical reading of the manuscript.	Abe N, 2011, BIOCONTROL SCI, V16, P139, DOI 10.4265/bio.16.139; Adams RI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091283; Adams RI, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078866, 10.1371/journal.pone.0067861]; Adams RI, 2013, ISME J, V7, P1262, DOI 10.1038/ismej.2013.28; Amend AS, 2010, P NATL ACAD SCI USA, V107, P13748, DOI 10.1073/pnas.1000454107; Anaissie EJ, 2003, BLOOD, V101, P2542, DOI 10.1182/blood-2002-02-0530; Andersen B, 2011, APPL ENVIRON MICROB, V77, P4180, DOI 10.1128/AEM.02513-10; [Anonymous], 2003, J OCCUP ENVIRON MED, V45, P470; Ara K, 2008, ALLERGOL INT, V53, P369; Barraclough G, 1978, TIMES ATLAS WORLD HI; Beumer RR, 2003, INT BIODETER BIODEGR, V51, P299, DOI 10.1016/S0964-8305(03)00041-6; Billings C G, 1998, Monaldi Arch Chest Dis, V53, P43; Birrenbach T, 2012, EMERG INFECT DIS, V18, P98, DOI 10.3201/eid1801.111192; Boekhout T, 1996, NONCONVENT YEASTS BI, P1, DOI [10.1007/978-3-642-79856-6_1, DOI 10.1007/978-3-642-79856-6_1]; Bonassoli LA, 2005, J HOSP INFECT, V59, P159, DOI 10.1016/j.jhin.2004.06.033; Brown SM, 2007, CURR OPIN MICROBIOL, V10, P320, DOI 10.1016/j.mib.2007.05.014; Butinar L, 2005, FEMS MICROBIOL LETT, V244, P229, DOI 10.1016/j.femsle.2005.01.043; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chotirmall SH, 2014, INT J BIOCHEM CELL B, V52, P161, DOI 10.1016/j.biocel.2014.03.001; Das I, 2011, INT J INFECT DIS, V15, pE759, DOI 10.1016/j.ijid.2011.06.006; de Hoog GS, 2004, STUD MYCOL, P489; de Hoog GS, 2014, ATLAS CLIN FUNGI ULT; Desnos-Ollivier M, 2014, J CLIN MICROBIOL, V52, P2196, DOI 10.1128/JCM.00039-14; DIXON DM, 1980, MYCOPATHOLOGIA, V70, P153, DOI 10.1007/BF00443026; Dogen A, 2013, MED MYCOL, V51, P493, DOI 10.3109/13693786.2012.738313; Doggett MS, 2000, APPL ENVIRON MICROB, V66, P1249, DOI 10.1128/AEM.66.3.1249-1251.2000; De Almeida GMD, 2008, MED MYCOL, V46, P547, DOI 10.1080/13693780801972490; Dunn RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064133; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Feazel LM, 2009, P NATL ACAD SCI USA, V106, P16393, DOI 10.1073/pnas.0908446106; Flores GE, 2013, ENVIRON MICROBIOL, V15, P588, DOI 10.1111/1462-2920.12036; Garber G, 2001, DRUGS, V61, P1, DOI 10.2165/00003495-200161001-00001; Garcia-Suarez J, 2011, MYCOSES, V54, P318, DOI 10.1111/j.1439-0507.2010.01868.x; Gardini F, 2001, FEMS YEAST RES, V1, P161; Girmenia C, 2005, J CLIN MICROBIOL, V43, P1818, DOI 10.1128/JCM.43.4.1818-1828.2005; Gostincar C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-549; Gostincar C, 2011, FUNGAL BIOL-UK, V115, P1008, DOI 10.1016/j.funbio.2011.03.004; Grandesso Stefano, 2012, Infez Med, V20, P25; GUEHO E, 1987, J CLIN MICROBIOL, V25, P1191; Gurgui M, 2011, J HOSP INFECT, V78, P274, DOI 10.1016/j.jhin.2011.01.027; Hageskal G, 2006, APPL ENVIRON MICROB, V72, P7586, DOI 10.1128/AEM.01628-06; Hamada N, 2010, BIOCONTROL SCI, V15, P51, DOI 10.4265/bio.15.51; Hamada N, 2009, MYCOSCIENCE, V50, P421, DOI 10.1007/s10267-009-0500-6; Heinrich J, 2011, INT J HYG ENVIR HEAL, V214, P3, DOI 10.1016/j.ijheh.2010.08.009; Heinrichs G, 2013, MYCOPATHOLOGIA, V175, P399, DOI 10.1007/s11046-013-9619-2; HIRUMA M, 1993, MYCOSES, V36, P1, DOI 10.1111/j.1439-0507.1993.tb00679.x; Horner WE, 2004, APPL ENVIRON MICROB, V70, P6394, DOI 10.1128/AEM.70.11.6394-6400.2004; Isola D, 2013, MYCOPATHOLOGIA, V175, P369, DOI 10.1007/s11046-013-9635-2; Jain A, 2010, J PHARM BIOALLIED SC, V2, P314, DOI 10.4103/0975-7406.72131; Kanzler D, 2008, MYCOSES, V51, P165, DOI 10.1111/j.1439-0507.2007.01454.x; Karuppayil SM, 1997, J MED VET MYCOL, V35, P379; Kauffmann-Lacroix C, 2008, PRESSE MED, V37, P751, DOI 10.1016/j.lpm.2007.09.015; Kinsey G., 2003, HDB WATER WASTEWATER, P77, DOI DOI 10.1016/B978-012470100-7/50006-6; Klepeis NE, 2001, J EXPO ANAL ENV EPID, V11, P231, DOI 10.1038/sj.jea.7500165; Kondori N, 2011, J CLIN MICROBIOL, V49, P1004, DOI 10.1128/JCM.01899-10; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P3, DOI 10.1016/B978-0-444-52149-1.00001-X; Lax S, 2014, SCIENCE, V345, P1048, DOI 10.1126/science.1254529; Levy SB, 2001, EMERG INFECT DIS, V7, P512, DOI 10.3201/eid0707.017705; Lian X, 2010, MED MYCOL, V48, P622, DOI 10.3109/13693780903405774; Libkind D, 2004, FOLIA MICROBIOL, V49, P19, DOI 10.1007/BF02931640; Lord ATK, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-11; LOURIA DB, 1960, NEW ENGL J MED, V263, P1281, DOI 10.1056/NEJM196012222632504; Lunardi LW, 2006, CLIN INFECT DIS, V43, pE60, DOI 10.1086/507036; MARTINO P, 1990, REV INFECT DIS, V12, P570; Matos T, 2002, MYCOSES, V45, P373, DOI 10.1046/j.1439-0507.2002.00779.x; Matos T, 2003, ANTON LEEUW INT J G, V83, P293, DOI 10.1023/A:1023373329502; MATSUMOTO T, 1993, MYCOSES, V36, P145, DOI 10.1111/j.1439-0507.1993.tb00743.x; Muller FMC, 2010, EXPERT REV ANTI-INFE, V8, P957, DOI [10.1586/eri.10.72, 10.1586/ERI.10.72]; MUOTOEOKAFOR FA, 1993, MYCOPATHOLOGIA, V122, P95, DOI 10.1007/BF01103605; NISHIMURA K, 1987, MYCOPATHOLOGIA, V97, P17, DOI 10.1007/BF00437326; Nishiuchi Y, 2009, JPN J INFECT DIS, V62, P182; O'Donnell K, 1998, MYCOLOGIA, V90, P465, DOI 10.2307/3761407; O'Donnell K, 2010, J CLIN MICROBIOL, V48, P3708, DOI 10.1128/JCM.00989-10; ODonnell K, 1997, MOL PHYLOGENET EVOL, V7, P103, DOI 10.1006/mpev.1996.0376; Ojima M, 2002, J APPL MICROBIOL, V93, P800, DOI 10.1046/j.1365-2672.2002.01746.x; Packeu A, 2012, J MED MICROBIOL, V61, P1226, DOI 10.1099/jmm.0.042317-0; Peat JK, 1998, ALLERGY, V53, P120, DOI 10.1111/j.1398-9995.1998.tb03859.x; Pfaller MA, 2004, J CLIN MICROBIOL, V42, P4419, DOI 10.1128/JCM.42.10.4419-4431.2004; Pihet M, 2009, MED MYCOL, V47, P387, DOI 10.1080/13693780802609604; Pires-Goncalves RH, 2008, LETT APPL MICROBIOL, V46, P542, DOI 10.1111/j.1472-765X.2008.02349.x; Pitkaranta M, 2008, APPL ENVIRON MICROB, V74, P233, DOI 10.1128/AEM.00692-07; Prenafeta-Boldu FX, 2006, FEMS MICROBIOL REV, V30, P109, DOI 10.1111/j.1574-6976.2005.00007.x; Randhawa HS, 2001, MYCOPATHOLOGIA, V151, P63, DOI 10.1023/A:1010906220888; Richardson G, 2005, J ADV NURS, V52, P328, DOI 10.1111/j.1365-2648.2005.03591.x; Russo Juan Pedro, 2010, Skinmed, V8, P366; SAMSON RA, 2001, MICROORGANISMS HOME, P287, DOI DOI 10.1201/9780203302934; Sautour M, 2012, INT J HYG ENVIR HEAL, V215, P286, DOI 10.1016/j.ijheh.2011.11.003; Schneider A, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/044003; Short DPG, 2011, J CLIN MICROBIOL, V49, P4264, DOI 10.1128/JCM.05468-11; Silva S, 2012, FEMS MICROBIOL REV, V36, P288, DOI 10.1111/j.1574-6976.2011.00278.x; Sowiak M, 2012, MED PR, V63, P1; Straus DC, 2009, TOXICOL IND HEALTH, V25, P617, DOI 10.1177/0748233709348287; Strausbaugh LJ, 1996, J CLIN MICROBIOL, V34, P471, DOI 10.1128/JCM.34.2.471-473.1996; Sudfeld CR, 2010, J CYST FIBROS, V9, P110, DOI 10.1016/j.jcf.2009.11.010; Sudhadham M, 2008, STUD MYCOL, P145, DOI 10.3114/sim.2008.61.15; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thrasher JD, 2009, TOXICOL IND HEALTH, V25, P583, DOI 10.1177/0748233709348386; Tournas VH, 2006, FOOD MICROBIOL, V23, P684, DOI 10.1016/j.fm.2006.01.003; Trofa D, 2008, CLIN MICROBIOL REV, V21, P606, DOI 10.1128/CMR.00013-08; Tuon FF, 2008, REV IBEROAM MICOL, V25, P135, DOI 10.1016/S1130-1406(08)70032-9; van den Ende AHGG, 1999, STUD MYCOL, P151; Vaux S, 2014, MBIO, V5, DOI 10.1128/mBio.02309-14; von Baum H, 2010, INFECTION, V38, P181, DOI 10.1007/s15010-010-0005-4; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wirth Fernanda, 2012, Interdiscip Perspect Infect Dis, V2012, P465717, DOI 10.1155/2012/465717; Yurlova NA, 2002, MYCOSES, V45, P443, DOI 10.1046/j.1439-0507.2002.d01-132.x; Zalar P, 2011, FUNGAL BIOL-UK, V115, P997, DOI 10.1016/j.funbio.2011.04.007; Zalar P, 2008, STUD MYCOL, P21, DOI 10.3114/sim.2008.61.02; Zalar P, 2015, FUNG BIOL; Zalar P, 2013, ELECT ABSTRACTS, P15; Zeng JS, 2007, J CLIN MICROBIOL, V45, P3713, DOI 10.1128/JCM.02012-06	111	60	62	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148166	10.1371/journal.pone.0148166	http://dx.doi.org/10.1371/journal.pone.0148166			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867131	gold, Green Submitted, Green Published			2022-12-27	WOS:000370050700009
J	Feldman, M; Hershkovitz, I; Sklan, EH; Bar-Gal, GK; Pap, I; Szikossy, I; Rosin-Arbesfeld, R				Feldman, Michal; Hershkovitz, Israel; Sklan, Ella H.; Bar-Gal, Gila Kahila; Pap, Ildiko; Szikossy, Ildiko; Rosin-Arbesfeld, Rina			Detection of a Tumor Suppressor Gene Variant Predisposing to Colorectal Cancer in an 18th Century Hungarian Mummy	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS DNA; POLYPOSIS-COLI GENE; APC E1317Q VARIANT; ADENOMATOUS POLYPOSIS; MALIGNANT-TUMORS; ANCIENT DNA; MUTATIONS; CARCINOMA; REMAINS; ABNORMALITIES	Mutations of the Adenomatous polyposis coli (APC) gene are common and strongly associated with the development of colorectal adenomas and carcinomas. While extensively studied in modern populations, reports on visceral tumors in ancient populations are scarce. To the best of our knowledge, genetic characterization of mutations associated with colorectal cancer in ancient specimens has not yet been described. In this study we have sequenced hotspots for mutations in the APC gene isolated from 18th century naturally preserved human Hungarian mummies. While wild type APC sequences were found in two mummies, we discovered the E1317Q missense mutation, known to be a colorectal cancer predisposing mutation, in a large intestine tissue of an 18th century mummy. Our data suggests that this genetic predisposition to cancer already existed in the pre-industrialization era. This study calls for similar investigations of ancient specimens from different periods and geographical locations to be conducted and shared for the purpose of obtaining a larger scale analysis that will shed light on past cancer epidemiology and on cancer evolution.	[Feldman, Michal; Hershkovitz, Israel] Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel; [Sklan, Ella H.; Rosin-Arbesfeld, Rina] Tel Aviv Univ, Sackler Fac Med, Dept Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel; [Bar-Gal, Gila Kahila] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Koret Sch Vet Med, IL-76100 Rehovot, Israel; [Pap, Ildiko; Szikossy, Ildiko] Hungarian Nat Hist Museum, Dept Anthropol, Budapest, Hungary	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Hebrew University of Jerusalem	Feldman, M (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel.	michalfe@gmail.com	Hershkovitz, Israel/ABH-4511-2020	Hershkovitz, Israel/0000-0001-5841-6090	Dan David Foundation; Tassia and Dr. Joseph Meychan Chair of the History and Philosophy of Medicine	Dan David Foundation; Tassia and Dr. Joseph Meychan Chair of the History and Philosophy of Medicine	This work was supported by: Dan David Foundation; The Tassia and Dr. Joseph Meychan Chair of the History and Philosophy of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2004, FORENSIC SCI INT, V139, P141, DOI 10.1016/j.forsciint.2003.10.008; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], SEQ VERS 5 3 SEQ AN; [Anonymous], [No title captured]; ARMINSKI T. C., 1964, DIS COLON RECTUM, V7, P249, DOI 10.1007/BF02630528; Bar-Gal GK, 2012, HEPATOLOGY, V56, P1671, DOI 10.1002/hep.25852; Binder M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090924; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Braudel F, 1992, CIVILIZATION CAPITAL; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Brothwell D.R., 1967, DIS ANTIQUITY SURVEY; CANNONALBRIGHT LA, 1988, NEW ENGL J MED, V319, P533, DOI 10.1056/NEJM198809013190902; Chan JZM, 2013, NEW ENGL J MED, V369, P289, DOI 10.1056/NEJMc1302295; Charlier P, 2009, ANN PATHOL, V29, P67, DOI 10.1016/j.annpat.2008.09.051; Chen TC, 1998, CANCER LETT, V134, P23, DOI 10.1016/S0304-3835(98)00238-9; Cooper A, 2000, SCIENCE, V289, P1139; David AR, 2010, NAT REV CANCER, V10, P728, DOI 10.1038/nrc2914; EIDE TJ, 1986, HISTOPATHOLOGY, V10, P111, DOI 10.1111/j.1365-2559.1986.tb02467.x; Faerman M, 2000, AM J PHYS ANTHROPOL, V111, P153; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Figer A, 2001, BRIT J CANCER, V85, P523, DOI 10.1054/bjoc.2001.1959; Fletcher HA, 2003, AM J PHYS ANTHROPOL, V120, P144, DOI 10.1002/ajpa.10114; Fletcher HA, 2003, MICROBIOL-SGM, V149, P143, DOI 10.1099/mic.0.25961-0; Fornaciari G, 1999, Med Secoli, V11, P85; Fornaciari G, 2012, PATHOBIOLOGY, V79, P257, DOI 10.1159/000337292; Fothi E, 2003, J PALEOPATHOL, V15, P23; Frayling IM, 1998, P NATL ACAD SCI USA, V95, P10722, DOI 10.1073/pnas.95.18.10722; Hahnloser D, 2003, CANCER EPIDEM BIOMAR, V12, P1023; Halperin EC, 2004, PERSPECT BIOL MED, V47, P1, DOI 10.1353/pbm.2004.0010; Hershkovitz I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003426; HORII A, 1992, CANCER RES, V52, P3231; HORII A, 1992, CANCER RES, V52, P6696; HOSS M, 1993, NUCLEIC ACIDS RES, V21, P3913, DOI 10.1093/nar/21.16.3913; JOSLYN G, 1991, CELL, V66, P601, DOI 10.1016/0092-8674(81)90022-2; Kay GL, 2015, NATURE COMMUNICATION, P6; Lamlum H, 2000, HUM MOL GENET, V9, P2215, DOI 10.1093/oxfordjournals.hmg.a018912; Lilienfeld AM, 1968, CANC EPIDEMIOLOGY ME; Lynnerup N, 2007, YEARB PHYS ANTHROPOL, V50, P162, DOI 10.1002/ajpa.20728; Marciniak S, 2015, J HUM EVOL, V79, P21, DOI 10.1016/j.jhevol.2014.11.003; Marcsik A., 2002, J PALEOPATHOLOGY, V14, P77; Marota I, 2002, CELL MOL LIFE SCI, V59, P97, DOI 10.1007/s00018-002-8408-8; Molnar Erika, 2009, Acta Biologica Szegediensis, V53, P117; NAGASE H, 1993, HUM MUTAT, V2, P425, DOI 10.1002/humu.1380020602; Nerlich AG, 2006, ONCOL REP, V16, P197; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; Pain S, 2007, NEW SCI, V196, P40, DOI 10.1016/S0262-4079(07)63157-1; PALFI G, 1989, Acta Universitatis Szegediensis Acta Biologica, V35, P207; Pap I, 1999, TUBERCULOSIS PRESENT, P419; Pap I., 1997, ACTA BIOL SZEGEDIENS, V42, P107; Pap I, 2011, ROUTLEDGE HANDBOOK OF ARCHAEOLOGICAL HUMAN REMAINS LEGISLATION: AN INTERNATIONAL GUIDE TO LAWS AND PRACTICE IN THE EXCAVATION AND TREATMENT OF ARCHAEOLOGICAL HUMAN REMAINS, P185; POLAKIS P, 1997, BIOCHIM BIOPHYS ACTA, V1332, P127; Popat S, 2000, CANCER LETT, V149, P203, DOI 10.1016/S0304-3835(99)00360-2; ri P, 2005, DEMOGRAFIA, V48, P43; Ries LAG, 2000, CANCER-AM CANCER SOC, V88, P2398, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2398::AID-CNCR26>3.0.CO;2-I; Roberts Charlotte, 2005, ARCHAEOLOGY DIS; Rothschild BM, 2001, MCGRAW HILL YB SCI T, P294; Schuenemann VJ, 2013, SCIENCE, V341, P179, DOI 10.1126/science.1238286; Schwarz C, 2009, NUCLEIC ACIDS RES, V37, P3215, DOI 10.1093/nar/gkp159; Sieber OM, 2000, MOL MED TODAY, V6, P462; Smith GE., 1924, EGYPTIAN MUMMIES; Spigelman M, 2015, TUBERCULOSIS; STROUHAL E, 1976, AM J PHYS ANTHROPOL, V45, P613, DOI 10.1002/ajpa.1330450328; Szikossy I, 2010, MUMMIES OF THE WORLD, P160; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; Tarver T, 2012, J CONS HLTH INTERNET, V16, P366, DOI 10.1080/15398285.2012.701177; UZAWA K, 1994, INT J CANCER, V58, P814, DOI 10.1002/ijc.2910580611; ZIMMERMAN MR, 1977, CANCER, V40, P1358, DOI 10.1002/1097-0142(197709)40:3<1358::AID-CNCR2820400354>3.0.CO;2-J; Zink A, 1999, ANTICANCER RES, V19, P4273	68	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0147217	10.1371/journal.pone.0147217	http://dx.doi.org/10.1371/journal.pone.0147217			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863316	gold, Green Submitted, Green Published			2022-12-27	WOS:000370046600021
J	Martinez-Montiel, N; Morales-Lara, L; Hernandez-Perez, JM; Martinez-Contreras, RD				Martinez-Montiel, Nancy; Morales-Lara, Laura; Hernandez-Perez, Julio M.; Martinez-Contreras, Rebeca D.			In Silico Analysis of the Structural and Biochemical Features of the NMD Factor UPF1 in Ustilago maydis	PLOS ONE			English	Article							MESSENGER-RNA DECAY; NONSENSE-MEDIATED DECAY; EXON JUNCTION COMPLEX; CAENORHABDITIS-ELEGANS; SURVEILLANCE COMPLEX; MOLECULAR-DYNAMICS; PROTEIN; GENE; PHOSPHORYLATION; TRANSLATION	The molecular mechanisms regulating the accuracy of gene expression are still not fully understood. Among these mechanisms, Nonsense-mediated Decay (NMD) is a quality control process that detects post-transcriptionally abnormal transcripts and leads them to degradation. The UPF1 protein lays at the heart of NMD as shown by several structural and functional features reported for this factor mainly for Homo sapiens and Saccharomyces cerevisiae. This process is highly conserved in eukaryotes but functional diversity can be observed in various species. Ustilago maydis is a basidiomycete and the best-known smut, which has become a model to study molecular and cellular eukaryotic mechanisms. In this study, we performed in silico analysis to investigate the structural and biochemical properties of the putative UPF1 homolog in Ustilago maydis. The putative homolog for UPF1 was recognized in the annotated genome for the basidiomycete, exhibiting 66% identity with its human counterpart at the protein level. The known structural and functional domains characteristic of UPF1 homologs were also found. Based on the crystal structures available for UPF1, we constructed different three-dimensional models for umUPF1 in order to analyze the secondary and tertiary structural features of this factor. Using these models, we studied the spatial arrangement of umUPF1 and its capability to interact with UPF2. Moreover, we identified the critical amino acids that mediate the interaction of umUPF1 with UPF2, ATP, RNA and with UPF1 itself. Mutating these amino acids in silico showed an important effect over the native structure. Finally, we performed molecular dynamic simulations for UPF1 proteins from H. sapiens and U. maydis and the results obtained show a similar behavior and physicochemical properties for the protein in both organisms. Overall, our results indicate that the putative UPF1 identified in U. maydis shows a very similar sequence, structural organization, mechanical stability, physicochemical properties and spatial organization in comparison to the NMD factor depicted for Homo sapiens. These observations strongly support the notion that human and fungal UPF1 could perform equivalent biological activities.	[Martinez-Montiel, Nancy; Martinez-Contreras, Rebeca D.] Benemerita Univ Autonoma Puebla, Lab Ecol Mol Microbiana, Ctr Invest Ciencias Microbiol, Puebla, Mexico; [Morales-Lara, Laura] Benemerita Univ Autonoma Puebla, Fac Ciencias Quim, Puebla, Mexico; [Hernandez-Perez, Julio M.] Benemerita Univ Autonoma Puebla, Posgrad Ciencias Quim, Puebla, Mexico	Benemerita Universidad Autonoma de Puebla; Benemerita Universidad Autonoma de Puebla; Benemerita Universidad Autonoma de Puebla	Martinez-Contreras, RD (corresponding author), Benemerita Univ Autonoma Puebla, Lab Ecol Mol Microbiana, Ctr Invest Ciencias Microbiol, Puebla, Mexico.	rebeca.martinez@correo.buap.mx	Martínez-Contreras, Rebeca/S-9605-2019	Hernandez-Perez, Julio M./0000-0002-1178-2146	Consejo Nacional de Ciencia y Tecnologia; Consejo Nacional de Ciencia y Tecnologia (Mexico)	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Consejo Nacional de Ciencia y Tecnologia (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	RMC received a grant from Consejo Nacional de Ciencia y Tecnologia for partial funding of this work. NMM received a PhD funding from Consejo Nacional de Ciencia y Tecnologia (Mexico).	ALTAMURA N, 1992, J MOL BIOL, V224, P575, DOI 10.1016/0022-2836(92)90545-U; Applequist SE, 1997, NUCLEIC ACIDS RES, V25, P814, DOI 10.1093/nar/25.4.814; Arciga-Reyes L, 2006, PLANT J, V47, P480, DOI 10.1111/j.1365-313X.2006.02802.x; Avery P, 2011, RNA, V17, P624, DOI 10.1261/rna.2404211; Azzalin CM, 2006, CELL CYCLE, V5, P1496, DOI 10.4161/cc.5.14.3093; Belostotsky DA, 2005, TRENDS PLANT SCI, V10, P347, DOI 10.1016/j.tplants.2005.05.004; Bhattacharya A, 2000, RNA, V6, P1226, DOI 10.1017/S1355838200000546; Bhuvanagiri M, 2010, BIOCHEM J, V430, P365, DOI 10.1042/BJ20100699; Bicknell AA, 2012, BIOESSAYS, V34, P1025, DOI 10.1002/bies.201200073; Chakrabarti S, 2011, MOL CELL, V41, P693, DOI 10.1016/j.molcel.2011.02.010; Chamieh H, 2008, NAT STRUCT MOL BIOL, V15, P85, DOI 10.1038/nsmb1330; CHANG JC, 1979, NATURE, V281, P602, DOI 10.1038/281602a0; Cheng ZH, 2007, EMBO J, V26, P253, DOI 10.1038/sj.emboj.7601464; Cho H, 2009, MOL CELL, V33, P75, DOI 10.1016/j.molcel.2008.11.022; Clerici M, 2009, EMBO J, V28, P2293, DOI 10.1038/emboj.2009.175; Combet C, 2002, BIOINFORMATICS, V18, P213, DOI 10.1093/bioinformatics/18.1.213; Compton J, 2003, ADV UNDERSTANDING MO, P210; Culbertson MR, 2007, GENETICS, V177, P1; Culbertson MR, 2003, CURR OPIN GENET DEV, V13, P207, DOI 10.1016/S0959-437X(03)00014-5; CZAPLINSKI K, 1995, RNA, V1, P610; Czaplinski K, 1998, GENE DEV, V12, P1665, DOI 10.1101/gad.12.11.1665; Dahlseid JN, 2003, EUKARYOT CELL, V2, P134, DOI 10.1128/EC.2.1.134-142.2003; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Fiorini F, 2012, METHOD ENZYMOL, V511, P255, DOI 10.1016/B978-0-12-396546-2.00012-7; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Franks TM, 2010, CELL, V143, P938, DOI 10.1016/j.cell.2010.11.043; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gleghorn ML, 2011, MOL CELL, V41, P621, DOI 10.1016/j.molcel.2011.03.001; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; He F, 1997, MOL CELL BIOL, V17, P1580, DOI 10.1128/MCB.17.3.1580; He F, 2003, MOL CELL, V12, P1439, DOI 10.1016/S1097-2765(03)00446-5; Ho EC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-334; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Huang LL, 2012, WIRES RNA, V3, P807, DOI 10.1002/wrna.1137; Hwang J, 2011, CURR OPIN GENET DEV, V21, P422, DOI 10.1016/j.gde.2011.03.008; Isken O, 2008, NAT REV GENET, V9, P699, DOI 10.1038/nrg2402; Ivanov PV, 2008, EMBO J, V27, P736, DOI 10.1038/emboj.2008.17; Jankowsky A, 2011, NUCLEIC ACIDS RES, V39, pD338, DOI 10.1093/nar/gkq1002; Jankowsky E, 2011, TRENDS BIOCHEM SCI, V36, P19, DOI 10.1016/j.tibs.2010.07.008; Jarmoskaite I, 2014, ANNU REV BIOCHEM, V83, P697, DOI 10.1146/annurev-biochem-060713-035546; Kadlec J, 2006, RNA, V12, P1817, DOI 10.1261/rna.177606; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Kaygun H, 2005, NAT STRUCT MOL BIOL, V12, P794, DOI 10.1038/nsmb972; Keeling KM, 2012, CRIT REV BIOCHEM MOL, V47, P444, DOI 10.3109/10409238.2012.694846; Kerenyi F, 2013, PLANT J, V76, P836, DOI 10.1111/tpj.12346; Khodadadi S, 2015, SOFT MATTER, V11, P4984, DOI 10.1039/c5sm00636h; Kojic M, 2002, MOL CELL, V10, P683, DOI 10.1016/S1097-2765(02)00632-9; Lasalde C, 2014, NUCLEIC ACIDS RES, V42, P1916, DOI 10.1093/nar/gkt1049; LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303; Lobanov MY, 2008, MOL BIOL+, V42, P623, DOI 10.1134/S0026893308040195; LOSSON R, 1979, P NATL ACAD SCI USA, V76, P5134, DOI 10.1073/pnas.76.10.5134; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Mahoney MW, 2000, J CHEM PHYS, V112, P8910, DOI 10.1063/1.481505; Maquat LE, 2006, NONSENSE MEDIATED MR; Medghalchi SM, 2001, HUM MOL GENET, V10, P99, DOI 10.1093/hmg/10.2.99; Mekouar M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r65; Mendell JT, 2000, MOL CELL BIOL, V20, P8944, DOI 10.1128/MCB.20.23.8944-8957.2000; Mitaku S, 1999, PROTEIN ENG, V12, P953, DOI 10.1093/protein/12.11.953; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Morozov IY, 2012, MOL CELL BIOL, V32, P2585, DOI 10.1128/MCB.00316-12; Munsterkotter M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-473; Muhlemann O, 2008, BIOCHEM SOC T, V36, P497, DOI 10.1042/BST0360497; Nyiko T, 2013, NUCLEIC ACIDS RES, V41, P6715, DOI 10.1093/nar/gkt366; Ohnishi T, 2003, MOL CELL, V12, P1187, DOI 10.1016/S1097-2765(03)00443-X; Okada-Katsuhata Y, 2012, NUCLEIC ACIDS RES, V40, P1251, DOI 10.1093/nar/gkr791; Padariya M, 2015, BBA-BIOMEMBRANES, V1848, P2065, DOI 10.1016/j.bbamem.2015.05.014; Page MF, 1999, MOL CELL BIOL, V19, P5943; Paillusson A, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni052; Perlick HA, 1996, P NATL ACAD SCI USA, V93, P10928, DOI 10.1073/pnas.93.20.10928; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PULAK R, 1993, GENE DEV, V7, P1885, DOI 10.1101/gad.7.10.1885; Rodriguez-Gabriel MA, 2006, MOL CELL BIOL, V26, P6347, DOI 10.1128/MCB.00286-06; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Schweingruber C, 2013, BBA-GENE REGUL MECH, V1829, P612, DOI 10.1016/j.bbagrm.2013.02.005; Serin G, 2001, MOL CELL BIOL, V21, P209, DOI 10.1128/MCB.21.1.209-223.2001; Singh Guramrit, 2006, P59; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Steinberg G, 2008, TRENDS CELL BIOL, V18, P61, DOI 10.1016/j.tcb.2007.11.008; Sun XL, 2001, MOL BIOL CELL, V12, P1009, DOI 10.1091/mbc.12.4.1009; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Takahashi S, 2008, RNA, V14, P1950, DOI 10.1261/rna.536308; Wang WR, 2001, EMBO J, V20, P880, DOI 10.1093/emboj/20.4.880; Wen JK, 2010, EMBO J, V29, P1537, DOI 10.1038/emboj.2010.48; Weng YM, 1996, MOL CELL BIOL, V16, P5477; Wittkopp N, 2009, MOL CELL BIOL, V29, P3517, DOI 10.1128/MCB.00177-09; Yamashita A, 2005, NAT STRUCT MOL BIOL, V12, P1054, DOI 10.1038/nsmb1016; Yamashita A, 2001, GENE DEV, V15, P2215, DOI 10.1101/gad.913001; Yamashita A, 2013, GENES CELLS, V18, P161, DOI 10.1111/gtc.12033; Yamashita A, 2009, GENE DEV, V23, P1091, DOI 10.1101/gad.1767209	90	0	0	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148191	10.1371/journal.pone.0148191	http://dx.doi.org/10.1371/journal.pone.0148191			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863136	gold, Green Submitted, Green Published			2022-12-27	WOS:000370046600046
J	Petropolis, DB; Faust, DM; Tolle, M; Riviere, L; Valentin, T; Neuveut, C; Hernandez-Cuevas, N; Dufour, A; Olivo-Marin, JC; Guillen, N				Petropolis, Debora B.; Faust, Daniela M.; Tolle, Matthieu; Riviere, Lise; Valentin, Tanguy; Neuveut, Christine; Hernandez-Cuevas, Nora; Dufour, Alexandre; Olivo-Marin, Jean-Christophe; Guillen, Nancy			Human Liver Infection in a Dish: Easy-To-Build 3D Liver Models for Studying Microbial Infection	PLOS ONE			English	Article							HEPATITIS-B; ENTAMOEBA-HISTOLYTICA; IN-VITRO; VIRUS-REPLICATION; X-PROTEIN; CELLS; CULTURE; SYSTEM; ENTRY; NTCP	Human liver infection is a major cause of death worldwide, but fundamental studies on infectious diseases affecting humans have been hampered by the lack of robust experimental models that accurately reproduce pathogen-host interactions in an environment relevant for the human disease. In the case of liver infection, one consequence of this absence of relevant models is a lack of understanding of how pathogens cross the sinusoidal endothelial barrier and parenchyma. To fill that gap we elaborated human 3D liver in vitro models, composed of human liver sinusoidal endothelial cells (LSEC) and Huh-7 hepatoma cells as hepatocyte model, layered in a structure mimicking the hepatic sinusoid, which enable studies of key features of early steps of hepatic infection. Built with established cell lines and scaffold, these models provide a reproducible and easy-to-build cell culture approach of reduced complexity compared to animal models, while preserving higher physiological relevance compared to standard 2D systems. For proof-of-principle we challenged the models with two hepatotropic pathogens: the parasitic amoeba Entamoeba histolytica and hepatitis B virus (HBV). We constructed four distinct setups dedicated to investigating specific aspects of hepatic invasion: 1) pathogen 3D migration towards hepatocytes, 2) hepatocyte barrier crossing, 3) LSEC and subsequent hepatocyte crossing, and 4) quantification of human hepatic virus replication (HBV). Our methods comprise automated quantification of E. histolytica migration and hepatic cells layer crossing in the 3D liver models. Moreover, replication of HBV virus occurs in our virus infection 3D liver model, indicating that routine in vitro assays using HBV or others viruses can be performed in this easy-to-build but more physiological hepatic environment. These results illustrate that our new 3D liver infection models are simple but effective, enabling new investigations on infectious disease mechanisms. The better understanding of these mechanisms in a human-relevant environment could aid the discovery of drugs against pathogenic liver infection.	[Petropolis, Debora B.; Faust, Daniela M.; Tolle, Matthieu; Valentin, Tanguy; Hernandez-Cuevas, Nora; Guillen, Nancy] Inst Pasteur, INSERM, U786, Cell Biol Parasitism Unit,BCI, F-75724 Paris, France; [Riviere, Lise; Neuveut, Christine] Inst Pasteur, Dept Virol, Hepaciviruses & Innate Immun Unit, Paris, France; [Petropolis, Debora B.; Dufour, Alexandre; Olivo-Marin, Jean-Christophe; Guillen, Nancy] Inst Pasteur, BCI, Quantitat Image Anal, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Petropolis, DB (corresponding author), Inst Pasteur, INSERM, U786, Cell Biol Parasitism Unit,BCI, F-75724 Paris, France.; Petropolis, DB (corresponding author), Inst Pasteur, BCI, Quantitat Image Anal, Paris, France.	petropolis.debora@gmail.com	Lauterbach-Riviere, Lise/AAF-2593-2021	Lauterbach-Riviere, Lise/0000-0001-6705-3439; Neuveut, Christine/0000-0001-6520-271X; Dufour, Alexandre/0000-0002-9417-7389	National French Research Agency [ANR-2010-GENM-0011-01]; French Parasitology consortium Labex ParaFrap [ANR-11-LABX0024]; DIM Ile de France	National French Research Agency(French National Research Agency (ANR)); French Parasitology consortium Labex ParaFrap; DIM Ile de France	The work was funded by the National French Research Agency (ANR-2010-GENM-0011-01, GENAMIBE), the French Parasitology consortium Labex ParaFrap (grant ANR-11-LABX0024). The authors wanted to acknowledge the generous support of "DIM Ile de France" for the Two-photon microscope acquirement and for the fellowship to D. Petropolis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bale SS, 2015, TISSUE ENG PART C-ME, V21, P413, DOI [10.1089/ten.tec.2014.0152, 10.1089/ten.TEC.2014.0152]; Bale SS, 2014, EXP BIOL MED, V239, P1180, DOI 10.1177/1535370214531872; Bhatia SN, 2014, NAT BIOTECHNOL, V32, P760, DOI 10.1038/nbt.2989; CHEN HS, 1993, J VIROL, V67, P1218, DOI 10.1128/JVI.67.3.1218-1226.1993; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Faust DM, 2012, MICROBES INFECT, V14, P1428, DOI 10.1016/j.micinf.2012.05.013; Faust DM, 2011, CELL MICROBIOL, V13, P1091, DOI 10.1111/j.1462-5822.2011.01604.x; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Gunness P, 2013, TOXICOL SCI, V133, P67, DOI 10.1093/toxsci/kft021; Jenne CN, 2013, NAT IMMUNOL, V14, P996, DOI 10.1038/ni.2691; Keasler VV, 2007, J VIROL, V81, P2656, DOI 10.1128/JVI.02020-06; Kim Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015456; Ladner SK, 1997, ANTIMICROB AGENTS CH, V41, P1715, DOI 10.1128/AAC.41.8.1715; Lucifora J, 2011, J HEPATOL, V55, P996, DOI 10.1016/j.jhep.2011.02.015; Mathur A, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt375; Ng S, 2015, STEM CELL REP, V4, P1; Ni Y, 2014, GASTROENTEROLOGY, V146, P1070, DOI 10.1053/j.gastro.2013.12.024; Nkongolo S, 2014, J HEPATOL, V60, P723, DOI 10.1016/j.jhep.2013.11.022; Petropolis DB, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004381; Petropolis DB, 2014, PEERJ, V2, DOI 10.7717/peerj.317; Protzer U, 2012, NAT REV IMMUNOL, V12, P201, DOI 10.1038/nri3169; Sainz B, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-103; Salmon P, 2000, MOL THER, V2, P404, DOI 10.1006/mthe.2000.0141; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Watashi K, 2014, INT J MOL SCI, V15, P2892, DOI 10.3390/ijms15022892; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049	27	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148667	10.1371/journal.pone.0148667	http://dx.doi.org/10.1371/journal.pone.0148667			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863526	gold, Green Submitted, Green Published			2022-12-27	WOS:000370046600095
J	Sorrentino, G; Haworth, M; Wahbi, S; Mahmood, T; Zuomin, S; Centritto, M				Sorrentino, Giuseppe; Haworth, Matthew; Wahbi, Said; Mahmood, Tariq; Zuomin, Shi; Centritto, Mauro			Abscisic Acid Induces Rapid Reductions in Mesophyll Conductance to Carbon Dioxide	PLOS ONE			English	Article							RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE OXYGENASE; CO2 TRANSFER CONDUCTANCE; RELATIVE WATER-CONTENT; ISOTOPE DISCRIMINATION; GAS-EXCHANGE; STOMATAL CONDUCTANCE; LEAF ANATOMY; PHOTOSYNTHETIC LIMITATIONS; CHLOROPHYLL FLUORESCENCE; ELECTRON-TRANSPORT	The rate of photosynthesis (A) of plants exposed to water deficit is a function of stomatal (g(s)) and mesophyll (g(m)) conductance determining the availability of CO2 at the site of carboxylation within the chloroplast. Mesophyll conductance often represents the greatest impediment to photosynthetic uptake of CO2, and a crucial determinant of the photosynthetic effects of drought. Abscisic acid (ABA) plays a fundamental role in signalling and coordination of plant responses to drought; however, the effect of ABA on g(m) is not welldefined. Rose, cherry, olive and poplar were exposed to exogenous ABA and their leaf gas exchange parameters recorded over a four hour period. Application with ABA induced reductions in values of A, g(s) and g(m) in all four species. Reduced g(m) occurred within one hour of ABA treatment in three of the four analysed species; indicating that the effect of ABA on g(m) occurs on a shorter timescale than previously considered. These declines in g(m) values associated with ABA were not the result of physical changes in leaf properties due to altered turgor affecting movement of CO2, or caused by a reduction in the sub-stomatal concentration of CO2 (C-i). Increased [ABA] likely induces biochemical changes in the properties of the interface between the sub-stomatal air-space and mesophyll layer through the actions of cooporins to regulate the transport of CO2. The results of this study provide further evidence that g(m) is highly responsive to fluctuations in the external environment, and stress signals such as ABA induce co-ordinated modifications of both g(s) and g(m) in the regulation of photosynthesis.	[Sorrentino, Giuseppe] CNR, Inst Mediterranean Agr & Forest Syst, Via Patacca 85, I-80056 Ercolano, NA, Italy; [Haworth, Matthew; Centritto, Mauro] CNR, Tree & Timber Inst, IVALSA, Via Madonna del Piano 10, I-50019 Sesto Fiorentino, FI, Italy; [Wahbi, Said] Univ Cadi Ayyad, Fac Sci Semlalia, Lab Biotechnol & Physiol Vegetale, Blvd My Abdellah BP 2390, Marrakech, Morocco; [Mahmood, Tariq] Pir Mehr Ali Shah Arid Agr Univ, Dept Environm Sci, Murree Rd, Rawalpindi, Pakistan; [Zuomin, Shi] Chinese Acad Forestry, Inst Forest Ecol Environm & Protect, Key Lab Forest Ecol & Environm Sci, State Forestry Adm, Beijing, Peoples R China	Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto per la Valorizzazione del Legno e delle Specie Arboree (IVALSA-CNR); Cadi Ayyad University of Marrakech; Arid Agriculture University; Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF	Haworth, M (corresponding author), CNR, Tree & Timber Inst, IVALSA, Via Madonna del Piano 10, I-50019 Sesto Fiorentino, FI, Italy.	haworth@ivalsa.cnr.it	Haworth, Matthew/B-7817-2013	WAHBI, Said/0000-0002-3066-5586; Haworth, Matthew/0000-0002-3225-6620	Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy: PRIN "PRO-ROOT" Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy: Progetto Premiale "Aqua"; Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy: PRIN "PRO-ROOT" and Progetto Premiale "Aqua"; Marie Curie IEF [2010-275626]	Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy: PRIN "PRO-ROOT" Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy: Progetto Premiale "Aqua"; Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy: PRIN "PRO-ROOT" and Progetto Premiale "Aqua"; Marie Curie IEF(European Commission)	This work was funded by Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy: PRIN 2010-2011 "PRO-ROOT" Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy: Progetto Premiale 2012 "Aqua". http://www.istruzione.it/Marie Curie IEF (2010-275626) http://ec.europa.eu/research/mariecurieactions/.; This work was supported by the Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy: PRIN 2010-2011 "PRO-ROOT" and Progetto Premiale 2012 "Aqua". MH acknowledges funding from a Marie Curie IEF (2010-275626).	Adachi S, 2013, J EXP BOT, V64, P1061, DOI 10.1093/jxb/ers382; Aganchich B, 2009, TREE PHYSIOL, V29, P685, DOI 10.1093/treephys/tpp012; Aroca R, 2006, ANN BOT-LONDON, V98, P1301, DOI 10.1093/aob/mcl219; Bernacchi CJ, 2002, PLANT PHYSIOL, V130, P1992, DOI 10.1104/pp.008250; BLACKMAN PG, 1983, J EXP BOT, V34, P1619, DOI 10.1093/jxb/34.12.1619; Bramley H, 2013, PLANT SOIL, V369, P257, DOI 10.1007/s11104-012-1568-x; Brilli F, 2013, J EXP BOT, V64, P519, DOI 10.1093/jxb/ers353; BROOKS A, 1985, PLANTA, V165, P397, DOI 10.1007/BF00392238; Centritto M, 2003, PLANT CELL ENVIRON, V26, P585, DOI 10.1046/j.1365-3040.2003.00993.x; Centritto M, 2009, J EXP BOT, V60, P2325, DOI 10.1093/jxb/erp123; Chater C, 2013, CURR OPIN PLANT BIOL, V16, P638, DOI 10.1016/j.pbi.2013.06.013; CORREIA MJ, 1995, PLANT CELL ENVIRON, V18, P511, DOI 10.1111/j.1365-3040.1995.tb00551.x; COWAN IR, 1982, AUST J PLANT PHYSIOL, V9, P489, DOI 10.1071/PP9820489; DAVIES WJ, 1991, ANNU REV PLANT PHYS, V42, P55, DOI 10.1146/annurev.pp.42.060191.000415; DIAZPEREZ JC, 1995, J EXP BOT, V46, P111, DOI 10.1093/jxb/46.1.111; Ethier GJ, 2004, PLANT CELL ENVIRON, V27, P137, DOI 10.1111/j.1365-3040.2004.01140.x; Evans JR, 2009, J EXP BOT, V60, P2235, DOI 10.1093/jxb/erp117; EVANS JR, 1994, AUST J PLANT PHYSIOL, V21, P475, DOI 10.1071/PP9940475; EVANS JR, 1986, AUST J PLANT PHYSIOL, V13, P281, DOI 10.1071/PP9860281; Flexas J, 2006, NEW PHYTOL, V172, P73, DOI 10.1111/j.1469-8137.2006.01794.x; Flexas J, 2002, FUNCT PLANT BIOL, V29, P461, DOI 10.1071/PP01119; Flexas J, 2008, PLANT CELL ENVIRON, V31, P602, DOI 10.1111/j.1365-3040.2007.01757.x; Flexas J, 2007, PLANT CELL ENVIRON, V30, P1284, DOI 10.1111/j.1365-3040.2007.01700.x; Flexas J, 2006, PLANT J, V48, P427, DOI 10.1111/j.1365-313X.2006.02879.x; Flexas J, 2013, PHOTOSYNTH RES, V117, P45, DOI 10.1007/s11120-013-9844-z; GEHRING CA, 1990, P NATL ACAD SCI USA, V87, P9645, DOI 10.1073/pnas.87.24.9645; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Gilbert ME, 2012, J EXP BOT, V63, P413, DOI 10.1093/jxb/err288; Gleason SM, 2012, FUNCT ECOL, V26, P343, DOI 10.1111/j.1365-2435.2012.01962.x; Grassi G, 2005, PLANT CELL ENVIRON, V28, P834, DOI 10.1111/j.1365-3040.2005.01333.x; Greenway H, 2003, FUNCT PLANT BIOL, V30, P999, DOI 10.1071/PP98096; Grondin A, 2015, PLANT CELL, V27, P1945, DOI 10.1105/tpc.15.00421; Hanba YT, 2004, PLANT CELL PHYSIOL, V45, P521, DOI 10.1093/pcp/pch070; HARLEY PC, 1992, PLANT PHYSIOL, V98, P1429, DOI 10.1104/pp.98.4.1429; Haworth M, 2016, FUNCT PLANT BIOL, V43, P26, DOI 10.1071/FP15232; Haworth M, 2015, AM J BOT, V102, P677, DOI 10.3732/ajb.1400508; Heckwolf M, 2011, PLANT J, V67, P795, DOI 10.1111/j.1365-313X.2011.04634.x; Hoagland DR, 1950, CAL AGR EXP STN CIRC, V347, DOI [DOI 10.1016/S0140-6736(00)73482-9, 10.1016/S0140-6736(00)73482-9]; Kaldenhoff R, 2012, CURR OPIN PLANT BIOL, V15, P276, DOI 10.1016/j.pbi.2012.01.011; KOK B., 1948, ENZYMOLOGIA [HAGUE], V13, P1; Laisk A, 1996, PLANT PHYSIOL, V110, P903, DOI 10.1104/pp.110.3.903; Laisk A.K., 1977, KINETICS PHOTOSYNTHE; Lauteri M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109054; Lee KH, 2006, CELL, V126, P1109, DOI 10.1016/j.cell.2006.07.034; LORETO F, 1992, PLANT PHYSIOL, V98, P1437, DOI 10.1104/pp.98.4.1437; Loreto F, 2003, PLANT CELL ENVIRON, V26, P595, DOI 10.1046/j.1365-3040.2003.00994.x; Loreto F, 2009, J EXP BOT, V60, P2283, DOI 10.1093/jxb/erp112; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; McAdam SAM, 2012, PLANT CELL, V24, P1510, DOI 10.1105/tpc.112.096404; Mizokami Y, 2015, PLANT CELL ENVIRON, V38, P388, DOI 10.1111/pce.12394; Pallozzi E, 2013, ENVIRON EXP BOT, V95, P50, DOI 10.1016/j.envexpbot.2013.06.001; Parida AK, 2004, TREES-STRUCT FUNCT, V18, P167, DOI 10.1007/s00468-003-0293-8; Pons TL, 2009, J EXP BOT, V60, P2217, DOI 10.1093/jxb/erp081; Rodeghiero M, 2007, PLANT CELL ENVIRON, V30, P1006, DOI 10.1111/j.1365-3040.2007.001689.x; Scartazza A, 1998, AUST J PLANT PHYSIOL, V25, P489, DOI 10.1071/PP98017; Schaufele R, 2011, PLANT CELL ENVIRON, V34, P127, DOI 10.1111/j.1365-3040.2010.02230.x; Shatil-Cohen A, 2011, PLANT J, V67, P72, DOI 10.1111/j.1365-313X.2011.04576.x; Shi Z, 2008, PLANT BIOSYST, V142, P525, DOI 10.1080/11263500802410876; SNAITH PJ, 1982, PLANT CELL ENVIRON, V5, P309, DOI 10.1111/1365-3040.ep11572699; Sun PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105165; TARDIEU F, 1992, PLANT PHYSIOL, V98, P540, DOI 10.1104/pp.98.2.540; Tardieu F, 1996, PLANT CELL ENVIRON, V19, P75, DOI 10.1111/j.1365-3040.1996.tb00228.x; Tazoe Y, 2015, PLANT CELL ENVIRON, V38, P385, DOI 10.1111/pce.12437; Tazoe Y, 2011, PLANT CELL ENVIRON, V34, P580, DOI 10.1111/j.1365-3040.2010.02264.x; Terashima I, 2006, J EXP BOT, V57, P343, DOI 10.1093/jxb/erj014; Terashima I, 2002, PLANT CELL PHYSIOL, V43, P70, DOI 10.1093/pcp/pcf001; Tholen D, 2012, PLANT CELL ENVIRON, V35, P2087, DOI 10.1111/j.1365-3040.2012.02538.x; Thomas DS, 1999, J EXP BOT, V50, P243, DOI 10.1093/jexbot/50.331.243; Tomas M, 2013, J EXP BOT, V64, P2269, DOI 10.1093/jxb/ert086; Tournaire-Roux C, 2003, NATURE, V425, P393, DOI 10.1038/nature01853; TREJO CL, 1991, J EXP BOT, V42, P1507, DOI 10.1093/jxb/42.12.1507; Uehlein N, 2008, PLANT CELL, V20, P648, DOI 10.1105/tpc.107.054023; Uehlein N, 2012, PLANT CELL ENVIRON, V35, P1077, DOI 10.1111/j.1365-3040.2011.02473.x; Vrabl D, 2009, J EXP BOT, V60, P2315, DOI 10.1093/jxb/erp115; Warren CR, 2007, 14 INT C PHOT JUL 22; Wilkinson S, 1997, PLANT PHYSIOL, V113, P559, DOI 10.1104/pp.113.2.559; Xu CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079618; Xu ZJ, 2002, PLANT PHYSIOL, V129, P1285, DOI 10.1104/pp.001784; Yin XY, 2011, J EXP BOT, V62, P3489, DOI 10.1093/jxb/err038; ZHANG J, 1990, PLANT CELL ENVIRON, V13, P277, DOI 10.1111/j.1365-3040.1990.tb01312.x; Zhou SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052439	81	34	36	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148554	10.1371/journal.pone.0148554	http://dx.doi.org/10.1371/journal.pone.0148554			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862904	Green Published, gold			2022-12-27	WOS:000370046600080
J	Cope, RC; Ross, JV; Wittmann, TA; Prowse, TAA; Cassey, P				Cope, Robert C.; Ross, Joshua V.; Wittmann, Talia A.; Prowse, Thomas A. A.; Cassey, Phillip			Integrative Analysis of the Physical Transport Network into Australia	PLOS ONE			English	Article							BIOLOGICAL INVASIONS; INSECT INVASIONS; EXOTIC BARK; TRADE; RISK; GLOBALIZATION; ESTABLISHMENT; COLEOPTERA; DISPERSAL; FRAMEWORK	Effective biosecurity is necessary to protect nations and their citizens from a variety of threats, including emerging infectious diseases, agricultural or environmental pests and pathogens, and illegal wildlife trade. The physical pathways by which these threats are transported internationally, predominantly shipping and air traffic, have undergone significant growth and changes in spatial distributions in recent decades. An understanding of the specific pathways and donor-traffic hotspots created by this integrated physical transport network is vital for the development of effective biosecurity strategies into the future. In this study, we analysed the physical transport network into Australia over the period 1999-2012. Seaborne and air traffic were weighted to calculate a "weighted cumulative impact" score for each source region worldwide, each year. High risk source regions, and those source regions that underwent substantial changes in risk over the study period, were determined. An overall risk ranking was calculated by integrating across all possible weighting combinations. The source regions having greatest overall physical connectedness with Australia were Singapore, which is a global transport hub, and the North Island of New Zealand, a close regional trading partner with Australia. Both those regions with large amounts of traffic across multiple vectors (e.g., Hong Kong), and those with high levels of traffic of only one type (e.g., Bali, Indonesia with respect to passenger flights), were represented among high risk source regions. These data provide a baseline model for the transport of individuals and commodities against which the effectiveness of biosecurity controls may be assessed, and are a valuable tool in the development of future biosecurity policy.	[Cope, Robert C.; Ross, Joshua V.] Univ Adelaide, Sch Math Sci, Adelaide, SA 5005, Australia; [Wittmann, Talia A.; Prowse, Thomas A. A.; Cassey, Phillip] Univ Adelaide, Benham Labs, Sch Biol Sci, Adelaide, SA 5005, Australia	University of Adelaide; University of Adelaide	Cope, RC (corresponding author), Univ Adelaide, Sch Math Sci, Adelaide, SA 5005, Australia.	robert.cope@adelaide.edu.au		Ross, Joshua/0000-0002-9918-8167; Cope, Robert/0000-0002-2048-858X; Prowse, Thomas/0000-0002-4093-767X; Cassey, Phillip/0000-0002-2626-0172	Australian Research Council Discovery Grant [DP140102319, FT0991420, FT130100254]	Australian Research Council Discovery Grant(Australian Research Council)	This study was supported by an Australian Research Council Discovery Grant (DP140102319) to PC and JVR, and Future Fellowships to PC (FT0991420) and JVR (FT130100254). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alacs E, 2008, AUST J FORENSIC SCI, V40, P147, DOI 10.1080/00450610802491382; [Anonymous], 2014, R LANG ENV STAT COMP; Banks NC, 2015, ECOL LETT, V18, P188, DOI 10.1111/ele.12397; Beale R., 2008, ONE BIOSECURITY WORK; Berdal Mats R., 2002, TRANSNATIONAL ORG CR; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Blackburn TM, 2015, J ORNITHOL, P1; Brockerhoff EG, 2006, CAN J FOREST RES, V36, P263, DOI 10.1139/x06-013; Brockerhoff EG, 2006, CAN J FOREST RES, V36, P289, DOI [10.1139/x05-250, 10.1139/X05-250]; Bureau of Infrastructure Transport and Regional Economics, 2014, INT AIRL ACT TIME SE; Coker RJ, 2011, LANCET, V377, P599, DOI 10.1016/S0140-6736(10)62004-1; Cope RC, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150039; Department of Agriculture Fisheries and Forestry Biosecurity, 2012, REP REV IMP IN PRESS; Garcia-Diaz P, 2015, GLOBAL CHANGE BIOL, V21, P1078, DOI 10.1111/gcb.12790; Haack RA, 2006, CAN J FOREST RES, V36, P269, DOI 10.1139/x05-249; Henderson W, 2011, WILDLIFE RES, V38, P501, DOI 10.1071/WR11089; Heymann David, 2003, J HUMAN DEV, V4, P191, DOI DOI 10.1080/1464988032000087541; Hulme PE, 2008, J APPL ECOL, V45, P403, DOI 10.1111/j.1365-2664.2007.01442.x; Hulme PE, 2015, J APPL ECOL, V52, P1418, DOI 10.1111/1365-2664.12470; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; International Maritime Organization, 2012, INT SHIPP FACTS FIG; Kaluza P, 2010, J R SOC INTERFACE, V7, P1093, DOI 10.1098/rsif.2009.0495; Kenis M, 2007, B ENTOMOL RES, V97, P489, DOI 10.1017/S0007485307005184; Lakoff Andrew, 2008, BIOSECURITY INTERVEN; Liebhold Andrew M., 2006, American Entomologist, V52, P48; Maritime & Port Authority of Singapore, 2014, ANN REPORT; Meyerson LA, 2003, FRONT ECOL ENVIRON, V1, P307, DOI 10.2307/3868091; Meyerson LA, 2002, BIOSCIENCE, V52, P593, DOI 10.1641/0006-3568(2002)052[0593:BMTACA]2.0.CO;2; Meyerson LA, 2007, FRONT ECOL ENVIRON, V5, P199, DOI 10.1890/1540-9295(2007)5[199:IASIAE]2.0.CO;2; Puth LM, 2005, ECOL LETT, V8, P715, DOI 10.1111/j.1461-0248.2005.00774.x; Pysek P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024890; Richardson DM, 2013, DIVERS DISTRIB, V19, P1461, DOI 10.1111/ddi.12150; RStudio and Inc, 2014, SHIN WEB APPL FRAM R; Ruiz GM, 1997, AM ZOOL, V37, P621; Seebens H, 2013, ECOL LETT, V16, P782, DOI 10.1111/ele.12111; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Tatem AJ, 2006, ADV PARASIT, V62, P293, DOI 10.1016/S0065-308X(05)62009-X; Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103; Tatem AJ, 2009, ECOGRAPHY, V32, P94, DOI 10.1111/j.1600-0587.2008.05588.x; United Nations, 2013, REV MAR TRANSP; Upham P, 2003, J AIR TRANSP MANAG, V9, P145, DOI 10.1016/S0969-6997(02)00078-9; WILSON D, 2002, SURVEILLANCE SOC, V5, P124, DOI DOI 10.24908/SS.V5I2.3431	42	10	10	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148831	10.1371/journal.pone.0148831	http://dx.doi.org/10.1371/journal.pone.0148831			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881782	Green Published, gold, Green Submitted			2022-12-27	WOS:000371219000027
J	Zheng, FH; Jang, WC; Fung, FKC; Lo, ACY; Wong, IYH				Zheng, Feihui; Jang, Wai-Chi; Fung, Frederic K. C.; Lo, Amy C. Y.; Wong, Ian Y. H.			Up-Regulation of ENO1 by HIF-1 alpha in Retinal Pigment Epithelial Cells after Hypoxic Challenge Is Not Involved in the Regulation of VEGF Secretion	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INDUCIBLE FACTOR-1; ALPHA-ENOLASE; CHOROIDAL NEOVASCULARIZATION; LACTATE-DEHYDROGENASE; PROTEIN EXPRESSION; OXIDATIVE STRESS; GENE; MECHANISMS; IDENTIFICATION	Purpose Alpha-enolase (ENO1), a major glycolytic enzyme, is reported to be over-expressed in various cancer tissues. It has been demonstrated to be regulated by the Hypoxia-inducible factor 1-alpha (HIF-1 alpha), a crucial transcriptional factor implicated in tumor progression and cancer angiogenesis. Choroidal neovascularization (CNV), which is a leading cause of severe vision loss caused by newly formed blood vessels in the choroid, is also engendered by hypoxic stress. In this report, we investigated the expression of ENO1 and the effects of its down-regulation upon cobalt (II) chloride-induced hypoxia in retinal pigment epithelial cells, identified as the primary source of ocular angiogenic factors. Methods HIF-1 alpha-diminished retinal pigment epithelial cells were generated by small interfering RNA (siRNA) technology in ARPE-19 cells, a human retinal pigment epithelial cell line. Both normal and HIF-1 alpha-diminished ARPE-19 cells were then subjected to hypoxic challenge using cobalt (II) chloride (CoCl2) or anaerobic chamber. The relation between ENO1 expression and vascular endothelial growth factor (VEGF) secretion by retinal pigment epithelial cells were examined. Protein levels of HIF-1 alpha and ENO1 were analyzed using Western Blot, while VEGF secretion was essayed by enzyme-linked immunosorbent assay (ELISA). Cytotoxicity after hypoxia was detected by Lactate Dehydrogenase (LDH) Assay. Results Upon 24 hr of CoCl2-induced hypoxia, the expression levels of ENO1 and VEGF were increased along with HIF-1 alpha in ARPE-19 cells, both of which can in turn be down-regulated by HIF-1 alpha siRNA application. However, knockdown of ENO1 alone or together with HIF-1 alpha did not help suppress VEGF secretion in hypoxic ARPE-19 cells. Conclusion ENO1 was demonstrated to be up-regulated by HIF-1 alpha in retinal pigment epithelial cells in response to hypoxia, without influencing VEGF secretion.	[Zheng, Feihui; Jang, Wai-Chi; Fung, Frederic K. C.; Lo, Amy C. Y.; Wong, Ian Y. H.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Ophthalmol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Lo, ACY; Wong, IYH (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Ophthalmol, Hong Kong, Hong Kong, Peoples R China.	amylo@hku.hk; wongyhi@hku.hk	CHENG, FREYA/GOH-0443-2022; Lo, Amy C. Y./C-1195-2009	CHENG, FREYA/0000-0001-9179-3461; Lo, Amy C. Y./0000-0003-4239-6851				AARONSON RM, 1995, J BIOL CHEM, V270, P27752, DOI 10.1074/jbc.270.46.27752; Adamus G, 1996, CLIN IMMUNOL IMMUNOP, V78, P120, DOI 10.1006/clin.1996.0021; Arjamaa O, 2006, EXP EYE RES, V83, P473, DOI 10.1016/j.exer.2006.01.016; Armstrong RA, 2014, OPHTHAL PHYSL OPT, V34, P502, DOI 10.1111/opo.12131; Baby SM, 2003, HISTOCHEM CELL BIOL, V120, P343, DOI 10.1007/s00418-003-0588-2; CHUNG EH, 1995, INVEST OPHTH VIS SCI, V36, P1336; DAMORE PA, 1994, INVEST OPHTH VIS SCI, V35, P3974; Dong A, 2009, J CELL PHYSIOL, V219, P544, DOI 10.1002/jcp.21698; Finnegan S, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-34; Forooghian F, 2007, BRIT J OPHTHALMOL, V91, DOI 10.1136/bjo.2007.123125; Gao J, 2013, ONCOL REP, V29, P1322, DOI 10.3892/or.2013.2269; GIALLONGO A, 1990, EUR J BIOCHEM, V190, P567, DOI 10.1111/j.1432-1033.1990.tb15611.x; Jang W-c, 2009, THESIS U HONG KONG H; Jester JV, 2005, INVEST OPHTH VIS SCI, V46, P2369, DOI 10.1167/iovs.04-1225; Jiang BH, 1997, CANCER RES, V57, P5328; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Joachim SC, 2007, GRAEF ARCH CLIN EXP, V245, P619, DOI 10.1007/s00417-006-0429-9; Kapphahn RJ, 2006, EXP EYE RES, V83, P165, DOI 10.1016/j.exer.2005.11.017; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; KRAFT HJ, 1994, EXP EYE RES, V58, P389, DOI 10.1006/exer.1994.1031; Lassen N, 2008, SEMIN CELL DEV BIOL, V19, P100, DOI 10.1016/j.semcdb.2007.10.004; Li H, 1996, J BIOL CHEM, V271, P21262, DOI 10.1074/jbc.271.35.21262; Lin MK, 2012, INVEST OPHTH VIS SCI, V53, P6197, DOI 10.1167/iovs.11-8936; Nielsen K, 2006, EXP EYE RES, V82, P201, DOI 10.1016/j.exer.2005.06.009; Pernemalm M, 2013, J PROTEOME RES, V12, P3934, DOI 10.1021/pr4002096; Piatigorsky Joram, 2003, Journal of Structural and Functional Genomics, V3, P131; Sang NL, 2002, MOL CELL BIOL, V22, P2984, DOI 10.1128/MCB.22.9.2984-2992.2002; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 2002, BIOCHEM PHARMACOL, V64, P993, DOI 10.1016/S0006-2952(02)01168-1; Sharma NK, 2013, J PROTEOMICS, V79, P277, DOI 10.1016/j.jprot.2012.12.020; Song Y, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-65; Spilsbury K, 2000, AM J PATHOL, V157, P135, DOI 10.1016/S0002-9440(10)64525-7; Srivastava OP, 2006, MOL VIS, V12, P1615; Trojanowicz B, 2009, J MOL ENDOCRINOL, V42, P249, DOI 10.1677/JME-08-0118; Wang-Su ST, 2003, INVEST OPHTH VIS SCI, V44, P4829, DOI 10.1167/iovs.03-0556; Weleber RG, 2005, AM J OPHTHALMOL, V139, P780, DOI 10.1016/j.ajo.2004.12.104; Wenger RH, 1997, KIDNEY INT, V51, P560, DOI 10.1038/ki.1997.79; Yeo EJ, 2003, J NATL CANCER I, V95, P516, DOI 10.1093/jnci/95.7.516	38	13	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0147961	10.1371/journal.pone.0147961	http://dx.doi.org/10.1371/journal.pone.0147961			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882120	Green Published, Green Submitted, gold			2022-12-27	WOS:000371219000011
J	Banhos, A; Hrbek, T; Sanaiotti, TM; Farias, IP				Banhos, Aureo; Hrbek, Tomas; Sanaiotti, Tania M.; Farias, Izeni Pires			Reduction of Genetic Diversity of the Harpy Eagle in Brazilian Tropical Forests	PLOS ONE			English	Article							ATLANTIC FOREST; MICROSATELLITE MARKERS; POPULATION-GENETICS; MUSEUM SPECIMENS; ESPIRITO-SANTO; MATO-GROSSO; CONSERVATION; AMAZON; PATTERNS; RECORDS	Habitat loss and fragmentation intensify the effects of genetic drift and endogamy, reducing genetic variability of populations with serious consequences for wildlife conservation. The Harpy Eagle (Harpia harpyja) is a forest dwelling species that is considered near threatened and suffers from habitat loss in the forests of the Neotropical region. In this study, 72 historical and current samples were assessed using eight autosomal microsatellite markers to investigate the distribution of genetic diversity of the Harpy Eagle of the Amazonian and Atlantic forests in Brazil. The results showed that the genetic diversity of Harpy Eagle decreased in the regions where deforestation is intense in the southern Amazon and Atlantic Forest.	[Banhos, Aureo] Univ Fed Espirito Santo, Ctr Ciencias Exatas Nat & Saude, Dept Biol, Alegre, ES, Brazil; [Hrbek, Tomas; Farias, Izeni Pires] Univ Fed Amazonas, Inst Ciencias Biol, Dept Genet, Lab Evolucao & Genet Anim, Manaus, Amazonas, Brazil; [Sanaiotti, Tania M.] Inst Nacl de Pesquisas da Amazonia, Coordenacao Biodiversidade, Manaus, Amazonas, Brazil; [Banhos, Aureo; Sanaiotti, Tania M.] Inst Nacl de Pesquisas da Amazonia, Programa Conservacao Gaviao Real, Manaus, Amazonas, Brazil	Universidade Federal do Espirito Santo; Universidade Federal de Amazonas; Institute Nacional de Pesquisas da Amazonia; Institute Nacional de Pesquisas da Amazonia	Banhos, A (corresponding author), Univ Fed Espirito Santo, Ctr Ciencias Exatas Nat & Saude, Dept Biol, Alegre, ES, Brazil.; Banhos, A (corresponding author), Inst Nacl de Pesquisas da Amazonia, Programa Conservacao Gaviao Real, Manaus, Amazonas, Brazil.	aureo.santos@ufes.br	Hrbek, Tomas/J-6988-2012; Farias, Izeni Pires/J-3069-2014	Hrbek, Tomas/0000-0003-3239-7068; Farias, Izeni Pires/0000-0002-1416-4351	National Counsel of Technological and Scientific Development (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM); Fundacao de Amparo a Pesquisa do Espirito Santo (FAPES); Fundacao Grupo Boticario de Protecao a Natureza (FBPN); Scott Neotropical Fund	National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)(Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)); Fundacao de Amparo a Pesquisa do Espirito Santo (FAPES); Fundacao Grupo Boticario de Protecao a Natureza (FBPN); Scott Neotropical Fund	This work was supported by the National Counsel of Technological and Scientific Development (CNPq) - http://www.cnpq.br/; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) - http://www.capes.gov.br/; Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM) - http://www.fapeam.am.gov.br/; Fundacao de Amparo a Pesquisa do Espirito Santo (FAPES) - http://www.fapes.es.gov.br/; Fundacao Grupo Boticario de Protecao a Natureza (FBPN) - http://www.fundacaogrupoboticario.org.br/; and the Scott Neotropical Fund - http://www.clevelandmetroparks.com/Zoo/Grants/Scott-Neotropical-Fund-1.aspx.	Ab'Saber A.N, 1977, GEOMORFOLOGIA, V52, P1, DOI DOI 10.3897/ZOOKEYS.150.2109; Aguiar-Silva FH, 2013, P 1 WORLDW RAPT C 20, P51; Aguiar-Silva FH, 2012, REV BRAS ORNITOL, V20, P148; Allendorf F., 2007, CONSERVATION GENETIC; Athrey G, 2011, CONSERV GENET, V12, P1345, DOI 10.1007/s10592-011-0235-8; Avise J, 2004, MOL MARKERS NATURAL; Banhos A, 2008, GENET MOL BIOL, V31, P146, DOI 10.1590/S1415-47572008000100025; Batalha H, 2013, J ORNITHOL, V154, P41, DOI 10.1007/s10336-012-0866-7; Bierregaard Richard O. Jr., 1995, Bird Conservation International, V5, P325; Bird JP, 2012, DIVERS DISTRIB, V18, P273, DOI 10.1111/j.1472-4642.2011.00843.x; Bourke BP, 2010, CONSERV GENET, V11, P1837, DOI 10.1007/s10592-010-0076-x; Busch JD, 2005, MOL ECOL NOTES, V5, P39, DOI 10.1111/j.1471-8286.2004.00823.x; Collar N.J., 1989, World Birdwatch, V11, P5; Coser R, 2014, CONSERV GENET RESOUR, V6, P999, DOI 10.1007/s12686-014-0268-7; Costa LP, 2003, J BIOGEOGR, V30, P71, DOI 10.1046/j.1365-2699.2003.00792.x; Costa MH, 2010, INT J CLIMATOL, V30, P1970, DOI 10.1002/joc.2048; DeLuca JJ, 2012, TROP CONSERV SCI, V5, P301, DOI 10.1177/194008291200500306; DiBattista JD, 2008, CONSERV GENET, V9, P141, DOI 10.1007/s10592-007-9317-z; DINERSTEIN E, 1990, CONSERV BIOL, V4, P417, DOI 10.1111/j.1523-1739.1990.tb00316.x; Eizirik E, 2001, MOL ECOL, V10, P65, DOI 10.1046/j.1365-294X.2001.01144.x; Evans SR, 2008, CONSERV BIOL, V22, P1016, DOI 10.1111/j.1523-1739.2008.00972.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Food and Agriculture Organization of the United Nations, 2015, PREPRINT; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Frankham R., 2010, INTRO CONSERVATION G, DOI DOI 10.1017/CBO9780511809002; Freitas MA, 2014, ATUAL ORNITOL, V178, P12; Fundacao SOS Mata Atlantica Instituto Nacional de Pesquisas Espaciais, 2015, PREPRINT; Galetti Mauro, 1997, Bulletin of the British Ornithologists' Club, V117, P27; Garner A, 2005, CONSERV BIOL, V19, P1215, DOI 10.1111/j.1523-1739.2005.00105.x; Hailer F, 2005, MOL ECOL NOTES, V5, P938, DOI 10.1111/j.1471-8286.2005.01122.x; Hailer F, 2006, BIOL LETTERS, V2, P316, DOI 10.1098/rsbl.2006.0453; Harvey MG, 2015, MOL PHYLOGENET EVOL, V83, P305, DOI 10.1016/j.ympev.2014.10.023; Aguiar-Silva FH, 2014, J RAPTOR RES, V48, P24, DOI 10.3356/JRR-13-00017.1; Horvath MB, 2005, J AVIAN BIOL, V36, P84, DOI 10.1111/j.0908-8857.2005.03370.x; Instituto Nacional de Pesquisas Espaciais, 2014, PROJ PROD MON FLOR A; International Birdlife, 2015, SPEC FACTSH HARP HAR; Johnson JA, 2009, MOL ECOL, V18, P54, DOI [10.1111/j.1365-294X.2009.04240.x, 10.1111/j.1365-294X.2008.04012.x]; Johnson PCD, 2005, MOL ECOL NOTES, V5, P208, DOI 10.1111/j.1471-8286.2005.00878.x; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kuniy AA, 2015, BRAZ J BIOL, V75, P1035, DOI 10.1590/1519-6984.24714; Laurance WF, 2001, SCIENCE, V291, P438, DOI 10.1126/science.291.5503.438; Leonard JA, 2008, MOL ECOL, V17, P4186, DOI 10.1111/j.1365-294X.2008.03891.x; Lerner HRL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007336; LINK C. A., 2005, MEGADIVERSIDADE, V1, P147, DOI DOI 10.1590/S0100-69912009000400001; Lopes Leonardo Esteves, 2009, Pap. Avulsos Zool. (São Paulo), V49, P9, DOI 10.1590/S0031-10492009000200001; Martinez-Cruz B, 2007, MOL ECOL, V16, P477, DOI 10.1111/j.1365-294X.2007.03147.x; Martinez-Cruz B, 2004, MOL ECOL, V13, P2243, DOI 10.1111/j.1365-294X.2004.02220.x; Martins Pereira Alexandre de Matos, 2006, Revista Brasileira de Ornitologia, V14, P157; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Mira S, 2005, MOL ECOL NOTES, V5, P493, DOI 10.1111/j.1471-8286.2005.00967.x; Muniz-Lopez Ruth, 2008, Cotinga, V29, P42; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; NEI M, 1978, GENETICS, V89, P583; Nesje M, 2000, MOL ECOL, V9, P1438, DOI 10.1046/j.1365-294x.2000.00999-4.x; Oliveira AL, 2006, REV BRAS ORNITOL, V14, P433; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pivatto M.A.C., 2006, ATUALIDADES ORNITOLO, V129, P1; Pritchard JK, 2000, GENETICS, V155, P945; Pritcharda JK, 2010, PREPRINT; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Rocha G.F., 2011, REV BRASILEIRA CARTO, V63, P341; ROY MS, 1994, EXPERIENTIA, V50, P551, DOI 10.1007/BF01921724; Sanaiotti TM, 2015, BRAZ J BIOL, V75, pS190, DOI [10.1590/1519-6984.00614BM, 10.1590/1519-6984.00614bm]; Sanchez-Lalinde C, 2011, REV BRAS ORNITOL, V19, P436; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Silva DA, 2013, REV BRAS ORNITOL, V21, P295; Silveira Luís Fábio, 2002, Pap. Avulsos Zool., V42, P265; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; Sobral-Souza T, 2015, EVOL ECOL, V29, P643, DOI 10.1007/s10682-015-9780-9; Spielman D, 2004, P NATL ACAD SCI USA, V101, P15261, DOI 10.1073/pnas.0403809101; Srbek-Araujo AC, 2006, REV BRAS ZOOL, V23, P1264, DOI 10.1590/S0101-81752006000400040; SWART MKJ, 1994, J HERED, V85, P261, DOI 10.1093/oxfordjournals.jhered.a111453; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; Trinca Cristiano Trape, 2008, Cotinga, V30, P12; Ubaid FK, 2011, REV BRAS ORNITOL, V19, P88; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vargas JD, 2006, ORNITOL NEOTROP, V17, P39; Wandeler P, 2007, TRENDS ECOL EVOL, V22, P634, DOI 10.1016/j.tree.2007.08.017; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	80	10	10	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148902	10.1371/journal.pone.0148902	http://dx.doi.org/10.1371/journal.pone.0148902			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871719	gold, Green Published, Green Submitted			2022-12-27	WOS:000370054100071
J	Barcelo, MA; Coll-Negre, M; Coll-de-Tuero, G; Saez, M				Barcelo, Maria A.; Coll-Negre, Montserrat; Coll-de-Tuero, Gabriel; Saez, Marc			Effects of the Financial Crisis on Psychotropic Drug Consumption in a Cohort from a Semi-Urban Region in Catalonia, Spain	PLOS ONE			English	Article							ECONOMIC RECESSION; MENTAL-DISORDERS; HEALTH; POPULATION; PRESCRIPTION; SUICIDE; UNEMPLOYMENT; DEPRESSION; AUSTERITY; ENGLAND	Purpose Evidence of whether the recent economic crisis has or has not had an effect on psychotropic drug consumption is very scarce. Our objective was to determine if there had in fact been an increase in psychotropic drug use as a result of the financial crisis. Methods In our study a retrospective cohort (between January 1, 2005, and December 31, 2012) was made up of individuals from the general population in a region in the northeast of Catalonia, Spain. We specified a generalized linear mixed model along with combined 'selection on observables' as (propensity scoring) matching and 'selection on unobservables' as (random coefficient) the panel data model methods, and performed inferences using a Bayesian framework. Results In the period following the economic crisis (post 2009), there was an increase in the consumption of psychotropic drugs which was significantly higher among those who had already been consuming psychotropic drugs prior to 2009 and those most likely to be unemployed. The increase was of greater significance when consumption was measured by the number of drugs being taken, rather than by the defined daily dose (DDD), with the greatest increase occurring in 2011; the very year in which Spain was most affected by the crisis. Conclusions Once the financial crisis had ended, there was an increase in the severity, rather than the intensity, of mental health disorders in individuals who had already had disorders before the crisis. This increase occurred in those most likely to be unemployed, and the severity was accentuated in the toughest year of the economic crisis.	[Barcelo, Maria A.; Saez, Marc] Univ Girona, Res Grp Stat Econometr & Hlth GRECS, Girona, Spain; [Barcelo, Maria A.; Coll-de-Tuero, Gabriel; Saez, Marc] CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain; [Coll-Negre, Montserrat] Cambian Churchill Hosp, Mental Hlth Serv, London, England; [Coll-de-Tuero, Gabriel] Univ Inst Res Primary Care Jordi Gol IdIAP Gol, Res Support Unit, Girona, Spain; [Coll-de-Tuero, Gabriel] Univ Girona, Dept Med Sci, Girona, Spain	Universitat de Girona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universitat de Girona	Saez, M (corresponding author), Univ Girona, Res Grp Stat Econometr & Hlth GRECS, Girona, Spain.; Saez, M (corresponding author), CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain.	marc.saez@udg.edu	Coll-de-Tuero, Gabriel/H-3475-2016; Barceló, Maria A/AAT-6212-2020	Coll-de-Tuero, Gabriel/0000-0001-7578-9569; Barceló, Maria A/0000-0001-9720-690X	'Crisis and Health', CIBER of Epidemiology and Public Health (CIBERESP), Spain [2014SGR551]; 'Compositional and Spatial Analysis' (COSDA), AGAUR, 'Generalitat de Catalunya' [2014SGR551]; Call of Singular Actions, University of Girona, Spain	'Crisis and Health', CIBER of Epidemiology and Public Health (CIBERESP), Spain; 'Compositional and Spatial Analysis' (COSDA), AGAUR, 'Generalitat de Catalunya'; Call of Singular Actions, University of Girona, Spain	This was developed within the scope of two projects: 'Crisis and Health', CIBER of Epidemiology and Public Health (CIBERESP), Spain, together with the 'Compositional and Spatial Analysis' (COSDA), AGAUR, 'Generalitat de Catalunya', 2014SGR551. It was partly supported by the 2012 Call of Singular Actions, University of Girona, Spain (http://www.udg.edu). The work did not obtain additional funding for its development.	Alameda-Palacios J, 2014, GAC SANIT, V28, P309, DOI 10.1016/j.gaceta.2013.12.005; Cordoba-Dona JA, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-55; Astell-Burt T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056674; Baumann A., 2010, MENTAL HLTH WELL BEI; Bernal JAL, 2013, EUR J PUBLIC HEALTH, V23, P732, DOI 10.1093/eurpub/ckt083; Bradford WD, 2014, HEALTH ECON, V23, P1301, DOI 10.1002/hec.2983; Chang SS, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5239; Chen J, 2014, J BEHAV HLT IN PRESS; Corcoran P, 2015, INT J EPIDEMIOL, V44, P969, DOI 10.1093/ije/dyv058; Craig P, 2012, J EPIDEMIOL COMMUN H, V66, P1182, DOI 10.1136/jech-2011-200375; Gili Margalida, 2014, Gac Sanit, V28 Suppl 1, P104, DOI 10.1016/j.gaceta.2014.02.005; Gili M, 2013, EUR J PUBLIC HEALTH, V23, P103, DOI 10.1093/eurpub/cks035; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hafslund B, 2012, CANCER NURS, V35, pE26, DOI 10.1097/NCC.0b013e3182341ddb; Heckman JJ, 1997, REV ECON STUD, V64, P605, DOI 10.2307/2971733; HM Treasury, GLOSS TREAS TERMS; Ilyas S, 2012, BRIT J PSYCHIAT, V200, P393, DOI 10.1192/bjp.bp.111.104257; Jones A.M., 2009, 0909 HEDG U YORK; Karanikolos M, 2013, LANCET, V381, P1323, DOI 10.1016/S0140-6736(13)60102-6; McInerney M, 2013, J HEALTH ECON, V32, P1090, DOI 10.1016/j.jhealeco.2013.09.002; Mckenzie SK, 2014, J EPIDEMIOL COMMUN H, V68, P253, DOI 10.1136/jech-2013-203013; Morris S, 2005, SOC SCI MED, V60, P1251, DOI 10.1016/j.socscimed.2004.07.016; Nandi A, 2013, J EPIDEMIOL COMMUN H, V67, P1038, DOI 10.1136/jech-2012-202260; Ng CG, 2013, PSYCHO-ONCOLOGY, V22, P762, DOI 10.1002/pon.3056; Nuffield Trust, 2014, FOC ANT PRESCR; Olesen J, 2003, EUR J NEUROL, V10, P471, DOI 10.1046/j.1468-1331.2003.00682.x; Perez-Garcia F, 2015, PUBLIC SERVICES REGI; Pinheiro J, 2001, MIXED EFFECTS MODELS; Ponsa J. A., 2003, FULLS EC SISTEMA SAN, V37, P8; Punekar RS, 2012, PSYCHO-ONCOLOGY, V21, P1237, DOI 10.1002/pon.2039; R Core Team, 2021, R LANGUAGE ENV STAT; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Ruhm CJ, 2000, Q J ECON, V115, P617, DOI 10.1162/003355300554872; Ruhm CJ, 2003, J HEALTH ECON, V22, P637, DOI 10.1016/S0167-6296(03)00041-9; Sáez M., 2003, Gac Sanit, V17, P412; Sargent-Cox K, 2011, SOC SCI MED, V73, P1105, DOI 10.1016/j.socscimed.2011.06.063; Saurina C, 2015, INT J EQUIT IN PRESS; Saurina C, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0192-9; Verdu ES, 2014, ATEN PRIM, V46, P416, DOI 10.1016/j.aprim.2013.11.006; Minana JS, 2012, ATEN PRIM, V44, P335, DOI 10.1016/j.aprim.2011.06.009; The R-INLA project, RAND WALK MOD ORD 1; Tresserras-Gaju Ricard, 2011, Med Clin (Barc), V137 Suppl 2, P16, DOI 10.1016/S0025-7753(11)70023-9; Urbanos-Garrido RM, 2015, EUR J HEALTH ECON, V16, P175, DOI 10.1007/s10198-014-0563-y; Uutela A, 2010, CURR OPIN PSYCHIATR, V23, P127, DOI 10.1097/YCO.0b013e328336657d; Sanchez MPV, 2013, REV ESP SALUD PUBLIC, V87, P247, DOI [10.4321/S1135-57272013000300004, 10.4321/s1135-57272013000300004]; Wang JL, 2010, CAN J PSYCHIAT, V55, P598, DOI 10.1177/070674371005500908; WHO Collaborating Center for Drug Statistics and Methodology, 2014, ATC DDD IND 2015; Wise J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3607; Zivin K, 2011, PSYCHOL MED, V41, P1343, DOI 10.1017/S003329171000173X	51	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148594	10.1371/journal.pone.0148594	http://dx.doi.org/10.1371/journal.pone.0148594			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6SI	26872210	gold, Green Published, Green Submitted			2022-12-27	WOS:000370054100038
J	Cameron, SJS; Lewis, KE; Huws, SA; Lin, WC; Hegarty, MJ; Lewis, PD; Mur, LAJ; Pachebat, JA				Cameron, Simon J. S.; Lewis, Keir E.; Huws, Sharon A.; Lin, Wanchang; Hegarty, Matthew J.; Lewis, Paul D.; Mur, Luis A. J.; Pachebat, Justin A.			Metagenomic Sequencing of the Chronic Obstructive Pulmonary Disease Upper Bronchial Tract Microbiome Reveals Functional Changes Associated with Disease Severity	PLOS ONE			English	Article							BACTERIAL-INFECTIONS; ACUTE EXACERBATION; CYSTIC-FIBROSIS; SIALIC ACIDS; COPD; PROGRESSION; PREVALENCE; BIOMARKERS; PROTEIN	Chronic Obstructive Pulmonary Disease (COPD) is a major source of mortality and morbidity worldwide. The microbiome associated with this disease may be an important component of the disease, though studies to date have been based on sequencing of the 16S rRNA gene, and have revealed unequivocal results. Here, we employed metagenomic sequencing of the upper bronchial tract (UBT) microbiome to allow for greater elucidation of its taxonomic composition, and revealing functional changes associated with the disease. The bacterial metagenomes within sputum samples from eight COPD patients and ten 'healthy' smokers (Controls) were sequenced, and suggested significant changes in the abundance of bacterial species, particularly within the Streptococcus genus. The functional capacity of the COPD UBT microbiome indicated an increased capacity for bacterial growth, which could be an important feature in bacterial-associated acute exacerbations. Regression analyses correlated COPD severity (FEV1% of predicted) with differences in the abundance of Streptococcus pneumoniae and functional classifications related to a reduced capacity for bacterial sialic acid metabolism. This study suggests that the COPD UBT microbiome could be used in patient risk stratification and in identifying novel monitoring and treatment methods, but study of a longitudinal cohort will be required to unequivocally relate these features of the microbiome with COPD severity.	[Cameron, Simon J. S.; Huws, Sharon A.; Lin, Wanchang; Hegarty, Matthew J.; Mur, Luis A. J.; Pachebat, Justin A.] Inst Biol Environm & Rural Sci, Edward Llywd Bldg,Penglais Campus, Aberystwyth SY23 3FG, Ceredigion, Wales; [Lewis, Keir E.] Hywel Dda Univ, Hlth Board, Prince Phillip Hosp, Dept Resp Med, Llanelli SA14 8QF, England; [Lewis, Keir E.; Lewis, Paul D.] Swansea Univ, Coll Med, Swansea SA2 8PP, W Glam, Wales	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); Swansea University	Mur, LAJ (corresponding author), Inst Biol Environm & Rural Sci, Edward Llywd Bldg,Penglais Campus, Aberystwyth SY23 3FG, Ceredigion, Wales.	lum@aber.ac.uk	Mur, Luis a. j./U-1052-2017	Mur, Luis a. j./0000-0002-0961-9817; Lewis, Keir/0000-0002-8248-6774; Pachebat, Justin/0000-0003-3369-3205; Lewis, Keir/0000-0001-9756-4723; Hegarty, Matthew/0000-0001-6547-3800; Huws, Sharon/0000-0002-9284-2453; Cameron, Simon/0000-0001-9570-135X	Aberystwyth University; National Institute for Social Care and Health Research; The British Council [172629373] Funding Source: researchfish	Aberystwyth University; National Institute for Social Care and Health Research; The British Council	This work was supported by Aberystwyth University through a studentship grant awarded to S.J.S.C. and partially supported through grants from National Institute for Social Care and Health Research, Wales to K.E.L. and P.D.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SJSC is grateful for studentship from Aberystwyth University. We wish to thank Dr Paul Griffiths, Consultant histopathologist, for sputum cytological assessment and Dr Chris Creevey and Dr Martin Swain for helpful discussion. This work was supported by Aberystwyth University through a studentship grant awarded to S.J.S.C. and partially supported through grants from National Institute for Social Care and Health Research, Wales to K.E.L. and P.D.L. In addition, we would like to thank the reviewers of this manuscript for their constructive comments, the addressing of which, we believe, have made for a better manuscript.	Bittar F, 2010, CLIN MICROBIOL INFEC, V16, P809, DOI 10.1111/j.1469-0691.2010.03236.x; Borges TJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00095; Cabrera-Rubio R, 2012, J CLIN MICROBIOL, V50, P3562, DOI 10.1128/JCM.00767-12; Cao HA, 2011, IMMUNOLOGY, V132, P18, DOI 10.1111/j.1365-2567.2010.03368.x; Carlin AF, 2007, J BACTERIOL, V189, P1231, DOI 10.1128/JB.01155-06; Chang YC, 2014, GLYCOBIOLOGY, V24, P818, DOI 10.1093/glycob/cwu067; Chiba S, 2006, MOL MICROBIOL, V60, P448, DOI 10.1111/j.1365-2958.2006.05104.x; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Ciofu O, 2013, CURR OPIN PULM MED, V19, P251, DOI 10.1097/MCP.0b013e32835f1afc; Dongarra J, 1979, LINPACK USERS GUIDES; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Field D, 2006, NAT BIOTECHNOL, V24, P801, DOI 10.1038/nbt0706-801; Friendly M, 2012, CORRGRAMS; Garcha DS, 2012, THORAX, V67, P1075, DOI 10.1136/thoraxjnl-2012-201924; Groenewegen KH, 2003, RESP MED, V97, P770, DOI 10.1016/S0954-6111(03)00026-X; Han MK, 2014, LANCET RESP MED, V2, P548, DOI 10.1016/S2213-2600(14)70069-4; Han MK, 2012, THORAX, V67, P456, DOI 10.1136/thoraxjnl-2011-201183; Hauser PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090934; Hirschmann JV, 2000, CHEST, V118, P193, DOI 10.1378/chest.118.1.193; Huang YJ, 2010, OMICS, V14, P9, DOI 10.1089/omi.2009.0100; Husgafvel-Pursiainen K, 2004, MUTAT RES-REV MUTAT, V567, P427, DOI 10.1016/j.mrrev.2004.06.004; Kherad O, 2010, CHEST, V138, P896, DOI 10.1378/chest.09-2225; Lim YW, 2013, J CYST FIBROS, V12, P154, DOI 10.1016/j.jcf.2012.07.009; Lopez AD, 2006, EUR RESPIR J, V27, P397, DOI 10.1183/09031936.06.00025805; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Monso E, 2003, EPIDEMIOL INFECT, V131, P799, DOI 10.1017/S0950268803008872; Morris A, 2013, AM J RESP CRIT CARE, V187, P1067, DOI 10.1164/rccm.201210-1913OC; Nseir S, 2006, CRIT CARE MED, V34, P2959, DOI 10.1097/01.CCM.0000245666.28867.C6; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Parr DG, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-136; Patel IS, 2002, THORAX, V57, P759, DOI 10.1136/thorax.57.9.759; Perez-Losada M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131819; Pragman AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047305; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Renom F, 2010, RESP MED, V104, P840, DOI 10.1016/j.rmed.2009.12.010; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; Shaughnessy J, 2009, INFECT IMMUN, V77, P2094, DOI 10.1128/IAI.01561-08; Shaw JG, 2014, J THORAC DIS, V6, P1532, DOI 10.3978/j.issn.2072-1439.2014.11.33; Sze MA, 2012, AM J RESP CRIT CARE, V185, P1073, DOI 10.1164/rccm.201111-2075OC; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; Vimr E, 2002, TRENDS MICROBIOL, V10, P254, DOI 10.1016/S0966-842X(02)02361-2; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Zawadzki MA, 2005, United State of America: US Patent, Patent No. [6837248 B2, 6837248]	46	34	34	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149095	10.1371/journal.pone.0149095	http://dx.doi.org/10.1371/journal.pone.0149095			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872143	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100101
J	Fung, C; Murek, M; Klinger-Gratz, PP; Fiechter, M; Z'Graggen, WJ; Gautschi, OP; El-Koussy, M; Gralla, J; Schaller, K; Zbinden, M; Arnold, M; Fischer, U; Mattle, HP; Raabe, A; Beck, J				Fung, Christian; Murek, Michael; Klinger-Gratz, Pascal P.; Fiechter, Michael; Z'Graggen, Werner J.; Gautschi, Oliver P.; El-Koussy, Marwan; Gralla, Jan; Schaller, Karl; Zbinden, Martin; Arnold, Marcel; Fischer, Urs; Mattle, Heinrich P.; Raabe, Andreas; Beck, Juergen			Effect of Decompressive Craniectomy on Perihematomal Edema in Patients with Intracerebral Hemorrhage	PLOS ONE			English	Article							ASSOCIATION/AMERICAN-STROKE-ASSOCIATION; MIDDLE CEREBRAL-ARTERY; BRAIN-INJURY; PERIHEMORRHAGIC EDEMA; MALIGNANT INFARCTION; THROMBIN; VOLUME; BLOOD; MECHANISMS; MANAGEMENT	Background Perihematomal edema contributes to secondary brain injury in the course of intracerebral hemorrhage. The effect of decompressive surgery on perihematomal edema after intracerebral hemorrhage is unknown. This study analyzed the course of PHE in patients who were or were not treated with decompressive craniectomy. Methods More than 100 computed tomography images from our published cohort of 25 patients were evaluated retrospectively at two university hospitals in Switzerland. Computed tomography scans covered the time from admission until day 100. Eleven patients were treated by decompressive craniectomy and 14 were treated conservatively. Absolute edema and hematoma volumes were assessed using 3-dimensional volumetric measurements. Relative edema volumes were calculated based on maximal hematoma volume. Results Absolute perihematomal edema increased from 42.9 ml to 125.6 ml (192.8%) after 21 days in the decompressive craniectomy group, versus 50.4 ml to 67.2 ml (33.3%) in the control group (Delta at day 21 = 58.4 ml, p = 0.031). Peak edema developed on days 25 and 35 in patients with decompressive craniectomy and controls respectively, and it took about 60 days for the edema to decline to baseline in both groups. Eight patients (73%) in the decompressive craniectomy group and 6 patients (43%) in the control group had a good outcome (modified Rankin Scale score 0 to 4) at 6 months (P = 0.23). Conclusions Decompressive craniectomy is associated with a significant increase in perihematomal edema compared to patients who have been treated conservatively. Perihematomal edema itself lasts about 60 days if it is not treated, but decompressive craniectomy ameliorates the mass effect exerted by the intracerebral hemorrhage plus the perihematomal edema, as reflected by the reduced midline shift.	[Fung, Christian; Murek, Michael; Fiechter, Michael; Z'Graggen, Werner J.; Raabe, Andreas; Beck, Juergen] Univ Hosp Bern, Dept Neurosurg, CH-3010 Bern, Switzerland; [Klinger-Gratz, Pascal P.; El-Koussy, Marwan; Gralla, Jan; Zbinden, Martin] Univ Hosp Bern, Inst Diagnost & Intervent Neuroradiol, CH-3010 Bern, Switzerland; [Fung, Christian; Gautschi, Oliver P.; Schaller, Karl] Univ Hosp Geneva, Dept Neurosurg, Geneva, Switzerland; [Arnold, Marcel; Fischer, Urs; Mattle, Heinrich P.] Univ Hosp Bern, Dept Neurol, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Geneva; University of Bern; University Hospital of Bern	Beck, J (corresponding author), Univ Hosp Bern, Dept Neurosurg, CH-3010 Bern, Switzerland.	Juergen.beck@insel.ch		Beck, Jurgen/0000-0002-7687-6098; Z'Graggen, Werner/0000-0002-5684-4419; Fischer, Urs/0000-0003-0521-4051				Appelboom G, 2013, J NEUROL NEUROSUR PS, V84, P488, DOI 10.1136/jnnp-2012-303160; Babu R, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.1.FOCUS11366; Bates D, LME4 LINEAR MIXED EF; Broderick J, 2007, STROKE, V38, P2001, DOI 10.1161/STROKEAHA.107.183689; BRODERICK JP, 1994, STROKE, V25, P1342, DOI 10.1161/01.STR.25.7.1342; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Butcher KS, 2004, STROKE, V35, P1879, DOI 10.1161/01.STR.0000131807.54742.1a; Castillo J, 2002, NEUROLOGY, V58, P624, DOI 10.1212/WNL.58.4.624; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; Dowlatshahi D, 2011, NEUROLOGY, V76, P1238, DOI 10.1212/WNL.0b013e3182143317; Ferro JM, 2011, STROKE, V42, P2825, DOI 10.1161/STROKEAHA.111.615393; Fung C, 2012, STROKE, V43, P3207, DOI 10.1161/STROKEAHA.112.666537; Gebel JM, 2002, STROKE, V33, P2636, DOI 10.1161/01.STR.0000035283.34109.EA; GIROUD M, 1991, J NEUROL NEUROSUR PS, V54, P595, DOI 10.1136/jnnp.54.7.595; Guresir E, 2011, J NEUROSURG, V114, P954, DOI 10.3171/2009.12.JNS091065; Hanley DF, 2009, STROKE, V40, P1533, DOI 10.1161/STROKEAHA.108.535419; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Hua Y, 2006, NEUROSURGERY, V58, P542, DOI 10.1227/01.NEU.0000197333.55473.AD; Kollmar R, 2010, STROKE, V41, P1684, DOI 10.1161/STROKEAHA.110.587758; Lee KR, 1997, J NEUROSURG, V86, P272, DOI 10.3171/jns.1997.86.2.0272; McCourt R, 2015, STROKE, V46, P954, DOI 10.1161/STROKEAHA.114.007544; Nagel A, 2009, NEUROCRIT CARE, V11, P384, DOI 10.1007/s12028-009-9269-x; Nakamura Takehiro, 2003, Neurosurg Focus, V15, pECP4; Park J, 2015, J NEUROSURG, V122, P383, DOI 10.3171/2014.9.JNS131784; REULEN HJ, 1977, J NEUROSURG, V46, P24, DOI 10.3171/jns.1977.46.1.0024; Schellinger PD, 2003, STROKE, V34, P1674, DOI 10.1161/01.STR.0000076010.10696.55; Staykov D, 2013, NEUROCRIT CARE, V18, P178, DOI 10.1007/s12028-012-9762-5; Staykov D, 2011, STROKE, V42, P2625, DOI 10.1161/STROKEAHA.111.618611; Team R.C., 2003, R LANG ENV STAT COMP; Tuhrim S, 1999, CRIT CARE MED, V27, P617, DOI 10.1097/00003246-199903000-00045; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Wagner I, 2011, STROKE, V42, P1540, DOI 10.1161/STROKEAHA.110.609479; Wagner KR, 1996, STROKE, V27, P490, DOI 10.1161/01.STR.27.3.490; Wagner S, 2001, J NEUROSURG, V94, P693, DOI 10.3171/jns.2001.94.5.0693; Weiner GM, 2010, NEUROSURGERY, V66, P1111, DOI 10.1227/01.NEU.0000369607.71913.3E; Wirtz C R, 1997, Neurosurg Focus, V2, pE3; Wu G, 2006, ACTA NEUROCHIR SUPPL, V96, P78; Wu JM, 2003, STROKE, V34, P2964, DOI 10.1161/01.STR.0000103140.52838.45; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xi GH, 1998, J NEUROSURG, V89, P991, DOI 10.3171/jns.1998.89.6.0991; Xi GH, 2003, J NEUROCHEM, V84, P3, DOI 10.1046/j.1471-4159.2003.01268.x; Yang J, 2015, STROKE, V46, P1009, DOI 10.1161/STROKEAHA.114.007154	43	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149169	10.1371/journal.pone.0149169	http://dx.doi.org/10.1371/journal.pone.0149169			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872068	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100118
J	Miskovich, TA; Pedersen, WS; Belleau, EL; Shollenbarger, S; Lisdahl, KM; Larson, CL				Miskovich, Tara A.; Pedersen, Walker S.; Belleau, Emily L.; Shollenbarger, Skyler; Lisdahl, Krista M.; Larson, Christine L.			Cortical Gyrification Patterns Associated with Trait Anxiety	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; FUNCTIONAL CONNECTIVITY; INDIVIDUAL-DIFFERENCES; ORBITOFRONTAL CORTEX; PERSONALITY-TRAITS; PANIC DISORDER; NETWORK; ADOLESCENTS; ABNORMALITIES; VARIABILITY	Dispositional anxiety is a stable personality trait that is a key risk factor for internalizing disorders, and understanding the neural correlates of trait anxiety may help us better understand the development of these disorders. Abnormal cortical folding is thought to reflect differences in cortical connectivity occurring during brain development. Therefore, assessing gyrification may advance understanding of cortical development and organization associated with trait anxiety. Previous literature has revealed structural abnormalities in trait anxiety and related disorders, but no study to our knowledge has examined gyrification in trait anxiety. We utilized a relatively novel measure, the local gyrification index (LGI), to explore differences in gyrification as a function of trait anxiety. We obtained structural MRI scans using a 3T magnetic resonance scanner on 113 young adults. Results indicated a negative correlation between trait anxiety and LGI in the left superior parietal cortex, specifically the precuneus, reflecting less cortical complexity among those high on trait anxiety. Our findings suggest that aberrations in cortical gyrification in a key region of the default mode network is a correlate of trait anxiety and may reflect disrupted local parietal connectivity.	[Miskovich, Tara A.; Pedersen, Walker S.; Belleau, Emily L.; Shollenbarger, Skyler; Lisdahl, Krista M.; Larson, Christine L.] Univ Wisconsin, Dept Psychol, Milwaukee, WI 53201 USA	University of Wisconsin System; University of Wisconsin Milwaukee	Larson, CL (corresponding author), Univ Wisconsin, Dept Psychol, Milwaukee, WI 53201 USA.	larsoncl@uwm.edu	Lisdahl, Krista/P-8470-2019	Lisdahl, Krista/0000-0001-9515-1335	National Institutes of Health [MH086809]; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH086809] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030354] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health (MH086809). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman-Gomez Y, 2013, J NEUROSCI, V33, P15004, DOI 10.1523/JNEUROSCI.1459-13.2013; ARMSTRONG E, 1995, CEREB CORTEX, V5, P56, DOI 10.1093/cercor/5.1.56; Barnes LLB, 2002, EDUC PSYCHOL MEAS, V62, P603, DOI 10.1177/0013164402062004005; Bartley AJ, 1997, BRAIN, V120, P257, DOI 10.1093/brain/120.2.257; Berman MG, 2011, SOC COGN AFFECT NEUR, V6, P548, DOI 10.1093/scan/nsq080; Blackford JU, 2012, CHILD ADOL PSYCH CL, V21, P501, DOI 10.1016/j.chc.2012.05.002; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; CHI JG, 1977, ANN NEUROL, V1, P86, DOI 10.1002/ana.410010109; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dauvermann MR, 2012, CURR PHARM DESIGN, V18, P434; Donzuso G, 2014, BRAIN BEHAV, V4, P504, DOI 10.1002/brb3.232; First MB, 2002, STRUCTURED CLIN INTE; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fuentes P, 2012, COGN AFFECT BEHAV NE, V12, P491, DOI 10.3758/s13415-012-0099-5; Gardini S, 2009, BRAIN RES BULL, V79, P265, DOI 10.1016/j.brainresbull.2009.03.005; Hahn A, 2011, NEUROIMAGE, V56, P881, DOI 10.1016/j.neuroimage.2011.02.064; Hardan AY, 2004, PSYCHIAT RES-NEUROIM, V131, P263, DOI 10.1016/j.pscychresns.2004.06.001; Hogstrom LJ, 2013, CEREB CORTEX, V23, P2521, DOI 10.1093/cercor/bhs231; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Klein D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084914; Kotov R, 2010, PSYCHOL BULL, V136, P768, DOI 10.1037/a0020327; Kuhn S, 2011, J AFFECT DISORDERS, V134, P315, DOI 10.1016/j.jad.2011.06.003; Lahey BB, 2009, AM PSYCHOL, V64, P241, DOI 10.1037/a0015309; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Lohmann G, 1999, CEREB CORTEX, V9, P754, DOI 10.1093/cercor/9.7.754; Milad MR, 2007, ANN NY ACAD SCI, V1121, P546, DOI 10.1196/annals.1401.006; Nixon NL, 2014, BRIT J PSYCHIAT, V204, P283, DOI 10.1192/bjp.bp.113.129965; Palaniyappan L, 2011, BIOL PSYCHIAT, V69, P974, DOI 10.1016/j.biopsych.2010.12.012; Pannekoek JN, 2013, J AFFECT DISORDERS, V145, P29, DOI 10.1016/j.jad.2012.07.006; Paulesu E, 2010, PSYCHOL MED, V40, P117, DOI 10.1017/S0033291709005649; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Rauch SL, 2005, NEUROREPORT, V16, P1909, DOI 10.1097/01.wnr.0000186599.66243.50; Raznahan A, 2011, J NEUROSCI, V31, P7174, DOI 10.1523/JNEUROSCI.0054-11.2011; Roy AK, 2009, NEUROIMAGE, V45, P614, DOI 10.1016/j.neuroimage.2008.11.030; Schaer M, 2008, IEEE T MED IMAGING, V27, P161, DOI 10.1109/TMI.2007.903576; Schaer M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00750; Schaer M, 2012, JOVE-J VIS EXP, DOI 10.3791/3417; Servaas MN, 2014, HUM BRAIN MAPP, V35, P4303, DOI 10.1002/hbm.22476; Spielberger C. D., 1983, MIND GARDEN; Strawn JR, 2015, J ANXIETY DISORD, V32, P81, DOI 10.1016/j.janxdis.2015.03.004; Strawn JR, 2013, NEUROPSYCHOBIOLOGY, V67, P224, DOI 10.1159/000347090; Strawn JR, 2012, DEPRESS ANXIETY, V29, P939, DOI 10.1002/da.21961; Sylvester CM, 2012, TRENDS NEUROSCI, V35, P527, DOI 10.1016/j.tins.2012.04.012; Tallinen T, 2014, P NATL ACAD SCI USA, V111, P12667, DOI 10.1073/pnas.1406015111; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Wallace GL, 2013, BRAIN, V136, P1956, DOI 10.1093/brain/awt106; White T, 2003, BIOL PSYCHIAT, V54, P418, DOI 10.1016/S0006-3223(03)00065-9; White T, 2002, CEREB CORTEX, V12, P486, DOI 10.1093/cercor/12.5.486; White T, 2010, BRAIN COGNITION, V72, P36, DOI 10.1016/j.bandc.2009.10.009; Wright CI, 2006, CEREB CORTEX, V16, P1809, DOI 10.1093/cercor/bhj118; Yoon S, 2013, J PSYCHIATR RES, V47, P1446, DOI 10.1016/j.jpsychires.2013.06.015; Zhang S, 2012, NEUROIMAGE, V59, P3548, DOI 10.1016/j.neuroimage.2011.11.023; Zhang YC, 2009, NEUROREPORT, V20, P378, DOI 10.1097/WNR.0b013e3283249b34; ZILLES K, 1988, ANAT EMBRYOL, V179, P173, DOI 10.1007/BF00304699	56	12	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149434	10.1371/journal.pone.0149434	http://dx.doi.org/10.1371/journal.pone.0149434			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872350	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100157
J	Nakanishi, H; Kurosaki, M; Takahashi, Y; Itakura, J; Ueda, K; Suzuki, S; Yasui, Y; Tamaki, N; Nakakuki, N; Takada, H; Ueda, M; Hayashi, T; Kuwabara, K; Takaura, K; Higuchi, M; Komiyama, Y; Yoshida, T; Izumi, N				Nakanishi, Hiroyuki; Kurosaki, Masayuki; Takahashi, Yuka; Itakura, Jun; Ueda, Ken; Suzuki, Shoko; Yasui, Yutaka; Tamaki, Nobuharu; Nakakuki, Natsuko; Takada, Hitomi; Ueda, Masako; Hayashi, Tsuguru; Kuwabara, Konomi; Takaura, Kenta; Higuchi, Mayu; Komiyama, Yasuyuki; Yoshida, Tsubasa; Izumi, Namiki			Pretreatment Gastric Lavage Reduces Postoperative Bleeding after Endoscopic Submucosal Dissection for Gastric Neoplasms	PLOS ONE			English	Article							CANCER; RESECTION; OUTCOMES	Aim For patients receiving endoscopic submucosal dissection (ESD), there is urgent need pertaining to the prevention of postoperative bleeding. We conducted a retrospective propensity score-matched study that evaluated whether pre-ESD gastric lavage prevents postoperative bleeding after ESD for gastric neoplasms. Methods From September 2002 to October 2015, the 760 consecutive patients receiving ESD for gastric neoplasm were enrolled and data regarding them were retrospectively analyzed. All patients received conventional preventive treatment against delayed bleeding after ESD, including the administration of proton pump inhibitor and preventive coagulation of visible vessels, at the end of the ESD procedure. Results Pre-ESD risk factors for postoperative bleeding included tumor size and no gastric lavage. Using multivariate analysis tumor size >2.0 cm (HR 2.90, 95% CI 1.65-5.10, p = 0.0002) and no gastric lavage (HR 3.20, 95% CI 1.13-9.11, p = 0.029) were found to be independent risk factors. Next, we evaluated the effect of gastric lavage on the prevention of post-ESD bleeding using a propensity score-matching method. A total of 284 subjects (142 per group) were selected. Adjusted odds ratio of gastric lavage for post-ESD bleeding was 0.25 (95% CI 0.071-0.886, p = 0.032). Conclusion Pretreatment gastric lavage reduced postoperative bleeding in patients receiving ESD for gastric neoplasm.	[Nakanishi, Hiroyuki; Kurosaki, Masayuki; Takahashi, Yuka; Itakura, Jun; Ueda, Ken; Suzuki, Shoko; Yasui, Yutaka; Tamaki, Nobuharu; Nakakuki, Natsuko; Takada, Hitomi; Ueda, Masako; Hayashi, Tsuguru; Kuwabara, Konomi; Takaura, Kenta; Higuchi, Mayu; Komiyama, Yasuyuki; Yoshida, Tsubasa; Izumi, Namiki] Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan		Izumi, N (corresponding author), Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan.	izumi012@musashino.jrc.or.jp	Nakanishi, Hiroyuki/AAD-9324-2020	Nakanishi, Hiroyuki/0000-0003-3982-3314; Tamaki, Nobuharu/0000-0003-4634-6616; Yasui, Yutaka/0000-0002-6117-4990				Abe N, 2012, GASTRIC CANCER, V15, P70, DOI 10.1007/s10120-011-0067-8; Akasaka T, 2011, DIGEST ENDOSC, V23, P73, DOI 10.1111/j.1443-1661.2010.01062.x; Chung IK, 2009, GASTROINTEST ENDOSC, V69, P1228, DOI 10.1016/j.gie.2008.09.027; Goto O, 2009, ENDOSCOPY, V41, P118, DOI 10.1055/s-0028-1119452; Gotoda T, 2010, BRIT J SURG, V97, P868, DOI 10.1002/bjs.7033; Gotoda T, 2007, GASTRIC CANCER, V10, P1, DOI 10.1007/s10120-006-0408-1; Hirasaki S, 2007, WORLD J GASTROENTERO, V13, P3981, DOI 10.3748/wjg.v13.i29.3981; Imagawa A, 2006, ENDOSCOPY, V38, P987, DOI 10.1055/s-2006-944716; Kakushima N, 2008, WORLD J GASTROENTERO, V14, P2962, DOI 10.3748/wjg.14.2962; Kato M, 2012, GASTRIC CANCER, V15, P15, DOI 10.1007/s10120-011-0050-4; Mori H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065377; Nakanishi T, 2014, ENDOSC INT OPEN, V2, pE141, DOI 10.1055/s-0034-1377274; Oda I., 2006, GASTRIC CANCER, V9, P262, DOI DOI 10.1007/S10120-006-0389-0]; Oka S, 2006, GASTROINTEST ENDOSC, V64, P877, DOI 10.1016/j.gie.2006.03.932; Ono H, 2016, DIGEST ENDOSC, V28, P3, DOI 10.1111/den.12518; Onogi F, 2010, ENDOSCOPY, V42, P441, DOI 10.1055/s-0029-1244013; Organization TWH, 2011, 2011 GUID DRINK WAT; Sugimoto Mitsushige, 2012, Diagn Ther Endosc, V2012, P791873, DOI 10.1155/2012/791873; Yamamoto H, 2005, BEST PRACT RES CL GA, V19, P909, DOI 10.1016/j.bpg.2005.03.004	19	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149235	10.1371/journal.pone.0149235	http://dx.doi.org/10.1371/journal.pone.0149235			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871449	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100132
J	Oudejans, C; Poutsma, A; Michel, O; Mulders, J; Visser, A; van Dijk, M; Nauta, T; Bokslag, A; Paulus, W; de Haas, A; Koolwijk, P; de Groot, CJM				Oudejans, Cees; Poutsma, Ankie; Michel, Omar; Mulders, Joyce; Visser, Allerdien; van Dijk, Marie; Nauta, Tessa; Bokslag, Anouk; Paulus, Walter; de Haas, Andreas; Koolwijk, Pieter; de Groot, Christianne J. M.			Genome-Wide Identification of Epigenetic Hotspots Potentially Related to Cardiovascular Risk in Adult Women after a Complicated Pregnancy	PLOS ONE			English	Article							DNA METHYLATION; DISEASE RISK; PREECLAMPSIA; ASSOCIATIONS; LEUKOCYTES	Background The physiological demands of pregnancy on the maternal cardiovascular system can catapult women into a metabolic syndrome that predisposes to atherosclerosis in later life. We sought to identify the nature of the epigenomic changes associated with the increased cardiovascular disease (CVD) risk in adult women following pre-eclampsia. Findings We assessed the genome wide epigenetic profile by methyl-C sequencing of monozygotic parous twin sister pairs discordant for a severe variant of pre-eclampsia. In the adult twin sisters at risk for CVD as a consequence of a complicated pregnancy, a set of 12 differentially methylated regions with at least 50% difference in methylation percentage and the same directional change was found to be shared between the affected twin sisters and significantly different compared to their unaffected monozygous sisters. Conclusion The current epigenetic marker set will permit targeted analysis of differentially methylated regions potentially related to CVD risk in large cohorts of adult women following complicated pregnancies.	[Oudejans, Cees; Poutsma, Ankie; Michel, Omar; Mulders, Joyce; Visser, Allerdien; van Dijk, Marie] Vrije Univ Amsterdam Med Ctr, Dept Clin Chem, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands; [Oudejans, Cees; Poutsma, Ankie; Michel, Omar; Mulders, Joyce; Visser, Allerdien; van Dijk, Marie] Vrije Univ Amsterdam Med Ctr, Inst Cardiovasc Res ICaR VU, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands; [Nauta, Tessa; Paulus, Walter; de Haas, Andreas; Koolwijk, Pieter] Vrije Univ Amsterdam Med Ctr, Dept Physiol, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands; [Nauta, Tessa] A Skin BV, De Boelelaan 1118, NL-1081 HZ Amsterdam, Netherlands; [Bokslag, Anouk; de Groot, Christianne J. M.] Vrije Univ Amsterdam Med Ctr, Dept Obstet Gynaecol, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Oudejans, C (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Clin Chem, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.	cbm.oudejans@vumc.nl	van Dijk, Marie/L-1901-2014	de Groot, Christianne/0000-0003-3277-2542; Oudejans, Cees/0000-0003-0717-4946; van Dijk, Marie/0000-0003-1461-3441	Netherlands Organisation for Scientific Research (NWO) [91611177]; Dutch Program for Tissue Engineering (DPTE); Netherlands Initiative for Regenerative Medicine (NIRM)	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Program for Tissue Engineering (DPTE); Netherlands Initiative for Regenerative Medicine (NIRM)	MvD is supported by the Netherlands Organisation for Scientific Research (NWO grant no 91611177). TN and PK are supported by the Dutch Program for Tissue Engineering (DPTE) and the Netherlands Initiative for Regenerative Medicine (NIRM). The funder (A-Skin) provided support in the form of salaries for authors [TN], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bock C, 2012, NAT REV GENET, V13, P705, DOI 10.1038/nrg3273; Brown MC, 2013, EUR J EPIDEMIOL, V28, P1, DOI 10.1007/s10654-013-9762-6; Fraser A, 2012, CIRCULATION, V125, P1367, DOI 10.1161/CIRCULATIONAHA.111.044784; Garovic VD, 2007, NAT CLIN PRACT NEPHR, V3, P613, DOI 10.1038/ncpneph0623; Hermes W, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-28; Koopmans Corine M, 2007, BMC Pregnancy Childbirth, V7, P14, DOI 10.1186/1471-2393-7-14; Krueger F, 2012, NAT METHODS, V9, P145, DOI [10.1038/NMETH.1828, 10.1038/nmeth.1828]; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Melas PA, 2012, FASEB J, V26, P2712, DOI 10.1096/fj.11-202069; Ordovas JM, 2010, NAT REV CARDIOL, V7, P510, DOI 10.1038/nrcardio.2010.104; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Ray JG, 2005, LANCET, V366, P1797, DOI 10.1016/S0140-6736(05)67726-4; Soreq L, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00010; Treloar SA, 2001, AM J OBSTET GYNECOL, V184, P374, DOI 10.1067/mob.2001.109400; Williams D, 2003, CURR OPIN OBSTET GYN, V15, P465, DOI 10.1097/00001703-200312000-00002; Wong AHC, 2005, HUM MOL GENET, V14, pR11, DOI 10.1093/hmg/ddi116; Yinon Y, 2010, CIRCULATION, V122, P1846, DOI 10.1161/CIRCULATIONAHA.110.948455	17	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148313	10.1371/journal.pone.0148313	http://dx.doi.org/10.1371/journal.pone.0148313			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26870946	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100023
J	Oliveira, MO; Freitas, BM; Scheper, J; Kleijn, D				Oliveira, Mikail O.; Freitas, Breno M.; Scheper, Jeroen; Kleijn, David			Size and Sex-Dependent Shrinkage of Dutch Bees during One-and-a-Half Centuries of Land-Use Change	PLOS ONE			English	Article							BODY-SIZE; CROP POLLINATION; CLIMATE-CHANGE; EVOLUTION; DECLINES; PLANTS; CONSTRAINTS; IMPACTS; HISTORY; LIFE	Land-use change and global warming are important factors driving bee decline, but it is largely unknown whether these drivers have resulted in changes in the life-history traits of bees. Recent studies have shown a stronger population decline of large-than small-bodied bee species, suggesting there may have been selective pressure on large, but not on small species to become smaller. Here we test this hypothesis by analyzing trends in bee body size of 18 Dutch species over a 147-year period using specimens from entomological collections. Large-bodied female bees shrank significantly faster than small-bodied female bees (6.5% and 0.5% respectively between 1900 and 2010). Changes in temperature during the flight period of bees did not influence the size-dependent shrinkage of female bees. Male bees did not shrink significantly over the same time period. Our results could imply that under conditions of declining habitat quantity and quality it is advantageous for individuals to be smaller. The size and sex-dependent responses of bees point towards an evolutionary response but genetic studies are required to confirm this. The declining body size of the large bee species that currently dominate flower visitation of both wild plants and insect-pollinated crops may have negative consequences for pollination service delivery.	[Oliveira, Mikail O.] Fed Univ Para, UFPA MPEG, Dept Zool, BR-66075110 Belem, PA, Brazil; [Freitas, Breno M.] Univ Fed Ceara, Dept Zootecnia, Pici Campus, BR-60356000 Fortaleza, CE, Brazil; [Scheper, Jeroen; Kleijn, David] Wageningen Univ, Resource Ecol Grp, Droevendaalsesteeg 3a, NL-6708 PB Wageningen, Netherlands; [Scheper, Jeroen; Kleijn, David] Alterra, Anim Ecol Team, POB 47, NL-6700 AA Wageningen, Netherlands; [Scheper, Jeroen; Kleijn, David] Wageningen Univ, Plant Ecol & Nat Conservat Grp, Droevendaalsesteeg 3a, NL-6708 PB Wageningen, Netherlands	Universidade Federal do Para; Universidade Federal do Ceara; Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Kleijn, D (corresponding author), Wageningen Univ, Resource Ecol Grp, Droevendaalsesteeg 3a, NL-6708 PB Wageningen, Netherlands.; Kleijn, D (corresponding author), Alterra, Anim Ecol Team, POB 47, NL-6700 AA Wageningen, Netherlands.; Kleijn, D (corresponding author), Wageningen Univ, Plant Ecol & Nat Conservat Grp, Droevendaalsesteeg 3a, NL-6708 PB Wageningen, Netherlands.	David.Kleijn@wur.nl	Kleijn, David/HCH-3477-2022; Freitas, Breno M/F-9509-2012; OLIVEIRA, MIKAIL O/GNH-1572-2022; Scheper, Jeroen/G-1385-2015	Freitas, Breno M/0000-0002-9932-2207; OLIVEIRA, MIKAIL O/0000-0003-1030-4289; Kleijn, David/0000-0003-2500-7164; Scheper, Jeroen/0000-0002-4314-996X	CNPq - Brasilia, Brazil [305126/2013-0]; CAPES - Brasilia, Brazil; Programa Ciencias Sem Fronteiras [BEX - 10619/13-5]; Dutch Science Foundation (NWO) through the programme 'Biodiversity works' [841.11.001]; BiodivERsa/FACCE-JPI [832.14.007]	CNPq - Brasilia, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES - Brasilia, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Programa Ciencias Sem Fronteiras; Dutch Science Foundation (NWO) through the programme 'Biodiversity works'; BiodivERsa/FACCE-JPI	This work was supported by CNPq - Brasilia, Brazil (# 305126/2013-0), CAPES - Brasilia, Brazil, Programa Ciencias Sem Fronteiras (BEX - 10619/13-5) and the Dutch Science Foundation (NWO) through the programme 'Biodiversity works' (project 841.11.001) and the 2012 BiodivERsa/FACCE-JPI joint call for research proposals (project 832.14.007; ECODEAL, www.cec.lu.se/research/ecodeal).	Agrawal AA, 2012, SCIENCE, V338, P113, DOI 10.1126/science.1225977; ALCOCK J, 1977, AM NAT, V111, P145, DOI 10.1086/283145; Amin MR, 2012, J INSECT BEHAV, V25, P362, DOI 10.1007/s10905-011-9306-4; [Anonymous], 2014, R LANG ENV STAT COMP; Bartomeus I, 2013, P NATL ACAD SCI USA, V110, P4656, DOI 10.1073/pnas.1218503110; Bauder JAS, 2015, J EVOLUTION BIOL, V28, P678, DOI 10.1111/jeb.12601; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bommarco R, 2012, P ROY SOC B-BIOL SCI, V279, P309, DOI 10.1098/rspb.2011.0647; Bosch J, 2002, ECOL ENTOMOL, V27, P129, DOI 10.1046/j.1365-2311.2002.00406.x; Bradshaw WE, 2006, SCIENCE, V312, P1477, DOI 10.1126/science.1127000; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; CANE JH, 1987, J KANSAS ENTOMOL SOC, V60, P145; de Beer H, 2004, ECON HUM BIOL, V2, P45, DOI 10.1016/j.ehb.2003.11.001; Deguines N, 2014, FRONT ECOL ENVIRON, V12, P212, DOI 10.1890/130054; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Goulson D, 2002, ANIM BEHAV, V64, P123, DOI 10.1006/anbe.2002.3041; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; HAWKINS BA, 1995, ECOL ENTOMOL, V20, P195, DOI 10.1111/j.1365-2311.1995.tb00446.x; Hedtke SM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-138; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Kevan PG, 2001, CONSERV ECOL, V5; Kleijn D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8414; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; KLOSTERMEYER E, 1973, J KANSAS ENTOMOL SOC, V46, P537; KNMI, 2015, KLIM DAGG WEER NED; Kremen C, 2002, P NATL ACAD SCI USA, V99, P16812, DOI 10.1073/pnas.262413599; Lytle DA, 2002, ECOLOGY, V83, P370; Muller A, 2006, BIOL CONSERV, V130, P604, DOI 10.1016/j.biocon.2006.01.023; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; OLROYD BP, 2007, PLOS BIOL, V5, pE168, DOI DOI 10.1371/J0URNAL.PBI0.0050168; Peat J, 2005, FUNCT ECOL, V19, P145, DOI 10.1111/j.0269-8463.2005.00946.x; Pereboom JJM, 2003, OECOLOGIA, V137, P42, DOI 10.1007/s00442-003-1324-2; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; PYKE GH, 1978, OECOLOGIA, V34, P255, DOI 10.1007/BF00344905; Radmacher S, 2010, APIDOLOGIE, V41, P169, DOI 10.1051/apido/2009064; Reemer M, 2012, DUTCH BEES HYMENOPTE, P103; Scheper J, 2014, P NATL ACAD SCI USA, V111, P17552, DOI 10.1073/pnas.1412973111; Schweiger O, 2010, BIOL REV, V85, P777, DOI 10.1111/j.1469-185X.2010.00125.x; Sheridan JA, 2011, NAT CLIM CHANGE, V1, P401, DOI 10.1038/NCLIMATE1259; Stulp G, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0211; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; WESTOBY M, 1995, J ECOL, V83, P531, DOI 10.2307/2261605	42	27	27	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148983	10.1371/journal.pone.0148983	http://dx.doi.org/10.1371/journal.pone.0148983			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863608	Green Submitted, Green Published, gold			2022-12-27	WOS:000370046600132
J	Qadeer, E; Fatima, R; Yaqoob, A; Tahseen, S; Haq, MU; Ghafoor, A; Asif, M; Straetemans, M; Tiemersma, EW				Qadeer, Ejaz; Fatima, Razia; Yaqoob, Aashifa; Tahseen, Sabira; Haq, Mahboob Ul; Ghafoor, Abdul; Asif, Muhammad; Straetemans, Masja; Tiemersma, Edine W.			Population Based National Tuberculosis Prevalence Survey among Adults (> 15 Years) in Pakistan, 2010-2011	PLOS ONE			English	Article							SEX-DIFFERENCES; LESSONS; GENDER; INDIA	Background We aimed to determine the prevalence of pulmonary tuberculosis (TB) amongst the adult population in 2010-2011 in Pakistan. Method A nationwide cross-sectional survey with multistage cluster sampling was conducted among adults (>= 15 years) in 95 clusters in 2010-2011. All consenting participants were screened for cough and by chest X-ray. Participants with presumptive TB submitted two sputum samples for smear microscopy, culture, and molecular testing if needed. The TB prevalence estimates were adjusted for missing data and the cluster design. Result Of 131,329 eligible individuals, 105,913 (81%) participated in the survey, of whom 10,471 (9.9%) were eligible for sputum examination. We found 341 bacteriologically positive TB cases of whom 233 had sputum smear-positive TB. The adjusted prevalence estimates for smear and bacteriologically positive TB were 270/100,000 (95% confidence interval (CI) 217-323), and 398/100,000 (95% CI 333-463), respectively. Only 61% of the diagnosed TB cases screened positive on symptoms (cough >2wks), whereas the other TB cases were detected based on X-ray abnormalities. The TB prevalence increased with age and was 1.8 times higher among men than women. The prevalence-to-notification ratio of smear-positive TB was 3.1 (95% CI 2.5-3.7), was higher among men than women, and increased with age. Conclusion Our data suggest that there is under-detection and/or - notification of TB, especially among men and elderly. TB control should be strengthened specifically in these risk groups. X-ray examination should be combined with symptom screening to enhance case detection.	[Qadeer, Ejaz; Fatima, Razia; Yaqoob, Aashifa; Tahseen, Sabira; Haq, Mahboob Ul; Ghafoor, Abdul; Asif, Muhammad] Natl TB Control Program Pakistan, Islamabad, Pakistan; [Straetemans, Masja; Tiemersma, Edine W.] KNCV TB Fdn, The Hague, Netherlands; [Straetemans, Masja] Royal Trop Inst KIT, Amsterdam, Netherlands	KNCV Tuberculosis Foundation	Fatima, R (corresponding author), Natl TB Control Program Pakistan, Islamabad, Pakistan.	drraziafatima@gmail.com	Tahseen, Sabira/AAV-8653-2020	Tahseen, Sabira/0000-0002-6887-8149; Ul Haq, Mahboob/0000-0002-3709-3496	American people through the United States Agency for International Development (USAID)	American people through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	This study was made possible by the generous support of the American people through the United States Agency for International Development (USAID). The contents are the responsibility of TB CARE I and do not necessarily reflect the views of USAID or the United States Government. KIT Biomedical Research provided support in the form of a salary for author MS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency CI, 2015, WORLD FACTBOOK; [Anonymous], 2011, GLOB TUB CONTR; Bhushan B, 2012, INT J TUBERC LUNG D, V16, P1210, DOI 10.5588/ijtld.11.0778; Borgdorff MW, 2000, INT J TUBERC LUNG D, V4, P123; Cambanis A, 2005, TROP MED INT HEALTH, V10, P330, DOI 10.1111/j.1365-3156.2005.01393.x; Dogar OF, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-244; Eddy JJ, 2015, TUBERCULOSIS, V95, pS23, DOI 10.1016/j.tube.2015.02.005; Fatima R, 2014, INT J TUBERC LUNG D, V18, P55, DOI 10.5588/ijtld.13.0198; Floyd S, 2013, EMERG THEMES EPIDEMI, V10, DOI 10.1186/1742-7622-10-10; HARBOE M, 1986, INFECT IMMUN, V52, P293, DOI 10.1128/IAI.52.1.293-302.1986; Harkanen T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1150; Ijaiya G. T., 2010, Pakistan Economic and Social Review, V48, P85; KUDOH S, 1974, B WORLD HEALTH ORGAN, V51, P71; Law I, 2015, TROP MED INT HEALTH, V20, P1146, DOI 10.1111/tmi.12536; Long NH, 1999, SOC SCI MED, V49, P815, DOI 10.1016/S0277-9536(99)00171-9; Mao TE, 2014, B WORLD HEALTH ORGAN, V92, P573, DOI 10.2471/BLT.13.131581; Monkongdee P, 2009, AM J RESP CRIT CARE, V180, P903, DOI 10.1164/rccm.200905-0692OC; Mushtaq MU, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-8; Naqvi SA, 2012, INT J TUBERC LUNG D, V16, P817, DOI 10.5588/ijtld.11.0440; National TB Control Program, 2013, EP REV TB PAK; National TB Control Program, 2014, NAT STRAT PLAN VIS 2; National TB Control Program, 2012, ANN REP 2011; National TB Control Program, 1990, PAK TUB PREV SURV 19; Nguyen BH, 2010, B WORLD HEALTH ORGAN, V88, P273, DOI 10.2471/BLT.09.067801; Nishtar S, 2013, LANCET, V381, P2193, DOI 10.1016/S0140-6736(13)60019-7; Onozaki I, 2015, TROP MED INT HEALTH, V20, P1128, DOI 10.1111/tmi.12534; Pakistan Bureau of Statistics, 2010, NAT HLTH ACC PAK 200; Rajagopalan S, 2000, Z GERONTOL GERIATR, V33, P374, DOI 10.1007/s003910070034; Rhines AS, 2013, TUBERCULOSIS, V93, P104, DOI 10.1016/j.tube.2012.10.012; Sudha G, 2003, TROP MED INT HEALTH, V8, P336, DOI 10.1046/j.1365-3156.2003.01010.x; Wang LX, 2014, LANCET, V383, P2057, DOI 10.1016/S0140-6736(13)62639-2; WHO, 2007, WHO GLOB TASK FORC T; WHO, 2014, GLOB TUB REP 2014; WHO, 2014, PAK HLTH PROF; World Health Organization,, 2011, TUB PREV SURV HDB, V2nd; World Health Organization, 2015, GLOB TUB REP 2015; Zaman K, 2006, EPIDEMIOL INFECT, V134, P1052, DOI 10.1017/S0950268806006108	37	40	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148293	10.1371/journal.pone.0148293	http://dx.doi.org/10.1371/journal.pone.0148293			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863617	Green Published, gold, Green Submitted			2022-12-27	WOS:000370046600051
J	Yueh, AE; Payne, SN; Leystra, AA; Van De Hey, DR; Foley, TM; Pasch, CA; Clipson, L; Matkowskyj, KA; Deming, DA				Yueh, Alexander E.; Payne, Susan N.; Leystra, Alyssa A.; Van De Hey, Dana R.; Foley, Tyler M.; Pasch, Cheri A.; Clipson, Linda; Matkowskyj, Kristina A.; Deming, Dustin A.			Colon Cancer Tumorigenesis Initiated by the H1047R Mutant PI3K	PLOS ONE			English	Article							GENETIC ALTERATIONS; COLORECTAL-CANCER; PIK3CA MUTATION; PATHWAY; INHIBITION	The phosphoinositide 3-kinase (PI3K) signaling pathway is critical for multiple important cellular functions, and is one of the most commonly altered pathways in human cancers. We previously developed a mouse model in which colon cancers were initiated by a dominant active PI3K p110-p85 fusion protein. In that model, well-differentiated mucinous adenocarcinomas developed within the colon and initiated through a non-canonical mechanism that is not dependent on WNT signaling. To assess the potential relevance of PI3K mutations in human cancers, we sought to determine if one of the common mutations in the human disease could also initiate similar colon cancers. Mice were generated expressing the Pik3-ca(H1047R) mutation, the analog of one of three human hotspot mutations in this gene. Mice expressing a constitutively active PI3K, as a result of this mutation, develop invasive adenocarcinomas strikingly similar to invasive adenocarcinomas found in human colon cancers. These tumors form without a polypoid intermediary and also lack nuclear CTNNB1 (beta-catenin), indicating a non-canonical mechanism of tumor initiation mediated by the PI3K pathway. These cancers are sensitive to dual PI3K/mTOR inhibition indicating dependence on the PI3K pathway. The tumor tissue remaining after treatment demonstrated reduction in cellular proliferation and inhibition of PI3K signaling.	[Yueh, Alexander E.; Van De Hey, Dana R.; Foley, Tyler M.; Deming, Dustin A.] Univ Wisconsin, Dept Med, Div Hematol & Oncol, Sch Med & Publ Hlth, Madison, WI USA; [Payne, Susan N.; Pasch, Cheri A.; Matkowskyj, Kristina A.; Deming, Dustin A.] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA; [Leystra, Alyssa A.; Clipson, Linda] Univ Wisconsin, Dept Oncol, Madison, WI USA; [Matkowskyj, Kristina A.] Univ Wisconsin, Dept Pathol & Lab Med, Sch Med & Publ Hlth Madison, Madison, WI USA; [Matkowskyj, Kristina A.; Deming, Dustin A.] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital	Deming, DA (corresponding author), Univ Wisconsin, Dept Med, Div Hematol & Oncol, Sch Med & Publ Hlth, Madison, WI USA.; Deming, DA (corresponding author), Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA.; Deming, DA (corresponding author), William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA.	ddeming@medicine.wisc.edu			National Institutes of Health [P30 CA014520]; UW Carbone Cancer Center; UW Department of Medicine; UW School of Medicine and Public Health; UW Graduate School through the Wisconsin Alumni Research Foundation; Funk Out Cancer; UW Carbone Cancer Center Gastrointestinal Disease Oriented Working Group; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UW Carbone Cancer Center; UW Department of Medicine; UW School of Medicine and Public Health; UW Graduate School through the Wisconsin Alumni Research Foundation; Funk Out Cancer; UW Carbone Cancer Center Gastrointestinal Disease Oriented Working Group; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by the National Institutes of Health (http://www.nih.gov/) P30 CA014520 (Core Grant, University of Wisconsin Carbone Cancer Center); start-up funds (D.A.D) from the UW Carbone Cancer Center, UW Department of Medicine, UW School of Medicine and Public Health, and the UW Graduate School through the Wisconsin Alumni Research Foundation; Funk Out Cancer (http://www.funkoutcancer.com/) and UW Carbone Cancer Center Gastrointestinal Disease Oriented Working Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JR, 2011, CANCER RES, V71, P2706, DOI 10.1158/0008-5472.CAN-10-0738; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Deming DA, 2014, ONCOGENE, V33, P2245, DOI 10.1038/onc.2013.167; Deming DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060709; Ebi H, 2013, P NATL ACAD SCI USA, V110, P21124, DOI 10.1073/pnas.1314124110; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Gopal AK, 2014, NEW ENGL J MED, V370, P1008, DOI 10.1056/NEJMoa1314583; Goss KH, 2000, J CLIN ONCOL, V18, P1967, DOI 10.1200/JCO.2000.18.9.1967; IJspeert JEG, 2015, NAT REV GASTRO HEPAT, V12, P401, DOI 10.1038/nrgastro.2015.73; Janku F, 2013, CANCER RES, V73, P276, DOI 10.1158/0008-5472.CAN-12-1726; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Leystra AA, 2012, CANCER RES, V72, P2931, DOI 10.1158/0008-5472.CAN-11-4097; Liu G, 2011, CLIN CANCER RES, V17, P7634, DOI 10.1158/1078-0432.CCR-11-1677; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Moore KN, 2015, J CLIN ONCOL, V33; Nosho K, 2008, NEOPLASIA, V10, P534, DOI 10.1593/neo.08336; Payne SN, ONCOGENESIS IN PRESS; Pena CE, 2015, J CLIN ONCOL, V33; Rodon J, 2013, CANC RES S1, V8, P73; Rodrigues HV, 2015, J CLIN ONCOL, V33; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Stelzer MK, 2010, CANCER PREV RES, V3, P1542, DOI 10.1158/1940-6207.CAPR-10-0228; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wong MH, 2000, P NATL ACAD SCI USA, V97, P12601, DOI 10.1073/pnas.230237997; Yap TA, 2015, CURR OPIN PHARMACOL, V23, P98, DOI 10.1016/j.coph.2015.05.016; Zhao L, 2010, CELL CYCLE, V9, P596, DOI 10.4161/cc.9.3.10599	30	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148730	10.1371/journal.pone.0148730	http://dx.doi.org/10.1371/journal.pone.0148730			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863299	Green Published, Green Submitted, gold			2022-12-27	WOS:000370046600102
J	Dua, R; Comella, K; Butler, R; Castellanos, G; Brazille, B; Claude, A; Agarwal, A; Liao, J; Ramaswamy, S				Dua, Rupak; Comella, Kristin; Butler, Ryan; Castellanos, Glenda; Brazille, Bryn; Claude, Andrew; Agarwal, Arvind; Liao, Jun; Ramaswamy, Sharan			Integration of Stem Cell to Chondrocyte-Derived Cartilage Matrix in Healthy and Osteoarthritic States in the Presence of Hydroxyapatite Nanoparticles	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; KNEE ARTHROSCOPIES; OSTEOCHONDRAL DEFECTS; ENGINEERED CARTILAGE; REPAIR; BONE; TRANSPLANTATION; REGENERATION; PHENOTYPE; FIXATION	We investigated the effectiveness of integrating tissue engineered cartilage derived from human bone marrow derived stem cells (HBMSCs) to healthy as well as osteoarthritic cartilage mimics using hydroxyapatite (HA) nanoparticles immersed within a hydrogel substrate. Healthy and diseased engineered cartilage from human chondrocytes (cultured in agar gels) were integrated with human bone marrow stem cell (HBMSC)-derived cartilaginous engineered matrix with and without HA, and evaluated after 28 days of growth. HBMSCs were seeded within photopolymerizable poly (ethylene glycol) diacrylate (PEGDA) hydrogels. In addition, we also conducted a preliminary in vivo evaluation of cartilage repair in rabbit knee chondral defects treated with subchondral bone microfracture and cell-free PEGDA with and without HA. Under in vitro conditions, the interfacial shear strength between tissue engineered cartilage derived from HBMSCs and osteoarthritic chondrocytes was significantly higher (p < 0.05) when HA nanoparticles were incorporated within the HBMSC culture system. Histological evidence confirmed a distinct spatial transition zone, rich in calcium phosphate deposits. Assessment of explanted rabbit knees by histology demonstrated that cellularity within the repair tissues that had filled the defects were of significantly higher number (p < 0.05) when HA was used. HA nanoparticles play an important role in treating chondral defects when osteoarthritis is a co-morbidity. We speculate that the calcified layer formation at the interface in the osteoarthritic environment in the presence of HA is likely to have attributed to higher interfacial strength found in vitro. From an in vivo standpoint, the presence of HA promoted cellularity in the tissues that subsequently filled the chondral defects. This higher presence of cells can be considered important in the context of accelerating long-term cartilage remodeling. We conclude that HA nanoparticles play an important role in engineered to native cartilage integration and cellular processes.	[Dua, Rupak; Comella, Kristin; Castellanos, Glenda; Ramaswamy, Sharan] Florida Int Univ, Dept Biomed Engn, TEMIM Lab, Tissue Engn Mech Imaging & Mat Lab, Miami, FL 33174 USA; [Butler, Ryan; Claude, Andrew] Mississippi State Univ, Coll Vet Med, Starkville, MS 39762 USA; [Brazille, Bryn; Liao, Jun] Mississippi State Univ, Dept Agr & Biol Engn, Tissue Bioengn Lab, Starkville, MS 39762 USA; [Agarwal, Arvind] Florida Int Univ, Dept Mech & Mat Engn, AMERI, Miami, FL 33174 USA	State University System of Florida; Florida International University; Mississippi State University; Mississippi State University; State University System of Florida; Florida International University	Ramaswamy, S (corresponding author), Florida Int Univ, Dept Biomed Engn, TEMIM Lab, Tissue Engn Mech Imaging & Mat Lab, Miami, FL 33174 USA.	sramaswa@fiu.edu	Dua, Rupak/AAJ-4313-2021; Sharan, Ramaswamy/H-4469-2019; Liao, Jun/AAW-3591-2021	Liao, Jun/0000-0003-1049-5783; Dua, Rupak/0000-0001-6897-7617; Ramaswamy, Sharan/0000-0003-4108-7141	College of Engineering and Computing at Florida International University (FIU); university graduate school at FIU	College of Engineering and Computing at Florida International University (FIU); university graduate school at FIU	Financial support for this study was provided by the College of Engineering and Computing at Florida International University (FIU). Additionally, a Dissertation Year Fellowship to support Rupak Dua, provided by the university graduate school at FIU is gratefully acknowledged.; Financial support for this study was provided by the College of Engineering and Computing at Florida International University (FIU). Additionally, a Dissertation Year Fellowship to support Rupak Dua, provided by the university graduate school at FIU is gratefully acknowledged. The authors sincerely acknowledge the equipment and services provided by the Advanced Materials Engineering Research Institute (AMERI) at FIU, related to the FEG-SEM with EDS capabilities. Finally, the authors wish to thank Dr. Nicolas Tsoukias for permitting access and use of facilities in his laboratory.	Aroen A, 2004, AM J SPORT MED, V32, P211, DOI 10.1177/0363546503259345; Benders KEM, 2013, TRENDS BIOTECHNOL, V31, P169, DOI 10.1016/j.tibtech.2012.12.004; Betz MW, 2008, J BIOMED MATER RES A, V86A, P662, DOI 10.1002/jbm.a.31640; Bruns TB, 2000, AM FAM PHYSICIAN, V61, P1383; Buckwalter JA, 1998, AAOS INSTR COURS LEC, V47, P487; Curl WW, 1997, ARTHROSCOPY, V13, P456, DOI 10.1016/S0749-8063(97)90124-9; Djouad F, 2009, TISSUE ENG PT A, V15, P2825, DOI [10.1089/ten.tea.2008.0663, 10.1089/ten.TEA.2008.0663]; Dua R, 2012, CYTOTECHNOLOGY, P1; Dua R, 2013, J BIOMEDICAL MAT R B; Fleming Braden C, 2005, Curr Opin Orthop, V16, P354, DOI 10.1097/01.bco.0000176423.07865.d2; Furman BD, 2006, J ORTHOP TRAUMA, V20, P719, DOI 10.1097/01.bot.0000211160.05864.14; Gebhard PM, 2003, J ORTHOPAED RES, V21, P96, DOI 10.1016/S0736-0266(02)00094-3; Gilbert J E, 1998, Am J Knee Surg, V11, P42; Goldring MB, 2012, THER ADV MUSCULOSKEL, V4, P269, DOI 10.1177/1759720X12448454; HERRMANN JB, 1970, ARCH SURG-CHICAGO, V100, P486; Hjelle K, 2002, ARTHROSCOPY, V18, P730, DOI 10.1053/jars.2002.32839; Hoemann CD, 2007, OSTEOARTHR CARTILAGE, V15, P78, DOI 10.1016/j.joca.2006.06.015; Huang CYC, 2004, ANAT REC PART A, V278A, P428, DOI 10.1002/ar.a.20010; Hunziker EB, 1998, J BONE JOINT SURG BR, V80B, P144, DOI 10.1302/0301-620X.80B1.7531; Khanarian NT, 2012, TISSUE ENG PT A, V18, P533, DOI [10.1089/ten.tea.2011.0279, 10.1089/ten.TEA.2011.0279]; Khashan Moursi, 2010, Harefuah, V149, P542; Kim YS, 2012, AM J SPORT MED, V40, P1824, DOI 10.1177/0363546512449292; Kuo CK, 2006, CURR OPIN RHEUMATOL, V18, P64, DOI 10.1097/01.bor.0000198005.88568.df; Lopa S, 2014, TISSUE ENG A; Martinez-Sanchez A, 2012, J BIOL CHEM, V287, P916, DOI 10.1074/jbc.M111.302430; Messner K, 1996, ACTA ORTHOP SCAND, V67, P523, DOI 10.3109/17453679608996682; Munirah S, 2010, TISSUE CELL, V42, P282, DOI 10.1016/j.tice.2010.07.002; MYERS TW, 1991, BIOCHEMISTRY-US, V30, P7661, DOI 10.1021/bi00245a001; Nettles DL, 2008, TISSUE ENG PT A, V14, P1133, DOI [10.1089/ten.tea.2007.0245, 10.1089/tea.2007.0245]; Panseri S, 2012, KNEE SURG SPORT TR A, V20, P1182, DOI 10.1007/s00167-011-1655-1; Perkins GL, 2005, DIFFERENTIATION, V73, P199, DOI 10.1111/j.1432-0436.2005.00024.x; Ramaswamy S, 2008, TISSUE ENG PART C-ME, V14, P243, DOI 10.1089/ten.tec.2007.0423; Ramaswamy S, 2008, J BIOMED MATER RES B, V86B, P375, DOI 10.1002/jbm.b.31030; ROBERTSON DB, 1986, AM J SPORT MED, V14, P398, DOI 10.1177/036354658601400512; Shelbourne KD, 2003, J BONE JOINT SURG AM, V85A, P8, DOI 10.2106/00004623-200300002-00002; Smyth NA, 2013, J BONE JOINT SURG AM, V95A, P2185, DOI 10.2106/JBJS.L.01497; Stengel D, 2009, AM J SPORT MED, V37, P1692, DOI 10.1177/0363546509333008; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vijayan S, 2010, INDIAN J ORTHOP, V44, P238, DOI 10.4103/0019-5413.65136; Wang DA, 2007, NAT MATER, V6, P385, DOI 10.1038/nmat1890; Zantop T, 2004, KNEE SURG SPORT TR A, V12, P520, DOI 10.1007/s00167-004-0509-5	41	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149121	10.1371/journal.pone.0149121	http://dx.doi.org/10.1371/journal.pone.0149121			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871903	gold, Green Submitted, Green Published			2022-12-27	WOS:000370054100108
J	Li, Q; Mao, M; Qiu, YL; Liu, GF; Sheng, TT; Yu, XF; Wang, S; Zhu, DL				Li, Qian; Mao, Min; Qiu, Yanli; Liu, Gaofeng; Sheng, Tingting; Yu, Xiufeng; Wang, Shuang; Zhu, Daling			Key Role of ROS in the Process of 15-Lipoxygenase/15-Hydroxyeicosatetraenoiccid-Induced Pulmonary Vascular Remodeling in Hypoxia Pulmonary Hypertension	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; NITRIC-OXIDE SYNTHASE; GROWTH-FACTOR; 15-HYDROXYEICOSATETRAENOIC ACID; OXIDATIVE STRESS; INDUCED PROLIFERATION; ENDOTHELIAL-CELLS; NAD(P)H OXIDASE; NADPH OXIDASES; ARTERY	We previously reported that 15-lipoxygenase (15-LO) and its metabolite 15-hydroxyeicosatetraenoic acid (15-HETE) were up-regulated in pulmonary arterial cells from both pulmonary artery hypertension patients and hypoxic rats and that these factors mediated the progression of pulmonary hypertension (PH) by affecting the proliferation and apoptosis of pulmonary arterial (PA) cells. However, the underlying mechanisms of the remodeling induced by 15-HETE have remained unclear. As reactive oxygen species (ROS) and 15-LO are both induced by hypoxia, it is possible that ROS are involved in the events of hypoxiainduced 15-LO expression that lead to PH. We employed immunohistochemistry, tube formation assays, bromodeoxyuridine (BrdU) incorporation assays, and cell cycle analyses to explore the role of ROS in the process of 15-HETE-mediated hypoxic pulmonary hypertension (HPH). We found that exogenous 15-HETE facilitated the generation of ROS and that this effect was mainly localized to mitochondria. In particular, the mitochondrial electron transport chain and nicotinamide-adenine dinucleotide phosphate oxidase 4 (Nox4) were responsible for the significant 15-HETE-stimulated increase in ROS production. Moreover, ROS induced by 15-HETE stimulated endothelial cell (EC) migration and promoted pulmonary artery smooth muscle cell (PASMC) proliferation under hypoxia via the p38 MAPK pathway. These results indicated that 15-HETE-regulated ROS mediated hypoxia-induced pulmonary vascular remodeling (PVR) via the p38 MAPK pathway.	[Li, Qian; Qiu, Yanli; Wang, Shuang] Harbin Med Univ, Dept Pharmaceut Anal, Coll Pharm, Harbin, Heilongjiang Pr, Peoples R China; [Li, Qian] Purdue Univ, Biol Sci, W Lafayette, IN 47907 USA; [Mao, Min; Sheng, Tingting; Yu, Xiufeng; Zhu, Daling] Harbin Med Univ Daqing, Dept Pathophysiol, Daqing, Heilongjiang Pr, Peoples R China; [Mao, Min; Zhu, Daling] Harbin Med Univ, Biopharmaceut Key Lab Harbin, Harbin, Heilongjiang Pr, Peoples R China; [Liu, Gaofeng] Harbin Med Univ, Affiliated Hosp 2, Dept Pharm, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Harbin Medical University; Harbin Medical University; Harbin Medical University	Zhu, DL (corresponding author), Harbin Med Univ Daqing, Dept Pathophysiol, Daqing, Heilongjiang Pr, Peoples R China.; Zhu, DL (corresponding author), Harbin Med Univ, Biopharmaceut Key Lab Harbin, Harbin, Heilongjiang Pr, Peoples R China.	liqian@ems.hrbmu.edu.cn			National Natural Science Foundation of China [31100835]; National Foundation for Post-doctoral Scholars [2013M531066]; Heilongjiang Province Foundation for Post-doctoral Scholars [LBH-Z11059]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Foundation for Post-doctoral Scholars; Heilongjiang Province Foundation for Post-doctoral Scholars	The authors are grateful for financial support from the National Natural Science Foundation of China (grant number 31100835); the National Foundation for Post-doctoral Scholars (2013M531066); the Heilongjiang Province Foundation for Post-doctoral Scholars (LBH-Z11059).	Ahmad M, 2010, AM J PHYSIOL-HEART C, V298, pH1879, DOI 10.1152/ajpheart.01228.2009; Archer SL, 2008, AM J PHYSIOL-HEART C, V294, pH570, DOI 10.1152/ajpheart.01324.2007; Barman SA, 2014, ARTERIOSCLER THROMB; Basuroy S, 2011, AM J PHYSIOL-CELL PH, V300, pC256, DOI 10.1152/ajpcell.00272.2010; Brahimi-Horn MC, 2007, J MOL MED-JMM, V85, P1301, DOI 10.1007/s00109-007-0281-3; DeMarco VG, 2010, WORLD J CARDIOL, V2, P316, DOI 10.4330/wjc.v2.i10.316; Fan YF, 2013, CARDIOVASC RES, V99, P395, DOI 10.1093/cvr/cvt109; Fernandes DJ, 2004, BRIT J PHARMACOL, V142, P1182, DOI 10.1038/sj.bjp.0705809; Fike CD, 2013, PULM CIRC, V3, P551, DOI 10.1086/674307; Fu SF, 2014, EXP THER MED, V8, P1453, DOI 10.3892/etm.2014.1971; Gao WY, 2014, MOLECULES, V19, P8503, DOI 10.3390/molecules19068503; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; Graham KA, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.3.12207; Guzik TJ, 2006, DRUG DISCOV TODAY, V11, P524, DOI 10.1016/j.drudis.2006.04.003; HISLOP A, 1976, BRIT J EXP PATHOL, V57, P542; Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291; Ismail S, 2009, AM J PHYSIOL-LUNG C, V296, pL489, DOI 10.1152/ajplung.90488.2008; Jiang J, 2011, J RECEPT SIG TRANSD, V31, P45, DOI 10.3109/10799893.2010.512013; Lan AP, 2013, NEUROCHEM RES, V38, P1454, DOI 10.1007/s11064-013-1044-x; Landmesser U, 2003, J CLIN INVEST, V111, P1201, DOI 10.1172/JCI200314172; Lee SH, 2010, AM J PHYSIOL-CELL PH, V298, pC847, DOI 10.1152/ajpcell.00418.2009; Li Q, 2014, MOLECULES, V19, P19036, DOI 10.3390/molecules191119036; Liu Y, 2012, INT J BIOCHEM CELL B, V44, P1184, DOI 10.1016/j.biocel.2012.04.009; Lu CL, 2006, CAN J PHYSIOL PHARM, V84, P1061, DOI 10.1139/Y06-057; Ma C, 2014, BRIT J PHARMACOL, V171, P3352, DOI 10.1111/bph.12594; Ma C, 2011, HYPERTENSION, V58, P679, DOI 10.1161/HYPERTENSIONAHA.111.171561; Ma J, 2013, INT J BIOCHEM CELL B, V45, P1031, DOI 10.1016/j.biocel.2013.02.018; Ma J, 2010, J CELL PHYSIOL, V222, P82, DOI 10.1002/jcp.21923; Mandegar M, 2004, MICROVASC RES, V68, P75, DOI 10.1016/j.mvr.2004.06.001; Montezano AC, 2011, CLIN SCI, V120, P131, DOI 10.1042/CS20100384; Morrell NW, 2009, J AM COLL CARDIOL, V54, pS20, DOI 10.1016/j.jacc.2009.04.018; Nie XW, 2013, INT J BIOCHEM CELL B, V45, P964, DOI 10.1016/j.biocel.2013.01.017; Nie XW, 2012, PROSTAG OTH LIPID M, V97, P50, DOI 10.1016/j.prostaglandins.2011.11.003; Nozik-Grayck E, 2007, ADV EXP MED BIOL, V618, P101; Ogura S, 2013, AM J PHYSIOL-HEART C, V305, pH155, DOI 10.1152/ajpheart.00169.2012; Park J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023211; Park S, 2010, J MOL MED, V88, P807, DOI 10.1007/s00109-010-0622-5; Pokreisz P, 2006, HYPERTENSION, V47, P762, DOI 10.1161/01.HYP.0000208299.62535.58; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Recchia AG, 2011, J BIOL CHEM, V286, P10773, DOI 10.1074/jbc.M110.172247; Schramm A, 2012, VASC PHARMACOL, V56, P216, DOI 10.1016/j.vph.2012.02.012; Schumacker Paul T, 2011, Proc Am Thorac Soc, V8, P477, DOI 10.1513/pats.201103-032MW; Shen TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083132; Sturrock A, 2006, AM J PHYSIOL-LUNG C, V290, pL661, DOI 10.1152/ajplung.00269.2005; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Touyz RM, 2012, CIRC RES, V110, P1159, DOI 10.1161/CIRCRESAHA.112.269068; Wang S, 2010, PROSTAG OTH LIPID M, V91, P51, DOI 10.1016/j.prostaglandins.2009.12.007; Ward JPT, 2006, J APPL PHYSIOL, V101, P993, DOI 10.1152/japplphysiol.00480.2006; Waypa GB, 2002, CIRC RES, V91, P719, DOI 10.1161/01.RES.0000036751.04896.F1; Waypa GB, 2008, EXP PHYSIOL, V93, P133, DOI 10.1113/expphysiol.2007.041236; Wei LP, 2014, CELL SIGNAL, V26, P1476, DOI 10.1016/j.cellsig.2014.03.008; Weir EK, 2006, J APPL PHYSIOL, V101, P995, DOI 10.1152/japplphysiol.00480a.2006; Welsh DJ, 2006, PULM PHARMACOL THER, V19, P128, DOI 10.1016/j.pupt.2005.04.008; Wolin MS, 2009, AM J PHYSIOL-HEART C, V296, pH539, DOI 10.1152/ajpheart.01167.2008; Xiao GF, 2014, EUR J PHARMACOL, V727, P29, DOI 10.1016/j.ejphar.2014.01.051; Yang XD, 2002, AM J RESP CELL MOL, V27, P688, DOI 10.1165/rcmb.2002-0067OC; Yuan DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096510; Zhu D, 2014, J CELL MOL MED; Zinkevich NS, 2011, AM J PHYSIOL-HEART C, V301, pH647, DOI 10.1152/ajpheart.01271.2010	59	22	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149164	10.1371/journal.pone.0149164	http://dx.doi.org/10.1371/journal.pone.0149164			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871724	Green Submitted, Green Published, gold			2022-12-27	WOS:000370054100116
J	Neumann, B; Wu, HJ; Hackmann, A; Krebber, H				Neumann, Bettina; Wu, Haijia; Hackmann, Alexandra; Krebber, Heike			Nuclear Export of Pre-Ribosomal Subunits Requires Dbp5, but Not as an RNA-Helicase as for mRNA Export	PLOS ONE			English	Article							BOX PROTEIN DBP5; SACCHAROMYCES-CEREVISIAE; PORE COMPLEX; YEAST; TRANSLATION; NUP159; GLE1; TRANSCRIPTION; NUCLEOPORIN; NMD3P	The DEAD-box RNA-helicase Dbp5/Rat8 is known for its function in nuclear mRNA export, where it displaces the export receptor Mex67 from the mRNA at the cytoplasmic side of the nuclear pore complex (NPC). Here we show that Dbp5 is also required for the nuclear export of both pre-ribosomal subunits. Yeast temperature-sensitive dbp5 mutants accumulate both ribosomal particles in their nuclei. Furthermore, Dbp5 genetically and physically interacts with known ribosomal transport factors such as Nmd3. Similar to mRNA export we show that also for ribosomal transport Dbp5 is required at the cytoplasmic side of the NPC. However, unlike its role in mRNA export, Dbp5 does not seem to undergo its ATPase cycle for this function, as ATPase-deficient dbp5 mutants that selectively inhibit mRNA export do not affect ribosomal transport. Furthermore, mutants of GLE1, the ATPase stimulating factor of Dbp5, show no major ribosomal export defects. Consequently, while Dbp5 uses its ATPase cycle to displace the export receptor Mex67 from the translocated mRNAs, Mex67 remains bound to ribosomal subunits upon transit to the cytoplasm, where it is detectable on translating ribosomes. Therefore, we propose a model, in which Dbp5 supports ribosomal transport by capturing ribosomal subunits upon their cytoplasmic appearance at the NPC, possibly by binding export factors such as Mex67. Thus, our findings reveal that although different ribonucleoparticles, mRNAs and pre-ribosomal subunits, use shared export factors, they utilize different transport mechanisms.	[Neumann, Bettina; Wu, Haijia; Hackmann, Alexandra; Krebber, Heike] Univ Gottingen, GZMB, Inst Mikrobiol & Genet, Abt Mol Genet, Gottingen, Germany; [Wu, Haijia] Carl von Ossietzky Univ Oldenburg, Biochem Grp, Dept Neurosci, Oldenburg, Germany	University of Gottingen; Carl von Ossietzky Universitat Oldenburg	Krebber, H (corresponding author), Univ Gottingen, GZMB, Inst Mikrobiol & Genet, Abt Mol Genet, Gottingen, Germany.	heike.krebber@biologie.uni-goettingen.de			Deutsche Forschungsgemeinschaft [SFB860]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft SFB860 to HK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcazar-Roman AR, 2006, NAT CELL BIOL, V8, P711, DOI 10.1038/ncb1427; Baierlein C, 2013, MOL CELL BIOL, V33, P4811, DOI 10.1128/MCB.00873-13; Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; Bolger Timothy A, 2008, Cell, V134, P624, DOI 10.1016/j.cell.2008.06.027; Del Priore V, 1997, J CELL SCI, V110, P2987; DelPriore V, 1996, MOL BIOL CELL, V7, P1601, DOI 10.1091/mbc.7.10.1601; Estruch F, 2003, MOL BIOL CELL, V14, P1664, DOI 10.1091/mbc.E02-09-0602; Estruch F, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-80; Faza MB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002915; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; Garre E, 2012, MOL BIOL CELL, V23, P137, DOI 10.1091/mbc.E11-05-0419; Gerhardy S, 2014, CHROMOSOMA, V123, P327, DOI 10.1007/s00412-014-0463-z; Gleizes PE, 2001, J CELL BIOL, V155, P923, DOI 10.1083/jcb.200108142; GORSCH LC, 1995, J CELL BIOL, V129, P939, DOI 10.1083/jcb.129.4.939; Gross T, 2007, SCIENCE, V315, P646, DOI 10.1126/science.1134641; Hackmann A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4123; Hackmann A, 2011, EMBO REP, V12, P1024, DOI 10.1038/embor.2011.155; Hedges J, 2005, EMBO J, V24, P567, DOI 10.1038/sj.emboj.7600547; Ho JHN, 2000, J CELL BIOL, V151, P1057, DOI 10.1083/jcb.151.5.1057; Hodge CA, 1999, EMBO J, V18, P5778, DOI 10.1093/emboj/18.20.5778; Hodge CA, 2011, GENE DEV, V25, P1052, DOI 10.1101/gad.2041611; KADOWAKI T, 1994, MOL BIOL CELL, V5, P1253, DOI 10.1091/mbc.5.11.1253; Kappel L, 2012, J CELL BIOL, V199, P771, DOI 10.1083/jcb.201205021; Kelly SM, 2009, TRAFFIC, V10, P1199, DOI 10.1111/j.1600-0854.2009.00944.x; Lei EP, 2001, GENE DEV, V15, P1771, DOI 10.1101/gad.892401; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Lund MK, 2005, MOL CELL, V20, P645, DOI 10.1016/j.molcel.2005.10.005; Milkereit P, 2003, J BIOL CHEM, V278, P4072, DOI 10.1074/jbc.M208898200; Moy TI, 2002, J CELL SCI, V115, P2985; Moy TI, 1999, GENE DEV, V13, P2118, DOI 10.1101/gad.13.16.2118; Murphy R, 1996, NATURE, V383, P357, DOI 10.1038/383357a0; Noble KN, 2011, GENE DEV, V25, P1065, DOI 10.1101/gad.2040611; Panse VG, 2010, TRENDS BIOCHEM SCI, V35, P260, DOI 10.1016/j.tibs.2010.01.001; Pertschy B, 2007, MOL CELL BIOL, V27, P6581, DOI 10.1128/MCB.00668-07; Scarcelli JJ, 2008, GENETICS, V179, P1945, DOI 10.1534/genetics.108.091256; Schmitt C, 1999, EMBO J, V18, P4332, DOI 10.1093/emboj/18.15.4332; Snay-Hodge CA, 1998, EMBO J, V17, P2663, DOI 10.1093/emboj/17.9.2663; Stage-Zimmermann T, 2000, MOL BIOL CELL, V11, P3777, DOI 10.1091/mbc.11.11.3777; Thomas F, 2003, J CELL SCI, V116, P2409, DOI 10.1242/jcs.00464; Tieg B, 2013, BBA-GENE REGUL MECH, V1829, P791, DOI 10.1016/j.bbagrm.2012.10.010; Tran EJ, 2007, MOL CELL, V28, P850, DOI 10.1016/j.molcel.2007.09.019; Trotta CR, 2003, EMBO J, V22, P2841, DOI 10.1093/emboj/cdg249; Tseng SSL, 1998, EMBO J, V17, P2651, DOI 10.1093/emboj/17.9.2651; Weirich CS, 2006, NAT CELL BIOL, V8, P668, DOI 10.1038/ncb1424; Weirich CS, 2004, MOL CELL, V16, P749, DOI 10.1016/j.molcel.2004.10.032; Wente SR, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000562; Windgassen M, 2004, MOL CELL BIOL, V24, P10479, DOI 10.1128/MCB.24.23.10479-10491.2004; Wu HJ, 2014, CELL REP, V8, P1630, DOI 10.1016/j.celrep.2014.08.021; Yao W, 2007, MOL CELL, V26, P51, DOI 10.1016/j.molcel.2007.02.018; Zemp I, 2009, J CELL BIOL, V185, P1167, DOI 10.1083/jcb.200904048	50	17	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149571	10.1371/journal.pone.0149571	http://dx.doi.org/10.1371/journal.pone.0149571			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872259	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100165
J	Blech-Hermoni, Y; Dasgupta, T; Coram, RJ; Ladd, AN				Blech-Hermoni, Yotam; Dasgupta, Twishasri; Coram, Ryan J.; Ladd, Andrea N.			Identification of Targets of CUG-BP, Elav-Like Family Member 1 (CELF1) Regulation in Embryonic Heart Muscle	PLOS ONE			English	Article							BINDING PROTEIN CUGBP1; MESSENGER-RNA DECAY; GU-RICH ELEMENTS; GENE-EXPRESSION; ALTERNATIVE POLYADENYLATION; DEVELOPMENTAL EXPRESSION; INCREASES TRANSLATION; SPLICING EVENTS; MODEL; OVEREXPRESSION	CUG-BP, Elav-like family member 1 (CELF1) is a highly conserved RNA binding protein that regulates pre-mRNA alternative splicing, polyadenylation, mRNA stability, and translation. In the heart, CELF1 is expressed in the myocardium, where its levels are tightly regulated during development. CELF1 levels peak in the heart during embryogenesis, and aberrant up-regulation of CELF1 in the adult heart has been implicated in cardiac pathogenesis in myotonic dystrophy type 1, as well as in diabetic cardiomyopathy. Either inhibition of CELF activity or over-expression of CELF1 in heart muscle causes cardiomyopathy in transgenic mice. Nonetheless, many of the cardiac targets of CELF1 regulation remain unknown. In this study, to identify cardiac targets of CELF1 we performed cross-linking immunoprecipitation (CLIP) for CELF1 from embryonic day 8 chicken hearts. We identified a previously unannotated exon in MYH7B as a novel target of CELF1-mediated regulation. We demonstrated that knockdown of CELF1 in primary chicken embryonic cardiomyocytes leads to increased inclusion of this exon and decreased MYH7B levels. We also investigated global changes in the transcriptome of primary embryonic cardiomyocytes following CELF1 knockdown in a published RNA-seq dataset. Pathway and network analyses identified strong associations between CELF1 and regulation of cell cycle and translation. Important regulatory proteins, including both RNA binding proteins and a cardiac transcription factor, were affected by loss of CELF1. Together, these data suggest that CELF1 is a key regulator of cardiomyocyte gene expression.	[Blech-Hermoni, Yotam; Dasgupta, Twishasri; Coram, Ryan J.; Ladd, Andrea N.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA; [Blech-Hermoni, Yotam; Ladd, Andrea N.] Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cell Biol Program, Cleveland, OH 44106 USA; [Blech-Hermoni, Yotam] NINDS, Hereditary Muscle Dis Unit, Neurogenet Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Dasgupta, Twishasri] Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Coram, Ryan J.] Ohio Univ, Heritage Coll Osteopath Med, Athens, OH 45701 USA	Cleveland Clinic Foundation; Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Case Western Reserve University; University System of Ohio; Ohio University	Ladd, AN (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA.; Ladd, AN (corresponding author), Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cell Biol Program, Cleveland, OH 44106 USA.	ladda@ccf.org			National Institutes of Health [R01HL089376, 5T32GM008056]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089376] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant to ANL from the National Institutes of Health (R01HL089376). YB-H was supported in part by a National Institutes of Health training grant (5T32GM008056). The National Institutes of Health had no involvement in the study design, collection, analysis, or interpretation of the data, or the writing or submission of this article for publication.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Balza RO, 2006, J BIOL CHEM, V281, P6498, DOI 10.1074/jbc.M509487200; Batra R, 2014, MOL CELL, V56, P311, DOI 10.1016/j.molcel.2014.08.027; Beisang D, 2014, GENE, V550, P93, DOI 10.1016/j.gene.2014.08.021; Beisang D, 2012, J BIOL CHEM, V287, P950, DOI 10.1074/jbc.M111.291658; Bell ML, 2010, MOL CELL BIOL, V30, P1937, DOI 10.1128/MCB.01370-09; Blech-Hermoni Y, 2013, DEV DYNAM, V242, P767, DOI 10.1002/dvdy.23959; Blech-Hermoni Y, 2015, GENOMICS DATA, P674; Brimacombe KR, 2007, DEV DYNAM, V236, P2216, DOI 10.1002/dvdy.21209; Castle JC, 2008, NAT GENET, V40, P1416, DOI 10.1038/ng.264; Charizanis K, 2012, NEURON, V75, P437, DOI 10.1016/j.neuron.2012.05.029; Chen F, 2002, CELL, V110, P713, DOI 10.1016/S0092-8674(02)00932-7; Cooper TA, 2005, METHODS, V37, P331, DOI 10.1016/j.ymeth.2005.07.015; Das D, 2007, NUCLEIC ACIDS RES, V35, P4845, DOI 10.1093/nar/gkm485; Dasgupta T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124462; Dasgupta T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056590; Dasgupta T, 2012, WIRES RNA, V3, P104, DOI 10.1002/wrna.107; Daughters RS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000600; Deutsch M, 1999, NUCLEIC ACIDS RES, V27, P3219, DOI 10.1093/nar/27.15.3219; Dujardin G, 2010, NUCLEIC ACIDS RES, V38, P7273, DOI 10.1093/nar/gkq573; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Esposito T, 2013, ORPHANET J RARE DIS, P891; Faustino N, 2005, MOL CELL BIOL, P25879; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Giudice J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4603; Graindorge A, 2008, NUCLEIC ACIDS RES, V36, P1861, DOI 10.1093/nar/gkn031; Ho T, 2004, EMBO J; Ho TH, 2005, HUM MOL GENET, V14, P1539, DOI 10.1093/hmg/ddi162; Iakova P, 2004, EMBO J, V23, P406, DOI 10.1038/sj.emboj.7600052; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Kanadia RN, 2003, GENE EXPR PATTERNS, V3, P459, DOI 10.1016/S1567-133X(03)00064-4; Kartha RV, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00008; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim E, 2007, NUCLEIC ACIDS RES, V35, P125, DOI 10.1093/nar/gkl924; Koshelev M, 2010, HUM MOL GENET, V19, P1066, DOI 10.1093/hmg/ddp570; Ladd A, 2004, J CELL SCI; Ladd A, 2005, MOL CELL BIOL; Ladd AN, 2005, DEV DYNAM, V233, P783, DOI 10.1002/dvdy.20382; Ladd AN, 2001, MOL CELL BIOL, V21, P1285, DOI 10.1128/MCB.21.4.1285-1296.2001; Lee JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011201; Lee KY, 2013, EMBO MOL MED, V5, P1887, DOI 10.1002/emmm.201303275; LeMasters KE, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-22; Liu Yong, 2014, Clin Invest Med, V37, pE10; Lovci MT, 2013, NAT STRUCT MOL BIOL, V20, P1434, DOI 10.1038/nsmb.2699; Lu HJ, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0544-8; Marquis J, 2006, BIOCHEM J, V400, P291, DOI 10.1042/BJ20060490; Masuda A, 2012, SCI REP, P2209; Moraes KCM, 2006, RNA, V12, P1084, DOI 10.1261/rna.59606; Mori D, 2008, J BIOCHEM, V143, P377, DOI 10.1093/jb/mvm230; Nelson TJ, 2005, J MOL CELL CARDIOL, V39, P479, DOI 10.1016/j.yjmcc.2005.05.004; Paillard L, 2003, BIOL CELL, V95, P107, DOI 10.1016/S0248-4900(03)00010-8; Palacios IM, 2013, BRIEF FUNCT GENOMICS, V12, P25, DOI 10.1093/bfgp/els051; Parra MK, 2012, MOL CELL BIOL, V32, P2044, DOI 10.1128/MCB.05716-11; Peng XP, 2015, BBA-MOL BASIS DIS, V1852, P1490, DOI 10.1016/j.bbadis.2015.04.010; Philippar U, 2004, MOL CELL, V16, P867, DOI 10.1016/j.molcel.2004.11.039; Philips A, 1998, SCIENCE; Rattenbacher B, 2010, MOL CELL BIOL, V30, P3970, DOI 10.1128/MCB.00624-10; Schoser B, 2010, CURR GENOMICS, V11, P77, DOI 10.2174/138920210790886844; Shin CH, 2002, CELL, V110, P725, DOI 10.1016/S0092-8674(02)00933-9; Takahashi N, 2000, BIOCHEM BIOPH RES CO; Terenzi F, 2010, RNA BIOL, V7, P43, DOI 10.4161/rna.7.1.10401; Terenzi F, 2009, J MOL CELL CARDIOL, V46, P395, DOI 10.1016/j.yjmcc.2008.10.030; Timchenko LT, 2006, J BIOL CHEM, V281, P32806, DOI 10.1074/jbc.M605701200; Timchenko NA, 2005, J BIOL CHEM, V280, P20549, DOI 10.1074/jbc.M409563200; Timchenko NA, 2004, J BIOL CHEM, V279, P13129, DOI 10.1074/jbc.M312923200; Timchenko NA, 2001, J BIOL CHEM, V276, P7820, DOI 10.1074/jbc.M005960200; Timchenko NA, 2001, MOL CELL BIOL, V21, P6927, DOI 10.1128/MCB.21.20.6927-6938.2001; Trivedi CM, 2011, J MOL CELL CARDIOL, V50, P1056, DOI 10.1016/j.yjmcc.2011.02.015; Tsuda K, 2009, NUCLEIC ACIDS RES, V37, P5151, DOI 10.1093/nar/gkp546; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Vajda NA, 2009, DEV DYNAM, V238, P3266, DOI 10.1002/dvdy.22155; Verma SK, 2013, J BIOL CHEM, V288, P35372, DOI 10.1074/jbc.M113.507426; Vlasova IA, 2008, MOL CELL, V29, P263, DOI 10.1016/j.molcel.2007.11.024; Vlasova IA, 2008, RNA BIOL, V5, P201, DOI 10.4161/rna.7056; Vlasova-St Louis I, 2013, BBA-GENE REGUL MECH, V1829, P695, DOI 10.1016/j.bbagrm.2013.01.001; Wang ET, 2012, CELL, V150, P710, DOI 10.1016/j.cell.2012.06.041; Wang GS, 2007, J CLIN INVEST, V117, P2802, DOI 10.1172/JCI32308; Warkman AS, 2012, CYTOSKELETON, V69, P324, DOI 10.1002/cm.21029; Zhang CL, 2013, NUCLEIC ACIDS RES, V41, P6793, DOI 10.1093/nar/gkt421; Zhang LB, 2008, J BIOL CHEM, V283, P22457, DOI 10.1074/jbc.M802803200; Zhang XM, 2003, AM J PHYSIOL-REG I, V285, pR552, DOI 10.1152/ajpregu.00631.2002	84	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149061	10.1371/journal.pone.0149061	http://dx.doi.org/10.1371/journal.pone.0149061			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866591	Green Published, Green Submitted, gold			2022-12-27	WOS:000370050700058
J	de la Riva, EG; Olmo, M; Poorter, H; Ubera, JL; Villar, R				de la Riva, Enrique G.; Olmo, Manuel; Poorter, Hendrik; Luis Ubera, Jose; Villar, Rafael			Leaf Mass per Area (LMA) and Its Relationship with Leaf Structure and Anatomy in 34 Mediterranean Woody Species along a Water Availability Gradient	PLOS ONE			English	Article							RELATIVE GROWTH-RATE; LITTER DECOMPOSITION RATE; PLANT ECONOMICS SPECTRUM; CHEMICAL-COMPOSITION; FUNCTIONAL TRAITS; PHOTOSYNTHETIC CAPACITY; CONSTRUCTION COSTS; LIFE-SPAN; DRY MASS; NUTRIENT	Leaf mass per area (LMA) is a morphological trait widely used as a good indicator of plant functioning (i.e. photosynthetic and respiratory rates, chemical composition, resistance to herbivory, etc.). The LMA can be broken down into the leaf density (LD) and leaf volume to area ratio (LVA or thickness), which in turn are determined by anatomical tissues and chemical composition. The aim of this study is to understand the anatomical and chemical characteristics related to LMA variation in species growing in the field along a water availability gradient. We determined LMA and its components (LD, LVA and anatomical tissues) for 34 Mediterranean (20 evergreen and 14 deciduous) woody species. Variation in LMA was due to variation in both LD and LVA. For both deciduous and evergreen species LVA variation was strongly and positively related with mesophyll volume per area (VA or thickness), but for evergreen species positive relationships of LVA with the VA of epidermis, vascular plus sclerenchyma tissues and air spaces were found as well. The leaf carbon concentration was positively related with mesophyll VA in deciduous species, and with VA of vascular plus sclerenchymatic tissues in evergreens. Species occurring at the sites with lower water availability were generally characterised by a high LMA and LD.	[de la Riva, Enrique G.; Olmo, Manuel; Villar, Rafael] Univ Cordoba, Fac Ciencias, Area Ecol, Cordoba 14071, Spain; [Poorter, Hendrik] Forschungszentrum Julich, Plant Sci IBG2, D-52425 Julich, Germany; [Luis Ubera, Jose] Univ Cordoba, Fac Ciencias, Area Bot, Cordoba 14071, Spain	Universidad de Cordoba; Helmholtz Association; Research Center Julich; Universidad de Cordoba	Villar, R (corresponding author), Univ Cordoba, Fac Ciencias, Area Ecol, Cordoba 14071, Spain.	rafael.villar@uco.es	Poorter, Hendrik/Y-2542-2019; Villar, Rafael/F-7507-2010; de la Riva, Enrique/R-5805-2016; Poorter, Hendrik/B-8062-2010	Poorter, Hendrik/0000-0001-9900-2433; Villar, Rafael/0000-0002-3895-9984; de la Riva, Enrique/0000-0002-3393-8375; Poorter, Hendrik/0000-0001-9900-2433	Spanish MEC coordinated project DIVERBOS [CGL2011-30285-C02-01, CGL2011-30285-C02-02]; ECO-MEDIT [CGL2014-53236-R]; Andalusian ANASINQUE project [PGC2010-RNM-5782]; Life + Biodehesa Project [11/BIO/ES/000726]; European FEDER funds	Spanish MEC coordinated project DIVERBOS; ECO-MEDIT; Andalusian ANASINQUE project; Life + Biodehesa Project; European FEDER funds(European Commission)	This study was funded by the Spanish MEC coordinated project DIVERBOS (CGL2011-30285-C02-01 and C02-02), ECO-MEDIT (CGL2014-53236-R), the Andalusian ANASINQUE project (PGC2010-RNM-5782), the Life + Biodehesa Project (11/BIO/ES/000726), and European FEDER funds.	Antunez I, 2001, OECOLOGIA, V128, P172, DOI 10.1007/s004420100645; Castro-Diez P, 2000, OECOLOGIA, V124, P476, DOI 10.1007/PL00008873; CHABOT BF, 1982, ANNU REV ECOL SYST, V13, P229, DOI 10.1146/annurev.es.13.110182.001305; CHOONG MF, 1992, NEW PHYTOL, V121, P597, DOI 10.1111/j.1469-8137.1992.tb01131.x; Cornelissen JHC, 1999, NEW PHYTOL, V143, P191, DOI 10.1046/j.1469-8137.1999.00430.x; Cornelissen JHC, 1997, NEW PHYTOL, V135, P109, DOI 10.1046/j.1469-8137.1997.00628.x; Cunningham SA, 1999, ECOL MONOGR, V69, P569, DOI 10.1890/0012-9615(1999)069[0569:EDILSA]2.0.CO;2; CUTLER JM, 1977, PHYSIOL PLANTARUM, V40, P255, DOI 10.1111/j.1399-3054.1977.tb04068.x; de la Riva EG, 2016, OIKOS, V125, P354, DOI 10.1111/oik.01875; de la Riva EG, 2016, J VEG SCI, V27, P187, DOI 10.1111/jvs.12341; Dominguez MT, 2012, PLANT SOIL, V357, P407, DOI 10.1007/s11104-012-1214-7; Fernandez-Mazuecos M, 2010, MOL ECOL, V19, P1381, DOI 10.1111/j.1365-294X.2010.04549.x; Field C., 1986, EC PLANT FORM FUNCTI, P22; Garcia de la Riva E., 2014, Ecosistemas, V23, P82; GARNIER E, 1994, NEW PHYTOL, V128, P725, DOI 10.1111/j.1469-8137.1994.tb04036.x; Garnier E, 2001, FUNCT ECOL, V15, P688, DOI 10.1046/j.0269-8463.2001.00563.x; Garnier E, 2012, AGRON SUSTAIN DEV, V32, P365, DOI 10.1007/s13593-011-0036-y; Givnish TJ, 2002, EVOL ECOL, V16, P213, DOI 10.1023/A:1019676410041; Groom PK, 1997, NEW PHYTOL, V136, P231, DOI 10.1046/j.1469-8137.1997.00732.x; John GP, 2013, AM J BOT, V100, P1936, DOI 10.3732/ajb.1200608; Leps J, 2011, ECOGRAPHY, V34, P856, DOI 10.1111/j.1600-0587.2010.06904.x; Lopez-Iglesias B, 2014, PLANT SOIL, V381, P177, DOI 10.1007/s11104-014-2109-6; Lopez-Iglesias B, 2014, ACTA OECOL, V56, P10, DOI 10.1016/j.actao.2014.01.003; Manos PS, 1999, MOL PHYLOGENET EVOL, V12, P333, DOI 10.1006/mpev.1999.0614; Maximov NA., 1929, PLANT RELATION WATER; Mediavilla S, 2003, NEW PHYTOL, V159, P203, DOI 10.1046/j.1469-8137.2003.00798.x; Mediavilla S, 2001, TREE PHYSIOL, V21, P251, DOI 10.1093/treephys/21.4.251; Meziane D, 1999, PLANT CELL ENVIRON, V22, P447, DOI 10.1046/j.1365-3040.1999.00423.x; MOONEY HA, 1970, EVOLUTION, V24, P292, DOI 10.1111/j.1558-5646.1970.tb01762.x; NIEMANN GJ, 1992, OECOLOGIA, V89, P567, DOI 10.1007/BF00317165; Niinemets U, 1999, NEW PHYTOL, V144, P35, DOI 10.1046/j.1469-8137.1999.00466.x; Niinemets U, 2001, ECOLOGY, V82, P453, DOI 10.1890/0012-9658(2001)082[0453:GSCCOL]2.0.CO;2; Niinemets U, 1999, INT J PLANT SCI, V160, P837, DOI 10.1086/314180; OREN R, 1986, OECOLOGIA, V70, P187, DOI 10.1007/BF00379238; Orme D., 2011, R FORGE COMP ANAL PH; PAMMENTER NW, 1986, NEW PHYTOL, V102, P143, DOI 10.1111/j.1469-8137.1986.tb00806.x; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Poorter H, 1998, INHERENT VARIATION IN PLANT GROWTH, P309; Poorter H, 2009, NEW PHYTOL, V182, P565, DOI 10.1111/j.1469-8137.2009.02830.x; Poorter H, 2014, NEW PHYTOL, V201, P378, DOI 10.1111/nph.12547; Poorter Hendrik, 1997, P39, DOI 10.1016/B978-012083490-7/50003-7; Pyankov VI, 1999, NEW PHYTOL, V143, P131, DOI 10.1046/j.1469-8137.1999.00435.x; Quero JL, 2006, NEW PHYTOL, V170, P819, DOI 10.1111/j.1469-8137.2006.01713.x; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; REICH PB, 1991, OECOLOGIA, V86, P16, DOI 10.1007/BF00317383; REICH PB, 1992, ECOL MONOGR, V62, P365, DOI 10.2307/2937116; Reich PB, 2014, J ECOL, V102, P275, DOI 10.1111/1365-2745.12211; Renton M, 2011, NEW PHYTOL, V190, P5, DOI 10.1111/j.1469-8137.2010.03629.x; Roderick ML, 1999, FUNCT ECOL, V13, P696, DOI 10.1046/j.1365-2435.1999.00369.x; Ruiz-Robleto J, 2005, PLANT BIOLOGY, V7, P484, DOI 10.1055/s-2005-865905; Sack L, 2013, J EXP BOT, V64, P4053, DOI 10.1093/jxb/ert316; SHIELDS LM, 1950, BOT REV, V16, P399, DOI 10.1007/BF02869988; SHIPLEY B, 1995, FUNCT ECOL, V9, P312, DOI 10.2307/2390579; Slaton MR, 2002, INT J PLANT SCI, V163, P937, DOI 10.1086/342517; TURNER IM, 1994, J BIOGEOGR, V21, P413, DOI 10.2307/2845759; Utrillas MJ, 1997, INT J PLANT SCI, V158, P313, DOI 10.1086/297443; VANARENDONK JJCM, 1994, PLANT CELL ENVIRON, V17, P963, DOI 10.1111/j.1365-3040.1994.tb00325.x; Verdu M, 2013, EVOLUTION, V67, P1756, DOI 10.1111/evo.12049; Villar R, 2001, NEW PHYTOL, V151, P213, DOI 10.1046/j.1469-8137.2001.00147.x; Villar R, 2006, PLANT CELL ENVIRON, V29, P1629, DOI 10.1111/j.1365-3040.2006.01540.x; Villar R, 2013, AM J BOT, V100, P1969, DOI 10.3732/ajb.1200562; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Wilson PJ, 1999, NEW PHYTOL, V143, P155, DOI 10.1046/j.1469-8137.1999.00427.x; WITKOWSKI ETF, 1991, OECOLOGIA, V88, P486, DOI 10.1007/BF00317710; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright IJ, 2001, FUNCT ECOL, V15, P423, DOI 10.1046/j.0269-8463.2001.00542.x	66	138	142	12	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148788	10.1371/journal.pone.0148788	http://dx.doi.org/10.1371/journal.pone.0148788			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867213	Green Published, gold, Green Submitted			2022-12-27	WOS:000370050700037
J	He, M; Lu, YB; Zhang, L; Zhang, HH; Gong, YS; Li, YQ				He, Mi; Lu, Yubao; Zhang, Lei; Zhang, Hehua; Gong, Yushun; Li, Yongqin			Combining Amplitude Spectrum Area with Previous Shock Information Using Neural Networks Improves Prediction Performance of Defibrillation Outcome for Subsequent Shocks in Out-Of-Hospital Cardiac Arrest Patients	PLOS ONE			English	Article							WAVE-FORM CHARACTERISTICS; VENTRICULAR-FIBRILLATION; CARDIOPULMONARY-RESUSCITATION; RHYTHM ANALYSIS; FREQUENCY; SUCCESS; VF; ELECTROCARDIOGRAM; RECURRENCE; ACCURACY	Objective Quantitative ventricular fibrillation (VF) waveform analysis is a potentially powerful tool to optimize defibrillation. However, whether combining VF features with additional attributes that related to the previous shock could enhance the prediction performance for subsequent shocks is still uncertain. Methods A total of 528 defibrillation shocks from199 patients experienced out-of-hospital cardiac arrest were analyzed in this study. VF waveform was quantified using amplitude spectrum area (AMSA) from defibrillator's ECG recordings prior to each shock. Combinations of AMSA with previous shock index (PSI) or/and change of AMSA (Delta AMSA) between successive shocks were exercised through a training dataset including 255shocks from 99patientswith neural networks. Performance of the combination methods were compared with AMSA based single feature prediction by area under receiver operating characteristic curve(AUC), sensitivity, positive predictive value (PPV), negative predictive value (NPV) and prediction accuracy (PA) through a validation dataset that was consisted of 273 shocks from 100patients. Results A total of61 (61.0%) patients required subsequent shocks (N = 173) in the validation dataset. Combining AMSA with PSI and.AMSA obtained highest AUC (0.904 vs. 0.819, p< 0.001) among different combination approaches for subsequent shocks. Sensitivity (76.5% vs. 35.3%, p< 0.001), NPV (90.2% vs. 76.9%, p = 0.007) and PA (86.1% vs. 74.0%, p = 0.005) were greatly improved compared with AMSA based single feature prediction with a threshold of 90% specificity. Conclusion In this retrospective study, combining AMSA with previous shock information using neural networks greatly improves prediction performance of defibrillation outcome for subsequent shocks.	[He, Mi; Gong, Yushun; Li, Yongqin] Third Mil Med Univ, Sch Biomed Engn, Chongqing 400038, Peoples R China; [Lu, Yubao] Third Mil Med Univ, Xinqiao Hosp, Emergency Dept, Chongqing 400038, Peoples R China; [Zhang, Lei] Third Mil Med Univ, Southwest Hosp, Emergency Dept, Chongqing 400038, Peoples R China; [Zhang, Hehua] Third Mil Med Univ, Daping Hosp, Dept Med Engn, Chongqing 400042, Peoples R China; [Zhang, Hehua] Third Mil Med Univ, Inst Surg Res, Chongqing 400042, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Army Medical University; Army Medical University	Li, YQ (corresponding author), Third Mil Med Univ, Sch Biomed Engn, Chongqing 400038, Peoples R China.	leeoken@gmail.com		HE, Mi/0000-0001-9983-8863	National Nature Science Foundation of China [NSFC81271656, NSFC41301397]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Nature Science Foundation of China (NSFC81271656 and NSFC41301397). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala U, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/872470; Bradley SM, 2010, RESUSCITATION, V81, P155, DOI 10.1016/j.resuscitation.2009.10.026; Brown CG, 1996, ANN EMERG MED, V27, P184, DOI 10.1016/S0196-0644(96)70346-3; Callaway CW, 2005, CURR OPIN CRIT CARE, V11, P192, DOI 10.1097/01.ccx.0000161725.71211.42; Conover Z, 2014, CIRC-ARRHYTHMIA ELEC, V7, P633, DOI 10.1161/CIRCEP.114.001506; Firoozabadi R, 2013, J ELECTROCARDIOL, V46, P473, DOI 10.1016/j.jelectrocard.2013.06.007; Gundersen K, 2008, RESUSCITATION, V78, P46, DOI 10.1016/j.resuscitation.2008.02.018; Gundersen K, 2008, RESUSCITATION, V76, P279, DOI 10.1016/j.resuscitation.2007.07.019; Hansen MB, 2014, RESUSCITATION, V85, P1681, DOI 10.1016/j.resuscitation.2014.08.038; Howe A, 2014, RESUSCITATION, V85, P343, DOI 10.1016/j.resuscitation.2013.11.021; Indik JH, 2006, RESUSCITATION, V69, P471, DOI 10.1016/j.resuscitation.2005.10.017; Indik JH, 2009, RESUSCITATION, V80, P1420, DOI 10.1016/j.resuscitation.2009.08.023; Inmaculada-C Alvarez, 2013, PANEL DATA TOOLBOX M; Krasteva V, 2010, ANN BIOMED ENG, V38, P1326, DOI 10.1007/s10439-009-9885-9; Kwok H, 2015, RESUSCITATION, V91, P26, DOI 10.1016/j.resuscitation.2015.02.031; Lin LY, 2010, RESUSCITATION, V81, P297, DOI 10.1016/j.resuscitation.2009.12.003; Lo MT, 2013, RESUSCITATION, V84, P1505, DOI 10.1016/j.resuscitation.2013.07.004; Marn-Pernat A, 2001, CRIT CARE MED, V29, P2360, DOI 10.1097/00003246-200112000-00019; Menegazzi JJ, 2004, CIRCULATION, V109, P926, DOI 10.1161/01.CIR.0000112606.41127.D2; Neurauter A, 2007, RESUSCITATION, V73, P253, DOI 10.1016/j.resuscitation.2006.10.002; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Olasveengen TM, 2009, RESUSCITATION, V80, P412, DOI 10.1016/j.resuscitation.2009.01.012; Podbregar M, 2003, RESUSCITATION, V57, P153, DOI 10.1016/S0300-9572(03)00030-3; Reynolds JC, 2012, RESUSCITATION, V83, P1497, DOI 10.1016/j.resuscitation.2012.04.013; Ristagno G, 2013, RESUSCITATION, V84, P1697, DOI 10.1016/j.resuscitation.2013.08.017; Salcido DD, 2009, RESUSCITATION, V80, P946, DOI 10.1016/j.resuscitation.2009.05.002; Schoene P, 2014, HEART RHYTHM, V11, P230, DOI 10.1016/j.hrthm.2013.10.049; Shanmugasundaram M, 2012, RESUSCITATION, V83, P1242, DOI 10.1016/j.resuscitation.2012.02.008; Sharad Shandilya, 2012, BMC MED INFORM DECIS, V12, P1; Sherman L, 2012, RESUSCITATION, V83, P511, DOI 10.1016/j.resuscitation.2011.09.026; Stiell IG, 2011, NEW ENGL J MED, V365, P787, DOI 10.1056/NEJMoa1010076; Strohmenger HU, 1996, RESUSCITATION, V31, P65, DOI 10.1016/0300-9572(95)00899-3; Valenzuela TD, 2000, NEW ENGL J MED, V343, P1206, DOI 10.1056/NEJM200010263431701; van Alem AP, 2003, RESUSCITATION, V59, P181, DOI 10.1016/S0300-9572(03)00208-9; Werther T, 2009, RESUSCITATION, V80, P1301, DOI 10.1016/j.resuscitation.2009.07.020; White RD, 2002, RESUSCITATION, V55, P17, DOI 10.1016/S0300-9572(02)00194-6; Wik L, 2003, JAMA-J AM MED ASSOC, V289, P1389, DOI 10.1001/jama.289.11.1389; Wu XB, 2013, RESUSCITATION, V84, P1704, DOI 10.1016/j.resuscitation.2013.08.005; Yang ZJ, 2005, RESUSCITATION, V64, P31, DOI 10.1016/j.resuscitation.2004.07.002	39	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149115	10.1371/journal.pone.0149115	http://dx.doi.org/10.1371/journal.pone.0149115			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863222	gold, Green Published, Green Submitted			2022-12-27	WOS:000370046600155
J	Li, SX; Kyvik, KO; Pang, ZC; Zhang, DF; Duan, HP; Tan, QH; Hjelmborg, J; Kruse, T; Dalgard, C				Li, Shuxia; Kyvik, Kirsten Ohm; Pang, Zengchang; Zhang, Dongfeng; Duan, Haiping; Tan, Qihua; Hjelmborg, Jacob; Kruse, Torben; Dalgard, Christine			Genetic and Environmental Regulation on Longitudinal Change of Metabolic Phenotypes in Danish and Chinese Adult Twins	PLOS ONE			English	Article							BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; HERITABILITY; LIPIDS; MODEL; INDEX; MASS; COMPONENTS; GLUCOSE; TRAITS	Objective The rate of change in metabolic phenotypes can be highly indicative of metabolic disorders and disorder-related modifications. We analyzed data from longitudinal twin studies on multiple metabolic phenotypes in Danish and Chinese twins representing two populations of distinct ethnic, cultural, social-economic backgrounds and geographical environments. Materials and Methods The study covered a relatively large sample of 502 pairs of Danish adult twins followed up for a long period of 12 years with a mean age at intake of 38 years (range: 18-65) and a total of 181 Chinese adult twin pairs traced for about 7 years with a mean baseline age of 39.5 years (range: 23-64). The classical twin models were fitted to the longitudinal change in each phenotype (Delta phenotype) to estimate the genetic and environmental contributions to the variation in Xi phenotype. Results Moderate to high contributions by the unique environment were estimated for all phenotypes in both Danish (from 0.51 for low density lipoprotein cholesterol up to 0.72 for triglycerides) and Chinese (from 0.41 for triglycerides up to 0.73 for diastolic blood pressure) twins; low to moderate genetic components were estimated for long-term change in most of the phenotypes in Danish twins except for triglycerides and hip circumference. Compared with Danish twins, the Chinese twins tended to have higher genetic control over the longitudinal changes in lipids ( except high density lipoprotein cholesterol) and glucose, higher unique environmental contribution to blood pressure but no genetic contribution to longitudinal change in body mass traits. Conclusion Our results emphasize the major contribution of unique environment to the observed intraindividual variation in all metabolic phenotypes in both samples, and meanwhile reveal differential patterns of genetic and common environmental regulation on changes over time in metabolic phenotypes across the two samples.	[Li, Shuxia; Tan, Qihua; Kruse, Torben] Univ Southern Denmark, Human Genet Unit, Dept Clin Res, Odense, Denmark; [Kyvik, Kirsten Ohm] Univ Southern Denmark, Dept Clin Res, Odense, Denmark; [Kyvik, Kirsten Ohm] Odense Univ Hosp, Odense Patient Data Explorat Network OPEN, DK-5000 Odense, Denmark; [Pang, Zengchang; Duan, Haiping] Qingdao Ctr Dis Control & Prevent, Qingdao, Peoples R China; [Zhang, Dongfeng] Qingdao Univ, Coll Med, Dept Publ Hlth, Qingdao 266071, Peoples R China; [Tan, Qihua; Hjelmborg, Jacob] Univ Southern Denmark, Epidemiol Biostat & Biodemog, Dept Publ Hlth, Odense, Denmark; [Dalgard, Christine] Univ Southern Denmark, Environm Med, Dept Publ Hlth, Odense, Denmark	University of Southern Denmark; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; Qingdao University; University of Southern Denmark; University of Southern Denmark	Li, SX (corresponding author), Univ Southern Denmark, Human Genet Unit, Dept Clin Res, Odense, Denmark.	sli@health.sdu.dk	Hjelmborg, Jacob/AAN-5966-2020; Tan, Qihua/AAG-2582-2019; Kyvik, Kirsten O/K-5680-2016; Tan, Qihua/F-1349-2015	Hjelmborg, Jacob/0000-0001-9630-9149; Tan, Qihua/0000-0003-3194-0030; Kyvik, Kirsten O/0000-0003-2981-0245; Tan, Qihua/0000-0003-3194-0030; Li, Shuxia/0000-0001-8095-3175; Dalgard, Christine/0000-0001-8184-3429	Region of South Denmark [127676]; Faculty of Health Science, University of Southern Denmark; Interreg 4a Southern Denmark-Schleswig-KERN - European Regional Development Fund; National Institute of Aging-National Institutes of Health, U.S.; Danish Research Council for Health and Disease; Danish Diabetes Association; NOVO Foundation; Danish Heart Foundation	Region of South Denmark; Faculty of Health Science, University of Southern Denmark; Interreg 4a Southern Denmark-Schleswig-KERN - European Regional Development Fund; National Institute of Aging-National Institutes of Health, U.S.; Danish Research Council for Health and Disease; Danish Diabetes Association; NOVO Foundation; Danish Heart Foundation	This study was supported by the Region of South Denmark PhD Grant 2012 j.nr. 127676 and the PhD grant from the Faculty of Health Science, University of Southern Denmark. The GEMINAKAR cohort study was supported by grants from Interreg 4a Southern Denmark-Schleswig-KERN funded by the European Regional Development Fund, National Institute of Aging-National Institutes of Health, U.S., the Danish Research Council for Health and Disease, The Danish Diabetes Association, The NOVO Foundation, and The Danish Heart Foundation.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Almgren P, 2011, DIABETOLOGIA, V54, P2811, DOI 10.1007/s00125-011-2267-5; Andreassi MG, 2009, MUTAT RES-FUND MOL M, V667, P35, DOI 10.1016/j.mrfmmm.2008.10.018; Austin MA, 1997, OBES RES, V5, P326, DOI 10.1002/j.1550-8528.1997.tb00559.x; Benyamin B, 2007, DIABETOLOGIA, V50, P1880, DOI 10.1007/s00125-007-0758-1; Bi ZQ, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130423; Blumenthal RS, 2005, ADV STUD MED, V5, ps496; Brown IJ, 2009, INT J EPIDEMIOL, V38, P791, DOI 10.1093/ije/dyp139; Duan HP, 2011, OBESITY FACTS, V4, P99, DOI 10.1159/000327735; Dubois L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030153; EAVES LJ, 1988, BEHAV GENET, V18, P27, DOI 10.1007/BF01067073; Fenger M, 2007, ATHEROSCLEROSIS, V191, P40, DOI 10.1016/j.atherosclerosis.2006.04.024; Ford ES, 2005, DIABETES CARE, V28, P1769, DOI 10.2337/diacare.28.7.1769; Fran CE, 2007, TWIN RES HUM GENET, V10, P537, DOI 10.1375/twin.10.4.537; Friedlander Y, 1997, AM J HUM GENET, V60, P1502, DOI 10.1086/515462; Goode EL, 2007, TWIN RES HUM GENET, V10, P703, DOI 10.1375/twin.10.5.703; Henneman P, 2008, J MED GENET, V45, P572, DOI 10.1136/jmg.2008.058388; Hjelmborg JVB, 2008, OBESITY, V16, P847, DOI 10.1038/oby.2007.135; Knudsen VK, 2012, FOOD NUTR RES, V56, DOI 10.3402/fnr.v56i0.17129; Koenis MMG, 2013, J CLIN ENDOCR METAB, V98, pE518, DOI 10.1210/jc.2012-3361; Li SX, 2014, HYPERTENS RES, V37, P954, DOI 10.1038/hr.2014.95; Li SX, 2013, OBESITY, V21, P1908, DOI 10.1002/oby.20217; Middelberg RP, 2006, TWIN RES HUM GENET, V9, P550, DOI 10.1375/twin.9.4.550; Middelberg RPS, 2007, TWIN RES HUM GENET, V10, P127, DOI 10.1375/twin.10.1.127; Ozaki K, 2011, BEHAV GENET, V41, P329, DOI 10.1007/s10519-010-9386-5; Panizzon MS, 2013, PSYCHONEUROENDOCRINO, V38, P2163, DOI 10.1016/j.psyneuen.2013.04.003; Peng YG, 2014, AM J CLIN NUTR, V100, P1448, DOI 10.3945/ajcn.114.089235; Phillips CM, 2013, NUTRIENTS, V5, P32, DOI 10.3390/nu5010032; Qin Y, 2014, J AM SOC HYPERTENS, V8, P909, DOI 10.1016/j.jash.2014.09.018; Rijsdijk Fruhling V, 2002, Brief Bioinform, V3, P119, DOI 10.1093/bib/3.2.119; Schousboe K, 2004, INT J OBESITY, V28, P39, DOI 10.1038/sj.ijo.0802524; Schousboe K, 2003, DIABETOLOGIA, V46, P1276, DOI 10.1007/s00125-003-1165-x; Schubert CM, 2006, INT J OBESITY, V30, P251, DOI 10.1038/sj.ijo.0803129; Shah SH, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.11; Silventoinen K, 2007, INT J OBESITY, V31, P615, DOI 10.1038/sj.ijo.0803577; Tan Qihua, 2014, BMC Proc, V8, pS82, DOI 10.1186/1753-6561-8-S1-S82; Turiano NA, 2012, J GERONTOL B-PSYCHOL, V67, P4, DOI 10.1093/geronb/gbr072; van Dongen J, 2013, J LIPID RES, V54, P2914, DOI 10.1194/jlr.P041673; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Yan L, 2011, CURR CARDIOVASC RISK, V5, P180, DOI 10.1007/s12170-011-0156-6; Yang S-S., 2010, CROSS CULTURAL COMMU, V6, P75, DOI DOI 10.3968/j.ccc.1923670020100602.009; Yousri NA, 2014, METABOLOMICS, V10, P1005, DOI 10.1007/s11306-014-0629-y; Yu ZH, 2012, AGING CELL, V11, P960, DOI 10.1111/j.1474-9726.2012.00865.x; Zabaneh D, 2009, DIABETOLOGIA, V52, P2585, DOI 10.1007/s00125-009-1504-7; Zarkesh M, 2012, GENET RES, V94, P331, DOI 10.1017/S001667231200050X; Zhang SC, 2010, PEDIATR RES, V68, P316, DOI 10.1203/00006450-201011001-00618; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546	47	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148396	10.1371/journal.pone.0148396	http://dx.doi.org/10.1371/journal.pone.0148396			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862898	gold, Green Published			2022-12-27	WOS:000370046600062
J	Lundberg, K; Rydnert, F; Broos, S; Andersson, M; Greiff, L; Lindstedt, M				Lundberg, Kristina; Rydnert, Frida; Broos, Sissela; Andersson, Morgan; Greiff, Lennart; Lindstedt, Malin			Allergen-Specific Immunotherapy Alters the Frequency, as well as the FcR and CLR Expression Profiles of Human Dendritic Cell Subsets	PLOS ONE			English	Article							HUMAN BLOOD; CROSS-PRESENTATION; STEADY-STATE; ANTIGEN; RECEPTORS; RECOGNITION; EFFICIENT; RESPONSES; COMPLEX; T(H)2	Allergen-specific immunotherapy (AIT) induces tolerance and shifts the Th2 response towards a regulatory T-cell profile. The underlying mechanisms are not fully understood, but dendritic cells (DC) play a vital role as key regulators of T-cell responses. DCs interact with allergens via Fc receptors (FcRs) and via certain C-type lectin receptors (CLRs), including CD209/DC-SIGN, CD206/MR and Dectin-2/CLEC6A. In this study, the effect of AIT on the frequencies as well as the FcR and CLR expression profiles of human DC subsets was assessed. PBMC was isolated from peripheral blood from seven allergic donors before and after 8 weeks and 1 year of subcutaneous AIT, as well as from six non-allergic individuals. Cells were stained with antibodies against DC subset-specific markers and a panel of FcRs and CLRs and analyzed by flow cytometry. After 1 year of AIT, the frequency of CD123(+) DCs was increased and a larger proportion expressed Fc epsilon RI. Furthermore, the expression of CD206 and Dectin-2 was reduced on CD141(+) DCs after 1 year of treatment and CD206 as well as Dectin-1 was additionally down regulated in CD1c(+) DCs. Interestingly, levels of DNGR1/CLEC9A on CD141(+) DCs were increased by AIT, reaching levels similar to cells isolated from non-allergic controls. The modifications in phenotype and occurrence of specific DC subsets observed during AIT suggest an altered capacity of DC subsets to interact with allergens, which can be part of the mechanisms by which AIT induces allergen tolerance.	[Lundberg, Kristina; Rydnert, Frida; Broos, Sissela; Lindstedt, Malin] Lund Univ, Dept Immunotechnol, Lund, Sweden; [Andersson, Morgan; Greiff, Lennart] Skane Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Lund, Sweden	Lund University; Lund University; Skane University Hospital	Lundberg, K (corresponding author), Lund Univ, Dept Immunotechnol, Lund, Sweden.	kristina.lundberg@immun.lth.se	Lindstedt, Malin/A-3855-2009	Lindstedt, Malin/0000-0001-9136-1087	Signhild Engkvist foundation; Faculty of Engineering (LTH); Skane County Council Research Foundation; Lund University Research Foundation (ALF)	Signhild Engkvist foundation; Faculty of Engineering (LTH); Skane County Council Research Foundation; Lund University Research Foundation (ALF)	This study was funded by grants from Signhild Engkvist foundation, Faculty of Engineering (LTH), Skane County Council Research Foundation and Lund University Research Foundation (ALF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis M, 2014, J ALLERGY CLIN IMMUN, V133, P621, DOI 10.1016/j.jaci.2013.12.1088; Barrett NA, 2011, J EXP MED, V208, P593, DOI 10.1084/jem.20100793; Boltjes A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00131; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; Dreschler K, 2011, J ALLERGY CLIN IMMUN, V127, P487, DOI 10.1016/j.jaci.2010.12.003; Farrell E, 2007, ALLERGY, V62, P1139, DOI 10.1111/j.1398-9995.2007.01465.x; Flinsenberg TWH, 2012, BLOOD, V120, P5163, DOI 10.1182/blood-2012-06-434498; Guilliams M, 2014, NAT REV IMMUNOL, V14, P94, DOI 10.1038/nri3582; Herzenberg LA, 2006, NAT IMMUNOL, V7, P681, DOI 10.1038/ni0706-681; Huang HJ, 2011, MUCOSAL IMMUNOL, V4, P519, DOI 10.1038/mi.2011.17; Hulse KE, 2008, J ALLERGY CLIN IMMUN, V121, P756, DOI 10.1016/j.jaci.2007.10.016; Joetham A, 2011, J IMMUNOL, V186, P113, DOI 10.4049/jimmunol.1001663; Joffre OP, 2010, EUR J IMMUNOL, V40, P1255, DOI 10.1002/eji.201040419; Joo H, 2015, J IMMUNOL, V195, P1723, DOI 10.4049/jimmunol.1402276; Kool M, 2009, J IMMUNOL, V183, P1074, DOI 10.4049/jimmunol.0900471; Li DP, 2012, J EXP MED, V209, P109, DOI 10.1084/jem.20110399; Lilly LM, 2012, J IMMUNOL, V189, P3653, DOI 10.4049/jimmunol.1201797; Lundberg K, 2008, CLIN IMMUNOL, V128, P358, DOI 10.1016/j.clim.2008.04.011; Lundberg K, 2014, IMMUNOLOGY, V142, P279, DOI 10.1111/imm.12252; Lundberg K, 2010, HUM IMMUNOL, V71, P931, DOI 10.1016/j.humimm.2010.07.008; Nouri-Aria KT, 2004, J IMMUNOL, V172, P3252, DOI 10.4049/jimmunol.172.5.3252; Osorio F, 2011, IMMUNITY, V34, P651, DOI 10.1016/j.immuni.2011.05.001; Palomares O, 2012, J ALLERGY CLIN IMMUN, V129, P510, DOI 10.1016/j.jaci.2011.09.031; Pulendran B, 2010, NAT IMMUNOL, V11, P647, DOI 10.1038/ni.1894; Royer PJ, 2010, J IMMUNOL, V185, P1522, DOI 10.4049/jimmunol.1000774; Rydnert F, 2014, IMMUNOL CELL BIOL, V92, P557, DOI 10.1038/icb.2014.23; Salazar F, 2013, J ALLERGY CLIN IMMUN, V132, P27, DOI 10.1016/j.jaci.2013.02.001; Schreibelt G, 2012, BLOOD, V119, P2284, DOI 10.1182/blood-2011-08-373944; Shreffler WG, 2006, J IMMUNOL, V177, P3677, DOI 10.4049/jimmunol.177.6.3677; Tel J, 2013, J IMMUNOL, V191, P5005, DOI 10.4049/jimmunol.1300787; Vittorakis S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/231036; Wang CM, 2013, ANN ALLERG ASTHMA IM, V110, P107, DOI 10.1016/j.anai.2012.11.019; Yu CI, 2014, J IMMUNOL, V193, P4335, DOI 10.4049/jimmunol.1401159	34	10	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148838	10.1371/journal.pone.0148838	http://dx.doi.org/10.1371/journal.pone.0148838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863539	gold, Green Submitted, Green Published			2022-12-27	WOS:000370046600113
J	Marchal, S; Bregeras, O; Puaux, D; Gervais, R; Ferry, B				Marchal, Sophie; Bregeras, Olivier; Puaux, Didier; Gervais, Remi; Ferry, Barbara			Rigorous Training of Dogs Leads to High Accuracy in Human Scent Matching-To-Sample Performance	PLOS ONE			English	Article							CANIS-FAMILIARIS; IDENTIFICATION; BLOODHOUNDS; RELIABILITY; DETECTORS; EFFICACY; ODORANT	Human scent identification is based on a matching-to-sample task in which trained dogs are required to compare a scent sample collected from an object found at a crime scene to that of a suspect. Based on dogs' greater olfactory ability to detect and process odours, this method has been used in forensic investigations to identify the odour of a suspect at a crime scene. The excellent reliability and reproducibility of the method largely depend on rigor in dog training. The present study describes the various steps of training that lead to high sensitivity scores, with dogs matching samples with 90% efficiency when the complexity of the scents presented during the task in the sample is similar to that presented in the in lineups, and specificity reaching a ceiling, with no false alarms in human scent matching-to-sample tasks. This high level of accuracy ensures reliable results in judicial human scent identification tests. Also, our data should convince law enforcement authorities to use these results as official forensic evidence when dogs are trained appropriately.	[Marchal, Sophie; Bregeras, Olivier; Puaux, Didier] Cent Serv Judicial Ident, Cent Direct Judicial Police, DTSP, Forens Sect, 31 Ave Franklin Roosevelt, F-69134 Ecully, France; [Gervais, Remi; Ferry, Barbara] Univ Lyon 1, Ctr Rech Neurosci Lyon, UMR CNRS 5292, INSERM U1028, 50 Ave Tony Garnier, F-69366 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet	Ferry, B (corresponding author), Univ Lyon 1, Ctr Rech Neurosci Lyon, UMR CNRS 5292, INSERM U1028, 50 Ave Tony Garnier, F-69366 Lyon, France.	barbara.ferry@cnrs.fr	Ferry, Barbara/N-6685-2014; Gervais, Remi/O-4470-2017	Ferry, Barbara/0000-0001-5191-3035; Gervais, Remi/0000-0001-8658-9490	LABEX CORTEX of Universite de Lyon [ANR-11-LABX-0042]; "Investissements d'Avenir" [ANR-11-IDEX-0007]	LABEX CORTEX of Universite de Lyon; "Investissements d'Avenir"(French National Research Agency (ANR))	The analysis, interpretation of data and the writing of the report were supported by the LABEX CORTEX of Universite de Lyon; Grant number: ANR-11-LABX-0042; Grant sponsor: "Investissements d'Avenir" operated by the French National Research Agency (ANR); Grant number: ANR-11-IDEX-0007.	BRISBIN IL, 1991, ANIM BEHAV, V42, P63, DOI 10.1016/S0003-3472(05)80606-2; Chaput MA, 2012, EUR J NEUROSCI, V35, P584, DOI 10.1111/j.1460-9568.2011.07976.x; Curran AM, 2007, J CHROMATOGR B, V846, P86, DOI 10.1016/j.jchromb.2006.08.039; Curran AM, 2010, FORENSIC SCI INT, V199, P103, DOI 10.1016/j.forsciint.2010.03.021; Curran AM, 2005, FORENSIC SCI COMMUN, V7, P1; Ensminger J, 2012, POLICE MILITARY DOGS, P101; Furton KG, 2001, TALANTA, V54, P487, DOI 10.1016/S0039-9140(00)00546-4; GROSSISSEROFF R, 1988, CHEM SENSES, V13, P191, DOI 10.1093/chemse/13.2.191; Harvey LM, 2006, J FORENSIC SCI, V51, P1109, DOI 10.1111/j.1556-4029.2006.00231.x; Harvey LM, 2003, J FORENSIC SCI, V48, P811; HEPPER PG, 1988, PERCEPTION, V17, P549, DOI 10.1068/p170549; Jezierski T, 2008, POL PSYCHOL B, V39, P71, DOI [10.2478/v10059-008-0010-y., DOI 10.2478/V10059-008-0010-Y]; Jezierski T, 2014, FORENSIC SCI INT, V237, P112, DOI 10.1016/j.forsciint.2014.01.013; KALMUS H., 1955, BRIT JOUR ANIMAL BEHAVIOUR, V3, P25, DOI 10.1016/S0950-5601(55)80072-X; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Kay LM, 2005, BEHAV NEUROSCI, V119, P726, DOI 10.1037/0735-7044.119.3.726; Laing DG, 2001, CHIMIA, V55, P413; Leitch O, 2013, FORENSIC SCI INT, V232, P92, DOI 10.1016/j.forsciint.2013.07.004; Lit L, 2011, ANIM COGN, V14, P387, DOI 10.1007/s10071-010-0373-2; Locard E., 1934, POLICE METHODES SCI; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; Nowlan M, 2007, J FORENSIC SCI, V52, P643, DOI 10.1111/j.1556-4029.2007.00408.x; Oesterhelweg L, 2008, FORENSIC SCI INT, V174, P35, DOI 10.1016/j.forsciint.2007.02.031; Ostrovskaya A, 2002, J COSMET SCI, V53, P147; Penn DJ, 2007, J R SOC INTERFACE, V4, P331, DOI 10.1098/rsif.2006.0182; Pinc L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020704; Roberts SC, 2005, CHEM SENSES, V30, P651, DOI 10.1093/chemse/bji058; Romanes GJ., 1887, NATURE, V36, P273; Schoon GAA, 1996, APPL ANIM BEHAV SCI, V49, P257, DOI 10.1016/0168-1591(95)00656-7; Schoon GAA, 1998, J FORENSIC SCI, V43, P70; SCHOON GAA, 1994, FORENSIC SCI INT, V69, P111, DOI 10.1016/0379-0738(94)90247-X; Schwartz B, 2002, PSYCHOL LEARNING BEH, P298; SOMMERVILLE BA, 1993, ANIM BEHAV, V46, P189, DOI 10.1006/anbe.1993.1174; Stockham RA, 2004, FORENSIC SCI COMM, V6; STOCKHAM RA, 2004, FORENSIC SCI COMMUNI, V6, P4; TASLITZ AE, 1990, HASTINGS LAW J, V42, P15; Williams M, 2002, APPL ANIM BEHAV SCI, V78, P55, DOI 10.1016/S0168-1591(02)00081-3; Xu Y, 2007, ANAL CHEM, V79, P5633, DOI 10.1021/ac070134w; Zubedat S, 2014, APPL ANIM BEHAV SCI, V158, P69, DOI 10.1016/j.applanim.2014.05.004	40	35	36	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0146963	10.1371/journal.pone.0146963	http://dx.doi.org/10.1371/journal.pone.0146963			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863620	gold, Green Published, Green Submitted			2022-12-27	WOS:000370046600015
J	Wieck, MM; Spurrier, RG; Levin, DE; Mojica, SG; Hiatt, MJ; Reddy, R; Hou, XG; Navarro, S; Lee, J; Lundin, A; Driscoll, B; Grikscheit, TC				Wieck, Minna M.; Spurrier, Ryan G.; Levin, Daniel E.; Mojica, Salvador Garcia; Hiatt, Michael J.; Reddy, Raghava; Hou, Xiaogang; Navarro, Sonia; Lee, Jooeun; Lundin, Amber; Driscoll, Barbara; Grikscheit, Tracy C.			Sequestration of Vascular Endothelial Growth Factor (VEGF) Induces Late Restrictive Lung Disease	PLOS ONE			English	Article							RESPIRATORY-DISTRESS; DOWN-REGULATION; CROSS-TALK; EXPRESSION; INHIBITION; ANGIOGENESIS; HYPEROXIA; CELLS; MMP-9; EPITHELIUM	Rationale Neonatal respiratory distress syndrome is a restrictive lung disease characterized by surfactant deficiency. Decreased vascular endothelial growth factor (VEGF), which demonstrates important roles in angiogenesis and vasculogenesis, has been implicated in the pathogenesis of restrictive lung diseases. Current animal models investigating VEGF in the etiology and outcomes of RDS require premature delivery, hypoxia, anatomically or temporally limited inhibition, or other supplemental interventions. Consequently, little is known about the isolated effects of chronic VEGF inhibition, started at birth, on subsequent developing lung structure and function. Objectives To determine whether inducible, mesenchyme-specific VEGF inhibition in the neonatal mouse lung results in long-term modulation of AECII and whole lung function. Methods Triple transgenic mice expressing the soluble VEGF receptor sFlt-1 specifically in the mesenchyme (Dermo-1/rtTA/sFlt-1) were generated and compared to littermate controls at 3 months to determine the impact of neonatal downregulation of mesenchymal VEGF expression on lung structure, cell composition and function. Reduced tissue VEGF bioavailability has previously been demonstrated with this model. Measurements and Main Results Triple transgenic mice demonstrated restrictive lung pathology. No differences in gross vascular development or protein levels of vascular endothelial markers was noted, but there was a significant decrease in perivascular smooth muscle and type I collagen. Mutants had decreased expression levels of surfactant protein C and hypoxia inducible factor 1-alpha without a difference in number of type II pneumocytes. Conclusions These data show that mesenchyme-specific inhibition of VEGF in neonatal mice results in late restrictive disease, making this transgenic mouse a novel model for future investigations on the consequences of neonatal RDS and potential interventions.	[Wieck, Minna M.; Spurrier, Ryan G.; Levin, Daniel E.; Mojica, Salvador Garcia; Hou, Xiaogang; Grikscheit, Tracy C.] Childrens Hosp Los Angeles, Saban Res Inst, Div Pediat Surg, Los Angeles, CA 90027 USA; [Hiatt, Michael J.; Reddy, Raghava; Navarro, Sonia; Lee, Jooeun; Lundin, Amber; Driscoll, Barbara; Grikscheit, Tracy C.] Childrens Hosp Los Angeles, Dev Biol & Regenerat Med Program, Saban Res Inst, Los Angeles, CA 90027 USA; [Navarro, Sonia] Univ So Calif, Herman Ostrow Sch Dent, Los Angeles, CA USA; [Driscoll, Barbara] Univ So Calif, Keck Sch Med, Integrat Biol Dis Grad Program, Los Angeles, CA 90033 USA	Children's Hospital Los Angeles; Children's Hospital Los Angeles; University of Southern California; University of Southern California	Grikscheit, TC (corresponding author), Childrens Hosp Los Angeles, Saban Res Inst, Div Pediat Surg, Los Angeles, CA 90027 USA.; Grikscheit, TC (corresponding author), Childrens Hosp Los Angeles, Dev Biol & Regenerat Med Program, Saban Res Inst, Los Angeles, CA 90027 USA.	tgrikscheit@chla.usc.edu			California Institute for Regenerative Medicine [RN 2 00946-1, RN 3 06425]	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine)	Support was provided by California Institute for Regenerative Medicine (https://www.cirm.ca.gov/) RN 2 00946-1 and RN 3 06425. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown KRS, 2001, AM J PHYSIOL-LUNG C, V281, pL1001, DOI 10.1152/ajplung.2001.281.4.L1001; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chun YS, 2002, J KOREAN MED SCI, V17, P581, DOI 10.3346/jkms.2002.17.5.581; Clement A, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-22; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; De Santis M, 2012, ANN RHEUM DIS, V71, P1461, DOI 10.1136/annrheumdis-2011-200657; Dishop MK, 2011, PAEDIATR RESPIR REV, V12, P230, DOI 10.1016/j.prrv.2011.01.002; Domigan CK, 2014, CELL, V159, P473, DOI 10.1016/j.cell.2014.10.008; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Glasser SW, 2003, J BIOL CHEM, V278, P14291, DOI 10.1074/jbc.M210909200; Greenberg JM, 2014, DEV DYNAM, V224, P144; Greenough A, 2008, NEONATOLOGY, V93, P324, DOI 10.1159/000121459; Hawinkels LJAC, 2008, EUR J CANCER, V44, P1904, DOI 10.1016/j.ejca.2008.06.031; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Hollborn M, 2007, INVEST OPHTH VIS SCI, V48, P4360, DOI 10.1167/iovs.06-1234; Jakkula M, 2000, AM J PHYSIOL-LUNG C, V279, pL600, DOI 10.1152/ajplung.2000.279.3.L600; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Klekamp JG, 1999, AM J PATHOL, V154, P823, DOI 10.1016/S0002-9440(10)65329-1; Knudsen L, 2010, J APPL PHYSIOL, V108, P412, DOI 10.1152/japplphysiol.01100.2009; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Lakka SS, 2002, ONCOGENE, V21, P5601, DOI 10.1038/sj.onc.1205646; Landry JS, 2014, AM J RESP CRIT CARE, pA2337; Larsen AK, 2011, PHARMACOL THERAPEUT, V131, P80, DOI 10.1016/j.pharmthera.2011.03.012; Lassus P, 2001, AM J RESP CRIT CARE, V164, P1981, DOI 10.1164/ajrccm.164.10.2012036; Lau AC, 2008, ARTHRITIS RHEUM-US, V58, P854, DOI 10.1002/art.23225; Le Cras TD, 2002, AM J PHYSIOL-LUNG C, V283, pL555, DOI 10.1152/ajplung.00408.2001; Levesque BM, 2014, NEONATOLOGY, V104, P56; Lichtenberger BM, 2010, CELL, V140, P268, DOI 10.1016/j.cell.2009.12.046; Liu FL, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-88; Maharaj ASR, 2006, AM J PATHOL, V168, P639, DOI 10.2353/ajpath.2006.050834; Mallampalli RK, 2015, ANNALS OF THE AMERIC; Matthews JA, 2012, J SURG RES, V172, P40, DOI 10.1016/j.jss.2011.04.043; Meller S, 2012, EXP LUNG RES, V38, P192, DOI 10.3109/01902148.2012.663454; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; MUSTONEN T, 1995, J CELL BIOL, V129, P895, DOI 10.1083/jcb.129.4.895; Nogee LM, 2004, ANNU REV PHYSIOL, V66, P601, DOI 10.1146/annurev.physiol.66.032102.134711; Olszewska-Pazdrak B, 2009, AM J PHYSIOL-CELL PH, V296, pC1162, DOI 10.1152/ajpcell.00533.2008; Perkett EA, 1998, CHEST, V114, p52S, DOI 10.1378/chest.114.1_Supplement.52S; Rovina N, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-53; Saini Y, 2008, J BIOL CHEM, V283, P33650, DOI 10.1074/jbc.M805927200; Sanchez-Esteban J, 2012, AM J RESP CELL MOL B, V30, P76; Santos S, 2003, AM J RESP CRIT CARE, V167, P1250, DOI 10.1164/rccm.200210-1233OC; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Siu MKY, 2003, ENDOCRINOLOGY, V144, P371, DOI 10.1210/en.2002-220786; Soll R., 1998, COCHRANE DB SYST REV, V1998, DOI [10.1002/14651858.CD001149, DOI 10.1002/14651858.CD001149]; Takahashi Y, 2013, INT J MED SCI, V10, P1702, DOI 10.7150/ijms.7114; Thebaud B, 2005, CIRCULATION, V112, P2477, DOI 10.1161/CIRCULATIONAHA.105.541524; Todorova L, 2010, RESP MED, V104, P1799, DOI 10.1016/j.rmed.2010.06.015; Tsao PN, 2005, PEDIATR PULM, V39, P461, DOI 10.1002/ppul.20205; Tuder RM, 2003, AM J RESP CELL MOL, V29, P88, DOI 10.1165/rcmb.2002-0228OC; Vadivel A, 2014, AM J RESP CELL MOL, V50, P96, DOI 10.1165/rcmb.2012-0250OC; White AC, 2007, DEVELOPMENT, V134, P3743, DOI 10.1242/dev.004879; Whitsett JA, 2015, ANNU REV PATHOL-MECH, V10, P371, DOI 10.1146/annurev-pathol-012513-104644; Yamamoto H, 2007, DEV BIOL, V308, P44, DOI 10.1016/j.ydbio.2007.04.042; Zhang X, 2012, FASEB J, V26, P2338, DOI 10.1096/fj.11-200139; Zhao LQ, 2005, MECH DEVELOP, V122, P877, DOI 10.1016/j.mod.2005.04.001; Zhong H, 2000, CANCER RES, V60, P1541	59	7	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148323	10.1371/journal.pone.0148323	http://dx.doi.org/10.1371/journal.pone.0148323			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863115	Green Submitted, Green Published, gold			2022-12-27	WOS:000370046600055
J	Chen, JH; He, JC; Chen, YY; Xu, JJ; Wu, HR; Wang, FF; Lu, F; Jiang, J				Chen, Junhong; He, Ji C.; Chen, Yunyun; Xu, Jingjing; Wu, Haoran; Wang, Feifu; Lu, Fan; Jiang, Jun			Interocular Difference of Peripheral Refraction in Anisomyopic Eyes of Schoolchildren	PLOS ONE			English	Article							AXIAL LENGTH; INTRAOCULAR-PRESSURE; MYOPIC ANISOMETROPIA; OPTICAL-COMPONENTS; CHILDREN; ORTHOKERATOLOGY; CYCLOPLEGIA; PROGRESSION; PREVALENCE; ERROR	Purpose Refraction in the peripheral visual field is believed to play an important role in the development of myopia. The purpose of this study was to investigate the differences in peripheral refraction among anisomyopia, isomyopia, and isoemmetropia for schoolchildren. Methods Thirty-eight anisomyopic children were recruited and divided into two groups: (1) both eyes were myopic (anisomyopic group, AM group) and (2) one eye was myopic and the contralateral eye was emmetropic (emmetropic anisomyopic group, EAM group). As controls, 45 isomyopic and isoemmetropic children were also recruited with age and central spherical equivalent (SE) matched to those of the AM and EAM groups. The controls were divided into three groups: (1) intermediate myopia group (SE matched to the more myopic eye of AM group), (2) low myopia group (SE matched to the less myopic eye of AM group and the more myopic eye of EAM group), and (3) emmetropia group (SE matched to the less myopic eye of EAM group). Peripheral refraction at 7 points across the central +/- 30 degrees on the horizontal visual field with a 10 degrees interval was measured with an autorefractor. Axial length (AL), corneal curvature (CC), and anterior chamber depth (ACD) were also determined by using the Zeiss IOL-Master. Results The relative peripheral spherical equivalent [RPR(M)] and relative peripheral spherical value [RPR(S)] of the more myopic eye was shifted more hyperopically than the contralateral eye in both the AM and the EAM groups (both p<0.0001). The RPR(M, S) of the less myopic eyes in the AM and EAM groups showed a relatively flat trend across the visual field and were not significantly different from the emmetropia group. The RPR(M, S) of less myopic eyes in the AM group were shifted less hyperopically than in the isomyopic low myopia group and the more myopic eye of the EAM group [RPR(M), p = 0.007; RPR(S), p = 0.001], although the central SEs of the three groups were not significantly different from each other. However, RPR(M, S) of the more myopic eyes were not different from the corresponding isomyopic groups. There was also no significant difference in the relative peripheral astigmatism [RPR(J0, J45)] between the more and the less myopic eyes in either the AM or the EAM group. Conclusion Refraction of anisomyopia differs between the two eyes not only at the central visual field but also at the off-axis periphery. The relative peripheral refraction of the more myopic eye of anisomyopia was shifted hyperopically, as occurs in isomyopia with similar central subjective SE values. Less myopic eyes were much less hyperopically shifted in relative peripheral refraction than the corresponding isomyopic eyes, but are comparable to emmetropic eyes. This emmetropia-like relative peripheral refraction in less myopic eyes might be a factor responsible for slowing down the progression of myopia.	[Chen, Junhong; He, Ji C.; Chen, Yunyun; Xu, Jingjing; Wu, Haoran; Wang, Feifu; Lu, Fan; Jiang, Jun] Wenzhou Med Coll, Sch Optometry & Ophthalmol, Wenzhou, Zhejiang, Peoples R China; [He, Ji C.] New England Coll Optometry, Boston, MA USA	Wenzhou Medical University	Lu, F; Jiang, J (corresponding author), Wenzhou Med Coll, Sch Optometry & Ophthalmol, Wenzhou, Zhejiang, Peoples R China.	lufan62@mail.eye.ac.cn; jjhsj@hotmail.com		Wu, Haoran/0000-0002-2248-3547	National Natural Science Foundation of China; Natural Science Foundation of Zhejiang Province; National Key Basic Research Program [81170869, LY14H120007, 2011CB504600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); National Key Basic Research Program(National Basic Research Program of China)	The study was supported by National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province, National Key Basic Research Program, Grants 81170869, LY14H120007, and 2011CB504600. The funders had participate in the design of this study.	Adenuga OO, 2014, MIDDLE EAST AFR J OP, V21, P275, DOI 10.4103/0974-9233.134695; Atchison DA, 2006, VISION RES, V46, P1450, DOI 10.1016/j.visres.2005.10.023; Atchison DA, 2005, INVEST OPHTH VIS SCI, V46, P2698, DOI 10.1167/iovs.04-1506; Awadein A, 2011, J AAPOS, V15, P545, DOI 10.1016/j.jaapos.2011.07.008; BONOMI L, 1982, INT OPHTHALMOL, V5, P145, DOI 10.1007/BF00149143; Borchert M, 2010, OPHTHALMOLOGY, V117, P148, DOI 10.1016/j.ophtha.2009.06.008; Chen X, 2010, VISION RES, V50, P31, DOI 10.1016/j.visres.2009.10.004; Cheung SW, 2009, CLIN EXP OPTOM, V92, P476, DOI 10.1111/j.1444-0938.2009.00419.x; Cheung SW, 2004, OPTOMETRY VISION SCI, V81, P653, DOI 10.1097/01.opx.0000144742.57847.b1; Deng L, 2012, INVEST OPHTH VIS SCI, V53, P3782, DOI 10.1167/iovs.11-8727; Downie LE, 2013, EYE CONTACT LENS, V39, P303, DOI 10.1097/ICL.0b013e318298ee76; Ehsaei A, 2011, OPHTHAL PHYSL OPT, V31, P413, DOI 10.1111/j.1475-1313.2011.00838.x; Feng L, 2012, OPTOMETRY VISION SCI, V89, P507, DOI 10.1097/OPX.0b013e318249d73a; Hashemi H, 2011, OPHTHAL EPIDEMIOL, V18, P122, DOI 10.3109/09286586.2011.574333; HOOGERHEIDE J, 1971, OPHTHALMOLOGICA, V163, P209, DOI 10.1159/000306646; Huang JH, 2012, OPTOMETRY VISION SCI, V89, P1691, DOI 10.1097/OPX.0b013e3182772f4f; Jiang ZP, 2013, EYE CONTACT LENS, V39, P277, DOI 10.1097/ICL.0b013e318296790b; Kang PL, 2011, OPTOMETRY VISION SCI, V88, P476, DOI 10.1097/OPX.0b013e31820f16fb; Kim Su-Young, 2013, Korean J Ophthalmol, V27, P44, DOI 10.3341/kjo.2013.27.1.44; Kuo NW, 2011, J CHIN MED ASSOC, V74, P310, DOI 10.1016/j.jcma.2011.05.007; Kwan WCK, 2009, CLIN EXP OPTOM, V92, P304, DOI 10.1111/j.1444-0938.2009.00378.x; Lam AKC, 2003, OPHTHAL PHYSL OPT, V23, P315, DOI 10.1046/j.1475-1313.2003.00122.x; Lam CSY, 2014, BRIT J OPHTHALMOL, V98, P40, DOI 10.1136/bjophthalmol-2013-303914; Lee SMY, 2000, OPTOMETRY VISION SCI, V77, P675, DOI 10.1097/00006324-200012000-00015; Lee TT, 2013, OPHTHAL PHYSL OPT, V33, P283, DOI 10.1111/opo.12057; Liang YB, 2009, OPHTHALMOLOGY, V116, P2119, DOI 10.1016/j.ophtha.2009.04.040; Mayer DL, 2001, ARCH OPHTHALMOL-CHIC, V119, P1625; MILLERMEEKS MJ, 1990, AM J OPHTHALMOL, V109, P199, DOI 10.1016/S0002-9394(14)75987-2; MILLODOT M, 1981, AM J OPTOM PHYS OPT, V58, P691; Mutti DO, 2007, INVEST OPHTH VIS SCI, V48, P2510, DOI 10.1167/iovs.06-0562; Okamoto F, 2001, OPHTHALMOLOGICA, V215, P435, DOI 10.1159/000050904; Queiros A, 2010, OPTOMETRY VISION SCI, V87, P323, DOI 10.1097/OPX.0b013e3181d951f7; Sankaridurg P, 2011, INVEST OPHTH VIS SCI, V52, P9362, DOI 10.1167/iovs.11-7260; Saunders KJ, 2002, BRIT J OPHTHALMOL, V86, P1035, DOI 10.1136/bjo.86.9.1035; Smith EL, 2007, INVEST OPHTH VIS SCI, V48, P3914, DOI 10.1167/iovs.06-1264; Smith EL, 2009, VISION RES, V49, P2386, DOI 10.1016/j.visres.2009.07.011; Sng CCA, 2011, INVEST OPHTH VIS SCI, V52, P7880, DOI 10.1167/iovs.11-7290; Sng CCA, 2011, INVEST OPHTH VIS SCI, V52, P1181, DOI 10.1167/iovs.10-5601; SORSBY A, 1962, VISION RES, V2, P43, DOI 10.1016/0042-6989(62)90062-7; Thibos LN, 1997, OPTOMETRY VISION SCI, V74, P367, DOI 10.1097/00006324-199706000-00019; Tian Y T J, 2006, INVEST OPHTHALMOL VI, V47; Vincent SJ, 2014, CLIN EXP OPTOM, V97, P291, DOI 10.1111/cxo.12171; Vincent SJ, 2011, OPTOMETRY VISION SCI, V88, P1454, DOI 10.1097/OPX.0b013e318233ee5f; VONNOORDEN GK, 1987, INVEST OPHTH VIS SCI, V28, P750; Walline JJ, 2013, OPTOMETRY VISION SCI, V90, P1207, DOI 10.1097/OPX.0000000000000036; Wallman J, 2004, NEURON, V43, P447, DOI 10.1016/j.neuron.2004.08.008; Weiss AH, 2003, BRIT J OPHTHALMOL, V87, P1025, DOI 10.1136/bjo.87.8.1025; Yekta A, 2010, STRABISMUS, V18, P104, DOI 10.3109/09273972.2010.502957; Yuksel N, 2014, J AAPOS, V18, P248, DOI 10.1016/j.jaapos.2014.01.013; Zhu MJ, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-141	50	3	4	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149110	10.1371/journal.pone.0149110	http://dx.doi.org/10.1371/journal.pone.0149110			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881745	Green Submitted, Green Published, gold			2022-12-27	WOS:000371219000046
J	Dalli, J; Sanger, JM; Rodriguez, AR; Chiang, N; Spur, BW; Serhan, CN				Dalli, Jesmond; Sanger, Julia M.; Rodriguez, Ana R.; Chiang, Nan; Spur, Bernd W.; Serhan, Charles N.			Identification and Actions of a Novel Third Maresin Conjugate in Tissue Regeneration: MCTR3	PLOS ONE			English	Article							LIPID MEDIATORS; RESOLUTION; RESOLVIN; INFLAMMATION; INFECTION; PATHWAYS; DISEASE	Maresin conjugates in tissue regeneration (MCTR) are a new family of evolutionarily conserved chemical signals that orchestrate host responses to promote tissue regeneration and resolution of infections. Herein, we identified the novel MCTR3 and established rank order potencies and matched the stereochemistries of MCTR1, MCTR2 and MCTR3 using material prepared by total organic synthesis and mediators isolated from both mouse and human systems. MCTR3 was produced from endogenous substrate by E. coli activated human macrophages and identified in sepsis patients. Each of the three synthetic MCTR dose-dependently (1-100nM) accelerated tissue regeneration in planaria by 0.6-0.9 days. When administered at the onset or peak of inflammation, each of the MCTR promoted resolution of E. coli infections in mice. They increased bacterial phagocytosis by exudate leukocytes (similar to 15-50%), limited neutrophil infiltration (similar to 20-50%), promoted efferocytosis (similar to 30%) and reduced eicosanoids. MCTR1 and MCTR2 upregulated human neutrophil and macrophage phagocytic responses where MCTR3 also proved to possess potent actions. These results establish the complete stereochemistry and rank order potencies for MCTR1, MCTR2 and MCTR3 that provide novel resolution moduli in regulating host responses to clear infections and promote tissue regeneration.	[Dalli, Jesmond; Sanger, Julia M.; Chiang, Nan; Serhan, Charles N.] Brigham & Womens Hosp, Harvard Inst Med, Ctr Expt Therapeut & Reperfus Injury, 75 Francis St, Boston, MA 02115 USA; [Dalli, Jesmond; Sanger, Julia M.; Chiang, Nan; Serhan, Charles N.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Rodriguez, Ana R.; Spur, Bernd W.] Rowan Univ SOM, Dept Cell Biol, Stratford, NJ USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Rowan University; Rowan University School of Osteopathic Medicine	Serhan, CN (corresponding author), Brigham & Womens Hosp, Harvard Inst Med, Ctr Expt Therapeut & Reperfus Injury, 75 Francis St, Boston, MA 02115 USA.; Serhan, CN (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	cnserhan@zeus.bwh.harvard.edu	Chiang, Nan/ABA-4924-2021	Chiang, Nan/0000-0003-1963-1585; Rodriguez Rosich, Ana/0000-0002-4802-2845; Spur, Bernd/0000-0002-7581-4741; Dalli, Jesmond/0000-0001-6328-3640	National Institutes of Health Institute of General Medical Sciences [P01GM095467]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM095467] Funding Source: NIH RePORTER	National Institutes of Health Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Institute of General Medical Sciences [Grant P01GM095467] to CNS.	Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Dalli J, 2015, FASEB J, V29, P2120, DOI 10.1096/fj.14-268441; Dalli J, 2014, P NATL ACAD SCI USA, V111, pE4753, DOI 10.1073/pnas.1415006111; Dalli J, 2013, FASEB J, V27, P2573, DOI 10.1096/fj.13-227728; El Kebir D, 2012, P NATL ACAD SCI USA, V109, P14983, DOI 10.1073/pnas.1206641109; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Haeggstrom JZ, 2004, J BIOL CHEM, V279, P50639, DOI 10.1074/jbc.R400027200; Marcon R, 2013, J IMMUNOL, V191, P4288, DOI 10.4049/jimmunol.1202743; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; NES WD, 1994, ISOPENTENOIDS OTHER; Rius B, 2014, FASEB J, V28, P836, DOI 10.1096/fj.13-235614; Rodriguez AR, 2015, TETRAHEDRON LETT, V56, P3936, DOI 10.1016/j.tetlet.2015.04.131; SAMUELSSON B, 1983, BIOSCIENCE REP, V3, P791, DOI 10.1007/BF01133779; Samuelsson B, 2012, J BIOL CHEM, V287, P10070, DOI 10.1074/jbc.X112.351437; Sanchez-Alvarado A, 2006, CELL, V124, P241, DOI 10.1016/j.cell.2006.01.012; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2013, CURR OPIN PHARMACOL, V13, P632, DOI 10.1016/j.coph.2013.05.012; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Terrando N, 2013, FASEB J, V27, P3564, DOI 10.1096/fj.13-230276; Vong L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039244	20	45	45	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149319	10.1371/journal.pone.0149319	http://dx.doi.org/10.1371/journal.pone.0149319			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881986	Green Submitted, Green Published, gold			2022-12-27	WOS:000371219000070
J	Centeno, M; Tierney, TM; Perani, S; Shamshiri, EA; StPier, K; Wilkinson, C; Konn, D; Banks, T; Vulliemoz, S; Lemieux, L; Pressler, RM; Clark, CA; Cross, JH; Carmichael, DW				Centeno, Maria; Tierney, Tim M.; Perani, Suejen; Shamshiri, Elhum A.; StPier, Kelly; Wilkinson, Charlotte; Konn, Daniel; Banks, Tina; Vulliemoz, Serge; Lemieux, Louis; Pressler, Ronit M.; Clark, Christopher A.; Cross, J. Helen; Carmichael, David W.			Optimising EEG-fMRI for Localisation of Focal Epilepsy in Children	PLOS ONE			English	Article							INTERICTAL EPILEPTIFORM DISCHARGES; RESPONSES; SURGERY; STATE; CONNECTIVITY; PATTERNS; ARTIFACT; TIME	Background Early surgical intervention in children with drug resistant epilepsy has benefits but requires using tolerable and minimally invasive tests. EEG-fMRI studies have demonstrated good sensitivity for the localization of epileptic focus but a poor yield although the reasons for this have not been systematically addressed. While adults EEG-fMRI studies are performed in the "resting state"; children are commonly sedated however, this has associated risks and potential confounds. In this study, we assessed the impact of the following factors on the tolerability and results of EEG-fMRI in children: viewing a movie inside the scanner; movement; occurrence of interictal epileptiform discharges (IED); scan duration and design efficiency. This work's motivation is to optimize EEG-fMRI parameters to make this test widely available to paediatric population Methods Forty-six children with focal epilepsy and 20 controls (6-18) underwent EEG-fMRI. For two 10 minutes sessions subjects were told to lie still with eyes closed, as it is classically performed in adult studies ("rest sessions"), for another two sessions, subjects watched a child friendly stimulation i.e. movie ("movie sessions"). IED were mapped with EEG-fMRI for each session and across sessions. The resulting maps were classified as concordant/discordant with the presumed epileptogenic focus for each subject. Findings Movement increased with scan duration, but the movie reduced movement by similar to 40% when played within the first 20 minutes. There was no effect of movie on the occurrence of IED, nor in the concordance of the test. Ability of EEG-fMRI to map the epileptogenic region was similar for the 20 and 40 minute scan durations. Design efficiency was predictive of concordance. Conclusions A child friendly natural stimulus improves the tolerability of EEG-fMRI and reduces in-scanner movement without having an effect on IED occurrence and quality of EEG-fMRI maps. This allowed us to scan children as young as 6 and obtain localising information without sedation. Our data suggest that similar to 20 minutes is the optimal length of scanning for EEG-fMRI studies in children with frequent IED. The efficiency of the fMRI design derived from spontaneous IED generation is an important factor for producing concordant results.	[Centeno, Maria; Tierney, Tim M.; Perani, Suejen; Shamshiri, Elhum A.; Banks, Tina; Clark, Christopher A.; Cross, J. Helen; Carmichael, David W.] UCL, Inst Child Hlth, Dev Imaging & Biophys Sect, London, England; [Centeno, Maria; StPier, Kelly; Wilkinson, Charlotte; Pressler, Ronit M.; Cross, J. Helen] Great Ormond St Hosp Sick Children, Epilepsy Unit, Great Ormond St, London WC1N 3JH, England; [Perani, Suejen] Kings Coll London, Inst Psychiat Psychol & Neurosci, Div Neurosci, London, England; [Konn, Daniel] Southampton Univ Hosp, Dept Neurophysiol, Southampton, Hants, England; [Vulliemoz, Serge] Univ Hosp Geneva, Neurol, EEG & Epilepsy Unit, Geneva, Switzerland; [Vulliemoz, Serge] Fac Med Geneva, Geneva, Switzerland; [Lemieux, Louis] UCL, Inst Neurol, Dept Clin & Expt Epilepsy, London, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; King's College London; University of Southampton; University of Geneva; University of Geneva; University of London; University College London	Centeno, M (corresponding author), UCL, Inst Child Hlth, Dev Imaging & Biophys Sect, London, England.; Centeno, M (corresponding author), Great Ormond St Hosp Sick Children, Epilepsy Unit, Great Ormond St, London WC1N 3JH, England.	m.centeno@ucl.ac.uk	Cross, J. Helen/ACK-3032-2022; Carmichael, David/A-5391-2009	Cross, J. Helen/0000-0001-7345-4829; Carmichael, David/0000-0001-9972-0718; Pressler, Ronit/0000-0002-2905-6839; Lemieux, Louis/0000-0003-3036-7412; Centeno, Maria/0000-0003-4801-4535	Action Medical Research grant [SP4646]; Engineering and Physical Sciences Research Council [EP/M001393/1]; James Lewis Foundation (via Great Ormond Street Hospital Children's Charity) the Child Health Research Appeal Trust; University College London Overseas Research Scholarship; NIHR Biomedical Research founding; Swiss National Science Foundation [SNF 141165]; National Institute of Health Research Great Ormond Street Hospital Biomedical Research Centre; EPSRC [EP/M001393/1] Funding Source: UKRI; Action Medical Research [1830] Funding Source: researchfish	Action Medical Research grant; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); James Lewis Foundation (via Great Ormond Street Hospital Children's Charity) the Child Health Research Appeal Trust; University College London Overseas Research Scholarship; NIHR Biomedical Research founding; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institute of Health Research Great Ormond Street Hospital Biomedical Research Centre; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Action Medical Research	This project was funded by Action Medical Research grant number SP4646. D. C. is supported by the Engineering and Physical Sciences Research Council grant EP/M001393/1. E. S. and T. T. are supported by the James Lewis Foundation (via Great Ormond Street Hospital Children's Charity) the Child Health Research Appeal Trust. E. S. is funded by University College London Overseas Research Scholarship. T. T. is founded by University College London IMPACT. S. P. is supported by NIHR Biomedical Research founding. S. V. is supported by Swiss National Science Foundation grant SNF 141165. The authors acknowledge the support of the National Institute of Health Research Great Ormond Street Hospital Biomedical Research Centre in performing this work.	Allen PJ, 1998, NEUROIMAGE, V8, P229, DOI 10.1006/nimg.1998.0361; Allen PJ, 2000, NEUROIMAGE, V12, P230, DOI 10.1006/nimg.2000.0599; An DM, 2013, EPILEPSIA, V54, P2184, DOI 10.1111/epi.12434; [Anonymous], 2014, R LANG ENV STAT COMP; Ansari SF, 2010, CHILD NERV SYST, V26, P945, DOI 10.1007/s00381-009-1056-7; Barnea-Goraly N, 2014, PEDIATR RADIOL, V44, P181, DOI 10.1007/s00247-013-2798-7; Binnie CD, 2003, LANCET NEUROL, V2, P725, DOI 10.1016/S1474-4422(03)00584-2; Centeno M, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00093; Chaudhary UJ, 2012, BRAIN, V135, P3645, DOI 10.1093/brain/aws302; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; de Bie HMA, 2012, HUM BRAIN MAPP, V33, P1189, DOI 10.1002/hbm.21280; Duncan JS, 2010, NAT REV NEUROL, V6, P537, DOI 10.1038/nrneurol.2010.131; Gotman J, 2005, P NATL ACAD SCI USA, V102, P15236, DOI 10.1073/pnas.0504935102; Gotman J, 2011, EPILEPSIA, V52, P38, DOI 10.1111/j.1528-1167.2011.03151.x; Hamandi K, 2006, NEUROIMAGE, V31, P1700, DOI 10.1016/j.neuroimage.2006.02.016; Jacobs J, 2007, EPILEPSIA, V48, P2068, DOI 10.1111/j.1528-1167.2007.01192.x; Laufs H, 2007, HUM BRAIN MAPP, V28, P1023, DOI 10.1002/hbm.20323; Lemieux L, 2008, HUM BRAIN MAPP, V29, P329, DOI 10.1002/hbm.20389; Magnuson ME, 2014, NMR BIOMED, V27, P291, DOI 10.1002/nbm.3062; Marcar VL, 2004, PEDIATR RES, V56, P104, DOI 10.1203/01.PDR.0000130479.43442.5C; Moeller F, 2013, EPILEPSIA, V54, P971, DOI 10.1111/epi.12197; Moeller F, 2010, EPILEPSIA, V51, P2000, DOI 10.1111/j.1528-1167.2010.02698.x; Murta T, 2012, NEUROIMAGE, V62, P1634, DOI 10.1016/j.neuroimage.2012.05.053; Ngugi AK, 2011, NEUROLOGY, V77, P1005, DOI 10.1212/WNL.0b013e31822cfc90; Pittau F, 2012, NEUROLOGY, V78, P1479, DOI 10.1212/WNL.0b013e3182553bf7; Rosenkranz K, 2010, MAGN RESON MATER PHY, V23, P309, DOI 10.1007/s10334-009-0196-9; Salek-Haddadi A, 2006, BRAIN RES, V1088, P148, DOI 10.1016/j.brainres.2006.02.098; Skirrow C, 2011, NEUROLOGY, V76, P1330, DOI 10.1212/WNL.0b013e31821527f0; Stamatakis EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014224; Tellez-Zenteno JF, 2005, BRAIN, V128, P1188, DOI 10.1093/brain/awh449; Thoresen M, 1997, ELECTROEN CLIN NEURO, V102, P152, DOI 10.1016/S0921-884X(96)96509-1; Thornton R, 2010, J NEUROL NEUROSUR PS, V81, P922, DOI 10.1136/jnnp.2009.196253; Tierney TM, 2016, NEUROIMAGE, V124, P1009, DOI 10.1016/j.neuroimage.2015.09.034; van Houdt P, 2013, CLIN NEUROPHYSIOL, V124, P2070, DOI 10.1016/j.clinph.2013.06.007; van Houdt PJ, 2013, NEUROIMAGE, V75, P238, DOI 10.1016/j.neuroimage.2013.02.033; Vanderwal T, 2014, NOVEL VIDEO PARADIGM; Vaudano AE, 2012, NEUROLOGY, V79, P249, DOI 10.1212/WNL.0b013e31825fdf3a; White T, 2014, BRAIN CONNECT, V4, P417, DOI 10.1089/brain.2013.0195; Wirrell EC, 2010, J CLIN NEUROPHYSIOL, V27, P239, DOI 10.1097/WNP.0b013e3181ea4288; Zijlmans M, 2007, BRAIN, V130, P2343, DOI 10.1093/brain/awm141	40	18	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149048	10.1371/journal.pone.0149048	http://dx.doi.org/10.1371/journal.pone.0149048			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872220	gold, Green Published, Green Submitted			2022-12-27	WOS:000370054100092
J	Handy, C; Yanaga, S; Reiss, A; Zona, N; Robinson, E; Saxton, KB				Handy, Christine; Yanaga, Stephanie; Reiss, Avery; Zona, Nicole; Robinson, Emily; Saxton, Katherine B.			Stress during Adolescence Alters Palatable Food Consumption in a Context-Dependent Manner	PLOS ONE			English	Article							DEPRESSION-LIKE BEHAVIORS; EARLY-LIFE STRESS; PRENATAL STRESS; FEEDING-BEHAVIOR; RESTRAINT STRESS; FEMALE RATS; ENVIRONMENTAL-INFLUENCES; INDUCED OBESITY; COMFORT FOODS; BODY-WEIGHT	Food consumption and preferences may be shaped by exposure to stressful environments during sensitive periods in development, and even small changes in consumption can have important effects on long term health. Adolescence is increasingly recognized as a sensitive period, in which adverse experiences can alter development, but the specific programming effects that may occur during adolescence remain incompletely understood. The current study seeks to explore the effects of stress during late adolescence on consumption of a palatable, high-fat, high-sugar food in adulthood-under basal conditions, as well following acute stress. Male Long-Evans rats were exposed to a regimen of variable stress for seven days in late adolescence (PND 45-51). During the stress regimen, stressed animals gained significantly less weight than control animals, but weight in adulthood was unaffected by adolescent stress. Palatable food consumption differed between experimental groups, and the direction of effect depended on context; stressed rats ate significantly more palatable food than controls upon first exposure, but ate less following an acute stressor. Leptin levels and exploratory behaviors did not differ between stressed and non-stressed groups, suggesting that other factors regulate preference for a palatable food. Altered food consumption following adolescent stress suggests that rats remain sensitive to stress during late adolescence, and that adult feeding behavior may be affected by previous adverse experiences. Such programming effects highlight adolescence as a period of plasticity, with the potential to shape long term food consumption patterns and preferences.	[Handy, Christine; Yanaga, Stephanie; Reiss, Avery; Zona, Nicole; Robinson, Emily; Saxton, Katherine B.] Santa Clara Univ, Dept Biol, Santa Clara, CA 95053 USA	Santa Clara University	Saxton, KB (corresponding author), Santa Clara Univ, Dept Biol, Santa Clara, CA 95053 USA.	ksaxton@scu.edu			Santa Clara University; Faculty Student Research Assistant Program award; Denardo Science Scholar Award	Santa Clara University; Faculty Student Research Assistant Program award; Denardo Science Scholar Award	Funds were provided by Santa Clara University, including a Faculty Student Research Assistant Program award to AR and NZ and a Denardo Science Scholar Award to ER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam TC, 2007, PHYSIOL BEHAV, V91, P449, DOI 10.1016/j.physbeh.2007.04.011; Adriani W, 2004, BEHAV PHARMACOL, V15, P341, DOI 10.1097/00008877-200409000-00005; Andersen SL, 2008, TRENDS NEUROSCI, V31, P183, DOI 10.1016/j.tins.2008.01.004; Barha CK, 2011, HIPPOCAMPUS, V21, P1216, DOI 10.1002/hipo.20829; Barker DJP, 1997, NUTRITION, V13, P807, DOI 10.1016/S0899-9007(97)00193-7; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Beery AK, 2011, NEUROSCI BIOBEHAV R, V35, P1552, DOI 10.1016/j.neubiorev.2011.03.012; Bingham B, 2011, NEUROPSYCHOPHARMACOL, V36, P896, DOI 10.1038/npp.2010.229; Bjorntorp P, 2001, Obes Rev, V2, P73, DOI 10.1046/j.1467-789x.2001.00027.x; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Brunton PJ, 2013, J ENDOCRINOL, V217, P161, DOI 10.1530/JOE-12-0540; Calvez J, 2011, PHYSIOL BEHAV, V104, P675, DOI 10.1016/j.physbeh.2011.07.012; Cartwright M, 2003, HEALTH PSYCHOL, V22, P362, DOI 10.1037/0278-6133.22.4.362; Casey BJ, 2008, ANN NY ACAD SCI, V1124, P111, DOI 10.1196/annals.1440.010; Chaby LE, 2015, ANIM BEHAV, V105, P37, DOI 10.1016/j.anbehav.2015.03.028; Clinton S, 2008, PSYCHONEUROENDOCRINO, V33, P162, DOI 10.1016/j.psyneuen.2007.10.012; Dallman MF, 2010, TRENDS ENDOCRIN MET, V21, P159, DOI 10.1016/j.tem.2009.10.004; DIETZ WH, 1994, AM J CLIN NUTR, V59, P955, DOI 10.1093/ajcn/59.5.955; Duckworth AL, 2013, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00608; Ellis BJ, 2011, DEV PSYCHOPATHOL, V23, P7, DOI 10.1017/S0954579410000611; Ely DR, 1997, PHYSIOL BEHAV, V61, P395, DOI 10.1016/S0031-9384(96)00450-7; Epel E.S., 2012, FOOD ADDICTION, P266, DOI [10.1093/med:psych/9780199738168.003.0040, DOI 10.1093/MED:PSYCH/9780199738168.003.0040]; Galvan A, 2012, DEV PSYCHOBIOL, V54, P433, DOI 10.1002/dev.20602; Gibson EL, 2006, PHYSIOL BEHAV, V89, P53, DOI 10.1016/j.physbeh.2006.01.024; Gluckman PD, 2005, P ROY SOC B-BIOL SCI, V272, P671, DOI 10.1098/rspb.2004.3001; Gugusheff JR, 2015, FASEB J, V29, P365, DOI 10.1096/fj.14-255976; Harris RBS, 1998, AM J PHYSIOL-REG I, V275, pR1928, DOI 10.1152/ajpregu.1998.275.6.R1928; Harris RBS, 2002, AM J PHYSIOL-REG I, V282, pR77, DOI 10.1152/ajpregu.2002.282.1.R77; Harris RBS, 2006, HORM BEHAV, V49, P615, DOI 10.1016/j.yhbeh.2005.12.001; Hill JO, 2009, AM J CLIN NUTR, V89, P477, DOI 10.3945/ajcn.2008.26566; Jenkins SK, 2005, COMPR CHILD ADOLES N, V28, P175, DOI 10.1080/01460860500227580; Johnson SB, 2012, J ADOLESCENT HEALTH, V51, pS34, DOI 10.1016/j.jadohealth.2012.04.021; Laviola G, 2003, NEUROSCI BIOBEHAV R, V27, P19, DOI 10.1016/S0149-7634(03)00006-X; Lesage J, 2004, J ENDOCRINOL, V181, P291, DOI 10.1677/joe.0.1810291; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Machado TD, 2013, STRESS, V16, P549, DOI 10.3109/10253890.2013.816841; Maniam J, 2012, NEUROPHARMACOLOGY, V63, P97, DOI 10.1016/j.neuropharm.2012.04.017; Martin SS, 2008, J AM COLL CARDIOL, V52, P1201, DOI 10.1016/j.jacc.2008.05.060; McCormick CM, 2008, BEHAV BRAIN RES, V187, P228, DOI 10.1016/j.bbr.2007.09.005; McCormick CM, 2010, PROG NEURO-PSYCHOPH, V34, P756, DOI 10.1016/j.pnpbp.2009.09.019; McCormick CM, 2010, BRAIN COGNITION, V72, P73, DOI 10.1016/j.bandc.2009.06.003; Miller SM, 2011, PHARMACOL BIOCHEM BE, V100, P130, DOI 10.1016/j.pbb.2011.08.002; Oliver G, 2000, PSYCHOSOM MED, V62, P853, DOI 10.1097/00006842-200011000-00016; Parker KJ, 2007, PSYCHONEUROENDOCRINO, V32, P785, DOI 10.1016/j.psyneuen.2007.05.008; Pervanidou P, 2012, METABOLISM, V61, P611, DOI 10.1016/j.metabol.2011.10.005; Pijiman FTA, 2003, BEHAV BRAIN RES, V139, P131, DOI 10.1016/S0166-4328(02)00124-9; Pohl J, 2007, BEHAV NEUROSCI, V121, P462, DOI 10.1037/0735-7044.121.3.462; Romeo RD, 2010, DEV PSYCHOBIOL, V52, P244, DOI 10.1002/dev.20437; Sanchez MM, 2001, DEV PSYCHOPATHOL, V13, P419, DOI 10.1017/S0954579401003029; Sandoval DA, 2003, J DIABETES COMPLICAT, V17, P108, DOI 10.1016/S1056-8727(02)00167-8; Saul ML, 2012, BEHAV BRAIN RES, V229, P226, DOI 10.1016/j.bbr.2012.01.022; Schmidt MV, 2006, J NEUROENDOCRINOL, V18, P865, DOI 10.1111/j.1365-2826.2006.01482.x; STEINBERG H, 1960, NATURE, V185, P615, DOI 10.1038/185615a0; Story M, 2002, J AM DIET ASSOC, V102, pS40, DOI 10.1016/S0002-8223(02)90421-9; Tamashiro KLK, 2009, DIABETES, V58, P1116, DOI 10.2337/db08-1129; Taylor PD, 2007, EXP PHYSIOL, V92, P287, DOI 10.1113/expphysiol.2005.032854; Toledo-Rodriguez M, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00017; Tomiyama AJ, 2012, PHYSIOL BEHAV, V107, P34, DOI 10.1016/j.physbeh.2012.04.021; Wilkin MM, 2012, BEHAV NEUROSCI, V126, P344, DOI 10.1037/a0027258	59	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148261	10.1371/journal.pone.0148261	http://dx.doi.org/10.1371/journal.pone.0148261			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6SI	26872268	Green Submitted, Green Published, gold			2022-12-27	WOS:000370054100021
J	Khan, S; Imran, A; Khan, AA; Abul Kalam, M; Alshamsan, A				Khan, Shahanavaj; Imran, Ahamad; Khan, Abdul Arif; Abul Kalam, Mohd; Alshamsan, Aws			Systems Biology Approaches for the Prediction of Possible Role of Chlamydia pneumoniae Proteins in the Etiology of Lung Cancer	PLOS ONE			English	Article							DNA-POLYMERASE-BETA; CHLAMYDOPHILA-PNEUMONIAE; GENOME SEQUENCES; CELL-CYCLE; INFECTION; RISK; LOCALIZATION; ASSOCIATION; INDUCTION; MISMATCH	Accumulating evidence has recently supported the association of bacterial infection with the growth and development of cancers, particularly in organs that are constantly exposed to bacteria such as the lungs, colon, cervical cancer etc. Our in silico study on the proteome of Chlamydia pneumoniae suggests an unprecedented idea of the etiology of lung cancer and have revealed that the infection of C. pneumoniae is associated with lung cancer development and growth. It is reasonable to assume that C. pneumoniae transports its proteins within host-intracellular organelles during infection, where they may work with host-cell proteome. The current study was performed for the prediction of nuclear targeting protein of C. pneumoniae in the host cell using bioinformatics predictors including ExPASy pI/Mw tool, nuclear localization signal (NLS) mapper, balanced sub cellular localization predictor (BaCeILo), and Hum-mPLoc 2.0. We predicted 47/1112 nuclear-targeting proteins of C. pneumoniae connected with several possible alterations in host replication and transcription during intracellular infection. These nuclear-targeting proteins may direct to competitive interactions of host and C. pneumoniae proteins with the availability of same substrate and may be involved as etiological agents in the growth and development of lung cancer. These novel findings are expected to access in better understanding of lung cancer etiology and identifying molecular targets for therapy.	[Khan, Shahanavaj; Khan, Abdul Arif; Abul Kalam, Mohd; Alshamsan, Aws] King Saud Univ, Coll Pharm, Dept Pharmaceut, Nanomed Res Unit, POB 2457, Riyadh 11451, Saudi Arabia; [Imran, Ahamad; Alshamsan, Aws] King Saud Univ, King Abdullah Inst Nanotechnol, POB 2455, Riyadh 11451, Saudi Arabia	King Saud University; King Saud University	Alshamsan, A (corresponding author), King Saud Univ, Coll Pharm, Dept Pharmaceut, Nanomed Res Unit, POB 2457, Riyadh 11451, Saudi Arabia.; Alshamsan, A (corresponding author), King Saud Univ, King Abdullah Inst Nanotechnol, POB 2455, Riyadh 11451, Saudi Arabia.	aalshamsan@ksu.edu.sa	Kalam, Mohd Abul/AAG-2864-2021; Kalam, Mohd Abul/ABA-9199-2020; Alshamsan, Aws/D-2569-2015; Khan, Abdul Arif/F-1938-2018; Khan, Shahanavaj/F-1032-2019	Kalam, Mohd Abul/0000-0002-5713-8858; Kalam, Mohd Abul/0000-0002-5713-8858; Alshamsan, Aws/0000-0002-8950-6571; Khan, Abdul Arif/0000-0002-8748-1841	Research Groups Program (Research Group), Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia [RG-1436-027]	Research Groups Program (Research Group), Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia	This project was funded by the Research Groups Program (Research Group number RG-1436-027), Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia.	Chaturvedi AK, 2010, CANCER EPIDEM BIOMAR, V19, P1498, DOI 10.1158/1055-9965.EPI-09-1261; Chu DJ, 2012, ASIAN PAC J CANCER P, V13, P2819, DOI 10.7314/APJCP.2012.13.6.2819; Dalal S, 2008, NUCLEIC ACIDS RES, V36, P411, DOI 10.1093/nar/gkm1053; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Eickhoff M, 2007, INFECT IMMUN, V75, P2853, DOI 10.1128/IAI.01045-06; Gisserot O, 2014, REV MED INTERNE, V35, P259, DOI 10.1016/j.revmed.2013.11.014; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; HATTORI H, 1992, CELL STRUCT FUNCT, V17, P77, DOI 10.1247/csf.17.77; Hess S, 2003, CELL MICROBIOL, V5, P785, DOI 10.1046/j.1462-5822.2003.00319.x; Jackson LA, 2000, CANCER EPIDEM BIOMAR, V9, P1263; Jeruzalmi D, 2001, CELL, V106, P417, DOI 10.1016/S0092-8674(01)00462-7; Kalman S, 1999, NAT GENET, V21, P385, DOI 10.1038/7716; KARIN M, 1990, New Biologist, V2, P126; Kocazeybek B, 2003, J MED MICROBIOL, V52, P721, DOI 10.1099/jmm.0.04845-0; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Koyi H, 2001, APMIS, V109, P572, DOI 10.1034/j.1600-0463.2001.d01-177.x; Kuper H, 2000, J INTERN MED, V248, P171, DOI 10.1046/j.1365-2796.2000.00742.x; la Cour T, 2003, NUCLEIC ACIDS RES, V31, P393, DOI 10.1093/nar/gkg101; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Laurila AL, 1997, INT J CANCER, V74, P31, DOI 10.1002/(SICI)1097-0215(19970220)74:1&lt;31::AID-IJC6&gt;3.0.CO;2-1; LEONARDI E, 1992, J CLIN PATHOL, V45, P416, DOI 10.1136/jcp.45.5.416; Lin TY, 2014, LUNG, V192, P159, DOI 10.1007/s00408-013-9523-z; Littman AJ, 2005, CANCER EPIDEM BIOMAR, V14, P773, DOI 10.1158/1055-9965.EPI-04-0599; Littman AJ, 2004, CANCER EPIDEM BIOMAR, V13, P1624; Mojica SA, 2015, MOL BIOL CELL, V26, P1918, DOI 10.1091/mbc.E14-11-1530; Mote J, 1998, J BIOL CHEM, V273, P16843, DOI 10.1074/jbc.273.27.16843; Myers GSA, 2009, J BACTERIOL, V191, P7225, DOI 10.1128/JB.00746-09; Nguyen BA, 2009, BMC BIOINFORMATICS, V10, P202, DOI [10.1186/1471-2105-10-202, DOI 10.1186/1471-2105-10-202]; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Pierleoni A, 2006, BIOINFORMATICS, V22, pE408, DOI 10.1093/bioinformatics/btl222; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; Redecke V, 1998, AM J RESP CELL MOL, V19, P721, DOI 10.1165/ajrcmb.19.5.3072; Shen HB, 2009, ANAL BIOCHEM, V394, P269, DOI 10.1016/j.ab.2009.07.046; Shirai M, 2000, NUCLEIC ACIDS RES, V28, P2311, DOI 10.1093/nar/28.12.2311; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Smith JS, 2008, INT J CANCER, V123, P2469, DOI 10.1002/ijc.23814; Sterrenberg JN, 2011, CANCER LETT, V312, P129, DOI 10.1016/j.canlet.2011.08.019; Su ECY, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S17-S13; Suzuki M, 2013, MUTAT RES-FUND MOL M, V743, P111, DOI 10.1016/j.mrfmmm.2012.07.003; Tan XH, 2015, INT J BIOL SCI, V11, P144, DOI 10.7150/ijbs.10692; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang SC, 2014, TRENDS PHARMACOL SCI, V35, P178, DOI 10.1016/j.tips.2014.02.004; World Health Organization, 2012, GLOBOCAN 2012 EST CA; Yang J, 2003, INFECT IMMUN, V71, P614, DOI 10.1128/IAI.71.2.614-620.2003; Zhan P, 2011, EUR J CANCER, V47, P742, DOI 10.1016/j.ejca.2010.11.003	46	24	26	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148530	10.1371/journal.pone.0148530	http://dx.doi.org/10.1371/journal.pone.0148530			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871581	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100034
J	Laliberte, C; Dunn, S; Pound, C; Sourial, N; Yasseen, AS; Millar, D; White, RR; Walker, M; Lacaze-Masmonteil, T				Laliberte, Corinne; Dunn, Sandra; Pound, Catherine; Sourial, Nadia; Yasseen, Abdool S., III; Millar, David; White, Ruth Rennicks; Walker, Mark; Lacaze-Masmonteil, Thierry			A Randomized Controlled Trial of Innovative Postpartum Care Model for Mother-Baby Dyads	PLOS ONE			English	Article							FEEDING SELF-EFFICACY; MATERNAL RECALL; HOME VISITS; SUPPORT; DISCHARGE; INFANTS; WORKERS; SCALE	Objective To evaluate the efficacy, safety, and maternal satisfaction of a newly established integrative postpartum community-based clinic providing comprehensive support for mothers during the first month after discharge from the hospital. Our primary interests were breastfeeding rates, readmission and patient satisfaction. Methods A randomized controlled trial was conducted in Ottawa, Canada, where 472 mothers were randomized via a 1: 2 ratio to either receive standard of care (n = 157) or to attend the postpartum breastfeeding clinic (n = 315). Outcome data were captured through questionnaires completed by the participants at 2, 4, 12 and 24 weeks postpartum. Unadjusted and adjusted logistic regression models were conducted to determine the effect of the intervention on exclusive breastfeeding at 12 weeks (primary outcome). Secondary outcomes included breastfeeding rate at 2, 4 and 24 weeks, breastfeeding self-efficacy scale, readmission rate, and satisfaction score. Results More mothers in the intervention group (n = 195, 66.1%) were exclusively breastfeeding at 12 weeks compared to mothers in the control group (n = 81, 60.5%), however no statistically significant difference was observed (OR = 1.28; 95% CI: 0.84-1.95)). The rate of emergency room visits at 2 weeks for the intervention group was 11.4% compared to the standard of care group (15.2%) (OR = 0.69; 95% CI: 0.39-1.23). The intervention group was significantly more satisfied with the overall care they received for breastfeeding compared to the control group (OR = 1.96; 95% CI: 3.50-6.88)). Conclusion This new model of care did not significantly increase exclusive breastfeeding at 12 weeks. However, there were clinically meaningful improvements in the rate of postnatal problems and satisfaction that support this new service delivery model for postpartum care. A community-based multidisciplinary postpartum clinic is feasible to implement and can provide appropriate and highly satisfactory care to mother-baby dyads. This model of care may be more beneficial in a population that is not already predisposed to breastfeed.	[Laliberte, Corinne; Dunn, Sandra; Pound, Catherine; Sourial, Nadia; Yasseen, Abdool S., III; Lacaze-Masmonteil, Thierry] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada; [Dunn, Sandra; Yasseen, Abdool S., III] Better Outcomes Registry & Network Ontario, Ottawa, ON, Canada; [Pound, Catherine; Lacaze-Masmonteil, Thierry] Univ Ottawa, Dept Paediat, Ottawa, ON, Canada; [Millar, David] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada; [White, Ruth Rennicks; Walker, Mark] Ottawa Hosp, Res Inst, Obstet & Maternal Newborn Invest, Ottawa, ON, Canada; [Walker, Mark] Univ Ottawa, Dept Obstet & Gynecol, Ottawa, ON, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Lacaze-Masmonteil, T (corresponding author), Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada.; Lacaze-Masmonteil, T (corresponding author), Univ Ottawa, Dept Paediat, Ottawa, ON, Canada.	tlacaze@cheo.on.ca		Yasseen, Abdool S./0000-0001-9814-9249	Ontario Ministry of Health and Long-Term Care	Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario)	All phases of this study were supported by the Ontario Ministry of Health and Long-Term Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funds were distributed to and managed by the Children's Hospital of Eastern Ontario Research Institute, The Ottawa Hospital Research Institute, and BORN.	Abbass-Dick J, 2015, PEDIATRICS, V135, P102, DOI 10.1542/peds.2014-1416; [Anonymous], 2010, IND ASS INF CHILD FE; [Anonymous], 2013, QUAL BAS PROC CLIN H; Bilirubin Screening and Management of Hyperbilirubinemia, 2006, BIL SCREEN MAN HYP; Blyth RJ, 2004, J HUM LACT, V20, P30, DOI 10.1177/0890334403261109; Busch DW, 2014, J PEDIATR HEALTH CAR, V28, P486, DOI 10.1016/j.pedhc.2014.02.007; Cheng CY, 2006, J PERINAT EDUC, V15, P34, DOI 10.1624/105812406X119002; City of Ottawa PH, 2005, INF CAR SURV; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Darj E, 2000, UPSALA J MED SCI, V105, P57, DOI 10.1517/03009734000000047; Dennis CL, 2003, JOGNN-J OBST GYN NEO, V32, P734, DOI 10.1177/0884217503258459; Souza EFD, 2014, ACTA PAUL ENFERM, V27, P465, DOI 10.1590/1982-0194201400076; Dodge KA, 2014, AM J PUBLIC HEALTH, V104, pS136, DOI 10.2105/AJPH.2013.301361; Escobar GJ, 2001, PEDIATRICS, V108, P719, DOI 10.1542/peds.108.3.719; Jolly K, 2012, MIDWIFERY, V28, P740, DOI 10.1016/j.midw.2011.08.005; Kramer MS, 2001, JAMA-J AM MED ASSOC, V285, P413, DOI 10.1001/jama.285.4.413; LAUNER LJ, 1992, J EPIDEMIOL COMMUN H, V46, P203, DOI 10.1136/jech.46.3.203; Li RW, 2005, NUTR REV, V63, P103, DOI 10.1111/j.1753-4887.2005.tb00128.x; Mannan I, 2008, J PERINATOL, V28, P632, DOI 10.1038/jp.2008.64; Morrell CJ, 2000, BRIT MED J, V321, P593, DOI 10.1136/bmj.321.7261.593; Morrow AL, 1999, LANCET, V353, P1226, DOI 10.1016/S0140-6736(98)08037-4; Parry JE, 2013, J HUM LACT, V29, P527, DOI 10.1177/0890334412474719; Paul IM, 2012, ARCH PEDIAT ADOL MED, V166, P263, DOI 10.1001/archpediatrics.2011.198; Pound CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119624; Pound CM, 2009, PAED CHILD HEALT-CAN, V14, P445, DOI 10.1093/pch/14.7.445; Public Health Agency of Canada, 2009, WHAT MOTH SAY CAN MA, P173; Quarles A, 1994, Matern Child Nurs J, V22, P102; Scott J A, 1999, Breastfeed Rev, V7, P5; Seagraves Kendra, 2013, Nurs Womens Health, V17, P498, DOI 10.1111/1751-486X.12078; Statistics Canada, CAN COMM HLTH SURV C; Steel O, 2002, CAN J PUBLIC HLTH, V94, P98; Stuebe AM, 2014, OBSTET GYNECOL, V123, P643, DOI 10.1097/AOG.0000000000000142; Thulier D, 2009, JOGNN-J OBST GYN NEO, V38, P259, DOI 10.1111/j.1552-6909.2009.01021.x; Wheeler BJ, 2013, JOGNN-J OBST GYN NEO, V42, P70, DOI 10.1111/j.1552-6909.2012.01431.x; Wisner KL, 2002, NEW ENGL J MED, V347, P194, DOI 10.1056/NEJMcp011542; World Health Organization, 2014, WHO REC POSTN CAR MO; Yang C, 2012, J PAEDIATR CHILD H, V48, P931, DOI 10.1111/j.1440-1754.2012.02519.x; Yang WC, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-145	38	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148520	10.1371/journal.pone.0148520	http://dx.doi.org/10.1371/journal.pone.0148520			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871448	gold, Green Published, Green Submitted			2022-12-27	WOS:000370054100033
J	Ritchie, C; Andersen, R; Eng, J; Garrigues, SK; Intinarelli, G; Kao, H; Kawahara, S; Patel, K; Sapiro, L; Thibault, A; Tunick, E; Barnes, DE				Ritchie, Christine; Andersen, Robin; Eng, Jessica; Garrigues, Sarah K.; Intinarelli, Gina; Kao, Helen; Kawahara, Suzanne; Patel, Kanan; Sapiro, Lisa; Thibault, Anne; Tunick, Erika; Barnes, Deborah E.			Implementation of an Interdisciplinary, Team-Based Complex Care Support Health Care Model at an Academic Medical Center: Impact on Health Care Utilization and Quality of Life	PLOS ONE			English	Article							OUTPATIENT GERIATRIC EVALUATION; CONTROLLED-TRIAL; MANAGEMENT; RESOURCES; MORTALITY	Introduction The Geriatric Resources for the Assessment and Care of Elders (GRACE) program has been shown to decrease acute care utilization and increase patient self-rated health in lowincome seniors at community-based health centers. Aims To describe adaptation of the GRACE model to include adults of all ages (named Care Support) and to evaluate the process and impact of Care Support implementation at an urban academic medical center. Setting 152 high-risk patients (>= 5 ED visits or >= 2 hospitalizations in the past 12 months) enrolled from four medical clinics from 4/29/2013 to 5/31/2014. Program Description Patients received a comprehensive in-home assessment by a nurse practitioner/social worker (NP/SW) team, who then met with a larger interdisciplinary team to develop an individualized care plan. In consultation with the primary care team, standardized care protocols were activated to address relevant key issues as needed. Program Evaluation A process evaluation based on the Consolidated Framework for Implementation Research identified key adaptations of the original model, which included streamlining of standardized protocols, augmenting mental health interventions and performing some assessments in the clinic. A summative evaluation found a significant decline in the median number of ED visits (5.5 to 0, p = 0.015) and hospitalizations (5.5 to 0, p<0.001) 6 months before enrollment in Care Support compared to 6 months after enrollment. In addition, the percent of patients reporting better self-rated health increased from 31% at enrollment to 64% at 9 months (p = 0.002). Semi-structured interviews with Care Support team members identified patients with multiple, complex conditions; little community support; and mild anxiety as those who appeared to benefit the most from the program. Discussion It was feasible to implement GRACE/Care Support at an academic medical center by making adaptations based on local needs. Care Support patients experienced significant reductions in acute care utilization and significant improvements in self-rated health.	[Ritchie, Christine; Eng, Jessica; Garrigues, Sarah K.; Kawahara, Suzanne; Patel, Kanan; Barnes, Deborah E.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Ritchie, Christine; Garrigues, Sarah K.; Kawahara, Suzanne; Patel, Kanan; Barnes, Deborah E.] Univ Calif San Francisco, Div Geriatr, Tideswell UCSF, San Francisco, CA 94143 USA; [Andersen, Robin; Intinarelli, Gina; Kao, Helen; Sapiro, Lisa; Thibault, Anne; Tunick, Erika] Univ Calif San Francisco, UCSF Hlth, San Francisco, CA 94143 USA; [Eng, Jessica] San Francisco VA Med Ctr, Geriatr Palliat & Extended Care Serv, San Francisco, CA USA; [Barnes, Deborah E.] San Francisco VA Med Ctr, Res Serv, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Ritchie, C; Barnes, DE (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA USA.; Ritchie, C; Barnes, DE (corresponding author), Univ Calif San Francisco, Div Geriatr, Tideswell UCSF, San Francisco, CA 94143 USA.; Barnes, DE (corresponding author), San Francisco VA Med Ctr, Res Serv, San Francisco, CA USA.	Christine.ritchie@ucsf.edu; Deborah.barnes@ucsf.edu			S.D. Bechtel, Jr. Foundation; SCAN Foundation	S.D. Bechtel, Jr. Foundation; SCAN Foundation	Evaluation of Care Support was supported by a grant to TideswellTM at UCSF from the S.D. Bechtel, Jr. Foundation. The SCAN Foundation provided support for the training and implementation assistance provided by the Indiana University Geriatrics GRACE Training and Resource Center to the UCSF Care Support program. The SCAN Foundation - advancing a coordinated and easily navigated system of high-quality services for older adults that preserve dignity and independence. For more information, please visit www.TheSCANFoundation.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodenheimer T., 2009, CARE MANAGEMENT PATI; Boult C, 2001, J AM GERIATR SOC, V49, P351, DOI 10.1046/j.1532-5415.2001.49076.x; Boult C, 2008, J GERONTOL A-BIOL, V63, P321, DOI 10.1093/gerona/63.3.321; Cohen HJ, 2002, NEW ENGL J MED, V346, P905, DOI 10.1056/NEJMsa010285; Conwell L. J., 2005, CHARACTERISTICS PERS; Counsell SR, 2007, JAMA-J AM MED ASSOC, V298, P2623, DOI 10.1001/jama.298.22.2623; Counsell SR, 2006, J AM GERIATR SOC, V54, P1136, DOI 10.1111/j.1532-5415.2006.00791.x; Counsell SR, 2009, J AM GERIATR SOC, V57, P1420, DOI 10.1111/j.1532-5415.2009.02383.x; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Dorr DA, 2008, J AM GERIATR SOC, V56, P2195, DOI 10.1111/j.1532-5415.2008.02005.x; Feder JL, 2011, HEALTH AFFAIR, V30, P416, DOI 10.1377/hlthaff.2011.0080; Fogarty CT, 2008, J AM BOARD FAM MED, V21, P398, DOI 10.3122/jabfm.2008.05.070082; Gagnon AJ, 1999, J AM GERIATR SOC, V47, P1118; Grant RW, 2011, ANN INTERN MED, V155, P797, DOI 10.7326/0003-4819-155-12-201112200-00001; Hickam DH, 2013, COMP EFFECTIVENESS R, V99; Huss A, 2008, J GERONTOL A-BIOL, V63, P298, DOI 10.1093/gerona/63.3.298; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kroenke K, 2009, PSYCHOSOMATICS, V50, P613, DOI 10.1176/appi.psy.50.6.613; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Mayo-Wilson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089257; Schraeder C, 2001, J GERONTOL A-BIOL, V56, pM106, DOI 10.1093/gerona/56.2.M106; Sledge William H, 2006, Dis Manag, V9, P328, DOI 10.1089/dis.2006.9.328; Stall N, 2014, J AM GERIATR SOC, V62, P2243, DOI 10.1111/jgs.13088; Stock R, 2008, J AM GERIATR SOC, V56, P1342, DOI 10.1111/j.1532-5415.2008.01763.x; Stuck AE, 2002, JAMA-J AM MED ASSOC, V287, P1022, DOI 10.1001/jama.287.8.1022; Weiss KB, 2007, J GEN INTERN MED, V22, P374, DOI 10.1007/s11606-007-0379-x	26	45	45	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148096	10.1371/journal.pone.0148096	http://dx.doi.org/10.1371/journal.pone.0148096			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6SI	26871704	Green Published, gold			2022-12-27	WOS:000370054100017
J	Vandewalle, B; Llibre, JM; Parienti, JJ; Ustianowski, A; Camacho, R; Smith, C; Miners, A; Ferreira, D; Felix, J				Vandewalle, Bjoern; Llibre, Josep M.; Parienti, Jean-Jacques; Ustianowski, Andrew; Camacho, Ricardo; Smith, Colette; Miners, Alec; Ferreira, Diana; Felix, Jorge			EPICE-HIV: An Epidemiologic Cost-Effectiveness Model for HIV Treatment	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; DISOPROXIL FUMARATE; INITIAL TREATMENT; DRUG-RESISTANCE; INFECTED ADULTS; VIRAL LOAD; ADHERENCE; MORTALITY; MEDICATION; PROGRAM	The goal of this research was to establish a new and innovative framework for cost-effectiveness modeling of HIV-1 treatment, simultaneously considering both clinical and epidemiological outcomes. EPICE-HIV is a multi-paradigm model based on a within-host microsimulation model for the disease progression of HIV-1 infected individuals and an agentbased sexual contact network (SCN) model for the transmission of HIV-1 infection. It includes HIV-1 viral dynamics, CD4(+) T cell infection rates, and pharmacokinetics/pharmacodynamics modeling. Disease progression of HIV-1 infected individuals is driven by the interdependent changes in CD4(+) T cell count, changes in plasma HIV-1 RNA, accumulation of resistance mutations and adherence to treatment. The two parts of the model are joined through a per-sexual-act and viral load dependent probability of disease transmission in HIV-discordant couples. Internal validity of the disease progression part of the model is assessed and external validity is demonstrated in comparison to the outcomes observed in the STaR randomized controlled clinical trial. We found that overall adherence to treatment and the resulting pattern of treatment interruptions are key drivers of HIV-1 treatment outcomes. Our model, though largely independent of efficacy data from RCT, was accurate in producing 96-week outcomes, qualitatively and quantitatively comparable to the ones observed in the STaR trial. We demonstrate that multi-paradigm micro-simulation modeling is a promising tool to generate evidence about optimal policy strategies in HIV-1 treatment, including treatment efficacy, HIV-1 transmission, and cost-effectiveness analysis.	[Vandewalle, Bjoern; Ferreira, Diana; Felix, Jorge] Exigo Consultores, Lisbon, Portugal; [Llibre, Josep M.] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Fundacio Lluita SIDA, E-08193 Barcelona, Spain; [Parienti, Jean-Jacques] Cote de Nacre Univ Hosp, Dept Clin Res & Biostat, Caen, France; [Ustianowski, Andrew] North Manchester Gen Hosp, Reg Infect Dis Unit, Manchester, Lancs, England; [Camacho, Ricardo] Katholieke Univ Leuven, Rega Inst Med Res, Leuven, Belgium; [Smith, Colette] UCL, Dept Infect & Populat Hlth, London, England; [Miners, Alec] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1, England	Autonomous University of Barcelona; Hospital Germans Trias i Pujol; CHU de Caen NORMANDIE; Universite de Caen Normandie; KU Leuven; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Felix, J (corresponding author), Exigo Consultores, Lisbon, Portugal.	jorge.felix@exigoconsultores.com	Parienti, Jean-Jacques/AAD-1701-2021	Parienti, Jean-Jacques/0000-0002-4774-5590; Smith, Colette/0000-0003-2847-3355; Felix, Jorge/0000-0003-0544-0323; Ustianowski, Andrew/0000-0002-6134-7855	Gilead	Gilead(Gilead Sciences)	Gilead contracted with Exigo for the development of the model and its validation using STaR clinical trial data. Gilead also made STaR study data available for external model validation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Exigo Consultores provided support in the form of salaries for authors BV, DF, JF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ` author contributions' section.	Administration DoHaA-TG, 2012, AUSTR PUBL ASS REP R, V2012; Aragao F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044774; Arnsten JH, 2001, CLIN INFECT DIS, V33, P1417, DOI 10.1086/323201; Bangsberg DR, 2008, J INFECT DIS, V197, pS272, DOI 10.1086/533415; Bangsberg DR, 2000, AIDS, V14, P357, DOI 10.1097/00002030-200003100-00008; Bhaskaran K, 2008, JAMA-J AM MED ASSOC, V300, P51, DOI 10.1001/jama.300.1.51; Bonora S, 2009, J MED VIROL, V81, P400, DOI 10.1002/jmv.21405; Braithwaite RS, 2007, VALUE HEALTH, V10, P204, DOI 10.1111/j.1524-4733.2007.00170.x; Broadhead RS, 2002, SOC SCI MED, V55, P235, DOI 10.1016/S0277-9536(01)00167-8; Callaway DS, 2002, B MATH BIOL, V64, P29, DOI 10.1006/bulm.2001.0266; Cohen C, 2014, ICAAC; Cohen C, 2014, AIDS, V28, P989, DOI 10.1097/QAD.0000000000000169; Cohen CJ, 2011, LANCET, V378, P229, DOI 10.1016/S0140-6736(11)60983-5; CONNOR RI, 1993, J VIROL, V67, P1772, DOI 10.1128/JVI.67.4.1772-1777.1993; Daar ES, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-7-201104050-00316; DeJesus E, 2012, LANCET, V379, P2429, DOI 10.1016/S0140-6736(12)60918-0; Fauci AS, 1996, ANN INTERN MED, V124, P654, DOI 10.7326/0003-4819-124-7-199604010-00006; Frentz D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094495; Gardner EM, 2009, AIDS, V23, P1035, DOI 10.1097/QAD.0b013e32832ba8ec; Goujard C, 2003, JAIDS-J ACQ IMM DEF, V34, P191, DOI 10.1097/00126334-200310010-00009; Gras G, 2012, JAIDS-J ACQ IMM DEF, V61, P265, DOI 10.1097/QAI.0b013e31826cc592; Howard AA, 2002, AIDS, V16, P2175, DOI 10.1097/00002030-200211080-00010; Jilek BL, 2012, NAT MED, V18, P446, DOI 10.1038/nm.2649; Kessler J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073269; Krakovska O, 2007, J THEOR BIOL, V246, P499, DOI 10.1016/j.jtbi.2006.12.038; Lewden C, 2007, JAIDS-J ACQ IMM DEF, V46, P72; Lewden C, 2012, INT J EPIDEMIOL, V41, P433, DOI 10.1093/ije/dyr164; Liu HH, 2001, ANN INTERN MED, V134, P968, DOI 10.7326/0003-4819-134-10-200105150-00011; Maldarelli F, 2007, PLOS PATHOG, V3, P484, DOI 10.1371/journal.ppat.0030046; Mannheimer S, 2002, CLIN INFECT DIS, V34, P1115, DOI 10.1086/339074; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Parienti JJ, 2010, CLIN INFECT DIS, V50, P1192, DOI 10.1086/651419; Parienti JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002783; Pearson CR, 2007, AIDS CARE, V19, P594, DOI 10.1080/09540120701203337; Phillips AN, 2007, HIV MED, V8, P536, DOI 10.1111/j.1468-1293.2007.00507.x; Phillips AN, 2011, AIDS, V25, P843, DOI 10.1097/QAD.0b013e328344037a; Pradier C, 2003, HIV CLIN TRIALS, V4, P121; Programs DoHaS, 2014, HIV CAR TREATM SERV; Raffi F, 2015, J ANTIMICROB CHEMOTH, V70, P2121, DOI 10.1093/jac/dkv083; Ramkissoon S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049492; Rawlings MK, 2003, JAIDS-J ACQ IMM DEF, V34, P174, DOI 10.1097/00126334-200310010-00007; Rodger AJ, 2013, AIDS, V27, P973, DOI 10.1097/QAD.0b013e32835cae9c; Rong LB, 2009, J THEOR BIOL, V260, P308, DOI 10.1016/j.jtbi.2009.06.011; Sax PE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031591; Schmid BV, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002470; Shen L, 2008, NAT MED, V14, P762, DOI 10.1038/nm1777; Siliciano RF, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a007096; Smith SR, 2003, PATIENT EDUC COUNS, V50, P187; Society EAC, 2014, GUID VERS 7 1; van Lunzen J, 2012, LANCET INFECT DIS, V12, P111, DOI 10.1016/S1473-3099(11)70290-0; Vercauteren J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061436; Walensky RP, 2013, NEW ENGL J MED, V369, P1715, DOI 10.1056/NEJMsa1214720; WEISS RA, 1993, SCIENCE, V260, P1273, DOI 10.1126/science.8493571; World Health Organization, 2013, CONSOLIDATED GUIDELI; Young B, 2014, 20 INT AIDS C 2014 J	55	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149007	10.1371/journal.pone.0149007	http://dx.doi.org/10.1371/journal.pone.0149007			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6SI	26870960	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000370054100086
J	Hedrick, MS; Moon, IJ; Woo, J; Won, JH				Hedrick, Mark S.; Moon, Il Joon; Woo, Jihwan; Won, Jong Ho			Effects of Physiological Internal Noise on Model Predictions of Concurrent Vowel Identification for Normal-Hearing Listeners	PLOS ONE			English	Article							AUDITORY-NERVE RESPONSES; DIFFERENT FUNDAMENTAL FREQUENCIES; COCKTAIL PARTY PROBLEM; PHENOMENOLOGICAL MODEL; NEURAL REPRESENTATION; OLIVOCOCHLEAR REFLEX; SPEECH-PERCEPTION; CORTICAL-NEURONS; CORTEX; ENHANCEMENT	Previous studies have shown that concurrent vowel identification improves with increasing temporal onset asynchrony of the vowels, even if the vowels have the same fundamental frequency. The current study investigated the possible underlying neural processing involved in concurrent vowel perception. The individual vowel stimuli from a previously published study were used as inputs for a phenomenological auditory-nerve (AN) model. Spectrotemporal representations of simulated neural excitation patterns were constructed (i.e., neurograms) and then matched quantitatively with the neurograms of the single vowels using the Neurogram Similarity Index Measure (NSIM). A novel computational decision model was used to predict concurrent vowel identification. To facilitate optimum matches between the model predictions and the behavioral human data, internal noise was added at either neurogram generation or neurogram matching using the NSIM procedure. The best fit to the behavioral data was achieved with a signal-to-noise ratio (SNR) of 8 dB for internal noise added at the neurogram but with a much smaller amount of internal noise (SNR of 60 dB) for internal noise added at the level of the NSIM computations. The results suggest that accurate modeling of concurrent vowel data from listeners with normal hearing may partly depend on internal noise and where internal noise is hypothesized to occur during the concurrent vowel identification process.	[Hedrick, Mark S.; Won, Jong Ho] Univ Tennessee, Hlth Sci Ctr, Dept Audiol & Speech Pathol, Knoxville, TN USA; [Moon, Il Joon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Woo, Jihwan] Univ Ulsan, Dept Biomed Engn, Ulsan 680749, South Korea	University of Tennessee System; University of Tennessee Health Science Center; Sungkyunkwan University (SKKU); Samsung Medical Center; University of Ulsan	Woo, J (corresponding author), Univ Ulsan, Dept Biomed Engn, Ulsan 680749, South Korea.	jhwoo@ulsan.ac.kr						Alain C, 2005, J COGNITIVE NEUROSCI, V17, P811, DOI 10.1162/0898929053747621; Arehart KH, 2011, J SPEECH LANG HEAR R, V54, P190, DOI 10.1044/1092-4388(2010/09-0145); ASSMANN PF, 1990, J ACOUST SOC AM, V88, P680, DOI 10.1121/1.399772; Assmann PF, 1996, J ACOUST SOC AM, V100, P1141, DOI 10.1121/1.416299; Baddeley A, 1998, PSYCHOL REV, V105, P158, DOI 10.1037/0033-295X.105.1.158; Bee MA, 2008, J COMP PSYCHOL, V122, P235, DOI 10.1037/0735-7036.122.3.235; Bregman AS, 1990, AUDITORY SCENE ANAL, p[65, 396, 491, 594, 625]; Bruce IC, 2003, J ACOUST SOC AM, V113, P369, DOI 10.1121/1.1519544; Chintanpalli A, 2014, JARO-J ASSOC RES OTO, V15, P823, DOI 10.1007/s10162-014-0475-7; Chintanpalli A, 2013, J ACOUST SOC AM, V134, P2988, DOI 10.1121/1.4820888; Chintanpalli A, 2012, JARO-J ASSOC RES OTO, V13, P219, DOI 10.1007/s10162-011-0310-3; CULLING JF, 1994, J ACOUST SOC AM, V95, P1559, DOI 10.1121/1.408543; de Cheveigne A, 1999, J ACOUST SOC AM, V106, P327, DOI 10.1121/1.427059; DECHEVEIGNE A, 1995, J ACOUST SOC AM, V97, P3736, DOI 10.1121/1.412389; deCheveigne A, 1997, J ACOUST SOC AM, V101, P2857, DOI 10.1121/1.419480; Doi E, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003761; Durstewitz D, 2008, EUR J NEUROSCI, V27, P217, DOI 10.1111/j.1460-9568.2007.05976.x; Fishman YI, 2014, J NEUROSCI, V34, P12425, DOI 10.1523/JNEUROSCI.0025-14.2014; Fishman YI, 2013, J NEUROSCI, V33, P10312, DOI 10.1523/JNEUROSCI.0020-13.2013; Garrett DD, 2010, J NEUROSCI, V30, P4914, DOI 10.1523/JNEUROSCI.5166-09.2010; Goldwyn JH, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002247; HALL JW, 1994, J ACOUST SOC AM, V96, P150, DOI 10.1121/1.410474; Handel S., 1989, LISTENING INTRO PERC, p[190, 235, 259, 521]; Hansel D, 2002, J NEUROSCI, V22, P5118, DOI 10.1523/JNEUROSCI.22-12-05118.2002; Haykin S, 2005, NEURAL COMPUT, V17, P1875, DOI 10.1162/0899766054322964; Hedrick MS, 2009, J SPEECH LANG HEAR R, V52, P696, DOI 10.1044/1092-4388(2008/07-0094); Hines A, 2012, SPEECH COMMUN, V54, P306, DOI 10.1016/j.specom.2011.09.004; Hines A, 2010, SPEECH COMMUN, V52, P736, DOI 10.1016/j.specom.2010.04.006; Javel E, 2000, J ACOUST SOC AM, V107, P908, DOI 10.1121/1.428269; Jones PR, 2013, J ACOUST SOC AM, V133, P970, DOI 10.1121/1.4773864; KAWASE T, 1993, J NEUROPHYSIOL, V70, P2533, DOI 10.1152/jn.1993.70.6.2533; KLATT DH, 1980, J ACOUST SOC AM, V67, P971, DOI 10.1121/1.383940; Lentz JJ, 2006, J SPEECH LANG HEAR R, V49, P1354, DOI 10.1044/1092-4388(2006/097); LIBERMAN MC, 1978, J ACOUST SOC AM, V63, P442, DOI 10.1121/1.381736; Manjarrez E, 2003, J NEUROSCI, V23, P1997; McClelland JL, 2006, TRENDS COGN SCI, V10, P363, DOI 10.1016/j.tics.2006.06.007; MCCLELLAND JL, 1986, COGNITIVE PSYCHOL, V18, P1, DOI 10.1016/0010-0285(86)90015-0; MEDDIS R, 1992, J ACOUST SOC AM, V91, P233, DOI 10.1121/1.402767; Mesgarani N, 2014, P NATL ACAD SCI USA, V111, P6792, DOI 10.1073/pnas.1318017111; Miller P, 2010, J NEUROSCI, V30, P2559, DOI 10.1523/JNEUROSCI.3047-09.2010; Moon IJ, 2014, J NEUROSCI, V34, P12145, DOI 10.1523/JNEUROSCI.1025-14.2014; Norris D, 2000, BEHAV BRAIN SCI, V23, P299, DOI 10.1017/S0140525X00003241; SCHEFFERS MTM, 1983, THESIS U GRONINGEN; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Snyder JS, 2005, COGNITIVE BRAIN RES, V24, P492, DOI 10.1016/j.cogbrainres.2005.03.002; SUMMERFIELD Q, 1992, PHILOS T ROY SOC B, V336, P357, DOI 10.1098/rstb.1992.0069; SUMMERFIELD Q, 1989, PERCEPT PSYCHOPHYS, V45, P529, DOI 10.3758/BF03208060; Tan Q, 2003, J ACOUST SOC AM, V114, P2007, DOI 10.1121/1.1608963; Valentine S, 2012, J SPEECH LANG HEAR R, V55, P1750, DOI 10.1044/1092-4388(2012/11-0033); Vinay, 2007, INT J AUDIOL, V46, P39, DOI 10.1080/14992020601077992; VOGELS R, 1989, EXP BRAIN RES, V77, P432, DOI 10.1007/BF00275002; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Zhang XD, 2001, J ACOUST SOC AM, V109, P648, DOI 10.1121/1.1336503; Zilany MSA, 2009, J ACOUST SOC AM, V126, P2390, DOI 10.1121/1.3238250	54	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149128	10.1371/journal.pone.0149128	http://dx.doi.org/10.1371/journal.pone.0149128			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866811	Green Published, gold, Green Submitted			2022-12-27	WOS:000370050700069
J	Gallagher, AM; Williams, T; Leufkens, HGM; de Vries, F				Gallagher, Arlene M.; Williams, Tim; Leufkens, Hubert G. M.; de Vries, Frank			The Impact of the Choice of Data Source in Record Linkage Studies Estimating Mortality in Venous Thromboembolism	PLOS ONE			English	Article							RISK; VALIDITY; VALIDATION; FRACTURE; CODES	Linked electronic healthcare databases are increasingly being used in observational research. The objective of this study was to investigate the impact of the choice of data source in estimating mortality following VTE, with a secondary aim to investigate the influence of the denominator definition. We used the UK Clinical Practice Research Datalink (CPRD) to identify patients aged 18+ with venous thromboembolism (VTE). Multiple cohorts were identified in order to assess how mortality rates differed with a range of data sources. For each of the cohorts, incidence rates per 1,000 person years (/1000py) and relative rates (RRs) of all-cause mortality were calculated. The lowest mortality rate was found when only primary care data were used for both the exposure (VTE) and the outcome (death) (108.4/1000py). The highest mortality rate was found for patients diagnosed in secondary care (237.2/1000py). When linked primary and secondary care data were included for eligible patients and for the overlapping period of data collection, a mortality rate of 173.2/1000py was found. Sensitivity analyses varying the denominator definition provided a range of results (140.6-164.3/1000py). The relative rates of mortality by gender and age were comparable across all cohorts. Depending on the choice of data source, the population studied may be different. This may have substantial impact on the main findings, in particular on incidence rates of mortality following VTE.	[Gallagher, Arlene M.; Williams, Tim] Med & Healthcare Prod Regulatory Agcy, Clin Practice Res Datalink, London, England; [Gallagher, Arlene M.; Leufkens, Hubert G. M.; de Vries, Frank] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands	The Medicines & Healthcare Products Regulatory Agency; Utrecht University	Gallagher, AM (corresponding author), Med & Healthcare Prod Regulatory Agcy, Clin Practice Res Datalink, London, England.; Gallagher, AM (corresponding author), Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands.	arlene.gallagher@cprd.com	de Vries, Frank/E-4934-2011	de Vries, Frank/0000-0003-3837-8319	IMI; TI Pharma; Netherlands Organisation for Health Research and Development (ZonMW); EU; Dutch Medicines Evaluation Board (MEB); National Health Care Institute (ZIN); Dutch Ministry of Health	IMI; TI Pharma; Netherlands Organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); EU(European Commission); Dutch Medicines Evaluation Board (MEB); National Health Care Institute (ZIN); Dutch Ministry of Health	The authors received no specific funding for this work. Bert Leufkens receives no direct funding or donations from private parties, including the pharmaceutical industry. Research funding from public-private partnerships, i.e. IMI and TI Pharma (www.tipharma.nl), has been accepted under the condition that no company-specific product or company related study is conducted. He has received unrestricted research funding from public sources, i.e. the Netherlands Organisation for Health Research and Development (ZonMW), the EU 7th Framework Program (FP7), the Dutch Medicines Evaluation Board (MEB), the National Health Care Institute (ZIN) and the Dutch Ministry of Health.	Bazelier MT, 2012, NEUROLOGY, V79, P922, DOI 10.1212/WNL.0b013e318266faae; Bazelier MT, 2012, MULT SCLER J, V18, P628, DOI 10.1177/1352458511426737; Bazelier MT, 2011, J BONE MINER RES, V26, P2271, DOI 10.1002/jbmr.418; Gallagher AM, 2012, CLIN APPL THROMB-HEM, V18, P370, DOI 10.1177/1076029611426139; Gallagher AM, 2011, PHARMACOEPIDEM DR S, V20, pS230; Herrett E., 2015, INT J EPIDEMIOL; Herrett E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2350; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; HSCIC, HOSP EP STAT; HSCIC, MORT DAT OFF NAT STA; Huerta C, 2007, ARCH INTERN MED, V167, P935, DOI 10.1001/archinte.167.9.935; Huerta C, 2008, THROMB J, V6, DOI 10.1186/1477-9560-6-10; Lawrenson R, 2000, BRIT J CLIN PHARMACO, V49, P591, DOI 10.1046/j.1365-2125.2000.00199.x; Lo Re V, 2013, PHARMACOEPIDEM DR S, V22, P861, DOI 10.1002/pds.3470; Movig KLL, 2003, J CLIN EPIDEMIOL, V56, P530, DOI 10.1016/S0895-4356(03)00006-4; Robertson LM, 2014, HLTH INFORM J; White RH, 2003, CIRCULATION, V107, pI4, DOI 10.1161/01.CIR.0000078468.11849.66	17	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148349	10.1371/journal.pone.0148349	http://dx.doi.org/10.1371/journal.pone.0148349			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863417	Green Published, Green Submitted, gold			2022-12-27	WOS:000370046600058
J	Lurquin, JH; Michaelson, LE; Barker, JE; Gustavson, DE; von Bastian, CC; Carruth, NP; Miyake, A				Lurquin, John H.; Michaelson, Laura E.; Barker, Jane E.; Gustavson, Daniel E.; von Bastian, Claudia C.; Carruth, Nicholas P.; Miyake, Akira			No Evidence of the Ego-Depletion Effect across Task Characteristics and Individual Differences: A Pre-Registered Study	PLOS ONE			English	Article							WORKING-MEMORY CAPACITY; SELF-REGULATORY STRENGTH; EXECUTIVE FUNCTIONS; LIMITED RESOURCE; MODEL; PERFORMANCE; ATTENTION; INTELLIGENCE; PSYCHOLOGY; MOTIVATION	Ego-depletion, a psychological phenomenon in which participants are less able to engage in self-control after prior exertion of self-control, has become widely popular in the scientific community as well as in the media. However, considerable debate exists among researchers as to the nature of the ego-depletion effect, and growing evidence suggests the effect may not be as strong or robust as the extant literature suggests. We examined the robustness of the ego-depletion effect and aimed to maximize the likelihood of detecting the effect by using one of the most widely used depletion tasks (video-viewing attention control task) and by considering task characteristics and individual differences that potentially moderate the effect. We also sought to make our research plan transparent by pre-registering our hypotheses, procedure, and planned analyses prior to data collection. Contrary to the ego-depletion hypothesis, participants in the depletion condition did not perform worse than control participants on the subsequent self-control task, even after considering moderator variables. These findings add to a growing body of evidence suggesting ego-depletion is not a reliable phenomenon, though more research is needed that uses large sample sizes, considers moderator variables, and pre-registers prior to data collection.	[Lurquin, John H.; Michaelson, Laura E.; Barker, Jane E.; Gustavson, Daniel E.; von Bastian, Claudia C.; Carruth, Nicholas P.; Miyake, Akira] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Lurquin, JH (corresponding author), Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA.	john.lurquin@colorado.edu	; von Bastian, Claudia/J-4551-2014	Michaelson, Laura/0000-0003-0321-025X; von Bastian, Claudia/0000-0002-0667-2460; Lurquin, John/0000-0001-5385-1181; MIYAKE, AKIRA/0000-0003-4671-7843	University of Colorado Boulder Libraries Open Access Fund	University of Colorado Boulder Libraries Open Access Fund	Publication of this article was funded by the University of Colorado Boulder Libraries Open Access Fund.	Asendorpf JB, 2013, EUR J PERSONALITY, V27, P108, DOI 10.1002/per.1919; Baumeister RF, 2005, J PERS SOC PSYCHOL, V88, P589, DOI 10.1037/0022-3514.88.4.589; Baumeister RF, 1998, J PERS SOC PSYCHOL, V74, P1252, DOI 10.1037/0022-3514.74.5.1252; Baumeister RF, 2007, CURR DIR PSYCHOL SCI, V16, P351, DOI 10.1111/j.1467-8721.2007.00534.x; Bray SR, 2008, PSYCHOPHYSIOLOGY, V45, P337, DOI 10.1111/j.1469-8986.2007.00625.x; Bruyneel S, 2006, INT J RES MARK, V23, P215, DOI 10.1016/j.ijresmar.2005.12.002; Burkley E, 2008, PERS SOC PSYCHOL B, V34, P419, DOI 10.1177/0146167207310458; Carter E.C., 2013, BMC PSYCHOL, V1, P1; Carter EC, 2015, J EXP PSYCHOL GEN, V144, P796, DOI 10.1037/xge0000083; Carter EC, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00823; Carter EC, 2013, BEHAV BRAIN SCI, V36, P683, DOI 10.1017/S0140525X13000952; Cesario J, 2014, PERSPECT PSYCHOL SCI, V9, P40, DOI 10.1177/1745691613513470; Conway ARA, 2003, TRENDS COGN SCI, V7, P547, DOI 10.1016/j.tics.2003.10.005; DeWall CN, 2007, J EXP SOC PSYCHOL, V43, P62, DOI 10.1016/j.jesp.2005.12.005; Doyen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029081; Engle RW, 2002, CURR DIR PSYCHOL SCI, V11, P19, DOI 10.1111/1467-8721.00160; Fanelli D., 2010, PLOS ONE, V5; Friedman NP, 2004, J MEM LANG, V51, P136, DOI 10.1016/j.jml.2004.03.008; Gailliot MT, 2006, J PERS SOC PSYCHOL, V91, P49, DOI 10.1037/0022-3514.91.1.49; Hagger MS, 2010, PSYCHOL BULL, V136, P495, DOI 10.1037/a0019486; Healey MK, 2011, J EXP PSYCHOL GEN, V140, P573, DOI 10.1037/a0024587; Hofmann W, 2008, J PERS SOC PSYCHOL, V95, P962, DOI 10.1037/a0012705; Hofmann W, 2012, TRENDS COGN SCI, V16, P174, DOI 10.1016/j.tics.2012.01.006; Inzlicht M, 2015, NEWS EGO DEPLETIONS, P1; Inzlicht M, 2012, PERSPECT PSYCHOL SCI, V7, P450, DOI 10.1177/1745691612454134; John LK, 2012, PSYCHOL SCI, V23, P524, DOI 10.1177/0956797611430953; Kane MJ, 2001, J EXP PSYCHOL GEN, V130, P169, DOI 10.1037/0096-3445.130.2.169; Kerr N L, 1998, Pers Soc Psychol Rev, V2, P196, DOI 10.1207/s15327957pspr0203_4; Kurzban R, 2013, BEHAV BRAIN SCI, V36, P661, DOI 10.1017/S0140525X12003196; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Miyake A, 2012, CURR DIR PSYCHOL SCI, V21, P8, DOI 10.1177/0963721411429458; Muraven M, 2003, PERS SOC PSYCHOL B, V29, P894, DOI 10.1177/0146167203029007008; Muraven M, 1998, J PERS SOC PSYCHOL, V74, P774, DOI 10.1037/0022-3514.74.3.774; Muraven M, 2006, J PERS SOC PSYCHOL, V91, P524, DOI 10.1037/0022-3514.91.3.524; Nuijten MB, 2016, BEHAV RES METHODS, V48, P1205, DOI 10.3758/s13428-015-0664-2; Pashler H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042510; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Schimmack U, 2012, PSYCHOL METHODS, V17, P551, DOI 10.1037/a0029487; Schmeichel BJ, 2003, J PERS SOC PSYCHOL, V85, P33, DOI 10.1037/0022-3514.85.1.33; Schmeichel BJ, 2007, J EXP PSYCHOL GEN, V136, P241, DOI 10.1037/0096-3445.136.2.241; Schmeichel BJ, 2008, J PERS SOC PSYCHOL, V95, P1526, DOI 10.1037/a0013345; Segerstrom SC, 2007, PSYCHOL SCI, V18, P275, DOI 10.1111/j.1467-9280.2007.01888.x; Shamosh NA, 2008, PSYCHOL SCI, V19, P904, DOI 10.1111/j.1467-9280.2008.02175.x; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Stillman TF, 2009, J SOC CLIN PSYCHOL, V28, P498, DOI 10.1521/jscp.2009.28.4.498; Tice DM, 2007, J EXP SOC PSYCHOL, V43, P379, DOI 10.1016/j.jesp.2006.05.007; TURNER ML, 1989, J MEM LANG, V28, P127, DOI 10.1016/0749-596X(89)90040-5; Unsworth N, 2004, J EXP PSYCHOL LEARN, V30, P1302, DOI 10.1037/0278-7393.30.6.1302; Vohs KD, 2012, J EXP SOC PSYCHOL, V48, P943, DOI 10.1016/j.jesp.2012.03.002; Vohs KD, 2000, PSYCHOL SCI, V11, P249, DOI 10.1111/1467-9280.00250; Xu X., 2014, PLOS ONE, V9	51	74	76	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0147770	10.1371/journal.pone.0147770	http://dx.doi.org/10.1371/journal.pone.0147770			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6PR	26863227	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000370046600038
J	Magirr, D; Jaki, T; Koenig, F; Posch, M				Magirr, Dominic; Jaki, Thomas; Koenig, Franz; Posch, Martin			Sample Size Reassessment and Hypothesis Testing in Adaptive Survival Trials	PLOS ONE			English	Article							CONDITIONAL ERROR FUNCTION; GROUP SEQUENTIAL-TESTS; CLINICAL-TRIALS; INTERIM ANALYSES; END-POINT; DESIGNS; SEAMLESS; ONCOLOGY; SELECTION; PHASE-3	Mid-study design modifications are becoming increasingly accepted in confirmatory clinical trials, so long as appropriate methods are applied such that error rates are controlled. It is therefore unfortunate that the important case of time-to-event endpoints is not easily handled by the standard theory. We analyze current methods that allow design modifications to be based on the full interim data, i.e., not only the observed event times but also secondary endpoint and safety data from patients who are yet to have an event. We show that the final test statistic may ignore a substantial subset of the observed event times. An alternative test incorporating all event times is found, where a conservative assumption must be made in order to guarantee type I error control. We examine the power of this approach using the example of a clinical trial comparing two cancer therapies.	[Magirr, Dominic; Koenig, Franz; Posch, Martin] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Sect Med Stat, Vienna, Austria; [Jaki, Thomas] Univ Lancaster, Med & Pharmaceut Stat Res Unit, Lancaster, England	Medical University of Vienna; Lancaster University	Magirr, D (corresponding author), Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Sect Med Stat, Vienna, Austria.	d.magirr@gmail.com	Jaki, Thomas/AAJ-1872-2020; Posch, Martin/C-7907-2009	Konig, Franz/0000-0002-6893-3304; Jaki, Thomas/0000-0002-1096-188X; Posch, Martin/0000-0001-8499-8573	Medical Research Council [MR/J004979/1]; Austrian Science Fund [FWF P23167]; National Institute for Health Research [NIHR-CDF-2010-03-32]; European Union [602552]; EU [FP7 HEALTH.2013.4.2-3, 603160]; Austrian Science Fund (FWF) [P 23167] Funding Source: researchfish; National Institute for Health Research [CDF-2010-03-16] Funding Source: researchfish; MRC [MR/J004979/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Austrian Science Fund(Austrian Science Fund (FWF)); National Institute for Health Research(National Institute for Health Research (NIHR)); European Union(European Commission); EU(European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	DM was funded by the Medical Research Council (MR/J004979/1) and the Austrian Science Fund (FWF P23167). TJ was supported by the National Institute for Health Research (NIHR-CDF-2010-03-32). FK was supported by European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602552 (IDEAL). MP was supported by the EU FP7 HEALTH.2013.4.2-3 project Asterix (Grant Number 603160). The views expressed in this publication are those of the authors and should not be attributed to any of the funding institutions, or organisations with which the authors are affiliated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer P, 2004, Stat Med, V23, P1333, DOI 10.1002/sim.1759; Bauer P, 2006, STAT MED, V25, P23, DOI 10.1002/sim.2180; BAUER P, 1994, BIOMETRICS, V50, P1029, DOI 10.2307/2533441; Bauer P, 2015, STATISTICS IN MEDICI; Brannath W, 2012, J AM STAT ASSOC, V107, P824, DOI 10.1080/01621459.2012.682540; Brannath W, 2009, STAT MED, V28, P1445, DOI 10.1002/sim.3559; Bretz F, 2009, STAT MED, V28, P1181, DOI 10.1002/sim.3538; Carreras M, 2015, STAT MED, V34, P1317, DOI 10.1002/sim.6407; Cox D.R., 1979, THEORETICAL STAT; Cuffe RL, 2014, PHARM STAT, V13, P229, DOI 10.1002/pst.1622; Desseaux K, 2007, STAT MED, V26, P5002, DOI 10.1002/sim.2966; Elsaesser A, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-383; European Medicines Agency Committee for Medicinal Products for Human Use, 2007, CHMPEWP245902 EUR ME; Food and Drug Administration, 2010, GUID IND AD IN PRESS; Friede T, 2011, STAT MED, V30, P1528, DOI 10.1002/sim.4202; Hampson LV, 2013, J R STAT SOC B, V75, P3, DOI 10.1111/j.1467-9868.2012.01030.x; Hommel G, 2001, BIOMETRICAL J, V43, P581, DOI 10.1002/1521-4036(200109)43:5<581::AID-BIMJ581>3.0.CO;2-J; Irle S, 2012, J AM STAT ASSOC, V107, P341, DOI 10.1080/01621459.2011.644141; Jahn-Eimermacher A, 2009, CONTEMP CLIN TRIALS, V30, P171, DOI 10.1016/j.cct.2008.12.002; Jennison C, 2006, BIOMETRIKA, V93, P1, DOI 10.1093/biomet/93.1.1; Jennison C, 2003, STAT MED, V22, P971, DOI 10.1002/sim.1457; Jennison C, 2000, GROUP SEQUENTIAL MET; Jiang ZX, 2012, INT J NANOMED, V7, P1, DOI 10.2147/IJN.S25268; LAGAKOS SW, 1984, BIOMETRICS, V40, P1037, DOI 10.2307/2531154; Lehmacher W, 1999, BIOMETRICS, V55, P1286, DOI 10.1111/j.0006-341X.1999.01286.x; Liu Q, 2005, J AM STAT ASSOC, V100, P493, DOI 10.1198/016214504000001790; Mehta C, 2014, STAT MED, V33, P4515, DOI 10.1002/sim.6272; Mehta CR, 2011, STAT MED, V30, P3267, DOI 10.1002/sim.4102; Muller HH, 2001, BIOMETRICS, V57, P886, DOI 10.1111/j.0006-341X.2001.00886.x; Posch M, 1999, BIOMETRICAL J, V41, P689, DOI 10.1002/(SICI)1521-4036(199910)41:6<689::AID-BIMJ689>3.0.CO;2-P; PROSCHAN MA, 1992, BIOMETRICS, V48, P1131, DOI 10.2307/2532704; Proschan MA, 1995, BIOMETRICS, V51, P1315, DOI 10.2307/2533262; Proschan MA, 2006, STAT BIOL HEALTH, P1; Ravandi F, 2015, LANCET ONCOL, V16, P1025, DOI 10.1016/S1470-2045(15)00201-6; Schafer H, 2001, STAT MED, V20, P3741, DOI 10.1002/sim.1136; Schmidli H, 2007, STAT MED, V26, P4925, DOI 10.1002/sim.2957; Stallard N, 2010, STAT MED, V29, P959, DOI 10.1002/sim.3863; Tsiatis AA, 2003, BIOMETRIKA, V90, P367, DOI 10.1093/biomet/90.2.367; Wang LQ, 1997, J APPL PROBAB, V34, P54, DOI 10.2307/3215174; Wassmer G, 2006, BIOMETRICAL J, V48, P714, DOI 10.1002/bimj.200510190; Whitehead J, 1997, THE DESIGN AND ANALY	43	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0146465	10.1371/journal.pone.0146465	http://dx.doi.org/10.1371/journal.pone.0146465			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863139	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000370046600010
J	Sroka, J; Krecioch, I; Zimolag, E; Lasota, S; Rak, M; Kedracka-Krok, S; Borowicz, P; Gajek, M; Madeja, Z				Sroka, Jolanta; Krecioch, Izabela; Zimolag, Eliza; Lasota, Slawomir; Rak, Monika; Kedracka-Krok, Sylwia; Borowicz, Pawel; Gajek, Marta; Madeja, Zbigniew			Lamellipodia and Membrane Blebs Drive Efficient Electrotactic Migration of Rat Walker Carcinosarcoma Cells WC 256	PLOS ONE			English	Article							CURRENT ELECTRIC-FIELD; DIRECTIONAL MIGRATION; DICTYOSTELIUM CELLS; HUMAN KERATINOCYTES; CALCIUM-IONS; FOLIC-ACID; GALVANOTAXIS; CHEMOTAXIS; SHAPE; LOCOMOTION	The endogenous electric field (EF) may provide an important signal for directional cell migration during wound healing, embryonic development and cancer metastasis but the mechanism of cell electrotaxis is poorly understood. Additionally, there is no research addressing the question on the difference in electrotactic motility of cells representing various strategies of cell movement-specifically blebbing vs. lamellipodial migration. In the current study we constructed a unique experimental model which allowed for the investigation of electrotactic movement of cells of the same origin but representing different modes of cell migration: weakly adherent, spontaneously blebbing (BC) and lamellipodia forming (LC) WC256 cells. We report that both BC and LC sublines show robust cathodal migration in a physiological EF (1-3 V/cm). The directionality of cell movement was completely reversible upon reversing the field polarity. However, the full reversal of cell direction after the change of EF polarity was much faster in the case of BC (10 minutes) than LC cells (30 minutes). We also investigated the distinct requirements for Rac, Cdc42 and Rho pathways and intracellular Ca2+ in electrotaxis of WC256 sublines forming different types of cell protrusions. It was found that Rac1 is required for directional movement of LC to a much greater extent than for BC, but Cdc42 and RhoA are more crucial for BC than for LC cells. The inhibition of ROCK did not affect electrotaxis of LC in contrast to BC cells. The results also showed that intracellular Ca2+ is essential only for the electrotactic reaction of BC cells. Moreover, inhibition of MLCK and myosin II did not affect the electrotaxis of LC in contrast to BC cells. In conclusion, our results revealed that both lamellipodia and membrane blebs can efficiently drive electrotactic migration of WC 256 carcinosarcoma cells, however directional migration is mediated by different signalling pathways.	[Sroka, Jolanta; Krecioch, Izabela; Zimolag, Eliza; Lasota, Slawomir; Rak, Monika; Borowicz, Pawel; Gajek, Marta; Madeja, Zbigniew] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Cell Biol, Gronostajowa 7, PL-30387 Krakow, Poland; [Kedracka-Krok, Sylwia] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Phys Biochem, Gronostajowa 7, PL-30387 Krakow, Poland; [Kedracka-Krok, Sylwia] Jagiellonian Univ, Malopolska Ctr Biotechnol, Gronostajowa 7b, PL-30387 Krakow, Poland	Jagiellonian University; Jagiellonian University; Jagiellonian University	Sroka, J; Madeja, Z (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Cell Biol, Gronostajowa 7, PL-30387 Krakow, Poland.	jolanta.sroka@uj.edu.pl; z.madeja@uj.edu.pl	; Rak, Monika/U-7025-2018	Sroka, Jolanta/0000-0003-3728-752X; Zimolag, Eliza/0000-0003-4104-0095; Krecioch, Izabela/0000-0002-3629-8123; Madeja, Zbigniew/0000-0002-5523-1215; Borowicz, Pawel/0000-0002-5604-5844; Rak, Monika/0000-0003-4746-944X; Lasota, Slawomir/0000-0002-9477-5338	National Science Centre, Poland [2012/07/B/NZ3/02909]; Ministry of Science and Higher Education; European Regional Development Fund [POIG.02.01.00-12-167/08]; National Science Center, Krakow, Poland [UMO-2012/05/B/NZ4/02428]	National Science Centre, Poland(National Science Centre, Poland); Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); European Regional Development Fund(European Commission); National Science Center, Krakow, Poland(National Science Centre, Poland)	This work was supported by a grant from the National Science Centre 2012/07/B/NZ3/02909, Poland. Faculty of Biochemistry, Biophysics and Biotechnology of Jagiellonian University is a partner of the Leading National Research Center (KNOW) supported by the Ministry of Science and Higher Education. The LC-MS/MS measurements were done with the equipment spectrometer Q-Exactive purchased by the European Regional Development Fund in the framework of the Polish Innovation Economy Operational Program (contract No. POIG.02.01.00-12-167/08, project Malopolska Center of Biotechnology) and supported by grant UMO-2012/05/B/NZ4/02428 from the National Science Center, Krakow, Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GM, 2013, CURR BIOL, V23, P560, DOI 10.1016/j.cub.2013.02.047; BARKER AT, 1982, AM J PHYSIOL, V242, pR358, DOI 10.1152/ajpregu.1982.242.3.R358; Bergert M, 2012, P NATL ACAD SCI USA, V109, P14434, DOI 10.1073/pnas.1207968109; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; BROWN MJ, 1994, J CELL BIOL, V127, P117, DOI 10.1083/jcb.127.1.117; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Chi QJ, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1072; COOPER MS, 1984, P NATL ACAD SCI-BIOL, V81, P160, DOI 10.1073/pnas.81.1.160; Djamgoz MBA, 2001, J CELL SCI, V114, P2697; DUNN GA, 1986, J CELL SCI, V83, P313; ERICKSON CA, 1984, J CELL BIOL, V98, P296, DOI 10.1083/jcb.98.1.296; FRIEDL P, 1993, J IMMUNOL METHODS, V165, P157, DOI 10.1016/0022-1759(93)90341-4; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; GRULER H, 1991, CELL MOTIL CYTOSKEL, V19, P121, DOI 10.1002/cm.970190207; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; Korohoda W, 2002, CELL MOTIL CYTOSKEL, V53, P1, DOI 10.1002/cm.10052; Korohoda W, 1997, CELL MOTIL CYTOSKEL, V38, P38, DOI 10.1002/(SICI)1097-0169(1997)38:1<38::AID-CM5>3.3.CO;2-O; Korohoda W, 2000, CELL MOTIL CYTOSKEL, V45, P10, DOI 10.1002/(SICI)1097-0169(200001)45:1<10::AID-CM2>3.0.CO;2-T; Krecioch I, 2015, ACTA BIOCHIM POL, V62, P401, DOI 10.18388/abp.2015_1019; Langridye PD, 2006, EXP CELL RES, V312, P2009, DOI 10.1016/j.yexcr.2006.03.007; Maeda M, 2011, MOL BIOL CELL, V22, P3840, DOI 10.1091/mbc.E11-04-0364; McCaig CD, 1997, BIOESSAYS, V19, P819, DOI 10.1002/bies.950190912; McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004; Mycielska ME, 2004, J CELL SCI, V117, P1631, DOI 10.1242/jcs.01125; Nakajima K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9532; Nishimura KY, 1996, J CELL SCI, V109, P199; ONUMA EK, 1988, J CELL BIOL, V106, P2067, DOI 10.1083/jcb.106.6.2067; Paluch EK, 2013, CURR OPIN CELL BIOL, V25, P582, DOI 10.1016/j.ceb.2013.05.005; Paul BZS, 1999, J BIOL CHEM, V274, P28293, DOI 10.1074/jbc.274.40.28293; Pullar CE, 2006, MOL BIOL CELL, V17, P4925, DOI 10.1091/mbc.E06-05-0433; Rajnicek AM, 2007, DEV BIOL, V312, P448, DOI 10.1016/j.ydbio.2007.09.051; RAPP B, 1988, EUR BIOPHYS J BIOPHY, V16, P313, DOI 10.1007/BF00254068; Rassokhin MA, 2014, CELL BIOCHEM BIOPHYS, V69, P555, DOI 10.1007/s12013-014-9831-9; Rassokhin MA, 2012, J MEMBRANE BIOL, V245, P521, DOI 10.1007/s00232-012-9433-7; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sheridan DM, 1996, J INVEST DERMATOL, V106, P642, DOI 10.1111/1523-1747.ep12345456; Sixt M, 2012, J CELL BIOL, V197, P346, DOI 10.1083/jcb.201204039; Sowa M, 2015, MAT SCI ENG C-MATER, V49, P159, DOI 10.1016/j.msec.2014.12.073; Sroka J, 2002, TOXICOLOGY, V180, P275, DOI 10.1016/S0300-483X(02)00419-5; Sroka J, 2002, INT J BIOCHEM CELL B, V34, P882, DOI 10.1016/S1357-2725(01)00178-9; Sta Iglesia Drina D., 1998, Wound Repair and Regeneration, V6, P531; Sun YH, 2013, CURR BIOL, V23, P569, DOI 10.1016/j.cub.2013.02.026; Tyson RA, 2014, P NATL ACAD SCI USA, V111, P11703, DOI 10.1073/pnas.1322291111; Wang CC, 2011, LAB CHIP, V11, P695, DOI 10.1039/c0lc00155d; Wang Q, 1998, CLIN ORTHOP RELAT R, P259; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; WOJCIAKSTOTHARD B, 1995, CELL BIOL INT, V19, P485, DOI 10.1006/cbir.1995.1092; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wu D, 2013, CELL BIOCHEM BIOPHYS, V67, P1115, DOI 10.1007/s12013-013-9615-7; Wu JD, 2014, ADV WOUND CARE, V3, P149, DOI 10.1089/wound.2013.0453; Yoshida K, 2006, J CELL SCI, V119, P3833, DOI 10.1242/jcs.03152; Zatulovskiy E, 2014, J CELL BIOL, V204, P1027, DOI 10.1083/jcb.201306147; Zhang JP, 2011, STEM CELL REV REP, V7, P987, DOI 10.1007/s12015-011-9247-5; Zhao M, 2009, SEMIN CELL DEV BIOL, V20, P674, DOI 10.1016/j.semcdb.2008.12.009	56	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149133	10.1371/journal.pone.0149133	http://dx.doi.org/10.1371/journal.pone.0149133			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863616	Green Submitted, Green Published, gold			2022-12-27	WOS:000370046600159
J	Lopes, FAC; Catao, ECP; Santana, RH; Cabral, AD; Paranhos, R; Rangel, TP; de Rezende, CE; Edwards, RA; Thompson, CC; Thompson, FL; Kruger, RH				Cardoso Lopes, Fabyano Alvares; Pires Catao, Elisa Caldeira; Santana, Renata Henrique; Cabral, Anderson de Souza; Paranhos, Rodolfo; Rangel, Thiago Pessanha; de Rezende, Carlos Eduardo; Edwards, Robert A.; Thompson, Cristiane C.; Thompson, Fabiano L.; Kruger, Ricardo Henrique			Microbial Community Profile and Water Quality in a Protected Area of the Caatinga Biome	PLOS ONE			English	Article							FRESH-WATER; NONPARAMETRIC-ESTIMATION; NORTHEASTERN BRAZIL; EMAMECTIN BENZOATE; SEQUENCING DATA; FLOW-CYTOMETRY; SOIL; BACTERIAL; PESTICIDES; POPULATION	The Caatinga is a semi-arid biome in northeast Brazil. The Paraguacu River is located in the Caatinga biome, and part of its course is protected by the National Park of Chapada Diamantina (PNCD). In this study we evaluated the effect of PNCD protection on the water quality and microbial community diversity of this river by analyzing water samples obtained from points located inside and outside the PNCD in both wet and dry seasons. Results of water quality analysis showed higher levels of silicate, ammonia, particulate organic carbon, and nitrite in samples from the unprotected area compared with those from protected areas. Pyrosequencing of the 16S rRNA genes revealed that Burkholderiales was abundant in samples from all three sites during both seasons and was represented primarily by the genus Polynucleobacter and members of the Comamonadaceae family (e.g., genus Limnohabitans). During the dry season, the unprotected area showed a higher abundance of Flavobacterium sp. and Arthrobacter sp., which are frequently associated with the presence and/or degradation of arsenic and pesticide compounds. In addition, genes that appear to be related to agricultural impacts on the environment, as well as those involved in arsenic and cadmium resistance, copper homeostasis, and propanediol utilization, were detected in the unprotected areas by metagenomic sequencing. Although PNCD protection improves water quality, agricultural activities around the park may affect water quality within the park and may account for the presence of bacteria capable of pesticide degradation and assimilation, evidencing possible anthropogenic impacts on the Caatinga.	[Cardoso Lopes, Fabyano Alvares; Pires Catao, Elisa Caldeira; Kruger, Ricardo Henrique] Univ Brasilia, Dept Cellular Biol, Brasilia, DF, Brazil; [Santana, Renata Henrique] Univ Catolica Brasilia, Genom Sci & Biotechnol, Brasilia, DF, Brazil; [Cabral, Anderson de Souza; Paranhos, Rodolfo; Thompson, Cristiane C.; Thompson, Fabiano L.] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil; [Rangel, Thiago Pessanha; de Rezende, Carlos Eduardo] Univ Estadual N Fluminen, Lab Environm Sci, Campos dos Goytacazes, Brazil; [Edwards, Robert A.] San Diego State Univ, Computat Sci Res Ctr, San Diego, CA 92182 USA; [Edwards, Robert A.] San Diego State Univ, Dept Comp Sci, San Diego, CA 92182 USA	Universidade de Brasilia; Universidade Catolica de Brasilia; Universidade Federal do Rio de Janeiro; California State University System; San Diego State University; California State University System; San Diego State University	Kruger, RH (corresponding author), Univ Brasilia, Dept Cellular Biol, Brasilia, DF, Brazil.; Thompson, FL (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil.	fabianothompson1@gmail.com; kruger@unb.br	Thompson, Cristiane C/I-5783-2016; Lopes, Fabyano Alvares Cardoso/E-1969-2015; Edwards, Robert/Q-1691-2019; Lopes, Fabyano A.C./F-7558-2018; de Rezende, Carlos E/I-1893-2015; Kruger, Ricardo/Y-9595-2019	Edwards, Robert/0000-0001-8383-8949; Lopes, Fabyano A.C./0000-0002-4565-9103; de Rezende, Carlos/0000-0003-2804-8930; Catao, Elisa C.P./0000-0003-4620-1097; Thompson, Fabiano/0000-0002-7562-1683; Kruger, Ricardo/0000-0002-8443-9402	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq; Instituto Chico Mendes de Conservacao da Biodiversidade - ICMBio [551994/2011-8]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); National Park of Chapada Diamantina; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) fellowship; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Instituto Chico Mendes de Conservacao da Biodiversidade (ICMBio); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); CAPES fellowship; Direct For Biological Sciences [1330800] Funding Source: National Science Foundation	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Chico Mendes de Conservacao da Biodiversidade - ICMBio; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); National Park of Chapada Diamantina; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) fellowship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Chico Mendes de Conservacao da Biodiversidade (ICMBio); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES fellowship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq - and Instituto Chico Mendes de Conservacao da Biodiversidade - ICMBio - (grant number 551994/2011-8; www.cnpq.br; www.icmbio.gov.br). The authors are grateful for the support offered by Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and National Park of Chapada Diamantina. F.A.C.L. is supported by a Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Instituto Chico Mendes de Conservacao da Biodiversidade (ICMBio), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). We are grateful for the support offered by Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and National Park of Chapada Diamantina. F.A.C.L. is supported by a CAPES fellowship.	Andrade L, 2003, J MICROBIOL METH, V55, P841, DOI 10.1016/j.mimet.2003.08.002; Armougom F., 2009, J COMPUT SCI SYST BI, V2, P74, DOI DOI 10.4172/JCSB.1000019; Boyd RA, 2000, SCI TOTAL ENVIRON, V248, P241, DOI 10.1016/S0048-9697(99)00546-X; Bruce T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036687; Brussaard CPD, 2000, J VIROL METHODS, V85, P175, DOI 10.1016/S0166-0934(99)00167-6; Cao LD, 2013, J ANAL METHODS CHEM, V2013, DOI 10.1155/2013/121783; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Carpenter SR, 2005, P NATL ACAD SCI USA, V102, P10002, DOI 10.1073/pnas.0503959102; Castro WD, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00812-14; CHAO A, 1984, SCAND J STAT, V11, P265; Chao A, 2003, ENVIRON ECOL STAT, V10, P429, DOI 10.1023/A:1026096204727; Compant S, 2008, FEMS MICROBIOL REV, V32, P607, DOI 10.1111/j.1574-6976.2008.00113.x; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; DEALBUQUERQUE SG, 1995, PESQUI AGROPECU BRAS, V30, P885; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; EPA S, 1995, MICR ASS AC DIG SIL; Fang H, 2014, SCI TOTAL ENVIRON, V470, P983, DOI 10.1016/j.scitotenv.2013.10.076; Fanigliulo A, 2008, Commun Agric Appl Biol Sci, V73, P651; Fiedler S, 2008, BIOGEOSCIENCES, V5, P1615, DOI 10.5194/bg-5-1615-2008; Gasol JM, 2000, SCI MAR, V64, P197, DOI 10.3989/scimar.2000.64n2197; Ghai R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023785; Giongo V., 2011, Dynamic Soil, Dynamic Plant, V5, P12; Giulietti AM, 2006, GREATER KNOWLEDGE BR, P11; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Gorlach-Lira K, 2007, BRAZ J MICROBIOL, V38, P135, DOI 10.1590/S1517-83822007000100028; Grasshoff K, 1999, METHODS SEAWATER ANA; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hahn MW, 2010, INT J SYST EVOL MICR, V60, P166, DOI 10.1099/ijs.0.010595-0; Hahn MW, 2009, INT J SYST EVOL MICR, V59, P2002, DOI 10.1099/ijs.0.005801-0; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hemme CL, 2010, ISME J, V4, P660, DOI 10.1038/ismej.2009.154; Hillebrand H, 2007, P NATL ACAD SCI USA, V104, P10904, DOI 10.1073/pnas.0701918104; Hundt K, 1998, CHEMOSPHERE, V36, P2321, DOI 10.1016/S0045-6535(97)10201-6; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Hussen A, 2007, J CHROMATOGR A, V1152, P247, DOI 10.1016/j.chroma.2007.02.076; Jezbera J, 2012, FEMS MICROBIOL ECOL, V81, P467, DOI 10.1111/j.1574-6941.2012.01372.x; Kavamura VN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073606; Kiaune L, 2011, REV ENVIRON CONTAM T, V213, P1, DOI 10.1007/978-1-4419-9860-6_1; Kuo JN, 2010, ENVIRON TOXICOL CHEM, V29, P1816, DOI 10.1002/etc.209; Liu JW, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00064; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Marcon AE, 2010, CHEMOSPHERE, V81, P773, DOI 10.1016/j.chemosphere.2010.07.006; Marie D, 1996, APPL ENVIRON MICROB, V62, P1649, DOI 10.1128/AEM.62.5.1649-1655.1996; Marie D, 2005, PHYTOPLANKTON CELL C; MARQUES JSJ, 2011, GEST COSTEIRA INTEG, V11, P379, DOI DOI 10.5894/RGCI183; Mattes TE, 2008, APPL ENVIRON MICROB, V74, P6405, DOI 10.1128/AEM.00197-08; Menezes RSC, 2012, BRAZ J BIOL, V72, P643, DOI 10.1590/S1519-69842012000400004; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; MMA-Ministerio do Meio Ambiente, 2010, PLAN AC PREV CONTR D; Monteiro JM, 2009, J MICROBIOL, V47, P363, DOI 10.1007/s12275-009-0048-3; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pacchioni RG, 2014, MICROBIOLOGYOPEN, V3, P299, DOI 10.1002/mbo3.169; Padro DE, 2003, ECOLOGIA CONSERVACAO; Paerl H, 2008, ADV EXP MED BIOL, V619, P217, DOI 10.1007/978-0-387-75865-7_10; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Paul D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118735; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; R Core Team, 2013, R LANG ENV STAT COMP; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Rezende CE, 2010, ESTUAR COAST SHELF S, V87, P479, DOI 10.1016/j.ecss.2010.02.008; Ribeiro CAO, 2006, PARTICIPACAO SOCIAL; Riedel SL, 2014, APPL MICROBIOL BIOT, V98, P1469, DOI 10.1007/s00253-013-5430-8; Ryan MP, 2007, J APPL MICROBIOL, V103, P754, DOI 10.1111/j.1365-2672.2007.03361.x; Sagarkar S, 2016, APPL MICROBIOL BIOT, V100, P903, DOI 10.1007/s00253-015-6975-5; Sant'Anna CL, 2011, NEUROTOX RES, V19, P389, DOI 10.1007/s12640-010-9177-z; Santana RH, 2015, MICROB ECOL, V70, P545, DOI 10.1007/s00248-015-0581-z; Shegunova P, 2007, ENVIRON POLLUT, V146, P257, DOI 10.1016/j.envpol.2006.03.057; Simek K, 2010, APPL ENVIRON MICROB, V76, P631, DOI 10.1128/AEM.02203-09; Starliper CE, 2011, J ADV RES, V2, P97, DOI 10.1016/j.jare.2010.04.001; Tseng CH, 2013, ISME J, V7, P2374, DOI 10.1038/ismej.2013.118; van-Elsas JD, 2006, MODERN SOIL MICROBIO, P83; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; Wang QF, 2013, INT BIODETER BIODEGR, V77, P63, DOI 10.1016/j.ibiod.2012.11.003; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang QY, 2009, SOIL BIOL BIOCHEM, V41, P1504, DOI 10.1016/j.soilbio.2009.04.010; Wilke A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-141; Willis KJ, 2003, AQUACULTURE, V221, P289, DOI 10.1016/S0044-8486(03)00066-8; Yan Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep08605; Zarcinas BA, 2004, ENVIRON GEOCHEM HLTH, V26, P343, DOI 10.1007/s10653-005-4669-0; Zhang JY, 2007, J ENVIRON SCI, V19, P338, DOI 10.1016/S1001-0742(07)60055-2; Zhao FJ, 2009, NEW PHYTOL, V181, P777, DOI 10.1111/j.1469-8137.2008.02716.x; Zorb C, 2014, J PLANT PHYSIOL, V171, P656, DOI 10.1016/j.jplph.2013.08.008	84	8	9	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148296	10.1371/journal.pone.0148296	http://dx.doi.org/10.1371/journal.pone.0148296			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881432	Green Published, gold, Green Submitted			2022-12-27	WOS:000371219000015
J	Wu, CC; Chen, BS				Wu, Chia-Chou; Chen, Bor-Sen			A Systems Biology Approach to the Coordination of Defensive and Offensive Molecular Mechanisms in the Innate and Adaptive Host-Pathogen Interaction Networks	PLOS ONE			English	Article							CANDIDA-ALBICANS; STAPHYLOCOCCUS-AUREUS; GLUCOSE SENSOR; ZEBRAFISH; IMMUNITY; INFECTION; IDENTIFICATION; NEUTROPHILS; RESISTANCE; MEMORY	Infected zebrafish coordinates defensive and offensive molecular mechanisms in response to Candida albicans infections, and invasive C. albicans coordinates corresponding molecular mechanisms to interact with the host. However, knowledge of the ensuing infection-activated signaling networks in both host and pathogen and their interspecific crosstalk during the innate and adaptive phases of the infection processes remains incomplete. In the present study, dynamic network modeling, protein interaction databases, and dual transcriptome data from zebrafish and C. albicans during infection were used to infer infectionactivated host-pathogen dynamic interaction networks. The consideration of host-pathogen dynamic interaction systems as innate and adaptive loops and subsequent comparisons of inferred innate and adaptive networks indicated previously unrecognized crosstalk between known pathways and suggested roles of immunological memory in the coordination of host defensive and offensive molecular mechanisms to achieve specific and powerful defense against pathogens. Moreover, pathogens enhance intraspecific crosstalk and abrogate host apoptosis to accommodate enhanced host defense mechanisms during the adaptive phase. Accordingly, links between physiological phenomena and changes in the coordination of defensive and offensive molecular mechanisms highlight the importance of host-pathogen molecular interaction networks, and consequent inferences of the host-pathogen relationship could be translated into biomedical applications.	[Wu, Chia-Chou; Chen, Bor-Sen] Natl Tsing Hua Univ, Automat Control Signal Proc & Syst Biol Lab, Hsinchu 30013, Taiwan	National Tsing Hua University	Chen, BS (corresponding author), Natl Tsing Hua Univ, Automat Control Signal Proc & Syst Biol Lab, Hsinchu 30013, Taiwan.	bschen@ee.nthu.edu.tw	Wu, Chia-Chou/L-1058-2013; Chen, Bor-Sen/D-9114-2017	Wu, Chia-Chou/0000-0002-4009-6858; 	Ministry of Science and Technology [MOST-103-2745-E-007-001-ASP]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	The authors are grateful for the support provided by the Ministry of Science and Technology through grant no. MOST-103-2745-E-007-001-ASP.	Ashida H, 2011, J CELL BIOL, V195, P931, DOI 10.1083/jcb.201108081; Basson NJ, 2000, J MED MICROBIOL, V49, P969, DOI 10.1099/0022-1317-49-11-969; Besedovsky L, 2012, PFLUG ARCH EUR J PHY, V463, P121, DOI 10.1007/s00424-011-1044-0; Bevan MJ, 2011, NAT IMMUNOL, V12, P463, DOI 10.1038/ni.2041; Brown HM, 2012, CELL MICROBIOL, V14, P1554, DOI 10.1111/j.1462-5822.2012.01820.x; Brown JN, 2010, J VIROL, V84, P12058, DOI 10.1128/JVI.01129-10; Brown V, 2006, EUKARYOT CELL, V5, P1726, DOI 10.1128/EC.00186-06; Buckley CD, 2013, NAT REV IMMUNOL, V13, P59, DOI 10.1038/nri3362; Chao CC, 2010, INFECT IMMUN, V78, P2512, DOI 10.1128/IAI.01293-09; Chasman D, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145120; Chatr-aryamontri A, 2015, NUCLEIC ACIDS RES, V43, pD470, DOI 10.1093/nar/gku1204; Chen YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072483; Ciarleglio CM, 2011, NEUROSCIENCE, V197, P8, DOI 10.1016/j.neuroscience.2011.09.036; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Duhring S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00625; Ferro VA, 2004, VACCINE, V22, P1024, DOI 10.1016/j.vaccine.2003.08.043; Frantz S, 2005, CIRC RES, V96, P15, DOI 10.1161/01.RES.0000153188.68898.ac; Gao Y, 2008, BIOCHEMISTRY-US, V47, P11367, DOI 10.1021/bi801122t; Gow NAR, 2012, NAT REV MICROBIOL, V10, P112, DOI 10.1038/nrmicro2711; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Hasnain SE, 2003, J BIOSCIENCES, V28, P349, DOI 10.1007/BF02970153; Hawn TR, 2015, IMMUNOL REV, V264, P344, DOI 10.1111/imr.12255; Inglis DO, 2012, NUCLEIC ACIDS RES, V40, pD667, DOI 10.1093/nar/gkr945; Johansson R, 1993, PRENTICE HALL INFORM; Johnson EE, 2012, MICROBES INFECT, V14, P207, DOI 10.1016/j.micinf.2011.10.001; Kaba HEJ, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-16; Kannarkat GT, 2013, J PARKINSON DIS, V3, P493, DOI 10.3233/JPD-130250; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Kuo ZY, 2013, J INNATE IMMUN, V5, P137, DOI 10.1159/000347104; Lan CY, 2004, MOL MICROBIOL, V53, P1451, DOI 10.1111/j.1365-2958.2004.04214.x; Leach MD, 2011, MOL BIOL CELL, V22, P687, DOI 10.1091/mbc.E10-07-0632; Lin C, 2014, BMC SYST BIOL, V8, DOI 10.1186/s12918-014-0116-0; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Maidan MM, 2005, BIOCHEM SOC T, V33, P291, DOI 10.1042/BST0330291; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Meijer AH, 2011, CURR DRUG TARGETS, V12, P1000; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Molnar E, 2012, J BIOL CHEM, V287, P42664, DOI 10.1074/jbc.M112.386045; Netea MG, 2015, NAT IMMUNOL, V16, P675, DOI 10.1038/ni.3178; Nitzan M, 2015, NUCLEIC ACIDS RES, V43, P1357, DOI 10.1093/nar/gkv001; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Rodaki A, 2009, MOL BIOL CELL, V20, P4845, DOI 10.1091/mbc.E09-01-0002; Rolf J, 2013, EUR J IMMUNOL, V43, P889, DOI 10.1002/eji.201243008; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Sabina J, 2009, EUKARYOT CELL, V8, P1314, DOI 10.1128/EC.00138-09; Scheiermann C, 2012, IMMUNITY, V37, P290, DOI 10.1016/j.immuni.2012.05.021; Spaan AN, 2013, ANNU REV MICROBIOL, V67, P629, DOI 10.1146/annurev-micro-092412-155746; Sun X, 2002, P NATL ACAD SCI USA, V99, P4686, DOI 10.1073/pnas.062585499; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tong SYC, 2012, SEMIN IMMUNOPATHOL, V34, P185, DOI 10.1007/s00281-011-0300-x; Trede NS, 2004, IMMUNITY, V20, P367, DOI 10.1016/S1074-7613(04)00084-6; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wang YC, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-79; Westermann AJ, 2012, NAT REV MICROBIOL, V10, P618, DOI 10.1038/nrmicro2852; Wu CC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0097902, 10.1371/journal.pone.0105362]; Yang DR, 2015, WORLD J GASTROENTERO, V21, P3786, DOI 10.3748/wjg.v21.i13.3786	56	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149303	10.1371/journal.pone.0149303	http://dx.doi.org/10.1371/journal.pone.0149303			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881892	Green Published, Green Submitted, gold			2022-12-27	WOS:000371219000069
J	Druzinsky, RE; Balhoff, JP; Crompton, AW; Done, J; German, RZ; Haendel, MA; Herrel, A; Herring, SW; Lapp, H; Mabee, PM; Muller, HM; Mungall, CJ; Sternberg, PW; Van Auken, K; Vinyard, CJ; Williams, SH; Wall, CE				Druzinsky, Robert E.; Balhoff, James P.; Crompton, Alfred W.; Done, James; German, Rebecca Z.; Haendel, Melissa A.; Herrel, Anthony; Herring, Susan W.; Lapp, Hilmar; Mabee, Paula M.; Muller, Hans-Michael; Mungall, Christopher J.; Sternberg, Paul W.; Van Auken, Kimberly; Vinyard, Christopher J.; Williams, Susan H.; Wall, Christine E.			Muscle Logic: New Knowledge Resource for Anatomy Enables Comprehensive Searches of the Literature on the Feeding Muscles of Mammals	PLOS ONE			English	Article							ONTOLOGIES; TOOL; UNIFICATION; ANNOTATION; MORPHOLOGY; EVOLUTION; ORGANISM; GENOMICS	Background In recent years large bibliographic databases have made much of the published literature of biology available for searches. However, the capabilities of the search engines integrated into these databases for text-based bibliographic searches are limited. To enable searches that deliver the results expected by comparative anatomists, an underlying logical structure known as an ontology is required. Development and Testing of the Ontology Here we present the Mammalian Feeding Muscle Ontology (MFMO), a multi-species ontology focused on anatomical structures that participate in feeding and other oral/pharyngeal behaviors. A unique feature of the MFMO is that a simple, computable, definition of each muscle, which includes its attachments and innervation, is true across mammals. This construction mirrors the logical foundation of comparative anatomy and permits searches using language familiar to biologists. Further, it provides a template for muscles that will be useful in extending any anatomy ontology. The MFMO is developed to support the Feeding Experiments End-User Database Project (FEED, https://feedexp.org/), a publicly-available, online repository for physiological data collected from in vivo studies of feeding (e.g., mastication, biting, swallowing) in mammals. Currently the MFMO is integrated into FEED and also into two literature-specific implementations of Textpresso, a text-mining system that facilitates powerful searches of a corpus of scientific publications. We evaluate the MFMO by asking questions that test the ability of the ontology to return appropriate answers (competency questions). We compare the results of queries of the MFMO to results from similar searches in PubMed and Google Scholar. Results and Significance Our tests demonstrate that the MFMO is competent to answer queries formed in the common language of comparative anatomy, but PubMed and Google Scholar are not. Overall, our results show that by incorporating anatomical ontologies into searches, an expanded and anatomically comprehensive set of results can be obtained. The broader scientific and publishing communities should consider taking up the challenge of semantically enabled search capabilities.	[Druzinsky, Robert E.] Univ Illinois, Dept Oral Biol, Chicago, IL USA; [Balhoff, James P.] RTI Int, Res Triangle Pk, NC USA; [Crompton, Alfred W.] Harvard Univ, Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Done, James; Muller, Hans-Michael; Sternberg, Paul W.; Van Auken, Kimberly] CALTECH, Div Biol & Biol Engn, M-C 156-29, Pasadena, CA 91125 USA; [German, Rebecca Z.; Vinyard, Christopher J.] Northeast Ohio Med Univ, Dept Anat & Neurobiol, Rootstown, OH USA; [Haendel, Melissa A.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Herrel, Anthony] Museum Natl Hist Nat, Dept Ecol & Gest Biodiversite, F-75231 Paris, France; [Herring, Susan W.] Univ Washington, Dept Orthodont, Seattle, WA 98195 USA; [Lapp, Hilmar] Natl Evolutionary Synth Ctr, Durham, NC USA; [Lapp, Hilmar] Duke Univ, Ctr Genom & Computat Biol, Durham, NC USA; [Mabee, Paula M.] Univ S Dakota, Dept Biol, Vermillion, SD 57069 USA; [Mungall, Christopher J.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA; [Sternberg, Paul W.] CALTECH, Howard Hughes Med Inst, M-C 156-29, Pasadena, CA 91125 USA; [Williams, Susan H.] Ohio Univ, Dept Biomed Sci, Heritage Coll Osteopath Med, Athens, OH 45701 USA; [Wall, Christine E.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Research Triangle Institute; Harvard University; California Institute of Technology; Northeast Ohio Medical University (NEOMED); Oregon Health & Science University; Museum National d'Histoire Naturelle (MNHN); University of Washington; University of Washington Seattle; The National Evolutionary Synthesis Center; Duke University; University of South Dakota; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; California Institute of Technology; Howard Hughes Medical Institute; University System of Ohio; Ohio University; Duke University	Druzinsky, RE (corresponding author), Univ Illinois, Dept Oral Biol, Chicago, IL USA.	druzinsk@uic.edu	Muller, Hans-Michael/J-9624-2015; Mungall, Chris/I-6006-2019; Herrel, Anthony/C-3712-2013	Mungall, Chris/0000-0002-6601-2165; Herrel, Anthony/0000-0003-0991-4434; Lapp, Hilmar/0000-0001-9107-0714; Williams, Susan/0000-0003-4167-678X; Haendel, Melissa/0000-0001-9114-8737; Balhoff, James/0000-0002-8688-6599	National Science Foundation [DBI-1062350, DBI-1062327, DBI-1062333, DBI-1343588, DBI-1062332, DBI-1062542, DEB-0956049]; National Evolutionary Synthesis Center [EF-0905606]; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; Phenotype Ontology Research Coordination Network [DEB-0956049]; Phenotype RCN; National Institutes of Health [U41-HG002223]; National Evolutionary Synthesis Center (NESCent) [EF-0905606]; Phenotype RCN (NSF) [DEB-0956049]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG002223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009980] Funding Source: NIH RePORTER; Direct For Biological Sciences [0956049, 1062350, 1062327] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1062333, 1062542, 1062404] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Evolutionary Synthesis Center; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); Phenotype Ontology Research Coordination Network; Phenotype RCN; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Evolutionary Synthesis Center (NESCent)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Phenotype RCN (NSF); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work received support from the following sources: National Science Foundation (nsf.gov) to RED DBI-1062350; to SHW DBI-1062327; to CEW DBI-1062333; to RZG DBI-1343588; to CJV DBI-1062332; to PMM DBI-1062542 and DEB-0956049; National Evolutionary Synthesis Center (https://www.nescent.org/; NESCent; NSF EF-0905606). NESCent hosted FEED Workshops in May, 2012, and May, 2014. CJM was supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231 (http://energy.gov/eere/vehicles/downloads/office-science-basicenergy-sciences). PMM acknowledges funding from the National Science Foundation (DBI-1062542) and the Phenotype Ontology Research Coordination Network (DEB-0956049). Phenotype RCN (www.phenotypercn.org/) also provided support for RED and CJM. National Institutes of Health (www.nih.gov/; U41-HG002223) to PWS. PWS is also an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Gowri Ramachandran and Matt O'Neill provided support to help organize and enter data on muscle anatomy and terminology. Kun Peng and Elizabeth Ro performed data entry for the Textpresso for FEED project. Work on the MFMO is supported by the National Science Foundation (DBI-1062350 to Robert Druzinsky). We thank Wasila Dahdul for all of her advice and support. We would like to thank Kathleen Smith, Allen Rodrigo, Susan Alberts, and the National Evolutionary Synthesis Center (NESCent; NSF EF-0905606). NESCent hosted FEED Workshops in May, 2012, and May, 2014. Chris Mungall was supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. Paula Mabee and Wasila Dahdul acknowledge funding from the National Science Foundation (DBI-1062542) and the Phenotype Ontology Research Coordination Network (DEB-0956049). The Phenotype RCN (NSF DEB-0956049) also provided support for Robert Druzinsky and Chris Mungall. Paul Sternberg is an investigator of the Howard Hughes Medical Institute.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balhoff JP, 2014, J BIOMED SEMANT, V5, DOI 10.1186/2041-1480-5-45; Balhoff JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010500; BALL SS, 1995, J MORPHOL, V224, P265, DOI 10.1002/jmor.1052240303; Bard JBL, 1998, MECH DEVELOP, V74, P111, DOI 10.1016/S0925-4773(98)00069-0; Becker KG, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-61; Bizer C, 2009, J WEB SEMANT, V7, P154, DOI 10.1016/j.websem.2009.07.002; Costa M, 2013, J BIOMED SEMANT, V4, DOI 10.1186/2041-1480-4-32; Cui H, 2012, J AM SOC INF SCI TEC, V63, P738, DOI 10.1002/asi.22618; Dahdul W, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav040; Dahdul WM, 2014, J BIOMED SEMANT, V5, DOI 10.1186/2041-1480-5-34; Dahdul WM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051070; Dahdul WM, 2010, SYST BIOL, V59, P369, DOI 10.1093/sysbio/syq013; Dahdul WM, 2010, EVOLUTIONARY CHARACT, Ve10708; Daly M, 2015, ZOOLOGISCHER ANZEIGE; Deans AR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002033; Drake RL., 2014, GRAYS ANATOMY STUDEN, P569; Gkoutos GV, 2004, COMP FUNCT GENOM, V5, P545, DOI 10.1002/cfg.430; Gkoutos GV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r8; Gruaninger Michael., 1995, METHODOLOGY DESIGN E; Haddock NT, 2008, J RECONSTR MICROSURG, V24, P343, DOI 10.1055/s-2008-1080537; HAENDEL MA, 2008, COMPUT BIOL SER, V6, P327; Haendel MA, 2014, J BIOMED SEMANT, V5, DOI 10.1186/2041-1480-5-21; Hayamizu TF, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r29; Heidorn PB, 2008, LIBR TRENDS, V57, P280; Herring SW, 2011, INTEGR COMP BIOL; Hoehndorf R, 2015, BRIEF BIOINFORM; Kardong K., 2006, VERTEBRATES COMP ANA; Katayama R, 2010, OPEN DENT J, V4, P1, DOI 10.2174/1874210601004010001; Kazakov Y, 2014, J AUTOM REASONING, V53, P1, DOI 10.1007/s10817-013-9296-3; Mabee PM, 2007, TRENDS ECOL EVOL, V22, P345, DOI 10.1016/j.tree.2007.03.013; Maglia AM, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P367; Midford PE, 2013, J BIOMED SEMANT, V4, DOI 10.1186/2041-1480-4-34; Muller HM, 2004, PLOS BIOL, V2, P1984, DOI 10.1371/journal.pbio.0020309; Mungall CJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r5; Osumi-Sutherland D, 2012, BIOINFORMATICS, V28, P1262, DOI 10.1093/bioinformatics/bts113; Rosse C., 2007, ANATOMY ONTOLOGIES B, P63, DOI [10.1007/978-1-84628-885-2_4, DOI 10.1007/978-1-84628-885-2_4]; Smith B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r46; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Trelease Robert B., 2006, Anatomical Record Part B:The New Anatomist, V289, P72, DOI 10.1002/ar.b.20095; Van Auken K, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas040; Van Slyke CE, 2014, J BIOMED SEMANT, V5, DOI 10.1186/2041-1480-5-12; Vinyard CJ, 2011, INTEGR COMP BIOL, V51, P260, DOI 10.1093/icb/icr066; WACHTER T, 2008, COMPU BIOL, P177; Wall CE, 2011, INTEGR COMP BIOL; Williams SH, 2011, INTEGR COMP BIOL, V51, P247, DOI 10.1093/icb/icr068; WINKLER LA, 1991, INT J PRIMATOL, V12, P45, DOI 10.1007/BF02547558; Yuan Ren, 2014, The Semantic Web: Trends and Challenges. 11th International Conference (ESWC 2014). Proceedings: LNCS 8465, P752, DOI 10.1007/978-3-319-07443-6_50	48	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149102	10.1371/journal.pone.0149102	http://dx.doi.org/10.1371/journal.pone.0149102			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26870952	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000370054100104
J	Warren, BH; Baudin, R; Franck, A; Hugel, S; Strasberg, D				Warren, Ben H.; Baudin, Remy; Franck, Antoine; Hugel, Sylvain; Strasberg, Dominique			Predicting Where a Radiation Will Occur: Acoustic and Molecular Surveys Reveal Overlooked Diversity in Indian Ocean Island Crickets (Mogoplistinae: Ornebius)	PLOS ONE			English	Article							ADAPTIVE RADIATION; MODEL; ORTHOPTERA; SPECIATION; EVOLUTION; DIVERGENCE; GRYLLOIDEA; PHYLOGENY; IMPACT; SCALE	Recent theory suggests that the geographic location of island radiations (local accumulation of species diversity due to cladogenesis) can be predicted based on island area and isolation. Crickets are a suitable group for testing these predictions, as they show both the ability to reach some of the most isolated islands in the world, and to speciate at small spatial scales. Despite substantial song variation between closely related species in many island cricket lineages worldwide, to date this characteristic has not received attention in the western Indian Ocean islands; existing species descriptions are based on morphology alone. Here we use a combination of acoustics and DNA sequencing to survey these islands for Ornebius crickets. We uncover a small but previously unknown radiation in the Mascarenes, constituting a three-fold increase in the Ornebius species diversity of this archipelago (from two to six species). A further new species is detected in the Comoros. Although double archipelago colonisation is the best explanation for species diversity in the Seychelles, in situ cladogenesis is the best explanation for the six species in the Mascarenes and two species of the Comoros. Whether the radiation of Mascarene Ornebius results from intra-or purely inter-island speciation cannot be determined on the basis of the phylogenetic data alone. However, the existence of genetic, song and ecological divergence at the intra-island scale is suggestive of an intra-island speciation scenario in which ecological and mating traits diverge hand-in-hand. Our results suggest that the geographic location of Ornebius radiations is partially but not fully explained by island area and isolation. A notable anomaly is Madagascar, where our surveys are consistent with existing accounts in finding no Ornebius species present. Possible explanations are discussed, invoking ecological differences between species and differences in environmental history between islands.	[Warren, Ben H.; Baudin, Remy; Strasberg, Dominique] Univ La Reunion, UMR PVBMT, 7 Chemin IRAT, Ligne Paradis 97410, Reunion, France; [Warren, Ben H.] Univ Zurich, Inst Systemat Bot, Zollikerstr 107, CH-8008 Zurich, Switzerland; [Franck, Antoine] Cirad, UMR PVBMT, 7 Chemin IRAT, Ligne Paradis 97410, Reunion, France; [Hugel, Sylvain] Univ Strasbourg, UPR CNRS 3212, 5 Rue Blaise Pascal, F-67084 Strasbourg 3, France	University of La Reunion; University of Zurich; CIRAD; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Warren, BH (corresponding author), Univ La Reunion, UMR PVBMT, 7 Chemin IRAT, Ligne Paradis 97410, Reunion, France.; Warren, BH (corresponding author), Univ Zurich, Inst Systemat Bot, Zollikerstr 107, CH-8008 Zurich, Switzerland.	ben.warren@systbot.uzh.ch		Strasberg, Dominique/0000-0003-3012-252X; Hugel, Sylvain/0000-0003-2464-3601	French National Research Agency's biodiversity programme [ANR-2006-BDIV002]; European Union [263958, 267243]; Societe Entomologique de France, Cirad Reunion; Fondation pour la Recherche sur la Biodiversite	French National Research Agency's biodiversity programme(French National Research Agency (ANR)); European Union(European Commission); Societe Entomologique de France, Cirad Reunion; Fondation pour la Recherche sur la Biodiversite	This work was supported by the French National Research Agency's biodiversity programme (ANR-2006-BDIV002) and the European Union Seventh Framework Programme (263958 and 267243). Additional fieldwork was supported by the Societe Entomologique de France, Cirad Reunion, the Fondation pour la Recherche sur la Biodiversite and self-funding by SH. Apart from the latter, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], NATURAL HIST MADAGAS; Bolivar I., 1912, Transactions of the Linnean Society London, V15; Bolivar J., 1895, Annales de la Societe Entomologique de France, P369; Boughman JW, 2002, TRENDS ECOL EVOL, V17, P571, DOI 10.1016/S0169-5347(02)02595-8; Chopard L., 1957, Memoires de l'Institut Scientifique de MadagascarTananarive (E), V8, P31; Chopard L, 1958, MEMOIRES I SCI MAD E, VX, P4; Colgan DJ, 1998, AUST J ZOOL, V46, P419, DOI 10.1071/ZO98048; DESCAMPS M, 1969, ANN SOC ENTOMOL FR, V5, P537; Doebeli M, 2000, AM NAT, V156, pS77, DOI 10.1086/303417; Duncan R. A., 2009, ENCY ISLANDS, V2, P620; Eades DC, 2012, ORTHOPTERA SPECIES F; Eisenhauer A., 1999, Linnean Society Occasional Publication, V2, P21; Erixon P, 2003, SYST BIOL, V52, P665, DOI 10.1080/10635150390235485; Farris JS, 1995, CLADISTICS, V10, P315, DOI [DOI 10.1111/J.1096-0031.1994.TB00181.X, DOI 10.1111/J.1096-0031.1996.TB00196.X]; Flook PK, 1997, MOL PHYLOGENET EVOL, V8, P89, DOI 10.1006/mpev.1997.0412; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gavrilets S, 2009, SCIENCE, V732, P1; Gavrilets S, 2009, SCIENCE, V323, P732, DOI 10.1126/science.1157966; Gillespie RG, 2010, THEORY OF ISLAND BIOGEOGRAPHY REVISITED, P358; Goodman S.M., 2014, EXTINCT MADAGASCAR P; Grace JL, 2012, CURR ZOOL, V58, P416, DOI 10.1093/czoolo/58.3.416; Grace JL, 2011, EVOLUTION, V65, P2184, DOI 10.1111/j.1558-5646.2011.01278.x; Guerin-Meneville MFE, 1844, ICONOGRAPHIE REGNE A; Heaney LR, 2000, GLOBAL ECOL BIOGEOGR, V9, P59, DOI 10.1046/j.1365-2699.2000.00163.x; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Hugel S, 2009, NEW LANDREVINAE MASC, V45; Hugel S, 2015, J INSECT CONSERV, V19, P87, DOI 10.1007/s10841-014-9746-1; Hugel S, 2012, J INSECT CONSERV, V16, P473, DOI 10.1007/s10841-012-9476-1; Ingrisch S, 2006, REV SUISSE ZOOL, V113, P133, DOI 10.5962/bhl.part.80345; Jaiswara R, 2012, ZOOL J LINN SOC-LOND, V164, P285, DOI 10.1111/j.1096-3642.2011.00769.x; Kisel Y, 2010, AM NAT, V175, P316, DOI 10.1086/650369; Lomolino M.V., 2010, BIOGEOGRAPHY, Vfourth; Losos JB, 2000, NATURE, V408, P847, DOI 10.1038/35048558; MAC ARTHUR ROBERT H., 1967; Mendelson TC, 2005, NATURE, V433, P375, DOI 10.1038/433375a; Montaggioni L., 1988, REUNION ILE MAURICE; Moore J, 2011, J VOLCANOL GEOTH RES, V207, P47, DOI 10.1016/j.jvolgeores.2011.07.005; Nattier R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048047; Nylander JAA., 2004, BIOINFORMATICS; Oneal E, 2010, J BIOGEOGR, V37, P530, DOI 10.1111/j.1365-2699.2009.02231.x; Otte D., 1983, MONOGRAPHS OF THE ACADEMY OF NATURAL SCIENCES OF PHILADELPHIA, V22, P1; Otte D., 1994, CRICKETS HAWAII ORIG; Parnaudeau Raphael, 2013, Bulletin de la Societe Entomologique de France, V118, P111; PEAKE JF, 1971, PHILOS T ROY SOC B, V260, P581, DOI 10.1098/rstb.1971.0027; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Price T, 2008, SPECIATION BIRDS; Rabosky DL, 2010, P NATL ACAD SCI USA, V107, P22178, DOI 10.1073/pnas.1007606107; Ragge D.R, 1998, SONGS GRASSHOPPERS C; Rosindell J, 2011, ECOL LETT, V14, P552, DOI 10.1111/j.1461-0248.2011.01617.x; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Schoener TW, 2010, THEORY OF ISLAND BIOGEOGRAPHY REVISITED, P52; Shaw KL, 2000, EVOLUTION, V54, P1303, DOI 10.1111/j.0014-3820.2000.tb00563.x; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; VIETTE P, 1991, FAUNE MADAGASCAR S, V2, P1; Warren BH, 2006, MOL ECOL, V15, P3769, DOI 10.1111/j.1365-294X.2006.03058.x; Warren BH, 2015, ECOL LETT, V18, P200, DOI 10.1111/ele.12398; Warren BH, 2012, EVOLUTION, V66, P1490, DOI 10.1111/j.1558-5646.2011.01550.x; Warren BH, 2010, CLADISTICS, V26, P526, DOI 10.1111/j.1096-0031.2009.00300.x; Warren BH, 2013, BIRDS AFRICA, V8, P35; XIONG B, 1991, GENOME, V34, P306, DOI 10.1139/g91-050	61	7	7	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148971	10.1371/journal.pone.0148971	http://dx.doi.org/10.1371/journal.pone.0148971			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871932	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000370054100081
J	Bach, AG; Taute, BM; Baasai, N; Wienke, A; Meyer, HJ; Schramm, D; Surov, A				Bach, Andreas Gunter; Taute, Bettina-Maria; Baasai, Nansalmaa; Wienke, Andreas; Meyer, Hans Jonas; Schramm, Dominik; Surov, Alexey			30-Day Mortality in Acute Pulmonary Embolism: Prognostic Value of Clinical Scores and Anamnestic Features	PLOS ONE			English	Article							RIGHT-VENTRICULAR DYSFUNCTION; SEVERITY; DISEASE; SCALE; COMA; CT	Purpose Identification of high-risk patients with pulmonary embolism is vital. The aim of the present study was to examine clinical scores, their single items, and anamnestic features in their ability to predict 30-day mortality. Materials and Methods A retrospective, single-center study from 06/2005 to 01/2010 was performed. Inclusion criteria were presence of pulmonary embolism, availability of patient records and 30-day follow-up. The following clinical scores were calculated: Acute Physiology and Chronic Health Evaluation II, original and simplified pulmonary embolism severity index, Glasgow Coma Scale, and euroSCORE II. Results In the study group of 365 patients 39 patients (10.7%) died within 30 days due to pulmonary embolism. From all examined scores and parameters the best predictor of 30-day mortality were the Glasgow Coma scale (<= 10) and parameters of the circulatory system including presence of mechanical ventilation, arterial pH (<7.335), and systolic blood pressure (<99 mm Hg). Conclusions Easy to ascertain circulatory parameters have the same or higher prognostic value than the clinical scores that were applied in this study. From all clinical scores studied the Glasgow Coma Scale was the most time- and cost-efficient one.	[Bach, Andreas Gunter; Baasai, Nansalmaa; Meyer, Hans Jonas; Schramm, Dominik; Surov, Alexey] Univ Halle Wittenberg, Dept Radiol, Ernst Grube Str 40, D-06120 Halle, Germany; [Taute, Bettina-Maria] Univ Halle Wittenberg, Dept Internal Med, Ernst Grube Str 40, D-06120 Halle, Germany; [Wienke, Andreas] Univ Halle Wittenberg, Inst Med Epidemiol Biostat & Informat, Magdeburger Str 8, D-06112 Halle, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Surov, A (corresponding author), Univ Halle Wittenberg, Dept Radiol, Ernst Grube Str 40, D-06120 Halle, Germany.	alex.surow@medizin.uni-halle.de	Wienke, Andreas/AAN-3707-2020					Ahun E, 2014, ULUS TRAVMA ACIL CER, V20, P241, DOI 10.5505/tjtes.2014.76399; Aujesky D, 2005, AM J RESP CRIT CARE, V172, P1041, DOI 10.1164/rccm.200506-862OC; Bertoletti L, 2012, EUR RESPIR J, V39, P862, DOI 10.1183/09031936.00058811; Castelli R, 2014, THROMB RES; Gong Xiao-wei, 2013, Zhonghua Yi Xue Za Zhi, V93, P2534; Henzler T, 2012, EUR RESPIR J, V39, P919, DOI 10.1183/09031936.00088711; Jimenez D, 2014, THORAX, V69, P109, DOI 10.1136/thoraxjnl-2012-202900; Jimenez D, 2010, ARCH INTERN MED, V170, P1383, DOI 10.1001/archinternmed.2010.199; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Masotti L, 2009, VASC HEALTH RISK MAN, V5, P567; Roques F, 2003, EUR HEART J, V24, P881, DOI 10.1016/S0195-668X(02)00799-6; Sanchez O, 2008, EUR HEART J, V29, P1569, DOI 10.1093/eurheartj/ehn208; TEASDALE G, 1974, LANCET, V2, P81; Torbicki A, 2010, REV ESP CARDIOL, V63, P832, DOI 10.1016/S0300-8932(10)70186-X; Vedovati MC, 2013, J THROMB HAEMOST, V11, P2092, DOI 10.1111/jth.12429	15	13	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148728	10.1371/journal.pone.0148728	http://dx.doi.org/10.1371/journal.pone.0148728			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866472	Green Published, gold, Green Submitted			2022-12-27	WOS:000370050700030
J	Bolch, SN; Dugger, DR; Chong, T; McDowell, JH; Smith, WC				Bolch, Susan N.; Dugger, Donald R.; Chong, Timothy; McDowell, J. Hugh; Smith, W. Clay			A Splice Variant of Bardet-Biedl Syndrome 5 (BBS5) Protein that Is Selectively Expressed in Retina	PLOS ONE			English	Article							MESSENGER-RNA DECAY; INTRACELLULAR CALCIUM; PHOTORECEPTOR CELLS; CILIARY MEMBRANE; BBSOME; MOUSE; MUTATION; MODEL; RETINOPATHY; PHENOTYPE	Purpose Bardet-Biedl syndrome is a complex ciliopathy that usually manifests with some form of retinal degeneration, amongst other ciliary-related deficiencies. One of the genetic causes of this syndrome results from a defect in Bardet-Biedl Syndrome 5 ( BBS5) protein. BBS5 is one component of the BBSome, a complex of proteins that regulates the protein composition in cilia. In this study, we identify a smaller molecular mass form of BBS5 as a variant formed by alternative splicing and show that expression of this splice variant is restricted to the retina. Methods Reverse transcription PCR from RNA was used to isolate and identify potential alternative transcripts of Bbs5. A peptide unique to the C-terminus of the BBS5 splice variant was synthesized and used to prepare antibodies that selectively recognized the BBS5 splice variant. These antibodies were used on immunoblots of tissue extracts to determine the extent of expression of the alternative transcript and on tissue slices to determine the localization of expressed protein. Pull-down of fluorescently labeled arrestin1 by immunoprecipitation of the BBS5 splice variant was performed to assess functional interaction between the two proteins. Results PCR from mouse retinal cDNA using Bbs5-specific primers amplified a unique cDNA that was shown to be a splice variant of BBS5 resulting from the use of cryptic splicing sites in Intron 7. The resulting transcript codes for a truncated form of the BBS5 protein with a unique 24 amino acid C-terminus, and predicted 26.5 kD molecular mass. PCR screening of RNA isolated from various ciliated tissues and immunoblots of protein extracts from these same tissues showed that this splice variant was expressed in retina, but not brain, heart, kidney, or testes. Quantitative PCR showed that the splice variant transcript is 8.9-fold (+/-1.1-fold) less abundant than the full-length transcript. In the retina, the splice variant of BBS5 appears to be most abundant in the connecting cilium of photoreceptors, where BBS5 is also localized. Like BBS5, the binding of BBS5L to arrestin1 can be modulated by phosphorylation through protein kinase C. Conclusions In this study we have identified a novel splice variant of BBS5 that appears to be expressed only in the retina. The BBS5 splice variant is expressed at approximately 10% of full-length BBS5 level. No unique functional or localization properties could be identified for the splice variant compared to BBS5.	[Bolch, Susan N.; Dugger, Donald R.; Chong, Timothy; McDowell, J. Hugh; Smith, W. Clay] Univ Florida, Dept Ophthalmol, Gainesville, FL USA	State University System of Florida; University of Florida	Smith, WC (corresponding author), Univ Florida, Dept Ophthalmol, Gainesville, FL USA.	wcsmith@ufl.edu	Smith, W. Clay/AAQ-1589-2021		National Institutes of Health [EY014864, EY021721]; Research to Prevent Blindness; C.M. Overstreet Retinal Eye Disease ARMD Research Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001427] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY021721, R01EY014864] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); C.M. Overstreet Retinal Eye Disease ARMD Research Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by grants from the National Institutes of Health (EY014864, EY021721), Research to Prevent Blindness, and the C.M. Overstreet Retinal Eye Disease ARMD Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge the gift of anti-RP1 antibody from Eric Pierce, and the Lions Eye Institute for Research and Translation for providing donor retinal tissue. This research was supported by grants from the National Institutes of Health (EY014864, EY021721), Research to Prevent Blindness, and the C.M. Overstreet Retinal Eye Disease ARMD Research Fund.	Al-Hamed Mohamed H, 2014, Cilia, V3, P3, DOI 10.1186/2046-2530-3-3; Besharse JC, 1990, PHOTORECEPTOR CONNEC, P389; Breslow DK, 2013, J CELL BIOL, V203, P129, DOI 10.1083/jcb.201212024; Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Brown JM, 2015, CURR BIOL, V25, P1583, DOI 10.1016/j.cub.2015.04.060; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Davis EE, 2012, CURR OPIN GENET DEV, V22, P290, DOI 10.1016/j.gde.2012.04.006; Davis RE, 2007, P NATL ACAD SCI USA, V104, P19422, DOI 10.1073/pnas.0708571104; Deveault C, 2011, HUM MUTAT, V32, P610, DOI 10.1002/humu.21480; Dose AC, 2003, MOL BIOL CELL, V14, P1058, DOI 10.1091/mbc.E02-06-0317; Eppig JT, 2015, NUCLEIC ACIDS RES, V43, pD726, DOI 10.1093/nar/gku967; Farkas MH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-486; Forsythe E, 2013, EUR J HUM GENET, V21, P8, DOI 10.1038/ejhg.2012.115; Gamsiz ED, 2012, GENOMICS, V99, P44, DOI 10.1016/j.ygeno.2011.09.003; Gerth C, 2008, VISION RES, V48, P392, DOI 10.1016/j.visres.2007.08.024; Hirano M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136317; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; Jin H, 2009, CURR BIOL, V19, pR472, DOI 10.1016/j.cub.2009.04.015; Lechtreck KF, 2013, J CELL BIOL, V201, P249, DOI 10.1083/jcb.201207139; Lechtreck KF, 2009, J CELL BIOL, V187, P1117, DOI 10.1083/jcb.200909183; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Liu Q, 2002, INVEST OPHTH VIS SCI, V43, P22; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loktev AV, 2008, DEV CELL, V15, P854, DOI 10.1016/j.devcel.2008.11.001; McDowell JH, 1999, BIOCHEMISTRY-US, V38, P6119, DOI 10.1021/bi990175p; McGlincy NJ, 2008, TRENDS BIOCHEM SCI, V33, P385, DOI 10.1016/j.tibs.2008.06.001; Mockel A, 2011, PROG RETIN EYE RES, V30, P258, DOI 10.1016/j.preteyeres.2011.03.001; Molnar T, 2012, J PHYSIOL-LONDON, V590, P3465, DOI 10.1113/jphysiol.2012.234641; Murphy D, 2015, MOL CELL BIOL, V35, P1860, DOI 10.1128/MCB.00040-15; Nachury MV, 2008, METHOD ENZYMOL, V439, P501, DOI 10.1016/S0076-6879(07)00434-X; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Nickless A, 2014, NAT MED, V20, P961, DOI 10.1038/nm.3620; Nishimura DY, 2004, P NATL ACAD SCI USA, V101, P16588, DOI 10.1073/pnas.0405496101; Ou GS, 2005, NATURE, V436, P583, DOI 10.1038/nature03818; Pretorius PR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000884; Riazuddin SA, 2010, AM J HUM GENET, V86, P805, DOI 10.1016/j.ajhg.2010.04.001; Schweingruber C, 2013, BBA-GENE REGUL MECH, V1829, P612, DOI 10.1016/j.bbagrm.2013.02.005; Seo S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002358; Smith TS, 2013, CELL MOL LIFE SCI, V70, P4603, DOI 10.1007/s00018-013-1403-4; Wan J, 2011, NUCLEIC ACIDS RES, V39, P7920, DOI 10.1093/nar/gkr545; Wang J, 2014, PROG RETIN EYE RES, V38, P1, DOI 10.1016/j.preteyeres.2013.08.004; Wheway G, 2014, ORGANOGENESIS, V10, P69, DOI 10.4161/org.26710; WOLFRUM U, 1995, CELL MOTIL CYTOSKEL, V32, P55, DOI 10.1002/cm.970320107; Woodruff ML, 2002, J PHYSIOL-LONDON, V542, P843, DOI 10.1113/jphysiol.2001.013987; Yuan SL, 2013, ANNU REV GENET, V47, P353, DOI 10.1146/annurev-genet-111212-133243	47	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148773	10.1371/journal.pone.0148773	http://dx.doi.org/10.1371/journal.pone.0148773			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867008	Green Published, Green Submitted, gold			2022-12-27	WOS:000370050700035
J	Krammer, J; Dutschke, A; Kaiser, CG; Schnitzer, A; Gerhardt, A; Radosa, JC; Brade, J; Schoenberg, SO; Wasser, K				Krammer, Julia; Dutschke, Anja; Kaiser, Clemens G.; Schnitzer, Andreas; Gerhardt, Axel; Radosa, Julia C.; Brade, Joachim; Schoenberg, Stefan O.; Wasser, Klaus			Impact of Tumor Localization and Method of Preoperative Biopsy on Sentinel Lymph Node Mapping After Periareolar Nuclide Injection	PLOS ONE			English	Article							BREAST-CANCER PATIENTS; SUBAREOLAR INJECTION; LYMPHOSCINTIGRAPHY; IDENTIFICATION; FAILURE; MANAGEMENT; IDENTIFY; DRAINAGE; DISEASE	Background To evaluate whether tumor localization and method of preoperative biopsy affect sentinel lymph node (SLN) detection after periareolar nuclide injection in breast cancer patients. Methods and Findings 767 breast cancer patients were retrospectively included. For lymphscintigraphy periareolar nuclide injection was performed and the SLN was located by gamma camera. Patient and tumor characteristics were correlated to the success rate of SLN mapping. SLN marking failed in 9/61 (14.7%) patients with prior vacuum-assisted biopsy and 80/706 (11.3%) patients with prior core needle biopsy. Individually evaluated, biopsy method (p = 0.4) and tumor localization (p = 0.9) did not significantly affect the SLN detection rate. Patients with a vacuum-assisted biopsy of a tumor in the upper outer quadrant had a higher odds ratio of failing in SLN mapping (OR 3.8, p = 0.09) compared to core needle biopsy in the same localization (OR 0.9, p = 0.5). Conclusions Tumor localization and preoperative biopsy method do not significantly impact SLN mapping with periareolar nuclide injection. However, the failure risk tends to rise if vacuum-assisted biopsy of a tumor in the upper outer quadrant is performed.	[Krammer, Julia; Dutschke, Anja; Kaiser, Clemens G.; Schnitzer, Andreas; Schoenberg, Stefan O.; Wasser, Klaus] Heidelberg Univ, Inst Clin Radiol & Nucl Med, Univ Med Ctr Mannheim, Med Fac Mannheim, Heidelberg, Germany; [Gerhardt, Axel] Heidelberg Univ, Dept Obstet & Gynaecol, Univ Med Ctr Mannheim, Med Fac Mannheim, Heidelberg, Germany; [Radosa, Julia C.] Saarland Univ Hosp, Dept Obstet & Gynaecol, Homburg, Germany; [Brade, Joachim] Heidelberg Univ, Inst Med Stat Biomath & Data Proc, Med Fac Mannheim, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Universitatsklinikum des Saarlandes; Ruprecht Karls University Heidelberg	Krammer, J (corresponding author), Heidelberg Univ, Inst Clin Radiol & Nucl Med, Univ Med Ctr Mannheim, Med Fac Mannheim, Heidelberg, Germany.	Julia.Knaudt@medma.uni-heidelberg.de	Radosa, Julia/AAH-8266-2019	Kaiser, Clemens/0000-0003-4438-3624				Ahrendt GM, 2002, J AM COLL SURGEONS, V194, P278, DOI 10.1016/S1072-7515(01)01174-7; Bembenek A, 2007, WORLD J SURG, V31, P267, DOI 10.1007/s00268-005-0720-7; Caruso G, 2014, ACTA RADIOL, V55, P39, DOI 10.1177/0284185113493775; Caudle AS, 2014, SURG ONCOL CLIN N AM, V23, P473, DOI 10.1016/j.soc.2014.03.007; Chagpar AB, 2005, AM J SURG, V190, P551, DOI 10.1016/j.amjsurg.2005.06.009; Chagpar AB, 2005, SURGERY, V138, P56, DOI 10.1016/j.surg.2005.03.003; D'Eredita G, 2003, ANN SURG ONCOL, V10, P942, DOI 10.1245/ASO.2003.01.022; Estourgie SH, 2007, BRIT J SURG, V94, P1088, DOI 10.1002/bjs.5763; Estourgie SH, 2004, ANN SURG, V239, P232, DOI 10.1097/01.sla.0000109156.26378.90; FISHER B, 1983, CANCER-AM CANCER SOC, V52, P1551, DOI 10.1002/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO;2-3; Goyal A, 2005, EUR J CANCER, V41, P238, DOI 10.1016/j.ejca.2004.05.008; Goyal A, 2006, BREAST CANCER RES TR, V99, P203, DOI 10.1007/s10549-006-9192-1; Gschwantler-Kaulich D, 2011, EUR J CANCER CARE, V20, P627, DOI 10.1111/j.1365-2354.2011.01241.x; Haigh PI, 2000, J NUCL MED, V41, P1682; Heuts EM, 2006, EJSO, V32, P278, DOI 10.1016/j.ejso.2005.09.001; Humphrey KL, 2014, RADIOGRAPHICS, V34, P1807, DOI 10.1148/rg.347130141; Kern KA, 2002, J AM COLL SURGEONS, V195, P467, DOI 10.1016/S1072-7515(02)01312-1; Kollias J, 2000, AUST NZ J SURG, V70, P485, DOI 10.1046/j.1440-1622.2000.01861.x; Leppanen E, 2002, EUR J SURG ONCOL, V28, P821, DOI 10.1053/ejso.2002.1325; Manguso N, 2015, ONCOLOGY-NY, V29, P733; Motomura K, 2002, BIOMED PHARMACOTHER, V56, p209S; Schrenk P, 2001, LANCET, V357, P122, DOI 10.1016/S0140-6736(00)03550-9; Sener SF, 2004, J AM COLL SURGEONS, V198, P732, DOI 10.1016/j.jamcollsurg.2004.01.006; Straalman K, 2008, BREAST, V17, P167, DOI 10.1016/j.breast.2007.08.008; Valero V, 2010, CLIN BREAST CANCER, V10, P477, DOI 10.3816/CBC.2010.n.063	25	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149018	10.1371/journal.pone.0149018	http://dx.doi.org/10.1371/journal.pone.0149018			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867137	gold, Green Published, Green Submitted			2022-12-27	WOS:000370050700054
J	Stehling, MK; Guenther, E; Mikus, P; Klein, N; Rubinsky, L; Rubinsky, B				Stehling, Michael K.; Guenther, Enric; Mikus, Paul; Klein, Nina; Rubinsky, Liel; Rubinsky, Boris			Synergistic Combination of Electrolysis and Electroporation for Tissue Ablation	PLOS ONE			English	Article							HIGH ELECTRIC-FIELDS; ELECTROCHEMICAL TREATMENT; TUMOR TREATMENT; IN-VIVO; IRREVERSIBLE ELECTROPORATION; CURRENT THERAPY; MAMMARY; MICROORGANISMS; DENSITY; CELLS	Electrolysis, electrochemotherapy with reversible electroporation, nanosecond pulsed electric fields and irreversible electroporation are valuable non-thermal electricity based tissue ablation technologies. This paper reports results from the first large animal study of a new non-thermal tissue ablation technology that employs "Synergistic electrolysis and electroporation" (SEE). The goal of this pre-clinical study is to expand on earlier studies with small animals and use the pig liver to establish SEE treatment parameters of clinical utility. We examined two SEE methods. One of the methods employs multiple electrochemotherapy-type reversible electroporation magnitude pulses, designed in such a way that the charge delivered during the electroporation pulses generates the electrolytic products. The second SEE method combines the delivery of a small number of electrochemotherapy magnitude electroporation pulses with a low voltage electrolysis generating DC current in three different ways. We show that both methods can produce lesion with dimensions of clinical utility, without the need to inject drugs as in electrochemotherapy, faster than with conventional electrolysis and with lower electric fields than irreversible electroporation and nanosecond pulsed ablation.	[Stehling, Michael K.; Guenther, Enric; Mikus, Paul; Rubinsky, Liel; Rubinsky, Boris] Inter Sci GmbH, Biophys, Luzern, Switzerland; [Klein, Nina] Inst Bildgebende Diagnost Tumortherapy Ctr, R&D, Offenbach, Germany		Guenther, E (corresponding author), Inter Sci GmbH, Biophys, Luzern, Switzerland.	enric@interscience.ch			MKS; Inter Science GmbH	MKS; Inter Science GmbH	The costs for the animal care facility was paid by MKS. Inter Science GmbH provided support in the form of salaries for authors MKS, EG, PM, LR and BR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. There was no additional funding for this study except the funds for the animal care facility by MKS.	Amory R, 1886, TREATISE ELECT ITS T; Apollonio F, 2012, ANT PROP EUCAP 2012; Pupo AEB, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-85; Ciria HMC, 2013, CHINESE J CANCER RES, V25, P223, DOI 10.3978/j.issn.1000-9604.2013.03.03; Colombo L, 2007, BIOELECTROCHEMISTRY, V71, P223, DOI 10.1016/j.bioelechem.2007.07.001; Czymek R, 2011, SAUDI J GASTROENTERO, V17, P335, DOI 10.4103/1319-3767.84491; Czymek R, 2012, SURG ONCOL, V21, P79, DOI 10.1016/j.suronc.2010.10.007; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; Edd JF, 2006, IEEE T BIO-MED ENG, V53, P1409, DOI 10.1109/TBME.2006.873745; GRIFFIN DT, 1995, BRIT J CANCER, V72, P31, DOI 10.1038/bjc.1995.272; GRIFFIN DT, 1994, BRIT J CANCER, V69, P875, DOI 10.1038/bjc.1994.169; Haggendal E, 1969, Int Anesthesiol Clin, V7, P353; HAMILTON WA, 1967, BIOCHIM BIOPHYS ACTA, V148, P789, DOI 10.1016/0304-4165(67)90053-0; Ivic MLA, 2003, J ELECTROANAL CHEM, V549, P129, DOI 10.1016/S0022-0728(03)00251-1; Martin RCG, 2013, J GASTROINTEST SURG, V17, P1850, DOI 10.1007/s11605-013-2309-z; Miklavcic D, 1997, ELECTRO MAGNETOBIOL, V16, P119, DOI 10.3109/15368379709009837; Miklavcic D, 1997, BIOELECTROCH BIOENER, V43, P253, DOI 10.1016/S0302-4598(96)05190-2; MIKLAVCIC D, 1994, BIOELECTROCH BIOENER, V35, P93, DOI 10.1016/0302-4598(94)87017-9; Miklavcic D, 2013, J MEMBRANE BIOL, V246, P723, DOI 10.1007/s00232-013-9595-y; MIR LM, 1991, EUR J CANCER, V27, P68, DOI 10.1016/0277-5379(91)90064-K; NEUMANN E, 1982, EMBO J, V1, P841, DOI 10.1002/j.1460-2075.1982.tb01257.x; NEUMANN E, 1972, J MEMBRANE BIOL, V10, P279, DOI 10.1007/BF01867861; Neumann E., 1989, ELECTROPORATION ELEC; Nilsson E, 1999, J ELECTROANAL CHEM, V460, P88, DOI 10.1016/S0022-0728(98)00352-0; Nilsson E, 1998, BIOELECTROCH BIOENER, V47, P11, DOI 10.1016/S0302-4598(98)00157-3; Nilsson E, 2000, BIOELECTROCHEMISTRY, V51, P1, DOI 10.1016/S0302-4598(99)00073-2; Noad HM, 1849, LECT ELECT COMPRISIN; NORDENSTROM B, 1978, IRCS (International Research Communications System) Medical Science Library Compendium, V6, P537; NORDENSTROM BEW, 1994, EUR J SURG, P93; Nuccitelli R, 2006, BIOCHEM BIOPH RES CO, V343, P351, DOI 10.1016/j.bbrc.2006.02.181; Olaiz N, 2010, ELECTROCHEM COMMUN, V12, P94, DOI 10.1016/j.elecom.2009.10.044; Onik G, 2007, TECHNOL CANCER RES T, V6, P295, DOI 10.1177/153303460700600405; Phillips M, 2015, TECHNOLOGY, V3, P45, DOI 10.1142/S233954781550003X; Phillips M, 2015, TECHNOL CANCER RES T, V14, P395, DOI 10.1177/1533034614560102; Jimenez RP, 2011, BIOELECTROMAGNETICS, V32, P120, DOI 10.1002/bem.20611; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P37, DOI 10.1177/153303460700600106; SALE AJH, 1968, BIOCHIM BIOPHYS ACTA, V163, P37, DOI 10.1016/0005-2736(68)90030-8; SALE AJH, 1967, BIOCHIM BIOPHYS ACTA, V148, P781, DOI 10.1016/0304-4165(67)90052-9; Schoenbach KH, 2001, BIOELECTROMAGNETICS, V22, P440, DOI 10.1002/bem.71; STAMPFLI R, 1957, EXPERIENTIA, V13, P297, DOI 10.1007/BF02158430; STAMPFLI R, 1958, J Physiol (Paris), V50, P520; STAMPFLJ R., 1958, AN ACAD BRASIL CIENC, V30, P57; Teissie J, 2014, METHODS MOL BIOL, V1121, P25, DOI 10.1007/978-1-4614-9632-8_2; TITOMIROV AV, 1991, BIOCHIM BIOPHYS ACTA, V1088, P131, DOI 10.1016/0167-4781(91)90162-F; Turjanski P, 2009, ELECTROCHIM ACTA, V54, P6199, DOI 10.1016/j.electacta.2009.05.062; Vernier PT, 2008, BIOELECTROCHEMISTRY, V73, P1, DOI 10.1016/j.bioelechem.2008.02.003; von Euler H, 1999, ELECTRO MAGNETOBIOL, V18, P93, DOI 10.3109/15368379909012903; von Euler H, 2001, BIOELECTROCHEMISTRY, V54, P117, DOI 10.1016/S1567-5394(01)00118-9; Weaver JC, 1996, BIOELECTROCH BIOENER, V41, P135, DOI 10.1016/S0302-4598(96)05062-3; ZIMMERMANN U, 1974, BIOPHYS J, V14, P881, DOI 10.1016/S0006-3495(74)85956-4	50	24	24	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148317	10.1371/journal.pone.0148317	http://dx.doi.org/10.1371/journal.pone.0148317			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866693	Green Published, gold			2022-12-27	WOS:000370050700014
J	Branstetter, BK; DeLong, CM; Dziedzic, B; Black, A; Bakhtiari, K				Branstetter, Brian K.; DeLong, Caroline M.; Dziedzic, Brandon; Black, Amy; Bakhtiari, Kimberly			Recognition of Frequency Modulated Whistle-Like Sounds by a Bottlenose Dolphin (Tursiops truncatus) and Humans with Transformations in Amplitude, Duration and Frequency	PLOS ONE			English	Article							SIGNATURE WHISTLES; HUMAN LISTENERS; DISCRIMINATION; PERCEPTION; COMMUNICATION; SONGBIRDS; CONTOURS; STIMULI; HEARING; OBJECTS	Bottlenose dolphins (Tursiops truncatus) use the frequency contour of whistles produced by conspecifics for individual recognition. Here we tested a bottlenose dolphin's (Tursiops truncatus) ability to recognize frequency modulated whistle-like sounds using a three alternative matching-to-sample paradigm. The dolphin was first trained to select a specific object (object A) in response to a specific sound (sound A) for a total of three object-sound associations. The sounds were then transformed by amplitude, duration, or frequency transposition while still preserving the frequency contour of each sound. For comparison purposes, 30 human participants completed an identical task with the same sounds, objects, and training procedure. The dolphin's ability to correctly match objects to sounds was robust to changes in amplitude with only a minor decrement in performance for short durations. The dolphin failed to recognize sounds that were frequency transposed by plus or minus 1/2 octaves. Human participants demonstrated robust recognition with all acoustic transformations. The results indicate that this dolphin's acoustic recognition of whistle-like sounds was constrained by absolute pitch. Unlike human speech, which varies considerably in average frequency, signature whistles are relatively stable in frequency, which may have selected for a whistle recognition system invariant to frequency transposition.	[Branstetter, Brian K.; Black, Amy; Bakhtiari, Kimberly] Natl Marine Mammal Fdn, San Diego, CA USA; [DeLong, Caroline M.; Dziedzic, Brandon] Rochester Inst Technol, Dept Psychol, Coll Liberal Arts, Rochester, NY 14623 USA	Rochester Institute of Technology	Branstetter, BK (corresponding author), Natl Marine Mammal Fdn, San Diego, CA USA.	brian.branstetter@nmmf.org	Branstetter, Brian/ABE-2593-2020		Office of Naval Research [N000141010500]; College of Liberal Arts Faculty Development Grant at the Rochester Institute of Technology	Office of Naval Research(Office of Naval Research); College of Liberal Arts Faculty Development Grant at the Rochester Institute of Technology	Support for this study was received from the Office of Naval Research (grant no. N000141010500) (http://www.onr.navy.mil/Science-Technology/Departments/Code-32/All-Programs/Atmosphere-Research-322/Marine-Mammals-Biology.aspx). Support was also received from a College of Liberal Arts Faculty Development Grant at the Rochester Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Gutierrez Alejandro, 2004, Aquatic Mammals, V30, P357, DOI 10.1578/AM.30.3.2004.357; [Anonymous], 2012, LANG ENV STAT COMP; Au W.W.L., 1988, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, P809; AU WWL, 1990, J ACOUST SOC AM, V88, P1635, DOI 10.1121/1.400323; Branstetter BK, 2003, BIOACOUSTICS, V14, P15, DOI 10.1080/09524622.2003.9753510; Branstetter BK, 2008, J ACOUST SOC AM, V124, P625, DOI 10.1121/1.2918545; Branstetter BK, 2013, J ACOUST SOC AM, V134, P2274, DOI 10.1121/1.4816404; Branstetter BK, 2013, J ACOUST SOC AM, V133, P1811, DOI 10.1121/1.4789939; Branstetter BK, 2012, J ACOUST SOC AM, V131, P1613, DOI 10.1121/1.3676694; Caldwell M.C., 1990, P199; Caldwell M.C., 1979, Behavior of Marine Animals, V3, P369; CALDWELL MC, 1965, NATURE, V207, P434, DOI 10.1038/207434a0; Caldwell MC, 1970, EXPT DEMONSTRATION A; Connine CM, 2006, LINGUIST REV, V23, P235, DOI 10.1515/TLR.2006.009; Connor RC, 2001, MG BEH ECOL, P408; CONNOR RC, 1992, P NATL ACAD SCI USA, V89, P987, DOI 10.1073/pnas.89.3.987; Connor RC, 2007, PHILOS T R SOC B, V362, P587, DOI 10.1098/rstb.2006.1997; CUDDY LL, 1976, Q J EXP PSYCHOL, V28, P255, DOI 10.1080/14640747608400555; DeLong CM, 2007, J COMP PSYCHOL, V121, P306, DOI 10.1037/0735-7036.121.3.306; DeLong CM, 2007, J ACOUST SOC AM, V121, P605, DOI 10.1121/1.2400848; Esch HC, 2009, MAR MAMMAL SCI, V25, P976, DOI 10.1111/j.1748-7692.2009.00289.x; Evans W. E., 1966, SYSTEMES SONARS ANIM, P363; Fletcher NH, 2004, J ACOUST SOC AM, V115, P2334, DOI 10.1121/1.1694997; FLOWERS PJ, 1990, J RES MUSIC EDUC, V38, P102, DOI 10.2307/3344930; Gellermann LW, 1933, PEDAGOG SEMIN J GEN, V42, P206; Harley HE, 1996, J EXP PSYCHOL ANIM B, V22, P164, DOI 10.1037/0097-7403.22.2.164; Harley HE, 2008, BEHAV PROCESS, V77, P243, DOI 10.1016/j.beproc.2007.11.002; Harries M, 2007, J LARYNGOL OTOL, V112, P451; HERMAN LM, 1984, COGNITION, V16, P129, DOI 10.1016/0010-0277(84)90003-9; Herman LM., 2010, INT J COMP PSYCHOL, V23, P310; Houser DS, 2006, J ACOUST SOC AM, V120, P4090, DOI 10.1121/1.2357993; HULSE SH, 1985, J COMP PSYCHOL, V99, P176, DOI 10.1037/0735-7036.99.2.176; Janik VM, 2006, P NATL ACAD SCI USA, V103, P8293, DOI 10.1073/pnas.0509918103; Janik VM, 2013, J COMP PHYSIOL A, V199, P479, DOI 10.1007/s00359-013-0817-7; Janik VM, 2000, J COMP PHYSIOL A, V186, P673, DOI 10.1007/s003590000120; JANIK VM, 1994, BEHAV ECOL SOCIOBIOL, V35, P243, DOI 10.1007/s002650050094; Janik VM, 1998, ANIM BEHAV, V56, P829, DOI 10.1006/anbe.1998.0881; Janik VM, 2013, P NATL ACAD SCI USA, V110, P1; Jensen FH, 2012, J ACOUST SOC AM, V131, P582, DOI 10.1121/1.3662067; Jensen FH, 2011, P ROY SOC B-BIOL SCI, V278, P3017, DOI 10.1098/rspb.2010.2604; Kastak CR, 2002, J EXP ANAL BEHAV, V78, P449, DOI 10.1901/jeab.2002.78-449; KING SL, 2013, PROCEEDINGS OF THE R, P280; Lammers MO, 2003, MAR MAMMAL SCI, V19, P249, DOI 10.1111/j.1748-7692.2003.tb01107.x; LILLY JC, 1963, SCIENCE, V139, P116, DOI 10.1126/science.139.3550.116; Madsen PT, 2012, BIOL LETTERS, V8, P211, DOI 10.1098/rsbl.2011.0701; Miller PJO, 2007, J ACOUST SOC AM, V121, P3932, DOI 10.1121/1.2722056; MORRIS DESMOND, 1957, BEHAVIOUR, V11, P1, DOI 10.1163/156853956X00057; RALSTON JV, 1995, J COMP PSYCHOL, V109, P268, DOI 10.1037/0735-7036.109.3.268; RICHARDS DG, 1984, J COMP PSYCHOL, V98, P10, DOI 10.1037/0735-7036.98.1.10; Ridgway S, 2009, J EXP BIOL, V212, P1519, DOI 10.1242/jeb.027896; Ridgway SH, 2001, J EXP BIOL, V204, P3829; Sayigh LS, 2007, ANIM BEHAV, V74, P1631, DOI 10.1016/j.anbehav.2007.02.018; Sayigh LS, 1999, ANIM BEHAV, V57, P41, DOI 10.1006/anbe.1998.0961; Smolker R, 1999, ETHOLOGY, V105, P595, DOI 10.1046/j.1439-0310.1999.00441.x; THOMPSON RKR, 1975, J ACOUST SOC AM, V57, P943, DOI 10.1121/1.380513; THOMPSON RKR, 1977, SCIENCE, V195, P501, DOI 10.1126/science.835012; TITZE IR, 1989, J ACOUST SOC AM, V85, P1699, DOI 10.1121/1.397959; Tyack PL, 2000, SCIENCE, V289, P1310, DOI 10.1126/science.289.5483.1310; Weisman R, 2014, BEHAV PROCESS, V104, P35, DOI 10.1016/j.beproc.2014.02.006; Wiley RH., 1983, ANIM BEHAV, V2, P156, DOI DOI 10.1016/S0271-5309(97)00009-8	60	3	3	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0147512	10.1371/journal.pone.0147512	http://dx.doi.org/10.1371/journal.pone.0147512			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863519	gold, Green Published, Green Submitted			2022-12-27	WOS:000370046600032
J	Chung, CY; Wang, JC; Chuang, HS				Chung, Chih-Yao; Wang, Jhih-Cheng; Chuang, Han-Sheng			Rapid Bead-Based Antimicrobial Susceptibility Testing by Optical Diffusometry	PLOS ONE			English	Article							ANTIBIOTIC SUSCEPTIBILITY; MICROFLUIDIC PLATFORM; BACTERIA; RESISTANCE; CAPTURE	This study combined optical diffusometry and bead-based immunoassays to develop a novel technique for quantifying the growth of specific microorganisms and achieving rapid AST. Diffusivity rises when live bacteria attach to particles, resulting in additional energy from motile microorganisms. However, when UV-sterilized (dead) bacteria attach to particles, diffusivity declines. The experimental data are consistent with the theoretical model predicted according to the equivalent volume diameter. Using this diffusometric platform, the susceptibility of Pseudomonas aeruginosa to the antibiotic gentamicin was tested. The result suggests that the proliferation of bacteria is effectively controlled by gentamicin. This study demonstrated a sensitive (one bacterium on single particles) and time-saving (within 2 h) platform with a small sample volume (similar to 0.5 mu L) and a low initial bacteria count (50 CFU per droplet similar to 10(5) CFU/mL) for quantifying the growth of microorganisms depending on Brownian motion. The technique can be applied further to other bacterial strains and increase the success of treatments against infectious diseases in the near future.	[Chung, Chih-Yao; Wang, Jhih-Cheng; Chuang, Han-Sheng] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 701, Taiwan; [Wang, Jhih-Cheng] Chi Mei Med Ctr, Div Urol, Dept Surg, Tainan, Taiwan; [Chuang, Han-Sheng] Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan 701, Taiwan	National Cheng Kung University; Chi Mei Hospital; National Cheng Kung University	Chuang, HS (corresponding author), Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 701, Taiwan.; Chuang, HS (corresponding author), Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan 701, Taiwan.	oswaldchuang@mail.ncku.edu.tw	Chung, Chih-Yao/AEY-3140-2022; Chuang, Han-Sheng/ABH-3992-2020	Chung, Chih-Yao/0000-0002-2263-4181; Chuang, Han-Sheng/0000-0002-7257-6565	Ministry of Science and Technology, Taiwan [102-2221-E-006-024-MY2]; Chimei Medical Center, Taiwan [CMNCKU10405]; Chimei Medical Center [CMNCKU10405]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Chimei Medical Center, Taiwan; Chimei Medical Center	This study was funded by the Ministry of Science and Technology, Taiwan (https://www.most.gov.tw/), grant number 102-2221-E-006-024-MY2 to HSC, and by Chimei Medical Center, Taiwan (http://www.chimei.org.tw/index_c.htm), grant number CMNCKU10405 to JCW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Ministry of Science and Technology under the grant number 102-2221-E-006-024-MY2. We appreciate Dr. H.C. Chang for his kind share of P. aeruginosa (ATCC 27853). Moreover, Dr. Wang would also like to thank Chimei Medical Center for the grant CMNCKU10405.	Angelani L, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.138302; Boedicker JQ, 2008, LAB CHIP, V8, P1265, DOI 10.1039/b804911d; Braibanti M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.108303; Cao BY, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4861661; Chen CH, 2010, ANAL CHEM, V82, P1012, DOI 10.1021/ac9022764; Cheng IF, 2013, SCI REP-UK, V3, DOI 10.1038/srep02365; Choi J, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009650; Chung CC, 2012, ANAL CHEM, V84, P3347, DOI 10.1021/ac300093w; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; Dong RY, 2015, MICROFLUID NANOFLUID, V19, P805, DOI 10.1007/s10404-015-1605-1; Einstein A, 1956, INVESTIGATIONS THEOR; Fan L.-S., 1998, SIZE PROPERTIES PART; Fan YJ, 2010, LANGMUIR, V26, P13751, DOI 10.1021/la102137j; Fan YJ, 2009, BIOSENS BIOELECTRON, V25, P688, DOI 10.1016/j.bios.2009.07.037; Gorti VA, 2008, LANGMUIR, V24, P2947, DOI 10.1021/la703224b; Jorgensen JH, 2009, CLIN INFECT DIS, V49, P1749, DOI 10.1086/647952; Kalashnikov M, 2012, LAB CHIP, V12, P4523, DOI 10.1039/c2lc40531h; KEANE RD, 1992, APPL SCI RES, V49, P191, DOI 10.1007/BF00384623; Kerremans JJ, 2008, J ANTIMICROB CHEMOTH, V61, P428, DOI 10.1093/jac/dkm497; Kinnunen P, 2011, BIOSENS BIOELECTRON, V26, P2751, DOI 10.1016/j.bios.2010.10.010; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Langevin P., 1908, CR ACAD SCI PARIS, V146; Leptos KC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.198103; Lever A, 2007, BMJ-BRIT MED J, V335, P879, DOI 10.1136/bmj.39346.495880.AE; Liu TY, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1546; Longo G, 2013, NAT NANOTECHNOL, V8, P522, DOI [10.1038/nnano.2013.120, 10.1038/NNANO.2013.120]; Mino G, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.048102; Mohan R, 2013, BIOSENS BIOELECTRON, V49, P118, DOI 10.1016/j.bios.2013.04.046; Rafai S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.098102; Sie YS, 2014, MICROFLUID NANOFLUID, V16, P65, DOI 10.1007/s10404-013-1219-4; Sinn I, 2012, ANAL CHEM, V84, P5250, DOI 10.1021/ac300128p; Sokolov A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.148101; Wang KC, 2014, LAB CHIP, V14, P3958, DOI 10.1039/c4lc00661e; Weibull E, 2014, J CLIN MICROBIOL, V52, P3310, DOI 10.1128/JCM.01161-14; Weile J, 2009, ANAL BIOANAL CHEM, V394, P731, DOI 10.1007/s00216-009-2779-8; Wen JL, 2014, SCI REP-UK, V4, DOI 10.1038/srep05191; Wu MM, 2006, APPL ENVIRON MICROB, V72, P4987, DOI 10.1128/AEM.00158-06; Yongsunthon R, 2006, J ELECTRON SPECTROSC, V150, P228, DOI 10.1016/j.elspec.2005.06.012	38	24	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148864	10.1371/journal.pone.0148864	http://dx.doi.org/10.1371/journal.pone.0148864			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863001	Green Submitted, Green Published, gold			2022-12-27	WOS:000370046600117
J	Csikar, J; Kang, J; Wyborn, C; Dyer, TA; Marshman, Z; Godson, J				Csikar, Julia; Kang, Jing; Wyborn, Ceri; Dyer, Tom A.; Marshman, Zoe; Godson, Jenny			The Self-Reported Oral Health Status and Dental Attendance of Smokers and Non-Smokers in England	PLOS ONE			English	Article							TREATMENT NEEDS; RISK-FACTORS; SMOKING; BURDEN	Smoking has been identified as the second greatest risk factor for global death and disability and has impacts on the oral cavity from aesthetic changes to fatal diseases such as oral cancer. The paper presents a secondary analysis of the National Adult Dental Health Survey (2009). The analysis used descriptive statistics, bivariate analyses and logistic regression models to report the self-reported oral health status and dental attendance of smokers and non-smokers in England. Of the 9,657 participants, 21% reported they were currently smoking. When compared with smokers; non-smokers were more likely to report 'good oral health' (75% versus 57% respectively, p<0.05). Smokers were twice as likely to attend the dentist symptomatically (OR = 2.27, CI = 2.02-2.55) compared with non-smoker regardless the deprivation status. Smokers were more likely to attend symptomatically in the most deprived quintiles (OR = 1.99, CI = 1.57-2.52) and perceive they had poorer oral health (OR = 1.77, CI = 1.42-2.20). The present research is consistent with earlier sub-national research and should be considered when planning early diagnosis and management strategies for smoking-related conditions, considering the potential impact dental teams might have on smoking rates.	[Csikar, Julia; Kang, Jing] Univ Leeds, Sch Dent, Leeds LS2 9LU, W Yorkshire, England; [Csikar, Julia; Godson, Jenny] Publ Hlth England, Blenheim House, Leeds LS1 4PL, W Yorkshire, England; [Wyborn, Ceri] Publ Hlth England, West Off, Stn Rise, York YO1 6GA, N Yorkshire, England; [Dyer, Tom A.; Marshman, Zoe] Univ Sheffield, Sch Clin Dent, Sheffield S10 2TA, S Yorkshire, England	University of Leeds; Public Health England; University of Sheffield	Csikar, J (corresponding author), Univ Leeds, Sch Dent, Leeds LS2 9LU, W Yorkshire, England.; Csikar, J (corresponding author), Publ Hlth England, Blenheim House, Leeds LS1 4PL, W Yorkshire, England.	denjic@leeds.ac.uk	Csikar, Julia/T-7646-2019	Csikar, Julia/0000-0002-6943-9762; Kang, Jing/0000-0002-2770-1099				Acheson D., 1998, INDEPENDENT INQUIRY; [Anonymous], 2009, DENT HLTH AD YORKSH; Baker SR, 2009, COMMUNITY DENT ORAL, V37, P485, DOI 10.1111/j.1600-0528.2009.00495.x; Cancer Research UK, 2012, ORAL CANC; Carr AB, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005084.pub3; Guarnizo-Herreno CC, 2012, AM J PUBLIC HEALTH, V102, P859, DOI 10.2105/AJPH.2011.300548; Csikar J, 2013, COMMUNITY DENT HLTH, V30, P26, DOI 10.1922/CDH_2899Csikar04; Csikar JI, 2016, COMMUNITY DENT ORAL, V44, P119, DOI 10.1111/cdoe.12195; Daly B., 2013, ESSENTIAL DENT PUBLI; Department for Communities and Local Government, 2011, ENGL IND DEPR 2010 2; Department of Health, 2015, DENT CONTR REF PROT; Department of Health, 1998, SMOK KILLS WHIT PAP; Dye BA, 2006, J AM DENT ASSOC, V137, P224, DOI 10.14219/jada.archive.2006.0148; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Fox C, 2010, BRIT DENT J, V208, P411, DOI 10.1038/sj.bdj.2010.400; Geneletti S, 2009, BIOSTATISTICS, V10, P17, DOI 10.1093/biostatistics/kxn010; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Health and Social Care Information Centre, 2012, STAT SMOK ENGL 2012; Hilgers K K, 2004, Int J Dent Hyg, V2, P56, DOI 10.1111/j.1601-5029.2004.00075.x; Johnson G K, 2001, J Dent Educ, V65, P313; Johnson NW, 2000, BRIT DENT J, V189, P200, DOI 10.1038/sj.bdj.4800721; Jorm LR, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-263; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lorenc T, 2013, J EPIDEMIOL COMMUN H, V67, P190, DOI 10.1136/jech-2012-201257; Millar WJ, 2007, J CAN DENT ASSOC, V73, P155; NHS Yorkshire & Humber, 2008, MAK EV CONT COUNT; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Office for National Statistics, 2010, GEN LIF SURV 2010; Office for National Statistics Social Survey Division and Information Centre for Health and Social Care, 2009, AD DENT HLTH SURV CO; Public Health England, 2014, SMOK SMIL HELP DENT; Public Health England, 2014, COMM BETT OR HLTH; Rivera-Hidalgo F, 2003, PERIODONTOL 2000, V32, P50, DOI 10.1046/j.0906-6713.2003.03205.x; Robinson PG, 1998, J PUBLIC HEALTH DENT, V58, P250, DOI 10.1111/j.1752-7325.1998.tb03002.x; The Health and Social Care Information Centre, 2011, FDN REP AD DENT HLTH; The Office of National Statistics, 2013, CANC REG STAT ENGL 2; Tilakaratne WM, 2006, ORAL ONCOL, V42, P561, DOI 10.1016/j.oraloncology.2005.08.005; Tomintz MN, 2008, AREA, V40, P341, DOI 10.1111/j.1475-4762.2008.00837.x; UK Government, 2014, DEL BETT OR HLTH EV; Watt RG, 2012, COMMUNITY DENT ORAL, V40, P289, DOI 10.1111/j.1600-0528.2012.00680.x; West R., 2012, SMOKING SMOKING CESS; Yorkshire & Humber Public Health Observatory, 2011, IMD 2010	41	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148700	10.1371/journal.pone.0148700	http://dx.doi.org/10.1371/journal.pone.0148700			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6PR	26863107	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000370046600100
J	Kim, HY; Heo, DY; Park, HM; Singh, D; Lee, CH				Kim, Hyang Yeon; Heo, Do Yeon; Park, Hye Min; Singh, Digar; Lee, Choong Hwan			Metabolomic and Transcriptomic Comparison of Solid-State and Submerged Fermentation of Penicillium expansum KACC 40815	PLOS ONE			English	Article							ANALYSIS REVEALS; FUNGUS; METABOLITES; LOVASTATIN; INHIBITORS; LIQUID	Penicillium spp. are known to harbor a wide array of secondary metabolites with cryptic bioactivities. However, the metabolomics of these species is not well-understood in terms of different fermentation models and conditions. The present study involved metabolomics profiling and transcriptomic analysis of Penicillium expansum 40815 under solid-state fermentation (SSF) and submerged fermentation (SmF). Metabolite profiling was carried out using ultra-performance liquid chromatography quadruple time-of-flight mass spectrometry with multivariate analysis, followed by transcriptomic analyses of differentially expressed genes. In principal component analysis, the metabolite profiling data was studied under different experimental sets, including SSF and SmF. The significantly different metabolites such as polyketide metabolites (agonodepside B, rotiorin, verrucosidin, and ochrephilone) and corresponding gene transcripts (polyketide synthase, aromatic prenyltransferase, and terpenoid synthase) were primarily detected under SmF conditions. In contrast, the meroterpenoid compounds (andrastin A and C) and their genes transcripts were exclusively detected under SSF conditions. We demonstrated that the metabolite production and its corresponding gene expression levels in P. expansum 40815 were significantly influenced by the varying growth parameters and the immediate environment. This study further provides a foundation to produce specific metabolites by regulating fermentation conditions.	[Kim, Hyang Yeon; Heo, Do Yeon; Park, Hye Min; Singh, Digar; Lee, Choong Hwan] Konkuk Univ, Dept Biosci & Biotechnol, 120 Neungdong Ro, Seoul 05029, South Korea	Konkuk University	Lee, CH (corresponding author), Konkuk Univ, Dept Biosci & Biotechnol, 120 Neungdong Ro, Seoul 05029, South Korea.	chlee123@konkuk.ac.kr		Kim, Hyang Yeon/0000-0003-3203-462X	Ministry of Science, ICT and Future Planning through the National Research Foundation [NRF-2014M3A9C4066462]; National Research Foundation of Korea (NRF) - Korea government (MSIP) [NRF-2014R1A2A1A11050884]	Ministry of Science, ICT and Future Planning through the National Research Foundation; National Research Foundation of Korea (NRF) - Korea government (MSIP)	This work was supported by the Bio-Synergy Research Project (NRF-2014M3A9C4066462) of the Ministry of Science, ICT and Future Planning through the National Research Foundation and by Basic Science Research Program through the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. NRF-2014R1A2A1A11050884).	Alfaro C, 2003, MUTAT RES-GEN TOX EN, V539, P187, DOI 10.1016/S1383-5718(03)00166-9; Balkan B, 2014, BIOTECHNOL BIOTECHNO, V28, P96; Rodriguez-Urra AB, 2012, ACS CHEM BIOL, V7, P599, DOI 10.1021/cb200455u; Bigelis R, 2006, J IND MICROBIOL BIOT, V33, P815, DOI 10.1007/s10295-006-0126-z; Cao SG, 2002, J NAT PROD, V65, P1037, DOI 10.1021/np010626i; Cheng JS, 2013, APPL MICROBIOL BIOT, V97, P5943, DOI 10.1007/s00253-013-4790-4; Choo SJ, 2005, J ANTIBIOT, V58, P210, DOI 10.1038/ja.2005.26; de Azeredo LAI, 2007, CURR MICROBIOL, V54, P361, DOI 10.1007/s00284-006-0425-7; Demain AL, 1999, APPL MICROBIOL BIOT, V52, P455, DOI 10.1007/s002530051546; DeRidder BP, 2002, PLANT PHYSIOL, V130, P1497, DOI 10.1104/pp.010066; Fernandez-Bodega MA, 2009, INT J FOOD MICROBIOL, V136, P18, DOI 10.1016/j.ijfoodmicro.2009.09.014; Ferreira Viviani, 2010, Int J Microbiol, V2010, DOI 10.1155/2010/276590; FRIDOVICH I, 1986, ARCH BIOCHEM BIOPHYS, V247, P1, DOI 10.1016/0003-9861(86)90526-6; Frisvad JC, 2004, STUD MYCOL, P201; Holker U, 2004, APPL MICROBIOL BIOT, V64, P175, DOI 10.1007/s00253-003-1504-3; Johnson CH, 2012, J CELL PHYSIOL, V227, P2975, DOI 10.1002/jcp.24002; Johnson CH, 2012, ANNU REV PHARMACOL, V52, P37, DOI 10.1146/annurev-pharmtox-010611-134748; Kim HY, 2012, J MICROBIOL METH, V90, P327, DOI 10.1016/j.mimet.2012.06.006; Kim JuHee, 2002, Research in Plant Disease, V8, P107; Kramer A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103320; Krug D, 2008, APPL ENVIRON MICROB, V74, P3058, DOI 10.1128/AEM.02863-07; Laparre J, 2014, MOL PLANT, V7, P554, DOI 10.1093/mp/sst136; MATSUZAKI K, 1995, J ANTIBIOT, V48, P703, DOI 10.7164/antibiotics.48.703; Miranda RU, 2014, FUNGAL BIOL-UK, V118, P979, DOI 10.1016/j.funbio.2014.09.002; MORTON AG, 1961, PROC R SOC SER B-BIO, V153, P548, DOI 10.1098/rspb.1961.0018; Nunez F, 2000, J FOOD PROTECT, V63, P231, DOI 10.4315/0362-028X-63.2.231; Omura S, 1996, J ANTIBIOT, V49, P414, DOI 10.7164/antibiotics.49.414; Pansuriya RC, 2010, BRAZ J MICROBIOL, V41, P164, DOI 10.1590/S1517-838220100001000024; Ramana Murthy M. V., 1993, ADV APPL MICROBIOLOG, V38, P99; Rossouw D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-530; Rouissi W, 2013, J FOOD PROTECT, V76, P1879, DOI 10.4315/0362-028X.JFP-13-072; Ruiz-Sanchez J, 2010, J APPL MICROBIOL, V109, P2144, DOI 10.1111/j.1365-2672.2010.04846.x; STASINOPOULOS SJ, 1992, APPL MICROBIOL BIOT, V36, P465; Subramaniyam RVR., 2012, INT J SCI NAT, V3, P480; Veglio F, 1998, PROCESS BIOCHEM, V33, P367, DOI 10.1016/S0032-9592(98)00006-5; VINAYAVEKHIN N, 2010, CURRENT PROTOCOLS MO, V30, P1, DOI DOI 10.1002/0471142727.MB3001S90; Wang XR, 2010, J NAT PROD, V73, P942, DOI 10.1021/np100142h; Yu K, 2010, MAR DRUGS, V8, P2744, DOI 10.3390/md8112744	38	13	13	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149012	10.1371/journal.pone.0149012	http://dx.doi.org/10.1371/journal.pone.0149012			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863302	gold, Green Published, Green Submitted			2022-12-27	WOS:000370046600138
J	Rosenbaum, S; Hirwa, JP; Silk, JB; Vigilant, L; Stoinski, TS				Rosenbaum, Stacy; Hirwa, Jean Paul; Silk, Joan B.; Vigilant, Linda; Stoinski, Tara S.			Infant Mortality Risk and Paternity Certainty Are Associated with Postnatal Maternal Behavior toward Adult Male Mountain Gorillas (Gorilla beringei beringei)	PLOS ONE			English	Article							MALE-FEMALE RELATIONSHIPS; SOCIAL RELATIONSHIPS; MULTIMALE GROUPS; REPRODUCTIVE COMPETITION; INDUCED-ABORTION; SEXUAL-BEHAVIOR; PRIMATE SOCIETY; MALE TAKEOVERS; WILD GELADAS; LIFE-HISTORY	Sexually selected infanticide is an important source of infant mortality in many mammalian species. In species with long-term male-female associations, females may benefit from male protection against infanticidal outsiders. We tested whether mountain gorilla (Gorilla beringei beringei) mothers in single and multi-male groups monitored by the Dian Fossey Gorilla Fund's Karisoke Research Center actively facilitated interactions between their infants and a potentially protective male. We also evaluated the criteria mothers in multi-male groups used to choose a preferred male social partner. In single male groups, where infanticide risk and paternity certainty are high, females with infants <1 year old spent more time near and affiliated more with males than females without young infants. In multi-male groups, where infanticide rates and paternity certainty are lower, mothers with new infants exhibited few behavioral changes toward males. The sole notable change was that females with young infants proportionally increased their time near males they previously spent little time near when compared to males they had previously preferred, perhaps to encourage paternity uncertainty and deter aggression. Rank was a much better predictor of females' social partner choice than paternity. Older infants (2-3 years) in multi-male groups mirrored their mothers' preferences for individual male social partners; 89% spent the most time in close proximity to the male their mother had spent the most time near when they were <1 year old. Observed discrepancies between female behavior in single and multi-male groups likely reflect different levels of postpartum intersexual conflict; in groups where paternity certainty and infanticide risk are both high, male-female interests align and females behave accordingly. This highlights the importance of considering individual and group-level variation when evaluating intersexual conflict across the reproductive cycle.	[Rosenbaum, Stacy] Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90024 USA; [Hirwa, Jean Paul] Dian Fossey Gorilla Fund Int, Musanze, Rwanda; [Silk, Joan B.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ USA; [Silk, Joan B.] Arizona State Univ, Inst Human Origins, Tempe, AZ USA; [Vigilant, Linda] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany; [Stoinski, Tara S.] Dian Fossey Gorilla Fund Int, Atlanta, GA USA	University of California System; University of California Los Angeles; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Max Planck Society	Rosenbaum, S (corresponding author), Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90024 USA.	srosenbaum@uchicago.edu		Rosenbaum, Stacy/0000-0002-7576-5302	LSB Leakey Foundation; National Science Foundation SBE Doctoral Dissertation Improvement Grant [1122321]; Wenner-Gren Foundation for Anthropological Research Dissertation Research Grant [201101446]; Rwandan government; Volcanoes National Park authorities; SBE Off Of Multidisciplinary Activities [1552185] Funding Source: National Science Foundation	LSB Leakey Foundation; National Science Foundation SBE Doctoral Dissertation Improvement Grant; Wenner-Gren Foundation for Anthropological Research Dissertation Research Grant; Rwandan government; Volcanoes National Park authorities; SBE Off Of Multidisciplinary Activities(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work was supported by an LSB Leakey Foundation Research Grant, http://www.leakeyfoundation.org/research-grants/ (to SR & JS); a National Science Foundation SBE Doctoral Dissertation Improvement Grant #1122321 http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=13453 (to SR); and a Wenner-Gren Foundation for Anthropological Research Dissertation Research Grant #201101446 http://www.wennergren.org/ programs/dissertation-fieldwork-grants (to SR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank W. Eckhart for contributing behavioral data, B. Scelza, S. Perry, and two anonymous reviewers for their comments on the manuscript, and P. Ender for assistance with statistical analyses. The Karisoke Research Center is a project of the Dian Fossey Gorilla Fund International (DFGFI). The authors and DFGFI thank the Rwandan government and Volcanoes National Park authorities for their long-term commitment to gorilla conservation, and their support of the Karisoke Research Center. DFGFI is greatly indebted to the many Karisoke field assistants and researchers for their work collecting demographic and behavioral data over the last 49 years. We wish to acknowledge the many staff members who have shown extraordinary commitment under dangerous conditions, in some cases giving their lives while protecting and studying the gorillas.	Anderson DR, 2002, J WILDLIFE MANAGE, V66, P912, DOI 10.2307/3803155; Arandjelovic M, 2010, BIOL CONSERV, V143, P1780, DOI 10.1016/j.biocon.2010.04.030; Arnqvist Goran, 2005, pUnpaginated; Beehner JC, 2008, AM J PRIMATOL, V70, P1152, DOI 10.1002/ajp.20614; BERGER J, 1983, NATURE, V303, P59, DOI 10.1038/303059a0; BERTRAM BCR, 1975, J ZOOL, V177, P463; BOELLSTORFF DE, 1994, ANIM BEHAV, V47, P1057, DOI 10.1006/anbe.1994.1144; Borries C, 1999, BEHAV ECOL SOCIOBIOL, V46, P350, DOI 10.1007/s002650050629; Borries C, 2011, BEHAV ECOL SOCIOBIOL, V65, P685, DOI 10.1007/s00265-010-1070-5; Bradley BJ, 2005, P NATL ACAD SCI USA, V102, P9418, DOI 10.1073/pnas.0502019102; Bradley BJ, 2001, CONSERV GENET, V2, P179, DOI 10.1023/A:1011847528045; BRUCE HM, 1960, J REPROD FERTIL, V1, P96, DOI 10.1530/jrf.0.0010096; CAMPAGNA C, 1992, ANIM BEHAV, V43, P541, DOI 10.1016/0003-3472(92)90077-M; Charpentier MJE, 2008, P NATL ACAD SCI USA, V105, P1988, DOI 10.1073/pnas.0711219105; Clarke Parry, 2009, P42; COLMENARES F, 1988, FOLIA PRIMATOL, V50, P157, DOI 10.1159/000156343; Cords M, 2010, INT J PRIMATOL, V31, P409, DOI [10.1007/s10764-010-9400-z, 10.1007/s10764-010-9405-7]; COULON J, 1995, ETHOL ECOL EVOL, V7, P191, DOI 10.1080/08927014.1995.9522965; Dahle B, 2003, J ANIM ECOL, V72, P660, DOI 10.1046/j.1365-2656.2003.00737.x; Doran DM, 1997, J HUM EVOL, V32, P323, DOI 10.1006/jhev.1996.0095; Dunbar R., 1984, REPROD DECISIONS EC; Ebensperger LA, 1998, BIOL REV, V73, P321, DOI 10.1017/S0006323198005209; ELWOOD RW, 1990, ANIM BEHAV, V40, P1080, DOI 10.1016/S0003-3472(05)80174-5; Enstam KL, 2002, INT J PRIMATOL, V23, P85, DOI 10.1023/A:1013249808137; FAIRBANKS LA, 1987, INT J PRIMATOL, V8, P351, DOI 10.1007/BF02737388; FAY JM, 1995, J HUM EVOL, V29, P93, DOI 10.1006/jhev.1995.1048; Fletcher A, 2001, MOUNTAIN GORILLAS 3, P153; Goodall J, 1986, THE CHIMPANZEES OF G; Harcourt A.H., 2007, GORILLA SOC CONFLICT; HARCOURT AH, 1979, ANIM BEHAV, V27, P325, DOI 10.1016/0003-3472(79)90166-0; HARCOURT AH, 1979, ANIM BEHAV, V27, P251, DOI 10.1016/0003-3472(79)90145-3; HARCOURT AH, 1987, ANIM BEHAV, V35, P182, DOI 10.1016/S0003-3472(87)80223-3; Harcourt AH, 2001, ANIM BEHAV, V62, P905, DOI 10.1006/anbe.2001.1835; Harcourt AH, 1981, REPROD BIOL GREAT AP, P310; Henzi P, 2003, EVOL ANTHROPOL, V12, P217, DOI 10.1002/evan.10121; HRDY SB, 1979, ETHOL SOCIOBIOL, V1, P13, DOI 10.1016/0162-3095(79)90004-9; Huchard E, 2013, BEHAV ECOL, V24, P229, DOI 10.1093/beheco/ars158; Janson Charles H., 2000, P469, DOI 10.1017/CBO9780511542312.021; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kitchen DM, 2003, BEHAV ECOL SOCIOBIOL, V53, P374, DOI 10.1007/s00265-003-0588-1; Klemme I, 2010, BIOL LETTERS, V6, P24, DOI 10.1098/rsbl.2009.0500; Lukas D, 2013, SCIENCE, V341, P526, DOI 10.1126/science.1238677; Lukas D, 2014, SCIENCE, V346, P841, DOI 10.1126/science.1257226; McElreath R, 2008, PHILOS T R SOC B, V363, P3515, DOI 10.1098/rstb.2008.0131; MORI U, 1985, Z TIERPSYCHOL, V67, P215; Moscovice LR, 2010, ANIM BEHAV, V79, P1007, DOI 10.1016/j.anbehav.2010.01.013; Neumann C, 2011, ANIM BEHAV, V82, P911, DOI 10.1016/j.anbehav.2011.07.016; Newton-Fisher NE, 2006, INT J PRIMATOL, V27, P1589, DOI 10.1007/s10764-006-9087-3; Nsubuga AM, 2004, MOL ECOL, V13, P2089, DOI 10.1111/j.1365-294X.2004.02207.x; OCONNELL SM, 1994, ANIM BEHAV, V48, P687, DOI 10.1006/anbe.1994.1288; Opie C, 2013, P NATL ACAD SCI USA, V110, P13328, DOI 10.1073/pnas.1307903110; PACKER C, 1983, AM NAT, V121, P716, DOI 10.1086/284097; PACKER C, 1990, AM NAT, V136, P1, DOI 10.1086/285079; Palombit RA, 1997, ANIM BEHAV, V54, P599, DOI 10.1006/anbe.1996.0457; Palombit Ryne, 2009, P377; Palombit Ryne A., 2012, P432; Palombit Ryne A., 2000, P123, DOI 10.1017/CBO9780511542312.008; PEREIRA ME, 1991, BEHAV ECOL SOCIOBIOL, V28, P141; Perry S, 2012, ADV STUD BEHAV, V44, P135, DOI 10.1016/B978-0-12-394288-3.00004-6; Persson J, 2003, WILDLIFE BIOL, V9, P21, DOI 10.2981/wlb.2003.004; PIELOU E C, 1969, P286; Pusey A. E., 1994, INFANTICIDE PARENTAL, P277; Robbins AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078256; Robbins MM, 2005, BEHAVIOUR, V142, P779, DOI 10.1163/1568539054729123; Robbins MM, 2004, AM J PRIMATOL, V64, P145, DOI 10.1002/ajp.20069; Robbins MM, 1999, ANIM BEHAV, V57, P1013, DOI 10.1006/anbe.1998.1063; Robbins MM, 1996, ETHOLOGY, V102, P942; ROBBINS MM, 2001, MOUNTAIN GORILLAS 3, P00029; Roberts EK, 2012, SCIENCE, V335, P1222, DOI 10.1126/science.1213600; Rodel HG, 2008, ETHOLOGY, V114, P22, DOI 10.1111/j.1439-0310.2007.01447.x; Rosenbaum S, 2016, PRIMATES, V57, P17, DOI 10.1007/s10329-015-0490-2; Rosenbaum S, 2015, ANIM BEHAV, V104, P13, DOI 10.1016/j.anbehav.2015.02.025; Rosenbaum S, 2011, AM J PRIMATOL, V73, P356, DOI 10.1002/ajp.20905; Scelza BA, 2010, CURR ANTHROPOL, V51, P295, DOI 10.1086/651051; Shenk MK, 2012, J BIOSOC SCI, V44, P549, DOI 10.1017/S0021932012000053; SICOTTE P, 1994, ETHOLOGY, V97, P47; Sicotte P., 2001, MOUNTAIN GORILLAS 3, P59, DOI [10.1017/CBO9780511661631.004, DOI 10.1017/CBO9780511661631.004]; Silk JB, 2002, BEHAVIOUR, V139, P421, DOI 10.1163/156853902760102735; Soltis J, 2000, BEHAV ECOL SOCIOBIOL, V48, P195, DOI 10.1007/s002650000224; STEHN RA, 1981, J MAMMAL, V62, P369, DOI 10.2307/1380713; Stewart K. J., 2001, MOUNTAIN GORILLAS 3, P184; Stoinski TS, 2009, BEHAVIOUR, V146, P1193, DOI 10.1163/156853909X419992; Stoinski TS, 2009, ANIM BEHAV, V77, P1155, DOI 10.1016/j.anbehav.2008.12.030; Stokes EJ, 2003, BEHAV ECOL SOCIOBIOL, V54, P329, DOI 10.1007/s00265-003-0630-3; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Teichroeb JA, 2012, BEHAV ECOL, V23, P1348, DOI 10.1093/beheco/ars128; van Dijk RE, 2008, ELS, DOI [10.1002/9780470015902.a0003665, DOI 10.1002/9780470015902.A0003665]; van Schaik Carel P., 2000, P61, DOI 10.1017/CBO9780511542312.005; VanSchaik CP, 1997, P ROY SOC B-BIOL SCI, V264, P1687, DOI 10.1098/rspb.1997.0234; Vigilant L, 2015, BEHAV ECOL SOCIOBIOL, V69, P1163, DOI 10.1007/s00265-015-1930-0; Watts David P., 1993, P148; WATTS DP, 1991, AM J PRIMATOL, V24, P211, DOI 10.1002/ajp.1350240307; Watts DP, 2000, PRIMATES, V41, P357, DOI 10.1007/BF02557646; WATTS DP, 1989, ETHOLOGY, V81, P1; WATTS DP, 1994, BEHAV ECOL SOCIOBIOL, V34, P347, DOI 10.1007/BF01209781; WATTS DP, 1992, AM J PRIMATOL, V28, P159, DOI 10.1002/ajp.1350280302; WATTS DP, 1990, ZOO BIOL, V9, P185, DOI 10.1002/zoo.1430090302; WOLFF JO, 1985, ANIM BEHAV, V33, P117, DOI 10.1016/S0003-3472(85)80125-1; WRANGHAM RW, 1993, HUM NATURE-INT BIOS, V4, P47, DOI 10.1007/BF02734089; WRANGHAM RW, 1979, SOC SCI INFORM, V18, P335; [No title captured]	101	6	6	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0147441	10.1371/journal.pone.0147441	http://dx.doi.org/10.1371/journal.pone.0147441			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863300	Green Published, gold, Green Submitted			2022-12-27	WOS:000370046600030
J	Swart, EM; van Gageldonk, PGM; de Melker, HE; van der Klis, FR; Berbers, GAM; Mollema, L				Swart, E. M.; van Gageldonk, P. G. M.; de Melker, H. E.; van der Klis, F. R.; Berbers, G. A. M.; Mollema, L.			Long-Term Protection against Diphtheria in the Netherlands after 50 Years of Vaccination: Results from a Seroepidemiological Study	PLOS ONE			English	Article							PERTUSSIS-VACCINE; TETANUS; ANTITOXIN; ADULTS; IMMUNOGENICITY; IMMUNIZATION; SEROPREVALENCE; ANTIBODIES; IMMUNITY; CHILDREN	Background and Aims To evaluate the National Immunisation Programme (NIP) a population-based cross-sectional seroepidemiological study was performed in the Netherlands. We assessed diphtheria antitoxin levels in the general Dutch population and in low vaccination coverage (LVC) areas where a relatively high proportion of orthodox Protestants live who decline vaccination based on religious grounds. Results were compared with a nationwide seroepidemiological study performed 11 years earlier. Methods In 2006/2007 a national serum bank was established. Blood samples were tested for diphtheria antitoxin IgG concentrations using a multiplex immunoassay for 6383 participants from the national sample (NS) and 1518 participants from LVC municipalities. A cut-off above 0.01 international units per ml (IU/ml) was used as minimum protective level. Results In the NS 91% of the population had antibody levels above 0.01 IU/ml compared to 88% in the 1995/1996 serosurvey (p<0.05). On average, 82% (vs. 78% in the 1995/1996 serosurvey, p<0.05) of individuals from the NS born before introduction of diphtheria vaccination in the NIP and 46% (vs. 37% in the 1995/1996 serosurvey, p = 0.11) of orthodox Protestants living in LVC areas had antibody levels above 0.01 IU/ml. Linear regression analysis among fully immunized individuals (six vaccinations) without evidence of revaccination indicated a continuous decline in antibodies in both serosurveys, but geometric mean antibodies remained well above 0.01 IU/ml in all age groups. Conclusions The NIP provides long-term protection against diphtheria, although antibody levels decline after vaccination. As a result of natural waning immunity, a substantial proportion of individuals born before introduction of diphtheria vaccination in the NIP lack adequate levels of diphtheria antibodies. Susceptibility due to lack of vaccination is highest among strictly orthodox Protestants. The potential risk of spread of diphtheria within the geographically clustered orthodox Protestant community after introduction in the Netherlands has not disappeared, despite national long-term high vaccination coverage.	[Swart, E. M.; van Gageldonk, P. G. M.; de Melker, H. E.; van der Klis, F. R.; Berbers, G. A. M.; Mollema, L.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment	Swart, EM (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands.	esther.swart@rivm.nl		van Gageldonk, Pieter/0000-0003-2753-9674				31European Commission, 2015, CAS DIPHTH SPAIN, P8; Bickel P.J., 2001, MATH STAT BASIC IDEA; BOOY R, 1992, LANCET, V339, P507, DOI 10.1016/0140-6736(92)90336-2; Both L, 2014, EUROSURVEILLANCE, V19, P19, DOI 10.2807/1560-7917.ES2014.19.24.20830; De Melker HE, 1998, EPIDEMIOL INFECT, V121, P637, DOI 10.1017/S0950268898001587; de Melker HE, 1999, EMERG INFECT DIS, V5, P694, DOI 10.3201/eid0505.990511; Di Giovine P, 2013, EPIDEMIOL INFECT, V141, P132, DOI 10.1017/S0950268812000210; Di Giovine P, 2010, CLIN VACCINE IMMUNOL, V17, P1282, DOI 10.1128/CVI.00096-10; Dittmann S, 2000, J INFECT DIS, V181, pS10, DOI 10.1086/315534; Galazka A, 2000, J INFECT DIS, V181, pS2, DOI 10.1086/315533; Hardy IRB, 1996, LANCET, V347, P1739, DOI 10.1016/S0140-6736(96)90811-9; Health Council of the Netherlands, 2004, VACC PERT; HENDRIKSEN CFM, 1989, J BIOL STAND, V17, P191, DOI 10.1016/0092-1157(89)90009-7; Hoppenbrouwers K, 2011, HDB VACCINATIES A; Kurugol Z, 2011, VACCINE, V29, P4341, DOI 10.1016/j.vaccine.2011.04.016; Melker HE, 2015, RIVM REPORT 2015 013; Melker HE, 2014, 1502020022013 RIVM; Miller E, 1997, VACCINE, V15, P51, DOI 10.1016/S0264-410X(96)00112-0; Mollema L, 2009, PIENTER 2 PROJECT 2; Neal S, 2007, Euro Surveill, V12, pE9; Olander RM, 2009, VACCINE, V27, P5295, DOI 10.1016/j.vaccine.2009.06.080; PICHICHERO ME, 1987, PEDIATR INFECT DIS J, V6, P352, DOI 10.1097/00006454-198704000-00004; R Core Team, 2021, R LANGUAGE ENV STAT; RAMSAY MEB, 1993, LANCET, V342, P203, DOI 10.1016/0140-6736(93)92298-8; Ruijs WLM, 2012, EUR J PUBLIC HEALTH, V22, P359, DOI 10.1093/eurpub/ckr081; Scheifele D., 2009, IMMUNOLOGICAL BASIS; Spijkerman J, 2013, JAMA-J AM MED ASSOC, V310, P930, DOI 10.1001/jama.2013.228052; van den Hof S, 1997, 213675005 RIVM; van der Klis FRM, 2009, NETH J MED, V67, P301; van Gageldonk PGM, 2011, CLIN VACCINE IMMUNOL, V18, P1183, DOI 10.1128/CVI.05081-11; van Lier EA, 2014, 1502020032014 RIVM; Volzke H, 2006, CLIN MICROBIOL INFEC, V12, P961, DOI 10.1111/j.1469-0691.2006.01477.x; von Hunolstein C, 2014, J IMMUNOL CLIN RES, V2, P1022; Wagner KS, 2009, VACCINE, V28, P14, DOI 10.1016/j.vaccine.2009.09.094; Wagner KS, 2012, VACCINE, V30, P7111, DOI 10.1016/j.vaccine.2012.09.029; Zasada AA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-551	36	21	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148605	10.1371/journal.pone.0148605	http://dx.doi.org/10.1371/journal.pone.0148605			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863307	gold, Green Published, Green Submitted			2022-12-27	WOS:000370046600084
J	Chen, Q; Zhao, YA; Pan, SL; Wang, Y				Chen, Qun; Zhao, Yunan; Pan, Shuangli; Wang, Yan			Survey of the Influence of the Width of Urban Branch Roads on the Meeting of Two-Way Vehicle Flows	PLOS ONE			English	Article							CELLULAR-AUTOMATON MODEL; MIXED TRAFFIC CONDITIONS; CAR-FOLLOWING MODEL; LANE WIDTH; COMMUNICATION; CAPACITY; MEMORY; INDIA	Branch roads, which are densely distributed in cities, allow for the flow of local traffic and provide connections between the city and outlying areas. Branch roads are typically narrow, and two-way traffic flows on branch roads are thus affected when vehicles traveling in opposite directions meet. This study investigates the changes in the velocities of vehicles when they meet on two-way branch roads. Various widths of branch roads were selected, and their influence on traffic flows was investigated via a video survey. The results show that, depending on the average vehicle velocity, branch roads require different widths to prevent a large decrease in velocity when vehicles meet. When the velocity on a branch road is not high (e.g., the average velocity without meeting is approximately 6 m/s), appropriately increasing the road width will notably increase the meeting velocity. However, when the velocity is high (e.g., the average velocity without meeting is greater than 10 m/s), there is a large decrease in velocity when meeting even if the road surface is wide (6.5 m). This study provides a basis for selecting the width of urban branch roads and the simulation of bidirectional traffic on such roads.	[Chen, Qun; Zhao, Yunan; Pan, Shuangli] Cent S Univ, Sch Traff & Transportat Engn, Changsha, Hunan, Peoples R China; [Wang, Yan] Cent S Univ, Sch Publ Adm, Changsha, Hunan, Peoples R China	Central South University; Central South University	Chen, Q (corresponding author), Cent S Univ, Sch Traff & Transportat Engn, Changsha, Hunan, Peoples R China.	chenqun631@csu.edu.cn	Chen, Qun/HGD-0868-2022		National Social Science Fund of China [13CGL001]; Research Fund for Young Scholars of Central South University [2014JSJJ015]	National Social Science Fund of China; Research Fund for Young Scholars of Central South University	This work was supported by the National Social Science Fund of China under Grant [number 13CGL001, QC receives funding] and the Research Fund for Young Scholars of Central South University under Grant [number 2014JSJJ015, QC receives funding]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Social Science Fund of China under Grant Number 13CGL001 and the Research Fund for Young Scholars of Central South University under Grant Number 2014JSJJ015.	AASHTO, 2011, POLICY GEOMETRIC DES; [Anonymous], 1995, 502201995 GB; Arasan VT, 2010, J TRANSP ENG, V136, P1110, DOI 10.1061/(ASCE)TE.1943-5436.0000176; Chandra S, 2003, J TRANSP ENG-ASCE, V129, P155, DOI 10.1061/(ASCE)0733-947X(2003)129:2(155); Chen Q, 2015, PHYSICA A, V432, P43, DOI 10.1016/j.physa.2015.03.004; Code for Design of Urban Road Engineering, 2012, 372012 CJJ; DAGANZO CF, 1994, TRANSPORT RES B-METH, V28, P269, DOI 10.1016/0191-2615(94)90002-7; Fitzpatrick K, 2008, TRANSPORT RES REC, P18, DOI 10.3141/2065-03; Fouladvand ME, 1999, PHYS REV E, V60, P6465, DOI 10.1103/PhysRevE.60.6465; Gibreel GM, 1999, J TRANSP ENG, V125, P305, DOI 10.1061/(ASCE)0733-947X(1999)125:4(305); Gross F, 2009, TRANSPORT RES REC, P42, DOI 10.3141/2103-06; Heimbach C. L., 1983, TRANSPORT RES REC, V923, P69; Helbing D, 1996, PHYS REV E, V53, P2366, DOI 10.1103/PhysRevE.53.2366; Highway Research Board, 1975, 87 HIGH RES BOARD NA; Hoogendoorn SP, 1998, TRANSPORT RES REC, P18, DOI 10.3141/1646-03; Institute of Transportation Engineers, 1992, GUID URB MAJ STREET; Isebrands H, 2015, ITE J, V85, P36; Jia B, 2005, PHYSICA A, V348, P544, DOI 10.1016/j.physa.2004.09.034; Jiang R, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.017101; Krishnamurthy K, 2014, J ADV TRANSPORT, V48, P1, DOI 10.1002/atr.196; Lee HW, 1997, J PHYS A-MATH GEN, V30, P8497, DOI 10.1088/0305-4470/30/24/014; Li PY, 2002, TRANSPORT RES C-EMER, V10, P275, DOI 10.1016/S0968-090X(02)00004-9; Lighthill M. J., 1955, PROC R SOC LON SER A, VA299, P317, DOI DOI 10.1098/RSPA.1955.0089; Mailaender T., 1999, HIGHWAY DESIGN TRAFF; Minocha VK, 2004, J TRANSP ENG, V130, P402, DOI 10.1061/(ASCE)0733-947X(2004)130:3(402); Payne HJ., 1979, TRANSP RES REC, V722, P68; Popkov V, 2000, J PHYS A-MATH GEN, V33, P3989, DOI 10.1088/0305-4470/33/22/303; Rosey F, 2009, TRANSPORT RES REC, P112, DOI 10.3141/2138-15; Simon PM, 1998, PHYS REV E, V57, P2441, DOI 10.1103/PhysRevE.57.2441; Tang TQ, 2014, MEASUREMENT, V58, P286, DOI 10.1016/j.measurement.2014.08.051; Tang TQ, 2014, NONLINEAR DYNAM, V76, P2017, DOI 10.1007/s11071-014-1265-9; Transportation Research Board, 2000, HIGHW CAP MAN 2000; Wang G, 1990, URBAN ROAD PLANNING; YAGAR S, 1983, TRANSPORT RES A-POL, V17, P315, DOI 10.1016/0191-2607(83)90094-8; Yu SW, 2015, PHYSICA A, V428, P206, DOI 10.1016/j.physa.2015.01.064; Yu SW, 2015, MEASUREMENT, V64, P34, DOI 10.1016/j.measurement.2014.12.036	36	0	0	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149188	10.1371/journal.pone.0149188	http://dx.doi.org/10.1371/journal.pone.0149188			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881427	Green Submitted, Green Published, gold			2022-12-27	WOS:000371219000055
J	Diekman, EF; Visser, G; Schmitz, JPJ; Nievelstein, RAJ; de Sain-van der Velden, M; Wardrop, M; Van der Pol, WL; Houten, SM; van Riel, NAW; Takken, T; Jeneson, JAL				Diekman, E. F.; Visser, G.; Schmitz, J. P. J.; Nievelstein, R. A. J.; de Sain-van der Velden, M.; Wardrop, M.; Van der Pol, W. L.; Houten, S. M.; van Riel, N. A. W.; Takken, T.; Jeneson, J. A. L.			Altered Energetics of Exercise Explain Risk of Rhabdomyolysis in Very Long-Chain Acyl-CoA Dehydrogenase Deficiency	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; DUCHENNE MUSCULAR-DYSTROPHY; MAXIMAL FAT OXIDATION; ACID BETA-OXIDATION; SKELETAL-MUSCLE; MITOCHONDRIAL MYOPATHIES; IN-VIVO; RESISTANCE; FATIGUE; KINASE	Rhabdomyolysis is common in very long-chain acyl-CoA dehydrogenase deficiency (VLCADD) and other metabolic myopathies, but its pathogenic basis is poorly understood. Here, we show that prolonged bicycling exercise against a standardized moderate workload in VLCADD patients is associated with threefold bigger changes in phosphocreatine (PCr) and inorganic phosphate (Pi) concentrations in quadriceps muscle and twofold lower changes in plasma acetyl-carnitine levels than in healthy subjects. This result is consistent with the hypothesis that muscle ATP homeostasis during exercise is compromised in VLCADD. However, the measured rates of PCr and Pi recovery post-exercise showed that the mitochondrial capacity for ATP synthesis in VLCADD muscle was normal. Mathematical modeling of oxidative ATP metabolism in muscle composed of three different fiber types indicated that the observed altered energy balance during submaximal exercise in VLCADD patients may be explained by a slow-to-fast shift in quadriceps fiber-type composition corresponding to 30% of the slow-twitch fiber-type pool in healthy quadriceps muscle. This study demonstrates for the first time that quadriceps energy balance during exercise in VLCADD patients is altered but not because of failing mitochondrial function. Our findings provide new clues to understanding the risk of rhabdomyolysis following exercise in human VLCADD.	[Diekman, E. F.; Visser, G.; de Sain-van der Velden, M.] Wilhelmina Childrens Hosp, Univ Med Ctr Utrecht, Dept Metab Dis, Utrecht, Netherlands; [Diekman, E. F.; Visser, G.; Houten, S. M.] Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, Lab Genet Metab Dis,Emma Childrens Hosp, NL-1105 AZ Amsterdam, Netherlands; [Diekman, E. F.; Visser, G.; Houten, S. M.] Univ Amsterdam, Acad Med Ctr, Dept Pediat, Lab Genet Metab Dis,Emma Childrens Hosp, NL-1105 AZ Amsterdam, Netherlands; [Schmitz, J. P. J.] Eindhoven Univ Technol, Dept Biomed Technol, Computat Biol Grp, POB 513, NL-5600 MB Eindhoven, Netherlands; [Schmitz, J. P. J.; van Riel, N. A. W.] Vrije Univ Amsterdam, Dept Life & Earth Sci, Syst Bioinformat, Amsterdam, Netherlands; [Nievelstein, R. A. J.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Wardrop, M.; Takken, T.; Jeneson, J. A. L.] Wilhelmina Childrens Hosp, Univ Med Ctr Utrecht, Child Dev & Exercise Ctr, Utrecht, Netherlands; [Van der Pol, W. L.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol & Neurosurg, Spieren Spieren Childrens Ctr, Utrecht, Netherlands; [Jeneson, J. A. L.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Lab Liver Digest & Metab Dis, NL-9713 AV Groningen, Netherlands; [Jeneson, J. A. L.] Univ Groningen, Univ Med Ctr Groningen, Div Neurosci, Neuroimaging Ctr, NL-9713 AV Groningen, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Eindhoven University of Technology; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; University of Groningen; University of Groningen	Jeneson, JAL (corresponding author), Wilhelmina Childrens Hosp, Univ Med Ctr Utrecht, Child Dev & Exercise Ctr, Utrecht, Netherlands.; Jeneson, JAL (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Lab Liver Digest & Metab Dis, NL-9713 AV Groningen, Netherlands.; Jeneson, JAL (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Div Neurosci, Neuroimaging Ctr, NL-9713 AV Groningen, Netherlands.	j.a.l.jeneson@umcg.nl	Takken, Tim/A-9912-2010; Houten, Sander/Y-3599-2019; van Riel, Natal/J-5319-2013	Houten, Sander/0000-0002-6167-9147; van Riel, Natal/0000-0001-9375-4730	Roorda Foundation; NIH [HL-072011]; ZonMW [20032006]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072011] Funding Source: NIH RePORTER	Roorda Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ZonMW(Netherlands Organization for Health Research and Development); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by ZonMW (dossiernr. 20032006) (to GV), Roorda Foundation (to TT), and NIH HL-072011 (to JALJ).	Achten J, 2002, MED SCI SPORT EXER, V34, P92, DOI 10.1097/00005768-200201000-00015; Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; ARNOLD DL, 1985, ANN NEUROL, V18, P189, DOI 10.1002/ana.410180205; Arnold GL, 2009, MOL GENET METAB, V96, P85, DOI 10.1016/j.ymgme.2008.09.008; Atkinson DF, 1978, J FOOD BIOCHEM, V2, P209, DOI [10.1111/j.1745-4514.1978.tb00613.x, DOI 10.1111/J.1745-4514.1978.TB00613.X]; BARBIROLI B, 1993, J NEUROL SCI, V119, P65, DOI 10.1016/0022-510X(93)90192-2; Baruteau J, 2013, J INHERIT METAB DIS, V36, P795, DOI 10.1007/s10545-012-9542-6; Bergmeyer HU, 1986, METHODS ENZYMATIC AN; Bonnefont JP, 1999, MOL GENET METAB, V68, P424, DOI 10.1006/mgme.1999.2938; Bottinelli R, 2000, PROG BIOPHYS MOL BIO, V73, P195, DOI 10.1016/S0079-6107(00)00006-7; BRUMBACK RA, 1980, J NEUROL SCI, V48, P383, DOI 10.1016/0022-510X(80)90110-0; Chuang CK, 2009, J CHROMATOGR A, V1216, P8947, DOI 10.1016/j.chroma.2009.10.074; DAWSON MJ, 1978, NATURE, V274, P861, DOI 10.1038/274861a0; de Sain-van der Velden MGM, 2013, MOL GENET METAB, V110, P116, DOI 10.1016/j.ymgme.2013.04.008; den Boer MEJ, 2003, J PEDIATR-US, V142, P684, DOI 10.1067/mpd.2003.231; den Boer MEJ, 2002, PEDIATRICS, V109, P99, DOI 10.1542/peds.109.1.99; DENNETT X, 1988, AUST PAEDIATR J, V24, P15; Diekman EF, 2014, J INHERIT METAB DIS, V37, P405, DOI 10.1007/s10545-013-9666-3; DUNN JF, 1991, BIOCHIM BIOPHYS ACTA, V1096, P115, DOI 10.1016/0925-4439(91)90048-E; Feneson JAL, 2010, MAGN RESON MED, V63, P257, DOI 10.1002/mrm.22179; FROM AHL, 1986, FEBS LETT, V206, P257, DOI 10.1016/0014-5793(86)80992-9; Houten SM, 2010, J INHERIT METAB DIS, V33, P469, DOI 10.1007/s10545-010-9061-2; Huerta-Alardin AL, 2005, CRIT CARE, V9, P158, DOI 10.1186/cc2978; HULTMAN E, 1995, P NUTR SOC, V54, P107, DOI 10.1079/PNS19950041; Jeneson JAL, 2007, ACTA PHYSIOL, V190, P151, DOI 10.1111/j.1748-1716.2007.01680.x; Jeneson JAL, 1997, MOL CELL BIOCHEM, V174, P17, DOI 10.1023/A:1006891420109; Jeneson JAL, 2000, AM J PHYSIOL-CELL PH, V279, pC813, DOI 10.1152/ajpcell.2000.279.3.C813; Jeneson JAL, 2011, AM J PHYSIOL-REG I, V300, pR1316, DOI 10.1152/ajpregu.00204.2010; Kahle M, 2015, MOL METAB, V4, P39, DOI 10.1016/j.molmet.2014.11.004; KIHIRA S, 1985, J NEUROL SCI, V70, P139, DOI 10.1016/0022-510X(85)90083-8; KIM DK, 1991, AM J PHYSIOL, V260, pH1767, DOI 10.1152/ajpheart.1991.260.6.H1767; Kushmerick MJ, 1985, AM J PHYSL; Laforet P, 2009, NEUROMUSCULAR DISORD, V19, P324, DOI 10.1016/j.nmd.2009.02.007; Lindner M, 2010, J INHERIT METAB DIS, V33, P521, DOI 10.1007/s10545-010-9076-8; McBride A, 2009, CELL METAB, V9, P23, DOI 10.1016/j.cmet.2008.11.008; MEYER RA, 1988, AM J PHYSIOL, V254, pC548, DOI 10.1152/ajpcell.1988.254.4.C548; Milone M, 2013, MOL GENET METAB, V110, P35, DOI 10.1016/j.ymgme.2013.07.007; Morris AAM, 1998, CURR OPIN NEUROL, V11, P485, DOI 10.1097/00019052-199810000-00011; Orngreen MC, 2014, NEUROLOGY, V82, P607, DOI 10.1212/WNL.0000000000000118; PERONNET F, 1991, CAN J SPORT SCI, V16, P23; PIPER MH, 1984, BASIC RES CARDIOL, V79, P186, DOI 10.1007/BF01908305; Roberts LD, 2014, CELL METAB, V19, P96, DOI 10.1016/j.cmet.2013.12.003; Rowell LB, HDB PHYSL EXERCISE R; Rubio-Gozalbo M. E., 2004, Molecular Aspects of Medicine, V25, P521, DOI 10.1016/j.mam.2004.06.007; Scholte HR, 1999, NEUROMUSCULAR DISORD, V9, P313, DOI 10.1016/S0960-8966(99)00032-2; Staron RS, 2000, J HISTOCHEM CYTOCHEM, V48, P623, DOI 10.1177/002215540004800506; STRAUSS AW, 1995, P NATL ACAD SCI USA, V92, P10496, DOI 10.1073/pnas.92.23.10496; ter Veld F, 2006, PFLUG ARCH EUR J PHY, V452, P342, DOI 10.1007/s00424-005-0041-6; Tosetti M, 2011, MUSCLE NERVE, V44, P816, DOI 10.1002/mus.22181; Tucci S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045429; van Brussel M, 2015, ACAD RADIOL, V22, P1443, DOI 10.1016/j.acra.2015.06.013; van Oorschot JWM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076628; Veech RL, 2001, IUBMB LIFE, V51, P241; VENTURA FV, 1995, BBA-MOL BASIS DIS, V1272, P14, DOI 10.1016/0925-4439(95)00064-B; Vianey-Saban C, 1998, CLIN CHIM ACTA, V269, P43, DOI 10.1016/S0009-8981(97)00185-X; Violante S, 2010, BBA-MOL BASIS DIS, V1802, P728, DOI 10.1016/j.bbadis.2010.06.002; Vissing CR, 2013, NEUROLOGY, V80, P1908, DOI 10.1212/WNL.0b013e3182929fb2; Visweswaran P, 1999, CRIT CARE CLIN, V15, P415, DOI 10.1016/S0749-0704(05)70061-0; WATANABE H, 1989, BIOCHIM BIOPHYS ACTA, V980, P315, DOI 10.1016/0005-2736(89)90318-0; WEBSTER C, 1988, CELL, V52, P503, DOI 10.1016/0092-8674(88)90463-1; Weibel ER, 1996, J EXP BIOL, V199, P1699; WESTERHOFF HV, 1995, BIOPHYS CHEM, V54, P137, DOI 10.1016/0301-4622(94)00129-8; Wu F, 2007, AM J PHYSIOL-CELL PH, V292, pC115, DOI 10.1152/ajpcell.00237.2006; York B, 2012, CELL METAB, V15, P752, DOI 10.1016/j.cmet.2012.03.020; Zakrzewski J, 2011, PEDIATR EXERC SCI, V23, P122, DOI 10.1123/pes.23.1.122	65	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0147818	10.1371/journal.pone.0147818	http://dx.doi.org/10.1371/journal.pone.0147818			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881790	Green Published, Green Submitted, gold			2022-12-27	WOS:000371219000007
J	Tuettenberg, A; Hahn, SA; Mazur, J; Gerhold-Ay, A; Scholma, J; Marg, I; Ulges, A; Satoh, K; Bopp, T; Joore, J; Jonuleit, H				Tuettenberg, Andrea; Hahn, Susanne A.; Mazur, Johanna; Gerhold-Ay, Aslihan; Scholma, Jetse; Marg, Iris; Ulges, Alexander; Satoh, Kazuki; Bopp, Tobias; Joore, Jos; Jonuleit, Helmut			Kinome Profiling of Regulatory T Cells: A Closer Look into a Complex Intracellular Network	PLOS ONE			English	Article							SUPPRESSIVE FUNCTION; PERIPHERAL-BLOOD; HELPER-CELLS; CANCER-CELLS; KINASE; ACTIVATION; RECEPTOR; PHOSPHORYLATION; PROLIFERATION; EXPRESSIONS	Regulatory T cells (Treg) are essential for T cell homeostasis and maintenance of peripheral tolerance. They prevent activation of auto-reactive T effector cells (Teff) in the context of autoimmunity and allergy. Otherwise, Treg also inhibit effective immune responses against tumors. Besides a number of Treg-associated molecules such as Foxp3, CTLA-4 or GARP, known to play critical roles in Treg differentiation, activation and function, the involvement of additional regulatory elements is suggested. Herein, kinase activities seem to play an important role in Treg fine tuning. Nevertheless, our knowledge regarding the complex intracellular signaling pathways controlling phenotype and function of Treg is still limited and based on single kinase cascades so far. To gain a more comprehensive insight into the pathways determining Treg function we performed kinome profiling using a phosphorylation- based kinome array in human Treg at different activation stages compared to Teff. Here we have determined intriguing quantitative differences in both populations. Resting and activated Treg showed an altered pattern of CD28-dependent kinases as well as of those involved in cell cycle progression. Additionally, significant up-regulation of distinct kinases such as EGFR or CK2 in activated Treg but not in Teff not only resemble data we obtained in previous studies in the murine system but also suggest that those specific molecular activation patterns can be used for definition of the activation and functional state of human Treg. Taken together, detailed investigation of kinome profiles opens the possibility to identify novel molecular mechanisms for a better understanding of Treg biology but also for development of effective immunotherapies against unwanted T cell responses in allergy, autoimmunity and cancer.	[Tuettenberg, Andrea; Hahn, Susanne A.; Marg, Iris; Satoh, Kazuki; Jonuleit, Helmut] Johannes Gutenberg Univ Mainz, Dept Dermatol, Univ Med Ctr Mainz, D-55122 Mainz, Germany; [Mazur, Johanna; Gerhold-Ay, Aslihan] Johannes Gutenberg Univ Mainz, IMBEI, Univ Med Ctr Mainz, D-55122 Mainz, Germany; [Ulges, Alexander; Bopp, Tobias] Johannes Gutenberg Univ Mainz, Inst Immunol, Univ Med Ctr Mainz, Obere Zahlbacher Str 67, Mainz, Germany; [Scholma, Jetse] Univ Twente, Dept Dev Bioengn, POB 217, NL-7500 AE Enschede, Netherlands; [Joore, Jos] Pepscope BV, Utrecht, Netherlands	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Twente	Tuettenberg, A (corresponding author), Johannes Gutenberg Univ Mainz, Dept Dermatol, Univ Med Ctr Mainz, D-55122 Mainz, Germany.	andrea.tuettenberg@unimedizin-mainz.de	Bopp, Tobias/A-4328-2018; Jonuleit, Helmut/D-8059-2011	Bopp, Tobias/0000-0002-3232-8065; Jonuleit, Helmut/0000-0002-5672-9365; Joore, Jos/0000-0002-2744-4862	Deutsche Forschungsgemeinschaft [SFB 1066]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Work was funded by the Deutsche Forschungsgemeinschaft, SFB 1066 to AT, TB and HJ. JJ and JS are employees of Pepscope BV. Both authors collected and analyzed data and were involved in the preparation of the manuscript. The company provided support in the form of salaries for authors JJ and JS, but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adler HS, 2008, CELL CYCLE, V7, P169, DOI 10.4161/cc.7.2.5312; Andersen P, 2008, INT J CANCER, V122, P342, DOI 10.1002/ijc.23109; Bianchini R, 2011, EUR J IMMUNOL, V41, P2269, DOI 10.1002/eji.201040943; Claperon A, 2012, ONCOGENE, V31, P1376, DOI 10.1038/onc.2011.334; Correll A, 2010, EXP DERMATOL, V19, pE213, DOI 10.1111/j.1600-0625.2009.01055.x; de Borst MH, 2007, AM J PHYSIOL-RENAL, V293, pF428, DOI 10.1152/ajprenal.00367.2006; Diks SH, 2004, J BIOL CHEM, V279, P49206, DOI 10.1074/jbc.M405028200; Dong ZC, 2013, SCI CHINA LIFE SCI, V56, P960, DOI 10.1007/s11427-013-4557-2; Fanayan S, 2013, J PROTEOME RES, V12, P1732, DOI 10.1021/pr3010869; Gemini-Piperni S, 2014, BIOTECHNOL BIOENG, V111, P1900, DOI 10.1002/bit.25246; Guereschi MG, 2013, EUR J IMMUNOL, V43, P1001, DOI 10.1002/eji.201243005; He HQ, 2014, IMMUNOLOGY, V141, P362, DOI 10.1111/imm.12198; Huynh A, 2015, NAT IMMUNOL, V16, P188, DOI 10.1038/ni.3077; Jaffer ZM, 2002, INT J BIOCHEM CELL B, V34, P713, DOI 10.1016/S1357-2725(01)00158-3; Jonuleit H, 2002, J EXP MED, V196, P255, DOI 10.1084/jem.20020394; Jonuleit H, 2005, METH MOLEC MED, V109, P285; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; King HA, 2014, BRIEF FUNCT GENOMICS; Knight JDR, 2013, J PROTEOMICS, V81, P43, DOI 10.1016/j.jprot.2012.10.015; Koenig A, 2014, J BIOL CHEM, V289, P1183, DOI 10.1074/jbc.M113.506428; Konig S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040896; Kubach J, 2007, BLOOD, V110, P1550, DOI 10.1182/blood-2007-01-069229; Lowenberg M, 2006, ENDOCRINOLOGY, V147, P3555, DOI 10.1210/en.2005-1602; Parikh K, 2010, CANCER RES, V70, P2575, DOI 10.1158/0008-5472.CAN-09-3989; Pietruczuk M, 2012, J BIOL REG HOMEOS AG, V26, P627; Roncarolo MG, 2008, EUR J IMMUNOL, V38, P925, DOI 10.1002/eji.200838168; Roorda BD, 2009, CANCER BIOL THER, V8, P1239, DOI 10.4161/cbt.8.13.8688; Sanman LE, 2014, ANNU REV BIOCHEM, V83, P249, DOI 10.1146/annurev-biochem-060713-035352; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Stassen M, 2004, J IMMUNOL, V173, P267, DOI 10.4049/jimmunol.173.1.267; Stassen M, 2004, EUR J IMMUNOL, V34, P1303, DOI 10.1002/eji.200324656; Svensson H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030695; Taher TE, 2010, ARTHRITIS RHEUM-US, V62, P2412, DOI 10.1002/art.27505; Ulges A, 2015, NAT IMMUNOL, V16, P267, DOI 10.1038/ni.3083; van der Sligte NE, 2014, PROTEOMICS; Wang L., 2015, J CLIN INVEST; Yao WF, 2012, AMINO ACIDS, V43, P2027, DOI 10.1007/s00726-012-1277-z; Yuan CH, 2015, ONCOTARGET, V6, P32138, DOI 10.18632/oncotarget.5171; Zaiss DMW, 2013, IMMUNITY, V38, P275, DOI 10.1016/j.immuni.2012.09.023	39	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149193	10.1371/journal.pone.0149193	http://dx.doi.org/10.1371/journal.pone.0149193			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881744	Green Published, gold, Green Submitted			2022-12-27	WOS:000371219000056
J	Beaulieu, YB; Machado, JAL; Ethier, S; Gaudreau, L; Steimle, V				Beaulieu, Yves B.; Machado, Jorge A. Leon; Ethier, Sylvain; Gaudreau, Luc; Steimle, Viktor			Degradation, Promoter Recruitment and Transactivation Mediated by the Extreme N-Terminus of MHC Class II Transactivator CIITA Isoform III	PLOS ONE			English	Article							LEUCINE-RICH REPEATS; TRANSCRIPTIONAL COACTIVATOR; PROTEIN; EXPRESSION; UBIQUITIN; COMPLEX; PROTEASOME; ASSOCIATION; TURNOVER; BINDING	Multiple relationships between ubiquitin-proteasome mediated protein turnover and transcriptional activation have been well documented, but the underlying mechanisms are still poorly understood. One way to induce degradation is via ubiquitination of the N-terminal alpha-amino group of proteins. The major histocompatibility complex (MHC) class II transactivator CIITA is the master regulator of MHC class II gene expression and we found earlier that CIITA is a short-lived protein. Using stable and transient transfections of different CIITA constructs into HEK-293 and HeLa cell lines, we show here that the extreme N-terminal end of CIITA isoform III induces both rapid degradation and transactivation. It is essential that this sequence resides at the N-terminal end of the protein since blocking of the N-terminal end with an epitope-tag stabilizes the protein and reduces transactivation potential. The first ten amino acids of CIITA isoform III act as a portable degron and transactivation sequence when transferred as N-terminal extension to truncated CIITA constructs and are also able to destabilize a heterologous protein. The same is observed with the N-terminal ends of several known N-terminal ubiquitination substrates, such as Id2, Cdt1 and MyoD. Arginine and proline residues within the N-terminal ends contribute to rapid turnover. The N-terminal end of CIITA isoform III is responsible for efficient in vivo recruitment to the HLA-DRA promoter and increased interaction with components of the transcription machinery, such as TBP, p300, p400/Domino, the 19S ATPase S8, and the MHC-II promoter binding complex RFX. These experiments reveal a novel function of free N-terminal ends of proteins in degradation-dependent transcriptional activation.	[Beaulieu, Yves B.; Machado, Jorge A. Leon; Ethier, Sylvain; Gaudreau, Luc; Steimle, Viktor] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada; [Ethier, Sylvain] McGill Univ, Dept Biochem, Montreal, PQ, Canada	University of Sherbrooke; McGill University	Steimle, V (corresponding author), Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada.	viktor.steimle@usherbrooke.ca			Natural Sciences and Engineering Research Council of Canada, (NSERC) [262845]; Canadian Institute for Health Research (CIHR)	Natural Sciences and Engineering Research Council of Canada, (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by the Natural Sciences and Engineering Research Council of Canada, (NSERC, #262845 to VS). LG holds a Canada research chair on mechanisms of gene transcription and is supported by the Canadian Institute for Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACCOLLA RS, 1983, J EXP MED, V157, P1053, DOI 10.1084/jem.157.3.1053; Auld KL, 2006, MOL CELL, V21, P861, DOI 10.1016/j.molcel.2006.02.020; Aviel S, 2000, J BIOL CHEM, V275, P23491, DOI 10.1074/jbc.M002052200; Ben-Saadon R, 2004, J BIOL CHEM, V279, P41414, DOI 10.1074/jbc.M407201200; Bhat KP, 2008, MOL IMMUNOL, V45, P2214, DOI 10.1016/j.molimm.2007.12.001; Bhat KP, 2011, BBA-GENE REGUL MECH, V1809, P150, DOI 10.1016/j.bbagrm.2010.11.006; Bhat KP, 2010, IMMUNOL CELL BIOL, V88, P807, DOI 10.1038/icb.2010.45; Bhat KP, 2010, J BIOL CHEM, V285, P25893, DOI 10.1074/jbc.M110.127746; Bontron S, 1997, MOL CELL BIOL, V17, P4249, DOI 10.1128/MCB.17.8.4249; Breitschopf K, 1998, EMBO J, V17, P5964, DOI 10.1093/emboj/17.20.5964; Brown JA, 1996, IMMUNOGENETICS, V43, P88; Camacho-Carvajal MM, 2004, INT IMMUNOL, V16, P65, DOI 10.1093/intimm/dxh010; CARREL S, 1981, MOL IMMUNOL, V18, P403, DOI 10.1016/0161-5890(81)90102-4; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Coulombe P, 2004, MOL CELL BIOL, V24, P6140, DOI 10.1128/MCB.24.14.6140-6150.2004; Drozina G, 2006, J BIOL CHEM, V281, P39963, DOI 10.1074/jbc.M608538200; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Fontes JD, 1997, NUCLEIC ACIDS RES, V25, P2522, DOI 10.1093/nar/25.12.2522; Fuchs M, 2001, CELL, V106, P297, DOI 10.1016/S0092-8674(01)00450-0; Geng FQ, 2012, ANNU REV BIOCHEM, V81, P177, DOI 10.1146/annurev-biochem-052110-120012; Geng FQ, 2012, P NATL ACAD SCI USA, V109, P6060, DOI 10.1073/pnas.1200854109; Gevry N, 2007, GENE DEV, V21, P1869, DOI 10.1101/gad.1545707; Greer SF, 2003, NAT IMMUNOL, V4, P1074, DOI 10.1038/ni985; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Hake SB, 2000, MOL CELL BIOL, V20, P7716, DOI 10.1128/MCB.20.20.7716-7725.2000; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Kodadek T, 2006, CELL, V127, P261, DOI 10.1016/j.cell.2006.10.002; Kravtsova-Ivantsiv Y, 2012, J CELL SCI, V125, P539, DOI 10.1242/jcs.093567; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Kurosu T, 2004, CURR BIOL, V14, P1112, DOI 10.1016/j.cub.2004.06.020; LeibundGut-Landmann S, 2004, EUR J IMMUNOL, V34, P1513, DOI 10.1002/eji.200424964; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Lipford JR, 2005, NATURE, V438, P113, DOI 10.1038/nature04098; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Marq JB, 2007, J VIROL, V81, P3187, DOI 10.1128/JVI.02465-06; Masternak K, 2000, GENE DEV, V14, P1156; Meinnel T, 2008, PROTEOMICS, V8, P626, DOI 10.1002/pmic.200700592; Meinnel T, 2006, BIOL CHEM, V387, P839, DOI 10.1515/BC.2006.107; MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851; Muratani M, 2005, CELL, V120, P887, DOI 10.1016/j.cell.2004.12.025; Nickerson K, 2001, J BIOL CHEM, V276, P19089, DOI 10.1074/jbc.M101295200; Noy T, 2012, BIOCHEM BIOPH RES CO, V418, P408, DOI 10.1016/j.bbrc.2012.01.045; Otten LA, 1998, EUR J IMMUNOL, V28, P473, DOI 10.1002/(SICI)1521-4141(199802)28:02<473::AID-IMMU473>3.0.CO;2-E; Reith W, 2005, NAT REV IMMUNOL, V5, P793, DOI 10.1038/nri1708; Scaglione KM, 2013, J BIOL CHEM, V288, P18784, DOI 10.1074/jbc.C113.477596; Schnappauf F, 2003, EUR J IMMUNOL, V33, P2337, DOI 10.1002/eji.200323490; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sikder D, 2006, J BIOL CHEM, V281, P27346, DOI 10.1074/jbc.M604706200; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; STEIMLE V, 1995, GENE DEV, V9, P1021, DOI 10.1101/gad.9.9.1021; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; TANGUAY RM, 1993, DEV GENET, V14, P112, DOI 10.1002/dvg.1020140205; Tatham MH, 2013, BIOCHEM J, V453, P137, DOI 10.1042/BJ20130244; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; TRIEZENBERG SJ, 1995, CURR OPIN GENET DEV, V5, P190, DOI 10.1016/0959-437X(95)80007-7; van den Elsen PJ, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00048; Zaman Z, 1998, COLD SPRING HARB SYM, V63, P167, DOI 10.1101/sqb.1998.63.167; Zhu XS, 2001, MOL CELL BIOL, V21, P7078, DOI 10.1128/MCB.21.20.7078-7088.2001	58	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148753	10.1371/journal.pone.0148753	http://dx.doi.org/10.1371/journal.pone.0148753			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871568	gold, Green Published, Green Submitted			2022-12-27	WOS:000370054100052
J	Choi, HI; Ma, SK; Bae, EH; Lee, J; Kim, SW				Choi, Hoon-In; Ma, Seong Kwon; Bae, Eun Hui; Lee, JongUn; Kim, Soo Wan			Peroxiredoxin 5 Protects TGF-beta Induced Fibrosis by Inhibiting Stat3 Activation in Rat Kidney Interstitial Fibroblast Cells	PLOS ONE			English	Article							RENAL TUBULOINTERSTITIAL FIBROSIS; TUBULAR EPITHELIAL-CELLS; OBSTRUCTIVE NEPHROPATHY; MESENCHYMAL TRANSITION; SIGNALING PATHWAY; MESANGIAL CELLS; ANTIOXIDANT; PREVENTS; GROWTH; CONTRIBUTES	Renal fibrosis is a common final pathway of end-stage kidney disease which is induced by aberrant accumulation of myofibroblasts. This process is triggered by reactive oxygen species (ROS) and proinflammatory cytokines generated by various source of injured kidney cells. Peroxiredoxin 5 (Prdx5) is a thiol-dependent peroxidase that reduces oxidative stress by catalyzing intramolecular disulfide bonds. Along with its antioxidant effects, expression level of Prdx5 also was involved in inflammatory regulation by immune stimuli. However, the physiological effects and the underlying mechanisms of Prdx5 in renal fibrosis have not been fully characterized. Sprague-Dawley rats were subjected to unilateral ureteral obstruction (UUO) for 1 or 7 days. For the in vitro model, NRK49F cells, a rat kidney interstitial fibroblast cell lines, were treated with transforming growth factor beta (TGF-beta) for 0, 1, 3, or 5 days. To access the involvement of its peroxidase activity in TGF-beta induced renal fibrosis, wild type Prdx5 (WT) and double mutant Prdx5 (DM), converted two active site cysteines at Cys 48 and Cys 152 residue to serine, were transiently expressed in NRK49F cells. The protein expression of Prdx5 was reduced in UUO kidneys. Upregulation of fibrotic markers, such as fibronectin and alpha-smooth muscle actin (a-SMA), declined at 5 days in time point of higher Prdx5 expression in TGF-beta treated NRK49F cells. The overexpression of wild type Prdx5 by transient transfection in NRK49F cells attenuated the TGF-beta induced upregulation of fibronectin and a-SMA. On the other hand, the transient transfection of double mutant Prdx5 did not prevent the activation of fibrotic markers. Overexpression of Prdx5 also suppressed the TGF-beta induced upregulation of Stat3 phosphorylation, while phosphorylation of Smad 2/3 was unchanged. In conclusion, Prdx5 protects TGF-beta induced fibrosis in NRK49F cells by modulating Stat3 activation in a peroxidase activity dependent manner.	[Choi, Hoon-In; Ma, Seong Kwon; Bae, Eun Hui; Kim, Soo Wan] Chonnam Natl Univ, Sch Med, Dept Internal Med, Gwangju, South Korea; [Lee, JongUn] Chonnam Natl Univ, Sch Med, Dept Physiol, Gwangju, South Korea	Chonnam National University; Chonnam National University	Kim, SW (corresponding author), Chonnam Natl Univ, Sch Med, Dept Internal Med, Gwangju, South Korea.	skimw@chonnam.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2014R1A1A3053193]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning [2013R1A2A2A01067611]; Pioneer Research Center Program through the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning [2014M3C1A3053036]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI); Ministry of Health & Welfare, Republic of Korea [HI14C2084]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning(National Research Foundation of Korea); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning(National Research Foundation of Korea); Pioneer Research Center Program through the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2014R1A1A3053193), by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning (2013R1A2A2A01067611), by the Pioneer Research Center Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning (2014M3C1A3053036), and by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number : HI14C2084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas K, 2009, FREE RADICAL BIO MED, V47, P794, DOI 10.1016/j.freeradbiomed.2009.06.018; Avila PC, 2008, LUNG, V186, P103, DOI 10.1007/s00408-007-9066-2; Banes AK, 2004, AM J PHYSIOL-RENAL, V286, pF653, DOI 10.1152/ajprenal.00163.2003; Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516; Choi HI, 2013, FREE RADICAL BIO MED, V65, P270, DOI 10.1016/j.freeradbiomed.2013.06.038; Chuang PY, 2010, KIDNEY INT, V78, P231, DOI 10.1038/ki.2010.158; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Eddy AA, 2000, PEDIATR NEPHROL, V15, P290, DOI 10.1007/s004670000461; Ellison MA, 2012, EUR J IMMUNOL, V42, P1609, DOI 10.1002/eji.201142157; Farris AB, 2012, CURR OPIN NEPHROL HY, V21, P289, DOI 10.1097/MNH.0b013e3283521cfa; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Fujii J, 2002, REDOX REP, V7, P123, DOI 10.1179/135100002125000352; Jiang F, 2011, PHARMACOL REV, V63, P218, DOI 10.1124/pr.110.002980; Kim J, 2009, AM J PHYSIOL-RENAL, V297, pF461, DOI 10.1152/ajprenal.90735.2008; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; Knoops B, 2011, ANTIOXID REDOX SIGN, V15, P817, DOI 10.1089/ars.2010.3584; Kopp JB, 1996, LAB INVEST, V74, P991; Krutilina Raisa I, 2006, J Inflamm (Lond), V3, P13, DOI 10.1186/1476-9255-3-13; Kuma A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103240; Kuratsune M, 2007, NEPHROLOGY, V12, P565, DOI 10.1111/j.1440-1797.2007.00881.x; Lee I, 2013, J PHARMACOL EXP THER, V345, P284, DOI 10.1124/jpet.112.201079; Lijnen PJ, 2012, J HYPERTENS, V30, P1986, DOI 10.1097/HJH.0b013e32835726c1; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Lu TC, 2009, KIDNEY INT, V76, P63, DOI 10.1038/ki.2009.98; Ma YN, 2014, FREE RADICAL BIO MED, V76, P251, DOI 10.1016/j.freeradbiomed.2014.08.015; Manevich Y, 2004, P NATL ACAD SCI USA, V101, P3780, DOI 10.1073/pnas.0400181101; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Matsui F, 2012, J SURG RES, V178, P339, DOI 10.1016/j.jss.2012.06.050; Mehra A, 2002, BIOCHEM CELL BIOL, V80, P605, DOI 10.1139/O02-161; Mei WJ, 2015, NEPHROLOGY, V20, P832, DOI 10.1111/nep.12515; Mu YB, 2012, CELL TISSUE RES, V347, P11, DOI 10.1007/s00441-011-1201-y; Nie J, 2012, CHINESE MED J-PEKING, V125, P2598, DOI 10.3760/cma.j.issn.0366-6999.2012.14.035; Oberley TD, 2001, FREE RADICAL BIO MED, V30, P412, DOI 10.1016/S0891-5849(00)00486-X; Pang MY, 2010, KIDNEY INT, V78, P257, DOI 10.1038/ki.2010.154; Qi WE, 2006, INT J BIOCHEM CELL B, V38, P1, DOI 10.1016/j.biocel.2005.09.005; Rhyu DY, 2005, J AM SOC NEPHROL, V16, P667, DOI 10.1681/ASN.2004050425; Runyan CE, 2005, J BIOL CHEM, V280, P8300, DOI 10.1074/jbc.M407939200; Sachse A, 2007, J AM SOC NEPHROL, V18, P2439, DOI 10.1681/ASN.2007020149; Strutz F, 2001, KIDNEY INT, V59, P579, DOI 10.1046/j.1523-1755.2001.059002579.x; Sun HN, 2010, J NEUROCHEM, V114, P39, DOI 10.1111/j.1471-4159.2010.06691.x; Wang MX, 2002, FEBS LETT, V531, P359, DOI 10.1016/S0014-5793(02)03511-1; Wang XD, 2002, DIABETES, V51, P3505, DOI 10.2337/diabetes.51.12.3505; Yuan YG, 2012, FREE RADICAL BIO MED, V53, P30, DOI 10.1016/j.freeradbiomed.2012.03.015; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	46	27	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149266	10.1371/journal.pone.0149266	http://dx.doi.org/10.1371/journal.pone.0149266			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872211	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100137
J	Lane, C; Milne, E; Freeth, M				Lane, Chloe; Milne, Elizabeth; Freeth, Megan			Cognition and Behaviour in Sotos Syndrome: A Systematic Review	PLOS ONE			English	Review							SYNDROME CEREBRAL GIGANTISM; DNA-BINDING/DIMERIZATION DOMAIN; NSD1; MUTATIONS; CHILDREN; MICRODELETIONS; INDIVIDUALS; DISORDER; LANGUAGE; WEAVER	Background Research investigating cognition and behaviour in Sotos syndrome has been sporadic and to date, there is no published overview of study findings. Method A systematic review of all published literature (1964-2015) presenting empirical data on cognition and behaviour in Sotos syndrome. Thirty four journal articles met inclusion criteria. Within this literature, data relating to cognition and/or behaviour in 247 individuals with a diagnosis of Sotos syndrome were reported. Ten papers reported group data on cognition and/or behaviour. The remaining papers employed a case study design. Results Intelligence quotient (IQ) scores were reported in twenty five studies. Intellectual disability (IQ < 70) or borderline intellectual functioning (IQ 70-84) was present in the vast majority of individuals with Sotos syndrome. Seven studies reported performance on subscales of intelligence tests. Data from these studies indicate that verbal IQ scores are consistently higher than performance IQ scores. Fourteen papers provided data on behavioural features of individuals with Sotos syndrome. Key themes that emerged in the behavioural literature were overlap with ASD, ADHD, anxiety and high prevalence of aggression/tantrums. Conclusion Although a range of studies have provided insight into cognition and behaviour in Sotos syndrome, specific profiles have not yet been fully specified. Recommendations for future research are provided.	[Lane, Chloe; Milne, Elizabeth; Freeth, Megan] Univ Sheffield, Dept Psychol, Western Bank, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Lane, C (corresponding author), Univ Sheffield, Dept Psychol, Western Bank, Sheffield S10 2TN, S Yorkshire, England.	clane2@sheffield.ac.uk	Freeth, Megan/L-4512-2016	Freeth, Megan/0000-0003-0534-9095; Lane, Chloe/0000-0002-7234-5783	Child Growth Foundation	Child Growth Foundation	CL's work was funded by the Child Growth Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALE AE, 1985, AM J MED GENET, V20, P613, DOI 10.1002/ajmg.1320200407; Ball LJ, 2005, AM J MED GENET A, V136A, P363, DOI 10.1002/ajmg.a.30799; BLOOM AS, 1983, J DEV BEHAV PEDIATR, V4, P250; COLE TRP, 1994, J MED GENET, V31, P20, DOI 10.1136/jmg.31.1.20; Compton MT, 2004, PSYCHOPATHOLOGY, V37, P190, DOI 10.1159/000079510; de Boer L, 2006, DEV MED CHILD NEUROL, V48, P582, DOI 10.1017/S0012162206001228; DODGE PR, 1983, DEV MED CHILD NEUROL, V25, P248; Fickie MR, 2011, AM J MED GENET A, V155A, P2105, DOI 10.1002/ajmg.a.34156; FINEGAN JAK, 1994, J AM ACAD CHILD PSY, V33, P1307, DOI 10.1097/00004583-199411000-00013; Fleiss JL., 1986, DESIGN ANAL CLIN EXP, DOI [10.1002/9781118032923.ch1, DOI 10.1002/9781118032923.CH1, DOI 10.1002/9781118032923]; Flynn S, 2015, J INTELLECTUAL DISAB; Gajre MP, 2014, J TAIBAH U MED SCI; Ginter D N, 1975, Birth Defects Orig Artic Ser, V11, P415; Goldsmith L, 2012, EUR J HUM GENET, V20, P811, DOI 10.1038/ejhg.2012.18; Gomes-Silva JM, 2006, SPEC CARE DENT, V26, P257, DOI 10.1111/j.1754-4505.2006.tb01664.x; Gosalakkal JA, 2004, INT PEDIAT, V19, P147; HAPPE FGE, 1994, J CHILD PSYCHOL PSYC, V35, P1461, DOI 10.1111/j.1469-7610.1994.tb01287.x; Horikoshi H, 2006, J CHILD NEUROL, V21, P614, DOI 10.1177/08830738060210071001; Kmet LM, 2004, STANDARD QUALITY ASS; Kurotaki N, 2002, NAT GENET, V30, P365, DOI 10.1038/ng863; Leventopoulos G, 2009, PEDIATR NEUROL, V40, P357, DOI 10.1016/j.pediatrneurol.2008.11.013; LIVINGOOD AB, 1981, CHILD PSYCHIAT HUM D, V12, P46, DOI 10.1007/BF00706673; Malan V, 2010, AM J HUM GENET, V87, P189, DOI 10.1016/j.ajhg.2010.07.001; Mauceri L, 2000, PEDIATR NEUROL, V22, P64, DOI 10.1016/S0887-8994(99)00105-8; Melo DG, 2002, ARQ NEURO-PSIQUIAT, V60, P234, DOI 10.1590/S0004-282X2002000200009; Mervis CB, 2000, BRAIN COGNITION, V44, P604, DOI 10.1006/brcg.2000.1232; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; MORROW JD, 1990, EUR J PEDIATR, V149, P567, DOI 10.1007/BF01957694; Mouridsen SE, 2002, EUR CHILD ADOLES PSY, V11, P43, DOI 10.1007/s007870200007; Novara F, 2014, AM J MED GENET A, V164, P2084, DOI 10.1002/ajmg.a.36591; Okamoto N, 2010, AM J MED GENET A, V152A, P2103, DOI 10.1002/ajmg.a.33544; Opitz JM, 1998, AM J MED GENET, V79, P294, DOI 10.1002/(SICI)1096-8628(19981002)79:4<294::AID-AJMG12>3.0.CO;2-M; Park SH, 2014, ANN CLIN LAB SCI, V44, P228; Patterson B, 1978, J PEDIATR PSYCHOL, V3, P6; Priolo M, 2012, GENE, V511, P103, DOI 10.1016/j.gene.2012.08.040; Rio M, 2003, J MED GENET, V40, P436, DOI 10.1136/jmg.40.6.436; RUTTER SC, 1991, DEV MED CHILD NEUROL, V33, P898; Sarimski K, 2003, DEV MED CHILD NEUROL, V45, P172, DOI 10.1017/S0012162203000331; Scarpa P., 1994, Genetic Counseling, V5, P155; SHAH A, 1993, J CHILD PSYCHOL PSYC, V34, P1351, DOI 10.1111/j.1469-7610.1993.tb02095.x; Shimojima K, 2015, AM J MED GENET A, V167, P724, DOI 10.1002/ajmg.a.36959; Silverman W, 2007, MENT RETARD DEV D R, V13, P228, DOI 10.1002/mrdd.20156; SOTOS JF, 1964, NEW ENGL J MED, V271, P109, DOI 10.1056/NEJM196407162710301; Sotos JF, 2014, PEDIATR ENDOCR REV P, V12, P2; Tatton-Brown K, 2004, CLIN DYSMORPHOL, V13, P199, DOI 10.1097/00019605-200410000-00001; Tatton-Brown K, 2005, AM J HUM GENET, V77, P193, DOI 10.1086/432082; Tatton-Brown K, 2005, J MED GENET, V42, P307, DOI 10.1136/jmg.2004.027755; Tatton-Brown K, 2007, EUR J HUM GENET, V15, P264, DOI 10.1038/sj.ejhg.5201686; Tei Satoshi, 2006, Kobe Journal of Medical Sciences, V52, P1; TRAD PV, 1991, J AM ACAD CHILD PSY, V30, P499; Turkmen S, 2003, EUR J HUM GENET, V11, P858, DOI 10.1038/sj.ejhg.5201050; VARLEY CK, 1984, J DEV BEHAV PEDIATR, V5, P132; Yoneda Y, 2012, J HUM GENET, V57, P207, DOI 10.1038/jhg.2012.7; ZAPPELLA M, 1990, Brain Dysfunction, V3, P241; Zechner U, 2009, EUR J MED GENET, V52, P306, DOI 10.1016/j.ejmg.2009.06.001	55	21	23	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149189	10.1371/journal.pone.0149189	http://dx.doi.org/10.1371/journal.pone.0149189			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6SI	26872390	Green Accepted, Green Published, gold			2022-12-27	WOS:000370054100121
J	Wagner, JM; Zollner, H; Wallner, C; Ismer, B; Schira, J; Abraham, S; Harati, K; Lehnhardt, M; Behr, B				Wagner, Johannes Maximilian; Zoellner, Hannah; Wallner, Christoph; Ismer, Britta; Schira, Jessica; Abraham, Stephanie; Harati, Kamran; Lehnhardt, Marcus; Behr, Bjoern			Surgical Debridement Is Superior to Sole Antibiotic Therapy in a Novel Murine Posttraumatic Osteomyelitis Model	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; ACUTE HEMATOGENOUS OSTEOMYELITIS; IN-VIVO; ANIMAL-MODEL; REDUCE INFECTION; BONE INFECTION; MOUSE MODEL; REAL-TIME; RATS; EFFICACY	Introduction Bone infections after trauma, i.e. posttraumatic osteomyelitis, pose one of the biggest problems of orthopedic surgery. Even after sufficient clinical therapy including vast debridement of infected bone and antibiotic treatment, regeneration of postinfectious bone seems to be restricted. One explanation includes the large sized defects resulting from sufficient debridement. Furthermore, it remains unclear if inflammatory processes after bone infection do affect bone regeneration. For continuing studies in this field, an animal model is needed where bone regeneration after sufficient treatment can be studied in detail. Methods For this purpose we created a stable infection in murine tibiae by Staphylococcus aureus inoculation. Thereafter, osteomyelitic bones were debrided thoroughly and animals were subsequently treated with antibiotics. Controls included debrided, non-infected, as well as infected animals exclusively treated with antibiotics. To verify sufficient treatment of infected bone, different assessments detecting S. aureus were utilized: agar plates, histology and RT-qPCR. Results All three detection methods revealed massive reduction or eradication of S. aureus within debrided bones 1 and 2 weeks postoperatively, whereas sole antibiotic therapy could not provide sufficient treatment of osteomyelitic bones. Debrided, previously infected bones showed significantly decreased bone formation, compared to debrided, non-infected controls. Discussion Thus, the animal model presented herein provides a reliable and fascinating tool to study posttraumatic osteomyelitis for clinical therapies.	[Wagner, Johannes Maximilian; Zoellner, Hannah; Wallner, Christoph; Ismer, Britta; Schira, Jessica; Abraham, Stephanie; Harati, Kamran; Lehnhardt, Marcus; Behr, Bjoern] Ruhr Univ Bochum, Dept Plast Surg, BG Bergmannsheil Bochum, Univ Str 150, Bochum, Germany	Ruhr University Bochum	Behr, B (corresponding author), Ruhr Univ Bochum, Dept Plast Surg, BG Bergmannsheil Bochum, Univ Str 150, Bochum, Germany.	bjorn.behr@rub.de	Behr, Björn/AAS-1877-2021; Harati, Kamran/AHD-3426-2022	Schira-Heinen, Jessica/0000-0002-2184-9746	Mercator Research Center Ruhr [An-2013-0053]	Mercator Research Center Ruhr	This work was supported by a grant of the Mercator Research Center Ruhr (An-2013-0053). The URL of the funder is: http://www.mercurresearch.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behr B, 2010, P NATL ACAD SCI USA, V107, P11853, DOI 10.1073/pnas.1003317107; Bertolini D, 1968, NATURE, V319, P516; Bilgili F, 2015, CLIN ORTHOP RELAT R, V473, P3190, DOI 10.1007/s11999-015-4331-9; Brin YS, 2008, J CONTROL RELEASE, V131, P121, DOI 10.1016/j.jconrel.2008.07.022; Brown Kate V, 2010, J Surg Orthop Adv, V19, P18; Buxton TB, 2005, COMPARATIVE MED, V55, P123; Chadha HS, 1999, J ORTHOPAED RES, V17, P376, DOI 10.1002/jor.1100170312; Chai HW, 2011, J MATER SCI-MATER M, V22, P2525, DOI 10.1007/s10856-011-4427-z; Chang YH, 2006, CLIN ORTHOP RELAT R, P242, DOI 10.1097/01.blo.0000229324.75911.c7; Cierny G, 2003, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000088564.81746.62; Claro T, 2013, MICROBIOL-SGM, V159, P147, DOI 10.1099/mic.0.063016-0; Costerton JW, 2006, CLIN ORTHOP RELAT R, V437, P7; Cremonesi P, 2014, FOOD MICROBIOL, V43, P35, DOI 10.1016/j.fm.2014.04.007; Darouiche RO, 2007, J BONE JOINT SURG AM, V89A, P792, DOI 10.2106/JBJS.F.00414; Ding H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085472; Eerenberg J P, 1994, J Invest Surg, V7, P453, DOI 10.3109/08941939409016511; Folsch C, 2015, INT ORTHOP, V39, P981, DOI 10.1007/s00264-014-2582-9; Funao H, 2012, INFECT IMMUN, V80, P733, DOI 10.1128/IAI.06166-11; Gatin L, 2014, ANTIMICROB AGENTS CH, V58, P6496, DOI 10.1128/AAC.03600-14; Gaudin A, 2011, LETT APPL MICROBIOL, V52, P253, DOI 10.1111/j.1472-765X.2010.02992.x; Guelcher SA, 2011, J ORTHOP TRAUMA, V25, P477, DOI 10.1097/BOT.0b013e31821f624c; GUSTILO RB, 1990, J BONE JOINT SURG AM, V72A, P299, DOI 10.2106/00004623-199072020-00023; Helbig L, 2014, INT ORTHOP, V38, P891, DOI 10.1007/s00264-013-2149-1; Inzana JA, 2015, BONE, V72, P128, DOI 10.1016/j.bone.2014.11.019; Isefuku S, 2003, J ORTHOP TRAUMA, V17, P212, DOI 10.1097/00005131-200303000-00010; Jones D, 2011, J CLIN INVEST, V121, P2534, DOI 10.1172/JCI46262; Karmakar S, 2010, RHEUM DIS CLIN N AM, V36, P385, DOI 10.1016/j.rdc.2010.03.003; Leung Andraay H C, 2015, Open Orthop J, V9, P372, DOI 10.2174/1874325001509010372; Lew DP, 2004, LANCET, V364, P369, DOI 10.1016/S0140-6736(04)16727-5; Li GY, 2013, J ORTHOP RES, V31, P949, DOI 10.1002/jor.22299; Lindsey BA, 2010, J ORTHOP RES, V28, P38, DOI 10.1002/jor.20960; Lucke M, 2003, J BIOMED MATER RES B, V67B, P593, DOI 10.1002/jbm.b.10051; Nanes MS, 2003, GENE, V321, P1, DOI 10.1016/S0378-1119(03)00841-2; Odekerken JC, 2014, BIOMED RES INT, V2014, DOI [10.1155/2014/424652, DOI 10.1155/2014/424652]; Ozturan KE, 2010, J ORTHOP RES, V28, P1368, DOI 10.1002/jor.21159; Patel Mitul, 2009, Semin Plast Surg, V23, P148, DOI 10.1055/s-0029-1214167; Penn-Barwell JG, 2012, J BONE JOINT SURG BR, V94B, P107, DOI 10.1302/0301-620X.94B1.27026; PINZUR MS, 1992, ORTHOPEDICS, V15, P1033; Pribaz JR, 2012, J ORTHOP RES, V30, P335, DOI 10.1002/jor.21519; Reizner W, 2014, EUR CELLS MATER, V27, P196, DOI 10.22203/eCM.v027a15; RISSING JP, 1985, INFECT IMMUN, V47, P581, DOI 10.1128/IAI.47.3.581-586.1985; Ritter V, 2009, J AOAC INT, V92, P1432; Sheehan E, 2004, J ORTHOP RES, V22, P39, DOI 10.1016/S0736-0266(03)00152-9; Shiels SM, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0699-7; SPAGNOLO N, 1993, INFECT IMMUN, V61, P5225, DOI 10.1128/IAI.61.12.5225-5230.1993; SPEERS DJ, 1985, INFECT IMMUN, V49, P443, DOI 10.1128/IAI.49.2.443-446.1985; Subasi M, 2001, ARCH ORTHOP TRAUM SU, V121, P170, DOI 10.1007/s004020000209; Wallner C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118823; Walsh NC, 2009, J BONE MINER RES, V24, P1572, DOI [10.1359/jbmr.090320, 10.1359/JBMR.090320]; Walter G, 2012, DTSCH ARZTEBL INT, V109, P257, DOI [10.3238/arztebl.012.0257, 10.3238/arztebl.2012.0257]; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Widaa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040586; Zhu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086874	53	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149389	10.1371/journal.pone.0149389	http://dx.doi.org/10.1371/journal.pone.0149389			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872128	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100155
J	Arnette, C; Frye, K; Kaverina, I				Arnette, Christopher; Frye, Keyada; Kaverina, Irina			Microtubule and Actin Interplay Drive Intracellular c-Src Trafficking	PLOS ONE			English	Article							ACTIVATION; KINASE; CELLS; METASTASIS; RESISTANCE; MEMBRANE; SURVIVAL; SIGNALS; CANCER; RHOB	The proto-oncogene c-Src is involved in a variety of signaling processes. Therefore, c-Src spatiotemporal localization is critical for interaction with downstream targets. However, the mechanisms regulating this localization have remained elusive. Previous studies have shown that c-Src trafficking is a microtubule-dependent process that facilitates c-Src turn-over in neuronal growth cones. As such, microtubule depolymerization lead to the inhibition of c-Src recycling. Alternatively, c-Src trafficking was also shown to be regulated by RhoB-dependent actin polymerization. Our results show that c-Src vesicles primarily exhibit microtubule-dependent trafficking; however, microtubule depolymerization does not inhibit vesicle movement. Instead, vesicular movement becomes both faster and less directional. This movement was associated with actin polymerization directly at c-Src vesicle membranes. Interestingly, it has been shown previously that c-Src delivery is an actin polymerization-dependent process that relies on small GTPase RhoB at c-Src vesicles. In agreement with this finding, microtubule depolymerization induced significant activation of RhoB, together with actin comet tail formation. These effects occurred downstream of GTP-exchange factor, GEF-H1, which was released from depolymerizing MTs. Accordingly, GEF-H1 activity was necessary for actin comet tail formation at the Src vesicles. Our results indicate that regulation of c-Src trafficking requires both microtubules and actin polymerization, and that GEF-H1 coordinates c-Src trafficking, acting as a molecular switch between these two mechanisms.	[Arnette, Christopher; Frye, Keyada; Kaverina, Irina] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN USA; [Arnette, Christopher] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA	Vanderbilt University; Northwestern University; Feinberg School of Medicine	Kaverina, I (corresponding author), Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN USA.	irina.kaverina@vanderbilt.edu			NIH Integrated Biological Systems Training in Oncology (IBSTO) training grant [5T32CA119925-03]; American Heart Predoctoral Fellowship [12PRE12040218]; NIH Training Grant in Mechanisms of Vascular Disease fellowship [5T32HL007751-19]; NIH [R01-GM078373]; American Heart Association [13GRNT16980096]; NATIONAL CANCER INSTITUTE [T32CA119925] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078373, R25GM062459] Funding Source: NIH RePORTER	NIH Integrated Biological Systems Training in Oncology (IBSTO) training grant; American Heart Predoctoral Fellowship; NIH Training Grant in Mechanisms of Vascular Disease fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH Integrated Biological Systems Training in Oncology (IBSTO) training grant (5T32CA119925-03) (to CA), American Heart Predoctoral Fellowship 12PRE12040218 (to CA), NIH Training Grant in Mechanisms of Vascular Disease (5T32HL007751-19) fellowship (to KF), NIH grant R01-GM078373 (to IK), and American Heart Association Grant-in-Aid 13GRNT16980096 (to IK).	Alvarez RH, 2006, CANCER-AM CANCER SOC, V107, P1918, DOI 10.1002/cncr.22215; Armaiz-Pena GN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2413; Birkenfeld J, 2007, DEV CELL, V12, P699, DOI 10.1016/j.devcel.2007.03.014; Bjorge JD, 2000, ONCOGENE, V19, P5620, DOI 10.1038/sj.onc.1203923; Chang YC, 2008, MOL BIOL CELL, V19, P2147, DOI 10.1091/mbc.E07-12-1269; Giannoni E, 2009, ONCOGENE, V28, P2074, DOI 10.1038/onc.2009.77; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Ichijo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116252; Kamon H, 2006, EMBO J, V25, P4108, DOI 10.1038/sj.emboj.7601286; KAPLAN KB, 1992, J CELL BIOL, V118, P321, DOI 10.1083/jcb.118.2.321; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Luis-Ravelo D, 2014, MOL ONCOL, V8, P196, DOI 10.1016/j.molonc.2013.11.001; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; Sandilands E, 2007, J CELL SCI, V120, P2555, DOI 10.1242/jcs.003657; Seddon B, 2002, J IMMUNOL, V169, P2997, DOI 10.4049/jimmunol.169.6.2997; Suter DM, 2004, CURR BIOL, V14, P1194, DOI 10.1016/j.cub.2004.06.049; Timpson P, 2001, CURR BIOL, V11, P1836, DOI 10.1016/S0960-9822(01)00583-8; Vega FM, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120076; Wu BB, 2008, MOL BIOL CELL, V19, P4611, DOI 10.1091/mbc.E08-06-0603; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366	20	15	15	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148996	10.1371/journal.pone.0148996	http://dx.doi.org/10.1371/journal.pone.0148996			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866809	Green Submitted, Green Published, gold			2022-12-27	WOS:000370050700051
J	Bekolo, CE; O'Bryan, G; Tchago, FE; Nangue, C; Bekoule, PS; Kollo, B				Bekolo, Cavin Epie; O'Bryan, Gillian; Tchago, Francois Edmond; Nangue, Charlette; Bekoule, Patrick Sylvestre; Kollo, Basile			Integrating Cervical Cancer Screening with HIV Care in Cameroon: Comparative Risk Analysis of Cervical Disease in HIV-Infected Women Receiving Antiretroviral Therapy to Women in the General Population	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN-PAPILLOMAVIRUS INFECTION; SQUAMOUS INTRAEPITHELIAL LESIONS; POSITIVE WOMEN; HAART; PREVALENCE; BEHAVIOR	Background While the effect of highly active antiretroviral therapy (HAART) on natural history of cervical lesions remains controversial, resource limited countries need to understand the relevance of their own data to their settings. We compared the risk of cervical disease in HAART-experienced women with that in women in the general population of Cameroon. Methods A retrospective cross sectional survey of women aged 35 years and above, attending a voluntary screening campaign for cervical cancer at the Nkongsamba Regional Hospital in Cameroon between February and May 2014. Squamous intraepithelial lesions (SIL) were determined by Pap smear. Multiple logistic regression was used to compare the odds of SIL in women on HAART to women from the community with unknown HIV status. Results Included were 302 women of whom 131(43.4%) were HIV-infected and receiving HAART on the site while 171 (56.6%) were women from the community. Cervical disease was observed in 51(16.9%) persons of whom 15 (11.5%) cases in the HAART group and 36 (21.1%) cases in the general group (p = 0.027). After controlling for age and other covariates, women in the HAART group had a 67% reduction in the odds of cervical lesions compared with the community group [adjusted odd ratio (aOR) = 0.33, 95% CI: 0.15-0.73, p = 0.006). Conclusion HIV-infected women receiving HAART have a lower risk of cancer than women in the general population. This finding may not be attributed to HAART alone but to all the health benefits derived from receiving a comprehensive HIV care.	[Bekolo, Cavin Epie] Ctr Med Arrondissement Bare, Nkongsamba, Cameroon; [O'Bryan, Gillian] I TECH, Seattle, WA USA; [Tchago, Francois Edmond; Bekoule, Patrick Sylvestre] Reg Hosp Nkongsamba, Nkongsamba, Cameroon; [Nangue, Charlette] Univ Teaching Hosp, Yaounde, Cameroon; [Kollo, Basile] Univ Douala, Dept Publ Hlth, Douala, Cameroon		Bekolo, CE (corresponding author), Ctr Med Arrondissement Bare, Nkongsamba, Cameroon.	cavinep@yahoo.co.uk	Bekolo, Cavin Epie/HIR-2638-2022	Bekolo, Cavin Epie/0000-0002-9845-9842				Abraham AG, 2013, JAIDS-J ACQ IMM DEF, V62, P405, DOI 10.1097/QAI.0b013e31828177d7; Adler DH, 2012, AIDS, V26, P1645, DOI 10.1097/QAD.0b013e32835536a3; Adler DH, 2010, CURR HIV RES, V8, P493, DOI 10.2174/157016210793499240; Atashili J, 2012, CANCER EPIDEMIOL, V36, P263, DOI 10.1016/j.canep.2011.10.003; Bekolo CE, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-236; Bekolo Cavin Epie, 2013, BMC Res Notes, V6, P512, DOI 10.1186/1756-0500-6-512; Bratcher Lara F, 2010, Infect Agent Cancer, V5, P8, DOI 10.1186/1750-9378-5-8; Bruni L, 2015, PAPILOMAVIRUS RELATE; BUCREP, 2010, POP CAM 2010; Del Mistro A, 2004, CLIN INFECT DIS, V38, P737, DOI 10.1086/381681; Fu TC, 2012, AIDS, V26, P2383, DOI 10.1097/QAD.0b013e32835ad438; Gravitt PE, 2010, J INFECT DIS, V201, P650, DOI 10.1086/650468; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Lillo FB, 2001, J INFECT DIS, V184, P547, DOI 10.1086/322856; Mandelblatt JS, 1999, CANCER EPIDEM BIOMAR, V8, P97; Minkoff HL, 1999, AM J OBSTET GYNECOL, V180, P824, DOI 10.1016/S0002-9378(99)70653-8; Minkoff H, 2010, J INFECT DIS, V201, P681, DOI 10.1086/650467; MINSANTE, 2011, RAPP ANN ACT LUTT CO; Mogtomo KML, 2009, INFECT AGENTS CANCER, V4, P9, DOI [10.1186/1750-9378-4-9, DOI 10.1186/1750-9378-4-9]; Mwanahamuntu MH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001032; Paramsothy P, 2009, OBSTET GYNECOL, V113, P26, DOI 10.1097/AOG.0b013e31819225cb; Sun XW, 1997, NEW ENGL J MED, V337, P1343, DOI 10.1056/NEJM199711063371903; Venkatesh KK, 2010, AIDS, V24, P2687, DOI 10.1097/QAD.0b013e32833e78d4; Wilson JMG, 1968, PRINCIPLES PRACTICE; World Health Organization, 2013, COMPR CERV CANC PREV	25	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149152	10.1371/journal.pone.0149152	http://dx.doi.org/10.1371/journal.pone.0149152			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866371	Green Submitted, gold, Green Published			2022-12-27	WOS:000370050700074
J	Mohan, DM; Kumar, P; Mahmood, F; Wong, KF; Agrawal, A; Elgendi, M; Shukla, R; Ang, N; Ching, A; Dauwels, J; Chan, AHD				Mohan, Dhanya Menoth; Kumar, Parmod; Mahmood, Faisal; Wong, Kian Foong; Agrawal, Abhishek; Elgendi, Mohamed; Shukla, Rohit; Ang, Natania; Ching, April; Dauwels, Justin; Chan, Alice H. D.			Effect of Subliminal Lexical Priming on the Subjective Perception of Images: A Machine Learning Approach	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; AUTOMATIC ACTIVATION; EMOTIONAL ADJECTIVES; BRAIN POTENTIALS; DECISION-MAKING; MASKED WORDS; TIME-COURSE; TASK; ERP; INFORMATION	The purpose of the study is to examine the effect of subliminal priming in terms of the perception of images influenced by words with positive, negative, and neutral emotional content, through electroencephalograms (EEGs). Participants were instructed to rate how much they like the stimuli images, on a 7-point Likert scale, after being subliminally exposed to masked lexical prime words that exhibit positive, negative, and neutral connotations with respect to the images. Simultaneously, the EEGs were recorded. Statistical tests such as repeated measures ANOVAs and two-tailed paired-samples t-tests were performed to measure significant differences in the likability ratings among the three prime affect types; the results showed a strong shift in the likeness judgment for the images in the positively primed condition compared to the other two. The acquired EEGs were examined to assess the difference in brain activity associated with the three different conditions. The consistent results obtained confirmed the overall priming effect on participants' explicit ratings. In addition, machine learning algorithms such as support vector machines (SVMs), and AdaBoost classifiers were applied to infer the prime affect type from the ERPs. The highest classification rates of 95.0% and 70.0% obtained respectively for average-trial binary classifier and average-trial multi-class further emphasize that the ERPs encode information about the different kinds of primes.	[Mohan, Dhanya Menoth; Agrawal, Abhishek; Dauwels, Justin] Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore 639798, Singapore; [Kumar, Parmod] INRIA Sophia Antipolis, Sophia Antipolis, France; [Mahmood, Faisal] Okinawa Inst Sci & Technol, Kunigami, Okinawa, Japan; [Wong, Kian Foong] Duke NUS Grad Med Sch, Ctr Cognit Neurosci, Singapore, Singapore; [Elgendi, Mohamed] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Shukla, Rohit] Univ Wisconsin, Madison, WI 53706 USA; [Ang, Natania; Ching, April; Chan, Alice H. D.] Nanyang Technol Univ, Linguist & Multilingual Studies, Sch Humanities & Social Sci, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Okinawa Institute of Science & Technology Graduate University; National University of Singapore; University of British Columbia; University of Wisconsin System; University of Wisconsin Madison; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Dauwels, J (corresponding author), Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore 639798, Singapore.; Chan, AHD (corresponding author), Nanyang Technol Univ, Linguist & Multilingual Studies, Sch Humanities & Social Sci, Singapore 639798, Singapore.	jdauwels@ntu.edu.sg; alice@ntu.edu.sg	Shukla, Rohit/AAG-5495-2019; Elgendi, Mohamed/I-8596-2016; Mahmood, Faisal/C-1021-2015	Shukla, Rohit/0000-0001-9367-9654; Elgendi, Mohamed/0000-0003-1831-0202; Menoth Mohan, Dhanya/0000-0002-4591-2412; Mahmood, Faisal/0000-0001-7587-1562	Singapore Ministry of Education [M4011102.040]; College of Humanities, Arts & Social Sciences at Nanyang Technological University [M58100050, M4011089, M4011393]; MOE Tier 1 grant [M4011102.040]	Singapore Ministry of Education(Ministry of Education, Singapore); College of Humanities, Arts & Social Sciences at Nanyang Technological University(Nanyang Technological University); MOE Tier 1 grant(Ministry of Education, Singapore)	This research was supported by the Singapore Ministry of Education (http://www.moe.gov.sg/) Tier 1 grant (M4011102.040) awarded to J.D., and grants (M58100050 and M4011089) from College of Humanities, Arts & Social Sciences at Nanyang Technological University (http://www.hss.ntu.edu.sg/Pages/Home.aspx) to A.H.D.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the MOE Tier 1 grant (M4011102.040) awarded to J.D., and grants (M58100050, M4011089, and M4011393) from College of Humanities, Arts & Social Sciences at Nanyang Technological University to A.H.D.C.	Aarts H, 2005, CONSCIOUS COGN, V14, P439, DOI 10.1016/j.concog.2004.11.001; Bayer M, 2012, PSYCHOPHYSIOLOGY, V49, P959, DOI 10.1111/j.1469-8986.2012.01381.x; Behroozi M, 2015, BRAIN IMAGING BEHAV, V9, P178, DOI 10.1007/s11682-014-9294-z; Behroozi M, 2014, J INTEGR NEUROSCI, V13, P645, DOI 10.1142/S0219635214500241; Bernat E, 2001, INT J PSYCHOPHYSIOL, V42, P11, DOI 10.1016/S0167-8760(01)00133-7; Bode S, 2012, J NEUROSCI, V32, P12488, DOI 10.1523/JNEUROSCI.1708-12.2012; Cheng WC, 2013, IEEE J BIOMED HEALTH, V17, P411, DOI 10.1109/JBHI.2012.2237034; Comesana M, 2013, COMPUT HUM BEHAV, V29, P588, DOI 10.1016/j.chb.2012.10.020; Cristinacce D., 2003, BMVC, P1; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; Daliri Mohammad Reza, 2013, J Med Signals Sens, V3, P37; Das K, 2010, NEUROIMAGE, V51, P1425, DOI 10.1016/j.neuroimage.2010.03.030; DAUBECHIES I, 1988, COMMUN PUR APPL MATH, V41, P909, DOI 10.1002/cpa.3160410705; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Draine SC, 1998, J EXP PSYCHOL GEN, V127, P286, DOI 10.1037/0096-3445.127.3.286; Esghaei M, 2014, DECODING VISUAL ATTE; Fazio RH, 2001, COGNITION EMOTION, V15, P115, DOI 10.1080/02699930125908; Fischler I, 2006, PROG BRAIN RES, V156, P185, DOI 10.1016/S0079-6123(06)56009-1; Freund Y., 1999, Journal of Japanese Society for Artificial Intelligence, V14, P771; Fruhholz S, 2011, BIOL PSYCHOL, V87, P265, DOI 10.1016/j.biopsycho.2011.03.008; Gibbons H, 2009, CONSCIOUS COGN, V18, P383, DOI 10.1016/j.concog.2009.02.007; GREENWALD AG, 1989, MEM COGNITION, V17, P35, DOI 10.3758/BF03199555; Greenwald AG, 1996, SCIENCE, V273, P1699, DOI 10.1126/science.273.5282.1699; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Herbert C, 2008, PSYCHOPHYSIOLOGY, V45, P487, DOI 10.1111/j.1469-8986.2007.00638.x; Herbert C, 2006, PSYCHOPHYSIOLOGY, V43, P197, DOI 10.1111/j.1469-8986.2006.00385.x; HERMANS D, 1994, COGNITION EMOTION, V8, P515, DOI 10.1080/02699939408408957; Houwer JD, 2009, SOCIAL PERSONALITY P, V3, P36, DOI [10.1111/j.1751-9004.2008.00162.x, DOI 10.1111/J.1751-9004.2008.00162.X]; Junghofer M, 2001, PSYCHOPHYSIOLOGY, V38, P175, DOI 10.1017/S0048577201000762; Kiefer M, 2002, COGNITIVE BRAIN RES, V13, P27, DOI 10.1016/S0926-6410(01)00085-4; Klauer KC, 1997, J EXP PSYCHOL LEARN, V23, P246, DOI 10.1037/0278-7393.23.1.246; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kotz SA, 2011, LANG LINGUIST COMPAS, V5, P108, DOI 10.1111/j.1749-818x.2010.00267.x; Kumar P, 2014, IEEE ENG MED BIO, P5438, DOI 10.1109/EMBC.2014.6944856; Liao K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085192; Lotte F, 2007, J NEURAL ENG, V4, pR1, DOI 10.1088/1741-2560/4/2/R01; Lowery BS, 2007, BASIC APPL SOC PSYCH, V29, P151, DOI 10.1080/01973530701331718; Lu Y, 2011, NEUROSCI LETT, V502, P182, DOI 10.1016/j.neulet.2011.07.040; Lv F, 2006, LECT NOTES COMPUT SC, V3954, P359; Makeig S, 1996, ADV NEUR IN, V8, P145; Mallat S., 1999, WAVELET TOUR SIGNAL, DOI 10.1016/B978-012466606-1/50008-8; Marcos JL, 2005, PSICOTHEMA, V17, P332; McFarland DJ, 2006, IEEE T NEUR SYS REH, V14, P135, DOI 10.1109/TNSRE.2006.875637; Mitchell JP, 2002, MEMORY, V10, P381, DOI 10.1080/09658210244000207; Morris J, 2011, LANG COGNITIVE PROC, V26, P558, DOI 10.1080/01690965.2010.495482; MURPHY ST, 1993, J PERS SOC PSYCHOL, V64, P723, DOI 10.1037/0022-3514.64.5.723; Newell BR, 2014, BEHAV BRAIN SCI, V37, P1, DOI 10.1017/S0140525X12003214; Niu B, 2006, PROTEIN PEPTIDE LETT, V13, P489, DOI 10.2174/092986606776819619; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Otten S, 1999, EUR J SOC PSYCHOL, V29, P1049, DOI 10.1002/(SICI)1099-0992(199912)29:8<1049::AID-EJSP985>3.0.CO;2-Q; Philiastides MG, 2006, J NEUROSCI, V26, P8965, DOI 10.1523/JNEUROSCI.1655-06.2006; Philiastides MG, 2006, CEREB CORTEX, V16, P509, DOI 10.1093/cercor/bhi130; Ross ED, 2008, BRAIN LANG, V104, P51, DOI 10.1016/j.bandl.2007.04.007; Rotteveel M, 2001, EMOTION, V1, P348, DOI 10.1037//1528-3542.1.4.348; Schacht A, 2009, COGN AFFECT BEHAV NE, V9, P28, DOI 10.3758/CABN.9.1.28; Schapire RE, 1999, MACH LEARN, V37, P297, DOI 10.1023/A:1007614523901; Schupp HT, 2004, PSYCHOPHYSIOLOGY, V41, P441, DOI 10.1111/j.1469-8986.2004.00174.x; Schupp HT, 2000, PSYCHOPHYSIOLOGY, V37, P257, DOI 10.1017/S0048577200001530; Seif Z, COGNITIVE NEURODYNAM, P1; Soman K.P., 2010, INSIGHT WAVELETS THE; Stewart AX, 2014, J NEUROSCI METH, V228, P1, DOI 10.1016/j.jneumeth.2014.02.014; Sugiyama M, 2007, J MACH LEARN RES, V8, P1027; Taghizadeh-Sarabi M., 2014, BRAIN TOPOGRAPHY, P1; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Winkielman P, 2005, PERS SOC PSYCHOL B, V31, P121, DOI 10.1177/0146167204271309; Zhang Q, 2006, BRAIN RES BULL, V71, P316, DOI 10.1016/j.brainresbull.2006.09.023; Zhang Q, 2010, BRAIN RES, V1329, P142, DOI 10.1016/j.brainres.2010.03.021	67	8	10	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148332	10.1371/journal.pone.0148332	http://dx.doi.org/10.1371/journal.pone.0148332			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6RE	26866807	gold, Green Published, Green Submitted			2022-12-27	WOS:000370050700015
J	Peng, L; Li, GY; Xiao, M; Xie, L				Peng, Lei; Li, Guangyao; Xiao, Mang; Xie, Li			Robust CPD Algorithm for Non-Rigid Point Set Registration Based on Structure Information	PLOS ONE			English	Article							MATCHING ALGORITHM	Recently, the Coherent Point Drift (CPD) algorithm has become a very popular and efficient method for point set registration. However, this method does not take into consideration the neighborhood structure information of points to find the correspondence and requires a manual assignment of the outlier ratio. Therefore, CPD is not robust for large degrees of degradation. In this paper, an improved method is proposed to overcome the two limitations of CPD. A structure descriptor, such as shape context, is used to perform the auxiliary calculation of the correspondence, and the proportion of each GMM component is adjusted by the similarity. The outlier ratio is formulated in the EM framework so that it can be automatically calculated and optimized iteratively. The experimental results on both synthetic data and real data demonstrate that the proposed method described here is more robust to deformation, noise, occlusion, and outliers than CPD and other state-of-the-art algorithms.	[Peng, Lei; Li, Guangyao; Xiao, Mang; Xie, Li] Tongji Univ, Coll Elect & Informat Engn, Shanghai 200092, Peoples R China; [Peng, Lei] Taishan Med Univ, Coll Informat Engn, Tai An, Shandong, Peoples R China	Tongji University; Shandong First Medical University & Shandong Academy of Medical Sciences	Peng, L (corresponding author), Tongji Univ, Coll Elect & Informat Engn, Shanghai 200092, Peoples R China.; Peng, L (corresponding author), Taishan Med Univ, Coll Informat Engn, Tai An, Shandong, Peoples R China.	pengleisd@163.com			Shandong Provincial Natural Science Foundation, China [ZR2015FL005]	Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province)	This work was supported by Shandong Provincial Natural Science Foundation, China, grant number ZR2015FL005 (http://www.sdnsf.gov.cn/portal/, recipient: Lei Peng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Belongie S, 2002, IEEE T PATTERN ANAL, V24, P509, DOI 10.1109/34.993558; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Chen J, 2015, SIGNAL PROCESS, V106, P62, DOI 10.1016/j.sigpro.2014.07.004; Chui HL, 2003, COMPUT VIS IMAGE UND, V89, P114, DOI 10.1016/S1077-3142(03)00009-2; de Sousa S, 2015, PATTERN RECOGN, V48, P368, DOI 10.1016/j.patcog.2014.06.011; Gao Y, 2014, PATTERN ANAL APPL, V17, P379, DOI 10.1007/s10044-013-0324-z; Ge S, 2014, IEEE COMPUT SOC CONF, P245, DOI 10.1109/CVPRW.2014.45; Gerogiannis D, 2012, NEUROCOMPUTING, V89, P122, DOI 10.1016/j.neucom.2012.02.018; Habert S, 2013, SPIE MED IMAGING; Han X, 2010, FEATURE CONSTRAINED, P63; Hu YP, 2010, LECT NOTES COMPUT SC, V6326, P60; Jian B, 2011, IEEE T PATTERN ANAL, V33, P1633, DOI 10.1109/TPAMI.2010.223; Jin F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095576; Lee JH, 2011, IEEE T PATTERN ANAL, V33, P427, DOI 10.1109/TPAMI.2010.179; Liu SL, 2015, J APPL REMOTE SENS, V9, DOI 10.1117/1.JRS.9.095085; Ma JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092282; Ma JY, 2013, PROC CVPR IEEE, P2147, DOI 10.1109/CVPR.2013.279; Myronenko A, 2010, IEEE T PATTERN ANAL, V32, P2262, DOI 10.1109/TPAMI.2010.46; Qu HB, 2014, INT C PATT RECOG, P58, DOI 10.1109/ICPR.2014.20; Sang Q, 2013, PATTERN RECOGN LETT, V34, P1557, DOI 10.1016/j.patrec.2013.06.019; Schlkopf B., 2006, ADV NEURAL INFORM PR, P1009; Sotiras A, 2013, IEEE T MED IMAGING, V32, P1153, DOI 10.1109/TMI.2013.2265603; Tang J, 2014, PATTERN RECOGN, V47, P1469, DOI 10.1016/j.patcog.2013.09.017; Tao WB, 2014, PROC CVPR IEEE, P1598, DOI 10.1109/CVPR.2014.207; Wang G, 2015, COMPUT VIS IMAGE UND, V141, P67, DOI 10.1016/j.cviu.2015.05.014; Wang G, 2015, BIOMED SIGNAL PROCES, V19, P68, DOI 10.1016/j.bspc.2015.03.004; Wang P, 2011, SCI CHINA INFORM SCI, V54, P2639, DOI 10.1007/s11432-011-4465-7; Wang SH, 2012, IEEE GEOSCI REMOTE S, V9, P649, DOI 10.1109/LGRS.2011.2177437; Yan XW, 2013, J CENT SOUTH UNIV, V20, P3077, DOI 10.1007/s11771-013-1831-1; Yang Y, 2015, PATTERN RECOGN, V48, P156, DOI 10.1016/j.patcog.2014.06.017; Zhang K, 2014, IEEE GEOSCI REMOTE S, V11, P469, DOI 10.1109/LGRS.2013.2267771; Zheng YF, 2006, IEEE T PATTERN ANAL, V28, P643, DOI 10.1109/TPAMI.2006.81; Zhou ZY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091381	34	18	18	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148483	10.1371/journal.pone.0148483	http://dx.doi.org/10.1371/journal.pone.0148483			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866918	Green Published, Green Submitted, gold			2022-12-27	WOS:000370050700016
J	Pugh, BF; Venters, BJ				Pugh, B. Franklin; Venters, Bryan J.			Genomic Organization of Human Transcription Initiation Complexes	PLOS ONE			English	Article							RNA-POLYMERASE-II; EMBRYONIC STEM-CELLS; BIDIRECTIONAL PROMOTERS; INTEGRATIVE ANALYSIS; MAMMALIAN PROMOTERS; YEAST; GENE; VISUALIZATION; RECRUITMENT; RESOURCES	A repertoire of transcription initiation factors engage the core promoter of mRNA genes to recruit RNA polymerase (Pol) II to initiate transcription, yet their precise spatial organization remains unclear. Using ChIP-exo, here we detail the interactions and genomic organization of initiation factors TBP, TFIIB, and Pol II at mRNA genes and within CpG islands. We find that when Pol II moves into a transcriptionally paused state, TBP/TFIIB remain at the promoter. We show that TBP and TFIIB bound to the core promoter at two separate, resolvable locations that coincided with sites of divergent transcription initiation. We also examine the precise binding of TBP at Pol III transcribed tRNA genes. We find that TBP crosslinked to tRNA genes in a similar manner as at Pol II transcribed genes. This comprehensive and high resolution genome-wide detection of the initiation machinery produces a consolidated view of transcription initiation events humans at Pol II coding and Pol III transcribed tRNA genes.	[Pugh, B. Franklin; Venters, Bryan J.] Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA; [Venters, Bryan J.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Vanderbilt University	Venters, BJ (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA.; Venters, BJ (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA.	bryan.venters@vanderbilt.edu			National Institutes of Health [GM059055]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059055] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant GM059055.	Albert I, 2008, BIOINFORMATICS, V24, P1305, DOI 10.1093/bioinformatics/btn119; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Carriere L, 2012, NUCLEIC ACIDS RES, V40, P270, DOI 10.1093/nar/gkr737; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Core LJ, 2014, NAT GENET, V46, P1311, DOI 10.1038/ng.3142; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fenouil R, 2012, GENOME RES, V22, P2399, DOI 10.1101/gr.138776.112; Gaertner B, 2014, DEVELOPMENT, V141, P1179, DOI 10.1242/dev.088492; GEIDUSCHEK EP, 1988, ANNU REV BIOCHEM, V57, P873, DOI 10.1146/annurev.bi.57.070188.004301; Gilmour DS, 2009, CHROMOSOMA, V118, P1, DOI 10.1007/s00412-008-0182-4; GILMOUR DS, 1986, MOL CELL BIOL, V6, P3984, DOI 10.1128/MCB.6.11.3984; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jonkers I, 2014, ELIFE, V3, DOI 10.7554/eLife.02407; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu LQ, 2014, CELL STEM CELL, V15, P574, DOI 10.1016/j.stem.2014.09.018; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Rhee Ho Sung, 2012, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2124s100; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Sainsbury S, 2013, NATURE, V493, P437, DOI 10.1038/nature11715; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schulz D, 2013, CELL, V155, P1075, DOI 10.1016/j.cell.2013.10.024; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Vannini A, 2012, MOL CELL, V45, P439, DOI 10.1016/j.molcel.2012.01.023; Venters BJ, 2013, NATURE, V502, P53, DOI 10.1038/nature12535; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; WHITE RJ, 1992, CELL, V71, P1041, DOI 10.1016/0092-8674(92)90398-V; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Zhang H, 2012, Cold Spring Harb Symp Quant Biol, V77, P161, DOI 10.1101/sqb.2012.77.014936	39	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149339	10.1371/journal.pone.0149339	http://dx.doi.org/10.1371/journal.pone.0149339			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866362	Green Accepted, Green Published, gold			2022-12-27	WOS:000370050700083
J	Xiao, M; Zhao, R; Zhang, Q; Fan, X; O'Sullivan, MVN; Li, DF; Wang, XY; Wu, HL; Kong, FR; Xu, YC				Xiao, Meng; Zhao, Rui; Zhang, Qi; Fan, Xin; O'Sullivan, Matthew V. N.; Li, Dong-Fang; Wang, Xin-Ying; Wu, Hong-Long; Kong, Fanrong; Xu, Ying-Chun			Genotypic Diversity of Staphylococcus aureus alpha-Hemolysin Gene (hla) and Its Association with Clonal Background: Implications for Vaccine Development	PLOS ONE			English	Article							METHICILLIN-RESISTANT; PASSIVE-IMMUNIZATION; MURINE MODEL; MOUSE MODEL; TOXIN GENE; SEQUENCE; EPIDEMIOLOGY; MUTAGENESIS; ADAPTATION; PROTECTION	The alpha-hemolysin, encoded by the hla gene, is a major virulence factor in S. aureus infections. Changes in key amino acid residues of a-hemolysin can result in reduction, or even loss, of toxicity. The aim of this study was to investigate the diversity of the hla gene sequence and the relationship of hla variants to the clonal background of S. aureus isolates. A total of 47 clinical isolates from China were used in this study, supplemented with in silico analysis of 318 well-characterized whole genome sequences from globally distributed isolates. A total of 28 hla genotypes were found, including three unique to isolates from China, 20 found only in the global genomes and five found in both. The hla genotype generally correlated with the clonal background, particularly the multilocus sequence type, but was not related to geographic origin, host source or methicillin-resistance phenotype. In addition, the hla gene showed greater diversity than the seven loci utilized in the MLST scheme for S. aureus. Our investigation has provided genetic data which may be useful for future studies of toxicity, immunogenicity and vaccine development.	[Xiao, Meng; Zhang, Qi; Fan, Xin; Xu, Ying-Chun] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Clin Lab, Beijing 100730, Peoples R China; [Zhao, Rui] Beijing Elect Power Hosp, Dept Lab, Beijing, Peoples R China; [O'Sullivan, Matthew V. N.; Kong, Fanrong] Univ Sydney, Westmead Hosp, Ctr Infect Dis & Microbiol Lab Serv, ICPMR Pathol West, Westmead, NSW 2145, Australia; [O'Sullivan, Matthew V. N.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia; [Li, Dong-Fang; Wang, Xin-Ying; Wu, Hong-Long] BGI Shenzhen, Binhai Genom Inst, BGI Tianjin, Tianjin, Peoples R China; [Li, Dong-Fang; Wang, Xin-Ying; Wu, Hong-Long] BGI Shenzhen, Tianjin Translat Genom Ctr, BGI Tianjin, Tianjin, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; University of Sydney; University of Sydney; Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI)	Xu, YC (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Clin Lab, Beijing 100730, Peoples R China.	xycpumch@139.com	Xiao, Meng/J-6518-2017	Xiao, Meng/0000-0003-2103-7008; O'Sullivan, Matthew/0000-0001-8783-5323	Ministry of Health of China [201402001]	Ministry of Health of China	YCX recieved a National Research Special Fund for Public Welfare Industry of Health of China (grant number 201402001, http://www.moh.gov.cn/qjjys/s3577/201401/e9f3635e7acb47778225ccb729ffec62.shtml) from the Ministry of Health of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Talib H, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-113; Berube BJ, 2013, TOXINS, V5, P1140, DOI 10.3390/toxins5061140; Carvalho KS, 2010, BRAZ J INFECT DIS, V14, P71, DOI 10.1590/S1413-86702010000100014; Chen HB, 2010, ANTIMICROB AGENTS CH, V54, P1842, DOI 10.1128/AAC.01563-09; Chen L, 2009, J CLIN MICROBIOL, V47, P3692, DOI 10.1128/JCM.00766-09; Chen Y, 2015, J INFECT DIS, V211, P472, DOI 10.1093/infdis/jiu462; DeLeo FR, 2011, P NATL ACAD SCI USA, V108, P18091, DOI 10.1073/pnas.1111084108; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; GRAY GS, 1984, INFECT IMMUN, V46, P615, DOI 10.1128/IAI.46.2.615-618.1984; Gray RR, 2011, MOL BIOL EVOL, V28, P1593, DOI 10.1093/molbev/msq319; Holden MTG, 2013, GENOME RES, V23, P653, DOI 10.1101/gr.147710.112; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Koreen L, 2004, J CLIN MICROBIOL, V42, P792, DOI 10.1128/JCM.42.2.792-799.2004; Kurt K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058155; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mathur Purva, 2013, J Lab Physicians, V5, P5, DOI 10.4103/0974-2727.115898; McAdam PR, 2012, P NATL ACAD SCI USA, V109, P9107, DOI 10.1073/pnas.1202869109; McGavin MJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00048; Mediavilla JR, 2012, CURR OPIN MICROBIOL, V15, P588, DOI 10.1016/j.mib.2012.08.003; Menzies BE, 1996, INFECT IMMUN, V64, P1839, DOI 10.1128/IAI.64.5.1839-1841.1996; MENZIES BE, 1994, INFECT IMMUN, V62, P1843, DOI 10.1128/IAI.62.5.1843-1847.1994; Mocca CP, 2014, CLIN VACCINE IMMUNOL, V21, P622, DOI 10.1128/CVI.00051-14; Ohlsen K, 2010, INT J MED MICROBIOL, V300, P402, DOI 10.1016/j.ijmm.2010.04.015; Ragle BE, 2009, INFECT IMMUN, V77, P2712, DOI 10.1128/IAI.00115-09; Stinear TP, 2014, GENOME BIOL EVOL, V6, P366, DOI 10.1093/gbe/evu022; Stryjewski ME, 2014, CLIN INFECT DIS, V58, pS10, DOI 10.1093/cid/cit613; Vandenesch F, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00012; WALKER B, 1992, J BIOL CHEM, V267, P10902; WALKER B, 1995, J BIOL CHEM, V270, P23065, DOI 10.1074/jbc.270.39.23065; Xiao M, 2013, J CLIN MICROBIOL, V51, P3638, DOI 10.1128/JCM.01375-13; Xiao YH, 2011, DRUG RESIST UPDATE, V14, P236, DOI 10.1016/j.drup.2011.07.001	33	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149112	10.1371/journal.pone.0149112	http://dx.doi.org/10.1371/journal.pone.0149112			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866483	gold, Green Published, Green Submitted			2022-12-27	WOS:000370050700066
J	Pishnamaz, M; Wilkmann, C; Na, HS; Pfeffer, J; Hanisch, C; Janssen, M; Bruners, P; Kobbe, P; Hildebrand, F; Schmitz-Rode, T; Pape, HC				Pishnamaz, Miguel; Wilkmann, Christoph; Na, Hong-Sik; Pfeffer, Jochen; Haenisch, Christoph; Janssen, Max; Bruners, Philipp; Kobbe, Philipp; Hildebrand, Frank; Schmitz-Rode, Thomas; Pape, Hans-Christoph			Electromagnetic Real Time Navigation in the Region of the Posterior Pelvic Ring: An Experimental In-Vitro Feasibility Study and Comparison of Image Guided Techniques	PLOS ONE			English	Article							STANDARD FLUOROSCOPIC METHOD; ILIOSACRAL SCREW INSERTION; SACROILIAC SCREWS; ACCURACY ANALYSIS; TRACKING; GUIDANCE; FRACTURES; PLACEMENT; LESIONS; BIOPSY	Background Electromagnetic tracking is a relatively new technique that allows real time navigation in the absence of radiation. The aim of this study was to prove the feasibility of this technique for the treatment of posterior pelvic ring fractures and to compare the results with established image guided procedures. Methods Tests were performed in pelvic specimens (Sawbones1) with standardized sacral fractures (Type Denis I or II). A gel matrix simulated the operative approach and a cover was used to disable visual control. The electromagnetic setup was performed by using a custom made carbon reference plate and a prototype stainless steel K-wire with an integrated sensor coil. Four different test series were performed: Group OCT: Optical navigation using preoperative CT-scans; group O3D: Optical navigation using intraoperative 3-D-fluoroscopy; group Fluoro: Conventional 2-D-fluoroscopy; group EMT: Electromagnetic navigation combined with a preoperative Dyna-CT. Accuracy of screw placement was analyzed by standardized postoperative CT-scan for each specimen. Operation time and intraoperative radiation exposure for the surgeon was documented. All data was analyzed using SPSS (Version 20, 76 Chicago, IL, USA). Statistical significance was defined as p<0.05. Results 160 iliosacral screws were placed (40 per group). EMT resulted in a significantly higher incidence of optimal screw placement (EMT: 36/40) compared to the groups Fluoro (30/40; p<0.05) and OCT (31/40; p<0.05). Results between EMT and O3D were comparable (O3D: 37/40; n.s.). Also, the operation time was comparable between groups EMT and O3D (EMT 7.62 min vs. O3D 7.98 min; n.s.), while the surgical time was significantly shorter compared to the Fluoro group (10.69 min; p<0.001) and the OCT group (13.3 min; p<0.001). Conclusion Electromagnetic guided iliosacral screw placement is a feasible procedure. In our experimental setup, this method was associated with improved accuracy of screw placement and shorter operation time when compared with the conventional fluoroscopy guided technique and compared to the optical navigation using preoperative CT- scans. Further studies are necessary to rule out drawbacks of this technique regarding ferromagnetic objects.	[Pishnamaz, Miguel; Janssen, Max; Kobbe, Philipp; Hildebrand, Frank; Pape, Hans-Christoph] Univ Aachen, Med Ctr, Dept Orthoped Trauma, Aachen, Germany; [Wilkmann, Christoph; Na, Hong-Sik; Pfeffer, Jochen; Bruners, Philipp] Univ Aachen, Med Ctr, Dept Diagnost & Intervent Radiol, Aachen, Germany; [Wilkmann, Christoph; Schmitz-Rode, Thomas] RWTH Aachen Univ & Hosp, Helmholtz Inst, Inst Appl Med Engn, Aachen, Germany; [Haenisch, Christoph] RWTH Aachen Univ & Hosp, Helmholtz Inst, Chair Med Engn, Aachen, Germany	RWTH Aachen University; RWTH Aachen University; Helmholtz Association; RWTH Aachen University; RWTH Aachen University Hospital; Helmholtz Association; RWTH Aachen University; RWTH Aachen University Hospital	Pishnamaz, M (corresponding author), Univ Aachen, Med Ctr, Dept Orthoped Trauma, Aachen, Germany.	mpishnamaz@ukaachen.de	Hildebrand, Frank/J-3176-2017; Bruners, Philipp/AAK-9165-2021	Bruners, Philipp/0000-0002-5790-3687; Schmitz-Rode, Thomas/0000-0002-1181-2165; Pape, Hans-Christoph/0000-0002-2059-4980	RWTH Aachen University START program for young scientists	RWTH Aachen University START program for young scientists	This study was supported by the RWTH Aachen University START program for young scientists. (http://www.medizin.rwth-aachen.de/cms/Medizin/Forschung/Foerderung/Interne-Programme/similar to tfy/START/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amalou H, 2012, J BRONCHOL INTERN PU, V19, P323, DOI 10.1097/LBR.0b013e31827157c9; Bale RJ, 2008, J VASC INTERV RADIOL, V19, P1093, DOI 10.1016/j.jvir.2008.04.006; Bates P, 2011, ORTHOP CLIN N AM, V42, P55, DOI 10.1016/j.ocl.2010.08.004; Bruners P, 2009, EUR RADIOL, V19, P990, DOI 10.1007/s00330-008-1227-z; Buckner CA, 2011, J ULTRAS MED, V30, P253, DOI 10.7863/jum.2011.30.2.253; Grossterlinden L, 2011, INT ORTHOP, V35, P1391, DOI 10.1007/s00264-010-1092-7; Hilgert RE, 2005, UNFALLCHIRURG, V108, P954, DOI 10.1007/s00113-005-0967-3; Hinsche AF, 2002, CLIN ORTHOP RELAT R, P135; Hoffmann M, 2015, INT J MED ROBOT COMP, V11, P52, DOI 10.1002/rcs.1572; Hoffmann M, 2014, SPORTS MED ARTHROSC, V22, P215, DOI 10.1097/JSA.0000000000000036; Hoffmann M, 2014, KNEE SURG SPORT TR A, V22, P2237, DOI 10.1007/s00167-013-2607-8; Hoffmann M, 2012, AM J SPORT MED, V40, P920, DOI 10.1177/0363546511434407; Krucker J, 2007, J VASC INTERV RADIOL, V18, P1141, DOI 10.1016/j.jvir.2007.06.014; Meyer BC, 2008, EUR RADIOL, V18, P2855, DOI 10.1007/s00330-008-1063-1; Ochs BG, 2010, INJURY, V41, P1297, DOI 10.1016/j.injury.2010.07.502; Pape HC, 2004, UNFALLCHIRURG, V107, P927, DOI 10.1007/s00113-004-0848-1; Penzkofer T, 2011, MINIM INVASIV THER, V20, P226, DOI 10.3109/13645706.2011.553256; Penzkofer T, 2010, EUR RADIOL, V20, P2656, DOI 10.1007/s00330-010-1837-0; Ricci WM, 2008, J ORTHOP TRAUMA, V22, P190, DOI 10.1097/BOT.0b013e31816731c7; Smith HE, 2006, SPINE, V31, P234, DOI 10.1097/01.brs.0000194788.45002.1b; Tian NF, 2009, INT ORTHOP, V33, P895, DOI 10.1007/s00264-009-0792-3; Tschoeke SK, 2007, J TRAUMA, V62, P1396, DOI 10.1097/TA.0b013e318047b7f0; van den Bosch EW, 2002, J TRAUMA, V53, P44, DOI 10.1097/00005373-200207000-00009; von Jako R, ACTA NEUROCHIR WIEN, V153, P589; von Jako RA, 2009, NEUROIMAGE, V47, pT127, DOI 10.1016/j.neuroimage.2009.05.002; Wood BJ, 2005, J VASC INTERV RADIOL, V16, P493, DOI 10.1097/01.RVI.0000148827.62296.B4; Yaniv Z, 2009, MED PHYS, V36, P876, DOI 10.1118/1.3075829; Zhang Hui, 2006, Comput Aided Surg, V11, P127; Zwingmann J, 2010, J TRAUMA, V69, P1501, DOI 10.1097/TA.0b013e3181d862db; Zwingmann J, 2013, ARCH ORTHOP TRAUM SU, V133, P1257, DOI 10.1007/s00402-013-1788-4	30	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148199	10.1371/journal.pone.0148199	http://dx.doi.org/10.1371/journal.pone.0148199			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863310	Green Published, gold			2022-12-27	WOS:000370046600048
J	Shin, JE; Shin, JC; Lee, Y; Kim, SJ				Shin, Jae Eun; Shin, Jong Chul; Lee, Young; Kim, Sa Jin			Serial Change in Cervical Length for the Prediction of Emergency Cesarean Section in Placenta Previa	PLOS ONE			English	Article							SPONTANEOUS ONSET; GESTATIONAL-AGE; RISK; PREGNANCY; WOMEN; HEMORRHAGE; DELIVERY; LABOR; TERM	Purpose To evaluate whether serial change in cervical length (CL) over time can be a predictor for emergency cesarean section (CS) in patients with placenta previa. Methods This was a retrospective cohort study of patients with placenta previa between January 2010 and November 2014. All women were offered serial measurement of CL by transvaginal ultrasound at 19 to 23 weeks (CL1), 24 to 28 weeks (CL2), 29 to 31 weeks (CL3), and 32 to 34 weeks (CL4). We compared clinical characteristics, serial change in CL, and outcomes between the emergency CS group (case group) and elective CS group (control group). The predictive value of change in CL for emergency CS was evaluated. Results A total of 93 women were evaluated; 31 had emergency CS due to massive vaginal bleeding. CL tended to decrease with advancing gestational age in each group. Until 29-31 weeks, CL showed no significant differences between the two groups, but after that, CL in the emergency CS group decreased abruptly, even though CL in the elective CS group continued to gradually decrease. On multivariate analysis to determine risk factors, only admissions for bleeding (odds ratio, 34.710; 95% CI, 5.239-229.973) and change in CL (odds ratio, 3.522; 95% CI, 1.210-10.253) were significantly associated with emergency CS. Analysis of the receiver operating characteristic curve showed that change in CL could be the predictor of emergency CS (area under the curve 0.734, p < 0.001), with optimal cutoff for predicting emergency cesarean delivery of 6.0 mm. Conclusions Previous admission for vaginal bleeding and change in CL are independent predictors of emergency CS in placenta previa. Women with change in CL more than 6 mm between the second and third trimester are at high risk of emergency CS in placenta previa. Single measurements of short CL at the second or third trimester do not seem to predict emergency CS.	[Shin, Jae Eun; Shin, Jong Chul; Lee, Young; Kim, Sa Jin] Catholic Univ Korea, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea	Catholic University of Korea	Kim, SJ (corresponding author), Catholic Univ Korea, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea.	ksajin@catholic.ac.kr						Bayramoglu O, 2005, AM J PERINAT, V22, P35, DOI 10.1055/s-2004-837268; Berghella V, 2007, OBSTET GYNECOL, V110, P311, DOI 10.1097/01.AOG.0000270112.05025.1d; Colombo DF, 2000, CLIN OBSTET GYNECOL, V43, P735, DOI 10.1097/00003081-200012000-00004; Cook CM, 1996, BRIT J OBSTET GYNAEC, V103, P16, DOI 10.1111/j.1471-0528.1996.tb09509.x; Dashe JS, 2002, OBSTET GYNECOL, V99, P692, DOI 10.1016/S0029-7844(02)01935-X; Fox NS, 2010, AM J OBSTET GYNECOL, V203, pE15, DOI 10.1016/j.ajog.2010.06.064; Fukushima K, 2012, J OBSTET GYNAECOL RE, V38, P192, DOI 10.1111/j.1447-0756.2011.01669.x; Garcia-Espinosa M, 2014, ULTRASOUND OBST GYN, V44, P16; Ghi T, 2009, ULTRASOUND OBST GYN, V33, P209, DOI 10.1002/uog.6301; Hasegawa J, 2011, J CLIN ULTRASOUND, V39, P458, DOI 10.1002/jcu.20849; Heath VCF, 1998, ULTRASOUND OBST GYN, V12, P304, DOI 10.1046/j.1469-0705.1998.12050304.x; Iams JD, 1996, NEW ENGL J MED, V334, P567, DOI 10.1056/NEJM199602293340904; Jenkins SM, 2006, ULTRASOUND OBST GYN, V27, P373, DOI 10.1002/uog.2741; Meijer-Hoogeveen M, 2008, ULTRASOUND OBST GYN, V32, P652, DOI 10.1002/uog.5291; Rosello JM, 2013, J MATERN-FETAL NEO M, V26, P1807, DOI 10.3109/14767058.2013.804049; Naim A, 2002, AM J OBSTET GYNECOL, V186, P887, DOI 10.1067/mob.2002.123058; Oppenheimer L, 2007, J OBSTET GYNAECOL CA, V29, P261, DOI 10.1016/S1701-2163(16)32401-X; Palacio M, 2007, ULTRASOUND OBST GYN, V29, P421, DOI 10.1002/uog.3950; Pritchard J, 2014, WILLIAMS OBSTET, P780; Sekiguchi A, 2015, J CLIN ULTRASOUND, V43, P17, DOI 10.1002/jcu.22205; Sotiriadis A, 2010, ULTRASOUND OBST GYN, V35, P54, DOI 10.1002/uog.7457; Souka AP, 2011, J ULTRAS MED, V30, P997, DOI 10.7863/jum.2011.30.7.997; Stafford IA, 2010, OBSTET GYNECOL, V116, P595, DOI 10.1097/AOG.0b013e3181ea2deb; Word RA, 2007, SEMIN REPROD MED, V25, P69, DOI 10.1055/s-2006-956777; Zaitoun MM, 2011, ARCH GYNECOL OBSTET, V284, P867, DOI 10.1007/s00404-010-1737-1	25	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149036	10.1371/journal.pone.0149036	http://dx.doi.org/10.1371/journal.pone.0149036			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863133	gold, Green Published, Green Submitted			2022-12-27	WOS:000370046600145
J	Sasaki, A; Sato, N; Suzuki, N; Kano, M; Tanaka, Y; Kanazawa, M; Aoki, M; Fukudo, S				Sasaki, Ayaka; Sato, Naoko; Suzuki, Naoki; Kano, Michiko; Tanaka, Yukari; Kanazawa, Motoyori; Aoki, Masashi; Fukudo, Shin			Associations between Single-Nucleotide Polymorphisms in Corticotropin-Releasing Hormone-Related Genes and Irritable Bowel Syndrome	PLOS ONE			English	Article							FUNCTIONAL GASTROINTESTINAL DISORDERS; ANTIDEPRESSANT TREATMENT RESPONSE; FACTOR BINDING-PROTEIN; POSTTRAUMATIC-STRESS; ADULT DEPRESSION; MAJOR DEPRESSION; CRHR1 GENE; PITUITARY; HAPLOTYPE; EXPRESSION	Irritable bowel syndrome (IBS) is a common functional disorder with distinct features of stress-related pathophysiology. A key mediator of the stress response is corticotropin-releasing hormone (CRH). Although some candidate genes have been identified in stress-related disorders, few studies have examined CRH-related gene polymorphisms. Therefore, we tested our hypothesis that single-nucleotide polymorphisms (SNPs) in CRH-related genes influence the features of IBS. Methods: In total, 253 individuals (123 men and 130 women) participated in this study. They comprised 111 IBS individuals and 142 healthy controls. The SNP genotypes in CRH (rs28364015 and rs6472258) and CRH-binding protein (CRH-BP) (rs10474485) were determined by direct sequencing and real-time polymerase chain reaction. The emotional states of the subjects were evaluated using the State-Trait Anxiety Inventory, Perceived Stress Scale, and the Self-rating Depression Scale. Results: Direct sequencing of the rs28364015 SNP of CRH revealed no genetic variation among the study subjects. There was no difference in the genotype distributions and allele frequencies of rs6472258 and rs10474485 between IBS individuals and controls. However, IBS subjects with diarrhea symptoms without the rs10474485 A allele showed a significantly higher emotional state score than carriers. Conclusions: These results suggest that the CRH and CRH-BP genes have no direct effect on IBS status. However, the CRH-BP SNP rs10474485 has some effect on IBS-related emotional abnormalities and resistance to psychosocial stress.	[Sasaki, Ayaka; Sato, Naoko; Kano, Michiko; Tanaka, Yukari; Kanazawa, Motoyori; Fukudo, Shin] Tohoku Univ, Grad Sch Med, Dept Behav Med, Sendai, Miyagi 980, Japan; [Suzuki, Naoki; Aoki, Masashi] Tohoku Univ, Dept Neurol, Grad Sch Med, Sendai, Miyagi 980, Japan; [Kano, Michiko] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University	Fukudo, S (corresponding author), Tohoku Univ, Grad Sch Med, Dept Behav Med, Sendai, Miyagi 980, Japan.	sfukudo@med.tohoku.ac.jp	Fukudo, Shin/J-4813-2014; Suzuki, Naoki/J-6331-2019	Suzuki, Naoki/0000-0001-8880-8554	Ministry of Education, Science, and Culture of Japan [15H04799, 15H15267]; Ministry of Health, Welfare, and Labor of Japan [26-4]	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Welfare, and Labor of Japan(Ministry of Health, Labour and Welfare, Japan)	This research was supported by Grant-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan No. 15H04799, 15H15267 (http://www.mext.go.jp/english/) and Grant-in-Aid for Scientific Research from the Ministry of Health, Welfare, and Labor of Japan (26-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksandra S, 2011, J AFFECT DISORDERS, V134, P138, DOI [10.1016/j.jad.2011.06.020, DOI 10.1016/J.JAD.2011.06.020]; Barr CS, 2009, P NATL ACAD SCI USA, V106, P14593, DOI 10.1073/pnas.0902863106; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BEHAN DP, 1995, FRONT NEUROENDOCRIN, V16, P362, DOI 10.1006/frne.1995.1013; Bevilacqua L, 2011, NATURE, V470, DOI 10.1038/nature09808; Binder EB, 2010, ARCH GEN PSYCHIAT, V67, P369, DOI 10.1001/archgenpsychiatry.2010.18; Bogdan R, 2010, GENES BRAIN BEHAV, V9, P658, DOI 10.1111/j.1601-183X.2010.00600.x; Bradley RG, 2008, ARCH GEN PSYCHIAT, V65, P190, DOI 10.1001/archgenpsychiatry.2007.26; Claes S, 2003, BIOL PSYCHIAT, V54, P867, DOI 10.1016/S0006-3223(03)00425-6; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Coste SC, 2000, NAT GENET, V24, P403, DOI 10.1038/74255; Davydow DS, 2014, J CRIT CARE, V29, P101, DOI 10.1016/j.jcrc.2013.08.016; de Kloet CS, 2007, PROG BRAIN RES, V167, P287, DOI 10.1016/S0079-6123(07)67025-3; De Luca V, 2010, J PSYCHOPHARMACOL, V24, P677, DOI 10.1177/0269881108097817; Dekker MJHJ, 2012, J CLIN ENDOCR METAB, V97, pE233, DOI 10.1210/jc.2011-0601; Enoch MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003620; Fujisawa TX, 2011, NEUROENDOCRINOL LETT, V32, P836; Fukuda K, 1973, Seishin Shinkeigaku Zasshi, V75, P673; Fukudo S, 2009, NEUROIMAGE, V47, P946, DOI 10.1016/j.neuroimage.2009.04.083; Fukudo S, 2007, J GASTROENTEROL, V42, P48, DOI 10.1007/s00535-006-1942-7; Grover M, 2008, CURR OPIN PHARMACOL, V8, P715, DOI 10.1016/j.coph.2008.07.012; Henry BA, 2005, J NEUROENDOCRINOL, V17, P135, DOI 10.1111/j.1365-2826.2005.01274.x; Iwahasi S, 2002, JPN J PSYCHOSOM MED, V42, P459; Jahn O, 2005, MINI-REV MED CHEM, V5, P953, DOI 10.2174/138955705774329500; Kanazawa M, 2004, DIGEST DIS SCI, V49, P1046, DOI 10.1023/B:DDAS.0000034570.52305.10; Kapeller J, 2009, GASTROENTEROLOGY, V136, pA155; Keck ME, 2008, AM J MED GENET B, V147B, P1196, DOI 10.1002/ajmg.b.30750; Korte SM, 2005, NEUROSCI BIOBEHAV R, V29, P3, DOI 10.1016/j.neubiorev.2004.08.009; Levran O, 2014, ANN HUM GENET, V78, P290, DOI 10.1111/ahg.12064; Levy RL, 2006, GASTROENTEROLOGY, V130, P1447, DOI 10.1053/j.gastro.2005.11.057; Li YY, 2007, DIGEST DIS SCI, V52, P2942, DOI 10.1007/s10620-006-9679-y; Licinio J, 2004, MOL PSYCHIATR, V9, P1075, DOI 10.1038/sj.mp.4001587; Liu ZC, 2006, NEUROSCI LETT, V404, P358, DOI 10.1016/j.neulet.2006.06.016; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Lovell RM, 2012, CLIN GASTROENTEROL H, V10, P712, DOI 10.1016/j.cgh.2012.02.029; McEwen Bruce S, 2006, Dialogues Clin Neurosci, V8, P367; NAKAZATO K, 1989, PERCEPT MOTOR SKILL, V69, P611, DOI 10.2466/pms.1989.69.2.611; NIESLER B, 2009, EUR J GASTROENTEROL; OWENS MJ, 1991, PHARMACOL REV, V43, P425; Polanczyk G, 2009, ARCH GEN PSYCHIAT, V66, P978, DOI 10.1001/archgenpsychiatry.2009.114; POTTER E, 1994, P NATL ACAD SCI USA, V91, P8777, DOI 10.1073/pnas.91.19.8777; Ray LA, 2011, ALCOHOL CLIN EXP RES, V35, P166, DOI 10.1111/j.1530-0277.2010.01333.x; Riedl A, 2008, J PSYCHOSOM RES, V64, P573, DOI 10.1016/j.jpsychores.2008.02.021; Sagami Y, 2004, GUT, V53, P958, DOI 10.1136/gut.2003.018911; Sanchez-Martin JR, 2011, PSYCHONEUROENDOCRINO, V36, P750, DOI 10.1016/j.psyneuen.2010.10.011; Sapolsky RM, 2001, COPING ENV NEURAL EN, P517; Sato N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042450; Seasholtz AF, 2002, J ENDOCRINOL, V175, P89, DOI 10.1677/joe.0.1750089; Sikander A, 2009, J CLIN GASTROENTEROL, V43, P957, DOI 10.1097/MCG.0b013e3181b37e8c; Southwick SM, 2005, ANNU REV CLIN PSYCHO, V1, P255, DOI 10.1146/annurev.clinpsy.1.102803.143948; Speert DB, 2002, ENDOCRINOLOGY, V143, P4730, DOI 10.1210/en.2002-220556; Speilberger, 1970, STAI MANUAL, P23; Talley NJ, 2008, NEUROGASTROENT MOTIL, V20, P121, DOI 10.1111/j.1365-2982.2008.01097.x; Tsartsali L, 2012, NEUROIMMUNOMODULAT, V19, P88, DOI 10.1159/000329592; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; van de Stolpe A, 2004, MOL ENDOCRINOL, V18, P2908, DOI 10.1210/me.2003-0446; Van Den Eede F, 2007, PSYCHIAT RES, V153, P17, DOI 10.1016/j.psychres.2006.12.018; van der Veek PPJ, 2005, EUR J GASTROEN HEPAT, V17, pA26; Villani A, 2009, GASTROENTEROLOGY, V296, pG211; Wasserman D, 2008, GENES BRAIN BEHAV, V7, P14, DOI 10.1111/j.1601-183X.2007.00310.x; WHITEHEAD WE, 1994, HEALTH PSYCHOL, V13, P99, DOI 10.1037/0278-6133.13.2.99; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	62	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149322	10.1371/journal.pone.0149322	http://dx.doi.org/10.1371/journal.pone.0149322			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882083	Green Submitted, gold, Green Published			2022-12-27	WOS:000371219000071
J	Ahlstrom, C; Barkema, HW; Stevenson, K; Zadoks, RN; Biek, R; Kao, R; Trewby, H; Haupstein, D; Kelton, DF; Fecteau, G; Labrecque, O; Keefe, GP; McKenna, SLB; Tahlan, K; De Buck, J				Ahlstrom, Christina; Barkema, Herman W.; Stevenson, Karen; Zadoks, Ruth N.; Biek, Roman; Kao, Rowland; Trewby, Hannah; Haupstein, Deb; Kelton, David F.; Fecteau, Gilles; Labrecque, Olivia; Keefe, Greg P.; McKenna, Shawn L. B.; Tahlan, Kapil; De Buck, Jeroen			Genome-Wide Diversity and Phylogeography of Mycobacterium avium subsp paratuberculosis in Canadian Dairy Cattle	PLOS ONE			English	Article							CYTOKINE RESPONSES; NETWORK ANALYSIS; VARIABLE-NUMBER; SEQUENCE; MACROPHAGES; STRAINS; TUBERCULOSIS; ANNOTATION; DISEASE; HERDS	Mycobacterium avium subsp. paratuberculosis (MAP) is the causative bacterium of Johne's disease (JD) in ruminants. The control of JD in the dairy industry is challenging, but can be improved with a better understanding of the diversity and distribution of MAP subtypes. Previously established molecular typing techniques used to differentiate MAP have not been sufficiently discriminatory and/or reliable to accurately assess the population structure. In this study, the genetic diversity of 182 MAP isolates representing all Canadian provinces was compared to the known global diversity, using single nucleotide polymorphisms identified through whole genome sequencing. MAP isolates from Canada represented a subset of the known global diversity, as there were global isolates intermingled with Canadian isolates, as well as multiple global subtypes that were not found in Canada. One Type III and six "Bison type" isolates were found in Canada as well as one Type II subtype that represented 86% of all Canadian isolates. Rarefaction estimated larger subtype richness in Quebec than in other Canadian provinces using a strict definition of MAP subtypes and lower subtype richness in the Atlantic region using a relaxed definition. Significant phylogeographic clustering was observed at the inter-provincial but not at the intra-provincial level, although most major clades were found in all provinces. The large number of shared subtypes among provinces suggests that cattle movement is a major driver of MAP transmission at the herd level, which is further supported by the lack of spatial clustering on an intra-provincial scale.	[Ahlstrom, Christina; Barkema, Herman W.; De Buck, Jeroen] Univ Calgary, Calgary, AB, Canada; [Stevenson, Karen; Zadoks, Ruth N.] Moredun Res Inst, Penicuik, Midlothian, Scotland; [Zadoks, Ruth N.; Biek, Roman; Kao, Rowland; Trewby, Hannah] Univ Glasgow, Glasgow, Lanark, Scotland; [Haupstein, Deb] SaskMilk, Regina, SK, Canada; [Kelton, David F.] Univ Guelph, Guelph, ON N1G 2W1, Canada; [Fecteau, Gilles] Univ Montreal, Montreal, PQ, Canada; [Labrecque, Olivia] Lab Epidemiosurveillance Anim Quebec, St Hyacinthe, PQ, Canada; [Keefe, Greg P.; McKenna, Shawn L. B.] Univ Prince Edward Isl, Charlottetown, PE C1A 4P3, Canada; [Tahlan, Kapil] Mem Univ Newfoundland, St John, NF, Canada; [Tahlan, Kapil] Labrador, St John, NF, Canada	University of Calgary; Moredun Research Institute; University of Glasgow; University of Guelph; Universite de Montreal; University of Prince Edward Island; Memorial University Newfoundland	De Buck, J (corresponding author), Univ Calgary, Calgary, AB, Canada.	jdebuck@ucalgary.ca	Biek, Roman/AAT-8109-2020; Barkema, Herman/B-9583-2008; De Buck, Jeroen/H-5509-2018	Biek, Roman/0000-0003-3471-5357; Barkema, Herman/0000-0002-9678-8378; De Buck, Jeroen/0000-0002-4824-9580; McKenna, Shawn/0000-0002-9699-1464; Kao, Rowland/0000-0003-0919-6401; Stevenson, Karen/0000-0003-0270-9550; Zadoks, Ruth/0000-0002-1164-8000	Alberta Livestock and Meat Agency; Dairy Farmers of Canada; SaskMilk; BBSRC [BB/M01262X/1, BB/L010569/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M01262X/1, 1096836, BB/L010569/1] Funding Source: researchfish; Alberta Innovates [201401123] Funding Source: researchfish	Alberta Livestock and Meat Agency; Dairy Farmers of Canada; SaskMilk; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Alberta Innovates	This research was supported by the Alberta Livestock and Meat Agency and Dairy Farmers of Canada. SaskMilk provided support in the form of salaries for author DH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Ahlstrom C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1387-6; Ahlstrom C, 2014, APPL ENVIRON MICROB, V80, P534, DOI 10.1128/AEM.03212-13; Alexander DC, 2009, J BACTERIOL, V191, P1018, DOI 10.1128/JB.01340-08; Amonsin A, 2004, J CLIN MICROBIOL, V42, P1694, DOI 10.1128/JCM.42.4.1694-1702.2004; [Anonymous], 2015, ATLANTIC JOHNES DIS; [Anonymous], 2013, ANIMAL IND MARKET IN; [Anonymous], 2015, ANIMAL IND MARKET IN; Barkema HW, 2011, ZOONOTIC PATHOGENS IN THE FOOD CHAIN, P197, DOI 10.1079/9781845936815.0197; Barkema HW, 2010, PARATUBERCULOSIS: ORGANISM, DISEASE, CONTROL, P10, DOI 10.1079/9781845936136.0010; Behr MA, 2010, INFLAMM BOWEL DIS, V16, P896, DOI 10.1002/ibd.21171; Biek R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003008; Borrmann E, 2011, VET MICROBIOL, V152, P101, DOI 10.1016/j.vetmic.2011.04.002; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; COLLINS DM, 1990, J CLIN MICROBIOL, V28, P1591, DOI 10.1128/JCM.28.7.1591-1596.1990; Collins DM, 2010, STRAIN CHARACTERIZAT; Coscolla Mireilla, 2010, Drug Discov Today Dis Mech, V7, pe43, DOI 10.1016/j.ddmec.2010.09.004; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dube C, 2008, TRANSBOUND EMERG DIS, V55, P382, DOI 10.1111/j.1865-1682.2008.01053.x; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Gollnick NS, 2007, VET IMMUNOL IMMUNOP, V120, P93, DOI 10.1016/j.vetimm.2007.07.017; Green DM, 2008, P R SOC B, V275, P1001, DOI 10.1098/rspb.2007.1601; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Janagama HK, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-10; Keim P, 2004, INFECT GENET EVOL, V4, P205, DOI 10.1016/j.meegid.2004.02.005; Lavers CJ, 2013, CAN VET J, V54, P1053; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li LL, 2005, P NATL ACAD SCI USA, V102, P12344, DOI 10.1073/pnas.0505662102; McKenna SLB, 2006, CAN VET J, V47, P1089; Motiwala AS, 2006, INFECT IMMUN, V74, P6046, DOI 10.1128/IAI.00326-06; Nouvellet P, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061588, 10.1371/currents.outbreaks.097a904d3f3619db2fe78d24bc776098]; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; R Core Team, R LANG ENV STAT COMP; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sohal JS, 2014, J CLIN MICROBIOL, V52, P2764, DOI 10.1128/JCM.00386-14; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Thibault VC, 2007, J CLIN MICROBIOL, V45, P2404, DOI 10.1128/JCM.00476-07; VARY PH, 1990, J CLIN MICROBIOL, V28, P933, DOI 10.1128/JCM.28.5.933-937.1990; Whittington RJ, 2001, MOL CELL PROBE, V15, P139, DOI 10.1006/mcpr.2001.0346; Wolf R, 2014, J DAIRY SCI, V97, P6250, DOI 10.3168/jds.2014-8101; Wynne JW, 2010, J BACTERIOL, V192, P6319, DOI 10.1128/JB.00972-10	43	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149017	10.1371/journal.pone.0149017	http://dx.doi.org/10.1371/journal.pone.0149017			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871723	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000370054100089
J	Allison, JR; Lechner, M; Hoeppner, MP; Poole, AM				Allison, Jane R.; Lechner, Marcus; Hoeppner, Marc P.; Poole, Anthony M.			Positive Selection or Free to Vary? Assessing the Functional Significance of Sequence Change Using Molecular Dynamics	PLOS ONE			English	Article							BRANCH-SITE; RNA; EVOLUTION; VIRUS; GENES; RECOGNITION; SIMULATIONS; SUPPRESSION; PREDICTION; ORIGINS	Evolutionary arms races between pathogens and their hosts may be manifested as selection for rapid evolutionary change of key genes, and are sometimes detectable through sequence-level analyses. In the case of protein-coding genes, such analyses frequently predict that specific codons are under positive selection. However, detecting positive selection can be non-trivial, and false positive predictions are a common concern in such analyses. It is therefore helpful to place such predictions within a structural and functional context. Here, we focus on the p19 protein from tombusviruses. P19 is a homodimer that sequesters siRNAs, thereby preventing the host RNAi machinery from shutting down viral infection. Sequence analysis of the p19 gene is complicated by the fact that it is constrained at the sequence level by overprinting of a viral movement protein gene. Using homology modeling, in silico mutation and molecular dynamics simulations, we assess how non-synonymous changes to two residues involved in forming the dimer interface-one invariant, and one predicted to be under positive selection-impact molecular function. Interestingly, we find that both observed variation and potential variation (where a non-synonymous change to p19 would be synonymous for the overprinted movement protein) does not significantly impact protein structure or RNA binding. Consequently, while several methods identify residues at the dimer interface as being under positive selection, MD results suggest they are functionally indistinguishable from a site that is free to vary. Our analyses serve as a caveat to using sequence-level analyses in isolation to detect and assess positive selection, and emphasize the importance of also accounting for how non-synonymous changes impact structure and function.	[Allison, Jane R.] Massey Univ Albany, Ctr Theoret Chem & Phys, Auckland, New Zealand; [Allison, Jane R.] Massey Univ Albany, Inst Nat & Math Sci, Auckland, New Zealand; [Allison, Jane R.; Poole, Anthony M.] Univ Canterbury, Biomol Interact Ctr, Christchurch 1, New Zealand; [Allison, Jane R.] Massey Univ Albany, Maurice Wilkins Ctr Mol Biodiscovery, Auckland, New Zealand; [Lechner, Marcus] Univ Marburg, Dept Pharmaceut Chem, Marburg, Germany; [Hoeppner, Marc P.] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Poole, Anthony M.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand	Massey University; Massey University; University of Canterbury; Massey University; University of Auckland; Philipps University Marburg; University of Kiel; University of Canterbury	Allison, JR (corresponding author), Massey Univ Albany, Ctr Theoret Chem & Phys, Auckland, New Zealand.; Allison, JR (corresponding author), Massey Univ Albany, Inst Nat & Math Sci, Auckland, New Zealand.; Allison, JR; Poole, AM (corresponding author), Univ Canterbury, Biomol Interact Ctr, Christchurch 1, New Zealand.; Allison, JR (corresponding author), Massey Univ Albany, Maurice Wilkins Ctr Mol Biodiscovery, Auckland, New Zealand.; Poole, AM (corresponding author), Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand.	j.allison@massey.ac.nz; anthony.poole@canterbury.ac.nz	Allison, Jane R/E-9582-2010	Allison, Jane R/0000-0002-5699-1726; Poole, Anthony/0000-0001-9940-2824	Royal Society of New Zealand Marsden Fund Fast Start award [13-MAU-039]; Royal Society of New Zealand Rutherford Discovery Fellowship [RDF-11-UOC-013]; Biomolecular Interaction Centre, University of Canterbury; Massey University Research Fund Early Career Grant; Swedish Research Council; Marsden Fund Fast Start award [13-MAU-039]; Rutherford Discovery Fellowships programme of the Royal Society of New Zealand; Biomolecular Interaction Centre at the University of Canterbury	Royal Society of New Zealand Marsden Fund Fast Start award; Royal Society of New Zealand Rutherford Discovery Fellowship(Royal Society of New Zealand); Biomolecular Interaction Centre, University of Canterbury; Massey University Research Fund Early Career Grant; Swedish Research Council(Swedish Research CouncilEuropean Commission); Marsden Fund Fast Start award(Royal Society of New ZealandMarsden Fund (NZ)); Rutherford Discovery Fellowships programme of the Royal Society of New Zealand; Biomolecular Interaction Centre at the University of Canterbury	The authors received funding from the following sources: Royal Society of New Zealand Marsden Fund Fast Start award (13-MAU-039) to JRA; Royal Society of New Zealand Rutherford Discovery Fellowship (RDF-11-UOC-013) to AMP; Biomolecular Interaction Centre, University of Canterbury (to AMP, JRA); Massey University Research Fund Early Career Grant (to JRA); and Swedish Research Council (to AMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to acknowledge the high performance computing facility at the University of Canterbury (UC HPC) for provision of supercomputing facilities, and financial support from the Biomolecular Interaction Centre at the University of Canterbury (JRA, AMP). JRA acknowledges support from a Massey University Research Fund Early Career Grant and a Marsden Fund Fast Start award (13-MAU-039). AMP acknowledges current support via the Rutherford Discovery Fellowships programme of the Royal Society of New Zealand, and past support from the Swedish Research Council.	Belshaw R, 2007, GENOME RES, V17, P1496, DOI 10.1101/gr.6305707; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Ding KY, 2005, MOL BIOL EVOL, V22, P148, DOI 10.1093/molbev/msh266; Dunoyer P, 2010, SCIENCE, V328, P912, DOI 10.1126/science.1185880; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; Firth AE, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-75; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hughes AL, 2001, J VIROL, V75, P7966, DOI 10.1128/JVI.75.17.7966-7972.2001; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Incarbone M, 2013, TRENDS PLANT SCI, V18, P382, DOI 10.1016/j.tplants.2013.04.001; Izaguirre JA, 2001, J CHEM PHYS, V114, P2090, DOI 10.1063/1.1332996; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KEESE P, 1993, CURR OPIN GENET DEV, V3, P873, DOI 10.1016/0959-437X(93)90007-C; KEESE PK, 1992, P NATL ACAD SCI USA, V89, P9489, DOI 10.1073/pnas.89.20.9489; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Klauda JB, 2005, J PHYS CHEM B, V109, P5300, DOI 10.1021/jp0468096; Li F, 2006, ANNU REV MICROBIOL, V60, P503, DOI 10.1146/annurev.micro.60.080805.142205; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; Merai Z, 2005, J VIROL, V79, P7217, DOI 10.1128/JVI.79.11.7217-7226.2005; Nozawa M, 2009, P NATL ACAD SCI USA, V106, P6700, DOI 10.1073/pnas.0901855106; Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pond SK, 2005, MOL BIOL EVOL, V22, P2375, DOI 10.1093/molbev/msi232; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rubinstein ND, 2011, MOL BIOL EVOL, V28, P3297, DOI 10.1093/molbev/msr162; Ruiz-Ferrer V, 2007, BIOESSAYS, V29, P319, DOI 10.1002/bies.20556; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sabath N, 2012, MOL BIOL EVOL, V29, P3767, DOI 10.1093/molbev/mss179; Scholthof HB, 2006, NAT REV MICROBIOL, V4, P405, DOI 10.1038/nrmicro1395; Schott G, 2012, EMBO J, V31, P2553, DOI 10.1038/emboj.2012.92; Shabalina SA, 2008, TRENDS ECOL EVOL, V23, P578, DOI 10.1016/j.tree.2008.06.005; Suzuki Y, 2004, MOL BIOL EVOL, V21, P914, DOI 10.1093/molbev/msh098; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vargason JM, 2003, CELL, V115, P799, DOI 10.1016/S0092-8674(03)00984-X; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Ye KQ, 2003, NATURE, V426, P874, DOI 10.1038/nature02213; Zambon RA, 2006, CELL MICROBIOL, V8, P880, DOI 10.1111/j.1462-5822.2006.00688.x	45	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0147619	10.1371/journal.pone.0147619	http://dx.doi.org/10.1371/journal.pone.0147619			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871901	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100009
J	Dahine, J; Mardini, L; Jayaraman, D				Dahine, Joseph; Mardini, Louay; Jayaraman, Dev			The Perceived Likelihood of Outcome of Critical Care Patients and Its Impact on Triage Decisions: A Case-Based Survey of Intensivists and Internists in a Canadian, Quaternary Care Hospital Network	PLOS ONE			English	Article							UNIT; DISAGREEMENT; RESIDENTS; FUTILITY	Introduction There is high variability amongst physicians' assessments of appropriate ICU admissions, which may be based on potential assessments of benefit. We aimed to examine whether opinions over benefit of ICU admissions of critically ill medical inpatients differed based on physician specialty, namely intensivists and internists. Materials and Methods We carried out an anonymous, web-based questionnaire survey containing 5 typical ICU cases to all ICU physicians regardless of their base specialty as well as to all internists in 3 large teaching hospitals. For each case, we asked the participants to determine if the patient was an appropriate ICU admission and to assess different parameters (e.g. baseline function, likelihood of survival to ICU discharge, etc.). Agreement was measured using kappa values. Results 21 intensivists and 22 internists filled out the survey (response rate = 87.5% and 35% respectively). Predictions of likelihood of survival to ICU admission, hospital discharge and return to baseline were not significantly different between the two groups. However, agreement between individuals within each group was only slight to fair (kappa range = 0.09-0.22). There was no statistically significant difference in predicting ICU survival and prediction of survival to hospital discharge between both groups. The accuracy with which physicians predicted actual outcomes ranged between 35% and 100% and did not significantly differ between the two groups. A greater proportion of internists favoured non resuscitative measures (24.6% of intensivists and 46.9% internists [p = 0.002]). Conclusion In a case-based survey, physician specialty base did not affect assessments of ICU admission benefit or accuracy in outcome prediction, but resulted in a statistically significant difference in level of care assignments. Of note, significant disagreement amongst individuals in each group was found.	[Dahine, Joseph; Mardini, Louay] McGill Univ, Royal Victoria Hosp, Ctr Hlth, Dept Crit Care, Montreal, PQ H3A 1A1, Canada; [Jayaraman, Dev] McGill Univ, Montreal Gen Hosp, Ctr Hlth, Dept Crit Care, Montreal, PQ H3G 1A4, Canada; [Jayaraman, Dev] McGill Univ, Montreal Gen Hosp, Ctr Hlth, Dept Gen Internal Med, Montreal, PQ H3G 1A4, Canada; [Jayaraman, Dev] McGill Univ, Jewish Gen Hosp, Dept Crit Care, Montreal, PQ H3T 1E2, Canada	McGill University; Royal Victoria Hospital; McGill University; McGill University; McGill University	Jayaraman, D (corresponding author), McGill Univ, Montreal Gen Hosp, Ctr Hlth, Dept Crit Care, Montreal, PQ H3G 1A4, Canada.; Jayaraman, D (corresponding author), McGill Univ, Montreal Gen Hosp, Ctr Hlth, Dept Gen Internal Med, Montreal, PQ H3G 1A4, Canada.; Jayaraman, D (corresponding author), McGill Univ, Jewish Gen Hosp, Dept Crit Care, Montreal, PQ H3T 1E2, Canada.	dev.jayaraman@mcgill.ca						[Anonymous], 2007, ETH LEG CONS MIT PAN; Azoulay E, 2009, INTENS CARE MED, V35, P623, DOI 10.1007/s00134-008-1310-6; Boumendil A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034387; BRANNEN AL, 1989, ARCH INTERN MED, V149, P1083, DOI 10.1001/archinte.149.5.1083; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Cohen J, 1960, EDUC PSYCHOL MEAS; Cook D, 2006, AM J CRIT CARE, V15, P269; COOK DJ, 1995, JAMA-J AM MED ASSOC, V273, P703, DOI 10.1001/jama.273.9.703; Frick S, 2003, CRIT CARE MED, V31, P456, DOI 10.1097/01.CCM.0000049945.69373.7C; Frost DW, 2011, CRIT CARE MED, V39, P1174, DOI 10.1097/CCM.0b013e31820eacf2; Joynt GM, 2001, INTENS CARE MED, V27, P1459, DOI 10.1007/s001340101041; Lanken PN, 1997, AM J RESP CRIT CARE, V156, P1282; Lorin S, 2005, CHEST, V127, P630, DOI 10.1378/chest.127.2.630; Meadow W, 2011, CRIT CARE MED, V39, P474, DOI 10.1097/CCM.0b013e318205df9b; POSES RM, 1989, CRIT CARE MED, V17, P827, DOI 10.1097/00003246-198908000-00021; POSES RM, 1991, CRIT CARE MED, V19, P1533, DOI 10.1097/00003246-199112000-00016; Public Health Agency of Canada Health Canada, LESS LEARN REV PUBL; Sinuff T, 2004, CRIT CARE MED, V32, P1588, DOI 10.1097/01.CCM.0000130175.38521.9F; Sprung CL, 2003, JAMA-J AM MED ASSOC, V290, P790, DOI 10.1001/jama.290.6.790; UEBERSAX JS, 1987, PSYCHOL BULL, V101, P140, DOI 10.1037/0033-2909.101.1.140; WEIL PA, 1981, ANN INTERN MED, V94, P691, DOI 10.7326/0003-4819-94-5-691; Wilkinson DJC, 2013, INTENS CARE MED, V39, P1128, DOI 10.1007/s00134-013-2871-6; Nguyen YL, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-29	24	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149196	10.1371/journal.pone.0149196	http://dx.doi.org/10.1371/journal.pone.0149196			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6SI	26871587	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100124
J	Iqbal, MB; Robinson, SD; Ding, LL; Fung, A; Aymong, E; Chan, AW; Hodge, S; Della Siega, A; Nadra, IJ				Iqbal, M. Bilal; Robinson, Simon D.; Ding, Lillian; Fung, Anthony; Aymong, Eve; Chan, Albert W.; Hodge, Steven; Della Siega, Anthony; Nadra, Imad J.		British Columbia Cardiac Registry	Intra-Aortic Balloon Pump Counterpulsation during Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction and Cardiogenic Shock: Insights from the British Columbia Cardiac Registry	PLOS ONE			English	Article							PROPENSITY SCORE; DIABETIC-PATIENTS; PCI REGISTRY; MORTALITY; TRIAL; MANAGEMENT; VARIABLES; SUPPORT; IMPACT; HEART	Background Cardiogenic shock complicating ST-elevation myocardial infarction (STEMI) is associated with significant morbidity and mortality. In the primary percutaneous coronary intervention (PPCI) era, randomized trials have not shown a survival benefit with intra-aortic balloon pump (IABP) therapy. This differs to observational data which show a detrimental effect, potentially reflecting bias and confounding. Without robust and valid risk adjustment, findings from non-randomized studies may remain biased. Methods We compared long-term mortality following IABP therapy in patients with cardiogenic shock undergoing PPCI during 2008-2013 from the British Columbia Cardiac Registry. We addressed measured and unmeasured confounding using propensity score and instrumental variable methods. Results A total of 12,105 patients with STEMI were treated with PPCI during the study period. Of these, 700 patients (5.8%) had cardiogenic shock. Of the patients with cardiogenic shock, 255 patients (36%) received IABP therapy. Multivariable analyses identified IABP therapy to be associated with increased mortality up to 3 years (HR = 1.67, 95% CI: 1.20-2.67, p< 0.001). This association was lost in propensity-matched analyses (HR = 1.23, 95% CI: 0.84-1.80, p = 0.288). When addressing measured and unmeasured confounders, instrumental variable analyses demonstrated that IABP therapy was not associated with mortality at 3 years (Delta = 16.7%, 95% CI: -12.7%, 46.1%, p = 0.281). Subgroup analyses demonstrated IABP was associated with increased mortality in non-diabetics; patients not undergoing multivessel intervention; patients without renal disease and patients not having received prior thrombolysis. Conclusions In this observational analysis of patients with STEMI and cardiogenic shock, when adjusting for confounding, IABP therapy had a neutral effect with no association with long-term mortality. These findings differ to previously reported observational studies, but are in keeping with randomized trial data.	[Iqbal, M. Bilal; Robinson, Simon D.; Della Siega, Anthony; Nadra, Imad J.] Victoria Heart Inst Fdn, Dept Cardiol, Victoria, BC, Canada; [Iqbal, M. Bilal; Robinson, Simon D.; Della Siega, Anthony; Nadra, Imad J.] Royal Jubilee Hosp, Dept Cardiol, Victoria, BC, Canada; [Ding, Lillian] Prov Hlth Serv Author, Cardiac Serv BC, Vancouver, BC, Canada; [Fung, Anthony] Vancouver Gen Hosp, Dept Cardiol, Vancouver, BC, Canada; [Aymong, Eve] St Pauls Hosp, Dept Cardiol, Vancouver, BC V6Z 1Y6, Canada; [Chan, Albert W.] Royal Columbian Hosp, Dept Cardiol, Vancouver, BC, Canada; [Hodge, Steven] Kelowna Gen Hosp, Dept Cardiol, Kelowna, BC, Canada	University of British Columbia; St. Paul's Hospital; University of Saskatchewan	Iqbal, MB (corresponding author), Victoria Heart Inst Fdn, Dept Cardiol, Victoria, BC, Canada.; Iqbal, MB (corresponding author), Royal Jubilee Hosp, Dept Cardiol, Victoria, BC, Canada.	biqbal@excite.com						Abdel-Wahab M, 2010, AM J CARDIOL, V105, P967, DOI 10.1016/j.amjcard.2009.11.021; Anderson ML, 2013, CIRC-CARDIOVASC QUAL, V6, P708, DOI 10.1161/CIRCOUTCOMES.113.000262; Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Barron HV, 2001, AM HEART J, V141, P933, DOI 10.1067/mhj.2001.115295; Brookhart M Alan, 2007, Int J Biostat, V3, P14; Cannon CP, 2001, J AM COLL CARDIOL, V38, P2114, DOI 10.1016/S0735-1097(01)01702-8; Cheng JM, 2013, INT J CARDIOL, V168, P3758, DOI 10.1016/j.ijcard.2013.06.009; DORTIMER AC, 1978, CIRCULATION, V57, P133, DOI 10.1161/01.CIR.57.1.133; Goldberg RJ, 1999, NEW ENGL J MED, V340, P1162, DOI 10.1056/NEJM199904153401504; Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901; KANTROWITZ A, 1968, J AMER MED ASSOC, V203, P113, DOI 10.1001/jama.203.2.113; Kip KE, 1996, CIRCULATION, V94, P1818, DOI 10.1161/01.CIR.94.8.1818; MCCLELLAN M, 1994, JAMA-J AM MED ASSOC, V272, P859, DOI 10.1001/jama.272.11.859; Perera D, 2013, CIRCULATION, V127, P207, DOI 10.1161/CIRCULATIONAHA.112.132209; Rassen JA, 2012, PHARMACOEPIDEM DR S, V21, P697, DOI 10.1002/pds.2256; SCHEIDT S, 1973, NEW ENGL J MED, V288, P979, DOI 10.1056/NEJM197305102881901; Sjauw KD, 2012, NETH HEART J, V20, P402, DOI 10.1007/s12471-012-0312-8; Sjauw KD, 2009, EUR HEART J, V30, P459, DOI 10.1093/eurheartj/ehn602; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Thiele H, 2013, LANCET, V382, P1638, DOI 10.1016/S0140-6736(13)61783-3; Thiele H, 2012, NEW ENGL J MED, V367, P1287, DOI 10.1056/NEJMoa1208410; Valgimigli M, 2012, JACC-CARDIOVASC INTE, V5, P23, DOI 10.1016/j.jcin.2011.08.018; Venkitachalam L, 2011, CIRC-CARDIOVASC QUAL, V4, P587, DOI 10.1161/CIRCOUTCOMES.111.960971; Vis MM, 2007, AM J CARDIOL, V99, P1201, DOI 10.1016/j.amjcard.2006.12.029; Vis MM, 2007, AM HEART J, V154, P1184, DOI 10.1016/j.ahj.2007.07.028; Zeymer U, 2004, EUR HEART J, V25, P322, DOI 10.1016/j.ehj.2003.12.008; Zeymer U, 2013, CLIN RES CARDIOL, V102, P223, DOI 10.1007/s00392-012-0523-4; Zeymer U, 2011, EUROINTERVENTION, V7, P437, DOI 10.4244/EIJV7I4A72	28	13	17	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148931	10.1371/journal.pone.0148931	http://dx.doi.org/10.1371/journal.pone.0148931			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26870950	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100077
J	Keogh, K; Kenny, DA; Cormican, P; McCabe, MS; Kelly, AK; Waters, SM				Keogh, Kate; Kenny, David A.; Cormican, Paul; McCabe, Matthew S.; Kelly, Alan K.; Waters, Sinead M.			Effect of Dietary Restriction and Subsequent Re-Alimentation on the Transcriptional Profile of Bovine Skeletal Muscle	PLOS ONE			English	Article							RESIDUAL FEED-INTAKE; BELGIAN-BLUE BULLS; ACUTE CALORIC RESTRICTION; GENE-EXPRESSION DATA; COMPENSATORY GROWTH; MITOCHONDRIAL BIOGENESIS; CARNITINE PALMITOYLTRANSFERASE; ENERGY RESTRICTION; PLASMA METABOLITES; DIFFERENT PERIODS	Compensatory growth (CG), an accelerated growth phenomenon which occurs following a period of dietary restriction is exploited worldwide in animal production systems as a method to lower feed costs. However the molecular mechanisms regulated CG expression remain to be elucidated fully. This study aimed to uncover the underlying biology regulating CG in cattle, through an examination of skeletal muscle transcriptional profiles utilising next generation mRNA sequencing technology. Twenty Holstein Friesian bulls were fed either a restricted diet for 125 days, with a target growth rate of 0.6 kg/day (Period 1), following which they were allowed feed ad libitum for a further 55 days (Period 2) or fed ad libitum for the entirety of the trial. M. longissimus dorsi biopsies were harvested from all bulls on days 120 and 15 of periods 1 and 2 respectively and RNAseq analysis was performed. During realimentation in Period 2, previously restricted animals displayed CG, growing at 1.8 times the rate of the ad libitum control animals. Compensating animals were also more feed efficient during re-alimentation and compensated for 48% of their previous dietary restriction. 1,430 and 940 genes were identified as significantly differentially expressed (Benjamini Hochberg adjusted P < 0.1) in periods 1 and 2 respectively. Additionally, 2,237 genes were differentially expressed in animals undergoing CG relative to dietary restriction. Dietary restriction in Period 1 was associated with altered expression of genes involved in lipid metabolism and energy production. CG expression in Period 2 occurred in association with greater expression of genes involved in cellular function and organisation. This study highlights some of the molecular mechanisms regulating CG in cattle. Differentially expressed genes identified are potential candidate genes for the identification of biomarkers for CG and feed efficiency, which may be incorporated into future breeding programmes.	[Keogh, Kate; Kenny, David A.; Cormican, Paul; McCabe, Matthew S.; Waters, Sinead M.] TEAGASC, Anim & Biosci Res Dept, Anim & Grassland Res & Innovat Ctr, Dunsany, Meath, Ireland; [Keogh, Kate; Kelly, Alan K.] UCD Sch Agr & Food Sci, Dublin 4, Ireland	Teagasc	Waters, SM (corresponding author), TEAGASC, Anim & Biosci Res Dept, Anim & Grassland Res & Innovat Ctr, Dunsany, Meath, Ireland.	sinead.waters@teagasc.ie	Keogh, Kate/AAY-2455-2020; Kenny, David/B-1653-2013	Keogh, Kate/0000-0001-8338-5177; Kenny, David/0000-0001-9204-098X	Science Foundation Ireland [09/RFP/GEN/2447]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	The authors received funding from Science Foundation Ireland, grant number: 09/RFP/GEN/2447	Ashfield A, 2014, J AGR SCI-CAMBRIDGE, V152, P805, DOI 10.1017/S0021859613000531; Barilli A, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-32; Bottje W, 2009, POULTRY SCI, V88, P1683, DOI 10.3382/ps.2009-00100; Bottje WG, 2009, J ANIM SCI, V87, pE48, DOI 10.2527/jas.2008-1379; BRITTON CH, 1995, P NATL ACAD SCI USA, V92, P1984, DOI 10.1073/pnas.92.6.1984; Byrne KA, 2005, J ANIM SCI, V83, P1; Cabaraux JF, 2003, ANIM SCI, V77, P205, DOI 10.1017/S135772980005894X; CARSTENS GE, 1991, J ANIM SCI, V69, P3251; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Chen Y, 2011, ANIM GENET, V42, P475, DOI 10.1111/j.1365-2052.2011.02182.x; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Connor EE, 2010, FUNCT INTEGR GENOMIC, V10, P39, DOI 10.1007/s10142-009-0138-7; Corton JC, 2004, J BIOL CHEM, V279, P46204, DOI 10.1074/jbc.M406739200; Dervishi E, 2011, MEAT SCI, V89, P91, DOI 10.1016/j.meatsci.2011.04.003; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; HAYDEN JM, 1993, J ANIM SCI, V71, P3327, DOI 10.2527/1993.71123327x; HENRIKSSON J, 1990, EUR J CLIN NUTR, V44, P55; Higami Y, 2006, J NUTR, V136, P343, DOI 10.1093/jn/136.2.343; Higami Y, 2003, FASEB J, V17, P415, DOI 10.1096/fj.03-0678fje; Hornick JL, 1998, J ANIM SCI, V76, P249; Hornick JL, 1998, J ANIM SCI, V76, P260; Hornick JL, 2000, DOMEST ANIM ENDOCRIN, V19, P121, DOI 10.1016/S0739-7240(00)00072-2; KEANE MG, 1994, IRISH J AGR FOOD RES, V33, P111; Kelly AK, 2011, PHYSIOL GENOMICS, V43, P12, DOI 10.1152/physiolgenomics.00213.2009; Keogh K, 2015, J ANIM SCI, V93, P3590, DOI 10.2527/jas.2014-8471; Keogh K, 2015, J ANIM SCI, V93, P3578, DOI 10.2527/jas.2014-8470; Keogh K., 2015, THESIS U COLL DUBLIN; Kolath WH, 2006, J ANIM SCI, V84, P861, DOI 10.2527/2006.844861x; Lehnert SA, 2006, J ANIM SCI, V84, P3239, DOI 10.2527/jas.2006-192; Lehninger AL, 1993, PRINCIPLES OF BIOCHE; Liu XJ, 2006, BIOINFORMATICS, V22, P2107, DOI 10.1093/bioinformatics/btl361; Lkhagvadorj S, 2010, AM J PHYSIOL-REG I, V298, pR494, DOI 10.1152/ajpregu.00632.2009; Loor JJ, 2007, PHYSIOL GENOMICS, V32, P105, DOI 10.1152/physiolgenomics.00188.2007; Lopez-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103; Lopez-Lluch G, 2008, EXP GERONTOL, V43, P813, DOI 10.1016/j.exger.2008.06.014; Matsuzaka T, 2002, J LIPID RES, V43, P911; MCGARRY JD, 1989, DIABETES METAB REV, V5, P271, DOI 10.1002/dmr.5610050305; Moibi JA, 2000, CAN J ANIM SCI, V80, P59, DOI 10.4141/A99-049; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; ROMPALA RE, 1985, J ANIM SCI, V61, P637, DOI 10.2527/jas1985.613637x; Ryan W. J., 1990, Nutrition Abstracts and Reviews. Series B, Livestock Feeds and Feeding, V60, P653; RYAN WJ, 1993, AUST J AGR RES, V44, P1623, DOI 10.1071/AR9931623; RYAN WJ, 1993, AUST J AGR RES, V44, P1609, DOI 10.1071/AR9931609; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; SAINZ RD, 1995, J ANIM SCI, V73, P2971; Selman C, 2006, PHYSIOL GENOMICS, V27, P187, DOI 10.1152/physiolgenomics.00084.2006; Selvey S, 2001, MOL CELL PROBE, V15, P307, DOI 10.1006/mcpr.2001.0376; Smith S, 2003, PROG LIPID RES, V42, P289, DOI 10.1016/S0163-7827(02)00067-X; Turyn J, 2010, MOL CELL BIOCHEM, V345, P181, DOI 10.1007/s11010-010-0571-x; van Weeghel M, 2012, FASEB J, V26, P4316, DOI 10.1096/fj.12-206326; Wanders RJA, 2010, J INHERIT METAB DIS, V33, P479, DOI 10.1007/s10545-010-9104-8; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yambayamba ESK, 1996, LIVEST PROD SCI, V46, P19, DOI 10.1016/0301-6226(96)00014-0; Yambayamba ESK, 1996, J ANIM SCI, V74, P57; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang DY, 2002, J BIOL CHEM, V277, P9127, DOI 10.1074/jbc.M112228200	59	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149373	10.1371/journal.pone.0149373	http://dx.doi.org/10.1371/journal.pone.0149373			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871690	Green Submitted, Green Published, gold			2022-12-27	WOS:000370054100152
J	Lopez-Cortes, LF; Castano, MA; Lopez-Ruz, MA; Rios-Villegas, MJ; Hernandez-Quero, J; Merino, D; Jimenez-Aguilar, P; Marquez-Solero, M; Terron-Pernia, A; Tellez-Perez, F; Viciana, P; Orihuela-Canadas, F; Palacios-Baena, Z; Vinuesa-Garcia, D; Fajardo-Pico, JM; Romero-Palacios, A; Ojeda-Burgos, G; Pasquau-Liano, J				Lopez-Cortes, Luis F.; Castano, Manuel A.; Lopez-Ruz, Miguel A.; Rios-Villegas, Maria J.; Hernandez-Quero, Jose; Merino, Dolores; Jimenez-Aguilar, Patricia; Marquez-Solero, Manuel; Terron-Pernia, Alberto; Tellez-Perez, Francisco; Viciana, Pompeyo; Orihuela-Canadas, Francisco; Palacios-Baena, Zaira; Vinuesa-Garcia, David; Fajardo-Pico, Jose M.; Romero-Palacios, Alberto; Ojeda-Burgos, Guillermo; Pasquau-Liano, Juan			Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens	PLOS ONE			English	Article							LOPINAVIR/RITONAVIR MONOTHERAPY; MAINTENANCE THERAPY; DARUNAVIR/RITONAVIR MONOTHERAPY; VIRAL SUPPRESSION; INDUCTION THERAPY; HIV-1 INFECTION; EFFICACY; TRIAL; RNA	Background and Objective Significant controversy still exists about ritonavir-boosted protease inhibitor monotherapy (mtPI/rtv) as a simplification strategy that is used up to now to treat patients that have not experienced previous virological failure (VF) while on protease inhibitor (PI) -based regimens. We have evaluated the effectiveness of two mtPI/rtv regimens in an actual clinical practice setting, including patients that had experienced previous VF with PI-based regimens. Methods This retrospective study analyzed 1060 HIV-infected patients with undetectable viremia that were switched to lopinavir/ritonavir or darunavir/ritonavir monotherapy. In cases in which the patient had previously experienced VF while on a PI-based regimen, the lack of major HIV protease resistance mutations to lopinavir or darunavir, respectively, was mandatory. The primary endpoint of this study was the percentage of participants with virological suppression after 96 weeks according to intention-to-treat analysis (non-complete/missing = failure). Results A total of 1060 patients were analyzed, including 205 with previous VF while on PI-based regimens, 90 of whom were on complex therapies due to extensive resistance. The rates of treatment effectiveness (intention-to-treat analysis) and virological efficacy (on-treatment analysis) at week 96 were 79.3% (CI95, 76.8-81.8) and 91.5% (CI95, 89.6-93.4), respectively. No relationships were found between VF and earlier VF while on PI-based regimens, the presence of major or minor protease resistance mutations, the previous time on viral suppression, CD4(+) T-cell nadir, and HCV-coinfection. Genotypic resistance tests were available in 49 out of the 74 patients with VFs and only four patients presented new major protease resistance mutations. Conclusion Switching to mtPI/rtv achieves sustained virological control in most patients, even in those with previous VF on PI-based regimens as long as no major resistance mutations are present for the administered drug.	[Lopez-Cortes, Luis F.; Viciana, Pompeyo] Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla, Seville, Spain; [Castano, Manuel A.; Orihuela-Canadas, Francisco] Hosp Univ Carlos Haya, Malaga, Spain; [Lopez-Ruz, Miguel A.; Pasquau-Liano, Juan] Hosp Univ Virgen de las Nieves, Granada, Spain; [Rios-Villegas, Maria J.; Palacios-Baena, Zaira] Hosp Univ Virgen Macarena, Seville, Spain; [Hernandez-Quero, Jose] Hosp Univ San Cecilio, Granada, Spain; [Merino, Dolores; Fajardo-Pico, Jose M.] Complejo Hosp Juan Ramon Jimenez, Huelva, Spain; [Jimenez-Aguilar, Patricia; Romero-Palacios, Alberto] Hosp Univ Puerto Real, Cadiz, Spain; [Marquez-Solero, Manuel; Ojeda-Burgos, Guillermo] Hosp Univ Virgen de la Victoria, Malaga, Spain; [Terron-Pernia, Alberto] Hosp Jerez de la Frontera, Cadiz, Spain; [Tellez-Perez, Francisco] Hosp La Linea, Cadiz, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Hospital Carlos Haya; Hospital Universitario Virgen de las Nieves; Hospital Universitario Virgen Macarena; Hospital Universitario San Cecilio; Universidad de Cadiz; Hospital Universitario Puerto Real; Hospital Virgen de la Victoria; Universidad de Malaga; Hospital de Jerez	Lopez-Cortes, LF (corresponding author), Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla, Seville, Spain.	lflopez@us.es	Lopez.Cortes, Luis Fernando/W-8323-2019; IBIS, VIH/O-8856-2015	Lopez.Cortes, Luis Fernando/0000-0002-3804-3458; Romero Palacios, Alberto/0000-0003-1345-4901; Tellez, Francisco/0000-0002-9997-6761; Ojeda Burgos, Guillermo/0000-0003-0544-4690; Palacios-Baena, Zaira R./0000-0002-1713-6807	Abbvie laboratories (Spain); Bristol-Myers Squibb; Glaxo Smithkline; Gilead Sciences; Janssen Espana; Merck Sharp Dohme Espana; Roche Pharma SA; ViiV Healthcare; Abbott laboratories (Spain); Janssen; Abbvie laboratories; Merck Sharp Dohme; Roche Pharma	Abbvie laboratories (Spain)(AbbVie); Bristol-Myers Squibb(Bristol-Myers Squibb); Glaxo Smithkline(GlaxoSmithKline); Gilead Sciences(Gilead Sciences); Janssen Espana; Merck Sharp Dohme Espana(Merck & Company); Roche Pharma SA; ViiV Healthcare; Abbott laboratories (Spain); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Abbvie laboratories(AbbVie); Merck Sharp Dohme(Merck & Company); Roche Pharma	FL and PV have received unrestricted grants for research and personal fees for speaking at symposia on behalf of Abbvie laboratories (Spain), Bristol-Myers Squibb, Glaxo Smithkline, Gilead Sciences, Janssen Espana, Merck Sharp & Dohme Espana, Roche Pharma SA, and ViiV Healthcare. MAL and MM have received unrestricted research grants and personal fees for speaking at symposia on behalf of Abbott laboratories (Spain), Janssen Espana, Merck Sharp & Dohme Espana, and ViiV Healthcare. JP has received unrestricted grants for research and speaker honoraria from Bristol-Myers Squibb, Janssen, Abbvie laboratories, Merck Sharp & Dohme, ViiV Healthcare, Gilead Sciences and Roche Pharma. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. All other authors have no competing interests to declare.	*AIDS CLIN TRIALS, 1996, TABL GRAD SEV AD ADV; Arribas JR, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-3; Arribas JR, 2009, JAIDS-J ACQ IMM DEF, V51, P147, DOI 10.1097/QAI.0b013e3181a56de5; Arribas JR, 2005, JAIDS-J ACQ IMM DEF, V40, P280, DOI 10.1097/01.qai.0000180077.59159.f4; BenMarzouk-Hidalgo OJ, 2014, CLIN MICROBIOL INFEC, V20, P1297, DOI 10.1111/1469-0691.12521; Brogan AJ, 2010, HIV CLIN TRIALS, V11, P133, DOI 10.1310/hct1103-133; Clumeck N, 2011, J ANTIMICROB CHEMOTH, V66, P1878, DOI 10.1093/jac/dkr199; Department for Health and Human Services, 2015, GUID US ANT AG HIV 1; Estebanez M, 2014, JAIDS-J ACQ IMM DEF, V67, P419, DOI 10.1097/QAI.0000000000000337; European AIDS Clinical Society, 2015, EUR GUID TREATM HIV; European AIDS Clinical Society (EACS), 2009, EUROPEAN AIDS CLIN S; Gunthard HF, 2014, JAMA-J AM MED ASSOC, V312, P410, DOI 10.1001/jama.2014.8722; Havlir DV, 1998, NEW ENGL J MED, V339, P1261, DOI 10.1056/NEJM199810293391801; Hoen B, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19034; Johnson Victoria A, 2010, Top HIV Med, V18, P156; Lambert-Niclot S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041390; Lambert-Niclot S, 2011, J INFECT DIS, V204, P1211, DOI 10.1093/infdis/jir518; Lambert-Niclot S, 2010, ANTIMICROB AGENTS CH, V54, P4910, DOI 10.1128/AAC.00725-10; Mathis S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022003; Meynard JL, 2010, J ANTIMICROB CHEMOTH, V65, P2436, DOI 10.1093/jac/dkq327; Panel de expertos de GeSIDA y Plan Nacional sobre el Sida, 2015, DOC CONS GES PLAN NA; Panel Expertos Gesida & Plan Nacl, 2009, ENFERM INFEC MICR CL, V27, P222, DOI 10.1016/j.eimc.2008.11.002; Pasquau J, 2012, APPL HEALTH ECON HEA, V10, P139, DOI 10.2165/11598380-000000000-00000; Perez-Valero I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069493; Pialoux G, 1998, NEW ENGL J MED, V339, P1269, DOI 10.1056/NEJM199810293391802; Pulido F, 2008, J ANTIMICROB CHEMOTH, V61, P1359, DOI 10.1093/jac/dkn103; Pulido F, 2009, ANTIVIR THER, V14, P195; Reijers MHE, 1998, LANCET, V352, P185, DOI 10.1016/S0140-6736(98)06193-5; Ruelle J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-100; Torres-Cornejo A, 2014, AIDS, V28, P201, DOI 10.1097/QAD.0000000000000060; Valantin MA, 2012, J ANTIMICROB CHEMOTH, V67, P691, DOI 10.1093/jac/dkr504; Verhofstede C, 2010, J CLIN VIROL, V47, P335, DOI 10.1016/j.jcv.2010.01.008; Vinuesa D, 2014, AIDS, V28, P1835, DOI 10.1097/QAD.0000000000000312; Williams I, 2014, HIV MED, V15, P1, DOI 10.1111/hiv.12119; Yeh RF, 2007, 11 EUR AIDS CLIN SOC	35	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148924	10.1371/journal.pone.0148924	http://dx.doi.org/10.1371/journal.pone.0148924			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872331	gold, Green Published			2022-12-27	WOS:000370054100075
J	Ruiz-Castellano, C; Tomas, G; Ruiz-Rodriguez, M; Martin-Galvez, D; Soler, JJ				Ruiz-Castellano, Cristina; Tomas, Gustavo; Ruiz-Rodriguez, Magdalena; Martin-Galvez, David; Jose Soler, Juan			Nest Material Shapes Eggs Bacterial Environment	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITY; AROMATIC PLANTS; INCUBATION BEHAVIOR; COLOR COMPOSITION; BLUE TITS; FEATHERS; STARLINGS; EVOLUTION; EGGSHELLS; SIZE	Selective pressures imposed by pathogenic microorganisms to embryos have selected in hosts for a battery of antimicrobial lines of defenses that includes physical and chemical barriers. Due to the antimicrobial properties of volatile compounds of green plants and of chemicals of feather degrading bacteria, the use of aromatic plants and feathers for nest building has been suggested as one of these barriers. However, experimental evidence suggesting such effects is scarce in the literature. During two consecutive years, we explored experimentally the effects of these nest materials on loads of different groups of bacteria (mesophilic bacteria, Enterobacteriaceae, Staphylococcus and Enterococcus) of eggshells in nests of spotless starlings (Sturnus unicolor) at the beginning and at the end of the incubation period. This was also explored in artificial nests without incubation activity. We also experimentally increased bacterial density of eggs in natural and artificial nests and explored the effects of nest lining treatments on eggshell bacterial load. Support for the hypothetical antimicrobial function of nest materials was mainly detected for the year and location with larger average values of eggshell bacterial density. The beneficial effects of feathers and plants were more easily detected in artificial nests with no incubation activity, suggesting an active role of incubation against bacterial colonization of eggshells. Pigmented and unpigmented feathers reduced eggshell bacterial load in starling nests and artificial nest boxes. Results from artificial nests allowed us to discuss and discard alternative scenarios explaining the detected association, particularly those related to the possible sexual role of feathers and aromatic plants in starling nests. All these results considered together confirm the antimicrobial functionality mainly of feathers but also of plants used as nest materials, and highlight the importance of temporally and geographically environmental variation associated with risk of bacterial proliferation determining the strength of such effects. Because of costs associated to nest building, birds should adjust nest building effort to expected bacterial environments during incubation, a prediction that should be further explored.	[Ruiz-Castellano, Cristina; Tomas, Gustavo; Ruiz-Rodriguez, Magdalena; Martin-Galvez, David; Jose Soler, Juan] CSIC, Dept Ecol Func & Evolut, Estn Expt Zonas Aridas, Almeria, Spain; [Tomas, Gustavo] UTPL, Dept Ciencias Nat, Loja, Ecuador; [Martin-Galvez, David] EBI, EMBL, Cambridge, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA); Universidad Tecnica Particular de Loja; European Molecular Biology Laboratory (EMBL)	Ruiz-Castellano, C (corresponding author), CSIC, Dept Ecol Func & Evolut, Estn Expt Zonas Aridas, Almeria, Spain.	cristinarc@eeza.csic.es	Tomas, Gustavo/J-7559-2012; Ruiz-Rodríguez, Magdalena/AAZ-6384-2021; Soler, J. J./H-2363-2011; Ruiz-Rodríguez, Magdalena/D-4226-2014; Martín-Gálvez, David/H-3707-2011	Tomas, Gustavo/0000-0001-6701-2055; Ruiz-Rodríguez, Magdalena/0000-0002-4202-5180; Soler, J. J./0000-0003-2990-1489; Ruiz-Rodríguez, Magdalena/0000-0002-4202-5180; Martín-Gálvez, David/0000-0002-1501-9578	Spanish Ministerio de Ciencia e Innovacion, European funds (FEDER) [CGL2010-19233-C03-01, CGL2010-19233-C03-03, CGL2013-48193-C3-1-P, CGL2013-48193-C3-3-P]; Spanish Government; Juan de la Cierva programme (Spain); Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion del Ecuador (SENESCYT) through a Prometeo research grant	Spanish Ministerio de Ciencia e Innovacion, European funds (FEDER); Spanish Government(Spanish GovernmentEuropean Commission); Juan de la Cierva programme (Spain); Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion del Ecuador (SENESCYT) through a Prometeo research grant	This work was financed by Spanish Ministerio de Ciencia e Innovacion, European funds (FEDER) (CGL2010-19233-C03-01, CGL2010-19233-C03-03, CGL2013-48193-C3-1-P, CGL2013-48193-C3-3-P). MRR and DMG received a postdoc from the programmes "JAE-Doc" and CRC had a predoctoral grant from the Spanish Government. GT was supported by Juan de la Cierva programme (Spain) and by Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion del Ecuador (SENESCYT) through a Prometeo research grant.	Berrang ME, 1999, J APPL POULTRY RES, V8, P499, DOI 10.1093/japr/8.4.499; Board R. G., 1994, P43; Bonisoli-Alquati A, 2010, BEHAV ECOL SOCIOBIOL, V64, P845, DOI 10.1007/s00265-010-0901-8; Bruce J., 1994, P63; Cantarero A, 2013, ACTA ORNITHOL, V48, P39, DOI 10.3161/000164513X669982; Chipeva VA, 2013, AFR J TRADIT COMPLEM, V10, P559, DOI 10.4314/ajtcam.v10i6.30; CLARK L, 1985, OECOLOGIA, V67, P169, DOI 10.1007/BF00384280; CLARK L, 1990, PARASITOL TODAY, V6, P358, DOI 10.1016/0169-4758(90)90415-Z; CLAYTON DH, 1993, TRENDS ECOL EVOL, V8, P60, DOI 10.1016/0169-5347(93)90160-Q; Cook MI, 2005, ECOL LETT, V8, P532, DOI 10.1111/j.1461-0248.2005.00748.x; Cook MI, 2005, BEHAV ECOL, V16, P30, DOI 10.1093/beheco/arh131; D'Alba L, 2015, J ORNITHOL, V156, pS399, DOI 10.1007/s10336-015-1226-1; D'Alba L, 2010, NATURWISSENSCHAFTEN, V97, P1089, DOI 10.1007/s00114-010-0735-2; de Roode JC, 2013, SCIENCE, V340, P150, DOI 10.1126/science.1235824; Dubiec A, 2013, AVIAN BIOL RES, V6, P133, DOI 10.3184/175815513X13615363233558; Fiamegos YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018127; GALVEZ A, 1994, ANTIMICROB AGENTS CH, V38, P1314, DOI 10.1128/AAC.38.6.1314; de Hierro LGL, 2013, ETHOLOGY, V119, P199, DOI 10.1111/eth.12053; Garcia-Navas V, 2015, ANIM BEHAV, V99, P95, DOI 10.1016/j.anbehav.2014.10.024; Godard RD, 2007, J AVIAN BIOL, V38, P709, DOI 10.1111/j.0908-8857.2007.04052.x; Gonzalez-Braojos S, 2012, ACTA ORNITHOL, V47, P119, DOI 10.3161/000164512X662223; Gwinner H, 2005, J ORNITHOL, V146, P365, DOI 10.1007/s10336-005-0012-x; Hilton GM, 2004, AUK, V121, P777, DOI 10.1642/0004-8038(2004)121[0777:UANTTI]2.0.CO;2; Horrocks NPC, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-49; Sanz JJ, 2011, BEHAV ECOL, V22, P240, DOI 10.1093/beheco/arq199; Soler JJ, 2015, OECOLOGIA, V179, P63, DOI 10.1007/s00442-015-3322-6; Soler JJ, 2011, NATURWISSENSCHAFTEN, V98, P807, DOI 10.1007/s00114-011-0830-z; Lafuma L, 2001, BEHAV PROCESS, V56, P113, DOI 10.1016/S0376-6357(01)00191-7; Lislevand T, 2004, ETHOLOGY, V110, P177, DOI 10.1111/j.1439-0310.2004.00967.x; Mainwaring MC, 2014, ECOL EVOL, V4, P3909, DOI 10.1002/ece3.1054; Mainwaring MC, 2013, AVIAN BIOL RES, V6, P12, DOI 10.3184/175815512X13528994072997; Peralta-Sanchez JM, 2014, MICROB ECOL, V67, P480, DOI 10.1007/s00248-013-0338-5; Martin-Vivaldi M, 2014, J ANIM ECOL, V83, P1289, DOI 10.1111/1365-2656.12243; Mazgajski TD, 2007, POL J ECOL, V55, P377; Mennerat A, 2009, OECOLOGIA, V161, P849, DOI 10.1007/s00442-009-1418-6; Mennerat A, 2009, ANIM BEHAV, V77, P569, DOI 10.1016/j.anbehav.2008.11.008; Meyre-Silva C, 2010, CURR PHARM DESIGN, V16, P3503, DOI 10.2174/138161210793563392; Moller AP, 2015, ECOL EVOL, V5, P1676, DOI 10.1002/ece3.1473; Moller AP, 2013, OECOLOGIA, V173, P169, DOI 10.1007/s00442-013-2600-4; Moller AP, 2000, BEHAV ECOL, V11, P472, DOI 10.1093/beheco/11.5.472; Moreno J, 2012, AVIAN BIOL RES, V5, P238, DOI 10.3184/175815512X13534385822786; Narushin VG, 1997, J AGR ENG RES, V68, P201, DOI 10.1006/jaer.1997.0188; Pacejka AJ, 1996, J FIELD ORNITHOL, V67, P558; Peralta-Sanchez JM, 2011, BIOL J LINN SOC, V102, P67, DOI 10.1111/j.1095-8312.2010.01557.x; Peralta-Sanchez JM, 2010, FUNCT ECOL, V24, P426, DOI 10.1111/j.1365-2435.2009.01669.x; PINOWSKI J, 1994, J BIOSCIENCES, V19, P441, DOI 10.1007/BF02703180; Playfair J, 2004, INFECT IMMUNITY; Polo V, 2006, J ANIM ECOL, V75, P942, DOI 10.1111/j.1365-2656.2006.01103.x; Quinn G.P., 2002, EXPT DESIGN DATA ANA, P111, DOI DOI 10.1017/CB09780511806384.007; Saino N, 2002, J EVOLUTION BIOL, V15, P735, DOI 10.1046/j.1420-9101.2002.00448.x; Selles C, 2013, NAT PROD RES, V27, P2231, DOI 10.1080/14786419.2013.811409; Shawkey MD, 2008, BEHAV ECOL, V19, P920, DOI 10.1093/beheco/arn019; Shawkey MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004522; Soler JJ, 2008, FUNCT ECOL, V22, P864, DOI 10.1111/j.1365-2435.2008.01448.x; Soler JJ, 2012, J EVOLUTION BIOL, V25, P1779, DOI 10.1111/j.1420-9101.2012.02561.x; Soler JJ, 1998, EVOL ECOL, V12, P427, DOI 10.1023/A:1006520821219; Soler Juan Jose, 2010, Open Ornithology Journal, V3, P93, DOI 10.2174/1874453201003010093; Suarez-Rodriguez M, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0931; Tomas G, 2012, BEHAV PROCESS, V90, P246, DOI 10.1016/j.beproc.2012.02.003; Tomas G, 2007, ANIM BEHAV, V73, P805, DOI 10.1016/j.anbehav.2006.06.016; Tomas G, 2013, BEHAV ECOL, V24, P926, DOI 10.1093/beheco/art015; Veiga JP, 2011, BEHAVIOUR, V148, P1359, DOI 10.1163/000579511X608684; Veiga JP, 2006, ETHOLOGY, V112, P196, DOI 10.1111/j.1439-0310.2006.01148.x; Veiga JP, 2005, BIOL LETT-UK, V1, P334, DOI 10.1098/rsbl.2005.0329; Wellman-Labadie O, 2008, COMP BIOCHEM PHYS B, V149, P640, DOI 10.1016/j.cbpb.2008.01.001; Windsor RL, 2013, J AVIAN BIOL, V44, P305, DOI 10.1111/j.1600-048X.2013.05768.x	66	34	35	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148894	10.1371/journal.pone.0148894	http://dx.doi.org/10.1371/journal.pone.0148894			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871451	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100069
J	Schalk, L; Saalbach, H; Stern, E				Schalk, Lennart; Saalbach, Henrik; Stern, Elsbeth			Approaches to Foster Transfer of Formal Principles: Which Route to Take?	PLOS ONE			English	Article							CONJUNCTION FALLACY; SELF-EXPLANATIONS; KNOWLEDGE; SIMILARITY; FRAMEWORK; EXAMPLES; CONCRETE; MATHEMATICS; ADVANTAGE; STUDENTS	Enabling learners to transfer knowledge about formal principles to new problems is a major aim of science and mathematics education, which, however, is notoriously difficult to reach. Previous research advocates different approaches of how to introduce principles to foster the transfer of knowledge about formal principles. One approach suggests teaching a generic formalism of the principles. Another approach suggests presenting (at least) two concrete cases instantiating the principle. A third approach suggests presenting a generic formalism accompanied by a case. As yet, though, empirical results regarding the transfer potential of these approaches are mixed and difficult to integrate as the three approaches have rarely been tested competitively. Furthermore, the approaches have been evaluated in relation to different control conditions, and they have been assessed using varying transfer measures. In the present experiment, we introduced undergraduates to the formal principles of propositional logic with the aim to systematically compare the transfer potential of the different approaches in relation to each other and to a common control condition by using various learning and transfer tasks. Results indicate that all approaches supported successful learning and transfer of the principles, but also caused systematic differences in the magnitude of transfer. Results indicate that the combination of a generic formalism with a case was surprisingly unsuccessful while learners who compared two cases outperformed the control condition. We discuss how the simultaneous assessment of the different approaches allows to more precisely capture the underlying learning mechanisms and to advance theory on how these mechanisms contribute to transfer performance.	[Schalk, Lennart; Stern, Elsbeth] ETH, Zurich, Switzerland; [Saalbach, Henrik] Univ Leipzig, D-04109 Leipzig, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Leipzig University	Schalk, L (corresponding author), ETH, Zurich, Switzerland.	schalk@ifv.gess.ethz.ch	Schalk, Lennart/AAF-5030-2020	Saalbach, Henrik/0000-0003-4387-9214; Schalk, Lennart/0000-0002-7144-1431				Ainsworth S, 1999, COMPUT EDUC, V33, P131, DOI 10.1016/S0360-1315(99)00029-9; Ainsworth S, 2006, LEARN INSTR, V16, P183, DOI 10.1016/j.learninstruc.2006.03.001; Alfieri L, 2013, EDUC PSYCHOL-US, V48, P87, DOI 10.1080/00461520.2013.775712; Barnett SM, 2002, PSYCHOL BULL, V128, P612, DOI 10.1037//0033-2909.128.4.612; Belenky DM, 2014, EDUC PSYCHOL REV, V26, P27, DOI 10.1007/s10648-014-9251-9; Bond L, 2008, NEW ED, V4, P216, DOI DOI 10.1080/15476880802234482; CATRAMBONE R, 1989, J EXP PSYCHOL LEARN, V15, P1147, DOI 10.1037/0278-7393.15.6.1147; Cepeda NJ, 2006, PSYCHOL BULL, V132, P354, DOI 10.1037/0033-2909.132.3.354; Chi MTH, 2014, EDUC PSYCHOL-US, V49, P219, DOI 10.1080/00461520.2014.965823; Chi MTH, 2012, EDUC PSYCHOL-US, V47, P177, DOI 10.1080/00461520.2012.695709; CHI MTH, 1989, COGNITIVE SCI, V13, P145, DOI 10.1207/s15516709cog1302_1; CHI MTH, 1994, COGNITIVE SCI, V18, P439, DOI 10.1016/0364-0213(94)90016-7; De Bock D, 2011, J RES MATH EDUC, V42, P109; De Corte E, 2003, CURR DIR PSYCHOL SCI, V12, P142, DOI 10.1111/1467-8721.01250; DeLoache JS, 2005, J COGN DEV, V6, P33, DOI 10.1207/s15327647jcd0601_3; FONG GT, 1986, COGNITIVE PSYCHOL, V18, P253, DOI 10.1016/0010-0285(86)90001-0; Gentner D, 1997, AM PSYCHOL, V52, P45, DOI 10.1037/0003-066X.52.1.45; Gentner D, 2003, J EDUC PSYCHOL, V95, P393, DOI 10.1037/0022-0663.95.2.393; Gentner D, 2010, COGNITIVE SCI, V34, P752, DOI 10.1111/j.1551-6709.2010.01114.x; GICK ML, 1983, COGNITIVE PSYCHOL, V15, P1, DOI 10.1016/0010-0285(83)90002-6; Goldstone RL, 2003, COGNITIVE PSYCHOL, V46, P414, DOI 10.1016/S0010-0285(02)00519-4; Goldstone RL, 2005, J LEARN SCI, V14, P69, DOI 10.1207/s15327809jls1401_4; Goldwater MB, PSYCHOL B IN PRESS; Hertwig R, 2008, COGNITION, V108, P740, DOI 10.1016/j.cognition.2008.06.008; Holyoak KJ., 2005, CAMBRIDGE HDB THINKI, P117; Jeffrey RC, 1990, FORMAL LOGIC ITS SCO; Kaminski JA, 2008, SCIENCE, V320, P454, DOI 10.1126/science.1154659; Kaminski JA, 2013, J EXP PSYCHOL-APPL, V19, P14, DOI 10.1037/a0031931; Landy D, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00275; Liepmann D., 2007, INTELLIGENZ STRUKTUR; Loewenstein J, 1999, PSYCHON B REV, V6, P586, DOI 10.3758/BF03212967; Mason L, 2004, INSTR SCI, V32, P293, DOI 10.1023/B:TRUC.0000026512.88700.32; Mason L, 2014, J EXPT ED, p[81, 356]; McNeil NM, 2012, LEARN INSTR, V22, P440, DOI 10.1016/j.learninstruc.2012.05.001; Mevarech ZR, 1997, J EXP CHILD PSYCHOL, V65, P68, DOI 10.1006/jecp.1996.2352; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Moreno R, 2011, J EDUC PSYCHOL, V103, P32, DOI 10.1037/a0021995; Nathan MJ, 2002, DISCOURSE PROCESS, V33, P1, DOI 10.1207/S15326950DP3301_01; Nickerson R.S., 1996, THINK REASONING, V2, P1, DOI DOI 10.1080/135467896394546; Nokes TJ, 2009, THINK REASONING, V15, P1, DOI 10.1080/13546780802490186; Rawson KA, 2011, J EXP PSYCHOL GEN, V140, P283, DOI 10.1037/a0023956; Resnick LB, 2010, EDUC RESEARCHER, V39, P183, DOI 10.3102/0013189X10364671; Rittle-Johnson B, 2007, J EDUC PSYCHOL, V99, P561, DOI 10.1037/0022-0663.99.3.561; Rohrer D, 2014, PSYCHON B REV, V21, P1323, DOI 10.3758/s13423-014-0588-3; Rohrer D, 2012, EDUC PSYCHOL REV, V24, P355, DOI 10.1007/s10648-012-9201-3; Ross BH, 1997, J EXP PSYCHOL LEARN, V23, P427, DOI 10.1037/0278-7393.23.2.427; ROSS BH, 1987, J EXP PSYCHOL LEARN, V13, P629, DOI 10.1037/0278-7393.13.4.629; SCHMIDT RA, 1992, PSYCHOL SCI, V3, P207, DOI 10.1111/j.1467-9280.1992.tb00029.x; Seufert T, 2003, LEARN INSTR, V13, P227, DOI 10.1016/S0959-4752(02)00022-1; Sloutsky VM, 2005, PSYCHON B REV, V12, P508, DOI 10.3758/BF03193796; Tinder R. F., 2000, ENG DIGITAL DESIGN; TVERSKY A, 1983, PSYCHOL REV, V90, P293, DOI 10.1037/0033-295X.90.4.293; WASON PC, 1968, Q J EXP PSYCHOL, V20, P273, DOI 10.1080/14640746808400161	53	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148787	10.1371/journal.pone.0148787	http://dx.doi.org/10.1371/journal.pone.0148787			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6SI	26871902	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100054
J	Zeh, C; Inzaule, SC; Ondoa, P; Nafisa, LG; Kasembeli, A; Otieno, F; Vandenhoudt, H; Amornkul, PN; Mills, LA; Nkengasong, JN				Zeh, Clement; Inzaule, Seth C.; Ondoa, Pascale; Nafisa, Lillian G.; Kasembeli, Alex; Otieno, Fredrick; Vandenhoudt, Hilde; Amornkul, Pauli N.; Mills, Lisa A.; Nkengasong, John N.			Molecular Epidemiology and Transmission Dynamics of Recent and Long-Term HIV-1 Infections in Rural Western Kenya	PLOS ONE			English	Article							DISEASE PROGRESSION; GENETIC DIVERSITY; GENITAL ULCERS; PREGNANT-WOMEN; TYPE-1; SUBTYPE; KISUMU; IDENTIFICATION; INTERVENTIONS; PREVALENCE	Objective To identify unique characteristics of recent versus established HIV infections and describe sexual transmission networks, we characterized circulating HIV-1 strains from two randomly selected populations of ART-naive participants in rural western Kenya. Methods Recent HIV infections were identified by the HIV-1 subtype B, E and D, immunoglobulin G capture immunoassay (IgG BED-CEIA) and BioRad avidity assays. Genotypic and phylogenetic analyses were performed on the pol gene to identify transmitted drug resistance (TDR) mutations, characterize HIV subtypes and potential transmission clusters. Factors associated with recent infection and clustering were assessed by logistic regression. Results Of the 320 specimens, 40 (12.5%) were concordantly identified by the two assays as recent infections. Factors independently associated with being recently infected were age <= 19 years (P = 0.001) and history of sexually transmitted infections (STIs) in the past six months (P = 0.004). HIV subtype distribution differed in recently versus chronically infected participants, with subtype A observed among 53% recent vs. 68% chronic infections (p = 0.04) and subtype D among 26% recent vs. 12% chronic infections (p = 0.012). Overall, the prevalence of primary drug resistance was 1.16%. Of the 258 sequences, 11.2% were in monophyletic clusters of between 2-4 individuals. In multivariate analysis factors associated with clustering included having recent HIV infection P = 0.043 and being from Gem region P = 0.002. Conclusions Recent HIV-1 infection was more frequent among 13-19 year olds compared with older age groups, underscoring the ongoing risk and susceptibility of younger persons for acquiring HIV infection. Our findings also provide evidence of sexual networks. The association of recent infections with clustering suggests that early infections may be contributing significant proportions of onward transmission highlighting the need for early diagnosis and treatment as prevention for ongoing prevention. Larger studies are needed to better understand the structure of these networks and subsequently implement and evaluate targeted interventions.	[Zeh, Clement; Amornkul, Pauli N.; Mills, Lisa A.] US Ctr Dis Control & Prevent, Div HIV AIDS Prevent CDC, Kisumu, Kenya; [Inzaule, Seth C.; Nafisa, Lillian G.; Kasembeli, Alex; Otieno, Fredrick; Mills, Lisa A.] Kenya Med Res Inst KEMRI CDC Res & Publ Hlth Coll, Kisumu Field Res Stn, Kisumu, Kenya; [Inzaule, Seth C.] Univ Amsterdam, Acad Med Ctr, AIGHD, Dept Global Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Vandenhoudt, Hilde] Inst Trop Med, B-2000 Antwerp, Belgium; [Nkengasong, John N.] CDC, Div Global HIV & TB, Ctr Global Hlth, Atlanta, GA 30333 USA	Kenya Medical Research Institute; University of Amsterdam; Academic Medical Center Amsterdam; Institute of Tropical Medicine (ITM); Centers for Disease Control & Prevention - USA	Zeh, C (corresponding author), US Ctr Dis Control & Prevent, Div HIV AIDS Prevent CDC, Kisumu, Kenya.	cbz2@cdc.gov		Otieno, Fredrick Odhiambo/0000-0003-0823-412X	Kenya Medical Research Institute; U.S. Centers for Disease Control and Prevention (CDC), Division of HIV/AIDS Prevention-Surveillance and Epidemiology [5U19C1000323-04]	Kenya Medical Research Institute; U.S. Centers for Disease Control and Prevention (CDC), Division of HIV/AIDS Prevention-Surveillance and Epidemiology(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by the Kenya Medical Research Institute through a cooperative agreement with the U.S. Centers for Disease Control and Prevention (CDC), Division of HIV/AIDS Prevention-Surveillance and Epidemiology, grant award number-5U19C1000323-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adazu K, 2005, AM J TROP MED HYG, V73, P1151, DOI 10.4269/ajtmh.2005.73.1151; Aldous JL, 2012, CLIN INFECT DIS, V55, P1135, DOI 10.1093/cid/cis612; Amornkul PN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006470; Bernasconi D, 2010, J CLIN VIROL, V48, P180, DOI 10.1016/j.jcv.2010.04.010; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Brown AJL, 2011, J INFECT DIS, V204, P1463, DOI 10.1093/infdis/jir550; Buve A, 2001, AIDS, V15, pS127, DOI 10.1097/00002030-200108004-00014; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; DeLong AK, 2012, AIDS RES HUM RETROV, V28, P894, DOI [10.1089/aid.2011.0120, 10.1089/AID.2011.0120]; Dobbs T, 2004, J CLIN MICROBIOL, V42, P2623, DOI 10.1128/JCM.42.6.2623-2628.2004; Easterbrook PJ, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-4; Glynn JR, 2001, AIDS, V15, pS51, DOI 10.1097/00002030-200108004-00006; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gregson S, 2002, LANCET, V359, P1896, DOI 10.1016/S0140-6736(02)08780-9; Hughes GJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000590; Johnson Victoria A, 2009, Top HIV Med, V17, P138; Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455; Kaleebu P, 2002, J INFECT DIS, V185, P1244, DOI 10.1086/340130; Khamadi SA, 2009, AIDS RES HUM RETROV, V25, P919, DOI 10.1089/aid.2009.0005; Khoja S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003191; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Novitsky V, 2008, AIDS CARE, V20, P806, DOI 10.1080/09540120701694055; O'Farrell N, 2002, SEX TRANSM INFECT, V78, P143, DOI 10.1136/sti.78.2.143; O'Farrell N, 2001, B WORLD HEALTH ORGAN, V79, P569; Oluoch Tom, 2011, Open AIDS J, V5, P125, DOI 10.2174/1874613601105010125; Pilcher CD, 2008, PLOS MED, V5, P350, DOI 10.1371/journal.pmed.0050069; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rothenberg R, 2009, CURR OPIN HIV AIDS, V4, P260, DOI 10.1097/COH.0b013e32832c7cfc; Skoura L, 2011, J ANTIMICROB CHEMOTH, V66, P2831, DOI 10.1093/jac/dkr386; Slaymaker E, 2009, SEX TRANSM INFECT, V85, pI12, DOI 10.1136/sti.2008.034009; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Syvertsen JL, 2015, DRUG ALCOHOL DEPEN, V151, P262, DOI 10.1016/j.drugalcdep.2015.02.037; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; White RG, 2008, SEX TRANSM INFECT, V84, pII12, DOI 10.1136/sti.2008.029918; Yang CF, 2004, AIDS RES HUM RETROV, V20, P565, DOI 10.1089/088922204323087822; Yerly S, 2001, AIDS, V15, P2287, DOI 10.1097/00002030-200111230-00010	37	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0147436	10.1371/journal.pone.0147436	http://dx.doi.org/10.1371/journal.pone.0147436			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871567	gold, Green Published, Green Submitted			2022-12-27	WOS:000370054100007
J	Brautaset, R; Birkeldh, U; Alstig, PF; Wiken, P; Nilsson, M				Brautaset, Rune; Birkeldh, Ulrika; Alstig, Petra Frehr; Wiken, Petra; Nilsson, Maria			Repeatability Using Automatic Tracing with Canon OCT-HS100 and Zeiss Cirrus HD-OCT 5000	PLOS ONE			English	Article							NERVE-FIBER LAYER; OPTICAL COHERENCE TOMOGRAPHY; THICKNESS MEASUREMENTS; EPIRETINAL MEMBRANE; RETINAL THICKNESS; PUPIL-DILATION; SD-OCT; DOMAIN; REPRODUCIBILITY; ABILITY	Background Optical coherence tomography (OCT), can be used in clinical practice to provide high resolution cross-sectional images of the retina, optic disc and macula structure. These measurements can be useful for early detection, diagnosis, monitoring and treatment guidance for retinal diseases. Therefore, repeatability of measurements in OCT is of great importance. Methods Macula and optic disc parameters from the right eye of 30 healthy subjects were obtained twice with the Canon OCT-HS100 and Zeiss Cirrus HD-OCT 5000. Repeatability was evaluated by use of the coefficient of repeatability (CR) and the coefficient of repeatability as a percentage of the mean (CR%), and the obtained measurements were compared between the instruments. Results CR% of optic disc parameters ranged between 0.90 and 22.22% and 0.00 and 16.00% with the Canon and Zeiss OCT respectively. For macular parameters CR% ranged between 0.62 and 2.81% and 0.99 and 1.81% with the Canon and Zeiss OCT respectively. No statistical difference could be found when comparing the CR of all macular and disc measurements between the instruments. Compared to our previously published data repeatability has significantly improved with the inclusion of automatic tracking systems with both the Canon and Zeiss OCT. Conclusion Automatic tracking function improves repeatability in both Canon OCT-HS100 and Zeiss Cirrus HD-OCT 5000. However, measurements generated by the two instruments are still not interchangeable.	[Brautaset, Rune; Birkeldh, Ulrika; Alstig, Petra Frehr; Wiken, Petra; Nilsson, Maria] Karolinska Inst, St Erik Eye Hosp, Dept Clin Neurosci, Unit Optometry, Stockholm, Sweden	Karolinska Institutet	Brautaset, R (corresponding author), Karolinska Inst, St Erik Eye Hosp, Dept Clin Neurosci, Unit Optometry, Stockholm, Sweden.	rune.brautaset@ki.se	Brautaset, Rune/GQZ-1681-2022	Nilsson, Maria/0000-0001-8416-4819				Altemir I, 2013, AM J OPHTHALMOL, V155, P171, DOI 10.1016/j.ajo.2012.06.012; Bentaleb-Machkour Z, 2012, SCI WORLD J, DOI 10.1100/2012/842795; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brautaset R, 2014, EUR J OPHTHALMOL, V24, P722, DOI 10.5301/ejo.5000437; Chen YL, 2009, OPT EXPRESS, V17, P4046, DOI 10.1364/OE.17.004046; Cheng CSM, 2011, CLIN EXP OPHTHALMOL, V39, P215, DOI 10.1111/j.1442-9071.2010.02460.x; de Sisternes L, 2015, INVEST OPHTH VIS SCI, V56, P3415, DOI 10.1167/iovs.14-16345; de Sisternes L, 2014, INVEST OPHTH VIS SCI, V55, P7093, DOI 10.1167/iovs.14-14918; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Huang Jianfeng, 2014, Zhonghua Yan Ke Za Zhi, V50, P900; Langenegger SJ, 2011, INVEST OPHTH VIS SCI, V52, P3338, DOI 10.1167/iovs.10-6611; Lee EJ, 2009, INVEST OPHTH VIS SCI, V50, P662, DOI 10.1167/iovs.08-1682; Lee HJ, 2015, INVEST OPHTH VIS SCI, V56, P4554, DOI 10.1167/iovs.15-16949; Liu XT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087996; Massa GC, 2010, EYE, V24, P1498, DOI 10.1038/eye.2010.72; Matlach J, 2014, INVEST OPHTH VIS SCI, V55, P6536, DOI 10.1167/iovs.14-15072; Menke MN, 2008, INVEST OPHTH VIS SCI, V49, P5386, DOI 10.1167/iovs.07-1435; Parravano M, 2010, INVEST OPHTH VIS SCI, V51, P4788, DOI 10.1167/iovs.09-4976; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; Pierro L, 2012, INVEST OPHTH VIS SCI, V53, P5912, DOI 10.1167/iovs.11-8644; Pinilla I, 2013, RETINA-J RET VIT DIS, V33, P1448, DOI 10.1097/IAE.0b013e3182807683; Sato S, 2012, CLIN EXP OPHTHALMOL, V40, P721, DOI 10.1111/j.1442-9071.2012.02782.x; Savini G, 2010, EYE, V24, P1503, DOI 10.1038/eye.2010.66; Schulze A, 2011, GRAEF ARCH CLIN EXP, V249, P1039, DOI 10.1007/s00417-010-1585-5; Serbecic N, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00020; Simavli H, 2015, AM J OPHTHALMOL, V159, P545, DOI 10.1016/j.ajo.2014.12.004; Talman LS, 2010, ANN NEUROL, V67, P749, DOI 10.1002/ana.22005; Wong E, 2015, OPTOMETRY VISION SCI, V92, P83, DOI 10.1097/OPX.0000000000000452	28	6	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149138	10.1371/journal.pone.0149138	http://dx.doi.org/10.1371/journal.pone.0149138			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867021	gold, Green Published, Green Submitted			2022-12-27	WOS:000370050700071
J	Dummer, LA; Araujo, IL; Campos, FS; da Rosa, MC; Finger, PF; de Oliveira, PD; Conceicao, FR; Fischer, G; Roehe, PM; Leite, FPL				Dummer, Luana A.; Araujo, Itaua L.; Campos, Fabricio S.; da Rosa, Matheus C.; Finger, Paula F.; de Oliveira, Patricia D.; Conceicao, Fabricio R.; Fischer, Geferson; Roehe, Paulo M.; Leite, Fabio P. L.			Development of an Indirect ELISA for Serological Diagnosis of Bovine herpesvirus 5	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; BOVINE HERPESVIRUSES TYPE-1; GLYCOPROTEIN-D; RESTRICTION-ENDONUCLEASE; TRUNCATED FORM; ANTIBODIES; EXPRESSION; BHV-1; DISEASE; YEAST	Bovine herpesviruses 1 and 5 (BoHV-1 and BoHV-5) are economically important pathogens, associated with a variety of clinical syndromes, including respiratory and genital disease, reproductive failure and meningoencephalitis. The standard serological assay to diagnose BoHV-1 and BoHV-5 infections is the virus neutralization test (VNT), a time consuming procedure that requires manipulation of infectious virus. In the present study a highly sensitive and specific single dilution indirect ELISA was developed using recombinant glycoprotein D from BoHV-5 as antigen (rgD5ELISA). Bovine serum samples (n = 450) were screened by VNT against BoHV-5a and by rgD5ELISA. Compared with the VNT, the rgD5ELISA demonstrated accuracy of 99.8%, with 100% sensitivity, 96.7% specificity and coefficient of agreement between the tests of 0.954. The rgD5ELISA described here shows excellent agreement with the VNT and is shown to be a simple, convenient, specific and highly sensitive virus-free assay for detection of serum antibodies to BoHV-5.	[Dummer, Luana A.; Araujo, Itaua L.; da Rosa, Matheus C.; de Oliveira, Patricia D.; Leite, Fabio P. L.] Univ Fed Pelotas, Ctr Desenvolvimento Tecnol, Nucleo Biotecnol, Bacteriol Lab, Pelotas, RS, Brazil; [Campos, Fabricio S.; Roehe, Paulo M.] Univ Fed Rio Grande do Sul, Virol Lab, Porto Alegre, RS, Brazil; [Finger, Paula F.; Conceicao, Fabricio R.] Univ Fed Pelotas, Ctr Desenvolvimento Tecnol, Nucleo Biotecnol, Lab Imunol Aplicada, Pelotas, RS, Brazil; [Fischer, Geferson] Univ Fed Pelotas, Fac Vet, Lab Virol & Imunol Anim, Pelotas, RS, Brazil; [Roehe, Paulo M.] Fundacao Estadual Pesquisa Agr, Saude Anim Inst Pesquisas Vet Desiderio Finamor I, Eldorado Do Sul, RS, Brazil	Universidade Federal de Pelotas; Universidade Federal do Rio Grande do Sul; Universidade Federal de Pelotas; Universidade Federal de Pelotas	Leite, FPL (corresponding author), Univ Fed Pelotas, Ctr Desenvolvimento Tecnol, Nucleo Biotecnol, Bacteriol Lab, Pelotas, RS, Brazil.	fabio_leite@ufpel.tche.br	Campos, Fabricio S/D-8819-2014; Diaz, Patrícia Silva/L-9364-2017; ROEHE, PAULO MICHEL/K-1208-2012	Campos, Fabricio S/0000-0002-5948-472X; Diaz, Patrícia Silva/0000-0001-9601-296X; ROEHE, PAULO MICHEL/0000-0002-2370-7661; Leston Araujo, Itaua/0000-0001-7973-512X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [478461/2004-6, 140287/2010-8]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (grants 478461/2004-6 and 140287/2010-8). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELMAGID OY, 1995, VIROLOGY, V206, P242, DOI 10.1016/S0042-6822(95)80039-5; Alvarado JF, 2002, J VET DIAGN INVEST, V14, P240, DOI 10.1177/104063870201400309; Ao JQ, 2003, J VIROL METHODS, V114, P145, DOI 10.1016/j.jviromet.2003.09.012; Babiuk LA, 1996, VET MICROBIOL, V53, P31, DOI 10.1016/S0378-1135(96)01232-1; Balamurugan V, 2010, EXPERT REV MOL DIAGN, V10, P731, DOI 10.1586/ERM.10.61; Bashir S, 2011, ASIAN PAC J TROP MED, V4, P363, DOI 10.1016/S1995-7645(11)60104-1; Campos FS, 2009, VET MICROBIOL, V139, P67, DOI 10.1016/j.vetmic.2009.05.015; Claus MP, 2007, BRAZ J MICROBIOL, V38, P485, DOI 10.1590/S1517-83822007000300019; Claus MP, 2002, HERPESVIRUS BOVINO T, V23, P131; COLLINS JK, 1985, VET MICROBIOL, V10, P133, DOI 10.1016/0378-1135(85)90015-X; D'Arce RCF, 2002, VET MICROBIOL, V88, P315, DOI 10.1016/S0378-1135(02)00126-8; Delhon G, 2003, J VIROL, V77, P10339, DOI 10.1128/JVI.77.19.10339-10347.2003; Dummer LA, 2014, VET RES, V45, DOI 10.1186/s13567-014-0111-x; Dummer LA, 2014, VACCINE, V32, P2413, DOI 10.1016/j.vaccine.2014.03.011; Dummer LA, 2009, J VIROL METHODS, V161, P84, DOI 10.1016/j.jviromet.2009.05.022; Esteves PA, 2008, VIRUS RES, V131, P16, DOI 10.1016/j.virusres.2007.08.004; Fischer G, 2007, VET IMMUNOL IMMUNOP, V116, P79, DOI 10.1016/j.vetimm.2007.01.003; Gabev E, 2010, J VIROL, V84, P5583, DOI 10.1128/JVI.00228-10; HOUSE JA, 1971, CORNELL VET, V61, P320; Huang CJ, 2006, J VIROL METHODS, V132, P40, DOI 10.1016/j.jviromet.2005.08.020; Jones C, 2003, CLIN MICROBIOL REV, V16, P79, DOI 10.1128/CMR.16.1.79-95.2003; Kramps JA, 2004, VET MICROBIOL, V102, P169, DOI 10.1016/j.vetmic.2004.07.003; KRAMPS JA, 1994, J CLIN MICROBIOL, V32, P2175, DOI 10.1128/JCM.32.9.2175-2181.1994; Li K, 2012, J VIROL METHODS, V180, P43, DOI 10.1016/j.jviromet.2011.12.008; Oliveira SAM, 2013, PESQUI VET BRASIL, V33, P41, DOI 10.1590/S0100-736X2013000100008; Pidone CL, 1999, J VET MED B, V46, P453, DOI 10.1046/j.1439-0450.1999.00257.x; Salvador SC, 1998, PESQUI VET BRASIL, V18, P76, DOI 10.1590/S0100-736X1998000200007; Shehata AA, 2012, J VIROL METHODS, V180, P18, DOI 10.1016/j.jviromet.2011.12.004; Souza VF, 2002, PESQUISA VET BRASIL, V22, P13, DOI 10.1590/S0100-736X2002000100004; STUDDERT MJ, 1989, VET REC, V125, P584; Takiuchi E., 2001, Semina: Ciencias Agrarias (Londrina), V22, P203; Traesel CK, 2014, VIRUS GENES, V48, P438, DOI 10.1007/s11262-014-1040-5; Varela APM, 2010, VET MICROBIOL, V142, P254, DOI 10.1016/j.vetmic.2009.10.016; Vogel Fernanda Silveira Flores, 2002, Cienc. Rural, V32, P881, DOI 10.1590/S0103-84782002000500022; Vogel FSF, 2003, J CLIN MICROBIOL, V41, P4512, DOI 10.1128/JCM.41.10.4512-4520.2003; Wang Zhan-yong, 2005, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V19, P159; Zajac MPD, 2006, RES VET SCI, V81, P327, DOI 10.1016/j.rvsc.2006.01.004	37	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149134	10.1371/journal.pone.0149134	http://dx.doi.org/10.1371/journal.pone.0149134			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866923	Green Published, Green Submitted, gold			2022-12-27	WOS:000370050700070
J	Leibler, JH; Jordan, JA; Brownstein, K; Lander, L; Price, LB; Perry, MJ				Leibler, Jessica H.; Jordan, Jeanne A.; Brownstein, Kirsten; Lander, Lina; Price, Lance B.; Perry, Melissa J.			Staphylococcus aureus Nasal Carriage among Beefpacking Workers in a Midwestern United States Slaughterhouse	PLOS ONE			English	Article							LIVESTOCK-ASSOCIATED MRSA; NORTH-CAROLINA; LACERATION INJURIES; MULTIDRUG-RESISTANT; GENETIC DIVERSITY; RISK-FACTORS; PREVALENCE; COLONIZATION; PERSISTENCE; INFECTIONS	Occupational contact with livestock is an established risk factor for exposure to livestock-associated methicillin-resistant Staphylococcus aureus (MRSA), particularly among industrial swine workers. While S. aureus is known to infect cattle, livestock-associated S. aureus carriage among workers in the beef production chain has received limited attention. Beefpacking workers, who slaughter, butcher and process cattle, have intensified exposure to potentially infectious animal materials and may be at risk of livestock-associated S. aureus exposure. We conducted a cross-sectional study of beefpacking workers (n = 137) at an industrial slaughterhouse in the Midwestern United States to evaluate prevalence and characteristics of S. aureus nasal colonization, specifically the absence of the scn gene to identify putative association with livestock, antibiotic susceptibility, presence of Panton-Valentin leukocidin (PVL) genes lukS-PV and lukF-PV, and spa type. Overall prevalence of S. aureus nasal carriage was 27.0%. No workers carried livestock-associated MRSA. Methicillin-sensitive S. aureus isolates (MSSA) recovered from five workers (3.6%) lacked the scn gene and were considered putative livestock-associated S. aureus (pLA-SA). Among pLA-SA isolates, spa types t338, t748, t1476 and t2379 were identified. To our knowledge, these spa types have not previously been identified as associated with livestock. Prevalence of human-adapted MRSA carriage in workers was 3.6%. MRSA isolates were identified as spa types t002, t008 and t024, and four of five MRSA isolates were PVL-positive. To date, this is the first study to indicate that industrial beefpacking workers in the United States may be exposed to livestock-associated S. aureus, notably MSSA, and to spa types not previously identified in livestock and livestock workers. Occupational exposure to livestock-associated S. aureus in the beef production chain requires further epidemiologic investigation.	[Leibler, Jessica H.] Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Jordan, Jeanne A.] George Washington Univ, Dept Epidemiol & Biostat, Milken Inst Sch Publ Hlth, Washington, DC USA; [Brownstein, Kirsten; Price, Lance B.; Perry, Melissa J.] George Washington Univ, Dept Environm & Occupat Hlth, Milken Inst Sch Publ Hlth, Washington, DC USA; [Lander, Lina] Univ Nebraska Med Ctr, Coll Publ Hlth, Dept Epidemiol, Omaha, NE USA; [Price, Lance B.] Translat Genom Res Inst, Div Pathogen Genom, Flagstaff, AZ USA	Boston University; George Washington University; George Washington University; University of Nebraska System; University of Nebraska Medical Center; Translational Genomics Research Institute	Leibler, JH (corresponding author), Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA.	jleibler@bu.edu		Lander, Lina/0000-0002-6180-223X; Leibler, Jessica/0000-0002-0605-0928	George Washington University	George Washington University	This study was funded by a pilot grant from the George Washington University to Dr. Leibler. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesiyun AA, 1998, J FOOD PROTECT, V61, P629, DOI 10.4315/0362-028X-61.5.629; Alba P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137143; Antoci Eugenio, 2013, Infez Med, V21, P125; Boost MV, 2013, FOODBORNE PATHOG DIS, V10, P705, DOI 10.1089/fpd.2012.1415; Bureau of Labor Statistics UD of L, INJ ILLN FAT; Cai CB, 2005, AM J IND MED, V47, P403, DOI 10.1002/ajim.20157; Capurro A, 2010, J DAIRY SCI, V93, P180, DOI 10.3168/jds.2009-2471; Casey JA, 2014, ENVIRON HEALTH PERSP, V122, P464, DOI 10.1289/ehp.1307370; Clinical Laboratory Standards Institute, 2010, 2009 S AUR CLSI BREA; Dorado-Garcia A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003272; Fessler A, 2010, J ANTIMICROB CHEMOTH, V65, P619, DOI 10.1093/jac/dkq021; Fluit AC, 2012, CLIN MICROBIOL INFEC, V18, P735, DOI 10.1111/j.1469-0691.2012.03846.x; Gilbert MJ, 2012, OCCUP ENVIRON MED, V69, P472, DOI 10.1136/oemed-2011-100069; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Graveland H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016830; Gustafson CJ, 2014, INT J DERMATOL, V53, P1091, DOI 10.1111/j.1365-4632.2012.05833.x; Hanson B M, 2011, J Infect Public Health, V4, P169, DOI 10.1016/j.jiph.2011.06.001; Harper AL, 2010, J AGROMEDICINE, V15, P101, DOI 10.1080/10599241003627110; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Knox J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049900; Kyeremateng-Amoah E, 2014, AM J IND MED, V57, P669, DOI 10.1002/ajim.22325; Lim SK, 2013, FOODBORNE PATHOG DIS, V10, P731, DOI 10.1089/fpd.2012.1436; Moodley A, 2008, SCAND J WORK ENV HEA, V34, P151, DOI 10.5271/sjweh.1219; Mulders MN, 2010, EPIDEMIOL INFECT, V138, P743, DOI 10.1017/S0950268810000075; Nadimpalli M, 2015, OCCUP ENVIRON MED, V72, P90, DOI 10.1136/oemed-2014-102095; Nemeghaire S, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-153; Neyra RC, 2014, ENVIRON HEALTH PERSP, V122, P471, DOI 10.1289/ehp.1306741; Normanno G, 2015, FOOD MICROBIOL, V51, P51, DOI 10.1016/j.fm.2015.04.007; Paterson GK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068463; Peton V, 2014, INFECT GENET EVOL, V21, P602, DOI 10.1016/j.meegid.2013.08.011; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Rinsky JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067641; Roberts MC, 2002, MOL BIOTECHNOL, V20, P261, DOI 10.1385/MB:20:3:261; Safdar N, 2008, AM J MED, V121, P310, DOI 10.1016/j.amjmed.2007.07.034; Smith Tara C, 2015, Curr Environ Health Rep, V2, P41, DOI 10.1007/s40572-014-0034-8; Smith TC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004564; Smith TC, 2011, VECTOR-BORNE ZOONOT, V11, P327, DOI 10.1089/vbz.2010.0072; Spoor LE, 2013, MBIO, V4, DOI 10.1128/mBio.00356-13; Stegger M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079645; Tenhagen BA, 2014, J ANIM SCI, V92, P2741, DOI 10.2527/jas.2014-7665; van Cleef BAGL, 2010, EPIDEMIOL INFECT, V138, P756, DOI 10.1017/S0950268810000245; van Cleef BAGL, 2011, J CLIN MICROBIOL, V49, P1030, DOI 10.1128/JCM.00493-10; van Duijkeren E, 2014, VET MICROBIOL, V171, P364, DOI 10.1016/j.vetmic.2013.12.024; Vandendriessche S, 2014, J ANTIMICROB CHEMOTH, V69, P355, DOI 10.1093/jac/dkt366; Vandendriessche S, 2013, J ANTIMICROB CHEMOTH, V68, P1510, DOI 10.1093/jac/dkt047; Vanderhaeghen W, 2013, J ANTIMICROB CHEMOTH, V68, P300, DOI 10.1093/jac/dks403; Vanderhaeghen W, 2010, VET MICROBIOL, V144, P166, DOI 10.1016/j.vetmic.2009.12.044; Waters AE, 2011, CLIN INFECT DIS, V52, P1227, DOI 10.1093/cid/cir181; Weese JS, 2012, ZOONOSES PUBLIC HLTH, V59, P144, DOI 10.1111/j.1863-2378.2011.01428.x; Weese JS, 2010, ILAR J, V51, P233, DOI 10.1093/ilar.51.3.233; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4	51	17	19	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148789	10.1371/journal.pone.0148789	http://dx.doi.org/10.1371/journal.pone.0148789			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866374	Green Published, gold			2022-12-27	WOS:000370050700038
J	Ogasawara, K; Yamada, K; Hatsugai, N; Imada, C; Nishimura, M				Ogasawara, Kimi; Yamada, Kenji; Hatsugai, Noriyuki; Imada, Chiaki; Nishimura, Mikio			Hexose Oxidase-Mediated Hydrogen Peroxide as a Mechanism for the Antibacterial Activity in the Red Seaweed Ptilophora subcostata	PLOS ONE			English	Article							ALGA CHONDRUS-CRISPUS; OXIDATIVE BURST; INNATE IMMUNITY; BACTERIAL FLAGELLIN; MARINE-ALGAE; DEFENSE; SYSTEM; PURIFICATION; MACROALGAE; PERCEPTION	Marine algae have unique defense strategies against microbial infection. However, their mechanisms of immunity remain to be elucidated and little is known about the similarity of the immune systems of marine algae and terrestrial higher plants. Here, we suggest a possible mechanism underlying algal immunity, which involves hexose oxidase (HOX)-dependent production of hydrogen peroxide (H2O2). We examined crude extracts from five different red algal species for their ability to prevent bacterial growth. The extract from one of these algae, Ptilophora subcostata, was particularly active and prevented the growth of gram-positive and -negative bacteria, which was completely inhibited by treatment with catalase. The extract did not affect the growth of either a yeast or a filamentous fungus. We partially purified from P. subcostata an enzyme involved in its antibacterial activity, which shared 50% homology with the HOX of red seaweed Chondrus crispus. In-gel carbohydrate oxidase assays revealed that P. subcostata extract had the ability to produce H2O2 in a hexose-dependent manner and this activity was highest in the presence of galactose. In addition, Bacillus subtilis growth was strongly suppressed near P. subcostata algal fronds on GYP agar plates. These results suggest that HOX plays a role in P. subcostata resistance to bacterial attack by mediating H2O2 production in the marine environment.	[Ogasawara, Kimi; Yamada, Kenji; Nishimura, Mikio] Natl Inst Nat Sci, Natl Inst Basic Biol, Dept Cell Biol, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan; [Ogasawara, Kimi; Imada, Chiaki] Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Minato Ku, 4-5-7 Konan, Tokyo 1088477, Japan; [Hatsugai, Noriyuki] Hokkaido Univ, Res Ctr Cooperat Projects, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Ogasawara, Kimi] Nagoya Univ, JST, ERATO, Higashiyama Live Holon Project,Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan; [Ogasawara, Kimi] Nagoya Univ, Grad Sch Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan; [Yamada, Kenji] Kyoto Univ, Dept Bot, Grad Sch Sci, Kyoto 6068502, Japan; [Hatsugai, Noriyuki] Univ Minnesota, Dept Plant Biol, Microbial & Plant Genom Inst, St Paul, MN 55108 USA	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Tokyo University of Marine Science & Technology; Hokkaido University; Japan Science & Technology Agency (JST); Nagoya University; Nagoya University; Kyoto University; University of Minnesota System; University of Minnesota Twin Cities	Ogasawara, K (corresponding author), Natl Inst Nat Sci, Natl Inst Basic Biol, Dept Cell Biol, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.; Ogasawara, K (corresponding author), Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Minato Ku, 4-5-7 Konan, Tokyo 1088477, Japan.; Ogasawara, K (corresponding author), Nagoya Univ, JST, ERATO, Higashiyama Live Holon Project,Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.; Ogasawara, K (corresponding author), Nagoya Univ, Grad Sch Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.	ogasawara.kimi@g.mbox.nagoya-u.ac.jp	Hatsugai, Noriyuki/O-9156-2015	Hatsugai, Noriyuki/0000-0002-5708-4263; Nishimura, Mikio/0000-0001-7960-9721	JST, ERATO	JST, ERATO(Japan Science & Technology Agency (JST))	This work was partly supported by JST, ERATO.	Bouarab K, 2004, PLANT PHYSIOL, V135, P1838, DOI 10.1104/pp.103.037622; Bouarab K, 1999, PLANT CELL, V11, P1635, DOI 10.1105/tpc.11.9.1635; Cabrita MT, 2010, MAR DRUGS, V8, P2301, DOI 10.3390/md8082301; Carter CJ, 2004, PLANT PHYSIOL, V134, P460, DOI 10.1104/pp.103.027482; Cook DE, 2015, ANNU REV PHYTOPATHOL, V53, P541, DOI 10.1146/annurev-phyto-080614-120114; Cosse A., 2007, ADV BOT RES, V46, P221, DOI DOI 10.1016/S0065-2296(07)46006-2; Egan S, 2014, ENVIRON MICROBIOL, V16, P925, DOI 10.1111/1462-2920.12288; Faulkner DJ, 2001, NAT PROD REP, V18, P1, DOI 10.1039/b006897g; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Gachon CMM, 2010, TRENDS PLANT SCI, V15, P633, DOI 10.1016/j.tplants.2010.08.005; Gomez-Gomez L, 2002, TRENDS PLANT SCI, V7, P251, DOI 10.1016/S1360-1385(02)02261-6; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; Groen BW, 1997, EUR J BIOCHEM, V244, P858, DOI 10.1111/j.1432-1033.1997.00858.x; Hansen OC, 1997, J BIOL CHEM, V272, P11581; Hao ZG, 2003, INSECT BIOCHEM MOLEC, V33, P1155, DOI 10.1016/j.ibmb.2003.07.001; Hara-Nishimura I, 2011, CELL DEATH DIFFER, V18, P1298, DOI 10.1038/cdd.2011.70; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kupper FC, 2001, PLANT PHYSIOL, V125, P278, DOI 10.1104/pp.125.1.278; Kwakman PHS, 2010, FASEB J, V24, P2576, DOI 10.1096/fj.09-150789; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Nicolson Susan W., 2007, P215, DOI 10.1007/978-1-4020-5937-7_5; Nylund GM, 2005, MAR ECOL PROG SER, V302, P27, DOI 10.3354/meps302027; Potin P, 1999, CURR OPIN MICROBIOL, V2, P276, DOI 10.1016/S1369-5274(99)80048-4; Potin P, 2002, CURR OPIN PLANT BIOL, V5, P308, DOI 10.1016/S1369-5266(02)00273-X; Rand T, 2006, FEBS J, V273, P2693, DOI 10.1111/j.1742-4658.2006.05285.x; SULLIVAN JD, 1973, BIOCHIM BIOPHYS ACTA, V309, P11, DOI 10.1016/0005-2744(73)90312-4; TAGG JR, 1971, APPL MICROBIOL, V21, P943, DOI 10.1128/AEM.21.5.943-943.1971; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; Wang SS, 2013, J APPL PHYCOL, V25, P1215, DOI 10.1007/s10811-012-9911-4; Wang XJ, 2013, J APPL PHYCOL, V25, P1895, DOI 10.1007/s10811-013-0009-4; Weinberger F, 1999, J PHYCOL, V35, P747, DOI 10.1046/j.1529-8817.1999.3540747.x; Weinberger F, 2005, J EXP BOT, V56, P1317, DOI 10.1093/jxb/eri132; Weinberger F, 2007, BIOL BULL-US, V213, P290, DOI 10.2307/25066646; Wojtaszek P, 1997, BIOCHEM J, V322, P681, DOI 10.1042/bj3220681; Zambounis A, 2012, MOL BIOL EVOL, V29, P1263, DOI 10.1093/molbev/msr296	35	6	6	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149084	10.1371/journal.pone.0149084	http://dx.doi.org/10.1371/journal.pone.0149084			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867214	gold, Green Submitted, Green Published			2022-12-27	WOS:000370050700064
J	Zhao, M; Finlay, D; Zharkikh, I; Vuori, K				Zhao, Ming; Finlay, Darren; Zharkikh, Irina; Vuori, Kristiina			Novel Role of Src in Priming Pyk2 Phosphorylation	PLOS ONE			English	Article							FOCAL ADHESION KINASE; PROTEIN-TYROSINE KINASE; FERM DOMAIN; SIGNAL-TRANSDUCTION; FAMILY KINASES; SH3 DOMAINS; ACTIVATION; FAK; BINDING; CANCER	Proline-rich tyrosine kinase 2 (Pyk2) is a member of the focal adhesion kinase (FAK) family of non-receptor tyrosine kinases and plays an important role in diverse cellular events downstream of the integrin-family of receptors, including cell migration, proliferation and survival. Here, we have identified a novel role for Src kinase in priming Pyk2 phosphorylation and subsequent activation upon cell attachment on the integrin-ligand fibronectin. By using complementary methods, we show that Src activity is indispensable for the initial Pyk2 phosphorylation on the Y402 site observed in response to cell attachment. In contrast, the initial fibronectin-induced autophosphorylation of FAK in the homologous Y397 site occurs in a Src-independent manner. We demonstrate that the SH2-domain of Src is required for Src binding to Pyk2 and for Pyk2 phosphorylation at sites Y402 and Y579. Moreover, Y402 phosphorylation is a prerequisite for the subsequent Y579 phosphorylation. While this initial phosphorylation of Pyk2 by Src is independent of Pyk2 kinase activity, subsequent autophosphorylation of Pyk2 in trans is required for full Pyk2 phosphorylation and activation. Collectively, our studies reveal a novel function of Src in priming Pyk2 (but not FAK) phosphorylation and subsequent activation downstream of integrins, and shed light on the signaling events that regulate the function of Pyk2.	[Zhao, Ming; Finlay, Darren; Zharkikh, Irina; Vuori, Kristiina] Sanford Burnham Prebys Med Discovery Inst, Ctr Canc, 10901 N Torrey Pines Rd, La Jolla, CA USA	Sanford Burnham Prebys Medical Discovery Institute	Vuori, K (corresponding author), Sanford Burnham Prebys Med Discovery Inst, Ctr Canc, 10901 N Torrey Pines Rd, La Jolla, CA USA.	kvuori@sbpdiscovery.org			NIH	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the NIH to KV. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Ericka Eggleston for technical assistance, and the various colleagues noted in "Materials and Methods" for reagents. This work was supported by grants from the NIH (to KV).	Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; AVRAHAM S, 1995, J BIOL CHEM, V270, P27742, DOI 10.1074/jbc.270.46.27742; BIBBINS KB, 1993, MOL CELL BIOL, V13, P7278, DOI 10.1128/MCB.13.12.7278; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Butler B, 2005, J BIOL CHEM, V280, P14556, DOI 10.1074/jbc.M411765200; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Canobbio I, 2015, BIOCHEM J, V469, P199, DOI 10.1042/BJ20150048; Ceccarelli DFJ, 2006, J BIOL CHEM, V281, P252, DOI 10.1074/jbc.M509188200; Cooper LA, 2003, MOL CELL BIOL, V23, P8030, DOI 10.1128/MCB.23.22.8030-8041.2003; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Dunty JM, 2004, MOL CELL BIOL, V24, P5353, DOI 10.1128/MCB.24.12.5353-5368.2004; Fan HP, 2011, J BIOL CHEM, V286, P18573, DOI 10.1074/jbc.M110.200717; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; HIRAI H, 1990, MOL CELL BIOL, V10, P1307, DOI 10.1128/MCB.10.4.1307; Hoelzinger DB, 2005, NEOPLASIA, V7, P7, DOI 10.1593/neo.04535; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kohno T, 2008, BIOCHEM J, V410, P513, DOI 10.1042/BJ20070665; Laird AD, 2003, MOL CANCER THER, V2, P461; Lechertier T, 2012, J PATHOL, V226, P404, DOI 10.1002/path.3018; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Lipinski CA, 2006, BIOCHEM BIOPH RES CO, V349, P939, DOI 10.1016/j.bbrc.2006.08.134; Mayer Bruce J., 1993, Trends in Cell Biology, V3, P8, DOI 10.1016/0962-8924(93)90194-6; Okigaki M, 2003, P NATL ACAD SCI USA, V100, P10740, DOI 10.1073/pnas.1834348100; Owen JD, 1999, MOL CELL BIOL, V19, P4806; Park SY, 2004, J BIOL CHEM, V279, P33315, DOI 10.1074/jbc.M313527200; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; PAWSON T, 1993, CURR BIOL, V3, P434, DOI 10.1016/0960-9822(93)90350-W; Riggs D, 2011, CELL SIGNAL, V23, P288, DOI 10.1016/j.cellsig.2010.09.015; Ruest PJ, 2001, MOL CELL BIOL, V21, P7641, DOI 10.1128/MCB.21.22.7641-7652.2001; SASAKI H, 1995, J BIOL CHEM, V270, P21206, DOI 10.1074/jbc.270.36.21206; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schlaepfer DD, 1998, TRENDS CELL BIOL, V8, P151, DOI 10.1016/S0962-8924(97)01172-0; Stokes JB, 2011, MOL CANCER THER, V10, P2135, DOI 10.1158/1535-7163.MCT-11-0261; Sulzmaier FJ, 2014, NAT REV CANCER, V14, P598, DOI 10.1038/nrc3792; Weis SM, 2008, J CELL BIOL, V181, P43, DOI 10.1083/jcb.200710038; XING Z, 1994, MOL BIOL CELL, V5, P413, DOI 10.1091/mbc.5.4.413; Yoon H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088587; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	39	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149231	10.1371/journal.pone.0149231	http://dx.doi.org/10.1371/journal.pone.0149231			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866924	Green Published, gold, Green Submitted			2022-12-27	WOS:000370050700079
J	Boundenga, L; Makanga, B; Ollomo, B; Gilabert, A; Rougeron, V; Mve-Ondo, B; Arnathau, C; Durand, P; Moukodoum, ND; Okouga, AP; Delicat-Loembet, L; Yacka-Mouele, L; Rahola, N; Leroy, E; Tidiane, BAC; Renaud, F; Prugnolle, F; Paupy, C				Boundenga, Larson; Makanga, Boris; Ollomo, Benjamin; Gilabert, Aude; Rougeron, Virginie; Mve-Ondo, Bertrand; Arnathau, Celine; Durand, Patrick; Moukodoum, Nancy Diamella; Okouga, Alain-Prince; Delicat-Loembet, Lucresse; Yacka-Mouele, Lauriane; Rahola, Nil; Leroy, Eric; Tidiane, Cheikh B. A.; Renaud, Francois; Prugnolle, Franck; Paupy, Christophe			Haemosporidian Parasites of Antelopes and Other Vertebrates from Gabon, Central Africa	PLOS ONE			English	Article							MALARIA PARASITES; PLASMODIUM-FALCIPARUM; PHYLOGENETIC ANALYSIS; CYTOCHROME-B; GREAT APES; DIVERSITY; EVOLUTION; ORIGIN; POLYCHROMOPHILUS; GAMETOCYTES	Re-examination, using molecular tools, of the diversity of haemosporidian parasites (among which the agents of human malaria are the best known) has generally led to rearrangements of traditional classifications. In this study, we explored the diversity of haemosporidian parasites infecting vertebrate species (particularly mammals, birds and reptiles) living in the forests of Gabon (Central Africa), by analyzing a collection of 492 bushmeat samples. We found that samples from five mammalian species (four duiker and one pangolin species), one bird and one turtle species were infected by haemosporidian parasites. In duikers (from which most of the infected specimens were obtained), we demonstrated the existence of at least two distinct parasite lineages related to Polychromophilus species (i. e., bat haemosporidian parasites) and to sauropsid Plasmodium (from birds and lizards). Molecular screening of sylvatic mosquitoes captured during a longitudinal survey revealed the presence of these haemosporidian parasite lineages also in several Anopheles species, suggesting a potential role in their transmission. Our results show that, differently from what was previously thought, several independent clades of haemosporidian parasites (family Plasmodiidae) infect mammals and are transmitted by anopheline mosquitoes.	[Boundenga, Larson; Makanga, Boris; Ollomo, Benjamin; Rougeron, Virginie; Mve-Ondo, Bertrand; Moukodoum, Nancy Diamella; Okouga, Alain-Prince; Delicat-Loembet, Lucresse; Yacka-Mouele, Lauriane; Rahola, Nil; Leroy, Eric; Prugnolle, Franck] CIRMF, BP 769, Franceville, Gabon; [Boundenga, Larson; Tidiane, Cheikh B. A.] Cheikh Anta Diop Univ Dakar, Fac Sci & Tech, Lab Evolutionary Biol Ecol & Management Ecosyst, Dakar, Senegal; [Makanga, Boris; Gilabert, Aude; Rougeron, Virginie; Arnathau, Celine; Durand, Patrick; Rahola, Nil; Leroy, Eric; Renaud, Francois; Prugnolle, Franck; Paupy, Christophe] Ctr IRD Montpellier, UMR IRD CNRS UM 224 5290, Lab MIVEGEC, F-34295 Montpellier, France; [Makanga, Boris] Inst Rech Ecol Trop, Libreville, Gabon	University Cheikh Anta Diop Dakar; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Boundenga, L (corresponding author), CIRMF, BP 769, Franceville, Gabon.; Boundenga, L (corresponding author), Cheikh Anta Diop Univ Dakar, Fac Sci & Tech, Lab Evolutionary Biol Ecol & Management Ecosyst, Dakar, Senegal.	larsonamedeo@yahoo.fr; franck.prugnolle@ird.fr	Paupy, Christophe/I-4847-2017; Gilabert, Aude/G-5884-2016; larson, Boundenga/AAK-5003-2020; RAHOLA, Nil/G-2397-2019; MAKANGA, Boris Kevin MBK/E-5239-2019; LEROY, Eric M/I-4347-2016; Rougeron, Virginie/AAH-7447-2020	Paupy, Christophe/0000-0002-7122-2079; Gilabert, Aude/0000-0003-0764-9171; larson, Boundenga/0000-0001-9551-3017; RAHOLA, Nil/0000-0003-4067-6438; MAKANGA, Boris Kevin MBK/0000-0003-1172-6109; LEROY, Eric M/0000-0003-0022-0890; Moukodoum, Nancy/0000-0003-0121-6068; Prugnolle, Franck/0000-0001-8519-1253; Rougeron, Virginie/0000-0001-5873-5681	Centre International de Recherches Medicales de Franceville (CIRMF, Gabon); Centre National de la Recherche Scientifique (CNRS, France); Institut de Recherche pour le Developpement (IRD, France); Agence Nationale de la Recherche (ANR, France) [ORIGIN JCJC 012]; ANBG	Centre International de Recherches Medicales de Franceville (CIRMF, Gabon); Centre National de la Recherche Scientifique (CNRS, France)(Centre National de la Recherche Scientifique (CNRS)); Institut de Recherche pour le Developpement (IRD, France); Agence Nationale de la Recherche (ANR, France)(French National Research Agency (ANR)); ANBG	The study was funded by the Centre International de Recherches Medicales de Franceville (CIRMF, Gabon), the Centre National de la Recherche Scientifique (CNRS, France), the Institut de Recherche pour le Developpement (IRD, France) and the Agence Nationale de la Recherche (ANR, France, grant ORIGIN JCJC 012). Larson Boundenga was financed by an ANBG scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, TRACER V1 6; Ayouba A, 2012, INT J PARASITOL, V42, P709, DOI 10.1016/j.ijpara.2012.05.004; Bensch S, 2007, J ANIM ECOL, V76, P112, DOI 10.1111/j.1365-2656.2006.01176.x; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Boundenga L, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0622-6; BRUCECHWATT LJ, 1966, B WORLD HEALTH ORGAN, V35, P405; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Duval L, 2012, INFECT GENET EVOL, V12, P1558, DOI 10.1016/j.meegid.2012.06.006; Escalante AA, 1998, P NATL ACAD SCI USA, V95, P8124, DOI 10.1073/pnas.95.14.8124; Garnham P. C. C., 1969, Bulletin de la Societe de Pathologie Exotique, V62, P325; GARNHAM P C C, 1966, Bulletin de la Societe de Pathologie Exotique, V59, P549; GARNHAM PCC, 1980, PROC R SOC SER B-BIO, V206, P395, DOI 10.1098/rspb.1980.0003; Gilles H. M., 1968, Tropical Diseases Bulletin, V65, P213; Gillies M. T., 1987, A supplement to the Anophelinae of Africa south of the Sahara (Afrotropical Region).; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; JORDAN HB, 1975, J PROTOZOOL, V22, P241, DOI 10.1111/j.1550-7408.1975.tb05859.x; Keeling PJ, 2015, PARASITOLOGY, V142, pS16, DOI 10.1017/S0031182014000766; KEYMER IF, 1966, ANN TROP MED PARASIT, V60, P129, DOI 10.1080/00034983.1966.11686396; KEYMER IF, 1969, PHILOS T R SOC B, V255, P33, DOI 10.1098/rstb.1969.0003; Kingdon J, 2011, KINGDON FIELD GUIDE, V4th; Krief S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000765; LANDAU I, 1979, ANN PARASIT HUM COMP, V54, P145, DOI 10.1051/parasite/1979542145; LANDAU I, 1980, ANN PARASIT HUM COMP, V55, P271, DOI 10.1051/parasite/1980553271; LANDAU I, 1979, CR ACAD SCI D NAT, V288, P521; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; Maganga GD, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-82; Manwell RD, 1943, AM J HYG, V38, P211, DOI 10.1093/oxfordjournals.aje.a118884; Martinsen ES, 2007, PARASITOLOGY, V134, P483, DOI 10.1017/S0031182006001922; Martinsen ES, 2008, MOL PHYLOGENET EVOL, V47, P261, DOI 10.1016/j.ympev.2007.11.012; Pacheco MA, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-299; Paupy C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057294; Pauwels Olivier S. G. VwJP., 2008, REPTILES GABON FRENC; Perkins SL, 2000, P ROY SOC B-BIOL SCI, V267, P2345, DOI 10.1098/rspb.2000.1290; Perkins SL, 2002, J PARASITOL, V88, P972, DOI 10.1645/0022-3395(2002)088[0972:AMPOMP]2.0.CO;2; Perkins SL, 2014, J PARASITOL, V100, P11, DOI 10.1645/13-362.1; Perkins SL, 2008, MITOCHONDR DNA, V19, P471, DOI 10.1080/19401730802570926; Pineda-Catalan O, 2013, J PARASITOL, V99, P1089, DOI 10.1645/13-296.1; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prugnolle F, 2011, P NATL ACAD SCI USA, V108, P11948, DOI 10.1073/pnas.1109368108; Prugnolle F, 2011, VIRULENCE, V2, P71, DOI 10.4161/viru.2.1.14608; Prugnolle F, 2010, P NATL ACAD SCI USA, V107, P1458, DOI 10.1073/pnas.0914440107; Rahola N, 2014, INFECT GENET EVOL, V28, P628, DOI 10.1016/j.meegid.2014.05.012; Ray S, 1999, SIMPLOT WINDOWS 95 9; Rich SM, 2009, P NATL ACAD SCI USA, V106, P14902, DOI 10.1073/pnas.0907740106; Schaer J, 2013, P NATL ACAD SCI USA, V110, P17415, DOI 10.1073/pnas.1311016110; Valkiunas G, 2005, J WILDLIFE DIS, V41, P580, DOI 10.7589/0090-3558-41.3.580; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Witsenburg F, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-53	49	23	23	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148958	10.1371/journal.pone.0148958	http://dx.doi.org/10.1371/journal.pone.0148958			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863304	Green Published, gold			2022-12-27	WOS:000370046600129
J	Izumi, Y; Zorumski, CF				Izumi, Yukitoshi; Zorumski, Charles F.			GABA and Endocannabinoids Mediate Depotentiation of Schaffer Collateral Synapses Induced by Stimulation of Temperoammonic Inputs	PLOS ONE			English	Article							LONG-TERM POTENTIATION; DIRECT CORTICAL INPUT; PERFORANT PATH; AREA CA1; RECEPTOR ACTIVATION; NMDA RECEPTORS; NITRIC-OXIDE; DEPRESSION; AMPA; PLASTICITY	Long-term potentiation (LTP) of Schaffer collateral (SC) synapses in the hippocampus is thought to play a key role in episodic memory formation. Because the hippocampus is a shorter-term, limited capacity storage system, repeated bouts of learning and synaptic plasticity require that SC synapses reset to baseline at some point following LTP. We previously showed that repeated low frequency activation of temperoammonic (TA) inputs to the CA1 region depotentiates SC LTP without persistently altering basal transmission. This heterosynaptic depotentiation involves adenosine A1 receptors but not N-methyl-D-aspartate receptors, metabotropic glutamate receptors or L-type calcium channels. In the present study, we used rat hippocampal slices to explore other messengers contributing to TA-induced SC depotentiation, and provide evidence for the involvement of cannabinoid-1 and gamma-aminobutyric acid (GABA) type-A receptors as more proximal signaling events leading to synaptic resetting, with A1 receptor activation serving as a downstream event. Surprisingly, we found that TA-induced SC depotentiation is independent of alpha-amino-3-hydroxy-5methyl-4-isoxazolepropionic acid (AMPA)/kainate glutamate receptors. We also examined the involvement of mitogen-activated protein kinases (MAPKs), and found a role for extra-cellular-signal related kinase 1/2 and p38 MAPK, but not c-Jun-N-terminal kinase. These results indicate that low frequency stimulation of TA inputs to CA1 activates a complex signaling network that instructs SC synaptic resetting. The involvement of GABA and endocannabinoids suggest mechanisms that could contribute to cognitive dysfunction associated with substance abuse and neuropsychiatric disorders.	[Izumi, Yukitoshi; Zorumski, Charles F.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Izumi, Yukitoshi; Zorumski, Charles F.] Washington Univ, Sch Med, Taylor Family Inst Innovat Psychiat Res, St Louis, MO USA; [Izumi, Yukitoshi; Zorumski, Charles F.] Washington Univ, Sch Med, Ctr Brain Res Mood Disorders, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Zorumski, CF (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.; Zorumski, CF (corresponding author), Washington Univ, Sch Med, Taylor Family Inst Innovat Psychiat Res, St Louis, MO USA.; Zorumski, CF (corresponding author), Washington Univ, Sch Med, Ctr Brain Res Mood Disorders, St Louis, MO USA.	zorumskc@wustl.edu			NIH [MH10184, MH077791, AA017413]; Bantly Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077791, R01MH101874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017413] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bantly Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Funded by NIH grants MH10184, MH077791 and AA017413 and the Bantly Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WC, 2001, P NATL ACAD SCI USA, V98, P10924, DOI 10.1073/pnas.181342098; Aksoy-Aksel Ayla, 2013, Front Synaptic Neurosci, V5, P5, DOI 10.3389/fnsyn.2013.00005; Basu J, 2016, SCIENCE, V351, P138, DOI 10.1126/science.aaa5694; Bushell TJ, 1996, BRIT J PHARMACOL, V117, P1457, DOI 10.1111/j.1476-5381.1996.tb15306.x; BUZSAKI G, 1995, HIPPOCAMPUS, V5, P141, DOI 10.1002/hipo.450050210; Castillo PE, 2012, NEURON, V76, P70, DOI 10.1016/j.neuron.2012.09.020; Chen JD, 2013, GLIA, V61, P178, DOI 10.1002/glia.22425; Chen ZC, 2014, J NEUROSCI, V34, P9621, DOI 10.1523/JNEUROSCI.3991-13.2014; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Chisari M, 2010, TRENDS NEUROSCI, V33, P299, DOI 10.1016/j.tins.2010.03.005; Chung HJ, 2009, P NATL ACAD SCI USA, V106, P635, DOI 10.1073/pnas.0811685106; COLBERT CM, 1993, BRAIN RES, V606, P87, DOI 10.1016/0006-8993(93)91573-B; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUDEK SM, 1993, J NEUROSCI, V13, P2910; EMPSON RM, 1995, HIPPOCAMPUS, V5, P104, DOI 10.1002/hipo.450050203; Heifets BD, 2009, ANNU REV PHYSIOL, V71, P283, DOI 10.1146/annurev.physiol.010908.163149; Huang CC, 1999, J NEUROSCI, V19, P9728; IZUMI Y, 1993, NEUROREPORT, V4, P1131; Izumi Y, 2008, J NEUROSCI, V28, P9557, DOI 10.1523/JNEUROSCI.3346-08.2008; Izumi Y, 2008, HIPPOCAMPUS, V18, P258, DOI 10.1002/hipo.20383; Izumi Y, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.133; Izumi Y, 2012, NEUROPSYCHOPHARMACOL, V37, P609, DOI 10.1038/npp.2011.243; JONES RSG, 1993, TRENDS NEUROSCI, V16, P58, DOI 10.1016/0166-2236(93)90018-H; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kim JI, 2011, NAT NEUROSCI, V14, P1447, DOI 10.1038/nn.2937; Kiss J, 1996, HIPPOCAMPUS, V6, P239, DOI 10.1002/(SICI)1098-1063(1996)6:3<239::AID-HIPO3>3.0.CO;2-I; Levy WB, 1998, LEARN MEMORY, V4, P510, DOI 10.1101/lm.4.6.510; LEVY WB, 1995, HIPPOCAMPUS, V5, P137, DOI 10.1002/hipo.450050209; Liang YC, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-13; Maccaferri G, 2011, J PHYSIOL-LONDON, V589, P1885, DOI 10.1113/jphysiol.2010.201079; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Otmakhova NA, 1999, J NEUROSCI, V19, P1437; Otmakhova NA, 2005, J NEUROPHYSIOL, V94, P1413, DOI 10.1152/jn.00217.2005; Otmakhova NA, 2002, J NEUROSCI, V22, P1199, DOI 10.1523/JNEUROSCI.22-04-01199.2002; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Peineau S, 2008, BRIT J PHARMACOL, V153, pS428, DOI 10.1038/bjp.2008.2; Peterfi Z, 2012, J NEUROSCI, V32, P14448, DOI 10.1523/JNEUROSCI.1676-12.2012; Remondes M, 2004, NATURE, V431, P699, DOI 10.1038/nature02965; Remondes M, 2002, NATURE, V416, P736, DOI 10.1038/416736a; Semyanov A, 2003, NAT NEUROSCI, V6, P484, DOI 10.1038/nn1043; Suh J, 2011, SCIENCE, V334, P1415, DOI 10.1126/science.1210125; Tokuda K, 2011, J NEUROSCI, V31, P9905, DOI 10.1523/JNEUROSCI.1660-11.2011; Tokuda K, 2010, J NEUROSCI, V30, P16788, DOI 10.1523/JNEUROSCI.4101-10.2010; Turrigiano G, 2011, ANNU REV NEUROSCI, V34, P89, DOI 10.1146/annurev-neuro-060909-153238; Wang JQ, 2007, J NEUROCHEM, V100, P1, DOI 10.1111/j.1471-4159.2006.04208.x; Xu JY, 2012, J PHYSIOL-LONDON, V590, P2305, DOI 10.1113/jphysiol.2011.223511; Xu JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010306; Yasuda H, 2008, P NATL ACAD SCI USA, V105, P3106, DOI 10.1073/pnas.0708349105; Zhang Q, 2005, J NEURAL TRANSM, V112, P121, DOI 10.1007/s00702-004-0119-x; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zhu YH, 2005, NEURON, V46, P905, DOI 10.1016/j.neuron.2005.04.037; Zorumski CF, 2012, NEUROSCI BIOBEHAV R, V36, P989, DOI 10.1016/j.neubiorev.2011.12.011	55	12	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149034	10.1371/journal.pone.0149034	http://dx.doi.org/10.1371/journal.pone.0149034			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862899	gold, Green Published, Green Submitted			2022-12-27	WOS:000370046600143
J	Petre, B; Saunders, DGO; Sklenar, J; Lorrain, C; Krasileva, KV; Win, J; Duplessis, S; Kamoun, S				Petre, Benjamin; Saunders, Diane G. O.; Sklenar, Jan; Lorrain, Cecile; Krasileva, Ksenia V.; Win, Joe; Duplessis, Sebastien; Kamoun, Sophien			Heterologous Expression Screens in Nicotiana benthamiana Identify a Candidate Effector of the Wheat Yellow Rust Pathogen that Associates with Processing Bodies	PLOS ONE			English	Article							PLANT IMMUNE-SYSTEM; STRIPE RUST; P-BODY; POSTEMBRYONIC DEVELOPMENT; RNA; PROTEINS; INFECTION; PATHWAY; TARGETS; BIOLOGY	Rust fungal pathogens of wheat (Triticum spp.) affect crop yields worldwide. The molecular mechanisms underlying the virulence of these pathogens remain elusive, due to the limited availability of suitable molecular genetic research tools. Notably, the inability to perform high-throughput analyses of candidate virulence proteins (also known as effectors) impairs progress. We previously established a pipeline for the fast-forward screens of rust fungal candidate effectors in the model plant Nicotiana benthamiana. This pipeline involves selecting candidate effectors in silico and performing cell biology and protein-protein interaction assays in planta to gain insight into the putative functions of candidate effectors. In this study, we used this pipeline to identify and characterize sixteen candidate effectors from the wheat yellow rust fungal pathogen Puccinia striiformis f sp tritici. Nine candidate effectors targeted a specific plant subcellular compartment or protein complex, providing valuable information on their putative functions in plant cells. One candidate effector, PST02549, accumulated in processing bodies (P-bodies), protein complexes involved in mRNA decapping, degradation, and storage. PST02549 also associates with the P-body-resident ENHANCER OF mRNA DECAPPING PROTEIN 4 (EDC4) from N. benthamiana and wheat. We propose that P-bodies are a novel plant cell compartment targeted by pathogen effectors.	[Petre, Benjamin; Saunders, Diane G. O.; Sklenar, Jan; Lorrain, Cecile; Krasileva, Ksenia V.; Win, Joe; Kamoun, Sophien] Sainsbury Lab, Norwich Res Pk, Norwich, Norfolk, England; [Petre, Benjamin; Lorrain, Cecile; Duplessis, Sebastien] INRA, Ctr INRA Nancy Lorraine, UMR Interact Arbres Microorganismes 1136, Champenoux, France; [Petre, Benjamin; Lorrain, Cecile; Duplessis, Sebastien] Univ Lorraine, Fac Sci & Technol, UMR Interact Arbres Microorganismes 1136, Vandoeuvre Les Nancy, France; [Saunders, Diane G. O.; Krasileva, Ksenia V.] Genome Anal Ctr, Norwich Res Pk, Norwich, Norfolk, England; [Saunders, Diane G. O.] John Innes Ctr Plant Sci Res, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; INRAE; Universite de Lorraine; Universite de Lorraine; The Genome Analysis Centre (TGAC); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Kamoun, S (corresponding author), Sainsbury Lab, Norwich Res Pk, Norwich, Norfolk, England.	Sophien.Kamoun@tsl.ac.uk	, DUPLESSIS/G-4150-2011; Win, Joe/H-2557-2014; Petre, Benjamin/AAF-1156-2019; Kamoun, Sophien/B-3529-2009; Lorrain, Cecile/ABB-2483-2021	, DUPLESSIS/0000-0002-2072-2989; Win, Joe/0000-0002-9851-2404; Petre, Benjamin/0000-0002-3204-4249; Kamoun, Sophien/0000-0002-0290-0315; Krasileva, Ksenia/0000-0002-1679-0700	French National Research Agency through the Labex ARBRE [ANR-12-LABXARBRE-01]; French National Research Agency through the Young Scientist Grant POPRUST [ANR-2010-JCJC-1709-01]; INRA Contrat Jeune Scientifique; European Union [267196]; Biotechnology and Biological Sciences Research Council; Gatsby Charitable Foundation; Leverhulme early career fellowship; fellowship in computational biology at TGAC; John Innes Centre; BBSRC [BBS/E/T/000PR6193, BBS/E/T/000PR5885] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR6193, BBS/E/T/000PR5885] Funding Source: researchfish	French National Research Agency through the Labex ARBRE(French National Research Agency (ANR)); French National Research Agency through the Young Scientist Grant POPRUST(French National Research Agency (ANR)); INRA Contrat Jeune Scientifique; European Union(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Gatsby Charitable Foundation; Leverhulme early career fellowship(Leverhulme Trust); fellowship in computational biology at TGAC; John Innes Centre; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	BP, CL, and SD were supported by the French National Research Agency through the Labex ARBRE (ANR-12-LABXARBRE-01) and the Young Scientist Grant POPRUST (ANR-2010-JCJC-1709-01). BP and CL are supported by an INRA Contrat Jeune Scientifique. BP was supported by the European Union, in the framework of the Marie-Curie FP7 COFUND People Programme, through the award of an AgreenSkills' fellowship (under grant agreement no 267196). BP, JS, JW, KVK, DGOS, and SK are supported by the Biotechnology and Biological Sciences Research Council and the Gatsby Charitable Foundation. DGOS is supported by a Leverhulme early career fellowship and a fellowship in computational biology at TGAC, in partnership with the John Innes Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariumi Y, 2011, J VIROL, V85, P6882, DOI 10.1128/JVI.02418-10; Beddow JM, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.132, 10.1038/nplants.2015.132]; Bombarely A, 2012, MOL PLANT MICROBE IN, V25, P1523, DOI 10.1094/MPMI-06-12-0148-TA; Cantu D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-270; Cantu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024230; Cesari S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00606; Chen WQ, 2014, MOL PLANT PATHOL, V15, P433, DOI 10.1111/mpp.12116; Dangl JL, 2013, SCIENCE, V341, P746, DOI 10.1126/science.1236011; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Emanuelle S, 2016, TRENDS PLANT SCI, V21, P341, DOI 10.1016/j.tplants.2015.11.001; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Eulalio A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017296; Fritzler MJ, 2012, ADV EXPT MED BIOL; Garnica DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067150; Goodin MM, 2008, MOL PLANT MICROBE IN, V21, P1015, DOI 10.1094/MPMI-21-8-1015; Hogenhout SA, 2009, MOL PLANT MICROBE IN, V22, P115, DOI 10.1094/MPMI-22-2-0115; Hubbard A, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0590-8; Maldonado-Bonilla LD, 2014, PLANT CELL PHYSIOL, V55, P412, DOI 10.1093/pcp/pct175; Martin F, 2012, EFFECTORS PLANT MICR; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Pais M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-211; Perez-Vilaro G, 2015, J HEPATOL, V62, P785, DOI 10.1016/j.jhep.2014.11.018; Petre B, 2016, CELL MICROBIOL, V18, P453, DOI 10.1111/cmi.12530; Petre B, 2015, MOL PLANT MICROBE IN, V28, P689, DOI 10.1094/MPMI-01-15-0003-R; Petre Benjamin, 2014, Front Plant Sci, V5, P416, DOI 10.3389/fpls.2014.00416; Qiao YL, 2015, P NATL ACAD SCI USA, V112, P5850, DOI 10.1073/pnas.1421475112; Reineke LC, 2013, VIROLOGY, V436, P255, DOI 10.1016/j.virol.2012.11.017; Roux ME, 2015, EMBO J, V34, P593, DOI 10.15252/embj.201488645; Sarris PF, 2015, ONCOTARGET, V6, P16824, DOI 10.18632/oncotarget.4838; Spanu PD, 2015, NEW PHYTOL, V207, P991, DOI 10.1111/nph.13495; Steffens A, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002188; Upadhyaya NM, 2014, MOL PLANT MICROBE IN, V27, P255, DOI 10.1094/MPMI-07-13-0187-FI; Weiberg A, 2014, ANNU REV PHYTOPATHOL, V52, P495, DOI 10.1146/annurev-phyto-102313-045933; Win J., 2012, COLD SPRING HARB SYM, V77, P235, DOI [10.1101/sqb.2012.77.015933, DOI 10.1101/SQB.2012.77.015933]; Wu CH, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00134; Xu J, 2006, PLANT CELL, V18, P3386, DOI 10.1105/tpc.106.047605; Xu J, 2009, PLANT CELL, V21, P3270, DOI 10.1105/tpc.109.070078; Zheng WM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3673	39	51	53	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149035	10.1371/journal.pone.0149035	http://dx.doi.org/10.1371/journal.pone.0149035			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863009	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000370046600144
J	Selingerova, I; Dolezelova, H; Horova, I; Katina, S; Zelinka, J				Selingerova, Iveta; Dolezelova, Hana; Horova, Ivanka; Katina, Stanislav; Zelinka, Jiri			Survival of Patients with Primary Brain Tumors: Comparison of Two Statistical Approaches	PLOS ONE			English	Article							STEREOTACTIC RADIOSURGERY; INTRACRANIAL MENINGIOMAS; RADIOTHERAPY; EFFICACY	Purpose We reviewed the survival time for patients with primary brain tumors undergoing treatment with stereotactic radiation methods at the Masaryk Memorial Cancer Institute Brno. We also identified risk factors and characteristics, and described their influence on survival time. Methods In summarizing survival data, there are two functions of principal interest, namely, the survival function and the hazard function. In practice, both of them can depend on some characteristics. We focused on nonparametric methods, propose a method based on kernel smoothing, and compared our estimates with the results of the Cox regression model. The hazard function is conditional to age and gross tumor volume and visualized as a color-coded surface. A multivariate Cox model was also designed. Results There were 88 patients with primary brain cancer, treated with stereotactic radiation. The median survival of our patient cohort was 47.8 months. The estimate of the hazard function has two peaks (about 10 months and about 40 months). The survival time of patients was significantly different for various diagnoses (p << 0.001), KI (p = 0.047) and stereotactic methods (p = 0.033). Patients with a greater GTV had higher risk of death. The suitable threshold for GTV is 20 cm(3). Younger patients with a survival time of about 50 months had a higher risk of death. In the multivariate Cox regression model, the selected variables were age, GTV, sex, diagnosis, KI, location, and some of their interactions. Conclusion Kernel methods give us the possibility to evaluate continuous risk variables and based on the results offer risk-prone patients a different treatment, and can be useful for verifying assumptions of the Cox model or for finding thresholds of continuous variables.	[Selingerova, Iveta; Horova, Ivanka; Katina, Stanislav; Zelinka, Jiri] Masaryk Univ, Fac Sci, Dept Math & Stat, Kotlarska 2, CS-61137 Brno, Czech Republic; [Selingerova, Iveta; Dolezelova, Hana] Masaryk Mem Canc Inst, Zluty Kopec 7, Brno 65653, Czech Republic	Masaryk University Brno; Masaryk Memorial Cancer Institute	Selingerova, I (corresponding author), Masaryk Univ, Fac Sci, Dept Math & Stat, Kotlarska 2, CS-61137 Brno, Czech Republic.; Selingerova, I (corresponding author), Masaryk Mem Canc Inst, Zluty Kopec 7, Brno 65653, Czech Republic.	xselinge@math.muni.cz	Selingerova, Iveta/AAF-6396-2019; Katina, Stanislav/W-3936-2018; Zelinka, Jiří/G-8014-2014	Selingerova, Iveta/0000-0003-3713-3504; Katina, Stanislav/0000-0002-3256-5482; 	Ministry of Education, Youth and Sports - National Programme for Sustainability I [NPS I - LO1413]; Czech Science Foundation [GA15 - 06991S]; project MEYS-NPS [I-LO1413]; Grant Agency of the Czech Republic (GACR) [GA15-06991S]	Ministry of Education, Youth and Sports - National Programme for Sustainability I; Czech Science Foundation(Grant Agency of the Czech Republic); project MEYS-NPS; Grant Agency of the Czech Republic (GACR)(Grant Agency of the Czech Republic)	This work was supported by Ministry of Education, Youth and Sports - National Programme for Sustainability I: NPS I - LO1413 (http://www.msmt.cz/?lang=2) and Czech Science Foundation: GA15 - 06991S (http://gacr.cz/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the project MEYS-NPS I-LO1413 and by the Grant Agency of the Czech Republic (GACR), GA15-06991S.	Attia A, 2012, J NEURO-ONCOL, V108, P179, DOI 10.1007/s11060-012-0828-1; Biswas T, 2009, RADIAT ONCOL, V4, DOI 10.1186/1748-717X-4-11; COX DR, 1972, J R STAT SOC B, V34, P187; Dolezelova H, 2012, Klin Onkol, V25, P445; Dusek L, 2014, Klin Onkol, V27, P406; El Majdoub F, 2012, ACTA NEUROCHIR, V154, P599, DOI 10.1007/s00701-012-1278-4; Fokas E, 2009, STRAHLENTHER ONKOL, V185, P235, DOI 10.1007/s00066-009-1753-x; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Horova I., 2012, KERNEL SMOOTHING MAT; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kong DS, 2008, CANCER-AM CANCER SOC, V112, P2046, DOI 10.1002/cncr.23402; Lakomy R, 2011, KLIN ONKOL, V24, P112; Liscak R, 2009, GAMMA KNIFE RADIOSUR, P77; Metellus P, 2005, NEUROSURGERY, V57, P873, DOI 10.1227/01.NEU.0000179924.76551.cd; Minniti G, 2009, RADIAT ONCOL, V4, DOI 10.1186/1748-717X-4-42; Novotny J, 2007, RADIAT ONCOL, P413; Pollock BE, 2012, INT J RADIAT ONCOL, V83, P1414, DOI 10.1016/j.ijrobp.2011.10.033; R Core Team, 2021, R LANGUAGE ENV STAT; Rodrigues G, 2013, CLIN ONCOL-UK, V25, P227, DOI 10.1016/j.clon.2012.11.006; Selingerova I, 2014, RECENT ADV ENERGY EN, P33; Slampa P, 2011, RAD ONCOLOGY PRACTIC, P201; Spierdijk L, 2008, COMPUT STAT DATA AN, V52, P2419, DOI 10.1016/j.csda.2007.08.007; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	23	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148733	10.1371/journal.pone.0148733	http://dx.doi.org/10.1371/journal.pone.0148733			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863415	gold, Green Published, Green Submitted			2022-12-27	WOS:000370046600103
J	Silva, G; Ribeiro, MJ; Costa, GN; Violante, I; Ramos, F; Saraiva, J; Castelo-Branco, M				Silva, Gilberto; Ribeiro, Maria J.; Costa, Gabriel N.; Violante, Ines; Ramos, Fabiana; Saraiva, Jorge; Castelo-Branco, Miguel			Peripheral Attentional Targets under Covert Attention Lead to Paradoxically Enhanced Alpha Desynchronization in Neurofibromatosis Type 1	PLOS ONE			English	Article							GAMMA-BAND ACTIVITY; VISUAL-SPATIAL ATTENTION; EEG ALPHA; OSCILLATORY ACTIVITY; NEURONAL DYNAMICS; FREQUENCY; CORTEX; INHIBITION; MECHANISMS; RESPONSES	The limited capacity of the human brain to process the full extent of visual information reaching the visual cortex requires the recruitment of mechanisms of information selection through attention. Neurofibromatosis type-1 (NF1) is a neurodevelopmental disease often exhibiting attentional deficits and learning disabilities, and is considered to model similar impairments common in other neurodevelopmental disorders such as autism. In a previous study, we found that patients with NF1 are more prone to miss targets under overt attention conditions. This finding was interpreted as a result of increased occipito-parietal alpha oscillations. In the present study, we used electroencephalography (EEG) to study alpha power modulations and the performance of patients with NF1 in a covert attention task. Covert attention was required in order to perceive changes (target offset) of a peripherally presented stimulus. Interestingly, alpha oscillations were found to undergo greater desynchronization under this task in the NF1 group compared with control subjects. A similar pattern of desynchronization was found for beta frequencies while no changes in gamma oscillations could be identified. These results are consistent with the notion that different attentional states and task demands generate different patterns of abnormal modulation of alpha oscillatory processes in NF1. Under covert attention conditions and while target offset was reported with relatively high accuracy (over 90% correct responses), excessive desynchronization was found. These findings suggest an abnormal modulation of oscillatory activity and attentional processes in NF1. Given the known role of alpha in modulating attention, we suggest that alpha patterns can show both abnormal increases and decreases that are task and performance dependent, in a way that enhanced alpha desynchronization may reflect a compensatory mechanism to keep performance at normal levels. These results suggest that dysregulation of alpha oscillations may occur in NF1 both in terms of excessive or diminished activation patterns.	[Silva, Gilberto; Costa, Gabriel N.; Castelo-Branco, Miguel] ICNAS Brain Imaging Network Portugal, Coimbra, Portugal; [Ribeiro, Maria J.; Costa, Gabriel N.; Castelo-Branco, Miguel] Univ Coimbra, Fac Med, IBILI Inst Biomed Imaging Life Sci, Coimbra, Portugal; [Ramos, Fabiana; Saraiva, Jorge] Pediat Hosp Coimbra, Dept Med Genet, Coimbra, Portugal; [Violante, Ines] Univ London Imperial Coll Sci Technol & Med, Computat Cognit & Clin Neuroimaging Lab, Div Brain Sci, London, England	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Imperial College London	Castelo-Branco, M (corresponding author), ICNAS Brain Imaging Network Portugal, Coimbra, Portugal.; Castelo-Branco, M (corresponding author), Univ Coimbra, Fac Med, IBILI Inst Biomed Imaging Life Sci, Coimbra, Portugal.	mcbranco@fmed.uc.pt	Castelo-Branco, Miguel/F-3866-2019; Ribeiro, Maria J/J-4618-2013	Castelo-Branco, Miguel/0000-0003-4364-6373; Ribeiro, Maria J/0000-0001-6422-3279; Saraiva, Jorge Manuel/0000-0002-7232-3509; Ribeiro Silva, Gilberto Miguel/0000-0002-2093-288X; Costa, Gabriel/0000-0001-9630-1155; Violante, Ines/0000-0002-4787-2901; Ramos, Fabiana/0000-0001-7780-9762	From molecules to man: novel diagnostic imaging tools in neurological and psychiatric disorders [CENTRO-07-ST24-FEDER-00205]; Taking imaging into the therapeutic domain: Self-regulation of brain systems for mental disorders [FP7-HEALTH-2013-INNOVATION-1 - 602186 - BRAINTRAIN-]; CNC. IBILI, Compete [POCI-01-0145-FEDER-007440, UID/NEU/04539/2013]; A direct test of the binding by synchrony hypothesis in humans: the neural correlates of coherent object perception, Bial Foundation [Bial 133/2012]; Fundacao para a Ciencia e Tecnologia [PTDC/SAU-ORG/118380/201]	From molecules to man: novel diagnostic imaging tools in neurological and psychiatric disorders; Taking imaging into the therapeutic domain: Self-regulation of brain systems for mental disorders; CNC. IBILI, Compete; A direct test of the binding by synchrony hypothesis in humans: the neural correlates of coherent object perception, Bial Foundation(Bial Foundation); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	MCB received funding from the following grants: CENTRO-07-ST24-FEDER-00205 From molecules to man: novel diagnostic imaging tools in neurological and psychiatric disorders 1176470,59 Euros 2013-2015; FP7-HEALTH-2013-INNOVATION-1 - 602186 - BRAINTRAIN- Taking imaging into the therapeutic domain: Self-regulation of brain systems for mental disorders; POCI-01-0145-FEDER-007440, CNC. IBILI, Compete, UID/NEU/04539/2013; Bial 133/2012 A direct test of the binding by synchrony hypothesis in humans: the neural correlates of coherent object perception, Bial Foundation, 2013; Fundacao para a Ciencia e Tecnologia, PTDC/SAU-ORG/118380/201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Capotosto P, 2009, J NEUROSCI, V29, P5863, DOI 10.1523/JNEUROSCI.0539-09.2009; Castelhano J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066363; Cooper NR, 2003, INT J PSYCHOPHYSIOL, V47, P65, DOI 10.1016/S0167-8760(02)00107-1; Dockree PM, 2007, EUR J NEUROSCI, V25, P900, DOI 10.1111/j.1460-9568.2007.05324.x; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Ergenoglu T, 2004, COGNITIVE BRAIN RES, V20, P376, DOI 10.1016/j.cogbrainres.2004.03.009; Foxe JJ, 1998, NEUROREPORT, V9, P3929, DOI 10.1097/00001756-199812010-00030; Foxe JJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00154; Fu KMG, 2001, COGNITIVE BRAIN RES, V12, P145, DOI 10.1016/S0926-6410(01)00034-9; Handel BF, 2011, J COGNITIVE NEUROSCI, V23, P2494, DOI 10.1162/jocn.2010.21557; Hanslmayr S, 2011, BRAIN RES REV, V67, P331, DOI 10.1016/j.brainresrev.2011.04.002; Herrmann CS, 2010, NEUROSCI BIOBEHAV R, V34, P981, DOI 10.1016/j.neubiorev.2009.09.001; Hoogenboom N, 2006, NEUROIMAGE, V29, P764, DOI 10.1016/j.neuroimage.2005.08.043; Hopfinger JB, 2006, NEUROIMAGE, V31, P774, DOI 10.1016/j.neuroimage.2005.12.049; Horschig JM, 2014, BRAIN TOPOGR; Kayl AE, 2000, BEHAV PHENOTYPE NEUR, V124, P117; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Levine Terry M, 2006, Semin Pediatr Neurol, V13, P8, DOI 10.1016/j.spen.2006.01.006; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Mazaheri A, 2009, HUM BRAIN MAPP, V30, P1791, DOI 10.1002/hbm.20763; Medendorp WP, 2007, CEREB CORTEX, V17, P2364, DOI 10.1093/cercor/bhl145; Muthukumaraswamy SD, 2013, NEUROIMAGE, V69, P223, DOI 10.1016/j.neuroimage.2012.12.038; Muthukumaraswamy SD, 2010, NEUROIMAGE, V49, P3349, DOI 10.1016/j.neuroimage.2009.11.045; Muthukumaraswamy SD, 2009, P NATL ACAD SCI USA, V106, P8356, DOI 10.1073/pnas.0900728106; O'Connell RG, 2009, J NEUROSCI, V29, P8604, DOI 10.1523/JNEUROSCI.5967-08.2009; Okazaki YO, 2015, REAL TIME MEG NEUROF; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; Orekhova EV, 2007, BIOL PSYCHIAT, V62, P1022, DOI 10.1016/j.biopsych.2006.12.029; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Ribeiro MJ, 2014, J NEURODEV DISORD, V6, DOI 10.1186/1866-1955-6-4; Rihs TA, 2007, EUR J NEUROSCI, V25, P603, DOI 10.1111/j.1460-9568.2007.05278.x; Sauseng P, 2005, EUR J NEUROSCI, V22, P2917, DOI 10.1111/j.1460-9568.2005.04482.x; Scheeringa R, 2011, NEURON, V69, P572, DOI 10.1016/j.neuron.2010.11.044; Schreckenberger M, 2004, NEUROIMAGE, V22, P637, DOI 10.1016/j.neuroimage.2004.01.047; Stumpf D, 1988, ARCH NEUROL; Sun LM, 2012, J NEUROSCI, V32, P9563, DOI 10.1523/JNEUROSCI.1073-12.2012; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; Toscani M, 2010, EXP BRAIN RES, V207, P213, DOI 10.1007/s00221-010-2444-7; Uhlhaas PJ, 2012, NEURON, V75, P963, DOI 10.1016/j.neuron.2012.09.004; van Driel J, 2012, J NEUROSCI, V32, P16795, DOI 10.1523/JNEUROSCI.0802-12.2012; van Pelt S, 2013, NEUROIMAGE, V78, P439, DOI 10.1016/j.neuroimage.2013.04.040; Vijayan S, 2013, J NEUROSCI, V33, P11070, DOI 10.1523/JNEUROSCI.5670-12.2013; Violante IR, 2013, BRAIN, V136, P918, DOI 10.1093/brain/aws368; Violante IR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038785; Wechsler D., 2003, ESCALA INTELIGENCIA; Williams VC, 2009, PEDIATRICS, V123, P124, DOI 10.1542/peds.2007-3204; Worden MS, 2000, J NEUROSCI, V20; Yamagishi N, 2003, NEUROIMAGE, V20, P98, DOI 10.1016/S1053-8119(03)00341-0	50	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148600	10.1371/journal.pone.0148600	http://dx.doi.org/10.1371/journal.pone.0148600			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881921	Green Published, Green Submitted, gold			2022-12-27	WOS:000371219000019
J	Adibi, M; Yoshida, S; Weijers, D; Fleck, C				Adibi, Milad; Yoshida, Saiko; Weijers, Dolf; Fleck, Christian			Centering the Organizing Center in the Arabidopsis thaliana Shoot Apical Meristem by a Combination of Cytokinin Signaling and Self-Organization	PLOS ONE			English	Article							STEM-CELL HOMEOSTASIS; RESPONSE REGULATORS; VASCULAR DEVELOPMENT; ESCHERICHIA-COLI; DIFFUSION; EXPRESSION; GENES; MODEL; FATE; DIFFERENTIATION	Plants have the ability to continously generate new organs by maintaining populations of stem cells throught their lives. The shoot apical meristem (SAM) provides a stable environment for the maintenance of stem cells. All cells inside the SAM divide, yet boundaries and patterns are maintained. Experimental evidence indicates that patterning is independent of cell lineage, thus a dynamic self-regulatory mechanism is required. A pivotal role in the organization of the SAM is played by the WUSCHEL gene (WUS). An important question in this regard is that how WUS expression is positioned in the SAM via a cell-lineage independent signaling mechanism. In this study we demonstrate via mathematical modeling that a combination of an inhibitor of the Cytokinin (CK) receptor, Arabidopsis histidine kinase 4 (AHK4) and two morphogens originating from the top cell layer, can plausibly account for the cell lineage-independent centering of WUS expression within SAM. Furthermore, our laser ablation and microsurgical experiments support the hypothesis that patterning in SAM occurs at the level of CK reception and signaling. The model suggests that the interplay between CK signaling, WUS/CLV feedback loop and boundary signals can account for positioning of the WUS expression, and provides directions for further experimental investigation.	[Adibi, Milad; Fleck, Christian] Wageningen Univ, Lab Syst & Synthet Biol, NL-6700 AP Wageningen, Netherlands; [Yoshida, Saiko; Weijers, Dolf] Wageningen Univ, Biochem Lab, NL-6700 AP Wageningen, Netherlands; [Adibi, Milad] Max Planck Inst Plant Breeding Res, Cologne, Germany; [Yoshida, Saiko] IST Austria, Campus 1, Klosterneuburg, Austria	Wageningen University & Research; Wageningen University & Research; Max Planck Society; Institute of Science & Technology - Austria	Adibi, M; Fleck, C (corresponding author), Wageningen Univ, Lab Syst & Synthet Biol, NL-6700 AP Wageningen, Netherlands.; Adibi, M (corresponding author), Max Planck Inst Plant Breeding Res, Cologne, Germany.	adibi@mpipz.mpg.de; christian.fleck@wur.nl	Yoshida, Saiko/AAE-5693-2019; Weijers, Dolf/ABI-1332-2020; Weijers, Dolf/A-2076-2010	Yoshida, Saiko/0000-0001-6111-9353; Weijers, Dolf/0000-0003-4378-141X; Weijers, Dolf/0000-0003-4378-141X; Fleck, Christian/0000-0002-6371-4495				Banasiak A, 2011, PLANTA, V233, P49, DOI 10.1007/s00425-010-1280-0; Barton MK, 2010, DEV BIOL, V341, P95, DOI 10.1016/j.ydbio.2009.11.029; Bauby H, 2007, PLANT CELL PHYSIOL, V48, P97, DOI 10.1093/pcp/pcl045; Besnard F, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.28788; Besnard F, 2014, NATURE, V505, P417, DOI 10.1038/nature12791; Brand U, 2002, PLANT PHYSIOL, V129, P565, DOI 10.1104/pp.001867; Carlsbecker A, 2010, NATURE, V465, P316, DOI 10.1038/nature08977; Chickarmane VS, 2012, P NATL ACAD SCI USA, V109, P4002, DOI 10.1073/pnas.1200636109; Daum G, 2014, P NATL ACAD SCI USA, V111, P14619, DOI 10.1073/pnas.1406446111; De Rybel B, 2014, SCIENCE, V345, DOI 10.1126/science.1255215; Dello Ioio R, 2007, CURR BIOL, V17, P678, DOI 10.1016/j.cub.2007.02.047; Dodsworth S, 2009, DEV BIOL, V336, P1, DOI 10.1016/j.ydbio.2009.09.031; Fujita H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018243; Goda H, 2008, PLANT J, V55, P526, DOI [10.1111/j.1365-313X.2008.03510.x, 10.1111/j.0960-7412.2008.03510.x]; Gordon SP, 2009, P NATL ACAD SCI USA, V106, P16529, DOI 10.1073/pnas.0908122106; Graf P, 2010, PLANT CELL, V22, P716, DOI 10.1105/tpc.109.068296; Grandjean O, 2004, PLANT CELL, V16, P74, DOI 10.1105/tpc.017962; Hohm T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009189; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Hwang I, 2012, ANNU REV PLANT BIOL, V63, P353, DOI 10.1146/annurev-arplant-042811-105503; Jacqmard A, 2002, PLANTA, V214, P970, DOI 10.1007/s00425-002-0742-4; Jensen KH, 2012, J THEOR BIOL, V304, P286, DOI 10.1016/j.jtbi.2012.03.012; Jonsson H, 2005, BIOINFORMATICS, V21, pI232, DOI 10.1093/bioinformatics/bti1036; Jonsson H, 2003, SIGNALLING MULTICELL, P156; Kalwarczyk T, 2012, BIOINFORMATICS, V28, P2971, DOI 10.1093/bioinformatics/bts537; Kieber Joseph J, 2014, Arabidopsis Book, V12, pe0168, DOI 10.1199/tab.0168; Kierzkowski D, 2012, SCIENCE, V335, P1096, DOI 10.1126/science.1213100; Kim CY, 2007, J PLANT BIOL, V50, P274, DOI 10.1007/BF03030655; Knauer S, 2013, DEV CELL, V24, P125, DOI 10.1016/j.devcel.2012.12.009; Kramer EM, 2007, J EXP BOT, V58, P3005, DOI 10.1093/jxb/erm155; Kudo T, 2010, J INTEGR PLANT BIOL, V52, P53, DOI 10.1111/j.1744-7909.2010.00898.x; Kurakawa T, 2007, NATURE, V445, P652, DOI 10.1038/nature05504; Kyozuka J, 2007, CURR OPIN PLANT BIOL, V10, P442, DOI 10.1016/j.pbi.2007.08.010; Laufs P, 1998, PLANT CELL, V10, P1375, DOI 10.1105/tpc.10.8.1375; Lee CH, 2013, WIRES DEV BIOL, V2, P671, DOI 10.1002/wdev.110; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Lenhard M, 2003, DEVELOPMENT, V130, P3163, DOI 10.1242/dev.00525; Mahonen AP, 2006, SCIENCE, V311, P94, DOI 10.1126/science.1118875; Maini PK, 2006, SCIENCE, V314, P1397, DOI 10.1126/science.1136396; Mason MG, 2005, PLANT CELL, V17, P3007, DOI 10.1105/tpc.105.035451; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Meinhardt H, 2000, BIOESSAYS, V22, P753, DOI 10.1002/1521-1878(200008)22:8<753::AID-BIES9>3.3.CO;2-Q; Muller B, 2008, NATURE, V453, P1094, DOI 10.1038/nature06943; Murray J. D., 2002, MATH BIOL, V2; Nakamasu A, 2009, P NATL ACAD SCI USA, V106, P8429, DOI 10.1073/pnas.0808622106; Nenninger A, 2010, J BACTERIOL, V192, P4535, DOI 10.1128/JB.00284-10; Reinhardt D, 2003, DEVELOPMENT, V130, P4073, DOI 10.1242/dev.00596; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; STEWART RN, 1970, AM J BOT, V57, P816, DOI 10.2307/2441339; To JPC, 2008, TRENDS PLANT SCI, V13, P85, DOI 10.1016/j.tplants.2007.11.005; To JPC, 2007, PLANT CELL, V19, P3901, DOI 10.1105/tpc.107.052662; To JPC, 2004, PLANT CELL, V16, P658, DOI 10.1105/tpc.018978; To JPC, 2007, PROQUEST; Tucker MR, 2007, TRENDS CELL BIOL, V17, P403, DOI 10.1016/j.tcb.2007.06.002; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Williams L, 2005, DEVELOPMENT, V132, P3657, DOI 10.1242/dev.01942; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Yadav RK, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.8; Yadav RK, 2011, GENE DEV, V25, P2025, DOI 10.1101/gad.17258511; Yadav RK, 2009, P NATL ACAD SCI USA, V106, P4941, DOI 10.1073/pnas.0900843106; Yanai O, 2005, CURR BIOL, V15, P1566, DOI 10.1016/j.cub.2005.07.060; Zhao Z, 2010, NATURE, V465, P1089, DOI 10.1038/nature09126; Zhou GK, 2007, PLANT CELL PHYSIOL, V48, P391, DOI 10.1093/pcp/pcm008	64	21	21	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0147830	10.1371/journal.pone.0147830	http://dx.doi.org/10.1371/journal.pone.0147830			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872130	gold, Green Published			2022-12-27	WOS:000370054100011
J	Beutel, ME; Klein, EM; Aufenanger, S; Brahler, E; Dreier, M; Muller, KW; Quiring, O; Reinecke, L; Schmutzer, G; Stark, B; Wolfling, K				Beutel, Manfred E.; Klein, Eva M.; Aufenanger, Stefan; Braehler, Elmar; Dreier, Michael; Mueller, Kai W.; Quiring, Oliver; Reinecke, Leonard; Schmutzer, Gabriele; Stark, Birgit; Woelfling, Klaus			Procrastination, Distress and Life Satisfaction across the Age Range - A German Representative Community Study	PLOS ONE			English	Article							VALIDATION; SCALE; PERSONALITY; EXTENSION; IDENTITY; VERSION; HEALTH	Addressing the lack of population-based data the purpose of this representative study was to assess procrastination and its associations with distress and life satisfaction across the life span. A representative German community sample (1,350 women; 1,177 men) between the ages of 14 and 95 years was examined by the short form of the General Procrastination Scale (GPS-K; 1) and standardized scales of perceived stress, depression, anxiety, fatigue and life satisfaction. As hypothesized, procrastination was highest in the youngest cohort (14-29 years). Only in the youngest and most procrastinating cohort (aged 14 to 29 years), men procrastinated more than women. As we had further hypothesized, procrastination was consistently associated with higher stress, more depression, anxiety, fatigue and reduced satisfaction across life domains, especially regarding work and income. Associations were also found with lack of a partnership and unemployment. Findings are discussed with regard to potential developmental and cohort effects. While procrastination appears to be a pervasive indicator for maladjustment, longitudinal analyses in high-risk samples (e.g. late adolescence, unemployment) are needed to identify means and mechanisms of procrastinating.	[Beutel, Manfred E.; Klein, Eva M.; Braehler, Elmar; Dreier, Michael; Mueller, Kai W.; Woelfling, Klaus] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Psychosomat Med & Psychotherapy, D-55122 Mainz, Germany; [Aufenanger, Stefan] Johannes Gutenberg Univ Mainz, Inst Educ, D-55122 Mainz, Germany; [Schmutzer, Gabriele] Univ Med Ctr Leipzig, Dept Med Psychol & Med Sociol, Leipzig, Germany; [Quiring, Oliver; Reinecke, Leonard; Stark, Birgit] Johannes Gutenberg Univ Mainz, Dept Commun, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Leipzig University; Johannes Gutenberg University of Mainz	Beutel, ME (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Psychosomat Med & Psychotherapy, D-55122 Mainz, Germany.	Manfred.Beutel@unimedizin-mainz.de	Braehler, Elmar/C-6535-2009; Reinecke, Leonard/S-7324-2019	Braehler, Elmar/0000-0002-2648-2728; Reinecke, Leonard/0000-0003-0927-5492; Quiring, Oliver/0000-0002-6671-583X				Adrian M, 2010, MARRIAGE FAM REV, V46, P327, DOI 10.1080/01494929.2010.527809; Beutel ME, 2011, CYBERPSYCH BEH SOC N, V14, P291, DOI 10.1089/cyber.2010.0199; Blanchard-Fields F, 2007, CURR DIR PSYCHOL SCI, V16, P26, DOI 10.1111/j.1467-8721.2007.00469.x; Brownlow S, 2000, J SOC BEHAV PERS, V15, P15; Carstensen LL, 1999, AM PSYCHOL, V54, P165, DOI 10.1037/0003-066X.54.3.165; Chu AHC, 2005, J SOC PSYCHOL, V145, P245; Cohen J.E., 1988, STAT POWER ANAL BEHA; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Daig I, 2015, Z KLIN PSYCHOL PSYCH, V40, P172; Davis RA, 2002, CYBERPSYCHOL BEHAV, V5, P331, DOI 10.1089/109493102760275581; Engberding M, 2011, VERHALTENSTHERAPIE, V21, P255, DOI 10.1159/000333392; Ferrari J.R., 2010, STILL PROCRASTINATIN; Gropel P, 2008, PERS INDIV DIFFER, V45, P406, DOI 10.1016/j.paid.2008.05.015; Helmke A., 2000, INTERESSE LERNMOTIVA, P207; Henrich G, 2000, EUR J PSYCHOL ASSESS, V16, P150, DOI 10.1027//1015-5759.16.3.150; Hocker A, 2008, VERHALTENSTHERAPIE, V18, P223, DOI 10.1159/000167857; Keller H., 2015, ENTWICKLUNG GENERATI; Klein EM, GERMAN VERSION UNPUB; Klingsieck KB, 2013, CURR PSYCHOL, V32, P175, DOI 10.1007/s12144-013-9171-8; Klingsieck KB, 2013, EUR PSYCHOL, V18, P24, DOI 10.1027/1016-9040/a000138; Klingsieck KB, 2012, DIAGNOSTICA, V58, P182, DOI 10.1026/0012-1924/a000060; Koch A, 2000, STICHPROBEN UMFRAGEP, P99; Kristensen TS, 2005, WORK STRESS, V19, P192, DOI 10.1080/02678370500297720; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; LAY CH, 1986, J RES PERS, V20, P474, DOI 10.1016/0092-6566(86)90127-3; Lay CH, 2004, COUNSELING PROCRASTI; Lee EH, 2012, ASIAN NURS RES, V6, P121, DOI 10.1016/j.anr.2012.08.004; Lowe B, 2010, J AFFECT DISORDERS, V122, P86, DOI 10.1016/j.jad.2009.06.019; Markus HR, 2010, J CONSUM RES, V37, P344, DOI 10.1086/651242; McCrae RR, 1999, DEV PSYCHOL, V35, P466, DOI 10.1037/0012-1649.35.2.466; Nguyen B, 2013, INT J SELECT ASSESS, V21, P388, DOI 10.1111/ijsa.12048; Nubling Matthias, 2006, Psychosoc Med, V3, pDoc05; Pejtersen JH, 2010, SCAND J PUBLIC HEALT, V38, P8, DOI 10.1177/1403494809349858; Rebetez MML, 2014, COMPR PSYCHIAT, V55, P1442, DOI 10.1016/j.comppsych.2014.04.024; Richter D., 2013, PSYCHOL SOZIALWISSEN, V1st; Roberts B.W., 2008, HDB PERSONALITY THEO, V3rd ed., P375; Rozental A., 2014, PSYCHOLOGY, V5, P1488, DOI [10.4236/psych.2014.513160, DOI 10.4236/PSYCH.2014.513160]; Schwartz SJ, 2005, YOUTH SOC, V37, P201, DOI 10.1177/0044118X05275965; Schwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000; Shanahan MJ, 2007, PERS INDIV DIFFER, V43, P901, DOI 10.1016/j.paid.2007.02.013; Sirois FM, 2007, PERS INDIV DIFFER, V43, P15, DOI 10.1016/j.paid.2006.11.003; Sirois FM, 2015, J BEHAV MED, V38, P578, DOI 10.1007/s10865-015-9629-2; Stead R, 2010, PERS INDIV DIFFER, V49, P175, DOI 10.1016/j.paid.2010.03.028; Steel P, 2001, PERS INDIV DIFFER, V30, P95, DOI 10.1016/S0191-8869(00)00013-1; Steel P, 2007, PSYCHOL BULL, V133, P65, DOI 10.1037/0033-2909.133.1.65; Steel P, 2013, EUR J PERSONALITY, V27, P51, DOI 10.1002/per.1851	46	76	79	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148054	10.1371/journal.pone.0148054	http://dx.doi.org/10.1371/journal.pone.0148054			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6SI	26871572	gold, Green Published, Green Submitted			2022-12-27	WOS:000370054100016
J	Chang, YT; Huang, CW; Chen, NC; Lin, KJ; Huang, SH; Chang, YH; Hsu, SW; Chang, WN; Lui, CC; Hsu, CW; Chang, CC				Chang, Ya-Ting; Huang, Chi-Wei; Chen, Nai-Ching; Lin, Kun-Ju; Huang, Shu-Hua; Chang, Yen-Hsiang; Hsu, Shih-Wei; Chang, Wen-Neng; Lui, Chun-Chung; Hsu, Che-Wei; Chang, Chiung-Chih			Prefrontal Lobe Brain Reserve Capacity with Resistance to Higher Global Amyloid Load and White Matter Hyperintensity Burden in Mild Stage Alzheimer's Disease	PLOS ONE			English	Article							COGNITIVE IMPAIRMENT; HIPPOCAMPAL ATROPHY; NORMAL INDIVIDUALS; MEMORY DECLINE; AMNESTIC MCI; FDG PET; MRI; DEMENTIA; LESIONS; ASSOCIATION	Background Amyloid deposition and white matter lesions (WMLs) in Alzheimer's disease (AD) are both considered clinically significant while a larger brain volume is thought to provide greater brain reserve (BR) against these pathological effects. This study identified the topography showing BR in patients with mild AD and explored the clinical balances among BR, amyloid, and WMLs burden. Methods Thirty patients with AD were enrolled, and AV-45 positron emission tomography was conducted to measure the regional standardized uptake value ratio (SUVr) in 8 cortical volumes-of-interests (VOIs). The quantitative WMLs burden was measured from magnetic resonance imaging while the normalized VOIs volumes represented BR in this study. The cognitive test represented major clinical correlates. Results Significant correlations between the prefrontal volume and global (r = 0.470, p = 0.024), but not regional (r = 0.264, p = 0.223) AV-45 SUVr were found. AD patients having larger regional volume in the superior- (r = 0.572, p = 0.004), superior medial- (r = 0.443, p = 0.034), and middle-prefrontal (r = 0.448, p = 0.032) regions had higher global AV-45 SUVr. For global WML loads, the prefrontal (r = -0.458, p = 0.019) and hippocampal volume (r = -0.469, p = 0.016) showed significant correlations while the prefrontal (r = -0.417, p = 0.043) or hippocampal volume (r = -0.422, p = 0.04) also predicted better composite memory scores. There were no interactions between amyloid SUVr and WML loads on the prefrontal volume. Conclusions BR of the prefrontal region might modulate the adverse global pathological burden caused by amyloid deposition. While prefrontal volume positively associated with hippocampal volume, WMLs had an adverse impact on the hippocampal volume that predicts memory performance in mild stage AD.	[Chang, Ya-Ting; Huang, Chi-Wei; Chen, Nai-Ching; Chang, Wen-Neng; Hsu, Che-Wei; Chang, Chiung-Chih] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Cognit & Aging Ctr, Dept Neurol,Coll Med, Kaohsiung, Taiwan; [Huang, Shu-Hua; Chang, Yen-Hsiang] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Nucl Med, Kaohsiung, Taiwan; [Hsu, Shih-Wei; Lui, Chun-Chung] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Radiol, Kaohsiung, Taiwan; [Lin, Kun-Ju] Chang Gung Mem Hosp, Dept Nucl Med, Taoyuan, Taiwan; [Lin, Kun-Ju] Chang Gung Mem Hosp, Ctr Adv Mol Imaging & Translat, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Chang, CC (corresponding author), Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Cognit & Aging Ctr, Dept Neurol,Coll Med, Kaohsiung, Taiwan.	neur099@adm.cgmh.org.tw	Lin, Kun-Ju/H-3120-2015	Lin, Kun-Ju/0000-0003-1933-4564	Chang Gung Memorial Hospital [8B1001, 8C0571, 8D0771]; National Research Program for Biopharmaceuticals [103-2325-B-182A-009]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Research Program for Biopharmaceuticals	This work was supported by grants from Chang Gung Memorial Hospital (8B1001, 8C0571 and 8D0771) and National Research Program for Biopharmaceuticals (103-2325-B-182A-009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes J, 2010, NEUROIMAGE, V53, P1244, DOI 10.1016/j.neuroimage.2010.06.025; Bartley AJ, 1997, BRAIN, V120, P257, DOI 10.1093/brain/120.2.257; Bourgeat P, 2010, NEUROLOGY, V74, P121, DOI 10.1212/WNL.0b013e3181c918b5; Cagnin A, 2001, BRAIN, V124, P2014, DOI 10.1093/brain/124.10.2014; Chetelat G, 2013, NEUROIMAGE-CLIN, V2, P356, DOI 10.1016/j.nicl.2013.02.006; Chetelat G, 2010, BRAIN, V133, P3349, DOI 10.1093/brain/awq187; Chu L. W., 2000, Annals Academy of Medicine Singapore, V29, P474; Clark CM, 2011, JAMA-J AM MED ASSOC, V305, P275, DOI 10.1001/jama.2010.2008; de Leeuw FE, 2004, NEUROLOGY, V62, P310, DOI 10.1212/01.WNL.0000103289.03648.AD; Defrancesco M, 2013, J ALZHEIMERS DIS, V34, P665, DOI 10.3233/JAD-122095; Dewey J, 2010, NEUROIMAGE, V51, P1334, DOI 10.1016/j.neuroimage.2010.03.033; Du AT, 2005, NEUROBIOL AGING, V26, P553, DOI 10.1016/j.neurobiolaging.2004.05.002; Dubois B, 2014, LANCET NEUROL, V13, P614, DOI 10.1016/S1474-4422(14)70090-0; Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4; Edison P, 2008, NEUROBIOL DIS, V32, P412, DOI 10.1016/j.nbd.2008.08.001; Erten-Lyons D, 2009, NEUROLOGY, V72, P354, DOI 10.1212/01.wnl.0000341273.18141.64; Godin O, 2009, CEREBROVASC DIS, V28, P177, DOI 10.1159/000226117; GOLOMB J, 1993, ARCH NEUROL-CHICAGO, V50, P967, DOI 10.1001/archneur.1993.00540090066012; Greenberg DL, 2008, NEUROBIOL AGING, V29, P290, DOI 10.1016/j.neurobiolaging.2006.09.016; Guedj E, 2009, EUR J NUCL MED MOL I, V36, P1101, DOI 10.1007/s00259-009-1060-x; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Huang CW, 2013, EUR J NEUROL, V20, P1191, DOI 10.1111/ene.12159; Huang CW, 2010, CURR ALZHEIMER RES, V7, P527; Huang KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058974; Huijbers W, 2015, BRAIN, V138, P1023, DOI 10.1093/brain/awv007; Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; Jansen WJ, 2015, JAMA-J AM MED ASSOC, V313, P1924, DOI 10.1001/jama.2015.4668; Karow DS, 2010, RADIOLOGY, V256, P932, DOI 10.1148/radiol.10091402; Kimura N, 2013, DEMENT GER COGN D EX, V3, P96, DOI 10.1159/000350317; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Mielke MM, 2012, ALZHEIMERS DEMENT, V8, P105, DOI 10.1016/j.jalz.2011.05.2416; Mori E, 1997, AM J PSYCHIAT, V154, P18, DOI 10.1176/ajp.154.1.18; Mormino EC, 2014, NEUROPSYCHOL REV, V24, P300, DOI 10.1007/s11065-014-9267-4; Mortimer JA, 1997, GERIATRICS, V52, pS50; Nemmi F, 2014, EUR J NUCL MED MOL I, V41, P1408, DOI 10.1007/s00259-014-2728-4; Nithianantharajah J, 2009, PROG NEUROBIOL, V89, P369, DOI 10.1016/j.pneurobio.2009.10.001; Nobili F, 2008, EUR J NUCL MED MOL I, V35, P2191, DOI 10.1007/s00259-008-0869-z; Okello A, 2009, NEUROLOGY, V72, P56, DOI 10.1212/01.wnl.0000338622.27876.0d; Pantoni L, 1997, STROKE, V28, P652, DOI 10.1161/01.STR.28.3.652; Perneczky R, 2006, J NEUROL NEUROSUR PS, V77, P1060, DOI 10.1136/jnnp.2006.094714; ROSEN WG, 1980, ANN NEUROL, V7, P486, DOI 10.1002/ana.410070516; Schmidt P, 2012, NEUROIMAGE, V59, P3774, DOI 10.1016/j.neuroimage.2011.11.032; Schofield PW, 1997, NEUROLOGY, V49, P30, DOI 10.1212/WNL.49.1.30; Springer MV, 2005, NEUROPSYCHOLOGY, V19, P181, DOI 10.1037/0894-4105.19.2.181; Stern Y, 1999, NEUROLOGY, V53, P1942, DOI 10.1212/WNL.53.9.1942; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van der Flier WM, 2004, NEUROLOGY, V62, P1862, DOI 10.1212/01.WNL.0000125337.65553.8A; Voevodskaya O, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00264; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318; Weiner Michael W, 2012, Alzheimers Dement, V8, pS1, DOI [10.1016/j.jalz.2013.05.1769, 10.1016/j.jalz.2011.09.172]; YLIKOSKI R, 1993, ARCH NEUROL-CHICAGO, V50, P818, DOI 10.1001/archneur.1993.00540080029009	51	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149056	10.1371/journal.pone.0149056	http://dx.doi.org/10.1371/journal.pone.0149056			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872386	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100094
J	Loy, BA; Shkedy, CI; Powell, AC; Happe, LE; Royalty, JA; Miao, MT; Smith, GL; Long, JW; Gupta, AK				Loy, Bryan A.; Shkedy, Clive I.; Powell, Adam C.; Happe, Laura E.; Royalty, Julie A.; Miao, Michael T.; Smith, Gary L.; Long, James W.; Gupta, Amit K.			Do Case Rates Affect Physicians' Clinical Practice in Radiation Oncology?: An Observational Study	PLOS ONE			English	Article							CANCER CARE; DRUGS	Case rate payments combined with utilization monitoring may have the potential to improve the quality of care by reducing over and under-treatment. Thus, a national managed care organization introduced case rate payments at one multi-site radiation oncology provider while maintaining only fee-for-service payments at others. This study examined whether the introduction of the payment method had an effect on radiation fractions administered when compared to clinical guidelines. The number of fractions of radiation therapy delivered to patients with bone metastases, breast, lung, prostate, and skin cancer was assessed for concordance with clinical guidelines. The proportion of guideline-based care ascertained from the payer's claims database was compared before (2011) and after (2013) the payment method introduction using relative risks (RR). After the introduction of case rates, there were no significant changes in guideline-based care in breast, lung, and skin cancer; however, patients with bone metastases and prostate cancer were significantly more likely to have received guideline-based care (RR = 2.0 and 1.1, respectively, p<0.05). For the aggregate of all cancers, the under-treatment rate significantly declined (p = 0.008) from 4% to 0% after the introduction of case rate payments, while the over-treatment rate remained steady at 9%, with no significant change (p = 0.20). These findings suggest that the introduction of case rate payments did not adversely affect the rate of guideline-based care at the provider examined. Additional research is needed to isolate the effect of the payment model and assess implications in other populations.	[Loy, Bryan A.; Happe, Laura E.; Royalty, Julie A.; Miao, Michael T.; Long, James W.] Humana Inc, Louisville, KY USA; [Shkedy, Clive I.; Powell, Adam C.; Smith, Gary L.; Gupta, Amit K.] HealthHelp LLC, Houston, TX USA	Humana Inc.	Powell, AC (corresponding author), HealthHelp LLC, Houston, TX USA.	powellad@healthhelp.com		Powell, Adam/0000-0001-6519-3120	HealthHelp LLC; Humana Inc.	HealthHelp LLC; Humana Inc.	The authors received no specific funding for this work. This study was completed by Humana, Inc. and HealthHelp, LLC, and authors worked on it as a part of their duties for their respective organization. HealthHelp LLC and Humana Inc. provided support in the form of paid employment or consulting fees for all the authors. (Humana: BL, LH, JR, MM, and JL. HealthHelp: CS, AP, GS, and AG.). The specific roles of these authors are articulated in the 'author contributions' section. This research represents the findings of a quality improvement project conducted by the funding organizations, which were both actively involved in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. URL of HealthHelp: www.healthhelp.com; URL of Humana: www.humana.com.	[Anonymous], REL RISK CALC VERS 1; [Anonymous], 2015, NCCN CLIN GUID ONC S; Bekelman JE, 2014, JAMA-J AM MED ASSOC, V312, P2542, DOI 10.1001/jama.2014.16616; Colla CH, 2012, J ONCOL PRACT, V8, DOI 10.1200/JOP.2012.000539; Cutler DM, 2012, NEW ENGL J MED, V366, P1075, DOI 10.1056/NEJMp1113361; Falit BP, 2014, INT J RADIAT ONCOL, V89, P950, DOI 10.1016/j.ijrobp.2014.04.023; Feinberg B, 2014, AM J MANAG CARE, V20, P303; Jacobson M, 2010, HEALTH AFFAIR, V29, P1391, DOI 10.1377/hlthaff.2009.0563; Jagsi R, 2014, INT J RADIAT ONCOL, V90, P1001, DOI 10.1016/j.ijrobp.2014.09.032; Lutz S, 2011, INT J RADIAT ONCOL, V79, P965, DOI 10.1016/j.ijrobp.2010.11.026; Medicare Program, 2012, FED REGISTER, V77, P68910; National Comprehensive Cancer Network, 2014, NCCN CLIN PRACT GUID; National Comprehensive Cancer Network, 2015, NCCN CLIN PRACT GUID; Newcomer LN, 2014, J ONCOL PRACT, V10, P322, DOI 10.1200/JOP.2014.001488; Smith BD, 2011, INT J RADIAT ONCOL, V81, P59, DOI 10.1016/j.ijrobp.2010.04.042	15	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149449	10.1371/journal.pone.0149449	http://dx.doi.org/10.1371/journal.pone.0149449			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26870963	Green Submitted, Green Published, gold			2022-12-27	WOS:000370054100158
J	Wu, TF; Li, YT; Liu, BH; Zhang, SQ; Wu, LQ; Zhu, XN; Chen, QX				Wu, Tingfeng; Li, Yuntao; Liu, Baohui; Zhang, Shenqi; Wu, Liquan; Zhu, Xiaonan; Chen, Qianxue			Expression of Ferritin Light Chain (FTL) Is Elevated in Glioblastoma, and FTL Silencing Inhibits Glioblastoma Cell Proliferation via the GADD45/JNK Pathway	PLOS ONE			English	Article							CANCER GENOMICS; APOPTOSIS; STRESS; GROWTH; TUMORS	Accumulating evidence suggests that iron-associated proteins contribute to tumor initiation and development. Ferritin light chain (FTL), a key protein in iron metabolism, is associated with the survival of glioblastoma multiforme (GBM) patients; however, the molecular mechanisms underlying this association remain largely unclear. Therefore, in the present study, we investigated the role of FTL in the pathogenesis of GBM. By using quantitative real-time RT-PCR, we found that expression of FTL was higher in patients with GBM than in those with low-grade glioma. Immunofluorescence showed that FTL was mainly localized in the nucleus of GBM cells and was closely associated with mitotic spindles. Knockdown of FTL resulted in inhibition of cell growth and activation of the GADD45A/JNK pathway in GBM cells. Immunoblotting revealed that levels of GADD45A protein decreased in GBM cells when FTL expression increased. Furthermore, transfection of GADD45A in GBM cells significantly decreased cell viability, and this effect was impeded by co-transfection of FTL. Moreover, FTL was found to localize with GADD45A in GBM cells, and a co-immunoprecipitation experiment showed that the two proteins physically interacted. Taken together, these results demonstrate a novel mechanism by which FTL regulates the growth of GBM cells via the GADD45/JNK pathway.	[Wu, Tingfeng; Li, Yuntao; Liu, Baohui; Zhang, Shenqi; Wu, Liquan; Zhu, Xiaonan; Chen, Qianxue] Wuhan Univ, Renmin Hosp, Dept Neurosurg, Wuhan 430072, Hubei Province, Peoples R China	Wuhan University	Chen, QX (corresponding author), Wuhan Univ, Renmin Hosp, Dept Neurosurg, Wuhan 430072, Hubei Province, Peoples R China.	chenqx666@sohu.com		Chen, Qianxue/0000-0002-9413-1030; Li, Yuntao/0000-0001-8788-7537	National Natural Science Foundation of China [81572489]; Neural tumor research project [csno-2013-MSD 004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Neural tumor research project	This work was supported by the National Natural Science Foundation of China (Grant No. 81572489, URL: http://www.nsfc.gov.cn/publish/portal1/), Neural tumor research project (csno-2013-MSD 004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (Grant No. 81572489, URL: http://www.nsfc.gov.cn/publish/portal1/), Neural tumor research project (csno-2013-MSD 004).	Alkhateeb AA, 2013, BBA-REV CANCER, V1836, P245, DOI 10.1016/j.bbcan.2013.07.002; AROSIO P, 1976, CANCER RES, V36, P1735; Bru A, 2007, MED ONCOL, V24, P436, DOI 10.1007/s12032-007-0025-9; Camorani S, 2014, MOL THER, V22, P828, DOI 10.1038/mt.2013.300; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cozzi A, 2004, BLOOD, V103, P2377, DOI 10.1182/blood-2003-06-1842; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gautam P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046153; Hollander MC, 2002, ONCOGENE, V21, P6228, DOI 10.1038/sj.onc.1205774; JAIN SK, 1985, J BIOL CHEM, V260, P1762; Ji J, 2007, ONCOGENE, V26, P6396, DOI 10.1038/sj.onc.1210469; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Knovich MA, 2009, BLOOD REV, V23, P95, DOI 10.1016/j.blre.2008.08.001; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Liebermann Dan A, 2008, J Mol Signal, V3, P15, DOI 10.1186/1750-2187-3-15; Liu XL, 2011, CANCER RES, V71, P2240, DOI 10.1158/0008-5472.CAN-10-1375; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Neumayer G, 2014, CELL MOL LIFE SCI, V71, P3027, DOI 10.1007/s00018-014-1582-7; Niehrs C, 2012, EMBO J, V31, P2705, DOI 10.1038/emboj.2012.124; Reddy SP, 2008, CLIN CANCER RES, V14, P2978, DOI 10.1158/1078-0432.CCR-07-4821; Salvador JM, 2013, ADV EXP MED BIOL, V793, P1, DOI 10.1007/978-1-4614-8289-5_1; Schrag JD, 2008, P NATL ACAD SCI USA, V105, P6566, DOI 10.1073/pnas.0800086105; Schwartzbaum JA, 2000, NUTR CANCER, V38, P40, DOI 10.1207/S15327914NC381_7; Shpyleva SI, 2011, BREAST CANCER RES TR, V126, P63, DOI 10.1007/s10549-010-0849-4; Thomas AA, 2014, JAMA NEUROL, V71, P1437, DOI 10.1001/jamaneurol.2014.1701; Tolmachev V, 2014, J NUCL MED, V55, P294, DOI 10.2967/jnumed.113.121814; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; Vinayagam A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001699	29	33	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149361	10.1371/journal.pone.0149361	http://dx.doi.org/10.1371/journal.pone.0149361			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871431	gold, Green Published			2022-12-27	WOS:000370054100150
J	Poudyal, N; Baral, N; Asah, ST				Poudyal, Niraj; Baral, Nabin; Asah, Stanley T.			Wolf Lethal Control and Livestock Depredations: Counter-Evidence from Respecified Models	PLOS ONE			English	Article							REPLICATION; RELIABILITY; INFERENCE; STRATEGY	We replicated the study conducted by Wielgus and Peebles (2014) on the effect of wolf mortality on livestock depredations in Montana, Wyoming and Idaho states in the US. Their best models were found to be misspecified due to the omission of the time index and incorrect functional form. When we respecified the models, this replication failed to confirm the magnitude, direction and often the very existence of the original results. Wielgus and Peebles (2014) reported that the increase in the number of wolves culled the previous year would increase the expected number of livestock killed this year by 4 to 6%. But our results showed that the culling of one wolf the previous year would decrease the expected number of cattle killed this year by 1.9%, and the expected number of sheep killed by 3.4%. However, for every wolf killed there is a corresponding 2.2% increase in the expected number of sheep killed in the same year. The increase in sheep depredation appears to be a short term phenomenon.	[Poudyal, Niraj] Kathmandu Univ, Sch Arts, Lalitpur, Nepal; [Baral, Nabin; Asah, Stanley T.] Univ Washington, Sch Environm & Forest Sci, Coll Environm, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Baral, N (corresponding author), Univ Washington, Sch Environm & Forest Sci, Coll Environm, Seattle, WA 98195 USA.	nbaral@uw.edu						Anderson DR, 2001, WILDLIFE SOC B, V29, P1294; Ausband DE, 2015, ANIM CONSERV, V18, P415, DOI 10.1111/acv.12187; Bradley EH, 2015, J WILDLIFE MANAGE, V79, P1337, DOI 10.1002/jwmg.948; Brainerd SM, 2008, J WILDLIFE MANAGE, V72, P89, DOI 10.2193/2006-305; CATCHPOLE CK, 1989, TRENDS ECOL EVOL, V4, P286, DOI 10.1016/0169-5347(89)90021-9; Duncan GJ, 2014, DEV PSYCHOL, V50, P2417, DOI 10.1037/a0037996; Duvendack M, 2013, PROG DEV STUD, V13, P307, DOI 10.1177/1464993413490480; EBERHARDT LL, 1991, ECOL MONOGR, V61, P53, DOI 10.2307/1942999; Johnson DH, 2002, J WILDLIFE MANAGE, V66, P919, DOI 10.2307/3802926; Kachigan S.K., 1986, STAT ANAL INTERDISCI; LEVINS R, 1966, AM SCI, V54, P421; Mayo DG, 2004, PHILOS SCI, V71, P1007, DOI 10.1086/425064; Myers J. L., 2010, RES DESIGN STAT ANAL; Peebles KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079713; Singh K, 2003, J MANAGE, V29, P533, DOI 10.1016/S0149-2063(03)00024-2; Spanos A, 2007, PHILOS SCI, V74, P1046, DOI 10.1086/525643; Spanos A, 2010, ECON MODEL, V27, P1436, DOI 10.1016/j.econmod.2010.07.007; Spanos A, 2010, J ECONOMETRICS, V158, P204, DOI 10.1016/j.jeconom.2010.01.011; Tsang EWK, 1999, ACAD MANAGE REV, V24, P759, DOI 10.2307/259353; Venables WN, 2002, MODERN APPL STAT R; Wielgus RB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113505	21	18	18	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148743	10.1371/journal.pone.0148743	http://dx.doi.org/10.1371/journal.pone.0148743			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866592	Green Published, gold, Green Submitted			2022-12-27	WOS:000370050700031
J	Wu, F; Koenig, KL; Zeleniuch-Jacquotte, A; Jonas, S; Afanasyeva, Y; Wojcik, OP; Costa, M; Chen, Y				Wu, Fen; Koenig, Karen L.; Zeleniuch-Jacquotte, Anne; Jonas, Saran; Afanasyeva, Yelena; Wojcik, Oktawia P.; Costa, Max; Chen, Yu			Serum Taurine and Stroke Risk in Women: A Prospective, Nested Case-Control Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CIGARETTE-SMOKING; CARDIOVASCULAR-DISEASES; NUTRITIONAL FACTOR; VEGETABLE INTAKE; ORAL TAURINE; MORTALITY; SUPPLEMENTATION; ASSOCIATION; POPULATIONS	Background Taurine (2-aminoethanesulfonic acid), a conditionally essential sulfur-containing amino acid, is mainly obtained from diet in humans. Experimental studies have shown that taurine's main biological actions include bile salt conjugation, blood pressure regulation, antioxidation, and anti-inflammation. Methods We conducted a prospective case-control study nested in the New York University Women's Health Study, a cohort study involving 14,274 women enrolled since 1985. Taurine was measured in pre-diagnostic serum samples of 241 stroke cases and 479 matched controls. Results There was no statistically significant association between serum taurine and stroke risk in the overall study population. The adjusted ORs for stroke were 1.0 (reference), 0.87 (95% CI, 0.59-1.28), and 1.03 (95% CI, 0.69-1.54) in increasing tertiles of taurine (64.3-126.6, 126.7-152.9, and 153.0-308.5 nmol/mL, respectively). A significant inverse association between serum taurine and stroke risk was observed among never smokers, with an adjusted OR of 0.66 (95% CI, 0.37-1.18) and 0.50 (95% CI, 0.26-0.94) for the second and third tertile, respectively (p for trend = 0.01), but not among past or current smokers (p for interaction < 0.01). Conclusions We observed no overall association between serum taurine and stroke risk, although a protective effect was observed in never smokers, which requires further investigation. Taurine, Stroke, Epidemiology, Prospective, Case-control study, NYUWHS.	[Wu, Fen; Koenig, Karen L.; Zeleniuch-Jacquotte, Anne; Afanasyeva, Yelena; Chen, Yu] NYU, Sch Med, Dept Populat Hlth, 650 First Ave, New York, NY USA; [Jonas, Saran] NYU, Dept Neurol, Sch Med, 462 First Ave, New York, NY 10016 USA; [Wojcik, Oktawia P.] Robert Wood Johnson Fdn, Route 1 & Coll Rd East, Princeton, NJ 08540 USA; [Costa, Max] NYU, Sch Med, Dept Environm Med, 57 Old Forge Rd, Tuxedo Pk, NY USA	New York University; New York University; Robert Wood Johnson Foundation (RWJF); New York University	Chen, Y (corresponding author), NYU, Sch Med, Dept Populat Hlth, 650 First Ave, New York, NY USA.	yu.chen@nyumc.org		Zeleniuch-Jacquotte, Anne/0000-0001-9350-1303; Chen, Yu/0000-0002-1519-4894	National Heart, Lung, and Blood Institute [R21-HL-106309]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL106309] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Lung, and Blood Institute (R21-HL-106309) received by YC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberg AJ, 2002, TOXICOLOGY, V180, P121, DOI 10.1016/S0300-483X(02)00386-4; Breslow N, 1980, STAT METHODS CANC RE, P248; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Dallongeville J, 1998, J NUTR, V128, P1450; Denipote F, 2011, CELL PHYSIOL BIOCHEM, V27, P291, DOI 10.1159/000327955; Dietrich M, 2003, AM J CLIN NUTR, V77, P160, DOI 10.1093/ajcn/77.1.160; Fennessy FM, 2003, CIRCULATION, V107, P410, DOI 10.1161/01.CIR.0000046447.72402.47; Fleiss JL., 1986, DESIGN ANAL CLIN EXP, DOI [10.1002/9781118032923.ch1, DOI 10.1002/9781118032923.CH1, DOI 10.1002/9781118032923]; Frankenfeld CL, 2008, AM J CLIN NUTR, V87, P1439, DOI 10.1093/ajcn/87.5.1439; FUJITA T, 1987, CIRCULATION, V75, P525, DOI 10.1161/01.CIR.75.3.525; Fung TT, 2009, CIRCULATION, V119, P1093, DOI 10.1161/CIRCULATIONAHA.108.816736; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; Janz KF, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.5.e63; Joshipura KJ, 1999, JAMA-J AM MED ASSOC, V282, P1233, DOI 10.1001/jama.282.13.1233; Liu LJ, 2001, HYPERTENS RES, V24, P315, DOI 10.1291/hypres.24.315; Liu SM, 1999, AM J CLIN NUTR, V70, P412; Martin LM, 2000, AM J PREV MED, V18, P215, DOI 10.1016/S0749-3797(99)00158-0; Mizushima S, 1996, ADV EXP MED BIOL, V403, P615; Mizushima S, 1997, J Cardiovasc Risk, V4, P191, DOI 10.1097/00043798-199706000-00006; Oh SW, 2005, DIABETES CARE, V28, P2064, DOI 10.2337/diacare.28.8.2064; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Parvez S, 2008, BASIC CLIN PHARMACOL, V102, P382, DOI 10.1111/j.1742-7843.2008.00208.x; Rosa FT, 2014, EUR J NUTR, V53, P823, DOI 10.1007/s00394-013-0586-7; Sagara M, 2015, ADV EXP MED BIOL, V803, P623, DOI 10.1007/978-3-319-15126-7_50; Sudlow CLM, 1997, STROKE, V28, P491, DOI 10.1161/01.STR.28.3.491; Tang L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-162; TONIOLO PG, 1991, BREAST CANCER RES TR, V18, pS23, DOI 10.1007/BF02633522; TRAUTWEIN EA, 1990, AM J CLIN NUTR, V52, P758, DOI 10.1093/ajcn/52.4.758; Ueshima H, 2008, CIRCULATION, V118, P2702, DOI 10.1161/CIRCULATIONAHA.108.790048; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Wojcik OP, 2013, EUR J NUTR, V52, P169, DOI 10.1007/s00394-011-0300-6; Wojcik OP, 2010, BRIT J NUTR, V104, P629, DOI 10.1017/S000711451000108X; Wojcik OP, 2010, ATHEROSCLEROSIS, V208, P19, DOI 10.1016/j.atherosclerosis.2009.06.002; Xiao C, 2008, DIABETOLOGIA, V51, P139, DOI 10.1007/s00125-007-0859-x; Yamori Y, 2001, HYPERTENS RES, V24, P453, DOI 10.1291/hypres.24.453; Yamori Y, 1996, ADV EXP MED BIOL, V403, P623; Yamori Yukio, 2004, Clin Exp Pharmacol Physiol, V31 Suppl 2, pS20, DOI 10.1111/j.1440-1681.2004.04122.x; Yamori Y, 2006, J HYPERTENS, V24, P1499, DOI 10.1097/01.hjh.0000239284.12691.2e; Yamori Y, 2009, ADV EXP MED BIOL, V643, P13, DOI 10.1007/978-0-387-75681-3_2; Zhang M, 2004, AMINO ACIDS, V26, P267, DOI 10.1007/s00726-003-0059-z	40	6	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149348	10.1371/journal.pone.0149348	http://dx.doi.org/10.1371/journal.pone.0149348			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866594	Green Submitted, gold, Green Published			2022-12-27	WOS:000370050700085
J	Ishijima, S				Ishijima, Sumio			Self-Sustained Oscillatory Sliding Movement of Doublet Microtubules and Flagellar Bend Formation	PLOS ONE			English	Article							SPERM; SPERMATOZOA; CAMP; CA2+; REGULATIONS; AXONEMES; AXIS	It is well established that the basis for flagellar and ciliary movements is ATP-dependent sliding between adjacent doublet microtubules. However, the mechanism for converting microtubule sliding into flagellar and ciliary movements has long remained unresolved. The author has developed new sperm models that use bull spermatozoa divested of their plasma membrane and midpiece mitochondrial sheath by Triton X-100 and dithiothreitol. These models enable the observation of both the oscillatory sliding movement of activated doublet microtubules and flagellar bend formation in the presence of ATP. A long fiber of doublet microtubules extruded by synchronous sliding of the sperm flagella and a short fiber of doublet microtubules extruded by metachronal sliding exhibited spontaneous oscillatory movements and constructed a one beat cycle of flagellar bending by alternately actuating. The small sliding displacement generated by metachronal sliding formed helical bends, whereas the large displacement by synchronous sliding formed planar bends. Therefore, the resultant waveform is a half-funnel shape, which is similar to ciliary movements.	[Ishijima, Sumio] Tokyo Inst Technol, Dept Bioengn, Grad Sch Biosci & Biotechnol, Meguro Ku, Tokyo 152, Japan	Tokyo Institute of Technology	Ishijima, S (corresponding author), Tokyo Inst Technol, Dept Bioengn, Grad Sch Biosci & Biotechnol, Meguro Ku, Tokyo 152, Japan.	sishijim@bio.titech.ac.jp						AFZELIUS B, 1959, J BIOPHYS BIOCHEM CY, V5, P269, DOI 10.1083/jcb.5.2.269; ISHIJIMA S, 1992, J EXP BIOL, V163, P15; ISHIJIMA S, 1986, GAMETE RES, V13, P185, DOI 10.1002/mrd.1120130302; Ishijima S, 1996, J CELL SCI, V109, P2833; ISHIJIMA S, 1993, BIOPHYS J, V65, P1445, DOI 10.1016/S0006-3495(93)81210-4; Ishijima S, 2007, CELL MOTIL CYTOSKEL, V64, P809, DOI 10.1002/cm.20228; Ishijima S, 2006, MOL REPROD DEV, V73, P1129, DOI 10.1002/mrd.20420; Ishijima S, 2015, P JPN ACAD B-PHYS, V91, P99, DOI 10.2183/pjab.91.99; Ishijima S, 2013, CELL STRUCT FUNCT, V38, P89, DOI 10.1247/csf.12021; KANOUS KS, 1993, CELL MOTIL CYTOSKEL, V26, P66, DOI 10.1002/cm.970260107; Ohmuro J, 2006, MOL REPROD DEV, V73, P1412, DOI 10.1002/mrd.20521; OLSON GE, 1977, J ULTRA MOL STRUCT R, V61, P21, DOI 10.1016/S0022-5320(77)90004-1; SALE WS, 1986, J CELL BIOL, V102, P2042, DOI 10.1083/jcb.102.6.2042; SMITHWICK EB, 1978, BIOL REPROD, V19, P280, DOI 10.1095/biolreprod19.2.280	14	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148880	10.1371/journal.pone.0148880	http://dx.doi.org/10.1371/journal.pone.0148880			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863204	Green Published, Green Submitted, gold			2022-12-27	WOS:000370046600119
J	Schmid, A; Neumann, H; Karrasch, T; Liebisch, G; Schaffler, A				Schmid, Andreas; Neumann, Hannah; Karrasch, Thomas; Liebisch, Gerhard; Schaeffler, Andreas			Bile Acid Metabolome after an Oral Lipid Tolerance Test by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)	PLOS ONE			English	Article							FARNESOID-X-RECEPTOR; FIBROBLAST GROWTH-FACTORS; SHORT-TERM; GLUCOSE; FIBROBLAST-GROWTH-FACTOR-19; BIOSYNTHESIS; EXPRESSION; DISEASE; CASCADE; SIGNAL	Context Besides their role in intestinal resorption of lipids, bile acids are regarded as endocrine and metabolic signaling molecules. The detailed profile of bile acid species in peripheral blood after an oral lipid tolerance test (OLTT) is unknown. Objective We quantified the regulation of 18 bile acids after OLTT in healthy individuals. Material and methods 100 volunteers were characterized by anthropometric and laboratory parameters and underwent OLTT. Venous blood was drawn in the fasted state (0 h) and at 2h, 4h, and 6 h after OLTT. Serum concentrations of 18 bile acids were measured by LC-MS/MS. Results All of the 6 taurine-conjugated bile acids (TUDCA, THDCA, TCA, TCDCA, TDCA, TLCA) and all of the 6 glycine-conjugated bile acids (GUDCA, GHDCA, GCA, GCDCA, GDCA, GLCA) rose significantly at 2h and remained elevated during OLTT. Of the primary bile acids, CA remained unchanged, whereas CDCA significantly decreased at 4h. Of the secondary bile acids, DCA, UDCA and HDCA were not altered, whereas LCA decreased. There was a significant positive correlation between the intestinal feed-back regulator of bile acid synthesis FGF-19 and bile acids. This correlation seems to depend on all of the six taurine-conjugated bile acids and on GCA, GDCA, and GCDCA. Females and users of hormonal contraception displayed higher levels of taurine-conjugated bile acids. Conclusions The novelty of the study is based on the identification of single bile acids during OLTT. LCMS/MS-based quantification of bile acids in serum provides a reliable tool for future investigation of endocrine and metabolic effects of bile acids.	[Schmid, Andreas; Neumann, Hannah; Karrasch, Thomas; Schaeffler, Andreas] Giessen Univ Hosp, Dept Internal Med 3, Giessen, Germany; [Liebisch, Gerhard] Regensburg Univ Hosp, Inst Clin Chem & Lab Med, Regensburg, Germany	University Hospital of Giessen & Marburg; University of Regensburg	Schmid, A (corresponding author), Giessen Univ Hosp, Dept Internal Med 3, Giessen, Germany.	andreas.schmid@innere.med.uni-giessen.de	Liebisch, Gerhard/G-6130-2010; Schäffler, Andreas/W-2384-2019	Liebisch, Gerhard/0000-0003-4886-0811; 				Adorini L, 2012, DRUG DISCOV TODAY, V17, P988, DOI 10.1016/j.drudis.2012.05.012; Angelin B, 2012, CELL METAB, V16, P693, DOI 10.1016/j.cmet.2012.11.001; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Cicione C, 2012, HEPATOLOGY, V56, P2404, DOI 10.1002/hep.25929; Cyphert HA, 2012, J BIOL CHEM, V287, P25123, DOI 10.1074/jbc.M112.375907; Fiorucci S, 2010, CURR MOL MED, V10, P579; Fiorucci S, 2010, CURR MED CHEM, V17, P139, DOI 10.2174/092986710790112666; Fiorucci S, 2010, PROG LIPID RES, V49, P171, DOI 10.1016/j.plipres.2009.11.001; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Jones S, 2008, MOL PHARMACEUT, V5, P42, DOI 10.1021/mp700105z; Karrasch T, 2014, EXP CLIN ENDOCR DIAB, V122, P126, DOI 10.1055/s-0033-1363262; Kharitonenkov A, 2009, CURR OPIN PHARMACOL, V9, P805, DOI 10.1016/j.coph.2009.07.001; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Lundasen T, 2006, J INTERN MED, V260, P530, DOI 10.1111/j.1365-2796.2006.01731.x; Matysik S, 2011, CHEM PHYS LIPIDS, V164, P525, DOI 10.1016/j.chemphyslip.2011.05.003; Prawitt J, 2010, METAB SYNDR RELAT D, V8, pS3, DOI 10.1089/met.2010.0096; Scherer M, 2009, J CHROMATOGR B, V877, P3920, DOI 10.1016/j.jchromb.2009.09.038; Schmid A, 2015, EXP CLIN ENDOCR DIAB, V123, P88, DOI 10.1055/s-0034-1395635; Schreuder TCMA, 2010, AM J PHYSIOL-GASTR L, V298, pG440, DOI 10.1152/ajpgi.00322.2009; Shaham O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.50; Staels B, 2010, CURR DIABETES REP, V10, P70, DOI 10.1007/s11892-009-0087-5; Stroeve JHM, 2010, LAB INVEST, V90, P1457, DOI 10.1038/labinvest.2010.107; Yang L, 2015, J LIPOSOME RES, V25, P58, DOI 10.3109/08982104.2014.928888; Zhao XJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE384, DOI 10.1152/ajpendo.90748.2008	26	30	31	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148869	10.1371/journal.pone.0148869	http://dx.doi.org/10.1371/journal.pone.0148869			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863103	gold, Green Published, Green Submitted			2022-12-27	WOS:000370046600118
J	Sood, C; Marin, M; Mason, CS; Melikyan, GB				Sood, Chetan; Marin, Mariana; Mason, Caleb S.; Melikyan, Gregory B.			Visualization of Content Release from Cell Surface-Attached Single HIV-1 Particles Carrying an Extra-Viral Fluorescent pH-Sensor	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CLATHRIN-MEDIATED ENDOCYTOSIS; PLASMA-MEMBRANE; VIROLOGICAL SYNAPSES; REQUIRE ENDOCYTOSIS; EARLY ENDOSOMES; 6-HELIX BUNDLE; T-LYMPHOCYTES; HOST ICAM-1; FUSION	HIV-1 fusion leading to productive entry has long been thought to occur at the plasma membrane. However, our previous single virus imaging data imply that, after Env engagement of CD4 and coreceptors at the cell surface, the virus enters into and fuses with intracellular compartments. We were unable to reliably detect viral fusion at the plasma membrane. Here, we implement a novel virus labeling strategy that biases towards detection of virus fusion that occurs in a pH-neutral environment-at the plasma membrane or, possibly, in early pH-neutral vesicles. Virus particles are co-labeled with an intra-viral content marker, which is released upon fusion, and an extra-viral pH sensor consisting of ecliptic pHluorin fused to the transmembrane domain of ICAM-1. This sensor fully quenches upon virus trafficking to a mildly acidic compartment, thus precluding subsequent detection of viral content release. As an interesting secondary observation, the incorporation of the pH-sensor revealed that HIV-1 particles occasionally shuttle between neutral and acidic compartments in target cells expressing CD4, suggesting a small fraction of viral particles is recycled to the plasma membrane and re-internalized. By imaging viruses bound to living cells, we found that HIV-1 content release in neutral-pH environment was a rare event (similar to 0.4% particles). Surprisingly, viral content release was not significantly reduced by fusion inhibitors, implying that content release was due to spontaneous formation of viral membrane defects occurring at the cell surface. We did not measure a significant occurrence of HIV-1 fusion at neutral pH above this defect-mediated background loss of content, suggesting that the pH sensor may destabilize the membrane of the HIV-1 pseudovirus and, thus, preclude reliable detection of single virus fusion events at neutral pH.	[Sood, Chetan; Marin, Mariana; Mason, Caleb S.; Melikyan, Gregory B.] Emory Univ, Sch Med, Div Pediat Infect Dis, Atlanta, GA USA; [Melikyan, Gregory B.] Childrens Healthcare Atlanta, Atlanta, GA USA	Emory University; Children's Healthcare of Atlanta (CHOA)	Melikyan, GB (corresponding author), Emory Univ, Sch Med, Div Pediat Infect Dis, Atlanta, GA USA.; Melikyan, GB (corresponding author), Childrens Healthcare Atlanta, Atlanta, GA USA.	gmeliki@emory.edu			NIH R01 grant [GM054787]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054787, R29GM054787] Funding Source: NIH RePORTER	NIH R01 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH R01 grant GM054787 to GBM.	Bastiani L, 1997, J VIROL, V71, P3444, DOI 10.1128/JVI.71.5.3444-3450.1997; Beausejour Y, 2004, J VIROL, V78, P11916, DOI 10.1128/JVI.78.21.11916-11925.2004; CLAVEL F, 1994, J VIROL, V68, P1179, DOI 10.1128/JVI.68.2.1179-1185.1994; Clotet-Codina I, 2009, ANTIVIR RES, V83, P94, DOI 10.1016/j.antiviral.2009.03.009; Daecke J, 2005, J VIROL, V79, P1581, DOI 10.1128/JVI.79.3.1581-1594.2005; Dale BM, 2011, CELL HOST MICROBE, V10, P551, DOI 10.1016/j.chom.2011.10.015; de la Vega M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-99; Demirkhanyan L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003431; Demirkhanyan LH, 2012, J BIOL CHEM, V287, P28821, DOI 10.1074/jbc.M112.375949; Desai TM, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0215-z; Gallo SA, 2001, BIOCHEMISTRY-US, V40, P12231, DOI 10.1021/bi0155596; Grover JR, 2015, J VIROL, V89, P454, DOI 10.1128/JVI.02178-14; Herold N, 2014, J VIROL, V88, P13956, DOI 10.1128/JVI.01543-14; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; Jalaguier P, 2015, J VIROL, V89, P323, DOI 10.1128/JVI.02701-14; Jha NK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001260; Jones DM, 2015, SCI REP-UK, V5, DOI 10.1038/srep13449; Koch P, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-84; Kondo N, 2015, J BIOL CHEM, V290, P6558, DOI 10.1074/jbc.M114.623181; Kondo N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044827; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; MADDON PJ, 1988, CELL, V54, P865, DOI 10.1016/S0092-8674(88)91241-X; Marechal V, 1998, J VIROL, V72, P2208; MCCLURE MO, 1988, EMBO J, V7, P513, DOI 10.1002/j.1460-2075.1988.tb02839.x; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Melikyan GB, 2015, J VIROL, V89; Melikyan GB, 2014, CURR OPIN VIROL, V4, P1, DOI 10.1016/j.coviro.2013.09.004; Melikyan GB, 2011, CURR TOP MEMBR, V68, P81, DOI 10.1016/B978-0-12-385891-7.00004-0; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Miyauchi K, 2011, BIOCHEM J, V434, P559, DOI 10.1042/BJ20101588; Miyauchi K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000585; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Padilla-Parra S, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-47; Padilla-Parra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071002; Padilla-Parra S, 2012, P NATL ACAD SCI USA, V109, P17627, DOI 10.1073/pnas.1211714109; Padilla-Parra S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002694; Permanyer M, 2010, TRENDS MICROBIOL, V18, P543, DOI 10.1016/j.tim.2010.09.003; Platt EJ, 2014, J VIROL, V88, P4304, DOI 10.1128/JVI.03447-13; Platt EJ, 2010, J VIROL, V84, P3106, DOI 10.1128/JVI.01958-09; Schaeffer E, 2004, J VIROL, V78, P1375, DOI 10.1128/JVI.78.3.1375-1383.2004; STEIN BS, 1987, CELL, V49, P659, DOI 10.1016/0092-8674(87)90542-3; Tardif MR, 2003, J VIROL, V77, P12299, DOI 10.1128/JVI.77.22.12299-12309.2003; Wei BDL, 2005, J VIROL, V79, P5705, DOI 10.1128/JVI.79.9.5705-5712.2005; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wilen CB, 2012, ADV EXP MED BIOL, V726, P223, DOI 10.1007/978-1-4614-0980-9_10	47	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148944	10.1371/journal.pone.0148944	http://dx.doi.org/10.1371/journal.pone.0148944			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863211	Green Published, Green Submitted, gold			2022-12-27	WOS:000370046600128
J	Lee, YM; Kim, MK; Ahn, DH; Kim, HW; Park, H; Shin, SC				Lee, Yung Mi; Kim, Mi-Kyeong; Ahn, Do Hwan; Kim, Han-Woo; Park, Hyun; Shin, Seung Chul			Comparative Analysis of Lacinutrix Genomes and Their Association with Bacterial Habitat	PLOS ONE			English	Article							SP-NOV.; EMENDED DESCRIPTION; ESCHERICHIA-COLI; MARINE SEDIMENT; BIOSYNTHESIS; DATABASE; OXYGEN	The genus Lacinutrix, which belongs to the family Flavobacteriaceae, consists of seven bacterial species that were mainly isolated from marine life and sediments. As most bacteria in the family Flavobacteriaceae favor aerobic conditions, the seven bacterial species in the genus Lacinutrix also showed aerobic growth. We selected four monophyletic bacterial species living in a polar environment. Two of these species were isolated from sediment and two types were isolated from algae. In a comparative analysis, we investigated how these different environments were related to genomic features of these four species in the genus Lacinutrix. We found that the gene sets for glycolysis, the Krebs cycle, and oxidative phosphorylation were conserved in these four type strains. However, the presence of nitrous oxide reductase for denitrification and the absence of essential components related to thiamin biosynthesis for aerobic respiration were only found in isolates from sediment. Elevated bacterial metabolism on the surface of marine sediments might limit the oxygen penetration into sediment, and such an environment might affect the genomes of bacteria isolated from these habitats.	[Lee, Yung Mi; Kim, Mi-Kyeong; Ahn, Do Hwan; Kim, Han-Woo; Park, Hyun; Shin, Seung Chul] Korea Polar Res Inst, 26 Songdomirae Ro, Inchon 406840, South Korea; [Ahn, Do Hwan; Park, Hyun] Univ Sci & Technol, Daejeon 305333, South Korea	Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI); University of Science & Technology (UST)	Shin, SC (corresponding author), Korea Polar Res Inst, 26 Songdomirae Ro, Inchon 406840, South Korea.	ssc@kopri.re.kr			Functional Genomics on Polar Organisms grant from the Korea Polar Research Institute (KOPRI) [PE15080, PE15070]	Functional Genomics on Polar Organisms grant from the Korea Polar Research Institute (KOPRI)(Korea Polar Research Institute of Marine Research Placement (KOPRI))	This work was supported by a Functional Genomics on Polar Organisms grant (PE15070 and PE15080) funded from the Korea Polar Research Institute (KOPRI).	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bae W, 1997, J BACTERIOL, V179, P7081, DOI 10.1128/jb.179.22.7081-7088.1997; Begley TP, 1999, ARCH MICROBIOL, V171, P293, DOI 10.1007/s002030050713; Bowman JP, 2005, INT J SYST EVOL MICR, V55, P1471, DOI 10.1099/ijs.0.63527-0; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; D'Amico S, 2006, EMBO REP, V7, P385, DOI 10.1038/sj.embor.7400662; D'Hondt S, 2015, NAT GEOSCI, V8, P299, DOI 10.1038/NGEO2387; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Du QL, 2011, INT J BIOL SCI, V7, P41, DOI 10.7150/ijbs.7.41; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Ferrer M, 2003, NAT BIOTECHNOL, V21, P1266, DOI 10.1038/nbt1103-1266; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Koike I., 1988, NITROGEN CYCLING COA, P251; Kraft B, 2011, J BIOTECHNOL, V155, P104, DOI 10.1016/j.jbiotec.2010.12.025; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lasa A, 2015, SYST APPL MICROBIOL, V38, P115, DOI 10.1016/j.syapm.2014.10.012; Lee YM, 2015, MAR GENOMICS; Lee YM, 2014, ANTON LEEUW INT J G, V106, P527, DOI 10.1007/s10482-014-0221-5; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Monteverde DR, 2015, FRONT MICROBIOL, P6; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Nedashkovskaya OI, 2008, INT J SYST EVOL MICR, V58, P2694, DOI 10.1099/ijs.0.65799-0; Park S, 2015, INT J SYST EVOL MICR; Pauleta SR, 2013, COORDIN CHEM REV, V257, P332, DOI 10.1016/j.ccr.2012.05.026; REVSBECH NP, 1980, SCIENCE, V207, P1355, DOI 10.1126/science.207.4437.1355; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Srinivas TNR, 2013, INT J SYST EVOL MICR, V63, P729, DOI 10.1099/ijs.0.040907-0; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wrighton KC, 2012, SCIENCE, V337, P1661, DOI 10.1126/science.1224041; Zhou MY, 2009, MICROB ECOL, V58, P582, DOI 10.1007/s00248-009-9506-z	31	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148889	10.1371/journal.pone.0148889	http://dx.doi.org/10.1371/journal.pone.0148889			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882010	Green Submitted, Green Published, gold			2022-12-27	WOS:000371219000030
J	Mu, YJ; Bi, H; Ekure, E; Ding, G; Wei, N; Hua, N; Qian, XH; Li, XR				Mu, Yajun; Bi, Hua; Ekure, Edgar; Ding, Gang; Wei, Nan; Hua, Ning; Qian, Xuehan; Li, Xiaorong			Performance of Spot Photoscreener in Detecting Amblyopia Risk Factors in Chinese Pre-school and School Age Children Attending an Eye Clinic	PLOS ONE			English	Article							VISION SCREENER; VALIDATION	Purpose To evaluate the effectiveness of Spot photoscreener in detecting amblyopia risk factors meeting 2013 the American Association of Pediatric Ophthalmology and Strabismus (AAPOS) criteria in Chinese preschool and school-age children. Methods One hundred and fifty-five children (310 eyes), aged between 4 to 7 years (5.74 +/- 1.2 years) underwent complete ophthalmologic examination, photoscreening, and cycloplegic retinoscopy refraction. The agreement of the results obtained with the photoscreening and retinoscopy was evaluated by linear regression and Bland-Altman plots. The sensitivity and specificity of detecting amblyopia risk factors were calculated based on the AAPOS 2013 guidelines. The overall effectiveness of detecting amblyopia risk factors was analyzed with Receiver Operating Characteristic (ROC) curves. Result The mean refractive errors measured with the Spot were: spherical equivalent (SE) = 0.70 +/- 1.99 D, J0 = 0.87 +/- 1.01 D, J45 = 0.09 +/- 0.60 D. The mean results from retinoscopy were: SE = 1.19 +/- 2.22 D, J0 = 0.77 +/- 1.00 D, J45 = -0.02 +/- 0.45 D. There was a strong linear agreement between results obtained from those two methods (R-2 = 0.88, P<0.01). Bland-Altman plot indicated a moderate agreement of cylinder values between the two methods. Based on the criteria specified by the AAPOS 2013 guidelines, the sensitivity and specificity (in respective order) for detecting hyperopia were 98.31% and 97.14%; for detecting myopia were 78.50% and 88.64%; for detecting astigmatism were 90.91% and 80.37%; for detecting anisometropia were 93.10% and 85.25%; and for detection of strabismus was 77.55% and 88.18%. Conclusion The refractive values measured from Spot photoscreener showed a moderate agreement with the results from cycloplegic retinoscopy refraction, however there was an overall myopic shift of -0.49D. The performance in detecting individual amblyopia risk factors was satisfactory, but could be further improved by optimizing criteria based on ROC curves.	[Mu, Yajun; Ding, Gang; Wei, Nan; Hua, Ning; Qian, Xuehan] Tianjin Med Univ, Dept Strabismus & Pediat Ophthalmol, Hosp Eye, Tianjin, Peoples R China; [Bi, Hua; Ekure, Edgar] Nova SE Univ, Coll Optometry, Ft Lauderdale, FL 33314 USA; [Li, Xiaorong] Tianjin Med Univ, Dept Retina & Vitreous, Hosp Eye, Tianjin, Peoples R China	Tianjin Medical University; Nova Southeastern University; Tianjin Medical University	Qian, XH (corresponding author), Tianjin Med Univ, Dept Strabismus & Pediat Ophthalmol, Hosp Eye, Tianjin, Peoples R China.; Li, XR (corresponding author), Tianjin Med Univ, Dept Retina & Vitreous, Hosp Eye, Tianjin, Peoples R China.	qianjohn@163.com; xiaorli@163.com	bi, huaqiang/GYJ-5005-2022					Amer Acad Pediat, 2008, PEDIATRICS, V122, P1401, DOI 10.1542/peds.2008-2624; American Academy of Ophthalmology Pediatric Ophthalmology/Strabismus_Panel, 2012, PREF PRACT PATT GUID; Barton M, 2011, PEDIATRICS, V127, P340, DOI 10.1542/peds.2010-3177; Carlton J, 2008, HEALTH TECHNOL ASSES, V12, P1; Chen X, 2015, BRIT J OPHTHALMOLOGY; Cotter S, 2003, AM J OPHTHALMOL, V136, P630, DOI 10.1016/S0002-9394(03)00458-6; Dahlmann-Noor AH, 2008, J AAPOS, V12, P104, DOI 10.1016/j.jaapos.2007.10.006; Donahue SP, 2013, J AAPOS, V17, P4, DOI 10.1016/j.jaapos.2012.09.012; Donahue SP, 2011, PEDIATRICS, V127, P569, DOI 10.1542/peds.2011-0020; Garry GA, 2014, J AAPOS, V18, P476, DOI 10.1016/j.jaapos.2014.07.156; Institut fur Qualitat und Wirtschaftlichkeit im Gesundheitswesen, 2008, FRUH SEHST BEI KIND, V6; Kirk S, 2014, J PEDIAT OPHTH STRAB, V51, P289, DOI 10.3928/01913913-20140701-01; Lagreze WA, 2010, DTSCH ARZTEBL INT, V107, P495, DOI 10.3238/arztebl.2010.0495; Matta NS, 2010, J AAPOS, V14, P147, DOI 10.1016/j.jaapos.2010.01.006; Moghaddam AAS, 2012, BRIT J OPHTHALMOL, V96, P83, DOI 10.1136/bjo.2010.190405; Peterseim MMW, 2014, J AAPOS, V18, P539, DOI 10.1016/j.jaapos.2014.07.176; Schimitzek T, 2005, GRAEF ARCH CLIN EXP, V243, P637, DOI 10.1007/s00417-004-1056-y; Silbert DI, 2014, J AAPOS, V18, P169, DOI 10.1016/j.jaapos.2013.11.019; Simons K, 2005, SURV OPHTHALMOL, V50, P123, DOI 10.1016/j.survophthal.2004.12.005; Yan XR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126052	20	27	28	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149561	10.1371/journal.pone.0149561	http://dx.doi.org/10.1371/journal.pone.0149561			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882106	Green Published, gold, Green Submitted			2022-12-27	WOS:000371219000081
J	Song, HM; Cheng, YJ; Bi, G; Zhu, YH; Jun, W; Ma, WL; Wu, HM				Song, Haoming; Cheng, Youjun; Bi, Gang; Zhu, Yihui; Jun, Wei; Ma, Wenlin; Wu, Huimin			Release of Matrix Metalloproteinases-2 and 9 by S-Nitrosylated Caveolin-1 Contributes to Degradation of Extracellular Matrix in tPA-Treated Hypoxic Endothelial Cells	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; TISSUE-PLASMINOGEN-ACTIVATOR; RECEPTOR-RELATED PROTEIN; CEREBRAL-ISCHEMIA; NITRIC-OXIDE; PROSTATE-CANCER; SECRETED CAVEOLIN-1; NEUROVASCULAR UNIT; STROKE; EXPRESSION	Intracranial hemorrhage remains the most feared complication in tissue plasminogen activator (tPA) thrombolysis for ischemic stroke. However, the underlying molecular mechanisms are still poorly elucidated. In this study, we reported an important role of caveolin-1 (Cav-1) s-nitrosylation in matrix metalloproteinase (MMP)-2 and 9 secretion from tPA-treated ischemic endothelial cells. Brain vascular endothelial cells (bEND3) were exposed to oxygen-glucose deprivation (OGD) for 2 h before adding recombinant human tPA for 6 h. This treatment induced a significant increase of MMP2 and 9 in the media of bEND3 cells and a simultaneous degradation of fibronectin and laminin beta-1, the two main components of extracellular matrix (ECM). Inhibition of MMP2 and 9 with SB-3CT completely blocked the degradation of fibronectin and laminin beta-1. ODG+tPA treatment led to Cav-1 shedding from bEND3 cells into the media. Notably, OGD triggered nitric oxide (NO) production and S-nitrosylation of Cav-1 (SNCav-1). Meanwhile tPA induced activation of ERK signal pathway and stimulates the secretion of SNCav-1. Pretreatment of bEND3 cells with C-PTIO (a NO scavenger) or U0126 (a specific ERK inhibitor) significantly reduced OGD-induced S-nitrosylation of Cav-1 in cells and blocked the secretion of Cav-1 and MMP2 and 9 into the media as well as the degradation of fibronectin and laminin beta-1 in OGD and tPA-treated cells. These data indicate that OGD-triggered Cav-1 S-nitrosylation interacts with tPA-induced ERK activation to augment MMP2 and 9 secretion and subsequent ECM degradation, which may account for the exacerbation of ischemic blood brain barrier damage following tPA thrombolysis for ischemic stroke.	[Song, Haoming; Ma, Wenlin] Tongji Univ, Sch Med, Tongji Hosp, Dept Cardiol, Shanghai 200065, Peoples R China; [Cheng, Youjun] Guangzhou Med Univ, Affiliated Hosp, Guangzhou Brain Hosp, Dept Neurol, Guangzhou 510370, Guangdong, Peoples R China; [Bi, Gang; Zhu, Yihui; Jun, Wei; Ma, Wenlin; Wu, Huimin] Tongji Univ, Sch Med, Tongji Hosp, Translat Ctr Stem Cell Res,Stem Cell Res Ctr, Shanghai 200065, Peoples R China; [Bi, Gang] Tongji Univ, Sch Med, Tongji Hosp, Dept Orthoped, Shanghai 200065, Peoples R China; [Jun, Wei; Wu, Huimin] Tongji Univ, Sch Med, Tongji Hosp, Dept Gen Surg, Shanghai 200065, Peoples R China	Tongji University; Guangzhou Medical University; Tongji University; Tongji University; Tongji University	Song, HM; Ma, WL (corresponding author), Tongji Univ, Sch Med, Tongji Hosp, Dept Cardiol, Shanghai 200065, Peoples R China.; Ma, WL; Wu, HM (corresponding author), Tongji Univ, Sch Med, Tongji Hosp, Translat Ctr Stem Cell Res,Stem Cell Res Ctr, Shanghai 200065, Peoples R China.; Wu, HM (corresponding author), Tongji Univ, Sch Med, Tongji Hosp, Dept Gen Surg, Shanghai 200065, Peoples R China.	songhao-ming@163.com; mawenlin@medmail.com.cn; 13621720055@139.com						Abu Fanne R, 2010, NEUROPHARMACOLOGY, V58, P972, DOI 10.1016/j.neuropharm.2009.12.017; Adya R, 2008, CARDIOVASC RES, V78, P356, DOI 10.1093/cvr/cvm111; Alam M, 2011, NEUROSCI LETT, V495, P135, DOI 10.1016/j.neulet.2011.03.056; Alberts MJ, 1998, NEUROLOGY, V51, pS53, DOI 10.1212/WNL.51.3_Suppl_3.S53; Chaudhry K, 2010, NEUROSCI LETT, V474, P109, DOI 10.1016/j.neulet.2010.03.020; Chi OZ, 1997, ANESTH ANALG, V84, P370, DOI 10.1097/00000539-199702000-00024; Correa F, 2011, J EXP MED, V208, P1229, DOI 10.1084/jem.20101880; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; del Zoppo GJ, 1998, J NEUROL NEUROSUR PS, V65, P1, DOI 10.1136/jnnp.65.1.1; Figueroa BE, 1998, STROKE, V29, P1202, DOI 10.1161/01.STR.29.6.1202; Gu Y, 2012, J NEUROCHEM, V120, P147, DOI 10.1111/j.1471-4159.2011.07542.x; HAMANN GF, 1995, STROKE, V26, P2120, DOI 10.1161/01.STR.26.11.2120; Han F, 2010, J SURG RES, V159, P443, DOI 10.1016/j.jss.2009.03.079; Ignatenko N, 2008, NEOPLASIA, V10, P140, DOI 10.1593/neo.07817; Inoue T, 2010, INVEST OPHTH VIS SCI, V51, P6461, DOI 10.1167/iovs.10-5318; Intengan HD, 2001, HYPERTENSION, V38, P581, DOI 10.1161/hy09t1.096249; Jin XC, 2012, NEUROBIOL DIS, V48, P309, DOI 10.1016/j.nbd.2012.07.007; Jin Y, 2009, FASEB J, V23, P341, DOI 10.1096/fj.08-108423; Lansberg MG, 2007, STROKE, V38, P2275, DOI 10.1161/STROKEAHA.106.480475; Leigh R, 2014, STROKE, V45, P2030, DOI 10.1161/STROKEAHA.114.005249; Liu J, 2012, J NEUROSCI, V32, P3044, DOI 10.1523/JNEUROSCI.6409-11.2012; Liu WL, 2007, J NEUROSCI RES, V85, P829, DOI 10.1002/jnr.21179; Maddahi A, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-56; Mantuano E, 2013, J BIOL CHEM, V288, P34009, DOI 10.1074/jbc.M113.509133; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Montagnani M, 2001, J BIOL CHEM, V276, P30392, DOI 10.1074/jbc.M103702200; Mukhopadhyay S, 2008, AM J PHYSIOL-HEART C, V295, pH1943, DOI 10.1152/ajpheart.00642.2008; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Navarro-Gonzalvez JA, 1998, CLIN CHEM, V44, P679; Parcq J, 2012, CELL DEATH DIFFER, V19, P1983, DOI 10.1038/cdd.2012.86; Polavarapu R, 2007, BLOOD, V109, P3270, DOI 10.1182/blood-2006-08-043125; Puddu A, 2008, BIOCHEM BIOPH RES CO, V375, P235, DOI 10.1016/j.bbrc.2008.08.003; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Schubert W, 2002, J BIOL CHEM, V277, P40091, DOI 10.1074/jbc.M205948200; Stamatovic SM, 2009, J BIOL CHEM, V284, P19053, DOI 10.1074/jbc.M109.000521; Suzuki Y, 2009, BLOOD, V114, P3352, DOI 10.1182/blood-2009-02-203919; Swendeman S, 2008, CIRC RES, V103, P916, DOI 10.1161/CIRCRESAHA.108.184416; Tahir SA, 2001, CANCER RES, V61, P3882; Tahir SA, 2008, CANCER RES, V68, P731, DOI 10.1158/0008-5472.CAN-07-2668; Taraboletti G, 2002, AM J PATHOL, V160, P673, DOI 10.1016/S0002-9440(10)64887-0; Taraboletti G, 2006, NEOPLASIA, V8, P96, DOI 10.1593/neo.05583; Tissue plasminogen activator for acute ischemic stroke, 1995, NEW ENGL J MED, V333, P1581, DOI [DOI 10.1056/NEJM199512143332401, 10.1056/NEJM199512143332401]; Wang XY, 2004, STROKE, V35, P2726, DOI 10.1161/01.STR.0000143219.16695.af; Wang XY, 2003, NAT MED, V9, P1313, DOI 10.1038/nm926; Won SJ, 2011, ANN NEUROL, V70, P583, DOI 10.1002/ana.22538; Wu DQ, 2002, J BIOL CHEM, V277, P40449, DOI 10.1074/jbc.M206270200; Xu PL, 2010, MOL CELL, V37, P551, DOI 10.1016/j.molcel.2010.01.034; Yamashita T, 2009, J CEREBR BLOOD F MET, V29, P715, DOI 10.1038/jcbfm.2008.164; Yang Y, 2011, STROKE, V42, P3323, DOI 10.1161/STROKEAHA.110.608257; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212; Zhao BQ, 2004, BLOOD, V103, P2610, DOI 10.1182/blood-2003-03-0835	51	20	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149269	10.1371/journal.pone.0149269	http://dx.doi.org/10.1371/journal.pone.0149269			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881424	gold, Green Published, Green Submitted			2022-12-27	WOS:000371219000065
J	Vanselow, KA; Samimi, C; Breckle, SW				Vanselow, Kim Andre; Samimi, Cyrus; Breckle, Siegmar-W.			Preserving a Comprehensive Vegetation Knowledge Base - An Evaluation of Four Historical Soviet Vegetation Maps of the Western Pamirs (Tajikistan)	PLOS ONE			English	Article							REGIONAL-SCALE ANALYSIS; CENTRAL-ASIA; CLIMATE; PLANTS; GIS	We edited, redrew, and evaluated four unpublished historical vegetation maps of the Western Pamirs (Tajikistan) by the Soviet geobotanist Okmir E. Agakhanjanz. These maps cover an area of 5,188 km(2) and date from 1958 to 1960. The purpose of this article is to make the historic vegetation data available to the scientific community and thus preserve a hitherto non available and up to now neglected or forgotten data source with great potential for studies on vegetation and ecosystem response to global change. The original hand-drawn maps were scanned, georeferenced, and digitized and the corresponding land cover class was assigned to each polygon. The partly differing legends were harmonized and plant names updated. Furthermore, a digital elevation model and generalized additive models were used to calculate response curves of the land cover classes and to explore vegetation-topography relationships quantitatively. In total, 2,216 polygons belonging to 13 major land cover classes were included that are characterized by 252 different plant species. As such, the presented maps provide excellent comparison data for studies on vegetation and ecosystem change in an area that is deemed to be an important water tower in Central Asia.	[Vanselow, Kim Andre] Univ Erlangen Nurnberg, Dept Geog, D-91054 Erlangen, Germany; [Samimi, Cyrus] Univ Bayreuth, Dept Geog, Bayreuth, Germany; [Breckle, Siegmar-W.] Univ Bielefeld, Dept Ecol, D-33615 Bielefeld, Germany; [Samimi, Cyrus] Univ Bayreuth, BayCEER, Bayreuth, Germany	University of Erlangen Nuremberg; University of Bayreuth; University of Bielefeld; University of Bayreuth	Vanselow, KA (corresponding author), Univ Erlangen Nurnberg, Dept Geog, D-91054 Erlangen, Germany.	kim.vanselow@fau.de	Samimi, Cyrus/H-8085-2012	Samimi, Cyrus/0000-0001-7001-7893	Schmauser Foundation [DFG VA 749/1-1, DFG VA 749/4-1]; German Academic Exchange Service (DAAD); GTZ-CCD project; DFG (Deutsche Forschungsgemeinschaft); DAAD (German Academic Exchange Service); GTZ-CCD-Project Bonn; Volkswagen Foundation [AZ I81 976, AZ 85 862]; Deutsche Forschungsgemeinschaft; Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)	Schmauser Foundation; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); GTZ-CCD project; DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); DAAD (German Academic Exchange Service)(Deutscher Akademischer Austausch Dienst (DAAD)); GTZ-CCD-Project Bonn; Volkswagen Foundation(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)	KAV received funding for travelling to the study area from Schmauser Foundation, https://www.zuv.fau.de/universitaet/stifter-foerderer/stiftungen/Schmauser-Stiftung/. SWB received funding for travelling to the study area from German Academic Exchange Service (DAAD), daad.de and the GTZ-CCD project, https://www.giz.de/fachexpertise/html/2560.html. Kim Andre Vanselow would like to thank DFG (Deutsche Forschungsgemeinschaft, www.dfg.de) and Schmauser Foundation (http://www.zuv.fau.de/universitaet/stifter-foerderer/stiftungen/Schmauser-Stiftung/) for financial support of the field campaigns in 2011 (DFG VA 749/1-1), 2014 (Schmauser), and 2015 (DFG VA 749/4-1). Siegmar-W. Breckle would like to thank DAAD (German Academic Exchange Service, www.daad.de) and GTZ-CCD-Project Bonn (www.giz.de) for financial help with the 2002 Expedition, as well as many local inhabitants and the Ministry of Environment in Dushanbe for many logistic helps. Cyrus Samimi received two research grants from Volkswagen Foundation (www.volkswagenstiftung.de, AZ I81 976, AZ 85 862) which made it possible to undertake numerous field campaigns in the Pamirs. We acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGACHANJANC OE, 1985, PETERMANN GEOGR MITT, V129, P17; Agachanjanz O, 1980, PAMIR AUFZEICHNUNGEN; Agachanjanz OE, 2002, WIND HEISST AFGHANE; AGAKHANJANZ O, 1995, ECOL STUD-ANAL SYNTH, V113, P63; Akhmadov KM, 2006, LAND USE CHANGE AND MOUNTAIN BIODIVERSITY, P239; Beg G. A., 2009, Experiences with and prospects for regional exchange and cooperation in mountain areas, Kathmandu, Nepal, Nov 30 - Dec 2, 2007., P184; Bohner J, 2006, BOREAS, V35, P279, DOI 10.1080/03009480500456073; Breckle SW, 2006, LAND USE CHANGE AND MOUNTAIN BIODIVERSITY, P225, DOI 10.1201/9781420002874.ch16; Breckle SW, 2013, VASCULAR PLANTS AFGH; Breu T., 2003, TAJIK PAMIRS CHALLEN; Chevallier P, 2014, HYDROLOG SCI J, V59, P1491, DOI 10.1080/02626667.2013.838004; Czerepanov SK., 1995, VASCULAR PLANTS RUSS; Frei E, 2010, BOT HELV, V120, P117, DOI 10.1007/s00035-010-0076-y; Giuliani A, 2011, MT RES DEV, V31, P16, DOI 10.1659/MRD-JOURNAL-D-10-00109.1; Gottfried M, 2012, NAT CLIM CHANGE, V2, P111, DOI [10.1038/nclimate1329, 10.1038/NCLIMATE1329]; GRABHERR G, 1994, NATURE, V369, P448, DOI 10.1038/369448a0; Grabherr G., 2010, CHALLENGES MOUNTAIN, P48; Gruber FE, 2013, NAT HAZARD EARTH SYS, V13, P2779, DOI 10.5194/nhess-13-2779-2013; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Herbers Hiltrud, 2006, LANDREFORM EXISTENZS; Kassam KA, 2009, HUM ECOL, V37, P677, DOI 10.1007/s10745-009-9284-8; Kayumov A, 2010, GLACIERS WATER RESOU; Khromova TE, 2006, REMOTE SENS ENVIRON, V102, P24, DOI 10.1016/j.rse.2006.01.019; Leyer I., 2007, MULTIVARIATE STAT OK; Loffler J, 2011, ERDKUNDE, V65, P189, DOI 10.3112/erdkunde.2011.02.06; Mamatumarov R, 2011, PLANTES MED PAMIR OR; McCullagh P, 1989, GEN LINEAR MODELS; Mergili M, 2011, NAT HAZARD EARTH SYS, V11, P1447, DOI 10.5194/nhess-11-1447-2011; Miehe G., 2001, ERDKUNDE, V55, P94, DOI [10.3112/erdkunde.2001.01.06, DOI 10.3112/ERDKUNDE.2001.01.06]; Mislimshoeva B, 2013, FOREST POLICY ECON, V37, P75, DOI 10.1016/j.forpol.2012.12.001; Narama C, 2001, GEOGR REP TOKYO METR, V36, P37; Oberhansli H, 2011, GLOBAL PLANET CHANGE, V76, P95, DOI 10.1016/j.gloplacha.2010.12.008; Ohara N, 2014, J HYDROL ENG, V19, DOI 10.1061/(ASCE)HE.1943-5584.0000988; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Qonunov Y, 2010, PASTORALISM RANGELAN, P82; Salick J, 2009, GLOBAL ENVIRON CHANG, V19, P147, DOI 10.1016/j.gloenvcha.2009.01.008; Schiemann R, 2008, INT J CLIMATOL, V28, P295, DOI 10.1002/joc.1532; Stone P., 1992, STATE WORLDS MOUNTAI; USGS NGA NASA, 2013, SHUTTL RAD TOP MISS; Walter H, 1994, OKOLOGIE DER ERDE; Walther GR, 2005, J VEG SCI, V16, P541, DOI 10.1111/j.1654-1103.2005.tb02394.x; Wood S, 2014, MIXED GAM COMPUTATIO; YEE TW, 1991, J VEG SCI, V2, P587, DOI 10.2307/3236170	43	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148930	10.1371/journal.pone.0148930	http://dx.doi.org/10.1371/journal.pone.0148930			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881428	Green Published, Green Submitted, gold			2022-12-27	WOS:000371219000035
J	Aizawa, N; Kunikata, H; Nitta, F; Shiga, Y; Omodaka, K; Tsuda, S; Nakazawa, T				Aizawa, Naoko; Kunikata, Hiroshi; Nitta, Fumihiko; Shiga, Yukihiro; Omodaka, Kazuko; Tsuda, Satoru; Nakazawa, Toru			Age- and Sex-Dependency of Laser Speckle Flowgraphy Measurements of Optic Nerve Vessel Microcirculation	PLOS ONE			English	Article							OCULAR BLOOD-FLOW; PULSE-WAVE ANALYSIS; HEAD CIRCULATION; 2-DIMENSIONAL MEASUREMENT; VISUAL IMPAIRMENT; NORMAL EYES; POPULATION; VELOCITY; RABBITS; INDEX	Purpose To investigate the relationship between various characteristics of a normal population and laser speckle flowgraphy (LSFG) measurements of mean blur rate (MBR) in the optic nerve head (ONH). Methods A total of 189 eyes of 189 normal subjects (93 male, 96 female, mean age 45 +/- 14 years old, age range: 20-72) without any history of hypertension, hyperlipidemia or diabetes were enrolled. ONH microcirculation was measured with LSFG and overall MBR (MA), vessel-area MBR (MV), and tissue-area MBR (MT) were derived from these measurements. The statistical association of these measurements with characteristics such as sex, age, intraocular pressure (IOP) and systolic blood pressure (SBP) was then determined. Results There was a trend towards decreased IOP and MV and increased SBP with age (P = 0.002, P = 0.035, and P = 0.006, respectively). Furthermore, IOP, MV and SBP were correlated with age (r = -0.23, P = 0.011; r = -0.24, P < 0.001; and r = 0.30, P < 0.001, respectively). Separate multiple regression analyses of independent contributing factors revealed that sex and IOP contributed to MA (P < 0.001 and P = 0.002, respectively), sex, IOP, and age contributed to MV (P < 0.001, P = 0.003, and P = 0.024, respectively), while only IOP contributed to MT (P = 0.003). Conclusion In a normal population, MBR was affected by IOP in both the large vessel and capillary areas of the ONH, but not by SBP. MV was also affected by age and sex, while MT was stable independent of age or sex.	[Aizawa, Naoko; Kunikata, Hiroshi; Nitta, Fumihiko; Shiga, Yukihiro; Omodaka, Kazuko; Tsuda, Satoru; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi 980, Japan; [Kunikata, Hiroshi; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Retinal Dis Control, Sendai, Miyagi 980, Japan; [Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Adv Ophthalm Med, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University	Kunikata, H (corresponding author), Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi 980, Japan.; Kunikata, H (corresponding author), Tohoku Univ, Grad Sch Med, Dept Retinal Dis Control, Sendai, Miyagi 980, Japan.	kunikata@oph.med.tohoku.ac.jp			JST grant from JSPS KAKENHI [26293372, 26462629, 26670751]	JST grant from JSPS KAKENHI	Support was provided by a JST grant from JSPS KAKENHI Grants-in-Aid for Scientific Research (B) (TN 26293372), Scientific Research (C) (HK 26462629), and Exploratory Research (TN 26670751). The funder had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Aizawa N, 2014, INVEST OPHTH VIS SCI, V55, P7991, DOI 10.1167/iovs.14-15373; Aizawa N, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-113; Aizawa N, 2011, CLIN OPHTHALMOL, V5, P1171, DOI 10.2147/OPTH.S22093; Boehm AG, 2005, INVEST OPHTH VIS SCI, V46, P1291, DOI 10.1167/iovs.04-0987; Chiba N, 2011, CLIN OPHTHALMOL, V5, P1549, DOI 10.2147/OPTH.S22097; Deegan BM, 2011, STROKE, V42, P1988, DOI 10.1161/STROKEAHA.110.605618; Demirkaya N, 2013, INVEST OPHTH VIS SCI, V54, P4934, DOI 10.1167/iovs.13-11913; FLORA GC, 1968, CIRCULATION, V38, P859, DOI 10.1161/01.CIR.38.5.859; Groh MJM, 1996, OPHTHALMOLOGY, V103, P529; Isono H, 2003, ARCH OPHTHALMOL-CHIC, V121, P225; Iwase A, 2006, OPHTHALMOLOGY, V113, P1354, DOI 10.1016/j.ophtha.2006.04.022; Joakimsen O, 1999, ARTERIOSCL THROM VAS, V19, P3007, DOI 10.1161/01.ATV.19.12.3007; Konishi N, 2002, OPT REV, V9, P163, DOI 10.1007/s10043-002-0163-4; Maekubo T, 2013, JPN J OPHTHALMOL, V57, P385, DOI 10.1007/s10384-013-0246-8; Nagahara M, 2011, INVEST OPHTH VIS SCI, V52, P87, DOI 10.1167/iovs.09-4422; Nomura H, 1999, OPHTHALMOLOGY, V106, P2016, DOI 10.1016/S0161-6420(99)90417-7; Quigley HA, 1996, NUMBER, V80, P389; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Rhodes LA, 2014, INVEST OPHTH VIS SCI, V55, P8123, DOI 10.1167/iovs.14-15251; Shiba T, 2012, J ATHEROSCLER THROMB, V19, P999, DOI 10.5551/jat.13631; Shiba T, 2012, GRAEF ARCH CLIN EXP, V250, P1275, DOI 10.1007/s00417-012-1952-5; Shiga Y, 2014, INVEST OPHTH VIS SCI, V55, P3899, DOI 10.1167/iovs.14-14116; Shiga Y, 2013, CURR EYE RES, V38, P691, DOI 10.3109/02713683.2012.758292; Sugiyama T, 1996, JPN J OPHTHALMOL, V40, P339; Sugiyama T, 2014, PHOTONICS, V1, P220, DOI 10.3390/photonics1030220; Sugiyama T, 2010, ACTA OPHTHALMOL, V88, P723, DOI 10.1111/j.1755-3768.2009.01586.x; Sugiyama T, 2009, ACTA OPHTHALMOL, V87, P797, DOI 10.1111/j.1755-3768.2008.01460.x; Sugiyama T, 2009, ARCH OPHTHALMOL-CHIC, V127, P454, DOI 10.1001/archophthalmol.2008.606; Swank R L, 1983, Neurol Res, V5, P37; Takahashi H, 2013, EXP EYE RES, V108, P10, DOI 10.1016/j.exer.2012.12.003; TAMAKI Y, 1994, INVEST OPHTH VIS SCI, V35, P3825; TAMAKI Y, 1995, EXP EYE RES, V60, P373, DOI 10.1016/S0014-4835(05)80094-6; Tamura Akiko, 2013, Nippon Ganka Gakkai Zasshi, V117, P110; Toker E, 2003, ACTA OPHTHALMOL SCAN, V81, P617, DOI 10.1111/j.1395-3907.2003.00160.x; Tsuda S, 2014, CURR EYE RES, V39, P1207, DOI 10.3109/02713683.2014.905608; Tsuda S, 2013, J GLAUCOMA, V22, P398, DOI 10.1097/IJG.0b013e318237c8b3; Wang L, 2012, INVEST OPHTH VIS SCI, V53, P8303, DOI 10.1167/iovs.12-10911; Watanabe G, 2008, JPN J OPHTHALMOL, V52, P175, DOI 10.1007/s10384-007-0521-7; Wright J. D., 2011, National Health Statistics Report; Xu L, 2006, OPHTHALMOLOGY, V113, P1134, DOI 10.1016/j.ophtha.2006.01.035; Yanagida K, 2015, INVEST OPHTH VIS SCI, V56, P4880, DOI 10.1167/iovs.15-16567; Yokoyama Y, 2011, CLIN OPHTHALMOL, V5, P1721, DOI 10.2147/OPTH.S23204	42	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148812	10.1371/journal.pone.0148812	http://dx.doi.org/10.1371/journal.pone.0148812			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872348	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100058
J	Dalili, H; Sheikh, M; Hardani, AK; Nili, F; Shariat, M; Nayeri, F				Dalili, Hosein; Sheikh, Mahdi; Hardani, Amir Kamal; Nili, Firouzeh; Shariat, Mamak; Nayeri, Fatemeh			Comparison of the Combined versus Conventional Apgar Scores in Predicting Adverse Neonatal Outcomes	PLOS ONE			English	Article								Objectives Assessing the value of the Combined-Apgar score in predicting neonatal mortality and morbidity compared to the Conventional-Apgar. Methods This prospective cohort study evaluated 942 neonates (166 very preterm, 233 near term, and 543 term) admitted to a tertiary referral hospital. At 1- and 5-minutes after delivery, the Conventional and Combined Apgar scores were recorded. The neonates were followed, and the following information was recorded: the occurrence of severe hyperbilirubinemia requiring medical intervention, the requirement for mechanical ventilation, the occurrence of intraventricular hemorrhage (IVH), and neonatal mortality. Results Before adjusting for the potential confounders, a low Conventional (< 7) or Combined (< 10) Apgar score at 5-minutes was associated with adverse neonatal outcomes. However, after adjustment for the gestational age, birth weight and the requirement for neonatal resuscitation in the delivery room, a depressed 5-minute Conventional-Apgar score lost its significant associations with all the measured adverse outcomes; after the adjustments, a low 5-minute Combined-Apgar score remained significantly associated with the requirement for mechanical ventilation (OR, 18.61; 95% CI, 6.75-51.29), IVH (OR, 4.8; 95% CI, 1.91-12.01), and neonatal mortality (OR, 20.22; 95% CI, 4.22-96.88). Additionally, using Receiver Operating Characteristics (ROC) curves, the area under the curve was higher for the Combined-Apgar than the Conventional-Apgar for the prediction of neonatal mortality and the measured morbidities among all the admitted neonates and their gestational age subgroups. Conclusions The newly proposed Combined-Apgar score can be a good predictor of neonatal mortality and morbidity in the admitted neonates, regardless of their gestational age and resuscitation status. It is also superior to the Conventional-Apgar in predicting adverse neonatal outcomes in very preterm, near term and term neonates.	[Dalili, Hosein; Shariat, Mamak; Nayeri, Fatemeh] Univ Tehran Med Sci, Vali Asr Hosp, Breastfeeding Res Ctr, Tehran, Iran; [Dalili, Hosein; Sheikh, Mahdi; Hardani, Amir Kamal; Nili, Firouzeh; Shariat, Mamak; Nayeri, Fatemeh] Univ Tehran Med Sci, Vali Asr Hosp, Maternal Fetal & Neonatal Res Ctr, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences	Sheikh, M (corresponding author), Univ Tehran Med Sci, Vali Asr Hosp, Maternal Fetal & Neonatal Res Ctr, Tehran, Iran.	mahdisheikh@gmail.com	hardani, amirkamal/N-1234-2017; Sheikh, Mahdi/E-9455-2015	hardani, amirkamal/0000-0002-7734-4181; Sheikh, Mahdi/0000-0003-3972-7824				[Anonymous], 2015, Obstet Gynecol, V126, pe52, DOI 10.1097/AOG.0000000000001108; [Anonymous], 1989, LANCET, V1, P591; APGAR V, 1953, Curr Res Anesth Analg, V32, P260; APGAR V, 1962, AM J DIS CHILD, V104, P419, DOI 10.1001/archpedi.1962.02080030421015; Committee on Obstetric Practice ACOG, 2006, Obstet Gynecol, V107, P1209; Dalili H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122116; Iliodromiti S, 2014, LANCET, V384, P1749, DOI 10.1016/S0140-6736(14)61135-1; Lagatta J, 2012, ACTA PAEDIATR, V101, pe243, DOI 10.1111/j.1651-2227.2011.02334.x; Li F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069072; Lopriore E, 2004, BRIT MED J, V329, P143, DOI 10.1136/bmj.38117.665197.F7; MARLOW N, 1992, ARCH DIS CHILD-FETAL, V67, P765, DOI 10.1136/adc.67.7_Spec_No.765; Misra P K, 1994, Indian Pediatr, V31, P1215; O'Donnell CPF, 2006, J PEDIATR-US, V149, P486, DOI 10.1016/j.jpeds.2006.05.040; Oh W, 1996, PEDIATRICS, V98, P141; Rudiger M, 2012, NEOREVIEWS, V13, pe336, DOI [10.1542/neo.13-6-e336, DOI 10.1097/PCC.0B013E318253C945]; Rudiger M, 2006, PEDIATRICS, V118, P1314, DOI 10.1542/peds.2006-1254; Rudiger M, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0334-7; Rudiger M, 2015, LANCET, V385, P505, DOI 10.1016/S0140-6736(15)60196-9; Rudiger M, 2011, EARLY HUM DEV, V87, P749, DOI 10.1016/j.earlhumdev.2011.08.019; Rudiger M, 2009, ACTA PAEDIATR, V98, P1433, DOI 10.1111/j.1651-2227.2009.01347.x	20	16	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149464	10.1371/journal.pone.0149464	http://dx.doi.org/10.1371/journal.pone.0149464			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871908	gold, Green Published, Green Submitted			2022-12-27	WOS:000370054100162
J	Llobera, J; Charbonnier, C; Chague, S; Preissmann, D; Antonietti, JP; Ansermet, F; Magistretti, PJ				Llobera, Joan; Charbonnier, Caecilia; Chague, Sylvain; Preissmann, Delphine; Antonietti, Jean-Philippe; Ansermet, Francois; Magistretti, Pierre J.			The Subjective Sensation of Synchrony: An Experimental Study	PLOS ONE			English	Article							INTERPERSONAL SYNCHRONY; PERCEPTION; CONSCIOUSNESS; DYNAMICS; ROCKING; MODEL	People performing actions together have a natural tendency to synchronize their behavior. Consistently, people doing a task together build internal representations not only of their actions and goals, but also of the other people performing the task. However, little is known about which are the behavioral mechanisms and the psychological factors affecting the subjective sensation of synchrony, or "connecting" with someone else. In this work, we sought to find which factors induce the subjective sensation of synchrony, combining motion capture data and psychological measures. Our results show that the subjective sensation of synchrony is affected by performance quality together with task category, and time. Psychological factors such as empathy and negative subjective affects also correlate with the subjective sensation of synchrony. However, when people estimate synchrony as seen from a third person perspective, their psychological factors do not affect the accuracy of the estimation. We suggest that to feel this sensation it is necessary to, first, have a good joint performance and, second, to assume the existence of an attention monitoring mechanism that reports that the attention of both participants (self and other) is focused on the task.	[Llobera, Joan] Ecole Polytech Fed Lausanne, Immers Interact Grp, CH-1015 Lausanne, Switzerland; [Charbonnier, Caecilia; Chague, Sylvain] Artanim Fdn, Dept Med Res, Geneva, Switzerland; [Preissmann, Delphine; Antonietti, Jean-Philippe] Univ Lausanne, Inst Psychol, Lausanne, Switzerland; [Preissmann, Delphine] Univ Lausanne, Dept Ecol, Lausanne, Switzerland; [Preissmann, Delphine; Ansermet, Francois] Univ Hosp Geneva, Dept Child & Adolescent Psychiat, Geneva, Switzerland; [Ansermet, Francois] Univ Geneva, Dept Psychiat, Geneva, Switzerland; [Magistretti, Pierre J.] KAUST, Thuwal, Makkah Province, Saudi Arabia; [Magistretti, Pierre J.] Ecole Polytech Fed Lausanne, Brain Mind Inst, CH-1015 Lausanne, Switzerland; [Llobera, Joan; Preissmann, Delphine; Ansermet, Francois; Magistretti, Pierre J.] Agalma Fdn, Geneva, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; University of Lausanne; University of Geneva; University of Geneva; King Abdullah University of Science & Technology; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Llobera, J (corresponding author), Ecole Polytech Fed Lausanne, Immers Interact Grp, CH-1015 Lausanne, Switzerland.; Llobera, J (corresponding author), Agalma Fdn, Geneva, Switzerland.	joan.llobera@epfl.ch	Llobera, Joan/T-9094-2017; Llobera, Joan/G-3918-2016	Llobera, Joan/0000-0003-4113-4251; Llobera, Joan/0000-0002-9471-1334; Charbonnier, Caecilia/0000-0002-7018-885X; Magistretti, Pierre Julius/0000-0002-6678-320X	Agalma Foundation	Agalma Foundation	This research project has been funded entirely by the Agalma Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Atmaca S, 2011, EXP BRAIN RES, V211, P371, DOI 10.1007/s00221-011-2709-9; Atmaca S, 2008, SOC NEUROSCI-UK, V3, P410, DOI 10.1080/17470910801900908; Baars BJ, 2002, TRENDS COGN SCI, V6, P47, DOI 10.1016/S1364-6613(00)01819-2; Bollen KA, 2006, WILEY SER PROBAB ST, P1; Casali AG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006294; Centelles L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015749; Codrons E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107538; CUTTING JE, 1977, B PSYCHONOMIC SOC, V9, P353, DOI 10.3758/BF03337021; Davis M, 1980, JSAS CATALOG SELECTE, V10; Demos AP, 2012, J EXP PSYCHOL GEN, V141, P49, DOI 10.1037/a0023843; Dobson AJ, 2008, INTRO GEN LINEAR MOD; Dumas G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012166; Duncan T. E., 2013, INTRO LATENT VARIABL, DOI DOI 10.4324/9780203879962; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; Gaudreau P, 2006, EUROPEAN J PSYCHOL A, V22, P9; Graziano MS, CONSCIOUSNESS SOCIAL; Hart Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087213; Helm JL, 2012, EMOTION, V12, P748, DOI 10.1037/a0025036; Hove MJ, 2009, SOC COGNITION, V27, P949, DOI 10.1521/soco.2009.27.6.949; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Kenny D. A., 2006, DYADIC DATA ANAL; Knoblich G, 2011, PSYCHOL LEARN MOTIV, V54, P59, DOI 10.1016/B978-0-12-385527-5.00003-6; Konvalinka I, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00215; Konvalinka I, 2011, P NATL ACAD SCI USA, V108, P8514, DOI 10.1073/pnas.1016955108; KOZLOWSKI LT, 1977, PERCEPT PSYCHOPHYS, V21, P575, DOI 10.3758/BF03198740; LONGFORD NT, 1994, COMPUT STAT DATA AN, V17, P1, DOI 10.1016/0167-9473(92)00062-V; Lumsden J, 2012, J EXP SOC PSYCHOL, V48, P746, DOI 10.1016/j.jesp.2011.12.007; Marsh KL, 2013, FRONTIERS INTEGRATIV; McCullagh P, 1989, GEN LINEAR MODELS; Miles LK, 2009, J EXP SOC PSYCHOL, V45, P585, DOI 10.1016/j.jesp.2009.02.002; Muller V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024893; Noy L, 2011, P NATL ACAD SCI USA, V108, P20947, DOI 10.1073/pnas.1108155108; Richardson MJ, 2007, HUM MOVEMENT SCI, V26, P867, DOI 10.1016/j.humov.2007.07.002; Thagard P, 2008, CONSCIOUS COGN, V17, P811, DOI 10.1016/j.concog.2007.05.014; Van De Kamp T, 2014, PLOS ONE, V9; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wiltermuth SS, 2009, PSYCHOL SCI, V20, P1, DOI 10.1111/j.1467-9280.2008.02253.x	38	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0147008	10.1371/journal.pone.0147008	http://dx.doi.org/10.1371/journal.pone.0147008			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6SI	26870943	Green Published, gold			2022-12-27	WOS:000370054100005
J	Schurgers, E; Moorlag, M; Hemker, C; Lindhout, T; Kelchtermans, H; de Laat, B				Schurgers, Evelien; Moorlag, Martijn; Hemker, Coenraad; Lindhout, Theo; Kelchtermans, Hilde; de Laat, Bas			Thrombin Generation in Zebrafish Blood	PLOS ONE			English	Article							COAGULATION PATHWAY; IDENTIFICATION; HEMOSTASIS; KNOCKDOWN	To better understand hypercoagulability as an underlying cause for thrombosis, the leading cause of death in the Western world, new assays to study ex vivo coagulation are essential. The zebrafish is generally accepted as a good model for human hemostasis and thrombosis, as the hemostatic system proved to be similar to that in man. Their small size however, has been a hurdle for more widespread use in hemostasis related research. In this study we developed a method that enables the measurement of thrombin generation in a single drop of non-anticoagulated zebrafish blood. Pre-treatment of the fish with inhibitors of FXa and thrombin, resulted in a dose dependent diminishing of thrombin generation, demonstrating the validity of the assay. In order to establish the relationship between whole blood thrombin generation and fibrin formation, we visualized the resulting fibrin network by scanning electron microscopy. Taken together, in this study we developed a fast and reliable method to measure thrombin generation in whole blood collected from a single zebrafish. Given the similarities between coagulation pathways of zebrafish and mammals, zebrafish may be an ideal animal model to determine the effect of novel therapeutics on thrombin generation. Additionally, because of the ease with which gene functions can be silenced, zebrafish may serve as a model organism for mechanistical research in thrombosis and hemostasis.	[Schurgers, Evelien; Moorlag, Martijn; Hemker, Coenraad; Lindhout, Theo; Kelchtermans, Hilde; de Laat, Bas] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands; [Schurgers, Evelien; Moorlag, Martijn; Hemker, Coenraad; Lindhout, Theo; Kelchtermans, Hilde; de Laat, Bas] Synapse BV, Maastricht, Netherlands	Maastricht University	Kelchtermans, H (corresponding author), Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands.; Kelchtermans, H (corresponding author), Synapse BV, Maastricht, Netherlands.	h.kelchtermans@thrombin.com		Hemker, Coen/0000-0003-1669-2358; Kelchtermans, Hilde/0000-0002-2724-3438; Schurgers, Evelien/0000-0001-8397-3112	Synapse BV	Synapse BV	Synapse BV provided support in the form of salaries for authors ES, MM, CH, TL, HK and BdL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Al Dieri R, 2012, BLOOD REV, V26, P197, DOI 10.1016/j.blre.2012.06.001; Carradice D, 2008, BLOOD, V111, P3331, DOI 10.1182/blood-2007-10-052761; Day K, 2004, BLOOD CELL MOL DIS, V32, P191, DOI 10.1016/j.bcmd.2003.09.004; Driever W, 1996, DEVELOPMENT, V123, P37; Gregory M, 2002, BLOOD CELL MOL DIS, V29, P286, DOI 10.1006/bcmd.2002.0568; Hemker HC, 2006, THROMB HAEMOSTASIS, V96, P553, DOI 10.1160/TH06-07-0408; Hemker HC, 2005, J THROMB HAEMOST, V3, P2399, DOI 10.1111/j.1538-7836.2005.01565.x; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; Jagadeeswaran P, 1999, BLOOD CELL MOL DIS, V25, P239, DOI 10.1006/bcmd.1999.0249; Jagadeeswaran P, 2000, BRIT J HAEMATOL, V110, P946, DOI 10.1046/j.1365-2141.2000.02284.x; Jagadeeswaran P, 1997, BLOOD CELL MOL DIS, V23, P410, DOI 10.1006/bcmd.1997.0158; Jagadeeswaran P, 1999, BRIT J HAEMATOL, V107, P731, DOI 10.1046/j.1365-2141.1999.01763.x; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Ninivaggi M, 2012, CLIN CHEM, V58, P1252, DOI 10.1373/clinchem.2012.184077; Ryan EA, 1999, BIOPHYS J, V77, P2813, DOI 10.1016/S0006-3495(99)77113-4; SHAH GA, 1985, THROMB RES, V40, P181, DOI 10.1016/0049-3848(85)90328-7; Sheehan J, 2001, P NATL ACAD SCI USA, V98, P8768, DOI 10.1073/pnas.131109398; Wolberg AS, 2008, TRANSFUS APHER SCI, V38, P15, DOI 10.1016/j.transci.2007.12.005	18	6	7	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149135	10.1371/journal.pone.0149135	http://dx.doi.org/10.1371/journal.pone.0149135			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872266	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100111
J	Asano, Y; Fairchild, MD; Blonde, L				Asano, Yuta; Fairchild, Mark D.; Blonde, Laurent			Individual Colorimetric Observer Model	PLOS ONE			English	Article							PIGMENT OPTICAL-DENSITY; HUMAN OCULAR MEDIA; COLOR-MATCHING FUNCTIONS; HUMAN CONE PHOTOPIGMENTS; AGE-RELATED MACULOPATHY; HUMAN CRYSTALLINE LENS; MACULAR PIGMENT; SERUM CONCENTRATIONS; ABSORPTION-SPECTRA; HIGH ILLUMINANCES	This study proposes a vision model for individual colorimetric observers. The proposed model can be beneficial in many color-critical applications such as color grading and soft proofing to assess ranges of color matches instead of a single average match. We extended the CIE 2006 physiological observer by adding eight additional physiological parameters to model individual color-normal observers. These eight parameters control lens pigment density, macular pigment density, optical densities of L-, M-, and S-cone photopigments, and lambda(max) shifts of L-, M-, and S-cone photopigments. By identifying the variability of each physiological parameter, the model can simulate color matching functions among color-normal populations using Monte Carlo simulation. The variabilities of the eight parameters were identified through two steps. In the first step, extensive reviews of past studies were performed for each of the eight physiological parameters. In the second step, the obtained variabilities were scaled to fit a color matching dataset. The model was validated using three different datasets: traditional color matching, applied color matching, and Rayleigh matches.	[Asano, Yuta; Fairchild, Mark D.] Rochester Inst Technol, Munsell Color Sci Lab, Rochester, NY 14623 USA; [Asano, Yuta] Motorola Mobil, Chicago, IL USA; [Blonde, Laurent] Technicolor, Rennes, France	Rochester Institute of Technology; Legend Holdings; Lenovo; Technicolor SA	Fairchild, MD (corresponding author), Rochester Inst Technol, Munsell Color Sci Lab, Rochester, NY 14623 USA.	Mark.Fairchild@rit.edu	Blondé, Laurent/G-6233-2010	Blondé, Laurent/0000-0003-3112-7701	Technicolor	Technicolor	The funder (Technicolor) provided support in the form of salaries for an author (YA), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the "author contributions" section. Also, the author Yuta Asano is affiliated with a company "Motorola Mobility".	Alfvin RL, 1997, COLOR RES APPL, V22, P174, DOI 10.1002/(SICI)1520-6378(199706)22:3<174::AID-COL6>3.0.CO;2-O; Allen E., 1970, P 1 AIC C COL, P771; ALPERN M, 1979, J PHYSIOL-LONDON, V288, P85; Artigas JM, 2012, INVEST OPHTH VIS SCI, V53, P4076, DOI 10.1167/iovs.12-9471; Asano, 2015, THESIS ROCHESTER I T; ASENJO AB, 1994, NEURON, V12, P1131, DOI 10.1016/0896-6273(94)90320-4; Berendschot TTJM, 2010, ESSENT OPHTHALMOL, P51, DOI 10.1007/978-3-540-85540-8_6; Berendschot TTJM, 2004, ARCH BIOCHEM BIOPHYS, V430, P149, DOI 10.1016/j.abb.2004.04.029; Berendschot TTJM, 1996, J PHYSIOL-LONDON, V492, P307, DOI 10.1113/jphysiol.1996.sp021310; Berendschot TTJM, 2002, ARCH OPHTHALMOL-CHIC, V120, P1732, DOI 10.1001/archopht.120.12.1732; Berendschot TTJM, 2002, INVEST OPHTH VIS SCI, V43, P1928; Bone RA, 2003, J NUTR, V133, P992, DOI 10.1093/jn/133.4.992; Broekmans WMR, 2002, AM J CLIN NUTR, V76, P595, DOI 10.1093/ajcn/76.3.595; BURNS SA, 1993, J OPT SOC AM A, V10, P221, DOI 10.1364/JOSAA.10.000221; BURNS SA, 1985, J OPT SOC AM A, V2, P698, DOI 10.1364/JOSAA.2.000698; CIE, 1989, CIE PUBL, V80; CIE, 2006, CIE PUBL, V170; Ciulla TA, 2001, OPHTHALMOLOGY, V108, P730, DOI 10.1016/S0161-6420(00)00655-2; COOK CA, 1994, VISION RES, V34, P2945, DOI 10.1016/0042-6989(94)90266-6; CVRL, STIL BURCH IND COL M; DARTNALL HJA, 1983, PROC R SOC SER B-BIO, V220, P115, DOI 10.1098/rspb.1983.0091; Delori FC, 2001, J OPT SOC AM A, V18, P1212, DOI 10.1364/JOSAA.18.001212; DENATALE R, 1992, INT OPHTHALMOL, V16, P1; DENATALE R, 1988, OPHTHALMOLOGICA, V197, P14, DOI 10.1159/000309911; ELSNER AE, 1988, J OPT SOC AM A, V5, P2106, DOI 10.1364/JOSAA.5.002106; Fairchild Mark D., 2013, Twenty-first Color and Imaging Conference. Color Science and Engineering Systems, Technologies, and Applications (CIC21). Proceedings, P185; Fairchild MD, 1996, OSA ANN M ROCH, V126; Hammond BR, 2005, OPTOMETRY VISION SCI, V82, P387, DOI 10.1097/01.OPX.0000162652.85875.D2; Hammond BR, 1996, VISION RES, V36, P2001, DOI 10.1016/0042-6989(95)00290-1; Hammond BR, 2000, INVEST OPHTH VIS SCI, V41, P1492; Hammond BR, 1999, OPHTHAL PHYSL OPT, V19, P300, DOI 10.1046/j.1475-1313.1999.00444.x; Heckaman RL, 2015, COLOR RES A IN PRESS; Howells O, 2013, INVEST OPHTH VIS SCI, V54, P2711, DOI 10.1167/iovs.12-10957; Howells O, 2011, GRAEF ARCH CLIN EXP, V249, P315, DOI 10.1007/s00417-010-1577-5; Iannaccone A, 2007, INVEST OPHTH VIS SCI, V48, P1458, DOI 10.1167/iovs.06-0438; JOHNSON CA, 1993, OPTOMETRY VISION SCI, V70, P944, DOI 10.1097/00006324-199311000-00012; KEUNEN JEE, 1987, INVEST OPHTH VIS SCI, V28, P985; Liew SHM, 2005, INVEST OPHTH VIS SCI, V46, P4430, DOI 10.1167/iovs.05-0519; LUTZE M, 1991, INVEST OPHTH VIS SCI, V32, P194; MCSL, MUNS COL SCI LAB US; MCSL, MUNSELL COLOR SCIENC; MELLERIO J, 1971, VISION RES, V11, P129, DOI 10.1016/0042-6989(71)90229-X; MERBS SL, 1992, SCIENCE, V258, P464, DOI 10.1126/science.1411542; MERBS SL, 1992, NATURE, V356, P433, DOI 10.1038/356433a0; Moreland JD, 1997, DOC OPHTH P, V59, P363; NAYATANI Y, 1983, COLOR RES APPL, V8, P47, DOI 10.1002/col.5080080110; NEITZ J, 1990, VISION RES, V30, P621, DOI 10.1016/0042-6989(90)90073-T; Neitz J, 1999, NAT NEUROSCI, V2, P884, DOI 10.1038/13185; NEITZ J, 1993, VISION RES, V33, P117, DOI 10.1016/0042-6989(93)90064-4; Neitz J, 2011, VISION RES, V51, P633, DOI 10.1016/j.visres.2010.12.002; Nolan J, 2004, INVEST OPHTH VIS SCI, V45, P3940, DOI 10.1167/iovs.04-0273; Nolan JM, 2007, EXP EYE RES, V84, P61, DOI 10.1016/j.exer.2006.08.016; NORREN DV, 1974, VISION RES, V14, P1237, DOI 10.1016/0042-6989(74)90222-3; NORTH AD, 1993, COLOR RES APPL, V18, P163, DOI 10.1002/col.5080180306; OHTA N, 1985, COLOR RES APPL, V10, P156, DOI 10.1002/col.5080100304; POKORNY J, 1976, J OPT SOC AM, V66, P705, DOI 10.1364/JOSA.66.000705; POKORNY J, 1987, APPL OPTICS, V26, P1437, DOI 10.1364/AO.26.001437; Polo V, 1997, INT OPHTHALMOL, V20, P7; Renner AB, 2004, VISUAL NEUROSCI, V21, P827, DOI 10.1017/S0952523804216030; RICH DC, 1995, COLOR RES APPL, V20, P29, DOI 10.1002/col.5080200106; Rufer F, 2012, GRAEF ARCH CLIN EXP, V250, P1267, DOI 10.1007/s00417-012-1949-0; SANOCKI E, 1993, VISION RES, V33, P2139, DOI 10.1016/0042-6989(93)90012-L; Savage GL, 2001, OPTOMETRY VISION SCI, V78, P386, DOI 10.1097/00006324-200106000-00010; Sharpe LT, 1998, J NEUROSCI, V18, P10053; Sharpe LT, 2001, COLOR VISION GENES P; Stiles W. S., 1959, OPT ACTA, V6, P1, DOI [10.1080/713826267, DOI 10.1080/713826267]; Stockman A, 1999, VISION RES, V39, P2901, DOI 10.1016/S0042-6989(98)00225-9; Swanson WH, 1996, VISION RES, V36, P2079, DOI 10.1016/0042-6989(95)00280-4; Thurston GM, 1997, CURR EYE RES, V16, P197, DOI 10.1076/ceyr.16.3.197.15410; Trieschmann M, 2006, GRAEF ARCH CLIN EXP, V244, P1565, DOI 10.1007/s00417-006-0289-3; van de Kraats J, 2007, J OPT SOC AM A, V24, P1842, DOI 10.1364/JOSAA.24.001842; VANNORREN D, 1985, INVEST OPHTH VIS SCI, V26, P1014; WEBSTER MA, 1988, J OPT SOC AM A, V5, P1722, DOI 10.1364/JOSAA.5.001722; WERNER JS, 1982, J OPT SOC AM, V72, P247, DOI 10.1364/JOSA.72.000247; Whitehead AJ, 2006, ARCH OPHTHALMOL-CHIC, V124, P1038, DOI 10.1001/archopht.124.7.1038; Wild JM, 1998, INVEST OPHTH VIS SCI, V39, P54; Wustemeyer H, 2003, GRAEF ARCH CLIN EXP, V241, P647, DOI 10.1007/s00417-003-0730-9; WYSZECKI G, 1980, VISION RES, V20, P23, DOI 10.1016/0042-6989(80)90138-8; Wyszecki G, 1982, COLOR SCI, Vsecond	79	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0145671	10.1371/journal.pone.0145671	http://dx.doi.org/10.1371/journal.pone.0145671			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862905	Green Published, gold, Green Submitted			2022-12-27	WOS:000370046600008
J	Diaz, P; Sibley, CP; Greenwood, SL				Diaz, Paula; Sibley, Colin P.; Greenwood, Susan L.			Oxygen-Sensitive K+ Channels Modulate Human Chorionic Gonadotropin Secretion from Human Placental Trophoblast	PLOS ONE			English	Article							OXIDATIVE STRESS; HUMAN CYTOTROPHOBLAST; VILLOUS EXPLANTS; CA2+ ENTRY; EXPRESSION; APOPTOSIS; DIFFERENTIATION; PREECLAMPSIA; HCG; SYNCYTIOTROPHOBLAST	Human chorionic gonadotropin (hCG) is a key autocrine/paracrine regulator of placental syncytiotrophoblast, the transport epithelium of the human placenta. Syncytiotrophoblast hCG secretion is modulated by the partial pressure of oxygen (pO(2)), reactive oxygen species (ROS) and potassium (K+) channels. Here we test the hypothesis that K+ channels mediate the effects of pO(2) and ROS on hCG secretion. Placental villous explants from normal term pregnancies were cultured for 6 days at 6% (normoxia), 21% (hyperoxia) or 1% (hypoxia) pO(2). On days 3-5, explants were treated with 5mM 4-aminopyridine (4-AP) or tetraethylammonium (TEA), blockers of pO(2)-sensitive voltage-gated K+ (K-V) channels, or ROS (10-1000 mu M H2O2). hCG secretion and lactate dehydrogenase (LDH) release, a marker of necrosis, were determined daily. At day 6, hCG and LDH were measured in tissue lysate and Rb-86 (K+) efflux assessed to estimate syncytiotrophoblast K+ permeability. hCG secretion and Rb-86 efflux were significantly greater in explants maintained in 21% pO(2) than normoxia. 4-AP/TEA inhibited hCG secretion to a greater extent at 21% than 6% and 1% pO(2), and reduced Rb-86 efflux at 21% but not 6% pO(2). LDH release and tissue LDH/hCG were similar in 6%, 21% and 1% pO(2) and unaffected by 4-AP/TEA. H2O2 stimulated Rb-86 efflux and hCG secretion at normoxia but decreased Rb-86 efflux, without affecting hCG secretion, at 21% pO(2). 4-AP/TEA-sensitive K+ channels participate in pO(2)-sensitive hCG secretion from syncytiotrophoblast. ROS effects on both hCG secretion and Rb-86 efflux are pO(2)-dependent but causal links between the two remain to be established.	[Diaz, Paula; Sibley, Colin P.; Greenwood, Susan L.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Inst Human Dev, Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England; [Diaz, Paula; Sibley, Colin P.; Greenwood, Susan L.] Cent Manchester Univ Hosp NHS Fdn Trust, St Marys Hosp, Manchester, Lancs, England	University of Manchester; University of Manchester	Diaz, P (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Inst Human Dev, Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England.; Diaz, P (corresponding author), Cent Manchester Univ Hosp NHS Fdn Trust, St Marys Hosp, Manchester, Lancs, England.	pdiaztm@gmail.com	DIAZ, PAULA/ABG-5263-2021	DIAZ, PAULA/0000-0003-1479-7340	Tommy's, the baby charity; CONICYT-Becas Chile [72090593]; Action Medical Research	Tommy's, the baby charity; CONICYT-Becas Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Action Medical Research	This work was supported by Tommy's, the baby charity, CONICYT-Becas Chile 72090593 and Action Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsat E, 1996, J CELL PHYSIOL, V168, P346, DOI 10.1002/(SICI)1097-4652(199608)168:2<346::AID-JCP13>3.0.CO;2-1; Appiah I, 2009, BRIT J PHARMACOL, V158, P1932, DOI 10.1111/j.1476-5381.2009.00490.x; Archer SL, 2004, BIOL CHEM, V385, P205, DOI 10.1515/BC.2004.014; Aris AK, 2007, CLIN BIOCHEM, V40, P94, DOI 10.1016/j.clinbiochem.2006.10.008; BOYD CAR, 1983, CIBA F SYMP, V95, P300; BROWN PD, 1993, PLACENTA, V14, P103, DOI 10.1016/S0143-4004(05)80253-X; Burg ED, 2006, J MEMBRANE BIOL, V209, P3, DOI 10.1007/s00232-005-0838-4; Burton GJ, 2009, J ANAT, V215, P27, DOI 10.1111/j.1469-7580.2008.00978.x; Cindrova-Davies T, 2009, PLACENTA, V30, pS55, DOI 10.1016/j.placenta.2008.11.020; Clarson LH, 2003, J PHYSIOL-LONDON, V550, P515, DOI 10.1113/jphysiol.2003.044149; Clarson LH, 2002, J PHYSL; Corcoran J, 2008, HYPERTENS PREGNANCY, V27, P75, DOI 10.1080/10641950701826158; Crocker IP, 2004, J PATHOL, V204, P11, DOI 10.1002/path.1610; Crocker IP, 2004, J HISTOCHEM CYTOCHEM, V52, P749, DOI 10.1369/jhc.3A6176.2004; CRONIER L, 1994, ENDOCRINOLOGY, V135, P402, DOI 10.1210/en.135.1.402; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Gutterman DD, 2005, ARTERIOSCL THROM VAS, V25, P671, DOI 10.1161/01.ATV.0000158497.09626.3b; Heazell AEP, 2008, PLACENTA, V29, P175, DOI 10.1016/j.placenta.2007.11.002; Hempstock J, 2003, PLACENTA, V24, P517, DOI 10.1053/plac.2002.0955; Higgins L, 2013, J MATERN-FETAL NEO M, V26, P783, DOI 10.3109/14767058.2012.760539; HSU CD, 1994, AM J OBSTET GYNECOL, V170, P1135, DOI 10.1016/S0002-9378(94)70108-3; Hung Tai-Ho, 2006, Taiwan J Obstet Gynecol, V45, P189; Huppertz B, 2014, J REPROD IMMUNOL, V101, P74, DOI 10.1016/j.jri.2013.04.003; Kharfi A, 2005, CLIN BIOCHEM, V38, P717, DOI 10.1016/j.clinbiochem.2005.04.011; Kingdom JCP, 1997, PLACENTA, V18, P613, DOI 10.1016/S0143-4004(97)90000-X; Kourie JI, 1998, AM J PHYSIOL-CELL PH, V275, pC1, DOI 10.1152/ajpcell.1998.275.1.C1; Lacey H, 2005, THE JOURNAL OF PHYSI, V565P, pPC173; Lim KH, 1997, AM J PATHOL, V151, P1809; Longtine MS, 2012, PLACENTA, V33, P971, DOI 10.1016/j.placenta.2012.09.013; Longtine MS, 2012, REPRODUCTION, V143, P107, DOI 10.1530/REP-11-0340; Lybaert P, 2013, PLACENTA, V34, P467, DOI 10.1016/j.placenta.2013.03.006; MEURIS S, 1994, BBA-MOL CELL RES, V1220, P101, DOI 10.1016/0167-4889(94)90124-4; Moll SJ, 2007, APOPTOSIS, V12, P1611, DOI 10.1007/s10495-007-0092-6; Myatt L, 2004, HISTOCHEM CELL BIOL, V122, P369, DOI 10.1007/s00418-004-0677-x; Myatt L, 2010, PLACENTA, V31, pS66, DOI 10.1016/j.placenta.2009.12.021; Patel AJ, 2001, EUR RESPIR J, V18, P221, DOI 10.1183/09031936.01.00204001; Platoshyn O, 2001, AM J PHYSIOL-LUNG C, V280, pL801, DOI 10.1152/ajplung.2001.280.4.L801; Poston L, 2011, AM J CLIN NUTR, V94, p1980S, DOI 10.3945/ajcn.110.001156; Raijmakers MTM, 2005, CURR PHARM DESIGN, V11, P711, DOI 10.2174/1381612053381837; Rogers PA, 2007, AM J PHYSIOL-HEART C, V292, pH1404, DOI 10.1152/ajpheart.00696.2006; Siman CM, 2001, AM J PHYSIOL-REG I, V280, pR1116, DOI 10.1152/ajpregu.2001.280.4.R1116; Takagi Y, 2004, VIRCHOWS ARCH, V444, P49, DOI 10.1007/s00428-003-0903-2; Turner MA, 2006, PLACENTA, V27, P98, DOI 10.1016/j.placenta.2004.12.004; Wang YP, 1996, J SOC GYNECOL INVEST, V3, P179, DOI 10.1016/1071-5576(96)00015-9; Weedon-Fekjraer MS, 2012, PLACENTA, V33, pS87, DOI 10.1016/j.placenta.2011.11.003; Williams JLR, 2008, AM J PHYSIOL-REG I, V295, pR1204, DOI 10.1152/ajpregu.00193.2008; Williams JLR, 2009, REPROD SCI, V16, p346A; Yoshida Yoshinobu, 2005, Medical Molecular Morphology, V38, P104, DOI 10.1007/s00795-004-0258-z	49	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149021	10.1371/journal.pone.0149021	http://dx.doi.org/10.1371/journal.pone.0149021			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863525	gold, Green Published, Green Submitted			2022-12-27	WOS:000370046600140
J	Dumas, D; Dunbar, KN				Dumas, Denis; Dunbar, Kevin N.			The Creative Stereotype Effect	PLOS ONE			English	Article							LATENT SEMANTIC ANALYSIS; DIVERGENT THINKING; PREDICTIVE-VALIDITY; TORRANCE TESTS; ORIGINALITY; PERFORMANCE; DISTANCE; FLUENCY; CRISIS; SCORES	Because of its fundamental relevance to scientific innovation, artistic expression, and human ingenuity, creativity has long been the subject of systematic psychological investigation. Concomitantly, the far-reaching effects of stereotypes on various cognitive and social processes have been widely researched. Bridging these two literatures, we show in a series of two studies that stereotypes related to creativity can both enhance and diminish individuals' performance on a divergent thinking task. Specifically, Study 1 demonstrated that participants asked to take on a stereotypically uninhibited perspective performed significantly better on a divergent thinking task than those participants who took on a stereotypically inhibited perspective, and a control group. Relatedly, Study 2 showed that the same effect is found within-subjects, with divergent thinking significantly improving when participants invoke an uninhibited stereotype. Moreover, we demonstrate the efficacy of Latent Semantic Analysis as an objective measure of the originality of ideas, and discuss implications of our findings for the nature of creativity. Namely, that creativity may not be best described as a stable individual trait, but as a malleable product of context and perspective.	[Dumas, Denis; Dunbar, Kevin N.] Univ Maryland, Dept Human Dev & Quantitat Methodol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Dunbar, KN (corresponding author), Univ Maryland, Dept Human Dev & Quantitat Methodol, College Pk, MD 20742 USA.	kndunbar@umd.edu						Abraham A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00095; Acar S, 2014, CREATIVITY RES J, V26, P229, DOI 10.1080/10400419.2014.901095; BEREITER C, 1960, J EDUC PSYCHOL, V51, P337, DOI 10.1037/h0041198; Bossomaier T, 2009, CREATIVITY RES J, V21, P64, DOI 10.1080/10400410802633517; Campion M, 2014, J POSIT PSYCHOL, V9, P137, DOI 10.1080/17439760.2013.848376; Cheng CY, 2013, SOC PSYCHOL PERS SCI, V4, P475, DOI 10.1177/1948550612462413; Colzato LS, 2015, PSYCHOL RES-PSYCH FO, V79, P709, DOI 10.1007/s00426-014-0610-4; Colzato LS, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00116; de Bloom J, 2014, TOURISM MANAGE, V44, P164, DOI 10.1016/j.tourman.2014.03.013; Dumas D, 2014, THINK SKILLS CREAT, V14, P56, DOI 10.1016/j.tsc.2014.09.003; Dunbar K. N., 2008, ARTS ED BRAIN LANGUA; Eysenck H.J., 1993, PSYCHOL INQ, V4, P147, DOI [DOI 10.1207/S15327965PLI0403_1, 10.1207/s15327965pli0403_1]; Fiske ST, 2014, P NATL ACAD SCI USA, V111, P13593, DOI 10.1073/pnas.1317505111; Florida R, 2004, HARVARD BUS REV, V82, P122; Foltz P., 2013, HDB AUTOMATED ESSAY; Forster E.A., 2009, P 31TH ANN C COGNITI, P602; Forster E. A., 2009, 2009 ANN M COGN SCI; Green AE, 2010, CEREB CORTEX, V20, P70, DOI 10.1093/cercor/bhp081; Guilford JP, 1950, AM PSYCHOL, V5, P444, DOI 10.1037/h0063487; Guilford J.P., 1967, NATURE HUMAN INTELLI; HARRINGTON DM, 1975, J PERS, V43, P434, DOI 10.1111/j.1467-6494.1975.tb00715.x; Hudson L., 1968, FRAMES MIND ABILITY; Jauk E, 2015, NEUROIMAGE, V111, P312, DOI 10.1016/j.neuroimage.2015.02.002; Jones LL, 2015, THINK REASONING, V21, P473, DOI 10.1080/13546783.2015.1036120; Kim KH, 2011, CREATIVITY RES J, V23, P285, DOI 10.1080/10400419.2011.627805; Kowal MA, 2015, PSYCHOPHARMACOLOGY, V232, P1123, DOI 10.1007/s00213-014-3749-1; Landauer TK, 1998, DISCOURSE PROCESS, V25, P259, DOI 10.1080/01638539809545028; Landauer TK, 1997, PSYCHOL REV, V104, P211, DOI 10.1037/0033-295X.104.2.211; Lanham D., 1997, P 19 ANN M COGN SCI, P979; Lewis C, 2013, THINK SKILLS CREAT, V9, P46, DOI 10.1016/j.tsc.2013.03.001; Oppezzo M, 2014, J EXP PSYCHOL LEARN, V40, P1142, DOI 10.1037/a0036577; Plucker J. A., 2010, CAMBRIDGE HDB CREATI, P48, DOI DOI 10.1017/CBO9780511763205.005; ROSCH E, 1976, J EXP PSYCHOL HUMAN, V2, P491, DOI 10.1037/0096-1523.2.4.491; Runco MA, 2012, CREATIVITY RES J, V24, P92, DOI 10.1080/10400419.2012.650092; Runco MA, 2012, CREATIVITY RES J, V24, P66, DOI 10.1080/10400419.2012.652929; Shih M, 2002, J PERS SOC PSYCHOL, V83, P638, DOI 10.1037//0022-3514.83.3.638; Silvia PJ, 2011, THINK SKILLS CREAT, V6, P24, DOI 10.1016/j.tsc.2010.06.001; Silvia PJ, 2009, THINK SKILLS CREAT, V4, P79, DOI 10.1016/j.tsc.2009.06.005; Simonton D. K., 2012, OXFORD HDB THINKING, P492; Spencer SJ, 1999, J EXP SOC PSYCHOL, V35, P4, DOI 10.1006/jesp.1998.1373; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; Sternberg R. J., 2010, CAMBRIDGE HDB CREATI, P467, DOI [10.1017/CBO9780511763205, DOI 10.1017/CBO9780511763205.029]; Sternberg R.J., 1992, SCHOOL PSYCHOL INT, V13, P243, DOI DOI 10.1177/0143034392133004; Storme M, 2012, J CREATIVE BEHAV, V46, P138, DOI 10.1002/jocb.10; TORRANCE EP, 1989, J CREATIVE BEHAV, V23, P219, DOI 10.1002/j.2162-6057.1989.tb00696.x; TORRANCE EP, 1972, J CREATIVE BEHAV, V6, P236, DOI 10.1002/j.2162-6057.1972.tb00936.x; Tsai P.H., 2013, B ED PSYCHOL, V45, P19; Van Overschelde JP, 2004, J MEM LANG, V50, P289, DOI 10.1016/j.jml.2003.10.003; WILSON RC, 1953, PSYCHOL BULL, V50, P362, DOI 10.1037/h0060857	50	15	15	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0142567	10.1371/journal.pone.0142567	http://dx.doi.org/10.1371/journal.pone.0142567			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6PR	26863143	Green Submitted, Green Published, gold			2022-12-27	WOS:000370046600001
J	Fiore-Gartland, A; Manso, BA; Friedrich, DP; Gabriel, EE; Finak, G; Moodie, Z; Hertz, T; De Rosa, SC; Frahm, N; Gilbert, PB; McElrath, MJ				Fiore-Gartland, Andrew; Manso, Bryce A.; Friedrich, David P.; Gabriel, Erin E.; Finak, Greg; Moodie, Zoe; Hertz, Tomer; De Rosa, Stephen C.; Frahm, Nicole; Gilbert, Peter B.; McElrath, M. Juliana			Pooled-Peptide Epitope Mapping Strategies Are Efficient and Highly Sensitive: An Evaluation of Methods for Identifying Human T Cell Epitope Specificities in Large-Scale HIV Vaccine Efficacy Trials	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; IMMUNE CONTROL; ELISPOT-ASSAY; HLA RESTRICTION; DOUBLE-BLIND; RESPONSES; TYPE-1; PROTECTION; PROTEIN; DESIGN	The interferon gamma, enzyme-linked immunospot (IFN-gamma ELISpot) assay is widely used to identify viral antigen-specific T cells is frequently employed to quantify T cell responses in HIV vaccine studies. It can be used to define T cell epitope specificities using panels of peptide antigens, but with sample and cost constraints there is a critical need to improve the efficiency of epitope mapping for large and variable pathogens. We evaluated two epitope mapping strategies, based on group testing, for their ability to identify vaccine-induced T-cells from participants in the Step HIV-1 vaccine efficacy trial, and compared the findings to an approach of assaying each peptide individually. The group testing strategies reduced the number of assays required by >7-fold without significantly altering the accuracy of T-cell breadth estimates. Assays of small pools containing 7-30 peptides were highly sensitive and effective at detecting single positive peptides as well as summating responses to multiple peptides. Also, assays with a single 15-mer peptide, containing an identified epitope, did not always elicit a response providing validation that 15-mer peptides are not optimal antigens for detecting CD8+ T cells. Our findings further validate pooling-based epitope mapping strategies, which are critical for characterizing vaccineinduced T-cell responses and more broadly for informing iterative vaccine design. We also show ways to improve their application with computational peptide: MHC binding predictors that can accurately identify the optimal epitope within a 15-mer peptide and within a pool of 15-mer peptides.	[Fiore-Gartland, Andrew; Manso, Bryce A.; Friedrich, David P.; Finak, Greg; Moodie, Zoe; De Rosa, Stephen C.; Frahm, Nicole; Gilbert, Peter B.; McElrath, M. Juliana] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA; [Gabriel, Erin E.] NIAID, Biostat Res Branch, Rockville, MD 20852 USA; [Hertz, Tomer] Ben Gurion Univ Negev, Shraga Segal Dept Microbiol Immunol & Genet, IL-84105 Beer Sheva, Israel	Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Ben Gurion University	Fiore-Gartland, A (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA.	agartlan@fredhutch.org	Hertz, Tomer/S-5744-2016	Hertz, Tomer/0000-0002-0561-1578; Manso, Ph.D., Bryce/0000-0002-4860-4888; Gabriel, Erin/0000-0002-0504-8404	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [UM1AI068635, UM1AI068618]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068635, UM1AI068618, R37AI054165, UM1AI068614] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award numbers UM1AI068635 and UM1AI068618. GF is an ISAC scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2003, COMPREHENSIVE EPITOP, V1, P2081; Anthony DD, 2003, METHODS, V29, P260, DOI 10.1016/S1046-2023(02)00348-1; Bihl FK, 2005, J TRANSL MED, V3; Borthwick N, 2014, MOL THER, V22, P464, DOI 10.1038/mt.2013.248; Boulet S, 2007, J IMMUNOL METHODS, V320, P18, DOI 10.1016/j.jim.2006.11.010; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Carlson JM, 2012, J VIROL, V86, P5230, DOI 10.1128/JVI.06728-11; Crawford H, 2007, J VIROL, V81, P8346, DOI 10.1128/JVI.00465-07; de Souza MS, 2012, J IMMUNOL, V188, P5166, DOI 10.4049/jimmunol.1102756; Douek DC, 2006, CELL, V124, P677, DOI 10.1016/j.cell.2006.02.005; Draenert R, 2004, J VIROL; Draenert R, 2004, AIDS; Finak G, 2014, BIOSTATISTICS, V15, P87, DOI 10.1093/biostatistics/kxt024; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Forrest BD, 2008, CLIN VACCINE IMMUNOL, V15, P1042, DOI 10.1128/CVI.00397-07; Frahm N, 2004, J VIROL, V78, P2187, DOI 10.1128/JVI.78.5.2187-2200.2004; Frahm N, 2012, J CLIN INVEST, V122, P359, DOI 10.1172/JCI60202; Gill DK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014330; Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566; Herr W, 1996, J IMMUNOL METHODS, V191, P131, DOI 10.1016/0022-1759(96)00007-5; Honeyborne I, 2007, J VIROL, V81, P3667, DOI 10.1128/JVI.02689-06; Horton H, 2004, J INFECT DIS, V190, P1692, DOI 10.1086/424490; Horton H, 2006, J IMMUNOL, V177, P7406, DOI 10.4049/jimmunol.177.10.7406; Hudgens MG, 2004, J IMMUNOL METHODS, V288, P19, DOI 10.1016/j.jim.2004.01.018; Hudgens MG, 2011, COMMUN STAT-THEOR M, V40, P436, DOI 10.1080/03610920903391303; Huygen K, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00321; Janes H, 2013, J INFECT DIS, V208, P1231, DOI 10.1093/infdis/jit322; Karlsson AC, 2003, J IMMUNOL METHODS, V283, P141, DOI 10.1016/j.jim.2003.09.001; Kaslow R, 1996, NAT MED; Keating SM, 2005, J IMMUNOL, V175, P5675, DOI 10.4049/jimmunol.175.9.5675; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kong WP, 2009, J VIROL, V83, P2201, DOI 10.1128/JVI.02256-08; Larsen ME, 2011, IMMUNOGENETICS, V63, P43, DOI 10.1007/s00251-010-0493-5; Lendle SD, 2012, BIOMETRICS, V68, P532, DOI 10.1111/j.1541-0420.2011.01674.x; Leslie A, 2010, J VIROL, V84, P9879, DOI 10.1128/JVI.00320-10; Li FS, 2006, VACCINE, V24, P6893, DOI 10.1016/j.vaccine.2006.06.009; Li FS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020479; Masemola A, 2004, HIERARCHICAL TARGETI; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; McMichael A, 2002, NAT REV IMMUNOL, V2, P283, DOI 10.1038/nri779; Moodie Z, 2006, CONTEMP CLIN TRIALS, V27, P147, DOI 10.1016/j.cct.2005.11.008; Moodie Z, 2010, CANCER IMMUNOL IMMUN, V59, P1489, DOI 10.1007/s00262-010-0875-4; Moodie Z, 2006, J IMMUNOL METHODS, V315, P121, DOI 10.1016/j.jim.2006.07.015; Moodie Z, 2012, METHODS MOL BIOL, V792, P185, DOI 10.1007/978-1-61779-325-7_15; Moorthy VS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-312; Moutaftsi M, 2006, NAT BIOTECHNOL, V24, P817, DOI 10.1038/nbt1215; Mwau M, 2002, AIDS RES HUM RETROV, V18, P611, DOI 10.1089/088922202760019301; Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796; Precopio ML, 2008, CYTOM PART A, V73A, P1071, DOI 10.1002/cyto.a.20646; Reece WHH, 2004, NAT MED, V10, P406, DOI 10.1038/nm1009; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Roederer M, 2003, J IMMUNOL METHODS, V274, P221, DOI 10.1016/S0022-1759(02)00423-4; Russell ND, 2003, J INFECT DIS, V187, P226, DOI 10.1086/367702; Saah AJ, 1998, AIDS, V12, P2107, DOI 10.1097/00002030-199816000-00005; Schmittel A, 1997, J IMMUNOL METHODS, V210, P167, DOI 10.1016/S0022-1759(97)00184-1; Shea PR, 2013, ANNU REV MED, V64, P203, DOI 10.1146/annurev-med-052511-135400; van Dissel JT, 2011, VACCINE, V29, P2100, DOI 10.1016/j.vaccine.2010.12.135; Yang SH, 2006, GENE THER, V13, P1110, DOI 10.1038/sj.gt.3302751; Yu XG, 2007, J VIROL, V81, P1619, DOI 10.1128/JVI.01580-06	61	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0147812	10.1371/journal.pone.0147812	http://dx.doi.org/10.1371/journal.pone.0147812			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863315	Green Published, Green Submitted, gold			2022-12-27	WOS:000370046600039
J	Hoffmann, A; Kunze, R; Helluy, X; Milford, D; Heiland, S; Bendszus, M; Pham, M; Marti, HH				Hoffmann, Angelika; Kunze, Reiner; Helluy, Xavier; Milford, David; Heiland, Sabine; Bendszus, Martin; Pham, Mirko; Marti, Hugo H.			High-Field MRI Reveals a Drastic Increase of Hypoxia-Induced Microhemorrhages upon Tissue Reoxygenation in the Mouse Brain with Strong Predominance in the Olfactory Bulb	PLOS ONE			English	Article							ALTITUDE CEREBRAL EDEMA; ACUTE MOUNTAIN-SICKNESS; ENDOTHELIAL-CELLS; BARRIER PERMEABILITY; VASCULAR LEAKAGE; RAT; EXPRESSION; MICROSCOPY; STRESS	Human pathophysiology of high altitude hypoxic brain injury is not well understood and research on the underlying mechanisms is hampered by the lack of well-characterized animal models. In this study, we explored the evolution of brain injury by magnetic resonance imaging (MRI) and histological methods in mice exposed to normobaric hypoxia at 8% oxygen for 48 hours followed by rapid reoxygenation and incubation for further 24 h under normoxic conditions. T2*-, diffusion-weighted and T2-relaxometry MRI was performed before exposure, immediately after 48 hours of hypoxia and 24 hours after reoxygenation. Cerebral microhemorrhages, previously described in humans suffering from severe high altitude cerebral edema, were also detected in mice upon hypoxia-reoxygenation with a strong region-specific clustering in the olfactory bulb, and to a lesser extent, in the basal ganglia and cerebral white matter. The number of microhemorrhages determined immediately after hypoxia was low, but strongly increased 24 hours upon onset of reoxygenation. Histologically verified microhemorrhages were exclusively located around cerebral microvessels with disrupted interendothelial tight junction protein ZO-1. In contrast, quantitative T2 and apparent-diffusion-coefficient values immediately after hypoxia and after 24 hours of reoxygenation did not show any region-specific alteration, consistent with subtle multifocal but not with regional or global brain edema.	[Hoffmann, Angelika; Bendszus, Martin; Pham, Mirko] Univ Heidelberg Hosp, Dept Neuroradiol, D-69120 Heidelberg, Germany; [Kunze, Reiner; Marti, Hugo H.] Heidelberg Univ, Inst Physiol & Pathophysiol, D-69120 Heidelberg, Germany; [Helluy, Xavier; Milford, David; Heiland, Sabine] Univ Heidelberg Hosp, Dept Neuroradiol, Div Expt Radiol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Hoffmann, A (corresponding author), Univ Heidelberg Hosp, Dept Neuroradiol, D-69120 Heidelberg, Germany.; Marti, HH (corresponding author), Heidelberg Univ, Inst Physiol & Pathophysiol, D-69120 Heidelberg, Germany.	angelika.hoffmann@med.uni-heidelberg.de; hugo.marti@physiologie.uni-heidelberg.de	Hoffmann, Ary/R-2972-2019; Pham, Mirko/AAI-8713-2020; Kunze, Reiner/K-8048-2019; Hoffmann, Angelika/E-5011-2019	Hoffmann, Ary/0000-0001-9497-7645; Kunze, Reiner/0000-0002-8428-1027; Hoffmann, Angelika/0000-0003-4552-0694; Marti, Hugo/0000-0002-8456-334X	University of Heidelberg; Dietmar-Hopp Stiftung; Else Kroner-Fresenius-Stiftung; Else Kroner-Fresenius-Stiftung [2012_A171]	University of Heidelberg; Dietmar-Hopp Stiftung; Else Kroner-Fresenius-Stiftung; Else Kroner-Fresenius-Stiftung	The expert technical assistance of Manuel Fischer, Maria Harlacher and Inge Keller is gratefully acknowledged. AH is supported by a postdoctoral fellowship of the University of Heidelberg, DM by a grant of the Dietmar-Hopp Stiftung, and MP by a memorial stipend of the Else Kroner-Fresenius-Stiftung. RK and HHM were supported by Else Kroner-Fresenius-Stiftung (2012_A171).	Barthelmes D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0011532; Bauer AT, 2010, J CEREBR BLOOD F MET, V30, P837, DOI 10.1038/jcbfm.2009.248; Binienda Z, 1996, INT J DEV NEUROSCI, V14, P399; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; DICKINSON J, 1983, THORAX, V38, P646, DOI 10.1136/thx.38.9.646; Dorr A, 2007, NEUROIMAGE, V35, P1409, DOI 10.1016/j.neuroimage.2006.12.040; Fagel DM, 2009, J NEUROSCI, V29, P1202, DOI 10.1523/JNEUROSCI.4516-08.2009; Fischer R, 2004, CEPHALALGIA, V24, P66, DOI 10.1111/j.1468-2982.2004.00619.x; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; Hackett PH, 1998, JAMA-J AM MED ASSOC, V280, P1920, DOI 10.1001/jama.280.22.1920; Hackett PH, 2004, HIGH ALT MED BIOL, V5, P136, DOI 10.1089/1527029041352054; Hackett PH, 1999, WILD ENVIRON MED, V10, P97, DOI 10.1580/1080-6032(1999)010[0097:TCEOHA]2.3.CO;2; Hunt JS, 2013, J CEREBR BLOOD F MET, V33, P372, DOI 10.1038/jcbfm.2012.184; Kallenberg K, 2008, J CEREBR BLOOD F MET, V28, P1635, DOI 10.1038/jcbfm.2008.55; Kallenberg K, 2007, J CEREBR BLOOD F MET, V27, P1064, DOI 10.1038/sj.jcbfm.9600404; Lai JCK, 2003, NEUROCHEM RES, V28, P933, DOI 10.1023/A:1023235712524; Lochhead JJ, 2010, J CEREBR BLOOD F MET, V30, P1625, DOI 10.1038/jcbfm.2010.29; Luks AM, 2014, WILD ENVIRON MED, V25, pS4, DOI 10.1016/j.wem.2014.06.017; Ma Y, 2005, NEUROSCIENCE, V135, P1203, DOI 10.1016/j.neuroscience.2005.07.014; Mairer K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050334; Martin SF, 2005, VASC PHARMACOL, V43, P148, DOI 10.1016/j.vph.2005.05.002; Natah SS, 2009, J APPL PHYSIOL, V107, P1348, DOI 10.1152/japplphysiol.91484.2008; Park SH, 2008, MAGN RESON MED, V59, P855, DOI 10.1002/mrm.21573; Patir H, 2012, FREE RADICAL BIO MED, V53, P659, DOI 10.1016/j.freeradbiomed.2012.06.010; Roach RC, 2001, J EXP BIOL, V204, P3161; Schoch HJ, 2002, BRAIN, V125, P2549, DOI 10.1093/brain/awf257; Schommer K, 2013, NEUROLOGY, V81, P1776, DOI 10.1212/01.wnl.0000435563.84986.78; Schoonman GG, 2008, J CEREBR BLOOD F MET, V28, P198, DOI 10.1038/sj.jcbfm.9600513; SHEPHERD GM, 1972, PHYSIOL REV, V52, P864, DOI 10.1152/physrev.1972.52.4.864; Williams RW, 2001, BEHAV GENET, V31, P61, DOI 10.1023/A:1010209925783; Wilson MH, 2013, ANN NEUROL, V73, P381, DOI 10.1002/ana.23796; Wilson MH, 2009, LANCET NEUROL, V8, P175, DOI 10.1016/S1474-4422(09)70014-6; Witt KA, 2003, AM J PHYSIOL-HEART C, V285, pH2820, DOI 10.1152/ajpheart.00589.2003; Witt KA, 2008, MICROVASC RES, V75, P91, DOI 10.1016/j.mvr.2007.06.004; Yu BT, 2013, HIGH ALT MED BIOL, V14, P61, DOI 10.1089/ham.2012.1080; Yu G, 2007, MICROCIRCULATION, V14, P125, DOI 10.1080/10739680601131218; Yu G, 2010, FREE RADICAL BIO MED, V49, P1008, DOI 10.1016/j.freeradbiomed.2010.06.005; Zehendner CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082823; Zehendner CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080749; Zulueta JJ, 1997, AM J PHYSIOL-LUNG C, V272, pL897, DOI 10.1152/ajplung.1997.272.5.L897	42	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148441	10.1371/journal.pone.0148441	http://dx.doi.org/10.1371/journal.pone.0148441			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863147	Green Published, gold			2022-12-27	WOS:000370046600073
J	Verma, S; Grover, S; Tyagi, C; Goyal, S; Jamal, S; Singh, A; Grover, A				Verma, Sharad; Grover, Sonam; Tyagi, Chetna; Goyal, Sukriti; Jamal, Salma; Singh, Aditi; Grover, Abhinav			Hydrophobic Interactions Are a Key to MDM2 Inhibition by Polyphenols as Revealed by Molecular Dynamics Simulations and MM/PBSA Free Energy Calculations	PLOS ONE			English	Article							P53; BINDING; PROTEIN; ANTAGONISTS; ACTIVATION; MECHANICS; GROMACS; CANCER; TOOL	p53, a tumor suppressor protein, has been proven to regulate the cell cycle, apoptosis, and DNA repair to prevent malignant transformation. MDM2 regulates activity of p53 and inhibits its binding to DNA. In the present study, we elucidated the MDM2 inhibition potential of polyphenols (Apigenin, Fisetin, Galangin and Luteolin) by MD simulation and MM/PBSA free energy calculations. All polyphenols bind to hydrophobic groove of MDM2 and the binding was found to be stable throughout MD simulation. Luteolin showed the highest negative binding free energy value of -173.80 kJ/mol followed by Fisetin with value of -172.25 kJ/mol. It was found by free energy calculations, that hydrophobic interactions (vdW energy) have major contribution in binding free energy.	[Verma, Sharad; Tyagi, Chetna; Grover, Abhinav] Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi 110067, India; [Grover, Sonam] Indian Inst Technol Delhi, Kusuma Sch Biol Sci, New Delhi, India; [Goyal, Sukriti; Jamal, Salma] Banasthali Vidyapith, Dept Biosci & Biotechnol, Tonk, Rajasthan, India; [Singh, Aditi] TERI Univ, Dept Biotechnol, New Delhi, India	Jawaharlal Nehru University, New Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Banasthali Vidyapith; TERI University	Grover, A (corresponding author), Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi 110067, India.	abhinavgr@gmail.com	Tyagi, Chetna/CAH-0155-2022	Tyagi, Chetna/0000-0001-7067-4770; verma, sharad/0000-0002-9261-6878; Singh, Aditi/0000-0001-7438-2863				AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Bautista AD, 2010, J AM CHEM SOC, V132, P2904, DOI 10.1021/ja910715u; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Birt DF, 1997, ANTICANCER RES, V17, P85; Bozzi F, 2013, LAB INVEST, V93, P1232, DOI 10.1038/labinvest.2013.107; Dastidar SG, 2009, BMC BIOINF P; Fasan R, 2004, ANGEW CHEM INT EDIT, V43, P2109, DOI 10.1002/anie.200353242; Fu T, 2012, INT J MOL SCI, V13, P9709, DOI 10.3390/ijms13089709; Gosu V, 2014, SCI REP-UK, V4, DOI 10.1038/srep05748; Homeyer N, 2012, MOL INFORM, V31, P114, DOI 10.1002/minf.201100135; Jones JC, 2012, P NATL ACAD SCI USA, V109, P7275, DOI 10.1073/pnas.1202943109; Joseph TL, 2010, CELL CYCLE, V9, P1167, DOI 10.4161/cc.9.6.11067; Kimira M, 1998, J Epidemiol, V8, P168; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kritzer JA, 2004, J AM CHEM SOC, V126, P9468, DOI 10.1021/ja031625a; Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lee SB, 2007, BIOL PHARM BULL, V30, P1074, DOI 10.1248/bpb.30.1074; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lin Y, 2008, CURR CANCER DRUG TAR, V8, P634, DOI 10.2174/156800908786241050; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Miyajima Y, 2004, BIOFACTORS, V21, P301; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Muller CR, 2007, INT J CANCER, V121, P199, DOI 10.1002/ijc.22643; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pishas KI, 2011, CLIN CANCER RES, V17, P494, DOI 10.1158/1078-0432.CCR-10-1587; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Seelinger G, 2008, MOLECULES, V13, P2628, DOI 10.3390/molecules13102628; Seufi AM, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-80; Sonnemann J, 2011, EUR J CANCER, V47, P1432, DOI 10.1016/j.ejca.2011.01.015; Stoll R, 2001, BIOCHEMISTRY-US, V40, P336, DOI 10.1021/bi000930v; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; van Gunsteren W. F., 1998, ENCY COMPUTATIONAL C, V2, P1211, DOI DOI 10.1002/0470845015.CGA011; Van Maerken T, 2006, CANCER RES, V66, P9646, DOI 10.1158/0008-5472.CAN-06-0792; vanAalten DMF, 1995, PROTEIN ENG, V8, P1129; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Verma S, 2013, MED CHEM RES, V22, P2778, DOI 10.1007/s00044-012-0274-9; Verma S, 2013, MOL INFORM, V32, P203, DOI 10.1002/minf.201200113; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Yamaguchi H, 1998, NUCLEIC ACIDS RES, V26, P1939, DOI 10.1093/nar/26.8.1939; Zauli G, 2007, J BONE MINER RES, V22, P1621, DOI 10.1359/JBMR.070618; Zhao JH, 2002, CANCER LETT, V183, P69, DOI 10.1016/S0304-3835(02)00084-8	44	81	83	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149014	10.1371/journal.pone.0149014	http://dx.doi.org/10.1371/journal.pone.0149014			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863418	Green Submitted, Green Published, gold			2022-12-27	WOS:000370046600139
J	Eldar-Yedidia, Y; Bar-Meir, M; Hillel, M; Abitbol, G; Broide, E; Falk, R; Assous, M; Schlesinger, Y				Eldar-Yedidia, Yifat; Bar-Meir, Maskit; Hillel, Miriam; Abitbol, Guila; Broide, Eti; Falk, Roni; Assous, Marc; Schlesinger, Yechiel			Low Interferon Relative-Response to Cytomegalovirus Is Associated with Low Likelihood of Intrauterine Transmission of the Virus	PLOS ONE			English	Article							PRIMARY INFECTION; EXHAUSTION; FETUS; WOMEN; RISK	Background Congenital Cytomegalovirus (CMV) is a very common intrauterine infection which can cause severe mental and hearing impairments. Notably, only 40% of primarily infected women transmit CMV to the fetus. CMV-specific T-cell response has a role in CMV disease but individual immune heterogeneity precludes reliable correlation between measurable T-cells response and intrauterine transmission. Study Aim To establish a correlation between maternal T-cells response and fetal CMV transmission using an individual normalized immune response. Methods We analyzed IFN-gamma secretion upon whole blood stimulation from primary CMV-infected pregnant women, with either CMV-peptides or PHA-mitogen. Results We established a new normalization method of individual IFN-gamma response to CMV by defining the ratio between specific-CMV response and non-specific mitogen response (defined as IFN-gamma relative response, RR), aiming to overcome high person-to-person immune variability. We found a unique subpopulation of women with low IFN-gamma RR strongly correlated with absence of transmission. IFN-gamma RR lower than 1.8% (threshold determined by ROC analysis) reduces the pre-test probability of transmission from 40% to 8%, revealing an unexpected link between low IFN-gamma RR and non-transmission. Conclusion In pregnant women with primary CMV infection, low IFN-gamma RR is associated with low risk of transmission.	[Eldar-Yedidia, Yifat; Hillel, Miriam; Abitbol, Guila; Schlesinger, Yechiel] Hebrew Univ Jerusalem, Sch Med, Shaare Zedek Med Ctr, Res Lab Infect Dis, IL-91010 Jerusalem, Israel; [Bar-Meir, Maskit; Schlesinger, Yechiel] Shaare Zedek Med Ctr, Dept Pediat, Jerusalem, Israel; [Broide, Eti; Falk, Roni; Assous, Marc] Shaare Zedek Med Ctr, Microbiol Immunol Labs, Jerusalem, Israel	Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Shaare Zedek Medical Center	Schlesinger, Y (corresponding author), Hebrew Univ Jerusalem, Sch Med, Shaare Zedek Med Ctr, Res Lab Infect Dis, IL-91010 Jerusalem, Israel.; Schlesinger, Y (corresponding author), Shaare Zedek Med Ctr, Dept Pediat, Jerusalem, Israel.	yechiel@szmc.org.il	ASSOUS, Marc Victor/CAH-0946-2022					Antoine P, 2012, J IMMUNOL, V189, P2665, DOI 10.4049/jimmunol.1101165; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Blank C, 2007, CANCER IMMUNOL IMMUN, V56, P739, DOI 10.1007/s00262-006-0272-1; Boppana SB, 2001, NEW ENGL J MED, V344, P1366, DOI 10.1056/NEJM200105033441804; Cannon MJ, 2009, J CLIN VIROL, V46, pS6, DOI 10.1016/j.jcv.2009.09.002; Cannon MJ, 2005, CLIN INFECT DIS, V40, P1701, DOI 10.1086/430172; Cheeran MCJ, 2009, CLIN MICROBIOL REV, V22, P99, DOI 10.1128/CMR.00023-08; de Vries JJC, 2011, REV MED VIROL, V21, P54, DOI 10.1002/rmv.679; Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544; Enders G, 2011, J CLIN VIROL, V52, P244, DOI 10.1016/j.jcv.2011.07.005; FERNANDO S, 1993, J MED VIROL, V41, P108, DOI 10.1002/jmv.1890410205; FOWLER KB, 1992, NEW ENGL J MED, V326, P663, DOI 10.1056/NEJM199203053261003; Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535; Lilleri D, 2008, J INFECT DIS, V198, P536, DOI 10.1086/590118; Lilleri D, 2007, J INFECT DIS, V195, P1062, DOI 10.1086/512245; Marshall EE, 2009, J INTERF CYTOK RES, V29, P609, DOI 10.1089/jir.2009.0064; Oliver SE, 2009, J CLIN VIROL, V46, pS22, DOI 10.1016/j.jcv.2009.08.012; Pereira L, 2013, CLIN INFECT DIS, V57, pS174, DOI 10.1093/cid/cit583; Revello MG, 1998, J INFECT DIS, V177, P1170, DOI 10.1086/515277; Revello MG, 2006, J INFECT DIS, V193, P269, DOI 10.1086/498872; Revello MG, 2002, CLIN MICROBIOL REV, V15, P680, DOI 10.1128/CMR.15.4.680-715.2002; RINALDO CR, 1977, J INFECT DIS, V136, P667, DOI 10.1093/infdis/136.5.667; Schleiss MR, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/501801; STAGNO S, 1986, JAMA-J AM MED ASSOC, V256, P1904, DOI 10.1001/jama.256.14.1904; STERN H, 1986, BRIT MED J, V292, P718, DOI 10.1136/bmj.292.6522.718; Wang CB, 2011, CLIN INFECT DIS, V52, pE11, DOI 10.1093/cid/ciq085; Yamamoto AY, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.11.018	27	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0147883	10.1371/journal.pone.0147883	http://dx.doi.org/10.1371/journal.pone.0147883			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881863	gold, Green Published, Green Submitted			2022-12-27	WOS:000371219000008
J	Rizzo, G; Veronese, M; Expert, P; Turkheimer, FE; Bertoldo, A				Rizzo, Gaia; Veronese, Mattia; Expert, Paul; Turkheimer, Federico E.; Bertoldo, Alessandra			MENGA: A New Comprehensive Tool for the Integration of Neuroimaging Data and the Allen Human Brain Transcriptome Atlas	PLOS ONE			English	Article							WATER-CONTENT; MYELIN; QUANTIFICATION; PET	Introduction Brain-wide mRNA mappings offer a great potential for neuroscience research as they can provide information about system proteomics. In a previous work we have correlated mRNA maps with the binding patterns of radioligands targeting specific molecular systems and imaged with positron emission tomography (PET) in unrelated control groups. This approach is potentially applicable to any imaging modality as long as an efficient procedure of imaging-genomic matching is provided. In the original work we considered mRNA brain maps of the whole human genome derived from the Allen human brain database (ABA) and we performed the analysis with a specific region-based segmentation with a resolution that was limited by the PET data parcellation. There we identified the need for a platform for imaging-genomic integration that should be usable with any imaging modalities and fully exploit the high resolution mapping of ABA dataset. Aim In this work we present MENGA (Multimodal Environment for Neuroimaging and Genomic Analysis), a software platform that allows the investigation of the correlation patterns between neuroimaging data of any sort (both functional and structural) with mRNA gene expression profiles derived from the ABA database at high resolution. Results We applied MENGA to six different imaging datasets from three modalities (PET, single photon emission tomography and magnetic resonance imaging) targeting the dopamine and serotonin receptor systems and the myelin molecular structure. We further investigated imaging-genomic correlations in the case of mismatch between selected proteins and imaging targets.	[Rizzo, Gaia; Bertoldo, Alessandra] Univ Padua, Dept Informat Engn, Padua, Italy; [Veronese, Mattia; Expert, Paul; Turkheimer, Federico E.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Neuroimaging, London WC2R 2LS, England	University of Padua; University of London; King's College London	Rizzo, G (corresponding author), Univ Padua, Dept Informat Engn, Padua, Italy.	gaia.rizzo@dei.unipd.it	Expert, Paul/AAX-6356-2020; Veronese, Mattia/A-6012-2013; Veronese, Mattia/S-3114-2019; Turkheimer, Federico E/B-9485-2012	Expert, Paul/0000-0002-5016-4623; Veronese, Mattia/0000-0003-3562-0683; Turkheimer, Federico E/0000-0002-3766-3815	Programme Grant "Quantitative methodologies for Positron Emission Tomography" (UK Medical Research Council) [G1100809/1]; Padova University grant "Neuroimaging Genetics: Models and Methods to Integrate Brain Phenotype and Genotype"; NITRC; NITRC-IR; NITRC-CE; National Institute of Biomedical Imaging and Bioengineering; National Institutes of Health; Department of Health and Human Services [GS-00F-0034P, HHSN268200100090U, 1 R43 NS074540-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R43NS074540] Funding Source: NIH RePORTER; Medical Research Council [G1100809] Funding Source: researchfish; MRC [G1100809] Funding Source: UKRI	Programme Grant "Quantitative methodologies for Positron Emission Tomography" (UK Medical Research Council); Padova University grant "Neuroimaging Genetics: Models and Methods to Integrate Brain Phenotype and Genotype"; NITRC; NITRC-IR; NITRC-CE; National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the Programme Grant "Quantitative methodologies for Positron Emission Tomography" (UK Medical Research Council No. G1100809/1) and by the Padova University grant "Neuroimaging Genetics: Models and Methods to Integrate Brain Phenotype and Genotype" (2013). NITRC, NITRC-IR, and NITRC-CE have been funded in whole or in part with Federal funds from the National Institute of Biomedical Imaging and Bioengineering, the National Institutes of Health, and the Department of Health and Human Services, under GSA Contract No. GS-00F-0034P, Order Number HHSN268200100090U and SBIR No. 1 R43 NS074540-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the Allen Institute for the data sharing and for the support during the development of the software. NITRC, NITRC-IR, and NITRC-CE have been funded in whole or in part with Federal funds from the National Institute of Biomedical Imaging and Bioengineering, the National Institutes of Health, and the Department of Health and Human Services, under GSA Contract No. GS-00F-0034P, Order Number HHSN268200100090U and SBIR No. 1 R43 NS074540-01.	Altman D.G., 1991, PRACTICAL STATISTIC; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Cheng MHY, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00134; French L, 2015, FRONTIERS NEUROSCIEN; Garcia-Gomez FJ, 2013, REV ESP MED NUCL IMA, V32, P350, DOI 10.1016/j.remn.2013.02.009; Grabner G, 2006, LECT NOTES COMPUT SC, V4191, P58; Grecchi E, 2014, PHYS MED BIOL, V59, P2517, DOI 10.1088/0031-9155/59/10/2517; Guo YF, 2008, ACTA BIOCH BIOPH SIN, V40, P426, DOI 10.1111/j.1745-7270.2008.00418.x; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Neeb H, 2008, NEUROIMAGE, V42, P1094, DOI 10.1016/j.neuroimage.2008.03.060; Neeb H, 2012, NEUROIMAGE-CLIN, V1, P121, DOI 10.1016/j.nicl.2012.09.013; Rizzo G, 2014, 20 ANN M ORG HUM BRA; Rizzo G, 2014, J CEREBR BLOOD F MET, V34, P827, DOI 10.1038/jcbfm.2014.21; Tonkova V, 2012, Z MED PHYS, V22, P133, DOI 10.1016/j.zemedi.2011.09.005; Vaughan RA, 2013, TRENDS PHARMACOL SCI, V34, P489, DOI 10.1016/j.tips.2013.07.005; Veronese M, 2015, J CEREBR BLOOD F MET, V35, P1771, DOI 10.1038/jcbfm.2015.120; Zanotti-Fregonara P, 2015, J NUCL MED, V56; Zanotti-Fregonara P, 2014, NUCL MED COMMUN, V35, P1254, DOI 10.1097/MNM.0000000000000196	19	34	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148744	10.1371/journal.pone.0148744	http://dx.doi.org/10.1371/journal.pone.0148744			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882227	Green Published, gold			2022-12-27	WOS:000371219000022
J	An, HY; Lim, C; Guillemin, GJ; Vollmer-Conna, U; Rawlinson, W; Bryant, K; Tedla, N				An, Hongyan; Lim, Chai; Guillemin, Gilles J.; Vollmer-Conna, Ute; Rawlinson, William; Bryant, Katherine; Tedla, Nicodemus			Serum Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3) Is Increased in Patients with Multiple Sclerosis and Is a Strong Independent Indicator of Disease Severity; 6.7kbp LILRA3 Gene Deletion Is Not Associated with Diseases Susceptibility	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; BALANCING SELECTION; 6.7-KBP DELETION; ILT6 GENE; VITAMIN-D; IMMUNE; INTERLEUKIN-10; PROTEIN; CELLS; IL-10	Leukocyte immunoglobulin-like receptor A3 (LILRA3) is a soluble immune regulatory molecule primarily expressed by monocytes and macrophages. A homozygous 6.7kbp LILRA3 gene deletion that removes the first seven of its eight exons is predicted to lead to lack of LILRA3 protein, although this has not been experimentally confirmed. Moreover, there are conflicting results with regards to the link between the LILRA3 homozygous genetic deletion and susceptibility to multiple sclerosis (MS) in different European populations. The aim of this study was to investigate whether LILRA3 gene deletion is associated with MS susceptibility in a North American cohort of European ancestry and assess if serum LILRA3 protein level is a marker of clinical subtype and/or disease severity in MS. A total of 456 patients with MS and 99 unrelated healthy controls were genotyped for the 6.7kbp LILRA3 gene deletion and levels of LILRA3 protein in sera determined by in-house sandwich ELISA. We showed that LILRA3 gene deletion was not associated with MS susceptibility and did not affect the age of disease onset, clinical subtype or disease severity. However, we discovered for the first time that homozygous LILRA3 gene deletion results in lack of production of LILRA3 protein. Importantly, LILRA3 protein level was significantly increased in sera of patients with MS when compared with control subjects, particularly in more severe type primary progressive MS. Multiple regression analysis showed that LILRA3 level in serum was one of the strongest independent markers of disease severity in MS, which potentially can be used as a diagnostic marker.	[An, Hongyan; Bryant, Katherine; Tedla, Nicodemus] Univ New S Wales, Sch Med Sci, Dept Pathol, Inflammat & Infect Res Ctr, Sydney, NSW 2052, Australia; [Lim, Chai; Guillemin, Gilles J.] Macquarie Univ, ASAM, MND & Neurodegenerat Dis Res Ctr, Sydney, NSW 2109, Australia; [Vollmer-Conna, Ute] Univ New S Wales, Sch Psychiat, Sydney, NSW 2050, Australia; [Rawlinson, William] Prince Wales Hosp, Dept Virol, South Eastern Sydney & Illawarra Hlth Serv, Sydney, NSW 2032, Australia; [Bryant, Katherine] Univ New S Wales, South Western Sydney Clin Sch, Sydney, NSW 2170, Australia	University of New South Wales Sydney; Macquarie University; University of New South Wales Sydney; University of New South Wales Sydney	Tedla, N (corresponding author), Univ New S Wales, Sch Med Sci, Dept Pathol, Inflammat & Infect Res Ctr, Sydney, NSW 2052, Australia.	n.tedla@unsw.edu.au	Guillemin, Gilles J/C-3878-2015; Bryant, Katherine/E-8574-2010; Lim, Edwin/R-5001-2019	Guillemin, Gilles J/0000-0001-8105-4470; Bryant, Katherine/0000-0002-8686-623X; Lim, Edwin/0000-0003-3526-8405	National Health and Medical Research Council [568771]; University of New South Wales Gold Star Award	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); University of New South Wales Gold Star Award	This research was supported by National Health and Medical Research Council, project grant # 568771 (https://www.nhmrc.gov.au/) and University of New South Wales Gold Star Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HY, 2010, J RHEUMATOL, V37, P1596, DOI 10.3899/jrheum.091119; Anderson KJ, 2009, IMMUNOLOGY, V127, P8, DOI 10.1111/j.1365-2567.2009.03097.x; Ascherio A, 2014, JAMA NEUROL, V71, P306, DOI 10.1001/jamaneurol.2013.5993; Barcellos LF, 1997, JAMA-J AM MED ASSOC, V278, P1256, DOI 10.1001/jama.278.15.1256; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Bonetti A, 2009, J NEUROIMMUNOL, V208, P119, DOI 10.1016/j.jneuroim.2009.01.003; Borges L, 2000, CYTOKINE GROWTH F R, V11, P209, DOI 10.1016/S1359-6101(00)00007-1; Brown D, 2004, TISSUE ANTIGENS, V64, P215, DOI 10.1111/j.0001-2815.2004.00290.x; Bush WS, 2010, AM J HUM GENET, V86, P621, DOI 10.1016/j.ajhg.2010.02.027; Byrnes AA, 2002, ANN NEUROL, V51, P165, DOI 10.1002/ana.10084; Compston A, 2006, MCALPINES MULTIPLE S, V4th; Du Y, 2014, ARTHRITIS RHEUMATOL, V66, P822, DOI 10.1002/art.38308; Gandhi R, 2010, J NEUROIMMUNOL, V221, P7, DOI 10.1016/j.jneuroim.2009.10.015; Gourraud PA, 2012, IMMUNOL REV, V248, P87, DOI 10.1111/j.1600-065X.2012.01134.x; Heine G, 2008, EUR J IMMUNOL, V38, P2210, DOI 10.1002/eji.200838216; Hirayasu K, 2006, HUM GENET, V119, P436, DOI 10.1007/s00439-006-0152-y; Hirayasu K, 2008, AM J HUM GENET, V82, P1075, DOI 10.1016/j.ajhg.2008.03.012; Hirayasu K, 2015, J HUM GENET, V60, P703, DOI 10.1038/jhg.2015.64; Jung M, 2004, EUR J IMMUNOL, V34, P481, DOI 10.1002/eji.200324323; Kane BA, 2014, J INNATE IMMUN, V6, P727, DOI 10.1159/000363449; KHOURY SJ, 1992, J EXP MED, V176, P1355, DOI 10.1084/jem.176.5.1355; Koch S, 2005, GENES IMMUN, V6, P445, DOI 10.1038/sj.gene.6364187; Kvarnstrom M, 2013, J NEUROL SCI, V325, P79, DOI 10.1016/j.jns.2012.12.001; Lee THY, 2013, J BIOL CHEM, V288, P32873, DOI 10.1074/jbc.M113.478578; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; McCauley JL, 2010, HUM MOL GENET, V19, P953, DOI 10.1093/hmg/ddp542; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Norman PJ, 2004, IMMUNOGENETICS, V56, P225, DOI 10.1007/s00251-004-0674-1; Norman PJ, 2003, IMMUNOGENETICS, V55, P165, DOI 10.1007/s00251-003-0561-1; Nylander A, 2012, J CLIN INVEST, V122, P1180, DOI 10.1172/JCI58649; Ordonez D, 2009, GENES IMMUN, V10, P579, DOI 10.1038/gene.2009.34; Ortiz MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134414; Patsopoulos NA, 2011, ANN NEUROL, V70, P897, DOI 10.1002/ana.22609; PORRINI AM, 1995, J NEUROIMMUNOL, V61, P27, DOI 10.1016/0165-5728(95)00070-I; Prat A, 2005, CURR OPIN NEUROL, V18, P225, DOI 10.1097/01.wco.0000169737.99040.31; Salmaggi A, 1996, J NEUROL, V243, P13; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schleithoff SS, 2006, AM J CLIN NUTR, V83, P754, DOI 10.1093/ajcn/83.4.754; Talwar S, 2006, GENE EXPRESSION PROF, P203; Tilg H, 1994, INTERLEUKIN 6 IL 6 A, P113; Torkar M, 2000, EUR J IMMUNOL, V30, P3655, DOI 10.1002/1521-4141(200012)30:12<3655::AID-IMMU3655>3.0.CO;2-Y; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; van Boxel-Dezaire AHH, 1999, ANN NEUROL, V45, P695, DOI 10.1002/1531-8249(199906)45:6<695::AID-ANA3>3.0.CO;2-R; Waubant E, 2001, J NEUROIMMUNOL, V112, P139, DOI 10.1016/S0165-5728(00)00355-6; Wende H, 1999, MAMM GENOME, V10, P154, DOI 10.1007/s003359900961; Wisniewski A, 2013, HUM IMMUNOL, V74, P353, DOI 10.1016/j.humimm.2012.12.006	46	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149200	10.1371/journal.pone.0149200	http://dx.doi.org/10.1371/journal.pone.0149200			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871720	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100125
J	De Giorgio, R; Mazzoni, M; Vallorani, C; Latorre, R; Bombardi, C; Bacci, ML; Forni, M; Falconi, M; Sternini, C; Clavenzani, P				De Giorgio, Roberto; Mazzoni, Maurizio; Vallorani, Claudia; Latorre, Rocco; Bombardi, Cristiano; Bacci, Maria Laura; Forni, Monica; Falconi, Mirella; Sternini, Catia; Clavenzani, Paolo			Regulation of alpha-Transducin and alpha-Gustducin Expression by a High Protein Diet in the Pig Gastrointestinal Tract	PLOS ONE			English	Article							BITTER TASTE RECEPTORS; ENTEROENDOCRINE STC-1 CELLS; CALCIUM-SENSING RECEPTOR; GLUCAGON-LIKE PEPTIDE-1; FOOD-INTAKE; UMAMI TASTE; SWEET TASTE; IMMUNOREACTIVE CELLS; SENSORY ORGAN; BODY-WEIGHT	Background The expression of taste receptors (TASRs) and their signalling molecules in the gastrointestinal (GI) epithelial cells, including enteroendocrine cells (EECs), suggests they participate in chemosensing mechanisms influencing GI physiology via the release of endocrine messengers. TASRs mediate gustatory signalling by interacting with different transducers, including alpha-gustducin (G(alpha gust)) and alpha-transducin (G(alpha tran)) G protein subunits. This study tested whether G(alpha tran) and G(alpha gust) immunoreactive (-IR) cells are affected by a short-term (3 days) and long-term (30 days) high protein (Hp) diet in the pig GI tract. Result In the stomach, G(alpha gust) and G(alpha tran)-IR cells contained serotonin (5-HT) and ghrelin (GHR), while in the small and large intestine, G(alpha gust) and G(alpha tran)-IR colocalized with 5-HT-, cholecystokinin (CCK)-and peptide YY (PYY)-IR. There was a significant increase in the density of G(alpha tran)-IR cells in the pyloric mucosa in both short- and long-term Hp diet groups (Hp3 and Hp30) vs. the control group (Ctr) (P<0.05), while the increase of G(alpha gust)-IR cells in the pyloric mucosa was significant in Hp30 group vs. Ctr and vs. Hp3 (P<0.05); these cells included G(alpha tran)/5HT-IR and G(alpha tran)/GHR-IR cells (P<0.05 and P<0.001 vs. Ctr, respectively) as well as G(alpha gust)/5-HT-IR or G(alpha gust)/GHR-IR cells (P<0.05 and P<0.01 vs. Ctr, respectively). In the small intestine, we recorded a significant increase in G(alpha tran)-IR cells in the duodenal cryptsand a significant increase of G(alpha gust)-IR cells in the jejunal crypts in Hp3 group compared to HP30 (P<0.05). With regard to the number of G(alpha tran)-G(alpha gust) IR cells colocalized with CCK or 5-HT, there was only a significant increase of G(alpha tran)/CCK-IR cells in Hp3 group compared to Ctr (P = 0.01). Conclusion This study showed an upregulation of selected subpopulations of G(alpha gust) / G(alpha tran)-IR cells in distinct regions of the pig GI tract by short- and long-term Hp diet lending support to TASR-mediated effects in metabolic homeostasis and satiety mechanisms.	[De Giorgio, Roberto] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy; [Mazzoni, Maurizio; Vallorani, Claudia; Latorre, Rocco; Bombardi, Cristiano; Bacci, Maria Laura; Forni, Monica; Clavenzani, Paolo] Univ Bologna, Dept Vet Med Sci, Bologna, Italy; [Falconi, Mirella] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy; [Sternini, Catia] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, CURE Digest Dis Res Ctr,Digest Dis Div, Los Angeles, CA 90095 USA; [Sternini, Catia] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Sternini, Catia] Greater Los Angeles Hlth Syst, Vet Adm, Los Angeles, CA USA	University of Bologna; University of Bologna; University of Bologna; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Mazzoni, M (corresponding author), Univ Bologna, Dept Vet Med Sci, Bologna, Italy.	m.mazzoni@unibo.it	Mazzoni, Maurizio/J-1918-2016	Mazzoni, Maurizio/0000-0002-7384-5990; Bacci, Maria Laura/0000-0001-6702-5868; Forni, Monica/0000-0003-1310-6202	National Institutes of Health (NIH) [DK09, 41301]; Italian Ministry of Education, University and Research (MIUR; PRIN); 'Fondazione Del Monte di Bologna e Ravenna', Italy; University of Bologna; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301, R01DK098447] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Ministry of Education, University and Research (MIUR; PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); 'Fondazione Del Monte di Bologna e Ravenna', Italy(Fondazione del Monte di Bologna e Ravenna); University of Bologna; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The present work was supported by National Institutes of Health (NIH) grants DK09 and 41301 (C.S.), grants from the Italian Ministry of Education, University and Research (MIUR; PRIN2009; R. De G.), from 'Fondazione Del Monte di Bologna e Ravenna', Italy, and funds from the University of Bologna (R. De G. and P.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batterham RL, 2006, CELL METAB, V4, P223, DOI 10.1016/j.cmet.2006.08.001; Bensaid A, 2002, PHYSIOL BEHAV, V75, P577, DOI 10.1016/S0031-9384(02)00646-7; Buchan AMJ, 2001, GASTROENTEROLOGY, V120, P1128, DOI 10.1053/gast.2001.23246; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Chen MC, 2006, AM J PHYSIOL-CELL PH, V291, pC726, DOI 10.1152/ajpcell.00003.2006; Choi S, 2007, AM J PHYSIOL-GASTR L, V292, pG98, DOI 10.1152/ajpgi.00295.2006; Conigrave AD, 2000, P NATL ACAD SCI USA, V97, P4814, DOI 10.1073/pnas.97.9.4814; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Daly K, 2013, AM J PHYSIOL-GASTR L, V304, pG271, DOI 10.1152/ajpgi.00074.2012; Dockray G J, 2003, J Physiol Pharmacol, V54 Suppl 4, P9; Fujita T, 1980, Adv Biochem Psychopharmacol, V25, P321; Fujita Y, 2009, AM J PHYSIOL-ENDOC M, V296, pE473, DOI 10.1152/ajpendo.90636.2008; Furness JB, 1999, AM J PHYSIOL-GASTR L, V277, pG922, DOI 10.1152/ajpgi.1999.277.5.G922; Furness JB, 2013, NAT REV GASTRO HEPAT, V10, P729, DOI 10.1038/nrgastro.2013.180; Gershon MD, 2007, GASTROENTEROLOGY, V132, P397, DOI 10.1053/j.gastro.2006.11.002; Glendinning JI, 2008, PHYSIOL BEHAV, V93, P757, DOI 10.1016/j.physbeh.2007.11.029; Haid D, 2011, J MOL HISTOL, V42, P355, DOI 10.1007/s10735-011-9339-1; Haid DC, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00065; Hao SZ, 2008, AM J PHYSIOL-REG I, V294, pR33, DOI 10.1152/ajpregu.00675.2007; Hao S, 2009, AM J PHYSIOL-REG I, V296, pR528, DOI 10.1152/ajpregu.90423.2008; He W, 2002, CHEM SENSES, V27, P719, DOI 10.1093/chemse/27.8.719; He W, 2004, J NEUROSCI, V24, P7674, DOI 10.1523/JNEUROSCI.2441-04.2004; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Hofer D, 1999, NEWS PHYSIOL SCI, V14, P18; Hofer D, 1996, P NATL ACAD SCI USA, V93, P6631, DOI 10.1073/pnas.93.13.6631; Hofer D, 1998, HISTOCHEM CELL BIOL, V110, P303, DOI 10.1007/s004180050292; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Janssen S, 2011, P NATL ACAD SCI USA, V108, P2094, DOI 10.1073/pnas.1011508108; Jeon TI, 2008, J CLIN INVEST, V118, P3693, DOI 10.1172/JCI36461; Kinsey-Jones JS, 2015, OBESITY, V23, P1194, DOI 10.1002/oby.21083; Latorre R, 2013, FISH PHYSIOL BIOCHEM, V39, P1555, DOI 10.1007/s10695-013-9808-4; Lejeune MPGM, 2006, AM J CLIN NUTR, V83, P89; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Liou AP, 2011, AM J PHYSIOL-GASTR L, V300, pG538, DOI 10.1152/ajpgi.00342.2010; Lobley GE, 2015, BRIT J NUTR, V113, P1254, DOI 10.1017/S0007114515000069; Maehashi K, 2009, CELL MOL LIFE SCI, V66, P1661, DOI 10.1007/s00018-009-8755-9; Margolskee RF, 2002, J BIOL CHEM, V277, P1, DOI 10.1074/jbc.R100054200; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Mazzoni M, 2015, FISH PHYSIOL BIOCHEM, V41, P603, DOI 10.1007/s10695-015-0031-3; Mazzoni M, 2013, J CELL MOL MED, V17, P466, DOI 10.1111/jcmm.12026; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Moran AW, 2010, BRIT J NUTR, V104, P637, DOI 10.1017/S0007114510000917; Moran TH, 2009, INT J OBESITY, V33, pS7, DOI 10.1038/ijo.2009.9; Nakamura E, 2011, DIGESTION, V83, P13, DOI 10.1159/000323399; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Potier M, 2009, CURR OPIN CLIN NUTR, V12, P54, DOI 10.1097/MCO.0b013e32831b9e01; Rozengurt N, 2006, AM J PHYSIOL-GASTR L, V291, pG792, DOI 10.1152/ajpgi.00074.2006; RUIZAVILA L, 1995, NATURE, V376, P80, DOI 10.1038/376080a0; Sainz E, 2007, DEV NEUROBIOL, V67, P948, DOI 10.1002/dneu.20403; Shirazi-Beechey SP, 2014, BRIT J NUTR, V111, pS1, DOI 10.1017/S000711451300233X; Steinert RE, 2011, CLIN NUTR, V30, P524, DOI 10.1016/j.clnu.2011.01.007; Sternini C, 2008, CURR OPIN ENDOCRINOL, V15, P73, DOI 10.1097/MED.0b013e3282f43a73; Sutherland K, 2007, AM J PHYSIOL-GASTR L, V292, pG1420, DOI 10.1152/ajpgi.00504.2006; Takahashi T, 2012, J ANIM SCI, V90, P4807, DOI 10.2527/jas.2011-4596; Vallejo-Cremades MT, 2004, REGUL PEPTIDES, V121, P113, DOI 10.1016/j.regpep.2004.04.016; Vancleef L, 2015, SCI REP-UK, V5, DOI 10.1038/srep15725; Vegezzi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107732; Wang SY, 2015, HORM RES PAEDIAT, V83, P19, DOI 10.1159/000362168; Ward DT, 2004, CELL CALCIUM, V35, P217, DOI 10.1016/j.ceca.2003.10.017; Wellendorph P, 2009, MOL PHARMACOL, V76, P453, DOI 10.1124/mol.109.055244; Widmayer P, 2011, HISTOCHEM CELL BIOL, V136, P37, DOI 10.1007/s00418-011-0824-0; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Wu SV, 2005, PHYSIOL GENOMICS, V22, P139, DOI 10.1152/physiolgenomics.00030.2005; Wu SV, 2002, P NATL ACAD SCI USA, V99, P2392, DOI 10.1073/pnas.042617699; Yasumatsu K, 2012, J PHYSIOL-LONDON, V590, P1155, DOI 10.1113/jphysiol.2011.211920; Young RL, 2009, GUT, V58, P337, DOI 10.1136/gut.2008.148932	67	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148954	10.1371/journal.pone.0148954	http://dx.doi.org/10.1371/journal.pone.0148954			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871573	Green Submitted, gold, Green Published			2022-12-27	WOS:000370054100079
J	Gordon, SL; Harper, CB; Smillie, KJ; Cousin, MA				Gordon, Sarah L.; Harper, Callista B.; Smillie, Karen J.; Cousin, Michael A.			A Fine Balance of Synaptophysin Levels Underlies Efficient Retrieval of Synaptobrevin II to Synaptic Vesicles	PLOS ONE			English	Article							HIPPOCAMPAL SYNAPSES; ENDOCYTOSIS; PROTEINS; SYNAPTOTAGMIN; TERMINALS; KINETICS; REVEALS; NEURONS; DOMAIN; BINDS	Synaptobrevin II (sybII) is a vesicular soluble NSF attachment protein receptor (SNARE) protein that is essential for neurotransmitter release, and thus its correct trafficking to synaptic vesicles (SVs) is critical to render them fusion competent. The SV protein synaptophysin binds to sybII and facilitates its retrieval to SVs during endocytosis. Synaptophysin and sybII are the two most abundant proteins on SVs, being present in a 1: 2 ratio. Synaptophysin and sybII are proposed to form a large multimeric complex, and the copy number of the proteins in this complex is also in a 1: 2 ratio. We investigated the importance of this ratio between these proteins for the localisation and trafficking of sybII in central neurons. SybII was overexpressed in mouse hippocampal neurons at either 1.6 or 2.15-2.35-fold over endogenous protein levels, in the absence or presence of varying levels of synaptophysin. In the absence of exogenous synaptophysin, exogenous sybII was dispersed along the axon, trapped on the plasma membrane and retrieved slowly during endocytosis. Coexpression of exogenous synaptophysin rescued all of these defects. Importantly, the expression of synaptophysin at nerve terminals in a 1: 2 ratio with sybII was sufficient to fully rescue normal sybII trafficking. These results demonstrate that the balance between synaptophysin and sybII levels is critical for the correct targeting of sybII to SVs and suggests that small alterations in synaptophysin levels might affect the localisation of sybII and subsequent presynaptic performance.	[Gordon, Sarah L.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, 30 Royal Parade, Parkville, Vic 3052, Australia; [Harper, Callista B.; Smillie, Karen J.; Cousin, Michael A.] Univ Edinburgh, Ctr Integrat Physiol, George Sq, Edinburgh EH8 9XD, Midlothian, Scotland	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Edinburgh	Gordon, SL (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, 30 Royal Parade, Parkville, Vic 3052, Australia.; Cousin, MA (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, George Sq, Edinburgh EH8 9XD, Midlothian, Scotland.	sarah.gordon@florey.edu.au; M.Cousin@ed.ac.uk		Cousin, Michael/0000-0002-1762-160X; Smillie, Karen/0000-0003-4369-0470	Biotechnology and Biological Sciences Research Council [BB/L019329/1]; National Health and Medical Research Council (NHMRC) of Australia [GNT1085483]; Victorian Government; Operational Infrastructure Support Grant; BBSRC [BB/L019329/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government; Operational Infrastructure Support Grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work is supported by a grant from the Biotechnology and Biological Sciences Research Council (BB/L019329/1) and The National Health and Medical Research Council (NHMRC) of Australia (GNT1085483). The Florey Institute of Neuroscience and Mental Health acknowledges the strong support from the Victorian Government and in particular the funding from the Operational Infrastructure Support Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13659; Arthur CP, 2007, STRUCTURE, V15, P707, DOI 10.1016/j.str.2007.04.011; Atluri PP, 2006, J NEUROSCI, V26, P2313, DOI 10.1523/JNEUROSCI.4425-05.2006; Baker K, 2015, J CLIN INVEST; Becher A, 1999, J NEUROSCI, V19, P1922; Bonanomi D, 2007, BIOCHEM J, V404, P525, DOI 10.1042/BJ20061907; Burrone J, 2006, NAT PROTOC, V1, P2970, DOI 10.1038/nprot.2006.449; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; Deak F, 2004, NAT CELL BIOL, V6, P1102, DOI 10.1038/ncb1185; Gordon SL, 2014, TRAFFIC, V15, P245, DOI 10.1111/tra.12140; Gordon SL, 2013, J NEUROSCI, V33, P13695, DOI 10.1523/JNEUROSCI.0636-13.2013; Gordon SL, 2011, J NEUROSCI, V31, P14032, DOI 10.1523/JNEUROSCI.3162-11.2011; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Kaempf N, 2015, P NATL ACAD SCI USA, V112, P7297, DOI 10.1073/pnas.1501627112; Kwon SE, 2011, NEURON, V70, P847, DOI 10.1016/j.neuron.2011.04.001; Lyles V, 2006, NEURON, V49, P349, DOI 10.1016/j.neuron.2005.12.029; Maritzen T, 2012, BIOL CELL, V104, P588, DOI 10.1111/boc.201200008; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; Mutch SA, 2011, J NEUROSCI, V31, P1461, DOI 10.1523/JNEUROSCI.3805-10.2011; Pan PY, 2015, J BIOL CHEM, V290, P22593, DOI 10.1074/jbc.M115.651711; Pennuto M, 2003, MOL BIOL CELL, V14, P4909, DOI 10.1091/mbc.E03-06-0380; Schikorski T, 1997, J NEUROSCI, V17, P5858; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Sugita S, 1996, J BIOL CHEM, V271, P1262, DOI 10.1074/jbc.271.3.1262; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Thiele C, 2000, NAT CELL BIOL, V2, P42, DOI 10.1038/71366; Wang J, 2014, P NATL ACAD SCI USA, V111, P13966, DOI 10.1073/pnas.1415849111; Wilhelm BG, 2014, SCIENCE, V344, P1023, DOI 10.1126/science.1252884; Xu JH, 2013, CELL REP, V3, P1414, DOI 10.1016/j.celrep.2013.03.010; Yelamanchili SV, 2005, EUR J CELL BIOL, V84, P467, DOI 10.1016/j.ejcb.2004.11.007; Zhang N, 2015, J NEUROSCI, V35, P2492, DOI 10.1523/JNEUROSCI.4248-14.2015; Zhang Z, 2013, J NEUROSCI, V33, P9169, DOI 10.1523/JNEUROSCI.0301-13.2013	34	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149457	10.1371/journal.pone.0149457	http://dx.doi.org/10.1371/journal.pone.0149457			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871701	Green Published, gold			2022-12-27	WOS:000370054100161
J	Izquierdo, L; Oliveira, C; Fournier, C; Descamps, V; Morel, V; Dubuisson, J; Brochot, E; Francois, C; Castelain, S; Duverlie, G; Helle, F				Izquierdo, Laure; Oliveira, Catarina; Fournier, Carole; Descamps, Veronique; Morel, Virginie; Dubuisson, Jean; Brochot, Etienne; Francois, Catherine; Castelain, Sandrine; Duverlie, Gilles; Helle, Francois			Hepatitis C Virus Resistance to Carbohydrate-Binding Agents	PLOS ONE			English	Article							CULTURE-ADAPTIVE MUTATIONS; ENVELOPE GLYCOPROTEIN E2; HEPATOMA-CELL LINES; N-LINKED GLYCANS; IN-VITRO; NEUTRALIZING ANTIBODIES; VIRION INFECTIVITY; EBOLA-VIRUS; PROTEIN; ENTRY	Carbohydrate binding agents (CBAs), including natural lectins, are more and more considered as broad-spectrum antivirals. These molecules are able to directly inhibit many viruses such as Human Immunodeficiency Virus (HIV), Hepatitis C Virus (HCV), Dengue Virus, Ebola Virus or Severe Acute Respiratory Syndrome Coronavirus through binding to envelope protein N-glycans. In the case of HIV, it has been shown that CBAs select for mutant viruses with N-glycosylation site deletions which are more sensitive to neutralizing antibodies. In this study we aimed at evaluating the HCV resistance to CBAs in vitro. HCV was cultivated in the presence of increasing Galanthus nivalis agglutinin (GNA), Cyanovirin-N, Concanavalin-A or Griffithsin concentrations, during more than eight weeks. At the end of lectin exposure, the genome of the isolated strains was sequenced and several potential resistance mutations in the E1E2 envelope glycoproteins were identified. The effect of these mutations on viral fitness as well as on sensitivity to inhibition by lectins, soluble CD81 or the 3/11 neutralizing antibody was assessed. Surprisingly, none of these mutations, alone or in combination, conferred resistance to CBAs. In contrast, we observed that some mutants were more sensitive to 3/11 or CD81-LEL inhibition. Additionally, several mutations were identified in the Core and the non-structural proteins. Thus, our results suggest that in contrast to HIV, HCV resistance to CBAs is not directly conferred by mutations in the envelope protein genes but could occur through an indirect mechanism involving mutations in other viral proteins. Further investigations are needed to completely elucidate the underlying mechanisms.	[Izquierdo, Laure; Oliveira, Catarina; Fournier, Carole; Descamps, Veronique; Morel, Virginie; Brochot, Etienne; Francois, Catherine; Castelain, Sandrine; Duverlie, Gilles; Helle, Francois] Ctr Hosp Univ, Ctr Univ Rech Sante, Lab Virol, EA4294, Amiens, France; [Izquierdo, Laure; Oliveira, Catarina; Fournier, Carole; Descamps, Veronique; Morel, Virginie; Brochot, Etienne; Francois, Catherine; Castelain, Sandrine; Duverlie, Gilles; Helle, Francois] Univ Picardie Jules Verne, Amiens, France; [Dubuisson, Jean] Univ Lille, CNRS, INSERM,CHU Lille, U1019,UMR 8204,CIIL,Inst Pasteur Lille,Ctr Infect, Lille, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille	Helle, F (corresponding author), Ctr Hosp Univ, Ctr Univ Rech Sante, Lab Virol, EA4294, Amiens, France.; Helle, F (corresponding author), Univ Picardie Jules Verne, Amiens, France.	francois.helle@u-picardie.fr	BROCHOT, ETIENNE/I-5318-2012; FRANCOIS, Catherine/AAJ-8289-2020; Castelain, Sandrine/AAA-6344-2019; CASTELAIN, SANDRINE/AAJ-7506-2020; HELLE, Francois/G-7427-2011; Dubuisson, Jean/E-6813-2016	BROCHOT, ETIENNE/0000-0002-8677-6349; CASTELAIN, SANDRINE/0000-0002-2670-3148; HELLE, Francois/0000-0001-6884-2456; Dubuisson, Jean/0000-0003-1626-7693	Conseil Regional de Picardie [Parivir, Hepanovir, Oncovir]	Conseil Regional de Picardie(Region Hauts-de-France)	This study was funded by the Conseil Regional de Picardie (grant no. Parivir, Hepanovir, Oncovir). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alen MMF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021658; Aligeti M, 2015, J VIROL, V89, P11523, DOI 10.1128/JVI.01185-15; Ashfaq UA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-248; Balzarini J, 2007, NAT REV MICROBIOL, V5, P583, DOI 10.1038/nrmicro1707; Balzarini O, 2005, LANCET INFECT DIS, V5, P726, DOI 10.1016/S1473-3099(05)70271-1; Barrientos LG, 2003, ANTIVIR RES, V58, P47, DOI 10.1016/S0166-3542(02)00183-3; Bertaux C, 2007, VIROLOGY, V366, P40, DOI 10.1016/j.virol.2007.04.008; Boson B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002144; Carlsen THR, 2013, J VIROL, V87, P1385, DOI 10.1128/JVI.00684-12; Castelain S, 2004, J CLIN VIROL, V31, P227, DOI 10.1016/j.jcv.2004.03.009; Combet C., 2009, Infectious Disorders - Drug Targets, V9, P272; Delgrange D, 2007, J GEN VIROL, V88, P2495, DOI 10.1099/vir.0.82872-0; Dhillon S, 2010, J VIROL, V84, P5494, DOI 10.1128/JVI.02153-09; DUBUISSON J, 1994, J VIROL, V68, P6147, DOI 10.1128/JVI.68.10.6147-6160.1994; Dubuisson J, 2014, J HEPATOL, V61, pS3, DOI 10.1016/j.jhep.2014.06.031; Falkowska E, 2007, J VIROL, V81, P8072, DOI 10.1128/JVI.00459-07; Flint M, 1999, J VIROL, V73, P6235, DOI 10.1128/JVI.73.8.6235-6244.1999; Fournier C, 2013, J GEN VIROL, V94, P996, DOI 10.1099/vir.0.049676-0; Gal-Tanamy M, 2008, P NATL ACAD SCI USA, V105, P19450, DOI 10.1073/pnas.0809879105; Garrison AR, 2014, ANTIVIR RES, V112, P1, DOI 10.1016/j.antiviral.2014.09.012; Goffard A, 2005, J VIROL, V79, P8400, DOI 10.1128/JVI.79.13.8400-8409.2005; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Goueslain L, 2010, J VIROL, V84, P773, DOI 10.1128/JVI.01190-09; Helle F, 2007, J VIROL, V81, P8101, DOI 10.1128/JVI.00127-07; Helle F, 2006, J BIOL CHEM, V281, P25177, DOI 10.1074/jbc.M602431200; Helle F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070809; Helle F, 2011, VIRUSES-BASEL, V3, P1909, DOI 10.3390/v3101909; Helle F, 2010, J VIROL, V84, P11905, DOI 10.1128/JVI.01548-10; Higginbottom A, 2000, J VIROL, V74, P3642, DOI 10.1128/JVI.74.8.3642-3649.2000; Jiang JY, 2012, J VIROL, V86, P8987, DOI 10.1128/JVI.00004-12; Jones CT, 2010, NAT BIOTECHNOL, V28, P167, DOI 10.1038/nbt.1604; Kachko A, 2013, MOL PHARMACEUT, V10, P4590, DOI 10.1021/mp400399b; Kang JI, 2009, VIRUS RES, V144, P107, DOI 10.1016/j.virusres.2009.04.002; Keck ZY, 2011, J VIROL, V85, P10451, DOI 10.1128/JVI.05259-11; Korber B, COMPUTATIONAL ANAL H, P55; Kumaki Y, 2011, ANTIVIR RES, V90, P22, DOI 10.1016/j.antiviral.2011.02.003; Li YL, 2015, J BIOL CHEM, V290, P10117, DOI 10.1074/jbc.M115.643528; Liu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044965; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; McCaffrey K, 2011, J GEN VIROL, V92, P112, DOI 10.1099/vir.0.026385-0; Meuleman P, 2011, ANTIMICROB AGENTS CH, V55, P5159, DOI 10.1128/AAC.00633-11; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; O'Keefe BR, 2010, J VIROL, V84, P2511, DOI 10.1128/JVI.02322-09; Pantua H, 2013, J MOL BIOL, V425, P1899, DOI 10.1016/j.jmb.2013.02.025; Pawlotsky JM, 2015, J HEPATOL, V62, pS87, DOI 10.1016/j.jhep.2015.02.006; Pawlotsky JM, 2015, GUT, V64, P362, DOI 10.1136/gutjnl-2014-307452; Russell RS, 2008, P NATL ACAD SCI USA, V105, P4370, DOI 10.1073/pnas.0800422105; Sabahi A, 2014, J VIROL, V88, P10280, DOI 10.1128/JVI.00874-14; Simmonds P, 2013, CURR TOP MICROBIOL, V369, P1, DOI 10.1007/978-3-642-27340-7_1; Takebe Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064449; Takeda M, 2012, J GEN VIROL, V93, P1422, DOI 10.1099/vir.0.040725-0; Tarr AW, 2006, HEPATOLOGY, V43, P592, DOI 10.1002/hep.21088; Vieyres G, 2010, J VIROL, V84, P10159, DOI 10.1128/JVI.01180-10; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yu LJ, 2010, J VIROL METHODS, V169, P380, DOI 10.1016/j.jviromet.2010.08.009	55	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149064	10.1371/journal.pone.0149064	http://dx.doi.org/10.1371/journal.pone.0149064			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871442	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100096
J	Smith, SH; Peredo, CE; Takeda, Y; Bui, T; Neil, J; Rickard, D; Millerman, E; Therrien, JP; Nicodeme, E; Brusq, JM; Birault, V; Viviani, F; Hofland, H; Jetten, AM; Cote-Sierra, J				Smith, Susan H.; Peredo, Carlos E.; Takeda, Yukimasa; Thi Bui; Neil, Jessica; Rickard, David; Millerman, Elizabeth; Therrien, Jean-Philippe; Nicodeme, Edwige; Brusq, Jean-Marie; Birault, Veronique; Viviani, Fabrice; Hofland, Hans; Jetten, Anton M.; Cote-Sierra, Javier			Development of a Topical Treatment for Psoriasis Targeting ROR gamma: From Bench to Skin	PLOS ONE			English	Article							NUCLEAR RECEPTORS; T-CELLS; DIFFERENTIATION; INFLAMMATION; POTENT; IDENTIFICATION; ACTIVATION; EXPRESSION; ANTIBODY; IL-17	Background Psoriasis is a chronic inflammatory skin disorder involving marked immunological changes. IL-17-targeting biologics have been successful in reducing the disease burden of psoriasis patients with moderate-to-severe disease. Unfortunately, the stratum corneum prevents penetration of large molecule weight proteins, including monoclonal antibodies. Thus, for the majority of psoriasis patients ineligible for systemic treatments, a small molecule targeting ROR gamma t, the master regulator of IL-17 family cytokines, may represent an alternative topical medicine with biologic-like efficacy. Methods and Findings The preclinical studies described in this manuscript bridge the gap from bench to bedside to provide the scientific foundation for a compound entering clinical trials for patients with mild to moderate psoriasis. In addition to several ex vivo reporter assays, primary T cell cultures, and the imiquimod mouse model, we demonstrate efficacy in a newly developed human ex vivo skin assay, where Th17-skewed cytokine expression is induced from skin-resident immune cells. Importantly, the skin barrier remains intact allowing for the demonstration of topical drug delivery. With the development of this novel assay, we demonstrate potent compound activity in the target tissue: human skin. Finally, target engagement by this small molecule was confirmed in ex vivo lesional psoriatic skin. Conclusions Our work describes a progressive series of assays to demonstrate the potential clinical value of a novel ROR gamma inverse agonist small molecule with high potency and selectivity, which will enter clinical trials in late 2015 for psoriasis patients.	[Smith, Susan H.; Peredo, Carlos E.; Thi Bui; Neil, Jessica; Millerman, Elizabeth; Therrien, Jean-Philippe; Hofland, Hans; Cote-Sierra, Javier] Stiefel, Discovery & Preclin Dev, Res Triangle Pk, NC USA; [Takeda, Yukimasa; Jetten, Anton M.] NIEHS, Immun Inflammat & Dis Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Nicodeme, Edwige; Brusq, Jean-Marie; Viviani, Fabrice] GlaxoSmithKline, Flexible Discovery Unit, Les Ulis, France; [Rickard, David] GlaxoSmithKline, MDR PTS, Res Triangle Pk, NC USA; [Birault, Veronique] GlaxoSmithKline, Med Res Ctr, Resp Therapeut Area, Gunnels Wood Rd, Stevenage, Herts, England; [Hofland, Hans] Dermira Inc, Redwood City, CA USA; [Cote-Sierra, Javier] Pfizer Inc, External R&D Innovat Inflammat & Immunol, Cambridge, MA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Pfizer	Smith, SH (corresponding author), Stiefel, Discovery & Preclin Dev, Res Triangle Pk, NC USA.	susan.h.smith@stiefel.com	Therrien, Jean-Philippe/AAW-8912-2021; Jetten, Anton/C-3736-2019	Therrien, Jean-Philippe/0000-0001-5878-6841; Jetten, Anton/0000-0003-0954-4445; Neil, Jessica/0000-0003-0770-5321	GlaxoSmithKline, plc.; Intramural Research Program of the NIEHS, NIH [Z01-ES-100485]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101586] Funding Source: NIH RePORTER	GlaxoSmithKline, plc.(GlaxoSmithKline); Intramural Research Program of the NIEHS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The funder (GlaxoSmithKline, plc.) provided support in the form of salaries for authors (SHS, CEP, TB, JN, DR, EM, JPT, EN, JMB, VB, HH, JCS). The specific roles these authors are articulated in the "author contributions" section. This work was also in part funded by the Intramural Research Program of the NIEHS, NIH (Z01-ES-100485) in the form of salaries for authors (YT and AMJ), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Berg EL, 2015, INT J MOL SCI, V16, P1008, DOI 10.3390/ijms16011008; Bergamini G, 2012, NAT CHEM BIOL, V8, P576, DOI [10.1038/NCHEMBIO.957, 10.1038/nchembio.957]; Bowcock AM, 2005, NAT REV IMMUNOL, V5, P699, DOI 10.1038/nri1689; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Clark RA, 2010, J INVEST DERMATOL, V130, P362, DOI 10.1038/jid.2009.247; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Di Meglio P, 2011, IMMUNITY, V35, P857, DOI 10.1016/j.immuni.2011.12.003; Fauber BP, 2014, J MED CHEM, V57, P5871, DOI 10.1021/jm401901d; Huh JR, 2013, ACS MED CHEM LETT, V4, P79, DOI 10.1021/ml300286h; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Kojetin DJ, 2014, NAT REV DRUG DISCOV, V13, P197, DOI 10.1038/nrd4100; Krueger JG, 2012, NAT MED, V18, P1750, DOI 10.1038/nm.3025; Kumar N, 2012, ACS CHEM BIOL, V7, P672, DOI 10.1021/cb200496y; Kumar N, 2010, MOL PHARMACOL, V77, P228, DOI 10.1124/mol.109.060905; Kurebayashi S, 2004, BIOCHEM BIOPH RES CO, V315, P919, DOI 10.1016/j.bbrc.2004.01.131; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Lin AM, 2011, J IMMUNOL, V187, P490, DOI 10.4049/jimmunol.1100123; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Qu XYA, 2014, DRUG DISCOV TODAY, V19, P1364, DOI 10.1016/j.drudis.2014.03.015; Rene O, 2015, ACS MED CHEM LETT, V6, P276, DOI 10.1021/ml500420y; Reynolds JM, 2010, CYTOKINE GROWTH F R, V21, P413, DOI 10.1016/j.cytogfr.2010.10.002; Skepner J, 2014, J IMMUNOL, V192, P2564, DOI 10.4049/jimmunol.1302190; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski AT, 2014, FASEB J, V28, P2775, DOI 10.1096/fj.13-242040; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Takeda Y, 2012, NUCLEIC ACIDS RES, V40, P8519, DOI 10.1093/nar/gks630; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Wang YH, 2014, BIOORGAN MED CHEM, V22, P692, DOI 10.1016/j.bmc.2013.12.021; Witte E, 2014, J INVEST DERMATOL, V134, P2757, DOI 10.1038/jid.2014.308; Xiao S, 2014, IMMUNITY, V40, P477, DOI 10.1016/j.immuni.2014.04.004; Xu T, 2011, J BIOL CHEM, V286, P22707, DOI 10.1074/jbc.C111.250407; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zhang W, 2012, MOL PHARMACOL, V82, P583, DOI 10.1124/mol.112.078667; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	38	62	63	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0147979	10.1371/journal.pone.0147979	http://dx.doi.org/10.1371/journal.pone.0147979			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26870941	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100014
J	Weston-Bell, NJ; Tapper, W; Gibson, J; Bryant, D; Moreno, Y; John, M; Ennis, S; Kluin-Nelemans, HC; Collins, AR; Sahota, SS				Weston-Bell, Nicola J.; Tapper, Will; Gibson, Jane; Bryant, Dean; Moreno, Yurany; John, Melford; Ennis, Sarah; Kluin-Nelemans, Hanneke C.; Collins, Andrew R.; Sahota, Surinder S.			Exome Sequencing in Classic Hairy Cell Leukaemia Reveals Widespread Variation in Acquired Somatic Mutations between Individual Tumours Apart from the Signature BRAF V(600) E Lesion	PLOS ONE			English	Article							B-CELLS; KINASES STRUCTURE; V600E MUTATION; IMMUNOGLOBULIN; CANCER; EXPRESSION; SIGNALS; VARIANT; MAP2K1; GENES	In classic Hairy cell leukaemia (HCLc), a single case has thus far been interrogated by whole exome sequencing (WES) in a treatment naive patient, in which BRAF V(600) E was identified as an acquired somatic mutation and confirmed as occurring near-universally in this form of disease by conventional PCR-based cohort screens. It left open however the question whether other genome-wide mutations may also commonly occur at high frequency in presentation HCLc disease. To address this, we have carried out WES of 5 such typical HCLc cases, using highly purified splenic tumour cells paired with autologous T cells for germline. Apart from BRAF V(600) E, no other recurrent somatic mutation was identified in these HCLc exomes, thereby excluding additional acquired mutations as also prevalent at a near-universal frequency in this form of the disease. These data then place mutant BRAF at the centre of the neoplastic drive in HCLc. A comparison of our exome data with emerging genetic findings in HCL indicates that additional somatic mutations may however occur recurrently in smaller subsets of disease. As mutant BRAF alone is insufficient to drive malignant transformation in other histological cancers, it suggests that individual tumours utilise largely differing patterns of genetic somatic mutations to coalesce with BRAF V(600) E to drive pathogenesis of malignant HCLc disease.	[Weston-Bell, Nicola J.; Bryant, Dean; Moreno, Yurany; Sahota, Surinder S.] Univ Southampton, Fac Med, Canc Sci Unit, Tumour Immunogenet Grp, Southampton SO9 5NH, Hants, England; [Tapper, Will; Ennis, Sarah; Collins, Andrew R.] Univ Southampton, Fac Med, Human Genet, Genet Epidemiol & Genom Informat Grp, Southampton SO9 5NH, Hants, England; [Gibson, Jane] Univ Southampton, Fac Nat & Environm Studies, Ctr Biol Sci, Southampton, Hants, England; [John, Melford] Univ W Indies, Fac Med Sci, Dept Preclin Sci, St Augustine, Trinidad Tobago; [Kluin-Nelemans, Hanneke C.] Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands	University of Southampton; University of Southampton; University of Southampton; University West Indies Mona Jamaica; University West Indies Saint Augustine; University of Groningen	Sahota, SS (corresponding author), Univ Southampton, Fac Med, Canc Sci Unit, Tumour Immunogenet Grp, Southampton SO9 5NH, Hants, England.	s.s.sahota@soton.ac.uk	Collins, Andrew/A-6595-2010; Kluin-Nelemans, Johanna C/F-8658-2018; Collins, Andrew/S-2196-2019; Gibson, Jane/I-1630-2012	Collins, Andrew/0000-0001-7108-0771; Kluin-Nelemans, Johanna C/0000-0003-2617-9427; Collins, Andrew/0000-0001-7108-0771; Gibson, Jane/0000-0002-0973-8285; Tapper, William/0000-0002-5896-1889; Weston-Bell, Nicola/0000-0003-0075-7276; Bryant, Dean/0000-0003-3163-608X	Bloodwise (United Kingdom)	Bloodwise (United Kingdom)	The project was funded by the Leukaemia & Lymphoma Research (United Kingdom) [now called Bloodwise (United Kingdom)].	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arcaini L, 2012, BLOOD, V119, P188, DOI 10.1182/blood-2011-08-368209; Arons E, 2009, BLOOD, V114, P4687, DOI 10.1182/blood-2009-01-201731; Berres ML, 2014, J EXP MED, V211, P669, DOI 10.1084/jem.20130977; Brown NA, 2014, BLOOD, V124, P1655, DOI 10.1182/blood-2014-05-577361; Brummer T, 2002, EMBO J, V21, P5611, DOI 10.1093/emboj/cdf588; Chakraborty R, 2014, BLOOD, V124, P3007, DOI 10.1182/blood-2014-05-577825; Chung SS, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008004; Dietrich S, 2015, BLOOD, V126, P1005, DOI 10.1182/blood-2015-04-643361; Dietrich S, 2012, NEW ENGL J MED, V366, P2038, DOI 10.1056/NEJMc1202124; Fajardo KVF, 2012, HUM MUTAT, V33, P609, DOI 10.1002/humu.22033; Forconi F, 2004, BLOOD, V104, P3312, DOI 10.1182/blood-2004-03-0950; Forconi F, 2001, BLOOD, V98, P1174, DOI 10.1182/blood.V98.4.1174; Forconi F, 2008, HAEMATOLOGICA, V93, P697, DOI 10.3324/haematol.12282; Forconi F, 2011, HEMATOL ONCOL, V29, P55, DOI 10.1002/hon.975; Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jun G, 2012, AM J HUM GENET, V91, P839, DOI 10.1016/j.ajhg.2012.09.004; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; KLUINNELEMANS HC, 1990, BLOOD, V75, P972; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kreitman RJ, 2013, CLIN CANCER RES, V19, P6873, DOI 10.1158/1078-0432.CCR-13-1752; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Laurini JA, 2012, AM J CLIN PATHOL, V138, P877, DOI 10.1309/AJCP5TWORA0TMXGL; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lefranc MP, 2014, BIOMOLECULES, V4, P1102, DOI 10.3390/biom4041102; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Matallanas David, 2011, Genes Cancer, V2, P232, DOI 10.1177/1947601911407323; Mullighan CG, 2013, BLOOD, V122, P3899, DOI 10.1182/blood-2013-08-460311; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Roskoski R, 2012, BIOCHEM BIOPH RES CO, V417, P5, DOI 10.1016/j.bbrc.2011.11.145; Roy DM, 2014, PROTEIN CELL, V5, P265, DOI 10.1007/s13238-014-0031-6; Seshan V., 2010, DNACOPY DNA COPY NUM; Stevenson FK, 2001, ADV CANCER RES, V83, P81, DOI 10.1016/S0065-230X(01)83004-9; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tiacci E, 2006, NAT REV CANCER, V6, P437, DOI 10.1038/nrc1888; Tiacci E, 2012, BLOOD, V119, P192, DOI 10.1182/blood-2011-08-371179; Tiacci E, 2011, NEW ENGL J MED, V364, P2305, DOI 10.1056/NEJMoa1014209; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang KP, 2015, ADV CANCER RES, V128, P173, DOI 10.1016/bs.acr.2015.04.014; Waterfall JJ, 2014, NAT GENET, V46, P8, DOI 10.1038/ng.2828; Weston-Bell N, 2009, LEUKEMIA, V23, P2075, DOI 10.1038/leu.2009.178; Weston-Bell NJ, 2013, LEUKEMIA, V27, P241, DOI 10.1038/leu.2012.163; Weston-Bell NJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086556; Xi LQ, 2012, BLOOD, V119, P3330, DOI 10.1182/blood-2011-09-379339	48	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149162	10.1371/journal.pone.0149162	http://dx.doi.org/10.1371/journal.pone.0149162			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871591	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000370054100115
J	Park, S; Yoon, JH; Sohn, J; Park, HS; Moon, HJ; Kim, MJ; Kim, EK; Kim, SI; Park, BW				Park, Seho; Yoon, Jung Hyun; Sohn, Joohyuk; Park, Hyung Seok; Moon, Hee Jung; Kim, Min Jung; Kim, Eun-Kyung; Kim, Seung Il; Park, Byeong-Woo			Magnetic Resonance Imaging after Completion of Neoadjuvant Chemotherapy Can Accurately Discriminate between No Residual Carcinoma and Residual Ductal Carcinoma In Situ in Patients with Triple-Negative Breast Cancer	PLOS ONE			English	Article							PATHOLOGICAL RESPONSE; PREOPERATIVE CHEMOTHERAPY; SYSTEMIC THERAPY; MRI; TRIAL; RECOMMENDATIONS; ULTRASOUND; PHENOTYPE; CONSENSUS; UPDATE	Background The accurate evaluation of favorable response to neoadjuvant chemotherapy (NCT) is critical to determine the extent of surgery. We investigated independent clinicopathological and radiological predictors to discriminate no residual carcinoma (ypT0) from residual ductal carcinoma in situ (ypTis) in breast cancer patients who received NCT. Patients and Methods Parameters of 117 patients attaining pathological complete response (CR) in the breast after NCT between January 2010 and December 2013 were retrospectively evaluated by univariate and multivariate analyses. All patients underwent mammography, ultrasound, and magnetic resonance imaging (MRI) before and after NCT. Results There were 67 (57.3%) patients with ypT0. These patients were associated with hormone receptor-negative status, human epidermal growth factor receptor-2 (HER2)-negative tumors, and a higher likelihood of breast-conservation surgery. Baseline mammographic and MRI presentation of the main lesion, absence of associated microcalcifications, shape, posterior features, and absence of calcifications on ultrasound were significantly associated with ypT0. CR in mammography, ultrasound, or MRI after NCT was also related to ypT0. By multivariate analysis, independent predictors of ypT0 were the triple-negative subtype [Odds ratio (OR), 4.23; 95% confidence interval (CI), 1.11-16.09] and CR in MRI after NCT (OR, 5.23; 95% CI, 1.53-17.85). Stratified analysis by breast cancer subtype demonstrated that MRI well predicted ypT0 in all subtypes except the HER2-positive subtype. In particular, of 40 triple-negative subtypes, 22 showed CR in MRI and 21 (95.5%) were ypT0 after NCT. Conclusion Among imaging modalities, breast MRI can potentially distinguish between ypT0 and ypTis after NCT, especially in patients with triple-negative breast cancer. This information can help clinicians evaluate tumor response to NCT and plan surgery for breast cancer patients of all subtypes except for those with HER2-enriched tumors after NCT.	[Park, Seho; Park, Hyung Seok; Kim, Seung Il; Park, Byeong-Woo] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea; [Yoon, Jung Hyun; Moon, Hee Jung; Kim, Min Jung; Kim, Eun-Kyung] Yonsei Univ, Coll Med, Severance Hosp, Dept Radiol,Res Inst Radiol Sci, Seoul, South Korea; [Sohn, Joohyuk] Yonsei Univ, Coll Med, Dept Internal Med, Div Med Oncol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, MJ (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Dept Radiol,Res Inst Radiol Sci, Seoul, South Korea.	mines@yuhs.ac	Kim, Eun-Kyung/E-5211-2017	Kim, Eun-Kyung/0000-0002-3368-5013; Moon, Hee Jung/0000-0002-5643-5885; Park, Hyung Seok/0000-0001-5322-6036; Park, Seho/0000-0001-8089-2755; Sohn, Joohyuk/0000-0002-2303-2764; Yoon, Jung Hyun/0000-0002-2100-3513; Park, Byeong-Woo/0000-0003-1353-2607	Bumsuk Academic Research Fund [2014-31-0768]	Bumsuk Academic Research Fund	The work was supported by the Bumsuk Academic Research Fund in 2014 (Grant No. 2014-31-0768), SP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrada BE, 2015, ANN SURG ONCOL, V22, P1111, DOI 10.1245/s10434-014-4113-8; Berruti Alfredo, 2011, Journal of the National Cancer Institute Monographs, P147, DOI 10.1093/jncimonographs/lgr037; Brown-Glaberman U, 2014, ONCOLOGY-NY, V28, P281; Buchholz TA, 2008, J CLIN ONCOL, V26, P791, DOI 10.1200/JCO.2007.15.0326; Chen K, 2011, AM SURGEON, V77, P1700; Choi HK, 2012, EUR J RADIOL, V81, P737, DOI 10.1016/j.ejrad.2011.01.013; Cortazar P, 2014, LANCET, V384, P164, DOI 10.1016/S0140-6736(13)62422-8; De los Santos JF, 2013, CANCER-AM CANCER SOC, V119, P1776, DOI 10.1002/cncr.27995; Gebreamlak EP, 2013, ANTI-CANCER AGENT ME, V13, P222; Gradishar WJ, 2014, J NATL COMPR CANC NE, V12, P542, DOI 10.6004/jnccn.2014.0058; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Hooley RJ, 2013, RADIOLOGY, V268, P642, DOI 10.1148/radiol.13121606; Kaufmann M, 2012, ANN SURG ONCOL, V19, P1508, DOI 10.1245/s10434-011-2108-2; Kim MJ, 2015, ACTA RADIOL, V56, P1069, DOI 10.1177/0284185114548507; Lee MC, 2015, ANN SURG ONCOL, V22, P2888, DOI 10.1245/s10434-014-4357-3; Li JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088853; Marchio Caterina, 2011, Journal of the National Cancer Institute Monographs, P86, DOI 10.1093/jncimonographs/lgr025; Marinovich ML, 2015, INT J CANCER, V136, P2730, DOI 10.1002/ijc.29323; Mercado CL, 2014, RADIOL CLIN N AM, V52, P481, DOI 10.1016/j.rcl.2014.02.008; Moon HG, 2013, ANN SURG, V257, P133, DOI 10.1097/SLA.0b013e3182686bd9; Mukhtar RA, 2013, ANN SURG ONCOL, V20, P3823, DOI 10.1245/s10434-013-3038-y; Trop I, 2014, RADIOGRAPHICS, V34, P1178, DOI 10.1148/rg.345130049; von Minckwitz G, 2012, J CLIN ONCOL, V30, P1796, DOI 10.1200/JCO.2011.38.8595; von Minckwitz G, 2012, BREAST CANCER RES TR, V132, P863, DOI 10.1007/s10549-011-1621-0; Wang SS, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-166; Weiss A, 2014, ANN SURG ONCOL, V21, P3310, DOI 10.1245/s10434-014-3914-0; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Yuan Y, 2010, AM J ROENTGENOL, V195, P260, DOI 10.2214/AJR.09.3908	28	9	10	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149347	10.1371/journal.pone.0149347	http://dx.doi.org/10.1371/journal.pone.0149347			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866475	Green Published, gold, Green Submitted			2022-12-27	WOS:000370050700084
J	Senft, RA; Meddle, SL; Baugh, AT				Senft, Rebecca A.; Meddle, Simone L.; Baugh, Alexander T.			Distribution and Abundance of Glucocorticoid and Mineralocorticoid Receptors throughout the Brain of the Great Tit (Parus major)	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; CORTICOSTEROID RECEPTORS; INDIVIDUAL VARIATION; NEURAL RESPONSE; STRESS-RESPONSE; FEMALE SONG; URBAN NOISE; BEHAVIOR; PERSONALITY; SPARROWS	The glucocorticoid stress response, regulated by the hypothalamic-pituitary-adrenal (HPA) axis, enables individuals to cope with stressors through transcriptional effects in cells expressing the appropriate receptors. The two receptors that bind glucocorticoids-the mineralocorticoid receptor (MR) and glucocorticoid receptor (GR)-are present in a variety of vertebrate tissues, but their expression in the brain is especially important. Neural receptor patterns have the potential to integrate multiple behavioral and physiological traits simultaneously, including self-regulation of glucocorticoid secretion through negative feedback processes. In the present work, we quantified the expression of GR and MR mRNA throughout the brain of a female great tit (Parus major), creating a distribution map encompassing 48 regions. This map, the first of its kind for P. major, demonstrated a widespread but not ubiquitous distribution of both receptor types. In the paraventricular nucleus of the hypothalamus (PVN) and the hippocampus (HP)-the two brain regions that we sampled from a total of 25 birds, we found high GR mRNA expression in the former and, unexpectedly, low MR mRNA in the latter. We examined the covariation of MR and GR levels in these two regions and found a strong, positive relationship between MR in the PVN and MR in the HP and a similar trend for GR across these two regions. This correlation supports the idea that hormone pleiotropy may constrain an individual's behavioral and physiological phenotype. In the female song system, we found moderate GR in hyperstriatum ventrale, pars caudalis (HVC), and moderate MR in robust nucleus of the arcopallium (RA). Understanding intra-and interspecific patterns of glucocorticoid receptor expression can inform us about the behavioral processes (e.g. song learning) that may be sensitive to stress and stimulate future hypotheses concerning the relationships between receptor expression, circulating hormone concentrations and performance traits under selection, including behavior.	[Senft, Rebecca A.; Baugh, Alexander T.] Swarthmore Coll, Dept Biol, Swarthmore, PA 19081 USA; [Meddle, Simone L.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin Inst, Easter Bush EH25 9RG, Midlothian, Scotland	Swarthmore College; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Senft, RA (corresponding author), Swarthmore Coll, Dept Biol, Swarthmore, PA 19081 USA.	senftrebecca@gmail.com	Baugh, Alexander T/E-4777-2010	Baugh, Alexander T/0000-0003-2032-892X; Senft, Rebecca/0000-0003-0081-4170	Alexander von Humboldt Foundation [1141248]; Max Planck Institute for Ornithology; Roslin Institute at the University of Edinburgh; Howard Hughes Medical Institute; Biology Department at Swarthmore College; BBSRC [BBS/E/D/20221656, BBS/E/D/20251969, BBS/E/D/20221655] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20221656, BBS/E/D/20221655, BBS/E/D/20251969] Funding Source: researchfish	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Max Planck Institute for Ornithology(Max Planck Society); Roslin Institute at the University of Edinburgh; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Biology Department at Swarthmore College; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by the Alexander von Humboldt Foundation grant number 1141248 (ATB), the Max Planck Institute for Ornithology (ATB), the Roslin Institute at the University of Edinburgh (SLM), Howard Hughes Medical Institute and the Biology Department at Swarthmore College (RAS, ATB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera G, 2012, FRONT NEUROENDOCRIN, V33, P67, DOI 10.1016/j.yfrne.2011.08.002; Aplin LM, 2013, ECOL LETT, V16, P1365, DOI 10.1111/ele.12181; BAPTISTA LF, 1993, ANIM BEHAV, V46, P511, DOI 10.1006/anbe.1993.1219; Baugh AT, 2014, GEN COMP ENDOCR, V208, P154, DOI 10.1016/j.ygcen.2014.08.014; Baugh AT, 2013, GEN COMP ENDOCR, V189, P96, DOI 10.1016/j.ygcen.2013.04.030; Baugh AT, 2012, GEN COMP ENDOCR, V175, P488, DOI 10.1016/j.ygcen.2011.12.012; Besedovsky L, 2014, EUR J IMMUNOL, V44, P1759, DOI 10.1002/eji.201344265; Blumenrath SH, 2007, ANIM BEHAV, V73, P789, DOI 10.1016/j.anbehav.2006.07.011; BRENOWITZ EA, 1991, SCIENCE, V251, P303, DOI 10.1126/science.1987645; Breuner CW, 1998, GEN COMP ENDOCR, V111, P386, DOI 10.1006/gcen.1998.7128; Breuner CW, 2001, J NEUROENDOCRINOL, V13, P412, DOI 10.1046/j.1365-2826.2001.00646.x; Butler A.B., 2005, COMP VERTEBRATE NEUR, Vsecond; Chung S, 2011, BBA-MOL BASIS DIS, V1812, P581, DOI 10.1016/j.bbadis.2011.02.003; Cockrem JF, 2007, J ORNITHOL, V148, pS169, DOI 10.1007/s10336-007-0175-8; Cole RL, 2005, J COMP NEUROL, V491, P246, DOI 10.1002/cne.20693; DEKLOET ER, 1991, FRONT NEUROENDOCRIN, V12, P95; Del Negro C, 1998, BEHAV BRAIN RES, V96, P151, DOI 10.1016/S0166-4328(98)00009-6; Deviche P, 2000, J NEUROBIOL, V42, P202, DOI 10.1002/(SICI)1097-4695(20000205)42:2<202::AID-NEU4>3.0.CO;2-G; Dickens M, 2009, J NEUROENDOCRINOL, V21, P832, DOI 10.1111/j.1365-2826.2009.01908.x; Dickens MJ, 2011, GEN COMP ENDOCR, V170, P569, DOI 10.1016/j.ygcen.2010.11.018; Dingemanse NJ, 2012, J ANIM ECOL, V81, P116, DOI 10.1111/j.1365-2656.2011.01877.x; Dingemanse NJ, 2002, ANIM BEHAV, V64, P929, DOI 10.1006/anbe.2002.2006; Dosmann A, 2015, ANIM BEHAV, V101, P179, DOI 10.1016/j.anbehav.2014.12.026; Ducrest AL, 2008, TRENDS ECOL EVOL, V23, P502, DOI 10.1016/j.tree.2008.06.001; Dumont Y, 1998, J COMP NEUROL, V402, P372; Farrell TM, 2015, ANIM BEHAV, V102, P157, DOI 10.1016/j.anbehav.2015.01.018; Flatt T, 2005, BIOESSAYS, V27, P999, DOI 10.1002/bies.20290; Gorissen L, 2004, AUK, V121, P184, DOI 10.1642/0004-8038(2004)121[0184:ICBMAF]2.0.CO;2; Halfwerk W, 2011, P NATL ACAD SCI USA, V108, P14549, DOI 10.1073/pnas.1109091108; Hamao S, 2011, ETHOL ECOL EVOL, V23, P111, DOI 10.1080/03949370.2011.554881; Hamilton KS, 1997, NEUROBIOL LEARN MEM, V68, P325, DOI 10.1006/nlme.1997.3781; Hau M, 2007, BIOESSAYS, V29, P133, DOI 10.1002/bies.20524; Heppner KM, 2015, ENDOCRINOLOGY, V156, P255, DOI 10.1210/en.2014-1675; Hodgson ZG, 2007, P ROY SOC B-BIOL SCI, V274, P239, DOI 10.1098/rspb.2006.3704; Krause JS, 2015, J NEUROENDOCRINOL, V27, P66, DOI 10.1111/jne.12237; Kriengwatana B, 2014, HORM BEHAV, V65, P285, DOI 10.1016/j.yhbeh.2013.12.013; Lattin CR, 2015, ENDOCRINOLOGY, V156, P1354, DOI 10.1210/en.2014-1811; Le PP, 2005, PLOS GENET, V1, P159, DOI 10.1371/journal.pgen.0010016; Liebl AL, 2013, GEN COMP ENDOCR, V183, P32, DOI 10.1016/j.ygcen.2012.11.021; Lind H, 1996, ANIM BEHAV, V52, P667, DOI 10.1006/anbe.1996.0211; Maguire SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063239; Matsunaga E, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00028; Medina CO, 2013, GEN COMP ENDOCR, V193, P27, DOI 10.1016/j.ygcen.2013.07.008; Mockford EJ, 2009, P ROY SOC B-BIOL SCI, V276, P2979, DOI 10.1098/rspb.2009.0586; Nelson RJ., 2005, INTRO BEHAV ENDOCRIN; Nixdorf-Bergweiler BE., 2007, STEREOTAXIC ATLAS BR; Oakley RH, 2013, J ALLERGY CLIN IMMUN, V132, P1033, DOI 10.1016/j.jaci.2013.09.007; Odom KJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4379; Patel PD, 2000, J PSYCHIATR RES, V34, P383, DOI 10.1016/S0022-3956(00)00035-2; Pryce CR, 2008, BRAIN RES REV, V57, P596, DOI 10.1016/j.brainresrev.2007.08.005; Riebel K, 2009, ANIM BEHAV, V78, P1397, DOI 10.1016/j.anbehav.2009.09.011; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Ronchi E, 1998, BRAIN RES, V780, P348, DOI 10.1016/S0006-8993(97)01303-6; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schmidt KL, 2013, ANIM BEHAV, V85, P825, DOI 10.1016/j.anbehav.2013.01.029; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Srividya R, 2004, NEUROREPORT, V15, P1831, DOI 10.1097/01.wnr.0000135698.68152.86; Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4; STOKES TM, 1974, J COMP NEUROL, V156, P337, DOI 10.1002/cne.901560305; Suzuki K, 2011, NEUROSCIENCE, V194, P72, DOI 10.1016/j.neuroscience.2011.07.073; Uz T, 2001, FASEB J, V15, P1792, DOI 10.1096/fj.00-0836fje; Wada H, 2008, J EXP BIOL, V211, P1696, DOI 10.1242/jeb.009191; Wada H, 2010, DEV NEUROBIOL, V70, P853, DOI 10.1002/dneu.20819; Wada H, 2009, PHYSIOL BIOCHEM ZOOL, V82, P325, DOI 10.1086/599320; Williams TD, 2008, PHILOS T R SOC B, V363, P1687, DOI 10.1098/rstb.2007.0003	65	16	18	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148516	10.1371/journal.pone.0148516	http://dx.doi.org/10.1371/journal.pone.0148516			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867218	Green Published, gold			2022-12-27	WOS:000370050700019
J	Wang, CQ; Zhang, X; Zheng, ZM				Wang, Chengqi; Zhang, Xiao; Zheng, Zhiming			Cryptanalysis and Improvement of a Biometric-Based Multi-Server Authentication and Key Agreement Scheme	PLOS ONE			English	Article							SMART-CARD; PASSWORD AUTHENTICATION; FUZZY EXTRACTORS; USER ANONYMITY; SECURE; PROTOCOL	With the security requirements of networks, biometrics authenticated schemes which are applied in the multi-server environment come to be more crucial and widely deployed. In this paper, we propose a novel biometric-based multi-server authentication and key agreement scheme which is based on the cryptanalysis of Mishra et al.'s scheme. The informal and formal security analysis of our scheme are given, which demonstrate that our scheme satisfies the desirable security requirements. The presented scheme provides a variety of significant functionalities, in which some features are not considered in the most of existing authentication schemes, such as, user revocation or re-registration and biometric information protection. Compared with several related schemes, our scheme has more secure properties and lower computation cost. It is obviously more appropriate for practical applications in the remote distributed networks.	[Zhang, Xiao; Zheng, Zhiming] Beihang Univ, Key Lab Math Informat & Behav Semant, Minist Educ, Beijing 100191, Peoples R China; Beihang Univ, Sch Math & Syst Sci, Beijing 100191, Peoples R China	Beihang University; Beihang University	Zhang, X; Zheng, ZM (corresponding author), Beihang Univ, Key Lab Math Informat & Behav Semant, Minist Educ, Beijing 100191, Peoples R China.	09621@buaa.edu.cn; zzheng@pku.edu.cn			National Natural Science Foundation of China [61402030]; Major Program of National Natural Science Foundation of China [11290141]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by the National Natural Science Foundation of China (No. 61402030, http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list, Xiao Zhang, Beihang University) and the Major Program of National Natural Science Foundation of China (No. 11290141, http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list, Zhiming Zheng, Beihang University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baruah KC, 2015, INT J SECUR APPL, V9, P397, DOI 10.14257/ijsia.2015.9.1.38; Benhammadi F, 2014, IMAGE VISION COMPUT, V32, P487, DOI 10.1016/j.imavis.2014.04.014; Cao LL, 2015, SECUR COMMUN NETW, V8, P617, DOI 10.1002/sec.1010; Chang YF, 2014, INT J COMMUN SYST, V27, P3430, DOI 10.1002/dac.2552; Choi Y, 2014, SCI WORLD J, DOI 10.1155/2014/281305; Chuang MC, 2014, EXPERT SYST APPL, V41, P1411, DOI 10.1016/j.eswa.2013.08.040; Dang Q, 2013, CRYPTOLOGIA, V37, P69, DOI 10.1080/01611194.2012.687431; Das AK, 2011, IET INFORM SECUR, V5, P145, DOI 10.1049/iet-ifs.2010.0125; Dodis Y, 2004, LECT NOTES COMPUT SC, V3027, P523; Dodis Y, 2012, IEEE T INFORM THEORY, V58, P6207, DOI 10.1109/TIT.2012.2200290; DOLEV D, 1983, IEEE T INFORM THEORY, V29, P198, DOI 10.1109/TIT.1983.1056650; Du WB, 2013, PHYSICA A, V392, P3505, DOI 10.1016/j.physa.2013.03.032; Farash MS, 2014, J SUPERCOMPUT, V69, P395, DOI 10.1007/s11227-014-1170-5; He DB, 2015, IEEE SYST J, V9, P816, DOI 10.1109/JSYST.2014.2301517; He DB, 2013, IEEE T CONSUM ELECTR, V59, P811, DOI 10.1109/TCE.2013.6689693; He DB, 2012, INFORM FUSION, V13, P223, DOI 10.1016/j.inffus.2011.01.001; Hsiang HC, 2009, COMPUT STAND INTER, V31, P1118, DOI 10.1016/j.csi.2008.11.002; Hsu CL, 2015, WIRELESS PERS COMMUN, V83, P163, DOI 10.1007/s11277-015-2386-2; Huang H, 2011, SECUR COMMUN NETW, V4, P1153, DOI 10.1002/sec.241; Islam SKH, 2014, WIRELESS PERS COMMUN, V79, P1975, DOI 10.1007/s11277-014-1968-8; Islam SKH, 2014, NONLINEAR DYNAM, V78, P2261, DOI 10.1007/s11071-014-1584-x; Khan MK, 2007, COMPUT STAND INTER, V29, P82, DOI 10.1016/j.csi.2006.01.002; Kocher P, 2011, J CRYPTOGR ENG, V1, P5, DOI 10.1007/s13389-011-0006-y; Kounga G, 2012, SECUR COMMUN NETW, V5, P87, DOI 10.1002/sec.279; Ku WC, 2004, IEEE T CONSUM ELECTR, V50, P204, DOI 10.1109/TCE.2004.1277863; LAMPORT L, 1981, COMMUN ACM, V24, P770, DOI 10.1145/358790.358797; Leung KC, 2003, IEEE T CONSUM ELECTR, V49, P1243, DOI 10.1109/TCE.2003.1261224; Li CS, 2011, J STAT COMPUT SIM, V81, P1081, DOI 10.1080/00949651003677410; Li XW, 2013, SECUR COMMUN NETW, V6, P631, DOI 10.1002/sec.595; Li X, 2015, WIRELESS PERS COMMUN, V80, P175, DOI 10.1007/s11277-014-2002-x; Li X, 2013, MATH COMPUT MODEL, V58, P85, DOI 10.1016/j.mcm.2012.06.033; Li X, 2011, J NETW COMPUT APPL, V34, P73, DOI 10.1016/j.jnca.2010.09.003; Liao YP, 2009, COMPUT STAND INTER, V31, P24, DOI 10.1016/j.csi.2007.10.007; Lu YR, 2015, SECUR COMMUN NETW, V8, P3219, DOI 10.1002/sec.1246; Lu YR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126323; Ma CG, 2014, INT J COMMUN SYST, V27, P2215, DOI 10.1002/dac.2468; Manuel S, 2011, DESIGN CODE CRYPTOGR, V59, P247, DOI 10.1007/s10623-010-9458-9; Messerges TS, 2002, IEEE T COMPUT, V51, P541, DOI 10.1109/TC.2002.1004593; Mishra Dheerendra, 2013, Information Systems Security. 9th International Conference, ICISS 2013. Proceedings: LNCS 8303, P247, DOI 10.1007/978-3-642-45204-8_19; Mishra D, 2017, INT J COMMUN SYST, V30, DOI 10.1002/dac.2946; Mishra D, 2016, WIRELESS PERS COMMUN, V86, P1095, DOI 10.1007/s11277-015-2975-0; Mishra D, 2015, J INF SECUR APPL, V23, P28, DOI 10.1016/j.jisa.2015.06.003; Mishra D, 2015, J MED SYST, V39, DOI 10.1007/s10916-015-0193-7; Mishra D, 2015, J MED SYST, V39, DOI 10.1007/s10916-014-0154-6; Mishra D, 2014, EXPERT SYST APPL, V41, P8129, DOI 10.1016/j.eswa.2014.07.004; Nam J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116709; Shamir A., 1984, LECT NOTES COMPUTER, P47, DOI [DOI 10.1007/3-540-39568-7, 10.1007/3-540-39568-7_5]; Sun HM, 2009, IEEE T MULTIMEDIA, V11, P947, DOI 10.1109/TMM.2009.2021790; Ustaoglu B, 2011, INT J INF SECUR, V10, P201, DOI 10.1007/s10207-011-0136-3; Xie QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092772; Xiong H, 2015, IEEE T INF FOREN SEC, V10, P1442, DOI 10.1109/TIFS.2015.2414399; Xiong H, 2013, J NETW COMPUT APPL, V36, P927, DOI 10.1016/j.jnca.2012.10.001; Xue KP, 2014, J COMPUT SYST SCI, V80, P195, DOI 10.1016/j.jcss.2013.07.004; Xue KP, 2012, COMMUN NONLINEAR SCI, V17, P2969, DOI 10.1016/j.cnsns.2011.11.025; Yang JH, 2009, COMPUT SECUR, V28, P138, DOI 10.1016/j.cose.2008.11.008; Yoon EJ, 2013, J SUPERCOMPUT, V63, P235, DOI 10.1007/s11227-010-0512-1; Zhang JS, 2014, KSII T INTERNET INF, V8, P2930, DOI 10.3837/tiis.2014.08.021; Zhang M, 2015, SECUR COMMUN NETW, V8, P682, DOI 10.1002/sec.1016; Zhu HF, 2015, NONLINEAR DYNAM, V81, P311, DOI 10.1007/s11071-015-1993-5; Zhu HF, 2015, KSII T INTERNET INF, V9, P811, DOI 10.3837/tiis.2015.02.19	60	40	41	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149173	10.1371/journal.pone.0149173	http://dx.doi.org/10.1371/journal.pone.0149173			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866606	gold, Green Published, Green Submitted			2022-12-27	WOS:000370050700076
J	Wang, K; Levinson, DM				Wang, Kai; Levinson, David M.			Towards a Metropolitan Fundamental Diagram Using Travel Survey Data	PLOS ONE			English	Article								Using travel diary data from 2000-2001 and 2010-2012 this research examines fundamental traffic relationships at the metropolitan level. The results of this paper can help to explain the causes of some traffic phenomena. Network average speed by time of day can be explained by trip length and cumulative number of vehicles on the road. A clockwise hysteresis loop is found in the Metropolitan Fundamental Diagram in the morning period and a reverse process happens in the afternoon.	[Wang, Kai] Beijing Univ Technol, Beijing Key Lab Traff Engn, Beijing 100124, Peoples R China; [Levinson, David M.] Dept Civil Environm & Geoengn, 500 Pillsbury Dr SE, Minneapolis, MN 55455 USA	Beijing University of Technology	Levinson, DM (corresponding author), Dept Civil Environm & Geoengn, 500 Pillsbury Dr SE, Minneapolis, MN 55455 USA.	dlevinson@umn.edu	Levinson, David/A-8554-2012	Levinson, David/0000-0002-4563-2963	National Basic Research Program of China [2012CB725403]; National Natural Science Foundation of China [51338008, 51378036]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors received funding from National Basic Research Program of China (No. 2012CB725403), and National Natural Science Foundation of China (Grant No.51338008 and 51378036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank HongZhi Guan, and funding from the National Basic Research Program of China (No. 2012CB725403) and the National Natural Science Foundation of China (Grant No.51338008 and 51378036). This work was conducted while Kai Wang was a Visiting Scholar at the University of Minnesota, Department of Civil, Environmental, and Geo-Engineering. The authors would like to thank Andrew Owen for the guidance of Open-TripPlanner's application. The authors also thank Jessica Schoner for help on ArcGIS during Kai's stay at the University of Minnesota, where this work was conducted. We would like to acknowledge comments from Mohsen Ramezani and Nikolas Geroliminis on an earlier draft of the work.	[Anonymous], 2012, PEAK TRAVEL PEAK CAR; Buisson C, 2009, TRANSP RES RECORD, P127, DOI 10.3141/2124-12; Daganzo CF, 2011, TRANSPORT RES B-METH, V45, P278, DOI 10.1016/j.trb.2010.06.006; Gayah VV, 2013, TRANSPORT RES REC, P76, DOI 10.3141/2390-09; Geroliminis N, 2008, TRANSPORT RES B-METH, V42, P759, DOI 10.1016/j.trb.2008.02.002; Geroliminis N, 2011, TRANSPORT RES A-POL, V45, P966, DOI 10.1016/j.tra.2011.04.004; Geroliminis N, 2011, TRANSPORT RES B-METH, V45, P605, DOI 10.1016/j.trb.2010.11.004; HERMAN R, 1979, SCIENCE, V204, P148, DOI 10.1126/science.204.4389.148; Leclercq L, 2014, TRANSPORT RES B-METH, V62, P1, DOI 10.1016/j.trb.2014.01.007; Mahmassani H., 1987, TRANSPORTATION TRAFF; Mahmassani H, 1984, TRANSPORT RES REC, P971; Mahmassani HS, 2013, TRANSPORT RES C-EMER, V36, P480, DOI 10.1016/j.trc.2013.07.002; MAHMASSANI HS, 1990, TRANSPORT RES A-POL, V24, P149, DOI 10.1016/0191-2607(90)90022-X; Mahmassani HS, 1993, TRANSPORT RES REC, p1408w; Metropolitan Council, 2013, 2010 MSP REG TRAV BE; Millard-Ball A, 2011, TRANSPORT REV, V31, P357, DOI 10.1080/01441647.2010.518291; Parthasarathi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077718; Puentes R, 2012, HAVE AM HIT PEAK TRA; Ramezani M, 2015, TRANSPORT RES B-METH, V74, P1, DOI 10.1016/j.trb.2014.12.010; Tang W, 2014, EMPIRICAL STUDY DEVI; Zhu SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134322	21	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148660	10.1371/journal.pone.0148660	http://dx.doi.org/10.1371/journal.pone.0148660			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6RE	26866913	Green Published, gold, Green Submitted			2022-12-27	WOS:000370050700025
J	Young, CCW; Olival, KJ				Young, Cristin C. W.; Olival, Kevin J.			Optimizing Viral Discovery in Bats	PLOS ONE			English	Article							NIPAH VIRUS; CORONAVIRUS; ALPHACORONAVIRUS; IDENTIFICATION; RICHNESS; SEROLOGY	Viral discovery studies in bats have increased dramatically over the past decade, yet a rigorous synthesis of the published data is lacking. We extract and analyze data from 93 studies published between 2007-2013 to examine factors that increase success of viral discovery in bats, and specific trends and patterns of infection across host taxa and viral families. Over the study period, 248 novel viruses from 24 viral families have been described. Using generalized linear models, at a study level we show the number of host species and viral families tested best explained number of viruses detected. We demonstrate that prevalence varies significantly across viral family, specimen type, and host taxonomy, and calculate mean PCR prevalence by viral family and specimen type across all studies. Using a logistic model, we additionally identify factors most likely to increase viral detection at an individual level for the entire dataset and by viral families with sufficient sample sizes. Our analysis highlights major taxonomic gaps in recent bat viral discovery efforts and identifies ways to improve future viral pathogen detection through the design of more efficient and targeted sample collection and screening approaches.	[Young, Cristin C. W.] Univ Calif Davis, Davis, CA 95616 USA; [Olival, Kevin J.] EcoHlth Alliance, New York, NY USA	University of California System; University of California Davis; EcoHealth Alliance	Olival, KJ (corresponding author), EcoHlth Alliance, New York, NY USA.	olival@ecohealthalliance.org		Olival, Kevin/0000-0003-3211-1875; Young, Cristin/0000-0002-0470-6321	National Science Foundation's Research Coordination Network Grant - EcoHealthNet [DEB-0955897]; National Institutes of Health National Institute of Allergy and Infectious Diseases [1R01 AI079231-01, 1R01AI110964]; United States Agency for International Development Emerging Pandemic Threats Program PREDICT project [GHN-A-OO-09-00010-00]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079231, R01AI110964] Funding Source: NIH RePORTER	National Science Foundation's Research Coordination Network Grant - EcoHealthNet; National Institutes of Health National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United States Agency for International Development Emerging Pandemic Threats Program PREDICT project(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in part, by: National Science Foundation's Research Coordination Network Grant - EcoHealthNet (DEB-0955897, KJO), National Institutes of Health National Institute of Allergy and Infectious Diseases awards (1R01 AI079231-01; 1R01AI110964, KJO), and United States Agency for International Development Emerging Pandemic Threats Program PREDICT project (GHN-A-OO-09-00010-00, KJO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amengual B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000566; Amman BR, 2015, J WILDLIFE DIS, V51, P113, DOI 10.7589/2014-08-198; Anthony SJ, 2013, MBIO, V4, DOI 10.1128/mBio.00598-13; Banyard AC, 2011, ADV VIRUS RES, V79, P239, DOI 10.1016/B978-0-12-387040-7.00012-3; Bossart KN, 2007, J VIROL METHODS, V142, P29, DOI 10.1016/j.jviromet.2007.01.003; Briese T, 2015, MBIO, V6, DOI 10.1128/mBio.01491-15; Burbelo Peter D, 2009, J Vis Exp, DOI 10.3791/1549; Calisher CH, 2014, ARCH VIROL, V159, P2189, DOI 10.1007/s00705-014-2008-4; Daszak P, 2011, ECOHEALTH, V7, pS135; Dobson AP, 2005, SCIENCE, V310, P628, DOI 10.1126/science.1120872; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; Emerson GL, 2013, EMERG INFECT DIS, V19, P1002, DOI 10.3201/eid1906.121713; Gay Noellie, 2014, International Journal for Parasitology Parasites and Wildlife, V3, P161, DOI 10.1016/j.ijppaw.2014.06.003; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; Gilbert AT, 2013, ECOHEALTH, V10, P298, DOI 10.1007/s10393-013-0856-0; IUCN, 2013, IUCN RED LIST THREAT; King A.M., 2012, VIRUS TAXONOMY CLASS, P289; Kohl C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043106; Kurth A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038688; Kuzmin IV, 2010, VIRUS RES, V149, P197, DOI 10.1016/j.virusres.2010.01.018; Kuzmin IV, 2010, EMERG INFECT DIS, V16, P352, DOI 10.3201/eid1602.091269; Lau SKP, 2012, J VIROL, V86, P11906, DOI 10.1128/JVI.01305-12; Lelli D, 2013, ZOONOSES PUBLIC HLTH, V60, P84, DOI 10.1111/zph.12001; Luis AD, 2015, ECOL LETT, V18, P1153, DOI 10.1111/ele.12491; Luis AD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2753; Memish ZA, 2013, EMERG INFECT DIS, V19, P1819, DOI 10.3201/eid1911.131172; Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5; O'Shea TJ, 2014, EMERG INFECT DIS, V20, P741, DOI 10.3201/eid2005.130539; Olival K. J., 2012, NEW DIRECTIONS CONSE, P195, DOI [10.1002/9781118818824.ch11, DOI 10.1002/9781118818824.CH11]; Olival KJ, 2014, VIRUSES-BASEL, V6, P1759, DOI 10.3390/v6041759; Pourrut X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-159; R Development Core Team R, 2013, R LANG ENV STAT COMP; Rahman SA, 2010, EMERG INFECT DIS, V16, P1990, DOI 10.3201/eid1612.091790; Rodriguez G., 2013, GEN LINEAR MODELS; Sonntag M, 2009, EMERG INFECT DIS, V15, P2052, DOI 10.3201/eid1512.090646; Turmelle AS, 2009, ECOHEALTH, V6, P522, DOI 10.1007/s10393-009-0263-8; Wacharapluesadee S, 2010, VECTOR-BORNE ZOONOT, V10, P183, DOI 10.1089/vbz.2008.0105; Wang LF, 2011, CURR OPIN VIROL, V1, P649, DOI 10.1016/j.coviro.2011.10.013; Wilson D.E., 1993, TAXONOMIC GEOGRAPHIC, V2nd ed.; Woo PCY, 2012, J VIROL, V86, P3995, DOI 10.1128/JVI.06540-11; Wu ZQ, 2012, J VIROL, V86, P10999, DOI 10.1128/JVI.01394-12; Wynne JW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003651	42	29	30	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149237	10.1371/journal.pone.0149237	http://dx.doi.org/10.1371/journal.pone.0149237			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867024	Green Published, Green Submitted, gold			2022-12-27	WOS:000370050700080
J	Preyer, O; Johansen, D; Holly, J; Stocks, T; Pompella, A; Nagel, G; Concin, H; Ulmer, H; Concin, N				Preyer, Oliver; Johansen, Dorthe; Holly, Jessica; Stocks, Tanja; Pompella, Alfonso; Nagel, Gabriele; Concin, Hans; Ulmer, Hanno; Concin, Nicole			gamma-Glutamyltransferase and Breast Cancer Risk Beyond Alcohol Consumption and Other Life Style Factors - A Pooled Cohort Analysis	PLOS ONE			English	Article							TRANSPEPTIDASE ACTIVITY; CARDIOVASCULAR-DISEASE; H2O2 PRODUCTION; ASSOCIATION; CELLS; MEN; MODULATION; MORTALITY	Objective Elevated gamma-Glutamyltransferase serum levels are associated with increased risk of overall cancer incidence and several site-specific malignancies. In the present prospective study we report on the associations of serum gamma-Glutamyltransferase with the risk of breast cancer in a pooled population-based cohort considering established life style risk factors. Methods Two cohorts were included in the present study, i. e. the Vorarlberg (n = 97,268) and the Malmoe cohort (n = 9,790). Cox proportional hazards regression models were fitted to estimate HRs for risk of breast cancer. Results In multivariate analysis adjusted for age, bodymass index and smoking status, women with gamma-Glutamyltransferase levels in the top quartile were at significantly higher risk for breast cancer compared to women in the lowest quartile (HR 1.21, 95% CI 1.09 to 1.35; p = 0.005). In the subgroup analysis of the Malmoe cohort, gamma-Glutamyltransferase remained an independent risk factor for breast cancer when additionally considering alcohol intake. A statistically significant increase in risk was seen in women with gamma-Glutamyltransferase-levels in the top versus lowest quartile in a multivariate model adjusted for age, body mass index, smoking status, physical activity, parity, oral contraceptive-use and alcohol consumption (HR 1.37, 95% CI 1.11-1.69, p = 0.006). Conclusion Our findings identified.-Glutamyltransferase as an independent risk factor for breast cancer beyond the consumption of alcohol and other life style risk factors.	[Preyer, Oliver; Nagel, Gabriele; Concin, Hans] Agcy Prevent & Social Med, Bregenz, Vorarlberg, Austria; [Johansen, Dorthe] Lund Univ, Surg Res Unit, Malmo, Sweden; [Holly, Jessica; Concin, Nicole] Med Univ Innsbruck, Dept Obstet & Gynaecol, A-6020 Innsbruck, Austria; [Stocks, Tanja] Lund Univ, Ctr Diabet, Diabet & Cardiovasc Dis Genet Epidemiol Dept Clin, CRC, Malmo, Sweden; [Pompella, Alfonso] Univ Pisa, Sch Med, Dept Expt Pathol, I-56100 Pisa, Italy; [Nagel, Gabriele] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany; [Ulmer, Hanno] Med Univ Innsbruck, Dept Med Stat Informat & Hlth Econ, A-6020 Innsbruck, Austria	Lund University; Medical University of Innsbruck; Lund University; University of Pisa; Ulm University; Medical University of Innsbruck	Concin, N (corresponding author), Med Univ Innsbruck, Dept Obstet & Gynaecol, A-6020 Innsbruck, Austria.	nicole.concin@i-med.ac.at	vhmpp, aks/F-9756-2012; Ulmer, Hanno/S-6615-2019; Nagel, Gabriele/C-3635-2012	Ulmer, Hanno/0000-0001-5911-1002; Nagel, Gabriele/0000-0001-6185-8535; Concin, Nicole/0000-0002-9795-2643				Corti A, 2010, ANTICANCER RES, V30, P1169; Corti A, 2009, MUTAT RES-FUND MOL M, V669, P112, DOI 10.1016/j.mrfmmm.2009.05.010; Del Bello B, 1999, FASEB J, V13, P69; Dominici S, 1999, FREE RADICAL BIO MED, V27, P623, DOI 10.1016/S0891-5849(99)00111-2; Dominici S, 2005, METHOD ENZYMOL, V401, P484, DOI 10.1016/S0076-6879(05)01029-3; Fentiman IS, 2010, BRIT J CANCER, V103, P90, DOI 10.1038/sj.bjc.6605719; Franzini M, 2006, EUR J CANCER, V42, P2623, DOI 10.1016/j.ejca.2006.04.016; Grimm C, 2013, BRIT J CANCER, V109, P610, DOI 10.1038/bjc.2013.323; Jousilahti P, 2000, STROKE, V31, P1851, DOI 10.1161/01.STR.31.8.1851; Lee DS, 2007, ARTERIOSCL THROM VAS, V27, P127, DOI 10.1161/01.ATV.0000251993.20372.40; Lee DH, 2006, EUR HEART J, V27, P2170, DOI 10.1093/eurheartj/ehl086; Maellaro E, 2000, J CELL SCI, V113, P2671; Nilsson-Ehle PGP, 2003, LAURELLS KLINISK KEM; Pompella A, 2006, BIOCHEM PHARMACOL, V71, P231, DOI 10.1016/j.bcp.2005.10.005; Pompella A, 2004, CLIN CHEM LAB MED, V42, P1085, DOI 10.1515/CCLM.2004.224; Pompella A, 2007, CURR OPIN PHARMACOL, V7, P360, DOI 10.1016/j.coph.2007.04.004; Ruttmann E, 2005, CIRCULATION, V112, P2130, DOI 10.1161/CIRCULATIONAHA.105.552547; Seebacher V, 2012, BRIT J CANCER, V106, P1551, DOI 10.1038/bjc.2012.16; SHIBUYA A, 1988, AM J HUM GENET, V43, P744; Staudigl C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125317; Strasak AM, 2008, INT J CANCER, V123, P1902, DOI 10.1002/ijc.23714; Strasak AM, 2008, CANCER RES, V68, P3970, DOI 10.1158/0008-5472.CAN-07-6686; Strasak AM, 2010, CANCER RES, V70, P3586, DOI 10.1158/0008-5472.CAN-09-3197; TRELL E, 1983, PREV MED, V12, P397, DOI 10.1016/0091-7435(83)90248-7; Tsuboya T, 2012, J EPIDEMIOL, V22, P144, DOI 10.2188/jea.JE20110071; Ulmer H, 2003, EUR HEART J, V24, P1004, DOI 10.1016/S0195-668X(03)00170-2; Van Hemelrijck M, 2011, EUR J CANCER, V47, P2033, DOI 10.1016/j.ejca.2011.03.010; Whitfield JB, 2001, CRIT REV CL LAB SCI, V38, P263, DOI 10.1080/20014091084227	28	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149122	10.1371/journal.pone.0149122	http://dx.doi.org/10.1371/journal.pone.0149122			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863311	Green Submitted, gold, Green Published			2022-12-27	WOS:000370046600156
J	Saini, ML; Bouzin, C; Weynand, B; Marbaix, E				Saini, Monika Lamba; Bouzin, Caroline; Weynand, Birgit; Marbaix, Etienne			An Appraisal of Proliferation and Apoptotic Markers in Papillary Thyroid Carcinoma: An Automated Analysis	PLOS ONE			English	Article							CYCLIN D1; PROSTATE-CANCER; BREAST-CANCER; CELL-CYCLE; FOLLICULAR VARIANT; PHOSPHOHISTONE H3; PROGNOSTIC VALUE; EXPRESSION; KI-67; BCL-2	Introduction Proliferation and apoptosis are opposing processes by which the cell numbers are kept in a delicate balance, essential for tissue homeostasis, whereas uncontrolled growth of cells is a hallmark of cancer. Papillary thyroid cancer (PTC) is the commonest type of thyroid cancer, with some PTC following an indolent course, whereas the other ones are more aggressive. Aim To evaluate respective contribution of proliferation and apoptosis in the tumorigenesis of PTC by automated analysis. Materials and Methods We investigated the immunolabeling of phosphorylated histone H3 (pHH3), cyclin D1, active caspase-3, and bcl-2 in thirteen cases each of metastatic PTC, follicular variant of PTC (FVPTC), papillary microcarcinoma (PMC) and well differentiated tumor of uncertain malignant potential (WDT-UMP). FVPTC cases comprised seven encapsulated and six unencapsulated cases. Results Proliferation, as assessed by pHH3 and cyclin D1 immunolabeling, was increased in all PTC variants, including the putative precursor lesion WDT-UMP, compared to normal thyroid tissue. pHH3 was immunolabeled in more cells of metastatic PTC than of PMC and of encapsulated FVPTC. Surprisingly, metastatic PTC and unencapsulated FVPTC also demonstrated more cleaved caspase-3 immunolabeled cells than the other types. In contrast, increased expression of bcl-2 protein was seen in normal thyroid areas, encapsulated FVPTC and PMC as compared to metastatic PTC. Metastatic PTC shows higher proliferation than other types of PTC but unexpectedly also higher apoptotic levels. Similar results were also seen with unencapsulated FVPTC, thus suggesting that unencapsulated FVPTC has a potential for adverse outcome. Bcl-2 was immunolabeled in a low percentage of cells in WDT-UMP. Conclusions The expression of the proliferative protein pHH3 together with the apoptotic marker cleaved caspase-3 may indicate an aggressive behaviour of PTC and loss of apoptosis inhibition by bcl-2 protein can further amplify the role of these proteins in tumor progression. Both cyclin D1 and bcl-2 could prove to be interesting markers of PTC precursor lesions. Automated/digital image quantification approach helps in refining the diagnostic accuracy.	[Saini, Monika Lamba; Marbaix, Etienne] Clin Univ St Luc, Serv Anat Pathol, Ave Hippocrate 10 T-1, B-1200 Brussels, Belgium; [Saini, Monika Lamba; Marbaix, Etienne] Catholic Univ Louvain, Inst Duve, Ave Hippocrate 10 T-1, B-1200 Brussels, Belgium; [Bouzin, Caroline] Catholic Univ Louvain, IREC Imaging Platform 2IP, Inst Rech Expt & Clin, B-1200 Brussels, Belgium; [Weynand, Birgit] Univ Ziekenhuis Leuven, Pathol Ontleedkunde, Herestr 49, B-3000 Leuven, Belgium	Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Universite Catholique Louvain; KU Leuven; University Hospital Leuven	Saini, ML (corresponding author), Clin Univ St Luc, Serv Anat Pathol, Ave Hippocrate 10 T-1, B-1200 Brussels, Belgium.; Saini, ML (corresponding author), Catholic Univ Louvain, Inst Duve, Ave Hippocrate 10 T-1, B-1200 Brussels, Belgium.	monikalamba@gmail.com	Weynand, Birgit/H-9587-2019		Televie fellowship from FRS-FNRS, Belgium	Televie fellowship from FRS-FNRS, Belgium	Dr Monika Lamba Saini was supported by a Televie fellowship from FRS-FNRS, Belgium.	Aaltomaa S, 2006, ANTICANCER RES, V26, P4873; Aksoy M, 2005, ACTA CHIR BELG, V105, P644, DOI 10.1080/00015458.2005.11679794; Arora N, 2009, CANCER-AM CANCER SOC, V115, P5421, DOI 10.1002/cncr.24616; Aune G, 2011, INT J CLIN EXP PATHO, V4, P444; Baloch ZW, 2007, J CLIN PATHOL, V60, P244, DOI 10.1136/jcp.2006.038604; Bassarova A, 2004, J CUTAN PATHOL, V31, P330, DOI 10.1111/j.0303-6987.2004.0178.x; Bouzin C, 2016, HISTOPATHOLOGY, V68, P888, DOI 10.1111/his.12867; Chan JKC, 2002, AM J CLIN PATHOL, V117, P16; Cvejic D, 2009, EUR J HISTOCHEM, V53, P65; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; DeLellis RAL R. V., 2004, WHO CLASSIFICATION T; Duan WR, 2003, J PATHOL, V199, P221, DOI 10.1002/path.1289; Fischer S, 2008, ARCH PATHOL LAB MED, V132, P359, DOI 10.1043/1543-2165(2008)132[359:AOITTN]2.0.CO;2; Fotedar R, 1996, Prog Cell Cycle Res, V2, P147; Furuya Y, 2003, ANTICANCER RES, V23, P577; Fusco A, 2002, AM J PATHOL, V160, P2157, DOI 10.1016/S0002-9440(10)61164-9; Ghaznavi F, 2013, ANNU REV PATHOL-MECH, V8, P331, DOI 10.1146/annurev-pathol-011811-120902; Ghossein R, 2009, ARCH PATHOL LAB MED, V133, P683, DOI 10.1043/1543-2165-133.5.683; Hamilton PW, 2014, METHODS, V70, P59, DOI 10.1016/j.ymeth.2014.06.015; Ito Y, 2010, WORLD J SURG, V34, P3015, DOI 10.1007/s00268-010-0746-3; Juan G, 1998, CYTOMETRY, V32, P71, DOI 10.1002/(SICI)1097-0320(19980601)32:2<71::AID-CYTO1>3.0.CO;2-H; Kayser G, 2013, ACTA HISTOCHEM, V115, P527, DOI 10.1016/j.acthis.2012.12.002; Khoo MLC, 2002, J CLIN ENDOCR METAB, V87, P1810, DOI 10.1210/jc.87.4.1810; Liu J, 2006, CANCER-AM CANCER SOC, V107, P1255, DOI 10.1002/cncr.22138; Liu SQ, 2001, CLIN CANCER RES, V7, P1716; Mishunina T. M., 2010, Experimental Oncology, V32, P269; Muller-Hocker J, 1999, HUM PATHOL, V30, P926, DOI 10.1016/S0046-8177(99)90246-0; Nasr MR, 2008, AM J DERMATOPATH, V30, P117, DOI 10.1097/DAD.0b013e3181624054; Perisanidis C, 2012, J ORAL PATHOL MED, V41, P40, DOI 10.1111/j.1600-0714.2011.01071.x; Pucci B, 2000, NEOPLASIA, V2, P291, DOI 10.1038/sj.neo.7900101; Ribalta T, 2004, AM J SURG PATHOL, V28, P1532, DOI 10.1097/01.pas.0000141389.06925.d5; Saffar H, 2013, PATHOL RES PRACT, V209, P195, DOI 10.1016/j.prp.2012.06.011; Saini ML, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0262-8; Saiz AD, 2002, J PATHOL, V198, P157, DOI 10.1002/path.1185; Sinicrope FA, 1996, CLIN CANCER RES, V2, P1999; Skaland I, 2007, MODERN PATHOL, V20, P1307, DOI 10.1038/modpathol.3800972; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Song QB, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-126; Telu KH, 2013, J PROTEOME RES, V12, P3317, DOI 10.1021/pr400143x; Trovisco V, 2007, ARQ BRAS ENDOCRINOL, V51, P643, DOI 10.1590/S0004-27302007000500002; Tsuta K, 2011, AM J CLIN PATHOL, V136, P252, DOI 10.1309/AJCPDXFOPXGEF0RP; Tu HC, 1996, INT J CANCER, V69, P357, DOI 10.1002/(SICI)1097-0215(19961021)69:5<357::AID-IJC1>3.0.CO;2-4; vandeSchepop HAM, 1996, J CLIN PATHOL-CL MOL, V49, pM214; Wang RA, 2013, J CELL MOL MED, V17, P205, DOI 10.1111/j.1582-4934.2012.01663.x; Wang S, 2000, MODERN PATHOL, V13, P882, DOI 10.1038/modpathol.3880157; Wang WL, 1996, ENDOCR PATHOL, V7, P37, DOI 10.1007/BF02739913; Williams ED, 2000, INT J SURG PATHOL, V8, P181, DOI 10.1177/106689690000800304; Wolff AC, 2014, ARCH PATHOL LAB MED, V138, P241, DOI 10.5858/arpa.2013-0953-SA; Zhang HY, 2009, CLIN EXP MED, V9, P207, DOI 10.1007/s10238-009-0031-7	50	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148656	10.1371/journal.pone.0148656	http://dx.doi.org/10.1371/journal.pone.0148656			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863116	gold, Green Published			2022-12-27	WOS:000370046600091
J	Streit, AK; Fan, YN; Masullo, L; Baines, RA				Streit, Anne K.; Fan, Yuen Ngan; Masullo, Laura; Baines, Richard A.			Calcium Imaging of Neuronal Activity in Drosophila Can Identify Anticonvulsive Compounds	PLOS ONE			English	Article							GATED SODIUM-CHANNEL; SEIZURE SUSCEPTIBILITY; ANTIEPILEPTIC DRUGS; EPILEPTIC SEIZURES; NEURAL CIRCUITS; SUPPRESSION; MODEL; MUTATIONS; EXCITABILITY; MELANOGASTER	Although there are now a number of antiepileptic drugs (AEDs) available, approximately one-third of epilepsy patients respond poorly to drug intervention. The reasons for this are complex, but are probably reflective of the increasing number of identified mutations that predispose individuals to this disease. Thus, there is a clear requirement for the development of novel treatments to address this unmet clinical need. The existence of gene mutations that mimic a seizure-like behaviour in the fruit fly, Drosophila melanogaster, offers the possibility to exploit the powerful genetics of this insect to identify novel cellular targets to facilitate design of more effective AEDs. In this study we use neuronal expression of GCaMP, a potent calcium reporter, to image neuronal activity using a non-invasive and rapid method. Expression in motoneurons in the isolated CNS of third instar larvae shows waves of calcium-activity that pass between segments of the ventral nerve cord. Time between calcium peaks, in the same neurons, between adjacent segments usually show a temporal separation of greater than 200 ms. Exposure to proconvulsants (picrotoxin or 4-aminopyridine) reduces separation to below 200 ms showing increased synchrony of activity across adjacent segments. Increased synchrony, characteristic of epilepsy, is similarly observed in genetic seizure mutants: bangsenseless(1) (bss(1)) and paralyticK1270T (paraK1270T). Exposure of bss(1) to clinically-used antiepileptic drugs (phenytoin or gabapentin) significantly reduces synchrony. In this study we use the measure of synchronicity to evaluate the effectiveness of known and novel anticonvulsive compounds (antipain, isethionate, etopiside rapamycin and dipyramidole) to reduce seizure-like CNS activity. We further show that such compounds also reduce the Drosophila voltage-gated persistent Na+ current (INaP) in an identified motoneuron (aCC). Our combined assays provide a rapid and reliable method to screen unknown compounds for potential to function as anticonvulsants.	[Streit, Anne K.; Fan, Yuen Ngan; Masullo, Laura; Baines, Richard A.] Univ Manchester, Fac Life Sci, Oxford Rd, Manchester M13 9PT, Lancs, England; [Masullo, Laura] MRC Lab Mol Biol, Cambridge Biomedical Campus, Cambridge CB2 0QH, England	University of Manchester; MRC Laboratory Molecular Biology	Baines, RA (corresponding author), Univ Manchester, Fac Life Sci, Oxford Rd, Manchester M13 9PT, Lancs, England.	Richard.Baines@manchester.ac.uk			Medical Research Council (UK) [MR/J009180/1]; Wellcome Trust [087742/Z/08/Z]; MRC [MR/J009180/1] Funding Source: UKRI; Medical Research Council [MR/J009180/1] Funding Source: researchfish	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (UK, MR/J009180/1). Work on this project benefited from the Manchester Fly Facility, established through funds from the University and the Wellcome Trust (087742/Z/08/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LL, 2014, EPILEPSIA, V55, P1274, DOI 10.1111/epi.12657; Baines RA, 1998, J NEUROSCI, V18, P4673; Baxendale S, 2012, DIS MODEL MECH, V5, P773, DOI 10.1242/dmm.010090; Broussard GJ, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00097; Cunliffe VT, 2015, SEIZURE-EUR J EPILEP, V24, P44, DOI 10.1016/j.seizure.2014.09.018; Fosque BF, 2015, SCIENCE, V347, P755, DOI 10.1126/science.1260922; GANETZKY B, 1982, GENETICS, V100, P597; Ghannad-Rezaie M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029869; GRIGLIATTI TA, 1973, MOL GEN GENET, V120, P107, DOI 10.1007/BF00267238; Guan Z, 2005, NEURON, V48, P91, DOI 10.1016/j.neuron.2005.08.036; Hekmat-Scafe DS, 2005, GENETICS, V169, P1477, DOI 10.1534/genetics.104.036558; Jefferys J.G.R., 2012, JASPERS BASIC MECH E, DOI DOI 10.1093/MED/9780199746545.003.0014; Jiruska P, 2013, J PHYSIOL-LONDON, V591, P787, DOI 10.1113/jphysiol.2012.239590; Kuebler D, 2001, J NEUROPHYSIOL, V86, P1211, DOI 10.1152/jn.2001.86.3.1211; Kuebler D, 2000, J NEUROPHYSIOL, V83, P998, DOI 10.1152/jn.2000.83.2.998; Lin WH, 2015, BRAIN, V138, P891, DOI 10.1093/brain/awv012; Lin WH, 2015, MOL NEUROBIOL, V51, P57, DOI 10.1007/s12035-014-8674-0; Lin WH, 2009, J NEUROPHYSIOL, V102, P1994, DOI 10.1152/jn.00613.2009; Mahr A, 2006, GENE EXPR PATTERNS, V6, P299, DOI 10.1016/j.modgep.2005.07.006; Marley R, 2011, J NEUROPHYSIOL, V106, P18, DOI 10.1152/jn.00808.2010; Meisler MH, 2010, J PHYSIOL-LONDON, V588, P1841, DOI 10.1113/jphysiol.2010.188482; Montaser-Kouhsari L, 2011, SEIZURE-EUR J EPILEP, V20, P409, DOI 10.1016/j.seizure.2011.01.014; Muraro Nara I, 2008, SEB Exp Biol Ser, V60, P141; Nieoczym D, 2013, PROG NEURO-PSYCHOPH, V47, P104, DOI 10.1016/j.pnpbp.2013.08.009; Noebels J, 2015, NAT NEUROSCI, V18, P344, DOI 10.1038/nn.3933; Parker L, 2011, GENETICS, V187, P523, DOI 10.1534/genetics.110.123299; Pulver SR, 2015, J NEUROPHYSIOL, V114, P2564, DOI 10.1152/jn.00731.2015; Reynolds ER, 2004, J NEUROBIOL, V58, P503, DOI 10.1002/neu.10297; Song J, 2008, PROG NEUROBIOL, V84, P182, DOI 10.1016/j.pneurobio.2007.10.006; Stafstrom Carl E, 2007, Epilepsy Curr, V7, P15, DOI 10.1111/j.1535-7511.2007.00156.x; Sun L, 2012, J NEUROSCI, V32, P14145, DOI 10.1523/JNEUROSCI.2932-12.2012; Tan JS, 2004, BRAIN RES, V1020, P45, DOI 10.1016/j.brainres.2004.05.111; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Warmke JW, 1997, J GEN PHYSIOL, V110, P119, DOI 10.1085/jgp.110.2.119	34	17	17	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148461	10.1371/journal.pone.0148461	http://dx.doi.org/10.1371/journal.pone.0148461			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863447	Green Published, Green Submitted, gold			2022-12-27	WOS:000370046600076
J	Villandre, L; Stephens, DA; Labbe, A; Gunthard, HF; Kouyos, R; Stadler, T				Villandre, Luc; Stephens, David A.; Labbe, Aurelie; Guenthard, Huldrych F.; Kouyos, Roger; Stadler, Tanja		Swiss HIV Cohort Study	Assessment of Overlap of Phylogenetic Transmission Clusters and Communities in Simple Sexual Contact Networks: Applications to HIV-1	PLOS ONE			English	Article							MODEL	Background Transmission patterns of sexually-transmitted infections (STIs) could relate to the structure of the underlying sexual contact network, whose features are therefore of interest to clinicians. Conventionally, we represent sexual contacts in a population with a graph, that can reveal the existence of communities. Phylogenetic methods help infer the history of an epidemic and incidentally, may help detecting communities. In particular, phylogenetic analyses of HIV-1 epidemics among men who have sex with men (MSM) have revealed the existence of large transmission clusters, possibly resulting from within-community transmissions. Past studies have explored the association between contact networks and phylogenies, including transmission clusters, producing conflicting conclusions about whether network features significantly affect observed transmission history. As far as we know however, none of them thoroughly investigated the role of communities, defined with respect to the network graph, in the observation of clusters. Methods The present study investigates, through simulations, community detection from phylogenies. We simulate a large number of epidemics over both unweighted and weighted, undirected random interconnected-islands networks, with islands corresponding to communities. We use weighting to modulate distance between islands. We translate each epidemic into a phylogeny, that lets us partition our samples of infected subjects into transmission clusters, based on several common definitions from the literature. We measure similarity between subjects' island membership indices and transmission cluster membership indices with the adjusted Rand index. Results and Conclusion Analyses reveal modest mean correspondence between communities in graphs and phylogenetic transmission clusters. We conclude that common methods often have limited success in detecting contact network communities from phylogenies. The rarely-fulfilled requirement that network communities correspond to clades in the phylogeny is their main drawback. Understanding the link between transmission clusters and communities in sexual contact networks could help inform policymaking to curb HIV incidence in MSMs.	[Villandre, Luc; Labbe, Aurelie] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Stephens, David A.] McGill Univ, Dept Math & Stat, Montreal, PQ, Canada; [Labbe, Aurelie] Douglas Mental Hlth Univ Inst, Dept Psychiat, Montreal, PQ, Canada; [Guenthard, Huldrych F.; Kouyos, Roger] Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, CH-8091 Zurich, Switzerland; [Guenthard, Huldrych F.; Kouyos, Roger] Univ Zurich, Inst Med Virol, Zurich, Switzerland; [Stadler, Tanja] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland; [Stadler, Tanja] Swiss Inst Bioinformat, Lausanne, Switzerland	McGill University; McGill University; University of Zurich; University Zurich Hospital; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Institute of Bioinformatics	Stadler, T (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland.; Stadler, T (corresponding author), Swiss Inst Bioinformat, Lausanne, Switzerland.	tanja.stadler@bsse.ethz.ch	gunthard, huldrych f/F-1724-2011; Stadler, Tanja/J-4742-2013; Kouyos, Roger/ABB-2291-2021; Kouyos, Roger/G-6226-2014	gunthard, huldrych f/0000-0002-1142-6723; Stadler, Tanja/0000-0001-6431-535X; Kouyos, Roger/0000-0002-9220-8348; Kouyos, Roger/0000-0002-9220-8348; TARR, Philip/0000-0002-1488-5407; Egger, Matthias/0000-0001-7462-5132; Stephens, David/0000-0001-9811-7140	ThinkSwiss program; Fonds de recherche du Quebec-Sante (FRQS); Fonds de recherche-Nature et technologies (FRQNT) [232259]; Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant; Canadian Institutes of Health Research (CIHR) grant [CIHR HHP-126781]; Swiss National Science Foundation (SNF) [148522, PZ00P3-142411, 320030_159868]; SHCS Research Foundation; Yvonne Jacob Foundation; European Research Council under the Seventh Framework Programme of the European Commission [335529]; Swiss HIV Cohort Study (SHCS project) [776]	ThinkSwiss program; Fonds de recherche du Quebec-Sante (FRQS); Fonds de recherche-Nature et technologies (FRQNT); Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR) grant(Canadian Institutes of Health Research (CIHR)); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); SHCS Research Foundation; Yvonne Jacob Foundation; European Research Council under the Seventh Framework Programme of the European Commission; Swiss HIV Cohort Study (SHCS project)	L.V.' s research stay at the D-BSSE was partly funded by the ThinkSwiss program (http://thinkswiss.tumblr.com/About). L.V. received a training award from the Fonds de recherche du Quebec-Sante (FRQS, http://www.frqs.gouv.qc.ca/en/). A.L. received a team grant from the Fonds de recherche-Nature et technologies (FRQNT, number 232259, http://www.frqnt.gouv.qc.ca/accueil). D.A.S. was awarded a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant (http://www.nserc-crsng.gc.ca/index_eng.asp). D.A.S. is funding L.V.' s work with a Canadian Institutes of Health Research (CIHR) grant (CIHR HHP-126781, http://www.cihr-irsc.gc.ca/e/193.html). The SHCS is supported by the Swiss National Science Foundation (SNF grant number 148522, http://www.snf.ch/en/Pages/default.aspx) and by the SHCS Research Foundation (http://www.shcs.ch). R. K. was supported by the Swiss National Science Foundation (SNF grant number PZ00P3-142411). H.F.G. was supported by the Swiss National Science Foundation (SNF grant number 320030_159868) and by the Yvonne Jacob Foundation. T.S. is supported in part by the European Research Council under the Seventh Framework Programme of the European Commission (PhyPD: grant agreement number 335529, http://erc.europa.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study has been conducted within the framework of the Swiss HIV Cohort Study (SHCS project number 776). The members of the SHCS are: Aubert V, Battegay M, Bernasconi E, Boni J, Bucher HC, Burton-Jeangros C, Calmy A, Cavassini M, Dollenmaier G, Egger M, Elzi L, Fehr J, Fellay J, Furrer H (Chairman of the Clinical and Laboratory Committee), Fux CA, Gorgievski M, Gunthard H (President of the SHCS), Haerry D (deputy of "Positive Council"), Hasse B, Hirsch HH, Hoffmann M, Hosli I, Kahlert C, Kaiser L, Keiser O, Klimkait T, Kouyos R, Kovari H, Ledergerber B, Martinetti G, Martinez de Tejada B, Metzner K, Muller N, Nadal D, Nicca D, Pantaleo G, Rauch A (Chairman of the Scientific Board), Regenass S, Rickenbach M (Head of Data Centre), Rudin C (Chairman of the Mother & Child Substudy), Schoni-Affolter F, Schmid P, Schupbach J, Speck R, Tarr P, Telenti A, Trkola A, Vernazza P, Weber R, Yerly S.	Allen LJS, 2008, LECT NOTES MATH, V1945, P81, DOI 10.1007/978-3-540-78911-6_3; [Anonymous], 2015, STAGES HIV INFECT; Avila D, 2014, AM J EPIDEMIOL, V179, P1514, DOI 10.1093/aje/kwu076; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bocour A, 2010, SEX TRANSM DIS, V37, P784, DOI 10.1097/OLQ.0b013e3181e7107f; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Brenner BG, 2013, JAIDS-J ACQ IMM DEF, V63, pS248, DOI 10.1097/QAI.0b013e3182986f96; Brenner BG, 2011, J INFECT DIS, V204, P1115, DOI 10.1093/infdis/jir468; Brown AJL, 2011, J INFECT DIS, V204, P1463, DOI 10.1093/infdis/jir550; Centers for Disease Control and Prevention, 2012, EST HIV INC US 2007; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Kouyos RD, 2011, CLIN INFECT DIS, V52, P532, DOI 10.1093/cid/ciq164; Kouyos RD, 2010, J INFECT DIS, V201, P1488, DOI 10.1086/651951; Leventhal GE, 2014, MOL BIOL EVOL, V31, P6, DOI 10.1093/molbev/mst172; Leventhal GE, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002413; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Nguyen X. V., 2009, P 26 ANN INT C MACHI, P1073, DOI [10.1145/1553374.1553511, DOI 10.1145/1553374.1553511]; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pons P, 2005, ARXIV PHYS E PRINTS; Prosperi MCF, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1325; Raghavan UN, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036106; Ragonnet-Cronin M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-317; Robinson K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003105; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Toivonen R, 2006, PHYSICA A, V371, P851, DOI 10.1016/j.physa.2006.03.050; Welch D, 2011, VIRUSES-BASEL, V3, P659, DOI 10.3390/v3060659; World Health Organization, 2012, PROGR UPD ANT TREATM; Zarrabi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046156	31	21	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148459	10.1371/journal.pone.0148459	http://dx.doi.org/10.1371/journal.pone.0148459			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863322	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000370046600075
J	Yang, JF; Wang, Q; He, FF; Ding, YX; Sun, QY; Hua, TM; Xi, MM				Yang, Jinfang; Wang, Qian; He, Fenfen; Ding, Yanxia; Sun, Qingyan; Hua, Tianmiao; Xi, Minmin			Dietary Restriction Affects Neuronal Response Property and GABA Synthesis in the Primary Visual Cortex	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; CALORIC RESTRICTION; NORADRENERGIC MODULATION; SYNAPTIC-TRANSMISSION; CORTICAL-CELLS; LIVE LONGER; BRAIN; INHIBITION; MECHANISMS; EXPRESSION	Previous studies have reported inconsistent effects of dietary restriction (DR) on cortical inhibition. To clarify this issue, we examined the response properties of neurons in the primary visual cortex (V1) of DR and control groups of cats using in vivo extracellular single-unit recording techniques, and assessed the synthesis of inhibitory neurotransmitter GABA in the V1 of cats from both groups using immunohistochemical and Western blot techniques. Our results showed that the response of V1 neurons to visual stimuli was significantly modified by DR, as indicated by an enhanced selectivity for stimulus orientations and motion directions, decreased visually-evoked response, lowered spontaneous activity and increased signal-to-noise ratio in DR cats relative to control cats. Further, it was shown that, accompanied with these changes of neuronal responsiveness, GABA immunoreactivity and the expression of a key GABA-synthesizing enzyme GAD67 in the V1 were significantly increased by DR. These results demonstrate that DR may retard brain aging by increasing the intracortical inhibition effect and improve the function of visual cortical neurons in visual information processing. This DR-induced elevation of cortical inhibition may favor the brain in modulating energy expenditure based on food availability.	[Yang, Jinfang; Wang, Qian; He, Fenfen; Ding, Yanxia; Sun, Qingyan; Hua, Tianmiao] Anhui Normal Univ, Coll Life Sci, Wuhu, Anhui, Peoples R China; [Xi, Minmin] Univ West Scotland, Sch Business, Glasgow, Lanark, Scotland	Anhui Normal University	Hua, TM (corresponding author), Anhui Normal Univ, Coll Life Sci, Wuhu, Anhui, Peoples R China.	tmhua@ahnu.edu.cn			National Natural Science Foundation of China [31171082]; Anhui Provincial Natural Science Foundation [070413138]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province)	This research was supported by the National Natural Science Foundation of China (No. 31171082), Anhui Provincial Natural Science Foundation (No. 070413138), and Foundation of Anhui university scientific research innovation platform team (No. AT161805). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen K, 2015, CURR OPIN NEUROBIOL, V31, P81, DOI 10.1016/j.conb.2014.08.016; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; BISHOP PO, 1962, J PHYSIOL-LONDON, V163, P466, DOI 10.1113/jphysiol.1962.sp006990; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Buzsaki G, 2007, NEURON, V56, P771, DOI 10.1016/j.neuron.2007.11.008; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Caputi A, 2013, CURR OPIN NEUROBIOL, V23, P179, DOI 10.1016/j.conb.2013.01.021; Chantranupong L, 2015, CELL, V161, P67, DOI 10.1016/j.cell.2015.02.041; [陈翠云 Chen Cuiyun], 2014, [解剖学报, Acta Anatomica Sinica], V45, P304; Cheng CM, 2004, J NEUROSCI RES, V77, P270, DOI 10.1002/jnr.20144; Chiu CQ, 2013, SCIENCE, V340, P759, DOI 10.1126/science.1234274; Chung KW, 2013, EXP GERONTOL, V48, P1049, DOI 10.1016/j.exger.2012.11.007; Colman RJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4557; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; COLOMBO JP, 1992, ANN NUTR METAB, V36, P23, DOI 10.1159/000177695; Duan WZ, 2001, J MOL NEUROSCI, V16, P1, DOI 10.1385/JMN:16:1:1; Ego-Stengel V, 2002, NEUROSCIENCE, V111, P275, DOI 10.1016/S0306-4522(02)00011-8; Escanilla O, 2010, EUR J NEUROSCI, V32, P458, DOI 10.1111/j.1460-9568.2010.07297.x; Flores CE, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00327; Fontan-Lozano A, 2008, MOL NEUROBIOL, V38, P167, DOI 10.1007/s12035-008-8040-1; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Gribble KE, 2013, J GERONTOL A-BIOL, V68, P349, DOI 10.1093/gerona/gls170; Hasselmo ME, 1997, J NEUROPHYSIOL, V77, P3326, DOI 10.1152/jn.1997.77.6.3326; Henneberger C, 2005, NEUROSCIENCE, V135, P749, DOI 10.1016/j.neuroscience.2005.06.044; Hestrin S, 2011, NEURON, V71, P197, DOI 10.1016/j.neuron.2011.07.007; Hirata A, 2006, J NEUROSCI, V26, P4426, DOI 10.1523/JNEUROSCI.5298-05.2006; Hong YM, 2014, GENET MOL RES, V13, P6455, DOI 10.4238/2014.August.25.9; Hu B, 2000, BRAIN RES, V885, P87, DOI 10.1016/S0006-8993(00)02946-2; Hua TM, 2008, BRAIN RES BULL, V75, P119, DOI 10.1016/j.brainresbull.2007.08.001; Hua TM, 2010, CURR BIOL, V20, P887, DOI 10.1016/j.cub.2010.03.066; Hua TM, 2009, NEUROSCI LETT, V451, P25, DOI 10.1016/j.neulet.2008.12.041; Hua TM, 2006, NEUROBIOL AGING, V27, P155, DOI 10.1016/j.neurobiolaging.2004.11.012; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Ikeda MZ, 2015, J NEUROSCI, V35, P9356, DOI 10.1523/JNEUROSCI.4445-14.2015; Ingram DK, 2007, NEUROSCIENCE, V145, P1359, DOI 10.1016/j.neuroscience.2006.10.031; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kishi T, 2015, INT HEART J, V56, P110, DOI 10.1536/ihj.14-168; Kuhla A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068778; Kullmann DM, 2012, NEURON, V75, P951, DOI 10.1016/j.neuron.2012.07.030; Lennie P, 2003, CURR BIOL, V13, P493, DOI 10.1016/S0960-9822(03)00135-0; Leonhardt S, 1999, J NEUROENDOCRINOL, V11, P613; Levenson CW, 2007, NUTR REV, V65, P412, DOI 10.1111/j.1753-4887.2007.tb00319.x; Leventhal AG, 2003, SCIENCE, V300, P812, DOI 10.1126/science.1082874; Liang Z, 2010, NEUROBIOL AGING, V31, P863, DOI 10.1016/j.neurobiolaging.2008.06.013; Ling LL, 2005, NEUROSCIENCE, V132, P1103, DOI 10.1016/j.neuroscience.2004.12.043; Luebke JI, 2004, NEUROSCIENCE, V125, P277, DOI 10.1016/j.neuroscience.2004.01.035; Mair W, 2010, AGING CELL, V9, P916, DOI 10.1111/j.1474-9726.2010.00602.x; Matsumoto T, 2006, MOL CELL NEUROSCI, V31, P70, DOI 10.1016/j.mcn.2005.09.002; Mattson MP, 2002, MECH AGEING DEV, V123, P947, DOI 10.1016/S0047-6374(02)00032-5; McGinley MJ, 2015, NEURON, V87, P1143, DOI 10.1016/j.neuron.2015.09.012; Meneguello-Coutinho M, 2014, IMMUNOL INVEST, V43, P113, DOI 10.3109/08820139.2013.847456; Meng JJ, 2013, EXP BRAIN RES, V225, P377, DOI 10.1007/s00221-012-3378-z; Moncada R, 2016, OBES SURG, V26, P1549, DOI 10.1007/s11695-015-1919-9; Mower GD, 2001, DEV BRAIN RES, V126, P65, DOI 10.1016/S0165-3806(00)00139-5; Moxon KA, 2007, BRAIN RES, V1147, P105, DOI 10.1016/j.brainres.2007.02.006; Mu SH, 2016, NEUROCHEM RES, V41, P707, DOI 10.1007/s11064-015-1739-2; Murphy T, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/563160; Nayak P, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-4; Newton IG, 2005, NEUROBIOL AGING, V26, P683, DOI 10.1016/j.neurobiolaging.2004.06.005; Okada M, 2003, MOL BRAIN RES, V111, P175, DOI 10.1016/S0169-328X(03)00028-7; Paille V, 2013, J NEUROSCI, V33, P9353, DOI 10.1523/JNEUROSCI.5796-12.2013; Palizvan MR, 2004, NEUROSCIENCE, V126, P955, DOI 10.1016/j.neuroscience.2004.03.053; Pani G, 2015, SEMIN CELL DEV BIOL, V40, P106, DOI 10.1016/j.semcdb.2015.03.004; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Peng Qing-Song, 2011, Zoological Research, V32, P337, DOI 10.3724/SP.J.1141.2011.03337; Pezet S, 2002, MOL CELL NEUROSCI, V21, P51, DOI 10.1006/mcne.2002.1166; Pinto JGA, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00016; Ribaric S, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/741468; Rico B, 2002, NAT NEUROSCI, V5, P225, DOI 10.1038/nn808; Roth LW, 2012, MATURITAS, V71, P315, DOI 10.1016/j.maturitas.2011.12.017; Rudofsky G, 2011, HORM METAB RES, V43, P343, DOI 10.1055/s-0031-1271778; Sanchez-Huertas C, 2011, CEREB CORTEX, V21, P777, DOI 10.1093/cercor/bhq150; Schmolesky MT, 2000, NAT NEUROSCI, V3, P384, DOI 10.1038/73957; Seki K, 2011, J EXP NEUROSCI, V5, P9, DOI 10.4137/JEN.S6833; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P287, DOI 10.1113/jphysiol.1975.sp011055; Smyers ME, 2015, PHYSIOL BEHAV, V139, P303, DOI 10.1016/j.physbeh.2014.11.044; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; Spolidoro M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1323; Tan N, 2016, HISTOPATHOLOGY, V68, P221, DOI 10.1111/his.12738; Thanos PK, 2008, SYNAPSE, V62, P50, DOI 10.1002/syn.20468; Tsutsumi A, 2011, BIOCHEM BIOPH RES CO, V404, P339, DOI 10.1016/j.bbrc.2010.11.120; Tucci P, 2012, AGING-US, V4, P525, DOI 10.18632/aging.100481; van de Lagemaat LN, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00394; Vaz SH, 2011, J BIOL CHEM, V286, P40464, DOI 10.1074/jbc.M111.232009; Vinck M, 2015, NEURON, V86, P740, DOI 10.1016/j.neuron.2015.03.028; Wang H, 2006, BRAIN RES, V1122, P93, DOI 10.1016/j.brainres.2006.09.010; Waterhouse EG, 2012, J NEUROSCI, V32, P14318, DOI 10.1523/JNEUROSCI.0709-12.2012; Xiang L, 2011, ANN NUTR METAB, V58, P42, DOI 10.1159/000323748; Yang Y, 2008, NEUROSCIENCE, V156, P748, DOI 10.1016/j.neuroscience.2008.08.007; Yoon H, 2008, BIOCHEM BIOPH RES CO, V371, P495, DOI 10.1016/j.bbrc.2008.04.102; Zhang F, 2011, PROG NEUROBIOL, V95, P373, DOI 10.1016/j.pneurobio.2011.09.001; Zhang K, 2014, NEUROSCIENCE, V275, P238, DOI 10.1016/j.neuroscience.2014.06.020; Zhou Jun, 2011, Zoological Research, V32, P533, DOI 10.3724/SP.J.1141.2011.05533	95	10	10	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149004	10.1371/journal.pone.0149004	http://dx.doi.org/10.1371/journal.pone.0149004			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863207	Green Submitted, Green Published, gold			2022-12-27	WOS:000370046600137
J	Ghanbari, S; Ramezankhani, A; Montazeri, A; Mehrabi, Y				Ghanbari, Shahla; Ramezankhani, Ali; Montazeri, Ali; Mehrabi, Yadollah			Health Literacy Measure for Adolescents (HELMA): Development and Psychometric Properties	PLOS ONE			English	Article							CONTENT VALIDITY; PUBLIC-HEALTH; VALIDATION; FRAMEWORK; EDUCATION; OUTCOMES; AGENDA; SKILLS	Background Health literacy refers to personal competencies for the access to, understanding of, appraisal of and application of health information in order to make sound decisions in everyday life. The aim of this study was to develop and evaluate the psychometric properties of an instrument for the measurement of health literacy among adolescents (the Health Literacy Measure for Adolescents-HELMA). Methods This study was made up of two phases, qualitative and quantitative, which were carried out in 2012-2014 in Tehran, Iran. In the qualitative part of the study, in-depth interviews with 67 adolescents aged 15-18 were carried out in 4 high schools to generate the initial item pool for the survey. The content validity of the items was then assessed by an expert panel review (n = 13) and face validity was assessed by interviewing adolescents (n = 16). In the quantitative part of the study, in order to describe the psychometric properties of the scale, validity, reliability (internal consistency and test-retest) and factor analysis were assessed. Results An item pool made up of 104 items was generated at the qualitative stage. After content validity was considered, this decreased to 47 items. In the quantitative stage, 582 adolescents aged 15-18 participated in the study with a mean age of 16.2 years. 51.2% of participants were females. In principal component factor analysis, 8 factors were loaded, which accounted for 53.37% of the variance observed. Reliability has been approved by alpha = 0.93 and the test-retest of the scale at two-week intervals indicated an appropriate stability for the scale (ICC = 0.93). The final questionnaire was approved with 44 items split into eight sections. The sections were titled: gain access to, reading, understanding, appraise, use, communication, self-efficacy and numeracy. Conclusion The Health Literacy Measure for Adolescents (HELMA) is a valid and reliable tool for the measurement of the health literacy of adolescents aged 15-18 and can be used to evaluate different levels of functional, interactive, and critical health literacy in adolescents.	[Ghanbari, Shahla; Ramezankhani, Ali] Shahid Beheshti Univ Med Sci, Sch Hlth, Dept Publ Hlth, Tehran, Iran; [Montazeri, Ali] ACECR, Iranian Inst Hlth Sci Res, Mental Hlth Res Grp, Hlth Metr Res Ctr, Tehran, Iran; [Mehrabi, Yadollah] Shahid Beheshti Univ Med Sci, Sch Hlth, Dept Epidemiol, Tehran, Iran	Shahid Beheshti University Medical Sciences; Academic Center for Education, Culture & Research (ACECR); Shahid Beheshti University Medical Sciences	Ramezankhani, A (corresponding author), Shahid Beheshti Univ Med Sci, Sch Hlth, Dept Publ Hlth, Tehran, Iran.; Montazeri, A (corresponding author), ACECR, Iranian Inst Hlth Sci Res, Mental Hlth Res Grp, Hlth Metr Res Ctr, Tehran, Iran.	aramezankhani@sbmu.ac.ir; montazeri@acecr.ac.ir	Mehrabi, Yadollah/J-4211-2016; Montazeri, Ali/C-9276-2009; Mehrabi, Yadollah/J-4211-2016	Mehrabi, Yadollah/0000-0001-8555-6160; Montazeri, Ali/0000-0002-5198-9539; Mehrabi, Yadollah/0000-0001-9837-4956				Abel T, 2015, HEALTH PROMOT INT, V30, P725, DOI 10.1093/heapro/dat096; Baumgartner T.A., 2001, MEAS PHYS EDUC EXERC, V5, P179, DOI DOI 10.1207/S15327841MPEE0503_4; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Chisolm DJ, 2007, J ADOLESCENT HEALTH, V41, P312, DOI 10.1016/j.jadohealth.2007.04.015; Costello AB., 2005, PRACT ASSESS RES EVA, V10, P7; Curtis LM, 2015, J HEALTH COMMUN, V20, P157, DOI 10.1080/10810730.2014.917744; Davis TC, 2006, PEDIATRICS, V118, pE1707, DOI 10.1542/peds.2006-1139; DeWalt DA, 2004, J GEN INTERN MED, V19, P1228, DOI 10.1111/j.1525-1497.2004.40153.x; DeWalt Darren A, 2009, Pediatrics, V124 Suppl 3, pS265, DOI 10.1542/peds.2009-1162B; Fink A, 1995, MEASURE SURVEY RELIA; Ghaddar SF, 2012, J SCHOOL HEALTH, V82, P28, DOI 10.1111/j.1746-1561.2011.00664.x; Ghanbari S, 2012, DANESHVAR MED, V19, P1; Hajizadeh E, 2011, STAT METHODS ANAL HL; Harrington D., 2008, CONFIRMATORY FACTOR; Javadzade H., 2013, IRAN J HLTH SYST RES, V9, P540; Kanj M, 2009, HEALTH LITERACY AND, P26; Kooshyar H., 2014, J MAZANDARAN U MED S, V23, P134; LAWSHE CH, 1975, PERS PSYCHOL, V28, P563, DOI 10.1111/j.1744-6570.1975.tb01393.x; Manganello JA, 2008, HEALTH EDUC RES, V23, P840, DOI 10.1093/her/cym069; Massey P, 2013, AM J HEALTH BEHAV, V37, P342, DOI 10.5993/AJHB.37.3.7; Massey PM, 2012, HEALTH EDUC RES, V27, P961, DOI 10.1093/her/cys054; Montazeri A., 2014, PAYESH, V13, P589, DOI DOI 10.5812/IRCMJ.17(5)2015.25831; Munro B. H., 2005, STAT METHODS HLTH CA, DOI DOI 10.1093/annonc/mdx645; NTRMANGANELLO JA, 2013, ACT YOUTH CTR EXCELL, V18, DOI DOI 10.1080/15398280802121406; Nunnally JC, 1967, MT PSYCHOMETRIC THEO; Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259; Nutbeam D, 2008, SOC SCI MED, V67, P2072, DOI 10.1016/j.socscimed.2008.09.050; Peerson A, 2011, INT J MENS HLTH, V10, P111, DOI DOI 10.3149/JMH.1002.111; Peerson A, 2009, HEALTH PROMOT INT, V24, P285, DOI 10.1093/heapro/dap014; Pleasant A, 2011, J HEALTH COMMUN, V16, P11, DOI 10.1080/10810730.2011.604392; Polit DF, 2006, RES NURS HEALTH, V29, P489, DOI 10.1002/nur.20147; Qobadi M, 2015, J FUNDAMENTALS MENTA, V17, P46; Reisi M, 2011, J HLTH SYST RES, V7, P469; Rowlands G, 2012, PERSPECT PUBLIC HEAL, V132, P23, DOI 10.1177/1757913911430916; Shone LP, 2010, J ADOLESCENT HEALTH, V46, pS11, DOI 10.1016/j.jadohealth.2009.11.027; Sistani MMN, 2014, J INVESTIG CLIN DENT, V5, DOI 10.1111/jicd.12042; Sorensen K, 2013, THESIS MAASTRIKHT U; Sorensen K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-80; Tehrani Banihashemi SA, 2007, JMED, V4, P1; Tol A, 2012, HOSPITAL, V11, P45; van der Heide I, 2013, J HEALTH COMMUN, V18, P172, DOI 10.1080/10810730.2013.825668; Vozikis A, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-15; World Health Organization Health Literacy, 2013, WHO HLTH LITERACY SO; Wu AD, 2010, HEALTH PROMOT INT, V25, P444, DOI 10.1093/heapro/daq032; Yuen EYN, 2014, BMC FAM PRACT, V15, DOI 10.1186/s12875-014-0202-9	45	40	40	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149202	10.1371/journal.pone.0149202	http://dx.doi.org/10.1371/journal.pone.0149202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3BP	26881933	Green Published, Green Submitted, gold			2022-12-27	WOS:000371219000058
J	Harris, WS; Luo, JH; Pottala, JV; Margolis, KL; Espeland, MA; Robinson, JG				Harris, William S.; Luo, Juhua; Pottala, James V.; Margolis, Karen L.; Espeland, Mark A.; Robinson, Jennifer G.			Red Blood Cell Fatty Acids and Incident Diabetes Mellitus in the Women's Health Initiative Memory Study	PLOS ONE			English	Article							DE-NOVO LIPOGENESIS; COA DESATURASE ACTIVITY; SKELETAL-MUSCLE CELLS; GAMMA-LINOLENIC ACID; METABOLIC SYNDROME; PALMITOLEIC ACID; CARDIOVASCULAR HEALTH; DIETARY-FAT; PROSPECTIVE ASSOCIATION; DELTA-6 DESATURASE	Context The relations between dietary and/or circulating levels of fatty acids and the development of type 2 diabetes is unclear. Protective associations with the marine omega-3 fatty acids and linoleic acid, and with a marker of fatty acid desaturase activity delta-5 desaturase (D5D ratio) have been reported, as have adverse relations with saturated fatty acids and D6D ratio. Objective To determine the associations between red blood cell (RBC) fatty acid distributions and incident type 2 diabetes. Design Prospective observational cohort study nested in the Women's Health Initiative Memory Study. Setting General population. Subjects Postmenopausal women. Main Outcome Measures Self-reported incident type 2 diabetes. Results There were 703 new cases of type 2 diabetes over 11 years of follow up among 6379 postmenopausal women. In the fully adjusted models, baseline RBC D5D ratio was inversely associated with incident type 2 diabetes [Hazard Ratio (HR) 0.88, 95% confidence interval (CI) 0.81-0.95) per 1 SD increase. Similarly, baseline RBC D6D ratio and palmitic acid were directly associated with incident type 2 diabetes (HR 1.14, 95% CI 1.04-1.25; and HR 1.24, 95% CI 1.14-1.35, respectively). None of these relations were materially altered by excluding incident cases in the first two years of follow-up. There were no significant relations with eicosapentaenoic, docosahexaenoic or linoleic acids. Conclusions Whether altered fatty acid desaturase activities or palmitic acid levels are causally related to the development of type 2 diabetes cannot be determined from this study, but our findings suggest that proportions of certain fatty acids in RBC membranes are associated with risk for type 2 diabetes.	[Harris, William S.] Univ S Dakota, Sanford Sch Med, Dept Internal Med, Sioux Falls, SD USA; [Harris, William S.] OmegaQuant Analyt LLC, Sioux Falls, SD USA; [Luo, Juhua] Indiana Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Bloomington, IN USA; [Pottala, James V.] Univ S Dakota, Sanford Sch Med, Dept Internal Med, Sioux Falls, SD USA; [Margolis, Karen L.] HealthPartners Fdn Educ & Res, Minneapolis, MN USA; [Espeland, Mark A.] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC USA; [Robinson, Jennifer G.] Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA	University of South Dakota; Indiana University System; Indiana University Bloomington; University of South Dakota; Wake Forest University; University of Iowa	Harris, WS (corresponding author), Univ S Dakota, Sanford Sch Med, Dept Internal Med, Sioux Falls, SD USA.; Harris, WS (corresponding author), OmegaQuant Analyt LLC, Sioux Falls, SD USA.	bill@omegaquant.com	Harris, William Stephen/T-1674-2019; , Jennifer/AAD-8336-2019	Harris, William Stephen/0000-0003-3042-9353; luo, juhua/0000-0002-8901-4462; Margolis, Karen/0000-0003-1862-7402	National Heart Lung and Blood Institute, Broad Area Announcement 19; HDL, Inc.; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001108] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute, Broad Area Announcement 19; HDL, Inc.; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funding provided by National Heart Lung and Blood Institute, Broad Area Announcement 19. The sponsor had no role in study design, study conduct, data analysis or manuscript preparation. HDL, Inc. provided support in the form of salary for JVP and WSH, and OmegaQuant Analytics, LLC provided support for WSH as he has an ownership interest the laboratory. However, neither organization played any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arab L, 2003, J NUTR, V133, p925S, DOI 10.1093/jn/133.3.925S; Bonds DE, 2006, DIABETOLOGIA, V49, P459, DOI 10.1007/s00125-005-0096-0; Chong MFF, 2008, AM J CLIN NUTR, V87, P817, DOI 10.1093/ajcn/87.4.817; CLANDININ MT, 1991, FASEB J, V5, P2761, DOI 10.1096/fasebj.5.13.1916101; CLANDININ MT, 1993, ANN NY ACAD SCI, V683, P151, DOI 10.1111/j.1749-6632.1993.tb35701.x; Djousse L, 2011, AM J CLIN NUTR, V94, P527, DOI 10.3945/ajcn.111.013334; Djousse L, 2011, AM J CLIN NUTR, V93, P143, DOI 10.3945/ajcn.110.005603; Enzenbach C, 2011, EUR J NUTR, V50, P625, DOI 10.1007/s00394-011-0169-4; Espeland MA, 2004, JAMA-J AM MED ASSOC, V291, P2959, DOI 10.1001/jama.291.24.2959; Forouhi NG, 2014, LANCET DIABETES ENDO, V2, P810, DOI 10.1016/S2213-8587(14)70146-9; Frangioudakis G, 2013, DIABETOLOGIA, V56, P2697, DOI 10.1007/s00125-013-3035-5; Harris WS, 2004, PREV MED, V39, P212, DOI 10.1016/j.ypmed.2004.02.030; Hodge AM, 2007, AM J CLIN NUTR, V86, P189, DOI 10.1093/ajcn/86.1.189; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Hodson L, 2014, J NUTR, V144, P33, DOI 10.3945/jn.113.183749; Jackson JM, 2014, MENOPAUSE, V21, P861, DOI [10.1097/GME.0000000000000189, 10.1097/gme.0000000000000189]; Jacobs S, 2015, AM J CLIN NUTR, V102, P155, DOI 10.3945/ajcn.114.102707; Kabagambe EK, 2008, CLIN CHEM, V54, P154, DOI 10.1373/clinchem.2007.095059; King IB, 2006, AM J CLIN NUTR, V83, P227; Krachler B, 2008, NUTR METAB CARDIOVAS, V18, P503, DOI 10.1016/j.numecd.2007.04.005; Kroger J, 2012, CURR OPIN LIPIDOL, V23, P4, DOI 10.1097/MOL.0b013e32834d2dc5; Kroger J, 2011, AM J CLIN NUTR, V93, P127, DOI 10.3945/ajcn.110.005447; Kurotani K, 2012, NUTR RES, V32, P669, DOI 10.1016/j.nutres.2012.07.004; Laaksonen DE, 2002, DIABETIC MED, V19, P456, DOI 10.1046/j.1464-5491.2002.00707.x; Lambert JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082599; Lankinen MA, 2015, DIABETOLOGIA, V58, P2533, DOI 10.1007/s00125-015-3730-5; LASSERRE M, 1985, LIPIDS, V20, P227, DOI 10.1007/BF02534193; Lee JJ, 2015, AM J CLIN NUTR, V101, P34, DOI 10.3945/ajcn.114.092262; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; Ma WJ, 2015, AM J CLIN NUTR, V101, P153, DOI 10.3945/ajcn.114.092601; Mahendran Y, 2014, AM J CLIN NUTR, V99, P79, DOI 10.3945/ajcn.113.069740; Margolis KL, 2008, CLIN TRIALS, V5, P240, DOI 10.1177/1740774508091749; Micha R, 2010, AM J CLIN NUTR, V91, P883, DOI 10.3945/ajcn.2009.28877; Mozaffarian D, 2010, ANN INTERN MED, V153, P790, DOI 10.7326/0003-4819-153-12-201012210-00005; Mozaffarian D, 2010, AM J CLIN NUTR, V92, P1350, DOI 10.3945/ajcn.110.003970; Patel PS, 2010, AM J CLIN NUTR, V92, P1214, DOI 10.3945/ajcn.2010.29182; Postic C, 2008, DIABETES METAB, V34, P643, DOI 10.1016/S1262-3636(08)74599-3; Pottala JV, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/160520; Pottala JV, 2012, LIPIDS, V47, P835, DOI 10.1007/s11745-012-3693-y; Powell DJ, 2004, BIOCHEM J, V382, P619, DOI 10.1042/BJ20040139; Rioux V, 2007, ANIMAL, V1, P820, DOI 10.1017/S1751731107000122; Riserus U, 2008, CURR OPIN CLIN NUTR, V11, P100, DOI 10.1097/MCO.0b013e3282f52708; Sethom MM, 2011, PROSTAG LEUKOTR ESS, V85, P137, DOI 10.1016/j.plefa.2011.06.006; Shumaker SA, 1998, CONTROL CLIN TRIALS, V19, P604, DOI 10.1016/S0197-2456(98)00038-5; VESSBY B, 1994, DIABETES, V43, P1353, DOI 10.2337/diabetes.43.11.1353; Vessby B, 2013, BRIT J NUTR, V110, P871, DOI 10.1017/S0007114512005934; Villegas R, 2011, AM J CLIN NUTR, V94, P543, DOI 10.3945/ajcn.111.013193; Virtanen JK, 2014, DIABETES CARE, V37, P189, DOI 10.2337/dc13-1504; Virtanen JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041046; Volk BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113605; Wallin A, 2012, DIABETES CARE, V35, P918, DOI 10.2337/dc11-1631; Wang L, 2003, AM J CLIN NUTR, V78, P91; Wang QY, 2015, DIABETES CARE, V38, P1099, DOI 10.2337/dc14-2101; Wang XP, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-25; Warensjo E, 2006, AM J CLIN NUTR, V84, P442; Zhou YP, 2012, BRIT J NUTR, V108, P408, DOI 10.1017/S0007114512002036; Zong G, 2013, AM J CLIN NUTR, V98, P319, DOI 10.3945/ajcn.113.061218	57	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0147894	10.1371/journal.pone.0147894	http://dx.doi.org/10.1371/journal.pone.0147894			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881936	Green Published, gold			2022-12-27	WOS:000371219000009
J	Iturbe-Espinoza, P; Gil-Moreno, S; Lin, WY; Calatayud, S; Palacios, O; Capdevila, M; Atrian, S				Iturbe-Espinoza, Paul; Gil-Moreno, Selene; Lin, Weiyu; Calatayud, Sara; Palacios, Oscar; Capdevila, Merce; Atrian, Silvia			The Fungus Tremella mesenterica Encodes the Longest Metallothionein Currently Known: Gene, Protein and Metal Binding Characterization	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; COPPER-METALLOTHIONEIN; CU; FEATURES; INSIGHT; YEAST; ZN; AMPLIFICATION; CADMIUM(II); EVOLUTION	Fungal Cu-thioneins, and among them, the paradigmatic Neurospora crassa metallothionein (MT) (26 residues), were once considered as the shortest MTs -the ubiquitous, versatile metal-binding proteins-among all organisms, and thus representatives of their primeval forms. Nowadays, fungal MTs of diverse lengths and sequence features are known, following the huge heterogeneity of the Kingdom of Fungi. At the opposite end of N. crassa MT, the recently reported Cryptococcus neoformans CnMT1 and CnMT2 (122 and 186 aa) constitute the longest reported fungal MTs, having been identified as virulence factors of this pathogen. CnMTs are high-capacity Cu-thioneins that appear to be built by tandem amplification of a basic unit, a 7-Cys segment homologous to N. crassa MT. Here, we report the in silico, in vivo and in vitro study of a still longer fungal MT, belonging to Tremella mesenterica (TmMT), a saprophytic ascomycete. The TmMT gene has 10 exons, and it yields a 779-bp mature transcript that encodes a 257 residue-long protein. This MT is also built by repeated fragments, but of variable number of Cys: six units of the 7-Cys building blocks-CXCX(3)CSCPPGXCXCAXCP-, two fragments of six Cys, plus three Cys at the N-terminus. TmMT metal binding abilities have been analyzed through the spectrophotometric and spectrometric characterization of its recombinant Zn-, Cd- and Cu-complexes. Results allow it to be unambiguous classified as a Cu-thionein, also of extraordinary coordinating capacity. According to this feature, when the TmMT cDNA is expressed in MT-devoid yeast cells, it is capable of restoring a high Cu tolerance level. Since it is not obvious that T. mesenterica shares the same physiological needs for a high capacity Cu-binding protein with C. neoformans, the existence of this peculiar MT might be better explained on the basis of a possible role in Cu-handling for the Cu-enzymes responsible in lignin degradation pathways.	[Iturbe-Espinoza, Paul; Lin, Weiyu; Calatayud, Sara; Atrian, Silvia] Univ Barcelona, Fac Biol, Dept Genet, Barcelona, Spain; [Gil-Moreno, Selene; Palacios, Oscar; Capdevila, Merce] Univ Autonoma Barcelona, Fac Ciencies, Dept Quim, E-08193 Barcelona, Spain	University of Barcelona; Autonomous University of Barcelona	Atrian, S (corresponding author), Univ Barcelona, Fac Biol, Dept Genet, Barcelona, Spain.	satrian@ub.edu	Palacios, Òscar/AAJ-3492-2021; Capdevila, Mercè/F-5374-2015; Palacios, Oscar/C-8974-2009; Capdevila, Mercè/ABG-4588-2020	Palacios, Òscar/0000-0002-2987-7303; Capdevila, Mercè/0000-0002-2246-0994; Palacios, Oscar/0000-0002-2987-7303; Capdevila, Mercè/0000-0002-2246-0994; Iturbe-Espinoza, Paul Adrian/0000-0002-1313-5532; Calatayud, Sara/0000-0001-8360-6179	Spanish Ministerio de Economia y Competitividad (MINECO) - European Union through the FEDER program [BIO2012-39682-C02-01, BIO2012-39682-C02-02]	Spanish Ministerio de Economia y Competitividad (MINECO) - European Union through the FEDER program	This work was supported by the Spanish Ministerio de Economia y Competitividad (MINECO), grants BIO2012-39682-C02-01 (to SA) and -02 (to MC), which are co-financed by the European Union through the FEDER program. Authors are members of the 2014SGR-423 Grup de Recerca de la Generalitat de Catalunya.	Adamo GM, 2012, MICROBIOL-SGM, V158, P2325, DOI 10.1099/mic.0.058024-0; Artells E, 2013, METALLOMICS, V5, P1397, DOI 10.1039/c3mt00123g; Binz PA, 1999, METALLOTHIONEIN IV, P7; Blindauer CA, 2014, RSC METALLOBIO SER, V2, P606; Bofill R, 1999, J INORG BIOCHEM, V73, P57, DOI 10.1016/S0162-0134(98)10091-0; Bofill R, 2009, METALLOMICS, V1, P229, DOI 10.1039/b904953c; BONGERS J, 1988, ANAL CHEM, V60, P2683, DOI 10.1021/ac00175a008; Capdevila M, 2005, ANGEW CHEM INT EDIT, V44, P4618, DOI 10.1002/anie.200501183; Capdevila M, 2012, COORDIN CHEM REV, V256, P46, DOI 10.1016/j.ccr.2011.07.006; Capdevila M, 1997, CELL MOL LIFE SCI, V53, P681, DOI 10.1007/s000180050088; Capdevila M, 2011, J BIOL INORG CHEM, V16, P977, DOI 10.1007/s00775-011-0798-3; Cols N, 1997, J INORG BIOCHEM, V68, P157, DOI 10.1016/S0162-0134(97)00085-8; CULOTTA VC, 1994, J BIOL CHEM, V269, P25295; Dallinger R, 2005, AM J PHYSIOL-REG I, V289, pR1185, DOI 10.1152/ajpregu.00052.2005; Diaz S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000291; Ding C, 2013, CELL HOST MICROBE, V13, P265, DOI 10.1016/j.chom.2013.02.002; Domenech J, 2008, BBA-PROTEINS PROTEOM, V1784, P693, DOI 10.1016/j.bbapap.2008.01.008; Espart A, 2015, MOL MICROBIOL, V98, P977, DOI 10.1111/mmi.13171; Espart Anna, 2015, Int J Biol Sci, V11, P456, DOI 10.7150/ijbs.11060; Fabris D, 1996, J AM CHEM SOC, V118, P12242, DOI 10.1021/ja962863r; Findley K, 2009, EUKARYOT CELL, V8, P353, DOI 10.1128/EC.00373-08; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Guirola M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043299; LERCH K, 1980, NATURE, V284, P368, DOI 10.1038/284368a0; Maiti BK, 2007, EUR J INORG CHEM, P5548, DOI 10.1002/ejic.200700784; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; MUNGER K, 1985, BIOCHEMISTRY-US, V24, P6751; NEMER M, 1985, P NATL ACAD SCI USA, V82, P4992, DOI 10.1073/pnas.82.15.4992; Pagani A, 2007, MOL MICROBIOL, V63, P256, DOI 10.1111/j.1365-2958.2006.05510.x; Palacios O, 2014, METALLOMICS, V6, P279, DOI 10.1039/c3mt00266g; Palacios O, 2011, J BIOL INORG CHEM, V16, P991, DOI 10.1007/s00775-011-0827-2; Palacios O, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-4; Perez-Rafael S, 2012, METALLOMICS, V4, P342, DOI 10.1039/c2mt00182a; PRINZ R, 1975, H-S Z PHYSIOL CHEM, V356, P767, DOI 10.1515/bchm2.1975.356.s1.767; Pushie MJ, 2012, BBA-BIOENERGETICS, V1817, P938, DOI 10.1016/j.bbabio.2011.10.004; Sherman F, 1994, METHODS YEAST GENETI, P151; Shuja RN, 2009, MOL BIOL REP, V36, P549, DOI 10.1007/s11033-008-9213-8; Sigel A., 2009, METAL IONS LIFE SCI, V5; Valls M, 2001, J BIOL CHEM, V276, P32835, DOI 10.1074/jbc.M102151200; Vasak M, 2000, CURR OPIN CHEM BIOL, V4, P177, DOI 10.1016/S1367-5931(00)00082-X; Wickerman L, 2012, DEPT AGRIC TECH BULL, V1029, P1; Winge D, 1994, BIOINORGANIC CHEM CO, P110; WINGE DR, 1985, J BIOL CHEM, V260, P4464	44	18	18	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148651	10.1371/journal.pone.0148651	http://dx.doi.org/10.1371/journal.pone.0148651			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882011	Green Published, gold, Green Submitted			2022-12-27	WOS:000371219000020
J	Foster, DM; Martin, LG; Papich, MG				Foster, Derek M.; Martin, Luke G.; Papich, Mark G.			Comparison of Active Drug Concentrations in the Pulmonary Epithelial Lining Fluid and Interstitial Fluid of Calves Injected with Enrofloxacin, Florfenicol, Ceftiofur, or Tulathromycin	PLOS ONE			English	Article							ANTIMICROBIAL AGENTS; TISSUE CONCENTRATIONS; BRONCHIAL-SECRETIONS; PHARMACOKINETICS; PLASMA; METABOLITE; BOVINE; DANOFLOXACIN; DISPOSITION; SERUM	Bacterial pneumonia is the most common reason for parenteral antimicrobial administration to beef cattle in the United States. Yet there is little information describing the antimicrobial concentrations at the site of action. The objective of this study was to compare the active drug concentrations in the pulmonary epithelial lining fluid and interstitial fluid of four antimicrobials commonly used in cattle. After injection, plasma, interstitial fluid, and pulmonary epithelial lining fluid concentrations and protein binding were measured to determine the plasma pharmacokinetics of each drug. A cross-over design with six calves per drug was used. Following sample collection and drug analysis, pharmacokinetic calculations were performed. For enrofloxacin and metabolite ciprofloxacin, the interstitial fluid concentration was 52% and 78% of the plasma concentration, while pulmonary fluid concentrations was 24% and 40% of the plasma concentration, respectively. The pulmonary concentrations (enrofloxacin + ciprofloxacin combined) exceeded the MIC90 of 0.06 mu g/mL at 48 hours after administration. For florfenicol, the interstitial fluid concentration was almost 98% of the plasma concentration, and the pulmonary concentrations were over 200% of the plasma concentrations, exceeding the breakpoint (<= 2 mu g/mL), and the MIC90 for Mannheimia haemolytica (1.0 mu g/mL) for the duration of the study. For ceftiofur, penetration to the interstitial fluid was only 5% of the plasma concentration. Pulmonary epithelial lining fluid concentration represented 40% of the plasma concentration. Airway concentrations exceeded the MIC breakpoint for susceptible respiratory pathogens (<= 2 mu g/mL) for a short time at 48 hours after administration. The plasma and interstitial fluid concentrations of tulathromcyin were lower than the concentrations in pulmonary fluid throughout the study. The bronchial concentrations were higher than the plasma or interstitial concentrations, with over 900% penetration to the airways. Despite high diffusion into the bronchi, the tulathromycin concentrations achieved were lower than the MIC of susceptible bacteria at most time points.	[Foster, Derek M.; Martin, Luke G.] NC State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC USA; [Papich, Mark G.] NC State Univ, Dept Mol & Biomed Sci, Coll Vet Med, Raleigh, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Foster, DM (corresponding author), NC State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC USA.	derek_foster@ncsu.edu		Foster, Derek/0000-0002-6859-9801; Papich, Mark/0000-0002-7591-7898	Bayer HealthCare LLC, Animal Health Division, Shawnee Mission, KS, USA [200893]	Bayer HealthCare LLC, Animal Health Division, Shawnee Mission, KS, USA	Funding was provided by Bayer HealthCare LLC, Animal Health Division, Shawnee Mission, KS, USA (http://animalhealth.bayer.com/ah/index.html). Grant #200893. Tulathromycin reference standard was provided as a gift from Zoetis Animal Health. Enrofloxacin reference standard was provided as a gift from Zoetis Animal Health. Florfenicol reference standard was provided as a gift from Merck Animal Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andes D, 2002, INT J ANTIMICROB AG, V19, P261, DOI 10.1016/S0924-8579(02)00022-5; BALDWIN DR, 1992, ANTIMICROB AGENTS CH, V36, P1171, DOI 10.1128/AAC.36.6.1171; BALDWIN DR, 1992, ANTIMICROB AGENTS CH, V36, P1176, DOI 10.1128/AAC.36.6.1176; Cox SR, 2010, INT J APPL RES VET M, V8, P129; Davis JL, 2007, J VET PHARMACOL THER, V30, P564, DOI 10.1111/j.1365-2885.2007.00914.x; Drusano GL, 2011, J ANTIMICROB CHEMOTH, V66, pIII61, DOI 10.1093/jac/dkr100; FDA, 1997, GUID IND GUID FORM C; Fischer CD, 2011, ANTIMICROB AGENTS CH, V55, P338, DOI 10.1128/AAC.01052-10; Galer D, 2004, J AGR FOOD CHEM, V52, P2179, DOI 10.1021/jf0351624; Giamarellos-Bourboulis EJ, 2008, INT J ANTIMICROB AG, V31, P12, DOI 10.1016/j.ijantimicag.2007.08.001; Giguere S, 2011, INT J APPL RES VET M, V9, P342; Gilliam JN, 2008, AM J VET RES, V69, P997, DOI 10.2460/ajvr.69.8.997; HALSTEAD SL, 1992, CAN J VET RES, V56, P269; Holmes K, 2012, J VET PHARMACOL THER, V35, P382, DOI 10.1111/j.1365-2885.2011.01323.x; JAGLAN PS, 1990, J ASSOC OFF ANA CHEM, V73, P26; Kiem S, 2008, ANTIMICROB AGENTS CH, V52, P24, DOI 10.1128/AAC.00133-06; Liu P, 2002, INT J ANTIMICROB AG, V19, P285, DOI 10.1016/S0924-8579(02)00024-9; MARCY TW, 1987, AM REV RESPIR DIS, V135, P1276; McKellar Q, 1999, ANTIMICROB AGENTS CH, V43, P1988, DOI 10.1128/AAC.43.8.1988; Menge M, 2012, J VET PHARMACOL THER, V35, P550, DOI 10.1111/j.1365-2885.2011.01349.x; Messenger KM, 2012, J VET PHARMACOL THER, V35, P452, DOI 10.1111/j.1365-2885.2011.01338.x; Mouton JW, 2008, J ANTIMICROB CHEMOTH, V61, P235, DOI 10.1093/jac/dkm476; PERRIER D, 1982, J PHARM SCI, V71, P474, DOI 10.1002/jps.2600710432; TerHune TN, 2005, AM J VET RES, V66, P342, DOI 10.2460/ajvr.2005.66.342; Theuretzbacher U, 2007, CURR OPIN PHARMACOL, V7, P498, DOI 10.1016/j.coph.2007.05.003; Villarino N, 2014, J VET PHARMACOL THER, V37, P211, DOI 10.1111/jvp.12080; Villarino N, 2013, J VET PHARMACOL THER, V36, P340, DOI 10.1111/jvp.12015; Yamazaki K, 2003, AM J RESP CRIT CARE, V168, P1304, DOI 10.1164/rccm.200301-111OC	28	24	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149100	10.1371/journal.pone.0149100	http://dx.doi.org/10.1371/journal.pone.0149100			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872361	Green Published, gold			2022-12-27	WOS:000370054100103
J	Hsu, AL; Chou, KH; Chao, YP; Fan, HY; Wu, CWW; Chen, JH				Hsu, Ai-Ling; Chou, Kun-Hsien; Chao, Yi-Ping; Fan, Hsin-Ya; Wu, Changwei W.; Chen, Jyh-Horng			Physiological Contribution in Spontaneous Oscillations: An Approximate Quality-Assurance Index for Resting-State fMRI Signals	PLOS ONE			English	Article							TO-NOISE RATIO; FUNCTIONAL CONNECTIVITY; RESPONSE FUNCTION; MOTION; BRAIN; NETWORK; MRI; RECONSTRUCTION; FLUCTUATIONS; ACTIVATION	Resting-state fMRI (rs-fMRI) is receiving substantial attention for its sensitivity to functional abnormality in the brain networks of people with psychiatric and neurological disorders. However, because of the variety of rs-fMRI processing methods, the necessity of rs-fMRI quality assurance is increasing. Conventionally, the temporal signal-to-noise ratio (tSNR) is generally adopted for quality examination, but the tSNR does not guarantee reliable functional connectivity (FC) outcomes. Theoretically, intrinsic FC is supposed to reflect the spontaneous synchronization of neuronal basis, rather than that from thermal noise or non-neuronal physiological noise. Therefore, we proposed a new quality-assurance index for rs-fMRI to estimate the physiological contributions in spontaneous oscillations (PICSO). The PICSO index was designed as a voxel-wise measure for facilitating practical applications to all existing rs-fMRI data sets on the basis of two assumptions: Gaussian distributions in temporal fluctuations and ultra-slow changes of neural-based physiological fluctuations. To thoroughly validate the sensitivity of the proposed PICSO index to FC, we calibrated the preprocessing steps according to phantom data and verified the relationship between the PICSO and factors that are considered to affect FC in healthy participants (n = 12). Our results demonstrated that FC showed a significantly positive correlation with the PICSO. Moreover, for generating robust FC outcomes, directly acquiring data at a relatively large voxel size was more effective than performing smoothness on high-resolution data sets. In conclusion, compared with tSNR, the PICSO index is more sensitive to the resulting FC, providing a practical quality-assurance indicator for all existing rs-fMRI data sets.	[Hsu, Ai-Ling; Chen, Jyh-Horng] Natl Taiwan Univ, Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Chou, Kun-Hsien] Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan; [Chao, Yi-Ping] Chang Gung Univ, Grad Inst Med Mechatron, Taoyuan, Taiwan; [Fan, Hsin-Ya] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan; [Wu, Changwei W.] Natl Cent Univ, Dept Biomed Sci & Engn, Taoyuan, Taiwan; [Wu, Changwei W.] Taipei Med Univ, Shuang Ho Hosp, Brain & Consciousness Res Ctr, New Taipei, Taiwan	National Taiwan University; National Yang Ming Chiao Tung University; Chang Gung University; National Yang Ming Chiao Tung University; National Central University; Taipei Medical University; Shuang Ho Hospital	Chen, JH (corresponding author), Natl Taiwan Univ, Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan.; Wu, CWW (corresponding author), Natl Cent Univ, Dept Biomed Sci & Engn, Taoyuan, Taiwan.; Wu, CWW (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Brain & Consciousness Res Ctr, New Taipei, Taiwan.	restingfmri@gmail.com; jyhhchen2@gmail.com	Chao, Yi-Ping/GOP-0833-2022	Chao, Yi-Ping/0000-0002-1681-5410; Hsu, Ai-Ling/0000-0002-6801-4658; Wu, Changwei W./0000-0001-8968-9366	Ministry of Science and Technology [MOST 104-2321-B-002-040, MOST 103-2320-B-008-001, MOST 104-2221-E-008-123]; Veterans General Hospitals University System of Taiwan [VGHUST103-G1-4-3]; Chang Gung Memorial Hospital [BMRPC78]; Chang Gung University Research Project [UERPD2D0081]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Veterans General Hospitals University System of Taiwan; Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Chang Gung University Research Project	This study was supported in part by Ministry of Science and Technology (MOST 104-2321-B-002-040, MOST 103-2320-B-008-001, and MOST 104-2221-E-008-123), Veterans General Hospitals University System of Taiwan Joint Research Program (VGHUST103-G1-4-3), the Chang Gung Memorial Hospital (BMRPC78) and Chang Gung University Research Project (UERPD2D0081).	Bianciardi M, 2009, MAGN RESON IMAGING, V27, P1019, DOI 10.1016/j.mri.2009.02.004; Birn RM, 2008, NEUROIMAGE, V40, P644, DOI 10.1016/j.neuroimage.2007.11.059; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bodurka J, 2007, NEUROIMAGE, V34, P542, DOI 10.1016/j.neuroimage.2006.09.039; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Chang C, 2009, NEUROIMAGE, V44, P857, DOI 10.1016/j.neuroimage.2008.09.029; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dietrich O, 2007, J MAGN RESON IMAGING, V26, P375, DOI 10.1002/jmri.20969; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Gonzalez-Castillo J, 2011, NEUROIMAGE, V54, P2764, DOI 10.1016/j.neuroimage.2010.11.020; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Guldenmund P, 2013, BRAIN CONNECT, V3, P273, DOI 10.1089/brain.2012.0117; Horovitz SG, 2009, P NATL ACAD SCI USA, V106, P11376, DOI 10.1073/pnas.0901435106; Huettel SA, 2009, FUNCTIONAL MAGNETIC; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kellman P, 2005, MAGNET RESON MED, V54, P1439, DOI 10.1002/mrm.20713; Kruger G, 2001, MAGNET RESON MED, V45, P595, DOI 10.1002/mrm.1081; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; Logothetis NK, 2007, NAT NEUROSCI, V10, P1230, DOI 10.1038/nn1007-1230; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Molloy EK, 2014, NEUROIMAGE, V86, P221, DOI 10.1016/j.neuroimage.2013.09.001; Murphy K, 2007, NEUROIMAGE, V34, P565, DOI 10.1016/j.neuroimage.2006.09.032; Power JD, 2015, NEUROIMAGE, V105, P536, DOI 10.1016/j.neuroimage.2014.10.044; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Reeder SB, 2005, MAGNET RESON MED, V54, P748, DOI 10.1002/mrm.20636; Scheinost D, 2014, NEUROIMAGE, V95, P13, DOI 10.1016/j.neuroimage.2014.03.035; Smith SM, 2013, NEUROIMAGE, V80, P144, DOI 10.1016/j.neuroimage.2013.05.039; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Triantafyllou C, 2005, NEUROIMAGE, V26, P243, DOI 10.1016/j.neuroimage.2005.01.007; Triantafyllou C, 2006, NEUROIMAGE, V32, P551, DOI 10.1016/j.neuroimage.2006.04.182; Triantafyllou C, 2011, NEUROIMAGE, V55, P597, DOI 10.1016/j.neuroimage.2010.11.084; Weisskoff RM, 1996, MAGN RESON MED, V36, P643, DOI 10.1002/mrm.1910360422; Wink AM, 2006, INT J BIOMED IMAGING, V2006, DOI 10.1155/IJBI/2006/12014; Wu CWW, 2011, BRAIN CONNECT, V1, P401, DOI 10.1089/brain.2011.0018; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198	36	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148393	10.1371/journal.pone.0148393	http://dx.doi.org/10.1371/journal.pone.0148393			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871897	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100027
J	Hsu, WY; Lin, CL; Kao, CH				Hsu, Wen-Yu; Lin, Cheng-Li; Kao, Chia-Hung			A Population-Based Cohort Study on Peripheral Arterial Disease in Patients with Schizophrenia	PLOS ONE			English	Article							ENDOTHELIAL FUNCTION; METABOLIC SYNDROME; DIABETES-MELLITUS; OCCLUSIVE DISEASE; RISK-FACTORS; PREVALENCE; MORTALITY; PEOPLE; ANTIPSYCHOTICS; HYPERLIPIDEMIA	Purpose Peripheral arterial disease (PAD) is considered the leading cause of atherosclerotic cardiovascular morbidity. Several risk factors of PAD have been observed in patients with schizophrenia. Therefore, we hypothesize that the incidence of PAD is higher in the schizophrenia population than in the general population. Methods The patients in this population-based cohort study were selected from the Taiwanese National Health Insurance Research Database on the basis of the claims data from 2000 to 2011. We compared the incidence of PAD between schizophrenia and nonschizophrenia cohorts. Cox proportional hazard regression models were employed for analyzing the risk of PAD after adjustment for sex, age, and comorbidities. Results The adjusted hazard ratio (HR) for PAD in the schizophrenia cohort was 1.26-fold higher than that in the nonschizophrenia cohort. Furthermore, patients with schizophrenia using atypical antipsychotics exhibited a high adjusted HR for PAD. Conclusion Compared with the general population, the risk of PAD is higher among patients with schizophrenia. Early diagnosis and intervention can mitigate complications resulting from cardiovascular diseases and lower mortality.	[Hsu, Wen-Yu] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Hsu, Wen-Yu] Lutung Christian Hosp, Dept Psychiat, Lukang, Taiwan; [Hsu, Wen-Yu] Chung Shan Med Univ, Sch Med, Dept Psychiat, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ, Coll Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan	China Medical University Taiwan; Chung Shan Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Kao, CH (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ, Coll Med, Sch Med, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, PET Ctr, Taichung, Taiwan.	d10040@mail.cmuh.org.tw			Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW104-TDU-B-212-113002]; China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project [BM104010092]; NRPB Stroke Clinical Trial Consortium [MOST 103-2325-B-039 -006]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW104-TDU-B-212-113002); China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project (BM104010092); NRPB Stroke Clinical Trial Consortium (MOST 103-2325-B-039 -006); Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Allison MA, 2007, AM J PREV MED, V32, P328, DOI 10.1016/j.amepre.2006.12.010; Bai YM, 2013, J AFFECT DISORDERS, V150, P57, DOI 10.1016/j.jad.2013.02.019; Barrett E, 2004, OBES RES, V12, P362; Beratis S, 2001, COMPR PSYCHIAT, V42, P393, DOI 10.1053/comp.2001.26273; Burghardt KJ, 2014, J PSYCHOPHARMACOL, V28, P349, DOI 10.1177/0269881113516200; Cacoub Patrice P, 2009, Atherosclerosis, V204, pe86, DOI 10.1016/j.atherosclerosis.2008.10.023; Carman TL, 2000, AM FAM PHYSICIAN, V61, P1027; Ciccone MM, 2014, J DIABETES METAB, V5, DOI 10.4172/2155-6156.1000364; de Leon J, 2005, SCHIZOPHR RES, V76, P135, DOI 10.1016/j.schres.2005.02.010; Ellingrod VL, 2011, SCHIZOPHR RES, V130, P20, DOI 10.1016/j.schres.2011.03.031; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Hooi JD, 2004, J CLIN EPIDEMIOL, V57, P294, DOI 10.1016/j.jclinepi.2003.09.003; Hooi JD, 2001, AM J EPIDEMIOL, V153, P666, DOI 10.1093/aje/153.7.666; Hsieh PH, 2013, J CLIN PSYCHOPHARM, V33, P299, DOI 10.1097/JCP.0b013e3182900dfe; Hsu JH, 2012, GEN HOSP PSYCHIAT, V34, P360, DOI 10.1016/j.genhosppsych.2012.02.004; Israel AK, 2011, SCHIZOPHR RES, V128, P44, DOI 10.1016/j.schres.2011.02.007; Leucht S, 2007, ACTA PSYCHIAT SCAND, V116, P317, DOI 10.1111/j.1600-0447.2007.01095.x; McCreadie RG, 2002, BRIT J PSYCHIAT, V181, P321, DOI 10.1192/bjp.181.4.321; McEvoy JP, 2005, SCHIZOPHR RES, V80, P19, DOI 10.1016/j.schres.2005.07.014; Mitchell AJ, 2013, SCHIZOPHRENIA BULL, V39, P306, DOI 10.1093/schbul/sbr148; Osborn DPJ, 2007, ARCH GEN PSYCHIAT, V64, P242, DOI 10.1001/archpsyc.64.2.242; Pande RL, 2011, CIRCULATION, V124, P17, DOI 10.1161/CIRCULATIONAHA.110.003954; Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123; Shammas NW, 2007, VASC HEALTH RISK MAN, V3, P229, DOI 10.2147/vhrm.2007.3.2.229; Sigvant B, 2007, J VASC SURG, V45, P1185, DOI 10.1016/j.jvs.2007.02.004; Stubbs B, 2015, ACTA PSYCHIAT SCAND, V132, P144, DOI 10.1111/acps.12439; Vancampfort D, 2012, ACTA PSYCHIAT SCAND, V125, P352, DOI 10.1111/j.1600-0447.2011.01814.x	29	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148759	10.1371/journal.pone.0148759	http://dx.doi.org/10.1371/journal.pone.0148759			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6SI	26871697	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100053
J	Lin, DS; Luo, XH; Meng, LY; Zhang, GH; Chen, WQ; Chen, HY				Lin, Dusheng; Luo, Xiaohong; Meng, Lingying; Zhang, Guihua; Chen, Weiqi; Chen, Haoyu			Optical Intensities of Different Compartments of Subretinal Fluid in Acute Vogt-Koyanagi-Harada Disease	PLOS ONE			English	Article							SEROUS RETINAL-DETACHMENT; COHERENCE TOMOGRAPHY; CYSTOID SPACES; FEATURES; DENSITY	Purpose To investigate the optical intensity in different compartments of subretinal fluid in acute Vogt-Koyanagi-Harada (VKH) disease by using spectral domain optical coherence tomography (SD-OCT). Methods Fifty acute VKH eyes and 25 cases with acute central serous chorioretinopathy (CSCR) were included in this retrospective comparative study. The optical intensities of subretinal fluid, vitreous humour and the entire scanned region displayed by SD-OCT were measured with Image J by three independent readers. In the VKH eyes with subretinal septa, the subretinal fluid was segmented into two types of compartments, supra-septa space and sub-septa space. Optical intensity ratios of different compartments of subretinal fluids divided by vitreous humour or the entire scanned region were compared. Results The measurement of optical intensity was highly reproducible (intraclass correlation coefficient >0.9). The optical intensity of the supra-septa space divided by the vitreous humour was significantly higher compared to that of sub-septa space in VKH (mean difference = 4.27 +/- 5.15, p <0.001). The optical intensity ratio of the supra-septa space (1.14 +/- 0.12), but not subsepta space (1.05 +/- 0.05) in VKH, was significantly higher compared to that of the subretinal space in VKH without the subretinal septa (1.07 +/- 0.08), and the subretinal fluid in CSCR (1.08 +/- 0.09). Similar results were found for the optical intensity ratios divided by the entire scan region. Conclusion The optical intensity in the supra-septa space of VKH is higher compared to the sub-septa space in VKH, subretinal space in VKH and CSCR, suggesting that the components in these spaces are different.	[Lin, Dusheng; Luo, Xiaohong; Zhang, Guihua; Chen, Weiqi; Chen, Haoyu] Shantou Univ, Joint Shantou Int Eye Ctr, Shantou, Guangdong, Peoples R China; [Lin, Dusheng; Luo, Xiaohong; Zhang, Guihua; Chen, Weiqi; Chen, Haoyu] Chinese Univ Hong Kong, Shantou, Guangdong, Peoples R China; [Meng, Lingying] Shantou Ctr Hosp, Shantou, Guangdong, Peoples R China	Shantou University	Chen, HY (corresponding author), Shantou Univ, Joint Shantou Int Eye Ctr, Shantou, Guangdong, Peoples R China.; Chen, HY (corresponding author), Chinese Univ Hong Kong, Shantou, Guangdong, Peoples R China.	drchenhaoyu@gmail.com	Chen, Haoyu/A-7432-2013; zhang, guihua/GVU-4494-2022	Chen, Haoyu/0000-0003-0676-4610; 	National Nature Science Foundation of China [81170853]; Medical Scientific Research Foundation of Guangdong Province [B2013288, B2013290]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Scientific Research Foundation of Guangdong Province	This study was supported by the National Nature Science Foundation of China (www.nsfc.gov.cn/ #81170853) and Medical Scientific Research Foundation of Guangdong Province (B2013288). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported in part by the National Nature Science Foundation of China (81170853) and Medical Scientific Research Foundation of Guangdong Province (B2013290). We would like to thank Dr. Chien-Fu Lin for copy-editing.	Ahlers C, 2009, INVEST OPHTH VIS SCI, V50, P3417, DOI 10.1167/iovs.08-2759; Alasil T, 2010, OPHTHALMOLOGY, V117, P2379, DOI 10.1016/j.ophtha.2010.03.051; Barthelmes D, 2008, INVEST OPHTH VIS SCI, V49, P3529, DOI 10.1167/iovs.07-1320; Chen XJ, 2013, INVEST OPHTH VIS SCI, V54, P6846, DOI 10.1167/iovs.13-12062; De Smet MD, 2005, AM J OPHTHALMOL, V140, P962, DOI 10.1016/j.ajo.2005.06.051; Gupta V, 2009, AM J OPHTHALMOL, V147, P148, DOI 10.1016/j.ajo.2008.07.028; Horu T, 2012, OPHTHALMOLOGY, V119, P1047, DOI 10.1016/j.ophtha.2011.10.030; Ikewaki Junko, 2011, International Ophthalmology, V31, P9, DOI 10.1007/s10792-010-9412-x; Ishihara K, 2009, OPHTHALMOLOGY, V116, P1799, DOI 10.1016/j.ophtha.2009.04.002; Kato Y, 2013, JPN J OPHTHALMOL, V57, P90, DOI 10.1007/s10384-012-0212-x; Keane PA, 2010, OPHTHALMOLOGY, V117, P642, DOI 10.1016/j.ophtha.2009.09.051; Lee Ji Eun, 2009, Korean J Ophthalmol, V23, P74, DOI 10.3341/kjo.2009.23.2.74; Lin DS, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-87; Maruyama Y, 2004, OPHTHAL SURG LAS IM, V35, P239, DOI 10.3928/1542-8877-20040501-12; MUTLAK JA, 1989, ACTA OPHTHALMOL, V67, P467; Nakayama M, 2012, RETINA-J RET VIT DIS, V32, P2061, DOI 10.1097/IAE.0b013e318256205a; Neudorfer M, 2012, INVEST OPHTH VIS SCI, V53, P3104, DOI 10.1167/iovs.11-8700; Parc C, 2005, OCUL IMMUNOL INFLAMM, V13, P225, DOI 10.1080/09273940490912416; Read RW, 2001, AM J OPHTHALMOL, V131, P647, DOI 10.1016/S0002-9394(01)00925-4; RUBSAMEN PE, 1991, ARCH OPHTHALMOL-CHIC, V109, P682, DOI 10.1001/archopht.1991.01080050096037; Sonoda S, 2013, INVEST OPHTH VIS SCI, V54, P5367, DOI 10.1167/iovs.13-12382; Tsujikawa A, 2005, AM J OPHTHALMOL, V139, P670, DOI 10.1016/j.ajo.2004.11.053; Yamaguchi Y, 2007, AM J OPHTHALMOL, V144, P260, DOI 10.1016/j.ajo.2007.04.007; Yamamoto M, 2011, JPN J OPHTHALMOL, V55, P1, DOI 10.1007/s10384-010-0900-3	24	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149376	10.1371/journal.pone.0149376	http://dx.doi.org/10.1371/journal.pone.0149376			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871896	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100153
J	Mdaki, KS; Larsen, TD; Weaver, LJ; Baack, ML				Mdaki, Kennedy S.; Larsen, Tricia D.; Weaver, Lucinda J.; Baack, Michelle L.			Age Related Bioenergetics Profiles in Isolated Rat Cardiomyocytes Using Extracellular Flux Analyses	PLOS ONE			English	Article							FATTY-ACID; MITOCHONDRIA; FETAL; RESPIRATION; GLYCOLYSIS; METABOLISM; HEALTH	Mitochondrial dysfunction is increasingly recognized and studied as a mediator of heart disease. Extracellular flux analysis (XF) has emerged as a powerful tool to investigate cellular bioenergetics in the context of cardiac health and disease, however its use and interpretation requires improved understanding of the normal metabolic differences in cardiomyocytes (CM) at various stages of maturation. This study standardized XF analyses methods (mitochondrial stress test, glycolytic stress test and palmitate oxidation test) and established age related differences in bioenergetics profiles of healthy CMs at newborn (NB1), weaning (3WK), adult (10WK) and aged (12-18MO) time points. Findings show that immature CMs demonstrate a more robust and sustained glycolytic capacity and a relative inability to oxidize fatty acids when compared to older CMs. The study also highlights the need to recognize the contribution of CO2 from the Krebs cycle as well as lactate from anaerobic glycolysis to the proton production rate before interpreting glycolytic capacity in CMs. Overall, this study demonstrates that caution should be taken to assure that translatable developmental time points are used to investigate mitochondrial dysfunction as a cause of cardiac disease. Specifically, XF analysis of newborn CMs should be reserved to study fetal/neonatal disease and older CMs (>= 10 weeks) should be used to investigate adult disease pathogenesis. Knowledge gained will aid in improved investigation of developmentally programmed heart disease and stress the importance of discerning maturational differences in bioenergetics when developing mitochondrial targeted preventative and therapeutic strategies for cardiac disease.	[Mdaki, Kennedy S.; Larsen, Tricia D.; Baack, Michelle L.] Sanford Res, Childrens Hlth Res Ctr, Sioux Falls, SD USA; [Weaver, Lucinda J.; Baack, Michelle L.] Univ S Dakota, Sanford Sch Med, Sioux Falls, SD USA; [Baack, Michelle L.] Sanford Childrens Hosp, Childrens Hlth Specialty Clin, Sioux Falls, SD USA	Sanford Health; University of South Dakota; Sanford Health	Baack, ML (corresponding author), Sanford Res, Childrens Hlth Res Ctr, Sioux Falls, SD USA.; Baack, ML (corresponding author), Univ S Dakota, Sanford Sch Med, Sioux Falls, SD USA.; Baack, ML (corresponding author), Sanford Childrens Hosp, Childrens Hlth Specialty Clin, Sioux Falls, SD USA.	michelle.baack@sanfordhealth.org	Baack, Michelle/T-4645-2019; Mdaki, Kennedy/A-7676-2018	Baack, Michelle/0000-0001-5966-669X; Mdaki, Kennedy/0000-0003-4642-2471	start up funds for The Baack Lab from Sanford Research; National Institutes of Health (NIH) The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [K08HD078504]; University of South Dakota-Sanford School of Medicine Faculty Grant; Sanford Health - South Dakota State University; NIH National Institute of General Medical Sciences (NIGMS) [P20GM103548]	start up funds for The Baack Lab from Sanford Research; National Institutes of Health (NIH) The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); University of South Dakota-Sanford School of Medicine Faculty Grant; Sanford Health - South Dakota State University; NIH National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was financially supported by start up funds for The Baack Lab from Sanford Research and grants obatined by MLB from the following: National Institutes of Health (NIH-http://www.nih.gov/) The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) K08HD078504, a University of South Dakota-Sanford School of Medicine Faculty Grant (http://www.usd.edu/medicine) and a Sanford Health - South Dakota State University (https://www.sdstate.edu/) Collaborative Research Grant. Additionally, Seahorse plates, stains and assistance were provided by the Sanford Research Cancer COBRE via support from the NIH National Institute of General Medical Sciences (NIGMS http://www.nigms.nih.gov/Research/Mechanisms/Pages/ProgramProjectGrants.aspx) P20GM103548.	Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Chacko BK, 2014, CLIN SCI, V127, P367, DOI 10.1042/CS20140101; Costantino S, 2016, J PHYSIOL-LONDON, V594, P2061, DOI 10.1113/JP270538; Divakaruni AS, 2013, P NATL ACAD SCI USA, V110, P5422, DOI 10.1073/pnas.1303360110; DOW JW, 1981, CARDIOVASC RES, V15, P483, DOI 10.1093/cvr/15.9.483; FISHER DJ, 1980, AM J PHYSIOL, V238, pH399, DOI 10.1152/ajpheart.1980.238.3.H399; Go AS, 2014, CIRCULATION, V129, P399, DOI 10.1161/01.cir.0000442015.53336.12; Green K, 2004, DIABETES, V53, pS110, DOI 10.2337/diabetes.53.2007.S110; Hill BG, 2009, BIOCHEM J, V424, P99, DOI 10.1042/BJ20090934; Inc. SB, SEAH BIOSC XF CELL M; Kenwood BM, 2014, MOL METAB, V3, P114, DOI 10.1016/j.molmet.2013.11.005; Kodde IF, 2007, COMP BIOCHEM PHYS A, V146, P26, DOI 10.1016/j.cbpa.2006.09.014; Liao XD, 2004, CELL RES, V14, P16, DOI 10.1038/sj.cr.7290198; Lopaschuk GD, 2010, J CARDIOVASC PHARM, V56, P130, DOI 10.1097/FJC.0b013e3181e74a14; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; LOPASCHUK GD, 1991, AM J PHYSIOL, V261, pH1698, DOI 10.1152/ajpheart.1991.261.6.H1698; Marin-Garcia J, 2008, HEART FAIL REV, V13, P137, DOI 10.1007/s10741-007-9079-1; Martin DS, 2010, CRIT CARE, V14, DOI 10.1186/cc9078; McQuaker SJ, 2013, CHEMBIOCHEM, V14, P993, DOI 10.1002/cbic.201300115; Mookerjee SA, 2015, BBA-BIOENERGETICS, V1847, P171, DOI 10.1016/j.bbabio.2014.10.005; Murphy MP, 2000, ADV DRUG DELIVER REV, V41, P235, DOI 10.1016/S0169-409X(99)00069-1; Nisr RB, 2014, BBA-BIOENERGETICS, V1837, P270, DOI 10.1016/j.bbabio.2013.10.012; OHTSUKA T, 1995, J APPL PHYSIOL, V79, P1286, DOI 10.1152/jappl.1995.79.4.1286; Orr DL, 2015, NAT CHEM BIOL, V11, P834, DOI [10.1038/nchembio.1910, 10.1038/NCHEMBIO.1910]; Readnower RD, 2012, PHYSIOL GENOMICS, V44, P1208, DOI 10.1152/physiolgenomics.00129.2012; Sansbury BE, 2011, CHEM-BIOL INTERACT, V191, P288, DOI 10.1016/j.cbi.2010.12.002; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Tigchelaar W, 2015, AM J PHYSIOL-CELL PH, V308, pC155, DOI 10.1152/ajpcell.00227.2014; Vega RB, 2015, CIRC RES, V116, P1820, DOI 10.1161/CIRCRESAHA.116.305420; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005; WERNER JC, 1983, AM J PHYSIOL, V245, pE19, DOI 10.1152/ajpendo.1983.245.1.E19; Yu H, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056514, 10.1371/journal.pone.0080815]	32	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149002	10.1371/journal.pone.0149002	http://dx.doi.org/10.1371/journal.pone.0149002			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872351	Green Submitted, Green Published, gold			2022-12-27	WOS:000370054100085
J	Shulgin, B; Helmlinger, G; Kosinsky, Y				Shulgin, Boris; Helmlinger, Gabriel; Kosinsky, Yuri			A Generic Mechanism for Enhanced Cytokine Signaling via Cytokine-Neutralizing Antibodies	PLOS ONE			English	Article							T-CELLS; IN-VIVO; BIOLOGICAL-ACTIVITY; ANTI-IL-2 MABS; CUTTING EDGE; RECEPTOR; COMPLEXES; IL-2; INTERNALIZATION; BINDING	Enhancement or inhibition of cytokine signaling and corresponding immune cells responses are critical factors in various disease treatments. Cytokine signaling may be inhibited by cytokine-neutralizing antibodies (CNAs), which prevents further activation of cytokine receptors. However, CNAs may result in enhanced-instead of inhibitory-cytokine signaling (an "agonistic effect") in various in vitro and in vivo experiments. This may lead to lack of efficacy or adverse events for cytokine-inhibiting based medicines. Alternatively, cytokine-antibody complexes may produce stronger signaling vs. cytokine alone, thereby increasing the efficacy of stimulating cytokine-based drugs, at equal or lower cytokine doses. In this paper, the effect of cytokine signaling enhancement by a CNA was studied in a generic mathematical model of interleukin-4 (IL-4) driven T-cell proliferation. The occurrence of the agonistic effect depends upon the antibody-to-cytokine binding affinity and initial concentrations of antibody and cytokine. Model predictions were in agreement with experimental studies. When the cytokine receptor consists of multiple subunits with substantially differing affinities (e.g., IL-4 case), the choice of the receptor chain to be blocked by the antibody is critical, for the agonistic effect to appear. We propose a generic mechanism for the effect: initially, binding of the CNA to the cytokine reduces free cytokine concentration; yet, cytokine molecules bound within the cytokine-CNA complex-and released later and over time-are "rescued" from earlier clearance via cellular internalization. Hence, although free cytokine-dependent signalling may be less potent initially, it will also be more sustained over time; and given non-linear dynamics, it will lead ultimately to larger cellular effector responses, vs. the same amount of free cytokine in the absence of CNA. We suggest that the proposed mechanism is a generic property of {cytokine, CNA, receptor} triads, both in vitro and in vivo, and can occur in a predictable fashion for a variety of cytokines of the immune system.	[Shulgin, Boris; Kosinsky, Yuri] M&S Decis LLC, Moscow, Russia; [Helmlinger, Gabriel] AstraZeneca Pharmaceut LP, Innovat Med, Early Clin Dev, Quantitat Clin Pharmacol, Waltham, MA USA	AstraZeneca	Helmlinger, G (corresponding author), AstraZeneca Pharmaceut LP, Innovat Med, Early Clin Dev, Quantitat Clin Pharmacol, Waltham, MA USA.	gabriel.helmlinger@astrazeneca.com	Shulgin, Boris V/ABI-7645-2020	Shulgin, Boris/0000-0003-2117-3499				BENDTZEN K, 1990, IMMUNOL TODAY, V11, P167, DOI 10.1016/0167-5699(90)90068-K; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Boyman O, 2012, TRANSPL P, V44, P1032, DOI 10.1016/j.transproceed.2012.01.093; Boyman O, 2008, J IMMUNOL, V180, P7265, DOI 10.4049/jimmunol.180.11.7265; Boyman Surh C, 2006, VACCINES ANTIBODIES, V6, P1323; CIECHANOVER A, 1983, J BIOL CHEM, V258, P9681; Dubois S, 2008, J IMMUNOL, V180, P2099, DOI 10.4049/jimmunol.180.4.2099; Fallon EM, 2000, BIOTECHNOL PROGR, V16, P905, DOI 10.1021/bp000097t; FINKELMAN FD, 1993, J IMMUNOL, V151, P1235; Friedrich K, 1999, EUR J BIOCHEM, V265, P457, DOI 10.1046/j.1432-1327.1999.00773.x; GALIZZI JP, 1989, J BIOL CHEM, V264, P6984; Garcia-Martinez K, 2012, INT IMMUNOL, V24, P427, DOI 10.1093/intimm/dxr120; Hamilton SE, 2010, J IMMUNOL, V185, P6584, DOI 10.4049/jimmunol.1001215; Hao JW, 2011, ANN NEUROL, V69, P721, DOI 10.1002/ana.22339; Jin GH, 2008, INT IMMUNOL, V20, P783, DOI 10.1093/intimm/dxn036; JONES AT, 1993, BLOOD, V82, P1133; Jung T, 1999, EUR J IMMUNOL, V29, P864, DOI 10.1002/(SICI)1521-4141(199903)29:03<864::AID-IMMU864>3.0.CO;2-T; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Leon K, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00439; Letourneau S, 2010, P NATL ACAD SCI USA, V107, P2171, DOI 10.1073/pnas.0909384107; Martin CE, 2013, BLOOD, V121, P4484, DOI 10.1182/blood-2012-08-449215; MAY LT, 1993, J IMMUNOL, V151, P3225; Molloy MJ, 2009, J IMMUNOL, V182, P4512, DOI 10.4049/jimmunol.0804175; Morelon E, 1998, J BIOL CHEM, V273, P22044, DOI 10.1074/jbc.273.34.22044; Mostbock S, 2009, CURR PHARM DESIGN, V15, P809, DOI 10.2174/138161209787582174; Phelan JD, 2008, J IMMUNOL, V180, P44, DOI 10.4049/jimmunol.180.1.44; Ramanathan M, 1996, PHARMACEUT RES, V13, P84, DOI 10.1023/A:1016033418207; RATHJEN DA, 1992, BRIT J CANCER, V65, P852, DOI 10.1038/bjc.1992.180; Reynolds J, 2013, FRONTIERS IMMUNOLOGY, V4, P1; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; Rubinstein MP, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-75; SATO TA, 1993, J IMMUNOL, V150, P2717; Votavova P, 2014, IMMUNOL LETT, V159, P1, DOI 10.1016/j.imlet.2014.01.017; Whitty A, 1998, P NATL ACAD SCI USA, V95, P13165, DOI 10.1073/pnas.95.22.13165; Zabeau L, 2001, EUR J IMMUNOL, V31, P1087, DOI 10.1002/1521-4141(200104)31:4<1087::AID-IMMU1087>3.0.CO;2-Q; Zhao Y, 2013, OXID STRESS CELL LON, V2013, P1, DOI DOI 10.1155/2013/316523	37	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149154	10.1371/journal.pone.0149154	http://dx.doi.org/10.1371/journal.pone.0149154			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26870966	Green Submitted, Green Published, gold			2022-12-27	WOS:000370054100113
J	Cullen, JK; Murad, NA; Yeo, A; McKenzie, M; Ward, M; Chong, KL; Schieber, NL; Parton, RG; Lim, YC; Wolvetang, E; Maghzal, GJ; Stocker, R; Lavin, MF				Cullen, Jason K.; Murad, Norazian Abdul; Yeo, Abrey; McKenzie, Matthew; Ward, Micheal; Chong, Kok Leong; Schieber, Nicole L.; Parton, Robert G.; Lim, Yi Chieh; Wolvetang, Ernst; Maghzal, Ghassan J.; Stocker, Roland; Lavin, Martin F.			AarF Domain Containing Kinase 3 (ADCK3) Mutant Cells Display Signs of Oxidative Stress, Defects in Mitochondrial Homeostasis and Lysosomal Accumulation	PLOS ONE			English	Article							COENZYME Q(10) DEFICIENCY; SACCHAROMYCES-CEREVISIAE; UBIQUINONE BIOSYNTHESIS; CAENORHABDITIS-ELEGANS; COQ(10) DEFICIENCY; CEREBELLAR-ATAXIA; RAT-LIVER; LIFE-SPAN; COMPLEX; MUTATIONS	Autosomal recessive ataxias are a clinically diverse group of syndromes that in some cases are caused by mutations in genes with roles in the DNA damage response, transcriptional regulation or mitochondrial function. One of these ataxias, known as Autosomal Recessive Cerebellar Ataxia Type-2 (ARCA-2, also known as SCAR9/COQ10D4; OMIM: #612016), arises due to mutations in the ADCK3 gene. The product of this gene (ADCK3) is an atypical kinase that is thought to play a regulatory role in coenzyme Q(10) (CoQ(10)) biosynthesis. Although much work has been performed on the S. cerevisiae orthologue of ADCK3, the cellular and biochemical role of its mammalian counterpart, and why mutations in this gene lead to human disease is poorly understood. Here, we demonstrate that ADCK3 localises to mitochondrial cristae and is targeted to this organelle via the presence of an N-terminal localisation signal. Consistent with a role in CoQ(10) biosynthesis, ADCK3 deficiency decreased cellular CoQ(10) content. In addition, endogenous ADCK3 was found to associate in vitro with recombinant Coq3, Coq5, Coq7 and Coq9, components of the CoQ(10) biosynthetic machinery. Furthermore, cell lines derived from ARCA-2 patients display signs of oxidative stress, defects in mitochondrial homeostasis and increases in lysosomal content. Together, these data shed light on the possible molecular role of ADCK3 and provide insight into the cellular pathways affected in ARCA-2 patients.	[Cullen, Jason K.; Murad, Norazian Abdul; Yeo, Abrey; Lim, Yi Chieh] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [McKenzie, Matthew] Ctr Genet Dis, Hudson Inst Med Res, Melbourne, Vic, Australia; [Ward, Micheal] Translat Res Inst, Glycat & Diabet Complicat Grp, Mater Med Res Inst, Brisbane, Qld, Australia; [Chong, Kok Leong] Queensland Univ Technol, ARC Ctr Excellence Free Radical Chem & Biotechnol, Brisbane, Qld 4001, Australia; [Schieber, Nicole L.; Parton, Robert G.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Schieber, Nicole L.; Parton, Robert G.] Ctr Microscopy & Microanal, St Lucia, Qld, Australia; [Wolvetang, Ernst] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia; [Maghzal, Ghassan J.; Stocker, Roland] Victor Chang Cardiac Res Inst, Vasc Biol Div, Darlinghurst, NSW, Australia; [Murad, Norazian Abdul] UKM Med Mol Biol Inst, Kuala Lumpur, Malaysia; [Lavin, Martin F.] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute; Hudson Institute of Medical Research; Mater Research; Queensland University of Technology (QUT); University of Queensland; University of Queensland; University of Queensland; Victor Chang Cardiac Research Institute; Universiti Kebangsaan Malaysia; University of Queensland	Cullen, JK (corresponding author), QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia.; Lavin, MF (corresponding author), Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia.	jason.cullen@qimrberghofer.edu.au; m.lavin@uq.edu.au	McKenzie, Matthew/H-4926-2019; Yeo, Abrey J/D-9695-2015; Wolvetang, Ernst jurgen/D-6644-2017; Stocker, Roland/AAV-4489-2021; Stocker, Roland/L-9157-2019; Parton, Robert/C-5673-2009; Lavin, Martin/F-5961-2014	McKenzie, Matthew/0000-0001-7508-1800; Yeo, Abrey J/0000-0003-4470-4854; Wolvetang, Ernst jurgen/0000-0002-2146-6614; Schieber, Nicole L./0000-0002-3212-5057; Lim, Yi Chieh/0000-0003-1261-5419; Parton, Robert/0000-0002-7494-5248; Lavin, Martin/0000-0002-5940-4769; Cullen, Jason/0000-0003-4961-1673	Australian Research Council (ARC) [DP1092466]	Australian Research Council (ARC)(Australian Research Council)	This work was supported by the Australian Research Council (ARC Discovery Project Grant DP1092466). See www.arc.gov.au.; We would like to thank Prof. Michel Koenig for supplying the adck3 mutant cell lines described in this work and Jason Liminos for generating lentiviral LC3-GFP particles. Many thanks also go to Dr. Sergei Kozlov and Dr. Olivier Becherel for advice related to experimentation and critical reading of the manuscript, and Dr. Kerenaftali Klein for statistical help. The authors also acknowledge the facilities and the scientific and technical assistance of 1) The Flow Cytometry and Imaging Facility, QIMR Berghofer Medical Research Institute and 2) The Australian Microscopy & Microanalysis Research Facility at the Centre for Microscopy and Microanalysis, The University of Queensland. This work was supported by the Australian Research Council (ARC Discovery Project Grant DP1092466).	Barlow C, 2000, P NATL ACAD SCI USA, V97, P871, DOI 10.1073/pnas.97.2.871; Bentinger M, 2007, MITOCHONDRION, V7, pS41, DOI 10.1016/j.mito.2007.02.006; Bentinger M, 2010, BIOCHEM BIOPH RES CO, V396, P74, DOI 10.1016/j.bbrc.2010.02.147; CHEN PC, 1978, NATURE, V274, P484, DOI 10.1038/274484a0; De Rasmo D, 2008, CELL SIGNAL, V20, P989, DOI 10.1016/j.cellsig.2008.01.017; Desagher S, 2001, MOL CELL, V8, P601, DOI 10.1016/S1097-2765(01)00335-5; Devun F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011792; Diomedi-Camassei F, 2007, J AM SOC NEPHROL, V18, P2773, DOI 10.1681/ASN.2006080833; Do TQ, 2001, J BIOL CHEM, V276, P18161, DOI 10.1074/jbc.M100952200; Duncan AJ, 2009, AM J HUM GENET, V84, P558, DOI 10.1016/j.ajhg.2009.03.018; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; Gazdag Z, 2011, FOLIA MICROBIOL, V56, P353, DOI 10.1007/s12223-011-0058-5; Gerards M, 2010, MITOCHONDRION, V10, P510, DOI 10.1016/j.mito.2010.05.008; Heeringa SF, 2011, J CLIN INVEST, V121, P2013, DOI 10.1172/JCI45693; Hsieh EJ, 2007, ARCH BIOCHEM BIOPHYS, V463, P19, DOI 10.1016/j.abb.2007.02.016; Iiizumi M, 2002, CANCER RES, V62, P1246; Ishii N, 2004, MECH AGEING DEV, V125, P41, DOI 10.1016/j.mad.2003.10.002; Johnston AJ, 2002, J BIOL CHEM, V277, P42197, DOI 10.1074/jbc.M205613200; Jonassen T, 2002, J BIOL CHEM, V277, P45020, DOI 10.1074/jbc.M204758200; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; KALEN A, 1990, J BIOL CHEM, V265, P1158; Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Larsen PL, 2002, SCIENCE, V295, P120, DOI 10.1126/science.1064653; Levavasseur F, 2001, J BIOL CHEM, V276, P46160, DOI 10.1074/jbc.M108980200; Lopez LC, 2006, AM J HUM GENET, V79, P1125, DOI 10.1086/510023; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marbois B, 2005, J BIOL CHEM, V280, P20231, DOI 10.1074/jbc.M501315200; Martin S, 2008, METHOD ENZYMOL, V438, P109, DOI 10.1016/S0076-6879(07)38008-7; McKenzie M, 2009, METHOD ENZYMOL, V456, P321, DOI 10.1016/S0076-6879(08)04418-2; Miyamoto Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016054; Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022; Mollet J, 2007, J CLIN INVEST, V117, P765, DOI 10.1172/JCI29089; Mossmann D, 2012, BBA-GENE REGUL MECH, V1819, P1098, DOI 10.1016/j.bbagrm.2011.11.007; Mugoni V, 2013, CELL, V152, P504, DOI 10.1016/j.cell.2013.01.013; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Nohl H, 2005, REDOX REP, V10, P199, DOI 10.1179/135100005X70170; Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092; Quinzii CM, 2008, FASEB J, V22, P1874, DOI 10.1096/fj.07-100149; Robin MA, 2003, J BIOL CHEM, V278, P18960, DOI 10.1074/jbc.M301807200; Rodriguez-Hernandez A, 2009, AUTOPHAGY, V5, P19, DOI 10.4161/auto.5.1.7174; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; SATTLER W, 1994, METHOD ENZYMOL, V233, P469; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schmidt O, 2011, CELL, V144, P227, DOI 10.1016/j.cell.2010.12.015; Smith Bryan John, 2003, Methods Mol Biol, V211, P19; Soubannier V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052830; Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057; Tang TD, 2009, J BIOL CHEM, V284, P5414, DOI 10.1074/jbc.M807797200; Tauche A, 2008, FEMS YEAST RES, V8, P1263, DOI 10.1111/j.1567-1364.2008.00436.x; TECLEBRHAN H, 1993, J BIOL CHEM, V268, P23081; Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007; Tran UC, 2006, J BIOL CHEM, V281, P16401, DOI 10.1074/jbc.M513267200; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; Walter L, 2002, FREE RADICAL RES, V36, P405, DOI 10.1080/10715760290021252; Wang YQ, 2012, AUTOPHAGY, V8, P1462, DOI 10.4161/auto.21211; Xie LTX, 2011, BBA-MOL CELL BIOL L, V1811, P348, DOI 10.1016/j.bbalip.2011.01.009; Zhao J, 2011, EMBO J, V30, P2762, DOI 10.1038/emboj.2011.198	60	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148213	10.1371/journal.pone.0148213	http://dx.doi.org/10.1371/journal.pone.0148213			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866375	Green Published, gold, Green Submitted			2022-12-27	WOS:000370050700011
J	de Greef, BTA; Hoeijmakers, JGJ; Wolters, EE; Smeets, HJM; van den Wijngaard, A; Merkies, ISJ; Faber, CG; Gerrits, MM				de Greef, Bianca T. A.; Hoeijmakers, Janneke G. J.; Wolters, Emma E.; Smeets, Hubertus J. M.; van den Wijngaard, Arthur; Merkies, Ingemar S. J.; Faber, Catharina G.; Gerrits, Monique M.			No Fabry Disease in Patients Presenting with Isolated Small Fiber Neuropathy	PLOS ONE			English	Article							ENZYME REPLACEMENT THERAPY; AGALSIDASE-BETA THERAPY; PAINFUL NEUROPATHY; BASE-LINE; DIAGNOSIS; MUTATIONS; DENSITY	Objective Screening for Fabry disease in patients with small fiber neuropathy has been suggested, especially since Fabry disease is potentially treatable. However, the diagnostic yield of testing for Fabry disease in isolated small fiber neuropathy patients has never been systematically investigated. Our aim is to determine the presence of Fabry disease in patients with small fiber neuropathy. Methods Patients referred to our institute, who met the criteria for isolated small fiber neuropathy were tested for Fabry disease by measurement of alpha-Galactosidase A activity in blood, lysosomal globotriaosylsphingosine in urine and analysis on possible GLA gene mutations. Results 725 patients diagnosed with small fiber neuropathy were screened for Fabry disease. No skin abnormalities were seen except for redness of the hands or feet in 30.9% of the patients. Alfa-Galactosidase A activity was tested in all 725 patients and showed diminished activity in eight patients. Lysosomal globotriaosylsphingosine was examined in 509 patients and was normal in all tested individuals. Screening of GLA for mutations was performed for 440 patients, including those with diminished alpha-Galactosidase A activity. Thirteen patients showed a GLA gene variant. One likely pathogenic variant was found in a female patient. The diagnosis Fabry disease could not be confirmed over time in this patient. Eventually none of the patients were diagnosed with Fabry disease. Conclusions In patients with isolated small fiber neuropathy, and no other signs compatible with Fabry disease, the diagnostic yield of testing for Fabry disease is extremely low. Testing for Fabry disease should be considered only in cases with additional characteristics, such as childhood onset, cardiovascular disease, renal failure, or typical skin lesions.	[de Greef, Bianca T. A.; Hoeijmakers, Janneke G. J.; Wolters, Emma E.; Merkies, Ingemar S. J.; Faber, Catharina G.] Maastricht Univ, Med Ctr, Dept Neurol, Sch Mental Hlth & Neurosci, NL-6200 MD Maastricht, Netherlands; [Smeets, Hubertus J. M.; van den Wijngaard, Arthur] Maastricht Univ, Med Ctr, Dept Clin Genet, NL-6200 MD Maastricht, Netherlands; [Merkies, Ingemar S. J.; Gerrits, Monique M.] Spaarne Hosp, Dept Neurol, Hoofddorp, Netherlands	Maastricht University; Maastricht University; Spaarne Hospital	de Greef, BTA (corresponding author), Maastricht Univ, Med Ctr, Dept Neurol, Sch Mental Hlth & Neurosci, NL-6200 MD Maastricht, Netherlands.	bianca.greef@mumc.nl	Hoeijmakers, Janneke/AAI-7260-2020	Gerrits, Monique/0000-0002-9503-9404	Prinses Beatrix Spierfonds [W.OR12-01]; GBS/CIDP foundation international for PeriNomS study; European Union 7th Framework Programme [602273]	Prinses Beatrix Spierfonds; GBS/CIDP foundation international for PeriNomS study; European Union 7th Framework Programme	The authors of this manuscript have the following competing interests: BTAG reports a grant from the Prinses Beatrix Spierfonds (W.OR12-01), outside the submitted work. JGJH reports no disclosure. EEW reports no disclosure. HJMS reports no disclosure. AW reports no disclosure. ISJM reports grants from GBS/CIDP foundation international for PeriNomS study and from European Union 7th Framework Programme (grant agreement no. 602273, 2013); Participation in steering committees of the Talecris ICE Study, CSL Behring, LFB, Novartis and Octapharma (a research foundation at the University of Maastricht received the honoraria on behalf of dr. Merkies), outside the submitted work. CGF reports grants from European Union 7th Framework Programme (grant agreement no. 602273, 2013), outside the submitted work, and the Prinses Beatrix Spierfonds (W.OR12-01), outside the submitted work. MMG reports a grant from European Union 7th Framework Programme (grant agreement no. 602273, 2013), outside the submitted work. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Auray-Blais C, 2010, CLIN CHIM ACTA, V411, P1906, DOI 10.1016/j.cca.2010.07.038; Bakkers M, 2015, MUSCLE NERVE, V51, P870, DOI 10.1002/mus.24473; Bakkers M, 2014, MUSCLE NERVE, V49, P329, DOI 10.1002/mus.23910; Banikazemi M, 2007, ANN INTERN MED, V146, P77, DOI 10.7326/0003-4819-146-2-200701160-00148; Bertelsen AK, 2013, J NEUROL, V260, P917, DOI 10.1007/s00415-012-6800-3; Biegstraaten M, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-013-0365-4; Biegstraaten M, 2012, MOL GENET METAB, V106, P135, DOI 10.1016/j.ymgme.2012.03.010; Biegstraaten M, 2011, EUR J PAIN, V15, P822, DOI 10.1016/j.ejpain.2011.01.014; Burlina AP, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-61; DESNICK RJ, 1973, J LAB CLIN MED, V81, P157; Desnick RJ IY, 2001, METABOLIC MOL BASES; El-Abassi R, 2014, J NEUROL SCI, V344, P5, DOI 10.1016/j.jns.2014.06.029; Faber CG, 2012, P NATL ACAD SCI USA, V109, P19444, DOI 10.1073/pnas.1216080109; Faber CG, 2012, ANN NEUROL, V71, P26, DOI 10.1002/ana.22485; Gal A, 2011, J INHERIT METAB DIS, V34, P509, DOI 10.1007/s10545-010-9261-9; Germain DP, 2007, J AM SOC NEPHROL, V18, P1547, DOI 10.1681/ASN.2006080816; Gorson KC, 2008, J NEUROL NEUROSUR PS, V79, P163, DOI 10.1136/jnnp.2007.128801; GORSON KC, 1995, ACTA NEUROL SCAND, V92, P376; Hilz MJ, 2004, NEUROLOGY, V62, P1066, DOI 10.1212/01.WNL.0000118207.84514.40; Hoeijmakers JG, 2012, NAT REV NEUROL, V8, P369, DOI 10.1038/nrneurol.2012.97; Huang JY, 2014, BRAIN, V137, P1627, DOI 10.1093/brain/awu079; Lauria G, 2010, J PERIPHER NERV SYST, V15, P202, DOI 10.1111/j.1529-8027.2010.00271.x; MacDermot J, 2001, EUR J PHARMACOL, V429, P121, DOI 10.1016/S0014-2999(01)01312-7; Mehta A, 2004, EUR J CLIN INVEST, V34, P236, DOI 10.1111/j.1365-2362.2004.01309.x; Mehta A, 2002, GENEREVIEWS; Peters MJH, 2013, NEUROLOGY, V81, P1356, DOI 10.1212/WNL.0b013e3182a8236e; Salviati A, 2010, NEUROL SCI, V31, P299, DOI 10.1007/s10072-009-0211-y; Samuelsson K, 2014, J CLIN NEUROL, V10, P108, DOI 10.3988/jcn.2014.10.2.108; Schiffmann R, 2006, MUSCLE NERVE, V34, P53, DOI 10.1002/mus.20550; Sharp A, 2000, HUM GENET, V107, P343, DOI 10.1007/s004390000382; STEWART JD, 1992, MUSCLE NERVE, V15, P661, DOI 10.1002/mus.880150605; Tanislav C, 2011, EUR J NEUROL, V18, P631, DOI 10.1111/j.1468-1331.2010.03227.x; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Uceyler N, 2011, J PERIPHER NERV SYST, V16, P304, DOI 10.1111/j.1529-8027.2011.00365.x; van der Tol L, 2014, J MED GENET, V51, P1, DOI 10.1136/jmedgenet-2013-101857; Wallis Y, 2013, ASS CLIN GENETIC SCI, P1; Weidemann F, 2009, CIRCULATION, V119, P524, DOI 10.1161/CIRCULATIONAHA.108.794529; YARNITSKY D, 1994, J NEUROL SCI, V125, P39, DOI 10.1016/0022-510X(94)90239-9; Zarate YA, 2008, LANCET, V372, P1427, DOI 10.1016/S0140-6736(08)61589-5	39	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148316	10.1371/journal.pone.0148316	http://dx.doi.org/10.1371/journal.pone.0148316			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866599	gold, Green Submitted, Green Published			2022-12-27	WOS:000370050700013
J	Ndir, A; Diop, A; Faye, PM; Cisse, MF; Ndoye, B; Astagneau, P				Ndir, Awa; Diop, Amadou; Faye, Pape Makhtar; Cisse, Moussa Fafa; Ndoye, Babacar; Astagneau, Pascal			Epidemiology and Burden of Bloodstream Infections Caused by Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae in a Pediatric Hospital in Senegal	PLOS ONE			English	Article							TIME-DEPENDENT BIAS; LENGTH-OF-STAY; RISK-FACTORS; ESCHERICHIA-COLI; KLEBSIELLA-PNEUMONIAE; ANTIBIOTIC-RESISTANCE; ECONOMIC-IMPACT; BACTEREMIA; MORTALITY; CHILDREN	Context Severe bacterial infections are not considered as a leading cause of death in young children in sub-Saharan Africa. The worldwide emergence of extended-spectrum beta-lactamase producing Enterobacteriaceae (ESBL-E) could change the paradigm, especially in neonates who are at high risk of developing healthcare-associated infections. Objective To evaluate the epidemiology and the burden of ESBL-E bloodstream infections (BSI). Methods A case-case-control study was conducted in patients admitted in a pediatric hospital during two consecutive years. Cases were patients with Enterobacteriaceae BSI and included ESBL-positive (cases 1) and ESBL-negative BSI (cases 2). Controls were patients with no BSI. Multivariate analysis using a stepwise logistic regression was performed to identify risk factors for ESBL acquisition and for fatal outcomes. A multistate model was used to estimate the excess length of hospital stay (LOS) attributable to ESBL production while accounting for time of infection. Cox proportional hazards models were performed to assess the independent effect of ESBL-positive and negative BSI on LOS. Results The incidence rate of ESBL-E BSI was of 1.52 cases/1000 patient-days (95% CI: 1.2-5.6 cases per 1000 patient-days). Multivariate analysis showed that independent risk factors for ESBL-BSI acquisition were related to underlying comorbidities (sickle cell disease OR = 3.1 (95% CI: 2.3-4.9), malnutrition OR = 2.0 (95% CI: 1.7-2.6)) and invasive procedures (mechanical ventilation OR = 3.5 (95% CI: 2.7-5.3)). Neonates were also identified to be at risk for ESBL-E BSI. Inadequate initial antibiotic therapy was more frequent in ESBL-positive BSI than ESBL-negative BSI (94.2% versus 5.7%, p<0.0001). ESBL-positive BSI was associated with higher case-fatality rate than ESBL-negative BSI (54.8% versus 15.4%, p<0.001). Multi-state modelling indicated an excess LOS attributable to ESBL production of 4.3 days. The adjusted end-of-LOS hazard ratio for ESBL-positive BSI was 0.07 (95% CI, 0.04-0.12). Conclusion Control of ESBL-E spread is an emergency in pediatric populations and could be achieved with simple cost-effective measures such as hand hygiene, proper management of excreta and better stewardship of antibiotic use, especially for empirical therapy.	[Ndir, Awa] Univ Paris 06, PhD Program, Paris, France; [Ndir, Awa] Inst Pasteur, Dakar, Senegal; [Diop, Amadou; Faye, Pape Makhtar; Cisse, Moussa Fafa] Hop Enfants Albert Royer, Dakar, Senegal; [Ndoye, Babacar] Minist Hlth, Natl Nosocomial Infect Program, Dakar, Senegal; [Astagneau, Pascal] Univ Sorbonne Paris Cite, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar	Ndir, A (corresponding author), Univ Paris 06, PhD Program, Paris, France.; Ndir, A (corresponding author), Inst Pasteur, Dakar, Senegal.	andir@pasteur.sn	Astagneau, Pascal/AAF-3473-2020					AALEN OO, 1978, SCAND J STAT, V5, P141; Aiken AM, 2011, LANCET, V378, P2021, DOI 10.1016/S0140-6736(11)61622-X; Anderson DJ, 2006, ANTIMICROB AGENTS CH, V50, P1715, DOI 10.1128/AAC.50.5.1715-1720.2006; Barnett AG, 2011, VALUE HEALTH, V14, P381, DOI 10.1016/j.jval.2010.09.008; Beyersmann J, 2008, STAT MED, V27, P6439, DOI 10.1002/sim.3437; Beyersmann J, 2008, J CLIN EPIDEMIOL, V61, P1216, DOI 10.1016/j.jclinepi.2008.02.008; Beyersmann J, 2011, BIOMETRICAL J, V53, P332, DOI 10.1002/bimj.201000146; Beyersmann J, 2009, INFECT CONT HOSP EP, V30, P273, DOI 10.1086/596020; Blomberg B, 2005, J CLIN MICROBIOL, V43, P745, DOI 10.1128/JCM.43.2.745-749.2005; Blomberg B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-43; Brun-Buisson C, 2003, INTENS CARE MED, V29, P1464, DOI 10.1007/s00134-003-1877-x; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Carbonnel A, 2013, J ANTIMICROB CHEMOTH, V68, P954, DOI 10.1093/jac/dks464; Carlin JB, 2008, LANCET, V371, P135, DOI 10.1016/S0140-6736(08)60106-3; De Angelis G, 2010, CLIN MICROBIOL INFEC, V16, P1729, DOI 10.1111/j.1469-0691.2010.03332.x; Giske CG, 2008, ANTIMICROB AGENTS CH, V52, P813, DOI 10.1128/AAC.01169-07; Green N, 2015, J PEDIAT INF DIS SOC, V4, P305, DOI 10.1093/jpids/piu073; Harris AD, 2001, CLIN INFECT DIS, V32, P1055, DOI 10.1086/319600; Harris AD, 2004, CLIN INFECT DIS, V39, P872, DOI 10.1086/423814; Haut Conseil de la Sante Publique, 2010, REC REL MES METTR OE; Hyle EP, 2005, CLIN INFECT DIS, V40, P1317, DOI 10.1086/429239; Hyle EP, 2005, ARCH INTERN MED, V165, P1375, DOI 10.1001/archinte.165.12.1375; Jarlier V, 2010, ARCH INTERN MED, V170, P552, DOI 10.1001/archinternmed.2010.32; Kaya O, 2013, J INFECT DEV COUNTR, V7, P507, DOI 10.3855/jidc.2788; Kaye KS, 2004, EMERG INFECT DIS, V10, P1125, DOI 10.3201/eid1006.020665; Kim BN, 2002, J HOSP INFECT, V52, P99, DOI 10.1053/jhin.2002.1288; Kim YK, 2002, ANTIMICROB AGENTS CH, V46, P1481, DOI 10.1128/AAC.46.5.1481-1491.2002; Kollef MH, 2000, CLIN INFECT DIS, V31, pS131, DOI 10.1086/314079; Lautenbach E, 2001, CLIN INFECT DIS, V32, P1162, DOI 10.1086/319757; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lee SY, 2006, INFECT CONT HOSP EP, V27, P1226, DOI 10.1086/507962; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Pena C, 1997, J HOSP INFECT, V35, P9, DOI 10.1016/S0195-6701(97)90163-8; Reseau d'alerte d'Investigation et de Surveillance des Infections Nosocomiales (RAISIN), 2011, SURV BACT MULT ET SA; Rodriguez-Bano J, 2008, EXPERT REV ANTI-INFE, V6, P671, DOI 10.1586/14787210.6.5.671; Schwaber MJ, 2007, J ANTIMICROB CHEMOTH, V60, P913, DOI 10.1093/jac/dkm318; Schwaber MJ, 2006, ANTIMICROB AGENTS CH, V50, P1257, DOI 10.1128/AAC.50.4.1257-1262.2006; Seale AC, 2014, LANCET INFECT DIS, V14, P731, DOI 10.1016/S1473-3099(14)70804-7; Societe Francaise de Microbiologie, 2015, EUR SOC CLIN MICR IN; Stewardson A, 2013, INFECT CONT HOSP EP, V34, P133, DOI 10.1086/669086; Tsai MH, 2014, PEDIATRICS, V133, pE322, DOI 10.1542/peds.2013-1248; Tumbarello M, 2006, ANTIMICROB AGENTS CH, V50, P498, DOI 10.1128/AAC.50.2.498-504.2006; Tumbarello M, 2008, ANTIMICROB AGENTS CH, V52, P3244, DOI 10.1128/AAC.00063-08; Tumbarello M, 2007, ANTIMICROB AGENTS CH, V51, P1987, DOI 10.1128/AAC.01509-06; Tumbarello M, 2010, ANTIMICROB AGENTS CH, V54, P4085, DOI 10.1128/AAC.00143-10; Zavascki AP, 2004, CLIN INFECT DIS, V39, P871, DOI 10.1086/423805	47	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0143729	10.1371/journal.pone.0143729	http://dx.doi.org/10.1371/journal.pone.0143729			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867226	Green Published, Green Submitted, gold			2022-12-27	WOS:000370050700001
J	Pain, M; Fuller, AW; Basore, K; Pillai, AD; Solomon, T; Bokhari, AAB; Desai, SA				Pain, Margaret; Fuller, Alexandra W.; Basore, Katherine; Pillai, Ajay D.; Solomon, Tsione; Bokhari, Abdullah A. B.; Desai, Sanjay A.			Synergistic Malaria Parasite Killing by Two Types of Plasmodial Surface Anion Channel Inhibitors	PLOS ONE			English	Article							FALCIPARUM IN-VITRO; RED-BLOOD-CELLS; INFECTED ERYTHROCYTES; NUTRIENT-UPTAKE; CLAG3 GENES; ANTIMALARIAL-DRUGS; MULTIGENE FAMILY; PERMEATION; MECHANISMS; RESISTANCE	Malaria parasites increase their host erythrocyte's permeability to a broad range of ions and organic solutes. The plasmodial surface anion channel (PSAC) mediates this uptake and is an established drug target. Development of therapies targeting this channel is limited by several problems including interactions between known inhibitors and permeating solutes that lead to incomplete channel block. Here, we designed and executed a high-throughput screen to identify a novel class of PSAC inhibitors that overcome this solute-inhibitor interaction. These new inhibitors differ from existing blockers and have distinct effects on channel-mediated transport, supporting a model of two separate routes for solute permeation though PSAC. Combinations of inhibitors specific for the two routes had strong synergistic action against in vitro parasite propagation, whereas combinations acting on a single route produced only additive effects. The magnitude of synergism depended on external nutrient concentrations, consistent with an essential role of the channel in parasite nutrient acquisition. The identified inhibitors will enable a better understanding of the channel's structure-function and may be starting points for novel combination therapies that produce synergistic parasite killing.	[Pain, Margaret; Fuller, Alexandra W.; Basore, Katherine; Pillai, Ajay D.; Solomon, Tsione; Bokhari, Abdullah A. B.; Desai, Sanjay A.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Desai, SA (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA.	sdesai@niaid.nih.gov	Singh, Balbir/A-3610-2009	Desai, Sanjay/0000-0003-2150-2483; Basore, Katherine/0000-0001-5974-0968	Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases; Medicines for Malaria Venture; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000882] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medicines for Malaria Venture; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases and by the Medicines for Malaria Venture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhalil A, 2007, CELL MICROBIOL, V9, P851, DOI 10.1111/j.1462-5822.2006.00834.x; Beck JR, 2014, NATURE, V511, P592, DOI 10.1038/nature13574; Bokhari A, 2008, J MEMBRANE BIOL, V226, P27, DOI 10.1007/s00232-008-9136-2; Bouyer G, 2011, BLOOD, V118, P2305, DOI 10.1182/blood-2011-01-329300; Burrows JN, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-187; CANFIELD CJ, 1995, EXP PARASITOL, V80, P373, DOI 10.1006/expr.1995.1049; Cohn JV, 2003, MOL BIOCHEM PARASIT, V132, P27, DOI 10.1016/j.molbiopara.2003.08.001; Cortes A, 2007, PLOS PATHOG, V3, P1023, DOI 10.1371/journal.ppat.0030107; Desai SA, 2005, J BIOL CHEM, V280, P16861, DOI 10.1074/jbc.M414629200; Desai SA, 2012, CELL MICROBIOL, V14, P1003, DOI 10.1111/j.1462-5822.2012.01790.x; Duranton C, 2008, CELL PHYSIOL BIOCHEM, V22, P395, DOI 10.1159/000185483; Ehrenkranz JRL, 2005, DIABETES-METAB RES, V21, P31, DOI 10.1002/dmrr.532; GINSBURG H, 1985, MOL BIOCHEM PARASIT, V14, P313, DOI 10.1016/0166-6851(85)90059-3; Guizetti J, 2013, CELL MICROBIOL, V15, P718, DOI 10.1111/cmi.12115; Hill DA, 2007, P NATL ACAD SCI USA, V104, P1063, DOI 10.1073/pnas.0610353104; Iriko H, 2008, MOL BIOCHEM PARASIT, V158, P11, DOI 10.1016/j.molbiopara.2007.11.004; Istvan ES, 2011, P NATL ACAD SCI USA, V108, P1627, DOI 10.1073/pnas.1011560108; Kaneko O, 2001, MOL BIOCHEM PARASIT, V118, P223, DOI 10.1016/S0166-6851(01)00391-7; KUTNER S, 1987, BIOCHEM PHARMACOL, V36, P123, DOI 10.1016/0006-2952(87)90389-3; Lisk G, 2005, EUKARYOT CELL, V4, P2153, DOI 10.1128/EC.4.12.2153-2159.2005; Lisk G, 2007, MOL PHARMACOL, V71, P1241, DOI 10.1124/mol.106.030734; Liu J, 2006, P NATL ACAD SCI USA, V103, P8840, DOI 10.1073/pnas.0601876103; Martin RE, 2007, BLOOD, V109, P2217, DOI 10.1182/blood-2005-11-026963; Mira-Martinez S, 2013, CELL MICROBIOL, V15, P1913, DOI 10.1111/cmi.12162; Nguitragool W, 2011, CELL, V145, P665, DOI 10.1016/j.cell.2011.05.002; Ohrt C, 2002, ANTIMICROB AGENTS CH, V46, P2518, DOI 10.1128/AAC.46.8.2518-2524.2002; Pillai AD, 2013, MOL MICROBIOL, V88, P20, DOI 10.1111/mmi.12159; Pillai AD, 2012, MOL PHARMACOL, V82, P1104, DOI 10.1124/mol.112.081224; Pillai AD, 2010, MOL PHARMACOL, V77, P724, DOI 10.1124/mol.109.062711; Rich SM, 2003, ADV PARASIT, V54, P255, DOI 10.1016/S0065-308X(03)54005-2; Rovira-Graells N, 2015, NUCLEIC ACIDS RES, V43, P8243, DOI 10.1093/nar/gkv730; Shanks GD, 2015, T ROY SOC TROP MED H, V109, P182, DOI 10.1093/trstmh/tru199; Sharma P, 2013, J BIOL CHEM, V288, P19429, DOI 10.1074/jbc.M113.468371; Snyder C, 2007, EXP PARASITOL, V115, P296, DOI 10.1016/j.exppara.2006.09.016; Sokolov S, 2010, J GEN PHYSIOL, V136, P225, DOI 10.1085/jgp.201010414; Spillman NJ, 2015, ANNU REV BIOCHEM, V84, P813, DOI 10.1146/annurev-biochem-060614-034157; Staines HM, 2007, INT J PARASITOL, V37, P475, DOI 10.1016/j.ijpara.2006.12.013; UPSTON JM, 1995, BBA-BIOMEMBRANES, V1236, P249, DOI 10.1016/0005-2736(95)00055-8; Vandenberg RJ, 2005, SCI STKE, V2005, pe17; Verloo P, 2004, J BIOL CHEM, V279, P10316, DOI 10.1074/jbc.M311540200; Voss TS, 2014, CURR OPIN MICROBIOL, V20, P88, DOI 10.1016/j.mib.2014.05.007; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Wagner MA, 2003, BIOPHYS J, V84, P116, DOI 10.1016/S0006-3495(03)74836-X; Wells TNC, 2015, NAT REV DRUG DISCOV, V14, P424, DOI 10.1038/nrd4573; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	45	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149214	10.1371/journal.pone.0149214	http://dx.doi.org/10.1371/journal.pone.0149214			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866812	Green Published, gold, Green Submitted			2022-12-27	WOS:000370050700078
J	Conlon, K; Monaghan, A; Hayden, M; Wilhelmi, O				Conlon, Kathryn; Monaghan, Andrew; Hayden, Mary; Wilhelmi, Olga			Potential Impacts of Future Warming and Land Use Changes on Intra-Urban Heat Exposure in Houston, Texas	PLOS ONE			English	Article							URBAN CANOPY MODEL; CLIMATE-CHANGE; AMBIENT-TEMPERATURE; HUMAN MORTALITY; EXTREME HEAT; STRESS; HEALTH; CITIES; OZONE; HOSPITALIZATIONS	Extreme heat events in the United States are projected to become more frequent and intense as a result of climate change. We investigated the individual and combined effects of land use and warming on the spatial and temporal distribution of daily minimum temperature (T-min) and daily maximum heat index (HImax) during summer in Houston, Texas. Present-day (2010) and near-future (2040) parcel-level land use scenarios were embedded within 1-km resolution land surface model (LSM) simulations. For each land use scenario, LSM simulations were conducted for climatic scenarios representative of both the present-day and near-future periods. LSM simulations assuming present-day climate but 2040 land use patterns led to spatially heterogeneous temperature changes characterized by warmer conditions over most areas, with summer average increases of up to 1.5 degrees C (T-min) and 7.3 degrees C (HImax) in some newly developed suburban areas compared to simulations using 2010 land use patterns. LSM simulations assuming present-day land use but a 1 degrees C temperature increase above the urban canopy (consistent with warming projections for 2040) yielded more spatially homogeneous metropolitan-wide average increases of about 1 degrees C (T-min) and 2.5 degrees C (HImax), respectively. LSM simulations assuming both land use and warming for 2040 led to summer average increases of up to 2.5 degrees C (T-min) and 8.3 degrees C (HImax), with the largest increases in areas projected to be converted to residential, industrial and mixed-use types. Our results suggest that urbanization and climate change may significantly increase the average number of summer days that exceed current threshold temperatures for initiating a heat advisory for metropolitan Houston, potentially increasing population exposure to extreme heat.	[Conlon, Kathryn; Monaghan, Andrew; Hayden, Mary; Wilhelmi, Olga] Natl Ctr Atmospher Res, POB 3000, Boulder, CO 80307 USA	National Center Atmospheric Research (NCAR) - USA	Conlon, K (corresponding author), Natl Ctr Atmospher Res, POB 3000, Boulder, CO 80307 USA.	kconlon@ucar.edu		Monaghan, Andrew/0000-0002-8170-2359	Climate and Health Program of the National Center for Environmental Health, U.S. Centers for Disease Control and Prevention; National Aeronautics and Space Administration [NNX10AK79G]; National Science Foundation	Climate and Health Program of the National Center for Environmental Health, U.S. Centers for Disease Control and Prevention; National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); National Science Foundation(National Science Foundation (NSF))	KC received funding from the Climate and Health Program of the National Center for Environmental Health, U.S. Centers for Disease Control and Prevention. AM, MH, and OW received funding from the National Aeronautics and Space Administration (grant NNX10AK79G). The National Science Foundation sponsors the National Center for Atmospheric Research.	Adachi SA, 2014, J APPL METEOROL CLIM, V53, P1886, DOI 10.1175/JAMC-D-13-0194.1; Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08; Anderson GB, 2013, AM J RESP CRIT CARE, V187, P1098, DOI 10.1164/rccm.201211-1969OC; Argueso D, 2014, CLIM DYNAM, V42, P2183, DOI 10.1007/s00382-013-1789-6; Basu R, 2002, EPIDEMIOL REV, V24, P190, DOI 10.1093/epirev/mxf007; Basu R, 2008, EPIDEMIOLOGY, V19, P138, DOI 10.1097/EDE.0b013e31815c1da7; Basu R, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-40; Bobb JF, 2014, JAMA-J AM MED ASSOC, V312, P2659, DOI 10.1001/jama.2014.15715; Borden KA, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-64; Chen F, 2001, MON WEATHER REV, V129, P569, DOI 10.1175/1520-0493(2001)129<0569:CAALSH>2.0.CO;2; Chen F, 2007, J APPL METEOROL CLIM, V46, P694, DOI 10.1175/JAM2463.1; Chen F, 2011, INT J CLIMATOL, V31, P273, DOI 10.1002/joc.2158; Cheng YY, 2008, ATMOS ENVIRON, V42, P7795, DOI 10.1016/j.atmosenv.2008.04.055; Ching J, 2009, B AM METEOROL SOC, V90, P1157, DOI 10.1175/2009BAMS2675.1; City of Houston, 2015, CODE OF ORDINANCES, V2015, P639; Cosgrove BA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003118; Council H-GA, 2013, REP REG GROWTH FOR Q; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Davis RE, 2002, CLIMATE RES, V22, P175, DOI 10.3354/cr022175; Demographer OotS, 2014, PROJ POP TEX COUNT T; Department GHPR, 2014, SOC EC DEM CHAR METR; Emerson M, 2014, 33 KINDER I HOUSTON; Georgescu M, 2013, NAT CLIM CHANGE, V3, P37, DOI 10.1038/nclimate1656; Gosling SN, 2009, CLIMATIC CHANGE, V92, P299, DOI [10.1007/s10584-008-9441-x, 10.1007/S10584-008-9441-X]; Gronlund CJ, 2014, ENV RES IN PRESS; Gulyas A, 2006, BUILD ENVIRON, V41, P1713, DOI 10.1016/j.buildenv.2005.07.001; Hajat S, 2010, AM J PUBLIC HEALTH, V100, P1137, DOI 10.2105/AJPH.2009.169748; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; Hao YP, 2015, AM J RESP CRIT CARE, V192, P337, DOI 10.1164/rccm.201410-1852OC; Harlan SL, 2006, SOC SCI MED, V63, P2847, DOI 10.1016/j.socscimed.2006.07.030; Heaton MJ, 2014, SPAT SPATIO-TEMPORAL, V8, P23, DOI 10.1016/j.sste.2014.01.002; Held IM, 2000, ANNU REV ENERG ENV, V25, P441, DOI 10.1146/annurev.energy.25.1.441; Hondula DM, 2014, SCI TOTAL ENVIRON, V490, P538, DOI 10.1016/j.scitotenv.2014.04.130; Huang CR, 2011, ENVIRON HEALTH PERSP, V119, P1681, DOI 10.1289/ehp.1103456; Inspector C, 2015, CLIM CHANG SCEN; Jerrett M, 2009, NEW ENGL J MED, V360, P1085, DOI 10.1056/NEJMoa0803894; Kosatsky Tom, 2005, Euro Surveill, V10, P148; Kovats RS, 2008, ANNU REV PUBL HEALTH, V29, P41, DOI 10.1146/annurev.publhealth.29.020907.090843; Kusaka H, 2001, BOUND-LAY METEOROL, V101, P329, DOI 10.1023/A:1019207923078; Kusaka H, 2012, J METEOROL SOC JPN, V90B, P47, DOI 10.2151/jmsj.2012-B04; Luber G, 1999, HEAT RELATED DEATHS, V2006; Martilli A, 2014, URBAN CLIMA IN PRESS; Mathes R, 2013, ONLINE JOURNAL OF PU, V5, pe156; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Michelozzi P, 2009, AM J RESP CRIT CARE, V179, P383, DOI 10.1164/rccm.200802-217OC; Monaghan AJ, 2014, J GEOPHYS RES-ATMOS, V119, P6376, DOI 10.1002/2013JD021227; NOAA NWS, BEAT HEAT WEATH READ; O'Neill MS, 2005, J URBAN HEALTH, V82, P191, DOI 10.1093/jurban/jti043; OKE TR, 1982, Q J ROY METEOR SOC, V108, P1, DOI 10.1002/qj.49710845502; Oleson KW, 2015, CLIMATIC CHANGE, V129, P525, DOI 10.1007/s10584-013-0936-8; Patz JA, 2000, ENVIRON HEALTH PERSP, V108, P367, DOI 10.2307/3454357; Robine JM, 2008, CR BIOL, V331, P171, DOI 10.1016/j.crvi.2007.12.001; Ruckstuhl C, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007850; Ruidavets JB, 2005, CIRCULATION, V111, P563, DOI 10.1161/01.CIR.0000154546.32135.6E; Sampson NR, 2013, GLOBAL ENVIRON CHANG, V23, P475, DOI 10.1016/j.gloenvcha.2012.12.011; SCHUMAN SH, 1972, ENVIRON RES, V5, P59, DOI 10.1016/0013-9351(72)90020-5; Solecki W.D., 2005, ENVIRON HAZARDS-UK, V6, P39, DOI [10.1016/j.hazards.2004.12.002, DOI 10.1016/J.HAZARDS.2004.12.002]; STEADMAN RG, 1979, J APPL METEOROL, V18, P861, DOI 10.1175/1520-0450(1979)018<0861:TAOSPI>2.0.CO;2; Stone B, 2012, CITY AND THE COMING CLIMATE: CLIMATE CHANGE IN THE PLACES WE LIVE, P1, DOI 10.1017/CBO9781139061353; Stone B, 2010, ENVIRON HEALTH PERSP, V118, P1425, DOI 10.1289/ehp.0901879; Stone B, 2013, ENVIRON SCI TECHNOL, V47, P7780, DOI 10.1021/es304352e; Vanos JK, 2010, INT J BIOMETEOROL, V54, P319, DOI 10.1007/s00484-010-0301-9; Voorhees AS, 2011, ENVIRON SCI TECHNOL, V45, P1450, DOI 10.1021/es102820y; Whitman S, 1997, AM J PUBLIC HEALTH, V87, P1515, DOI 10.2105/AJPH.87.9.1515; Wilhelmi O, 2015, EOS T AM GE IN PRESS; Wilhelmi OV, 2015, 95 ANN M AM MET SOC, V2015; Willett KM, 2008, J CLIMATE, V21, P5364, DOI 10.1175/2008JCLI2274.1; Xia YL, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016048; Zhou WH, 2014, ENVIRON RES, V135, P81, DOI 10.1016/j.envres.2014.08.025	69	26	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148890	10.1371/journal.pone.0148890	http://dx.doi.org/10.1371/journal.pone.0148890			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863298	Green Published, Green Submitted, gold			2022-12-27	WOS:000370046600120
J	Hsu, KH; Su, BH; Tu, YS; Lin, OA; Tseng, YFJ				Hsu, Kuo-Hsiang; Su, Bo-Han; Tu, Yi-Shu; Lin, Olivia A.; Tseng, Yufeng J.			Mutagenicity in a Molecule: Identification of Core Structural Features of Mutagenicity Using a Scaffold Analysis	PLOS ONE			English	Article							CARCINOGENICITY; TOXICOLOGY; CLASSIFICATION; PREDICTION; SYSTEMS; ALERTS	With advances in the development and application of Ames mutagenicity in silico prediction tools, the International Conference on Harmonisation (ICH) has amended its M7 guideline to reflect the use of such prediction models for the detection of mutagenic activity in early drug safety evaluation processes. Since current Ames mutagenicity prediction tools only focus on functional group alerts or side chain modifications of an analog series, these tools are unable to identify mutagenicity derived from core structures or specific scaffolds of a compound. In this study, a large collection of 6512 compounds are used to perform scaffold tree analysis. By relating different scaffolds on constructed scaffold trees with Ames mutagenicity, four major and one minor novel mutagenic groups of scaffold are identified. The recognized mutagenic groups of scaffold can serve as a guide for medicinal chemists to prevent the development of potentially mutagenic therapeutic agents in early drug design or development phases, by modifying the core structures of mutagenic compounds to form non-mutagenic compounds. In addition, five series of substructures are provided as recommendations, for direct modification of potentially mutagenic scaffolds to decrease associated mutagenic activities.	[Hsu, Kuo-Hsiang; Tu, Yi-Shu; Lin, Olivia A.; Tseng, Yufeng J.] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Su, Bo-Han; Tseng, Yufeng J.] Natl Taiwan Univ, Dept Comp Sci & Informat Engn, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University	Tseng, YFJ (corresponding author), Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan.; Tseng, YFJ (corresponding author), Natl Taiwan Univ, Dept Comp Sci & Informat Engn, Taipei 10764, Taiwan.	yjtseng@csie.ntu.edu.tw	Tu, Yi-shu/H-3180-2013; Tseng, Yufeng/AAY-4971-2021	Tu, Yi-shu/0000-0003-0210-3778; Tseng, Yufeng Jane/0000-0002-8461-6181	Ministry of Science and Technology, Taiwan [103-2325-B-002-048-, 104-2321-B-002-037-, 104-2325-B-400-014-]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was funded by the Ministry of Science and Technology, Taiwan, grant numbers 103-2325-B-002-048-, 104-2321-B-002-037-, and 104-2325-B-400-014-. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES BN, 1973, P NATL ACAD SCI USA, V70, P782, DOI 10.1073/pnas.70.3.782; AMES BN, 1975, MUTAT RES, V31, P347, DOI 10.1016/0165-1161(75)90046-1; [Anonymous], 2015, MULT GUID M7 GEN IMP; ASHBY J, 1985, ENVIRON MUTAGEN, V7, P919, DOI 10.1002/em.2860070613; Benigni R, 2008, 23241 EUR EN, p[1, 23241]; Benigni R, 2013, CHEM REV, V113, P2940, DOI 10.1021/cr300206t; Benigni R, 2011, CHEM REV, V111, P2507, DOI 10.1021/cr100222q; Benigni R, 2010, EXPERT OPIN DRUG MET, V6, P809, DOI 10.1517/17425255.2010.486400; Chemaxon Inc, 2015, MARV SUIT; Contrera JF, 2013, REGUL TOXICOL PHARM, V67, P285, DOI 10.1016/j.yrtph.2013.08.008; [European Medicines Agency Committee for Medicinal Products for Human Use (CHMP)], 2006, GUID LIM GEN IMP; Feng J, 2003, J CHEM INF COMP SCI, V43, P1463, DOI 10.1021/ci034032s; FERGUSON LR, 1988, MUTAT RES, V204, P207, DOI 10.1016/0165-1218(88)90091-2; Griffiths AJ, 2000, INTRO GENETIC ANAL, V7th; Hansen K, 2009, J CHEM INF MODEL, V49, P2077, DOI 10.1021/ci900161g; Helma C, 2004, J CHEM INF COMP SCI, V44, P1402, DOI 10.1021/ci034254q; Hillebrecht A, 2011, CHEM RES TOXICOL, V24, P843, DOI 10.1021/tx2000398; Judson PN, 2005, TOXICOLOGY, V213, P117, DOI 10.1016/j.tox.2005.05.014; Kazius J, 2005, J MED CHEM, V48, P312, DOI 10.1021/jm040835a; Kho R, 2005, J MED CHEM, V48, P6671, DOI 10.1021/jm050564j; KLOPMAN G, 1992, QUANT STRUCT-ACT REL, V11, P176, DOI 10.1002/qsar.19920110208; Lead-scope Inc, 2013, LEADSC MOD APPL COL; MARON DM, 1983, MUTAT RES, V113, P173, DOI 10.1016/0165-1161(83)90010-9; MATIJASEVIC Z, 1985, MUTAT RES, V142, P149, DOI 10.1016/0165-7992(85)90014-4; Mostrag-Szlichtyng A, 2010, EXPERT OPIN DRUG MET, V6, P785, DOI 10.1517/17425255.2010.489551; Nagarathna K.M., 2013, INT J PHARM SCI REV, V22, P236; Nantasenamat C, 2009, EXCLI J, V8, P74; Ridings JE, 1996, TOXICOLOGY, V106, P267, DOI 10.1016/0300-483X(95)03190-Q; U. S. National Library of Medicine, 2014, GEN TOX DAT BANK GEN; U. S. National Library of Medicine, 2009, CHEM CARC RES INF SY; von der Ohe PC, 2005, CHEM RES TOXICOL, V18, P536, DOI 10.1021/tx0497954; Webb SJ, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-8; Wetzel S, 2009, NAT CHEM BIOL, V5, P581, DOI 10.1038/nchembio.187	33	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148900	10.1371/journal.pone.0148900	http://dx.doi.org/10.1371/journal.pone.0148900			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863515	Green Submitted, Green Published, gold			2022-12-27	WOS:000370046600122
J	Josephson, MP; Chai, YP; Ou, GS; Lundquist, EA				Josephson, Matthew P.; Chai, Yongping; Ou, Guangshuo; Lundquist, Erik A.			EGL-20/Wnt and MAB-5/Hox Act Sequentially to Inhibit Anterior Migration of Neuroblasts in C. elegans	PLOS ONE			English	Article							WNT-PRODUCING CELLS; CAENORHABDITIS-ELEGANS; NEURONAL MIGRATION; GENE-EXPRESSION; HOX GENES; ASYMMETRY; NEMATODE; UNC-40/DCC; PROTEINS; SYSTEM	Directed neuroblast and neuronal migration is important in the proper development of nervous systems. In C. elegans the bilateral Q neuroblasts QR (on the right) and QL (on the left) undergo an identical pattern of cell division and differentiation but migrate in opposite directions (QR and descendants anteriorly and QL and descendants posteriorly). EGL-20/Wnt, via canonical Wnt signaling, drives the expression of MAB-5/Hox in QL but not QR. MAB-5 acts as a determinant of posterior migration, and mab-5 and egl-20 mutants display anterior QL descendant migrations. Here we analyze the behaviors of QR and QL descendants as they begin their anterior and posterior migrations, and the effects of EGL-20 and MAB-5 on these behaviors. The anterior and posterior daughters of QR (QR.a/p) after the first division immediately polarize and begin anterior migration, whereas QL.a/p remain rounded and non-migratory. After similar to 1 hour, QL. a migrates posteriorly over QL.p. We find that in egl-20/Wnt, bar-1/beta-catenin, and mab-5/Hox mutants, QL.a/p polarize and migrate anteriorly, indicating that these molecules normally inhibit anterior migration of QL.a/p. In egl-20/Wnt mutants, QL.a/p immediately polarize and begin migration, whereas in bar-1/beta-catenin and mab-5/Hox, the cells transiently retain a rounded, non-migratory morphology before anterior migration. Thus, EGL-20/Wnt mediates an acute inhibition of anterior migration independently of BAR-1/beta-catenin and MAB-5/Hox, and a later, possible transcriptional response mediated by BAR-1/beta-catenin and MAB-5/Hox. In addition to inhibiting anterior migration, MAB-5/Hox also cell-autonomously promotes posterior migration of QL. a (and QR. a in a mab-5 gain-of-function).	[Josephson, Matthew P.; Lundquist, Erik A.] Univ Kansas, Dept Mol Biosci, Genet Program, Lawrence, KS 66045 USA; [Josephson, Matthew P.; Lundquist, Erik A.] Univ Kansas, Dept Mol Biosci, Program Mol Cellular & Dev Biol, Lawrence, KS 66045 USA; [Chai, Yongping; Ou, Guangshuo] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China	University of Kansas; University of Kansas; Tsinghua University	Lundquist, EA (corresponding author), Univ Kansas, Dept Mol Biosci, Genet Program, Lawrence, KS 66045 USA.; Lundquist, EA (corresponding author), Univ Kansas, Dept Mol Biosci, Program Mol Cellular & Dev Biol, Lawrence, KS 66045 USA.	erikl@ku.edu			National Institutes of Health [R01 NS040945, R21 NS070417, P20 GM103638, P20 GM103418]; National Basic Research Program of China (973 Program) [2013CB945600, 2012CB945002]; National Natural Science Foundation of China [31201009, 31222035, 31171295, 31190063]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103638, P20GM103418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS070417, R01NS040945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005803] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funded by National Institutes of Health grants R01 NS040945, R21 NS070417, P20 GM103638, and P20 GM103418 to E.A.L. (http://www.nih.gov/), The National Basic Research Program of China to G.O. (973 Program, 2013CB945600 and 2012CB945002) (http://rd.zju.edu.cn/en/index.php?c = main&a = detail&id=93), and The National Natural Science Foundation of China to G.O. and Y.C. (31201009, 31222035, 31171295 and 31190063) (http://www.nsfc.gov.cn/publish/portal1/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boitard M, 2015, CELL REP, V10, P1349, DOI 10.1016/j.celrep.2015.01.061; Branda CS, 2000, DEV BIOL, V226, P137, DOI 10.1006/dbio.2000.9853; CHALFIE M, 1983, SCIENCE, V221, P61, DOI 10.1126/science.6857263; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; Chapman JO, 2008, DEV BIOL, V324, P245, DOI 10.1016/j.ydbio.2008.09.014; CHOW KL, 1994, DEVELOPMENT, V120, P2579; Cordes S, 2006, DEVELOPMENT, V133, P2747, DOI 10.1242/dev.02447; Coudreuse DYM, 2006, SCIENCE, V312, P921, DOI 10.1126/science.1124856; Eisenmann David M, 2005, WormBook, P1, DOI 10.1895/wormbook.1.7.1; Freese JL, 2010, NEUROBIOL DIS, V38, P148, DOI 10.1016/j.nbd.2009.09.003; Harris J, 1996, DEVELOPMENT, V122, P3117; Herman MA, 2003, WNT SIGNALING DEV, P187; Honigberg L, 2000, DEVELOPMENT, V127, P4655; Ji N, 2013, CELL, V155, P869, DOI 10.1016/j.cell.2013.09.060; KENYON C, 1986, CELL, V46, P477, DOI 10.1016/0092-8674(86)90668-9; Korswagen HC, 2000, NATURE, V406, P527, DOI 10.1038/35020099; Mentink RA, 2014, DEV CELL, V31, P188, DOI 10.1016/j.devcel.2014.08.008; Middelkoop Teije C, 2014, WormBook, P1, DOI 10.1895/wormbook.1.173.1; Minevich G, 2012, GENETICS, V192, P1249, DOI 10.1534/genetics.112.144204; Ou GS, 2009, J CELL BIOL, V185, P77, DOI 10.1083/jcb.200812077; Pan CL, 2006, DEV CELL, V10, P367, DOI 10.1016/j.devcel.2006.02.010; Penigault JB, 2011, DEV BIOL, V357, P428, DOI 10.1016/j.ydbio.2011.06.006; SALSER SJ, 1993, GENE DEV, V7, P1714, DOI 10.1101/gad.7.9.1714; SALSER SJ, 1992, NATURE, V355, P255, DOI 10.1038/355255a0; Schafer ST, 2015, J NEUROSCI, V35, P4983, DOI 10.1523/JNEUROSCI.4130-14.2015; Shen ZF, 2014, DEV CELL, V30, P625, DOI 10.1016/j.devcel.2014.07.017; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Sundararajan L, 2015, G3-GENES GENOM GENET, V5, P1567, DOI 10.1534/g3.115.018770; Sundararajan L, 2014, DEV BIOL, V392, P141, DOI 10.1016/j.ydbio.2014.06.009; Sundararajan L, 2012, GENETICS, V192, P1373, DOI 10.1534/genetics.112.145706; Tamayo JV, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-304; Thompson O, 2013, GENOME RES, V23, P1749, DOI 10.1101/gr.157651.113; Tian D, 2015, CURR BIOL, V25, P1135, DOI 10.1016/j.cub.2015.02.072; Wang XM, 2013, P NATL ACAD SCI USA, V110, P11175, DOI 10.1073/pnas.1301849110; Whangbo J, 1999, MOL CELL, V4, P851, DOI 10.1016/S1097-2765(00)80394-9; Yang PT, 2008, DEV CELL, V14, P140, DOI 10.1016/j.devcel.2007.12.004; Zinovyeva AY, 2008, GENETICS, V179, P1357, DOI 10.1534/genetics.108.090290	37	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148658	10.1371/journal.pone.0148658	http://dx.doi.org/10.1371/journal.pone.0148658			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863303	Green Published, gold, Green Submitted			2022-12-27	WOS:000370046600093
J	Tang, MF; Hammond, GR; Badcock, DR				Tang, Matthew F.; Hammond, Geoffrey R.; Badcock, David R.			Are Participants Aware of the Type and Intensity of Transcranial Direct Current Stimulation?	PLOS ONE			English	Article							MOTOR CORTEX; VISUAL PSYCHOPHYSICS; MAJOR DEPRESSION; DC STIMULATION; CLINICAL-TRIAL; TDCS; MODULATION; CONSOLIDATION; PERCEPTION; COMFORT	Transcranial direct current stimulation (tDCS) is commonly used to alter cortical excitability but no experimental study has yet determined whether human participants are able to distinguish between the different types (anodal, cathodal, and sham) of stimulation. If they can then they are not blind to experimental conditions. We determined whether participants could identify different types of stimulation (anodal, cathodal, and sham) and current strengths after experiencing the sensations of stimulation during current onset and offset (which are associated with the most intense sensations) in Experiment 1 and also with a prolonged period of stimulation in Experiment 2. We first familiarized participants with anodal, cathodal, and sham stimulation at both 1 and 2 mA over either primary motor or visual cortex while their sensitivity to small changes in visual stimuli was assessed. The different stimulation types were then applied for a short (Experiment 1) or extended (Experiment 2) period with participants indicating the type and strength of the stimulation on the basis of the evoked sensations. Participants were able to identify the intensity of stimulation with shorter, but not longer periods, of stimulation at better than chance levels but identification of the different stimulation types was at chance levels. This result suggests that even after exposing participants to stimulation, and ensuring they are fully aware of the existence of a sham condition, they are unable to identify the type of stimulation from transient changes in stimulation intensity or from more prolonged stimulation. Thus participants are able to identify intensity of stimulation but not the type of stimulation.	[Tang, Matthew F.; Hammond, Geoffrey R.; Badcock, David R.] Univ Western Australia, Sch Psychol, Crawley, WA, Australia; [Tang, Matthew F.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia	University of Western Australia; University of Queensland	Tang, MF (corresponding author), Univ Western Australia, Sch Psychol, Crawley, WA, Australia.; Tang, MF (corresponding author), Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia.	m.tang1@uq.edu.au	Badcock, David R/A-4913-2008; Tang, Matthew/E-6520-2016	Badcock, David R/0000-0002-4517-435X; Tang, Matthew/0000-0001-5858-5126	Australian Research Council [DP130102580, DP110104553]; University of Western Australia	Australian Research Council(Australian Research Council); University of Western Australia	This work was supported by Australian Research Council grants DP130102580 and DP110104553 to DRB. The University of Western Australia also provided a scholarship to MFT.	Accornero N, 2007, EXP BRAIN RES, V178, P261, DOI 10.1007/s00221-006-0733-y; Antal A, 2003, EXP BRAIN RES, V150, P375, DOI 10.1007/s00221-003-1459-8; Antal A, 2006, BRAIN RES BULL, V68, P459, DOI 10.1016/j.brainresbull.2005.10.006; Boggio PS, 2008, INT J NEUROPSYCHOPH, V11, P249, DOI 10.1017/S1461145707007833; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brunoni AR, 2014, CLIN NEUROPHYSIOL, V125, P298, DOI 10.1016/j.clinph.2013.07.020; Cecere R, 2013, J NEUROSCI, V33, P6469, DOI 10.1523/JNEUROSCI.3431-12.2013; Dundas JE, 2007, CLIN NEUROPHYSIOL, V118, P1166, DOI 10.1016/j.clinph.2007.01.010; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Horvath JC, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00002; Jacobson L, 2012, EXP BRAIN RES, V216, P1, DOI 10.1007/s00221-011-2891-9; Kessler SK, 2012, BRAIN STIMUL, V5, P155, DOI 10.1016/j.brs.2011.02.007; METHA AB, 1993, BEHAV RES METH INSTR, V25, P371, DOI 10.3758/BF03204528; Moos K, 2012, J NEUROSCI, V32, P16360, DOI 10.1523/JNEUROSCI.6233-11.2012; Nitsche MA, 2007, J NEUROPHYSIOL, V97, P3109, DOI 10.1152/jn.01312.2006; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2003, J COGNITIVE NEUROSCI, V15, P619, DOI 10.1162/089892903321662994; Nitsche MA, 2003, J PHYSIOL-LONDON, V553, P293, DOI 10.1113/jphysiol.2003.049916; O'Connell NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047514; Palm U, 2013, BRAIN STIMUL, V6, P690, DOI 10.1016/j.brs.2013.01.005; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Peters MAK, 2013, NEUROPSYCHOLOGIA, V51, P1234, DOI 10.1016/j.neuropsychologia.2013.03.013; Petrov Y, 2005, J NEUROSCI, V25, P8704, DOI 10.1523/JNEUROSCI.2871-05.2005; Poreisz C, 2007, BRAIN RES BULL, V72, P208, DOI 10.1016/j.brainresbull.2007.01.004; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; Russo R, 2013, BRAIN STIMUL, V6, P946, DOI 10.1016/j.brs.2013.05.009; Spiegel DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036220; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Tang MF, 2013, J VISION, V13, DOI 10.1167/13.13.20; Tang MF, 2013, EUR J NEUROSCI, V38, P2802, DOI 10.1111/ejn.12280; TANG MF, 2015, J VISION, V15, DOI DOI 10.1167/15.13.4	31	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148825	10.1371/journal.pone.0148825	http://dx.doi.org/10.1371/journal.pone.0148825			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863314	Green Submitted, gold, Green Published			2022-12-27	WOS:000370046600111
J	Varga, L; Kovacs, A; Toth, G; Papp, I; Neda, Z				Varga, Levente; Kovacs, Andras; Toth, Geza; Papp, Istvan; Neda, Zoltan			Further We Travel the Faster We Go	PLOS ONE			English	Article							MOBILITY; PREDICTABILITY; MIGRATION; MODEL	The average travelling speed increases in a nontrivial manner with the travel distance. This leads to scaling-like relations on quite extended spatial scales, for all mobility modes taken together and also for a given mobility mode in part. We offer a wide range of experimental results, investigating and quantifying this universal effect and its measurable causes. The increasing travelling speed with the travel distance arises from the combined effects of: choosing the most appropriate travelling mode; the structure of the travel networks; the travel times lost in the main hubs, starting or target cities; and the speed limit of roads and vehicles.	[Varga, Levente; Papp, Istvan; Neda, Zoltan] Univ Babes Bolyai, Dept Phys, R-3400 Cluj Napoca, Romania; [Kovacs, Andras] Edutus Coll, Dept Trade & Mkt, Tatabanya, Hungary; [Toth, Geza] Hungarian Cent Stat Off, Budapest, Hungary	Babes Bolyai University from Cluj	Neda, Z (corresponding author), Univ Babes Bolyai, Dept Phys, R-3400 Cluj Napoca, Romania.	zneda@phys.ubbcluj.ro	Varga, Levente/E-2434-2016; Toth, Geza/AAX-3967-2020; Tóth, Géza/I-2683-2013; Néda, Zoltán/C-3754-2011	Varga, Levente/0000-0002-7770-6680; Tóth, Géza/0000-0002-9233-1899; Papp, Istvan/0000-0001-9711-399X	UEFISCDI, Romania [PCE-IDEI-0348/2011]	UEFISCDI, Romania(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI))	This work was supported by UEFISCDI, Romania, grant number: PCE-IDEI-0348/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Cohen JE, 2008, P NATL ACAD SCI USA, V105, P15269, DOI 10.1073/pnas.0808185105; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Dusek T, 2009, COMMUNICATION; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Gallotti R, 2014, SCI REP-UK, V4, DOI 10.1038/srep06911; Gonzales CM, 2015, P NATL ACAD IN PRESS; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Goodchild MF, 2007, GEOJOURNAL, V69, P211, DOI 10.1007/s10708-007-9111-y; GPSlib, 2015, GPS TRACKS HOST SERV; Helbing D, 2001, REV MOD PHYS, V73, P1067, DOI 10.1103/RevModPhys.73.1067; Hungarian central statistical office, 2015, REG ATL HUNG TERR BR; Kung KS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096180; Li G, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.018701; Liang X, 2013, SCI REP-UK, V3, DOI 10.1038/srep02983; Liu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086026; Mokhtarian PL, 2004, TRANSPORT RES A-POL, V38, P643, DOI 10.1016/j.tra.2003.12.004; Neubert L, 1999, PHYS REV E, V60, P6480, DOI 10.1103/PhysRevE.60.6480; Noulas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037027; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Roth C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015923; Silvers AL, 1974, URBAN PLANNING ANAL; Simini F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060069; Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856; Yan XY, 2013, SCI REP-UK, V3, DOI 10.1038/srep02678	28	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148913	10.1371/journal.pone.0148913	http://dx.doi.org/10.1371/journal.pone.0148913			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863605	Green Published, gold, Green Submitted			2022-12-27	WOS:000370046600123
J	Yu, PL; Chen, LH; Chung, KR				Yu, Pei-Ling; Chen, Li-Hung; Chung, Kuang-Ren			How the Pathogenic Fungus Alternaria alternata Copes with Stress via the Response Regulators SSK1 and SHO1	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; TANGERINE PATHOTYPE; OXIDATIVE STRESS; PLANT INFECTION; PROTEIN-KINASE; VIRULENCE; ACTIVATION; RESISTANCE; SYSTEM; ROLES	The tangerine pathotype of Alternaria alternata is a necrotrophic fungal pathogen causing brown spot disease on a number of citrus cultivars. To better understand the dynamics of signal regulation leading to oxidative and osmotic stress response and fungal infection on citrus, phenotypic characterization of the yeast SSK1 response regulator homolog was performed. It was determined that SSK1 responds to diverse environmental stimuli and plays a critical role in fungal pathogenesis. Experiments to determine the phenotypes resulting from the loss of SSK1 reveal that the SSK1 gene product may be fulfilling similar regulatory roles in signaling pathways involving a HOG1 MAP kinase during ROS resistance, osmotic resistance, fungicide sensitivity and fungal virulence. The SSK1 mutants display elevated sensitivity to oxidants, fail to detoxify H2O2 effectively, induce minor necrosis on susceptible citrus leaves, and displays resistance to dicarboximide and phenylpyrrole fungicides. Unlike the SKN7 response regulator, SSK1 and HOG1 confer resistance to salt-induced osmotic stress via an unknown kinase sensor rather than the "two component" histidine kinase HSK1. SSK1 and HOG1 play a moderate role in sugar-induced osmotic stress. We also show that SSK1 mutants are impaired in their ability to produce germ tubes from conidia, indicating a role for the gene product in cell differentiation. SSK1 also is involved in multidrug resistance. However, deletion of the yeast SHO1 (synthetic high osmolarity) homolog resulted in no noticeable phenotypes. Nonetheless, our results show that A. alternata can sense and react to different types of stress via SSK1, HOG1 and SKN7 in a cooperative manner leading to proper physiological and pathological functions.	[Yu, Pei-Ling; Chen, Li-Hung; Chung, Kuang-Ren] Natl Chung Hsing Univ, Coll Agr & Nat Resources, Dept Plant Pathol, Taichung 40227, Taiwan; [Chen, Li-Hung] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA	National Chung Hsing University; University of California System; University of California Davis	Chung, KR (corresponding author), Natl Chung Hsing Univ, Coll Agr & Nat Resources, Dept Plant Pathol, Taichung 40227, Taiwan.	krchung@nchu.edu.tw	Chung, Kuang-Ren/Q-1157-2019; YU, PEI-LING/M-1348-2019	Chen, Li-Hung/0000-0002-9636-9501	Ministry of Science and Technology of Taiwan [103-2313-B-005-044-MY2]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by a grant from the Ministry of Science and Technology of Taiwan (103-2313-B-005-044-MY2) to KRC. The funder had no roles in experimental design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Appleby JL, 1996, CELL, V86, P845, DOI 10.1016/S0092-8674(00)80158-0; Chen LH, 2013, MOL PLANT PATHOL, V14, P497, DOI 10.1111/mpp.12021; Chen LH, 2012, FUNGAL GENET BIOL, V49, P802, DOI 10.1016/j.fgb.2012.07.006; Chung KR, 2002, FEMS MICROBIOL LETT, V213, P33, DOI 10.1111/j.1574-6968.2002.tb11282.x; Chung KR, 2014, PLANT PATHOL B, V23, P307; Chung KR, 2014, PHYSIOL MOL PLANT P, V88, P10, DOI 10.1016/j.pmpp.2014.08.001; Chung KR, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/635431; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; Gu Q, 2015, NEW PHYTOL, V206, P315, DOI 10.1111/nph.13158; Hao N, 2007, CURR BIOL, V17, P659, DOI 10.1016/j.cub.2007.02.044; Jiang JH, 2011, MOL PLANT PATHOL, V12, P425, DOI 10.1111/j.1364-3703.2010.00684.x; KATEKAR GF, 1980, PLANT PHYSIOL, V66, P1190, DOI 10.1104/pp.66.6.1190; KOHMOTO K, 1993, PHYTOPATHOLOGY, V83, P495, DOI 10.1094/Phyto-83-495; Kruppa M, 2006, FEMS YEAST RES, V6, P149, DOI 10.1111/j.1567-1364.2006.00024.x; Lanver D, 2010, PLANT CELL, V22, P2085, DOI 10.1105/tpc.109.073734; Li S, 1998, EMBO J, V17, P6952, DOI 10.1093/emboj/17.23.6952; Lin CH, 2011, CURR MICROBIOL, V62, P807, DOI 10.1007/s00284-010-9795-y; Lin CH, 2010, FUNGAL GENET BIOL, V47, P818, DOI 10.1016/j.fgb.2010.06.009; Lin CH, 2010, FUNGAL GENET BIOL, V47, P381, DOI 10.1016/j.fgb.2009.12.009; Lin CH, 2009, MOL PLANT MICROBE IN, V22, P942, DOI 10.1094/MPMI-22-8-0942; Liu WD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001261; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; MAEDA T, 1995, SCIENCE, V269, P554, DOI 10.1126/science.7624781; Motoyama T, 2008, CURR GENET, V54, P185, DOI 10.1007/s00294-008-0211-0; Nerud F, 2001, CHEMOSPHERE, V44, P957, DOI 10.1016/S0045-6535(00)00482-3; Perez-Nadales E, 2015, MOL PLANT PATHOL, V16, P593, DOI 10.1111/mpp.12217; Posas F, 1998, EMBO J, V17, P1385, DOI 10.1093/emboj/17.5.1385; Raitt DC, 2000, EMBO J, V19, P4623, DOI 10.1093/emboj/19.17.4623; Saito H, 2012, GENETICS, V192, P289, DOI 10.1534/genetics.112.140863; Tatebayashi K, 2007, EMBO J, V26, P3521, DOI 10.1038/sj.emboj.7601796; Tatebayashi K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7975; Thomason P, 2000, J CELL SCI, V113, P3141; Tsai HC, 2014, MICROBIOL-SGM, V160, P1453, DOI 10.1099/mic.0.077818-0; Tsuge T, 2013, FEMS MICROBIOL REV, V37, P44, DOI 10.1111/j.1574-6976.2012.00350.x; Vargas-Perez I, 2007, EUKARYOT CELL, V6, P1570, DOI 10.1128/EC.00085-07; Wang ZL, 2014, APPL MICROBIOL BIOT, V98, P5607, DOI 10.1007/s00253-014-5644-4; Yan LY, 2011, APPL MICROBIOL BIOT, V90, P215, DOI 10.1007/s00253-010-3027-z; Yang SL, 2016, ENVIRON MICROBIOL, V18, P923, DOI 10.1111/1462-2920.13125; Yang SL, 2013, MOL PLANT PATHOL, V14, P543, DOI 10.1111/mpp.12026; Yang SL, 2012, MOL PLANT PATHOL, V13, P900, DOI 10.1111/j.1364-3703.2012.00799.x; Yang SL, 2010, FUNGAL BIOL-UK, V114, P64, DOI 10.1016/j.mycres.2009.10.007; Yang SL, 2009, PHYSIOL MOL PLANT P, V74, P100, DOI 10.1016/j.pmpp.2009.09.007; Yoshimi A, 2005, EUKARYOT CELL, V4, P1820, DOI 10.1128/EC.4.11.1820-1828.2005	45	21	22	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149153	10.1371/journal.pone.0149153	http://dx.doi.org/10.1371/journal.pone.0149153			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863027	Green Published, Green Submitted, gold			2022-12-27	WOS:000370046600162
J	Schaming, TD				Schaming, Taza D.			Clark's Nutcracker Breeding Season Space Use and Foraging Behavior	PLOS ONE			English	Article							HOME-RANGE; WHITEBARK-PINE; NUCIFRAGA-COLUMBIANA; DENSITY-ESTIMATION; HABITAT USE; CONSERVATION; SELECTION; DISPERSAL; EMIGRATION; RESOURCES	Considering the entire life history of a species is fundamental to developing effective conservation strategies. Decreasing populations of five-needle white pines may be leading to the decline of Clark's nutcrackers (Nucifraga columbiana). These birds are important seed dispersers for at least ten conifer species in the western U.S., including whitebark pine (Pinus albicaulis), an obligate mutualist of Clark's nutcrackers. For effective conservation of both Clark's nutcrackers and whitebark pine, it is essential to ensure stability of Clark's nutcracker populations. My objectives were to examine Clark's nutcracker breeding season home range size, territoriality, habitat selection, and foraging behavior in the southern Greater Yellowstone Ecosystem, a region where whitebark pine is declining. I radio-tracked Clark's nutcrackers in 2011, a population-wide nonbreeding year following a low whitebark pine cone crop, and 2012, a breeding year following a high cone crop. Results suggest Douglas-fir (Pseudotsuga menziesii) communities are important habitat for Clark's nutcrackers because they selected it for home ranges. In contrast, they did not select whitebark pine habitat. However, Clark's nutcrackers did adjust their use of whitebark pine habitat between years, suggesting that, in some springs, whitebark pine habitat may be used more than previously expected. Newly extracted Douglas-fir seeds were an important food source both years. On the other hand, cached seeds made up a relatively lower proportion of the diet in 2011, suggesting cached seeds are not a reliable spring food source. Land managers focus on restoring whitebark pine habitat with the assumption that Clark's nutcrackers will be available to continue seed dispersal. In the Greater Yellowstone Ecosystem, Clark's nutcracker populations may be more likely to be retained year-round when whitebark pine restoration efforts are located adjacent to Douglas-fir habitat. By extrapolation, whitebark pine restoration efforts in other regions may consider prioritizing restoration of whitebark pine stands near alternative seed sources.	[Schaming, Taza D.] Cornell Univ, Dept Nat Resources, Cornell Lab Ornithol, Fernow Hall, Ithaca, NY 14853 USA	Cornell University	Schaming, TD (corresponding author), Cornell Univ, Dept Nat Resources, Cornell Lab Ornithol, Fernow Hall, Ithaca, NY 14853 USA.	tds55@cornell.edu			Athena Fund of the Cornell Lab of Ornithology; Meg and Bert Raynes Wildlife Fund Research Grant; Cornell Lab of Ornithology; NASA Harriett G. Jenkins Pre-doctoral Fellowship [NNX10AU20A]; Cornell Lab of Ornithology Kramer Graduate Fellowship; Cornell Lab of Ornithology Halberstadt Graduate Fellowship; Cornell University Research Travel Grant; Cornell University Sigma Xi; Cornell Lab of Ornithology Samuel and Linda Kramer Award; Andrew W. Mellon Student Research Grant; American Ornithologists' Union; Mazamas Graduate Student Research Grant; Conservation and Research Foundation Research Grant; Western Bird Banding Association Research Grant; Wyoming Wildlife - The Foundation; Wyoming Community Foundation [20120167]; American Philosophical Society Lewis and Clark Fund; Garden Club of America Frances M. Peacock Scholarship; Charles Redd Center for Western Studies Summer Award for Upper Division and Graduate Students; Wilson Ornithological Society Paul A. Stewart Research Award; Explorers Club Exploration Fund; Fischer Equipment Grant; Havahart Equipment Grant	Athena Fund of the Cornell Lab of Ornithology; Meg and Bert Raynes Wildlife Fund Research Grant; Cornell Lab of Ornithology; NASA Harriett G. Jenkins Pre-doctoral Fellowship; Cornell Lab of Ornithology Kramer Graduate Fellowship; Cornell Lab of Ornithology Halberstadt Graduate Fellowship; Cornell University Research Travel Grant; Cornell University Sigma Xi; Cornell Lab of Ornithology Samuel and Linda Kramer Award; Andrew W. Mellon Student Research Grant; American Ornithologists' Union; Mazamas Graduate Student Research Grant; Conservation and Research Foundation Research Grant; Western Bird Banding Association Research Grant; Wyoming Wildlife - The Foundation; Wyoming Community Foundation; American Philosophical Society Lewis and Clark Fund; Garden Club of America Frances M. Peacock Scholarship; Charles Redd Center for Western Studies Summer Award for Upper Division and Graduate Students; Wilson Ornithological Society Paul A. Stewart Research Award; Explorers Club Exploration Fund; Fischer Equipment Grant; Havahart Equipment Grant	This study was generously funded by the Athena Fund of the Cornell Lab of Ornithology (www.birds.cornell.edu), Meg and Bert Raynes Wildlife Fund Research Grant (www.rayneswildlifefund.org)*, Cornell Lab of Ornithology (www.birds.cornell.edu), NASA Harriett G. Jenkins Pre-doctoral Fellowship (#NNX10AU20A, www.nasa.gov), Cornell Lab of Ornithology Kramer Graduate Fellowship (www.birds.cornell.edu), Cornell Lab of Ornithology Halberstadt Graduate Fellowship (www.birds.cornell.edu), Cornell University Research Travel Grant (www.cornell.edu), Cornell University Sigma Xi Grants-in-Aid of Research (www.sigmaxi.org), Cornell Lab of Ornithology Samuel and Linda Kramer Award (www.cornell.edu), Andrew W. Mellon Student Research Grant (www.mellon.org), American Ornithologists' Union (www.aou.org), Mazamas Graduate Student Research Grant (www.mazamas.org), Conservation and Research Foundation Research Grant (http://conservationresearch.wordpress.com), Western Bird Banding Association Research Grant (www.westernbirdbanding.org), Wyoming Wildlife - The Foundation, Wyoming Community Foundation, Research Grant (# 20120167; www.wyomingwildlifefoundation.org)*, American Philosophical Society Lewis and Clark Fund (http://www.amphilsoc.org), The Garden Club of America Frances M. Peacock Scholarship (www.gcamerica.org), Charles Redd Center for Western Studies Summer Award for Upper Division and Graduate Students, (https://reddcenter.byu.edu), Wilson Ornithological Society Paul A. Stewart Research Award (www.wilsonsociety.org), Explorers Club Exploration Fund (www.explorers.org), Fischer Equipment Grant (www.fischersports.com), and Havahart Equipment Grant (www.havahart.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, with the exception of Cornell University and Cornell Lab of Ornithology students, professors, researchers and statisticians who provided feedback throughout the study design process, answered analyses questions and encouraged the decision to publish. TDS received all funding, with the exception of the two grants starred above (*). TDS wrote the two grants, and used the funding for her research only; however, per Cornell University policy, Janis Dickinson, TDS's advisor was the P.I.	Aldridge CL, 2007, ECOL APPL, V17, P508, DOI 10.1890/05-1871; Baldwin RF, 2006, J HERPETOL, V40, P442, DOI 10.1670/0022-1511(2006)40[442:CPFASW]2.0.CO;2; Barg JJ, 2005, J ANIM ECOL, V74, P139, DOI 10.1111/j.1365-2656.2004.00906.x; Barringer LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037663; Boal CW, 2003, CONDOR, V105, P811, DOI 10.1650/7138; Bradbury W. C., 1917, Condor Hollywood, V19, DOI 10.2307/1362616; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Caro T., 1998, BEHAV ECOLOGY CONSER; Davis J., 1957, Condor, V59, P297, DOI 10.2307/1364965; Dohms KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079621; Dooley EM, 2012, THESIS SYRACUSE U SY; Duong T, 2003, J NONPARAMETR STAT, V15, P17, DOI 10.1080/10485250306039; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Faccio SD, 2003, J HERPETOL, V37, P479, DOI 10.1670/155-02A; FARNES PE, 1990, USDA INTERM, V270, P302; Fogg AM, 2014, AVIAN CONSERV ECOL, V9, DOI 10.5751/ACE-00671-090203; GIUNTOLI M, 1978, AUK, V95, P595; Greater Yellowstone Coordinating Committee Whitebark Pine Subcommi.ttee, 2011, WHIT PIN STRAT GREAT; HARRIS S, 1990, MAMMAL REV, V20, P97, DOI 10.1111/j.1365-2907.1990.tb00106.x; HUTCHINS HE, 1982, OECOLOGIA, V55, P192, DOI 10.1007/BF00384487; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Jones MC, 1996, J AM STAT ASSOC, V91, P401, DOI 10.2307/2291420; Keane RE, 2012, RANGE WIDE RESTORATI, P108; Kernohan Brian J., 2001, P125, DOI 10.1016/B978-012497781-5/50006-2; Kie JG, 1996, WILDLIFE SOC B, V24, P342; LAIR H, 1987, ECOLOGY, V68, P1092, DOI 10.2307/1938381; Lanner R. M., 1996, MADE EACH OTHER SYMB; Law BS, 1998, BIODIVERS CONSERV, V7, P323, DOI 10.1023/A:1008877611726; Lorenz T., 2009, FINAL REPORT CLARKS; Lorenz TJ, 2011, AUK, V128, P237, DOI 10.1525/auk.2011.10101; Lorenz TJ, 2009, CONDOR, V111, P326, DOI 10.1525/cond.2009.080070; Macfarlane WW, 2013, ECOL APPL, V23, P421, DOI 10.1890/11-1982.1; Macfarlane WW, USING LANDSCAPE ASSE; Manly B., 1993, RESOURCE SELECTION A; Marzluff JM, 2004, ECOLOGY, V85, P1411, DOI 10.1890/03-0114; McKinney ST, 2009, ECOL APPL, V19, P597, DOI 10.1890/08-0151.1; MEWALDT L. RICHARD, 1956, CONDOR, V58, P3, DOI 10.2307/1365043; Millspaugh JJ, 2006, J WILDLIFE MANAGE, V70, P384, DOI 10.2193/0022-541X(2006)70[384:AORSUU]2.0.CO;2; Nielsen SE, 2006, BIOL CONSERV, V130, P217, DOI 10.1016/j.biocon.2005.12.016; ODUM E. P., 1955, AUK, V72, P128; Otis DL, 1999, J WILDLIFE MANAGE, V63, P1039, DOI 10.2307/3802819; Rota CT, 2014, FOREST ECOL MANAG, V313, P161, DOI 10.1016/j.foreco.2013.10.048; Runge CA, 2015, CONSERV BIOL, V29, P865, DOI 10.1111/cobi.12440; Savage RE, 1931, FISH INVESTIG LONG 2, V12; Schaming TD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123917; Seaman DE, 1999, J WILDLIFE MANAGE, V63, P739, DOI 10.2307/3802664; Sherry TW, 1996, ECOLOGY, V77, P36, DOI 10.2307/2265652; TOMBACK D F, 1977, Living Bird, V16, P123; Tomback DF, 2010, FOREST PATHOL, V40, P186, DOI 10.1111/j.1439-0329.2010.00655.x; Tomback D.F., 2001, WHITEBARK PINE COMMU; Tomback D. F., 1998, BIRDS N AM ONLINE; TOMBACK DF, 1982, J ANIM ECOL, V51, P451, DOI 10.2307/3976; TOMBACK DF, 1977, THESIS U CALIFORNIA; VANDERWALL SB, 1977, ECOL MONOGR, V47, P89, DOI 10.2307/1942225; VANDERWALL SB, 1981, CONDOR, V83, P162; VANDERWALL SB, 1983, CAN FIELD NAT, V97, P208; VANDERWALL SB, 1988, CONDOR, V90, P621, DOI 10.2307/1368351; White G.C., 1990, ANAL WILDLIFE RADIO; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	59	7	9	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149116	10.1371/journal.pone.0149116	http://dx.doi.org/10.1371/journal.pone.0149116			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881774	Green Published, Green Submitted, gold			2022-12-27	WOS:000371219000047
J	An, XB; Wang, JJ; Li, H; Lu, ZZ; Bai, Y; Xiao, H; Zhang, YY; Song, Y				An, Xiangbo; Wang, Jingjing; Li, Hao; Lu, Zhizhen; Bai, Yan; Xiao, Han; Zhang, Youyi; Song, Yao			Speckle Tracking Based Strain Analysis Is Sensitive for Early Detection of Pathological Cardiac Hypertrophy	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; TISSUE DOPPLER; PRESSURE; ECHOCARDIOGRAPHY; MECHANISMS; FAILURE; MOUSE	Cardiac hypertrophy is a key pathological process of many cardiac diseases. However, early detection of cardiac hypertrophy is difficult by the currently used non-invasive method and new approaches are in urgent need for efficient diagnosis of cardiac malfunction. Here we report that speckle tracking-based strain analysis is more sensitive than conventional echocardiography for early detection of pathological cardiac hypertrophy in the isoproterenol (ISO) mouse model. Pathological hypertrophy was induced by a single subcutaneous injection of ISO. Physiological cardiac hypertrophy was established by daily treadmill exercise for six weeks. Strain analysis, including radial strain (RS), radial strain rate (RSR) and longitudinal strain (LS), showed marked decrease as early as 3 days after ISO injection. Moreover, unlike the regional changes in cardiac infarction, strain analysis revealed global cardiac dysfunction that affects the entire heart in ISO-induced hypertrophy. In contrast, conventional echocardiography, only detected altered E/E', an index reflecting cardiac diastolic function, at 7 days after ISO injection. No change was detected on fractional shortening (FS), E/A and E'/A' at 3 days or 7 days after ISO injection. Interestingly, strain analysis revealed cardiac dysfunction only in ISO-induced pathological hypertrophy but not the physiological hypertrophy induced by exercise. Taken together, our study indicates that strain analysis offers a more sensitive approach for early detection of cardiac dysfunction than conventional echocardiography. Moreover, multiple strain readouts distinguish pathological cardiac hypertrophy from physiological hypertrophy.	[An, Xiangbo; Wang, Jingjing; Li, Hao; Lu, Zhizhen; Bai, Yan; Xiao, Han; Zhang, Youyi; Song, Yao] Peking Univ, Key Lab Cardiovasc Mol Biol & Regulatory Peptide, Beijing Key Lab Cardiovasc Receptors Res, Hosp 3,Inst Vasc Med,Minist Hlth, Beijing 100191, Peoples R China	Peking University	Zhang, YY; Song, Y (corresponding author), Peking Univ, Key Lab Cardiovasc Mol Biol & Regulatory Peptide, Beijing Key Lab Cardiovasc Receptors Res, Hosp 3,Inst Vasc Med,Minist Hlth, Beijing 100191, Peoples R China.	zhangyy@bjmu.edu.cn; songyao@bjmu.edu.cn	Xiao, Han/T-5032-2019	, Wang/0000-0002-5119-3960	national natural science foundation of China [81530009, 81300067]; National Key Basic Research Program of the People's Republic of China [2012CB518000]	national natural science foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of the People's Republic of China	The study was supported by national natural science foundation of China (81530009, 81300067, http://www.nsfc.gov.cn) and National Key Basic Research Program of the People's Republic of China (2012CB518000, http://english.iee.cas.cn). YZ received the grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer M, 2011, CIRC RES, V108, P908, DOI 10.1161/CIRCRESAHA.110.239574; Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; Condorelli Gianluigi, 2008, Heart Fail Monit, V5, P112; Edvardsen T, 2006, PROG CARDIOVASC DIS, V49, P207, DOI 10.1016/j.pcad.2006.08.008; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Hashimoto I, 2003, J AM COLL CARDIOL, V42, P1574, DOI 10.1016/j.jacc.2003.05.002; Hoit BD, 2006, TOXICOL PATHOL, V34, P105, DOI 10.1080/01926230500369535; Hunter JJ, 1999, NEW ENGL J MED, V341, P1276, DOI 10.1056/NEJM199910213411706; Ingul CB, 2010, J AM SOC ECHOCARDIOG, V23, P432, DOI 10.1016/j.echo.2010.01.018; Jassal DS, 2009, J AM SOC ECHOCARDIOG, V22, P418, DOI 10.1016/j.echo.2009.01.016; Lapa C, 2015, INT J CARDIOL, V194, P44, DOI 10.1016/j.ijcard.2015.05.073; Li C, 2010, EUR J ECHOCARDIOGR, V11, P296, DOI 10.1093/ejechocard/jep218; Meoli DF, 2004, J CLIN INVEST, V113, P1684, DOI 10.1172/JCI200420352; Moreira-Goncalves D, 2015, J PHYSIOL-LONDON, V593, P3885, DOI 10.1113/JP270685; Perk G, 2007, J AM SOC ECHOCARDIOG, V20, P234, DOI 10.1016/j.echo.2006.08.023; Powers SK, 2014, PHYSIOLOGY, V29, P27, DOI 10.1152/physiol.00030.2013; Saeed M, 2015, CARDIOVASC DIAGN THE, V5, P290, DOI 10.3978/j.issn.2223-3652.2015.06.07; Stanton T, 2010, JACC-CARDIOVASC IMAG, V3, P867, DOI 10.1016/j.jcmg.2010.05.011; Strijkers GJ, 2009, NMR BIOMED, V22, P182, DOI 10.1002/nbm.1299; Thibault H, 2009, J AM SOC ECHOCARDIOG, V22, P198, DOI 10.1016/j.echo.2008.11.019; Zhang Y, 2005, J AM COLL CARDIOL, V46, P864, DOI 10.1016/j.jacc.2005.05.054; Zhong M, 2013, J NUCL MED, V54, P609, DOI 10.2967/jnumed.112.108092	22	16	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149155	10.1371/journal.pone.0149155	http://dx.doi.org/10.1371/journal.pone.0149155			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871457	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100114
J	Duan, RH; Shi, YT; Yu, L; Zhang, GH; Li, J; Lin, YT; Guo, JF; Wang, JL; Shen, L; Jiang, H; Wang, GH; Tang, BS				Duan, Ranhui; Shi, Yuting; Yu, Li; Zhang, Gehan; Li, Jia; Lin, Yunting; Guo, Jifeng; Wang, Junling; Shen, Lu; Jiang, Hong; Wang, Guanghui; Tang, Beisha			UBA5 Mutations Cause a New Form of Autosomal Recessive Cerebellar Ataxia	PLOS ONE			English	Article							UBIQUITIN-ACTIVATING ENZYME; UFM1	Autosomal recessive cerebellar ataxia (ARCA) comprises a large and heterogeneous group of neurodegenerative disorders. For many affected patients, the genetic cause remains undetermined. Through whole-exome sequencing, we identified compound heterozygous mutations in ubiquitin-like modifier activating enzyme 5 gene (UBA5) in two Chinese siblings presenting with ARCA. Moreover, copy number variations in UBA5 or ubiquitin-fold modifier 1 gene (UFM1) were documented with the phenotypes of global developmental delays and gait disturbances in the ClinVar database. UBA5 encodes UBA5, the ubiquitin-activating enzyme of UFM1. However, a crucial role for UBA5 in human neurological disease remains to be reported. Our molecular study of UBA5-R246X revealed a dramatically decreased half-life and loss of UFM1 activation due to the absence of the catalytic cysteine Cys250. UBA5-K310E maintained its interaction with UFM1, although with less stability, which may affect the ability of this UBA5 mutant to activate UFM1. Drosophila modeling revealed that UBA5 knockdown induced locomotive defects and a shortened lifespan accompanied by aberrant neuromuscular junctions (NMJs). Strikingly, we found that UFM1 and E2 cofactor knockdown induced markedly similar phenotypes. Wild-type UBA5, but not mutant UBA5, significantly restored neural lesions caused by the absence of UBA5. The finding of a UBA5 mutation in cerebellar ataxia suggests that impairment of the UFM1 pathway may contribute to the neurological phenotypes of ARCA.	[Shi, Yuting; Guo, Jifeng; Wang, Junling; Shen, Lu; Jiang, Hong; Tang, Beisha] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China; [Duan, Ranhui; Yu, Li; Zhang, Gehan; Li, Jia; Lin, Yunting; Guo, Jifeng; Wang, Junling; Shen, Lu; Jiang, Hong; Tang, Beisha] Cent S Univ, Sch Life Sci, State Key Lab Med Genet, Changsha, Hunan, Peoples R China; [Wang, Guanghui] Soochow Univ, Coll Pharmaceut Sci, Dept Pharmacol, Suzhou, Jiangsu, Peoples R China; [Guo, Jifeng; Wang, Junling; Shen, Lu; Jiang, Hong; Tang, Beisha] Cent S Univ, Key Lab Hunan Prov Neurodegenerat Disorders, Changsha, Hunan, Peoples R China	Central South University; Central South University; Soochow University - China; Central South University	Tang, BS (corresponding author), Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China.; Duan, RH; Tang, BS (corresponding author), Cent S Univ, Sch Life Sci, State Key Lab Med Genet, Changsha, Hunan, Peoples R China.; Tang, BS (corresponding author), Cent S Univ, Key Lab Hunan Prov Neurodegenerat Disorders, Changsha, Hunan, Peoples R China.	duanranhui@sklmg.edu.cn; bstang7398@163.com	Wang, Guanghui/U-3979-2017	Wang, Guanghui/0000-0001-8551-6468	State Key Program of the National Natural Science Foundation of China [81130021]; National Natural Science Foundation of China [81571253, 81172513, 81071028]	State Key Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The State Key Program of the National Natural Science Foundation of China (grant number: 81130021), National Natural Science Foundation of China (grant number: 81571253, 81172513, 81071028).	Anheim M, 2012, NEW ENGL J MED, V366, P636, DOI 10.1056/NEJMra1006610; Azfer A, 2006, AM J PHYSIOL-HEART C, V291, pH1411, DOI 10.1152/ajpheart.01378.2005; Bacik JP, 2010, J BIOL CHEM, V285, P20273, DOI 10.1074/jbc.M110.102921; Collins CA, 2007, CURR OPIN NEUROBIOL, V17, P35, DOI 10.1016/j.conb.2007.01.001; Daniel J, 2014, CELLS-BASEL, V3, P627, DOI 10.3390/cells3020627; De Michele G, 2004, J NEUROL, V251, P913, DOI 10.1007/s00415-004-0484-2; Depondt C, 2014, NEUROLOGY, V82, P1749, DOI 10.1212/WNL.0000000000000416; Ha BH, 2011, J BIOL CHEM, V286, P10248, DOI 10.1074/jbc.M110.172171; Hersheson J, 2012, HUM MUTAT, V33, P1324, DOI 10.1002/humu.22132; Hertel P, 2013, J BIOL CHEM, V288, P10661, DOI 10.1074/jbc.M113.458000; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; Lemaire K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018517; Ronnebaum Sarah M, 2014, Hum Genome Var, V1, P14018, DOI 10.1038/hgv.2014.18; Sailer A, 2012, CURR NEUROL NEUROSCI, V12, P227, DOI 10.1007/s11910-012-0267-6; Shi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081884; Shiwaku H, 2010, EMBO J, V29, P2446, DOI 10.1038/emboj.2010.116; Tatsumi K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1182; Tatsumi K, 2010, J BIOL CHEM, V285, P5417, DOI 10.1074/jbc.M109.036814; Vermeer S, 2011, J MED GENET, V48, P651, DOI 10.1136/jmedgenet-2011-100210; Willemsen MH, 2013, J MED GENET, V50, P507, DOI 10.1136/jmedgenet-2012-101490; Xing GL, 2014, J BIOL CHEM, V289, P31867, DOI 10.1074/jbc.M114.574897; Zhang M, 2015, CELL DEATH DIFFER, V51; Zheng M, 2008, J CELL BIOCHEM, V104, P2324, DOI 10.1002/jcb.21791	23	40	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149039	10.1371/journal.pone.0149039	http://dx.doi.org/10.1371/journal.pone.0149039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872069	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100091
J	Guarnieri, G; Bevilacqua, S; De Leo, F; Farella, G; Maffia, A; Terlizzi, A; Fraschetti, S				Guarnieri, Giuseppe; Bevilacqua, Stanislao; De Leo, Francesco; Farella, Giulio; Maffia, Anna; Terlizzi, Antonio; Fraschetti, Simonetta			The Challenge of Planning Conservation Strategies in Threatened Seascapes: Understanding the Role of Fine Scale Assessments of Community Response to Cumulative Human Pressures	PLOS ONE			English	Article							HUMAN DISTURBANCE; MARINE HABITATS; MULTIVARIATE; SEA; ASSEMBLAGES; PATTERNS; UNIVARIATE; IMPACT; AREAS	Assessing the distribution and intensity of human threats to biodiversity is a prerequisite for effective spatial planning, harmonizing conservation purposes with sustainable development. In the Mediterranean Sea, the management of Marine Protected Areas (MPAs) is rarely based on explicit consideration of the distribution of multiple stressors, with direct assessment of their effects on ecosystems. This gap limits the effectiveness of protection and is conducive to conflicts among stakeholders. Here, a fine scale assessment of the potential effects of different combinations of stressors (both land- and marine-based) on vulnerable rocky habitats (i.e. lower midlittoral and shallow infralittoral) along 40 km of coast in the western Mediterranean (Ionian Sea) has been carried out. The study area is a paradigmatic example of socio-ecological interactions, where several human uses and conservation measures collide. Significant differences in the structure of assemblages according to different combinations of threats were observed, indicating distinct responses of marine habitats to different sets of human pressures. A more complex three-dimensional structure, higher taxon richness and beta-diversity characterized assemblages subject to low versus high levels of human pressure, consistently across habitats. In addition, the main drivers of change were: closeness to the harbour, water quality, and the relative extension of beaches. Our findings suggest that, although efforts to assess cumulative impacts at large scale may help in individuating priority areas for conservation purposes, the fact that such evaluations are often based on expert opinions and not on actual studies limits their ability to represent real environmental conditions at local scale. Systematic evaluations of local scale effects of anthropogenic drivers of change on biological communities should complement broad scale management strategies to achieve effective sustainability of human exploitation of marine resources.	[Guarnieri, Giuseppe; Bevilacqua, Stanislao; De Leo, Francesco; Farella, Giulio; Maffia, Anna; Terlizzi, Antonio; Fraschetti, Simonetta] Univ Salento, Dept Biol & Environm Sci & Technol, CoNISMa, I-73100 Lecce, Italy	CoNISMa; University of Salento	Guarnieri, G (corresponding author), Univ Salento, Dept Biol & Environm Sci & Technol, CoNISMa, I-73100 Lecce, Italy.	giuseppe.guarnieri@unisalento.it	Bevilacqua, Stanislao/I-1393-2019; Terlizzi, Antonio/B-6131-2015; Fraschetti, Simonetta/R-8716-2019	Bevilacqua, Stanislao/0000-0002-6417-7134; Terlizzi, Antonio/0000-0001-5968-4548; Fraschetti, Simonetta/0000-0002-1780-1651; Farella, Giulio/0000-0001-5710-911X; DE LEO, FRANCESCO/0000-0001-9709-6114; Guarnieri, Giuseppe/0000-0002-7334-9030	European Community [287844]; Italian Ministry of the Research PRIN TETRIS	European Community(European Commission); Italian Ministry of the Research PRIN TETRIS	The research leading to these results received funding from the European Community's 7th Framework Programme (FP7/2007-2013) under Grant Agreement No. 287844 for the project 'Towards COast to COast NETworks of marine protected areas (from the shore to the high and deep sea), coupled with sea-based wind energy potential' (COCONET, http://www.coconet-fp7.eu/). The support from the Italian Ministry of the Research PRIN TETRIS is also acknowledged.	Airoldi L, 2003, OCEANOGR MAR BIOL, V41, P161; Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Andersen JH, 2015, ESTUAR COAST SHELF S, V161, P88, DOI 10.1016/j.ecss.2015.05.002; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; [Anonymous], 2008, OFF J EUR COMMUNITIE, V164, P19, DOI DOI 10.1016/J.BIOCON.2008.10.006; Ban NC, 2009, CONSERV LETT, V2, P206, DOI 10.1111/j.1755-263X.2009.00071.x; Ban SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135465; Batista MI, 2014, OCEAN COAST MANAGE, V102, P248, DOI 10.1016/j.ocecoaman.2014.09.020; Benedetti-Cecchi L, 2001, MAR ECOL PROG SER, V214, P137, DOI 10.3354/meps214137; Bevilacqua S, 2006, J ANIM ECOL, V75, P908, DOI 10.1111/j.1365-2656.2006.01108.x; Bulleri F, 2010, J APPL ECOL, V47, P26, DOI 10.1111/j.1365-2664.2009.01751.x; Cheng BS, 2015, GLOBAL CHANGE BIOL, V21, P2488, DOI 10.1111/gcb.12895; Chryssovergis F, 1995, OCEANOL ACTA, V18, P649; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; Claudet J, 2010, BIOL CONSERV, V143, P2195, DOI 10.1016/j.biocon.2010.06.004; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; Douvere F, 2008, MAR POLICY, V32, P762, DOI 10.1016/j.marpol.2008.03.021; Fernandez-Macho J, 2015, MAR POLICY, V60, P49, DOI 10.1016/j.marpol.2015.05.010; Ferretti M, 2011, STATE ITALIAN MARINE, P185; Fraschetti S, 2001, MAR ECOL PROG SER, V212, P1, DOI 10.3354/meps212001; Fraschetti S, 2009, MAR ECOL PROG SER, V375, P13, DOI 10.3354/meps07781; Gray JS, 1997, BIODIVERS CONSERV, V6, P153, DOI 10.1023/A:1018335901847; Guidetti P, 2003, MAR BIOL, V143, P1135, DOI 10.1007/s00227-003-1163-z; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2007, CONSERV BIOL, V21, P1301, DOI 10.1111/j.1523-1739.2007.00752.x; Knight AT, 2008, CONSERV BIOL, V22, P610, DOI 10.1111/j.1523-1739.2008.00914.x; Lubchenco J, 2003, ECOL APPL, V13, pS3; Mazor T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104489; McLeod K.L., 2005, SCI CONSENSUS STATEM; Micheli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079889; Parravicini V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075767; Perkol-Finkel S, 2007, J EXP MAR BIOL ECOL, V340, P25, DOI 10.1016/j.jembe.2006.08.008; Perkol-Finkel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010791; Philippart CJM, 2012, ESTUAR COAST SHELF S, V108, P52, DOI 10.1016/j.ecss.2012.05.014; Pinto H, 2015, MAR POLICY, V57, P167, DOI 10.1016/j.marpol.2015.03.029; Piola RF, 2008, DIVERS DISTRIB, V14, P329, DOI 10.1111/j.1472-4642.2007.00430.x; Roberts JJ, 2010, ENVIRON MODELL SOFTW, V25, P1197, DOI 10.1016/j.envsoft.2010.03.029; Smith SDA, 1996, MAR POLLUT BULL, V33, P309, DOI 10.1016/S0025-326X(96)00124-5; Tamburello L, 2012, MAR ECOL PROG SER, V457, P29, DOI 10.3354/meps09703; Terlizzi A, 2005, MAR ECOL PROG SER, V289, P27, DOI 10.3354/meps289027; Terlizzi A, 2007, MAR ECOL PROG SER, V332, P25, DOI 10.3354/meps332025; Thibaut T, 2005, MAR POLLUT BULL, V50, P1472, DOI 10.1016/j.marpolbul.2005.06.014; Turner SJ, 1997, MAR ENVIRON RES, V43, P181, DOI 10.1016/0141-1136(96)00086-4; Wernberg T, 2012, GLOBAL CHANGE BIOL, V18, P1491, DOI 10.1111/j.1365-2486.2012.02656.x	48	19	19	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149253	10.1371/journal.pone.0149253	http://dx.doi.org/10.1371/journal.pone.0149253			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871942	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100135
J	Kolekar, PS; Waman, VP; Kale, MM; Kulkarni-Kale, U				Kolekar, Pandurang S.; Waman, Vaishali P.; Kale, Mohan M.; Kulkarni-Kale, Urmila			RV-Typer: A Web Server for Typing of Rhinoviruses Using Alignment-Free Approach	PLOS ONE			English	Article							MOSAIC STRUCTURE; RECOMBINATION; SEQUENCES; CLASSIFICATION; PHYLOGENY; PROPOSALS; ALGORITHM; VP1	Rhinoviruses (RV) are increasingly being reported to cause mild to severe infections of respiratory tract in humans. RV are antigenically the most diverse species of the genus Enterovirus and family Picornaviridae. There are three species of RV (RV-A, -B and -C), with 80, 32 and 55 serotypes/types, respectively. Antigenic variation is the main limiting factor for development of a cross-protective vaccine against RV. Serotyping of Rhinoviruses is carried out using cross-neutralization assays in cell culture. However, these assays become laborious and time-consuming for the large number of strains. Alternatively, serotyping of RV is carried out by alignment-based phylogeny of both protein and nucleotide sequences of VP1. However, serotyping of RV based on alignment-based phylogeny is a multi-step process, which needs to be repeated every time a new isolate is sequenced. In view of the growing need for serotyping of RV, an alignment-free method based on "return time distribution" (RTD) of amino acid residues in VP1 protein has been developed and implemented in the form of a web server titled RV-Typer. RV-Typer accepts nucleotide or protein sequences as an input and computes return times of di-peptides (k = 2) to assign serotypes. The RV-Typer performs with 100% sensitivity and specificity. It is significantly faster than alignment based methods.	[Kolekar, Pandurang S.; Waman, Vaishali P.; Kulkarni-Kale, Urmila] Savitribai Phule Pune Univ, Bioinformat Ctr, Pune 411007, Maharashtra, India; [Kale, Mohan M.] Savitribai Phule Pune Univ, Dept Stat, Pune 411007, Maharashtra, India	Savitribai Phule Pune University; Savitribai Phule Pune University	Kulkarni-Kale, U (corresponding author), Savitribai Phule Pune Univ, Bioinformat Ctr, Pune 411007, Maharashtra, India.	urmila@bioinfo.net.in	Kolekar, Pandurang/ABF-7389-2020; Kulkarni-Kale, Urmila/G-6946-2011	Kolekar, Pandurang/0000-0003-0044-0076; 	Centre of Excellence (COE) Grant by the DBT, Government of India; BioInformatics National Certification (BINC) fellowship, Department of Biotechnology (DBT) by the Government of India; DBT fellowship; Centre of Excellence (COE) Grant by the DBT	Centre of Excellence (COE) Grant by the DBT, Government of India; BioInformatics National Certification (BINC) fellowship, Department of Biotechnology (DBT) by the Government of India; DBT fellowship; Centre of Excellence (COE) Grant by the DBT	This work was supported under the Centre of Excellence (COE) Grant by the DBT, Government of India to the Bioinformatics Centre, Savitribai Phule Pune University, Pune (India). PSK acknowledges the BioInformatics National Certification (BINC) fellowship awarded by the Department of Biotechnology (DBT), Government of India. VPW acknowledges DBT fellowship. UKK acknowledges the Centre of Excellence (COE) Grant by the DBT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported under the Centre of Excellence (COE) Grant by the DBT, Government of India to the Bioinformatics Centre, Savitribai Phule Pune University, Pune (India). PSK acknowledges the BioInformatics National Certification (BINC) fellowship awarded by the Department of Biotechnology (DBT), Government of India. VPW acknowledges DBT fellowship. UKK acknowledges the Centre of Excellence (COE) Grant by the DBT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 1967, NATURE, V213, P761, DOI 10.1038/213761a0; Benson DA, 2015, NUCLEIC ACIDS RES, V43, pD30, DOI 10.1093/nar/gku1216; Bizzintino J, 2011, EUR RESPIR J, V37, P1037, DOI 10.1183/09031936.00092410; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Glanville N, 2015, CURR OPIN VIROL, V11, P83, DOI 10.1016/j.coviro.2015.03.004; HAMPARIAN VV, 1987, VIROLOGY, V159, P191; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knowles NJ, 2012, VIRUS TAXONOMY CLASS, P855, DOI DOI 10.1016/B978-0-12-384684-6.00074-4; Kolekar P, 2011, IMMUNOME RES, V7, P1; Kolekar P, 2011, MOL EVOLUTION PHYLOG; Kolekar P, 2014, J VIROL METHODS, V198, P41, DOI 10.1016/j.jviromet.2013.12.012; Kolekar P, 2012, MOL PHYLOGENET EVOL, V65, P510, DOI 10.1016/j.ympev.2012.07.003; Kolekar PS, 2010, AIP CONF PROC, V1298, P307, DOI 10.1063/1.3516320; Laine P, 2005, J GEN VIROL, V86, P697, DOI 10.1099/vir.0.80445-0; Ledford RM, 2004, J VIROL, V78, P3663, DOI 10.1128/JVI.78.7.3663-3674.2004; Linder JE, 2013, J ALLERGY CLIN IMMUN, V131, P69, DOI 10.1016/j.jaci.2012.09.033; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; McIntyre CL, 2013, J GEN VIROL, V94, P1791, DOI 10.1099/vir.0.053686-0; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Palmenberg AC, 2009, SCIENCE, V324, P55, DOI 10.1126/science.1165557; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Ruuskanen O, 2013, PEDIATR INFECT DIS J, V32, P553, DOI 10.1097/INF.0b013e3182833c90; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Simmonds P, 2010, J GEN VIROL, V91, P2409, DOI 10.1099/vir.0.023994-0; SMITH JM, 1992, J MOL EVOL, V34, P126; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Waman VP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088981; Wong KM, 2008, SCIENCE, V319, P473, DOI 10.1126/science.1151532	33	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149350	10.1371/journal.pone.0149350	http://dx.doi.org/10.1371/journal.pone.0149350			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26870949	Green Published, gold			2022-12-27	WOS:000370054100149
J	Varga-Szemes, A; Kiss, P; Rab, A; Suranyi, P; Lenkey, Z; Simor, T; Bryant, RG; Elgavish, GA				Varga-Szemes, Akos; Kiss, Pal; Rab, Andras; Suranyi, Pal; Lenkey, Zsofia; Simor, Tamas; Bryant, Robert G.; Elgavish, Gabriel A.			In Vitro Longitudinal Relaxivity Profile of Gd (ABE-DTTA), an Investigational Magnetic Resonance Imaging Contrast Agent	PLOS ONE			English	Article							HIGH-FIELD MRI; SOLVENT PROTONS; CARDIAC MRI; 7 TESLA; RELAXATION; DEPENDENCE; GADOLINIUM; STRENGTH; INFARCT; LESIONS	Purpose MRI contrast agents (CA) whose contrast enhancement remains relatively high even at the higher end of the magnetic field strength range would be desirable. The purpose of this work was to demonstrate such a desired magnetic field dependency of the longitudinal relaxivity for an experimental MRI CA, Gd(ABE-DTTA). Materials and Methods The relaxivity of 0.5mM and 1mM Gd(ABE-DTTA) was measured by Nuclear Magnetic Relaxation Dispersion (NMRD) in the range of 0.0002 to 1T. Two MRI and five NMR instruments were used to cover the range between 1.5 to 20T. Parallel measurement of a GdDTPA sample was performed throughout as reference. All measurements were carried out at 37 degrees C and pH 7.4. Results The relaxivity values of 0.5mM and 1mM Gd(ABE-DTTA) measured at 1.5, 3, and 7T, within the presently clinically relevant magnetic field range, were 15.3, 11.8, 12.4 s(-1)mM(-1) and 18.1, 16.7, and 13.5 s(-1)mM(-1), respectively. The control 4 mM Gd-DTPA relaxivities at the same magnetic fields were 3.6, 3.3, and 3.0 s(-1)mM(-1), respectively. Conclusions The longitudinal relaxivity of Gd(ABE-DTTA) measured within the presently clinically relevant field range is three to five times higher than that of most commercially available agents. Thus, Gd(ABE-DTTA) could be a practical choice at any field strength currently used in clinical imaging including those at the higher end.	[Varga-Szemes, Akos; Kiss, Pal; Rab, Andras; Suranyi, Pal; Lenkey, Zsofia; Simor, Tamas; Elgavish, Gabriel A.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL USA; [Varga-Szemes, Akos; Kiss, Pal; Rab, Andras; Suranyi, Pal; Lenkey, Zsofia; Simor, Tamas; Elgavish, Gabriel A.] Elgavish Paramagnet Inc, Birmingham, AL USA; [Lenkey, Zsofia; Simor, Tamas] Univ Pecs, Sch Med, Inst Heart, Pecs, Hungary; [Bryant, Robert G.] Univ Virginia, Dept Chem, Charlottesville, VA USA	University of Alabama System; University of Alabama Birmingham; University of Pecs; University of Virginia	Elgavish, GA (corresponding author), Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL USA.; Elgavish, GA (corresponding author), Elgavish Paramagnet Inc, Birmingham, AL USA.	gabi@uab.edu	Rab, András/AAR-7804-2021; Rab, Andras/AAI-9402-2021; Varga-Szemes, Akos/AAI-9849-2020	Rab, András/0000-0003-2154-0017; Varga-Szemes, Akos/0000-0002-2781-7462	National Institutes of Health (NIH) [5R42 HL084844]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R42HL084844] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institutes of Health (NIH) Grant 5R42 HL084844 (A.V.S.) to Elgavish Paramagnetics Inc. Drs. Kiss, Lenkey, Rab, Suranyi, and Varga-Szemes were employees, Dr. Simor is consultant, and Dr. Elgavish is officer of Elgavish Paramagnetics Inc. Elgavish Paramagnetics Inc. provided direct support in the form of salaries for the authors (except RGB), but did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absinta M, 2013, ANN NEUROL, V74, P669, DOI 10.1002/ana.23959; Adzamli K, 1999, INVEST RADIOL, V34, P410, DOI 10.1097/00004424-199906000-00004; Aime S, 2009, J MAGN RESON IMAGING, V30, P1259, DOI 10.1002/jmri.21969; Caravan P, 2009, CONTRAST MEDIA MOL I, V4, P89, DOI 10.1002/cmmi.267; Conijn MMA, 2012, NEUROIMAGE, V59, P950, DOI 10.1016/j.neuroimage.2011.08.059; Craven I, 2011, CLIN RADIOL, V66, P278, DOI 10.1016/j.crad.2010.10.010; Dagia C., 2009, CLIN PEDIAT IMAGING, V68, P309, DOI DOI 10.1016/J.EJRAD.2008.05.019; Diakova G, 2011, J MAGN RESON, V208, P195, DOI 10.1016/j.jmr.2010.11.001; Dougherty L, 2001, MAGNET RESON MED, V45, P176, DOI 10.1002/1522-2594(200101)45:1<176::AID-MRM1025>3.0.CO;2-E; Jacques V, 2010, INVEST RADIOL, V45, P613, DOI 10.1097/RLI.0b013e3181ee6a49; Kaldoudi E, 1993, CONCEPT MAGNETIC RES, V5, P217, DOI [DOI 10.1002/CMR.1820050303, 10.1002/cmr.1820050303]; Kellar KE, 1997, MAGNET RESON MED, V37, P730, DOI 10.1002/mrm.1910370515; Kirschner R, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-22; Kiss P, 2009, PROSTATE, V69, P449, DOI 10.1002/pros.20880; KOENIG SH, 1986, INVEST RADIOL, V21, P697, DOI 10.1097/00004424-198609000-00004; KOENIG SH, 1984, MAGN RESON MED, V1, P478, DOI 10.1002/mrm.1910010407; KOENIG SH, 1984, MAGNET RESON MED, V1, P496, DOI 10.1002/mrm.1910010408; Kwon DH, 2012, ANN NEUROL, V71, P267, DOI 10.1002/ana.22592; Nael Kambiz, 2007, Magn Reson Imaging Clin N Am, V15, P291, DOI 10.1016/j.mric.2007.08.002; Nakada T, 2007, BRAIN DEV-JPN, V29, P325, DOI 10.1016/j.braindev.2006.10.005; Noebauer-Huhmann IM, 2010, INVEST RADIOL, V45, P554, DOI 10.1097/RLI.0b013e3181ebd4e3; Pakin SK, 2006, ACAD RADIOL, V13, P1135, DOI 10.1016/j.acra.2006.06.007; Regatte RR, 2007, J MAGN RESON IMAGING, V25, P262, DOI 10.1002/jmri.20814; Rinck PA, 1999, EUR RADIOL, V9, P998, DOI 10.1007/s003300050781; Rohrer M, 2005, INVEST RADIOL, V40, P715, DOI 10.1097/01.rli.0000184756.66360.d3; Ruzsics B, 2006, PHARMACOLOGY, V77, P188, DOI 10.1159/000094864; Saab-Ismail NH, 1999, J MED CHEM, V42, P2852, DOI 10.1021/jm980454v; Simor T, 2005, J MAGN RESON IMAGING, V21, P536, DOI 10.1002/jmri.20326; Suranyi P, 2006, MAGN RESON MED, V56, P535, DOI 10.1002/mrm.20979; van Rooden Sanneke, 2014, Alzheimers Dement, V10, pe19, DOI 10.1016/j.jalz.2013.02.002; van Veluw SJ, 2013, J CEREBR BLOOD F MET, V33, P322, DOI 10.1038/jcbfm.2012.196; Vaughan T, 2006, MAGN RESON MED, V56, P1274, DOI 10.1002/mrm.21073; von Knobelsdorff-Brenkenhoff F, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-23; Webb A., 2002, ANN REP NMR SPECTR, V45, P1, DOI DOI 10.1016/S0066-4103(02)45009-0	34	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149260	10.1371/journal.pone.0149260	http://dx.doi.org/10.1371/journal.pone.0149260			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872055	gold, Green Published, Green Submitted			2022-12-27	WOS:000370054100136
J	Berdan, CA; Erion, KA; Burritt, NE; Corkey, BE; Deeney, JT				Berdan, Charles A.; Erion, Karel A.; Burritt, Nathan E.; Corkey, Barbara E.; Deeney, Jude T.			Inhibition of Monoacylglycerol Lipase Activity Decreases Glucose-Stimulated Insulin Secretion in INS-1 (832/13) Cells and Rat Islets	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; ACYL-COA ESTERS; POTASSIUM CHANNEL; CHRONIC EXPOSURE; EXOCYTOSIS; 2-ARACHIDONOYLGLYCEROL; MODULATION; ACTIVATION; MECHANISMS; LIPOLYSIS	Lipid signals derived from lipolysis and membrane phospholipids play an important role in glucose-stimulated insulin secretion (GSIS), though the exact secondary signals remain unclear. Previous reports have documented a stimulatory role of exogenously added monoacyl-glycerol (MAG) on insulin secretion from cultured beta-cells and islets. In this report we have determined effects of increasing intracellular MAG in the beta-cell by inhibiting monoacyl-glycerol lipase (MGL) activity, which catalyzes the final step in triacylglycerol breakdown, namely the hydrolysis of MAG to glycerol and free fatty acid (FA). To determine the role of MGL in GSIS, we used three different pharmacological agents (JZL184, MJN110 and URB602). All three inhibited GSIS and depolarization-induced insulin secretion in INS-1 (832/13). JZL184 significantly inhibited both GSIS and depolarization-induced insulin secretion in rat islets. JZL184 significantly decreased lipolysis and increased both mono- and diacyglycerol species in INS-1 cells. Analysis of the kinetics of GSIS showed that inhibition was greater during the sustained phase of secretion. A similar pattern was observed in the response of Ca2+ to glucose and depolarization but to a lesser degree suggesting that altered Ca2+ handling alone could not explain the reduction in insulin secretion. In addition, a significant reduction in long chain-CoA (LC-CoA) was observed in INS-1 cells at both basal and stimulatory glucose following inhibition of MGL. Our data implicate an important role for MGL in insulin secretion.	[Berdan, Charles A.; Erion, Karel A.; Burritt, Nathan E.; Corkey, Barbara E.; Deeney, Jude T.] Boston Univ, Sch Med, Dept Med, Obes Res Ctr, Boston, MA 02118 USA	Boston University	Deeney, JT (corresponding author), Boston Univ, Sch Med, Dept Med, Obes Res Ctr, Boston, MA 02118 USA.	jdeeney@bu.edu		Deeney, Jude/0000-0003-0988-9419	National Institutes of Health [DK74778, DK35914]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035914, R37DK035914, R56DK035914, R01DK074778, T32DK007201] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health grant number DK74778, National Institutes of Health grant number DK35914. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Bollheimer LC, 1998, J CLIN INVEST, V101, P1094, DOI 10.1172/JCI420; Branstrom R, 1998, J BIOL CHEM, V273, P31395, DOI 10.1074/jbc.273.47.31395; Brown H, 2000, DIABETES, V49, P383, DOI 10.2337/diabetes.49.3.383; Brown H, 1998, EMBO J, V17, P5048, DOI 10.1093/emboj/17.17.5048; CORKEY BE, 1989, J BIOL CHEM, V264, P21608; Corkey BE, 2000, J NUTR, V130, p299S, DOI 10.1093/jn/130.2.299S; CORKEY BE, 1988, METHOD ENZYMOL, V166, P55; Cunningham BA, 1996, AM J PHYSIOL-ENDOC M, V271, pE702, DOI 10.1152/ajpendo.1996.271.4.E702; De Marchi U, 2014, J BIOL CHEM, V289, P9182, DOI 10.1074/jbc.M113.513184; DEENEY JT, 1992, J BIOL CHEM, V267, P19840; Deeney JT, 2000, J BIOL CHEM, V275, P9363, DOI 10.1074/jbc.275.13.9363; Erion KA, 2015, J BIOL CHEM, V290, P16191, DOI 10.1074/jbc.M114.620351; Gauthier BR, 2008, AM J PHYSIOL-ENDOC M, V295, pE1279, DOI 10.1152/ajpendo.90568.2008; Gribble FM, 1998, J BIOL CHEM, V273, P26383, DOI 10.1074/jbc.273.41.26383; Halban PA, 2014, DIABETES CARE, V37, P1751, DOI 10.2337/dc14-0396; Henquin JC, 2011, DIABETES RES CLIN PR, V93, pS27, DOI 10.1016/S0168-8227(11)70010-9; Hohmann AG, 2005, NATURE, V435, P1108, DOI 10.1038/nature03658; Iglesias J, 2016, J LIPID RES, V57, P131, DOI 10.1194/jlr.D058438; Labar G, 2010, CURR MED CHEM, V17, P2588, DOI 10.2174/092986710791859414; Larsson O, 1996, J BIOL CHEM, V271, P10623, DOI 10.1074/jbc.271.18.10623; Li C, 2012, CELL PHYSIOL BIOCHEM, V30, P347, DOI 10.1159/000339069; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143; Mulvihill MM, 2013, LIFE SCI, V92, P492, DOI 10.1016/j.lfs.2012.10.025; Niphakis MJ, 2013, ACS CHEM NEUROSCI, V4, P1322, DOI 10.1021/cn400116z; Olofsson CS, 2007, DIABETES, V56, P1888, DOI 10.2337/db06-1150; OLSZEWSKI S, 1994, J BIOL CHEM, V269, P27987; Oprescu AI, 2007, DIABETES, V56, P2927, DOI 10.2337/db07-0075; Peyot ML, 2004, DIABETES, V53, P1733, DOI 10.2337/diabetes.53.7.1733; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Prentki M, 2012, MOL CELL ENDOCRINOL, V353, P88, DOI 10.1016/j.mce.2011.11.004; Saadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030200; Sato Y, 1999, ENDOCRINOLOGY, V140, P2252, DOI 10.1210/en.140.5.2252; Stein DT, 1996, J CLIN INVEST, V97, P2728, DOI 10.1172/JCI118727; Tian YR, 2008, AM J PHYSIOL-ENDOC M, V294, pE1178, DOI 10.1152/ajpendo.90237.2008; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Winzell MS, 2006, NUTR METAB CARDIOVAS, V16, pS11, DOI 10.1016/j.numecd.2005.11.006; Yaney GC, 2002, AM J PHYSIOL-ENDOC M, V283, pE880, DOI 10.1152/ajpendo.00474.2001; Zhao SG, 2014, CELL METAB, V19, P993, DOI 10.1016/j.cmet.2014.04.003	40	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149008	10.1371/journal.pone.0149008	http://dx.doi.org/10.1371/journal.pone.0149008			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867016	gold, Green Submitted, Green Published			2022-12-27	WOS:000370050700053
J	Burkill, S; Copas, A; Couper, MP; Clifton, S; Prah, P; Datta, J; Conrad, F; Wellings, K; Johnson, AM; Erens, B				Burkill, Sarah; Copas, Andrew; Couper, Mick P.; Clifton, Soazig; Prah, Philip; Datta, Jessica; Conrad, Frederick; Wellings, Kaye; Johnson, Anne M.; Erens, Bob			Using the Web to Collect Data on Sensitive Behaviours: A Study Looking at Mode Effects on the British National Survey of Sexual Attitudes and Lifestyles	PLOS ONE			English	Article							FACE-TO-FACE; MAIL; METHODOLOGY; POPULATION; WOMEN; BIAS; MEN	Background Interviewer-administered surveys are an important method of collecting population-level epidemiological data, but suffer from declining response rates and increasing costs. Web surveys offer more rapid data collection and lower costs. There are concerns, however, about data quality from web surveys. Previous research has largely focused on selection biases, and few have explored measurement differences. This paper aims to assess the extent to which mode affects the responses given by the same respondents at two points in time, providing information on potential measurement error if web surveys are used in the future. Methods 527 participants from the third British National Survey of Sexual Attitudes and Lifestyles (Natsal-3), which uses computer assisted personal interview (CAPI) and self-interview (CASI) modes, subsequently responded to identically-worded questions in a web survey. McNemar tests assessed whether within-person differences in responses were at random or indicated a mode effect, i.e. higher reporting of more sensitive responses in one mode. An analysis of pooled responses by generalized estimating equations addressed the impact of gender and question type on change. Results Only 10% of responses changed between surveys. However mode effects were found for about a third of variables, with higher reporting of sensitive responses more commonly found on the web compared with Natsal-3. Conclusions The web appears a promising mode for surveys of sensitive behaviours, most likely as part of a mixed-mode design. Our findings suggest that mode effects may vary by question type and content, and by the particular mix of modes used. Mixed-mode surveys need careful development to understand mode effects and how to account for them.	[Burkill, Sarah; Copas, Andrew; Clifton, Soazig; Prah, Philip; Johnson, Anne M.; Erens, Bob] UCL, Res Dept Infect & Populat Hlth, London, England; [Burkill, Sarah] Karolinska Inst, Dept Med Solna, Stockholm, Sweden; [Couper, Mick P.; Conrad, Frederick] Univ Michigan, Inst Social Res, Ann Arbor, MI USA; [Datta, Jessica; Wellings, Kaye] Univ London London Sch Hyg & Trop Med, Dept Social & Environm Res, Keppel St, London WC1E 7HT, England; [Erens, Bob] Univ London London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, Keppel St, London WC1E 7HT, England	University of London; University College London; Karolinska Institutet; University of Michigan System; University of Michigan; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Burkill, S (corresponding author), UCL, Res Dept Infect & Populat Hlth, London, England.; Burkill, S (corresponding author), Karolinska Inst, Dept Med Solna, Stockholm, Sweden.	sarah.burkill@ki.se	Weatherburn, Peter/AAC-2701-2019	Johnson, Anne/0000-0003-1330-7100; Copas, Andrew/0000-0001-8968-5963; Clifton, Soazig/0000-0002-4171-0805	Medical Research Council [G0701757]; Wellcome Trust [084840]; National Institute for Health Research [NF-SI-0508-10244, NIHR-RMFI-2014-05-28-101] Funding Source: researchfish; MRC [G0701757] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Natsal-3 was supported by grants to AMJ from the Medical Research Council (G0701757) (http://www.mrc.ac.uk/), and the Wellcome Trust (084840) (http://www.wellcome.ac.uk/), with contributions from the Economic and Social Research Council and Department of Health. The follow-up web survey with Natsal-3 participants was funded by supplementary grant from the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAPOR, 2010, AAPOR REP ONL PAN; Andreeva VA, 2015, J EPIDEMIOL COMMUN H, V69, P893, DOI 10.1136/jech-2014-205263; Aritomi T, 2011, SURVEY PRACTICE, V4; Bajardi P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114925; Borkan B, 2010, SOC SCI COMPUT REV, V28, P371, DOI 10.1177/0894439309350698; Campanelli P, ISER WORKING PAPER S, V2015-18; Chang L, 2010, PUBLIC OPIN QUART, V74, P154, DOI 10.1093/poq/nfp090; Clark S, 2011, INT PERSPECT SEX R H, V37, P181, DOI 10.1363/3718111; Colon HM, 2001, INT J EPIDEMIOL, V30, P1042, DOI 10.1093/ije/30.5.1042; Couper Mick P, 2013, J Surv Stat Methodol, V1, P171; Couper MP, 2011, PUBLIC OPIN QUART, V75, P889, DOI 10.1093/poq/nfr046; Dayan Y, 2009, RESPONDING SENSITIVE; de Bernardo DH, 2013, RES AGING, V35, P220, DOI 10.1177/0164027512441611; De Leeuw E.D, 2005, J OFF STAT, V21, P233, DOI DOI 10.1111/J.1524-4733.2007.00231.X; Erens B, 2014, J MED INTERNET RES, V16, P98, DOI 10.2196/jmir.3382; Erens B, 2014, SEX TRANSM INFECT, V90, P84, DOI 10.1136/sextrans-2013-051359; European Commission, 2011, BROADB COV EUR 2011; Fenton KA, 2001, SEX TRANSM INFECT, V77, P84, DOI 10.1136/sti.77.2.84; Heerwegh D, 2008, PUBLIC OPIN QUART, V72, P836, DOI 10.1093/poq/nfn045; Hox JJ, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00087; Jackle A, UNDERSTANDING SOC WO, V2013-03; Kelly CA, 2013, INT PERSPECT SEX R H, V39, P14, DOI 10.1363/3901413; Klausch T, 2015, J R STAT SOC A; Link MW, 2005, EPIDEMIOLOGY, V16, P701, DOI 10.1097/01.ede.0000172138.67080.7f; Link MW, 2005, J STUD ALCOHOL, V66, P239, DOI 10.15288/jsa.2005.66.239; McCallum EB, 2012, J SEX RES, V49, P212, DOI 10.1080/00224499.2012.658923; Meiklejohn J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035527; Mercer CH, 2013, LANCET, V382, P1781, DOI 10.1016/S0140-6736(13)62035-8; Mercer CH, 2009, INT J EPIDEMIOL, V38, P206, DOI 10.1093/ije/dyn216; National Research Council, 2013, NONR SOC SCI SURV RE; Newman JC, 2002, AM J PUBLIC HEALTH, V92, P294, DOI 10.2105/AJPH.92.2.294; Phillips AE, 2010, INT J EPIDEMIOL, V39, P1541, DOI 10.1093/ije/dyq114; Prah P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135203; Rhodes SD, 2003, J EPIDEMIOL COMMUN H, V57, P68, DOI 10.1136/jech.57.1.68; Roberts C, 2007, MIXING MODES DATA CO; Tourangeau R., 2013, SCI WEB SURVEYS; Tourangeau R, 2003, WSS FCSM SEM FUND OP; Turner CF, 2009, INT J EPIDEMIOL, V38, P1118, DOI 10.1093/ije/dyp210; UK Cabinet Office, 2008, HELP SHAP TOM 2011 C; UK Cabinet Office, 2015, CONS RESP COMM LIF S; United States Census Bureau, 2014, AM COMMUNITY SURVEY; Wadsworth J, 1996, J R STAT SOC A STAT, V159, P111, DOI 10.2307/2983472	42	54	54	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0147983	10.1371/journal.pone.0147983	http://dx.doi.org/10.1371/journal.pone.0147983			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6RE	26866687	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000370050700005
J	Pradhan, A; Anasuya, A; Pradhan, MM; Kavitha, AK; Kar, P; Sahoo, KC; Panigrahi, P; Dutta, A				Pradhan, Ashirbad; Anasuya, Anita; Pradhan, Madan Mohan; Kavitha, A. K.; Kar, Priyanka; Sahoo, Krushna Chandra; Panigrahi, Pinaki; Dutta, Ambarish			Trends in Malaria in Odisha, India-An Analysis of the 2003-2013 Time-Series Data from the National Vector Borne Disease Control Program	PLOS ONE			English	Article							SEGMENTED REGRESSION; PREVALENCE; BURDEN; IMPACT; POLICY	Background Although Odisha is the largest contributor to the malaria burden in India, no systematic study has examined its malaria trends. Hence, the spatio-temporal trends in malaria in Odisha were assessed against the backdrop of the various anti-malaria strategies implemented in the state. Methods Using the district-wise malaria incidence and blood examination data (2003-2013) from the National Vector Borne Disease Control Program, blood examination-adjusted time-trends in malaria incidence were estimated and predicted for 2003-2013 and 2014-2016, respectively. An interrupted time series analysis using segmented regression was conducted to compare the disease trends between the pre (2003-2007) and post-intensification (2009-2013) periods. Key-informant interviews of state stakeholders were used to collect the information on the various anti-malaria strategies adopted in the state. Results The state annual malaria incidence declined from 10.82/1000 to 5.28/1000 during 2003-2013 (adjusted annual decline: -0.54/1000, 95% CI: -0.78 to -0.30). However, the annual blood examination rate remained almost unchanged from 11.25% to 11.77%. The keyinformants revealed that intensification of anti-malaria activities in 2008 led to a more rapid decline in malaria incidence during 2009-2013 as compared to that in 2003-2007 [adjusted decline: -0.83 (-1.30 to -0.37) and -0.27 (-0.41 to -0.13), respectively]. There was a significant difference in the two temporal slopes, i.e., -0.054 (-0.10 to -0.002, p = 0.04) per 1000 population per month, between these two periods, indicating almost a 200% greater decline in the post-intensification period. Although, the seven southern high-burden districts registered the highest decline, they continued to remain in that zone, thereby, making the achievement of malaria elimination (incidence <1/1000) unlikely by 2017. Conclusion The anti-malaria strategies in Odisha, especially their intensification since 2008, have helped improve its malaria situation in recent years. These successful measures need to be sustained and perhaps intensified further for eliminating malaria from Odisha.	[Pradhan, Ashirbad; Kavitha, A. K.; Sahoo, Krushna Chandra; Dutta, Ambarish] Asian Inst Publ Hlth, Ctr Dis Epidemiol & Surveillance, Bhubaneswar, Odisha, India; [Anasuya, Anita] United Kingdom Supported Tech & Management Suppor, Dept Int Dev, Bhubaneswar, Odisha, India; [Pradhan, Madan Mohan; Kar, Priyanka] Govt Odisha, Natl Vector Borne Dis Control Programme, Dept Hlth & Family Welf, Bhubaneswar, Odisha, India; [Panigrahi, Pinaki] Univ Nebraska Med Ctr, Coll Publ Hlth, Ctr Global Hlth & Dev, Omaha, NE USA; [Dutta, Ambarish] Publ Hlth Fdn India, Indian Inst Publ Hlth, Bhubaneswar, Odisha, India	Indian Council of Medical Research (ICMR); ICMR - Vector Control Research Center (VCRC); University of Nebraska System; University of Nebraska Medical Center; Public Health Foundation of India	Dutta, A (corresponding author), Asian Inst Publ Hlth, Ctr Dis Epidemiol & Surveillance, Bhubaneswar, Odisha, India.; Dutta, A (corresponding author), Publ Hlth Fdn India, Indian Inst Publ Hlth, Bhubaneswar, Odisha, India.	Ambarish.dutta@iiphb.org	Sahoo, Krushna Chandra/AAF-2813-2020	Dutta, Ambarish/0000-0002-4019-7472; PRADHAN, ASHIRBAD/0000-0003-2400-1385	Department for International Development (DFID), Government of United Kingdom; DFID; CARE India	Department for International Development (DFID), Government of United Kingdom; DFID; CARE India	This study was funded by the Department for International Development (DFID), Government of United Kingdom, through a project support (Odisha Health Sector Plan) to the Government of Odisha, channelized through Infrastructure Professional Enterprises (IPE) Global Private Limited, one of the consortium partners of the project, the other being Options Consulting UK and CARE India. Neither of the three agencies were funding agencies, however they were implementing partners for the project. The funding support from DFID is acknowledged, however, there was no influence of DFID on the conduct of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-173; [Anonymous], 2012, ODISHA HTLH SECTOR P, P1; [Anonymous], 2007, STRATEGIC ACTION PLA, P1; [Anonymous], 2012, EVALUATION USE LLIN; [Anonymous], 2009, GUID PRINC MATH CURR, P1; [Anonymous], 2012, STRATEGIC ACTION PLA, P1; [Anonymous], 2011, ANN REPORT PEOPLE HL, P1; [Anonymous], 2009, OPERATIONAL MANUAL I, P19; Anvikar AR, 2014, INDIAN J MED RES, V139, P205; Aregawi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106359; Aregawi MW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-46; Das A, 2012, ACTA TROP, V121, P267, DOI 10.1016/j.actatropica.2011.11.008; Dayer MJ, 2015, LANCET, V385, P1219, DOI 10.1016/S0140-6736(14)62007-9; Dhingra N, 2010, LANCET, V376, P1768, DOI 10.1016/S0140-6736(10)60831-8; Fox J., 2002, TIME SERIES REGRESSI, P1; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; HINKLEY DV, 1970, BIOMETRIKA, V57, P1; Jandoc R, 2015, J CLIN EPIDEMIOL, V68, P950, DOI 10.1016/j.jclinepi.2014.12.018; Kamuliwo M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-437; Karema C, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-236; Kumar A, 2007, AM J TROP MED HYG, V77, P69, DOI 10.4269/ajtmh.2007.77.69; Lagarde M, 2012, HEALTH POLICY PLANN, V27, P76, DOI 10.1093/heapol/czr004; Ngomane L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-19; Okiro EA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-285; Patil Rajan R, 2011, Trop Parasitol, V1, P26, DOI 10.4103/2229-5070.72111; R Core Team, 2016, R FDN STAT COMP; Sahu SS, 2011, INDIAN J MED RES, V133, P655; Shah NK, 2011, LANCET, V377, P991, DOI 10.1016/S0140-6736(11)60378-4; Shah NK, 2012, LANCET, V380, P560, DOI 10.1016/S0140-6736(12)61322-1; Singh N, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-274; Taljaard M, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-77; Valadez JJ, 2014, TROP MED INT HEALTH, V19, P1226, DOI 10.1111/tmi.12354; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x	34	32	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149126	10.1371/journal.pone.0149126	http://dx.doi.org/10.1371/journal.pone.0149126			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866696	Green Submitted, Green Published, gold			2022-12-27	WOS:000370050700068
J	Huang, T; Li, JY; Zhang, C; Hong, QX; Jiang, DJ; Ye, M; Duan, SW				Huang, Tao; Li, Jinyun; Zhang, Cheng; Hong, Qingxiao; Jiang, Danjie; Ye, Meng; Duan, Shiwei			Distinguishing Lung Adenocarcinoma from Lung Squamous Cell Carcinoma by Two Hypomethylated and Three Hypermethylated Genes: A Meta-Analysis	PLOS ONE			English	Article							ABERRANT PROMOTER METHYLATION; TRANSCRIPTION FACTOR-I; DNA METHYLATION; PROGNOSTIC-SIGNIFICANCE; T-CADHERIN; RUNX3 GENE; CANCER; CDH13; EXPRESSION; INACTIVATION	Significant differences in the aberrant methylation of genes exist among various histological types of non-small cell lung cancer (NSCLC), which includes adenocarcinoma (AC) and squamous cell carcinoma (SCC). Different chemotherapeutic regimens should be administered to the two NSCLC subtypes due to their unique genetic and epigenetic profiles. The purpose of this meta-analysis was to generate a list of differentially methylated genes between AC and SCC. Our meta-analysis encompassed 151 studies on 108 genes among 12946 AC and 10243 SCC patients. Our results showed two hypomethylated genes (CDKN2A and MGMT) and three hypermethylated genes (CDH13, RUNX3 and APC) in ACs compared with SCCs. In addition, our results showed that the pooled specificity and sensitivity values of CDH13 and APC were higher than those of CDKN2A, MGMT and RUNX3. Our findings might provide an alternative method to distinguish between the two NSCLC subtypes.	[Huang, Tao; Li, Jinyun; Zhang, Cheng; Hong, Qingxiao; Jiang, Danjie; Duan, Shiwei] Ningbo Univ, Sch Med, Zhejiang Prov Key Lab Pathophysiol, Ningbo 315211, Zhejiang, Peoples R China; [Ye, Meng] Ningbo Univ, Affiliated Hosp, Ningbo 315000, Zhejiang, Peoples R China	Ningbo University; Ningbo University	Duan, SW (corresponding author), Ningbo Univ, Sch Med, Zhejiang Prov Key Lab Pathophysiol, Ningbo 315211, Zhejiang, Peoples R China.; Ye, M (corresponding author), Ningbo Univ, Affiliated Hosp, Ningbo 315000, Zhejiang, Peoples R China.	yemeng@nbu.edu.cn; duanshiwei@nbu.edu.cn	Huang, Tao/L-8505-2019; Duan, Shiwei/AAA-4782-2022	Duan, Shiwei/0000-0001-7682-2877	National Natural Science Foundation of China [31100919, 81371469]; Natural Science Foundation of Zhejiang Province [LR13H020003]; K. C. Wong Magna Fund in Ningbo University; Zhejiang Provincial Natural Science Foundation of China [LY16H160005]; Project of Scientific Innovation Team of Ningbo [2015B11050]; Ningbo Natural Science Foundation [2014A610235]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); K. C. Wong Magna Fund in Ningbo University; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Project of Scientific Innovation Team of Ningbo; Ningbo Natural Science Foundation	The research was supported by the grants from the National Natural Science Foundation of China (31100919 and 81371469), the Natural Science Foundation of Zhejiang Province (LR13H020003), the K. C. Wong Magna Fund in Ningbo University, the Zhejiang Provincial Natural Science Foundation of China (LY16H160005), Project of Scientific Innovation Team of Ningbo (2015B11050) and the Ningbo Natural Science Foundation (2014A610235). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2014, CANC FACTS FIG 2014; Angst BD, 2001, J CELL SCI, V114, P629; Balgkouranidou I, 2015, MUTAT RES-FUND MOL M, V778, P46, DOI 10.1016/j.mrfmmm.2015.05.002; Bangsow C, 2001, GENE, V279, P221, DOI 10.1016/S0378-1119(01)00760-0; Belinsky SA, 2004, NAT REV CANCER, V4, P707, DOI 10.1038/nrc1432; Bian YS, 2002, GASTROENTEROLOGY, V122, P1113, DOI 10.1053/gast.2002.32370; Calvisi DF, 2007, J CLIN INVEST, V117, P2713, DOI 10.1172/JCI31457; Castro M, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-86; Chan DW, 2008, INT J CANCER, V123, P1043, DOI 10.1002/ijc.23634; Chan EC, 2005, CANCER GENET CYTOGEN, V162, P10, DOI 10.1016/j.cancergencyto.2005.03.008; Daraselia N, 2012, AM J CANCER RES, V2, P93; Esteller M, 2000, CANCER RES, V60, P4366; Esteller M, 1999, CANCER RES, V59, P793; Fabbro D, 1996, EUR J CANCER, V32A, P512, DOI 10.1016/0959-8049(95)00560-9; Feinberg AP, 2008, JAMA-J AM MED ASSOC, V299, P1345, DOI 10.1001/jama.299.11.1345; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Foulkes WD, 1997, MOL MED, V3, P5, DOI 10.1007/BF03401664; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Hibi K, 2004, BRIT J CANCER, V90, P1030, DOI 10.1038/sj.bjc.6601647; Hirsch FR, 2008, J THORAC ONCOL, V3, P1468, DOI 10.1097/JTO.0b013e318189f551; Hong Huazhang, 2014, Zhonghua Zhong Liu Za Zhi, V36, P341; Hou J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010312; Hsiung CA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001051; Jin MJ, 2009, CANCER SCI, V100, P2325, DOI 10.1111/j.1349-7006.2009.01321.x; Juergens RA, 2011, CANCER DISCOV, V1, P598, DOI 10.1158/2159-8290.CD-11-0214; Kelemen LE, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/815894; Kim TY, 2004, LAB INVEST, V84, P479, DOI 10.1038/labinvest.3700060; Kim WJ, 2005, CANCER RES, V65, P9347, DOI 10.1158/0008-5472.CAN-05-1647; Klajic J, 2014, CLIN CANCER RES, V20, P6357, DOI 10.1158/1078-0432.CCR-14-0297; Kohonen-Corish MRJ, 2005, J CLIN ONCOL, V23, P2318, DOI 10.1200/JCO.2005.00.109; Li QL, 2004, BIOCHEM BIOPH RES CO, V314, P223, DOI 10.1016/j.bbrc.2003.12.079; Lipsey MW, 2001, PRACTICAL METAANALYS, Vix; Liu J, 2014, GENET MOL RES, V13, P95, DOI 10.4238/2014.January.8.8; Lockwood WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037775; Maruyama R, 2002, CLIN CANCER RES, V8, P514; Michailidi C, 2015, EXP BIOL MED, V240, P1599, DOI 10.1177/1535370215583800; MIYAKI M, 1994, CANCER RES, V54, P3011; Muller HM, 2003, CANCER RES, V63, P7641; Narayan Gopeshwar, 2003, Mol Cancer, V2, P24, DOI 10.1186/1476-4598-2-24; Niklinska W, 2009, FOLIA HISTOCHEM CYTO, V47, P275, DOI 10.2478/v10042-009-0091-2; Nosaka K, 2000, CANCER RES, V60, P1043; Ogino S, 2007, CARCINOGENESIS, V28, P1985, DOI 10.1093/carcin/bgm160; Pelosi G, 2001, AM J SURG PATHOL, V25, P363, DOI 10.1097/00000478-200103000-00011; Peng DF, 2014, J CANCER RES THER, V10, pC292, DOI 10.4103/0973-1482.151535; Ren JZ, 2012, MED ONCOL, V29, P915, DOI 10.1007/s12032-011-9836-9; Rosell R, 2004, SEMIN ONCOL, V31, P20, DOI 10.1053/j.seminoncol.2003.12.011; Rubina Kseniya, 2007, Angiogenesis, V10, P183, DOI 10.1007/s10456-007-9072-2; Scagliotti G, 2011, J THORAC ONCOL, V6, P64, DOI 10.1097/JTO.0b013e3181f7c6d4; Scagliotti G, 2009, ONCOLOGIST, V14, P253, DOI 10.1634/theoncologist.2008-0232; Shima K, 2011, INT J CANCER, V128, P1080, DOI 10.1002/ijc.25432; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Soejima H, 2005, BIOCHEM CELL BIOL, V83, P429, DOI 10.1139/O05-140; Sun D, 2007, ORAL ONCOL, V43, P82, DOI 10.1016/j.oraloncology.2006.01.007; Takeuchi T, 2001, HISTOL HISTOPATHOL, V16, P1287, DOI 10.14670/HH-16.1287; Tan DF, 2003, HUM PATHOL, V34, P597, DOI 10.1016/S0046-8177(03)00180-1; Terry J, 2010, AM J SURG PATHOL, V34, P1805, DOI 10.1097/PAS.0b013e3181f7dae3; Toyooka KO, 2001, CANCER RES, V61, P4556; Toyooka S, 2001, MOL CANCER THER, V1, P61; Toyooka S, 2003, INT J CANCER, V103, P153, DOI 10.1002/ijc.10787; Toyooka S, 2002, CANCER RES, V62, P3382; Usadel H, 2002, CANCER RES, V62, P371; Whitehall VLJ, 2001, CANCER RES, V61, P827; Widschwendter A, 2004, INT J CANCER, V109, P163, DOI 10.1002/ijc.11706; Xue RL, 2014, ONCOTARGETS THER, V7, P1987, DOI 10.2147/OTT.S67355; Yanagawa N, 2007, LUNG CANCER, V58, P131, DOI 10.1016/j.lungcan.2007.05.011; Zhang XY, 2015, CANCER INVEST, V33, P121, DOI 10.3109/07357907.2014.1003934; Zhu WG, 2001, ONCOGENE, V20, P7787, DOI 10.1038/sj.onc.1204970	67	29	34	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149088	10.1371/journal.pone.0149088	http://dx.doi.org/10.1371/journal.pone.0149088			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862903	Green Submitted, Green Published, gold			2022-12-27	WOS:000370046600152
J	Kitts, JA; Leal, DF; Felps, W; Jones, TM; Berman, SL				Kitts, James A.; Leal, Diego F.; Felps, Will; Jones, Thomas M.; Berman, Shawn L.			Greed and Fear in Network Reciprocity: Implications for Cooperation among Organizations	PLOS ONE			English	Article							EVOLUTIONARY GAMES; SOCIAL-STRUCTURE; DECENTRALIZED INSTITUTIONS; PROMOTE COOPERATION; DILEMMA GAMES; PUBLIC-GOODS; DYNAMICS; EMERGENCE; TRUST; COLLABORATION	Extensive interdisciplinary literatures have built on the seminal spatial dilemmas model, which depicts the evolution of cooperation on regular lattices, with strategies propagating locally by relative fitness. In this model agents may cooperate with neighbors, paying an individual cost to enhance their collective welfare, or they may exploit cooperative neighbors and diminish collective welfare. Recent research has extended the model in numerous ways, incorporating behavioral noise, implementing other network topologies or adaptive networks, and employing alternative dynamics of replication. Although the underlying dilemma arises from two distinct dimensions-the gains for exploiting cooperative partners (Greed) and the cost of cooperating with exploitative partners (Fear)-most work following from the spatial dilemmas model has argued or assumed that the dilemma can be represented with a single parameter: This research has typically examined Greed or Fear in isolation, or a composite such as the K-index of Cooperation or the ratio of the benefit to cost of cooperation. We challenge this claim on theoretical grounds-showing that embedding interaction in networks generally leads Greed and Fear to have divergent, interactive, and highly nonlinear effects on cooperation at the macro level, even when individuals respond identically to Greed and Fear. Using computational experiments, we characterize both dynamic local behavior and long run outcomes across regions of this space. We also simulate interventions to investigate changes of Greed and Fear over time, showing how model behavior changes asymmetrically as boundaries in payoff space are crossed, leading some interventions to have irreversible effects on cooperation. We then replicate our experiments on inter-organizational network data derived from links through shared directors among 2,400 large US corporations, thus demonstrating our findings for Greed and Fear on a naturally-occurring network. In closing, we discuss implications of our main findings regarding Greed and Fear for the problem of cooperation on inter-organizational networks.	[Kitts, James A.; Leal, Diego F.] Univ Massachusetts, Dept Sociol, Amherst, MA 01003 USA; [Felps, Will] Univ New S Wales, Australian Sch Business, Sydney, NSW, Australia; [Jones, Thomas M.] Univ Washington, Foster Sch Business, Seattle, WA 98195 USA; [Berman, Shawn L.] Univ New Mexico, Anderson Sch Management, Albuquerque, NM 87131 USA	University of Massachusetts System; University of Massachusetts Amherst; University of New South Wales Sydney; University of Washington; University of Washington Seattle; University of New Mexico	Kitts, JA (corresponding author), Univ Massachusetts, Dept Sociol, Amherst, MA 01003 USA.	jkitts@soc.umass.edu	Berman, Shawn L/M-9795-2016; Felps, Will/K-2038-2012	Berman, Shawn L/0000-0002-8283-8071; Felps, Will/0000-0003-2147-075X	National Science Foundation [BCS-0433086]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation under grant BCS-0433086. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson G, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.030901; Ahn TK, 2001, PUBLIC CHOICE, V106, P137, DOI 10.1023/A:1005219123532; Axelrod R, 2009, J CONFLICT RESOLUT, V39, P183; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Bandura Albert, 1977, SOCIAL LEARNING THEO; Baum JAC, 1999, ADV STRAT M, V16, P155; BROWNING LD, 1995, ACAD MANAGE J, V38, P113, DOI 10.2307/256730; BRUINS JJ, 1989, EUR J SOC PSYCHOL, V19, P155, DOI 10.1002/ejsp.2420190207; Centola D, 2007, J CONFLICT RESOLUT, V51, P905, DOI 10.1177/0022002707307632; Centola D, 2007, PHYSICA A, V374, P449, DOI 10.1016/j.physa.2006.06.018; Centola DM, 2013, RATION SOC, V25, P3, DOI 10.1177/1043463112473734; Cimini G, 2015, JASSS-J ARTIF SOC S, V18, DOI 10.18564/jasss.2726; Coleman J., 1990, FDN SOCIAL THEORY; DAWES RM, 1986, AM POLIT SCI REV, V80, P1171, DOI 10.2307/1960862; DIMAGGIO PJ, 1983, AM SOCIOL REV, V48, P147, DOI 10.2307/2095101; Domhoff WG, 2012, DATABASE; Domhoff WG, 2013, WHO RULES AM; Dyer JH, 1997, STRATEGIC MANAGE J, V18, P535, DOI 10.1002/(SICI)1097-0266(199708)18:7<535::AID-SMJ885>3.3.CO;2-Q; Fang C, 2002, GROUP DECIS NEGOT, V11, P449, DOI 10.1023/A:1020639132471; Fehl K, 2011, ECOL LETT, V14, P546, DOI 10.1111/j.1461-0248.2011.01615.x; GILSON RJ, 1993, YALE LAW J, V102, P871, DOI 10.2307/796835; Ginsberg A, 1999, ADV STRAT M, V16, P81; Gomez-Gardenes J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108103; Gracia-Lazaro C, 2012, P NATL ACAD SCI USA, V109, P12922, DOI 10.1073/pnas.1206681109; GRANOVETTER M, 1985, AM J SOCIOL, V91, P481, DOI 10.1086/228311; Greve HR, 1998, STRATEGIC MANAGE J, V19, P967, DOI 10.1002/(SICI)1097-0266(199810)19:10<967::AID-SMJ981>3.0.CO;2-L; Grujic J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013749; Hagen JM, 1998, ACAD MANAGE REV, V23, P589, DOI 10.2307/259296; Hanaki N, 2007, MANAGE SCI, V53, P1036, DOI 10.1287/mnsc.1060.0625; HAVEMAN HA, 1993, ADMIN SCI QUART, V38, P593, DOI 10.2307/2393338; Helbing D, 2009, P NATL ACAD SCI USA, V106, P3680, DOI 10.1073/pnas.0811503106; Hofbauer J., 1998, EVOLUTIONARY GAMES R; HUBERMAN BA, 1993, P NATL ACAD SCI USA, V90, P7716, DOI 10.1073/pnas.90.16.7716; Hwang P, 1999, J CONFLICT RESOLUT, V43, P117, DOI 10.1177/0022002799043001007; JONES TM, 1995, ACAD MANAGE REV, V20, P404, DOI 10.2307/258852; Keefer P, 1995, EC POLIT, V7, P1251; Kim HJ, 1997, AM SOCIOL REV, V62, P70, DOI 10.2307/2657453; King AA, 2005, ACAD MANAGE J, V48, P1091, DOI 10.5465/AMJ.2005.19573111; Kitts J. A., 1999, Computational & Mathematical Organization Theory, V5, P129, DOI 10.1023/A:1009670804792; Kitts JA, 2006, SIMUL MODEL PRACT TH, V14, P407, DOI 10.1016/j.simpat.2005.09.006; KOMORITA SS, 1980, J PERS SOC PSYCHOL, V38, P504, DOI 10.1037/0022-3514.38.3.504; KOMORITA SS, 1993, J EXP SOC PSYCHOL, V29, P252, DOI 10.1006/jesp.1993.1011; Kuwabara K, 2005, SOC FORCES, V84, P1257, DOI 10.1353/sof.2006.0020; LaPorta R, 1997, AM ECON REV, V87, P333; Lenox M.J., 2003, BUS STRATEG ENVIRON, V12, P343, DOI [10.1002/bse.380, DOI 10.1002/BSE.380]; Lenox MJ, 2006, ORGAN SCI, V17, P677, DOI 10.1287/orsc.1060.0211; Li QT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079746; LIEBRAND WBG, 1986, J CONFLICT RESOLUT, V30, P77, DOI 10.1177/0022002786030001006; Lomi A, 1997, J MATH SOCIOL, V22, P151, DOI 10.1080/0022250X.1997.9990199; Lozano S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001892; Marwell G., 1993, CRITICAL MASS COLLEC; Masuda N, 2003, PHYS LETT A, V313, P55, DOI 10.1016/S0375-9601(03)00693-5; MCCUSKER C, 1995, ORGAN BEHAV HUM DEC, V61, P190, DOI 10.1006/obhd.1995.1015; Messick D M, 1997, Pers Soc Psychol Rev, V1, P129, DOI 10.1207/s15327957pspr0102_2; Meyer KE, 2009, STRATEGIC MANAGE J, V30, P61, DOI 10.1002/smj.720; Mitnick BM., 1980, POLITICAL EC REGULAT; Noll Roger G., 1985, REGULATORY POLICY SO, P9; North D. C., 1990, I I CHANGE EC PERFOR; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; NOWAK MA, 1994, P NATL ACAD SCI USA, V91, P4877, DOI 10.1073/pnas.91.11.4877; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Nowak MA, 1993, INT J BIFURCAT CHAOS, V3, P35, DOI 10.1142/S0218127493000040; Nowak Martin A., 2000, P135, DOI 10.1017/CBO9780511525537.010; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Pearce JL, 2001, ORG MANAGEMENT EMBRA; Pearce JL, 2009, ACAD MANAG ANN, V3, P503, DOI 10.1080/19416520903047541; POPPE M, 1986, J ECON PSYCHOL, V7, P61, DOI 10.1016/0167-4870(86)90012-7; Porter K.A., 2005, CLUSTERS NETWORKS IN, P261; Powell WW, 2005, AM J SOCIOL, V110, P1132, DOI 10.1086/421508; Rand DG, 2014, P NATL ACAD SCI USA, V111, P17093, DOI 10.1073/pnas.1400406111; Rand DG, 2011, P NATL ACAD SCI USA, V108, P19193, DOI 10.1073/pnas.1108243108; Rao AN, 2005, J INT BUS STUD, V36, P104, DOI 10.1057/palgrave.jibs.8400116; RAPOPORT A, 1989, ORGAN BEHAV HUM DEC, V44, P325, DOI 10.1016/0749-5978(89)90012-5; Roca CP, 2009, EUR PHYS J B, V71, P587, DOI 10.1140/epjb/e2009-00189-0; Roca CP, 2012, J MATH SOCIOL, V36, P1, DOI 10.1080/0022250X.2010.520830; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Roca CP, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046106; Rosenkopf L, 2008, ORGAN SCI, V19, P669, DOI 10.1287/orsc.1070.0339; Samuelson L., 1997, EVOLUTIONARY GAMES E; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Santos FC, 2006, J EVOLUTION BIOL, V19, P726, DOI 10.1111/j.1420-9101.2005.01063.x; Santos FC, 2012, J THEOR BIOL, V299, P88, DOI 10.1016/j.jtbi.2011.09.003; Schelling T., 1978, MICROMOTIVES MACROBE; Schmidt D, 2001, J ECON BEHAV ORGAN, V46, P357, DOI 10.1016/S0167-2681(01)00158-5; Simpson B, 2003, SOC FORCES, V82, P35, DOI 10.1353/sof.2003.0081; Skyrms B, 2003, STAG HUNT EVOLUTION; Strang D, 2001, AM J SOCIOL, V107, P147, DOI 10.1086/323039; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Tomochi M, 2004, SOC NETWORKS, V26, P309, DOI 10.1016/j.socnet.2004.08.003; Tsvetkova M, 2013, SOCIO METH RES, V00, P1; Uzzi B, 1997, ADMIN SCI QUART, V42, P35, DOI 10.2307/2393808; Voelkl B, 2009, BIOL LETTERS, V5, P462, DOI 10.1098/rsbl.2009.0204; Vogel D, 2008, ANNU REV POLIT SCI, V11, P261, DOI 10.1146/annurev.polisci.11.053106.141706; Wang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040218; Wang Z, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021115; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WORCHEL P, 1969, J CONFLICT RESOLUT, V13, P103, DOI 10.1177/002200276901300107; YAMAGISHI T, 1986, J PERS SOC PSYCHOL, V50, P67, DOI 10.1037/0022-3514.50.1.67; Yamauchi A, 2011, BIOSYSTEMS, V103, P85, DOI 10.1016/j.biosystems.2010.10.006; Zeng M, 2003, ACAD MANAGE REV, V28, P587; Zhang CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035183; Zhang CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026724; Zimmermann MG, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.065102	104	3	3	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0147264	10.1371/journal.pone.0147264	http://dx.doi.org/10.1371/journal.pone.0147264			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6PR	26863540	gold, Green Submitted, Green Published			2022-12-27	WOS:000370046600023
J	Mao, HF; Chang, LH; Tsai, AYJ; Huang, WN; Wang, J				Mao, Hui-Fen; Chang, Ling-Hui; Tsai, Athena Yi-Jung; Huang, Wen-Ni; Wang, Jye			Developing a Referral Protocol for Community-Based Occupational Therapy Services in Taiwan: A Logistic Regression Analysis	PLOS ONE			English	Article							HOME-CARE; ELDERLY-PEOPLE; INTERVENTION; REHABILITATION; DEMENTIA; OUTCOMES; FEAR; PREVALENCE; DISABILITY; CAREGIVERS	Because resources for long-term care services are limited, timely and appropriate referral for rehabilitation services is critical for optimizing clients' functions and successfully integrating them into the community. We investigated which client characteristics are most relevant in predicting Taiwan's community-based occupational therapy (OT) service referral based on experts' beliefs. Data were collected in face-to-face interviews using the Multidimensional Assessment Instrument (MDAI). Community-dwelling participants (n = 221) >= 18 years old who reported disabilities in the previous National Survey of Long-term Care Needs in Taiwan were enrolled. The standard for referral was the judgment and agreement of two experienced occupational therapists who reviewed the results of the MDAI. Logistic regressions and Generalized Additive Models were used for analysis. Two predictive models were proposed, one using basic activities of daily living (BADLs) and one using instrumental ADLs (IADLs). Dementia, psychiatric disorders, cognitive impairment, joint range-of-motion limitations, fear of falling, behavioral or emotional problems, expressive deficits (in the BADL-based model), and limitations in IADLs or BADLs were significantly correlated with the need for referral. Both models showed high area under the curve (AUC) values on receiver operating curve testing (AUC = 0.977 and 0.972, respectively). The probability of being referred for community OT services was calculated using the referral algorithm. The referral protocol facilitated communication between healthcare professionals to make appropriate decisions for OT referrals. The methods and findings should be useful for developing referral protocols for other long-term care services.	[Mao, Hui-Fen] Natl Taiwan Univ, Sch Occupat Therapy, Coll Med, Taipei 10764, Taiwan; [Chang, Ling-Hui] Natl Cheng Kung Univ, Coll Med, Inst Allied Hlth Sci, Dept Occupat Therapy, Tainan 70101, Taiwan; [Chang, Ling-Hui] Natl Cheng Kung Univ, Coll Med, Inst Allied Hlth Sci, Tainan 701, Taiwan; [Tsai, Athena Yi-Jung] Kaohsiung Med Univ, Dept Occupat Therapy, Kaohsiung, Taiwan; [Huang, Wen-Ni] I Shou Univ, Dept Phys Therapy, Kaohsiung, Taiwan; [Wang, Jye] Chang Jung Christian Univ, Dept Hlth Care Adm, Tainan, Taiwan	National Taiwan University; National Cheng Kung University; National Cheng Kung University; Kaohsiung Medical University; I Shou University; Chang Jung Christian University	Wang, J (corresponding author), Chang Jung Christian Univ, Dept Hlth Care Adm, Tainan, Taiwan.	jyewang@mail.cjcu.edu.tw	Chang, Ling-Hui/AAG-2410-2019	Chang, Ling Hui/0000-0003-4129-6947; MAO, HUI-FEN/0000-0002-4847-4243	Ministry of Health and Welfare, Taiwan (R.O.C.) [102N6021]; Ministry of Health and Welfare	Ministry of Health and Welfare, Taiwan (R.O.C.); Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Grant Number 102N6021 from the Ministry of Health and Welfare, Taiwan (R.O.C.), to AYJT (http://www.mohw.gov.tw/EN/Ministry/Index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the study participants and their caregivers for their cooperation and support, the Ministry of Health and Welfare officials responsible for LTC insurance planning in Taiwan, and the interviewers for their valuable contributions. This study is supported by a grant from the Ministry of Health and Welfare for Dr. Athena Yi-Jung Tsa. The findings and opinions expressed in this study are the sole responsibilities of the authors and do not necessarily represent the official position of the government of the Republic of China, Taiwan.	Archer KR, 2009, PHYS THER, V89, P893, DOI 10.2522/ptj.20080321; Buhr GT, 2006, J AM MED DIR ASSOC, V7, P180, DOI 10.1016/j.jamda.2005.12.003; Campbell JC, 2000, HEALTH AFFAIR, V19, P26, DOI 10.1377/hlthaff.19.3.26; CAOT, 2008, CAOT POS STAT OCC TH; Cheng L, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0203-1; Chiu HC, 2002, J AGING SOC POLICY, V13, P217; Chu TK, 2015, PUBLIC GOVERNANCE Q, V3, P108; Cohen-Mansfield J., 1991, INSTRUCTION MANUAL C; Crocker T, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004294.pub3; Deb S, 2001, J INTELL DISABIL RES, V45, P495, DOI 10.1046/j.1365-2788.2001.00374.x; DEIMLING GT, 1986, J GERONTOL, V41, P778, DOI 10.1093/geronj/41.6.778; Dopp CME, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-70; Emerson E, 2001, RES DEV DISABIL, V22, P77, DOI 10.1016/S0891-4222(00)00061-5; Executive Yuan T ROC, 2010, NAT LONG TERM CAR NE; Executive Yuan Taiwan Reublic of China, 2014, REP CHIN YB; Friedman SM, 2002, J AM GERIATR SOC, V50, P1329, DOI 10.1046/j.1532-5415.2002.50352.x; Gauthier R, 2006, OCCUPATIONAL THERAPY, V8, P10; Gitlin LN, 2006, J AM GERIATR SOC, V54, P950, DOI 10.1111/j.1532-5415.2006.00733.x; Gitlin LN, 2006, J AM GERIATR SOC, V54, P809, DOI 10.1111/j.1532-5415.2006.00703.x; Gitlin LN, 2001, GERONTOLOGIST, V41, P4, DOI 10.1093/geront/41.1.4; Gitlin LN, 2003, GERONTOLOGIST, V43, P532, DOI 10.1093/geront/43.4.532; Graff MJL, 2007, J GERONTOL A-BIOL, V62, P1002, DOI 10.1093/gerona/62.9.1002; Graff MJL, 2008, BMJ-BRIT MED J, V336, P134, DOI 10.1136/bmj.39408.481898.BE; Harding K, 2009, BRIT J OCCUP THER, V72, P153, DOI 10.1177/030802260907200403; Harris-Kojetin L., 2013, LONG TERM CARE SERVI; Hershkovitz A, 2007, ARCH PHYS MED REHAB, V88, P916, DOI 10.1016/j.apmr.2007.03.029; Hirdes JP, 2006, AGE AGEING, V35, P329, DOI 10.1093/ageing/afl036; Hirdes JP, 2004, GERONTOLOGIST, V44, P665, DOI 10.1093/geront/44.5.665; Hirdes JP, 1997, CAN J AGING, V16, P53; Hirdes JP., 2010, INTERRAI CONTACT ASS; Huang C. P., 2006, TAIWANESE J PSYCHIAT, V20, P3; Johnston KN, 2013, PRIM CARE RESP J, V22, P319, DOI 10.4104/pcrj.2013.00062; Kim SY, 2012, NEUROREHABILITATION, V31, P107, DOI 10.3233/NRE-2012-0779; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lee Y.C., 2013, COMMUNITY DEV J, V141, P26; Legters K, 2002, PHYS THER, V82, P264, DOI 10.1093/ptj/82.3.264; MAHONEY F I, 1965, Md State Med J, V14, P61; Miller EA, 2012, J AGING SOC POLICY, V24, P101, DOI 10.1080/08959420.2012.659912; Ministry of Health and Welfare, 2007, PLAN 10 YEAR LONG TE; Mohammed R, 2013, PHYSIOTHER CAN, V65, P125, DOI 10.3138/ptc.2012-09; Morris JN, 1997, J AM GERIATR SOC, V45, P1017, DOI 10.1111/j.1532-5415.1997.tb02975.x; Nursing and Health Care Division, 2013, LONG TERM CAR SERV N; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Polensek SH, 2009, INT J CLIN PRACT, V63, P1604, DOI 10.1111/j.1742-1241.2009.02104.x; Reisberg B, 1996, Int Psychogeriatr, V8 Suppl 3, P301; ROBINSON BC, 1983, J GERONTOL, V38, P344, DOI 10.1093/geronj/38.3.344; Seymour CW, 2010, JAMA-J AM MED ASSOC, V304, P747, DOI 10.1001/jama.2010.1140; Steultjens EMJ, 2004, AGE AGEING, V33, P453, DOI 10.1093/ageing/afh174; Wahl HW, 2009, GERONTOLOGIST, V49, P355, DOI 10.1093/geront/gnp056; WALKER JE, 1991, AM J OCCUP THER, V45, P119, DOI 10.5014/ajot.45.2.119; Wang HH, 2012, KAOHSIUNG J MED SCI, V28, P465, DOI 10.1016/j.kjms.2012.04.002; WILLER B, 1981, AM J MENT DEF, V86, P252; Wu CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108548; Yee TW, 1996, J ROY STAT SOC B MET, V58, P481; Yee TW, 2013, VGAM VECTOR GEN LINE	55	3	3	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148414	10.1371/journal.pone.0148414	http://dx.doi.org/10.1371/journal.pone.0148414			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6PR	26863544	Green Published, Green Submitted, gold			2022-12-27	WOS:000370046600068
J	Marimon, JM; Ercibengoa, M; Tamayo, E; Alonso, M; Perez-Trallero, E				Marimon, Jose M.; Ercibengoa, Maria; Tamayo, Esther; Alonso, Marta; Perez-Trallero, Emilio			Long-Term Epidemiology of Streptococcus pneumoniae Serogroup 6 in a Region of Southern Europe with Special Reference to Serotype 6E	PLOS ONE			English	Article							PREVALENCE	Streptococcus pneumoniae serotype 6E has recently been described, but its long-term epidemiology is not well known. From 1981-2013, 704 serogroup 6 clinical isolates were obtained in Gipuzkoa, Basque Country, Spain. All invasive and one in four non-invasive isolates were included. Overall, 75, 97, 51 and 45 serotypes 6A, 6B, 6C and 6E isolates, respectively, were detected. No serotype 6D isolates were identified. The prevalence of serotypes 6E and 6B, but not that of serotypes 6A and 6C, declined after the introduction of pneumococcal conjugate vaccines. Serotype 6E isolates showed the highest resistance rate. Most serotype 6E isolates were ST90.	[Marimon, Jose M.; Alonso, Marta; Perez-Trallero, Emilio] Hosp Univ Donostia, Inst Biodonostia, Dept Microbiol, San Sebastian, Spain; [Marimon, Jose M.; Ercibengoa, Maria; Tamayo, Esther; Perez-Trallero, Emilio] Biomed Res Ctr Network Resp Dis CIBERES, San Sebastian, Spain; [Perez-Trallero, Emilio] Univ Basque Country, UPV EHU, Fac Med, San Sebastian, Spain	Instituto de Investigacion Sanitaria Biodonostia; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; CIBERESP; University of Basque Country	Marimon, JM (corresponding author), Hosp Univ Donostia, Inst Biodonostia, Dept Microbiol, San Sebastian, Spain.; Marimon, JM (corresponding author), Biomed Res Ctr Network Resp Dis CIBERES, San Sebastian, Spain.	JOSEMARIA.MARIMONORTIZDEZ@osakidetza.eus	MARIMON, JOSE MARIA/AAM-5581-2021; Ercibengoa, María/ABH-9481-2020	MARIMON, JOSE MARIA/0000-0002-2787-7094; Alonso, Marta/0000-0002-8909-4968; Tamayo, Esther/0000-0002-4185-1210	Basque Country Government's Department of Education, Universities and Research [IT656/13]; Fondo de Investigaciones Sanitarias-Health Research Fund, Instituto de Salud Carlos III, Spanish Ministry of Health, Social Services and Equality;  [PI 13/01708]	Basque Country Government's Department of Education, Universities and Research; Fondo de Investigaciones Sanitarias-Health Research Fund, Instituto de Salud Carlos III, Spanish Ministry of Health, Social Services and Equality; 	This work was partially financed by the grant IT656/13 from the Basque Country Government's Department of Education, Universities and Research and from the grant PI 13/01708 (http://www.hezkuntza.ejgv.euskadi.eus/r43-2591/es) and Fondo de Investigaciones Sanitarias-Health Research Fund, Instituto de Salud Carlos III, Spanish Ministry of Health, Social Services and Equality (http://www.isciii.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamiak P, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-143; Baek JY, 2014, DIAGN MICR INFEC DIS, V80, P334, DOI 10.1016/j.diagmicrobio.2014.08.017; Baek JY, 2014, J CLIN MICROBIOL, V52, P2096, DOI 10.1128/JCM.00228-14; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Clinical and Laboratory Standards Institute (CLSI), 2010, M100S20CLSI; Jin P, 2009, J INFECT DIS, V200, P1375, DOI 10.1086/606118; Kawaguchiya M, 2015, MICROB DRUG RESIST, V21, P209, DOI 10.1089/mdr.2014.0181; Ko KS, 2013, J CLIN MICROBIOL, V51, P3395, DOI 10.1128/JCM.01645-13; Marimon JM, 2010, J MICROBIOL METH, V80, P274, DOI 10.1016/j.mimet.2010.01.011; Marimon JM, 2003, MICROB DRUG RESIST, V9, P133, DOI 10.1089/107662903765826714; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Shi W, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-467; van der Linden M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060848; van Tonder AJ, 2015, J CLIN MICROBIOL, V53, P2271, DOI 10.1128/JCM.00744-15	14	2	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149047	10.1371/journal.pone.0149047	http://dx.doi.org/10.1371/journal.pone.0149047			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863305	Green Published, gold, Green Submitted			2022-12-27	WOS:000370046600147
J	Domiciano, IG; Domit, C; Broadhurst, MK; Koch, MS; Bracarense, APFRL				Domiciano, Isabela G.; Domit, Camila; Broadhurst, Matt K.; Koch, Mariana S.; Bracarense, Ana Paula F. R. L.			Assessing Disease and Mortality among Small Cetaceans Stranded at a World Heritage Site in Southern Brazil	PLOS ONE			English	Article							PORPOISES PHOCOENA-PHOCOENA; DOLPHINS DELPHINUS-DELPHIS; SOTALIA-GUIANENSIS; MARINE MAMMALS; HEAVY-METAL; MORBILLIVIRUS; CONSERVATION; PATHOLOGY; BYCATCH; LESIONS	Cetaceans are considered environmental sentinels and their health often reflects either anthropogenic or natural spatio-temporal disturbances. This study investigated the pathological findings and mortality of small cetaceans with the aim of detecting hazards and monitoring health trends in a high-biodiversity area. Between 2007 and 2012, 218 stranded cetaceans were recorded on the Parana coast, southern Brazil. Fifty-seven (26.1%) of these animals, including 50 Sotalia guianensis, 2 Pontoporia blainvillei, 2 Stenella frontalis, 1 Stenella longirostris, 1 Tursiops truncatus and 1 Globicephala melas were necropsied and samples were collected for histopathology. Causes of death were determined in 46 of the 57 (80.7%) animals and most (30 or 65.2%) were ascribed to anthropogenic activities, including fisheries bycatch (28/30) and trauma (2/30). The remaining 16 fatalities were considered natural, and attributed to pneumonia (10/16), emaciation (3/16), septicemia (1/16), neonatal pathology (1/16) and choking via food obstruction (1/16). Irrespective of the cause, bronchointerstitial pneumonia, associated with parasitism, lymphadenitis and membranous glomerulonephritis were common findings among all fatalities. These results suggest, that while anthropogenic activities are a leading cause of cetacean strandings in Parana, underlying pre-existing diseases may contribute towards deaths. Although the studied area is considered a biosphere reserve by UNESCO, complex anthropogenic and natural interactions might be occurring, increasing cetacean susceptibility to hazards. This study may help facilitate developing an effective conservation plan for coastal cetaceans focusing on reducing fisheries interactions, habitat degradation and pollution as mechanisms for ultimately increasing species resilience.	[Domiciano, Isabela G.; Koch, Mariana S.; Bracarense, Ana Paula F. R. L.] Univ Estadual Londrina, Dept Vet Prevent Med, Lab Anim Pathol, Londrina, Parana, Brazil; [Domiciano, Isabela G.; Domit, Camila; Koch, Mariana S.] Univ Fed Parana, Ctr Estudos Mar, Lab Ecol & Conservat, Pontal Do Parana, Parana, Brazil; [Broadhurst, Matt K.] NSW Dept Primary Ind, Fisheries Conservat Technol Unit, Coffs Harbour, Australia; [Broadhurst, Matt K.] Univ Queensland, Sch Biol Sci, Marine & Estuarine Ecol Unit, Brisbane, Qld, Australia	Universidade Estadual de Londrina; Universidade Federal do Parana; NSW Department of Primary Industries; University of Queensland	Bracarense, APFRL (corresponding author), Univ Estadual Londrina, Dept Vet Prevent Med, Lab Anim Pathol, Londrina, Parana, Brazil.	ana.bracarense@pq.cnpq.br	Domit, Camila/J-8038-2016; Broadhurst, Matt/I-6783-2015	Domit, Camila/0000-0001-6158-6963; Broadhurst, Matt/0000-0003-0184-7249; Koch, Mariana/0000-0002-1838-5987	CNPq Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [551399]	CNPq Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The study was partially financed by CNPq Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (grant 551399).	Altrao CS, 2013, 22 ENC AN IN CIENT; Andriguetto-Filho J.M., 2006, PESCA MARINHA ESTUAR, P117; Arbelo M, 2013, DIS AQUAT ORGAN, V103, P87, DOI 10.3354/dao02558; Beineke A, 2010, VET IMMUNOL IMMUNOP, V133, P81, DOI 10.1016/j.vetimm.2009.06.019; Bloch Dorete, 1993, Reports of the International Whaling Commission Special Issue, V14, P163; Bogomolni AL, 2010, DIS AQUAT ORGAN, V88, P143, DOI 10.3354/dao02146; Bossart GD, 2011, VET PATHOL, V48, P676, DOI 10.1177/0300985810388525; Burri P.H., 1999, LUNG DEV, P122; Carvalho VL, 2010, VET PARASITOL, V173, P116, DOI 10.1016/j.vetpar.2010.06.023; Chaves P.T.C., 2003, ATLANTICA, V25, P53; Crespo Enrique A., 2010, Latin American Journal of Aquatic Mammals, V8, P47; Dailey MD, 2001, CRC HANDBOOK OF MARINE MAMMAL MEDICINE, SECOND EDITION, P357; Di Beneditto A. P. M., 2003, LAT AM J AQUAT MAMM, V2, P79, DOI DOI 10.5597/LAJAM00035; Di Guardo G, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00211; Diaz-Delgado J, 2012, J VET MED SCI, V74, P1063, DOI 10.1292/jvms.11-0573; Domiciano IG, 2012, CLIN VET, V99, P100; Fauquier DA, 2009, DIS AQUAT ORGAN, V88, P85, DOI 10.3354/dao02095; Flores PAC, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P1188; Geraci JR., 2005, MARINE MAMMALS ASHOR, V2; Gonzales-Vieira O, 2015, J COMP PATHOL; Groch KR, 2014, EMERG INFECT DIS, V20, P511, DOI 10.3201/eid2003.131557; Guimaraes JP, 2015, J PARASITOL, V101, P248, DOI 10.1645/14-513.1; Gulland FMD, 2007, ECOHEALTH, V4, P135, DOI 10.1007/s10393-007-0097-1; Headley SA, 2009, J VET DIAGN INVEST, V21, P588, DOI 10.1177/104063870902100502; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jepson PD, 2000, VET REC, V146, P721, DOI 10.1136/vr.146.25.721; Kuwamura M, 2007, J VET MED SCI, V69, P531, DOI 10.1292/jvms.69.531; Lane EP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107038; Lavery TJ, 2009, MAR ENVIRON RES, V67, P1, DOI 10.1016/j.marenvres.2008.09.005; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Lopez A., 2007, PATHOLOGIC BASIS VET, P463; Mannocci L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032615; Marigo J, 2010, J WILDLIFE DIS, V46, P599, DOI 10.7589/0090-3558-46.2.599; Martineau D, 2007, INT J COMP PHYSL, V20, P194; Martins CC, 2012, SCI TOTAL ENVIRON, V417, P158, DOI 10.1016/j.scitotenv.2011.11.086; Mcfee WE, 2009, J WILDLIFE DIS, V45, P575; Mizerkowski BD, 2012, OCEAN DYNAM, V62, P1409, DOI 10.1007/s10236-012-0569-x; Moore MJ, 2013, DIS AQUAT ORGAN, V103, P229, DOI 10.3354/dao02566; Motta MRA, 2006, THESIS U ESTADUAL CE; Moura JF, 2014, REV ENVIRON CONTAM T, V228, P1, DOI [10.1007/978-3-319-01619-1_1, DOI 10.1007/978-3-319-01619-1_1]; Ninomiya H, 2005, J VET MED SCI, V67, P473, DOI 10.1292/jvms.67.473; Noernberg M. A., 2008, Brazilian Journal of Aquatic Science & Technology, V12, P49; O'Shea TJ, 2008, J MAMMAL, V89, P529, DOI 10.1644/07-MAMM-S-416R.1; Osinga N, 2008, EUR J WILDLIFE RES, V54, P667, DOI 10.1007/s10344-008-0193-8; Parsons E.C.M., 2013, INTRO MARINE MAMMAL; Pellisso SC, 2008, VET IMMUNOL IMMUNOP, V121, P189, DOI 10.1016/j.vetimm.2007.09.009; Peltier H, 2014, ECOL INDIC, V39, P203, DOI 10.1016/j.ecolind.2013.12.019; Perrin W. F., 1984, REPORT INT WHALING C, P181; Perrin William F., 2002, Mammalian Species, V702, P1, DOI 10.1644/1545-1410(2002)702<0001:SF>2.0.CO;2; Perrin William F., 1998, Mammalian Species, V599, P1; Read AJ, 2006, CONSERV BIOL, V20, P163, DOI 10.1111/j.1523-1739.2006.00338.x; Reeves R. R., 2013, ENDANGER SPECIES RES, V20, P71; Robert MC, 2012, RELATORIO TECNICO CO; Rosa C, 2008, SCI TOTAL ENVIRON, V399, P165, DOI 10.1016/j.scitotenv.2008.01.062; Rosas FCW, 2002, MAMMALIA, V66, P231, DOI 10.1515/mamm.2002.66.2.231; Rosas FCW, 2002, J MAMMAL, V83, P507; Rosas Fernando C. Weber, 2002, Latin American Journal of Aquatic Mammals, V1, P161; Ruoppolo V, THESIS U SAO PAULO; Ryser-Degiorgis MP, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-223; Secchi Eduardo R., 2003, Journal of Cetacean Research and Management, V5, P61; Siebert U, 2001, J COMP PATHOL, V124, P102, DOI 10.1053/jcpa.2000.0436; Simmonds MP, 2009, J MAR BIOL ASSOC UK, V89, P203, DOI 10.1017/S0025315408003196; Van Bressem MF, 2014, VIRUSES-BASEL, V6, P5145, DOI 10.3390/v6125145; Van Bressem MF, 2009, DIS AQUAT ORGAN, V86, P143, DOI 10.3354/dao02101; Van Waerebeek Koen, 2007, Latin American Journal of Aquatic Mammals, V6, P43; Wright A.J., 2007, INTERJ COMP PSYCHO, V20, P274, DOI DOI 10.5070/P4202009994	66	22	22	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149295	10.1371/journal.pone.0149295	http://dx.doi.org/10.1371/journal.pone.0149295			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871703	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100143
J	Lee, WJ; Kim, SC; Yoon, JH; Yoon, SJ; Lim, J; Kim, YS; Kwon, SW; Park, JH				Lee, Won Jun; Kim, Sang Cheol; Yoon, Jung-Ho; Yoon, Sang Jun; Lim, Johan; Kim, You-Sun; Kwon, Sung Won; Park, Jeong Hill			Meta-Analysis of Tumor Stem-Like Breast Cancer Cells Using Gene Set and Network Analysis	PLOS ONE			English	Article							EXPRESSION; METASTASIS; ENRICHMENT; IDENTIFICATION; MODULARITY; CARCINOMA; MARKERS	Generally, cancer stem cells have epithelial-to-mesenchymal-transition characteristics and other aggressive properties that cause metastasis. However, there have been no confident markers for the identification of cancer stem cells and comparative methods examining adherent and sphere cells are widely used to investigate mechanism underlying cancer stem cells, because sphere cells have been known to maintain cancer stem cell characteristics. In this study, we conducted a meta-analysis that combined gene expression profiles from several studies that utilized tumorsphere technology to investigate tumor stem-like breast cancer cells. We used our own gene expression profiles along with the three different gene expression profiles from the Gene Expression Omnibus, which we combined using the ComBat method, and obtained significant gene sets using the gene set analysis of our datasets and the combined dataset. This experiment focused on four gene sets such as cytokine-cytokine receptor interaction that demonstrated significance in both datasets. Our observations demonstrated that among the genes of four significant gene sets, six genes were consistently up-regulated and satisfied the p-value of < 0.05, and our network analysis showed high connectivity in five genes. From these results, we established CXCR4, CXCL1 and HMGCS1, the intersecting genes of the datasets with high connectivity and p-value of < 0.05, as significant genes in the identification of cancer stem cells. Additional experiment using quantitative reverse transcription-polymerase chain reaction showed significant up-regulation in MCF-7 derived sphere cells and confirmed the importance of these three genes. Taken together, using meta-analysis that combines gene set and network analysis, we suggested CXCR4, CXCL1 and HMGCS1 as candidates involved in tumor stem-like breast cancer cells. Distinct from other meta-analysis, by using gene set analysis, we selected possible markers which can explain the biological mechanisms and suggested network analysis as an additional criterion for selecting candidates.	[Lee, Won Jun; Yoon, Sang Jun; Kwon, Sung Won; Park, Jeong Hill] Seoul Natl Univ, Coll Pharm, Seoul 08826, South Korea; [Lee, Won Jun; Yoon, Sang Jun; Kwon, Sung Won; Park, Jeong Hill] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul 08826, South Korea; [Kim, Sang Cheol] KCDC, Natl Inst Hlth, Ctr Genome Sci, Dept Biomed Informat, Choongchung Buk Do 28159, South Korea; [Yoon, Jung-Ho; Kim, You-Sun] Ajou Univ, Sch Med, Dept Biochem, Suwon 16499, South Korea; [Yoon, Jung-Ho; Kim, You-Sun] Ajou Univ, Sch Med, Dept Biomed Sci, Suwon 16499, South Korea; [Lim, Johan] Seoul Natl Univ, Dept Stat, Seoul 08826, South Korea	Seoul National University (SNU); Seoul National University (SNU); Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science; Ajou University; Ajou University; Seoul National University (SNU)	Park, JH (corresponding author), Seoul Natl Univ, Coll Pharm, Seoul 08826, South Korea.; Park, JH (corresponding author), Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul 08826, South Korea.	hillpark@snu.ac.kr			Bio-Synergy Research Project of the Ministry of Science, ICT and Future Planning through the National Research Foundation [NRF-2012M3A9C4048796]; National Research Foundation of Korea (NRF) grant - Korean government (MSIP) [2009-0083533]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2011-0023057, NRF-2013R1A1A1A05005753]	Bio-Synergy Research Project of the Ministry of Science, ICT and Future Planning through the National Research Foundation; National Research Foundation of Korea (NRF) grant - Korean government (MSIP); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This work was supported by the Bio-Synergy Research Project of the Ministry of Science, ICT and Future Planning through the National Research Foundation (NRF-2012M3A9C4048796), the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (No. 2009-0083533), Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2011-0023057) and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2013R1A1A1A05005753).	Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Bruin SC, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-662; Bylesjo M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-106; Calcagno AM, 2010, JNCI-J NATL CANCER I, V102, P1637, DOI 10.1093/jnci/djq361; Carbone C, 2011, CLIN CANCER RES, V17, P5822, DOI 10.1158/1078-0432.CCR-11-1185; Chen L, 2012, BIOMATERIALS, V33, P1437, DOI 10.1016/j.biomaterials.2011.10.056; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Chopra P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014305; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dong J, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-24; Ferrara CT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000034; Fuller TF, 2007, MAMM GENOME, V18, P463, DOI 10.1007/s00335-007-9043-3; Ghazalpour A, 2006, PLOS GENET, V2, P1182, DOI 10.1371/journal.pgen.0020130; Gil M, 2013, P NATL ACAD SCI USA, V110, pE1291, DOI 10.1073/pnas.1220580110; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Goonesekere NCW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093046; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hilvo M, 2011, CANCER RES, V71, P3236, DOI 10.1158/0008-5472.CAN-10-3894; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Hulsegge Ina, 2009, BMC Proc, V3 Suppl 4, pS10, DOI 10.1186/1753-6561-3-S4-S10; Hwang-Verslues WW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008377; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kim HS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-348; Kim YJ, 2014, BIOMATERIALS, V35, P7501, DOI 10.1016/j.biomaterials.2014.05.039; Kluger HM, 2005, CANCER RES, V65, P5578, DOI 10.1158/0008-5472.CAN-05-0108; Kuo PL, 2012, CARCINOGENESIS, V33, P2477, DOI 10.1093/carcin/bgs299; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Leek JT, 2008, P NATL ACAD SCI USA, V105, P18718, DOI 10.1073/pnas.0808709105; Lehmann C, 2012, INT J ONCOL, V41, P1932, DOI 10.3892/ijo.2012.1654; Li B, 2014, NATURE, V513, P251, DOI 10.1038/nature13557; Lien HC, 2007, ONCOGENE, V26, P7859, DOI 10.1038/sj.onc.1210593; Lips EH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3049; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Magkoufopoulou C, 2012, CARCINOGENESIS, V33, P1421, DOI 10.1093/carcin/bgs182; MEHTA K, 1994, INT J CANCER, V58, P400, DOI 10.1002/ijc.2910580316; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Oberthuer A, 2007, CANCER LETT, V250, P250, DOI 10.1016/j.canlet.2006.10.016; Oztemur Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126837; Plaisier CL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000642; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Presson AP, 2009, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-95; Ramasamy A, 2008, PLOS MED, V5, P1320, DOI 10.1371/journal.pmed.0050184; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rhodes LV, 2011, CANCER RES, V71, P603, DOI 10.1158/0008-5472.CAN-10-3185; Samal A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-118; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Wang HW, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/510905; Wang R, 2014, J THORAC DIS, V6, P829, DOI 10.3978/j.issn.2072-1439.2014.03.38; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yu YH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00584	62	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148818	10.1371/journal.pone.0148818	http://dx.doi.org/10.1371/journal.pone.0148818			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26870956	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100059
J	Meekrathok, P; Suginta, W				Meekrathok, Piyanat; Suginta, Wipa			Probing the Catalytic Mechanism of Vibrio harveyi GH20 beta-N-Acetylglucosaminidase by Chemical Rescue	PLOS ONE			English	Article							LYTIC POLYSACCHARIDE MONOOXYGENASE; SUBSTRATE-ASSISTED CATALYSIS; TAY-SACHS-DISEASE; CHITIN UTILIZATION; MARINE-BACTERIA; GLYCOSIDE HYDROLASES; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; HEXOSAMINIDASE-B; SANDHOFF-DISEASE	Background Vibrio harveyi GH20 beta-N-acetylglucosaminidase (VhGlcNAcase) is a chitinolytic enzyme responsible for the successive degradation of chitin fragments to GlcNAc monomers, activating the onset of the chitin catabolic cascade in marine Vibrios. Methods Two invariant acidic pairs (Asp303-Asp304 and Asp437-Glu438) of VhGlcNAcase were mutated using a site-directed mutagenesis strategy. The effects of these mutations were examined and the catalytic roles of these active-site residues were elucidated using a chemical rescue approach. Enhancement of the enzymic activity of the VhGlcNAcase mutants was evaluated by a colorimetric assay using pNP-GlcNAc as substrate. Results Substitution of Asp303, Asp304, Asp437 or Glu438 with Ala/Asn/Gln produced a dramatic loss of the GlcNAcase activity. However, the activity of the inactive D437A mutant was recovered in the presence of sodium formate. Our kinetic data suggest that formate ion plays a nucleophilic role by mimicking the beta-COO-side chain of Asp437, thereby stabilizing the reaction intermediate during both the glycosylation and the deglycosylation steps. Conclusions Chemical rescue of the inactive D437A mutant of VhGlcNAcase by an added nucleophile helped to identify Asp437 as the catalytic nucleophile/base, and hence its acidic partner Glu438 as the catalytic proton donor/acceptor. General Significance Identification of the catalytic nucleophile of VhGlcNAcases supports the proposal of a substrate-assisted mechanism of GH20 GlcNAcases, requiring the catalytic pair Asp437-Glu438 for catalysis. The results suggest the mechanistic basis of the participation of beta-Nacetylglucosaminidase in the chitin catabolic pathway of marine Vibrios.	[Meekrathok, Piyanat; Suginta, Wipa] Suranaree Univ Technol, Inst Sci, Biochem Electrochem Res Unit, Nakhon Ratchasima 30000, Thailand; [Meekrathok, Piyanat; Suginta, Wipa] Suranaree Univ Technol, Inst Sci, Sch Biochem, Nakhon Ratchasima 30000, Thailand; [Suginta, Wipa] Suranaree Univ Technol, Ctr Excellence Adv Funct Mat, Nakhon Ratchasima 30000, Thailand	Suranaree University of Technology; Suranaree University of Technology; Suranaree University of Technology	Suginta, W (corresponding author), Suranaree Univ Technol, Inst Sci, Biochem Electrochem Res Unit, Nakhon Ratchasima 30000, Thailand.; Suginta, W (corresponding author), Suranaree Univ Technol, Inst Sci, Sch Biochem, Nakhon Ratchasima 30000, Thailand.; Suginta, W (corresponding author), Suranaree Univ Technol, Ctr Excellence Adv Funct Mat, Nakhon Ratchasima 30000, Thailand.	wipa@sut.ac.th		Meekrathok, Piyanat/0000-0003-3566-1231	Suranaree University of Technology (SUT); Office of the Higher Education Commission under the NRU project of Thailand; Thailand Research Fund (TRF); SUT [BRG578001, PHD/0084/2550]	Suranaree University of Technology (SUT); Office of the Higher Education Commission under the NRU project of Thailand; Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); SUT	This work was financially supported by Suranaree University of Technology (SUT) and the Office of the Higher Education Commission under the NRU project of Thailand. PM received a Ph.D. Scholarship through the Royal Golden Jubilee Ph.D. Program from the Thailand Research Fund (TRF) and SUT (Grant no. PHD/0084/2550). WS was funded by TRF and SUT through the Basic Research Grant (Grant no. BRG578001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSLER BL, 1991, J BIOL CHEM, V266, P24268; BASSLER BL, 1991, J BIOL CHEM, V266, P24276; Cobucci-Ponzano B, 2003, BIOCHEMISTRY-US, V42, P9525, DOI 10.1021/bi035036t; Comfort DA, 2007, BIOCHEMISTRY-US, V46, P3319, DOI 10.1021/bi061521n; Drouillard S, 1997, BIOCHEM J, V328, P945, DOI 10.1042/bj3280945; Fujita K, 2007, J BIOCHEM, V142, P301, DOI 10.1093/jb/mvm124; Hamre AG, 2015, CARBOHYD RES, V407, P166, DOI 10.1016/j.carres.2015.02.010; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; Hunt DE, 2008, APPL ENVIRON MICROB, V74, P44, DOI 10.1128/AEM.01412-07; JEUNIAUX C, 1991, BIOCHEM SYST ECOL, V19, P347, DOI 10.1016/0305-1978(91)90051-Z; Keyhani NO, 1999, BBA-GEN SUBJECTS, V1473, P108, DOI 10.1016/S0304-4165(99)00172-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lemieux MJ, 2006, J MOL BIOL, V359, P913, DOI 10.1016/j.jmb.2006.04.004; Li XB, 2004, P NATL ACAD SCI USA, V101, P627, DOI 10.1073/pnas.0307645100; Lo Leggio L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6961; MACLEOD AM, 1994, BIOCHEMISTRY-US, V33, P6371, DOI 10.1021/bi00186a042; Maier T, 2003, J MOL BIOL, V328, P669, DOI 10.1016/S0022-2836(03)00311-5; Mark BL, 1998, J BIOL CHEM, V273, P19618, DOI 10.1074/jbc.273.31.19618; Mark BL, 2003, J MOL BIOL, V327, P1093, DOI 10.1016/S0022-2836(03)00216-X; Mark BL, 2001, J BIOL CHEM, V276, P10330, DOI 10.1074/jbc.M011067200; McIlvaine TC, 1921, J BIOL CHEM, V49, P183; Paal K, 2004, BIOCHEM J, V378, P141, DOI 10.1042/BJ20031028; Park JK, 2000, J BIOL CHEM, V275, P33077, DOI 10.1074/jbc.M001042200; Prag G, 2000, J MOL BIOL, V300, P611, DOI 10.1006/jmbi.2000.3906; Rao FV, 2006, EMBO J, V25, P1569, DOI 10.1038/sj.emboj.7601026; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Shallom D, 2002, J BIOL CHEM, V277, P43667, DOI 10.1074/jbc.M208285200; Sirimontree P, 2016, J BIOCHEM, V159, P191, DOI 10.1093/jb/mvv087; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Suginta W, 2005, FEBS J, V272, P3376, DOI 10.1111/j.1742-4658.2005.04753.x; Suginta W, 2004, ARCH BIOCHEM BIOPHYS, V424, P171, DOI 10.1016/j.abb.2004.01.017; Suginta W, 2013, J BIOL CHEM, V288, P11038, DOI 10.1074/jbc.M113.454108; Suginta W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055126; Suginta W, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-40; Sumida T, 2009, J MOL BIOL, V392, P87, DOI 10.1016/j.jmb.2009.06.025; Tews I, 1996, NAT STRUCT BIOL, V3, P638, DOI 10.1038/nsb0796-638; Vallmitjana M, 2001, BIOCHEMISTRY-US, V40, P5975, DOI 10.1021/bi002947j; Viladot JL, 1998, BIOCHEMISTRY-US, V37, P11332, DOI 10.1021/bi980586q; Vocadlo DJ, 2005, BIOCHEMISTRY-US, V44, P12809, DOI 10.1021/bi051121k; Vocadlo DJ, 2000, BIOCHEMISTRY-US, V39, P117, DOI 10.1021/bi991958d; Williams SJ, 2002, J BIOL CHEM, V277, P40055, DOI 10.1074/jbc.M206481200; YU C, 1991, J BIOL CHEM, V266, P24260; Zechel DL, 2001, CURR OPIN CHEM BIOL, V5, P643, DOI 10.1016/S1367-5931(01)00260-5; Zobell CE, 1938, J BACTERIOL, V35, P275, DOI 10.1128/JB.35.3.275-287.1938	45	18	18	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149228	10.1371/journal.pone.0149228	http://dx.doi.org/10.1371/journal.pone.0149228			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26870945	Green Submitted, Green Published, gold			2022-12-27	WOS:000370054100131
J	Lehtihet, M; Bonde, Y; Beckman, L; Berinder, K; Hoybye, C; Rudling, M; Sloan, JH; Konrad, RJ; Angelin, B				Lehtihet, Mikael; Bonde, Ylva; Beckman, Lena; Berinder, Katarina; Hoybye, Charlotte; Rudling, Mats; Sloan, John H.; Konrad, Robert J.; Angelin, Bo			Circulating Hepcidin-25 Is Reduced by Endogenous Estrogen in Humans	PLOS ONE			English	Article							BILE-ACID SYNTHESIS; C-REACTIVE PROTEIN; IRON-METABOLISM; GROWTH-HORMONE; REPLACEMENT THERAPY; RESPONSE ELEMENT; TESTOSTERONE; FERROPORTIN; SERUM; LIVER	Objective Hepcidin reduces iron absorption by binding to the intestinal iron transporter ferroportin, thereby causing its degradation. Although short-term administration of testosterone or growth hormone (GH) has been reported to decrease circulating hepcidin levels, little is known about how hepcidin is influenced in human endocrine conditions associated with anemia. Research design and methods We used a sensitive and specific dual-monoclonal antibody sandwich immunoassay to measure hepcidin-25 in patients (a) during initiation of in vitro fertilization when endogenous estrogens were elevated vs. suppressed, (b) with GH deficiency before and after 12 months substitution treatment, (c) with hyperthyroidism before and after normalization, and (d) with hyperprolactinemia before and after six months of treatment with a dopamine agonist. Results In response to a marked stimulation of endogenous estrogen production, median hepcidin levels decreased from 4.85 to 1.43 ng/mL (p < 0.01). Hyperthyroidism, hyperprolactinemia, or GH substitution to GH-deficient patients did not influence serum hepcidin-25 levels. Conclusions In humans, gonadotropin-stimulated endogenous estrogen markedly decreases circulating hepcidin-25 levels. No clear and stable correlation between iron biomarkers and hepcidin-25 was seen before or after treatment of hyperthyroidism, hyperprolactinemia or growth hormone deficiency.	[Lehtihet, Mikael; Bonde, Ylva; Beckman, Lena; Berinder, Katarina; Hoybye, Charlotte; Rudling, Mats; Angelin, Bo] Karolinska Inst, Karolinska Univ Hosp, Dept Endocrinol Metab & Diabet, Dept Med, S-14186 Huddinge, Sweden; [Lehtihet, Mikael; Bonde, Ylva; Beckman, Lena; Berinder, Katarina; Hoybye, Charlotte; Rudling, Mats; Angelin, Bo] Karolinska Inst, Karolinska Univ Hosp, Dept Endocrinol Metab & Diabet, Dept Mol Med & Surg, S-14186 Huddinge, Sweden; [Bonde, Ylva; Beckman, Lena; Rudling, Mats; Angelin, Bo] Karolinska Inst, Karolinska Univ Hosp, Mol Nutr Unit, Ctr Innovat Med,Dept Biosci & Nutr, S-14186 Huddinge, Sweden; [Sloan, John H.; Konrad, Robert J.] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Eli Lilly	Lehtihet, M (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Dept Endocrinol Metab & Diabet, Dept Med, S-14186 Huddinge, Sweden.; Lehtihet, M (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Dept Endocrinol Metab & Diabet, Dept Mol Med & Surg, S-14186 Huddinge, Sweden.	Mikael.lehtihet@ki.se	Girelli, Domenico/B-1183-2008	Girelli, Domenico/0000-0001-9684-1899; Berinder, Katarina/0000-0003-2488-0375	Lilly Research Laboratories, Eli Lilly Co	Lilly Research Laboratories, Eli Lilly Co	The authors received no specific funding for this work. Lilly Research Laboratories, Eli Lilly & Co, provided support in the form of salaries for authors JHS and RJK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Atanasiu V, 2007, EUR J HAEMATOL, V78, P1, DOI 10.1111/j.1600-0609.2006.00772.x; Bachman E, 2010, J CLIN ENDOCR METAB, V95, P4743, DOI 10.1210/jc.2010-0864; BANG P, 1991, ACTA ENDOCRINOL-COP, V124, P620, DOI 10.1530/acta.0.1240620; Beggs LA, 2014, AM J PHYSIOL-ENDOC M, V307, pE456, DOI 10.1152/ajpendo.00184.2014; Berinder K, 2011, PITUITARY, V14, P199, DOI 10.1007/s11102-010-0277-9; Bonde Y, 2014, J LIPID RES, V55, P2408, DOI 10.1194/jlr.M051664; Butterfield AM, 2010, CLIN CHEM, V56, P1725, DOI 10.1373/clinchem.2010.151522; Centanni M, 1999, ARCH INTERN MED, V159, P1726, DOI 10.1001/archinte.159.15.1726; Ellegala DB, 2003, J NEUROSURG, V98, P974, DOI 10.3171/jns.2003.98.5.0974; Galesloot TE, 2011, BLOOD, V117, pE218, DOI 10.1182/blood-2011-02-337907; Gianoukakis AG, 2009, CLIN ENDOCRINOL, V70, P781, DOI 10.1111/j.1365-2265.2008.03382.x; GOLDE DW, 1977, SCIENCE, V196, P1112, DOI 10.1126/science.870971; Goyal J, 2013, AM J HEMATOL, V88, P976, DOI 10.1002/ajh.23519; Guo W, 2013, AGING CELL, V12, P280, DOI 10.1111/acel.12052; Hou YL, 2012, GENE, V511, P398, DOI 10.1016/j.gene.2012.09.060; Kasvosve I, 2013, CLIN CHIM ACTA, V416, P20, DOI 10.1016/j.cca.2012.11.013; Kemna EHJM, 2007, HAEMATOLOGICA, V93, P90, DOI 10.3324/haematol.11705; Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7; Latour C, 2014, HEPATOLOGY, V59, P683, DOI 10.1002/hep.26648; Lundberg J, 2013, J INTERN MED, V274, P227, DOI 10.1111/joim.12112; MILMAN N, 1992, ANN HEMATOL, V65, P96, DOI 10.1007/BF01698138; Nicolas G, 2003, NAT GENET, V34, P97, DOI 10.1038/ng1150; Nishioka H, 2005, J ENDOCRINOL INVEST, V28, P528, DOI 10.1007/BF03347241; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Persson L, 2012, ARTERIOSCL THROM VAS, V32, P810, DOI 10.1161/ATVBAHA.111.242461; Pietrangelo A, 2007, HEPATOLOGY, V46, P1291, DOI 10.1002/hep.21886; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Qian Y, 2015, CELL SIGNAL, V27, P934, DOI 10.1016/j.cellsig.2015.01.017; Qiao B, 2012, CELL METAB, V15, P918, DOI 10.1016/j.cmet.2012.03.018; Raso GM, 2009, BIOCHEM PHARMACOL, V78, P1001, DOI 10.1016/j.bcp.2009.05.034; RICOUX R, 1994, ANN BIOL CLIN-PARIS, V52, P125; Rigas AS, 2014, TRANSFUSION, V54, P789, DOI 10.1111/trf.12518; Ross SL, 2012, CELL METAB, V15, P905, DOI 10.1016/j.cmet.2012.03.017; Schumann K, 2007, J TRACE ELEM MED BIO, V21, P147, DOI 10.1016/j.jtemb.2007.06.002; Shifren JL, 2008, J CLIN ENDOCR METAB, V93, P1702, DOI 10.1210/jc.2007-2193; Smitz J, 2007, HUM REPROD, V22, P676, DOI 10.1093/humrep/del445; TenHave SMTH, 1997, CLIN ENDOCRINOL, V47, P565, DOI 10.1046/j.1365-2265.1997.3241124.x; Troutt JS, 2012, CLIN CHEM, V58, P1225, DOI 10.1373/clinchem.2012.186866; Yang Q, 2012, ENDOCRINOLOGY, V153, P3170, DOI 10.1210/en.2011-2045	39	43	44	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148802	10.1371/journal.pone.0148802	http://dx.doi.org/10.1371/journal.pone.0148802			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866603	gold, Green Published, Green Submitted			2022-12-27	WOS:000370050700040
J	Moya-Alvarez, V; Mireku, MO; Ayotte, P; Cot, M; Bodeau-Livinec, F				Moya-Alvarez, Violeta; Mireku, Michael Osei; Ayotte, Pierre; Cot, Michel; Bodeau-Livinec, Florence			Elevated Blood Lead Levels Are Associated with Reduced Risk of Malaria in Beninese Infants	PLOS ONE			English	Article							IRON-DEFICIENCY; FALCIPARUM-MALARIA; CHILDREN; COUNTRIES; TOXICITY	Introduction Elevated blood lead levels (BLL) and malaria carry an important burden of disease in West Africa. Both diseases might cause anemia and they might entail long-term consequences for the development and the health status of the child. Albeit the significant impact of malaria on lead levels described in Nigeria, no evaluation of the effect of elevated BLL on malaria risk has been investigated so far. Materials and Methods Between 2010 and 2012, blood lead levels of 203 Beninese infants from Allada, a semi-rural area 50km North from Cotonou, were assessed at 12 months of age. To assess lead levels, blood samples were analyzed by mass spectrometry. In parallel, clinical, microbiological and hematological data were collected. More precisely, hemoglobin, serum ferritin, CRP, vitamin B12, folate levels, and Plasmodium falciparum parasitemia were assessed and stool samples were also analyzed. Results At 12 months, the mean BLL of infants was 7.41 mu g/dL (CI: 65.2; 83), and 128 infants (63%) had elevated blood lead levels, defined by the CDC as BLL>5 mu g/dL. Lead poisoning, defined as BLL>10 mu g/dL, was found in 39 infants (19%). Twenty-five infants (12.5%) had a positive blood smear at 12 months and 144 infants were anemic (71%, hemoglobin<110 g/L). Elevated blood lead levels were significantly associated with reduced risk of a positive blood smear (AOR = 0.38, P-value = 0.048) and P. falciparum parasite density (beta-estimate = -1.42, P-value = 0.03) in logistic and negative binomial regression multivariate models, respectively, adjusted on clinical and environmental indicators. Conclusion Our study shows for the first time that BLL are negatively associated with malarial risk considering other risk factors. Malaria is one of the main causes of morbidity and mortality in infants under 5 years worldwide, and lead poisoning is the 6th most important contributor to the global burden of diseases measured in disability adjusted life years (DALYs) according to the Institute of Health Metrics. In conclusion, due to the high prevalence of elevated BLL, health interventions should look forward to minimize the exposure to lead to better protect the population in West Africa.	[Moya-Alvarez, Violeta; Mireku, Michael Osei; Cot, Michel] IRD, Mere & Enfant Face Infect Trop UMR MERIT 216, Paris, France; [Moya-Alvarez, Violeta; Mireku, Michael Osei] Univ Paris 06, Ecole Doctorale Pierre Louis Sante Publ, Paris, France; [Moya-Alvarez, Violeta] Ecole Hautes Etud Sante Publ, Rennes, France; [Mireku, Michael Osei; Bodeau-Livinec, Florence] Ecole Hautes Etud Sante Publ, Dept Epidemiol & Biostat, Rennes, France; [Ayotte, Pierre] Univ Laval, Dept Med Sociale & Prevent, Quebec City, PQ, Canada; [Ayotte, Pierre] CHU Quebec, Ctr Rech, Axe Sante Populat & Prat Optimales Sante, Quebec City, PQ, Canada; [Ayotte, Pierre] INSPQ, Direct Sante Environm & Toxicol, Quebec City, PQ, Canada; [Cot, Michel] Univ Paris 05, PRES Sorbonne Paris Cite, Fac Sci Pharmaceut & Biol, Paris, France; [Bodeau-Livinec, Florence] Paris Descartes Univ, Ctr Epidemiol & Stat, DHU Risks Pregnancy,Sorbonne Paris Cite, Inserm UMR Obstet Perinatal & Pediat Epidemiol Re, Paris, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Laval University; Laval University; Institut national de sante publique du Quebec (INSPQ); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Moya-Alvarez, V (corresponding author), IRD, Mere & Enfant Face Infect Trop UMR MERIT 216, Paris, France.; Moya-Alvarez, V (corresponding author), Univ Paris 06, Ecole Doctorale Pierre Louis Sante Publ, Paris, France.; Moya-Alvarez, V (corresponding author), Ecole Hautes Etud Sante Publ, Rennes, France.	vmoyaalvarez@gmail.com	Bodeau-Livinec, Florence/U-9053-2017; Cot, Michel/E-7633-2011; Moya-Alvarez, Violeta/AAK-2238-2020; Mireku, Michael/O-1714-2018	Bodeau-Livinec, Florence/0000-0002-4266-6287; Cot, Michel/0000-0003-3014-4294; Moya-Alvarez, Violeta/0000-0001-7901-2263; Mireku, Michael/0000-0002-2157-8456	Ecole des Hautes Etudes en Sante Publique-Direction Generale de l'Armement grant; Univeriste Pierre et Marie Curie grant; NIH; Bill and Melinda Gates foundation	Ecole des Hautes Etudes en Sante Publique-Direction Generale de l'Armement grant; Univeriste Pierre et Marie Curie grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates foundation(Bill & Melinda Gates Foundation)	VMA received the Ecole des Hautes Etudes en Sante Publique-Direction Generale de l'Armement grant for her doctoral fellowship. MOM received the Univeriste Pierre et Marie Curie grant for his doctoral fellowship. The NIH and the Bill and Melinda Gates foundation contributed to the funding of the study.	Baghurst PA, 1992, N ENGL J MED, V1279-1284; Batista-Foguet JM, 2004, SOC INDIC RES, V67, P315, DOI 10.1023/B:SOCI.0000032341.14612.b8; Bayoumi RAL, 1997, MED HYPOTHESES, V48, P11, DOI 10.1016/S0306-9877(97)90017-7; BELLINGER DC, 1992, PEDIATRICS, V90, P855; BOUHAROUNTAYOUN H, 1992, INFECT IMMUN, V60, P1473, DOI 10.1128/IAI.60.4.1473-1481.1992; CDC, CDC RESP ADV COMM CH; Clune AL, 2011, J HLTH POLLUTION, P1; CORTINOVIS I, 1993, SOC SCI MED, V36, P1087, DOI 10.1016/0277-9536(93)90127-P; Dapul Heda, 2014, Adv Pediatr, V61, P313, DOI 10.1016/j.yapd.2014.04.004; GRAZIANO JH, 1991, ARCH ENVIRON HEALTH, V46, P347, DOI 10.1080/00039896.1991.9934401; Heo Y, 1996, TOXICOL APPL PHARM, V138, P149, DOI 10.1006/taap.1996.0108; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; Kwong WT, 2004, SCI TOTAL ENVIRON, V330, P21, DOI 10.1016/j.scitotenv.2004.03.017; LUBRAN MM, 1980, ANN CLIN LAB SCI, V10, P402; Lynes MA, 2006, TOXICOL APPL PHARM, V210, P9, DOI 10.1016/j.taap.2005.04.021; Maizels RM, 2004, IMMUNOL REV, V201, P89, DOI 10.1111/j.0105-2896.2004.00191.x; Mendelsohn AL, 1998, PEDIATRICS, P101; Mireku MO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003463; Moya-alvarez V, 2015, OPEN FORUM INFECT DI, P1; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Ngueta G, 2013, TROP MED INT HEALTH, V18, P1283, DOI 10.1111/tmi.12179; Nriagu J, 2008, INT J HYG ENVIR HEAL, V211, P591, DOI 10.1016/j.ijheh.2008.05.001; Okebe JU, 2011, COCHRANE DATABASE SY; Planche T, 2001, AM J TROP MED HYG, V65, P599, DOI 10.4269/ajtmh.2001.65.599; Pruss-Ustun A, 2002, PREVENTING DIS HLTH; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wright NJ, 2005, ARCH DIS CHILD, V90, P262, DOI 10.1136/adc.2003.043562; Wright RO, 2003, J PEDIATR-US, V142, P9, DOI 10.1067/mpd.2003.mpd0344	30	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149049	10.1371/journal.pone.0149049	http://dx.doi.org/10.1371/journal.pone.0149049			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866471	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000370050700057
J	Nakagawa, Y; Muneta, T; Otabe, K; Ozeki, N; Mizuno, M; Udo, M; Saito, R; Yanagisawa, K; Ichinose, S; Koga, H; Tsuji, K; Sekiya, I				Nakagawa, Yusuke; Muneta, Takeshi; Otabe, Koji; Ozeki, Nobutake; Mizuno, Mitsuru; Udo, Mio; Saito, Ryusuke; Yanagisawa, Katsuaki; Ichinose, Shizuko; Koga, Hideyuki; Tsuji, Kunikazu; Sekiya, Ichiro			Cartilage Derived from Bone Marrow Mesenchymal Stem Cells Expresses Lubricin In Vitro and In Vivo	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; AUTOLOGOUS CHONDROCYTE IMPLANTATION; SUPERFICIAL ZONE PROTEIN; ARTICULAR-CARTILAGE; ADIPOSE-TISSUE; FRICTIONAL-PROPERTIES; RECOMBINANT LUBRICIN; SYNOVIAL-FLUID; RAT MODEL; OSTEOARTHRITIS	Objective Lubricin expression in the superficial cartilage will be a crucial factor in the success of cartilage regeneration. Mesenchymal stem cells (MSCs) are an attractive cell source and the use of aggregates of MSCs has some advantages in terms of chondrogenic potential and efficiency of cell adhesion. Lubricin expression in transplanted MSCs has not been fully elucidated so far. Our goals were to determine (1) whether cartilage pellets of human MSCs expressed lubricin in vitro chondrogenesis, (2) whether aggregates of human MSCs promoted lubricin expression, and (3) whether aggregates of MSCs expressed lubricin in the superficial cartilage after transplantation into osteochondral defects in rats. Methods For in vitro analysis, human bone marrow (BM) MSCs were differentiated into cartilage by pellet culture, and also aggregated using the hanging drop technique. For an animal study, aggregates of BM MSCs derived from GFP transgenic rats were transplanted to the osteochondral defect in the trochlear groove of wild type rat knee joints. Lubricin expression was mainly evaluated in differentiated and regenerated cartilages. Results In in vitro analysis, lubricin was detected in the superficial zone of the pellets and conditioned medium. mRNA expression of Proteoglycan4 (Prg4), which encodes lubricin, in pellets was significantly higher than that of undifferentiated MSCs. Aggregates showed different morphological features between the superficial and deep zone, and the Prg4 mRNA expression increased after aggregate formation. Lubricin was also found in the aggregate. In a rat study, articular cartilage regeneration was significantly better in the MSC group than in the control group as shown by macroscopical and histological analysis. The transmission electron microscope showed that morphology of the superficial cartilage in the MSC group was closer to that of the intact cartilage than in the control group. GFP positive cells remained in the repaired tissue and expressed lubricin in the superficial cartilage. Conclusion Cartilage derived from MSCs expressed lubricin protein both in vitro and in vivo. Aggregation promoted lubricin expression of MSCs in vitro and transplantation of aggregates of MSCs regenerated cartilage including the superficial zone in a rat osteochondral defect model. Our results indicate that aggregated MSCs could be clinically relevant for therapeutic approaches to articular cartilage regeneration with an appropriate superficial zone in the future.	[Nakagawa, Yusuke; Muneta, Takeshi; Udo, Mio; Saito, Ryusuke; Yanagisawa, Katsuaki; Koga, Hideyuki] Tokyo Med & Dent Univ, Grad Sch, Dept Joint Surg & Sports Med, Tokyo, Japan; [Nakagawa, Yusuke; Otabe, Koji; Ozeki, Nobutake; Mizuno, Mitsuru; Sekiya, Ichiro] Tokyo Med & Dent Univ, Ctr Stem Cell & Regenerat Med, Tokyo, Japan; [Ichinose, Shizuko] Tokyo Med & Dent Univ, Res Ctr Med & Dent Sci, Tokyo, Japan; [Tsuji, Kunikazu] Tokyo Med & Dent Univ, Dept Cartilage Regenerat, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Sekiya, I (corresponding author), Tokyo Med & Dent Univ, Ctr Stem Cell & Regenerat Med, Tokyo, Japan.	sekiya.arm@tmd.ac.jp	Tsuji, Kunikazu/HDM-9242-2022; Nakagawa, Yusuke/H-7320-2019; Koga, Hideyuki/B-2448-2019; Mitsuru, Mizuno/K-3962-2017	Tsuji, Kunikazu/0000-0002-1013-8359; Koga, Hideyuki/0000-0003-4574-1796; Mitsuru, Mizuno/0000-0002-4410-3621; Muneta, Takeshi/0000-0003-1018-2939	Highway Program for Realization of Regenerative Medicine from Japan Agency for Medical Research and Development	Highway Program for Realization of Regenerative Medicine from Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This study was supported by the Highway Program for Realization of Regenerative Medicine from Japan Agency for Medical Research and Development (to IS).	Abramson SB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2655; Aigner T, 2002, CELL MOL LIFE SCI, V59, P5, DOI 10.1007/s00018-002-8400-3; Andrades JA, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3793; Bao JP, 2011, MOL BIOL REP, V38, P2879, DOI 10.1007/s11033-010-9949-9; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Chevalier X, 2010, CURR DRUG TARGETS, V11, P546, DOI 10.2174/138945010791011866; Coles JM, 2010, ARTHRITIS RHEUM-US, V62, P1666, DOI 10.1002/art.27436; Cui Z, 2015, BONE, V74, P37, DOI 10.1016/j.bone.2014.12.065; Drewniak EI, 2012, ARTHRITIS RHEUM-US, V64, P465, DOI 10.1002/art.33337; Elsaid KA, 2008, ARTHRITIS RHEUM-US, V58, P1707, DOI 10.1002/art.23495; Flannery CR, 2009, ARTHRITIS RHEUM-US, V60, P840, DOI 10.1002/art.24304; Flannery CR, 1999, BIOCHEM BIOPH RES CO, V254, P535, DOI 10.1006/bbrc.1998.0104; Gleghorn JP, 2007, EUR CELLS MATER, V14, P20, DOI 10.22203/eCM.v014a02; Guzman-Morales J, 2014, OSTEOARTHR CARTILAGE, V22, P323, DOI 10.1016/j.joca.2013.12.011; Hollander AP, 1995, J CLIN INVEST, V96, P2859, DOI 10.1172/JCI118357; Hughes L C, 2005, Eur Cell Mater, V9, P68; Ichinose S, 2010, LAB INVEST, V90, P210, DOI 10.1038/labinvest.2009.125; Ikegawa S, 2000, CYTOGENET CELL GENET, V90, P291, DOI 10.1159/000056791; Inoue H, 2005, BIOCHEM BIOPH RES CO, V329, P288, DOI 10.1016/j.bbrc.2005.01.132; Jay GD, 2007, ARTHRITIS RHEUM-US, V56, P3662, DOI 10.1002/art.22974; Jay GD, 2010, ARTHRITIS RHEUM-US, V62, P2382, DOI 10.1002/art.27550; Johnstone B, 2013, EUR CELLS MATER, V25, P248, DOI 10.22203/eCM.v025a18; Katagiri H, 2013, BIOCHEM BIOPH RES CO, V435, P603, DOI 10.1016/j.bbrc.2013.05.026; Koga H, 2008, CELL TISSUE RES, V333, P207, DOI 10.1007/s00441-008-0633-5; Lee SY, 2010, TISSUE ENG PT A, V16, P317, DOI [10.1089/ten.tea.2009.0104, 10.1089/ten.TEA.2009.0104]; Mandelbaum B, 2005, ORTHOPEDICS, V28, pS207; Marcelino J, 1999, NAT GENET, V23, P319, DOI 10.1038/15496; Musumeci G, 2015, SCAND J MED SCI SPOR, V25, pe222, DOI 10.1111/sms.12290; Musumeci G, 2015, HISTOL HISTOPATHOL, V30, P1, DOI 10.14670/HH-30.1; Musumeci G, 2014, ACTA HISTOCHEM, V116, P1407, DOI 10.1016/j.acthis.2014.09.008; Musumeci G, 2014, HISTOL HISTOPATHOL, V29, P707, DOI 10.14670/HH-29.707; Musumeci G, 2013, J NUTR BIOCHEM, V24, P2064, DOI 10.1016/j.jnutbio.2013.07.007; Musumeci G, 2013, J BONE MINER METAB, V31, P274, DOI 10.1007/s00774-012-0414-9; Musumeci G, 2011, EXP BIOL MED, V236, P1333, DOI 10.1258/ebm.2011.011183; Nakagawa Y, 2015, OSTEOARTHR CARTILAGE, V23, P1007, DOI 10.1016/j.joca.2015.02.008; Nakagawa Y, 2016, J MAGN RESON IMAGING, V43, P434, DOI 10.1002/jmri.24988; Niikura T, 2007, ARTHRITIS RHEUM, V56, P2312, DOI 10.1002/art.22659; Ogawa H, 2014, GENE DEV, V28, P127, DOI 10.1101/gad.231969.113; Otabe K, 2015, J ORTHOP RES, V33, P1, DOI 10.1002/jor.22750; Pedersen DR, 2013, ORTHOP RES REV, V5, P13, DOI 10.2147/ORR.S38400; Rees SG, 2002, MATRIX BIOL, V21, P593, DOI 10.1016/S0945-053X(02)00056-2; Rhee DK, 2005, J CLIN INVEST, V115, P622, DOI 10.1172/JCI200522263; Ruan MZC, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005409; Sakaguchi Y, 2004, BLOOD, V104, P2728, DOI 10.1182/blood-2003-12-4452; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; Schubert T, 2009, INT J MOL MED, V23, P455, DOI 10.3892/ijmm_00000151; Schumacher BL, 2005, J ORTHOP RES, V23, P562, DOI 10.1016/j.orthres.2004.11.011; Segawa Y, 2009, J ORTHOP RES, V27, P435, DOI 10.1002/jor.20786; Sekiya I, 2015, CLIN ORTHOP RELAT R, V473, P2316, DOI 10.1007/s11999-015-4324-8; Sekiya I, 2012, J ORTHOP RES, V30, P943, DOI 10.1002/jor.22029; Su JL, 2001, HYBRIDOMA, V20, P149, DOI 10.1089/027245701750293475; Sun YL, 2006, CONNECT TISSUE RES, V47, P215, DOI 10.1080/03008200600846754; Suzuki S, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3869; Teeple E, 2008, J ORTHOP RES, V26, P231, DOI 10.1002/jor.20492; Teeple E, 2011, AM J SPORT MED, V39, P164, DOI 10.1177/0363546510378088; Tins BJ, 2005, RADIOLOGY, V234, P501, DOI 10.1148/radiol.2342031970; WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013; Yoshimura H, 2007, CELL TISSUE RES, V327, P449, DOI 10.1007/s00441-006-0308-z; Young AA, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1898	59	31	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148777	10.1371/journal.pone.0148777	http://dx.doi.org/10.1371/journal.pone.0148777			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867127	gold, Green Published, Green Submitted			2022-12-27	WOS:000370050700036
J	Carlson, N; Hommel, K; Olesen, JB; Soja, AM; Vilsboll, T; Kamper, AL; Torp-Pedersen, C; Gislason, G				Carlson, Nicholas; Hommel, Kristine; Olesen, Jonas Bjerring; Soja, Anne-Merete; Vilsboll, Tina; Kamper, Anne-Lise; Torp-Pedersen, Christian; Gislason, Gunnar			Dialysis-Requiring Acute Kidney Injury in Denmark 2000-2012: Time Trends of Incidence and Prevalence of Risk Factors-A Nationwide Study	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; CARDIAC-SURGERY; MORTALITY; POPULATION; OUTCOMES; REGISTRY; DISEASE; VALIDATION; MORBIDITY; VALIDITY	Introduction Dialysis-requiring acute kidney injury is a severe illness associated with poor prognosis. However, information pertaining to incidence rates and prevalence of risk factors remains limited in spite of increasing focus. We evaluate time trends of incidence rates and changing patterns in prevalence of comorbidities, concurrent medication, and other risk factors in nationwide retrospective cohort study. Materials and Methods All patients with dialysis-requiring acute kidney injury were identified between January 1st 2000 and December 31st 2012. By cross-referencing data from national administrative registries, the association of changing patterns in dialysis treatment, comorbidity, concurrent medication and demographics with incidence of dialysis-requiring acute kidney injury was evaluated. Results A total of 18,561 adult patients with dialysis-requiring AKI were identified between 2000 and 2012. Crude incidence rate of dialysis-requiring AKI increased from 143 per million (95% confidence interval, 137-144) in 2000 to 366 per million (357-375) in 2006, and remained stable hereafter. Notably, incidence of continuous veno-venous hemodialysis (CRRT) and use of acute renal replacement therapy in elderly >75 years increased substantially from 23 per million (20-26) and 328 per million (300-355) in 2000, to 213 per million (206-220) and 1124 per million (1076-1172) in 2012, respectively. Simultaneously, patient characteristics and demographics shifted towards increased age and comorbidity. Conclusions Although growth in crude incidence rate of dialysis-requiring AKI stabilized in 2006, continuous growth in use of CRRT, and acute renal replacement therapy of elderly patients >75 years, was observed. Our results indicate an underlying shift in clinical paradigm, as opposed to unadulterated growth in incidence of dialysis-requiring AKI.	[Carlson, Nicholas; Olesen, Jonas Bjerring; Gislason, Gunnar] Univ Copenhagen, Dept Cardiol, Gentofte Hosp, Gentofte, Denmark; [Carlson, Nicholas; Hommel, Kristine] Univ Copenhagen, Herlev Hosp, Dept Nephrol, DK-2730 Herlev, Denmark; [Soja, Anne-Merete] Univ Copenhagen, Hvidovre Hosp, Dept Cardiol, DK-2650 Hvidovre, Denmark; [Vilsboll, Tina] Univ Copenhagen, Gentofte Hosp, Ctr Diabet Res, Gentofte, Denmark; [Kamper, Anne-Lise] Univ Copenhagen, Rigshosp, Dept Nephrol, DK-2100 Copenhagen, Denmark; [Torp-Pedersen, Christian] Aalborg Univ, Inst Hlth Sci & Technol, Aalborg, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; Aalborg University	Carlson, N (corresponding author), Univ Copenhagen, Dept Cardiol, Gentofte Hosp, Gentofte, Denmark.; Carlson, N (corresponding author), Univ Copenhagen, Herlev Hosp, Dept Nephrol, DK-2730 Herlev, Denmark.	Nicholas.carlson@regionh.dk	Gislason, Gunnar/B-7561-2009; Vilsboll, Tina/I-6562-2016; Carlson, Nicholas/M-2666-2016	Gislason, Gunnar/0000-0002-0548-402X; Kamper, Anne-Lise/0000-0001-7523-6569; Carlson, Nicholas/0000-0002-4374-470X	Danish Heart Foundation; Danish Kidney Foundation; Department of Cardiology at Copenhagen University Hospital Gentofte; Department of Nephrology at Copenhagen University Hospital Herlev; Helen and Ejnar Bjoernows Foundation; Danish Society of Nephrology; Health Foundation; Novo Nordisk Foundation; Bristol-Myers Squibb; Boehringer Ingelheim; Lundbeck Foundation; Capital Region of Denmark; Novo Nordisk Fonden [NNF16OC0020224, NNF12OC1015904, NNF15OC0016230, NNF12OC1015957] Funding Source: researchfish	Danish Heart Foundation; Danish Kidney Foundation; Department of Cardiology at Copenhagen University Hospital Gentofte; Department of Nephrology at Copenhagen University Hospital Herlev; Helen and Ejnar Bjoernows Foundation; Danish Society of Nephrology; Health Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Bristol-Myers Squibb(Bristol-Myers Squibb); Boehringer Ingelheim(Boehringer Ingelheim); Lundbeck Foundation(Lundbeckfonden); Capital Region of Denmark; Novo Nordisk Fonden(Novo Nordisk Foundation)	NC: Grants received from The Danish Heart Foundation, The Danish Kidney Foundation, The Department of Cardiology at Copenhagen University Hospital Gentofte and the Department of Nephrology at Copenhagen University Hospital Herlev, Helen and Ejnar Bjoernows Foundation, The Danish Society of Nephrology and the Health Foundation. GG: Supported by an unrestricted clinical research scholarship from the Novo Nordisk Foundation. JO: Has received speaker fees and funding for research from Bristol-Myers Squibb and Boehringer Ingelheim, the Lundbeck Foundation, and The Capital Region of Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, and no funding was specifically designated for this work.	Afshinnia F, 2009, RENAL FAILURE, V31, P647, DOI 10.3109/08860220903151401; [Anonymous], 2012, KIDNEY INT SUPPL, V2, P1, DOI [10.1038/kisup.2012.1, DOI 10.1038/KISUP.2012.1]; Blichert-Hansen Linea, 2013, Clin Epidemiol, V5, P9, DOI 10.2147/CLEP.S37763; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Fagugli RM, 2014, J NEPHROL; Gammelager H, 2013, CRIT CARE, V17, DOI 10.1186/cc12824; Grams ME, 2014, CLIN J AM SOC NEPHRO, V9, P682, DOI 10.2215/CJN.07650713; Hamel MB, 2005, J AM GERIATR SOC, V53, P424, DOI 10.1111/j.1532-5415.2005.53159.x; Hommel K, 2010, NEPHROL DIAL TRANSPL, V25, P947, DOI 10.1093/ndt/gfp571; Hsu CY, 2008, KIDNEY INT, V74, P101, DOI 10.1038/ki.2008.107; Hsu CY, 2007, KIDNEY INT, V72, P208, DOI 10.1038/sj.ki.5002297; Hsu RK, 2013, CLIN J AM SOC NEPHRO, V8, P1476, DOI 10.2215/CJN.12611212; Hsu RK, 2013, J AM SOC NEPHROL, V24, P37, DOI 10.1681/ASN.2012080800; Johannesdottir Sigrun Alba, 2012, Clin Epidemiol, V4, P303, DOI 10.2147/CLEP.S37587; JURGENSEN HJ, 1986, METHOD INFORM MED, V25, P158; Karkouti K, 2009, CIRCULATION, V119, P495, DOI 10.1161/CIRCULATIONAHA.108.786913; Kearns B, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-49; Khera S, 2013, AM J CARDIOL, V112, P1279, DOI 10.1016/j.amjcard.2013.06.008; Kheterpal S, 2009, ANESTHESIOLOGY, V110, P505, DOI 10.1097/ALN.0b013e3181979440; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Kolhe NV, 2015, KIDNEY INT, V88, P1161, DOI 10.1038/ki.2015.234; Lameire NH, 2013, LANCET, V382, P170, DOI 10.1016/S0140-6736(13)60647-9; Lenihan CR, 2013, ANN THORAC SURG, V95, P20, DOI 10.1016/j.athoracsur.2012.05.131; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lewington AJP, 2013, KIDNEY INT, V84, P457, DOI 10.1038/ki.2013.153; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Matuszkiewicz-Rowinska J, 2015, KIDNEY INT, V87, P1264, DOI 10.1038/ki.2015.61; O'Hare AM, 2012, AM J KIDNEY DIS, V59, P513, DOI 10.1053/j.ajkd.2011.11.044; Olesen Jonas Bjerring, 2011, BMJ, V342, pd124, DOI 10.1136/bmj.d124; Rodrigues FB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069998; Sakhuja A, 2015, AM J RESP CRIT CARE, V192, P951, DOI 10.1164/rccm.201502-0329OC; Siew ED, 2015, KIDNEY INT, V87, P46, DOI 10.1038/ki.2014.293; Susantitaphong P, 2013, CLIN J AM SOC NEPHRO, V8, P1482, DOI 10.2215/CJN.00710113; Thakar CV, 2003, AM J KIDNEY DIS, V41, P742, DOI 10.1016/S0272-6386(03)00021-0; Thakar CV, 2013, INT J NEPHROL, V2013, DOI [10.1155/2013/827459, DOI 10.1155/2013/827459]; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; Toft P, 2000, Ugeskr Laeger, V162, P2868; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1143, DOI 10.1681/ASN.2005091017; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1688, DOI 10.1681/ASN.2006010073; Wald R, 2015, AM J KIDNEY DIS, V65, P870, DOI 10.1053/j.ajkd.2014.10.017; Wang HE, 2012, AM J NEPHROL, V35, P349, DOI 10.1159/000337487; Wonnacott A, 2014, CLIN J AM SOC NEPHRO; Xue JL, 2006, J AM SOC NEPHROL, V17, P1135, DOI 10.1681/ASN.2005060668	45	19	20	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148809	10.1371/journal.pone.0148809	http://dx.doi.org/10.1371/journal.pone.0148809			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863015	Green Published, gold			2022-12-27	WOS:000370046600108
J	Lee, HH; Hou, MF; Wei, SY; Lin, SD; Luo, KH; Huang, MY; Ou-Yang, F; Huang, CJ				Lee, Hsin-Hua; Hou, Ming-Feng; Wei, Shu-Yi; Lin, Sin-Daw; Luo, Kuei-Hau; Huang, Ming-Yii; Ou-Yang, Fu; Huang, Chih-Jen			Comparison of Long-Term Outcomes of Postmastectomy Radiotherapy between Breast Cancer Patients with and without Immediate Flap Reconstruction	PLOS ONE			English	Article							PREMENOPAUSAL WOMEN; RADIATION-THERAPY; LOCAL RECURRENCE; MASTECTOMY; SURVIVAL; SURGERY; CHEMOTHERAPY	Purpose To compare the long-term clinical outcomes of postmastectomy radiotherapy (PMRT) between breast cancer patients with and without immediate transverse rectus abdominis myocutaneous (TRAM) flap reconstruction. Methods The study included 492 patients with stage II or III breast cancer who underwent modified radical mastectomy (MRM) and chemotherapy followed by PMRT between 1997 and 2011. Cox regression model and Kaplan-Meier curves were calculated, and the log-rank test was used to evaluate the differences between overall and disease-free survival rates in the 2 groups. Results Among 492 patients, 213 patients had immediate TRAM flap reconstruction. The mean follow-up was 7.2 years (range, 11-191 months). The 5-year and 10-year disease free survival rates were 81% and 76% for the TRAM flap group and 78% and 73% for the non-flap group. The 5-year and 10-year overall survival rates were 89% and 73% for the TRAM flap group and 83% and 74% for the non-flap group. Conclusions There exists no statistically significant difference in the rates of local recurrence, distant metastasis, disease-free and overall survival when comparing immediate TRAM flap reconstruction with no reconstruction. Our results suggest that immediate TRAM flap reconstruction does not compromise long term clinical outcomes in breast cancer patients requiring PMRT.	[Lee, Hsin-Hua; Huang, Ming-Yii; Huang, Chih-Jen] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Radiat Oncol, Div Radiat Oncol, Kaohsiung, Taiwan; [Lee, Hsin-Hua] Antai Tian Sheng Mem Hosp, Dept Radiat Oncol, Pingtung, Taiwan; [Hou, Ming-Feng; Lin, Sin-Daw; Huang, Ming-Yii; Huang, Chih-Jen] Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung, Taiwan; [Hou, Ming-Feng; Lin, Sin-Daw; Ou-Yang, Fu] Kaohsiung Med Univ Hosp, Dept Gen Surg, Kaohsiung, Taiwan; [Hou, Ming-Feng; Lin, Sin-Daw] Natl Sun Yat Sen Univ Kaohsiung Med Univ Joint Re, Kaohsiung, Taiwan; [Wei, Shu-Yi] Kaohsiung Municipal United Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Wei, Shu-Yi] Yuh Ing Jr Coll Hlth Care Management, Kaohsiung, Taiwan; [Luo, Kuei-Hau] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Occupat & Environm Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Huang, CJ (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Radiat Oncol, Div Radiat Oncol, Kaohsiung, Taiwan.; Huang, CJ (corresponding author), Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung, Taiwan.	ccjjhh@kmu.edu.tw	Lee, Hsin-Hua/AAZ-1009-2020; Huang, Ming-Yii/AAS-8132-2021	Lee, Hsin-Hua/0000-0001-5655-4641; Hou, Ming-Feng/0000-0001-6030-9702; lin, sindaw/0000-0002-2269-8484	Ministry of Health and Welfare of the Republic of China [MOHW103-TD-B-111-05]	Ministry of Health and Welfare of the Republic of China	This work was supported by the Ministry of Health and Welfare of the Republic of China for financial support under contract No. MOHW103-TD-B-111-05.	Abe O, 2005, LANCET, V366, P2087; Agarwal J, 2012, BREAST J, V18, P226, DOI 10.1111/j.1524-4741.2012.01235.x; Agarwal S, 2010, BREAST J, V16, P503, DOI 10.1111/j.1524-4741.2010.00958.x; Alderman AK, 2006, JAMA-J AM MED ASSOC, V295, P387, DOI 10.1001/jama.295.4.387; Alderman AK, 2010, CANCER-AM CANCER SOC, V116, P1791, DOI 10.1002/cncr.24891; Barry M, 2011, BREAST CANCER RES TR, V127, P15, DOI 10.1007/s10549-011-1401-x; Berry T, 2010, ANN SURG ONCOL, V17, pS202, DOI 10.1245/s10434-010-1261-3; Bezuhly M, 2009, CANCER, V115, P4648, DOI 10.1002/cncr.24511; Cordeiro PG, 2008, NEW ENGL J MED, V359, P1590, DOI 10.1056/NEJMct0802899; Darby S, 2007, 43 ANN M AM SOC CLIN; Downes KJ, 2005, CANCER-AM CANCER SOC, V103, P906, DOI 10.1002/cncr.20851; Early Breast Canc Trialists Collab, 2011, LANCET, V378, P1707, DOI 10.1016/S0140-6736(11)61629-2; Foster RD, 2005, ARCH SURG-CHICAGO, V140, P196, DOI 10.1001/archsurg.140.2.196; Ho A, 2012, CANCER-AM CANCER SOC, V118, P2552, DOI 10.1002/cncr.26521; Huang CJ, 2006, PLAST RECONSTR SURG, V118, P1079, DOI 10.1097/01.prs.0000220527.35442.44; Jhaveri JD, 2008, INT J RADIAT ONCOL, V72, P859, DOI 10.1016/j.ijrobp.2008.01.055; Katz A, 2000, J CLIN ONCOL, V18, P2817, DOI 10.1200/JCO.2000.18.15.2817; Kronowitz SJ, 2006, CANCER-AM CANCER SOC, V107, P893, DOI 10.1002/cncr.22079; Kronowitz SJ, 2012, PLAST RECONSTR SURG, V130, p513E, DOI 10.1097/PRS.0b013e318262f059; Kronowitz SJ, 2011, PLAST RECONSTR SURG, V127, P2154, DOI 10.1097/PRS.0b013e3182131b8e; MacDonald SM, 2011, BREAST J, V17, P579, DOI 10.1111/j.1524-4741.2011.01150.x; McCormick B, 2008, CANCER J, V14, P264, DOI 10.1097/PPO.0b013e31817fbe4b; Overgaard M, 1997, NEW ENGL J MED, V337, P949, DOI 10.1056/NEJM199710023371401; Ragaz J, 1997, NEW ENGL J MED, V337, P956, DOI 10.1056/NEJM199710023371402; Veronesi P, 2011, BREAST, V20, pS104, DOI 10.1016/S0960-9776(11)70305-8; Weichman KE, 2015, PLAST RECONSTR SURG, V136, P213, DOI 10.1097/PRS.0000000000001418; Wong JS, 2008, BREAST J, V14, P49, DOI 10.1111/j.1524-4741.2007.00522.x	27	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148318	10.1371/journal.pone.0148318	http://dx.doi.org/10.1371/journal.pone.0148318			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863006	gold, Green Published, Green Submitted			2022-12-27	WOS:000370046600054
J	Motta, C; Palermo, E; Studer, V; Germanotta, M; Germani, G; Centonze, D; Cappa, P; Rossi, S; Rossi, S				Motta, Caterina; Palermo, Eduardo; Studer, Valeria; Germanotta, Marco; Germani, Giorgio; Centonze, Diego; Cappa, Paolo; Rossi, Silvia; Rossi, Stefano			Disability and Fatigue Can Be Objectively Measured in Multiple Sclerosis	PLOS ONE			English	Article							SCALE; IMPAIRMENT; IMPACT; MS	Background The available clinical outcome measures of disability in multiple sclerosis are not adequately responsive or sensitive. Objective To investigate the feasibility of inertial sensor-based gait analysis in multiple sclerosis. Methods A cross-sectional study of 80 multiple sclerosis patients and 50 healthy controls was performed. Lower-limb kinematics was evaluated by using a commercially available magnetic inertial measurement unit system. Mean and standard deviation of range of motion (mROM, sROM) for each joint of lower limbs were calculated in one minute walking test. A motor performance index (E) defined as the sum of sROMs was proposed. Results We established two novel observer-independent measures of disability. Hip mROM was extremely sensitive in measuring lower limb motor impairment, being correlated with muscle strength and also altered in patients without clinically detectable disability. On the other hand, E index discriminated patients according to disability, being altered only in patients with moderate and severe disability, regardless of walking speed. It was strongly correlated with fatigue and patient-perceived health status. Conclusions Inertial sensor-based gait analysis is feasible and can detect clinical and subclinical disability in multiple sclerosis.	[Motta, Caterina; Studer, Valeria; Germani, Giorgio; Centonze, Diego; Rossi, Silvia] Univ Roma Tor Vergata, Dipartimento Med Sistemi, Rome, Italy; [Motta, Caterina; Centonze, Diego; Rossi, Silvia] IRCCS Ist Neurol Mediterraneo INM Neuromed, Pozzilli, Italy; [Palermo, Eduardo; Cappa, Paolo] Univ Roma La Sapienza, Dept Mech & Aerosp Engn, Rome, Italy; [Studer, Valeria; Germani, Giorgio] Fdn Santa Lucia, CERC, Rome, Italy; [Germanotta, Marco] Don Carlo Gnocchi Onlus Fdn, Milan, Italy; [Rossi, Silvia] IRCCS Fdn Carlo Besta Neurol Inst, Neuroimmunol & Neuromuscolar Dis Unit, Milan, Italy; [Rossi, Stefano] Univ Tuscia, Dept Econ & Management Ind Engn, Viterbo, Italy	University of Rome Tor Vergata; IRCCS Neuromed; Sapienza University Rome; IRCCS Santa Lucia; IRCCS Fondazione Don Carlo Gnocchi Onlus; IRCCS Istituto Neurologico Besta; Tuscia University	Rossi, S (corresponding author), Univ Roma Tor Vergata, Dipartimento Med Sistemi, Rome, Italy.; Rossi, S (corresponding author), IRCCS Ist Neurol Mediterraneo INM Neuromed, Pozzilli, Italy.; Rossi, S (corresponding author), IRCCS Fdn Carlo Besta Neurol Inst, Neuroimmunol & Neuromuscolar Dis Unit, Milan, Italy.	silvia.rossi@istituto-besta.it	Centonze, Diego/J-7767-2016; Palermo, Eduardo/AAX-8426-2021; Rossi, Stefano/AAB-9111-2020; Germanotta, Marco/J-3893-2018; Motta, Caterina/L-1513-2018	Centonze, Diego/0000-0002-8390-8545; Palermo, Eduardo/0000-0002-3213-8261; Germanotta, Marco/0000-0002-0747-831X; studer, valeria/0000-0003-2529-7640; ROSSI, Stefano/0000-0003-0006-7013	Italian Institute of Technology (IIT)	Italian Institute of Technology (IIT)(Istituto Italiano di Tecnologia - IIT)	Part of this work was supported by a grant from the Italian Institute of Technology (IIT) - Project Seed ("ITINERE-Interactive Technology: an Instrumented Novel Exoskeleton for Rehabilitation" 2009).	Aminian K, 2004, COMPUT ANIMAT VIRT W, V15, P79, DOI 10.1002/cav.2; Behrens J, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-89; Burschka JM, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-161; Cohen JA, 2012, LANCET NEUROL, V11, P467, DOI 10.1016/S1474-4422(12)70059-5; Cutter GR, 1999, BRAIN, V122, P871, DOI 10.1093/brain/122.5.871; Ebers GC, 2008, NEUROLOGY, V71, P624, DOI 10.1212/01.wnl.0000313034.46883.16; Hobart JC, 2003, NEUROLOGY, V60, P31, DOI 10.1212/WNL.60.1.31; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lublin FD, 2014, NEUROLOGY, V83, P278, DOI 10.1212/WNL.0000000000000560; McKenna SP, 2010, VALUE HEALTH, V13, P946, DOI 10.1111/j.1524-4733.2010.00767.x; Palermo E, 2014, PHYSIOL MEAS, V35, P399, DOI 10.1088/0967-3334/35/3/399; Palermo E, 2014, MEASUREMENT, V52, P145, DOI 10.1016/j.measurement.2014.03.004; Pearson OR, 2004, QJM-INT J MED, V97, P463, DOI 10.1093/qjmed/hch084; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Remelius JG, 2012, ARCH PHYS MED REHAB, V93, P1637, DOI 10.1016/j.apmr.2012.02.019; Rossi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073139; Sehle A, 2014, J NEUROL, V261, P1752, DOI 10.1007/s00415-014-7415-7; Smith MM, 2005, MULT SCLER J, V11, P602, DOI 10.1191/1352458505ms1204oa; Sosnoff JJ, 2011, GAIT POSTURE, V34, P145, DOI 10.1016/j.gaitpost.2011.03.020; Spain RI, 2012, GAIT POSTURE, V35, P573, DOI 10.1016/j.gaitpost.2011.11.026; Tellez N, 2005, MULT SCLER J, V11, P198, DOI 10.1191/1352458505ms1148oa	22	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148997	10.1371/journal.pone.0148997	http://dx.doi.org/10.1371/journal.pone.0148997			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863109	Green Submitted, Green Published, gold			2022-12-27	WOS:000370046600136
J	Park, J; Khloya, P; Seo, Y; Kumar, S; Lee, HK; Jeon, DK; Jo, S; Sharma, PK; Namkung, W				Park, Jinhong; Khloya, Poonam; Seo, Yohan; Kumar, Satish; Lee, Ho K.; Jeon, Dong-Kyu; Jo, Sungwoo; Sharma, Pawan K.; Namkung, Wan			Potentiation of Delta F508-and G551D-CFTR-Mediated Cl- Current by Novel Hydroxypyrazolines	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CHLORIDE CHANNEL ACTIVATORS; SMALL-MOLECULE CORRECTORS; CYSTIC-FIBROSIS; IN-VITRO; CFTR POTENTIATOR; MUTATION; PROTEIN; CELLS; INHIBITORS	The most common mutation of CFTR, affecting approximately 90% of CF patients, is a deletion of phenylalanine at position 508 (F508del, Delta F508). Misfolding of Delta F508-CFTR impairs both its trafficking to the plasma membrane and its chloride channel activity. To identify small molecules that can restore channel activity of Delta F508-CFTR, we synthesized and evaluated eighteen novel hydroxypyrazoline analogues as CFTR potentiators. To elucidate potentiation activities of hydroxypyrazolines for Delta F508-CFTR, CFTR activity was measured using a halide-sensitive YFP assay, Ussing chamber assay and patch-clamp technique. Compounds 7p, 7q and 7r exhibited excellent potentiation with EC50 value < 10 mu M. Among the compounds, 7q (a novel CFTR potentiator, CP7q) showed the highest potentiation activity with EC50 values of 0.88 +/- 0.11 and 4.45 +/- 0.31 mu M for wild-type and Delta F508-CFTR, respectively. In addition, CP7q significantly potentiated chloride conductance of G551D-CFTR, a CFTR gating mutant; its maximal potentiation activity was 1.9 fold higher than the well-known CFTR potentiator genistein. Combination treatment with CP7q and VX-809, a corrector of Delta F508-CFTR, significantly enhanced functional rescue of Delta F508-CFTR compared with VX-809 alone. CP7q did not alter the cytosolic cAMP level and showed no cytotoxicity at the concentration showing maximum efficacy. The hydroxypyrazolines may be potential development candidates for drug therapy of cystic fibrosis.	[Park, Jinhong; Seo, Yohan; Jeon, Dong-Kyu; Jo, Sungwoo; Namkung, Wan] Yonsei Univ, Yonsei Inst Pharmaceut Sci, Coll Pharm, Inchon 406840, South Korea; [Park, Jinhong; Seo, Yohan; Lee, Ho K.; Namkung, Wan] Yonsei Univ, WCU Program Grad Sch, Dept Integrated OMICS Biomed Sci, Seoul 120749, South Korea; [Khloya, Poonam; Kumar, Satish; Sharma, Pawan K.] Kurukshetra Univ, Dept Chem, Kurukshetra 136119, Haryana, India	Yonsei University; Yonsei University; Kurukshetra University	Namkung, W (corresponding author), Yonsei Univ, Yonsei Inst Pharmaceut Sci, Coll Pharm, Inchon 406840, South Korea.; Namkung, W (corresponding author), Yonsei Univ, WCU Program Grad Sch, Dept Integrated OMICS Biomed Sci, Seoul 120749, South Korea.; Sharma, PK (corresponding author), Kurukshetra Univ, Dept Chem, Kurukshetra 136119, Haryana, India.	pksharma@kuk.ac.in; wnamkung@yonsei.ac.kr	서, 요한/AAZ-6433-2020; Sharma, Pawan K./AAQ-8877-2020	Sharma, Pawan K./0000-0001-6613-1634	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2012R1A1A1040142]; Korea Healthcare technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea [HI08C2149]	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); Korea Healthcare technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2012R1A1A1040142) and a grant of the Korea Healthcare technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea (HI08C2149).	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Becq F, 2006, CURR PHARM DESIGN, V12, P471, DOI 10.2174/138161206775474459; Boinot C, 2014, J PHARMACOL EXP THER, V350, P624, DOI 10.1124/jpet.114.214890; Boumendjel A, 2008, J MED CHEM, V51, P2307, DOI 10.1021/jm0708331; Carlile GW, 2015, J CYST FIBROS, V14, P16, DOI 10.1016/j.jcf.2014.06.001; Chandak N, 2013, EUR J MED CHEM, V59, P203, DOI 10.1016/j.ejmech.2012.11.015; Cholon DM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008680; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; Davis PB, 2012, NAT REV DRUG DISCOV, V11, P349, DOI 10.1038/nrd3723; Favia M, 2014, AM J PHYSIOL-LUNG C, V307, pL48, DOI 10.1152/ajplung.00305.2013; French PJ, 1997, AM J PHYSIOL-CELL PH, V273, pC747, DOI 10.1152/ajpcell.1997.273.2.C747; Galietta LJV, 2001, J BIOL CHEM, V276, P19723, DOI 10.1074/jbc.M101892200; Huang CS, 1998, J NAT PROD, V61, P1283, DOI 10.1021/np980026s; Illek B, 1998, AM J PHYSIOL-LUNG C, V275, pL902, DOI 10.1152/ajplung.1998.275.5.L902; Illek B, 2000, AM J PHYSIOL-CELL PH, V279, pC1838, DOI 10.1152/ajpcell.2000.279.6.C1838; Khloya P, 2014, EUR J MED CHEM, V76, P284, DOI 10.1016/j.ejmech.2014.02.023; Knapp JM, 2012, J MED CHEM, V55, P1242, DOI 10.1021/jm201372q; Kumar S, 2012, BIOORGAN MED CHEM, V20, P4237, DOI 10.1016/j.bmc.2012.05.074; Liu XH, 2012, BIOCHEMISTRY-US, V51, P5113, DOI 10.1021/bi300018e; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; Moran O, 2005, CELL MOL LIFE SCI, V62, P446, DOI 10.1007/s00018-004-4422-3; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Pasyk S, 2009, BIOCHEM J, V418, P185, DOI 10.1042/BJ20081424; Pedemonte N, 2005, MOL PHARMACOL, V67, P1797, DOI 10.1124/mol.105.010959; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Phuan PW, 2014, MOL PHARMACOL, V86, P42, DOI 10.1124/mol.114.092478; Pyle LC, 2011, AM J PHYSIOL-LUNG C, V301, pL587, DOI 10.1152/ajplung.00465.2010; QUINTON PM, 1983, NATURE, V301, P421, DOI 10.1038/301421a0; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Robert R, 2008, MOL PHARMACOL, V73, P478, DOI 10.1124/mol.107.040725; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Sharma PK, 2012, MED CHEM RES, V21, P2945, DOI 10.1007/s00044-011-9823-x; SOLIMAN R, 1979, J MED CHEM, V22, P321, DOI 10.1021/jm00189a022; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Veit G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008889; Wang F, 1998, J GEN PHYSIOL, V111, P477, DOI 10.1085/jgp.111.3.477; Wang W, 2011, J BIOL CHEM, V286, P41937, DOI 10.1074/jbc.M111.296061; Weinreich F, 1997, PFLUG ARCH EUR J PHY, V434, P484, DOI 10.1007/s004240050424; Wellhauser L, 2009, MOL PHARMACOL, V75, P1430, DOI 10.1124/mol.109.055608; Wine JJ, 1995, CURR BIOL, V5, P1357, DOI 10.1016/S0960-9822(95)00269-7; Ye L, 2010, J MED CHEM, V53, P3772, DOI 10.1021/jm100235h; Yoon JH, 2000, ANN OTO RHINOL LARYN, V109, P594, DOI 10.1177/000348940010900612; Yu GJ, 2008, J MED CHEM, V51, P6044, DOI 10.1021/jm800533c; Yu HH, 2012, J CYST FIBROS, V11, P237, DOI 10.1016/j.jcf.2011.12.005	48	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149131	10.1371/journal.pone.0149131	http://dx.doi.org/10.1371/journal.pone.0149131			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863533	Green Submitted, gold, Green Published			2022-12-27	WOS:000370046600158
J	Tung, H; Wei, SC; Lo, HR; Chao, YC				Tung, Hsuan; Wei, Sung-Chan; Lo, Huei-Ru; Chao, Yu-Chan			Baculovirus IE2 Stimulates the Expression of Heat Shock Proteins in Insect and Mammalian Cells to Facilitate Its Proper Functioning	PLOS ONE			English	Article							GENE-TRANSFER; DNA-REPLICATION; PROMOTER; HSP90; IDENTIFICATION; ACTIVATION; INDUCTION; APOPTOSIS; VECTOR; SITES	Baculoviruses have gained popularity as pest control agents and for protein production in insect systems. These viruses are also becoming popular for gene expression, tissue engineering and gene therapy in mammalian systems. Baculovirus infection triggers a heat shock response, and this response is crucial for its successful infection of host insect cells. However, the viral protein(s) or factor(s) that trigger this response are not yet clear. Previously, we revealed that IE2-an early gene product of the baculovirus-could form unique nuclear bodies for the strong trans-activation of various promoters in mammalian cells. Here, we purified IE2 nuclear bodies from Vero E6 cells and investigated the associated proteins by using mass spectrometry. Heat shock proteins (HSPs) were found to be one of the major IE2-associated proteins. Our experiments show that HSPs are greatly induced by IE2 and are crucial for the trans-activation function of IE2. Interestingly, blocking both heat shock protein expression and the proteasome pathway preserved the IE2 protein and its nuclear body structure, and revived its function. These observations reveal that HSPs do not function directly to assist the formation of the nuclear body structure, but may rather protect IE2 from proteasome degradation. Aside from functional studies in mammalian cells, we also show that HSPs were stimulated and required to determine IE2 protein levels, in insect cells infected with baculovirus. Upon inhibiting the expression of heat shock proteins, baculovirus IE2 was substantially suppressed, resulting in a significantly suppressed viral titer. Thus, we demonstrate a unique feature in that IE2 can function in both insect and non-host mammalian cells to stimulate HSPs, which may be associated with IE2 stabilization and lead to the protection of the its strong gene activation function in mammalian cells. On the other hand, during viral infection in insect cells, IE2 could also strongly stimulate HSPs and ultimately affect viral replication.	[Tung, Hsuan; Chao, Yu-Chan] Acad Sinica, Taiwan Int Grad Program, Mol & Biol Agr Sci, Taipei 115, Taiwan; [Tung, Hsuan; Chao, Yu-Chan] Natl Chung Hsing Univ, Taichung 40227, Taiwan; [Tung, Hsuan; Wei, Sung-Chan; Lo, Huei-Ru; Chao, Yu-Chan] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan; [Tung, Hsuan] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan; [Wei, Sung-Chan] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chao, Yu-Chan] Natl Chung Hsing Univ, Ctr Biotechnol, Taichung 40227, Taiwan	Academia Sinica - Taiwan; National Chung Hsing University; Academia Sinica - Taiwan; National Chung Hsing University; National Defense Medical Center; National Chung Hsing University	Chao, YC (corresponding author), Acad Sinica, Taiwan Int Grad Program, Mol & Biol Agr Sci, Taipei 115, Taiwan.; Chao, YC (corresponding author), Natl Chung Hsing Univ, Taichung 40227, Taiwan.; Chao, YC (corresponding author), Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan.; Chao, YC (corresponding author), Natl Chung Hsing Univ, Ctr Biotechnol, Taichung 40227, Taiwan.	mbycchao@gate.sinica.edu.tw	Chao, Yu-Chan/ABF-6571-2021	Chao, Yu-Chan/0000-0002-9528-8806	MOST from the Ministry of Science and Technology [104-2321-B-001-040, 103-2325-B-001-030-CC2, 103-2811-B-001-141, 104-2811-B-001-112]; Academia Sinica, Taiwan [022361]	MOST from the Ministry of Science and Technology; Academia Sinica, Taiwan(Academia Sinica - Taiwan)	This research was funded by grants MOST 104-2321-B-001-040, 103-2325-B-001-030-CC2, 103-2811-B-001-141, and 104-2811-B-001-112 from the Ministry of Science and Technology, and by grant 022361 from Academia Sinica, Taiwan.	Airenne KJ, 2013, MOL THER, V21, P739, DOI 10.1038/mt.2012.286; AYRES MD, 1994, VIROLOGY, V202, P586, DOI 10.1006/viro.1994.1380; Barford D, 2013, CURR OPIN STRUC BIOL, V23, P357, DOI 10.1016/j.sbi.2013.03.009; Bastian TW, 2010, J VIROL, V84, P2384, DOI 10.1128/JVI.01686-09; Boyce FM, 1996, P NATL ACAD SCI USA, V93, P2348, DOI 10.1073/pnas.93.6.2348; Breitenbach JE, 2013, ARCH VIROL, V158, P1517, DOI 10.1007/s00705-013-1640-8; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; Burch AD, 2004, J VIROL, V78, P7175, DOI 10.1128/JVI.78.13.7175-7185.2004; CARSON DD, 1988, VIROLOGY, V162, P444, DOI 10.1016/0042-6822(88)90485-0; Cox MMJ, 2011, J INVERTEBR PATHOL, V107, pS31, DOI 10.1016/j.jip.2011.05.003; Crouch EA, 2005, ARCH VIROL, V150, P1563, DOI 10.1007/s00705-005-0527-8; Dai CK, 2012, J CELL PHYSIOL, V227, P2982, DOI 10.1002/jcp.24017; Elia G, 1999, EUR J BIOCHEM, V264, P736, DOI 10.1046/j.1432-1327.1999.00610.x; Goldberg AL, 2012, J CELL BIOL, V199, P583, DOI 10.1083/jcb.201210077; HOFMANN C, 1995, P NATL ACAD SCI USA, V92, P10099, DOI 10.1073/pnas.92.22.10099; Imai N, 2000, ACTA VIROL, V44, P199; Imai N, 2005, J GEN VIROL, V86, P637, DOI 10.1099/vir.0.80523-0; Katsuma S, 2011, J GEN VIROL, V92, P699, DOI 10.1099/vir.0.027573-0; Kim TS, 2006, MOL BIOL CELL, V17, P824, DOI 10.1091/mbc.E05-08-0713; KOOL M, 1994, P NATL ACAD SCI USA, V91, P11212, DOI 10.1073/pnas.91.23.11212; Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095; Li G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016546; Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001491; Lin CY, 2010, CURR GENE THER, V10, P242, DOI 10.2174/156652310791321242; Liu CYY, 2010, CURR GENE THER, V10, P232; Liu CYY, 2009, J VIROL, V83, P3604, DOI 10.1128/JVI.01778-08; Livingston CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000619; Lo HR, 2004, BIOTECHNOL PROGR, V20, P354, DOI 10.1021/bp034132i; Lyupina YV, 2011, VIROLOGY, V421, P34, DOI 10.1016/j.virol.2011.09.010; Lyupina YV, 2010, VIROLOGY, V406, P336, DOI 10.1016/j.virol.2010.07.039; Mainz D, 2002, J VIROL, V76, P5198, DOI 10.1128/JVI.76.10.5198-5207.2002; Makhnevych T, 2012, BBA-MOL CELL RES, V1823, P674, DOI 10.1016/j.bbamcr.2011.09.001; Manwell LA, 2007, COMP BIOCHEM PHYS A, V148, P521, DOI 10.1016/j.cbpa.2007.06.422; Mayer MP, 2005, REV PHYSIOL BIOCH P, V153, P1, DOI 10.1007/s10254-004-0025-5; Mena JA, 2011, EXPERT REV VACCINES, V10, P1063, DOI [10.1586/ERV.11.24, 10.1586/erv.11.24]; Monteiro F, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00391; Nobiron I, 2003, J GEN VIROL, V84, P3029, DOI 10.1099/vir.0.19270-0; OReilly DR, 1994, BACULOVIRUS EXPRESSI, Vxiii; PASSARELLI AL, 1993, J VIROL, V67, P2149, DOI 10.1128/JVI.67.4.2149-2158.1993; RODEMS SM, 1995, J VIROL, V69, P5368, DOI 10.1128/JVI.69.9.5368-5375.1995; Rohrmann GF, 2013, BACULOVIRUS MOL BIOL, V3rd; Sagisaka A, 2010, VIRUS RES, V147, P166, DOI 10.1016/j.virusres.2009.10.015; Sahin E, 2011, INT J HYPERTHER, V27, P63, DOI 10.3109/02656736.2010.528139; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Salem TZ, 2011, VIROLOGY, V412, P167, DOI 10.1016/j.virol.2011.01.006; Schultz KLW, 2009, J VIROL, V83, P262, DOI 10.1128/JVI.01827-08; Shippam-Brett CE, 2001, VIRUS RES, V75, P13, DOI 10.1016/S0168-1702(00)00253-7; Stewart TM, 2005, J VIROL, V79, P4619, DOI 10.1128/JVI.79.8.4619-4629.2005; Summers MD, 2006, ADV VIRUS RES, V68, P3, DOI 10.1016/S0065-3527(06)68001-9; Svensson RU, 2007, CANCER RES, V67, P10445, DOI 10.1158/0008-5472.CAN-07-1955; Teng Y, 2012, J BIOL CHEM, V287, P10051, DOI 10.1074/jbc.M111.335000; van Oers MM, 2011, J INVERTEBR PATHOL, V107, pS3, DOI 10.1016/j.jip.2011.05.001; Wang X, 2010, BIOSYSTEMS, V100, P31, DOI 10.1016/j.biosystems.2009.12.005; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Wu CP, 2008, VIRUS RES, V138, P7, DOI 10.1016/j.virusres.2008.07.026; Wu YL, 2008, VIRUS RES, V135, P247, DOI 10.1016/j.virusres.2008.04.001; Wu YL, 2011, J VIROL, V85, P6856, DOI 10.1128/JVI.01843-10; Xiao A, 2010, ARCH VIROL, V155, P1021, DOI 10.1007/s00705-010-0691-3; Xu YZ, 2010, MOL BIOL CELL, V21, P811, DOI 10.1091/mbc.E09-06-0534; Yokota S, 2000, CANCER RES, V60, P2942; YOO SH, 1994, VIROLOGY, V202, P746, DOI 10.1006/viro.1994.1396; YOO SH, 1994, VIROLOGY, V202, P164, DOI 10.1006/viro.1994.1332; Zhang L, 2011, CELL CYCLE, V10, P3515, DOI 10.4161/cc.10.20.17789	63	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148578	10.1371/journal.pone.0148578	http://dx.doi.org/10.1371/journal.pone.0148578			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863132	Green Published, Green Submitted, gold			2022-12-27	WOS:000370046600082
J	Wang, JN; Guan, M; Yamada, K; Hippe, DS; Kerwin, WS; Yuan, C; Bornert, P; Zhao, XH				Wang, Jinnan; Guan, Maobin; Yamada, Kiyofumi; Hippe, Daniel S.; Kerwin, William S.; Yuan, Chun; Boernert, Peter; Zhao, Xihai			In Vivo Validation of Simultaneous Non-Contrast Angiography and intraPlaque Hemorrhage (SNAP) Magnetic Resonance Angiography: An Intracranial Artery Study	PLOS ONE			English	Article							MIDDLE CEREBRAL-ARTERY; SENSITIVE INVERSION-RECOVERY; CAROTID-ARTERY; ATHEROSCLEROTIC DISEASE; ISCHEMIC-STROKE; MR-ANGIOGRAPHY; STENOSIS; SEQUENCE; EVENTS; BURDEN	Objectives Simultaneous Non-contrast Angiography and intraPlaque hemorrhage (SNAP) technique was recently proposed for joint MRA and intraplaque hemorrhage (IPH) imaging. The purpose of this study is to validate SNAP's MRA performance in patients with suspected intracranial artery disease. Methods SNAP and time-of-flight (TOF) techniques with matched field of view and resolution were applied on 15 patients with suspected intracranial artery disease. Both techniques were evaluated based on their detection of luminal stenosis of bilateral middle cerebral arteries (MCA) and the delineation of smallest visible branches (SVB) of the MCA. Statistical analysis was conducted on the artery level. Results The SNAP MRA was found to provide similar stenosis detection performance when compared with TOF (Cohen's. 0.79; 95% Confidence Interval: 0.56-0.99). For the SVB comparison, SNAP was found to provide significantly better small artery delineation than TOF (p = 0.017). Inter-reader reproducibility for both measurements on SNAP was over 0.7. SNAP also detected IPH lesions on 13% of the patients. Conclusions The SNAP technique's MRA performance was optimized and compared against TOF for intracranial artery atherosclerosis imaging and was found to provide comparable stenosis detection accuracy. Along with its IPH detection capability, SNAP holds the potential to become a first-line screening tool for high risk intracranial atherosclerosis disease evaluation.	[Wang, Jinnan] Philips Res North Amer, Clin Sites Res Program, Briarcliff Manor, NY USA; [Guan, Maobin] Yangzhou First Peoples Hosp, Dept Radiol, Yangzhou, Jiangsu, Peoples R China; [Yamada, Kiyofumi; Hippe, Daniel S.; Kerwin, William S.; Yuan, Chun] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Yuan, Chun; Zhao, Xihai] Tsinghua Univ, Dept Biomed Engn, Ctr Biomed Imaging Res, Beijing 100084, Peoples R China; [Boernert, Peter] Philips Res Europe, Tomog Imaging Syst, Hamburg, Germany	Philips; Philips Research; University of Washington; University of Washington Seattle; Tsinghua University; Philips; Philips Research	Zhao, XH (corresponding author), Tsinghua Univ, Dept Biomed Engn, Ctr Biomed Imaging Res, Beijing 100084, Peoples R China.	xihaizhao@tsinghua.edu.cn	Börnert, Peter/AAA-9380-2022; Zhao, Xihai/AAD-7181-2020	Hippe, Daniel/0000-0003-2427-4404; Bornert, Peter/0000-0001-9216-5117	National Institutes of Health [1R01HL103609]; Natural Science Foundation of China [81271536]; Beijing Municipal Science & Technology Commission [D111107003111007]; Philips Research Europe; Philips Research North America; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083503] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission); Philips Research Europe; Philips Research North America; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (No. 1R01HL103609), Natural Science Foundation of China (No. 81271536) and Beijing Municipal Science & Technology Commission (No. D111107003111007). These research fundings provided support to data collection and data analysis. Philips Research Europe and Philips Research North America provided support in the form of salaries for authors PB and JW respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions section".	Altaf N, 2008, J VASC SURG, V47, P337, DOI 10.1016/j.jvs.2007.09.064; Chen XY, 2014, INT J STROKE, V9, pE19, DOI 10.1111/ijs.12277; Davidson A.C., 1997, BOOTSTRAP METHODS TH; De Silva DA, 2007, STROKE, V38, P2592, DOI 10.1161/STROKEAHA.107.484584; Ghazali Rozita Mohd, 2003, Malays J Med Sci, V10, P37; GIBO H, 1981, J NEUROSURG, V54, P151, DOI 10.3171/jns.1981.54.2.0151; Gorelick PB, 2008, STROKE, V39, P2396, DOI 10.1161/STROKEAHA.107.505776; HEISERMAN JE, 1992, RADIOLOGY, V185, P667, DOI 10.1148/radiology.185.3.1438743; Kellman P, 2002, MAGNET RESON MED, V47, P372, DOI 10.1002/mrm.10051; Li ML, 2009, ATHEROSCLEROSIS, V204, P447, DOI 10.1016/j.atherosclerosis.2008.10.019; MOORE WS, 1995, STROKE, V26, P188, DOI 10.1161/01.STR.26.1.188; Park JK, 2011, J NEUROIMAGING, V21, pe64, DOI 10.1111/j.1552-6569.2010.00499.x; PATRUX B, 1994, NEURORADIOLOGY, V36, P193, DOI 10.1007/BF00588129; Remonda L, 2002, AM J NEURORADIOL, V23, P213; Ryu CW, 2009, CEREBROVASC DIS, V27, P433, DOI 10.1159/000209238; Singh N, 2009, RADIOLOGY, V252, P502, DOI 10.1148/radiol.2522080792; Takaya N, 2005, CIRCULATION, V111, P2768, DOI 10.1161/CIRCULATIONAHA.104.504167; Turan TN, 2011, J NEUROIMAGING, V21, pe159, DOI 10.1111/j.1552-6569.2009.00442.x; Underhill HR, 2009, JACC-CARDIOVASC IMAG, V2, P1381, DOI 10.1016/j.jcmg.2009.08.007; Wang JN, 2013, MAGN RESON MED, V69, P337, DOI 10.1002/mrm.24254; Wang JN, 2010, MAGN RESON MED, V64, P1332, DOI 10.1002/mrm.22539; White H, 2005, CIRCULATION, V111, P1327, DOI 10.1161/01.CIR.0000157736.19739.D0; Wityk RJ, 1996, STROKE, V27, P1974, DOI 10.1161/01.STR.27.11.1974; Wong LKS, 2006, INT J STROKE, V1, P158, DOI 10.1111/j.1747-4949.2006.00045.x; Xu WH, 2012, ANN NEUROL, V71, P195, DOI 10.1002/ana.22626	25	17	23	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149130	10.1371/journal.pone.0149130	http://dx.doi.org/10.1371/journal.pone.0149130			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863432	Green Submitted, Green Published, gold			2022-12-27	WOS:000370046600157
J	Smilowitz, NR; Maduro, GA; Lobach, IV; Chen, Y; Reynolds, HR				Smilowitz, Nathaniel R.; Maduro, Gil A., Jr.; Lobach, Iryna V.; Chen, Yu; Reynolds, Harmony R.			Adverse Trends in Ischemic Heart Disease Mortality among Young New Yorkers, Particularly Young Black Women	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; SEX-DIFFERENCES; UNITED-STATES; CERTIFICATE DIAGNOSIS; EMERGENCY-DEPARTMENT; ATHEROSCLEROSIS RISK; SYMPTOM PRESENTATION; RACIAL-DIFFERENCES	Background Ischemic heart disease (IHD) mortality has been on the decline in the United States for decades. However, declines in IHD mortality have been slower in certain groups, including young women and black individuals. Hypothesis Trends in IHD vary by age, sex, and race in New York City (NYC). Young female minorities are a vulnerable group that may warrant renewed efforts to reduce IHD. Methods IHD mortality trends were assessed in NYC 1980-2008. NYC Vital Statistics data were obtained for analysis. Age-specific IHD mortality rates and confidence bounds were estimated. Trends in IHD mortality were compared by age and race/ethnicity using linear regression of log-transformed mortality rates. Rates and trends in IHD mortality rates were compared between subgroups defined by age, sex and race/ethnicity. Results The decline in IHD mortality rates slowed in 1999 among individuals aged 35-54 years but not >= 55. IHD mortality rates were higher among young men than women age 35-54, but annual declines in IHD mortality were slower for women. Black women age 35-54 had higher IHD mortality rates and slower declines in IHD mortality than women of other race/ethnicity groups. IHD mortality trends were similar in black and white men age 35-54. Conclusions The decline in IHD mortality rates has slowed in recent years among younger, but not older, individuals in NYC. There was an association between sex and race/ethnicity on IHD mortality rates and trends. Young black women may benefit from targeted medical and public health interventions to reduce IHD mortality.	[Smilowitz, Nathaniel R.; Reynolds, Harmony R.] NYU, Sch Med, Cardiovasc Clin Res Ctr, New York, NY USA; [Maduro, Gil A., Jr.] New York City Dept Hlth & Mental Hlth, New York, NY USA; [Lobach, Iryna V.] NYU, Sch Med, Dept Biostat, New York, NY USA; [Chen, Yu] NYU, Sch Med, Dept Populat Hlth, New York, NY USA	New York University; New York City Department of Health & Mental Hygiene; New York University; New York University	Reynolds, HR (corresponding author), NYU, Sch Med, Cardiovasc Clin Res Ctr, New York, NY USA.	Harmony.Reynolds@NYUMC.org	Reynolds, Harmony/AAU-3154-2021	Reynolds, Harmony/0000-0003-0284-0655; Chen, Yu/0000-0002-1519-4894	American Heart Association; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was funded by the American Heart Association Founders Affiliate via a Clinical Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson R N, 2001, Natl Vital Stat Rep, V49, P1; [Anonymous], 2013, NEW NEW YORK IMM REP; [Anonymous], 2011, TOT POP MUT EXCL RAC; Brancati FL, 2000, JAMA-J AM MED ASSOC, V283, P2253, DOI 10.1001/jama.283.17.2253; Canto JG, 2012, JAMA-J AM MED ASSOC, V307, P813, DOI 10.1001/jama.2012.199; Carnethon MR, 2006, ARCH INTERN MED, V166, P1196, DOI 10.1001/archinte.166.11.1196; Coady SA, 2001, J CLIN EPIDEMIOL, V54, P40, DOI 10.1016/S0895-4356(00)00272-9; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; Eastwood JA, 2013, J WOMENS HEALTH, V22, P724, DOI 10.1089/jwh.2012.4031; Feinstein M, 2012, CIRCULATION, V126, P50, DOI 10.1161/CIRCULATIONAHA.111.057232; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Flink LE, 2013, CLIN CARDIOL, V36, P133, DOI 10.1002/clc.22092; Ford ES, 2007, J AM COLL CARDIOL, V50, P2128, DOI 10.1016/j.jacc.2007.05.056; Ford ES, 2011, ANNU REV PUBL HEALTH, V32, P5, DOI 10.1146/annurev-publhealth-031210-101211; Gerhard GT, 1998, AM J CARDIOL, V82, P1040, DOI 10.1016/S0002-9149(98)00554-2; Gillum RF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-410; Gomez SL, 2006, CANCER CAUSE CONTROL, V17, P771, DOI 10.1007/s10552-006-0013-y; Gupta A, 2014, J AM COLL CARDIOL, V64, P337, DOI 10.1016/j.jacc.2014.04.054; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Iribarren C, 1998, AM J CARDIOL, V82, P50, DOI 10.1016/S0002-9149(98)00240-9; Jolly S, 2010, AM J MED, V123, P811, DOI 10.1016/j.amjmed.2010.04.020; Kaul P, 2007, CAN MED ASSOC J, V177, P1193, DOI 10.1503/cmaj.060711; Kershaw KN, 2015, CIRCULATION, V131, P141, DOI 10.1161/CIRCULATIONAHA.114.011345; Khan NA, 2013, JAMA INTERN MED, V173, P1863, DOI 10.1001/jamainternmed.2013.10149; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Lehto Hanna-Riikka, 2007, BMC Cardiovasc Disord, V7, P35, DOI 10.1186/1471-2261-7-35; Lopez L, 2010, ACAD EMERG MED, V17, P801, DOI 10.1111/j.1553-2712.2010.00823.x; Pope JH, 2000, NEW ENGL J MED, V342, P1163, DOI 10.1056/NEJM200004203421603; Redmond N, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000447; Rosamond WD, 2012, CIRCULATION, V125, P1848, DOI 10.1161/CIRCULATIONAHA.111.047480; Rubia M, 2002, AM J PREV MED, V22, P30, DOI 10.1016/S0749-3797(01)00400-7; Safford MM, 2012, JAMA-J AM MED ASSOC, V308, P1768, DOI 10.1001/jama.2012.14306; Smilowitz NR, 2011, AM HEART J, V161, P681, DOI 10.1016/j.ahj.2010.12.022; Tavora F, 2008, CARDIOVASC PATHOL, V17, P178, DOI 10.1016/j.carpath.2007.07.010; Thomas KL, 2010, AM HEART J, V160, P744, DOI 10.1016/j.ahj.2010.06.014; Tracy S, 2004, CANCER RES, V64, P7241, DOI 10.1158/0008-5472.CAN-04-1905; Vaccarino V, 2005, NEW ENGL J MED, V353, P671, DOI 10.1056/NEJMsa032214; Vaccarino V, 1999, NEW ENGL J MED, V341, P217, DOI 10.1056/NEJM199907223410401; Vaccarino V, 2001, ANN INTERN MED, V134, P173, DOI 10.7326/0003-4819-134-3-200102060-00007; Van Wye Gretchen, 2008, Prev Chronic Dis, V5, pA48; Wei GS, 2011, DIABETES CARE, V34, P873, DOI 10.2337/dc10-1786; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wyatt SB, 2003, AM J MED SCI, V325, P315, DOI 10.1097/00000441-200306000-00003; Xu J, 2010, DEATHS FINAL DATA 20	44	13	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149015	10.1371/journal.pone.0149015	http://dx.doi.org/10.1371/journal.pone.0149015			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882207	Green Published, Green Submitted, gold			2022-12-27	WOS:000371219000042
J	Erguler, K; Smith-Unna, SE; Waldock, J; Proestos, Y; Christophides, GK; Lelieveld, J; Parham, PE				Erguler, Kamil; Smith-Unna, Stephanie E.; Waldock, Joanna; Proestos, Yiannis; Christophides, George K.; Lelieveld, Jos; Parham, Paul E.			Large-Scale Modelling of the Environmentally-Driven Population Dynamics of Temperate Aedes albopictus (Skuse)	PLOS ONE			English	Article							BLOOD-FEEDING BEHAVIOR; ANOPHELES-GAMBIAE; AEGYPTI DIPTERA; CHIKUNGUNYA-DISEASE; EMILIA-ROMAGNA; CULICIDAE; VECTOR; SURVIVAL; COMPETITION; DENGUE	The Asian tiger mosquito, Aedes albopictus, is a highly invasive vector species. It is a proven vector of dengue and chikungunya viruses, with the potential to host a further 24 arboviruses. It has recently expanded its geographical range, threatening many countries in the Middle East, Mediterranean, Europe and North America. Here, we investigate the theoretical limitations of its range expansion by developing an environmentally-driven mathematical model of its population dynamics. We focus on the temperate strain of Ae. albopictus and compile a comprehensive literature-based database of physiological parameters. As a novel approach, we link its population dynamics to globally-available environmental datasets by performing inference on all parameters. We adopt a Bayesian approach using experimental data as prior knowledge and the surveillance dataset of Emilia-Romagna, Italy, as evidence. The model accounts for temperature, precipitation, human population density and photoperiod as the main environmental drivers, and, in addition, incorporates the mechanism of diapause and a simple breeding site model. The model demonstrates high predictive skill over the reference region and beyond, confirming most of the current reports of vector presence in Europe. One of the main hypotheses derived from the model is the survival of Ae. albopictus populations through harsh winter conditions. The model, constrained by the environmental datasets, requires that either diapausing eggs or adult vectors have increased cold resistance. The model also suggests that temperature and photoperiod control diapause initiation and termination differentially. We demonstrate that it is possible to account for unobserved properties and constraints, such as differences between laboratory and field conditions, to derive reliable inferences on the environmental dependence of Ae. albopictus populations.	[Erguler, Kamil; Waldock, Joanna; Lelieveld, Jos] Cyprus Inst, Energy Environm & Water Res Ctr, 2121 Aglantzia, Nicosia, Cyprus; [Smith-Unna, Stephanie E.] Univ Cambridge, Dept Plant Sci, Downing St, Cambridge CB2 3EA, England; [Smith-Unna, Stephanie E.] Univ Cambridge, Sainsbury Lab, Bateman St, Cambridge CB2 1LR, England; [Waldock, Joanna; Christophides, George K.] Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Dept Life Sci, South Kensington Campus, London SW7 2AZ, England; [Proestos, Yiannis; Christophides, George K.] Cyprus Inst, Computat Based Sci & Technol Res Ctr, 2121 Aglantzia, Nicosia, Cyprus; [Lelieveld, Jos] Max Planck Inst Chem, Dept Atmospher Chem, D-55128 Mainz, Germany; [Parham, Paul E.] Univ Liverpool, Fac Hlth & Life Sci, Dept Publ Hlth & Policy, Liverpool L69 3GL, Merseyside, England; [Parham, Paul E.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Grantham Inst Climate Change, Dept Infect Dis Epidemiol, St Marys Campus, London W2 1PG, England	University of Cambridge; University of Cambridge; Imperial College London; Max Planck Society; University of Liverpool; Imperial College London	Erguler, K (corresponding author), Cyprus Inst, Energy Environm & Water Res Ctr, 2121 Aglantzia, Nicosia, Cyprus.; Parham, PE (corresponding author), Univ Liverpool, Fac Hlth & Life Sci, Dept Publ Hlth & Policy, Liverpool L69 3GL, Merseyside, England.; Parham, PE (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Grantham Inst Climate Change, Dept Infect Dis Epidemiol, St Marys Campus, London W2 1PG, England.	k.erguler@cyi.ac.cy; paul.parham@liverpool.ac.uk	Lelieveld, Jos/A-1986-2013; Erguler, Kamil/ABD-4636-2020; Erguler, Kamil/Y-5990-2019	Lelieveld, Jos/0000-0001-6307-3846; Erguler, Kamil/0000-0002-2674-592X; Waldock, Joanna/0000-0002-3622-5899; Christophides, George/0000-0002-3323-1687; Proestos, Yiannis/0000-0001-5991-0322	European Regional Development Fund; Republic of Cyprus through the Research Promotion Foundation [EIA/EIA/0311(BIE)/13]; European Research Council under the European Union's Seventh Framework Programme (FP7)/ERC [226144]; Imperial College London through the Wellcome Trust Institutional Strategic Support Fund for a Sabbatical at the Cyprus Institute	European Regional Development Fund(European Commission); Republic of Cyprus through the Research Promotion Foundation; European Research Council under the European Union's Seventh Framework Programme (FP7)/ERC(European Research Council (ERC)); Imperial College London through the Wellcome Trust Institutional Strategic Support Fund for a Sabbatical at the Cyprus Institute	This work was co-funded by the European Regional Development Fund and the Republic of Cyprus through the Research Promotion Foundation (Project Upsilon Gamma EIA/Delta Upsilon Gamma EIA/0311(BIE)/13). The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/20072013)/ERC grant agreement number 226144. PEP would like to thank the University of Liverpool for financial support throughout this research. GKC would like to acknowledge funding by Imperial College London through the Wellcome Trust Institutional Strategic Support Fund for a Sabbatical at the Cyprus Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhami J, 1998, J AM MOSQUITO CONTR, V14, P340; Aguiar e Oliveira Junior H., 2012, STOCHASTIC GLOBAL OP, P33, DOI [10.1007/978-3-642-27479-4_4, DOI 10.1007/978-3-642-27479-4_4]; Albieri A, 2010, B INSECTOL, V63, P209; Alto BW, 2001, J MED ENTOMOL, V38, P646, DOI 10.1603/0022-2585-38.5.646; Alto BW, 2001, J MED ENTOMOL, V38, P548, DOI 10.1603/0022-2585-38.4.548; [Anonymous], GRIDD POP WORLD FUT; Bellini R, COMMUNICATION; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Braks MAH, 2006, MED VET ENTOMOL, V20, P53, DOI 10.1111/j.1365-2915.2006.00612.x; Braks MAH, 2004, ANN ENTOMOL SOC AM, V97, P130, DOI 10.1603/0013-8746(2004)097[0130:ICBTIS]2.0.CO;2; Briegel H, 2001, J MED ENTOMOL, V38, P566, DOI 10.1603/0022-2585-38.4.566; Calado Daniéla C., 2002, Rev. Bras. entomol., V46, P93, DOI 10.1590/S0085-56262002000100011; Carrieri M, 2011, J VECTOR ECOL, V36, P108, DOI 10.1111/j.1948-7134.2011.00147.x; Christiansen-Jucht C, 2015, INT J ENV RES PUB HE, V12, P5975, DOI 10.3390/ijerph120605975; de Almeida SJ, 2010, ENVIRON MODELL SOFTW, V25, P1490, DOI 10.1016/j.envsoft.2010.04.021; Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105; Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026; Dumont Y, 2008, MATH BIOSCI, V213, P80, DOI 10.1016/j.mbs.2008.02.008; Dumont Y, 2012, J MATH BIOL, V65, P809, DOI 10.1007/s00285-011-0477-6; Erguler K, 2018, HOPPMCMC ADAPTIVE BA; Erguler K, 2011, MOL BIOSYST, V7, P1593, DOI 10.1039/c0mb00107d; Erickson RA, 2010, ECOL MODEL, V221, P2899, DOI 10.1016/j.ecolmodel.2010.08.036; Erickson RA, 2010, ECOL MODEL, V221, P1273, DOI 10.1016/j.ecolmodel.2010.01.018; Estrada-Franco J. G., 1995, Technical Paper - Pan American Health Organization; Fischer D, 2011, GLOBAL PLANET CHANGE, V78, P54, DOI 10.1016/j.gloplacha.2011.05.008; FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003; Fontenille D, 2007, ECOL CONT VECTOR-BOR, V1, P169; Gavotte L, 2009, J MED ENTOMOL, V46, P451, DOI 10.1603/033.046.0306; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Hall F.G., 2003, INT SATELLITE LAND S; HANSON SM, 1994, J MED ENTOMOL, V31, P192, DOI 10.1093/jmedent/31.2.192; Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1; HIEN D S, 1975, Acta Parasitologica Polonica, V23, P537; HOBBS JH, 1991, J AM MOSQUITO CONTR, V7, P488; Huang J, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-87; Imai C, 1976, JAPANESE J SANITARY; Juliano SA, 2004, OECOLOGIA, V139, P583, DOI 10.1007/s00442-004-1532-4; Kamgang B, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-57; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Lacour G, 2012, P 18 EUR SOC VECT EC; Lacour G, 2014, J INSECT PHYSIOL, V71, P87, DOI 10.1016/j.jinsphys.2014.10.008; Lounibos L. P., 2001, Biological Invasions, V3, P151, DOI 10.1023/A:1014519919099; Lunde TM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-28; Lunde TM, 2013, PARASITE VECTOR, V6, P1, DOI 10.1186/1756-3305-6-20; Manore CA, 2014, J THEOR BIOL, V356, P174, DOI 10.1016/j.jtbi.2014.04.033; MORI A, 1981, Tropical Medicine, V23, P79; Moulay D, 2011, MATH BIOSCI, V229, P50, DOI 10.1016/j.mbs.2010.10.008; Moulay D, 2013, J THEOR BIOL, V318, P129, DOI 10.1016/j.jtbi.2012.11.008; Moulay D, 2012, MATH BIOSCI ENG, V9, P369, DOI 10.3934/mbe.2012.9.369; Muturi EJ, 2011, J MED ENTOMOL, V48, P243, DOI 10.1603/ME10017; NAWROCKI SJ, 1987, J AM MOSQUITO CONTR, V3, P314; Neto PL, 2004, NEOTROP ENTOMOL, V33, P29, DOI 10.1590/S1519-566X2004000100006; O'Donnell D, 2010, INFECT GENET EVOL, V10, P669, DOI 10.1016/j.meegid.2010.03.011; OMEARA GF, 1995, J MED ENTOMOL, V32, P554, DOI 10.1093/jmedent/32.4.554; Otero M, 2010, MATH BIOSCI, V223, P32, DOI 10.1016/j.mbs.2009.10.005; Paaijmans KP, 2008, HYDROL PROCESS, V22, P4789, DOI 10.1002/hyp.7099; Parham PE, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-271; Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Proestos Y, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0554; Reynolds JA, 2012, J INSECT PHYSIOL, V58, P966, DOI 10.1016/j.jinsphys.2012.04.013; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Richards SL, 2006, J MED ENTOMOL, V43, P543, DOI 10.1603/0022-2585(2006)43[543:HPOAAD]2.0.CO;2; Scholte EJ, 2008, MED VET ENTOMOL, V22, P352, DOI 10.1111/j.1365-2915.2008.00763.x; Simard F, 2005, J MED ENTOMOL, V42, P726, DOI 10.1603/0022-2585(2005)042[0726:GDABSP]2.0.CO;2; SOTA T, 1992, OECOLOGIA, V90, P353, DOI 10.1007/BF00317691; Stephenson TS, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009127; Tandon Neelam, 2000, Dengue Bulletin, V24, P117; Teng HJ, 2000, J MED ENTOMOL, V37, P40, DOI 10.1603/0022-2585-37.1.40; Thomas SM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-100; Tran A, 2013, INT J ENV RES PUB HE, V10, P1698, DOI 10.3390/ijerph10051698; Tsuda Y, 1994, TROPICAL MED, V36; Udaka M., 1959, Kontyu Tokyo, V27, P202; Urbanski J, 2012, AM NAT, V179, P490, DOI 10.1086/664709; Waldock J, 2013, PATHOG GLOB HEALTH, V107, P224, DOI 10.1179/2047773213Y.0000000100; Wang R. l., 1966, Acta Entomologica Sinica, V15, P75; Wang RI., 1966, ACTA ENTOMOL SINICA; Watson R, 2007, BRIT MED J, V335, P532, DOI 10.1136/bmj.39332.708738.DB; White MT, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-153; Xu CG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000830	81	29	29	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149282	10.1371/journal.pone.0149282	http://dx.doi.org/10.1371/journal.pone.0149282			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871447	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100141
J	Lund, LD; Ingmer, H; Frokiaer, H				Lund, Lisbeth Drozd; Ingmer, Hanne; Frokiaer, Hanne			D-Alanylation of Teichoic Acids and Loss of Poly-N-Acetyl Glucosamine in Staphylococcus aureus during Exponential Growth Phase Enhance IL-12 Production in Murine Dendritic Cells	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; LIPOTEICHOIC ACID; LACTOBACILLUS-ACIDOPHILUS; CAPSULAR POLYSACCHARIDE; GENE-EXPRESSION; RECEPTOR 2; PEPTIDOGLYCAN; RECOGNITION; INFECTION; MECHANISM	Staphylococcus aureus is a major human pathogen that has evolved very efficient immune evading strategies leading to persistent colonization. During different stages of growth, S. aureus express various surface molecules, which may affect the immune stimulating properties, but very little is known about their role in immune stimulation and evasion. Depending on the growth phase, S. aureus may affect antigen presenting cells differently. Here, the impact of growth phases and the surface molecules lipoteichoic acid, peptidoglycan and poly-N-acetyl glucosamine on the induction of IL-12 imperative for an efficient clearance of S. aureus was studied in dendritic cells (DCs). Exponential phase (EP) S. aureus was superior to stationary phase (SP) bacteria in induction of IL-12, which required actin-mediated endocytosis and endosomal acidification. Moreover, addition of staphylococcal cell wall derived peptidoglycan to EP S. aureus stimulated cells increased bacterial uptake but abrogated IL-12 induction, while addition of lipoteichoic acid increased IL-12 production but had no effect on the bacterial uptake. Depletion of the capability to produce poly-N-acetyl glucosamine increased the IL-12 inducing activity of EP bacteria. Furthermore, the mutant dltA unable to produce D-alanylated teichoic acids failed to induce IL-12 but like peptidoglycan and the toll-like receptor (TLR) ligands LPS and Pam3CSK4 the mutant stimulated increased macropinocytosis. In conclusion, the IL-12 response by DCs against S. aureus is highly growth phase dependent, relies on cell wall D-alanylation, endocytosis and subsequent endosomal degradation, and is abrogated by receptor induced macropinocytosis.	[Lund, Lisbeth Drozd; Ingmer, Hanne; Frokiaer, Hanne] Univ Copenhagen, Dept Vet Dis Biol, Frederiksberg, Denmark	University of Copenhagen	Frokiaer, H (corresponding author), Univ Copenhagen, Dept Vet Dis Biol, Frederiksberg, Denmark.	hafr@sund.ku.dk	FrÃkiÃr, Hanne/P-7409-2018	Ingmer, Hanne/0000-0002-8350-5631; Hojgaard, Lisbeth Drozd/0000-0002-1052-3337; Frokiaer, Hanne/0000-0003-1472-9698	Danish Council for Independent Research \ Natural Sciences [0602-01522B]	Danish Council for Independent Research \ Natural Sciences(Det Frie Forskningsrad (DFF))	The study was sponsored by The Danish Council for Independent Research vertical bar Natural Sciences grant number 0602-01522B: "Phagocytosis and macropinocytosis in antigen presenting cells-importance for immune response development."	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bertsche U, 2011, ANTIMICROB AGENTS CH, V55, P3922, DOI 10.1128/AAC.01226-10; Bogdan C, 2004, IMMUNOL REV, V202, P33, DOI 10.1111/j.0105-2896.2004.00207.x; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; Cunnion KM, 2001, INFECT IMMUN, V69, P6796, DOI 10.1128/IAI.69.11.6796-6803.2001; den Dunnen J, 2012, BLOOD, V120, P112, DOI 10.1182/blood-2011-12-399931; Dziarski R, 2005, INFECT IMMUN, V73, P5212, DOI 10.1128/IAI.73.8.5212-5216.2005; Farooqui AA, 2006, PHARMACOL REV, V58, P591, DOI 10.1124/pr.58.3.7; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; George EA, 2007, CHEMBIOCHEM, V8, P847, DOI 10.1002/cbic.200700023; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Gratz N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001345; Haaber J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041075; Hashimoto M, 2006, INT IMMUNOL, V18, P355, DOI 10.1093/intimm/dxh374; Hashimoto M, 2006, J IMMUNOL, V177, P3162, DOI 10.4049/jimmunol.177.5.3162; Hultgren OH, 2001, ARTHRITIS RES, V3, P41, DOI 10.1186/ar138; IORDANESCU S, 1976, J GEN MICROBIOL, V96, P277, DOI 10.1099/00221287-96-2-277; Ip WKE, 2010, J IMMUNOL, V184, P7071, DOI 10.4049/jimmunol.1000110; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kropec A, 2005, INFECT IMMUN, V73, P6868, DOI 10.1128/IAI.73.10.6868-6876.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Matsuo M, 2011, MICROBIOL-SGM, V157, P1786, DOI 10.1099/mic.0.044727-0; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Nilsen NJ, 2008, J LEUKOCYTE BIOL, V84, P280, DOI 10.1189/jlb.0907656; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Pohlmann-Dietze P, 2000, INFECT IMMUN, V68, P4865, DOI 10.1128/IAI.68.9.4865-4871.2000; Reichmann NT, 2013, MICROBIOL-SGM, V159, P1868, DOI 10.1099/mic.0.069898-0; Roses RE, 2008, J IMMUNOL, V181, P5120, DOI 10.4049/jimmunol.181.7.5120; Schaffler H, 2014, INFECT IMMUN, V82, P4681, DOI 10.1128/IAI.02043-14; Schindler D, 2012, AM J PATHOL, V181, P1327, DOI 10.1016/j.ajpath.2012.06.039; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Smits HH, 2004, EUR J IMMUNOL, V34, P1371, DOI 10.1002/eji.200324815; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Thakker M, 1998, INFECT IMMUN, V66, P5183, DOI 10.1128/IAI.66.11.5183-5189.1998; Toledo-Arana A, 2005, J BACTERIOL, V187, P5318, DOI 10.1128/JB.187.15.5318-5329.2005; Travassos LH, 2004, EMBO REP, V5, P1000, DOI 10.1038/sj.embor.7400248; Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x; Wang JH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00606; Weber SM, 2000, J IMMUNOL, V165, P1534, DOI 10.4049/jimmunol.165.3.1534; Weiss G, 2012, J IMMUNOL, V189, P2860, DOI 10.4049/jimmunol.1103491; Weiss G, 2010, IMMUNOLOGY, V131, P268, DOI 10.1111/j.1365-2567.2010.03301.x; Weiss G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011065; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Zeuthen LH, 2008, IMMUNOLOGY, V124, P489, DOI 10.1111/j.1365-2567.2007.02800.x; Zhao YX, 1998, IMMUNOLOGY, V93, P80	56	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149092	10.1371/journal.pone.0149092	http://dx.doi.org/10.1371/journal.pone.0149092			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872029	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100100
J	Midde, NM; Rahman, MA; Rathi, C; Li, JH; Meibohm, B; Li, WH; Kumar, S				Midde, Narasimha M.; Rahman, Mohammad A.; Rathi, Chetan; Li, Junhao; Meibohm, Bernd; Li, Weihua; Kumar, Santosh			Effect of Ethanol on the Metabolic Characteristics of HIV-1 Integrase Inhibitor Elvitegravir and Elvitegravir/Cobicistat with CYP3A: An Analysis Using a Newly Developed LC-MS/MS Method	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; LIQUID-CHROMATOGRAPHY; PROTEASE INHIBITORS; SIMULTANEOUS QUANTIFICATION; CYTOCHROME-P450 ISOFORMS; DIFFERENTIAL INHIBITION; ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY; DRUG-INTERACTIONS; ALCOHOL-USE	Elvitegravir (EVG), an integrase inhibitor for the treatment HIV infection, is increasingly becoming the part of first-line antiretroviral therapy (ART) regimen. EVG is mainly metabolized through cytochrome P450 (CYP) 3A4. Previously, we have shown that ethanol alters ART-CYP3A4 interactions with protease inhibitors thereby altering their metabolisms. However, as EVG is a fairly new class of drug, its kinetic characteristics and the effect of ethanol on EVG-CYPP3A4 interaction is poorly understood. In this study, we characterized EVG and cobicistat (COBI)-boosted EVG metabolism in human microsomes followed by ethanol-EVG, ethanol-COBI-EVG interaction with CYP3A. First, we developed and validated a simple, sensitive, and robust liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the quantification of EVG in the human liver microsomes. The lower limit of quantification for the drug was at 0.003 mu M (1.34ng/ml). Extraction yield, matrix effects, drug stability, and calibration curves for the proposed method were validated according to the FDA guidelines. Time dependent kinetics data showed that 20mM ethanol decreases the apparent half-life of EVG degradation by similar to 50% compared to EVG alone. Our substrate kinetic results revealed that ethanol mildly decreases the catalytic efficiency for EVG metabolism. Inhibition studies demonstrated that EVG inhibits CYP3A4, and 20 mM ethanol causes a decrease in the IC50 of EVG. However, in the presence of COBI we were unable to determine these parameters effectively because COBI, being a strong inhibitor of CYP3A4, blocked the EVG/ethanol-CYP3A4 interactions. Docking studies predicted a shift of EVG or COBI binding to the active site of CYP3A4 in the presence of ethanol. Taken together, these results suggest that ethanol interacts with microsomal CYP3A and alters EVG-CYP3A4 interaction thereby altering EVG metabolism and inhibition of CYP3A4 by EVG. This finding has clinical significance because alcohol use is highly prevalent in HIV population, and there are no separate guidelines for these patients while they are on ART medication.	[Midde, Narasimha M.; Rahman, Mohammad A.; Rathi, Chetan; Meibohm, Bernd; Kumar, Santosh] Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Pharmaceut Sci, Memphis, TN 38163 USA; [Li, Junhao; Li, Weihua] E China Univ Sci & Technol, Sch Pharm, Shanghai Key Lab New Drug Design, Shanghai 200237, Peoples R China	University of Tennessee System; University of Tennessee Health Science Center; East China University of Science & Technology	Kumar, S (corresponding author), Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Pharmaceut Sci, Memphis, TN 38163 USA.; Li, WH (corresponding author), E China Univ Sci & Technol, Sch Pharm, Shanghai Key Lab New Drug Design, Shanghai 200237, Peoples R China.	whli@ecust.edu.cn; ksantosh@uthsc.edu	LI, Weihua/G-7190-2011	Meibohm, Bernd/0000-0003-3923-3648	Bernd Meibohm [S10OD016226]; National Natural Science Foundation of China [81373328]; National Institute of Health (NIAAA/NIH) [AA-022063]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA022063] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016226] Funding Source: NIH RePORTER	Bernd Meibohm; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute of Health (NIAAA/NIH); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by grants from the National Institute of Health to Santosh Kumar (NIAAA/NIH AA-022063) and Bernd Meibohm (S10OD016226), and the National Natural Science Foundation of China to Weihua Li (Grant 81373328). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by grant from the National Institute of Health to Santosh Kumar (NIAAA/NIH AA-022063) and the National Natural Science Foundation of China to Weihua Li (Grant 81373328).	Abbas W, 2015, VIRUSES-BASEL, V7, P1578, DOI 10.3390/v7041578; Annesley TM, 2003, CLIN CHEM, V49, P1041, DOI 10.1373/49.7.1041; Aouri M, 2013, J MASS SPECTROM, V48, P616, DOI 10.1002/jms.3200; Aquaro S, 1997, J LEUKOCYTE BIOL, V62, P138, DOI 10.1002/jlb.62.1.138; Aquaro Stefano, 2005, Methods Mol Biol, V304, P445; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; D'Avolio A, 2007, J CHROMATOGR B, V859, P234, DOI 10.1016/j.jchromb.2007.10.003; Davydov DR, 2008, EXPERT OPIN DRUG MET, V4, P1523, DOI 10.1517/17425250802500028 ; Eagling VA, 1997, BRIT J CLIN PHARMACO, V44, P190, DOI 10.1046/j.1365-2125.1997.00644.x; Earla R, 2014, DRUG METAB DISPOS, V42, P2097, DOI 10.1124/dmd.114.059378; Earla R, 2014, DRUG METAB DISPOS, V42, P282, DOI 10.1124/dmd.113.055186; Granfors MT, 2006, BASIC CLIN PHARMACOL, V98, P79, DOI 10.1111/j.1742-7843.2006.pto_249.x; Gu HD, 2014, ANAL CHEM, V86, P8959, DOI 10.1021/ac5018265; Hendershot CS, 2009, JAIDS-J ACQ IMM DEF, V52, P180, DOI 10.1097/QAI.0b013e3181b18b6e; Hidalgo M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00217; Hughes NC, 2007, AAPS J, V9, pE353, DOI 10.1208/aapsj0903042; Jin M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.78; Jin MY, 2011, ALCOHOL CLIN EXP RES, V35, P132, DOI 10.1111/j.1530-0277.2010.01330.x; Kumar A, 2014, CURR HIV RES, V12, P233, DOI 10.2174/1570162X1204140813095942; Kumar S. R. S., 2012, International Journal of Advanced Life Sciences (IJALS), V1, P1; Kumar S, 2015, EXPERT OPIN DRUG MET, V11, P343, DOI 10.1517/17425255.2015.996546; Kumar S, 2012, EXPERT OPIN DRUG MET, V8, P1363, DOI 10.1517/17425255.2012.714366; Kumar S, 2011, ALCOHOL CLIN EXP RES, V35, P2121, DOI 10.1111/j.1530-0277.2011.01575.x; Kumar S, 2010, BIOCHEM BIOPH RES CO, V402, P163, DOI 10.1016/j.bbrc.2010.10.014; Blanco JL, 2015, EXPERT OPIN PHARMACO, V16, P1313, DOI 10.1517/14656566.2015.1044436; Matuszewski BK, 2003, ANAL CHEM, V75, P3019, DOI 10.1021/ac020361s; Molina PE, 2014, CURR HIV RES, V12, P265, DOI 10.2174/1570162X12666140721121849; Mudra DR, 2011, CURR DRUG METAB, V12, P750; Neuman MG, 2006, SUBST USE MISUSE, V41, P1395, DOI 10.1080/10826080600846235; Pommier Y, 2005, NAT REV DRUG DISCOV, V4, P236, DOI 10.1038/nrd1660; Ramanathan S, 2011, CLIN PHARMACOKINET, V50, P229, DOI 10.2165/11584570-000000000-00000; Ramanathan S, 2010, JAIDS-J ACQ IMM DEF, V53, P209, DOI 10.1097/QAI.0b013e3181ba4536; Rokitta D, 2013, TOXICOL MECH METHOD, V23, P576, DOI 10.3109/15376516.2013.806622; Scott EE, 2005, TRENDS BIOCHEM SCI, V30, P5, DOI 10.1016/j.tibs.2004.11.004; Shah V P, 2000, Pharm Res, V17, P1551, DOI 10.1023/A:1007669411738; Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z; Silverstein PS, 2014, ALCOHOL CLIN EXP RES, V38, P604, DOI 10.1111/acer.12282; Souverain S, 2004, J CHROMATOGR A, V1058, P61, DOI 10.1016/j.chroma.2004.08.118; Stribild, ELV COB EMTR TEN CLI; Vallano PT, 2005, J PHARMACEUT BIOMED, V36, P1073, DOI 10.1016/j.jpba.2004.09.010; von Moltke LL, 2001, J CLIN PHARMACOL, V41, P85, DOI 10.1177/00912700122009728; Walubo A, 2007, EXPERT OPIN DRUG MET, V3, P583, DOI 10.1517/17425225.3.4.583; Xu LH, 2010, ACS MED CHEM LETT, V1, P209, DOI 10.1021/ml1000257	43	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149225	10.1371/journal.pone.0149225	http://dx.doi.org/10.1371/journal.pone.0149225			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872388	Green Published, gold			2022-12-27	WOS:000370054100130
J	Renz, C; Oeljeklaus, S; Grinhagens, S; Warscheid, B; Johnsson, N; Gronemeyer, T				Renz, Christian; Oeljeklaus, Silke; Grinhagens, Soeren; Warscheid, Bettina; Johnsson, Nils; Gronemeyer, Thomas			Identification of Cell Cycle Dependent Interaction Partners of the Septins by Quantitative Mass Spectrometry	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; HIGHER-ORDER STRUCTURES; BUDDING YEAST; SACCHAROMYCES-CEREVISIAE; GLOBAL ANALYSIS; AXIAL LANDMARK; AMINO-ACIDS; PHOSPHORYLATION; PROTEOMICS; KINASE	The septins are a conserved family of GTP-binding proteins that, in the baker's yeast, assemble into a highly ordered array of filaments at the mother bud neck. These filaments undergo significant structural rearrangements during the cell cycle. We aimed at identifying key components that are involved in or regulate the transitions of the septins. By combining cell synchronization and quantitative affinity-purification mass-spectrometry, we performed a screen for specific interaction partners of the septins at three distinct stages of the cell cycle. A total of 83 interaction partners of the septins were assigned. Surprisingly, we detected DNA-interacting/nuclear proteins and proteins involved in ribosome biogenesis and protein synthesis predominantly present in alpha-factor arrested that do not display an assembled septin structure. Furthermore, two distinct sets of regulatory proteins that are specific for cells at S-phase with a stable septin collar or at mitosis with split septin rings were identified. Complementary methods like SPLIFF and immunoprecipitation allowed us to more exactly define the spatial and temporal characteristics of selected hits of the AP-MS screen.	[Renz, Christian; Grinhagens, Soeren; Johnsson, Nils; Gronemeyer, Thomas] Univ Ulm, Dept Mol Genet & Cell Biol, D-89069 Ulm, Germany; [Oeljeklaus, Silke; Warscheid, Bettina] Univ Freiburg, Dept Biochem & Funct Prote, Inst Biol 2, Fac Biol, Hugstetter Str 55, D-79106 Freiburg, Germany; [Oeljeklaus, Silke; Warscheid, Bettina] BIOSS Ctr Biol Signalling Studies, Freiburg, Germany	Ulm University; University of Freiburg	Gronemeyer, T (corresponding author), Univ Ulm, Dept Mol Genet & Cell Biol, D-89069 Ulm, Germany.	thomas.gronemeyer@uni-ulm.de		Renz, Christian/0000-0003-3164-3597; Warscheid, Bettina/0000-0001-5096-1975	Deutsche Forschungsgemeinschaft; Excellence Initiative of the German Federal Government [EXC 294]; Excellence Initiative of the German State Government [EXC 294]; Bundesministerium fur Bildung und Forschung (BMBF Initiative SysTec) [0315690B]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal Government; Excellence Initiative of the German State Government; Bundesministerium fur Bildung und Forschung (BMBF Initiative SysTec)(Federal Ministry of Education & Research (BMBF))	Research in the BW laboratory is supported by the Deutsche Forschungsgemeinschaft and the Excellence Initiative of the German Federal & State Governments (EXC 294 BIOSS Centre for Biological Signalling Studies). CR was supported by a grant of the Bundesministerium fur Bildung und Forschung (BMBF Initiative SysTec 0315690B) to NJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Barral Y, 1999, GENE DEV, V13, P176, DOI 10.1101/gad.13.2.176; Bertin A, 2008, P NATL ACAD SCI USA, V105, P8274, DOI 10.1073/pnas.0803330105; Bridges AA, 2014, P NATL ACAD SCI USA, V111, P2146, DOI 10.1073/pnas.1314138111; Carroll CW, 1998, J CELL BIOL, V143, P709, DOI 10.1083/jcb.143.3.709; CHANT J, 1995, J CELL BIOL, V129, P767, DOI 10.1083/jcb.129.3.767; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; DeMarini DJ, 1997, J CELL BIOL, V139, P75, DOI 10.1083/jcb.139.1.75; DeMay BS, 2011, J CELL BIOL, V193, P1065, DOI 10.1083/jcb.201012143; Dunkler A, 2015, METHODS MOL BIOL, V1346, P151, DOI 10.1007/978-1-4939-2987-0_11; Pablo-Hernando ME, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-55; Finnigan GC, 2015, GENETICS, V200, P841, DOI 10.1534/genetics.115.176495; Garcia G, 2011, J CELL BIOL, V195, P993, DOI 10.1083/jcb.201107123; Hanrahan J, 2003, MOL CELL, V12, P663, DOI 10.1016/j.molcel.2003.08.006; Hernandez-Rodriguez Y, 2012, CURR OPIN MICROBIOL, V15, P660, DOI 10.1016/j.mib.2012.09.007; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Iwase M, 2006, MOL BIOL CELL, V17, P1110, DOI 10.1091/mbc.E05-08-0793; Jimenez J, 1998, J CELL BIOL, V143, P1617, DOI 10.1083/jcb.143.6.1617; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Kang PJ, 2013, J CELL SCI, V126, P1218, DOI 10.1242/jcs.118521; Kang PJ, 2012, J CELL SCI, V125, P3840, DOI 10.1242/jcs.103697; Khan A, 2015, ANNU REV MICROBIOL, V69, P487, DOI 10.1146/annurev-micro-091014-104250; Layton AT, 2011, CURR BIOL, V21, P184, DOI 10.1016/j.cub.2011.01.012; Longtine MS, 1998, J CELL BIOL, V143, P719, DOI 10.1083/jcb.143.3.719; McMurray MA, 2008, CURR BIOL, V18, P1203, DOI 10.1016/j.cub.2008.07.020; McMurray MA, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-18; McMurray MA, 2009, CELL CYCLE, V8, P195, DOI 10.4161/cc.8.2.7381; Merlini L, 2015, MOL BIOL CELL, V26, P3245, DOI 10.1091/mbc.E15-06-0366; Mitchell L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025336; Moreno D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.3; Mortensen EM, 2002, MOL BIOL CELL, V13, P2091, DOI 10.1091/mbc.01-10-0500; Muller J, 2008, CHEMBIOCHEM, V9, P2029, DOI 10.1002/cbic.200800190; Nakahira M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013799; Oeljeklaus S, 2012, J PROTEOME RES, V11, P2567, DOI 10.1021/pr3000333; Oeljeklaus S, 2009, FEBS LETT, V583, P1674, DOI 10.1016/j.febslet.2009.04.018; Oh Y, 2011, TRENDS CELL BIOL, V21, P141, DOI 10.1016/j.tcb.2010.11.006; Ong K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6698; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Qiu WJ, 2008, GENETICS, V180, P1445, DOI 10.1534/genetics.108.091900; Renz C, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-60; Sanders SL, 1996, J CELL BIOL, V134, P413, DOI 10.1083/jcb.134.2.413; Schneider C, 2013, J CELL SCI, V126, P3390, DOI 10.1242/jcs.125302; Stimpson HEM, 2009, MOL BIOL CELL, V20, P4640, DOI 10.1091/mbc.E09-05-0429; Tang CSL, 2002, CELL CYCLE, V1, P42, DOI 10.4161/cc.1.1.99; Versele M, 2004, J CELL BIOL, V164, P701, DOI 10.1083/jcb.200312070; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Walther TC, 2010, J CELL BIOL, V190, P491, DOI 10.1083/jcb.201004052; Wang XR, 2008, MOL CELL PROTEOMICS, V7, P46, DOI 10.1074/mcp.M700261-MCP200; Wiese S, 2007, MOL CELL PROTEOMICS, V6, P2045, DOI 10.1074/mcp.M700169-MCP200; Wloka C, 2011, BIOL CHEM, V392, P813, DOI 10.1515/BC.2011.083; Zongzhi Huang, 2014, REPRESENTATION PRACT, V1, P1	53	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148340	10.1371/journal.pone.0148340	http://dx.doi.org/10.1371/journal.pone.0148340			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871441	Green Submitted, gold, Green Published			2022-12-27	WOS:000370054100024
J	Taylor, CM; Jost, R; Erskine, W; Nelson, MN				Taylor, Candy M.; Jost, Ricarda; Erskine, William; Nelson, Matthew N.			Identifying Stable Reference Genes for qRT-PCR Normalisation in Gene Expression Studies of Narrow-Leafed Lupin (Lupinus angustifolius L.)	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; POLYMERASE-CHAIN-REACTION; HOUSEKEEPING GENES; BETA-ACTIN; RT-PCR; QUANTITATIVE PCR; INTERNAL CONTROL; QUANTIFICATION; TRANSCRIPT; SELECTION	Quantitative Reverse Transcription PCR (qRT-PCR) is currently one of the most popular, high-throughput and sensitive technologies available for quantifying gene expression. Its accurate application depends heavily upon normalisation of gene-of-interest data with reference genes that are uniformly expressed under experimental conditions. The aim of this study was to provide the first validation of reference genes for Lupinus angustifolius (narrow-leafed lupin, a significant grain legume crop) using a selection of seven genes previously trialed as reference genes for the model legume, Medicago truncatula. In a preliminary evaluation, the seven candidate reference genes were assessed on the basis of primer specificity for their respective targeted region, PCR amplification efficiency, and ability to discriminate between cDNA and gDNA. Following this assessment, expression of the three most promising candidates [Ubiquitin C (UBC), Helicase (HEL), and Polypyrimidine tract-binding protein (PTB)] was evaluated using the NormFinder and RefFinder statistical algorithms in two narrow-leafed lupin lines, both with and without vernalisation treatment, and across seven organ types (cotyledons, stem, leaves, shoot apical meristem, flowers, pods and roots) encompassing three developmental stages. UBC was consistently identified as the most stable candidate and has sufficiently uniform expression that it may be used as a sole reference gene under the experimental conditions tested here. However, as organ type and developmental stage were associated with greater variability in relative expression, it is recommended using UBC and HEL as a pair to achieve optimal normalisation. These results highlight the importance of rigorously assessing candidate reference genes for each species across a diverse range of organs and developmental stages. With emerging technologies, such as RNAseq, and the completion of valuable transcriptome data sets, it is possible that other potentially more suitable reference genes will be identified for this species in future.	[Taylor, Candy M.; Jost, Ricarda; Nelson, Matthew N.] Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia; [Jost, Ricarda] La Trobe Univ, ARC Ctr Excellence Plant Energy Biol, Dept Anim Plant & Soil Sci, Sch Life Sci, Bundoora, Vic, Australia; [Erskine, William] Univ Western Australia, Sch Plant Biol, Ctr Plant Genet Breeding, Crawley, WA, Australia; [Erskine, William; Nelson, Matthew N.] Univ Western Australia, UWA Inst Agr, Crawley, WA, Australia; [Nelson, Matthew N.] Royal Bot Gardens Kew, Nat Capital & Plant Hlth, Wakehurst Pl, Ardingly, W Sussex, England	University of Western Australia; La Trobe University; University of Western Australia; University of Western Australia; Royal Botanic Gardens, Kew	Taylor, CM (corresponding author), Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia.	candy.taylor@research.uwa.edu.au	Jost, Ricarda/B-1254-2011; Nelson, Matthew/A-1421-2008	Jost, Ricarda/0000-0002-3819-6358; Nelson, Matthew/0000-0001-6766-4117; Taylor, Candy/0000-0003-2314-5520; Erskine, William/0000-0002-2074-4299	Grains Research and Development Corporation [UHS10659]	Grains Research and Development Corporation(Grains R&D Corp)	The Grains Research and Development Corporation contributed to the funding of this research via award of an Undergraduate Honours Scholarship (award number: UHS10659) to CMT. The URL for the Grains Research and Development Corporation is http://www.grdc.com.au/. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Bemeur C, 2004, NEUROSCI LETT, V357, P211, DOI 10.1016/j.neulet.2003.12.081; Berger JD, 2012, THEOR APPL GENET, V124, P637, DOI 10.1007/s00122-011-1736-z; Berger JD, 2013, CROP PASTURE SCI, V64, P361, DOI 10.1071/CP13092; Brady SM, 2006, PLANT CELL, V18, P2101, DOI 10.1105/tpc.105.037572; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Chao WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042839; Condori Jose, 2011, BMC Res Notes, V4, P392, DOI 10.1186/1756-0500-4-392; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; De Spiegelaere W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122515; Dracup M., 1996, LUPIN DEV GUIDE; FAOSTAT, 2014, FAOSTAT PROD DAT; Foley RC, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0485-6; Garg R, 2010, BIOCHEM BIOPH RES CO, V396, P283, DOI 10.1016/j.bbrc.2010.04.079; Gerard GF, 1997, MOL BIOTECHNOL, V8, P61, DOI 10.1007/BF02762340; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Glare EM, 2002, THORAX, V57, P765, DOI 10.1136/thorax.57.9.765; Haller F, 2004, ANAL BIOCHEM, V335, P1, DOI 10.1016/j.ab.2004.08.024; Kakar K, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-18; Kamphuis LG, 2015, PLANT BIOTECHNOL J, V13, P14, DOI 10.1111/pbi.12229; Kim DH, 2009, ANNU REV CELL DEV BI, V25, P277, DOI 10.1146/annurev.cellbio.042308.113411; Kroc M, 2014, THEOR APPL GENET, V127, P1237, DOI 10.1007/s00122-014-2294-y; Lambers H, 2013, AM J BOT, V100, P263, DOI 10.3732/ajb.1200474; Lin F, 2014, PLANT MOL BIOL, V86, P543, DOI 10.1007/s11103-014-0246-1; LUDWIG SR, 1987, P NATL ACAD SCI USA, V84, P5833, DOI 10.1073/pnas.84.16.5833; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; McCulloch RS, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-36; Nelson M. N., 2010, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V5, P1, DOI 10.1079/PAVSNNR20105017; Nelson MN, 2006, THEOR APPL GENET, V113, P225, DOI 10.1007/s00122-006-0288-0; Nuruzzaman M, 2005, PLANT SOIL, V271, P175, DOI 10.1007/s11104-004-2386-6; O'Rourke JA, 2013, PLANT PHYSIOL, V161, P705, DOI 10.1104/pp.112.209254; OPPENHEIMER DG, 1988, GENE, V63, P87, DOI 10.1016/0378-1119(88)90548-3; Paim Rafaela M., 2012, BMC Research Notes, V5, DOI 10.1186/1756-0500-5-128; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Parra-Gonzalez LB, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-425; Perez R, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-79; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Ponchel F, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-18; Przysiecka L, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00268; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Selvey S, 2001, MOL CELL PROBE, V15, P307, DOI 10.1006/mcpr.2001.0376; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Tenea Gabriela N, 2011, BMC Res Notes, V4, P373, DOI 10.1186/1756-0500-4-373; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wan HJ, 2010, ANAL BIOCHEM, V399, P257, DOI 10.1016/j.ab.2009.12.008; Warzybok A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072887; Wiame I, 2000, BIOTECHNIQUES, V29, P252, DOI 10.2144/00292bm11; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Yang HL, 2014, GENE, V538, P113, DOI 10.1016/j.gene.2013.12.057; Yuan XY, 2014, APPL BIOCHEM BIOTECH, V173, P1431, DOI 10.1007/s12010-014-0951-x	53	24	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148300	10.1371/journal.pone.0148300	http://dx.doi.org/10.1371/journal.pone.0148300			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872362	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100022
J	Van Holle, V; Van Cauwenberg, J; Gheysen, F; Van Dyck, D; Deforche, B; Van de Weghe, N; De Bourdeaudhuij, I				Van Holle, Veerle; Van Cauwenberg, Jelle; Gheysen, Freja; Van Dyck, Delfien; Deforche, Benedicte; Van de Weghe, Nico; De Bourdeaudhuij, Ilse			The Association between Belgian Older Adults' Physical Functioning and Physical Activity: What Is the Moderating Role of the Physical Environment?	PLOS ONE			English	Article							NEIGHBORHOOD WALKABILITY; BUILT ENVIRONMENT; COMPUTER-SCIENCE; WALKING; PEOPLE; PERFORMANCE; ATTRIBUTES; DECLINES; VALIDITY; MOBILITY	Background Better physical functioning in the elderly may be associated with higher physical activity levels. Since older adults spend a substantial part of the day in their residential neighborhood, the neighborhood physical environment may moderate associations between functioning and older adults' physical activity. The present study investigated the moderating role of the objective and perceived physical environment on associations between Belgian older adults' physical functioning and transport walking, recreational walking, and moderate-to-vigorous physical activity. Methods Data from 438 older adults were included. Objective physical functioning was assessed using the Short Physical Performance Battery. Potential moderators included objective neighborhood walkability and perceptions of land use mix diversity, access to recreational facilities, access to services, street connectivity, physical barriers for walking, aesthetics, crime-related safety, traffic speeding-related safety, and walking infrastructure. Transport and recreational walking were self-reported, moderate-to-vigorous physical activity was assessed through accelerometers. Multi-level regression analyses were conducted using MLwiN to examine two-way interactions between functioning and the environment on both walking outcomes. Based on a previous study where environment x neighborhood income associations were found for Belgian older adults' moderate-to-vigorous physical activity, three-way functioning x environment x income interactions were examined for moderate-to-vigorous physical activity. Results Objectively-measured walkability moderated the association between functioning and transport walking; this positive association was only present in high-walkable neighborhoods. Moreover, a three-way interaction was observed for moderate-to-vigorous physical activity. Only in high-income, high-walkable neighborhoods, there was a positive association between functioning and moderate-to-vigorous physical activity. No functioning x walkability interactions were observed for recreational walking, and none of the perceived environmental variables moderated the positive association between physical functioning and the physical activity outcomes. Conclusions For older adults with better physical functioning, living in a high-walkable neighborhood could be beneficial to engage in more transport walking. Living in high-income, high-walkable neighborhoods and having better functioning might also be beneficial for more engagement in moderate-to-vigorous physical activity. This might suggest a protective role of neighborhood walkability for preventing declining physical functioning and consequently decreasing physical activity levels in older adults. However, given the cross-sectional design of the present study, this suggestion needs to be confirmed through longitudinal assessment investigating over-time changes in the observed associations.	[Van Holle, Veerle; Gheysen, Freja; Van Dyck, Delfien; De Bourdeaudhuij, Ilse] Univ Ghent, Dept Movement & Sport Sci, B-9000 Ghent, Belgium; [Van Cauwenberg, Jelle; Deforche, Benedicte] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium; [Van Cauwenberg, Jelle; Deforche, Benedicte] Vrije Univ Brussel, Dept Human Biometry & Biomech, Brussels, Belgium; [Van de Weghe, Nico] Univ Ghent, Dept Geog, B-9000 Ghent, Belgium; [Van Holle, Veerle; Van Cauwenberg, Jelle; Van Dyck, Delfien] Res Fdn Flanders FWO, Brussels, Belgium	Ghent University; Ghent University; Vrije Universiteit Brussel; Ghent University	Van Dyck, D (corresponding author), Univ Ghent, Dept Movement & Sport Sci, B-9000 Ghent, Belgium.; Van Dyck, D (corresponding author), Res Fdn Flanders FWO, Brussels, Belgium.	delfien.vandyck@ugent.be	Van de Weghe, Nico/N-4214-2019; Van de Weghe, Nico/B-7680-2011; Van Dyck, Delfien/AAO-8981-2020; De+Bourdeaudhuij, Ilse/AAC-5528-2019	Van de Weghe, Nico/0000-0002-5327-4000; Van de Weghe, Nico/0000-0002-5327-4000; De+Bourdeaudhuij, Ilse/0000-0001-9969-7597; Van Cauwenberg, Jelle/0000-0003-1292-6241; Van Dyck, Delfien/0000-0003-1783-9075	Fund for Scientific Research Flanders (FWO) [11O3115N, 11N0313N, WO12/PDO/158]	Fund for Scientific Research Flanders (FWO)(FWO)	VVH, JVC and DVD were supported by a grant from the Fund for Scientific Research Flanders (FWO; www.fwo.be). Grant numbers: VVH: 11O3115N, JVC: 11N0313N, DVD: WO12/PDO/158.	Adams MA, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-43; Berke EM, 2007, AM J PUBLIC HEALTH, V97, P486, DOI 10.2105/AJPH.2006.085837; Bruce DG, 2002, J AM GERIATR SOC, V50, P84, DOI 10.1046/j.1532-5415.2002.50012.x; Cain K.L., 2011, ACCELEROMETER DATA C; Van Cauwenberg J, 2011, HEALTH PLACE, V17, P458, DOI 10.1016/j.healthplace.2010.11.010; Cerin E, 2013, PREV MED, V56, P86, DOI 10.1016/j.ypmed.2012.10.024; Cerin E, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-84; Choi L, 2012, MED SCI SPORT EXER, V44, P2009, DOI 10.1249/MSS.0b013e318258cb36; Copeland JL, 2009, J AGING PHYS ACTIV, V17, P17, DOI 10.1123/japa.17.1.17; Giehl MWC, 2012, REV SAUDE PUBL, V46, P516, DOI 10.1590/S0034-89102012000300014; da Costa EM, 2012, ARCH PUBLIC HEALTH, V70, DOI 10.1186/0778-7367-70-1; Daly M, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01044; Denkinger MD, 2015, AM J GERIAT PSYCHIAT, V23, P72, DOI 10.1016/j.jagp.2014.03.002; Devereux K, 2005, AUST J PHYSIOTHER, V51, P102, DOI 10.1016/S0004-9514(05)70038-6; Ferreira FR, 2010, J URBAN HEALTH, V87, P54, DOI 10.1007/s11524-009-9406-z; Forsyth A, 2009, TRANSPORT RES D-TR E, V14, P42, DOI 10.1016/j.trd.2008.10.003; Frank LD, 2010, BRIT J SPORT MED, V44, P924, DOI 10.1136/bjsm.2009.058701; Frank L, 2010, J PHYS ACT HEALTH, V7, pS82, DOI 10.1123/jpah.7.s1.s82; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Frontera WR, 2000, AM J PHYSIOL-CELL PH, V279, pC611, DOI 10.1152/ajpcell.2000.279.3.C611; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hall KS, 2010, HEALTH EDUC RES, V25, P478, DOI 10.1093/her/cyq019; King AC, 2011, SOC SCI MED, V73, P1525, DOI 10.1016/j.socscimed.2011.08.032; Kirkendall DT, 1998, AM J SPORT MED, V26, P598, DOI 10.1177/03635465980260042401; Kremers SPJ, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-9; Lim K, 2005, PREV MED, V40, P33, DOI 10.1016/j.ypmed.2004.04.046; Manini TM, 2009, BRIT J SPORT MED, V43, P28, DOI 10.1136/bjsm.2008.053736; Matthews C.E., 2002, PHYS ACTIVITY ASSESS, P107; MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401; MELANSON EL, 1995, MED SCI SPORT EXER, V27, P934; Milanovic Z, 2013, CLIN INTERV AGING, V8, DOI 10.2147/CIA.S44112; Morie M, 2010, J AM GERIATR SOC, V58, P1727, DOI 10.1111/j.1532-5415.2010.03012.x; Murtagh EM, 2010, CURR OPIN CARDIOL, V25, P490, DOI 10.1097/HCO.0b013e32833ce972; National Institute of Statistics-Belgium, 2014, FOD EC KMO MIDD EN; NEWMAN PWG, 1991, TRANSPORT REV, V11, P249, DOI 10.1080/01441649108716787; Peace S., 2007, AGEING SOC, P209; Prince F, 1997, GAIT POSTURE, V5, P128, DOI 10.1016/S0966-6362(97)01118-1; Pruitt LA, 2008, J AGING PHYS ACTIV, V16, P416, DOI 10.1123/japa.16.4.416; Rasinaho M, 2007, J AGING PHYS ACTIV, V15, P90, DOI 10.1123/japa.15.1.90; Rimmer James H, 2005, Phys Med Rehabil Clin N Am, V16, P41, DOI 10.1016/j.pmr.2004.06.013; Rockwood K, 2004, J GERONTOL A-BIOL, V59, P1310, DOI 10.1093/gerona/59.12.1310; Sahlqvist S, 2012, PREV MED, V55, P206, DOI 10.1016/j.ypmed.2012.06.028; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Satariano WA, 2010, AM J PREV MED, V38, P419, DOI 10.1016/j.amepre.2009.12.031; Shigematsu R, 2009, MED SCI SPORT EXER, V41, P314, DOI 10.1249/MSS.0b013e318185496c; Shimura H, 2014, J PHYS ACT HEALTH, V11, P1078, DOI 10.1123/jpah.2012-0244; Shimura H, 2012, J PHYS ACT HEALTH, V9, P1004, DOI 10.1123/jpah.9.7.1004; SIEGEL PZ, 1995, AM J PUBLIC HEALTH, V85, P706, DOI 10.2105/AJPH.85.5.706; Stathi A, 2012, J AGING PHYS ACTIV, V20, P148, DOI 10.1123/japa.20.2.148; Thompson CW, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2012-091718; Twisk JWR., 2006, APPL MULTILEVEL ANAL, DOI [10.1017/CBO9780511610806, DOI 10.1017/CBO9780511610806]; United Nations, 2013, WORLD POP AG AG 2013, P114, DOI ST/ESA/SER.A/348; Van Cauwenberg J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-142; Van Dyck D, 2015, J SPORT MED PHYS FIT, V55, P776; Van Dyck D, 2010, PREV MED, V50, pS74, DOI 10.1016/j.ypmed.2009.07.027; Van Holle V, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1785-3; Van Holle V, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0110-3; Wahl HW, 2004, ANNU REV GERONTOL GE, V23, P1; Wang L, 2002, J AM GERIATR SOC, V50, P1525, DOI 10.1046/j.1532-5415.2002.50408.x; Yorston LC, 2012, J AM GERIATR SOC, V60, P719, DOI 10.1111/j.1532-5415.2012.03906.x	60	34	34	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148398	10.1371/journal.pone.0148398	http://dx.doi.org/10.1371/journal.pone.0148398			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6SI	26872017	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100028
J	Wang, YC; Gu, WR; Xie, TL; Li, LJ; Sun, Y; Zhang, H; Li, J; Wei, S				Wang, Yongchao; Gu, Wanrong; Xie, Tenglong; Li, Lijie; Sun, Yang; Zhang, He; Li, Jing; Wei, Shi			Mixed Compound of DCPTA and CCC Increases Maize Yield by Improving Plant Morphology and Up-Regulating Photosynthetic Capacity and Antioxidants	PLOS ONE			English	Article							ACID-INDUCED CHANGES; COTTON PLANT; OXIDATIVE STRESS; IRRIGATED MAIZE; WHEAT SEEDLINGS; NITRIC-OXIDE; GROWTH; TOLERANCE; METABOLISM; ENZYMES	DCPTA (2-diethylaminoethyl-3, 4-dichlorophenylether) and CCC (2-chloroethyltrimethylammonium chloride) have a great effect on maize growth, but applying DCPTA individually can promote the increase of plant height, resulting in the rise of lodging percent. Plant height and lodging percent decrease in CCC-treated plants, but the accumulation of biomass reduce, resulting in yield decrease. Based on the former experiments, the performance of a mixture which contained 40 mg DCPTA and 20 mg CCC as active ingredients per liter of solution, called PCH was tested with applying 40mg/L DCPTA and 20mg/L CCC individually. Grain yield, yield components, internode characters, leaf area per plant, plant height and lodging percent as well as chlorophyll content, chlorophyll fluorescence, enzymatic antioxidants, membranous peroxide and organic osmolyte were analyzed in two years (2011 and 2012), using maize hybrid, Zhengdan 958 (ZD 958) at density of 6.75 plants m-2. CCC, DCPTA and PCH were sprayed on the whole plant leaves at 7 expanded leaves stage and water was used as control. Compared to control, PCH significantly increased grain yield (by 9.53% and 6.68%) from 2011 to 2012. CCC significantly decreased kernel number per ear (by 6.78% and 5.69%) and thousand kernel weight (TKW) (by 8.57% and 6.55%) from 2011 to 2012. Kernel number per ear and TKW increased in DCPTA-treated and PCH-treated plants, but showed no significant difference between them. In CCCtreated and PCH-treated plants, internode length and plant height decreased, internode diameter increased, resulting in the significant decline of lodging percent. With DCPTA application, internode diameter increased, but internode length and plant height increased at the same time, resulting in the augment of lodging percent. Bending strength and puncture strength were increased by applying different plant growth regulators (PGRs). In PCHtreated plants, bending strength and puncture strength were greater than other treatments. Compared to control, the bending strength of 3rd internode was increased by 14.47% in PCH-treated plants in 2011, increased by 18.40% in 2012, and the difference was significant. Puncture strength of 1st, 3rd and 5th internode was increased by 37.25%, 29.17% and 26.09% in 2011 and 34.04%, 25% and 23.68% in 2012, compared to control. Leaf area and dry weight per plant reduced significantly in CCC-treated plants, increased in DCPTA-treated and PCH-treated plants from 2011 to 2012. Chlorophyll content and chlorophyll fluorescence improved with CCC and DCPTA application. Due to the additive effect of DCPTA and CCC, PCH showed the significant effect on chlorophyll content and chlorophyll fluorescence. Compared to control, total enzyme activity (SOD, POD, CAT, APX and GR) and soluble protein content increased, malonaldehyde (MDA) and hydrogen peroxide (H2O2) content reduced in PCH-treated plants. The transportation of soluble sugar from leaf to kernel improved significantly at the late silking stage. The research provided the way for the further use of DCPTA and CCC into the production practice.	[Wang, Yongchao; Gu, Wanrong; Xie, Tenglong; Li, Lijie; Sun, Yang; Zhang, He; Li, Jing; Wei, Shi] Northeast Agr Univ, Coll Agr, Harbin 150030, Heilongjiang, Peoples R China; [Gu, Wanrong; Li, Jing; Wei, Shi] Minist Agr Crop Cultivat Sci Northeast Area, Observat Expt Stn, Harbin 150030, Heilongjiang, Peoples R China	Northeast Agricultural University - China	Wei, S (corresponding author), Northeast Agr Univ, Coll Agr, Harbin 150030, Heilongjiang, Peoples R China.; Wei, S (corresponding author), Minist Agr Crop Cultivat Sci Northeast Area, Observat Expt Stn, Harbin 150030, Heilongjiang, Peoples R China.	weishi5608@163.com	Li, Li/AEM-3636-2022; li, li/HII-4157-2022		National Natural Science Foundation of Youth Science Foundation [31201164]; China Postdoctoral Science Foundation [2012M510913]; Heilongjiang Postdoctoral Fund [LBH-Z12036]	National Natural Science Foundation of Youth Science Foundation; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Heilongjiang Postdoctoral Fund	This study was supported by National Natural Science Foundation of Youth Science Foundation (31201164); China Postdoctoral Science Foundation (2012M510913); Heilongjiang Postdoctoral Fund (LBH-Z12036).	Akram NA, 2012, SCI HORTIC-AMSTERDAM, V142, P143, DOI 10.1016/j.scienta.2012.05.007; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Aphalo PJ, 1997, NEW FOREST, V14, P167, DOI 10.1023/A:1006568813442; Ashraf M, 2009, BIOTECHNOL ADV, V27, P84, DOI 10.1016/j.biotechadv.2008.09.003; Avice JC, 2014, J EXP BOT, V65, P3813, DOI 10.1093/jxb/eru177; Cassman KG, 2003, ANNU REV ENV RESOUR, V28, P315, DOI 10.1146/annurev.energy.28.040202.122858; CHANCE B, 1955, METHOD ENZYMOL, V2, P764, DOI 10.1016/S0076-6879(55)02300-8; Ci DW, 2009, CHEMOSPHERE, V77, P1620, DOI 10.1016/j.chemosphere.2009.08.062; Ci XK, 2012, EUPHYTICA, V185, P395, DOI 10.1007/s10681-011-0560-5; DemmigAdams B, 1996, PHYSIOL PLANTARUM, V98, P253, DOI 10.1034/j.1399-3054.1996.980206.x; Dey A, 2013, ACTA PHYSIOL PLANT, V35, P1775, DOI 10.1007/s11738-013-1214-0; Dong ShuTing, 1997, Acta Agronomica Sinica, V23, P318; Downes BP, 1998, PLANT MOL BIOL, V37, P437, DOI 10.1023/A:1005920732211; ESECHIE HA, 1992, J AGR SCI, V119, P165, DOI 10.1017/S0021859600014076; Eum HL, 2009, FOOD SCI TECHNOL INT, V15, P223, DOI 10.1177/1082013208339706; Fischer AM, 2012, CRIT REV PLANT SCI, V31, P124, DOI 10.1080/07352689.2011.616065; FOYER CH, 1976, PLANTA, V133, P21, DOI 10.1007/BF00386001; Foyer CH, 2012, PLANT CELL ENVIRON, V35, P199, DOI 10.1111/j.1365-3040.2011.02453.x; GAUSMAN HW, 1985, BIO-TECHNOL, V3, P255, DOI 10.1038/nbt0385-255; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Grassini P, 2011, FIELD CROP RES, V120, P142, DOI 10.1016/j.fcr.2010.09.012; [顾万荣 GU Wanrong], 2008, [华北农学报, Acta Agriculturae Boreali-Sinica], V23, P85; Hajiboland R, 2010, PLANT SOIL, V331, P313, DOI 10.1007/s11104-009-0255-z; Hernandez JA, 2000, PLANT CELL ENVIRON, V23, P853, DOI 10.1046/j.1365-3040.2000.00602.x; Hu HX, 2013, THEOR APPL GENET, V126, P2257, DOI 10.1007/s00122-013-2132-7; Jiao ZL, 2012, POTATO RES, V55, P293, DOI 10.1007/s11540-012-9223-8; Jung S, 2004, PLANT PHYSIOL BIOCH, V42, P225, DOI 10.1016/j.plaphy.2004.01.001; KEITHLY JH, 1990, PLANT GROWTH REGUL, V9, P127, DOI 10.1007/BF00027440; KHOSRAVI GR, 1991, PLANT GROWTH REGUL, V10, P27, DOI 10.1007/BF00035128; Kumar PP, 2013, PLANT CELL REP, V32, P943, DOI 10.1007/s00299-013-1460-z; Kumari GJ, 2006, BIOL PLANTARUM, V50, P219, DOI 10.1007/s10535-006-0010-8; Lacan D, 1998, PLANTA, V204, P377, DOI 10.1007/s004250050269; Li CZ, 2004, PLANT SCI, V166, P303, DOI 10.1016/j.plantsci.2003.09.019; Li HS, 1998, PRINCIPLE TECHNOLOGY, P56; Manjunatha G, 2010, BIOTECHNOL ADV, V28, P489, DOI 10.1016/j.biotechadv.2010.03.001; Mason TG, 1928, ANN BOT-LONDON, V42, P571, DOI 10.1093/oxfordjournals.aob.a090131; Mason TG, 1928, ANN BOT-LONDON, V42, P189, DOI 10.1093/oxfordjournals.aob.a090110; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Miret JA, 2015, ANN NY ACAD SCI, V1340, P29, DOI 10.1111/nyas.12639; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; NBSC, 2014, CHIN STAT YB; NORBERG OS, 1988, AGRON J, V80, P768, DOI 10.2134/agronj1988.00021962008000050015x; PATEL R, 1992, J EXP BOT, V43, P257, DOI 10.1093/jxb/43.2.257; Perveen S, 2010, PAK J BOT, V42, P3073; Porra RJ, 2002, PHOTOSYNTH RES, V73, P149, DOI 10.1023/A:1020470224740; Qiu ZB, 2013, ECOTOX ENVIRON SAFE, V88, P135, DOI 10.1016/j.ecoenv.2012.11.001; RADEMACHER W, 1992, CURR PLANT SCI BIOT, V13, P571; Rademacher W, 2000, ANNU REV PLANT PHYS, V51, P501, DOI 10.1146/annurev.arplant.51.1.501; Richter A, 2010, PLANT CELL PHYSIOL, V51, P670, DOI 10.1093/pcp/pcq047; RUSSELL WA, 1985, MAYDICA, V30, P85; Shan CJ, 2010, PLANT SCI, V178, P130, DOI 10.1016/j.plantsci.2009.11.002; Sharaf AE, 2010, J AM SCI, V6, P559; Sharkey TD, 2010, J INTEGR PLANT BIOL, V52, P712, DOI 10.1111/j.1744-7909.2010.00975.x; Sharma N, 1998, PLANT GROWTH REGUL, V26, P97, DOI 10.1023/A:1006087729077; Shekoofa A., 2008, Journal of Agronomy, V7, P41; Tang JH, 2007, EUPHYTICA, V155, P117, DOI 10.1007/s10681-006-9312-3; Teng F, 2013, PLANT J, V73, P405, DOI 10.1111/tpj.12038; Varga B, 2012, ACTA PHYSIOL PLANT, V34, P849, DOI 10.1007/s11738-011-0882-x; Wang HQ, 2009, J PLANT GROWTH REGUL, V28, P21, DOI 10.1007/s00344-008-9069-0; Wang SH, 2004, BOT BULL ACAD SINICA, V45, P203; Wang YS, 2004, ACTA BOT SIN, V46, P819; WEI L M, 1991, ARID ZONE RES, V8, P38; Wu QS, 2006, J PLANT PHYSIOL, V163, P1101, DOI 10.1016/j.jplph.2005.09.001; Xie ZX, 2008, J PLANT PHYSIOL, V165, P375, DOI 10.1016/j.jplph.2007.06.001; Yamori W, 2010, PLANT PHYSIOL, V152, P388, DOI 10.1104/pp.109.145862; Zhang MC, 2008, PLANT GROWTH REGUL, V56, P257, DOI 10.1007/s10725-008-9305-4; Zhang Q, 2014, FIELD CROP RES, V164, P82, DOI 10.1016/j.fcr.2014.06.006; Zhang ZL, 2001, EXPT GUIDE PLANT PHY, P28; Zhou Tian, 2004, Pratacultural Science, V21, P31	70	30	31	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149404	10.1371/journal.pone.0149404	http://dx.doi.org/10.1371/journal.pone.0149404			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872260	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100156
J	Dixon, BREA; Radin, JN; Piazuelo, MB; Contreras, DC; Algood, HMS				Dixon, Beverly R. E. A.; Radin, Jana N.; Piazuelo, M. Blanca; Contreras, Diana C.; Algood, Holly M. Scott			IL-17a and IL-22 Induce Expression of Antimicrobials in Gastrointestinal Epithelial Cells and May Contribute to Epithelial Cell Defense against Helicobacter pylori	PLOS ONE			English	Article							INNATE LYMPHOID-CELLS; HOST-DEFENSE; INFLAMMATORY RESPONSES; GASTRIC-MUCOSA; TH17 CELLS; IN-VITRO; INFECTION; INTERLEUKIN-22; SUBFAMILY; CYTOKINES	Helicobacter pylori colonization of the human stomach can lead to adverse clinical outcomes including gastritis, peptic ulcers, or gastric cancer. Current data suggest that in addition to bacterial virulence factors, the magnitude and types of immune responses influence the outcome of colonization. Specifically, CD4(+) T cell responses impact the pathology elicited in response to H. pylori. Because gastritis is believed to be the initiating host response to more detrimental pathological outcomes, there has been a significant interest in pro-inflammatory T cell cytokines, including the cytokines produced by T helper 17 cells. Th17 cells produce IL-17A, IL-17F, IL-21 and IL-22. While these cytokines have been linked to inflammation, IL-17A and IL-22 are also associated with anti-microbial responses and control of bacterial colonization. The goal of this research was to determine the role of IL-22 in activation of antimicrobial responses in models of H. pylori infection using human gastric epithelial cell lines and the mouse model of H. pylori infection. Our data indicate that IL-17A and IL-22 work synergistically to induce antimicrobials and chemokines such as IL-8, components of calprotectin (CP), lipocalin (LCN) and some beta-defensins in both human and primary mouse gastric epithelial cells (GEC) and gastroids. Moreover, IL-22 and IL-17A-activated GECs were capable of inhibiting growth of H. pylori in vitro. While antimicrobials were activated by IL-17A and IL-22 in vitro, using a mouse model of H. pylori infection, the data herein indicate that IL-22 deficiency alone does not render mice more susceptible to infection, change their antimicrobial gene transcription, or significantly change their inflammatory response.	[Algood, Holly M. Scott] Vet Affairs Tennessee Valley Healthcare Serv, Nashville, TN USA; [Dixon, Beverly R. E. A.; Radin, Jana N.; Piazuelo, M. Blanca; Algood, Holly M. Scott] Vanderbilt Univ, Dept Med, Nashville, TN USA; [Contreras, Diana C.; Algood, Holly M. Scott] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Radin, Jana N.] Univ Illinois, Dept Microbiol, 131 Burrill Hall, Urbana, IL 61801 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University; University of Illinois System; University of Illinois Urbana-Champaign	Algood, HMS (corresponding author), Vet Affairs Tennessee Valley Healthcare Serv, Nashville, TN USA.; Algood, HMS (corresponding author), Vanderbilt Univ, Dept Med, Nashville, TN USA.; Algood, HMS (corresponding author), Vanderbilt Univ, Dept Pathol Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA.	holly.m.algood@vanderbilt.edu	Dixon, Beverly R.E.A./AAD-5714-2020	Dixon, Beverly R.E.A./0000-0001-9207-3386; Contreras Healey, Diana C/0000-0001-6981-8386	Office of Medical Research, Department of Veterans Affairs [IBX000915A]; National Institutes of Health [P30DK058404]; NIH [P30DK058404]; NATIONAL CANCER INSTITUTE [P01CA028842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000915] Funding Source: NIH RePORTER	Office of Medical Research, Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work has been funded primarily by a Merit Review Grant IBX000915A (to HMSA) from the Office of Medical Research, Department of Veterans Affairs. Core Services including use of the Cell Imaging Shared Resource were performed through Vanderbilt University Medical Center's Digestive Disease Research Center supported by National Institutes of Health grant P30DK058404 Core Scholarship (Richard Peek). The contents of this paper do not represent the views of the U.S. Department of Veterans Affairs or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We express sincere gratitude to Tudor Ilca and Vicki Cope for worthy contributions to this work; and Lydia Wroblewski for her valuable time spent in training laboratory personnel in generating murine gastroids. We also acknowledge Core Services performed through Vanderbilt University Medical Center's Digestive Disease Research Center supported by NIH grant P30DK058404.	Algood HMS, 2007, FEMS IMMUNOL MED MIC, V51, P577, DOI 10.1111/j.1574-695X.2007.00338.x; Algood HMS, 2009, J IMMUNOL, V183, P5837, DOI 10.4049/jimmunol.0901206; Allen AJ, 2011, VET IMMUNOL IMMUNOP, V141, P258, DOI 10.1016/j.vetimm.2011.03.014; Andoh A, 2005, GASTROENTEROLOGY, V129, P969, DOI 10.1053/j.gastro.2005.06.071; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Bamford KB, 1998, GASTROENTEROLOGY, V114, P482, DOI 10.1016/S0016-5085(98)70531-1; Basu R, 2013, IMMUNOL REV, V252, P89, DOI 10.1111/imr.12035; Basu R, 2012, IMMUNITY, V37, P1061, DOI 10.1016/j.immuni.2012.08.024; Bauer B., 2011, ULCERS, V2011, DOI [DOI 10.1155/2011/340157, 10.1155/2011/340157]; Behnsen J, 2014, IMMUNITY, V40, P262, DOI 10.1016/j.immuni.2014.01.003; Behrends J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057379; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Busman-Sahay KO, 2015, J LEUKOCYTE BIOL, V97, P499, DOI 10.1189/jlb.3RU0814-386R; Carbo A, 2012, PNAS; Carbo A, 2014, MBIO, V5, DOI 10.1128/mBio.01243-14; Carrion M, 2013, RHEUMATOLOGY, V52, P2177, DOI 10.1093/rheumatology/ket315; Caruso R, 2008, EUR J IMMUNOL, V38, P470, DOI 10.1002/eji.200737635; Chen JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097350; Conti P, 2003, IMMUNOL LETT, V88, P171, DOI 10.1016/S0165-2478(03)00087-7; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Cover TL, 2013, GUT MICROBES, V4, P482, DOI 10.4161/gmic.26262; De Falco M, 2015, J CELL PHYSIOL, V230, P1702, DOI 10.1002/jcp.24933; Eidenschenk C, 2014, CURR TOP MICROBIOL, V380, P213, DOI 10.1007/978-3-662-43492-5_10; Ferreira RM, 2014, BEST PRACT RES CL GA, V28, P1003, DOI 10.1016/j.bpg.2014.09.004; Gaddy JA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004450; Gaddy JA, 2013, INFECT IMMUN, V81, P2258, DOI 10.1128/IAI.01271-12; Ghavami S, 2008, BBA-MOL CELL RES, V1783, P297, DOI 10.1016/j.bbamcr.2007.10.015; Graham AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017171; Haeberle HA, 1997, INFECT IMMUN, V65, P4229, DOI 10.1128/IAI.65.10.4229-4235.1997; Harper EG, 2009, J INVEST DERMATOL, V129, P2175, DOI 10.1038/jid.2009.65; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Horvath DJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00056; Itoh T, 2003, HELICOBACTER, V8, P268, DOI 10.1046/j.1523-5378.2003.00154.x; Ji YH, 2014, INT J CLIN EXP PATHO, V7, P3694; Jia L, 2014, ADV EXP MED BIOL, V841, P209, DOI 10.1007/978-94-017-9487-9_8; Kanda N, 2009, EUR J IMMUNOL, V39, P996, DOI 10.1002/eji.200838852; KARTTUNEN R, 1995, GUT, V36, P341, DOI 10.1136/gut.36.3.341; Kehl-Fie TE, 2011, CELL HOST MICROBE, V10, P158, DOI 10.1016/j.chom.2011.07.004; Lejeune D, 2002, J BIOL CHEM, V277, P33676, DOI 10.1074/jbc.M204204200; Li LJ, 2014, WORLD J GASTROENTERO, V20, P18177, DOI 10.3748/wjg.v20.i48.18177; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Liang SC, 2010, J IMMUNOL, V185, P5531, DOI 10.4049/jimmunol.0904091; Liao F, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.70; Lindholm C, 1998, INFECT IMMUN, V66, P5964, DOI 10.1128/IAI.66.12.5964-5971.1998; Liu JZ, 2012, CELL HOST MICROBE, V11, P227, DOI 10.1016/j.chom.2012.01.017; Liu JZ, 2009, CYTOKINE, V48, P156, DOI 10.1016/j.cyto.2009.07.005; Liu T, 2012, J CLIN IMMUNOL, V32, P1332, DOI 10.1007/s10875-012-9718-8; Luzza F, 2001, DIGEST LIVER DIS, V33, P14, DOI 10.1016/S1590-8658(01)80130-4; Manta C, 2013, MUCOSAL IMMUNOL, V6, P177, DOI 10.1038/mi.2012.61; Mizuno T, 2005, WORLD J GASTROENTERO, V11, P6305, DOI 10.3748/wjg.v11.i40.6305; Nakagome K, 2011, J IMMUNOL, V187, P5077, DOI 10.4049/jimmunol.1001560; Noto JM, 2015, J INFECT DIS, V211, P1790, DOI 10.1093/infdis/jiu805; Noto JM, 2013, J CLIN INVEST, V123, P479, DOI 10.1172/JCI64373; Noto Jennifer M, 2012, Methods Mol Biol, V921, P7; Ota N, 2011, NAT IMMUNOL, V12, P941, DOI 10.1038/ni.2089; Otani K, 2009, BIOCHEM BIOPH RES CO, V382, P252, DOI 10.1016/j.bbrc.2009.02.107; Rahman MT, 2014, RHEUMATOLOGY, V53, P270, DOI 10.1093/rheumatology/ket375; Rutz S, 2014, NAT REV IMMUNOL, V14, P783, DOI 10.1038/nri3766; Sabat R, 2014, NAT REV DRUG DISCOV, V13, P21, DOI 10.1038/nrd4176; Shiomi S, 2008, HELICOBACTER, V13, P518, DOI 10.1111/j.1523-5378.2008.00629.x; Sommer F, 1998, INFECT IMMUN, V66, P5543, DOI 10.1128/IAI.66.11.5543-5546.1998; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Sugimoto M, 2009, CANCER SCI, V100, P2152, DOI 10.1111/j.1349-7006.2009.01291.x; Tsai SY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003848; Wilson MS, 2010, J IMMUNOL, V184, P4378, DOI 10.4049/jimmunol.0903416; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Wozniak KL, 2014, MICROBIOL-SGM, V160, P1440, DOI 10.1099/mic.0.073445-0; Wroblewski LE, 2015, GUT, V64, P720, DOI 10.1136/gutjnl-2014-307650; Xiang XG, 2012, IMMUNOL CELL BIOL, V90, P611, DOI 10.1038/icb.2011.79; Yamaoka Y, 2014, FUTURE ONCOL, V10, P1487, DOI [10.2217/fon.14.29, 10.2217/FON.14.29]; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zhuang Y, 2015, GUT, V64, P1368, DOI 10.1136/gutjnl-2014-307020; Zhuang Y, 2012, CANCER IMMUNOL IMMUN, V61, P1965, DOI 10.1007/s00262-012-1241-5; Zindl CL, 2013, P NATL ACAD SCI USA, V110, P12768, DOI 10.1073/pnas.1300318110	74	46	51	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148514	10.1371/journal.pone.0148514	http://dx.doi.org/10.1371/journal.pone.0148514			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867135	Green Published, gold, Green Submitted			2022-12-27	WOS:000370050700018
J	Fushimi, Y; Okada, T; Takagi, Y; Funaki, T; Takahashi, JC; Miyamoto, S; Togashi, K				Fushimi, Yasutaka; Okada, Tomohisa; Takagi, Yasushi; Funaki, Takeshi; Takahashi, Jun C.; Miyamoto, Susumu; Togashi, Kaori			Voxel Based Analysis of Surgical Revascularization for Moyamoya Disease: Pre- and Postoperative SPECT Studies	PLOS ONE			English	Article							EXTRACRANIAL-INTRACRANIAL BYPASS; NEUROLOGIC DETERIORATION; CEREBRAL HYPERPERFUSION; SURGERY; TOMOGRAPHY; TRIAL; ONSET	Moyamoya disease (MMD) is a chronic, progressive, cerebrovascular occlusive disease that causes abnormal enlargement of collateral pathways (moyamoya vessels) in the region of the basal ganglia and thalamus. Cerebral revascularization procedures remain the preferred treatment for patients with MMD, improving the compromised cerebral blood flow (CBF). However, voxel based analysis (VBA) of revascularization surgery for MMD based on data from pre- and postoperative data has not been established. The latest algorithm called as Diffeomorphic Anatomical Registration Through Exponentiated Lie Algebra (DAR-TEL) has been introduced for VBA as the function of statistical parametric mapping (SPM8), and improved registration has been achieved by SPM8 with DARTEL. In this study, VBA was conducted to evaluate pre- and postoperative single photon emission computed tomography (SPECT) images for MMD by SPM8 with DARTEL algorithm, and the results were compared with those from SPM8 without DARTEL (a conventional method). Thirty-two patients with MMD who underwent superficial temporal artery-middle cerebral artery (STA-MCA) bypass surgery as the first surgery were included and all patients underwent pre- and postoperative 3D T1-weighted imaging and SPECT. Pre- and postoperative SPECT images were registered to 3D T1-weighted images, then VBA was conducted. Postoperative SPECT showed more statistically increased CBF areas in the bypassed side cerebral hemisphere by using SPM8 with DARTEL (58,989 voxels; P<0.001), and increased ratio of CBF after operation was less than 15%. Meanwhile, postoperative SPECT showed less CBF increased areas by SPM8 without DARTEL. In conclusion, VBA was conducted for patients with MMD, and SPM8 with DARTEL revealed that postoperative SPECT showed statistically significant CBF increases over a relatively large area and with at most 15% increase ratio.	[Fushimi, Yasutaka; Okada, Tomohisa; Togashi, Kaori] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto 6068507, Japan; [Takagi, Yasushi; Funaki, Takeshi; Takahashi, Jun C.; Miyamoto, Susumu] Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto 6068507, Japan	Kyoto University; Kyoto University	Fushimi, Y (corresponding author), Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto 6068507, Japan.	yfushimi@kuhp.kyoto-u.ac.jp	Fushimi, Yasutaka/L-8922-2017; Okada, Tomohisa/C-5939-2008	Fushimi, Yasutaka/0000-0002-1982-3168; Okada, Tomohisa/0000-0003-2312-5677	JSPS KAKENHI grant [25461815]; Nihon Medi-Physics	JSPS KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Nihon Medi-Physics	This study was supported by JSPS KAKENHI grant number 25461815, https://www.jsps.go.jp/english/index.html, and Nihon Medi-Physics, http://www.nmp.co.jp/eng/nuclear_medicine/cooperation.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, NEUROL MED-CHIR, V52, P245, DOI [DOI 10.2176/NMC.52.245, 10.2176/nmc.52.245]; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Fujimura M, 2007, SURG NEUROL, V67, P273, DOI 10.1016/j.surneu.2006.07.017; Fujimura M, 2011, NEUROSURGERY, V68, P957, DOI 10.1227/NEU.0b013e318208f1da; Fukui M, 1997, CLIN NEUROL NEUROSUR, V99, pS238; Funaki T, 2014, ACTA NEUROCHIR, V156, P551, DOI 10.1007/s00701-013-1975-7; Guzman R, 2009, J NEUROSURG, V111, P927, DOI 10.3171/2009.4.JNS081649; Han JS, 2011, STROKE, V42, P3047, DOI 10.1161/STROKEAHA.111.615955; Houkin K, 1997, CLIN NEUROL NEUROSUR, V99, pS142; Houkin K, 1996, STROKE, V27, P1342, DOI 10.1161/01.STR.27.8.1342; KARASAWA J, 1992, J NEUROSURG, V77, P84, DOI 10.3171/jns.1992.77.1.0084; Kelly ME, 2006, CEREBROVASC DIS, V22, P109, DOI 10.1159/000093238; Lee HY, 2004, J NUCL MED, V45, P202; Lee M, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.1.FOCUS08300; Miyamoto S, 1998, Neurosurg Focus, V5, pe5; Miyamoto S, 2004, NEUROL MED-CHIR, V44, P218, DOI 10.2176/nmc.44.218; Miyamoto S, 2014, STROKE, V45, P1415, DOI 10.1161/STROKEAHA.113.004386; Pandey P, 2011, STROKE, V42, P3304, DOI 10.1161/STROKEAHA.110.598565; Sakamoto T, 1997, ANESTH ANALG, V85, P1060, DOI 10.1097/00000539-199711000-00018; Shigemoto Y, 2013, NEUROIMAGE-CLIN, V2, P491, DOI 10.1016/j.nicl.2013.03.017; Sugino T, 2013, J STROKE CEREBROVASC, V22, P811, DOI 10.1016/j.jstrokecerebrovasdis.2012.05.010; Takeuchi R, 2003, NEUROL MED-CHIR, V43, P153, DOI 10.2176/nmc.43.153; Uchino H, 2012, STROKE, V43, P2610, DOI 10.1161/STROKEAHA.112.654723; van Mook WNKA, 2005, LANCET NEUROL, V4, P877, DOI 10.1016/S1474-4422(05)70251-9; Yun TJ, 2009, RADIOLOGY, V251, P216, DOI 10.1148/radiol.2511080654; Zhang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057595	27	12	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148925	10.1371/journal.pone.0148925	http://dx.doi.org/10.1371/journal.pone.0148925			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867219	Green Published, gold			2022-12-27	WOS:000370050700046
J	Tseng, Y; Su, C; Ho, Y				Tseng, Yuhwai; Su, Chauchin; Ho, Yingchieh			Evaluation and Verification of Channel Transmission Characteristics of Human Body for Optimizing Data Transmission Rate in Electrostatic-Coupling Intra Body Communication System: A Comparative Analysis	PLOS ONE			English	Article							EQUIVALENT-CIRCUIT; IMPEDANCE; MODEL	Background Intra-body communication is a new wireless scheme for transmitting signals through the human body. Understanding the transmission characteristics of the human body is therefore becoming increasingly important. Electrostatic-coupling intra-body communication system in a ground-free situation that integrate electronic products that are discretely located on individuals, such as mobile phones, PDAs, wearable computers, and biomedical sensors, are of particular interest. Materials and Methods The human body is modeled as a simplified Resistor-Capacitor network. A virtual ground between the transmitter and receiver in the system is represented by a resister-capacitor network. Value of its resistance and capacitance are determined from a system perspective. The system is characterized by using a mathematical unit step function in digital baseband transmission scheme with and without Manchester code. As a result, the signal-to-noise and to-intersymbol-interference ratios are improved by manipulating the load resistor. The data transmission rate of the system is optimized. A battery-powered transmitter and receiver are developed to validate the proposal. Results A ground-free system fade signal energy especially for a low-frequency signal limited system transmission rate. The system transmission rate is maximized by simply manipulating the load resistor. Experimental results demonstrate that for a load resistance of 10k-50k Omega, the high-pass 3 dB frequency of the band-pass channel is 400kHz-2MHz in the worst-case scenario. The system allows a Manchester-coded baseband signal to be transmitted at speeds of up to 20M bit per second with signal-to-noise and signal-to-intersymbol-interference ratio of more than 10 dB. Conclusion The human body can function as a high speed transmission medium with a data transmission rate of 20Mbps in an electrostatic-coupling intra-body communication system. Therefore, a wideband signal can be transmitted directly through the human body with a good signal-to-noise quality of 10 dB if the high-pass 3 dB frequency is suitably selected.	[Tseng, Yuhwai; Su, Chauchin] Natl Chiao Tung Univ, Dept Elect & Control Engn, Hsinchu 30050, Taiwan; [Ho, Yingchieh] Natl Dong Hwa Univ, Dept Elect Engn, Hualien 97401, Taiwan	National Yang Ming Chiao Tung University; National Dong Hwa University	Tseng, Y (corresponding author), Natl Chiao Tung Univ, Dept Elect & Control Engn, Hsinchu 30050, Taiwan.	yuhwaitseng@mail.nctu.edu.tw						Callejon MA, 2013, IEEE T INSTRUM MEAS, V62, P2446, DOI 10.1109/TIM.2013.2258766; Andre D, 2011, J POWER SOURCES, V196, P5349, DOI 10.1016/j.jpowsour.2010.07.071; Asai Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062956; Barber DC, 1984, J PHYS E, V12, P443; Buffa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058533; Chiang YH, 2011, J POWER SOURCES, V196, P3921, DOI 10.1016/j.jpowsour.2011.01.005; Cho N, 2007, IEEE T MICROW THEORY, V55, P1080, DOI 10.1109/TMTT.2007.895640; Diatchka K, 2003, ECE399H; Dorgan S J, 1999, IEEE Trans Rehabil Eng, V7, P341, DOI 10.1109/86.788470; Dubarry M, 2007, J POWER SOURCES, V174, P856, DOI 10.1016/j.jpowsour.2007.06.157; Dubarry M, 2009, J POWER SOURCES, V186, P500, DOI 10.1016/j.jpowsour.2008.10.051; Gatterer H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109729; Hachisuka K, 2003, BOSTON TRANSDUCERS'03: DIGEST OF TECHNICAL PAPERS, VOLS 1 AND 2, P1722; Hachisuka K, 2005, SOL STAT SENS ACT MI, V1, P5; Haga N, 2013, IEEE T ANTENN PROPAG, V61, P2807, DOI 10.1109/TAP.2013.2246534; Handa T, 1997, TRANSDUCERS 97 - 1997 INTERNATIONAL CONFERENCE ON SOLID-STATE SENSORS AND ACTUATORS, DIGEST OF TECHNICAL PAPERS, VOLS 1 AND 2, P1003, DOI 10.1109/SENSOR.1997.635344; Handa T, 1997, 1997 INT C SOL STAT, P16; Hu XS, 2012, J POWER SOURCES, V198, P359, DOI 10.1016/j.jpowsour.2011.10.013; Hu Y, 2011, J POWER SOURCES, V196, P2913, DOI 10.1016/j.jpowsour.2010.10.072; Hu Y, 2009, CONTROL ENG PRACT, V17, P1190, DOI 10.1016/j.conengprac.2009.05.002; Hung CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093647; KANAI H, 1984, IEEE T MICROW THEORY, V32, P763, DOI 10.1109/TMTT.1984.1132770; KANAI H, 1987, MED PROG TECHNOL, V12, P159; Kibret B, 2014, IEEE J BIOMED HEALTH, V18, P1196, DOI 10.1109/JBHI.2014.2301165; Knudsen NN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087466; Lamb Maxine J E, 2014, PLoS One, V9, pe106134, DOI 10.1371/journal.pone.0106134; Liaw BY, 2004, SOLID STATE IONICS, V175, P835, DOI 10.1016/j.ssi.2004.09.049; Lin YT, 2011, IEEE T IND ELECTRON, V58, P690, DOI 10.1109/TIE.2010.2046571; Lucev Z, 2011, IEEE IMTC P, P845; Post ER, 1997, FIRST INTERNATIONAL SYMPOSIUM ON WEARABLE COMPUTERS - DIGEST OF PAPERS, P52, DOI 10.1109/ISWC.1997.629919; Ruiz JA, 2006, IEEE WCNC, P2240; Smith-Ryan AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091750; Song SJ, 2007, IEEE J SOLID-ST CIRC, V42, P2021, DOI 10.1109/JSSC.2007.903080; Song Y, 2012, OPT EXPRESS, V20, P13488, DOI 10.1364/OE.20.013488; Tseng YW, 2010, IEICE T INF SYST, VE93D, P1656, DOI 10.1587/transinf.E93.D.1656; Tseng YW, 2009, IEICE T COMMUN, VE92B, P3557, DOI 10.1587/transcom.E92.B.3557; Tsukada S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033689; Valente-dos-Santos J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107219; Webster J G, 1998, MED INSTRUMENTATION; Webster JG, 1989, ELECT IMPEDANCE TOMO; Xu R., 2009, P IEEE ANT PROP SOC, P1; Yu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058771; Zhao YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077759; Zimmerman TG, 1996, IBM SYST J, V35, P609, DOI 10.1147/sj.353.0609	44	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148964	10.1371/journal.pone.0148964	http://dx.doi.org/10.1371/journal.pone.0148964			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866602	Green Submitted, Green Published, gold			2022-12-27	WOS:000370050700049
J	Huang, WF; Zhang, HX; Hao, YM; Xu, XB; Zhai, Y; Wang, SX; Li, Y; Ma, FC; Li, YF; Wang, ZF; Zhang, Y; Zhang, XM; Liang, RX; Wei, ZL; Cui, Y; Li, YQ; Yu, XS; Ji, HZ; He, FC; Xie, WM; Zhou, GQ				Huang, Wenfeng; Zhang, Hongxing; Hao, Yumin; Xu, Xiaobing; Zhai, Yun; Wang, Shaoxia; Li, Yang; Ma, Fuchao; Li, Yuanfeng; Wang, Zhifu; Zhang, Yang; Zhang, Xiumei; Liang, Renxiang; Wei, Zhongliang; Cui, Ying; Li, Yongqiang; Yu, Xinsen; Ji, Hongzan; He, Fuchu; Xie, Weimin; Zhou, Gangqiao			A Non-Synonymous Single Nucleotide Polymorphism in the HJURP Gene Associated with Susceptibility to Hepatocellular Carcinoma among Chinese	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; CENP-A; HOMOLOGOUS RECOMBINATION; CHROMOSOMAL INSTABILITY; REPAIR GENES; DNA-DAMAGE; CANCER; ANEUPLOIDY; CARCINOGENESIS; ACTIVATION	Objective HJURP (Holliday Junction-Recognizing Protein) plays dual roles in DNA repair and in accurate chromosome segregation during mitosis. We examined whether the single nucleotide polymorphisms (SNPs) of HJURP were associated with the risk of occurrence of hepatocellular carcinoma (HCC) among chronic hepatitis B virus (HBV) carriers from well-known high-risk regions for HCC in China. Methods Twenty-four haplotype-tagging SNPs across HJURP were selected from HapMap data using the Haploview software. We genotyped these 24 SNPs using the using Sequenom's iPLEX assay in the Fusui population, consisting of 348 patients with HCC and 359 cancer-free controls, and further investigated the significantly associated SNP using the TaqMan assay in the Haimen population, consisting of 100 cases and 103 controls. The genetic associations with the risk of HCC were analyzed by logistic regression. Results We observed an increased occurrence of HCC consistently associated with A/C or C/C genotypes of the non-synonymous SNP rs3771333 compared with the A/A genotype in both the Fusui and Haimen populations, with a pooled odds ratio 1.82 (95% confidence interval, 1.33-2.49; P = 1.9 x 10(-4)). Case-only analysis further indicated that carriers of the at-risk C allele were younger than those carrying the A/A genotype (P = 0.0016). In addition, the expression levels of HJURP in C allele carriers were lower than that in A/A genotype carriers (P = 0.0078 and 0.0010, for mRNA and protein levels, respectively). Conclusion Our findings suggest that rs3771333 in HJURP may play a role in mediating the susceptibility to HCC among Chinese.	[Huang, Wenfeng; Zhang, Hongxing; Hao, Yumin; Zhai, Yun; Li, Yuanfeng; Wang, Zhifu; Zhang, Yang; Zhang, Xiumei; He, Fuchu; Zhou, Gangqiao] Beijing Inst Radiat Med, State Key Lab Prote, Beijing Proteome Res Ctr, Beijing, Peoples R China; [Huang, Wenfeng; Zhang, Hongxing; Hao, Yumin; Zhai, Yun; Li, Yuanfeng; Wang, Zhifu; Zhang, Yang; Zhang, Xiumei; He, Fuchu; Zhou, Gangqiao] Natl Engn Res Ctr Prot Drugs, Beijing, Peoples R China; [Huang, Wenfeng; Zhang, Hongxing; Hao, Yumin; Zhai, Yun; Li, Yuanfeng; Wang, Zhifu; Zhang, Yang; Zhang, Xiumei; He, Fuchu; Zhou, Gangqiao] Natl Ctr Prot Sci Beijing, Beijing, Peoples R China; [Huang, Wenfeng; Cui, Ying; Li, Yongqiang; Xie, Weimin] Guangxi Med Univ, Affiliated Canc Hosp, Nanning, Guangxi, Peoples R China; [Huang, Wenfeng] Guangxi Med Univ, Affiliated Hosp 3, Nanning, Guangxi, Peoples R China; [Xu, Xiaobing; Ji, Hongzan] Second Mil Med Univ, Dept Gastroenterol & Hepatol, Jinling Hosp, Clin Sch Nanjing, Nanjing, Jiangsu, Peoples R China; [Wang, Shaoxia; Li, Yang] Beijing Inst Radiat Med, Dept Expt Pathol, Beijing, Peoples R China; [Ma, Fuchao] Guangxi Med Univ, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China; [Liang, Renxiang; Wei, Zhongliang] Liver Canc Inst Fusui Cty, Shanghai, Guangxi, Peoples R China; [Yu, Xinsen] Dis Prevent & Control Ctr Haimen Cty, Haimen, Jiangsu, Peoples R China	Academy of Military Medical Sciences - China; Guangxi Medical University; Guangxi Medical University; Naval Medical University; Academy of Military Medical Sciences - China; Guangxi Medical University	Xie, WM; Zhou, GQ (corresponding author), Beijing Inst Radiat Med, State Key Lab Prote, Beijing Proteome Res Ctr, Beijing, Peoples R China.; Zhou, GQ (corresponding author), Natl Engn Res Ctr Prot Drugs, Beijing, Peoples R China.; Zhou, GQ (corresponding author), Natl Ctr Prot Sci Beijing, Beijing, Peoples R China.; Xie, WM (corresponding author), Guangxi Med Univ, Affiliated Canc Hosp, Nanning, Guangxi, Peoples R China.	xieweimin3358@163.com; zhougq114@126.com		Li, Yuanfeng/0000-0001-8227-7019; Huang, Wenfeng/0000-0002-3194-4368	National Natural Science Foundation of China [81125017, 81222027, 81060169]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 81125017, 81222027 and 81060169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MJ, 1989, J CLIN EPIDEMIOL, V42, P659, DOI 10.1016/0895-4356(89)90009-7; Barash H, 2010, P NATL ACAD SCI USA, V107, P2207, DOI 10.1073/pnas.0908867107; BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J; Bill CA, 2004, P NATL ACAD SCI USA, V101, P11135, DOI 10.1073/pnas.0403925101; Chung K-T, 2010, WOMEN PIONEERS MED R, Vvii; Coates P, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2567; Dandri M, 2002, HEPATOLOGY, V35, P217, DOI 10.1053/jhep.2002.30203; Dumon-Jones V, 2003, CANCER RES, V63, P7263; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Hu LM, 2012, HEPATOLOGY, V55, P1426, DOI 10.1002/hep.24799; Hu Z, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2487; Jiang DK, 2013, NAT GENET, V45, P72, DOI 10.1038/ng.2483; Kato T, 2007, CANCER RES, V67, P8544, DOI 10.1158/0008-5472.CAN-07-1307; Li R, 2011, CARCINOGENESIS, V32, P530, DOI 10.1093/carcin/bgr018; Li SP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002791; Loomba R, 2013, CLIN GASTROENTEROL H, V11, P1636, DOI 10.1016/j.cgh.2013.04.043; Martin-Lluesma S, 2008, HEPATOLOGY, V48, P1467, DOI 10.1002/hep.22542; Mellone BG, 2009, CELL, V137, P409, DOI 10.1016/j.cell.2009.04.035; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; SHEN FM, 1991, AM J HUM GENET, V49, P88; Shuaib M, 2010, P NATL ACAD SCI USA, V107, P1349, DOI 10.1073/pnas.0913709107; Subramanian L, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140043; Teoh NC, 2008, HEPATOLOGY, V47, P2078, DOI 10.1002/hep.22194; Tong WM, 2002, CANCER RES, V62, P6990; Vineis P, 2009, JNCI-J NATL CANCER I, V101, P24, DOI 10.1093/jnci/djn437; Wang JY, 2014, J BIOL CHEM, V289, P8326, DOI 10.1074/jbc.M113.529958; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Wilkens L, 2004, P NATL ACAD SCI USA, V101, P1309, DOI 10.1073/pnas.0305817101; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; YU MW, 1994, CRIT REV ONCOL HEMAT, V17, P71, DOI 10.1016/1040-8428(94)90020-5; Yu MW, 2000, J NATL CANCER I, V92, P1159, DOI 10.1093/jnci/92.14.1159; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zhai Y, 2006, GASTROENTEROLOGY, V130, P2001, DOI 10.1053/j.gastro.2006.02.030; Zhang HX, 2010, NAT GENET, V42, P755, DOI 10.1038/ng.638	42	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148618	10.1371/journal.pone.0148618	http://dx.doi.org/10.1371/journal.pone.0148618			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863619	Green Published, Green Submitted, gold			2022-12-27	WOS:000370046600087
J	Lin, YW; Zhang, Q; Chen, W; Shi, JR; Han, SQ; Song, XL; Xu, Y; Ling, L				Lin, Yanwei; Zhang, Qi; Chen, Wen; Shi, Jingrong; Han, Siqi; Song, Xiaolei; Xu, Yong; Ling, Li			Association between Social Integration and Health among Internal Migrants in ZhongShan, China	PLOS ONE			English	Article							ARTERY RISK DEVELOPMENT; MENTAL-HEALTH; YOUNG-ADULTS; PERCEIVED STRESS; DEPRESSION; MIGRATION; WORKERS; ACCULTURATION; IMMIGRANTS; LIFE	Internal migrants are the individuals who migrate between regions in one country. The number of internal migrants were estimated at 245 million in China in 2013. Results were inconsistent in the literature about the relationship between their health statuses and social integration. The main difference exists on how to measure the social integration and whether health statuses of internal migrants improve with years of residence. To complement the existing literature, this study measured social integration more comprehensively and estimated the internal migrants' health statuses with varying years of residence, and explored the associations between the migrants' social integration and health. We used the data from 2014 Internal Migrant Dynamic Monitoring Survey of Health and Family Planning in ZhongShan, China. Health status was measured from four aspects: self-reported health, subjective well-being, perception of stress, mental health. We measured social integration through four dimensions: economy, social communication, acculturation, and self-identity. The analyses used multiple linear regressions to examine the associations between selfreported health, subjective well-being, and perception of stress, mental health and social integration. The analytical sample included 1,999 households of the internal migrants and 1,997 local registered households, who were permanent residents in ZhongShan. Among the internal migrants, Adults in the labor force, who were aged 25 to 44 years old, accounted for 91.2% of the internal migrant population, while 74.6% of the registered population were in that age group. Median residential time among migrants was 2.8 (1.3-6.2) years, and 20.2% of them were migrating in the same Guangdong province. Except for mental health, other health statuses among migrants had significant differences compared with local registered population, e. g. self-reported health was better, but subjective well-being was worse. However, these health measurements were improved with more years of residence. Moreover, our results show that two aspects of social integration, economic integration and selfidentity, were significantly associated with health status. Subjective feeling of relative social status levels were more associated with health, which prompted the attention to social fairness and the creation of a fair and respectful culture. More interventions could be experimented, such as encouraging internal migrants to participate in community activities more actively, educating local registered residents to treat internal migrants more equally, and developing self-identity among internal migrants. Better social, economic, and cultural environment can benefit internal migrants' health statuses.	[Lin, Yanwei; Chen, Wen; Shi, Jingrong; Han, Siqi; Song, Xiaolei; Xu, Yong; Ling, Li] Sun Yat Sen Univ, Sch Publ Hlth, Fac Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Yanwei; Zhang, Qi; Chen, Wen; Shi, Jingrong; Han, Siqi; Song, Xiaolei; Xu, Yong; Ling, Li] Sun Yat Sen Univ, Ctr Migrant Hlth Policy, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Yanwei] Baotou Med Coll, Sch Publ Hlth, Baotou, Peoples R China; [Zhang, Qi] Old Dominion Univ, Sch Community & Environm Hlth, Norfolk, VA USA; [Ling, Li] Sun Yat Sen Univ, 74,North Campus, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Baotou Medical College; Old Dominion University; Sun Yat Sen University	Ling, L (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Fac Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China.; Ling, L (corresponding author), Sun Yat Sen Univ, Ctr Migrant Hlth Policy, Guangzhou 510275, Guangdong, Peoples R China.; Ling, L (corresponding author), Sun Yat Sen Univ, 74,North Campus, Guangzhou 510275, Guangdong, Peoples R China.	lingli@mail.sysu.edu.cn			Bureau of Population; Family Planning of ZhongShan; China Medical Board [12-111]	Bureau of Population; Family Planning of ZhongShan; China Medical Board	This study was supported by Bureau of Population and Family Planning of ZhongShan, and sponsored by China Medical Board, award number: 12-111.	Aroian KJ, 2003, COMPR PSYCHIAT, V44, P420, DOI 10.1016/S0010-440X(03)00103-2; Butler M, 2015, INT REV PSYCHIATR, V27, P51, DOI 10.3109/09540261.2014.996858; Carta MG, 2012, J AFFECT DISORDERS, V141, P255, DOI 10.1016/j.jad.2012.03.038; Chang HC, 2016, ETHNIC HEALTH, V21, P20, DOI 10.1080/13557858.2014.992299; Chen J, 2011, SOC SCI MED, V72, P1294, DOI 10.1016/j.socscimed.2011.02.016; Cheung NWT, 2014, HEALTH PLACE, V27, P142, DOI 10.1016/j.healthplace.2014.01.013; Cho HJ, 2015, BRAIN BEHAV IMMUN, V46, P319, DOI 10.1016/j.bbi.2015.02.023; Cho HJ, 2010, AM J GERIAT PSYCHIAT, V18, P442, DOI 10.1097/JGP.0b013e3181ca3a2d; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cotera FAU, 2008, NEFROLOGIA, V28, P57; De Maio FG, 2010, GLOB PUBLIC HEALTH, V5, P462, DOI 10.1080/17441690902942480; de Waure C, 2015, BMC INT HEALTH HUM R, V15, DOI 10.1186/s12914-014-0032-9; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; division Nhafpcotfp, 2013, REP CHIN MIGR POP DE; Fiorati RC, 2015, REV LAT-AM ENFERM, V23, P329, DOI 10.1590/0104-1169.0187.2559; Flippen C, 2014, POPUL RES POLICY REV, V33, P31, DOI 10.1007/s11113-013-9308-3; Ford K, 2014, AIDS BEHAV, V18, P390, DOI 10.1007/s10461-013-0410-7; Freedman R, 1949, AM J SOCIOL, V55, P171, DOI 10.1086/220487; Gao XL, 2014, J IMMIGR MINOR HEALT, V16, P926, DOI 10.1007/s10903-013-9789-5; Gee EM, 2004, CAN J AGING, V23, pS61; Gee GC, 2002, AM J PUBLIC HEALTH, V92, P615, DOI 10.2105/AJPH.92.4.615; Gui YX, 2012, INT J INTERCULT REL, V36, P598, DOI 10.1016/j.ijintrel.2011.11.007; Haasen C, 2008, EUR PSYCHIAT, V23, pS10, DOI 10.1016/S0924-9338(08)70056-7; Hener T, 1997, INT J SOC PSYCHIATR, V43, P247, DOI 10.1177/002076409704300402; Hilario CT, 2014, J IMMIGR MINOR HEALT, V16, P1121, DOI 10.1007/s10903-014-9978-x; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Kaplan GA, 1996, INT J EPIDEMIOL, V25, P259, DOI 10.1093/ije/25.2.259; Kayser Anke, 2010, Krankenpfl Soins Infirm, V103, P16; Kim G, 2015, ASSESSMENT; Kim HS, 2010, PUBLIC HEALTH NURS, V27, P561, DOI 10.1111/j.1525-1446.2010.00883.x; Lerner Y, 2005, PSYCHOL MED, V35, P1805, DOI 10.1017/S0033291705005726; Leu J, 2011, AM J COMMUN PSYCHOL, V48, P168, DOI 10.1007/s10464-010-9360-7; Li L, 2007, SOC PSYCH PSYCH EPID, V42, P716, DOI 10.1007/s00127-007-0221-0; Li Lu, 2002, Zhonghua Yufang Yixue Zazhi, V36, P109; Lo HYLK, 2008, WORK, V30, P39; Lu Y, 2014, SOC SCI MED, V102, P41, DOI 10.1016/j.socscimed.2013.11.040; Mladovsky P, 2012, HEALTH POLICY, V105, P1, DOI 10.1016/j.healthpol.2012.01.007; Mou J, 2013, BRIT MED BULL, V106, P19, DOI 10.1093/bmb/ldt016; Myers HF, 2009, J BEHAV MED, V32, P9, DOI 10.1007/s10865-008-9181-4; Newbold Bruce, 2005, J Health Serv Res Policy, V10, P77, DOI 10.1258/1355819053559074; Newbold KB, 2005, SOC SCI MED, V60, P1359, DOI 10.1016/j.socscimed.2004.06.048; Newnham EA, 2007, J AFFECT DISORDERS, V98, P91, DOI 10.1016/j.jad.2006.07.001; Ozbek E, 2015, J IMMIGR MINOR HEALT, V17, P1687, DOI 10.1007/s10903-015-0203-3; Peigang Wang XC, SOCIAL CAPITAL SOCIA, P81; Peiper N, 2015, PSYCHOL ASSESS; Pernice R, 2009, INT J SOC PSYCHIATR, V55, P272, DOI 10.1177/0020764008093685; Plagerson S, 2015, HEALTH POLICY PLANN, V30, P163, DOI 10.1093/heapol/czt107; Ponizovsky A, 2000, COMPR PSYCHIAT, V41, P289, DOI 10.1053/comp.2000.7433; Pontin E, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-150; Qiu PY, 2011, J AFFECT DISORDERS, V134, P198, DOI 10.1016/j.jad.2011.05.043; Raitakari SHRJ, 2015, TACKLING COMMUNITY I; Reis RS, 2010, J HEALTH PSYCHOL, V15, P107, DOI 10.1177/1359105309346343; Ritsner M, 1997, ACTA PSYCHIAT SCAND, V95, P494, DOI 10.1111/j.1600-0447.1997.tb10137.x; Seeman TE, 2014, PSYCHONEUROENDOCRINO, V43, P126, DOI 10.1016/j.psyneuen.2014.02.008; Statistics CNBo, 2014, CHIN STAT YB; Tong YY, 2012, POPUL RES POLICY REV, V31, P497, DOI 10.1007/s11113-012-9240-y; Vasunilashorn S, 2013, STRESS, V16, P600, DOI 10.3109/10253890.2013.823943; Vazquez ML, 2011, HEALTH POLICY, V101, P70, DOI 10.1016/j.healthpol.2010.08.026; Wang B, 2010, SOC SCI MED, V71, P84, DOI 10.1016/j.socscimed.2010.03.021; Williams BR, 2015, J WOMEN AGING, V27, P195, DOI 10.1080/08952841.2014.933635; Xu L., 2014, ACAD WORLD, P84; Yang, 2009, POPUL RES, V33, P17; Yang J., 2010, POPULATION EC, P64; Yang TZ, 2012, COMMUNITY MENT HLT J, V48, P342, DOI 10.1007/s10597-011-9395-8; Zhou H., 2012, POPUL RES, V36, P27	65	43	46	6	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148397	10.1371/journal.pone.0148397	http://dx.doi.org/10.1371/journal.pone.0148397			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6PR	26863008	gold, Green Published, Green Submitted			2022-12-27	WOS:000370046600063
J	Mukaihara, K; Suehara, Y; Kohsaka, S; Akaike, K; Tanabe, Y; Kubota, D; Ishii, M; Fujimura, T; Kazuno, S; Okubo, T; Takagi, T; Yao, T; Kaneko, K; Saito, T				Mukaihara, Kenta; Suehara, Yoshiyuki; Kohsaka, Shinji; Akaike, Keisuke; Tanabe, Yu; Kubota, Daisuke; Ishii, Midori; Fujimura, Tsutomu; Kazuno, Saiko; Okubo, Taketo; Takagi, Tatsuya; Yao, Takashi; Kaneko, Kazuo; Saito, Tsuyoshi			Protein Expression Profiling of Giant Cell Tumors of Bone Treated with Denosumab	PLOS ONE			English	Article							CARBONIC-ANHYDRASE-II; NF-KAPPA-B; GENE-EXPRESSION; MATRIX-METALLOPROTEINASE; RECEPTOR ACTIVATOR; CREATINE-KINASE; STROMAL CELLS; RANK LIGAND; RESORPTION; CANCER	Giant cell tumors of bone (GCTB) are locally aggressive osteolytic bone tumors. Recently, some clinical trials have shown that denosumab is a novel and effective therapeutic option for aggressive and recurrent GCTB. This study was performed to investigate the molecular mechanism underlying the therapeutic effect of denosumab. Comparative proteomic analyses were performed using GCTB samples which were taken before and after denosumab treatment. Each expression profile was analyzed using the software program to further understand the affected biological network. One of identified proteins was further evaluated by gelatin zymography and an immunohistochemical analysis. We identified 13 consistently upregulated proteins and 19 consistently downregulated proteins in the pre- and post-denosumab samples. Using these profiles, the software program identified molecular interactions between the differentially expressed proteins that were indirectly involved in the RANK/RANKL pathway and in several non-canonical subpathways including the Matrix metalloproteinase pathway. The data analysis also suggested that the identified proteins play a critical functional role in the osteolytic process of GCTB. Among the most downregulated proteins, the activity of MMP-9 was significantly decreased in the denosumab-treated samples, although the residual stromal cells were found to express MMP-9 by an immunohistochemical analysis. The expression level of MMP-9 in the primary GCTB samples was not correlated with any clinicopathological factors, including patient outcomes. Although the replacement of tumors by fibro-osseous tissue or the diminishment of osteoclast-like giant cells have been shown as therapeutic effects of denosumab, the residual tumor after denosumab treatment, which is composed of only stromal cells, might be capable of causing bone destruction; thus the therapeutic application of denosumab would be still necessary for these lesions. We believe that the protein expression patterns and the results of the network analysis will provide a better understanding of the effects of denosumab administration in patients with GCTB.	[Mukaihara, Kenta; Suehara, Yoshiyuki; Akaike, Keisuke; Tanabe, Yu; Kubota, Daisuke; Ishii, Midori; Okubo, Taketo; Takagi, Tatsuya; Kaneko, Kazuo] Juntendo Univ, Sch Med, Dept Orthoped Surg, Tokyo 113, Japan; [Kohsaka, Shinji] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Fujimura, Tsutomu; Kazuno, Saiko] Juntendo Univ, Sch Med, Lab Biochem Anal, Cent Lab Med Sci, Tokyo 113, Japan; [Yao, Takashi; Saito, Tsuyoshi] Juntendo Univ, Sch Med, Dept Human Pathol, Tokyo 113, Japan	Juntendo University; Memorial Sloan Kettering Cancer Center; Juntendo University; Juntendo University	Suehara, Y (corresponding author), Juntendo Univ, Sch Med, Dept Orthoped Surg, Tokyo 113, Japan.	ysuehara@juntendo.ac.jp		Fujimura, Tsutomu/0000-0003-1744-7725	Ministry of Education, Science, Sports and Culture, Tokyo, Japan [26670286, 15H04964]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [26893267, 26670286] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for General Scientific Research 412 from the Ministry of Education, Science, Sports and Culture (no. 26670286 to 413 Tsuyoshi Saito and no. 15H04964 to Yoshiyuki Suehara), Tokyo, Japan.	Akaike K, 2014, SKELETAL RADIOL, V43, P1767, DOI 10.1007/s00256-014-1961-z; Atkins GJ, 2006, J BONE MINER RES, V21, P1339, DOI 10.1359/JBMR.060604; Balke M, 2010, LANCET ONCOL, V11, P218, DOI 10.1016/S1470-2045(10)70027-9; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Branstetter DG, 2012, CLIN CANCER RES, V18, P4415, DOI 10.1158/1078-0432.CCR-12-0578; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Chang EJ, 2008, NAT MED, V14, P966, DOI 10.1038/nm.1860; Chen JF, 2010, J BIOL CHEM, V285, P36315, DOI 10.1074/jbc.M110.157743; Conti A, 2011, AM J PATHOL, V178, P88, DOI 10.1016/j.ajpath.2010.11.035; Dalberg K, 2000, WORLD J SURG, V24, P334, DOI 10.1007/s002689910053; Datta A, 2010, J PROTEOME RES, V9, P472, DOI 10.1021/pr900829h; Dufresne Armelle, 2012, Bonekey Rep, V1, P149, DOI 10.1038/bonekey.2012.149; Evans C, 2012, ANAL BIOANAL CHEM, V404, P1011, DOI 10.1007/s00216-012-5918-6; Fujisaki K, 2007, LIFE SCI, V80, P1311, DOI 10.1016/j.lfs.2006.12.037; Glen A, 2008, J PROTEOME RES, V7, P897, DOI 10.1021/pr070378x; Halleen JM, 2006, CLIN LAB, V52, P499; Herbrich SM, 2013, J PROTEOME RES, V12, P594, DOI 10.1021/pr300624g; Huang L, 2000, AM J PATHOL, V156, P761, DOI 10.1016/S0002-9440(10)64942-5; Kobayashi D, 2009, MOL CELL PROTEOMICS, V8, P2350, DOI 10.1074/mcp.M900179-MCP200; Lau CPY, 2013, CONNECT TISSUE RES, V54, P439, DOI 10.3109/03008207.2013.848202; Lee CH, 2008, MODERN PATHOL, V21, P531, DOI 10.1038/modpathol.3801023; Lieveld M, 2014, VIRCHOWS ARCH, V465, P703, DOI 10.1007/s00428-014-1666-7; Logar DB, 2007, J BONE MINER METAB, V25, P219, DOI 10.1007/s00774-007-0753-0; Lu X, 2009, GENE DEV, V23, P1882, DOI 10.1101/gad.1824809; Masui F, 1998, PATHOL INT, V48, P355; Mendenhall WM, 2006, AM J CLIN ONCOL-CANC, V29, P96, DOI 10.1097/01.coc.0000195089.11620.b7; Moreno CS, 2005, CANCER RES, V65, P10214, DOI 10.1158/0008-5472.CAN-05-0884; Nannuru KC, 2010, CANCER RES, V70, P3494, DOI 10.1158/0008-5472.CAN-09-3251; Nikitovic D, 2008, IUBMB LIFE, V60, P818, DOI 10.1002/iub.131; Rabinovich Alexander, 2009, Open Bone J, V1, P46; Rao VH, 1997, CLIN EXP METASTAS, V15, P400, DOI 10.1023/A:1018450204980; Roux S, 2002, AM J CLIN PATHOL, V117, P210; Shingleton WD, 1996, BIOCHEM CELL BIOL, V74, P759, DOI 10.1139/o96-083; SLY WS, 1983, P NATL ACAD SCI-BIOL, V80, P2752, DOI 10.1073/pnas.80.9.2752; Steensma MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069101; Sundaram K, 2007, EXP CELL RES, V313, P168, DOI 10.1016/j.yexcr.2006.10.001; Tanabe N, 2005, LIFE SCI, V77, P615, DOI 10.1016/j.lfs.2004.10.079; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Thomas D, 2010, LANCET ONCOL, V11, P275, DOI 10.1016/S1470-2045(10)70010-3; Ueda Y, 1996, AM J PATHOL, V148, P611; Viguet-Carrin S, 2006, OSTEOPOROSIS INT, V17, P319, DOI 10.1007/s00198-005-2035-9; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055; Werner M, 2006, INT ORTHOP, V30, P484, DOI 10.1007/s00264-006-0215-7; Zucker S, 2000, ONCOGENE, V19, P6642, DOI 10.1038/sj.onc.1204097	44	15	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148401	10.1371/journal.pone.0148401	http://dx.doi.org/10.1371/journal.pone.0148401			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863138	Green Submitted, Green Published, gold			2022-12-27	WOS:000370046600064
J	Reddy, DS; Bhatnagar-Mathur, P; Reddy, PS; Cindhuri, KS; Ganesh, AS; Sharma, KK				Reddy, Dumbala Srinivas; Bhatnagar-Mathur, Pooja; Reddy, Palakolanu Sudhakar; Cindhuri, Katamreddy Sri; Ganesh, Adusumalli Sivaji; Sharma, Kiran Kumar			Identification and Validation of Reference Genes and Their Impact on Normalized Gene Expression Studies across Cultivated and Wild Cicer Species	PLOS ONE			English	Article							REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; INTERNAL REFERENCE GENES; SUPERIOR REFERENCE GENES; DRAFT GENOME SEQUENCE; RT-PCR; QRT-PCR; HOUSEKEEPING GENES; BRASSICA-NAPUS; TRANSCRIPT NORMALIZATION	Quantitative Real-Time PCR (qPCR) is a preferred and reliable method for accurate quantification of gene expression to understand precise gene functions. A total of 25 candidate reference genes including traditional and new generation reference genes were selected and evaluated in a diverse set of chickpea samples. The samples used in this study included nine chickpea genotypes (Cicer spp.) comprising of cultivated and wild species, six abiotic stress treatments (drought, salinity, high vapor pressure deficit, abscisic acid, cold and heat shock), and five diverse tissues (leaf, root, flower, seedlings and seed). The geNorm, NormFinder and RefFinder algorithms used to identify stably expressed genes in four sample sets revealed stable expression of UCP and G6PD genes across genotypes, while TIP41 and CAC were highly stable under abiotic stress conditions. While PP2A and ABCT genes were ranked as best for different tissues, ABCT, UCP and CAC were most stable across all samples. This study demonstrated the usefulness of new generation reference genes for more accurate qPCR based gene expression quantification in cultivated as well as wild chickpea species. Validation of the best reference genes was carried out by studying their impact on normalization of aquaporin genes PIP1;4 and TIP3;1, in three contrasting chickpea genotypes under high vapor pressure deficit (VPD) treatment. The chickpea TIP3;1 gene got significantly up regulated under high VPD conditions with higher relative expression in the drought susceptible genotype, confirming the suitability of the selected reference genes for expression analysis. This is the first comprehensive study on the stability of the new generation reference genes for qPCR studies in chickpea across species, different tissues and abiotic stresses.	[Reddy, Dumbala Srinivas; Bhatnagar-Mathur, Pooja; Reddy, Palakolanu Sudhakar; Cindhuri, Katamreddy Sri; Ganesh, Adusumalli Sivaji; Sharma, Kiran Kumar] Int Crops Res Inst Semi Arid Trop, Genet Transformat Lab, Patancheru 502324, Telangana, India	CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT)	Bhatnagar-Mathur, P (corresponding author), Int Crops Res Inst Semi Arid Trop, Genet Transformat Lab, Patancheru 502324, Telangana, India.	p.bhatnagar@cgiar.org	Sharma, Kiran/GZL-1834-2022		CGIAR	CGIAR(CGIAR)	This work has received funding from the CGIAR research program on grain legumes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-78; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Berr A, 2010, PLANT CELL, V22, P3232, DOI 10.1105/tpc.110.079962; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chandna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036918; Chen X, 2010, ANAL BIOCHEM, V405, P138, DOI 10.1016/j.ab.2010.05.032; Chi XY, 2012, MOL GENET GENOMICS, V287, P167, DOI 10.1007/s00438-011-0665-5; Cruz F, 2009, MOL BREEDING, V23, P607, DOI 10.1007/s11032-009-9259-x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Demidenko NV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019434; Die JV, 2010, PLANTA, V232, P145, DOI 10.1007/s00425-010-1158-1; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Fan CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056573; Garg R, 2010, BIOCHEM BIOPH RES CO, V396, P283, DOI 10.1016/j.bbrc.2010.04.079; Gimeno J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091474; Goulao LF, 2012, PLANT MOL BIOL REP, V30, P741, DOI 10.1007/s11105-011-0382-6; Gu CS, 2011, MOL BIOTECHNOL, V49, P192, DOI 10.1007/s12033-011-9394-6; Gutierrez N, 2011, MOL BREEDING, V28, P13, DOI 10.1007/s11032-010-9456-7; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Hong SM, 2010, PLANT CELL PHYSIOL, V51, P1694, DOI 10.1093/pcp/pcq128; Imai T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086492; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jain M, 2013, PLANT J, V74, P715, DOI 10.1111/tpj.12173; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Jiang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092262; Jukanti AK, 2012, BRIT J NUTR, V108, pS11, DOI 10.1017/S0007114512000797; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046487; Li JD, 2014, PLANT MOL BIOL REP, V32, P1002, DOI 10.1007/s11105-014-0701-9; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; Ling H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097469; Long XY, 2010, PLANT MOL BIOL, V74, P307, DOI 10.1007/s11103-010-9666-8; Manoli A, 2012, J PLANT PHYSIOL, V169, P807, DOI 10.1016/j.jplph.2012.01.019; Miranda Vivian de Jesus, 2013, BMC Res Notes, V6, P196, DOI 10.1186/1756-0500-6-196; Nakayama TJ, 2014, GENET MOL RES, V13, P860, DOI 10.4238/2014.February.13.4; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Olsvik Pal A, 2008, BMC Res Notes, V1, P47, DOI 10.1186/1756-0500-1-47; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Ray Debashree L, 2014, BMC Res Notes, V7, P304, DOI 10.1186/1756-0500-7-304; Reddy DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078555; Reddy PS., 2015, PLANT GENE, V1, P35, DOI [DOI 10.1016/J.PLGENE.2015.02.001, 10.1016/j.plgene.2015.02.001]; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Saha GC, 2013, PLANT MOL BIOL REP, V31, P1109, DOI 10.1007/s11105-013-0579-y; Silberberg G, 2009, ANAL BIOCHEM, V391, P91, DOI 10.1016/j.ab.2009.05.026; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Stajner N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068228; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vadez V, 2001, J EXP BOT, V52, P153, DOI 10.1093/jexbot/52.354.153; Vadez V., 2015, PLANT GENE, V1, P18, DOI DOI 10.1016/J.PLGENE.2014.12.002; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Wang HB, 2015, SCI REP-UK, V5, DOI 10.1038/srep08094; Wang HL, 2014, PHYSIOL PLANTARUM, V152, P529, DOI 10.1111/ppl.12206; Wang Y, 2012, MOL BIOL REP, V39, P1585, DOI 10.1007/s11033-011-0897-9; Wang Z, 2014, MOL GENET GENOMICS, V289, P1023, DOI 10.1007/s00438-014-0853-1; Warzybok A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072887; Yang HL, 2014, GENE, V538, P113, DOI 10.1016/j.gene.2013.12.057; Yang Q, 2014, MOL BIOL REP, V41, P2325, DOI 10.1007/s11033-014-3086-9; Yuan XY, 2014, APPL BIOCHEM BIOTECH, V173, P1431, DOI 10.1007/s12010-014-0951-x; Zaman-Allah M, 2011, FUNCT PLANT BIOL, V38, P270, DOI 10.1071/FP10244; Zhu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054411, 10.1371/journal.pone.0053196]	64	34	38	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148451	10.1371/journal.pone.0148451	http://dx.doi.org/10.1371/journal.pone.0148451			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863232	Green Published, gold, Green Submitted			2022-12-27	WOS:000370046600074
J	Zhao, JS; Niu, HL; Li, AY; Nie, L				Zhao, Jingshan; Niu, Honglin; Li, Aiying; Nie, Lei			Acetylbritannilactone Modulates Vascular Endothelial Growth Factor Signaling and Regulates Angiogenesis in Endothelial Cells	PLOS ONE			English	Article							FACTOR RECEPTOR FLK1; TUMOR ANGIOGENESIS; VEGF; MICE; NEUROPILIN-1; TRAFFICKING; EXPRESSION; SURVIVAL; CANCER; GENE	The present study was conducted to determine the effects of 1-O-acetylbritannilactone (ABL), a compound extracted from Inula britannica L., on vascular endothelial growth factor (VEGF) signaling and angiogenesis in endothelial cells (ECs). We showed that ABL promotes VEGF-induced cell proliferation, growth, migration, and tube formation in cultured human ECs. Furthermore, the modulatory effect of ABL on VEGF-induced Akt, MAPK p42/44, and p38 phosphorylation, as well as on upstream VEGFR-2 phosphorylation, were associated with VEGF-dependent Matrigel angiogenesis in vivo. In addition, animals treated with ABL (26 mg/kg/day) recovered blood flow significantly earlier than control animals, suggesting that ABL affects ischemia-mediated angiogenesis and arteriogenesis in vivo. Finally, we demonstrated that ABL strongly reduced the levels of VEGFR-2 on the cell surface, enhanced VEGFR-2 endocytosis, which consistent with inhibited VE-cadherin, a negative regulator of VEGF signaling associated with VEGFR-2 complex formation, but did not alter VE-cadherin or VEGFR-2 expression in ECs. Our results suggest that ABL may serve as a novel therapeutic intervention for various cardiovascular diseases, including chronic ischemia, by regulating VEGF signaling and modulating angiogenesis.	[Zhao, Jingshan; Li, Aiying] Hebei Univ Chinese Med, Dept Biochem & Mol Biol, Coll Basic Med, Shijiazhuang 050200, Peoples R China; [Niu, Honglin] Hebei Med Univ, Hosp 3, Dept Nephrol, Shijiazhuang 050051, Peoples R China; [Niu, Honglin] Key Lab Kidney Dis Hebei Prov, Shijiazhuang 050071, Peoples R China; [Nie, Lei] Hebei Med Univ, Minist Educ, Key Lab Med Biotechnol Hebei Prov, Shijiazhuang 050017, Peoples R China; [Nie, Lei] Hebei Med Univ, Minist Educ, Key Lab Neural & Vasc Biol, Shijiazhuang 050017, Peoples R China; [Nie, Lei] Hebei Med Univ, Coll Basic Med, Dept Biochem & Mol Biol, Shijiazhuang 050017, Peoples R China	Hebei University of Chinese Medicine; Hebei Medical University; Hebei Medical University; Hebei Medical University; Hebei Medical University	Nie, L (corresponding author), Hebei Med Univ, Minist Educ, Key Lab Med Biotechnol Hebei Prov, Shijiazhuang 050017, Peoples R China.; Nie, L (corresponding author), Hebei Med Univ, Minist Educ, Key Lab Neural & Vasc Biol, Shijiazhuang 050017, Peoples R China.; Nie, L (corresponding author), Hebei Med Univ, Coll Basic Med, Dept Biochem & Mol Biol, Shijiazhuang 050017, Peoples R China.	nieleinl@yahoo.com		Li, Aiying/0000-0001-7779-1814	National Natural Science Foundation of China [31271466, 31571176]; Hebei Province Science and Technique Supporting Project [13277739D]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hebei Province Science and Technique Supporting Project	This project was supported by the National Natural Science Foundation of China (No. 31271466 and 31571176) and Hebei Province Science and Technique Supporting Project (No. 13277739D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker CM, 2002, CANCER BIOL THER, V1, P548, DOI 10.4161/cbt.1.5.176; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Decaussin M, 1999, J PATHOL, V188, P369; Fang XM, 2011, ONCOL REP, V26, P1181, DOI 10.3892/or.2011.1411; He ZF, 2015, BIOCHEM BIOPH RES CO, V464, P422, DOI 10.1016/j.bbrc.2015.06.126; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Lanahan AA, 2010, DEV CELL, V18, P713, DOI 10.1016/j.devcel.2010.02.016; Li YW, 2002, J EXP MED, V195, P1575, DOI 10.1084/jem.20020072; Liu B, 2008, J PHARMACOL EXP THER, V324, P292, DOI 10.1124/jpet.107.127407; Liu B, 2011, INT J CARDIOL, V149, P30, DOI 10.1016/j.ijcard.2009.11.036; Liu YP, 2007, EUR J PHARMACOL, V577, P28, DOI 10.1016/j.ejphar.2007.08.030; Nakamura Y, 2008, CIRC RES, V102, P1182, DOI 10.1161/CIRCRESAHA.107.167080; Nie L, 2013, J CLIN INVEST, V123, P5082, DOI 10.1172/JCI67752; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; Niu HL, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-135; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Prahst C, 2008, J BIOL CHEM, V283, P25110, DOI 10.1074/jbc.C800137200; Reynolds AR, 2004, CANCER RES, V64, P8643, DOI 10.1158/0008-5472.CAN-04-2760; Rivera CG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024887; Salikhova A, 2008, CIRC RES, V103, pE71, DOI 10.1161/CIRCRESAHA.108.183327; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Simons M, 2012, PHYSIOLOGY, V27, P213, DOI 10.1152/physiol.00016.2012; Witte L, 1998, CANCER METAST REV, V17, P155, DOI 10.1023/A:1006094117427; Zhang HF, 2008, J CLIN INVEST, V118, P3904, DOI 10.1172/JCI36168	25	0	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148968	10.1371/journal.pone.0148968	http://dx.doi.org/10.1371/journal.pone.0148968			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863518	Green Published, gold, Green Submitted			2022-12-27	WOS:000370046600131
J	Mok, HJ; Shin, H; Lee, JW; Lee, GK; Suh, CS; Kim, KP; Lim, HJ				Mok, Hyuck Jun; Shin, Hyejin; Lee, Jae Won; Lee, Geun-Kyung; Suh, Chang Suk; Kim, Kwang Pyo; Lim, Hyunjung Jade			Age-Associated Lipidome Changes in Metaphase II Mouse Oocytes	PLOS ONE			English	Article							PROTEIN-KINASE-C; OXIDATIVE STRESS; MASS-SPECTROMETRY; CELLULAR SENESCENCE; DEVELOPMENTAL COMPETENCE; MEMBRANE-FLUIDITY; SIGNALING LIPIDS; GENE-EXPRESSION; CRYOPRESERVATION; QUANTIFICATION	The quality of mammalian oocytes declines with age, which negatively affects fertilization and developmental potential. The aging process often accompanies damages to macromolecules such as proteins, DNA, and lipids. To investigate if aged oocytes display an altered lipidome compared to young oocytes, we performed a global lipidomic analysis between oocytes from 4-week-old and 42 to 50-week-old mice. Increased oxidative stress is often considered as one of the main causes of cellular aging. Thus, we set up a group of 4-week-old oocytes treated with hydrogen peroxide (H2O2), a commonly used oxidative stressor, to compare if similar lipid species are altered between aged and oxidative-stressed oocytes. Between young and aged oocytes, we identified 26 decreased and 6 increased lipids in aged oocytes; and between young and H2O2-treated oocytes, we identified 35 decreased and 26 increased lipids in H2O2-treated oocytes. The decreased lipid species in these two comparisons were overlapped, whereas the increased lipid species were distinct. Multiple phospholipid classes, phosphatidic acid (PA), phosphatidylinositol (PI), phosphatidylserine (PS), and lysophosphatidylserine (LPS) significantly decreased both in H2O2-treated and aged oocytes, suggesting that the integrity of plasma membrane is similarly affected under these conditions. In contrast, a dramatic increase in diacylglycerol (DG) was only noted in H2O2-treated oocytes, indicating that the acute effect of H2O2-caused oxidative stress is distinct from aging-associated lipidome alteration. In H2O2-treated oocytes, the expression of lysophosphatidylcholine acyltransferase 1 increased along with increases in phosphatidylcholine. Overall, our data reveal that several classes of phospholipids are affected in aged oocytes, suggesting that the integrity of plasma membrane is associated with maintaining fertilization and developmental potential of mouse oocytes.	[Mok, Hyuck Jun; Lee, Jae Won; Kim, Kwang Pyo] Kyung Hee Univ, Inst Nat Sci, Dept Appl Chem, Yongin, Gyeonggi Do, South Korea; [Shin, Hyejin; Lee, Geun-Kyung; Lim, Hyunjung Jade] Konkuk Univ, Inst Biomed Sci & Technol, Dept Biomed Sci & Technol, Seoul, South Korea; [Suh, Chang Suk] Seoul Natl Univ, Dept Obstet & Gynecol, Bundang Hosp, Seongnam, Gyeonggi Do, South Korea; [Lim, Hyunjung Jade] Konkuk Univ, Dept Vet Med, Seoul, South Korea	Kyung Hee University; Konkuk University; Seoul National University (SNU); Konkuk University; Konkuk University Medical Center	Kim, KP (corresponding author), Kyung Hee Univ, Inst Nat Sci, Dept Appl Chem, Yongin, Gyeonggi Do, South Korea.; Lim, HJ (corresponding author), Konkuk Univ, Inst Biomed Sci & Technol, Dept Biomed Sci & Technol, Seoul, South Korea.; Lim, HJ (corresponding author), Konkuk Univ, Dept Vet Med, Seoul, South Korea.	kimkp@khu.ac.kr; hlim@konkuk.ac.kr	Lim, Hyunjung J/D-5343-2011; Kim, Kwang Pyo/AAG-1815-2020	Lim, Hyunjung J/0000-0003-2191-666X; Kim, Kwang Pyo/0000-0003-0095-3787	Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI12C0055]	Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant from the Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI12C0055) (https://www.htdream.kr/).	Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28; Alberts B., 1995, TRENDS BIOCHEM SCI, V20, P210, DOI DOI 10.1016/S0968-0004(00)89011-8; Ambruosi B, 2009, THERIOGENOLOGY, V71, P1093, DOI 10.1016/j.theriogenology.2008.12.002; Bogliolo L, 2013, J ASSIST REPROD GEN, V30, P877, DOI 10.1007/s10815-013-0046-6; Butcher RA, 2009, P NATL ACAD SCI USA, V106, P1875, DOI 10.1073/pnas.0810338106; Dall'Armi C, 2013, CURR BIOL, V23, pR33, DOI 10.1016/j.cub.2012.10.041; de la Haba C, 2013, BBA-BIOMEMBRANES, V1828, P357, DOI 10.1016/j.bbamem.2012.08.013; Di Emidio G, 2014, HUM REPROD, V29, P2006, DOI 10.1093/humrep/deu160; Duan HM, 2005, INT J BIOCHEM CELL B, V37, P1407, DOI 10.1016/j.biocel.2005.01.010; Dunning KR, 2014, REPRODUCTION, V148, pR15, DOI 10.1530/REP-13-0251; Freikman I, 2008, BBA-BIOMEMBRANES, V1778, P2388, DOI 10.1016/j.bbamem.2008.06.008; Frippiat C, 2002, FREE RADICAL BIO MED, V33, P1334, DOI 10.1016/S0891-5849(02)01044-4; Furukawa A, 2007, CELL PHYSIOL BIOCHEM, V20, P45, DOI 10.1159/000104152; Genicot G, 2005, THERIOGENOLOGY, V63, P1181, DOI 10.1016/j.theriogenology.2004.06.006; Giraud MN, 2000, HUM REPROD, V15, P2160, DOI 10.1093/humrep/15.10.2160; Gopalacharyulu PV, 2009, MOL BIOSYST, V5, P276, DOI 10.1039/b815347g; Gray A, 2003, ANAL BIOCHEM, V313, P234, DOI 10.1016/S0003-2697(02)00607-3; Haag M, 2012, METABOLITES, V2, P57, DOI 10.3390/metabo2010057; Hagio M, 2009, J LIPID RES, V50, P173, DOI 10.1194/jlr.D800041-JLR200; Hamatani T, 2004, HUM MOL GENET, V13, P2263, DOI 10.1093/hmg/ddh241; Han XL, 2012, MASS SPECTROM REV, V31, P134, DOI 10.1002/mas.20342; Hatch GM, 2002, J LIPID RES, V43, P1380, DOI 10.1194/jlr.M200130-JLR200; Haughey NJ, 2004, ANN NEUROL, V55, P257, DOI 10.1002/ana.10828; Hawkins PT, 2015, BBA-MOL CELL BIOL L, V1851, P882, DOI 10.1016/j.bbalip.2014.12.006; Hekimi S, 2011, TRENDS CELL BIOL, V21, P569, DOI 10.1016/j.tcb.2011.06.008; Honda A, 2008, J LIPID RES, V49, P2063, DOI 10.1194/jlr.D800017-JLR200; HUANG KP, 1989, TRENDS NEUROSCI, V12, P425, DOI 10.1016/0166-2236(89)90091-X; Jiao Ze-Xu, 2012, Fertil Steril, V98, P480, DOI 10.1016/j.fertnstert.2012.04.035; Johnson KR, 2003, J BIOL CHEM, V278, P34541, DOI 10.1074/jbc.M301741200; Jung J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102620; Jungheim ES, 2011, FERTIL STERIL, V95, P1970, DOI 10.1016/j.fertnstert.2011.01.154; Lee JW, 2013, J CHROMATOGR A, V1279, P98, DOI 10.1016/j.chroma.2013.01.020; Lim J, 2011, BIOL REPROD, V84, P775, DOI 10.1095/biolreprod.110.088583; Lizaso A, 2013, AUTOPHAGY, V9, P1228, DOI 10.4161/auto.24893; Lolicato F, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.120634; Masoodi M, 2006, RAPID COMMUN MASS SP, V20, P3023, DOI 10.1002/rcm.2697; Metwally M, 2007, REPROD BIOMED ONLINE, V15, P532, DOI 10.1016/S1472-6483(10)60385-9; Miao YL, 2009, HUM REPROD UPDATE, V15, P573, DOI 10.1093/humupd/dmp014; Milne S, 2006, METHODS, V39, P92, DOI 10.1016/j.ymeth.2006.05.014; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Ottolenghi C, 2004, ANN NY ACAD SCI, V1034, P117, DOI 10.1196/annals.1335.015; Pan H, 2008, DEV BIOL, V316, P397, DOI 10.1016/j.ydbio.2008.01.048; Prates EG, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/692067; Prokazova NV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P797, DOI 10.1134/S0006297907080019; Sasaki M, 2014, BIOCHEM BIOPH RES CO, V452, P622, DOI 10.1016/j.bbrc.2014.08.123; Seidler EA, 2015, SEMIN REPROD MED, V33, P396, DOI 10.1055/s-0035-1567822; Selesniemi K, 2011, P NATL ACAD SCI USA, V108, P12319, DOI 10.1073/pnas.1018793108; Soupene E, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-8; Takahashi T, 2003, MOL REPROD DEV, V66, P143, DOI 10.1002/mrd.10341; Takekoshi S, 1995, BIOCHEM BIOPH RES CO, V217, P654, DOI 10.1006/bbrc.1995.2824; Tarin JJ, 1996, MOL HUM REPROD, V2, P717, DOI 10.1093/molehr/2.10.717; Tatone C, 2013, FERTIL STERIL, V99, P12, DOI 10.1016/j.fertnstert.2012.11.029; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Vance JE, 2008, BIOCHEMISTRY OF LIPI; Yang J, 2011, MOL BIOSYST, V7, P2428, DOI 10.1039/c1mb00002k; Yang K, 2011, METABOLITES, V1, P21, DOI 10.3390/metabo1010021; Zhang W, 2012, ANIM REPROD SCI, V132, P115, DOI 10.1016/j.anireprosci.2012.05.008; Zhang X, 2006, CELL RES, V16, P841, DOI 10.1038/sj.cr.7310095; Ziegler DV, 2015, AGING CELL, V14, P1, DOI 10.1111/acel.12287	59	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148577	10.1371/journal.pone.0148577	http://dx.doi.org/10.1371/journal.pone.0148577			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881843	Green Published, gold, Green Submitted			2022-12-27	WOS:000371219000018
J	Niu, YF; Ahammed, GJ; Tang, CX; Guo, LB; Yu, JQ				Niu, Yaofang; Ahammed, Golam Jalal; Tang, Caixian; Guo, Longbiao; Yu, Jingquan			Physiological and Transcriptome Responses to Combinations of Elevated CO2 and Magnesium in Arabidopsis thaliana	PLOS ONE			English	Article							ATMOSPHERIC CARBON-DIOXIDE; ENZYME-ACTIVITIES; PHOTOSYSTEM-II; BEAN-PLANTS; ROOT HAIRS; L. HEYNH; DEFICIENCY; GENE; TRANSPORTER; EXPRESSION	The unprecedented rise in atmospheric CO2 concentration and injudicious fertilization or heterogeneous distribution of Mg in the soil warrant further research to understand the synergistic and holistic mechanisms involved in the plant growth regulation. This study investigated the influence of elevated CO2 (800 mu L L-1) on physiological and transcriptomic profiles in Arabidopsis cultured in hydroponic media treated with 1 mu M (low), 1000 mu M (normal) and 10000 mu M (high) Mg2+. Following 7-d treatment, elevated CO2 increased the shoot growth and chlorophyll content under both low and normal Mg supply, whereas root growth was improved exclusively under normal Mg nutrition. Notably, the effect of elevated CO2 on mineral homeostasis in both shoots and roots was less than that ofMg supply. Irrespective of CO2 treatment, high Mg increased number of young leaf but decreased root growth and absorption of P, K, Ca, Fe andMn whereas low Mg increased the concentration of P, K, Ca and Fe in leaves. Transcriptomics results showed that elevated CO2 decreased the expression of genes related to cell redox homeostasis, cadmium response, and lipid localization, but enhanced signal transduction, protein phosphorylation, NBS-LRR disease resistance proteins and subsequently programmed cell death in low-Mg shoots. By comparison, elevated CO2 enhanced the response of lipid localization (mainly LTP transfer protein/protease inhibitor), endomembrane system, heme binding and cell wall modification in high-Mg roots. Some of these transcriptomic results are substantially in accordance with our physiological and/or biochemical analysis. The present findings broaden our current understanding on the interactive effect of elevated CO2 and Mg levels in the Arabidopsis, which may help to design the novelmetabolic engineering strategies to cope with Mg deficiency/excess in crops under elevated CO2.	[Niu, Yaofang; Guo, Longbiao] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou 310006, Zhejiang, Peoples R China; [Niu, Yaofang; Ahammed, Golam Jalal; Yu, Jingquan] Zhejiang Univ, Coll Agr & Biotechnol, Dept Hort, Hangzhou 310058, Zhejiang, Peoples R China; [Tang, Caixian] La Trobe Univ, Ctr AgriBiosci, Melbourne Campus, Bundoora, Vic 3086, Australia	Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Zhejiang University; La Trobe University	Guo, LB (corresponding author), China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou 310006, Zhejiang, Peoples R China.; Yu, JQ (corresponding author), Zhejiang Univ, Coll Agr & Biotechnol, Dept Hort, Hangzhou 310058, Zhejiang, Peoples R China.	guolongb@mail.hz.zj.cn; jqyu@zju.edu.cn	Ahammed, Golam Jalal/B-7548-2012; Tang, Caixian/S-8702-2019; Yu, J.Q./C-9509-2015	Ahammed, Golam Jalal/0000-0001-9621-8431; Tang, Caixian/0000-0002-9138-8770; Yu, J.Q./0000-0002-7626-1165	China Postdoctoral Science Foundation [517000-X91403]; National Natural Science Foundation of China [31550110201]; Zhejiang Provincial priority projects in forestry sciences [KF201310, KF201311]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial priority projects in forestry sciences	This work was supported by grants of the China Postdoctoral Science Foundation (517000-X91403, http://jj.chinapostdoctor.org.cn/V1/Program1/Default.aspx), the National Natural Science Foundation of China (31550110201, http://www.nsfc.gov.cn/), the Zhejiang Provincial priority projects in forestry sciences (KF201310 and KF201311, http://kjc2.zafu.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank anonymous reviewers for their constructive comments on the manuscript. We thank Hangzhou Guhe Information and Technology Co., Ltd for the help with RNA-seq sequencing and bioinformatics analysis. This work was financially supported by Grants of the China Postdoctoral Science Foundation (517000-X91403, http://jj.chinapostdoctor.org.cn/V1/Program1/Default.aspx), the National Natural Science Foundation of China (31550110201, http://www.nsfc.gov.cn/) and the Zhejiang Provincial priority projects in forestry sciences (KF201310 and KF201311).	Ahuja I, 2010, TRENDS PLANT SCI, V15, P664, DOI 10.1016/j.tplants.2010.08.002; Armengaud P, 2004, PLANT PHYSIOL, V136, P2556, DOI 10.1104/pp.104.046482; Azam A, 2013, J SCI FOOD AGR, V93, P3237, DOI 10.1002/jsfa.6165; BassiriRad H, 2001, OECOLOGIA, V126, P305, DOI 10.1007/s004420000524; Berntson GM, 1997, GLOBAL CHANGE BIOL, V3, P247, DOI 10.1046/j.1365-2486.1997.00070.x; CAKMAK I, 1994, J EXP BOT, V45, P1245, DOI 10.1093/jxb/45.9.1245; CAKMAK I, 1994, J EXP BOT, V45, P1251, DOI 10.1093/jxb/45.9.1251; Cakmak I, 2008, PHYSIOL PLANTARUM, V133, P692, DOI 10.1111/j.1399-3054.2007.01042.x; CARTER DP, 1980, ARCH BIOCHEM BIOPHYS, V200, P374, DOI 10.1016/0003-9861(80)90367-7; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; David-Assael O, 2005, J EXP BOT, V56, P1039, DOI 10.1093/jxb/eri097; Rodriguez-Hernandez MD, 2014, PLANT CELL PHYSIOL, V55, P2047, DOI 10.1093/pcp/pcu130; Ding Y, 2006, ANN APPL BIOL, V149, P111, DOI 10.1111/j.1744-7348.2006.00080.x; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Gan YB, 2006, PLANT CELL, V18, P1383, DOI 10.1105/tpc.106.041533; Gardner RC, 2003, CURR OPIN PLANT BIOL, V6, P263, DOI 10.1016/S1369-5266(03)00032-3; Gebert M, 2009, PLANT CELL, V21, P4018, DOI 10.1105/tpc.109.070557; Gerendas J, 2013, PLANT SOIL, V368, P101, DOI 10.1007/s11104-012-1555-2; Hermans C, 2005, J EXP BOT, V56, P2153, DOI 10.1093/jxb/eri215; Hermans C, 2005, PLANTA, V220, P541, DOI 10.1007/s00425-004-1376-5; Hermans C, 2004, PLANTA, V220, P344, DOI 10.1007/s00425-004-1340-4; Hermans C, 2006, TRENDS PLANT SCI, V11, P610, DOI 10.1016/j.tplants.2006.10.007; Hermans C, 2010, NEW PHYTOL, V187, P132, DOI 10.1111/j.1469-8137.2010.03257.x; Hermans C, 2010, NEW PHYTOL, V187, P119, DOI 10.1111/j.1469-8137.2010.03258.x; Huber DM, 2013, PLANT SOIL, V368, P73, DOI 10.1007/s11104-012-1476-0; Iyer-Pascuzzi A, 2009, CURR OPIN PLANT BIOL, V12, P165, DOI 10.1016/j.pbi.2008.11.002; Jin CW, 2009, PLANT PHYSIOL, V150, P272, DOI 10.1104/pp.109.136721; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Karley AJ, 2009, CURR OPIN PLANT BIOL, V12, P291, DOI 10.1016/j.pbi.2009.04.013; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kogawara S, 2006, TREE PHYSIOL, V26, P25, DOI 10.1093/treephys/26.1.25; Kramer U, 2007, FEBS LETT, V581, P2263, DOI 10.1016/j.febslet.2007.04.010; Lake JA, 2009, J EXP BOT, V60, P3123, DOI 10.1093/jxb/erp147; Li LG, 2008, MOL PLANT, V1, P675, DOI 10.1093/mp/ssn031; Long SP, 2004, ANNU REV PLANT BIOL, V55, P591, DOI 10.1146/annurev.arplant.55.031903.141610; Maguire ME, 2002, BIOMETALS, V15, P203, DOI 10.1023/A:1016058229972; Maser P, 2001, PLANT PHYSIOL, V126, P1646, DOI 10.1104/pp.126.4.1646; Misson J, 2005, P NATL ACAD SCI USA, V102, P11934, DOI 10.1073/pnas.0505266102; Moller IS, 2009, PLANT CELL, V21, P2163, DOI 10.1105/tpc.108.064568; Morel M, 2009, PLANT PHYSIOL, V149, P894, DOI 10.1104/pp.108.130294; Muller AH, 2009, PLANT PHYSIOL, V150, P157, DOI 10.1104/pp.109.135277; Mundy J, 2006, TRENDS PLANT SCI, V11, P63, DOI 10.1016/j.tplants.2005.12.003; Nakata M, 2012, PLANT CELL, V24, P519, DOI 10.1105/tpc.111.092858; Neuhaus C, 2013, PLANT SOIL, V368, P41, DOI 10.1007/s11104-013-1711-3; Niu YF, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.29720; Niu YF, 2014, PLANT CELL ENVIRON, V37, P2795, DOI 10.1111/pce.12362; Niu YF, 2013, J EXP BOT, V64, P355, DOI 10.1093/jxb/ers341; Niu YF, 2011, PLANT CELL ENVIRON, V34, P1304, DOI 10.1111/j.1365-3040.2011.02330.x; Oerke EC., 1994, CROP PRODUCTION CROP; Osuna D, 2007, PLANT J, V49, P463, DOI 10.1111/j.1365-313X.2006.02979.x; Rasmussen S, 2013, PLANT PHYSIOL, V161, P1783, DOI 10.1104/pp.112.210773; Reddy AR, 2010, CURR SCI INDIA, V99, P46; Shabala S, 2005, PLANTA, V221, P56, DOI 10.1007/s00425-004-1425-0; Shaul O, 1999, EMBO J, V18, P3973, DOI 10.1093/emboj/18.14.3973; Shaul O, 2002, BIOMETALS, V15, P309, DOI 10.1023/A:1016091118585; Shin R, 2004, P NATL ACAD SCI USA, V101, P8827, DOI 10.1073/pnas.0401707101; STITT M, 1991, PLANTA, V183, P40, DOI 10.1007/BF00197565; STULEN I, 1993, VEGETATIO, V104, P99, DOI 10.1007/BF00048147; STURN A, 2000, THESIS GRAZ U TECHNO; Taub D., 2010, NAT ED KNOWL, V3, P21; Tewari RK, 2006, SCI HORTIC-AMSTERDAM, V108, P7, DOI 10.1016/j.scienta.2005.12.006; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Usadel B, 2008, PLANT CELL ENVIRON, V31, P518, DOI 10.1111/j.1365-3040.2007.01763.x; Visscher AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012348; Wang H, 2013, PLANTA, V237, P137, DOI 10.1007/s00425-012-1763-2	67	17	17	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149301	10.1371/journal.pone.0149301	http://dx.doi.org/10.1371/journal.pone.0149301			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881808	Green Submitted, Green Published, gold			2022-12-27	WOS:000371219000068
J	Xie, YC; Shi, CM; Tong, ML; Zhang, M; Li, TT; Xu, YQ; Guo, XR; Qin, H; Chi, X				Xie, Yachun; Shi, Chunmei; Tong, Meiling; Zhang, Min; Li, Tingting; Xu, Yaqin; Guo, Xirong; Hong, Qin; Chi, Xia			Developmental Eye Movement (DEM) Test Norms for Mandarin Chinese-Speaking Chinese Children	PLOS ONE			English	Article							READING DISABILITIES; SKILLS; POPULATION; DYSLEXIA	The Developmental Eye Movement (DEM) test is commonly used as a clinical visual-verbal ocular motor assessment tool to screen and diagnose reading problems at the onset. No established norm exists for using the DEM test with Mandarin Chinese-speaking Chinese children. This study aims to establish the normative values of the DEM test for the Mandarin Chinese-speaking population in China; it also aims to compare the values with three other published norms for English-, Spanish-, and Cantonese-speaking Chinese children. A random stratified sampling method was used to recruit children from eight kindergartens and eight primary schools in the main urban and suburban areas of Nanjing. A total of 1,425 Mandarin Chinese-speaking children aged 5 to 12 years took the DEM test in Mandarin Chinese. A digital recorder was used to record the process. All of the subjects completed a symptomatology survey, and their DEM scores were determined by a trained tester. The scores were computed using the formula in the DEM manual, except that the "vertical scores" were adjusted by taking the vertical errors into consideration. The results were compared with the three other published norms. In our subjects, a general decrease with age was observed for the four eye movement indexes: vertical score, adjusted horizontal score, ratio, and total error. For both the vertical and adjusted horizontal scores, the Mandarin Chinese-speaking children completed the tests much more quickly than the norms for English- and Spanish-speaking children. However, the same group completed the test slightly more slowly than the norms for Cantonese-speaking children. The differences in the means were significant (P<0.001) in all age groups. For several ages, the scores obtained in this study were significantly different from the reported scores of Cantonese-speaking Chinese children (P<0.005). Compared with English-speaking children, only the vertical score of the 6-year-old group, the vertical-horizontal time ratio of the 8-year-old group and the errors of 9-year-old group had no significant difference (P>0.05); compared with Spanish-speaking children, the scores were statistically significant (P<0.001) for the total error scores of the age groups, except the 6-, 9-, 10-, and 11-year-old age groups (P>0.05). DEM norms may be affected by differences in language, cultural, and educational systems among various ethnicities. The norms of the DEM test are proposed for use with Mandarin Chinese-speaking children in Nanjing and will be proposed for children throughout China.	[Xie, Yachun; Shi, Chunmei; Tong, Meiling; Zhang, Min; Li, Tingting; Xu, Yaqin; Guo, Xirong; Hong, Qin; Chi, Xia] Nanjing Med Univ, Nanjing Matern & Child Hlth Care Hosp, Dept Children Hlth Care, Nanjing, Jiangsu, Peoples R China; [Tong, Meiling; Guo, Xirong; Chi, Xia] Nanjing Med Univ, Inst Pediat, Nanjing, Jiangsu, Peoples R China; [Li, Tingting] Dachang Community Hlth Serv Ctr, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Chi, X (corresponding author), Nanjing Med Univ, Nanjing Matern & Child Hlth Care Hosp, Dept Children Hlth Care, Nanjing, Jiangsu, Peoples R China.; Chi, X (corresponding author), Nanjing Med Univ, Inst Pediat, Nanjing, Jiangsu, Peoples R China.	chixia2001@njmu.edu.cn			National Natural Science Foundation of China [81250008, 81270928, 81500674]; Program for Medical Talents of Jiangsu Province [RC2011022]; Nanjing Technological Development Program [201108007, WYKK12097]; Science and Technology Development Fund of Nanjing Medical University [2014NJMUZD041]; Nanjing Talent Training Program [QRX11108]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Medical Talents of Jiangsu Province; Nanjing Technological Development Program; Science and Technology Development Fund of Nanjing Medical University; Nanjing Talent Training Program	This work was supported by grants from the National Natural Science Foundation of China (81250008, 81270928, 81500674), the Program for Medical Talents of Jiangsu Province (RC2011022), the Nanjing Technological Development Program (201108007, WYKK12097), the Science and Technology Development Fund of Nanjing Medical University (2014NJMUZD041) and the Nanjing Talent Training Program (QRX11108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen XY, 1997, DEV PSYCHOL, V33, P518, DOI 10.1037/0012-1649.33.3.518; Dandache S, 2014, DYSLEXIA, V20, P305, DOI 10.1002/dys.1482; EDEN GF, 1994, VISION RES, V34, P1345, DOI 10.1016/0042-6989(94)90209-7; FernandezVelazquez FJ, 1995, OPTOMETRY VISION SCI, V72, P902, DOI 10.1097/00006324-199512000-00009; Fluss J, 2008, ARCH PEDIATRIE, V15, P1049, DOI 10.1016/j.arcped.2008.02.012; Garzia R, 2008, OPTOMETRIC CLIN PRAC; Garzia R P, 1990, J Am Optom Assoc, V61, P124; Baptista AMG, 2011, OPTOMETRY VISION SCI, V88, P864, DOI 10.1097/OPX.0b013e3182195dae; Ho CS-H., 1999, EDUC CHILD PSYCHOL, V16, P4, DOI DOI 10.1177/0022219409345016; Jimenez R, 2003, OPHTHAL PHYSL OPT, V23, P97, DOI 10.1046/j.1475-1313.2003.00093.x; Kozeis N, 2006, INT J NEUROSCI, V116, P1347, DOI 10.1080/00207450500514011; Kulp MT, 1997, OPTOMETRY VISION SCI, V74, P37, DOI 10.1097/00006324-199701000-00018; Kulp MT, 1998, OPTOMETRY VISION SCI, V75, P284, DOI 10.1097/00006324-199804000-00026; Kunert R, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01129; Marandi RZ, 2014, BASIC CLIN NEUROSCI, V5, P55; Meng XZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108274; Palomo-Alvarez C, 2009, GRAEF ARCH CLIN EXP, V247, P1243, DOI 10.1007/s00417-009-1076-8; Pang PC, 2010, CLIN EXP OPTOM, V93, P341, DOI 10.1111/j.1444-0938.2010.00501.x; Pang PC, 2010, CLIN EXP OPTOM, V93, P213, DOI 10.1111/j.1444-0938.2010.00470.x; Powers Maureen, 2008, Optometry, V79, P228, DOI 10.1016/j.optm.2007.07.014; Richman J. E., 2009, DEV EYE MOVEMENT TES; Shaywitz SE, 1998, NEW ENGL J MED, V338, P307, DOI 10.1056/NEJM199801293380507; Solan H A, 1998, J Am Optom Assoc, V69, P455; STEVENSON HW, 1982, CHILD DEV, V53, P1164, DOI 10.2307/1129005; Tassinari J T, 2005, Optometry, V76, P387, DOI 10.1016/j.optm.2005.05.006; Webber AL, 2009, OPTOMETRY VISION SCI, V86, P760, DOI 10.1097/OPX.0b013e3181a523b7; YGGE J, 1993, ACTA OPHTHALMOL, V71, P10	27	10	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148481	10.1371/journal.pone.0148481	http://dx.doi.org/10.1371/journal.pone.0148481			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881754	Green Submitted, Green Published, gold			2022-12-27	WOS:000371219000016
J	Xiong, WJ; Dong, HP; Wang, JJ; Zou, XM; Wen, Q; Luo, W; Liu, SD; He, JC; Cai, SX; Ma, L				Xiong, Wenjing; Dong, Haiping; Wang, Juanjuan; Zou, Xiaoming; Wen, Qian; Luo, Wei; Liu, Sudong; He, Jianchun; Cai, Shaoxi; Ma, Li			Analysis of Plasma Cytokine and Chemokine Profiles in Patients with and without Tuberculosis by Liquid Array-Based Multiplexed Immunoassays	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; MYCOBACTERIUM-TUBERCULOSIS; BIOMARKERS; INFECTION; RESPONSES; INTERLEUKIN-1-BETA; DISEASE; INFLAMMATION; ASSOCIATION; PERFORMANCE	The aim of this study was to establish plasma cytokine/chemokine profiles in patients with 3 different presentations of active tuberculosis (TB), compared to the profiles observed in bacillus Calmette-Guerin (BCG)-vaccinated healthy individuals and patients with other pulmonary diseases (non-TB patients). To this end, plasma samples were collected from 151 TB patients including 68 pulmonary TB (PTB), 43 endobronchial TB, and 40 tuberculosis pleurisy (TP) patients, as well as 107 no-TB cases including 26 non-TB patients and 81 BCG-vaccinated healthy controls. A liquid array-based multiplexed immunoassay was used to screen plasma samples for 20 distinct cytokines and chemokines. Multinomial logistic regression was used to analyze associations between cytokines/chemokines and TB/non-TB patients. Compared to our findings with the no-TB donors, the median plasma levels of the proinflammatory cytokines/chemokines TNF-alpha, IL-6, IP-10, IFN-gamma, and MIP-1 beta were significantly elevated in TB patients, suggesting their potential use as biomarkers for diagnosing TB patients. Further comparisons with healthy donors showed that only the median TNF-alpha plasma level was highly produced in the plasma of all 3 types of TB patients. Plasma IL-6 production was higher only in TP patients, while the plasma levels of IP-10, IFN-gamma, and MIP-1 beta were markedly enhanced in both PTB and TP patients. Unexpectedly, among the above cytokines/chemokines, MIP-1 beta was also highly expressed in non-TB patients, compared with healthy donors. Our results suggested that TNF-alpha may be an ideal biomarker for diagnosing the 3 forms of TB presentation, while the other factors (IL-6, IP-10, MCP-1, and IFN-gamma) can potentially facilitate differential diagnosis for the 3 TB presentation types. Further characterization of immune responses associated with different types of TB diseases will provide a basis for developing novel TB diagnostics.	[Xiong, Wenjing; Dong, Haiping; Wang, Juanjuan; Wen, Qian; Luo, Wei; Liu, Sudong; He, Jianchun; Ma, Li] Southern Med Univ, Inst Mol Immunol, Sch Biotechnol, Guangzhou 510515, Guangdong, Peoples R China; [Dong, Haiping; Cai, Shaoxi] Southern Med Univ, Nanfang Hosp, Dept Resp & Crit Care Med, Guangzhou 510515, Guangdong, Peoples R China; [Zou, Xiaoming] First Peoples Hosp Kashi, Xinjiang 844000, Peoples R China	Southern Medical University - China; Southern Medical University - China	Ma, L (corresponding author), Southern Med Univ, Inst Mol Immunol, Sch Biotechnol, Guangzhou 510515, Guangdong, Peoples R China.; Cai, SX (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Resp & Crit Care Med, Guangzhou 510515, Guangdong, Peoples R China.	hxkcai@126.com; maryhmz@126.com	wang, juanjuan/GYV-5540-2022	Ma, Li/0000-0001-5847-2375	National Science and Technology Key Projects on Major Infectious Diseases [2012ZX10003002-007]; National Natural Science Foundation of China [81371764, 81171539, 81571951]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; Guangdong Natural Science Foundation [2014A030313322]; Science and Technology Project of Guangdong Province [2013B010404020]; Scientific and Technological Innovation Project of Guangdong Province Discipline Construction Special Funds [2013KJCX0036]; Science and Technology Supporting Project of Xinjiang Uygur Autonomous Region [2013911122]; Institute of Molecular Immunology	National Science and Technology Key Projects on Major Infectious Diseases; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Science and Technology Project of Guangdong Province; Scientific and Technological Innovation Project of Guangdong Province Discipline Construction Special Funds; Science and Technology Supporting Project of Xinjiang Uygur Autonomous Region; Institute of Molecular Immunology	This work was supported by National Science and Technology Key Projects on Major Infectious Diseases (2012ZX10003002-007) http://www.most.gov.cn/index.htm; National Natural Science Foundation of China (81371764, 81171539, 81571951) http://www.nsfc.gov.cn/; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2012) http://www.gdhed.edu.cn/; Guangdong Natural Science Foundation (2014A030313322) http://www.gdstc.gov.cn/; Science and Technology Project of Guangdong Province (2013B010404020) http://www.gdstc.gov.cn/; Scientific and Technological Innovation Project of Guangdong Province Discipline Construction Special Funds (2013KJCX0036) http://www.gdhed.edu.cn/; Science and Technology Supporting Project of Xinjiang Uygur Autonomous Region (2013911122) http://www.most.gov.cn/index.htm; all of these support Institute of Molecular Immunology and Li Ma is the recipient. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akarsu S, 2005, MEDIAT INFLAMM, P2, DOI 10.1155/MI.2005.2; Algood HMS, 2003, CYTOKINE GROWTH F R, V14, P467, DOI 10.1016/S1359-6101(03)00054-6; Bhat IA, 2014, META GENE, V2, P123, DOI 10.1016/j.mgene.2013.12.002; Brock L, 2004, AM J RESP CRIT CARE, V170, P65, DOI 10.1164/rccm.200402-232OC; Chegou NN, 2014, EUR RESPIR J, V43, P1472, DOI 10.1183/09031936.00151413; Clute SC, 2010, J IMMUNOL, V185, P6753, DOI 10.4049/jimmunol.1000812; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Dhanasekaran S, 2013, GENES IMMUN, V14, P356, DOI 10.1038/gene.2013.26; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dorhoi A, 2014, SEMIN IMMUNOL, V26, P203, DOI 10.1016/j.smim.2014.04.003; Etna MP, 2014, SEMIN IMMUNOL, V26, P543, DOI 10.1016/j.smim.2014.09.011; Feng JY, 2013, DIAGN MICR INFEC DIS, V77, P46, DOI 10.1016/j.diagmicrobio.2013.05.020; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Hasan Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008459; Idriss HT, 2000, MICROSC RES TECHNIQ, V50, P184, DOI 10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H; Jo EK, 2003, CURR OPIN INFECT DIS, V16, P205, DOI 10.1097/00001432-200306000-00004; John SH, 2012, BIOMARKERS, V17, P1, DOI 10.3109/1354750X.2011.628048; Kabeer BSA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009051; Kang DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016161; Klimiuk J, 2015, ADV EXP MED BIOL, V852, P21, DOI 10.1007/5584_2014_105; Kwan ML, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1263-4; Lalor MK, 2011, J INFECT DIS, V204, P1075, DOI 10.1093/infdis/jir515; Lin YG, 1998, INFECT IMMUN, V66, P1121, DOI 10.1128/IAI.66.3.1121-1126.1998; Liu Z, 2012, CURR MICROBIOL, V65, P313, DOI 10.1007/s00284-012-0157-9; Lou XL, 2013, CAN J MICROBIOL, V59, P620, DOI 10.1139/cjm-2013-0259; Mihret A, 2013, J INFECTION, V66, P357, DOI 10.1016/j.jinf.2012.11.005; Monin L, 2014, SEMIN IMMUNOL, V26, P552, DOI 10.1016/j.smim.2014.09.004; MUNK ME, 1995, EUR RESPIR J, V8, pS668; Murdoch C, 2000, BLOOD, V95, P3032; Nolan A, 2013, INT J TUBERC LUNG D, V17, P922, DOI 10.5588/ijtld.12.0610; Ray JCJ, 2009, J IMMUNOL, V182, P3706, DOI 10.4049/jimmunol.0802297; Sharma SK, 2004, INDIAN J MED RES, V120, P316; Shen ZT, 2013, J IMMUNOL, V191, P5139, DOI 10.4049/jimmunol.1300852; Siawaya JFD, 2009, CYTOKINE, V47, P132, DOI 10.1016/j.cyto.2009.05.016; Singh PP, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-686; Tadele A, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0585-1; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; Toujani S, 2015, REV PNEUMOL CLIN, V71, P73, DOI 10.1016/j.pneumo.2015.02.001; Tsao TCY, 2000, CHEST, V117, P103, DOI 10.1378/chest.117.1.103; Valdes L, 1998, ARCH INTERN MED, V158, P2017, DOI 10.1001/archinte.158.18.2017; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; Wang L, 2014, CANCER RES, V74, P4720, DOI 10.1158/0008-5472.CAN-14-0960; Xue Q, 2011, EUR J CLIN MICROBIOL, V30, P1039, DOI 10.1007/s10096-011-1205-2; Yamada H, 2000, LAB INVEST, V80, P759, DOI 10.1038/labinvest.3780079; Yang J, 2003, MICROB PATHOGENESIS, V34, P17, DOI 10.1016/S0882-4010(02)00190-0	45	16	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148885	10.1371/journal.pone.0148885	http://dx.doi.org/10.1371/journal.pone.0148885			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881918	Green Submitted, Green Published, gold			2022-12-27	WOS:000371219000029
J	Diep, CS; Lemaitre, RN; Chen, TA; Baranowski, T; Lutsey, PL; Manichaikul, AW; Rich, SS; St-Jules, DE; Steffen, BT; Tsai, MY; Siscovick, DS; Frazier-Wood, AC				Diep, Cassandra S.; Lemaitre, Rozenn N.; Chen, Tzu-An; Baranowski, Tom; Lutsey, Pamela L.; Manichaikul, Ani W.; Rich, Stephen S.; St-Jules, David E.; Steffen, Brian T.; Tsai, Michael Y.; Siscovick, David S.; Frazier-Wood, Alexis C.			Acculturation and Plasma Fatty Acid Concentrations in Hispanic and Chinese-American Adults: The Multi-Ethnic Study of Atherosclerosis	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; UNITED-STATES; ASIAN-AMERICANS; HEART-DISEASE; RISK-FACTORS; HEALTH; ASSOCIATION; BEHAVIORS; DIETARY; IMMIGRANTS	Background Acculturation to the U.S. is associated with increased risk of cardiovascular disease, but the etiologic pathways are not fully understood. Plasma fatty acid levels exhibit ethnic differences and are emerging as biomarkers and predictors of cardiovascular disease risk. Thus, plasma fatty acids may represent one pathway underlying the association between acculturation and cardiovascular disease. We investigated the cross-sectional relationship between acculturation and plasma phospholipid fatty acids in a diverse sample of Hispanic- and Chinese-American adults. Methods and Findings Participants included 377 Mexican, 320 non-Mexican Hispanic, and 712 Chinese adults from the Multi-Ethnic Study of Atherosclerosis, who had full plasma phospholipid assays and acculturation information. Acculturation was determined from three proxy measures: nativity, language spoken at home, and years in the U.S., with possible scores ranging from 0 (least acculturated) to 5 (most acculturated) points. a-Linolenic acid, linoleic acid, eicosapentaenoic acid, docosahexaenoic acid, and arachidonic acid were measured in fasting plasma. Linear regression models were conducted in race/ethnicity-stratified analyses, with acculturation as the predictor and plasma phospholipid fatty acids as the outcome variables. We ran secondary analyses to examine associations between acculturation and dietary fatty acids for comparison. Covariates included age, gender, education, and income. Contrary to our hypothesis, no statistically significant associations were detected between acculturation and plasma phospholipid fatty acids for Chinese, non-Mexican Hispanic, or Mexican participants. However, acculturation was related to dietary total n-6 fatty acids and dietary n-3/n-6 ratios in expected directions for Mexican, non-Mexican Hispanic, and combined Hispanic participants. In Chinese individuals, acculturation was unexpectedly associated with lower arachidonic acid intake. Conclusion Absence of associations between acculturation and plasma phospholipid fatty acids suggests that changes in the plasma phospholipid fatty acids studied do not account for the observed associations of acculturation to the U.S. and cardiovascular disease risk. Similar findings were observed for eicosapentaenoic acid and docosahexaenoic acid, when using dietary intake. However, the observed associations between dietary n-6 fatty acids and acculturation in Hispanic individuals suggest that dietary intake may be more informative than phospholipids when investigating acculturation effects. In Chinese individuals, acculturation may have a possible protective effect through decreased arachidonic acid intake. Further research on dietary fatty acids and other cardiovascular disease biomarkers is needed to identify possible etiologic mechanisms between acculturation and cardiovascular disease.	[Diep, Cassandra S.; Chen, Tzu-An; Baranowski, Tom; Frazier-Wood, Alexis C.] Baylor Coll Med, Dept Pediat, Childrens Nutr Res Ctr, USDA ARS, Houston, TX 77030 USA; [Diep, Cassandra S.] Univ Texas MD Anderson Canc Ctr, Dept Hlth Dispar Res, Houston, TX 77030 USA; [Lemaitre, Rozenn N.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Lutsey, Pamela L.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Manichaikul, Ani W.; Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA; [St-Jules, David E.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Steffen, Brian T.; Tsai, Michael Y.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Siscovick, David S.] New York Acad Med, New York, NY USA	Baylor College of Medicine; United States Department of Agriculture (USDA); University of Texas System; UTMD Anderson Cancer Center; University of Washington; University of Washington Seattle; University of Minnesota System; University of Minnesota Twin Cities; University of Virginia; Harvard University; Harvard T.H. Chan School of Public Health; University of Minnesota System; University of Minnesota Twin Cities; New York Academy of Medicine	Diep, CS (corresponding author), Baylor Coll Med, Dept Pediat, Childrens Nutr Res Ctr, USDA ARS, Houston, TX 77030 USA.; Diep, CS (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Hlth Dispar Res, Houston, TX 77030 USA.	cassandra.diep@gmail.com	Wood, Lekki/B-8053-2010	Wood, Lekki/0000-0001-7616-2119; Steffen, Brian/0000-0001-8010-2530; Rich, Stephen/0000-0003-3872-7793; Manichaikul, Ani/0000-0002-5998-795X; Lutsey, Pamela/0000-0002-1572-1340; Tsai, Michael/0000-0001-7553-3408; Baranowski, Tom/0000-0002-0653-2222	USDA/ARS [58-6250-0-008]; National Research Service Award [T32 HP10031]; American Heart Association [14BGIA18740011]; National Heart, Lung, and Blood Institute (NHLBI); National Heart, Lung, and Blood Institute [N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC95162, N01-HC-95163, N01-HC-95164, N01-HC95165, N01-HC-95166, N01-HC-95167, N01-HC95168, N01-HC-95169]; NCRR [UL1-TR000040, UL1-TR-001079]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079, UL1TR000040] Funding Source: NIH RePORTER	USDA/ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work is a publication of the United States Department of Agriculture (USDA/ARS) Children's Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, and had been funded in part with federal funds from the USDA/ARS under Cooperative Agreement No. 58-6250-0-008. The contents of this publication do not necessarily reflect the views or policies of the USDA, nor does mention of trade names, commercial products, or organizations imply endorsement from the US government. CSD was supported by a Primary Care Research Training Grant from National Research Service Award (#T32 HP10031). ACF-W was supported in part by American Heart Association grant number 14BGIA18740011. MESA and the MESA SHARe project are conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with MESA investigators. Support for MESA is provided by contracts N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC95162, N01-HC-95163, N01-HC-95164, N01-HC95165, N01-HC-95166, N01-HC-95167, N01-HC95168, and N01-HC-95169 from the National Heart, Lung, and Blood Institute and by grants UL1-TR000040 and UL1-TR-001079 from NCRR. A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org.	Abraido-Lanza AF, 2005, SOC SCI MED, V61, P1243, DOI 10.1016/j.socscimed.2005.01.016; Antecol H, 2006, DEMOGRAPHY, V43, P337, DOI 10.1353/dem.2006.0011; Ayala GX, 2008, J AM DIET ASSOC, V108, P1330, DOI 10.1016/j.jada.2008.05.009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; BLOCK G, 1990, J CLIN EPIDEMIOL, V43, P1327, DOI 10.1016/0895-4356(90)90099-B; Chowdhury R, 2014, ANN INTERN MED, V160, P398, DOI 10.7326/M13-1788; Chung HJ, 2008, J NUTR, V138, P2422, DOI 10.3945/jn.108.089631; Cohen J.E., 1988, STAT POWER ANAL BEHA; Connor WE, 2000, AM J CLIN NUTR, V71, p171S, DOI 10.1093/ajcn/71.1.171S; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; CUSHMAN M, 1995, CLIN CHEM, V41, P264; Demory-Luce DK, 2005, NUTR RES, V25, P213, DOI 10.1016/j.nutres.2004.12.005; Diep CS, 2015, J IMMIGR MINOR HEALT, V17, P591, DOI 10.1007/s10903-013-9905-6; Fang CY, 2014, PSYCHOSOM MED, V76, P320, DOI 10.1097/PSY.0000000000000065; Gordon-Larsen P, 2003, SOC SCI MED, V57, P2023, DOI 10.1016/S0277-9536(03)00072-8; Harris WS, 2009, CIRCULATION, V119, P902, DOI 10.1161/CIRCULATIONAHA.108.191627; Hodson L, 2001, EUR J CLIN NUTR, V55, P908, DOI 10.1038/sj.ejcn.1601234; Kandula NR, 2008, DIABETES CARE, V31, P1621, DOI 10.2337/dc07-2182; Koya DL, 2007, J GEN INTERN MED, V22, P841, DOI 10.1007/s11606-007-0163-y; Lauderdale DS, 2000, INT J OBESITY, V24, P1188, DOI 10.1038/sj.ijo.0801365; Li WW, 2007, J TRANSCULT NURS, V18, P331, DOI 10.1177/1043659607305194; Lutsey PL, 2008, AM J PUBLIC HEALTH, V98, P1963, DOI 10.2105/AJPH.2007.123844; Lv N, 2004, J AM DIET ASSOC, V104, P771, DOI 10.1016/j.jada.2004.02.032; Lv N, 2010, J NUTR EDUC BEHAV, V42, P106, DOI 10.1016/j.jneb.2009.04.005; MARMOT MG, 1976, AM J EPIDEMIOL, V104, P225, DOI 10.1093/oxfordjournals.aje.a112296; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mayer-Davis EJ, 1999, ANN EPIDEMIOL, V9, P314, DOI 10.1016/S1047-2797(98)00070-2; Molendi-Coste O, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/364040; Otto MCD, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000506; Palaniappan LP, 2010, CIRCULATION, V122, P1242, DOI 10.1161/CIR.0b013e3181f22af4; Pan YL, 1999, J AM DIET ASSOC, V99, P54, DOI 10.1016/S0002-8223(99)00016-4; Patterson E, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/539426; Ramsden Christopher E, 2009, Curr Treat Options Cardiovasc Med, V11, P289; Reddy KS, 2004, PUBLIC HEALTH NUTR, V7, P167, DOI 10.1079/PHN2003587; Riediger ND, 2009, J AM DIET ASSOC, V109, P668, DOI 10.1016/j.jada.2008.12.022; Satia-Abouta J, 2002, J AM DIET ASSOC, V102, P1105, DOI 10.1016/S0002-8223(02)90247-6; SCHAKEL SF, 1988, J AM DIET ASSOC, V88, P1268; Simopoulos AP, 1999, AM J CLIN NUTR, V70, p560S, DOI 10.1093/ajcn/70.3.560s; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; Simopoulos AP, 2004, FOOD REV INT, V20, P77, DOI 10.1081/FRI-120028831; SIMOPOULOS AP, 1991, AM J CLIN NUTR, V54, P438, DOI 10.1093/ajcn/54.3.438; Singh GK, 2002, HUM BIOL, V74, P83, DOI 10.1353/hub.2002.0011; Song YJ, 2004, PREV MED, V39, P147, DOI 10.1016/j.ypmed.2004.01.013; Sundquist J, 1999, AM J PUBLIC HEALTH, V89, P723, DOI 10.2105/AJPH.89.5.723; Taylor VM, 2007, J COMMUN HEALTH, V32, P299, DOI 10.1007/s10900-007-9057-5; US Census Bureau, ACS DEM HOUS EST 201; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Wong SS, 2013, J IMMIGR MINOR HEALT, V15, P560, DOI 10.1007/s10903-012-9669-4	49	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149267	10.1371/journal.pone.0149267	http://dx.doi.org/10.1371/journal.pone.0149267			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6SI	26872329	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100138
J	Rabhi, S; Rabhi, I; Trentin, B; Piquemal, D; Regnault, B; Goyard, S; Lang, T; Descoteaux, A; Enninga, J; Guizani-Tabbane, L				Rabhi, Sameh; Rabhi, Imen; Trentin, Bernadette; Piquemal, David; Regnault, Beatrice; Goyard, Sophie; Lang, Thierry; Descoteaux, Albert; Enninga, Jost; Guizani-Tabbane, Lamia			Lipid Droplet Formation, Their Localization and Dynamics during Leishmania major Macrophage Infection	PLOS ONE			English	Article							MYCOBACTERIUM-LEPRAE; INTRACELLULAR DOMAINS; INFLAMMATORY RESPONSE; EICOSANOID FORMATION; IN-VIVO; HOST; BODIES; CHOLESTEROL; CELLS; AMAZONENSIS	Leishmania, the causative agent of vector-borne diseases, known as leishmaniases, is an obligate intracellular parasite within mammalian hosts. The outcome of infection depends largely on the activation status of macrophages, the first line of mammalian defense and the major target cells for parasite replication. Understanding the strategies developed by the parasite to circumvent macrophage defense mechanisms and to survive within those cells help defining novel therapeutic approaches for leishmaniasis. We previously showed the formation of lipid droplets (LDs) in L. major infected macrophages. Here, we provide novel insights on the origin of the formed LDs by determining their cellular distribution and to what extent these high-energy sources are directed to the proximity of Leishmania parasites. We show that the ability of L. major to trigger macrophage LD accumulation is independent of parasite viability and uptake and can also be observed in non-infected cells through paracrine stimuli suggesting that LD formation is from cellular origin. The accumulation of LDs is demonstrated using confocal microscopy and live-cell imagin in parasite-free cytoplasmic region of the host cell, but also promptly recruited to the proximity of Leishmania parasites. Indeed LDs are observed inside parasitophorous vacuole and in parasite cytoplasm suggesting that Leishmania parasites besides producing their own LDs, may take advantage of these high energy sources. Otherwise, these LDs may help cells defending against parasitic infection. These metabolic changes, rising as common features during the last years, occur in host cells infected by a large number of pathogens and seem to play an important role in pathogenesis. Understanding how Leishmania parasites and different pathogens exploit this LD accumulation will help us define the common mechanism used by these different pathogens to manipulate and/or take advantage of this high-energy source.	[Rabhi, Sameh; Rabhi, Imen; Guizani-Tabbane, Lamia] Univ Tunis El Manar, Inst Pasteur Tunis, Lab Parasitol Med Biotechnol & Biomol, 13,Pl Pasteur BP 74, Tunis 1002, Tunisia; [Rabhi, Sameh] Univ Carthage, Ave Republ BP 77, Carthage 1054, Tunisia; [Rabhi, Imen] Univ Manouba, Biotechnol & Biogeo Resources Valorizat Lab LR11E, Sidi Thabet 2020, Ariana, Tunisia; [Rabhi, Imen] Univ Manouba, Higher Inst Biotechnol, Sidi Thabet 2020, Ariana, Tunisia; [Trentin, Bernadette; Piquemal, David] Acobiom Cap Delta Biopole Euromed II, 1682 Rue Valsiere, F-34184 Montpellier 4, France; [Regnault, Beatrice] Inst Pasteur Paris, Genopole, DNA Chip Platform, 25-28 Rue Dr Roux, F-75015 Paris, France; [Goyard, Sophie; Lang, Thierry] Inst Pasteur, Dept Infect & Epidemiol, Lab Proc Infect Trypanosomatides, 26 Rue Dr Roux, F-75724 Paris 15, France; [Descoteaux, Albert] INRS Inst Armand Frappier, 531 Blvd Prairies, Laval, PQ H7V 1B7, Canada; [Descoteaux, Albert] Ctr Host Parasite Interact, 531 Blvd Prairies, Laval, PQ H7V 1B7, Canada; [Enninga, Jost] Inst Pasteur, Dynam Host Pathogen Interact Unit, 25 Rue Dr Roux, F-75724 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Universite de Carthage; Universite de la Manouba; Universite de la Manouba; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Quebec; Institut national de la recherche scientifique (INRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Guizani-Tabbane, L (corresponding author), Univ Tunis El Manar, Inst Pasteur Tunis, Lab Parasitol Med Biotechnol & Biomol, 13,Pl Pasteur BP 74, Tunis 1002, Tunisia.	lamia.guizani@pasteur.rns.tn	Descoteaux, Albert/ABE-6326-2021	REGNAULT, Beatrice/0000-0002-3914-1914; Goyard, Sophie/0000-0002-8937-2796; Lang, Thierry/0000-0001-5032-8360; RABHI, Imen/0000-0002-9403-576X; Piquemal, David/0000-0002-5870-4276	European community grant [37231]; L'Oreal-UNESCO Pan Arab Regional Fellowship For Women in Science; ERC [261166]; Canadian Institutes of Health Research [MOP-12933]; Institut Pasteur International Network (RIIP-Calmette)	European community grant(European Commission); L'Oreal-UNESCO Pan Arab Regional Fellowship For Women in Science(L'Oreal Group); ERC(European Research Council (ERC)European Commission); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Institut Pasteur International Network (RIIP-Calmette)	L. G. T. was supported by funds from European community grant (Proposal number: 37231), I. R. was supported by a L'Oreal-UNESCO Pan Arab Regional Fellowship For Women in Science, J. E. was supported by an ERC starting grant (Rupteffects, number 261166), and is a member of the LabEx consortia IBEID and Milieu Interieur at the Institut Pasteur and A. D. was supported by the Canadian Institutes of Health Research (MOP-12933). S. R. was supported with a Traineeship grants to facilitate mobility within the Institut Pasteur International Network (RIIP-Calmette) for a 3 months traineeship in the lab of A. D. and with a 6 months fellowship, from L'Oreal-UNESCO Pan Arab Regional Fellowship For Women in Science that I. R. was granted, for a traineeship spent in the Lab of Dr Jost Enninga. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida PE, 2009, J IMMUNOL, V183, P1337, DOI 10.4049/jimmunol.0900365; Araujo-Santos T, 2014, J INFECT DIS, V210, P1951, DOI 10.1093/infdis/jiu299; Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200; Bashmakov Yuriy K, 2010, Comp Hepatol, V9, P3, DOI 10.1186/1476-5926-9-3; Bozza PT, 2007, PHARMACOL THERAPEUT, V113, P30, DOI 10.1016/j.pharmthera.2006.06.006; Bozza PT, 2009, BBA-MOL CELL BIOL L, V1791, P540, DOI 10.1016/j.bbalip.2009.01.005; Cao F, 2007, INFECT IMMUN, V75, P753, DOI 10.1128/IAI.01386-06; Charron AJ, 2002, J CELL SCI, V115, P3049; D'Avila H, 2008, CELL MICROBIOL, V10, P2589, DOI 10.1111/j.1462-5822.2008.01233.x; D'Avila H, 2006, J IMMUNOL, V176, P3087, DOI 10.4049/jimmunol.176.5.3087; D'Avila H, 2011, J INFECT DIS, V204, P951, DOI 10.1093/infdis/jir432; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; Das P, 2014, INDIAN J BIOCHEM BIO, V51, P542; De Cicco NNT, 2012, EXP PARASITOL, V130, P330, DOI 10.1016/j.exppara.2012.02.014; de Mattos KA, 2012, MEM I OSWALDO CRUZ, V107, P156, DOI 10.1590/S0074-02762012000900023; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Feingold KR, 2012, J LIPID RES, V53, P2487, DOI 10.1194/jlr.E033407; Feingold KR, 2010, J LIPID RES, V51, P682, DOI 10.1194/jlr.E005454; Franca-Costa J, 2015, J INFECT DIS, V211, P426, DOI 10.1093/infdis/jiu455; Ghosh J, 2012, J LIPID RES, V53, P2560, DOI 10.1194/jlr.M026914; Harris C, 2011, J BIOL CHEM, V286, P42615, DOI 10.1074/jbc.M111.285148; Harris CA, 2011, J LIPID RES, V52, P657, DOI 10.1194/jlr.M013003; Herker E, 2012, J BIOL CHEM, V287, P2280, DOI 10.1074/jbc.R111.300202; Jaramillo M, 2011, CELL HOST MICROBE, V9, P331, DOI 10.1016/j.chom.2011.03.008; Kellner-Weibel G, 2001, J LIPID RES, V42, P768; Khatchadourian A, 2012, BBA-MOL CELL BIOL L, V1821, P607, DOI 10.1016/j.bbalip.2012.01.007; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Kumar Y, 2006, CURR BIOL, V16, P1646, DOI 10.1016/j.cub.2006.06.060; Lecoeur H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002276; Martens GW, 2008, INFECT IMMUN, V76, P3464, DOI 10.1128/IAI.00037-08; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Martin S, 2005, SEMIN CELL DEV BIOL, V16, P163, DOI 10.1016/j.semcdb.2005.01.007; Matheoud D, 2013, CELL HOST MICROBE, V14, P15, DOI 10.1016/j.chom.2013.06.003; Matte C, 2001, PARASITE IMMUNOL, V23, P177, DOI 10.1046/j.1365-3024.2001.00372.x; Mattos KA, 2011, CELL MICROBIOL, V13, P259, DOI 10.1111/j.1462-5822.2010.01533.x; Mattos KA, 2010, J LEUKOCYTE BIOL, V87, P371, DOI 10.1189/jlb.0609433; Mellouk N, 2014, CELL HOST MICROBE, V16, P517, DOI 10.1016/j.chom.2014.09.005; Melo RCN, 2006, INFLAMM RES, V55, P342, DOI 10.1007/s00011-006-5205-0; Melo RCN, 2003, TISSUE CELL, V35, P59, DOI 10.1016/S0040-8166(02)00105-2; Melo RCN, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002729; Melo RCN, 2011, J HISTOCHEM CYTOCHEM, V59, P540, DOI 10.1369/0022155411404073; Nawabi P, 2008, MOL MICROBIOL, V68, P173, DOI 10.1111/j.1365-2958.2008.06142.x; Osorio y Fortea Jose, 2009, BMC Genomics, V10, P119, DOI 10.1186/1471-2164-10-119; Passero LFD, 2008, PARASITOL RES, V102, P1025, DOI 10.1007/s00436-007-0871-6; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Pinheiro RO, 2009, MICROBES INFECT, V11, P181, DOI 10.1016/j.micinf.2008.11.006; Polando R, 2013, J LEUKOCYTE BIOL, V93, P921, DOI 10.1189/jlb.0212086; Portugal LR, 2008, MICROBES INFECT, V10, P276, DOI 10.1016/j.micinf.2007.12.001; Pulido-Mendez M, J SUBMICROSC CYTOL P, V38, P143; Rabhi I, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001763; Rank RG, 2011, INFECT IMMUN, V79, P3291, DOI 10.1128/IAI.00200-11; Rodriguez-Acosta A, 1998, J SUBMICR CYTOL PATH, V30, P299; Saka HA, 2012, ANNU REV CELL DEV BI, V28, P411, DOI 10.1146/annurev-cellbio-092910-153958; Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632; Vinet AF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000628; WHO, 2015, LEISHM; Xu NY, 2012, J CELL BIOL, V198, P895, DOI 10.1083/jcb.201201139	57	43	43	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148640	10.1371/journal.pone.0148640	http://dx.doi.org/10.1371/journal.pone.0148640			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871576	Green Published, gold			2022-12-27	WOS:000370054100043
J	Soriano-Maldonado, A; Klokker, L; Bartholdy, C; Bandak, E; Ellegaard, K; Bliddal, H; Henriksen, M				Soriano-Maldonado, Alberto; Klokker, Louise; Bartholdy, Cecilie; Bandak, Elisabeth; Ellegaard, Karen; Bliddal, Henning; Henriksen, Marius			Intra-Articular Corticosteroids in Addition to Exercise for Reducing Pain Sensitivity in Knee Osteoarthritis: Exploratory Outcome from a Randomized Controlled Trial	PLOS ONE			English	Article							THERAPY	Objective To assess the effects of one intra-articular corticosteroid injection two weeks prior to an exercise-based intervention program for reducing pain sensitivity in patients with knee osteoarthritis (OA). Design Randomized, masked, parallel, placebo-controlled trial involving 100 participants with clinical and radiographic knee OA that were randomized to one intra-articular injection on the knee with either 1 ml of 40 mg/ml methylprednisolone (corticosteroid) dissolved in 4 ml lidocaine (10 mg/ml) or 1 ml isotonic saline (placebo) mixed with 4 ml lidocaine (10 mg/ml). Two weeks after the injections all participants undertook a 12-week supervised exercise program. Main outcomes were changes from baseline in pressure-pain sensitivity (pressurepain threshold [PPT] and temporal summation [TS]) assessed using cuff pressure algometry on the calf. These were exploratory outcomes from a randomized controlled trial. Results A total of 100 patients were randomized to receive either corticosteroid (n = 50) or placebo (n = 50); 45 and 44, respectively, completed the trial. Four participants had missing values for PPT and one for TS at baseline; thus modified intention-to-treat populations were analyzed. The mean group difference in changes from baseline at week 14 was 0.6 kPa (95% CI: -1.7 to 2.8; P = 0.626) for PPT and 384 mmxsec (95% CI: -2980 to 3750; P = 0.821) for TS. Conclusions These results suggest that adding intra-articular corticosteroid injection 2 weeks prior to an exercise program does not provide additional benefits compared to placebo in reducing pain sensitivity in patients with knee OA.	[Soriano-Maldonado, Alberto] Univ Granada, Fac Sport Sci, Dept Phys Educ & Sport, Granada, Spain; [Klokker, Louise; Bartholdy, Cecilie; Bandak, Elisabeth; Ellegaard, Karen; Bliddal, Henning; Henriksen, Marius] Copenhagen Univ Hosp Bispebjerg & Frederiksberg, Parker Inst, Frederiksberg, Denmark; [Bartholdy, Cecilie; Henriksen, Marius] Copenhagen Univ Hosp Bispebjerg & Frederiksberg, Dept Phys & Occupat Therapy, Frederiksberg, Denmark	University of Granada; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Bispebjerg Hospital	Henriksen, M (corresponding author), Copenhagen Univ Hosp Bispebjerg & Frederiksberg, Parker Inst, Frederiksberg, Denmark.; Henriksen, M (corresponding author), Copenhagen Univ Hosp Bispebjerg & Frederiksberg, Dept Phys & Occupat Therapy, Frederiksberg, Denmark.	marius.henriksen@regionh.dk	Soriano-Maldonado, Alberto/I-6379-2015; Bartholdy, Cecilie/AAJ-5496-2020; Henriksen, Marius/ABD-7887-2020; Bliddal, Henning/AAB-3168-2019	Soriano-Maldonado, Alberto/0000-0002-4626-420X; Bartholdy, Cecilie/0000-0001-5700-385X; Henriksen, Marius/0000-0003-1091-2962; Bliddal, Henning/0000-0002-7951-1668	Danish Council for Independent Research, Medical Science [10093704]; Oak Foundation; Association of Danish Physiotherapists; Lundbeck Foundation; Capital Region of Denmark; Spanish Ministry of Education, Culture and Sport [FPU12/00963]	Danish Council for Independent Research, Medical Science(Det Frie Forskningsrad (DFF)); Oak Foundation; Association of Danish Physiotherapists; Lundbeck Foundation(Lundbeckfonden); Capital Region of Denmark; Spanish Ministry of Education, Culture and Sport(Spanish Government)	This study was supported by grant 10093704 from the Danish Council for Independent Research, Medical Science and by the Oak Foundation, Association of Danish Physiotherapists, Lundbeck Foundation, and Capital Region of Denmark. AS-M was supported by the Spanish Ministry of Education, Culture and Sport (FPU12/00963). The funding sources had no role in the study design, data collection and analysis, interpretation or reporting of this work, or the decision to submit the work for publication. All authors are independent of the funding sources.	Arendt-Nielsen L, 2010, PAIN, V149, P573, DOI 10.1016/j.pain.2010.04.003; Arroll B, 2004, BMJ-BRIT MED J, V328, P869, DOI 10.1136/bmj.38039.573970.7C; Cross M, 2014, ANN RHEUM DIS, V73, P1323, DOI 10.1136/annrheumdis-2013-204763; Finan PH, 2013, ARTHRITIS RHEUM-US, V65, P363, DOI 10.1002/art.34646; Fingleton C, 2015, OSTEOARTHR CARTILAGE, V23, P1043, DOI 10.1016/j.joca.2015.02.163; Henriksen M, 2015, JAMA INTERN MED, V175, P923, DOI 10.1001/jamainternmed.2015.0461; Henriksen M, 2014, ARTHRIT CARE RES, V66, P1836, DOI 10.1002/acr.22375; Hochberg MC, 2012, ARTHRIT CARE RES, V64, P465, DOI 10.1002/acr.21596; Jorgensen TS, 2014, PAIN RES TREAT, V2014, DOI 10.1155/2014/710490; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Polianskis R, 2001, EUR J PAIN, V5, P267, DOI 10.1053/eujp.2001.0245; Roos Ewa M, 2003, Health Qual Life Outcomes, V1, P64, DOI 10.1186/1477-7525-1-64; Sharif B, 2015, OSTEOARTHR CARTILAGE, V23, P1654, DOI 10.1016/j.joca.2015.05.029; Suokas AK, 2012, OSTEOARTHR CARTILAGE, V20, P1075, DOI 10.1016/j.joca.2012.06.009	14	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149168	10.1371/journal.pone.0149168	http://dx.doi.org/10.1371/journal.pone.0149168			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871954	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100117
J	Zaloba, P; Bailey-Elkin, BA; Derksen, M; Mark, BL				Zaloba, Patryk; Bailey-Elkin, Ben A.; Derksen, Miriam; Mark, Brian L.			Structural and Biochemical Insights into the Peptidoglycan Hydrolase Domain of FlgJ from Salmonella typhimurium	PLOS ONE			English	Article							N-ACETYLGLUCOSAMINIDASE; CATALYTIC MECHANISM; CRYSTAL-STRUCTURE; GLUCOSAMINIDASE; AUTOLYSIN; VIRULENCE; PROTEIN; AUTO	FlgJ is a glycoside hydrolase (GH) enzyme belonging to the Carbohydrate Active enZyme (CAZy) family GH73. It facilitates passage of the bacterial flagellum through the peptidoglycan (PG) layer by cleaving the beta-1,4 glycosidic bond between N-acetylglucosamine and N-acetylmuramic acid sugars that comprise the glycan strands of PG. Here we describe the crystal structure of the GH domain of FlgJ from bacterial pathogen Salmonella typhimurium (StFlgJ). Interestingly, the active site of StFlgJ was blocked by the C-terminal alpha-helix of a neighbouring symmetry mate and a beta-hairpin containing the putative catalytic glutamic acid residue Glu223 was poorly resolved and could not be completely modeled into the electron density, suggesting it is flexible. Previous reports have shown that the GH73 enzyme Auto from Listeria monocytogenes is inhibited by an N-terminal a-helix that may occlude the active site in similar fashion. To investigate if the C-terminus of StFlgJ inhibits GH activity, the glycolytic activity of StFlgJ was assessed with and without the C-terminal alpha-helix. The GH activity of StFlgJ was unaffected by the presence or absence of the alpha-helix, suggesting it is not involved in regulating activity. Removal of the C-terminal alpha-helix did, however, allow a crystal structure of the domain to be obtained where the flexible beta-hairpin containing residue Glu223 was entirely resolved. The beta-hairpin was positioned such that the active site groove was fully solvent-exposed, placing Glu223 nearly 21.6 away from the putative general ac/base residue Glu184, which is too far apart for these two residues to coordinate glycosidic bond hydrolysis. The mobile nature of the StFlgJ beta-hairpin is consistent with structural studies of related GH73 enzymes, suggesting that a dynamic active site may be common to many GH73 enzymes, in which the active site opens to capture substrate and then closes to correctly orient active site residues for catalysis.	[Zaloba, Patryk; Bailey-Elkin, Ben A.; Derksen, Miriam; Mark, Brian L.] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada; [Derksen, Miriam] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba	Mark, BL (corresponding author), Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada.	brian.mark@umanitoba.ca		Mark, Brian/0000-0002-7344-1355	Natural Sciences and Engineering Research Council (NSERC) [311775-2010, 2015-05310]; Manitoba Graduate fellowship	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Manitoba Graduate fellowship	This research was supported by Natural Sciences and Engineering Research Council (NSERC) grants 311775-2010 and 2015-05310 (to B.L.M.). P.Z. held a Manitoba Graduate fellowship. B.B.E. holds an NSERC Postgraduate Scholarship (Doctoral). M.D. held a University of Manitoba Faculty of Science Undergraduate Student Research Award (USRA). B.L.M. holds a Manitoba Research Chair.	Abbott DW, 2009, J BIOL CHEM, V284, P11676, DOI 10.1074/jbc.M809663200; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bai XH, 2014, J BIOL CHEM, V289, P23403, DOI 10.1074/jbc.M114.579714; Bublitz M, 2009, MOL MICROBIOL, V71, P1509, DOI 10.1111/j.1365-2958.2009.06619.x; Cabanes D, 2004, MOL MICROBIOL, V51, P1601, DOI 10.1111/j.1365-2958.2003.03945.x; Camiade E, 2010, J BACTERIOL, V192, P2373, DOI 10.1128/JB.01546-09; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; De las Rivas B, 2002, J BACTERIOL, V184, P4988, DOI 10.1128/JB.184.18.4988-5000.2002; Dennis RJ, 2006, NAT STRUCT MOL BIOL, V13, P365, DOI 10.1038/nsmb1079; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Eckert C, 2006, J BACTERIOL, V188, P8513, DOI 10.1128/JB.01145-06; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gosink KK, 2000, INFECT IMMUN, V68, P5690, DOI 10.1128/IAI.68.10.5690-5695.2000; Hashimoto W, 2009, BIOCHEM BIOPH RES CO, V381, P16, DOI 10.1016/j.bbrc.2009.01.186; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; Herlihey FA, 2014, J BIOL CHEM, V289, P31029, DOI 10.1074/jbc.M114.603944; Hirano T, 2001, J MOL BIOL, V312, P359, DOI 10.1006/jmbi.2001.4963; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; Inagaki N, 2009, GENE, V447, P61, DOI 10.1016/j.gene.2009.08.004; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; Lipski A, 2015, GLYCOBIOLOGY, V25, P319, DOI 10.1093/glycob/cwu113; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Mark BL, 2002, CAN J CHEM, V80, P1064, DOI 10.1139/V02-130; Mark BL, 2001, J BIOL CHEM, V276, P10330, DOI 10.1074/jbc.M011067200; Markovic-Housley Z, 2000, STRUCTURE, V8, P1025, DOI 10.1016/S0969-2126(00)00511-6; Maruyama Y, 2010, J BASIC MICROB, V50, P311, DOI 10.1002/jobm.200900249; Moens S, 1996, CRIT REV MICROBIOL, V22, P67, DOI 10.3109/10408419609106456; Nambu T, 1999, J BACTERIOL, V181, P1555, DOI 10.1128/JB.181.5.1555-1561.1999; Schrodinger, 2010, PYMOL MOL GRAPHICS S; Steen A, 2005, FEBS J, V272, P2854, DOI 10.1111/j.1742-4658.2005.04706.x; Tews I, 1996, NAT STRUCT BIOL, V3, P638, DOI 10.1038/nsb0796-638; van Aalten DMF, 2001, P NATL ACAD SCI USA, V98, P8979, DOI 10.1073/pnas.151103798; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Yokoi KJ, 2008, GENE, V416, P66, DOI 10.1016/j.gene.2008.03.004; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+	37	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149204	10.1371/journal.pone.0149204	http://dx.doi.org/10.1371/journal.pone.0149204			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871950	gold, Green Published			2022-12-27	WOS:000370054100126
J	Zhang, ZY; Shi, L; Pang, WH; Liu, WW; Li, JF; Wang, HB; Shi, GG				Zhang, Zhiyu; Shi, Lei; Pang, Wenhui; Liu, Wenwen; Li, Jianfeng; Wang, Haibo; Shi, Guanggang			Dietary Fiber Intake Regulates Intestinal Microflora and Inhibits Ovalbumin-Induced Allergic Airway Inflammation in a Mouse Model	PLOS ONE			English	Article							GUT MICROBIOTA; TH2 RESPONSES; PULMONARY INFLAMMATION; HYGIENE HYPOTHESIS; HEALTH-BENEFITS; ASTHMA; RHINITIS; DISEASES; MECHANISMS; UPDATE	Background Recently, academic studies suggest that global growth of airway allergic disease has a close association with dietary changes including reduced consumption of fiber. Therefore, appropriate dietary fiber supplementation might be potential to prevent airway allergic disease (AAD). Objective We investigated whether dietary fiber intake suppressed the induction of AAD and tried to elucidate the possible underlying mechanisms. Methods The control mice and AAD model mice fed with 4% standard-fiber chow, while low-fiber group of mice fed with a 1.75% low-fiber chow. The two fiber-intervened groups including mice, apart from a standard-fiber diet, were also intragastric (i.g.) administrated daily with poorly fermentable cellulose or readily fermentable pectin (0.4% of daily body weight), respectively. All animals except normal mice were sensitized and challenged with ovalbumin (OVA) to induce airway allergic inflammation. Hallmarks of AAD were examined by histological analysis and ELISA. The variation in intestinal bacterial composition was assessed by qualitative analysis of 16S ribosomal DNA (rDNA) content in fecal samples using real-time PCR. Results Low-fiber diet aggravated inflammatory response in ovalbumin-induced allergic mice, whereas dietary fiber intake significantly suppressed the allergic responses, attenuated allergic symptoms of nasal rubbing and sneezing, decreased the pathology of eosinophil infiltration and goblet cell metaplasia in the nasal mucosa and lung, inhibited serum OVA-specific IgE levels, and lowered the levels of Th2 cytokines in NALF and BALF, but, increased Th1 (IFN-gamma) cytokines. Additionally, dietary fiber intake also increased the proportion of Bacteroidetes and Actinobacteria, and decreased Firmicutes and Proteobacteria. Levels of probiotic bacteria, such as Lactobacillus and Bifidobacterium, were upgraded significantly. Conclusion Long-term deficiency of dietary fiber intake increases the susceptibility to AAD, whereas proper fiber supplementation promotes effectively the balance of Th1/Th2 immunity and then attenuates allergic inflammatory responses significantly, as well as optimizes the structure of intestinal microbiota, which suggests potential for novel preventive and therapeutic intervention.	[Zhang, Zhiyu; Shi, Lei; Liu, Wenwen; Li, Jianfeng; Wang, Haibo; Shi, Guanggang] Shandong Univ, Shandong Prov Hosp, Dept Otolaryngol Head & Neck Surg, Jinan 250100, Peoples R China; [Zhang, Zhiyu; Liu, Wenwen; Li, Jianfeng; Wang, Haibo; Shi, Guanggang] Shandong Prov Key Lab Otol, Shandong Inst Otolaryngol, Jinan, Peoples R China; [Pang, Wenhui] Fudan Univ, Affiliated Eye Ear Nose & Throat Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai 200433, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Fudan University	Shi, GG (corresponding author), Shandong Univ, Shandong Prov Hosp, Dept Otolaryngol Head & Neck Surg, Jinan 250100, Peoples R China.; Shi, GG (corresponding author), Shandong Prov Key Lab Otol, Shandong Inst Otolaryngol, Jinan, Peoples R China.	shiguangangent@hotmail.com						Akdis M, 2011, J ALLERGY CLIN IMMUN, V127, P701, DOI 10.1016/j.jaci.2010.11.050; Anderson JW, 2009, NUTR REV, V67, P188, DOI 10.1111/j.1753-4887.2009.00189.x; Bickert T, 2009, INT ARCH ALLERGY IMM, V149, P219, DOI 10.1159/000199717; Bjorksten B, 2001, J ALLERGY CLIN IMMUN, V108, P516, DOI 10.1067/mai.2001.118130; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Brooks C, 2013, CURR OPIN ALLERGY CL, V13, P70, DOI 10.1097/ACI.0b013e32835ad0d2; Brozek JL, 2010, J ALLERGY CLIN IMMUN, V126, P466, DOI 10.1016/j.jaci.2010.06.047; Cho KS, 2009, STEM CELLS, V27, P259, DOI 10.1634/stemcells.2008-0283; Ciprandi G, 2015, EXPERT REV CLIN IMMU, P1; Compalati E, 2010, EXPERT REV CLIN IMMU, V6, P413, DOI [10.1586/ECI.10.15, 10.1586/eci.10.15]; de Moura PN, 2013, IMMUN INFLAMM DIS, V1, P63, DOI 10.1002/iid3.8; Devereux G, 2006, NAT REV IMMUNOL, V6, P869, DOI 10.1038/nri1958; Faith A, 2012, ALLERGY, V67, P1007, DOI 10.1111/j.1398-9995.2012.02852.x; Frei R, 2012, ALLERGY, V67, P451, DOI 10.1111/j.1398-9995.2011.02783.x; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Gophna U, 2011, SCIENCE, V334, P45, DOI 10.1126/science.1213799; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Kang JH, 2009, AM J RESP CRIT CARE, V179, P875, DOI 10.1164/rccm.200806-893OC; Kim JY, 2008, J MICROBIOL BIOTECHN, V18, P1393; Kukkonen K, 2010, PEDIAT ALLERG IMM-UK, V21, P67, DOI 10.1111/j.1399-3038.2009.00907.x; Lin IP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090293; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; Meyer Diederick, 2015, Adv Food Nutr Res, V74, P47, DOI 10.1016/bs.afnr.2014.11.002; Nakaji S, 2002, EUR J NUTR, V41, P222, DOI 10.1007/s00394-002-0379-x; Nauta AJ, 2008, EUR J PHARMACOL, V585, P354, DOI 10.1016/j.ejphar.2008.02.094; Noverr MC, 2005, CLIN EXP ALLERGY, V35, P1511, DOI 10.1111/j.1365-2222.2005.02379.x; Osborn DA, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006474.pub3; Pang WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059174; Penders J, 2007, GUT, V56, P661, DOI 10.1136/gut.2006.100164; Bernaud FSR, 2013, ARQ BRAS ENDOCRINOL, V57, P397, DOI 10.1590/S0004-27302013000600001; Saliganti V, 2015, BR J NUTR, P1; Shinmei Y, 2009, IMMUNOPHARM IMMUNOT, V31, P688, DOI 10.3109/08923970903078443; Skapenko Alla, 2007, V136, P87; Slavin J, 2013, NUTRIENTS, V5, P1417, DOI 10.3390/nu5041417; Spiess PC, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-107; Stokes JR, 2015, J ALLER CL IMM-PRACT, V3, P162, DOI 10.1016/j.jaip.2014.10.010; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Thorburn AN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8320; Thorburn AN, 2014, IMMUNITY, V40, P833, DOI 10.1016/j.immuni.2014.05.014; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Velez EM, 2015, BR J NUTR, P1; Wang DY, 2000, AM J RHINOL, V14, P325, DOI 10.2500/105065800781329483; Wang T, 2009, EUR RESPIR J, V33, P1122, DOI 10.1183/09031936.00055908; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yu WK, 2015, ANN ALLERG ASTHMA IM, V115, P63, DOI 10.1016/j.anai.2015.04.025	46	54	59	7	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0147778	10.1371/journal.pone.0147778	http://dx.doi.org/10.1371/journal.pone.0147778			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872019	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100010
J	Cilano, K; Mazanek, Z; Khan, M; Metcalfe, S; Zhang, XN				Cilano, Kevin; Mazanek, Zachary; Khan, Mahmuda; Metcalfe, Sarah; Zhang, Xiao-Ning			A New Mutation, hap1-2, Reveals a C Terminal Domain Function in AtMago Protein and Its Biological Effects in Male Gametophyte Development in Arabidopsis thaliana	PLOS ONE			English	Article							EXON JUNCTION COMPLEX; MESSENGER-RNA DECAY; NONSENSE-MEDIATED DECAY; MAGO-NASHI; SWISS-MODEL; CRYSTAL-STRUCTURE; DROSOPHILA; GENE; NUCLEOLUS; UPF3	The exon-exon junction complex (EJC) is a conserved eukaryotic multiprotein complex that examines the quality of and determines the availability of messenger RNAs (mRNAs) post-transcriptionally. Four proteins, MAGO, Y14, eIF4AIII and BTZ, function as core components of the EJC. The mechanisms of their interactions and the biological indications of these interactions are still poorly understood in plants. A new mutation, hap1-2. leads to premature pollen death and a reduced seed production in Arabidopsis. This mutation introduces a viable truncated transcript AtMago Delta C. This truncation abolishes the interaction between AtMago and AtY14 in vitro, but not the interaction between AtMago and AteIF4AIII. In addition to a strong nuclear presence of AtMago, both AtMago and AtMago Delta C exhibit processing-body (P-body) localization. This indicates that AtMago Delta C may replace AtMago in the EJC when aberrant transcripts are to be degraded. When introducing an NMD mutation, upf3-1, into the existing HAP1/hap1-2 mutant, plants showed a severely reduced fertility. However, the change of splicing pattern of a subset of SR protein transcripts is mostly correlated with the sr45-1 and upf3-1 mutations, not the hap1-2 mutation. These results imply that the C terminal domain (CTD) of AtMago is required for the AtMago-AtY14 heterodimerization during EJC assembly, UPF3-mediated NMD pathway and the AtMago-AtY14 heterodimerization work synergistically to regulate male gametophyte development in plants.	[Cilano, Kevin; Khan, Mahmuda; Zhang, Xiao-Ning] St Bonaventure Univ, Dept Biol, St Bonaventure, NY 14778 USA; [Mazanek, Zachary; Metcalfe, Sarah; Zhang, Xiao-Ning] St Bonaventure Univ, Biochem Program, St Bonaventure, NY 14778 USA; [Cilano, Kevin] St Francis Inn Minist, Philadelphia, PA USA; [Mazanek, Zachary] Johns Hopkins Univ, Dept Chem, Baltimore, MD USA; [Khan, Mahmuda] George Washington Univ, Sch Med, Washington, DC USA	Johns Hopkins University; George Washington University	Zhang, XN (corresponding author), St Bonaventure Univ, Dept Biol, St Bonaventure, NY 14778 USA.; Zhang, XN (corresponding author), St Bonaventure Univ, Biochem Program, St Bonaventure, NY 14778 USA.	xzhang@sbu.edu	Zhang, Xiao-Ning/J-1737-2019	Zhang, Xiao-Ning/0000-0001-8650-1356; Metcalfe, Sarah/0000-0002-6926-443X	National Science Foundation [NSF0950158]; Direct For Biological Sciences [1146300, 1147144] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work received financial support from The National Science Foundation, Grant number: NSF0950158. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali GS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000471; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006; Boothby TC, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-45; BOSWELL RE, 1991, DEVELOPMENT, V113, P373; Buchwald G, 2010, P NATL ACAD SCI USA, V107, P10050, DOI 10.1073/pnas.1000993107; Chamieh H, 2008, NAT STRUCT MOL BIOL, V15, P85, DOI 10.1038/nsmb1330; Dostie J, 2002, CURR BIOL, V12, P1060, DOI 10.1016/S0960-9822(02)00902-8; EYAL Y, 1995, PLANT CELL, V7, P373, DOI 10.1105/tpc.7.3.373; Fang YD, 2005, MOL BIOL CELL, V16, P5710, DOI 10.1091/mbc.E05-08-0706; Gehring NH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000120; Gehring NH, 2009, CELL, V137, P536, DOI 10.1016/j.cell.2009.02.042; Gong PC, 2014, PLANT J, V80, P905, DOI 10.1111/tpj.12672; Gong PC, 2014, PLANT PHYSIOL, V165, P1047, DOI 10.1104/pp.114.237958; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hachet O, 2004, NATURE, V428, P959, DOI 10.1038/nature02521; Hori K, 2005, PLANT J, V43, P530, DOI 10.1111/j.1365-313X.2005.02473.x; Johnson MA, 2004, GENETICS, V168, P971, DOI 10.1534/genetics.104.029447; Kataoka N, 2001, EMBO J, V20, P6424, DOI 10.1093/emboj/20.22.6424; Kawano T, 2004, MECH DEVELOP, V121, P27, DOI 10.1016/j.mod.2003.11.003; Kerenyi Z, 2008, EMBO J, V27, P1585, DOI 10.1038/emboj.2008.88; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim SH, 2009, PLANT CELL, V21, P2045, DOI 10.1105/tpc.109.067736; Koroleva OA, 2009, PLANT CELL, V21, P1592, DOI 10.1105/tpc.108.060434; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Lykke-Andersen J, 2001, SCIENCE, V293, P1836, DOI 10.1126/science.1062786; Ma Hong, 2005, Annu Rev Plant Biol, V56, P393, DOI 10.1146/annurev.arplant.55.031903.141717; Micklem DR, 1997, CURR BIOL, V7, P468, DOI 10.1016/S0960-9822(06)00218-1; Nielsen KH, 2009, RNA, V15, P67, DOI 10.1261/rna.1283109; Palusa SG, 2010, NEW PHYTOL, V185, P83, DOI 10.1111/j.1469-8137.2009.03065.x; Palusa SG, 2007, PLANT J, V49, P1091, DOI 10.1111/j.1365-313X.2006.03020.x; Park NI, 2007, PLANTA, V225, P625, DOI 10.1007/s00425-006-0385-y; Park NI, 2009, PLANT SCI, V176, P461, DOI 10.1016/j.plantsci.2008.12.016; Parma DH, 2007, DEV BIOL, V308, P507, DOI 10.1016/j.ydbio.2007.06.007; Pendle AF, 2005, MOL BIOL CELL, V16, P260, DOI 10.1091/mbc.E04-09-0791; Popp MWL, 2013, ANNU REV GENET, V47, P139, DOI 10.1146/annurev-genet-111212-133424; Reddy ASN, 2007, ANNU REV PLANT BIOL, V58, P267, DOI 10.1146/annurev.arplant.58.032806.103754; Roignant JY, 2010, CELL, V143, P238, DOI 10.1016/j.cell.2010.09.036; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sheth U, 2006, CELL, V125, P1095, DOI 10.1016/j.cell.2006.04.037; Shi H, 2003, GENE DEV, V17, P971, DOI 10.1101/gad.260403; Singh KK, 2013, RNA BIOL, V10, P1291, DOI 10.4161/rna.25827; Tange TO, 2004, CURR OPIN CELL BIOL, V16, P279, DOI 10.1016/j.ceb.2004.03.012; Zhang XN, 2009, PLANT PHYSIOL, V150, P1450, DOI 10.1104/pp.109.138180	46	22	25	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148200	10.1371/journal.pone.0148200	http://dx.doi.org/10.1371/journal.pone.0148200			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867216	Green Published, Green Submitted, gold			2022-12-27	WOS:000370050700010
J	Stubblefield, WB; Alves, NJ; Rondina, MT; Kline, JA				Stubblefield, William B.; Alves, Nathan J.; Rondina, Matthew T.; Kline, Jeffrey A.			Variable Resistance to Plasminogen Activator Initiated Fibrinolysis for Intermediate-Risk Pulmonary Embolism	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; VENOUS THROMBOSIS; THROMBOLYTIC THERAPY; CLOT PERMEABILITY; RANDOMIZED-TRIAL; HYPOFIBRINOLYSIS; METAANALYSIS; LYSIS; MULTICENTER; EFFICACY	Background We examine the clinical significance and biomarkers of tissue plasminogen activator (tPA)-catalyzed clot lysis time (CLT) in patients with intermediate-risk pulmonary embolism (PE). Methods Platelet-poor, citrated plasma was obtained from patients with PE. Healthy age-and sex-matched patients served as disease-negative controls. Fibrinogen, alpha(2)-antiplasmin, plasminogen, thrombin activatable fibrinolysis inhibitor (TAFI), plasminogen activator Inhibitor 1 (PAI-1), thrombin time and D-dimer were quantified. Clotting was induced using CaCl2, tissue factor, and phospholipid. Lysis was induced using 60 ng/mL tPA. Time to 50% clot lysis (CLT) was assessed by both thromboelastography (TEG) and turbidimetry (A405). Results Compared with disease-negative controls, patients with PE exhibited significantly longer mean CLT on TEG (+2,580 seconds, 95% CI 1,380 to 3,720 sec). Patients with PE and a short CLT who were treated with tenecteplase had increased risk of bleeding, whereas those with long CLT had significantly worse exercise tolerance and psychometric testing for quality of life at 3 months. A multivariate stepwise removal regression model selected PAI-1 and TAFI as predictive biomarkers of CLT. Conclusion The CLT from TEG predicted increased risk of bleeding and clinical failure with tenecteplase treatment for intermediate-risk PE. Plasmatic PAI-1 and TAFI were independent predictors of CLT.	[Stubblefield, William B.] Louisiana State Univ, Hlth Sci Ctr, New Orleans, LA USA; [Alves, Nathan J.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Rondina, Matthew T.] Univ Utah, Sch Med, Salt Lake City, UT USA; [Kline, Jeffrey A.] Indiana Univ Sch Med, Dept Emergency Med, Indianapolis, IN 46202 USA; [Kline, Jeffrey A.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Indiana University System; Indiana University Bloomington; Utah System of Higher Education; University of Utah; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Kline, JA (corresponding author), Indiana Univ Sch Med, Dept Emergency Med, Indianapolis, IN 46202 USA.; Kline, JA (corresponding author), Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA.	jefkline@iu.edu	Alves, Nathan J/E-8033-2012; Alves, Nathan/AIA-0217-2022	Alves, Nathan J/0000-0003-3816-5137; Alves, Nathan/0000-0003-3816-5137; Stubblefield, William-May/0000-0003-3817-1414	NHLBI [HL112311]; Lilly physician scientist initiative; Genentech; Indiana Clinical and Translational Sciences Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL112311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG048022] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Lilly physician scientist initiative; Genentech(Roche HoldingGenentech); Indiana Clinical and Translational Sciences Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded in part by: Indiana Clinical and Translational Sciences Institute and the NHLBI (HL112311 to MTR); The Lilly physician scientist initiative to JAK; and tissue plasminogen activator was in-kind gift of Genentech. The original clinical trial was investigator-initiated, funded by Genentech. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi MC, 2008, THROMB HAEMOSTASIS, V99, P995, DOI 10.1160/TH07-11-0682; Bombardier C, 2012, THROMB RES, V130, P343, DOI 10.1016/j.thromres.2012.03.030; Brookes K, 2010, BRIT J CANCER, V102, P1524, DOI 10.1038/sj.bjc.6605661; Chatterjee S, 2014, JAMA-J AM MED ASSOC, V311, P2414, DOI 10.1001/jama.2014.5990; Collet JP, 2003, J BIOL CHEM, V278, P21331, DOI 10.1074/jbc.M212734200; Collet JP, 1999, THROMB HAEMOSTASIS, V82, P1482; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Dekker SE, 2014, ANESTHESIOLOGY, V121, P89, DOI 10.1097/ALN.0000000000000229; Dunn EJ, 2006, DIABETOLOGIA, V49, P1071, DOI 10.1007/s00125-006-0197-4; Ebben HP, 2014, EUR J VASC ENDOVASC, V48, P551, DOI 10.1016/j.ejvs.2014.06.042; Fareed J, 1999, SEMIN THROMB HEMOST, V25, P367, DOI 10.1055/s-2007-994940; Hays R D, 1993, Health Econ, V2, P217, DOI 10.1002/hec.4730020305; Huber K, 2001, J THROMB THROMBOLYS, V11, P195, DOI 10.1023/A:1011952602122; Kahn SR, 2006, J CLIN EPIDEMIOL, V59, P1049, DOI 10.1016/j.jclinepi.2005.10.016; KEYT BA, 1994, P NATL ACAD SCI USA, V91, P3670, DOI 10.1073/pnas.91.9.3670; Kline JA, 2014, J THROMB HAEMOST, V12, P459, DOI 10.1111/jth.12521; Kline JA, 2013, EMERG MED AUSTRALAS, V25, P515, DOI 10.1111/1742-6723.12159; Kucher N, 2014, CIRCULATION, V129, P479, DOI 10.1161/CIRCULATIONAHA.113.005544; Lisman T, 2005, BLOOD, V105, P1102, DOI 10.1182/blood-2004-08-3253; Lisman T, 2001, GASTROENTEROLOGY, V121, P131, DOI 10.1053/gast.2001.25481; Lobo JL, 2009, J THROMB HAEMOST, V7, P1795, DOI 10.1111/j.1538-7836.2009.03576.x; Marti C, 2015, EUR HEART J, V36, P605, DOI 10.1093/eurheartj/ehu218; Meltzer ME, 2010, J THROMB HAEMOST, V8, P605, DOI 10.1111/j.1538-7836.2009.03715.x; Meltzer ME, 2008, PLOS MED, V5, P751, DOI 10.1371/journal.pmed.0050097; Meyer G, 2014, NEW ENGL J MED, V370, P1402, DOI 10.1056/NEJMoa1302097; Nakamura S, 2014, J THROMB HAEMOST, V12, P1086, DOI 10.1111/jth.12608; Natorska J, 2013, J THROMB HAEMOST, V11, P733, DOI 10.1111/jth.12122; Nilsson CU, 2013, SCAND J CLIN LAB INV, V73, P457, DOI 10.3109/00365513.2013.801509; Pankiw-Bembenek O, 2012, THROMB HAEMOSTASIS, V107, P513, DOI 10.1160/TH11-09-0662; Reddel CJ, 2013, THROMB RES, V131, P457, DOI 10.1016/j.thromres.2013.03.015; Riera-Mestre A, 2014, THROMB RES, V134, P1265, DOI 10.1016/j.thromres.2014.10.004; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Sharifi M, 2013, AM J CARDIOL, V111, P273, DOI 10.1016/j.amjcard.2012.09.027; Stewart D, 2003, BLOOD, V101, P3002, DOI 10.1182/blood-2002-08-2546; Stewart LK, 2015, J THROMB THROMBOLYS, V40, P161, DOI 10.1007/s11239-014-1155-5; Traby L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051447; TURI ZG, 1993, AM J CARDIOL, V71, P1009, DOI 10.1016/0002-9149(93)90564-S; Undas A, 2006, J THROMB HAEMOST, V4, P1029, DOI 10.1111/j.1538-7836.2006.01882.x; Undas A, 2006, ARTERIOSCL THROM VAS, V26, P1397, DOI 10.1161/01.ATV.0000219688.43572.75; Wang C, 2010, CHEST, V137, P254, DOI 10.1378/chest.09-0765; Weitz JI, 1998, CIRCULATION, V97, P544; WEITZ JI, 1988, J CLIN INVEST, V82, P1700, DOI 10.1172/JCI113783; Zhang Z, 2014, THROMB RES, V133, P357, DOI 10.1016/j.thromres.2013.12.026	43	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148747	10.1371/journal.pone.0148747	http://dx.doi.org/10.1371/journal.pone.0148747			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866684	Green Published, gold, Green Submitted			2022-12-27	WOS:000370050700032
J	Arnold, M; Liesirova, K; Broeg-Morvay, A; Meisterernst, J; Schlager, M; Mono, ML; El-Koussy, M; Kagi, G; Jung, S; Sarikaya, H				Arnold, Marcel; Liesirova, Kai; Broeg-Morvay, Anne; Meisterernst, Julia; Schlager, Markus; Mono, Marie-Luise; El-Koussy, Marwan; Kaegi, Georg; Jung, Simon; Sarikaya, Hakan			Dysphagia in Acute Stroke: Incidence, Burden and Impact on Clinical Outcome	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; OROPHARYNGEAL DYSPHAGIA; RESPIRATORY-INFECTIONS; NOSOCOMIAL INFECTIONS; ASPIRATION PNEUMONIA; SWALLOWING DISORDERS; POSTSTROKE DYSPHAGIA; CIRCULATION STROKES	Background Reported frequency of post-stroke dysphagia in the literature is highly variable. In view of progress in stroke management, we aimed to assess the current burden of dysphagia in acute ischemic stroke. Methods We studied 570 consecutive patients treated in a tertiary stroke center. Dysphagia was evaluated by using the Gugging Swallowing Screen (GUSS). We investigated the relationship of dysphagia with pneumonia, length of hospital stay and discharge destination and compared rates of favourable clinical outcome and mortality at 3 months between dysphagic patients and those without dysphagia. Results Dysphagia was diagnosed in 118 of 570 (20.7%) patients and persisted in 60 (50.9%) at hospital discharge. Thirty-six (30.5%) patients needed nasogastric tube because of severe dysphagia. Stroke severity rather than infarct location was associated with dysphagia. Dysphagic patients suffered more frequently from pneumonia (23.1% vs. 1.1%, p<0.001), stayed longer at monitored stroke unit beds (4.4 +/- 2.8 vs. 2.7 +/- 2.4 days; p<0.001) and were less often discharged to home (19.5% vs. 63.7%, p = 0.001) as compared to those without dysphagia. At 3 months, dysphagic patients less often had a favourable outcome (35.7% vs. 69.7%; p<0.001), less often lived at home (38.8% vs. 76.5%; p<0.001), and more often had died (13.6% vs. 1.6%; p<0.001). Multivariate analyses identified dysphagia to be an independent predictor of discharge destination and institutionalization at 3 months, while severe dysphagia requiring tube placement was strongly associated with mortality. Conclusion Dysphagia still affects a substantial portion of stroke patients and may have a large impact on clinical outcome, mortality and institutionalization.	[Arnold, Marcel; Liesirova, Kai; Broeg-Morvay, Anne; Meisterernst, Julia; Schlager, Markus; Mono, Marie-Luise; Jung, Simon; Sarikaya, Hakan] Univ Hosp Bern, Dept Neurol, CH-3010 Bern, Switzerland; [El-Koussy, Marwan] Univ Hosp Bern, Dept Neuroradiol, CH-3010 Bern, Switzerland; [Kaegi, Georg] Kantonsspital, Dept Neurol & Neurophysiol, St Gallen, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; Kantonsspital Aarau AG (KSA); Kantonsspital St. Gallen	Arnold, M (corresponding author), Univ Hosp Bern, Dept Neurol, CH-3010 Bern, Switzerland.	marcel.arnold@insel.ch			Nestec S.A.	Nestec S.A.	This study was supported by Nestec S.A. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman KW, 2010, ARCH OTOLARYNGOL, V136, P784, DOI 10.1001/archoto.2010.129; BOGOUSSLAVSKY J, 1988, STROKE, V19, P1083, DOI 10.1161/01.STR.19.9.1083; Bonilha HS, 2014, DYSPHAGIA, V29, P545, DOI 10.1007/s00455-014-9543-8; Broadley S, 2003, J CLIN NEUROSCI, V10, P300, DOI 10.1016/S0967-5868(03)00022-5; Brogan E, 2014, DYSPHAGIA, V29, P340, DOI 10.1007/s00455-013-9514-5; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Carandang R, 2006, JAMA-J AM MED ASSOC, V296, P2939, DOI 10.1001/jama.296.24.2939; Crary MA, 2005, ARCH PHYS MED REHAB, V86, P1516, DOI 10.1016/j.apmr.2004.11.049; Daniels SK, 2012, STROKE, V43, P892, DOI 10.1161/STROKEAHA.111.640946; De Marchis GM, 2011, J NEUROL NEUROSUR PS, V82, P33, DOI 10.1136/jnnp.2010.211151; Doggett DL, 2001, DYSPHAGIA, V16, P279, DOI 10.1007/s00455-001-0087-3; Drakulovic MB, 1999, LANCET, V354, P1851, DOI 10.1016/S0140-6736(98)12251-1; Ellis C, 2012, STROKE, V43, P1429, DOI 10.1161/STROKEAHA.111.647339; Falsetti P, 2009, J STROKE CEREBROVASC, V18, P329, DOI 10.1016/j.jstrokecerebrovasdis.2009.01.009; Fang MC, 2014, AM J MED, V127, P608, DOI 10.1016/j.amjmed.2014.03.017; Finlayson O, 2011, NEUROLOGY, V77, P1338, DOI 10.1212/WNL.0b013e31823152b1; Fourrier F, 2000, INTENS CARE MED, V26, P1239, DOI 10.1007/s001340000585; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Goldhill DR, 2007, AM J CRIT CARE, V16, P50; Gonzalez-Fernandez Marlis, 2013, Curr Phys Med Rehabil Rep, V1, P187; Hamdy S, 1997, LANCET, V350, P686, DOI 10.1016/S0140-6736(97)02068-0; Heckert KD, 2009, STROKE, V40, P1381, DOI 10.1161/STROKEAHA.108.533489; KIDD D, 1995, QJM-MON J ASSOC PHYS, V88, P409; Langdon PC, 2009, NEUROEPIDEMIOLOGY, V32, P107, DOI 10.1159/000177036; Langdon PC, 2007, J CLIN NEUROSCI, V14, P630, DOI 10.1016/j.jocn.2006.04.009; Langmore SE, 1998, DYSPHAGIA, V13, P69, DOI 10.1007/PL00009559; Langmore SE, 2002, DYSPHAGIA, V17, P298, DOI 10.1007/s00455-002-0072-5; Lawrence ES, 2001, STROKE, V32, P1279, DOI 10.1161/01.STR.32.6.1279; Lee S, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000269; Li L, 2015, EUR J PHYS REHAB MED, V51, P71; Mann G, 2000, CEREBROVASC DIS, V10, P380, DOI 10.1159/000016094; Mann G, 1999, STROKE, V30, P744, DOI 10.1161/01.STR.30.4.744; Martino R, 2005, STROKE, V36, P2756, DOI 10.1161/01.STR.0000190056.76543.eb; Meng NH, 2000, AM J PHYS MED REHAB, V79, P170, DOI 10.1097/00002060-200003000-00010; Metheny NA, 2002, AM J CRIT CARE, V11, P150, DOI 10.4037/ajcc2002.11.2.150; Milins B, 2003, GERONTOLOGY, V49, P173, DOI 10.1159/000069171; Momosaki R, 2014, NEUROMODULATION, V17, P637, DOI 10.1111/ner.12137; Nilsson H, 1998, DYSPHAGIA, V13, P32, DOI 10.1007/PL00009547; Okubo PCMI, 2012, CEREBROVASC DIS, V33, P501, DOI 10.1159/000336240; Paciaroni M, 2004, EUR NEUROL, V51, P162, DOI 10.1159/000077663; Sarikaya H, 2011, STROKE, V42, P2498, DOI 10.1161/STROKEAHA.110.607614; Sato S, 2008, NEUROLOGY, V70, P2371, DOI 10.1212/01.wnl.0000304346.14354.0b; Smithard DG, 2007, AGE AGEING, V36, P90, DOI 10.1093/ageing/afl149; Smithard DG, 1996, STROKE, V27, P1200, DOI 10.1161/01.STR.27.7.1200; Tatu L, 1998, NEUROLOGY, V50, P1699, DOI 10.1212/WNL.50.6.1699; Trapl M, 2007, STROKE, V38, P2948, DOI 10.1161/STROKEAHA.107.483933; Upadya A, 2004, J CRIT CARE, V19, P16, DOI 10.1016/j.jcrc.2004.02.004; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; VEIS SL, 1985, ARCH PHYS MED REHAB, V66, P372; Walter U, 2007, J NEUROL, V254, P1323, DOI 10.1007/s00415-007-0520-0; Wilson RD, 2012, J STROKE CEREBROVASC, V21, P61, DOI 10.1016/j.jstrokecerebrovasdis.2010.05.002; Yeh SJ, 2011, J NEUROL SCI, V306, P38, DOI 10.1016/j.jns.2011.04.001	52	169	181	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148424	10.1371/journal.pone.0148424	http://dx.doi.org/10.1371/journal.pone.0148424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863627	Green Published, Green Submitted, gold			2022-12-27	WOS:000370046600069
J	Jeffries, MD; Gannon, TW; Brosnan, JT; Ahmed, KA; Breeden, GK				Jeffries, Matthew D.; Gannon, Travis W.; Brosnan, James T.; Ahmed, Khalied A.; Breeden, Gregory K.			Factors Influencing Dislodgeable 2, 4-D Plant Residues from Hybrid Bermudagrass (Cynodon dactylon L. x C. transvaalensis) Athletic Fields	PLOS ONE			English	Article							LEAF WETNESS DURATION; CREEPING BENTGRASS; ANNUAL BLUEGRASS; 2,4-D; ABSORPTION; EXPOSURE; ACID; TRANSLOCATION; CHLORPYRIFOS; METABOLISM	Research to date has confirmed 2,4-D residues may dislodge from turfgrass; however, experiments have not been conducted on hybrid bermudagrass (Cynodon dactylon L. x C. transvaalensis), the most common athletic field turfgrass in subtropical climates. More specifically, previous research has not investigated the effect of post-application irrigation on dislodgeable 2,4-D residues from hybrid bermudagrass and across turfgrass species, research has been nondescript regarding sample time within a d (TWD) or conducted in the afternoon when the turfgrass canopy is dry, possibly underestimating potential for dislodgement. The effect of irrigation and TWD on 2,4-D dislodgeability was investigated. Dislodgeable 2,4-D amine was reduced > 300% following irrigation. From 2 to 7 d after treatment (DAT), <= 0.5% of applied 2,4-D was dislodged from irrigated turfgrass, while <= 2.3% of applied 2,4-D was dislodged when not irrigated. 2,4-D dislodgeability decreased as TWD increased. Dislodgeable 2,4-D residues declined to < 0.1% of the applied at 1 DAT-13: 00, and increased to 1 to 3% of the applied 2 DAT-5: 00, suggesting 2,4-D re-suspended on treated turfgrass vegetation overnight. In conclusion, irrigating treated turfgrass reduced dislodgeable 2,4-D. 2,4-D dislodgeability increased as TWD decreased, which was attributed to non-precipitation climatic conditions favoring turfgrass canopy wetness. This research will improve turfgrass management practices and research designed to minimize human 2,4-D exposure.	[Jeffries, Matthew D.; Gannon, Travis W.; Ahmed, Khalied A.] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA; [Brosnan, James T.; Breeden, Gregory K.] Univ Tennessee, Dept Plant Sci, Knoxville, TN USA	University of North Carolina; North Carolina State University; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Jeffries, MD (corresponding author), N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA.	mdjeffri@ncsu.edu		Gannon, Travis/0000-0001-7140-8896				[Anonymous], 2009, 2007 CENS AGR US SUM; [Anonymous], 2007, 2 4 D CHEM SUMM; [Anonymous], 2001, REV REP ACT SUBST 2; [Anonymous], 2020, ASOPOS 20 ASSESSMENT; BAIER W., 1966, AGR METEOROL, V3, P103, DOI 10.1016/0002-1571(66)90008-2; Bus JS, 2007, CROP PROT, V26, P266, DOI 10.1016/j.cropro.2005.06.010; CARROLL MJ, 1993, WEED TECHNOL, V7, P437, DOI 10.1017/S0890037X00027858; Christians N, 2011, FUNDAMENTALS TURFGRA, P59; Cisar J. L., 2001, International Turfgrass Society Research Journal, V9, P12; COUPLAND D, 1981, WEED SCI, V29, P556, DOI 10.1017/S0043174500063724; DeBoer DW, 2001, APPL ENG AGRIC, V17, P11; Department of Health and Human Service: Centers for Disease Control & Prevention, 2005, NCEH PUB; Garabrant DH, 2002, CRIT REV TOXICOL, V32, P233, DOI 10.1080/20024091064237; Giesler LJ, 1996, AGR FOREST METEOROL, V81, P145, DOI 10.1016/0168-1923(95)02302-X; GOH KS, 1986, B ENVIRON CONTAM TOX, V37, P27, DOI 10.1007/BF01607724; HARRIS SA, 1992, J ENVIRON SCI HEAL B, V27, P9, DOI 10.1080/03601239209372764; HILL RH, 1989, ARCH ENVIRON CON TOX, V18, P469, DOI 10.1007/BF01055011; Hoffmann EJ, 2012, J ECON ENTOMOL, V105, P67, DOI 10.1603/EC11251; Hubal EAC, 2000, ENVIRON HEALTH PERSP, V108, P475, DOI 10.2307/3454607; HUGHES RN, 1994, AGR FOREST METEOROL, V67, P173, DOI 10.1016/0168-1923(94)90002-7; Hurto KA, 2009, PESTICIDES URBAN ENV, P86; Junge A, 2004, AM J SPORT MED, V32, p23S, DOI 10.1177/0363546503261246; Kennepohl E, 2001, HDB PESTICIDE TOXICO, V2, P1623; Kincaid DC, 1996, T ASAE, V39, P839, DOI 10.13031/2013.27568; Kohler EA, 2002, WEED SCI, V50, P576, DOI 10.1614/0043-1745(2002)050[0576:SOUATA]2.0.CO;2; Krolski M.E., 2010, ACS S SERIES, P43; Kruit RJW, 2008, ATMOS ENVIRON, V42, P5304, DOI 10.1016/j.atmosenv.2008.02.061; Lawrence MG, 2005, B AM METEOROL SOC, V86, P225, DOI 10.1175/BAMS-86-2-225; Loughner DL, 2010, APPL TURFGRASS SCI; Lutgens FK, 2007, ATMOSPHERE INTRO MET, P110; Magri A, 2009, J ENVIRON QUAL, V38, P4, DOI 10.2134/jeq2007.0620; McCullough PE, 2009, WEED SCI, V57, P470, DOI 10.1614/WS-09-025.1; Milesi C, 2005, ENVIRON MANAGE, V36, P426, DOI 10.1007/s00267-004-0316-2; Moody RP, 1997, TOXICOL IN VITRO, V11, P251, DOI 10.1016/S0887-2333(97)00013-1; Morgan MK, 2008, J EXPO SCI ENV EPID, V18, P486, DOI 10.1038/sj.jes.7500641; MUNRO IC, 1992, J AM COLL TOXICOL, V11, P559, DOI 10.3109/10915819209141893; Nishioka MG, 2001, ENVIRON HEALTH PERSP, V109, P1185, DOI 10.2307/3454867; Nishioka MG, 2002, B ENVIRON CONTAM TOX, V68, P64, DOI 10.1007/s00128-001-0220-x; Petrovic AM, 1994, HDB INTEGRATED PEST, P30; Puhalla J, 1999, SPORTS FIELDS MANUAL, P119; SEARS MK, 1987, PESTIC SCI, V20, P223, DOI 10.1002/ps.2780200307; Sentelhas PC, 2007, INT J BIOMETEOROL, V51, P265, DOI 10.1007/s00484-006-0070-7; Shaner DL, 2014, HERBICIDE HDB, P16; Shin EH, 2011, BIOMED CHROMATOGR, V25, P124, DOI 10.1002/bmc.1513; Snyder GH, 1998, ASSESSMENT RISKS ASS, P647; Steel RGD, 1997, PRINCIPLES PROCEDURE, V3, P352; Steffen K, 2007, BRIT J SPORT MED, V41, pI33, DOI 10.1136/bjsm.2007.036665; THOMPSON DG, 1984, PESTIC SCI, V15, P353, DOI 10.1002/ps.2780150405; U.S. EPA, 2005, MEM 24 D HES REV HUM; United States Census Bureau, 2012, PART SEL SPORTS ACT; US EPA (US Environmental Protection Agency), 2012, STAND OP PROC RES PE; Weisenberger D, 2012, 2011 ANN REPORT PURD, P22; Wilson TB, 1999, AGR FOREST METEOROL, V93, P111, DOI 10.1016/S0168-1923(98)00116-6; Yu JL, 2013, WEED SCI, V61, P217, DOI 10.1614/WS-D-12-00136.1	54	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148992	10.1371/journal.pone.0148992	http://dx.doi.org/10.1371/journal.pone.0148992			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863005	Green Published, Green Submitted, gold			2022-12-27	WOS:000370046600135
J	Ribeiro, JC; Simoes, J; Silva, F; Silva, ED; Hummel, C; Hummel, T; Paiva, A				Ribeiro, Joao Carlos; Simoes, Joao; Silva, Filipe; Silva, Eduardo D.; Hummel, Cornelia; Hummel, Thomas; Paiva, Antonio			Cultural Adaptation of the Portuguese Version of the "Sniffin' Sticks" Smell Test: Reliability, Validity, and Normative Data	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; OLFACTORY FUNCTION-TEST; OF-PENNSYLVANIA SMELL; ODOR IDENTIFICATION; PARKINSONS-DISEASE; DISCRIMINATION; DYSFUNCTION; THRESHOLDS; UNIVERSITY; POPULATION	The cross-cultural adaptation and validation of the Sniffin` Sticks test for the Portuguese population is described. Over 270 people participated in four experiments. In Experiment 1, 67 participants rated the familiarity of presented odors and seven descriptors of the original test were adapted to a Portuguese context. In Experiment 2, the Portuguese version of Sniffin` Sticks test was administered to 203 healthy participants. Older age, male gender and active smoking status were confirmed as confounding factors. The third experiment showed the validity of the Portuguese version of Sniffin` Sticks test in discriminating healthy controls from patients with olfactory dysfunction. In Experiment 4, the test-retest reliability for both the composite score (r(71) = 0.86) and the identification test (r(71) = 0.62) was established (p< 0.001). Normative data for the Portuguese version of Sniffin` Sticks test is provided, showing good validity and reliability and effectively distinguishing patients from healthy controls with high sensitivity and specificity. The Portuguese version of Sniffin` Sticks test identification test is a clinically suitable screening tool in routine outpatient Portuguese settings.	[Ribeiro, Joao Carlos; Simoes, Joao; Paiva, Antonio] Coimbra Univ Hosp CHUC, Dept Otorhinolaryngol, Coimbra, Portugal; [Ribeiro, Joao Carlos; Simoes, Joao; Silva, Eduardo D.; Paiva, Antonio] Univ Coimbra, Fac Med, Coimbra, Portugal; [Ribeiro, Joao Carlos; Silva, Filipe; Silva, Eduardo D.] Univ Coimbra, Fac Med, IBILI, Ctr Ophthalmol & Vis Sci, Coimbra, Portugal; [Hummel, Cornelia; Hummel, Thomas] Univ Dresden, Sch Med, Dept Otorhinolaryngol, Dresden, Germany	Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra; Universidade de Coimbra; Technische Universitat Dresden	Ribeiro, JC (corresponding author), Coimbra Univ Hosp CHUC, Dept Otorhinolaryngol, Coimbra, Portugal.; Ribeiro, JC (corresponding author), Univ Coimbra, Fac Med, Coimbra, Portugal.; Ribeiro, JC (corresponding author), Univ Coimbra, Fac Med, IBILI, Ctr Ophthalmol & Vis Sci, Coimbra, Portugal.	jcarlosribeiro@uc.pt	Ribeiro, Joao Carlos/AAW-4573-2020; Simões, João/AAK-6207-2020; Simões, João/O-1483-2016	Ribeiro, Joao Carlos/0000-0002-1039-6358; Simões, João/0000-0002-3276-0448; Simões, João/0000-0002-3276-0448	Fundacao para a Ciencia e Tecnologia [71016_2010]; Else Kroner-Fresenius Stiftung [2015_A71];  [E-Rare4/0001/2012E];  [UID/04539/2013]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Else Kroner-Fresenius Stiftung; ; 	This work was supported by E-Rare4/0001/2012E (EDS); Fundacao para a Ciencia e Tecnologia Post Doctoral Grant 71016_2010 (FS); UID/04539/2013 (EDS); Else Kroner-Fresenius Stiftung (http://www.ekfs.de/; grant number 2015_A71) (TH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boesveldt S, 2008, RHINOLOGY, V46, P131; CAIN WS, 1988, LARYNGOSCOPE, V98, P83; Catana IV, 2013, CLUJUL MEDICAL, V86, pS56; DEEMS DA, 1991, ARCH OTOLARYNGOL, V117, P519; Doty RL, 2012, NAT REV NEUROL, V8, P329, DOI 10.1038/nrneurol.2012.80; DOTY RL, 1984, LARYNGOSCOPE, V94, P176, DOI 10.1288/00005537-198402000-00004; Doty RL, 1995, CHEM SENSES, V20, P645, DOI 10.1093/chemse/20.6.645; Doty RL, 1996, LARYNGOSCOPE, V106, P353, DOI 10.1097/00005537-199603000-00021; DOTY RL, 1989, PERCEPT PSYCHOPHYS, V45, P381, DOI 10.3758/BF03210709; Eibenstein A, 2005, Acta Otorhinolaryngol Ital, V25, P18; Fjaeldstad A, 2015, CLIN OTOLARYNGOLOGY; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Haehner A, 2009, CHEM SENSES, V34, P705, DOI 10.1093/chemse/bjp057; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Hummel T, 2013, OTOLARYNGOLOGIA POLS, V68, P308; Kobal G, 2000, EUR ARCH OTO-RHINO-L, V257, P205, DOI 10.1007/s004050050223; Konstantinidis I, 2008, RHINOLOGY, V46, P292; Landis BN, 2004, LARYNGOSCOPE, V114, P1764, DOI 10.1097/00005537-200410000-00017; Lotsch J, 2008, CHEM SENSES, V33, P17, DOI 10.1093/chemse/bjm058; Lotsch J, 2004, CHEM SENSES, V29, P311, DOI 10.1093/chemse/bjh034; Mackay-Sim A, 2004, J CLIN NEUROSCI, V11, P874, DOI 10.1016/j.jocn.2003.12.001; Neumann C, 2012, CLIN OTOLARYNGOL, V37, P23, DOI 10.1111/j.1749-4486.2012.02431.x; Oniz A, 2013, J NEUROL SCI-TURK, V30, P270; Running CA, 2015, ATTEN PERCEPT PSYCHO, V77, P692, DOI 10.3758/s13414-014-0798-9; Shu CH, 2007, AM J RHINOL, V21, P570, DOI 10.2500/ajr.2007.21.3075; Silveira-Moriyama L, 2009, MOVEMENT DISORD, V24, P1229, DOI 10.1002/mds.22545; Silveira-Moriyama L, 2008, MOVEMENT DISORD, V23, P2328, DOI 10.1002/mds.22241; Sorokowska A, 2015, ATTEN PERCEPT PSYCHO, V77, P731, DOI 10.3758/s13414-014-0811-3; Vennemann MM, 2008, J NEUROL, V255, P1121, DOI 10.1007/s00415-008-0807-9; Wild D, 2005, VALUE HEALTH, V8, P94, DOI 10.1111/j.1524-4733.2005.04054.x; Yuan BC, 2010, J CHIN MED ASSOC, V73, P483, DOI 10.1016/S1726-4901(10)70103-9	32	26	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148937	10.1371/journal.pone.0148937	http://dx.doi.org/10.1371/journal.pone.0148937			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863023	Green Published, Green Submitted, gold			2022-12-27	WOS:000370046600126
J	Saar-Ashkenazy, R; Veksler, R; Guez, J; Jacob, Y; Shelef, I; Shalev, H; Friedman, A; Cohen, JE				Saar-Ashkenazy, Rotem; Veksler, Ronel; Guez, Jonathan; Jacob, Yael; Shelef, Ilan; Shalev, Hadar; Friedman, Alon; Cohen, Jonathan E.			Breakdown of Inter-Hemispheric Connectivity Is Associated with Posttraumatic Symptomatology and Memory Impairment	PLOS ONE			English	Article							ANISOTROPIC WATER DIFFUSION; ADMINISTERED PTSD SCALE; WHITE-MATTER INTEGRITY; HUMAN CORPUS-CALLOSUM; STRESS-DISORDER; ANTERIOR CINGULATE; NERVOUS-SYSTEM; BRAIN; SURVIVORS; TRAUMA	Altered brain anatomy in specific gray-matter regions has been shown in patients with post-traumatic stress disorder (PTSD). Recently, white-matter tracts have become a focus of research in PTSD. The corpus callosum (CC) is the principal white-matter fiber bundle, crucial in relaying sensory, motor and cognitive information between hemispheres. Alterations in CC fibers have been reported in PTSD and might be assumed to underlie substantial behavioral and cognitive sequelae; however most diffusion tensor imaging (DTI) studies in adult-onset PTSD failed to address the clinical correlates between imaging and PTSD symptoms severity, behavioral manifestation and cognitive functions. In the current study we examined (a) to what extent microstructural integrity of the CC is associated with memory performance and (b) whether imaging and cognitive parameters are associated with PTSD symptom severity. DTI data were obtained and fractional anisotropy (FA) values were computed for 16 patients and 14 controls. PTSD symptom severity was assessed by employing the clinician administered PTSD scale (CAPS) and memory was tested using a task probing item and associative memory for words and pictures. Significant correlations were found between PTSD symptoms severity, memory accuracy and reaction-time to CC FA values in the PTSD group. This study demonstrates meaningful clinical and cognitive correlates of microstructural connectivity. These results have implications for diagnostic tools and future studies aimed at identifying individuals at risk for PTSD.	[Saar-Ashkenazy, Rotem; Friedman, Alon] Ben Gurion Univ Negev, Dept Brain & Cognit Neurosci, Zlotowski Ctr Neurosci Ben Gurion, IL-84105 Beer Sheva, Israel; [Saar-Ashkenazy, Rotem] Ashkelon Acad Coll, Dept Psychol, Ashqelon, Israel; [Saar-Ashkenazy, Rotem] Ashkelon Acad Coll, Sch Social Work, Ashqelon, Israel; [Veksler, Ronel; Friedman, Alon] Ben Gurion Univ Negev, Dept Physiol & Cell Biol, IL-84105 Beer Sheva, Israel; [Guez, Jonathan] Achva Acad Coll, Dept Psychol, Beer Tuvia Reg Council, Tel Aviv, Israel; [Guez, Jonathan] Beer Sheva Mental Hlth Ctr, Beer Sheva, Israel; [Jacob, Yael] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Jacob, Yael] Tel Aviv Univ, Funct Brain Imaging Unit, Wohl Inst Adv Imaging, IL-69978 Tel Aviv, Israel; [Shelef, Ilan] Soroka Univ, Med Ctr, Dept Radiol, Beer Sheva, Israel; [Shalev, Hadar] Soroka Univ, Med Ctr, Dept Psychiat, Beer Sheva, Israel; [Friedman, Alon] Dalhousie Univ, Dept Med Neurosci, Fac Med, Halifax, NS, Canada; [Cohen, Jonathan E.] Hadassah Hebrew Univ, Med Ctr, Sharett Inst Oncol, Jerusalem, Israel	Ben Gurion University; Ben Gurion University; Tel Aviv University; Tel Aviv University; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center; Dalhousie University; Hebrew University of Jerusalem; Hadassah University Medical Center	Cohen, JE (corresponding author), Hadassah Hebrew Univ, Med Ctr, Sharett Inst Oncol, Jerusalem, Israel.	cohenjon@hadassah.org.il	Guez, Jonathan/M-1620-2019	Guez, Jonathan/0000-0002-4964-7206; Cohen, Jonathan/0000-0001-8120-3827; shelef, ilan/0000-0002-8398-6455	Deutsche Forschungsgemeinschaft (DFG) [KI 537/29-2]; Israeli Ministry of Health [87365411]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Israeli Ministry of Health	This work was supported by Deutsche Forschungsgemeinschaft (DFG): KI 537/29-2, Israeli Ministry of Health: 87365411.	Abe O, 2006, PSYCHIAT RES-NEUROIM, V146, P231, DOI 10.1016/j.pscychresns.2006.01.004; ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; American Psychiatric Association, 2013, DIAGNOSTIC AND STATI; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bester M, 2013, J NEUROL SCI, V330, P61, DOI 10.1016/j.jns.2013.04.005; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Borgaro SR, 2003, BRAIN INJURY, V17, P545, DOI 10.1080/0269905031000070206; Bremner JD, 1995, PSYCHIAT RES, V59, P97; Bustamante V, 2001, J TRAUMA STRESS, V14, P791, DOI 10.1023/A:1013050423901; Daniels JK, 2013, DEPRESS ANXIETY, V30, P207, DOI 10.1002/da.22044; De Bellis MD, 2002, BIOL PSYCHIAT, V52, P1066, DOI 10.1016/S0006-3223(02)01459-2; Eluvathingal TJ, 2006, PEDIATRICS, V117, P2093, DOI 10.1542/peds.2005-1727; Frederiksen KS, 2013, DAN MED J, V60; Gazzaniga MS, 2000, BRAIN, V123, P1293, DOI 10.1093/brain/123.7.1293; Gilbertson MW, 2006, J ABNORM PSYCHOL, V115, P484, DOI 10.1037/0021-843X.115.3.484; Golier JA, 2002, AM J PSYCHIAT, V159, P1682, DOI 10.1176/appi.ajp.159.10.1682; Guez J, 2013, PSYCHIAT RES, V209, P479, DOI 10.1016/j.psychres.2012.12.013; Guez J, 2011, J TRAUMA STRESS, V24, P260, DOI 10.1002/jts.20635; Horner MD, 2002, NEUROPSYCHOL REV, V12, P15, DOI 10.1023/A:1015439106231; Jackowski AP, 2008, PSYCHIAT RES-NEUROIM, V162, P256, DOI 10.1016/j.pscychresns.2007.08.006; Jenkins MA, 1998, AM J PSYCHIAT, V155, P278; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Keedwell PA, 2012, BIOL PSYCHIAT, V72, P296, DOI 10.1016/j.biopsych.2012.01.022; Kennis M, 2015, NEUROPSYCHOPHARMACOL, V40, P2434, DOI 10.1038/npp.2015.94; Kim MJ, 2005, NEUROREPORT, V16, P1049, DOI 10.1097/00001756-200507130-00004; Kim SJ, 2006, NEUROPSYCHOBIOLOGY, V54, P120, DOI 10.1159/000098262; Kitayama N, 2007, J NERV MENT DIS, V195, P1027, DOI 10.1097/NMD.0b013e31815c044f; Kleim B, 2008, J CONSULT CLIN PSYCH, V76, P231, DOI 10.1037/0022-006X.76.2.231; Kochunov P, 2010, NEUROIMAGE, V53, P1109, DOI 10.1016/j.neuroimage.2010.01.078; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lu SJ, 2013, AUST NZ J PSYCHIAT, V47, P1183, DOI 10.1177/0004867413508454; McNally RJ, 1998, CLIN PSYCHOL REV, V18, P971, DOI 10.1016/S0272-7358(98)00036-1; Mehta MA, 2009, J CHILD PSYCHOL PSYC, V50, P943, DOI 10.1111/j.1469-7610.2009.02084.x; MOSELEY ME, 1990, RADIOLOGY, V176, P439, DOI 10.1148/radiology.176.2.2367658; Navas-Sanchez FJ, 2013, HUMAN BRAIN MAPPING, V3, P22355; NELSON DL, 1976, J EXP PSYCHOL-HUM L, V2, P523, DOI 10.1037/0278-7393.2.5.523; Papadaki EZ, 2014, EUR J NEUROL, V21, P499, DOI 10.1111/ene.12338; Parslow RA, 2007, AM J PSYCHIAT, V164, P509, DOI 10.1176/appi.ajp.164.3.509; Pfefferbaum A, 2003, J MAGN RESON IMAGING, V18, P427, DOI 10.1002/jmri.10377; Rubinstein O, 2005, NORMS FOR WORDS IN H; Saar-Ashkenazy R, 2015, PSYCHIAT RES-NEUROIM, V233, P165, DOI 10.1016/j.pscychresns.2015.05.015; Saar-Ashkenazy R, 2014, J TRAUMA STRESS, V27, P18, DOI 10.1002/jts.21887; Schuff N, 2011, NEUROIMAGE, V54, pS62, DOI 10.1016/j.neuroimage.2010.05.024; Spielberger CD, 1983, MANUAL FOR THE STATE; Tavanti M, 2012, NEUROL SCI, V33, P59, DOI 10.1007/s10072-011-0659-4; Thomaes K, 2010, J CLIN PSYCHIAT, V71, P1636, DOI 10.4088/JCP.08m04754blu; Treit S, 2013, NEUROSCIENCE, V16, P019; Van Boven RW, 2009, J REHABIL RES DEV, V46, P717, DOI 10.1682/JRRD.2008.12.0161; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; Villarreal G, 2004, PSYCHIAT RES-NEUROIM, V131, P227, DOI 10.1016/j.pscychresns.2004.05.002; Villarreal G, 2002, BIOL PSYCHIAT, V52, P119, DOI 10.1016/S0006-3223(02)01359-8; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; Zhang L, 2011, J AFFECT DISORDERS, V133, P294, DOI 10.1016/j.jad.2011.03.040	56	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0144766	10.1371/journal.pone.0144766	http://dx.doi.org/10.1371/journal.pone.0144766			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863536	gold, Green Submitted, Green Published			2022-12-27	WOS:000370046600005
J	Guo, HK; Wang, GJ; Huang, LY; Hu, YX; Yuan, C; Li, R; Zhao, XH				Guo, Hengkai; Wang, Guijin; Huang, Lingyun; Hu, Yuxin; Yuan, Chun; Li, Rui; Zhao, Xihai			A Robust and Accurate Two-Step Auto-Labeling Conditional Iterative Closest Points (TACICP) Algorithm for Three-Dimensional Multi-Modal Carotid Image Registration	PLOS ONE			English	Article							NONRIGID REGISTRATION; ACTIVE CONTOURS; ULTRASOUND; SEGMENTATION; ARTERIES; PLAQUE; MRI; QUANTIFICATION; MODEL	Atherosclerosis is among the leading causes of death and disability. Combining information from multi-modal vascular images is an effective and efficient way to diagnose and monitor atherosclerosis, in which image registration is a key technique. In this paper a feature-based registration algorithm, Two-step Auto-labeling Conditional Iterative Closed Points (TACICP) algorithm, is proposed to align three-dimensional carotid image datasets from ultrasound (US) and magnetic resonance (MR). Based on 2D segmented contours, a coarse-to-fine strategy is employed with two steps: rigid initialization step and non-rigid refinement step. Conditional Iterative Closest Points (CICP) algorithm is given in rigid initialization step to obtain the robust rigid transformation and label configurations. Then the labels and CICP algorithm with non-rigid thin-plate-spline (TPS) transformation model is introduced to solve non-rigid carotid deformation between different body positions. The results demonstrate that proposed TACICP algorithm has achieved an average registration error of less than 0.2mm with no failure case, which is superior to the state-of-the-art feature-based methods.	[Guo, Hengkai; Wang, Guijin] Tsinghua Univ, Dept Elect Engn, Res Inst Image & Informat, Beijing 100084, Peoples R China; [Hu, Yuxin; Yuan, Chun; Li, Rui; Zhao, Xihai] Tsinghua Univ, Ctr Biomed Imaging Res, Dept Biomed Engn, Beijing 100084, Peoples R China; [Yuan, Chun] Univ Washington, Dept Radiol, 850 Republican St, Seattle, WA 98195 USA; [Huang, Lingyun] Philips Res China, Healthcare Dept, Shanghai, Peoples R China	Tsinghua University; Tsinghua University; University of Washington; University of Washington Seattle; Philips; Philips Research	Li, R (corresponding author), Tsinghua Univ, Ctr Biomed Imaging Res, Dept Biomed Engn, Beijing 100084, Peoples R China.	leerui@tsinghua.edu.cn	Zhao, Xihai/AAD-7181-2020					Balu N, 2011, P INT SOC MAG RESON, P113; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Bourke P., 1988, CALCULATING AREA CEN; Carvalho DDB, 2014, MED PHYS, V41, DOI 10.1118/1.4870383; Carvalho DDB, 2012, INT J COMPUT ASS RAD, V7, P207, DOI 10.1007/s11548-011-0633-x; Chan RC, 2006, PROC SPIE, V6144, DOI 10.1117/12.651786; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Chiu B, 2008, MED PHYS, V35, P3691, DOI 10.1118/1.2955550; Chiu B, 2012, J ULTRAS MED, V31, P1567; Chui HL, 2003, COMPUT VIS IMAGE UND, V89, P114, DOI 10.1016/S1077-3142(03)00009-2; Feldmar J, 1996, INT J COMPUT VISION, V18, P99, DOI 10.1007/BF00054998; Gupta A, 2012, BIOMED SIGNAL PROCES, V7, P560, DOI 10.1016/j.bspc.2012.05.003; He B, 2011, IEICE T INF SYST, VE94D, P2541, DOI 10.1587/transinf.E94.D.2541; Hill DLG, 2001, PHYS MED BIOL, V46, pR1, DOI 10.1088/0031-9155/46/3/201; IMPARATO AM, 1979, STROKE, V10, P238, DOI 10.1161/01.STR.10.3.238; Jian B, 2011, IEEE T PATTERN ANAL, V33, P1633, DOI 10.1109/TPAMI.2010.223; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Nanayakkara ND, 2008, IEEE T MED IMAGING, V27, P1378, DOI 10.1109/TMI.2008.918326; Nanayakkara ND, 2009, MED PHYS, V36, P373, DOI 10.1118/1.3056458; Nazem F, 2014, INT J COMPUT ASS RAD, V9, P39, DOI 10.1007/s11548-013-0907-6; Pan X, 2014, SPIE MED IMAGING; Pohl KA, 2006, NEUROIMAGE, V31, P228, DOI 10.1016/j.neuroimage.2005.11.044; Rusinkiewicz S, 2001, THIRD INTERNATIONAL CONFERENCE ON 3-D DIGITAL IMAGING AND MODELING, PROCEEDINGS, P145, DOI 10.1109/IM.2001.924423; Saam T, 2005, ARTERIOSCL THROM VAS, V25, P234, DOI 10.1161/01.ATV.0000149867.61851.31; Slomka PJ, 2001, ULTRASOUND MED BIOL, V27, P945, DOI 10.1016/S0301-5629(01)00387-8; Tang H., 2011, SPIE MED IMAGING; Tang H, 2012, MED IMAGE ANAL, V16, P1202, DOI 10.1016/j.media.2012.05.014; Wahba G., 1990, SPLINE MODELS OBSERV, V59; Wang JN, 2013, MAGN RESON MED, V69, P337, DOI 10.1002/mrm.24254; Yezzi A, 2003, MED IMAGE ANAL, V7, P171, DOI 10.1016/S1361-8415(03)00004-5; Yuan C, 2006, NMR BIOMED, V19, P636, DOI 10.1002/nbm.1065	31	2	2	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148783	10.1371/journal.pone.0148783	http://dx.doi.org/10.1371/journal.pone.0148783			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881433	gold, Green Published			2022-12-27	WOS:000371219000025
J	Jacobi, JL; Yang, B; Li, X; Menze, AK; Laurentz, SM; Janle, EM; Ferruzzi, MG; McCabe, GP; Chapple, C; Kirchmaier, AL				Jacobi, Jennifer L.; Yang, Bo; Li, Xu; Menze, Anna K.; Laurentz, Sara M.; Janle, Elsa M.; Ferruzzi, Mario G.; McCabe, George P.; Chapple, Clint; Kirchmaier, Ann L.			Impacts on Sirtuin Function and Bioavailability of the Dietary Bioactive Compound Dihydrocoumarin	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; HISTONE H3; SILENT CHROMATIN; CELL-CYCLE; LIFE-SPAN; TELOMERIC HETEROCHROMATIN; ADP-RIBOSYLTRANSFERASE; CANCER CHEMOPREVENTION; DEPENDENT DEACETYLASE; MULTIDRUG-RESISTANCE	The plant secondary metabolite and common food additive dihydrocoumarin (DHC) is an inhibitor of the Sirtuin family of NAD(+)-dependent deacetylases. Sirtuins are key regulators of epigenetic processes that maintain silent chromatin in yeast and have been linked to gene expression, metabolism, apoptosis, tumorogenesis and age-related processes in multiple organisms, including humans. Here we report that exposure to the polyphenol DHC led to defects in several Sirtuin-regulated processes in budding yeast including the establishment and maintenance of Sir2p-dependent silencing by causing disassembly of silent chromatin, Hst1p-dependent repression of meiotic-specific genes during the mitotic cell cycle. As both transient and prolonged exposure to environmental and dietary factors have the potential to lead to heritable alterations in epigenetic states and to modulate additional Sirtuin-dependent phenotypes, we examined the bioavailability and digestive stability of DHC using an in vivo rat model and in vitro digestive simulator. Our analyses revealed that DHC was unstable during digestion and could be converted to melilotic acid (MA), which also caused epigenetic defects, albeit less efficiently. Upon ingestion, DHC was observed primarily in intestinal tissues, but did not accumulate over time and was readily cleared from the animals. MA displayed a wider tissue distribution and, in contrast to DHC, was also detected in the blood plasma, interstitial fluid, and urine, implying that the conversion of DHC to the less bioactive compound, MA, occurred efficiently in vivo.	[Jacobi, Jennifer L.; Yang, Bo; Li, Xu; Chapple, Clint; Kirchmaier, Ann L.] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Jacobi, Jennifer L.; Yang, Bo; Kirchmaier, Ann L.] Purdue Univ, Purdue Ctr Canc Res, W Lafayette, IN 47907 USA; [Menze, Anna K.; Janle, Elsa M.] Purdue Univ, Dept Foods & Nutr, W Lafayette, IN 47907 USA; [Ferruzzi, Mario G.] Purdue Univ, Dept Food Sci, Smith Hall, W Lafayette, IN 47907 USA; [Laurentz, Sara M.; McCabe, George P.] Purdue Univ, Dept Stat, W Lafayette, IN 47907 USA; [Yang, Bo] Gene Foci Biotech Beijing Ltd Co, Room 608,Bldg 7,19 TianRong Rd, Beijing 100089, Peoples R China; [Li, Xu] N Carolina State Univ, Dept Plant & Microbial Biol, Raleigh, NC 27695 USA; [Li, Xu] N Carolina State Univ, Plants Human Hlth Inst, Kannapolis, NC USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Kirchmaier, AL (corresponding author), Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA.; Kirchmaier, AL (corresponding author), Purdue Univ, Purdue Ctr Canc Res, W Lafayette, IN 47907 USA.	kirchmaier@purdue.edu	Chapple, Clint CS/Q-5456-2017	Chapple, Clint CS/0000-0002-5195-562X; Kirchmaier, Ann/0000-0001-9938-9105; Ferruzzi, Mario/0000-0003-1384-2672; Li, Xu/0000-0002-4640-2529	Purdue-UAB NIH Botanicals Research Center grant NIH-NCCAM Grant [P50-AT00477]; Purdue Department of Biochemistry; NCI [CCSG CA23168]; NATIONAL CANCER INSTITUTE [P30CA023168] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001108] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [P50AT000477] Funding Source: NIH RePORTER	Purdue-UAB NIH Botanicals Research Center grant NIH-NCCAM Grant; Purdue Department of Biochemistry; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported by the Purdue-UAB NIH Botanicals Research Center grant NIH-NCCAM Grant P50-AT00477 (https://nccih.nih.gov) and the Purdue Department of Biochemistry (https://ag.purdue.edu/biochem/). This research was also supported by NCI CCSG CA23168 (http://www.cancer.gov) for data acquired in the Purdue University Center for Cancer Research DNA Sequencing Facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams A, 1997, METHODS YEAST GENETI; Adams TB, 1998, FOOD CHEM TOXICOL, V36, P249, DOI 10.1016/S0278-6915(97)00163-4; Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Ahuja N, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705488200; Bachmeier BE, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-129; BALZI E, 1994, J BIOL CHEM, V269, P2206; Barber MF, 2012, NATURE, V487, P114, DOI 10.1038/nature11043; Bedalov A, 2001, P NATL ACAD SCI USA, V98, P15113, DOI 10.1073/pnas.261574398; Benet LZ, 2009, MOL PHARMACEUT, V6, P1631, DOI 10.1021/mp900253n; Biasutto L, 2009, CELL PHYSIOL BIOCHEM, V24, P557, DOI 10.1159/000257512; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Borel P, 2013, NUTR REV, V71, P319, DOI 10.1111/nure.12026; Born SL, 2000, TOXICOL SCI, V58, P23, DOI 10.1093/toxsci/58.1.23; Born SL, 2003, FOOD CHEM TOXICOL, V41, P247, DOI 10.1016/S0278-6915(02)00227-2; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; COHEN AJ, 1979, FOOD COSMET TOXICOL, V17, P277, DOI 10.1016/0015-6264(79)90289-X; Costa LG, 2003, J TOXICOL-CLIN TOXIC, V41, P37, DOI 10.1081/CLT-120018269; Crampton A, 2008, MOL CELL, V30, P156, DOI 10.1016/j.molcel.2008.02.019; Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; de Kok TM, 2008, EUR J NUTR, V47, P51, DOI 10.1007/s00394-008-2006-y; Del Rio D, 2010, BRIT J NUTR, V104, pS67, DOI 10.1017/S0007114510003958; Draganov DI, 2004, N-S ARCH PHARMACOL, V369, P78, DOI 10.1007/s00210-003-0833-1; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; EHLERS D, 1995, Z LEBENSM UNTERS FOR, V201, P278, DOI 10.1007/BF01193004; Failla ML, 2014, FOOD FUNCT, V5, P1101, DOI 10.1039/c3fo60599j; Fazly A, 2012, J BIOL CHEM; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Ferruzzi MG, 2012, ADV NUTR, V3, P813, DOI 10.3945/an.112.003202; Ferruzzi MG, 2006, J AGR FOOD CHEM, V54, P2780, DOI 10.1021/jf0530603; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Ford E, 2006, GENE DEV, V20, P1075, DOI 10.1101/gad.1399706; Furuya T, 1958, CHEM PHARM BULL, V6, P701; FURUYA T, 1958, CHEM PHARM BULL, V6, P706; Gallo CA, 2004, MOL CELL BIOL, V24, P1301, DOI 10.1128/MCB.24.3.1301-1312.2004; Gao L, 2008, MOL CELL BIOL, V28, P3979, DOI 10.1128/MCB.00019-08; Garrett DA, 1999, J AGR FOOD CHEM, V47, P4301, DOI 10.1021/jf9903298; Gerhauser C, 2013, TOP CURR CHEM, V329, P73, DOI 10.1007/128_2012_360; Gil R, 2013, NUCLEIC ACIDS RES, V41, P8537, DOI 10.1093/nar/gkt642; Grob A, 2009, J CELL SCI, V122, P489, DOI 10.1242/jcs.042382; Guo Y, 2013, MOL NUTR FOOD RES, V57, P896, DOI 10.1002/mnfr.201200619; HAGAN E. C., 1967, FOOD COSMET TOXICOL, V5, P141, DOI 10.1016/S0015-6264(67)82961-4; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; HASSETT C, 1991, BIOCHEMISTRY-US, V30, P10141, DOI 10.1021/bi00106a010; Hirao M, 2003, J BIOL CHEM, V278, P52773, DOI 10.1074/jbc.M308966200; Hoppe GJ, 2002, MOL CELL BIOL, V22, P4167, DOI 10.1128/MCB.22.12.4167-4180.2002; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hyland EA, 2005, MOL CELL BIOL, V25, P10060, DOI 10.1128/MCB.25.22.10060-10070.2005; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jenner P. M., 1964, FOOD COSMET, V2, P327, DOI DOI 10.1016/S0015-6264(64)80192-9; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; Kaidi A, 2010, SCIENCE, V329, P1348, DOI 10.1126/science.1192049; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kemperman RA, 2010, MICROBIOL-SGM, V156, P3224, DOI 10.1099/mic.0.042127-0; Kim CY, 2011, J AGR FOOD CHEM, V59, P1012, DOI 10.1021/jf103873k; Kirchmaier AL, 2006, MOL CELL BIOL, V26, P852, DOI 10.1128/MCB.26.3.852-862.2006; Kirchmaier AL, 2001, SCIENCE, V291, P646, DOI 10.1126/science.291.5504.646; KOSUGE T, 1962, J BIOL CHEM, V237, P1653; Kugel S, 2014, TRENDS BIOCHEM SCI, V39, P72, DOI 10.1016/j.tibs.2013.12.002; Kutner M., 2004, APPL LINEAR STAT MOD; Lake BG, 2002, FOOD CHEM TOXICOL, V40, P809, DOI 10.1016/S0278-6915(02)00036-4; Leko V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066283; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Link A, 2010, BIOCHEM PHARMACOL, V80, P1771, DOI 10.1016/j.bcp.2010.06.036; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Luo KH, 2002, GENE DEV, V16, P1528, DOI 10.1101/gad.988802; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; MACKNESS MI, 1989, CLIN BIOCHEM, V22, P475, DOI 10.1016/S0009-9120(89)80101-8; MACKNESS MI, 1989, BIOCHEM PHARMACOL, V38, P385, DOI 10.1016/0006-2952(89)90376-6; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; McCord RA, 2009, AGING-US, V1, P109, DOI 10.18632/aging.100011; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Michishita E, 2009, CELL CYCLE, V8, P2664, DOI 10.4161/cc.8.16.9367; Miller A, 2008, GENETICS, V179, P793, DOI 10.1534/genetics.107.084525; Misaka S, 2013, CURR OPIN PHARMACOL, V13, P847, DOI 10.1016/j.coph.2013.08.010; Mochizuki H, 1998, GENE, V213, P149, DOI 10.1016/S0378-1119(98)00193-0; Mogarekar MR, 2013, INDIAN J GASTROENTER, V32, P307, DOI 10.1007/s12664-013-0334-1; Monagas M, 2010, FOOD FUNCT, V1, P233, DOI 10.1039/c0fo00132e; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; National Toxicology Program, 1993, NTP TOX CARC STUD 3; Neilson AP, 2009, J AGR FOOD CHEM, V57, P9418, DOI 10.1021/jf902919k; Ng CJ, 2001, J BIOL CHEM, V276, P44444, DOI 10.1074/jbc.M105660200; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; North BJ, 2007, J BIOL CHEM, V282, P19546, DOI 10.1074/jbc.M702990200; Olaharski AJ, 2005, PLOS GENET, V1, P689, DOI 10.1371/journal.pgen.0010077; Paredes S, 2014, CLIN CANCER RES, V20, P1741, DOI 10.1158/1078-0432.CCR-13-1547; Perrod S, 2001, EMBO J, V20, P197, DOI 10.1093/emboj/20.1.197; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Posakony J, 2004, J MED CHEM, V47, P2635, DOI 10.1021/jm030473r; Prasad R, 2012, ANNU REV MICROBIOL, V66, P39, DOI 10.1146/annurev-micro-092611-150111; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; Rastogi SC, 1996, CONTACT DERMATITIS, V34, P423, DOI 10.1111/j.1600-0536.1996.tb02246.x; Reddy ST, 2001, ARTERIOSCL THROM VAS, V21, P542, DOI 10.1161/01.ATV.21.4.542; Rickett FL, 1974, DEER TONGUE SOME OTH, P1; RINE J, 1987, GENETICS, V116, P9; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Rusche LN, 2002, MOL BIOL CELL, V13, P2207, DOI 10.1091/mbc.E02-03-0175; SCHELINE RR, 1968, ACTA PHARMACOL TOX, V26, P325; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Shin JY, 2013, CELL REP, V5, P654, DOI 10.1016/j.celrep.2013.10.007; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Su D, 2012, NATURE, V483, P104, DOI 10.1038/nature10861; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Tham WH, 2002, ONCOGENE, V21, P512, DOI 10.1038/sj.onc.1205078; Tsai YC, 2014, MOL CELL PROTEOMICS, V13, P73, DOI 10.1074/mcp.M113.031377; U. S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER), 2005, GUID IND E14 CLIN EV, P1; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; Van Leeuwen F, 2002, METHOD ENZYMOL, V350, P165, DOI 10.1016/S0076-6879(02)50962-9; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang DJ, 2013, FOOD CHEM, V138, P1564, DOI 10.1016/j.foodchem.2012.09.103; Wang Y, 2012, PHARMACOL THERAPEUT, V136, P305, DOI 10.1016/j.pharmthera.2012.08.009; Watanabe S, 2013, SCIENCE, V340, P195, DOI 10.1126/science.1229758; Weber JM, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-100; Wilkins BJ, 2014, SCIENCE, V343, P77, DOI 10.1126/science.1244508; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Xie JX, 1999, EMBO J, V18, P6448, DOI 10.1093/emboj/18.22.6448; Xu F, 2007, MOL CELL, V27, P890, DOI 10.1016/j.molcel.2007.07.021; Yang B, 2008, MOL BIOL CELL, V19, P4993, DOI 10.1091/mbc.E08-05-0524; Yang B, 2006, MOL BIOL CELL, V17, P5287, DOI 10.1091/mbc.E06-08-0669; Yang B, 2009, CELL CYCLE, V8, P2662, DOI 10.4161/cc.8.16.9329; Young TJ, 2012, BBA-GENE REGUL MECH, V1819, P303, DOI 10.1016/j.bbagrm.2011.10.006	133	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149207	10.1371/journal.pone.0149207	http://dx.doi.org/10.1371/journal.pone.0149207			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882112	gold, Green Published			2022-12-27	WOS:000371219000060
J	Zhao, HY; Speir, JA; Matsui, T; Lin, ZH; Liang, LF; Lynn, AY; Varnado, B; Weiss, TM; Tang, L				Zhao, Haiyan; Speir, Jeffrey A.; Matsui, Tsutomu; Lin, Zihan; Liang, Lingfei; Lynn, Anna Y.; Varnado, Brittany; Weiss, Thomas M.; Tang, Liang			Structure of a Bacterial Virus DNA-Injection Protein Complex Reveals a Decameric Assembly with a Constricted Molecular Channel	PLOS ONE			English	Article							NEAR-ATOMIC-RESOLUTION; SCATTERING DATA-ANALYSIS; CRYO-EM STRUCTURE; BACTERIOPHAGE T7; 3-DIMENSIONAL STRUCTURE; TAILED BACTERIOPHAGES; ELECTRON-MICROSCOPY; DATA-ACQUISITION; OUTER-MEMBRANE; PORTAL PROTEIN	The multi-layered cell envelope structure of Gram-negative bacteria represents significant physical and chemical barriers for short-tailed phages to inject phage DNA into the host cytoplasm. Here we show that a DNA-injection protein of bacteriophage Sf6, gp12, forms a 465-kDa, decameric assembly in vitro. The electron microscopic structure of the gp12 assembly shows a similar to 150-angstrom, mushroom-like architecture consisting of a crown domain and a tube-like domain, which embraces a 25-angstrom-wide channel that could precisely accommodate dsDNA. The constricted channel suggests that gp12 mediates rapid, uni-directional injection of phage DNA into host cells by providing a molecular conduit for DNA translocation. The assembly exhibits a 10-fold symmetry, which may be a common feature among DNA-injection proteins of P22-like phages and may suggest a symmetry mismatch with respect to the 6-fold symmetric phage tail. The gp12 monomer is highly flexible in solution, supporting a mechanism for translocation of the protein through the conduit of the phage tail toward the host cell envelope, where it assembles into a DNA-injection device.	[Zhao, Haiyan; Lin, Zihan; Liang, Lingfei; Lynn, Anna Y.; Varnado, Brittany; Tang, Liang] Univ Kansas, Dept Mol Biosci, 1200 Sunnyside Ave, Lawrence, KS 66045 USA; [Speir, Jeffrey A.] Scripps Res Inst, Natl Resource Automated Mol Microscopy, La Jolla, CA 92037 USA; [Matsui, Tsutomu; Weiss, Thomas M.] Stanford Univ, SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, 14 2575 Sand Hill Rd,MS69, Menlo Pk, CA USA	University of Kansas; Scripps Research Institute; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Tang, L (corresponding author), Univ Kansas, Dept Mol Biosci, 1200 Sunnyside Ave, Lawrence, KS 66045 USA.	tangl@ku.edu		Matsui, Tsutomu/0000-0001-7101-5259	National Institute of General Medical Sciences of the National Institutes of Health [R01GM090010]; National Institute of General Medical Sciences [P41GM103310]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, R01GM090010, P41GM103310] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the grant R01GM090010 from the National Institute of General Medical Sciences of the National Institutes of Health (http://www.nigms.nih.gov) to L.T.; We thank Drs. Bridget Carragher and Clint Potter for access to the facilities at the National Resource for Automated Molecular Microscopy (NRAMM) for High-throughput electron microscopy data collection. NRAMM is supported by a grant from the National Institute of General Medical Sciences (P41GM103310). The SAXS data were collected at the beamline BL4-2 at the Stanford Synchrotron Radiation Lightsource. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences (including P41GM103393). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS or NIH. This work was supported by the grant R01GM090010 from the National Institute of General Medical Sciences of the National Institutes of Health to L.T.	Agirrezabala X, 2005, EMBO J, V24, P3820, DOI 10.1038/sj.emboj.7600840; Bhardwaj A, 2011, J BIOL CHEM, V286, P30867, DOI 10.1074/jbc.M111.260877; Bhardwaj A, 2009, J MOL BIOL, V391, P227, DOI 10.1016/j.jmb.2009.05.069; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Campbell MG, 2014, J STRUCT BIOL, V188, P183, DOI 10.1016/j.jsb.2014.09.008; Casjens S, 2004, J MOL BIOL, V339, P379, DOI 10.1016/j.jmb.2004.03.068; Casjens SR, 2012, ADV EXP MED BIOL, V726, P143, DOI 10.1007/978-1-4614-0980-9_7; Casjens SR, 2011, NAT REV MICROBIOL, V9, P647, DOI 10.1038/nrmicro2632; Chang CY, 2010, VIROLOGY, V398, P176, DOI 10.1016/j.virol.2009.12.002; Chang J, 2006, STRUCTURE, V14, P1073, DOI 10.1016/j.str.2006.05.007; Chang JT, 2010, J MOL BIOL, V402, P731, DOI 10.1016/j.jmb.2010.07.058; Fokine Andrei, 2014, Bacteriophage, V4, pe28281; Gelbart WM, 2009, SCIENCE, V323, P1682, DOI 10.1126/science.1170645; Guo F, 2013, P NATL ACAD SCI USA, V110, P6811, DOI 10.1073/pnas.1215563110; HENDRIX RW, 1978, P NATL ACAD SCI USA, V75, P4779, DOI 10.1073/pnas.75.10.4779; Hu B, 2013, SCIENCE, V339, P576, DOI 10.1126/science.1231887; Hugel T, 2007, PLOS BIOL, V5, P558, DOI 10.1371/journal.pbio.0050059; ISRAEL V, 1977, J VIROL, V23, P91, DOI 10.1128/JVI.23.1.91-97.1977; Johnson JE, 2007, CURR OPIN STRUC BIOL, V17, P237, DOI 10.1016/j.sbi.2007.03.011; Kanamaru S, 2002, NATURE, V415, P553, DOI 10.1038/415553a; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kostyuchenko VA, 2005, NAT STRUCT MOL BIOL, V12, P810, DOI 10.1038/nsmb975; Lander GC, 2006, SCIENCE, V312, P1791, DOI 10.1126/science.1127981; Lander GC, 2013, NUCLEIC ACIDS RES, V41, P4518, DOI 10.1093/nar/gkt137; Lander GC, 2009, STRUCTURE, V17, P789, DOI 10.1016/j.str.2009.04.006; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Leavitt JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070936; Lebedev AA, 2007, EMBO J, V26, P1984, DOI 10.1038/sj.emboj.7601643; Leiman PG, 2004, CELL, V118, P419, DOI 10.1016/j.cell.2004.07.022; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liu SX, 2014, CELL, V157, P702, DOI 10.1016/j.cell.2014.02.034; Martel A, 2012, J SYNCHROTRON RADIAT, V19, P431, DOI 10.1107/S0909049512008072; Matsui T, 2014, J MOL BIOL, V426, P3773, DOI 10.1016/j.jmb.2014.09.009; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Molineux IJ, 2013, NAT REV MICROBIOL, V11, P194, DOI 10.1038/nrmicro2988; Molineux IJ, 2001, MOL MICROBIOL, V40, P1, DOI 10.1046/j.1365-2958.2001.02357.x; Olia AS, 2007, NAT STRUCT MOL BIOL, V14, P1221, DOI 10.1038/nsmb1317; Olia AS, 2011, NAT STRUCT MOL BIOL, V18, P597, DOI 10.1038/nsmb.2023; Parent KN, 2012, VIROLOGY, V427, P177, DOI 10.1016/j.virol.2012.01.040; Perez GL, 2009, J BACTERIOL, V191, P135, DOI 10.1128/JB.00778-08; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Qiu XY, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028102; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Serwer Philip, 2008, BMC Res Notes, V1, P36, DOI 10.1186/1756-0500-1-36; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Sousa D, 2007, J STRUCT BIOL, V157, P201, DOI 10.1016/j.jsb.2006.08.003; Sun L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8548; Sun L, 2014, NATURE, V505, P432, DOI 10.1038/nature12816; Sun S, 2008, CELL, V135, P1251, DOI 10.1016/j.cell.2008.11.015; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tang JH, 2011, STRUCTURE, V19, P496, DOI 10.1016/j.str.2011.02.010; Tang L, 2005, EMBO J, V24, P2087, DOI 10.1038/sj.emboj.7600695; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Woolfson DN, 2012, CURR OPIN STRUC BIOL, V22, P432, DOI 10.1016/j.sbi.2012.03.002; Zhao HY, 2013, P NATL ACAD SCI USA, V110, P8075, DOI 10.1073/pnas.1301133110; Zhao H, 2011, VIROLOGY, V409, P319, DOI 10.1016/j.virol.2010.10.030	58	19	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149337	10.1371/journal.pone.0149337	http://dx.doi.org/10.1371/journal.pone.0149337			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882199	Green Published, gold, Green Submitted			2022-12-27	WOS:000371219000072
J	Bachstetter, AD; Zhou, ZQ; Rowe, RK; Xing, B; Goulding, DS; Conley, AN; Sompol, P; Meier, S; Abisambra, JF; Lifshitz, J; Watterson, DM; Van Eldik, LJ				Bachstetter, Adam D.; Zhou, Zhengqiu; Rowe, Rachel K.; Xing, Bin; Goulding, Danielle S.; Conley, Alyssa N.; Sompol, Pradoldej; Meier, Shelby; Abisambra, Jose F.; Lifshitz, Jonathan; Watterson, D. Martin; Van Eldik, Linda J.			MW151 Inhibited IL-1 beta Levels after Traumatic Brain Injury with No Effect on Microglia Physiological Responses	PLOS ONE			English	Article							ATTENUATES SYNAPTIC DYSFUNCTION; CYTOKINE UP-REGULATION; PROINFLAMMATORY CYTOKINE; ALZHEIMERS-DISEASE; MOUSE MODEL; GLIAL ACTIVATION; P38-ALPHA MAPK; INFLAMMATION; NEUROINFLAMMATION; PROGRESSION	A prevailing neuroinflammation hypothesis is that increased production of proinflammatory cytokines contributes to progressive neuropathology, secondary to the primary damage caused by a traumatic brain injury (TBI). In support of the hypothesis, post-injury interventions that inhibit the proinflammatory cytokine surge can attenuate the progressive pathology. However, other post-injury neuroinflammatory responses are key to endogenous recovery responses. Therefore, it is critical that pharmacological attenuation of detrimental or dysregulated neuroinflammatory processes avoid pan-suppression of inflammation. MW151 is a CNS-penetrant, small molecule experimental therapeutic that restores injuryor disease-induced overproduction of proinflammatory cytokines towards homeostasis without immunosuppression. Post-injury administration of MW151 in a closed head injury model of mild TBI suppressed acute cytokine up-regulation and downstream cognitive impairment. Here, we report results from a diffuse brain injury model in mice using midline fluid percussion. Low dose (0.5-5.0 mg/kg) administration of MW151 suppresses interleukin-1 beta (IL-1 beta) levels in the cortex while sparing reactive microglia and astrocyte responses. To probe molecular mechanisms, we used live cell imaging of the BV-2 microglia cell line to demonstrate that MW151 does not affect proliferation, migration, or phagocytosis of the cells. Our results provide insight into the roles of glial responses to brain injury and indicate the feasibility of using appropriate dosing for selective therapeutic modulation of injurious IL-1 beta increases while sparing other glial responses to injury.	[Bachstetter, Adam D.; Zhou, Zhengqiu; Xing, Bin; Goulding, Danielle S.; Conley, Alyssa N.; Sompol, Pradoldej; Meier, Shelby; Abisambra, Jose F.; Van Eldik, Linda J.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Bachstetter, Adam D.; Rowe, Rachel K.; Lifshitz, Jonathan; Van Eldik, Linda J.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr SCoBIRC, Lexington, KY USA; [Bachstetter, Adam D.; Rowe, Rachel K.; Lifshitz, Jonathan; Van Eldik, Linda J.] Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA; [Abisambra, Jose F.] Univ Kentucky, Dept Physiol, Lexington, KY USA; [Watterson, D. Martin] Northwestern Univ, Dept Pharmacol, Chicago, IL 60611 USA; [Rowe, Rachel K.; Lifshitz, Jonathan] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Rowe, Rachel K.; Lifshitz, Jonathan] Univ Arizona, Coll Med Phoenix, Dept Child Hlth, Phoenix, AZ USA; [Rowe, Rachel K.; Lifshitz, Jonathan] Phoenix Veteran Affairs Healthcare Syst, Phoenix, AZ USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; Northwestern University; Barrow Neurological Institute; Phoenix Children's Hospital; University of Arizona	Van Eldik, LJ (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA.; Van Eldik, LJ (corresponding author), Univ Kentucky, Spinal Cord & Brain Injury Res Ctr SCoBIRC, Lexington, KY USA.; Van Eldik, LJ (corresponding author), Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA.	linda.vaneldik@uky.edu	Abisambra, Joe/AAP-3269-2020; Abisambra, Jose/V-6860-2019	Abisambra, Jose/0000-0001-6341-679X; Bachstetter, Adam/0000-0003-4646-6757; Watterson, Daniel/0000-0001-7605-5866; Rowe, Rachel/0000-0002-9034-3159; Meier, Shelby/0000-0003-1946-9004	NIH/NIA [K99 AG044445, U01 AG050636]; Kentucky Spinal Cord and Head Injury Research Trust [12-20A]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K99AG044445, U01AG050636, U01AG043415] Funding Source: NIH RePORTER	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Kentucky Spinal Cord and Head Injury Research Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by NIH/NIA (K99 AG044445 to ADB, and U01 AG050636 to LVE and DMW), and the Kentucky Spinal Cord and Head Injury Research Trust (12-20A to LVE).	Bachstetter AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0289-5; Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; Bachstetter AD, 2012, J NEUROSCI, V32, P10201, DOI 10.1523/JNEUROSCI.1496-12.2012; Bachstetter AD, 2011, NEUROBIOL AGING, V32, P2030, DOI 10.1016/j.neurobiolaging.2009.11.022; Bachstetter AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-79; Beschorner R, 2002, ACTA NEUROPATHOL, V103, P541, DOI 10.1007/s00401-001-0503-7; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; Chrzaszcz M, 2010, J NEUROTRAUM, V27, P1283, DOI 10.1089/neu.2009.1227; Craft JM, 2006, GLIA, V53, P484, DOI 10.1002/glia.20306; Craft JM, 2004, NEUROBIOL AGING, V25, P1283, DOI 10.1016/j.neurobiolaging.2004.01.006; Craft JM, 2004, J MOL NEUROSCI, V24, P115, DOI 10.1385/JMN:24:1:115; Eakin K, 2015, FRONTIERS NEUROENGIN; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; Greer JE, 2013, ACTA NEUROPATHOL, V126, P59, DOI 10.1007/s00401-013-1119-4; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Hu WH, 2007, BIOORG MED CHEM LETT, V17, P414, DOI 10.1016/j.bmcl.2006.10.028; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; James ML, 2012, ANESTHESIOLOGY, V116, P1299, DOI 10.1097/ALN.0b013e318253a02a; Jenrow KA, 2013, RADIAT RES, V179, P549, DOI 10.1667/RR3026.1; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Karpus WJ, 2008, J NEUROIMMUNOL, V203, P73, DOI 10.1016/j.jneuroim.2008.06.039; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Macauley SL, 2014, J NEUROSCI, V34, P13077, DOI 10.1523/JNEUROSCI.2518-14.2014; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Ranaivo HR, 2006, J NEUROSCI, V26, P662, DOI 10.1523/JNEUROSCI.4652-05.2006; Rowe RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082507; Roy SM, 2015, ACS CHEM NEUROSCI, V6, P666, DOI 10.1021/acschemneuro.5b00002; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Shineman DW, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt90; Somera-Molina KC, 2007, EPILEPSIA, V48, P1785, DOI 10.1111/j.1528-1167.2007.01135.x; Somera-Molina KC, 2009, BRAIN RES, V1282, P162, DOI 10.1016/j.brainres.2009.05.073; Villarino AV, 2015, J IMMUNOL, V194, P21, DOI 10.4049/jimmunol.1401867; Watterson DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066226; Webster SJ, 2015, J NEUROSCI, V35, P6554, DOI 10.1523/JNEUROSCI.0291-15.2015; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818	39	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149451	10.1371/journal.pone.0149451	http://dx.doi.org/10.1371/journal.pone.0149451			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871438	gold, Green Published, Green Submitted			2022-12-27	WOS:000370054100159
J	Cebey-Lopez, M; Pardo-Seco, J; Gomez-Carballa, A; Martinon-Torres, N; Martinon-Sanchez, JM; Justicia-Grande, A; Rivero-Calle, I; Pinnock, E; Salas, A; Fink, C; Martinon-Torres, F				Cebey-Lopez, Miriam; Pardo-Seco, Jacobo; Gomez-Carballa, Alberto; Martinon-Torres, Nazareth; Maria Martinon-Sanchez, Jose; Justicia-Grande, Antonio; Rivero-Calle, Irene; Pinnock, Elli; Salas, Antonio; Fink, Colin; Martinon-Torres, Federico		GENDRES Network	Bacteremia in Children Hospitalized with Respiratory Syncytial Virus Infection	PLOS ONE			English	Article							BACTERIAL-INFECTION; FEBRILE INFANTS; INFLUENZA-VIRUS; ANTIBIOTIC USE; RISK	Background The risk of bacteremia is considered low in children with acute bronchiolitis. However the rate of occult bacteremia in infants with RSV infection is not well established. The aim was to determine the actual rate and predictive factors of bacteremia in children admitted to hospital due to confirmed RSV acute respiratory illness (ARI), using both conventional culture and molecular techniques. Methods A prospective multicenter study (GENDRES-network) was conducted between 2011-2013 in children under the age of two admitted to hospital because of an ARI. Among those RSV-positive, bacterial presence in blood was assessed using PCR for Meningococcus, Streptococcus pneumoniae, Haemophilus influenzae, Streptococcus pyogenes, Klebsiella pneumoniae, Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus, in addition to conventional cultures. Results 66 children with positive RSV respiratory illness were included. In 10.6% patients, bacterial presence was detected: H. influenzae (n = 4) and S. pneumoniae (n = 2). In those patients with bacteremia, there was a previous suspicion of bacterial superinfection and had received empirical antibiotic treatment 6 out of 7 (85.7%) patients. There were significant differences in terms of severity between children with positive bacterial PCR and those with negative results: PICU admission (100% vs. 50%, P-value = 0.015); respiratory support necessity (100% vs. 18.6%, P-value < 0.001); Wood-Downes score (mean = 8.7 vs. 4.8 points, P-value < 0.001); GENVIP scale (mean = 17 vs. 10.1, P-value < 0.001); and length of hospitalization (mean = 12.1 vs. 7.5 days, P-value = 0.007). Conclusion Bacteremia is not frequent in infants hospitalized with RSV respiratory infection, however, it should be considered in the most severe cases.	[Cebey-Lopez, Miriam; Pardo-Seco, Jacobo; Gomez-Carballa, Alberto; Martinon-Torres, Nazareth; Maria Martinon-Sanchez, Jose; Justicia-Grande, Antonio; Rivero-Calle, Irene; Salas, Antonio; Martinon-Torres, Federico] Hosp Clin Univ, Grp Invest Genet Vacunas Infecc & Pediat GENVIP W, Galicia, Spain; [Cebey-Lopez, Miriam; Pardo-Seco, Jacobo; Gomez-Carballa, Alberto; Martinon-Torres, Nazareth; Maria Martinon-Sanchez, Jose; Justicia-Grande, Antonio; Rivero-Calle, Irene; Salas, Antonio; Martinon-Torres, Federico] Univ Santiago de Compostela, Galicia, Spain; [Cebey-Lopez, Miriam; Pardo-Seco, Jacobo; Gomez-Carballa, Alberto; Martinon-Torres, Nazareth; Maria Martinon-Sanchez, Jose; Justicia-Grande, Antonio; Rivero-Calle, Irene; Martinon-Torres, Federico] Hosp Clin Univ Santiago, Dept Pediat, Translat Pediat & Infect Dis Sect, Santiago De Compostela, Galicia, Spain; [Pardo-Seco, Jacobo; Gomez-Carballa, Alberto; Salas, Antonio] Univ Santiago de Compostela, Fac Med, Unidade Xenet, Dept Anat Patolox & Ciencias Forenses, Galicia, Spain; [Pardo-Seco, Jacobo; Gomez-Carballa, Alberto; Salas, Antonio] Univ Santiago de Compostela, Fac Med, Inst Ciencias Forenses, GMX, Galicia, Spain; [Pinnock, Elli; Fink, Colin] Univ Warwick, Micropathol Ltd, Coventry CV4 7AL, W Midlands, England	Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; University of Warwick	Martinon-Torres, F (corresponding author), Hosp Clin Univ, Grp Invest Genet Vacunas Infecc & Pediat GENVIP W, Galicia, Spain.; Martinon-Torres, F (corresponding author), Univ Santiago de Compostela, Galicia, Spain.; Martinon-Torres, F (corresponding author), Hosp Clin Univ Santiago, Dept Pediat, Translat Pediat & Infect Dis Sect, Santiago De Compostela, Galicia, Spain.	federico.martinon.torres@sergas.es	rivero, irene/ABC-9006-2020; Salas, Antonio/U-2029-2019; Gómez-Carballa, Alberto/I-4610-2014; Pardo-Seco, Jacobo J/G-3752-2016; Salas, Antonio/E-3977-2012; Cebey, Miriam/K-9347-2014; Martinon-Torres, Federico/E-4982-2016	Salas, Antonio/0000-0002-2336-702X; Gómez-Carballa, Alberto/0000-0003-0927-1272; Pardo-Seco, Jacobo J/0000-0002-8059-8908; Salas, Antonio/0000-0002-2336-702X; Cebey, Miriam/0000-0003-0599-7519; Martinon-Torres, Federico/0000-0002-9023-581X; Rivero Calle, Irene/0000-0002-3678-9264; Justicia Grande, Antonio/0000-0002-0410-3328	Spanish Government [PI10/00540 y PI13/02382]; Regional Galician funds (Promotion of Research Project) [10 PXIB 918 184 PR]; Ministerio de Ciencia e Innovacion [SAF2011-26983]; Plan Galego IDT, Xunta de Galicia [EM 2012/045]; Instituto de Investigacion Sanitaria de Santiago de Compostela; Instituto Carlos III (Intensificacion de la actividad investigadora); European Union [279185]	Spanish Government(Spanish GovernmentEuropean Commission); Regional Galician funds (Promotion of Research Project); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Plan Galego IDT, Xunta de Galicia; Instituto de Investigacion Sanitaria de Santiago de Compostela; Instituto Carlos III (Intensificacion de la actividad investigadora)(Instituto de Salud Carlos III); European Union(European Commission)	This work was supported by the Spanish Government (Research Program Health Research Fund (FIS; PI10/00540 y PI13/02382) National Plan I + D + I and FEDER funds) and Regional Galician funds (Promotion of Research Project 10 PXIB 918 184 PR) (FMT), and Ministerio de Ciencia e Innovacion (SAF2011-26983) and the Plan Galego IDT, Xunta de Galicia (EM 2012/045) (AS). MC's research activities had been supported by grants from Instituto de Investigacion Sanitaria de Santiago de Compostela. FMT's research activities have been supported by grants from Instituto Carlos III (Intensificacion de la actividad investigadora). Investigators received funding from the European Union's Seventh Framework Program under ECGA no. 279185 (EUCLIDS) during the production of this paper.	Behrendt CE, 1998, EUR J PEDIATR, V157, P215, DOI 10.1007/s004310050798; Bloomfield P, 2004, ARCH DIS CHILD, V89, P363, DOI 10.1136/adc.2003.035105; Cebey-Lopez M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136526; Farley R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005189.pub4; Fitzgerald DA, 2004, MED J AUSTRALIA, V180, P399, DOI 10.5694/j.1326-5377.2004.tb05993.x; Greenes DS, 1999, PEDIATR INFECT DIS J, V18, P258, DOI 10.1097/00006454-199903000-00010; Hall C, 2009, TXB PEDIAT INFECT DI, P2462; HALL CB, 1988, J PEDIATR-US, V113, P266; Hishiki H, 2011, J INFECT CHEMOTHER, V17, P87, DOI 10.1007/s10156-010-0097-x; Jansen AGSC, 2008, EPIDEMIOL INFECT, V136, P1448, DOI 10.1017/S0950268807000271; Jartti T, 2013, PAEDIATR RESPIR REV, V14, P38, DOI 10.1016/j.prrv.2012.04.002; Justicia-Grande A, 2015, 33 ANN M EUR SOC PAE; Levine DA, 2004, PEDIATRICS, V113, P1728, DOI 10.1542/peds.113.6.1728; Luginbuhl LM, 2008, PEDIATRICS, V122, P947, DOI 10.1542/peds.2007-3206; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; Melendez E, 2003, PEDIATR INFECT DIS J, V22, P1053, DOI 10.1097/01.inf.0000101296.68993.4d; Randolph AG, 2004, PEDIATR INFECT DIS J, V23, P990, DOI 10.1097/01.inf.0000143647.88873.66; Sacco RE, 2014, VET PATHOL, V51, P427, DOI 10.1177/0300985813501341; Schrenzel J, 2007, INT J ANTIMICROB AG, V30, pS2, DOI 10.1016/j.ijantimicag.2007.06.030; Thibeault R, 2007, J CLIN VIROL, V39, P169, DOI 10.1016/j.jcv.2007.04.013; Thorburn K, 2006, THORAX, V61, P611, DOI 10.1136/thx.2005.048397; Titus MO, 2003, PEDIATRICS, V112, P282, DOI 10.1542/peds.112.2.282; Weinberger DM, 2013, EMERG INFECT DIS, V19, P1084, DOI 10.3201/eid1907.121625	23	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0146599	10.1371/journal.pone.0146599	http://dx.doi.org/10.1371/journal.pone.0146599			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872131	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100002
J	Even, DY; Kedmi, A; Basch-Barzilay, S; Ideses, D; Tikotzki, R; Shir-Shapira, H; Shefi, O; Juven-Gershon, T				Even, Dan Y.; Kedmi, Adi; Basch-Barzilay, Shani; Ideses, Diana; Tikotzki, Ravid; Shir-Shapira, Hila; Shefi, Orit; Juven-Gershon, Tamar			Engineered Promoters for Potent Transient Overexpression	PLOS ONE			English	Article							RNA-POLYMERASE-II; CORE PROMOTER; GENE-EXPRESSION; TATA-BOX; KEY COMPONENT; TFIID BINDS; TRANSCRIPTION; ELEMENT; DOWNSTREAM; DROSOPHILA	The core promoter, which is generally defined as the region to which RNA Polymerase II is recruited to initiate transcription, plays a pivotal role in the regulation of gene expression. The core promoter consists of different combinations of several short DNA sequences, termed core promoter elements or motifs, which confer specific functional properties to each promoter. Earlier studies that examined the ability to modulate gene expression levels via the core promoter, led to the design of strong synthetic core promoters, which combine different core elements into a single core promoter. Here, we designed a new core promoter, termed super core promoter 3 (SCP3), which combines four core promoter elements (the TATA box, Inr, MTE and DPE) into a single promoter that drives prolonged and potent gene expression. We analyzed the effect of core promoter architecture on the temporal dynamics of reporter gene expression by engineering EGFP expression vectors that are driven by distinct core promoters. We used live cell imaging and flow cytometric analyses in different human cell lines to demonstrate that SCPs, particularly the novel SCP3, drive unusually strong long-term EGFP expression. Importantly, this is the first demonstration of long-term expression in transiently transfected mammalian cells, indicating that engineered core promoters can provide a novel non-viral strategy for biotechnological as well as gene-therapy-related applications that require potent expression for extended time periods.	[Even, Dan Y.; Kedmi, Adi; Basch-Barzilay, Shani; Ideses, Diana; Tikotzki, Ravid; Shir-Shapira, Hila; Juven-Gershon, Tamar] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-5290002 Ramat Gan, Israel; [Shefi, Orit] Bar Ilan Univ, Fac Engn, IL-5290002 Ramat Gan, Israel; [Shefi, Orit] Bar Ilan Univ, Bar Ilan Inst Nanotechnol & Adv Mat, IL-5290002 Ramat Gan, Israel	Bar Ilan University; Bar Ilan University; Bar Ilan University	Juven-Gershon, T (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-5290002 Ramat Gan, Israel.	tamar.gershon@biu.ac.il	Juven-Gershon, Tamar/AAC-7799-2022	Juven-Gershon, Tamar/0000-0003-2607-5476	Legacy Heritage Biomedical Program of the Israel Science Foundation [1447/13]	Legacy Heritage Biomedical Program of the Israel Science Foundation	This research was supported in part by the Legacy Heritage Biomedical Program of the Israel Science Foundation (grant No. 1447/13) to OS and TJ-G.	Blazeck J, 2013, BIOTECHNOL J, V8, P46, DOI 10.1002/biot.201200120; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Burke TW, 1996, GENE DEV, V10, P711, DOI 10.1101/gad.10.6.711; Butler JEF, 2001, GENE DEV, V15, P2515, DOI 10.1101/gad.924301; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Cianfrocco MA, 2013, CELL, V152, P120, DOI 10.1016/j.cell.2012.12.005; Danino YM, 2015, BBA-GENE REGUL MECH, V1849, P1116, DOI 10.1016/j.bbagrm.2015.04.003; Deng WS, 2007, CHROMOSOMA, V116, P417, DOI 10.1007/s00412-007-0113-9; Deng WS, 2005, GENE DEV, V19, P2418, DOI 10.1101/gad.342405; Duttke SHC, 2014, J BIOL CHEM, V289, P20396, DOI 10.1074/jbc.M114.563254; EMAMI KH, 1995, MOL CELL BIOL, V15, P5906; Garraway IP, 1996, P NATL ACAD SCI USA, V93, P4336, DOI 10.1073/pnas.93.9.4336; Goldberg ML., 1979, THESIS; Heintzman ND, 2007, CELL MOL LIFE SCI, V64, P386, DOI 10.1007/s00018-006-6295-0; Juven-Gershon T, 2008, GENE DEV, V22, P2823, DOI 10.1101/gad.1698108; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Juven-Gershon T, 2006, NAT METHODS, V3, P917, DOI 10.1038/NMETH937; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Kadonaga JT, 2012, WIRES DEV BIOL, V1, P40, DOI 10.1002/wdev.21; Kutach AK, 2000, MOL CELL BIOL, V20, P4754, DOI 10.1128/MCB.20.13.4754-4764.2000; Lagrange T, 1998, GENE DEV, V12, P34, DOI 10.1101/gad.12.1.34; Lee DH, 2005, MOL CELL BIOL, V25, P9674, DOI 10.1128/MCB.25.21.9674-9686.2005; Lenhard B, 2012, NAT REV GENET, V13, P233, DOI 10.1038/nrg3163; Lewis BA, 2000, P NATL ACAD SCI USA, V97, P7172, DOI 10.1073/pnas.120181197; Lim CY, 2004, GENE DEV, V18, P1606, DOI 10.1101/gad.1193404; Luse DS, 2013, TRANSCRIPTION, V5; Macias MP, 1996, J VIROL, V70, P3628, DOI 10.1128/JVI.70.6.3628-3635.1996; Martinez E, 2012, TRANSCR-AUSTIN, V3, P295, DOI 10.4161/trns.21846; Muller F, 2014, BBA-GENE REGUL MECH, V1839, P118, DOI 10.1016/j.bbagrm.2013.11.003; Ohtsuki S, 1998, GENE DEV, V12, P547, DOI 10.1101/gad.12.4.547; Parry TJ, 2010, GENE DEV, V24, P2013, DOI 10.1101/gad.1951110; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Smale ST, 2001, GENE DEV, V15, P2503, DOI 10.1101/gad.937701; STENBERG RM, 1984, J VIROL, V49, P190, DOI 10.1128/JVI.49.1.190-199.1984; Theisen JWM, 2010, MOL CELL BIOL, V30, P3471, DOI 10.1128/MCB.00053-10; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Yang CH, 2007, GENE, V389, P52, DOI 10.1016/j.gene.2006.09.029; Zehavi Y, 2014, J BIOL CHEM, V289, P11993, DOI 10.1074/jbc.M114.550251	40	15	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148918	10.1371/journal.pone.0148918	http://dx.doi.org/10.1371/journal.pone.0148918			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872062	gold, Green Published, Green Submitted			2022-12-27	WOS:000370054100073
J	Lenguerrand, E; Wylde, V; Gooberman-Hill, R; Sayers, A; Brunton, L; Beswick, AD; Dieppe, P; Blom, AW				Lenguerrand, Erik; Wylde, Vikki; Gooberman-Hill, Rachael; Sayers, Adrian; Brunton, Luke; Beswick, Andrew D.; Dieppe, Paul; Blom, Ashley W.			Trajectories of Pain and Function after Primary Hip and Knee Arthroplasty: The ADAPT Cohort Study	PLOS ONE			English	Article							TOTAL JOINT REPLACEMENT; QUALITY-OF-LIFE; CLINICALLY IMPORTANT DIFFERENCES; OUTCOMES; RECOVERY; OSTEOARTHRITIS; PREDICTORS; RESPONSIVENESS; EXPECTATION; SF-36	Background and Purpose Pain and function improve dramatically in the first three months after hip and knee arthroplasty but the trajectory after three months is less well described. It is also unclear how pre-operative pain and function influence short-and long-term recovery. We explored the trajectory of change in function and pain until and beyond 3-months post-operatively and the influence of pre-operative self-reported symptoms. Methods The study was a prospective cohort study of 164 patients undergoing primary hip (n = 80) or knee (n = 84) arthroplasty in the United Kingdom. Self-reported measures of pain and function using the Western Ontario and McMaster Universities Osteoarthritis index were collected pre-operatively and at 3 and 12 months post-operatively. Hip and knee arthroplasties were analysed separately, and patients were split into two groups: those with high or low symptoms pre-operatively. Multilevel regression models were used for each outcome (pain and function), and the trajectories of change were charted (0-3 months and 3-12 months). Results Hip: Most improvement occurred within the first 3 months following hip surgery and patients with worse pre-operative scores had greater changes. The mean changes observed between 3 and twelve months were statistically insignificant. One year after surgery, patients with worse pre-operative scores had post-operative outcomes similar to those observed among patients with less severe pre-operative symptoms. Knee: Most improvement occurred in the first 3 months following knee surgery with no significant change thereafter. Despite greater mean change during the first three months, patients with worse pre-operative scores had not 'caught-up' with those with less severe pre-operative symptoms 12 months after their surgery. Conclusion Most symptomatic improvement occurred within the first 3 months after surgery with no significant change between 3-12 months. Further investigations are now required to determine if patients with severe symptoms at the time of their knee arthroplasty have a different pre-surgical history than those with less severe symptoms and if they could benefit from earlier surgical intervention and tailored rehabilitation to achieve better post-operative patient-reported outcomes.	[Lenguerrand, Erik; Wylde, Vikki; Gooberman-Hill, Rachael; Sayers, Adrian; Brunton, Luke; Beswick, Andrew D.; Blom, Ashley W.] Univ Bristol, Sch Clin Sci, Musculoskeletal Res Unit, Bristol, Avon, England; [Dieppe, Paul] Univ Exeter, Sch Med, Exeter, Devon, England	University of Bristol; University of Exeter	Lenguerrand, E (corresponding author), Univ Bristol, Sch Clin Sci, Musculoskeletal Res Unit, Bristol, Avon, England.	erik.lenguerrand@bristol.ac.uk	Sayers, Adrian/AAU-8134-2020	Sayers, Adrian/0000-0001-7452-5043; Beswick, Andrew/0000-0002-7032-7514; Blom, Ashley/0000-0002-9940-1095; Gooberman-Hill, Rachael/0000-0003-3353-2882; Wylde, Vikki/0000-0002-8460-1529; Lenguerrand, Erik/0000-0002-0371-731X	National Institute for Health Research (NIHR) under Programme Grants for Applied Research programme [RP-PG-0407-10070]; NIHR, through the Comprehensive Clinical Research Network; National Institute for Health Research [RP-PG-0407-10070] Funding Source: researchfish	National Institute for Health Research (NIHR) under Programme Grants for Applied Research programme(National Institute for Health Research (NIHR)); NIHR, through the Comprehensive Clinical Research Network; National Institute for Health Research(National Institute for Health Research (NIHR))	This article presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research programme (RP-PG-0407-10070). http://www.nihr.ac.uk/. All authors were funded by the above grant to perform the current work: EL VW RGH AS LB ADB PD AWB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research team acknowledges the support of the NIHR, through the Comprehensive Clinical Research Network. The authors would like to acknowledge and thank the participants of the ADAPT study, members of the Project Steering Committee and the following research team members: Cindy Mann, Debbie Delgado, Connie Jamera, Louise Hawkins, Sue Bowman, Leigh Morrison, Dave Rea and Jenny Tyler.	Arirachakaran Alisara, 2015, Eur J Orthop Surg Traumatol, V25, P799, DOI 10.1007/s00590-015-1610-9; Bachmeier CJM, 2001, OSTEOARTHR CARTILAGE, V9, P137, DOI 10.1053/joca.2000.0369; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Beswick AD, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000435; Browne JP, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-128; Culliford DJ, 2012, OSTEOARTHR CARTILAGE, V20, P519, DOI 10.1016/j.joca.2012.02.636; Culliford DJ, 2010, J BONE JOINT SURG BR, V92B, P130, DOI 10.1302/0301-620X.92B1.22654; Davis AM, 2011, OSTEOARTHR CARTILAGE, V19, P1413, DOI 10.1016/j.joca.2011.08.007; Dempsey KE, 2013, RHEUMATOLOGY, V52, P1802, DOI 10.1093/rheumatology/ket180; Dieppe P, 2013, RHEUMATOLOGY, V52, P1737, DOI 10.1093/rheumatology/ket242; Escobar A, 2007, OSTEOARTHR CARTILAGE, V15, P273, DOI 10.1016/j.joca.2006.09.001; Ethgen O, 2004, J BONE JOINT SURG AM, V86A, P963, DOI 10.2106/00004623-200405000-00012; Fitz Gerald JD, 2004, ARTHRIT RHEUM-ARTHR, V51, P100, DOI 10.1002/art.20090; Fortin PR, 1999, ARTHRITIS RHEUM, V42, P1722, DOI 10.1002/1529-0131(199908)42:8<1722::AID-ANR22>3.0.CO;2-R; Fortin PR, 2002, ARTHRITIS RHEUM, V46, P3327, DOI 10.1002/art.10631; Garbuz DS, 2006, CLIN ORTHOP RELAT R, P79, DOI 10.1097/01.blo.0000203477.19421.ed; Garbuz DS, 2006, J ARTHROPLASTY, V21, P998, DOI 10.1016/j.arth.2006.01.014; Hajat Shakoor, 2002, J Health Serv Res Policy, V7, P19, DOI 10.1258/1355819021927638; Halket A, 2010, J ARTHROPLASTY, V25, P254, DOI 10.1016/j.arth.2009.01.007; Hamilton D, 2012, POSTGRAD MED J, V88, P627, DOI 10.1136/postgradmedj-2011-130715; Jenny JY, 2012, ORTHOP TRAUMATOL-SUR, V98, P409, DOI 10.1016/j.otsr.2012.03.004; Johansson Henning R, 2010, J Orthop Surg (Hong Kong), V18, P6; Judge A, 2011, OSTEOARTHR CARTILAGE, V19, P659, DOI 10.1016/j.joca.2011.03.009; Judge A, 2013, BMJ OPEN, V3; Judge A, 2012, RHEUMATOLOGY, V51, P1804, DOI 10.1093/rheumatology/kes075; Judge A, 2010, ARTHRIT CARE RES, V62, P480, DOI 10.1002/acr.20038; Kennedy DM, 2008, PHYS THER, V88, P22, DOI 10.2522/ptj.20070051; Kennedy DM, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-100; Kennedy DM, 2011, J ORTHOP SPORT PHYS, V41, P232, DOI 10.2519/jospt.2011.3516; Kennedy DM, 2006, J ARTHROPLASTY, V21, P559, DOI 10.1016/j.arth.2005.07.010; Larsen K, 2012, KNEE SURG SPORT TR A, V20, P1128, DOI 10.1007/s00167-012-1919-4; Lavernia C, 2009, J ARTHROPLASTY, V24, P1033, DOI 10.1016/j.arth.2008.09.010; Leckie G, 2013, J STAT SOFTW, V52, P1; Liddle AD, 2014, LANCET, V384, P1437, DOI 10.1016/S0140-6736(14)60419-0; Lingard EA, 2004, J BONE JOINT SURG AM, V86A, P2179, DOI 10.2106/00004623-200410000-00008; LITTLE RJA, 1995, J AM STAT ASSOC, V90, P1112, DOI 10.2307/2291350; Lombardi AV, 2009, CLIN ORTHOP RELAT R, V467, P1450, DOI 10.1007/s11999-009-0731-z; Losina E, 2013, ARTHRITIS RHEUM-US, V65, P1157, DOI 10.1002/art.37903; MacWilliam CH, 1996, HEALTH SERV RES, V31, P623; Mahomed NN, 2002, J RHEUMATOL, V29, P1273; Moran M, 2003, ANN ROY COLL SURG, V85, P204, DOI 10.1308/003588403321661415; Naylor JM, 2009, AUST HEALTH REV, V33, P124, DOI 10.1071/AH090124; Nilsdotter AK, 2003, ANN RHEUM DIS, V62, P923, DOI 10.1136/ard.62.10.923; Nilsdotter A, 2011, ARTHRIT CARE RES, V63, pS200, DOI 10.1002/acr.20549; Quintana JM, 2005, OSTEOARTHR CARTILAGE, V13, P1076, DOI 10.1016/j.joca.2005.06.012; Ramisetty N, 2015, J HIP PRESERVATION S, P1; Roder C, 2007, J BONE JOINT SURG AM, V89A, P11, DOI 10.2106/JBJS.E.00012; Rolfson O, 2009, J BONE JOINT SURG BR, V91B, P157, DOI 10.1302/0301-620X.91B2.20765; Roos Ewa M, 2003, Health Qual Life Outcomes, V1, P17, DOI 10.1186/1477-7525-1-17; Singh JA, 2010, OSTEOARTHR CARTILAGE, V18, P515, DOI 10.1016/j.joca.2009.12.001; Steinhoff AK, 2016, KNEE SURG SPORT TR A, V24, P2627, DOI 10.1007/s00167-014-3433-3; Troelsen A, 2012, DAN MED J, V59; Vissers MM, 2012, SEMIN ARTHRITIS RHEU, V41, P576, DOI 10.1016/j.semarthrit.2011.07.003; Wylde V, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-220	54	57	58	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149306	10.1371/journal.pone.0149306	http://dx.doi.org/10.1371/journal.pone.0149306			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871909	Green Submitted, Green Published, gold			2022-12-27	WOS:000370054100144
J	Liew, YJ; Ryu, T; Aranda, M; Ravasi, T				Liew, Yi Jin; Ryu, Taewoo; Aranda, Manuel; Ravasi, Timothy			miRNA Repertoires of Demosponges Stylissa carteri and Xestospongia testudinaria	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; MICRORNAS; PROTEIN; EVOLUTION; INSIGHTS; RNAS; COMPLEXITY; ROLES	MicroRNAs (miRNAs) are small regulatory RNAs that are involved in many biological process in eukaryotes. They play a crucial role in modulating genetic expression of their targets, which makes them integral components of transcriptional regulatory networks. As sponges (phylum Porifera) are commonly considered the most basal metazoan, the indepth capture of miRNAs from these organisms provides additional clues to the evolution of miRNA families in metazoans. Here, we identified the core proteins involved in the biogenesis of miRNAs, and obtained evidence for bona fide miRNA sequences for two marine sponges Stylissa carteri and Xestospongia testudinaria (11 and 19 respectively). Our analysis identified several miRNAs that are conserved amongst demosponges, and revealed that all of the novel miRNAs identified in these two species are specific to the class Demospongiae.	[Liew, Yi Jin; Ryu, Taewoo; Aranda, Manuel; Ravasi, Timothy] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Thuwal 239556900, Saudi Arabia; [Liew, Yi Jin; Aranda, Manuel] King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal 239556900, Saudi Arabia; [Ryu, Taewoo; Ravasi, Timothy] King Abdullah Univ Sci & Technol, KEEP, Thuwal 239556900, Saudi Arabia	King Abdullah University of Science & Technology; King Abdullah University of Science & Technology; King Abdullah University of Science & Technology	Aranda, M; Ravasi, T (corresponding author), King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Thuwal 239556900, Saudi Arabia.; Aranda, M (corresponding author), King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal 239556900, Saudi Arabia.; Ravasi, T (corresponding author), King Abdullah Univ Sci & Technol, KEEP, Thuwal 239556900, Saudi Arabia.	manuel.aranda@kaust.edu.sa; timothy.ravasi@kaust.edu.sa	Ravasi, Timothy/B-8777-2008; Liew, Yi Jin/AAI-6307-2021; Ryu, Taewoo/AAN-2634-2020; Aranda Lastra, Manuel/D-9530-2011	Liew, Yi Jin/0000-0003-2553-8870; Aranda Lastra, Manuel/0000-0001-6673-016X; Ravasi, Timothy/0000-0002-9950-465X	King Abdullah University of Science and Technology (KAUST)	King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology)	This research and all the authors are supported by the King Abdullah University of Science and Technology.; We thank Annika Haywood, Feras Lafi and Holly Bream for extracting the RNA used for sequencing, as well as two anonymous reviewers for their invaluable suggestions. This project was supported by the King Abdullah University of Science and Technology (KAUST).	Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Huang Y, 2009, NATURE, V461, P823, DOI 10.1038/nature08433; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liew YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091101; Lingel A, 2003, NATURE, V426, P465, DOI 10.1038/nature02123; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Maniar JM, 2011, CURR BIOL, V21, P449, DOI 10.1016/j.cub.2011.02.019; Moran Y, 2013, MOL BIOL EVOL, V30, P2541, DOI 10.1093/molbev/mst159; Mulder Nicola, 2007, V396, P59; Nehammer C, 2015, SCI REP-UK, V5, DOI 10.1038/srep08866; Peterson KJ, 2009, BIOESSAYS, V31, P736, DOI 10.1002/bies.200900033; Prochnik SE, 2007, DEV GENES EVOL, V217, P73, DOI 10.1007/s00427-006-0116-1; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Robinson JM, 2013, J EXP ZOOL PART B, V320B, P84, DOI 10.1002/jez.b.22485; Rodriguez AJ, 2005, RNA, V11, P646, DOI 10.1261/rna.7198205; Sempere LF, 2006, J EXP ZOOL PART B, V306B, P575, DOI 10.1002/jez.b.21118; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Song XW, 2012, PLANT J, V71, P378, DOI 10.1111/j.1365-313X.2012.05001.x; Sperling EA, 2010, GEOBIOLOGY, V8, P24, DOI 10.1111/j.1472-4669.2009.00225.x; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vidigal JA, 2015, TRENDS CELL BIOL, V25, P137, DOI 10.1016/j.tcb.2014.11.004; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; Yeom KH, 2006, NUCLEIC ACIDS RES, V34, P4622, DOI 10.1093/nar/gkl458; Zong J, 2009, GENE, V447, P29, DOI 10.1016/j.gene.2009.07.004	41	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149080	10.1371/journal.pone.0149080	http://dx.doi.org/10.1371/journal.pone.0149080			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871907	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100099
J	Steiner, M; Hawranek, T; Schneider, M; Ferreira, F; Horejs-Hoeck, J; Harrer, A; Himly, M				Steiner, Markus; Hawranek, Thomas; Schneider, Michael; Ferreira, Fatima; Horejs-Hoeck, Jutta; Harrer, Andrea; Himly, Martin			Elevated Toll-Like Receptor-Induced CXCL8 Secretion in Human Blood Basophils from Allergic Donors Is Independent of Toll-Like Receptor Expression Levels	PLOS ONE			English	Article							PERIPHERAL-BLOOD; INFLAMMATION; AGGREGATION; ACTIVATION; RESPONSES; TLR4	Human blood basophils have recently gained interest in addition to their function as allergic effector cells. Previous work suggests the involvement of innate immune mechanisms in the development and exacerbation of allergic responses, which might be mediated by basophils. We assayed the expression levels of Toll-like receptor (TLR) 1, 2, 4 and 6 on purified basophils from birch pollen-, house dust mite-, and non-allergic individuals. Additionally, we compared cytokine and chemokine secretion upon TLR stimulation in these basophil donor groups. Expression of TLR4 on the basophils of the allergic donor groups was decreased and CXCL8 secretion was elevated upon stimulation of TLR1/2 and TLR2/6 compared to the non-allergic donors. Decreased TLR expression and elevated CXCL8 secretion may represent possible mechanisms for aggravation of allergic symptoms in case of parasitic infection.	[Steiner, Markus; Ferreira, Fatima; Horejs-Hoeck, Jutta; Harrer, Andrea; Himly, Martin] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Steiner, Markus] Paracelsus Med Univ, Lab Immunol & Mol Canc Res, Salzburg, Austria; [Hawranek, Thomas] Paracelsus Med Univ, Dept Dermatol, Salzburg, Austria; [Schneider, Michael] Buhlmann Labs AG, Schonenbuch, Switzerland; [Harrer, Andrea] Paracelsus Med Univ, Dept Neurol, Salzburg, Austria	Salzburg University; Paracelsus Private Medical University; Paracelsus Private Medical University; Paracelsus Private Medical University	Himly, M (corresponding author), Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria.	martin.himly@sbg.ac.at	Horejs-Hoeck, Jutta/AAF-1735-2019; Ferreira, Fatima/E-4889-2011; Ferreira, Fatima/AAB-4321-2019; Horejs-Hoeck, Jutta/E-5010-2011; Himly, Martin/D-1568-2015	Horejs-Hoeck, Jutta/0000-0002-0984-204X; Ferreira, Fatima/0000-0003-0989-2335; Ferreira, Fatima/0000-0003-0989-2335; Horejs-Hoeck, Jutta/0000-0002-0984-204X; Steiner, Markus/0000-0003-4424-6347; Himly, Martin/0000-0001-5416-085X; Harrer, Andrea/0000-0001-7717-6125	Austrian Science Fund (FWF) [P18820-B13]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grant P18820-B13 of the Austrian Science Fund (FWF). Buehlmann Laboratories AG did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries (Michael Schneider) and/or research materials (stimulation buffer for basophils).; We thank Sven Mostboeck for his advice concerning statistical data analysis. This work was supported by grant P18820-B13 of the Austrian Science Fund (FWF).	Akira S, 2003, CURR OPIN IMMUNOL, V15, P5, DOI 10.1016/S0952-7915(02)00013-4; Baranek T, 2007, J IMMUNOL, V179, P6184, DOI 10.4049/jimmunol.179.9.6184; Bieneman AP, 2005, J ALLERGY CLIN IMMUN, V115, P295, DOI 10.1016/j.jaci.2004.10.018; Boumiza R, 2003, CLIN EXP ALLERGY, V33, P259, DOI 10.1046/j.1365-2222.2003.01594.x; Gibbs BF, 2005, CLIN EXP MED, V5, P43, DOI 10.1007/s10238-005-0064-5; Gilmartin L, 2008, INT ARCH ALLERGY IMM, V145, P182, DOI 10.1159/000109287; Gyimesi E, 2013, INFLAMM RES, V62, P213, DOI 10.1007/s00011-012-0569-9; Hollingsworth JW, 2006, J IMMUNOL, V176, P5856, DOI 10.4049/jimmunol.176.10.5856; Jeon JH, 2015, MOL IMMUNOL, V65, P168, DOI 10.1016/j.molimm.2015.01.022; Johnson CM, 2007, J IMMUNOL, V178, P7520, DOI 10.4049/jimmunol.178.12.7520; Komiya A, 2006, INT ARCH ALLERGY IMM, V140, P23, DOI 10.1159/000092707; Kucuksezer UC, 2013, J ALLERGY CLIN IMMUN, V131, P875, DOI 10.1016/j.jaci.2012.10.051; Omueti KO, 2005, J BIOL CHEM, V280, P36616, DOI 10.1074/jbc.M504320200; Sabroe I, 2002, J IMMUNOL, V168, P4701, DOI 10.4049/jimmunol.168.9.4701; Siracusa MC, 2013, J ALLERGY CLIN IMMUN, V132, P789, DOI 10.1016/j.jaci.2013.07.046; Suurmond J, 2014, EUR J IMMUNOL, V44, P386, DOI 10.1002/eji.201343617; Tulic MK, 2011, J ALLERGY CLIN IMMUN, V127, P470, DOI 10.1016/j.jaci.2010.09.020; Watanabe T, 2013, J GASTROENTEROL, V48, P247, DOI 10.1007/s00535-012-0626-8; Yi MH, 2015, CYTOKINE, V75, P356, DOI 10.1016/j.cyto.2015.07.011; Zhang GY, 2009, J IMMUNOL, V182, P7997, DOI 10.4049/jimmunol.0802884	20	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149275	10.1371/journal.pone.0149275	http://dx.doi.org/10.1371/journal.pone.0149275			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26870962	Green Published, gold			2022-12-27	WOS:000370054100140
J	Wiecki, TV; Antoniades, CA; Stevenson, A; Kennard, C; Borowsky, B; Owen, G; Leavitt, B; Roos, R; Durr, A; Tabrizi, SJ; Frank, MJ				Wiecki, Thomas V.; Antoniades, Chrystalina A.; Stevenson, Alexander; Kennard, Christopher; Borowsky, Beth; Owen, Gail; Leavitt, Blair; Roos, Raymund; Durr, Alexandra; Tabrizi, Sarah J.; Frank, Michael J.			A Computational Cognitive Biomarker for Early-Stage Huntington's Disease	PLOS ONE			English	Article							BASAL GANGLIA; PREFRONTAL CORTEX; RESPONSE-INHIBITION; FRONTAL-CORTEX; TRACK-HD; ATROPHY; MODEL; ONSET; TASK; DEFICITS	Huntington's disease (HD) is genetically determined but with variability in symptom onset, leading to uncertainty as to when pharmacological intervention should be initiated. Here we take a computational approach based on neurocognitive phenotyping, computational modeling, and classification, in an effort to provide quantitative predictors of HD before symptom onset. A large sample of subjects-consisting of both pre-manifest individuals carrying the HD mutation (pre-HD), and early symptomatic-as well as healthy controls performed the antisaccade conflict task, which requires executive control and response inhibition. While symptomatic HD subjects differed substantially from controls in behavioral measures [reaction time (RT) and error rates], there was no such clear behavioral differences in pre-HD. RT distributions and error rates were fit with an accumulator-based model which summarizes the computational processes involved and which are related to identified mechanisms in more detailed neural models of prefrontal cortex and basal ganglia. Classification based on fitted model parameters revealed a key parameter related to executive control differentiated pre-HD from controls, whereas the response inhibition parameter declined only after symptom onset. These findings demonstrate the utility of computational approaches for classification and prediction of brain disorders, and provide clues as to the underlying neural mechanisms.	[Wiecki, Thomas V.; Frank, Michael J.] Cognit Linguist & Psychol Sci, Providence, RI USA; [Antoniades, Chrystalina A.; Stevenson, Alexander; Kennard, Christopher] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Div Clin Neurol, Level 6 West Wing, Oxford OX3 9DU, England; [Borowsky, Beth] CHDI Fdn, CHDI Management Inc, 155 Village Blvd,Suite 200, Princeton, NJ 08540 USA; [Owen, Gail; Tabrizi, Sarah J.] UCL Inst Neurol, Huntingtons Dis Res Ctr, 2nd Floor Russell Sq House,10-12 Russell Sq, London WC1B 5EH, England; [Leavitt, Blair] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 2B5, Canada; [Roos, Raymund] Leiden Univ, Dept Neurol, Med Ctr, NL-2300 RC Leiden, Netherlands; [Durr, Alexandra] Hop La Pitie Salpetriere, AP HP, Dept Genet & Cytogenet, F-75013 Paris, France; [Durr, Alexandra] Hop La Pitie Salpetriere, AP HP, INSERM, UMR S679, F-75013 Paris, France	University of Oxford; University of London; University College London; University of British Columbia; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Frank, MJ (corresponding author), Cognit Linguist & Psychol Sci, Providence, RI USA.	michael_frank@brown.edu	Leavitt, Blair R/G-1934-2012	Tabrizi, Sarah/0000-0003-2716-2045; Antoniades, Chrystalina/0000-0002-1192-3834; Owen, Gail/0000-0001-5685-3692	CHDI/High Q Foundation; MRC [MR/J003832/1, MR/L012936/1] Funding Source: UKRI; Medical Research Council [MR/J003832/1, MR/P007015/1, MR/L012936/1] Funding Source: researchfish; Wellcome Trust [200181/Z/15/Z] Funding Source: researchfish	CHDI/High Q Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by CHDI/High Q Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Andre R, 2014, DRUG DISCOV TODAY, P2; Antoniades CA, 2007, NEUROREPORT, V18, P1133, DOI 10.1097/WNR.0b013e32821c560d; Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Aylward EH, 2004, NEUROLOGY, V63, P66, DOI 10.1212/01.WNL.0000132965.14653.D1; Badre D, 2008, TRENDS COGN SCI, V12, P193, DOI 10.1016/j.tics.2008.02.004; Baier B, 2010, J NEUROSCI, V30, P9788, DOI 10.1523/JNEUROSCI.1513-10.2010; Bissett PG, 2012, J EXP PSYCHOL HUMAN, V38, P746, DOI 10.1037/a0025429; Blekher T, 2009, INVEST OPHTH VIS SCI, V50, P5707, DOI 10.1167/iovs.09-3538; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Cavanagh JF, 2014, J EXPT PSYCHOL GEN; Chambers CD, 2009, NEUROSCI BIOBEHAV R, V33, P631, DOI 10.1016/j.neubiorev.2008.08.016; Chatham CH, 2014, NEURON, V81, P930, DOI 10.1016/j.neuron.2014.01.002; Collins AGE, 2014, PSYCHOL REV, V121, P337, DOI 10.1037/a0037015; Collins AGE, 2013, PSYCHOL REV, V120, P190, DOI 10.1037/a0030852; Congdon E, 2009, BIOL PSYCHOL, V81, P144, DOI 10.1016/j.biopsycho.2009.03.005; Dunovan K, 2015, ELIFE, V4, DOI 10.7554/eLife.08723; Egner T, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00154; Frank MJ, 2001, COGN AFFECT BEHAV NE, V1, P137, DOI 10.3758/CABN.1.2.137; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; FUNAHASHI S, 1993, NATURE, V365, P753, DOI 10.1038/365753a0; Golding CVP, 2006, NEUROLOGY, V67, P485, DOI 10.1212/01.wnl.0000218215.43328.88; Hicks SL, 2008, PROG BRAIN RES, V171, P555, DOI 10.1016/S0079-6123(08)00678-X; Hobbs NZ, 2009, NEUROIMAGE, V47, P1659, DOI 10.1016/j.neuroimage.2009.06.003; Isoda M, 2007, NAT NEUROSCI, V10, P240, DOI 10.1038/nn1830; Johnson KA, 2001, EXP BRAIN RES, V138, P492, DOI 10.1007/s002210100733; Johnston K, 2006, J NEUROSCI, V26, P12471, DOI 10.1523/JNEUROSCI.4101-06.2006; Kassubek J, 2005, CEREB CORTEX, V15, P846, DOI 10.1093/cercor/bhh185; Kieburtz K, 2012, LANCET NEUROL, V11, P24, DOI 10.1016/S1474-4422(11)70285-X; King JA, 2010, J NEUROSCI, V30, P12759, DOI 10.1523/JNEUROSCI.3274-10.2010; Klempir J, 2005, FUNCTIONAL NEUROLOGY, V21, P217; Kloppel S, 2008, BRAIN, V131, P196, DOI 10.1093/brain/awm275; Kravitz AV, 2012, NATURE NEUROSCIENCE; Langbehn DR, 2004, CLIN GENET, V65, P267, DOI 10.1111/j.1399-0004.2004.00241.x; MacMillan J., 1996, HUNTINGTONS DIS, P317; Maia TV, 2011, NAT NEUROSCI, V14, P154, DOI 10.1038/nn.2723; Majid DSA, 2013, J NEUROSCI, V33, P13259, DOI 10.1523/JNEUROSCI.5651-12.2013; Majid DSA, 2011, MOVEMENT DISORD, V26, P2544, DOI 10.1002/mds.23912; Majid DSA, 2011, MOVEMENT DISORD, V26, P1481, DOI 10.1002/mds.23656; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Milnerwood AJ, 2010, NEURON, V65, P178, DOI 10.1016/j.neuron.2010.01.008; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Montague PR, 2012, TRENDS COGN SCI, V16, P72, DOI 10.1016/j.tics.2011.11.018; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Noorani I, 2012, EUROPEAN J NEUROSCIE, V37, P1; Ober JK, 2003, MODEL MEAS MED, P187; Paulsen JS, 2010, BRAIN RES BULL, V82, P201, DOI 10.1016/j.brainresbull.2010.04.003; Peltsch A, 2008, EXP BRAIN RES, V186, P457, DOI 10.1007/s00221-007-1248-x; Rao JA, 2014, CORTEX, V58, P72, DOI 10.1016/j.cortex.2014.04.018; Ratcliff R, 2008, NEURAL COMPUT, V20, P873, DOI 10.1162/neco.2008.12-06-420; Ridderinkhof KR, 2011, WIRES COGN SCI, V2, P174, DOI 10.1002/wcs.99; Ridderinkhof KR, 2005, J ABNORM PSYCHOL, V114, P197, DOI 10.1037/0021-843X.114.2.197; SchlagRey M, 1997, NATURE, V390, P398, DOI 10.1038/37114; SHOULSON I, 1979, NEUROLOGY, V29, P1, DOI 10.1212/WNL.29.1.1; Tabrizi SJ, 2013, LANCET NEUROL, V12, P637, DOI 10.1016/S1474-4422(13)70088-7; Tabrizi SJ, 2009, LANCET NEUROL, V8, P791, DOI 10.1016/S1474-4422(09)70170-X; Turner BM, 2013, PSYCHONOMIC B REV; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P3, DOI 10.3758/BF03194023; Wales DJ, 1997, J PHYS CHEM A, V101, P5111, DOI 10.1021/jp970984n; Watanabe M, 2011, EUR J NEUROSCI, V33, P2070, DOI 10.1111/j.1460-9568.2011.07691.x; Wegener SP, 2008, EXP BRAIN RES, V190, P463, DOI 10.1007/s00221-008-1488-4; Wiecki TV, 2015, CLIN PSYCHOL SCI, V3, P378, DOI 10.1177/2167702614565359; Wiecki TV, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00014; Wiecki TV, 2013, PSYCHOL REV, V120, P329, DOI 10.1037/a0031542	67	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148409	10.1371/journal.pone.0148409	http://dx.doi.org/10.1371/journal.pone.0148409			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872129	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100029
J	Kiesewetter, J; Fischer, F; Fischer, MR				Kiesewetter, Jan; Fischer, Frank; Fischer, Martin R.			Collaboration Expertise in Medicine - No Evidence for Cross-Domain Application from a Memory Retrieval Study	PLOS ONE			English	Article							SCRIPTS; KNOWLEDGE; REPRESENTATION; PERSPECTIVE; PERFORMANCE; CHESS	Background Is there evidence for expertise on collaboration and, if so, is there evidence for cross-domain application? Recall of stimuli was used to measure so-called internal collaboration scripts of novices and experts in two studies. Internal collaboration scripts refer to an individual's knowledge about how to interact with others in a social situation. Method-Study 1 Ten collaboration experts and ten novices of the content domain social science were presented with four pictures of people involved in collaborative activities. The recall texts were coded, distinguishing between superficial and collaboration script information. Results-Study 1 Experts recalled significantly more collaboration script information (M = 25.20; SD = 5.88) than did novices (M = 13.80; SD = 4.47). Differences in superficial information were not found. Study 2 Study 2 tested whether the differences found in Study 1 could be replicated. Furthermore, the cross-domain application of internal collaboration scripts was explored. Method-Study 2 Twenty collaboration experts and 20 novices of the content domain medicine were presented with four pictures and four videos of their content domain and a video and picture of another content domain. All stimuli showed collaborative activities typical for the respective content domains. Results-Study 2 As in Study 1, experts recalled significantly more collaboration script information of their content domain (M = 71.65; SD = 33.23) than did novices (M = 54.25; SD = 15.01). For the novices, no differences were found for the superficial information nor for the retrieval of collaboration script information recalled after the other content domain stimuli. Discussion There is evidence for expertise on collaboration in memory tasks. The results show that experts hold substantially more collaboration script information than did novices. Furthermore, the differences between collaboration novices and collaboration experts occurred only in their own content domain, indicating that internal collaboration scripts are not easily stored and retrieved in memory tasks other than in the own content domain.	[Kiesewetter, Jan; Fischer, Martin R.] Klinikum Ludwig Maximilians Univ Munchen, Inst Didakt & Ausbildungsforsch Med, Munich, Germany; [Fischer, Frank] Univ Munich, Dept Educ Sci & Educ Psychol, Munich, Germany	University of Munich; University of Munich	Kiesewetter, J (corresponding author), Klinikum Ludwig Maximilians Univ Munchen, Inst Didakt & Ausbildungsforsch Med, Munich, Germany.	jan.kiesewetter@med.lmu.de	Kiesewetter, Jan/AFQ-5216-2022	Kiesewetter, Jan/0000-0001-8165-402X				Alexander PA, 1998, J EDUC PSYCHOL, V90, P435, DOI 10.1037/0022-0663.90.3.435; Bortz J., 2006, FORSCHUNGSMETHODEN E; Carmien S, 2007, COMPUT-SUPP COLLAB L, V6, P303; Charlin B, 2012, MED EDUC, V46, P454, DOI 10.1111/j.1365-2923.2012.04242.x; CHASE WG, 1973, COGNITIVE PSYCHOL, V4, P55, DOI 10.1016/0010-0285(73)90004-2; CHI MTH, 1981, COGNITIVE SCI, V5, P121, DOI 10.1207/s15516709cog0502_2; Custers EJFM, 1998, COGNITION INSTRUCT, V16, P367, DOI 10.1207/s1532690xci1604_1; De Groot A, 1965, CHOICE IN CHESS; Elstein AS, 1978, MED PROBLEM SOLVING; Feltovich PJ, 2006, CAMBRIDGE HANDBOOK OF EXPERTISE AND EXPERT PERFORMANCE, P41; Fischer F, 2013, EDUC PSYCHOL-US, V48, P56, DOI 10.1080/00461520.2012.748005; Gardner H., 1985, FRAMES MIND THEORY M; Getzels J.W., 1976, CREATIVE VISION LONG; Gobet F, 1996, COGNITIVE PSYCHOL, V31, P1, DOI 10.1006/cogp.1996.0011; Gruber H., 1996, EXPERTISEFORSCHUNG T, P18; Gruber H, 2001, HANDWORTERBUCH PADAG, P183; HUNTER JE, 1986, J VOCAT BEHAV, V29, P340, DOI 10.1016/0001-8791(86)90013-8; Kiesewetter J, GMS Z MED A IN PRESS; King A, 2007, COMPUT-SUPP COLLAB L, V6, P13; Kollar I, 2006, EDUC PSYCHOL REV, V18, P159, DOI 10.1007/s10648-006-9007-2; Kolodner JL, 2007, COMPUT-SUPP COLLAB L, V6, P237; Lajoie S., 2003, EDUC RESEARCHER, V32, P21, DOI [DOI 10.3102/0013189X032008021, 10.3102/0013189X032008021]; O'Donnell A. M., 1992, INTERACTION COOPERAT, P120, DOI DOI 10.1080/00461520.1998.9653294; Palincsar A. S., 1984, COGNITION INSTRUCT, P117, DOI [DOI 10.1207/S1532690XCI0102_1, 10.1207/S1532690XCI0102_1]; Rummel N, 2005, J LEARN SCI, V14, P201, DOI 10.1207/s15327809jls1402_2; Schank RC, 1999, DYNAMIC MEMORY REVIS; Schank RC., 1977, SCRIPTS PLANS GOALS; Strasser J., 2008, LEHREREXPERTISE, P237; Sturmer K., 2014, AM ED RES J; TZINER A, 1985, J APPL PSYCHOL, V70, P85, DOI 10.1037/0021-9010.70.1.85; Vygotskii L.S., 1978, MIND SOC DEV HIGHER; Weber H, 2007, PATIENT EDUC COUNS, V67, P343, DOI 10.1016/j.pec.2007.04.011; Weinberger A, 2005, INSTR SCI, V33, P1, DOI 10.1007/s11251-004-2322-4; Weinberger A, 2007, COMPUT-SUPP COLLAB L, V6, P191	34	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148754	10.1371/journal.pone.0148754	http://dx.doi.org/10.1371/journal.pone.0148754			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6RE	26866801	Green Submitted, Green Published, gold			2022-12-27	WOS:000370050700033
J	Oyallon, J; Vanzo, N; Krzemien, J; Morin-Poulard, I; Vincent, A; Crozatier, M				Oyallon, Justine; Vanzo, Nathalie; Krzemien, Joanna; Morin-Poulard, Ismael; Vincent, Alain; Crozatier, Michele			Two Independent Functions of Collier/Early B Cell Factor in the Control of Drosophila Blood Cell Homeostasis	PLOS ONE			English	Article							HEMATOPOIETIC PROGENITOR MAINTENANCE; LYMPH-GLAND; IMMUNE-RESPONSE; SIGNALING CENTER; STEM-CELL; DUAL ROLE; NICHE; DIFFERENTIATION; MODEL; PROTEIN	Blood cell production in the Drosophila hematopoietic organ, the lymph gland, is controlled by intrinsic factors and extrinsic signals. Initial analysis of Collier/Early B Cell Factor function in the lymph gland revealed the role of the Posterior Signaling Center (PSC) in mounting a dedicated cellular immune response to wasp parasitism. Further, premature blood cell differentiation when PSC specification or signaling was impaired, led to assigning the PSC a role equivalent to the vertebrate hematopoietic niche. We report here that Collier is expressed in a core population of lymph gland progenitors and cell autonomously maintains this population. The PSC contributes to lymph gland homeostasis by regulating blood cell differentiation, rather than by maintaining core progenitors. In addition to PSC signaling, switching off Collier expression in progenitors is required for efficient immune response to parasitism. Our data show that two independent sites of Collier/Early B Cell Factor expression, hematopoietic progenitors and the PSC, achieve control of hematopoiesis.	[Oyallon, Justine; Vanzo, Nathalie; Krzemien, Joanna; Morin-Poulard, Ismael; Vincent, Alain; Crozatier, Michele] Univ Toulouse 3, Ctr Biol Dev, Ctr Biol Integrat, CNRS, 118 Route Narbonne, F-31062 Toulouse 09, France; [Oyallon, Justine] Univ Nacl Autonoma Mexico, Lab Citogenet & Mutagenesis Ambientales, Ctr Ciencias Atmosfera, Ciudad Univ Coyoacan, Mexico City 04510, DF, Mexico; [Krzemien, Joanna] Univ St Andrews, St Andrews KY16 9RJ, Fife, Scotland; [Morin-Poulard, Ismael] Hubrecht Inst, Dev Biol & Stem Cell Res, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universidad Nacional Autonoma de Mexico; University of St Andrews; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Vincent, A; Crozatier, M (corresponding author), Univ Toulouse 3, Ctr Biol Dev, Ctr Biol Integrat, CNRS, 118 Route Narbonne, F-31062 Toulouse 09, France.	alain.vincent@univ-tlse3.fr; michele.crozatier-borde@univ-tlse3.fr	Vincent, Alain/AAE-4712-2019	Morin-Poulard, Ismael/0000-0002-8234-0716	CNRS, University Toulouse III, Ministere de la Recherche [ANR-11-BSV2-0008]; ARC (Association pour la Recherche sur le Cancer); FRM (Fondation pour la Recherche Medicale) [DEQ20090515429]	CNRS, University Toulouse III, Ministere de la Recherche; ARC (Association pour la Recherche sur le Cancer)(Fondation ARC pour la Recherche sur le Cancer); FRM (Fondation pour la Recherche Medicale)(Fondation pour la Recherche Medicale)	This work was financially supported by the CNRS, University Toulouse III, Ministere de la Recherche (ANR-11-BSV2-0008), ARC (Association pour la Recherche sur le Cancer), and FRM (Fondation pour la Recherche Medicale, grant number DEQ20090515429).; We thank E. Agius, L. Bataille, M. Boube, M. Meister, C. Monod and M. Suzanne for critical reading of the manuscript and members of the Vincent/Crozatier's Lab for discussion. We also thank C. Monod for skilled assistance during this work. We thank I. Ando and T. Trenczek for antibodies and T. Williams for vectors. We thank L. Waltzer and M. Haenlin for personal communication concerning increased progenitor differentiation upon col knock-down in the medullary zone (tep4-Gal4 > icol). We are grateful to the Toulouse RIO imaging platform. O. Bohner, J. Favier, and V. Nicolas for fly culture. This work was financially supported by the CNRS, University Toulouse III, Ministere de la Recherche (ANR-11-BSV2-0008), ARC (Association pour la Recherche sur le Cancer) and FRM (Fondation pour la Recherche Medicale, grant number DEQ20090515429).	Benmimoun B, 2015, P NATL ACAD SCI USA, V112, P9052, DOI 10.1073/pnas.1423967112; Benmimoun B, 2012, DEVELOPMENT, V139, P1713, DOI 10.1242/dev.080259; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bourbon HM, 2002, MECH DEVELOP, V110, P71, DOI 10.1016/S0925-4773(01)00566-4; Crozatier M, 2004, PLOS BIOL, V2, P1107, DOI 10.1371/journal.pbio.0020196; Crozatier M, 2007, CELL CYCLE, V6, P1443; Crozatier M, 2011, DIS MODEL MECH, V4, P439, DOI 10.1242/dmm.007351; Daburon V, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-131; Dragojlovic-Munther M, 2013, DEV BIOL, V384, P313, DOI 10.1016/j.ydbio.2013.04.004; Dragojlovic-Munther M, 2012, DEVELOPMENT, V139, P3752, DOI 10.1242/dev.074203; Ferguson GB, 2014, CURR BIOL, V24, P2665, DOI 10.1016/j.cub.2014.09.081; Fossett N, 2013, BBA-GEN SUBJECTS, V1830, P2375, DOI 10.1016/j.bbagen.2012.06.005; Gao HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107768; Gao HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074684; Gao HJ, 2011, GENESIS, V49, P105, DOI 10.1002/dvg.20711; Ghosh S, 2015, DEV CELL, V33, P478, DOI 10.1016/j.devcel.2015.03.014; Gold KS, 2014, EXP HEMATOL, V42, P717, DOI 10.1016/j.exphem.2014.06.002; Grigorian M, 2011, DEV GENES EVOL, V221, P121, DOI 10.1007/s00427-011-0364-6; Gyory I, 2012, GENE DEV, V26, P668, DOI 10.1101/gad.187328.112; Irving P, 2005, CELL MICROBIOL, V7, P335, DOI 10.1111/j.1462-5822.2004.00462.x; Jung SH, 2005, DEVELOPMENT, V132, P2521, DOI 10.1242/dev.01837; Khadilkar RJ, 2014, P NATL ACAD SCI USA, V111, P4898, DOI 10.1073/pnas.1303559111; Kieslinger M, 2010, CELL STEM CELL, V7, P496, DOI 10.1016/j.stem.2010.07.015; Krzemien J, 2008, THESIS U TOULOUSE 3; Krzemien J, 2007, NATURE, V446, P325, DOI 10.1038/nature05650; Krzemien J, 2010, INT J DEV BIOL, V54, P1117, DOI 10.1387/ijdb.093053jk; Krzemien J, 2010, DEV BIOL, V346, P310, DOI 10.1016/j.ydbio.2010.08.003; Lam V, 2014, BIOCHEM BIOPH RES CO, V453, P467, DOI 10.1016/j.bbrc.2014.09.109; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Lebestky T, 2003, GENE DEV, V17, P348, DOI 10.1101/gad.1052803; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Rivas ML, 2008, EMBO REP, V9, P1114, DOI 10.1038/embor.2008.170; Makki R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000441; Mandal L, 2004, NAT GENET, V36, P1019, DOI 10.1038/ng1404; Mandal L, 2007, NATURE, V446, P320, DOI 10.1038/nature05585; Martinez-Agosto JA, 2007, GENE DEV, V21, P3044, DOI 10.1101/gad.1602607; Minakhina S, 2011, DEV BIOL, V352, P308, DOI 10.1016/j.ydbio.2011.01.035; Minakhina S, 2010, DEVELOPMENT, V137, P27, DOI 10.1242/dev.043943; Mondal BC, 2014, ELIFE, V3, DOI 10.7554/eLife.03626; Mondal BC, 2011, CELL, V147, P1589, DOI 10.1016/j.cell.2011.11.041; Mukherjee T, 2011, SCIENCE, V332, P1210, DOI 10.1126/science.1199643; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Pennetier D, 2012, P NATL ACAD SCI USA, V109, P3389, DOI 10.1073/pnas.1109407109; Russo J, 1996, PARASITOLOGY, V112, P135, DOI 10.1017/S0031182000065173; Shim J, 2013, CELL, V155, P1141, DOI 10.1016/j.cell.2013.10.032; Shim J, 2013, DEVELOPMENT, V140, P4647, DOI 10.1242/dev.079087; Sinenko SA, 2012, EMBO REP, V13, P83, DOI 10.1038/embor.2011.223; Sinenko SA, 2009, DEV CELL, V16, P756, DOI 10.1016/j.devcel.2009.03.003; Sorrentino RP, 2007, DEV BIOL, V311, P311, DOI 10.1016/j.ydbio.2007.08.011; Sorrentino RP, 2002, DEV BIOL, V243, P65, DOI 10.1006/dbio.2001.0542; Tokusumi T, 2015, DEVELOPMENT, V142, P2261, DOI 10.1242/dev.121798; Tokusumi T, 2011, DEVELOPMENT, V138, P3879, DOI 10.1242/dev.069336; Tokusumi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041604; Tokusumi Y, 2010, DEVELOPMENT, V137, P3561, DOI 10.1242/dev.053728	54	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148978	10.1371/journal.pone.0148978	http://dx.doi.org/10.1371/journal.pone.0148978			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866694	Green Submitted, Green Published, gold			2022-12-27	WOS:000370050700050
J	Zhang, GY; Fan, X; Wu, YX				Zhang, Guoyin; Fan, Xu; Wu, Yanxia			Minimal Increase Network Coding for Dynamic Networks	PLOS ONE			English	Article								Because of the mobility, computing power and changeable topology of dynamic networks, it is difficult for random linear network coding (RLNC) in static networks to satisfy the requirements of dynamic networks. To alleviate this problem, a minimal increase network coding (MINC) algorithm is proposed. By identifying the nonzero elements of an encoding vector, it selects blocks to be encoded on the basis of relationship between the nonzero elements that the controls changes in the degrees of the blocks; then, the encoding time is shortened in a dynamic network. The results of simulations show that, compared with existing encoding algorithms, the MINC algorithm provides reduced computational complexity of encoding and an increased probability of delivery.	[Zhang, Guoyin; Fan, Xu; Wu, Yanxia] Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Heilongjiang, Peoples R China	Harbin Engineering University	Fan, X (corresponding author), Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Heilongjiang, Peoples R China.	fanxu@hrbeu.edu.cn	Wu, yanxia/HGA-0318-2022		National Natural Science Foundation of China [61073042, 61170241]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by No. 61073042 and No. 61170241, http://www.nsfc.gov.cn/, National Natural Science Foundation of China, GZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlswede R, 2000, IEEE T INFORM THEORY, V46, P1204, DOI 10.1109/18.850663; Akhtar AM, 2013, IEEE T COMMUN, V61, P1498, DOI 10.1109/TCOMM.2013.012913.120288; Cai QC, 2013, IEEE T PARALL DISTR, V24, P1682, DOI 10.1109/TPDS.2012.211; Chou P., 2003, 51 ALL C COMM CONTR; Deb S, 2006, IEEE T INFORM THEORY, V52, P2486, DOI 10.1109/TIT.2006.874532; Feizi S, 2014, INT SYMP NETW COD; Fiandrotti A, 2014, IEEE T MULTIMEDIA, V16, P521, DOI 10.1109/TMM.2013.2285518; Gkantsidis C, 2005, IEEE INFOCOM SER, P2235; Ho T, 2006, IEEE T INFORM THEORY, V52, P4413, DOI 10.1109/TIT.2006.881746; Niu D, 2011, IEEE T PARALL DISTR, V22, P1842, DOI 10.1109/TPDS.2011.53; Ortolf C, 2009, INTERNET WEB APPL SE, V2009, P24; Rout RR, 2013, IEEE T WIREL COMMUN, V12, P656, DOI 10.1109/TWC.2012.111412.112124; Yoon J, 2003, IEEE INFOCOM SER, P1312	13	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148725	10.1371/journal.pone.0148725	http://dx.doi.org/10.1371/journal.pone.0148725			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867211	Green Published, Green Submitted, gold			2022-12-27	WOS:000370050700028
J	Grunspan, DZ; Eddy, SL; Brownell, SE; Wiggins, BL; Crowe, AJ; Goodreau, SM				Grunspan, Daniel Z.; Eddy, Sarah L.; Brownell, Sara E.; Wiggins, Benjamin L.; Crowe, Alison J.; Goodreau, Steven M.			Males Under-Estimate Academic Performance of Their Female Peers in Undergraduate Biology Classrooms	PLOS ONE			English	Article							SELF-EFFICACY; GENDER; SCIENCE; PARTICIPATION; STUDENTS; BELIEFS; MODELS; WOMEN	Women who start college in one of the natural or physical sciences leave in greater proportions than their male peers. The reasons for this difference are complex, and one possible contributing factor is the social environment women experience in the classroom. Using social network analysis, we explore how gender influences the confidence that college-level biology students have in each other's mastery of biology. Results reveal that males are more likely than females to be named by peers as being knowledgeable about the course content. This effect increases as the term progresses, and persists even after controlling for class performance and outspokenness. The bias in nominations is specifically due to males over-nominating their male peers relative to their performance. The over-nomination of male peers is commensurate with an overestimation of male grades by 0.57 points on a 4 point grade scale, indicating a strong male bias among males when assessing their classmates. Females, in contrast, nominated equitably based on student performance rather than gender, suggesting they lacked gender biases in filling out these surveys. These trends persist across eleven surveys taken in three different iterations of the same Biology course. In every class, the most renowned students are always male. This favoring of males by peers could influence student self-confidence, and thus persistence in this STEM discipline.	[Grunspan, Daniel Z.; Goodreau, Steven M.] Univ Washington, Dept Anthropol, Seattle, WA 98185 USA; [Eddy, Sarah L.] Univ Texas Austin, Coll Nat Sci, Texas Inst Discovery Educ Sci, Austin, TX 78712 USA; [Brownell, Sara E.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Wiggins, Benjamin L.; Crowe, Alison J.] Univ Washington, Dept Biol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Texas System; University of Texas Austin; Arizona State University; Arizona State University-Tempe; University of Washington; University of Washington Seattle	Grunspan, DZ (corresponding author), Univ Washington, Dept Anthropol, Seattle, WA 98185 USA.	grunny@uw.edu	Goodreau, Steven/P-2366-2017		NSF DUE grant [1244847];  [R01-HD068395]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD068395] Funding Source: NIH RePORTER; Division Of Undergraduate Education [1244847] Funding Source: National Science Foundation	NSF DUE grant; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Division Of Undergraduate Education(National Science Foundation (NSF)NSF - Directorate for STEM Education (EDU))	This research was supported in part by NSF DUE grant 1244847 (AJC). SMG was supported by R01-HD068395.	Becker JR, 1984, J ED EQUITY LEADERSH, V4, P39; Butts CT, 2008, J STAT SOFTWARE; Cech E, 2011, AM SOCIOL REV, V76, P641, DOI 10.1177/0003122411420815; Ceci SJ, 2011, P NATL ACAD SCI USA, V108, P3157, DOI 10.1073/pnas.1014871108; Cohen GL, 1999, PERS SOC PSYCHOL B, V25, P1302, DOI 10.1177/0146167299258011; Eddy SL, 2014, CBE-LIFE SCI EDUC, V13, P478, DOI 10.1187/cbe.13-10-0204; Eddy SL, 2015, CBE-LIFE SCI EDUC, P14; Eddy SL, 2015, PHYS REV SPECIAL TOP; Gillen A., 2014, EXPLORING GENDER IMB; Hunter David R, 2008, J Stat Softw, V24, pnihpa54860; Isbell LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049682; Leslie SJ, 2015, SCIENCE, V347, P262, DOI 10.1126/science.1261375; Martin SN, 2006, J RES SCI TEACH, V43, P819, DOI 10.1002/tea.20154; Milkman K. L., 2014, FIELD EXPT EXPLORING; Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109; National Science Board, 2014, SCI ENG IND; National Science Foundation NCfSaES, 2013, 13304 NCFSAES NSF; Nosek BA, 2002, GROUP DYN-THEOR RES, V6, P101, DOI 10.1037//1089-2699.6.1.101; Nosek BA, 2011, AM EDUC RES J, V48, P1125, DOI 10.3102/0002831211410683; O'Brien LT, 2015, CULT DIVERS ETHN MIN, V21, P169, DOI 10.1037/a0037944; Olson S., 2012, ENGAGE EXCEL PRODUCI; Robins G, 2007, SOC NETWORKS, V29, P173, DOI 10.1016/j.socnet.2006.08.002; Robnett RD, 2013, J RES ADOLESCENCE, V23, P652, DOI 10.1111/jora.12013; Rosenthal L, 2011, SEX ROLES, V65, P725, DOI 10.1007/s11199-011-9945-0; ROTHBART M, 1978, J EXP SOC PSYCHOL, V14, P237, DOI 10.1016/0022-1031(78)90013-6; Schmader T, 2004, SEX ROLES, V50, P835, DOI 10.1023/B:SERS.0000029101.74557.a0; Settles IH, 2006, PSYCHOL WOMEN QUART, V30, P47, DOI 10.1111/j.1471-6402.2006.00261.x; Seymour E., 1997, TALKING LEAVING WHY; Sheltzer JM, 2014, P NATL ACAD SCI USA, V111, P10107, DOI 10.1073/pnas.1403334111; Swim JK, 2001, J SOC ISSUES, V57, P31, DOI 10.1111/0022-4537.00200; Thompson M., 2002, ANAL SOCIAL ISSUES P, V2, P183, DOI [DOI 10.1111/J.1530-2415.2002.00037.X, 10.1111/j.1530-2415.2002.00037.x]; Usher EL, 2008, REV EDUC RES, V78, P751, DOI 10.3102/0034654308321456; Wiens DJ, 2003, J COLL SCI TEACH, V33, P32; Young DM, 2013, PSYCHOL WOMEN QUART, V37, P283, DOI 10.1177/0361684313482109; Zeldin AL, 2000, AM EDUC RES J, V37, P215, DOI 10.2307/1163477	35	109	111	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148405	10.1371/journal.pone.0148405	http://dx.doi.org/10.1371/journal.pone.0148405			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6PR	26863320	Green Published, Green Submitted, gold			2022-12-27	WOS:000370046600066
J	Maldonado, JH; Moreno-Sanchez, RD				Higinio Maldonado, Jorge; del Pilar Moreno-Sanchez, Rocio			Exacerbating the Tragedy of the Commons: Private Inefficient Outcomes and Peer Effect in Experimental Games with Fishing Communities	PLOS ONE			English	Article							PUBLIC GOOD; GOVERNANCE	Economic Experimental Games have shown that individuals make decisions that deviate down from the suboptimal Nash equilibrium. However, few studies have analyzed the case when deviation is above the Nash equilibrium. Extracting from above the Nash equilibrium is inefficient not only socially but also privately and it would exacerbate the tragedy of the commons. That would be the case of a race to the fish when stocks are becoming depleted or driver behavior on a highly congested road. The objective of this study is to analyze private inefficient extraction behavior in experimental games and to associate the type of player and the type of player group with such inefficient outcomes. To do this, we carried out economic experimental games with local coastal fishermen in Colombia, using a setting where the scarcity of the resource allows for an interior Nash equilibrium and inefficient over-extraction is possible. The state of the resource, the type of player and the composition of the group explain, in part, this inefficient behavior.	[Higinio Maldonado, Jorge; del Pilar Moreno-Sanchez, Rocio] Univ Los Andes, Dept Econ, CEDE, Bogota, Colombia; [del Pilar Moreno-Sanchez, Rocio] Conservat Strategy Fund, Bogota, Colombia; [Higinio Maldonado, Jorge] Univ Los Andes, Dept Econ, Calle 19 A 1-37 E Bq W 814, Bogota 111711, Colombia	Universidad de los Andes (Colombia); Universidad de los Andes (Colombia)	Maldonado, JH (corresponding author), Univ Los Andes, Dept Econ, CEDE, Bogota, Colombia.; Maldonado, JH (corresponding author), Univ Los Andes, Dept Econ, Calle 19 A 1-37 E Bq W 814, Bogota 111711, Colombia.	jmaldona@uniandes.edu.co		Maldonado, Jorge/0000-0001-5501-6374	Latin American and Caribbean Environmental Economics Program (LACEEP); Colombian Institute for Development of Science and Technology Francisco Jose de Caldas (COLCIENCIAS); National Oceanic and Atmospheric Administration (NOAA) USA; Universidad de los Andes' Center of Studies for Development Studies (CEDE)	Latin American and Caribbean Environmental Economics Program (LACEEP); Colombian Institute for Development of Science and Technology Francisco Jose de Caldas (COLCIENCIAS)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); National Oceanic and Atmospheric Administration (NOAA) USA; Universidad de los Andes' Center of Studies for Development Studies (CEDE)	The Latin American and Caribbean Environmental Economics Program (LACEEP) funded Rocio Moreno-Sanchez for a portion of the conducted field experiments and their subsequent analysis. The Colombian Institute for Development of Science and Technology Francisco Jose de Caldas (COLCIENCIAS) funded a project executed by Universidad de los Andes in the National Natural Park Corales del Rosario y San Bernardo, which contributed greatly to this research. Additional funds came from a grant from the National Oceanic and Atmospheric Administration (NOAA) USA, and from the Universidad de los Andes' Center of Studies for Development Studies (CEDE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cardenas J.C., 2000, ENVIRON DEV SUSTAIN, V2, P305, DOI [DOI 10.1023/A:1011422313042, 10.1023/A:1011422313042]; Cardenas JC, 2000, WORLD DEV, V28, P1719, DOI 10.1016/S0305-750X(00)00055-3; Cardenas JC, 2004, FOREST POLICY ECON, V6, P229, DOI 10.1016/j.forpol.2004.03.006; Cardenas JC, 2002, ECOL ECON, V40, P379, DOI 10.1016/S0921-8009(01)00285-3; Cardenas JC, 2003, ADV UNDERSTANDING ST; Chen MH, 2015, APPL MATH COMPUT, V251, P192, DOI 10.1016/j.amc.2014.11.052; CORNES R, 1983, AM ECON REV, V73, P787; Davis DD., 1993, EXP ECON, DOI [10.1515/9780691233376, DOI 10.1515/9780691233376]; Moreno-Sanchez RD, 2010, ECOL ECON, V69, P2557, DOI 10.1016/j.ecolecon.2010.07.032; Gordon HS, 1954, J POLIT ECON, V62, P124, DOI 10.1086/257497; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Herr A, 1997, GAME ECON BEHAV, V19, P77, DOI 10.1006/game.1997.0541; Isaac R. M., 1998, EXP ECON, V1, P191, DOI [DOI 10.1023/, 10.1023/A:1009996324622, DOI 10.1023/A:1009996324622]; Kagel JH, 1995, HDB EXPT EC; Keser C, 1996, ECON LETT, V50, P359, DOI 10.1016/0165-1765(95)00769-5; Meng XK, 2015, PHYS LETT A, V379; Ostrom E, 1998, AM POLIT SCI REV, V92, P1, DOI 10.2307/2585925; Ostrom E., 1991, LAB RES POLITICAL EC, P287; Ostrom E., 1990, GOVERNING COMMONS EV; van Soest D, 2012, USING EXPT METHODS E, P113; vanDijk F, 1997, J PUBLIC ECON, V64, P323, DOI 10.1016/S0047-2727(96)01620-9; Willinger M., 2001, Experimental Economics, V4, P131; Xia CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129542; Xia CY, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/58002	24	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148403	10.1371/journal.pone.0148403	http://dx.doi.org/10.1371/journal.pone.0148403			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6PR	26863228	Green Submitted, Green Published, gold			2022-12-27	WOS:000370046600065
J	Kalia, P; Brooks, RA; Kinrade, SD; Morgan, DJ; Brown, AP; Rushton, N; Jugdaohsingh, R				Kalia, Priya; Brooks, Roger A.; Kinrade, Stephen D.; Morgan, David J.; Brown, Andrew P.; Rushton, Neil; Jugdaohsingh, Ravin			Adsorption of Amorphous Silica Nanoparticles onto Hydroxyapatite Surfaces Differentially Alters Surfaces Properties and Adhesion of Human Osteoblast Cells	PLOS ONE			English	Article							SUBSTITUTED HYDROXYAPATITE; IN-VITRO; GROWTH; RATS; VIVO	Silicon (Si) is suggested to be an important/essential nutrient for bone and connective tissue health. Silicon-substituted hydroxyapatite (Si-HA) has silicate ions incorporated into its lattice structure and was developed to improve attachment to bone and increase new bone formation. Here we investigated the direct adsorption of silicate species onto an HA coated surface as a cost effective method of incorporating silicon on to HA surfaces for improved implant osseointegration, and determined changes in surface characteristics and osteoblast cell adhesion. Plasma-sprayed HA-coated stainless steel discs were incubated in silica dispersions of different concentrations (0-42 mM Si), at neutral pH for 12 h. Adsorbed Si was confirmed by XPS analysis and quantified by ICP-OES analysis following release from the HA surface. Changes in surface characteristics were determined by AFM and measurement of surface wettability. Osteoblast cell adhesion was determined by vinculin plaque staining. Maximum Si adsorption to the HA coated disc occurred after incubation in the 6 mM silica dispersion and decreased progressively with higher silica concentrations, while no adsorption was observed with dispersions below 6 mM Si. Comparison of the Si dispersions that produced the highest and lowest Si adsorption to the HA surface, by TEM-based analysis, revealed an abundance of small amorphous nanosilica species (NSP) of similar to 1.5 nm in diameter in the 6 mM Si dispersion, with much fewer and larger NSP in the 42 mM Si dispersions. 29Si-NMR confirmed that the NSPs in the 6 mM silica dispersion were polymeric and similar in composition to the larger NSPs in the 42 mM Si dispersion, suggesting that the latter were aggregates of the former. Amorphous NSP adsorbed from the 6 mM dispersion on to a HA-coated disc surface increased the surface's water contact angle by 53 degrees, whereas that adsorbed from the 42 mM dispersion decreased the contact angle by 18 degrees, indicating increased and decreased hydrophobicity, respectively. AFM showed an increase in surface roughness of the 6 mM Si treated surface, which correlated well with an increase in number of vinculin plaques. These findings suggest that NSP of the right size (relative to charge) adsorb readily to the HA surface, changing the surface characteristics and, thus, improving osteoblast cell adhesion. This treatment provides a simple way to modify plasma-coated HA surfaces that may enable improved osseointegration of bone implants.	[Kalia, Priya; Brooks, Roger A.; Rushton, Neil] Univ Cambridge, Div Trauma & Orthopaed Surg, Cambridge, England; [Kinrade, Stephen D.] Lakehead Univ, Dept Chem, Thunder Bay, ON P7B 5E1, Canada; [Morgan, David J.] Cardiff Univ, Sch Chem, Cardiff Catalysis Inst, Cardiff CF10 3AX, S Glam, Wales; [Brown, Andrew P.] Univ Leeds, Sch Chem & Proc Engn, Leeds, W Yorkshire, England; [Jugdaohsingh, Ravin] MRC Human Nutr Res, Elsie Widdowson Lab, Cambridge, Cambs, England; [Kalia, Priya] Instinctif Partners, Div Life Sci, London, England	University of Cambridge; Lakehead University; Cardiff University; University of Leeds; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research	Kalia, P (corresponding author), Univ Cambridge, Div Trauma & Orthopaed Surg, Cambridge, England.; Kalia, P (corresponding author), Instinctif Partners, Div Life Sci, London, England.	priyakalia@gmail.com	Morgan, David John/F-6285-2010; , Roger/N-7021-2019	Morgan, David John/0000-0002-6571-5731; Brown, Andy/0000-0001-9692-2154	National Institute of Health Research (NIHR); Medical Research Council [MC_US_A090_0008/U1059]; Engineering and Physical Sciences Research Council (UK) [EP/F019823/1, EP/K023853/1]; Orthopaedic Research UK; EPSRC [EP/E059678/1, EP/F019823/1, EP/P00122X/1, EP/K023853/1] Funding Source: UKRI; MRC [MC_U105960399] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K023853/1, EP/F019823/1, EP/P00122X/1, EP/E059678/1] Funding Source: researchfish; Medical Research Council [MC_U105960399] Funding Source: researchfish	National Institute of Health Research (NIHR)(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Orthopaedic Research UK; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors acknowledge the National Institute of Health Research (NIHR) and the Medical Research Council, grant number MC_US_A090_0008/Unit Programme number U1059, www.mrc.ac.uk, to RJ; Engineering and Physical Sciences Research Council (UK), grant number EP/F019823/1 (https://www.epsrc.ac.uk) to PK, DJM; Engineering and Physical Sciences Research Council (UK), grant number EP/K023853/1 (https://www.epsrc.ac.uk) "Leeds EPSRC Nanoscience and Nanotechnology Research Equipment Facility (LENNF)" to APB and PK. Orthopaedic Research UK Grant "Drug Delivery of Silicon from the Furlong HA-C Hip" (www.oruk.org) to PK, RAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTANKOV G, 1994, J MATER SCI-MATER M, V5, P732, DOI 10.1007/BF00120366; Botelho CM, 2006, J BIOMED MATER RES A, V79A, P723, DOI 10.1002/jbm.a.30806; Botelho CM, 2002, J MATER SCI-MATER M, V13, P1123, DOI 10.1023/A:1021177601899; CARLISLE EM, 1972, SCIENCE, V178, P619, DOI 10.1126/science.178.4061.619; Coathup MJ, 2011, J BONE JOINT SURG AM, V93A, P2219, DOI [10.2106/JBJS.I.01623, 10.2106/JBJS.J.01623]; Gomes PS, 2010, J BIOMED MATER RES B, V94B, P337, DOI 10.1002/jbm.b.31656; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Jugdaohsingh R, 2007, J NUTR HEALTH AGING, V11, P99; Jugdaohsingh R, 2004, J BONE MINER RES, V19, P297, DOI 10.1359/JBMR.0301225; Jugdaohsingh R, 2008, BONE, V43, P596, DOI 10.1016/j.bone.2008.04.014; KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607; Patel N, 2002, J MATER SCI-MATER M, V13, P1199, DOI 10.1023/A:1021114710076; Porter AE, 2004, J BIOMED MATER RES A, V69A, P670, DOI 10.1002/jbm.a.30035; Rai A, 2010, LANGMUIR, V26, P4152, DOI 10.1021/la903366a; Reffitt DM, 2003, BONE, V32, P127, DOI 10.1016/S8756-3282(02)00950-X; RUARDY TG, 1995, J BIOMED MATER RES, V29, P1415, DOI 10.1002/jbm.820291113; SCHWARZ K, 1972, NATURE, V239, P333, DOI 10.1038/239333a0; Tang Q, 2010, J MATER SCI-MATER M, V21, P173, DOI 10.1007/s10856-009-3841-y; Wiens M, 2009, BIOMATERIALS, V30, P1648, DOI 10.1016/j.biomaterials.2008.12.021; Zamir E, 1999, J CELL SCI, V112, P1655; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004; Zou S, 2009, J BIOMED MATER RES B, V90B, P123, DOI 10.1002/jbm.b.31262	22	11	11	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0144780	10.1371/journal.pone.0144780	http://dx.doi.org/10.1371/journal.pone.0144780			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863624	Green Published, Green Accepted, gold			2022-12-27	WOS:000370046600006
J	Marsh, A; Casey-Green, K; Probert, F; Withall, D; Mitchell, DA; Dilly, SJ; James, S; Dimitri, W; Ladwa, SR; Taylor, PC; Singer, DRJ				Marsh, Andrew; Casey-Green, Katherine; Probert, Fay; Withall, David; Mitchell, Daniel A.; Dilly, Suzanne J.; James, Sean; Dimitri, Wade; Ladwa, Sweta R.; Taylor, Paul C.; Singer, Donald R. J.			Simvastatin Sodium Salt and Fluvastatin Interact with Human Gap Junction Gamma-3 Protein	PLOS ONE			English	Article							PHAGE DISPLAY TECHNOLOGY; ENHANCED ATP RELEASE; PANNEXIN CHANNELS; NATURAL-PRODUCTS; CONNEXIN EXPRESSION; MOUSE; IDENTIFICATION; HEMICHANNELS; SEQUENCE; RNA	Finding pleiomorphic targets for drugs allows new indications or warnings for treatment to be identified. As test of concept, we applied a new chemical genomics approach to uncover additional targets for the widely prescribed lipid-lowering pro-drug simvastatin. We used mRNA extracted from internal mammary artery from patients undergoing coronary artery surgery to prepare a viral cardiovascular protein library, using T7 bacteriophage. We then studied interactions of clones of the bacteriophage, each expressing a different cardiovascular polypeptide, with surface-bound simvastatin in 96-well plates. To maximise likelihood of identifying meaningful interactions between simvastatin and vascular peptides, we used a validated photo-immobilisation method to apply a series of different chemical linkers to bind simvastatin so as to present multiple orientations of its constituent components to potential targets. Three rounds of biopanning identified consistent interaction with the clone expressing part of the gene GJC3, which maps to Homo sapiens chromosome 7, and codes for gap junction gamma-3 protein, also known as connexin 30.2/31.3 (mouse connexin Cx29). Further analysis indicated the binding site to be for the N-terminal domain putatively 'regulating' connexin hemichannel and gap junction pores. Using immunohistochemistry we found connexin 30.2/31.3 to be present in samples of artery similar to those used to prepare the bacteriophage library. Surface plasmon resonance revealed that a 25 amino acid synthetic peptide representing the discovered N-terminus did not interact with simvastatin lactone, but did bind to the hydrolysed HMG CoA inhibitor, simvastatin acid. This interaction was also seen for fluvastatin. The gap junction blockers carbenoxolone and flufenamic acid also interacted with the same peptide providing insight into potential site of binding. These findings raise key questions about the functional significance of GJC3 transcripts in the vasculature and other tissues, and this connexin's role in therapeutic and adverse effects of statins in a range of disease states.	[Dilly, Suzanne J.; Ladwa, Sweta R.] Tangent Reprofiling Ltd, Cent Point, SEEK, 45 Beech St, London EC2Y 8AD, England; [James, Sean; Dimitri, Wade; Singer, Donald R. J.] Univ Hosp Coventry & Warwickshire, Clifford Bridge Rd, Coventry CV2 2DX, W Midlands, England; [Marsh, Andrew; Casey-Green, Katherine; Probert, Fay; Withall, David; Taylor, Paul C.] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England; [Singer, Donald R. J.] 11 Chandos St, London W1G 9EB, England; [Singer, Donald R. J.] Univ Warwick, Warwick Med Sch, Clin Sci Res Labs, Div Metab & Vasc Hlth, Coventry CV2 2DX, W Midlands, England	University of Warwick; University of Warwick; University of Warwick	Singer, DRJ (corresponding author), Univ Hosp Coventry & Warwickshire, Clifford Bridge Rd, Coventry CV2 2DX, W Midlands, England.; Marsh, A (corresponding author), Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England.; Singer, DRJ (corresponding author), 11 Chandos St, London W1G 9EB, England.; Singer, DRJ (corresponding author), Univ Warwick, Warwick Med Sch, Clin Sci Res Labs, Div Metab & Vasc Hlth, Coventry CV2 2DX, W Midlands, England.	a.marsh@warwick.ac.uk; fpm.chandos@gmail.com	Marsh, Andrew/F-4478-2011; Mitchell, Daniel/A-6580-2009	Marsh, Andrew/0000-0001-8845-3562; Probert, Fay/0000-0002-8580-2023; Mitchell, Daniel/0000-0003-0936-6212	Engineering and Physical Sciences Research Council, United Kingdom (EPSRC); Tangent Reprofiling Ltd; University of Warwick; Advantage West Midlands (AWM); European Regional Development Fund (ERDF); Biotechnology and Biological Sciences Research Council [BB/C524338/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council, United Kingdom (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Tangent Reprofiling Ltd; University of Warwick; Advantage West Midlands (AWM); European Regional Development Fund (ERDF)(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank the Engineering and Physical Sciences Research Council, United Kingdom (EPSRC), and Tangent Reprofiling Ltd, for funding this study. Katherine Casey-Green received an EPSRC Small and Medium-sized Enterprise Collaborative Award in Science and Engineering (CASE) Studentship with Tangent Reprofiling Limited. Andrew Marsh and Paul Taylor received EPSRC Impact Funding from the University of Warwick, which employed Fay Probert and David Withall. EPSRC played no part in the design of the research or preparation of the manuscript. There are no patents, products in development or marketed products arising from this research to declare. The SPR equipment used in this research was obtained through Birmingham Science City: Innovative Uses for Advanced Materials in the Modern World (West Midlands Centre for Advanced Materials Project 2), with Support from Advantage West Midlands (AWM) and partly funded by the European Regional Development Fund (ERDF). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Abascal F, 2013, BBA-BIOMEMBRANES, V1828, P4, DOI 10.1016/j.bbamem.2012.02.007; Ahn M, 2008, J NEUROSCI RES, V86, P992, DOI 10.1002/jnr.21561; Altevogt BM, 2002, J NEUROSCI, V22, P6458; Altevogt BM, 2000, MOL BIOL CELL, V11, p330A; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; [Anonymous], 2015, GJC3 TISSUE EXPRESSI; Azzazy HME, 2002, CLIN BIOCHEM, V35, P425, DOI 10.1016/S0009-9120(02)00343-0; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bedner P, 2012, BBA-BIOMEMBRANES, V1818, P1971, DOI 10.1016/j.bbamem.2011.10.016; Bento AP, 2014, NUCLEIC ACIDS RES, V42, pD1083, DOI 10.1093/nar/gkt1031; Berger SI, 2011, WIRES SYST BIOL MED, V3, P129, DOI 10.1002/wsbm.114; Beyer EC, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00067; Beyer EC, 2012, BBA-BIOMEMBRANES, V1818, P1823, DOI 10.1016/j.bbamem.2011.10.011; Billaud M, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005824; Billaud M, 2014, PHARMACOL REV, V66, P513, DOI 10.1124/pr.112.007351; Bjaelde RG, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00238; Boehmerle W, 2006, P NATL ACAD SCI USA, V103, P18356, DOI 10.1073/pnas.0607240103; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Bosco D, 2011, PHYSIOL REV, V91, P1393, DOI 10.1152/physrev.00027.2010; Bukauskas FF, 2006, P NATL ACAD SCI USA, V103, P9726, DOI 10.1073/pnas.0603372103; Bulusu KC, 2014, NUCLEIC ACIDS RES, V42, pD1040, DOI 10.1093/nar/gkt1182; Burnham MP, 2014, BRIT J PHARMACOL, V171, P4808, DOI 10.1111/bph.12554; Casey-Green K, 2011, THESIS; Cavaletti G, 2011, LANCET ONCOL, V12, P1151, DOI 10.1016/S1470-2045(11)70131-0; Chadjichristos CE, 2006, CIRCULATION, V113, P2835, DOI 10.1161/CIRCULATIONAHA.106.627703; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cruciani V, 2006, CELL MOL LIFE SCI, V63, P1125, DOI 10.1007/s00018-005-5571-8; D'hondt C, 2013, BIOCHEM BIOPH RES CO, V432, P707, DOI 10.1016/j.bbrc.2013.01.066; Dahl G, 2014, FEBS LETT, V588, P1396, DOI 10.1016/j.febslet.2014.03.007; Dahl G, 2013, NEUROPHARMACOLOGY, V75, P583, DOI 10.1016/j.neuropharm.2013.02.019; Delmar M, 2004, CARDIOVASC RES, V62, P268, DOI 10.1016/j.cardiores.2003.12.030; Derda R, 2011, MOLECULES, V16, P1776, DOI 10.3390/molecules16021776; Derda R, 2010, ANGEW CHEM INT EDIT, V49, P5301, DOI 10.1002/anie.201001143; Dilly SJ, 2007, CHEM COMMUN, P2808, DOI 10.1039/b704271j; Dilly SJ, 2006, LANGMUIR, V22, P8144, DOI 10.1021/la060743j; Dilly SJ, 2011, MOL BIOSYST, V7, P116, DOI 10.1039/c0mb00118j; Duffy HS, 2001, CELL COMMUN ADHES, V8, P225, DOI 10.3109/15419060109080728; Eiberger J, 2001, CELL COMMUN ADHES, V8, P163, DOI 10.3109/15419060109080717; Favis R, 2011, PHARMACOGENET GENOM, V21, P121, DOI 10.1097/FPC.0b013e3283436b45; Firth AE, 2012, J GEN VIROL, V93, P1385, DOI 10.1099/vir.0.042499-0; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gnanasekar M, 2009, ANTIMICROB AGENTS CH, V53, P1054, DOI 10.1128/AAC.01222-08; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Grosely R, 2013, J BIOL CHEM, V288, P24857, DOI 10.1074/jbc.M113.454389; Harris AL D., 2009, CONNEXINS A GUIDE; Herve JC, 2012, BBA-BIOMEMBRANES, V1818, P1844, DOI 10.1016/j.bbamem.2011.12.009; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Jayasinghe S, 2001, J MOL BIOL, V312, P927, DOI 10.1006/jmbi.2001.5008; Kalmatsky BD, 2012, ARCH BIOCHEM BIOPHYS, V526, P1, DOI 10.1016/j.abb.2012.05.027; Kang M, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0058-6; Kanoh N, 2005, ANGEW CHEM INT EDIT, V44, P3559, DOI 10.1002/anie.200462370; Kanoh N, 2003, ANGEW CHEM INT EDIT, V42, P5584, DOI 10.1002/anie.200352164; Knezl V, 2008, NEUROENDOCRINOL LETT, V29, P798; Koh KK, 2011, ATHEROSCLEROSIS, V215, P1, DOI 10.1016/j.atherosclerosis.2010.10.036; Kramer RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng058; Krumpe LRH, 2006, PROTEOMICS, V6, P4210, DOI 10.1002/pmic.200500606; Kwak BR, 2002, ARTERIOSCL THROM VAS, V22, P225, DOI 10.1161/hq0102.104125; Kyle JW, 2009, J BIOL CHEM, V284, P20418, DOI 10.1074/jbc.M109.016907; Ladwa SR, 2008, CHEMMEDCHEM, V3, P742, DOI 10.1002/cmdc.200700317; Leslie BJ, 2008, CHEM SOC REV, V37, P1347, DOI 10.1039/b702942j; Lewandowski Rebecca, 2009, P129, DOI 10.1007/978-1-59745-489-6_5; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; Li J, 2007, GLIA, V55, P93, DOI 10.1002/glia.20427; Li X, 2004, NEUROSCIENCE, V126, P611, DOI 10.1016/j.neuroscience.2004.03.063; Liang WG, 2011, CELL BIOCHEM BIOPHYS, V61, P189, DOI 10.1007/s12013-011-9188-2; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Lohman AW, 2014, FEBS LETT, V588, P1379, DOI 10.1016/j.febslet.2014.02.004; Lohman AW, 2012, CARDIOVASC RES, V95, P269, DOI 10.1093/cvr/cvs187; MA PTS, 1986, P NATL ACAD SCI USA, V83, P8370, DOI 10.1073/pnas.83.21.8370; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Martinez AD, 2011, BIOCHEM J, V436, P35, DOI 10.1042/BJ20110008; Meigh L, 2013, ELIFE, V2, DOI 10.7554/eLife.01213; Moreno AP, 2007, PROG BIOPHYS MOL BIO, V94, P107, DOI 10.1016/j.pbiomolbio.2007.03.004; Nagy JI, 2003, J COMP NEUROL, V464, P356, DOI 10.1002/cne.10797; Nakagawa S, 2010, CURR OPIN STRUC BIOL, V20, P423, DOI 10.1016/j.sbi.2010.05.003; Nickel R, 2008, CURR OPIN OTOLARYNGO, V16, P452, DOI 10.1097/MOO.0b013e32830e20b0; Nigam SK, 2015, NAT REV DRUG DISCOV, V14, P29, DOI 10.1038/nrd4461; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oh S, 2004, BIOPHYS J, V87, P912, DOI 10.1529/biophysj.103.038448; Oshima A, 2011, J MOL BIOL, V405, P724, DOI 10.1016/j.jmb.2010.10.032; Peddibhotla S, 2007, J AM CHEM SOC, V129, P12222, DOI 10.1021/ja0733686; Penuela S, 2014, BIOCHEM J, V461, P371, DOI 10.1042/BJ20140447; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prueksaritanont T, 2002, DRUG METAB DISPOS, V30, P505, DOI 10.1124/dmd.30.5.505; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; R Core Team, 2012, R LANG ENV STAT COMP; Riedmaier S, 2010, CLIN PHARMACOL THER, V87, P65, DOI 10.1038/clpt.2009.181; Robles O, 2014, NAT PROD REP, V31, P318, DOI 10.1039/c3np70087a; Ruan J, 2008, NUCLEIC ACIDS RES, V36, pD735, DOI 10.1093/nar/gkm1005; Saba TG, 2005, HUM GENET, V116, P167, DOI 10.1007/s00439-004-1193-8; Sargiannidou I, 2008, NEUROBIOL DIS, V30, P221, DOI 10.1016/j.nbd.2008.01.009; Sche PP, 1999, CHEM BIOL, V6, P707, DOI 10.1016/S1074-5521(00)80018-6; Severs NJ, 2008, CARDIOVASC RES, V80, P9, DOI 10.1093/cvr/cvn133; Shen J, 2010, J CARDIOVASC PHARM T, V15, P296, DOI 10.1177/1074248410373750; Shitara Y, 2006, PHARMACOL THERAPEUT, V112, P71, DOI 10.1016/j.pharmthera.2006.03.003; Skottheim IB, 2008, EUR J PHARM SCI, V33, P317, DOI 10.1016/j.ejps.2007.12.009; Snider C, 2009, PROTEIN SCI, V18, P2624, DOI 10.1002/pro.256; Sohl G, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00083; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Sohl G, 2003, CELL COMMUN ADHES, V10, P27, DOI 10.1080/15419060390220468; Sohl G, 2001, BIOL CHEM, V382, P973, DOI 10.1515/BC.2001.122; Sonntag S, 2009, EUR J CELL BIOL, V88, P65, DOI 10.1016/j.ejcb.2008.08.004; Sosinsky GE, 2011, CHANNELS, V5, P193, DOI 10.4161/chan.5.3.15765; Su C-C, 2012, CELL BIOCH BIOPHYS, P1; Takakusagi Y, 2010, EXPERT OPIN DRUG DIS, V5, P361, DOI 10.1517/17460441003653155; Taylor PC, 2013, CHEM COMMUN, V49, P9588, DOI 10.1039/c3cc44647f; Tovar KR, 2009, J NEUROPHYSIOL, V102, P974, DOI 10.1152/jn.00060.2009; Tribulova N, 2008, PHYSIOL RES, V57, pS1, DOI 10.33549/physiolres.931546; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Verselis VK, 2013, NEUROPHARMACOLOGY, V75, P517, DOI 10.1016/j.neuropharm.2013.03.020; Vodnik M, 2011, MOLECULES, V16, P790, DOI 10.3390/molecules16010790; Wang LH, 2005, INT J CARDIOL, V100, P467, DOI 10.1016/j.ijcard.2004.12.005; Wang WH, 2010, AUDIOL NEURO-OTOL, V15, P81, DOI 10.1159/000231633; Wang WH, 2001, MOL VIS, V7, P89; Wang X, 2012, BBA-BIOMEMBRANES, V1818, P1148, DOI 10.1016/j.bbamem.2011.12.027; Weitz-Schmidt G, 2001, NAT MED, V7, P687, DOI 10.1038/89058; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076; Yang JJ, 2005, BIOCHEM BIOPH RES CO, V338, P723, DOI 10.1016/j.bbrc.2005.09.193; Zhou CY, 2010, ORG LETT, V12, P2104, DOI 10.1021/ol100587j; Zhou QH, 2013, J AM CHEM SOC, V135, P12994, DOI 10.1021/ja407739y; Zhou YB, 2007, J BIOL CHEM, V282, P35005, DOI 10.1074/jbc.M707728200	123	2	2	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148266	10.1371/journal.pone.0148266	http://dx.doi.org/10.1371/journal.pone.0148266			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863535	Green Published, gold			2022-12-27	WOS:000370046600050
J	Li, ZY; Huang, ZY; Sharma, DB; Xue, YB; Wang, Z; Ren, BZ				Li, Zhiyong; Huang, Zachary Y.; Sharma, Dhruv B.; Xue, Yunbo; Wang, Zhi; Ren, Bingzhong			Drone and Worker Brood Microclimates Are Regulated Differentially in Honey Bees, Apis mellifera	PLOS ONE			English	Article							COLONIAL THERMOREGULATION; PUPAL DEVELOPMENT; TEMPERATURE; NEST; ORGANIZATION; DIVERSITY; HUMIDITY	Background Honey bee (Apis mellifera) drones and workers show differences in morphology, physiology, and behavior. Because the functions of drones are more related to colony reproduction, and those of workers relate to both survival and reproduction, we hypothesize that the microclimate for worker brood is more precisely regulated than that of drone brood. Methodology/Principal Findings We assessed temperature and relative humidity (RH) inside honey bee colonies for both drone and worker brood throughout the three-stage development period, using digital HOBO (R) Data Loggers. The major findings of this study are that 1) both drone and worker castes show the highest temperature for eggs, followed by larvae and then pupae; 2) temperature in drones are maintained at higher precision (smaller variance) in drone eggs and larvae, but at a lower precision in pupae than the corresponding stages of workers; 3) RH regulation showed higher variance in drone than workers across all brood stages; and 4) RH regulation seems largely due to regulation by workers, as the contribution from empty honey combs are much smaller compared to that from adult workers. Conclusions/Significance We conclude that honey bee colonies maintain both temperature and humidity actively; that the microclimate for sealed drone brood is less precisely regulated than worker brood; and that combs with honey contribute very little to the increase of RH in honey bee colonies. These findings increase our understanding of microclimate regulation in honey bees and may have implications for beekeeping practices.	[Li, Zhiyong; Ren, Bingzhong] NE Normal Univ, Sch Life Sci, Jilin Key Lab Anim Resource Conservat & Utilizat, Changchun, Jilin Province, Peoples R China; [Li, Zhiyong; Xue, Yunbo; Wang, Zhi] Jilin Inst Apicultural Res, Jilin, Jilin Province, Peoples R China; [Huang, Zachary Y.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [Sharma, Dhruv B.] Michigan State Univ, Ctr Stat Training & Consulting, E Lansing, MI 48824 USA	Northeast Normal University - China; Michigan State University; Michigan State University	Ren, BZ (corresponding author), NE Normal Univ, Sch Life Sci, Jilin Key Lab Anim Resource Conservat & Utilizat, Changchun, Jilin Province, Peoples R China.; Huang, ZY (corresponding author), Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA.	bees@msu.edu; bzren@163.com	Huang, Zachary/D-5485-2011	Huang, Zachary/0000-0001-5354-5547	Natural Science Foundation of Jilin Province [20101574]; Special Fund for Agro-scientific Research in the Public Interest [201203080-3]	Natural Science Foundation of Jilin Province; Special Fund for Agro-scientific Research in the Public Interest	This work was supported by the Natural Science Foundation of Jilin Province (No. 20101574) and Special Fund for Agro-scientific Research in the Public Interest (201203080-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, SAS MIXED MODELS; Aronstein KA, 2010, J INVERTEBR PATHOL, V103, pS20, DOI 10.1016/j.jip.2009.06.018; Bujok B, 2002, NATURWISSENSCHAFTEN, V89, P299, DOI 10.1007/s00114-002-0338-7; Cook CN, 2013, ANIM BEHAV, V86, P323, DOI 10.1016/j.anbehav.2013.05.021; DOULL K M, 1976, Apidologie, V7, P61, DOI 10.1051/apido:19760104; Ellis MB, 2010, NATURWISSENSCHAFTEN, V97, P429, DOI 10.1007/s00114-010-0655-1; Ellis MB, 2008, J INSECT PHYSIOL, V54, P1516, DOI 10.1016/j.jinsphys.2008.08.011; ESCH H, 1991, NATURWISSENSCHAFTEN, V78, P325, DOI 10.1007/BF01221422; FREE JB, 1975, ANIM BEHAV, V23, P650, DOI 10.1016/0003-3472(75)90143-8; Graham S, 2006, INSECT SOC, V53, P226, DOI 10.1007/s00040-005-0862-5; Groh C, 2004, P NATL ACAD SCI USA, V101, P4268, DOI 10.1073/pnas.0400773101; HIMMER A., 1927, ZEITSCHR WISSENSCHAFT BIOL ABT C ZEITSCHR VERGLEICH PHYSIOL, V5, P375; Hrassnigg N, 2005, APIDOLOGIE, V36, P255, DOI 10.1051/apido:2005015; Human H, 2006, NATURWISSENSCHAFTEN, V93, P397, DOI 10.1007/s00114-006-0117-y; Jones JC, 2004, SCIENCE, V305, P402, DOI 10.1126/science.1096340; Jones JC, 2007, ADV INSECT PHYSIOL, V33, P153, DOI 10.1016/S0065-2806(06)33003-2; Kleinhenz M, 2003, J EXP BIOL, V206, P4217, DOI 10.1242/jeb.00680; KRONENBERG F, 1982, J COMP PHYSIOL, V148, P65, DOI 10.1007/BF00688889; LE CONTE Y, 1990, ENVIRON ENTOMOL, V19, P1780, DOI 10.1093/ee/19.6.1780; LEVIN CG, 1990, J APICULT RES, V29, P35, DOI 10.1080/00218839.1990.11101195; LINDAUER M., 1955, BEE WORLD, V36, P62; SEELEY TD, 1974, J INSECT PHYSIOL, V20, P2301, DOI 10.1016/0022-1910(74)90052-3; Seeley TD, 2003, INSECT SOC, V50, P134, DOI 10.1007/s00040-003-0638-8; Seeley TD, 2002, BIOL BULL-US, V202, P314, DOI 10.2307/1543484; SIMPSON J, 1961, SCIENCE, V133, P1327, DOI 10.1126/science.133.3461.1327; SOUTHWICK EE, 1987, J INSECT PHYSIOL, V33, P623, DOI 10.1016/0022-1910(87)90130-2; SOUTHWICK EE, 1991, BEHAVIOUR AND PHYSIOLOGY OF BEES, P28; Stabentheiner A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008967; Starks PT, 2000, NATURWISSENSCHAFTEN, V87, P229, DOI 10.1007/s001140050709; Starks PT, 1999, NATURWISSENSCHAFTEN, V86, P438, DOI 10.1007/s001140050648; Tautz J, 2003, P NATL ACAD SCI USA, V100, P7343, DOI 10.1073/pnas.1232346100; Weidenmuller A, 2002, ANIM BEHAV, V63, P1065, DOI 10.1006/anbe.2002.3020; Wharton KE, 2008, BEHAV ECOL, V19, P1075, DOI 10.1093/beheco/arn108; Winston Mark, 1991, BIOL HONEY BEE, P199; [No title captured]	35	9	11	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148740	10.1371/journal.pone.0148740	http://dx.doi.org/10.1371/journal.pone.0148740			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882104	Green Published, gold			2022-12-27	WOS:000371219000021
J	Lui, NS; Yang, YW; van Zante, A; Buchanan, P; Jablons, DM; Lemjabbar-Alaoui, H				Lui, Natalie S.; Yang, Yi-Wei; van Zante, Annemieke; Buchanan, Petra; Jablons, David M.; Lemjabbar-Alaoui, Hassan			SULF2 Expression Is a Potential Diagnostic and Prognostic Marker in Lung Cancer	PLOS ONE			English	Article							TYROSINE KINASE INHIBITORS; HEPARAN-SULFATE; EXTRACELLULAR SULFATASES; HEPATOCELLULAR-CARCINOMA; PANCREATIC-CANCER; GROWTH; HSULF-1; GENES; CELLS; CHEMOSENSITIVITY	Aims Lung cancer is one of the most deadly cancers; median survival from diagnosis is less than one year in those with advanced disease. Novel lung cancer biomarkers are desperately needed. In this study, we evaluated SULF2 expression by immunohistochemistry and its association with overall survival in a cohort of patients with non-small cell lung cancer (NSCLC). We also looked for the presence of SULF2 protein in plasma to evaluate its potential as an early detection biomarker for NSCLC. Methods We identified patients who underwent surgical resection for pulmonary adenocarcinoma or squamous cell carcinoma at our institution. A section from each paraffin-embedded specimen was stained with a SULF2 antibody. A pathologist determined the percentage and intensity of tumor cell staining. Survival analysis was performed using a multivariate Cox proportional hazards model. Using a novel SULF2 ELISA assay, we analyzed plasma levels of SULF2 in a small cohort of healthy donors and patients with early stage NSCLC. Results SULF2 staining was present in 82% of the lung cancer samples. Squamous cell carcinomas had a higher mean percentage of staining than adenocarcinomas (100% vs. 60%; p<0.0005). After adjusting for age, sex, race, histologic type, stage, and neoadjuvant therapy, there was a non- significant (31%; p = 0.65) increase in the risk of death for patients with adenocarcinoma with SULF2 staining in tumor cells. In contrast, there was a significant decrease in the risk of death (89%; p = 0.02) for patients with squamous cell carcinoma with SULF2 staining in tumor cells. SULF2 protein was present in plasma of patients with early stage NSCLC, and soluble SULF2 levels increased with age. Finally, plasma SULF2 levels were significantly elevated in early stage NSCLC patients, compared to healthy controls. Conclusions Tumor expression of SULF2 may affect prognosis in NSCLC, while blood SULF2 levels may have a significant role in the diagnosis of this fatal disease.	[Lui, Natalie S.; Yang, Yi-Wei; Buchanan, Petra; Jablons, David M.; Lemjabbar-Alaoui, Hassan] Univ Calif San Francisco, Dept Surg, Thorac Oncol Program, San Francisco, CA USA; [van Zante, Annemieke] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lemjabbar-Alaoui, H (corresponding author), Univ Calif San Francisco, Dept Surg, Thorac Oncol Program, San Francisco, CA USA.	hassan.lemjabbar-alaoui@ucsf.edu			National Cancer Institute (NCI), National Institutes of Health (NIH), NIH/NCI [U01CA168878]; NATIONAL CANCER INSTITUTE [U01CA168878] Funding Source: NIH RePORTER	National Cancer Institute (NCI), National Institutes of Health (NIH), NIH/NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH), NIH/NCI U01 grant U01CA168878 (http://www.nih.gov/about/almanac/organization/NCI.htm). The recipient of this grant is HLA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bret C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-72; Dai YM, 2005, J BIOL CHEM, V280, P40066, DOI 10.1074/jbc.M508136200; Engelman JA, 2008, CLIN CANCER RES, V14, P2895, DOI 10.1158/1078-0432.CCR-07-2248; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Fossella F, 2003, J CLIN ONCOL, V21, P3016, DOI 10.1200/JCO.2003.12.046; Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI13713; Howlader N, 2015, SEER CANC STAT REV 1; Johansson FK, 2005, ONCOGENE, V24, P3896, DOI 10.1038/sj.onc.1208553; Johansson FK, 2004, P NATL ACAD SCI USA, V101, P11334, DOI 10.1073/pnas.0402716101; Kumar V, 2005, LUNG CANC ROBBINS CO; Lai JP, 2008, HEPATOLOGY, V47, P1211, DOI 10.1002/hep.22202; Lai JP, 2010, HEPATOLOGY, V52, P1680, DOI 10.1002/hep.23848; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Lei WD, 1999, ANTICANCER RES, V19, P221; Lemjabbar-Alaoui H, 2010, ONCOGENE, V29, P635, DOI 10.1038/onc.2009.365; Li JS, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-14; Lui NS, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001624; Minna JD, 2006, HARRISONS PRINCIPLES; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Nawroth R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000392; Osada H, 2002, ONCOGENE, V21, P7421, DOI 10.1038/sj.onc.1205802; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Phillips JJ, 2012, J CLIN INVEST, V122, P911, DOI 10.1172/JCI58215; Proctor RN, 2001, NAT REV CANCER, V1, P82, DOI 10.1038/35094091; Rosen SD, 2010, EXPERT OPIN THER TAR, V14, P935, DOI 10.1517/14728222.2010.504718; Sato M, 2007, J THORAC ONCOL, V2, P327, DOI 10.1097/01.JTO.0000263718.69320.4c; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Singer MS, 2015, CLIN CHIM ACTA, V440, P72, DOI 10.1016/j.cca.2014.10.038; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Society AC, 2015, CANC FACTS FIG 2015; Tessema M, 2011, ONCOGENE, V12, P1; Uchimura K, 2006, METHOD ENZYMOL, V416, P243, DOI 10.1016/S0076-6879(06)16015-2; Uchimura Kenji, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-2; Vicente CM, 2015, MOL CANCER RES, V13, P510, DOI 10.1158/1541-7786.MCR-14-0372; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang L, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-173	38	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148911	10.1371/journal.pone.0148911	http://dx.doi.org/10.1371/journal.pone.0148911			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882224	Green Published, gold			2022-12-27	WOS:000371219000032
J	Czub, B; Shah, AZ; Alfano, G; Kruczek, PM; Chakarova, CF; Bhattacharya, SS				Czub, Barbara; Shah, Amna Z.; Alfano, Giovanna; Kruczek, Przemyslaw M.; Chakarova, Christina F.; Bhattacharya, Shomi S.			TOPORS, a Dual E3 Ubiquitin and Sumo1 Ligase, Interacts with 26 S Protease Regulatory Subunit 4, Encoded by the PSMC1 Gene	PLOS ONE			English	Article							DOMINANT RETINITIS-PIGMENTOSA; PARKINSONS-DISEASE; RETINAL DEGENERATION; TOPOISOMERASE-I; MOUSE-BRAIN; SYSTEM; P53; LOCALIZATION; BINDING; NEURODEGENERATION	The significance of the ubiquitin-proteasome system (UPS) for protein degradation has been highlighted in the context of neurodegenerative diseases, including retinal dystrophies. TOPORS, a dual E3 ubiquitin and SUMO1 ligase, forms a component of the UPS and selected substrates for its enzymatic activities, such as DJ-1/PARK7 and APOBEC2, are important for neuronal as well as retinal homeostasis, respectively. TOPORS is ubiquitously expressed, yet its mutations are only known to result in autosomal dominant retinitis pigmentosa. We performed a yeast two-hybrid (Y2H) screen of a human retinal cDNA library in order to identify interacting protein partners of TOPORS from the retina, and thus begin delineating the putative disease mechanism(s) associated with the retina-specific phenotype resulting from mutations in TOPORS. The screen led to isolation of the 26 S protease regulatory subunit 4 (P26s4/PSMC1), an ATPase indispensable for correct functioning of UPS-mediated proteostasis. The interaction between endogenous TOPORS and P26s4 proteins was validated by co-immuno-precipitation from mammalian cell extracts and further characterised by immunofluorescent co-localisation studies in cell lines and retinal sections. Findings from hTERT-RPE1 and 661W cells demonstrated that TOPORS and P26s4 co-localise at the centrosome in cultured cells. Immunofluorescent staining of mouse retinae revealed a strong P26s4 reactivity at the interface between retinal pigmented epithelium (RPE) layer and the photoreceptors outer segments (OS). This finding leads us to speculate that P26s4, along with TOPORS, may have a role(s) in RPE phagocytosis, in addition to contributing to the overall photoreceptor and retinal homeostasis via the UPS.	[Czub, Barbara; Shah, Amna Z.; Alfano, Giovanna; Kruczek, Przemyslaw M.; Chakarova, Christina F.; Bhattacharya, Shomi S.] UCL, Inst Ophthalmol, London EC1V 9EL, England; [Bhattacharya, Shomi S.] Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Seville 41092, Spain	University of London; University College London; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER)	Czub, B; Shah, AZ (corresponding author), UCL, Inst Ophthalmol, London EC1V 9EL, England.	barbara.czub.10@ucl.ac.uk; amna.shah@ucl.ac.uk	Bhattacharya, Shom/N-2926-2016	Bhattacharya, Shom/0000-0002-1601-6344; Kramarz, Barbara/0000-0002-3898-1727	BRITISH EYE RESEARCH FOUNDATION (Fight for Sight) [1111438, 1816]; THE TERESA ROSENBAUM GOLDEN CHARITABLE TRUST (Rosetrees Trust) [298582, M233-CD1]; THE SPECIAL TRUSTEES OF MOORFIELDS EYE HOSPITAL GENERAL FUND [228064]; MOORFIELDS EYE CHARITY (Moorfields Eye Hospital NHS Foundation Trust) [1140679]; National Institute for Health Research	BRITISH EYE RESEARCH FOUNDATION (Fight for Sight); THE TERESA ROSENBAUM GOLDEN CHARITABLE TRUST (Rosetrees Trust); THE SPECIAL TRUSTEES OF MOORFIELDS EYE HOSPITAL GENERAL FUND; MOORFIELDS EYE CHARITY (Moorfields Eye Hospital NHS Foundation Trust); National Institute for Health Research(National Institute for Health Research (NIHR))	The work was funded by the following: 1. BRITISH EYE RESEARCH FOUNDATION (Fight for Sight; charity number 1111438): www.fightforsight.org.uk (PhD Studentship 1816 grant to BC and SSB); 2. THE TERESA ROSENBAUM GOLDEN CHARITABLE TRUST (Rosetrees Trust; charity number 298582): www.rosetreestrust.co.uk (Grant number M233-CD1 to BC AZS GA SSB); 3. THE SPECIAL TRUSTEES OF MOORFIELDS EYE HOSPITAL GENERAL FUND (Charity number 228064): www.moorfields.nhs.uk (Personal award to SSB for infrastructures); 4. MOORFIELDS EYE CHARITY (Moorfields Eye Hospital NHS Foundation Trust; charity number 1140679): www.moorfields.nhs.uk (Personal award to SSB for infrastructures); and 5. National Institute for Health Research: http://www.nihr.ac.uk (Personal award to SSB for infrastructures).	Anderson R.E., 2010, RETINAL DEGENERATIVE; Ardley HC, 2005, FEBS LETT, V579, P571, DOI 10.1016/j.febslet.2004.12.058; Bedford L, 2008, J NEUROSCI, V28, P8189, DOI 10.1523/JNEUROSCI.2218-08.2008; Bettencourt-Dias M, 2008, TRENDS CELL BIOL, V18, P8, DOI 10.1016/j.tcb.2007.11.002; Bowne SJ, 2008, MOL VIS, V14, P922; Campello L, 2013, MOL NEUROBIOL, V47, P790, DOI 10.1007/s12035-012-8391-5; Chakarova CF, 2007, AM J HUM GENET, V81, P1098, DOI 10.1086/521953; Chakarova CF, 2011, HUM MOL GENET, V20, P975, DOI 10.1093/hmg/ddq543; Chih B, 2012, NAT CELL BIOL, V14, P61, DOI 10.1038/ncb2410; Denuc A, 2010, BIOCHEM SOC T, V38, P34, DOI 10.1042/BST0380034; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gomez-Garre P, 2012, EUR NEUROL, V68, P193, DOI 10.1159/000339003; Haluska P, 1999, NUCLEIC ACIDS RES, V27, P2538, DOI 10.1093/nar/27.12.2538; Hsiao Yi-Chun, 2012, Cilia, V1, P4, DOI 10.1186/2046-2530-1-4; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; Kato I, 2013, MOL CELL BIOL, V33, P340, DOI 10.1128/MCB.01350-12; Kee H Lynn, 2013, Cilia, V2, P11, DOI 10.1186/2046-2530-2-11; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kimura A, 2012, BIOCHEMISTRY-US, V51, P8856, DOI 10.1021/bi3007862; Lee KH, 2012, PLANT SIGNAL BEHAV, V7, P973, DOI 10.4161/psb.20934; Lieberman AP, 1998, LANCET, V351, P884, DOI 10.1016/S0140-6736(05)70296-8; Lipson C, 2008, J BIOL CHEM, V283, P7166, DOI 10.1074/jbc.M705893200; Liu YP, 2014, J CLIN INVEST, V124, P2059, DOI 10.1172/JCI71898; Lobanova ES, 2013, P NATL ACAD SCI USA, V110, P9986, DOI 10.1073/pnas.1305521110; Martins-Branco D, 2012, EXP NEUROL, V238, P89, DOI 10.1016/j.expneurol.2012.08.008; Mazelova J, 2009, EMBO J, V28, P183, DOI 10.1038/emboj.2008.267; McNaught KSP, 2001, NAT REV NEUROSCI, V2, P589, DOI 10.1038/35086067; Miteva M, 2010, SUBCELL BIOCHEM, V54, P195, DOI 10.1007/978-1-4419-6676-6_16; Nozawa YI, 2013, CURR OPIN GENET DEV, V23, P429, DOI 10.1016/j.gde.2013.04.008; Paine SML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054711; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Park HJ, 2008, BIOCHEMISTRY-US, V47, P13887, DOI 10.1021/bi801904q; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Powell C, 2014, J BIOL CHEM, V289, P28924, DOI 10.1074/jbc.M114.603043; Pungaliya P, 2007, J PROTEOME RES, V6, P3918, DOI 10.1021/pr0703674; Puram SV, 2013, CELL REP, V4, P19, DOI 10.1016/j.celrep.2013.06.006; Rachel Rivka A, 2012, Cilia, V1, P22, DOI 10.1186/2046-2530-1-22; Rajendra R, 2004, J BIOL CHEM, V279, P36440, DOI 10.1074/jbc.C400300200; Rezvani N, 2012, NEUROSCI LETT, V521, P130, DOI 10.1016/j.neulet.2012.05.070; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Selmer KK, 2010, ACTA OPHTHALMOL, V88, P323, DOI 10.1111/j.1755-3768.2008.01465.x; Shinbo YM, 2005, INT J ONCOL, V26, P641; Simossis V., 2003, CURR PROTOC BIOINFOR; Sullivan LS, 2013, INVEST OPHTHALMOL VI; Tanahashi N, 1998, BIOCHEM BIOPH RES CO, V243, P229, DOI 10.1006/bbrc.1997.7892; Tosini G, 2014, SPR SER VIS RES, V1, P1, DOI 10.1007/978-1-4614-9613-7; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Weger S, 2005, FEBS LETT, V579, P5007, DOI 10.1016/j.febslet.2005.07.088; Weger S, 2003, EXP CELL RES, V290, P13, DOI 10.1016/S0014-4827(03)00292-1; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Wigley WC, 1999, J CELL BIOL, V145, P481; Wilson VG, 2008, EXPERT REV PROTEOMIC, V5, P121, DOI 10.1586/14789450.5.1.121; Yang XM, 2009, J BIOL CHEM, V284, P18588, DOI 10.1074/jbc.C109.001560; Ying MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023863; Zhou R, 1999, GENE, V235, P93, DOI 10.1016/S0378-1119(99)00203-6	56	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148678	10.1371/journal.pone.0148678	http://dx.doi.org/10.1371/journal.pone.0148678			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872363	Green Published, gold			2022-12-27	WOS:000370054100049
J	Kaasboll, OJ; Moe, IT; Ahmed, MS; Stang, E; Hagelin, EMV; Attramadal, H				Kaasboll, Ole Jorgen; Moe, Ingvild Tronstad; Ahmed, Mohammad Shakil; Stang, Espen; Hagelin, Else Marie Valbjorn; Attramadal, Havard			CTGF/CCN2 Postconditioning Increases Tolerance of Murine Hearts towards Ischemia-Reperfusion Injury	PLOS ONE			English	Article							TISSUE-GROWTH-FACTOR; PERCUTANEOUS CORONARY INTERVENTION; FIBROBLAST PROLIFERATION; CARDIAC-HYPERTROPHY; CCN FAMILY; PROTECTION; PROTEINS; DYSFUNCTION; ACTIVATION; MECHANISMS	Background and Purpose Previous studies of ischemia-reperfusion injury (IRI) in hearts from mice with cardiacrestricted overexpression of CCN2 have shown that CCN2 increases tolerance towards IRI. The objectives of this study were to investigate to what extent post-ischemic administration of recombinant human CCN2 (rhCCN2) would limit infarct size and improve functional recovery and what signaling pathways are involved. Experimental Approach Isolated mice hearts were perfused ad modum Langendorff, subjected to no-flow, global ischemia, and subsequently, exposed to mammalian cell derived, full-length (38-40kDa) rhCCN2 (250 nM) or vehicle during the first 15 min of a 60 min reperfusion period. Key Results Post-ischemic administration of rhCCN2 resulted in attenuation of infarct size from 58 +/- 4% to 34 +/- 2% (p < 0.001) which was abrogated by concomitant administration of the PI3 kinase inhibitor LY294002 (45 +/- 3% vs. 50 +/- 3%, ns). In congruence with reduction of infarct size rhCCN2 also improved recovery of left ventricular developed pressure (p < 0.05). Western blot analyses of extracts of ex vivo-perfused murine hearts also revealed that rhCCN2 evoked concentration-dependent increase of cardiac phospho-GSK3 beta (serine-9) contents. Conclusions and Implications We demonstrate that post-ischemic administration of rhCCN2 increases the tolerance of ex vivo-perfused murine hearts to IRI. Mechanistically, this postconditioning effect of rhCCN2 appeared to be mediated by activation of the reperfusion injury salvage kinase pathway as demonstrated by sensitivity to PI3 kinase inhibition and increased CCN2-induced phosphorylation of GSK3 beta (Ser - 9). Thus, the rationale for testing rhCCN2-mediated post-ischemic conditioning of the heart in more complex models is established.	[Kaasboll, Ole Jorgen; Moe, Ingvild Tronstad; Ahmed, Mohammad Shakil; Hagelin, Else Marie Valbjorn; Attramadal, Havard] Oslo Univ Hosp, Inst Surg Res, Oslo, Norway; [Kaasboll, Ole Jorgen; Moe, Ingvild Tronstad; Ahmed, Mohammad Shakil; Hagelin, Else Marie Valbjorn; Attramadal, Havard] Univ Oslo, Oslo, Norway; [Kaasboll, Ole Jorgen; Moe, Ingvild Tronstad; Ahmed, Mohammad Shakil; Hagelin, Else Marie Valbjorn; Attramadal, Havard] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway; [Stang, Espen] Oslo Univ Hosp, Dept Pathol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo	Attramadal, H (corresponding author), Oslo Univ Hosp, Inst Surg Res, Oslo, Norway.; Attramadal, H (corresponding author), Univ Oslo, Oslo, Norway.; Attramadal, H (corresponding author), Univ Oslo, Ctr Heart Failure Res, Oslo, Norway.	havard.attramadal@medisin.uio.no		Attramadal, Havard/0000-0001-9506-0687	South Eastern Norway Regional Health Authority [OUS30334_HSO2010, OUS39315_HSO2011006]; Norwegian Council on Cardiovascular Disease [2010.ST.068, 2011.DR.100]	South Eastern Norway Regional Health Authority; Norwegian Council on Cardiovascular Disease	This study was supported by grants from The South Eastern Norway Regional Health Authority (http://www.helse-sorost.no/omoss_/english_/) - grant no. OUS30334_HSO2010 (HA) and grant no. OUS39315_HSO2011006 (HA) and grants from the Norwegian Council on Cardiovascular Disease (http://www.nasjonalforeningen.no/no/Hjerte/Hjerteforskning/Forskningsprosjekter/) - grant no. 2010.ST.068 (HA; fellowship to OJK) and grant no. 2011.DR.100 (HA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Accornero F, 2015, MOL CELL BIOL, V35, P2154, DOI 10.1128/MCB.00199-15; Ahmed MS, 2011, AM J PHYSIOL-HEART C, V300, pH1291, DOI 10.1152/ajpheart.00604.2010; Ahmed MS, 2004, J MOL CELL CARDIOL, V36, P393, DOI 10.1016/j.yjmcc.2003.12.004; Bohr W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0016000; Chen CC, 2007, EMBO J, V26, P1257, DOI 10.1038/sj.emboj.7601596; Crean JK, 2006, FASEB J, V20, P1712, DOI 10.1096/fj.05-5010fje; Durgan DJ, 2010, CIRC RES, V106, P546, DOI 10.1161/CIRCRESAHA.109.209346; Frangogiannis NG, 2012, PHYSIOL REV, V92, P635, DOI 10.1152/physrev.00008.2011; Gravning J, 2013, INT J CARDIOL, V168, P2049, DOI 10.1016/j.ijcard.2013.01.165; Gravning J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052120; Grotendorst GR, 2005, FASEB J, V19, P729, DOI 10.1096/fj.04-3217com; Grotendorst GR, 2004, FASEB J, V18, P469, DOI 10.1096/fj.03-0699com; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Hausenloy DJ, 2010, BASIC RES CARDIOL, V105, P677, DOI 10.1007/s00395-010-0121-4; Hausenloy DJ, 2005, AM J PHYSIOL-HEART C, V288, pH971, DOI 10.1152/ajpheart.00374.2004; Hausenloy DJ, 2004, CARDIOVASC RES, V61, P448, DOI 10.1016/j.cardiores.2003.09.024; Hausenloy DJ, 2011, NAT REV CARDIOL; Ibanez B, 2013, CIRCULATION, V128, P1495, DOI 10.1161/CIRCULATIONAHA.113.003653; Inoki I, 2001, FASEB J, V15, P219, DOI 10.1096/fj.01-0332fje; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Jun JI, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8386; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Kim HS, 1997, P NATL ACAD SCI USA, V94, P12981, DOI 10.1073/pnas.94.24.12981; Kireeva ML, 1997, EXP CELL RES, V233, P63, DOI 10.1006/excr.1997.3548; KLONER RA, 1974, AM J PATHOL, V74, P399; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; LIU GS, 1991, CIRCULATION, V84, P350, DOI 10.1161/01.CIR.84.1.350; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Maeda A, 2009, J BIOCHEM, V145, P207, DOI 10.1093/jb/mvn159; Moe IT, 2013, J CELL COMMUN SIGNAL, V7, P31, DOI 10.1007/s12079-012-0183-1; Moran AE, 2014, CIRCULATION, V129, P1483, DOI 10.1161/CIRCULATIONAHA.113.004042; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Nishida T, 2011, ENDOCRINOLOGY, V152, P4232, DOI 10.1210/en.2011-0234; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Panek AN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006743; Pizarro G, 2014, J AM COLL CARDIOL, V63, P2356, DOI 10.1016/j.jacc.2014.03.014; Pride YB, 2010, AM J CARDIOL, V106, P635, DOI 10.1016/j.amjcard.2010.04.012; Reichelt ME, 2009, EXP PHYSIOL, V94, P54, DOI 10.1113/expphysiol.2008.043554; Spoon DB, 2014, CIRCULATION, V129, P1286, DOI 10.1161/CIRCULATIONAHA.113.006518; Staat P, 2005, CIRCULATION, V112, P2143, DOI 10.1161/CIRCULATIONAHA.105.558122; Sutherland FJ, 2003, CLIN EXP PHARMACOL P, V30, P867, DOI 10.1046/j.1440-1681.2003.03925.x; Szabo Z, 2014, HYPERTENSION, V63, P1235, DOI 10.1161/HYPERTENSIONAHA.114.03279; Tsang A, 2004, CIRC RES, V95, P230, DOI 10.1161/01.RES.0000138303.76488.fe; Wang QD, 2001, ACTA PHYSIOL SCAND, V171, P123, DOI 10.1046/j.1365-201x.2001.00788.x; Wang SN, 2001, KIDNEY INT, V60, P96, DOI 10.1046/j.1523-1755.2001.00776.x; Weir RAP, 2006, AM J CARDIOL, V97, p13F, DOI 10.1016/j.amjcard.2006.03.005; Yellon D.M, 2007, NEW ENGL J MED, V357, P1121, DOI [10.1056/NEJMra071667, DOI 10.1056/NEJMRA071667]; Yoon PO, 2010, J MOL CELL CARDIOL, V49, P294, DOI 10.1016/j.yjmcc.2010.04.010	49	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149000	10.1371/journal.pone.0149000	http://dx.doi.org/10.1371/journal.pone.0149000			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872261	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100084
J	Lian, JN; Choi, J; Tan, YS; Howe, A; Wen, ZY; Jarboe, LR				Lian, Jieni; Choi, Jinlyung; Tan, Yee Shiean; Howe, Adina; Wen, Zhiyou; Jarboe, Laura R.			Identification of Soil Microbes Capable of Utilizing Cellobiosan	PLOS ONE			English	Article							LEVOGLUCOSAN KINASE; ASPERGILLUS-NIGER; PYROLYSIS; FERMENTATION; PURIFICATION	Approximately 100 million tons of anhydrosugars, such as levoglucosan and cellobiosan, are produced through biomass burning every year. These sugars are also produced through fast pyrolysis, the controlled thermal depolymerization of biomass. While the microbial pathways associated with levoglucosan utilization have been characterized, there is little known about cellobiosan utilization. Here we describe the isolation and characterization of six cellobiosan-utilizing microbes from soil samples. Each of these organisms is capable of using both cellobiosan and levoglucosan as sole carbon source, though both minimal and rich media cellobiosan supported significantly higher biomass production than levoglucosan. Ribosomal sequencing was used to identify the closest reported match for these organisms: Sphingobacterium multivorum, Acinetobacter oleivorans JC3-1, Enterobacter sp SJZ-6, and Microbacterium sps FXJ8.207 and 203 and a fungal species Cryptococcus sp. The commercially-acquired Enterobacter cloacae DSM 16657 showed growth on levoglucosan and cellobiosan, supporting our isolate identification. Analysis of an existing database of 16S rRNA amplicons from Iowa soil samples confirmed the representation of our five bacterial isolates and four previously-reported levoglucosan-utilizing bacterial isolates in other soil samples and provided insight into their population distributions. Phylogenetic analysis of the 16S rRNA and 18S rRNA of strains previously reported to utilize levoglucosan and our newfound isolates showed that the organisms isolated in this study are distinct from previously described anhydrosugar-utilizing microbial species.	[Lian, Jieni] Iowa State Univ, Bioecon Inst, Ames, IA USA; [Choi, Jinlyung; Howe, Adina] Iowa State Univ, Dept Agr & Biosyst Engn, Ames, IA USA; [Tan, Yee Shiean; Jarboe, Laura R.] Iowa State Univ, Dept Chem & Biol Engn, Ames, IA USA; [Wen, Zhiyou] Iowa State Univ, Dept Food Sci & Human Nutr, Ames, IA USA	Iowa State University; Iowa State University; Iowa State University; Iowa State University	Jarboe, LR (corresponding author), Iowa State Univ, Dept Chem & Biol Engn, Ames, IA USA.	ljarboe@iastate.edu			Iowa State University Presidential Initiate; EPSCoR [1101284] Funding Source: National Science Foundation	Iowa State University Presidential Initiate; EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was funded by Iowa State University Presidential Initiate. The funder had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Areekul Suvit, 1996, Journal of the Medical Association of Thailand, V79, P395; Bach EM, 2014, SOIL BIOL BIOCHEM, V69, P54, DOI 10.1016/j.soilbio.2013.10.033; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Elias VO, 2001, GEOCHIM COSMOCHIM AC, V65, P267, DOI 10.1016/S0016-7037(00)00522-6; Erdogan E. E., 2012, African Journal of Biotechnology, V11, P4853; Fine PM, 2004, ENVIRON ENG SCI, V21, P705, DOI 10.1089/ees.2004.21.705; Gao S, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002324; Helle S, 2007, CARBOHYD RES, V342, P2365, DOI 10.1016/j.carres.2007.07.016; Jagannadham MV, 2000, ARCH MICROBIOL, V173, P418, DOI 10.1007/s002030000163; Jarboe LR, 2011, APPL MICROBIOL BIOT, V91, P1519, DOI 10.1007/s00253-011-3495-9; Jarchow ME, 2013, GCB BIOENERGY, V5, P281, DOI 10.1111/j.1757-1707.2012.01186.x; Kehrwald N, 2012, TELLUS B, V64, DOI 10.3402/tellusb.v64i0.18196; KITAMURA Y, 1991, AGR BIOL CHEM TOKYO, V55, P523, DOI 10.1080/00021369.1991.10870618; Knicker H, 2013, GEODERMA, V197, P43, DOI 10.1016/j.geoderma.2012.12.021; Kuzhiyil N, 2012, CHEMSUSCHEM, V5, P2228, DOI 10.1002/cssc.201200341; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Layton DS, 2011, BIORESOURCE TECHNOL, V102, P8318, DOI 10.1016/j.biortech.2011.06.011; LEVINE JS, 1995, ENVIRON SCI TECHNOL, V29, pA120; Lian JN, 2013, BIORESOURCE TECHNOL, V133, P183, DOI 10.1016/j.biortech.2013.01.031; LOMAX JA, 1991, J ANAL APPL PYROL, V19, P65, DOI 10.1016/0165-2370(91)80035-7; Malfliet S, 2013, FOOD MICROBIOL, V36, P406, DOI 10.1016/j.fm.2013.06.025; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mullaugh KM, 2014, CHEMOSPHERE, V107, P51, DOI 10.1016/j.chemosphere.2014.03.014; NAKAHARA K, 1994, BIOSCI BIOTECH BIOCH, V58, P2193, DOI 10.1271/bbb.58.2193; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Ning JY, 2008, WORLD J MICROB BIOT, V24, P15, DOI 10.1007/s11274-007-9432-5; Paczia N, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-122; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pruitt K, 2012, NCBI HDB; Radlein D, 1987, PREPR PAP AM CHEM SO, V32; RADLEIN DSG, 1987, J ANAL APPL PYROL, V12, P39, DOI 10.1016/0165-2370(87)80013-X; Rover MR, 2014, CHEMSUSCHEM; Vicente A, 2013, ATMOS ENVIRON, V71, P295, DOI 10.1016/j.atmosenv.2013.01.062; Wallner P, 2013, INT J HYG ENVIR HEAL, V216, P280, DOI 10.1016/j.ijheh.2012.05.001; Xie HJ, 2005, FEMS MICROBIOL LETT, V251, P313, DOI 10.1016/j.femsle.2005.08.024; Xie HJ, 2006, WORLD J MICROB BIOT, V22, P887, DOI 10.1007/s11274-006-9133-5; Zhuang XL, 2002, PROTEIN EXPRES PURIF, V26, P71, DOI 10.1016/S1046-5928(02)00501-6; Zhuang XL, 2001, BIORESOURCE TECHNOL, V79, P63, DOI 10.1016/S0960-8524(01)00023-2	38	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149336	10.1371/journal.pone.0149336	http://dx.doi.org/10.1371/journal.pone.0149336			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872347	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100148
J	Lin, CM; Tseng, YC; Hsu, HL; Chen, CJ; Chen, DYT; Yan, FX; Chiu, WT				Lin, Che-Ming; Tseng, Ying-Chi; Hsu, Hui-Ling; Chen, Chi-Jen; Chen, David Yen-Ting; Yan, Feng-Xian; Chiu, Wen-Ta			Arterial Spin Labeling Perfusion Study in the Patients with Subacute Mild Traumatic Brain Injury	PLOS ONE			English	Article							CEREBRAL BLOOD-VOLUME; SEVERE HEAD-INJURY; TECHNETIUM-99M-HMPAO SPECT; ISCHEMIA; FLOW; MRI; 3T; CT	Background This study uses a MRI technique, three-dimension pulse continuous arterial spin labeling (3D-PCASL), to measure the patient's cerebral blood flow (CBF) at the subacute stage of mild traumatic brain injury (MTBI) in order to analyze the relationship between cerebral blood flow and neurocognitive deficits. Objective To provide the relationship between cortical CBF and neuropsychological dysfunction for the subacute MTBI patients. Methods After MTBI, perfusion MR imaging technique (3D-PCASL) measures the CBF of MTBI patients (n = 23) within 1 month and that of normal controls (n = 22) to determine the quantity and location of perfusion defect. The correlation between CBF abnormalities and cognitive deficits was elucidated by combining the results of the neuropsychological tests of the patients. Result We observed a substantial reduction in CBF in the bilateral frontal and left occipital cortex as compared with the normal persons. In addition, there were correlation between post concussive symptoms (including dizziness and simulator sickness) and CBF in the hypoperfused areas. The more severe symptom was correlated with higher CBF in bilateral frontal and left occipital lobes. Conclusion First, this study determined that despite no significant abnormality detected on conventional CT and MRI studies, hypoperfusion was observed in MTBI group using 3D-PCASL technique in subacute stage, which suggested that this approach may increase sensitivity to MTBI. Second, the correlation between CBF and the severity of post concussive symptoms suggested that changes in cerebral hemodynamicsmay play a role in pathophysiology underlies the symptoms.	[Lin, Che-Ming; Tseng, Ying-Chi; Hsu, Hui-Ling; Chen, Chi-Jen; Chen, David Yen-Ting; Yan, Feng-Xian; Chiu, Wen-Ta] Taipei Med Univ, Shuang Ho Hosp, Dept Diagnost Radiol, New Taipei, Taiwan; [Lin, Che-Ming; Tseng, Ying-Chi; Hsu, Hui-Ling; Chen, Chi-Jen; Chen, David Yen-Ting; Yan, Feng-Xian; Chiu, Wen-Ta] Taipei Med Univ, Shuang Ho Hosp, Brain & Consciousness Res Ctr, New Taipei, Taiwan; [Chiu, Wen-Ta] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei, Taiwan; [Lin, Che-Ming; Tseng, Ying-Chi; Hsu, Hui-Ling; Chen, Chi-Jen; Chen, David Yen-Ting; Yan, Feng-Xian] Taipei Med Univ, Sch Med, Dept Radiol, Coll Med, New Taipei, Taiwan; [Chen, Chi-Jen] Minist Hlth & Welf, Chia Yi Hosp, Chiayi, Taiwan	Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University	Hsu, HL (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Diagnost Radiol, New Taipei, Taiwan.; Hsu, HL (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Brain & Consciousness Res Ctr, New Taipei, Taiwan.; Hsu, HL (corresponding author), Taipei Med Univ, Sch Med, Dept Radiol, Coll Med, New Taipei, Taiwan.	anne.hlh@gmail.com						Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; Audenaert K., 2003, MED SCI MONITOR, V9, P112; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; BOUMA GJ, 1993, ACTA NEUROCHIR, P34; Bullock R, 1992, Acta Neurochir Suppl (Wien), V55, P14; Chang TY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076072; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Davis P, 2012, EXPERT PANEL ON NEUR, V14; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Grossman EJ, 2009, J MAGN RESON IMAGING, V29, P1425, DOI 10.1002/jmri.21794; JACOBS A, 1994, J NUCL MED, V35, P942; Jacobs A, 1996, J NUCL MED, V37, P1605; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; Lorberboym M, 2002, AM J EMERG MED, V20, P310, DOI 10.1053/ajem.2002.34201; Nariai T, 2001, J NEUROTRAUM, V18, P1323, DOI 10.1089/08977150152725623; Piker EG, 2008, J AM ACAD AUDIOL, V19, P337, DOI 10.3766/jaaa.19.4.6; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; Schroder ML, 1998, NEUROSURGERY, V42, P1276, DOI 10.1097/00006123-199806000-00042; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tan CO, 2014, NEUROLOGY, V83, P1665, DOI 10.1212/WNL.0000000000000944; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Wong AM, 2014, J MAGN RESON IMAGING, V39, P427, DOI 10.1002/jmri.24178	32	38	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149109	10.1371/journal.pone.0149109	http://dx.doi.org/10.1371/journal.pone.0149109			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871696	gold, Green Published, Green Submitted			2022-12-27	WOS:000370054100107
J	Sabel, BO; Buric, K; Karara, N; Thierfelder, KM; Dinkel, J; Sommer, WH; Meinel, FG				Sabel, Bastian O.; Buric, Kristijan; Karara, Nora; Thierfelder, Kolja M.; Dinkel, Julien; Sommer, Wieland H.; Meinel, Felix G.			High-Pitch CT Pulmonary Angiography in Third Generation Dual-Source CT: Image Quality in an Unselected Patient Population	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; VASCULAR ENHANCEMENT; CONTRAST MATERIAL; DOSE REDUCTION; CHEST CT; RADIATION; EMBOLISM; PROTOCOLS; FEASIBILITY; PRINCIPLES	Objectives To investigate the feasibility of high-pitch CT pulmonary angiography (CTPA) in 3rd generation dual-source CT (DSCT) in unselected patients. Methods Forty-seven patients with suspected pulmonary embolism underwent high-pitch CTPA on a 3rd generation dual-source CT scanner. CT dose index (CTDIvol) and dose length product (DLP) were obtained. Objective image quality was analyzed by calculating signal-to-noise-ratio (SNR) and contrast-to-noise ratio (CNR). Subjective image quality on the central, lobar, segmental and subsegmental level was rated by two experienced radiologists. Results Median CTDI was 8.1 mGy and median DLP was 274 mGy*cm. Median SNR was 32.9 in the central and 31.9 in the segmental pulmonary arteries. CNR was 29.2 in the central and 28.2 in the segmental pulmonary arteries. Median image quality was "excellent" in central and lobar arteries and "good" in subsegmental arteries according to both readers. Segmental arteries varied between "excellent" and "good". Image quality was non-diagnostic in one case (2%), beginning in the lobar arteries. Thirteen patients (28%) showed minor motion artifacts. Conclusions In third-generation dual-source CT, high-pitch CTPA is feasible for unselected patients. It yields excellent image quality with minimal motion artifacts. However, compared to standard-pitch cohorts, no distinct decrease in radiation dose was observed.	[Sabel, Bastian O.; Buric, Kristijan; Karara, Nora; Thierfelder, Kolja M.; Dinkel, Julien; Sommer, Wieland H.; Meinel, Felix G.] Ludwig Maximilians Univ Hosp, Inst Clin Radiol, Munich, Germany	University of Munich	Sabel, BO (corresponding author), Ludwig Maximilians Univ Hosp, Inst Clin Radiol, Munich, Germany.	bastian.sabel@med.uni-muenchen.de		Meinel, Felix/0000-0002-3201-1033				Bae KT, 2005, EUR RADIOL, V15, pE46, DOI 10.1007/s10406-005-0165-y; Bae KT, 2007, RADIOLOGY, V242, P582, DOI 10.1148/radiol.2422052132; Bauer RW, 2012, J THORAC IMAG, V27, P376, DOI 10.1097/RTI.0b013e318250067e; Bolen MA, 2013, AM J ROENTGENOL, V201, P971, DOI 10.2214/AJR.13.10597; Boone JMSK, 2011, REPORT AM ASS PHYS M, DOI DOI 10.37206/143; Christner JA, 2012, RADIOLOGY, V265, P841, DOI 10.1148/radiol.12112365; Co SJ, 2013, EUR J RADIOL, V82, P1571, DOI 10.1016/j.ejrad.2013.04.043; De Zordo T, 2012, EUR RADIOL, V22, P279, DOI 10.1007/s00330-011-2251-y; Deak PD, 2010, RADIOLOGY, V257, P158, DOI 10.1148/radiol.10100047; Faggioni L, 2012, AM J ROENTGENOL, V199, P1220, DOI 10.2214/AJR.11.8122; Goble EW, 2014, CLIN RADIOL, V69, P36, DOI 10.1016/j.crad.2013.07.023; Heyer CM, 2007, RADIOLOGY, V245, P577, DOI 10.1148/radiol.2452061919; Holmquist F, 2009, ACTA RADIOL, V50, P181, DOI 10.1080/02841850802657269; Hou DJ, 2013, EUR J RADIOL, V82, P1793, DOI 10.1016/j.ejrad.2013.05.003; Huisman MV, 2013, J THROMB HAEMOST, V11, P412, DOI 10.1111/jth.12124; Jones SE, 2005, RADIOLOGY, V237, P329, DOI 10.1148/radiol.2371041520; Kerl JM, 2012, EUR J RADIOL, V81, P2887, DOI 10.1016/j.ejrad.2011.09.018; Krazinski AW, 2014, EUR RADIOL, V24, P2677, DOI 10.1007/s00330-014-3312-9; Laverman P, 2000, J PHARMACOL EXP THER, V293, P996; Lu GM, 2014, EUR RADIOL; McLaughlin PD, 2014, EMERG RADIOL; Meinel FG, 2014, EUR RADIOL, V24, P1643, DOI 10.1007/s00330-014-3194-x; Nyman U, 2012, ACTA RADIOL, V53, P1004, DOI 10.1258/ar.2012.120327; Pontana F, 2013, RADIOLOGY, V267, P609, DOI 10.1148/radiol.12120414; Ramadan SU, 2010, EUR RADIOL, V20, P2100, DOI 10.1007/s00330-010-1782-y; Schueller-Weidekamm C, 2006, RADIOLOGY, V241, P899, DOI 10.1148/radiol.2413040128; Sigal-Cinqualbre AB, 2004, RADIOLOGY, V231, P169, DOI 10.1148/radiol.2311030191; Sodickson A, 2012, EMERG RADIOL, V19, P437, DOI 10.1007/s10140-012-1046-z; Spearman JV, 2015, RADIOLOGY; Stein PD, 2007, RADIOLOGY, V242, P15, DOI 10.1148/radiol.2421060971; Szucs-Farkas Z, 2008, INVEST RADIOL, V43, P871, DOI 10.1097/RLI.0b013e3181875e86; Wintermark M, 2000, AM J NEURORADIOL, V21, P1881; Yu LF, 2011, RADIOGRAPHICS, V31, P835, DOI 10.1148/rg.313105079; Zamboni GA, 2012, EUR J RADIOL, V81, pE580, DOI 10.1016/j.ejrad.2011.06.051	34	25	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0146949	10.1371/journal.pone.0146949	http://dx.doi.org/10.1371/journal.pone.0146949			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872262	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100003
J	Sharma, A; Rana, SK; Prinja, S; Kumar, R				Sharma, Atul; Rana, Saroj Kumar; Prinja, Shankar; Kumar, Rajesh			Quality of Health Management Information System for Maternal & Child Health Care in Haryana State, India	PLOS ONE			English	Article								Background Despite increasing importance being laid on use of routine data for decision making in India, it has frequently been reported to be riddled with problems. Evidence suggests lack of quality in the health management information system (HMIS), however there is no robust analysis to assess the extent of its inaccuracy. We aim to bridge this gap in evidence by assessing the extent of completeness and quality of HMIS in Haryana state of India. Methods Data on utilization of key maternal and child health (MCH) services were collected using a cross-sectional household survey from 4807 women in 209 Sub-Centre (SC) areas across all 21 districts of Haryana state. Information for same services was also recorded from HMIS records maintained by auxiliary nurse midwives (ANMs) at SCs to check under- or over-recording (Level 1 discordance). Data on utilisation of MCH services from SC ANM records, for a subset of the total women covered in the household survey, were also collected and compared with monthly reports submitted by ANMs to assess over-reporting while report preparation (Level 2 discordance) to paint the complete picture for quality and completeness of routine HMIS. Results Completeness of ANM records for various MCH services ranged from 73% for DPT1 vaccination dates to 94.6% for dates of delivery. Average completeness level for information recorded in HMIS was 88.5%. Extent of Level 1 discordance for iron-folic acid (IFA) supplementation, 3 or more ante-natal care (ANC) visits and 2 Tetanus toxoid (TT) injections was 41%, 16% and 2% respectively. In 48.2% cases, respondents from community as well as HMIS records reported at least one post-natal care (PNC) home visit by ANM. Extent of Level 2 discordance ranged from 1.6% to 6%. These figures were highest for number of women who completed IFA supplementation, contraceptive intra-uterine device insertion and provision of 2nd TT injection during ANC. Conclusions HMIS records for MCH services at sub-centre level in Haryana state were satisfactory in terms of completeness. However, there were significant differences in terms of reported and evaluated coverage of MCH services. Quality of HMIS needs to be improved in order to make it relevant for public health program planning and research.	[Sharma, Atul; Rana, Saroj Kumar; Prinja, Shankar; Kumar, Rajesh] Postgrad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh 160012, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Prinja, S (corresponding author), Postgrad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh 160012, India.	shankarprinja@gmail.com			National Health Mission, Haryana	National Health Mission, Haryana	The study was funded by the National Health Mission, Haryana. The funding agency had no role in study design, collection of data, analysis or report writing.	[Anonymous], 2013, CONC EV NAT HLTH MIS; Bhojani UM, 2010, INT C HLTH SYST STRE; Chadha VK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042625; Harikumar S., 2013, 8 SREE CHITR TIR I M; Health Metrics Network, 2014, ISS HLTH INF NAT SUB; Husain Z, 2012, 40014 MPRA; Khandade Tukaram Narayan, 2013, Indian J Public Health, V57, P283, DOI 10.4103/0019-557X.123258; Kumar R, 1993, World Health Forum, V14, P305; Kumar R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-549; Madhulekha Bhattacharya, 2012, Journal of Health Informatics in Developing Countries, V6, P385; NRHM, 2008, MOHFW LAUNCH HMIS WE; Pandey A., 2010, DEMOGRAPHY INDIA, V39, P111; Prinja S, 2013, INDIAN J MED RES, V138, P1003; UNICEF, 2009, CONV EV SURV 2009 HA; Verma R, 2007, INDIAN J COMMUNITY M, V32, P185; Verma R, 2007, INDIAN J COMMUNITY M, V1, P90; WHO, 2010, MONITORING BUILDING; WHO, 2007, EV BUS STRENGTH HLTH	18	31	32	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148449	10.1371/journal.pone.0148449	http://dx.doi.org/10.1371/journal.pone.0148449			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872353	Green Published, gold			2022-12-27	WOS:000370054100031
J	Tuia, D; Camps-Valls, G				Tuia, Devis; Camps-Valls, Gustau			Kernel Manifold Alignment for Domain Adaptation	PLOS ONE			English	Article								The wealth of sensory data coming from different modalities has opened numerous opportunities for data analysis. The data are of increasing volume, complexity and dimensionality, thus calling for new methodological innovations towards multimodal data processing. However, multimodal architectures must rely on models able to adapt to changes in the data distribution. Differences in the density functions can be due to changes in acquisition conditions (pose, illumination), sensors characteristics (number of channels, resolution) or different views (e.g. street level vs. aerial views of a same building). We call these different acquisition modes domains, and refer to the adaptation problem as domain adaptation. In this paper, instead of adapting the trained models themselves, we alternatively focus on finding mappings of the data sources into a common, semantically meaningful, representation domain. This field of manifold alignment extends traditional techniques in statistics such as canonical correlation analysis (CCA) to deal with nonlinear adaptation and possibly non-corresponding data pairs between the domains. We introduce a kernel method for manifold alignment (KEMA) that can match an arbitrary number of data sources without needing corresponding pairs, just few labeled examples in all domains. KEMA has interesting properties: 1) it generalizes other manifold alignment methods, 2) it can align manifolds of very different complexities, performing a discriminative alignment preserving each manifold inner structure, 3) it can define a domain-specific metric to cope with multimodal specificities, 4) it can align data spaces of different dimensionality, 5) it is robust to strong nonlinear feature deformations, and 6) it is closed-form invertible, which allows transfer across-domains and data synthesis. To authors' knowledge this is the first method addressing all these important issues at once. We also present a reduced-rank version of KEMA for computational efficiency, and discuss the generalization performance of KEMA under Rademacher principles of stability. Aligning multimodal data with KEMA reports outstanding benefits when used as a data pre-conditioner step in the standard data analysis processing chain. KEMA exhibits very good performance over competing methods in synthetic controlled examples, visual object recognition and recognition of facial expressions tasks. KEMA is especially well-suited to deal with high-dimensional problems, such as images and videos, and under complicated distortions, twists and warpings of the data manifolds. A fully functional toolbox is available at https://github.com/dtuia/KEMA.git.	[Tuia, Devis] Univ Zurich, MultiModal Remote Sensing, Zurich, Switzerland; [Camps-Valls, Gustau] Univ Valencia, Image Proc Lab, Valencia, Spain	University of Zurich; University of Valencia	Tuia, D (corresponding author), Univ Zurich, MultiModal Remote Sensing, Zurich, Switzerland.	devis.tuia@geo.uzh.ch	Tuia, Devis/AAE-9339-2019; Camps-Valls, Gustavo/A-2532-2011; , Gustavo/ABC-1706-2022	Tuia, Devis/0000-0003-0374-2459; Camps-Valls, Gustavo/0000-0003-1683-2138; 	Swiss National Science Foundation [PP00P2-150593]; Spanish Ministry of Economy and Competitiveness [TIN2012-38102-C03-01]; European research council [647423]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government); European research council(European Research Council (ERC)European Commission)	DT was supported by Swiss National Science Foundation, project PP00P2-150593 (http://www.snf.ch/en/Pages/default.aspx). GCV was supported by Spanish Ministry of Economy and Competitiveness, project TIN2012-38102-C03-01 (http://www.mineco.gob.es/portal/site/mineco?lang_choosen = en) and European research council, project 647423 (http://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakir G, 2003, P NIPS; Baktashmotlagh M, 2014, PROC CVPR IEEE, P2481, DOI 10.1109/CVPR.2014.318; Camps-Valls G, IEEE T GEOSCIENCE RE, V45, P2044; Chapelle O., 2006, SEMISUPERVISED LEARN; Courty Nicolas, 2014, Machine Learning and Knowledge Discovery in Databases. European Conference, ECML PKDD 2014. Proceedings: LNCS 8724, P274, DOI 10.1007/978-3-662-44848-9_18; Dhanjal C, 2009, IEEE T PATTERN ANAL, V31, P1347, DOI 10.1109/TPAMI.2008.171; Donahue J, 2014, PR MACH LEARN RES, V32; Donahue J, 2013, PROC CVPR IEEE, P668, DOI 10.1109/CVPR.2013.92; Duan LX, 2012, IEEE T PATTERN ANAL, V34, P465, DOI 10.1109/TPAMI.2011.114; Farhadi A, 2008, LECT NOTES COMPUT SC, V5302, P154, DOI 10.1007/978-3-540-88682-2_13; Gong BQ, 2012, PROC CVPR IEEE, P2066, DOI 10.1109/CVPR.2012.6247911; Gopalan R, 2011, IEEE I CONF COMP VIS, P999, DOI 10.1109/ICCV.2011.6126344; Gretton A, 2005, LECT NOTES ARTIF INT, V3734, P63; Ham J., 2005, P ANN C UNC ART INT, P120; Hoffman J, 2013, P ICLR SCOTTSD AZ; Hotelling H, 1936, BIOMETRIKA, V28, P321, DOI 10.2307/2333955; Jhuo IH, 2012, PROC CVPR IEEE, P2168, DOI 10.1109/CVPR.2012.6247924; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; JONES LK, 1992, ANN STAT, V20, P608, DOI 10.1214/aos/1176348546; Kulis B, 2011, PROC CVPR IEEE, P1785, DOI 10.1109/CVPR.2011.5995702; Kwok JTY, 2004, IEEE T NEURAL NETWOR, V15, P1517, DOI 10.1109/TNN.2004.837781; Lai PL, 2000, IEEE IJCNN, P614; Long MS, 2013, IEEE I CONF COMP VIS, P2200, DOI 10.1109/ICCV.2013.274; López-Pérez Diana, 2014, Polibotánica, P1, DOI 10.1109/FIE.2014.7044379; Mackey L, 2014, ANN PROBABILITY; Maji S, 2008, 2008 IEEE COMP SOC C; Mika S, 1999, ADV NEUR IN, V11, P536; Pan SJ, 2011, IEEE T NEURAL NETWOR, V22, P199, DOI 10.1109/TNN.2010.2091281; Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191; Patel VM, 2015, IEEE SIGNAL PROC MAG, V32, P53, DOI 10.1109/MSP.2014.2347059; Quinonero-Candela J, 2009, NEURAL INF PROCESS S, pXI; Reed M., 1981, FUNCTIONAL ANAL, V1; Riesz F., 1955, FUNCTIONAL ANAL; Saenko K, 2010, LECT NOTES COMPUT SC, V6314, P213, DOI 10.1007/978-3-642-15561-1_16; Scholkopf B, 1998, NEURAL COMPUT, V10, P1299, DOI 10.1162/089976698300017467; SHARMA A, 2012, PROC CVPR IEEE, P2160, DOI DOI 10.1109/CVPR.2012.6247923; Shawe-Taylor J, 2005, IEEE T INFORM THEORY, V51, P2510, DOI 10.1109/TIT.2005.850052; Song L., 2007, ICML, P815; Torralba A, 2011, PROC CVPR IEEE, P1521, DOI 10.1109/CVPR.2011.5995347; Tuia D, 2013, IEEE INT GEOSC REM S; Tuia D, 2014, IEEE T GEOSCI REMOTE, V52, P7708, DOI 10.1109/TGRS.2014.2317499; Tuia D, 2013, IEEE T GEOSCI REMOTE, V51, P329, DOI 10.1109/TGRS.2012.2200045; Wang C., 2011, IJCAI, P1541; Wang C., 2011, MANIFOLD LEARNING TH; Yan SC, 2007, IEEE T PATTERN ANAL, V29, P40, DOI 10.1109/TPAMI.2007.250598; Zhu F, 2014, MACHING LEARNING SIG	47	53	54	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148655	10.1371/journal.pone.0148655	http://dx.doi.org/10.1371/journal.pone.0148655			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872269	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000370054100048
J	Zhang, J; Guo, H; Chen, QX; Zhang, FX; Fang, Q				Zhang, Jie; Guo, Hong; Chen, Qingxiu; Zhang, Fuxian; Fang, Qin			The N-Terminal of Aquareovirus NS80 Is Required for Interacting with Viral Proteins and Viral Replication	PLOS ONE			English	Article							GRASS CARP REOVIRUS; FACTORY-LIKE INCLUSIONS; KAPPA-B ACTIVATION; MU-NS; SIGMA-NS; GENUS AQUAREOVIRUS; FAMILY REOVIRIDAE; STRANDED-RNA; VIRUS; CORE	Reovirus replication and assembly occurs within viral inclusion bodies that formed in specific intracellular compartments of cytoplasm in infected cells. Previous study indicated that aquareovirus NS80 is able to form inclusion bodies, and also can retain viral proteins within its inclusions. To better understand how NS80 performed in viral replication and assembly, the functional regions of NS80 associated with other viral proteins in aquareovirus replication were investigated in this study. Deletion mutational analysis and rotavirus NSP5-based protein association platform were used to detect association regions. Immunofluorescence images indicated that different N-terminal regions of NS80 could associate with viral proteins VP1, VP4, VP6 and NS38. Further co-immunoprecipitation analysis confirmed the interaction between VP1, VP4, VP6 or NS38 with different regions covering the N-terminal amino acid (aa, 1-471) of NS80, respectively. Moreover, removal of NS80 N-terminal sequences required for interaction with proteins VP1, VP4, VP6 or NS38 not only prevented the capacity of NS80 to support viral replication in NS80 shRNA-based replication complementation assays, but also inhibited the expression of aquareovirus proteins, suggesting that N-terminal regions of NS80 are necessary for viral replication. These results provided a foundational basis for further understanding the role of NS80 in viral replication and assembly during aquareovirus infection.	[Zhang, Jie; Guo, Hong; Chen, Qingxiu; Zhang, Fuxian; Fang, Qin] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China; [Chen, Qingxiu] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Fang, Q (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China.	qfang@wh.iov.cn	fang, qin/GQA-8223-2022	Zhang, Fuxian/0000-0001-8486-3820	National Natural Science Foundation of China [31372565, 31172434, 31370190, 31402340]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by grants from the National Natural Science Foundation of China (31372565, 31172434, 31370190 and 31402340).	[Anonymous], 2011, VIRUS TAXONOMY; Arnold MM, 2008, VIROLOGY, V375, P412, DOI 10.1016/j.virol.2008.02.024; Arnoldi F, 2007, J VIROL, V81, P2128, DOI 10.1128/JVI.01494-06; Attoui H, 2002, J GEN VIROL, V83, P1941, DOI 10.1099/0022-1317-83-8-1941; Becker MM, 2003, J VIROL, V77, P5948, DOI 10.1128/JVI.77.10.5948-5963.2003; Berois M, 2003, J VIROL, V77, P1757, DOI 10.1128/JVI.77.3.1757-1763.2003; Brandariz-Nunez A, 2010, J VIROL, V84, P4289, DOI 10.1128/JVI.02534-09; Broering TJ, 2005, J VIROL, V79, P6194, DOI 10.1128/JVI.79.10.6194-6206.2005; Broering TJ, 2004, J VIROL, V78, P1882, DOI 10.1128/JVI.78.4.1882-1892.2004; BROOKES SM, 1993, J GEN VIROL, V74, P525, DOI 10.1099/0022-1317-74-3-525; Cheng LP, 2008, J MOL BIOL, V382, P213, DOI 10.1016/j.jmb.2008.06.075; Cheng LP, 2010, J MOL BIOL, V397, P852, DOI 10.1016/j.jmb.2009.12.027; Contin R, 2010, J GEN VIROL, V91, P1782, DOI 10.1099/vir.0.019133-0; DALES S, 1963, P NATL ACAD SCI USA, V50, P268, DOI 10.1073/pnas.50.2.268; Desmet EA, 2014, MBIO, V5, DOI 10.1128/mBio.01463-14; DOBOS P, 1976, J CLIN MICROBIOL, V3, P373; Eichwald C, 2004, J GEN VIROL, V85, P625, DOI 10.1099/vir.0.19611-0; Fabbretti E, 1999, J GEN VIROL, V80, P333, DOI 10.1099/0022-1317-80-2-333; Fan C, 2010, ARCH VIROL, V155, P1755, DOI 10.1007/s00705-010-0753-6; Fan Liming, 2014, Virologica Sinica, V29, P86, DOI 10.1007/s12250-014-3366-5; Fang Q, 2000, BIOCHEM BIOPH RES CO, V274, P762, DOI 10.1006/bbrc.2000.3215; Fang Q, 2005, SCI CHINA SER C, V48, P593, DOI 10.1360/062004-105; Fang Q, 1989, VIROL SIN, V3, P315; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Gillian AL, 2000, J VIROL, V74, P5939, DOI 10.1128/JVI.74.13.5939-5948.2000; Kar AK, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-4; Ke F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063737; Kobayashi T, 2006, J VIROL, V80, P9053, DOI 10.1128/JVI.00276-06; Kobayashi T, 2009, J VIROL, V83, P2892, DOI 10.1128/JVI.01495-08; Miller CL, 2010, J VIROL, V84, P867, DOI 10.1128/JVI.01571-09; Parker JSL, 2002, J VIROL, V76, P4483, DOI 10.1128/JVI.76.9.4483-4496.2002; PETRIE BL, 1984, VIRUS RES, V1, P133, DOI 10.1016/0168-1702(84)90069-8; Rangel AAC, 1999, J GEN VIROL, V80, P2399, DOI 10.1099/0022-1317-80-9-2399; Shao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055334; Shao L, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-347; Shao Ling, 2010, Virologica Sinica, V25, P123, DOI 10.1007/s12250-010-3115-3; Silvestri LS, 2004, J VIROL, V78, P7763, DOI 10.1128/JVI.78.14.7763-7774.2004; Touris-Otero F, 2004, J MOL BIOL, V341, P361, DOI 10.1016/j.jmb.2004.06.026; Touris-Otero F, 2004, VIROLOGY, V319, P94, DOI 10.1016/j.virol.2003.10.034; Viskovska M, 2014, J VIROL, V88, P12866, DOI 10.1128/JVI.02251-14; Wei TY, 2006, J GEN VIROL, V87, P429, DOI 10.1099/vir.0.81425-0; Wen DW, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-133; Yan LM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126127; Yan LM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-89; Zhang J, 2013, J VIROL, V87, P12935, DOI 10.1128/JVI.01952-13; Zhang J, 2013, MED MICROBIOL IMMUN, V202, P313, DOI 10.1007/s00430-013-0295-0; Zhang LL, 2010, J VIROL METHODS, V169, P28, DOI 10.1016/j.jviromet.2010.06.009	47	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148550	10.1371/journal.pone.0148550	http://dx.doi.org/10.1371/journal.pone.0148550			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871941	gold, Green Submitted, Green Published			2022-12-27	WOS:000370054100036
J	El Karkouri, K; Pontarotti, P; Raoult, D; Fournier, PE				El Karkouri, Khalid; Pontarotti, Pierre; Raoult, Didier; Fournier, Pierre-Edouard			Origin and Evolution of Rickettsial Plasmids	PLOS ONE			English	Article							GENOME SEQUENCE; VIRULENCE PLASMIDS; DIVERSITY; GENE; REVEALS	Background Rickettsia species are strictly intracellular bacteria that have undergone a reductive genomic evolution. Despite their allopatric lifestyle, almost half of the 26 currently validated Rickettsia species have plasmids. In order to study the origin, evolutionary history and putative roles of rickettsial plasmids, we investigated the evolutionary processes that have shaped 20 plasmids belonging to 11 species, using comparative genomics and phylogenetic analysis between rickettsial, microbial and non-microbial genomes. Results Plasmids were differentially present among Rickettsia species. The 11 species had 1 to 4 plasmid (s) with a size ranging from 12 kb to 83 kb. We reconstructed pRICO, the last common ancestor of the current rickettsial plasmids. pRICO was vertically inherited mainly from Rickettsia/Orientia chromosomes and diverged vertically into a single or multiple plasmid(s) in each species. These plasmids also underwent a reductive evolution by progressive gene loss, similar to that observed in rickettsial chromosomes, possibly leading to cryptic plasmids or complete plasmid loss. Moreover, rickettsial plasmids exhibited ORFans, recent gene duplications and evidence of horizontal gene transfer events with rickettsial and non-rickettsial genomes mainly from the alpha/gamma-proteobacteria lineages. Genes related to maintenance and plasticity of plasmids, and to adaptation and resistance to stress mostly evolved under vertical and/or horizontal processes. Those involved in nucleotide/carbohydrate transport and metabolism were under the influence of vertical evolution only, whereas genes involved in cell wall/membrane/envelope biogenesis, cycle control, amino acid/lipid/coenzyme and secondary metabolites biosynthesis, transport and metabolism underwent mainly horizontal transfer events. Conclusion Rickettsial plasmids had a complex evolution, starting with a vertical inheritance followed by a reductive evolution associated with increased complexity via horizontal gene transfer as well as gene duplication and genesis. The plasmids are plastic and mosaic structures that may play biological roles similar to or distinct from their co-residing chromosomes in an obligate intracellular lifestyle.	[El Karkouri, Khalid; Raoult, Didier; Fournier, Pierre-Edouard] Aix Marseille Univ, Inst Hosp Univ Mediterranee Infect, Fac Med, CNRS7278,IRD198,INSERMU1095,URMITE,UM63, 27 Blvd Jean Moulin, F-13385 Marseille 5, France; [Pontarotti, Pierre] Aix Marseille Univ, CNRS, Equipe Evolut Biol & Modelisat, Cent Marseille,UMR 7373 I2M, F-13385 Marseille 5, France	Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Fournier, PE (corresponding author), Aix Marseille Univ, Inst Hosp Univ Mediterranee Infect, Fac Med, CNRS7278,IRD198,INSERMU1095,URMITE,UM63, 27 Blvd Jean Moulin, F-13385 Marseille 5, France.	pierre-edouard.fournier@univ-amu.fr	Fournier, Pierre-Edouard/AAC-6155-2021; , pontarotti/ABB-1753-2021; RAOULT, Didier/A-8434-2008	Fournier, Pierre-Edouard/0000-0001-8463-8885; RAOULT, Didier/0000-0002-0633-5974; Pierre, Pontarotti/0000-0001-7202-3648	Mediterranean-Infection foundation; Mediterranee-Infection foundation	Mediterranean-Infection foundation; Mediterranee-Infection foundation	The study was funded by the Mediterranean-Infection foundation, http://en.mediterranee-infection.com/article.php?larub=83&titre = the-foundation.; The study was funded by the Mediterranee-Infection foundation.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson JO, 1999, MOL BIOL EVOL, V16, P1178, DOI 10.1093/oxfordjournals.molbev.a026208; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Baldridge GD, 2008, APPL ENVIRON MICROB, V74, P645, DOI 10.1128/AEM.02262-07; Baldridge GD, 2010, APPL ENVIRON MICROB, V76, P1718, DOI 10.1128/AEM.02988-09; Bechah Y, 2010, GENOME RES, V20, P655, DOI 10.1101/gr.103564.109; Blanc G, 2007, GENOME RES, V17, P1657, DOI 10.1101/gr.6742107; Blanc G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030014; Bocs S, 2003, NUCLEIC ACIDS RES, V31, P3723, DOI 10.1093/nar/gkg590; Burkhardt NY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029511; Chan KF, 2012, INFECT IMMUN, V80, P1519, DOI 10.1128/IAI.06326-11; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Darby AC, 2007, TRENDS GENET, V23, P511, DOI 10.1016/j.tig.2007.08.002; Driscoll T, 2013, GENOME BIOL EVOL, V5, P621, DOI 10.1093/gbe/evt036; Duron O, 2013, HEREDITY, V111, P330, DOI 10.1038/hdy.2013.56; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellison DW, 2008, INFECT IMMUN, V76, P542, DOI 10.1128/IAI.00952-07; Felsheim RF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008361; Feng Y, 2012, INFECT GENET EVOL, V12, P1058, DOI 10.1016/j.meegid.2012.03.004; Fournier PE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-166; Fournier PE, 2009, J INFECT DIS, V199, P1097, DOI 10.1086/597211; Fournier PE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002289; Garcillan-Barcia MP, 2009, FEMS MICROBIOL REV, V33, P657, DOI 10.1111/j.1574-6976.2009.00168.x; Gillespie JJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000266; Guy L, 2010, BIOINFORMATICS, V26, P2334, DOI 10.1093/bioinformatics/btq413; Halary S, 2010, P NATL ACAD SCI USA, V107, P127, DOI 10.1073/pnas.0908978107; Johnson TJ, 2009, MICROBIOL MOL BIOL R, V73, P750, DOI 10.1128/MMBR.00015-09; Kloesges T, 2011, MOL BIOL EVOL, V28, P1057, DOI 10.1093/molbev/msq297; Kristensen DM, 2010, BIOINFORMATICS, V26, P1481, DOI 10.1093/bioinformatics/btq229; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; McLeod MP, 2004, J BACTERIOL, V186, P5842, DOI 10.1128/JB.186.17.5842-5855.2004; Merhej V, 2011, BIOL REV, V86, P379, DOI 10.1111/j.1469-185X.2010.00151.x; Ogata H, 2005, PLOS BIOL, V3, P1391, DOI 10.1371/journal.pbio.0030248; Ogata H, 2001, SCIENCE, V293, P2093, DOI 10.1126/science.1061471; Ogata H, 2006, PLOS GENET, V2, P733, DOI 10.1371/journal.pgen.0020076; Parola P, 2013, CLIN MICROBIOL REV, V26, P657, DOI 10.1128/CMR.00032-13; Puigbo P, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0066-4; Rahman MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003399; Raoult D, 1997, CLIN MICROBIOL REV, V10, P694, DOI 10.1128/CMR.10.4.694; Sahni SK, 2013, FUTURE MICROBIOL, V8, P1265, DOI 10.2217/fmb.13.102; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smillie C, 2010, MICROBIOL MOL BIOL R, V74, P434, DOI 10.1128/MMBR.00020-10; Snel B, 2002, GENOME RES, V12, P17, DOI 10.1101/gr.176501; STOTHARD DR, 1994, INT J SYST BACTERIOL, V44, P798, DOI 10.1099/00207713-44-4-798; Tamminen M, 2012, MOL BIOL EVOL, V29, P1225, DOI 10.1093/molbev/msr292; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tautz D, 2011, NAT REV GENET, V12, P692, DOI 10.1038/nrg3053; Tejerizo GT, 2014, FEMS MICROBIOL ECOL, V88, P565, DOI 10.1111/1574-6941.12325; Weinert LA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-6; Whidden C, 2014, SYST BIOL, V63, P566, DOI 10.1093/sysbio/syu023; Wolf YI, 2013, BIOESSAYS, V35, P829, DOI 10.1002/bies.201300037; Wood DO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034715; Yin YB, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-63; Yomtovian I, 2010, BIOINFORMATICS, V26, P996, DOI 10.1093/bioinformatics/btq093; Zheng JS, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-262	56	13	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0147492	10.1371/journal.pone.0147492	http://dx.doi.org/10.1371/journal.pone.0147492			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866478	gold, Green Published, Green Submitted			2022-12-27	WOS:000370050700003
J	Tang, YL; Fu, XQ; Shen, Q; Tang, KX				Tang, Yueli; Fu, Xueqing; Shen, Qian; Tang, Kexuan			Roles of MPBQ-MT in Promoting a/gamma-Tocopherol Production and Photosynthesis under High Light in Lettuce	PLOS ONE			English	Article							SYNECHOCYSTIS SP PCC-6803; VITAMIN-E; SINGLET OXYGEN; ASCORBATE-PEROXIDASE-2 EXPRESSION; HOMOGENTISATE PHYTYLTRANSFERASE; PROTEIN-PHOSPHORYLATION; ANTIOXIDANT PROPERTIES; ARABIDOPSIS LEAVES; HYDROGEN-PEROXIDE; ALPHA-TOCOPHEROL	2-methyl-6-phytyl-1, 4-benzoquinol methyltransferase (MPBQ-MT) is a vital enzyme catalyzing a key methylation step in both a/gamma-tocopherol and plastoquinone biosynthetic pathway. In this study, the gene encoding MPBQ-MT was isolated from lettuce (Lactuca sativa) by rapid amplification of cDNA ends (RACE), named LsMT. Overexpression of LsMT in lettuce brought about a significant increase of a-and.-tocopherol contents with a reduction of phylloquinone (vitamin K1) content, suggesting a competition for a common substrate phytyl diphosphate (PDP) between the two biosynthetic pathways. Besides, overexpression of LsMT significantly increased plastoquinone (PQ) level. The increase of tocopherol and plastoquinone levels by LsMT overexpression conduced to the improvement of plants' tolerance and photosynthesis under high light stress, by directing excessive light energy toward photosynthetic production rather than toward generation of more photooxidative damage. These findings suggest that the role and function of MPBQ-MT can be further explored for enhancing vitamin E value, strengthening photosynthesis and phototolerance under high light in plants.	[Tang, Yueli; Fu, Xueqing; Shen, Qian; Tang, Kexuan] Shanghai Jiao Tong Univ, Sch Agr & Biol, Fudan SJTU Nottingham Plant Biotechnol R&D Ctr, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Tang, KX (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Fudan SJTU Nottingham Plant Biotechnol R&D Ctr, Shanghai 200030, Peoples R China.	kxtang@sjtu.edu.cn.com	Tang, Kexuan/E-3555-2013; SHEN, QIAN/O-6347-2015	Tang, Kexuan/0000-0002-8748-9624; SHEN, QIAN/0000-0002-4621-4659	China Ministry of Science & Technology (China national High-Tech "863" Program [2011AA100605]; China Ministry of Agriculture (China Transgenic Research Program [2013ZX08002-001]; Shanghai Education Committee	China Ministry of Science & Technology (China national High-Tech "863" Program; China Ministry of Agriculture (China Transgenic Research Program; Shanghai Education Committee	Support was provided by the China Ministry of Science & Technology (China national High-Tech "863" Program (grant no. 2011AA100605)); China Ministry of Agriculture (China Transgenic Research Program (grant No. 2013ZX08002-001)). The Shanghai Education Committee funded Shanghai Leading Academic Discipline Project (Horticulture).	Allen JF, 2000, PHILOS T R SOC B, V355, P1351, DOI 10.1098/rstb.2000.0697; Cahoon EB, 2003, NAT BIOTECHNOL, V21, P1082, DOI 10.1038/nbt853; Chang CCC, 2004, PLANT J, V38, P499, DOI 10.1111/j.1365-313X.2004.02066.x; Chen SY, 2006, TRANSGENIC RES, V15, P655, DOI 10.1007/s11248-006-9012-8; Cheng ZG, 2003, PLANT CELL, V15, P2343, DOI 10.1105/tpc.013656; Collakova E, 2001, PLANT PHYSIOL, V127, P1113, DOI 10.1104/pp.010421; Cruz JA, 2005, J EXP BOT, V56, P395, DOI 10.1093/jxb/eri022; DellaPenna D, 2005, J PLANT PHYSIOL, V162, P729, DOI 10.1016/j.jplph.2005.04.004; Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397; Foyer CH, 2011, PLANT PHYSIOL, V155, P93, DOI 10.1104/pp.110.166181; Fryer MJ, 2003, PLANT J, V33, P691, DOI 10.1046/j.1365-313X.2003.01656.x; Hasunuma T, 2008, J BIOSCI BIOENG, V105, P518, DOI 10.1263/jbb.105.518; Horvath G, 2006, PHYTOCHEMISTRY, V67, P1185, DOI 10.1016/j.phytochem.2006.04.004; Hosomi A, 1997, FEBS LETT, V409, P105, DOI 10.1016/S0014-5793(97)00499-7; HUGHES DE, 1983, J PHARM SCI-US, V72, P126, DOI 10.1002/jps.2600720208; Ivanov B, 2007, FEBS LETT, V581, P1342, DOI 10.1016/j.febslet.2007.02.044; KamalEldin A, 1996, LIPIDS, V31, P671, DOI 10.1007/BF02522884; Karpinski S, 1997, PLANT CELL, V9, P627, DOI 10.1105/tpc.9.4.627; Karpinski S, 1999, SCIENCE, V284, P654, DOI 10.1126/science.284.5414.654; KRUK J, 1994, FREE RADICAL RES, V21, P409, DOI 10.3109/10715769409056593; Kruk J, 1997, CHEM PHYS LIPIDS, V87, P73, DOI 10.1016/S0009-3084(97)00027-3; Kruk J, 2003, BIOCHEMISTRY-US, V42, P8501, DOI 10.1021/bi034036q; Kruk J, 2008, BBA-BIOENERGETICS, V1777, P154, DOI 10.1016/j.bbabio.2007.10.008; Ksas B, 2015, SCI REP-UK, V5, DOI 10.1038/srep10919; Laurent MS, 2010, PLANT PHYSIOL BIOCH, V48, P301; Li Y, 2011, BIOL PLANTARUM, V55, P453, DOI 10.1007/s10535-011-0110-y; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Martinis J, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-23; Morales M, 2014, PLANTA, V240, P437, DOI 10.1007/s00425-014-2104-4; Munekage YN, 2008, PLANT CELL PHYSIOL, V49, P1688, DOI 10.1093/pcp/pcn140; Munne-Bosch S, 2002, CRIT REV PLANT SCI, V21, P31, DOI 10.1016/S0735-2689(02)80037-5; Murchie EH, 2011, PLANT PHYSIOL, V155, P86, DOI 10.1104/pp.110.168831; Niyogi KK, 2005, J EXP BOT, V56, P375, DOI 10.1093/jxb/eri056; Pfannschmidt T, 1999, NATURE, V397, P625, DOI 10.1038/17624; Pfannschmidt T, 2003, TRENDS PLANT SCI, V8, P33, DOI 10.1016/S1360-1385(02)00005-5; Pinto-Marijuan M, 2014, J EXP BOT, V65, P3845, DOI 10.1093/jxb/eru086; Ramel F, 2012, PLANT PHYSIOL, V158, P1267, DOI 10.1104/pp.111.182394; Savidge B, 2002, PLANT PHYSIOL, V129, P321, DOI 10.1104/pp.010747; Scheibe R, 2005, J EXP BOT, V56, P1481, DOI 10.1093/jxb/eri181; Schneider C, 2005, MOL NUTR FOOD RES, V49, P7, DOI 10.1002/mnfr.200400049; Singh DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047547; Slesak I, 2003, PLANT CELL PHYSIOL, V44, P573, DOI 10.1093/pcp/pcg073; Triantaphylides C, 2008, PLANT PHYSIOL, V148, P960, DOI 10.1104/pp.108.125690; Van Eenennaam AL, 2003, PLANT CELL, V15, P3007, DOI 10.1105/tpc.015875; Vener AV, 1998, CURR OPIN PLANT BIOL, V1, P217, DOI 10.1016/S1369-5266(98)80107-6; Wolf G, 2005, J NUTR, V135, P363, DOI 10.1093/jn/135.3.363; Yang DH, 2001, PHOTOSYNTH RES, V68, P163, DOI 10.1023/A:1011849919438; Zer H, 2003, TRENDS BIOCHEM SCI, V28, P467, DOI 10.1016/S0968-0004(03)00173-7	48	14	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148490	10.1371/journal.pone.0148490	http://dx.doi.org/10.1371/journal.pone.0148490			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867015	Green Published, Green Submitted, gold			2022-12-27	WOS:000370050700017
J	Tsujimoto, M; Kuroyanagi, G; Matsushima-Nishiwaki, R; Kito, Y; Enomoto, Y; Iida, H; Ogura, S; Otsuka, T; Tokuda, H; Kozawa, O; Iwama, T				Tsujimoto, Masanori; Kuroyanagi, Gen; Matsushima-Nishiwaki, Rie; Kito, Yuko; Enomoto, Yukiko; Iida, Hiroki; Ogura, Shinji; Otsuka, Takanobu; Tokuda, Haruhiko; Kozawa, Osamu; Iwama, Toru			Factor Xa Inhibitor Suppresses the Release of Phosphorylated HSP27 from Collagen-Stimulated Human Platelets: Inhibition of HSP27 Phosphorylation via p44/p42 MAP Kinase	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; ALPHA-B-CRYSTALLIN; ATRIAL-FIBRILLATION; STROKE PREVENTION; PDGF-AB; RIVAROXABAN; AGGREGATION; ACTIVATION; MECHANISMS; DISEASE	Selective inhibitors of factor Xa (FXa) are widely recognized as useful therapeutic tools for stroke prevention in non-valvular atrial fibrillation or venous thrombosis. Thrombin, which is rapidly generated from pro-thrombin through the activation of factor X to FXa, acts as a potent activator of human platelets. Thus, the reduction of thrombin generation by FXa inhibitor eventually causes a suppressive effect on platelet aggregation. However, little is known whether FXa inhibitors directly affect the function of human platelets. We have previously reported that collagen induces the phosphorylation of heat shock protein 27 (HSP27), a low-molecular weight heat shock protein via Rac-dependent activation of p44/p42 mitogen-activated protein (MAP) kinase in human platelets, eventually resulting in the release of HSP27. In the present study, we investigated the direct effect of FXa inhibitor on the collagen-induced human platelet activation. Rivaroxaban as well as edoxaban significantly reduced the collagen-induced phosphorylation of both HSP27 and p44/p42 MAP kinase without affecting the platelet aggregation. Rivaroxaban significantly inhibited the release of phosphorylated HSP27 from collagen-stimulated platelets but not the secretion of platelet derived growth factor-AB. In patients administrated with rivaroxaban, the collagen-induced levels of phosphorylated HSP27 were markedly diminished after 2 days of administration, which failed to affect the platelet aggregation. These results strongly suggest that FXa inhibitor reduces the collagen-stimulated release of phosphorylated HSP27 from human platelets due to the inhibition of HSP27 phosphorylation via p44/p42 MAP kinase.	[Tsujimoto, Masanori; Enomoto, Yukiko; Iwama, Toru] Gifu Univ, Grad Sch Med, Dept Neurosurg, Gifu, Japan; [Tsujimoto, Masanori; Kuroyanagi, Gen; Matsushima-Nishiwaki, Rie; Tokuda, Haruhiko; Kozawa, Osamu] Gifu Univ, Grad Sch Med, Dept Pharmacol, Gifu, Japan; [Ogura, Shinji] Gifu Univ, Grad Sch Med, Dept Emergency & Disaster Med, Gifu, Japan; [Kuroyanagi, Gen; Otsuka, Takanobu] Nagoya City Univ, Dept Orthoped Surg, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Kito, Yuko; Iida, Hiroki] Gifu Univ, Grad Sch Med, Dept Anesthesiol & Pain Med, Gifu, Japan; [Tokuda, Haruhiko] Natl Ctr Geriatr & Gerontol, Dept Clin Lab, Obu, Aichi, Japan	Gifu University; Gifu University; Gifu University; Nagoya City University; Gifu University; National Center for Geriatrics & Gerontology	Kozawa, O (corresponding author), Gifu Univ, Grad Sch Med, Dept Pharmacol, Gifu, Japan.	okozawa@gifu-u.ac.jp		Iwama, Toru/0000-0002-9426-284X; Ogura, Shinji/0000-0001-7686-6001	Research Funding for Longevity Sciences from National Center for Geriatrics and Gerontology (NCGG), Japan [25-4]; Bayer Yakuhin, Ltd.	Research Funding for Longevity Sciences from National Center for Geriatrics and Gerontology (NCGG), Japan; Bayer Yakuhin, Ltd.	This investigation was supported in part by the Research Funding for Longevity Sciences (25-4) from National Center for Geriatrics and Gerontology (NCGG), Japan, and research funding from Bayer Yakuhin, Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acunzo J, 2012, INT J BIOCHEM CELL B, V44, P1622, DOI 10.1016/j.biocel.2012.04.002; Ahrens I, 2014, SEMIN HEMATOL, V51, P147, DOI 10.1053/j.seminhematol.2014.03.004; Arrigo AP, 2007, ADV EXP MED BIOL, V594, P14; Bakthisaran R, 2015, BBA-PROTEINS PROTEOM, V1854, P291, DOI 10.1016/j.bbapap.2014.12.019; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Benjamin IJ, 1998, CIRC RES, V83, P117, DOI 10.1161/01.RES.83.2.117; Black SA, 2015, THROMB HAEM IN PRESS, V114; Borensztajn K, 2011, EXPERT OPIN THER TAR, V15, P341, DOI 10.1517/14728222.2011.553608; Borissoff JI, 2011, NEW ENGL J MED, V364, P1746, DOI 10.1056/NEJMra1011670; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Butt E, 2001, J BIOL CHEM, V276, P7108, DOI 10.1074/jbc.M009234200; Chen CH, 2015, INT J CARDIOL, V191, P244, DOI 10.1016/j.ijcard.2015.03.369; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Doi T, 2010, INT J MOL MED, V26, P387, DOI 10.3892/ijmm_00000477; Eller T, 2014, CLIN CHEM LAB MED, V52, P835, DOI 10.1515/cclm-2013-0936; Eriksson BI, 2011, ANNU REV MED, V62, P41, DOI 10.1146/annurev-med-062209-095159; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Gong IY, 2013, CAN J CARDIOL, V29, pS24, DOI 10.1016/j.cjca.2013.04.002; Hanai Y, 2009, LIFE SCI, V85, P386, DOI 10.1016/j.lfs.2009.07.003; Jin CH, 2014, MOL MED, V20, P280, DOI 10.2119/molmed.2014.00058; Kageyama Y, 2013, INT J MOL MED, V32, P813, DOI 10.3892/ijmm.2013.1455; Kato H, 2010, THROMB RES, V126, P39, DOI 10.1016/j.thromres.2009.12.003; Kato K, 1996, J NEUROCHEM, V66, P946; Kubitza D, 2007, BRIT J CLIN PHARMACO, V63, P469, DOI 10.1111/j.1365-2125.2006.02776.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDRY J, 1992, J BIOL CHEM, V267, P794; Lip GYH, 2015, JAMA-J AM MED ASSOC, V313, P1950, DOI 10.1001/jama.2015.4369; Mackman N, 2007, ARTERIOSCL THROM VAS, V27, P1687, DOI 10.1161/ATVBAHA.107.141911; Mega JL, 2012, NEW ENGL J MED, V366, P9, DOI 10.1056/NEJMoa1112277; Merendino AM, 2002, CELL STRESS CHAPERON, V7, P269, DOI 10.1379/1466-1268(2002)007<0269:HSPPHB>2.0.CO;2; Moroi M, 2004, THROMB RES, V114, P221, DOI 10.1016/j.thromres.2004.06.046; Mymrikov EV, 2011, PHYSIOL REV, V91, P1123, DOI 10.1152/physrev.00023.2010; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Perzborn E, 2015, J CARDIOVAS IN PRESS; Rayner K, 2008, CIRC RES, V103, P133, DOI 10.1161/CIRCRESAHA.108.172155; Saklatvala J, 1996, J BIOL CHEM, V271, P6586, DOI 10.1074/jbc.271.12.6586; Salari S, 2013, CELL STRESS CHAPERON, V18, P53, DOI 10.1007/s12192-012-0356-0; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Spronk HMH, 2014, CARDIOVASC RES, V101, P344, DOI 10.1093/cvr/cvt343; Tokuda H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128977; Wong PC, 2010, THROMB HAEMOSTASIS, V104, P302, DOI 10.1160/TH10-02-0097; ZHU Y, 1994, BLOOD, V84, P3715, DOI 10.1182/blood.V84.11.3715.bloodjournal84113715	43	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149077	10.1371/journal.pone.0149077	http://dx.doi.org/10.1371/journal.pone.0149077			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867010	Green Published, Green Submitted, gold			2022-12-27	WOS:000370050700062
J	Angelini, E; Camerini, G; Diop, M; Roche, P; Rodi, T; Schippa, C; Thomas, T				Angelini, Eric; Camerini, Gerard; Diop, Malick; Roche, Patrice; Rodi, Thomas; Schippa, Christine; Thomas, Thierry			Respiratory Health - Exposure Measurements and Modeling in the Fragrance and Flavour Industry	PLOS ONE			English	Article							MICROWAVE-POPCORN PLANT; BRONCHIOLITIS OBLITERANS; LUNG-DISEASE; DIACETYL; WORKERS	Although the flavor and fragrance industry is about 150 years old, the use of synthetic materials started more than 100 years ago, and the awareness of the respiratory hazard presented by some flavoring substances emerged only recently. In 2001, the US National Institute of Occupational Safety and Health (NIOSH) identified for the first time inhalation exposure to flavoring substances in the workplace as a possible occupational hazard. As a consequence, manufacturers must comply with a variety of workplace safety requirements, and management has to ensure the improvement of health and safety of the employees exposed to hazardous volatile organic compounds. In this sensitive context, MANE opened its facilities to an intensive measuring campaign with the objective to better estimate the real level of hazardous respiratory exposure of workers. In this study, exposure to 27 hazardous volatile substances were measured during several types of handling operations (weighing-mixing, packaging, reconditioning-transferring), 430 measurement results were generated, and were exploited to propose an improved model derived from the well-known ECETOC-TRA model. The quantification of volatile substances in the working atmosphere involved three main steps: adsorption of the chemicals on a solid support, thermal desorption, followed by analysis by gas chromatography-mass spectrometry. Our approach was to examine experimental measures done in various manufacturing workplaces and to define correction factors to reflect more accurately working conditions and habits. Four correction factors were adjusted in the ECETOC-TRA to integrate important exposure variation factors: exposure duration, percentage of the substance in the composition, presence of collective protective equipment and wearing of personal protective equipment. Verification of the validity of the model is based on the comparison of the values obtained after adaptation of the ECETOC-TRA model, according to various exposure scenarios, with the experimental values measured under real conditions. After examination of the predicted results, 98% of the values obtained with the proposed new model were above the experimental values measured in real conditions. This must be compared with the results of the classical ECETOC-TRA system, which generates only 37% of overestimated values. As the values generated by the new model intended to help decision-makers of the industry to implement adapted protective action and information, and considering the high variability of the working environments, it was of the utmost importance to us not to underestimate the exposure level. The proposed correction factors have been designed to achieve this goal. We wish to propose the present method as an improved monitoring tool to improve respiratory health and safety in the flavor and fragrance manufacturing facilities.	[Angelini, Eric; Camerini, Gerard; Diop, Malick; Roche, Patrice; Rodi, Thomas; Schippa, Christine; Thomas, Thierry] V Mane Fils Sa, Le Barp, France		Schippa, C (corresponding author), V Mane Fils Sa, Le Barp, France.	christine.schippa@mane.com			V. MANE FILS SA	V. MANE FILS SA	This study was funded by V. MANE FILS SA. The authors are paid employees of V. MANE FILS SA, and they participated in study design, data collection, decision to publish and preparation of the manuscript.	[Anonymous], 2013, EFSA J, V11, P3474; [Anonymous], 2013, X43298 NF AFNOR; [Anonymous], 2008, EUSES 2 1 1 US MAN; [Anonymous], 2013, 13137 NF EN ISO AFNO; [Anonymous], 2014, X43267 NF AFNOR; [Anonymous], 2003, PV2118 OSHA; [Anonymous], 2010, 1076 NF EN AFNOR; [Anonymous], 2011, ISO 16000 6 INDOOR A; Boylstein Randy, 2006, J Occup Environ Hyg, V3, P530, DOI 10.1080/15459620600909708; Cox-Ganser J, 2011, J OCCUP ENVIRON HYG, V8, P59, DOI 10.1080/15459624.2011.540168; Delmaar C., 2006, CONSEXPO CONSUMER EX; ECETOC, 2012, 114 ECETOC; Fedan JS, 2006, TOXICOL APPL PHARM, V215, P17, DOI 10.1016/j.taap.2006.02.001; Kanwal R, 2006, J OCCUP ENVIRON MED, V48, P149, DOI 10.1097/01.jom.0000194152.48728.fb; Kreiss K, 2002, NEW ENGL J MED, V347, P330, DOI 10.1056/NEJMoa020300; Kullman G, 2005, J OCCUP ENVIRON HYG, V2, P169, DOI 10.1080/15459620590923091; Kullman G, 2007, 200603033043 HETA NI; Martyny JW, 2008, J OCCUP ENVIRON HYG, V5, P679, DOI 10.1080/15459620802368463; NIOSH, 2003, 2557 NIOSH; Pierce JS, 2015, TOXICOL REP, V2, P1200, DOI 10.1016/j.toxrep.2015.08.006; RIFM, 2012, RIFM LAUNCH 2 BOX IN; SafeWorkAustralia, 2012, AUSTR WORKPLACE BARO; Sahakian N, 2009, ADV FOOD NUTR RES, V55, P163, DOI 10.1016/S1043-4526(08)00403-8; Singal M, 2008, HOUSEHOLD PERSONAL C, V3, P40; Tielemans E, 2008, ANN OCCUP HYG, V52, P577, DOI 10.1093/annhyg/men059; Urban AM, 2015, SOC TOX 54 ANN M TOX; Van Rooy GBGJ, 2005, RESP EFFECTS WORKERS	27	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148769	10.1371/journal.pone.0148769	http://dx.doi.org/10.1371/journal.pone.0148769			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863607	gold, Green Published, Green Submitted			2022-12-27	WOS:000370046600105
J	Baker, BJ; Winston, CA; Liu, YC; France, AM; Cain, KP				Baker, Brian J.; Winston, Carla A.; Liu, Yecai; France, Anne Marie; Cain, Kevin P.			Abrupt Decline in Tuberculosis among Foreign- Born Persons in the United States	PLOS ONE			English	Article							US-BOUND IMMIGRANTS; LATENT TUBERCULOSIS; INFECTION; RISK; IMPLEMENTATION; SURVEILLANCE; TRENDS	While the number of reported tuberculosis (TB) cases in the United States has declined over the past two decades, TB morbidity among foreign-born persons has remained persistently elevated. A recent unexpected decline in reported TB cases among foreign-born persons beginning in 2007 provided an opportunity to examine contributing factors and inform future TB control strategies. We investigated the relative influence of three factors on the decline: 1) changes in the size of the foreign-born population through immigration and emigration, 2) changes in distribution of country of origin among foreign-born persons, and 3) changes in the TB case rates among foreign-born subpopulations. Using data from the U.S. National Tuberculosis Surveillance System and the American Community Survey, we examined TB case counts, TB case rates, and population estimates, stratified by years since U.S. entry and country of origin. Regression modeling was used to assess statistically significant changes in trend. Among foreign-born recent entrants (<3 years since U.S. entry), we found a 39.5% decline (-1,013 cases) beginning in 2007 (P<0.05 compared to 2000-2007) and ending in 2011 (P<0.05 compared to 2011-2014). Among recent entrants from Mexico, 80.7% of the decline was attributable to a decrease in population, while the declines among recent entrants from the Philippines, India, Vietnam, and China were almost exclusively (95.5%-100%) the result of decreases in TB case rates. Among foreign-born non-recent entrants (>= 3 years since U.S. entry), we found an 8.9% decline (-443 cases) that resulted entirely (100%) from a decrease in the TB case rate. Both recent and non-recent entrants contributed to the decline in TB cases; factors contributing to the decline among recent entrants varied by country of origin. Strategies that impact both recent and non-recent entrants (e.g., investment in overseas TB control) as well as those that focus on non-recent entrants (e.g., expanded targeted testing of high-risk subgroups among non-recent entrants) will be necessary to achieve further declines in TB morbidity among foreign-born persons.	[Baker, Brian J.; Winston, Carla A.; France, Anne Marie] US Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; [Liu, Yecai] US Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA USA; [Cain, Kevin P.] US Ctr Dis Control & Prevent, Div TB Eliminat, Kisumu, Kenya	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Baker, BJ (corresponding author), US Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA.	bjbaker@cdc.gov						[Anonymous], 2000, MMWR Recomm Rep, V49, P1; Baker BJ, 2014, INT J TUBERC LUNG D, V18, P289, DOI 10.5588/ijtld.13.0684; Baker Brian J, 2014, Ann Am Thorac Soc, V11, P1335, DOI 10.1513/AnnalsATS.201406-291LE; Baker Brian J, 2014, Ann Am Thorac Soc, V11, P480, DOI 10.1513/AnnalsATS.201402-065OC; Cain KP, 2008, JAMA-J AM MED ASSOC, V300, P405, DOI 10.1001/jama.300.4.405; Cain KP, 2007, AM J RESP CRIT CARE, V175, P75, DOI 10.1164/rccm.200608-1178OC; Campbell J, 2014, CAN MED ASSOC J, V186, P246, DOI 10.1503/cmaj.131025; Centers for Disease Control and Prevention, 2015, REP TUB US 2014; Centers for Disease Control and Prevention, 2008, MMWR MORB MORTAL WKL, V57, P292; Chin DP, 1998, AM J RESP CRIT CARE, V158, P1797, DOI 10.1164/ajrccm.158.6.9804029; Clegg LX, 2009, STAT MED, V28, P3670, DOI 10.1002/sim.3733; [Division of Global Migration and Quarantine Centers for Disease Control and Prevention (CDC)], 2013, TUB SCREEN TREATM TE; France AM, 2015, AM J EPIDEMIOL, V182, P799, DOI 10.1093/aje/kwv121; Ghosh S, 2012, INFECT GENET EVOL, V12, P782, DOI 10.1016/j.meegid.2011.10.013; Gonzalez-Barrera A, MEXICANS LEAVING COM; Hill AN, 2012, EPIDEMIOL INFECT, V140, P1862, DOI 10.1017/S095026881100286X; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Lee D P R, 2009, MMWR REP, V62, P1; Liu YC, 2015, ANN INTERN MED, V162, P420, DOI 10.7326/M14-2082; Liu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032158; Liu YC, 2009, NEW ENGL J MED, V360, P2406, DOI 10.1056/NEJMoa0809497; Lopez MH, DRIVING POPULATION G; Lowenthal P, 2011, INT J TUBERC LUNG D, V15, P761, DOI 10.5588/ijtld.10.0370; Maloney SA, 2006, ARCH INTERN MED, V166, P234, DOI 10.1001/archinte.166.2.234; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; [National Center for Emerging and Zoonotic Infectious Diseases Centers for Disease Control and Prevention (CDC)], 2009, CDC IMM REQ TECHN IN; Passel J, NET MIGRATION MEXICO; Patel S, 2007, CHEST, V131, P1811, DOI 10.1378/chest.06-2601; Posey DL, 2014, MMWR-MORBID MORTAL W, V63, P234; Schwartzman K, 2005, NEW ENGL J MED, V353, P1008, DOI 10.1056/NEJMsa043194; Scott C, 2015, MMWR-MORBID MORTAL W, V64, P265; Sterling TR, 2006, AM J RESP CRIT CARE, V173, P927, DOI 10.1164/rccm.200510-1563OC; United States Census Bureau, 2015, AM COMM SURV; Walter ND, 2014, AM J RESP CRIT CARE, V189, P88, DOI 10.1164/rccm.201308-1480OC; Wingate LT, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2530-7; Wingate LT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124116; Winston CA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-846; Winston CA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-206; Woodruff RSY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065276; World Health Organization, 2015, GLOB TUB REP 2015; Zuber PLF, 1997, JAMA-J AM MED ASSOC, V278, P304, DOI 10.1001/jama.278.4.304	41	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0147353	10.1371/journal.pone.0147353	http://dx.doi.org/10.1371/journal.pone.0147353			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863004	gold, Green Submitted, Green Published			2022-12-27	WOS:000370046600027
J	Flones, I; Sztromwasser, P; Haugarvoll, K; Dolle, C; Lykouri, M; Schwarzlmuller, T; Jonassen, I; Miletic, H; Johansson, S; Knappskog, PM; Bindoff, LA; Tzoulis, C				Flones, Irene; Sztromwasser, Pawel; Haugarvoll, Kristoffer; Dolle, Christian; Lykouri, Maria; Schwarzlmuller, Thomas; Jonassen, Inge; Miletic, Hrvoje; Johansson, Stefan; Knappskog, Per M.; Bindoff, Laurence A.; Tzoulis, Charalampos			Novel SLC19A3 Promoter Deletion and Allelic Silencing in Biotin-Thiamine-Responsive Basal Ganglia Encephalopathy	PLOS ONE			English	Article							DISEASE; MUTATIONS; FRAMEWORK	Background Biotin-thiamine responsive basal ganglia disease is a severe, but potentially treatable disorder caused by mutations in the SLC19A3 gene. Although the disease is inherited in an autosomal recessive manner, patients with typical phenotypes carrying single heterozygous mutations have been reported. This makes the diagnosis uncertain and may delay treatment. Methods and Results In two siblings with early-onset encephalopathy dystonia and epilepsy, whole-exome sequencing revealed a novel single heterozygous SLC19A3 mutation (c. 337T> C). Although Sanger-sequencing and copy-number analysis revealed no other aberrations, RNA-sequencing in brain tissue suggested the second allele was silenced. Whole-genome sequencing resolved the genetic defect by revealing a novel 45,049 bp deletion in the 5'-UTR region of the gene abolishing the promoter. High dose thiamine and biotin therapy was started in the surviving sibling who remains stable. In another patient two novel compound heterozygous SLC19A3 mutations were found. He improved substantially on thiamine and biotin therapy. Conclusions We show that large genomic deletions occur in the regulatory region of SLC19A3 and should be considered in genetic testing. Moreover, our study highlights the power of whole-genome sequencing as a diagnostic tool for rare genetic disorders across a wide spectrum of mutations including non-coding large genomic rearrangements.	[Flones, Irene; Haugarvoll, Kristoffer; Dolle, Christian; Lykouri, Maria; Bindoff, Laurence A.; Tzoulis, Charalampos] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway; [Flones, Irene; Haugarvoll, Kristoffer; Dolle, Christian; Lykouri, Maria; Schwarzlmuller, Thomas; Bindoff, Laurence A.; Tzoulis, Charalampos] Univ Bergen, Dept Clin Med, Bergen, Norway; [Sztromwasser, Pawel; Johansson, Stefan; Knappskog, Per M.] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Sztromwasser, Pawel; Johansson, Stefan; Knappskog, Per M.] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Sztromwasser, Pawel; Jonassen, Inge] Univ Bergen, Dept Informat, Computat Biol Unit, N-5008 Bergen, Norway; [Johansson, Stefan; Knappskog, Per M.] Univ Bergen, KG Jebsen Ctr Res Neuropsychiat Disorders, Bergen, Norway; [Schwarzlmuller, Thomas] Haukeland Hosp, Dept Radiol, N-5021 Bergen, Norway; [Miletic, Hrvoje] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway; [Miletic, Hrvoje] Univ Bergen, Dept Biomed, Bergen, Norway; [Miletic, Hrvoje] Univ Bergen, KG Jebsen Brain Tumor Res Ctr, Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen	Tzoulis, C (corresponding author), Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.; Tzoulis, C (corresponding author), Univ Bergen, Dept Clin Med, Bergen, Norway.	Charalampos.Tzoulis@nevro.uib.no	Haugarvoll, Kristoffer/AAB-5860-2019; Johansson, Stefan/C-4394-2011; Tzoulis, Charalampos/AGD-5114-2022; Jonassen, Inge/AAC-7035-2020; Haugarvoll, Kristoffer/L-1486-2015	Haugarvoll, Kristoffer/0000-0001-9381-1109; Johansson, Stefan/0000-0002-2298-7008; Tzoulis, Charalampos/0000-0003-0341-5191; Haugarvoll, Kristoffer/0000-0001-9381-1109; Jonassen, Inge/0000-0003-4110-0748; Flones, Irene/0000-0001-9612-0696; Sztromwasser, Pawel/0000-0002-0661-8800; Bindoff, Laurence/0000-0003-0988-276X; Schwarzlmuller, Thomas/0000-0002-8771-5548	Regional Health Authority of Western Norway (Helse Vest) [911903, 911810]; Bergen Research Foundation	Regional Health Authority of Western Norway (Helse Vest); Bergen Research Foundation	This work was supported (authors CT and PMK) by grants from the Regional Health Authority of Western Norway (Helse Vest, http://www.helse-vest.no/en/Sider/default.aspx, grant no 911903 and 911810), and the Bergen Research Foundation bioinformatics grant. These grants covered the expenses for the genetic tests and analyses.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Debs R, 2010, ARCH NEUROL-CHICAGO, V67, P126, DOI 10.1001/archneurol.2009.293; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Jhala SS, 2011, NEUROCHEM INT, V58, P248, DOI 10.1016/j.neuint.2010.11.019; Keogh MJ, 2015, J NEUROL, V262, P1822, DOI 10.1007/s00415-015-7772-x; Kevelam SH, 2013, BRAIN, V136, P1534, DOI 10.1093/brain/awt054; Kono S, 2009, NEW ENGL J MED, V360, P1792, DOI 10.1056/NEJMc0809100; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nabokina SM, 2004, AM J PHYSIOL-GASTR L, V287, pG822, DOI 10.1152/ajpgi.00234.2004; Ortigoza-Escobar JD, 2015, BRAIN J NEUROLOGY; Ozand PT, 1998, BRAIN, V121, P1267, DOI 10.1093/brain/121.7.1267; Pyle A, 2015, BRAIN, V138, P276, DOI 10.1093/brain/awu348; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Subramanian VS, 2006, AM J PHYSIOL-CELL PH, V291, pC851, DOI 10.1152/ajpcell.00105.2006; Tabarki B, 1993, GENEREVIEWS R; Tabarki B, 2015, EUR J PAEDIATR NEURO, V19, P547, DOI 10.1016/j.ejpn.2015.05.008; Tzoulis C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066145; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yamada K, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-171; Zeng WQ, 2005, AM J HUM GENET, V77, P16, DOI 10.1086/431216	23	15	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149055	10.1371/journal.pone.0149055	http://dx.doi.org/10.1371/journal.pone.0149055			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863430	gold, Green Published, Green Submitted			2022-12-27	WOS:000370046600148
J	Nakajima, W; Jitsuki, S; Sano, A; Takahashi, T				Nakajima, Waki; Jitsuki, Susumu; Sano, Akane; Takahashi, Takuya			Sustained Enhancement of Lateral Inhibitory Circuit Maintains Cross Modal Cortical Reorganization	PLOS ONE			English	Article							AMPA-RECEPTOR TRAFFICKING; PRIMARY SENSORY CORTICES; RAT BARREL CORTEX; SYNAPTIC PLASTICITY; INTRACORTICAL CIRCUITS; SOCIAL-ISOLATION; IN-VIVO; EXPERIENCE; SUBUNIT; HIPPOCAMPUS	Deprivation of one modality can lead to the improvement of other intact modalities. We have previously reported that visual deprivation drives AMPA receptors into synapses from layer4 to 2/3 in the barrel cortex and sharpens functional whisker-barrel map at layer2/3 2 days after the beginning of visual deprivation. Enhanced excitatory synaptic transmission at layer4-2/3 synapses is transient and returns to the base line level a week after the beginning of visual deprivation. Here we found that sharpened whisker-barrel function is maintained at least for a week in visually deprived animals. While increased AMPA receptor-mediated synaptic transmission at layer4-2/3 synapses dropped to the base line a week after the beginning of visual deprivation, lateral inhibitory synaptic transmission onto the neighboring barrel was kept strengthened for a week of visually deprived animals. Thus, transient strengthening of excitatory synapses at layer4-2/3 in the barrel cortex could trigger the enhancement of inhibitory inputs to neighboring barrel, and sustained lateral inhibition can maintain the sharpening of whisker-barrel map in visually deprived animals.	[Nakajima, Waki; Jitsuki, Susumu; Sano, Akane; Takahashi, Takuya] Yokohama City Univ, Grad Sch Med, Dept Physiol, Yokohama, Kanagawa 232, Japan	Yokohama City University	Takahashi, T (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Physiol, Yokohama, Kanagawa 232, Japan.	takahast@yokohama-cu.ac.jp			Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; MEXT of Japan	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Special Coordination Funds for Promoting Science and Technology from the Japan Science and Technology Agency (TT), "Development of biomarker candidates for social behavior" carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (TT), and the Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/Minds) carried out under the Strategic Research Program for Brain Sciences by the MEXT of Japan (TT), Grant-in-Aid for Scientific Research on Innovative Areas "Neural Diversity and Neocortical Organization" from the MEXT of Japan (SJ), Grant-in-Aid for Young Scientists (B) of the MEXT of Japan (SJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Clem RL, 2006, NEURON, V49, P663, DOI 10.1016/j.neuron.2006.01.019; Goel A, 2006, NAT NEUROSCI, V9, P1001, DOI 10.1038/nn1725; Griebel G, 2013, NEUROPHARMACOLOGY, V70, P19, DOI 10.1016/j.neuropharm.2012.12.008; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; Jitsuki S, 2011, NEURON, V69, P780, DOI 10.1016/j.neuron.2011.01.016; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Lee HK, 2015, CURR OPIN NEUROBIOL, V35, P119, DOI 10.1016/j.conb.2015.08.002; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Meng XY, 2015, CELL REP, V12, P955, DOI 10.1016/j.celrep.2015.07.018; Mitsushima D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3760; Mitsushima D, 2011, P NATL ACAD SCI USA, V108, P12503, DOI 10.1073/pnas.1104558108; Miyazaki T, 2013, EUR J NEUROSCI, V37, P1602, DOI 10.1111/ejn.12188; Miyazaki T, 2012, J CLIN INVEST, V122, P2690, DOI 10.1172/JCI63060; Miyazaki T, 2012, BRAIN RES, V1435, P1, DOI 10.1016/j.brainres.2011.11.033; Morishita W, 1997, J PHYSIOL-LONDON, V505, P307, DOI 10.1111/j.1469-7793.1997.307bb.x; Nemeth K, 2014, J PHARMACEUT BIOMED, V88, P579, DOI 10.1016/j.jpba.2013.10.017; Petrus E, 2015, J NEUROSCI, V35, P8790, DOI 10.1523/JNEUROSCI.4975-14.2015; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Tada H, 2013, NEUROSCIENCE, V248, P664, DOI 10.1016/j.neuroscience.2013.06.040; Tada H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131359; Takahashi T, 2003, SCIENCE, V299, P1585, DOI 10.1126/science.1079886; Teegarden BR, 2008, CURR TOP MED CHEM, V8, P969, DOI 10.2174/156802608784936700; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Zhang Y, 2015, NAT NEUROSCI, V18, P402, DOI 10.1038/nn.3936	28	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149068	10.1371/journal.pone.0149068	http://dx.doi.org/10.1371/journal.pone.0149068			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863615	gold, Green Submitted, Green Published			2022-12-27	WOS:000370046600150
J	Eike, LM; Mauseth, B; Camilio, KA; Rekdal, O; Sveinbjornsson, B				Eike, Liv-Marie; Mauseth, Brynjar; Camilio, Ketil Andre; Rekdal, Oystein; Sveinbjornsson, Baldur			The Cytolytic Amphipathic beta(2,2)-Amino Acid LTX-401 Induces DAMP Release in Melanoma Cells and Causes Complete Regression of B16 Melanoma	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; CYTOCHROME-C; INTRATUMORAL INJECTION; MOLECULAR-PATTERNS; ANTITUMOR-ACTIVITY; IMMUNE MODULATION; DENDRITIC CELLS; CANCER; DEATH; TUMOR	In the present study we examined the ability of the amino acid derivative LTX-401 to induce cell death in cancer cell lines, as well as the capacity to induce regression in a murine melanoma model. Mode of action studies in vitro revealed lytic cell death and release of danger-associated molecular pattern molecules, preceded by massive cytoplasmic vacuolization and compromised lysosomes in treated cells. The use of a murine melanoma model demonstrated that the majority of animals treated with intratumoural injections of LTX-401 showed complete and long-lasting remission. Taken together, these results demonstrate the potential of LTX-401 as an immunotherapeutic agent for the treatment of solid tumors.	[Eike, Liv-Marie; Mauseth, Brynjar; Camilio, Ketil Andre; Rekdal, Oystein; Sveinbjornsson, Baldur] Univ Tromso, Inst Med Biol, Fac Hlth, Dept Mol Inflammat Res, N-9037 Tromso, Norway; [Rekdal, Oystein] Lytix Biopharma, Oslo, Norway; [Sveinbjornsson, Baldur] Karolinska Inst, Dept Womens & Childrens Hlth, Childhood Canc Res Unit, Stockholm, Sweden	UiT The Arctic University of Tromso; Karolinska Institutet	Sveinbjornsson, B (corresponding author), Univ Tromso, Inst Med Biol, Fac Hlth, Dept Mol Inflammat Res, N-9037 Tromso, Norway.; Sveinbjornsson, B (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Childhood Canc Res Unit, Stockholm, Sweden.	baldur.sveinbjornsson@uit.no			University of Tromso; Lytix Biopharma; Northern Regional Health Authority; University Hospital of North Norway	University of Tromso; Lytix Biopharma; Northern Regional Health Authority; University Hospital of North Norway	The study was funded by grants from the University of Tromso, Lytix Biopharma and the Northern Regional Health Authority and the University Hospital of North Norway. Lytix Biopharma AS provided support in the form of salaries for the authors [B.S, O.R and K.A.C], but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.; The study was funded by grants from the University of Tromso, Lytix Biopharma and the Northern Regional Health Authority, and the University Hospital of North Norway.	Adachi N, 2004, CLIN CHIM ACTA, V342, P127, DOI 10.1016/j.cccn.2003.12.011; Al-Benna S, 2011, INT J MOL SCI, V12, P8027, DOI 10.3390/ijms12118027; Ausbacher D, 2012, BBA-BIOMEMBRANES, V1818, P2917, DOI 10.1016/j.bbamem.2012.07.005; Aymeric L, 2010, CANCER RES, V70, P855, DOI 10.1158/0008-5472.CAN-09-3566; Ayna G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040069; Baird JR, 2013, J IMMUNOL, V190, P469, DOI 10.4049/jimmunol.1201209; Berge G, 2010, CANCER IMMUNOL IMMUN, V59, P1285, DOI 10.1007/s00262-010-0857-6; Bianchi ME, 2014, CELL DEATH DIFFER, V21, P1, DOI 10.1038/cdd.2013.147; Camilio KA, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.29181; Camilio KA, 2014, CANCER IMMUNOL IMMUN, V63, P601, DOI 10.1007/s00262-014-1540-0; Carta S, 2009, J LEUKOCYTE BIOL, V86, P549, DOI 10.1189/jlb.1008598; Chiang EY, 2003, J IMMUNOL, V170, P4515, DOI 10.4049/jimmunol.170.9.4515; Choi KY, 2012, J INNATE IMMUN, V4, P361, DOI 10.1159/000336630; Danielli R, 2015, CANCER IMMUNOL IMMUN, V64, P999, DOI 10.1007/s00262-015-1704-6; Eliassen LT, 2002, ANTICANCER RES, V22, P2703; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Griffith G, 1993, FIXATION FINE STRUCT; Guerriero JL, 2011, J IMMUNOL, V186, P3517, DOI 10.4049/jimmunol.1003267; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hansen T, 2012, EUR J MED CHEM, V58, P22, DOI 10.1016/j.ejmech.2012.09.048; Hayat M. A., 1993, STAIN CYTOCHEMICAL M; Hilchie AL, 2013, NAT CHEM BIOL, V9, P761, DOI [10.1038/NCHEMBIO.1393, 10.1038/nchembio.1393]; Huang YB, 2012, INT J MOL SCI, V13, P6849, DOI 10.3390/ijms13066849; Huang YB, 2011, MOL CANCER THER, V10, P416, DOI 10.1158/1535-7163.MCT-10-0811; Inoue H, 2014, CELL DEATH DIFFER, V21, P39, DOI 10.1038/cdd.2013.84; Jemmerson R, 2002, CELL DEATH DIFFER, V9, P538, DOI 10.1038/sj.cdd.4400981; Kepp O, 2011, CANCER METAST REV, V30, P61, DOI 10.1007/s10555-011-9273-4; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Krysko O, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.156; Ladoire S, 2014, ANTIOXID REDOX SIGN, V20, P1098, DOI 10.1089/ars.2012.5133; Lichty BD, 2014, NAT REV CANCER, V14, P559, DOI 10.1038/nrc3770; Liu YA, 2012, J IMMUNOTHER, V35, P299, DOI 10.1097/CJI.0b013e3182518e83; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Maletzki C, 2014, ONCOTARGET, V5, P4467, DOI 10.18632/oncotarget.2039; Martins I, 2012, AUTOPHAGY, V8, P413, DOI 10.4161/auto.19009; Midura-Nowaczek K, 2014, PERSPECT MED CHEM, V6, P73, DOI 10.4137/PMC.S13215; Palombo F, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00503; Pierce RH, 2015, HUM VACC IMMUNOTHER, V11, P1901, DOI 10.1080/21645515.2015.1049779; Pokrovskaya ID, 2012, CELL MICROBIOL, V14, P656, DOI 10.1111/j.1462-5822.2012.01747.x; Prestwich RJ, 2008, CLIN CANCER RES, V14, P7358, DOI 10.1158/1078-0432.CCR-08-0831; Pullerits R, 2005, RHEUMATOLOGY, V44, P32, DOI 10.1093/rheumatology/keh406; Rozera C, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0473-5; SHIMOYAMA Y, 1989, J SURG ONCOL, V41, P12, DOI 10.1002/jso.2930410107; Singh M, 2015, CANCER IMMUNOL IMMUN, V64, P911, DOI 10.1007/s00262-015-1727-z; Strom MB, 2003, J MED CHEM, V46, P1567, DOI 10.1021/jm0340039; Szczepanski Claudia, 2014, Genes Cancer, V5, P186; Tang DL, 2010, BBA-GENE REGUL MECH, V1799, P131, DOI 10.1016/j.bbagrm.2009.11.014; Ullrich E, 2008, CELL DEATH DIFFER, V15, P21, DOI 10.1038/sj.cdd.4402266; Vacchelli E, 2014, ONCOIMMUNOLOGY, V3, DOI [10.4161/onci.27048, 10.4161/onci.27878]; Wenceslau CF, 2014, EUR HEART J, V35, P1172, DOI 10.1093/eurheartj/ehu047; Yang H, 2012, MOL MED, V18, P250, DOI 10.2119/molmed.2011.00389; Yang N, 2004, J PEPT SCI, V10, P37, DOI 10.1002/psc.470; Yang N, 2002, J PEPT RES, V60, P187, DOI 10.1034/j.1399-3011.2002.21008.x; Yang NN, 2003, J PEPT SCI, V9, P300, DOI 10.1002/psc.457; Zitvogel L, 2008, J CLIN INVEST, V118, P1991, DOI 10.1172/JCI35180	56	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148980	10.1371/journal.pone.0148980	http://dx.doi.org/10.1371/journal.pone.0148980			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881822	Green Published, Green Submitted, gold			2022-12-27	WOS:000371219000038
J	Lai, XJ; Zhang, B; Jiang, YX; Li, JC; Zhao, RN; Yang, X; Zhang, XY; Zhu, SL; Wu, Q; Cai, S; Zhang, YX				Lai, Xingjian; Zhang, Bo; Jiang, Yuxin; Li, Jianchu; Zhao, Ruina; Yang, Xiao; Zhang, Xiaoyan; Zhu, Shenling; Wu, Qiong; Cai, Sheng; Zhang, Yixiu			Sonographic and Clinical Features of Papillary Thyroid Microcarcinoma Less than or Equal to Five Millimeters: A Retrospective Study	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; MULTIFOCALITY	Objective To retrospectively compare the sonographic and clinical features of papillary thyroid micro-carcinoma (PTMC) <= 5 mm and PTMC >5 mm to improve the diagnostic value of ultrasonography. Methods A total of 367 cases of PTMC between January 2013 and December 2014 was included in this study. The patients were classified into group A (<= 5 mm, n = 181) or group B (>5 mm, n = 186), and the sonographic and clinical features were reviewed and compared between the two groups. Results There was no significant difference in the shape, ratio of length/width, boundary, peripheral halo ring, echogenicity, cystic change and accompanying Hashimoto's thyroiditis between these two groups. However, the calcification (61.3% vs. 72.6%) and hypervascularity (13.8% vs. 24.7%) were more frequent in group B (p = 0.026 and 0.008, respectively). The patients were younger, and more patients were aged less than 45 years (41.4% vs. 57.0%) in group B. Capsular invasion (7.2% vs. 34.4%), multifocality (21.5% vs. 48.9%), bilaterality (17.1% vs. 39.8%), central lymph node metastasis (13.8% vs. 38.2%) and lateral lymph node metastasis (1.1% vs. 5.4%) were more frequent in group B. No clinical or sonographic feature was related to cervical lymph node metastasis in group A, while less than 45 years in age (p = 0.010), male gender (p = 0.040), capsular invasion (p<0.001), multifocality (p = 0.016) and calcification (p = 0.042) were related to cervical lymph node metastasis in group B. Conclusions The sonographic features of PTMC <= 5 mm were similar to those of PTMC >5 mm, including an irregular shape, a length/width ratio of >= 1, an unclear boundary, no peripheral halo ring, hypoechogenicity, no cystic change, calcification, no hypervascularity and no accompanying Hashimoto's thyroiditis. The clinical features of PTMC <= 5 mm were less aggressive than those of PTMC >5 mm.	[Jiang, Yuxin] Chinese Acad Med Sci, Dept Ultrasound, Beijing 100730, Peoples R China; Beijing Union Med Coll Hosp, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Jiang, YX (corresponding author), Chinese Acad Med Sci, Dept Ultrasound, Beijing 100730, Peoples R China.	jiangyxpumch@163.com	zhao, ruina/GOH-3374-2022		National Natural Science Foundation of China [81171354]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (81171354). YJ received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by the National Natural Science Foundation of China (81171354).	Baloch ZW, 2006, ADV ANAT PATHOL, V13, P69, DOI 10.1097/01.pap.0000213006.10362.17; Bin-yu L, 2010, CHIN J END MET, V26, P282; Chow SM, 2003, CANCER-AM CANCER SOC, V98, P31, DOI 10.1002/cncr.11442; Gu WJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000841; HARACH HR, 1985, CANCER-AM CANCER SOC, V56, P531, DOI 10.1002/1097-0142(19850801)56:3<531::AID-CNCR2820560321>3.0.CO;2-3; Ito Y, 2003, THYROID, V13, P381, DOI 10.1089/105072503321669875; KASAI N, 1987, CANCER-AM CANCER SOC, V60, P1767, DOI 10.1002/1097-0142(19871015)60:8<1767::AID-CNCR2820600816>3.0.CO;2-P; Kim Joonseok, 2013, Case Rep Med, V2013, P131395, DOI 10.1155/2013/131395; Kwak JY, 2009, ANN SURG ONCOL, V16, P1348, DOI 10.1245/s10434-009-0384-x; Lee HS, 2013, EUR ARCH OTO-RHINO-L, V270, P2969, DOI 10.1007/s00405-013-2634-6; Lee SH, 2008, LARYNGOSCOPE, V118, P659, DOI 10.1097/MLG.0b013e318161f9d1; Moon HJ, 2011, ANN SURG ONCOL, V18, P1916, DOI 10.1245/s10434-011-1556-z; Moon WJ, 2008, RADIOLOGY, V247, P762, DOI 10.1148/radiol.2473070944; Page C, 2009, EUR ARCH OTO-RHINO-L, V266, P1959, DOI 10.1007/s00405-009-0952-5; SOBIN LH, 1990, HISTOPATHOLOGY, V16, P513; Wada N, 2003, ANN SURG, V237, P399, DOI 10.1097/00000658-200303000-00015; Wang Y, 2012, ULTRASOUND MED BIOL, V38, P1681, DOI 10.1016/j.ultrasmedbio.2012.05.019; Xia Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114080; Zhang L, 2012, J CLIN ENDOCR METAB, V97, P1250, DOI 10.1210/jc.2011-1546; Zhao QZ, 2013, ANN SURG ONCOL, V20, P746, DOI 10.1245/s10434-012-2654-2	20	4	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148567	10.1371/journal.pone.0148567	http://dx.doi.org/10.1371/journal.pone.0148567			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881783	Green Submitted, gold, Green Published			2022-12-27	WOS:000371219000017
J	Lorenz, R; Grant, E; Muyindike, W; Maling, S; Card, C; Henry, C; Nazarali, AJ				Lorenz, Rick; Grant, Eisha; Muyindike, Winnie; Maling, Samuel; Card, Claire; Henry, Carol; Nazarali, Adil J.			Caregivers' Attitudes towards HIV Testing and Disclosure of HIV Status to At-Risk Children in Rural Uganda	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; PEDIATRIC-PATIENTS; DIAGNOSIS; ADHERENCE; CANCER; NUTRITION; FAMILIES; IMPACT	Caregivers of HIV-positive children were interviewed in the Mbarara and Isingiro districts of Uganda to identify current trends in practices related to HIV testing and the disclosure of HIV status to the child. A total of 28 caregivers of at least one HIV-positive child participated in semi-structured interviews exploring when and why they tested the child for HIV, when the child was informed of their positive status, and what the caregiver did to prepare themselves and the child for status disclosure. For a majority (96%) of respondents, the decision to test the child for HIV was due to existing illness in either the child or a relative. Other common themes identified included the existence of stigma in the caregivers' communities and doubt that the children truly understood what was being explained to them when their status was disclosed. Most (65%) children were informed of their HIV status between the ages of 5 and 9, with the mean age of disclosure occurring at the age of 7. General provision of HIV information typically began at the same age as disclosure, and as many as two thirds (64%) of the caregivers sought advice from an HIV counsellor prior to disclosure. How a caregiver chose to prepare themselves and the child did not affect the caregiver's perception of whether the disclosure experience was beneficial or not. These findings suggest that the HIV disclosure experience in Mbarara and Isingiro districts differs from current guidelines, especially with respect to age of disclosure, how caregivers prepare themselves and the child, and approaching disclosure as an ongoing process. The doubts expressed by caregivers regarding the child's level of HIV understanding following the disclosure experience suggest the children may be insufficiently prepared at the time of the initial disclosure event. The findings also suggest that examining the content of pre-disclosure counselling and HIV education, and how health care professionals are trained to facilitate the disclosure process as important avenues for further research.	[Lorenz, Rick; Grant, Eisha; Henry, Carol; Nazarali, Adil J.] Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK, Canada; [Card, Claire] Minist Hlth, Kampala, Uganda; [Grant, Eisha] MUST, Fac Med, Mbarara, Uganda; [Muyindike, Winnie; Maling, Samuel] Univ Saskatchewan, Western Coll Vet Med, Saskatoon, SK S7N 0W0, Canada	University of Saskatchewan; University of Saskatchewan	Nazarali, AJ (corresponding author), Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK, Canada.	aj.nazarali@usask.ca	Muyindike, Winnie/W-2892-2019		University of Saskatchewan President's Social Sciences and Humanities Research Council (Canada) Research Fund; International Development Research Centre (IDRC)/University of Saskatchewan Global Partners Fund; Veterinarians Without Borders-Veterinaires sans Frontieres	University of Saskatchewan President's Social Sciences and Humanities Research Council (Canada) Research Fund; International Development Research Centre (IDRC)/University of Saskatchewan Global Partners Fund; Veterinarians Without Borders-Veterinaires sans Frontieres	Funding for this study was provided by the University of Saskatchewan President's Social Sciences and Humanities Research Council (Canada) Research Fund (AN), International Development Research Centre (IDRC)/University of Saskatchewan Global Partners Fund (AN), and Veterinarians Without Borders-Veterinaires sans Frontieres (CC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to all the caregivers' for their participation in this study. We thank the nursing staff and physicians at the ISS clinic and the staff at FAOC. Funding for this study was provided by the University of Saskatchewan President's Social Sciences and Humanities Research Council (Canada) Research Fund, the International Development Research Centre (IDRC)/University of Saskatchewan Global Partners Fund, and Veterinarians Without Borders-Veterinaires sans Frontieres. We thank Andrea Silver for reviewing the manuscript.	Beale EA, 2005, J CLIN ONCOL, V23, P3629, DOI 10.1200/JCO.2005.11.015; BIBACE R, 1980, PEDIATRICS, V66, P912; Bikaako-Kajura W, 2006, AIDS BEHAV, V10, pS85, DOI 10.1007/s10461-006-9141-3; Blasini I, 2004, J DEV BEHAV PEDIATR, V25, P181, DOI 10.1097/00004703-200406000-00007; Bolton-Moore C, 2007, JAMA-J AM MED ASSOC, V298, P1888, DOI 10.1001/jama.298.16.1888; Brady MT, 2010, JAIDS-J ACQ IMM DEF, V53, P86, DOI 10.1097/QAI.0b013e3181b9869f; Cantrell K, 2013, AIDS EDUC PREV, V25, P302, DOI 10.1521/aeap.2013.25.4.302; Dewey KG, 2011, MATERN CHILD NUTR, V7, P5, DOI 10.1111/j.1740-8709.2011.00349.x; Flanagan-Klygis E, 2001, J CLIN ETHIC, V12, P150; FREEMAN HE, 1980, AM J PUBLIC HEALTH, V70, P1277, DOI 10.2105/AJPH.70.12.1277; Government of Uganda, 2013, 2013 UG HIV AIDS COU; Haberer JE, 2014, AIDS CARE, P1; KATZ ER, 1984, CLIN PSYCHOL REV, V4, P525, DOI 10.1016/0272-7358(84)90042-4; Kiwanuka J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093276; Kouyoumdjian FG, 2005, J TROP PEDIATRICS, V51, P285, DOI 10.1093/tropej/fmi014; Kuhanen Jan, 2008, HIST AFR, V35, P301, DOI [DOI 10.1353/HIA.0.0009, 10.1353/hia.0.0009]; LIPSON M, 1993, HASTINGS CENT REP, V23, P6, DOI 10.2307/3562811; Mellins CA., 2002, CLIN CHILD PSYCHOL P, V7, P101, DOI [10.1177/1359104502007001008, DOI 10.1177/1359104502007001008]; Miller L G, 2000, HIV Clin Trials, V1, P36; Ministry of Health (MoH) Uganda, 2003, UG NAT POL GUID HIV; New York State Department of Health AIDS Institute, 2009, DISCL HIV PER INF CH; Rwemisisi J, 2008, HEALTH POLICY PLANN, V23, P36, DOI 10.1093/heapol/czm040; SIGMAN M, 1991, J CHILD PSYCHOL PSYC, V32, P307, DOI 10.1111/j.1469-7610.1991.tb00309.x; SLAVIN LA, 1982, AM J PSYCHIAT, V139, P179; Thorne C, 2000, CHILD CARE HLTH DEV, V26, P29, DOI 10.1046/j.1365-2214.2000.00128.x; UNAIDS, 2010, UNAIDS EX SUMM REP G; Vaz L, 2008, AIDS CARE, V20, P842, DOI 10.1080/09540120701742276; Vaz LME, 2010, AIDS PATIENT CARE ST, V24, P247, DOI 10.1089/apc.2009.0217; Vreeman RC, 2010, AIDS PATIENT CARE ST, V24, P639, DOI 10.1089/apc.2010.0079; Wagner GJ, 2000, AIDS CARE, V12, P405, DOI 10.1080/09540120050123800; Waugh S, 2003, AIDS CARE, V15, P169, DOI 10.1080/0954012031000068317; WHO, 2013, GLOB UPD HIV TREATM; WIENER L, 1994, AM J ORTHOPSYCHIAT, V64, P485, DOI 10.1037/h0079539; Wiener LS, 1998, CHILD WELFARE, V77, P115; World Health Organization, 2010, UN ACC SCAL PRIOR HI	35	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148950	10.1371/journal.pone.0148950	http://dx.doi.org/10.1371/journal.pone.0148950			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3BP	26881773	Green Submitted, Green Published, gold			2022-12-27	WOS:000371219000037
J	Belle, A; Ansari, S; Spadafore, M; Convertino, VA; Ward, KR; Derksen, H; Najarian, K				Belle, Ashwin; Ansari, Sardar; Spadafore, Maxwell; Convertino, Victor A.; Ward, Kevin R.; Derksen, Harm; Najarian, Kayvan			A Signal Processing Approach for Detection of Hemodynamic Instability before Decompensation	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; COMPLEX WAVELETS; BLOOD-PRESSURE; MORTALITY	Advanced hemodynamic monitoring is a critical component of treatment in clinical situations where aggressive yet guided hemodynamic interventions are required in order to stabilize the patient and optimize outcomes. While there are many tools at a physician's disposal to monitor patients in a hospital setting, the reality is that none of these tools allow hi-fidelity assessment or continuous monitoring towards early detection of hemodynamic instability. We present an advanced automated analytical system which would act as a continuous monitoring and early warning mechanism that can indicate pending decompensation before traditional metrics can identify any clinical abnormality. This system computes novel features or bio-markers from both heart rate variability (HRV) as well as the morphology of the electrocardiogram (ECG). To compare their effectiveness, these features are compared with the standard HRV based bio-markers which are commonly used for hemodynamic assessment. This study utilized a unique database containing ECG waveforms from healthy volunteer subjects who underwent simulated hypovolemia under controlled experimental settings. A support vector machine was utilized to develop a model which predicts the stability or instability of the subjects. Results showed that the proposed novel set of features outperforms the traditional HRV features in predicting hemodynamic instability.	[Belle, Ashwin; Ansari, Sardar; Ward, Kevin R.; Najarian, Kayvan] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Belle, Ashwin; Ansari, Sardar; Ward, Kevin R.; Derksen, Harm; Najarian, Kayvan] Univ Michigan, Michigan Ctr Integrat Res Crit Care, Ann Arbor, MI 48109 USA; [Derksen, Harm] Univ Michigan, Dept Math, Ann Arbor, MI 48109 USA; [Najarian, Kayvan] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Spadafore, Maxwell] Univ Michigan, Coll Literature Sci & Arts, Ann Arbor, MI 48109 USA; [Convertino, Victor A.] US Army Inst Surg Res, Combat Casualty Care Res Program, San Antonio, TX USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; United States Department of Defense; United States Army	Belle, A (corresponding author), Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA.; Belle, A (corresponding author), Univ Michigan, Michigan Ctr Integrat Res Crit Care, Ann Arbor, MI 48109 USA.	bellea@med.umich.edu		Spadafore, Maxwell/0000-0001-5927-1428; Convertino, Victor/0000-0001-9246-0554	U.S. Army Medical Research and Material Command Combat Casualty Care Research Program [05-0033-02]	U.S. Army Medical Research and Material Command Combat Casualty Care Research Program	Initial work of this project was funded by: U.S. Army Medical Research and Material Command Combat Casualty Care Research Program, Grant: 05-0033-02: KN KW. The authors had no role in the design of experimental setup and data collection for the LBNP study. The LBNP study was designed and data was collected by USASR which partially funded the project in the early stages.	Bradley AP, 2004, CLIN NEUROPHYSIOL, V115, P1114, DOI 10.1016/j.clinph.2003.11.016; Brunk HD., 1972, STAT INFERENCE ORDER; Buchman Timothy G, 2002, Curr Opin Crit Care, V8, P311, DOI 10.1097/00075198-200208000-00007; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Choi H, 2000, INT CONF ACOUST SPEE, P133, DOI 10.1109/ICASSP.2000.861889; Chouhan V, 2007, TOTAL REMOVAL BASELI, P512; Convertino VA, 2012, AVIAT SPACE ENVIR MD, V83, P614, DOI 10.3357/ASEM.3204.2012; Convertino VA, 2011, J TRAUMA, V71, pS25, DOI 10.1097/TA.0b013e3182211601; Cooke WH, 2004, J APPL PHYSIOL, V96, P1249, DOI 10.1152/japplphysiol.01155.2003; Daubechies I., 1992, SOC IND APPL MATH, DOI [DOI 10.1137/1.9781611970104, 10.1137/1.9781611970104]; Davies PL, 2001, ANN STAT, V29, P1, DOI 10.1214/aos/996986501; Engelse W. A. H., 1979, Computers in Cardiology, P37; FARRAR DE, 1967, REV ECON STAT, V49, P92, DOI 10.2307/1937887; Guelen I, 2003, BLOOD PRESS MONIT, V8, P27, DOI 10.1097/00126097-200302000-00006; HOCKING RR, 1976, BIOMETRICS, V32, P1, DOI 10.2307/2529336; Ji SY, 2013, J CLIN MONIT COMPUT, V27, P289, DOI 10.1007/s10877-013-9434-9; Katz MH, 2006, MULTIVARIABLE ANALYSIS: A PRACTICAL GUIDE FOR CLINICIANS, 2ND EDITION, P1, DOI 10.1017/CBO9780511811692; Kingsbury N, 2003, IEEE IMAGE PROC, P1013; Kingsbury N, 2001, APPL COMPUT HARMON A, V10, P234, DOI 10.1006/acha.2000.0343; Kingsbury NG, 1998, P 8 IEEE DSP WORKSH, P120; MALLAT SG, 1989, IEEE T PATTERN ANAL, V11, P674, DOI 10.1109/34.192463; McQuillan P, 1998, BMJ-BRIT MED J, V316, P1853; Meyer Y., 1995, WAVELETS OPERATORS, V1; Miller AJ, 2002, SUBSET SELECTION REG, DOI DOI 10.1201/9781420035933; Moody G. B., 1985, Computers in Cardiology (Cat. No.85CH2217-8), P113; Najarian K., 2005, BIOMEDICAL SIGNAL IM; Nolan J, 1998, CIRCULATION, V98, P1510, DOI 10.1161/01.CIR.98.15.1510; Oppenheim A.V., 1989, OTHERS DISCRETE TIME, V2; Rabiner L. R., 1978, DIGITAL PROCESSING S; Romberg J, 2000, 2000 INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, VOL II, PROCEEDINGS, P371, DOI 10.1109/ICIP.2000.899396; Ryan ML, 2011, J TRAUMA, V70, P1371, DOI 10.1097/TA.0b013e31821858e6; Saritha C., 2008, Bulgarian Journal of Physics, V35, P68; Schafer RW, 2011, IEEE SIGNAL PROC MAG, V28, P111, DOI 10.1109/MSP.2011.941097; Selesnick IW, 2005, IEEE SIGNAL PROC MAG, V22, P123, DOI 10.1109/MSP.2005.1550194; Stoica P., 1997, INTRO SPECTRAL ANAL, V1; Tarvainen MP, 2008, KUBIOS HRV VERSION 2; Tavakolian K, 2014, SHOCK, V41, P91, DOI 10.1097/SHK.0000000000000077; Winters BD, 2006, JAMA-J AM MED ASSOC, V296, P1645, DOI 10.1001/jama.296.13.1645; WO CCJ, 1993, CRIT CARE MED, V21, P218, DOI 10.1097/00003246-199302000-00012	39	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148544	10.1371/journal.pone.0148544	http://dx.doi.org/10.1371/journal.pone.0148544			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871715	Green Submitted, gold, Green Published			2022-12-27	WOS:000370054100035
J	Santiago, MJ; Fernandez, SN; Lazaro, A; Gonzalez, R; Urbano, J; Lopez, J; Solana, MJ; Toledo, B; del Castillo, J; Tejedor, A; Lopez-Herce, J				Jose Santiago, Maria; Nicole Fernandez, Sarah; Lazaro, Alberto; Gonzalez, Rafael; Urbano, Javier; Lopez, Jorge; Jose Solana, Maria; Toledo, Blanca; del Castillo, Jimena; Tejedor, Alberto; Lopez-Herce, Jesus			Cisplatin-Induced Non-Oliguric Acute Kidney Injury in a Pediatric Experimental Animal Model in Piglets	PLOS ONE			English	Article							INDUCED NEPHROTOXICITY; NEPHROPATHY; RATS	Objective To design an experimental pediatric animal model of acute kidney injury induced by cisplatin. Methods Prospective comparative observational animal study in two different phases. Acute kidney injury was induced using three different doses of cisplatin (2, 3 and 5 mg/kg). The development of nephrotoxicity was assessed 2 to 4 days after cisplatin administration by estimating biochemical parameters, diuresis and renal morphology. Analytical values and renal morphology were compared between 15 piglets treated with cisplatin 3 mg/kg and 15 control piglets in the second phase of the study. Results 41 piglets were studied. The dose of 3 mg/kg administered 48 hours before the experience induced a significant increase in serum creatinine and urea without an increase in potassium levels. Piglets treated with cisplatin 3 mg/kg had significantly higher values of creatinine, urea, phosphate and amylase, less diuresis and lower values of potassium, sodium and bicarbonate than control piglets. Histological findings showed evidence of a dose-dependent increase in renal damage. Conclusions a dose of 3 mg/kg of cisplatin induces a significant alteration in renal function 48 hours after its administration, so it can be used as a pediatric animal model of non-oliguric acute kidney injury.	[Jose Santiago, Maria; Nicole Fernandez, Sarah; Gonzalez, Rafael; Urbano, Javier; Lopez, Jorge; Jose Solana, Maria; Toledo, Blanca; del Castillo, Jimena; Lopez-Herce, Jesus] Hosp Gen Univ Gregorio Maranon, Inst Invest Sanitaria Gregorio Maranon, Paediat Intens Care Dept, Madrid, Spain; [Jose Santiago, Maria; Nicole Fernandez, Sarah; Gonzalez, Rafael; Urbano, Javier; Lopez, Jorge; Jose Solana, Maria; Toledo, Blanca; del Castillo, Jimena; Lopez-Herce, Jesus] Spanish Hlth Inst Carlos III Maternal Child Hlth, Madrid, Spain; [Jose Santiago, Maria; Nicole Fernandez, Sarah; Gonzalez, Rafael; Urbano, Javier; Lopez, Jorge; Jose Solana, Maria; Toledo, Blanca; del Castillo, Jimena; Tejedor, Alberto; Lopez-Herce, Jesus] Univ Complutense Madrid, Madrid, Spain; [Lazaro, Alberto; Tejedor, Alberto] Hosp Gen Univ Gregorio Maranon, Inst Invest Sanitaria Gregorio Maranon, Dept Nephrol, Lab Renal Physiopathol, Madrid, Spain	General University Gregorio Maranon Hospital; Complutense University of Madrid; General University Gregorio Maranon Hospital	Lopez-Herce, J (corresponding author), Hosp Gen Univ Gregorio Maranon, Inst Invest Sanitaria Gregorio Maranon, Paediat Intens Care Dept, Madrid, Spain.; Lopez-Herce, J (corresponding author), Spanish Hlth Inst Carlos III Maternal Child Hlth, Madrid, Spain.; Lopez-Herce, J (corresponding author), Univ Complutense Madrid, Madrid, Spain.	pielvi@hotmail.com	Fernandez Lafever, Sarah Nicole/AAE-4978-2022; Lopez, Jorge/AAD-4109-2022; Santiago, Maria José/AAZ-5412-2020; Cortes, Rafael Gonzalez/ABB-4855-2020; Lopez-Herce, Jesus/A-1602-2019; Lazaro, Alberto/A-9291-2016	Fernandez Lafever, Sarah Nicole/0000-0003-4859-5966; Lopez, Jorge/0000-0002-9942-6399; Cortes, Rafael Gonzalez/0000-0002-3259-7898; Lopez-Herce, Jesus/0000-0001-6105-9178; Lazaro, Alberto/0000-0002-1095-679X; SOLANA, MARIA JOSE/0000-0001-6083-2528; Urbano, Javier/0000-0002-3511-2905; del castillo, jimena/0000-0002-0702-1520	Carlos III Institute of Health, Spain [PI12/0128, PI11-01132]; Comunidad Autonoma de Madrid (Consorcio para la Investigacion del Fracaso Renal Agudo-CIFRA-) [S2010/BMD-2378]	Carlos III Institute of Health, Spain(Instituto de Salud Carlos III); Comunidad Autonoma de Madrid (Consorcio para la Investigacion del Fracaso Renal Agudo-CIFRA-)	This study was supported by grant PI12/0128 and PI11-01132 from Carlos III Institute of Health, Spain, and Comunidad Autonoma de Madrid (Consorcio para la Investigacion del Fracaso Renal Agudo-CIFRA-) S2010/BMD-2378.	Basu RK, 2011, PEDIATR CRIT CARE ME, V12, P339, DOI 10.1097/PCC.0b013e3181fe2e0b; Choi Dae Eun, 2009, Korean Journal of Internal Medicine, V24, P238, DOI 10.3904/kjim.2009.24.3.238; Chrysikos DT, 2015, J PANCREAS, V16, P176, DOI 10.6092/1590-8577/2952; DAUGAARD G, 1990, DAN MED BULL, V37, P1; Eshraghi-Jazi F, 2013, IRAN J KIDNEY DIS, V7, P383; Hesketh EE, 2014, J VIS EXP, V88; Humanes B, 2012, KIDNEY INT, V82, P652, DOI 10.1038/ki.2012.199; Hur E, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/313528; Kim YJ, 2014, PLANTA MED, V80, P645, DOI 10.1055/s-0034-1368571; Li S, 2011, CRIT CARE MED, V39, P1493, DOI 10.1097/CCM.0b013e31821201d3; Lieberthal W, 2000, AM J PHYSIOL-RENAL, V278, pF1, DOI 10.1152/ajprenal.2000.278.1.F1; Miller RP, 2010, TOXINS, V2, P2490, DOI 10.3390/toxins2112490; Moghadasali R, 2014, CYTOTHERAPY, V16, P734, DOI 10.1016/j.jcyt.2014.01.004; Oh Gi-Su, 2014, Electrolyte Blood Press, V12, P55, DOI 10.5049/EBP.2014.12.2.55; Pisani A, 2014, CLIN EXP NEPHROL, V18, P424, DOI 10.1007/s10157-013-0828-2; Ramesh G, METHODS MOL BIOL, V1194, P421; Santiago MJ, 2010, INTENS CARE MED, V36, P843, DOI 10.1007/s00134-010-1858-9; Stein J H, 1985, Transplant Proc, V17, P72; Wang JW, 2013, KIDNEY BLOOD PRESS R, V37, P414, DOI 10.1159/000350154; Ware K, 2013, AM J PHYSIOL-RENAL, V304, pF1421, DOI 10.1152/ajprenal.00689.2012; Wei QQ, 2012, AM J PHYSIOL-RENAL, V303, pF1487, DOI 10.1152/ajprenal.00352.2012	21	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149013	10.1371/journal.pone.0149013	http://dx.doi.org/10.1371/journal.pone.0149013			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871589	Green Submitted, Green Published, gold			2022-12-27	WOS:000370054100088
J	Miller, AC; Nelson, AK; Livchits, V; Greenfield, SF; Yanova, G; Yanov, S; Connery, HS; Atwood, S; Lastimoso, CS; Shin, SS				Miller, Ann C.; Nelson, A. Katrina; Livchits, Viktoria; Greenfield, Shelly F.; Yanova, Galina; Yanov, Sergei; Connery, Hilary S.; Atwood, Sidney; Lastimoso, Charmaine S.; Shin, Sonya S.		Tomsk Tuberculosis Alcohol Working	Understanding HIV Risk Behavior among Tuberculosis Patients with Alcohol Use Disorders in Tomsk, Russian Federation	PLOS ONE			English	Article							MULTICENTER AIDS COHORT; GENDER-DIFFERENCES; ST-PETERSBURG; CONSUMPTION; MORTALITY; INFECTION; HEALTH; IDENTIFICATION; MANAGEMENT; DRINKING	Russian Federation's (RF) HIV epidemic is the fastest growing of any country. This study explores factors associated with high HIV risk behavior in tuberculosis (TB) patients with alcohol use disorders in Tomsk, RF. This analysis was nested within the Integrated Management of Physician-delivered Alcohol Care for TB Patients (IMPACT, trial number NCT00675961) randomized controlled study of integrating alcohol treatment into TB treatment in Tomsk. Demographics, HIV risk behavior (defined as participant report of high-risk intravenous drug use and/or multiple sexual partners with inconsistent condom use in the last six months), clinical data, alcohol use, depression and psychosocial factors were collected from 196 participants (161 male and 35 female) at baseline. Forty-six participants (23.5%) endorsed HIV risk behavior at baseline. Incarceration history(Odds Ratio (OR) 3.93, 95% confidence interval (CI) 1.95, 7.95), age under 41 (OR: 2.97, CI: 1.46, 6.04), drug addiction(OR: 3.60 CI: 1.10, 11.77), history of a sexually transmitted disease(STD)(OR 2.00 CI: 1.02, 3.90), low social capital (OR: 2.81 CI: 0.99, 8.03) and heavier alcohol use (OR: 2.56 CI: 1.02, 6.46) were significantly more likely to be associated with HIV risk behavior at baseline. In adjusted analysis, age under 41(OR: 4.93, CI: 2.10, 11.58), incarceration history (OR: 3.56 CI: 1.55, 8.17) and STD history (OR: 3.48, CI: 1.5, 8.10) continued to be significantly associated with HIV risk behavior. Understanding HIV transmission dynamics in Russia remains an urgent priority to inform strategies to address the epidemic. Larger studies addressing sex differences in risks and barriers to protective behavior are needed.	[Miller, Ann C.; Shin, Sonya S.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA; [Nelson, A. Katrina; Atwood, Sidney; Lastimoso, Charmaine S.; Shin, Sonya S.] Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA; [Livchits, Viktoria] Partners Hlth Representat Off Russian Federat, Moscow, Russia; [Greenfield, Shelly F.; Connery, Hilary S.] McLean Hosp, Alcohol & Drug Abuse Treatment Program, 115 Mill St, Belmont, MA 02178 USA; [Greenfield, Shelly F.; Connery, Hilary S.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Greenfield, Shelly F.] McLean Hosp, Div Womens Mental Hlth, 115 Mill St, Belmont, MA 02178 USA; [Yanova, Galina; Yanov, Sergei] Tomsk Oblast TB Hosp, Tomsk, Russia	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; McLean Hospital; Harvard University; Harvard Medical School; Harvard University; McLean Hospital	Miller, AC (corresponding author), Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA.	Ann_miller@hms.harvard.edu	Yanova, Galina/S-5085-2016	Yanova, Galina/0000-0003-2222-6281	US National Institutes of Health [R01AA016318]; US National Institute on Drug Abuse [U10DA15831, K24 DA 019855]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U10DA015831, K24DA019855] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by the US National Institutes of Health (www.nih.gov) (grant R01AA016318, S.S.) and the US National Institute on Drug Abuse (www.drugabuse.gov) (grant U10DA15831, H.S.C) (grant K24 DA 019855, S.F.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GLOB HIV AIDS RESP E; Blume SB, 1991, ALCOHOL HEALTH RES W, V15, P136; Brooks A, 2010, SUBST USE MISUSE, V45, P2444, DOI 10.3109/10826084.2010.490928; Chander G, 2006, JAIDS-J ACQ IMM DEF, V43, P411, DOI 10.1097/01.qai.0000243121.44659.a4; Cooper ML, 2002, J STUD ALCOHOL, P101, DOI 10.15288/jsas.2002.s14.101; Crooks D, 2015, AIDS BEHAV, V19, P405, DOI 10.1007/s10461-014-0754-7; Ehrenstein V, 2004, DRUG ALCOHOL DEPEN, V73, P159, DOI 10.1016/j.drugalcdep.2003.10.011; Fleming MF, 2006, INT J TUBERC LUNG D, V10, P565; Hessol NA, 2007, CLIN INFECT DIS, V44, P287, DOI 10.1086/510488; Kalichman SC, 2007, PREV SCI, V8, P141, DOI 10.1007/s11121-006-0061-2; [Кладов С.Ю. Kladov S.Yu.], 2010, [Бюллетень сибирской медицины, Byulleten' sibirskoi meditsiny], V9, P126; Krupitsky EM, 2006, EUR ADDICT RES, V12, P12, DOI 10.1159/000088578; Krupitsky EM, 2005, DRUG ALCOHOL DEPEN, V79, P251, DOI 10.1016/j.drugalcdep.2005.01.015; Laatikainen T, 2002, ALCOHOL ALCOHOLISM, V37, P282, DOI 10.1093/alcalc/37.3.282; Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6; Mathew TA, 2009, EUR J PUBLIC HEALTH, V19, P16, DOI 10.1093/eurpub/ckn093; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-S; METZGER DS, 1993, J ACQ IMMUN DEF SYND, V6, P1049; Miller AC, 2012, INT J TUBERC LUNG D, V16, P891, DOI 10.5588/ijtld.11.0795; NAVALINE HA, 1994, AIDS RES HUM RETROV, V10, pS281; Organization WH, 2013, KEY FACTS HIV EP RUS; PENKOWER L, 1991, AM J PUBLIC HEALTH, V81, P194, DOI 10.2105/AJPH.81.2.194; Ruchkina EV, 1996, TERAPEVT ARKH, V68, P51; Samet JH, 2008, ADDICTION, V103, P1474, DOI 10.1111/j.1360-0443.2008.02251.x; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Shin S, 2013, ADDICTION, V108, P1387, DOI 10.1111/add.12148; Shin Sonya S., 2010, Central European Journal of Public Health, V18, P132; Shuter J, 1999, J URBAN HEALTH, V76, P237, DOI 10.1007/BF02344679; Sobell L. C., 1992, MEASURING ALCOHOL CO, P41, DOI [10.1007/978-1-4612-0357-5_3, 10.1007/978-1-4612-0357-5, DOI 10.1007/978-1-4612-0357-5_3]; Stickley A, 2013, DRUG ALCOHOL DEPEN, V133, P838, DOI 10.1016/j.drugalcdep.2013.08.028; Stimson GV, 2005, INT J DRUG POLICY, V16, pS7, DOI 10.1016/j.drugpo.2005.02.007; Vasquez C, 2013, AIDS PATIENT CARE ST, V27, P304, DOI 10.1089/apc.2013.0019; Weinhardt L S, 2000, Annu Rev Sex Res, V11, P125; WEISSMAN MM, 1977, AM J EPIDEMIOL, V106, P203, DOI 10.1093/oxfordjournals.aje.a112455; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wilsnack RW, 2000, ADDICTION, V95, P251, DOI 10.1046/j.1360-0443.2000.95225112.x; Wirtz AL, 2016, AIDS BEHAV, V20, P523, DOI 10.1007/s10461-015-1066-2; Zaridze D, 2014, LANCET, V383, P1465, DOI 10.1016/S0140-6736(13)62247-3	38	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148910	10.1371/journal.pone.0148910	http://dx.doi.org/10.1371/journal.pone.0148910			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6SI	26871943	Green Submitted, Green Published, gold			2022-12-27	WOS:000370054100072
J	Pinto, SM; Almendinger, J; Cabello, J; Hengartner, MO				Pinto, Sergio M.; Almendinger, Johann; Cabello, Juan; Hengartner, Michael O.			Loss of Acetylcholine Signaling Reduces Cell Clearance Deficiencies in Caenorhabditis elegans	PLOS ONE			English	Article							APOPTOTIC CELLS; C-ELEGANS; MEDIATES RECOGNITION; CORPSE CLEARANCE; ALPHA-7 SUBUNIT; PHOSPHATIDYLSERINE; ENGULFMENT; PHAGOCYTOSIS; NEMATODE; PROMOTES	The ability to eliminate undesired cells by apoptosis is a key mechanism to maintain organismal health and homeostasis. Failure to clear apoptotic cells efficiently can cause autoimmune diseases in mammals. Genetic studies in Caenorhabditis elegans have greatly helped to decipher the regulation of apoptotic cell clearance. In this study, we show that the loss of levamisole-sensitive acetylcholine receptor, but not of a typical neuronal acetylcholine receptor causes a reduction in the number of persistent cell corpses in worms suffering from an engulfment deficiency. This reduction is not caused by impaired or delayed cell death but rather by a partial restoration of the cell clearance capacity. Mutants in acetylcholine turn-over elicit a similar phenotype, implying that acetylcholine signaling is the process responsible for these observations. Surprisingly, tissue specific RNAi suggests that UNC-38, a major component of the levamisole-sensitive receptor, functions in the dying germ cell to influence engulfment efficiency. Animals with loss of acetylcholine receptor exhibit a higher fraction of cell corpses positive for the "eat-me" signal phosphatidylserine. Our results suggest that modulation by ion channels of ion flow across plasma membrane in dying cells can influence the dynamics of phosphatidylserine exposure and thus clearance efficiency.	[Pinto, Sergio M.; Almendinger, Johann; Hengartner, Michael O.] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Pinto, Sergio M.] Univ Porto, Grad Program Areas Basic & Appl Biol, Rua Campo Alegre 823, P-4100 Porto, Portugal; [Cabello, Juan] Ctr Biomed Res La Rioja CIBIR, Logrono, La Rioja, Spain	University of Zurich; Universidade do Porto	Hengartner, MO (corresponding author), Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland.	michael.hengartner@imls.uzh.ch	Cabello, Juan/AAM-1683-2020	Cabello, Juan/0000-0002-3835-0116; Hengartner, Michael/0000-0002-7584-596X	Swiss National Science Foundation [31003A-143932]; Portuguese Foundation for Science and Technology; NIH Office of Research Infrastructure Programs [P40 OD010440]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Swiss National Science Foundation (grant no. 31003A-143932 to MOH) (http://www.snf.ch/ and by a doctoral fellowship from the Portuguese Foundation for Science and Technology (SMP) (http://www.fct.pt/). Some C. elegans strains were provided by the Caenorhabditis Genetics Center (CGC; https://www.cbs.umn.edu/research/resources/cgc), which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akakura S, 2005, J CELL PHYSIOL, V204, P344, DOI 10.1002/jcp.20288; BARNARD EA, 1992, TRENDS BIOCHEM SCI, V17, P368, DOI 10.1016/0968-0004(92)90002-Q; Boulin T, 2008, P NATL ACAD SCI USA, V105, P18590, DOI 10.1073/pnas.0806933105; BRENNER S, 1974, GENETICS, V77, P71; Chen YZ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3726; Combes D, 2000, J MOL BIOL, V300, P727, DOI 10.1006/jmbi.2000.3917; Cuttell L, 2008, CELL, V135, P524, DOI 10.1016/j.cell.2008.08.033; DeBakker CD, 2004, CURR BIOL, V14, P2208, DOI 10.1016/j.cub.2004.12.029; Drisdel RC, 2000, J NEUROSCI, V20, P133, DOI 10.1523/JNEUROSCI.20-01-00133.2000; FADOK VA, 1992, J IMMUNOL, V148, P2207; GALZI JL, 1995, NEUROPHARMACOLOGY, V34, P563, DOI 10.1016/0028-3908(95)00034-4; Gottschalk A, 2005, EMBO J, V24, P2566, DOI 10.1038/sj.emboj.7600741; Gronski MA, 2009, CELL DEATH DIFFER, V16, P1323, DOI 10.1038/cdd.2009.55; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; HENGARTNER MO, 1992, NATURE, V356, P494, DOI 10.1038/356494a0; Hurwitz ME, 2009, PLOS BIOL, V7, P876, DOI 10.1371/journal.pbio.1000099; Jones AK, 2004, BIOESSAYS, V26, P39, DOI 10.1002/bies.10377; Jones Andrew K., 2007, Invertebrate Neuroscience, V7, P129, DOI 10.1007/s10158-007-0049-z; Jospin M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000265; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Kinchen JM, 2005, NATURE, V434, P93, DOI 10.1038/nature03263; Levin M, 2012, DEV CELL, V22, P1101, DOI 10.1016/j.devcel.2012.04.004; LEWIS JA, 1980, GENETICS, V95, P905; Li Z, 2015, PLOS GENET, V11, DOI [10.1371/journal.pgen.1005285, 10.1371/journal.pgen.1005418]; Liu QA, 1998, CELL, V93, P961, DOI 10.1016/S0092-8674(00)81202-7; Mapes J, 2012, CURR BIOL, V22, P1267, DOI 10.1016/j.cub.2012.05.052; Maus ADJ, 1998, MOL PHARMACOL, V54, P779, DOI 10.1124/mol.54.5.779; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Pinto SM, 2012, CURR OPIN CELL BIOL, V24, P881, DOI 10.1016/j.ceb.2012.11.002; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Schnabel R, 1997, DEV BIOL, V184, P234, DOI 10.1006/dbio.1997.8509; Schwartz HT, 2007, NAT PROTOC, V2, P705, DOI 10.1038/nprot.2007.93; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Stanfield GM, 2000, MOL CELL, V5, P423, DOI 10.1016/S1097-2765(00)80437-2; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Venegas V, 2007, MOL BIOL CELL, V18, P3180, DOI 10.1091/mbc.E07-02-0138; VERNINO S, 1992, NEURON, V8, P127, DOI 10.1016/0896-6273(92)90114-S; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang XC, 2007, NAT CELL BIOL, V9, P541, DOI 10.1038/ncb1574; Wang XC, 2010, NAT CELL BIOL, V12, P655, DOI 10.1038/ncb2068; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Yang HW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6717; Yu XM, 2006, DEV CELL, V10, P743, DOI 10.1016/j.devcel.2006.04.007	47	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149274	10.1371/journal.pone.0149274	http://dx.doi.org/10.1371/journal.pone.0149274			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872385	Green Submitted, Green Published, gold			2022-12-27	WOS:000370054100139
J	Sood, RF; Arbabi, S; Honari, S; Gibran, NS				Sood, Ravi F.; Arbabi, Saman; Honari, Shari; Gibran, Nicole S.			Missense Variant in MAPK Inactivator PTPN5 Is Associated with Decreased Severity of Post-Burn Hypertrophic Scarring	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ACTIVATED PROTEIN-KINASES; BURN WOUNDS; NEUROPSYCHIATRIC DISORDERS; TYROSINE PHOSPHATASES; RISK-FACTORS; PATHWAYS; CSMD1; EPIDEMIOLOGY; INFLAMMATION	Background Hypertrophic scarring (HTS) is hypothesized to have a genetic mechanism, yet its genetic determinants are largely unknown. The mitogen-activated protein kinase (MAPK) pathways are important mediators of inflammatory signaling, and experimental evidence implicates MAPKs in HTS formation. We hypothesized that single-nucleotide polymorphisms (SNPs) in MAPK-pathway genes would be associated with severity of post-burn HTS. Methods We analyzed data from a prospective-cohort genome-wide association study of post-burn HTS. We included subjects with deep-partial-thickness burns admitted to our center who provided blood for genotyping and had at least one Vancouver Scar Scale (VSS) assessment. After adjusting for HTS risk factors and population stratification, we tested MAPK-pathway gene SNPs for association with the four VSS variables in a joint regression model. In addition to individual-SNP analysis, we performed gene-based association testing. Results Our study population consisted of 538 adults (median age 40 years) who were predominantly White (76%) males (71%) admitted to our center from 2007-2014 with small-to-moderate- sized burns (median burn size 6% total body surface area). Of 2,146 SNPs tested, a rare missense variant in the PTPN5 gene (rs56234898; minor allele frequency 1.5%) was significantly associated with decreased severity of post-burn HTS (P = 1.3x10(-6)). In gene-based analysis, PTPN5 (P = 1.2x10(-5)) showed a significant association and BDNF (P = 9.5x10(-4)) a borderline-significant association with HTS severity. Conclusions We report PTPN5 as a novel genetic locus associated with HTS severity. PTPN5 is a MAPK inhibitor expressed in neurons, suggesting a potential role for neurotrophic factors and neuroinflammatory signaling in HTS pathophysiology.	[Sood, Ravi F.; Arbabi, Saman; Honari, Shari; Gibran, Nicole S.] Univ Washington, Harborview Med Ctr, Dept Surg, UW Med Reg Burn Ctr, Seattle, WA 98104 USA	Harborview Medical Center; University of Washington; University of Washington Seattle	Sood, RF (corresponding author), Univ Washington, Harborview Med Ctr, Dept Surg, UW Med Reg Burn Ctr, Seattle, WA 98104 USA.	rfsood@uw.edu		Gibran, Nicole/0000-0003-4697-0988	NIH [R01 GM089704, T32 GM007037]; David & Nancy Auth-Washington Research Foundation Endowed Chair for Restorative Burn Surgery; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089704, T32GM007037] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David & Nancy Auth-Washington Research Foundation Endowed Chair for Restorative Burn Surgery; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by NIH R01 GM089704, NIH T32 GM007037, and the David & Nancy Auth-Washington Research Foundation Endowed Chair for Restorative Burn Surgery.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Arbabi S, 2002, CRIT CARE MED, V30, pS74, DOI 10.1097/00003246-200201001-00010; Autry AE, 2012, PHARMACOL REV, V64, P238, DOI 10.1124/pr.111.005108; Baryza Mary Jo, 1995, Journal of Burn Care and Rehabilitation, V16, P535, DOI 10.1097/00004630-199509000-00013; Branski LK, 2012, TOTAL BURN CARE, P1; CASTAGNOLI C, 1990, HUM IMMUNOL, V29, P229, DOI 10.1016/0198-8859(90)90117-8; DEITCH EA, 1983, J TRAUMA, V23, P895, DOI 10.1097/00005373-198310000-00009; Du QC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075635; Escudero-Esparza A, 2013, FASEB J, V27, P5083, DOI 10.1096/fj.13-230706; Eswaran J, 2006, BIOCHEM J, V395, P483, DOI 10.1042/BJ20051931; Fitzpatrick CJ, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00047; Friedstat JS, 2014, ANN PLAS SURG, V72, pS198, DOI 10.1097/SAP.0000000000000103; Galesloot TE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095923; Gangemi EN, 2008, ARCH FACIAL PLAST S, V10, P93, DOI 10.1001/archfaci.10.2.93; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Han S, 2014, SPINAL CORD, V52, P867, DOI 10.1038/sc.2014.173; Harvey A. R., 2014, BRAIN RES; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hirano S, 2002, J SURG RES, V102, P77, DOI 10.1006/jsre.2001.6315; Ipaktchi K, 2006, SHOCK, V26, P201, DOI 10.1097/01.shk.0000225739.13796.f2; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karasawa T, 2014, NEUROSCI RES, V89, P1, DOI 10.1016/j.neures.2014.08.018; Kraus DM, 2006, J IMMUNOL, V176, P4419, DOI 10.4049/jimmunol.176.7.4419; Lamel SA, 2013, CUTAN OCUL TOXICOL, V32, P67, DOI 10.3109/15569527.2012.684419; Lawrence JW, 2012, J BURN CARE RES, V33, P136, DOI 10.1097/BCR.0b013e3182374452; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Liang Z, 2004, BURNS, V30, P57, DOI 10.1016/j.burns.2003.09.004; LOMBROSO PJ, 1991, P NATL ACAD SCI USA, V88, P7242, DOI 10.1073/pnas.88.16.7242; Lotan A, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00331; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Munoz JJ, 2003, BIOCHEM J, V372, P193, DOI 10.1042/BJ20021941; O'Reilly PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034861; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; R Core Team, R LANG ENV STAT COMP; Scott JR, 2007, WOUND REPAIR REGEN, V15, pS27, DOI 10.1111/j.1524-475X.2007.00222.x; Scott JR, 2005, PLAST RECONSTR SURG, V115, P1095, DOI 10.1097/01.PRS.0000156151.54042.DA; Sood R. F., 2015, J BURN CARE RES S1, V36, pS279; Sood RF, 2015, ANN SURG, V262, P563, DOI 10.1097/SLA.0000000000001439; Sood RF, 2015, J INVEST DERMATOL, V135, P2394, DOI 10.1038/jid.2015.197; Szade A, 2015, IUBMB LIFE, V67, P145, DOI 10.1002/iub.1358; Tang MR, 2012, APOPTOSIS, V17, P927, DOI 10.1007/s10495-012-0727-0; Thompson CM, 2013, J BURN CARE RES, V34, P477, DOI 10.1097/BCR.0b013e3182a2aa41; van der Veer WM, 2009, BURNS, V35, P15, DOI 10.1016/j.burns.2008.06.020; Warsen A., WOUND REPAIR R UNPUB; Yoshii A, 2010, DEV NEUROBIOL, V70, P304, DOI 10.1002/dneu.20765; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zhu KQ, 2007, WOUND REPAIR REGEN, V15, pS32, DOI 10.1111/j.1524-475X.2007.00223.x; Zhu ZS, 2013, J CELL COMMUN SIGNAL, V7, P239, DOI 10.1007/s12079-013-0195-5	50	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149206	10.1371/journal.pone.0149206	http://dx.doi.org/10.1371/journal.pone.0149206			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872063	gold, Green Published, Green Submitted			2022-12-27	WOS:000370054100127
J	Wang, XJ; Tang, T; Farid, M; Quek, R; Tao, M; Lim, ST; Wee, HL; Chan, A				Wang, Xiao Jun; Tang, Tiffany; Farid, Mohamad; Quek, Richard; Tao, Miriam; Lim, Soon Thye; Wee, Hwee Lin; Chan, Alexandre			Routine Primary Prophylaxis for Febrile Neutropenia with Biosimilar Granulocyte Colony-Stimulating Factor (Nivestim) or Pegfilgrastim Is Cost Effective in Non-Hodgkin Lymphoma Patients undergoing Curative-Intent R-CHOP Chemotherapy	PLOS ONE			English	Article							ELDERLY-PATIENTS; SECONDARY PROPHYLAXIS; AGGRESSIVE LYMPHOMA; UNITED-STATES; SOLID TUMOR; FILGRASTIM; CANCER; RISK	Objective This study aims to compare the cost-effectiveness of various strategies of myeloid growth factor prophylaxis for reducing the risk of febrile neutropenia (FN) in patients with non-Hodgkin lymphoma in Singapore who are undergoing R-CHOP chemotherapy with curative intent. Methods A Markov model was created to compare seven prophylaxis strategies: 1) primary prophylaxis (PP) with nivestim (biosimilar filgrastim) throughout all cycles of chemotherapy; 2) PP with nivestim during the first two cycles of chemotherapy; 3) secondary prophylaxis (SP) with nivestim; 4) PP with pegfilgrastim throughout all cycles of chemotherapy; 5) PP with pegfilgrastim during the first two cycles of chemotherapy; 6) SP with pegfilgrastim; and 7) no prophylaxis (NP). The perspective of a hospital was taken and cost-effectiveness was expressed as the cost per episode of FN avoided over six cycles of chemotherapy. A probabilistic sensitivity analysis was conducted. Results Strategies 3, 6, and 7 were dominated in the base case analysis by strategy 5. The costs associated with strategies 2, 5, 1, and 4 were US$3,813, US$4,056, US$4,545, and US $5,331, respectively. The incremental cost-effectiveness ratios for strategy 5 vs. strategy 2, strategy 1 vs. strategy 5, and strategy 4 vs. strategy 1 were US$13,532, US$22,565, and US$30,452, respectively, per episode of FN avoided. Strategy 2 has the highest probability to be cost-effective (ranged from 48% to 60%) when the willingness to pay (WTP) threshold is lower than US$10,000 per FN episode prevented. Conclusion In Singapore, routine PP with granulocyte colony-stimulating factor (nivestim or pegfilgrastim) is cost-effective for reducing the risk of FN in patients receiving R-CHOP.	[Wang, Xiao Jun; Wee, Hwee Lin; Chan, Alexandre] Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore; [Wang, Xiao Jun; Chan, Alexandre] Natl Canc Ctr Singapore, Dept Pharm, Singapore, Singapore; [Tang, Tiffany; Farid, Mohamad; Quek, Richard; Tao, Miriam; Lim, Soon Thye] Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore	National University of Singapore; National Cancer Centre Singapore (NCCS); National Cancer Centre Singapore (NCCS)	Chan, A (corresponding author), Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore.; Chan, A (corresponding author), Natl Canc Ctr Singapore, Dept Pharm, Singapore, Singapore.	phaac@nus.edu.sg	Wee, Hwee Lin/D-4126-2012; Chan, Alexandre/D-5035-2016	Wee, Hwee Lin/0000-0002-7150-1801; Chan, Alexandre/0000-0003-4391-4219				Aapro Matti, 2012, J Oncol Pharm Pract, V18, P171, DOI 10.1177/1078155211407367; Aarts MJ, 2013, J CLIN ONCOL, V31, P4283, DOI 10.1200/JCO.2012.48.3644; Chan A, 2014, SUPPORT CARE CANCER, V22, P1105, DOI 10.1007/s00520-013-2067-1; Chan A, 2011, ASIA-PAC J CLIN ONCO, V7, P75, DOI 10.1111/j.1743-7563.2010.01355.x; Chan KKW, 2012, J CLIN ONCOL, V30, P1064, DOI 10.1200/JCO.2011.36.8647; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Department of Statistics Singapore, CONS PRIC IND; Gascon P, 2013, SUPPORT CARE CANCER, V21, P2925, DOI 10.1007/s00520-013-1911-7; Henry D, 2014, SEMIN ONCOL, V41, pS13, DOI 10.1053/j.seminoncol.2014.03.009; Hill Gregory, 2014, J Med Econ, V17, P32, DOI 10.3111/13696998.2013.844160; Kamioner D, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-547; Lathia N, 2013, JNCI-J NATL CANCER I, V105, P1078, DOI 10.1093/jnci/djt182; Lyman G, 2009, CURR MED RES OPIN, V25, P401, DOI 10.1185/03007990802636817 ; Lyman GH, 2003, LEUKEMIA LYMPHOMA, V44, P2069, DOI 10.1080/1042819031000119262; Michels SL, 2012, PHARMACOECONOMICS, V30, P809, DOI 10.2165/11592980-000000000-00000; Morton LM, 2006, BLOOD, V107, P265, DOI 10.1182/blood-2005-06-2508; NCCN.org, CLIN PRACT GUID ONC; Osby E, 2003, BLOOD, V101, P3840, DOI 10.1182/blood-2002-10-3238; Smith TJ, 2006, J CLIN ONCOL, V24, P3187, DOI 10.1200/JCO.2006.06.4451; Szende A, 2007, EQ 5D VALUE SETS INV, P63; The World Bank, PPP CONV FACT GDP; Waller CF, 2010, ONKOLOGIE, V33, P504, DOI 10.1159/000319693; Wang XJ, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-434; Wang XJ, 2015, PSYCHOMETRIC PROPERT; Wong M, 2012, ANN ACAD MED SINGAP, V41, P287	25	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148901	10.1371/journal.pone.0148901	http://dx.doi.org/10.1371/journal.pone.0148901			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871584	gold, Green Published			2022-12-27	WOS:000370054100070
J	Higami, Y; Ogawa, E; Ryujin, Y; Goto, K; Seto, R; Wada, H; Tho, NV; Lan, LTT; Pare, PD; Nakano, Y				Higami, Yuichi; Ogawa, Emiko; Ryujin, Yasushi; Goto, Kenichi; Seto, Ruriko; Wada, Hiroshi; Nguyen Van Tho; Le Thi Tuyet Lan; Pare, Peter D.; Nakano, Yasutaka			Increased Epicardial Adipose Tissue Is Associated with the Airway Dominant Phenotype of Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							VISCERAL ABDOMINAL FAT; PERICARDIAL FAT; COMPUTED-TOMOGRAPHY; RISK-FACTORS; RHEUMATOID-ARTHRITIS; MORTALITY; COPD; CALCIFICATION; ACCUMULATION; DIMENSIONS	Background Epicardial adipose tissue (EAT) has been shown to be a non-invasive marker that predicts the progression of cardiovascular disease (CVD). It has been reported that the EAT volume is increased in patients with chronic obstructive pulmonary disease (COPD). However, little is known about which phenotypes of COPD are associated with increased EAT. Methods One hundred and eighty smokers who were referred to the clinic were consecutively enrolled. A chest CT was used for the quantification of the emphysematous lesions, airway lesions, and EAT. These lesions were assessed as the percentage of low attenuation volume (LAV%), the square root of airway wall area of a hypothetical airway with an internal perimeter of 10 mm (root Aaw at Pi10) and the EAT area, respectively. The same measurements were made on 225 Vietnamese COPD patients to replicate the results. Results Twenty-six of the referred patients did not have COPD, while 105 were diagnosed as having COPD based on a FEV1/FVC<0.70. The EAT area was significantly associated with age, BMI, FEV1 (% predicted), FEV1/FVC, self-reported hypertension, self-reported CVD, statin use, LAV%, and root Aaw at Pi10 in COPD patients. The multiple regression analyses showed that only BMI, self-reported CVD and root Aaw at Pi10 were independently associated with the EAT area (R-2 = 0.51, p<0.0001). These results were replicated in the Vietnamese population. Conclusions The EAT area is independently associated with airway wall thickness. Because EAT is also an independent predictor of CVD risk, these data suggest a mechanistic link between the airway predominant form of COPD and CVD.	[Higami, Yuichi; Ogawa, Emiko; Ryujin, Yasushi; Goto, Kenichi; Seto, Ruriko; Wada, Hiroshi; Nguyen Van Tho; Nakano, Yasutaka] Shiga Univ Med Sci, Dept Internal Med, Div Resp Med, Otsu, Shiga, Japan; [Ogawa, Emiko] Shiga Univ Med Sci, Hlth Adm Ctr, Otsu, Shiga, Japan; [Nguyen Van Tho; Le Thi Tuyet Lan] Univ Med Ctr, Resp Care Ctr, Ho Chi Minh City, Vietnam; [Pare, Peter D.] Univ British Columbia, St Pauls Hosp, Ctr Heart Lung Innovat, Vancouver, BC V5Z 1M9, Canada	Shiga University of Medical Science; Shiga University of Medical Science; St. Paul's Hospital; University of British Columbia; University of Saskatchewan	Ogawa, E (corresponding author), Shiga Univ Med Sci, Dept Internal Med, Div Resp Med, Otsu, Shiga, Japan.; Ogawa, E (corresponding author), Shiga Univ Med Sci, Hlth Adm Ctr, Otsu, Shiga, Japan.	eogawa@belle.shiga-med.ac.jp	Pare, Peter D/C-7425-2011	Nguyen, Tho/0000-0002-0198-6284				Abbara S, 2006, EUR J RADIOL, V57, P417, DOI 10.1016/j.ejrad.2005.12.030; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; [Anonymous], 2004, Nihon Kokyuki Gakkai Zasshi, VSuppl, P1; Anthonisen NR, 2005, ANN INTERN MED, V142, P233, DOI 10.7326/0003-4819-142-4-200502150-00005; Balci A, 2010, DERMATOLOGY, V220, P32, DOI 10.1159/000254482; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Celli B, 2011, AM J RESP CRIT CARE, V183, P317, DOI 10.1164/rccm.201004-0665OC; Ding JZ, 2009, AM J CLIN NUTR, V90, P499, DOI 10.3945/ajcn.2008.27358; Furutate R, 2011, INT J CHRONIC OBSTR, V6, P423, DOI 10.2147/COPD.S22885; Giles JT, 2010, ARTHRITIS RHEUM-US, V62, P3173, DOI 10.1002/art.27629; Kaplan O, 2015, EUR REV MED PHARMACO, V19, P2461; Kishida K, 2012, ANN MED, V44, P233, DOI 10.3109/07853890.2011.564202; Kranenburg AR, 2006, AM J CLIN PATHOL, V126, P725, DOI 10.1309/JC477FAEL1YKV54W; Lee HM, 2012, CHEST, V142, P1118, DOI 10.1378/chest.11-2421; Mahabadi AA, 2013, J AM COLL CARDIOL, V61, P1388, DOI 10.1016/j.jacc.2012.11.062; Mahabadi AA, 2009, EUR HEART J, V30, P850, DOI 10.1093/eurheartj/ehn573; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Nakano Y, 2000, AM J RESP CRIT CARE, V162, P1102, DOI 10.1164/ajrccm.162.3.9907120; Nakano Y, 2005, AM J RESP CRIT CARE, V171, P142, DOI 10.1164/rccm.200407-874OC; Nakano Y, 2002, CHEST, V122, p271S, DOI 10.1378/chest.122.6_suppl.271S-a; Tho NV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098335; Ogawa E, 2009, THORAX, V64, P20, DOI 10.1136/thx.2008.097543; Oyama N, 2011, JPN J RADIOL, V29, P104, DOI 10.1007/s11604-010-0524-z; Rosito GA, 2008, CIRCULATION, V117, P605, DOI 10.1161/CIRCULATIONAHA.107.743062; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Soriano JB, 2005, CHEST, V128, P2099, DOI 10.1378/chest.128.4.2099; Taguchi R, 2001, ATHEROSCLEROSIS, V157, P203, DOI 10.1016/S0021-9150(00)00709-7; Tatsumi K, 2004, RESPIROLOGY, V9, P331, DOI 10.1111/j.1440-1843.2004.00611.x; Tho NV, 2015, ANN AM THORAC SOC, DOI [10.1513/AnnalsATS.201411-501OC, DOI 10.1513/ANNALSATS.201411-5010C]; van den Borst B, 2012, AM J CLIN NUTR, V96, P516, DOI 10.3945/ajcn.112.040774; Williams MC, 2014, THORAX, V69, P718, DOI 10.1136/thoraxjnl-2012-203151; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624; Zagaceta J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065593	34	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148794	10.1371/journal.pone.0148794	http://dx.doi.org/10.1371/journal.pone.0148794			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866482	Green Published, Green Submitted, gold			2022-12-27	WOS:000370050700039
J	Lehners, N; Tabatabai, J; Prifert, C; Wedde, M; Puthenparambil, J; Weissbrich, B; Biere, B; Schweiger, B; Egerer, G; Schnitzler, P				Lehners, Nicola; Tabatabai, Julia; Prifert, Christiane; Wedde, Marianne; Puthenparambil, Joe; Weissbrich, Benedikt; Biere, Barbara; Schweiger, Brunhilde; Egerer, Gerlinde; Schnitzler, Paul			Long-Term Shedding of Influenza Virus, Parainfluenza Virus, Respiratory Syncytial Virus and Nosocomial Epidemiology in Patients with Hematological Disorders	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; RISK-FACTORS; G-PROTEIN; MOLECULAR CHARACTERIZATION; ANTIVIRAL THERAPY; VIRAL-INFECTIONS; GROUP-A; OUTBREAK; RECIPIENTS; PNEUMONIA	Respiratory viruses are a cause of upper respiratory tract infections (URTI), but can be associated with severe lower respiratory tract infections (LRTI) in immunocompromised patients. The objective of this study was to investigate the genetic variability of influenza virus, parainfluenza virus and respiratory syncytial virus (RSV) and the duration of viral shedding in hematological patients. Nasopharyngeal swabs from hematological patients were screened for influenza, parainfluenza and RSV on admission as well as on development of respiratory symptoms. Consecutive swabs were collected until viral clearance. Out of 672 tested patients, a total of 111 patients (17%) were infected with one of the investigated viral agents: 40 with influenza, 13 with parainfluenza and 64 with RSV; six patients had influenza/RSV or parainfluenza/RSV co-infections. The majority of infected patients (n = 75/111) underwent stem cell transplantation (42 autologous, 48 allogeneic, 15 autologous and allogeneic). LRTI was observed in 48 patients, of whom 15 patients developed severe LRTI, and 13 patients with respiratory tract infection died. Phylogenetic analysis revealed a variety of influenza A (H1N1) pdm09, A(H3N2), influenza B, parainfluenza 3 and RSV A, B viruses. RSV A was detected in 54 patients, RSV B in ten patients. The newly emerging RSV A genotype ON1 predominated in the study cohort and was found in 48 (75%) of 64 RSV-infected patients. Furthermore, two distinct clusters were detected for RSV A genotype ON1, identical RSV G gene sequences in these patients are consistent with nosocomial transmission. Long-term viral shedding for more than 30 days was significantly associated with prior allogeneic transplantation (p = 0.01) and was most pronounced in patients with RSV infection (n = 16) with a median duration of viral shedding for 80 days (range 35-334 days). Long-term shedding of respiratory viruses might be a catalyzer of nosocomial transmission and must be considered for efficient infection control in immunocompromised patients.	[Lehners, Nicola; Puthenparambil, Joe; Egerer, Gerlinde] Heidelberg Univ, Dept Internal Med 5, Heidelberg, Germany; [Tabatabai, Julia; Schnitzler, Paul] Heidelberg Univ, Dept Infect Dis, Virol, Heidelberg, Germany; [Prifert, Christiane; Weissbrich, Benedikt] Univ Wurzburg, Inst Virol & Immunobiol, D-97070 Wurzburg, Germany; [Wedde, Marianne; Biere, Barbara; Schweiger, Brunhilde] Robert Koch Inst, Natl Reference Ctr Influenza, Berlin, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Wurzburg; Robert Koch Institute	Schnitzler, P (corresponding author), Heidelberg Univ, Dept Infect Dis, Virol, Heidelberg, Germany.	Paul_Schnitzler@med.uni-heidelberg.de	Tabatabai, Julia/AFQ-1931-2022		Robert Koch Institute from Federal Ministry of Health [FKZ 1369-393]	Robert Koch Institute from Federal Ministry of Health	This study was supported by the Robert Koch Institute from funds of the Federal Ministry of Health (FKZ 1369-393).	Abdallah A, 2003, BONE MARROW TRANSPL, V32, P195, DOI 10.1038/sj.bmt.1704116; Avetisyan G, 2009, TRANSPLANTATION, V88, P1222, DOI 10.1097/TP.0b013e3181bb477e; Buda S, 2013, INFLUENZA WEEKLY REP; CANE PA, 1995, J VIROL, V69, P2918, DOI 10.1128/JVI.69.5.2918-2925.1995; Chemaly RF, 2006, MEDICINE, V85, P278, DOI 10.1097/01.md.0000232560.22098.4e; DeVincenzo JP, 2012, ANTIVIR THER, V17, P213, DOI 10.3851/IMP2064; du Prel JB, 2009, CLIN INFECT DIS, V49, P861, DOI 10.1086/605435; Englund JA, 2013, VACCINE, V31, P5706, DOI 10.1016/j.vaccine.2013.09.046; Eshaghi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032807; European Centre for Disease Prevention and Control, 2013, INFL VIR CHAR SUMM E; Falcone V, 2013, ARCH VIROL, V158, P1297, DOI 10.1007/s00705-013-1610-1; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; GARCIA O, 1994, J VIROL, V68, P5448; Geis S, 2013, J CLIN MICROBIOL, V51, P155, DOI 10.1128/JCM.02151-12; Grund S, 2010, ARCH VIROL, V155, P1797, DOI 10.1007/s00705-010-0771-4; Hayden Frederick G., 1997, American Journal of Medicine, V102, P55, DOI 10.1016/S0002-9343(97)80013-7; Hirsch H, 2012, 4 EUR C INF LEUK JUA; Jalal H, 2007, J CLIN MICROBIOL, V45, P1690, DOI 10.1128/JCM.01912-06; Karron RA, 2013, CURR TOP MICROBIOL, V372, P259, DOI 10.1007/978-3-642-38919-1_13; Khanna N, 2008, CLIN INFECT DIS, V46, P402, DOI 10.1086/525263; Lavergne V, 2011, BONE MARROW TRANSPL, V46, P137, DOI 10.1038/bmt.2010.67; Lehners N, 2013, BONE MARROW TRANSPL, V48, P1548, DOI 10.1038/bmt.2013.94; Lehners N, 2013, EMERG INFECT DIS, V19, P748, DOI [10.3201/eid1905.120034, 10.3201/eid1905.130034]; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; Ljungman P, 2009, BONE MARROW TRANSPL, V44, P521, DOI 10.1038/bmt.2009.263; Luchsinger V, 2012, CLIN INFECT DIS, V54, P905, DOI 10.1093/cid/cir955; Mayer JL, 2014, ROFO-FORTSCHR RONTG, V186, P686, DOI 10.1055/s-0033-1356353; Mazzulli T, 1999, J INFECT DIS, V180, P1686, DOI 10.1086/315085; McCarthy AJ, 1999, BONE MARROW TRANSPL, V24, P1315, DOI 10.1038/sj.bmt.1702078; Milano F, 2010, BLOOD, V115, P2088, DOI 10.1182/blood-2009-09-244152; Nichols WG, 2004, CLIN INFECT DIS, V39, P1300, DOI 10.1086/425004; Nichols WG, 2001, BLOOD, V98, P573, DOI 10.1182/blood.V98.3.573; Panayiotou C, 2014, EPIDEMIOL INFECT, V142, P2406, DOI 10.1017/S0950268814000028; Peret TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221; Pollara CP, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-127; Pretorius MA, 2013, J INFECT DIS, V208, pS227, DOI 10.1093/infdis/jit477; Prifert C, 2013, EMERG INFECT DIS, V19, P1029, DOI 10.3201/eid1906.121582; Reiche J, 2009, J CLIN MICROBIOL, V47, P1800, DOI 10.1128/JCM.02286-08; Renaud C, 2013, BIOL BLOOD MARROW TR, V19, P1220, DOI 10.1016/j.bbmt.2013.05.005; Tabatabai J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109191; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor GS, 2001, J CLIN MICROBIOL, V39, P801, DOI 10.1128/JCM.39.2.801-803.2001; Tomblyn M, 2009, BIOL BLOOD MARROW TR, V15, P1143, DOI 10.1016/j.bbmt.2009.06.019; Torres HA, 2007, HAEMATOLOGICA, V92, P1216, DOI 10.3324/haematol.11300; Trento A, 2003, J GEN VIROL, V84, P3115, DOI 10.1099/vir.0.19357-0; Trento A, 2010, J VIROL, V84, P7500, DOI 10.1128/JVI.00345-10; Whimbey E, 1996, CLIN INFECT DIS, V22, P778, DOI 10.1093/clinids/22.5.778	48	66	66	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148258	10.1371/journal.pone.0148258	http://dx.doi.org/10.1371/journal.pone.0148258			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866481	Green Published, gold			2022-12-27	WOS:000370050700012
J	Mladenoff, DJ; Sahajpal, R; Johnson, CP; Rothstein, DE				Mladenoff, David J.; Sahajpal, Ritvik; Johnson, Christopher P.; Rothstein, David E.			Recent Land Use Change to Agriculture in the US Lake States: Impacts on Cellulosic Biomass Potential and Natural Lands	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; MARGINAL LAND; BIOENERGY PRODUCTION; CLIMATE-CHANGE; FOREST COVER; BIOFUELS; WILLOW; GRASSLANDS; ETHANOL; ENERGY	Perennial cellulosic feedstocks may have potential to reduce life-cycle greenhouse gas (GHG) emissions by offsetting fossil fuels. However, this potential depends on meeting a number of important criteria involving land cover change, including avoiding displacement of agricultural production, not reducing uncultivated natural lands that provide biodiversity habitat and other valued ecosystem services, and avoiding the carbon debt (the amount of time needed to repay the initial carbon loss) that accompanies displacing natural lands. It is unclear whether recent agricultural expansion in the United States competes with lands potentially suited for bioenergy feedstocks. Here, we evaluate how recent land cover change (2008-2013) has affected the availability of lands potentially suited for bioenergy feedstock production in the U.S. Lake States (Minnesota, Wisconsin, Michigan) and its impact on other natural ecosystems. The region is potentially well suited for a diversity of bioenergy production systems, both grasses and woody biomass, due to the widespread forest economy in the north and agricultural economy in the south. Based on remotely-sensed data, our results show that between 2008 and 2013, 836,000 ha of non-agricultural open lands were already converted to agricultural uses in the Lake States, a loss of nearly 37%. The greatest relative changes occurred in the southern half that includes some of the most diverse cultivable lands in the country. We use transition diagrams to reveal gross changes that can be obscured if only net change is considered. Our results indicate that expansion of row crops (corn, soybean) was responsible for the majority of open land loss. Even if recently lost open lands were brought into perennial feedstock production, there would a substantial carbon debt. This reduction in open land availability for biomass production is closing the window of opportunity to establish a sustainable cellulosic feedstock economy in the Lake States as mandated by current Federal policy, incurring a substantial GHG debt, and displacing a range of other natural ecosystems and their services.	[Mladenoff, David J.; Sahajpal, Ritvik; Johnson, Christopher P.] Univ Wisconsin, Dept Forest & Wildlife Ecol, 1630 Linden Dr, Madison, WI 53706 USA; [Rothstein, David E.] Michigan State Univ, Dept Forestry, 126 Nat Resource Bldg, E Lansing, MI 48824 USA; [Sahajpal, Ritvik] Univ Maryland, Dept Geog Sci, 2181 Samuel J Lefrak Hall, College Pk, MD 20742 USA	University of Wisconsin System; University of Wisconsin Madison; Michigan State University; University System of Maryland; University of Maryland College Park	Mladenoff, DJ (corresponding author), Univ Wisconsin, Dept Forest & Wildlife Ecol, 1630 Linden Dr, Madison, WI 53706 USA.	david.mladenoff@wisc.edu	Sahajpal, Ritvik/N-4565-2013	Sahajpal, Ritvik/0000-0002-6418-289X	US Department of Agriculture, Agriculture and Food Research Initiative, Sustainable Bioenergy Program [2010-03866]	US Department of Agriculture, Agriculture and Food Research Initiative, Sustainable Bioenergy Program	Funding from US Department of Agriculture, Agriculture and Food Research Initiative, Sustainable Bioenergy Program (2010-03866) to DER and DJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding from US Department of Agriculture, Agriculture and Food Research Initiative, Sustainable Bioenergy Program (2010-03866).	Amichev BY, 2012, GCB BIOENERGY, V4, P70, DOI 10.1111/j.1757-1707.2011.01110.x; Aust C, 2014, GCB BIOENERGY, V6, P521, DOI 10.1111/gcbb.12083; Baum S, 2012, GCB BIOENERGY, V4, P728, DOI 10.1111/j.1757-1707.2012.01162.x; Becker DR, 2009, ENERG POLICY, V37, P5687, DOI 10.1016/j.enpol.2009.08.033; Boryan C, 2011, GEOCARTO INT, V2011, P1, DOI DOI 10.1080/10106049.2011.562309; Brown TR, 2013, BIOFUEL BIOPROD BIOR, V7, P235, DOI 10.1002/bbb.1387; Campbell SP, 2012, BIOMASS BIOENERG, V47, P342, DOI 10.1016/j.biombioe.2012.09.026; Cunningham MA, 2006, LANDSCAPE URBAN PLAN, V78, P217, DOI 10.1016/j.landurbplan.2005.08.002; Dauber J., 2012, BIORISK, P5, DOI [10.3897/biorisk.7.3036, DOI 10.3897/biorisk.7.3036]; Davis SC, 2012, FRONT ECOL ENVIRON, V10, P69, DOI 10.1890/110003; Desiree JI, 2014, GCB BIOENERGY, V6, P183, DOI 10.1111/gcbb.12067; Djomo SN, 2011, GCB BIOENERGY, V3, P181, DOI 10.1111/j.1757-1707.2010.01073.x; Dominguez-Faus R, 2013, ENVIRON SCI TECHNOL, V47, P6030, DOI 10.1021/es400435n; Donner SD, 2008, P NATL ACAD SCI USA, V105, P4513, DOI 10.1073/pnas.0708300105; Emili LA, 2014, LAND-BASEL, V3, P658, DOI 10.3390/land3030658; EPA, 2010, FED REGISTER, V75; Faber S., 2012, PLOWED CROP SUBSIDIE; Fargione JE, 2010, ANNU REV ECOL EVOL S, V41, P351, DOI 10.1146/annurev-ecolsys-102209-144720; Fargione JE, 2009, BIOSCIENCE, V59, P767, DOI 10.1525/bio.2009.59.9.8; Fassnacht KS, 2006, FOREST ECOL MANAG, V222, P167, DOI 10.1016/j.foreco.2005.09.026; Fatal Y. S., 2014, Journal of Agricultural and Applied Economics, V46, P157; Feng HL, 2010, AM J AGR ECON, V92, P789, DOI 10.1093/ajae/aaq023; Foley JA, 2004, GEOPHYS MONOGR SER, V153, P249, DOI 10.1029/153GM19; GAP, 2013, US GEOL SURV GAP AN; Gelfand I, 2013, NATURE, V493, P514, DOI 10.1038/nature11811; Gelfand I, 2011, P NATL ACAD SCI USA, V108, P13864, DOI 10.1073/pnas.1017277108; Gibson W.P., 2002, P 13 AMS C APPL CLIM, P181; Gopalakrishnan G, 2011, J ENVIRON QUAL, V40, P1593, DOI 10.2134/jeq2010.0539; Grace PR, 2011, AGR SYST, V104, P292, DOI 10.1016/j.agsy.2010.09.001; Han WG, 2012, COMPUT ELECTRON AGR, V84, P111, DOI 10.1016/j.compag.2012.03.005; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hertel TW, 2010, BIOSCIENCE, V60, P223, DOI 10.1525/bio.2010.60.3.8; Hill J, 2009, P NATL ACAD SCI USA, V106, P2077, DOI 10.1073/pnas.0812835106; Jager HI, 2010, GCB BIOENERGY, V2, P248, DOI 10.1111/j.1757-1707.2010.01059.x; Johnston CA, 2014, LANDSCAPE ECOL, V29, P81, DOI 10.1007/s10980-013-9947-0; Johnston CA, 2013, WETLANDS, V33, P175, DOI 10.1007/s13157-012-0365-x; Kang S, 2013, LAND USE POLICY, V30, P106, DOI 10.1016/j.landusepol.2012.03.002; Kloiber SM, 2013, STATUS AND TRENDS OF; Langpap C, 2011, ENVIRON RESOUR ECON, V49, P147, DOI 10.1007/s10640-010-9428-8; Lark TJ, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/4/044003; Liu T.-Y., 2012, P 18 IEEE INT S AS C, P1; Lubowski R., 2006, ENV EFFECTS AGR LAND; Luman D., 2008, ASSESSMENT POTENTIAL; McNab WH, 2005, DESCRIPTION ECOLOGIC; Mehaffey M, 2012, ECOL APPL, V22, P8, DOI 10.1890/10-1573.1; Mooney D., 2013, Staff Paper - Agricultural and Applied Economics, University of Wisconsin-Madison; NASS, 2013, USDA NAT AGR STAT SE; Palmer MM, 2014, GCB BIOENERGY, V6, P450, DOI 10.1111/gcbb.12069; Plevin RJ, 2010, ENVIRON SCI TECHNOL, V44, P8015, DOI 10.1021/es101946t; Rhemtulla JM, 2007, LANDSCAPE ECOL, V22, P57, DOI 10.1007/s10980-007-9117-3; Rowe RL, 2013, GCB BIOENERGY, V5, P257, DOI 10.1111/gcbb.12040; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; Searchinger TD, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/2/024007; Sexton JO, 2015, REMOTE SENS ENVIRON, V156, P418, DOI 10.1016/j.rse.2014.08.038; Stubbs M, 2013, CONSERVATION RESERVE, P7; Theobald DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094628; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970; Werling BP, 2014, P NATL ACAD SCI USA, V111, P1652, DOI 10.1073/pnas.1309492111; Wickham JD, 2013, REMOTE SENS ENVIRON, V130, P294, DOI 10.1016/j.rse.2012.12.001; Wilkerson CG, 2014, SCIENCE, V344, P90, DOI 10.1126/science.1250161; Wright CK, 2013, P NATL ACAD SCI USA, V110, P4134, DOI 10.1073/pnas.1215404110; Xue C, GLOBAL CHAGNE BIOL B; Zalesny RS, 2012, FOREST ECOL MANAG, V284, P45, DOI 10.1016/j.foreco.2012.07.022	63	15	15	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148566	10.1371/journal.pone.0148566	http://dx.doi.org/10.1371/journal.pone.0148566			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866474	gold, Green Published, Green Submitted			2022-12-27	WOS:000370050700021
J	Nolin, F; Michel, J; Wortham, L; Tchelidze, P; Banchet, V; Lalun, N; Terryn, C; Ploton, D				Nolin, Frederique; Michel, Jean; Wortham, Laurence; Tchelidze, Pavel; Banchet, Vincent; Lalun, Nathalie; Terryn, Christine; Ploton, Dominique			Stage-Specific Changes in the Water, Na+, Cl- and K+ Contents of Organelles during Apoptosis, Demonstrated by a Targeted Cryo Correlative Analytical Approach	PLOS ONE			English	Article							X-RAY-MICROANALYSIS; CYTOCHROME-C; OXIDATIVE STRESS; NANO ANALYSIS; ACTIVATION; DEATH; MITOCHONDRIA; IONS; CONDENSATION; DECREASE	Many studies have demonstrated changes in the levels of several ions during apoptosis, but a few recent studies have reported conflicting results concerning the changes in water content in apoptotic cells. We used a correlative light and cryo-scanning transmission electron microscopy method to quantify water and ion/element contents simultaneously at a nanoscale resolution in the various compartments of cells, from the onset to the end of apoptosis. We used stably transfected HeLa cells producing H2B-GFP to identify the stages of apoptosis in cells and for a targeted elemental analysis within condensed chromatin, nucleoplasm, mitochondria and the cytosol. We found that the compartments of apoptotic cells contained, on average, 10% more water than control cells. During mitochondrial outer membrane permeabilization, we observed a strong increase in the Na+ and Cl- contents of the mitochondria and a strong decrease in mitochondrial K+ content. During the first step in apoptotic volume decrease (AVD), Na+ and Cl- levels decreased in all cell compartments, but remained higher than those in control cells. Conversely, during the second step of AVD, Na+ and Cl- levels increased considerably in the nucleus and mitochondria. During these two steps of AVD, K+ content decreased steadily in all cell compartments. We also determined in vivo ion status during caspase-3 activity and chromatin condensation. Finally, we found that actinomycin D-tolerant cells had water and K+ contents similar to those of cells entering apoptosis but lower Na+ and Cl- contents than both cells entering apoptosis and control cells.	[Nolin, Frederique; Michel, Jean; Wortham, Laurence; Banchet, Vincent] Univ Reims, Lab Rech Nanosci, EA 4682, Reims, France; [Tchelidze, Pavel; Lalun, Nathalie; Ploton, Dominique] Univ Reims, CNRS, UMR 7369, Reims, France; [Terryn, Christine] Univ Reims, PICT, Reims, France	Universite de Reims Champagne-Ardenne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Reims Champagne-Ardenne; Universite de Reims Champagne-Ardenne	Ploton, D (corresponding author), Univ Reims, CNRS, UMR 7369, Reims, France.	dominique.ploton@univ-reims.fr	Ploton, Dominique DP/W-7169-2018	Ploton, Dominique DP/0000-0002-4541-3146	INSERM; Region Champagne Ardenne	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Champagne Ardenne(Region Grand-Est)	This work was supported by INSERM (www.inserm.fr) (Physicancer program: Noci-cytox); and Region Champagne Ardenne (www.cr-champagne-ardenne.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allahverdi A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08512; Altschuler SJ, 2010, CELL, V141, P559, DOI 10.1016/j.cell.2010.04.033; Arrebola F, 2006, AM J PHYSIOL-CELL PH, V290, pC638, DOI 10.1152/ajpcell.00364.2005; Bellissent-Funel MC, 2011, WATER: THE FORGOTTEN BIOLOGICAL MOLECULE, P23; Benitez-Rangel E, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2010.93; Benninger R.K.P., 2013, CURR PROTOC CELL BIO, P1; Borjesson SI, 2011, J BIOL CHEM, V286, P39823, DOI 10.1074/jbc.M111.262725; Bortner CD, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0104; Bortner CD, 2011, CELL PHYSIOL BIOCHEM, V28, P1079, DOI 10.1159/000335864; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Burger K, 2010, J BIOL CHEM, V285, P12416, DOI 10.1074/jbc.M109.074211; Chaplin M, 2011, WATER: THE FORGOTTEN BIOLOGICAL MOLECULE, P3; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; Dedkova EN, 2012, J MOL CELL CARDIOL, V52, P48, DOI 10.1016/j.yjmcc.2011.08.030; Fernandez-Segura E, 2008, METHOD CELL BIOL, V88, P19, DOI 10.1016/S0091-679X(08)00402-0; Flusberg DA, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/3/035002; Galluzzi L, 2015, CELL DEATH DIFFER, V22, P58, DOI 10.1038/cdd.2014.137; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Goldman A, 2011, PLOS ONE, V6, pe2385; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Goldstein JC, 2005, CELL DEATH DIFFER, V12, P453, DOI 10.1038/sj.cdd.4401596; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Hansen JC., 2000, ANNU REV BIOPH BIOM, V31, P361; Hughes FM, 1997, J BIOL CHEM, V272, P30567, DOI 10.1074/jbc.272.48.30567; Jemmerson R, 2002, CELL DEATH DIFFER, V9, P538, DOI 10.1038/sj.cdd.4400981; Kaasik A, 2007, AM J PHYSIOL-CELL PH, V292, pC157, DOI 10.1152/ajpcell.00272.2006; Kagan VE, 2009, FREE RADICAL BIO MED, V46, P1439, DOI 10.1016/j.freeradbiomed.2009.03.004; Kasim NR, 2013, APOPTOSIS, V18, P521, DOI 10.1007/s10495-013-0804-z; Kim NH, 2006, J BIOCHEM MOL BIOL, V39, P452; Ko SK, 2014, NAT CHEM, V6, P885, DOI [10.1038/NCHEM.2021, 10.1038/nchem.2021]; Martinez-Fabregas J, 2014, MOL CELL PROTEOMICS, V13, P1439, DOI 10.1074/mcp.M113.034322; Mentre P, 2012, J BIOL PHYS, V38, P13, DOI 10.1007/s10867-011-9225-9; Mitra K, 2010, CURR PROTOC CELL BIO; Model MA, 2014, AM J PHYSIOL-CELL PH, V306, pC417, DOI 10.1152/ajpcell.00328.2013; Nolin F, 2015, METHODS MOL BIOL, V1228, P145, DOI 10.1007/978-1-4939-1680-1_12; Nolin F, 2013, CELL MOL LIFE SCI, V70, P2383, DOI 10.1007/s00018-013-1267-7; Nolin F, 2012, J STRUCT BIOL, V180, P352, DOI 10.1016/j.jsb.2012.08.011; Nur-E-Kamal A, 2004, J BIOL CHEM, V279, P24911, DOI 10.1074/jbc.C400051200; Orlov SN, 2013, J PHYSIOL-LONDON, V591, P6123, DOI 10.1113/jphysiol.2013.258624; Platonova A, 2012, APOPTOSIS, V17, P429, DOI 10.1007/s10495-011-0694-x; Samejima K, 2001, J BIOL CHEM, V276, P45427, DOI 10.1074/jbc.M108844200; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Spencer SL, 2011, CELL, V144, P926, DOI 10.1016/j.cell.2011.03.002; Sun MG, 2007, NAT CELL BIOL, V9, P1057, DOI 10.1038/ncb1630; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tomaskova Z, 2010, FEBS LETT, V584, P2085, DOI 10.1016/j.febslet.2010.01.035; Tone S, 2007, EXP CELL RES, V313, P3635, DOI 10.1016/j.yexcr.2007.06.018; WARLEY A, 1983, J CELL SCI, V60, P217; Wu CC, 2013, ANTIOXID REDOX SIGN, V19, P546, DOI 10.1089/ars.2012.4905; Yang KT, 2006, CELL DEATH DIFFER, V13, P1815, DOI 10.1038/sj.cdd.4401813; Yang KT, 2004, FASEB J, V18, P1442, DOI 10.1096/fj.03-1038fje	51	11	12	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148727	10.1371/journal.pone.0148727	http://dx.doi.org/10.1371/journal.pone.0148727			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866363	Green Submitted, Green Published, gold			2022-12-27	WOS:000370050700029
J	Ventura, E; Cordazzo, C; Quarto, R; Zardi, L; Rosano, C				Ventura, Elisa; Cordazzo, Cinzia; Quarto, Rodolfo; Zardi, Luciano; Rosano, Camillo			C6: A Monoclonal Antibody Specific for a Fibronectin Epitope Situated at the Interface between the Oncofoetal Extra-Domain B and the Repeat III8	PLOS ONE			English	Article							ISOFORM; MARKER	Background Fibronectin (FN) is a large multidomain molecule that is involved in many cellular processes. Different FN isoforms arise from alternative splicing of the pre-mRNA including, most notably, the FN isoform that contains the "extra-domain-B" (ED-B). The FN isoform containing ED-B (known as B-FN) is undetectable in healthy adult tissues but is present in large amounts in neoplastic and foetal tissues as well as on the blood vessels during angiogenesis. Thus, antibodies specific for B-FN can be useful for detecting and targeting neoplastic tissues in vivo. We previously characterised C6, a new monoclonal antibody specific for human B-FN and we suggested that it reacts with the B-C loop of the type III repeat 8 which is masked in FN isoforms lacking ED-B and that the insertion of ED-B in FN molecules unmasked it. Here we have now consolidated and refined the characterization of this B-FN specific antibody demonstrating that the epitope recognized by C6 also includes loop E-F of ED-B. Methodology We built the three dimensional model of the variable regions of the mAb C6 and of the FN fragment EDB-III8 and performed protein: protein docking simulation using the web server ClusPro2.0. To confirm the data obtained by protein: protein docking we generated mutant fragments of the recombinant FN fragment EDB-III8 and tested their reactivity with C6. Conclusion The monoclonal antibody C6 reacts with an epitope formed by the B-C loop of domain III8 and the E-F loop of ED-B. Both loops are required for an immunological reaction, thus this monoclonal is strictly specific for B-FN but the part of the epitope on III8 confers the human specificity.	[Ventura, Elisa] G Gaslini Inst Children, Lab Oncol, Genoa, Italy; [Cordazzo, Cinzia; Zardi, Luciano] Sirius Biotech, Adv Biotechnol Ctr, Genoa, Italy; [Quarto, Rodolfo] Univ Genoa, Lab Stem Cells, Genoa, Italy; [Quarto, Rodolfo] IRCCS AOU San Martino IST, Lab Regenerat Med, Genoa, Italy; [Rosano, Camillo] IRCCS AOU San Martino IST, Lab Biopolymers & Prote, Genoa, Italy; [Ventura, Elisa] Univ Zurich Hosp, Dept Neurol, Lab Mol Neurooncol, CH-8091 Zurich, Switzerland; [Ventura, Elisa] Univ Zurich, Zurich, Switzerland	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST; University of Zurich; University Zurich Hospital; University of Zurich	Zardi, L (corresponding author), Sirius Biotech, Adv Biotechnol Ctr, Genoa, Italy.	luciano.zardi@sirius-biotech.com	Quarto, Rodolfo/AAB-2182-2019; Rosano, Camillo/D-5386-2011; Rosano, Camillo/AAA-9954-2021	Rosano, Camillo/0000-0003-2949-9215; Rosano, Camillo/0000-0003-2949-9215; Ventura, Elisa/0000-0002-5999-7613; Quarto, Rodolfo/0000-0002-1146-894X	Sirius-biotech	Sirius-biotech	This study was partially supported by Sirius-biotech. The funder provided support in the form of salaries for authors (L.Z. and partially to C.C.) and for research materials but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific roles of these authors are articulated in the author contribution sections.	Balza E, 2009, INT J CANCER, V125, P751, DOI 10.1002/ijc.24473; Bencharit S, 2007, J MOL BIOL, V367, P303, DOI 10.1016/j.jmb.2006.10.017; Berndorff D, 2006, J NUCL MED, V47, P1707; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARNEMOLLA B, 1989, J CELL BIOL, V108, P1139, DOI 10.1083/jcb.108.3.1139; Carnemolla B, 1996, INT J CANCER, V68, P397, DOI 10.1002/(SICI)1097-0215(19961104)68:3<397::AID-IJC20>3.3.CO;2-D; Castellani P, 2002, AM J PATHOL, V161, P1695, DOI 10.1016/S0002-9440(10)64446-X; CASTELLANI P, 1994, INT J CANCER, V59, P612, DOI 10.1002/ijc.2910590507; Chen SL, 2012, INVEST OPHTH VIS SCI, V53, P8333, DOI 10.1167/iovs.12-9766; Comeau SR, 2007, PROTEINS, V69, P781, DOI 10.1002/prot.21795; KACZMAREK J, 1994, INT J CANCER, V59, P11, DOI 10.1002/ijc.2910590104; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kosmehl H, 1996, VIRCHOWS ARCH, V429, P311; Kraft S, 2015, J MOL MED BERL, P65; Mariani G, 1997, CANCER, V80, P2378, DOI 10.1002/(SICI)1097-0142(19971215)80:12+<2378::AID-CNCR7>3.0.CO;2-7; Neri D, 2005, NAT REV CANCER, V5, P436, DOI 10.1038/nrc1627; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Sauer S, 2009, BLOOD, V113, P2265, DOI 10.1182/blood-2008-06-160416; Schiefner A, 2012, J BIOL CHEM, V287, P17578, DOI 10.1074/jbc.M111.303131; Ventura E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009145; Yamada K.M., 1996, MOL CELLULAR BIOL WO, P51; ZARDI L, 1987, EMBO J, V6, P2337, DOI 10.1002/j.1460-2075.1987.tb02509.x	22	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148103	10.1371/journal.pone.0148103	http://dx.doi.org/10.1371/journal.pone.0148103			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867013	Green Submitted, Green Published, gold			2022-12-27	WOS:000370050700008
J	Ducasse, D; Jaussent, I; Olie, E; Guillaume, S; Lopez-Castroman, J; Courtet, P				Ducasse, Deborah; Jaussent, Isabelle; Olie, Emilie; Guillaume, Sebastien; Lopez-Castroman, Jorge; Courtet, Philippe			Personality Traits of Suicidality Are Associated with Premenstrual Syndrome and Premenstrual Dysphoric Disorder in a Suicidal Women Sample	PLOS ONE			English	Article							ANGER-EXPRESSION; MENSTRUAL-CYCLE; CEREBROSPINAL-FLUID; GABA CONCENTRATIONS; LUTEAL-PHASE; PAIN; SEROTONIN; BEHAVIOR; MOOD; ALLOPREGNANOLONE	Objective Both Premenstrual Syndrome (PMS) and Premenstrual Dysphoric Disorder (PMDD) might increase the risk of suicidal behavior. The aim of this study was to assess the relationship between personality dimensions specifically involved in suicidal vulnerability and PMS/PMDD. Method We collected data from 232 women consecutively hospitalized after a suicide attempt. We examined the relationship between impulsivity, aggressiveness/hostility, hopelessness, trait anger, affect intensity, emotional lability, and PMS/PMDD. Notably, we created an algorithm from the shortened Premenstrual Assessment form in order to assess PMDD status. Results The proportions of PMS and PMDD among female suicide attempters were 50% and 23% respectively. Women with PMS or PMDD were more likely to endorse most of these personality traits to than those without even after controlling for potential confounders. We found an impulsive-aggressive pattern of personality in women with PMS or PMDD, independently from the time of the menstrual cycle. Interestingly, trait anger remained associated with both PMS and PMDD independently of every other personality traits. The higher the anger level, the higher the risk was to suffer from both PMS and PMDD. Conclusions This study demonstrates a strong, independent association between PMS/PMDD and trait anger among a representative sample of female suicide attempters. It is of major interest for clinicians in view of addressing a substantial public health problem among women of reproductive age.	[Ducasse, Deborah; Olie, Emilie; Guillaume, Sebastien; Lopez-Castroman, Jorge; Courtet, Philippe] CHU Montpellier, Lapeyronie Hosp, Dept Psychiat Emergency & Acute Care, Montpellier, France; [Ducasse, Deborah; Jaussent, Isabelle; Olie, Emilie; Guillaume, Sebastien; Lopez-Castroman, Jorge; Courtet, Philippe] Univ Montpellier I, INSERM, U1061, Montpellier, France; [Ducasse, Deborah; Olie, Emilie; Guillaume, Sebastien; Lopez-Castroman, Jorge; Courtet, Philippe] Fondamental Fdn, Creteil, France	Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Ducasse, D (corresponding author), CHU Montpellier, Lapeyronie Hosp, Dept Psychiat Emergency & Acute Care, Montpellier, France.; Ducasse, D (corresponding author), Univ Montpellier I, INSERM, U1061, Montpellier, France.; Ducasse, D (corresponding author), Fondamental Fdn, Creteil, France.	d-ducasse@chu-montpellier.fr	Castroman, Lopez/A-6192-2014	Castroman, Lopez/0000-0003-0618-0690; Jaussent, Isabelle/0000-0002-8205-7590; ducasse, deborah/0000-0003-3874-5748	Programme Hospitalier de Recherche Clinique (CHU of Montpellier - PHRC UF) [7653]	Programme Hospitalier de Recherche Clinique (CHU of Montpellier - PHRC UF)	This study was financially supported by Programme Hospitalier de Recherche Clinique (CHU of Montpellier - PHRC UF 7653). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyol ES, 2013, COMPR PSYCHIAT, V54, P850, DOI 10.1016/j.comppsych.2013.03.013; American College of Obstetricians and Gynecologists (ACOG), 2000, ACOG PRACTICE BULLET, V15; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; ASBERG M, 1976, ARCH GEN PSYCHIAT, V33, P1193; Bailey JW, 1999, J WOMEN HEALTH GEN-B, V8, P1181, DOI 10.1089/jwh.1.1999.8.1181; Baron KG, 2007, J BEHAV MED, V30, P1, DOI 10.1007/s10865-006-9086-z; Bartley EJ, 2015, CLIN J PAIN, V31, P304, DOI 10.1097/AJP.0000000000000112; Beck A., 1996, BECK DEPRESSION INVE, DOI 10.1037/t00742-000; BECK AT, 1979, J CONSULT CLIN PSYCH, V47, P343, DOI 10.1037/0022-006X.47.2.343; BECK AT, 1974, J CONSULT CLIN PSYCH, V42, P861, DOI 10.1037/h0037562; Berlin RE, 2001, J CLIN PSYCHIAT, V62, P337, DOI 10.4088/JCP.v62n0505; Bhagwagar Z, 2004, AM J PSYCHIAT, V161, P368, DOI 10.1176/appi.ajp.161.2.368; Borteyrou X, 2008, ENCEPHALE, V34, P249, DOI 10.1016/j.encep.2007.06.001; BOUVARD M, 1992, Encephale, V18, P237; Bruehl S, 2012, PAIN, V153, P2352, DOI 10.1016/j.pain.2012.08.001; Bruehl S, 2011, PSYCHOSOM MED, V73, P612, DOI 10.1097/PSY.0b013e318227cb88; Burns JW, 2005, J BEHAV MED, V28, P555, DOI 10.1007/s10865-005-9020-9; BUSS AH, 1957, J CONSULT PSYCHOL, V21, P343, DOI 10.1037/h0046900; Buzsaki G, 2007, NEURON, V56, P771, DOI 10.1016/j.neuron.2007.11.008; Cirillo PC, 2012, REV BRAS PSIQUIATR, V34, P467, DOI 10.1016/j.rbp.2012.04.010; Coccaro EF, 2010, J NEURAL TRANSM, V117, P241, DOI 10.1007/s00702-009-0359-x; Courtet P, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.6; Courtet P., 2013, SUICIDE ENV SOCIAL; Critchlow DG, 2001, J CLIN PSYCHIAT, V62, P688, DOI 10.4088/JCP.v62n0905; Dennerstein Lorraine, 2012, Menopause Int, V18, P48, DOI 10.1258/mi.2012.012013; Ducasse D, 2014, PSYCHOTHERA IN PRESS; Duke AA, 2013, PSYCHOL BULL, V139, P1148, DOI 10.1037/a0031544; Ende G, 2015, NEUROPSYCHOPHARMACOL; Endicott J, 1999, J WOMEN HEALTH GEN-B, V8, P663, DOI 10.1089/jwh.1.1999.8.663; Epperson CN, 2012, AM J PSYCHIAT, V169, P465, DOI 10.1176/appi.ajp.2012.11081302; Freeman Ellen W., 2003, Prim Care Companion J Clin Psychiatry, V5, P30; Gaetz W, 2011, NEUROIMAGE, V55, P616, DOI 10.1016/j.neuroimage.2010.12.077; Girdler SS, 2001, BIOL PSYCHIAT, V49, P788, DOI 10.1016/S0006-3223(00)01044-1; Glick Amy R, 2015, Int J Adolesc Med Health, V27, P143, DOI 10.1515/ijamh-2015-5005; Halbreich U, 2003, PSYCHONEUROENDOCRINO, V28, P1, DOI 10.1016/S0306-4530(03)00098-2; Halbreich U, 2003, PSYCHONEUROENDOCRINO, V28, P55, DOI 10.1016/S0306-4530(03)00097-0; HALBREICH U, 1981, MED HYPOTHESES, V7, P1045, DOI 10.1016/0306-9877(81)90100-6; Halbreich U, 2010, J AFFECT DISORDERS, V122, P10, DOI 10.1016/j.jad.2009.05.018; Hantsoo L, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0628-3; Hartlage SA, 2002, PSYCHOL REP, V90, P189, DOI 10.2466/PR0.90.1.189-202; HARVEY PD, 1989, J CLIN PSYCHOL, V45, P786, DOI 10.1002/1097-4679(198909)45:5<786::AID-JCLP2270450515>3.0.CO;2-P; Hayes SC, 2006, BEHAV RES THER, V44, P1, DOI 10.1016/j.brat.2005.06.006; Haywood A, 2002, J PSYCHOSOM RES, V52, P223, DOI 10.1016/S0022-3999(02)00297-0; Heinemann LAJ, 2012, HEALTH CARE WOMEN IN, V33, P109, DOI 10.1080/07399332.2011.610530; Holmes EA, 2007, J BEHAV THER EXP PSY, V38, P423, DOI 10.1016/j.jbtep.2007.10.004; Hong JP, 2012, SOC PSYCH PSYCH EPID, V47, P1937, DOI 10.1007/s00127-012-0509-6; Horesh N, 1997, PSYCHOTHER PSYCHOSOM, V66, P92, DOI 10.1159/000289115; Jandl M, 2010, J AFFECT DISORDERS, V123, P138, DOI 10.1016/j.jad.2009.09.011; Keilp JG, 2006, PSYCHOL MED, V36, P1779, DOI 10.1017/S0033291706008725; KERNS RD, 1994, J BEHAV MED, V17, P57, DOI 10.1007/BF01856882; Kim D R, 2004, Arch Womens Ment Health, V7, P37, DOI 10.1007/s00737-003-0027-3; KOSTEN TA, 1992, AM J PSYCHIAT, V149, P1225; KUCZMIERCZYK AR, 1986, PERCEPT MOTOR SKILL, V63, P387, DOI 10.2466/pms.1986.63.2.387; Lambert JJ, 2003, PROG NEUROBIOL, V71, P67, DOI 10.1016/j.pneurobio.2003.09.001; Larsen RJ, 1996, J PERS, V64, P185, DOI 10.1111/j.1467-6494.1996.tb00819.x; Lee L. K., 2006, SMJ Singapore Medical Journal, V47, P869; LESTER D, 1995, PHARMACOPSYCHIATRY, V28, P45, DOI 10.1055/s-2007-979587; Liu B, 2015, PSYCHIAT RES-NEUROIM, V231, P64, DOI 10.1016/j.pscychresns.2014.10.020; Luoma JB, 2012, COGN BEHAV PRACT, V19, P265; Mann JJ, 1998, NAT MED, V4, P25, DOI 10.1038/nm0198-025; Marjoribanks J, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001396.pub3; McGirr A, 2007, J CLIN PSYCHIAT, V68, P721, DOI 10.4088/JCP.v68n0509; Moberg T, 2011, J AFFECT DISORDERS, V132, P173, DOI 10.1016/j.jad.2011.01.018; N-Wihlback AC, 2006, PSYCHOPHARMACOLOGY, V186, P388, DOI 10.1007/s00213-005-0185-2; Oquendo MA, 2004, AM J PSYCHIAT, V161, P1433, DOI 10.1176/appi.ajp.161.8.1433; Oquendo MA, 2014, AM J PSYCHIAT, V171, P1259, DOI 10.1176/appi.ajp.2014.14020194; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pearlstein T, 2005, J AFFECT DISORDERS, V85, P275, DOI 10.1016/j.jad.2004.10.004; Perroud N, 2013, J AFFECT DISORDERS, V146, P246, DOI 10.1016/j.jad.2012.09.012; Perroud N, 2011, J AFFECT DISORDERS, V134, P112, DOI 10.1016/j.jad.2011.05.048; Pettit JW, 2009, DEPRESS ANXIETY, V26, P758, DOI 10.1002/da.20512; Pilver CE, 2013, SOC PSYCH PSYCH EPID, V48, P437, DOI 10.1007/s00127-012-0548-z; Preisig M, 1999, EUR ARCH PSY CLIN N, V249, P174, DOI 10.1007/s004060050084; Quartana PJ, 2007, EMOTION, V7, P400, DOI 10.1037/1528-3542.7.2.400; Rae CD, 2014, NEUROCHEM RES, V39, P1, DOI 10.1007/s11064-013-1199-5; Rapkin A, 2003, PSYCHONEUROENDOCRINO, V28, P39, DOI 10.1016/S0306-4530(03)00096-9; RAPKIN AJ, 1987, OBSTET GYNECOL, V70, P533; RAPKIN AJ, 1992, CLIN OBSTET GYNECOL, V35, P629, DOI 10.1097/00003081-199209000-00022; Rapkin AJ, 1997, OBSTET GYNECOL, V90, P709, DOI 10.1016/S0029-7844(97)00417-1; Rapkin Andrea J, 2012, Menopause Int, V18, P52, DOI 10.1258/mi.2012.012014; Rapkin Andrea J, 2009, Expert Rev Pharmacoecon Outcomes Res, V9, P157, DOI 10.1586/erp.09.14; Rhudy JL, 2014, PAIN, V155, P2144, DOI 10.1016/j.pain.2014.08.011; Robins CJ, 2012, J CLIN PSYCHOL, V68, P117, DOI 10.1002/jclp.20857; Rodrigues D, 2013, PAIN THER, V2, P113, DOI 10.1007/s40122-013-0017-8; ROSEN LN, 1988, ACTA PSYCHIAT SCAND, V77, P446, DOI 10.1111/j.1600-0447.1988.tb05149.x; Roy A, 2014, ARCH SUICIDE RES, V18, P28, DOI 10.1080/13811118.2013.801816; Sanacora G, 2002, AM J PSYCHIAT, V159, P663, DOI 10.1176/appi.ajp.159.4.663; Sassoon SA, 2011, ARCH WOMEN MENT HLTH, V14, P257, DOI 10.1007/s00737-011-0212-8; Saunders KEA, 2006, PSYCHOL MED, V36, P901, DOI 10.1017/S0033291706007392; Schimmack U, 2004, PERS SOC PSYCHOL B, V30, P1062, DOI 10.1177/0146167204264292; Schiola A, 2011, VALUE HEALTH, V14, pS93, DOI 10.1016/j.jval.2011.05.008; SCHMIDT PJ, 1994, J CLIN ENDOCR METAB, V79, P1256, DOI 10.1210/jc.79.5.1256; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shelef L, 2015, EUR PSYCHIAT, V30, P765, DOI 10.1016/j.eurpsy.2014.12.004; Smith MJ, 2003, BIOL PSYCHIAT, V54, P757, DOI 10.1016/S0006-3223(02)01924-8; Spielberger C.D., 1983, MANUAL STATE TRAIT A, DOI DOI 10.1002/9780470479216.CORPSY0943; Steiner M, 2000, INT CLIN PSYCHOPHARM, V15, pS5; Steiner M, 2000, J PSYCHIATR NEUROSCI, V25, P459; Straneva PA, 2002, HEALTH PSYCHOL, V21, P358, DOI 10.1037//0278-6133.21.4.358; TAYLOR DL, 1984, NEUROPSYCHOBIOLOGY, V12, P16, DOI 10.1159/000118103; Turecki G, 2005, J PSYCHIATR NEUROSCI, V30, P398; Uchino BN, 2004, J SOC CLIN PSYCHOL, V23, P123, DOI 10.1521/jscp.23.2.123.31014; Veehof MM, 2011, PAIN, V152, P533, DOI 10.1016/j.pain.2010.11.002; Vowles KE, 2011, BEHAV RES THER, V49, P748, DOI 10.1016/j.brat.2011.08.002; Wang H, 2010, LANCET, V380, p2071 , DOI DOI 10.1016/S0140-6736(12)61719-X; WEGNER DM, 1994, J PERS, V62, P615, DOI 10.1111/j.1467-6494.1994.tb00311.x; Williams WR, 2007, MED SCI MONITOR, V13, pCR118; Yonkers Kimberly Ann, 2008, Lancet, V371, P1200, DOI 10.1016/S0140-6736(08)60527-9	108	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148653	10.1371/journal.pone.0148653	http://dx.doi.org/10.1371/journal.pone.0148653			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6PR	26863007	Green Published, Green Submitted, gold			2022-12-27	WOS:000370046600090
J	Garcia-Gonzalez, R; Aldezabal, A; Laskurain, NA; Margalida, A; Novoa, C				Garcia-Gonzalez, Ricardo; Aldezabal, Arantza; Laskurain, Nere Amaia; Margalida, Antoni; Novoa, Claude			Factors Affecting Diet Variation in the Pyrenean Rock Ptarmigan (Lagopus muta pyrenaica): Conservation Implications	PLOS ONE			English	Article							CHEMICAL-COMPOSITION; WILLOW PTARMIGAN; BARNACLE GEESE; GROUSE; SNOW; NUTRITION; ALPINE; TETRIX; HISPANIENSIS; LIMITATIONS	The Pyrenean rock ptarmigan (Lagopus muta pyrenaica) lives at one of the southernmost limits of the ptarmigan range. Their small population sizes and the impacts of global changes are limiting factors in the conservation of this threatened subspecies. An effective conservation policy requires precise basic knowledge of a species' food and habitat requirements, information that is practically non-existent for this Pyrenean population. Here, we describe the diet of a ptarmigan population in the Eastern Pyrenees, the environmental factors influencing its variability and the relationship between diet floristic composition and quality. Diet composition was determined by microhistological analysis of faeces and diet quality was estimated from free-urate faecal N content. Our results show that grouse diet is based mainly on arctic-alpine shrubs of the Ericaceae family, as well as dwarf willows (Salix spp.) and Dryas octopetala. The most frequently consumed plant species was Rhododendron ferrugineum, but its abundance in the diet was negatively related to the diet nitrogen content. Conversely, the abundance of Salix spp., grass leaves and arthropods increased the nitrogen content of the diet. Seasonality associated with snow-melting contributed the most to variability in the Pyrenean ptarmigan diet, differentiating winter from spring/summer diets. The latter was characterised by a high consumption of dwarf willows, flowers, arthropods and tender forb leaves. Geographic area and sex-age class influenced diet variability to a lesser extent. Current temperature increases in the Pyrenees due to global warming may reduce the persistence and surface area of snow-packs where preferred plants for rock ptarmigan usually grow, thus reducing food availability. The high consumption of Rh. ferrugineum characterised the diet of the Pyrenean population. Given the toxicity of this plant for most herbivores, its potential negative effect on Pyrenean ptarmigan populations should be evaluated.	[Garcia-Gonzalez, Ricardo] CSIC, Inst Pirenaico Ecol, Jaca, Spain; [Aldezabal, Arantza; Laskurain, Nere Amaia] Univ Basque Country, Plant Biol & Ecol Dept, Bilbao, Spain; [Margalida, Antoni] Univ Lleida, Dept Anim Prod, Div Wildlife, Fac Life Sci & Engn, Lleida, Spain; [Margalida, Antoni] Univ Bern, Inst Ecol & Evolut, Div Conservat Biol, Bern, Switzerland; [Novoa, Claude] Off Natl Chasse & Faune Sauvage, Prades, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE); University of Basque Country; Universitat de Lleida; University of Bern	Margalida, A (corresponding author), Univ Lleida, Dept Anim Prod, Div Wildlife, Fac Life Sci & Engn, Lleida, Spain.; Margalida, A (corresponding author), Univ Bern, Inst Ecol & Evolut, Div Conservat Biol, Bern, Switzerland.	amargalida@prodan.udl.cat	Margalida, Antoni/A-2723-2011; Margalida, Antoni/AAG-5337-2020; Aldezabal, Arantza/V-7930-2017; Margalida, Antoni/A-2723-2011	Margalida, Antoni/0000-0002-0576-3993; Aldezabal, Arantza/0000-0001-7917-7690; Margalida, Antoni/0000-0002-7383-671X; Laskurain, Nere Amaia/0000-0002-9521-8584; Garcia-Gonzalez, Ricardo/0000-0001-5625-8690; Margalida, Antoni/0000-0002-3904-6212	RTA (Agricultural Technologies and Resources) [2005-00160-C02-02]; MAM Spanish projects [2484/2002]; LEDDRA Desertification process and land degradation (SICA-EU) [FW7 ENV.2009.2.1.3.2]; Ministry of Economy and Competitiveness [RYC-2012-11867]	RTA (Agricultural Technologies and Resources); MAM Spanish projects; LEDDRA Desertification process and land degradation (SICA-EU); Ministry of Economy and Competitiveness	This work was carried out with a cooperation agreement between the Office National de la Chasse et de la Faune Sauvage (France) and the Consejo Superior de Investigaciones Cientificas (Spain). Additional funds were provided by RTA (Agricultural Technologies and Resources) 2005-00160-C02-02, MAM 2484/2002 Spanish projects and LEDDRA FW7 ENV.2009.2.1.3.2 Desertification process and land degradation (SICA-EU). AM was supported by a Ramon y Cajal research contract from the Ministry of Economy and Competitiveness (RYC-2012-11867).	Allen T, 2005, ANIM BEHAV, V70, P305, DOI 10.1016/j.anbehav.2004.10.022; Ameztegui A, 2010, GLOBAL ECOL BIOGEOGR, V19, P632, DOI 10.1111/j.1466-8238.2010.00550.x; ANDREEV AV, 1988, CAN J ZOOL, V66, P1382, DOI 10.1139/z88-203; [Anonymous], 1965, ANATOMY DICOTYLEDONS; ANTOR RJ, 1995, J AVIAN BIOL, V26, P81, DOI 10.2307/3677216; Arlettaz R, 2007, P R SOC B, V274, P1219, DOI 10.1098/rspb.2006.0434; Atlas Flora Pyrenaea, 2015, POCTEFA CTP UE PROJ; Atta-ur-Rahman, 2003, STUDIES NATURAL PROD; Bech N, 2013, HEREDITY, V111, P402, DOI 10.1038/hdy.2013.62; Bech N, 2009, ANIM CONSERV, V12, P138, DOI 10.1111/j.1469-1795.2008.00233.x; BERNARDLAURENT A, 1983, REV ECOL-TERRE VIE, V37, P241; Bolos O, 1990, FLORA MANUAL PAISOS; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Bossert A., 1980, Ornithologische Beobachter, V77, P121; BOUDAREL P, 1991, ACTA BIOL MONTANA, V10, P11; Braun-Blanquet J., 1948, VEGETATION ALPINE PY; BRITTAS R, 1988, ORNIS SCAND, V19, P49, DOI 10.2307/3676527; Carey Cynthia, 1996, P324; Chapuis JL, 1986, REGIME ALIMENTAIRE G; Charrier O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092976; Davies S, 2014, HORM BEHAV, V66, P41, DOI 10.1016/j.yhbeh.2014.04.003; DELBARRIO G, 1990, MT RES DEV, V10, P227, DOI 10.2307/3673602; Elson LT, 2007, NORTHEAST NAT, V14, P89, DOI 10.1656/1092-6194(2007)14[89:WFHOLL]2.0.CO;2; Filacorda S, 1997, WILDLIFE BIOL, V3, P187, DOI 10.2981/wlb.1997.023; Forbey JS, 2013, WILDLIFE BIOL, V19, P374, DOI 10.2981/13-014; Frutos P, 2002, ANIM FEED SCI TECH, V95, P215, DOI 10.1016/S0377-8401(01)00323-6; Ganan N, 2002, REU TECHNICAL SERIES, V66, P86; Garcia-Gonzalez R, 2006, PIRINEOS, V161, P85; Garcia-Gonzalez R., 1992, PLANT AN INT WORKSH, P6; Garcia-Gonzalez R, 1987, ACTA BIOL MONTANA, V7, P35; GarciaGonzalez R, 1996, FOREST ECOL MANAG, V88, P15, DOI 10.1016/S0378-1127(96)03805-4; Garin I, 2008, REV ECOLOGIE TERRE V, V63, P85; Gelting P., 1937, SUDIES FOOD E GREENL; GONZALEZ G, 1989, REV ECOL-TERRE VIE, V44, P347; Imperio S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081598; [IUCN WPA], 2009, 41 WPAIUCN IUCNSSC R; Jensen GH, 2014, POLAR BIOL, V37, P1, DOI 10.1007/s00300-013-1404-7; JONES PJ, 1976, IBIS, V118, P547, DOI 10.1111/j.1474-919X.1976.tb03516.x; Legendre P., 2012, NUMERICAL ECOLOGY; Lopez-Moreno JI, 2008, GLOBAL PLANET CHANGE, V61, P300, DOI 10.1016/j.gloplacha.2007.10.004; Martin K, 2004, INTEGR COMP BIOL, V44, P177, DOI 10.1093/icb/44.2.177; Martinez C., 1985, Donana Acta Vertebrata, V12, P174; MOODY S, 1978, AM NAT, V112, P965, DOI 10.1086/283339; MOSS R, 1972, BRIT J NUTR, V27, P285, DOI 10.1079/BJN19720093; MOSS R, 1972, J ANIM ECOL, V41, P411, DOI 10.2307/3477; Moss R, 1997, P NUTR SOC, V56, P1137, DOI 10.1079/PNS19970116; Moss R., 1968, Symposia of the Zoological Society of London, VNo. 21, P207; MOSS R, 1984, IBIS, V126, P212, DOI 10.1111/j.1474-919X.1984.tb08000.x; MOSS R, 1990, ORNIS SCAND, V21, P115, DOI 10.2307/3676806; Nelli L, 2013, WILDLIFE BIOL, V19, P382, DOI 10.2981/13-009; Novoa C, 1999, REV ECOL-TERRE VIE, V54, P149; Novoa C, J ORNITHOLO IN PRESS; Novoa C, 2008, IBIS, V150, P270, DOI 10.1111/j.1474-919X.2007.00771.x; Pasche F, 2004, BIOL CONSERV, V118, P101, DOI 10.1016/j.biocon.2003.07.012; Petraitis PS, 1996, FUNCT ECOL, V10, P421, DOI 10.2307/2389934; PROP J, 1992, FUNCT ECOL, V6, P180, DOI 10.2307/2389753; PROP J, 1993, ORNIS SCAND, V24, P110, DOI 10.2307/3676360; PULLIAINEN E, 1991, HOLARCTIC ECOL, V14, P156; Robbins C. T., 1993, WILDLIFE FEEDING NUT; Schweiger AK, 2012, EUR J WILDLIFE RES, V58, P35, DOI 10.1007/s10344-011-0537-7; Sedinger JS, 1997, CONDOR, V99, P314, DOI 10.2307/1369937; Skrede I, 2006, MOL ECOL, V15, P1827, DOI 10.1111/j.1365-294X.2006.02908.x; SPIDSO TK, 1980, ORNIS SCAND, V11, P99, DOI 10.2307/3675914; Storch I, 2000, WILDLIFE BIOL, V6, P195, DOI 10.2981/wlb.2000.016; SUTLUPMAR N, 1993, ARCH TOXICOL, V67, P148, DOI 10.1007/BF01973687; Tape KD, 2010, ECOSCIENCE, V17, P186, DOI 10.2980/17-2-3323; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; TERPSTRA K, 1974, Zeitschrift fuer Tierphysiologie Tierernaehrung und Futtermittelkunde, V32, P306; UNANDER S, 1985, Polar Research, V3, P239, DOI 10.1111/j.1751-8369.1985.tb00510.x; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; Visser ME, 2004, ADV ECOL RES, V35, P89, DOI 10.1016/S0065-2504(04)35005-1; WEEDEN RB, 1969, AUK, V86, P271, DOI 10.2307/4083500; [No title captured]	74	3	3	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148614	10.1371/journal.pone.0148614	http://dx.doi.org/10.1371/journal.pone.0148614			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863532	Green Published, gold			2022-12-27	WOS:000370046600086
J	Thibault, L; van den Berg, R; Cavanagh, P; Sergent, C				Thibault, Louis; van den Berg, Ronald; Cavanagh, Patrick; Sergent, Claire			Retrospective Attention Gates Discrete Conscious Access to Past Sensory Stimuli	PLOS ONE			English	Article							VISUAL WORKING-MEMORY; ORIENTING ATTENTION; PERCEPTION; REPRESENTATIONS; LOCATIONS; CONTRAST; BLINK; PSYCHOPHYSICS; NEUROSCIENCE; VARIABILITY	Cueing attention after the disappearance of visual stimuli biases which items will be remembered best. This observation has historically been attributed to the influence of attention on memory as opposed to subjective visual experience. We recently challenged this view by showing that cueing attention after the stimulus can improve the perception of a single Gabor patch at threshold levels of contrast. Here, we test whether this retro-perception actually increases the frequency of consciously perceiving the stimulus, or simply allows for a more precise recall of its features. We used retro-cues in an orientation-matching task and performed mixture-model analysis to independently estimate the proportion of guesses and the precision of non-guess responses. We find that the improvements in performance conferred by retrospective attention are overwhelmingly determined by a reduction in the proportion of guesses, providing strong evidence that attracting attention to the target's location after its disappearance increases the likelihood of perceiving it consciously.	[Thibault, Louis; Cavanagh, Patrick; Sergent, Claire] Univ Paris 05, CNRS, UMR 8242, Lab Psychol Percept, F-75006 Paris, France; [van den Berg, Ronald] Uppsala Univ, Dept Psychol, Judgment & Decis Making Grp, S-75105 Uppsala, Sweden	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Uppsala University	Thibault, L; Sergent, C (corresponding author), Univ Paris 05, CNRS, UMR 8242, Lab Psychol Percept, F-75006 Paris, France.	louis.thibault@parisdescartes.fr; claire.sergent@parisdescartes.fr		van den Berg, Ronald/0000-0001-7353-5960	Chaire de Partenariat; University of Paris-Descartes; Centre National de la Recherche Scientifique (CNRS)	Chaire de Partenariat; University of Paris-Descartes; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	The study was funded by a "Chaire de Partenariat" to Claire Sergent, a joint subsidy program between the University of Paris-Descartes and the Centre National de la Recherche Scientifique (CNRS). (http://www.cnrs.fr/ and http://www.parisdescartes.fr/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPELLE S, 1972, PSYCHOL BULL, V78, P266, DOI 10.1037/h0033117; Asplund CL, 2014, PSYCHOL SCI, V25, P824, DOI 10.1177/0956797613513810; Astle DE, 2012, ATTEN PERCEPT PSYCHO, V74, P146, DOI 10.3758/s13414-011-0218-3; Baars BJ, 2005, PROG BRAIN RES, V150, P45, DOI 10.1016/S0079-6123(05)50004-9; Block N, 2007, BEHAV BRAIN SCI, V30, P481, DOI 10.1017/S0140525X07002786; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; CHEAL ML, 1994, Q J EXP PSYCHOL-A, V47, P699, DOI 10.1080/14640749408401134; Cohen MA, 2011, TRENDS COGN SCI, V15, P358, DOI 10.1016/j.tics.2011.06.008; Dehaene S, 2003, P NATL ACAD SCI USA, V100, P8520, DOI 10.1073/pnas.1332574100; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; Fougnie D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2237; Griffin IC, 2003, J COGNITIVE NEUROSCI, V15, P1176, DOI 10.1162/089892903322598139; KAERNBACH C, 1991, PERCEPT PSYCHOPHYS, V49, P227, DOI 10.3758/BF03214307; KINCHLA RA, 1995, PERCEPT PSYCHOPHYS, V57, P441, DOI 10.3758/BF03213070; Koch C, 2007, TRENDS COGN SCI, V11, P16, DOI 10.1016/j.tics.2006.10.012; Kouider S, 2010, TRENDS COGN SCI, V14, P301, DOI 10.1016/j.tics.2010.04.006; Lamme VAF, 2003, TRENDS COGN SCI, V7, P12, DOI 10.1016/S1364-6613(02)00013-X; Lamme VAF, 2006, TRENDS COGN SCI, V10, P494, DOI 10.1016/j.tics.2006.09.001; Luck SJ, 2013, TRENDS COGN SCI, V17, P391, DOI 10.1016/j.tics.2013.06.006; Ma WJ, 2014, NAT NEUROSCI, V17, P347, DOI 10.1038/nn.3655; Pertzov Y, 2013, J EXP PSYCHOL HUMAN, V39, P1224, DOI 10.1037/a0030947; Pestilli F, 2005, VISION RES, V45, P1867, DOI 10.1016/j.visres.2005.01.019; Prinzmetal W, 2008, PERCEPT PSYCHOPHYS, V70, P1139, DOI 10.3758/PP.70.7.1139; ROCK I, 1981, J EXP PSYCHOL HUMAN, V7, P275, DOI 10.1037/0096-1523.7.2.275; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sergent C, 2005, NAT NEUROSCI, V8, P1391, DOI 10.1038/nn1549; Sergent C, 2004, PSYCHOL SCI, V15, P720, DOI 10.1111/j.0956-7976.2004.00748.x; Sergent C, 2012, ARCH ITAL BIOL, V150, P91, DOI 10.4449/aib.v150i2.1270; Sergent C, 2013, CURR BIOL, V23, P150, DOI 10.1016/j.cub.2012.11.047; Sligte IG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001699; Sperling G, 1960, PSYCHOL MONOGRAPHS; Tanaka Y, 1998, P NATL ACAD SCI USA, V95, P12729, DOI 10.1073/pnas.95.21.12729; Tsuchiya N, 2005, NAT NEUROSCI, V8, P1096, DOI 10.1038/nn1500; van den Berg R, 2014, PSYCHOL REV, V121, P124, DOI 10.1037/a0035234; van den Berg R, 2012, P NATL ACAD SCI USA, V109, P8780, DOI 10.1073/pnas.1117465109; Vogel EK, 2005, J COGNITIVE NEUROSCI, V17, P1907, DOI 10.1162/089892905775008599; Yeshurun Y, 2008, VISION RES, V48, P80, DOI 10.1016/j.visres.2007.10.015; Zhang WW, 2008, NATURE, V453, P233, DOI 10.1038/nature06860	38	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148504	10.1371/journal.pone.0148504	http://dx.doi.org/10.1371/journal.pone.0148504			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863625	Green Published, gold, Green Submitted			2022-12-27	WOS:000370046600078
J	Mohan, I; Gupta, R; Misra, A; Sharma, KK; Agrawal, A; Vikram, NK; Sharma, V; Shrivastava, U; Pandey, RM				Mohan, Indu; Gupta, Rajeev; Misra, Anoop; Sharma, Krishna Kumar; Agrawal, Aachu; Vikram, Naval K.; Sharma, Vinita; Shrivastava, Usha; Pandey, Ravindra M.			Disparities in Prevalence of Cardiometablic Risk Factors in Rural, Urban-Poor, and Urban-Middle Class Women in India	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; GLOBAL BURDEN; TRANSITION; HEALTH; EPIDEMIOLOGY; POPULATION; COUNTRIES; MORTALITY	Objective Urbanization is an important determinant of cardiovascular disease (CVD) risk. To determine location-based differences in CVD risk factors in India we performed studies among women in rural, urban-poor and urban middle-class locations. Methods Population-based cross-sectional studies in rural, urban-poor, and urban-middle class women (35-70y) were performed at multiple sites. We evaluated 6853 women (rural 2616, 5 sites; urban-poor 2008, 4 sites; urban middle-class 2229, 11 sites) for socioeconomic, lifestyle, anthropometric and biochemical risk factors. Descriptive statistics are reported. Results Mean levels of body mass index (BMI), waist circumference, waist-hip ratio (WHR), systolic BP, fasting glucose and cholesterol in rural, urban-poor and urban-middle class women showed significantly increasing trends (ANOVA(trend), p < 0.001). Age-adjusted prevalence of diabetes and risk factors among rural, urban-poor and urban-middle class women, respectively was, diabetes (2.2, 9.3, 17.7%), overweight BMI >= 25 kg/m(2) (22.5, 45.6, 57.4%), waist >80 cm (28.3, 63.4, 61.9%), waist >90 cm (8.4, 31.4, 38.2%), waist hip ratio (WHR) >0.8 (60.4, 90.7, 88.5), WHR>0.9 (13.0, 44.3, 56.1%), hypertension (31.6, 48.2, 59.0%) and hypercholesterolemia (13.5, 27.7, 37.4%) (Mantel Haenszel X-2 p(trend) < 0.01). Inverse trend was observed for tobacco use (41.6, 19.6, 9.4%). There was significant association of hypertension, hypercholesterolemia and diabetes with overweight and obesity (adjusted R-2 0.89-0.99). Conclusions There are significant location based differences in cardiometabolic risk factors in India. The urban-middle class women have the highest risk compared to urban-poor and rural.	[Mohan, Indu] RUHS Coll Med Sci, Dept Prevent & Social Med, Jaipur, Rajasthan, India; [Gupta, Rajeev] Fortis Escorts Hosp, Dept Med, Jaipur, Rajasthan, India; [Misra, Anoop; Shrivastava, Usha] Fortis C DOC Ctr Excellence, Dept Diabet & Metab Dis, Chiragh Enclave, New Delhi, India; [Sharma, Krishna Kumar] Rajasthan Univ Hlth Sci, Dept Pharmacol, Jaipur, Rajasthan, India; [Agrawal, Aachu] Univ Rajasthan, Dept Home Sci, Jaipur 302004, Rajasthan, India; [Vikram, Naval K.] All India Inst Med Sci, Dept Med, New Delhi 110029, India; [Sharma, Vinita] Govt India, Dept Sci & Technol, Sci & Soc Div, New Delhi, India; [Pandey, Ravindra M.] All India Inst Med Sci, Dept Biostat, New Delhi, India	Fortis Escorts Hospital; University of Rajasthan; All India Institute of Medical Sciences (AIIMS) New Delhi; Department of Science & Technology (India); All India Institute of Medical Sciences (AIIMS) New Delhi	Gupta, R (corresponding author), Fortis Escorts Hosp, Dept Med, Jaipur, Rajasthan, India.	rajeevgg@gmail.com			Science and Society Division, Department of Science and Technology, Government of India, New Delhi, India; South Asian Society for Atherosclerosis and Thrombosis, Bangalore, India	Science and Society Division, Department of Science and Technology, Government of India, New Delhi, India(Department of Science & Technology (India)); South Asian Society for Atherosclerosis and Thrombosis, Bangalore, India	The studies were funded by Science and Society Division, Department of Science and Technology, Government of India, New Delhi, India; and South Asian Society for Atherosclerosis and Thrombosis, Bangalore, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The studies are financially supported by Science and Society Division, Department of Science and Technology, Government of India, New Delhi; and South Asian Society for Atherosclerosis and Thrombosis, Bangalore, India.	Ahuja R, 1999, SOC INDIA CONCEPTS T; Allender S, 2011, J URBAN HEALTH, V88, P906, DOI 10.1007/s11524-011-9586-1; Allender S, 2010, B WORLD HEALTH ORGAN, V88, P297, DOI 10.2471/BLT.09.065847; Anand SS, 2008, EUR HEART J, V29, P932, DOI 10.1093/eurheartj/ehn018; [Anonymous], 2009, REP CAUS DEATH IND 2; BarrettConnor E, 1997, CIRCULATION, V95, P252, DOI 10.1161/01.CIR.95.1.252; Bhan N, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001348; Bharathi AV, 2000, INDIAN J MED RES, V111, P95; Cockerham WC, 2007, SOCIAL CAUSES HLTH D, p[25, 102]; Defo BK, 2014, GLOB HLTH ACTION, V7; Ezzati M, 2005, PLOS MED, V2, P404, DOI 10.1371/journal.pmed.0020133; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gupta R, 2008, HEART, V94, P16, DOI 10.1136/hrt.2007.132951; GUPTA R, 1994, BRIT MED J, V309, P1332, DOI 10.1136/bmj.309.6965.1332; Gupta R, 1997, NATL MED J INDIA, V10, P139; Gupta R, 1995, Indian Heart J, V47, P331; Gupta R, 2012, PLOS ONE, V7; Gupta R, 2015, J GLOB HEALTH, V5, P150, DOI 10.7189/jogh.05.010411; Gupta R, 2012, WORLD J CARDIOL, V4, P112, DOI 10.4330/wjc.v4.i4.112; Gupta Rajeev, 2009, Indian Heart J, V61, P358; Joshi P, 2007, JAMA-J AM MED ASSOC, V297, P286, DOI 10.1001/jama.297.3.286; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; Krishna A., 2010, ONE ILLNESS AWAY WHY; Liu YL, 1998, HEALTH POLICY, V44, P103, DOI 10.1016/S0168-8510(98)00010-4; Luepkar RV, 2002, CARDIOVASCULAR SURVE; Marmot M, 2002, STRESS AND THE HEART: PSYCHOSOCIAL PATHWAYS TO CORONARY HEART DISEASE, P5; McKinsey Global Institute, 2010, INDIAS URBAN AWAKENI; Misra A, 2001, INT J OBESITY, V25, P1722, DOI 10.1038/sj.ijo.0801748; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Pandey RM, 2013, INT J CARDIOL, V163, P157, DOI 10.1016/j.ijcard.2011.06.008; Prabhakaran D, 2013, INT J EPIDEMIOL, V42, P1431, DOI 10.1093/ije/dyt119; Rydin Y, 2012, LANCET, V379, P2079, DOI 10.1016/S0140-6736(12)60435-8; Satija A, 2015, PUBLIC HEALTH NUTR, V18; Sullivan R, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-13; Task Force on Noncommunicable Diseases, 2014, EM CRIS NONC DIS; Vaz M, 2009, ASIA PAC J CLIN NUTR, V18, P71; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	40	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149437	10.1371/journal.pone.0149437	http://dx.doi.org/10.1371/journal.pone.0149437			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881429	Green Submitted, gold, Green Published			2022-12-27	WOS:000371219000075
J	Seoane, IV; Ortiz, AM; Piris, L; Lamana, A; Juarranz, Y; Garcia-Vicuna, R; Gonzalez-Alvaro, I; Gomariz, RP; Martinez, C				Seoane, Iria V.; Ortiz, Ana M.; Piris, Lorena; Lamana, Amalia; Juarranz, Yasmina; Garcia-Vicuna, Rosario; Gonzalez-Alvaro, Isidoro; Gomariz, Rosa P.; Martinez, Carmen			Clinical Relevance of VPAC1 Receptor Expression in Early Arthritis: Association with IL-6 and Disease Activity	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; EARLY RHEUMATOID-ARTHRITIS; RHEUMATOLOGY/EUROPEAN LEAGUE; SYNOVIAL FIBROBLASTS; AUTOIMMUNE-DISEASES; ALTERED EXPRESSION; AMERICAN-COLLEGE; IMMUNE CELLS; TASK-FORCE; MICE	Background The vasoactive intestinal peptide (VIP) receptors VPAC1 and VPAC2 mediate anti-inflammatory and immunoregulatory responses in rheumatoid arthritis (RA). Data on the expression of these receptors could complement clinical assessment in the management of RA. Our goal was to investigate the correlation between expression of both receptors and the 28-Joint Disease Activity Score (DAS28) in peripheral blood mononuclear cells (PBMCs) from patients with early arthritis (EA). We also measured expression of IL-6 to evaluate the association between VIP receptors and systemic inflammation. Methods We analyzed 250 blood samples collected at any of the 5 scheduled follow-up visits from 125 patients enrolled in the Princesa Early Arthritis Register Longitudinal study. Samples from 22 healthy donors were also analyzed. Sociodemographic, clinical, and therapeutic data were systematically recorded. mRNA expression levels were determined using real-time PCR. Then, longitudinal multivariate analyses were performed. Results PBMCs from EA patients showed significantly higher expression of VPAC2 receptors at baseline compared to healthy donors (p<0.001). With time, however, VPAC2 expression tended to be significantly lower while VPAC1 receptor expression increased in correlation with a reduction in DAS28 index. Our results reveal that more severe inflammation, based on high levels of IL-6, is associated with lower expression of VPAC1 (p<0.001) and conversely with increased expression of VPAC2 (p<0.001). A major finding of this study is that expression of VPAC1 is lower in patients with increased disease activity (p = 0.001), thus making it possible to differentiate between patients with various degrees of clinical disease activity. Conclusion Patients with more severe inflammation and higher disease activity show lower levels of VPAC1 expression, which is associated with patient-reported impairment. Therefore, VPAC1 is a biological marker in EA.	[Seoane, Iria V.; Juarranz, Yasmina; Gomariz, Rosa P.] Univ Complutense Madrid, Fac Biol, Dept Biol Celular, E-28040 Madrid, Spain; [Ortiz, Ana M.; Lamana, Amalia; Garcia-Vicuna, Rosario; Gonzalez-Alvaro, Isidoro] Hosp Univ Princesa, Inst Invest Sanitaria Princesa, Serv Reumatol, Madrid, Spain; [Piris, Lorena] Hosp Univ Princesa, Inst Invest Sanitaria Princesa, Unidad Apoyo Metodol, Madrid, Spain; [Martinez, Carmen] Univ Complutense Madrid, Dept Biol Celular, Fac Med, Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid	Martinez, C (corresponding author), Univ Complutense Madrid, Dept Biol Celular, Fac Med, Madrid, Spain.	cmmora@bio.ucm.es	Juarranz, Yasmina/H-5545-2019; LAMANA, AMALIA/I-6971-2017; de VicuÃa, Rosario Garcia/ABD-7892-2020; Juarranz, Yasmina/H-7942-2016; Martínez, Carmen/AAC-2077-2020	Juarranz, Yasmina/0000-0001-5886-8273; LAMANA, AMALIA/0000-0001-8779-5034; de VicuÃa, Rosario Garcia/0000-0001-9096-3780; Juarranz, Yasmina/0000-0001-5886-8273; 	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III - Fondo Europeo de Desarrollo Regional (FEDER) [PI14/00477, PI14/001236, PI11/00195, PI11/00505, PI12/0758, RD12/0009]; FEDER funds from EU; Comunidad de Madrid [S2010/BMD-2350]	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III - Fondo Europeo de Desarrollo Regional (FEDER); FEDER funds from EU; Comunidad de Madrid(Comunidad de Madrid)	This work was supported by the Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III (Grant No PI14/00477, PI14/001236, PI11/00195, PI11/00505, PI12/0758, RD12/0009) cofinanced by Fondo Europeo de Desarrollo Regional (FEDER), and by FEDER funds from EU, S2010/BMD-2350 from Comunidad de Madrid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2009, ARTHRIT RHEUM-ARTHR, V61, P313, DOI 10.1002/art.24282; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Carrion M, 2011, ARTHRITIS RHEUM-US, V63, P1626, DOI 10.1002/art.30294; Castrejon I, 2008, CLIN EXP RHEUMATOL, V26, P769; Centola M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060635; Choy E, 2012, CURR MED RES OPIN, V28, P1733, DOI 10.1185/03007995.2012.731388; Combe B, 2007, ANN RHEUM DIS, V66, P34, DOI 10.1136/ard.2005.044354; Couvineau A, 2012, BRIT J PHARMACOL, V166, P42, DOI 10.1111/j.1476-5381.2011.01676.x; Delgado M, 2002, J MOL MED, V80, P16, DOI 10.1007/s00109-001-0291-5; Delgado M, 2008, BRAIN BEHAV IMMUN, V22, P1146, DOI 10.1016/j.bbi.2008.06.001; Delgado M, 2008, ARTHRITIS RHEUM-US, V58, P1010, DOI 10.1002/art.23482; Dorsam Glenn Paul, 2011, World J Biol Chem, V2, P146, DOI 10.4331/wjbc.v2.i6.146; Eriksson C, 2013, SCAND J RHEUMATOL, V42, P260, DOI 10.3109/03009742.2012.754937; Felson DT, 2011, ARTHRITIS RHEUM-US, V63, P573, DOI 10.1002/art.30129; Ganea D, 2015, ACTA PHYSIOL, V213, P442, DOI 10.1111/apha.12427; Goetzl EJ, 2001, P NATL ACAD SCI USA, V98, P13854, DOI 10.1073/pnas.241503798; Gomariz RP, 2001, CURR PHARM DESIGN, V7, P89, DOI 10.2174/1381612013398374; Gonzalez-Alvaro I, 2015, CURR PHARM DESIGN, V21, P170; Gonzalez-Rey E, 2007, ANN RHEUM DIS, V66, P70, DOI 10.1136/ard.2007.078519; Gutierrez-Canas I, 2008, BRAIN BEHAV IMMUN, V22, P312, DOI 10.1016/j.bbi.2007.09.007; Hauk V, 2014, CLIN EXP IMMUNOL, V177, P662, DOI 10.1111/cei.12378; Heiberg T, 2008, ANN RHEUM DIS, V67, P967, DOI 10.1136/ard.2007.077503; Jimeno R, 2015, J LEUKOCYTE BIOL, V98, P257, DOI 10.1189/jlb.3A0714-327R; Jimeno R, 2015, J MOL MED, V93, P457, DOI 10.1007/s00109-014-1232-4; Juarranz MG, 2004, RHEUMATOLOGY, V43, P416, DOI 10.1093/rheumatology/keh061; Juarranz Y, 2005, ARTHRITIS RES THER, V7, pR1034, DOI 10.1186/ar1779; Juarranz Y, 2008, ARTHRITIS RHEUM, V58, P1086, DOI 10.1002/art.23403; Keystone EC, 2012, RHEUMATOLOGY, V51, pV48, DOI 10.1093/rheumatology/kes122; Kirwan John R, 2005, J Rheumatol, V32, P2250; Lara-Marquez ML, 2001, J IMMUNOL, V166, P2522, DOI 10.4049/jimmunol.166.4.2522; Martinez C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085248; Nishimoto N, 2006, NAT CLIN PRACT RHEUM, V2, P619, DOI 10.1038/ncprheum0338; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Shimamoto K, 2013, J RHEUMATOL, V40, P1074, DOI 10.3899/jrheum.121389; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Sun W, 2006, INT IMMUNOL, V18, P1691, DOI 10.1093/intimm/dxl103; Tan YV, 2015, BRAIN BEHAV IMMUN, V44, P167, DOI 10.1016/j.bbi.2014.09.020; VANLEEUWEN MA, 1993, BRIT J RHEUMATOL, V32, P9; Voice JK, 2003, J IMMUNOL, V170, P308, DOI 10.4049/jimmunol.170.1.308; Zhao PW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095346	41	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149141	10.1371/journal.pone.0149141	http://dx.doi.org/10.1371/journal.pone.0149141			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881970	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000371219000050
J	Forero-Castro, M; Robledo, C; Benito, R; Abaigar, M; Martin, AA; Arefi, M; Fuster, JL; de las Heras, N; Rodriguez, JN; Quintero, J; Riesco, S; Hermosin, L; de la Fuente, I; Recio, I; Ribera, J; Labrador, J; Alonso, JM; Olivier, C; Sierra, M; Megido, M; Corchete-Sanchez, LA; Pizarro, JC; Garcia, JL; Ribera, JM; Hernandez-Rivas, JM				Forero-Castro, Maribel; Robledo, Cristina; Benito, Rocio; Abaigar, Maria; Africa Martin, Ana; Arefi, Maryam; Luis Fuster, Jose; de las Heras, Natalia; Rodriguez, Juan N.; Quintero, Jonathan; Riesco, Susana; Hermosin, Lourdes; de la Fuente, Ignacio; Recio, Isabel; Ribera, Jordi; Labrador, Jorge; Alonso, Jose M.; Olivier, Carmen; Sierra, Magdalena; Megido, Marta; Corchete-Sanchez, Luis A.; Ciudad Pizarro, Juana; Luis Garcia, Juan; Ribera, Jose M.; Hernandez-Rivas, Jesus M.			Genome-Wide DNA Copy Number Analysis of Acute Lymphoblastic Leukemia Identifies New Genetic Markers Associated with Clinical Outcome	PLOS ONE			English	Article							CHEMOTHERAPY INCLUDING RITUXIMAB; MINIMAL RESIDUAL DISEASE; CONCERTED ACTION REPORT; CHROMOSOMAL REARRANGEMENTS; GLUCOCORTICOID RESISTANCE; PEDIATRIC DISEASE; CANCER GENOMES; CHROMOTHRIPSIS; HYBRIDIZATION; CHILDHOOD	Identifying additional genetic alterations associated with poor prognosis in acute lymphoblastic leukemia (ALL) is still a challenge. Aims: To characterize the presence of additional DNA copy number alterations (CNAs) in children and adults with ALL by whole-genome oligonucleotide array (aCGH) analysis, and to identify their associations with clinical features and outcome. Array-CGH was carried out in 265 newly diagnosed ALLs (142 children and 123 adults). The NimbleGen CGH 12x135K array (Roche) was used to analyze genetic gains and losses. CNAs were analyzed with GISTIC and aCGHweb software. Clinical and biological variables were analyzed. Three of the patients showed chromothripsis (cth6, cth14q and cth15q). CNAs were associated with age, phenotype, genetic subtype and overall survival (OS). In the whole cohort of children, the losses on 14q32.33 (p = 0.019) and 15q13.2 (p = 0.04) were related to shorter OS. In the group of children without good-or poor-risk cytogenetics, the gain on 1p36.11 was a prognostic marker independently associated with shorter OS. In adults, the gains on 19q13.2 (p = 0.001) and Xp21.1 (p = 0.029), and the loss of 17p (p = 0.014) were independent markers of poor prognosis with respect to OS. In summary, CNAs are frequent in ALL and are associated with clinical parameters and survival. Genome-wide DNA copy number analysis allows the identification of genetic markers that predict clinical outcome, suggesting that detection of these genetic lesions will be useful in the management of patients newly diagnosed with ALL.	[Forero-Castro, Maribel; Robledo, Cristina; Benito, Rocio; Abaigar, Maria; Africa Martin, Ana; Hernandez-Rivas, Jesus M.] Univ Salamanca, CSIC, IBMCC, IBSAL,Canc Res Ctr, E-37008 Salamanca, Spain; [Forero-Castro, Maribel] Pedag & Technol Univ Colombia UPTC, Sch Biol Sci GEBIMOL, Tunja, Colombia; [Africa Martin, Ana; Corchete-Sanchez, Luis A.; Hernandez-Rivas, Jesus M.] Univ Hosp Salamanca, Dept Hematol, Salamanca, Spain; [Arefi, Maryam] Clin Univ Hosp Valladolid, Dept Hematol, Valladolid, Spain; [Luis Fuster, Jose] Clin Univ Hosp Virgen Arrixaca, Dept Pediat Oncohematol, Murcia, Spain; [de las Heras, Natalia] Virgen Blanca Hosp, Dept Hematol, Leon, Spain; [Rodriguez, Juan N.] Juan Raman Jimenez Hosp, Dept Hematol, Huelva, Spain; [Quintero, Jonathan] Miguel Servet Hosp, Dept Hematol, Zaragoza, Spain; [Riesco, Susana] Univ Hosp Salamanca, Dept Pediat Oncohematol, Salamanca, Spain; [Hermosin, Lourdes] Jerez Hosp, Jerez Frontera, Dept Hematol, Cadiz, Spain; [de la Fuente, Ignacio] Rio Hortega Hosp, Dept Hematol, Valladolid, Spain; [Recio, Isabel] Nuestra Senora Sonsoles Hosp, Dept Hematol, Avila, Spain; [Ribera, Jordi] Josep Carreras Res Inst, ICO Hosp Germans Trias & Pujol, Dept Hematol, Badalona, Spain; [Labrador, Jorge; Ribera, Jose M.] Univ Hosp Burgos, Dept Hematol, Burgos, Spain; [Alonso, Jose M.] Rio Carrion Hosp, Dept Hematol, Palencia, Spain; [Olivier, Carmen] Gen Hosp Segovia, Dept Hematol, Segovia, Spain; [Sierra, Magdalena] Virgen Concha Hosp, Dept Hematol, Zamora, Spain; [Megido, Marta] Bierzo Hosp, Dept Hematol, Leon Ponferrada, Spain; [Ciudad Pizarro, Juana] USAL, Cytometry Serv NUCLEUS Res Support Platform, Salamanca, Spain; [Luis Garcia, Juan] Inst Hlth Sci Studies Castile & Leon IESCYL, Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Universidad Pedagogica y Tecnologica de Colombia (UPTC); University of Salamanca; Hospital Clinico Universitario Virgen de la Arrixaca; Miguel Servet University Hospital; Hospital del Rio Hortega; Catalan Institute of Oncology; Institut de Recerca Contra la Leucemia Josep Carreras (IJC); University of Salamanca	Hernandez-Rivas, JM (corresponding author), Univ Salamanca, CSIC, IBMCC, IBSAL,Canc Res Ctr, E-37008 Salamanca, Spain.; Hernandez-Rivas, JM (corresponding author), Univ Hosp Salamanca, Dept Hematol, Salamanca, Spain.	jmhr@usal.es	Sánchez, Luis Antonio Corchete/D-1336-2018; Forero-Castro, Maribel/O-6035-2019; Alvarado, María Abáigar/V-9309-2017; Ribera, Jordi/K-6597-2014; Robledo Montero, Cristina/B-4495-2017; Ribera, JM/B-8181-2009; Hernández, Jesus M/B-5459-2017; BENITO, ROCIO/B-4271-2017; garcia, Juan/B-4617-2017; Riesco, Susana/AAF-7159-2021	Sánchez, Luis Antonio Corchete/0000-0003-4577-8599; Alvarado, María Abáigar/0000-0002-5716-6242; Ribera, Jordi/0000-0003-4796-6470; Robledo Montero, Cristina/0000-0003-0445-3210; Ribera, JM/0000-0003-1042-6024; Hernández, Jesus M/0000-0002-9661-9371; BENITO, ROCIO/0000-0001-9781-4198; garcia, Juan/0000-0002-2146-5726; DE LA FUENTE GRACIANI, IGNACIO/0000-0001-5381-820X; Forero-Castro, Maribel/0000-0002-5205-8891	European Union [306242-NGS-PTL]; Fundacion Castellano Leonesa de Hematologia y Hemoterapia (FUCALHH); Consejeria de Educacion, Junta de Castilla y Leon [HUS272U13]; Proyectos de Investigacion del SACYL, Spain [GRS 994/A/14, BIO/SA10/14, BIO/SA31/13]; Spanish Fondo de Investigaciones Sanitarias [FIS 09/01543, PI12/00281]; COST Action EuGESMA [BM0801]; Fundacion Espanola de Hematologia y Hemoterapia (FEHH); Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III (ISCIII) [RD12/0036/0069]; Spanish Ministry of Economy and Competitiveness; European Regional Development Fund (ERDF) "Una manera de hacer Europa" (Innocampus) [CEI-2010-1-0010]; Universidad Pedagogica y Tecnologica de Colombia, Colombia [223-2011]	European Union(European Commission); Fundacion Castellano Leonesa de Hematologia y Hemoterapia (FUCALHH); Consejeria de Educacion, Junta de Castilla y Leon(Junta de Castilla y Leon); Proyectos de Investigacion del SACYL, Spain; Spanish Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); COST Action EuGESMA(European Cooperation in Science and Technology (COST)); Fundacion Espanola de Hematologia y Hemoterapia (FEHH); Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III (ISCIII); Spanish Ministry of Economy and Competitiveness(Spanish Government); European Regional Development Fund (ERDF) "Una manera de hacer Europa" (Innocampus); Universidad Pedagogica y Tecnologica de Colombia, Colombia	The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no306242-NGS-PTL, the Fundacion Castellano Leonesa de Hematologia y Hemoterapia (FUCALHH 2013), the Consejeria de Educacion, Junta de Castilla y Leon (HUS272U13), Proyectos de Investigacion del SACYL, Spain: GRS 994/A/14, BIO/SA10/14, BIO/SA31/13. The work was partially supported by grants from the Spanish Fondo de Investigaciones Sanitarias FIS 09/01543, PI12/00281, COST Action EuGESMA (BM0801), Fundacion Espanola de Hematologia y Hemoterapia (FEHH), and by grants (RD12/0036/0069) from the Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III (ISCIII), the Spanish Ministry of Economy and Competitiveness and the European Regional Development Fund (ERDF) "Una manera de hacer Europa" (Innocampus; CEI-2010-1-0010). MFC was supported by study commission (no. 223-2011) granted by the Universidad Pedagogica y Tecnologica de Colombia, Colombia.	Agueli C, 2010, AM J HEMATOL, V85, P575, DOI 10.1002/ajh.21758; Bacher U, 2009, CANCER GENET CYTOGEN, V188, P108, DOI 10.1016/j.cancergencyto.2008.09.004; Baughn LB, 2015, CANCER GENET-NY, V208, P1, DOI 10.1016/j.cancergen.2014.11.003; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Bhojwani D, 2015, PEDIATR CLIN N AM, V62, P47, DOI 10.1016/j.pcl.2014.09.004; Bokemeyer A, 2014, HAEMATOLOGICA, V99, P706, DOI 10.3324/haematol.2012.072470; Bungaro S, 2009, GENE CHROMOSOME CANC, V48, P22, DOI 10.1002/gcc.20616; Cai H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-82; Chiaretti S, 2013, HAEMATOLOGICA, V98, pE59, DOI 10.3324/haematol.2012.076786; Dawson AJ, 2011, CURR ONCOL, V18, pE210; DICCIANNI MB, 1994, BLOOD, V84, P3105; Forment JV, 2012, NAT REV CANCER, V12, P663, DOI 10.1038/nrc3352; Garcia JL, 2003, LEUKEMIA, V17, P2016, DOI 10.1038/sj.leu.2403080; Harrison CJ, 2015, BLOOD, V125, P1383, DOI 10.1182/blood-2014-08-569228; Hatch EM, 2015, CURR BIOL, V25, pR397, DOI 10.1016/j.cub.2015.02.033; Hof J, 2011, J CLIN ONCOL, V29, P3185, DOI 10.1200/JCO.2011.34.8144; Iacobucci I, 2012, CURR HEMATOL MALIG R, V7, P133, DOI 10.1007/s11899-012-0122-5; Jones CL, 2014, J BIOL CHEM, V289, P20502, DOI 10.1074/jbc.M114.569889; Jones MJK, 2012, DEV CELL, V23, P908, DOI 10.1016/j.devcel.2012.10.010; Kawamata N, 2008, BLOOD, V111, P776, DOI 10.1182/blood-2007-05-088310; Kinsella M, 2014, NUCLEIC ACIDS RES, V42, P8231, DOI 10.1093/nar/gku525; Kloosterman WP, 2014, CURR OPIN ONCOL, V26, P64, DOI 10.1097/CCO.0000000000000038; Korbel JO, 2013, CELL, V152, P1226, DOI 10.1016/j.cell.2013.02.023; Kowalczyk JR, 2010, CANCER GENET CYTOGEN, V200, P161, DOI 10.1016/j.cancergencyto.2010.04.016; Krijgsman O, 2012, GENE CHROMOSOME CANC, V51, P344, DOI 10.1002/gcc.21920; Kuchinskaya E, 2008, BRIT J HAEMATOL, V140, P572, DOI 10.1111/j.1365-2141.2007.06917.x; Kuiper RP, 2007, LEUKEMIA, V21, P1258, DOI 10.1038/sj.leu.2404691; Lai W, 2008, BIOINFORMATICS, V24, P1014, DOI 10.1093/bioinformatics/btn067; Li YL, 2014, NATURE, V508, P98, DOI 10.1038/nature13115; Lucio P, 2001, LEUKEMIA, V15, P1185, DOI 10.1038/sj.leu.2402150; Michels E, 2007, GENET MED, V9, P574, DOI 10.1097/GIM.0b013e318145b25b; Moorman AV, 2012, J CLIN ONCOL, V30, P3100, DOI 10.1200/JCO.2011.40.3907; Muhlbacher V, 2016, LEUKEMIA, V30, P318, DOI 10.1038/leu.2015.276; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2012, HEMATOL-AM SOC HEMAT, P389, DOI 10.1182/asheducation-2012.1.389; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Mullighan CG, 2009, SEMIN HEMATOL, V46, P3, DOI 10.1053/j.seminhematol.2008.09.005; Neale GAM, 2004, LEUKEMIA, V18, P934, DOI 10.1038/sj.leu.2403348; O'Reilly J, 2013, PATHOLOGY, V45, P609, DOI 10.1097/PAT.0b013e3283653bd1; Okamoto R, 2010, HAEMATOL-HEMATOL J, V95, P1481, DOI 10.3324/haematol.2009.011114; Olsson L, 2014, LEUKEMIA, V28, P302, DOI 10.1038/leu.2013.206; Othman Moneeb A K, 2014, Leuk Res Treatment, V2014, P357123, DOI 10.1155/2014/357123; Paulsson K, 2008, P NATL ACAD SCI USA, V105, P6708, DOI 10.1073/pnas.0800408105; Paulsson K, 2015, NAT GENET, V47, P672, DOI 10.1038/ng.3301; Pellestor F, 2014, M S-MED SCI, V30, P266, DOI 10.1051/medsci/20143003014; Ploner C, 2005, J STEROID BIOCHEM, V93, P153, DOI 10.1016/j.jsbmb.2004.12.017; Porwit-MacDonald A, 2000, LEUKEMIA, V14, P816, DOI 10.1038/sj.leu.2401741; Pui CH, 1998, NEW ENGL J MED, V339, P605, DOI 10.1056/NEJM199808273390907; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Rabin KR, 2008, PEDIATR BLOOD CANCER, V51, P171, DOI 10.1002/pbc.21488; Ribera JM, 2013, CANCER-AM CANCER SOC, V119, P1660, DOI 10.1002/cncr.27918; Roberts KG, 2015, NAT REV CLIN ONCOL, V12, P344, DOI 10.1038/nrclinonc.2015.38; Safavi S, 2015, HAEMATOLOGICA, V100, P55, DOI 10.3324/haematol.2014.112912; Sorzano COS, 2013, CELL CYCLE, V12, P2016, DOI 10.4161/cc.25266; Simons A, 2011, GENE CHROMOSOME CANC, V50, P969, DOI 10.1002/gcc.20919; Steinemann D, 2008, GENE CHROMOSOME CANC, V47, P471, DOI 10.1002/gcc.20557; Strefford JC, 2007, ONCOGENE, V26, P4306, DOI 10.1038/sj.onc.1210190; Strefford Jon C., 2009, V538, P151, DOI 10.1007/978-1-59745-418-6_8; Usvasalo A, 2010, LEUKEMIA RES, V34, P1476, DOI 10.1016/j.leukres.2010.02.031; Usvasalo A, 2009, CANCER GENET CYTOGEN, V192, P10, DOI 10.1016/j.cancergencyto.2009.02.015; van Dongen JJM, 2012, LEUKEMIA, V26, P1908, DOI 10.1038/leu.2012.120; Wang Chang, 2008, Zhonghua Nei Ke Za Zhi, V47, P111; Woo JS, 2014, EXP HEMATOL ONCOL, V3, DOI 10.1186/2162-3619-3-16; Wyatt AW, 2013, J PATHOL, V231, P1, DOI 10.1002/path.4220; Xicoy B, 2014, LEUKEMIA LYMPHOMA, V55, P2341, DOI 10.3109/10428194.2013.878933; Yasar D, 2010, CANCER GENET CYTOGEN, V197, P122, DOI 10.1016/j.cancergencyto.2009.11.018; Zakaria Z, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-41; Zhang CZ, 2013, GENE DEV, V27, P2513, DOI 10.1101/gad.229559.113; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087637	70	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148972	10.1371/journal.pone.0148972	http://dx.doi.org/10.1371/journal.pone.0148972			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872047	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100082
J	Silvestre, A; Sarlet, M; Huart, J; Dardenne, B				Silvestre, Aude; Sarlet, Marie; Huart, Johanne; Dardenne, Benoit			Benevolent Ideology and Women's Economic Decision-Making: When Sexism Is Hurting Men's Wallet	PLOS ONE			English	Article							BARGAINING EXPERIMENTS; AGENTIC WOMEN; AMBIVALENT; HOSTILE; PRESCRIPTION; STEREOTYPES; INVENTORY; ATTITUDES; BACKLASH; FACES	Can ideology, as a widespread "expectation creator," impact economic decisions? In two studies we investigated the influence of the Benevolent Sexism (BS) ideology (which dictates that men should provide for passive and nurtured women) on women's economic decision-making. In Study 1, using a Dictator Game in which women decided how to share amounts of money with men, results of a Generalized Linear Mixed Model analysis show that higher endorsement of BS and contextual expectations of benevolence were associated with more very unequal offers. Similarly, in an Ultimatum Game in which women received monetary offers from men, Study 2's Generalized Linear Mixed Model's results revealed that BS led women to reject more very unequal offers. If women's endorsement of BS ideology and expectations of benevolence prove contrary to reality, they may strike back at men. These findings show that BS ideology creates expectations that shape male-female relationships in a way that could be prejudicial to men.	[Silvestre, Aude; Sarlet, Marie; Huart, Johanne; Dardenne, Benoit] Univ Liege, PsyNCog Res Unit, Liege, Belgium; [Silvestre, Aude; Sarlet, Marie] Fonds Rech Sci FNRS, Brussels, Belgium	University of Liege; Fonds de la Recherche Scientifique - FNRS	Dardenne, B (corresponding author), Univ Liege, PsyNCog Res Unit, Liege, Belgium.	b.dardenne@ulg.ac.be		Dardenne, Benoit/0000-0002-4001-7101	Fonds de la Recherche Scientifique	Fonds de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS)	The first and second authors received funding from the Fonds de la Recherche Scientifique (http://www.fnrs.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar F, 2009, EXP ECON, V12, P93, DOI 10.1007/s10683-008-9199-z; [Anonymous], 2008, INQ 3 0 2 0 COMP SOF; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; BARGAD A, 1991, PSYCHOL WOMEN QUART, V15, P181, DOI 10.1111/j.1471-6402.1991.tb00791.x; BEN-NER A., 2008, J SOCIO-ECON, V37, P1775, DOI [DOI 10.1016/J.SOCEC.2007.11.004, 10.1016/j.socec.2007.11.004]; BOLTON GE, 1995, GAME ECON BEHAV, V10, P95, DOI 10.1006/game.1995.1026; Branas-Garza P, 2014, 60046 MUN PERS REPEC; Buhren C, 2015, JUDGM DECIS MAK, V10, P185; Burgoyne C, 2004, FEM PSYCHOL, V14, P165, DOI 10.1177/0959-353504040319; Chang LJ, 2013, SOC COGN AFFECT NEUR, V8, P277, DOI 10.1093/scan/nsr094; Chowdhury SM, 2013, 1306 UEA CTR BEH EXP; Crockett MJ, 2008, SCIENCE, V320, P1739, DOI 10.1126/science.1155577; Dardenne B, 2007, J PERS SOC PSYCHOL, V93, P764, DOI 10.1037/0022-3514.93.5.764; Dardenne B, 2006, ANN PSYCHOL, V106, P235; Dardenne B, 2013, NEUROREPORT, V24, P572, DOI 10.1097/WNR.0b013e3283625b5b; Delacollette N, 2013, SEX ROLES, V68, P296, DOI 10.1007/s11199-012-0232-5; Delacollette N, 2010, ANN PSYCHOL, V110, P127; Dumont M, 2010, SEX ROLES, V62, P545, DOI 10.1007/s11199-008-9582-4; Engel C, 2011, EXP ECON, V14, P583, DOI 10.1007/s10683-011-9283-7; Exposito F, 2010, PSYCHOL WOMEN QUART, V34, P36, DOI 10.1111/j.1471-6402.2009.01539.x; Fischer AR, 2006, PSYCHOL WOMEN QUART, V30, P410, DOI 10.1111/j.1471-6402.2006.00316.x; FORSYTHE R, 1994, GAME ECON BEHAV, V6, P347, DOI 10.1006/game.1994.1021; Glick P, 2004, J PERS SOC PSYCHOL, V86, P713, DOI 10.1037/0022-3514.86.5.713; Glick P, 1996, J PERS SOC PSYCHOL, V70, P491, DOI 10.1037/0022-3514.70.3.491; Glick P, 2001, AM PSYCHOL, V56, P109, DOI 10.1037//0003-066X.56.2.109; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; GUTH W, 1995, J ECON BEHAV ORGAN, V27, P329, DOI 10.1016/0167-2681(94)00071-L; Hebl MR, 2007, J APPL PSYCHOL, V92, P1499, DOI 10.1037/0021-9010.92.6.1499; Jackman M. R, 1994, THE VELVET GLOVE PAT; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Judd CM, 2012, J PERS SOC PSYCHOL, V103, P54, DOI 10.1037/a0028347; Moya M, 2007, PERS SOC PSYCHOL B, V33, P1421, DOI 10.1177/0146167207304790; Phelan JE, 2010, SEX ROLES, V62, P35, DOI 10.1007/s11199-009-9711-8; RENZETTI CM, 1987, SEX ROLES, V16, P265, DOI 10.1007/BF00289954; Rudman LA, 1999, J PERS SOC PSYCHOL, V77, P1004, DOI 10.1037/0022-3514.77.5.1004; Rudman LA, 2001, J SOC ISSUES, V57, P743, DOI 10.1111/0022-4537.00239; Sanfey A.G., 2009, MIND SOC, V8, P93, DOI [10.1007/s11299-009-0053-6, DOI 10.1007/S11299-009-0053-6]; Sarlet M, 2012, PSYCHOL WOMEN QUART, V36, P444, DOI 10.1177/0361684312454842; Todorov A, 2013, CURR OPIN NEUROBIOL, V23, P373, DOI 10.1016/j.conb.2012.12.010; Todorov A, 2009, SOC COGNITION, V27, P813, DOI 10.1521/soco.2009.27.6.813; Viki GT, 2002, SEX ROLES, V47, P289, DOI 10.1023/A:1021342912248	41	3	3	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148629	10.1371/journal.pone.0148629	http://dx.doi.org/10.1371/journal.pone.0148629			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6SI	26870955	Green Submitted, Green Published, gold			2022-12-27	WOS:000370054100041
J	Tallam, A; Perumal, TM; Antony, PM; Jager, C; Fritz, JV; Vallar, L; Balling, R; del Sol, A; Michelucci, A				Tallam, Aravind; Perumal, Thaneer M.; Antony, Paul M.; Jaeger, Christian; Fritz, Joelle V.; Vallar, Laurent; Balling, Rudi; del Sol, Antonio; Michelucci, Alessandro			Gene Regulatory Network Inference of Immunoresponsive Gene 1 (IRG1) Identifies Interferon Regulatory Factor 1 (IRF1) as Its Transcriptional Regulator in Mammalian Macrophages	PLOS ONE			English	Article							NITRIC-OXIDE PRODUCTION; IMMUNE-RESPONSIVE GENE-1; FACTOR-I; IFN-BETA; MYCOBACTERIUM-TUBERCULOSIS; NO SYNTHASE; EXPRESSION; BINDING; PROTEIN; INDUCTION	Immunoresponsive gene 1 (IRG1) is one of the highest induced genes in macrophages under pro-inflammatory conditions. Its function has been recently described: it codes for immune-responsive gene 1 protein/cis-aconitic acid decarboxylase (IRG1/CAD), an enzyme catalysing the production of itaconic acid from cis-aconitic acid, a tricarboxylic acid (TCA) cycle intermediate. Itaconic acid possesses specific antimicrobial properties inhibiting isocitrate lyase, the first enzyme of the glyoxylate shunt, an anaplerotic pathway that bypasses the TCA cycle and enables bacteria to survive on limited carbon conditions. To elucidate the mechanisms underlying itaconic acid production through IRG1 induction in macrophages, we examined the transcriptional regulation of IRG1. To this end, we studied IRG1 expression in human immune cells under different inflammatory stimuli, such as TNF alpha and IFN gamma, in addition to lipopolysaccharides. Under these conditions, as previously shown in mouse macrophages, IRG1/CAD accumulates in mitochondria. Furthermore, using literature information and transcription factor prediction models, we re-constructed raw gene regulatory networks (GRNs) for IRG1 in mouse and human macrophages. We further implemented a contextualization algorithm that relies on genome-wide gene expression data to infer putative cell type-specific gene regulatory interactions in mouse and human macrophages, which allowed us to predict potential transcriptional regulators of IRG1. Among the computationally identified regulators, siRNA-mediated gene silencing of interferon regulatory factor 1 (IRF1) in macrophages significantly decreased the expression of IRG1/CAD at the gene and protein level, which correlated with a reduced production of itaconic acid. Using a synergistic approach of both computational and experimental methods, we here shed more light on the transcriptional machinery of IRG1 expression and could pave the way to therapeutic approaches targeting itaconic acid levels.	[Tallam, Aravind; Perumal, Thaneer M.; Antony, Paul M.; Jaeger, Christian; Fritz, Joelle V.; Balling, Rudi; del Sol, Antonio; Michelucci, Alessandro] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg; [Vallar, Laurent] Luxembourg Inst Hlth, Genom Res Lab, Luxembourg, Luxembourg; [Michelucci, Alessandro] Luxembourg Inst Hlth, NORLUX Neurooncol Lab, Luxembourg, Luxembourg; [Tallam, Aravind] Zentrum Expt & Klin Infekt Forsch, TWINCORE, Hannover, Germany; [Perumal, Thaneer M.] Sage Bionetworks, Seattle, WA USA	University of Luxembourg; Luxembourg Institute of Health; Luxembourg Institute of Health	del Sol, A; Michelucci, A (corresponding author), Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg.; Michelucci, A (corresponding author), Luxembourg Inst Hlth, NORLUX Neurooncol Lab, Luxembourg, Luxembourg.	antonio.delsol@uni.lu; alessandro.michelucci@lih.lu	del Sol, Antonio/M-7431-2017; Antony, Paul/C-8152-2016	del Sol, Antonio/0000-0002-9926-617X; Perumal, Thanneer Malai/0000-0003-1168-8982; Michelucci, Alessandro/0000-0003-1230-061X; Fritz, Joelle/0000-0002-4694-3923; Balling, Rudi/0000-0003-2902-5650; Antony, Paul/0000-0002-0450-9301; Vallar, Laurent/0000-0002-4404-1010	Fondation du Pelican de Mie et Pierre Hippert-Faber under the aegis of Fondation de Luxembourg	Fondation du Pelican de Mie et Pierre Hippert-Faber under the aegis of Fondation de Luxembourg	AT was supported by Fondation du Pelican de Mie et Pierre Hippert-Faber under the aegis of Fondation de Luxembourg.	Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; Aly S, 2009, J CELL MOL MED, V13, P2069, DOI 10.1111/j.1582-4934.2008.00470.x; Basler T, 2006, J LEUKOCYTE BIOL, V79, P628, DOI 10.1189/jlb.0905520; Bertholet S, 1999, J LEUKOCYTE BIOL, V65, P50, DOI 10.1002/jlb.65.1.50; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen B, 2003, MOL ENDOCRINOL, V17, P2340, DOI 10.1210/me.2003-0207; Cheon YP, 2003, ENDOCRINOLOGY, V144, P5623, DOI 10.1210/en.2003-0585; Chiang JH, 2003, BIOINFORMATICS, V19, P1417, DOI 10.1093/bioinformatics/btg160; Cho H, 2013, NAT MED, V19, P458, DOI 10.1038/nm.3108; Crespo I, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-140; Crespo I, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks785; De Smet R, 2010, NAT REV MICROBIOL, V8, P717, DOI 10.1038/nrmicro2419; Degrandi D, 2009, J INTERF CYTOK RES, V29, P55, DOI 10.1089/jir.2008.0013; DING AH, 1988, J IMMUNOL, V141, P2407; Dorsett Y, 2004, NAT REV DRUG DISCOV, V3, P318, DOI 10.1038/nrd1345; Farlik M, 2010, IMMUNITY, V33, P25, DOI 10.1016/j.immuni.2010.07.001; Hall CJ, 2013, CELL METAB, V18, P265, DOI 10.1016/j.cmet.2013.06.018; Hattori Y, 1996, BIOCHEM MOL BIOL INT, V40, P889; Haury AC, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-145; He F, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.56; Hiller K, 2009, ANAL CHEM, V81, P3429, DOI 10.1021/ac802689c; Hirotani T, 2005, BIOCHEM BIOPH RES CO, V328, P383, DOI 10.1016/j.bbrc.2004.12.184; Iglesias MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032306; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; KIMURA T, 1994, SCIENCE, V264, P1921, DOI 10.1126/science.8009222; LEE CGL, 1995, IMMUNOGENETICS, V41, P263, DOI 10.1007/BF00172150; Li YL, 2013, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2013-11; Liang K-C, 2013, GENE; LIN RT, 1994, J BIOL CHEM, V269, P17542; Lin RT, 1999, MOL CELL BIOCHEM, V191, P169, DOI 10.1023/A:1006850009017; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Maruyama S, 2003, J IMMUNOL, V170, P997, DOI 10.4049/jimmunol.170.2.997; Matsuno F, 1996, J BIOCHEM-TOKYO, V119, P524; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; MORRIS SM, 1994, AM J PHYSIOL, V266, pE829, DOI 10.1152/ajpendo.1994.266.6.E829; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Negishi H, 2006, P NATL ACAD SCI USA, V103, P15136, DOI 10.1073/pnas.0607181103; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; Panaro M. A., 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P210, DOI 10.2174/1568008033340216; Preusse M, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-293; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; Rodriguez A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127216; Rodriguez N, 2007, PHYSIOL GENOMICS, V30, P134, DOI 10.1152/physiolgenomics.00011.2007; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Schneemann M, 2002, NAT IMMUNOL, V3, P102, DOI 10.1038/ni0202-102a; Schneemann M, 2007, J LEUKOCYTE BIOL, V81, P579, DOI 10.1189/jlb.1106702; Shi SP, 2005, J IMMUNOL, V175, P3318, DOI 10.4049/jimmunol.175.5.3318; Spink J, 1997, J BIOL CHEM, V272, P24417, DOI 10.1074/jbc.272.39.24417; Sugiyama T, 2004, MICROBIOL IMMUNOL, V48, P957, DOI 10.1111/j.1348-0421.2004.tb03625.x; Takahashi K, 2013, BIOMED RES-TOKYO, V34, P205; Tan RSP, 1999, INFECT IMMUN, V67, P2277, DOI 10.1128/IAI.67.5.2277-2283.1999; Taniguchi T, 1997, BBA-REV CANCER, V1333, pM9, DOI 10.1016/S0304-419X(97)00014-0; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Upreti M, 2005, MOL BIOL REP, V32, P103, DOI 10.1007/s11033-004-6940-3; WATANABE N, 1991, NUCLEIC ACIDS RES, V19, P4421, DOI 10.1093/nar/19.16.4421; WEINBERG JB, 1995, BLOOD, V86, P1184; Weinberg JB, 1998, MOL MED, V4, P557, DOI 10.1007/BF03401758; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yang E, 2007, ANN BIOMED ENG, V35, P1053, DOI 10.1007/s10439-007-9268-z; Zhang LM, 2012, MOL MED, V18, P201, DOI 10.2119/molmed.2011.00282	66	47	49	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149050	10.1371/journal.pone.0149050	http://dx.doi.org/10.1371/journal.pone.0149050			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872335	gold, Green Published, Green Submitted			2022-12-27	WOS:000370054100093
J	Ballke, C; Gran, E; Baekkevold, ES; Jahnsen, FL				Ballke, Christina; Gran, Einar; Baekkevold, Espen S.; Jahnsen, Frode L.			Characterization of Regulatory T-Cell Markers in CD4+T Cells of the Upper Airway Mucosa	PLOS ONE			English	Article							ALLERGIC RHINITIS; IN-VIVO; HOMEOSTASIS; HELIOS; CTLA-4	CD4+ T regulatory cells (Tregs) comprise a heterogeneous population of cells the regulate immune responses and prevent autoimmunity. Most reports on human Tregs are derived from studies of peripheral blood, although Tregs mainly exert their functions in the periphery. Here we performed a detailed analysis of Tregs in the human upper airway mucosa under non-inflammatory conditions, and found that 10% of all CD4+ T cells expressed the transcription factor FOXP3 and the memory marker CD45RO, as well as high levels of CTLA-4. The majority of FOXP3+CD4+ T cells co-expressed the transcription factor Helios and produced very little cytokines, compatible with being thymus-derived Tregs. FOXP3 +Helios-CD4+ T cells were more heterogeneous. A mean of 24% produced the immunomodulatory cytokine IL-10, whereas a large fraction also produced IL-2, IFN-mu or IL-17. A significant population (6%) of FOXP3-negative T cells also produced IL-10, usually in combination with IFN-mu. Together, we found that CD4+ T cells in the upper airways differed functionally from their counterparts in peripheral blood, including higher expression of IL-10. Moreover, our findings suggest that several subsets of CD4+ T cells with functionally distinct regulatory properties reside in the upper airway mucosa which should be taken into account when targeting Tregs for therapy.	[Ballke, Christina; Baekkevold, Espen S.; Jahnsen, Frode L.] Oslo Univ Hosp, Dept Pathol, Oslo, Norway; [Ballke, Christina; Baekkevold, Espen S.; Jahnsen, Frode L.] Univ Oslo, Oslo, Norway; [Gran, Einar] Lovisenberg Diakonale Hosp, Dept Otorhinolaryngol, Oslo, Norway	University of Oslo; University of Oslo	Baekkevold, ES; Jahnsen, FL (corresponding author), Oslo Univ Hosp, Dept Pathol, Oslo, Norway.; Baekkevold, ES; Jahnsen, FL (corresponding author), Univ Oslo, Oslo, Norway.	esbaekke@rr-research.no; fjahnsen@rr-research.no			Research Council of Norway through its Centers of Excellence funding scheme [179573]; South Eastern Norway Regional Health Authority [1012105]	Research Council of Norway through its Centers of Excellence funding scheme; South Eastern Norway Regional Health Authority	This work was partly supported by the Research Council of Norway through its Centers of Excellence funding scheme, project number 179573, and grants from the South Eastern Norway Regional Health Authority, project number 1012105.	Abbas AK, 2013, NAT IMMUNOL, V14, P307, DOI 10.1038/ni.2554; Akdis CA, 2009, J ALLERGY CLIN IMMUN, V123, P735, DOI 10.1016/j.jaci.2009.02.030; Akdis M, 2004, J EXP MED, V199, P1567, DOI 10.1084/jem.20032058; Akimova T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024226; Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Bauchau V, 2004, EUR RESPIR J, V24, P758, DOI 10.1183/09031936.04.00013904; Chen JZ, 2009, J LEUKOCYTE BIOL, V86, P1305, DOI 10.1189/jlb.0609406; Cosmi L, 2006, CLIN EXP ALLERGY, V36, P261, DOI 10.1111/j.1365-2222.2006.02429.x; Danilova E, 2015, MUCOSAL IMMUNOL, V8, P107, DOI 10.1038/mi.2014.46; Do JS, 2016, MUCOSAL IMMUNOL, V9, P137, DOI 10.1038/mi.2015.45; Dudda JC, 2008, J EXP MED, V205, P1559, DOI 10.1084/jem.20072594; Engelhardt KR, 2013, J ALLERGY CLIN IMMUN, V131, P825, DOI 10.1016/j.jaci.2012.09.025; Gagliani N, 2013, NAT MED, V19, P739, DOI 10.1038/nm.3179; Grindebacke H, 2004, CLIN EXP ALLERGY, V34, P1364, DOI 10.1111/j.1365-2222.2004.02067.x; Himmel ME, 2013, J IMMUNOL, V190, P2001, DOI 10.4049/jimmunol.1201379; Holt PG, 2008, NAT REV IMMUNOL, V8, P142, DOI 10.1038/nri2236; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Kim HJ, 2015, SCIENCE, V350, P334, DOI 10.1126/science.aad0616; Kim YC, 2012, BLOOD, V119, P2810, DOI 10.1182/blood-2011-09-377895; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Lord JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136485; Mercer F, 2014, J IMMUNOL, V193, P1047, DOI 10.4049/jimmunol.1302936; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Raffin C, 2013, J IMMUNOL, V191, P4619, DOI 10.4049/jimmunol.1301378; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Shevach EM, 2014, IMMUNOL REV, V259, P88, DOI 10.1111/imr.12160; Skrindo I, 2015, CLIN EXP ALLERGY, V45, P1296, DOI 10.1111/cea.12543; Skrindo I, 2011, CLIN EXP ALLERGY, V41, P954, DOI 10.1111/j.1365-2222.2011.03710.x; Stock P, 2004, NAT IMMUNOL, V5, P1149, DOI 10.1038/ni1122; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Wang R, 2009, P NATL ACAD SCI USA, V106, P13439, DOI 10.1073/pnas.0901965106; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wing K, 2011, TRENDS IMMUNOL, V32, P428, DOI 10.1016/j.it.2011.06.002; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822	36	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148826	10.1371/journal.pone.0148826	http://dx.doi.org/10.1371/journal.pone.0148826			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866695	Green Published, gold, Green Submitted			2022-12-27	WOS:000370050700041
J	Faber, IR; Elferink-Gemser, MT; Faber, NR; Oosterveld, FGJ; Nijhuis-Van der Sanden, MWG				Faber, Irene R.; Elferink-Gemser, Marije T.; Faber, Niels R.; Oosterveld, Frits G. J.; Nijhuis-Van der Sanden, Maria W. G.			Can Perceptuo-Motor Skills Assessment Outcomes in Young Table Tennis Players (7-11 years) Predict Future Competition Participation and Performance? An Observational Prospective Study	PLOS ONE			English	Article							SPORT; YOUTH; RELIABILITY; SUCCESS	Forecasting future performance in youth table tennis players based on current performance is complex due to, among other things, differences between youth players in growth, development, maturity, context and table tennis experience. Talent development programmes might benefit from an assessment of underlying perceptuo-motor skills for table tennis, which is hypothesized to determine the players' potential concerning the perceptuo-motor domain. The Dutch perceptuo-motor skills assessment intends to measure the perceptuomotor potential for table tennis in youth players by assessing the underlying skills crucial for developing technical and tactical qualities. Untrained perceptuo-motor tasks are used as these are suggested to represent a player's future potential better than specific sport skills themselves as the latter depend on exposure to the sport itself. This study evaluated the value of the perceptuo-motor skills assessment for a talent developmental programme by evaluating its predictive validity for competition participation and performance in 48 young table tennis players (7-11 years). Players were tested on their perceptuo-motor skills once during a regional talent day, and the subsequent competition results were recorded halfyearly over a period of 2.5 years. Logistic regression analysis showed that test scores did not predict future competition participation (p > 0.05). Yet, the Generalized Estimating Equations analysis, including the test items 'aiming at target', 'throwing a ball', and 'eye-hand coordination' in the best fitting model, revealed that the outcomes of the perceptuo-motor skills assessment were significant predictors for future competition results (R-2 = 51%). Since the test age influences the perceptuo-motor skills assessment's outcome, another multivariable model was proposed including test age as a covariate (R-2 = 53%). This evaluation demonstrates promising prospects for the perceptuo-motor skills assessment to be included in a talent development programme. Future studies are needed to clarify the predictive value in a larger sample of youth competition players over a longer period in time.	[Faber, Irene R.; Oosterveld, Frits G. J.] Saxion Univ Appl Sci, Fac Phys Act & Hlth, Enschede, Netherlands; [Faber, Irene R.; Nijhuis-Van der Sanden, Maria W. G.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, IQ Healthcare, Nijmegen, Netherlands; [Faber, Irene R.] Int Table Tennis Federat, Lausanne, Switzerland; [Elferink-Gemser, Marije T.] HAN Univ Appl Sci, Inst Studies Sports & Exercise, Nijmegen, Netherlands; [Elferink-Gemser, Marije T.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [Faber, Niels R.] Hanze Univ Appl Sci, Int Business Sch, Groningen, Netherlands; [Faber, Niels R.] Radboud Univ Nijmegen, Nijmegen Sch Management, NL-6525 ED Nijmegen, Netherlands	Saxion University of Applied Sciences; Radboud University Nijmegen; University of Groningen; Radboud University Nijmegen	Faber, IR (corresponding author), Saxion Univ Appl Sci, Fac Phys Act & Hlth, Enschede, Netherlands.; Faber, IR (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, IQ Healthcare, Nijmegen, Netherlands.; Faber, IR (corresponding author), Int Table Tennis Federat, Lausanne, Switzerland.	i.r.faber@saxion.nl	Faber, Irene Renate/C-9699-2019; der Sanden, Maria WG Nijhuis-van/B-3463-2012; Oosterveld, Frits/D-4530-2015	Faber, Irene Renate/0000-0002-4994-0453; der Sanden, Maria WG Nijhuis-van/0000-0003-2637-6877; 	Saxion University of Applied Sciences	Saxion University of Applied Sciences	Financial support was given by Saxion University of Applied Sciences for I.R. Faber. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERNETHY B, 1991, INT J SPORT PSYCHOL, V22, P189; Ak E, 2010, PERCEPT MOTOR SKILL, V110, P879, DOI 10.2466/PMS.110.3.879-887; Akpinar S, 2012, PERCEPT MOTOR SKILL, V115, P581, DOI 10.2466/30.25.27.PMS.115.5.581-593; Baker J, 2005, J APPL SPORT PSYCHOL, V17, P64, DOI 10.1080/10413200590907577; Brouwers J, 2012, SPORT MANAG REV, V15, P461, DOI 10.1016/j.smr.2012.05.002; Chu C. Y., 2012, INT J TABLE TENNIS S, V7, P86; Silva MJCE, 2010, J SPORT MED PHYS FIT, V50, P174; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; Elferink-Gemser MT, 2011, BRIT J SPORT MED, V45, P683, DOI 10.1136/bjsports-2011-090254; Elliott BC., 1990, AUSTRALIAIN J SPORT, V22, P87; Faber IR, 2014, ANN RES SPORTS PHYS, V5, P53, DOI DOI 10.14195/2182-7087_; Faber IR, 2012, INT J TABLE TENNIS S, V7, P15; Faber IR, 2015, J SPORT SCI, V33, P1149, DOI 10.1080/02640414.2014.986503; Faber IR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085657; Gagne F, 2004, HIGH ABIL STUD, V15, P119, DOI 10.1080/1359813042000314682; George D, 2003, SPSS WINDOWS STEP ST; German Table Tennis Association, 2008, KOORD TISCHT; Gillet N, 2009, EUR J SPORT SCI, V9, P151, DOI 10.1080/17461390902736793; Girard O, 2009, J STRENGTH COND RES, V23, P1867, DOI 10.1519/JSC.0b013e3181b3df89; Heller I, 2008, VISIE, V65, P16; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Horsch R., 1990, TISCHTENNIS SCHULE 4; Kannekens R, 2011, SCAND J MED SCI SPOR, V21, P846, DOI 10.1111/j.1600-0838.2010.01104.x; Knudsen EI, 2004, J COGNITIVE NEUROSCI, V16, P1412, DOI 10.1162/0898929042304796; Kondric M, 2013, J SPORT SCI MED, V12, P362; Kovacs MS, 2007, SPORTS MED, V37, P189, DOI 10.2165/00007256-200737030-00001; Lane A. M., 2002, Journal of Sport Behavior, V25, P331; Lees A, 2003, J SPORT SCI, V21, P707, DOI 10.1080/0264041031000140275; Limoochi S., 2006, INT J TABLE TENNIS S, V6, P280; Liu WN, 2012, J HUM KINET, V33, P173, DOI 10.2478/v10078-012-0056-y; Lopez A., 2012, INT J TABLE TENNIS S, V7, P1; Lubbers P, 2006, ITF COACHING SPORT S, V39, P7; Malina RM, 2005, MED SCI SPORT EXER, V37, P1044, DOI 10.1249/01.mss.0000171622.45134.cb; MCCULLAGH P, 1993, PEDIATR EXERC SCI, V5, P224; Morrow J.R., 2011, MEASUREMENT EVALUATI, V5th ed., P89; Netherlands Table Tennis Association, 2013, CALC COMP SCOR; Netherlands Table Tennis Association, 2011, TEST PROT NAT DAY TA; Panjan A, 2010, KINESIOLOGY, V42, P98; Phillips E, 2010, SPORTS MED, V40, P271, DOI 10.2165/11319430-000000000-00000; Pion JA, 2015, J STRENGTH COND RES, V29, P1480, DOI 10.1519/JSC.0000000000000778; Raab M, 2005, HUM MOVEMENT SCI, V24, P326, DOI 10.1016/j.humov.2005.06.004; Reid M, 2007, J SPORT SCI, V25, P667, DOI 10.1080/02640410600811932; Schmidt R. A, 2011, MOTOR CONTROL LEARNI; Stang Jamie, 2005, GUIDELINES ADOLESCEN; Toriola AL, 2004, PERCEPT MOTOR SKILL, V98, P584; Unierzyski P., 2006, ITF COACHING SPORT S, V39, P3; Vaeyens R, 2008, SPORTS MED, V38, P703, DOI 10.2165/00007256-200838090-00001; Van Rossum JH., 1994, EUR J HIGH ABILITY, V5, P68, DOI DOI 10.1080/0937445940050107; Vandorpe B, 2012, J SPORT SCI, V30, P497, DOI 10.1080/02640414.2012.654399; Wall M., 2007, Physical Education and Sport Pedagogy, V12, P77, DOI 10.1080/17408980601060358; Watanabe D, 2007, EXP BRAIN RES, V176, P332, DOI 10.1007/s00221-006-0619-z	51	17	17	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149037	10.1371/journal.pone.0149037	http://dx.doi.org/10.1371/journal.pone.0149037			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6PR	26863212	Green Submitted, Green Published, gold			2022-12-27	WOS:000370046600146
J	Kimura, Y; Soma, T; Kasahara, N; Delobel, D; Hanami, T; Tanaka, Y; de Hoon, MJL; Hayashizaki, Y; Usui, K; Harbers, M				Kimura, Yasumasa; Soma, Takahiro; Kasahara, Naoko; Delobel, Diane; Hanami, Takeshi; Tanaka, Yuki; de Hoon, Michiel J. L.; Hayashizaki, Yoshihide; Usui, Kengo; Harbers, Matthias			Edesign: Primer and Enhanced Internal Probe Design Tool for Quantitative PCR Experiments and Genotyping Assays	PLOS ONE			English	Article							RESOLUTION MELTING ANALYSIS; THIAZOLE ORANGE; DNA; FLUORESCENCE; THERMODYNAMICS; MUTATIONS	Analytical PCR experiments preferably use internal probes for monitoring the amplification reaction and specific detection of the amplicon. Such internal probes have to be designed in close context with the amplification primers, and may require additional considerations for the detection of genetic variations. Here we describe Edesign, a new online and standalone tool for designing sets of PCR primers together with an internal probe for conducting quantitative real-time PCR (qPCR) and genotypic experiments. Edesign can be used for selecting standard DNA oligonucleotides like for instance TaqMan probes, but has been further extended with new functions and enhanced design features for Eprobes. Eprobes, with their single thiazole orange-labelled nucleotide, allow for highly sensitive genotypic assays because of their higher DNA binding affinity as compared to standard DNA oligonucleotides. Using new thermodynamic parameters, Edesign considers unique features of Eprobes during primer and probe design for establishing qPCR experiments and genotyping by melting curve analysis. Additional functions in Edesign allow probe design for effective discrimination between wild-type sequences and genetic variations either using standard DNA oligonucleotides or Eprobes. Edesign can be freely accessed online at http://www.dnaform.com/edesign2/, and the source code is available for download.	[Kimura, Yasumasa] KK DNAFORM, Tsurumi Ku, 75-1 Ono Cho, Yokohama, Kanagawa 2300046, Japan; [Kimura, Yasumasa; Soma, Takahiro; Delobel, Diane; Hanami, Takeshi; Tanaka, Yuki; de Hoon, Michiel J. L.; Usui, Kengo; Harbers, Matthias] RIKEN Ctr Life Sci Technol, Div Genom Technol, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan; [Kasahara, Naoko] RIKEN Om Sci Ctr, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan; [Hayashizaki, Yoshihide; Usui, Kengo] RIKEN Prevent Med & Diag Innovat Program, 2-1 Hirosawa, Wako, Saitama 3510198, Japan; [Kimura, Yasumasa] Univ Tokyo, Inst Med Sci, Div Syst Immunol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan; [Kasahara, Naoko] Tohoku Univ, Tohoku Med Megabank Org, Dept Bioclin Informat, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808573, Japan	RIKEN; RIKEN; RIKEN; University of Tokyo; Tohoku University	Kimura, Y (corresponding author), KK DNAFORM, Tsurumi Ku, 75-1 Ono Cho, Yokohama, Kanagawa 2300046, Japan.; Kimura, Y; Harbers, M (corresponding author), RIKEN Ctr Life Sci Technol, Div Genom Technol, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.; Kimura, Y (corresponding author), Univ Tokyo, Inst Med Sci, Div Syst Immunol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	y.kimura.sc@gmail.com; matthias.harbers@riken.jp	TANAKA, Yuki/AAE-4497-2019; Delobel, Diane/C-4152-2017; Hanami, Takeshi/C-3653-2017; Hayashizaki, Yoshihide/N-6590-2015	Delobel, Diane/0000-0002-1644-1228; Hanami, Takeshi/0000-0003-1868-1409; Harbers, Matthias/0000-0002-5613-7220; de Hoon, Michiel/0000-0003-0489-2352	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) through RIKEN Preventive Medicine and Diagnosis Innovation Program; K.K. DNAFORM	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) through RIKEN Preventive Medicine and Diagnosis Innovation Program; K.K. DNAFORM	This work was supported by (1) research grants for RIKEN Omics Science Center from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) to YH, (2) a research grant from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) through RIKEN Preventive Medicine and Diagnosis Innovation Program to YH, and (3) a Research Grant from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) to the RIKEN Center for Life Science Technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Partial funding was also provided by K.K. DNAFORM. The funder provided support in the form of salaries for authors [YK, MH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alvarez-Fernandez R, 2013, METHOD ENZYMOL, V529, P1, DOI 10.1016/B978-0-12-418687-3.00001-X; Atsumi J, 2015, ONCOL REP, V33, P2719, DOI 10.3892/or.2015.3883; Caplin BE, 1999, BIOCHEMICA, P2; Davis AR, 2010, BIOCHEMISTRY-US, V49, P8669, DOI 10.1021/bi100146z; Didenko VV, 2001, BIOTECHNIQUES, V31, P1106, DOI 10.2144/01315rv02; Hanami T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070942; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Ikeda S, 2008, BIOCONJUGATE CHEM, V19, P1719, DOI 10.1021/bc800201m; Ikeda S, 2008, CHEM-ASIAN J, V3, P958, DOI 10.1002/asia.200800014; Ikeda S, 2009, ANGEW CHEM INT EDIT, V48, P6480, DOI 10.1002/anie.200902000; Kierzek R, 1999, BIOCHEMISTRY-US, V38, P14214, DOI 10.1021/bi991186l; Kimura Y, 2012, BIOCHEMISTRY-US, V51, P6056, DOI 10.1021/bi300293d; LEE LG, 1986, CYTOMETRY, V7, P508, DOI 10.1002/cyto.990070603; Liu YP, 2014, SCI REP-UK, V4, DOI 10.1038/srep07521; Mann T, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp443; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; McTigue PM, 2004, BIOCHEMISTRY-US, V43, P5388, DOI 10.1021/bi035976d; Morrison TB, 1998, BIOTECHNIQUES, V24, P954; Naiser T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-509; Okamoto A, 2011, CHEM SOC REV, V40, P5815, DOI 10.1039/c1cs15025a; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rozen S, 2000, Methods Mol Biol, V132, P365; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; SantaLucia John Jr., 2007, V402, P3; SPIELMANN HP, 1995, BIOCHEMISTRY-US, V34, P8542, DOI 10.1021/bi00027a004; Sugizaki K, 2010, BIOCONJUGATE CHEM, V21, P2276, DOI 10.1021/bc1002949; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Vossen RHAM, 2009, HUM MUTAT, V30, P860, DOI 10.1002/humu.21019; Wittwer CT, 2009, HUM MUTAT, V30, P857, DOI 10.1002/humu.20951; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	34	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0146950	10.1371/journal.pone.0146950	http://dx.doi.org/10.1371/journal.pone.0146950			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863543	Green Submitted, Green Published, gold			2022-12-27	WOS:000370046600014
J	Koo, HJ; Lee, M; Kim, J; Woo, CW; Jeong, SY; Choi, EK; Kim, N; Lee, JS				Koo, Hyun Jung; Lee, Myoungsun; Kim, Jin; Woo, Chul Woong; Jeong, Seong-Yun; Choi, Eun Kyung; Kim, Namkug; Lee, Jin Seong			Synergistic Effect of Anti-Angiogenic and Radiation Therapy: Quantitative Evaluation with Dynamic Contrast Enhanced MR Imaging	PLOS ONE			English	Article							IONIZING-RADIATION; GROWTH-FACTOR; TUMOR MICROCIRCULATION; ANTIANGIOGENIC THERAPY; RECTAL-CARCINOMA; CANCER; PERFUSION; INHIBITION; CHEMOTHERAPY; ANGIOSTATIN	Purpose We assessed the effects of anti-angiogenic therapy (AAT) on radiation therapy (RT), evaluating the tumor growth and perfusion patterns on dynamic contrast enhanced MR (DCE-MR) images. Methods Thirteen nude mice with heterotopic xenograft cancer of human lung cancer cell line were used. To observe the interval change of the tumor size and demonstrate the time-signal intensity enhancement curve of the tumor, the mice were subdivided into four groups: control (n = 2), AAT (n = 2), RT (n = 5), and combined therapy (AART, n = 4). DCE-MR images were taken four weeks after treatment. Perfusion parameters were obtained based on the Brix model. To compare the interval size changes in the RT group with those in the AART group, repeated measures ANOVA was used. Perfusion parameters in both the RT and AART groups were compared using a Mann-Whitney U test. Results Tumor growth was more suppressed in AART group than in the other groups. Control group showed the rapid wash-in and wash-out pattern on DCE-MR images. In contrast to RT group with delayed and prolonged enhancement, both AAT and AART groups showed the rapid wash-in and plateau pattern. The signal intensity in the plateau/time to peak enhancement (P<0.016) and the maximum enhancement ratio (P<0.016) of AART group were higher than those of RT group. Conclusions AART showed synergistic effects in anticancer treatment. The pattern of the time-intensity curve on the DCE-MR images in each group implies that AAT might help maintain the perfusion in the cancer of AART group.	[Koo, Hyun Jung; Lee, Myoungsun; Kim, Jin; Kim, Namkug; Lee, Jin Seong] Univ Ulsan, Res Inst Radiol, Coll Med, Asan Med Ctr, Seoul, South Korea; [Koo, Hyun Jung; Lee, Myoungsun; Kim, Jin; Kim, Namkug; Lee, Jin Seong] Univ Ulsan, Dept Radiol, Coll Med, Asan Med Ctr, Seoul, South Korea; [Lee, Myoungsun; Kim, Jin; Woo, Chul Woong; Jeong, Seong-Yun] Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea; [Choi, Eun Kyung] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiat Oncol, Seoul, South Korea	University of Ulsan; University of Ulsan; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Lee, JS (corresponding author), Univ Ulsan, Res Inst Radiol, Coll Med, Asan Med Ctr, Seoul, South Korea.; Lee, JS (corresponding author), Univ Ulsan, Dept Radiol, Coll Med, Asan Med Ctr, Seoul, South Korea.	jslee@amc.seoul.kr	Kim, Namkug/E-3843-2012	Kim, Namkug/0000-0002-3438-2217; Koo, Hyun Jung/0000-0001-5640-3835	Korean Health Technology R&D Project of the Ministry of Health & Welfare of the Republic of Korea [HI10C2014]	Korean Health Technology R&D Project of the Ministry of Health & Welfare of the Republic of Korea	This study was supported by a grant (HI10C2014) of the Korean Health Technology R&D Project of the Ministry of Health & Welfare of the Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akisik MF, 2010, RADIOLOGY, V256, P441, DOI 10.1148/radiol.10091733; Barentsz JO, 1998, RADIOLOGY, V207, P791, DOI 10.1148/radiology.207.3.9609906; BRIX G, 1991, J COMPUT ASSIST TOMO, V15, P621, DOI 10.1097/00004728-199107000-00018; BUCKLEY DL, 1994, MAGNET RESON MED, V32, P646, DOI 10.1002/mrm.1910320514; de Vries A, 2000, RADIOLOGY, V217, P385, DOI 10.1148/radiology.217.2.r00nv02385; Deplanque G, 2000, EUR J CANCER, V36, P1713, DOI 10.1016/S0959-8049(00)00149-0; DeVries AF, 2001, CANCER RES, V61, P2513; Galbraith SM, 2003, J CLIN ONCOL, V21, P2831, DOI 10.1200/JCO.2003.05.187; George ML, 2001, BRIT J SURG, V88, P1628, DOI 10.1046/j.0007-1323.2001.01947.x; Gorski DH, 1999, CANCER RES, V59, P3374; Gorski DH, 1998, CANCER RES, V58, P5686; Griffin RJ, 2002, CANCER RES, V62, P1702; Juan CJ, 2009, EUR RADIOL, V19, P94, DOI 10.1007/s00330-008-1104-9; Knopp M V, 1994, Magn Reson Imaging Clin N Am, V2, P633; Leach MO, 2005, BRIT J CANCER, V92, P1599, DOI 10.1038/sj.bjc.6602550; Lee CG, 2000, CANCER RES, V60, P5565; Loges S, 2009, CANCER CELL, V15, P167, DOI 10.1016/j.ccr.2009.02.007; Mauceri HJ, 1998, NATURE, V394, P287, DOI 10.1038/28412; Mauceri HJ, 1996, CANCER RES, V56, P4311; Maxwell RJ, 2002, NMR BIOMED, V15, P89, DOI 10.1002/nbm.754; Mayr NA, 2000, J MAGN RESON IMAGING, V12, P1027, DOI 10.1002/1522-2586(200012)12:6<1027::AID-JMRI31>3.0.CO;2-5; Morgan B, 2003, J CLIN ONCOL, V21, P3955, DOI 10.1200/JCO.2003.08.092; Nielsen DL, 2012, EXPERT OPIN BIOL TH, V12, P795, DOI 10.1517/14712598.2012.679655; Padhani AR, 2005, ABDOM IMAGING, V30, P324, DOI 10.1007/s00261-004-0265-5; Reddick WE, 1999, JMRI-J MAGN RESON IM, V10, P277, DOI 10.1002/(SICI)1522-2586(199909)10:3<277::AID-JMRI8>3.0.CO;2-S; Rodjan F, 2012, AM J NEURORADIOL, V7, P7; Sorensen AG, 2012, CANCER RES, V72, P402, DOI 10.1158/0008-5472.CAN-11-2464; Teicher BA, 1998, ANTICANCER RES, V18, P2567; Thukral A, 2007, RADIOLOGY, V244, P727, DOI 10.1148/radiol.2443060926; Timke C, 2008, CLIN CANCER RES, V14, P2210, DOI 10.1158/1078-0432.CCR-07-1893; VANDERWOUDE HJ, 1995, AM J ROENTGENOL, V165, P593, DOI 10.2214/ajr.165.3.7645476; Wachsberger P, 2003, CLIN CANCER RES, V9, P1957; Wang J, 2004, AM J ROENTGENOL, V183, P713, DOI 10.2214/ajr.183.3.1830713; Yoo DS, 2012, CLIN CANCER RES, V18, P1404, DOI 10.1158/1078-0432.CCR-11-1982	34	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148784	10.1371/journal.pone.0148784	http://dx.doi.org/10.1371/journal.pone.0148784			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862906	Green Published, Green Submitted, gold			2022-12-27	WOS:000370046600107
J	Martinez, C; Chavarria, C; Sharpe, DMT; De Leon, LF				Martinez, Celestino; Chavarria, Carmen; Sharpe, Diana M. T.; De Leon, Luis Fernando			Low Predictability of Colour Polymorphism in Introduced Guppy (Poecilia reticulata) Populations in Panama	PLOS ONE			English	Article							LIFE-HISTORY EVOLUTION; MALE PREDATION RISK; FEMALE MATE CHOICE; TRINIDADIAN GUPPIES; SEXUAL SELECTION; MATING PREFERENCES; RAPID EVOLUTION; PHENOTYPIC VARIATION; GEOGRAPHIC-VARIATION; ADAPTIVE EVOLUTION	Colour polymorphism is a recurrent feature of natural populations, and its maintenance has been studied in a range of taxa in their native ranges. However, less is known about whether (and how) colour polymorphism is maintained when populations are removed from their native environments, as in the case of introduced species. We here address this issue by analyzing variation in colour patterns in recently-discovered introduced populations of the guppy (Poecilia reticulata) in Panama. Specifically, we use classic colour analysis to estimate variation in the number and the relative area of different colour spots across low predation sites in the introduced Panamanian range of the species. We then compare this variation to that found in the native range of the species under low-and high predation regimes. We found aspects of the colour pattern that were both consistent and inconsistent with the classical paradigm of colour evolution in guppies. On one hand, the same colours that dominated in native populations (orange, iridescent and black) were also the most dominant in the introduced populations in Panama. On the other, there were no clear differences between either introduced-low and native low-and high predation populations. Our results are therefore only partially consistent with the traditional role of female preference in the absence of predators, and suggest that additional factors could influence colour patterns when populations are removed from their native environments. Future research on the interaction between female preference and environmental variability (e.g. multifarious selection), could help understand adaptive variation in this widely-introduced species, and the contexts under which variation in adaptive traits parallels (or not) variation in the native range.	[Martinez, Celestino; Chavarria, Carmen; De Leon, Luis Fernando] Inst Invest Cient & Serv Alta Tecnol INDICASAT AI, Ctr Biodiversidad & Descubrimiento Drogas, Panama City, Panama; [Sharpe, Diana M. T.] McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada	Instituto de Investigacion Cientificas y Servicios de Alta Tecnologia (INDICASAT-AIP); McGill University	De Leon, LF (corresponding author), Inst Invest Cient & Serv Alta Tecnol INDICASAT AI, Ctr Biodiversidad & Descubrimiento Drogas, Panama City, Panama.	luis.deleonreyna@gmail.com	De León, Luis/H-1112-2011	De León, Luis/0000-0001-9317-420X	Secretaria Nacional de Ciencia, Tecnologia e Innovacion (SENACYT, Panama) [ITE12-002]; Sistema Nacional de Investigacion (SNI); Fonds Quebecois de la Recherche sur la Nature et les Technologies (FRQNT, Canada)	Secretaria Nacional de Ciencia, Tecnologia e Innovacion (SENACYT, Panama); Sistema Nacional de Investigacion (SNI); Fonds Quebecois de la Recherche sur la Nature et les Technologies (FRQNT, Canada)	Funding was provided by the Secretaria Nacional de Ciencia, Tecnologia e Innovacion (SENACYT, Panama), in the form of a Grant No. ITE12-002 to LFD. LFD and DMTS were supported by the Sistema Nacional de Investigacion (SNI). DMTS was also supported by a post-doctoral fellowship from The Fonds Quebecois de la Recherche sur la Nature et les Technologies (FRQNT, Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey RM, 1963, POECILIID FISHES CYP, V126, P1; Blows MW, 2003, EVOLUTION, V57, P1622, DOI 10.1111/j.0014-3820.2003.tb00369.x; Bond AB, 2007, ANNU REV ECOL EVOL S, V38, P489, DOI 10.1146/annurev.ecolsys.38.091206.095728; BREDEN F, 1987, NATURE, V329, P831, DOI 10.1038/329831a0; BROOKS R, 1995, ANIM BEHAV, V50, P301, DOI 10.1006/anbe.1995.0246; Brooks R, 2002, GENETICA, V116, P343, DOI 10.1023/A:1021228308636; Brooks R, 2001, EVOLUTION, V55, P1002, DOI 10.1554/0014-3820(2001)055[1002:DAISSA]2.0.CO;2; Brooks R, 1999, AM NAT, V154, P37, DOI 10.1086/303219; Brower AVZ, 1996, EVOLUTION, V50, P195, DOI 10.1111/j.1558-5646.1996.tb04486.x; Deacon AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024416; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Easty LK, 2011, ANIM BEHAV, V82, P1085, DOI 10.1016/j.anbehav.2011.08.001; Egea-Serrano A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3266; Endler J.A., 1978, Evolutionary Biology (New York), V11, P319; ENDLER JA, 1983, ENVIRON BIOL FISH, V9, P173, DOI 10.1007/BF00690861; ENDLER JA, 1995, EVOLUTION, V49, P456, DOI [10.2307/2410270, 10.1111/j.1558-5646.1995.tb02278.x]; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; FARR JA, 1977, EVOLUTION, V31, P162, DOI 10.1111/j.1558-5646.1977.tb00993.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Godin JGJ, 2005, ANIM BEHAV, V69, P999, DOI 10.1016/j.anbehav.2004.07.016; Godin JGJ, 2003, BEHAV ECOL, V14, P194, DOI 10.1093/beheco/14.2.194; Godin JGJ, 1996, P NATL ACAD SCI USA, V93, P10262, DOI 10.1073/pnas.93.19.10262; Gonzalez L, 2004, THESIS U PANAMA; Gordon SP, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1244; Gotanda KM, 2013, OECOLOGIA, V172, P155, DOI 10.1007/s00442-012-2485-7; Gotanda KM, 2014, USING ADAPTIVE TRAIT, P108; Gray SM, 2007, TRENDS ECOL EVOL, V22, P71, DOI 10.1016/j.tree.2006.10.005; Gray SM, 2011, CAN J FISH AQUAT SCI, V68, P330, DOI 10.1139/F10-151; Grether GF, 2004, P ROY SOC B-BIOL SCI, V271, P45, DOI 10.1098/rspb.2003.2526; Grether GF, 2001, ECOLOGY, V82, P1546, DOI 10.1890/0012-9658(2001)082[1546:RFCCRA]2.0.CO;2; Hall M, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-1; Haskins C. P., 1961, POLYMORPHISM POPULAT; Hedrick PW, 2001, MOL ECOL, V10, P851, DOI 10.1046/j.1365-294X.2001.01243.x; Hendry AP, 2013, EVOL ECOL RES, V15, P111; Hildebrand S. F., 1938, Field Museum Publications Chicago Zoological Series, V22, P219; HOAGLAND KE, 1977, BIOL BULL, V152, P360, DOI 10.2307/1540424; Hoopes M.F., 2009, INVASION ECOLOGY, Vsecond; Houde A.E., 1997, SEX COLOR MATE CHOIC; HOUDE AE, 1987, EVOLUTION, V41, P1, DOI 10.1111/j.1558-5646.1987.tb05766.x; HOUDE AE, 1990, SCIENCE, V248, P1405, DOI 10.1126/science.248.4961.1405; Houde AE, 1997, ANIM BEHAV, V53, P343, DOI 10.1006/anbe.1996.0399; Hudon J, 2003, PHYSIOL BIOCHEM ZOOL, V76, P776, DOI 10.1086/378138; Huey RB, 2000, SCIENCE, V287, P308, DOI 10.1126/science.287.5451.308; Hugall AF, 2012, NATURE, V485, P631, DOI 10.1038/nature11050; Hughes KA, 2013, NATURE, V503, P108, DOI 10.1038/nature12717; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Karim N, 2007, J EVOLUTION BIOL, V20, P1339, DOI 10.1111/j.1420-9101.2007.01350.x; Kelehear C, 2012, ECOL LETT, V15, P329, DOI 10.1111/j.1461-0248.2012.01742.x; Kemp DJ, 2009, P ROY SOC B-BIOL SCI, V276, P4335, DOI 10.1098/rspb.2009.1226; Kemp DJ, 2008, BIOL J LINN SOC, V95, P734, DOI 10.1111/j.1095-8312.2008.01112.x; Kettlewell B, 1973, EVOLUTION MELANISM S; Kiritome A, 2012, ICHTHYOL RES, V59, P304, DOI 10.1007/s10228-012-0287-x; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Kodric-Brown A, 2001, BEHAV ECOL SOCIOBIOL, V50, P346, DOI 10.1007/s002650100374; Kolbe JJ, 2012, SCIENCE, V335, P1086, DOI 10.1126/science.1209566; Kordric-Brown A, 1985, BEHAV ECOL SOCIOBIOL, V25, P393; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Lindholm A, 2002, AM NAT, V160, pS214, DOI 10.1086/342898; Lindholm AK, 2014, J EVOLUTION BIOL, V27, P437, DOI 10.1111/jeb.12313; Lindholm AK, 2005, MOL ECOL, V14, P3671, DOI 10.1111/j.1365-294X.2005.02697.x; Locatello L, 2006, J EVOLUTION BIOL, V19, P1595, DOI 10.1111/j.1420-9101.2006.01117.x; Loftin H., 1965, THESIS FLORIDA STATE; MAGURRAN AE, 2005, EVOLUTIONARY ECOLOGY; Millar NP, 2012, ENVIRON BIOL FISH, V94, P513, DOI 10.1007/s10641-011-9801-7; Millar NP, 2006, OIKOS, V113, P1; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; MULLER F, 1879, P ENTOMOL SOC LOND, pR20; O'Steen S, 2002, EVOLUTION, V56, P776, DOI 10.1111/j.0014-3820.2002.tb01388.x; Olendorf R, 2006, NATURE, V441, P633, DOI 10.1038/nature04646; Phillips BL, 2006, NATURE, V439, P803, DOI 10.1038/439803a; Poulton EB, 1890, THE COLOURS OF ANIMA, DOI [10.5962/bhl.title.11353, DOI 10.5962/BHL.TITLE.11353]; Price AC, 2008, ZEBRAFISH, V5, P297, DOI 10.1089/zeb.2008.0551; REZNICK DA, 1990, NATURE, V346, P357, DOI 10.1038/346357a0; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; ROBISSON P, 1993, ETHOLOGY, V94, P279; Rodd FH, 2002, P ROY SOC B-BIOL SCI, V269, P475, DOI 10.1098/rspb.2001.1891; Roulin A, 2004, BIOL REV, V79, P815, DOI 10.1017/S1464793104006487; Ruell EW, 2013, P R SOC B, V280, P2012, DOI DOI 10.1098/RSPB.2012.2019; Schwartz AK, 2010, FUNCT ECOL, V24, P354, DOI 10.1111/j.1365-2435.2009.01652.x; STONER G, 1988, BEHAV ECOL SOCIOBIOL, V22, P285, DOI 10.1007/BF00299844; Team R. D. C, 2011, R LANG ENV STAT COMP; Templeton CN, 2004, BEHAV ECOL, V15, P673, DOI 10.1093/beheco/arh065; Torres-Dowdall J, 2012, EVOLUTION, V66, P3432, DOI 10.1111/j.1558-5646.2012.01694.x; Tripathi N, 2009, P ROY SOC B-BIOL SCI, V276, P2195, DOI 10.1098/rspb.2008.1930; Vega AJ, 2006, TECNOCIENCIA, V8, P87; Vignal C, 2004, NATURE, V430, P448, DOI 10.1038/nature02645; WINGE O, 1947, HEREDITY, V1, P65, DOI 10.1038/hdy.1947.4; Winge O, 1922, J GENET, V12, P145, DOI 10.1007/BF02983078; ZARET TM, 1971, ECOLOGY, V52, P336, DOI 10.2307/1934593	89	3	3	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148040	10.1371/journal.pone.0148040	http://dx.doi.org/10.1371/journal.pone.0148040			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863538	Green Submitted, gold, Green Published			2022-12-27	WOS:000370046600041
J	Prothmann, M; von Knobelsdorff-Brenkenhoff, F; Topper, A; Dieringer, MA; Shahid, E; Graessl, A; Rieger, J; Lysiak, D; Thalhammer, C; Huelnhagen, T; Kellman, P; Niendorf, T; Schulz-Menger, J				Prothmann, Marcel; von Knobelsdorff-Brenkenhoff, Florian; Toepper, Agnieszka; Dieringer, Matthias A.; Shahid, Etham; Graessl, Andreas; Rieger, Jan; Lysiak, Darius; Thalhammer, C.; Huelnhagen, Till; Kellman, Peter; Niendorf, Thoralf; Schulz-Menger, Jeanette			High Spatial Resolution Cardiovascular Magnetic Resonance at 7.0 Tesla in Patients with Hypertrophic Cardiomyopathy - First Experiences: Lesson Learned from 7.0 Tesla	PLOS ONE			English	Article							MYOCARDIAL CRYPTS; TASK-FORCE; PREVALENCE; DIAGNOSIS; FIBROSIS; DISEASE; DESIGN	Background Cardiovascular Magnetic Resonance (CMR) provides valuable information in patients with hypertrophic cardiomyopathy (HCM) based on myocardial tissue differentiation and the detection of small morphological details. CMR at 7.0T improves spatial resolution versus today's clinical protocols. This capability is as yet untapped in HCM patients. We aimed to examine the feasibility of CMR at 7.0T in HCM patients and to demonstrate its capability for the visualization of subtle morphological details. Methods We screened 131 patients with HCM. 13 patients (9 males, 56 +/- 31 years) and 13 healthy age-and gender-matched subjects (9 males, 55 +/- 31years) underwent CMR at 7.0T and 3.0T (Siemens, Erlangen, Germany). For the assessment of cardiac function and morphology, 2D CINE imaging was performed (voxel size at 7.0T: (1.4x1.4x2.5) mm(3) and (1.4x1.4x4.0) mm(3); at 3.0T: (1.8x1.8x6.0) mm(3)). Late gadolinium enhancement (LGE) was performed at 3.0T for detection of fibrosis. Results All scans were successful and evaluable. At 3.0T, quantification of the left ventricle (LV) showed similar results in short axis view vs. the biplane approach (LVEDV, LVESV, LVMASS, LVEF) (p = 0.286; p = 0.534; p = 0.155; p = 0.131). The LV-parameters obtained at 7.0T where in accordance with the 3.0T data (p(LVEDV) = 0.110; p(LVESV) = 0.091; p(LVMASS) = 0.131; p(LVEF) = 0.182). LGE was detectable in 12/13 (92%) of the HCM patients. High spatial resolution CINE imaging at 7.0T revealed hyperintense regions, identifying myocardial crypts in 7/13 (54%) of the HCM patients. All crypts were located in the LGE-positive regions. The crypts were not detectable at 3.0T using a clinical protocol. Conclusions CMR at 7.0T is feasible in patients with HCM. High spatial resolution gradient echo 2D CINE imaging at 7.0T allowed the detection of subtle morphological details in regions of extended hypertrophy and LGE.	[Prothmann, Marcel; von Knobelsdorff-Brenkenhoff, Florian; Toepper, Agnieszka; Dieringer, Matthias A.; Shahid, Etham; Graessl, Andreas; Lysiak, Darius; Thalhammer, C.; Huelnhagen, Till; Niendorf, Thoralf; Schulz-Menger, Jeanette] Max Delbruck Ctr Mol Med, BUFF, Berlin, Germany; [Prothmann, Marcel; von Knobelsdorff-Brenkenhoff, Florian; Toepper, Agnieszka; Dieringer, Matthias A.; Shahid, Etham; Schulz-Menger, Jeanette] Expt & Clin Res Ctr, Working Grp Cardiovasc Magnet Resonance, Berlin, Germany; [Prothmann, Marcel; von Knobelsdorff-Brenkenhoff, Florian; Toepper, Agnieszka; Dieringer, Matthias A.; Shahid, Etham; Schulz-Menger, Jeanette] HELIOS Klinikum Berlin Buch, Dept Cardiol & Nephrol, Berlin, Germany; [Rieger, Jan; Lysiak, Darius; Niendorf, Thoralf] MRI TOOLS GmbH, Berlin, Germany; [Kellman, Peter] NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA; [Niendorf, Thoralf; Schulz-Menger, Jeanette] DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helios Kliniken; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); German Centre for Cardiovascular Research	Schulz-Menger, J (corresponding author), Max Delbruck Ctr Mol Med, BUFF, Berlin, Germany.; Schulz-Menger, J (corresponding author), Expt & Clin Res Ctr, Working Grp Cardiovasc Magnet Resonance, Berlin, Germany.; Schulz-Menger, J (corresponding author), HELIOS Klinikum Berlin Buch, Dept Cardiol & Nephrol, Berlin, Germany.; Schulz-Menger, J (corresponding author), DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany.	Jeanette.Schulz-Menger@charite.de		Schulz-Menger, Jeanette/0000-0003-3100-1092; Huelnhagen, Till/0000-0002-6755-2171	Charite	Charite	The study was supported by university funds (Charite) hold by Prof. Dr. med. Jeanette Schulz Menger. Thoralf Niendorf is founder and CEO of MRI. TOOLS GmbH, Berlin, Germany. Jan Rieger is founder and CTO of MRI. TOOLS GmbH, Berlin, Germany. Darius Lysiak is currently employee of MRI. TOOLS GmbH, Berlin, Germany. MRI. TOOLS GmbH provided support in the form of salaries for authors Jan Rieger and Darius Lysiak, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Brouwer WP, 2012, EUR HEART J-CARD IMG, V13, P292, DOI 10.1093/ehjci/jes005; Bruder O, 2010, J AM COLL CARDIOL, V56, P875, DOI 10.1016/j.jacc.2010.05.007; Child N, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0066-0; Commission IE, 2013, 60601233 IEC; Deva DP, 2013, RADIOLOGY, V269, P68, DOI 10.1148/radiol.13122344; Elliott PM, 2014, EUR HEART J; Frauenrath T, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-67; Gersh BJ, 2011, J AM COLL CARDIOL, V58, pE212, DOI 10.1016/j.jacc.2011.06.011; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Graessl A, 2014, MAGN RESON MED, V72, P276, DOI 10.1002/mrm.24903; Hezel F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052324; Kellman P, 2009, MAGN RESON MED, V61, P215, DOI 10.1002/mrm.21657; Klix S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117095; Kramer CM, 2015, AM HEART J, V170, P223, DOI 10.1016/j.ahj.2015.05.013; KURIBAYASHI T, 1992, AM J CARDIOL, V70, P1333, DOI 10.1016/0002-9149(92)90771-P; Mainero C, 2009, NEUROLOGY, V73, P941, DOI 10.1212/WNL.0b013e3181b64bf7; Maron MS, 2012, CIRC-CARDIOVASC IMAG, V5, P441, DOI 10.1161/CIRCIMAGING.112.972760; Moon JCC, 2004, J AM COLL CARDIOL, V43, P2260, DOI 10.1016/j.jacc.2004.03.035; O'Hanlon R, 2010, J AM COLL CARDIOL, V56, P867, DOI 10.1016/j.jacc.2010.05.010; Petryka J, 2014, CIRC-CARDIOVASC IMAG, V7, P259, DOI 10.1161/CIRCIMAGING.113.001241; Rickers C, 2005, CIRCULATION, V112, P855, DOI 10.1161/CIRCULATIONAHA.104.507723; Rudolph A, 2009, J AM COLL CARDIOL, V53, P284, DOI 10.1016/j.jacc.2008.08.064; Santoro D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049963; Schulz-Menger J, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-35; Sinnecker T, 2012, ARCH NEUROL-CHICAGO, V69, P739, DOI 10.1001/archneurol.2011.2450; Thalhammer C, 2012, J MAGN RESON IMAGING, V36, P847, DOI 10.1002/jmri.23724; van Elderen SGC, 2009, MAGN RESON MED, V62, P1379, DOI 10.1002/mrm.22168; von Knobelsdorff-Brenkenhoff F, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-23; von Knobelsdorff-Brenkenhoff F, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-53; von Knobelsdorff-Brenkenhoff F, 2010, EUR RADIOL, V20, P2844, DOI 10.1007/s00330-010-1888-2; Winter L, 2015, MAGN RESON MED, V74, P999, DOI 10.1002/mrm.25483	31	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148066	10.1371/journal.pone.0148066	http://dx.doi.org/10.1371/journal.pone.0148066			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863618	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000370046600042
J	Detree, C; Chabenat, A; Lallier, FH; Satoh, N; Shoguchi, E; Tanguy, A; Mary, J				Detree, Camille; Chabenat, Apolline; Lallier, Francois H.; Satoh, Nori; Shoguchi, Eiichi; Tanguy, Arnaud; Mary, Jean			Multiple I-Type Lysozymes in the Hydrothermal Vent Mussel Bathymodiolus azoricus and Their Role in Symbiotic Plasticity	PLOS ONE			English	Article							GOOSE-TYPE LYSOZYME; MID-ATLANTIC RIDGE; OYSTER CRASSOSTREA-VIRGINICA; INVERTEBRATE-TYPE LYSOZYMES; EASTERN OYSTER; CDNA CLONING; DE-NOVO; ANTIMICROBIAL ACTIVITY; RECOMBINANT PROTEIN; ADAPTIVE EVOLUTION	The aim of this study was first to identify lysozymes paralogs in the deep sea mussel Bathymodiolus azoricus then to measure their relative expression or activity in different tissue or conditions. B. azoricus is a bivalve that lives close to hydrothermal chimney in the Mid-Atlantic Ridge (MAR). They harbour in specialized gill cells two types of endosymbiont (grambacteria): sulphide oxidizing bacteria (SOX) and methanotrophic bacteria (MOX). This association is thought to be ruled by specific mechanism or actors of regulation to deal with the presence of symbiont but these mechanisms are still poorly understood. Here, we focused on the implication of lysozyme, a bactericidal enzyme, in this endosymbiosis. The relative expression of Ba-lysozymes paralogs and the global anti-microbial activity, were measured in natural population (Lucky Strike - 1700m, Mid-Atlantic Ridge), and in in situ experimental conditions. B. azoricus individuals were moved away from the hydrothermal fluid to induce a loss of symbiont. Then after 6 days some mussels were brought back to the mussel bed to induce a re-acquisition of symbiotic bacteria. Results show the presence of 6 paralogs in B. azoricus. In absence of symbionts, 3 paralogs are up-regulated while others are not differentially expressed. Moreover the global activity of lysozyme is increasing with the loss of symbiont. All together these results suggest that lysozyme may play a crucial role in symbiont regulation.	[Detree, Camille; Chabenat, Apolline; Lallier, Francois H.; Tanguy, Arnaud; Mary, Jean] Univ Paris 06, Sorbonne Univ, CNRS,Stn Biol Roscoff, UMR 7144,Adaptat & Divers Milieu Marin,Equipe ABI, F-29680 Roscoff, France; [Satoh, Nori; Shoguchi, Eiichi] Okinawa Inst Sci & Technol, Marine Genom Unit, Onna, Japan	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Okinawa Institute of Science & Technology Graduate University	Mary, J (corresponding author), Univ Paris 06, Sorbonne Univ, CNRS,Stn Biol Roscoff, UMR 7144,Adaptat & Divers Milieu Marin,Equipe ABI, F-29680 Roscoff, France.	jmary@sb-roscoff.fr	Satoh, Nori/C-4123-2009; Mary, Jean/H-2344-2011; Detree, Camille/P-7073-2019	Satoh, Nori/0000-0002-4480-3572; Mary, Jean/0000-0002-2438-8383; Detree, Camille/0000-0001-5518-2380	Region Bretagne; JST/CNRS program	Region Bretagne(Region Bretagne); JST/CNRS program	This study was supported by the Region Bretagne (C.D.) and the JST/CNRS program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We would like to thank the crew and pilot of the N/O Pourquoi pas? and the ROV Victor 6000 for their assistance and technical support as well as the chief scientist of the Momarsat 2013 cruise, Jerome Blandin. We also want to thank Celine Wichlacz and Aurelie Tasiemski from the Universite de Lille for their help on lysozyme activity measurements and Didier Jollivet for his help on phylogeny. We are very grateful to the Region Bretagne and to JST/CNRS program for funding.	Allam B, 2000, J INVERTEBR PATHOL, V76, P63, DOI 10.1006/jipa.2000.4940; Anselme C, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-43; Bachali S, 2002, J MOL EVOL, V54, P652, DOI 10.1007/s00239-001-0061-6; Bathige SDNK, 2013, FISH SHELLFISH IMMUN, V35, P1369, DOI 10.1016/j.fsi.2013.07.048; Boutet I, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-530; Broderick NA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00072; Callewaert L, 2010, J BIOSCIENCES, V35, P127, DOI 10.1007/s12038-010-0015-5; CAVANAUGH CM, 1992, APPL ENVIRON MICROB, V58, P3799, DOI 10.1128/AEM.58.12.3799-3803.1992; CAVANAUGH CM, 1987, NATURE, V325, P346, DOI 10.1038/325346a0; CHENG TC, 1983, AM ZOOL, V23, P129; CHIPMAN DM, 1969, SCIENCE, V165, P454, DOI 10.1126/science.165.3892.454; Chu HT, 2013, NAT IMMUNOL, V14, P668, DOI 10.1038/ni.2635; Colaco A, 2002, DEEP-SEA RES PT I, V49, P395, DOI 10.1016/S0967-0637(01)00060-7; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cong LN, 2009, J BIOSCI BIOENG, V107, P583, DOI 10.1016/j.jbiosc.2009.01.016; De Busserolles F, 2009, DEEP-SEA RES PT II, V56, P1649, DOI 10.1016/j.dsr2.2009.05.011; Ding JF, 2011, FISH SHELLFISH IMMUN, V30, P163, DOI 10.1016/j.fsi.2010.10.008; Duperron S, 2009, CR BIOL, V332, P298, DOI 10.1016/j.crvi.2008.08.003; Fiala-Medioni A, 2002, MAR BIOL, V141, P1035, DOI 10.1007/s00227-002-0903-9; FIALAMEDIONI A, 1994, CR ACAD SCI III-VIE, V317, P239; FISHER CR, 1987, MAR BIOL, V96, P59, DOI 10.1007/BF00394838; Futahashi R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064557; Goto T, 2007, J BIOL CHEM, V282, P27459, DOI 10.1074/jbc.M704555200; Guezi H, 2014, SYMBIOSIS, V63, P19, DOI 10.1007/s13199-014-0284-0; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; He CB, 2012, COMP BIOCHEM PHYS B, V162, P34, DOI 10.1016/j.cbpb.2012.02.002; Itoh N, 2007, FISH SHELLFISH IMMUN, V23, P957, DOI 10.1016/j.fsi.2007.03.006; Itoh N, 2007, COMP BIOCHEM PHYS B, V148, P160, DOI 10.1016/j.cbpb.2007.05.005; JOLLES J, 1989, J MOL EVOL, V28, P528, DOI 10.1007/BF02602933; Jolles J, 1996, J MOL EVOL, V43, P523, DOI 10.1007/BF02337523; Kadar E, 2005, J EXP MAR BIOL ECOL, V318, P99, DOI 10.1016/j.jembe.2004.12.025; Kim JK, 2014, DEV COMP IMMUNOL, V43, P10, DOI 10.1016/j.dci.2013.10.010; Kleiner M, 2012, CURR OPIN MICROBIOL, V15, P621, DOI 10.1016/j.mib.2012.09.003; Konig S, 2015, MICROSC RES TECHNIQ, V78, P173, DOI 10.1002/jemt.22458; Kuwano Y, 2013, BIOSCI BIOTECH BIOCH, V77, P2269, DOI 10.1271/bbb.130534; LEPENNEC M, 1995, COMP BIOCHEM PHYS A, V111, P183, DOI 10.1016/0300-9629(94)00211-B; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Matsumoto T, 2006, COMP BIOCHEM PHYS B, V145, P325, DOI 10.1016/j.cbpb.2006.08.003; MCHENERY JG, 1979, COMP BIOCHEM PHYS B, V63, P25, DOI 10.1016/0305-0491(79)90228-1; Nakabachi A, 2005, P NATL ACAD SCI USA, V102, P5477, DOI 10.1073/pnas.0409034102; Nilsen IW, 2003, CELL MOL LIFE SCI, V60, P2210, DOI 10.1007/s00018-003-3252-z; Nishikori K, 2009, J INSECT PHYSIOL, V55, P351, DOI 10.1016/j.jinsphys.2009.01.001; PAGE HM, 1990, MAR BIOL, V104, P251, DOI 10.1007/BF01313266; Pan BP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123296; Paskewitz SM, 2008, INSECT MOL BIOL, V17, P217, DOI 10.1111/j.1365-2583.2008.00797.x; Petersen JM, 2011, NATURE, V476, P176, DOI 10.1038/nature10325; Raulfs EC, 2004, J MAR BIOL ASSOC UK, V84, P229, DOI 10.1017/S0025315404009087h; Ren Q, 2012, FISH SHELLFISH IMMUN, V33, P909, DOI 10.1016/j.fsi.2012.07.019; Riou V, 2008, BIOGEOSCIENCES, V5, P1681, DOI 10.5194/bg-5-1681-2008; Royet J, 2011, NAT REV IMMUNOL, V11, P837, DOI 10.1038/nri3089; SALTON MRJ, 1957, BACTERIOL REV, V21, P82, DOI 10.1128/MMBR.21.2.82-100.1957; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; SHUGAR D, 1952, BIOCHIM BIOPHYS ACTA, V8, P302, DOI 10.1016/0006-3002(52)90045-0; STEWART CB, 1987, NATURE, V330, P401, DOI 10.1038/330401a0; Von Cosel R, 1999, VELIGER, V42, P218; Wang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067469; Wang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045148; Wendeberg A, 2012, ISME J, V6, P104, DOI 10.1038/ismej.2011.81; Xue QG, 2007, CELL MOL LIFE SCI, V64, P82, DOI 10.1007/s00018-006-6386-y; Xue QG, 2004, COMP BIOCHEM PHYS B, V139, P11, DOI 10.1016/j.cbpc.2004.05.011; Xue QG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-213; Zavalova LL, 2004, BIOCHEMISTRY-MOSCOW+, V69, P776, DOI 10.1023/B:BIRY.0000040203.37624.ef; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhao J, 2007, MOL IMMUNOL, V44, P1198, DOI 10.1016/j.molimm.2006.06.008	65	10	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148988	10.1371/journal.pone.0148988	http://dx.doi.org/10.1371/journal.pone.0148988			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882089	Green Published, gold			2022-12-27	WOS:000371219000041
J	Gupta, A; Montepiedra, G; Gupte, A; Zeldow, B; Jubulis, J; Detrick, B; Violari, A; Madhi, S; Bobat, R; Cotton, M; Mitchell, C; Spector, S				Gupta, Amita; Montepiedra, Grace; Gupte, Akshay; Zeldow, Bret; Jubulis, Jennifer; Detrick, Barbara; Violari, Avy; Madhi, Shabir; Bobat, Raziya; Cotton, Mark; Mitchell, Charles; Spector, Stephen		IMPAACT NWCS113; P1041 Study Team	Low Vitamin-D Levels Combined with PKP3-SIGIRR-TMEM16J Host Variants Is Associated with Tuberculosis and Death in HIV-Infected and -Exposed Infants	PLOS ONE			English	Article							HUMAN GENETIC SUSCEPTIBILITY; D-RECEPTOR POLYMORPHISMS; D DEFICIENCY; PULMONARY TUBERCULOSIS; CHILDREN; AUTOPHAGY; COHORT	Background This study examined the associations of 25-hydroxyvitamin D and specific host genetic variants that affect vitamin D levels or its effects on immune function, with the risk of TB or mortality in children. Methods A case-cohort sample of 466 South African infants enrolled in P1041 trial (NCT00080119) underwent 25-hydroxyvitamin D testing by chemiluminescent immunoassay. Single nucleotide polymorphisms (SNPs) that alter the effect of vitamin D [e.g. vitamin D receptor (VDR)], vitamin D levels [e.g. vitamin D binding protein (VDBP)], or toll like receptor (TLR) expression (SIGIRR including adjacent genes PKP3 and TMEM16J) were identified by real-time PCR. Outcomes were time to TB, and to the composite of TB or death by 192 weeks of follow-up. Effect modification between vitamin D status and SNPs for outcomes was assessed. Findings Median age at 25-hydroxyvitamin D determination was 8 months; 11% were breastfed, 51% were HIV-infected and 26% had low 25-hydroxyvitamin D (< 32ng/mL). By 192 weeks, 138 incident TB cases (43 definite/probable, and 95 possible) and 26 deaths occurred. Adjusting for HIV status and potential confounders, low 25-hydroxyvitamin D was associated with any TB (adjusted hazard ratio [aHR] 1.76, 95% CI 1.01-3.05; p = 0.046) and any TB or death (aHR 1.76, 95% CI 1.03-3.00; p = 0.038). Children with low 25-hydroxyvitamin D and TMEM 16J rs7111432-AA or PKP3 rs10902158-GG were at increased risk for probable/definite TB or death (aHR 8.12 and 4.83, p < 0.05) and any TB or death (aHR 4.78 and 3.26, p < 0.005) respectively; SNPs in VDBP, VDR, and vitamin D precursor or hydroxylation genes were not. There was significant interaction between low 25-hydroxyvitamin D and, TMEM 16J rs7111432-AA (p = 0.04) and PKP3 rs10902158-GG (p = 0.02) SNPs. Conclusions Two novel SNPs, thought to be associated with innate immunity, in combination with low vitamin D levels were identified as increasing a young child's risk of developing TB disease or death. Identifying high-risk children and providing targeted interventions such as vitamin D supplementation may be beneficial.	[Gupta, Amita; Gupte, Akshay; Jubulis, Jennifer; Detrick, Barbara] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Gupta, Amita; Gupte, Akshay] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Montepiedra, Grace; Zeldow, Bret] Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA; [Violari, Avy] Univ Witwatersrand, Fac Hlth Sci, Perinatal HIV Res Unit, Johannesburg, South Africa; [Madhi, Shabir] Univ Witwatersrand, Med Res Council Resp & Meningeal Pathogens Res Un, Johannesburg, South Africa; [Madhi, Shabir] Univ Witwatersrand, Dept Sci & Technol, Natl Res Fdn Vaccine Preventable Dis, Johannesburg, South Africa; [Bobat, Raziya] Univ KwaZulu Natal, Dept Pediat, Durban, South Africa; [Cotton, Mark] Univ Stellenbosch, Fac Med & Hlth Sci, Childrens Infect Dis Clin Res Unit, ZA-7600 Stellenbosch, South Africa; [Mitchell, Charles] Univ Miami, Miami, FL USA; [Spector, Stephen] Univ Calif San Diego, La Jolla, CA 92093 USA; [Spector, Stephen] Rady Childrens Hosp, San Diego, CA USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Witwatersrand; University of Witwatersrand; National Research Foundation - South Africa; University of Witwatersrand; University of Kwazulu Natal; Stellenbosch University; University of Miami; University of California System; University of California San Diego; Rady Childrens Hospital San Diego	Gupta, A (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD USA.; Gupta, A (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA.; Spector, S (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.; Spector, S (corresponding author), Rady Childrens Hosp, San Diego, CA USA.	agupta25@jhmi.edu; saspector@ucsd.edu	Cotton, Mark/AAQ-9936-2020	Cotton, Mark/0000-0003-2559-6034; Gupta, Amita/0000-0001-7036-2718	National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) [UM1AI068632, UM1AI068616, UM1AI106716]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute of Mental Health (NIMH); NIAID [UM1AI069465]; NINDS [5R01NS077874]; Ujala Foundation; Gilead Foundation; NICHD International and Domestic Pediatric and Maternal HIV Clinical Trials Network (NICHD) [N01-DK-9-001/HHSN267200800001C]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR016587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068616, UM1AI069453, UM1AI069465, UM1AI106716, UM1AI068632, UM1AI069536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077874] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Ujala Foundation; Gilead Foundation(Gilead Sciences); NICHD International and Domestic Pediatric and Maternal HIV Clinical Trials Network (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Overall support for the International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) was provided by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) under Award Numbers UM1AI068632 (IMPAACT LOC), UM1AI068616 (IMPAACT SDMC) and UM1AI106716 (IMPAACT LC), with co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Institute of Mental Health (NIMH). Additional support for the study was provided by NIAID UM1AI069465 (Gupta A.) and NINDS 5R01NS077874 (Spector S.). The Ujala Foundation and Gilead Foundation also supported Gupte A. and Gupta A. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.; We thank the P1041 study team; and the parents/legal guardians for allowing their children to participant in this study. We would also like to thank Bruno Andrade for his assistance in preparing Figs 2 and 4. Overall support for the International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) was provided by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) under Award Numbers UM1AI068632 (IMPAACT LOC), UM1AI068616 (IMPAACT SDMC) and UM1AI106716 (IMPAACT LC), with co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Institute of Mental Health (NIMH). Support of the sites was provided by NIAID and the NICHD International and Domestic Pediatric and Maternal HIV Clinical Trials Network (NICHD contract number N01-DK-9-001/HHSN267200800001C), NIAID UM1AI069465 (Gupta A.) and NINDS 5R01NS077874 (Spector S.A.). The Ujala Foundation also supported Gupte A. and Gupta A. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	[Anonymous], 2004, S AFRICAN NATL TUBER; Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X; Campbell GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003017; Campbell GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002689; Chapman SJ, 2012, NAT REV GENET, V13, P175, DOI 10.1038/nrg3114; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Deluca Hector F, 2014, Bonekey Rep, V3, P479, DOI 10.1038/bonekey.2013.213; Dodd PJ, 2014, LANCET GLOB HEALTH, V2, pE453, DOI 10.1016/S2214-109X(14)70245-1; Gao L, 2010, INT J TUBERC LUNG D, V14, P15; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Graham SM, 2012, J INFECT DIS, V205, pS199, DOI 10.1093/infdis/jis008; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hesseling AC, 2009, CLIN INFECT DIS, V48, P108, DOI 10.1086/595012; Horne DJ, 2012, J INFECT DIS, V205, P586, DOI 10.1093/infdis/jir785; Levin GP, 2012, JAMA-J AM MED ASSOC, V308, P1898, DOI 10.1001/jama.2012.17304; Lewis SJ, 2005, INT J TUBERC LUNG D, V9, P1174; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Madhi SA, 2011, NEW ENGL J MED, V365, P21, DOI 10.1056/NEJMoa1011214; Mark SD, 2006, J AM STAT ASSOC, V101, P460, DOI 10.1198/016214505000000952; Martineau AR, 2010, EUR RESPIR J, V35, P1106, DOI 10.1183/09031936.00087009; Martineau AR, 2011, LANCET, V377, P242, DOI 10.1016/S0140-6736(10)61889-2; Martineaua AR, 2011, P NATL ACAD SCI USA, V108, P19013, DOI 10.1073/pnas.1111825108; Misra M, 2008, PEDIATRICS, V122, P398, DOI 10.1542/peds.2007-1894; Moller M, 2010, TUBERCULOSIS, V90, P71, DOI 10.1016/j.tube.2010.02.002; Moller M, 2010, FEMS IMMUNOL MED MIC, V58, P3, DOI 10.1111/j.1574-695X.2009.00600.x; Netea MG, 2012, NAT IMMUNOL, V13, P535, DOI 10.1038/ni.2284; Nnoaham KE, 2008, INT J EPIDEMIOL, V37, P113, DOI 10.1093/ije/dym247; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Perez-Velez CM, 2012, NEW ENGL J MED, V367, P348, DOI 10.1056/NEJMra1008049; Poopedi MA, 2011, PUBLIC HEALTH NUTR, V14, P334, DOI 10.1017/S136898001000234X; PRENTICE RL, 1986, BIOMETRIKA, V73, P1; Ralph AR, 2013, LANCET INFECT DIS, V13, P77, DOI 10.1016/S1473-3099(12)70275-X; Selvaraj P, 2010, TUBERCULOSIS, V90, P306, DOI 10.1016/j.tube.2010.08.001; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Valdivielso JM, 2006, CLIN CHIM ACTA, V371, P1, DOI 10.1016/j.cca.2006.02.016; Walker VP, 2009, PEDIATR RES, V65, p106R, DOI 10.1203/PDR.0b013e31819dba91; WHO, 2013, GLOB TUB REP GEN; Wilkinson RJ, 2000, LANCET, V355, P618, DOI 10.1016/S0140-6736(99)02301-6; Williams B, 2008, PEDIATR INFECT DIS J, V27, P941, DOI 10.1097/INF.0b013e31817525df; Zeng JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126014	40	12	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148649	10.1371/journal.pone.0148649	http://dx.doi.org/10.1371/journal.pone.0148649			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872154	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100047
J	He, GJ; Li, J; Yang, L; Hou, CH; Ni, TJ; Yang, ZJ; Qian, XL; Li, CZ				He, Guangjie; Li, Jing; Yang, Lu; Hou, Chunhua; Ni, Tianjun; Yang, Zhijun; Qian, Xinlai; Li, Changzheng			The Synthesis of a Coumarin Carbohydrazide Dinuclear Copper Complex Based Fluorescence Probe and Its Detection of Thiols	PLOS ONE			English	Article							SELECTIVE DETECTION; LIVING CELLS; INTRACELLULAR THIOLS; OXIDATIVE STRESS; CYSTEINE; GLUTATHIONE; HOMOCYSTEINE; BIOTHIOLS; CHEMOSENSORS; NAPHTHALIMIDE	Small-molecule thiols, such as cysteine (CYS) and glutathione (GSH), are essential for maintaining the cellular redox environment and play important roles in regulating various cellular physiological functions. A fluorescence probe (compound 1-Cu2+) for thiols based on coumarin carbohydrazide dinuclear copper complex was developed. Compound 1 was synthesized from the reaction of 7-(diethylamino)-2-oxo-2H-chromene-3-carbohydrazide with 4-tert-butyl-2,6-diformylphenol. Accordingly, the copper complex (compound 1-Cu2+) was prepared by mixing compound 1 with 2 equivalents copper ions. Compound 1 had strong fluorescence while compound 1-Cu2+ hardly possessed fluorescence owing to the quenching nature of paramagnetism Cu2+ to the fluorescence molecule excited state. However, the fluorescence intensity of compound 1-Cu2+ was increased dramatically after the addition of thiol-containing amino acids, but not the other non-sulfhydryl amino acids. UV-vis absorption and fluorescence spectra indicated that compound 1-Cu2+ had good selectivity and sensitivity for thiols such as glutathione in CH3CN:H2O (3:2, v/v) PBS solution. The fluorescence imaging experiments implied that compound 1-Cu2+ has potential application in thiol-containing amino acids detection in living cells.	[He, Guangjie; Li, Jing] Xinxiang Med Univ, Dept Forens Med, Jinsui Rd 601, Xinxiang 453003, Peoples R China; [Yang, Lu; Ni, Tianjun; Yang, Zhijun; Qian, Xinlai; Li, Changzheng] Xinxiang Med Univ, Sch Basic Med Sci, Jinsui Rd 601, Xinxiang 453003, Peoples R China; [Hou, Chunhua] Xinxiang Med Univ, Coll Pharm, Jinsui Rd 601, Xinxiang 453003, Peoples R China	Xinxiang Medical University; Xinxiang Medical University; Xinxiang Medical University	He, GJ (corresponding author), Xinxiang Med Univ, Dept Forens Med, Jinsui Rd 601, Xinxiang 453003, Peoples R China.; Li, CZ (corresponding author), Xinxiang Med Univ, Sch Basic Med Sci, Jinsui Rd 601, Xinxiang 453003, Peoples R China.	guangjiehe@163.com; changzhenl@yahoo.com			National Natural Science Foundation [21371148, 81401470, 21571153]; National Natural Science Foundation of China; Key Scientific and Technological Project of Henan Province [122102310196]; Science and Technology Department of Henan Province; Education Project of Henan Province [12A150019]; Education Department of Henan Provincial	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Scientific and Technological Project of Henan Province; Science and Technology Department of Henan Province; Education Project of Henan Province; Education Department of Henan Provincial	This work was financially supported by the following: (1) National Natural Science Foundation (No.21371148), National Natural Science Foundation of China and G. He received the funding, http://www.nsfc.gov.cn/. (2) National Natural Science Foundation (No.81401470), National Natural Science Foundation of China and T. Ni received the funding, http://www.nsfc.gov.cn/. (3) Key Scientific and Technological Project of Henan Province (No.122102310196), the Science and Technology Department of Henan Province and G. He received the funding, http://www.henan.gov.cn/zwgk/system/2006/09/15/010007049. shtml. (4) The financial support from Education Project of Henan Province (No. 12A150019), the Education Department of Henan Provincial and G. He received the funding, http://www.haedu.gov.cn/.; This work was financially supported by the National Natural Science Foundation (No. 21371148, 81401470 and 21571153), the financial support from Key Scientific and Technological Project of Henan Province (No. 122102310196) and the financial support from Education Project of Henan Province (No. 12A150019).	Chen X, 2010, CHEM SOC REV, V39, P2120, DOI 10.1039/b925092a; Dai ZC, 2013, ANAL CHEM, V85, P11658, DOI 10.1021/ac403370g; Dalton TD, 1999, ANNU REV PHARMACOL, V39, P67, DOI 10.1146/annurev.pharmtox.39.1.67; Han QX, 2014, ORG BIOMOL CHEM, V12, P5023, DOI 10.1039/c4ob00463a; He GJ, 2008, INORG CHEM, V47, P5169, DOI 10.1021/ic702494s; He GJ, 2010, TETRAHEDRON, V66, P9762, DOI 10.1016/j.tet.2010.09.043; Hong R, 2006, J AM CHEM SOC, V128, P1078, DOI 10.1021/ja056726i; Hong V, 2009, J AM CHEM SOC, V131, P9986, DOI 10.1021/ja809345d; Jung HS, 2013, CHEM SOC REV, V42, P6019, DOI 10.1039/c3cs60024f; Jung HS, 2011, CHEM COMMUN, V47, P5142, DOI 10.1039/c1cc10672d; Kong FP, 2013, CHEM COMMUN, V49, P9176, DOI 10.1039/c3cc45519j; Lee JH, 2015, J INCL PHENOM MACRO, V82, P117, DOI 10.1007/s10847-015-0486-y; Lee MH, 2013, CHEM REV, V113, P5071, DOI 10.1021/cr300358b; Lee MH, 2012, J AM CHEM SOC, V134, P1316, DOI 10.1021/ja210065g; Li HL, 2009, CHEM COMMUN, P5904, DOI 10.1039/b907511a; Li J, 2014, ANAL CHEM, V86, P3037, DOI 10.1021/ac403885n; Lim CS, 2011, J AM CHEM SOC, V133, P11132, DOI 10.1021/ja205081s; Lim SY, 2014, J AM CHEM SOC, V136, P7018, DOI 10.1021/ja500962u; Lindoy LF, 1998, SYNTHESIS-STUTTGART, P1029; Liu J, 2014, J AM CHEM SOC, V136, P574, DOI 10.1021/ja409578w; Liu SR, 2014, ANAL CHIM ACTA, V849, P64, DOI 10.1016/j.aca.2014.08.024; Long LL, 2013, ORG BIOMOL CHEM, V11, P8214, DOI 10.1039/c3ob41741g; Lou ZR, 2013, CHEM COMMUN, V49, P391, DOI 10.1039/c2cc36839k; Ma YM, 2004, J MED CHEM, V47, P6349, DOI 10.1021/jm049751s; Maeda H, 2005, ANGEW CHEM INT EDIT, V44, P2922, DOI 10.1002/anie.200500114; Malwal SR, 2014, CHEM COMMUN, V50, P11533, DOI 10.1039/c4cc05462h; Niu LY, 2015, CHEM SOC REV, V44, P6143, DOI 10.1039/c5cs00152h; Niu LY, 2012, J AM CHEM SOC, V134, P18928, DOI 10.1021/ja309079f; Peng HJ, 2012, SENSORS-BASEL, V12, P15907, DOI 10.3390/s121115907; Reddy GU, 2014, CHEM COMMUN, V50, P9899, DOI 10.1039/c4cc04214j; Reiss A, 2014, BIOINORG CHEM APPL, V2014, DOI 10.1155/2014/926287; Sarkar D, 2014, J LUMIN, V146, P480, DOI 10.1016/j.jlumin.2013.09.080; Shi YG, 2013, BIOORG MED CHEM LETT, V23, P2538, DOI 10.1016/j.bmcl.2013.03.004; Sobhakumari A, 2013, TOXICOL APPL PHARM, V272, P736, DOI 10.1016/j.taap.2013.07.013; Su DD, 2014, BIOMATERIALS, V35, P6078, DOI 10.1016/j.biomaterials.2014.04.035; Takechi H, 2000, CHEM PHARM BULL, V48, P1702; Tang B, 2007, J AM CHEM SOC, V129, P11666, DOI 10.1021/ja072572q; Tian MG, 2014, ORG BIOMOL CHEM, V12, P6128, DOI 10.1039/c4ob00382a; Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X; Tu FQ, 2014, ELECTROPHORESIS, V35, P1188, DOI 10.1002/elps.201300452; Wang FY, 2014, CHEM-EUR J, V20, P11471, DOI 10.1002/chem.201403450; Wang P, 2012, ORG LETT, V14, P520, DOI 10.1021/ol203123t; Wei MJ, 2013, CHEM COMMUN, V49, P4640, DOI 10.1039/c3cc39045d; Xu C, 2015, BIOSENS BIOELECTRON, V72, P275, DOI 10.1016/j.bios.2015.05.030; Yi L, 2009, ANGEW CHEM INT EDIT, V48, P4034, DOI 10.1002/anie.200805693; Yu CW, 2014, SENSORS-BASEL, V14, P21375, DOI 10.3390/s141121375; Zhang HT, 2015, CHEM COMMUN, V51, P2029, DOI 10.1039/c4cc08156k; Zhang HT, 2012, CHEM COMMUN, V48, P10672, DOI 10.1039/c2cc35513b; Zhang Q, 2014, CHEM COMMUN, V50, P14002, DOI 10.1039/c4cc04978k; Zhao LZ, 2014, ACS APPL MATER INTER, V6, P11190, DOI 10.1021/am501249p; Zhao X., 2010, FAGUANG XUEBAO, V31, P433; Zitka O, 2012, ONCOL LETT, V4, P1247, DOI 10.3892/ol.2012.931; Zong J, 2014, BIOSENS BIOELECTRON, V51, P330, DOI 10.1016/j.bios.2013.07.042	53	15	15	5	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148026	10.1371/journal.pone.0148026	http://dx.doi.org/10.1371/journal.pone.0148026			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871436	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100015
J	Naud, MJ; Sauer, WHH; McKeown, NJ; Shaw, PW				Naud, Marie-Jose; Sauer, Warwick H. H.; McKeown, Niall J.; Shaw, Paul W.			Multiple Mating, Paternity and Complex Fertilisation Patterns in the Chokka Squid Loligo reynaudii	PLOS ONE			English	Article							CRYPTIC FEMALE CHOICE; REPRODUCTIVE SUCCESS; PARENTAL GENOTYPES; GIANT CUTTLEFISH; SPERM PRECEDENCE; EGG CAPSULES; DYNAMICS; MOLLUSCA; DNA; CEPHALOPODA	Polyandry is widespread and influences patterns of sexual selection, with implications for sexual conflict over mating. Assessing sperm precedence patterns is a first step towards understanding sperm competition within a female and elucidating the roles of male- and female-controlled factors. In this study behavioural field data and genetic data were combined to investigate polyandry in the chokka squid Loligo reynaudii. Microsatellite DNA-based paternity analysis revealed multiple paternity to be the norm, with 79% of broods sired by at least two males. Genetic data also determined that the male who was guarding the female at the moment of sampling was a sire in 81% of the families tested, highlighting mate guarding as a successful male tactic with postcopulatory benefits linked to sperm deposition site giving privileged access to extruded egg strings. As females lay multiple eggs in capsules (egg strings) wherein their position is not altered during maturation it is possible to describe the spatial / temporal sequence of fertilisation / sperm precedence There were four different patterns of fertilisation found among the tested egg strings: 1) unique sire; 2) dominant sire, with one or more rare sires; 3) randomly mixed paternity (two or more sires); and 4) a distinct switch in paternity occurring along the egg string. The latter pattern cannot be explained by a random use of stored sperm, and suggests postcopulatory female sperm choice. Collectively the data indicate multiple levels of male- and female-controlled influences on sperm precedence, and highlights squid as interesting models to study the interplay between sexual and natural selection.	[Naud, Marie-Jose] Royal Holloway Univ London, Sch Biol Sci, Egham, Surrey, England; [Sauer, Warwick H. H.; Shaw, Paul W.] Rhodes Univ, Dept Ichthyol & Fisheries Sci, ZA-6140 Grahamstown, South Africa; [McKeown, Niall J.; Shaw, Paul W.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth SY23 3FG, Dyfed, Wales	University of London; Royal Holloway University London; Rhodes University; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Shaw, PW (corresponding author), Rhodes Univ, Dept Ichthyol & Fisheries Sci, ZA-6140 Grahamstown, South Africa.; Shaw, PW (corresponding author), Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth SY23 3FG, Dyfed, Wales.	pws3@aber.ac.uk	McKeown, Niall/AAK-5989-2020; Sauer, Warwick/GJI-2267-2022	McKeown, Niall/0000-0002-7351-5553; Sauer, Warwick/0000-0002-9756-1757; Shaw, Paul/0000-0003-2637-6332	EU Marie Curie Fellowship; National Research Foundation (NRF, South Africa); South African Squid Management Industrial Association (SASMIA, South Africa)	EU Marie Curie Fellowship(European Commission); National Research Foundation (NRF, South Africa)(National Research Foundation - South Africa); South African Squid Management Industrial Association (SASMIA, South Africa)	M-JN was supported through this study by an EU Marie Curie Fellowship. This study was supported financially by the National Research Foundation (NRF, South Africa) and the South African Squid Management Industrial Association (SASMIA, South Africa).	Arbuthnott D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090207; Barbosa F, 2009, BEHAV ECOL, V20, P957, DOI 10.1093/beheco/arp083; Birkhead T.R., 1998, P579, DOI 10.1016/B978-012100543-6/50039-8; Birkhead TR, 1998, EVOLUTION, V52, P1212, DOI [10.1111/j.1558-5646.1998.tb01848.x, 10.2307/2411251]; BOLETZKY SV, 1986, AM MALACOL BULL, V4, P217; Boyle P. R., 2005, CEPHALOPODS ECOLOGY; Buresch KC, 2009, MAR ECOL PROG SER, V387, P197, DOI 10.3354/meps08052; Buresch KM, 2001, MAR ECOL PROG SER, V210, P161, DOI 10.3354/meps210161; den Boer SPA, 2010, SCIENCE, V327, P1506, DOI 10.1126/science.1184709; DeWoody JA, 2000, GENETICS, V154, P1907; Dottorini T, 2012, PATHOG GLOB HEALTH, V106, P405, DOI 10.1179/2047773212Y.0000000058; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Emery AM, 2001, MOL ECOL, V10, P1265, DOI 10.1046/j.1365-294X.2001.01258.x; Hanlon RT, 1997, BIOL BULL, V193, P212, DOI 10.1086/BBLv193n2p212; Hanlon RT, 2004, MAR BIOL, V145, P923, DOI 10.1007/s00227-004-1383-x; Hanlon RT, 2002, B MAR SCI, V71, P331; Hanlon RT, 1996, CEPHALOPOD BEHAV; Harvey IF, 2000, P ROY SOC B-BIOL SCI, V267, P2537, DOI 10.1098/rspb.2000.1317; Iwata Y, 2005, MAR ECOL PROG SER, V298, P219, DOI 10.3354/meps298219; Iwata Y, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-236; Jantzen TM, 2003, BIOL BULL-US, V204, P305, DOI 10.2307/1543601; Jones AG, 2005, MOL ECOL NOTES, V5, P708, DOI 10.1111/j.1471-8286.2005.01029.x; Liu JX, 2011, MAR BIOL, V158, P893, DOI 10.1007/s00227-010-1616-0; Maynard Smith J., 1982, pi; Naud MJ, 2008, MOL ECOL RESOUR, V8, P943, DOI 10.1111/j.1755-0998.2008.02125.x; Naud MJ, 2006, MAR BIOL, V148, P559, DOI 10.1007/s00227-005-0109-z; Naud MJ, 2004, ANIM BEHAV, V67, P1043, DOI 10.1016/j.anbehav.2003.10.005; Neff BD, 2002, J FISH BIOL, V61, P739, DOI 10.1111/j.1095-8649.2002.tb00908.x; ONO T, 1989, PHYSIOL ENTOMOL, V14, P195, DOI 10.1111/j.1365-3032.1989.tb00952.x; Pizzari T, 2000, NATURE, V405, P787, DOI 10.1038/35015558; Pizzari T, 2013, PHILOS T R SOC B, P368; Ribou AC, 2012, P ROY SOC B-BIOL SCI, V279, P2196, DOI 10.1098/rspb.2011.2422; Roderick GK, 2003, ANN ENTOMOL SOC AM, V96, P631, DOI 10.1603/0013-8746(2003)096[0631:SPICPB]2.0.CO;2; Rosengrave P, 2008, BEHAV ECOL, V19, P1179, DOI 10.1093/beheco/arn089; Sauer WHH, 1995, S AFR J MARINE SCI, V16, P185; Sauer WHH, 1997, BIOL BULL, V192, P203, DOI 10.2307/1542714; Schlechter-Helas J, 2011, NATURWISSENSCHAFTEN, V98, P855, DOI 10.1007/s00114-011-0836-6; Shashar N, 2013, J EXP MAR BIOL ECOL, V447, P65, DOI 10.1016/j.jembe.2013.02.011; Shaw PW, 2010, MAR ECOL PROG SER, V408, P117, DOI 10.3354/meps08593; Shaw PW, 2004, MAR ECOL PROG SER, V270, P173, DOI 10.3354/meps270173; Shaw PW, 1997, MAR ECOL PROG SER, V160, P279, DOI 10.3354/meps160279; Simmons L. W., 2001, MG BEH ECOL; Simmons LW, 2005, ANNU REV ECOL EVOL S, V36, P125, DOI 10.1146/annurev.ecolsys.36.102403.112501; Sugg DW, 1996, TRENDS ECOL EVOL, V11, P338, DOI 10.1016/0169-5347(96)20050-3; van Camp LM, 2005, MAR FRESHWATER RES, V56, P933, DOI 10.1071/MF04287; WAAGE JK, 1979, SCIENCE, V203, P916, DOI 10.1126/science.203.4383.916; Walker D, 2007, MAR BIOL, V151, P53, DOI 10.1007/s00227-006-0463-5; WINNEPENNINCKX B, 1993, TRENDS GENET, V9, P407; Wolfner MF, 2009, J HERED, V100, P399, DOI 10.1093/jhered/esp013	49	21	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0146995	10.1371/journal.pone.0146995	http://dx.doi.org/10.1371/journal.pone.0146995			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872354	Green Submitted, gold, Green Published			2022-12-27	WOS:000370054100004
J	Villahermosa, D; Corzo, A; Garcia-Robledo, E; Gonzalez, JM; Papaspyrou, S				Villahermosa, Desiree; Corzo, Alfonso; Garcia-Robledo, Emilio; Gonzalez, Juan M.; Papaspyrou, Sokratis			Kinetics of Indigenous Nitrate Reducing Sulfide Oxidizing Activity in Microaerophilic Wastewater Biofilms	PLOS ONE			English	Article							BACTERIAL SULFATE REDUCTION; HYDROGEN-SULFIDE; OXYGEN-UPTAKE; AUTOTROPHIC DENITRIFICATION; NITROGEN TRANSFORMATIONS; OXIDATION; INHIBITION; DIFFUSION; REMOVAL; WASTEWATERS	Nitrate decreases sulfide release in wastewater treatment plants (WWTP), but little is known on how it affects the microzonation and kinetics of related microbial processes within the biofilm. The effect of nitrate addition on these properties for sulfate reduction, sulfide oxidation, and oxygen respiration were studied with the use of microelectrodes in microaerophilic wastewater biofilms. Mass balance calaculations and community composition analysis were also performed. At basal WWTP conditions, the biofilm presented a double-layer system. The upper microaerophilic layer (similar to 300 mu m) showed low sulfide production (0.31 mu mol cm(-3) h(-1)) and oxygen consumption rates (0.01 mu mol cm(-3) h(-1)). The anoxic lower layer showed high sulfide production (2.7 mu mol cm(-3) h(-1)). Nitrate addition decreased net sulfide production rates, caused by an increase in sulfide oxidation rates (SOR) in the upper layer, rather than an inhibition of sulfate reducing bacteria (SRB). This suggests that the indigenous nitrate reducing-sulfide oxidizing bacteria (NR-SOB) were immediately activated by nitrate. The functional vertical structure of the biofilm changed to a triple-layer system, where the previously upper sulfide-producing layer in the absence of nitrate split into two new layers: 1) an upper sulfide-consuming layer, whose thickness is probably determined by the nitrate penetration depth within the biofilm, and 2) a middle layer producing sulfide at an even higher rate than in the absence of nitrate in some cases. Below these layers, the lower net sulfide-producing layer remained unaffected. Net SOR varied from 0.05 to 0.72 mu mol cm(-3) h(-1) depending on nitrate and sulfate availability. Addition of low nitrate concentrations likely increased sulfate availability within the biofilm and resulted in an increase of both net sulfate reduction and net sulfide oxidation by overcoming sulfate diffusional limitation from the water phase and the strong coupling between SRB and NR-SOB syntrophic relationship.	[Villahermosa, Desiree; Corzo, Alfonso; Garcia-Robledo, Emilio; Papaspyrou, Sokratis] Univ Cadiz, Dept Biol, Fac Ciencias Mar & Ambientales, Pol Rio San Pedro S-N, Cadiz 11510, Spain; [Gonzalez, Juan M.] IRNAS CSIC, Inst Recursos Nat & Agrobiol, Avda Reina Mercedes 10, Seville 41012, Spain; [Garcia-Robledo, Emilio] Aarhus Univ, Dept Biosci, Microbiol Sect, DK-8000 Aarhus, Denmark; [Papaspyrou, Sokratis] Univ Cadiz, Dept Biomed Biotecnol & Salud Publ, Pol Rio San Pedro S-N, Puerto Real 11510, Spain	Universidad de Cadiz; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Sevilla (IRNAS); Aarhus University; Universidad de Cadiz	Corzo, A (corresponding author), Univ Cadiz, Dept Biol, Fac Ciencias Mar & Ambientales, Pol Rio San Pedro S-N, Cadiz 11510, Spain.	alfonso.corzo@uca.es	Corzo, Alfonso/L-9669-2015; Papaspyrou, Sokratis/H-5022-2011; Garcia-Robledo, Emilio/B-3781-2017; Villahermosa Caballero, Desiree/F-3745-2017	Corzo, Alfonso/0000-0003-3718-941X; Papaspyrou, Sokratis/0000-0003-4406-0702; Garcia-Robledo, Emilio/0000-0002-4337-6433; Villahermosa Caballero, Desiree/0000-0003-4072-6159; Gonzalez, Juan Miguel/0000-0003-4746-6775	Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia [RNM-214, BIO-288]; Spanish Ministry of Economy and Competitiveness [CTM2013-43857-R];  [P06-RNM-01787];  [P11-RNM-7199]	Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia(Junta de Andalucia); Spanish Ministry of Economy and Competitiveness(Spanish Government); ; 	AC was funded by projects P06-RNM-01787, P11-RNM-7199, the PAI group RNM-214 from Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia and CTM2013-43857-R from the Spanish Ministry of Economy and Competitiveness. JMG was funded by the PAI group BIO-288 from Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was funded by projects P06-RNM-01787, P11-RNM-7199, the PAI groups RNM-214 and BIO-288 from Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia and CTM2013-43857-R from the Spanish Ministry of Economy and Competitiveness. We also want to acknowledge the personnel from Guadalete WWTP and AJEMSA for the technical help during the biofilm growth in situ and collection for experiments.	ABDOLLAHI H, 1979, MICROB ECOL, V5, P73, DOI 10.1007/BF02010581; American Society of Civil Engineers, 1989, SULF WAST COLL TREAT; Andrussow L., 1969, LANDOLTBORNSTEIN ZAH, VII, P513; [Anonymous], 2005, STANDARD METHODS EXA; BAK F, 1991, FEMS MICROBIOL ECOL, V85, P43; Barton LL, 2007, SULPHATE-REDUCING BACTERIA: ENVIRONMENTAL AND ENGINEERED SYSTEMS, P1, DOI 10.1017/CBO9780511541490; Berg P, 1998, LIMNOL OCEANOGR, V43, P1500, DOI 10.4319/lo.1998.43.7.1500; Cardoso RB, 2006, BIOTECHNOL BIOENG, V95, P1148, DOI 10.1002/bit.21084; Bodtker G, 2008, J IND MICROBIOL BIOT, V35, P1625, DOI 10.1007/s10295-008-0406-x; Boeije G, 1999, CHEMOSPHERE, V38, P699, DOI 10.1016/S0045-6535(98)00311-7; BOWER CE, 1980, CAN J FISH AQUAT SCI, V37, P794, DOI 10.1139/f80-106; Can-Dogan E, 2010, WATER SCI TECHNOL, V62, P2286, DOI 10.2166/wst.2010.545; Chen Y, 2008, BIORESOURCE TECHNOL, V99, P4044, DOI 10.1016/j.biortech.2007.01.057; Cirne Dores G., 2008, Reviews in Environmental Science and Bio/Technology, V7, P93, DOI 10.1007/s11157-008-9128-9; CLAUS G, 1985, APPL MICROBIOL BIOT, V22, P283; De Gusseme B, 2009, FEMS MICROBIOL ECOL, V67, P151, DOI 10.1111/j.1574-6941.2008.00598.x; de Lomas JG, 2006, BIOTECHNOL BIOENG, V93, P801, DOI 10.1002/bit.20768; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Eary LE, 1990, ACS S SERIES; Gadekar S, 2006, WATER RES, V40, P2436, DOI 10.1016/j.watres.2006.04.007; Garcia de Lomas J, 2007, WATER RES, V41, P3121, DOI DOI 10.1016/J.WATRES.2007.04.004; Garcia-Robledo E, 2014, MAR CHEM, V162, P30, DOI 10.1016/j.marchem.2014.03.002; Gevertz D, 2000, APPL ENVIRON MICROB, V66, P2491, DOI 10.1128/AEM.66.6.2491-2501.2000; Gonzalez JM, 2003, J MICROBIOL METH, V55, P459, DOI 10.1016/S0167-7012(03)00171-4; Greene EA, 2003, ENVIRON MICROBIOL, V5, P607, DOI 10.1046/j.1462-2920.2003.00446.x; HALL POJ, 1989, LIMNOL OCEANOGR, V34, P734, DOI 10.4319/lo.1989.34.4.0734; Haveman SA, 2004, J BACTERIOL, V186, P7944, DOI 10.1128/JB.186.23.7944-7950.2004; Hoor A.T.-T., 1975, NOV NETH J SEA RES, V9, P344, DOI DOI 10.1016/0077-7579(75)90008-3; INGVORSEN K, 1984, APPL ENVIRON MICROB, V47, P403, DOI 10.1128/AEM.47.2.403-408.1984; INGVORSEN K, 1981, APPL ENVIRON MICROB, V42, P1029, DOI 10.1128/AEM.42.6.1029-1036.1981; Isaksen MF, 1996, APPL ENVIRON MICROB, V62, P408, DOI 10.1128/AEM.62.2.408-414.1996; Ito T, 2002, APPL ENVIRON MICROB, V68, P1392, DOI 10.1128/AEM.68.3.1392-1402.2002; JAENCHEN R, 1984, ARCH MICROBIOL, V137, P362, DOI 10.1007/BF00410735; Jiang GM, 2013, WATER RES, V47, P1783, DOI 10.1016/j.watres.2012.12.036; Jiang GM, 2009, WATER RES, V43, P4430, DOI 10.1016/j.watres.2009.07.001; JORGENSEN BB, 1985, LIMNOL OCEANOGR, V30, P111, DOI 10.4319/lo.1985.30.1.0111; KUHL M, 1992, APPL ENVIRON MICROB, V58, P1164; LENS PN, 1995, WATER RES, V29, P871, DOI 10.1016/0043-1354(94)00195-D; LI YH, 1974, GEOCHIM COSMOCHIM AC, V38, P703; MCCARTNEY DM, 1991, WATER RES, V25, P203, DOI 10.1016/0043-1354(91)90030-T; MILLERO FJ, 1986, MAR CHEM, V18, P121, DOI 10.1016/0304-4203(86)90003-4; Mohanakrishnan J, 2011, APPL MICROBIOL BIOT, V91, P1647, DOI 10.1007/s00253-011-3330-3; Mora M, 2015, APPL MICROBIOL BIOT, V99, P77, DOI 10.1007/s00253-014-5688-5; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nemati M, 2001, BIOTECHNOL PROGR, V17, P852, DOI 10.1021/bp010084v; NIELSEN PH, 1987, APPL ENVIRON MICROB, V53, P27, DOI 10.1128/AEM.53.1.27-32.1987; Okabe S, 1999, APPL ENVIRON MICROB, V65, P5107; Okabe S, 1999, APPL ENVIRON MICROB, V65, P3182; Okabe S, 2005, APPL ENVIRON MICROB, V71, P2520, DOI 10.1128/AEM.71.5.2520-2529.2005; Okabe S, 2003, WATER SCI TECHNOL, V47, P281, DOI 10.2166/wst.2003.0616; Okabe S, 2003, APPL MICROBIOL BIOT, V63, P322, DOI 10.1007/s00253-003-1395-3; Okabe S, 1998, WATER SCI TECHNOL, V37, P131, DOI 10.1016/S0273-1223(98)00095-X; ONUMA M, 1985, BIOTECHNOL BIOENG, V27, P1533, DOI 10.1002/bit.260271103; Paredes D, 2007, ENG LIFE SCI, V7, P13, DOI 10.1002/elsc.200620170; Portillo MC, 2008, ANTON LEEUW INT J G, V94, P157, DOI 10.1007/s10482-008-9221-7; Portillo MC, 2011, APPL ENVIRON MICROB, V77, P351, DOI 10.1128/AEM.01316-10; Portillo MC, 2009, ANTON LEEUW INT J G, V96, P559, DOI 10.1007/s10482-009-9371-2; Raju HP, 2009, J SCI IND RES INDIA, V68, P406; RAMSING NB, 1993, APPL ENVIRON MICROB, V59, P3840, DOI 10.1128/AEM.59.11.3840-3849.1993; RASMUSSEN H, 1992, MAR ECOL PROG SER, V81, P289, DOI 10.3354/meps081289; REIS MAM, 1992, BIOTECHNOL BIOENG, V40, P593, DOI 10.1002/bit.260400506; Revsbech NP, 2006, ANTON LEEUW INT J G, V90, P361, DOI 10.1007/s10482-006-9087-5; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; REVSBECH NP, 1986, ADV MICROB ECOL, V9, P293; Santegoeds CM, 1998, APPL ENVIRON MICROB, V64, P3731; SIEGRIST H, 1985, WATER RES, V19, P1369, DOI 10.1016/0043-1354(85)90303-3; Soreanu G, 2008, WATER SCI TECHNOL, V57, P201, DOI 10.2166/wst.2008.023; Soreanu G, 2008, J ENVIRON ENG SCI, V7, P543, DOI 10.1139/S08-023; Stewart PS, 2003, J BACTERIOL, V185, P1485, DOI 10.1128/JB.185.5.1485-1491.2003; Stewart PS, 1998, BIOTECHNOL BIOENG, V59, P261, DOI 10.1002/(SICI)1097-0290(19980805)59:3<261::AID-BIT1>3.0.CO;2-9; Villahermosa D, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1738-3; Watnick P, 2000, J BACTERIOL, V182, P2675, DOI 10.1128/JB.182.10.2675-2679.2000; Zeng H, 2005, WATER RES, V39, P4941, DOI 10.1016/j.watres.2005.09.034	73	4	4	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149096	10.1371/journal.pone.0149096	http://dx.doi.org/10.1371/journal.pone.0149096			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872267	Green Submitted, Green Published, gold			2022-12-27	WOS:000370054100102
J	Lundstrom, J; Ohman, K; Ronnqvist, M; Gustafsson, L				Lundstrom, Johanna; Ohman, Karin; Ronnqvist, Mikael; Gustafsson, Lena			Considering Future Potential Regarding Structural Diversity in Selection of Forest Reserves	PLOS ONE			English	Article							CLIMATE-CHANGE; BIODIVERSITY INDICATORS; CONSERVATION; BOREAL; TREES; PRIORITIES; PINE	A rich structural diversity in forests promotes biodiversity. Forests are dynamic and therefore it is crucial to consider future structural potential when selecting reserves, to make robust conservation decisions. We analyzed forests in boreal Sweden based on 17,599 National Forest Inventory (NFI) plots with the main aim to understand how effectiveness of reserves depends on the time dimension in the selection process, specifically by considering future structural diversity. In the study both the economic value and future values of 15 structural variables were simulated during a 100 year period. To get a net present structural value (NPSV), a single value covering both current and future values, we used four discounting alternatives: (1) only considering present values, (2) giving equal importance to values in each of the 100 years within the planning horizon, (3) applying an annual discount rate considering the risk that values could be lost, and (4) only considering the values in year 100. The four alternatives were evaluated in a reserve selection model under budget-constrained and area-constrained selections. When selecting young forests higher structural richness could be reached at a quarter of the cost over almost twice the area in a budget-constrained selection compared to an area-constrained selection. Our results point to the importance of considering future structural diversity in the selection of forest reserves and not as is done currently to base the selection on existing values. Targeting future values increases structural diversity and implies a relatively lower cost. Further, our results show that a re-orientation from old to young forests would imply savings while offering a more extensive reserve network with high structural qualities in the future. However, caution must be raised against a drastic reorientation of the current old-forest strategy since remnants of ancient forests will need to be prioritized due to their role for disturbance-sensitive species.	[Lundstrom, Johanna; Ohman, Karin] Swedish Univ Agr Sci, Dept Forest Resource Management, S-90183 Umea, Sweden; [Ronnqvist, Mikael] Univ Laval, Dept Genie Mecan, Quebec City, PQ, Canada; [Gustafsson, Lena] Swedish Univ Agr Sci, Dept Ecol, Box 7044, SE-75007 Uppsala, Sweden	Swedish University of Agricultural Sciences; Laval University; Swedish University of Agricultural Sciences	Lundstrom, J (corresponding author), Swedish Univ Agr Sci, Dept Forest Resource Management, S-90183 Umea, Sweden.	johanna.lundstrom@slu.se	Ronnqvist, Mikael/S-9045-2017	Ronnqvist, Mikael/0000-0002-1940-6129; Ohman, Karin/0000-0002-0216-6536; Gustafsson, Lena/0000-0003-2467-7289; Lundstrom, Johanna/0000-0003-0207-1198	Swedish Research Council Formas grant [230-2006-351]	Swedish Research Council Formas grant(Swedish Research Council Formas)	This work was funded by the Swedish Research Council Formas grant 230-2006-351 to LG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahti T., 1968, Annales Botanici Fennici, Helsinki, V5, P168; Alagador D, 2014, J APPL ECOL, V51, P703, DOI 10.1111/1365-2664.12230; Ando A, 1998, SCIENCE, V279, P2126, DOI 10.1126/science.279.5359.2126; [Anonymous], 2013, QUICK GUID AICH BIOD; [Anonymous], 2013, SKOGSDATA 2013; Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Berg J, 2010, FORMAS FOKUSERAR SVE, P185; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Carroll C, 2010, GLOBAL CHANGE BIOL, V16, P891, DOI 10.1111/j.1365-2486.2009.01965.x; Esseen Per-Anders, 1997, Ecological Bulletins, V46, P16; Ferris R, 1999, FORESTRY, V72, P313, DOI 10.1093/forestry/72.4.313; Fridman J, 2014, SILVA FENNICA, P48, DOI 10.14214/sf.1095; Gollier C, 2010, J ECON THEORY, V145, P812, DOI 10.1016/j.jet.2009.10.001; Grantham HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011430; Hampicke U, 2011, ECOL ECON, V72, P45, DOI 10.1016/j.ecolecon.2011.08.028; Hartig F, 2008, BIOL CONSERV, V141, P2625, DOI 10.1016/j.biocon.2008.07.028; Junninen K, 2006, ECOGRAPHY, V29, P75, DOI 10.1111/j.2005.0906-7590.04358.x; KIRKPATRICK JB, 1983, BIOL CONSERV, V25, P127, DOI 10.1016/0006-3207(83)90056-3; Kruys N, 2013, FOREST ECOL MANAG, V304, P312, DOI 10.1016/j.foreco.2013.05.018; Kujala H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053315; Lamas T, 2015, SCAND J FOREST RES, V30, P526, DOI 10.1080/02827581.2015.1028435; Leckebusch GC, 2006, CLIM RES, V31, P59, DOI 10.3354/cr031059; Lindenmayer D.B., 2002, CONSERVING FOREST BI; Lindenmayer D.B., 2003, FOREST SUSTAINABILIT; Lindenmayer DB, 2012, SCIENCE, V338, P1305, DOI 10.1126/science.1231070; Lindenmayer DB, 2000, CONSERV BIOL, V14, P941, DOI 10.1046/j.1523-1739.2000.98533.x; Linder P, 1998, BIOL CONSERV, V85, P9, DOI 10.1016/S0006-3207(97)00168-7; Lofman S, 2001, SCAND J FOREST RES, V16, P44, DOI 10.1080/028275801300004406; Lundgren J., 2010, OPTIMIZATION; Lundstrom J, 2011, J APPL ECOL, V48, P133, DOI 10.1111/j.1365-2664.2010.01897.x; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Martikainen P, 2000, BIOL CONSERV, V94, P199, DOI 10.1016/S0006-3207(99)00175-5; Moilanen A., 2009, SPATIAL CONSERVATION; Moilanen A, 2006, CONSERV BIOL, V20, P1688, DOI 10.1111/j.1523-1739.2006.00560.x; Monkkonen M, 2011, EUR J FOREST RES, V130, P717, DOI 10.1007/s10342-010-0461-5; Nilsson SG, 2002, FOREST ECOL MANAG, V161, P189, DOI 10.1016/S0378-1127(01)00480-7; Nilsson SG, 2001, SCAND J FOREST RES, P10, DOI 10.1080/028275801300090546; Overton JM, 2013, AMBIO, V42, P100, DOI 10.1007/s13280-012-0342-x; Peltola H, 1999, CAN J FOREST RES, V29, P647, DOI 10.1139/cjfr-29-6-647; Penttila R, 2004, BIOL CONSERV, V117, P271, DOI 10.1016/j.biocon.2003.12.007; Ramsey FP, 1928, ECON J, V38, P543, DOI 10.2307/2224098; Regan HM, 2007, BIODIVERS CONSERV, V16, P2715, DOI 10.1007/s10531-006-9100-3; Remm J, 2011, FOREST ECOL MANAG, V262, P579, DOI 10.1016/j.foreco.2011.04.028; Roberge JM, 2015, J ENVIRON MANAGE, V154, P284, DOI 10.1016/j.jenvman.2015.02.040; Sarkar S, 2005, CONSERV BIOL, V19, P815, DOI 10.1111/j.1523-1739.2005.00236.x; Simonsson P, 2015, SCAND J FOREST RES, V30, P154, DOI 10.1080/02827581.2014.968201; Snall T, 2011, BIOL CONSERV, V144, P804, DOI 10.1016/j.biocon.2010.11.010; Solomon S., 2007, PHYS SCI BASIS WORKI; Spanos KA, 2007, MANAG ENVIRON QUAL, V18, P475, DOI 10.1108/14777830710753857; Stokland J.N., 2012, BIODIVERSITY DEAD WO; Swanson ME, 2011, FRONT ECOL ENVIRON, V9, P117, DOI 10.1890/090157; Swedish Forest Agency, SKOGSST ARSB 2013; Swedish Government, 2009, HALLB SKYDD NAT PROP; Van Teeffelen AJA, 2012, BIOL CONSERV, V153, P239, DOI 10.1016/j.biocon.2012.05.001; Wikstrom P, 2011, MATH COMPUT FOR NAT-, V3, P87	56	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148960	10.1371/journal.pone.0148960	http://dx.doi.org/10.1371/journal.pone.0148960			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866480	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000370050700048
J	Montero, R; Yubero, D; Villarroya, J; Henares, D; Jou, C; Rodriguez, MA; Ramos, F; Nascimento, A; Ortez, CI; Campistol, J; Perez-Duenas, B; O'Callaghan, M; Pineda, M; Garcia-Cazorla, A; Oferil, JC; Montoya, J; Ruiz-Pesini, E; Emperador, S; Meznaric, M; Campderros, L; Kalko, SG; Villarroya, F; Artuch, R; Jimenez-Mallebrera, C				Montero, Raquel; Yubero, Delia; Villarroya, Joan; Henares, Desiree; Jou, Cristina; Angeles Rodriguez, Maria; Ramos, Federico; Nascimento, Andres; Ignacio Ortez, Carlos; Campistol, Jaume; Perez-Duenas, Belen; O'Callaghan, Mar; Pineda, Mercedes; Garcia-Cazorla, Angeles; Colomer Oferil, Jaume; Montoya, Julio; Ruiz-Pesini, Eduardo; Emperador, Sonia; Meznaric, Marija; Campderros, Laura; Kalko, Susana G.; Villarroya, Francesc; Artuch, Rafael; Jimenez-Mallebrera, Cecilia			GDF-15 Is Elevated in Children with Mitochondrial Diseases and Is Induced by Mitochondrial Dysfunction	PLOS ONE			English	Article							GROWTH-DIFFERENTIATION FACTOR-15; INHIBITORY CYTOKINE-1; DISORDERS; BIOMARKER; DEFICIENCY; EXPRESSION; MUTATIONS; INDUCTION; CRITERIA; THERAPY	Background We previously described increased levels of growth and differentiation factor 15 (GDF-15) in skeletal muscle and serum of patients with mitochondrial diseases. Here we evaluated GDF-15 as a biomarker for mitochondrial diseases affecting children and compared it to fibroblast-growth factor 21 (FGF-21). To investigate the mechanism of GDF-15 induction in these pathologies we measured its expression and secretion in response to mitochondrial dysfunction. Methods We analysed 59 serum samples from 48 children with mitochondrial disease, 19 samples from children with other neuromuscular diseases and 33 samples from aged-matched healthy children. GDF-15 and FGF-21 circulating levels were determined by ELISA. Results Our results showed that in children with mitochondrial diseases GDF-15 levels were on average increased by 11-fold (mean 4046pg/ml, 1492 SEM) relative to healthy (350, 21) and myopathic (350, 32) controls. The area under the curve for the receiver-operating-characteristic curve for GDF-15 was 0.82 indicating that it has a good discriminatory power. The overall sensitivity and specificity of GDF-15 for a cut-off value of 550pg/mL was 67.8% (54.4%-79.4%) and 92.3%(81.5%-97.9%), respectively. We found that elevated levels of GDF-15 and or FGF-21 correctly identified a larger proportion of patients than elevated levels of GDF-15 or FGF-21 alone. GDF-15, as well as FGF-21, mRNA expression and protein secretion, were significantly induced after treatment of myotubes with oligomycin and that levels of expression of both factors significantly correlated. Conclusions Our data indicate that GDF-15 is a valuable serum quantitative biomarker for the diagnosis of mitochondrial diseases in children and that measurement of both GDF-15 and FGF-21 improves the disease detection ability of either factor separately. Finally, we demonstrate for the first time that GDF-15 is produced by skeletal muscle cells in response to mitochondrial dysfunction and that its levels correlate in vitro with FGF-21 levels.	[Montero, Raquel; Yubero, Delia; Artuch, Rafael] Hosp St Joan de Deu, Dept Clin Biochem, Barcelona, Spain; [Montero, Raquel; Yubero, Delia; Jou, Cristina; Nascimento, Andres; Campistol, Jaume; Perez-Duenas, Belen; Pineda, Mercedes; Garcia-Cazorla, Angeles; Montoya, Julio; Ruiz-Pesini, Eduardo; Emperador, Sonia; Artuch, Rafael; Jimenez-Mallebrera, Cecilia] Ctr Biomed Res Rare Dis CIBERER, Madrid, Spain; [Montero, Raquel; Yubero, Delia; Jou, Cristina; Nascimento, Andres; Campistol, Jaume; Perez-Duenas, Belen; Pineda, Mercedes; Garcia-Cazorla, Angeles; Montoya, Julio; Ruiz-Pesini, Eduardo; Emperador, Sonia; Artuch, Rafael; Jimenez-Mallebrera, Cecilia] Inst Salud Carlos III, Madrid, Spain; [Montero, Raquel; Yubero, Delia; Villarroya, Joan; Jou, Cristina; Angeles Rodriguez, Maria; Nascimento, Andres; Ignacio Ortez, Carlos; Campistol, Jaume; Perez-Duenas, Belen; O'Callaghan, Mar; Pineda, Mercedes; Garcia-Cazorla, Angeles; Campderros, Laura; Villarroya, Francesc; Artuch, Rafael; Jimenez-Mallebrera, Cecilia] Inst Pediat Res St Joan de Deu, Barcelona, Spain; [Villarroya, Joan; Campderros, Laura; Villarroya, Francesc] IBUB, Biochem & Mol Biol Dept, Ctr Biomed Res Obes & Nutr CIBEROBN, Madrid, Spain; [Henares, Desiree; Angeles Rodriguez, Maria; Nascimento, Andres; Ignacio Ortez, Carlos; Colomer Oferil, Jaume; Jimenez-Mallebrera, Cecilia] Hosp St Joan de Deu, Fdn Sant Joan de Deu, Neuromuscular Unit, Neuropaediat Dept, Barcelona, Spain; [Jou, Cristina] Hosp St Joan de Deu, Dept Pathol, Barcelona, Spain; [Ramos, Federico; Campistol, Jaume; Perez-Duenas, Belen; O'Callaghan, Mar; Garcia-Cazorla, Angeles] Hosp St Joan de Deu, Neuropaediat Dept, Barcelona, Spain; [Montoya, Julio; Ruiz-Pesini, Eduardo; Emperador, Sonia] Univ Zaragoza, Biochem & Mol Biol Dept, Zaragoza, Spain; [Ruiz-Pesini, Eduardo] Univ Zaragoza, Fdn ARAID, Zaragoza, Spain; [Meznaric, Marija] Univ Ljubljana, Fac Med, Inst Anat, Ljubljana, Slovenia; [Kalko, Susana G.] Hosp Clin Barcelona, Bioinformat Core Facil, IDIBAPS, Barcelona, Spain	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Barcelona; University of Barcelona; University of Barcelona; University of Zaragoza; University of Zaragoza; University of Ljubljana; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Jimenez-Mallebrera, C (corresponding author), Ctr Biomed Res Rare Dis CIBERER, Madrid, Spain.; Jimenez-Mallebrera, C (corresponding author), Inst Salud Carlos III, Madrid, Spain.; Jimenez-Mallebrera, C (corresponding author), Inst Pediat Res St Joan de Deu, Barcelona, Spain.; Jimenez-Mallebrera, C (corresponding author), Hosp St Joan de Deu, Fdn Sant Joan de Deu, Neuromuscular Unit, Neuropaediat Dept, Barcelona, Spain.	cjimenezm@hsjdbcn.org	Marija, Meznaric/A-5112-2016; Jiménez-Mallebrera, Cecilia/F-5030-2016; Perez-Duenas, Belen/AAG-9054-2019; Villarroya, Joan/W-4066-2018; Campderros, Laura/AAM-4550-2021; Villarroya, Francesc/K-4357-2014; Henares Bonilla, Desiree/K-2543-2017	Marija, Meznaric/0000-0002-5907-6929; Jiménez-Mallebrera, Cecilia/0000-0001-8203-7103; Villarroya, Joan/0000-0002-7859-1109; Campderros, Laura/0000-0003-4377-034X; Kalko, Susana/0000-0002-6701-0233; Ortez Gonzalez, Carlos Ignacio/0000-0001-8187-8103; Artuch, Rafael/0000-0002-3422-9685; PEREZ DUENAS, BELEN/0000-0002-4979-2788; Henares Bonilla, Desiree/0000-0003-2631-2718; Villarroya, Francesc/0000-0003-1266-9142; Yubero, Delia/0000-0001-7742-0589	Instituto de Salud Carlos III-Subdireccion General de Evaluacion y Fomento de la Investigacion Sanitaria [PI10/00177, PI13/00837, PI14/00028, PI14/00005]; European Regional Development Fund (FEDER); Hospital Sant Joan de Deu; Instituto de Salud Carlos III grant [CP09/00011]; Departamento de Ciencia, Tecnologia y Universidad del Gobierno de Aragon [B33]; Ministerio de Economia y Competitividad, MINECO [SAF2014-55725-R]; Generalitat de Catalunya [2014SGR-141]; Plan Nacional de I+D+I	Instituto de Salud Carlos III-Subdireccion General de Evaluacion y Fomento de la Investigacion Sanitaria; European Regional Development Fund (FEDER)(European Commission); Hospital Sant Joan de Deu; Instituto de Salud Carlos III grant(Instituto de Salud Carlos III); Departamento de Ciencia, Tecnologia y Universidad del Gobierno de Aragon(Gobierno de Aragon); Ministerio de Economia y Competitividad, MINECO(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Plan Nacional de I+D+I	This work was funded by the "Plan Nacional de I+D+I and Instituto de Salud Carlos III-Subdireccion General de Evaluacion y Fomento de la Investigacion Sanitaria", projects PI10/00177 (CJM), PI13/00837 (MAR, CJ, AN, JC, CJM), PI14/00028 (RA), PI14/00005 (SE, JM) and the European Regional Development Fund (FEDER). MAR is sponsored by the Hospital Sant Joan de Deu Reserch Grants. CJM is funded by the Instituto de Salud Carlos III grant CP09/00011. JM is funded by Departamento de Ciencia, Tecnologia y Universidad del Gobierno de Aragon (Grupos Consolidados B33). JV, LC and FV are funded by grants from the "Ministerio de Economia y Competitividad, MINECO" (SAF2014-55725-R) and "Generalitat de Catalunya" (2014SGR-141).	Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00; Bottner M, 1999, CELL TISSUE RES, V297, P103, DOI 10.1007/s004410051337; Brito S, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00102; Chi CS, 2015, PEDIATR NEONATOL, V56, P7, DOI 10.1016/j.pedneo.2014.03.009; de Mast Q, 2010, HAEMATOL-HEMATOL J, V95, P1068, DOI 10.3324/haematol.2009.019331; DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126; Dominguez-Rodriguez A, 2011, AM J CARDIOL, V108, P955, DOI 10.1016/j.amjcard.2011.05.028; Dostalova I, 2009, EUR J ENDOCRINOL, V161, P397, DOI 10.1530/EJE-09-0417; Fujita Y, 2015, MITOCHONDRION, V20, P34, DOI 10.1016/j.mito.2014.10.006; Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092; Kalko SG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-91; Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018; Kahli A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105759; Koene S, 2015, JIMD REP, DOI [10.1007/89042015436, DOI 10.1007/89042015436]; Lajer M, 2010, DIABETES CARE, V33, P1567, DOI 10.2337/dc09-2174; Liang C, 2014, BBA-GEN SUBJECTS, V1840, P1360, DOI 10.1016/j.bbagen.2013.10.040; Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54; O'Callaghan MM, 2015, MITOCHONDRION, V22, P17, DOI 10.1016/j.mito.2015.03.001; Park SH, 2012, J BIOL CHEM, V287, P19841, DOI 10.1074/jbc.M111.330639; Ribas F, 2014, BIOCHEM J, V463, P191, DOI 10.1042/BJ20140403; Rodenburg RJT, 2011, J INHERIT METAB DIS, V34, P283, DOI 10.1007/s10545-010-9081-y; Roth P, 2010, CLIN CANCER RES, V16, P3851, DOI 10.1158/1078-0432.CCR-10-0705; Strelau J, 2000, ADV RES NEURODEGENER, V8, P273; Strelau J, 2009, J NEUROSCI, V29, P13640, DOI 10.1523/JNEUROSCI.1133-09.2009; Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7; Tulinius M, 2011, SEMIN FETAL NEONAT M, V16, P229, DOI 10.1016/j.siny.2011.04.001; Vasta V, 2009, GENOME MED, V1, DOI 10.1186/gm100; Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506; Yubero D, 2014, BMC PEDIATR, V14, DOI 10.1186/s12887-014-0284-5; Zimmers TA, 2006, J SURG RES, V130, P45, DOI 10.1016/j.jss.2005.07.036; Zimmers TA, 2005, SHOCK, V23, P543, DOI 10.1097/01.shk.0000163393.55350.70	31	88	91	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148709	10.1371/journal.pone.0148709	http://dx.doi.org/10.1371/journal.pone.0148709			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867126	Green Published, Green Submitted, gold			2022-12-27	WOS:000370050700027
J	O'Brien, KM; Nonnenmann, MW				O'Brien, Kate M.; Nonnenmann, Matthew W.			Airborne Influenza A Is Detected in the Personal Breathing Zone of Swine Veterinarians	PLOS ONE			English	Article							IN-VITRO; ALVEOLAR MACROPHAGES; GENETIC REASSORTMENT; VIRUS; DUST; TRANSMISSION; PIGS; EXPOSURE; INHALATION; PREVENTION	The 2009 H1N1 pandemic emphasized a need to evaluate zoonotic transmission of influenza A in swine production. Airborne influenza A virus has been detected in swine facilities during an outbreak. However, the personal exposure of veterinarians treating infected swine has not been characterized. Two personal bioaerosol samplers, the NIOSH bioaerosol sampler and the personal high-flow inhalable sampler head (PHISH), were placed in the breathing zone of veterinarians treating swine infected with either H1N1 or H3N2 influenza A. A greater number of viral particles were recovered from the NIOSH bioaerosol sampler (2094 RNA copies/m(3)) compared to the PHISH sampler (545 RNA copies/m(3)). In addition, the majority of viral particles were detected by the NIOSH bioaerosol sampler in the > 4 mu m size fraction. These results suggest that airborne influenza A virus is present in the breathing zone of veterinarians treating swine, and the aerosol route of zoonotic transmission of influenza virus should be further evaluated among agricultural workers.	[O'Brien, Kate M.; Nonnenmann, Matthew W.] Univ Iowa, Coll Publ Hlth, Dept Occupat & Environm Hlth, Iowa City, IA USA	University of Iowa	Nonnenmann, MW (corresponding author), Univ Iowa, Coll Publ Hlth, Dept Occupat & Environm Hlth, Iowa City, IA USA.	matthew-nonnenmann@uiowa.edu	Nonnenmann, Matthew/K-6245-2019	Nonnenmann, Matthew/0000-0001-8920-1877	University of Iowa College of Public Health New Investigator Award-MWN	University of Iowa College of Public Health New Investigator Award-MWN	The research was funded by the University of Iowa College of Public Health New Investigator Award-MWN. The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135675; Anthony TR, 2010, ANN OCCUP HYG, V54, P427, DOI 10.1093/annhyg/meq029; Blachere FM, 2007, INFLUENZA OTHER RESP, V1, P113, DOI 10.1111/j.1750-2659.2007.00020.x; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; CASTRUCCI MR, 1993, VIROLOGY, V193, P503, DOI 10.1006/viro.1993.1155; Chen PS, 2010, ENVIRON HEALTH PERSP, V118, P1211, DOI 10.1289/ehp.0901782; Choi MJ, 2015, CLIN INFECT DIS, V61, P1355, DOI 10.1093/cid/civ618; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Corzo CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071444; Corzo CA, 2013, VET J, V196, P171, DOI 10.1016/j.tvjl.2012.09.024; Ellenbecker MJ, 1996, AM J IND MED, V29, P303, DOI 10.1002/(SICI)1097-0274(199604)29:4<303::AID-AJIM5>3.0.CO;2-P; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gray GC, 2007, EMERG INFECT DIS, V13, P1871, DOI 10.3201/eid1312.061323; Kim HM, 2008, J VIROL, V82, P4265, DOI 10.1128/JVI.02602-07; Knetter SM, 2014, VET IMMUNOL IMMUNOP, V157, P20, DOI 10.1016/j.vetimm.2013.10.019; Koehler KA, 2012, ANN OCCUP HYG, V56, P194, DOI 10.1093/annhyg/mer077; Lamb RA, 2001, FIELDS VIROL, V1, P1487; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Ma Wenjun, 2008, J Mol Genet Med, V3, P158; Myers KP, 2006, CLIN INFECT DIS, V42, P14, DOI 10.1086/498977; Nelli RK, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-4; Osterholm MT, 2005, NEW ENGL J MED, V352, P1839, DOI 10.1056/NEJMp058068; Palmberg L, 1998, THORAX, V53, P260, DOI 10.1136/thx.53.4.260; Pasick J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09484; Poole JA, 2008, J ALLERGY CLIN IMMUN, V122, P375, DOI 10.1016/j.jaci.2008.05.023; Rabinowitz P, 2013, J AGROMEDICINE, V18, P304, DOI 10.1080/1059924X.2013.826603; Roelofs CF, 2003, AIHA J, V64, P62, DOI 10.1080/15428110308984788; Schofield L, 2005, AVIAN INFLUENZA AERO; Shaw M, 2002, J MED VIROL, V66, P107, DOI 10.1002/jmv.2118; Shu B, 2011, J CLIN MICROBIOL, V49, P2614, DOI 10.1128/JCM.02636-10; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Steel J, 2014, CURR TOP MICROBIOL, V385, P377, DOI 10.1007/82_2014_395; Tao H, 2015, J VIROL, V89, P8453, DOI 10.1128/JVI.01162-15; Urbain B, 1999, AM J VET RES, V60, P1055; Vincent AL, 2008, ADV VIRUS RES, V72, P127, DOI 10.1016/S0065-3527(08)00403-X; Wang Z, 1997, EUR RESPIR J, V10, P381, DOI 10.1183/09031936.97.10020381; Zhou NN, 1999, J VIROL, V73, P8851, DOI 10.1128/JVI.73.10.8851-8856.1999	37	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149083	10.1371/journal.pone.0149083	http://dx.doi.org/10.1371/journal.pone.0149083			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867129	Green Published, gold			2022-12-27	WOS:000370050700063
J	Saba, C; Paoloni, M; Mazcko, C; Kisseberth, W; Burton, JH; Smith, A; Wilson-Robles, H; Allstadt, S; Vail, D; Henry, C; Lana, S; Ehrhart, EJ; Charles, B; Kent, M; Lawrence, J; Burgess, K; Borgatti, A; Suter, S; Woods, P; Gordon, I; Vrignaud, P; Khanna, C; LeBlanc, AK				Saba, Corey; Paoloni, Melissa; Mazcko, Christina; Kisseberth, William; Burton, Jenna H.; Smith, Annette; Wilson-Robles, Heather; Allstadt, Sara; Vail, David; Henry, Carolyn; Lana, Susan; Ehrhart, E. J.; Charles, Brad; Kent, Michael; Lawrence, Jessica; Burgess, Kristine; Borgatti, Antonella; Suter, Steve; Woods, Paul; Gordon, Ira; Vrignaud, Patricia; Khanna, Chand; LeBlanc, Amy K.			A Comparative Oncology Study of Iniparib Defines Its Pharmacokinetic Profile and Biological Activity in a Naturally-Occurring Canine Cancer Model	PLOS ONE			English	Article							TRANSLATION; TRIALS	Development of iniparib as an anti-cancer agent was hindered in part by lingering questions regarding its mechanism of action, the activity of its metabolites, and their potential accumulation in tumors. Due to strong similarities in metabolism of iniparib between humans and dogs, a veterinary clinical trial in pet dogs with spontaneous cancers was designed to answer specific questions pertaining to pharmacokinetic exposures and tolerability of iniparib. Dogs were treated with iniparib alone and in combination with carboplatin chemotherapy. Iniparib doses ranged between 10-70 mg/kg intravenously (IV). Plasma, tumor and normal tissue samples were collected before and at various time points scheduled after exposure for pharmacokinetic and biologic analysis. The primary endpoints included characterization of dose-limiting toxicities (DLT) and determination of the drug exposures that could be achieved in both normal and tumor tissues. Nineteen dogs were treated. DLT included fever, anorexia, diarrhea, neutropenia, and thrombocytopenia; most effects were attributable to carboplatin based on the timing of adverse event onset. The maximum tolerated dose (MTD) of iniparib was not identified. Moderate to high variability in plasma exposure was noted for iniparib and all metabolites between animals. When quantifiable, iniparib and metabolite plasma:tumor ratios were < 0.088 and < 1.7, respectively. In this study, iniparib was well tolerated as a single agent and in combination with carboplatin over a range of doses. However, clinically relevant concentrations of the parent drug and selected metabolites were not detectable in canine tumor tissues at any studied dose, thus eliminating expectations for clinical responses in dogs or humans. Negative clinical trials in humans, and the uncertainties of its mechanism of action, ultimately led to the decision to stop clinical development of the drug. Nevertheless, the questions that can be asked and answered within the comparative oncology approach are evident from this successfully executed comparative clinical trial and exemplify the value of such studies in drug development.	[Saba, Corey; Lawrence, Jessica] Univ Georgia, Coll Vet Med, Athens, GA USA; [Paoloni, Melissa; Mazcko, Christina; Gordon, Ira; Khanna, Chand; LeBlanc, Amy K.] NCI, Comparat Oncol Program, Ctr Canc Res, Bethesda, MD 20892 USA; [Kisseberth, William] Ohio State Univ, Coll Vet Med, Columbus, OH 43210 USA; [Burton, Jenna H.; Lana, Susan; Ehrhart, E. J.; Charles, Brad] Colorado State Univ, Coll Vet Med & Biol Sci, Ft Collins, CO 80523 USA; [Smith, Annette] Auburn Univ, Coll Vet Med, Auburn, AL 36849 USA; [Wilson-Robles, Heather] Texas A&M Univ, Coll Vet Med, College Stn, TX 77843 USA; [Allstadt, Sara; Kent, Michael] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA; [Vail, David] Univ Wisconsin, Sch Vet Med, Madison, WI 53706 USA; [Henry, Carolyn] Univ Missouri, Coll Vet Med, Columbia, MO USA; [Burgess, Kristine] Tufts Univ, Sch Vet Med, 200 Westboro Rd, North Grafton, MA 01536 USA; [Borgatti, Antonella] Univ Minnesota, Coll Vet Med, St Paul, MN 55108 USA; [Suter, Steve] N Carolina State Univ, Coll Vet Med, Raleigh, NC USA; [Woods, Paul] Univ Guelph, Ontario Vet Coll, Guelph, ON N1G 2W1, Canada; [Vrignaud, Patricia] Sanofi Aventis, F-94403 Vitry Sur Seine, France	University System of Georgia; University of Georgia; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Ohio; Ohio State University; Colorado State University; Auburn University System; Auburn University; Texas A&M University System; Texas A&M University College Station; University of California System; University of California Davis; University of Wisconsin System; University of Wisconsin Madison; University of Missouri System; University of Missouri Columbia; Tufts University; University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; North Carolina State University; University of Guelph; Sanofi-Aventis	LeBlanc, AK (corresponding author), NCI, Comparat Oncol Program, Ctr Canc Res, Bethesda, MD 20892 USA.	amy.leblanc@nih.gov	Kisseberth, William/A-2587-2013; Burton, Jenna H/AAK-6753-2021; Lawrence, Jessica/AAD-8460-2019; Wilson-Robles, Heather/D-4209-2016	Burton, Jenna H/0000-0002-1895-8298; Lawrence, Jessica/0000-0002-8315-1909; Wilson-Robles, Heather/0000-0002-6489-8468; , Carolyn/0000-0002-2761-5203; Kent, Michael/0000-0002-7703-7720	Intramural Research Program of the National Institutes of Health (NIH), NCI, Center for Cancer Research	Intramural Research Program of the National Institutes of Health (NIH), NCI, Center for Cancer Research	This research was supported in part by the Intramural Research Program of the National Institutes of Health (NIH), NCI, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported in part by the Intramural Research Program of the National Institutes of Health (NIH), NCI, Center for Cancer Research. The results and interpretations presented herein do not reflect the views of the US Government. We wish to thank the clinical staff at each participating COTC site, and the pets and their owners for participation.	[Anonymous], 2012, VET COMP ONCOL; Blakeley JO, 2015, J NEURO-ONCOL, V125, P123, DOI 10.1007/s11060-015-1876-0; Gordon I, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000161; Gordon IK, 2010, ILAR J, V51, P214, DOI 10.1093/ilar.51.3.214; Le Tourneau C, 2009, JNCI-J NATL CANCER I, V101, P708, DOI 10.1093/jnci/djp079; Liu XS, 2012, CLIN CANCER RES, V18, P510, DOI 10.1158/1078-0432.CCR-11-1973; London CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027018; Marech I, 2014, CRIT REV ONCOL HEMAT, V91, P98, DOI 10.1016/j.critrevonc.2013.12.011; O'Shaughnessy J, 2014, J CLIN ONCOL, V32, P3840, DOI 10.1200/JCO.2014.55.2984; O'Shaughnessy J, 2011, NEW ENGL J MED, V364, P205, DOI 10.1056/NEJMoa1011418; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; Paoloni MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004972; Patel AG, 2012, CLIN CANCER RES, V18, P1655, DOI 10.1158/1078-0432.CCR-11-2890; Printz C, 2015, CANCER-AM CANCER SOC, V121, P1529, DOI 10.1002/cncr.28994; Ranieri G, 2013, CRIT REV ONCOL HEMAT, V88, P187, DOI 10.1016/j.critrevonc.2013.03.005; Schwartz LH, 2009, EUR J CANCER, V45, P261, DOI 10.1016/j.ejca.2008.10.028; Telli ML, 2015, J CLIN ONCOL, V33, P1895, DOI 10.1200/JCO.2014.57.0085; Williams R, 2015, EXPERT OPIN INV DRUG, V24, P95, DOI 10.1517/13543784.2015.971154	18	14	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149194	10.1371/journal.pone.0149194	http://dx.doi.org/10.1371/journal.pone.0149194			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866698	Green Submitted, Green Published, gold			2022-12-27	WOS:000370050700077
J	Geng, HY; Wu, F; Kong, LT; Tang, YQ; Zhou, Q; Chang, M; Zhou, YF; Jiang, XW; Li, SB; Wang, F				Geng, Haiyang; Wu, Feng; Kong, Lingtao; Tang, Yanqing; Zhou, Qian; Chang, Miao; Zhou, Yifang; Jiang, Xiaowei; Li, Songbai; Wang, Fei			Disrupted Structural and Functional Connectivity in Prefrontal-Hippocampus Circuitry in First-Episode Medication-Nave Adolescent Depression	PLOS ONE			English	Article							WHITE-MATTER MICROSTRUCTURE; MAJOR DEPRESSION; FORNIX INTEGRITY; NAIVE PATIENTS; DEFAULT MODE; BRAIN; DISORDER; ABNORMALITIES; VOLUME; ACTIVATION	Background Evidence implicates abnormalities in prefrontal-hippocampus neural circuitry in major depressive disorder (MDD). This study investigates the potential disruptions in prefrontal-hippocampus structural and functional connectivity, as well as their relationship in first-episode medication-naive adolescents with MDD in order to investigate the early stage of the illness without confounds of illness course and medication exposure. Methods Diffusion tensor imaging and resting-state functional magnetic resonance imaging (rs-fMRI) data were acquired from 26 first-episode medication-naive MDD adolescents and 31 healthy controls (HC). Fractional anisotropy (FA) values of the fornix and the prefrontal-hippocampus functional connectivity was compared between MDD and HC groups. The correlation between the FA value of fornix and the strength of the functional connectivity in the prefrontal cortex (PFC) region showing significant differences between the two groups was identified. Results Compared with the HC group, adolescent MDD group had significant lower FA values in the fornix, as well as decreased functional connectivity in four PFC regions. Significant negative correlations were observed between fornix FA values and functional connectivity from hippocampus to PFC within the HC group. There was no significant correlation between the fornix FA and the strength of functional connectivity within the adolescent MDD group. Conclusions First-episode medication-naIve adolescent MDD showed decreased structural and functional connectivity as well as deficits of the association between structural and functional connectivity shown in HC in the PFC-hippocampus neural circuitry. These findings suggest that abnormal PFC-hippocampus neural circuitry may present in the early onset of MDD and play an important role in the neuropathophysiology of MDD.	[Geng, Haiyang; Chang, Miao; Jiang, Xiaowei; Li, Songbai; Wang, Fei] China Med Univ, Affiliated Hosp 1, Dept Radiol, Shenyang 110001, Peoples R China; [Wu, Feng; Kong, Lingtao; Tang, Yanqing; Zhou, Qian; Chang, Miao; Wang, Fei] China Med Univ, Affiliated Hosp 1, Dept Psychiat, Shenyang 110001, Liaoning, Peoples R China; [Tang, Yanqing; Zhou, Yifang] China Med Univ, Affiliated Hosp 1, Dept Gerontol, Shenyang 110001, Liaoning, Peoples R China; [Wang, Fei] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06511 USA	China Medical University; China Medical University; China Medical University; Yale University	Li, SB; Wang, F (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Radiol, Shenyang 110001, Peoples R China.; Wang, F (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Psychiat, Shenyang 110001, Liaoning, Peoples R China.; Wang, F (corresponding author), Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06511 USA.	songbaili001@163.com; fei.wang@mail.cmu.edu.cn			National Natural Science Foundation of China [81101012, 81301166, 81071099, 81271499]; Liaoning Doctor Scientific Foundation [20111099]; Liaoning Pandeng Scholar; National Institution of Health [K01MH086621]; National Alliance for Research on Schizophrenia and Depression; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH086621] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Liaoning Doctor Scientific Foundation; Liaoning Pandeng Scholar; National Institution of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Alliance for Research on Schizophrenia and Depression(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the National Natural Science Foundation of China (81101012 to F. Wu, 81301166 to LK, 81071099 and 81271499 to YT), the Liaoning Doctor Scientific Foundation (20111099 to F. Wu), the Liaoning Pandeng Scholar (to F. Wang), the National Institution of Health (K01MH086621 to F. Wang), the National Alliance for Research on Schizophrenia and Depression (F. Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajani M, 2014, PSYCHOL MED, V44, P2287, DOI 10.1017/S0033291713003000; Anand A, 2009, PSYCHIAT RES-NEUROIM, V171, P189, DOI 10.1016/j.pscychresns.2008.03.012; Barnea-Goraly N, 2009, BIOL PSYCHIAT, V66, P238, DOI 10.1016/j.biopsych.2009.02.025; Bessette KL, 2014, BRAIN IMAGING BEHAV, V8, P531, DOI 10.1007/s11682-013-9274-8; Birmaher B, 2007, J AM ACAD CHILD PSY, V46, P1503, DOI 10.1097/chi.0b013e318145ae1c; Birmaher B, 2009, BIPOLAR DISORD, V11, P52, DOI 10.1111/j.1399-5618.2008.00659.x; Bora E, 2012, J AFFECT DISORDERS, V138, P9, DOI 10.1016/j.jad.2011.03.049; Bracht T, 2015, J AFFECT DISORDERS, V187, P45, DOI 10.1016/j.jad.2015.06.041; Cao XH, 2012, J AFFECT DISORDERS, V141, P194, DOI 10.1016/j.jad.2012.03.002; Cui ZX, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00042; Cullen KR, 2010, J AM ACAD CHILD PSY, V49, P173, DOI 10.1016/j.jaac.2009.11.005; Davidson CA, 2012, SCHIZOPHR RES, V134, P165, DOI 10.1016/j.schres.2011.11.012; de Kwaasteniet B, 2013, BIOL PSYCHIAT, V74, P40, DOI 10.1016/j.biopsych.2012.12.024; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Eichenbaum H, 2013, NEURON, V77, P999, DOI 10.1016/j.neuron.2013.02.034; Elliott R, 1998, PSYCHOL MED, V28, P559, DOI 10.1017/S0033291798006709; Fairhall SL, 2010, BIOL PSYCHOL, V85, P499, DOI 10.1016/j.biopsycho.2010.09.002; Fales CL, 2008, BIOL PSYCHIAT, V63, P377, DOI 10.1016/j.biopsych.2007.06.012; Forbes EE, 2006, J CHILD PSYCHOL PSYC, V47, P1031, DOI 10.1111/j.1469-7610.2006.01673.x; Forbes EE, 2009, AM J PSYCHIAT, V166, P64, DOI 10.1176/appi.ajp.2008.07081336; Frodl T, 2011, J CLIN PSYCHIAT, V72, P448, DOI 10.4088/JCP.09m05393blu; Fu CHY, 2007, AM J PSYCHIAT, V164, P599, DOI 10.1176/appi.ajp.164.4.599; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gong QY, 2015, BIOL PSYCHIAT, V77, P223, DOI 10.1016/j.biopsych.2014.08.009; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Hulvershorn LA, 2011, BRAIN IMAGING BEHAV, V5, P307, DOI 10.1007/s11682-011-9134-3; Jin CW, 2011, NEUROSCI LETT, V503, P105, DOI 10.1016/j.neulet.2011.08.017; Kelley R, 2013, PSYCHIAT RES-NEUROIM, V211, P119, DOI 10.1016/j.pscychresns.2012.06.008; Kerestes R, 2012, PSYCHIAT RES-NEUROIM, V202, P30, DOI 10.1016/j.pscychresns.2011.11.004; Kong LT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0079055; Kong LT, 2013, J PSYCHIATR RES, V47, P733, DOI 10.1016/j.jpsychires.2013.02.003; Kuroki N, 2006, BIOL PSYCHIAT, V60, P22, DOI 10.1016/j.biopsych.2005.09.021; Lee BT, 2008, PROG NEURO-PSYCHOPH, V32, P778, DOI 10.1016/j.pnpbp.2007.12.009; Li WJ, 2014, J NEUROL SCI, V338, P46, DOI 10.1016/j.jns.2013.12.016; Liu H, 2014, SCHIZOPHRENIA BULL, V40, P469, DOI 10.1093/schbul/sbt044; Liu H, 2011, J MAGN RESON IMAGING, V34, P1430, DOI 10.1002/jmri.22784; Lowe MJ, 2000, NEUROIMAGE, V12, P582, DOI 10.1006/nimg.2000.0654; MacMaster FP, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-2; Mielke MM, 2012, ALZHEIMERS DEMENT, V8, P105, DOI 10.1016/j.jalz.2011.05.2416; Milne AMB, 2012, J PSYCHIATR NEUROSCI, V37, P28, DOI 10.1503/jpn.110004; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Nardi B, 2013, EUR REV MED PHARMACO, V17, P1546; Peng DH, 2014, J AFFECT DISORDERS, V168, P21, DOI 10.1016/j.jad.2014.05.061; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Pine DS, 1998, ARCH GEN PSYCHIAT, V55, P56, DOI 10.1001/archpsyc.55.1.56; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rao U, 2010, BIOL PSYCHIAT, V67, P357, DOI 10.1016/j.biopsych.2009.10.017; Renouf AG, 1997, J AM ACAD CHILD PSY, V36, P998, DOI 10.1097/00004583-199707000-00023; Savitz JB, 2009, NEUROSCIENCE, V164, P300, DOI 10.1016/j.neuroscience.2009.03.082; Shad MU, 2012, J CHILD ADOL PSYCHOP, V22, P190, DOI 10.1089/cap.2011.0005; Sheline YI, 2011, BIOL PSYCHIAT, V70, P308, DOI 10.1016/j.biopsych.2011.06.006; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Steffens DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022697; Tang Y, 2013, PSYCHOL MED, V43, P1921, DOI 10.1017/S0033291712002759; Tang YQ, 2007, PSYCHIAT RES-NEUROIM, V156, P83, DOI 10.1016/j.pscychresns.2007.03.005; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wang LH, 2008, PSYCHIAT RES-NEUROIM, V163, P143, DOI 10.1016/j.pscychresns.2007.10.004; Wang YF, 2014, NEUROENDOCRINOL LETT, V35, P697; Wang Z, 2015, NEUROSCI BULL, V31, P13, DOI 10.1007/s12264-014-1489-1; Wang ZJ, 2015, NEUROSCIENTIST, V21, P290, DOI 10.1177/1073858414537560; Wu F, 2011, PSYCHIAT RES-NEUROIM, V191, P80, DOI 10.1016/j.pscychresns.2010.09.002; Xu K, 2013, J PSYCHIATR NEUROSCI, V38, P43, DOI 10.1503/jpn.110132; Ye M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133775; Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018; Zou K, 2010, BIOL PSYCHIAT, V67, P186, DOI 10.1016/j.biopsych.2009.09.014	65	22	24	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148345	10.1371/journal.pone.0148345	http://dx.doi.org/10.1371/journal.pone.0148345			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863301	Green Published, gold, Green Submitted			2022-12-27	WOS:000370046600057
J	Bozoyan, C; Vogt, S				Bozoyan, Christiane; Vogt, Sonja			The Impact of Third-Party Information on Trust: Valence, Source, and Reliability	PLOS ONE			English	Article							E-COMMERCE; REPUTATION; TRUSTWORTHINESS; AUCTIONS; EBAY; RECIPROCITY; GAMES	Economic exchange between strangers happens extremely frequently due to the growing number of internet transactions. In trust situations like online transactions, a trustor usually does not know whether she encounters a trustworthy trustee. However, the trustor might form beliefs about the trustee's trustworthiness by relying on third-party information. Different kinds of third-party information can vary dramatically in their importance to the trustor. We ran a factorial design to study how the different characteristics of third-party information affect the trustor's decision to trust. We systematically varied unregulated third-party information regarding the source (friend or a stranger), the reliability (gossip or experiences), and the valence (positive or negative) of the information. The results show that negative information is more salient for withholding trust than positive information is for placing trust. If third-party information is positive, experience of a friend has the strongest effect on trusting followed by friend's gossip. Positive information from a stranger does not matter to the trustor. With respect to negative information, the data show that even the slightest hint of an untrustworthy trustee leads to significantly less placed trust irrespective of the source or the reliability of the information.	[Bozoyan, Christiane] Univ Munich, Inst Sociol, Munich, Germany; [Vogt, Sonja] Univ Zurich, Dept Econ, Zurich, Switzerland; [Vogt, Sonja] Univ Zurich, Lab Social & Neural Syst Res, Zurich, Switzerland	University of Munich; University of Zurich; University of Zurich	Bozoyan, C (corresponding author), Univ Munich, Inst Sociol, Munich, Germany.; Vogt, S (corresponding author), Univ Zurich, Dept Econ, Zurich, Switzerland.; Vogt, S (corresponding author), Univ Zurich, Lab Social & Neural Syst Res, Zurich, Switzerland.	christiane.bozoyan@soziologie.uni-muenchen.de; sonja.vogt@econ.uzh.ch		Vogt, Sonja/0000-0002-5462-309X	Netherlands Organization for Scientific Research [446-07-024]; Swiss National Science Foundation [100014-130127/1]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Netherlands Organization for Scientific Research (Grant No. 446-07-024 to SV), http://www.nwo.nl/; Swiss National Science Foundation (Grant No. 100014-130127/1 to SV), http://www.snf.ch/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrow K. J., 1974, LIMITS ORG; Auspurg K, 2015, FACTORIAL SURVEY MET; Barrera D, 2007, INT SOCIOL, V22, P367, DOI 10.1177/0268580907076576; Barrera D, 2012, HANDBOOK OF RESEARCH METHODS ON TRUST, P199; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Blau P.M., 1968, INT ENCY SOC SCI, V7, P452; Bohnet I, 2005, J EUR ECON ASSOC, V3, P322; Bohnet I, 2004, AM ECON REV, V94, P362, DOI 10.1257/0002828041301506; Bolton GE, 2004, MANAGE SCI, V50, P1587, DOI 10.1287/mnsc.1030.0199; Bowles S., 2004, ROUNDTABLE SER BEHAV; Brown M, 2007, J MONEY CREDIT BANK, V39, P1883, DOI 10.1111/j.1538-4616.2007.00092.x; BURT RS, 1995, RATION SOC, V7, P255, DOI 10.1177/1043463195007003003; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Campos-Castillo C, 2014, SOC SCI RES, V44, P60, DOI 10.1016/j.ssresearch.2013.11.001; Charness G, 2011, GAME ECON BEHAV, V72, P361, DOI 10.1016/j.geb.2010.09.002; Coleman J., 1990, FDN SOCIAL THEORY; Corritore CL, 2003, INT J HUM-COMPUT ST, V58, P737, DOI 10.1016/S1071-5819(03)00041-7; Dal Bo P, 2005, AM ECON REV, V95, P1591; Dasgupta P., 1988, TRUST MAKING BREAKIN, P49; Diekmann A., 2009, ETRUST FORMING RELAT, P139; Duffy J, 2013, ECON THEOR, V52, P669, DOI 10.1007/s00199-011-0659-x; Ermisch J, 2009, J R STAT SOC A STAT, V172, P749, DOI 10.1111/j.1467-985X.2009.00591.x; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; Fehr E, 2008, RES PERSPECT END INT, P47, DOI 10.1007/978-3-540-79288-8_4; Fehr E, 2009, J EUR ECON ASSOC, V7, P235, DOI 10.1162/JEEA.2009.7.2-3.235; Ferrin DL, 2006, J APPL PSYCHOL, V91, P870, DOI 10.1037/0021-9010.91.4.870; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; Flanagin AJ, 2011, INFORM COMMUN SOC, V14, P355, DOI 10.1080/1369118X.2010.542823; Gefen D, 2000, OMEGA-INT J MANAGE S, V28, P725, DOI 10.1016/S0305-0483(00)00021-9; GRANOVETTER M, 1985, AM J SOCIOL, V91, P481, DOI 10.1086/228311; Greiner B, 2004, ONLINE RECRUITMENT S, V10, P63; Hardin Russell, 2002, RUSSELL SAGE FDN SER; Houser D, 2006, J ECON MANAGE STRAT, V15, P353, DOI 10.1111/j.1530-9134.2006.00103.x; Jasso G, 2006, SOCIOL METHOD RES, V34, P334, DOI 10.1177/0049124105283121; Keser C, 2002, RC22533 IBM; Kollock P., 1999, COMMUNITIES CYBERSPA; Kreps D. M., 1990, FIRMS ORG CONTRACTS, P221; Lucking-Reiley D, 2007, J IND ECON, V55, P223, DOI 10.1111/j.1467-6451.2007.00309.x; Masuda N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044169; Misztal BA., 2001, J SOCIOLOGY, V37; Misztal BA, 1996, TRUST MODERN SOC SEA; Mood C, 2010, EUR SOCIOL REV, V26, P67, DOI 10.1093/esr/jcp006; Nicolaou AI, 2006, INFORM SYST RES, V17, P332, DOI 10.1287/isre.1060.0103; Reips U.D., 2000, PSYCHOL EXPT INTERNE, P89, DOI DOI 10.1016/B978-012099980-4/50005-8; Resnick P, 2002, ADV APP M-E, V11, P127; Rossi PeterHenry., 1982, MEASURING SOCIAL JUD; Sommerfeld RD, 2007, P NATL ACAD SCI USA, V104, P17435, DOI 10.1073/pnas.0704598104; Standifird SS, 2001, J MANAGE, V27, P279, DOI 10.1016/S0149-2063(01)00092-7; Wallander L, 2009, SOC SCI RES, V38, P505, DOI 10.1016/j.ssresearch.2009.03.004; Whitmeyer JM, 2000, SOC SCI RES, V29, P188, DOI 10.1006/ssre.1999.0663	50	7	7	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149542	10.1371/journal.pone.0149542	http://dx.doi.org/10.1371/journal.pone.0149542			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3BP	26882013	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000371219000080
J	Chun, Y; Kim, R; Lee, S				Chun, Younghwa; Kim, Raehyung; Lee, Soojin			Centromere Protein (CENP)-W Interacts with Heterogeneous Nuclear Ribonucleoprotein (hnRNP) U and May Contribute to Kinetochore-Microtubule Attachment in Mitotic Cells	PLOS ONE			English	Article							CENP-T; CHROMOSOME CONGRESSION; OUTER KINETOCHORE; MATRIX PROTEIN; HELA-CELLS; SAF-A; RNA; CHECKPOINT; TUBULIN; CANCER	Background Recent studies have shown that heterogeneous nuclear ribonucleoprotein U (hnRNP U), a component of the hnRNP complex, contributes to stabilize the kinetochore-microtubule interaction during mitosis. CENP-W was identified as an inner centromere component that plays crucial roles in the formation of a functional kinetochore complex. Results We report that hnRNP U interacts with CENP-W, and the interaction between hnRNP U and CENP-W mutually increased each other's protein stability by inhibiting the proteasome-mediated degradation. Further, their co-localization was observed chiefly in the nuclear matrix region and at the microtubule-kinetochore interface during interphase and mitosis, respectively. Both microtubule-stabilizing and microtubule-destabilizing agents significantly decreased the protein stability of CENP-W. Furthermore, loss of microtubules and defects in microtubule organization were observed in CENP-W-depleted cells. Conclusion Our data imply that CENP-W plays an important role in the attachment and interaction between microtubules and kinetochore during mitosis.	[Chun, Younghwa; Kim, Raehyung; Lee, Soojin] Chungnam Natl Univ, Dept Microbiol & Mol Biol, Coll Biosci & Biotechnol, Daejeon, South Korea	Chungnam National University	Lee, S (corresponding author), Chungnam Natl Univ, Dept Microbiol & Mol Biol, Coll Biosci & Biotechnol, Daejeon, South Korea.	leesoojin@cnu.ac.kr		Lee, Soojin/0000-0002-0383-5025	Basic Science Research Program by the Ministry of Education, Science and Technology of Korea [2013R1A1A3A04005274]; Chungnam National University	Basic Science Research Program by the Ministry of Education, Science and Technology of Korea; Chungnam National University	This research was supported by the Basic Science Research Program by the Ministry of Education, Science and Technology of Korea (2013R1A1A3A04005274) and the research fund of Chungnam National University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by Basic Science Research Program by the Ministry of Education, Science and Technology of Korea (2013R1A1A3A04005274) and research fund of Chungnam National University.	Akoumianaki T, 2009, J CELL SCI, V122, P1111, DOI 10.1242/jcs.043034; Ameyar-Zazoua M, 2009, J BIOL CHEM, V284, P27974, DOI 10.1074/jbc.M109.037929; Amin MA, 2008, FEBS LETT, V582, P3839, DOI 10.1016/j.febslet.2008.10.023; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Chun Y, 2013, J BIOL CHEM, V288, P27208, DOI 10.1074/jbc.M113.469221; Chun Y, 2011, J BIOL CHEM, V286, P42758, DOI 10.1074/jbc.M111.228411; Hasegawa Y, 2010, DEV CELL, V19, P469, DOI 10.1016/j.devcel.2010.08.006; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Kaczmarczyk A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106464; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; Kim H, 2009, MOL CELLS, V27, P697, DOI 10.1007/s10059-009-0083-2; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Lee S, 2007, BIOCHEM BIOPH RES CO, V360, P633, DOI 10.1016/j.bbrc.2007.06.102; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Ma N, 2007, J CELL SCI, V120, P2091, DOI 10.1242/jcs.008771; Ma N, 2011, J CELL SCI, V124, P394, DOI 10.1242/jcs.063347; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Mellone B, 2006, NAT CELL BIOL, V8, P427, DOI 10.1038/ncb0506-427; MITHIEUX G, 1984, J BIOL CHEM, V259, P5523; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nishino T, 2013, EMBO J, V32, P424, DOI 10.1038/emboj.2012.348; Nishino T, 2012, CELL, V148, P487, DOI 10.1016/j.cell.2011.11.061; Quenet D, 2012, CHROMOSOME RES, V20, P465, DOI 10.1007/s10577-012-9301-4; ROMIG H, 1992, EMBO J, V11, P3431, DOI 10.1002/j.1460-2075.1992.tb05422.x; Rosic S, 2014, J CELL BIOL, V207, P335, DOI 10.1083/jcb.201404097; Screpanti E, 2011, CURR BIOL, V21, P391, DOI 10.1016/j.cub.2010.12.039; Tanenbaum ME, 2010, CHROMOSOMA, V119, P415, DOI 10.1007/s00412-010-0267-8; Yeh IT, 2004, CELL MOTIL CYTOSKEL, V57, P96, DOI 10.1002/cm.10157	29	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149127	10.1371/journal.pone.0149127	http://dx.doi.org/10.1371/journal.pone.0149127			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881882	gold, Green Published, Green Submitted			2022-12-27	WOS:000371219000049
J	Mateus, CS; Almeida, PR; Mesquita, N; Quintella, BR; Alves, MJ				Mateus, Catarina Sofia; Almeida, Pedro Raposo; Mesquita, Natacha; Quintella, Bernardo Ruivo; Alves, Maria Judite			European Lampreys: New Insights on Postglacial Colonization, Gene Flow and Speciation	PLOS ONE			English	Article							LAMPETRA-FLUVIATILIS L.; MICROSATELLITE LOCI; PETROMYZONTIFORMES PETROMYZONTIDAE; ICHTHYOMYZON-UNICUSPIS; POPULATION-GENETICS; MIGRATION RATES; PLANERI BLOCH; I. FOSSOR; BROOK; RIVER	Ice ages are known to be the most dominant palaeoclimatic feature occurring on Earth, producing severe climatic oscillations and consequently shaping the distribution and the population structure of several species. Lampreys constitute excellent models to study the colonization of freshwater systems, as they commonly appear in pairs of closely related species of anadromous versus freshwater resident adults, thus having the ability to colonize new habitats, through the anadromous species, and establish freshwater resident derivates. We used 10 microsatellite loci to investigate the spatial structure, patterns of gene flow and migration routes of Lampetra populations in Europe. We sampled 11 populations including the migratory L. fluviatilis and four resident species, L. planeri, L. alavariensis, L. auremensis and L. lusitanica, the last three endemic to the Iberian Peninsula. In this southern glacial refugium almost all sampled populations represent a distinct genetic cluster, showing high levels of allopatric differentiation, reflecting long periods of isolation. As result of their more recent common ancestor, populations from northern Europe are less divergent among them, they are represented by fewer genetic clusters, and there is evidence of strong recent gene flow among populations. These previously glaciated areas from northern Europe may have been colonized from lampreys expanding out of the Iberian refugia. The pair L. fluviatilis/L. planeri is apparently at different stages of speciation in different locations, showing evidences of high reproductive isolation in the southern refugium, and low differentiation in the north.	[Mateus, Catarina Sofia; Almeida, Pedro Raposo; Quintella, Bernardo Ruivo] Univ Evora, MARE Ctr Ciencias Mar & Ambiente, Evora, Portugal; [Mateus, Catarina Sofia; Mesquita, Natacha; Alves, Maria Judite] Univ Lisbon, Museu Nacl Hist Nat & Ciencia, P-1699 Lisbon, Portugal; [Mateus, Catarina Sofia; Mesquita, Natacha; Alves, Maria Judite] Univ Lisbon, Ctr Ecol Evolucao & Alteracoes Ambientais, P-1699 Lisbon, Portugal; [Almeida, Pedro Raposo] Univ Evora, Escola Ciencias & Tecnol, Dept Biol, Evora, Portugal; [Quintella, Bernardo Ruivo] Univ Lisbon, Fac Ciencias, Dept Biol Anim, Lisbon, Portugal	University of Evora; Universidade de Lisboa; Universidade de Lisboa; University of Evora; Universidade de Lisboa	Mateus, CS (corresponding author), Univ Evora, MARE Ctr Ciencias Mar & Ambiente, Evora, Portugal.; Mateus, CS (corresponding author), Univ Lisbon, Museu Nacl Hist Nat & Ciencia, P-1699 Lisbon, Portugal.; Mateus, CS (corresponding author), Univ Lisbon, Ctr Ecol Evolucao & Alteracoes Ambientais, P-1699 Lisbon, Portugal.	csmateus@fc.ul.pt	Almeida, Pedro R./B-1895-2012; Quintella, Bernardo/B-4028-2012; Alves, Maria Judite/K-9315-2014	Almeida, Pedro R./0000-0002-2776-5420; Quintella, Bernardo/0000-0002-0509-4515; Alves, Maria Judite/0000-0002-0550-4190; Mateus, Catarina/0000-0002-8067-4536	Fundacao para a Ciencia e a Tecnologia (FCT); FEDER; COMPETE; QREN [PTDC/BIA-BDE/71826/2006, PEst-OE/MAR/UI0199/2011]; FCT-Foundation for Science and Technology [UID/MAR/04292/2013]; FCT [SFRH/BD/44029/2008, SFRH/BPD/14557/2003]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FEDER(European Commission); COMPETE; QREN; FCT-Foundation for Science and Technology(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	Financial support was provided by Fundacao para a Ciencia e a Tecnologia (FCT), FEDER, COMPETE, and QREN through project funding (PTDC/BIA-BDE/71826/2006), the pluriannual funding program to the Center of Oceanography (PEst-OE/MAR/UI0199/2011) and by National Funds through FCT-Foundation for Science and Technology under the Project UID/MAR/04292/2013. CSM and NM were supported by FCT grants SFRH/BD/44029/2008 and SFRH/BPD/14557/2003, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors especially thank Alpo Huhmarniemi and Jaakko Erkinaro (Finnish Game and Fisheries Research Institute, Finland), Michael Ovidio (University of Liege, Belgium) and Martin Krappe (Society for Nature Conservation and Landscape Ecology, Kratzeburg, Germany) for the donation of samples. We are also grateful to Hugo Gante and Vitor Sousa for valuable suggestions on data analysis, to Maria Drago for assistance in early phases of the labwork and to Carlos Alexandre and Tadeu Pereira for assistance in the fieldwork. We thank the collecting permits provided by Instituto da Conservacao da Natureza e das Florestas (ICNF), and Fluviario de Mora for logistic support. Financial support was provided by Fundacao para a Ciencia e a Tecnologia (FCT), FEDER, COMPETE, and QREN through project funding (PTDC/BIABDE/71826/2006) and), through the pluriannual funding program to the Center of Oceanography (PEst-OE/MAR/UI0199/2011).) and by National Funds through FCT - Foundation for Science and Technology under the Project UID/MAR/04292/2013. C.S. Mateus and N. Mesquita were supported by FCT grants SFRH/BD/44029/2008 and SFRH/BPD/14557/2003, respectively.	Aboim MA, 2013, BIOL J LINN SOC, V109, P656, DOI 10.1111/bij.12059; ABOUSEEDO FS, 1979, J ZOOL, V188, P5; Anderson EC, 2002, GENETICS, V160, P1217; [Anonymous], 1996, 5000 CNRS UMR; Beerli P, 2004, MOL ECOL, V13, P827, DOI 10.1111/j.1365-294X.2004.02101.x; Bell M.A., 1997, EXS, V82, P323; Blank M, 2008, CAN J FISH AQUAT SCI, V65, P2780, DOI 10.1139/F08-178; Boguski DA, 2012, J FISH BIOL, V81, P1891, DOI 10.1111/j.1095-8649.2012.03417.x; Bracken FSA, 2015, MOL ECOL, V24, P1188, DOI 10.1111/mec.13112; Bryan MB, 2003, CONSERV GENET, V4, P113, DOI 10.1023/A:1021808909811; Consuegra S, 2002, MOL ECOL, V11, P2037, DOI 10.1046/j.1365-294X.2002.01592.x; Cornuet JM, 1999, GENETICS, V153, P1989; Docker MF, 2012, CONSERV GENET, V13, P823, DOI 10.1007/s10592-012-0332-3; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Espanhol R, 2007, MOL ECOL, V16, P1909, DOI 10.1111/j.1365-294X.2007.03279.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Filcek KB, 2005, N AM J FISH MANAGE, V25, P502, DOI 10.1577/M03-206.1; Fu YX, 1997, GENETICS, V147, P915; Gante HF, 2009, MOL ECOL, V18, P3240, DOI 10.1111/j.1365-294X.2009.04264.x; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Goodman DH, 2008, J FISH BIOL, V72, P400, DOI 10.1111/j.1095-8649.2007.01731.x; Hardisty M.W., 1971, P85; Hardisty M. W., 1986, FRESHWATER FISHES 1, V1, P19; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hubbs CL, 1940, AM NAT, V74, P198, DOI 10.1086/280888; Hubbz C. L., 1925, Papers from the Michigan Academy of Science, V4, P587; Kemp PS, 2011, RIVER RES APPL, V27, P488, DOI 10.1002/rra.1364; Lorenzini R, 2006, BIOL J LINN SOC, V88, P85, DOI 10.1111/j.1095-8312.2006.00606.x; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Luzier CW, 2010, CONSERV GENET RESOUR, V2, P71, DOI 10.1007/s12686-009-9155-z; Mateus CS, 2011, CONSERV GENET, V12, P1061, DOI 10.1007/s10592-011-0209-x; Mateus CS, 2013, CURR BIOL, V23, pR649, DOI 10.1016/j.cub.2013.06.026; Mateus CS, 2013, CONTRIB ZOOL, V82, P37, DOI 10.1163/18759866-08201003; Mateus Catarina S., 2012, Endangered Species Research, V16, P183, DOI 10.3354/esr00405; McFarlane CT, 2009, CONSERV GENET RESOUR, V1, P377, DOI 10.1007/s12686-009-9087-7; Mesquita N, 2005, MOL ECOL, V14, P1939, DOI 10.1111/j.1365-294X.2005.02569.x; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A., 2014, TRACER V1 6; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rougemont Q, 2015, J EVOLUTION BIOL, V28, P2248, DOI 10.1111/jeb.12750; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schreiber A, 1998, J ZOOL SYST EVOL RES, V36, P85, DOI 10.1111/j.1439-0469.1998.tb00781.x; Spice EK, 2012, MOL ECOL, V21, P2916, DOI 10.1111/j.1365-294X.2012.05585.x; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TAJIMA F, 1989, GENETICS, V123, P585; Takeshima H, 2005, MOL ECOL NOTES, V5, P812, DOI 10.1111/j.1471-8286.2005.01072.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; VLADYKOV VD, 1979, CAN J ZOOL, V57, P860, DOI 10.1139/z79-106; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilson GA, 2003, GENETICS, V163, P1177; ZANANDREA G, 1959, NATURE, V184, P380	63	22	23	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148107	10.1371/journal.pone.0148107	http://dx.doi.org/10.1371/journal.pone.0148107			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871930	gold, Green Published			2022-12-27	WOS:000370054100018
J	Yang, LP; Sun, GX; Guo, Y; Hou, ZF; Chen, S				Yang, Lanping; Sun, Guoxiang; Guo, Yong; Hou, Zhifei; Chen, Shuai			Holistic Evaluation of Quality Consistency of Ixeris sonchifolia (Bunge) Hance Injectables by Quantitative Fingerprinting in Combination with Antioxidant Activity and Chemometric Methods	PLOS ONE			English	Article							CHROMATOGRAPHIC FINGERPRINTS; PILL; IDENTIFICATION; ASSAY; TOOL	A widely used herbal medicine, Ixeris sonchifolia (Bge.) Hance Injectable (ISHI) was investigated for quality consistency. Characteristic fingerprints of 23 batches of the ISHI samples were generated at five wavelengths and evaluated by the systematic quantitative fingerprint method (SQFM) as well as simultaneous analysis of the content of seven marker compounds. Chemometric methods, i.e., support vector machine (SVM) and principal component analysis (PCA) were performed to assist in fingerprint evaluation of the ISHI samples. Qualitative classification of the ISHI samples by SVM was consistent with PCA, and in agreement with the quantitative evaluation by SQFM. In addition, the antioxidant activities of the ISHI samples were determined by both the off-line and on-line DPPH (2, 2-diphenyl-1- picryldrazyl) radical scavenging assays. A fingerprint-efficacy relationship linking the chemical components and in vitro antioxidant activity was established and validated using the partial least squares (PLS) and orthogonal projection to latent structures (OPLS) models; and the online DPPH assay further revealed those components that had position contribution to the total antioxidant activity. Therefore, the combined use of the chemometric methods, quantitative fingerprint evaluation by SQFM, and multiple marker compound analysis in conjunction with the assay of antioxidant activity provides a powerful and holistic approach to evaluate quality consistency of herbal medicines and their preparations.	[Yang, Lanping; Sun, Guoxiang; Hou, Zhifei; Chen, Shuai] Shenyang Pharmaceut Univ, Sch Pharm, Shenyang 110016, Peoples R China; [Guo, Yong] Fairleigh Dickinson Univ, Sch Pharm, Florham Pk, NJ 07932 USA	Shenyang Pharmaceutical University; Fairleigh Dickinson University	Sun, GX (corresponding author), Shenyang Pharmaceut Univ, Sch Pharm, Shenyang 110016, Peoples R China.	gxswmwys@163.com		Guo, Yong/0000-0003-0488-3093				Alaerts G, 2014, J PHARMACEUT BIOMED, V95, P34, DOI 10.1016/j.jpba.2014.02.006; Babbar N, 2014, J FOOD SCI TECH MYS, V51, P2568, DOI 10.1007/s13197-012-0754-4; Benzi G, 1997, PHARMACOL RES, V35, P355, DOI 10.1006/phrs.1997.0132; Bhandari P, 2010, INDIAN J EXP BIOL, V48, P323; Chang YX, 2008, J CHROMATOGR A, V1208, P76, DOI 10.1016/j.chroma.2008.08.054; [陈春光 Chen Chunguang], 2012, [中国临床药理学杂志, The Chinese Journal of Clinical Pharmacology], V28, P196; China Drug Administration Bureau of, 2000, CHIN TRAD PAT MED, V22, P671; Custers D, 2014, TALANTA, V123, P78, DOI 10.1016/j.talanta.2014.01.020; Ding XP, 2009, J CHROMATOGR A, V1216, P2204, DOI 10.1016/j.chroma.2008.08.115; European Medicines Agency, 2010, GUID DECL HERB SUBST; Food and Drug Administration, 2004, GUID IND BOT DRUG PR; Ghandi M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003711; Ibrahim FA, 2014, ACTA CHIM SLOV, V61, P11; Information Office of the State Council of the People's Republic of China, 2008, STAT QUO DRUG SUP CH; Li ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067451; Liang J, 2013, J CHROMATOGR A, V1294, P58, DOI 10.1016/j.chroma.2013.04.016; [刘睿 Liu Rui], 2013, [中草药, Chinese Traditional and Herbal Drugs], V44, P2542; Liu Ying, 2013, Zhongguo Zhong Yao Za Zhi, V38, P2675; Pomerantsev AL, 2014, J CHEMOMETR, V28, P429, DOI 10.1002/cem.2506; Prevc T, 2013, TALANTA, V109, P13, DOI 10.1016/j.talanta.2013.03.046; Sharma OP, 2009, FOOD CHEM, V113, P1202, DOI 10.1016/j.foodchem.2008.08.008; Shi PY, 2011, PHYTOCHEM ANALYSIS, V22, P66, DOI 10.1002/pca.1253; Sun Guo-xiang, 2009, Yaoxue Xuebao, V44, P401; Sun GX, 2013, ANN TRANSL MED, V1, DOI 10.3978/j.issn.2305-5839.2013.03.03; Sun GX, 2014, ANAL METHODS-UK, V6, P838, DOI 10.1039/c3ay41670d; Sun GX, 2009, CHIN J CHROMATOGR, V27, P318; Tistaert C, 2011, ANAL CHIM ACTA, V690, P148, DOI 10.1016/j.aca.2011.02.023; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; WHO, 1991, GUIDELINES ASSESSMEN; Wu JH, 2008, J AGR FOOD CHEM, V56, P328, DOI 10.1021/jf072314c; Yin L, 2013, J CHROMATOGR B, V931, P12, DOI 10.1016/j.jchromb.2013.04.039; Zhang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057928; Zhang WZ, 2008, J ASIAN NAT PROD RES, V10, P1087, DOI 10.1080/10286020802361180; Zhang YC, 2013, FOOD CHEM TOXICOL, V59, P272, DOI 10.1016/j.fct.2013.05.058; Zhang YC, 2013, CHEM BIODIVERS, V10, P1373, DOI 10.1002/cbdv.201100234; Zhu JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087462	36	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148878	10.1371/journal.pone.0148878	http://dx.doi.org/10.1371/journal.pone.0148878			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872364	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100067
J	Abboud, J; Nougarou, F; Descarreaux, M				Abboud, Jacques; Nougarou, Francois; Descarreaux, Martin			Muscle Activity Adaptations to Spinal Tissue Creep in the Presence of Muscle Fatigue	PLOS ONE			English	Article							LOW-BACK-PAIN; TRUNK MOTOR VARIABILITY; SURFACE EMG SIGNAL; LUMBAR SPINE; FLEXION-RELAXATION; STABILIZING SYSTEM; PROLONGED FLEXION; SPECTRAL-ANALYSIS; PASSIVE STRETCH; STATIC FLEXION	Aim The aim of this study was to identify adaptations in muscle activity distribution to spinal tissue creep in presence of muscle fatigue. Methods Twenty-three healthy participants performed a fatigue task before and after 30 minutes of passive spinal tissue deformation in flexion. Right and left erector spinae activity was recorded using large-arrays surface electromyography (EMG). To characterize muscle activity distribution, dispersion was used. During the fatigue task, EMG amplitude root mean square (RMS), median frequency and dispersion in x-and y-axis were compared before and after spinal creep. Results Important fatigue-related changes in EMG median frequency were observed during muscle fatigue. Median frequency values showed a significant main creep effect, with lower median frequency values on the left side under the creep condition (p <= 0.0001). A significant main creep effect on RMS values was also observed as RMS values were higher after creep deformation on the right side (p = 0.014); a similar tendency, although not significant, was observed on the left side (p = 0.06). A significant creep effects for x-axis dispersion values was observed, with higher dispersion values following the deformation protocol on the left side (p <= 0.001). Regarding y-axis dispersion values, a significant creep x fatigue interaction effect was observed on the left side (p = 0.016); a similar tendency, although not significant, was observed on the right side (p = 0.08). Conclusion Combined muscle fatigue and creep deformation of spinal tissues led to changes in muscle activity amplitude, frequency domain and distribution.	[Abboud, Jacques] Univ Quebec Trois Rivieres, Dept Anat, Quebec City, PQ, Canada; [Nougarou, Francois] Univ Quebec Trois Rivieres, Dept Genie Elect, Quebec City, PQ, Canada; [Descarreaux, Martin] Univ Quebec Trois Rivieres, Dept Sci Activite Phys, Quebec City, PQ, Canada	University of Quebec; University of Quebec Trois Rivieres; University of Quebec; University of Quebec Trois Rivieres; University of Quebec; University of Quebec Trois Rivieres	Abboud, J (corresponding author), Univ Quebec Trois Rivieres, Dept Anat, Quebec City, PQ, Canada.	jacques.abboud@uqtr.ca		Descarreaux, Martin/0000-0002-3545-5860	Universite du Quebec a Trois-Rivieres Excellence Fund; Natural Sciences and Engineering Research Council of Canada	Universite du Quebec a Trois-Rivieres Excellence Fund; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Universite du Quebec a Trois-Rivieres Excellence Fund and the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud J, 2015, J MANIP PHYSIOL THER, V38, P359, DOI 10.1016/j.jmpt.2015.06.007; Abboud J, 2014, EUR J APPL PHYSIOL, V114, P2645, DOI 10.1007/s00421-014-2985-8; Arjmand N, 2006, J BIOMECH, V39, P510, DOI 10.1016/j.jbiomech.2004.11.030; Avela J, 2004, J APPL PHYSIOL, V96, P2325, DOI 10.1152/japplphysiol.01010.2003; Bonato P, 2002, IEEE T NEUR SYS REH, V10, P38, DOI 10.1109/TNSRE.2002.1021585; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Callaghan JP, 1998, PHYS THER, V78, P8, DOI 10.1093/ptj/78.1.8; CHAFFIN DB, 1973, AM IND HYG ASSOC J, V34, P513, DOI 10.1080/0002889738506892; Champagne A, 2009, J MANIP PHYSIOL THER, V32, P521, DOI 10.1016/j.jmpt.2009.08.008; Cifrek M, 2009, CLIN BIOMECH, V24, P327, DOI 10.1016/j.clinbiomech.2009.01.010; CRISCO JJ, 1992, CLIN BIOMECH, V7, P19, DOI 10.1016/0268-0033(92)90003-M; DE LUCA CJ, 1993, MUSCLE NERVE, V16, P210, DOI 10.1002/mus.880160216; Dickey JP, 2003, CLIN BIOMECH, V18, P783, DOI 10.1016/S0268-0033(03)00166-9; Dupeyron A, 2010, J ELECTROMYOGR KINES, V20, P426, DOI 10.1016/j.jelekin.2009.05.004; Falla D, 2014, PAIN, V155, P944, DOI 10.1016/j.pain.2014.01.027; Farina D, 2000, J ELECTROMYOGR KINES, V10, P337, DOI 10.1016/S1050-6411(00)00025-0; Farina D, 2008, J ELECTROMYOGR KINES, V18, P16, DOI 10.1016/j.jelekin.2006.08.005; Fowles JR, 2000, J APPL PHYSIOL, V89, P1179, DOI 10.1152/jappl.2000.89.3.1179; Fuller JR, 2011, EXP BRAIN RES, V211, P133, DOI 10.1007/s00221-011-2661-8; Gerhardt JJ, 2002, AMERICAN MEDICAL A T; Gonzalez-Izal M, 2012, J ELECTROMYOGR KINES, V22, P501, DOI 10.1016/j.jelekin.2012.02.019; Granata KP, 2005, CLIN BIOMECH, V20, P16, DOI 10.1016/j.clinbiomech.2004.09.001; Granata KP, 2000, SPINE, V25, P1398, DOI 10.1097/00007632-200006010-00012; Granata KR, 2004, HUM FACTORS, V46, P81, DOI 10.1518/hfes.46.1.81.30391; Guo HR, 2002, OCCUP ENVIRON MED, V59, P680, DOI 10.1136/oem.59.10.680; Hansen L, 2006, SPINE, V31, P1888, DOI 10.1097/01.brs.0000229232.66090.58; Herrmann CM, 2006, J ELECTROMYOGR KINES, V16, P637, DOI 10.1016/j.jelekin.2005.11.004; Hodges PW, 1999, ARCH PHYS MED REHAB, V80, P1005, DOI 10.1016/S0003-9993(99)90052-7; Hollman JH, 2013, GAIT POSTURE, V38, P161, DOI 10.1016/j.gaitpost.2012.10.028; Howarth SJ, 2013, J ELECTROMYOGR KINES, V23, P794, DOI 10.1016/j.jelekin.2013.04.002; Lariviere C, 2003, EUR J APPL PHYSIOL, V89, P171, DOI 10.1007/s00421-002-0769-z; Lehman Gregory J, 2005, Chiropr Osteopat, V13, P23, DOI 10.1186/1746-1340-13-23; Mannion AF, 1997, J REHABIL RES DEV, V34, P427; MARRAS WS, 1993, SPINE, V18, P617, DOI 10.1097/00007632-199304000-00015; MCGILL SM, 1992, CLIN BIOMECH, V7, P43, DOI 10.1016/0268-0033(92)90007-Q; MCLAIN RF, 1994, SPINE, V19, P495, DOI 10.1097/00007632-199403000-00001; Ng JKF, 2001, SPINE, V26, P53, DOI 10.1097/00007632-200101010-00011; O'Sullivan PB, 2002, SPINE, V27, P1238, DOI 10.1097/00007632-200206010-00019; Olson MW, 2014, HUM MOVEMENT SCI, V34, P12, DOI 10.1016/j.humov.2014.03.004; Olson MW, 2004, CLIN BIOMECH, V19, P769, DOI 10.1016/j.clinbiomech.2004.05.007; PANJABI MM, 1992, J SPINAL DISORD, V5, P383, DOI 10.1097/00002517-199212000-00001; Rogers EL, 2006, SPINE, V31, P839, DOI 10.1097/01.brs.0000206361.53451.c7; Sanchez-Zuriaga D, 2010, SPINE, V35, P517, DOI 10.1097/BRS.0b013e3181b967ea; Shin G, 2007, CLIN BIOMECH, V22, P965, DOI 10.1016/j.clinbiomech.2007.06.003; Shin G, 2009, SPINE, V34, P1873, DOI 10.1097/BRS.0b013e3181aa6a55; Solomonow M, 1999, SPINE, V24, P2426, DOI 10.1097/00007632-199912010-00003; Solomonow M, 1998, SPINE, V23, P2552, DOI 10.1097/00007632-199812010-00010; Solomonow M, 2012, J ELECTROMYOGR KINES, V22, P155, DOI 10.1016/j.jelekin.2011.11.008; THOMPSON WR, 2010, ACSMS GUIDELINES FOR; Toosizadeh N, 2013, ERGONOMICS, V56, P954, DOI 10.1080/00140139.2013.785601; Trajano GS, 2014, J APPL PHYSIOL, V117, P1486, DOI 10.1152/japplphysiol.00809.2014; Tucker K, 2009, J ELECTROMYOGR KINES, V19, P373, DOI 10.1016/j.jelekin.2007.10.003; VANDIEEN JH, 1993, ERGONOMICS, V36, P407, DOI 10.1080/00140139308967898; Vydevska-Chichova M, 2007, J ELECTROMYOGR KINES, V17, P131, DOI 10.1016/j.jelekin.2006.01.004; Zwarts MJ, 2003, MUSCLE NERVE, V28, P1, DOI 10.1002/mus.10358	55	15	15	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149076	10.1371/journal.pone.0149076	http://dx.doi.org/10.1371/journal.pone.0149076			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866911	Green Published, Green Submitted, gold			2022-12-27	WOS:000370050700061
J	Gregorini, M; Corradetti, V; Rocca, C; Pattonieri, EF; Valsania, T; Milanesi, S; Serpieri, N; Bedino, G; Esposito, P; Libetta, C; Avanzini, MA; Mantelli, M; Ingo, D; Peressini, S; Albertini, R; Dal Canton, A; Rampino, T				Gregorini, Marilena; Corradetti, Valeria; Rocca, Chiara; Pattonieri, Eleonora Francesca; Valsania, Teresa; Milanesi, Samantha; Serpieri, Nicoletta; Bedino, Giulia; Esposito, Pasquale; Libetta, Carmelo; Avanzini, Maria Antonietta; Mantelli, Melissa; Ingo, Daniela; Peressini, Sabrina; Albertini, Riccardo; Dal Canton, Antonio; Rampino, Teresa			Mesenchymal Stromal Cells Prevent Renal Fibrosis in a Rat Model of Unilateral Ureteral Obstruction by Suppressing the Renin-Angiotensin System via HuR	PLOS ONE			English	Article							EXPERIMENTAL KIDNEY-TRANSPLANTATION; STEM-CELLS; MESSENGER-RNA; TUBULOINTERSTITIAL FIBROSIS; THERAPEUTIC APPLICATIONS; GLOMERULAR HEMODYNAMICS; INFLAMMATORY RESPONSE; INTERSTITIAL FIBROSIS; NEPHROPATHY; RECEPTOR	We studied Mesenchymal Stromal Cells (MSC) effects in experimental Unilateral Ureteral Obstruction (UUO), a fibrogenic renal disease. Rats were divided in 5 groups: sham, UUO, MSC treated-UUO, ACEi treated-UUO, MSC+ACEi treated-UUO. Data were collected at 1, 7, 21 days. UUO induced monocyte renal infiltration, tubular cell apoptosis, tubular atrophy, interstitial fibrosis and overexpression of TGF beta, Renin mRNA (RENmRNA), increase of Renin, Angiotensin II (AII) and aldosterone serum levels. Both lisinopril (ACEi) and MSC treatment prevented monocyte infiltration, reduced tubular cell apoptosis, renal fibrosis and TGF beta expression. Combined therapy provided a further suppression of monocyte infiltration and tubular injury. Lisinopril alone caused a rebound activation of Renin-Angiotensin System (RAS), while MSC suppressed RENmRNA and Renin synthesis and induced a decrease of AII and aldosterone serum levels. Furthermore, in in-vitro and in-vivo experiments, MSC inhibit Human antigen R (HuR) trascription, an enhancer of RENmRNA stability by IL10 release. In conclusion, we demonstrate that in UUO MSC prevent fibrosis, by decreasing HuR-dependent RENmRNA stability. Our findings give a clue to understand the molecular mechanism through which MSC may prevent fibrosis in a wide and heterogeneous number of diseases that share RAS activation as common upstream pathogenic mechanism.	[Gregorini, Marilena; Corradetti, Valeria; Rocca, Chiara; Pattonieri, Eleonora Francesca; Valsania, Teresa; Milanesi, Samantha; Serpieri, Nicoletta; Bedino, Giulia; Esposito, Pasquale; Libetta, Carmelo; Dal Canton, Antonio; Rampino, Teresa] Fdn IRCCS Policlin San Matteo, Nephrol Unit, Dialysis, Transplantat, Pavia, Italy; [Gregorini, Marilena; Corradetti, Valeria; Rocca, Chiara; Pattonieri, Eleonora Francesca; Valsania, Teresa; Milanesi, Samantha; Serpieri, Nicoletta; Bedino, Giulia; Esposito, Pasquale; Libetta, Carmelo; Dal Canton, Antonio; Rampino, Teresa] Univ Pavia, Via Palestro 3, I-27100 Pavia, Italy; [Avanzini, Maria Antonietta; Mantelli, Melissa; Ingo, Daniela] Fdn IRCCS Policlin S Matteo, Lab Transplant Immunol Cell Factory, Pavia, Italy; [Peressini, Sabrina; Albertini, Riccardo] Fdn IRCCS Policlin San Matteo, Clin Chem Lab, Pavia, Italy	IRCCS Fondazione San Matteo; University of Pavia; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo	Corradetti, V (corresponding author), Fdn IRCCS Policlin San Matteo, Nephrol Unit, Dialysis, Transplantat, Pavia, Italy.	valeria.corradetti@gmail.com	Pasquale, Esposito/I-8338-2012; Rampino, Teresa/AFI-8315-2022; Rampino, Teresa/AAF-3988-2022; CORRADETTI, VALERIA/P-7882-2015; Milanesi, Samantha/AAB-9539-2020; Avanzini, Maria Antonietta/K-7839-2016; albertini, riccardo/AAB-7779-2019	Pasquale, Esposito/0000-0002-0834-5586; Rampino, Teresa/0000-0002-5311-9174; Rampino, Teresa/0000-0002-5311-9174; CORRADETTI, VALERIA/0000-0003-4143-5345; Milanesi, Samantha/0000-0001-8055-1686; Avanzini, Maria Antonietta/0000-0002-6056-9018; GREGORINI, MARILENA/0000-0003-1440-6872; PATTONIERI, ELEONORA FRANCESCA/0000-0001-7870-2094; Mantelli, Melissa/0000-0001-9945-1861	Italian Society of Nephrology	Italian Society of Nephrology	Giulia Bedino received a grant from Italian Society of Nephrology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Experiments have been supported by a grant of Italian Society of Nephrology.	Adams DJ, 2003, J BIOL CHEM, V278, P44894, DOI 10.1074/jbc.M307782200; Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Asanuma H, 2011, J SURG RES, V168, pE51, DOI 10.1016/j.jss.2010.06.022; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Cantaluppi V, 2013, AM J KIDNEY DIS, V61, P300, DOI 10.1053/j.ajkd.2012.05.027; CANTON AD, 1977, KIDNEY INT, V12, P403, DOI 10.1038/ki.1977.131; Chaabane W, 2013, AM J PHYSIOL-RENAL, V304, pF432, DOI 10.1152/ajprenal.00425.2012; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Ciccocioppo R, 2014, CYTOTHERAPY, V16, P1080, DOI 10.1016/j.jcyt.2014.03.002; Ciccocioppo R, 2011, GUT, V60, P788, DOI 10.1136/gut.2010.214841; DALCANTON A, 1979, KIDNEY INT, V15, P457, DOI 10.1038/ki.1979.61; DALCANTON A, 1980, KIDNEY INT, V17, P491; De Martino M, 2010, TRANSPL P, V42, P1331, DOI 10.1016/j.transproceed.2010.03.079; Docherty NG, 2006, AM J PHYSIOL-RENAL, V290, pF4, DOI 10.1152/ajprenal.00045.2005; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Doorn J, 2012, TISSUE ENG PART B-RE, V18, P101, DOI [10.1089/ten.teb.2011.0488, 10.1089/ten.TEB.2011.0488]; Duffield JS, 2010, SEMIN NEPHROL, V30, P234, DOI 10.1016/j.semnephrol.2010.03.003; Esteban V, 2004, J AM SOC NEPHROL, V15, P1514, DOI 10.1097/01.ASN.0000130564.75008.F5; Grande MT, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-19; Gregorini M, 2014, BMC IMMUNOL, V15, DOI 10.1186/s12865-014-0044-1; Gregorini M, 2013, MAYO CLIN PROC, V88, P1174, DOI 10.1016/j.mayocp.2013.06.021; Greish Sahar, 2012, World J Stem Cells, V4, P101, DOI 10.4252/wjsc.v4.i10.101; Hou FF, 2006, NEW ENGL J MED, V354, P131, DOI 10.1056/NEJMoa053107; Huang Y, 2006, KIDNEY INT, V69, P105, DOI 10.1038/sj.ki.5000011; Ishidoya S, 1996, KIDNEY INT, V49, P1110, DOI 10.1038/ki.1996.161; ISHIDOYA S, 1995, KIDNEY INT, V47, P1285, DOI 10.1038/ki.1995.183; Iwai N, 1996, HYPERTENSION, V27, P399, DOI 10.1161/01.HYP.27.3.399; KANETO H, 1993, KIDNEY INT, V44, P313, DOI 10.1038/ki.1993.246; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; Krishnamurthy P, 2010, FASEB J, V24, P2484, DOI 10.1096/fj.09-149815; Krishnamurthy P, 2009, CIRC RES, V104, pE9, DOI 10.1161/CIRCRESAHA.108.188243; Liu X, 2011, J PEDIATR SURG, V46, P537, DOI 10.1016/j.jpedsurg.2010.09.040; Lopez-Hernandez FJ, 2012, CELL TISSUE RES, V347, P141, DOI 10.1007/s00441-011-1275-6; Ma XL, 2013, CELL TRANSPLANT, V22, P2279, DOI 10.3727/096368912X658692; Minguell JJ, 2001, EXP BIOL MED, V226, P507, DOI 10.1177/153537020122600603; Morris BJ, 2004, ACTA PHYSIOL SCAND, V181, P369, DOI 10.1111/j.1365-201X.2004.01307.x; Morrissey JJ, 1997, KIDNEY INT, V52, P926, DOI 10.1038/ki.1997.414; Morrissey JJ, 1999, AM J PHYSIOL-RENAL, V276, pF39, DOI 10.1152/ajprenal.1999.276.1.F39; Morrissey JJ, 1996, KIDNEY INT, V49, pS83; Muller DN, 2006, CLIN J AM SOC NEPHRO, V1, P221, DOI 10.2215/CJN.01201005; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Pati S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025171; Rajasingh J, 2006, FASEB J, V20, P2112, DOI 10.1096/fj.06-6084fje; Rampino Teresa, 2011, G Ital Nefrol, V28, P132; Rampino T, 2011, CLIN SCI, V120, P25, DOI 10.1042/CS20100147; Reinders MEJ, 2013, CYTOTHERAPY, V15, P663, DOI 10.1016/j.jcyt.2013.01.010; Reinders MEJ, 2010, NEPHROL DIAL TRANSPL, V25, P17, DOI 10.1093/ndt/gfp552; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; Sakoda M, 2007, HYPERTENS RES, V30, P1139, DOI 10.1291/hypres.30.1139; Semedo P, 2009, STEM CELLS, V27, P3063, DOI 10.1002/stem.214; SHARMA AK, 1993, KIDNEY INT, V44, P774, DOI 10.1038/ki.1993.312; Sugiyama H, 2005, NEPHROL DIAL TRANSPL, V20, P2670, DOI 10.1093/ndt/gfi045; Suzuki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067475; Truong LD, 2011, CONTRIB NEPHROL, V169, P311, DOI 10.1159/000314578; Ueno T, 2013, KIDNEY INT, V84, P297, DOI 10.1038/ki.2013.81; Vernon MA, 2010, SEMIN NEPHROL, V30, P302, DOI 10.1016/j.semnephrol.2010.03.004; Vidotti DB, 2004, AM J PHYSIOL-RENAL, V286, pF1039, DOI 10.1152/ajprenal.00371.2003; Visavadiya NP, 2011, NEPHRON EXP NEPHROL, V117, pE62, DOI [10.1159/000320593, 10.1159/000320594]; Wang SH, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-19; Wang YP, 2011, J AM SOC NEPHROL, V22, P21, DOI 10.1681/ASN.2010030269; Yi T, 2012, ARCH PHARM RES, V35, P213, DOI 10.1007/s12272-012-0202-z; Zonta S, 2010, TRANSPL P, V42, P1336, DOI 10.1016/j.transproceed.2010.03.081	63	24	25	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148542	10.1371/journal.pone.0148542	http://dx.doi.org/10.1371/journal.pone.0148542			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866372	Green Published, gold, Green Submitted			2022-12-27	WOS:000370050700020
J	Hegde, S; Kesterson, RA; Srivastava, OP				Hegde, Shylaja; Kesterson, Robert A.; Srivastava, Om P.			CRY beta A3/A1-Crystallin Knockout Develops Nuclear Cataract and Causes Impaired Lysosomal Cargo Clearance and Calpain Activation	PLOS ONE			English	Article							GAMMA-CRYSTALLIN; EYE LENS; ORGANELLE DEGRADATION; DOMINANT CATARACT; EPITHELIAL-CELLS; BETA-CRYSTALLIN; CALCIUM-BINDING; AUTOPHAGY; MUTATION; PROTEIN	beta A3/A1-crystallin is an abundant structural protein of the lens that is very critical for lens function. Many different genetic mutations have been shown to associate with different types of cataracts in humans and in animal models. beta A3/A1-crystallin has four Greek key-motifs that organize into two crystallin domains. It shown to bind calcium with moderate affinity and has putative calcium-binding site. Other than in the lens, beta A3/A1 is also expressed in retinal astrocytes, retinal pigment epithelial (RPE) cells, and retinal ganglion cells. The function of beta A3/A1-crystallin in the retinal cell types is well studied; however, a clear understanding of the function of this protein in the lens has not yet been established. In the current study, we generated the beta A3/A1-crystallin knockout (KO) mouse and explored the function of beta A3/A1-crystallin in lens development. Our results showed that beta A3-KO mice develop congenital nuclear cataract and exhibit persistent fetal vasculature condition. At the cellular level KO lenses show defective lysosomal clearance and accumulation of nuclei, mitochondria, and autophagic cargo in the outer cortical region of the lens. In addition, the calcium level and the expression and activity of calpain-3 were increased in KO lenses. Taken together, these results suggest the lack of beta A3-crystallin function in lenses, alters calcium homeostasis which in turn causes lysosomal defects and calpain activation. These defects are responsible for the development of nuclear cataract in KO lenses.	[Hegde, Shylaja; Srivastava, Om P.] Univ Alabama Birmingham, Sch Optometry, Dept Vis Sci, Birmingham, AL 35294 USA; [Kesterson, Robert A.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Srivastava, OP (corresponding author), Univ Alabama Birmingham, Sch Optometry, Dept Vis Sci, Birmingham, AL 35294 USA.	srivasta@uab.edu			NIH [EY-06400, P30EY003039, P30 CA13148, P30 AR048311, P30 DK074038, P30 DK05336, P60 DK079626]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY006400, P30EY003039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK074038, P60DK079626] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is funded by NIH grants EY-06400 (OS) and P30EY003039 [http://www.nih.gov/grants-funding]. For assistance in creating the mouse model, we thank the UAB Transgenic & Genetically Engineered Models Core; [supported by awards NIH P30 CA13148, P30 AR048311, P30 DK074038, P30 DK05336, and P60 DK079626 (RAK)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bai F, 2003, J BIOL CHEM, V278, P36876, DOI 10.1074/jbc.M304010200; Bateman JB, 2000, INVEST OPHTH VIS SCI, V41, P3278; BERBERS GAM, 1984, EUR J BIOCHEM, V139, P467, DOI 10.1111/j.1432-1033.1984.tb08029.x; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; BLUNDELL T, 1981, NATURE, V289, P771, DOI 10.1038/289771a0; Chen JJ, 2011, AM J HUM GENET, V88, P827, DOI 10.1016/j.ajhg.2011.05.008; CLAYTON RM, 1986, CURR TOP DEV BIOL, V20, P137, DOI 10.1016/S0070-2153(08)60660-2; Clout NJ, 2001, STRUCTURE, V9, P115, DOI 10.1016/S0969-2126(01)00573-1; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; Dirks RPH, 1998, EXP EYE RES, V66, P267, DOI 10.1006/exer.1997.0439; Ferrini W, 2004, INVEST OPHTH VIS SCI, V45, P1436, DOI 10.1167/iovs.03-0760; Gehlbach P, 2006, NEUROSCIENCE, V137, P447, DOI 10.1016/j.neuroscience.2005.08.084; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Graw J, 1999, GENOMICS, V62, P67, DOI 10.1006/geno.1999.5974; Gupta R, 2010, MOL VIS, V16, P2242; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Jobby MK, 2007, FEBS J, V274, P4135, DOI 10.1111/j.1742-4658.2007.05941.x; Kannabiran C, 1998, Mol Vis, V4, P21; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Lampi KJ, 1997, J BIOL CHEM, V272, P2268; Matsui M, 2006, BIOCHEM BIOPH RES CO, V339, P485, DOI 10.1016/j.bbrc.2005.11.044; Medina DL, 2015, NAT CELL BIOL, V17, P288, DOI 10.1038/ncb3114; Medina DL, 2011, DEV CELL, V21, P421, DOI 10.1016/j.devcel.2011.07.016; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Morishita H, 2013, J BIOL CHEM, V288, P11436, DOI 10.1074/jbc.M112.437103; NIXON RA, 1986, J NEUROSCI, V6, P1264; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Parkinson-Lawrence EJ, 2010, PHYSIOLOGY, V25, P102, DOI 10.1152/physiol.00041.2009; Parthasarathy G, 2011, J MOL HISTOL, V42, P59, DOI 10.1007/s10735-010-9307-1; Pena-Llopis S, 2011, EMBO J, V30, P3242, DOI 10.1038/emboj.2011.257; Qi YH, 2004, HUM GENET, V114, P192, DOI 10.1007/s00439-003-1049-7; Reddy MA, 2004, HUM MOL GENET, V13, P945, DOI 10.1093/hmg/ddh110; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; SIMAN R, 1984, P NATL ACAD SCI-BIOL, V81, P3572, DOI 10.1073/pnas.81.11.3572; Sinha D, 2008, MOL CELL NEUROSCI, V37, P85, DOI 10.1016/j.mcn.2007.08.016; Srivastava OP, 1999, BBA-PROTEIN STRUCT M, V1434, P331, DOI 10.1016/S0167-4838(99)00183-1; Testa G, 2004, GENESIS, V38, P151, DOI 10.1002/gene.20012; Valapala M, 2014, AUTOPHAGY, V10, P480, DOI 10.4161/auto.27292; Valapala M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2624; Venugopal B, 2007, AM J HUM GENET, V81, P1070, DOI 10.1086/521954; Wenk M, 1999, J MOL BIOL, V286, P1533, DOI 10.1006/jmbi.1999.2582; Werten PJL, 1999, MOL BIOL REP, V26, P201, DOI 10.1023/A:1007046926233; Xi JH, 2003, MOL VIS, V9, P410; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhang C, 2005, DEV DYNAM, V234, P36, DOI 10.1002/dvdy.20494; Zhang C, 2011, EUR J CELL BIOL, V90, P440, DOI 10.1016/j.ejcb.2011.01.003; Zou J, 2015, NEUROLOGY S, V84	49	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149027	10.1371/journal.pone.0149027	http://dx.doi.org/10.1371/journal.pone.0149027			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863613	Green Published, Green Submitted, gold			2022-12-27	WOS:000370046600141
J	Heremans, E; Nackaerts, E; Vervoort, G; Broeder, S; Swinnen, SP; Nieuwboer, A				Heremans, Elke; Nackaerts, Evelien; Vervoort, Griet; Broeder, Sanne; Swinnen, Stephan P.; Nieuwboer, Alice			Impaired Retention of Motor Learning of Writing Skills in Patients with Parkinson's Disease with Freezing of Gait	PLOS ONE			English	Article							EXTERNAL CUES; REHABILITATION; MICROGRAPHIA; CHALLENGE; MOVEMENTS; WHITE; STATE	Background Patients with Parkinson's disease (PD) and freezing of gait (FOG) suffer from more impaired motor and cognitive functioning than their non-freezing counterparts. This underlies an even higher need for targeted rehabilitation programs in this group. However, so far it is unclear whether FOG affects the ability for consolidation and generalization of motor learning and thus the efficacy of rehabilitation. Objective To investigate the hallmarks of motor learning in people with FOG compared to those without by comparing the effects of an intensive motor learning program to improve handwriting. Methods Thirty five patients with PD, including 19 without and 16 with FOG received six weeks of handwriting training consisting of exercises provided on paper and on a touch-sensitive writing tablet. Writing training was based on single-and dual-task writing and was supported by means of visual target zones. To investigate automatization, generalization and retention of learning, writing performance was assessed before and after training in the presence and absence of cues and dual tasking and after a six-week retention period. Writing amplitude was measured as primary outcome measure and variability of writing and dual-task accuracy as secondary outcomes. Results Significant learning effects were present on all outcome measures in both groups, both for writing under single-and dual-task conditions. However, the gains in writing amplitude were not retained after a retention period of six weeks without training in the patient group without FOG. Furthermore, patients with FOG were highly dependent on the visual target zones, reflecting reduced generalization of learning in this group. Conclusions Although short-term learning effects were present in both groups, generalization and retention of motor learning were specifically impaired in patients with PD and FOG. The results of this study underscore the importance of individualized rehabilitation protocols.	[Heremans, Elke; Nackaerts, Evelien; Vervoort, Griet; Broeder, Sanne; Nieuwboer, Alice] KU, Neuromotor Rehabil Res Grp, Dept Rehabil Sci, Leuven, Belgium; [Swinnen, Stephan P.] KU, Movement Control & Neuroplast Res Grp, Dept Kinesiol, Leuven, Belgium	KU Leuven; KU Leuven	Heremans, E (corresponding author), KU, Neuromotor Rehabil Res Grp, Dept Rehabil Sci, Leuven, Belgium.	elke.heremans@faber.kuleuven.be	Nieuwboer, Alice/F-5643-2013	Nieuwboer, Alice/0000-0003-1193-6229; Nackaerts, Evelien/0000-0002-6580-4902; Broeder, Sanne/0000-0002-0891-3264	Research Foundation - Flanders (FWO) [G.0906.11]	Research Foundation - Flanders (FWO)(FWO)	The project was funded by the Research Foundation - Flanders (FWO) (project G.0906.11). EH is a Postdoctoral Researcher and EN a Research Assistant at the Research Foundation - Flanders (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amboni M, 2008, MOVEMENT DISORD, V23, P395, DOI 10.1002/mds.21850; Bachlin M, 2010, METHOD INFORM MED, V49, P88, DOI 10.3414/ME09-02-0003; Broeder S, 2014, NEUROSCIENCE, V263, P193, DOI 10.1016/j.neuroscience.2014.01.019; Bryant MS, 2010, CLIN REHABIL, V24, P1021, DOI 10.1177/0269215510371420; Mendes FAD, 2012, PHYSIOTHERAPY, V98, P217, DOI 10.1016/j.physio.2012.06.001; Doyon J., 2002, NEUROPSYCHOLOGY MEMO, P225; Egerton CJ, 2015, PHYSIOTHER THEOR PR, V31, P518, DOI 10.3109/09593985.2015.1037874; Fasano A, 2015, J PARKINSON DIS, V5, P241, DOI 10.3233/JPD-150536; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ginis P, PARKINSONIS IN PRESS; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Heremans E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142874; Heremans E, 2013, J NEURAL TRANSM, V120, P543, DOI 10.1007/s00702-012-0964-y; Herman T, 2014, MOVEMENT DISORD, V29, P134, DOI 10.1002/mds.25697; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; King LA, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0474-2; Kostic VS, 2012, NEUROLOGY, V78, P409, DOI 10.1212/WNL.0b013e318245d23c; Krakauer JW, 2011, CURR OPIN NEUROBIOL, V21, P636, DOI 10.1016/j.conb.2011.06.012; Nackaerts E, MOV DISORD IN PRESS; Nackaerts E, 2015, NEUROREHABIL NEURAL; Nackaerts E, 2013, NEUROSCI BIOBEHAV R, V37, P349, DOI 10.1016/j.neubiorev.2013.01.015; Naismith SL, 2010, MOVEMENT DISORD, V25, P1000, DOI 10.1002/mds.23005; Nanhoe-Mahabier W, 2012, MOVEMENT DISORD, V27, P574, DOI 10.1002/mds.24935; Nieuwboer A, 2008, MOVEMENT DISORD, V23, pS475, DOI 10.1002/mds.21978; Nieuwboer A, 2009, GAIT POSTURE, V30, P459, DOI 10.1016/j.gaitpost.2009.07.108; Nieuwboer A, 2009, NEUROREHAB NEURAL RE, V23, P831, DOI 10.1177/1545968309337136; Nutt JG, 2011, LANCET NEUROL, V10, P734, DOI 10.1016/S1474-4422(11)70143-0; Oliveira RM, 1997, J NEUROL NEUROSUR PS, V63, P429, DOI 10.1136/jnnp.63.4.429; Onla-or S, 2008, NEUROREHAB NEURAL RE, V22, P385, DOI 10.1177/1545968307313508; Penhune VB, 2002, J NEUROSCI, V22, P1397, DOI 10.1523/JNEUROSCI.22-04-01397.2002; Petzinger GM, 2013, LANCET NEUROL, V12, P716, DOI 10.1016/S1474-4422(13)70123-6; Plotnik M, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/459321; Redgrave P, 2010, NAT REV NEUROSCI, V11, P760, DOI 10.1038/nrn2915; Rocha PA, 2014, CLIN NEUROL NEUROSUR, V124, P127, DOI 10.1016/j.clineuro.2014.06.026; Rochester L, 2010, BRAIN RES, V1319, P103, DOI 10.1016/j.brainres.2010.01.001; Ronsse R, 2011, CEREB CORTEX, V21, P1283, DOI 10.1093/cercor/bhq209; Shine JM, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00061; Shukla AW, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000628; Spildooren J, 2012, NEUROSCIENCE, V207, P298, DOI 10.1016/j.neuroscience.2012.01.024; Tessitore A, 2012, PARKINSONISM RELAT D, V18, P781, DOI 10.1016/j.parkreldis.2012.03.018; Tomlinson CL, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002817.pub4; Tucha O, 2006, J NEURAL TRANSM, V113, P1575, DOI 10.1007/s00702-005-0437-7; Vandenbossche J, 2012, NEUROSCIENCE, V206, P144, DOI 10.1016/j.neuroscience.2011.12.048; Vandenbossche J, 2013, NEUROPSYCHOLOGY, V27, P28, DOI 10.1037/a0031278; Vercruysse S, 2014, CEREB CORTEX, V24, P3154, DOI 10.1093/cercor/bht170; Vercruysse S, 2014, NEUROSCI BIOBEHAV R, V43, P213, DOI 10.1016/j.neubiorev.2014.04.010; Vercruysse S, 2015, MOVEMENT DISORD, V30, P567, DOI 10.1002/mds.26130; Vercruysse S, 2012, NEUROREHAB NEURAL RE, V26, P636, DOI 10.1177/1545968311431964	49	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148933	10.1371/journal.pone.0148933	http://dx.doi.org/10.1371/journal.pone.0148933			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862915	Green Submitted, gold, Green Published			2022-12-27	WOS:000370046600125
J	Ho, JE; Larson, MG; Ghorbani, A; Cheng, S; Chen, MH; Keyes, M; Rhee, EP; Clish, CB; Vasan, RS; Gerszten, RE; Wang, TJ				Ho, Jennifer E.; Larson, Martin G.; Ghorbani, Anahita; Cheng, Susan; Chen, Ming-Huei; Keyes, Michelle; Rhee, Eugene P.; Clish, Clary B.; Vasan, Ramachandran S.; Gerszten, Robert E.; Wang, Thomas J.			Metabolomic Profiles of Body Mass Index in the Framingham Heart Study Reveal Distinct Cardiometabolic Phenotypes	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; INSULIN-RESISTANCE; AMINO-ACIDS; BRANCHED-CHAIN; GLUCOSE-TOLERANCE; RISK; SMOKING; DISEASE; OBESE; LIPOPROTEIN	Background Although obesity and cardiometabolic traits commonly overlap, underlying pathways remain incompletely defined. The association of metabolite profiles across multiple cardiometabolic traits may lend insights into the interaction of obesity and metabolic health. We sought to investigate metabolic signatures of obesity and related cardiometabolic traits in the community using broad-based metabolomic profiling. Methods and Results We evaluated the association of 217 assayed metabolites and cross-sectional as well as longitudinal changes in cardiometabolic traits among 2,383 Framingham Offspring cohort participants. Body mass index (BMI) was associated with 69 of 217 metabolites (P<0.00023 for all), including aromatic (tyrosine, phenylalanine) and branched chain amino acids (valine, isoleucine, leucine). Additional metabolic pathways associated with BMI included the citric acid cycle (isocitrate, alpha-ketoglutarate, aconitate), the tryptophan pathway (kynurenine, kynurenic acid), and the urea cycle. There was considerable overlap in metabolite profiles between BMI, abdominal adiposity, insulin resistance [IR] and dyslipidemia, modest overlap of metabolite profiles between BMI and hyperglycemia, and little overlap with fasting glucose or elevated blood pressure. Metabolite profiles were associated with longitudinal changes in fasting glucose, but the involved metabolites (ornithine, 5-HIAA, aminoadipic acid, isoleucine, cotinine) were distinct from those associated with baseline glucose or other traits. Obesity status appeared to "modify" the association of 9 metabolites with IR. For example, bile acid metabolites were strongly associated with IR among obese but not lean individuals, whereas isoleucine had a stronger association with IR in lean individuals. Conclusions In this large-scale metabolite profiling study, body mass index was associated with a broad range of metabolic alterations. Metabolite profiling highlighted considerable overlap with abdominal adiposity, insulin resistance, and dyslipidemia, but not with fasting glucose or blood pressure traits.	[Ho, Jennifer E.; Larson, Martin G.; Cheng, Susan; Chen, Ming-Huei; Vasan, Ramachandran S.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Ho, Jennifer E.; Larson, Martin G.; Cheng, Susan; Chen, Ming-Huei; Vasan, Ramachandran S.] Boston Univ, Sch Med, Framingham, MA USA; [Ho, Jennifer E.; Keyes, Michelle; Rhee, Eugene P.; Gerszten, Robert E.] Harvard Univ, Sch Med, Dept Med, Cardiovasc Res Ctr,Massachusetts Gen Hosp, Boston, MA USA; [Ho, Jennifer E.; Gerszten, Robert E.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol,Dept Med, Boston, MA USA; [Larson, Martin G.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Ghorbani, Anahita] Mt Auburn Hosp, Cambridge, MA USA; [Cheng, Susan] Harvard Univ, Brigham & Womens Hosp, Div Cardiol, Sch Med, Boston, MA 02115 USA; [Rhee, Eugene P.] Harvard Univ, Sch Med, Dept Med, Renal Div,Massachusetts Gen Hosp, Boston, MA USA; [Rhee, Eugene P.; Clish, Clary B.; Gerszten, Robert E.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Vasan, Ramachandran S.] Boston Univ, Div Cardiol & Prevent Med, Dept Med, Boston, MA 02215 USA; [Wang, Thomas J.] Vanderbilt Univ, Dept Med, Div Cardiovasc Med, Nashville, TN USA	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Boston University; Harvard University; Mount Auburn Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Boston University; Vanderbilt University	Ho, JE (corresponding author), NHLBI, Framingham Heart Study, Framingham, MA USA.; Ho, JE (corresponding author), Boston Univ, Sch Med, Framingham, MA USA.; Ho, JE (corresponding author), Harvard Univ, Sch Med, Dept Med, Cardiovasc Res Ctr,Massachusetts Gen Hosp, Boston, MA USA.; Ho, JE (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol,Dept Med, Boston, MA USA.	jho1@mgh.harvard.edu	Ramachandran, Vasan/Y-2527-2019; Clish, Clary B/ABB-9374-2021; Clish, Clary/AAB-7124-2019	Ramachandran, Vasan/0000-0001-7357-5970; Clish, Clary B/0000-0001-8259-9245; Wang, Thomas/0000-0003-4063-6508; Cheng, Susan/0000-0002-4977-036X; Ho, Jennifer/0000-0002-7987-4768; Chen, Ming-Huei/0000-0003-3551-8726	National Heart, Lung and Blood Institute's Framingham Heart Study [N01-HC-25195, HHSN268201500001I]; National Institutes of Health [K23-HL116780, 2R01-DK081572]; Boston University School of Medicine Department of Medicine Career Investment Award; Ellison Foundation; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL116780, R00HL107642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081572] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute's Framingham Heart Study(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston University School of Medicine Department of Medicine Career Investment Award; Ellison Foundation(Lawrence Ellison Foundation); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was partially supported by the National Heart, Lung and Blood Institute's Framingham Heart Study (Contract No. N01-HC-25195 and HHSN268201500001I), National Institutes of Health grants K23-HL116780 (JEH), 2R01-DK081572 (MGL, REG, TJW), a Boston University School of Medicine Department of Medicine Career Investment Award (JEH), and the Ellison Foundation (SC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad NN, 2013, INT J OBESITY, V37, P1553, DOI 10.1038/ijo.2013.38; Batch BC, 2013, METABOLISM, V62, P961, DOI 10.1016/j.metabol.2013.01.007; Benowitz NL, 2009, AM J EPIDEMIOL, V169, P236, DOI 10.1093/aje/kwn301; Berlin I, 2008, DIABETES METAB, V34, P307, DOI 10.1016/j.diabet.2008.01.008; Bonasera SJ, 2000, PHARMACOL THERAPEUT, V88, P133, DOI 10.1016/S0163-7258(00)00087-5; Borch-Johnsen K, 1999, LANCET, V354, P617; Campbell C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084260; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Cheng SS, 2012, CIRCULATION, V125, P2222, DOI 10.1161/CIRCULATIONAHA.111.067827; Ferrannini E, 2013, DIABETES, V62, P1730, DOI 10.2337/db12-0707; Festa A, 2004, DIABETES, V53, P1549, DOI 10.2337/diabetes.53.6.1549; Fizelova M, 2015, ATHEROSCLEROSIS, V240, P272, DOI 10.1016/j.atherosclerosis.2015.03.034; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; Fox CS, 2006, CIRCULATION, V113, P2914, DOI 10.1161/CIRCULATIONAHA.106.613828; Frati AC, 1996, DIABETES CARE, V19, P112, DOI 10.2337/diacare.19.2.112; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Ho JE, 2013, DIABETES, V62, P2689, DOI 10.2337/db12-0754; Huffman KM, 2009, DIABETES CARE, V32, P1678, DOI 10.2337/dc08-2075; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Koh HJ, 2004, J BIOL CHEM, V279, P39968, DOI 10.1074/jbc.M402260200; Kramer CK, 2013, ANN INTERN MED, V159, P758, DOI 10.7326/0003-4819-159-11-201312030-00008; Krebs M, 2002, DIABETES, V51, P599, DOI 10.2337/diabetes.51.3.599; Lam Daniel D, 2007, Expert Rev Mol Med, V9, P1; Lee YT, 2005, EUR J PHARMACOL, V513, P145, DOI 10.1016/j.ejphar.2005.02.010; Li TG, 2012, J BIOL CHEM, V287, P1861, DOI 10.1074/jbc.M111.305789; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Palmer ND, 2015, J CLIN ENDOCR METAB, V100, pE463, DOI 10.1210/jc.2014-2357; Patti ME, 1998, J CLIN INVEST, V101, P1519, DOI 10.1172/JCI1326; Preis SR, 2010, OBESITY, V18, P2191, DOI 10.1038/oby.2010.59; Rhee EP, 2011, J CLIN INVEST, V121, P1402, DOI 10.1172/JCI44442; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Sailer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063950; Sambola A, 2003, CIRCULATION, V107, P973, DOI 10.1161/01.CIR.0000050621.67499.7D; Schianca GPC, 2003, DIABETES CARE, V26, P1333, DOI 10.2337/diacare.26.5.1333; Stancakova A, 2012, DIABETES, V61, P1895, DOI 10.2337/db11-1378; Stegemann C, 2014, CIRCULATION, V129, P1821, DOI 10.1161/CIRCULATIONAHA.113.002500; Suhre K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013953; Thalacker-Mercer AE, 2014, DIABETES, V63, P791, DOI 10.2337/db13-0396; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Vincent RP, 2013, ANN CLIN BIOCHEM, V50, P360, DOI 10.1177/0004563212473450; Wang TJ, 2013, J CLIN INVEST, V123, P4309, DOI 10.1172/JCI64801; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wang-Sattler R, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.43; Weir JM, 2013, J LIPID RES, V54, P2898, DOI 10.1194/jlr.P035808; Wurtz P, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001765; Wurtz P, 2013, DIABETES CARE, V36, P648, DOI 10.2337/dc12-0895; Wurtz P, 2012, DIABETES, V61, P1372, DOI 10.2337/db11-1355; Yeh HC, 2010, ANN INTERN MED, V152, P10, DOI 10.7326/0003-4819-152-1-201001050-00005	50	121	123	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148361	10.1371/journal.pone.0148361	http://dx.doi.org/10.1371/journal.pone.0148361			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863521	gold, Green Published, Green Submitted			2022-12-27	WOS:000370046600059
J	Kirmeier, T; Gopalakrishnan, R; Gormanns, V; Werner, AM; Cuboni, S; Rudolf, GC; Hofner, G; Wanner, KT; Sieber, SA; Schmidt, U; Holsboer, F; Rein, T; Hausch, F				Kirmeier, Thomas; Gopalakrishnan, Ranganath; Gormanns, Vanessa; Werner, Anna M.; Cuboni, Serena; Rudolf, Georg C.; Hoefner, Georg; Wanner, Klaus T.; Sieber, Stephan A.; Schmidt, Ulrike; Holsboer, Florian; Rein, Theo; Hausch, Felix			Azidobupramine, an Antidepressant-Derived Bifunctional Neurotransmitter Transporter Ligand Allowing Covalent Labeling and Attachment of Fluorophores	PLOS ONE			English	Article							IMIPRAMINE BINDING-SITES; RAT-BRAIN; DOPAMINE TRANSPORTER; 5-HYDROXYTRYPTAMINE UPTAKE; SEROTONIN TRANSPORTER; TRICYCLIC ANTIDEPRESSANTS; DRUG DISCOVERY; H-3 IMIPRAMINE; COCAINE; IDENTIFICATION	The aim of this study was to design, synthesize and validate a multifunctional antidepressant probe that is modified at two distinct positions. The purpose of these modifications was to allow covalent linkage of the probe to interaction partners, and decoration of probe-target complexes with fluorescent reporter molecules. The strategy for the design of such a probe (i.e., azidobupramine) was guided by the need for the introduction of additional functional groups, conveying the required properties while keeping the additional moieties as small as possible. This should minimize the risk of changing antidepressant-like properties of the new probe azidobupramine. To control for this, we evaluated the binding parameters of azidobupramine to known target sites such as the transporters for serotonin (SERT), norepinephrine (NET), and dopamine (DAT). The binding affinities of azidobupramine to SERT, NET, and DAT were in the range of structurally related and clinically active antidepressants. Furthermore, we successfully visualized azidobupramine-SERT complexes not only in SERT-enriched protein material but also in living cells stably overexpressing SERT. To our knowledge, azidobupramine is the first structural analogue of a tricyclic antidepressant that can be covalently linked to target structures and further attached to reporter molecules while preserving antidepressant-like properties and avoiding radioactive isotopes.	[Kirmeier, Thomas; Holsboer, Florian] Max Planck Inst Psychiat, Clin Dept, Munich, Germany; [Gopalakrishnan, Ranganath; Gormanns, Vanessa; Werner, Anna M.; Cuboni, Serena; Schmidt, Ulrike; Rein, Theo; Hausch, Felix] Max Planck Inst Psychiat, Dept Translat Res Psychiat, Munich, Germany; [Rudolf, Georg C.; Sieber, Stephan A.] Tech Univ Munich, IAS, CIPSM, Dept Chem, Garching, Germany; [Hoefner, Georg; Wanner, Klaus T.] Univ Munich, Dept Pharm, Zentrum Pharmaforsch, Munich, Germany; [Kirmeier, Thomas; Holsboer, Florian] HMNC GmbH, Munich, Germany; [Gopalakrishnan, Ranganath] Max Planck Inst Mol Physiol, Dept Biol Chem, AstraZeneca MPI Satellite Unit, Rheinlanddamm 201, D-44139 Dortmund, Germany; [Werner, Anna M.] Bernhard Nocht Inst Trop Med, Bernhard Nocht Str 74, D-20359 Hamburg, Germany; [Cuboni, Serena] Prosteros Biostruct GmbH, Planegg Martinsried, Germany; [Rudolf, Georg C.] BASF Chem India Pvt Ltd, TTC Area, Turbhe, Navi Mumbai, India	Max Planck Society; Max Planck Society; Technical University of Munich; University of Munich; Max Planck Society; Bernhard Nocht Institut fur Tropenmedizin; BASF	Rein, T; Hausch, F (corresponding author), Max Planck Inst Psychiat, Dept Translat Res Psychiat, Munich, Germany.	theorein@mpipsykl.mpg.de; hausch@mpipsykl.mpg.de		Wanner, Klaus/0000-0003-4399-1425; Rein, Theo/0000-0003-2850-4289				Arnold Thomas, 2008, Curr Protoc Protein Sci, VChapter 4, DOI 10.1002/0471140864.ps0408s53; Basile A, 2001, CURR PROTOC NEUROSCI, DOI DOI 10.1002/0471142301.NS0706S01/ABSTRACT; Besanceney-Webler C, 2011, ANGEW CHEM INT EDIT, V50, P8051, DOI 10.1002/anie.201101817; Bianchi MT, 2008, MED HYPOTHESES, V70, P951, DOI 10.1016/j.mehy.2007.09.012; Bianchi MT, 2010, MED HYPOTHESES, V74, P297, DOI 10.1016/j.mehy.2009.09.003; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; BOPP B, 1974, LIFE SCI, V14, P415, DOI 10.1016/0024-3205(74)90356-7; Callingham BA, 1967, EXCERPTA MEDICA  122, V122, P35; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cisar JS, 2012, J AM CHEM SOC, V134, P10385, DOI 10.1021/ja304213w; Cuboni S, 2014, ANGEW CHEM INT EDIT, V53, P5008, DOI 10.1002/anie.201310567; DAMATO RJ, 1987, J PHARMACOL EXP THER, V242, P364; Grimm SH, 2015, CHEMMEDCHEM, V10, P1027, DOI 10.1002/cmdc.201500084; Gurevich EV, 1996, NEUROPSYCHOPHARMACOL, V14, P309, DOI 10.1016/0893-133X(95)00139-5; Hopkins AL, 2009, NATURE, V462, P167, DOI 10.1038/462167a; HORMAZABAL L, 1985, PSYCHOPHARMACOLOGY, V86, P205, DOI 10.1007/BF00431710; HORN AS, 1974, BRIT J PHARMACOL, V51, P399, DOI 10.1111/j.1476-5381.1974.tb10675.x; Hrdina PD, 1986, RECEPTOR BINDING, P455; Kelly JP, 1999, EUR NEUROPSYCHOPHARM, V9, P101, DOI 10.1016/S0924-977X(98)00010-8; Kubinyi H, 2002, J BRAZIL CHEM SOC, V13, P717, DOI 10.1590/S0103-50532002000600002; Lapinsky DJ, 2012, BIOORGAN MED CHEM, V20, P6237, DOI 10.1016/j.bmc.2012.09.010; Lapinsky DJ, 2011, BIOORGAN MED CHEM, V19, P504, DOI 10.1016/j.bmc.2010.11.002; Leslie BJ, 2008, CHEM SOC REV, V37, P1347, DOI 10.1039/b702942j; Lo G, 2014, BIOCONJUGATE CHEM, V25, P1172, DOI 10.1021/bc500195w; MAXWELL RA, 1969, J PHARMACOL EXP THER, V166, P320; Moellering RE, 2012, CHEM BIOL, V19, P11, DOI 10.1016/j.chembiol.2012.01.001; NAKAKI T, 1985, J NEUROCHEM, V45, P920, DOI 10.1111/j.1471-4159.1985.tb04081.x; Newman AH, 2006, J MED CHEM, V49, P6621, DOI 10.1021/jm0603973; Owens MJ, 1997, J PHARMACOL EXP THER, V283, P1305; PACHOLCZYK T, 1991, NATURE, V350, P350, DOI 10.1038/350350a0; Parnas ML, 2008, MOL PHARMACOL, V73, P1141, DOI 10.1124/mol.107.043679; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Peters JU, 2009, CHEMMEDCHEM, V4, P680, DOI 10.1002/cmdc.200800411; Raghavan AS, 2009, DRUG DISCOV TODAY, V14, P178, DOI 10.1016/j.drudis.2008.09.014; ROTMAN A, 1982, BIOCHIM BIOPHYS ACTA, V714, P173, DOI 10.1016/0304-4165(82)90141-6; Sanchez C, 1999, CELL MOL NEUROBIOL, V19, P467, DOI 10.1023/A:1006986824213; SEGAWA T, 1977, J PHARM PHARMACOL, V29, P139, DOI 10.1111/j.2042-7158.1977.tb11270.x; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Sinning S, 2010, J BIOL CHEM, V285, P8363, DOI 10.1074/jbc.M109.045401; STOCKERT M, 1986, J RECEPTOR RES, V6, P283, DOI 10.3109/10799898609074815; Sumranjit J, 2013, MOLECULES, V18, P10425, DOI 10.3390/molecules180910425; Tate CG, 2003, BBA-BIOMEMBRANES, V1610, P141, DOI 10.1016/S0005-2736(02)00719-8; TODRICK A, 1969, J PHARM PHARMACOL, V21, P751, DOI 10.1111/j.2042-7158.1969.tb08164.x; USDIN TB, 1991, P NATL ACAD SCI USA, V88, P11168, DOI 10.1073/pnas.88.24.11168; Vaughan RA, 2007, J BIOL CHEM, V282, P8915, DOI 10.1074/jbc.M610633200; Wang H, 2013, NATURE, V503, P141, DOI 10.1038/nature12648; WENNOGLE LP, 1985, EMBO J, V4, P971, DOI 10.1002/j.1460-2075.1985.tb03726.x; Wurdak H, 2010, P NATL ACAD SCI USA, V107, P16542, DOI 10.1073/pnas.1010300107	48	5	5	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148608	10.1371/journal.pone.0148608	http://dx.doi.org/10.1371/journal.pone.0148608			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863431	Green Published, Green Submitted, gold			2022-12-27	WOS:000370046600085
J	Maharani, A; Tampubolon, G				Maharani, Asri; Tampubolon, Gindo			National Economic Development Status May Affect the Association between Central Adiposity and Cognition in Older Adults	PLOS ONE			English	Article							C-REACTIVE PROTEIN; BODY-MASS INDEX; RISK-FACTORS; OBESITY; PERFORMANCE; OVERWEIGHT; POPULATION; PREVENTION; LIFE	Background Obesity is becoming a global problem, rather than one found only in developed countries. Although recent studies have suggested a detrimental effect of obesity on cognition, studies of the relationship between obesity and cognition among older adults have been limited to developed countries. We aimed to examine the associations between central obesity, as measured by waist circumference, and cognition level in adults aged 50 years and older in England and Indonesia. Methods We used linear regression models to analyse these associations and multiple imputation to manage missing data. The 2006 English Longitudinal Study of Ageing Wave 3 is the source of data from England, while data from Indonesia is sourced from the 2007 Indonesian Family Life Survey Wave 4. Findings Centrally obese respondents had lower cognition levels than non-centrally obese respondents in England. In contrast, central adiposity had a statistically significant positive association with cognition in Indonesia. Higher levels of education and higher economic status were associated with higher cognitive ability, while age was associated with lower cognition in both countries. Elevated C-reactive protein (CRP) concentrations and smoking behaviour, both linked to higher risk of obesity, were negatively associated with cognitive ability among older adults in England, but they had no statistically significant association with cognition among Indonesians. Interpretation The contradictory findings on obesity and cognition in England and Indonesia not only create a puzzle, but they may also have different policy implications in these countries. Reducing the prevalence of obesity may be the main focus in England and other developed countries to maintain older adults' cognition. However, Indonesia and other developing countries should place more emphasis on education, in addition to continued efforts to tackle the double burden of malnutrition, in order to prevent cognitive impairment among older adults.	[Maharani, Asri] Brawijaya Univ, Fac Med, Malang, Indonesia; [Maharani, Asri; Tampubolon, Gindo] Univ Manchester, Cathie Marsh Inst Social Res, Humanities Bridgeford St Bldg,Oxford Rd, Manchester M13 9PL, Lancs, England	Brawijaya University; University of Manchester	Maharani, A (corresponding author), Brawijaya Univ, Fac Med, Malang, Indonesia.; Maharani, A (corresponding author), Univ Manchester, Cathie Marsh Inst Social Res, Humanities Bridgeford St Bldg,Oxford Rd, Manchester M13 9PL, Lancs, England.	asri.maharani@postgrad.manchester.ac.uk	; Maharani, Asri/U-7663-2017	Tampubolon, Gindo/0000-0002-9081-2349; Maharani, Asri/0000-0002-5931-8692	Medical Research Council; Economic Research Council through the Lifelong Health and Wellbeing programme [G1001375/1]; MRC [G1001375] Funding Source: UKRI; Medical Research Council [G1001375] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic Research Council through the Lifelong Health and Wellbeing programme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Gindo Tampubolon was supported by the Medical Research Council and Economic Research Council through the Lifelong Health and Wellbeing programme (grant reference: G1001375/1).	Asparouhov T., 2010, SIMPLE 2 ORDER CHI S, P1; Berg E. van den, 2007, Neurology, V69, P979, DOI 10.1212/01.wnl.0000271381.30143.75; Bettcher BM, 2012, BRAIN BEHAV IMMUN, V26, P103, DOI 10.1016/j.bbi.2011.07.240; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Corsi DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025120; Cournot M, 2006, NEUROLOGY, V67, P1208, DOI 10.1212/01.wnl.0000238082.13860.50; Dinsa GD, 2012, OBES REV, V13, P1067, DOI 10.1111/j.1467-789X.2012.01017.x; Dobbelsteyn CJ, 2001, INT J OBESITY, V25, P652, DOI 10.1038/sj.ijo.0801582; Elias Merrill F, 2005, Neurobiol Aging, V26 Suppl 1, P11, DOI 10.1016/j.neurobiolaging.2005.08.019; Fergenbaum JH, 2009, OBESITY, V17, P1957, DOI 10.1038/oby.2009.161; Fiocco AJ, 2010, ARCH NEUROL-CHICAGO, V67, P876, DOI 10.1001/archneurol.2010.130; Gunstad J, 2006, J CLIN NEUROSCI, V13, P540, DOI 10.1016/j.jocn.2005.08.010; Guxens M, 2008, AM J EPIDEMIOL, V1, P1; Hu FB, 2008, OBESITY EPIDEMIOLOGY; Jagust W, 2005, ARCH NEUROL-CHICAGO, V62, P1545, DOI 10.1001/archneur.62.10.1545; Kiliaan AJ, 2014, LANCET NEUROL, V13, P913, DOI 10.1016/S1474-4422(14)70085-7; Kimani-Murage EW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129943; Kuo HK, 2005, LANCET NEUROL, V4, P371, DOI 10.1016/S1474-4422(05)70099-5; Kuo HK, 2006, J AM GERIATR SOC, V54, P97, DOI 10.1111/j.1532-5415.2005.00522.x; Marmot M., 2015, ENGLISH LONGITUDINAL, DOI [10.5255/UKDA-SN-5050-10., DOI 10.5255/UKDA-SN-5050-10, http://dx.doi.org/10.5255/UKDA-SN-5050-10]; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nilsson LG, 2009, SCAND J PSYCHOL, V50, P660, DOI 10.1111/j.1467-9450.2009.00777.x; Nyberg L, 1996, J GERONTOL B-PSYCHOL, V51, pP234, DOI 10.1093/geronb/51B.4.P234; Nyberg L, 1997, EXP AGING RES, V23, P137, DOI 10.1080/03610739708254029; Osika W, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a699; Paccaud F, 2000, J CLIN EPIDEMIOL, V53, P393, DOI 10.1016/S0895-4356(99)00184-5; Riggs N, 2010, CHILD NEUROPSYCHOL, V16, P279, DOI 10.1080/09297041003601488; Schneeweis N, 2014, DEMOGRAPHY, V51, P619, DOI 10.1007/s13524-014-0281-1; Skirbekk V, 2013, INTELLIGENCE, V41, P169, DOI 10.1016/j.intell.2013.02.001; Skirbekk V, 2012, P NATL ACAD SCI USA, V109, P770, DOI 10.1073/pnas.1112173109; Smith E, 2011, OBES REV, V12, P740, DOI 10.1111/j.1467-789X.2011.00920.x; Sobal J., 2001, SOCIAL CULTURAL INFL; Strauss J., 2009, WR6751NIANICHD RAND; Sweat V, 2008, INFLAMMATION, V31, P198, DOI 10.1007/s10753-008-9065-3; Tampubolon G, 2015, ALZHEIMERS DEMENT, P1; Teunissen CE, 2003, J NEUROIMMUNOL, V134, P142, DOI 10.1016/S0165-5728(02)00398-3; West NA, 2009, J GERONTOL A-BIOL, V64, P103, DOI 10.1093/gerona/gln006; WHO, 2008, WAIST CIRCUMFERENCE; World Bank, 2013, DOUBL BURD MALN IND; Yaffe K, 2013, CHRONIC MED DIS COGN	41	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148406	10.1371/journal.pone.0148406	http://dx.doi.org/10.1371/journal.pone.0148406			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6PR	26863443	Green Published, gold, Green Submitted			2022-12-27	WOS:000370046600067
J	West, JD; Carrier, EJ; Bloodworth, NC; Schroer, AK; Chen, P; Ryzhova, LM; Gladson, S; Shay, S; Hutcheson, JD; Merryman, WD				West, James D.; Carrier, Erica J.; Bloodworth, Nathaniel C.; Schroer, Alison K.; Chen, Peter; Ryzhova, Larisa M.; Gladson, Santhi; Shay, Sheila; Hutcheson, Joshua D.; Merryman, W. David			Serotonin 2B Receptor Antagonism Prevents Heritable Pulmonary Arterial Hypertension	PLOS ONE			English	Article							5-HYDROXYTRYPTAMINE TRANSPORTER GENE; SMOOTH-MUSCLE; 5-HT2B RECEPTORS; TRANSGENIC MOUSE; KNOCKOUT MICE; CROSS-TALK; CELLS; SRC; CONTRACTION; DISEASE	Serotonergic anorexigens are the primary pharmacologic risk factor associated with pulmonary arterial hypertension (PAH), and the resulting PAH is clinically indistinguishable from the heritable form of disease, associated with BMPR2 mutations. Both BMPR2 mutation and agonists to the serotonin receptor HTR2B have been shown to cause activation of SRC tyrosine kinase; conversely, antagonists to HTR2B inhibit SRC trafficking and downstream function. To test the hypothesis that a HTR2B antagonist can prevent BMRP2 mutation induced PAH by restricting aberrant SRC trafficking and downstream activity, we exposed BMPR2 mutant mice, which spontaneously develop PAH, to a HTR2B antagonist, SB204741, to block the SRC activation caused by BMPR2 mutation. SB204741 prevented the development of PAH in BMPR2 mutant mice, reduced recruitment of inflammatory cells to their lungs, and reduced muscularization of their blood vessels. By atomic force microscopy, we determined that BMPR2 mutant mice normally had a doubling of vessel stiffness, which was substantially normalized by HTR2B inhibition. SB204741 reduced SRC phosphorylation and downstream activity in BMPR2 mutant mice. Gene expression arrays indicate that the primary changes were in cytoskeletal and muscle contractility genes. These results were confirmed by gel contraction assays showing that HTR2B inhibition nearly normalizes the 400% increase in gel contraction normally seen in BMPR2 mutant smooth muscle cells. Heritable PAH results from increased SRC activation, cellular contraction, and vascular resistance, but antagonism of HTR2B prevents SRC phosphorylation, downstream activity, and PAH in BMPR2 mutant mice.	[West, James D.; Carrier, Erica J.; Chen, Peter; Gladson, Santhi; Shay, Sheila] Vanderbilt Univ, Med Ctr, Div Allergy Pulm & Crit Care Med, Nashville, TN 37232 USA; [Bloodworth, Nathaniel C.; Schroer, Alison K.; Ryzhova, Larisa M.; Hutcheson, Joshua D.; Merryman, W. David] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	West, JD (corresponding author), Vanderbilt Univ, Med Ctr, Div Allergy Pulm & Crit Care Med, Nashville, TN 37232 USA.; Merryman, WD (corresponding author), Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37232 USA.	j.west@vanderbilt.edu; david.merryman@vanderbilt.edu	Merryman, W. David/AAY-4781-2021; West, James/E-2960-2010	Hutcheson, Joshua/0000-0002-8383-4435; West, James/0000-0002-6004-0202	NIH [R01 HL095797, P01 HL108800, R01 HL115103]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115103, F30HL126280, P01HL108800, R01HL095797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the following NIH grants: R01 HL095797 and P01 HL108800 (to JDW) and R01 HL115103 (to WDM). NCB was supported as an AHA Pre-Doctoral Fellow (15PRE23260021); AKS was supported as an NSF Graduate Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Abenhaim L, 1996, NEW ENGL J MED, V335, P609, DOI 10.1056/NEJM199608293350901; Adnot S, 2013, HANDB EXP PHARMACOL, V218, P365, DOI 10.1007/978-3-642-38664-0_15; Austin ED, 2009, SEMIN RESP CRIT CARE, V30, P386, DOI 10.1055/s-0029-1233308; Bloodworth NC, 2015, HYPERTENSION, V65, P483, DOI 10.1161/HYPERTENSIONAHA.114.04652; Chen WC, 2013, JOVE-J VIS EXP, DOI 10.3791/50023; Crona Daniel, 2009, BMC Pulm Med, V9, P19, DOI 10.1186/1471-2466-9-19; de Raaf MA, 2015, AM J PHYSIOL-LUNG C, V309, pL1164, DOI 10.1152/ajplung.00127.2015; Ebrahimkhani MR, 2011, NAT MED, V17, P1668, DOI 10.1038/nm.2490; Eddahibi S, 2000, J CLIN INVEST, V105, P1555, DOI 10.1172/JCI8678; Eddahibi S, 2001, J PHARMACOL EXP THER, V297, P148; FORBES IT, 1995, J MED CHEM, V38, P855, DOI 10.1021/jm00006a001; GURTNER HP, 1985, COR VASA, V27, P160; Hemnes AR, 2014, AM J RESP CRIT CARE, V189, P325, DOI 10.1164/rccm.201306-1086OC; Hu J, 2015, AM J CARDIOVASC DRUG; Hutcheson JD, 2012, J MOL CELL CARDIOL, V53, P707, DOI 10.1016/j.yjmcc.2012.08.012; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Johnson JA, 2011, AM J PHYSL LUNG CELL; Keegan A, 2001, CIRC RES, V89, P1231, DOI 10.1161/hh2401.100426; Lane Kirk L, 2011, Pulm Circ, V1, P72; Launay JM, 2012, BLOOD, V119, P1772, DOI 10.1182/blood-2011-06-358374; Launay JM, 2002, NAT MED, V8, P1129, DOI 10.1038/nm764; Liu F, 2010, J CELL BIOL, V190, P693, DOI 10.1083/jcb.201004082; Long L, 2006, CIRC RES, V98, P818, DOI 10.1161/01.RES.0000215809.47923.fd; Machiyama H, 2014, J CELL SCI, V127, P3440, DOI 10.1242/jcs.143438; MacLean MR, 2010, ADV EXP MED BIOL, V661, P309, DOI 10.1007/978-1-60761-500-2_20; MacLean MR, 2004, CIRCULATION, V109, P2150, DOI 10.1161/01.CIR.0000127375.56172.92; Merryman WD, 2007, TISSUE ENG, V13, P2281, DOI 10.1089/ten.2006.0324; Nebigil CG, 2000, P NATL ACAD SCI USA, V97, P2591, DOI 10.1073/pnas.050282397; Parekh A, 2011, BIOPHYS J, V100, P573, DOI 10.1016/j.bpj.2010.12.3733; Paulin R, 2011, AM J PHYSIOL-HEART C, V301, pH1798, DOI 10.1152/ajpheart.00654.2011; Pozzi A, 2000, P NATL ACAD SCI USA, V97, P2202, DOI 10.1073/pnas.040378497; Prewitt AR, 2015, J BIOL CHEM, V290, P960, DOI 10.1074/jbc.M114.591057; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Roth BL, 2007, NEW ENGL J MED, V356, P6, DOI 10.1056/NEJMp068265; Rothman RB, 2000, CIRCULATION, V102, P2836; Sewell-Loftin MK, 2014, BIOMATERIALS, V35, P2809, DOI 10.1016/j.biomaterials.2013.12.051; Sewell-Loftin MK, 2012, J HEART VALVE DIS, V21, P513; Stacher E, 2012, AM J RESP CRIT CARE, V186, P261, DOI 10.1164/rccm.201201-0164OC; Tada Y, 2007, AM J PHYSIOL-LUNG C, V292, pL1556, DOI 10.1152/ajplung.00305.2006; Talati M, 2014, DISEASES, V2, P20; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; West J, 2004, CIRC RES, V94, P1109, DOI 10.1161/01.RES.0000126047.82846.20; West J, 2008, AM J PHYSIOL-LUNG C, V295, pL744, DOI 10.1152/ajplung.90255.2008; West J, 2010, ADV EXP MED BIOL, V661, P265, DOI 10.1007/978-1-60761-500-2_17; Wong WKP, 2005, AM J RESP CELL MOL, V33, P438, DOI 10.1165/rcmb.2005-0103OC; Yao Q, 2014, J BIOL CHEM, V289, P12666, DOI 10.1074/jbc.M113.546481	48	59	63	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148657	10.1371/journal.pone.0148657	http://dx.doi.org/10.1371/journal.pone.0148657			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863209	Green Published, gold, Green Submitted			2022-12-27	WOS:000370046600092
J	Yin, XC; Zhang, BW; Cui, XP; Qu, J; Geng, B; Zhou, F; Song, L; Hao, HW				Yin, Xu-Cheng; Zhang, Bo-Wen; Cui, Xiao-Ping; Qu, Jiao; Geng, Bin; Zhou, Fang; Song, Li; Hao, Hong-Wei			ISART: A Generic Framework for Searching Books with Social Information	PLOS ONE			English	Article							RETRIEVAL	Effective book search has been discussed for decades and is still future-proof in areas as diverse as computer science, informatics, e-commerce and even culture and arts. A variety of social information contents (e.g, ratings, tags and reviews) emerge with the huge number of books on the Web, but how they are utilized for searching and finding books is seldom investigated. Here we develop an Integrated Search And Recommendation Technology (ISART), which breaks new ground by providing a generic framework for searching books with rich social information. ISART comprises a search engine to rank books with book contents and professional metadata, a Generalized Content-based Filtering model to thereafter rerank books with user-generated social contents, and a learning-to-rank technique to finally combine a wide range of diverse reranking results. Experiments show that this technology permits embedding social information to promote book search effectiveness, and ISART, by making use of it, has the best performance on CLEF/INEX Social Book Search Evaluation datasets of all 4 years (from 2011 to 2014), compared with some other state-ofthe- art methods.	[Yin, Xu-Cheng; Zhang, Bo-Wen; Cui, Xiao-Ping; Qu, Jiao; Geng, Bin; Zhou, Fang] Univ Sci & Technol Beijing, Dept Comp Sci & Technol, Sch Comp & Commun Engn, Beijing 100083, Peoples R China; [Song, Li; Hao, Hong-Wei] Chinese Acad Sci, Inst Automat, Beijing 100190, Peoples R China	University of Science & Technology Beijing; Chinese Academy of Sciences; Institute of Automation, CAS	Yin, XC (corresponding author), Univ Sci & Technol Beijing, Dept Comp Sci & Technol, Sch Comp & Commun Engn, Beijing 100083, Peoples R China.	xuchengyin@ustb.edu.cn		Yin, Xucheng/0000-0003-0023-0220	National Natural Science Foundation of China [61175020, 61473036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Natural Science Foundation of China (61175020) supported Hong-Wei Hao's work by providing computing resources. The National Natural Science Foundation of China (61473036) supported Xu-Cheng Yin's work by providing computing resources.	Adriaans F, 2013, INEX 13 WORKSH PREPR, P50; [Anonymous], P 23 ACM INT C C INF, DOI DOI 10.1145/2661829.2661940; [Anonymous], 2013, ACM SIGIR FORUM, DOI [DOI 10.1145/2568388.2568393, 10.1145/2568388.2568393]; [Anonymous], INEX; [Anonymous], INT WORKSH INITIATIV, DOI DOI 10.1007/978-3-642-35734-3_3; Barabasi AL, 2011, NATURE COMMUNICATION, V394; Benkoussas C, 2013, CLEF 2013, P11; Benkoussas C, COLLABORATIVE FILTER; Benkoussasy C, 2013, INEX 13 WORKSH PREPR, P40; Blummer BA, 2007, J WEB LIBRARIANSH, V1, P45, DOI 10.1300/J502v01n01_04; Bogers T, 2013, INEX 13 WORKSH PREPR, P31; Bogers T, 2013, INEX 13 WORKSH PREPR, P30; Bogers T, 2012, CLEF 2012 EV LAB WOR, P30; Bonnefoy L, 2012, CLEF 2012 EV LAB WOR, P1; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cantador I., 2010, RECSYS, P237, DOI [10.1145/ 1864708.1864756, DOI 10.1145/1864708.1864756]; Cao Z., 2007, P 24 INT C MACH LEAR, P129, DOI DOI 10.1145/1273496.1273513; Chang E, 2003, IEEE T CIRC SYST VID, V13, P26, DOI 10.1109/TCSVT.2002.808079; Croft B., 2009, SEARCH ENGINES INFOR; Deveaud R, 2012, FOCUSED RETRIEVAL CO, V7427, P68; Djeraba C, 2003, IEEE T KNOWL DATA EN, V15, P118, DOI 10.1109/TKDE.2003.1161586; Efron M, 2013, J AM SOC INFORM SCI, V50, P1; Felfernig A, 2011, RECOMMENDER SYSTEMS; Furner J, 2002, J AM SOC INF SCI TEC, V53, P747, DOI 10.1002/asi.10080; Guo Q, 2009, P 9 C DIG LIB JCDL, P389; Hafsi M, 2014, CLEF 2014 C, P40; Huurdeman H, 2012, CLEF 2012 EV LAB WOR, P40; Huurdeman H, 2012, INEX 12 WORKSH PREPR, P109; Jones KS, 2000, INFORM PROCESS MANAG, V36, P779, DOI DOI 10.1016/S0306-4573(00)00015-7; Jung S, 2008, J AM SOC INF SCI TEC, V59, P375, DOI 10.1002/asi.20749; Kazai G, 2009, PROCEEDINGS OF THE 2009 SIXTH INTERNATIONAL CONFERENCE ON INFORMATION TECHNOLOGY: NEW GENERATIONS, VOLS 1-3, P1554, DOI 10.1109/ITNG.2009.281; Kim JY, 2012, P 21 ACM C INF KNOWL, P744; Koolen Marijn, 2014, Advances in Information Retrieval. 36th European Conference on IR Research, ECIR 2014. Proceedings: LNCS 8416, P323, DOI 10.1007/978-3-319-06028-6_27; Koolen M, 2012, FOCUSED RETRIEVAL CO, P1; Koolen M, 2014, CLEF 2014 C SHEFF UK, P462; Koolen M, 2012, INEX 12 WORKSH PREPR, P1; Koolen M, 2013, INEX 13 WORKSH PREPR, P60; Koolen M, 2013, INEX 13 WORKSH PREPR, P1; Koolen M, 2012, P 21 ACM INT C INF K, P185, DOI [10.1145/2396761.2396788, DOI 10.1145/2396761.2396788]; Kumar H, 2014, INFORM SCIENCES, V281, P399, DOI 10.1016/j.ins.2014.05.008; Lew MS, 2006, ACM T MULTIM COMPUT, V2, P1, DOI 10.1145/1126004.1126005; Lops P, 2011, RECOMMENDER SYSTEMS HANDBOOK, P73, DOI 10.1007/978-0-387-85820-3_3; Melville P, 2010, ENCY MACHINE LEARNIN, V1, P829; Metzler D., 2005, SIGIR 2005. Proceedings of the Twenty-Eighth Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P472, DOI 10.1145/1076034.1076115; Mooney R. J., 2000, ACM 2000. Digital Libraries. Proceedings of the Fifth ACM Conference on Digital Libraries, P195, DOI 10.1145/336597.336662; Reuter K, 2007, J AM SOC INF SCI TEC, V58, P1745, DOI 10.1002/asi.20657; Ricci F, 2011, RECOMMENDER SYSTEMS HANDBOOK, P1, DOI 10.1007/978-0-387-85820-3_1; Ronen I, 2014, SIGIR'14: PROCEEDINGS OF THE 37TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P243, DOI 10.1145/2600428.2609596; Sakai Tetsuya, 2014, ACM SIGIR Forum, V48, P3; Wang F, 2012, INFORM RETRIEVAL, V15, P179, DOI 10.1007/s10791-012-9199-7; Zhang BW, 2014, INEX 14 WORKSH PREPR, P30	52	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148479	10.1371/journal.pone.0148479	http://dx.doi.org/10.1371/journal.pone.0148479			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863545	Green Published, gold, Green Submitted			2022-12-27	WOS:000370046600077
J	Kim, NS; Mbongue, JC; Nicholas, DA; Esebanmen, GE; Unternaehrer, JJ; Firek, AF; Langridge, WHR				Kim, Nan-Sun; Mbongue, Jacques C.; Nicholas, Dequina A.; Esebanmen, Grace E.; Unternaehrer, Juli J.; Firek, Anthony F.; Langridge, William H. R.			Chimeric Vaccine Stimulation of Human Dendritic Cell Indoleamine 2, 3-Dioxygenase Occurs via the Non-Canonical NF-kappa B Pathway	PLOS ONE			English	Article							T-CELLS; NF-KAPPA-B2 P100; NOD MICE; CD40-TRAF6; INDUCTION; KINASE; CD40; IDO; 2,3-DIOXYGENASE; ACTIVATION	A chimeric protein vaccine composed of the cholera toxin B subunit fused to proinsulin (CTB-INS) was shown to suppress type 1 diabetes onset in NOD mice and upregulate biosynthesis of the tryptophan catabolic enzyme indoleamine 2, 3-dioxygenase (IDO1) in human dendritic cells (DCs). Here we demonstrate siRNA inhibition of the NF-kappa B-inducing kinase (NIK) suppresses vaccine-induced IDO1 biosynthesis as well as IKKa phosphorylation. Chromatin immunoprecipitation (ChIP) analysis of CTB-INS inoculated DCs showed that RelB bound to NF-kappa B consensus sequences in the IDO1 promoter, suggesting vaccine stimulation of the non-canonical NF-kappa B pathway activates IDO1 expression in vivo. The addition of Tumor Necrosis Factor Associated Factors (TRAF) TRAF 2, 3 and TRAF6 blocking peptides to vaccine inoculated DCs was shown to inhibit IDO1 biosynthesis. This experimental outcome suggests vaccine activation of the TNFR super-family receptor pathway leads to upregulation of IDO1 biosynthesis in CTB-INS inoculated dendritic cells. Together, our experimental data suggest the CTB-INS vaccine uses a TNFR-dependent signaling pathway of the non-canonical NF-kappa B signaling pathway resulting in suppression of dendritic cell mediated type 1 diabetes autoimmunity.	[Kim, Nan-Sun; Mbongue, Jacques C.; Nicholas, Dequina A.; Esebanmen, Grace E.; Langridge, William H. R.] Loma Linda Univ, Sch Med, Dept Basic Sci, Ctr Hlth Dispar & Mol Med, Loma Linda, CA USA; [Kim, Nan-Sun] Chonbuk Natl Univ, Dept Mol Biol, Jeonju 561756, South Korea; [Mbongue, Jacques C.] Loma Linda Univ, Sch Med, Dept Basic Sci, Div Physiol, Loma Linda, CA USA; [Esebanmen, Grace E.] Loma Linda Univ, Sch Med, Dept Earth & Biol Sci, Loma Linda, CA USA; [Nicholas, Dequina A.; Unternaehrer, Juli J.; Langridge, William H. R.] Loma Linda Univ, Sch Med, Dept Basic Sci, Div Biochem, Loma Linda, CA USA; [Firek, Anthony F.] JL Pettis Mem VA Med Ctr, Endocrinol Sect, Loma Linda, CA USA	Loma Linda University; Jeonbuk National University; Loma Linda University; Loma Linda University; Loma Linda University	Langridge, WHR (corresponding author), Loma Linda Univ, Sch Med, Dept Basic Sci, Ctr Hlth Dispar & Mol Med, Loma Linda, CA USA.; Langridge, WHR (corresponding author), Loma Linda Univ, Sch Med, Dept Basic Sci, Div Biochem, Loma Linda, CA USA.	blangridge@llu.edu	Nicholas, Dequina/AAF-1412-2019	Mbongue, Jacques/0000-0002-7123-3480; Nicholas, Dequina/0000-0003-4996-2190; Unternaehrer-Hamm, Julia/0000-0001-5864-4704	NIH [DK-99-013, NRF-20151A1A3A04001542]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded in part by NIH award DK-99-013 to WHRL, by the NRF-20151A1A3A04001542 to NSK, to the Loma Linda University Center for Health Disparities and Molecular Medicine and to the Loma Linda University Research Fund to AFF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JS, 2009, DIABETES, V58, P138, DOI 10.2337/db08-0964; Aspord C, 2002, CLIN EXP IMMUNOL, V130, P204, DOI 10.1046/j.1365-2249.2002.01988.x; Bergerot I, 1997, P NATL ACAD SCI USA, V94, P4610, DOI 10.1073/pnas.94.9.4610; Bishop GA, 2003, CYTOKINE GROWTH F R, V14, P297, DOI 10.1016/S1359-6101(03)00024-8; Bishop GA, 2007, ADV EXP MED BIOL, V597, P131; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Chatzigeorgiou A, 2014, P NATL ACAD SCI USA, V111, P4644, DOI 10.1073/pnas.1403231111; Chatzigeorgioua A, 2014, P NATL ACAD SCI USA, V111, P2686, DOI 10.1073/pnas.1400419111; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; Denes B, 2005, J IMMUNOTHER, V28, P438, DOI 10.1097/01.cji.0000171315.82997.9a; EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Ganguly D, 2013, NAT REV IMMUNOL, V13, P566, DOI 10.1038/nri3477; Grohmann U, 2007, NAT MED, V13, P579, DOI 10.1038/nm1563; Harnett Margaret M, 2004, Sci STKE, V2004, ppe25, DOI 10.1126/stke.2372004pe25; Hostager BS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00376; Hsu HL, 1997, J BIOL CHEM, V272, P13471, DOI 10.1074/jbc.272.21.13471; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Lutgens E, 2012, VASC PHARMACOL, V56, P337, DOI 10.1016/j.vph.2011.08.092; Ma DY, 2009, SEMIN IMMUNOL, V21, P265, DOI 10.1016/j.smim.2009.05.010; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Manches O, 2012, P NATL ACAD SCI USA, V109, P14122, DOI 10.1073/pnas.1204032109; Mbongue J, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/857143; Mbongue JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118562; Melendez-Ramirez LY, 2010, ENDOCRIN METAB CLIN, V39, P625, DOI 10.1016/j.ecl.2010.05.009; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; Morrison MD, 2005, J BIOL CHEM, V280, P10018, DOI 10.1074/jbc.M413634200; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Novack DV, 2003, J EXP MED, V198, P771, DOI 10.1084/jem.20030116; Odumosu O, 2010, TOXINS, V2, P1612, DOI 10.3390/toxins2071612; Pallotta MT, 2011, NAT IMMUNOL, V12, P870, DOI 10.1038/ni.2077; Ploix C, 1999, DIABETES, V48, P2150, DOI 10.2337/diabetes.48.11.2150; Portillo JAC, 2014, INVEST OPHTH VIS SCI, V55, P8590, DOI 10.1167/iovs.14-15340; Portillo JAC, 2015, IMMUNOLOGY, V144, P21, DOI 10.1111/imm.12361; Puccetti P, 2007, NAT REV IMMUNOL, V7, P817, DOI 10.1038/nri2163; Solan NJ, 2002, J BIOL CHEM, V277, P1405, DOI 10.1074/jbc.M109619200; Song YJ, 2010, VIRUS GENES, V41, P174, DOI 10.1007/s11262-010-0505-4; Sun SC, 2008, TRENDS IMMUNOL, V29, P469, DOI 10.1016/j.it.2008.07.003; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Sun SC, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3123pe18; Tas SW, 2007, BLOOD, V110, P1540, DOI 10.1182/blood-2006-11-056010; Theill LE, 2002, ANNU REV IMMUNOL, V20, P795, DOI 10.1146/annurev.immunol.20.100301.064753; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Volpi C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2874; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Xiao GT, 2004, J BIOL CHEM, V279, P30099, DOI 10.1074/jbc.M401428200; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3	50	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0147509	10.1371/journal.pone.0147509	http://dx.doi.org/10.1371/journal.pone.0147509			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881431	Green Submitted, Green Published, gold			2022-12-27	WOS:000371219000005
J	Wada, M; Yano, S; Hamano, T; Nabika, T; Kumakura, S				Wada, Masayuki; Yano, Shozo; Hamano, Tsuyoshi; Nabika, Toru; Kumakura, Shunichi			Effect of Serum Cholesterol on Insulin Secretory Capacity: Shimane CoHRE Study	PLOS ONE			English	Article							BETA-CELL DYSFUNCTION; WOMEN; MEN	Objectives Previous studies indicate that, in addition to the blood glucose level, the lipid level in the blood may affect functions of pancreatic beta cells. In this study, we aimed to examine whether there was a relationship between the serum level of total cholesterol (TC) and the insulin secretory capacity in healthy subjects. Subjects and Methods In participants of health examinations conducted from 2006 to 2010, we analyzed data from a total of 2,499 subjects (1,057 men and 1,442 women) after exclusion of individuals with dyslipidemia, thyroid dysfunction, diabetes, HbA1c >= 6.5%, or fasting blood glucose >= 126 mg/dL. Homeostasis model assessment for beta cell function (HOMA-beta) was utilized as a model representing the pancreatic beta cell function. Results Although the serum TC level had a positive correlation with HOMA-beta in a univariate correlation analysis, after adjustment by confounding factors in a multiple regression analysis, HOMA-beta had a negative correlation with TC. This was further confirmed in a multiple logistic regression analysis, showing that higher TC was an independent risk factor for decreased insulin secretory capacity (defined as HOMA-beta >= 30%) together with higher age, lower BMI, lower TG, male sex and regular alcohol intake. After the participants were stratified by BMI into three groups, the effect of TC on HOMA-beta increased along with the increase in BMI, and it was highly significant in the highest tertile. Conclusion This cross-sectional study indicated that increased serum TC level might be related to the decrease of insulin secretory capacity in aged healthy population and that reduction of TC is more necessary in obese subjects to prevent diabetes.	[Wada, Masayuki] Okuizumo Municipal Hosp, Dept Internal Med, Hamada, Shimane, Japan; [Yano, Shozo] Shimane Univ, Fac Med, Dept Lab Med, Hamada, Shimane, Japan; [Yano, Shozo; Hamano, Tsuyoshi; Nabika, Toru] Ctr Community Based Hlth Res & Educ CoHRE, Hamada, Shimane, Japan; [Nabika, Toru] Shimane Univ, Fac Med, Dept Funct Pathol, Hamada, Shimane, Japan; [Wada, Masayuki; Kumakura, Shunichi] Shimane Univ, Fac Med, Dept Med Educ & Res, Hamada, Shimane, Japan	Shimane University; Shimane University; Shimane University	Yano, S (corresponding author), Shimane Univ, Fac Med, Dept Lab Med, Hamada, Shimane, Japan.; Yano, S (corresponding author), Ctr Community Based Hlth Res & Educ CoHRE, Hamada, Shimane, Japan.	syano@med.shimane-u.ac.jp		Hamano, Tsuyoshi/0000-0002-6755-9138				Brunham LR, 2007, NAT MED, V13, P340, DOI 10.1038/nm1546; Freeman DJ, 2001, CIRCULATION, V103, P357; Garg M K, 2011, Indian J Endocrinol Metab, V15, pS44, DOI 10.4103/2230-8210.83059; Hamano T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049122; Hao M, 2007, DIABETES, V56, P2328, DOI 10.2337/db07-0056; Iwao T, 2014, INTERNAL MED, V53, P383, DOI 10.2169/internalmedicine.53.0337; Johns BR, 2011, CLIN CHEM, V57, P627, DOI 10.1373/clinchem.2010.152744; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Khan HA, 2007, CLIN EXP MED, V7, P24, DOI 10.1007/s10238-007-0121-3; Kruit JK, 2011, DIABETES, V60, P3186, DOI 10.2337/db11-0081; Lu XL, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-123; Lu XL, 2011, CELL STRESS CHAPERON, V16, P539, DOI 10.1007/s12192-011-0265-7; Mahalle Namita, 2014, Indian J Endocrinol Metab, V18, P48, DOI 10.4103/2230-8210.126532; Ministry of Health Labour and Welfare, 2012, OUTL RES NAT HLTH NU; Oda E, 2009, INTERNAL MED, V48, P1607, DOI 10.2169/internalmedicine.48.2398; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Sakurai M, 2009, DIABETIC MED, V26, P753, DOI 10.1111/j.1464-5491.2009.02773.x; Vergeer M, 2010, DIABETES CARE, V33, P869, DOI 10.2337/dc09-1562; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Yano S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141035; Zheng TP, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-634	21	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149452	10.1371/journal.pone.0149452	http://dx.doi.org/10.1371/journal.pone.0149452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881755	gold, Green Published, Green Submitted			2022-12-27	WOS:000371219000076
J	Aggarwal, V; Dickinson, RB; Lele, TP				Aggarwal, Varun; Dickinson, Richard B.; Lele, Tanmay P.			Concentration Sensing by the Moving Nucleus in Cell Fate Determination: A Computational Analysis	PLOS ONE			English	Article							NEURAL-TUBE; ASYMMETRIC INHERITANCE; MIGRATION; NEUROGENESIS; DIFFERENTIATION; NEUROEPITHELIA; PROLIFERATION; EPITHELIUM; NEURONS; RETINA	During development of the vertebrate neuroepithelium, the nucleus in neural progenitor cells (NPCs) moves from the apex toward the base and returns to the apex (called interkinetic nuclear migration) at which point the cell divides. The fate of the resulting daughter cells is thought to depend on the sampling by the moving nucleus of a spatial concentration profile of the cytoplasmic Notch intracellular domain (NICD). However, the nucleus executes complex stochastic motions including random waiting and back and forth motions, which can expose the nucleus to randomly varying levels of cytoplasmic NICD. How nuclear position can determine daughter cell fate despite the stochastic nature of nuclear migration is not clear. Here we derived a mathematical model for reaction, diffusion, and nuclear accumulation of NICD in NPCs during interkinetic nuclear migration (INM). Using experimentally measured trajectory-dependent probabilities of nuclear turning, nuclear waiting times and average nuclear speeds in NPCs in the developing zebrafish retina, we performed stochastic simulations to compute the nuclear trajectory-dependent probabilities of NPC differentiation. Comparison with experimentally measured nuclear NICD concentrations and trajectory-dependent probabilities of differentiation allowed estimation of the NICD cytoplasmic gradient. Spatially polarized production of NICD, rapid NICD cytoplasmic consumption and the time-averaging effect of nuclear import/export kinetics are sufficient to explain the experimentally observed differentiation probabilities. Our computational studies lend quantitative support to the feasibility of the nuclear concentration-sensing mechanism for NPC fate determination in zebrafish retina.	[Aggarwal, Varun; Dickinson, Richard B.; Lele, Tanmay P.] Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Lele, TP (corresponding author), Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA.	tlele@che.ufl.edu	Dickinson, Richard B/A-4435-2012	Dickinson, Richard B/0000-0002-7415-2889; Aggarwal, Varun/0000-0002-8406-0961	National Science Foundation [CMMI 0954302]; National Institutes of Health [R01GM102486, R01EB014869]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB014869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102486] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Science Foundation (www.nsf.org) under award CMMI 0954302 (T.P.L.) and by the National Institutes of Health (www.nih.org) under awards R01GM102486 (T.P.L. and R.B.D.) and R01EB014869 (T.P.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000390; Baye LM, 2007, J NEUROSCI, V27, P10143, DOI 10.1523/JNEUROSCI.2754-07.2007; Bort R, 2006, DEV BIOL, V290, P44, DOI 10.1016/j.ydbio.2005.11.006; Cardarelli F, 2012, J BIOL CHEM, V287, P5554, DOI 10.1074/jbc.M111.304899; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Clark BS, 2012, DEVELOPMENT, V139, P1599, DOI 10.1242/dev.078097; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; DORSKY RI, 1995, NEURON, V14, P487, DOI 10.1016/0896-6273(95)90305-4; FUJITA S, 1962, EXP CELL RES, V28, P52, DOI 10.1016/0014-4827(62)90311-7; Grosse AS, 2011, DEVELOPMENT, V138, P4423, DOI 10.1242/dev.065789; Kosodo Y, 2011, EMBO J, V30, P1690, DOI 10.1038/emboj.2011.81; Leung L, 2011, DEVELOPMENT, V138, P5003, DOI 10.1242/dev.071522; Meyer EJ, 2011, CURR BIOL, V21, P485, DOI 10.1016/j.cub.2011.02.002; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Norden C, 2009, CELL, V138, P1195, DOI 10.1016/j.cell.2009.06.032; Perumalsamy LR, 2009, CELL DEATH DIFFER, V16, P879, DOI 10.1038/cdd.2009.20; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; SAUER ME, 1959, EXP CELL RES, V16, P1, DOI 10.1016/0014-4827(59)90189-2; SAUER ME, 1959, P SOC EXP BIOL MED, V101, P557; Schenk J, 2009, P NATL ACAD SCI USA, V106, P16487, DOI 10.1073/pnas.0908928106; SIDMAN RL, 1959, EXP NEUROL, V1, P322, DOI 10.1016/0014-4886(59)90024-X; Tsai JW, 2010, NAT NEUROSCI, V13, P1463, DOI 10.1038/nn.2665; Tsujikawa M, 2007, P NATL ACAD SCI USA, V104, P14819, DOI 10.1073/pnas.0700178104	25	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149213	10.1371/journal.pone.0149213	http://dx.doi.org/10.1371/journal.pone.0149213			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872214	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100128
J	Daniels-Treffandier, H; de Nie, K; Marsay, L; Dold, C; Sadarangani, M; Reyes-Sandoval, A; Langford, PR; Wyllie, D; Hill, F; Pollard, AJ; Rollier, CS				Daniels-Treffandier, Helene; de Nie, Karlijn; Marsay, Leanne; Dold, Christina; Sadarangani, Manish; Reyes-Sandoval, Arturo; Langford, Paul R.; Wyllie, David; Hill, Fergal; Pollard, Andrew J.; Rollier, Christine S.			Impact of Reducing Complement Inhibitor Binding on the Immunogenicity of Native Neisseria meningitidis Outer Membrane Vesicles	PLOS ONE			English	Article							MENINGOCOCCAL SEROGROUP-B; FACTOR-H FH; BACTERICIDAL ACTIVITY; ANTIBODY-RESPONSES; VACCINE CANDIDATE; SERUM RESISTANCE; PROTEIN COMPLEX; DISEASE; MICE; ADJUVANTS	Neisseria meningitidis recruits host human complement inhibitors to its surface to down-regulate complement activation and enhance survival in blood. We have investigated whether such complement inhibitor binding occurs after vaccination with native outer membrane vesicles (nOMVs), and limits immunogenicity of such vaccines. To this end, nOMVs reactogenic lipopolysaccharide was detoxified by deletion of the lpxl1 gene (nOMV(lpxl1)). nOMVs unable to bind human complement factor H (hfH) were generated by additional deletions of the genes encoding factor H binding protein (fHbp) and neisserial surface protein A (NspA) (nOMV(dis)). Antibody responses elicited in mice with nOMVdis were compared to those elicited with nOMVlpxl1 in the presence of hfH. Results demonstrate that the administration of human fH to mice immunized with fHbp containing OMVlpxl1 decreased immunogenicity against fHbp (but not against the OMV as a whole). The majority of the OMV-induced bactericidal immune response (OMVlpxl1 or OMVdis) was versus PorA. Despite a considerable reduction of hfH binding to nOMV(dis), and the absence of the vaccine antigen fHbp, immunogenicity in mice was not different from nOMV(lpxl1), in the absence or presence of hfH (serum bactericidal titers of 1:64 vs 1:128 after one dose in the nOMV(dis) and nOMV(lpxl1)-immunized groups respectively). Therefore, partial inhibition of fH binding did not enhance immunity in this model.	[Daniels-Treffandier, Helene; de Nie, Karlijn; Marsay, Leanne; Dold, Christina; Sadarangani, Manish; Pollard, Andrew J.; Rollier, Christine S.] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford OX3 7LE, England; [Daniels-Treffandier, Helene; de Nie, Karlijn; Marsay, Leanne; Dold, Christina; Sadarangani, Manish; Pollard, Andrew J.; Rollier, Christine S.] Churchill Hosp, Ctr Clin Vaccinol & Trop Med, NIHR Oxford Biomed Res Ctr, Oxford OX3 7LE, England; [Reyes-Sandoval, Arturo; Wyllie, David] Univ Oxford, Jenner Inst, Ctr Cellular & Mol Physiol, Henry Wellcome Bldg Mol Physiol,Roosevelt Dr, Oxford OX3 7BN, England; [Langford, Paul R.] Univ London Imperial Coll Sci Technol & Med, Paediat Sect, St Marys Campus, London W2 1PG, England; [Hill, Fergal] Imaxio, 99 Rue Gerland, F-69007 Lyon, France	University of Oxford; University of Oxford; University of Oxford; Jenner Institute; Imperial College London	Rollier, CS (corresponding author), Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford OX3 7LE, England.; Rollier, CS (corresponding author), Churchill Hosp, Ctr Clin Vaccinol & Trop Med, NIHR Oxford Biomed Res Ctr, Oxford OX3 7LE, England.	christine.rollier@paediatrics.ox.ac.uk	Daniels-Treffandier, Hélène Sophie/Y-7461-2019; DANIELS-TREFFANDIER, Hélène/AAN-8475-2021; Dold, Christina/ABA-4237-2021; Sadarangani, Manish/V-5609-2019; Hill, Fergal/AAI-1329-2021	Reyes-Sandoval, Arturo/0000-0002-2648-1696; Sadarangani, Manish/0000-0002-9985-6452; dold, christina/0000-0003-2314-507X; Daniels, Helene/0000-0001-7426-2423	Sparks for Children's Health [10OXF01]; Meningitis UK; Action Medical Research; NIHR Oxford Biomedical Research Centre (Vaccine theme); Sparks Charity [10OXF01] Funding Source: researchfish	Sparks for Children's Health; Meningitis UK; Action Medical Research; NIHR Oxford Biomedical Research Centre (Vaccine theme); Sparks Charity	This work was supported by a project grant from Sparks for Children's Health (grant number 10OXF01). CR was also supported by research grants from Meningitis UK and Action Medical Research. She is a Jenner Institute Investigator and an Oxford Martin fellow. AJP and CR are supported by the NIHR Oxford Biomedical Research Centre (Vaccine theme). AJP is a Jenner Investigator and James Martin Senior Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Imaxio provided support in the form of salaries for author [FH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author (FH) are articulated in the 'author contributions' section.	Beernink PT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002688; Beernink PT, 2011, J IMMUNOL, V186, P3606, DOI 10.4049/jimmunol.1003470; Borrow R, 2005, CLIN DIAGN LAB IMMUN, V12, P970, DOI 10.1128/CDLI.12.8.970-976.2005; Bosse JT, 2009, APPL ENVIRON MICROB, V75, P6124, DOI 10.1128/AEM.00809-09; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Fakhouri F, 2010, KIDNEY INT, V78, P279, DOI 10.1038/ki.2010.132; FINNE J, 1983, LANCET, V2, P355; Frandoloso R, 2015, INFECT IMMUN, V83, P1030, DOI 10.1128/IAI.02572-14; Giuntini S, 2015, INFECT IMMUN, V83, P1536, DOI 10.1128/IAI.02984-14; Granoff DM, 2015, J INFECT DIS, V212, P784, DOI 10.1093/infdis/jiv081; Granoff DM, 2013, CLIN VACCINE IMMUNOL, V20, P1099, DOI 10.1128/CVI.00260-13; Granoff DM, 2009, INFECT IMMUN, V77, P764, DOI 10.1128/IAI.01191-08; Griffiths NJ, 2011, MOL MICROBIOL, V82, P1129, DOI 10.1111/j.1365-2958.2011.07876.x; Halperin SA, 2012, VACCINE, V30, pB26, DOI 10.1016/j.vaccine.2011.12.032; Jarva H, 2005, J IMMUNOL, V174, P6299, DOI 10.4049/jimmunol.174.10.6299; Lai ZZ, 2011, CLIN VACCINE IMMUNOL, V18, P724, DOI 10.1128/CVI.00053-11; Lewis LA, 2013, MBIO, V4, DOI 10.1128/mBio.00339-13; Lewis LA, 2012, J IMMUNOL, V188, P5063, DOI 10.4049/jimmunol.1103748; Lewis LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001027; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; Masignani V, 2003, J EXP MED, V197, P789, DOI 10.1084/jem.20021911; McNeil LK, 2013, MICROBIOL MOL BIOL R, V77, P234, DOI 10.1128/MMBR.00056-12; Nadel S, 2012, ARCH DIS CHILD, V97, P993, DOI 10.1136/archdischild-2012-302036; Nagaputra JC, 2014, CLIN VACCINE IMMUNOL, V21, P234, DOI 10.1128/CVI.00561-13; Pajon R, 2010, VACCINE, V28, P2122, DOI 10.1016/j.vaccine.2009.12.027; Rollier CS, 2015, EXPERT OPIN BIOL TH, V15, P131, DOI 10.1517/14712598.2015.983897; Sadarangani M, 2010, LANCET INFECT DIS, V10, P112, DOI 10.1016/S1473-3099(09)70324-X; Sambrook J., 2001, MOL CLONING LAB MANU; Sanders H, 2011, EXPERT REV VACCINES, V10, P323, DOI [10.1586/erv.11.10, 10.1586/ERV.11.10]; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; Tappero JW, 1999, JAMA-J AM MED ASSOC, V281, P1520, DOI 10.1001/jama.281.16.1520; Ufret-Vincenty RL, 2010, INVEST OPHTH VIS SCI, V51, P5878, DOI 10.1167/iovs.09-4457; van Dam V, 2012, METHODS MOL BIOL, V799, P55, DOI 10.1007/978-1-61779-346-2_4; van de Waterbeemd B, 2012, VACCINE, V30, P3683, DOI 10.1016/j.vaccine.2012.03.028; van der Ley P, 2011, HUM VACCINES, V7, P886, DOI 10.4161/hv.7.8.16086; van der Veen S, 2014, INFECT IMMUN, V82, P1157, DOI 10.1128/IAI.01183-13; VANDERLEY P, 1992, INFECT IMMUN, V60, P3156, DOI 10.1128/IAI.60.8.3156-3161.1992; VanDerVoort ER, 1996, INFECT IMMUN, V64, P2745, DOI 10.1128/IAI.64.7.2745-2751.1996; Wu YM, 2006, P NATL ACAD SCI USA, V103, P18243, DOI 10.1073/pnas.0608545103; Zariri A, 2013, VACCINE, V31, P5585, DOI 10.1016/j.vaccine.2013.07.069	40	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148840	10.1371/journal.pone.0148840	http://dx.doi.org/10.1371/journal.pone.0148840			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871712	gold, Green Published, Green Submitted			2022-12-27	WOS:000370054100062
J	Manigart, O; Trotter, C; Findlow, H; Assefa, A; Mihret, W; Demisse, TM; Yeshitela, B; Osei, I; Hodgson, A; Quaye, SL; Sow, S; Coulibaly, M; Diallo, K; Traore, A; Collard, JM; Boukary, RM; Djermakoye, O; Mahamane, AE; Jusot, JF; Sokhna, C; Alavo, S; Doucoure, S; Ba, E; Dieng, M; Diallo, A; Daugla, DM; Omotara, B; Chandramohan, D; Hassan-King, M; Nascimento, M; Woukeu, A; Borrow, R; Stuart, JM; Greenwood, B				Manigart, Olivier; Trotter, Caroline; Findlow, Helen; Assefa, Abraham; Mihret, Wude; Demisse, Tesfaye Moti; Yeshitela, Biruk; Osei, Isaac; Hodgson, Abraham; Quaye, Stephen Laryea; Sow, Samba; Coulibaly, Mamadou; Diallo, Kanny; Traore, Awa; Collard, Jean-Marc; Boukary, Rahamatou Moustapha; Djermakoye, Oumarou; Mahamane, Ali Elhaji; Jusot, Jean-Francois; Sokhna, Cheikh; Alavo, Serge; Doucoure, Souleymane; Ba, El Hadj; Dieng, Marietou; Diallo, Aldiouma; Daugla, Doumagoum Moto; Omotara, Babatunji; Chandramohan, Daniel; Hassan-King, Musa; Nascimento, Maria; Woukeu, Arouna; Borrow, Ray; Stuart, James M.; Greenwood, Brian			A Seroepidemiological Study of Serogroup A Meningococcal Infection in the African Meningitis Belt	PLOS ONE			English	Article							A CAPSULAR POLYSACCHARIDE; NEISSERIA-MENINGITIDIS; MALARIA TRANSMISSION; SEROLOGICAL MARKERS; IMMUNE-RESPONSE; ANTIBODY; VACCINE; CARRIAGE	The pattern of epidemic meningococcal disease in the African meningitis belt may be influenced by the background level of population immunity but this has been measured infrequently. A standardised enzyme-linked immunosorbent assay (ELISA) for measuring meningococcal serogroup A IgG antibodies was established at five centres within the meningitis belt. Antibody concentrations were then measured in 3930 individuals stratified by age and residence from six countries. Seroprevalence by age was used in a catalytic model to determine the force of infection. Meningococcal serogroup A IgG antibody concentrations were high in each country but showed heterogeneity across the meningitis belt. The geometric mean concentration (GMC) was highest in Ghana (9.09 mu g/mL [95% CI 8.29, 9.97]) and lowest in Ethiopia (1.43 mu g/mL [95% CI 1.31, 1.57]) on the margins of the belt. The force of infection was lowest in Ethiopia (lambda = 0.028). Variables associated with a concentration above the putative protective level of 2 mu g/mL were age, urban residence and a history of recent vaccination with a meningococcal vaccine. Prior to vaccination with the serogroup A meningococcal conjugate vaccine, meningococcal serogroup A IgG antibody concentrations were high across the African meningitis belt and yet the region remained susceptible to epidemics.	[Manigart, Olivier; Chandramohan, Daniel; Hassan-King, Musa; Nascimento, Maria; Woukeu, Arouna; Stuart, James M.; Greenwood, Brian] London Sch Hyg & Trop Med, Fac Infect Dis, London WC1, England; [Manigart, Olivier] MRC Unit, Fajara, Gambia; [Trotter, Caroline] Univ Cambridge, Dept Vet Med, Cambridge, England; [Findlow, Helen; Borrow, Ray] Publ Hlth England Vaccine Evaluat Unit, Manchester, Lancs, England; [Assefa, Abraham; Mihret, Wude; Demisse, Tesfaye Moti; Yeshitela, Biruk] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Osei, Isaac; Hodgson, Abraham; Quaye, Stephen Laryea] Navrongo Hlth Res Ctr, Navrongo, Ghana; [Sow, Samba; Coulibaly, Mamadou; Diallo, Kanny; Traore, Awa] Ctr Vaccins Dev, Bamako, Mali; [Collard, Jean-Marc; Boukary, Rahamatou Moustapha; Djermakoye, Oumarou; Mahamane, Ali Elhaji; Jusot, Jean-Francois] Ctr Rech Med & Sanitaire CERMES, Niamey, Niger; [Sokhna, Cheikh; Alavo, Serge; Doucoure, Souleymane; Ba, El Hadj; Dieng, Marietou; Diallo, Aldiouma] Inst Rech Dev, Dakar, Senegal; [Daugla, Doumagoum Moto] CSSI, Ndjamena, Chad; [Omotara, Babatunji] Univ Maiduguri, Dept Community Med, Maiduguri, Nigeria	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Cambridge; Navrongo Health Research Center; Institut de Recherche pour le Developpement (IRD)	Greenwood, B (corresponding author), London Sch Hyg & Trop Med, Fac Infect Dis, London WC1, England.	brian.greenwood@lshtm.ac.uk	Trotter, Caroline L/H-5077-2013; Aseffa, Abraham/J-3248-2016; Collard, Jean-Marc/Q-2342-2019; Woldemedhin, Wude Mihret/AAD-5840-2021	Aseffa, Abraham/0000-0002-8028-1150; Collard, Jean-Marc/0000-0002-1490-3978; Diallo, Kanny/0000-0002-0905-3980; Trotter, Caroline/0000-0003-4000-2708	Wellcome Trust [086546/Z/08/Z]; Bill & Melinda Gates Foundation [51251]	Wellcome Trust(Wellcome TrustEuropean Commission); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	This work was supported by Wellcome Trust (grant no. 086546/Z/08/Z), www.wellcome.ac.uk; Bill & Melinda Gates Foundation (grant no. 51251), www.gatesfoundation.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali O, 2013, TROP MED INT HEALTH, V18, P968, DOI 10.1111/tmi.12125; CARLONE GM, 1992, J CLIN MICROBIOL, V30, P154, DOI 10.1128/JCM.30.1.154-159.1992; CEESAY SJ, 1993, J INFECT DIS, V167, P1212, DOI 10.1093/infdis/167.5.1212; Collard JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-576; Cook J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025137; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Ferraro CF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101129; Frasch CE, 2009, VACCINE, V27, pB112, DOI 10.1016/j.vaccine.2009.04.065; GOLD R, 1978, J INFECT DIS, V137, P112, DOI 10.1093/infdis/137.2.112; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1327, DOI 10.1084/jem.129.6.1327; Greenwood B, 1999, T ROY SOC TROP MED H, V93, P341, DOI 10.1016/S0035-9203(99)90106-2; GREENWOOD BM, 1980, T ROY SOC TROP MED H, V74, P340, DOI 10.1016/0035-9203(80)90095-4; GRIFFISS JM, 1975, J IMMUNOL, V114, P1779; GUIRGUIS N, 1985, J EXP MED, V162, P1837, DOI 10.1084/jem.162.6.1837; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; MacLennan J, 1999, VACCINE, V17, P3086, DOI 10.1016/S0264-410X(99)00139-5; MenAfriCar Consortium, 2015, J INFECT DIS; Mueller JE, 2011, J INFECT DIS, V204, P1787, DOI 10.1093/infdis/jir623; Norheim G, 2008, CLIN VACCINE IMMUNOL, V15, P863, DOI 10.1128/CVI.00252-07; PELTOLA H, 1977, NEW ENGL J MED, V297, P686, DOI 10.1056/NEJM197709292971302; ROBBINS JB, 1972, INFECT IMMUN, V6, P651, DOI 10.1128/IAI.6.5.651-656.1972; ROBBINS JB, 1975, J ALLERGY CLIN IMMUN, V56, P141, DOI 10.1016/0091-6749(75)90119-0; Sow SO, 2011, NEW ENGL J MED, V364, P2293, DOI 10.1056/NEJMoa1003812; Trotter CL, 2008, CLIN VACCINE IMMUNOL, V15, P1694, DOI 10.1128/CVI.00279-08; Trotter CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055486; VANN WF, 1976, INFECT IMMUN, V13, P1654, DOI 10.1128/IAI.13.6.1654-1662.1976; Wong J, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-451	27	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0147928	10.1371/journal.pone.0147928	http://dx.doi.org/10.1371/journal.pone.0147928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872255	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000370054100012
J	Potenza, L; Vallerini, D; Barozzi, P; Riva, G; Gilioli, A; Forghieri, F; Candoni, A; Cesaro, S; Quadrelli, C; Maertens, J; Rossi, G; Morselli, M; Codeluppi, M; Mussini, C; Colaci, E; Messerotti, A; Paolini, A; Maccaferri, M; Fantuzzi, V; Del Giovane, C; Stefani, A; Morandi, U; Maffei, R; Marasca, R; Narni, F; Fanin, R; Comoli, P; Romani, L; Beauvais, A; Viale, PL; Latge, JP; Lewis, RE; Luppi, M				Potenza, Leonardo; Vallerini, Daniela; Barozzi, Patrizia; Riva, Giovanni; Gilioli, Andrea; Forghieri, Fabio; Candoni, Anna; Cesaro, Simone; Quadrelli, Chiara; Maertens, Johan; Rossi, Giulio; Morselli, Monica; Codeluppi, Mauro; Mussini, Cristina; Colaci, Elisabetta; Messerotti, Andrea; Paolini, Ambra; Maccaferri, Monica; Fantuzzi, Valeria; Del Giovane, Cinzia; Stefani, Alessandro; Morandi, Uliano; Maffei, Rossana; Marasca, Roberto; Narni, Franco; Fanin, Renato; Comoli, Patrizia; Romani, Luigina; Beauvais, Anne; Viale, Pier Luigi; Latge, Jean Paul; Lewis, Russell E.; Luppi, Mario			Mucorales-Specific T Cells in Patients with Hematologic Malignancies	PLOS ONE			English	Article							INVASIVE FUNGAL-INFECTIONS; MUCORMYCOSIS; ZYGOMYCOSIS; DIAGNOSIS; PULMONARY; ASPERGILLOSIS; EPIDEMIOLOGY; IMMUNITY; MANAGEMENT; DISEASES	Background Invasive mucormycosis (IM) is an emerging life-threatening fungal infection. It is difficult to obtain a definite diagnosis and to initiate timely intervention. Mucorales-specific T cells occur during the course of IM and are involved in the clearance of the infection. We have evaluated the feasibility of detecting Mucorales-specific T cells in hematological patients at risk for IM, and have correlated the detection of such cells with the clinical conditions of the patients. Methods and Findings By using an enzyme linked immunospot assay, the presence of Mucorales-specific T cells in peripheral blood (PB) samples has been investigated at three time points during high-dose chemotherapy for hematologic malignancies. Mucorales-specific T cells producing interferon-., interleukin-10 and interleukin-4 were analysed in order to detect a correlation between the immune response and the clinical picture. Twenty-one (10.3%) of 204 patients, accounting for 32 (5.3%) of 598 PB samples, tested positive for Mucorales-specific T cells. Two groups could be identified. Group 1, including 15 patients without signs or symptoms of invasive fungal diseases (IFD), showed a predominance of Mucorales-specific T cells producing interferon-gamma. Group 2 included 6 patients with a clinical picture consistent with invasive fungal disease (IFD): 2 cases of proven IM and 4 cases of possible IFD. The proven patients had significantly higher number of Mucorales-specific T cells producing interleukin-10 and interleukin-4 and higher rates of positive samples by using derived diagnostic cut-offs when compared with the 15 patients without IFD. Conclusions Mucorales-specific T cells can be detected and monitored in patients with hematologic malignancies at risk for IM. Mucorales-specific T cells polarized to the production of T helper type 2 cytokines are associated with proven IM and may be evaluated as a surrogate diagnostic marker for IM.	[Potenza, Leonardo; Vallerini, Daniela; Barozzi, Patrizia; Riva, Giovanni; Gilioli, Andrea; Forghieri, Fabio; Quadrelli, Chiara; Morselli, Monica; Colaci, Elisabetta; Messerotti, Andrea; Paolini, Ambra; Maccaferri, Monica; Fantuzzi, Valeria; Maffei, Rossana; Marasca, Roberto; Narni, Franco; Luppi, Mario] Univ Modena & Reggio Emilia, Sect Hematol, Dept Surg & Med Sci, Azienda Osped Univ Policlin, Modena, Italy; [Candoni, Anna; Fanin, Renato] Azienda Osped Univ Santa Maria della Misericordia, Hematol & Bone Marrow Transplantat, Udine, Italy; [Cesaro, Simone] Policlin GB Rossi, Pediat Hematol Oncol, Verona, Italy; [Maertens, Johan] Univ Ziekenhuizen Leuven, Dept Hematol, Campus Gasthuisberg, Leuven, Belgium; [Rossi, Giulio] Azienda Osped Univ Policlin, Dept Pathol, Modena, Italy; [Codeluppi, Mauro; Mussini, Cristina] Azienda Osped Univ Policlin, Clin Infect Dis, Integrated Dept Med Emergency Med & Med Specialti, Modena, Italy; [Del Giovane, Cinzia] Univ Modena & Reggio Emilia, Azienda Osped Univ Policlin, Sect Stat, Dept Diagnost Clin & Publ Hlth Med, Modena, Italy; [Stefani, Alessandro; Morandi, Uliano] Univ Modena & Reggio Emilia, Azienda Osped Univ Policlin, Div Thorac Surg, Dept Surg & Med Sci, Modena, Italy; [Comoli, Patrizia] IRCCS Policlin S Matteo, Pediat Hematol Oncol & Transplantat, Pavia, Italy; [Romani, Luigina] Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy; [Beauvais, Anne; Latge, Jean Paul] Inst Pasteur, Unite Aspergillus, Paris, France; [Viale, Pier Luigi; Lewis, Russell E.] Univ Bologna, Clin Infect Dis, Dept Internal Med Geriatr & Nephrol Dis, S Orsola Malpighi Hosp, Bologna, Italy	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; Hospital Santa Maria della Misericordia; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; KU Leuven; University Hospital Leuven; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; IRCCS Fondazione San Matteo; University of Perugia; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna	Potenza, L; Luppi, M (corresponding author), Univ Modena & Reggio Emilia, Sect Hematol, Dept Surg & Med Sci, Azienda Osped Univ Policlin, Modena, Italy.	leonardo.potenza@unimore.it; mario.luppi@unimore.it	Maffei, Rossana/O-4836-2016; Luppi, Mario/J-3668-2016; Lewis, Russell E/A-4616-2015; Beauvais, Anne/A-6358-2012; Barozzi, Patrizia/Q-2638-2016; Cesaro, Simone/I-3272-2019; Rossi, Giulio/K-6217-2016; Candoni, Anna/AAU-6289-2020; Maccaferri, Monica/J-1737-2018; Potenza, Leonardo/P-9579-2016; Romani, Luigina/O-9987-2018; Rossi, Antonio/K-7054-2016; Candoni, Anna/ABE-1708-2021; Comoli, Patrizia/K-2732-2018; Paolini, Ambra/J-8237-2018; Mussini, Cristina/K-8672-2016; Stefani, Alessandro/I-8199-2014; Marasca, Roberto/I-8072-2013; Cesaro, Simone/F-8118-2019; Morandi, Uliano/C-9451-2017	Maffei, Rossana/0000-0002-3518-2006; Luppi, Mario/0000-0002-0373-1154; Lewis, Russell E/0000-0002-2002-4339; Barozzi, Patrizia/0000-0002-8936-1114; Cesaro, Simone/0000-0002-8698-9547; Rossi, Giulio/0000-0001-8855-1218; Candoni, Anna/0000-0003-4436-1310; Maccaferri, Monica/0000-0003-2818-6516; Potenza, Leonardo/0000-0002-2738-6105; Rossi, Antonio/0000-0003-3295-0345; Comoli, Patrizia/0000-0001-5964-0553; Paolini, Ambra/0000-0002-0786-1802; Mussini, Cristina/0000-0002-6615-4198; Stefani, Alessandro/0000-0003-4547-6232; Marasca, Roberto/0000-0002-6431-6878; Cesaro, Simone/0000-0002-8698-9547; Morandi, Uliano/0000-0002-4039-7626; NARNI, Franco/0000-0003-3994-9101; Del Giovane, Cinzia/0000-0002-5028-932X; Romani, Luigina/0000-0002-1356-525X; Maccaferri, Monica/0000-0002-1413-825X	Associazione Italiana per la Ricerca sul Cancro, Milan, Italy [AIRC IG-14797]; Associazione Italiana Lotta alle Leucemie, Linfoma e Mieloma (AIL)-Sezione "Luciano Pavarotti''-Modena-ONLUS (LP and FF); Societa' Italiana di Ematologia Sperimentale (SIES); Gilead Sciences	Associazione Italiana per la Ricerca sul Cancro, Milan, Italy(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana Lotta alle Leucemie, Linfoma e Mieloma (AIL)-Sezione "Luciano Pavarotti''-Modena-ONLUS (LP and FF); Societa' Italiana di Ematologia Sperimentale (SIES); Gilead Sciences(Gilead Sciences)	This work was supported by the Associazione Italiana per la Ricerca sul Cancro [grant number AIRC IG-14797], Milan, Italy (ML); the Associazione Italiana Lotta alle Leucemie, Linfoma e Mieloma (AIL)-Sezione "Luciano Pavarotti''-Modena-ONLUS (LP and FF); Gilead Fellowship Program 2012-2014 (ML); the Societa' Italiana di Ematologia Sperimentale (SIES, "Piero Martino'' awarded to LP); and research funds by Gilead Sciences to ML. The funders had no role in study design, data collection; This work was supported by the Associazione Italiana per la Ricerca sul Cancro [grant number AIRC IG-14797], Milan, Italy (ML); the Associazione Italiana Lotta alle Leucemie, Linfoma e Mieloma (AIL)-Sezione "Luciano Pavarotti"-Modena-ONLUS (LP and FF); Gilead Fellowship Program 2012-2014 (ML); the Societa' Italiana di Ematologia Sperimentale (SIES, "Piero Martino" award to LP) and research funds by Gilead Sciences to ML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.and analysis, decision to publish, or preparation of the manuscript.	Bacher P, 2015, AM J RESP CRIT CARE, V191, P348, DOI 10.1164/rccm.201407-1235LE; Bitar D, 2009, EMERG INFECT DIS, V15, P1395, DOI 10.3201/eid1509.090334; Bozza S, 2009, J IMMUNOL, V183, P2407, DOI 10.4049/jimmunol.0900961; Chamilos G, 2005, CLIN INFECT DIS, V41, P60, DOI 10.1086/430710; Chamilos G, 2008, CLIN INFECT DIS, V47, P503, DOI 10.1086/590004; Chamilos G, 2006, HAEMATOL-HEMATOL J, V91, P986; Cornely OA, 2014, CLIN MICROBIOL INFEC, V20, P5, DOI 10.1111/1469-0691.12371; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Hebart H, 2002, BLOOD, V100, P4521, DOI 10.1182/blood-2002-01-0265; Kontoyiannis DP, 2006, INFECT DIS CLIN N AM, V20, P581, DOI 10.1016/j.idc.2006.06.003; Kontoyiannis DP, 2012, CLIN INFECT DIS, V54, pS79, DOI 10.1093/cid/cir886; Kontoyiannis DP, 2010, CLIN INFECT DIS, V50, P1091, DOI 10.1086/651263; Kontoyiannis DP, 2005, J INFECT DIS, V191, P1350, DOI 10.1086/428780; Lass-Florl C, 2007, CLIN INFECT DIS, V45, pE101, DOI 10.1086/521245; Lewis RE, 2013, MYCOSES, V56, P638, DOI 10.1111/myc.12081; Lewis RE, 2013, FUTURE MICROBIOL, V8, P1163, DOI 10.2217/fmb.13.78; Pagano L, 2013, HAEMATOLOGICA, V98, DOI 10.3324/haematol.2012.083063; Pagano L, 2009, BRIT J HAEMATOL, V146, P597, DOI 10.1111/j.1365-2141.2009.07738.x; Pantaleo G, 2006, NAT REV IMMUNOL, V6, P417, DOI 10.1038/nri1840; Pappas PG, 2010, CLIN INFECT DIS, V50, P1101, DOI 10.1086/651262; Petrikkos G, 2012, CLIN INFECT DIS, V54, pS23, DOI 10.1093/cid/cir866; Potenza L, 2007, LEUKEMIA, V21, P578, DOI 10.1038/sj.leu.2404504; Potenza L, 2008, CLIN VACCINE IMMUNOL, V15, P1625, DOI 10.1128/CVI.00198-08; Potenza L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074326; Potenza L, 2011, BLOOD, V118, P5416, DOI 10.1182/blood-2011-07-366526; Roden MM, 2005, CLIN INFECT DIS, V41, P634, DOI 10.1086/432579; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Skiada A, 2013, HAEMATOLOGICA, V98, P492, DOI 10.3324/haematol.2012.065110; Spellberg B, 2010, CLIN INFECT DIS, V48, P1743; Sun HY, 2011, LANCET INFECT DIS, V11, P301, DOI 10.1016/S1473-3099(10)70316-9; Walsh TJ, 2012, CLIN INFECT DIS, V54, pS55, DOI 10.1093/cid/cir868	31	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149108	10.1371/journal.pone.0149108	http://dx.doi.org/10.1371/journal.pone.0149108			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871570	Green Published, gold			2022-12-27	WOS:000370054100106
J	Singhal, G; Fisher, FM; Chee, MJ; Tan, TG; El Ouaamari, A; Adams, AC; Najarian, R; Kulkarni, RN; Benoist, C; Flier, JS; Maratos-Flier, E				Singhal, Garima; Fisher, Ffolliott Martin; Chee, Melissa J.; Tan, Tze Guan; El Ouaamari, Abdelfattah; Adams, Andrew C.; Najarian, Robert; Kulkarni, Rohit N.; Benoist, Christophe; Flier, Jeffrey S.; Maratos-Flier, Eleftheria			Fibroblast Growth Factor 21 (FGF21) Protects against High Fat Diet Induced Inflammation and Islet Hyperplasia in Pancreas	PLOS ONE			English	Article							IMPROVES INSULIN SENSITIVITY; ADIPOSE-TISSUE; PPAR-ALPHA; METABOLIC REGULATOR; RESISTANT STATES; MICE; RECEPTOR; LIVER; FIBROBLAST-GROWTH-FACTOR-21; ACTIVATION	Fibroblast growth factor 21 (FGF21) is an important endocrine metabolic regulator expressed in multiple tissues including liver and adipose tissue. Although highest levels of expression are in pancreas, little is known about the function of FGF21 in this tissue. In order to understand the physiology of FGF21 in the pancreas, we analyzed its expression and regulation in both acinar and islet tissues. We found that acinar tissue express 20-fold higher levels than that observed in islets. We also observed that pancreatic FGF21 is nutritionally regulated; a marked reduction in FGF21 expression was noted with fasting while obesity is associated with 3-4 fold higher expression. Acinar and islet cells are targets of FGF21, which when systemically administered, leads to phosphorylation of the downstream target ERK 1/2 in about half of acinar cells and a small subset of islet cells. Chronic, systemic FGF21 infusion down-regulates its own expression in the pancreas. Mice lacking FGF21 develop significant islet hyperplasia and periductal lymphocytic inflammation when fed with a high fat obesogenic diet. Inflammatory infiltrates consist of TCRb+Thy1+T lymphocytes with increased levels of Foxp3+ regulatory T cells. Increased levels of inflammatory cells were coupled with elevated expression of cytokines such as TNF alpha, IFN gamma and IL1 beta. We conclude that FGF21 acts to limit islet hyperplasia and may also prevent pancreatic inflammation.	[Singhal, Garima; Fisher, Ffolliott Martin; Chee, Melissa J.; Flier, Jeffrey S.; Maratos-Flier, Eleftheria] Beth Israel Deaconess Med Ctr, Div Endocrinol, Boston, MA 02215 USA; [Tan, Tze Guan; Benoist, Christophe] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02215 USA; [El Ouaamari, Abdelfattah; Kulkarni, Rohit N.] Joslin Diabet Ctr, Sect Islet Cell Biol & Regenerat Med, Boston, MA 02215 USA; [Adams, Andrew C.] Lilly Res Labs, Diabet Res, Indianapolis, IN 46225 USA; [Najarian, Robert] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Joslin Diabetes Center, Inc.; Eli Lilly; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Maratos-Flier, E (corresponding author), Beth Israel Deaconess Med Ctr, Div Endocrinol, Boston, MA 02215 USA.	emaratos@bidmc.harvard.edu	Flier, jeffrey/AAG-6223-2019; Chee, Melissa/G-4150-2014	Chee, Melissa/0000-0003-3815-9095	NIH [DK28082]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK028082, R01DK067536, R37DK028082, R01DK103215] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The research work presented here is is funded by different sources as given below: NIH DK28082 (EMF) for study design, data collection, data analysis, writing manuscript. NIH RO1 DK67536 (RNK) and RO1 DK103215 (RNK) for data collection. Lilly research laboratories provided recombinant FGF21 and FGF21 Knock out mice on the basis of a Material transfer agreement. One of the co-authors, ACA, is employed and therefore paid by the company. Lilly research laboratories did not provide funding for the present manuscript. They do not have any role in study design, data collection, data analysis or writing manuscript. The authors have added the following statement to the amended funding statement. The funder provided support in the form of salaries for authors [ACA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of ACA is articulated in the 'author contributions' section.	Adams AC, 2012, CURR DIABETES REV, V8, P285, DOI 10.2174/157339912800840505; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Badman MK, 2009, ENDOCRINOLOGY, V150, P4931, DOI 10.1210/en.2009-0532; Bonner-Weir S., 1993, P759; CAMPBELL IL, 1994, AM J PATHOL, V145, P157; Camporez JPG, 2013, ENDOCRINOLOGY, V154, P3099, DOI 10.1210/en.2013-1191; Chartoumpekis DV, 2011, MOL MED, V17, P736, DOI 10.2119/molmed.2011.00075; Dawson DW, 2013, CANCER PREV RES, V6, P1064, DOI 10.1158/1940-6207.CAPR-13-0065; Dirice E, 2014, DIABETES, V63, P188, DOI 10.2337/db13-0204; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; El Ouaamari A, 2013, CELL REP, V3, P401, DOI 10.1016/j.celrep.2013.01.007; Fisher FM, 2014, GASTROENTEROLOGY, V147, P1073, DOI 10.1053/j.gastro.2014.07.044; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Flier SN, 2001, P NATL ACAD SCI USA, V98, P7475, DOI 10.1073/pnas.131192998; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Gimeno RE, 2014, TRENDS ENDOCRIN MET, V25, P303, DOI 10.1016/j.tem.2014.03.001; Hondares E, 2011, J BIOL CHEM, V286, P12983, DOI 10.1074/jbc.M110.215889; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Johnson CL, 2014, AM J PHYSIOL-ENDOC M, V306, pE916, DOI 10.1152/ajpendo.00559.2013; Johnson CL, 2009, GASTROENTEROLOGY, V137, P1795, DOI 10.1053/j.gastro.2009.07.064; Junnila RK, 2013, NAT REV ENDOCRINOL, V9, P366, DOI 10.1038/nrendo.2013.67; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kim A, 2009, ISLETS, V1, P129, DOI 10.4161/isl.1.2.9480; Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Kulkarni RN, 1999, J CLIN INVEST, V104, pR69, DOI 10.1172/JCI8339; Markan KR, 2014, DIABETES, V63, P4057, DOI 10.2337/db14-0595; Omar BA, 2014, DIABETES, V63, P101, DOI 10.2337/db13-0710; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Planavila A, 2015, CARDIOVASC RES, V106, P19, DOI 10.1093/cvr/cvu263; So WY, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.80; So WY, 2013, DIABETES, V62, P3751, DOI 10.2337/db13-0645; Tanaka N, 2015, BBA-MOL BASIS DIS, V1852, P1242, DOI 10.1016/j.bbadis.2015.02.012; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Uonaga T, 2010, ISLETS, V2, P247, DOI 10.4161/isl.2.4.12402; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Wente W, 2006, DIABETES, V55, P2470, DOI 10.2337/db05-1435; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Xu J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1105, DOI 10.1152/ajpendo.00348.2009; Yakar S, 2004, J CLIN INVEST, V113, P96, DOI 10.1172/JCI200417763; Yan XQ, 2015, J CELL MOL MED, V19, P1557, DOI 10.1111/jcmm.12530	42	78	82	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148252	10.1371/journal.pone.0148252	http://dx.doi.org/10.1371/journal.pone.0148252			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872145	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100020
J	Blazquez, R; Sachez-Margallo, FM; Crisostomo, V; Baez, C; Maestre, J; Alvarez, V; Casado, JG				Blazquez, Rebeca; Miguel Sachez-Margallo, Francisco; Crisostomo, Veronica; Baez, Claudia; Maestre, Juan; Alvarez, Veronica; Casado, Javier G.			Intrapericardial Delivery of Cardiosphere-Derived Cells: An Immunological Study in a Clinically Relevant Large Animal Model	PLOS ONE			English	Article							GAMMA-GLUTAMYL-TRANSFERASE; MESENCHYMAL STEM-CELLS; INTERFERON-ALPHA THERAPY; ISCHEMIC CARDIOMYOPATHY; INFLAMMATORY CYTOKINES; MYOCARDIAL-INFARCTION; ALKALINE-PHOSPHATASE; PERICARDIAL FLUID; DIFFERENT FORMS; HEART-FAILURE	Introduction The intrapericardial delivery has been defined as an efficient method for pharmacological agent delivery. Here we hypothesize that intrapericardial administration of cardiosphere-derived cells (CDCs) may have an immunomodulatory effect providing an optimal microenvironment for promoting cardiac repair. To our knowledge, this is the first report studying the effects of CDCs for myocardial repair using the intrapericardial delivery route. Material and Methods CDCs lines were isolated, expanded and characterized by flow cytometry and PCR. Their differentiation ability was determined using specific culture media and differential staining. 300,000 CDCs/kg were injected into the pericardial space of a swine myocardial infarcted model. Magnetic resonance imaging, biochemical analysis of pericardial fluid and plasma, cytokine measurements and flow cytometry analysis were performed. Results Our results showed that, phenotype and differentiation behavior of porcine CDCs were equivalent to previously described CDCs. Moreover, the intrapericardial administration of CDCs fulfilled the safety aspects as non-adverse effects were reported. Finally, the phenotypes of resident lymphocytes and TH1 cytokines in the pericardial fluid were significantly altered after CDCs administration. Conclusions The pericardial fluid could be considered as a safe and optimal vehicle for CDCs administration. The observed changes in the studied immunological parameters could exert a modulation in the inflammatory environment of infarcted hearts, indirectly benefiting the endogenous cardiac repair.	[Blazquez, Rebeca; Miguel Sachez-Margallo, Francisco; Alvarez, Veronica; Casado, Javier G.] Jesus Uson Minimally Invas Surg Ctr, Stem Cell Therapy Unit, Caceres, Spain; [Crisostomo, Veronica; Baez, Claudia; Maestre, Juan] Jesus Uson Minimally Invas Surg Ctr, Endoluminal Therapy & Diag, Caceres, Spain		Casado, JG (corresponding author), Jesus Uson Minimally Invas Surg Ctr, Stem Cell Therapy Unit, Caceres, Spain.	jgarcia@ccmijesususon.com	Pérez, Verónica Álvarez/AAP-1021-2020; Blázquez, Rebeca/Q-2588-2019; García, Javier/AAH-1330-2020; G Casado, Javier/ABE-9043-2021; Sánchez Margallo, Francisco Miguel Miguel/I-5605-2019; Garcia, Javier/X-4319-2018; Blazquez, Rebeca/D-9523-2017; Blazquez Duran, Rebeca/A-9008-2015	Pérez, Verónica Álvarez/0000-0002-7319-6089; Blázquez, Rebeca/0000-0002-1149-8305; Sánchez Margallo, Francisco Miguel Miguel/0000-0003-2138-988X; Blazquez, Rebeca/0000-0002-1149-8305; Blazquez Duran, Rebeca/0000-0002-1149-8305; Baez Diaz, Claudia/0000-0001-9031-2929; G Casado, Javier/0000-0001-6797-7287; Crisostomo, Veronica/0000-0003-1740-7029	GobEx (Ayuda a grupos catalogados de la Junta de Extremadura) [GR15175]; Junta de Extremadura (FEDER/FSE) [TA13042, IB13123]; Redes tematicas de investigacion cooperativa en salud [RD12/0042/0025]; UEX; Junta de Extremadura; MICINN; FEDER; FSE	GobEx (Ayuda a grupos catalogados de la Junta de Extremadura); Junta de Extremadura (FEDER/FSE); Redes tematicas de investigacion cooperativa en salud; UEX; Junta de Extremadura; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); FEDER(European Commission); FSE(European Social Fund (ESF))	This work was supported in part by one grant from GobEx (Ayuda a grupos catalogados de la Junta de Extremadura, GR15175), two grants from Junta de Extremadura to JGC (TA13042 and IB13123 co-financed by FEDER/FSE) and two grants from Redes tematicas de investigacion cooperativa en salud (RD12/0042/0025 to FMSM and CB).; Technical and human support provided by Facility of Bioscience Applied Techniques of SAIUEx (financed by UEX, Junta de Extremadura, MICINN, FEDER and FSE).	Battula VL, 2009, HAEMATOL-HEMATOL J, V94, P173, DOI 10.3324/haematol.13740; Bjorkstrom NK, 2008, J IMMUNOL, V181, P4219, DOI 10.4049/jimmunol.181.6.4219; Blazquez R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122377; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Boonen A, 1999, CLIN RHEUMATOL, V18, P177, DOI 10.1007/s100670050081; Brassard DL, 2002, J LEUKOCYTE BIOL, V71, P565; Burr SP, 2013, IMMUNOL CELL BIOL, V91, P12, DOI 10.1038/icb.2012.60; Caliskan M, 2007, J HYPERTENS, V25, P2497, DOI 10.1097/HJH.0b013e3282f05bf1; Chugh AR, 2012, CIRCULATION, V126, pS54, DOI 10.1161/CIRCULATIONAHA.112.092627; Cooper AM, 2007, TRENDS IMMUNOL, V28, P33, DOI 10.1016/j.it.2006.11.002; de Couto G, 2015, J CLIN INVEST, V125, P3147, DOI 10.1172/JCI81321; Denyer MS, 2006, VET IMMUNOL IMMUNOP, V110, P279, DOI 10.1016/j.vetimm.2005.10.005; Dib N, 2011, J CARDIOVASC TRANSL, V4, P177, DOI 10.1007/s12265-010-9253-z; Ege T, 2003, CYTOKINE, V23, P47, DOI 10.1016/S1043-4666(03)00180-7; Freyman T, 2006, EUR HEART J, V27, P1114, DOI 10.1093/eurheartj/ehi818; Fukushima S, 2013, FUTUR CARDIOL, V9, P215, DOI [10.2217/FCA.12.85, 10.2217/fca.12.85]; Gebler A, 2012, TRENDS MOL MED, V18, P128, DOI 10.1016/j.molmed.2011.10.004; Gressens B, 2004, ACTA GASTRO-ENT BELG, V67, P301; Hoogduijn MJ, 2011, HUM GENE THER, V22, P1587, DOI 10.1089/hum.2011.039; Huang NF, 2009, REGEN MED, V4, P527, DOI 10.2217/RME.09.32; Ishigami S, 2015, CIRC RES, V116, P653, DOI 10.1161/CIRCRESAHA.116.304671; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Jiang SY, 2013, EXP CLIN CARDIOL, V18, P53; Johnston PV, 2009, CIRCULATION, V120, P1075, DOI 10.1161/CIRCULATIONAHA.108.816058; Kanazawa H, 2015, CIRC-HEART FAIL, V8, P322, DOI 10.1161/CIRCHEARTFAILURE.114.001484; KELLEY KW, 1973, J ANIM SCI, V36, P927; Kwon Yoo-Wook, 2010, Int J Stem Cells, V3, P8; Ladage D, 2011, GENE THER, V18, P979, DOI 10.1038/gt.2011.52; Lalu MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047559; Lee DH, 2006, EUR HEART J, V27, P2170, DOI 10.1093/eurheartj/ehl086; Lee ST, 2011, J AM COLL CARDIOL, V57, P455, DOI 10.1016/j.jacc.2010.07.049; Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Malliaras K, 2013, CIRCULATION, V128, P2764, DOI 10.1161/CIRCULATIONAHA.113.002863; Malliaras K, 2014, J AM COLL CARDIOL, V63, P110, DOI 10.1016/j.jacc.2013.08.724; Mazo M, 2011, J CARDIOVASC TRANSL, V4, P145, DOI 10.1007/s12265-010-9246-y; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Mornet E, 2001, J BIOL CHEM, V276, P31171, DOI 10.1074/jbc.M102788200; Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa; O'Connor MD, 2008, STEM CELLS, V26, P1109, DOI 10.1634/stemcells.2007-0801; Pankuweit S, 2000, HERZ, V25, P748, DOI 10.1007/PL00001993; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Poelzl G, 2009, CIRC-HEART FAIL, V2, P294, DOI 10.1161/CIRCHEARTFAILURE.108.826735; Popescu C, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-30; RIEMANN D, 1994, INT ARCH ALLERGY IMM, V104, P48, DOI 10.1159/000236708; Sanganalmath SK, 2013, CIRC RES, V113, P810, DOI 10.1161/CIRCRESAHA.113.300219; Sheng CC, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/547902; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Smith Rachel Ruckdeschel, 2013, Biomatter, V3, DOI 10.4161/biom.24490; Suzuki G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113009; Trivedi P, 2010, STEM CELLS DEV, V19, P1109, DOI 10.1089/scd.2009.0465; van Ramshorst J, 2011, J CARDIOVASC TRANSL, V4, P182, DOI 10.1007/s12265-010-9249-8; Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147; Wollert KC, 2005, CIRC RES, V96, P151, DOI 10.1161/01.RES.0000155333.69009.63; Yang Y, 2012, NMR BIOMED, V25, P227, DOI 10.1002/nbm.1735	55	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149001	10.1371/journal.pone.0149001	http://dx.doi.org/10.1371/journal.pone.0149001			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866919	Green Published, Green Submitted, gold			2022-12-27	WOS:000370050700052
J	Koga, H; Fujitani, H; Morino, Y; Miyamoto, N; Tsuchimoto, J; Shibata, TF; Nozawa, M; Shigenobu, S; Ogura, A; Tachibana, K; Kiyomoto, M; Amemiya, S; Wada, H				Koga, Hiroyuki; Fujitani, Haruka; Morino, Yoshiaki; Miyamoto, Norio; Tsuchimoto, Jun; Shibata, Tomoko F.; Nozawa, Masafumi; Shigenobu, Shuji; Ogura, Atsushi; Tachibana, Kazunori; Kiyomoto, Masato; Amemiya, Shonan; Wada, Hiroshi			Experimental Approach Reveals the Role of alx1 in the Evolution of the Echinoderm Larval Skeleton	PLOS ONE			English	Article							GENE REGULATORY NETWORK; SEA-URCHIN EMBRYO; PHYLOGENETIC ANALYSES; HOMEOBOX GENE; EXPRESSION; INSIGHTS; RNA; SKELETOGENESIS; PLASTICITY; TISSUES	Over the course of evolution, the acquisition of novel structures has ultimately led to wide variation in morphology among extant multicellular organisms. Thus, the origins of genetic systems for new morphological structures are a subject of great interest in evolutionary biology. The larval skeleton is a novel structure acquired in some echinoderm lineages via the activation of the adult skeletogenic machinery. Previously, VEGF signaling was suggested to have played an important role in the acquisition of the larval skeleton. In the present study, we compared expression patterns of Alx genes among echinoderm classes to further explore the factors involved in the acquisition of a larval skeleton. We found that the alx1 gene, originally described as crucial for sea urchin skeletogenesis, may have also played an essential role in the evolution of the larval skeleton. Unlike those echinoderms that have a larval skeleton, we found that alx1 of starfish was barely expressed in early larvae that have no skeleton. When alx1 overexpression was induced via injection of alx1 mRNA into starfish eggs, the expression patterns of certain genes, including those possibly involved in skeletogenesis, were altered. This suggested that a portion of the skeletogenic program was induced solely by alx1. However, we observed no obvious external phenotype or skeleton. We concluded that alx1 was necessary but not sufficient for the acquisition of the larval skeleton, which, in fact, requires several genetic events. Based on these results, we discuss how the larval expression of alx1 contributed to the acquisition of the larval skeleton in the putative ancestral lineage of echinoderms.	[Koga, Hiroyuki; Fujitani, Haruka; Morino, Yoshiaki; Miyamoto, Norio; Wada, Hiroshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Miyamoto, Norio] Japan Agcy Marine Earth Sci & Technol, Inst Biogeosci, 2-15 Natsushimacho, Yokosuka, Kanagawa 2370061, Japan; [Tsuchimoto, Jun] Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Life Sci, Kanazawa, Ishikawa 9201192, Japan; [Tsuchimoto, Jun] Aichi Med Univ, Inst Mol Sci Med, Nagakute, Aichi 48011, Japan; [Shibata, Tomoko F.; Shigenobu, Shuji] Natl Inst Basic Biol, Okazaki, Aichi 444, Japan; [Nozawa, Masafumi] Natl Inst Genet, Ctr Informat Biol, Mishima, Shizuoka 411, Japan; [Nozawa, Masafumi] Grad Univ Adv Studies, Dept Genet, Mishima, Shizuoka, Japan; [Shigenobu, Shuji] Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi, Japan; [Ogura, Atsushi] Nagahama Inst Biosci & Technol, Nagahama, Japan; [Tachibana, Kazunori] Tokyo Inst Technol, Grad Sch Biosci, Yokohama, Kanagawa 227, Japan; [Kiyomoto, Masato; Amemiya, Shonan] Ochanomizu Univ, Marine & Coastal Res Ctr, Tateyama, Toyama, Japan; [Amemiya, Shonan] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan; [Amemiya, Shonan] Keio Univ, Res & Educ Ctr Nat Sci, Yokohama, Kanagawa 223, Japan; [Koga, Hiroyuki] Univ Tokyo, Grad Sch Sci, Tokyo 113, Japan; [Shibata, Tomoko F.] Tohoku Univ, Tohoku Med Megabank Org, Sendai, Miyagi 980, Japan	University of Tsukuba; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Kanazawa University; Aichi Medical University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Graduate University for Advanced Studies - Japan; Tokyo Institute of Technology; Ochanomizu University; University of Tokyo; Keio University; University of Tokyo; Tohoku University	Koga, H (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.	hiro1224koga@gmail.com	Nozawa, Masafumi/S-9054-2019; Koga, Hiroyuki/AAG-1165-2019; Shigenobu, Shuji/B-6239-2011	Koga, Hiroyuki/0000-0001-7060-9565; Shigenobu, Shuji/0000-0003-4640-2323; Morino, Yoshiaki/0000-0001-5437-9464; Miyamoto, Norio/0000-0002-3051-3945	 [11J00274];  [23128502]	; 	This work was supported by Grant-in-Aid for JSPS Fellows 11J00274 to HK, and Grant-in-Aid for Scientific Research on Innovative Areas 23128502 to HW.	Adomako-Ankomah A, 2013, DEVELOPMENT, V140, P4214, DOI 10.1242/dev.100479; Amemiya S, 2015, ACTA ZOOL-STOCKHOLM, V96, P37, DOI 10.1111/azo.12049; Cameron CB, 2000, P NATL ACAD SCI USA, V97, P4469, DOI 10.1073/pnas.97.9.4469; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cheers MS, 2005, DEV BIOL, V283, P384, DOI 10.1016/j.ydbio.2005.02.037; Cheng XR, 2014, DEV BIOL, V391, P147, DOI 10.1016/j.ydbio.2014.04.015; Ciliberti S, 2007, P NATL ACAD SCI USA, V104, P13591, DOI 10.1073/pnas.0705396104; Ciliberti S, 2007, PLOS COMPUT BIOL, V3, P164, DOI 10.1371/journal.pcbi.0030015; Clausen S, 2005, NATURE, V438, P351, DOI 10.1038/nature04109; Costa C, 2012, DEV GENES EVOL, V222, P245, DOI 10.1007/s00427-012-0405-9; Davidson EH, 2006, REG GEN GEN REG; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Duloquin L, 2007, DEVELOPMENT, V134, P2293, DOI 10.1242/dev.005108; Ettensohn CA, 2003, DEVELOPMENT, V130, P2917, DOI 10.1242/dev.00511; ETTENSOHN CA, 1988, DEV BIOL, V125, P396, DOI 10.1016/0012-1606(88)90220-5; Ettensohn CA, 2007, DEVELOPMENT, V134, P3077, DOI 10.1242/dev.009092; Ettensohn CA, 2013, GENESIS, V51, P383, DOI 10.1002/dvg.22380; Ettensohn CA, 2009, DEVELOPMENT, V136, P11, DOI 10.1242/dev.023564; Gao F, 2008, P NATL ACAD SCI USA, V105, P6091, DOI 10.1073/pnas.0801201105; Garfield D, 2012, EVOL DEV, V14, P152, DOI 10.1111/j.1525-142X.2012.00532.x; Garfield DA, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001696; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hinman VF, 2007, P NATL ACAD SCI USA, V104, P19404, DOI 10.1073/pnas.0709994104; Hinman VF, 2014, GENESIS, V52, P193, DOI 10.1002/dvg.22757; Hyman LH, 1955, INVERTEBRATES ECHINO, VIV; Illies MR, 2002, DEV GENES EVOL, V212, P419, DOI 10.1007/s00427-002-0261-0; KILLIAN CE, 1989, DEV BIOL, V133, P148, DOI 10.1016/0012-1606(89)90306-0; Killian CE, 2010, GENE EXPR PATTERNS, V10, P135, DOI 10.1016/j.gep.2010.01.002; Kitajima T, 1996, DEV GROWTH DIFFER, V38, P687; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Koga H, 2014, GENESIS, V52, P186, DOI 10.1002/dvg.22758; Koga H, 2010, DEV GENES EVOL, V220, P107, DOI 10.1007/s00427-010-0333-5; LEMAIRE P, 1995, CELL, V81, P85, DOI 10.1016/0092-8674(95)90373-9; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Livingston BT, 2006, DEV BIOL, V300, P335, DOI 10.1016/j.ydbio.2006.07.047; Mann K, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-22; McCauley BS, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-17; McCauley BS, 2010, DEV BIOL, V340, P200, DOI 10.1016/j.ydbio.2009.11.020; McGonnell IM, 2011, EVOL DEV, V13, P343, DOI 10.1111/j.1525-142X.2011.00489.x; Miyamoto N, 2010, EVOL DEV, V12, P416, DOI 10.1111/j.1525-142X.2010.00428.x; Morino Y, 2012, EVOL DEV, V14, P428, DOI 10.1111/j.1525-142X.2012.00563.x; Nakano H, 2003, NATURE, V421, P158, DOI 10.1038/nature01236; Oliveri P, 2008, P NATL ACAD SCI USA, V105, P5955, DOI 10.1073/pnas.0711220105; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Pespeni MH, 2013, EVOLUTION, V67, P1901, DOI 10.1111/evo.12036; Rafiq K, 2014, DEVELOPMENT, V141, P950, DOI 10.1242/dev.105585; Rafiq K, 2012, DEVELOPMENT, V139, P579, DOI 10.1242/dev.073049; RICHARDSON W, 1989, DEV BIOL, V132, P266, DOI 10.1016/0012-1606(89)90222-4; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Roshan U, 2006, BIOINFORMATICS, V22, P2715, DOI 10.1093/bioinformatics/btl472; Rottinger E, 2004, DEVELOPMENT, V131, P1075, DOI 10.1242/dev.01000; Sharma T, 2010, DEVELOPMENT, V137, P1149, DOI 10.1242/dev.048652; SHIMIZUNISHIKAWA K, 1990, DEV GROWTH DIFFER, V32, P629; Shoguchi E, 2000, DEV GROWTH DIFFER, V42, P61; Smith AB, 2005, GEOL J, V40, P255, DOI 10.1002/gj.1018; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sun JQ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-219; Sun ZL, 2014, GENE EXPR PATTERNS, V16, P93, DOI 10.1016/j.gep.2014.10.002; Telford MJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0479; WADA H, 1994, P NATL ACAD SCI USA, V91, P1801, DOI 10.1073/pnas.91.5.1801; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wagner A., 2005, ROBUSTNESS EVOLVABIL; YAMASHITA M, 1985, BIOL BULL, V169, P131, DOI 10.2307/1541393	64	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149067	10.1371/journal.pone.0149067	http://dx.doi.org/10.1371/journal.pone.0149067			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866800	Green Published, gold			2022-12-27	WOS:000370050700060
J	Mollet, IG; Patel, D; Govani, FS; Giess, A; Paschalaki, K; Periyasamy, M; Lidington, EC; Mason, JC; Jones, MD; Game, L; Ali, S; Shovlin, CL				Mollet, Ines G.; Patel, Dilipkumar; Govani, Fatima S.; Giess, Adam; Paschalaki, Koralia; Periyasamy, Manikandan; Lidington, Elaine C.; Mason, Justin C.; Jones, Michael D.; Game, Laurence; Ali, Simak; Shovlin, Claire L.			Low Dose Iron Treatments Induce a DNA Damage Response in Human Endothelial Cells within Minutes	PLOS ONE			English	Article							TRANSFERRIN-BOUND IRON; HEREDITARY HEMORRHAGIC TELANGIECTASIA; PERIPHERAL ARTERIAL-DISEASE; HEMODIALYSIS-PATIENTS; BETA-THALASSEMIA; FERROUS SULFATE; P53; ACTIVATION; STORES; REDUCTION	Background Spontaneous reports from patients able to report vascular sequelae in real time, and recognition that serum non transferrin bound iron may reach or exceed 10 mu mol/L in the blood stream after iron tablets or infusions, led us to hypothesize that conventional iron treatments may provoke acute vascular injury. This prompted us to examine whether a phenotype could be observed in normal human endothelial cells treated with low dose iron. Methodology Confluent primary human endothelial cells (EC) were treated with filter-sterilized iron (II) citrate or fresh media for RNA sequencing and validation studies. RNA transcript profiles were evaluated using directional RNA sequencing with no pre-specification of target sequences. Alignments were counted for exons and junctions of the gene strand only, blinded to treatment types. Principal Findings Rapid changes in RNA transcript profiles were observed in endothelial cells treated with 10 mu mol/L iron (II) citrate, compared to media-treated cells. Clustering for Gene Ontology (GO) performed on all differentially expressed genes revealed significant differences in biological process terms between iron and media-treated EC, whereas 10 sets of an equivalent number of randomly selected genes from the respective EC gene datasets showed no significant differences in any GO terms. After 1 hour, differentially expressed genes clustered to vesicle mediated transport, protein catabolism, and cell cycle (Benjamini p = 0.0016, 0.0024 and 0.0032 respectively), and by 6 hours, to cellular response to DNA damage stimulus most significantly through DNA repair genes FANCG, BLM, and H2AFX. Comet assays demonstrated that 10 mu M iron treatment elicited DNA damage within 1 hour. This was accompanied by a brisk DNA damage response pulse, as ascertained by the development of DNA damage response (DDR) foci, and p53 stabilization. Significance These data suggest that low dose iron treatments are sufficient to modify the vascular endothelium, and induce a DNA damage response.	[Mollet, Ines G.; Patel, Dilipkumar; Govani, Fatima S.; Paschalaki, Koralia; Lidington, Elaine C.; Mason, Justin C.; Shovlin, Claire L.] Univ London Imperial Coll Sci Technol & Med, NHLI Cardiovasc Sci, London, England; [Giess, Adam; Jones, Michael D.; Game, Laurence] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, London, England; [Periyasamy, Manikandan; Ali, Simak] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [Govani, Fatima S.; Giess, Adam] Univ Oxford, Nuffield Dept Med, Oxford, England	Imperial College London; Imperial College London; Imperial College London; University of Oxford	Shovlin, CL (corresponding author), Univ London Imperial Coll Sci Technol & Med, NHLI Cardiovasc Sci, London, England.	c.shovlin@imperial.ac.uk	Periyasamy, Manikandan/AAL-6211-2020; Mollet, Ines Guerra/H-8526-2019; periyasamy, manikandan/AAB-7924-2020; Ali, Simak/N-4740-2019; Paschalaki, Koralia/B-4465-2018	Mollet, Ines Guerra/0000-0002-1422-1336; Ali, Simak/0000-0002-1320-0816; Shovlin, Claire/0000-0001-9007-5775; Coombes, Raoul Charles/0000-0002-4811-1100; Paschalaki, Koralia/0000-0002-4114-6140; Periyasamy, Manikandan/0000-0001-7626-2531; Giess, Adam/0000-0003-1683-2146; Mason, Justin/0000-0001-7783-1660	Averil Macdonald Memorial Trust; National Institute for Health Research (NIHR) Imperial College Biomedical Research Centre; British Heart Foundation [PG/09/041/27515]; Cancer Research UK [18784] Funding Source: researchfish	Averil Macdonald Memorial Trust; National Institute for Health Research (NIHR) Imperial College Biomedical Research Centre; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK)	This work received funding from the Averil Macdonald Memorial Trust, the National Institute for Health Research (NIHR) Imperial College Biomedical Research Centre; the British Heart Foundation (PG/09/041/27515); and other donations from families and friends of HHT patients. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja HS, 2003, J BIOL REG HOMEOS AG, V17, P29; Akhlaghpoor S, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-62; Alberts B, 2014, MOL BIOL CELL, DOI DOI 10.1201/9780203833445; Blake JA, 2013, NUCLEIC ACIDS RES, V41, pD530, DOI 10.1093/nar/gks1050; BRAVERMAN IM, 1990, J INVEST DERMATOL, V95, P422, DOI 10.1111/1523-1747.ep12555569; Breuer W, 2000, TRANSFUS SCI, V23, P185, DOI 10.1016/S0955-3886(00)00087-4; Chan KL, 2011, SEMIN CELL DEV BIOL, V22, P906, DOI 10.1016/j.semcdb.2011.07.001; Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882; Chan S, 2014, ACTA HAEMATOL-BASEL, V132, P200, DOI 10.1159/000356808; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; Croteau DL, 2014, ANNU REV BIOCHEM, V83, P519, DOI 10.1146/annurev-biochem-060713-035428; de Feraudy S, 2010, P NATL ACAD SCI USA, V107, P6870, DOI 10.1073/pnas.1002175107; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dentelli P, 2010, ARTERIOSCL THROM VAS, V30, P1562, DOI 10.1161/ATVBAHA.110.206201; DePalma RG, 2010, J VASC SURG, V51, P1498, DOI 10.1016/j.jvs.2009.12.068; Dresow B, 2008, BIOMETALS, V21, P273, DOI 10.1007/s10534-007-9116-5; Erster S, 2004, MOL CELL BIOL, V24, P6728, DOI 10.1128/MCB.24.15.6728-6741.2004; Finnamore H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076516; Gaenzer H, 2002, J AM COLL CARDIOL, V40, P2189, DOI 10.1016/S0735-1097(02)02611-6; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Govani FS, 2013, MOL SYNDROMOL, V4, P184, DOI 10.1159/000350208; Houschyar KS, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-54; Hutchinson C, 2004, EUR J CLIN INVEST, V34, P782, DOI 10.1111/j.1365-2362.2004.01416.x; Jiang H, 2008, BIOINFORMATICS, V24, P2395, DOI 10.1093/bioinformatics/btn429; Kartikasari AER, 2006, FASEB J, V20, P353, DOI 10.1096/fj.05-4700fje; Kautz L, 2014, NAT GENET, V46, P678, DOI 10.1038/ng.2996; Kee Y, 2012, J CLIN INVEST, V122, P3799, DOI 10.1172/JCI58321; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Lin L, 2007, BLOOD, V110, P2182, DOI 10.1182/blood-2007-04-087593; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Loewer A, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-114; Mollet IG, 2010, NUCLEIC ACIDS RES, V38, P4740, DOI 10.1093/nar/gkq197; Munoz-Bravo C, 2013, NUTRIENTS, V5, P2384, DOI 10.3390/nu5072384; Musallam KM, 2013, CURR OPIN HEMATOL, V20, P187, DOI 10.1097/MOH.0b013e32835f5a5c; Nelson M, 2004, J HUM NUTR DIET, V17, P43, DOI 10.1046/j.1365-277X.2003.00497.x; Nikolova T, 2014, TOXICOL SCI, V140, P103, DOI 10.1093/toxsci/kfu066; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Roeckel N, 2009, CANCER RES, V69, P292, DOI 10.1158/0008-5472.CAN-08-3314; Rudini N, 2008, EMBO J, V27, P993, DOI 10.1038/emboj.2008.46; Scheiber-Mojdehkar B, 2004, J AM SOC NEPHROL, V15, P1648, DOI 10.1097/01.ASN.0000130149.18412.56; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Schumann K, 2012, FOOD NUTR BULL, V33, P128, DOI 10.1177/156482651203300206; Scientific Advisory Committee on Nutrition, SACN IR HLTH REP; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shovlin CL, 2015, ANGIOGENESIS, V18, P566; Shovlin CL, 2014, AM J RESP CRIT CARE, V190, P1217, DOI 10.1164/rccm.201407-1254CI; Shovlin CL, 2010, BLOOD REV, V24, P203, DOI 10.1016/j.blre.2010.07.001; Shovlin Claire L, 2010, PLoS One, V5, pe9154, DOI 10.1371/journal.pone.0009154; SULLIVAN JL, 1981, LANCET, V1, P1293; Tian XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038164; Van Campenhout A, 2008, BIOMETALS, V21, P159, DOI 10.1007/s10534-007-9104-9; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Wen YY, 2010, CANCER SCI, V101, P73, DOI 10.1111/j.1349-7006.2009.01339.x; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Zacharski LR, 2007, JAMA-J AM MED ASSOC, V297, P603, DOI 10.1001/jama.297.6.603; Zacharski LR, 2011, AM HEART J, V162, DOI 10.1016/j.ahj.2011.08.013; Zhang XP, 2010, J BIOL CHEM, V285, P31571, DOI 10.1074/jbc.M110.134650	59	28	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0147990	10.1371/journal.pone.0147990	http://dx.doi.org/10.1371/journal.pone.0147990			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866805	gold, Green Published, Green Submitted			2022-12-27	WOS:000370050700006
J	Alors, D; Lumbsch, HT; Divakar, PK; Leavitt, SD; Crespo, A				Alors, David; Lumbsch, H. Thorsten; Divakar, Pradeep K.; Leavitt, Steven D.; Crespo, Ana			An Integrative Approach for Understanding Diversity in the Punctelia rudecta Species Complex (Parmeliaceae, Ascomycota)	PLOS ONE			English	Article							LICHEN FAMILY PARMELIACEAE; PHYLOGENETIC INFERENCE; ADJACENT TERRITORIES; MOLECULAR PHYLOGENY; PARMELIOID LICHENS; CETRARIA-ACULEATA; GENERIC CONCEPTS; DELIMITATION; DNA; CHARACTERS	High levels of cryptic diversity have been documented in lichenized fungi, especially in Parmeliaceae, and integrating various lines of evidence, including coalescent-based species delimitation approaches, help establish more robust species circumscriptions. In this study, we used an integrative taxonomic approach to delimit species in the lichen-forming fungal genus Punctelia (Parmeliaceae), with a particular focus on the cosmopolitan species P. rudecta. Nuclear, mitochondrial ribosomal DNA and protein-coding DNA sequences were analyzed in phylogenetic and coalescence-based frameworks. Additionally, morphological, ecological and geographical features of the sampled specimens were evaluated. Five major strongly supported monophyletic clades were recognized in the genus Punctelia, and each clade could be characterized by distinct patterns in medullary chemistry. Punctelia rudecta as currently circumscribed was shown to be polyphyletic. A variety of empirical species delimitation methods provide evidence for a minimum of four geographically isolated species within the nominal taxon Punctelia rudecta, including a newly described saxicolous species, P. guanchica, and three corticolous species. In order to facilitate reliable sample identification for biodiversity, conservation, and air quality bio-monitoring research, these three species have been epitypified, in addition to the description of a new species.	[Alors, David; Divakar, Pradeep K.; Crespo, Ana] Univ Complutense Madrid, Fac Farm, Dept Biol Vegetal 2, Plaza Ramon y Cajal S-N, Madrid, Spain; [Lumbsch, H. Thorsten; Leavitt, Steven D.] Field Museum Nat Hist, Sci & Educ, Chicago, IL 60605 USA	Complutense University of Madrid; Field Museum of Natural History (Chicago)	Alors, D (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Biol Vegetal 2, Plaza Ramon y Cajal S-N, Madrid, Spain.	d.alors@gmail.com	Crespo, Ana/N-6236-2014; ALors, David/L-1618-2017; Divakar, Pradeep K/E-5603-2014; Leavitt, Steven D./AAC-6462-2021	Crespo, Ana/0000-0002-5271-0157; ALors, David/0000-0001-7288-9521; Divakar, Pradeep K/0000-0002-0300-0124; Leavitt, Steven D./0000-0002-5034-9724; Lumbsch, Thorsten/0000-0003-1512-835X	Spanish Ministerio de Ciencia e Innovacion [CGL2013-42498-P]; Universidad Complutense-Banco Santander [GR3/14]; National Science Foundation [DEB-0949147]; Ministerio de CIencia e Innovacion [BES-2011-046091]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Universidad Complutense-Banco Santander; National Science Foundation(National Science Foundation (NSF)); Ministerio de CIencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by the Spanish Ministerio de Ciencia e Innovacion (CGL2013-42498-P), the Universidad Complutense-Banco Santander (GR3/14), and the National Science Foundation ("Hidden diversity in parmelioid lichens", DEB-0949147). And David Alors is developing his work thanks to a Grant by the Ministerio de CIencia e Innovacion BES-2011-046091	de Paz GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039683; de Paz GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028161; Arguello A, 2007, BIOL J LINN SOC, V91, P455, DOI 10.1111/j.1095-8312.2007.00810.x; Arup U, 2013, NORD J BOT, V31, P16, DOI 10.1111/j.1756-1051.2013.00062.x; Blanco O, 2006, MOL PHYLOGENET EVOL, V39, P52, DOI 10.1016/j.ympev.2005.12.015; Canez LS, 2009, ESTUDOS TAXONOMICOS; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Carstens BC, 2010, SYST BIOL, V59, P400, DOI 10.1093/sysbio/syq024; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Crespo A, 2004, LICHENOLOGIST, V36, P299, DOI 10.1017/S0024282904014434; Crespo A, 2001, TAXON, V50, P807, DOI 10.2307/1223708; Crespo A, 2010, IMA FUNGUS, V1, P167, DOI 10.5598/imafungus.2010.01.02.09; Crespo A, 2011, LICHENOLOGIST, V43, P511, DOI 10.1017/S0024282911000570; Crespo A, 2010, TAXON, V59, P1735, DOI 10.1002/tax.596008; Crespo A, 2009, AN JARDIN BOT MADRID, V66, P71, DOI 10.3989/ajbm.2225; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Del-Prado R, 2013, TAXON, V62, P928, DOI 10.12705/625.22; Divakar PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083115; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; ELIX JA, 1988, MYCOTAXON, V31, P491; Elix JA, 2009, SYST BIODIVERS, V7, P479, DOI 10.1017/S1477200009990223; Ence DD, 2011, MOL ECOL RESOUR, V11, P473, DOI 10.1111/j.1755-0998.2010.02947.x; Esselstyn JA, 2012, P ROY SOC B-BIOL SCI, V279, P3678, DOI 10.1098/rspb.2012.0705; Fernandez-Mendoza F, 2011, MOL ECOL, V20, P1208, DOI 10.1111/j.1365-294X.2010.04993.x; Fernandez-Mendoza F, 2013, MOL ECOL, V22, P1961, DOI 10.1111/mec.12210; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Fujita MK, 2012, TRENDS ECOL EVOL, V27, P480, DOI 10.1016/j.tree.2012.04.012; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; HALE MASON E., 1965, SVENSK BOT TTOSKR, V59, P37; Hawksworth DL, 2008, LICHENOLOGIST, V40, P1, DOI 10.1017/S0024282908007329; Hawksworth DL, 2011, LICHENOLOGIST, V43, P639, DOI 10.1017/S0024282911000454; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Kalb K, 2007, BIBLIOTHECA LICHENOL, V95, P297; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kraichak E, 2015, SCI REPORTS IN PRESS; KROG H, 1982, Nordic Journal of Botany, V2, P287, DOI 10.1111/j.1756-1051.1982.tb01191.x; KROG H, 1977, NORW J BOT, V24, P167; Leavitt S.D., 2015, RECENT ADV LICHENOLO, P11, DOI 10.1007/978-81-322-2235-4_2; Leavitt SD, 2013, J BIOGEOGR, V40, P1792, DOI 10.1111/jbi.12118; Leavitt SD, 2012, BIOL J LINN SOC, V107, P920, DOI 10.1111/j.1095-8312.2012.01978.x; Leavitt SD, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-176; Lendemer JC, 2010, LICHENOLOGIST, V42, P405, DOI 10.1017/S0024282910000101; Lindblom L, 2008, LICHENOLOGIST, V40, P399, DOI 10.1017/S0024282908007937; Lumbsch HT, 2008, AUST SYST BOT, V21, P217, DOI 10.1071/SB07049; Lumbsch HT, 2006, BIOL J LINN SOC, V89, P615, DOI 10.1111/j.1095-8312.2006.00696.x; Lumbsch HT, 2014, SYST BIODIVERS, V12, P271, DOI 10.1080/14772000.2014.905506; Lumbsch HT, 2011, FUNGAL DIVERS, V50, P59, DOI 10.1007/s13225-011-0123-z; Lumbsch H. Thorsten, 2002, P281; Lumbsch HT, 2008, BMC EVOLUTIONARY BIO, V8; Maddison WP, 2011, MESQUITE MODULAR SYS; Matheny PB, 2002, AM J BOT, V89, P688, DOI 10.3732/ajb.89.4.688; Miralles A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068242; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Moncada B, 2014, BRYOLOGIST, V117, P119, DOI 10.1639/0007-2745-117.2.119; Myllys L, 2011, LICHENOLOGIST, V43, P617, DOI 10.1017/S0024282911000132; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Otalora MAG, 2010, AM J BOT, V97, P216, DOI 10.3732/ajb.0900064; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parnmen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052245; Perez-Ortega S, 2012, ANN BOT-LONDON, V109, P1133, DOI 10.1093/aob/mcs042; Platt JL, 2000, MYCOLOGIA, V92, P475, DOI 10.2307/3761506; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rambaut A., 2009, FIGTREE 1 2 2; Rambaut A, 2009, TREE ANNOTATOR; RDT, 2008, R LANG ENV STAT COMP; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schmitt I, 2004, MOL PHYLOGENET EVOL, V33, P43, DOI 10.1016/j.ympev.2004.04.014; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Serusiaux E, 2011, J BIOGEOGR, V38, P1138, DOI 10.1111/j.1365-2699.2010.02469.x; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Strimmer K, 2002, P ROY SOC B-BIOL SCI, V269, P137, DOI 10.1098/rspb.2001.1862; Tan G, 2015, SYST BIOL, P1; Thell A, 2012, NORD J BOT, V30, P641, DOI 10.1111/j.1756-1051.2012.00008.x; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wirtz N, 2012, ORG DIVERS EVOL, V12, P17, DOI 10.1007/s13127-011-0066-y; Yang ZH, 2014, MOL BIOL EVOL, V31, P3125, DOI 10.1093/molbev/msu279; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zoller S, 1999, LICHENOLOGIST, V31, P511	86	29	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0146537	10.1371/journal.pone.0146537	http://dx.doi.org/10.1371/journal.pone.0146537			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863231	Green Published, Green Submitted, gold			2022-12-27	WOS:000370046600011
J	Gucyetmez, B; Atalan, HK				Gucyetmez, Bulent; Atalan, Hakan K.			C-Reactive Protein and Hemogram Parameters for the Non-Sepsis Systemic Inflammatory Response Syndrome and Sepsis: What Do They Mean?	PLOS ONE			English	Article							EOSINOPENIA; PROCALCITONIN; MARKERS; INFECTION; COUNT	Objectives Sepsis is one of the most common reasons of increased mortality and morbidity in the intensive care unit. The changes in CRP levels and hemogram parameters and their combinations may help to distinguish sepsis from non-sepsis SIRS. The aim of this study is to investigate the CRP and hemogram parameters as an indicator of sepsis. Methods A total of 2777 patients admitted to the ICU of two centers between 2006-2013 were evaluated retrospectively. The patients were diagnosed as SIRS (-), non-sepsis SIRS and sepsis. The patients who were under 18 years old, re-admitted, diagnosed with hematological disease, on corticosteroid and immunosuppressive therapy, SIRS (-), culture negative, undocumented laboratory values and outcomes were excluded. 1257 patients were divided into 2 groups as non-sepsis SIRS and sepsis. The patients' demographic data, CRP levels, hemogram parameters, length of ICU stay and mortality were recorded. Results 1257 patients were categorized as non-sepsis SIRS (816, 64.9%) and sepsis (441, 35.1%). In the multivariate analysis, the likelihood of sepsis was increased 3.2 (2.2-4.6), 1.7 (1.22.4), 1.6 (1.2-2.1), 2.3 (1.4-3.8), 1.5 (1.1-2.1) times by the APACHE II >= 13, SOFA score >= 4, CRP >= 4.0, Lym(C)<0.45 and PLTC<150 respectively (p<0.001 p = 0.007 p = 0.004 p<0.001 p = 0.027). The likelihood of sepsis was increased 18.1 (8.4-38.7) times by the combination of CRP >= 4.0, lym(C)<0.45 and PLTC<150 (P<0.001). Conclusions While WBCC, NeuC, Neu%, NLCR and Eo(C) are far from being the indicators to distinguish sepsis from non-sepsis SIRS, the combinations of CRP, Lym(C) and PLTC can be used to determine the likelihood of sepsis.	[Gucyetmez, Bulent] Acibadem Univ, Dept Anesthesiol, Fac Med, Istanbul, Turkey; [Atalan, Hakan K.] Atasehir Mem Hosp, Intens Care Unit, Istanbul, Turkey	Acibadem University; Memorial Healthcare Group	Gucyetmez, B (corresponding author), Acibadem Univ, Dept Anesthesiol, Fac Med, Istanbul, Turkey.	bulentgucyetmez@gmail.com	Atalan, Hakan Korkut/I-1384-2018; Gucyetmez, Bulent/D-1033-2016	Atalan, Hakan Korkut/0000-0001-9306-3657; Gucyetmez, Bulent/0000-0002-4464-4591				Abidi K, 2008, CRIT CARE, V12, DOI 10.1186/cc6883; Agrawal A, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/319215; BARNES PJ, 1993, TRENDS PHARMACOL SCI, V14, P436, DOI 10.1016/0165-6147(93)90184-L; BASS DA, 1975, J CLIN INVEST, V56, P870, DOI 10.1172/JCI108166; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bouloukaki Izolde, 2015, World J Exp Med, V5, P77, DOI 10.5493/wjem.v5.i2.77; Castelli GP, 2006, MINERVA ANESTESIOL, V72, P69; de Jager CPC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046561; de Jager CPC, 2010, CRIT CARE, V14, DOI 10.1186/cc9309; Dellinger RP, 2013, CRIT CARE MED, V41, P637, DOI [DOI 10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-015-3827-9]; Gil H, 2003, REV MED INTERNE, V24, P431, DOI 10.1016/S0248-8663(03)00138-3; Hawkins CA, 2006, INTERN MED J, V36, P385, DOI 10.1111/j.1445-5994.2006.01076.x; Jilma B, 1999, AM J RESP CRIT CARE, V159, P857, DOI 10.1164/ajrccm.159.3.9805087; Kim YH, 2013, J KOREAN MED SCI, V28, P114, DOI 10.3346/jkms.2013.28.1.114; Luzzani A, 2003, CRIT CARE MED, V31, P1737, DOI 10.1097/01.CCM.0000063440.19188.ED; Meisner M, 1999, CRIT CARE, V3, P45, DOI 10.1186/cc306; Muller B, 2000, CRIT CARE MED, V28, P977, DOI 10.1097/00003246-200004000-00011; MUNCK A, 1994, ANN NY ACAD SCI, V746, P115, DOI 10.1111/j.1749-6632.1994.tb39221.x; Povoa P, 1998, INTENS CARE MED, V24, P1052, DOI 10.1007/s001340050715; Saito I, 2014, CLIN MED INSIGHTS-CA, V8, P35, DOI 10.4137/CMC.S17066; Sessler Curtis N, 2002, Curr Opin Crit Care, V8, P465, DOI 10.1097/00075198-200210000-00016; Setterberg MJ, 2004, CLIN INFECT DIS, V38, P460, DOI 10.1086/380846; Shaw JG, 2014, J THORAC DIS, V6, P1532, DOI 10.3978/j.issn.2072-1439.2014.11.33; Simon CE, 1922, MANUAL CLIN DIAGNOSI; Terradas R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042860; Wibrow BA, 2011, ANAESTH INTENS CARE, V39, P224, DOI 10.1177/0310057X1103900211; Zahorec R, 2001, Bratisl Lek Listy, V102, P5	27	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148699	10.1371/journal.pone.0148699	http://dx.doi.org/10.1371/journal.pone.0148699			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863002	gold, Green Published, Green Submitted			2022-12-27	WOS:000370046600099
J	Hernandez, J; Moore, C; Si, XM; Richer, S; Jackson, J; Wang, W				Hernandez, Jerome; Moore, Cecil; Si, Xuemei; Richer, Stuart; Jackson, Janet; Wang, Wei			Aging Dogs Manifest Myopia as Measured by Autorefractor	PLOS ONE			English	Article							OPTICAL DEFOCUS; SURESIGHT	Objective Dogs, like humans, experience eye changes with aging: hardening and clouding of the lens and accumulated oxidative damage from UV sunlight. It has been debated whether such changes could be affecting the visual function of dogs. The objective of this study was to determine if autorefractometry could be used to measure visual function in dogs. Animals and Methods Nine Beagle dogs (ages 1 to 14 years) were examined by a veterinary ophthalmologist and their eyes determined to be free of cataracts. Spherical equivalent refractive error was measured by handheld autorefractor (Welch Allyn SureSight) under both indirect and direct lighting conditions with five measurements per condition, per eye. Measures were repeated on three different days for each dog within six weeks. Nonparametric statistics were used to detect differences among lighting conditions and test days, and between eyes. Spearmen correlation assessed the visual measurement outcomes' association with age. Results There was no difference for day-to-day or between-eye measurements. Significantly, the Beagles showed a myopic shift with aging (average spherical equivalent ranged from plano to -3.00 diopters), suggesting that dogs become more near-sighted as they age (r = -0.48 and -0.73 under direct and indirect lights; p<0.05 both). Younger dogs were able to make larger accommodation changes from indirect light to direct light conditions, indicating a more flexible lens (r = -0.50, p<0.05). Conclusions Although designed for humans, the hand-held autorefractor technique is applicable to dogs and sensitive to light conditions. The age-associated myopic shift could be expected to compromise dogs' visual functions.	[Hernandez, Jerome] Nestle Purina Res, St Joseph, MO USA; [Moore, Cecil] Univ Missouri, Dept Vet Med & Surg, Columbia, MO USA; [Si, Xuemei; Jackson, Janet; Wang, Wei] Nestle Res Ctr, St Louis, MO USA; [Richer, Stuart] Captain James A Lovell Fed Hlth Care Facil, Ophthalmol, N Chicago, IL USA	University of Missouri System; University of Missouri Columbia; Nestle SA	Wang, W (corresponding author), Nestle Res Ctr, St Louis, MO USA.	wei.wang@rd.nestle.com			Nestle	Nestle(Nestle SA)	This study was supported by Nestle. The funder played a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Berliner ML, 1966, BIOMICROSCOPY EYE, P1147; Chylack L.T.KPM, 2000, PRINCIPLES PRACTICE, P227; DAVIDSON MG, 2007, VET OPHTHALMOLOGY, P859; Groth AD, 2013, VET OPHTHALMOL, V16, P319, DOI 10.1111/j.1463-5224.2012.01075.x; Kubai MA, 2008, AM J VET RES, V69, P946, DOI 10.2460/ajvr.69.7.946; MURPHY CJ, 1992, INVEST OPHTH VIS SCI, V33, P2459; Murphy CJ, 1997, AM J VET RES, V58, P414; Mutti DO, 1999, INVEST OPHTH VIS SCI, V40, P1577; Ofri R, 2012, AM J VET RES, V73, P546, DOI 10.2460/ajvr.73.4.546; Steele G, 2003, OPTOMETRY VISION SCI, V80, P573, DOI 10.1097/00006324-200308000-00010; Tobias G, 1998, AM J VET RES, V59, P945; Williams LA, 2011, OPTOMETRY VISION SCI, V88, P269, DOI 10.1097/OPX.0b013e3182058ff0; Ying GS, 2011, INVEST OPHTH VIS SCI, V52, P9658, DOI 10.1167/iovs.11-8559	13	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148436	10.1371/journal.pone.0148436	http://dx.doi.org/10.1371/journal.pone.0148436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26862919	Green Published, Green Submitted, gold			2022-12-27	WOS:000370046600071
J	Mu, WJ; Zhong, WJ; Yao, JY; Li, LJ; Peng, YL; Wang, Y; Liu, LS; Xiao, Y; Liu, SJ; Wu, CJ; Jiang, YX; Parajuly, SS; Xu, P; Hao, Y; Li, J; Luo, BM; Zhi, H				Mu, Wen-Jie; Zhong, Wen-Jing; Yao, Ji-Yi; Li, Lu-Jing; Peng, Yu-lan; Wang, Yi; Liu, Li-sha; Xiao, Ying; Liu, Shou-jun; Wu, Chang-jun; Jiang, Yu-xin; Parajuly, Shyam Sundar; Xu, Ping; Hao, Yi; Li, Jing; Luo, Bao-Ming; Zhi, Hui			Ultrasonic Elastography Research Based on a Multicenter Study: Adding Strain Ratio after 5-Point Scoring Evaluation or Not	PLOS ONE			English	Article							BREAST-LESIONS; US-ELASTOGRAPHY; DIFFERENTIAL-DIAGNOSIS; BENIGN; SONOELASTOGRAPHY; NODULES; MASSES	Background This study aimed to confirm whether strain ratio should be added after evaluation of lesions with 5-point elasticity scoring for differentiating benign and malignant breast lesions on ultrasonographic elastography(UE). Materials and Methods From June 2010 to March 2012, 1080 consecutive female patients with breast lesions were recruited into a multicenter retrospective study, which involved 8 centers across China. Each institutional ethic review board approved the study, and all the patients gave written informed consent. All the patients underwent the UE procedure and the strain ratios were calculated and the final diagnosis was made by histological findings. The sensitivity, specificity, accuracy, PPV and NPV were calculated for each of the two evaluation systems and the areas under the ROC curve were compared. Results The strain ratios of benign lesions (mean, 2.6 +/- 2.0) and malignant lesions (mean, 7.9 +/- 5.8) were significantly different (p < 0.01). When the cutoff point was 3.01, strain ratio method had 79.8% sensitivity, 82.8% specificity, and 81.3% accuracy, while the 5-point scoring method had 93.1% sensitivity, 73.0% specificity, and 76.8% accuracy. The areas under the ROC curve with the strain ratio method and 5-point scoring method were 0.863 and 0.865, respectively(p>0.05). The strain ratio method shows better a diagnosis performance of the lesions with elasticity score 3 and 4. Conclusions Although the two UE methods have similar diagnostic performance, separate calculation of the strain ratios seems compulsory, especially for the large solid breast lesions and the lesions with elasticity score 3 and 4.	[Mu, Wen-Jie; Zhong, Wen-Jing; Yao, Ji-Yi; Li, Lu-Jing; Luo, Bao-Ming; Zhi, Hui] Sun Yat Sen Univ, Dept Ultrasound, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Peng, Yu-lan; Parajuly, Shyam Sundar] Sichuan Univ, Dept Diagnost Ultrasound, West China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Peng, Yu-lan; Parajuly, Shyam Sundar] Sichuan Univ, Natl Key Discipline Med Imaging & Nucl Med, West China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Wang, Yi; Xu, Ping] Fudan Univ, Dept Ultrasound, Huashan Hosp, Shanghai 200433, Zhejiang, Peoples R China; [Liu, Li-sha; Hao, Yi] Xinjiang Med Univ, Tumor Hosp Affiliated, Dept Ultrasound, Urumqi, Xinjiang Provin, Peoples R China; [Xiao, Ying] Cent S Univ, Xiangya Hosp, Dept Ultrasound, Changsha, Hunan, Peoples R China; [Liu, Shou-jun; Li, Jing] China Med Univ, ShengJing Hosp, Dept Ultrasound, Shenyang, Liaoning Provin, Peoples R China; [Wu, Chang-jun] Harbin Med Univ, Affiliated Hosp 1, Dept Ultrasound, Harbin, Heilongjiang Pr, Peoples R China; [Jiang, Yu-xin] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Ultrasound, Beijing, Hebei Province, Peoples R China; [Wu, Chang-jun] Peking Union Med Coll, Beijing, Hebei Province, Peoples R China	Sun Yat Sen University; Sichuan University; Sichuan University; Fudan University; Xinjiang Medical University; Central South University; China Medical University; Harbin Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Luo, BM; Zhi, H (corresponding author), Sun Yat Sen Univ, Dept Ultrasound, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China.	bmluo2005@126.com; zhihui18123@163.com	Li, Lujing/AAW-3653-2020; peng, yu/GXW-2071-2022					Asteria C, 2008, THYROID, V18, P523, DOI 10.1089/thy.2007.0323; Cho N, 2008, KOREAN J RADIOL, V9, P111, DOI 10.3348/kjr.2008.9.2.111; Cho N, 2011, EUR RADIOL, V21, P1618, DOI 10.1007/s00330-011-2103-9; Garra BS, 1997, RADIOLOGY, V202, P79, DOI 10.1148/radiology.202.1.8988195; Hiltawsky KM, 2001, ULTRASOUND MED BIOL, V27, P1461, DOI 10.1016/S0301-5629(01)00434-3; Itoh A, 2006, RADIOLOGY, V239, P341, DOI 10.1148/radiol.2391041676; Kelly KM, 1995, J ULTRAS MED, V14, P72; Lee JW, 2008, J SURG ONCOL, V98, P15, DOI 10.1002/jso.21077; Levy L, 2007, EUR J RADIOL, V61, P202, DOI 10.1016/j.ejrad.2006.08.035; Lu R, 2014, J ULTRAS MED, V33, P667, DOI 10.7863/ultra.33.4.667; Ophir J, 2000, ULTRASOUND MED BIOL, V26, pS23, DOI 10.1016/S0301-5629(00)00156-3; Scaperrotta G, 2008, EUR RADIOL, V18, P2381, DOI 10.1007/s00330-008-1032-8; Schaefer FKW, 2011, EUR J RADIOL, V77, P450, DOI 10.1016/j.ejrad.2009.08.026; Stachs A, 2013, ULTRASCHALL MED, V34, P131, DOI 10.1055/s-0032-1313168; STAVROS AT, 1995, RADIOLOGY, V196, P123, DOI 10.1148/radiology.196.1.7784555; Tardivon A, 2007, J RADIOL, V88, P657, DOI 10.1016/S0221-0363(07)89872-6; Tatsumi C, 2008, INTERVIROLOGY, V51, P27, DOI 10.1159/000122602; Thitaikumar A, 2008, PHYS MED BIOL, V53, P4809, DOI 10.1088/0031-9155/53/17/022; Thomas A, 2006, ACAD RADIOL, V13, P1496, DOI 10.1016/j.acra.2006.08.012; Waki K, 2007, P ISICE, P449; Yerli H, 2011, J ULTRAS MED, V30, P179, DOI 10.7863/jum.2011.30.2.179; Yi A, 2012, EUR RADIOL, V22, P1033, DOI 10.1007/s00330-011-2341-x; Zhi H, 2008, ACAD RADIOL, V15, P1347, DOI 10.1016/j.acra.2008.08.003; Zhi H, 2013, CLIN BREAST CANCER, V13, P392, DOI 10.1016/j.clbc.2013.02.015; Zhi H, 2010, ACAD RADIOL, V17, P1227, DOI 10.1016/j.acra.2010.05.004	25	12	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148330	10.1371/journal.pone.0148330	http://dx.doi.org/10.1371/journal.pone.0148330			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863208	gold, Green Published, Green Submitted			2022-12-27	WOS:000370046600056
J	Westerman, E; Monteiro, A				Westerman, Erica; Monteiro, Antonia			Rearing Temperature Influences Adult Response to Changes in Mating Status	PLOS ONE			English	Article							BICYCLUS-ANYNANA BUTTERFLIES; MATE CHOICE; SOCIAL EXPERIENCES; WING PATTERNS; PHENOTYPIC PLASTICITY; BRAIN-DEVELOPMENT; CLIMATE-CHANGE; FEMALE; INSECTS; EJACULATE	Rearing environment can have an impact on adult behavior, but it is less clear how rearing environment influences adult behavior plasticity. Here we explore the effect of rearing temperature on adult mating behavior plasticity in the butterfly Bicyclus anynana, a species that has evolved two seasonal forms in response to seasonal changes in temperature. These seasonal forms differ in both morphology and behavior. Females are the choosy sex in cohorts reared at warm temperatures (WS butterflies), and males are the choosy sex in cohorts reared at cooler temperatures (DS butterflies). Rearing temperature also influences mating benefits and costs. In DS butterflies, mated females live longer than virgin females, and mated males live shorter than virgin males. No such benefits or costs to mating are present in WS butterflies. Given that choosiness and mating costs are rearing temperature dependent in B. anynana, we hypothesized that temperature may also impact male and female incentives to remate in the event that benefits and costs of second matings are similar to those of first matings. We first examined whether lifespan was affected by number of matings. We found that two matings did not significantly increase lifespan for either WS or DS butterflies relative to single matings. However, both sexes of WS but not DS butterflies experienced decreased longevity when mated to a non-virgin relative to a virgin. We next observed pairs of WS and DS butterflies and documented changes in mating behavior in response to changes in the mating status of their partner. WS but not DS butterflies changed their mating behavior in response to the mating status of their partner. These results suggest that rearing temperature influences adult mating behavior plasticity in B. anynana. This developmentally controlled behavioral plasticity may be adaptive, as lifespan depends on the partner's mating status in one seasonal form, but not in the other.	[Westerman, Erica; Monteiro, Antonia] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA; [Westerman, Erica] Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA; [Monteiro, Antonia] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Monteiro, Antonia] Yale NUS Coll, Singapore, Singapore	Yale University; University of Chicago; National University of Singapore; Yale NUS College	Westerman, E (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA.; Westerman, E (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	ewesterman@uchicago.edu	Monteiro, Antonia/J-6452-2013	Monteiro, Antonia/0000-0001-9696-459X	National Science Foundation [IOS-110382]; Yale University	National Science Foundation(National Science Foundation (NSF)); Yale University	This research was funded by a National Science Foundation (www.nsf.gov) IOS-110382 Doctoral Dissertation Improvement Grant to EW and AM, and Yale University (www.yale.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamy M, 2012, NEUROSCI BIOBEHAV R, V36, P1463, DOI 10.1016/j.neubiorev.2012.03.009; Altermatt F, 2010, P ROY SOC B-BIOL SCI, V277, P1281, DOI 10.1098/rspb.2009.1910; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Bailey NW, 2008, P ROY SOC B-BIOL SCI, V275, P2645, DOI 10.1098/rspb.2008.0859; Beldade P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-130; Bissoondath CJ, 1996, FUNCT ECOL, V10, P457, DOI 10.2307/2389938; Boggs Carol L., 1995, P215; BRAKEFIELD PM, 1993, ACTA BIOTHEOR, V41, P447, DOI 10.1007/BF00709376; BRAKEFIELD PM, 1995, J EVOLUTION BIOL, V8, P559, DOI 10.1046/j.1420-9101.1995.8050559.x; BRAKEFIELD PM, 1991, ECOL ENTOMOL, V16, P291, DOI 10.1111/j.1365-2311.1991.tb00220.x; BRAKEFIELD PM, 1984, BIOL J LINN SOC, V22, P1, DOI 10.1111/j.1095-8312.1984.tb00795.x; Bro-Jorgensen J, 2010, BIOL REV, DOI [10.1111/j.1469-185X.2010.00149, DOI 10.1111/J.1469-185X.2010.00149]; Champagne FA, 2005, CURR OPIN NEUROBIOL, V15, P704, DOI 10.1016/j.conb.2005.10.001; Champagne FA, 2010, DEV PSYCHOBIOL, V52, P299, DOI 10.1002/dev.20436; Chapman JW, 2015, ECOL LETT, V18, P287, DOI 10.1111/ele.12407; Cook PA, 1996, P ROY SOC B-BIOL SCI, V263, P1047, DOI 10.1098/rspb.1996.0154; de Jong MA, 2013, MOL ECOL, V22, P341, DOI 10.1111/mec.12114; de Jong MA, 2010, CLIM RES, V43, P91, DOI 10.3354/cr00881; Devictor V, 2008, P ROY SOC B-BIOL SCI, V275, P2743, DOI 10.1098/rspb.2008.0878; Doi H, 2008, BIOL LETTERS, V4, P388, DOI 10.1098/rsbl.2008.0234; Engqvist L, 2001, P ROY SOC B-BIOL SCI, V268, P729, DOI 10.1098/rspb.2000.1423; Etges WJ, 2007, EVOLUTION, V61, P1106, DOI 10.1111/j.1558-5646.2007.00104.x; ETGES WJ, 1992, EVOLUTION, V46, P1945, DOI [10.2307/2410042, 10.1111/j.1558-5646.1992.tb01180.x]; Everett A, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-232; Fagiolini M, 2009, CURR OPIN NEUROBIOL, V19, P207, DOI 10.1016/j.conb.2009.05.009; Fedorka KM, 2002, ANIM BEHAV, V64, P361, DOI 10.1006/anbe.2002.3052; FOWLER K, 1989, NATURE, V338, P760, DOI 10.1038/338760a0; Fowler-Finn KD, 2012, EVOLUTION, V66, P459, DOI 10.1111/j.1558-5646.2011.01446.x; Friberg U, 2006, ANIM BEHAV, V72, P1259, DOI 10.1016/j.anbehav.2006.03.021; Froy O, 2003, SCIENCE, V300, P1303, DOI 10.1126/science.1084874; Hardling R, 2008, AM NAT, V172, P259, DOI 10.1086/589452; Heinze S, 2012, J COMP NEUROL, V520, P1599, DOI 10.1002/cne.23054; HEISENBERG M, 1995, J NEUROSCI, V15, P1951, DOI 10.1523/JNEUROSCI.15-03-01951.1995; Jia ZY, 2000, ECOL ENTOMOL, V25, P115, DOI 10.1046/j.1365-2311.2000.00239.x; Joron M, 2003, NATURE, V424, P191, DOI 10.1038/nature01713; Karlsson B, 1998, ECOLOGY, V79, P2931, DOI 10.1890/0012-9658(1998)079[2931:NGRBAR]2.0.CO;2; Kemp DJ, 2004, OIKOS, V105, P65, DOI 10.1111/j.0030-1299.2004.12874.x; Kooi RE, 1999, J INSECT PHYSIOL, V45, P201, DOI 10.1016/S0022-1910(98)00093-6; Kozak GM, 2009, EVOLUTION, V63, P353, DOI 10.1111/j.1558-5646.2008.00564.x; Laviola G, 1998, NEUROSCI BIOBEHAV R, V23, P197, DOI 10.1016/S0149-7634(98)00021-9; Leech DI, 2007, IBIS, V149, P128, DOI 10.1111/j.1474-919X.2007.00729.x; Macias-Munoz A, 2015, MOLECULAR BIOLOGY AN, DOI [10.1093/molbev/msv197, DOI 10.1093/M0LBEV/MSV197]; Migaud M, 2015, FRONT NEUROENDOCRIN, V37, P146, DOI 10.1016/j.yfrne.2014.11.004; Monteiro A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064061, DOI 10.1371/J0URNAL.P0NE.0064061]; MORAN NA, 1992, AM NAT, V139, P971, DOI 10.1086/285369; Musolin DL, 2012, ENTOMOL REV, V92, P715, DOI DOI 10.1134/S0013873812070019; Nieberding CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002751; Nijhout HF, 2003, EVOL DEV, V5, P9, DOI 10.1046/j.1525-142X.2003.03003.x; Nylin S, 2013, PHYSIOL ENTOMOL, V38, P96, DOI 10.1111/phen.12014; Papadopoulos NT, 2009, PHYSIOL ENTOMOL, V34, P238, DOI 10.1111/j.1365-3032.2009.00680.x; Pfennig KS, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0599; Prado EL, 2014, NUTR REV, V72, P267, DOI 10.1111/nure.12102; Prudic KL, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1531; Prudic KL, 2011, SCIENCE, V331, P73, DOI 10.1126/science.1197114; Robertson KA, 2005, P ROY SOC B-BIOL SCI, V272, P1541, DOI 10.1098/rspb.2005.3142; Rypstra AL, 2003, ETHOLOGY, V109, P315, DOI 10.1046/j.1439-0310.2003.00874.x; Sandvik M, 2000, P ROY SOC B-BIOL SCI, V267, P2151, DOI 10.1098/rspb.2000.1262; SHAPIRO A.M., 1976, EVOL BIOL, V9, P259, DOI DOI 10.1007/978-1-4615-6950-3_6; Sherry DF, 2015, FRONT NEUROENDOCRIN, V37, P158, DOI 10.1016/j.yfrne.2014.11.008; Sherry DF, 2010, PHILOS T R SOC B, V365, P933, DOI 10.1098/rstb.2009.0220; SIMMONS LW, 1994, J EVOLUTION BIOL, V7, P189, DOI 10.1046/j.1420-9101.1994.7020189.x; Singer MC, 2010, PHILOS T R SOC B, V365, P3161, DOI 10.1098/rstb.2010.0144; Snell-Rood EC, 2011, BEHAV ECOL, V22, P291, DOI 10.1093/beheco/arq169; South SH, 2009, P ROY SOC B-BIOL SCI, V276, P3671, DOI 10.1098/rspb.2009.0991; Thomas ML, 2011, BIOL REV, V86, P1, DOI 10.1111/j.1469-185X.2010.00130.x; Vahed K, 1998, BIOL REV, V73, P43, DOI 10.1017/S0006323197005112; Verzijden MN, 2012, TRENDS ECOL EVOL, V27, P511, DOI 10.1016/j.tree.2012.05.007; Wainwright PE, 2006, AM J CLIN NUTR, V84, P961, DOI 10.1093/ajcn/84.5.961; Wedell N, 2004, ANIM BEHAV, V67, P1059, DOI 10.1016/j.anbehav.2003.10.007; Wedell N, 1999, P ROY SOC B-BIOL SCI, V266, P1033, DOI 10.1098/rspb.1999.0740; Westerman EL, 2014, J INSECT BEHAV, V27, P478, DOI 10.1007/s10905-014-9441-9; Westerman EL, 2014, EVOLUTION, V68, P1661, DOI 10.1111/evo.12381; Westerman EL, 2013, ANIM BEHAV, V86, P1139, DOI 10.1016/j.anbehav.2013.09.002; Westerman EL, 2012, P NATL ACAD SCI USA, V109, P10948, DOI 10.1073/pnas.1118378109; WIKLUND C, 1982, ANIM BEHAV, V30, P790, DOI 10.1016/S0003-3472(82)80151-6; WINDIG JJ, 1994, ECOL ENTOMOL, V19, P285, DOI 10.1111/j.1365-2311.1994.tb00420.x; Zhu HS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001345; Zhu HS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-14	78	7	7	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0146546	10.1371/journal.pone.0146546	http://dx.doi.org/10.1371/journal.pone.0146546			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863319	Green Published, Green Submitted, gold			2022-12-27	WOS:000370046600012
J	Zhang, HN; Liu, YH; Guan, SY; Qu, D; Wang, L; Wang, XS; Li, XB; Zhou, SM; Zhou, Y; Wang, N; Meng, JR; Ma, X				Zhang, Huinan; Liu, Yunhan; Guan, Shaoyu; Qu, Di; Wang, Ling; Wang, Xinshang; Li, Xubo; Zhou, Shimeng; Zhou, Ying; Wang, Ning; Meng, Jingru; Ma, Xue			An Orally Active Allosteric GLP-1 Receptor Agonist Is Neuroprotective in Cellular and Rodent Models of Stroke	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; FOCAL CEREBRAL-ISCHEMIA; EXENDIN-4; RATS; ACTIVATION; EXPRESSION; MICE; ANTAGONIST; INFARCTION; APOPTOSIS	Diabetes is a major risk factor for the development of stroke. Glucagon-like peptide-1 receptor (GLP-1R) agonists have been in clinical use for the treatment of diabetes and also been reported to be neuroprotective in ischemic stroke. The quinoxaline 6,7-dichloro-2-methylsulfonyl-3-N-tert-butylaminoquinoxaline (DMB) is an agonist and allosteric modulator of the GLP-1R with the potential to increase the affinity of GLP-1 for its receptor. The aim of this study was to evaluate the neuroprotective effects of DMB on transient focal cerebral ischemia. In cultured cortical neurons, DMB activated the GLP-1R, leading to increased intracellular cAMP levels with an EC50 value about 100 fold that of exendin-4. Pretreatment of neurons with DMB protected against necrotic and apoptotic cell death was induced by oxygen-glucose deprivation (OGD). The neuroprotective effects of DMB were blocked by GLP1R knockdown with shRNA but not by GLP-1R antagonism. In C57BL/6 mice, DMB was orally administered 30 min prior to middle cerebral artery occlusion (MCAO) surgery. DMB markedly reduced the cerebral infarct size and neurological deficits caused by MCAO and reperfusion. The neuroprotective effects were mediated by activation of the GLP-1R through the cAMP-PKA-CREB signaling pathway. DMB exhibited anti-apoptotic effects by modulating Bcl-2 family members. These results provide evidence that DMB, a small molecular GLP-1R agonist, attenuates transient focal cerebral ischemia injury and inhibits neuronal apoptosis induced by MCAO. Taken together, these data suggest that DMB is a potential neuroprotective agent against cerebral ischemia.	[Zhang, Huinan; Guan, Shaoyu; Qu, Di; Wang, Xinshang; Li, Xubo; Zhou, Shimeng; Zhou, Ying; Wang, Ning; Meng, Jingru; Ma, Xue] Fourth Mil Med Univ, Sch Pharm, Dept Pharmacol, Xian 710032, Peoples R China; [Liu, Yunhan] Fourth Mil Med Univ, Sch Nurse, Xian 710032, Peoples R China; [Wang, Ling] Fourth Mil Med Univ, Dept Hlth Stat, Fac Preventat Med, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Meng, JR; Ma, X (corresponding author), Fourth Mil Med Univ, Sch Pharm, Dept Pharmacol, Xian 710032, Peoples R China.	mjrfmmu@hotmail.com; maxuel@fmmu.edu.cn			National Natural Science Foundation of China [81571278, 81471093, 81402931]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Nos. 81571278 (Xue Ma), 81471093 (Jingru Meng) and 81402931 (Ying Zhou).	Ashabi G, 2014, METAB BRAIN DIS, V29, P47, DOI 10.1007/s11011-013-9475-2; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Briyal S, 2012, BRAIN RES, V1427, P23, DOI 10.1016/j.brainres.2011.10.026; Camos S, 2010, MOLECULES, V15, P9104, DOI 10.3390/molecules15129104; Chen T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05531; Darsalia V, 2015, J CEREBR BLOOD F MET, V35, P718, DOI 10.1038/jcbfm.2015.17; Darsalia V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103114; Darsalia V, 2012, CLIN SCI, V122, P473, DOI 10.1042/CS20110374; de Maturana RL, 2003, J BIOL CHEM, V278, P10195, DOI 10.1074/jbc.M212147200; DEACON CF, 1995, DIABETES, V44, P1126, DOI 10.2337/diabetes.44.9.1126; Ding L, 2012, ACTA PHARMACOL SIN, V33, P75, DOI 10.1038/aps.2011.149; Dong YF, 2013, CNS NEUROSCI THER, V19, P617, DOI 10.1111/cns.12117; Go AS, 2014, CIRCULATION, V129, P399, DOI 10.1161/01.cir.0000442015.53336.12; GOKE R, 1993, J BIOL CHEM, V268, P19650; Green CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044284; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Holscher C, 2012, CNS DRUGS, V26, P871, DOI 10.2165/11635890-000000000-00000; Kieffer TJ, 1999, ENDOCR REV, V20, P876, DOI 10.1210/er.20.6.876; Knudsen LB, 2007, P NATL ACAD SCI USA, V104, P937, DOI 10.1073/pnas.0605701104; Lee CH, 2011, J NEUROSCI RES, V89, P1103, DOI 10.1002/jnr.22596; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Lin F, 2009, J MOL MODEL, V15, P53, DOI 10.1007/s00894-008-0372-2; MacManus JP, 2000, J NEUROTRAUM, V17, P899, DOI 10.1089/neu.2000.17.899; Manandhar B, 2015, J MED CHEM, V58, P1020, DOI 10.1021/jm500810s; Meloni BP, 2001, NEUROSCIENCE, V108, P17, DOI 10.1016/S0306-4522(01)00396-7; Nakka VP, 2010, NEUROTOX RES, V17, P189, DOI 10.1007/s12640-009-9110-5; Panjwani N, 2013, ENDOCRINOLOGY, V154, P127, DOI 10.1210/en.2012-1937; Perry T, 2003, TRENDS PHARMACOL SCI, V24, P377, DOI 10.1016/S0165-6147(03)00160-3; Pyke C, 2014, ENDOCRINOLOGY, V155, P1280, DOI 10.1210/en.2013-1934; Pyke C, 2013, ENDOCRINOLOGY, V154, P4, DOI 10.1210/en.2012-2124; Sairanen T, 2006, BRAIN, V129, P189, DOI 10.1093/brain/awh645; Sanderson TH, 2009, NEUROL RES, V31, P947, DOI 10.1179/174313209X382449; Sato K, 2013, INT J MOL SCI, V14, P21513, DOI 10.3390/ijms141121513; Tanne D, 2008, ADV CARDIOL, V45, P107, DOI 10.1159/000115190; Teramoto S, 2011, J CEREBR BLOOD F MET, V31, P1696, DOI 10.1038/jcbfm.2011.51; THORENS B, 1993, DIABETES, V42, P1678, DOI 10.2337/diabetes.42.11.1678; THORENS B, 1992, P NATL ACAD SCI USA, V89, P8641, DOI 10.1073/pnas.89.18.8641; Turner RC, 2013, J NEUROSURG, V118, P1072, DOI 10.3171/2012.11.JNS12408; Tzefos M, 2012, ANN PHARMACOTHER, V46, P68, DOI 10.1345/aph.1Q379; Wu F, 2013, MOL CELL NEUROSCI, V52, P9, DOI 10.1016/j.mcn.2012.10.001; Wu ZH, 2014, THERANOSTICS, V4, P770, DOI 10.7150/thno.7759; Zhang HN, 2015, EUR J PHARM SCI, V70, P82, DOI 10.1016/j.ejps.2015.01.010; Zhang ZY, 2014, FREE RADICAL BIO MED, V68, P8, DOI 10.1016/j.freeradbiomed.2013.11.007	44	29	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148827	10.1371/journal.pone.0148827	http://dx.doi.org/10.1371/journal.pone.0148827			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863436	Green Published, gold, Green Submitted			2022-12-27	WOS:000370046600112
J	De Luca, D; Catanese, G; Procaccini, G; Fiorito, G				De Luca, Daniele; Catanese, Gaetano; Procaccini, Gabriele; Fiorito, Graziano			Octopus vulgaris (Cuvier, 1797) in the Mediterranean Sea: Genetic Diversity and Population Structure	PLOS ONE			English	Article							DNA MARKERS; PHYLOGENETIC-RELATIONSHIPS; MOLLUSCA CEPHALOPODA; IBERIAN PENINSULA; RE-IMPLEMENTATION; COMPUTER-PROGRAM; N-E; SQUID; DIFFERENTIATION; OCTOPODIDAE	The common octopus, Octopus vulgaris Cuvier 1797, is a largely exploited cephalopod species in the Mediterranean Sea and the Atlantic Ocean, as well as along the coasts of Africa, Brazil and Japan, where its taxonomic identity is still debated. The assessment of its genetic structure is a pressing need to correctly manage the resource and to avoid over-fishing and collapsing of local stocks. Here we analysed genetic variation and population structure of O. vulgaris using thirteen microsatellite loci in seven sampling localities from the Mediterranean Sea and one from the Atlantic Ocean. We also used a DNA barcoding approach by COI gene fragment to understand the phylogenetic relationships among the specimens here investigated and the ones whose sequences are available in literature. Our results reveal high levels of allelic richness and moderate heterozygosity in all samples investigated, and a pronounced differentiation of the Atlantic and Sicilian specimens. This latter aspect seems to support the isolation of the biota within the Strait of Messina. A certain degree of differentiation was detected among the other geographic samples within the Mediterranean Sea, which is more compatible with an island model than isolation by distance. The occurrence of null alleles affected more genetic diversity indices than population structure estimations. This study provides new insights about the genetic diversity and structure of O. vulgaris in the area of interest, which can be used as guidelines for a fisheries management perspective.	[De Luca, Daniele; Catanese, Gaetano; Procaccini, Gabriele; Fiorito, Graziano] Stn Zool Anton Dohrn, I-80121 Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli	De Luca, D (corresponding author), Stn Zool Anton Dohrn, I-80121 Naples, Italy.	daniele.deluca088@gmail.com	Procaccini, Gabriele/A-6618-2010; De Luca, Daniele/AAG-8715-2020; Procaccini, Gabriele/AAA-7040-2019; CATANESE, GAETANO/A-7510-2009	Procaccini, Gabriele/0000-0002-6179-468X; De Luca, Daniele/0000-0002-1639-9138; Procaccini, Gabriele/0000-0002-6179-468X; CATANESE, GAETANO/0000-0001-6219-4494	Ritmare Italian Flagship Project [SP2_WP4AZ2UO03]; Stazione Zoologica Anton Dohrn di Napoli	Ritmare Italian Flagship Project; Stazione Zoologica Anton Dohrn di Napoli	Funding provided by SP2_WP4AZ2UO03, www.ritmare.it, Ritmare Italian Flagship Project, GP GF and www.szn.it, Stazione Zoologica Anton Dohrn di Napoli, GP GF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison JA, 2005, BIOL LETTERS, V1, P450, DOI 10.1098/rsbl.2005.0353; Addison JA, 2008, MOL ECOL, V17, P4222, DOI 10.1111/j.1365-294X.2008.03905.x; Alberto F., 2006, STANDARICH V1 00 R P; Allendorf F, 2013, CONSERV GENET, V2nd; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; Bahri-Sfar L, 2000, P ROY SOC B-BIOL SCI, V267, P929, DOI 10.1098/rspb.2000.1092; Belkhir K, 1996, GENETIX 4 05 LOGICIE; BIGNAMI F, 1990, NATO ADV SCI I C-MAT, V318, P95; Boyle PR, 1996, PHILOS T R SOC B, V351, P985, DOI 10.1098/rstb.1996.0089; Buresch KC, 2006, MAR ECOL PROG SER, V310, P263, DOI 10.3354/meps310263; Cabranes C, 2008, ICES J MAR SCI, V65, P12, DOI 10.1093/icesjms/fsm178; Caddy JF, 1983, ADV ASSESSMENT WORLD, V231, P416; Casu M, 2002, ITAL J ZOOL, V69, P295, DOI 10.1080/11250000209356472; Dai LN, 2012, MOL ECOL RESOUR, V12, P437, DOI 10.1111/j.1755-0998.2012.03118.x; De Luca D, 2015, CONSERV GENET RESOUR, V7, P299, DOI 10.1007/s12686-014-0365-7; De Luca D, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00055; Sales JBD, 2013, J SHELLFISH RES, V32, P325, DOI 10.2983/035.032.0211; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fadhlaoui-Zid K, 2012, CR BIOL, V335, P625, DOI 10.1016/j.crvi.2012.10.004; Faure V, 2000, FISH OCEANOGR, V9, P343, DOI 10.1046/j.1365-2419.2000.00149.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Forsythe J.W., 1987, P135; Forsythe John W., 1993, P133; Forsythe JW, 2004, MAR FRESHWATER RES, V55, P331, DOI 10.1071/MF03146; Garoia F, 2004, HEREDITY, V93, P166, DOI 10.1038/sj.hdy.6800489; Gerlach G, 2010, MOL ECOL, V19, P3845, DOI 10.1111/j.1365-294X.2010.04784.x; Giantsis IA, 2014, J MAR BIOL ASSOC UK, V94, P797, DOI 10.1017/S0025315414000174; Greatorex EC, 2000, MOL ECOL, V9, P641, DOI 10.1046/j.1365-294x.2000.00882-7.x; Guerra A, 2010, ICES J MAR SCI, V67, P1401, DOI 10.1093/icesjms/fsq040; Hale ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045170; Hauser L, 2002, P NATL ACAD SCI USA, V99, P11742, DOI 10.1073/pnas.172242899; Haye PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088613; Hellberg ME, 2009, ANNU REV ECOL EVOL S, V40, P291, DOI 10.1146/annurev.ecolsys.110308.120223; Herke SW, 2002, MAR BIOL, V140, P103, DOI 10.1007/s002270100680; Hernandez-Lopez JL, 2001, FISH B-NOAA, V99, P679; Higgins KL, 2013, MAR ECOL PROG SER, V486, P203, DOI 10.3354/meps10330; Hoffman JI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063954; Hoffman JI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032415; Ibanez CM, 2012, J MAR BIOL ASSOC UK, V92, P197, DOI 10.1017/S0025315411000440; Ibanez CM, 2011, MAR ECOL PROG SER, V431, P163, DOI 10.3354/meps09133; Jereb P, 2013, CEPHALOPODS WORLD AN, V3; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Kaneko N, 2011, MALACOLOGIA, V54, P97, DOI 10.4002/040.054.0102; Kenchington EL, 2006, MOL ECOL, V15, P1781, DOI 10.1111/j.1365-294X.2006.02915.x; Keskin E, 2013, MITOCHONDR DNA, V24, P440, DOI 10.3109/19401736.2012.762576; Keskin E, 2011, BIOCHEM SYST ECOL, V39, P277, DOI 10.1016/j.bse.2011.08.015; Li JJ, 2014, BIOCHEM SYST ECOL, V56, P8, DOI 10.1016/j.bse.2014.04.011; Lo Bianco Salvatore, 1909, Mitteilungen aus der Zoologischen Station zu Neapel Berlin, V19; Lu ZM, 2013, GENET MOL RES, V12, P3755, DOI 10.4238/2013.September.19.7; Maltagliati F, 2002, B MAR SCI, V71, P473; Mangold K., 1983, P335; MATHER JA, 1994, J ZOOL, V233, P359, DOI 10.1111/j.1469-7998.1994.tb05270.x; Meriam T, 2015, MOL BIOL REP, V42, P77, DOI 10.1007/s11033-014-3743-z; Moreira AA, 2011, J EXP MAR BIOL ECOL, V407, P34, DOI 10.1016/j.jembe.2011.06.029; Moreno A, 2009, J PLANKTON RES, V31, P73, DOI 10.1093/plankt/fbn103; Murphy JM, 2002, B MAR SCI, V71, P545; Nomura T, 2008, EVOL APPL, V1, P462, DOI 10.1111/j.1752-4571.2008.00015.x; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Patarnello T, 2007, MOL ECOL, V16, P4426, DOI 10.1111/j.1365-294X.2007.03477.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perez-Losada M, 2002, HEREDITY, V89, P417, DOI 10.1038/sj.hdy.6800160; Perez-Ruzafa A, 2006, BIOL CONSERV, V129, P244, DOI 10.1016/j.biocon.2005.10.040; Pierce GJ, 2008, HYDROBIOLOGIA, V612, P49, DOI 10.1007/s10750-008-9489-7; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; R Core Team, 2021, R LANGUAGE ENV STAT; Ranzi S., 1930, ATT 9 C GEOGR IT, V2, P1; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reichow D, 2001, MOL ECOL, V10, P1101, DOI 10.1046/j.1365-294X.2001.01257.x; Robinson A.R., 2001, OCEAN CURRENTS MEDIT, DOI [10.1006/rwos.2001.0376, DOI 10.1006/RWOS.2001.0376]; Rose CG, 2006, J HERED, V97, P158, DOI 10.1093/jhered/esj019; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Serra IA, 2010, MOL ECOL, V19, P557, DOI 10.1111/j.1365-294X.2009.04462.x; Shaw PW, 2004, MAR BIOL, V144, P961, DOI 10.1007/s00227-003-1260-z; Shaw PW, 2000, MOL ECOL, V9, P237, DOI 10.1046/j.1365-294x.2000.00804.x; SMALE MJ, 1981, MAR BIOL, V65, P1, DOI 10.1007/BF00397061; Strugnell JM, 2014, HYDROBIOLOGIA, V725, P215, DOI 10.1007/s10750-013-1517-6; Takumiya M, 2005, ZOOL SCI, V22, P147, DOI 10.2108/zsj.22.147; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teske PR, 2007, MAR BIOL, V151, P2119, DOI 10.1007/s00227-007-0644-x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Villamor A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101135; Villanueva R, 1997, J EXP MAR BIOL ECOL, V208, P169, DOI 10.1016/S0022-0981(96)02670-6; Villanueva R, 2014, CEPHALOPOD CULTURE, P479, DOI DOI 10.1007/978-94-017-8648-5_26; Wang CL, 2012, GENETICS, V192, P651, DOI 10.1534/genetics.112.139519; Waples RS, 2010, EVOL APPL, V3, P244, DOI 10.1111/j.1752-4571.2009.00104.x; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; Weersing K, 2009, MAR ECOL PROG SER, V393, P1, DOI 10.3354/meps08287; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whitlock MC, 2011, MOL ECOL, V20, P1083, DOI 10.1111/j.1365-294X.2010.04996.x; Williams RC, 2015, MOL ECOL, V24, P3316, DOI 10.1111/mec.13255; Xavier JC, 2015, J MAR BIOL ASSOC UK, V95, P999, DOI 10.1017/S0025315414000782	98	21	21	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149496	10.1371/journal.pone.0149496	http://dx.doi.org/10.1371/journal.pone.0149496			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881847	Green Submitted, gold, Green Published			2022-12-27	WOS:000371219000078
J	Oba, J; Nakahara, T; Hashimoto-Hachiya, A; Liu, M; Abe, T; Hagihara, A; Yokomizo, T; Furue, M				Oba, Junna; Nakahara, Takeshi; Hashimoto-Hachiya, Akiko; Liu, Min; Abe, Takeru; Hagihara, Akihito; Yokomizo, Takehiko; Furue, Masutaka			CD10-Equipped Melanoma Cells Acquire Highly Potent Tumorigenic Activity: A Plausible Explanation of Their Significance for a Poor Prognosis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CARCINOMA IN-VITRO; NEUTRAL ENDOPEPTIDASE; MALIGNANT-MELANOMA; TUMOR PROGRESSION; BREAST-CANCER; STROMAL CELLS; CUTANEOUS MELANOMA; CD10 EXPRESSION; GENE-EXPRESSION	CD10 has been widely used in cancer diagnosis. We previously demonstrated that its expression in melanoma increased with tumor progression and predicted poor patient survival. However, the mechanism by which CD10 promotes melanoma progression remains unclear. In order to elucidate the role of CD10 in melanoma, we established CD10-overexpressing A375 melanoma cells and performed DNA microarray and qRT-PCR analyses to identify changes in the gene expression profile. The microarray analysis revealed that upregulated genes in CD10-A375 were mostly involved in cell proliferation, angiogenesis, and resistance to apoptosis; down-regulated genes mostly belonged to the categories associated with cell adhesion and migration. Accordingly, in functional experiments, CD10-A375 showed significantly greater cell proliferation in vitro and higher tumorigenicity in vivo; CD10 enzymatic inhibitors, thiorphan and phosphoramidon, significantly blocked the tumor growth of CD10-A375 in mice. In migration and invasion assays, CD10-A375 displayed lower migratory and invasive capacity than mock-A375. CD10 augmented melanoma cell resistance to apoptosis mediated by etoposide and gemcitabine. These findings indicate that CD10 may promote tumor progression by regulating the expression profiles of genes related to cell proliferation, angiogenesis, and resistance to apoptosis.	[Oba, Junna; Nakahara, Takeshi; Hashimoto-Hachiya, Akiko; Furue, Masutaka] Kyushu Univ, Dept Dermatol, Grad Sch Med Sci, Fukuoka 812, Japan; [Liu, Min; Yokomizo, Takehiko] Juntendo Univ, Sch Med, Dept Biochem, Tokyo 113, Japan; [Abe, Takeru; Hagihara, Akihito] Kyushu Univ, Dept Hlth Serv Management & Policy, Grad Sch Med Sci, Fukuoka 812, Japan; [Nakahara, Takeshi] Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Div Skin Surface Sensing, Fukuoka 812, Japan; [Liu, Min] Shanghai Jiao Tong Univ, Sch Med, Dept Endocrinol, Shanghai Peoples Hosp 9, Shanghai 200030, Peoples R China; [Abe, Takeru] Yokohama City Univ, Med Ctr, Adv Crit Care & Emergency Ctr, Yokohama, Kanagawa 232, Japan	Kyushu University; Juntendo University; Kyushu University; Kyushu University; Shanghai Jiao Tong University; Yokohama City University	Nakahara, T (corresponding author), Kyushu Univ, Dept Dermatol, Grad Sch Med Sci, Fukuoka 812, Japan.	nakahara@dermatol.med.kyushu-u.ac.jp	Abe, Takeru/J-9512-2014; Oba, Junna/AAV-7048-2020; Yokomizo, Takehiko/P-5673-2016	Abe, Takeru/0000-0003-3496-1953; Yokomizo, Takehiko/0000-0002-5219-1553; Oba, Junna/0000-0002-2899-3919	Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labor and Welfare; World Fusion Co., Ltd.; Government to the National Cancer Center, Japan [21S-7[6]]; Grants-in-Aid for Scientific Research [15H05897] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); World Fusion Co., Ltd.; Government to the National Cancer Center, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by grants from the Ministry of Education, Culture, Sports, Science and Technology, the Ministry of Health, Labor and Welfare, and the Government to the National Cancer Center (21S-7[6]), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We appreciate the technical support from the Research Support Center, Kyushu University. The microarray analysis was supported by World Fusion Co., Ltd.	Abdou AG, 2007, APMIS, V115, P1206, DOI 10.1111/j.1600-0643.2007.00645.x; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Bilalovic N, 2004, MODERN PATHOL, V17, P1251, DOI 10.1038/modpathol.3800174; Celia-Terrassa T, 2012, J CLIN INVEST, V122, P1849, DOI 10.1172/JCI59218; Chu PG, 2000, AM J CLIN PATHOL, V113, P374, DOI 10.1309/8VAV-J2FU-8CU9-EK18; Dai HY, 2005, CANCER RES, V65, P4059, DOI 10.1158/0008-5472.CAN-04-3953; Dall'Era Marc A, 2007, BMC Urol, V7, P3, DOI 10.1186/1471-2490-7-3; David C, 1999, J MED CHEM, V42, P5197, DOI 10.1021/jm9903040; Desmedt C, 2012, CLIN CANCER RES, V18, P1004, DOI 10.1158/1078-0432.CCR-11-0383; Fleischmann A, 2011, VIRCHOWS ARCH, V458, P741, DOI 10.1007/s00428-011-1084-z; Fleischmann A, 2008, CLIN CANCER RES, V14, P7838, DOI 10.1158/1078-0432.CCR-08-1432; Ganju RK, 1996, BLOOD, V88, P4159; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Giese A, 1996, INT J CANCER, V67, P275, DOI 10.1002/(SICI)1097-0215(19960717)67:2<275::AID-IJC20>3.0.CO;2-9; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Godard S, 2003, CANCER RES, V63, P6613; Godlewski J, 2010, MOL CELL, V37, P620, DOI 10.1016/j.molcel.2010.02.018; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Huang WB, 2005, JPN J CLIN ONCOL, V35, P245, DOI 10.1093/jjco/hyi076; Ikenaga N, 2010, GASTROENTEROLOGY, V139, P1041, DOI 10.1053/j.gastro.2010.05.084; Jerby L, 2012, CANCER RES, V72, P5712, DOI 10.1158/0008-5472.CAN-12-2215; Kajiyama H, 2005, CLIN CANCER RES, V11, P1798, DOI 10.1158/1078-0432.CCR-04-2395; Kuniyasu H, 2010, GUT, V59, P348, DOI 10.1136/gut.2009.178376; Lee KW, 2015, INT J CANCER, V136, P310, DOI 10.1002/ijc.29006; Lee KW, 2012, ANN SURG ONCOL, V19, P326, DOI 10.1245/s10434-011-1867-0; Maguer-Satta V, 2011, STEM CELLS, V29, P389, DOI 10.1002/stem.592; Mandala M, 2014, VIRCHOWS ARCH, V464, P265, DOI 10.1007/s00428-013-1526-x; Markert EK, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.140; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Oba J, 2011, BRIT J DERMATOL, V165, P506, DOI 10.1111/j.1365-2133.2011.10409.x; Oba J, 2014, J AM ACAD DERMATOL, V70, P954, DOI 10.1016/j.jaad.2014.01.880; Oba J, 2011, J AM ACAD DERMATOL, V65, P1152, DOI 10.1016/j.jaad.2010.10.019; Oefner C, 2000, J MOL BIOL, V296, P341, DOI 10.1006/jmbi.1999.3492; Omran OM, 2012, J ENVIRON PATHOL TOX, V31, P203, DOI 10.1615/JEnvironPatholToxicolOncol.v31.i3.20; Rothberg BEG, 2009, JNCI-J NATL CANCER I, V101, P452, DOI 10.1093/jnci/djp038; SHIPP MA, 1993, BLOOD, V82, P1052, DOI 10.1182/blood.V82.4.1052.bloodjournal8241052; Sumitomo M, 2005, BBA-PROTEINS PROTEOM, V1751, P52, DOI 10.1016/j.bbapap.2004.11.001; Terauchi M, 2005, ONCOLOGY-BASEL, V69, P52, DOI 10.1159/000087476; Tsuji T, 2008, CANCER RES, V68, P10377, DOI 10.1158/0008-5472.CAN-08-1444; Velazquez EF, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-2; Voutsadakis IA, 2012, UROL INT, V88, P158, DOI 10.1159/000335299; Waldman YY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003806; Xie LN, 2010, CANCER SCI, V101, P2570, DOI 10.1111/j.1349-7006.2010.01735.x	43	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149285	10.1371/journal.pone.0149285	http://dx.doi.org/10.1371/journal.pone.0149285			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881775	Green Submitted, gold, Green Published			2022-12-27	WOS:000371219000067
J	Antharam, VC; McEwen, DC; Garrett, TJ; Dossey, AT; Li, EC; Kozlov, AN; Mesbah, Z; Wang, GP				Antharam, Vijay C.; McEwen, Daniel C.; Garrett, Timothy J.; Dossey, Aaron T.; Li, Eric C.; Kozlov, Andrew N.; Mesbah, Zhubene; Wang, Gary P.			An Integrated Metabolomic and Microbiome Analysis Identified Specific Gut Microbiota Associated with Fecal Cholesterol and Coprostanol in Clostridium difficile Infection	PLOS ONE			English	Article							INTESTINAL MICROFLORA; SUGAR-CHOLESTANOLS; BILE-SALTS; CONVERSION; BACTERIA; RISK; BIOHYDROGENATION; TRANSPLANTATION; COPROSTEROL; PATTERNS	Clostridium difficile infection (CDI) is characterized by dysbiosis of the intestinal microbiota and a profound derangement in the fecal metabolome. However, the contribution of specific gut microbes to fecal metabolites in C. difficile-associated gut microbiome remains poorly understood. Using gas-chromatography mass spectrometry (GC-MS) and 16S rRNA deep sequencing, we analyzed the metabolome and microbiome of fecal samples obtained longitudinally from subjects with Clostridium difficile infection (n = 7) and healthy controls (n = 6). From 155 fecal metabolites, we identified two sterol metabolites at > 95% match to cholesterol and coprostanol that significantly discriminated C. difficile-associated gut microbiome from healthy microbiota. By correlating the levels of cholesterol and coprostanol in fecal extracts with 2,395 bacterial operational taxonomic units (OTUs) determined by 16S rRNA sequencing, we identified 63 OTUs associated with high levels of coprostanol and 2 OTUs correlated with low coprostanol levels. Using indicator species analysis (ISA), 31 of the 63 coprostanol-associated bacteria correlated with health, and two Veillonella species were associated with low coprostanol levels that correlated strongly with CDI. These 65 bacterial taxa could be clustered into 12 sub-communities, with each community containing a consortium of organisms that co-occurred with one another. Our studies identified 63 human gut microbes associated with cholesterol-reducing activities. Given the importance of gut bacteria in reducing and eliminating cholesterol from the GI tract, these results support the recent finding that gut microbiome may play an important role in host lipid metabolism.	[Antharam, Vijay C.; Li, Eric C.; Kozlov, Andrew N.; Mesbah, Zhubene; Wang, Gary P.] Univ Florida, Dept Med, Div Infect Dis & Global Med, Gainesville, FL USA; [McEwen, Daniel C.] Minnesota State Univ Moorhead, Dept Biosci, Moorhead, MN USA; [Garrett, Timothy J.] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Dossey, Aaron T.] All Things Bugs LLC, Athens, GA USA; [Wang, Gary P.] North Florida South Georgia Vet Hlth Syst, Med Serv, Gainesville, FL USA	State University System of Florida; University of Florida; Minnesota State Colleges & Universities; Minnesota State University Moorhead; State University System of Florida; University of Florida	Antharam, VC (corresponding author), Univ Florida, Dept Med, Div Infect Dis & Global Med, Gainesville, FL USA.	vantharam@methodist.edu	Garrett, Timothy/T-9833-2019	Garrett, Timothy/0000-0003-1623-009X; Dossey, Aaron T/0000-0002-6652-964X; Kozlov, Andrew/0000-0002-3181-6470	National Center for Advancing Translational Sciences of the National Institutes of Health under University of Florida Clinical and Translational Science Award [UL1RR029890, UL1 TR000064]; National Institutes of Health, National Institute of Allergy and Infectious Diseases [KO8 AI077713]; Merck Investigator-Initiated grant [IISP 38992]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064, UL1TR001427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI077713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097209] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences of the National Institutes of Health under University of Florida Clinical and Translational Science Award; National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Merck Investigator-Initiated grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research reported in this publication was supported in part by the National Center for Advancing Translational Sciences of the National Institutes of Health under University of Florida Clinical and Translational Science Award **UL1RR029890 and **UL1 TR000064**. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This work was also supported by National Institutes of Health, National Institute of Allergy and Infectious Diseases KO8 AI077713 awarded to GPW (http://www.niaid.nih.gov/Pages/default.aspx), and Merck Investigator-Initiated grant IISP 38992 awarded to GPW (http://engagezone.merck.com/clostridium.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthakrishnan AN, 2008, GUT, V57, P205, DOI 10.1136/gut.2007.128231; Antharam VC, 2013, J CLIN MICROBIOL, V51, P2884, DOI 10.1128/JCM.00845-13; Bakken JS, 2009, ANAEROBE, V15, P285, DOI 10.1016/j.anaerobe.2009.09.007; Bauer MP, 2009, CURR OPIN INFECT DIS, V22, P517, DOI 10.1097/QCO.0b013e32833229ce; Benno Peter, 2005, Microbial Ecology in Health and Disease, V17, P200, DOI 10.1080/08910600500519854; Borody TJ, 2000, AM J GASTROENTEROL, V95, P3028; BORRIELLO SP, 1986, J MED MICROBIOL, V21, P299, DOI 10.1099/00222615-21-4-299; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Campbell LA, 2004, NAT REV MICROBIOL, V2, P23, DOI 10.1038/nrmicro796; CHANG TW, 1980, J INFECT DIS, V142, P113, DOI 10.1093/infdis/142.1.113; Curry S, 2010, CLIN LAB MED, V30, P329, DOI 10.1016/j.cll.2010.04.001; Dam H, 1934, BIOCHEM J, V28, P820, DOI 10.1042/bj0280820; Dam H, 1934, BIOCHEM J, V28, P815, DOI 10.1042/bj0280815; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; EYSSEN H, 1974, AM J CLIN NUTR, V27, P1329, DOI 10.1093/ajcn/27.11.1329; EYSSEN HJ, 1973, EUR J BIOCHEM, V36, P411, DOI 10.1111/j.1432-1033.1973.tb02926.x; Faried A, 2007, CANCER SCI, V98, P1358, DOI 10.1111/j.1349-7006.2007.00563.x; Fu JY, 2015, CIRC RES, V117, P817, DOI 10.1161/CIRCRESAHA.115.306807; Gerard P, 2004, FEMS MICROBIOL ECOL, V47, P337, DOI 10.1016/S0168-6496(03)00285-X; Gerard P, 2007, APPL ENVIRON MICROB, V73, P5742, DOI 10.1128/AEM.02806-06; Giel JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008740; Giesemann T, 2006, J BIOL CHEM, V281, P10808, DOI 10.1074/jbc.M512720200; Gylling H, 1996, J HEPATOL, V24, P444, DOI 10.1016/S0168-8278(96)80165-6; Hahismoto S, 2008, GLYCOCONJUGATE J, V25, P531, DOI 10.1007/s10719-008-9108-x; Hayatsu M, 2008, SOIL SCI PLANT NUTR, V54, P33, DOI 10.1111/j.1747-0765.2007.00195.x; Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105; KELLY CP, 1994, NEW ENGL J MED, V330, P257, DOI 10.1056/NEJM199401273300406; Kerzmann A, 2006, ACS CHEM BIOL, V1, P141, DOI 10.1021/cb600133b; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Kumar M, 2012, EXP DIABETES RES, DOI 10.1155/2012/902917; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; LICHTENSTEIN AH, 1990, ANN MED, V22, P49, DOI 10.3109/07853899009147241; LIPKIN M, 1981, J CLIN INVEST, V67, P304, DOI 10.1172/JCI110027; Lye HS, 2010, J DAIRY SCI, V93, P1383, DOI 10.3168/jds.2009-2574; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; MIDTVEDT AC, 1993, J PEDIATR GASTR NUTR, V17, P161, DOI 10.1097/00005176-199308000-00006; MIDTVEDT AC, 1988, J PEDIATR GASTR NUTR, V7, P559, DOI 10.1097/00005176-198807000-00014; MIDTVEDT T, 1990, APMIS, V98, P839, DOI 10.1111/j.1699-0463.1990.tb05004.x; Motzkus-Feagans CA, 2012, GUT, V61, P1538, DOI 10.1136/gutjnl-2011-301378; Naggie S, 2011, AM J MED, V124, P276, DOI 10.1016/j.amjmed.2010.10.013; Navder K P, 1992, Indian J Med Sci, V46, P275; Pereira DIA, 2002, APPL ENVIRON MICROB, V68, P4689, DOI 10.1128/AEM.68.9.4689-4693.2002; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; SADZIKOWSKI MR, 1977, APPL ENVIRON MICROB, V34, P355, DOI 10.1128/AEM.34.4.355-362.1977; SALYERS AA, 1977, S AFR MED J, V51, P823; Schwan C, 2011, J BIOL CHEM, V286, P29356, DOI 10.1074/jbc.M111.261925; SEKIMOTO H, 1983, JPN J MED, V22, P14; Sorg JA, 2008, J BACTERIOL, V190, P2505, DOI 10.1128/JB.01765-07; Theriot CM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4114; Veiga P, 2005, FEMS MICROBIOL LETT, V242, P81, DOI 10.1016/j.femsle.2004.10.042; WAINFAN E, 1954, J BIOL CHEM, V207, P843; Weingarden A, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0070-0; Weingarden AR, 2014, AM J PHYSIOL-GASTR L, V306, pG310, DOI 10.1152/ajpgi.00282.2013; WILKINS TD, 1974, CANCER RES, V34, P2250; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319	56	67	70	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148824	10.1371/journal.pone.0148824	http://dx.doi.org/10.1371/journal.pone.0148824			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871580	Green Submitted, gold, Green Published			2022-12-27	WOS:000370054100061
J	Baur, B; Bozdag, S				Baur, Brittany; Bozdag, Serdar			A Feature Selection Algorithm to Compute Gene Centric Methylation from Probe Level Methylation Data	PLOS ONE			English	Article							DNA METHYLATION; EXPRESSION; EPIGENOMICS; TOOL	DNA methylation is an important epigenetic event that effects gene expression during development and various diseases such as cancer. Understanding the mechanism of action of DNA methylation is important for downstream analysis. In the Illumina Infinium HumanMethylation 450K array, there are tens of probes associated with each gene. Given methylation intensities of all these probes, it is necessary to compute which of these probes are most representative of the gene centric methylation level. In this study, we developed a feature selection algorithm based on sequential forward selection that utilized different classification methods to compute gene centric DNA methylation using probe level DNA methylation data. We compared our algorithm to other feature selection algorithms such as support vector machines with recursive feature elimination, genetic algorithms and ReliefF. We evaluated all methods based on the predictive power of selected probes on their mRNA expression levels and found that a K-Nearest Neighbors classification using the sequential forward selection algorithm performed better than other algorithms based on all metrics. We also observed that transcriptional activities of certain genes were more sensitive to DNA methylation changes than transcriptional activities of other genes. Our algorithm was able to predict the expression of those genes with high accuracy using only DNA methylation data. Our results also showed that those DNA methylation-sensitive genes were enriched in Gene Ontology terms related to the regulation of various biological processes.	[Baur, Brittany; Bozdag, Serdar] Marquette Univ, Dept Math Stat & Comp Sci, Milwaukee, WI 53233 USA	Marquette University	Bozdag, S (corresponding author), Marquette Univ, Dept Math Stat & Comp Sci, Milwaukee, WI 53233 USA.	Serdar.bozdag@marquette.edu			Marquette University	Marquette University	This work is supported by the startup funding to SB from Marquette University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MATLAB STAT TOOLB RE; Baur B, 2015, J COMPUT BIOL, V22, P289, DOI 10.1089/cmb.2014.0296; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; de la Rica L, 2013, J AUTOIMMUN, V41, P6, DOI 10.1016/j.jaut.2012.12.005; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Farre P, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0011-y; Friedman J. H., 1977, ACM Transactions on Mathematical Software, V3, P209, DOI 10.1145/355744.355745; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; John GH, 1995, P 11 C UNC ART INT S; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Li HL, 2014, ONCOTARGET, V5, P587, DOI 10.18632/oncotarget.1782; Li J, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S5-S10; Maeda O, 2014, ONCOL REP, V31, P1883, DOI 10.3892/or.2014.3014; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Oluleye B., 2014, INT J ELECT COMMUN C, V5, P899; Quinlan JR, 1999, INT J HUM-COMPUT ST, V51, P497, DOI 10.1006/ijhc.1987.0321; Rhee JK, 2013, NUCLEIC ACIDS RES, V41, P8464, DOI 10.1093/nar/gkt643; Schuebel KE, 2007, PLOS GENET, V3, P1709, DOI 10.1371/journal.pgen.0030157; Selamat SA, 2012, GENOME RES, V22, P1197, DOI 10.1101/gr.132662.111; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112; Weisenberger DJ, ILLUMINA EPIGENETIC; Yan K, 2015, SENSOR ACTUAT B-CHEM, V212, P353, DOI 10.1016/j.snb.2015.02.025	29	16	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148977	10.1371/journal.pone.0148977	http://dx.doi.org/10.1371/journal.pone.0148977			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872146	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100083
J	Bruinsma, SM; van der Heide, A; van der Lee, ML; Vergouwe, Y; Rietjens, JAC				Bruinsma, S. M.; van der Heide, A.; van der Lee, M. L.; Vergouwe, Y.; Rietjens, J. A. C.			No Negative Impact of Palliative Sedation on Relatives' Experience of the Dying Phase and Their Wellbeing after the Patient's Death: An Observational Study	PLOS ONE			English	Article							CONTINUOUS DEEP SEDATION; OF-LIFE CARE; RANDOMIZED CONTROLLED-TRIAL; FAMILY-MEMBERS; BEREAVED RELATIVES; CANCER-PATIENTS; EUROPEAN COUNTRIES; MEDICAL-CARE; UNTIL DEATH; EUTHANASIA	Background Palliative sedation is the widely-used intervention of administering sedating agents to induce a state of unconsciousness to take away a dying patient's perception of otherwise irrelievable symptoms. However, it remains questionable whether this ethically complex intervention is beneficial for patients and whether the associated lack of communication in the last phase of life has a negative impact on relatives' wellbeing. Methods An observational questionnaire study was conducted among relatives of a consecutive sample of patients who died a non-sudden death in the Erasmus MC Cancer Institute or in the hospice 'Laurens Cadenza' (both in Rotterdam) between 2010 and 2013. Results Relatives filled in questionnaires regarding 151 patients who had been sedated and 90 patients who had not been sedated. The median time since all patients had passed away was 21 (IQR 14-32) months. No significant differences were found in relatives 'assessments of the quality of end-of-life care, patients 'quality of life in the last week before death and their quality of dying, between patients who did and did not receive sedation, or in relatives' satisfaction with their own life, their general health and their mental wellbeing after the patient's death. Conclusions The use of sedation in these patients appears to have no negative effect on bereaved relatives' evaluation of the patient's dying phase, or on their own wellbeing after the patient's death.	[Bruinsma, S. M.; van der Heide, A.; Vergouwe, Y.; Rietjens, J. A. C.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [van der Lee, M. L.] Helen Dowling Inst, Bilthoven, Netherlands	Erasmus University Rotterdam; Erasmus MC	Bruinsma, SM (corresponding author), Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.	s.m.bruinsma@erasmusmc.nl		van der Lee, Marije/0000-0002-1316-7008	Economic and Social Research Council (UK); Research Foundation Flanders (BE); Flemish Cancer Association (BE); Research Council of Ghent University (BE); Netherlands Organisation for Scientific Research (NL); Netherlands Organisation for Health Research and Development (NL) [11510006]; Innovational Research Incentives Scheme Veni of the Netherlands Organisation for Scientific Research (NWO); UNESCO; L'Oreal	Economic and Social Research Council (UK)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Research Foundation Flanders (BE)(FWO); Flemish Cancer Association (BE); Research Council of Ghent University (BE); Netherlands Organisation for Scientific Research (NL)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Health Research and Development (NL)(Netherlands Organization for Health Research and Development); Innovational Research Incentives Scheme Veni of the Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); UNESCO; L'Oreal(L'Oreal Group)	The research on which this paper is based is linked to a larger project, the 'UNBIASED' study (UK - Netherlands - Belgium InternAtional SEDation study) is a collaboration between research teams in the UK, Belgium and the Netherlands with funding from the Economic and Social Research Council (UK), the Research Foundation Flanders (BE), the Flemish Cancer Association (BE), the Research Council of Ghent University (BE), the Netherlands Organisation for Scientific Research (NL) and the Netherlands Organisation for Health Research and Development (NL) (grant number: 11510006). Dr. Rietjens was supported by the Innovational Research Incentives Scheme Veni of the Netherlands Organisation for Scientific Research (NWO) and the 'For Women in Science' fellowship of UNESCO and L'Oreal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the senior clinical staff members of the participating settings for recruitment of the bereaved participants, as well as the bereaved persons who participated in this study. Dr Rietjens was supported by the Innovational Research Incentives Scheme Veni of the Netherlands Organisation for Scientific Research (NWO) and the 'For Women in Science' fellowship of UNESCO and L'Oreal.	Addington-Hall J, 1998, J EPIDEMIOL COMMUN H, V52, P802, DOI 10.1136/jech.52.12.802; Addington-Hall JM, 2009, PALLIATIVE MED, V23, P190, DOI 10.1177/0269216309102525; Aktas A, 2015, SUPPORT CARE CANCER, V23, P2189, DOI 10.1007/s00520-015-2732-7; Andershed B, 1999, NURS SCI QUART, V12, P45, DOI 10.1177/08943189922106404; Andershed B, 2006, J CLIN NURS, V15, P1158, DOI 10.1111/j.1365-2702.2006.01473.x; Anquinet L, 2012, J PAIN SYMPTOM MANAG, V44, P33, DOI 10.1016/j.jpainsymman.2011.07.007; AstedtKurki P, 1997, J ADV NURS, V25, P908, DOI 10.1046/j.1365-2648.1997.1997025908.x; Billings JA, 1996, J PALLIAT CARE, V12, P21, DOI 10.1177/082585979601200404; Bilsen J, 2007, SOC SCI MED, V65, P803, DOI 10.1016/j.socscimed.2007.04.016; Bruera E, 1991, J Palliat Care, V7, P6; Bruinsma SM, 2014, SUPPORT CARE CANCER, V22, P3243, DOI 10.1007/s00520-014-2344-7; Bruinsma S, 2013, J PALLIAT MED, V16, P349, DOI 10.1089/jpm.2012.0410; Bruinsma SM, 2012, J PAIN SYMPTOM MANAG, V44, P431, DOI 10.1016/j.jpainsymman.2011.09.006; Cantril H., 1965, PATTERN HUMAN CONCER; Carpenter J S, 1996, J Nurs Meas, V4, P171; Chambaere K, 2010, ARCH INTERN MED, V170, P490, DOI 10.1001/archinternmed.2009.542; Cherny NI, 2009, PALLIATIVE MED, V23, P581, DOI 10.1177/0269216309107024; Claessen S, 2009, WEG NAAR EEN CQ INDE; Curtis JR, 2002, J PAIN SYMPTOM MANAG, V24, P17, DOI 10.1016/S0885-3924(02)00419-0; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Gallagher R, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-25; GREER DS, 1986, J CHRON DIS, V39, P9, DOI 10.1016/0021-9681(86)90103-7; Hudson P, 2014, BMJ SUPPORT PALLIAT, V4, P231, DOI 10.1136/bmjspcare-2013-000500; KANE RL, 1984, LANCET, V1, P890; Lautrette A, 2007, NEW ENGL J MED, V356, P469, DOI 10.1056/NEJMoa063446; Mercadante S, 2009, J PAIN SYMPTOM MANAG, V37, P771, DOI 10.1016/j.jpainsymman.2008.04.020; Miccinesi G, 2006, J PAIN SYMPTOM MANAG, V31, P122, DOI 10.1016/j.jpainsymman.2005.07.004; Morita T, 2004, J PAIN SYMPTOM MANAG, V28, P557, DOI 10.1016/j.jpainsymman.2004.03.004; Morita T, 2004, SUPPORT CARE CANCER, V12, P885, DOI 10.1007/s00520-004-0678-2; Onwuteaka-Philipsen BD, 2012, LANCET, V380, P908, DOI 10.1016/S0140-6736(12)61034-4; Pierson CM, 2002, AIDS CARE, V14, P587, DOI 10.1080/0954012021000005416; Rietjens J, 2008, BRIT MED J, V336, P810, DOI 10.1136/bmj.39504.531505.25; Rietjens JAC, 2006, PALLIATIVE MED, V20, P685, DOI 10.1177/0269216306070241; Royal Dutch Medical Association (KNMG), 2009, GUID PALL SED; Seale C, 2009, PALLIATIVE MED, V23, P198, DOI 10.1177/0269216308102042; Seale C RK, 2014, HEALTH IN PRESS; Seale C, 2010, J PAIN SYMPTOM MANAG, V39, P44, DOI 10.1016/j.jpainsymman.2009.06.007; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; Steinhauser KE, 2014, PALLIAT SUPPORT CARE, V8, P1, DOI DOI 10.1097/SPC.0000000000000035; STROEBE MS, 1989, OMEGA-J DEATH DYING, V20, P1, DOI 10.2190/C3JE-C9L1-5R91-DWDU; Swarte NB, 2003, BMJ-BRIT MED J, V327, P189, DOI 10.1136/bmj.327.7408.189; Teno JM, 2001, J PAIN SYMPTOM MANAG, V22, P738, DOI 10.1016/S0885-3924(01)00335-9; van Delden JJM, 2011, KNOWLEDGE OPINIONS G; van Dooren S, 2009, J PAIN SYMPTOM MANAG, V38, P452, DOI 10.1016/j.jpainsymman.2008.11.011; Veerbeek L, 2008, AM J HOSP PALLIAT ME, V25, P207, DOI 10.1177/1049909108315515; Ware J., 1993, SF 36 HLTH SURVEY MA; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wilson KG, 2004, CAN J PSYCHIAT, V49, P350, DOI 10.1177/070674370404900603; World Health Organization, 2008, DEF PALL CAR; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665	50	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149250	10.1371/journal.pone.0149250	http://dx.doi.org/10.1371/journal.pone.0149250			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6SI	26871717	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100134
J	Cleeve, A; Byamugisha, J; Gemzell-Danielsson, K; Tumwesigye, NM; Atuhairwe, S; Faxelid, E; Klingberg-Allvin, M				Cleeve, Amanda; Byamugisha, Josaphat; Gemzell-Danielsson, Kristina; Tumwesigye, Nazarius Mbona; Atuhairwe, Susan; Faxelid, Elisabeth; Klingberg-Allvin, Marie			Women's Acceptability of Misoprostol Treatment for Incomplete Abortion by Midwives and Physicians - Secondary Outcome Analysis from a Randomized Controlled Equivalence Trial at District Level in Uganda	PLOS ONE			English	Article							MANUAL VACUUM ASPIRATION; POSTABORTION CARE; SUBLINGUAL MISOPROSTOL; HEALTH-CARE	Objective This study aimed to assess women's acceptability of diagnosis and treatment of incomplete abortion with misoprostol by midwives, compared with physicians. Methods This was an analysis of secondary outcomes from a multi-centre randomized controlled equivalence trial at district level in Uganda. Women with first trimester incomplete abortion were randomly allocated to clinical assessment and treatment with misoprostol by a physician or a midwife. The randomisation (1:1) was done in blocks of 12 and stratified for health care facility. Acceptability was measured in expectations and satisfaction at a follow up visit 14-28 days following treatment. Analysis of women's overall acceptability was done using a generalized linear mixed-effects model with an equivalence range of -4% to 4%. The study was not masked. The trial is registered at ClinicalTrials. org, NCT 01844024. Results From April 2013 to June 2014, 1108 women were assessed for eligibility of which 1010 were randomized (506 to midwife and 504 to physician). 953 women were successfully followed up and included in the acceptability analysis. 95% (904) of the participants found the treatment satisfactory and overall acceptability was found to be equivalent between the two study groups. Treatment failure, not feeling calm and safe following treatment, experiencing severe abdominal pain or heavy bleeding following treatment, were significantly associated with non-satisfaction. No serious adverse events were recorded. Conclusions Treatment of incomplete abortion with misoprostol by midwives and physician was highly, and equally, acceptable to women.	[Cleeve, Amanda; Gemzell-Danielsson, Kristina; Klingberg-Allvin, Marie] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Cleeve, Amanda; Gemzell-Danielsson, Kristina] Karolinska Univ Hosp, WHO Ctr Human Reprod, Stockholm, Sweden; [Byamugisha, Josaphat; Atuhairwe, Susan] Mulago Hosp, Dept Obstet & Gynaecol, Kampala, Uganda; [Byamugisha, Josaphat; Atuhairwe, Susan] Makerere Univ, Coll Hlth Sci, Dept Obstet & Gynaecol, Kampala, Uganda; [Tumwesigye, Nazarius Mbona] Makerere Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda; [Faxelid, Elisabeth] Karolinska Inst, Dept Publ Hlth Sci, Global Hlth IHCAR, Stockholm, Sweden; [Klingberg-Allvin, Marie] Dalarna Univ, Sch Educ Hlth & Social Studies, Falun, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Mulago National Referral Hospital; Makerere University; Makerere University; Karolinska Institutet; Dalarna University	Cleeve, A (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden.; Cleeve, A (corresponding author), Karolinska Univ Hosp, WHO Ctr Human Reprod, Stockholm, Sweden.	amanda.cleeve@ki.se	Byamugisha, Josaphat/AAL-5776-2020	Byamugisha, Josaphat/0000-0002-3438-9662; Cleeve, Amanda/0000-0001-8115-5503; Klingberg-Allvin, Marie/0000-0002-8947-2949; Tumwesigye, Nazarius Mbona/0000-0001-7085-8780	Swedish Research Council [521-20092605]; Karolinska Institutet; Dalarna University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); Dalarna University	The Swedish Research Council (521-20092605), Karolinska Institutet, and Dalarna University, funded this randomized controlled trial. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blandine T, 2012, INT J GYNECOL OBSTET, V119, P166, DOI 10.1016/j.ijgo.2012.05.036; Blum J, 2007, INT J GYNECOL OBSTET, V99, pS186, DOI 10.1016/j.ijgo.2007.09.009; Dabash R, 2010, INT J GYNECOL OBSTET, V111, P131, DOI 10.1016/j.ijgo.2010.06.021; Dah Talemoh, 2011, Afr J Reprod Health, V15, P42; Dao B, 2007, BJOG-INT J OBSTET GY, V114, P1368, DOI 10.1111/j.1471-0528.2007.01468.x; East Central and Southern African Health Community (ECSA-HC), 2010, TASK SHIFT UG CAS ST; Faundes A, 2010, BEST PRACT RES CL OB, V24, P467, DOI 10.1016/j.bpobgyn.2010.02.003; Fawole AO, 2012, INT J GYNECOL OBSTET, V119, P170, DOI 10.1016/j.ijgo.2012.06.012; Gaye A, 2014, INT J GYNECOL OBSTET, V126, P223, DOI 10.1016/j.ijgo.2014.03.028; Hussain R, 2013, UNINTENDED PREGNANCY; Kallner HK, 2012, CONTRACEPTION, V85, P394, DOI 10.1016/j.contraception.2011.08.009; Karki C, 2009, INT J GYNECOL OBSTET, V106, P39, DOI 10.1016/j.ijgo.2009.02.007; Klingberg-Allvin M, 2015, LANCET, V385, P2392, DOI 10.1016/S0140-6736(14)61935-8; Lehmann U, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-49; Levesque JF, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-18; Mbonye AK, 2007, INT J GYNECOL OBSTET, V96, P220, DOI 10.1016/j.ijgo.2006.12.017; Nabudere H, 2011, INT J TECHNOL ASSESS, V27, P173, DOI 10.1017/S0266462311000055; Paul M, 2015, PLOS ONE IN PRESS; Paul M, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-28; Piaggio G, 2012, JAMA-J AM MED ASSOC, V308, P2594, DOI 10.1001/jama.2012.87802; Rasch V, 2011, ACTA OBSTET GYN SCAN, V90, P692, DOI 10.1111/j.1600-0412.2011.01165.x; Shah IH, 2014, CONTRACEPTION, V90, pS39, DOI 10.1016/j.contraception.2014.04.004; Shochet T, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-127; Shwekerel B, 2007, BJOG-INT J OBSTET GY, V114, P1363, DOI 10.1111/j.1471-0528.2007.01469.x; Tang OS, 2007, INT J GYNECOL OBSTET, V99, pS160, DOI 10.1016/j.ijgo.2007.09.004; Turner KL, 2004, WOMAN CTR COMPREHENS; Turner KL, 2010, MED ABORTION TRAININ; Uganda Ministry of Health, 2015, RED MAT MORT UNS AB; Weeks A, 2001, Afr Health Sci, V1, P52; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; World Health Organization, 2012, SAF AB TECHN POL GUI, V2nd ed.; World Health Organization, 2015, HLTH WORK ROL PROV S	32	17	17	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149172	10.1371/journal.pone.0149172	http://dx.doi.org/10.1371/journal.pone.0149172			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872219	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100119
J	Kuljis, DA; Gad, L; Loh, DH; Kaswan, ZM; Hitchcock, ON; Ghiani, CA; Colwell, CS				Kuljis, Dika A.; Gad, Laura; Loh, Dawn H.; Kaswan, Zoe MacDowell; Hitchcock, Olivia N.; Ghiani, Cristina A.; Colwell, Christopher S.			Sex Differences in Circadian Dysfunction in the BACHD Mouse Model of Huntington's Disease	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; WHEEL-RUNNING ACTIVITY; SLEEP-WAKE CYCLE; SUPRACHIASMATIC NUCLEUS; FUNCTIONAL DECLINE; GENDER-DIFFERENCES; HUMAN-BRAIN; AGE; RHYTHMS; DEPRESSION	Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder that affects men and women in equal numbers, but some epidemiological studies indicate there may be sex differences in disease progression. One of the early symptoms of HD is disruptions in the circadian timing system, but it is currently unknown whether sex is a factor in these alterations. Since sex differences in HD could provide important insights to understand cellular and molecular mechanism(s) and designing early intervention strategies, we used the bacterial artificial chromosome transgenic mouse model of HD (BACHD) to examine whether sex differences in circadian behavioral rhythms are detectable in an animal model of the disease. Similar to BACHD males, BACHD females display circadian disruptions at both 3 and 6 months of age; however, deficits to BACHD female mouse activity levels, rhythm precision, and behavioral fragmentation are either delayed or less severe relative to males. These sex differences are associated with a smaller suprachiasmatic nucleus (SCN) in BACHD male mice at age of symptom onset (3 months), but are not associated with sex-specific differences in SCN daytime electrical activity deficits, or peptide expression (arginine vasopressin, vasoactive intestinal peptide) within the SCN. Notably, BACHD females exhibited delayed motor coordination deficits, as measured using rotarod and challenge beam. These findings suggest a sex specific factor plays a role both in non-motor and motor symptom progression for the BACHD mouse.	[Kuljis, Dika A.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA USA; [Gad, Laura; Loh, Dawn H.; Kaswan, Zoe MacDowell; Hitchcock, Olivia N.; Ghiani, Cristina A.; Colwell, Christopher S.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Ghiani, Cristina A.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Colwell, CS (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA.	CColwell@mednet.ucla.edu	Ghiani, Cristina/Q-9385-2019; Colwell, Chris/AAM-6111-2020	Ghiani, Cristina/0000-0002-9867-6185; Colwell, Christopher/0000-0002-1059-184X	CHDI Foundation "Circadian Disruption in Mouse Models of Huntington's Disease" [A-7293]; NIH [T32 HD 07228-26]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007228] Funding Source: NIH RePORTER	CHDI Foundation "Circadian Disruption in Mouse Models of Huntington's Disease"; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by CHDI Foundation "Circadian Disruption in Mouse Models of Huntington's Disease" A-7293 http://chdifoundation. org/CC; NIH Training Grant T32 HD 07228-26 DK. The funders had no roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abada YSK, 2013, BEHAV BRAIN RES, V238, P243, DOI 10.1016/j.bbr.2012.10.039; Abizaid A, 2004, EUR J NEUROSCI, V20, P2767, DOI 10.1111/j.1460-9568.2004.03737.x; Adan A, 2002, CHRONOBIOL INT, V19, P709, DOI 10.1081/CBI-120005390; Aziz NA, 2010, PARKINSONISM RELAT D, V16, P345, DOI 10.1016/j.parkreldis.2010.02.009; Aziz NA, 2009, J NEUROL, V256, P1961, DOI 10.1007/s00415-009-5196-1; Aziz NA, 2009, J CLIN ENDOCR METAB, V94, P1223, DOI 10.1210/jc.2008-2543; Bailey M, 2014, FRONT NEUROENDOCRIN, V35, P111, DOI 10.1016/j.yfrne.2013.11.003; Besedovsky L, 2012, PFLUG ARCH EUR J PHY, V463, P121, DOI 10.1007/s00424-011-1044-0; Blattner MS, 2013, J BIOL RHYTHM, V28, P291, DOI 10.1177/0748730413497190; Butler MP, 2012, ENDOCRINOLOGY, V153, P2344, DOI 10.1210/en.2011-1842; Cain SW, 2010, J BIOL RHYTHM, V25, P288, DOI 10.1177/0748730410374943; Cohen S, 2009, ARCH INTERN MED, V169, P62, DOI 10.1001/archinternmed.2008.505; DAVIS FC, 1983, AM J PHYSIOL, V244, pR93, DOI 10.1152/ajpregu.1983.244.1.R93; Duff K, 2007, BIOL PSYCHIAT, V62, P1341, DOI 10.1016/j.biopsych.2006.11.034; Duffy JF, 2011, P NATL ACAD SCI USA, V108, P15602, DOI 10.1073/pnas.1010666108; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Ehlen JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062205; Epping EA, 2013, J PSYCHIATR RES, V47, P1423, DOI 10.1016/j.jpsychires.2013.05.026; Fahrenkrug J, 2007, J MOL NEUROSCI, V31, P139, DOI 10.1385/JMN/31:02:139; Farajnia S, 2012, J NEUROSCI, V32, P5891, DOI 10.1523/JNEUROSCI.0469-12.2012; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Foroud T, 1999, J NEUROL NEUROSUR PS, V66, P52, DOI 10.1136/jnnp.66.1.52; Goodman Anna O G, 2010, PLoS Curr, V2, pRRN1189, DOI 10.1371/currents.RRN1189; Goodman AOG, 2011, CURR NEUROL NEUROSCI, V11, P211, DOI 10.1007/s11910-010-0163-x; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Hatori M, 2014, ELIFE, V3, DOI 10.7554/eLife.03357; Helfrich-Forster C, 2000, J BIOL RHYTHM, V15, P135, DOI 10.1177/074873040001500208; HEUSER IJE, 1991, BIOL PSYCHIAT, V30, P943, DOI 10.1016/0006-3223(91)90007-9; HOFMAN MA, 1988, J ANAT, V160, P127; Iwahana E, 2008, HORM BEHAV, V53, P422, DOI 10.1016/j.yhbeh.2007.11.014; Kalliolia E, 2014, MOVEMENT DISORD, V29, P1511, DOI 10.1002/mds.26003; Karatsoreos IN, 2007, ENDOCRINOLOGY, V148, P5487, DOI 10.1210/en.2007-0775; Konturek PC, 2011, J PHYSIOL PHARMACOL, V62, P139; Kopp C, 2006, BEHAV BRAIN RES, V167, P165, DOI 10.1016/j.bbr.2005.09.001; Krishnan V, 2006, CURR OPIN PULM MED, V12, P383, DOI 10.1097/01.mcp.0000245705.69440.6a; Kudo T, 2011, EXP NEUROL, V228, P80, DOI 10.1016/j.expneurol.2010.12.011; Kuljis DA, 2013, ENDOCRINOLOGY, V154, P1501, DOI 10.1210/en.2012-1921; Laermans J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110176; Lee TM, 2004, ANN NY ACAD SCI, P262; Leproult R, 2014, DIABETES, V63, P1860, DOI 10.2337/db13-1546; Li Q, 2015, NEUROBIOL DIS, V77, P155, DOI 10.1016/j.nbd.2015.03.009; Loh DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069993; Marder K, 2000, NEUROLOGY, V54, P452, DOI 10.1212/WNL.54.2.452; Markianos M, 2005, ANN NEUROL, V57, P520, DOI 10.1002/ana.20428; MATTSSON B, 1974, ACTA PSYCHIAT SCAND, P221; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; MOE KE, 1991, J AM GERIATR SOC, V39, P383, DOI 10.1111/j.1532-5415.1991.tb02904.x; Moldofsky H, 2001, SLEEP MED REV, V5, P387, DOI 10.1053/smrv.2001.0179; Morton AJ, 2013, EXP NEUROL, V243, P34, DOI 10.1016/j.expneurol.2012.10.014; Morton AJ, 2005, J NEUROSCI, V25, P157, DOI 10.1523/JNEUROSCI.3842-04.2005; Mullington JM, 2009, PROG CARDIOVASC DIS, V51, P294, DOI 10.1016/j.pcad.2008.10.003; Nakamura TJ, 2011, J NEUROSCI, V31, P10201, DOI 10.1523/JNEUROSCI.0451-11.2011; Papalexi E, 2005, EUR J NEUROSCI, V22, P1541, DOI 10.1111/j.1460-9568.2005.04324.x; Paul KN, 2008, J WOMENS HEALTH, V17, P1201, DOI 10.1089/jwh.2008.0841; Paul KN, 2006, SLEEP, V29, P1211, DOI 10.1093/sleep/29.9.1211; Paulsen Jane S, 2005, Adv Neurol, V96, P209; Paulsen JS, 2013, J NEUROL NEUROSUR PS, V84, P1233, DOI 10.1136/jnnp-2013-305114; Paulsen JS, 2006, BIOL PSYCHIAT, V59, P57, DOI 10.1016/j.biopsych.2005.06.003; Paulsen JS, 2005, J NEUROPSYCH CLIN N, V17, P496, DOI 10.1176/appi.neuropsych.17.4.496; Paulsen JS, 2011, HUNTINGTON DIS, V82, P201; Peavy GM, 2010, MOVEMENT DISORD, V25, P1163, DOI 10.1002/mds.22953; Pekmezovic T, 2007, EUR J EPIDEMIOL, V22, P523, DOI 10.1007/s10654-007-9157-7; Petit D, 2004, J PSYCHOSOM RES, V56, P487, DOI 10.1016/j.jpsychores.2004.02.001; Roenneberg T, 2003, J BIOL RHYTHM, V18, P80, DOI 10.1177/0748730402239679; Roenneberg T, 2007, SLEEP MED REV, V11, P429, DOI 10.1016/j.smrv.2007.07.005; ROOS RAC, 1991, J MED GENET, V28, P515, DOI 10.1136/jmg.28.8.515; ROPER TJ, 1976, PHYSIOL BEHAV, V17, P549, DOI 10.1016/0031-9384(76)90121-9; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; SHERMAN BM, 1976, J CLIN ENDOCR METAB, V42, P629, DOI 10.1210/jcem-42-4-629; Shirbin CA, 2013, PSYCHONEUROENDOCRINO, V38, P2439, DOI 10.1016/j.psyneuen.2012.10.020; SORENSEN SA, 1992, J MED GENET, V29, P911, DOI 10.1136/jmg.29.12.911; SWAAB DF, 1985, BRAIN RES, V342, P37, DOI 10.1016/0006-8993(85)91350-2; TAKAHASHI JS, 1980, AM J PHYSIOL, V239, pR497, DOI 10.1152/ajpregu.1980.239.5.R497; Valentinuzzi VS, 1997, AM J PHYSIOL-REG I, V273, pR1957, DOI 10.1152/ajpregu.1997.273.6.R1957; van der Vinne V, 2015, J BIOL RHYTHM, V30, P53, DOI 10.1177/0748730414564786; van Duijn E, 2010, BRAIN RES BULL, V83, P232, DOI 10.1016/j.brainresbull.2010.08.006; Van Raamsdonk JM, 2007, NEUROBIOL DIS, V26, P512, DOI 10.1016/j.nbd.2007.01.006; Van Raamsdonk JM, 2005, HUM MOL GENET, V14, P1379, DOI 10.1093/hmg/ddi147; van Wamelen DJ, 2013, SLEEP, V36, P117, DOI 10.5665/sleep.2314; Vonsattel J, 1985, J NEUROPATHOL EXP NE, P559; WEVER RA, 1984, EXPERIENTIA, V40, P1226, DOI 10.1007/BF01946652; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; Wirz-Justice A, 2006, INT CLIN PSYCHOPHARM, V21, pS11, DOI 10.1097/01.yic.0000195660.37267.cf; WOLLNIK F, 1988, PHYSIOL BEHAV, V43, P389, DOI 10.1016/0031-9384(88)90204-1; Yan L, 2007, COLD SH Q B, V72, P527, DOI 10.1101/sqb.2007.72.037; ZHOU JN, 1995, NEUROBIOL AGING, V16, P571, DOI 10.1016/0197-4580(95)00043-E; Zielonka D, 2013, PARKINSONISM RELAT D, V19, P192, DOI 10.1016/j.parkreldis.2012.09.012; ZUCKER I, 1973, PHYSIOL BEHAV, V11, P239, DOI 10.1016/0031-9384(73)90356-9	88	21	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0147583	10.1371/journal.pone.0147583	http://dx.doi.org/10.1371/journal.pone.0147583			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871695	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100008
J	Qin, YS; Liu, L; He, YN; Wang, C; Liang, MY; Chen, XL; Hao, HS; Qin, T; Zhao, XM; Wang, D				Qin, YuSheng; Liu, Ling; He, YaNan; Wang, Chen; Liang, MingYuan; Chen, XiaoLi; Hao, HaiSheng; Qin, Tong; Zhao, XueMing; Wang, Dong			Testicular Busulfan Injection in Mice to Prepare Recipients for Spermatogonial Stem Cell Transplantation Is Safe and Non-Toxic	PLOS ONE			English	Article							MOUSE TESTES; GERM-CELLS; MALE-INFERTILITY; SPERMATOGENESIS; RECOVERY; SPERM; RESTORATION	Current methods of administering busulfan to remove the endogenous germ cells cause hematopoietic toxicity, require special instruments and a narrow transplantation time. We use a direct testicular injection of busulfan method for preparing recipients for SSC transplantation. Male ICR mice (recipients) were divided into four groups, and two experimental groups were treated with a bilateral testicular injection of 4 or 6 mg/kg/side busulfan (n = 60 per concentration group). Mice received an intraperitoneal injection (i.p.) of 40 mg/kg busulfan (n = 60, positive control) and bilateral testicular injections of 50% DMSO (n = 60, negative control). Donor SSCs from RFP-transgenic C57BL/6J mice were introduced into the seminiferous tubules of each recipient testis via efferent duct injection on day 16-17 after busulfan treatment. Recipient mice mated with mature female ICR mice and the number of progeny was recorded. The index detected at day 14, 21, 28, 35 and 70 after busulfan treatment. Blood analysis shows that the toxicity of busulfan treated groups was much lower than i.p. injection groups. Fertility was restored in mice treated with busulfan and donor-derived offspring were obtained after SSC transplantation. Our study indicated that intratesticular injection busulfan for the preparation of recipients in mice is safe and feasible.	[Qin, YuSheng; Liu, Ling; He, YaNan; Chen, XiaoLi; Hao, HaiSheng; Qin, Tong; Zhao, XueMing; Wang, Dong] Chinese Acad Agr Sci, Inst Anim Sci, Minist Agr China, Key Lab Farm Anim Genet Resources & Utilizat, Beijing 100193, Peoples R China; [Liang, MingYuan] Jilin Agr Univ, Coll Anim Sci & Technol, Changchun 130118, Peoples R China; [Wang, Chen] Guangxi Univ, Nanning 530004, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Ministry of Agriculture & Rural Affairs; Jilin Agricultural University; Guangxi University	Wang, D (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Minist Agr China, Key Lab Farm Anim Genet Resources & Utilizat, Beijing 100193, Peoples R China.	dwangcn2002@vip.sina.com			National Science and Technology Support Program of China [2011BAD19B02]; Agricultural Science and Technology Innovation Program (ASTIP) [cxgc-ias-06]; Beijing Innovation Team of Technology System in Dairy Industry	National Science and Technology Support Program of China; Agricultural Science and Technology Innovation Program (ASTIP); Beijing Innovation Team of Technology System in Dairy Industry	This work was supported by grants from the National Science and Technology Support Program of China (No. 2011BAD19B02), the Agricultural Science and Technology Innovation Program (ASTIP) (cxgc-ias-06) and the Beijing Innovation Team of Technology System in Dairy Industry.	Abuelhija M, 2012, TOXICOL SCI, V126, P545, DOI 10.1093/toxsci/kfs021; Adly MA, 2010, PATHOL ONCOL RES, V16, P427, DOI 10.1007/s12253-009-9232-3; Benoff S, 2000, HUM REPROD UPDATE, V6, P107, DOI 10.1093/humupd/6.2.107; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; BUCCI LR, 1987, MUTAT RES, V176, P259, DOI 10.1016/0027-5107(87)90057-1; Clouthier DE, 1996, NATURE, V381, P418, DOI 10.1038/381418a0; Dobrinski I, 1999, BIOL REPROD, V61, P1331, DOI 10.1095/biolreprod61.5.1331; Hermann BP, 2012, CELL STEM CELL, V11, P715, DOI 10.1016/j.stem.2012.07.017; Herrid M, 2013, ANIM BIOTECHNOL, V24, P293, DOI 10.1080/10495398.2013.785431; Hill JR, 2006, REPROD FERT DEVELOP, V18, P13, DOI 10.1071/RD05123; Hoff J, 2000, LAB ANIMAL, V29, P47; Honaramooz A, 2005, J ANDROL, V26, P698, DOI 10.2164/jandrol.05032; Jahnukainen K, 2011, HUM REPROD, V26, P1945, DOI 10.1093/humrep/der160; Johnson GD, 2011, REPRODUCTION, V141, P21, DOI 10.1530/REP-10-0322; Kanatsu-Shinohara M, 2008, BIOL REPROD, V78, P611, DOI 10.1095/biolreprod.107.065615; Knoch J, 2012, EUR J DERMATOL, V22, P443, DOI 10.1684/ejd.2012.1654; Krausz C, 2011, BEST PRACT RES CL EN, V25, P271, DOI 10.1016/j.beem.2010.08.006; Ma WZ, 2011, BIOL REPROD, V85, P670, DOI 10.1095/biolreprod.110.089623; Matzuk MM, 2012, CELL, V150, P673, DOI 10.1016/j.cell.2012.06.045; Moisan AE, 2003, REPRODUCTION, V126, P205, DOI 10.1530/rep.0.1260205; Molyneux G, 2008, INT J EXP PATHOL, V89, P159, DOI 10.1111/j.1365-2613.2008.00580.x; Nagano M, 2001, P NATL ACAD SCI USA, V98, P13090, DOI 10.1073/pnas.231473498; Nagano M, 2002, FERTIL STERIL, V78, P1225, DOI 10.1016/S0015-0282(02)04345-5; Nozawa M, 2014, MOL BIOL EVOL, V31, P614, DOI 10.1093/molbev/mst239; Oatley JM, 2002, J ANIM SCI, V80, P1925; Ogawa T, 1999, BIOL REPROD, V60, P515, DOI 10.1095/biolreprod60.2.515; Omran HM, 2013, MOL MED REP, V7, P1631, DOI 10.3892/mmr.2013.1390; Qin YS, 2016, REPROD FERT DEVELOP, V28, P1916, DOI 10.1071/RD14290; Rajender S, 2011, MUTAT RES-REV MUTAT, V727, P62, DOI 10.1016/j.mrrev.2011.04.002; Trefil P, 2010, THERIOGENOLOGY, V74, P1670, DOI 10.1016/j.theriogenology.2010.07.002; Wakeley KE, 2000, CURR OPIN OBSTET GYN, V12, P43, DOI 10.1097/00001703-200002000-00008; Wang DZ, 2010, ASIAN J ANDROL, V12, P263, DOI 10.1038/aja.2009.67; Yamashita KM, 2011, J THROMB HAEMOST, V9, P2057, DOI 10.1111/j.1538-7836.2011.04449.x; Zhang Wei, 2009, Zhonghua Nan Ke Xue, V15, P703; Zhang Z, 2006, J ANDROL, V27, P365, DOI 10.2164/jandrol.05179; Zohni K, 2012, HUM REPROD, V27, P44, DOI 10.1093/humrep/der357; Zorrilla Michelle, 2013, Curr Genet Med Rep, V1, DOI 10.1007/s40142-013-0027-1	38	22	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148388	10.1371/journal.pone.0148388	http://dx.doi.org/10.1371/journal.pone.0148388			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871566	gold, Green Submitted, Green Published			2022-12-27	WOS:000370054100025
J	Qiu, ZW; Yue, JP; Wang, XQ; Yue, S				Qiu, Zhiwei; Yue, Jianping; Wang, Xueqin; Yue, Shun			Spaceborne SAR Imaging Algorithm for Coherence Optimized	PLOS ONE			English	Article								This paper proposes SAR imaging algorithm with largest coherence based on the existing SAR imaging algorithm. The basic idea of SAR imaging algorithm in imaging processing is that output signal can have maximum signal-to-noise ratio (SNR) by using the optimal imaging parameters. Traditional imaging algorithm can acquire the best focusing effect, but would bring the decoherence phenomenon in subsequent interference process. Algorithm proposed in this paper is that SAR echo adopts consistent imaging parameters in focusing processing. Although the SNR of the output signal is reduced slightly, their coherence is ensured greatly, and finally the interferogram with high quality is obtained. In this paper, two scenes of Envisat ASAR data in Zhangbei are employed to conduct experiment for this algorithm. Compared with the interferogram from the traditional algorithm, the results show that this algorithm is more suitable for SAR interferometry (InSAR) research and application.	[Qiu, Zhiwei; Yue, Jianping; Wang, Xueqin; Yue, Shun] Hohai Univ, Sch Earth Sci & Engn, Nanjing 211100, Jiangsu, Peoples R China; [Qiu, Zhiwei] Henan Univ Urban Construct, Sch Surveying & Engn, Pingdingshan 467036, Peoples R China	Hohai University; Henan University of Urban Construction	Qiu, ZW (corresponding author), Hohai Univ, Sch Earth Sci & Engn, Nanjing 211100, Jiangsu, Peoples R China.; Qiu, ZW (corresponding author), Henan Univ Urban Construct, Sch Surveying & Engn, Pingdingshan 467036, Peoples R China.	qiuzhiwei-2008@163.com			National Natural Science Foundation of China [41174002]; Hunan Provincial Key Laboratory of Hydropower Development Key Technology [PKLHD201311]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Key Laboratory of Hydropower Development Key Technology	This work has been partially supported by the National Natural Science Foundation of China, (Grant No. 41174002), and also by Hunan Provincial Key Laboratory of Hydropower Development Key Technology, (Grant No. PKLHD201311).	Bamler R., 1992, Patent Appl, Patent No. [909,843, 909843]; Bamler R., 1992, U. S. Patent, Patent No. [5,237,329, 5237329]; Chang C. Y., 1989, P IGARSS S, P2567; Cumming I, 2001, INT GEOSCI REMOTE SE, P2645, DOI 10.1109/IGARSS.2001.978117; CUMMING I, 1992, INTERNATIONAL SPACE YEAR : SPACE REMOTE SENSING, VOLS 1 AND 2, P376; Cumming I.G., 2005, ARTECH REM; Ding XL, 2005, INT GEOSCI REMOTE SE, P4825; Ferretti A., 2007, INSAR PRINCIPLES GUI; Goldstein RM, 1998, GEOPHYS RES LETT, V25, P4035, DOI 10.1029/1998GL900033; HUANG YH, 1993, INT GEOSCI REMOTE SE, P1182, DOI 10.1109/IGARSS.1993.322125; IMPAGNATIELLO F, 1995, INT GEOSCI REMOTE SE, P1819, DOI 10.1109/IGARSS.1995.524036; JIN MY, 1993, INT GEOSCI REMOTE SE, P1169, DOI 10.1109/IGARSS.1993.322129; Loffeld O, 1998, INT GEOSCI REMOTE SE, P630, DOI 10.1109/IGARSS.1998.699533; MADSEN SN, 1989, IEEE T AERO ELEC SYS, V25, P134, DOI 10.1109/7.18675; Norvang Madsen S., 1989, IEEE T AEROSPACE ELE, VAES-25; Papoulis A., 1968, SYSTEMS TRANSFORMS A; Raney R. K., 1991, Patent Appl, Patent No. [729,641, 729641]; Raney R. K., 1991, U. S. Patent, Patent No. [5,179,383, 5179383]; RANEY RK, 1994, IEEE T GEOSCI REMOTE, V32, P786, DOI 10.1109/36.298008; Runge H., 1992, P IGARSS, P372; Wong F, 1996, IEEE T GEOSCI REMOTE, V34, P696, DOI 10.1109/36.499749	21	4	4	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148823	10.1371/journal.pone.0148823	http://dx.doi.org/10.1371/journal.pone.0148823			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871446	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100060
J	van der Maten, E; van Selm, S; Langereis, JD; Bootsma, HJ; van Opzeeland, FJH; de Groot, R; de Jonge, MI; van der Flier, M				van der Maten, Erika; van Selm, Saskia; Langereis, Jeroen D.; Bootsma, Hester J.; van Opzeeland, Fred J. H.; de Groot, Ronald; de Jonge, Marien I.; van der Flier, Michiel			Alternative Pathway Inhibition by Exogenous Factor H Fails to Attenuate Inflammation and Vascular Leakage in Experimental Pneumococcal Sepsis in Mice	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; COMPLEMENT PATHWAY; CLASSICAL PATHWAY; C5A; DISEASE; AMPLIFICATION; DEFICIENCIES; ACTIVATION; EXPRESSION; PROTECTION	Streptococcus pneumoniae is a common cause of sepsis. Effective complement activation is an important component of host defence against invading pathogens, whilst excessive complement activation has been associated with endothelial dysfunction and organ damage. The alternative pathway amplification loop is important for the enhancement of complement activation. Factor H is a key negative regulator of the alternative pathway amplification loop and contributes to tight control of complement activation. We assessed the effect of inhibition of the alternative pathway on sepsis associated inflammation and disease severity using human factor H treatment in a clinically relevant mice model of pneumococcal sepsis. Mice were infected intravenously with live Streptococcus pneumoniae. At the first clinical signs of infection, 17 hours post-infection, mice were treated with ceftriaxone antibiotic. At the same time purified human factor H or in controls PBS was administered. Treatment with human factor H did not attenuate disease scores, serum pro-inflammatory cytokines, or vascular permeability and did not significantly affect C3 and C3a production at 26 h post-infection. Therefore, we conclude that inhibition of the alternative complement pathway by exogenous human factor H fails to attenuate inflammation and vascular leakage at a clinically relevant intervention time point in pneumococcal sepsis in mice.	[van der Maten, Erika; van Selm, Saskia; Langereis, Jeroen D.; Bootsma, Hester J.; van Opzeeland, Fred J. H.; de Groot, Ronald; de Jonge, Marien I.; van der Flier, Michiel] Radboudumc, Radboud Inst Mol Life Sci, Dept Pediat, Lab Pediat Infect Dis, Nijmegen, Netherlands; [van der Flier, Michiel] Radboudumc, Dept Pediat, Pediat Infect Dis & Immunol, Nijmegen, Netherlands; [Bootsma, Hester J.] RIVM, Ctr Infect Dis Control, Lab Infect Dis & Screening, Bilthoven, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Netherlands National Institute for Public Health & the Environment	van der Flier, M (corresponding author), Radboudumc, Radboud Inst Mol Life Sci, Dept Pediat, Lab Pediat Infect Dis, Nijmegen, Netherlands.; van der Flier, M (corresponding author), Radboudumc, Dept Pediat, Pediat Infect Dis & Immunol, Nijmegen, Netherlands.	Michiel.vanderFlier@radboudumc.nl	Langereis, Jeroen/H-1042-2013; van der Flier, M./L-4307-2015; de Jonge, Marien I./P-5869-2015; van der Maten, Erika/G-4497-2016	Langereis, Jeroen/0000-0001-5317-3202; van der Flier, M./0000-0003-1296-0159; de Jonge, Marien I./0000-0003-2812-5895; 	European Union's seventh Framework program [EC-GA] [279185]; European childhood life-threatening infectious diseases study (EUCLIDS) (RdG)	European Union's seventh Framework program [EC-GA]; European childhood life-threatening infectious diseases study (EUCLIDS) (RdG)	This work was supported by the European Union's seventh Framework program [EC-GA#279185], European childhood life-threatening infectious diseases study (EUCLIDS) (RdG received the grant and salary of EvdM was paid by this grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali YM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002793; Ali YM, 2014, P NATL ACAD SCI USA, V111, P5301, DOI 10.1073/pnas.1401011111; Angus DC, 2013, NEW ENGL J MED, V369, P2063, DOI 10.1056/NEJMc1312359; Baig K, 2007, ANN THORAC SURG, V83, P1477, DOI 10.1016/j.athoracsur.2006.10.049; Brandtzaeg P, 1996, J INFECT DIS, V173, P647, DOI 10.1093/infdis/173.3.647; Brown JS, 2002, P NATL ACAD SCI USA, V99, P16969, DOI 10.1073/pnas.012669199; Czermak BJ, 1999, NAT MED, V5, P788, DOI 10.1038/10512; Dahlke K, 2011, J IMMUNOL, V186, P3066, DOI 10.4049/jimmunol.1002741; Davis AE, 2007, IMMUNOBIOLOGY, V212, P313, DOI 10.1016/j.imbio.2006.10.003; Ding JD, 2015, AM J PATHOL, V185, P29, DOI 10.1016/j.ajpath.2014.08.026; Fakhouri F, 2010, KIDNEY INT, V78, P279, DOI 10.1038/ki.2010.132; Flierl MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002560; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hajishengallis G, 2010, TRENDS IMMUNOL, V31, P154, DOI 10.1016/j.it.2010.01.002; Harboe M, 2004, CLIN EXP IMMUNOL, V138, P439, DOI 10.1111/j.1365-2249.2004.02627.x; Harboe M, 2008, J CELL MOL MED, V12, P1074, DOI 10.1111/j.1582-4934.2008.00350.x; Huber-Lang MS, 2001, FASEB J, V15, P568; Hyams C, 2013, INFECT IMMUN, V81, P354, DOI 10.1128/IAI.00862-12; Igonin AA, 2012, CRIT CARE MED, V40, P770, DOI 10.1097/CCM.0b013e318236edb8; Jansen AGSC, 2009, CLIN INFECT DIS, V49, pE23, DOI 10.1086/600045; Jansen PM, 1998, J IMMUNOL, V160, P475; Lappegard KT, 2009, P NATL ACAD SCI USA, V106, P15861, DOI 10.1073/pnas.0903613106; Liu D, 2007, J IMMUNOL, V179, P3966; Liu ZM, 2010, MOL IMMUNOL, V47, P1325, DOI 10.1016/j.molimm.2009.11.001; Lu L, 2008, J IMMUNOL, V181, P7138, DOI 10.4049/jimmunol.181.10.7138; Makou E, 2013, BIOCHEMISTRY-US, V52, P3949, DOI 10.1021/bi4003452; Muhammad Riyadh D, 2013, Clin Infect Dis, V56, pe59, DOI 10.1093/cid/cis971; Niederbichler AD, 2006, J EXP MED, V203, P53, DOI 10.1084/jem.20051207; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257; Pettigrew HD, 2009, ANN NY ACAD SCI, V1173, P108, DOI 10.1111/j.1749-6632.2009.04633.x; Ram S, 2010, CLIN MICROBIOL REV, V23, P740, DOI 10.1128/CMR.00048-09; Riedemann NC, 2002, J CLIN INVEST, V110, P101, DOI 10.1172/JCI200215409; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Rowinska-Zyrek M, 2013, NEW J CHEM, V37, P58, DOI 10.1039/c2nj40558j; Silasi-Mansat R, 2010, BLOOD, V116, P1002, DOI 10.1182/blood-2010-02-269746; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; von Drygalski A, 2012, THROMB HAEMOSTASIS, V108, P981, DOI 10.1160/TH12-03-0196; WEILER JM, 1976, P NATL ACAD SCI USA, V73, P3268, DOI 10.1073/pnas.73.9.3268; WHALEY K, 1976, J EXP MED, V144, P1147, DOI 10.1084/jem.144.5.1147; Woehrl B, 2011, J CLIN INVEST, V121, P3943, DOI 10.1172/JCI57522; Younger JG, 2010, ACAD EMERG MED, V17, P353, DOI 10.1111/j.1553-2712.2010.00713.x; Zhang XH, 2007, BLOOD, V110, P228, DOI 10.1182/blood-2006-12-063636; Zimmer J, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00689	44	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149307	10.1371/journal.pone.0149307	http://dx.doi.org/10.1371/journal.pone.0149307			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872035	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100145
J	Espana-Agusti, J; Zou, XG; Wong, K; Fu, BY; Yang, FT; Tuveson, DA; Adams, DJ; Matakidou, A				Espana-Agusti, Judit; Zou, Xiangang; Wong, Kim; Fu, Beiyuan; Yang, Fengtang; Tuveson, David A.; Adams, David J.; Matakidou, Athena			Generation and Characterisation of a Pax8-CreER(T2) Transgenic Line and a Slc22a6-CreER(T2) Knock-In Line for Inducible and Specific Genetic Manipulation of Renal Tubular Epithelial Cells	PLOS ONE			English	Article							LINDAU TUMOR-SUPPRESSOR; MOUSE PROXIMAL TUBULE; CRE/LOX RECOMBINATION; CRE RECOMBINASE; CYST FORMATION; KIDNEY; MICE; EXPRESSION; INACTIVATION; DNA	Genetically relevant mouse models need to recapitulate the hallmarks of human disease by permitting spatiotemporal gene targeting. This is especially important for replicating the biology of complex diseases like cancer, where genetic events occur in a sporadic fashion within developed somatic tissues. Though a number of renal tubule targeting mouse lines have been developed their utility for the study of renal disease is limited by lack of inducibility and specificity. In this study we describe the generation and characterisation of two novel mouse lines directing CreER(T2) expression to renal tubular epithelia. The Pax8-CreER(T2) transgenic line uses the mouse Pax8 promoter to direct expression of CreERT2 to all renal tubular compartments (proximal and distal tubules as well as collecting ducts) whilst the Slc22a6-CreER(T2) knock-in line utilises the endogenous mouse Slc22a6 locus to specifically target the epithelium of proximal renal tubules. Both lines show high organ and tissue specificity with no extrarenal activity detected. To establish the utility of these lines for the study of renal cancer biology, Pax8-CreER(T2) and Slc22a6-CreER(T2) mice were crossed to conditional Vhl knockout mice to induce long-term renal tubule specific Vhl deletion. These models exhibited renal specific activation of the hypoxia inducible factor pathway (a VHL target). Our results establish Pax8-CreER(T2) and Slc22a6-CreER(T2) mice as valuable tools for the investigation and modelling of complex renal biology and disease.	[Espana-Agusti, Judit; Tuveson, David A.; Matakidou, Athena] Univ Cambridge, CRUK Cambridge Inst, Dept Oncol, Cambridge, England; [Zou, Xiangang] Univ Cambridge, Transgen Facil, CRUK Cambridge Inst, Cambridge, England; [Wong, Kim; Adams, David J.] Wellcome Trust Sanger Inst, Expt Canc Genet, Wellcome Genome Campus, Cambridge, England; [Fu, Beiyuan; Yang, Fengtang] Wellcome Trust Sanger Inst, Cytogenet Facil, Wellcome Genome Campus, Cambridge, England; [Tuveson, David A.] Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY USA	CRUK Cambridge Institute; University of Cambridge; CRUK Cambridge Institute; University of Cambridge; Wellcome Trust Sanger Institute; Wellcome Trust Sanger Institute; Cold Spring Harbor Laboratory	Matakidou, A (corresponding author), Univ Cambridge, CRUK Cambridge Inst, Dept Oncol, Cambridge, England.	Athena.Matakidou@cruk.cam.ac.uk	Yang, Fan/GYU-4249-2022	Yang, Fengtang/0000-0002-3573-2354; Adams, David/0000-0001-9490-0306; Wong, Kim/0000-0002-0984-1477	Cancer Research UK Clinician Scientist Fellowship award [C37839/A12177]; Wellcome Trust Sanger Institute [WT098051]; Cancer Research UK [12177, 13031] Funding Source: researchfish	Cancer Research UK Clinician Scientist Fellowship award; Wellcome Trust Sanger Institute(Wellcome Trust); Cancer Research UK(Cancer Research UK)	This work was supported by a Cancer Research UK Clinician Scientist Fellowship award (C37839/A12177; http://www.cancerresearchuk.org) to AM. DA, BF, FY are funded by the Wellcome Trust Sanger Institute (grant number WT098051; http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouchard M, 2004, GENESIS, V38, P105, DOI 10.1002/gene.20008; Dworniczak B, 2007, NEPHRON EXP NEPHROL, V106, pE11, DOI 10.1159/000100554; Eraly SA, 2006, J BIOL CHEM, V281, P5072, DOI 10.1074/jbc.M508050200; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Frew IJ, 2008, EMBO J, V27, P1747, DOI 10.1038/emboj.2008.96; Ge YQ, 2008, AM J PHYSIOL-RENAL, V295, pF1635, DOI 10.1152/ajprenal.90279.2008; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Hwang JS, 2010, HISTOL HISTOPATHOL, V25, P33, DOI 10.14670/HH-25.33; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Kusaba T, 2014, P NATL ACAD SCI USA, V111, P1527, DOI 10.1073/pnas.1310653110; LAKSO M, 1992, P NATL ACAD SCI USA, V89, P6232, DOI 10.1073/pnas.89.14.6232; Lantinga-van Leeuwen IS, 2007, HUM MOL GENET, V16, P3188, DOI 10.1093/hmg/ddm299; Lee CM, 2009, ONCOGENE, V28, P1694, DOI 10.1038/onc.2009.12; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; Mathia S, 2013, ACTA PHYSIOL, V207, P565, DOI 10.1111/apha.12058; Muyrers JPP, 2001, TRENDS BIOCHEM SCI, V26, P325, DOI 10.1016/S0968-0004(00)01757-6; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Pavlova A, 2000, AM J PHYSIOL-RENAL, V278, pF635, DOI 10.1152/ajprenal.2000.278.4.F635; Rankin EB, 2006, CANCER RES, V66, P2576, DOI 10.1158/0008-5472.CAN-05-3241; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rubera I, 2003, J CLIN INVEST, V112, P554, DOI 10.1172/JCI200316956; Rubera I, 2004, J AM SOC NEPHROL, V15, P2050, DOI 10.1097/01.ASN.0000133023.89251.01; Shao XL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016444.90348.50; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tannenbaum M, 1971, Pathol Annu, V6, P249; Traykova-Brauch M, 2008, NAT MED, V14, P979, DOI 10.1038/nm.1865; Wang SS, 2014, P NATL ACAD SCI US	31	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148055	10.1371/journal.pone.0148055	http://dx.doi.org/10.1371/journal.pone.0148055			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866916	Green Published, gold, Green Accepted			2022-12-27	WOS:000370050700007
J	Sheng, SR; Xu, HZ; Wang, YL; Zhu, QA; Mao, FM; Lin, Y; Wang, XY				Sheng, Sun-Ren; Xu, Hua-Zi; Wang, Yong-Li; Zhu, Qing-An; Mao, Fang-Min; Lin, Yan; Wang, Xiang-Yang			Comparison of Cervical Spine Anatomy in Calves, Pigs and Humans	PLOS ONE			English	Article							HUMAN LUMBAR SPINE; BIOMECHANICAL EVALUATION; PORCINE SPINE; DEER SPINE; THORACIC SPINE; CANINE MODEL; CALF; SHEEP; STABILITY; JOINT	Background Context Animals are commonly used to model the human spine for in vitro and in vivo experiments. Many studies have investigated similarities and differences between animals and humans in the lumbar and thoracic vertebrae. However, a quantitative anatomic comparison of calf, pig, and human cervical spines has not been reported. Purpose To compare fundamental structural similarities and differences in vertebral bodies from the cervical spines of commonly used experimental animal models and humans. Study Design Anatomical morphometric analysis was performed on cervical vertebra specimens harvested from humans and two common large animals (i.e., calves and pigs). Methods Multiple morphometric parameters were directly measured from cervical spine specimens of twelve pigs, twelve calves and twelve human adult cadavers. The following anatomical parameters were measured: vertebral body width (VBW), vertebral body depth (VBD), vertebral body height (VBH), spinal canal width (SCW), spinal canal depth (SCD), pedicle width (PW), pedicle depth (PD), pedicle inclination (PI), dens width (DW), dens depth (DD), total vertebral width (TVW), and total vertebral depth (TVD). Results The atlantoaxial (C1-2) joint in pigs is similar to that in humans and could serve as a human substitute. The pig cervical spine is highly similar to the human cervical spine, except for two large transverse processes in the anterior regions ofC4-C6. The width and depth of the calf odontoid process were larger than those in humans. VBW and VBD of calf cervical vertebrae were larger than those in humans, but the spinal canal was smaller. Calf C7 was relatively similar to human C7, thus, it may be a good substitute. Conclusion Pig cervical vertebrae were more suitable human substitutions than calf cervical vertebrae, especially with respect to C1, C2, and C7. The biomechanical properties of nerve vascular anatomy and various segment functions in pig and calf cervical vertebrae must be considered when selecting an animal model for research on the spine.	[Sheng, Sun-Ren; Xu, Hua-Zi; Wang, Yong-Li; Mao, Fang-Min; Lin, Yan; Wang, Xiang-Yang] Wenzhou Med Univ, Affiliated Hosp 2, Dept Orthoped Surg, Wenzhou, Peoples R China; [Zhu, Qing-An] Southern Med Univ, Nan Fang Hosp, Guangzhou, Guangdong, Peoples R China	Wenzhou Medical University; Southern Medical University - China	Wang, XY (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Dept Orthoped Surg, Wenzhou, Peoples R China.	xiangyangwang@126.com			Qianjiang Talents Project of Technology Office of Zhejiang Province [2010R10075]; Natural Science Foundation of Zhejiang Province [LR12H06001]; Science and Technology Bureau of Wenzhou city [Y20100091]; National Nature Foundation of China [81371988]	Qianjiang Talents Project of Technology Office of Zhejiang Province; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Science and Technology Bureau of Wenzhou city; National Nature Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by grants from Qianjiang Talents Project of Technology Office of Zhejiang Province (Grant No: 2010R10075), Natural Science Foundation of Zhejiang Province for Distinguished Young Scholars (Grant No: LR12H06001), The project of Science and Technology Bureau of Wenzhou city (Grant No: Y20100091) and National Nature Foundation of China (Grant No. 81371988).; This work was supported by grants from the Qianjiang Talents Project of Technology Office of Zhejiang Province (Grant No: 2010R10075), the Natural Science Foundation of Zhejiang Province for Distinguished Young Scholars (Grant No: LR12H06001), the Science and Technology Bureau of Wenzhou City (Grant No: Y20100091) and the National Nature Foundation of China (Grant No. 81371988).	AERSSENS J, 1994, CLIN RHEUMATOL, V13, P54; Bozkus H, 2005, SURG ENDOSC, V19, P1652, DOI 10.1007/s00464-005-0159-9; Busscher I, 2010, EUR SPINE J, V19, P1104, DOI 10.1007/s00586-010-1326-9; Busscher I, 2010, SPINE, V35, pE35, DOI 10.1097/BRS.0b013e3181b21885; COTTERILL PC, 1986, J ORTHOPAED RES, V4, P298, DOI 10.1002/jor.1100040306; Demarteau O, 2006, OSTEOARTHR CARTILAGE, V14, P589, DOI 10.1016/j.joca.2005.12.011; Demers CN, 2004, SPINE, V29, P2793, DOI 10.1097/01.brs.0000147744.74215.b0; Ettema Anke M, 2006, Hand (N Y), V1, P78, DOI 10.1007/s11552-006-9009-z; Gomez M, 2004, VET RADIOL ULTRASOUN, V45, P29, DOI 10.1111/j.1740-8261.2004.04005.x; GREGORY CR, 1986, SPINE, V11, P1044, DOI 10.1097/00007632-198612000-00019; Hakalo J, 2008, J Orthop Surg (Hong Kong), V16, P9; Kandziora F, 2001, SPINE, V26, P1028, DOI 10.1097/00007632-200105010-00008; Koehler CL, 2005, AM J VET RES, V66, P678, DOI 10.2460/ajvr.2005.66.678; Kouwenhoven JWM, 2007, SPINE, V32, P2545, DOI 10.1097/BRS.0b013e318158cd86; Kumar N, 2000, ANAT RECORD, V260, P189, DOI 10.1002/1097-0185(20001001)260:2<189::AID-AR80>3.0.CO;2-N; Kumar N, 2000, ANAT REC, V266, P108; Lei W, 2006, EUR SPINE J, V15, P321, DOI 10.1007/s00586-004-0867-1; Lim TH, 1997, SPINE, V22, P261, DOI 10.1097/00007632-199702010-00005; PANJABI MM, 1988, SPINE, V13, P803, DOI 10.1097/00007632-198807000-00016; Riley LH, 2004, SPINE, V29, pE217, DOI 10.1097/00007632-200406010-00021; Sato F, 1982, Nihon Jibiinkoka Gakkai Kaiho, V85, P951; Schmidt R, 2005, SPINE, V30, P1275, DOI 10.1097/01.brs.0000164096.71261.c2; Seel EH, 2007, J BONE JOINT SURG BR, V89B, P253, DOI 10.1302/0301-620X.89B2.17928; Shahar R, 2006, VET SURG, V35, P144, DOI 10.1111/j.1532-950X.2006.00125.x; Sheng SR, 2010, EUR SPINE J, V19, P46, DOI 10.1007/s00586-009-1192-5; SHIRADO O, 1991, J BONE JOINT SURG AM, V73A, P518, DOI 10.2106/00004623-199173040-00007; Tai CL, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-84; Takeuchi T, 1999, SPINE, V24, P1414, DOI 10.1097/00007632-199907150-00005; TOMINAGA T, 1995, SPINE, V20, P131, DOI 10.1097/00007632-199501150-00001; Wilke H J, 1997, Eur Spine J, V6, P129, DOI 10.1007/BF01358746; Wilke HJ, 1996, J ORTHOPAED RES, V14, P500, DOI 10.1002/jor.1100140321; Wilke HJ, 1997, ANAT RECORD, V247, P542, DOI 10.1002/(SICI)1097-0185(199704)247:4<542::AID-AR13>3.0.CO;2-P; Wilke HJ, 1997, SPINE, V22, P2365, DOI 10.1097/00007632-199710150-00009; WITTENBERG RH, 1992, SPINE, V17, pS121, DOI 10.1097/00007632-199206001-00010; Yazici M, 2006, SPINE, V31, pE826, DOI 10.1097/01.brs.0000240759.06855.e6; Yingling VR, 1999, J SPINAL DISORD, V12, P415; ZRUNEK M, 1988, ACTA OTO-LARYNGOL, V105, P155, DOI 10.3109/00016488809119460	37	14	16	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148610	10.1371/journal.pone.0148610	http://dx.doi.org/10.1371/journal.pone.0148610			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866593	Green Submitted, Green Published, gold			2022-12-27	WOS:000370050700022
J	Killgrove, K; Montgomery, J				Killgrove, Kristina; Montgomery, Janet			All Roads Lead to Rome: Exploring Human Migration to the Eternal City through Biochemistry of Skeletons from Two Imperial-Era Cemeteries (1st-3rd c AD)	PLOS ONE			English	Article							STRONTIUM ISOTOPE RATIOS; BIOLOGICALLY AVAILABLE STRONTIUM; HUMAN TOOTH ENAMEL; RESIDENTIAL-MOBILITY; OXYGEN ISOTOPES; BONE PHOSPHATE; AGE; PERIOD; IMMIGRATION; RECONSTRUCTION	Migration within the Roman Empire occurred at multiple scales and was engaged in both voluntarily and involuntarily. Because of the lengthy tradition of classical studies, bioarchaeological analyses must be fully contextualized within the bounds of history, material culture, and epigraphy. In order to assess migration to Rome within an updated contextual framework, strontium isotope analysis was performed on 105 individuals from two cemeteries associated with Imperial Rome/Casal Bertone and Castellaccio Europarco- and oxygen and carbon isotope analyses were performed on a subset of 55 individuals. Statistical analysis and comparisons with expected local ranges found several outliers who likely immigrated to Rome from elsewhere. Demographics of the immigrants show men and children migrated, and a comparison of carbon isotopes from teeth and bone samples suggests the immigrants may have significantly changed their diet. These data represent the first physical evidence of individual migrants to Imperial Rome. This case study demonstrates the importance of employing bioarchaeology to generate a deeper understanding of a complex ancient urban center.	[Killgrove, Kristina] Univ W Florida, Dept Anthropol, Pensacola, FL 32514 USA; [Montgomery, Janet] Univ Durham, Dept Archaeol, Durham, England	State University System of Florida; University of West Florida; Durham University	Killgrove, K (corresponding author), Univ W Florida, Dept Anthropol, Pensacola, FL 32514 USA.	killgrove@uwf.edu	Killgrove, Kristina/H-2807-2019	Killgrove, Kristina/0000-0003-0452-3856	National Science Foundation [BCS-0622452]; Wenner-Gren Dissertation Fieldwork Grant; University of North Carolina at Chapel Hill	National Science Foundation(National Science Foundation (NSF)); Wenner-Gren Dissertation Fieldwork Grant; University of North Carolina at Chapel Hill	Data collection in Rome and carbon and oxygen isotope analyses were funded by a Doctoral Dissertation Research Improvement Grant from the National Science Foundation (BCS-0622452) awarded to KK (http://www.nsf.gov/div/index.jsp?div=bcs). Strontium isotope analyses were funded by a Wenner-Gren Dissertation Fieldwork Grant awarded to KK (http://www.wennergren.org/programs/dissertation-fieldwork-grants). Internal grants from the University of North Carolina at Chapel Hill awarded to KK also helped fund oxygen isotope analyses (http://anthropology.unc.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acsadi G., 1970, HIST HUMAN LIFESPAN; Aicher Peter J., 1995, GUIDE AQUEDUCTS ANCI; Anderson D L, 1976, J Forensic Sci, V21, P191; Andreau J., 1999, BANKING BUSINESS ROM; [Anonymous], 2003, COMPRENSORIO NECROPO; ANTHONY DW, 1990, AM ANTHROPOL, V92, P895, DOI 10.1525/aa.1990.92.4.02a00030; Baker BJ., 2005, OSTEOLOGY INFANTS CH; BARBIERI M, 1979, CHEM GEOL, V24, P181, DOI 10.1016/0009-2541(79)90121-9; Barbieri M, 1997, P INT S GEOL ENV IST, P77; Bentley RA, 2006, J ARCHAEOL METHOD TH, V13, P135, DOI 10.1007/s10816-006-9009-x; Bentley RA, 2005, ARCHAEOMETRY, V47, P629, DOI 10.1111/j.1475-4754.2005.00223.x; Bollongino R, 2013, SCIENCE, V342, P479, DOI 10.1126/science.1245049; Bowen GJ, 2002, GEOLOGY, V30, P315, DOI 10.1130/0091-7613(2002)030<0315:SDOOIM>2.0.CO;2; Bowman Alan K., 1998, LIFE LETT ROMAN FRON; Bradley Keith, 1994, SLAVERY SOC ROME; Brooks S, 1990, HUM EVOL, V5, P227, DOI DOI 10.1007/BF02437238; Bruun C., 2010, J ROMAN ARCHAEOL, V23, P109, DOI DOI 10.1017/S1047759400002324; Buccellato A, 2007, ANTICA LAURENTINA AR, P88; Buccellato A., 2008, DOSSIERS ARCHEOLOGIE, V330, P14; Buccellato A., 2008, DOSSIERS ARCHEOLOGIE, V330, P22; Budd Paul, 2000, EUR J ARCHAEOL, V3, P370, DOI DOI 10.1177/146195710000300304; Buikstra JE, 1994, ARKANSAS ARCHEOLOGIC; Buzon MR, 2010, ARCHAEOMETRY, V52, P855, DOI 10.1111/j.1475-4754.2009.00503.x; Buzon MR, 2007, J ARCHAEOL SCI, V34, P1391, DOI 10.1016/j.jas.2006.10.029; Catalano P., 2001, MITTEILUNGEN DTSCH A, V108, P355; Catalano P., 2001, URBANIZZAZIONE CAMPA, P127; Catalano P., 2008, DOSSIERS ARCHEOLOGIE, V330, P10; Catalano P., 2001, ARCHEOLOGIA GIUBILEO, P123; Champlin Edward, 1982, AM J ANCIENT HIST, V7, P97; Chenery C, 2011, J ARCHAEOL SCI, V38, P1525, DOI 10.1016/j.jas.2011.02.018; Chenery C, 2010, J ARCHAEOL SCI, V37, P150, DOI 10.1016/j.jas.2009.09.025; COPLEN TB, 1988, CHEM GEOL, V72, P293, DOI 10.1016/0168-9622(88)90042-5; CRAIG H, 1961, SCIENCE, V133, P1702, DOI 10.1126/science.133.3465.1702; Cucina A, 2006, INT J OSTEOARCHAEOL, V16, P104, DOI 10.1002/oa.808; CUNDARI A, 1979, CONTRIB MINERAL PETR, V70, P9, DOI 10.1007/BF00371867; Daux V, 2008, J HUM EVOL, V55, P1138, DOI 10.1016/j.jhevol.2008.06.006; Dupras TL, 2001, J ARCHAEOL SCI, V28, P1199, DOI 10.1006/jasc.2001.0640; Dyson SL, 1988, TRIBE POLITY LATE PR, P193; Eckardt H, 2009, J ARCHAEOL SCI, V36, P2816, DOI 10.1016/j.jas.2009.09.010; Egidi R., 2003, ASPETTI VITA QUOTIDI; Ellwood NTW, 2009, J LIMNOL, V68, P288, DOI 10.4081/jlimnol.2009.288; Erdkamp P., 2008, PEOPLE LAND POLITICS, P417; Evans J, 2006, J ARCHAEOL SCI, V33, P265, DOI 10.1016/j.jas.2005.07.011; Evans JA, 2012, J ANAL ATOM SPECTROM, V27, P754, DOI 10.1039/c2ja10362a; Ezzo JA, 1997, J ARCHAEOL SCI, V24, P447, DOI 10.1006/jasc.1996.0129; Faure G., 1972, STRONTIUM ISOTOPE GE; FEDERICO M, 1994, CONTRIB MINERAL PETR, V115, P384, DOI 10.1007/BF00320973; Fildes V.A., 1986, BREASTS BOTTLES BABI; Frier Bruce, 1999, LIFE DEATH ENTERTAIN, P85; Garnsey P, 1989, FOOD HLTH CULTURE CL, V1, P50; Gat JR, 1996, ANNU REV EARTH PL SC, V24, P225, DOI 10.1146/annurev.earth.24.1.225; Goldsworthy AK, 2003, THE COMPLETE ROMAN A; Grupe G, 1997, APPL GEOCHEM, V12, P517, DOI 10.1016/S0883-2927(97)00030-9; GUSTAFSON G, 1974, ODONTOL REVY, V25, P297; Haak W, 2008, P NATL ACAD SCI USA, V105, P18226, DOI 10.1073/pnas.0807592105; HOAGLIN DC, 1986, J AM STAT ASSOC, V81, P991, DOI 10.2307/2289073; Hopkins K., 1978, CONQUERORS SLAVES; Hulsen C, 1906, ROMAN FORUM ITS HIST; Iacumin P, 1996, EARTH PLANET SC LETT, V142, P1, DOI 10.1016/0012-821X(96)00093-3; Killgrove K, 2015, ROMAN OSTEOLOGY DATA, DOI [http://dx.doi.org/10.6084/m9.figshare.1468571, DOI 10.6084/M9.FIGSHARE.1468571]; Killgrove K, 2010, J ROMAN ARCHAEOLOG S, P157; Killgrove K., 2010, THESIS U N CAROLINA; Killgrove K, 2016, BIOARCHAEOLOGY CONTA; Killgrove K, 2013, POSTCLASSICAL ARCHAE, V3, P41; Killgrove K., 2010, J ROMAN ARCHAEOL, V23, P133, DOI DOI 10.1017/S1047759400002336; Killgrove K, 2014, SAA 79 ANN M, P394; Killgrove K, 2013, J ANTHROPOL ARCHAEOL, V32, P28, DOI 10.1016/j.jaa.2012.08.002; Knudson KJ, 2007, AM J PHYS ANTHROPOL, V132, P25, DOI 10.1002/ajpa.20480; Laurence R., 1999, ROADS ROMAN ITALY MO; Leach S, 2010, ANTIQUITY, V84, P131, DOI 10.1017/S0003598X00099816; Leach S, 2009, AM J PHYS ANTHROPOL, V140, P546, DOI 10.1002/ajpa.21104; Lefkowitz M.R., 2005, WOMENS LIFE GREECE R; Levinson A.A., 1987, APPL GEOCHEM, V2, P367, DOI DOI 10.1016/0883-2927(87)90021-7; LONGINELLI A, 1984, GEOCHIM COSMOCHIM AC, V48, P385, DOI 10.1016/0016-7037(84)90259-X; Longinelli A, 2003, J HYDROL, V270, P75; LOVEJOY CO, 1985, AM J PHYS ANTHROPOL, V68, P15, DOI 10.1002/ajpa.1330680103; LUZ B, 1984, GEOCHIM COSMOCHIM AC, V48, P1689, DOI 10.1016/0016-7037(84)90338-7; MEINDL RS, 1985, AM J PHYS ANTHROPOL, V68, P57, DOI 10.1002/ajpa.1330680106; Minissale A, 2002, EARTH PLANET SC LETT, V203, P709, DOI 10.1016/S0012-821X(02)00875-0; Moatti C, 2006, CLASSICAL ANTIQUITY, V25, P109, DOI 10.1525/ca.2006.25.1.109; Montgomery J, 2005, AM J PHYS ANTHROPOL, V126, P123, DOI 10.1002/ajpa.20111; Montgomery J., 2002, THESIS U BRADFORD; Montgomery J, 2010, J ROMAN ARCHAEOLOG S, p[78, 199]; Montgomery J, 2007, APPL GEOCHEM, V22, P1502, DOI 10.1016/j.apgeochem.2007.02.009; MOORREES CF, 1963, AM J PHYS ANTHROPOL, V21, P205, DOI 10.1002/ajpa.1330210212; MOORREES COENRAAD F.A., 1963, JOUR DENT RES, V42, P1490, DOI 10.1177/00220345630420062701; Morley N., 1996, METROPOLIS HINTERLAN; Muldner G, 2011, J ARCHAEOL SCI, V38, P280, DOI 10.1016/j.jas.2010.09.003; Musco S., 2008, DOSSIERS ARCH, V330, P32; Nafplioti A, 2008, J ARCHAEOL SCI, V35, P2307, DOI 10.1016/j.jas.2008.03.006; Nanni A., 2004, NODO ROMA PENETRAZIO; Noy D., 2000, FOREIGNERROME CITI; Ottini L., 2001, MITTEILUNGEN DTSCH A, V108, P364; Palombo MR, 2005, QUATERN INT, V126, P153, DOI 10.1016/j.quaint.2004.04.020; Pantano W, 2007, NECROPOLI LOCALITA C; Parkin T., 1992, DEMOGRAPHY ROMAN SOC; Pellegrini M, 2008, RAPID COMMUN MASS SP, V22, P1714, DOI 10.1002/rcm.3521; Perry MA, 2007, J ANTHROPOL ARCHAEOL, V26, P486, DOI 10.1016/j.jaa.2007.02.002; PHENICE TW, 1969, AM J PHYS ANTHROPOL, V30, P297, DOI 10.1002/ajpa.1330300214; Pollard A., 2007, ANAL CHEM ARCHAEOLOG; Pollard AM, 2011, AM J PHYS ANTHROPOL, V146, P446, DOI 10.1002/ajpa.21602; Price TD, 2002, ARCHAEOMETRY, V44, P117, DOI 10.1111/1475-4754.00047; PRICE TD, 1994, APPL GEOCHEM, V9, P413; Price TD, 2001, ANTIQUITY, V75, P593, DOI 10.1017/S0003598X00088827; PRICE TD, 1994, J ARCHAEOL SCI, V21, P315, DOI 10.1006/jasc.1994.1031; Price TD, 2000, J ARCHAEOL SCI, V27, P903, DOI 10.1006/jasc.1999.0504; Prowse T. L., 2010, J ROMAN ARCHAEOLOG S, V2010, P175; Prowse TL, 2008, AM J PHYS ANTHROPOL, V137, P294, DOI 10.1002/ajpa.20870; Prowse TL, 2007, AM J PHYS ANTHROPOL, V132, P510, DOI 10.1002/ajpa.20541; Rutgers LV, 2009, J ARCHAEOL SCI, V36, P1127, DOI 10.1016/j.jas.2008.12.015; Scheeres M, 2013, J ARCHAEOL SCI, V40, P3614, DOI 10.1016/j.jas.2013.05.003; Scheidel W, 2005, J ROMAN STUD, V95, P64, DOI 10.3815/000000005784016270; Scheidel W, 2004, J ROMAN STUD, V94, P1, DOI 10.2307/4135008; Scheidel W, 1997, J ROMAN STUD, V87, P156, DOI 10.1017/S0075435800058123; Scheidel W., 2008, ROMAN POPULATION SIZ, P17; Scheidel W., 2001, DEBATING ROMAN DEMOG, P1; Schroeder H, 2009, AM J PHYS ANTHROPOL, V139, P547, DOI 10.1002/ajpa.21019; Schweissing MM, 2003, J ARCHAEOL SCI, V30, P1373, DOI 10.1016/S0305-4403(03)00025-6; Sponheimer M., 1999, THESIS RUTGERS U; Storey G.R., 1997, INTEGRATING ARCHAEOL, V24, P101; Storey GR, 1997, ANTIQUITY, V71, P966, DOI 10.1017/S0003598X00085859; Tafuri MA, 2005, BAR INT SERIES S, VS1359; Tafuri MA, INT J OSTEO IN PRESS; Taylor R., 2000, PUBLIC NEEDS PRIVATE; Todd TW, 1921, AM J PHYS ANTHROPOL, V4, P1, DOI 10.1002/ajpa.1330040102; Todd TW, 1920, AM J PHYS ANTHROPOL, V3, P285, DOI 10.1002/ajpa.1330030301; Toynbee J. M. C., 1971, DEATH BURIAL ROMAN W; Turner BL, 2009, J ARCHAEOL SCI, V36, P317, DOI 10.1016/j.jas.2008.09.018; Underwood EA, 1977, TRACE ELEMENTS HUMAN; Vinciguerra S, 2009, TECTONOPHYSICS, V471, P161, DOI 10.1016/j.tecto.2008.08.010; VOLLMER R, 1976, GEOCHIM COSMOCHIM AC, V40, P283, DOI 10.1016/0016-7037(76)90205-2; Webster J., 2005, J ROMAN ARCHAEOL, V18, P161, DOI DOI 10.1017/S1047759400007261; Webster J, 2008, ARCHAEOL DIALOG, V15, P103, DOI 10.1017/S1380203808002596; White CD, 2004, J ANTHROPOL ARCHAEOL, V23, P385, DOI 10.1016/j.jaa.2004.08.002; White T.D., 2005, HUMAN BONE MANUAL, DOI [DOI 10.1016/B978-0-12-088467-4.50018-1, 10.1016/B978-0-12-088467-4.50018-1]; Wiseman T. P., 1969, J ROMAN STUD, V59, P59, DOI [10.2307/299848, DOI 10.2307/299848]; Witcher R., 2005, J ROMAN ARCHAEOL, V18, P120, DOI DOI 10.1017/S1047759400007248	137	54	57	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0147585	10.1371/journal.pone.0147585	http://dx.doi.org/10.1371/journal.pone.0147585			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DD6PR	26863610	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000370046600033
J	Langenhof, MR; Apperloo, R; Komdeur, J				Langenhof, M. Rohaa; Apperloo, Rienk; Komdeur, Jan			Small Variations in Early-Life Environment Can Affect Coping Behaviour in Response to Foraging Challenge in the Three-Spined Stickleback	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; CLIMATE-CHANGE; GASTEROSTEUS-ACULEATUS; PERSONALITY-TRAITS; SOCIAL-ENVIRONMENT; INFORMATION USE; POPULATIONS; INDIVIDUALS; EXPLORATION; STRESSORS	Context An increasing concern in the face of human expansion throughout natural habitats is whether animal populations can respond adaptively when confronted with challenges like environmental change and novelty. Behavioural flexibility is an important factor in estimating the adaptive potential of both individuals and populations, and predicting the degree to which they can cope with change. Study Design This study on the three-spined stickleback (Gasterosteus aculeatus) is an empiric illustration of the degree of behavioural variation that can emerge between semi-natural systems within only a single generation. Wild-caught adult sticklebacks (P, N = 400) were randomly distributed in equal densities over 20 standardized semi-natural environments (ponds), and one year later offspring (F1, N = 652) were presented with repeated behavioural assays. Individuals were challenged to reach a food source through a novel transparent obstacle, during which exploration, activity, foraging, sociability and wall-biting behaviours were recorded through video observation. We found that coping responses of individuals from the first generation to this unfamiliar foraging challenge were related to even relatively small, naturally diversified variation in developmental environment. All measured behaviours were correlated with each other. Especially exploration, sociability and wall-biting were found to differ significantly between ponds. These differences could not be explained by stickleback density or the turbidity of the water. Findings Our findings show that a) differences in early-life environment appear to affect stickleback feeding behaviour later in life; b) this is the case even when the environmental differences are only small, within natural parameters and diversified gradually; and c) effects are present despite semi-natural conditions that fluctuate during the year. Therefore, in behaviourally plastic animals like the stickleback, the adaptive response to human-induced habitat disturbance may occur rapidly (within one generation) and vary strongly based on the system's (starting) conditions. This has important implications for the variability in animal behaviour, which may be much larger than expected from studying laboratory systems, as well as for the validity of predictions of population responses to change.	[Langenhof, M. Rohaa; Apperloo, Rienk; Komdeur, Jan] Univ Groningen, Groningen Inst Evolutionary Life Sci, Behav & Physiol Ecol, Nijenborgh 7, NL-9747 AG Groningen, Netherlands	University of Groningen	Langenhof, MR (corresponding author), Univ Groningen, Groningen Inst Evolutionary Life Sci, Behav & Physiol Ecol, Nijenborgh 7, NL-9747 AG Groningen, Netherlands.	m.b.w.langenhof@gmail.com	Komdeur, Jan/X-1261-2019	Komdeur, Jan/0000-0002-9241-0124; Langenhof, M. Rohaa/0000-0003-3434-4357	Ubbo Emmius scholarschip; Schure-Beijerink-Popping Fonds	Ubbo Emmius scholarschip; Schure-Beijerink-Popping Fonds	An Ubbo Emmius scholarschip was awarded to MRL to carry out PhD research on personality development. A E2000 grant from the Schure-Beijerink-Popping Fonds was awarded to MRL to cover expenses of a field expedition to gather, transport and house the animals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abellan P, 2009, MOL ECOL, V18, P3885, DOI 10.1111/j.1365-294X.2009.04319.x; Anisman H, 1998, INT J DEV NEUROSCI, V16, P149, DOI 10.1016/S0736-5748(98)00025-2; Balemans MCM, 2010, BEHAV BRAIN RES, V208, P47, DOI 10.1016/j.bbr.2009.11.008; Bell AM, 2011, J EVOLUTION BIOL, V24, P943, DOI 10.1111/j.1420-9101.2011.02247.x; Bell AM, 2007, ECOL LETT, V10, P828, DOI 10.1111/j.1461-0248.2007.01081.x; Bell AM, 2010, J COMP PHYSIOL B, V180, P211, DOI 10.1007/s00360-009-0395-8; Bell AM, 2005, J EVOLUTION BIOL, V18, P464, DOI 10.1111/j.1420-9101.2004.00817.x; Bell AM, 2004, ANIM BEHAV, V68, P1339, DOI 10.1016/j.anbehav.2004.05.007; Bjaerke O, 2010, ECOL FRESHW FISH, V19, P249, DOI 10.1111/j.1600-0633.2010.00409.x; Boyce WT, 2005, DEV PSYCHOPATHOL, V17, P271, DOI 10.1017/S0954579405050145; Bradbury RB, 2001, TRENDS ECOL EVOL, V16, P440, DOI 10.1016/S0169-5347(01)02189-9; Bradshaw WE, 2010, ANNU REV PHYSIOL, V72, P147, DOI 10.1146/annurev-physiol-021909-135837; Calsbeek R, 2009, J EVOLUTION BIOL, V22, P97, DOI 10.1111/j.1420-9101.2008.01625.x; Crooks KR, 2011, PHILOS T R SOC B, V366, P2642, DOI 10.1098/rstb.2011.0120; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Day T, 1996, OECOLOGIA, V108, P380, DOI 10.1007/BF00334665; Dingemanse NJ, 2007, J ANIM ECOL, V76, P1128, DOI 10.1111/j.1365-2656.2007.01284.x; Dingemanse NJ, 2012, J ANIM ECOL, V81, P116, DOI 10.1111/j.1365-2656.2011.01877.x; Fletcher RJ, 2010, CONDOR, V112, P225, DOI 10.1525/cond.2010.090236; Garduno-Paz MV, 2010, BIOL J LINN SOC, V100, P407, DOI 10.1111/j.1095-8312.2010.01423.x; Gonda A, 2009, P ROY SOC B-BIOL SCI, V276, P2085, DOI 10.1098/rspb.2009.0026; Gracceva G, 2011, DEV PSYCHOBIOL, V53, P614, DOI 10.1002/dev.20586; Grether GF, 2005, AM NAT, V166, pE115, DOI 10.1086/432023; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Harcourt JL, 2010, ETHOLOGY, V116, P440, DOI 10.1111/j.1439-0310.2010.01757.x; Hecky RE, 2010, FRESHWATER BIOL, V55, P19, DOI 10.1111/j.1365-2427.2009.02374.x; Herczeg G, 2009, ANIM BEHAV, V77, P575, DOI 10.1016/j.anbehav.2008.10.023; Heuschele J, 2009, BEHAV ECOL, V20, P1223, DOI 10.1093/beheco/arp123; Hofmann HA, 1999, P NATL ACAD SCI USA, V96, P14171, DOI 10.1073/pnas.96.24.14171; Huntingford FA, 2009, J FISH BIOL, V75, P1943, DOI 10.1111/j.1095-8649.2009.02420.x; Jenssen BM, 2006, ENVIRON HEALTH PERSP, V114, P76, DOI 10.1289/ehp.8057; Keith DA, 2008, BIOL LETTERS, V4, P560, DOI 10.1098/rsbl.2008.0049; Koolhaas JM, 2011, NEUROSCI BIOBEHAV R, V35, P1291, DOI 10.1016/j.neubiorev.2011.02.003; Kraak SBM, 1999, BEHAV ECOL, V10, P696, DOI 10.1093/beheco/10.6.696; Laland KN, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1019; Lande R, 2009, J EVOLUTION BIOL, V22, P1435, DOI 10.1111/j.1420-9101.2009.01754.x; Langenhof MBW, 2013, SUSTAINABILITY-BASEL, V5, P1764, DOI 10.3390/su5051764; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Minderman J, 2009, BEHAV ECOL, V20, P830, DOI 10.1093/beheco/arp067; Naguib M, 2011, DEV PSYCHOBIOL, V53, P592, DOI 10.1002/dev.20533; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; Ostlund-Nilsson S, 2006, BIOL 3 SPINED STICKL; Pike TW, 2010, BIOL LETTERS, V6, P466, DOI 10.1098/rsbl.2009.1014; Richter S, 2012, OECOLOGIA, V169, P269, DOI 10.1007/s00442-011-2191-x; Scheiber IBR, 2009, HORM BEHAV, V55, P133, DOI 10.1016/j.yhbeh.2008.09.006; Sih A, 2011, EVOL APPL, V4, P367, DOI 10.1111/j.1752-4571.2010.00166.x; Stamps J, 2010, BIOL REV, V85, P301, DOI 10.1111/j.1469-185X.2009.00103.x; Storey KB, 2012, CABI CLIM CHANGE SER, V3, P1; Sweeney K, 2013, ETHOLOGY, V119, P436, DOI 10.1111/eth.12081; Tuomainen U, 2011, BIOL REV, V86, P640, DOI 10.1111/j.1469-185X.2010.00164.x; Vlieger L, 2009, J FISH BIOL, V75, P2163, DOI 10.1111/j.1095-8649.2009.02403.x; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276	52	2	2	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0147000	10.1371/journal.pone.0147000	http://dx.doi.org/10.1371/journal.pone.0147000			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6PR	26862908	Green Submitted, Green Published, gold			2022-12-27	WOS:000370046600017
J	Matsudaira, K; Hara, N; Oka, H; Kunogi, J; Yamazaki, T; Takeshita, K; Atsushi, S; Tanaka, S				Matsudaira, Ko; Hara, Nobuhiro; Oka, Hiroyuki; Kunogi, Junichi; Yamazaki, Takashi; Takeshita, Katsushi; Atsushi, Seichi; Tanaka, Sakae			Predictive Factors for Subjective Improvement in Lumbar Spinal Stenosis Patients with Nonsurgical Treatment: A 3-Year Prospective Cohort Study	PLOS ONE			English	Article							MANAGEMENT; SYMPTOMS; OUTCOMES; LIFE	Objective To assess the predictive factors for subjective improvement with nonsurgical treatment in consecutive patients with lumbar spinal stenosis (LSS). Materials and Methods Patients with LSS were enrolled from 17 medical centres in Japan. We followed up 274 patients (151 men; mean age, 71 +/- 7.4 years) for 3 years. A multivariable logistic regression model was used to assess the predictive factors for subjective symptom improvement with nonsurgical treatment. Results In 30% of patients, conservative treatment led to a subjective improvement in the symptoms; in 70% of patients, the symptoms remained unchanged, worsened, or required surgical treatment. The multivariable analysis of predictive factors for subjective improvement with nonsurgical treatment showed that the absence of cauda equina symptoms (only radicular symptoms) had an odds ratio (OR) of 3.31 (95% confidence interval [CI]: 1.50-7.31); absence of degenerative spondylolisthesis/scoliosis had an OR of 2.53 (95% CI: 1.13-5.65); <1-year duration of illness had an OR of 3.81 (95% CI: 1.46-9.98); and hypertension had an OR of 2.09 (95% CI: 0.92-4.78). Conclusions The predictive factors for subjective symptom improvement with nonsurgical treatment in LSS patients were the presence of only radicular symptoms, absence of degenerative spondylolisthesis/scoliosis, and an illness duration of <1 year.	[Matsudaira, Ko; Oka, Hiroyuki] Univ Tokyo, Fac Med, Dept Med Res & Management Musculoskeletal Pain, 22nd Century Med & Res Ctr, Tokyo 113, Japan; [Hara, Nobuhiro; Yamazaki, Takashi] Musashino Red Cross Hosp, Dept Orthopaed Surg, Tokyo, Japan; [Kunogi, Junichi] Japanese Red Cross Med Ctr, Dept Spine & Orthopaed Surg, Tokyo, Japan; [Takeshita, Katsushi] Jichi Med Univ, Dept Orthopaed Surg, Shimotsuke, Tochigi, Japan; [Atsushi, Seichi] Mitsui Mem Hosp, Dept Orthopaed Surg, Tokyo 101, Japan; [Tanaka, Sakae] Univ Tokyo, Dept Orthopaed Surg, Tokyo, Japan	University of Tokyo; Japanese Red Cross Medical Center; University of Tokyo; Jichi Medical University; Mitsui Memorial Hospital; University of Tokyo	Oka, H (corresponding author), Univ Tokyo, Fac Med, Dept Med Res & Management Musculoskeletal Pain, 22nd Century Med & Res Ctr, Tokyo 113, Japan.	okah-tky@umin.ac.jp	Tanaka, Sakae/Y-3061-2019	Tanaka, Sakae/0000-0001-9210-9414				Almeida OP, 1999, INT J GERIATR PSYCH, V14, P858, DOI 10.1002/(SICI)1099-1166(199910)14:10<858::AID-GPS35>3.0.CO;2-8; Amundsen T, 2000, SPINE, V25, P1424, DOI 10.1097/00007632-200006010-00016; Athiviraham A, 2007, CLIN ORTHOP RELAT R, P90, DOI 10.1097/BLO.0b013e31803799a9; Atlas SJ, 2000, SPINE, V25, P556, DOI 10.1097/00007632-200003010-00005; Atlas SJ, 2005, SPINE, V30, P936, DOI 10.1097/01.brs.0000158953.57966.c0; Benoist M, 2002, JOINT BONE SPINE, V69, P450, DOI 10.1016/S1297-319X(02)00429-3; Bridwell KH, 2009, SPINE, V34, P2171, DOI 10.1097/BRS.0b013e3181a8fdc8; Everett CR, 2007, SPINE, V32, pS130, DOI 10.1097/BRS.0b013e318134ea88; Ishimoto Y, 2012, OSTEOARTHR CARTILAGE, V20, P1103, DOI 10.1016/j.joca.2012.06.018; JOHNSSON KE, 1991, SPINE, V16, P615, DOI 10.1097/00007632-199106000-00003; Katz JN, 2008, NEW ENGL J MED, V358, P818, DOI 10.1056/NEJMcp0708097; Kauppila LI, 2004, SPINE, V29, P2147, DOI 10.1097/01.brs.0000141168.77393.b8; Kobayashi S, 2004, J ORTHOP RES, V22, P170, DOI 10.1016/S0736-0266(03)00131-1; Kovacs FM, 2011, SPINE, V36, pE1335, DOI 10.1097/BRS.0b013e31820c97b1; Lotan R, 2008, J SPINAL DISORD TECH, V21, P247, DOI 10.1097/BSD.0b013e31813707af; Miyamoto H, 2008, J SPINAL DISORD TECH, V21, P563, DOI 10.1097/BSD.0b013e31815d896c; Munting E, 2015, EUR SPINE J, V24, P358, DOI 10.1007/s00586-014-3349-0; Ng LCL, 2007, EUR SPINE J, V16, P199, DOI 10.1007/s00586-006-0078-z; Rothoerl RD, 1998, BRIT J NEUROSURG, V12, P250; Siebert E, 2009, NAT REV NEUROL, V5, P392, DOI 10.1038/nrneurol.2009.90; Stucki G, 1996, SPINE, V21, P796, DOI 10.1097/00007632-199604010-00004; Uesugi K, 2013, SPINE, V38, pE540, DOI 10.1097/BRS.0b013e31828a2517; VERBIEST H, 1954, J BONE JOINT SURG BR, V36, P230, DOI 10.1302/0301-620X.36B2.230; Weinstein JN, 2007, NEW ENGL J MED, V356, P2257, DOI 10.1056/NEJMoa070302	24	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148584	10.1371/journal.pone.0148584	http://dx.doi.org/10.1371/journal.pone.0148584			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863214	Green Submitted, Green Published, gold			2022-12-27	WOS:000370046600083
J	Rosslau, K; Herholz, SC; Knief, A; Ortmann, M; Deuster, D; Schmidt, CM; Zehnhoff-Dinnesen, A; Pantev, C; Dobel, C				Rosslau, Ken; Herholz, Sibylle C.; Knief, Arne; Ortmann, Magdalene; Deuster, Dirk; Schmidt, Claus-Michael; Zehnhoff-Dinnesen, Antoinetteam; Pantev, Christo; Dobel, Christian			Song Perception by Professional Singers and Actors: An MEG Study	PLOS ONE			English	Article							AUDITORY-CORTEX; MUSICAL SYNTAX; LANGUAGE; BRAIN; SPEECH; MUSICIANS; IMAGERY; ERP; SEMANTICS; ATTENTION	The cortical correlates of speech and music perception are essentially overlapping, and the specific effects of different types of training on these networks remain unknown. We compared two groups of vocally trained professionals for music and speech, singers and actors, using recited and sung rhyme sequences from German art songs with semantic and/or prosodic/melodic violations (i.e. violations of pitch) of the last word, in order to measure the evoked activation in a magnetoencephalographic (MEG) experiment. MEG data confirmed the existence of intertwined networks for the sung and spoken modality in an early time window after word violation. In essence for this early response, higher activity was measured after melodic/prosodic than semantic violations in predominantly right temporal areas. For singers as well as for actors, modality-specific effects were evident in predominantly left-temporal lateralized activity after semantic expectancy violations in the spoken modality, and right-dominant temporal activity in response to melodic violations in the sung modality. As an indication of a special group-dependent audiation process, higher neuronal activity for singers appeared in a late time window in right temporal and left parietal areas, both after the recited and the sung sequences.	[Rosslau, Ken; Knief, Arne; Deuster, Dirk; Schmidt, Claus-Michael; Zehnhoff-Dinnesen, Antoinetteam] Univ Hosp Muenster, Dept Phoniatr & Pedaudiol, Munster, Germany; [Herholz, Sibylle C.; Ortmann, Magdalene; Pantev, Christo; Dobel, Christian] Univ Munster, Inst Biomagnetism & Biosignalanal, D-48149 Munster, Germany; [Herholz, Sibylle C.] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Ortmann, Magdalene] Univ Hosp Cologne, Jean Uhrmacher Inst Clin ENT Res, Cologne, Germany; [Dobel, Christian] Univ Jena, Dept Otorhinolaryngol, Jena, Germany	University of Munster; University of Munster; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Cologne; Friedrich Schiller University of Jena	Rosslau, K (corresponding author), Univ Hosp Muenster, Dept Phoniatr & Pedaudiol, Munster, Germany.	ken.rosslau@uni-muenster.de			Medical Faculty of the Westfalische-Wilhelms-University of Muenster; Deutsche Forschungsgemeinschaft [DO 711/7-1, HE6067/3-1, PA 392/12-2]; Open Access Publication Fund of University of Muenster	Medical Faculty of the Westfalische-Wilhelms-University of Muenster; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Fund of University of Muenster	Ken Rosslau is supported by the Deanery of the Medical Faculty of the Westfalische-Wilhelms-University of Muenster; Deutsche Forschungsgemeinschaft and Open Access Publication Fund of University of Muenster. Christian Dobel received support from Deutsche Forschungsgemeinschaft DO 711/7-1. Sibylle C. Herholz received support from Deutsche Forschungsgemeinschaft HE6067/3-1. Christo Pantev received support from Deutsche Forschungsgemeinschaft PA 392/12-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besson M, 2001, ANN NY ACAD SCI, V930, P232, DOI 10.1111/j.1749-6632.2001.tb05736.x; BESSON M, 1987, PSYCHOPHYSIOLOGY, V24, P14, DOI 10.1111/j.1469-8986.1987.tb01853.x; BESSON M, 1995, J EXP PSYCHOL HUMAN, V21, P1278, DOI 10.1037/0096-1523.21.6.1278; Bonnel AM, 2001, PERCEPT PSYCHOPHYS, V63, P1201, DOI 10.3758/BF03194534; Brodsky W, 2008, J EXP PSYCHOL HUMAN, V34, P427, DOI 10.1037/0096-1523.34.2.427; Brockelmann AK, 2011, J NEUROSCI, V31, P7801, DOI 10.1523/JNEUROSCI.6236-10.2011; Dick F, 2010, CEREB CORTEX; Dobel C, 2010, J COGNITIVE NEUROSCI, V22, P1251, DOI 10.1162/jocn.2009.21297; Friederici AD, 2003, NEUROIMAGE, V20, pS8, DOI 10.1016/j.neuroimage.2003.09.003; Gaab N, 2003, ANN NY ACAD SCI, V999, P385, DOI 10.1196/annals.1284.048; Geukes S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084029; Gordon EE, 1993, LEARING SEQUENCES MU; Gordon RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009889; Guenther FH, 2006, J COMMUN DISORD, V39, P350, DOI 10.1016/j.jcomdis.2006.06.013; Hagoort P, 2000, NEUROPSYCHOLOGIA, V38, P1518, DOI 10.1016/S0028-3932(00)00052-X; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Herholz SC, 2012, J COGNITIVE NEUROSCI, V24, P1382, DOI 10.1162/jocn_a_00216; Herholz SC, 2008, EUR J NEUROSCI, V28, P2352, DOI 10.1111/j.1460-9568.2008.06515.x; Hirschfeld G, 2011, BRAIN LANG, V116, P91, DOI 10.1016/j.bandl.2010.07.002; Hubbard TL, 2010, PSYCHOL BULL, V136, P302, DOI 10.1037/a0018436; Hyde KL, 2008, NEUROPSYCHOLOGIA, V46, P632, DOI 10.1016/j.neuropsychologia.2007.09.004; Jancke L, 2001, CEREB CORTEX, V11, P114, DOI 10.1093/cercor/11.2.114; Keuper K, 2012, HUM BRAIN MAPP; Kleber B, 2007, NEUROIMAGE, V36, P889, DOI 10.1016/j.neuroimage.2007.02.053; Kleber B, 2010, CEREB CORTEX, V20, P1144, DOI 10.1093/cercor/bhp177; Koelsch S, 2000, J COGNITIVE NEUROSCI, V12, P520, DOI 10.1162/089892900562183; Koelsch S, 2005, CURR OPIN NEUROBIOL, V15, P207, DOI 10.1016/j.conb.2005.03.005; Koelsch S, 2004, NAT NEUROSCI, V7, P302, DOI 10.1038/nn1197; Koelsch S, 2001, ANN NY ACAD SCI, V930, P420, DOI 10.1111/j.1749-6632.2001.tb05758.x; Koelsch S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00110; Kolinsky R, 2009, COGNITION, V112, P1, DOI 10.1016/j.cognition.2009.02.014; Kreitewolf J, 2014, NEUROIMAGE, V102, P332, DOI 10.1016/j.neuroimage.2014.07.038; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Lau EF, 2008, NAT REV NEUROSCI, V9, P920, DOI 10.1038/nrn2532; Maess B, 2001, NAT NEUROSCI, V4, P540, DOI 10.1038/87502; Maess B, 2006, BRAIN RES, V1096, P163, DOI 10.1016/j.brainres.2006.04.037; Moreno S, 2009, CEREB CORTEX, V19, P712, DOI 10.1093/cercor/bhn120; Mueller W, 1827, WINTERREISE, P1; Mueller W, 1823, DIE SCHONE MULLERIN, V1, p[4, 6824]; Patel AD, 1998, J COGNITIVE NEUROSCI, V10, P717, DOI 10.1162/089892998563121; Peretz I, 2009, ANN NY ACAD SCI, V1169, P256, DOI 10.1111/j.1749-6632.2009.04557.x; Peyk P, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/861705; Sammler D, 2009, ANN NY ACAD SCI, V1169, P494, DOI 10.1111/j.1749-6632.2009.04792.x; Sammler D, 2013, NEUROIMAGE, V64, P134, DOI 10.1016/j.neuroimage.2012.09.035; SAMSON S, 1994, NEUROPSYCHOLOGIA, V32, P231, DOI 10.1016/0028-3932(94)90008-6; Schneider S, 2007, J NEUROL, V254, P1339, DOI 10.1007/s00415-006-0523-2; Schon D, 2004, PSYCHOPHYSIOLOGY, V41, P341, DOI 10.1111/1469-8986.00172.x; Schon D, 2008, COGNITION, V106, P975, DOI 10.1016/j.cognition.2007.03.005; Schon D, 2005, ANN NY ACAD SCI, V1060, P71, DOI 10.1196/annals.1360.006; Schon D, 2010, NEUROIMAGE, V51, P450, DOI 10.1016/j.neuroimage.2010.02.023; Schulze K, 2010, HUM BRAIN MAPP; Steinbeis N, 2008, CEREB CORTEX, V18, P1169, DOI 10.1093/cercor/bhm149; Van Petten C, 2006, BRAIN LANG, V97, P279, DOI 10.1016/j.bandl.2005.11.003; Warren JD, 2006, NEUROIMAGE, V31, P1389, DOI 10.1016/j.neuroimage.2006.01.034; Warrier CM, 2004, BRAIN, V127, P1616, DOI 10.1093/brain/awh183; Wolters CH, 2004, P ANN INT IEEE EMBS, V26, P3569; Zarate JM, 2008, NEUROIMAGE, V40, P1871, DOI 10.1016/j.neuroimage.2008.01.026; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7; Zatorre Robert J, 2009, Ann N Y Acad Sci, V1169, P1, DOI 10.1111/j.1749-6632.2009.04794.x; Zatorre RJ, 2010, J COGNITIVE NEUROSCI, V22, P775, DOI 10.1162/jocn.2009.21239	61	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0147986	10.1371/journal.pone.0147986	http://dx.doi.org/10.1371/journal.pone.0147986			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6PR	26863437	Green Published, gold			2022-12-27	WOS:000370046600040
J	Wada, T; Mitsushio, T; Inoue, S; Koike, H; Kawabe, R				Wada, Toshifumi; Mitsushio, Takahiro; Inoue, Shinya; Koike, Hiroko; Kawabe, Ryo			Movement Patterns and Residency of the Critically Endangered Horseshoe Crab Tachypleus tridentatus in a Semi-Enclosed Bay Determined Using Acoustic Telemetry	PLOS ONE			English	Article							LIMULUS-POLYPHEMUS; CIRCADIAN-RHYTHMS; SEASONAL MOVEMENT; LOCOMOTION; CONSERVATION; TRACKING; BEHAVIOR; TURTLES; ESTUARY; USA	The horseshoe crab Tachypleus tridentatus is critically endangered in Japan due to rapidly decreasing numbers resulting from the loss of tidal flats and sandy beaches, and the deterioration of coastal environments. We monitored the year-round migratory patterns and residency of this species in a coastal embayment at Tsuyazaki, Japan, using acoustic telemetry. Total 20 adult crabs (15 males and 5 females) were tagged with ultrasonic transmitters and tracked during two periods (2006-2008; n = 10 and 2007-2009; n = 10). Adult crabs were more active during periods of higher water temperatures and their activity peaked in July, during the spawning period. Water temperature appeared to be one of the key factors influencing the movement patterns for the species. Moreover, the crabs tended to be more active at night than in the day. The nocturnal activity pattern was clearly evident before and during the reproductive period (May-August). Tracking data also showed that one pair-bond was maintained for a maximum of 17 days after the pair-bonded female had spawned. Overall, 11 males (73% of 15 individuals) remained in the bay area over winter, whereas three females (60% of 5 individuals) overwintered outside of the bay. Telemetry data showed that over 60% (13 of 20) of tagged crabs overwintered within the bay where there are sandy beaches, mudflats, and scattered seagrass beds. This year-round residence by adult T. tridentatus in the bay area identifies it as a critical habitat for the management of this species, regardless of life-stage. Not only is it a comprehensive management strategy that effectively reflects this species' habitat use patterns but also its implementation, such as the establishment of a protected area, would contribute to its conservation.	[Wada, Toshifumi] Univ Hyogo, Inst Nat & Environm Sci, Sanda, Hyogo, Japan; [Mitsushio, Takahiro] Fukuoka Prefectural Fisheries High Sch, Fukuoka, Japan; [Inoue, Shinya] Kyushu Technol Univ, Kitakyushu, Fukuoka, Japan; [Koike, Hiroko] Kyushu Univ, Grad Sch Social & Cultural Studies, Fukuoka 812, Japan; [Kawabe, Ryo] Nagasaki Univ, Grad Sch Fisheries & Environm Sci, Inst East China Sea Res, Nagasaki 852, Japan	University of Hyogo; Kyushu University; Nagasaki University	Wada, T (corresponding author), Univ Hyogo, Inst Nat & Environm Sci, Sanda, Hyogo, Japan.	wada@hitohaku.jp		Kawabe, Ryo/0000-0002-4030-6667	Mikimoto Fund for Marine Ecology	Mikimoto Fund for Marine Ecology(Mikimoto Fund for Marine Ecology)	This study was partially supported by the Mikimoto Fund for Marine Ecology. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARLOW RB, 1986, BIOL BULL, V171, P310, DOI 10.2307/1541674; BARLOW RB, 1983, J NEUROSCI, V3, P856; BJORNDAL KA, 1983, BIOL CONSERV, V26, P65, DOI 10.1016/0006-3207(83)90049-6; Black JM, 2001, BEHAV ECOL, V12, P640, DOI 10.1093/beheco/12.5.640; Bojorquez-Tapia LA, 2003, CONSERV BIOL, V17, P367, DOI 10.1046/j.1523-1739.2003.01309.x; Botton ML, 1996, ZOOL SCI, V13, P151, DOI 10.2108/zsj.13.151; Brousseau LJ, 2004, N AM J FISH MANAGE, V24, P1376, DOI 10.1577/1548-8675(2004)24<1376:AAROHC>2.0.CO;2; Casale P, 2012, AQUAT CONSERV, V22, P144, DOI 10.1002/aqc.2222; Chabot CC, 2004, BIOL BULL-US, V207, P72, DOI 10.2307/1543630; Chabot CC, 2008, BIOL BULL-US, V215, P34, DOI 10.2307/25470681; Chabot CC, 2011, MAR FRESHW BEHAV PHY, V44, P43, DOI 10.1080/10236244.2010.541992; Chabot CC, 2010, CURR ZOOL, V56, P499, DOI 10.1093/czoolo/56.5.499; Chen CP, 2004, BIODIVERS CONSERV, V13, P1889, DOI 10.1023/B:BIOC.0000035868.11083.84; Ens BJ, 1996, PARTNERSHIPS BIRDS S, P334; Fujioka K, 2010, FISHERIES SCI, V76, P403, DOI 10.1007/s12562-010-0228-4; Heupel MR, 2006, MAR FRESHWATER RES, V57, P1, DOI 10.1071/MF05091; Itow T, 1991, B MANAGE INFORM JOBU, V4, P29; James-Pirri MJ, 2010, CURR ZOOL, V56, P575, DOI 10.1093/czoolo/56.5.575; Kawahara D., 1982, AQUABIOLOGY KAIYOU S, V4, P380; Leese JM, 2012, ANIM BEHAV, V83, P1187, DOI 10.1016/j.anbehav.2012.02.009; Lillywhite HB, 2012, J ZOOL, V286, P194, DOI 10.1111/j.1469-7998.2011.00866.x; Maeda Kosaku, 2000, Japanese Journal of Benthology, V55, P15; Miller J.D., 1997, BIOL SEA TURTLES; Ministry of the Environment, 2006, THREAT WILDL JAP RED, V7; Ministry of the Environment, 2000, RED LIST THREAT WILD; Moore S, 2007, ESTUAR COAST, V30, P1016, DOI 10.1007/BF02841392; Murray SW, 2004, J ZOOL, V262, P197, DOI 10.1017/S0952836903004503; Nishida S, 2009, BIOLOGY AND CONSERVATION OF HORSESHOE CRABS, P183, DOI 10.1007/978-0-387-89959-6_11; Sanchez-Macouzet O, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2843; Schaller SY, 2010, CURR ZOOL, V56, P587, DOI 10.1093/czoolo/56.5.587; Seino S, 1995, BIOTELEMETRY, VXIII, P205; Seino S, 2000, ANN J HYDRAULIC ENG, V44, P1206; Seino S, 2000, CHIKYU MONTHLY, V29, P60; Seino S, 1999, P COASTAL ENG, V46, P1296; Sekiguchi K., 1988, BIOL HORSESHOE CRABS; Shin PKS, 2009, BIOLOGY AND CONSERVATION OF HORSESHOE CRABS, P347, DOI 10.1007/978-0-387-89959-6_22; Wada T, 2008, JPN J CONSERV ECOL, V13, P199; Wada T., 2010, JAPANESE J CONSERVAT, V15, P163; Watson WH, 2008, BIOL BULL-US, V215, P46, DOI 10.2307/25470682; Watson WH, 2010, CURR ZOOL, V56, P599, DOI 10.1093/czoolo/56.5.599; Zhou H, 2004, J NAT HIST, V38, P1915, DOI 10.1080/0022293031000155377	41	11	13	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0147429	10.1371/journal.pone.0147429	http://dx.doi.org/10.1371/journal.pone.0147429			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863205	Green Published, gold			2022-12-27	WOS:000370046600029
J	Zhao, Y; Li, MY; Zhao, J; Knorz, MC; Sun, L; Tian, M; Zhou, XT				Zhao, Yu; Li, Meiyan; Zhao, Jing; Knorz, Michael C.; Sun, Ling; Tian, Mi; Zhou, Xingtao			Posterior Corneal Elevation after Small Incision Lenticule Extraction for Moderate and High Myopia	PLOS ONE			English	Article							IN-SITU KERATOMILEUSIS; REFRACTIVE SURGERY; ORBSCAN-II; PHOTOREFRACTIVE KERATECTOMY; LASIK EYES; POST-LASIK; PENTACAM; SURFACE; THICKNESS; SMILE	Purpose To investigate the changes of posterior corneal elevation after small incision lenticule extraction (SMILE) for moderate and high myopia. Methods In this prospective study, fifty consecutive eyes of thirty patients (10 male, 20 female) who underwent SMILE for myopia and myopic astigmatism were included. Eyes were divided in two groups based on the preoperative spherical equivalent refraction: high myopia group (32 eyes, range -6.25D to -10.00D) and moderate myopia group (18 eyes, range -3.00D to -6.00D). Posterior corneal surfaces were measured by a Scheimpflug camera (Pentacam, Oculus Germany) preoperatively and 1 month, 3 months, 6 months and 12 months post-operatively. Posterior central elevation (PCE) and posterior mean elevation (PME) at 17 predetermined points in the central-4mm area above the best-fit sphere were analyzed. Results No significant difference in the amount of posterior corneal elevation changes in the high myopia group was noted over time (P = 0.23 and P = 0.94 for PCE and PME, respectively). Similarly, the changes in the moderate myopia group before and after SMILE were not significant either (P = 0.34 and P = 0.40 for PCE and PME). A statistically significant correlation was found between the residual bed thickness and the shift of the PCE in the high myopia group at 12 months postoperatively (r = 0.53, P = 0.01). Conclusions The results of this study suggest that the posterior corneal surface remain stable within one year after SMILE for both moderate and high myopia. The changes of PCE correlate to the residual bed thickness for high myopia. Long-term changes of posterior corneal surface need further investigation.	[Zhao, Yu; Li, Meiyan; Zhao, Jing; Sun, Ling; Tian, Mi; Zhou, Xingtao] Fudan Univ, Dept Ophthalmol, Eye & ENT Hosp, Myopia Key Lab,Hlth Minist, Shanghai 200433, Peoples R China; [Knorz, Michael C.] Heidelberg Univ, Med Fac Mannheim, Mannheim, Germany	Fudan University; Ruprecht Karls University Heidelberg	Zhou, XT (corresponding author), Fudan Univ, Dept Ophthalmol, Eye & ENT Hosp, Myopia Key Lab,Hlth Minist, Shanghai 200433, Peoples R China.	xingtaozhou@163.com	zhou, xt/GWZ-9212-2022		Key Project of Science and Technology of Shanghai [11JC1402000]; National Natural Science Foundation of China [81570879]; Outstanding Academic Leaders Program of Shanghai [XBR2013098]	Key Project of Science and Technology of Shanghai; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Academic Leaders Program of Shanghai	The work was supported by The Key Project of Science and Technology of Shanghai (Grant No. 11JC1402000), by the National Natural Science Foundation of China (Grant No. 81570879), and by the Outstanding Academic Leaders Program of Shanghai (Grant No. XBR2013098). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek TM, 2001, OPHTHALMOLOGY, V108, P317, DOI 10.1016/S0161-6420(00)00502-9; Belin Michael W., 1993, CLAO (Contact Lens Association of Ophthalmologists) Journal, V19, P64; Blum M, 2010, GRAEF ARCH CLIN EXP, V248, P1019, DOI 10.1007/s00417-009-1293-1; Chakrabarti HS, 2001, J CATARACT REFR SURG, V27, P1823, DOI 10.1016/S0886-3350(01)01089-6; Chen D, 2007, J CATARACT REFR SURG, V33, P448, DOI 10.1016/j.jcrs.2006.11.008; Ciolino JB, 2007, J CATARACT REFR SURG, V33, P1366, DOI 10.1016/j.jcrs.2007.04.016; Ciolino JB, 2006, J CATARACT REFR SURG, V32, P1426, DOI 10.1016/j.jcrs.2006.03.037; Dong ZX, 2014, BRIT J OPHTHALMOL, V98, P263, DOI 10.1136/bjophthalmol-2013-303415; Grewal DS, 2011, J REFRACT SURG, V27, P261, DOI 10.3928/1081597X-20100618-01; Ha BJ, 2009, J REFRACT SURG, V25, P290, DOI 10.3928/1081597X-20090301-09; Hashemi H, 2007, J CATARACT REFR SURG, V33, P841, DOI 10.1016/j.jcrs.2007.01.019; Khairat YM, 2013, CLIN OPHTHALMOL, V7, P1771, DOI 10.2147/OPTH.S48077; Kim H, 2006, OPHTHALMOLOGICA, V220, P37, DOI 10.1159/000089273; Kunert KS, 2015, KLIN MONATSBL AUGENH, V232, P67, DOI 10.1055/s-0034-1383053; Mihaltz K, 2009, CORNEA, V28, P976, DOI 10.1097/ICO.0b013e31819e34de; Modis L, 2001, CORNEA, V20, P711, DOI 10.1097/00003226-200110000-00008; Nilforoushan MR, 2008, J CATARACT REFR SURG, V34, P623, DOI 10.1016/j.jcrs.2007.11.054; Nishimura R, 2007, OPHTHALMOLOGY, V114, P1104, DOI 10.1016/j.ophtha.2006.09.014; Pallikaris IG, 2001, J CATARACT REFR SURG, V27, P1796, DOI 10.1016/S0886-3350(01)01090-2; Reinstein DZ, 2013, J REFRACT SURG, V29, P454, DOI 10.3928/1081597X-20130617-03; Riau AK, 2011, INVEST OPHTH VIS SCI, V52, P6213, DOI 10.1167/iovs.11-7439; Roy AS, 2014, J CATARACT REFR SURG, V40, P971, DOI 10.1016/j.jcrs.2013.08.065; Seiler T, 1998, J CATARACT REFR SURG, V24, P1007, DOI 10.1016/S0886-3350(98)80057-6; Sekundo W, 2014, GRAEF ARCH CLIN EXP, V252, P837, DOI 10.1007/s00417-014-2608-4; Sekundo W, 2011, BRIT J OPHTHALMOL, V95, P335, DOI 10.1136/bjo.2009.174284; Twa MD, 2005, J CATARACT REFR SURG, V31, P61, DOI 10.1016/j.jcrs.2004.09.032; Wang Z, 1999, OPHTHALMOLOGY, V106, P406, DOI 10.1016/S0161-6420(99)90083-0; Wu D, 2014, J CATARACT REFR SURG, V40, P954, DOI 10.1016/j.jcrs.2013.07.056; Yao PJ, 2013, J REFRACT SURG, V29, P669, DOI 10.3928/1081597X-20130806-01; Zhang L, 2010, INVEST OPHTH VIS SCI, V51, P3468, DOI 10.1167/iovs.09-4811	30	19	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148370	10.1371/journal.pone.0148370	http://dx.doi.org/10.1371/journal.pone.0148370			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863612	gold, Green Published, Green Submitted			2022-12-27	WOS:000370046600060
J	Feinauer, C; Szurmant, H; Weigt, M; Pagnani, A				Feinauer, Christoph; Szurmant, Hendrik; Weigt, Martin; Pagnani, Andrea			Inter-Protein Sequence Co-Evolution Predicts Known Physical Interactions in Bacterial Ribosomes and the Trp Operon	PLOS ONE			English	Article							STRUCTURAL BASIS; IDENTIFICATION; CONSERVATION; COMPLEXES; CONTACTS; SYNTHASE; ORDER	Interaction between proteins is a fundamental mechanism that underlies virtually all biological processes. Many important interactions are conserved across a large variety of species. The need to maintain interaction leads to a high degree of co-evolution between residues in the interface between partner proteins. The inference of protein-protein interaction networks from the rapidly growing sequence databases is one of the most formidable tasks in systems biology today. We propose here a novel approach based on the Direct-Coupling Analysis of the co-evolution between inter-protein residue pairs. We use ribosomal and trp operon proteins as test cases: For the small resp. large ribosomal subunit our approach predicts protein-interaction partners at a true-positive rate of 70% resp. 90% within the first 10 predictions, with areas of 0.69 resp. 0.81 under the ROC curves for all predictions. In the trp operon, it assigns the two largest interaction scores to the only two interactions experimentally known. On the level of residue interactions we show that for both the small and the large ribosomal subunit our approach predicts interacting residues in the system with a true positive rate of 60% and 85% in the first 20 predictions. We use artificial data to show that the performance of our approach depends crucially on the size of the joint multiple sequence alignments and analyze how many sequences would be necessary for a perfect prediction if the sequences were sampled from the same model that we use for prediction. Given the performance of our approach on the test data we speculate that it can be used to detect new interactions, especially in the light of the rapid growth of available sequence data.	[Feinauer, Christoph; Pagnani, Andrea] Politecn Torino, Dept Appl Sci & Technol, Turin, Italy; [Feinauer, Christoph; Pagnani, Andrea] Politecn Torino, Ctr Computat Sci, Turin, Italy; [Szurmant, Hendrik] Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Weigt, Martin] Univ Paris 04, UPMC, UMR 7238, Computat & Quantitat Biol, Paris, France; [Weigt, Martin] CNRS, UMR 7238, Computat & Quantitat Biol, Paris, France; [Pagnani, Andrea] Human Genet Fdn, Ctr Mol Biotechnol, Turin, Italy	Polytechnic University of Turin; Polytechnic University of Turin; Scripps Research Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Pagnani, A (corresponding author), Politecn Torino, Dept Appl Sci & Technol, Turin, Italy.; Pagnani, A (corresponding author), Politecn Torino, Ctr Computat Sci, Turin, Italy.; Weigt, M (corresponding author), Univ Paris 04, UPMC, UMR 7238, Computat & Quantitat Biol, Paris, France.; Weigt, M (corresponding author), CNRS, UMR 7238, Computat & Quantitat Biol, Paris, France.; Pagnani, A (corresponding author), Human Genet Fdn, Ctr Mol Biotechnol, Turin, Italy.	martin.weigt@upmc.fr; andrea.pagnani@polito.it	Feinauer, Christoph/AAU-3423-2021; Weigt, Martin/L-8851-2016; Pagnani, Andrea/J-2363-2015	Weigt, Martin/0000-0002-0492-3684; Pagnani, Andrea/0000-0002-6509-0807	EU Marie Curie Training Network NETADIS, (FP7 Grant) [290038]; US National Institute of General Medical Sciences, National Institutes of Health [GM106085, GM019416]; Agence Nationale de la Recherche project COEVSTAT [ANR-13-BS04-0012-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106085, R37GM019416, R01GM019416] Funding Source: NIH RePORTER	EU Marie Curie Training Network NETADIS, (FP7 Grant); US National Institute of General Medical Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Agence Nationale de la Recherche project COEVSTAT(French National Research Agency (ANR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Christoph Feinauer and Andrea Pagnani received financial support from EU Marie Curie Training Network NETADIS, (FP7 Grant 290038, http://cordis.europa.eu/fp7/home_en.html). Hendrik Szurmant received financial support from the US National Institute of General Medical Sciences, National Institutes of Health, grants GM106085 and GM019416 (http://www.nigms.nih.gov/Research/Pages/default.aspx). Martin Weigt received financial support from Agence Nationale de la Recherche project COEVSTAT (ANR-13-BS04-0012-01, http://www.agence-nationale-recherche.fr/en/anr-funded-project/?tx_lwmsuivibilan_pi2%5BCODE%5D=ANR-13-BS04-0012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CF and AP are supported from the EU Marie Curie Training Network NETADIS, (FP7 Grant 290038). HS was supported by grants GM106085 and GM019416 from the US National Institute of General Medical Sciences, National Institutes of Health. MW was supported by the Agence Nationale de la Recherche project COEVSTAT (ANR-13-BS04-0012-01). CF and AP acknowledge Riccardo Zecchina and Carlo Baldassi for many interesting discussions.	Altenhoff AM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002514; Balakrishnan S, 2011, PROTEINS, V79, P1061, DOI 10.1002/prot.22934; Baldassi C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092721; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Borovinskaya MA, 2007, NAT STRUCT MOL BIOL, V14, P727, DOI 10.1038/nsmb1271; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Burger L, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100203; Cheng RR, 2014, P NATL ACAD SCI USA, V111, pE563, DOI 10.1073/pnas.1323734111; Dago AE, 2012, P NATL ACAD SCI USA, V109, pE1733, DOI 10.1073/pnas.1201301109; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; de Juan D, 2013, NAT REV GENET, V14, P249, DOI 10.1038/nrg3414; Ekeberg M, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.012707; Feinauer C, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003847; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Galperin MY, 2000, NAT BIOTECHNOL, V18, P609, DOI 10.1038/76443; Harrington ED, 2008, FEBS LETT, V582, P1251, DOI 10.1016/j.febslet.2008.02.033; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hopf TA, 2014, ELIFE, V3, DOI 10.7554/eLife.03430; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Juan D, 2008, P NATL ACAD SCI USA, V105, P934, DOI 10.1073/pnas.0709671105; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Knochel T, 1999, P NATL ACAD SCI USA, V96, P9479, DOI 10.1073/pnas.96.17.9479; Lathe WC, 2000, TRENDS BIOCHEM SCI, V25, P474, DOI 10.1016/S0968-0004(00)01663-7; Marcotte Cynthia J Verjovsky, 2002, Appl Bioinformatics, V1, P93; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Nehrt NL, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002073; Ovchinnikov S, 2014, ELIFE, V3, DOI 10.7554/eLife.02030; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Pazos F, 2002, PROTEINS, V47, P219, DOI 10.1002/prot.10074; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Procaccini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019729; Rogozin IB, 2004, BRIEF BIOINFORM, V5, P131, DOI 10.1093/bib/5.2.131; Schug A, 2009, P NATL ACAD SCI USA, V106, P22124, DOI 10.1073/pnas.0912100106; Valencia A, 2002, CURR OPIN STRUC BIOL, V12, P368, DOI 10.1016/S0959-440X(02)00333-0; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; Weyand M, 2002, J BIOL CHEM, V277, P10647, DOI 10.1074/jbc.M111285200; WILMANNS M, 1992, J MOL BIOL, V223, P477, DOI 10.1016/0022-2836(92)90665-7; WLODAWER A, 1984, J MOL BIOL, V180, P301, DOI 10.1016/S0022-2836(84)80006-6; Yeang CH, 2007, PLOS COMPUT BIOL, V3, P2122, DOI 10.1371/journal.pcbi.0030211	40	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149166	10.1371/journal.pone.0149166	http://dx.doi.org/10.1371/journal.pone.0149166			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882169	Green Published, Green Submitted, gold			2022-12-27	WOS:000371219000052
J	Andersen, MM; Thisted, DLA; Amer-Wahlin, I; Krebs, L				Andersen, Malene M.; Thisted, Dorthe L. A.; Amer-Wahlin, Isis; Krebs, Lone		Danish CTG Monitoring VBAC Study	Can Intrapartum Cardiotocography Predict Uterine Rupture among Women with Prior Caesarean Delivery?: A Population Based Case-Control Study	PLOS ONE			English	Article							FETAL HEART-RATE; RATE TRACINGS; LABOR; PATTERNS; TRIAL; FORM	Objective To compare cardiotocographic abnormalities recorded during labour in women with prior caesarean delivery (CD) and complete uterine rupture with those recorded in controls with prior CD without uterine rupture. Study Design Women with complete uterine rupture during labour between 1997 and 2008 were identified in the Danish Medical Birth Registry (n = 181). Cases were validated by review of medical records and 53 cases with prior CD, trial of labour, available cardiotocogram (CTG) and complete uterine rupture were included and compared with 43 controls with prior CD, trial of labour and available CTG. The CTG tracings were assessed by 19 independent experts divided into groups of three different experts for each tracing. The assessors were blinded to group, outcome and clinical data. They analyzed occurrence of defined abnormalities and classified the traces as normal, suspicious, pathological or pre-terminal according to international guidelines (FIGO). Results A pathological CTG during the first stage of labour was present in 77% of cases and in 53% of the controls (OR 2.58 [CI: 0.96-6.94] P = 0.066). Fetal tachycardia was more frequent in cases with uterine rupture (OR 2.50 [CI: 1.0-6.26] P = 0.053). Significantly more cases showed more than 10 severe variable decelerations compared with controls (OR 22 [ CI: 1.54-314.2] P = 0.022). Uterine tachysystole was not correlated with the presence of uterine rupture. Conclusion A pathological cardiotocogram should lead to particular attention on threatening uterine rupture but cannot be considered a strong predictor as it is common in all women with trial of labour after caesarean delivery.	[Andersen, Malene M.; Thisted, Dorthe L. A.; Krebs, Lone] Univ Copenhagen, Holbaek Hosp, Dept Obstet & Gynaecol, Holbaek, Denmark; [Thisted, Dorthe L. A.] Univ Copenhagen, Hvidovre Hosp, Dept Obstet & Gynecol, DK-2650 Hvidovre, Denmark; [Amer-Wahlin, Isis] Karolinska Inst, Dept Women & Child Hlth, Stockholm, Sweden	Holbaek Hospital; University of Copenhagen; University of Copenhagen; Karolinska Institutet	Andersen, MM (corresponding author), Univ Copenhagen, Holbaek Hosp, Dept Obstet & Gynaecol, Holbaek, Denmark.	malenemie@yahoo.com	Krebs, Lone/AAD-8273-2021	Krebs, Lone/0000-0001-5433-4776	Regional Research Unit in Holbaek Sygehus	Regional Research Unit in Holbaek Sygehus	MA received a 3 month scholarship from the Regional Research Unit in Holbaek Sygehus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfirevic Z, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006066; Amer-Wahlin I, 2011, ACTA OBSTET GYN SCAN, V90, P990, DOI 10.1111/j.1600-0412.2011.01203.x; American College of Obstetricians and Gynecologists, 2010, OBSTET GYNECOL 1, V116, P450; Ayres AW, 2001, INT J GYNECOL OBSTET, V74, P235, DOI 10.1016/S0020-7292(01)00445-3; Ayres-de-Campos D, 2011, BJOG-INT J OBSTET GY, V118, P978, DOI 10.1111/j.1471-0528.2011.03003.x; Pryor EC, 2007, AM J PERINAT, V24, P317, DOI 10.1055/s-2007-981433; Doria V, 2007, BJOG-INT J OBSTET GY, V114, P1202, DOI 10.1111/j.1471-0528.2007.01480.x; Guiliano M, 2014, EUR J OBSTET GYN R B, V179, P130, DOI 10.1016/j.ejogrb.2014.05.004; Lydon-Rochelle M, 2001, NEW ENGL J MED, V345, P3, DOI 10.1056/NEJM200107053450101; Patel RM, 2010, SEMIN PERINATOL, V34, P272, DOI 10.1053/j.semperi.2010.03.007; Phelan JP, 1998, OBSTET GYNECOL, V92, P394, DOI 10.1016/S0029-7844(98)00232-4; Ridgeway JJ, 2004, OBSTET GYNECOL, V103, P506, DOI 10.1097/01.AOG.0000113619.67704.99; Santo S, 2012, CURR OPIN OBSTET GYN, V24, P84, DOI 10.1097/GCO.0b013e3283505b3c; Schiermeier S, 2008, BJOG-INT J OBSTET GY, V115, P1557, DOI 10.1111/j.1471-0528.2008.01857.x; Scott JR, 2014, BJOG-INT J OBSTET GY, V121, P157, DOI 10.1111/1471-0528.12449; Sheiner E, 2004, J REPROD MED, V49, P373; Thisted DLA, 2014, EUR J OBSTET GYN R B, V173, P23, DOI 10.1016/j.ejogrb.2013.10.033	17	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0146347	10.1371/journal.pone.0146347	http://dx.doi.org/10.1371/journal.pone.0146347			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872018	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100001
J	Chan, KF; Wong, PY; Yu, P; Hardick, J; Wong, KY; Wilson, SA; Wu, T; Hui, Z; Gaydos, C; Wong, SS				Chan, Kamfai; Wong, Pui-Yan; Yu, Peter; Hardick, Justin; Wong, Kah-Yat; Wilson, Scott A.; Wu, Tiffany; Hui, Zoe; Gaydos, Charlotte; Wong, Season S.			A Rapid and Low-Cost PCR Thermal Cycler for Infectious Disease Diagnostics	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; REAL-TIME PCR; REACTION AMPLIFICATION; MICROFLUIDIC DEVICES; SAMPLE PREPARATION; DNA AMPLIFICATION; ESCHERICHIA-COLI; RT-PCR; CHIP; FUTURE	The ability to make rapid diagnosis of infectious diseases broadly available in a portable, low-cost format would mark a great step forward in global health. Many molecular diagnostic assays are developed based on using thermal cyclers to carry out polymerase chain reaction (PCR) and reverse-transcription PCR for DNA and RNA amplification and detection, respectively. Unfortunately, most commercial thermal cyclers are expensive and need continuous electrical power supply, so they are not suitable for uses in low-resource settings. We have previously reported a low-cost and simple approach to amplify DNA using vacuum insulated stainless steel thermoses food cans, which we have named it thermos thermal cycler or TTC. Here, we describe the use of an improved set up to enable the detection of viral RNA targets by reverse-transcription PCR (RT-PCR), thus expanding the TTC's ability to identify highly infectious, RNA virus-based diseases in low resource settings. The TTC was successful in demonstrating high-speed and sensitive detection of DNA or RNA targets of sexually transmitted diseases, HIV/AIDS, Ebola hemorrhagic fever, and dengue fever. Our innovative TTC costs less than $200 to build and has a capacity of at least eight tubes. In terms of speed, the TTC's performance exceeded that of commercial thermal cyclers tested. When coupled with low-cost endpoint detection technologies such as nucleic acid lateral-flow assay or a cell-phone-based fluorescence detector, the TTC will increase the availability of on-site molecular diagnostics in low-resource settings.	[Chan, Kamfai; Wong, Pui-Yan; Yu, Peter; Wong, Kah-Yat; Wilson, Scott A.; Wu, Tiffany; Hui, Zoe; Wong, Season S.] AI Biosci Inc, College Stn, TX USA; [Hardick, Justin; Gaydos, Charlotte] Johns Hopkins Univ, Dept Med, Baltimore, MD USA	Johns Hopkins University	Wong, SS (corresponding author), AI Biosci Inc, College Stn, TX USA.	season.wong@aibiosciences.com	Gaydos, Charlotte A./E-9937-2010		Small Business Innovative Research (SBIR) from US National Institutes of Health [1R43AI106239, 1R43AI107984]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI106239, R43AI107984] Funding Source: NIH RePORTER	Small Business Innovative Research (SBIR) from US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by Small Business Innovative Research (SBIR) grants from the US National Institutes of Health, Grant #s 1R43AI106239 and 1R43AI107984. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Belgrader P, 2003, ANAL CHEM, V75, P3446, DOI 10.1021/ac034062u; Brooks HA, 2005, J VIROL METHODS, V127, P109, DOI 10.1016/j.jviromet.2005.03.017; Butler D, 2006, NATURE, V440, P6, DOI 10.1038/440006a; Chen ZY, 2004, ANAL CHEM, V76, P3707, DOI 10.1021/ac049914k; Cheng JY, 2005, ANALYST, V130, P931, DOI 10.1039/b501061f; Chin CD, 2007, LAB CHIP, V7, P41, DOI 10.1039/b611455e; Chiou J, 2001, ANAL CHEM, V73, P2018, DOI 10.1021/ac001227f; Elenitoba-Johnson O, 2008, BIOTECHNIQUES, V44, P487, DOI 10.2144/000112722; Farrar JS, 2015, CLIN CHEM, V61, P145, DOI 10.1373/clinchem.2014.228304; Frey O, 2007, BIOMED MICRODEVICES, V9, P711, DOI 10.1007/s10544-007-9080-4; Hennig M, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2051787; Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005; Khandurina J, 2000, ANAL CHEM, V72, P2995, DOI 10.1021/ac991471a; King DA, 2006, SCIENCE, V313, P1392, DOI 10.1126/science.1129134; Kopp MU, 1998, SCIENCE, V280, P1046, DOI 10.1126/science.280.5366.1046; Lin MH, 2001, CLIN BIOCHEM, V34, P661, DOI 10.1016/S0009-9120(01)00281-8; Liu P, 2007, ANAL CHEM, V79, P1881, DOI 10.1021/ac061961k; Liu RH, 2004, ANAL CHEM, V76, P1824, DOI 10.1021/ac0353029; Logan J., 2009, REAL TIME PCR CURREN; Lu XY, 2014, J CLIN MICROBIOL, V52, P67, DOI 10.1128/JCM.02533-13; MANNUCCI A, 1994, INT J LEGAL MED, V106, P190, DOI 10.1007/BF01371335; Nachamkin I, 1997, CLIN INFECT DIS, V24, P894, DOI 10.1093/clinids/24.5.894; Noble RT, 2010, APPL ENVIRON MICROB, V76, P7437, DOI 10.1128/AEM.00651-10; Obeid PJ, 2003, ANAL CHEM, V75, P288, DOI 10.1021/ac0260239; Oda RP, 1998, ANAL CHEM, V70, P4361, DOI 10.1021/ac980452i; Oh MH, 2009, J FOOD PROTECT, V72, P1262, DOI 10.4315/0362-028X-72.6.1262; Pipper J, 2008, ANGEW CHEM INT EDIT, V47, P3900, DOI 10.1002/anie.200705016; Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311; Sauer S, 2005, NAT REV GENET, V6, P465, DOI 10.1038/nrg1618; Syvanen AC, 2005, NAT GENET, V37, pS5, DOI 10.1038/ng1558; Walker FM, 2014, ANAL CHEM, V86, P9236, DOI 10.1021/ac5022419; Wang H, 2006, ANAL CHEM, V78, P6223, DOI 10.1021/ac060568b; WEISSENSTEINER T, 2004, PCR TECHNOLOGY CURRE; Wheeler EK, 2004, ANAL CHEM, V76, P4011, DOI 10.1021/ac034941g; WITTWER CT, 1989, NUCLEIC ACIDS RES, V17, P4353, DOI 10.1093/nar/17.11.4353; Wong G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131701; Xiang Q, 2005, BIOMED MICRODEVICES, V7, P273, DOI 10.1007/s10544-005-6069-8; Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064; Yang S, 2004, LANCET INFECT DIS, V4, P337, DOI 10.1016/S1473-3099(04)01044-8; Yu CY, 2007, J CHIN INST CHEM ENG, V38, P333, DOI 10.1016/j.jcice.2007.05.001; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhang CS, 2006, BIOTECHNOL ADV, V24, P243, DOI 10.1016/j.biotechadv.2005.10.002; [No title captured]	43	16	17	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149150	10.1371/journal.pone.0149150	http://dx.doi.org/10.1371/journal.pone.0149150			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872358	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100112
J	Damij, N; Boskoski, P; Bohanec, M; Boshkoska, BM				Damij, Nadja; Boskoski, Pavle; Bohanec, Marko; Boshkoska, Biljana Mileva			Ranking of Business Process Simulation Software Tools with DEX/QQ Hierarchical Decision Model	PLOS ONE			English	Article							PRODUCT	The omnipresent need for optimisation requires constant improvements of companies' business processes (BPs). Minimising the risk of inappropriate BP being implemented is usually performed by simulating the newly developed BP under various initial conditions and "what-if" scenarios. An effectual business process simulations software (BPSS) is a prerequisite for accurate analysis of an BP. Characterisation of an BPSS tool is a challenging task due to the complex selection criteria that includes quality of visual aspects, simulation capabilities, statistical facilities, quality reporting etc. Under such circumstances, making an optimal decision is challenging. Therefore, various decision support models are employed aiding the BPSS tool selection. The currently established decision support models are either proprietary or comprise only a limited subset of criteria, which affects their accuracy. Addressing this issue, this paper proposes a new hierarchical decision support model for ranking of BPSS based on their technical characteristics by employing DEX and qualitative to quantitative (QQ) methodology. Consequently, the decision expert feeds the required information in a systematic and user friendly manner. There are three significant contributions of the proposed approach. Firstly, the proposed hierarchical model is easily extendible for adding new criteria in the hierarchical structure. Secondly, a fully operational decision support system (DSS) tool that implements the proposed hierarchical model is presented. Finally, the effectiveness of the proposed hierarchical model is assessed by comparing the resulting rankings of BPSS with respect to currently available results.	[Damij, Nadja; Boshkoska, Biljana Mileva] Fac Informat Studies, Ulica Talcev 8, Novo Mesto, Slovenia; [Boskoski, Pavle] Jozef Stefan Inst, Dept Syst & Control, Jamova Cesta 39, Ljubljana, Slovenia; [Bohanec, Marko; Boshkoska, Biljana Mileva] Jozef Stefan Inst, Dept Knowledge Technol, Jamova Cesta 39, Ljubljana, Slovenia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Boshkoska, BM (corresponding author), Fac Informat Studies, Ulica Talcev 8, Novo Mesto, Slovenia.; Boshkoska, BM (corresponding author), Jozef Stefan Inst, Dept Knowledge Technol, Jamova Cesta 39, Ljubljana, Slovenia.	biljana.mileva@fis.unm.si	Boshkoska, Biljana Mileva/N-6298-2015; Bohanec, Marko/P-3523-2019	Boshkoska, Biljana Mileva/0000-0002-1137-9795; 	Slovenian Research Agency [P1-0383, J1-5454]; Creative Core "Simulations'' project - European Union [FISNM-3330-13-500033]; European Regional Development Fund	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Creative Core "Simulations'' project - European Union; European Regional Development Fund(European Commission)	The authors acknowledge the support of the Slovenian Research Agency through Research Programme P1-0383, and Research Project J1-5454. The work was also supported by the Creative Core FISNM-3330-13-500033 "Simulations'' project funded by the European Union, the European Regional Development Fund.	Azadeh A, 2010, INT J ADV MANUF TECH, V47, P381, DOI 10.1007/s00170-009-2205-6; Bana E Costa CA, 1999, MATH MODEL-THEOR APP, V4, P131; Baracskai Z, 2003, INT C COMP CYB SIOF; BOHANEC M, 1992, ACTA PSYCHOL, V80, P67, DOI 10.1016/0001-6918(92)90041-B; Bohanec M., 1990, SISTEMICA, V145; Bohanec M., 23 INT C MULT CRIT D, P215; Bohanec M., 2015, DP11897 IJS; Boshkoska BM., 2013, QUALITATIVE QUANTITA; Bosilj-Vuksic V., 2007, INTERDISCIPL J INF K, V2, P73, DOI [10.28945/101, DOI 10.28945/101]; Changyun L, 2012, INT DISC, P1; Damij N, 2014, PROGR IN IS; Damij N, 2008, INFORM SOFTWARE TECH, V50, P1127, DOI 10.1016/j.infsof.2007.11.004; Ding S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097762; Greco S, 2001, EUR J OPER RES, V129, P1, DOI 10.1016/S0377-2217(00)00167-3; Jacquet-Lagreze E, 2001, EUR J OPER RES, V130, P233, DOI 10.1016/S0377-2217(00)00035-7; Jadhav AS, 2009, INFORM SOFTWARE TECH, V51, P555, DOI 10.1016/j.infsof.2008.09.003; Jahangirian M, 2010, EUR J OPER RES, V203, P1, DOI 10.1016/j.ejor.2009.06.004; Jansen-Vullers M, 2006, WORKSH TUT PRACT US; Kaschek R, 2007, TECHNOLOGIES BUSINES, P25; Kellner MI, 1999, J SYST SOFTWARE, V46, P91, DOI 10.1016/S0164-1212(99)00003-5; Laguna M, 2005, BUSINESS PROCESS MOD; Larichev OI, 2001, EUR J OPER RES, V131, P550, DOI 10.1016/S0377-2217(00)00096-5; Lin HY, 2007, EXPERT SYST APPL, V32, P939, DOI 10.1016/j.eswa.2006.01.031; Norton D, 2010, MAGIC QUADRANT BUSIN; Patig S, 2013, INFORM SOFTWARE TECH, V55, P58, DOI 10.1016/j.infsof.2012.07.002; Pidd M, 2006, J SIMUL, V1, P7, DOI 10.1057/palgrave.jos.4250004; Rucker B, 2008, BUILDING OPEN SOURCE; Saven RS, 2003, INT FED INFO PROC, V129, P375; Sinur J, 2010, MAGIC QUADRANT BUSIN; Tuzun E, 2015, INFORM SOFTWARE TECH, V60, P77, DOI 10.1016/j.infsof.2014.12.007	30	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148391	10.1371/journal.pone.0148391	http://dx.doi.org/10.1371/journal.pone.0148391			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871694	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000370054100026
J	Feng, YF; Hodiamont, CJ; van Hest, RM; Brul, S; Schultsz, C; ter Kuile, BH				Feng, Yanfang; Hodiamont, Caspar J.; van Hest, Reinier M.; Brul, Stanley; Schultsz, Constance; ter Kuile, Benno H.			Development of Antibiotic Resistance during Simulated Treatment of Pseudomonas aeruginosa in Chemostats	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; ANTIMICROBIAL RESISTANCE; THERAPY; CEFTAZIDIME; MUTATIONS; MEROPENEM; SURVIVAL; IMPACT; COSTS	During treatment of infections with antibiotics in critically ill patients in the intensive care resistance often develops. This study aims to establish whether under those conditions this resistance can develop de novo or that genetic exchange between bacteria is by necessity involved. Chemostat cultures of Pseudomonas aeruginosa were exposed to treatment regimes with ceftazidime and meropenem that simulated conditions expected in patient plasma. Development of antibiotic resistance was monitored and mutations in resistance genes were searched for by sequencing PCR products. Even at the highest concentrations that can be expected in patients, sufficient bacteria survived in clumps of filamentous cells to recover and grow out after 3 to 5 days. At the end of a 7 days simulated treatment, the minimal inhibitory concentration (MIC) had increased by a factor between 10 and 10,000 depending on the antibiotic and the treatment protocol. The fitness costs of resistance were minimal. In the resistant strains, only three mutations were observed in genes associated with beta-lactam resistance. The development of resistance often observed during patient treatment can be explained by de novo acquisition of resistance and genetic exchange of resistance genes is not by necessity involved. As far as conclusions based on an in vitro study using P. aeruginosa and only two antibiotics can be generalized, it seems that development of resistance can be minimized by treating with antibiotics in the highest concentration the patient can endure for the shortest time needed to eliminate the infection.	[Feng, Yanfang; Brul, Stanley; ter Kuile, Benno H.] Univ Amsterdam, Swammerdam Inst Life Sci, Dept Mol Biol & Microbial Food Safety, Amsterdam, Netherlands; [Hodiamont, Caspar J.; Schultsz, Constance] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [van Hest, Reinier M.] Univ Amsterdam, Acad Med Ctr, Dept Hosp Pharm & Clin Pharmacol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Schultsz, Constance] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, Dept Global Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [ter Kuile, Benno H.] Netherlands Food & Consumer Prod Safety Author, Off Risk Assessment & Res Coordinat, Utrecht, Netherlands	University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	ter Kuile, BH (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Dept Mol Biol & Microbial Food Safety, Amsterdam, Netherlands.; ter Kuile, BH (corresponding author), Netherlands Food & Consumer Prod Safety Author, Off Risk Assessment & Res Coordinat, Utrecht, Netherlands.	B.H.terKuile@uva.nl	Kuile, Benno Ter/AAD-1699-2021	van Hest, Reinier/0000-0002-2506-8795	Netherlands Food and Consumer Product Safety Authority; Chinese Research Council	Netherlands Food and Consumer Product Safety Authority; Chinese Research Council	This project was funded by The Netherlands Food and Consumer Product Safety Authority. Yanfang Feng received a scholarship from the Chinese Research Council.	Andersson DI, 2006, CURR OPIN MICROBIOL, V9, P461, DOI 10.1016/j.mib.2006.07.002; Sanchez-Romero MA, 2014, P NATL ACAD SCI USA, V111, P355, DOI 10.1073/pnas.1316084111; Benko AS, 1996, ANTIMICROB AGENTS CH, V40, P691, DOI 10.1128/AAC.40.3.691; Berthoin K, 2010, J ANTIMICROB CHEMOTH, V65, P1073, DOI 10.1093/jac/dkq044; Blot S, 2003, J HOSP INFECT, V53, P18, DOI 10.1053/jhin.2002.1329; Bos J, 2015, P NATL ACAD SCI USA, V112, P178, DOI 10.1073/pnas.1420702111; Brusselaers N, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-47; Coward C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004359; Delattre IK, 2012, CLIN BIOCHEM, V45, P780, DOI 10.1016/j.clinbiochem.2012.03.030; Drlica K, 2007, CLIN INFECT DIS, V44, P681, DOI 10.1086/511642; Feng YF, 2014, ANTIBIOTICS-BASEL, V3, P49, DOI 10.3390/antibiotics3010049; Fernandez L, 2011, DRUG RESIST UPDATE, V14, P1, DOI 10.1016/j.drup.2011.01.001; Fish DN, 2006, CRIT CARE CLIN, V22, P291, DOI 10.1016/j.ccc.2006.02.006; Gaieski DF, 2010, CRIT CARE MED, V38, P1045, DOI 10.1097/CCM.0b013e3181cc4824; Garnacho-Montero J, 2003, CRIT CARE MED, V31, P2742, DOI 10.1097/01.CCM.0000098031.24329.10; Handel N, 2014, ANTIMICROB AGENTS CH, V58, P4371, DOI 10.1128/AAC.02892-14; Handel N, 2013, ANTIMICROB AGENTS CH, V57, P3752, DOI 10.1128/AAC.02096-12; Henrichfreise B, 2007, ANTIMICROB AGENTS CH, V51, P3642, DOI 10.1128/AAC.00160-07; Hoiby N, 2001, MICROBES INFECT, V3, P23, DOI 10.1016/S1286-4579(00)01349-6; Jin L, 2012, ANTIMICROB AGENTS CH, V56, P5240, DOI 10.1128/AAC.00713-12; Justice SS, 2008, NAT REV MICROBIOL, V6, P162, DOI 10.1038/nrmicro1820; Kollef MH, 2001, CRIT CARE, V5, P189, DOI 10.1186/cc1022; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Martinez JL, 2000, ANTIMICROB AGENTS CH, V44, P1771, DOI 10.1128/AAC.44.7.1771-1777.2000; Melnyk AH, 2015, EVOL APPL, V8, P273, DOI 10.1111/eva.12196; Mogre A, 2014, DNA RES, V21, P711, DOI 10.1093/dnares/dsu032; Oz T, 2014, MOL BIOL EVOL, V31, P2387, DOI 10.1093/molbev/msu191; Roberts JA, 2008, CRIT CARE MED, V36, P2433, DOI 10.1097/CCM.0b013e318180fe62; Schuurmans JM, 2009, J MICROBIOL METH, V79, P44, DOI 10.1016/j.mimet.2009.07.017; Singh R, 2012, ANTIMICROB AGENTS CH, V56, P1680, DOI 10.1128/AAC.05693-11; Smith Susan V, 2004, Expert Rev Anti Infect Ther, V2, P227, DOI 10.1586/14787210.2.2.227; Toprak E, 2012, NAT GENET, V44, P101, DOI 10.1038/ng.1034; van der Horst MA, 2011, MICROB DRUG RESIST, V17, P141, DOI 10.1089/mdr.2010.0101; Vega NM, 2014, CURR OPIN MICROBIOL, V21, P28, DOI 10.1016/j.mib.2014.09.003	35	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149310	10.1371/journal.pone.0149310	http://dx.doi.org/10.1371/journal.pone.0149310			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872140	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100146
J	Huson, MAM; Scicluna, BP; van Vught, LA; Wiewel, MA; Hoogendijk, AJ; Cremer, OL; Bonten, MJM; Schultz, MJ; Franitza, M; Toliat, MR; Nurnberg, P; Grobusch, MP; van der Poll, T				Huson, Michaela A. M.; Scicluna, Brendon P.; van Vught, Lonneke A.; Wiewel, Maryse A.; Hoogendijk, Arie J.; Cremer, Olaf L.; Bonten, Marc J. M.; Schultz, Marcus J.; Franitza, Marek; Toliat, Mohammad R.; Nuernberg, Peter; Grobusch, Martin P.; van der Poll, Tom			The Impact of HIV Co-Infection on the Genomic Response to Sepsis	PLOS ONE			English	Article							GENE-EXPRESSION; HOST RESPONSE; SEPTIC SHOCK; INFECTIONS; CARE; DEFINITIONS; BIOMARKER	HIV patients have an increased risk to develop sepsis and HIV infection affects several components of the immune system involved in sepsis pathogenesis. We hypothesized that HIV infection might aggrevate the aberrant immune response during sepsis, so we aimed to determine the impact of HIV infection on the genomic host response to sepsis. We compared whole blood leukocyte gene expression profiles among sepsis patients with or without HIV co-infection in the intensive care unit (ICU) and validated our findings in a cohort of patients admitted to the same ICUs in a different time frame. To examine the influence of HIV infection per se, we also determined the expression of genes of interest in a cohort of asymptomatic HIV patients. We identified a predominantly common host response in sepsis patients with or without HIV co-infection. HIV positive sepsis patients in both ICU cohorts showed overexpression of genes involved in granzyme signaling (GZMA, GZMB), cytotoxic T-cell signaling (CD8A, CD8B) and T-cell inhibitory signaling (LAG3), compared to HIV negative patients. Enhanced expression of CD8A, CD8B and LAG3 was also unmasked in asymptomatic HIV patients. Plasma levels of granzymes in sepsis patients were largely below detection limit, without differences according to HIV status. These results demonstrate that sepsis is characterized by a massive common response with few differences between HIV positive and HIV negative sepsis patients. Observed differences in granzyme signaling, cytotoxic T-cell signaling and T-cell inhibitory signaling appear to be changes commonly observed in asymptomatic HIV patients which persist during sepsis.	[Huson, Michaela A. M.; Scicluna, Brendon P.; van Vught, Lonneke A.; Wiewel, Maryse A.; Hoogendijk, Arie J.; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Huson, Michaela A. M.; Grobusch, Martin P.] Ctr Rech Med Lambarene, Lambarene, Gabon; [Cremer, Olaf L.] Univ Med Ctr Utrecht, Dept Intens Care Med, Utrecht, Netherlands; [Bonten, Marc J. M.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Bonten, Marc J. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, Dept Intens Care, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Franitza, Marek; Toliat, Mohammad R.; Nuernberg, Peter] Univ Cologne, CCG, D-50931 Cologne, Germany; [Franitza, Marek; Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Nuernberg, Peter] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Grobusch, Martin P.] Univ Amsterdam, Acad Med Ctr, Ctr Trop Med & Travel Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Grobusch, Martin P.; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Div Infect Dis, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Amsterdam; University of Cologne; University of Cologne; University of Cologne; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Huson, MAM (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.; Huson, MAM (corresponding author), Ctr Rech Med Lambarene, Lambarene, Gabon.	m.a.huson@amc.uva.nl	Cremer, Olaf L/G-3855-2016; Schultz, Marcus/AAB-6379-2021; Scicluna, Brendon/T-8112-2018	Cremer, Olaf L/0000-0003-4264-1108; Schultz, Marcus/0000-0003-3969-7792; Scicluna, Brendon/0000-0003-2826-0341	CTMM, the Center for Translational Molecular Medicine, project MARS [04I-201]	CTMM, the Center for Translational Molecular Medicine, project MARS	This research was performed within the framework of CTMM, the Center for Translational Molecular Medicine (www.ctmm.nl), project MARS (grant 04I-201).	Amancio RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068730; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Calandra T, 2005, CRIT CARE MED, V33, P1538, DOI 10.1097/01.CCM.0000168253.91200.83; Chiang HH, 2011, CRIT CARE, V15, DOI 10.1186/cc10419; Ewen CL, 2012, CELL DEATH DIFFER, V19, P28, DOI 10.1038/cdd.2011.153; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gekonge B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041153; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Huson MAM, 2015, J INFECT DIS, V212, P474, DOI 10.1093/infdis/jiv074; Huson MAM, 2015, LANCET INFECT DIS, V15, P95, DOI 10.1016/S1473-3099(14)70917-X; Huson MAM, 2014, CLIN INFECT DIS, V58, P79, DOI 10.1093/cid/cit596; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Khaitan Alka, 2011, Curr HIV/AIDS Rep, V8, P4, DOI 10.1007/s11904-010-0066-0; Klouwenberg PMCK, 2013, CRIT CARE MED, V41, P2373, DOI 10.1097/CCM.0b013e3182923712; Larsson M, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-31; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Lieberman J, 2003, NAT REV IMMUNOL, V3, P361, DOI 10.1038/nri1083; Mankhambo LA, 2010, CRIT CARE, V14, DOI 10.1186/cc9025; Parlato M, 2015, METHODS MOL BIOL, V1237, P149, DOI 10.1007/978-1-4939-1776-1_15; Rosenberg AL, 2001, CRIT CARE MED, V29, P548, DOI 10.1097/00003246-200103000-00013; Ruijter JM, 2013, METHODS, V59, P32, DOI 10.1016/j.ymeth.2012.08.011; Scicluna BP, 2015, AM J RESP CRIT CARE, V192, P826, DOI 10.1164/rccm.201502-0355OC; Silva JM, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17344; Smith PR, 2000, J CLIN PATHOL, V53, P177, DOI 10.1136/jcp.53.3.177; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Spaeny-Dekking EHA, 1998, J IMMUNOL, V160, P3610; Tang BM, 2010, CRIT CARE, V14, DOI 10.1186/cc9392; Tang BMP, 2008, CRIT CARE MED, V36, P1125, DOI 10.1097/CCM.0b013e3181692c0b; van Lieshout MH, 2014, AM J RESP CELL MOL, V50, P699, DOI 10.1165/rcmb.2013-0015OC; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wong HR, 2012, CRIT CARE, V16, DOI [10.1186/cc10537, 10.1186/cc10811]; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Zeerleder S, 2005, CLIN IMMUNOL, V116, P158, DOI 10.1016/j.clim.2005.03.006	38	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148955	10.1371/journal.pone.0148955	http://dx.doi.org/10.1371/journal.pone.0148955			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871709	Green Submitted, Green Published, gold			2022-12-27	WOS:000370054100080
J	Lombard, R; Doz, E; Carreras, F; Epardaud, M; Le Vern, Y; Buzoni-Gatel, D; Winter, N				Lombard, Robin; Doz, Emilie; Carreras, Florence; Epardaud, Mathieu; Le Vern, Yves; Buzoni-Gatel, Dominique; Winter, Nathalie			IL-17RA in Non-Hematopoietic Cells Controls CXCL-1 and 5 Critical to Recruit Neutrophils to the Lung of Mycobacteria-Infected Mice during the Adaptive Immune Response	PLOS ONE			English	Article							PULMONARY HOST-DEFENSE; CD4 T-CELLS; TUBERCULOSIS INFECTION; VACCINATION; RECEPTOR; BCG; INTERLEUKIN-17; GRANULOMA; FAMILY; INFLAMMATION	During chronic infection with Mycobacterium tuberculosis (Mtb), bacilli multiplication is constrained within lung granulomas until excessive inflammation destroys the lung. Neutrophils are recruited early and participate in granuloma formation, but excessive neutrophilia exacerbates the tuberculosis disease. Neutrophils thus appear as potential targets for therapeutic interventions, especially in patients for whom no antibiotic treatment is possible. Signals that regulate neutrophil recruitment to the lung during mycobacterial infection need to be better understood. We demonstrated here, in the mouse model, that neutrophils were recruited to the lung in two waves after intranasal infection with virulent Mtb or the live attenuated vaccine strain Bacillus Calmette Guerin (BCG). A first wave of neutrophils was swiftly recruited, followed by a subsequent adaptive wave that reached the lung together with IFN-gamma and IL-17A-producing T cells. Interestingly, the second neutrophil wave did not participate to mycobacteria control in the lung and established contacts with T cells. The adaptive wave was critically dependent on the expression of IL-17RA, the receptor for IL-17A, expressed in non-hematopoietic cells. In absence of this receptor, curtailed CXCL-1 and 5 production in the lung restrained neutrophil recruitment. CXCL-1 and 5 instillation reconstituted lung neutrophil recruitment in BCG-infected IL17RA-/- mice.	[Lombard, Robin; Doz, Emilie; Carreras, Florence; Epardaud, Mathieu; Le Vern, Yves; Buzoni-Gatel, Dominique; Winter, Nathalie] Univ Tours, INRA, UMR 1282, Infectiol & Sante Publ, Nouzilly, France	INRAE; Universite de Tours	Winter, N (corresponding author), Univ Tours, INRA, UMR 1282, Infectiol & Sante Publ, Nouzilly, France.	nathalie.winter@tours.inra.fr	Winter, Nathalie/U-2690-2018	Winter, Nathalie/0000-0003-0994-7834; Doz-Deblauwe, Emilie/0000-0002-3126-4004	gence Nationale pour la Recherche (FR) Grant [ANR-008-MIEN-00117MycImPact]; Region Centre (FR) [2013-00085470]	gence Nationale pour la Recherche (FR) Grant; Region Centre (FR)(Region Centre-Val de Loire)	This work was supported by the Agence Nationale pour la Recherche (FR) Grant No ANR-008-MIEN-00117MycImPact to NW, the Region Centre (FR) 2013-00085470 to NW and the Region Centre (FR) fellowship to RL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2005, BLOOD, V106, P1843, DOI 10.1182/blood-2005-03-1281; APPELBERG R, 1992, IMMUNOLOGY, V75, P414; APPELBERG R, 1989, CLIN EXP IMMUNOL, V78, P478; APPLEBERG R, 1991, Clinical and Experimental Immunology, V83, P231; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Aujla SJ, 2007, EXP LUNG RES, V33, P507, DOI 10.1080/01902140701756604; Basile JI, 2011, J INFECT DIS, V204, P1054, DOI 10.1093/infdis/jir460; Bhatia M, 2012, AM J RESP CELL MOL, V46, P566, DOI 10.1165/rcmb.2011-0392TR; BLOCH H, 1955, AM REV TUBERC PULM, V71, P228; Blomgran R, 2011, J IMMUNOL, V186, P7110, DOI 10.4049/jimmunol.1100001; Chen SC, 2001, J IMMUNOL, V166, P3362, DOI 10.4049/jimmunol.166.5.3362; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Cruz A, 2010, J EXP MED, V207, P1609, DOI 10.1084/jem.20100265; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Desvignes L, 2009, IMMUNITY, V31, P974, DOI 10.1016/j.immuni.2009.10.007; Doz E, 2013, J IMMUNOL, V191, P3818, DOI 10.4049/jimmunol.1300527; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Fine PEM, 2001, SCAND J INFECT DIS, V33, P243, DOI 10.1080/003655401300077144; Freches D, 2013, IMMUNOLOGY, V140, P220, DOI 10.1111/imm.12130; Gaffen SL, 2011, CURR OPIN IMMUNOL, V23, P613, DOI 10.1016/j.coi.2011.07.006; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Gheorghiu M, 1988, J BIOL STAND, V16, P168; Gopal R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004099; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Lee WB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002614; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Lopez A, 1984, BRIT J HAEMATOL, V184, P489; Lowe DM, 2012, TRENDS IMMUNOL, V33, P14, DOI 10.1016/j.it.2011.10.003; Martino A, 2011, NEUTROPHILS IN INFECTIOUS DISEASES, P42; Martino A, 2010, J IMMUNOL, V184, P2038, DOI 10.4049/jimmunol.0903348; Nandi B, 2011, J EXP MED, V208, P2251, DOI 10.1084/jem.20110919; Nouailles G, 2014, J CLIN INVEST, V124, P1268, DOI 10.1172/JCI72030; ORME IM, 1988, INFECT IMMUN, V56, P3310, DOI 10.1128/IAI.56.12.3310-3312.1988; Pedrosa J, 2000, INFECT IMMUN, V68, P577, DOI 10.1128/IAI.68.2.577-583.2000; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Schwander S, 2011, AM J RESP CRIT CARE, V183, P696, DOI 10.1164/rccm.201006-0963PP; Seiler P, 2003, EUR J IMMUNOL, V33, P2676, DOI 10.1002/eji.200323956; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Wallis RS, 2015, NAT REV IMMUNOL, V15, P255, DOI 10.1038/nri3813; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Yoshida YO, 2010, J IMMUNOL, V184, P4414, DOI 10.4049/jimmunol.0903332; Zhang X, 2009, IMMUNITY, V31, P761, DOI 10.1016/j.immuni.2009.09.016	45	45	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149455	10.1371/journal.pone.0149455	http://dx.doi.org/10.1371/journal.pone.0149455			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871571	gold, Green Published, Green Submitted			2022-12-27	WOS:000370054100160
J	Schmitt, M; Boras, S; Tjoa, A; Watanabe, T; Jansen, S				Schmitt, Marco; Boras, Sven; Tjoa, Aiyen; Watanabe, Toshihiro; Jansen, Steven			Aluminium Accumulation and Intra-Tree Distribution Patterns in Three Arbor aluminosa (Symplocos) Species from Central Sulawesi	PLOS ONE			English	Article							MELASTOMA-MALABATHRICUM; INTERNAL DETOXIFICATION; ACID SOILS; PLANTS; RESISTANCE; TOXICITY; GROWTH; ROOT; AL; HYPERACCUMULATION	Accumulation of Aluminium (Al) at concentrations far above 1,000 mg kg(-1) in aboveground plant tissues of Arbor aluminosa (Symplocos) species is the main reason why traditional Indonesian weavers rely on their leaves and bark as a mordant for dyeing textile. Recently, Symplocos species have become a flagship species for the conservation efforts of weaving communities due to their traditionally non-sustainable sampling and increasing demand for Symplocos plant material. Here we investigated Symplocos odoratissima, S. ophirensis and S. ambangensis at three montane rainforest sites in Central Sulawesi to measure Al levels in different tissues and organs. The highest Al concentrations were found in old leaves (24,180 +/- 7,236 mg.kg(-1) dry weight, mean +/- SD), while young leaves had significantly lower Al levels (20,708 +/- 7,025 mg.kg(-1)). Al accumulation was also lower in bark and wood tissue of the trunk (17,231 +/- 8,356 mg.kg(-1) and 5,181 +/- 2,032 mg.kg(-1), respectively). Two Al excluding species (Syzigium sp. and Lithocarpus sp.) contained only high Al levels in their roots. Moreover, no difference was found in soil pH (4.7 +/- 0.61) and nutrient (K, Ca, Fe, Mg) availability at different soil levels and within or outside the crown of Symplocos trees, except for the upper soil layer. Furthermore, a positive and significant correlation between Al and Ca concentrations was found at the whole plant level for Symplocos, and at the leaf level for S. ophirensis and S. ambangensis, suggesting a potential role of Ca in Al uptake and/or detoxification within the plant. Our results provide evidence for strong Al accumulation in Symplocos species and illustrate that both Al accumulation and exclusion represent two co-occurring strategies of montane rainforest plants for dealing with Al toxicity. Indonesian weavers should be encouraged to harvest old leaves, which have the most efficient mordant capacity due to high Al concentrations.	[Schmitt, Marco; Boras, Sven; Jansen, Steven] Univ Ulm, Inst Systemat Bot & Ecol, D-89069 Ulm, Germany; [Tjoa, Aiyen] Tadulako Univ, Fac Agr, Palu, Indonesia; [Watanabe, Toshihiro] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido, Japan	Ulm University; Universitas Tadulako; Hokkaido University	Jansen, S (corresponding author), Univ Ulm, Inst Systemat Bot & Ecol, D-89069 Ulm, Germany.	steven.jansen@uni-ulm.de	Watanabe, Toshihiro/AAT-6071-2021; Jansen, Steven/A-9868-2012	Watanabe, Toshihiro/0000-0003-4466-811X; Jansen, Steven/0000-0002-4476-5334	Ministry for Science, Research and the Arts of Baden-Wurttemberg; Grants-in-Aid for Scientific Research [15K14673, 15H04465] Funding Source: KAKEN	Ministry for Science, Research and the Arts of Baden-Wurttemberg; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank the Ministry for Science, Research and the Arts of Baden-Wurttemberg for financial support to SJ (Zukunftsoffensive IV Juniorprofessoren-Programm; https://mwk.badenwuerttemberg.de/de/startseite/).	Akashi N, 1999, FOREST ECOL MANAG, V113, P75, DOI 10.1016/S0378-1127(98)00415-0; Baker AJM, 2000, PHYTOREMEDIATION OF CONTAMINATED SOIL AND WATER, P85; BAKER AJM, 1981, J PLANT NUTR, V3, P643, DOI 10.1080/01904168109362867; Barberon M, 2014, PLANT PHYSIOL, V166, P528, DOI 10.1104/pp.114.246124; Barcelo J, 2002, ENVIRON EXP BOT, V48, P75, DOI 10.1016/S0098-8472(02)00013-8; Boyd RS, 2007, PLANT SOIL, V293, P153, DOI 10.1007/s11104-007-9240-6; Brunner I, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00172; Burkill IH, 2002, DICT EC PRODUCTS MAL, VI; Burkill IH, 2002, DICT EC PRODUCTS MAL, VII; CHENERY E. M., 1948, Kew Bulletin, P173, DOI 10.2307/4119757; Chenery EM., 1949, KEW B, V4, P463, DOI DOI 10.2307/4109057; Colwell RK, 2009, P NATL ACAD SCI USA, V106, P19651, DOI 10.1073/pnas.0901650106; Culmsee H, 2009, BLUMEA, V54, P119, DOI 10.3767/000651909X475473; Culmsee H, 2011, BIODIVERS CONSERV, V20, P1103, DOI 10.1007/s10531-011-0019-y; Cunningham AB, 2011, ECON BOT, V65, P241, DOI 10.1007/s12231-011-9161-4; Driessen F, 1902, REV GEN MAT COLOR, V6, P252; Freeman JL, 2009, AM J BOT, V96, P1075, DOI 10.3732/ajb.0800287; Fung KF, 2008, J SCI FOOD AGR, V88, P1582, DOI 10.1002/jsfa.3254; Grevenstuk T, 2013, METALLOMICS, V5, P1584, DOI 10.1039/c3mt00232b; HARIDASAN M, 1988, FOREST ECOL MANAG, V24, P15, DOI 10.1016/0378-1127(88)90021-7; HARIDASAN M, 1987, CAPACIDAD BIOPRODUCT, P309; Haridasan Mundayatan, 2008, Braz. J. Plant Physiol., V20, P183, DOI 10.1590/S1677-04202008000300003; HUANG JWW, 1992, PLANTA, V188, P414, DOI 10.1007/BF00192809; HUTCHINSON GE, 1945, SOIL SCI, V60, P29, DOI 10.1097/00010694-194507000-00004; Hutchinson GE, 1943, Q REV BIOL, V18, P1, DOI 10.1086/394666; Hutchinson GE, 1943, T CONN ACAD ARTS SCI, V35, P73; Jansen S, 2004, PLANT BIOLOGY, V6, P498, DOI 10.1055/s-2004-820980; Jansen S, 2002, ANN BOT-LONDON, V90, P53, DOI 10.1093/aob/mcf142; Jansen S, 2002, BOT REV, V68, P235, DOI 10.1663/0006-8101(2002)068[0235:AHIAAR]2.0.CO;2; KINRAIDE TB, 1991, PLANT SOIL, V134, P167, DOI 10.1007/BF00010729; Kinraide TB, 1997, J EXP BOT, V48, P1115, DOI 10.1093/jxb/48.5.1115; KIRKBY EA, 1984, PLANT CELL ENVIRON, V7, P397, DOI 10.1111/j.1365-3040.1984.tb01429.x; Klug B, 2010, NEW PHYTOL, V187, P380, DOI 10.1111/j.1469-8137.2010.03288.x; Kochian LV, 2015, ANNU REV PLANT BIOL, V66, P571, DOI 10.1146/annurev-arplant-043014-114822; Kochian LV, 2005, PLANT SOIL, V274, P175, DOI 10.1007/s11104-004-1158-7; Kochian LV, 2004, ANNU REV PLANT BIOL, V55, P459, DOI 10.1146/annurev.arplant.55.031903.141655; Kochian LV, 2002, PLANT SOIL, V247, P109, DOI 10.1023/A:1021141212073; Lemmens RHMJ, 1992, DYE TANNIN PRODUCING; Ma JF, 1997, NATURE, V390, P569, DOI 10.1038/37518; Ma JF, 2001, TRENDS PLANT SCI, V6, P273, DOI 10.1016/S1360-1385(01)01961-6; Ma JF, 1998, PLANT PHYSIOL, V117, P753, DOI 10.1104/pp.117.3.753; Ma JF, 1997, PLANT PHYSIOL, V113, P1033, DOI 10.1104/pp.113.4.1033; Ma JF, 2000, PLANTA, V211, P355, DOI 10.1007/s004250000292; Ma JF, 2007, INT REV CYTOL, V264, P225, DOI 10.1016/S0074-7696(07)64005-4; Maejima E, 2014, BOTANY, V92, P327, DOI 10.1139/cjb-2013-0298; MARSCHNER H, 1987, J PLANT NUTR, V10, P1175, DOI 10.1080/01904168709363645; Martens SN, 2002, AM J BOT, V89, P998, DOI 10.3732/ajb.89.6.998; Masunaga T, 1998, SOIL SCI PLANT NUTR, V44, P315, DOI 10.1080/00380768.1998.10414454; MATSUMOTO H, 1976, PLANT CELL PHYSIOL, V17, P627; Mazen AMA, 2004, RUSS J PLANT PHYSL+, V51, P281, DOI 10.1023/B:RUPP.0000019226.03536.21; Medeiros R. A. de, 1985, Plant and Soil, V88, P433, DOI 10.1007/BF02197499; MEDINA E, 1990, J BIOGEOGR, V17, P403, DOI 10.2307/2845370; Meharg AA, 2003, NEW PHYTOL, V157, P25, DOI 10.1046/j.1469-8137.2003.00541.x; Meharg AA, 2002, NEW PHYTOL, V156, P1, DOI 10.1046/j.1469-8137.2002.00513.x; Metali F, 2015, NEW PHYTOL, V205, P280, DOI 10.1111/nph.12987; Metali F, 2012, NEW PHYTOL, V193, P637, DOI 10.1111/j.1469-8137.2011.03965.x; Mundim FM, 2009, ENTOMOL EXP APPL, V130, P47, DOI 10.1111/j.1570-7458.2008.00789.x; Nguyen NT, 2003, TREE PHYSIOL, V23, P1041, DOI 10.1093/treephys/23.15.1041; Pogue AL, 2014, FRONT NEUROL, V5, DOI [10.3389/fneur.2014.00262, 10.3389/fneur.2014.00043]; Poschenrieder C, 2008, SCI TOTAL ENVIRON, V400, P356, DOI 10.1016/j.scitotenv.2008.06.003; Radlkofer L, 1904, BER DEUT BOT GES, V22, P216; Reeves RD, 2000, PHYTOREMEDIATION OF TOXIC METALS, P193; Rehmus A, 2014, PLANT SOIL, V382, P301, DOI 10.1007/s11104-014-2110-0; Rengel Z, 2015, J SOIL SCI PLANT NUT, V15, P397; Serrano HC, 2015, J PLANT ECOL, V8, P41, DOI 10.1093/jpe/rtu007; Tolra R, 2011, J PLANT RES, V124, P165, DOI 10.1007/s10265-010-0344-3; Von Faber F.C, 1925, FLORA, V118, P89; VONUEXKULL HR, 1995, PLANT SOIL, V171, P1, DOI 10.1007/BF00009558; Watanabe T, 1998, PLANT SOIL, V201, P165, DOI 10.1023/A:1004341415878; Watanabe T, 2005, CAN J BOT, V83, P1518, DOI 10.1139/b05-111; Watanabe T, 2005, NEW PHYTOL, V165, P773, DOI 10.1111/j.1469-8137.2004.01261.x; Watanabe T, 2001, PLANT SOIL, V237, P63, DOI 10.1023/A:1013395814958; Watanabe T, 1997, SOIL SCI PLANT NUTR, V43, P827, DOI 10.1080/00380768.1997.10414649; Watanabe T, 2007, NEW PHYTOL, V174, P516, DOI 10.1111/j.1469-8137.2007.02078.x; Watanabe T, 2006, PLANT CELL ENVIRON, V29, P2124, DOI 10.1111/j.1365-3040.2006.001586.x; WEBB L. J., 1954, AUSTRALIAN JOUR BOT, V2, P176, DOI 10.1071/BT9540176; Wehnert A., 1906, ANATOMISCH SYSTEMATI; YOSHII Y., 1932, SCI REPT TOHOKU IMP UNIV [SER 4], V7, P65; Zeng QL, 2013, TREE PHYSIOL, V33, P96, DOI 10.1093/treephys/tps117	79	16	18	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149078	10.1371/journal.pone.0149078	http://dx.doi.org/10.1371/journal.pone.0149078			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871698	Green Published, gold, Green Submitted			2022-12-27	WOS:000370054100098
J	Smits, FM; Porcaro, C; Cottone, C; Cancelli, A; Rossini, PM; Tecchio, F				Smits, Fenne Margreeth; Porcaro, Camillo; Cottone, Carlo; Cancelli, Andrea; Rossini, Paolo Maria; Tecchio, Franca			Electroencephalographic Fractal Dimension in Healthy Ageing and Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; FUNCTIONAL SOURCE SEPARATION; CORTICAL RHYTHMS; FREE COPPER; EEG; BRAIN; COMPLEXITY; STATE; ADULTS; SCALE	Brain activity is complex; a reflection of its structural and functional organization. Among other measures of complexity, the fractal dimension is emerging as being sensitive to neuronal damage secondary to neurological and psychiatric diseases. Here, we calculated Higuchi's fractal dimension (HFD) in resting-state eyes-closed electroencephalography (EEG) recordings from 41 healthy controls (age: 20-89 years) and 67 Alzheimer's Disease (AD) patients (age: 50-88 years), to investigate whether HFD is sensitive to brain activity changes typical in healthy aging and in AD. Additionally, we considered whether AD-accelerating effects of the copper fraction not bound to ceruloplasmin (also called "free" copper) are reflected in HFD fluctuations. The HFD measure showed an inverted U-shaped relationship with age in healthy people (R-2 = .575, p < .001). Onset of HFD decline appeared around the age of 60, and was most evident in central-parietal regions. In this region, HFD decreased with aging stronger in the right than in the left hemisphere (p = .006). AD patients demonstrated reduced HFD compared to age-and education-matched healthy controls, especially in temporal-occipital regions. This was associated with decreasing cognitive status as assessed by mini-mental state examination, and with higher levels of non-ceruloplasmin copper. Taken together, our findings show that resting-state EEG complexity increases from youth to maturity and declines in healthy, aging individuals. In AD, brain activity complexity is further reduced in correlation with cognitive impairment. In addition, elevated levels of non-ceruloplasmin copper appear to accelerate the reduction of neural activity complexity. Overall, HDF appears to be a proper indicator for monitoring EEG-derived brain activity complexity in healthy and pathological aging.	[Smits, Fenne Margreeth; Porcaro, Camillo; Cottone, Carlo; Cancelli, Andrea; Tecchio, Franca] Osped Fatebenefratelli, LETS, ISTC, CNR, Rome, Italy; [Smits, Fenne Margreeth] Univ Amsterdam, Amsterdam, Netherlands; [Porcaro, Camillo] Newcastle Univ, Sch Med, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Cancelli, Andrea; Rossini, Paolo Maria] Univ Cattolica Sacro Cuore, Inst Neurol, Rome, Italy; [Rossini, Paolo Maria; Tecchio, Franca] IRCCS San Raffaele Pisana, Unit Neuroimaging, Rome, Italy; [Porcaro, Camillo] Univ Politecn Marche, Dept Informat Engn, Ancona, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); University of Amsterdam; Newcastle University - UK; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS San Raffaele Pisana; Marche Polytechnic University	Tecchio, F (corresponding author), Osped Fatebenefratelli, LETS, ISTC, CNR, Rome, Italy.; Tecchio, F (corresponding author), IRCCS San Raffaele Pisana, Unit Neuroimaging, Rome, Italy.	franca.tecchio@cnr.it	Cancelli, Andrea/K-7824-2016; Porcaro, Camillo/K-7864-2016; tecchio, franca/AAX-2770-2020; Rossini, Paolo Maria/D-4994-2013	Cancelli, Andrea/0000-0002-3654-323X; Porcaro, Camillo/0000-0003-4847-163X; tecchio, franca/0000-0002-1325-5059; Rossini, Paolo Maria/0000-0003-2665-534X; Smits, Fenne/0000-0001-9697-1028	FISM - Fondazione Italiana Sclerosi Multipla [2014/R]; MIUR [2010SH7H3F]; PNR-CNR Aging Program	FISM - Fondazione Italiana Sclerosi Multipla(Fondazione Italiana Sclerosi Multipla (FISM)); MIUR(Ministry of Education, Universities and Research (MIUR)); PNR-CNR Aging Program	This work was supported by FISM - Fondazione Italiana Sclerosi Multipla-Cod.2014/R [FaReMuS CuNeH], MIUR Prot. 2010SH7H3F 'Functional connectivity and neuroplasticity in physiological and pathological aging [ConnAge]' and PNR-CNR Aging Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi K, 2013, NEUROSCI LETT, V535, P7, DOI 10.1016/j.neulet.2012.12.043; Ahmadlou M, 2011, ALZ DIS ASSOC DIS, V25, P85, DOI 10.1097/WAD.0b013e3181ed1160; Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Babiloni C, 2006, CLIN NEUROPHYSIOL, V117, P252, DOI 10.1016/j.clinph.2005.09.019; Babiloni C, 2006, HUM BRAIN MAPP, V27, P162, DOI 10.1002/hbm.20175; Babiloni C, 2007, CLIN NEUROPHYSIOL, V118, P1244, DOI 10.1016/j.clinph.2007.03.016; Barbati G, 2004, CLIN NEUROPHYSIOL, V115, P1220, DOI 10.1016/j.clinph.2003.12.015; Bo J, 2014, BRAIN CONNECT, V4, P166, DOI 10.1089/brain.2013.0155; Buzsaki G, 2014, NAT REV NEUROSCI, V15, P264, DOI 10.1038/nrn3687; Cottone C, 2013, BRAIN TOPOGR, V26, P186, DOI 10.1007/s10548-012-0240-3; Dauwels J, 2010, NEUROIMAGE, V49, P668, DOI 10.1016/j.neuroimage.2009.06.056; Dolcos F, 2002, NEUROSCI BIOBEHAV R, V26, P819, DOI 10.1016/S0149-7634(02)00068-4; Filippo Z, 2015, PLOS ONE IN PRESS; Fjell AM, 2013, J NEUROSCI, V33, P8237, DOI 10.1523/JNEUROSCI.5506-12.2013; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gaal ZA, 2010, NEUROSCI LETT, V479, P79, DOI 10.1016/j.neulet.2010.05.037; Goldberger AL, 2002, NEUROBIOL AGING, V23, P23, DOI 10.1016/S0197-4580(01)00266-4; Graziadio S, 2010, J NEUROSCI, V30, P3663, DOI 10.1523/JNEUROSCI.5621-09.2010; Handwerker DA, 2012, NEUROIMAGE, V63, P1712, DOI 10.1016/j.neuroimage.2012.06.078; He BYJ, 2011, J NEUROSCI, V31, P13786, DOI 10.1523/JNEUROSCI.2111-11.2011; Helmberger M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087515; HIGUCHI T, 1988, PHYSICA D, V31, P277, DOI 10.1016/0167-2789(88)90081-4; Jeong JS, 2004, CLIN NEUROPHYSIOL, V115, P1490, DOI 10.1016/j.clinph.2004.01.001; Liddell Belinda J., 2007, Journal of Integrative Neuroscience, V6, P141, DOI 10.1142/S0219635207001374; Long XJ, 2013, HUM BRAIN MAPP, V34, P3400, DOI 10.1002/hbm.22157; McBridea JC, 2014, COMPUT METH PROG BIO, V114, P153, DOI 10.1016/j.cmpb.2014.01.019; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Medaglia MT, 2009, CONTRADICTION UNIVER, V4197, P4187; Meerwijk EL, 2015, BIOL PSYCHOL, V105, P106, DOI 10.1016/j.biopsycho.2015.01.003; Mizuno T, 2010, CLIN NEUROPHYSIOL, V121, P1438, DOI 10.1016/j.clinph.2010.03.025; Moledina S, 2011, HEART, V97, P1245, DOI 10.1136/hrt.2010.214130; Narayanan B, 2013, J STUD ALCOHOL DRUGS, V74, P245, DOI 10.15288/jsad.2013.74.245; Niedermeyer E., 2004, ELECTROENCEPHALOGRAP; Pal A, 2015, J ALZHEIMERS DIS, V44, P343, DOI 10.3233/JAD-141194; Pascual-Leone A, 2011, BRAIN TOPOGR, V24, P302, DOI 10.1007/s10548-011-0196-8; Pereda E, 1999, NEUROSCI LETT, V263, P37, DOI 10.1016/S0304-3940(99)00104-4; Porcaro C, 2009, HAND SOMATOSENSORY S, V674, P660; Porcaro C, 2015, NEUROIMAGE, V105, P171, DOI 10.1016/j.neuroimage.2014.10.049; Porcaro C, 2014, SIGNALS COMMUN TECHN, P521, DOI 10.1007/978-3-642-55016-4_19; Ramon C, 2015, CURR OPIN NEUROBIOL, V31, P127, DOI 10.1016/j.conb.2014.10.001; Roberts JA, 2014, J NEUROSCI, V34, P6557, DOI 10.1523/JNEUROSCI.4701-13.2014; Sala-Llonch R, 2012, FRONTIERS HUMAN NEUR; Salustri C, 2010, CLIN NEUROPHYSIOL, V121, P502, DOI 10.1016/j.clinph.2009.11.090; Smith SM, 2012, P NATL ACAD SCI USA, V109, P3131, DOI 10.1073/pnas.1121329109; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P2266, DOI 10.1016/j.clinph.2005.06.011; Staudinger T, 2011, IEEE ENG MED BIO, P2033, DOI 10.1109/IEMBS.2011.6090374; Sun JF, 2012, AGING DIS, V3, P181; Tecchio F, 2007, J PHYSIOL-LONDON, V580, P703, DOI 10.1113/jphysiol.2007.129163; Tononi G, 1998, TRENDS COGN SCI, V2, P474, DOI 10.1016/S1364-6613(98)01259-5; Walshe JM, 2003, ANN CLIN BIOCHEM, V40, P115, DOI 10.1258/000456303763046021; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Zappasodi F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100199	53	68	69	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149587	10.1371/journal.pone.0149587	http://dx.doi.org/10.1371/journal.pone.0149587			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26872349	gold, Green Published, Green Submitted			2022-12-27	WOS:000370054100166
J	Kim, S; Kim, Y; Park, SM				Kim, Sujin; Kim, Yongjoo; Park, Sang Min			Body Mass Index and Decline of Cognitive Function	PLOS ONE			English	Article							LATE-LIFE; DEPRESSIVE SYMPTOMS; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; INCIDENT DEMENTIA; KEY ROLE; RISK; OBESITY; METAANALYSIS; OVERWEIGHT	Background The association between body mass index (BMI) and cognitive function is a public health issue. This study investigated the relationship between obesity and cognitive impairment which was assessed by the Korean version of the Mini-mental state examination (K-MMSE) among mid- and old-aged people in South Korea. Methods A cohort of 5,125 adults, age 45 or older with normal cognitive function (K-MMSE >= 24) at baseline (2006), was derived from the Korean Longitudinal Study of Aging (KLoSA) 2006 similar to 2012. The association between baseline BMI and risk of cognitive impairment was assessed using multiple logistic regression models. We also assessed baseline BMI and change of cognitive function over the 6-year follow-up using multiple linear regressions. Results During the follow-up, 358 cases of severe cognitive impairment were identified. Those with baseline BMI >= 25 kg/m(2) than normal-weight (18.5 >= BMI<23 kg/m(2)) were marginally less likely to experience the development of severe cognitive impairment (adjusted odds ratio [aOR] = 0.73, 95% CI = 0.52 to 1.03; P-trend = 0.03). This relationship was stronger among female (aOR = 0.63, 95% CI = 0.40 to 1.00; P-trend = 0.01) and participants with low-normal K-MMSE score (MMSE: 24-26) at baseline (aOR = 0.59, 95% CI = 0.35 to 0.98; P-trend<0.01). In addition, a slower decline of cognitive function was observed in obese individuals than those with normal weight, especially among women and those with low-normal K-MMSE score at baseline. Conclusion In this nationally representative study, we found that obesity was associated with lower risk of cognitive decline among mid- and old-age population.	[Kim, Sujin; Park, Sang Min] Harvard Univ, TH Chan Sch Publ Hlth, Takemi Program Int Hlth, Boston, MA 02115 USA; [Kim, Yongjoo] Harvard Univ, TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Park, Sang Min] Seoul Natl Univ, Coll Med, Dept Family Med, Seoul, South Korea; [Park, Sang Min] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Seoul National University (SNU); Seoul National University (SNU)	Park, SM (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Takemi Program Int Hlth, Boston, MA 02115 USA.; Park, SM (corresponding author), Seoul Natl Univ, Coll Med, Dept Family Med, Seoul, South Korea.; Park, SM (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea.	smpark.snuh@gmail.com	Kim, Yongjoo/N-9751-2019; Park, Sang Min/V-9194-2019	Kim, Yongjoo/0000-0002-0768-9256; Kim, Sujin/0000-0002-4251-6318				Anstey KJ, 2011, OBES REV, V12, pe426, DOI 10.1111/j.1467-789X.2010.00825.x; Aslan AKD, 2015, AGE AGEING, V44, P59, DOI 10.1093/ageing/afu108; Atti AR, 2008, J AM GERIATR SOC, V56, P111, DOI 10.1111/j.1532-5415.2007.01458.x; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Beydoun MA, 2008, OBES REV, V9, P204, DOI 10.1111/j.1467-789X.2008.00473.x; Brayne C, 2005, NEUROBIOL AGING, V26, pS6, DOI 10.1016/j.neurobiolaging.2005.09.030; Bryant AN, 2014, AM J GERIAT PSYCHIAT, V22, P653, DOI 10.1016/j.jagp.2013.08.006; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Chen HL, 2009, AM J EPIDEMIOL, V169, P1064, DOI 10.1093/aje/kwp033; Coin A, 2012, J NUTR HEALTH AGING, V16, P553, DOI 10.1007/s12603-012-0052-x; Dahl AK, 2013, INT J OBESITY, V37, P296, DOI 10.1038/ijo.2012.37; Dahl AK, 2013, EPIDEMIOL REV, V35, P22, DOI 10.1093/epirev/mxs002; Diniz BS, 2013, BRIT J PSYCHIAT, V202, P329, DOI 10.1192/bjp.bp.112.118307; Dong JY, 2012, STROKE, V43, P32, DOI 10.1161/STROKEAHA.111.630871; Douketis JD, 2005, CAN MED ASSOC J, V172, P995, DOI 10.1503/cmaj.045170; Emmerzaal TL, 2015, J ALZHEIMERS DIS, V43, P739, DOI 10.3233/JAD-141086; Euser SM, 2009, SERUM URIC ACID AND; Fitzpatrick AL, 2009, ARCH NEUROL-CHICAGO, V66, P336, DOI 10.1001/archneurol.2008.582; Folstein MF, 2005, HYPERTENSION, V46, P654; Han Changsu, 2009, Arch Gerontol Geriatr, V49, pe133, DOI 10.1016/j.archger.2008.11.005; Hughes TF, 2009, NEUROLOGY, V72, P1741, DOI 10.1212/WNL.0b013e3181a60a58; Kang Y., 1997, J KOREAN NEUROL ASS, V15, P300; Kohler S, 2010, J AM GERIATR SOC, V58, P873, DOI 10.1111/j.1532-5415.2010.02807.x; Korea Labor Institutue, 2007, US GUID 2007 KLOSA; Loef M, 2013, OBESITY, V21, pE51, DOI 10.1002/oby.20037; Luchsinger JA, ADIPOSITY ALZHEIMERE; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Nazare JA, 2012, AM J CLIN NUTR, V96, P714, DOI 10.3945/ajcn.112.035758; Nourhashash, 2002, CMAJ, V50, P1796; Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530; Pan A, 2011, JAMA-J AM MED ASSOC, V306, P1241, DOI 10.1001/jama.2011.1282; Prickett C, 2015, OBES RES CLIN PRACT, V9, P93, DOI 10.1016/j.orcp.2014.05.001; Qizilbash N, 2015, LANCET DIABETES ENDO, V3, P431, DOI 10.1016/S2213-8587(15)00033-9; Rugulies R, 2002, AM J PREV MED, V23, P51, DOI 10.1016/S0749-3797(02)00439-7; Schuurman AG, 2002, NEUROLOGY, V58, P1501, DOI 10.1212/WNL.58.10.1501; Sergi G, 2005, J GERONTOL A-BIOL, V60, P866, DOI 10.1093/gerona/60.7.866; Shen CC, 2013, NEUROLOGY, V81, P1538, DOI 10.1212/WNL.0b013e3182a956ad; Smith E, 2011, OBES REV, V12, P740, DOI 10.1111/j.1467-789X.2011.00920.x; Snijder MB, 2004, DIABETES CARE, V27, P372, DOI 10.2337/diacare.27.2.372; Stevens J, 1998, NEW ENGL J MED, V338, P1, DOI 10.1056/NEJM199801013380101; Stewart R, 2005, ARCH NEUROL-CHICAGO, V62, P55, DOI 10.1001/archneur.62.1.55; Suemoto CK, 2015, INT J OBESITY, V39, P1383, DOI 10.1038/ijo.2015.83; Suk SH, 2003, STROKE, V34, P1586, DOI 10.1161/01.STR.0000075294.98582.2F; Thomas F, 2005, HYPERTENSION, V46, P654, DOI 10.1161/01.HYP.0000184282.51550.00; Tolppanen AM, 2014, J ALZHEIMERS DIS, V38, P201, DOI 10.3233/JAD-130698; Van der Kooy K, 2007, INT J GERIATR PSYCH, V22, P613, DOI 10.1002/gps.1723; Wen CP, 2009, PUBLIC HEALTH NUTR, V12, P497, DOI 10.1017/S1368980008002802; World Health Organization and Alzheimer's Disease International, 2012, DEM PUBL HLTH PRIOR; Xiang XL, 2015, ARCH GERONTOL GERIAT, V60, P394, DOI 10.1016/j.archger.2015.02.008; Xu WL, 2011, NEUROLOGY, V76, P1568, DOI 10.1212/WNL.0b013e3182190d09; Yaffe K, 1999, ARCH GEN PSYCHIAT, V56, P425, DOI 10.1001/archpsyc.56.5.425; Yoon K, 2014, ARCH GERONTOL GERIAT, V59, P584, DOI 10.1016/j.archger.2014.08.008	52	51	53	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0148908	10.1371/journal.pone.0148908	http://dx.doi.org/10.1371/journal.pone.0148908			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867138	gold, Green Published, Green Submitted			2022-12-27	WOS:000370050700045
J	Sun, JR; Zhang, XC; Cao, YN; Zhao, QL; Bao, ED; Lv, YJ				Sun, Jiarui; Zhang, Xinchen; Cao, Yinan; Zhao, Qiling; Bao, Endong; Lv, Yingjun			Ovarian Toxicity in Female Rats after Oral Administration of Melamine or Melamine and Cyanuric Acid	PLOS ONE			English	Article							DOSE-RESPONSE ASSESSMENT; REPRODUCTIVE TOXICITY; OXIDATIVE STRESS; COMBINED-EXPOSURE; NRK-52E CELLS; F344 RATS; MICE; APOPTOSIS; NEPHROTOXICITY; PATHWAY	Although the toxicity of melamine to the kidneys and testes is well known, few studies have investigated the effects of melamine on female reproductive organs. Therefore, this study explores the effects of oral administration melamine or melamine and cyanuric acid for 28 days on the ovaries of female rats. Rats that were exposed to the mixture exhibited reduced ovarian and uterine weights, a shorter estrous cycle, and reduced serum estrogen and progesterone levels compared to rats that were exposed to melamine and control rats. Furthermore, morphological analysis revealed pathological changes in the ovaries of rats exposed to melamine or the mixture, such as more atretic follicles and necrosis of oocytes and granulosa cells. TUNEL staining revealed that the exposed groups had a higher proportion of TUNEL-positive granulosa cells than the control group, and the mRNA expressions of SOD1, GPX1, GPX2, P450scc, 17 beta-HSD I, and 17 beta-HSD II were reduced in the exposure groups compared with the control group. These results indicated that exposure to melamine alone or to the melamine-cyanuric acid mixture could damage the ovaries in rats.	[Sun, Jiarui; Zhang, Xinchen; Cao, Yinan; Zhao, Qiling; Bao, Endong; Lv, Yingjun] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Lv, YJ (corresponding author), Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China.	lyj@njau.edu.cn			Natural Science Foundation of China [31101786]; National Key Basic Research Program of China (973 Program) [2014CB138502]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the Natural Science Foundation of China, http://www.nsfc.gov.cn/, number: 31101786, receiver: YL; National Key Basic Research Program of China (973 Program), http://www.973.gov.cn/, number: 2014CB138502, receiver: EB; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), http:// jsycw.ec.js.edu.cn/, number: none, receiver: YL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by grants from the Natural Science Foundation of China (31101786), the National Key Basic Research Program of China (973 Program) (2014CB138502) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	ALLEN LM, 1982, DRUG METAB REV, V13, P499, DOI 10.3109/03602538209029992; Berisha B, 2002, ENDOCRINE, V17, P207, DOI 10.1385/ENDO:17:3:207; Britt KL, 2000, ENDOCRINOLOGY, V141, P2614, DOI 10.1210/en.141.7.2614; Brown CA, 2007, J VET DIAGN INVEST, V19, P525, DOI 10.1177/104063870701900510; Chan JYW, 2011, FOOD CHEM TOXICOL, V49, P1544, DOI 10.1016/j.fct.2011.03.046; Chang LL, 2014, REPROD TOXICOL, V46, P1, DOI 10.1016/j.reprotox.2014.02.008; Chio L, 2010, TOXICOL ENV HLTH A, V73, P1407, DOI [10.1080/15287394.2010.511540, DOI 10.1080/15287394.2010.511540]; da Costa GG, 2012, TOXICOL APPL PHARM, V262, P99, DOI 10.1016/j.taap.2012.04.031; Dai XX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142564; Dobson RLM, 2008, TOXICOL SCI, V106, P251, DOI 10.1093/toxsci/kfn160; Dorne JL, 2013, TOXICOL APPL PHARM, V270, P218, DOI 10.1016/j.taap.2012.01.012; Duan X, 2015, HUM REPROD, V30, P1643, DOI 10.1093/humrep/dev091; Dufour Alfred P., 2006, Journal of Water and Health, V4, P425; Edson MA, 2009, ENDOCR REV, V30, P624, DOI 10.1210/er.2009-0012; Ferre C, 2013, EXP TOXICOL PATHOL, V65, P397, DOI 10.1016/j.etp.2011.12.004; Fu Y, 2014, LIFE SCI, V100, P61, DOI 10.1016/j.lfs.2014.01.081; Guo CZ, 2012, CELL BIOL INT, V36, P383, DOI 10.1042/CBI20110504; Guo CZ, 2012, CELL BIOL INT, V36, P183, DOI 10.1042/CBI20110036; HAMMOND BG, 1986, ENVIRON HEALTH PERSP, V69, P287, DOI 10.2307/3430400; Jacob CC, 2011, TOXICOL SCI, V119, P391, DOI 10.1093/toxsci/kfq333; Ji AL, 2014, WORLD J PEDIATR, V10, P7, DOI 10.1007/s12519-014-0447-3; Kim GH, 2014, J TOXICOL ENV HEAL A, V77, P22; Kim SH, 2011, J APPL TOXICOL, V31, P506, DOI 10.1002/jat.1703; Lv YJ, 2013, REGUL TOXICOL PHARM, V65, P183, DOI 10.1016/j.yrtph.2012.11.011; Matsuda F, 2012, J REPROD DEVELOP, V58, P44, DOI 10.1262/jrd.2011-012; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Reimschuessel R, 2010, FOOD CHEM TOXICOL, V48, P2898, DOI 10.1016/j.fct.2010.07.024; Reimschuessel R, 2010, J MED TOXICOL, V6, P468, DOI 10.1007/s13181-010-0107-5; Skinner CG, 2010, J MED TOXICOL, V6, P50, DOI 10.1007/s13181-010-0038-1; Son JY, 2014, TOX RESEARCH, V30, P99, DOI 10.5487/TR.2014.30.2.099; Stine CB, 2014, FOOD CHEM TOXICOL, V68, P142, DOI 10.1016/j.fct.2014.02.029; Stocco DM, 2001, ANNU REV PHYSIOL, V63, P193, DOI 10.1146/annurev.physiol.63.1.193; Takahashi N, 2012, REPROD TOXICOL, V33, P27, DOI 10.1016/j.reprotox.2011.10.010; Trinei M, 2002, ONCOGENE, V21, P3872, DOI 10.1038/sj.onc.1205513; Walters KA, 2015, REPRODUCTION, V149, pR193, DOI 10.1530/REP-14-0517; Yin RH, 2013, RES VET SCI, V94, P618, DOI 10.1016/j.rvsc.2012.11.010	36	12	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149063	10.1371/journal.pone.0149063	http://dx.doi.org/10.1371/journal.pone.0149063			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26866683	gold, Green Submitted, Green Published			2022-12-27	WOS:000370050700059
J	Zungsontiporn, N; Tello, RR; Zhang, GX; Mitchell, BI; Budoff, M; Kallianpur, KJ; Nakamoto, BK; Keating, SM; Norris, PJ; Ndhlovu, LC; Souza, SA; Shikuma, CM; Chow, DC				Zungsontiporn, Nath; Tello, Raquel R.; Zhang, Guangxiang; Mitchell, Brooks I.; Budoff, Matthew; Kallianpur, Kalpana J.; Nakamoto, Beau K.; Keating, Sheila M.; Norris, Philip J.; Ndhlovu, Lishomwa C.; Souza, Scott A.; Shikuma, Cecilia M.; Chow, Dominic C.			Non-Classical Monocytes and Monocyte Chemoattractant Protein-1 (MCP-1) Correlate with Coronary Artery Calcium Progression in Chronically HIV-1 Infected Adults on Stable Antiretroviral Therapy	PLOS ONE			English	Article							HIV-INFECTION; SUBCLINICAL ATHEROSCLEROSIS; MYOCARDIAL-INFARCTION; DISEASE EVENTS; RISK-FACTORS; MARKERS; INFLAMMATION; IMMUNODEFICIENCY; HETEROGENEITY; ASSOCIATIONS	Background Persistent inflammation and immune activation has been hypothesized to contribute to increased prevalence of subclinical atherosclerosis and cardiovascular disease (CVD) risk in patients with chronic HIV infection. In this study, we examined the correlation of peripheral monocyte subsets and soluble biomarkers of inflammation to coronary artery calcium (CAC) progression, as measured by cardiac computed tomography scan. Methods We conducted a longitudinal analysis utilizing baseline data of 78 participants with HIV infection on stable antiretroviral therapy (ART) in the Hawaii Aging with HIV-Cardiovascular study who had available baseline monocyte subset analysis as well as CAC measurement at baseline and at 2-year follow up. Monocyte phenotypes were assessed from cryopreserved blood by flow cytometry and plasma was assayed for soluble biomarkers using antibody-coated beads in a high sensitivity Milliplex Luminex platform. Change in CAC over 2 years was analyzed as the primary outcome variable. Results Of all monocyte subsets and biomarkers tested, higher non-classical monocyte percentage (rho = 0.259, p = 0.022), interleukin (IL)-6 (rho = 0.311, p = 0.012), and monocyte chemoattractant protein (MCP)-1 (rho = 0.524, p = <0.001) were significantly correlated to higher 2-year CAC progression in unadjusted Spearman's correlation. Non-classical monocyte percentage (rho = 0.247, p = 0.039), and MCP-1 (rho = 0.487, p = <0.001), remained significantly correlated to 2-year CAC progression, while IL-6 was not (rho = 0.209, p = 0.120) after adjustment for age, hypertension, diabetes mellitus, total/HDL cholesterol ratio, smoking history, and BMI. Conclusion The percentage of non-classical monocytes and plasma MCP-1 levels were independently associated with CAC progression and may be related to the progression of atherosclerosis and increased CVD risk associated with chronic HIV infection on stable ART.	[Zungsontiporn, Nath; Tello, Raquel R.; Mitchell, Brooks I.; Kallianpur, Kalpana J.; Nakamoto, Beau K.; Ndhlovu, Lishomwa C.; Souza, Scott A.; Shikuma, Cecilia M.; Chow, Dominic C.] Univ Hawaii, John A Burns Sch Med, Dept Med, Hawaii Ctr AIDS, Honolulu, HI 96822 USA; [Zhang, Guangxiang; Mitchell, Brooks I.; Ndhlovu, Lishomwa C.] Univ Hawaii, John A Burns Sch Med, Dept Trop Med, Honolulu, HI 96822 USA; [Nakamoto, Beau K.] Straub Hosp, Honolulu, HI USA; [Keating, Sheila M.; Norris, Philip J.] Blood Syst Res Inst, San Francisco, CA USA; [Norris, Philip J.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Norris, Philip J.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Budoff, Matthew] Harbor UCLA, Los Angeles Biomed Res Inst, Los Angeles, CA USA	University of Hawaii System; University of Hawaii System; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Chow, DC (corresponding author), Univ Hawaii, John A Burns Sch Med, Dept Med, Hawaii Ctr AIDS, Honolulu, HI 96822 USA.	dominicc@hawaii.edu	n, l/AAX-3992-2020; Budoff, Matthew/ABD-5175-2021	Budoff, Matthew/0000-0002-9616-1946; Keating, Sheila/0000-0002-8324-3694; Chow, Dominic/0000-0001-7395-038X; Ndhlovu, Lishomwa/0000-0001-5427-4187	National Institutes of Health [R01HL095135, K23HL088981, U54MD007584]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL088981, R01HL095135] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007584] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	R01HL095135 and K23HL088981 and U54MD007584 are funded by the National Institutes of Health (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Aiello RJ, 1999, ARTERIOSCL THROM VAS, V19, P1518, DOI 10.1161/01.ATV.19.6.1518; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Baker JV, 2014, AIDS, V28, P831, DOI 10.1097/QAD.0000000000000145; Barbour JD, 2014, ATHEROSCLEROSIS, V232, P52, DOI 10.1016/j.atherosclerosis.2013.10.021; Budoff MJ, 2013, J AM COLL CARDIOL, V61, P1231, DOI 10.1016/j.jacc.2012.12.035; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Dawson TC, 1999, ATHEROSCLEROSIS, V143, P205; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Duprez DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044454; Fisher SD, 2006, ATHEROSCLEROSIS, V185, P1, DOI 10.1016/j.atherosclerosis.2005.09.025; Floris-Moore M, 2009, AIDS, V23, P941, DOI 10.1097/QAD.0b013e328329c76b; Ford ES, 2010, AIDS, V24, P1509, DOI 10.1097/QAD.0b013e32833ad914; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Han JY, 2009, JAIDS-J ACQ IMM DEF, V52, P553, DOI 10.1097/QAI.0b013e3181c1d4fe; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hsue PY, 2009, AIDS, V23, P1059, DOI 10.1097/QAD.0b013e32832b514b; Libby P, 2013, SEMIN IMMUNOPATHOL, V35, P553, DOI 10.1007/s00281-013-0387-3; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Lo J, 2010, AIDS, V24, P243, DOI 10.1097/QAD.0b013e328333ea9e; Maniar A, 2013, EUR J PREV CARDIOL, V20, P720, DOI 10.1177/2047487312447843; McKibben RA, 2015, J INFECT DIS, V211, P1219, DOI 10.1093/infdis/jiu594; Parra S, 2010, HIV MED, V11, P225, DOI 10.1111/j.1468-1293.2009.00766.x; Post WS, 2014, ANN INTERN MED, V160, P458, DOI 10.7326/M13-1754; Raggi P, 2004, ARTERIOSCL THROM VAS, V24, P1272, DOI 10.1161/01.ATV.0000127024.40516.ef; Sangiorgi G, 1998, J AM COLL CARDIOL, V31, P126, DOI 10.1016/S0735-1097(97)00443-9; Shikuma CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090330; Shikuma CM, 2014, AIDS RES HUM RETROV, V30, P142, DOI [10.1089/aid.2013.0183, 10.1089/AID.2013.0183]; Shikuma CM, 2012, AIDS RES HUM RETROV, V28, P793, DOI [10.1089/aid.2011.0086, 10.1089/AID.2011.0086]; Tallone T, 2011, J CARDIOVASC TRANSL, V4, P211, DOI 10.1007/s12265-011-9256-4; Thomas G, 2015, NONCLASSICAL PATROLL; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Triant VA, 2009, JAIDS-J ACQ IMM DEF, V51, P268, DOI 10.1097/QAI.0b013e3181a9992c; Ulrich C, 2008, AM J TRANSPLANT, V8, P103, DOI 10.1111/j.1600-6143.2007.02035.x; Westhorpe CLV, 2014, IMMUNOL CELL BIOL, V92, P133, DOI 10.1038/icb.2013.84; Wong KL, 2012, IMMUNOL RES, V53, P41, DOI 10.1007/s12026-012-8297-3; Zawada AM, 2012, IMMUNOBIOLOGY, V217, P1273, DOI 10.1016/j.imbio.2012.07.001; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558; Zungsontiporn N, 2015, HIV CLIN TRIALS, V10, P1	40	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2016	11	2							e0149143	10.1371/journal.pone.0149143	http://dx.doi.org/10.1371/journal.pone.0149143			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6RE	26867220	gold, Green Published, Green Submitted			2022-12-27	WOS:000370050700073
J	Dik, JWH; Dinkelacker, AG; Vemer, P; Lo-Ten-Foe, JR; Lokate, M; Sinha, B; Friedrich, AW; Postma, MJ				Dik, Jan-Willem H.; Dinkelacker, Ariane G.; Vemer, Pepijn; Lo-Ten-Foe, Jerome R.; Lokate, Mariette; Sinha, Bhanu; Friedrich, Alex W.; Postma, Maarten J.			Cost-Analysis of Seven Nosocomial Outbreaks in an Academic Hospital	PLOS ONE			English	Article							NOROVIRUS INFECTION; MANAGEMENT; STANDARDS; IMPACT	Objectives Nosocomial outbreaks, especially with (multi-)resistant microorganisms, are a major problem for health care institutions. They can cause morbidity and mortality for patients and controlling these costs substantial amounts of funds and resources. However, how much is unclear. This study sets out to provide a comparable overview of the costs of multiple outbreaks in a single academic hospital in the Netherlands. Methods Based on interviews with the involved staff, multiple databases and stored records from the Infection Prevention Division all actions undertaken, extra staff employment, use of resources, bed-occupancy rates, and other miscellaneous cost drivers during different outbreaks were scored and quantified into Euros. This led to total costs per outbreak and an estimated average cost per positive patient per outbreak day. Results Seven outbreaks that occurred between 2012 and 2014 in the hospital were evaluated. Total costs for the hospital ranged between (sic)10,778 and (sic)356,754. Costs per positive patient per outbreak day, ranged between (sic)10 and (sic)1,369 (95% CI: (sic)49-(sic)1,042), with a mean of (sic)546 and a median of (sic)519. Majority of the costs (50%) were made because of closed beds. Conclusions This analysis is the first to give a comparable overview of various outbreaks, caused by different microorganisms, in the same hospital and all analyzed with the same method. It shows a large variation within the average costs due to different factors (e.g. closure of wards, type of ward). All outbreaks however cost considerable amounts of efforts and money (up to (sic)356,754), including missed revenue and control measures.	[Dik, Jan-Willem H.; Dinkelacker, Ariane G.; Lo-Ten-Foe, Jerome R.; Lokate, Mariette; Sinha, Bhanu; Friedrich, Alex W.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands; [Dinkelacker, Ariane G.] Univ Tubingen Hosp, Dept Med Microbiol, Tubingen, Germany; [Vemer, Pepijn; Postma, Maarten J.] Univ Groningen, Univ Med Ctr Groningen, Dept Pharm, Unit PharmacoEpidemiol & PharmacoEcon, Groningen, Netherlands; [Vemer, Pepijn; Postma, Maarten J.] Univ Groningen, Univ Med Ctr Groningen, Inst Sci Hlth Aging & HealthcaRE SHARE, NL-9713 AV Groningen, Netherlands; [Vemer, Pepijn; Postma, Maarten J.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9713 AV Groningen, Netherlands	University of Groningen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Groningen; University of Groningen; University of Groningen	Friedrich, AW (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands.	alex.friedrich@umcg.nl	Friedrich, Alex/ABG-9823-2020	Dik, Jan-Willem/0000-0003-3258-8817; Postma, Maarten/0000-0002-6306-3653; Sinha, Bhanu/0000-0003-1634-0010	European Union; German state of North Rhine-Westphalia; German state of Lower Saxony; Dutch province Overijssel via the EurSafety Health-net project [Interreg IVa III-1-01=073]; Dutch province Gelderland via the EurSafety Health-net project [Interreg IVa III-1-01=073]; Dutch province Limburg via the EurSafety Health-net project [Interreg IVa III-1-01=073]	European Union(European Commission); German state of North Rhine-Westphalia; German state of Lower Saxony; Dutch province Overijssel via the EurSafety Health-net project; Dutch province Gelderland via the EurSafety Health-net project; Dutch province Limburg via the EurSafety Health-net project	This work was partly supported by the European Union, the German states of North Rhine-Westphalia and Lower Saxony and the Dutch provinces Overijssel, Gelderland and Limburg via the EurSafety Health-net project [Interreg IVa III-1-01=073]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorholt I, 2004, EUR J CLIN MICROBIOL, V23, P688, DOI 10.1007/s10096-004-1198-1; Bode LGM, 2011, J HOSP INFECT, V79, P198, DOI 10.1016/j.jhin.2011.05.009; Bou R, 2009, J HOSP INFECT, V71, P138, DOI 10.1016/j.jhin.2008.07.018; Christiansen KJ, 2004, INFECT CONT HOSP EP, V25, P384, DOI 10.1086/502410; Fretz R, 2009, WIEN KLIN WOCHENSCHR, V121, P137, DOI 10.1007/s00508-008-1135-x; Gandra S, 2014, CLIN MICROBIOL INFEC, V20, P973, DOI 10.1111/1469-0691.12798; Hakkaart-van Roijen L, 2010, HANDLEIDING KOSTENON; Husereau D, 2013, VALUE HEALTH, V16, P231, DOI 10.1016/j.jval.2013.02.002; Jiang YS, 2016, SURG INFECT, V17, P58, DOI 10.1089/sur.2015.036; Johnston CP, 2007, CLIN INFECT DIS, V45, P534, DOI 10.1086/520666; Navas E, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2289-x; Perencevich EN, 2007, INFECT CONT HOSP EP, V28, P1121, DOI 10.1086/521852; Piednoir E, 2011, CRIT CARE MED, V39, P2672, DOI 10.1097/CCM.0b013e31822827e0; Roberts RR, 2009, CLIN INFECT DIS, V49, P1175, DOI 10.1086/605630; Sadique Z, 2016, J INFECT DIS, V213, pS19, DOI 10.1093/infdis/jiv410; Stone PW, 2005, AM J INFECT CONTROL, V33, P501, DOI 10.1016/j.ajic.2005.04.246; van den Brink R, 2013, END ANTIBIOTICS; WHO, 2014, EV THREAT ANT RES OP; Zingg W, 2005, INFECT CONT HOSP EP, V26, P263, DOI 10.1086/502537	19	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149226	10.1371/journal.pone.0149226	http://dx.doi.org/10.1371/journal.pone.0149226			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863145	Green Published, gold, Green Submitted			2022-12-27	WOS:000370046600163
J	Jeong, D; Han, C; Kang, I; Park, HT; Kim, J; Ryu, H; Gho, YS; Park, J				Jeong, Dayeong; Han, Chungmin; Kang, Inhye; Park, Hyun Taek; Kim, Jiyoon; Ryu, Hayoung; Gho, Yong Song; Park, Jaesung			Effect of Concentrated Fibroblast-Conditioned Media on In Vitro Maintenance of Rat Primary Hepatocyte	PLOS ONE			English	Article							CELL-CELL INTERACTIONS; NONPARENCHYMAL CELLS; LIVER; CULTURE; COCULTURES; SURFACES; ENZYMES	The effects of concentrated fibroblast-conditioned media were tested to determine whether hepatocyte function can be maintained without direct contact between hepatocytes and fibroblasts. Primary rat hepatocytes cultured with a concentrated conditioned media of NIH-3T3 J2 cell line (final concentration of 55 mg/ml) showed significantly improved survival and functions (albumin and urea) compared to those of control groups. They also showed higher expression levels of mRNA, albumin and tyrosine aminotransferase compared to hepatocyte monoculture. The results suggest that culture with concentrated fibroblast-conditioned media could be an easy method for in vitro maintenance of primary hepatocytes. They also could be contribute to understand and analyze co-culture condition of hepatocyte with stroma cells.	[Jeong, Dayeong; Kim, Jiyoon; Park, Jaesung] Pohang Univ Sci & Technol POSTECH, Sch Interdisciplinary Biosci & Bioengn, Pohang, Gyeong Buk, South Korea; [Han, Chungmin; Kang, Inhye; Park, Jaesung] Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, Pohang, Gyeong Buk, South Korea; [Park, Hyun Taek; Gho, Yong Song] Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang, Gyeong Buk, South Korea; [Park, Hyun Taek; Gho, Yong Song] Pohang Univ Sci & Technol POSTECH, Div Mol & Life Sci, Pohang, Gyeong Buk, South Korea; [Ryu, Hayoung] Chadwick Int Sch, Songdo, Incheon, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Park, J (corresponding author), Pohang Univ Sci & Technol POSTECH, Sch Interdisciplinary Biosci & Bioengn, Pohang, Gyeong Buk, South Korea.; Park, J (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, Pohang, Gyeong Buk, South Korea.	jpark@postech.ac.kr			National Research Foundation of Korea (NRF) - Korea government (MSIP) [2011-0030075, 2011-0028845]	National Research Foundation of Korea (NRF) - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2011-0030075, and 2011-0028845). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acikgoz A, 2013, BIOMOLECULES, V3, P242, DOI 10.3390/biom3010242; Auth M K, 1998, Transpl Int, V11 Suppl 1, pS439, DOI 10.1007/s001470050516; Beigel J, 2008, TOXICOL IN VITRO, V22, P171, DOI 10.1016/j.tiv.2007.06.019; Bhatia SN, 1998, J BIOMAT SCI-POLYM E, V9, P1137, DOI 10.1163/156856298X00695; Bhatia SN, 1998, BIOTECHNOL PROGR, V14, P378, DOI 10.1021/bp980036j; Bhatia SN, 1999, FASEB J, V13, P1883, DOI 10.1096/fasebj.13.14.1883; Bierwolf J, 2011, BIOTECHNOL BIOENG, V108, P141, DOI 10.1002/bit.22924; Brieva TA, 2001, BIOTECHNOL BIOENG, V76, P295, DOI 10.1002/bit.10041; Cho CH, 2008, BIOTECHNOL BIOENG, V101, P345, DOI 10.1002/bit.21911; Cho CH, 2007, BIOTECHNOL BIOENG, V97, P188, DOI 10.1002/bit.21225; CORLU A, 1991, J CELL BIOL, V115, P505, DOI 10.1083/jcb.115.2.505; De Smet K, 2001, BIOCHEM PHARMACOL, V61, P1293, DOI 10.1016/S0006-2952(01)00612-8; DONATO MT, 1990, IN VITRO CELL DEV B, V26, P1057; DUNN JCY, 1989, FASEB J, V3, P174, DOI 10.1096/fasebj.3.2.2914628; Evenou F, 2011, BIOTECHNOL PROGR, V27, P1146, DOI 10.1002/btpr.626; Hansen LK, 1999, J CELL SCI, V112, P2971; Hewitt NJ, 2007, DRUG METAB REV, V39, P159, DOI 10.1080/03602530601093489; Hui EE, 2007, P NATL ACAD SCI USA, V104, P5722, DOI 10.1073/pnas.0608660104; Jindal R, 2009, FASEB J, V23, P2288, DOI 10.1096/fj.08-114934; Kang YH, 2004, EXP CELL RES, V293, P239, DOI 10.1016/j.yexcr.2003.10.011; Khetani SR, 2004, HEPATOLOGY, V40, P545, DOI 10.1002/hep.20351; KOIDE N, 1990, EXP CELL RES, V186, P227, DOI 10.1016/0014-4827(90)90300-Y; LANDRY J, 1985, J CELL BIOL, V101, P914, DOI 10.1083/jcb.101.3.914; LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126/science.1079562; Leite SB, 2011, TOXICOL IN VITRO, V25, P825, DOI 10.1016/j.tiv.2011.02.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malarkey DE, 2005, TOXICOL PATHOL, V33, P27, DOI 10.1080/01926230590881826; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; MORIN O, 1986, J CELL PHYSIOL, V129, P103, DOI 10.1002/jcp.1041290115; Morin O, 1988, Revis Biol Celular, V15, P1; SATO Y, 1994, HEPATOLOGY, V19, P1023, DOI 10.1002/hep.1840190430; Tisaoussis J, 2001, LIVER TRANSPLANT, V7, P2, DOI 10.1053/jlts.2001.20845; Uyama N, 2002, J HEPATOL, V36, P590, DOI 10.1016/S0168-8278(02)00023-5; Zinchenko YS, 2006, TISSUE ENG, V12, P751, DOI 10.1089/ten.2006.12.751	34	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148846	10.1371/journal.pone.0148846	http://dx.doi.org/10.1371/journal.pone.0148846			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863621	Green Published, gold			2022-12-27	WOS:000370046600114
J	Lopes, C; Aubert, S; Bourgois-Rocha, F; Barnat, M; Rego, AC; Deglon, N; Perrier, AL; Humbert, S				Lopes, Carla; Aubert, Sophie; Bourgois-Rocha, Fany; Barnat, Monia; Rego, Ana Cristina; Deglon, Nicole; Perrier, Anselme L.; Humbert, Sandrine			Dominant-Negative Effects of Adult-Onset Huntingtin Mutations Alter the Division of Human Embryonic Stem Cells-Derived Neural Cells	PLOS ONE			English	Article							MITOTIC SPINDLE ORIENTATION; MUTANT HUNTINGTIN; CAG REPEAT; DISEASE; DIFFERENTIATION; LINES; PROGENITORS; DERIVATION; EXPANSION; TRANSPORT	Mutations of the huntingtin protein (HTT) gene underlie both adult-onset and juvenile forms of Huntington's disease (HD). HTT modulates mitotic spindle orientation and cell fate in mouse cortical progenitors from the ventricular zone. Using human embryonic stem cells (hESC) characterized as carrying mutations associated with adult-onset disease during pre-implantation genetic diagnosis, we investigated the influence of human HTT and of an adult-onset HD mutation on mitotic spindle orientation in human neural stem cells (NSCs) derived from hESCs. The RNAi-mediated silencing of both HTT alleles in neural stem cells derived from hESCs disrupted spindle orientation and led to the mislocalization of dynein, the p150(Glued) subunit of dynactin and the large nuclear mitotic apparatus (NuMA) protein. We also investigated the effect of the adult-onset HD mutation on the role of HTT during spindle orientation in NSCs derived from HD-hESCs. By combining SNP-targeting allele-specific silencing and gain-of-function approaches, we showed that a 46-glutamine expansion in human HTT was sufficient for a dominant-negative effect on spindle orientation and changes in the distribution within the spindle pole and the cell cortex of dynein, p150(Glued) and NuMA in neural cells. Thus, neural derivatives of disease-specific human pluripotent stem cells constitute a relevant biological resource for exploring the impact of adult-onset HD mutations of the HTT gene on the division of neural progenitors, with potential applications in HD drug discovery targeting HTT-dynein-p150(Glued) complex interactions.	[Lopes, Carla; Barnat, Monia; Humbert, Sandrine] Grenoble Inst Neurosci, Grenoble, France; [Lopes, Carla; Barnat, Monia; Humbert, Sandrine] INSERM, U836, Grenoble, France; [Lopes, Carla; Barnat, Monia; Humbert, Sandrine] Grenoble Alpes Univ, Grenoble, France; [Lopes, Carla; Rego, Ana Cristina] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Lopes, Carla] Univ Coimbra IIIUC, Inst Interdisciplinary Res, Coimbra, Portugal; [Aubert, Sophie] AFM, I STEM, CECS, Corbeil Essonnes, France; [Bourgois-Rocha, Fany; Perrier, Anselme L.] AFM, I STEM, INSERM, U861, Corbeil Essonnes, France; [Bourgois-Rocha, Fany; Perrier, Anselme L.] AFM, I STEM, UEVE U861, Evry, France; [Rego, Ana Cristina] Univ Coimbra, Fac Med, Coimbra, Portugal; [Deglon, Nicole] Lausanne Univ Hosp CHUV, DNC, LNCM, Lausanne, Switzerland	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Universidade de Coimbra; Universidade de Coimbra; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Universidade de Coimbra; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Humbert, S (corresponding author), Grenoble Inst Neurosci, Grenoble, France.; Perrier, AL; Humbert, S (corresponding author), INSERM, U836, Grenoble, France.; Perrier, AL (corresponding author), AFM, I STEM, INSERM, U861, Corbeil Essonnes, France.; Perrier, AL (corresponding author), AFM, I STEM, UEVE U861, Evry, France.	aperrier@istem.fr; sandrine.humbert@ujf-grenoble.fr	Perrier, Anselme L/B-2272-2019; BARNAT, Monia/AAK-6305-2021; Rego, Ana Cristina C/L-4272-2014; Rego, Ana Cristina/AAH-2606-2020; Deglon, Nicole/A-2265-2012; Lopes, Carla/V-6557-2018; Humbert, Sandrine/S-2981-2016	Perrier, Anselme L/0000-0001-7915-1968; Rego, Ana Cristina C/0000-0003-0700-3776; Deglon, Nicole/0000-0003-4475-9476; Lopes, Carla/0000-0002-2543-8821; Humbert, Sandrine/0000-0002-9501-2658	Agence Nationale pour la Recherche - Maladies Rares [ANR-12-SVSE4 HUGE]; DIM-STEM POLE Region Ile de France fellowship; Fondation pour la Recherche Medicale [FRM DEQ20120323715]; INSERM; Canceropole Ile de France [INCA-6517-2013]; laboratoire d'Excellence Revive [ANR-10-LABX-73]; NeurATRIS: A Translational Research Infrastructure for Biotherapies in Neurosciences [Investissement d'Avenir - ANR-11-INBS-0011]; INGESTEM: the National Infrastructure Engineering for Pluripotent and differentiated Stem cells [ANR-11-INBS-0009]; Fundacao para a Ciencia e a Tecnologia [SFRH/BD/51192/2010]; Association Francaise contre les Myopathies (AFM-Telethon)	Agence Nationale pour la Recherche - Maladies Rares(French National Research Agency (ANR)); DIM-STEM POLE Region Ile de France fellowship(Region Ile-de-France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Canceropole Ile de France(Region Ile-de-France); laboratoire d'Excellence Revive; NeurATRIS: A Translational Research Infrastructure for Biotherapies in Neurosciences; INGESTEM: the National Infrastructure Engineering for Pluripotent and differentiated Stem cells; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Association Francaise contre les Myopathies (AFM-Telethon)	This work was supported by Agence Nationale pour la Recherche - Maladies Rares, http://www.agence-nationale-recherche.fr/ (ANR-12-SVSE4 HUGE, S.H.); DIM-STEM POLE Region Ile de France fellowship, http://www.dim-biotherapies.com/ (F.B-R.); Fondation pour la Recherche Medicale, http://www.frm.org/ (FRM DEQ20120323715, equipe labellisee, S.H.); INSERM, http://www.inserm.fr/ (S.H. & A.L.P.); Canceropole Ile de France, http://www.canceropole-idf.fr/ (INCA-6517-2013); the laboratoire d'Excellence Revive, http://www.gouvernement.fr/investissements-d-avenir-cgi/(Investissement d'Avenir; ANR-10-LABX-73, A.L.P.), NeurATRIS: A Translational Research Infrastructure for Biotherapies in Neurosciences, http://www.gouvernement.fr/investissements-d-avenir-cgi/ (Investissement d'Avenir - ANR-11-INBS-0011, A.L.P.); INGESTEM: the National Infrastructure Engineering for Pluripotent and differentiated Stem cells, http://www.gouvernement.fr/investissements-d-avenir-cgi/(Investissement d'Avenir - ANR-11-INBS-0009, A.L.P.). C. Lopes was supported by a PhD fellowship from 'Fundacao para a Ciencia e a Tecnologia', http://www.fct.pt/ (SFRH/BD/51192/2010). I-Stem is part of the Biotherapies Institute for Rare Diseases (BIRD) supported by the Association Francaise contre les Myopathies (AFM-Telethon). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Anne SL, 2007, J NEUROSCI, V27, P7318, DOI 10.1523/JNEUROSCI.1831-07.2007; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bradley CK, 2011, STEM CELLS DEV, V20, P495, DOI 10.1089/scd.2010.0120; Camnasio S, 2012, NEUROBIOL DIS, V46, P41, DOI 10.1016/j.nbd.2011.12.042; Carroll JB, 2011, MOL THER, V19, P2178, DOI 10.1038/mt.2011.201; Caviston JP, 2007, P NATL ACAD SCI USA, V104, P10045, DOI 10.1073/pnas.0610628104; CONNEALLY PM, 1984, AM J HUM GENET, V36, P506; Drouet V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099341; Drouet V, 2009, ANN NEUROL, V65, P276, DOI 10.1002/ana.21569; Elias S, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002142; Elias S, 2014, STEM CELL REP, V2, P491, DOI 10.1016/j.stemcr.2014.02.011; Feyeux M, 2012, HUM MOL GENET, V21, P3883, DOI 10.1093/hmg/dds216; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Godin JD, 2010, NEURON, V67, P392, DOI 10.1016/j.neuron.2010.06.027; Group T. H. D. C. R., 1993, CELL, V72, P971, DOI [10.1016/0092-8674(93)90585-E8458085, DOI 10.1016/0092-8674(93)90585-E8458085]; Heins N, 2004, STEM CELLS, V22, P367, DOI 10.1634/stemcells.22-3-367; Juopperi TA, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-17; Keryer G, 2011, J CLIN INVEST, V121, P4372, DOI 10.1172/JCI57552; Killoran A, 2013, NEUROLOGY, V80, P2022, DOI 10.1212/WNL.0b013e318294b304; Lee JK, 2012, NEUROLOGY, V79, P668, DOI 10.1212/WNL.0b013e3182648b65; Mattis VB, 2015, HUM MOL GENET, V24, P3257, DOI 10.1093/hmg/ddv080; Molina-Calavita M, 2014, J NEUROSCI, V34, P10034, DOI 10.1523/JNEUROSCI.0715-14.2014; Morin X, 2011, DEV CELL, V21, P102, DOI 10.1016/j.devcel.2011.06.012; Nicoleau C, 2013, STEM CELLS, V31, P1763, DOI 10.1002/stem.1462; Nopoulos PC, 2011, BRAIN, V134, P137, DOI 10.1093/brain/awq280; Ooi J, 2014, MOL NEUROBIOL; Pardo R, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-17; PERSICHETTI F, 1995, MOL MED, V1, P374, DOI 10.1007/BF03401575; Rubinsztein DC, 1996, AM J HUM GENET, V59, P16; Shitamukai A, 2012, DEV GROWTH DIFFER, V54, P277, DOI 10.1111/j.1440-169X.2012.01345.x; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; Sousa CM, 2013, J HUNTINGTONS DIS, V2, P395, DOI 10.3233/JHD-130082; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	36	11	11	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148680	10.1371/journal.pone.0148680	http://dx.doi.org/10.1371/journal.pone.0148680			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863614	Green Published, Green Submitted, gold			2022-12-27	WOS:000370046600096
J	Norman, JF; Phillips, F; Cheeseman, JR; Thomason, KE; Ronning, C; Behari, K; Kleinman, K; Calloway, AB; Lamirande, D				Norman, J. Farley; Phillips, Flip; Cheeseman, Jacob R.; Thomason, Kelsey E.; Ronning, Cecilia; Behari, Kriti; Kleinman, Kayla; Calloway, Autum B.; Lamirande, Davora			Perceiving Object Shape from Specular Highlight Deformation, Boundary Contour Deformation, and Active Haptic Manipulation	PLOS ONE			English	Article							SURFACE ORIENTATION; VISUAL-PERCEPTION; SOLID SHAPE; MOTION; DEPTH; DISCRIMINATION; RECOGNITION; CURVATURE; MOVEMENTS; PATTERNS	It is well known that motion facilitates the visual perception of solid object shape, particularly when surface texture or other identifiable features (e. g., corners) are present. Conventional models of structure-from-motion require the presence of texture or identifiable object features in order to recover 3-D structure. Is the facilitation in 3-D shape perception similar in magnitude when surface texture is absent? On any given trial in the current experiments, participants were presented with a single randomly-selected solid object (bell pepper or randomly-shaped "glaven") for 12 seconds and were required to indicate which of 12 (for bell peppers) or 8 (for glavens) simultaneously visible objects possessed the same shape. The initial single object's shape was defined either by boundary contours alone (i. e., presented as a silhouette), specular highlights alone, specular highlights combined with boundary contours, or texture. In addition, there was a haptic condition: in this condition, the participants haptically explored with both hands (but could not see) the initial single object for 12 seconds; they then performed the same shape-matching task used in the visual conditions. For both the visual and haptic conditions, motion (rotation in depth or active object manipulation) was present in half of the trials and was not present for the remaining trials. The effect of motion was quantitatively similar for all of the visual and haptic conditions-e. g., the participants' performance in Experiment 1 was 93.5 percent higher in the motion or active haptic manipulation conditions (when compared to the static conditions). The current results demonstrate that deforming specular highlights or boundary contours facilitate 3-D shape perception as much as the motion of objects that possess texture. The current results also indicate that the improvement with motion that occurs for haptics is similar in magnitude to that which occurs for vision.	[Norman, J. Farley; Cheeseman, Jacob R.; Thomason, Kelsey E.; Ronning, Cecilia; Calloway, Autum B.; Lamirande, Davora] Western Kentucky Univ, Ogden Coll Sci & Engn, Dept Psychol Sci, Bowling Green, KY 42101 USA; [Phillips, Flip; Behari, Kriti; Kleinman, Kayla] Skidmore Coll, Dept Psychol, Saratoga Springs, NY 12866 USA; [Phillips, Flip; Behari, Kriti; Kleinman, Kayla] Skidmore Coll, Neurosci Program, Saratoga Springs, NY 12866 USA	Western Kentucky University; Skidmore College; Skidmore College	Norman, JF (corresponding author), Western Kentucky Univ, Ogden Coll Sci & Engn, Dept Psychol Sci, Bowling Green, KY 42101 USA.	Farley.Norman@wku.edu	Norman, Farley/A-7169-2012	Norman, Farley/0000-0001-5877-1914				BRAUNSTE.ML, 1966, J EXP PSYCHOL, V72, P683, DOI 10.1037/h0023735; BRAUNSTEIN M, 1976, DEPTH PERCEPTION MOT; Bruckstein A, 2005, AUTON ROBOT, V18, P21, DOI 10.1023/B:AURO.0000047302.46654.e3; Dostmohamed H, 2005, EXP BRAIN RES, V164, P387, DOI 10.1007/s00221-005-2262-5; Fleming RW, 2004, J VISION, V4, P798, DOI 10.1167/4.9.10; GIBSON JJ, 1962, PSYCHOL REV, V69, P477, DOI 10.1037/h0046962; GREEN BF, 1961, J EXP PSYCHOL, V62, P272, DOI 10.1037/h0045622; HELLER MA, 1983, J GEN PSYCHOL, V108, P225, DOI 10.1080/00221309.1983.9711496; Helmholtz H., 1925, TREATISE PHYSL OPTIC, V3; HOFFMAN DD, 1986, BIOL CYBERN, V54, P71, DOI 10.1007/BF00320477; Holt RJ, 1997, INT J COMPUT VISION, V23, P5, DOI 10.1023/A:1007966223801; Hughes JF, 2014, COMPUTER GRAPHICS PR; Jao RJ, 2015, NEUROPSYCHOLOGIA, V77, P76, DOI 10.1016/j.neuropsychologia.2015.08.008; Kappers AML, 1996, PERCEPTION, V25, P739, DOI 10.1068/p250739; Koenderink J., 1990, SOLID SHAPE; Koenderink JJ, 1996, J EXP PSYCHOL HUMAN, V22, P869, DOI 10.1037/0096-1523.22.4.869; KOENDERINK JJ, 1980, OPT ACTA, V27, P981, DOI 10.1080/713820338; KOENDERINK JJ, 1976, BIOL CYBERN, V24, P51, DOI 10.1007/BF00365595; KOENDERINK JJ, 1991, J OPT SOC AM A, V8, P377, DOI 10.1364/JOSAA.8.000377; LEDERMAN SJ, 1987, COGNITIVE PSYCHOL, V19, P342, DOI 10.1016/0010-0285(87)90008-9; Norman JF, 2008, ACTA PSYCHOL, V129, P198, DOI 10.1016/j.actpsy.2008.06.002; Norman JF, 2008, PERCEPTION, V37, P185, DOI 10.1068/p5679; Norman JF, 2007, PERCEPT PSYCHOPHYS, V69, P23, DOI 10.3758/BF03194450; Norman JF, 2006, PERCEPTION, V35, P1383, DOI 10.1068/p5504; Norman JF, 2012, EXP BRAIN RES, V222, P321, DOI 10.1007/s00221-012-3220-7; Norman JF, 2009, ACTA PSYCHOL, V131, P1, DOI 10.1016/j.actpsy.2009.01.007; NORMAN JF, 1993, PERCEPT PSYCHOPHYS, V53, P279, DOI 10.3758/BF03205183; Norman JF, 2004, PSYCHOL SCI, V15, P565, DOI 10.1111/j.0956-7976.2004.00720.x; Norman JF, 2004, PERCEPT PSYCHOPHYS, V66, P342, DOI 10.3758/BF03194883; NORMAN JF, 1995, PERCEPT PSYCHOPHYS, V57, P629; NORMAN JF, 1994, J EXP PSYCHOL HUMAN, V20, P343, DOI 10.1037/0096-1523.20.2.343; NORMAN JF, 1992, PERCEPT PSYCHOPHYS, V51, P386, DOI 10.3758/BF03211632; Norman JF, 2000, PERCEPTION, V29, P135, DOI 10.1068/p2994; Norman JF, 2002, PERCEPT PSYCHOPHYS, V64, P1145, DOI 10.3758/BF03194763; Peachey D. R., 1985, Computer Graphics, V19, P279, DOI 10.1145/325165.325246; Perlin K., 1985, Computer Graphics, V19, P287, DOI 10.1145/325165.325247; Phillips F, 2004, PERCEPTION, V33, P837, DOI 10.1068/p5141; Phillips F, 2004, PERCEPTION, V33, P21, DOI 10.1068/p5099; Phillips Flip, 2009, Proceedings of the SPIE - The International Society for Optical Engineering, V7240, DOI 10.1117/12.817167; Phillips F, 2009, ACTA PSYCHOL, V132, P259, DOI 10.1016/j.actpsy.2009.07.010; Phillips F, 2010, SEEING PERCEIVING, V23, P263, DOI 10.1163/187847510X516412; Pont SC, 1999, PERCEPT PSYCHOPHYS, V61, P874, DOI 10.3758/BF03206903; Shreiner D., 2010, OPENGL PROGRAMMING G, V7th; Stilla R, 2008, HUM BRAIN MAPP, V29, P1123, DOI 10.1002/hbm.20456; Todd JT, 2004, TRENDS COGN SCI, V8, P115, DOI 10.1016/j.tics.2004.01.006; TODD JT, 1988, PERCEPT PSYCHOPHYS, V43, P179, DOI 10.3758/BF03214196; TODD JT, 1991, PERCEPT PSYCHOPHYS, V50, P509, DOI 10.3758/BF03207535; TODD JT, 1983, J EXP PSYCHOL HUMAN, V9, P583, DOI 10.1037/0096-1523.9.4.583; ULLMAN S, 1979, PROC R SOC SER B-BIO, V203, P405, DOI 10.1098/rspb.1979.0006; WALLACH H, 1953, J EXP PSYCHOL, V45, P205, DOI 10.1037/h0056880; Wheatstone C., 1838, PHILOS T ROY SOC LON, P371, DOI DOI 10.1098/RSTL.1838.0019	51	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0149058	10.1371/journal.pone.0149058	http://dx.doi.org/10.1371/journal.pone.0149058			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DD6PR	26863531	Green Published, gold			2022-12-27	WOS:000370046600149
J	Xu, J; Sayed, BA; Casas-Ferreira, AM; Srinivasan, P; Heaton, N; Rela, M; Ma, Y; Fuggle, S; Legido-Quigley, C; Jassem, W				Xu, Jin; Sayed, Blayne Amir; Maria Casas-Ferreira, Ana; Srinivasan, Parthi; Heaton, Nigel; Rela, Mohammed; Ma, Yun; Fuggle, Susan; Legido-Quigley, Cristina; Jassem, Wayel			The Impact of Ischemia/Reperfusion Injury on Liver Allografts from Deceased after Cardiac Death versus Deceased after Brain Death Donors	PLOS ONE			English	Article							ENDOTHELIAL-CELL APOPTOSIS; ISCHEMIC RAT-LIVER; MOLECULAR-MECHANISMS; PRESERVATION INJURY; TRANSPLANTATION; REPERFUSION; ACTIVATION; PLATELETS; CERAMIDE; SURVIVAL	Background and aims The shortage of organs for transplantation has led to increased use of organs procured from donors after cardiac death (DCD). The effects of cardiac death on the liver remain poorly understood, however. Using livers obtained from DCD versus donors after brain death (DBD), we aimed to understand how ischemia/reperfusion (I/R) injury alters expression of pro-inflammatory markers ceramides and influences graft leukocyte infiltration. Methods Hepatocyte inflammation, as assessed by ceramide expression, was evaluated in DCD (n = 13) and DBD (n = 10) livers. Allograft expression of inflammatory and cell death markers, and allograft leukocyte infiltration were evaluated from a contemporaneous independent cohort of DCD (n = 22) and DBD (n = 13) livers. Results When examining the differences between transplant stages in each group, C18, C20, C24 ceramides showed significant difference in DBD (p<0.05) and C22 ceramide (p<0.05) were more pronounced for DCD. C18 ceramide is correlated to bilirubin, INR, and creatinine after transplant in DCD. Prior to transplantation, DCD livers have reduced leukocyte infiltration compared to DBD allografts. Following reperfusion, the neutrophil infiltration and platelet deposition was less prevalent in DCD grafts while cell death and recipients levels of serum aspartate aminotransferase (AST) of DCD allografts had significantly increased. Conclusion These data suggest that I/R injury generate necrosis in the absence of a strong inflammatory response in DCD livers with an appreciable effect on early graft function. The long-term consequences of increased inflammation in DBD and increased cell death in DCD allografts are unknown and warrant further investigation.	[Xu, Jin; Sayed, Blayne Amir; Srinivasan, Parthi; Heaton, Nigel; Rela, Mohammed; Ma, Yun; Jassem, Wayel] Univ Coll London Hosp, Liver Transplant Unit, Inst Liver Studies, London, England; [Xu, Jin; Maria Casas-Ferreira, Ana; Legido-Quigley, Cristina] Kings Coll London, Inst Pharmaceut Sci, Fac Life Sci & Med, London WC2R 2LS, England; [Sayed, Blayne Amir] Emory Univ, Dept Transplant Surg, Atlanta, GA 30322 USA; [Maria Casas-Ferreira, Ana] Univ Salamanca, Dept Analyt Chem Nutr & Food Sci, E-37008 Salamanca, Spain; [Fuggle, Susan] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg, Oxford OX3 9DU, England	University College London Hospitals NHS Foundation Trust; University of London; King's College London; University College London; University of London; King's College London; Emory University; University of Salamanca; University of Oxford	Xu, J; Jassem, W (corresponding author), Univ Coll London Hosp, Liver Transplant Unit, Inst Liver Studies, London, England.; Xu, J (corresponding author), Kings Coll London, Inst Pharmaceut Sci, Fac Life Sci & Med, London WC2R 2LS, England.	jin.xu@kcl.ac.uk; wayel.jassem@kcl.ac.uk	Sayed, Blayne Amir/AAF-9501-2019; Heaton, Nigel/AAK-8363-2020; Casas Ferreira, Ana Maria/F-2668-2016	Xu, Jin/0000-0003-3072-1899; Jassem, Wayel/0000-0003-2918-5232; Casas Ferreira, Ana Maria/0000-0002-9640-2797; Sayed, Blayne Amir/0000-0003-3224-8871; Legido-Quigley, Cristina/0000-0002-4018-214X	Roche Organ Transplantation Research Foundation; National Health Service (NHS) Blood & Transplant (BT) Grant [09-11-01-03]; Medical Research Council [MR/J006742/1] Funding Source: researchfish	Roche Organ Transplantation Research Foundation; National Health Service (NHS) Blood & Transplant (BT) Grant; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding was provided by the the following. Roche Organ Transplantation Research Foundation (http://www.rotrf.org/): CLQ. National Health Service (NHS) Blood & Transplant (BT) Grant (09-11-01-03) (http://www.nhsbt.nhs.uk/): YM and WJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abt P, 2003, TRANSPLANTATION, V75, P1659, DOI 10.1097/01.TP.0000062574.18648.7C; Abt PL, 2004, ANN SURG, V239, P87, DOI 10.1097/01.sla.0000103063.82181.2c; Abu-Zidan FM, 1999, EUR J SURG, V165, P383; CYWES R, 1993, HEPATOLOGY, V18, P635, DOI 10.1002/hep.1840180324; Doshi MD, 2007, AM J TRANSPLANT, V7, P122, DOI 10.1111/j.1600-6143.2006.01587.x; Fahy E, 2007, NUCLEIC ACIDS RES, V35, pW606, DOI 10.1093/nar/gkm324; Feng S, 2014, CLIN LIVER DIS, V18, P633, DOI 10.1016/j.cld.2014.05.005; FUGGLE SV, 1993, TRANSPLANTATION, V55, P117, DOI 10.1097/00007890-199301000-00022; Gao WS, 1998, HEPATOLOGY, V27, P1652, DOI 10.1002/hep.510270626; GOMEZ R, 1994, J HEPATOL, V21, P441, DOI 10.1016/S0168-8278(05)80325-3; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Jassem W, 2003, TRANSPLANTATION, V75, P2001, DOI 10.1097/01.TP.0000061605.30685.03; Jassem W, 2006, J BIOENERG BIOMEMBR, V38, P49, DOI 10.1007/s10863-006-9005-6; Jay CL, 2011, ANN SURG, V253, P259, DOI 10.1097/SLA.0b013e318204e658; Kapitulnik J, 2012, FRONT PHARMACOL, V3; Khan NM, 2012, FREE RADICAL BIO MED, V53, P1152, DOI 10.1016/j.freeradbiomed.2012.07.007; Koo DDH, 1999, KIDNEY INT, V56, P1551, DOI 10.1046/j.1523-1755.1999.00657.x; Kotsch K, 2008, ANN SURG, V248, P1042, DOI 10.1097/SLA.0b013e318190e70c; Lang E, 2015, HEPATOLOGY, V61, P275, DOI 10.1002/hep.27338; Leithead JA, 2014, J HEPATOL, V60, P1180, DOI 10.1016/j.jhep.2014.02.019; Mace HS, 2015, CAN J ANESTH, V62, P258, DOI 10.1007/s12630-014-0283-x; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Malhi H, 2008, GASTROENTEROLOGY, V134, P1641, DOI 10.1053/j.gastro.2008.03.002; Matas AJ, 2014, AM J TRANSPLANT, V14, P11, DOI 10.1111/ajt.12579; Mateo R, 2006, AM J TRANSPLANT, V6, P791, DOI 10.1111/j.1600-6143.2006.01243.x; MCKEOWN CMB, 1988, TRANSPLANTATION, V46, P178, DOI 10.1097/00007890-198808000-00001; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Novgorodov Sergei A, 2011, Int J Biochem Mol Biol, V2, P347; Osawa Y, 2005, J BIOL CHEM, V280, P27879, DOI 10.1074/jbc.M503002200; Park JW, 2013, HEPATOLOGY, V57, P525, DOI 10.1002/hep.26015; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10911, DOI 10.1074/jbc.M109.077610; Pratschke J, 1999, TRANSPLANTATION, V67, P343, DOI 10.1097/00007890-199902150-00001; Proitsi P, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2014.127; Sakai T, 2003, TRANSPL INT, V16, P88, DOI 10.1111/j.1432-2277.2003.tb00269.x; Sass DA, 2011, GASTROENTEROL CLIN N, V40, P641, DOI 10.1016/j.gtc.2011.06.007; Sindram D, 2000, GASTROENTEROLOGY, V118, P183, DOI 10.1016/S0016-5085(00)70427-6; Sindram D, 2001, FASEB J, V15, P1230, DOI 10.1096/fj.00-0554fje; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Takada M, 1998, TRANSPLANTATION, V65, P1533, DOI 10.1097/00007890-199806270-00001; Valsecchi M, 2007, J LIPID RES, V48, P417, DOI 10.1194/jlr.M600344-JLR200; van der Hoeven JAB, 1999, TRANSPLANT P, V31, P1006, DOI 10.1016/S0041-1345(98)01877-6; Van der Hoeven JAB, 2001, TRANSPLANTATION, V72, P1632, DOI 10.1097/00007890-200111270-00009; Warnes GR, 2014, GPLOTS VARIOUS R PRO; Weiss S, 2007, AM J TRANSPLANT, V7, P1584, DOI 10.1111/j.1600-6143.2007.01799.x; Whiley L, 2012, ANAL CHEM, V84, P5992, DOI 10.1021/ac300716u; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810	46	26	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2016	11	2							e0148815	10.1371/journal.pone.0148815	http://dx.doi.org/10.1371/journal.pone.0148815			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6PR	26863224	Green Published, gold, Green Submitted			2022-12-27	WOS:000370046600110
J	Kim, SS; Rawat, R; Mwangi, EM; Tesfaye, R; Abebe, Y; Baker, J; Frongillo, EA; Ruel, MT; Menon, P				Kim, Sunny S.; Rawat, Rahul; Mwangi, Edina M.; Tesfaye, Roman; Abebe, Yewelsew; Baker, Jean; Frongillo, Edward A.; Ruel, Marie T.; Menon, Purnima			Exposure to Large-Scale Social and Behavior Change Communication Interventions Is Associated with Improvements in Infant and Young Child Feeding Practices in Ethiopia	PLOS ONE			English	Article							HEALTH EXTENSION PROGRAM; EVALUATION DESIGNS; NUTRITION; IMPACT; PROVISION; COUNTRIES; EDUCATION; GROWTH	Optimal breastfeeding (BF) practices in Ethiopia are far below the government's targets, and complementary feeding practices are poor. The Alive & Thrive initiative aimed to improve infant and young child feeding (IYCF) practices through large-scale implementation of social and behavior change communication interventions in four regions of Ethiopia. The study assessed the effects of the interventions on IYCF practices and anthropometry over time in two regions-Southern Nations, Nationalities and Peoples Region and Tigray. A pre- and post-intervention adequacy evaluation design was used; repeated cross-sectional surveys of households with children aged 0-23.9 mo (n = 1481 and n = 1494) and with children aged 24-59.9 mo (n = 1481 and n = 1475) were conducted at baseline (2010) and endline (2014), respectively. Differences in outcomes over time were estimated using regression models, accounting for clustering and covariates. Plausibility analyses included tracing recall of key messages and promoted foods and dose-response analyses. We observed improvements in most WHO-recommended IYCF indicators. Early BF initiation and exclusive BF increased by 13.7 and 9.4 percentage points (pp), respectively. Differences for timely introduction of complementary foods, minimum dietary diversity (MDD), minimum meal frequency (MMF), minimum acceptable diet (MAD), and consumption of iron-rich foods were 22.2, 3.3, 26.2, 3.5, and 2.7 pp, respectively. Timely introduction and intake of foods promoted by the interventions improved significantly, but anthropometric outcomes did not. We also observed a dose-response association between health post visits and early initiation of BF (OR: 1.8); higher numbers of home visits by community volunteers and key messages recalled were associated with 1.8-4.4 times greater odds of achieving MDD, MMF, and MAD, and higher numbers of radio spots heard were associated with 3 times greater odds of achieving MDD and MAD. The interventions were associated with plausible improvements in IYCF practices, but large gaps in improving children's diets in Ethiopia remain, particularly during complementary feeding.	[Kim, Sunny S.; Mwangi, Edina M.; Ruel, Marie T.] Int Food Policy Res Inst, Poverty Hlth & Nutr Div, Washington, DC 20036 USA; [Rawat, Rahul] Int Food Policy Res Inst, Poverty Hlth & Nutr Div, Dakar, Senegal; [Tesfaye, Roman] Int Food Policy Res Inst, Poverty Hlth & Nutr Div, Addis Ababa, Ethiopia; [Abebe, Yewelsew] Alive & Thrive, FHI 360, Addis Ababa, Ethiopia; [Baker, Jean] Alive & Thrive, FHI 360, Washington, DC USA; [Frongillo, Edward A.] Univ South Carolina, Dept Hlth Promot Educ & Behav, Columbia, SC USA; [Menon, Purnima] Int Food Policy Res Inst, Poverty Hlth & Nutr Div, New Delhi, India	CGIAR; International Food Policy Research Institute (IFPRI); CGIAR; International Food Policy Research Institute (IFPRI); CGIAR; International Food Policy Research Institute (IFPRI); University of South Carolina System; University of South Carolina Columbia; CGIAR; International Food Policy Research Institute (IFPRI)	Kim, SS (corresponding author), Int Food Policy Res Inst, Poverty Hlth & Nutr Div, Washington, DC 20036 USA.	sunny.kim@cgiar.org		Ruel, Marie/0000-0002-9506-348X	Regional Health Bureaus of Tigray; SNNPR; A&T implementing partners; Bill & Melinda Gates Foundation, through Alive Thrive; CGIAR Research Program on Agriculture for Nutrition and Health [A4NH]	Regional Health Bureaus of Tigray; SNNPR; A&T implementing partners; Bill & Melinda Gates Foundation, through Alive Thrive(CGIAR); CGIAR Research Program on Agriculture for Nutrition and Health(CGIAR)	Funding for this evaluation and the implementation of the interventions was provided by the Bill & Melinda Gates Foundation, through Alive & Thrive, managed by FHI360; additional financial support to the evaluation study was provided by the CGIAR Research Program on Agriculture for Nutrition and Health (A4NH), led by the International Food Policy Research Institute (IFPRI).; The support from the Regional Health Bureaus of Tigray and SNNPR, woreda health officials, health extension workers, community health volunteers, and the A&T implementing partners, particularly Integrated Family Health Program (IFHP) and Relief Society of Tigray (REST), were critical for data collection. We gratefully acknowledge data collection by Addis Continental Institute of Public Health (ACIPH), Addis Ababa. We thank all the study participants for sharing their time and information. We also gratefully acknowledge comments on this manuscript from Ellen Piwoz (Bill & Melinda Gates Foundation), Silvia Alayon (A&T and Save the Children), and Kim Winnard (FHI 360).	Abebe Bekele, 2008, Ethiopian Journal of Health Development, V22, P302; Ali D, J NUTR; Alive & Thrive, 2014, IMPROVING CHILD FEED; Baker J, 2013, FOOD NUTR BULL, V34, pS146, DOI 10.1177/15648265130343S202; Banteyerga H, 2011, MEDICC REV, V13, P46, DOI 10.37757/MR2011V13.N3.11; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Bhutta ZA, 2011, LANCET, V378, P378, DOI 10.1016/S0140-6736(11)60897-0; Caulfield Laura E., 1999, Food and Nutrition Bulletin, V20, P183; Central Statistical Agency,, 2012, ETH DEM HLTH SURV 20; Central Statistical Agency, 2014, 2014 ETH MIN HLTH SU; Central statistics agency ORC, 2006, ETH DEM HLTH SURV 20; Cogill B, 2003, ANTHROPOMETRIC INDIC; Daelmans B, 2009, FOOD NUTR BULL, V30, pS256, DOI 10.1177/15648265090302S210; Devereux S., 2000, FOOD INSECURITY ETHI; Dewey KG, 2008, REV ARTICLE SYSTEMAT, P24; Ethiopian Public Health Institute, 2015, ETH NAT NUTR PROGR E; Ethiopian Public Health Institute, 2013, ETH NAT FOOD CONS SU; Federal Democratic Republic of Ethiopia Ministry of Health, 2010, HLTH SECT DEV PROGR; Gillespie S, 2015, ADV NUTR, V6, P440, DOI 10.3945/an.115.008276; Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10; Haroon S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S20; Hoddinott J., 2002, DIETARY DIVERSITY FO; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S24; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S25; Kim SS, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1650-4; Lassi ZS, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S13; Menon P, COMBINING INTE UNPUB; Menon P, 2013, FOOD NUTR BULL, V34, pS195, DOI 10.1177/15648265130343S206; Perez-Escamilla R, 2012, ADV NUTR, V3, P790, DOI 10.3945/an.112.002873; Rawat R, INCORPORATI IN PRESS; REYNOLDS WM, 1982, J CLIN PSYCHOL, V38, P119, DOI 10.1002/1097-4679(198201)38:1<119::AID-JCLP2270380118>3.0.CO;2-I; Sanghvi T, 2013, FOOD NUTR BULL, V34, pS169, DOI 10.1177/15648265130343S204; Sima, 2013, EVALUATION ETHIOPIAS; Sinha B, 2015, ACTA PAEDIATR, V104, P114, DOI 10.1111/apa.13127; Teklehaimanot HD, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-39; White J., 2012, ASSESSING IMPACT CHI; WHO Multicentre Growth Reference Study Group, 2006, PAEDIATRIA CROATIC S; WHO; UNICEF USAID AED UCDAVIS IFPRI, 2008, IND ASS INF YOUNG 2; World Bank, 2014, WORLD DEV IND 2014	39	178	186	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2016	11	10							e0164800	10.1371/journal.pone.0164800	http://dx.doi.org/10.1371/journal.pone.0164800			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ9NV	26881746	Green Published, gold, Green Submitted			2022-12-27	WOS:000386203800035
J	Perez-Cembranos, A; Leon, A; Perez-Mellado, V				Perez-Cembranos, Ana; Leon, Alicia; Perez-Mellado, Valentin			Omnivory of an Insular Lizard: Sources of Variation in the Diet of Podarcis lilfordi (Squamata, Lacertidae)	PLOS ONE			English	Article							PLANT CONSUMPTION; FEEDING ECOLOGY; DRY-WEIGHT; EVOLUTION; SELECTION; ENERGETICS; DIVERSITY; BIOMASS; LENGTH	Through 17 years and from a sample of 7,790 faecal pellets and 26,346 prey items, we studied the diet of the Balearic lizard Podarcis lilfordi in Aire Island (Menorca, Balearic Islands, Spain). We analysed the diet in terms of prey frequencies, as well as by their volume and biomass contributions. The diet of the Balearic lizard was extremely variable through the years, months and areas under study. The dominance of small clumped prey, particularly ants, was confirmed. However, the main contribution by volume corresponded to beetles, with a relevant role for Diplopoda and terrestrial Isopoda during some months and at particular areas of the island. Several prey items were probably captured at the base of shrubs, under stones or inside rock crevices. Therefore, our estimations of electivity would only be reliable for epigeal and flying prey. The capacity of the Balearic lizard to include marine subsidies in its diet, such as coastal crustaceans, is noteworthy. Also, its consumption of carrion from carcasses of gulls and rabbits and leftovers from human visitors is remarkable. Juvenile conspecifics can also be a sporadic food resource, especially during the second half of summer, whereas the consumption of vegetal matter is constant for each whole year. The shifts of vegetal exploitation among areas of the island and months take place according to availability of different plant species at each area or during a given period. Thus, lizards are able to conduct a thorough monitoring of plant phenology, exploiting a large variety of plant species. Omnivory does not imply the indiscriminate inclusion of any edible food in its diet. Rather, the inclusion of several food items means the adoption of a wide range of foraging behaviours adapted to the exploitation of each food resource.	[Perez-Cembranos, Ana; Leon, Alicia; Perez-Mellado, Valentin] Univ Salamanca, Dept Anim Biol, E-37008 Salamanca, Spain	University of Salamanca	Perez-Mellado, V (corresponding author), Univ Salamanca, Dept Anim Biol, E-37008 Salamanca, Spain.	valentin@usal.es	Carvalheiro, Roberto/I-2239-2013; Utsunomiya, Yuri Tani T/K-5214-2013; Carmo, Adriana S/E-4342-2016; Pérez-Cembranos, Ana/H-8542-2015; de Rezende Neves, Haroldo Henrique/F-9521-2012; León, Alicia/ABF-2086-2021; Carvalheiro, Roberto/AAG-2222-2020; MILANESI, Marco/P-7473-2015; Contreras-Castillo, Carmen Josefina/C-4696-2012; AJMONE MARSAN, Paolo/M-2466-2018	Carvalheiro, Roberto/0000-0002-4506-0555; Utsunomiya, Yuri Tani T/0000-0002-6526-8337; Carmo, Adriana S/0000-0002-2712-4789; Pérez-Cembranos, Ana/0000-0002-8296-2283; León, Alicia/0000-0001-5919-1858; Carvalheiro, Roberto/0000-0002-4506-0555; MILANESI, Marco/0000-0001-6244-7455; Contreras Castillo, Carmen Josefina/0000-0002-0554-4694; Solkner, Johann/0000-0002-1517-5829; AJMONE MARSAN, Paolo/0000-0003-3165-4579	Ministerio de Economia y Competitividad [CGL2012-39850-CO2-02]; FEDER funds from the European Union	Ministerio de Economia y Competitividad(Spanish Government); FEDER funds from the European Union(European Commission)	The study was funded by the research project CGL2012-39850-CO2-02 from the Spanish Ministry of Science and Innovation (currently: Ministerio de Economia y Competitividad) co-funded by FEDER funds from the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Angelici FM, 1997, ITAL J ZOOL, V64, P267, DOI 10.1080/11250009709356207; BAUMGARTNER LUTHER L., 1939, JOUR WILDLIFE MANAGEMENT, V3, P266, DOI 10.2307/3796113; BEST TL, 1984, J HERPETOL, V18, P291, DOI 10.2307/1564083; Bowles E, 2011, MOL ECOL RESOUR, V11, P530, DOI 10.1111/j.1755-0998.2010.02974.x; Boyer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075962; Bradley BJ, 2007, AM J PRIMATOL, V69, P699, DOI 10.1002/ajp.20384; BROWN RP, 1992, OECOLOGIA, V91, P500, DOI 10.1007/BF00650322; BROWN RP, 1994, FUNCT ECOL, V8, P427, DOI 10.2307/2390065; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; CALVER MC, 1982, AUST WILDLIFE RES, V9, P293; Canyelles X, 2003, INSECTES ILLES BALEA; Capizzi Dario, 1999, Herpetozoa, V11, P117; Castilla AM, 1996, COPEIA, P991, DOI 10.2307/1447663; CASTILLA AM, 1991, J HERPETOL, V25, P30, DOI 10.2307/1564791; Civantos E, 2013, AFR J HERPETOL, V62, P78, DOI 10.1080/21564574.2013.799101; COLLINS PT, 1992, AM MIDL NAT, V128, P404, DOI 10.2307/2426474; Cooper WE, 2002, J ZOOL, V257, P487, DOI 10.1017/S0952836902001085; Cronquist A., 1988, EVOLUTION CLASSIFICA; Diaz J.A., 1990, Donana Acta Vertebrata, V17, P67; Fialho RF, 2000, J HERPETOL, V34, P325, DOI 10.2307/1565437; Fish FE, 2007, J EXP BIOL, V210, P2811, DOI 10.1242/jeb.004267; Gillon Y, 1967, SECONDARY PRODUCTIVI, V2, P519; Hawlena D, 2009, OECOLOGIA, V161, P411, DOI 10.1007/s00442-009-1375-0; Herrel A, 2004, J EVOLUTION BIOL, V17, P974, DOI 10.1111/j.1420-9101.2004.00758.x; Herrel A, 2008, P NATL ACAD SCI USA, V105, P4792, DOI 10.1073/pnas.0711998105; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hodar JA, 1996, ACTA OECOL, V17, P421; Hodar JA, 1997, MISC ZOOL, V20, P1; Ivlev V.S., 1961, EXPT ECOLOGY FEEDING; JACOBS J, 1974, OECOLOGIA, V14, P413, DOI 10.1007/BF00384581; Johnson MK, 1983, SAE831684 TECH PAP S, P1; Luiselli L, 2006, J TROP ECOL, V22, P91, DOI 10.1017/S0266467405002877; MacArthur R.H., 1967, THEORY ISLAND BIOGEO; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Magnusson WE, 2003, COPEIA, P13, DOI 10.1643/0045-8511(2003)003[0013:UOGFTE]2.0.CO;2; Magurran A.E., 2004, MEASURING BIOL DIVER; Maragou P., 1996, Herpetozoa, V9, P105; MARTIN J, 1993, OIKOS, V66, P318, DOI 10.2307/3544820; Mateo JA, ZOOL ANZ IN PRESS; Monti DM, 2013, BIOL J LINN SOC, V108, P144, DOI 10.1111/j.1095-8312.2012.02019.x; Moore P.D., 1991, BLACKWELL SCI PUBLI; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Ortmann Sylvia, 2006, P397; Ouboter MP, 1981, AMPHIB REPTIL, V2, P243; Pafilis P, 2009, NATURWISSENSCHAFTEN, V96, P1107, DOI 10.1007/s00114-009-0564-3; Pallmann P, 2012, MOL ECOL RESOUR, V12, P1068, DOI 10.1111/1755-0998.12004; Perera A, 2004, REV MENORCA, V86, P159; Perez-Cembranos A, 2015, SALAMANDRA, V51, P63; Perez-Cembranos A, 2015, ANIM COGN, V18, P629, DOI 10.1007/s10071-014-0831-3; Perez-Mellado V, HERPETOFAUNAS MEDITE; Perez-Mellado V., 1989, REV MENORCA, V80, P455; Perez-Mellado V., 1998, FAUNA IBERICA, P272; Perez-Mellado V., 2009, QUADERNS NATURA BALE; Perez-Mellado V., 2007, MAINLAND INSULAR LAC, P133; Perez-Mellado V, 2008, AMPHIBIA-REPTILIA, V29, P49, DOI 10.1163/156853808783431587; Perez-Mellado V, 2011, AMPHIBIA-REPTILIA, V32, P1, DOI 10.1163/017353710X530212; Perez-Mellado Valentin, 1993, Bonner Zoologische Beitraege, V44, P193; Pianka ER, 2003, WINDOWS EVOLUTION DI; POLIS GA, 1985, J HERPETOL, V19, P99, DOI 10.2307/1564425; Provenza Frederick D., 1993, P78; Punt W, 1980, NW EUROPEAN FLORA 2; Quayle A., 1983, British Journal of Herpetology, V6, P309; R Core Team, 2021, R LANGUAGE ENV STAT; Raia P, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-289; Roman P, 1971, TEJIDOS VEGETALES; SADEK RA, 1981, ZOOL J LINN SOC-LOND, V73, P313, DOI 10.1111/j.1096-3642.1981.tb01599.x; SAGE RD, 1982, AM MIDL NAT, V108, P407, DOI 10.2307/2425505; Sagonas K, 2014, BIOL J LINN SOC, V112, P469, DOI 10.1111/bij.12290; SALVADOR A., 1986, HDB REPTILIEN AMPHIB, P83; Scherer R., 2014, SIMBOOT SIMULTANEOUS; Stephens D.W., 1986, pi; Teerink B. J., 2003, HAIR W EUROPEAN MAMM; Valdes B., 1987, ATLAS POLINICO ANDAL; Van Damme R, 1999, J HERPETOL, V33, P663; VANDERPLOEG HA, 1979, ECOL MODEL, V7, P135, DOI 10.1016/0304-3800(79)90004-8; Westfall P.H., 1993, RESAMPLING BASED MUL, V279	77	42	42	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148947	10.1371/journal.pone.0148947	http://dx.doi.org/10.1371/journal.pone.0148947			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871439	Green Published, Green Submitted, gold			2022-12-27	WOS:000370054100078
J	Pereira, AGT; Utsunomiya, YT; Milanesi, M; Torrecilha, RBP; Carmo, AS; Neves, HHR; Carvalheiro, R; Ajmone-Marsan, P; Sonstegard, TS; Solkner, J; Contreras-Castillo, CJ; Garcia, JF				Pereira, Anirene G. T.; Utsunomiya, Yuri T.; Milanesi, Marco; Torrecilha, Rafaela B. P.; Carmo, Adriana S.; Neves, Haroldo H. R.; Carvalheiro, Roberto; Ajmone-Marsan, Paolo; Sonstegard, Tad S.; Solkner, Johann; Contreras-Castillo, Carmen J.; Garcia, Jose F.			Pleiotropic Genes Affecting Carcass Traits in Bos indicus (Nellore) Cattle Are Modulators of Growth	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FACTOR-I CONCENTRATION; LINEAR MIXED MODELS; VISUAL SCORES; EXPRESSION; VARIANTS; ANGUS; PROOPIOMELANOCORTIN; MYOSTATIN; THICKNESS	Two complementary methods, namely Multi-Trait Meta-Analysis and Versatile Gene-Based Test for Genome-wide Association Studies (VEGAS), were used to identify putative pleiotropic genes affecting carcass traits in Bos indicus (Nellore) cattle. The genotypic data comprised over 777,000 single-nucleotide polymorphism markers scored in 995 bulls, and the phenotypic data included deregressed breeding values (dEBV) for weight measurements at birth, weaning and yearling, as well visual scores taken at weaning and yearling for carcass finishing precocity, conformation and muscling. Both analyses pointed to the pleomorphic adenoma gene 1 (PLAG1) as a major pleiotropic gene. VEGAS analysis revealed 224 additional candidates. From these, 57 participated, together with PLAG1, in a network involved in the modulation of the function and expression of IGF1 (insulin like growth factor 1), IGF2 (insulin like growth factor 2), GH1 (growth hormone 1), IGF1R (insulin like growth factor 1 receptor) and GHR (growth hormone receptor), suggesting that those pleiotropic genes operate as satellite regulators of the growth pathway.	[Pereira, Anirene G. T.; Contreras-Castillo, Carmen J.] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Dept Agroind Alimentos & Nutr, Piracicaba, Brazil; [Utsunomiya, Yuri T.; Torrecilha, Rafaela B. P.; Carmo, Adriana S.; Garcia, Jose F.] UNESP Univ Estadual Paulista, Dept Med Vet Prevent & Reprod Anim, Fac Ciencias Agr & Vet, Jaboticabal, SP, Brazil; [Milanesi, Marco; Garcia, Jose F.] UNESP Univ Estadual Paulista, Dept Apoio Prod & Saude Anim, Fac Med Vet & Aracatuba, Aracatuba, SP, Brazil; [Pereira, Anirene G. T.; Utsunomiya, Yuri T.; Milanesi, Marco; Torrecilha, Rafaela B. P.; Carmo, Adriana S.; Garcia, Jose F.] IAEA, Collaborating Ctr Anim Genom & Bioinformat, Aracatuba, SP, Brazil; [Neves, Haroldo H. R.] GenSys Consultores Assoc, Porto Alegre, RS, Brazil; [Carvalheiro, Roberto] UNESP Univ Estadual Paulista, Dept Zootecnia, Fac Ciencias Agr & Vet, Jaboticabal, SP, Brazil; [Ajmone-Marsan, Paolo] Univ Cattolica Sacro Cuore, Piacenza, Italy; [Sonstegard, Tad S.] Recombinetics Inc, St Paul, MN USA; [Solkner, Johann] BOKU Univ Nat Resources & Life Sci, Dept Sustainable Agr Syst, Div Livestock Sci, Vienna, Austria	Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; Catholic University of the Sacred Heart; University of Natural Resources & Life Sciences, Vienna	Garcia, JF (corresponding author), UNESP Univ Estadual Paulista, Dept Med Vet Prevent & Reprod Anim, Fac Ciencias Agr & Vet, Jaboticabal, SP, Brazil.; Garcia, JF (corresponding author), UNESP Univ Estadual Paulista, Dept Apoio Prod & Saude Anim, Fac Med Vet & Aracatuba, Aracatuba, SP, Brazil.; Garcia, JF (corresponding author), IAEA, Collaborating Ctr Anim Genom & Bioinformat, Aracatuba, SP, Brazil.	jfgarcia@fmva.unesp.br	Carvalheiro, Roberto/I-2239-2013; Utsunomiya, Yuri Tani T/K-5214-2013; Carmo, Adriana S/E-4342-2016; Pérez-Cembranos, Ana/H-8542-2015; de Rezende Neves, Haroldo Henrique/F-9521-2012; León, Alicia/ABF-2086-2021; Carvalheiro, Roberto/AAG-2222-2020; MILANESI, Marco/P-7473-2015; Contreras-Castillo, Carmen Josefina/C-4696-2012; AJMONE MARSAN, Paolo/M-2466-2018	Carvalheiro, Roberto/0000-0002-4506-0555; Utsunomiya, Yuri Tani T/0000-0002-6526-8337; Carmo, Adriana S/0000-0002-2712-4789; Pérez-Cembranos, Ana/0000-0002-8296-2283; León, Alicia/0000-0001-5919-1858; Carvalheiro, Roberto/0000-0002-4506-0555; MILANESI, Marco/0000-0001-6244-7455; Contreras Castillo, Carmen Josefina/0000-0002-0554-4694; Solkner, Johann/0000-0002-1517-5829; AJMONE MARSAN, Paolo/0000-0003-3165-4579	National Counsel of Technological and Scientific Development (CNPq) [560922/2010-8, 483590/2010-0]; Sao Paulo Research Foundation (FAPESP) [2014/01095-8, 2013/02552-0]; Gensys Consultores Associados; Recombinetics, Inc	National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Gensys Consultores Associados; Recombinetics, Inc	This research was supported by: National Counsel of Technological and Scientific Development (CNPq-http://www.cnpq.br/) (process 560922/2010-8 and 483590/2010-0); and Sao Paulo Research Foundation (FAPESP-http://www.fapesp.br/) (process 2014/01095-8 and 2013/02552-0). Gensys Consultores Associados and Recombinetics, Inc provided support in the form of salaries for authors HHRN and TSS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adoligbe C, 2012, MOL BIOL REP, V39, P4067, DOI 10.1007/s11033-011-1188-1; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bogdanovich S, 2008, MUSCLE NERVE, V37, P308, DOI 10.1002/mus.20920; Boligon AA, 2011, LIVEST SCI, V135, P238, DOI 10.1016/j.livsci.2010.07.011; Bolormaa S, 2011, J ANIM SCI, V89, P2297, DOI 10.2527/jas.2010-3138; Bolormaa S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004198; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Cancian PH, 2014, SCI AGR, V71, P17, DOI 10.1590/S0103-90162014000100002; Cao JX, 2015, SCI REP-UK, V5, DOI 10.1038/srep13950; Capomaccio S, 2015, BIOINFORMATICS, V31, P2380, DOI 10.1093/bioinformatics/btv144; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen L, 2005, FRONT BIOSCI-LANDMRK, V10, P1961, DOI 10.2741/1671; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Davis ME, 2003, J ANIM SCI, V81, P2164; Davis ME, 1997, J ANIM SCI, V75, P317; DeAtley KL, 2011, J ANIM SCI, V89, P2031, DOI 10.2527/jas.2010-3293; Eppig JT, 2015, NUCLEIC ACIDS RES, V43, pD726, DOI 10.1093/nar/gku967; Fortes M, 2013, EVIDENCE PLEIOTROPIS; Fortes M, 2012, BIOL; Fortes MRS, 2013, ANDROLOGY-US, V1, P644, DOI 10.1111/j.2047-2927.2013.00101.x; Fortes MRS, 2012, ANIM PROD SCI, V52, P143, DOI 10.1071/AN11165; Garrick DJ, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-17; Garrick DJ, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-55; Hartati H, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0229-5; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Karim L, 2011, NAT GENET, V43, P405, DOI 10.1038/ng.814; Keady SM, 2013, J ANIM SCI, V91, P654, DOI 10.2527/jas.2012-5850; Lindholm-Perry AK, 2012, ANIM GENET, V43, P216, DOI 10.1111/j.1365-2052.2011.02232.x; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/nmeth.1681, 10.1038/NMETH.1681]; Listgarten J, 2012, NAT METHODS, V9, P525, DOI 10.1038/nmeth.2037; Littlejohn M, 2012, GENETIC VARIATION PL; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; McPherron Alexandra C., 2010, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V10, P217; Neto LRP, 2012, ANIM GENET, V43, P785, DOI 10.1111/j.1365-2052.2012.02330.x; Neves HHR, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-17; Nishimura S, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-40; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rimbault M, 2013, GENOME RES, V23, P1985, DOI 10.1101/gr.157339.113; Ronnegrard L, 2010, HGLM PACKAGE FITTING, V2; ROSIE R, 1992, J NEUROENDOCRINOL, V4, P625, DOI 10.1111/j.1365-2826.1992.tb00212.x; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Taylor JA, 2007, BIOL REPROD, V76, P524, DOI 10.1095/biolreprod.106.055533; Taylor JF, 2014, AQUACULTURE, V420, pS8, DOI 10.1016/j.aquaculture.2013.02.017; Utsunomiya YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088561; Utsunomiya YT, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-52; Velazquez MA, 2008, DOMEST ANIM ENDOCRIN, V35, P325, DOI 10.1016/j.domaniend.2008.07.002; Versteyhe Soetkin, 2013, Front Endocrinol (Lausanne), V4, P98, DOI 10.3389/fendo.2013.00098; Voz ML, 2000, CANCER RES, V60, P106; Xu Z Y, 2010, Animal, V4, P1541, DOI 10.1017/S1751731110000649; Xue M, 2011, INDIAN J ANIMAL SCI; Yang J, 2014, NAT GENET, V46, P100, DOI 10.1038/ng.2876; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011	55	42	42	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158165	10.1371/journal.pone.0158165	http://dx.doi.org/10.1371/journal.pone.0158165			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	26871439	gold, Green Published, Green Submitted			2022-12-27	WOS:000379508300019
J	Kim, SB; Kang, OH; Lee, YS; Han, SH; Ahn, YS; Cha, SW; Seo, YS; Kong, R; Kwon, DY				Kim, Sung-Bae; Kang, Ok-Hwa; Lee, Young-Seob; Han, Sin-Hee; Ahn, Young-Sup; Cha, Seon-Woo; Seo, Yun-Soo; Kong, Ryong; Kwon, Dong-Yeul			Hepatoprotective Effect and Synergism of Bisdemethoycurcumin against MCD Diet-Induced Nonalcoholic Fatty Liver Disease in Mice	PLOS ONE			English	Article							CURCUMA-LONGA; HEPATIC STEATOSIS; 3T3-L1 ADIPOCYTES; PPAR-GAMMA; STEATOHEPATITIS; ACID; POPULATION; OBESITY; ALPHA; BISDEMETHOXYCURCUMIN	Nonalcoholic fatty liver disease (NAFLD), the hepatic manifestation of the metabolic syndrome, has become one of the most common causes of chronic liver disease over the last decade in developed countries. NAFLD includes a spectrum of pathological hepatic changes, such as steatosis, steatohepatitis, advanced fibrosis, and cirrhosis. Bisdemethoxycurcumin (BDMC) is polyphenolic compounds with a diarylheptanoid skeleton, curcumin close analogues, which is derived from the Curcumae Longae Rhizoma. While the rich bioavailability research of curcumin, BDMC is the poor studies. We investigated whether BDMC has the hepatoprotective effect and combinatory preventive effect with silymarin on methionine choline deficient (MCD)-diet-induced NAFLD in C57BL/6J mice. C57BL/6J mice were divided into five groups of normal (normal diet without any treatment), MCD diet (MCD diet only), MCD + silymarin (SIL) 100 mg/kg group, MCD + BDMC 100 mg/kg group, MCD + SIL 50 mg/kg + BDMC 50 mg/kg group. Body weight, liver weight, liver function tests, histological changes were assessed and quantitative real-time polymerase chain reaction and Western blot analyses were conducted after 4 weeks. Mice lost body weight on the MCD-diet, but BDMC did not lose less than the MCD-diet group. Liver weights decreased from BDMC, but they increased significantly in the MCD-diet groups. All liver function test values decreased from the MCD-diet, whereas those from the BDMC increased significantly. The MCD-diet induced severe hepatic fatty accumulation, but the fatty change was reduced in the BDMC. The BDMC showed an inhibitory effect on liver lipogenesis by reducing associated gene expression caused by the MCD-diet. In all experiments, the combinations of BDMC with SIL had a synergistic effect against MCD-diet models. In conclusion, our findings indicate that BDMC has a potential suppressive effect on NAFLD. Therefore, our data suggest that BDMC may act as a novel and potent therapeutic agent against NAFLD.	[Kim, Sung-Bae; Kang, Ok-Hwa; Seo, Yun-Soo; Kwon, Dong-Yeul] Wonkwang Univ, Wonkwang Oriental Med Res Inst, Dept Oriental Pharm, Coll Pharm, Iksan 570749, Jeonbuk, South Korea; [Lee, Young-Seob; Kong, Ryong] Wonkwang Univ, Profess Grad Sch Oriental Med, Plus Team BK21, Iksan 570749, Jeonbuk, South Korea; [Han, Sin-Hee; Ahn, Young-Sup; Cha, Seon-Woo] RDA, Dept Herbal Crop Res, Natl Inst Hort & Herbal Sci, 92 Bisanro, Eumsung 369873, Chungbuk, South Korea	Wonkwang University; Wonkwang University; National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea; Rural Development Administration (RDA), Republic of Korea	Kwon, DY (corresponding author), Wonkwang Univ, Wonkwang Oriental Med Res Inst, Dept Oriental Pharm, Coll Pharm, Iksan 570749, Jeonbuk, South Korea.	sssimi@wku.ac.kr		Ruel, Marie/0000-0002-9506-348X	Basic Science Research Program through the National Research Foundation (NRF) of Korea - Ministry of Education [NRF-2013R1A1A2064673, 2013060380]; Korea government (MSIP) [20080062484]; Cooperative Research Program for Agriculture Science & Technology Development, Rural Development Administration, Republic of Korea [PJ00962201]	Basic Science Research Program through the National Research Foundation (NRF) of Korea - Ministry of Education; Korea government (MSIP); Cooperative Research Program for Agriculture Science & Technology Development, Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This study was supported by the Basic Science Research Program through the National Research Foundation (NRF) of Korea funded by the Ministry of Education (NRF-2013R1A1A2064673), 2013060380, the Korea government (MSIP) (20080062484), and Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ00962201), Rural Development Administration, Republic of Korea.	Abdelmegeed MA, 2011, J NUTR, V141, P603, DOI 10.3945/jn.110.135210; Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Ahsan H, 1999, CHEM-BIOL INTERACT, V121, P161, DOI 10.1016/S0009-2797(99)00096-4; Alappat L, 2010, NUTR REV, V68, P729, DOI 10.1111/j.1753-4887.2010.00341.x; AMMON HPT, 1991, PLANTA MED, V57, P1, DOI 10.1055/s-2006-960004; Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Begriche K, 2006, MITOCHONDRION, V6, P1, DOI 10.1016/j.mito.2005.10.004; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Chowdhry S, 2010, FREE RADICAL BIO MED, V48, P357, DOI 10.1016/j.freeradbiomed.2009.11.007; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; de Melo CL, 2010, CHEM-BIOL INTERACT, V185, P59, DOI 10.1016/j.cbi.2010.02.028; Ejaz A, 2009, J NUTR, V139, P919, DOI 10.3945/jn.108.100966; Hamaguchi M, 2005, ANN INTERN MED, V143, P722, DOI 10.7326/0003-4819-143-10-200511150-00009; Heikkinen S, 2007, BBA-MOL CELL BIOL L, V1771, P999, DOI 10.1016/j.bbalip.2007.03.006; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hu YC, 2014, J SEP SCI, V37, P404, DOI 10.1002/jssc.201301102; Ip E, 2003, HEPATOLOGY, V38, P123, DOI 10.1053/jhep.2003.50307; Jang HH, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-27; Jayaprakasha GK, 2002, J AGR FOOD CHEM, V50, P3668, DOI 10.1021/jf025506a; Kim DSHL, 2001, NEUROSCI LETT, V303, P57, DOI 10.1016/S0304-3940(01)01677-9; Klover PJ, 2003, DIABETES, V52, P2784, DOI 10.2337/diabetes.52.11.2784; Koteish A, 2002, BEST PRACT RES CL GA, V16, P679, DOI 10.1053/bega.2002.0332; Leclercq IA, 2000, J CLIN INVEST, V105, P1067, DOI 10.1172/JCI8814; Lee YK, 2009, J AGR FOOD CHEM, V57, P305, DOI 10.1021/jf802737z; Li YY, 2013, BIOCHEM PHARMACOL, V86, P1517, DOI 10.1016/j.bcp.2013.08.015; Mesa M. D., 2000, ARS PHARM, V41, P307; Nan YM, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-124; Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719; Oguz A, 2013, EUR REV MED PHARMACO, V17, P457; OSAWA T, 1995, BIOSCI BIOTECH BIOCH, V59, P1609, DOI 10.1271/bbb.59.1609; Ramadori G, 1999, SEMIN LIVER DIS, V19, P141, DOI 10.1055/s-2007-1007106; Rizki G, 2006, J LIPID RES, V47, P2280, DOI 10.1194/jlr.M600198-JLR200; Salamone F, 2012, DIGEST LIVER DIS, V44, P334, DOI 10.1016/j.dld.2011.11.010; Semenkovich CF, 1997, PROG LIPID RES, V36, P43, DOI 10.1016/S0163-7827(97)00003-9; Semwal AD, 1997, J FOOD SCI TECH MYS, V34, P67; Simon A, 1998, CANCER LETT, V129, P111, DOI 10.1016/S0304-3835(98)00092-5; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Suzuki A, 2005, HEPATOLOGY, V41, P64, DOI 10.1002/hep.20543; TODA S, 1985, CHEM PHARM BULL, V33, P1725; Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506; YAO Z, 1990, BIOCHEM CELL BIOL, V68, P552, DOI 10.1139/o90-079; You Y, 2010, FOOD CHEM TOXICOL, V48, P1632, DOI 10.1016/j.fct.2010.03.037; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	44	178	186	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0147745	10.1371/journal.pone.0147745	http://dx.doi.org/10.1371/journal.pone.0147745			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26881746	Green Submitted, Green Published, gold			2022-12-27	WOS:000371219000006
